Citrus Sinensis ID: 001142
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1142 | 2.2.26 [Sep-21-2011] | |||||||
| Q54R82 | 942 | Mitogen-activated protein | no | no | 0.196 | 0.237 | 0.277 | 3e-19 | |
| Q55A09 | 1331 | Probable serine/threonine | no | no | 0.187 | 0.160 | 0.299 | 1e-17 | |
| Q39008 | 608 | Mitogen-activated protein | no | no | 0.216 | 0.406 | 0.314 | 1e-17 | |
| P38692 | 1080 | Serine/threonine-protein | yes | no | 0.179 | 0.189 | 0.307 | 1e-17 | |
| Q54XJ4 | 1495 | Probable serine/threonine | no | no | 0.140 | 0.107 | 0.330 | 2e-17 | |
| Q5R8Z4 | 681 | Serine/threonine-protein | yes | no | 0.179 | 0.301 | 0.269 | 2e-17 | |
| Q9NQU5 | 681 | Serine/threonine-protein | yes | no | 0.179 | 0.301 | 0.269 | 2e-17 | |
| Q55EC7 | 960 | RasGEF domain-containing | no | no | 0.175 | 0.208 | 0.336 | 2e-17 | |
| Q8BTW9 | 593 | Serine/threonine-protein | yes | no | 0.150 | 0.290 | 0.305 | 3e-17 | |
| Q3ULB5 | 682 | Serine/threonine-protein | no | no | 0.152 | 0.255 | 0.293 | 3e-17 |
| >sp|Q54R82|MKKA_DICDI Mitogen-activated protein kinase kinase kinase A OS=Dictyostelium discoideum GN=mkkA PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 98.2 bits (243), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 81/292 (27%), Positives = 128/292 (43%), Gaps = 68/292 (23%)
Query: 837 VRTLKVCGSSAD-EIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHH 895
V+ L++ ++D +++N S E+ ++ +LRH IV G + +L
Sbjct: 198 VKQLEIVDINSDPKLKNMILSFSKEIEVMRSLRHDNIVRYLGTSLDQSFL---------- 247
Query: 896 LLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 955
++F+EY+ GGS+ + + K E + V + + L LH+ I+HRDI
Sbjct: 248 ----SVFLEYIPGGSISSLLGKFGAFSENVIKV-----YTKQILQGLSFLHANSIIHRDI 298
Query: 956 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCV-GTPRWMA 1014
K NILID K +VKL DF C + GI + + GTP WMA
Sbjct: 299 KGANILIDT-------KGIVKLSDFG-----------CSKSFSGIVSQFKSMQGTPYWMA 340
Query: 1015 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDEL 1074
PEV+ K +G DIWS GC+++E+ T Q P+ ++EL
Sbjct: 341 PEVI----KQTGHGRSSDIWSLGCVIVEMATAQPPWSNITEL------------------ 378
Query: 1075 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1126
+ + +A S S P + + +F D C + +P ERP A L
Sbjct: 379 ----AAVMYHIASSNSIPNIP-SHMSQEAF--DFLNLCFKRDPKERPDANQL 423
|
Regulates cell-type differentiation and spatial patterning, required for the proper induction and maintenance of prespore cell differentiation. Dictyostelium discoideum (taxid: 44689) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 5 |
| >sp|Q55A09|Y9963_DICDI Probable serine/threonine-protein kinase DDB_G0272254 OS=Dictyostelium discoideum GN=DDB_G0272254 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 93.2 bits (230), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 79/264 (29%), Positives = 121/264 (45%), Gaps = 50/264 (18%)
Query: 814 EAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIV 873
E GK S + + + D A K + + I+ F+ EV +LG+L+H +V
Sbjct: 1078 EIGKGHFSKVLKGNWKGKDVAVKKLNSNKDKAREEMIQEFK----AEVELLGSLQHPNLV 1133
Query: 874 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKL--- 930
YG+ + NP I ME++ G++ I S+ E+ S+KL
Sbjct: 1134 TCYGYSL----------NP------MCIVMEFLPSGNLFELIH--SKPSEQQQSIKLDST 1175
Query: 931 -ALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSF 989
L IA D+A + LH+++I+HRD+KS N+L+D +K+ D A SF
Sbjct: 1176 LILAIAFDIARGMQHLHTRNIIHRDLKSSNLLMDKHFN-------IKIADLGIARE-TSF 1227
Query: 990 LHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1049
T +GT W APE+LR H+ Y + D++SY +L ELLT + P
Sbjct: 1228 TQTMT-----------TIGTVAWTAPEILR--HES--YNQKADVYSYAIVLYELLTGEEP 1272
Query: 1050 YMGLSELEIHDLI-QMGKRPRLTD 1072
Y G+ + L+ G RP L D
Sbjct: 1273 YQGIPPMNAGILVASKGLRPELPD 1296
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39008|M3K1_ARATH Mitogen-activated protein kinase kinase kinase 1 OS=Arabidopsis thaliana GN=MEKK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 93.2 bits (230), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 101/321 (31%), Positives = 139/321 (43%), Gaps = 74/321 (23%)
Query: 816 GKSVSSSLFRCKFGSADA-AAKVRTLKVCGSSADE-IRNFEYSCLGEVRMLGALRHSCIV 873
G+ S++ G D A K +L GS A E I+ E GE+++L L+H IV
Sbjct: 340 GRGSFGSVYEGISGDGDFFAVKEVSLLDQGSQAQECIQQLE----GEIKLLSQLQHQNIV 395
Query: 874 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALF 933
G + DG+ + IF+E V GS + KL + + SV ++L+
Sbjct: 396 RYRGT--------AKDGSNLY------IFLELVTQGS----LLKLYQRYQLRDSV-VSLY 436
Query: 934 IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC 993
Q + L LH K +HRDIK NIL+D A+G VKL DF A + F
Sbjct: 437 TRQ-ILDGLKYLHDKGFIHRDIKCANILVD-----ANG--AVKLADFGLA-KVSKFNDIK 487
Query: 994 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGL 1053
C GTP WMAPEV+ + YG DIWS GC +LE+ T Q+PY L
Sbjct: 488 S-----------CKGTPFWMAPEVINRKDS-DGYGSPADIWSLGCTVLEMCTGQIPYSDL 535
Query: 1054 SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 1113
++ I G P + D L L+ F++ +C
Sbjct: 536 EPVQALFRIGRGTLPEVPDTL-----------------------SLDARLFIL----KCL 568
Query: 1114 EENPTERPTAGDLYEM-FVAR 1133
+ NP ERPTA +L FV R
Sbjct: 569 KVNPEERPTAAELLNHPFVRR 589
|
Involved in the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6) downstream of bacterial flagellin receptor FLS2. May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). Activates downstream MKK2, MKK4 and MKK5. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|P38692|KIC1_YEAST Serine/threonine-protein kinase KIC1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=KIC1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 92.8 bits (229), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 83/270 (30%), Positives = 120/270 (44%), Gaps = 65/270 (24%)
Query: 821 SSLF-------RCKFGSADAAAKVRTLKVCG-------SSADEIRNFEYSCLGEVRMLGA 866
SSLF R KFG V+T +V S +DE+ + + E++ L +
Sbjct: 20 SSLFKRTEVIGRGKFGVVYKGYNVKTGRVYAIKVLNLDSDSDEVEDVQR----EIQFLAS 75
Query: 867 LRH-SCIVEMYGH--KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGE 923
L+ S I YG K +S W I ME+ GGS+++ + + + E
Sbjct: 76 LKQISNITRYYGSYLKDTSLW----------------IIMEHCAGGSLRSLL-RPGKIDE 118
Query: 924 KHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA 983
K++ V I +++ AL +H +++HRDIK+ N+LI E VKLCDF A
Sbjct: 119 KYIGV-----IMRELLVALKCIHKDNVIHRDIKAANVLITNEGN-------VKLCDFGVA 166
Query: 984 VPL-RSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042
+ ++ L +A GTP WMAPEV+ Y +VDIWS G E
Sbjct: 167 AQVNQTSLRRQTMA-----------GTPYWMAPEVIMEGV---YYDTKVDIWSLGITTYE 212
Query: 1043 LLTLQVPYMGLSELEIHDLIQMGKRPRLTD 1072
+ T PY + L LI K PRL D
Sbjct: 213 IATGNPPYCDVEALRAMQLIIKSKPPRLED 242
|
Protein kinase involved in morphogenesis and cell integrity. Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (taxid: 559292) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54XJ4|Y8901_DICDI Probable serine/threonine-protein kinase DDB_G0278901 OS=Dictyostelium discoideum GN=DDB_G0278901 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 92.4 bits (228), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 67/203 (33%), Positives = 97/203 (47%), Gaps = 42/203 (20%)
Query: 854 EYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKN 913
+ S + E+ +L L H IV Y H +PS+ S I ME+++ GS++
Sbjct: 66 QISLMAEINLLKVLSHHNIVRYYEH------IPSSS--------HSYIVMEFIENGSLEK 111
Query: 914 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 973
I++ E V+V +IAQ V L LH + ++HRDIK+ N+LI DG
Sbjct: 112 IIKRHGLLPESLVTV----YIAQ-VLNGLEYLHRQGVIHRDIKAANLLIS-----TDGS- 160
Query: 974 VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV-- 1031
+KL DF A + D GTP WMAPEV++ + G+
Sbjct: 161 -IKLADFGVATKVSDL--------SSDNPDDTFAGTPYWMAPEVIQ------MQGISTAC 205
Query: 1032 DIWSYGCLLLELLTLQVPYMGLS 1054
D+WS GC ++ELLT PY GL+
Sbjct: 206 DVWSLGCTIIELLTGTPPYFGLA 228
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5R8Z4|PAK6_PONAB Serine/threonine-protein kinase PAK 6 OS=Pongo abelii GN=PAK6 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 92.4 bits (228), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 73/271 (26%), Positives = 121/271 (44%), Gaps = 66/271 (24%)
Query: 858 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 917
EV ++ +H +VEMY + + L + ME+++GG++ + + +
Sbjct: 450 FNEVVIMRDYQHFNVVEMYKSYLVGEEL--------------WVLMEFLQGGALTDIVSQ 495
Query: 918 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 977
+ E+ +V + V AL LH++ ++HRDIKS++IL+ L DG+ VKL
Sbjct: 496 VRLNEEQIATV------CEAVLQALAYLHAQGVIHRDIKSDSILLTL-----DGR--VKL 542
Query: 978 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1037
DF C + +P VGTP WMAPEV+ +LY EVDIWS G
Sbjct: 543 SDFG----------FCAQISKDVPKRKSLVGTPYWMAPEVISR----SLYATEVDIWSLG 588
Query: 1038 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 1097
+++E++ + PY S ++ ++ P+L + H+V+
Sbjct: 589 IMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKN---------SHKVS----------- 628
Query: 1098 ELETLSFLVDVFRRCTEENPTERPTAGDLYE 1128
L D R +P ER TA +L +
Sbjct: 629 -----PVLRDFLERMLVRDPQERATAQELLD 654
|
Serine/threonine protein kinase that plays a role in the regulation of gene transcription. The kinase activity is induced by various effectors including AR or MAP2K6/MAPKK6. Phosphorylates the DNA-binding domain of androgen receptor/AR and thereby inhibits AR-mediated transcription. Inhibits also ESR1-mediated transcription. May play a role in cytoskeleton regulation by interacting with IQGAP1. May protect cells from apoptosis through phosphorylation of BAD. Pongo abelii (taxid: 9601) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9NQU5|PAK6_HUMAN Serine/threonine-protein kinase PAK 6 OS=Homo sapiens GN=PAK6 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 92.4 bits (228), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 73/271 (26%), Positives = 121/271 (44%), Gaps = 66/271 (24%)
Query: 858 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 917
EV ++ +H +VEMY + + L + ME+++GG++ + + +
Sbjct: 450 FNEVVIMRDYQHFNVVEMYKSYLVGEEL--------------WVLMEFLQGGALTDIVSQ 495
Query: 918 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 977
+ E+ +V + V AL LH++ ++HRDIKS++IL+ L DG+ VKL
Sbjct: 496 VRLNEEQIATV------CEAVLQALAYLHAQGVIHRDIKSDSILLTL-----DGR--VKL 542
Query: 978 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1037
DF C + +P VGTP WMAPEV+ +LY EVDIWS G
Sbjct: 543 SDFG----------FCAQISKDVPKRKSLVGTPYWMAPEVISR----SLYATEVDIWSLG 588
Query: 1038 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 1097
+++E++ + PY S ++ ++ P+L + H+V+
Sbjct: 589 IMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKN---------SHKVS----------- 628
Query: 1098 ELETLSFLVDVFRRCTEENPTERPTAGDLYE 1128
L D R +P ER TA +L +
Sbjct: 629 -----PVLRDFLERMLVRDPQERATAQELLD 654
|
Serine/threonine protein kinase that plays a role in the regulation of gene transcription. The kinase activity is induced by various effectors including AR or MAP2K6/MAPKK6. Phosphorylates the DNA-binding domain of androgen receptor/AR and thereby inhibits AR-mediated transcription. Inhibits also ESR1-mediated transcription. May play a role in cytoskeleton regulation by interacting with IQGAP1. May protect cells from apoptosis through phosphorylation of BAD. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55EC7|GEFX_DICDI RasGEF domain-containing serine/threonine-protein kinase X OS=Dictyostelium discoideum GN=gefX PE=2 SV=1 | Back alignment and function description |
|---|
Score = 92.0 bits (227), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 84/250 (33%), Positives = 117/250 (46%), Gaps = 50/250 (20%)
Query: 806 FPSLSSCDEAGKSVSSSLFR-CKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRML 864
F SL ++ GK S+FR C G A K+ AD+ +Y EV ML
Sbjct: 18 FESLEFNEKIGKGSFGSVFRGCYLGLDVAIKKIE-------KADDPEYLKY-IDREVSML 69
Query: 865 GALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG-E 923
+LRH IV G + S L I E+V GG V+ ++K G +
Sbjct: 70 QSLRHPFIVNFSGICVHSSGL--------------YIVTEFVSGGDVRQLLKKTPPIGWD 115
Query: 924 KHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA 983
K VS IA D+A A+V LH+K I+HRD+KS+NIL+D ++ ++LCDF A
Sbjct: 116 KRVS------IAVDLAKAMVFLHAKKIIHRDLKSKNILLDEFQR-------IRLCDFGFA 162
Query: 984 VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043
R T H + GT W+APE+L M Y D++SYG +L EL
Sbjct: 163 ---RMSEQTKKSRHMTM------CGTEGWVAPEILLGMS----YDTSCDVFSYGVVLAEL 209
Query: 1044 LTLQVPYMGL 1053
+T + P + L
Sbjct: 210 ITGRKPGVDL 219
|
Promotes the exchange of Ras-bound GDP by GTP. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8BTW9|PAK4_MOUSE Serine/threonine-protein kinase PAK 4 OS=Mus musculus GN=Pak4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 92.0 bits (227), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 41/213 (19%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
EV ++ RH +VEMY + L + ME+++GG++ + +
Sbjct: 368 EVVIMRDYRHENVVEMYNSYLVGDEL--------------WVVMEFLEGGALTDIVTHTR 413
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
E+ +V LA V AL LH++ ++HRDIKS++IL+ DG+ VKL D
Sbjct: 414 MNEEQIAAVCLA------VLQALAVLHAQGVIHRDIKSDSILLT-----HDGR--VKLSD 460
Query: 980 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039
F C + +P VGTP WMAPE++ + YG EVDIWS G +
Sbjct: 461 FG----------FCAQVSKEVPRRKSLVGTPYWMAPELISRLP----YGPEVDIWSLGVM 506
Query: 1040 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTD 1072
++E++ + PY L+ +I+ PRL +
Sbjct: 507 VIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKN 539
|
Serine/threonine protein kinase that plays a role in a variety of different signaling pathways including cytoskeleton regulation, cell migration, growth, proliferation or cell survival. Activation by various effectors including growth factor receptors or active CDC42 and RAC1 results in a conformational change and a subsequent autophosphorylation on several serine and/or threonine residues. Phosphorylates and inactivates the protein phosphatase SSH1, leading to increased inhibitory phosphorylation of the actin binding/depolymerizing factor cofilin. Decreased cofilin activity may lead to stabilization of actin filaments. Phosphorylates LIMK1, a kinase that also inhibits the activity of cofilin. Phosphorylates integrin beta5/ITGB5 and thus regulates cell motility. Phosphorylates ARHGEF2 and activates the downstream target RHOA that plays a role in the regulation of assembly of focal adhesions and actin stress fibers. Stimulates cell survival by phosphorylating the BCL2 antagonist of cell death BAD. Alternatively, inhibits apoptosis by preventing caspase-8 binding to death domain receptors in a kinase independent manner. Plays a role in cell-cycle progression by controlling levels of the cell-cycle regulatory protein CDKN1A and by phosphorylating RAN. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3ULB5|PAK6_MOUSE Serine/threonine-protein kinase PAK 6 OS=Mus musculus GN=Pak6 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 91.7 bits (226), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 41/215 (19%)
Query: 858 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 917
EV ++ +H +VEMY + + L + ME+++GG++ + I +
Sbjct: 451 FNEVVIMRDYQHLNVVEMYKSYLVGEEL--------------WVLMEFLQGGALTDIISQ 496
Query: 918 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 977
+ E+ +V + V AL LH++ ++HRDIKS++IL+ L DG+ VKL
Sbjct: 497 VRLNEEQIATV------CEAVLQALAYLHAQGVIHRDIKSDSILLTL-----DGR--VKL 543
Query: 978 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1037
DF C + +P VGTP WMAPEV+ +LY EVDIWS G
Sbjct: 544 SDFG----------FCAQISKDVPKRKSLVGTPYWMAPEVISR----SLYATEVDIWSLG 589
Query: 1038 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTD 1072
+++E++ + PY S ++ ++ P+L +
Sbjct: 590 IMVIEMVDGEPPYFSDSPVQAMKRLRDSAPPKLKN 624
|
Serine/threonine protein kinase that plays a role in the regulation of gene transcription. The kinase activity is induced by various effectors including AR or MAP2K6/MAPKK6. Phosphorylates the DNA-binding domain of androgen receptor/AR and thereby inhibits AR-mediated transcription. Inhibits also ESR1-mediated transcription. May play a role in cytoskeleton regulation by interacting with IQGAP1. May protect cells from apoptosis through phosphorylation of BAD. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1142 | ||||||
| 225432806 | 1117 | PREDICTED: uncharacterized protein LOC10 | 0.974 | 0.996 | 0.683 | 0.0 | |
| 255552033 | 1152 | ATP binding protein, putative [Ricinus c | 0.944 | 0.936 | 0.667 | 0.0 | |
| 449433293 | 1131 | PREDICTED: uncharacterized protein LOC10 | 0.972 | 0.982 | 0.601 | 0.0 | |
| 224099855 | 1214 | predicted protein [Populus trichocarpa] | 0.900 | 0.846 | 0.654 | 0.0 | |
| 356534187 | 1109 | PREDICTED: uncharacterized protein LOC10 | 0.964 | 0.992 | 0.609 | 0.0 | |
| 15219675 | 1112 | leucine-rich repeat protein kinase-like | 0.936 | 0.962 | 0.574 | 0.0 | |
| 297843232 | 1115 | leucine-rich repeat family protein [Arab | 0.944 | 0.967 | 0.567 | 0.0 | |
| 356574435 | 1021 | PREDICTED: uncharacterized protein LOC10 | 0.872 | 0.975 | 0.613 | 0.0 | |
| 449525764 | 970 | PREDICTED: uncharacterized protein LOC10 | 0.831 | 0.979 | 0.604 | 0.0 | |
| 218193736 | 1112 | hypothetical protein OsI_13471 [Oryza sa | 0.922 | 0.946 | 0.475 | 0.0 |
| >gi|225432806|ref|XP_002279386.1| PREDICTED: uncharacterized protein LOC100249467 [Vitis vinifera] gi|297737117|emb|CBI26318.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1534 bits (3972), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 783/1146 (68%), Positives = 921/1146 (80%), Gaps = 33/1146 (2%)
Query: 1 MQLTNSVEITQKSPEGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIES 60
MQL +S E+ + E + + +K + + N+ DD S++DVSG+ ++F ++E+
Sbjct: 1 MQLPDSGEVVS------VTEPVKDDQSKPLDAASTGENNADDQSILDVSGRNLEFSVLEN 54
Query: 61 YGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQ 120
+++VEGLYLYKNV NLIP+ +G +L+ LKFF NEINLFP E NL+GLECLQ
Sbjct: 55 C-----ESTVEGLYLYKNVFNLIPQRLGELGRLKMLKFFANEINLFPPEFRNLVGLECLQ 109
Query: 121 IKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLP 180
+K+SSPG+NG L+KL+GLKELEL KVPPRPS LLSEIAGLKCLTKLSVCHFSIRYLP
Sbjct: 110 VKLSSPGLNGLPLHKLRGLKELELCKVPPRPSAFPLLSEIAGLKCLTKLSVCHFSIRYLP 169
Query: 181 PEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDL 240
PEIGCL+NLE LDLSFNKMK LPTEI YL ALISLKVANNKLVELPSGL LQRLENLDL
Sbjct: 170 PEIGCLNNLEDLDLSFNKMKSLPTEISYLSALISLKVANNKLVELPSGLSSLQRLENLDL 229
Query: 241 SNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSA 300
SNNRLTSLGSL+L MHNLQNLNLQYNKLLS CQ+PSWICCNLEGNGKD+ ND+FISSS
Sbjct: 230 SNNRLTSLGSLELVSMHNLQNLNLQYNKLLSCCQIPSWICCNLEGNGKDACNDEFISSSV 289
Query: 301 EMDVYEGPMLENDGNVSFSAESDAGSRHTSSSISTVSSSNSRSLTARKSSKQWKR-HHLQ 359
EMDV E E D ++ + GS +TSSS T SSNSR AR S K WKR ++LQ
Sbjct: 290 EMDVLETTNQEIDESICCN-----GSPNTSSSTLTGPSSNSRCFVARMSQKGWKRRYYLQ 344
Query: 360 QRARQERLNNSRKWRGEGHAQT-SMKEGQRYKSGNLDALASETPSEEASDIIGLDDDDKQ 418
QRARQERLNNSRKW+ E HA+ ++K ++ + G L L E+ +E A DI+ LD+DDKQ
Sbjct: 345 QRARQERLNNSRKWKSEDHAEVLTIKAAEKCEHGKLAVLHPESLAEHAPDIVVLDNDDKQ 404
Query: 419 LLSPEAESENLLFSVEDDKIRSGTGLHVENCSCAGLESTG--KEGNDECSKHDSSSLSTA 476
LLS EAESENLL SVED + G SCA L+S + EC+ D+S S +
Sbjct: 405 LLSEEAESENLLNSVEDAESGPRKG------SCAVLDSIAINQGSKSECNDDDASLSSLS 458
Query: 477 NGATEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKSRKSMGENSNASQKYSSVSFCSIE 536
GA+E++EGSSSE SK+ K+KRHSDRDLDNPKPCK+R+ + E+SN S KYS +S+C+IE
Sbjct: 459 KGASEKNEGSSSEVSKSTPKSKRHSDRDLDNPKPCKARRPVNEHSNLSCKYSKISYCNIE 518
Query: 537 DRLPDGFYDAGRDRPFMQLTGYEQTPHLDSREVILVDRKSDEELDAIALSAQALVLHLKQ 596
DRLPDGFYDAGRDRPFM LT YEQ H DSREVIL+DR+ DEELDAI LSAQALV LKQ
Sbjct: 519 DRLPDGFYDAGRDRPFMPLTVYEQNFHFDSREVILLDRERDEELDAITLSAQALVSQLKQ 578
Query: 597 LNGLTKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTCS 656
LNGLTK+ DNLQIA LLALFVSDHFGGSD+S ++ERTRK+VSGSNY+KPFVC+CS
Sbjct: 579 LNGLTKERKQVTDDNLQIASLLALFVSDHFGGSDKSALIERTRKSVSGSNYQKPFVCSCS 638
Query: 657 TGNSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLL 716
TGN ++ +TS KQ LD VEDIV+SDLCEKSLRSIK++RNS++VPIG++QFGVCRHRAVL+
Sbjct: 639 TGNRNNISTSNKQNLDTVEDIVVSDLCEKSLRSIKARRNSIIVPIGTLQFGVCRHRAVLM 698
Query: 717 KYLCDRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDACRPHDIREEADPEYF 776
KYLCDR+EPPVPCELVRGYLDF PHAWN + K+GDSW+RMIVDACRPHDIREE DPEYF
Sbjct: 699 KYLCDRMEPPVPCELVRGYLDFLPHAWNVVHTKRGDSWVRMIVDACRPHDIREETDPEYF 758
Query: 777 IRYIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAK 836
RYIPL R P ST+S +P +G GSFPSLS+CDE + SSSL +CKFGS +AAAK
Sbjct: 759 CRYIPLSRINVPLSTQS--TPVTG---GSFPSLSACDEIANAPSSSLIQCKFGSVEAAAK 813
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
VR L+VCG S DE+RNFEY CLGEVR+LGAL+HSCIVE+YGH+ISSKW+P++DGN EH +
Sbjct: 814 VRILEVCGDSVDEVRNFEYCCLGEVRILGALKHSCIVEIYGHQISSKWIPASDGNLEHRV 873
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
LQSAI ME+VKGGS+K+Y+EKLSE GEKHV V+LAL IA+DVA+AL ELHSKHI+HRDIK
Sbjct: 874 LQSAILMEHVKGGSLKSYLEKLSEAGEKHVPVELALCIARDVASALAELHSKHIIHRDIK 933
Query: 957 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1016
SENILIDL++K+ADG PVVKLCDFDRAVPLRSFLH+CCIAH GIP PDVCVGTPRWMAPE
Sbjct: 934 SENILIDLDKKRADGTPVVKLCDFDRAVPLRSFLHSCCIAHIGIPPPDVCVGTPRWMAPE 993
Query: 1017 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEA 1076
VLRAMHK +YGLEVDIWSYGCLLLELLTLQVPY LSE + HD +QMGKRP+L +ELEA
Sbjct: 994 VLRAMHKREIYGLEVDIWSYGCLLLELLTLQVPYFELSESQFHDQLQMGKRPQLPEELEA 1053
Query: 1077 LGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSS 1136
LGS E E+AQSG E PE E+E L FLVD+ R CT+ NPT+RPTA +LY+M + +T +
Sbjct: 1054 LGS-QEPEMAQSGKE-EGPETEVEKLGFLVDLVRWCTKGNPTDRPTAENLYKMLLTQTRT 1111
Query: 1137 SISSRS 1142
SSRS
Sbjct: 1112 FTSSRS 1117
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255552033|ref|XP_002517061.1| ATP binding protein, putative [Ricinus communis] gi|223543696|gb|EEF45224.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1458 bits (3775), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 735/1101 (66%), Positives = 867/1101 (78%), Gaps = 22/1101 (1%)
Query: 49 SGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPS 108
+GK++DF Y D+S++GLYLYKNV +L+PKSVG KLR KFFGNE+NLFP
Sbjct: 67 TGKSLDF----DYLLEKADDSLDGLYLYKNVFSLVPKSVGNLGKLRTFKFFGNEVNLFPI 122
Query: 109 EVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTK 168
E GNL+GLE LQ+K+SS G+NG LNKLKGLKELELSK P RPSV T+LSEIAGLKCLTK
Sbjct: 123 EFGNLVGLERLQVKVSSLGLNGLGLNKLKGLKELELSKAPSRPSVFTILSEIAGLKCLTK 182
Query: 169 LSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG 228
LSVCHFSIRYLPPEIGCL+ LE LD+SFNK+K LP EI +L ALISLKVANN+L+ELPS
Sbjct: 183 LSVCHFSIRYLPPEIGCLNKLEYLDISFNKIKSLPIEISHLNALISLKVANNRLMELPSA 242
Query: 229 LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGK 288
L LLQRLENLDLSNNRLTSLGSL L LMHNLQNL+LQ+NKLLS C +P+WICCNLEGNG
Sbjct: 243 LSLLQRLENLDLSNNRLTSLGSLQLGLMHNLQNLDLQHNKLLSCCHIPAWICCNLEGNGL 302
Query: 289 DSSNDDFISSSAEMDVYEGPMLENDGNVSFSAESDAGSRHTSSSISTVSSSNSRSLTARK 348
D SNDD ISSS EMDVYE + + + FS GS++ +SS+ T SNS+ AR+
Sbjct: 303 DLSNDDSISSSVEMDVYETTIQSD--HTKFSCN---GSQNATSSLLTGPPSNSKCFAARR 357
Query: 349 SSKQWKR-HHLQQRARQERLNNSRKWRGEGHAQTSM-KEGQRYKSGNLDALASETPSEEA 406
+K+WKR H+LQQRARQERLNNSRKW+GEG A S KE + KS NLD L SET +
Sbjct: 358 LNKRWKRRHYLQQRARQERLNNSRKWKGEGRADLSTPKESKNCKSDNLDLLTSETCEDGT 417
Query: 407 SDIIGL-----DDDDKQLLSPEAESENLLFSVEDDKIRSGTGLHVENCSCAGLESTGKEG 461
SDIIGL D +DK + S E E+ENLL S +DD++ S G ++++CS ES
Sbjct: 418 SDIIGLVDNNEDKEDKVVPSSEVEAENLLVSGKDDRMNSKKGFYIKSCS-HNPESVSNGE 476
Query: 462 NDECSKHDSSSLSTANGATEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKSRKSMGENS 521
DEC H+ S T NG + +DEGSSSEN+K + K+KRH D LDNPKPCK R+ ++
Sbjct: 477 EDECCVHEKSLALTQNGVSGEDEGSSSENTKFILKSKRHFDGALDNPKPCKCRRPTEDSL 536
Query: 522 NASQKYSSVSFCSIEDRLPDGFYDAGRDRPFMQLTGYEQTPHLDSREVILVDRKSDEELD 581
+ S KYS +SFCS ED LPDGFYDAGRDRPFM L YEQ HLDSREVIL+DR+ DE+LD
Sbjct: 537 SLSHKYSDLSFCSTEDHLPDGFYDAGRDRPFMPLRRYEQILHLDSREVILLDREKDEKLD 596
Query: 582 AIALSAQALVLHLKQLNGLTKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKT 641
A LSAQALV LK+LNG ++G + VD LQIA LLALFVSDHFGGSDRS +ERTRK
Sbjct: 597 ATVLSAQALVCRLKRLNGFFEEGNKDAVDVLQIASLLALFVSDHFGGSDRSFTIERTRKA 656
Query: 642 VSGSNYRKPFVCTCSTGNSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPI 701
VSGSNY+KPFVCTCSTGN +S NTS KQIL + EDIV SDLCEKSLRS+K+KRNS++VP+
Sbjct: 657 VSGSNYKKPFVCTCSTGNDESINTSTKQILGSAEDIVFSDLCEKSLRSVKAKRNSIIVPL 716
Query: 702 GSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDA 761
G++QFGVCRHRA+L KYLCDR++PP+PCELVRGYLDF PHAWNTILVK+GDSW+RM+VDA
Sbjct: 717 GNLQFGVCRHRALLFKYLCDRMDPPIPCELVRGYLDFIPHAWNTILVKRGDSWVRMLVDA 776
Query: 762 CRPHDIREEADPEYFIRYIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDEAGKSVSS 821
CRPHDIREE DPEYF RY+PL T P STES HSP S S S+ DE K+V S
Sbjct: 777 CRPHDIREETDPEYFCRYVPLSHTRVPLSTESIHSPGC-----SITSFSTHDELEKTVLS 831
Query: 822 SLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 881
++ +CKF S +AAAKVRTL++C + DEIRNFEYSC+GEVR+L ALRH CIVE+YGH+IS
Sbjct: 832 TVIQCKFESVEAAAKVRTLEICETPVDEIRNFEYSCIGEVRILRALRHPCIVELYGHQIS 891
Query: 882 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAA 941
SKW+ + DG P H +L+S I ME+VKGGS+K+YIEK+S+T +KHV + AL IA+D++ A
Sbjct: 892 SKWIHAEDGKPPHQILRSTILMEHVKGGSLKSYIEKMSKTSKKHVPMDFALCIARDISCA 951
Query: 942 LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIP 1001
+ +LHSKHI+HRD+KSENILIDL+ K+ADG PVVKLCDFDRAVPLRSFLHTCCIAH GIP
Sbjct: 952 MADLHSKHIIHRDVKSENILIDLDSKRADGMPVVKLCDFDRAVPLRSFLHTCCIAHNGIP 1011
Query: 1002 APDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDL 1061
PDVCVGTPRWMAPEVLRAMHK N YGLEVDIWS+GCLLLELLTLQ+PY GLSE I +L
Sbjct: 1012 PPDVCVGTPRWMAPEVLRAMHKRNPYGLEVDIWSFGCLLLELLTLQIPYSGLSEFHIKEL 1071
Query: 1062 IQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121
+QMG+RP LTDELE L S +E QSGS PEAE ETL FLVD+FRRCTE NP RP
Sbjct: 1072 LQMGERPPLTDELETLVSMNEPVATQSGSDVAAPEAESETLRFLVDLFRRCTEANPASRP 1131
Query: 1122 TAGDLYEMFVARTSSSISSRS 1142
TA ++YE+ + +S+ SSRS
Sbjct: 1132 TAAEIYELLLGCSSAFTSSRS 1152
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449433293|ref|XP_004134432.1| PREDICTED: uncharacterized protein LOC101218031 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1332 bits (3447), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 687/1143 (60%), Positives = 877/1143 (76%), Gaps = 32/1143 (2%)
Query: 1 MQLTNSVEITQKSPEGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIES 60
MQL NS E S E + E +++++ + ++ + ND DD SV+DVSG+ +D +E
Sbjct: 1 MQLINSEETVADSSETGLVESRNLKSSELVSFEDDNGNDADD-SVLDVSGRNLDSNFLE- 58
Query: 61 YGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQ 120
G +SV+GLY+++N NLIPKSVG + +LR LKFFGNEINLFPSE+ N +GLECLQ
Sbjct: 59 ----GSSSSVKGLYVFRNAFNLIPKSVGDFRELRMLKFFGNEINLFPSELKNFVGLECLQ 114
Query: 121 IKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLP 180
+K+SSPG G +L+KLKGLKELELSK+PP+PS +LSEIAGLKCLTKLSVCHFSIR+LP
Sbjct: 115 VKLSSPGFGGLSLHKLKGLKELELSKIPPKPSSFPILSEIAGLKCLTKLSVCHFSIRFLP 174
Query: 181 PEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDL 240
PEIGCL++LE LDLSFNK+K LP+EI YL +LISL+VANNKLVELP L LQ+LENLDL
Sbjct: 175 PEIGCLNSLEYLDLSFNKLKSLPSEIGYLNSLISLRVANNKLVELPPALSSLQKLENLDL 234
Query: 241 SNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGK-DSSNDDFISSS 299
S+NRLTSLGSL+L MH+L+NLNLQYNKLL CQ+PSWICCN EGN + D++N+++ISS+
Sbjct: 235 SSNRLTSLGSLELVSMHSLRNLNLQYNKLLKSCQIPSWICCNFEGNLEYDTANEEWISST 294
Query: 300 AEMDVYEGPMLENDGNVSFSAESDAGSRHTSSSISTVSSSNSRSLTARKSSKQW-KRHHL 358
EMDVYE +N+ + G R+ SS++ S+NSRS +++S K+W +RH+L
Sbjct: 295 VEMDVYEATDQDNENSFPLK-----GMRNISSNLLMGPSTNSRSFASKRSGKRWRRRHYL 349
Query: 359 QQRARQERLNNSRKWRGEGHAQTSMKEGQRYKSGNLD-ALASETPSEEASDIIGLDDDDK 417
QQ+ARQERLN+SRKW+G H T +K + + LD A SET ++S I L D K
Sbjct: 350 QQKARQERLNSSRKWKGVDH-HTEVKIHENQEPERLDSASISETTVGDSSAIDEL-FDSK 407
Query: 418 QLLSPEAESENLLFSVEDDKIRSGTGLHVENCS--CAGLESTGKEGNDECSKHDSSSLST 475
+ AE EN + S E+D VE+CS C T +EC + + T
Sbjct: 408 ETCDVGAERENHIESHENDNFDPKKEFPVEDCSSICDAAAETMTRDENECCETSKTLPLT 467
Query: 476 ANGATEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKSRKSMGENSNASQKYSSVSFCSI 535
NGA +Q EGSSS+ SK K KR S+++LDNPKPCKSRK + +S+ S KY+S SFC++
Sbjct: 468 GNGAHDQ-EGSSSQVSKDNAKLKRCSEKELDNPKPCKSRKPVEYSSSLSCKYNSTSFCNV 526
Query: 536 EDRLPDGFYDAGRDRPFMQLTGYEQTPHLDSREVILVDRKSDEELDAIALSAQALVLHLK 595
ED LPDGFYDAGRDRPFM L YEQ HLDSREVI+V+R+ DE LD+I ++A++LVL LK
Sbjct: 527 EDYLPDGFYDAGRDRPFMPLRNYEQNFHLDSREVIIVNREHDEVLDSITIAAKSLVLRLK 586
Query: 596 QLNGLT--KDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVC 653
Q+N LT +D VI D++ IA LLALFVSDHFGGSDRS +VE+TR+ VSGS Y+KPFVC
Sbjct: 587 QINQLTQERDQVI---DDVYIAQLLALFVSDHFGGSDRSAMVEKTRRVVSGSKYQKPFVC 643
Query: 654 TCSTGNSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRA 713
TCSTG+ D+ +S K +D EDI+ +D+CEKSLRSIK+ RNS++VP+G++QFGVCRHRA
Sbjct: 644 TCSTGDRDNLTSSTKLTVDNYEDILFTDICEKSLRSIKASRNSIIVPLGALQFGVCRHRA 703
Query: 714 VLLKYLCDRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDACRPHDIREEADP 773
+LLKYLCDR+EPPVPCELVRGYLDF PHAWN ILV++G++ +RM+VDACRP+DIREEADP
Sbjct: 704 LLLKYLCDRMEPPVPCELVRGYLDFLPHAWNVILVQRGNTLVRMVVDACRPNDIREEADP 763
Query: 774 EYFIRYIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADA 833
EYF RYIPL R P S SP G+ SFPSLS+CDE K+ SSS+ +CK S +A
Sbjct: 764 EYFCRYIPLSRAKLPISFGVTSSP--GI---SFPSLSNCDEIEKAPSSSVIKCKLASVEA 818
Query: 834 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 893
AAK+R +VC SS +EIRNFE+SCLGEVR+LGAL+HSCIV+MYGH+ISS+W+PS +G P+
Sbjct: 819 AAKLRKREVCESSFEEIRNFEFSCLGEVRILGALKHSCIVQMYGHQISSEWIPSENGKPK 878
Query: 894 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 953
LL+SAIF+E+VKGGS+K+Y++KL + G++HV + LAL +A+DVA+ALVELHSKHI+HR
Sbjct: 879 RRLLRSAIFLEHVKGGSLKSYMDKLYKAGKEHVPMDLALHVARDVASALVELHSKHIIHR 938
Query: 954 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 1013
DIKSENIL+D + +K+DG P+VKLCDFDRAVPLRS LHTCCIAH GIP PDVCVGTPRWM
Sbjct: 939 DIKSENILMDFD-EKSDGVPIVKLCDFDRAVPLRSLLHTCCIAHTGIPPPDVCVGTPRWM 997
Query: 1014 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDE 1073
APEVLRAMH P++YGLEVDIWS+GCLLLELLTLQ+P++GL+EL+I D +QMGKRP L +
Sbjct: 998 APEVLRAMHTPHVYGLEVDIWSFGCLLLELLTLQIPFLGLTELQIFDHLQMGKRPELAGD 1057
Query: 1074 L-EALGSCHEHEVAQSG-SGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFV 1131
L E LG+ + ++QS E E + ET + L+D+FR+CT+ENP +RPTA +L+ + +
Sbjct: 1058 LEEELGTIKQSTMSQSSVQESEGQEKDQETKALLIDLFRKCTQENPNDRPTAEELHRILL 1117
Query: 1132 ART 1134
T
Sbjct: 1118 EHT 1120
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224099855|ref|XP_002311646.1| predicted protein [Populus trichocarpa] gi|222851466|gb|EEE89013.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1310 bits (3391), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 705/1077 (65%), Positives = 822/1077 (76%), Gaps = 49/1077 (4%)
Query: 1 MQLTNSVEITQKS---PEGPIKEKLPSEANKINNEKNGSVNDD---------DDDSVIDV 48
MQ +NS E KS PE P K PS + +D DD+ V+DV
Sbjct: 1 MQPSNSTESNSKSTDNPENPKSPKSPSTEFNATATTVTATSDSSFEKNSENVDDEVVLDV 60
Query: 49 SGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPS 108
GK+++F L+E D+SVEGLYLYKN +L+PKSVG +KLR LKFFGNE+NLFP+
Sbjct: 61 IGKSLEFDLLEK-----ADDSVEGLYLYKNAFSLVPKSVGGLKKLRTLKFFGNEVNLFPA 115
Query: 109 EVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTK 168
E GNL+GLECLQ+K+SSPG+NG + NKLKGLKELELS+VPPRPSVLT+LSEI+G+KCLTK
Sbjct: 116 EFGNLVGLECLQVKVSSPGLNGLSFNKLKGLKELELSRVPPRPSVLTILSEISGIKCLTK 175
Query: 169 LSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG 228
LSVCHFS+RYLPPEIGCLSNLE LDLSFNK+K LP EI YL ALISLKV+NNKLVELPS
Sbjct: 176 LSVCHFSVRYLPPEIGCLSNLEFLDLSFNKIKSLPNEITYLNALISLKVSNNKLVELPSS 235
Query: 229 LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGK 288
L LQ LE+LDLSNNRLTSLGSL+L MHNLQ+LNLQYNKLLS CQ+PSWICCNLEGNGK
Sbjct: 236 LSSLQLLESLDLSNNRLTSLGSLELTSMHNLQHLNLQYNKLLSCCQIPSWICCNLEGNGK 295
Query: 289 DSSNDDFISSSAEMDVYEGPMLENDGNVSFSAESDAGSRHTSSSISTVSSSNSRSLTARK 348
D SND+FISSS EMDVYE E+D S + GS H+ SSI T SSN + R
Sbjct: 296 DLSNDEFISSSVEMDVYETSFQEDDRKFSCN-----GSNHSMSSIVTGPSSNRSFASRRS 350
Query: 349 SSKQWKRHHLQQRARQERLNNSRKWRGEGHAQT-SMKEGQRYKSGNLDALASETPSEEAS 407
S + +RH+LQQ+ARQERLNNSRKW+GEG A+ ++KE + +KS NLD L E S
Sbjct: 351 SKRWKRRHYLQQKARQERLNNSRKWKGEGCAEALALKESESFKSNNLDVLTPEVHEGGTS 410
Query: 408 DIIGLDDDDKQL-LSPEAESENLLFSVEDDKIRSGTGLHVENCSCAGLESTGKEGNDECS 466
D++G+DDD++++ LS EAE ENL SVEDDKI S VE+CSC L S K + C
Sbjct: 411 DVVGVDDDNEKVELSVEAEGENLHTSVEDDKISSKKVFSVESCSC-DLGSINKSEEEVCC 469
Query: 467 KHDSSSLSTANGATEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKSRKSMGENSNASQK 526
D ST + A QDE SSSE SK K+KRH DRD+DNPKPCK R+ ++SN S K
Sbjct: 470 VQDEPLASTRDEAASQDESSSSEKSKITYKSKRHHDRDIDNPKPCKCRRPTEDSSNFSCK 529
Query: 527 YSSVSFCSIEDRLPDGFYDAGRDRPFMQLTGYEQTPHLDSREVILVDRKSDEELDAIALS 586
YS +SFCSIEDRLPDGFYDAGRDRPFM L +EQ LDSREVIL+DR+ DE+LDA+ALS
Sbjct: 530 YSELSFCSIEDRLPDGFYDAGRDRPFMPLRRFEQILPLDSREVILLDREKDEQLDAVALS 589
Query: 587 AQALVLHLKQLNGLTKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSN 646
AQALV K+ NG TK+ VDNLQIA LLALFVSDHFGGSDRSG VERTRK VSGSN
Sbjct: 590 AQALVFRFKRSNGSTKERNKVAVDNLQIASLLALFVSDHFGGSDRSGAVERTRKAVSGSN 649
Query: 647 YRKPFVCTCSTGNSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQF 706
YRKPFVCTC TGN++S + + KQ L+ VEDI+ SDLCE+SLRSIK++R S+V+P+GS+QF
Sbjct: 650 YRKPFVCTCPTGNNESISLAGKQALETVEDIIFSDLCERSLRSIKARRGSIVIPLGSLQF 709
Query: 707 GVCRHRAVLLKYLCDRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDACRPHD 766
GVCRHRA+L+KYLCDR++PPVPCELVRGYLDF PHAWN IL ++GDS +RM+VDAC PHD
Sbjct: 710 GVCRHRALLMKYLCDRMDPPVPCELVRGYLDFMPHAWNVILRRRGDSLVRMVVDACHPHD 769
Query: 767 IREEADPEYFIRYIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDEAGKSVSSSLFRC 826
IREE DPEYF RYIPL RT P STES P SFP++S+ D+ K+ SS+L RC
Sbjct: 770 IREETDPEYFCRYIPLSRTKVPLSTESVPGPGC-----SFPTMSTSDKIEKAGSSTLIRC 824
Query: 827 KFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 886
KFGS +AAAKVRTL+VC +SADEIRNFEY CLGE +SSKW+P
Sbjct: 825 KFGSVEAAAKVRTLEVCEASADEIRNFEYICLGE-------------------LSSKWVP 865
Query: 887 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELH 946
S DGNPE +LQS I MEYV GGS+KNY+E++S+TGEKHV V++AL IA+DVA AL E+H
Sbjct: 866 SEDGNPERRILQSVILMEYVDGGSLKNYLEEVSKTGEKHVPVEMALCIARDVACALAEIH 925
Query: 947 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC 1006
SK I+HRDIKSENILIDL+ +ADG PVVKLCDFDRAVP +SFLHTCCIAHRGI PDVC
Sbjct: 926 SKDIIHRDIKSENILIDLDDTRADGMPVVKLCDFDRAVPRKSFLHTCCIAHRGIAPPDVC 985
Query: 1007 VGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQ 1063
VGTPRWMAPEVLR M K N Y LEVDIWSYGCLLLELLTLQVPY GL E IH+L+Q
Sbjct: 986 VGTPRWMAPEVLRTMDKRNTYALEVDIWSYGCLLLELLTLQVPYAGLPESRIHELLQ 1042
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356534187|ref|XP_003535639.1| PREDICTED: uncharacterized protein LOC100819959 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1294 bits (3349), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 693/1137 (60%), Positives = 839/1137 (73%), Gaps = 36/1137 (3%)
Query: 1 MQLTNSVEITQKSPEGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIES 60
MQL +S E + + P K P N + + DD + +DV+GK+V+FP E+
Sbjct: 1 MQLLHSDEPAPERGDSPEKPDDP------NADTDSLDPGTDDGAALDVTGKSVEFPAAEN 54
Query: 61 YGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQ 120
G+ S E LY+YKNV +LIPKSV R +LR LKFFGNEINLF E GNL LECLQ
Sbjct: 55 AGD-----SAESLYVYKNVYSLIPKSVSRLARLRTLKFFGNEINLFAPEFGNLTALECLQ 109
Query: 121 IKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLP 180
+KISSPG+ G L+ LKGLKELELSK PPRPS +L+EI+GLKCLTKLS+CHFSIRYLP
Sbjct: 110 MKISSPGIGGLQLHTLKGLKELELSKGPPRPSAFPILTEISGLKCLTKLSICHFSIRYLP 169
Query: 181 PEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDL 240
PEIGCL LE LDLSFNKMK LP EI YLK LIS+KVANNKLVELP+ + L RLE LDL
Sbjct: 170 PEIGCLKKLEYLDLSFNKMKTLPAEISYLKGLISMKVANNKLVELPAAMSSLSRLERLDL 229
Query: 241 SNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSA 300
SNNRLTSLGSL+L MH LQ LNLQYNKLL Q+PSWICCN++GN K DD SSS
Sbjct: 230 SNNRLTSLGSLELASMHRLQELNLQYNKLLGIFQIPSWICCNMDGNDKARCKDD-CSSSV 288
Query: 301 EMDVYEGPMLENDGNVSFSAESDAGSRHTSSSISTVSSSNSRSLTARKSSKQWKR-HHLQ 359
EMD+YE END +S G +TSSS+ T SSS+SR +RKS K+WKR HHLQ
Sbjct: 289 EMDLYESNFQENDETLS------DGPHNTSSSMLTSSSSSSRCFASRKSGKRWKRRHHLQ 342
Query: 360 QRARQERLNNSRKWRGEGHAQT--SMKEGQRYKSGNLDALASETPSEEASDIIGLDDDDK 417
Q+ARQERLNNSRKW+ H S K + + N D+LASE+ +E S+ LDD++K
Sbjct: 343 QKARQERLNNSRKWKAVDHDDQLLSKKIHRISEPENHDSLASESCAEIVSENGSLDDNNK 402
Query: 418 QLLSPEAESENLLFSVEDDKIRSGTGLHVENCSCAGLESTGKEGNDECSKHDSSSLSTAN 477
++ S A ++N + + +D++ + E+C E DE + S S
Sbjct: 403 RISSERAVNDNAIDNDNNDEVITEKQFSGEDCCTT-------ESKDE---KEESLCSLDK 452
Query: 478 GATEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKSRKSMGENSNASQKYSSVSFCSIED 537
+EQDE S E + V K+KRH DRDLDNPKPCKSRKS+ +S S KYS +SFC IED
Sbjct: 453 RPSEQDEASCLELLECVSKSKRHLDRDLDNPKPCKSRKSISSSSLLSCKYSKISFCGIED 512
Query: 538 RLPDGFYDAGRDRPFMQLTGYEQTPHLDSREVILVDRKSDEELDAIALSAQALVLHLKQL 597
L DGFYDAGRDR FM L YEQ L SREVIL+DRK DEELDA+ L+AQALV +LK+L
Sbjct: 513 HLSDGFYDAGRDRLFMPLECYEQNHCLASREVILLDRKIDEELDAVMLAAQALVYNLKKL 572
Query: 598 NGLTKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTCST 657
NGL++ G + VDNLQ+A LLALFVSDHFGGSDRSGIVERTRK+VSGSNY KPFVCTCS
Sbjct: 573 NGLSRYGNQDGVDNLQMASLLALFVSDHFGGSDRSGIVERTRKSVSGSNYNKPFVCTCSA 632
Query: 658 GNSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLK 717
G+S S ++ + + + +EDI LS + EKSL SIK +RNS+++PIGSVQ+GVCRHRA+L K
Sbjct: 633 GSSTSISSPTEPVANTIEDITLSKMSEKSLDSIKKRRNSIIIPIGSVQYGVCRHRALLFK 692
Query: 718 YLCDRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDACRPHDIREEADPEYFI 777
YLCD +EPPVPCELVRGYLDF PHAWN IL+K+G +W+RM++DACRP DIREE DPEYF
Sbjct: 693 YLCDHMEPPVPCELVRGYLDFSPHAWNIILIKRGATWVRMLIDACRPLDIREEKDPEYFC 752
Query: 778 RYIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKV 837
RYIPL RT P S+ P SFPSL++CDE S++L +CKFGS +AAAKV
Sbjct: 753 RYIPLNRTTIPISSIGSPGP-----DYSFPSLTTCDELETKASTTLVKCKFGSVEAAAKV 807
Query: 838 RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLL 897
RTL+ GSSAD+I+NFEY+CLGE+R+LGAL+H CIVEMYGH+IS +W SADGNPEH +L
Sbjct: 808 RTLEEQGSSADKIKNFEYNCLGEIRILGALKHPCIVEMYGHQISCQWSVSADGNPEHRVL 867
Query: 898 QSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 957
+SAIFMEYV+GGS+KNY+EKLSE GEKHV V+LAL IA+DV+ AL ELHSKHI+HRDIKS
Sbjct: 868 RSAIFMEYVEGGSLKNYLEKLSEAGEKHVPVELALHIAKDVSCALSELHSKHIIHRDIKS 927
Query: 958 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 1017
ENIL +L+RK+ DG P VKLCDFD AVPLRS LH CCIAH G P P +CVGTPRWMAPEV
Sbjct: 928 ENILFNLDRKRDDGTPTVKLCDFDSAVPLRSTLHVCCIAHAGTPPPCICVGTPRWMAPEV 987
Query: 1018 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEAL 1077
+R M+K N YGLE DIWS+GCLLLE+LTLQ+PY GLS+ D +QMGKRP+LTDEL L
Sbjct: 988 MRTMYKKNSYGLEADIWSFGCLLLEMLTLQIPYSGLSDSHFLDSLQMGKRPQLTDELRVL 1047
Query: 1078 GSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1134
S + + SG EK +A ++ L FLVD+F +C EENP++RPTA ++++M +A T
Sbjct: 1048 SSMNGPTMIPSGEELEKSDAGVDMLKFLVDLFHKCVEENPSKRPTAEEIHKMVLAHT 1104
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15219675|ref|NP_171917.1| leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana] gi|3142291|gb|AAC16742.1| Contains similarity to adenylate cyclase gb|AF012921 from Magnaporthe grisae. EST gb|Z24512 comes from this gene [Arabidopsis thaliana] gi|20466532|gb|AAM20583.1| unknown protein [Arabidopsis thaliana] gi|34365545|gb|AAQ65084.1| At1g04210 [Arabidopsis thaliana] gi|332189549|gb|AEE27670.1| leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1225 bits (3169), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 631/1098 (57%), Positives = 795/1098 (72%), Gaps = 28/1098 (2%)
Query: 41 DDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFG 100
+DDSV+DVSG+ ++F L+++ D+SV+GLY ++NV NLIPKS+G +LR LKFF
Sbjct: 34 EDDSVVDVSGQNLEFSLLDNV-----DDSVKGLYFFRNVFNLIPKSIGGLGRLRKLKFFS 88
Query: 101 NEINLFPSEVGNLLGLECLQIKISSPGV-NGFALNKLKGLKELELSKVPPRPSVLTLLSE 159
NEI+LFP E+GNL+ LE LQ+KISSPG +G + +KLKGLKELEL+KVP R S LTLLSE
Sbjct: 89 NEIDLFPPELGNLVNLEYLQVKISSPGFGDGLSWDKLKGLKELELTKVPKRSSALTLLSE 148
Query: 160 IAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVAN 219
I+GLKCLT+LSVCHFSIRYLPPEIGCL +LE LDLSFNK+K LP EI YL +L LKVA+
Sbjct: 149 ISGLKCLTRLSVCHFSIRYLPPEIGCLKSLEYLDLSFNKIKSLPNEIGYLSSLTFLKVAH 208
Query: 220 NKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWI 279
N+L+EL L LLQ LE+LD+SNNRLT+L LDL LM LQ LNL+YNKL SYC +P+WI
Sbjct: 209 NRLMELSPVLALLQNLESLDVSNNRLTTLHPLDLNLMPRLQILNLRYNKLPSYCWIPTWI 268
Query: 280 CCNLEGNGKDSSNDDFISSSAEMDVYEGPMLENDGNVSFSAESDAGSRHTSSSISTVSSS 339
CN EGN ++ D SS EMDV+E P N V GS ++ST SS
Sbjct: 269 QCNFEGNYEEMGVDTCSSSMVEMDVFETPYENNVITVPHK-----GSHRNPLNMSTGISS 323
Query: 340 NSRSLTARKSSKQWKR--HHLQQRARQERLNNSRKWRGEGHAQTSMKEGQRYKSGNLDAL 397
SR +ARKSSK+WKR ++ QQRARQERLNNSRKW+GE + + + ++G
Sbjct: 324 ISRCFSARKSSKRWKRRQYYFQQRARQERLNNSRKWKGEVPPEGLSLKMEVEETGKQGMK 383
Query: 398 ASETPSEEASDIIGLDDDDKQLLSPEAESENLLFSVEDDKIRSGTGLHVENCSCAGLEST 457
+ + D D++DK E + + E+++ + +N C + T
Sbjct: 384 VPQNTDRGSVDNSCSDENDKLF------EEASVITSEEEESSLKADVVSDNSQCVETQLT 437
Query: 458 GKEGNDECSKHDSSSLSTANGATEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKSRKSM 517
+ N E + +SS S+ + D SSSE K K+KR S++ LDNPK K K
Sbjct: 438 SERDNYESCEIKTSSPSSGDAPGTVDYNSSSERKKPNNKSKRCSEKYLDNPKGSKCHKLS 497
Query: 518 GENSNASQKYSSVSFCSIEDRLPDGFYDAGRDRPFMQLTGYEQTPHLDSREVILVDRKSD 577
+ +N S+KYSS SFCS ED LPDGF+DAGRDRPFM L+ YE+ LDSREVIL+DR D
Sbjct: 498 TDITNLSRKYSSNSFCSTEDSLPDGFFDAGRDRPFMTLSKYEKVLPLDSREVILLDRAKD 557
Query: 578 EELDAIALSAQALVLHLKQLNGLTKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVER 637
E LDAI LSA+ALV LK+LN LT D +DNLQ+A LALFVSDHFGGSDR+ I+ER
Sbjct: 558 EVLDAITLSARALVARLKKLNCLTPDVDQVSIDNLQVASFLALFVSDHFGGSDRTAIIER 617
Query: 638 TRKTVSGSNYRKPFVCTCSTGNSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSV 697
TRK VSG+NY+KPF+CTC TGN D KQ+ ED +LSD+CEKSLRSIKSKRNS+
Sbjct: 618 TRKAVSGTNYQKPFICTCLTGNQDDLAALNKQVSTTAEDAILSDVCEKSLRSIKSKRNSI 677
Query: 698 VVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRM 757
VVP+G +QFG+CRHRA+L+KYLCDR+EPPVPCELVRGYLDF PHAWN + VK+G SW+RM
Sbjct: 678 VVPLGKLQFGICRHRALLMKYLCDRMEPPVPCELVRGYLDFMPHAWNIVPVKQGSSWVRM 737
Query: 758 IVDACRPHDIREEADPEYFIRYIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDEAGK 817
+VDACRPHDIRE+ D EYF RYIPL R + L+PG S S + +
Sbjct: 738 VVDACRPHDIREDTDQEYFCRYIPLNRLNESIRIKEK------LEPGCSVSSLSTGKGVE 791
Query: 818 SVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 877
+SSL RCK GS +A K+RTL+V G+S D+IR FEY+CLGEVR+LGAL+H CIVE+YG
Sbjct: 792 RANSSLIRCKLGSTEAVVKMRTLEVSGASLDDIRTFEYTCLGEVRILGALKHDCIVELYG 851
Query: 878 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQD 937
H+ISSKW+ S +GN EH +LQS+I ME++KGGS+K +IEKLSE G+ HV + LAL IA+D
Sbjct: 852 HEISSKWITSENGN-EHRVLQSSILMEHIKGGSLKGHIEKLSEAGKHHVPMDLALSIARD 910
Query: 938 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 997
++ AL+ELHSK I+HRDIKSEN+LIDL+ + A+G+P+VKLCDFDRAVPLRS LH CCIAH
Sbjct: 911 ISGALMELHSKDIIHRDIKSENVLIDLDNQSANGEPIVKLCDFDRAVPLRSHLHGCCIAH 970
Query: 998 RGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE 1057
GIP P++CVGTPRWM+PEV RAMH+ N YGLEVDIWS+GCL+ ELLTLQ PY LSEL+
Sbjct: 971 VGIPPPNICVGTPRWMSPEVFRAMHEQNFYGLEVDIWSFGCLIFELLTLQNPYFDLSELQ 1030
Query: 1058 IHDLIQMGKRPRLTDELEALGSCHEHEVAQS--GSGFEKPEAELETLSFLVDVFRRCTEE 1115
IH+ +Q GKRP+L +LE L S E E + + F+ E++L+T+ FL+DVF +CTEE
Sbjct: 1031 IHESLQNGKRPKLPKKLETLISETEEEESTNKLSEVFDLTESDLDTMRFLIDVFHQCTEE 1090
Query: 1116 NPTERPTAGDLYEMFVAR 1133
+P++R AGDL+EM ++R
Sbjct: 1091 SPSDRLNAGDLHEMILSR 1108
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297843232|ref|XP_002889497.1| leucine-rich repeat family protein [Arabidopsis lyrata subsp. lyrata] gi|297335339|gb|EFH65756.1| leucine-rich repeat family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1218 bits (3151), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 626/1104 (56%), Positives = 792/1104 (71%), Gaps = 25/1104 (2%)
Query: 36 SVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRN 95
SV +D+SV+DVSG+ ++F L+++ D+SV+GLY ++NV NL+PKS+G +LR
Sbjct: 29 SVISLEDESVVDVSGQNLEFSLLDNV-----DDSVKGLYFFRNVFNLLPKSIGGLGRLRK 83
Query: 96 LKFFGNEINLFPSEVGNLLGLECLQIKISSPGV-NGFALNKLKGLKELELSKVPPRPSVL 154
LKFF NEI+LFP E+GNL+ LE LQ+KISSPG +G + +KLKGLKELEL+KVP R S L
Sbjct: 84 LKFFSNEIDLFPPELGNLVNLEYLQVKISSPGFGDGLSWDKLKGLKELELTKVPKRSSAL 143
Query: 155 TLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALIS 214
TLLSEI+GLKCLT+LSVCHFSIRYLP EIGCL +LE LDLSFNK+K LP EI YL +L
Sbjct: 144 TLLSEISGLKCLTRLSVCHFSIRYLPAEIGCLKSLEYLDLSFNKIKSLPNEIGYLSSLTF 203
Query: 215 LKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQ 274
LKVA+N+L+EL L LLQ LE+LD+SNNRLT+L LDL LM LQ LNL+YNKL SYC
Sbjct: 204 LKVAHNRLMELSPALALLQNLESLDVSNNRLTNLHPLDLSLMPRLQILNLRYNKLPSYCW 263
Query: 275 VPSWICCNLEGNGKDSSNDDFISSSAEMDVYEGPMLENDGNVSFSAESDAGSRHTSSSIS 334
+P+WI CNLEGN ++ D SS EMDV+E P N V GS ++S
Sbjct: 264 IPTWIHCNLEGNYEEMGVDTCSSSMVEMDVFETPYENNTITVPHK-----GSHRNPLNMS 318
Query: 335 TVSSSNSRSLTARKSSKQWKR--HHLQQRARQERLNNSRKWRGEGHAQTSMKEGQRYKSG 392
T SS SR +ARKSSK+WKR H+ QQRARQERLNNSRKW+GE + + ++G
Sbjct: 319 TGISSISRCFSARKSSKRWKRRQHYFQQRARQERLNNSRKWKGEVPPGGLSLKMEVEETG 378
Query: 393 NLDALASETPSEEASDIIGLDDDDKQLLSPEAESENLLFSVEDDKIRSGTGLHVENCSCA 452
E + D D+DK L E+ + E+++ +N
Sbjct: 379 KQGMKVPENTDRGSVDSTYSGDNDKLL----EEASVITSEEEEEESSLKAKFASDNSRFV 434
Query: 453 GLESTGKEGNDECSKHDSSSLSTANGATEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCK 512
+ T + N+E + +SS S+ + D SSSE K K+KR S++ LDNPK K
Sbjct: 435 ETQLTSERDNNESCEIKASSPSSGDAPGTADYNSSSERKKPNNKSKRCSEKYLDNPKGSK 494
Query: 513 SRKSMGENSNASQKYSSVSFCSIEDRLPDGFYDAGRDRPFMQLTGYEQTPHLDSREVILV 572
+ + +N S KYS SFCS ED LPDGF+DAGRDRPFM L+ YE+ LDSREVIL+
Sbjct: 495 CHRPSTDFANLSHKYSRNSFCSTEDSLPDGFFDAGRDRPFMSLSKYEEILPLDSREVILL 554
Query: 573 DRKSDEELDAIALSAQALVLHLKQLNGLTKDGVIEPVDNLQIALLLALFVSDHFGGSDRS 632
DR DE LDAI LSA+ LV LK+LN LT D +DNLQ+A LALFVSDHFGGSDR+
Sbjct: 555 DRAKDEVLDAITLSARTLVARLKKLNCLTPDVDQVSIDNLQVASFLALFVSDHFGGSDRT 614
Query: 633 GIVERTRKTVSGSNYRKPFVCTCSTGNSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKS 692
I+ERTRK VSG+NY+KPF+CTC TGN D KQ+ ED++LSD+CEKSLRSIKS
Sbjct: 615 AIIERTRKAVSGTNYQKPFICTCLTGNQDDLAALNKQVSTTAEDVILSDVCEKSLRSIKS 674
Query: 693 KRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRGYLDFQPHAWNTILVKKGD 752
KRNS+VVP+G +QFG+CRHRA+L+KYLCDR+EPPVPCELVRGYLDF PHAWN + VK+G
Sbjct: 675 KRNSIVVPLGKLQFGICRHRALLMKYLCDRMEPPVPCELVRGYLDFMPHAWNIVPVKQGS 734
Query: 753 SWIRMIVDACRPHDIREEADPEYFIRYIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSC 812
SW+RM+VDACRPHDIRE+ D EYF RYIPL R T+ + L+PG S
Sbjct: 735 SWVRMVVDACRPHDIREDTDQEYFCRYIPLNRLNESIRTKEN------LEPGCSVSSLLT 788
Query: 813 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCI 872
+ + +SSL RCK GS +A K+RTL+V G+S D+IR FEY+CLGEVR+LGAL+H CI
Sbjct: 789 GKGVERANSSLIRCKLGSTEAVVKMRTLEVSGASLDDIRTFEYTCLGEVRILGALKHDCI 848
Query: 873 VEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLAL 932
VE+YGH+ISSKW+ S +G+ +LQS+I ME++KGGS+K +IEKLSE G+ HV + LAL
Sbjct: 849 VELYGHEISSKWITSENGDEHRRVLQSSILMEHIKGGSLKGHIEKLSEAGKHHVPMDLAL 908
Query: 933 FIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHT 992
IA+D++ AL+ELHSK I+HRDIKSEN+LIDL+ + A+G+ +VKLCDFDRAVPLRS LH
Sbjct: 909 SIARDISGALMELHSKDIIHRDIKSENVLIDLDNQSANGEAIVKLCDFDRAVPLRSHLHG 968
Query: 993 CCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1052
CCIAH GIP P++CVGTPRWM+PEV RAMH+ N YGLEVDIWS+GCL+ ELLTLQ PY
Sbjct: 969 CCIAHVGIPPPNICVGTPRWMSPEVFRAMHEQNFYGLEVDIWSFGCLIFELLTLQNPYFD 1028
Query: 1053 LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG--SGFEKPEAELETLSFLVDVFR 1110
LSEL+IH+ +Q GKRP+L +LE L S E + + + F+ E++L+T+ FL+DVF
Sbjct: 1029 LSELQIHESLQKGKRPKLPKKLETLSSETEEDESTNKLCEEFDLTESDLDTMRFLIDVFH 1088
Query: 1111 RCTEENPTERPTAGDLYEMFVART 1134
+CTEE+P++R AGDL+EM ++RT
Sbjct: 1089 QCTEESPSDRLNAGDLHEMILSRT 1112
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356574435|ref|XP_003555353.1| PREDICTED: uncharacterized protein LOC100811118 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1178 bits (3047), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 633/1032 (61%), Positives = 768/1032 (74%), Gaps = 36/1032 (3%)
Query: 1 MQLTNSVEITQKSPEGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIES 60
MQL +S E + + P K + P N ++ +G+ DD + +DV+GK+V+FP E+
Sbjct: 1 MQLVHSDEPAPERRDWPEKPEDPKADN--DSLDSGT----DDGAALDVTGKSVEFPAAEN 54
Query: 61 YGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQ 120
++S E LY+YKNV +LIPKSV R +LR LKFFGNEINLF E GNL LECLQ
Sbjct: 55 -----AEDSAECLYVYKNVYSLIPKSVSRLARLRTLKFFGNEINLFAPEFGNLTTLECLQ 109
Query: 121 IKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLP 180
+KISSPG+ G L+ LKGLKELELSK PPRPS +L+EI+GLKCLTKLS+CHFSIRYLP
Sbjct: 110 MKISSPGIGGLPLHTLKGLKELELSKGPPRPSAFPILTEISGLKCLTKLSICHFSIRYLP 169
Query: 181 PEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDL 240
PEIGCL LE LDLSFNKMK LP EI YLK LIS+KVANNKLVELP+ + L RLE+LDL
Sbjct: 170 PEIGCLKKLEYLDLSFNKMKTLPAEITYLKGLISMKVANNKLVELPAAMSSLSRLESLDL 229
Query: 241 SNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSA 300
SNNRLTSLGSL+L MH LQ LNLQYNKLL Q+PSW+CCN+EGN + DD SSS
Sbjct: 230 SNNRLTSLGSLELASMHRLQELNLQYNKLLRIFQIPSWMCCNMEGNDEARYKDD-CSSSV 288
Query: 301 EMDVYEGPMLENDGNVSFSAESDAGSRHTSSSISTVSSSNSRSLTARKSSKQWKR-HHLQ 359
EMD+YE END +S G +TSSS+ T SS+SR +RKS K+WKR ++LQ
Sbjct: 289 EMDLYESNFQENDETLS------DGPHNTSSSMLTSPSSSSRCFASRKSGKRWKRRYYLQ 342
Query: 360 QRARQERLNNSRKWRGEGHAQT--SMKEGQRYKSGNLDALASETPSEEASDIIGLDDDDK 417
Q+ARQERLNNSRKW+ H S K + +SGN D+LASE+ +E S+ LDD++K
Sbjct: 343 QKARQERLNNSRKWKAVDHDDLLLSKKIHRISESGNHDSLASESCAEIESENGSLDDNNK 402
Query: 418 QLLSPEAESENLLFSVEDDKIRSGTGLHVENCSCAGLESTGKEGNDECSKHDSSSLSTAN 477
++ S A ++N + + +D++ + E+C E DE D+S S
Sbjct: 403 RIFSERAVNDNAIDNDNNDEVITEKQFSGEDCCTT-------ESKDE---KDASLCSLEK 452
Query: 478 GATEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKSRKSMGENSNASQKYSSVSFCSIED 537
+EQ+E S E ++V K+KRH DRDLDNPKPCKSRKS+ +S S KYS +SFC ED
Sbjct: 453 RQSEQEEASCLELLESVSKSKRHLDRDLDNPKPCKSRKSISSSSLLSCKYSKISFCGTED 512
Query: 538 RLPDGFYDAGRDRPFMQLTGYEQTPHLDSREVILVDRKSDEELDAIALSAQALVLHLKQL 597
L DGFYDAGRDRPFM L YEQ L SREVIL+DRK DEELDA+ L+AQALV +LK+L
Sbjct: 513 HLSDGFYDAGRDRPFMPLESYEQNQCLASREVILLDRKRDEELDAVMLAAQALVYNLKKL 572
Query: 598 NGLTKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTCST 657
NGL + G VDNLQ A LLALFVSDHFGGSDRS IVERTRK+VSGSNY KPFVCTCS
Sbjct: 573 NGLNRHGNQVGVDNLQTASLLALFVSDHFGGSDRSAIVERTRKSVSGSNYNKPFVCTCSA 632
Query: 658 GNSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLK 717
G+S S ++ + + + +EDI LS + EKSL S+K ++NS+++PIGSVQ+GVCRHRA+L K
Sbjct: 633 GSSTSISSPTEPVANTIEDITLSKMSEKSLDSMKKRQNSIIIPIGSVQYGVCRHRALLFK 692
Query: 718 YLCDRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDACRPHDIREEADPEYFI 777
YLCD +EPPVPCELVRGYLDF PHAWN IL+K+G +W+RM++DAC+P DIREE DPEYF
Sbjct: 693 YLCDHMEPPVPCELVRGYLDFSPHAWNIILIKRGATWVRMLIDACQPLDIREEKDPEYFC 752
Query: 778 RYIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKV 837
RYIPL RT P ST C G D SFPSL++CDE S+SL +CKFGS +AAAKV
Sbjct: 753 RYIPLNRTTIPLSTIG----CPGPD-YSFPSLTTCDELETKASTSLVKCKFGSVEAAAKV 807
Query: 838 RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLL 897
RTL+ GSSAD+I+NF+Y+CLGE+R+LGAL+H CIVEMYGH+IS +W SADGNPEH +L
Sbjct: 808 RTLEEQGSSADKIKNFKYNCLGEIRILGALKHPCIVEMYGHQISCQWSVSADGNPEHRVL 867
Query: 898 QSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 957
+SAIFMEYV+GGS+K+Y+EKLSE GEKHV V+LAL IA+DV+ AL ELHS+HI+HRDIKS
Sbjct: 868 RSAIFMEYVEGGSLKSYLEKLSEAGEKHVPVELALLIAKDVSCALSELHSRHIIHRDIKS 927
Query: 958 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 1017
ENIL DL+RK+ DG P VKLCDFD AVPLRS LH CCIAH G P P VCVGTPRWMAPEV
Sbjct: 928 ENILFDLDRKRDDGTPTVKLCDFDSAVPLRSTLHACCIAHAGTPPPCVCVGTPRWMAPEV 987
Query: 1018 LRAMHKPNLYGL 1029
+R M+K N YGL
Sbjct: 988 MRTMYKKNSYGL 999
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449525764|ref|XP_004169886.1| PREDICTED: uncharacterized protein LOC101227936, partial [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1150 bits (2974), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 590/976 (60%), Positives = 751/976 (76%), Gaps = 26/976 (2%)
Query: 168 KLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPS 227
K+ FS R+LPPEIGCL++LE LDLSFNK+K LP+EI YL +LISL+VANNKLVELP
Sbjct: 1 KICCVSFSFRFLPPEIGCLNSLEYLDLSFNKLKSLPSEIGYLNSLISLRVANNKLVELPP 60
Query: 228 GLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNG 287
L LQ+LENLDLS+NRLTSLGSL+L MH+L+NLNLQYNKLL CQ+PSWICCN EGN
Sbjct: 61 ALSSLQKLENLDLSSNRLTSLGSLELVSMHSLRNLNLQYNKLLKSCQIPSWICCNFEGNL 120
Query: 288 K-DSSNDDFISSSAEMDVYEGPMLENDGNVSFSAESDAGSRHTSSSISTVSSSNSRSLTA 346
+ D++N+++ISS+ EMDVYE + +N+ + G R+ SS++ S+NSRS +
Sbjct: 121 EYDTANEEWISSTVEMDVYEATVQDNENSFPLK-----GMRNISSNLLMGPSTNSRSFAS 175
Query: 347 RKSSKQWKR-HHLQQRARQERLNNSRKWRGEGHAQTSMKEGQRYKSGNLD-ALASETPSE 404
++S K+W+R H+LQQ+ARQERLN+SRKW+G H T +K + + LD A SET
Sbjct: 176 KRSGKRWRRRHYLQQKARQERLNSSRKWKGVDH-HTEVKIHENQEPERLDSASISETTVG 234
Query: 405 EASDIIGLDDDDKQLLSPEAESENLLFSVEDDKIRSGTGLHVENCS--CAGLESTGKEGN 462
++S I L D K+ + AE EN + S E+D VE+CS C T
Sbjct: 235 DSSAIDELFDS-KETCAVGAERENHIESHENDNFDPKKEFPVEDCSSICDAAAETMTRDE 293
Query: 463 DECSKHDSSSLSTANGATEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKSRKSMGENSN 522
+EC + + T NGA +Q EGSSS+ SK K KR S+R+LDNPKPCKSRK + +S+
Sbjct: 294 NECCETSKTLPLTGNGAHDQ-EGSSSQVSKDNAKLKRCSERELDNPKPCKSRKPVEYSSS 352
Query: 523 ASQKYSSVSFCSIEDRLPDGFYDAGRDRPFMQLTGYEQTPHLDSREVILVDRKSDEELDA 582
S KY+S SFC++ED LPDGFYDAGRDRPFM L YEQ HLDSREVI+V+R+ DE LD+
Sbjct: 353 LSCKYNSTSFCNVEDYLPDGFYDAGRDRPFMPLRNYEQNFHLDSREVIIVNREHDEVLDS 412
Query: 583 IALSAQALVLHLKQLNGLT--KDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRK 640
I ++A++LVL LKQ+N LT +D VI D++ IA LLALFVSDHFGGSDRS +VE+TR+
Sbjct: 413 ITIAAKSLVLRLKQINQLTQERDQVI---DDVYIAQLLALFVSDHFGGSDRSAMVEKTRR 469
Query: 641 TVSGSNYRKPFVCTCSTGNSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVP 700
VSGS Y+KPFVCTCSTG+ D+ +S K +D EDI+ +D+CEKSLRSIK+ RNS++VP
Sbjct: 470 AVSGSKYQKPFVCTCSTGDRDNLTSSTKLTVDNYEDILFTDICEKSLRSIKASRNSIIVP 529
Query: 701 IGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVD 760
+G++QFGVCRHRA+LLKYLCDR+EPPVPCELVRGYLDF PHAWN ILV++G++ +RM+VD
Sbjct: 530 LGALQFGVCRHRALLLKYLCDRMEPPVPCELVRGYLDFLPHAWNVILVQRGNTLVRMVVD 589
Query: 761 ACRPHDIREEADPEYFIRYIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDEAGKSVS 820
ACRP+DIREEADPEYF RYIPL R P S SP G+ SFPSLS+CDE K+ S
Sbjct: 590 ACRPNDIREEADPEYFCRYIPLSRAKLPISFGVTSSP--GI---SFPSLSNCDEIEKAPS 644
Query: 821 SSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 880
SS+ +CK S +AAAK+R +VC SS +EIRNFE+SCLGEVR+LGAL+HSCIV+MYGH+I
Sbjct: 645 SSVIKCKLASVEAAAKLRKREVCESSFEEIRNFEFSCLGEVRILGALKHSCIVQMYGHQI 704
Query: 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAA 940
SS+W+PS +G P+ LL+SAIF+E+VKGGS+K+Y++KL + G++HV + LAL +A+DVA+
Sbjct: 705 SSEWIPSENGKPKRRLLRSAIFLEHVKGGSLKSYMDKLYKAGKEHVPMDLALHVARDVAS 764
Query: 941 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGI 1000
ALVELHSKHI+HRDIKSENIL+D + +K+DG P+VKLCDFDRAVPLRS LHTCCIAH GI
Sbjct: 765 ALVELHSKHIIHRDIKSENILMDFD-EKSDGVPIVKLCDFDRAVPLRSLLHTCCIAHTGI 823
Query: 1001 PAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHD 1060
P PDVCVGTPRWMAPEVLRAMH PN+YGLEVDIWS+GCLLLELLTLQ+P++GL+EL+I D
Sbjct: 824 PPPDVCVGTPRWMAPEVLRAMHTPNVYGLEVDIWSFGCLLLELLTLQIPFLGLTELQIFD 883
Query: 1061 LIQMGKRPRLTDEL-EALGSCHEHEVAQSG-SGFEKPEAELETLSFLVDVFRRCTEENPT 1118
+QMGKRP L +L E LG+ + ++QS E E + ET + L+D+FR+CT+ENP
Sbjct: 884 HLQMGKRPELAGDLEEELGTIKQSTMSQSSVQESEGQEKDQETKALLIDLFRKCTQENPN 943
Query: 1119 ERPTAGDLYEMFVART 1134
+RPTA +L+ + + T
Sbjct: 944 DRPTAEELHRILLEHT 959
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|218193736|gb|EEC76163.1| hypothetical protein OsI_13471 [Oryza sativa Indica Group] | Back alignment and taxonomy information |
|---|
Score = 949 bits (2453), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 531/1116 (47%), Positives = 711/1116 (63%), Gaps = 63/1116 (5%)
Query: 47 DVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYE-KLRNLKFFGNEINL 105
DV+G T D + E +Y+Y+N NL+P+S+G +R+LKFFGN++ +
Sbjct: 22 DVAGNTWDLAALPPPPPAARGGGGE-VYIYRNTYNLVPRSIGGCRGSVRSLKFFGNDVEV 80
Query: 106 FPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKC 165
P E G L LE LQ+K+S+P V+G L +++ LKELELS VPPRPS ++L E+A LKC
Sbjct: 81 LPPEAGELDQLESLQVKVSAPRVSGAPLRRMRALKELELSIVPPRPSACSILVEVAALKC 140
Query: 166 LTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVEL 225
LTKL++CHFSIRYLPPEIG L L++LDLSFNK+K LP I L AL LKV NNKLV+L
Sbjct: 141 LTKLTICHFSIRYLPPEIGSLRKLQELDLSFNKLKNLPNCITELGALKFLKVTNNKLVDL 200
Query: 226 PSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEG 285
PSG+ L+ LE+LDLSNNRLTSLGS+ L M LQ LNLQ+N++ + C +P+W+CC++ G
Sbjct: 201 PSGISSLRCLESLDLSNNRLTSLGSVKLISMLTLQYLNLQFNRISNSCVIPAWVCCDMRG 260
Query: 286 NGKDSSNDDFISSSAEMDVYEGPMLENDGNVSFSAESDAGSRHTSSSISTVS----SSNS 341
NG+++ + S A + + SAES + + HT ++ S S+N
Sbjct: 261 NGENNMKPGKLKSIAVVS-------------NTSAESRSMN-HTCNASRLCSHPEASANL 306
Query: 342 RSLTARKSSKQWKRHH-LQQRARQERLNNSRKWRGEGHAQT-------------SMKEGQ 387
+ +K+ K WKR LQQ+ARQERL +SR + + M+
Sbjct: 307 KVHPTQKTKKGWKRRDCLQQQARQERLESSRSKLNDDYVDEMAVNMTEDESPLHDMENKS 366
Query: 388 RYKSGNLDALASETPSEEAS---DIIGLDDDDKQLLSPEAESENLLFSVEDDKIRSGTGL 444
K + +A + P E +S D+ + DDD + ++ +++ + G +
Sbjct: 367 EMKGIDEEASLQDLPKETSSISEDLSCIVDDDSY---GHIKDSGMMLQDHNEEEKPGLSM 423
Query: 445 HVE-NCSC----AGLESTGKEGNDECSKHDSSSLSTANGATEQDEGSSSENSKAVCKTKR 499
NCSC + S + + E DS+ S+ + A E + SE SK K+KR
Sbjct: 424 KSHGNCSCISGNTDILSRRRIRSVENELEDSA--SSVHDAAVVVEENPSETSKHSWKSKR 481
Query: 500 HSDRDLDNPKPCKSRKSMGENSNASQKYSSVSFCSIEDRLPDGFYDAGRDRPFMQLTGYE 559
H D D NPKP K + E S S KYS SFCSI+D LPDGFYDAGRD PFM L YE
Sbjct: 482 HPDMDC-NPKPSKCPRPFDECSKLSYKYSVQSFCSIDDHLPDGFYDAGRDMPFMPLEEYE 540
Query: 560 QTPHLDSREVILVDRKSDEELDAIALSAQALVLHLKQLNGLTKDGVIEPVDNLQIALLLA 619
++ L +REVIL+DR+ DEELDAIA SAQ L+ +LK + D + +L A +LA
Sbjct: 541 RSIGLYAREVILLDREQDEELDAIASSAQILLSNLKMPSCFVADE--DAGQDLLRASVLA 598
Query: 620 LFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTCSTGNSDSANTSQKQILDAVEDIVL 679
LFVSD FGG DRS + RTR+ + +PFVCTCS G+ + + K+I +
Sbjct: 599 LFVSDCFGGCDRSASLSRTRRAIVSLRKEQPFVCTCSAGSICDSIEASKRINNLYGHFDF 658
Query: 680 SDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRGYLDFQ 739
+ LC+KS+ IK +RNS +VPIG++QFGVCRHRAVL+KYLCDR +PP+PCELVRG+LD+
Sbjct: 659 TGLCDKSIHIIKERRNSGIVPIGALQFGVCRHRAVLMKYLCDRADPPIPCELVRGHLDYT 718
Query: 740 PHAWNTILVKKGDSWIRMIVDACRPHDIREEADPEYFIRYIPLYRTIAPFSTESDHSPCS 799
PHAWN + V+KG++W+RMIVDAC P +I+EE DPEYF RY+PL R +
Sbjct: 719 PHAWNVVPVRKGNTWVRMIVDACYPTNIKEETDPEYFCRYVPLSRLQIILDDQ------- 771
Query: 800 GLDPGS-FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCL 858
G P S FPS+S C E + SSS++ CK G+ DAAAKVR L +S+DE++NFEY L
Sbjct: 772 GYTPRSPFPSVSLCKEIETTASSSVYYCKIGAVDAAAKVRYLDTRCASSDEVKNFEYKLL 831
Query: 859 GEVRMLGALR-HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 917
EVRMLGALR H IVE+YGH++ SKW+ AD + E+ +LQS I MEYVKGGS+K Y+ K
Sbjct: 832 AEVRMLGALRKHQSIVEIYGHQLYSKWV-QADDDKEYKILQSTIMMEYVKGGSLKGYLTK 890
Query: 918 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 977
L + G+KH + LA +I ++VA AL+ELH K ++HRDIKSEN+L+DL+ +++DG PVVKL
Sbjct: 891 LLKEGKKHAPIDLAFYIVREVACALLELHKKLVIHRDIKSENVLVDLDLERSDGTPVVKL 950
Query: 978 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1037
DFD A+PL S HTCCIAH G P+VCVGTP WMAPEVLRAM N YGLEVDIWS+G
Sbjct: 951 SDFDNAIPLHSLSHTCCIAHLGTYPPNVCVGTPCWMAPEVLRAMRDKNQYGLEVDIWSFG 1010
Query: 1038 CLLLELLTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPE 1096
C LLE+LTL++PY GL + EI+DLI K RPRLT ELEA + + + + G +
Sbjct: 1011 CFLLEMLTLRIPYQGLPDSEIYDLIMRKKQRPRLTQELEAFWTL-DKPITRLELGITS-D 1068
Query: 1097 AELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVA 1132
A E L L+D+F +CT+ +ERP A +Y + +
Sbjct: 1069 AHAEKLRLLIDLFYQCTKGIASERPKAEAVYNLLCS 1104
|
Source: Oryza sativa Indica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1142 | ||||||
| TAIR|locus:2020220 | 1112 | AT1G04210 [Arabidopsis thalian | 0.929 | 0.954 | 0.546 | 2.5e-303 | |
| TAIR|locus:2194055 | 992 | AT1G18160 [Arabidopsis thalian | 0.056 | 0.065 | 0.420 | 7.4e-19 | |
| TAIR|locus:2027794 | 1030 | AT1G73660 [Arabidopsis thalian | 0.056 | 0.063 | 0.420 | 5.4e-18 | |
| DICTYBASE|DDB_G0278509 | 1248 | DDB_G0278509 "MLK family prote | 0.077 | 0.071 | 0.426 | 7.6e-15 | |
| TAIR|locus:2143009 | 880 | AT5G11850 [Arabidopsis thalian | 0.077 | 0.1 | 0.320 | 1.1e-14 | |
| DICTYBASE|DDB_G0269250 | 3184 | pats1 "LRRK family protein kin | 0.154 | 0.055 | 0.298 | 2.3e-14 | |
| DICTYBASE|DDB_G0279417 | 2147 | roco6 "LRRK family protein kin | 0.143 | 0.076 | 0.299 | 2.9e-14 | |
| DICTYBASE|DDB_G0286127 | 1867 | roco8 "LRRK family protein kin | 0.140 | 0.085 | 0.294 | 3.3e-14 | |
| TAIR|locus:2076416 | 809 | AT3G58640 [Arabidopsis thalian | 0.175 | 0.247 | 0.243 | 7.1e-14 | |
| TAIR|locus:2025515 | 933 | EDR1 "ENHANCED DISEASE RESISTA | 0.062 | 0.076 | 0.448 | 1.1e-13 |
| TAIR|locus:2020220 AT1G04210 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2911 (1029.8 bits), Expect = 2.5e-303, P = 2.5e-303
Identities = 595/1089 (54%), Positives = 750/1089 (68%)
Query: 50 GKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSE 109
G+ ++F L+++ D+SV+GLY ++NV NLIPKS+G +LR LKFF NEI+LFP E
Sbjct: 43 GQNLEFSLLDNV-----DDSVKGLYFFRNVFNLIPKSIGGLGRLRKLKFFSNEIDLFPPE 97
Query: 110 VGNLLGLECLQIKISSPGV-NGFAXXXXXXXXXXXXXXVPPRPSVLTLLSEIAGLKCLTK 168
+GNL+ LE LQ+KISSPG +G + VP R S LTLLSEI+GLKCLT+
Sbjct: 98 LGNLVNLEYLQVKISSPGFGDGLSWDKLKGLKELELTKVPKRSSALTLLSEISGLKCLTR 157
Query: 169 LSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG 228
LSVCHFSIRYLPPEIGCL +LE LDLSFNK+K LP EI YL +L LKVA+N+L+EL
Sbjct: 158 LSVCHFSIRYLPPEIGCLKSLEYLDLSFNKIKSLPNEIGYLSSLTFLKVAHNRLMELSPV 217
Query: 229 LYLLQRLENLDLSNNRLTSLGSLDXXXXXXXXXXXXXXXXXXSYCQVPSWICCNLEGNGK 288
L LLQ LE+LD+SNNRLT+L LD SYC +P+WI CN EGN +
Sbjct: 218 LALLQNLESLDVSNNRLTTLHPLDLNLMPRLQILNLRYNKLPSYCWIPTWIQCNFEGNYE 277
Query: 289 DSSNDDFISSSAEMDVYEGPMLENDGNVSFSAESDAGXXXXXXXXXXXXXXXXXXXXXXX 348
+ D SS EMDV+E P EN NV G
Sbjct: 278 EMGVDTCSSSMVEMDVFETPY-EN--NVITVPHK--GSHRNPLNMSTGISSISRCFSARK 332
Query: 349 XXKQWKR--HHLQQRARQERLNNSRKWRGEGHAQTSMKEGQRYKSGNLDALASETPSEEA 406
K+WKR ++ QQRARQERLNNSRKW+GE + + + ++G + +
Sbjct: 333 SSKRWKRRQYYFQQRARQERLNNSRKWKGEVPPEGLSLKMEVEETGKQGMKVPQNTDRGS 392
Query: 407 SDIIGLDDDDKQLLSPEAESENLLFSVEDDKIRSGTGLHVENCSCAGLESTGKEGNDECS 466
D D++DK L EA + + E+++ + +N C + T + N E
Sbjct: 393 VDNSCSDENDK--LFEEAS----VITSEEEESSLKADVVSDNSQCVETQLTSERDNYESC 446
Query: 467 KHDSSSLSTANGATEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKSRKSMGENSNASQK 526
+ +SS S+ + D SSSE K K+KR S++ LDNPK K K + +N S+K
Sbjct: 447 EIKTSSPSSGDAPGTVDYNSSSERKKPNNKSKRCSEKYLDNPKGSKCHKLSTDITNLSRK 506
Query: 527 YSSVSFCSIEDRLPDGFYDAGRDRPFMQLTGYEQTPHLDSREVILVDRKSDEELDAIALS 586
YSS SFCS ED LPDGF+DAGRDRPFM L+ YE+ LDSREVIL+DR DE LDAI LS
Sbjct: 507 YSSNSFCSTEDSLPDGFFDAGRDRPFMTLSKYEKVLPLDSREVILLDRAKDEVLDAITLS 566
Query: 587 AQALVLHLKQLNGLTKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSN 646
A+ALV LK+LN LT D +DNLQ+A LALFVSDHFGGSDR+ I+ERTRK VSG+N
Sbjct: 567 ARALVARLKKLNCLTPDVDQVSIDNLQVASFLALFVSDHFGGSDRTAIIERTRKAVSGTN 626
Query: 647 YRKPFVCTCSTGNSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQF 706
Y+KPF+CTC TGN D KQ+ ED +LSD+CEKSLRSIKSKRNS+VVP+G +QF
Sbjct: 627 YQKPFICTCLTGNQDDLAALNKQVSTTAEDAILSDVCEKSLRSIKSKRNSIVVPLGKLQF 686
Query: 707 GVCRHRAVLLKYLCDRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDACRPHD 766
G+CRHRA+L+KYLCDR+EPPVPCELVRGYLDF PHAWN + VK+G SW+RM+VDACRPHD
Sbjct: 687 GICRHRALLMKYLCDRMEPPVPCELVRGYLDFMPHAWNIVPVKQGSSWVRMVVDACRPHD 746
Query: 767 IREEADPEYFIRYIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDEAGKSVSSSLFRC 826
IRE+ D EYF RYIPL R ES L+PG S S + + +SSL RC
Sbjct: 747 IREDTDQEYFCRYIPLNRL-----NESIRIK-EKLEPGCSVSSLSTGKGVERANSSLIRC 800
Query: 827 KFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 886
K GS +A K+RTL+V G+S D+IR FEY+CLGEVR+LGAL+H CIVE+YGH+ISSKW+
Sbjct: 801 KLGSTEAVVKMRTLEVSGASLDDIRTFEYTCLGEVRILGALKHDCIVELYGHEISSKWIT 860
Query: 887 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELH 946
S +GN EH +LQS+I ME++KGGS+K +IEKLSE G+ HV + LAL IA+D++ AL+ELH
Sbjct: 861 SENGN-EHRVLQSSILMEHIKGGSLKGHIEKLSEAGKHHVPMDLALSIARDISGALMELH 919
Query: 947 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC 1006
SK I+HRDIKSEN+LIDL+ + A+G+P+VKLCDFDRAVPLRS LH CCIAH GIP P++C
Sbjct: 920 SKDIIHRDIKSENVLIDLDNQSANGEPIVKLCDFDRAVPLRSHLHGCCIAHVGIPPPNIC 979
Query: 1007 VGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1066
VGTPRWM+PEV RAMH+ N YGLEVDIWS+GCL+ ELLTLQ PY LSEL+IH+ +Q GK
Sbjct: 980 VGTPRWMSPEVFRAMHEQNFYGLEVDIWSFGCLIFELLTLQNPYFDLSELQIHESLQNGK 1039
Query: 1067 RPRLTDELEALGSCHEHEVAQS--GSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124
RP+L +LE L S E E + + F+ E++L+T+ FL+DVF +CTEE+P++R AG
Sbjct: 1040 RPKLPKKLETLISETEEEESTNKLSEVFDLTESDLDTMRFLIDVFHQCTEESPSDRLNAG 1099
Query: 1125 DLYEMFVAR 1133
DL+EM ++R
Sbjct: 1100 DLHEMILSR 1108
|
|
| TAIR|locus:2194055 AT1G18160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 127 (49.8 bits), Expect = 7.4e-19, Sum P(5) = 7.4e-19
Identities = 29/69 (42%), Positives = 41/69 (59%)
Query: 689 SIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRG--YLDFQPHAWNTI 746
S+K+ S+V+P+GS+ G+ RHRA+L K LCD V VPC +V+G Y A N+I
Sbjct: 282 SLKATLRSMVLPLGSLTIGLARHRALLFKVLCDSVG--VPCRIVKGQQYTGSDDVAMNSI 339
Query: 747 LVKKGDSWI 755
G +I
Sbjct: 340 KTDDGREYI 348
|
|
| TAIR|locus:2027794 AT1G73660 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 126 (49.4 bits), Expect = 5.4e-18, Sum P(4) = 5.4e-18
Identities = 29/69 (42%), Positives = 41/69 (59%)
Query: 689 SIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRG--YLDFQPHAWNTI 746
S+K+ S+V+P+GS+ G+ RHRA+L K LCD V VPC +V+G Y + A N I
Sbjct: 306 SLKATLGSMVLPLGSLTIGLARHRALLFKVLCDSVG--VPCRIVKGQQYTGSEDVAMNFI 363
Query: 747 LVKKGDSWI 755
G +I
Sbjct: 364 KADDGREYI 372
|
|
| DICTYBASE|DDB_G0278509 DDB_G0278509 "MLK family protein kinase DDB_G0278509" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 163 (62.4 bits), Expect = 7.6e-15, Sum P(5) = 7.6e-15
Identities = 38/89 (42%), Positives = 55/89 (61%)
Query: 160 IAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVAN 219
+A L L KL++ + I+ LP I LS+L +L+ S N ++ LP ICYL L L + N
Sbjct: 614 VASLSRLAKLTISNNKIKQLPFAINNLSSLIELNASNNVIELLPDSICYLSNLKKLNLNN 673
Query: 220 NKLVELPSGLYLLQRLENLDLSNNRLTSL 248
N L ELPS + L +L +L L NN+++SL
Sbjct: 674 NNLKELPSNIGFLTKLVDLQLYNNQISSL 702
|
|
| TAIR|locus:2143009 AT5G11850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 123 (48.4 bits), Expect = 1.1e-14, Sum P(4) = 1.1e-14
Identities = 33/103 (32%), Positives = 56/103 (54%)
Query: 974 VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 1033
VVK+CDF L H ++ + GTP WMAPEVLR ++P + D+
Sbjct: 745 VVKVCDFG----LSRMKHHTYLSSKST------AGTPEWMAPEVLR--NEPA--NEKCDV 790
Query: 1034 WSYGCLLLELLTLQVPYMGLSELEIHDLIQM-GKRPRLTDELE 1075
+S+G +L EL T +VP+ GL+ +++ + +R + D+++
Sbjct: 791 YSFGVILWELATSRVPWKGLNPMQVVGAVGFQNRRLEIPDDID 833
|
|
| DICTYBASE|DDB_G0269250 pats1 "LRRK family protein kinase Pats1" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 168 (64.2 bits), Expect = 2.3e-14, Sum P(2) = 2.3e-14
Identities = 55/184 (29%), Positives = 85/184 (46%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRYEK-LRNLKFFGNEINLFPSEVG---NLLGLECLQIKIS 124
S+ L L N L +P + K L+ L N + P +G NL+ L+ ++ +S
Sbjct: 1467 SLTELNLSSNQLIDLPIEFSMFSKSLKKLHLKNNRFSAIPEVLGMLENLIELDLSELDLS 1526
Query: 125 SPGVNGFAXXXXXXXXXXXXXXVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIG 184
S +G + ++ L E LK L KL + S+ LP
Sbjct: 1527 SSTNSGVGIPTKLSKLCILNLN---QTRIVELPKEFGDLKSLEKLYLDFNSLVTLPHSFR 1583
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNR 244
L+NLE+L LSFN M LP E+C+L L L + N++ LP+ + L +L L++ N+
Sbjct: 1584 QLTNLEELSLSFNSMTELPREVCFLINLKKLMIEGNQIQFLPNEISQLSKLMILNVCKNK 1643
Query: 245 LTSL 248
L SL
Sbjct: 1644 LDSL 1647
|
|
| DICTYBASE|DDB_G0279417 roco6 "LRRK family protein kinase Roco6" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 172 (65.6 bits), Expect = 2.9e-14, Sum P(3) = 2.9e-14
Identities = 56/187 (29%), Positives = 94/187 (50%)
Query: 903 MEYVKGGSVKNYIEKLSETGEK-HVSVKLALFIAQDVAAALVELHS--KHIMHRDIKSEN 959
MEY+ G + ++ S G++ + + L L +A D+A + LHS ++HRD+KS N
Sbjct: 1429 MEYIDCGDLHKFLH--SPIGDQLNGNWALILKLALDIAKGMEFLHSVTPPLLHRDLKSPN 1486
Query: 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1019
+L+ ++ DG K+ DF + R F+ R P VG W+APE+LR
Sbjct: 1487 VLLSMK----DGVYTAKVGDF--GLSSRMFIQALKHKLRNFP-----VGNITWVAPEILR 1535
Query: 1020 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPY--MGLSELEIH-DLIQMGKRPRLTDELEA 1076
Y ++ D++++G +L ELLT + PY S + + D I+ G RP ++
Sbjct: 1536 EEE----YTVKSDVYAFGLILHELLTRKHPYREFNYSMVSLQEDAIKNGLRPTISPSYTQ 1591
Query: 1077 LGSCHEH 1083
+ HE+
Sbjct: 1592 TVTGHEY 1598
|
|
| DICTYBASE|DDB_G0286127 roco8 "LRRK family protein kinase Roco8" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 154 (59.3 bits), Expect = 3.3e-14, Sum P(3) = 3.3e-14
Identities = 55/187 (29%), Positives = 89/187 (47%)
Query: 900 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS--KHIMHRDIKS 957
AI MEY+ GS+ ++++K E G+ + ++ L I D+A+ + LH+ ++HRD+KS
Sbjct: 1666 AIVMEYMDIGSLSSFLKKKKEDGQV-LDWQMLLKIVTDIASGMAFLHNITPPLVHRDLKS 1724
Query: 958 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 1017
NIL+ + K+ DF + RS + V P W +PEV
Sbjct: 1725 PNILL-ASHPTNPNEISAKVSDFGLS---RSIVQNFS---------SKVVDNPTWQSPEV 1771
Query: 1018 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY-----MGLSELEIHDLIQMGKRPRLTD 1072
L+ M Y + DI+S+G +L E L++P+ +S LE D I G RP +
Sbjct: 1772 LKGME----YNEKSDIYSFGMILWECYHLELPFDEFDFKFMSTLE--DNILSGLRPSINQ 1825
Query: 1073 ELEALGS 1079
+ S
Sbjct: 1826 NCNRMYS 1832
|
|
| TAIR|locus:2076416 AT3G58640 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 111 (44.1 bits), Expect = 7.1e-14, Sum P(4) = 7.1e-14
Identities = 54/222 (24%), Positives = 94/222 (42%)
Query: 648 RKPFVCTCSTGNSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFG 707
+K + +G + T K+I V D+ + +S +S N + +G ++ G
Sbjct: 126 QKQLITKLVSGLNSKPATIIKKIAGLVADVYKQSTLQSPAKSTQSFENCGIQLLGQIKHG 185
Query: 708 VCRHRAVLLKYLCD------RVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDA 761
CR RA+L K L D R+ +P + +D H T+L+ + M+VD
Sbjct: 186 SCRPRAILFKVLADTVGLQSRLVVGLPSDGAAESVDSYSHISVTVLLNS----VEMLVDL 241
Query: 762 CR-PHDIREEADPEYFIRYIPLYRTIAPFSTESDHSPC-SGLDPGS----FPSLSSCDEA 815
R P + + F+ +I + A S +++ C S L+P S +P + A
Sbjct: 242 MRFPGQLIPLSTKAIFMSHI----SAAGESDSAENDSCDSPLEPNSPMFGYPEKFDHENA 297
Query: 816 GKSVSSSLFRCKFGSADAAAKV-RTLKVCGSSADEIRNFEYS 856
K + SL R GS + + R + + +SA E R +S
Sbjct: 298 EKDENLSLHRKLDGSPNTSGPPSRNMLLRSASALE-RKLSFS 338
|
|
| TAIR|locus:2025515 EDR1 "ENHANCED DISEASE RESISTANCE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 126 (49.4 bits), Expect = 1.1e-13, Sum P(3) = 1.1e-13
Identities = 35/78 (44%), Positives = 45/78 (57%)
Query: 673 AVED--IVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCE 730
+ ED IVL+ EKS K+ N+ V PIG V+ G+ RHRA+L K L D V +PC
Sbjct: 233 SAEDSSIVLARWTEKS-SEFKAALNTCVFPIGFVKIGISRHRALLFKVLADSVR--LPCR 289
Query: 731 LVRG--YLDFQPHAWNTI 746
LV+G Y + A NTI
Sbjct: 290 LVKGSHYTGNEDDAVNTI 307
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1142 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 9e-40 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-39 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-37 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-37 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-33 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-32 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-32 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-31 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-30 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-30 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-29 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-26 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 7e-26 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-25 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-25 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-24 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-23 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-23 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-21 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-21 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-21 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-21 | |
| pfam14381 | 203 | pfam14381, EDR1, Ethylene-responsive protein kinas | 1e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-20 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-20 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-20 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-20 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-20 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-19 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-19 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-18 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 9e-18 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-17 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-17 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-17 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-17 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-16 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-16 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-16 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-16 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-16 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-15 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-15 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-15 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-15 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 7e-15 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-14 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-14 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-14 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-14 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-14 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-13 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-13 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-13 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-13 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-13 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-13 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-13 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-13 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 9e-13 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-12 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-12 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-12 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-12 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-12 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-12 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-12 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-12 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 9e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 9e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-11 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-11 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-11 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-11 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-11 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-11 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-11 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-11 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-11 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 8e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-11 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-10 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-10 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-10 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-10 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-10 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-10 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 9e-10 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-09 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-09 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-09 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-09 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-09 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-09 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-09 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-09 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-09 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 8e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 8e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 9e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-08 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-08 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-08 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-08 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-08 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-08 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 7e-08 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-08 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 8e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 9e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-07 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-07 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-07 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-07 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-07 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 9e-07 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-06 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-06 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-06 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-06 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-06 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-06 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-06 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-06 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 9e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-06 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-05 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-05 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-05 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-05 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-05 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-05 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-05 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-05 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-05 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-05 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-05 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 8e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-04 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-04 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-04 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-04 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-04 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 6e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-04 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 7e-04 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 7e-04 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.001 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 0.001 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 0.001 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.001 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.001 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.002 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 0.002 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 9e-40
Identities = 83/282 (29%), Positives = 117/282 (41%), Gaps = 71/282 (25%)
Query: 848 DEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVK 907
+I+ L E+++L L+H IV +Y E L + MEY +
Sbjct: 35 KKIKKDRERILREIKILKKLKHPNIVRLYDV-----------FEDEDKLY---LVMEYCE 80
Query: 908 GGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 967
GG + + ++K +S A F + + +AL LHSK I+HRD+K ENIL+
Sbjct: 81 GGDLFDLLKK-----RGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILL----- 130
Query: 968 KADGKPVVKLCDFD--RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 1025
D VKL DF R + L T GTP +MAPEVL
Sbjct: 131 --DEDGHVKLADFGLARQLDPGEKLTTFV-------------GTPEYMAPEVLLGKG--- 172
Query: 1026 LYGLEVDIWSYGCLLLELLTLQVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHEHE 1084
YG VDIWS G +L ELLT + P+ G +L E+ I K P E +
Sbjct: 173 -YGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDI-------- 223
Query: 1085 VAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1126
PEA D+ R+ ++P +R TA +
Sbjct: 224 ---------SPEA--------KDLIRKLLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 2e-39
Identities = 77/281 (27%), Positives = 118/281 (41%), Gaps = 60/281 (21%)
Query: 848 DEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVK 907
E + + E+R+L L H IV + A + +H + MEY +
Sbjct: 36 SEKSKKDQTARREIRILRRLSHPNIVRLID----------AFEDKDH----LYLVMEYCE 81
Query: 908 GGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 967
GG + +Y+ + +S A IA + L LHS I+HRD+K ENIL+
Sbjct: 82 GGDLFDYLSR-----GGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILL----- 131
Query: 968 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 1027
D VVK+ DF A + + VGTP +MAPEVL N Y
Sbjct: 132 --DENGVVKIADFGLA----------KKLLKSSSSLTTFVGTPWYMAPEVLL---GGNGY 176
Query: 1028 GLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ 1087
G +VD+WS G +L ELLT + P+ G + L+ LI+ P L
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPL----------------- 219
Query: 1088 SGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1128
+ E + ++C ++P++RPTA ++ +
Sbjct: 220 EFDEPKWSSGSEEAKDLI----KKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 1e-37
Identities = 65/230 (28%), Positives = 94/230 (40%), Gaps = 46/230 (20%)
Query: 816 GKSVSSSLFRCKFGSAD--AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIV 873
G+ +++ + A K+ + S +E+ E+ +L L H IV
Sbjct: 2 GEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLR-------EIEILKKLNHPNIV 54
Query: 874 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALF 933
++YG L + MEY +GGS+K+ +++ E +S L
Sbjct: 55 KLYGVFEDENHL--------------YLVMEYCEGGSLKDLLKEN----EGKLSEDEILR 96
Query: 934 IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC 993
I + L LHS I+HRD+K ENIL+D VKL DF + L S
Sbjct: 97 ILLQILEGLEYLHSNGIIHRDLKPENILLD------SDNGKVKLADFGLSKLLTSDKSLL 150
Query: 994 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043
VGTP +MAPEVL Y + DIWS G +L EL
Sbjct: 151 K----------TIVGTPAYMAPEVLLGKGY---YSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 92/297 (30%), Positives = 131/297 (44%), Gaps = 79/297 (26%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
V+++++ G S +E+ + E+R+L +L+H IV YG + ++ L
Sbjct: 30 VKSVELSGDSEEELE----ALEREIRILSSLQHPNIVRYYGSERD---------EEKNTL 76
Query: 897 LQSAIFMEYVKGGSVKNYIEK---LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 953
IF+EYV GGS+ + ++K L E + + + L LHS I+HR
Sbjct: 77 N---IFLEYVSGGSLSSLLKKFGKLPEPVIRKY--------TRQILEGLAYLHSNGIVHR 125
Query: 954 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 1013
DIK NIL+D +DG VVKL DF A L GTP WM
Sbjct: 126 DIKGANILVD-----SDG--VVKLADFGCAKRLGDIETGEGTGSV--------RGTPYWM 170
Query: 1014 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRP--RLT 1071
APEV+R YG DIWS GC ++E+ T GK P L
Sbjct: 171 APEVIRGE----EYGRAADIWSLGCTVIEMAT-------------------GKPPWSELG 207
Query: 1072 DELEALGSCHEHEVAQSGSGFEKPEAEL--ETLSFLVDVFRRCTEENPTERPTAGDL 1126
+ + AL +++ SG E PE L E FL R+C +P +RPTA +L
Sbjct: 208 NPMAAL-----YKIGSSGEPPEIPE-HLSEEAKDFL----RKCLRRDPKKRPTADEL 254
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 85/306 (27%), Positives = 126/306 (41%), Gaps = 81/306 (26%)
Query: 825 RCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG--HKISS 882
R K + A KV L+ I E+++L +H IV+ YG K
Sbjct: 20 RHKRTGKEVAIKVIKLESKEKKEKIIN--------EIQILKKCKHPNIVKYYGSYLKKDE 71
Query: 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-GEKHVSVKLALFIAQDVAAA 941
W I ME+ GGS+K+ ++ ++T E ++ ++ +++
Sbjct: 72 LW----------------IVMEFCSGGSLKDLLKSTNQTLTESQIA-----YVCKELLKG 110
Query: 942 LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIP 1001
L LHS I+HRDIK+ NIL+ +DG+ VKL DF + L
Sbjct: 111 LEYLHSNGIIHRDIKAANILL-----TSDGE--VKLIDFGLSAQLSD-----------TK 152
Query: 1002 APDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDL 1061
A + VGTP WMAPEV+ Y + DIWS G +EL + PY SEL
Sbjct: 153 ARNTMVGTPYWMAPEVINGKP----YDYKADIWSLGITAIELAEGKPPY---SELPPMKA 205
Query: 1062 IQMGKRPRLTDELEALGSCHEHEVAQSGS-GFEKPEAELETLSFLVDVFRRCTEENPTER 1120
+ +A +G G P E + F D ++C ++NP +R
Sbjct: 206 LFK--------------------IATNGPPGLRNP--EKWSDEF-KDFLKKCLQKNPEKR 242
Query: 1121 PTAGDL 1126
PTA L
Sbjct: 243 PTAEQL 248
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 77/297 (25%), Positives = 125/297 (42%), Gaps = 74/297 (24%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
V+TLK +S +I F L E R++ L H IV++ G + ++ E +
Sbjct: 33 VKTLKE-DASEQQIEEF----LREARIMRKLDHPNIVKLLG--VCTE--------EEPLM 77
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
+ MEY+ GG + +Y L + K +S+ L A +A + L SK+ +HRD+
Sbjct: 78 IV----MEYMPGGDLLDY---LRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLA 130
Query: 957 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMA 1014
+ N L+ VVK+ DF R + + +P RWMA
Sbjct: 131 ARNCLVGENL-------VVKISDFGLSRDLYDDDYYKV---KGGKLPI--------RWMA 172
Query: 1015 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 1073
PE L+ + + D+WS+G LL E+ TL + PY G+S E+ + ++ G R
Sbjct: 173 PESLKE----GKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYR------ 222
Query: 1074 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130
L +C L + +C E+P +RPT +L E+
Sbjct: 223 LPKPPNCPPE---------------------LYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 124 bits (315), Expect = 8e-32
Identities = 76/297 (25%), Positives = 125/297 (42%), Gaps = 75/297 (25%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
V+TLK +S +I F L E R++ L H +V++ G + ++ E
Sbjct: 33 VKTLKE-DASEQQIEEF----LREARIMRKLDHPNVVKLLG--VCTE--------EEPLY 77
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
+ MEY++GG + +Y+ K +S+ L A +A + L SK+ +HRD+
Sbjct: 78 IV----MEYMEGGDLLSYLRKN----RPKLSLSDLLSFALQIARGMEYLESKNFIHRDLA 129
Query: 957 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMA 1014
+ N L+ VVK+ DF R + + +P RWMA
Sbjct: 130 ARNCLV-------GENLVVKISDFGLSRDLYDDDYYRK---RGGKLPI--------RWMA 171
Query: 1015 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 1073
PE L+ + + D+WS+G LL E+ TL + PY G+S E+ + ++ G R
Sbjct: 172 PESLKEGK----FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYR------ 221
Query: 1074 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130
L +C L D+ +C E+P +RPT +L E+
Sbjct: 222 LPQPPNCPPE---------------------LYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 76/297 (25%), Positives = 125/297 (42%), Gaps = 74/297 (24%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
V+TLK G+S +E F L E ++ L H IV + G + ++ L
Sbjct: 33 VKTLK-EGASEEEREEF----LEEASIMKKLSHPNIVRLLG--VCTQ---------GEPL 76
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
I EY+ GG + +++ K E +++K L +A +A + L SK+ +HRD+
Sbjct: 77 Y---IVTEYMPGGDLLDFLRKHGE----KLTLKDLLQMALQIAKGMEYLESKNFVHRDLA 129
Query: 957 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMA 1014
+ N L+ VVK+ DF R + + G P +WMA
Sbjct: 130 ARNCLV-------TENLVVKISDFGLSRDIYEDDYYR----KRGGGKLP------IKWMA 172
Query: 1015 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 1073
PE L+ + + D+WS+G LL E+ TL + PY G+S E+ +L++ G R
Sbjct: 173 PESLKDGK----FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYR------ 222
Query: 1074 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130
L +C + L ++ +C +P +RPT +L E
Sbjct: 223 LPRPENCPDE---------------------LYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 78/286 (27%), Positives = 118/286 (41%), Gaps = 67/286 (23%)
Query: 844 GSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM 903
S E + L EV++L L H I++ Y L I M
Sbjct: 37 NMSEKERED----ALNEVKILKKLNHPNIIKYYESFEEKG-----------KLC---IVM 78
Query: 904 EYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963
EY GG + I+K + G K + L + AL LHS+ I+HRDIK +NI +
Sbjct: 79 EYADGGDLSQKIKKQKKEG-KPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLT 137
Query: 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 1023
++G +VKL DF + + T +A VGTP +++PE+ + +K
Sbjct: 138 -----SNG--LVKLGDFGIS---KVLSSTVDLAK-------TVVGTPYYLSPELCQ--NK 178
Query: 1024 PNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEH 1083
P Y + DIWS GC+L EL TL+ P+ G + LE+ I G+ P +
Sbjct: 179 P--YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPI------------- 223
Query: 1084 EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1129
P L LV +++P ERP+ + +
Sbjct: 224 -----------PSQYSSELRNLVS---SLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 78/274 (28%), Positives = 115/274 (41%), Gaps = 74/274 (27%)
Query: 859 GEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKL 918
E+ +L L+H IV+ G + L IF+E V GGS+ ++K
Sbjct: 51 QEIALLSKLQHPNIVQYLGTEREEDNL--------------YIFLELVPGGSLAKLLKKY 96
Query: 919 SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 978
E + L+ Q + L LH ++ +HRDIK NIL+D +G VVKL
Sbjct: 97 GSFPEPVIR----LYTRQ-ILLGLEYLHDRNTVHRDIKGANILVD-----TNG--VVKLA 144
Query: 979 DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1038
DF A + F G+P WMAPEV+ + YGL DIWS GC
Sbjct: 145 DFGMAKQVVEFSFA-----------KSFKGSPYWMAPEVIA---QQGGYGLAADIWSLGC 190
Query: 1039 LLLELLTLQVPYMGLSELE----IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK 1094
+LE+ T + P+ S+LE + + + + P + D L
Sbjct: 191 TVLEMATGKPPW---SQLEGVAAVFKIGRSKELPPIPDHLS------------------- 228
Query: 1095 PEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1128
EA+ D +C + +P+ RPTA +L E
Sbjct: 229 DEAK--------DFILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 77/299 (25%), Positives = 127/299 (42%), Gaps = 70/299 (23%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
V+TLK +S +E ++F L E R++ L H +V + G + ++ E L
Sbjct: 28 VKTLK-EDASEEERKDF----LKEARVMKKLGHPNVVRLLG--VCTE---------EEPL 71
Query: 897 LQSAIFMEYVKGGSVKNYIEK----LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 952
+ +EY++GG + +Y+ K + +S+K L A +A + L SK +H
Sbjct: 72 Y---LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVH 128
Query: 953 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 1012
RD+ + N L+ VVK+ DF + + + +P RW
Sbjct: 129 RDLAARNCLV-------GEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPI--------RW 173
Query: 1013 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLT 1071
MAPE L K ++ + D+WS+G LL E+ TL PY GLS E+ + ++ G R
Sbjct: 174 MAPESL----KDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRL--- 226
Query: 1072 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130
KPE + L ++ C + +P +RPT +L E
Sbjct: 227 ---------------------PKPEYCPDELY---ELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 1e-28
Identities = 72/281 (25%), Positives = 118/281 (41%), Gaps = 88/281 (31%)
Query: 858 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGS----V 911
+ E+ ++ +H IV+ Y + +L+ ++ MEY+ GGS +
Sbjct: 63 INEILIMKDCKHPNIVDYY----------------DSYLVGDELWVVMEYMDGGSLTDII 106
Query: 912 KNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 971
+++E ++ ++ ++V L LHS++++HRDIKS+NIL+ DG
Sbjct: 107 TQNFVRMNEP---QIA-----YVCREVLQGLEYLHSQNVIHRDIKSDNILLSK-----DG 153
Query: 972 KPVVKLCDF------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 1025
VKL DF + R+ + VGTP WMAPEV++
Sbjct: 154 --SVKLADFGFAAQLTKEKSKRNSV----------------VGTPYWMAPEVIKR----K 191
Query: 1026 LYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEV 1085
YG +VDIWS G + +E+ + PY+ L LI P L +
Sbjct: 192 DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNP------------ 239
Query: 1086 AQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1126
EK E FL +C ++P +RP+A +L
Sbjct: 240 -------EKWSPEF--KDFL----NKCLVKDPEKRPSAEEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 69/211 (32%), Positives = 92/211 (43%), Gaps = 52/211 (24%)
Query: 856 SCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 915
S + E+ +L L+H IV+ G +S L I +EY + GS++ I
Sbjct: 45 SIMQEIDLLKNLKHPNIVKYIGSIETSDSL--------------YIILEYAENGSLRQII 90
Query: 916 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 975
+K E V+V ++ Q V L LH + ++HRDIK+ NIL DG VV
Sbjct: 91 KKFGPFPESLVAV----YVYQ-VLQGLAYLHEQGVIHRDIKAANILT-----TKDG--VV 138
Query: 976 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV--DI 1033
KL DF A L VGTP WMAPEV+ + G DI
Sbjct: 139 KLADFGVATKLNDVSKD----------DASVVGTPYWMAPEVI------EMSGASTASDI 182
Query: 1034 WSYGCLLLELLTLQVPYMGLSELEIHDLIQM 1064
WS GC ++ELLT PY +DL M
Sbjct: 183 WSLGCTVIELLTGNPPY--------YDLNPM 205
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 59/164 (35%), Positives = 81/164 (49%), Gaps = 26/164 (15%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
+EY GG + +++ K E S + A F A ++ AL LHS I++RD+K ENIL+
Sbjct: 72 LEYAPGGELFSHLSK-----EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILL 126
Query: 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1022
D ADG +KL DF A L S + GTP ++APEVL +
Sbjct: 127 D-----ADGH--IKLTDFGLAKELSSEGSRT----------NTFCGTPEYLAPEVL--LG 167
Query: 1023 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1066
K YG VD WS G LL E+LT + P+ EI++ I
Sbjct: 168 KG--YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDP 209
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 81/269 (30%), Positives = 120/269 (44%), Gaps = 59/269 (21%)
Query: 859 GEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKL 918
E+++L L+H +V+ YG E H + IFMEY GG+ +E+L
Sbjct: 48 DEMKVLELLKHPNLVKYYG--------------VEVHREKVYIFMEYCSGGT----LEEL 89
Query: 919 SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 978
E G + ++ Q + L LHS I+HRDIK NI +D +G V+KL
Sbjct: 90 LEHGRILDEHVIRVYTLQ-LLEGLAYLHSHGIVHRDIKPANIFLD-----HNG--VIKLG 141
Query: 979 DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1038
DF AV L++ +T + GTP +MAPEV+ K +G DIWS GC
Sbjct: 142 DFGCAVKLKN--NTTTMGEEV----QSLAGTPAYMAPEVITG-GKGKGHGRAADIWSLGC 194
Query: 1039 LLLELLTLQVPYMGL-SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 1097
++LE+ T + P+ L +E +I + G +P + D L+
Sbjct: 195 VVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGK---------------- 238
Query: 1098 ELETLSFLVDVFRRCTEENPTERPTAGDL 1126
D RC E +P +RPTA +L
Sbjct: 239 ---------DFLDRCLESDPKKRPTASEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 3e-25
Identities = 77/271 (28%), Positives = 115/271 (42%), Gaps = 69/271 (25%)
Query: 859 GEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK- 917
E+++L L+H IV+ YG + E +IFMEY+ GGSVK+ ++
Sbjct: 53 CEIQLLKNLQHERIVQYYG----------CLRDDET----LSIFMEYMPGGSVKDQLKAY 98
Query: 918 --LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 975
L+ET V+ K I + V LHS I+HRDIK NIL D V
Sbjct: 99 GALTET----VTRKYTRQILEGVEY----LHSNMIVHRDIKGANILRDSAGN-------V 143
Query: 976 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 1035
KL DF + L T C + G+ + GTP WM+PEV+ YG + D+WS
Sbjct: 144 KLGDFGAS----KRLQTICSSGTGMKS---VTGTPYWMSPEVISG----EGYGRKADVWS 192
Query: 1036 YGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKP 1095
GC ++E+LT + P+ + + ++ +P P
Sbjct: 193 VGCTVVEMLTEKPPWAEFEAMAA--IFKIATQP------------------------TNP 226
Query: 1096 EAELETLSFLVDVFRRCTEENPTERPTAGDL 1126
+ + RR EN +RP+A +L
Sbjct: 227 QLPSHVSPDARNFLRRTFVENAKKRPSAEEL 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 9e-25
Identities = 78/269 (28%), Positives = 110/269 (40%), Gaps = 71/269 (26%)
Query: 860 EVRMLGALRHSCIVEMYGH--KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 917
E++ L R I + YG K S W I MEY GGS + + K
Sbjct: 49 EIQFLSQCRSPYITKYYGSFLKGSKLW----------------IIMEYCGGGSCLDLL-K 91
Query: 918 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 977
+ E +++ FI ++V L LH + +HRDIK+ NIL+ +G VKL
Sbjct: 92 PGKLDETYIA-----FILREVLLGLEYLHEEGKIHRDIKAANILLS-----EEGD--VKL 139
Query: 978 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1037
DF + L S ++ R + VGTP WMAPEV+ K + Y + DIWS G
Sbjct: 140 ADFGVSGQLTS-----TMSKR-----NTFVGTPFWMAPEVI----KQSGYDEKADIWSLG 185
Query: 1038 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 1097
+EL + P L + + LI P L G+ F KP
Sbjct: 186 ITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLE-----------------GNKFSKP-- 226
Query: 1098 ELETLSFLVDVFRRCTEENPTERPTAGDL 1126
D C ++P ERP+A +L
Sbjct: 227 -------FKDFVSLCLNKDPKERPSAKEL 248
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 66/219 (30%), Positives = 93/219 (42%), Gaps = 45/219 (20%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
EV +L L+H IV Y I + + L I MEY +GG + I+K
Sbjct: 49 EVNILRELKHPNIVRYYDRII----------DRSNQTLY--IVMEYCEGGDLAQLIQKCK 96
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELH-----SKHIMHRDIKSENILIDLERKKADGKPV 974
+ + + + I + AL E H ++HRD+K NI +D
Sbjct: 97 KERKY-IEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLD-------ANNN 148
Query: 975 VKLCDFDRAVPL---RSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 1031
VKL DF A L SF T VGTP +M+PE L M Y +
Sbjct: 149 VKLGDFGLAKILGHDSSFAKTY-------------VGTPYYMSPEQLNHMS----YDEKS 191
Query: 1032 DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL 1070
DIWS GCL+ EL L P+ ++L++ I+ GK R+
Sbjct: 192 DIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRI 230
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-23
Identities = 76/293 (25%), Positives = 108/293 (36%), Gaps = 43/293 (14%)
Query: 851 RNFEYSCLGEVRMLGALRH-SCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGG 909
L E+++L +L H IV++Y + MEYV GG
Sbjct: 38 SKEVERFLREIQILASLNHPPNIVKLYDFFQDEG--------------SLYLVMEYVDGG 83
Query: 910 SVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 969
S+++ ++K+ G +S ALFI + +AL LHSK I+HRDIK ENIL+D + +
Sbjct: 84 SLEDLLKKIGRKGP--LSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRV- 140
Query: 970 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGL 1029
VKL DF L L P VGTP +MAPEVL +
Sbjct: 141 -----VKLIDF----GLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAY-ASS 190
Query: 1030 EVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG 1089
DIWS G L ELLT P+ G T L
Sbjct: 191 SSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL--------------- 235
Query: 1090 SGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSSISSRS 1142
+ P D+ ++ ++P R ++ + S
Sbjct: 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDL 288
|
Length = 384 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 71/229 (31%), Positives = 95/229 (41%), Gaps = 52/229 (22%)
Query: 901 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960
I MEY +GGSV+ + K EK++SV I ++V AL +H ++HRDIK+ NI
Sbjct: 79 IIMEYAEGGSVRT-LMKAGPIAEKYISV-----IIREVLVALKYIHKVGVIHRDIKAANI 132
Query: 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1020
L+ VKLCDF A L VGTP WMAPEV+
Sbjct: 133 LVTNTGN-------VKLCDFGVAALLNQ----------NSSKRSTFVGTPYWMAPEVIT- 174
Query: 1021 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC 1080
+ Y + DIWS G + E+ T PY + LI K PRL D
Sbjct: 175 --EGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDN------- 225
Query: 1081 HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1129
G+ K L + C +E P ER +A +L +
Sbjct: 226 ----------GYSK---------LLREFVAACLDEEPKERLSAEELLKS 255
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 1e-21
Identities = 65/210 (30%), Positives = 100/210 (47%), Gaps = 43/210 (20%)
Query: 857 CLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 916
L E R+L ++RH +V +YG L +L+ MEYV GG + +++
Sbjct: 48 VLNEKRILQSIRHPFLVNLYGSFQDDSNL---------YLV-----MEYVPGGELFSHLR 93
Query: 917 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 976
K E A F A V AL LHS I++RD+K EN+L+D +DG +K
Sbjct: 94 KSGRFPEPV-----ARFYAAQVVLALEYLHSLDIVYRDLKPENLLLD-----SDGY--IK 141
Query: 977 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1036
+ DF A ++ +T C GTP ++APE++ K YG VD W+
Sbjct: 142 ITDFGFAKRVKGRTYTLC-------------GTPEYLAPEIIL--SKG--YGKAVDWWAL 184
Query: 1037 GCLLLELLTLQVPYMGLSELEIHDLIQMGK 1066
G L+ E+L P+ + ++I++ I GK
Sbjct: 185 GILIYEMLAGYPPFFDDNPIQIYEKILEGK 214
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 76/272 (27%), Positives = 107/272 (39%), Gaps = 67/272 (24%)
Query: 859 GEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKL 918
E+ ML RH IV +G + L I MEY GGS+++ +
Sbjct: 49 QEISMLKECRHPNIVAYFGSYLRRDKL--------------WIVMEYCGGGSLQDIYQVT 94
Query: 919 SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 978
+S ++ ++ L LH +HRDIK NIL+ DG VKL
Sbjct: 95 RG----PLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILL-----TEDGD--VKLA 143
Query: 979 DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1038
DF + L T IA R +GTP WMAPEV A+ + Y + DIW+ G
Sbjct: 144 DFGVSAQL-----TATIAKR-----KSFIGTPYWMAPEVA-AVERKGGYDGKCDIWALGI 192
Query: 1039 LLLELLTLQVPYMGLSELEIHDLIQMGKR----PRLTDELEALGSCHEHEVAQSGSGFEK 1094
+EL LQ P L + L + K P+L D+
Sbjct: 193 TAIELAELQPPMFDLHPMRA--LFLISKSNFPPPKLKDK--------------------- 229
Query: 1095 PEAELETLSFLVDVFRRCTEENPTERPTAGDL 1126
E + F D ++C ++P +RPTA L
Sbjct: 230 ---EKWSPVF-HDFIKKCLTKDPKKRPTATKL 257
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 3e-21
Identities = 76/269 (28%), Positives = 118/269 (43%), Gaps = 70/269 (26%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 917
EV ++ +H IVEMY +L+ ++ ME+++GG++ + +
Sbjct: 66 EVVIMRDYQHPNIVEMYSS----------------YLVGDELWVVMEFLEGGALTDIVTH 109
Query: 918 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 977
E+ +V LA V AL LH++ ++HRDIKS++IL+ +DG VKL
Sbjct: 110 TRMNEEQIATVCLA------VLKALSFLHAQGVIHRDIKSDSILL-----TSDG--RVKL 156
Query: 978 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1037
DF F C + +P VGTP WMAPEV+ P YG EVDIWS G
Sbjct: 157 SDF-------GF---CAQVSKEVPRRKSLVGTPYWMAPEVIS--RLP--YGTEVDIWSLG 202
Query: 1038 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 1097
+++E++ + PY L+ I+ P+L + H+V+ F
Sbjct: 203 IMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLK---------NLHKVSPRLRSF----- 248
Query: 1098 ELETLSFLVDVFRRCTEENPTERPTAGDL 1126
R +P +R TA +L
Sbjct: 249 -----------LDRMLVRDPAQRATAAEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 4e-21
Identities = 75/302 (24%), Positives = 113/302 (37%), Gaps = 70/302 (23%)
Query: 833 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGN 891
A K+ + + +EI+ E +L H I YG I N
Sbjct: 34 VAIKI--MDIIEDEEEEIKE-------EYNILRKYSNHPNIATFYGAFIKK--------N 76
Query: 892 PEHHLLQSAIFMEYVKGGSVKNYIEKLSETG----EKHVSVKLALFIAQDVAAALVELHS 947
P + Q + ME GGSV + ++ L + G E+ ++ +I ++ L LH
Sbjct: 77 PPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA-----YILRETLRGLAYLHE 131
Query: 948 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCV 1007
++HRDIK +NIL+ K A+ VKL DF + L S L + +
Sbjct: 132 NKVIHRDIKGQNILLT---KNAE----VKLVDFGVSAQLDSTLG----------RRNTFI 174
Query: 1008 GTPRWMAPEVLRAMHKPNL-YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1066
GTP WMAPEV+ +P+ Y D+WS G +EL + P + + I
Sbjct: 175 GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP 234
Query: 1067 RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1126
P L E + F D C +N +RP +L
Sbjct: 235 PPTLK------------------------SPENWSKKF-NDFISECLIKNYEQRPFMEEL 269
Query: 1127 YE 1128
E
Sbjct: 270 LE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|222722 pfam14381, EDR1, Ethylene-responsive protein kinase Le-CTR1 | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 1e-20
Identities = 69/255 (27%), Positives = 93/255 (36%), Gaps = 75/255 (29%)
Query: 521 SNASQKYSSVSFCSIEDRLPDGFYD---------AGRDRPFMQLTGYEQTPHLD-SREVI 570
S +Y S +D++PDGFYD L + P D S EV+
Sbjct: 5 EALSHRYWVYGCLSYDDKIPDGFYDIYGMDPCSDLKEFGRIPSLEDLQAVPPGDSSFEVV 64
Query: 571 LVDRKSDEELDAIALSAQALVLHLKQLNGLTKDGVIEPVDNLQIALLLALFVSDHFGGSD 630
LVDR++D +L + A+ LV + + LA VSDH GG
Sbjct: 65 LVDRRTDPKLKELEQLARCLVSGC-------------GTNTAALVQKLAGLVSDHMGGP- 110
Query: 631 RSGIVERTRKTVSGSNYRKPFVCTCSTGNSDSANTSQKQILDAVEDIVLSDLCEKSLRSI 690
V + S L S
Sbjct: 111 -----------VKDAE---------------------------------SMLARWKECSN 126
Query: 691 KSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRG--YLDFQPHAWNTILV 748
+ K NS VVP+GS++ G+CRHRA+L K L D + +PC LV+G Y A N LV
Sbjct: 127 ELKENSGVVPLGSLKIGLCRHRALLFKVLADSIG--LPCRLVKGCKYCGSDDDASN--LV 182
Query: 749 KKGDSWIRMIVDACR 763
K D +VD
Sbjct: 183 KFDDG-REYLVDLMG 196
|
EDR1 regulates disease resistance and ethylene-induced senescence, and is also involved in stress response signalling and cell death regulation. Length = 203 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 2e-20
Identities = 82/308 (26%), Positives = 136/308 (44%), Gaps = 74/308 (24%)
Query: 833 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMY-GHKISSK-WLPSADG 890
AAAK+ ++ S +E+ +F + E+ +L +H IV +Y + +K W
Sbjct: 33 AAAKIIQIE----SEEELEDF----MVEIDILSECKHPNIVGLYEAYFYENKLW------ 78
Query: 891 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHI 950
I +E+ GG++ + + +L E+ ++ ++ + + AL LHS +
Sbjct: 79 ----------ILIEFCDGGALDSIMLEL----ERGLTEPQIRYVCRQMLEALNFLHSHKV 124
Query: 951 MHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP 1010
+HRD+K+ NIL+ L+ VKL DF + +S L D +GTP
Sbjct: 125 IHRDLKAGNILLTLDGD-------VKLADFGVSAKNKSTLQK----------RDTFIGTP 167
Query: 1011 RWMAPEVLRA-MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPR 1069
WMAPEV+ K N Y + DIWS G L+EL ++ P+ L+ + + I + P
Sbjct: 168 YWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPT 227
Query: 1070 LTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1129
L Q S + SF D + C ++P +RPTA +L +
Sbjct: 228 L---------------DQP-SKWSS--------SF-NDFLKSCLVKDPDDRPTAAELLKH 262
Query: 1130 -FVARTSS 1136
FV+ S
Sbjct: 263 PFVSDQSD 270
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 2e-20
Identities = 60/217 (27%), Positives = 91/217 (41%), Gaps = 57/217 (26%)
Query: 856 SCLGEVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSV 911
+ L E+ +L L+H IV++ H +L +F + +
Sbjct: 44 TALREISLLKELKHPNIVKLLDVIHTERKLYL---------------VFEYCDM----DL 84
Query: 912 KNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 971
K Y++K +S L I + L HS I+HRD+K +NILI +
Sbjct: 85 KKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI-------NR 133
Query: 972 KPVVKLCDFD--RA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 1027
V+KL DF RA +PLR++ H V T + APE+L Y
Sbjct: 134 DGVLKLADFGLARAFGIPLRTYTHE--------------VVTLWYRAPEILLGSKH---Y 176
Query: 1028 GLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 1064
VDIWS GC+ E++T + + G S EI L ++
Sbjct: 177 STAVDIWSVGCIFAEMITGKPLFPGDS--EIDQLFKI 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 2e-20
Identities = 51/171 (29%), Positives = 76/171 (44%), Gaps = 26/171 (15%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
+EY G + YI K + K F A ++ AL LHSK I+HRD+K ENIL+
Sbjct: 81 LEYAPNGELLQYIRKYGS-----LDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILL 135
Query: 963 DLERKKADGKPVVKLCDFDRA-------VPLRSFLHTCCIAHRGIPAPDVC---VGTPRW 1012
D D +K+ DF A P + I + VGT +
Sbjct: 136 D-----KDMH--IKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEY 188
Query: 1013 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQ 1063
++PE+L KP G D+W+ GC++ ++LT + P+ G +E I
Sbjct: 189 VSPELLN--EKP--AGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL 235
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 3e-20
Identities = 77/285 (27%), Positives = 117/285 (41%), Gaps = 90/285 (31%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
E+ L L H IV+ G E +IF+EYV GGS+ + +
Sbjct: 58 EIETLKDLDHLNIVQYLGF--------------ETTEEYLSIFLEYVPGGSIGSCLRTYG 103
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
E+ V F + V L LHSK I+HRD+K++N+L+D ADG + K+ D
Sbjct: 104 RFEEQLVR-----FFTEQVLEGLAYLHSKGILHRDLKADNLLVD-----ADG--ICKISD 151
Query: 980 F------------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 1027
F D+ + ++ G+ WMAPEV+ + + Y
Sbjct: 152 FGISKKSDDIYDNDQNMSMQ--------------------GSVFWMAPEVIHSYSQG--Y 189
Query: 1028 GLEVDIWSYGCLLLELLTLQVPYMGLSELE-IHDLIQMG---KRPRLTDELEALGSCHEH 1083
+VDIWS GC++LE+ + P+ S+ E I + ++G P + ++ S
Sbjct: 190 SAKVDIWSLGCVVLEMFAGRRPW---SDEEAIAAMFKLGNKRSAPPIPPDVSMNLS---- 242
Query: 1084 EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1128
P A L FL C NP RPTA +L +
Sbjct: 243 -----------PVA----LDFL----NACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 76/321 (23%), Positives = 125/321 (38%), Gaps = 69/321 (21%)
Query: 813 DEAGKSVSSSLFR--CKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS 870
+ G ++ ++ C + A K L+ C +S DE+R EV+ + H
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRK-------EVQAMSQCNHP 59
Query: 871 CIVEMYGHKI--SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE-KLSETGEKHVS 927
+V+ Y + W + M Y+ GGS+ + ++ G
Sbjct: 60 NVVKYYTSFVVGDELW----------------LVMPYLSGGSLLDIMKSSYPRGGLDEAI 103
Query: 928 VKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR 987
+ + ++V L LHS +HRDIK+ NIL+ DG VK+ DF +
Sbjct: 104 IA---TVLKEVLKGLEYLHSNGQIHRDIKAGNILLG-----EDGS--VKIADFGVSA--- 150
Query: 988 SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 1047
S + VGTP WMAPEV M + + Y + DIWS+G +EL T
Sbjct: 151 SLADGGDRTRK---VRKTFVGTPCWMAPEV---MEQVHGYDFKADIWSFGITAIELATGA 204
Query: 1048 VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVD 1107
PY +++ L P L + + F K ++
Sbjct: 205 APYSKYPPMKVLMLTLQNDPPSLE---------TGADYKKYSKSFRK----------MIS 245
Query: 1108 VFRRCTEENPTERPTAGDLYE 1128
C +++P++RPTA +L +
Sbjct: 246 ---LCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 3e-20
Identities = 75/278 (26%), Positives = 122/278 (43%), Gaps = 67/278 (24%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
EV ++ +H +VEMY + + L + ME+++GG++ + + +
Sbjct: 68 EVVIMRDYQHQNVVEMYKSYLVGEEL--------------WVLMEFLQGGALTDIVSQTR 113
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
E+ +V + V AL LHS+ ++HRDIKS++IL+ L DG+ VKL D
Sbjct: 114 LNEEQIATV------CESVLQALCYLHSQGVIHRDIKSDSILLTL-----DGR--VKLSD 160
Query: 980 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039
F C + +P VGTP WMAPEV+ YG EVDIWS G +
Sbjct: 161 FG----------FCAQISKDVPKRKSLVGTPYWMAPEVI----SRTPYGTEVDIWSLGIM 206
Query: 1040 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 1099
++E++ + PY S ++ ++ P+L + H+++
Sbjct: 207 VIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKN---------AHKIS------------- 244
Query: 1100 ETLSFLVDVFRRCTEENPTERPTAGDLYEM-FVARTSS 1136
L D R P ER TA +L + F+ +T
Sbjct: 245 ---PVLRDFLERMLTREPQERATAQELLDHPFLLQTGL 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 6e-20
Identities = 68/268 (25%), Positives = 104/268 (38%), Gaps = 66/268 (24%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
E+ +L IV+ YG + L I MEY GSV + ++ +
Sbjct: 48 EISILKQCDSPYIVKYYGSYFKNT-----------DLW---IVMEYCGAGSVSDIMKITN 93
Query: 920 ET-GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 978
+T E+ ++ I L LHS +HRDIK+ NIL++ +G KL
Sbjct: 94 KTLTEEEIAA-----ILYQTLKGLEYLHSNKKIHRDIKAGNILLN-----EEG--QAKLA 141
Query: 979 DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1038
DF + L + A R +GTP WMAPEV+ + Y + DIWS G
Sbjct: 142 DFGVSGQLTDTM-----AKRN-----TVIGTPFWMAPEVI----QEIGYNNKADIWSLGI 187
Query: 1039 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 1098
+E+ + PY +IH + + P + PE
Sbjct: 188 TAIEMAEGKPPYS-----DIHPMRAIFMIPN-----------------KPPPTLSDPE-- 223
Query: 1099 LETLSFLVDVFRRCTEENPTERPTAGDL 1126
+ D ++C ++P ERP+A L
Sbjct: 224 -KWSPEFNDFVKKCLVKDPEERPSAIQL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-19
Identities = 74/234 (31%), Positives = 110/234 (47%), Gaps = 46/234 (19%)
Query: 843 CGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF 902
++ E+ E C E+++L LRH IV+ YG +PE L +IF
Sbjct: 41 SQETSKEVNALE--C--EIQLLKNLRHDRIVQYYG----------CLRDPEEKKL--SIF 84
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
+EY+ GGS+K+ ++ E V+ + I Q V+ LHS I+HRDIK NIL
Sbjct: 85 VEYMPGGSIKDQLKAYGALTEN-VTRRYTRQILQGVSY----LHSNMIVHRDIKGANIL- 138
Query: 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1022
D VKL DF + + T C++ GI + GTP WM+PEV+
Sbjct: 139 ------RDSAGNVKLGDFGAS----KRIQTICMSGTGIKS---VTGTPYWMSPEVISG-- 183
Query: 1023 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE----IHDLIQMGKRPRLTD 1072
YG + D+WS C ++E+LT + P+ +E E I + +P L D
Sbjct: 184 --EGYGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQPTKPMLPD 232
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 1e-19
Identities = 73/290 (25%), Positives = 116/290 (40%), Gaps = 58/290 (20%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
V+ + +++ E + E+R++ L H I+ M G A H
Sbjct: 30 VKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLG----------ATCEDSHF- 78
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
+F+E++ GGSV + + K E V + + + L LH I+HRD+K
Sbjct: 79 ---NLFVEWMAGGSVSHLLSKYGAFKEA-VIINYTEQLLR----GLSYLHENQIIHRDVK 130
Query: 957 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1016
N+LID + G+ +++ DF A L + T +G +GT +MAPE
Sbjct: 131 GANLLID-----STGQ-RLRIADFGAAARLAAKG-TGAGEFQG-----QLLGTIAFMAPE 178
Query: 1017 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEA 1076
VLR YG D+WS GC+++E+ T K P ++
Sbjct: 179 VLRGEQ----YGRSCDVWSVGCVIIEMAT-------------------AKPPWNAEKH-- 213
Query: 1077 LGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1126
S H + + S P L DV RC E P +RP + +L
Sbjct: 214 --SNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSREL 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 4e-19
Identities = 61/207 (29%), Positives = 88/207 (42%), Gaps = 37/207 (17%)
Query: 857 CLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 916
CL E+ +L L H +++ I + L I +E G + I+
Sbjct: 49 CLKEIDLLKQLDHPNVIKYLASFIENNEL--------------NIVLELADAGDLSRMIK 94
Query: 917 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 976
+ + + Q + +AL +HSK IMHRDIK N+ I A G VVK
Sbjct: 95 HFKKQKRLIPERTIWKYFVQ-LCSALEHMHSKRIMHRDIKPANVFIT-----ATG--VVK 146
Query: 977 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1036
L D R F AH VGTP +M+PE + N Y + DIWS
Sbjct: 147 LGDLGLG---RFFSSKTTAAHS-------LVGTPYYMSPERIHE----NGYNFKSDIWSL 192
Query: 1037 GCLLLELLTLQVPYMGLSELEIHDLIQ 1063
GCLL E+ LQ P+ G ++ ++ L +
Sbjct: 193 GCLLYEMAALQSPFYG-DKMNLYSLCK 218
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 7e-19
Identities = 71/227 (31%), Positives = 104/227 (45%), Gaps = 38/227 (16%)
Query: 833 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 892
A +V V SS D R+ + E+ +L L+H IV+ G + + L
Sbjct: 29 AVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL------- 81
Query: 893 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 952
IF+EYV GGSV + E V F+ Q + L LH++ I+H
Sbjct: 82 -------NIFLEYVPGGSVAALLNNYGAFEETLVRN----FVRQ-ILKGLNYLHNRGIIH 129
Query: 953 RDIKSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTP 1010
RDIK NIL+D K +K+ DF + + S L T R P + G+
Sbjct: 130 RDIKGANILVD-------NKGGIKISDFGISKKLEANS-LSTKTNGAR----PSL-QGSV 176
Query: 1011 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE 1057
WMAPEV+ K Y + DIWS GCL++E+LT + P+ ++L+
Sbjct: 177 FWMAPEVV----KQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 65/191 (34%), Positives = 93/191 (48%), Gaps = 35/191 (18%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
E+++L L H IV+ YG E L +IFME++ GGS+K+ ++
Sbjct: 54 EIQLLKNLLHERIVQYYG---------CLRDPMERTL---SIFMEHMPGGSIKDQLKSYG 101
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
E V+ K I + V+ LHS I+HRDIK NIL D VKL D
Sbjct: 102 ALTEN-VTRKYTRQILEGVSY----LHSNMIVHRDIKGANIL-------RDSVGNVKLGD 149
Query: 980 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039
F + L T C++ G+ + GTP WM+PEV+ YG + DIWS GC
Sbjct: 150 FGAS----KRLQTICLSGTGMKS---VTGTPYWMSPEVISG----EGYGRKADIWSVGCT 198
Query: 1040 LLELLTLQVPY 1050
++E+LT + P+
Sbjct: 199 VVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 3e-18
Identities = 65/191 (34%), Positives = 92/191 (48%), Gaps = 35/191 (18%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
E+++L L+H IV+ YG E L IFMEY+ GGSVK+ ++
Sbjct: 54 EIQLLKNLQHERIVQYYG---------CLRDRAEKTL---TIFMEYMPGGSVKDQLKAYG 101
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
E V+ K + + + LHS I+HRDIK NIL D VKL D
Sbjct: 102 ALTES-VTRKYT----RQILEGMSYLHSNMIVHRDIKGANIL-------RDSAGNVKLGD 149
Query: 980 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039
F + L T C++ GI + GTP WM+PEV+ YG + D+WS GC
Sbjct: 150 FGAS----KRLQTICMSGTGIRS---VTGTPYWMSPEVISG----EGYGRKADVWSLGCT 198
Query: 1040 LLELLTLQVPY 1050
++E+LT + P+
Sbjct: 199 VVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 3e-18
Identities = 74/267 (27%), Positives = 118/267 (44%), Gaps = 66/267 (24%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
EV ++ +H +VEMY + L + ME+++GG++ + +
Sbjct: 67 EVVIMRDYQHENVVEMYNSYLVGDEL--------------WVVMEFLEGGALTDIVTHTR 112
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
E+ +V LA V AL LH++ ++HRDIKS++IL+ DG+ VKL D
Sbjct: 113 MNEEQIAAVCLA------VLKALSVLHAQGVIHRDIKSDSILL-----THDGR--VKLSD 159
Query: 980 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039
F C + +P VGTP WMAPE++ + YG EVDIWS G +
Sbjct: 160 FG----------FCAQVSKEVPRRKSLVGTPYWMAPELISRLP----YGPEVDIWSLGIM 205
Query: 1040 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 1099
++E++ + PY L+ +I+ P+L + H+V+ S GF
Sbjct: 206 VIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKN---------LHKVSPSLKGF------- 249
Query: 1100 ETLSFLVDVFRRCTEENPTERPTAGDL 1126
R +P +R TA +L
Sbjct: 250 ---------LDRLLVRDPAQRATAAEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 57/168 (33%), Positives = 80/168 (47%), Gaps = 22/168 (13%)
Query: 901 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960
+ MEY+ GG + + +E + E ++IA+ + AL LHS I+HRD+K +NI
Sbjct: 70 LVMEYLPGGDLASLLENVGSLDEDVA----RIYIAE-IVLALEYLHSNGIIHRDLKPDNI 124
Query: 961 LIDLERKKADGKPVVKLCDFDRAVPLRSF-LHTCCIAHRGIPAPDV-CVGTPRWMAPEVL 1018
LID ++G +KL DF L L I D VGTP ++APEV+
Sbjct: 125 LID-----SNGH--LKLTDFG----LSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 1019 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1066
+ VD WS GC+L E L P+ G + EI I GK
Sbjct: 174 LGQG----HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGK 217
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 7e-18
Identities = 55/172 (31%), Positives = 89/172 (51%), Gaps = 27/172 (15%)
Query: 901 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960
+ ME+++GG++ + + E+ +V L+ V AL LH++ ++HRDIKS++I
Sbjct: 96 VVMEFLEGGALTDIVTHTRMNEEQIATVCLS------VLRALSYLHNQGVIHRDIKSDSI 149
Query: 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1020
L+ +DG+ +KL DF C + +P VGTP WMAPEV+
Sbjct: 150 LL-----TSDGR--IKLSDFG----------FCAQVSKEVPKRKSLVGTPYWMAPEVISR 192
Query: 1021 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTD 1072
+ YG EVDIWS G +++E++ + PY L+ I+ PR+ D
Sbjct: 193 LP----YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKD 240
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 8e-18
Identities = 78/293 (26%), Positives = 125/293 (42%), Gaps = 55/293 (18%)
Query: 846 SADEIRNFEYSCLGEVRMLGALRHSCIVEMY-GHKISSKWLPSADGNPEHHLLQSAIFME 904
++++ + L EV++L LRH IV + + + +L+ E
Sbjct: 39 DDEDVKK---TALREVKVLRQLRHENIVNLKEAFRRKGRL----------YLV-----FE 80
Query: 905 YVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964
YV ++ +E S G +V+ ++ + A+ HS +I+HRDIK ENIL+
Sbjct: 81 YV-ERTLLELLEA-SPGGLPPDAVRSYIW---QLLQAIAYCHSHNIIHRDIKPENILVSE 135
Query: 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHK 1023
V+KLCDF A LR+ R V T RW APE+L
Sbjct: 136 SG-------VLKLCDFGFARALRA---------RPASPLTDYVAT-RWYRAPELLV---G 175
Query: 1024 PNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEH 1083
YG VD+W+ GC++ ELL + + G S+++ LIQ P L + L S +
Sbjct: 176 DTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGP-LPPSHQELFSSNPR 234
Query: 1084 -------EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1129
E +Q S + ++ S +D + C +P ER T +L +
Sbjct: 235 FAGVAFPEPSQPESLERRYPGKVS--SPALDFLKACLRMDPKERLTCDELLQH 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 9e-18
Identities = 65/276 (23%), Positives = 111/276 (40%), Gaps = 67/276 (24%)
Query: 855 YSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY 914
L E+ +L L+H I+ Y H + L I MEY GG
Sbjct: 44 RDALNEIVILSLLQHPNIIAYYNHFMDDNTL--------------LIEMEYANGG---TL 86
Query: 915 IEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 974
+K+ + ++ L+ + +A+ +H I+HRDIK+ NI + KA +
Sbjct: 87 YDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLT----KAG---L 139
Query: 975 VKLCDFDRAVPLRS-FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 1033
+KL DF + L S + + VGTP +M+PE+ + + Y + DI
Sbjct: 140 IKLGDFGISKILGSEYSMA-----------ETVVGTPYYMSPELCQGVK----YNFKSDI 184
Query: 1034 WSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE 1093
W+ GC+L ELLTL+ + + L + I G + V+ S
Sbjct: 185 WALGCVLYELLTLKRTFDATNPLNLVVKIVQGN--------------YTPVVSVYSSE-- 228
Query: 1094 KPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1129
L+ + +++P +RPTA ++ +
Sbjct: 229 -----------LISLVHSLLQQDPEKRPTADEVLDQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 2e-17
Identities = 59/184 (32%), Positives = 80/184 (43%), Gaps = 38/184 (20%)
Query: 893 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 952
E HL + MEY+ GG + N + + E+ A F ++ AL +H +H
Sbjct: 73 EEHLY---LVMEYMPGGDLMNLLIRKDVFPEET-----ARFYIAELVLALDSVHKLGFIH 124
Query: 953 RDIKSENILIDLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPA 1002
RDIK +NILID ADG +KL DF DR L + + +
Sbjct: 125 RDIKPDNILID-----ADGH--IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177
Query: 1003 PD---------VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGL 1053
D VGTP ++APEVLR YGLE D WS G +L E+L P+
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVLRGTP----YGLECDWWSLGVILYEMLYGFPPFYSD 233
Query: 1054 SELE 1057
+ E
Sbjct: 234 TLQE 237
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 58/217 (26%), Positives = 87/217 (40%), Gaps = 45/217 (20%)
Query: 848 DEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVK 907
+RN L E R+L L H +V ++ + + E+ L ++ +
Sbjct: 42 GSVRNV----LNERRILQELNHPFLVNLW----------YSFQDEENMYL----VVDLLL 83
Query: 908 GGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 967
GG ++ ++ + + E+ V F ++ AL LHSK I+HRDIK +NIL+D
Sbjct: 84 GGDLRYHLSQKVKFSEEQVK-----FWICEIVLALEYLHSKGIIHRDIKPDNILLD---- 134
Query: 968 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 1027
G V + DF+ A GTP +MAPEVL Y
Sbjct: 135 -EQGH--VHITDFNIA----------TKVTPDTLTTSTS-GTPGYMAPEVLCR----QGY 176
Query: 1028 GLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 1064
+ VD WS G E L + PY G S +
Sbjct: 177 SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK 213
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 3e-17
Identities = 61/207 (29%), Positives = 93/207 (44%), Gaps = 43/207 (20%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
E R+L + H I+ ++ + + L + MEYV GG + +Y+
Sbjct: 51 EKRVLKEVSHPFIIRLF-----------WTEHDQRFLY---MLMEYVPGGELFSYLR--- 93
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
S LF A ++ AL LHSK I++RD+K ENIL+D +G +KL D
Sbjct: 94 --NSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLD-----KEGH--IKLTD 144
Query: 980 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039
F A LR T C GTP ++APEV+++ + VD W+ G L
Sbjct: 145 FGFAKKLRDRTWTLC-------------GTPEYLAPEVIQSKG----HNKAVDWWALGIL 187
Query: 1040 LLELLTLQVPYMGLSELEIHDLIQMGK 1066
+ E+L P+ + I++ I GK
Sbjct: 188 IYEMLVGYPPFFDDNPFGIYEKILAGK 214
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 4e-17
Identities = 50/165 (30%), Positives = 75/165 (45%), Gaps = 32/165 (19%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
MEYV GG + +I++ E A F A ++ L LH + I++RD+K +N+L+
Sbjct: 75 MEYVNGGDLMFHIQRSGRFDEPR-----ARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL 129
Query: 963 DLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1019
D ++G +K+ DF + T C GTP ++APE+L
Sbjct: 130 D-----SEGH--IKIADFGMCKEGILGGVTTSTFC-------------GTPDYIAPEILS 169
Query: 1020 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 1064
YG VD W+ G LL E+L Q P+ G E E+ I
Sbjct: 170 YQ----PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE 210
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 70/283 (24%), Positives = 106/283 (37%), Gaps = 77/283 (27%)
Query: 858 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM--EYVKGGSVKNYI 915
L E ++ +L H ++ +YG +L + M E GS+ +
Sbjct: 44 LKEAAIMHSLDHENLIRLYGV-----------------VLTHPLMMVTELAPLGSL---L 83
Query: 916 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 975
++L + H + A +A + L SK +HRD+ + NIL+ + K V
Sbjct: 84 DRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDK-------V 136
Query: 976 KLCDFD--RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM---HKPNLYGLE 1030
K+ DF RA+P H H +P W APE LR H
Sbjct: 137 KIGDFGLMRALPQNE-DHYVMEEHLKVPFA--------WCAPESLRTRTFSHAS------ 181
Query: 1031 VDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG 1089
D+W +G L E+ T + P+ GLS +I I E E L
Sbjct: 182 -DVWMFGVTLWEMFTYGEEPWAGLSGSQILKKID--------KEGERL------------ 220
Query: 1090 SGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVA 1132
E+PEA + + +V +C NP +RPT L E
Sbjct: 221 ---ERPEACPQD---IYNVMLQCWAHNPADRPTFAALREFLPE 257
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 6e-17
Identities = 53/162 (32%), Positives = 74/162 (45%), Gaps = 29/162 (17%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
MEY GG + + E A F V A LH++ I++RD+K EN+L+
Sbjct: 72 MEYCLGGELWTILRDRGLFDEYT-----ARFYIACVVLAFEYLHNRGIIYRDLKPENLLL 126
Query: 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1022
D ++G VKL DF A L+S T GTP ++APE++
Sbjct: 127 D-----SNG--YVKLVDFGFAKKLKSGQKTWTF-----------CGTPEYVAPEIILNKG 168
Query: 1023 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSE--LEIHDLI 1062
Y VD WS G LL ELLT + P+ E +EI++ I
Sbjct: 169 ----YDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDI 206
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 6e-17
Identities = 54/158 (34%), Positives = 85/158 (53%), Gaps = 30/158 (18%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
MEYV GG + +I+++ + E H A+F A ++A L LHSK I++RD+K +N+++
Sbjct: 80 MEYVNGGDLMYHIQQVGKFKEPH-----AVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134
Query: 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH--RGIPAPDVCVGTPRWMAPEVLRA 1020
D A+G +K+ DF C + G C GTP ++APE++
Sbjct: 135 D-----AEGH--IKIADFGM-----------CKENIFGGKTTRTFC-GTPDYIAPEII-- 173
Query: 1021 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEI 1058
++P YG VD W++G LL E+L Q P+ G E E+
Sbjct: 174 AYQP--YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 7e-17
Identities = 67/204 (32%), Positives = 97/204 (47%), Gaps = 42/204 (20%)
Query: 901 IFMEYVKGGSVKNYI-EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959
+ MEY+ GGS+ + + E + G+ + ++ AL LHS ++HRDIKS+N
Sbjct: 93 VVMEYLAGGSLTDVVTETCMDEGQIAA-------VCRECLQALEFLHSNQVIHRDIKSDN 145
Query: 960 ILIDLERKKADGKPVVKLCDFD---RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1016
IL+ + DG VKL DF + P +S T VGTP WMAPE
Sbjct: 146 ILLGM-----DGS--VKLTDFGFCAQITPEQSKRST-------------MVGTPYWMAPE 185
Query: 1017 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLT--DEL 1074
V+ YG +VDIWS G + +E++ + PY+ + L LI P L ++L
Sbjct: 186 VVTRKA----YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKL 241
Query: 1075 EA-----LGSCHEHEVAQSGSGFE 1093
A L C E +V + GS E
Sbjct: 242 SAIFRDFLNRCLEMDVEKRGSAKE 265
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 7e-17
Identities = 61/238 (25%), Positives = 98/238 (41%), Gaps = 70/238 (29%)
Query: 900 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSE 958
+I +EY+ GGS+ + ++K+ + E ++ +IA+ + L LH+K HI+HRDIK
Sbjct: 75 SIVLEYMDGGSLADLLKKVGKIPEPVLA-----YIARQILKGLDYLHTKRHIIHRDIKPS 129
Query: 959 NILIDLERKKADGKPVVKLCDF-------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR 1011
N+LI+ K VK+ DF + +F VGT
Sbjct: 130 NLLINS-------KGEVKIADFGISKVLENTLDQCNTF-----------------VGTVT 165
Query: 1012 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDL---IQMGKRP 1068
+M+PE ++ Y DIWS G LLE + P++ + +L I G P
Sbjct: 166 YMSPERIQGES----YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPP 221
Query: 1069 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1126
L E E E F+ C +++P +RP+A +L
Sbjct: 222 SLPAE----------------------EFSPEFRDFI----SACLQKDPKKRPSAAEL 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 84/320 (26%), Positives = 127/320 (39%), Gaps = 67/320 (20%)
Query: 813 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYS--CLGEVRMLGALRHS 870
DE G+ V L + +G AA + T R+ Y E+ + L+H
Sbjct: 8 DENGERVV--LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65
Query: 871 CIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKL 930
IV+ G + + IFME V GGS+ + S+ G + +
Sbjct: 66 NIVQYLGSDSENGFF--------------KIFMEQVPGGSLSALLR--SKWGPLKDNEQT 109
Query: 931 ALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFL 990
+F + + L LH I+HRDIK +N+L++ VVK+ DF
Sbjct: 110 IIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSG------VVKISDFG--------- 154
Query: 991 HTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1050
T P + GT ++MAPEV+ P YG DIWS GC ++E+ T + P+
Sbjct: 155 -TSKRLAGINPCTETFTGTLQYMAPEVID--KGPRGYGAPADIWSLGCTIVEMATGKPPF 211
Query: 1051 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL-ETLSFLVDVF 1109
I++G E + A G K E+ E+LS F
Sbjct: 212 -----------IELG----------------EPQAAMFKVGMFKIHPEIPESLSAEAKNF 244
Query: 1110 -RRCTEENPTERPTAGDLYE 1128
RC E +P +R +A DL +
Sbjct: 245 ILRCFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 60/215 (27%), Positives = 92/215 (42%), Gaps = 38/215 (17%)
Query: 856 SCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 915
+ E+R+L ++ H I+ + DGN + I MEY G + I
Sbjct: 45 DAVNEIRILASVNHPNIISYKEAFL--------DGN------KLCIVMEYAPFGDLSKAI 90
Query: 916 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 975
K + K + + I + L LH + I+HRD+KS NIL+ +V
Sbjct: 91 SKRKKKR-KLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILL------VAND-LV 142
Query: 976 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 1035
K+ D + L+ + I GTP +MAPEV + +P Y + DIWS
Sbjct: 143 KIGDLGISKVLKKNMAKTQI------------GTPHYMAPEVWKG--RP--YSYKSDIWS 186
Query: 1036 YGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL 1070
GCLL E+ T P+ S ++ +Q GK P +
Sbjct: 187 LGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPI 221
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 72/235 (30%), Positives = 101/235 (42%), Gaps = 52/235 (22%)
Query: 900 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959
I MEY +GGS+ + +K+ + G + + K+ IA+ V L LHS+ I+HRDIK N
Sbjct: 77 GIAMEYCEGGSLDSIYKKVKKRGGR-IGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSN 135
Query: 960 ILIDLERKKADGKPVVKLCDFDRAVPL-RSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1018
IL+ K VKLCDF + L S T GT +MAPE
Sbjct: 136 ILLTR-------KGQVKLCDFGVSGELVNSLAGT-------------FTGTSFYMAPE-- 173
Query: 1019 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY-----MGLSELEIHDLIQMGKRPRLTDE 1073
R KP Y + D+WS G LLE+ + P+ L +E+ I P L DE
Sbjct: 174 RIQGKP--YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDE 231
Query: 1074 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1128
P ++ D ++C E++PT RPT D+ E
Sbjct: 232 ---------------------PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 55/174 (31%), Positives = 78/174 (44%), Gaps = 33/174 (18%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
MEYV GG + + L E H A F ++ A+ LH +HRD+K EN LI
Sbjct: 80 MEYVPGGDFRTLLNNLGVLSEDH-----ARFYMAEMFEAVDALHELGYIHRDLKPENFLI 134
Query: 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1022
D A G +KL DF + + ++ ++ VG+P +MAPEVLR
Sbjct: 135 D-----ASGH--IKLTDFGLSKGIVTYANS-------------VVGSPDYMAPEVLRGKG 174
Query: 1023 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI----QMGKRPRLTD 1072
Y VD WS GC+L E L P+ G + E + + + +RP D
Sbjct: 175 ----YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDD 224
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 66/227 (29%), Positives = 102/227 (44%), Gaps = 52/227 (22%)
Query: 826 CKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885
C+ + ++ + V + DE + E ++L L H I+E Y + + K L
Sbjct: 19 CRRKADQKLVIIKQIPVEQMTKDE----RLAAQNECQVLKLLSHPNIIEYYENFLEDKAL 74
Query: 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK-----LSETGEKHVSVKLALFIAQDVAA 940
I MEY GG++ YI+K L E H V++ L
Sbjct: 75 --------------MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILL-------- 112
Query: 941 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGI 1000
AL +H+K I+HRD+K++NIL+D + K VVK+ DF + L S
Sbjct: 113 ALHHVHTKLILHRDLKTQNILLD--KHKM----VVKIGDFGISKILSS-----------K 155
Query: 1001 PAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 1047
VGTP +++PE+ KP Y + DIW+ GC+L EL +L+
Sbjct: 156 SKAYTVVGTPCYISPELCEG--KP--YNQKSDIWALGCVLYELASLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 2e-16
Identities = 54/162 (33%), Positives = 83/162 (51%), Gaps = 30/162 (18%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
MEYV GG + I+++ E H A+F A ++A L LHSK I++RD+K +N+++
Sbjct: 80 MEYVNGGDLMYQIQQVGRFKEPH-----AVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134
Query: 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH--RGIPAPDVCVGTPRWMAPEVLRA 1020
D E +K+ DF C + G+ C GTP ++APE++
Sbjct: 135 DSEGH-------IKIADFGM-----------CKENMWDGVTTKTFC-GTPDYIAPEIIA- 174
Query: 1021 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 1062
++P YG VD W++G LL E+L Q P+ G E E+ I
Sbjct: 175 -YQP--YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 66/235 (28%), Positives = 96/235 (40%), Gaps = 59/235 (25%)
Query: 901 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSEN 959
I MEY+ GGS ++K+ + + + ++ IA V L LH KH I+HRD+K N
Sbjct: 76 ICMEYMDGGS----LDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSN 131
Query: 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1019
IL++ + G+ +KLCDF + L +A VGT +MAPE ++
Sbjct: 132 ILVN-----SRGQ--IKLCDFGVSGQL-----VNSLA-------KTFVGTSSYMAPERIQ 172
Query: 1020 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG-----LSELEIHDLIQMGKRPRLTDEL 1074
N Y ++ DIWS G L+EL T + PY E+ I PRL
Sbjct: 173 ----GNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLP--- 225
Query: 1075 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1129
F D C ++P ERP+ +L E
Sbjct: 226 --------------SGKFSPD---------FQDFVNLCLIKDPRERPSYKELLEH 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 7e-16
Identities = 52/162 (32%), Positives = 83/162 (51%), Gaps = 30/162 (18%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
MEYV GG + +I+++ + E A+F A +++ L LH + I++RD+K +N+++
Sbjct: 80 MEYVNGGDLMYHIQQVGKFKEPQ-----AVFYAAEISVGLFFLHRRGIIYRDLKLDNVML 134
Query: 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH--RGIPAPDVCVGTPRWMAPEVLRA 1020
D E +K+ DF C H G+ C GTP ++APE++
Sbjct: 135 DSEGH-------IKIADFGM-----------CKEHMVDGVTTRTFC-GTPDYIAPEII-- 173
Query: 1021 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 1062
++P YG VD W+YG LL E+L Q P+ G E E+ I
Sbjct: 174 AYQP--YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 1e-15
Identities = 76/297 (25%), Positives = 122/297 (41%), Gaps = 63/297 (21%)
Query: 829 GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 888
GS V+TL+ G++ E + F L E ++ H IV++ G
Sbjct: 23 GSGPIRVAVKTLRK-GATDQEKKEF----LKEAHLMSNFNHPNIVKLLG--------VCL 69
Query: 889 DGNPEHHLLQSAIFMEYVKGGSVKNYIE--KLSETGEKHVSVKLALFIAQDVAAALVELH 946
P++ I ME ++GG + +Y+ ++ G +++K L I DVA V L
Sbjct: 70 LNEPQY------IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE 123
Query: 947 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC 1006
H +HRD+ + N L+ K D VVK+ DF A + + +P
Sbjct: 124 QMHFIHRDLAARNCLV--SEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV---- 177
Query: 1007 VGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMG 1065
RWMAPE L + + D+WS+G L+ E+LTL Q PY L+ E+ + G
Sbjct: 178 ----RWMAPESL----LDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG 229
Query: 1066 KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122
R L+ +C + + + C ++P+ERPT
Sbjct: 230 GR------LQKPENCPDK---------------------IYQLMTNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 63/220 (28%), Positives = 95/220 (43%), Gaps = 41/220 (18%)
Query: 858 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 917
L E +L H IV++ G P + I ME V GGS+ ++ K
Sbjct: 40 LQEAEILKQYDHPNIVKLIG--------VCVQKQPIY------IVMELVPGGSLLTFLRK 85
Query: 918 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 977
+ ++VK L ++ D AA + L SK+ +HRD+ + N L+ V+K+
Sbjct: 86 ----KKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENN-------VLKI 134
Query: 978 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1037
DF + ++T + IP +W APE L Y E D+WSYG
Sbjct: 135 SDFGMSREEEGGIYTVSDGLKQIPI--------KWTAPEALNY----GRYTSESDVWSYG 182
Query: 1038 CLLLELLTL-QVPYMGLSELEIHDLIQMGKR---PRLTDE 1073
LL E +L PY G+S + + I+ G R P+L E
Sbjct: 183 ILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPE 222
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 3e-15
Identities = 70/245 (28%), Positives = 101/245 (41%), Gaps = 51/245 (20%)
Query: 831 ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK------- 883
AA K+ L++ D I+ GEV+++ RH ++Y K+ SK
Sbjct: 29 EKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLV---RHKSSKQVYAMKLLSKFEMIKRS 85
Query: 884 -----WLPS---ADGNPE-----HHLLQSA----IFMEYVKGGSVKNYIEKLSETGEKHV 926
W A N E H+ Q + MEY+ GG + N +
Sbjct: 86 DSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNL------MSNYDI 139
Query: 927 SVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPL 986
K A F +V AL +HS +HRD+K +N+L+D G +KL DF
Sbjct: 140 PEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD-----KSGH--LKLADFG----- 187
Query: 987 RSFLHTCCIAHR-GIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045
TC G+ D VGTP +++PEVL++ YG E D WS G L E+L
Sbjct: 188 -----TCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 242
Query: 1046 LQVPY 1050
P+
Sbjct: 243 GDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 3e-15
Identities = 53/162 (32%), Positives = 74/162 (45%), Gaps = 26/162 (16%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
MEY+ GG + +I+ E A F A ++ L LH K I++RD+K +N+L+
Sbjct: 75 MEYLNGGDLMFHIQSSGRFDEAR-----ARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL 129
Query: 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1022
D DG +K+ DF C G GTP ++APE+L
Sbjct: 130 D-----KDGH--IKIADFG----------MCKENMNGEGKASTFCGTPDYIAPEIL---- 168
Query: 1023 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 1064
K Y VD WS+G LL E+L Q P+ G E E+ D I
Sbjct: 169 KGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 3e-15
Identities = 72/272 (26%), Positives = 104/272 (38%), Gaps = 69/272 (25%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
EV +L +L+H IV+ G + + +IFME+V GGS+ + + +
Sbjct: 52 EVDLLKSLKHVNIVQYLGTCLDDNTI--------------SIFMEFVPGGSISSILNRFG 97
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
E V K I VA LH+ ++HRDIK N+++ +G ++KL D
Sbjct: 98 PLPEP-VFCKYTKQILDGVAY----LHNNCVVHRDIKGNNVML-----MPNG--IIKLID 145
Query: 980 FDRAVPLRSFLHTCCIAHRGIPAPDVCV---GTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1036
F A L ++ GTP WMAPEV+ YG + DIWS
Sbjct: 146 FGCARRL-------AWVGLHGTHSNMLKSMHGTPYWMAPEVINESG----YGRKSDIWSI 194
Query: 1037 GCLLLELLTLQVPYMGLSELEIHDLI--QMGKRPRLTDELEALGSCHEHEVAQSGSGFEK 1094
GC + E+ T + P + L I G PRL D A
Sbjct: 195 GCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA---------------- 238
Query: 1095 PEAELETLSFLVDVFRRCTEENPTERPTAGDL 1126
+D C + ERP+A L
Sbjct: 239 -----------IDFVTSCLTRDQHERPSALQL 259
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 73/244 (29%), Positives = 106/244 (43%), Gaps = 44/244 (18%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
E+ M+ +H IV +G +S + L I MEY GGS+++
Sbjct: 56 EIFMVKECKHCNIVAYFGSYLSREKL--------------WICMEYCGGGSLQDIYHVTG 101
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
E ++ ++ ++ L LHSK MHRDIK NIL+ D VKL D
Sbjct: 102 PLSELQIA-----YVCRETLQGLAYLHSKGKMHRDIKGANILLT---DNGD----VKLAD 149
Query: 980 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039
F A + T IA R +GTP WMAPEV A+ K Y DIW+ G
Sbjct: 150 FGVAAKI-----TATIAKR-----KSFIGTPYWMAPEV-AAVEKNGGYNQLCDIWAVGIT 198
Query: 1040 LLELLTLQVPYMGLSELEIHDLIQMGKR----PRLTDELEALGSCHEH-EVAQSGSGFEK 1094
+EL LQ P L + L M K P+L D+ + + H +++ + + ++
Sbjct: 199 AIELAELQPPMFDLHPMRA--LFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKR 256
Query: 1095 PEAE 1098
P AE
Sbjct: 257 PTAE 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 3e-15
Identities = 53/162 (32%), Positives = 78/162 (48%), Gaps = 30/162 (18%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
ME+V GG + +I+K E A F A ++ +AL+ LH K I++RD+K +N+L+
Sbjct: 75 MEFVNGGDLMFHIQKSRRFDEAR-----ARFYAAEITSALMFLHDKGIIYRDLKLDNVLL 129
Query: 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA--HRGIPAPDVCVGTPRWMAPEVLRA 1020
D E KL DF C G C GTP ++APE+L+
Sbjct: 130 DHEGH-------CKLADFGM-----------CKEGIFNGKTTSTFC-GTPDYIAPEILQE 170
Query: 1021 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 1062
M LYG VD W+ G LL E+L P+ +E ++ + I
Sbjct: 171 M----LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 64/277 (23%), Positives = 108/277 (38%), Gaps = 58/277 (20%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
E+ +L L H IV+ G + G L+ MEY+ GS+++Y+++
Sbjct: 56 EIEILRTLDHENIVKYKG-------VCEKPGGRSLRLI-----MEYLPSGSLRDYLQRHR 103
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
+ +++K L + + + L S+ +HRD+ + NIL++ E VK+ D
Sbjct: 104 D----QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDL-------VKISD 152
Query: 980 F--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1037
F + +P + P W APE LR + + D+WS+G
Sbjct: 153 FGLAKVLPEDKDYYY-VKEPGESPI--------FWYAPECLRT----SKFSSASDVWSFG 199
Query: 1038 CLLLELLTL----QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE 1093
L EL T Q P + QM +T LE L + G
Sbjct: 200 VTLYELFTYGDPSQSPPAEFLRMIGIAQGQM----IVTRLLELL---------KEGERLP 246
Query: 1094 KPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130
+P + + D+ + C E P +RP+ DL +
Sbjct: 247 RPPS---CPDEVYDLMKLCWEAEPQDRPSFADLILIV 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 5e-15
Identities = 71/234 (30%), Positives = 107/234 (45%), Gaps = 49/234 (20%)
Query: 901 IFMEYVKGGSVKNYI-EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959
+ MEY+ GGS+ + + E + G+ + ++ AL LHS ++HRDIKS+N
Sbjct: 94 VVMEYLAGGSLTDVVTETCMDEGQIAA-------VCRECLQALEFLHSNQVIHRDIKSDN 146
Query: 960 ILIDLERKKADGKPVVKLCDFD---RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1016
IL+ + DG VKL DF + P +S VGTP WMAPE
Sbjct: 147 ILLGM-----DGS--VKLTDFGFCAQITPEQS-------------KRSTMVGTPYWMAPE 186
Query: 1017 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLT--DEL 1074
V+ YG +VDIWS G + +E++ + PY+ + L LI P L ++L
Sbjct: 187 VVTR----KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL 242
Query: 1075 EA-----LGSCHEHEVAQSGSG-------FEKPEAELETLSFLVDVFRRCTEEN 1116
A L C + +V + GS F K L +L+ L+ + T+ N
Sbjct: 243 SAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEATKNN 296
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 5e-15
Identities = 61/203 (30%), Positives = 94/203 (46%), Gaps = 40/203 (19%)
Query: 901 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960
+ MEY+ GGS+ + + +ET + + ++ AL LH+ ++HRDIKS+N+
Sbjct: 93 VVMEYLAGGSLTDVV---TETCMDEAQIAA---VCRECLQALEFLHANQVIHRDIKSDNV 146
Query: 961 LIDLERKKADGKPVVKLCDFD---RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 1017
L+ ++ VKL DF + P +S T VGTP WMAPEV
Sbjct: 147 LLGMDGS-------VKLTDFGFCAQITPEQSKRST-------------MVGTPYWMAPEV 186
Query: 1018 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDE---- 1073
+ YG +VDIWS G + +E++ + PY+ + L LI P L +
Sbjct: 187 VTR----KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 242
Query: 1074 ---LEALGSCHEHEVAQSGSGFE 1093
+ L C E +V + GS E
Sbjct: 243 PIFRDFLNRCLEMDVEKRGSAKE 265
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 7e-15
Identities = 67/204 (32%), Positives = 96/204 (47%), Gaps = 42/204 (20%)
Query: 901 IFMEYVKGGSVKNYI-EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959
+ MEY+ GGS+ + + E + G+ + ++ AL LHS ++HRDIKS+N
Sbjct: 93 VVMEYLAGGSLTDVVTETCMDEGQIAA-------VCRECLQALDFLHSNQVIHRDIKSDN 145
Query: 960 ILIDLERKKADGKPVVKLCDFD---RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1016
IL+ + DG VKL DF + P +S T VGTP WMAPE
Sbjct: 146 ILLGM-----DGS--VKLTDFGFCAQITPEQSKRST-------------MVGTPYWMAPE 185
Query: 1017 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLT--DEL 1074
V+ YG +VDIWS G + +E++ + PY+ + L LI P L + L
Sbjct: 186 VVTR----KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERL 241
Query: 1075 EA-----LGSCHEHEVAQSGSGFE 1093
A L C E +V + GS E
Sbjct: 242 SAVFRDFLNRCLEMDVDRRGSAKE 265
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-14
Identities = 72/270 (26%), Positives = 115/270 (42%), Gaps = 59/270 (21%)
Query: 806 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLG 865
FP+L K++ + L R K D K+R L++ + ++ GEV+++
Sbjct: 12 FPAL----RKNKNIDNFLNRYK----DTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLV- 62
Query: 866 ALRHSCIVEMYGHKISSKW--LPSADGN---PEHHLLQSA-------------------I 901
RH ++Y K+ SK+ + +D E ++ A +
Sbjct: 63 --RHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 120
Query: 902 FMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 961
MEY+ GG + N + V K A F +V AL +HS +HRD+K +N+L
Sbjct: 121 VMEYMPGGDLVNLMSNYD------VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNML 174
Query: 962 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHR-GIPAPDVCVGTPRWMAPEVLRA 1020
+D +KL DF TC ++ G+ D VGTP +++PEVL++
Sbjct: 175 LDKSGH-------LKLADFG----------TCMKMNKEGMVRCDTAVGTPDYISPEVLKS 217
Query: 1021 MHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1050
YG E D WS G L E+L P+
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 63/311 (20%), Positives = 115/311 (36%), Gaps = 71/311 (22%)
Query: 825 RCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884
G + ++T+ S E F L E ++ +V + G + S
Sbjct: 29 GVVKGEPETRVAIKTVNENASM-RERIEF----LNEASVMKEFNCHHVVRLLG--VVST- 80
Query: 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKH-----VSVKLALFIAQDVA 939
G P + + ME + G +K+Y+ E + +++ + +A ++A
Sbjct: 81 -----GQP------TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129
Query: 940 AALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG 999
+ L +K +HRD+ + N ++ + VK+ DF + +
Sbjct: 130 DGMAYLAAKKFVHRDLAARNCMVAEDL-------TVKIGDFGMTRDIYETDYYRKGGKGL 182
Query: 1000 IPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEI 1058
+P RWMAPE L K ++ + D+WS+G +L E+ TL + PY GLS E+
Sbjct: 183 LPV--------RWMAPESL----KDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV 230
Query: 1059 HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1118
+ G L + L+++ R C + NP
Sbjct: 231 LKFVIDGGHLDLPENCP---------------------------DKLLELMRMCWQYNPK 263
Query: 1119 ERPTAGDLYEM 1129
RPT ++
Sbjct: 264 MRPTFLEIVSS 274
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-14
Identities = 65/240 (27%), Positives = 103/240 (42%), Gaps = 51/240 (21%)
Query: 836 KVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW--LPSADGN-- 891
K+R L++ D ++ GEV+++ RH ++Y K+ SK+ + +D
Sbjct: 34 KIRKLQMKAEDYDVVKVIGRGAFGEVQLV---RHKSSQKVYAMKLLSKFEMIKRSDSAFF 90
Query: 892 -PEHHLLQSA-------------------IFMEYVKGGSVKNYIEKLSETGEKHVSVKLA 931
E ++ A + MEY+ GG + N + V K A
Sbjct: 91 WEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD------VPEKWA 144
Query: 932 LFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLH 991
F +V AL +HS ++HRD+K +N+L+D +KL DF
Sbjct: 145 KFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGH-------LKLADFG---------- 187
Query: 992 TCC-IAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1050
TC + G+ D VGTP +++PEVL++ YG E D WS G L E+L P+
Sbjct: 188 TCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 3e-14
Identities = 59/207 (28%), Positives = 87/207 (42%), Gaps = 41/207 (19%)
Query: 934 IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC 993
I + L +H HRD+K EN+L+ G VVK+ DF A +RS
Sbjct: 104 IIYQILQGLAHIHKHGFFHRDLKPENLLV-------SGPEVVKIADFGLAREIRS----- 151
Query: 994 CIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1052
P V T RW APE+L + + Y VDIW+ GC++ EL TL+ + G
Sbjct: 152 ------RPPYTDYVST-RWYRAPEIL--LRSTS-YSSPVDIWALGCIMAELYTLRPLFPG 201
Query: 1053 LSELEIHDLIQ--MGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE---LETL----- 1102
SE++ I +G P D E +++A GF P+ L L
Sbjct: 202 SSEIDQLYKICSVLGT-PTKQDWPEG------YKLASK-LGFRFPQFAPTSLHQLIPNAS 253
Query: 1103 SFLVDVFRRCTEENPTERPTAGDLYEM 1129
+D+ + +P +RPTA +
Sbjct: 254 PEAIDLIKDMLRWDPKKRPTASQALQH 280
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 3e-14
Identities = 51/162 (31%), Positives = 75/162 (46%), Gaps = 26/162 (16%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
MEY+ GG + +I+ + + A F A ++ L LHSK I++RD+K +NIL+
Sbjct: 75 MEYLNGGDLMFHIQSCHK-----FDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILL 129
Query: 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1022
D + +K+ DF C G GTP ++APE+L
Sbjct: 130 DTDGH-------IKIADFG----------MCKENMLGDAKTCTFCGTPDYIAPEILLGQK 172
Query: 1023 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 1064
Y VD WS+G LL E+L Q P+ G E E+ I+M
Sbjct: 173 ----YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-14
Identities = 68/219 (31%), Positives = 98/219 (44%), Gaps = 30/219 (13%)
Query: 54 DFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRY-EKLRNLKFFGNEINLFPSEVGN 112
L + ++ L L N + IP +G L+ L N+I PS + N
Sbjct: 102 LNRLRSNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIESLPSPLRN 161
Query: 113 LLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVC 172
L LK L+LS + L ++ L L L +
Sbjct: 162 L-----------------------PNLKNLDLSF----NDLSDLPKLLSNLSNLNNLDLS 194
Query: 173 HFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLL 232
I LPPEI LS LE+LDLS N + L + + LK L L+++NNKL +LP + L
Sbjct: 195 GNKISDLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLEDLPESIGNL 254
Query: 233 QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
LE LDLSNN+++S+ S L + NL+ L+L N L +
Sbjct: 255 SNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSN 291
|
Length = 394 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 78/285 (27%), Positives = 125/285 (43%), Gaps = 68/285 (23%)
Query: 860 EVRMLGALRHSCIV---EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 916
E+RML LRH +V E++ K + +L+ E+V +V + +E
Sbjct: 50 EIRMLKQLRHENLVNLIEVFRRK--KRL----------YLV-----FEFVDH-TVLDDLE 91
Query: 917 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 976
K G V+ LF + + HS +I+HRDIK ENIL+ VVK
Sbjct: 92 KY-PNGLDESRVRKYLF---QILRGIEFCHSHNIIHRDIKPENILVSQSG-------VVK 140
Query: 977 LCDFDRAVPLRS--FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 1034
LCDF A L + ++T +A R AP++ VG + YG VDIW
Sbjct: 141 LCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTK---------------YGRAVDIW 185
Query: 1035 SYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS--GSGF 1092
+ GCL+ E+LT + + G S++ D + + L L H+ ++ +G
Sbjct: 186 AVGCLVTEMLTGEPLFPGDSDI---DQLY-----HIIKCLGNLIPRHQEIFQKNPLFAGM 237
Query: 1093 EKPEA-ELETL--------SFLVDVFRRCTEENPTERPTAGDLYE 1128
PE E+E L ++D+ ++C +P +RP++ L
Sbjct: 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 5e-14
Identities = 66/206 (32%), Positives = 92/206 (44%), Gaps = 54/206 (26%)
Query: 941 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGI 1000
L LHS I+HRD+K N+LI +DG V+KL DF A RSF
Sbjct: 114 GLEYLHSNWILHRDLKPNNLLIA-----SDG--VLKLADFGLA---RSF----------- 152
Query: 1001 PAPDVCVGTP----RWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM-GLS 1054
+P+ T RW APE+L YG+ VD+WS GC+ ELL L+VP++ G S
Sbjct: 153 GSPNR-KMTHQVVTRWYRAPELLFG---ARHYGVGVDMWSVGCIFAELL-LRVPFLPGDS 207
Query: 1055 ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ-----SGSGFEK-PEAELETL-----S 1103
+++ Q+GK EALG+ E F+ P L+ +
Sbjct: 208 DID-----QLGKI------FEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASD 256
Query: 1104 FLVDVFRRCTEENPTERPTAGDLYEM 1129
+D+ +R NP +R TA E
Sbjct: 257 DALDLLQRLLTLNPNKRITARQALEH 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (181), Expect = 6e-14
Identities = 60/212 (28%), Positives = 86/212 (40%), Gaps = 54/212 (25%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE--- 916
E+++L LRH IV + S + +I+M V Y++
Sbjct: 48 EIKLLQKLRHPNIVRLKEIVTSKG--------------KGSIYM-------VFEYMDHDL 86
Query: 917 -KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 975
L ++ E + + + L LHS I+HRDIK NILI+ DG V+
Sbjct: 87 TGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILIN-----NDG--VL 139
Query: 976 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR----WM-APEVLRAMHKPNLYGLE 1030
KL DF A R + T R W PE+L + YG E
Sbjct: 140 KLADFGLA--------------RPYTKRNSADYTNRVITLWYRPPELL--LGATR-YGPE 182
Query: 1031 VDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 1062
VD+WS GC+L EL + + G +ELE + I
Sbjct: 183 VDMWSVGCILAELFLGKPIFQGSTELEQLEKI 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 6e-14
Identities = 60/236 (25%), Positives = 95/236 (40%), Gaps = 57/236 (24%)
Query: 901 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960
I ME V+GG ++ T + VK + + ++ AA + L SKH +HRD+ + N
Sbjct: 70 IVMELVQGGDFLTFLR----TEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNC 125
Query: 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1020
L+ K V+K+ DF + ++ + IP +W APE L
Sbjct: 126 LV-------TEKNVLKISDFGMSREEEDGVYASTGGMKQIPV--------KWTAPEALNY 170
Query: 1021 MHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGS 1079
Y E D+WS+G LL E +L VPY LS + + I+ G R L
Sbjct: 171 ----GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR------LPCPEL 220
Query: 1080 CHEHEVAQSGSGFEKPEAELETLSFLVDVFR---RCTEENPTERPTAGDLYEMFVA 1132
C + V+R RC E +P +RP+ +++ +
Sbjct: 221 CPD------------------------AVYRLMERCWEYDPGQRPSFSTVHQELQS 252
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 8e-14
Identities = 73/278 (26%), Positives = 119/278 (42%), Gaps = 73/278 (26%)
Query: 858 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 917
L E +++ LRH +V++Y + S + P + I EY+ GS+ ++++
Sbjct: 49 LQEAQIMKKLRHDKLVQLYA--VCS------EEEPIY------IVTEYMSKGSLLDFLK- 93
Query: 918 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 977
S G+K +L AQ +A + L S++ +HRD+ + NIL+ V K+
Sbjct: 94 -SGEGKKLRLPQLVDMAAQ-IAEGMAYLESRNYIHRDLAARNILV-------GENLVCKI 144
Query: 978 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG---LEVDIW 1034
DF A R A G P +W APE YG ++ D+W
Sbjct: 145 ADFGLA---RLIEDDEYTAREGAKFP------IKWTAPEAA-------NYGRFTIKSDVW 188
Query: 1035 SYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGF 1092
S+G LL E++T +VPY G++ E+ + ++ G R PR + C
Sbjct: 189 SFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPN-------C------------ 229
Query: 1093 EKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130
PE L D+ +C +++P ERPT L
Sbjct: 230 --PEE-------LYDLMLQCWDKDPEERPTFEYLQSFL 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 1e-13
Identities = 82/311 (26%), Positives = 138/311 (44%), Gaps = 70/311 (22%)
Query: 833 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 892
AAAKV K S +E+ ++ + E+ +L H IV++ G + W DG
Sbjct: 40 AAAKVIETK----SEEELEDY----MVEIEILATCNHPYIVKLLG---AFYW----DG-- 82
Query: 893 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 952
+ I +E+ GG+V + +L + G +++ I + + AL LHS I+H
Sbjct: 83 -----KLWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQV---ICRQMLEALQYLHSMKIIH 133
Query: 953 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 1012
RD+K+ N+L+ L DG +KL DF V ++ + + D +GTP W
Sbjct: 134 RDLKAGNVLLTL-----DGD--IKLADF--GVSAKNV--------KTLQRRDSFIGTPYW 176
Query: 1013 MAPEVLRA-MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLT 1071
MAPEV+ K Y + DIWS G L+E+ ++ P+ L+ + + I + P L+
Sbjct: 177 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLS 236
Query: 1072 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM-F 1130
+ + +E FL + +++P RP+A L E F
Sbjct: 237 ---------------------QPSKWSMEFRDFL----KTALDKHPETRPSAAQLLEHPF 271
Query: 1131 VARTSSSISSR 1141
V+ +S+ R
Sbjct: 272 VSSVTSNRPLR 282
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 62/256 (24%), Positives = 101/256 (39%), Gaps = 35/256 (13%)
Query: 816 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 875
G +++ + A ++ + V G +EI+ E+ ML H +
Sbjct: 15 GNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ-------EINMLKKYSHHRNIAT 67
Query: 876 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 935
Y K P D Q + ME+ GSV + I+ T + + +I
Sbjct: 68 YYGAFIKKNPPGMDD-------QLWLVMEFCGAGSVTDLIKN---TKGNTLKEEWIAYIC 117
Query: 936 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 995
+++ L LH ++HRDIK +N+L+ + VKL DF + L
Sbjct: 118 REILRGLSHLHQHKVIHRDIKGQNVLLTENAE-------VKLVDFGVSAQL--------- 161
Query: 996 AHRGIPAPDVCVGTPRWMAPEVLRAMHKPN-LYGLEVDIWSYGCLLLELLTLQVPYMGLS 1054
R + + +GTP WMAPEV+ P+ Y + D+WS G +E+ P +
Sbjct: 162 -DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 220
Query: 1055 ELEIHDLIQMGKRPRL 1070
+ LI PRL
Sbjct: 221 PMRALFLIPRNPAPRL 236
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 51/152 (33%), Positives = 79/152 (51%), Gaps = 23/152 (15%)
Query: 901 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960
I MEY GG + I + + G ++ + Q ++ L +H + I+HRDIKS+NI
Sbjct: 76 IVMEYCDGGDLMKRINR--QRGVLFSEDQILSWFVQ-ISLGLKHIHDRKILHRDIKSQNI 132
Query: 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1020
+ +G V KL DF A R + +A+ CVGTP +++PE+ +
Sbjct: 133 FL-----SKNGM-VAKLGDFGIA---RQLNDSMELAY-------TCVGTPYYLSPEICQ- 175
Query: 1021 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1052
++P Y + DIWS GC+L EL TL+ P+ G
Sbjct: 176 -NRP--YNNKTDIWSLGCVLYELCTLKHPFEG 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-13
Identities = 48/174 (27%), Positives = 78/174 (44%), Gaps = 25/174 (14%)
Query: 894 HHLLQSAIF----MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH 949
H+ Q M+Y GG + + K E + +A F ++ A+ +H
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVLAIDSVHQLG 122
Query: 950 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 1009
+HRDIK +N+L+D ++L DF + L + G +V VGT
Sbjct: 123 YVHRDIKPDNVLLDKNGH-------IRLADFGSCLRLLA---------DGTVQSNVAVGT 166
Query: 1010 PRWMAPEVLRAMHK-PNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 1062
P +++PE+L+AM YG E D WS G + E+L + P+ S +E + I
Sbjct: 167 PDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 62/238 (26%), Positives = 98/238 (41%), Gaps = 37/238 (15%)
Query: 835 AKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPE 893
A ++ + V +EI+ E+ ML H I YG I +P
Sbjct: 44 AAIKVMDVTEDEEEEIKL-------EINMLKKYSHHRNIATYYGAFIKK--------SPP 88
Query: 894 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 953
H Q + ME+ GSV + ++ K + +I +++ L LH+ ++HR
Sbjct: 89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA---YICREILRGLAHLHAHKVIHR 145
Query: 954 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 1013
DIK +N+L+ + A+ VKL DF + L R + + +GTP WM
Sbjct: 146 DIKGQNVLLT---ENAE----VKLVDFGVSAQL----------DRTVGRRNTFIGTPYWM 188
Query: 1014 APEVLRAMHKPN-LYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL 1070
APEV+ P+ Y DIWS G +E+ P + + LI P+L
Sbjct: 189 APEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL 246
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 71/244 (29%), Positives = 106/244 (43%), Gaps = 44/244 (18%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
E+ M+ +HS IV +G + L I ME+ GGS+++
Sbjct: 56 EIIMMKDCKHSNIVAYFGSYLRRDKL--------------WICMEFCGGGSLQDIYHVTG 101
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
E ++ +++++ L LHSK MHRDIK NIL+ VKL D
Sbjct: 102 PLSESQIA-----YVSRETLQGLYYLHSKGKMHRDIKGANILL-------TDNGHVKLAD 149
Query: 980 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039
F + + T IA R +GTP WMAPEV A+ + Y DIW+ G
Sbjct: 150 FGVSAQI-----TATIAKR-----KSFIGTPYWMAPEV-AAVERKGGYNQLCDIWAVGIT 198
Query: 1040 LLELLTLQVPYMGLSELEIHDLIQMGKR----PRLTDELEALGSCHEH-EVAQSGSGFEK 1094
+EL LQ P L + L M K P+L D+++ S H ++A + + ++
Sbjct: 199 AIELAELQPPMFDLHPMRA--LFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKR 256
Query: 1095 PEAE 1098
P AE
Sbjct: 257 PTAE 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 65/231 (28%), Positives = 100/231 (43%), Gaps = 50/231 (21%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSENIL 961
ME++ GS+ +K + V++ IA V L L++ H IMHRDIK NIL
Sbjct: 82 MEFMDCGSLDRIYKKGGP-----IPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNIL 136
Query: 962 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 1021
+ + + +KLCDF + L + IA D VGT +M+PE ++
Sbjct: 137 V-------NSRGQIKLCDFGVSGELIN-----SIA-------DTFVGTSTYMSPERIQG- 176
Query: 1022 HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH 1081
K Y ++ D+WS G ++EL + P+ + + MG L+ L
Sbjct: 177 GK---YTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGI-------LDLL---- 222
Query: 1082 EHEVAQSGSGFEKPEAELETLSF---LVDVFRRCTEENPTERPTAGDLYEM 1129
++ Q +P L + F L D C ++PTERPT L M
Sbjct: 223 -QQIVQ------EPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 2e-13
Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 35/203 (17%)
Query: 901 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960
+ M+Y GG + + K E + +A F ++ A+ +H H +HRDIK +NI
Sbjct: 78 LVMDYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNI 133
Query: 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1020
L+D+ ++L DF + L G V VGTP +++PE+L+A
Sbjct: 134 LMDMNGH-------IRLADFGSCLKL---------MEDGTVQSSVAVGTPDYISPEILQA 177
Query: 1021 MHK-PNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL--------- 1070
M YG E D WS G + E+L + P+ S +E + I M + R
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI-MNHKERFQFPAQVTDV 236
Query: 1071 ----TDELEALGSCHEHEVAQSG 1089
D + L EH + Q+G
Sbjct: 237 SEDAKDLIRRLICSREHRLGQNG 259
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 56/231 (24%), Positives = 107/231 (46%), Gaps = 51/231 (22%)
Query: 901 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960
I E++ G N ++ L E + V+ + L++A +++A+ L K+ +HRD+ + N
Sbjct: 79 IITEFMTYG---NLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNC 135
Query: 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1020
L+ E +VK+ DF + + +T AH G P +W APE L
Sbjct: 136 LVG-ENH------LVKVADFGLSRLMTGDTYT---AHAGAKFP------IKWTAPESLAY 179
Query: 1021 MHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKRPRLTDELEALGS 1079
N + ++ D+W++G LL E+ T + PY G+ ++++L++ G R
Sbjct: 180 ----NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR------------ 223
Query: 1080 CHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130
E+PE + ++ R C + NP++RP+ ++++ F
Sbjct: 224 ------------MERPEGCPPK---VYELMRACWQWNPSDRPSFAEIHQAF 259
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 3e-13
Identities = 34/100 (34%), Positives = 45/100 (45%), Gaps = 19/100 (19%)
Query: 945 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1004
+H+ IMHRD+K N+LI ADG V+K+ DF A
Sbjct: 115 MHANGIMHRDLKPANLLIS-----ADG--VLKIADFGLARLFSE---------EEPRLYS 158
Query: 1005 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044
V T + APE+L K Y VD+W+ GC+ ELL
Sbjct: 159 HQVATRWYRAPELLYGARK---YDPGVDLWAVGCIFAELL 195
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 59/196 (30%), Positives = 84/196 (42%), Gaps = 36/196 (18%)
Query: 857 CLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 916
C+ E+ +L L H +++ Y I L I +E G + I+
Sbjct: 49 CIKEIDLLKQLNHPNVIKYYASFIEDNEL--------------NIVLELADAGDLSRMIK 94
Query: 917 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 976
+ + + Q + +AL +HS+ +MHRDIK N+ I A G VVK
Sbjct: 95 HFKKQKRLIPEKTVWKYFVQ-LCSALEHMHSRRVMHRDIKPANVFI-----TATG--VVK 146
Query: 977 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1036
L D R F AH VGTP +M+PE +H+ N Y + DIWS
Sbjct: 147 LGDLGLG---RFFSSKTTAAHS-------LVGTPYYMSPE---RIHE-NGYNFKSDIWSL 192
Query: 1037 GCLLLELLTLQVPYMG 1052
GCLL E+ LQ P+ G
Sbjct: 193 GCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 69/251 (27%), Positives = 111/251 (44%), Gaps = 61/251 (24%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
V+TLK +S D ++FE E +L +H IV+ YG +G+P
Sbjct: 40 VKTLKE-TASNDARKDFER----EAELLTNFQHENIVKFYG--------VCTEGDPPI-- 84
Query: 897 LQSAIFMEYVKGGSVKNYIEK-------LSETGEKHVSVKLA--LFIAQDVAAALVELHS 947
+F EY++ G + ++ L + L+ L IA +A+ +V L S
Sbjct: 85 ---MVF-EYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS 140
Query: 948 KHIMHRDIKSENILI--DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV 1005
+H +HRD+ + N L+ DL VVK+ DF + + + + H +P
Sbjct: 141 QHFVHRDLATRNCLVGYDL---------VVKIGDFGMSRDVYTTDYYRVGGHTMLPI--- 188
Query: 1006 CVGTPRWMAPEVLRAMHKPNLYG---LEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDL 1061
RWM PE + +Y E D+WS+G +L E+ T + P+ GLS E+ +
Sbjct: 189 -----RWMPPESI-------MYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC 236
Query: 1062 IQMGK---RPR 1069
I G+ RPR
Sbjct: 237 ITQGRLLQRPR 247
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 5e-13
Identities = 67/248 (27%), Positives = 102/248 (41%), Gaps = 52/248 (20%)
Query: 901 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSEN 959
I ME++ GGS+ ++K E + I+ V L L KH IMHRD+K N
Sbjct: 76 ICMEHMDGGSLDQVLKKAGRIPENILGK-----ISIAVLRGLTYLREKHKIMHRDVKPSN 130
Query: 960 ILIDLERKKADGKPVVKLCDFDRAVPL-----RSFLHTCCIAHRGIPAPDVCVGTPRWMA 1014
IL++ + G+ +KLCDF + L SF VGT +M+
Sbjct: 131 ILVN-----SRGE--IKLCDFGVSGQLIDSMANSF-----------------VGTRSYMS 166
Query: 1015 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDEL 1074
PE L+ H Y ++ DIWS G L+E+ + P E+ + E
Sbjct: 167 PERLQGTH----YTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKES 222
Query: 1075 EALGSCHEHEVAQSGSGFE-------KPEAELETLSF---LVDVFRRCTEENPTERPTAG 1124
S H + + + FE +P +L + +F D +C ++NP ER
Sbjct: 223 HRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERA--- 279
Query: 1125 DLYEMFVA 1132
DL E+
Sbjct: 280 DLKELTKH 287
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 5e-13
Identities = 50/163 (30%), Positives = 68/163 (41%), Gaps = 33/163 (20%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
MEY GG + +I S A+F A V L LH I++RD+K +N+L+
Sbjct: 81 MEYAAGGDLMMHIH------TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLL 134
Query: 963 DLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1019
D E VK+ DF + T C GTP ++APEVL
Sbjct: 135 DTE-------GFVKIADFGLCKEGMGFGDRTSTFC-------------GTPEFLAPEVLT 174
Query: 1020 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 1062
Y VD W G L+ E+L + P+ G E E+ D I
Sbjct: 175 ETS----YTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSI 213
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 5e-13
Identities = 57/208 (27%), Positives = 85/208 (40%), Gaps = 55/208 (26%)
Query: 858 LGEVRMLGALRHSCIV---EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY 914
L E+++L L H I+ +++ HK L + E++
Sbjct: 46 LREIKLLKELNHPNIIKLLDVFRHK--------------GDL---YLVFEFMDTD----- 83
Query: 915 IEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 974
+ KL + ++ + L + L HS I+HRD+K EN+LI +G V
Sbjct: 84 LYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLI-----NTEG--V 136
Query: 975 VKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP----RWM-APEVLRAMHKPNLYGL 1029
+KL DF A RSF V T RW APE+L Y
Sbjct: 137 LKLADFGLA---RSF------------GSPVRPYTHYVVTRWYRAPELLLGD---KGYST 178
Query: 1030 EVDIWSYGCLLLELLTLQVPYMGLSELE 1057
VDIWS GC+ ELL+ + + G SE++
Sbjct: 179 PVDIWSVGCIFAELLSRRPLFPGKSEID 206
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 5e-13
Identities = 77/287 (26%), Positives = 113/287 (39%), Gaps = 80/287 (27%)
Query: 858 LGEVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 915
+ EVR L LRH +E G + + WL MEY G S + +
Sbjct: 63 IKEVRFLQQLRHPNTIEYKGCYLREHTAWL----------------VMEYCLG-SASDIL 105
Query: 916 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 975
E + ++ V++A I L LHS +HRDIK+ NIL+ G V
Sbjct: 106 EVHKKPLQE---VEIAA-ICHGALQGLAYLHSHERIHRDIKAGNILL-----TEPG--TV 154
Query: 976 KLCDFDRAV---PLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 1032
KL DF A P SF VGTP WMAPEV+ AM + Y +VD
Sbjct: 155 KLADFGSASLVSPANSF-----------------VGTPYWMAPEVILAMDEGQ-YDGKVD 196
Query: 1033 IWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS-G 1091
+WS G +EL + P + + + AL + +AQ+ S
Sbjct: 197 VWSLGITCIELAERKPPLFNM------------------NAMSAL-----YHIAQNDSPT 233
Query: 1092 FEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM-FVARTSSS 1137
+ +F+ C ++ P +RP++ +L + FV R
Sbjct: 234 LSSNDWSDYFRNFV----DSCLQKIPQDRPSSEELLKHRFVLRERPP 276
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 6e-13
Identities = 61/275 (22%), Positives = 97/275 (35%), Gaps = 75/275 (27%)
Query: 857 CLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 916
+ E R+L L S I+ Y + L I MEY + G + ++
Sbjct: 46 AIDEARVLAKLDSSYIIRYYESFLDKGKL--------------NIVMEYAENGDLHKLLK 91
Query: 917 K-----LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 971
L E +++ L L LHSK I+HRDIKS N+ +D D
Sbjct: 92 MQRGRPLPEDQVWRFFIQILL--------GLAHLHSKKILHRDIKSLNLFLD----AYDN 139
Query: 972 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 1031
VK+ D A L I VGTP +++PE+ KP Y +
Sbjct: 140 ---VKIGDLGVA----KLLSDNTNFANTI------VGTPYYLSPELCE--DKP--YNEKS 182
Query: 1032 DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSG 1091
D+W+ G +L E T + P+ ++ + I G P +
Sbjct: 183 DVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPV------------------SQM 224
Query: 1092 FEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1126
+ + L + +C ++ +RP L
Sbjct: 225 YSQQ---------LAQLIDQCLTKDYRQRPDTFQL 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 7e-13
Identities = 57/192 (29%), Positives = 86/192 (44%), Gaps = 30/192 (15%)
Query: 941 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGI 1000
AL +HS +++HRD+K NIL++ + + VKL DF A RS + +
Sbjct: 119 ALKYIHSGNVIHRDLKPSNILLNSDCR-------VKLADFGLA---RSL--SELEENPEN 166
Query: 1001 PAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIH 1059
P V T RW APE+L + Y VD+WS GC+L E+L + + G S L
Sbjct: 167 PVLTDYVAT-RWYRAPEILLGSTR---YTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQL 222
Query: 1060 DLIQMGKRPRLTDE-LEALGSCHEHEV-AQSGSGFEKPEAEL------ETLSFLVDVFRR 1111
+ I + + E +E++ S + S KP EL + L L ++
Sbjct: 223 EKI-IEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLL----KK 277
Query: 1112 CTEENPTERPTA 1123
NP +R TA
Sbjct: 278 LLVFNPNKRLTA 289
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 9e-13
Identities = 68/240 (28%), Positives = 101/240 (42%), Gaps = 55/240 (22%)
Query: 901 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960
I MEY+ GGS + + K E +++ I +++ L LHS+ +HRDIK+ N+
Sbjct: 79 IIMEYLGGGSALDLL-KPGPLEETYIAT-----ILREILKGLDYLHSERKIHRDIKAANV 132
Query: 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1020
L+ ++ D VKL DF A L T R + VGTP WMAPEV+
Sbjct: 133 LLS---EQGD----VKLADFGVAGQL-----TDTQIKR-----NTFVGTPFWMAPEVI-- 173
Query: 1021 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC 1080
K + Y + DIWS G +EL + P L + + LI P L +
Sbjct: 174 --KQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQ------- 224
Query: 1081 HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE-MFVARTSSSIS 1139
+ KP + C ++P RPTA +L + F+ R + S
Sbjct: 225 -----------YSKP---------FKEFVEACLNKDPRFRPTAKELLKHKFITRYTKKTS 264
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-12
Identities = 46/163 (28%), Positives = 76/163 (46%), Gaps = 21/163 (12%)
Query: 901 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960
+ M+Y GG + + K E + +A F ++ A+ +H H +HRDIK +N+
Sbjct: 78 LVMDYYVGGDLLTLLSKF----EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNV 133
Query: 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1020
L+D+ ++L DF + + G V VGTP +++PE+L+A
Sbjct: 134 LLDMNGH-------IRLADFGSCLKMNQ---------DGTVQSSVAVGTPDYISPEILQA 177
Query: 1021 MHKP-NLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 1062
M YG E D WS G + E+L + P+ S +E + I
Sbjct: 178 MEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 56/230 (24%), Positives = 97/230 (42%), Gaps = 44/230 (19%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
E +++ L H +V++YG + +K P I EY+ G + NY+ +
Sbjct: 49 EAKVMMKLSHPNLVQLYG--VCTKQRPIF------------IVTEYMANGCLLNYLRERK 94
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
+ L + DV A+ L S +HRD+ + N L+ + VVK+ D
Sbjct: 95 GKLGT----EWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDN-------VVKVSD 143
Query: 980 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039
F A R L + +G P +W PEV + + + + D+WS+G L
Sbjct: 144 FGLA---RYVLDDQYTSSQGTKFP------VKWAPPEVF--DY--SRFSSKSDVWSFGVL 190
Query: 1040 LLELLTL-QVPYMGLSELEIHDLIQMG---KRPRL--TDELEALGSCHEH 1083
+ E+ + ++PY S E+ + + G RP+L T+ + SC
Sbjct: 191 MWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHE 240
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 1e-12
Identities = 46/153 (30%), Positives = 77/153 (50%), Gaps = 32/153 (20%)
Query: 901 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960
+ +EYV GG + ++++ + E+H A F A ++ AL LH + I++RD+K +N+
Sbjct: 73 LVIEYVNGGDLMFHMQRQRKLPEEH-----ARFYAAEICIALNFLHERGIIYRDLKLDNV 127
Query: 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC---VGTPRWMAPEV 1017
L+D ADG +KL D+ + G+ D GTP ++APE+
Sbjct: 128 LLD-----ADGH--IKLTDYG-------------MCKEGLGPGDTTSTFCGTPNYIAPEI 167
Query: 1018 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1050
LR YG VD W+ G L+ E++ + P+
Sbjct: 168 LRGEE----YGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-12
Identities = 49/162 (30%), Positives = 79/162 (48%), Gaps = 26/162 (16%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
ME++ GG + +I+ + + A F A ++ L LHSK I++RD+K +N+++
Sbjct: 75 MEFLNGGDLMFHIQD-----KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML 129
Query: 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1022
D DG +K+ DF C G GTP ++APE+L+ +
Sbjct: 130 D-----RDGH--IKIADFG----------MCKENVFGDNRASTFCGTPDYIAPEILQGLK 172
Query: 1023 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 1064
Y VD WS+G LL E+L Q P+ G E E+ + I++
Sbjct: 173 ----YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 81/353 (22%), Positives = 145/353 (41%), Gaps = 107/353 (30%)
Query: 814 EAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIV 873
E GK V ++ FR K + V+ LK +S+ E+R+ L E +L + H ++
Sbjct: 12 EFGKVVKATAFRLKGRAGYTTVAVKMLKE-NASSSELRDL----LSEFNLLKQVNHPHVI 66
Query: 874 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI------------------ 915
++YG S DG + +EY K GS+++++
Sbjct: 67 KLYG-------ACSQDGPL-------LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRN 112
Query: 916 -EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 974
L E+ +++ + A ++ + L ++HRD+ + N+L+ A+G+
Sbjct: 113 SSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV------AEGR-K 165
Query: 975 VKLCDF--------DRAVPLRSFLHTCCIAHRG-IPAPDVCVGTPRWMAPEVLRAMHKPN 1025
+K+ DF + + RS +G IP +WMA E L H
Sbjct: 166 MKISDFGLSRDVYEEDSYVKRS---------KGRIPV--------KWMAIESL-FDH--- 204
Query: 1026 LYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHE 1084
+Y + D+WS+G LL E++TL PY G++ + +L++ G R
Sbjct: 205 IYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYR----------------- 247
Query: 1085 VAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT----AGDLYEMFVAR 1133
E+PE E + L+ C ++ P +RPT + +L +M V
Sbjct: 248 -------MERPENCSEEMYNLM---LTCWKQEPDKRPTFADISKELEKMMVKS 290
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-12
Identities = 57/174 (32%), Positives = 90/174 (51%), Gaps = 28/174 (16%)
Query: 889 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK 948
D ++L A+ ++Y G ++ I+ ++T + L Q V A+ +HSK
Sbjct: 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQ-VLLAVHHVHSK 162
Query: 949 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV--- 1005
H++HRDIKS NIL+ ++G +VKL DF + + + T + DV
Sbjct: 163 HMIHRDIKSANILL-----CSNG--LVKLGDFGFS---KMYAATV--------SDDVGRT 204
Query: 1006 -CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEI 1058
C GTP ++APE+ R KP Y + D++S G LL ELLTL+ P+ G + E+
Sbjct: 205 FC-GTPYYVAPEIWR--RKP--YSKKADMFSLGVLLYELLTLKRPFDGENMEEV 253
|
Length = 496 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 2e-12
Identities = 51/168 (30%), Positives = 79/168 (47%), Gaps = 33/168 (19%)
Query: 901 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960
+E+V GG + ++ K +A F ++ A LHSK I++RD+K EN+
Sbjct: 95 FLLEFVVGGELFTHLRKAGRFPND-----VAKFYHAELVLAFEYLHSKDIIYRDLKPENL 149
Query: 961 LIDLERKKADGKPVVKLCDFDRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1018
L+ D K VK+ DF A VP R+F T C GTP ++APEV+
Sbjct: 150 LL-------DNKGHVKVTDFGFAKKVPDRTF--TLC-------------GTPEYLAPEVI 187
Query: 1019 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1066
++ +G VD W+ G LL E + P+ + I++ I G+
Sbjct: 188 QSKG----HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR 231
|
Length = 329 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 2e-12
Identities = 50/164 (30%), Positives = 79/164 (48%), Gaps = 34/164 (20%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
MEYV GG + I++ + E + F A +V AL+ LH +++RD+K +NIL+
Sbjct: 75 MEYVNGGDLMFQIQRSRKFDEPR-----SRFYAAEVTLALMFLHRHGVIYRDLKLDNILL 129
Query: 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCV----GTPRWMAPEVL 1018
D A+G KL DF + GI V GTP ++APE+L
Sbjct: 130 D-----AEGH--CKLADFG-------------MCKEGI-LNGVTTTTFCGTPDYIAPEIL 168
Query: 1019 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 1062
+ + YG VD W+ G L+ E++ Q P+ +E ++ + I
Sbjct: 169 QELE----YGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 2e-12
Identities = 48/174 (27%), Positives = 79/174 (45%), Gaps = 27/174 (15%)
Query: 881 SSKWLPSADG--NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDV 938
+S W+P + +L + MEY GG + + + + + ++ +A F ++
Sbjct: 59 NSPWIPQLQYAFQDKDNLY---LVMEYQPGGDLLSLLNRYEDQFDE----DMAQFYLAEL 111
Query: 939 AAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHR 998
A+ +H +HRDIK EN+LID +KL DF A L +
Sbjct: 112 VLAIHSVHQMGYVHRDIKPENVLIDRTGH-------IKLADFGSAARLTANKMV------ 158
Query: 999 GIPAPDVCVGTPRWMAPEVLRAMH--KPNLYGLEVDIWSYGCLLLELLTLQVPY 1050
+ VGTP ++APEVL M+ YG+E D WS G + E++ + P+
Sbjct: 159 ---NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-12
Identities = 59/184 (32%), Positives = 86/184 (46%), Gaps = 37/184 (20%)
Query: 901 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960
+ +EY+ GG + ++E+ E A F +++ AL LH + I++RD+K ENI
Sbjct: 77 LILEYLSGGELFMHLER-----EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENI 131
Query: 961 LIDLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 1017
L+D A G VKL DF ++ + HT C GT +MAPE+
Sbjct: 132 LLD-----AQGH--VKLTDFGLCKESIHEGTVTHTFC-------------GTIEYMAPEI 171
Query: 1018 L-RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK---RPRLTDE 1073
L R+ H G VD WS G L+ ++LT P+ + + D I GK P LT E
Sbjct: 172 LMRSGH-----GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPE 226
Query: 1074 LEAL 1077
L
Sbjct: 227 ARDL 230
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 63/287 (21%), Positives = 115/287 (40%), Gaps = 72/287 (25%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
V+TLK + L E +++ LRH ++++Y P +
Sbjct: 35 VKTLKPGTMDPKDF-------LAEAQIMKKLRHPKLIQLYA--------VCTLEEPIY-- 77
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
I E +K GS+ Y++ + + + + +A VA+ + L +++ +HRD+
Sbjct: 78 ----IVTELMKYGSLLEYLQG---GAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLA 130
Query: 957 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1016
+ N+L+ + + K+ DF A R A G P +W APE
Sbjct: 131 ARNVLV------GENN-ICKVADFGLA---RVIKEDIYEAREGAKFP------IKWTAPE 174
Query: 1017 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELE 1075
N + ++ D+WS+G LL E++T ++PY G++ E+ + G R +
Sbjct: 175 AALY----NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR------MP 224
Query: 1076 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122
C P+ L D+ C +E+P +RPT
Sbjct: 225 CPPGC--------------PKE-------LYDIMLDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 51/171 (29%), Positives = 79/171 (46%), Gaps = 22/171 (12%)
Query: 901 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960
I +E+ GG+V + +L E+ ++ + + AL LH I+HRD+K+ NI
Sbjct: 79 ILIEFCAGGAVDAVMLEL----ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNI 134
Query: 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1020
L L DG +KL DF + R I D +GTP WMAPEV+
Sbjct: 135 LFTL-----DGD--IKLADFGVSAK----------NTRTIQRRDSFIGTPYWMAPEVVMC 177
Query: 1021 -MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL 1070
K Y + D+WS G L+E+ ++ P+ L+ + + I + P L
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL 228
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 3e-12
Identities = 56/226 (24%), Positives = 98/226 (43%), Gaps = 55/226 (24%)
Query: 901 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960
+ EY G + N++ + E+ ++++ L + VA + L SK+ +HRD+ + N+
Sbjct: 116 VITEYCCYGDLLNFLRRKRES---FLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNV 172
Query: 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG---IPAPDVCVGTPRWMAPEV 1017
L+ GK +VK+CDF A R ++ +G +P +WMAPE
Sbjct: 173 LL------THGK-IVKICDFGLA---RDIMNDSNYVVKGNARLPV--------KWMAPES 214
Query: 1018 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKRPRLTDELEA 1076
+ +Y E D+WSYG LL E+ +L PY G+ D
Sbjct: 215 IFN----CVYTFESDVWSYGILLWEIFSLGSNPYPGM----------------PVDSK-- 252
Query: 1077 LGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122
+++ + G +PE + D+ + C + +P +RPT
Sbjct: 253 -----FYKLIKEGYRMAQPEHAPAE---IYDIMKTCWDADPLKRPT 290
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 71/274 (25%), Positives = 111/274 (40%), Gaps = 62/274 (22%)
Query: 857 CLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 916
C+ E+ +L L H ++ K+L S + E + I +E G + I+
Sbjct: 49 CVKEIDLLKQLNHPNVI---------KYLDSFIEDNELN-----IVLELADAGDLSQMIK 94
Query: 917 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 976
+ + + Q + +A+ +HS+ +MHRDIK N+ I A G VVK
Sbjct: 95 YFKKQKRLIPERTVWKYFVQ-LCSAVEHMHSRRVMHRDIKPANVFI-----TATG--VVK 146
Query: 977 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1036
L D R F AH VGTP +M+PE +H+ N Y + DIWS
Sbjct: 147 LGDLGLG---RFFSSKTTAAHS-------LVGTPYYMSPE---RIHE-NGYNFKSDIWSL 192
Query: 1037 GCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE 1096
GCLL E+ LQ P+ G D++ C + E + P
Sbjct: 193 GCLLYEMAALQSPFYG-------------------DKMNLFSLCQKIEQC------DYPP 227
Query: 1097 AELETLS-FLVDVFRRCTEENPTERPTAGDLYEM 1129
E S L ++ C +P +RP G ++++
Sbjct: 228 LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 3e-12
Identities = 44/151 (29%), Positives = 77/151 (50%), Gaps = 32/151 (21%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
+E+V GG + ++++ + E+H A F + +++ AL LH + I++RD+K +N+L+
Sbjct: 75 IEFVSGGDLMFHMQRQRKLPEEH-----ARFYSAEISLALNFLHERGIIYRDLKLDNVLL 129
Query: 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC---VGTPRWMAPEVLR 1019
D A+G +KL D+ + GI D GTP ++APE+LR
Sbjct: 130 D-----AEGH--IKLTDYG-------------MCKEGIRPGDTTSTFCGTPNYIAPEILR 169
Query: 1020 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1050
YG VD W+ G L+ E++ + P+
Sbjct: 170 GED----YGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 71/319 (22%), Positives = 113/319 (35%), Gaps = 82/319 (25%)
Query: 818 SVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 877
SV ++ K G A V+TLK + I + L E ++ L H CIV + G
Sbjct: 10 SVVKGVYLMKSGKEVEVA-VKTLK-----QEHIAAGKKEFLREASVMAQLDHPCIVRLIG 63
Query: 878 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQD 937
+ + ME G + Y++K + + V +A
Sbjct: 64 VCKGEPLM---------------LVMELAPLGPLLKYLKK-----RREIPVSDLKELAHQ 103
Query: 938 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCI 995
VA + L SKH +HRD+ + N+L L + K+ DF RA+ S +
Sbjct: 104 VAMGMAYLESKHFVHRDLAARNVL--LVNRHQ-----AKISDFGMSRALGAGSDYYR--- 153
Query: 996 AHRGIPAPDVCVGTPRWMAPEVL---RAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYM 1051
A P +W APE + + K D+WSYG L E + PY
Sbjct: 154 ATTAGRWP------LKWYAPECINYGKFSSKS-------DVWSYGVTLWEAFSYGAKPYG 200
Query: 1052 GLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRR 1111
+ E+ +++ G+R L C + + +
Sbjct: 201 EMKGAEVIAMLESGER------LPRPEECPQE---------------------IYSIMLS 233
Query: 1112 CTEENPTERPTAGDLYEMF 1130
C + P +RPT +L F
Sbjct: 234 CWKYRPEDRPTFSELESTF 252
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-12
Identities = 60/228 (26%), Positives = 100/228 (43%), Gaps = 52/228 (22%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI---- 915
E +L L+H IV+ YG DG+P + EY+K G + ++
Sbjct: 57 EAELLTNLQHEHIVKFYG--------VCGDGDP------LIMVFEYMKHGDLNKFLRAHG 102
Query: 916 ---------EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 966
+ GE + + L IA +A+ +V L S+H +HRD+ + N L+
Sbjct: 103 PDAMILVDGQPRQAKGE--LGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV---- 156
Query: 967 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 1026
+VK+ DF + + S + H +P RWM PE + M++
Sbjct: 157 ---GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI--------RWMPPESI--MYRK-- 201
Query: 1027 YGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGK---RPRL 1070
+ E D+WS+G +L E+ T + P+ LS E+ + I G+ RPR+
Sbjct: 202 FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRV 249
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 51/150 (34%), Positives = 72/150 (48%), Gaps = 23/150 (15%)
Query: 901 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960
+ ++YV GG + ++ + E V V +A ++ AL LH I++RDIK ENI
Sbjct: 82 LILDYVNGGELFTHLYQREHFTESEVRVYIA-----EIVLALDHLHQLGIIYRDIKLENI 136
Query: 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1020
L+D ++G V L DF + + FL A A C GT +MAPEV+R
Sbjct: 137 LLD-----SEGH--VVLTDFGLS---KEFL-----AEEEERAYSFC-GTIEYMAPEVIRG 180
Query: 1021 MHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1050
+ VD WS G L ELLT P+
Sbjct: 181 --GSGGHDKAVDWWSLGVLTFELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 5e-12
Identities = 66/267 (24%), Positives = 116/267 (43%), Gaps = 67/267 (25%)
Query: 858 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 917
L E ++ L+H +V +Y + +K P I EY+ GS+ ++++
Sbjct: 49 LEEANLMKTLQHDKLVRLYA--VVTKEEPIY------------IITEYMAKGSLLDFLK- 93
Query: 918 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 977
S+ G K + KL F AQ +A + + K+ +HRD+++ N+L+ + K+
Sbjct: 94 -SDEGGKVLLPKLIDFSAQ-IAEGMAYIERKNYIHRDLRAANVLVS-------ESLMCKI 144
Query: 978 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1037
DF A + +T A G P +W APE + + ++ D+WS+G
Sbjct: 145 ADFGLARVIEDNEYT---AREGAKFP------IKWTAPEAINF----GSFTIKSDVWSFG 191
Query: 1038 CLLLELLTL-QVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKP 1095
LL E++T ++PY G+S ++ +Q G R PR+ + C +
Sbjct: 192 ILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMEN-------CPDE------------ 232
Query: 1096 EAELETLSFLVDVFRRCTEENPTERPT 1122
L D+ + C +E ERPT
Sbjct: 233 ---------LYDIMKTCWKEKAEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-12
Identities = 66/269 (24%), Positives = 117/269 (43%), Gaps = 72/269 (26%)
Query: 858 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 917
L E ++ L+H +V++ H + +K P + I E++ GS+ ++++
Sbjct: 49 LAEANVMKTLQHDKLVKL--HAVVTK-------EPIY------IITEFMAKGSLLDFLK- 92
Query: 918 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 977
S+ G K KL F AQ +A + + ++ +HRD+++ NIL+ V K+
Sbjct: 93 -SDEGSKQPLPKLIDFSAQ-IAEGMAFIEQRNYIHRDLRAANILVS-------ASLVCKI 143
Query: 978 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG---LEVDIW 1034
DF A + +T A G P +W APE + +G ++ D+W
Sbjct: 144 ADFGLARVIEDNEYT---AREGAKFP------IKWTAPEAIN-------FGSFTIKSDVW 187
Query: 1035 SYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE 1093
S+G LL+E++T ++PY G+S E+ ++ G R + +C E
Sbjct: 188 SFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPE------NCPEE---------- 231
Query: 1094 KPEAELETLSFLVDVFRRCTEENPTERPT 1122
L ++ RC + P ERPT
Sbjct: 232 -----------LYNIMMRCWKNRPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 6e-12
Identities = 64/214 (29%), Positives = 91/214 (42%), Gaps = 51/214 (23%)
Query: 856 SCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVK---GGS 910
S L E+ +L LRH IVE+ + K L S IF MEY +
Sbjct: 52 SSLREITLLLNLRHPNIVELK-EVVVGKHLDS-------------IFLVMEYCEQDLASL 97
Query: 911 VKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 970
+ N SE+ VK + + L LH I+HRD+K N+L+
Sbjct: 98 LDNMPTPFSES-----QVKC---LMLQLLRGLQYLHENFIIHRDLKVSNLLL-------T 142
Query: 971 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV--CVGTPRWMAPEVLRAMHKPNLYG 1028
K +K+ DF A R++ G+PA + V T + APE+L Y
Sbjct: 143 DKGCLKIADFGLA---RTY---------GLPAKPMTPKVVTLWYRAPELLLGCTT---YT 187
Query: 1029 LEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 1062
+D+W+ GC+L ELL + G SE+E DLI
Sbjct: 188 TAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLI 221
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 7e-12
Identities = 62/206 (30%), Positives = 91/206 (44%), Gaps = 34/206 (16%)
Query: 901 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960
I ME + G++ N+ L G VSV L + DVA + L SK ++HRD+ + NI
Sbjct: 75 IVMELMSKGNLVNF---LRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNI 131
Query: 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1020
L+ DG V K+ DF +A G D +W APE L
Sbjct: 132 LV-----SEDG--VAKVSDFG-------------LARVGSMGVDNSKLPVKWTAPEAL-- 169
Query: 1021 MHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEA--- 1076
K + + D+WSYG LL E+ + + PY +S E+ + ++ G R + A
Sbjct: 170 --KHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVY 227
Query: 1077 --LGSCHEHEVAQSGSGFEKPEAELE 1100
+ SC E E + S F K +LE
Sbjct: 228 VLMTSCWETEPKKRPS-FHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 7e-12
Identities = 56/191 (29%), Positives = 87/191 (45%), Gaps = 37/191 (19%)
Query: 941 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGI 1000
+L +H I HRDIK ENILI + ++KL DF +C +
Sbjct: 112 SLDHMHRNGIFHRDIKPENILIKDD--------ILKLADFG----------SCRGIYSKP 153
Query: 1001 PAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE-- 1057
P + + T RW APE L YG ++DIW+ GC+ E+L+L + G +EL+
Sbjct: 154 PYTEY-IST-RWYRAPECLLTD---GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQI 208
Query: 1058 --IHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEK--PEAELETLSFLVDVFRRC 1112
IHD+ +G + + + + ++ G+G K P A E L D+ ++
Sbjct: 209 AKIHDV--LGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGL----DLLKKL 262
Query: 1113 TEENPTERPTA 1123
+P ER TA
Sbjct: 263 LAYDPDERITA 273
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 8e-12
Identities = 51/154 (33%), Positives = 70/154 (45%), Gaps = 24/154 (15%)
Query: 901 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960
I MEY GG + ++K+ K L + + +H K ++HRDIKS+NI
Sbjct: 75 IVMEYCDGGDL---MQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNI 131
Query: 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1020
+ +GK VKL DF A L S C VGTP ++ PE+
Sbjct: 132 FL-----TQNGK--VKLGDFGSARLLTSPGAYAC----------TYVGTPYYVPPEIWEN 174
Query: 1021 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLS 1054
M Y + DIWS GC+L EL TL+ P+ S
Sbjct: 175 MP----YNNKSDIWSLGCILYELCTLKHPFQANS 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 9e-12
Identities = 48/163 (29%), Positives = 74/163 (45%), Gaps = 26/163 (15%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
M + GG +K +I GE A+F A + L LH + I++RD+K EN+L+
Sbjct: 72 MTLMNGGDLKYHI---YNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL 128
Query: 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1022
D G V++ D AV L +G GTP +MAPEVL
Sbjct: 129 D-----DHGN--VRISDLGLAVEL-----------KGGKKIKGRAGTPGYMAPEVL---- 166
Query: 1023 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSE-LEIHDLIQM 1064
+ +Y VD ++ GC L E++ + P+ E +E +L +
Sbjct: 167 QGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR 209
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 9e-12
Identities = 52/181 (28%), Positives = 90/181 (49%), Gaps = 35/181 (19%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
MEY GG + ++ + E+ + + A F ++ +AL LHS+ +++RDIK EN+++
Sbjct: 74 MEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML 128
Query: 963 DLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1019
D DG +K+ DF + + + T C GTP ++APEVL
Sbjct: 129 D-----KDGH--IKITDFGLCKEGISDGATMKTFC-------------GTPEYLAPEVL- 167
Query: 1020 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMG--KRPR-LTDELEA 1076
+ N YG VD W G ++ E++ ++P+ + +LI M + PR L+ E ++
Sbjct: 168 ---EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKS 224
Query: 1077 L 1077
L
Sbjct: 225 L 225
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 9e-12
Identities = 44/148 (29%), Positives = 66/148 (44%), Gaps = 30/148 (20%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
MEY+ GG + I+ L E +A +V + +LH + I+HRDIK EN+LI
Sbjct: 76 MEYLNGGDCASLIKTLGGLPEDWAKQYIA-----EVVLGVEDLHQRGIIHRDIKPENLLI 130
Query: 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1022
D G +KL DF ++ G+ VGTP ++APE + +
Sbjct: 131 D-----QTGH--LKLTDFG-------------LSRNGLENKKF-VGTPDYLAPETI--LG 167
Query: 1023 KPNLYGLEVDIWSYGCLLLELLTLQVPY 1050
+ D WS GC++ E L P+
Sbjct: 168 VGDDK--MSDWWSLGCVIFEFLFGYPPF 193
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 45/152 (29%), Positives = 73/152 (48%), Gaps = 33/152 (21%)
Query: 911 VKNYIEKLSETGEKHVSVKLALF-IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 969
+K +++ +G +K LF + Q +A HS ++HRD+K +N+LI+
Sbjct: 85 LKKFMDASPLSGIPLPLIKSYLFQLLQGLAFC----HSHRVLHRDLKPQNLLIN-----T 135
Query: 970 DGKPVVKLCDFDRA----VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 1025
+G +KL DF A VP+R++ H V T + APE+L
Sbjct: 136 EGA--IKLADFGLARAFGVPVRTYTHE--------------VVTLWYRAPEILLGC---K 176
Query: 1026 LYGLEVDIWSYGCLLLELLTLQVPYMGLSELE 1057
Y VDIWS GC+ E++T + + G SE++
Sbjct: 177 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEID 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 1e-11
Identities = 53/164 (32%), Positives = 79/164 (48%), Gaps = 34/164 (20%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
++YV GG + ++++ E+ A F A ++A+AL LHS +I++RD+K ENIL+
Sbjct: 75 LDYVNGGELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL 129
Query: 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV----CVGTPRWMAPEVL 1018
D + G V L DF + GI C GTP ++APEVL
Sbjct: 130 D-----SQGH--VVLTDFG-------------LCKEGIEHSKTTSTFC-GTPEYLAPEVL 168
Query: 1019 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 1062
R +P Y VD W G +L E+L P+ E++D I
Sbjct: 169 R--KQP--YDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 74/311 (23%), Positives = 111/311 (35%), Gaps = 94/311 (30%)
Query: 853 FEYSCLGEVRMLGALRHSCIV---EMY--GHKISSKWLPS---------AD-----GNPE 893
F + L E+++L L+H +V +M S + S D NP
Sbjct: 50 FPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPS 109
Query: 894 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 953
L +S I K Y+ +L E G + LH HI+HR
Sbjct: 110 VKLTESQI----------KCYMLQLLE-GINY-------------------LHENHILHR 139
Query: 954 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV-----CVG 1008
DIK+ NILI D + ++K+ DF A R + +G V
Sbjct: 140 DIKAANILI-------DNQGILKIADFGLA---RPY-DGPPPNPKGGGGGGTRKYTNLVV 188
Query: 1009 TPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKR 1067
T RW PE+L + + Y VDIW GC+ E+ T + G S+++ LI
Sbjct: 189 T-RWYRPPELL--LGERR-YTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI----- 239
Query: 1068 PRLTDELEALGSCHEHE--VAQSGSGFEKPEAELETLSFLVDVFRRCTEE---------- 1115
+ G+ E +S G E + L + F + E
Sbjct: 240 ------FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLS 293
Query: 1116 -NPTERPTAGD 1125
+P +R TA D
Sbjct: 294 LDPYKRLTASD 304
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-11
Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 26/148 (17%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
+EYV GG + ++++ + E+H A F + +++ AL LH + I++RD+K +N+L+
Sbjct: 75 IEYVNGGDLMFHMQRQRKLPEEH-----ARFYSAEISLALNYLHERGIIYRDLKLDNVLL 129
Query: 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1022
D E +KL D+ C R GTP ++APE+LR
Sbjct: 130 DSEGH-------IKLTDYG----------MCKEGLRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 1023 KPNLYGLEVDIWSYGCLLLELLTLQVPY 1050
YG VD W+ G L+ E++ + P+
Sbjct: 173 ----YGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (162), Expect = 1e-11
Identities = 43/161 (26%), Positives = 70/161 (43%), Gaps = 33/161 (20%)
Query: 890 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH 949
+ H+L M+Y+K G + + ++K E +S I + + AL +LH +
Sbjct: 79 TTLKGHVL----IMDYIKDGDLFDLLKK-----EGKLSEAEVKKIIRQLVEALNDLHKHN 129
Query: 950 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 1009
I+H DIK EN+L D + + + LCD+ C I P GT
Sbjct: 130 IIHNDIKLENVLYDRAKDR------IYLCDYG----------LCKIIG----TPSCYDGT 169
Query: 1010 PRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1050
+ +PE ++ Y + D W+ G L ELLT + P+
Sbjct: 170 LDYFSPEKIK--GHN--YDVSFDWWAVGVLTYELLTGKHPF 206
|
Length = 267 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-11
Identities = 75/274 (27%), Positives = 103/274 (37%), Gaps = 77/274 (28%)
Query: 858 LGEVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 915
+ EV+ L L+H +E G K + WL MEY G +
Sbjct: 69 IKEVKFLQQLKHPNTIEYKGCYLKEHTAWL----------------VMEYCLGSA----- 107
Query: 916 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 975
L E +K + I L LHS +++HRDIK+ NIL+ + V
Sbjct: 108 SDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ-------V 160
Query: 976 KLCDFDRAV---PLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 1032
KL DF A P SF VGTP WMAPEV+ AM + Y +VD
Sbjct: 161 KLADFGSASKSSPANSF-----------------VGTPYWMAPEVILAMDEGQ-YDGKVD 202
Query: 1033 IWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF 1092
+WS G +EL + P ++ + I P L +E S GF
Sbjct: 203 VWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL----------QSNEWTDSFRGF 252
Query: 1093 EKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1126
VD C ++ P ERP + +L
Sbjct: 253 -------------VDY---CLQKIPQERPASAEL 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 2e-11
Identities = 71/242 (29%), Positives = 103/242 (42%), Gaps = 59/242 (24%)
Query: 901 IFMEYVKGGSVKNYIEK--LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 958
I MEY+ GGS + +E L ET ++A I +++ L LHS+ +HRDIK+
Sbjct: 79 IIMEYLGGGSALDLLEPGPLDET-------QIAT-ILREILKGLDYLHSEKKIHRDIKAA 130
Query: 959 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1018
N+L+ + VKL DF A L T R + VGTP WMAPEV+
Sbjct: 131 NVLLSEHGE-------VKLADFGVAGQL-----TDTQIKR-----NTFVGTPFWMAPEVI 173
Query: 1019 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALG 1078
K + Y + DIWS G +EL + P+ L +++ LI P L
Sbjct: 174 ----KQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLE------- 222
Query: 1079 SCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE-MFVARTSSS 1137
+ KP L + C + P+ RPTA +L + F+ R +
Sbjct: 223 -----------GNYSKP---------LKEFVEACLNKEPSFRPTAKELLKHKFIVRFAKK 262
Query: 1138 IS 1139
S
Sbjct: 263 TS 264
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-11
Identities = 53/178 (29%), Positives = 87/178 (48%), Gaps = 29/178 (16%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
MEY GG + ++ + E+ S A F ++ +AL LHS +++RD+K EN+++
Sbjct: 74 MEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLML 128
Query: 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1022
D DG +K+ DF S G C GTP ++APEVL
Sbjct: 129 D-----KDGH--IKITDFGLCKEGISD---------GATMKTFC-GTPEYLAPEVL---- 167
Query: 1023 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMG--KRPR-LTDELEAL 1077
+ N YG VD W G ++ E++ ++P+ ++ +LI M + PR L+ E ++L
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSL 225
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 58/298 (19%), Positives = 119/298 (39%), Gaps = 68/298 (22%)
Query: 837 VRTLKVCGSSADEIRNF--EYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEH 894
V+T+K+ + EI F E +C+ + H ++++ G + S+
Sbjct: 32 VKTMKLDIHTYSEIEEFLSEAACMKD------FDHPNVMKLIGVCFEA----SSLQKIPK 81
Query: 895 HLLQSAIFMEYVKGGSVKNYI-EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 953
+ + + ++K G + +++ + + ++ L D+A + L +++ +HR
Sbjct: 82 PM----VILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHR 137
Query: 954 DIKSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR 1011
D+ + N ++ + V + DF + + + IA +P +
Sbjct: 138 DLAARNCMLREDMT-------VCVADFGLSKKIYSGDYYRQGRIAK--MPV--------K 180
Query: 1012 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRL 1070
W+A E L +Y + D+W++G + E+ T Q PY G+ EI+D ++ G R
Sbjct: 181 WIAIESL----ADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR--- 233
Query: 1071 TDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1128
++PE + L L D+ C +P +RPT L E
Sbjct: 234 ---------------------LKQPE---DCLDELYDLMYSCWRADPKDRPTFTKLRE 267
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 3e-11
Identities = 65/240 (27%), Positives = 104/240 (43%), Gaps = 45/240 (18%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
E +++ L H +V++YG + +K P I EY+ G + NY L
Sbjct: 49 EAKVMMKLSHEKLVQLYG--VCTKQRPIY------------IVTEYMSNGCLLNY---LR 91
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
E G++ +L L + +DV + L SK +HRD+ + N L+D G VK+ D
Sbjct: 92 EHGKRFQPSQL-LEMCKDVCEGMAYLESKQFIHRDLAARNCLVD-----DQG--CVKVSD 143
Query: 980 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039
F + R L + G P RW PEVL + + D+W++G L
Sbjct: 144 FGLS---RYVLDDEYTSSVGSKFP------VRWSPPEVLLYSK----FSSKSDVWAFGVL 190
Query: 1040 LLELLTL-QVPYMGLSELEIHDLIQMGK---RPRLTDE--LEALGSCHEHEVAQSGSGFE 1093
+ E+ +L ++PY + E + + G RP L E + SC HE A+ F+
Sbjct: 191 MWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCW-HEKAEERPTFQ 249
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 39/209 (18%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
EV+ L LRH ++ + + S G P + I E ++ GS+ + L
Sbjct: 52 EVQALKRLRHKHLISL--FAVCSV------GEPVY------IITELMEKGSLLAF---LR 94
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
+ + V + +A VA + L ++ +HRD+ + NIL+ + V K+ D
Sbjct: 95 SPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDL-------VCKVAD 147
Query: 980 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039
F A ++ ++ + + IP +W APE + + D+WS+G L
Sbjct: 148 FGLARLIKEDVYLS--SDKKIPY--------KWTAPEAASHGT----FSTKSDVWSFGIL 193
Query: 1040 LLELLTL-QVPYMGLSELEIHDLIQMGKR 1067
L E+ T QVPY G++ E++D I G R
Sbjct: 194 LYEMFTYGQVPYPGMNNHEVYDQITAGYR 222
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-11
Identities = 65/229 (28%), Positives = 97/229 (42%), Gaps = 62/229 (27%)
Query: 901 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960
+ +++++GG + + K E+ V LA ++A AL LHS I++RD+K ENI
Sbjct: 75 LILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-----ELALALDHLHSLGIIYRDLKPENI 129
Query: 961 LIDLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 1017
L+D +G +KL DF ++ ++ C GT +MAPEV
Sbjct: 130 LLD-----EEGH--IKLTDFGLSKESIDHEKKAYSFC-------------GTVEYMAPEV 169
Query: 1018 L-RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEA 1076
+ R H D WS+G L+ E+LT +P+ G E +I K
Sbjct: 170 VNRRGHT-----QSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK---------- 214
Query: 1077 LGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1125
LG F PEA+ S L +F+R NP R AG
Sbjct: 215 LGMPQ----------FLSPEAQ----SLLRALFKR----NPANRLGAGP 245
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-11
Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 38/209 (18%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
E+ L A H IV+ + D + LL + MEY GG + I++
Sbjct: 115 ELHCLAACDHFGIVKHFD-----------DFKSDDKLL---LIMEYGSGGDLNKQIKQRL 160
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP--VVKL 977
+ ++ L Q + AL E+HS+ +MHRD+KS NI + P ++KL
Sbjct: 161 KEHLPFQEYEVGLLFYQ-IVLALDEVHSRKMMHRDLKSANIFL---------MPTGIIKL 210
Query: 978 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1037
DF + + + + + A C GTP ++APE+ Y + D+WS G
Sbjct: 211 GDFGFS---KQYSDSVSLD----VASSFC-GTPYYLAPELWERKR----YSKKADMWSLG 258
Query: 1038 CLLLELLTLQVPYMGLSELEIHDLIQMGK 1066
+L ELLTL P+ G S+ EI + GK
Sbjct: 259 VILYELLTLHRPFKGPSQREIMQQVLYGK 287
|
Length = 478 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 72/301 (23%), Positives = 117/301 (38%), Gaps = 92/301 (30%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
V+ LK ++A + L E ++ LRH +V++ G GNP +
Sbjct: 34 VKCLKDDSTAAQ-------AFLAEASVMTTLRHPNLVQLLG--------VVLQGNPLY-- 76
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
I EY+ GS+ +Y L G +++ L A DV + L K+ +HRD+
Sbjct: 77 ----IVTEYMAKGSLVDY---LRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLA 129
Query: 957 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP------ 1010
+ N+L+ + V K+ DF G+ A + G
Sbjct: 130 ARNVLVSEDL-------VAKVSDF------------------GL-AKEASQGQDSGKLPV 163
Query: 1011 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPY--MGLSELEIHDLIQMGKR 1067
+W APE LR + + D+WS+G LL E+ + +VPY + L ++ H ++ G R
Sbjct: 164 KWTAPEALRE----KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPH--VEKGYR 217
Query: 1068 PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY 1127
+EA C + V + C E +P +RPT L
Sbjct: 218 ------MEAPEGCPPE---------------------VYKVMKDCWELDPAKRPTFKQLR 250
Query: 1128 E 1128
E
Sbjct: 251 E 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 4e-11
Identities = 49/149 (32%), Positives = 76/149 (51%), Gaps = 28/149 (18%)
Query: 901 IFMEYVKGGSVKNYI--EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 958
I M+Y +GG + I ++ E + L F+ + AL +H + I+HRDIKS+
Sbjct: 76 IVMDYCEGGDLYKKINAQRGVLFPEDQI---LDWFV--QICLALKHVHDRKILHRDIKSQ 130
Query: 959 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1018
NI + DG +KL DF A L S T +A C+GTP +++PE+
Sbjct: 131 NIFL-----TKDG--TIKLGDFGIARVLNS---TVELAR-------TCIGTPYYLSPEIC 173
Query: 1019 RAMHKPNLYGLEVDIWSYGCLLLELLTLQ 1047
++P Y + DIW+ GC+L E+ TL+
Sbjct: 174 E--NRP--YNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 4e-11
Identities = 61/212 (28%), Positives = 91/212 (42%), Gaps = 47/212 (22%)
Query: 837 VRTLKV-CGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHH 895
V+TLK CG E+ +L L H IV+ G ++ +
Sbjct: 38 VKTLKRECGQQNTS------GWKKEINILKTLYHENIVKYKG--------CCSEQGGKGL 83
Query: 896 LLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 955
L MEYV GS+++Y+ K +++ L AQ + + LHS+H +HRD+
Sbjct: 84 QL----IMEYVPLGSLRDYLPKHK------LNLAQLLLFAQQICEGMAYLHSQHYIHRDL 133
Query: 956 KSENILIDLERKKADGKPVVKLCDFD--RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 1013
+ N+L+D +R +VK+ DF +AVP +R D V W
Sbjct: 134 AARNVLLDNDR-------LVKIGDFGLAKAVP------EGHEYYRVREDGDSPV---FWY 177
Query: 1014 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045
A E L K N + D+WS+G L ELLT
Sbjct: 178 AVECL----KENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 87/298 (29%), Positives = 123/298 (41%), Gaps = 88/298 (29%)
Query: 858 LGEVRMLGALRHSCIV---EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY 914
L E+RML L+H +V E++ K + L HL+ EY +V N
Sbjct: 48 LREIRMLKQLKHPNLVNLIEVFRRK---RKL---------HLV-----FEYCDH-TVLNE 89
Query: 915 IEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 974
+EK +H+ K+ Q V H + +HRD+K ENILI K
Sbjct: 90 LEKNPRGVPEHLIKKIIWQTLQAVNFC----HKHNCIHRDVKPENILI----TKQG---Q 138
Query: 975 VKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV----CVGTPRWM-APEVLRAMHKPNLYGL 1029
+KLCDF A R + P V T RW APE+L + YG
Sbjct: 139 IKLCDFGFA--------------RILTGPGDDYTDYVAT-RWYRAPELLVGDTQ---YGP 180
Query: 1030 EVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQ--MGKR-PRLTDELEALGSCHEHEVA 1086
VD+W+ GC+ ELLT Q + G S+++ LI+ +G PR H+ +
Sbjct: 181 PVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPR-----------HQQIFS 229
Query: 1087 QSG--SGFEKPEAE----LE---------TLSFLVDVFRRCTEENPTERPTAGDLYEM 1129
+ G PE E LE LSFL + C + +PTER + +L E
Sbjct: 230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFL----KGCLQMDPTERLSCEELLEH 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 5e-11
Identities = 66/234 (28%), Positives = 102/234 (43%), Gaps = 50/234 (21%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
MEYV+GG ++ + + V +A + AL LH+ I+HRD+K +N+LI
Sbjct: 80 MEYVEGGDCATLLKNIGA-----LPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLI 134
Query: 963 DLERKKADGKPVVKLCDFDRA----VPLRSFLHTCCIAH--RGIPAPDVCVGTPRWMAPE 1016
+ G +KL DF + + L + L+ I R VC GTP ++APE
Sbjct: 135 -----TSMGH--IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC-GTPEYIAPE 186
Query: 1017 V-LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELE 1075
V LR YG VD W+ G +L E L VP+ G + E+ + ++D++E
Sbjct: 187 VILRQG-----YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV-------ISDDIE 234
Query: 1076 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1129
G E A+ + D+ R +NP ER G +E+
Sbjct: 235 WPE------------GDEALPADAQ------DLISRLLRQNPLERLGTGGAFEV 270
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 6e-11
Identities = 64/247 (25%), Positives = 93/247 (37%), Gaps = 72/247 (29%)
Query: 901 IFMEYVKGGSVKNYI-------EKLS-----ETGEKHVSVKLALFIAQDVAAALVELHSK 948
+ +EY G++++++ E S E L F Q VA + L SK
Sbjct: 93 VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQ-VARGMEFLASK 151
Query: 949 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG 1008
+HRD+ + N+L+ + V+K+ DF A R I D
Sbjct: 152 KCIHRDLAARNVLVTEDH-------VMKIADFGLA--------------RDIHHIDYYRK 190
Query: 1009 TPR------WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ-VPYMGLSELEIHDL 1061
T WMAPE L +Y + D+WS+G LL E+ TL PY G+ E+ L
Sbjct: 191 TTNGRLPVKWMAPEALFD----RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246
Query: 1062 IQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121
++ G R EKP L + R C E P++RP
Sbjct: 247 LKEGYR------------------------MEKP---QNCTQELYHLMRDCWHEVPSQRP 279
Query: 1122 TAGDLYE 1128
T L E
Sbjct: 280 TFKQLVE 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 6e-11
Identities = 67/245 (27%), Positives = 109/245 (44%), Gaps = 51/245 (20%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
V+TLK +S + ++F E +L L+H IV+ YG +G+P
Sbjct: 40 VKTLK--DASDNARKDFHR----EAELLTNLQHEHIVKFYG--------VCVEGDP---- 81
Query: 897 LQSAIFMEYVKGGSVKNYIEK------LSETGE--KHVSVKLALFIAQDVAAALVELHSK 948
+ EY+K G + ++ L G ++ L IAQ +AA +V L S+
Sbjct: 82 --LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ 139
Query: 949 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG 1008
H +HRD+ + N L+ +VK+ DF + + S + H +P
Sbjct: 140 HFVHRDLATRNCLV-------GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI------ 186
Query: 1009 TPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGK- 1066
RWM PE + M++ + E D+WS G +L E+ T + P+ LS E+ + I G+
Sbjct: 187 --RWMPPESI--MYRK--FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV 240
Query: 1067 --RPR 1069
RPR
Sbjct: 241 LQRPR 245
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 6e-11
Identities = 61/232 (26%), Positives = 87/232 (37%), Gaps = 47/232 (20%)
Query: 840 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 899
LKV RN L E +L L H + +Y + +L L+
Sbjct: 31 LKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYL---------CLV-- 79
Query: 900 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959
M+Y GG L K +S ++A F A +V AL LH I++RD+K EN
Sbjct: 80 ---MDYCPGG---ELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPEN 133
Query: 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLH-TCCIAHRGIPAPDV------------- 1005
IL+ G + L DFD + +G V
Sbjct: 134 ILL-----HESGH--IMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPS 186
Query: 1006 -----CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1052
VGT ++APEV+ + +G VD W+ G LL E+L P+ G
Sbjct: 187 FRSNSFVGTEEYIAPEVISG----DGHGSAVDWWTLGILLYEMLYGTTPFKG 234
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 7e-11
Identities = 67/249 (26%), Positives = 106/249 (42%), Gaps = 57/249 (22%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
V+ LK SA + +F+ E +L L+H IV YG +G P
Sbjct: 40 VKALKEASESARQ--DFQR----EAELLTVLQHQHIVRFYG--------VCTEGRP---- 81
Query: 897 LQSAIFMEYVKGGSVKNYIE------KLSETGEKHVSVKLAL----FIAQDVAAALVELH 946
+ EY++ G + ++ K+ GE +L L IA +A+ +V L
Sbjct: 82 --LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA 139
Query: 947 SKHIMHRDIKSENILI--DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1004
S H +HRD+ + N L+ L VVK+ DF + + S + +P
Sbjct: 140 SLHFVHRDLATRNCLVGQGL---------VVKIGDFGMSRDIYSTDYYRVGGRTMLPI-- 188
Query: 1005 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQ 1063
RWM PE + +++ + E DIWS+G +L E+ T + P+ LS E + I
Sbjct: 189 ------RWMPPESI--LYRK--FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT 238
Query: 1064 MGK---RPR 1069
G+ RPR
Sbjct: 239 QGRELERPR 247
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 7e-11
Identities = 74/309 (23%), Positives = 114/309 (36%), Gaps = 83/309 (26%)
Query: 834 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 893
V+TL S DE +F L E ++ H IV + G S + P
Sbjct: 38 QVAVKTLPESCSEQDES-DF----LMEALIMSKFNHQNIVRLIG--------VSFERLPR 84
Query: 894 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLA--LFIAQDVAAALVELHSKHIM 951
I +E + GG +K+++ + E+ S+ + LF A+DVA L H +
Sbjct: 85 F------ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFI 138
Query: 952 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV-----C 1006
HRDI + N L+ K G+ V K+ DF A R I
Sbjct: 139 HRDIAARNCLLT---CKGPGR-VAKIADFGMA--------------RDIYRASYYRKGGR 180
Query: 1007 VGTP-RWMAPEVLRAMHKPNLYGL---EVDIWSYGCLLLELLTL-QVPYMGLSELEIHDL 1061
P +WM PE L G+ + D+WS+G LL E+ +L +PY G + E+ +
Sbjct: 181 AMLPIKWMPPEAF-------LDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF 233
Query: 1062 IQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121
+ G R L+ C P + + C + P +RP
Sbjct: 234 VTGGGR------LDPPKGC--------------PGP-------VYRIMTDCWQHTPEDRP 266
Query: 1122 TAGDLYEMF 1130
+ E
Sbjct: 267 NFATILERI 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 8e-11
Identities = 51/172 (29%), Positives = 83/172 (48%), Gaps = 34/172 (19%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
MEYV GG + ++ + E+ S F ++ +AL LHS I++RD+K EN+++
Sbjct: 74 MEYVNGGELFFHLSR-----ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML 128
Query: 963 DLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1019
D DG +K+ DF + + + T C GTP ++APEVL
Sbjct: 129 D-----KDGH--IKITDFGLCKEGITDAATMKTFC-------------GTPEYLAPEVL- 167
Query: 1020 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMG--KRPR 1069
+ N YG VD W G ++ E++ ++P+ ++ +LI M K PR
Sbjct: 168 ---EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR 216
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 8e-11
Identities = 72/271 (26%), Positives = 108/271 (39%), Gaps = 45/271 (16%)
Query: 805 SFPSLSSCDEA----GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGE 860
SFP S E GK +F+ + A V+ L D I + + E
Sbjct: 12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKIL-------DPIHDIDEEIEAE 64
Query: 861 VRMLGALR-HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
+L AL H +V+ YG K + + D Q + +E GGSV + ++
Sbjct: 65 YNILKALSDHPNVVKFYG-MYYKKDVKNGD--------QLWLVLELCNGGSVTDLVKGFL 115
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
+ GE+ + + +I + L LH +HRD+K NIL+ E VKL D
Sbjct: 116 KRGER-MEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG-------VKLVD 167
Query: 980 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK-PNLYGLEVDIWSYGC 1038
F + L S + VGTP WMAPEV+ + + Y D+WS G
Sbjct: 168 FGVSAQLTSTRLR----------RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGI 217
Query: 1039 LLLELLTLQVPYMGLSELEIHDLIQMGKRPR 1069
+EL P ++H + + K PR
Sbjct: 218 TAIELGDGDPPLA-----DLHPMRALFKIPR 243
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 9e-11
Identities = 53/226 (23%), Positives = 86/226 (38%), Gaps = 58/226 (25%)
Query: 914 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 973
Y+ K + G + + + + + + LHS I+HRD+K +NIL+ + +
Sbjct: 95 YLSKCPKPG---LPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ------ 145
Query: 974 VVKLCDF------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 1027
VK+ DF + L S V T + APEVL + Y
Sbjct: 146 -VKIADFGLARIYSFEMALTS-----------------VVVTLWYRAPEVL--LQSS--Y 183
Query: 1028 GLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHE--- 1084
VD+WS GC+ EL + + G SE + D I + +G E E
Sbjct: 184 ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKI-----------FDVIGLPSEEEWPR 232
Query: 1085 -VAQSGSGFE----KPEAEL--ETLSFLVDVFRRCTEENPTERPTA 1123
V+ S F + E +D+ ++ NP +R +A
Sbjct: 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISA 278
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 1e-10
Identities = 41/115 (35%), Positives = 52/115 (45%), Gaps = 23/115 (20%)
Query: 941 ALVELHSKH-IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG 999
AL L KH ++HRD+K NIL+D A G VKLCDF I+ R
Sbjct: 126 ALHYLKEKHGVIHRDVKPSNILLD-----ASG--NVKLCDFG-------------ISGRL 165
Query: 1000 IP--APDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1052
+ A G +MAPE + Y + D+WS G L+EL T Q PY
Sbjct: 166 VDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 51/198 (25%), Positives = 78/198 (39%), Gaps = 46/198 (23%)
Query: 934 IAQDVAAALVELHSK-HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHT 992
IA + AL LHSK ++HRD+K N+LI+ + VKLCDF + L +
Sbjct: 108 IAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQ-------VKLCDFGISGYLVDSV-- 158
Query: 993 CCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1052
A + G +MAPE + Y ++ D+WS G ++EL T + PY
Sbjct: 159 ---------AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPY-- 207
Query: 1053 LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF-LVDVFRR 1111
+ L +V + S P+ E S D +
Sbjct: 208 ---------------DSWKTPFQQL-----KQVVEEPS----PQLPAEKFSPEFQDFVNK 243
Query: 1112 CTEENPTERPTAGDLYEM 1129
C ++N ERP +L +
Sbjct: 244 CLKKNYKERPNYPELLQH 261
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 47/158 (29%), Positives = 73/158 (46%), Gaps = 31/158 (19%)
Query: 901 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960
+ + + GG +K +I + G + + ALF A ++ L +LH ++ ++RD+K ENI
Sbjct: 77 LVLTIMNGGDLKFHIYNMGNPGFEE---ERALFYAAEILCGLEDLHRENTVYRDLKPENI 133
Query: 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC---VGTPRWMAPEV 1017
L+D G +++ D AV IP + VGT +MAPEV
Sbjct: 134 LLD-----DYGH--IRISDLGLAVK--------------IPEGESIRGRVGTVGYMAPEV 172
Query: 1018 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSE 1055
L Y L D W GCL+ E++ Q P+ G E
Sbjct: 173 L----NNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 43/148 (29%), Positives = 67/148 (45%), Gaps = 25/148 (16%)
Query: 908 GGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 967
GG +K +I + G + A+F A ++ L +LH + I++RD+K ENIL+D
Sbjct: 84 GGDLKFHIYNMGNPGFDE---ERAVFYAAEITCGLEDLHRERIVYRDLKPENILLD---- 136
Query: 968 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 1027
+++ D AV + I R VGT +MAPEV+ K Y
Sbjct: 137 ---DYGHIRISDLGLAVEIPE---GETIRGR--------VGTVGYMAPEVV----KNERY 178
Query: 1028 GLEVDIWSYGCLLLELLTLQVPYMGLSE 1055
D W GCL+ E++ + P+ E
Sbjct: 179 TFSPDWWGLGCLIYEMIEGKSPFRQRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 38/118 (32%), Positives = 57/118 (48%), Gaps = 29/118 (24%)
Query: 945 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF--DRA--VPLRSFLHTCCIAHRGI 1000
H +MHRD+K +N+L+D K ++K+ D RA +P++S+ H
Sbjct: 126 CHKHGVMHRDLKPQNLLVD------KQKGLLKIADLGLGRAFSIPVKSYTHE-------- 171
Query: 1001 PAPDVCVGTPRWMAPEVLR-AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE 1057
+ T + APEVL + H Y VDIWS GC+ E+ Q + G SEL+
Sbjct: 172 ------IVTLWYRAPEVLLGSTH----YSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ 219
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 58/240 (24%), Positives = 90/240 (37%), Gaps = 56/240 (23%)
Query: 897 LQSAIF--MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHR 953
++ A++ MEY+ GS+ T V L I V L L +H I+HR
Sbjct: 70 IEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDV-LR-RITYAVVKGLKFLKEEHNIIHR 127
Query: 954 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 1013
D+K N+L+ +G VKLCDF + L + L I G +M
Sbjct: 128 DVKPTNVLV-------NGNGQVKLCDFGVSGNLVASLAKTNI------------GCQSYM 168
Query: 1014 APEVLRA--MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM---GKRP 1068
APE +++ ++ Y ++ D+WS G +LE+ + PY + I + G P
Sbjct: 169 APERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPP 228
Query: 1069 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1128
L +A+ D +C + P RPT L E
Sbjct: 229 TLPSGYS-------------------DDAQ--------DFVAKCLNKIPNRRPTYAQLLE 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 2e-10
Identities = 88/324 (27%), Positives = 127/324 (39%), Gaps = 97/324 (29%)
Query: 828 FGSADAAAKVRTLKVCGSSADEIRNFEYS----------CLGEVRMLGALRHSCIVEMYG 877
FG+ A VRT +V I+ YS + EV+ L ++H +E G
Sbjct: 38 FGAVYFARDVRTNEVVA-----IKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 878 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQD 937
+ EH + + MEY G + L E +K + I
Sbjct: 93 CYLR-----------EH---TAWLVMEYCLGSA-----SDLLEVHKKPLQEVEIAAITHG 133
Query: 938 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV---PLRSFLHTCC 994
L LHS +++HRDIK+ NIL+ + VKL DF A P SF
Sbjct: 134 ALQGLAYLHSHNMIHRDIKAGNILLTEPGQ-------VKLADFGSASIASPANSF----- 181
Query: 995 IAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLS 1054
VGTP WMAPEV+ AM + Y +VD+WS G +EL + P +
Sbjct: 182 ------------VGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPLFNM- 227
Query: 1055 ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRR--- 1111
+ + AL + +AQ+ E P + S D FR
Sbjct: 228 -----------------NAMSAL-----YHIAQN----ESPTLQSNEWS---DYFRNFVD 258
Query: 1112 -CTEENPTERPTAGDLYE-MFVAR 1133
C ++ P +RPT+ +L + MFV R
Sbjct: 259 SCLQKIPQDRPTSEELLKHMFVLR 282
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 44/150 (29%), Positives = 69/150 (46%), Gaps = 31/150 (20%)
Query: 912 KNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 971
K Y++ TG +K ++ Q + + HS ++HRD+K +N+LID E
Sbjct: 85 KKYMDSSPLTGLDPPLIKS--YLYQ-LLQGIAYCHSHRVLHRDLKPQNLLIDREG----- 136
Query: 972 KPVVKLCDFDRA----VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 1027
+KL DF A VP+R++ H V T + APE+L Y
Sbjct: 137 --ALKLADFGLARAFGVPVRTYTHE--------------VVTLWYRAPEILLGSR---QY 177
Query: 1028 GLEVDIWSYGCLLLELLTLQVPYMGLSELE 1057
VDIWS GC+ E++ + + G SE++
Sbjct: 178 STPVDIWSIGCIFAEMVNRRPLFPGDSEID 207
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 47/203 (23%), Positives = 80/203 (39%), Gaps = 59/203 (29%)
Query: 932 LFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLH 991
L IA+ VAA + L + +HRD+ + N L+ VVK+ DF +
Sbjct: 133 LCIAKQVAAGMAYLSERKFVHRDLATRNCLV-------GENMVVKIADFGLS-------- 177
Query: 992 TCCIAHRGIPAPDVCVGTP------RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045
R I + D + RWM PE + N Y E D+W+YG +L E+ +
Sbjct: 178 ------RNIYSADYYKASENDAIPIRWMPPESIFY----NRYTTESDVWAYGVVLWEIFS 227
Query: 1046 LQV-PYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF 1104
+ PY G++ E+ ++ G + SC ++
Sbjct: 228 YGMQPYYGMAHEEVIYYVRDGN----------VLSCPDN-----------------CPLE 260
Query: 1105 LVDVFRRCTEENPTERPTAGDLY 1127
L ++ R C + P++RP+ +
Sbjct: 261 LYNLMRLCWSKLPSDRPSFASIN 283
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 60/267 (22%), Positives = 108/267 (40%), Gaps = 64/267 (23%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
E ++L L H IV+ + + I EY +G + +E+L
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAF--------------CIITEYCEGRDLDCKLEELK 97
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
TG+ ++ + Q + + +H + I+HRD+K++NI + ++K+ D
Sbjct: 98 HTGKTLSENQVCEWFIQ-LLLGVHYMHQRRILHRDLKAKNIFLK--------NNLLKIGD 148
Query: 980 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039
F + R + +C +A GTP +M+PE L+ H+ Y + DIWS GC+
Sbjct: 149 FGVS---RLLMGSCDLA-------TTFTGTPYYMSPEALK--HQG--YDSKSDIWSLGCI 194
Query: 1040 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 1099
L E+ L + G + L + I G P L PE
Sbjct: 195 LYEMCCLAHAFEGQNFLSVVLRIVEGPTPSL------------------------PETYS 230
Query: 1100 ETLSFLVDVFRRCTEENPTERPTAGDL 1126
L+ ++ ++P+ RP+A ++
Sbjct: 231 RQLNSIMQ---SMLNKDPSLRPSAAEI 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 66/256 (25%), Positives = 102/256 (39%), Gaps = 41/256 (16%)
Query: 816 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVE 874
GK +++ + A V+ L D I + + E +L +L H +V+
Sbjct: 31 GKGTYGKVYKVTNKKDGSLAAVKIL-------DPISDVDEEIEAEYNILQSLPNHPNVVK 83
Query: 875 MYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFI 934
YG + L Q + +E GGSV ++ L G++ ++ +I
Sbjct: 84 FYGMFYKADKLVGG---------QLWLVLELCNGGSVTELVKGLLICGQRLDEAMIS-YI 133
Query: 935 AQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCC 994
L LH+ I+HRD+K NIL+ E VKL DF + L T
Sbjct: 134 LYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG-------VKLVDFGVSAQL-----TST 181
Query: 995 IAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL-YGLEVDIWSYGCLLLELLTLQVPYMGL 1053
R + VGTP WMAPEV+ + + Y D+WS G +EL P
Sbjct: 182 RLRR-----NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL--- 233
Query: 1054 SELEIHDLIQMGKRPR 1069
++H + + K PR
Sbjct: 234 --FDMHPVKTLFKIPR 247
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-10
Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 35/205 (17%)
Query: 858 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI-- 915
L E ++ L H IV +Y I S DG+P ++ M Y++G ++K+ +
Sbjct: 50 LREAKIAADLIHPGIVPVY--SICS------DGDPVYYT------MPYIEGYTLKSLLKS 95
Query: 916 ----EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 971
E LS+ + SV L I + A + +HSK ++HRD+K +NIL+ L G
Sbjct: 96 VWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLF-----G 150
Query: 972 KPVV------KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 1025
+ V+ + L + I + + P VGTP +MAPE L
Sbjct: 151 EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG----V 206
Query: 1026 LYGLEVDIWSYGCLLLELLTLQVPY 1050
DI++ G +L ++LTL PY
Sbjct: 207 PASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 39/117 (33%), Positives = 61/117 (52%), Gaps = 30/117 (25%)
Query: 946 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA----VPLRSFLH-TCCIAHRGI 1000
HS+ ++HRD+K +N+LI D K V+KL DF A +P+R + H + +R
Sbjct: 118 HSRRVLHRDLKPQNLLI-------DNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYR-- 168
Query: 1001 PAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE 1057
AP+V +G+PR+ P VDIWS G + E+ T + + G SE++
Sbjct: 169 -APEVLLGSPRYSTP---------------VDIWSIGTIFAEMATKKPLFHGDSEID 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (154), Expect = 2e-10
Identities = 54/204 (26%), Positives = 85/204 (41%), Gaps = 60/204 (29%)
Query: 945 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1004
LHS +++HRD+K NIL++ +K+CDF A RG+ +
Sbjct: 119 LHSANVIHRDLKPSNILVNSN-------CDLKICDFGLA--------------RGVDPDE 157
Query: 1005 VCVG------TPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE 1057
G RW APE+L + + Y +DIWS GC+ ELLT + + G ++
Sbjct: 158 DEKGFLTEYVVTRWYRAPELLLSSSR---YTKAIDIWSVGCIFAELLTRKPLFPGRDYID 214
Query: 1058 IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF-----LVDVFRRC 1112
+LI +E LG+ E ++ S EK L++L L +F
Sbjct: 215 QLNLI-----------VEVLGTPSEEDLKFITS--EKARNYLKSLPKKPKKPLSKLFPGA 261
Query: 1113 TEE-----------NPTERPTAGD 1125
+ E +P +R TA +
Sbjct: 262 SPEAIDLLEKMLVFDPKKRITADE 285
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 3e-10
Identities = 71/304 (23%), Positives = 120/304 (39%), Gaps = 85/304 (27%)
Query: 848 DEIRNFEYSCLGEVRMLGALRHSCIVEM----YGHKISSKWLPSADGNPEHHLLQSAIF- 902
E F + L E+ +L L+H IV + G + I+
Sbjct: 42 KEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDK------------------IYM 83
Query: 903 -MEYVKGGSVKNYIEKLSE---TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 958
MEYV+ +K+ +E + + E VK + + + + LH I+HRD+K+
Sbjct: 84 VMEYVEH-DLKSLMETMKQPFLQSE----VK---CLMLQLLSGVAHLHDNWILHRDLKTS 135
Query: 959 NILIDLERKKADGKPVVKLCDFDRA----VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMA 1014
N+L++ + ++K+CDF A PL+ + V T + A
Sbjct: 136 NLLLN-------NRGILKICDFGLAREYGSPLKPYTQL--------------VVTLWYRA 174
Query: 1015 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL---- 1070
PE+L + Y +D+WS GC+ ELLT + + G SE++ Q+ K +L
Sbjct: 175 PELLLGAKE---YSTAIDMWSVGCIFAELLTKKPLFPGKSEID-----QLNKIFKLLGTP 226
Query: 1071 TDE-------LEALGSCH--EHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121
T++ L ++ Q F P L F D+ R +P +R
Sbjct: 227 TEKIWPGFSELPGAKKKTFTKYPYNQLRKKF--PALSLSDNGF--DLLNRLLTYDPAKRI 282
Query: 1122 TAGD 1125
+A D
Sbjct: 283 SAED 286
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 51/189 (26%), Positives = 86/189 (45%), Gaps = 37/189 (19%)
Query: 905 YVKGGSVKNYIEK---LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 961
Y+ G++K ++++ + +S + + +A +A + LH + ++H+DI + N +
Sbjct: 90 YMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCV 149
Query: 962 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT----P-RWMAPE 1016
ID E + VK+ D A+ F P C+G P +WMA E
Sbjct: 150 IDEELQ-------VKITD--NALSRDLF-----------PMDYHCLGDNENRPVKWMALE 189
Query: 1017 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR----PRLT 1071
L Y D+WS+G LL EL+TL Q PY+ + E+ ++ G R
Sbjct: 190 SLVN----KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQPINCP 245
Query: 1072 DELEALGSC 1080
DEL A+ +C
Sbjct: 246 DELFAVMAC 254
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 4e-10
Identities = 39/115 (33%), Positives = 53/115 (46%), Gaps = 27/115 (23%)
Query: 945 LHSKHIMHRDIKSENILIDLERKKADGKP--VVKLCDFDRA----VPLRSFLHTCCIAHR 998
LHS ++HRD+K NIL+ +G VVK+ D A PL+
Sbjct: 124 LHSNWVLHRDLKPANILV-----MGEGPERGVVKIGDLGLARLFNAPLKPLADL------ 172
Query: 999 GIPAPDVCVGTPRWMAPEVLR-AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1052
D V T + APE+L A H Y +DIW+ GC+ ELLTL+ + G
Sbjct: 173 -----DPVVVTIWYRAPELLLGARH----YTKAIDIWAIGCIFAELLTLEPIFKG 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 61/217 (28%), Positives = 87/217 (40%), Gaps = 53/217 (24%)
Query: 860 EVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 917
EVR L LRH ++ G + + WL MEY G +
Sbjct: 65 EVRFLQKLRHPNTIQYRGCYLREHTAWL----------------VMEYCLGSA-----SD 103
Query: 918 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP-VVK 976
L E +K + + L LHS +++HRD+K+ NIL+ +P +VK
Sbjct: 104 LLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS--------EPGLVK 155
Query: 977 LCDFDRA---VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 1033
L DF A P F VGTP WMAPEV+ AM + Y +VD+
Sbjct: 156 LGDFGSASIMAPANXF-----------------VGTPYWMAPEVILAMDEGQ-YDGKVDV 197
Query: 1034 WSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL 1070
WS G +EL + P ++ + I + P L
Sbjct: 198 WSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL 234
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 5e-10
Identities = 73/276 (26%), Positives = 121/276 (43%), Gaps = 37/276 (13%)
Query: 856 SCLGEVRMLGALRHSCIVEMYGHKI--SSKWLPSADGNPEHHLLQSA-IFMEYVKGGSVK 912
L E++++ L H IV++Y + S L G+ L S I EY++ +
Sbjct: 48 HALREIKIIRRLDHDNIVKVY-EVLGPSGSDLTEDVGSLTE--LNSVYIVQEYMET-DLA 103
Query: 913 NYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 972
N +E+ E+H LF+ Q + L +HS +++HRD+K N+ I+ E
Sbjct: 104 NVLEQ-GPLSEEHAR----LFMYQ-LLRGLKYIHSANVLHRDLKPANVFINTE------D 151
Query: 973 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEV 1031
V+K+ DF A + +H+G + + +W +P +L + PN Y +
Sbjct: 152 LVLKIGDFGLARIVDPHY-----SHKGYLSEGL---VTKWYRSPRLLLS---PNNYTKAI 200
Query: 1032 DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRP--RLTDELEALGSCHEHEVAQSG 1089
D+W+ GC+ E+LT + + G ELE LI + P R D E L + V G
Sbjct: 201 DMWAAGCIFAEMLTGKPLFAGAHELEQMQLI-LESVPVVREEDRNELL-NVIPSFVRNDG 258
Query: 1090 SGFEKPEAEL--ETLSFLVDVFRRCTEENPTERPTA 1123
+P +L +D + NP +R TA
Sbjct: 259 GEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTA 294
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 6e-10
Identities = 48/166 (28%), Positives = 72/166 (43%), Gaps = 31/166 (18%)
Query: 904 EYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963
+Y+ GG + +++K E S A F ++ AL LH I++RD+K ENIL+D
Sbjct: 76 DYMSGGELFWHLQK-----EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLD 130
Query: 964 LERKKADGKPVVKLCDFDRAVPLRS---FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1020
A G + LCDF + + +T C GT ++APEVL
Sbjct: 131 -----ATGH--IALCDFGLSKANLTDNKTTNTFC-------------GTTEYLAPEVLL- 169
Query: 1021 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1066
Y VD WS G L+ E+ P+ +++ I GK
Sbjct: 170 --DEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK 213
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 6e-10
Identities = 56/178 (31%), Positives = 81/178 (45%), Gaps = 42/178 (23%)
Query: 894 HHLLQSA----IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH 949
H+ Q+A ++YV GG + ++++ E+ A F A +VA+A+ LHS +
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQR-----ERCFLEPRARFYAAEVASAIGYLHSLN 116
Query: 950 IMHRDIKSENILIDLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVC 1006
I++RD+K ENIL+D + V L DF V T C
Sbjct: 117 IIYRDLKPENILLDSQGH-------VVLTDFGLCKEGVEPEETTSTFC------------ 157
Query: 1007 VGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 1064
GTP ++APEVLR +P Y VD W G +L E+L GL D+ QM
Sbjct: 158 -GTPEYLAPEVLR--KEP--YDRTVDWWCLGAVLYEML------YGLPPFYSRDVSQM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 6e-10
Identities = 54/195 (27%), Positives = 75/195 (38%), Gaps = 63/195 (32%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
M+Y+ GG + + + +L E LA F ++ A+ +H +HRDIK +NILI
Sbjct: 80 MDYIPGGDMMSLLIRLGIFEED-----LARFYIAELTCAIESVHKMGFIHRDIKPDNILI 134
Query: 963 DLERKKADGKPVVKLCDF-----------------------------------DRAVP-- 985
D DG +KL DF DR
Sbjct: 135 DR-----DGH--IKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKP 187
Query: 986 ---LRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042
R H C+AH VGTP ++APEVL Y D WS G +L E
Sbjct: 188 LERRRKRQHQRCLAHS-------LVGTPNYIAPEVLLRTG----YTQLCDWWSVGVILYE 236
Query: 1043 LLTLQVPYMGLSELE 1057
+L Q P++ + E
Sbjct: 237 MLVGQPPFLADTPAE 251
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 6e-10
Identities = 60/226 (26%), Positives = 97/226 (42%), Gaps = 57/226 (25%)
Query: 901 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960
I EY++ GS+ ++++ + G K KL AQ +A + + K+ +HRD+++ NI
Sbjct: 77 IITEYMENGSLVDFLK--TPEGIKLTINKLIDMAAQ-IAEGMAFIERKNYIHRDLRAANI 133
Query: 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1020
L+ K+ DF A R A G P +W APE +
Sbjct: 134 LVSETL-------CCKIADFGLA---RLIEDNEYTAREGAKFP------IKWTAPEAIN- 176
Query: 1021 MHKPNLYG---LEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEA 1076
YG ++ D+WS+G LL E++T ++PY G++ E+ ++ G R D
Sbjct: 177 ------YGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPD---- 226
Query: 1077 LGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122
+C PE L ++ R C +E P ERPT
Sbjct: 227 --NC--------------PEE-------LYELMRLCWKEKPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 6e-10
Identities = 50/146 (34%), Positives = 71/146 (48%), Gaps = 23/146 (15%)
Query: 909 GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 968
VKN LS+ G + ++ L VA + L SK+ +HRD+ + N+L+
Sbjct: 220 SEVKNL---LSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL------ 270
Query: 969 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 1028
A GK +VK+CDF A R +H +G V +WMAPE + NLY
Sbjct: 271 AQGK-IVKICDFGLA---RDIMHDSNYVSKGSTFLPV-----KWMAPESIF----DNLYT 317
Query: 1029 LEVDIWSYGCLLLELLTL-QVPYMGL 1053
D+WSYG LL E+ +L PY G+
Sbjct: 318 TLSDVWSYGILLWEIFSLGGTPYPGM 343
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 7e-10
Identities = 48/166 (28%), Positives = 82/166 (49%), Gaps = 33/166 (19%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENIL 961
MEY GG + ++ + E+ S A F ++ +AL LHS K++++RD+K EN++
Sbjct: 74 MEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLM 128
Query: 962 IDLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1018
+D DG +K+ DF + + + T C GTP ++APEVL
Sbjct: 129 LD-----KDGH--IKITDFGLCKEGIKDGATMKTFC-------------GTPEYLAPEVL 168
Query: 1019 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 1064
+ N YG VD W G ++ E++ ++P+ ++ +LI M
Sbjct: 169 ----EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 210
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 8e-10
Identities = 54/232 (23%), Positives = 98/232 (42%), Gaps = 43/232 (18%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
++TLK GSS + +F L E ++G H I+ + G S+ +
Sbjct: 37 IKTLKA-GSSDKQRLDF----LTEASIMGQFDHPNIIRLEGVVTKSRPV----------- 80
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
I EY++ GS+ + L E K +L + + + +A+ + L + +HRD+
Sbjct: 81 ---MIITEYMENGSLDKF---LRENDGKFTVGQL-VGMLRGIASGMKYLSEMNYVHRDLA 133
Query: 957 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1016
+ NIL++ V K+ DF + L T IP RW APE
Sbjct: 134 ARNILVNSNL-------VCKVSDFGLSRRLEDSEATYTTKGGKIPI--------RWTAPE 178
Query: 1017 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR 1067
+ + D+WS+G ++ E+++ + PY +S ++ ++ G R
Sbjct: 179 AIAYRK----FTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYR 226
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 9e-10
Identities = 39/128 (30%), Positives = 60/128 (46%), Gaps = 28/128 (21%)
Query: 946 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA----VPLRSFLHTCCIAHRGIP 1001
HS ++HRD+K +N+LID +KL DF A +P+R+F H
Sbjct: 119 HSHRVLHRDLKPQNLLIDRRTN------ALKLADFGLARAFGIPVRTFTHE--------- 163
Query: 1002 APDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL-EIHD 1060
V T + APE+L Y VDIWS GC+ E++ + + G SE+ E+
Sbjct: 164 -----VVTLWYRAPEILLGSRH---YSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFK 215
Query: 1061 LIQMGKRP 1068
+ ++ P
Sbjct: 216 IFRILGTP 223
|
Length = 294 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 70/276 (25%), Positives = 106/276 (38%), Gaps = 78/276 (28%)
Query: 858 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 917
L E R+L H IV++ G + ++ P I ME V GG +++ K
Sbjct: 40 LSEARILKQYDHPNIVKLIG--VCTQRQPIY------------IVMELVPGGDFLSFLRK 85
Query: 918 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 977
+ + VK AL D AA + L SK+ +HRD+ + N L+ V+K+
Sbjct: 86 KKDELKTKQLVKFAL----DAAAGMAYLESKNCIHRDLAARNCLVGENN-------VLKI 134
Query: 978 CDF------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 1031
DF D + S L + IP +W APE L Y E
Sbjct: 135 SDFGMSRQEDDGIYSSSGL-------KQIPI--------KWTAPEALNY----GRYSSES 175
Query: 1032 DIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS 1090
D+WSYG LL E +L V PY G++ + + ++ G R + C +
Sbjct: 176 DVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYR------MSCPQKCPDD------- 222
Query: 1091 GFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1126
+ V +RC + P RP +L
Sbjct: 223 --------------VYKVMQRCWDYKPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-09
Identities = 51/163 (31%), Positives = 79/163 (48%), Gaps = 32/163 (19%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
+++V GG + ++++ E+ A F A ++A+AL LHS +I++RD+K ENIL+
Sbjct: 75 LDFVNGGELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILL 129
Query: 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCV---GTPRWMAPEVLR 1019
D + G V L DF + GI D GTP ++APEV+R
Sbjct: 130 D-----SQGHVV--LTDFG-------------LCKEGIAQSDTTTTFCGTPEYLAPEVIR 169
Query: 1020 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 1062
+P Y VD W G +L E+L P+ E++D I
Sbjct: 170 --KQP--YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 67/235 (28%), Positives = 113/235 (48%), Gaps = 52/235 (22%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
V+TLK G+ + E S L E +++ LRH +V++Y + S+ P +
Sbjct: 35 VKTLKP-GTMSPE------SFLEEAQIMKKLRHDKLVQLYA--VVSE-------EPIY-- 76
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
I EY+ GS+ ++ L + + + + + +A VAA + + + +HRD++
Sbjct: 77 ----IVTEYMSKGSLLDF---LKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLR 129
Query: 957 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1016
S NIL+ DG V K+ DF A + +T A +G P +W APE
Sbjct: 130 SANILV------GDGL-VCKIADFGLARLIEDNEYT---ARQGAKFP------IKWTAPE 173
Query: 1017 VLRAMHKPNLYG---LEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR 1067
LYG ++ D+WS+G LL EL+T +VPY G++ E+ + ++ G R
Sbjct: 174 AA-------LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR 221
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 66/269 (24%), Positives = 115/269 (42%), Gaps = 72/269 (26%)
Query: 858 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 917
L E +++ LRH +V +Y P + I E++ GS+ ++
Sbjct: 49 LQEAQIMKKLRHDKLVPLYA---------VVSEEPIY------IVTEFMGKGSLLDF--- 90
Query: 918 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 977
L E K++ + + +A +A + + + +HRD+++ NIL+ D V K+
Sbjct: 91 LKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILV------GDNL-VCKI 143
Query: 978 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG---LEVDIW 1034
DF A + +T A +G P +W APE LYG ++ D+W
Sbjct: 144 ADFGLARLIEDNEYT---ARQGAKFP------IKWTAPEAA-------LYGRFTIKSDVW 187
Query: 1035 SYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE 1093
S+G LL EL+T +VPY G+ E+ + ++ G R + C
Sbjct: 188 SFGILLTELVTKGRVPYPGMVNREVLEQVERGYR------MPCPQGC------------- 228
Query: 1094 KPEAELETLSFLVDVFRRCTEENPTERPT 1122
PE+ L ++ + C +++P ERPT
Sbjct: 229 -PES-------LHELMKLCWKKDPDERPT 249
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-09
Identities = 67/240 (27%), Positives = 100/240 (41%), Gaps = 55/240 (22%)
Query: 901 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960
I MEY+ GGS + + + E ++ L +++ L LHS+ +HRDIK+ N+
Sbjct: 79 IIMEYLGGGSALDLL-RAGPFDEFQIATML-----KEILKGLDYLHSEKKIHRDIKAANV 132
Query: 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1020
L+ + VKL DF A L T R + VGTP WMAPEV++
Sbjct: 133 LLSEQGD-------VKLADFGVAGQL-----TDTQIKR-----NTFVGTPFWMAPEVIQQ 175
Query: 1021 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC 1080
+ Y + DIWS G +EL + P + + + LI P LT E
Sbjct: 176 ----SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGE------- 224
Query: 1081 HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE-MFVARTSSSIS 1139
F KP E C ++P+ RPTA +L + F+ + + S
Sbjct: 225 -----------FSKPFKEF---------IDACLNKDPSFRPTAKELLKHKFIVKNAKKTS 264
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 70/292 (23%), Positives = 122/292 (41%), Gaps = 69/292 (23%)
Query: 845 SSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFME 904
S+A+ +R+FE E+ +L +L+H IV+ G S+ G L+ ME
Sbjct: 44 STAEHLRDFER----EIEILKSLQHDNIVKYKGVCYSA-------GRRNLRLV-----ME 87
Query: 905 YVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964
Y+ GS+++Y++K E+ KL L+ +Q + + L SK +HRD+ + NIL++
Sbjct: 88 YLPYGSLRDYLQK---HRERLDHRKLLLYASQ-ICKGMEYLGSKRYVHRDLATRNILVES 143
Query: 965 ERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR-----WMAPEV 1017
E + VK+ DF + +P + V P W APE
Sbjct: 144 ENR-------VKIGDFGLTKVLPQDKEYYK--------------VREPGESPIFWYAPES 182
Query: 1018 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEAL 1077
L + + + D+WS+G +L EL T + MG D+ +
Sbjct: 183 L----TESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMR---MMGN-----DKQGQM 230
Query: 1078 GSCHEHEVAQSGSGFEKPE---AELETLSFLVDVFRRCTEENPTERPTAGDL 1126
H E+ ++ P AE+ + + C +P++RP+ +L
Sbjct: 231 IVYHLIELLKNNGRLPAPPGCPAEIYAI------MKECWNNDPSQRPSFSEL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 59/234 (25%), Positives = 88/234 (37%), Gaps = 65/234 (27%)
Query: 900 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959
+I E++ GGS+ Y K+ E HV + IA V L L S I+HRD+K N
Sbjct: 75 SICTEFMDGGSLDVY-RKIPE----HVLGR----IAVAVVKGLTYLWSLKILHRDVKPSN 125
Query: 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1019
+L++ + VKLCDF + L + + VGT +MAPE +
Sbjct: 126 MLVNTRGQ-------VKLCDFGVSTQLVNSIAK------------TYVGTNAYMAPERIS 166
Query: 1020 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM-------GLSELEIHDLIQMGKRPRLTD 1072
YG+ D+WS G +EL + PY L L++ I P L
Sbjct: 167 GEQ----YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPV 222
Query: 1073 ELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1126
+ ++ V +C + P ERP +L
Sbjct: 223 ----------GQFSEK----------------FVHFITQCMRKQPKERPAPENL 250
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-09
Identities = 66/271 (24%), Positives = 99/271 (36%), Gaps = 78/271 (28%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
M+Y+ GG + + + ++ E LA F ++ A+ +H +HRDIK +NILI
Sbjct: 80 MDYIPGGDMMSLLIRMEVFPEV-----LARFYIAELTLAIESVHKMGFIHRDIKPDNILI 134
Query: 963 DLERKKADGKPVVKLCDF-----------------------------------------D 981
DL DG +KL DF D
Sbjct: 135 DL-----DGH--IKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGD 187
Query: 982 RAVPLRSFL---HTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1038
R L H C+AH VGTP ++APEVL + K Y D WS G
Sbjct: 188 RLKTLEQRATKQHQRCLAHS-------LVGTPNYIAPEVL--LRKG--YTQLCDWWSVGV 236
Query: 1039 LLLELLTLQVPYMGLSELE-----------IHDLIQMGKRPRLTDELEALGSCHEHEVAQ 1087
+L E+L Q P++ + E +H Q+ P D + L E + +
Sbjct: 237 ILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGR 296
Query: 1088 SGSGFEKPEAELETLSFLVDVFRRCTEENPT 1118
+G+ K + F D+ + P
Sbjct: 297 NGADDIKAHPFFSEVDFSSDIRTQPAPYVPK 327
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 50/156 (32%), Positives = 71/156 (45%), Gaps = 28/156 (17%)
Query: 945 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1004
LHS I+HRDIK N+L+ + V+K+CDF A + + +
Sbjct: 119 LHSAGILHRDIKPGNLLV-------NSNCVLKICDFGLA-RVEEPDESKHMTQE------ 164
Query: 1005 VCVGTPRWMAPEVLR-AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQ 1063
V T + APE+L + H Y VDIWS GC+ ELL ++ + S ++ DLI
Sbjct: 165 --VVTQYYRAPEILMGSRH----YTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLIT 218
Query: 1064 --MGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 1097
+G T LEA+ S E A G KP +
Sbjct: 219 DLLG-----TPSLEAMRSACEGARAHILRGPHKPPS 249
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 65/247 (26%), Positives = 103/247 (41%), Gaps = 53/247 (21%)
Query: 816 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 875
G+ + +C+ ++ K ++E + + L E++ML L+ IVE+
Sbjct: 10 GEGAYGVVLKCRHKETKEIVAIKKFK----DSEENEEVKETTLRELKMLRTLKQENIVEL 65
Query: 876 YGHKISSKWLPSADGNPEHHLLQSAIFM--EYVKGGSVKNYIEKLSETGEKHVSVKLALF 933
E + +++ EYV+ KN +E L E K+ +
Sbjct: 66 ----------------KEAFRRRGKLYLVFEYVE----KNMLELLEEMPNGVPPEKVRSY 105
Query: 934 IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFL--- 990
I Q + A+ H I+HRDIK EN+LI V+KLCDF A L
Sbjct: 106 IYQ-LIKAIHWCHKNDIVHRDIKPENLLIS-------HNDVLKLCDFGFARNLSEGSNAN 157
Query: 991 HTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1050
+T +A R +P++ +G P YG VD+WS GC+L EL Q +
Sbjct: 158 YTEYVATRWYRSPELLLGAP----------------YGKAVDMWSVGCILGELSDGQPLF 201
Query: 1051 MGLSELE 1057
G SE++
Sbjct: 202 PGESEID 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-09
Identities = 67/271 (24%), Positives = 102/271 (37%), Gaps = 78/271 (28%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
M+Y+ GG + + + ++ E LA F ++ A+ +H +HRDIK +NILI
Sbjct: 80 MDYIPGGDMMSLLIRMGIFPED-----LARFYIAELTCAVESVHKMGFIHRDIKPDNILI 134
Query: 963 DLERKKADGKPVVKLCDF-----------------------------------------D 981
D DG +KL DF D
Sbjct: 135 D-----RDGH--IKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGD 187
Query: 982 RAVPLR---SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1038
R PL + H C+AH VGTP ++APEVL L D WS G
Sbjct: 188 RLKPLERRAARQHQRCLAHS-------LVGTPNYIAPEVLLRTGYTQL----CDWWSVGV 236
Query: 1039 LLLELLTLQVPYMGLSELE-----------IHDLIQMGKRPRLTDELEALGSCHEHEVAQ 1087
+L E+L Q P++ + LE +H Q P +D + L E + +
Sbjct: 237 ILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGK 296
Query: 1088 SGSGFEKPEAELETLSFLVDVFRRCTEENPT 1118
+G+ K +T+ F D+ ++ P
Sbjct: 297 NGADEIKAHPFFKTIDFSSDLRQQSAPYIPK 327
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 3e-09
Identities = 68/255 (26%), Positives = 105/255 (41%), Gaps = 58/255 (22%)
Query: 900 AIFMEYVKGGSVKNYIEKLSETGEKHV-SVKLALFIAQDVAAALVELHSKH-IMHRDIKS 957
+I ME++ GGS+ ++K E+ + V +A V L L KH IMHRD+K
Sbjct: 79 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA------VIKGLTYLREKHKIMHRDVKP 132
Query: 958 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 1017
NIL+ + + +KLCDF + L + + VGT +M+PE
Sbjct: 133 SNILV-------NSRGEIKLCDFGVSGQLIDSM------------ANSFVGTRSYMSPER 173
Query: 1018 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEAL 1077
L+ H Y ++ DIWS G L+E+ + P + + +L M P D E+
Sbjct: 174 LQGTH----YSVQSDIWSMGLSLVEMAIGRYP---IPPPDAKELELMFGCPVEGDPAESE 226
Query: 1078 GSCHEHEVAQSGSGF----EKPEAELETLSFLV-----------------DVFRRCTEEN 1116
S + S + P A E L ++V D +C +N
Sbjct: 227 TSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKN 286
Query: 1117 PTERPTAGDLYEMFV 1131
P ER DL ++ V
Sbjct: 287 PAER---ADLKQLMV 298
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 53/188 (28%), Positives = 90/188 (47%), Gaps = 37/188 (19%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
E ++L L+H IV Y W DG I M + +GG + + +++
Sbjct: 49 EAQLLSQLKHPNIV-AY----RESW-EGEDG-------LLYIVMGFCEGGDLYHKLKE-- 93
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
+ G+ ++ + Q +A AL LH KHI+HRD+K++N+ L R ++K+ D
Sbjct: 94 QKGKLLPENQVVEWFVQ-IAMALQYLHEKHILHRDLKTQNVF--LTRTN-----IIKVGD 145
Query: 980 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039
A R + C +A +GTP +M+PE+ +KP Y + D+W+ GC
Sbjct: 146 LGIA---RVLENQCDMA-------STLIGTPYYMSPELFS--NKP--YNYKSDVWALGCC 191
Query: 1040 LLELLTLQ 1047
+ E+ TL+
Sbjct: 192 VYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-09
Identities = 51/160 (31%), Positives = 79/160 (49%), Gaps = 26/160 (16%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
++Y+ GG + ++++ E+ A F A ++A+AL LHS +I++RD+K ENIL+
Sbjct: 75 LDYINGGELFYHLQR-----ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL 129
Query: 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1022
D + + L DF L I H G + GTP ++APEVL H
Sbjct: 130 DSQGH-------IVLTDFG--------LCKENIEHNGTTS--TFCGTPEYLAPEVL---H 169
Query: 1023 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 1062
K Y VD W G +L E+L P+ + E++D I
Sbjct: 170 K-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 45/214 (21%)
Query: 858 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 917
L E +++ LRH +V++Y P + I EY+ GS+ ++++
Sbjct: 49 LQEAQVMKKLRHEKLVQLYA---------VVSEEPIY------IVTEYMSKGSLLDFLK- 92
Query: 918 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 977
E G+ +L AQ +A+ + + + +HRD+++ NIL+ V K+
Sbjct: 93 -GEMGKYLRLPQLVDMAAQ-IASGMAYVERMNYVHRDLRAANILVG-------ENLVCKV 143
Query: 978 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG---LEVDIW 1034
DF A + +T A +G P +W APE LYG ++ D+W
Sbjct: 144 ADFGLARLIEDNEYT---ARQGAKFP------IKWTAPEAA-------LYGRFTIKSDVW 187
Query: 1035 SYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR 1067
S+G LL EL T +VPY G+ E+ D ++ G R
Sbjct: 188 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 221
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 45/153 (29%), Positives = 71/153 (46%), Gaps = 31/153 (20%)
Query: 901 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960
+ + + GG +K +I + E G + A+F A ++ L +LH + I++RD+K ENI
Sbjct: 77 LVLTLMNGGDLKFHIYHMGEAGFEE---GRAVFYAAEICCGLEDLHQERIVYRDLKPENI 133
Query: 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC---VGTPRWMAPEV 1017
L+D G +++ D AV +P VGT +MAPEV
Sbjct: 134 LLD-----DHGH--IRISDLGLAV--------------HVPEGQTIKGRVGTVGYMAPEV 172
Query: 1018 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1050
+ K Y D W+ GCLL E++ Q P+
Sbjct: 173 V----KNERYTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 4e-09
Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 35/154 (22%)
Query: 901 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALF-IAQDVAAALVELHSKHIMHRDIKSEN 959
+ +E++ GGS++ H++ + L +A+ + + + LH +HI+HRDIK N
Sbjct: 149 VLLEFMDGGSLEG----------THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSN 198
Query: 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1019
+LI+ + VK+ DF + L + C + VGT +M+PE +
Sbjct: 199 LLINSAKN-------VKIADFGVSRILAQTMDPC----------NSSVGTIAYMSPERIN 241
Query: 1020 AMHKPNLY-GLEVDIWSYGCLLLELLTLQVPYMG 1052
Y G DIWS G +LE Y+G
Sbjct: 242 TDLNHGAYDGYAGDIWSLGVSILEF------YLG 269
|
Length = 353 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 5e-09
Identities = 51/195 (26%), Positives = 85/195 (43%), Gaps = 50/195 (25%)
Query: 938 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 997
VA + L SK+ +HRD+ + NIL+ R + K+CDF A +R+ + +
Sbjct: 223 VAKGMSFLASKNCIHRDLAARNILLTHGR-------ITKICDFGLARDIRNDSNYVVKGN 275
Query: 998 RGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLS-E 1055
+P +WMAPE + +Y E D+WSYG LL E+ +L PY G+ +
Sbjct: 276 ARLPV--------KWMAPESIFNC----VYTFESDVWSYGILLWEIFSLGSSPYPGMPVD 323
Query: 1056 LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE-AELETLSFLVDVFRRCTE 1114
+ + +I+ G R PE A E + D+ + C +
Sbjct: 324 SKFYKMIKEGYR------------------------MLSPECAPSE----MYDIMKSCWD 355
Query: 1115 ENPTERPTAGDLYEM 1129
+P +RPT + ++
Sbjct: 356 ADPLKRPTFKQIVQL 370
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 5e-09
Identities = 58/240 (24%), Positives = 99/240 (41%), Gaps = 58/240 (24%)
Query: 901 IFMEYVKGGSVKNYIEKLSETG-----------EKHVSVKLALFIAQDVAAALVELHSKH 949
+ +EY G+++ Y+ G E+ ++ K + A VA + L S+
Sbjct: 95 VLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK 154
Query: 950 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 1009
+HRD+ + N+L+ + V+K+ DF A + + + + +P
Sbjct: 155 CIHRDLAARNVLVTEDN-------VMKIADFGLARDVHNIDYYKKTTNGRLPV------- 200
Query: 1010 PRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRP 1068
+WMAPE L +Y + D+WS+G LL E+ TL PY G+ E+ L++ G R
Sbjct: 201 -KWMAPEALF----DRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHR- 254
Query: 1069 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1128
++ +C HE L + R C P++RPT L E
Sbjct: 255 -----MDKPANC-THE--------------------LYMIMRECWHAVPSQRPTFKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 6e-09
Identities = 60/246 (24%), Positives = 100/246 (40%), Gaps = 70/246 (28%)
Query: 901 IFMEYVKGGSVKNYIE-----------KLSETGEKHVSVKLALFIAQDVAAALVELHSKH 949
+ +EY G+++ ++ +++ E+ +S K + A VA + L S+
Sbjct: 95 VIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR 154
Query: 950 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 1009
+HRD+ + N+L+ + V+K+ DF A RG+ D T
Sbjct: 155 CIHRDLAARNVLVTEDN-------VMKIADFGLA--------------RGVHDIDYYKKT 193
Query: 1010 P------RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLI 1062
+WMAPE L +Y + D+WS+G L+ E+ TL PY G+ E+ L+
Sbjct: 194 SNGRLPVKWMAPEALF----DRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLL 249
Query: 1063 QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122
+ G R ++ +C HE L + R C PT+RPT
Sbjct: 250 REGHR------MDKPSNC-THE--------------------LYMLMRECWHAVPTQRPT 282
Query: 1123 AGDLYE 1128
L E
Sbjct: 283 FKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 8e-09
Identities = 59/240 (24%), Positives = 96/240 (40%), Gaps = 58/240 (24%)
Query: 901 IFMEYVKGGSVKNYIEKLSETG-----------EKHVSVKLALFIAQDVAAALVELHSKH 949
+ +EY G+++ Y+ G E+ +S K + A VA + L SK
Sbjct: 101 VIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK 160
Query: 950 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 1009
+HRD+ + N+L+ + V+K+ DF A + + + +P
Sbjct: 161 CIHRDLAARNVLVTEDN-------VMKIADFGLARDIHHIDYYKKTTNGRLPV------- 206
Query: 1010 PRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRP 1068
+WMAPE L +Y + D+WS+G LL E+ TL PY G+ E+ L++ G R
Sbjct: 207 -KWMAPEALF----DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR- 260
Query: 1069 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1128
+KP L ++ R C P++RPT L E
Sbjct: 261 -----------------------MDKPSNCTNELYMMM---RDCWHAVPSQRPTFKQLVE 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 8e-09
Identities = 69/296 (23%), Positives = 115/296 (38%), Gaps = 78/296 (26%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
V+T K C +S F L E ++ H IV++ G + ++ NP
Sbjct: 39 VKTCKNC-TSPSVREKF----LQEAYIMRQFDHPHIVKLIG--VITE-------NP---- 80
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
I ME G +++Y++ + + L L+ Q ++ AL L SK +HRDI
Sbjct: 81 --VWIVMELAPLGELRSYLQVNKYSLD---LASLILYSYQ-LSTALAYLESKRFVHRDIA 134
Query: 957 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG-IPAPDVCVGTPRWM 1013
+ N+L+ VKL DF R + S+ A +G +P +WM
Sbjct: 135 ARNVLV-------SSPDCVKLGDFGLSRYLEDESYYK----ASKGKLPI--------KWM 175
Query: 1014 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKRPRLTD 1072
APE + + D+W +G + E+L L V P+ G+ ++ I+ G+R
Sbjct: 176 APESINFRR----FTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL---- 227
Query: 1073 ELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1128
P TL L+ +C +P++RP +L
Sbjct: 228 --------------------PMPPNCPPTLYSLM---TKCWAYDPSKRPRFTELKA 260
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 9e-09
Identities = 59/272 (21%), Positives = 104/272 (38%), Gaps = 65/272 (23%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI---- 915
E+ M L H +V + G + P + +L EY G +K ++
Sbjct: 58 ELDMFRKLSHKNVVRLLGL--------CREAEPHYMIL------EYTDLGDLKQFLRATK 103
Query: 916 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 975
K + +S K + + +A + L + +HRD+ + N L+ +R+
Sbjct: 104 SKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL-- 161
Query: 976 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 1035
L + V + R P RW+APE ++ + + + D+WS
Sbjct: 162 SLS---KDVYNSEYYK-----LRNALIP------LRWLAPEAVQE----DDFSTKSDVWS 203
Query: 1036 YGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK 1094
+G L+ E+ T ++P+ GLS+ E+ + +Q GK E
Sbjct: 204 FGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK-------------------------LEL 238
Query: 1095 PEAELETLSFLVDVFRRCTEENPTERPTAGDL 1126
P E S L + RC NP +RP+ +L
Sbjct: 239 PVPE-GCPSRLYKLMTRCWAVNPKDRPSFSEL 269
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-08
Identities = 41/148 (27%), Positives = 69/148 (46%), Gaps = 26/148 (17%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
+ ++ GG + +++++ E + A F ++ AL LH ++++RD+K ENIL+
Sbjct: 72 LAFINGGELFHHLQR-----EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL 126
Query: 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1022
D + A LCDF C + + + GTP ++APE+L
Sbjct: 127 DYQGHIA-------LCDFG----------LCKLNMKDDDKTNTFCGTPEYLAPELLLGHG 169
Query: 1023 KPNLYGLEVDIWSYGCLLLELLTLQVPY 1050
Y VD W+ G LL E+LT P+
Sbjct: 170 ----YTKAVDWWTLGVLLYEMLTGLPPF 193
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 61/273 (22%), Positives = 102/273 (37%), Gaps = 72/273 (26%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
E +++ L H +V++YG K L I E+++ G + NY+ +
Sbjct: 49 EAKVMMKLSHPKLVQLYGVCTQQKPL--------------YIVTEFMENGCLLNYLRQ-- 92
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
+ +S + L + QDV + L +HRD+ + N L+ VVK+ D
Sbjct: 93 --RQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTG-------VVKVSD 143
Query: 980 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039
F R L + G P +W PEV + Y + D+WS+G L
Sbjct: 144 FGMT---RYVLDDEYTSSSGAKFP------VKWSPPEVFNF----SKYSSKSDVWSFGVL 190
Query: 1040 LLELLTL-QVPYMGLSELEIHDLIQMGKR---PRLTDELEALGSCHEHEVAQSGSGFEKP 1095
+ E+ T ++P+ S E+ ++I G R P+L +
Sbjct: 191 MWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKL--------ASM-------------- 228
Query: 1096 EAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1128
+ +V C E P RPT +L
Sbjct: 229 --------TVYEVMYSCWHEKPEGRPTFAELLR 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 45/175 (25%), Positives = 80/175 (45%), Gaps = 28/175 (16%)
Query: 901 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960
+ M + GG +K +I + GE+ + ++ + + + ++ LHS I++RD+K EN+
Sbjct: 70 LVMSLMNGGDLKYHIYNV---GERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENV 126
Query: 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1020
L+D + +L D AV L+ A GT +MAPE+L
Sbjct: 127 LLDDQGN-------CRLSDLGLAVELKDGKTITQRA-----------GTNGYMAPEIL-- 166
Query: 1021 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELE 1075
K Y VD ++ GC + E++ + P+ E + + KR L DE++
Sbjct: 167 --KEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL---KRRTLEDEVK 216
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 50/180 (27%), Positives = 78/180 (43%), Gaps = 26/180 (14%)
Query: 901 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960
+ ++Y+ GG + ++ + E+ V + ++ AL LH I++RDIK ENI
Sbjct: 82 LILDYINGGELFTHLSQRERFKEQEVQIYSG-----EIVLALEHLHKLGIIYRDIKLENI 136
Query: 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1020
L+D ++G V L DF + + F A C GT +MAP+++R
Sbjct: 137 LLD-----SNGHVV--LTDFGLS---KEFH-----EDEVERAYSFC-GTIEYMAPDIVRG 180
Query: 1021 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQ---MGKRPRLTDELEAL 1077
+ VD WS G L+ ELLT P+ E I + P E+ AL
Sbjct: 181 GDGG--HDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL 238
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 44/137 (32%), Positives = 66/137 (48%), Gaps = 28/137 (20%)
Query: 932 LFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLH 991
L IA +AA + L S H +HRD+ + N L+ +G VK+ DF + + S +
Sbjct: 127 LHIAIQIAAGMEYLSSHHFVHRDLAARNCLV------GEGL-TVKISDFGLSRDIYSADY 179
Query: 992 TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG---LEVDIWSYGCLLLELLT--L 1046
+ +P RWM PE + LYG E DIWS+G +L E+ + L
Sbjct: 180 YRVQSKSLLPV--------RWMPPEAI-------LYGKFTTESDIWSFGVVLWEIFSYGL 224
Query: 1047 QVPYMGLSELEIHDLIQ 1063
Q PY G S E+ ++I+
Sbjct: 225 Q-PYYGFSNQEVIEMIR 240
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 47/152 (30%), Positives = 72/152 (47%), Gaps = 31/152 (20%)
Query: 900 AIFMEYVKGGSVKNYIEKLSETGEKHV-SVKLALFIAQDVAAALVELHSKH-IMHRDIKS 957
+I ME++ GGS+ +++ E+ + V +A V L L KH IMHRD+K
Sbjct: 79 SICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA------VLRGLAYLREKHQIMHRDVKP 132
Query: 958 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 1017
NIL+ + + +KLCDF + L + + VGT +M+PE
Sbjct: 133 SNILV-------NSRGEIKLCDFGVSGQLIDSM------------ANSFVGTRSYMSPER 173
Query: 1018 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1049
L+ H Y ++ DIWS G L+EL + P
Sbjct: 174 LQGTH----YSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 3e-08
Identities = 48/157 (30%), Positives = 73/157 (46%), Gaps = 38/157 (24%)
Query: 901 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960
+ ++YV GG + ++ + E V F + ++ AL LH I++RDIK ENI
Sbjct: 82 LILDYVSGGEMFTHLYQRDNFSEDEVR-----FYSGEIILALEHLHKLGIVYRDIKLENI 136
Query: 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFL-------HTCCIAHRGIPAPDVCVGTPRWM 1013
L+D ++G V L DF + + FL ++ C GT +M
Sbjct: 137 LLD-----SEGHVV--LTDFGLS---KEFLSEEKERTYSFC-------------GTIEYM 173
Query: 1014 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1050
APE++R +G VD WS G L+ ELLT P+
Sbjct: 174 APEIIRGKGG---HGKAVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 4e-08
Identities = 62/230 (26%), Positives = 93/230 (40%), Gaps = 60/230 (26%)
Query: 907 KGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 966
K S E+ E ++ ++++ + + VA + L S+ +HRD+ + NIL+
Sbjct: 151 KSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLS--- 207
Query: 967 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGI-PAPD-VCVGTPR----WMAPEVLRA 1020
VVK+CDF A R I PD V G R WMAPE +
Sbjct: 208 ----ENNVVKICDFGLA--------------RDIYKDPDYVRKGDARLPLKWMAPESIF- 248
Query: 1021 MHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKRPRLTDELEALGS 1079
+Y + D+WS+G LL E+ +L PY G+ E + + K
Sbjct: 249 ---DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EFCRRLKE------------ 291
Query: 1080 CHEHEVAQSGSGFEKPE-AELETLSFLVDVFRRCTEENPTERPTAGDLYE 1128
G+ PE A E S ++D C NP +RPT +L E
Sbjct: 292 ---------GTRMRAPEYATPEIYSIMLD----CWHNNPEDRPTFSELVE 328
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 57/232 (24%), Positives = 94/232 (40%), Gaps = 61/232 (26%)
Query: 903 MEYVKGGSVKNYIEK-----------LSETGEKHVSVKLALFIAQDVAAALVELHSKHIM 951
+EY G++ +++ K ++ + +S + L A DVA + L K +
Sbjct: 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFI 146
Query: 952 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR 1011
HRD+ + NIL+ V K+ DF + ++ +P R
Sbjct: 147 HRDLAARNILVGENY-------VAKIADFGLSRGQEVYVKK---TMGRLPV--------R 188
Query: 1012 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRL 1070
WMA E L ++Y D+WSYG LL E+++L PY G++ E+++ + G R
Sbjct: 189 WMAIESLNY----SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR--- 241
Query: 1071 TDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122
EKP L + D+ R+C E P ERP+
Sbjct: 242 ---------------------LEKP---LNCDDEVYDLMRQCWREKPYERPS 269
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 4e-08
Identities = 42/173 (24%), Positives = 63/173 (36%), Gaps = 50/173 (28%)
Query: 903 MEYVKGGSVKNYIEK---LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959
MEY+ GG + + K +E + F + A+ +H +HRDIK +N
Sbjct: 80 MEYLPGGDMMTLLMKKDTFTE--------EETRFYIAETILAIDSIHKLGYIHRDIKPDN 131
Query: 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSF---LHTCCIAHRGIPAPDV----------- 1005
+L+D A G +KL DF L+ ++H
Sbjct: 132 LLLD-----AKGH--IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRK 184
Query: 1006 --------------CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044
VGTP ++APEV Y E D WS G ++ E+L
Sbjct: 185 AETWKRNRRALAYSTVGTPDYIAPEVF----LQTGYNKECDWWSLGVIMYEML 233
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 4e-08
Identities = 45/158 (28%), Positives = 63/158 (39%), Gaps = 36/158 (22%)
Query: 902 FMEYVKGGSVKN-----YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
M Y GS ++ + E L E FI +DV AL +HSK +HR +K
Sbjct: 80 LMAY---GSCEDLLKTHFPEGLPEL--------AIAFILKDVLNALDYIHSKGFIHRSVK 128
Query: 957 SENILIDLERKKADGKPVVKLCDFDRAVPL--RSFLHTCCIAHRGIPAPDVCVGTPRWMA 1014
+ +IL+ DGK V L +V + P V W++
Sbjct: 129 ASHILLS-----GDGK--VVLSGLRYSVSMIKHGKRQRVVHDF-----PKSSVKNLPWLS 176
Query: 1015 PEVLRAMHKPNL--YGLEVDIWSYGCLLLELLTLQVPY 1050
PEVL+ NL Y + DI+S G EL VP+
Sbjct: 177 PEVLQQ----NLQGYNEKSDIYSVGITACELANGHVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 4e-08
Identities = 34/100 (34%), Positives = 48/100 (48%), Gaps = 23/100 (23%)
Query: 945 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1004
+HS ++HRD+K NILI+ + D +K+CDF A P
Sbjct: 124 VHSAGVVHRDLKPSNILIN---ENCD----LKICDFGLARIQD-------------PQMT 163
Query: 1005 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044
V T + APE++ K Y +EVDIWS GC+ E+L
Sbjct: 164 GYVSTRYYRAPEIMLTWQK---YDVEVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (137), Expect = 5e-08
Identities = 44/172 (25%), Positives = 79/172 (45%), Gaps = 41/172 (23%)
Query: 901 IFMEYVKGGSVKNYIEKLSETG---EKHVSVKLALFIAQDVAAALVELHS-------KHI 950
I ME+ G + I+K + E+H V I + + AL H+ + +
Sbjct: 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVD----ITRQLLHALAYCHNLKDGPNGERV 146
Query: 951 MHRDIKSENIL----------IDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHR 998
+HRD+K +NI I + +G+P+ K+ DF + + + S H+C
Sbjct: 147 LHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSC----- 201
Query: 999 GIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1050
VGTP + +PE+L +H+ Y + D+W+ GC++ EL + + P+
Sbjct: 202 --------VGTPYYWSPELL--LHETKSYDDKSDMWALGCIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 7e-08
Identities = 50/158 (31%), Positives = 74/158 (46%), Gaps = 38/158 (24%)
Query: 938 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 997
VA + L SK+ +HRD+ + N+LI +GK +VK+CDF A R +
Sbjct: 248 VANGMEFLASKNCVHRDLAARNVLI------CEGK-LVKICDFGLA---RDIMRDSNYIS 297
Query: 998 RG---IPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGL 1053
+G +P +WMAPE + NLY D+WS+G LL E+ TL PY
Sbjct: 298 KGSTFLPL--------KWMAPESIFN----NLYTTLSDVWSFGILLWEIFTLGGTPY--- 342
Query: 1054 SELEIHDLI--------QMGKRPRLTDEL-EALGSCHE 1082
EL +++ +M K +DE+ E + C E
Sbjct: 343 PELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWE 380
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 8e-08
Identities = 41/148 (27%), Positives = 66/148 (44%), Gaps = 22/148 (14%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
M + GG ++ +I + E A F + + L LH + I++RD+K EN+L+
Sbjct: 72 MTIMNGGDLRYHIYNVDEENPG-FPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLL 130
Query: 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1022
D DG V++ D AV L+ G GTP +MAPE+L+
Sbjct: 131 D-----NDGN--VRISDLGLAVELKD----------GQSKTKGYAGTPGFMAPELLQGEE 173
Query: 1023 KPNLYGLEVDIWSYGCLLLELLTLQVPY 1050
Y VD ++ G L E++ + P+
Sbjct: 174 ----YDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-08
Identities = 60/274 (21%), Positives = 106/274 (38%), Gaps = 72/274 (26%)
Query: 858 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM--EYVKGGSVKNYI 915
L E ++ LRHS +V++ G + K +++ EY+ GS+ +Y
Sbjct: 47 LAEASVMTQLRHSNLVQLLGVIVEEK---------------GGLYIVTEYMAKGSLVDY- 90
Query: 916 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 975
L G + L + DV A+ L + + +HRD+ + N+L+ + V
Sbjct: 91 --LRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDN-------VA 141
Query: 976 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 1035
K+ DF S T +P +W APE LR + + D+WS
Sbjct: 142 KVSDFGLTKEASSTQDTG-----KLPV--------KWTAPEALRE----KKFSTKSDVWS 184
Query: 1036 YGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK 1094
+G LL E+ + +VPY + ++ ++ G + ++A C
Sbjct: 185 FGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK------MDAPDGC-------------- 224
Query: 1095 PEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1128
P + DV ++C + RP+ L E
Sbjct: 225 PPV-------VYDVMKQCWHLDAATRPSFLQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 9e-08
Identities = 52/236 (22%), Positives = 90/236 (38%), Gaps = 52/236 (22%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
+E+ G +KNY+ + + +A +VA+ L+ LH +H D+ N +
Sbjct: 74 LEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQL 133
Query: 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIP----APDVCVGTP-RWMAPEV 1017
AD VK+ D+ +A P C P RW+APE+
Sbjct: 134 -----TADLS--VKIGDYG-------------LALEQYPEDYYITKDCHAVPLRWLAPEL 173
Query: 1018 LRAMH---KPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKRPRLTDE 1073
+ P + +IWS G + EL T PY LS+ ++ + + +L
Sbjct: 174 VEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKL--- 230
Query: 1074 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1129
KP+ +L+ +V + C + P RPTA +++E+
Sbjct: 231 -------------------PKPQLDLKYSDRWYEVMQFCWLD-PETRPTAEEVHEL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 42/162 (25%), Positives = 72/162 (44%), Gaps = 27/162 (16%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
++ + GG + ++ + EK + F A ++ L +H++ +++RD+K NIL+
Sbjct: 76 LDLMNGGDLHYHLSQHGVFSEKEMR-----FYATEIILGLEHMHNRFVVYRDLKPANILL 130
Query: 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1022
D E + CDF + P S VGT +MAPEVL+
Sbjct: 131 D-EHGHVRISDLGLACDFSKKKPHAS------------------VGTHGYMAPEVLQ--- 168
Query: 1023 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 1064
K Y D +S GC+L +LL P+ + H++ +M
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 210
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 49/207 (23%), Positives = 83/207 (40%), Gaps = 77/207 (37%)
Query: 856 SCLGEVRMLGALRHSCIVEMYG-----HKIS----------SKWLPSADGNPEHHLLQSA 900
S L E+ +L L+H IV +Y K++ K+ S +G+ + +++S
Sbjct: 45 SALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSF 104
Query: 901 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960
+F + +KG L HS +++HRD+K +N+
Sbjct: 105 MF-QLLKG---------------------------------LAFCHSHNVLHRDLKPQNL 130
Query: 961 LIDLERKKADGKPVVKLCDFDRA----VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1016
LI+ +G+ +KL DF A +P+R + V T + P+
Sbjct: 131 LIN-----KNGE--LKLADFGLARAFGIPVRCYSAE--------------VVTLWYRPPD 169
Query: 1017 VLRAMHKPNLYGLEVDIWSYGCLLLEL 1043
VL LY +D+WS GC+ EL
Sbjct: 170 VLFG---AKLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 38/132 (28%), Positives = 60/132 (45%), Gaps = 22/132 (16%)
Query: 933 FIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHT 992
F A ++ L +H++ +++RD+K NIL+D E + CDF + P S
Sbjct: 101 FYAAEIILGLEHMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHAS---- 155
Query: 993 CCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1052
VGT +MAPEVL+ K Y D +S GC+L +LL P+
Sbjct: 156 --------------VGTHGYMAPEVLQ---KGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 198
Query: 1053 LSELEIHDLIQM 1064
+ H++ +M
Sbjct: 199 HKTKDKHEIDRM 210
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 64/314 (20%), Positives = 127/314 (40%), Gaps = 67/314 (21%)
Query: 818 SVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 877
SV + + + GS A V+ LK S+ +I F L E + H ++++ G
Sbjct: 14 SVREAQLKSEDGSFQKVA-VKMLKADIFSSSDIEEF----LREAACMKEFDHPNVIKLIG 68
Query: 878 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFI--A 935
+ S+ + L + + ++K G + ++ +S GE+ ++ L +
Sbjct: 69 VSLRSR--------AKGRLPIPMVILPFMKHGDLHTFL-LMSRIGEEPFTLPLQTLVRFM 119
Query: 936 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS--FLHTC 993
D+A+ + L SK+ +HRD+ + N +++ V + DF + + S +
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNENMT-------VCVADFGLSKKIYSGDYYRQG 172
Query: 994 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMG 1052
C + +P +W+A E L N+Y D+W++G + E++T Q PY G
Sbjct: 173 CASK--LPV--------KWLALESL----ADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG 218
Query: 1053 LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 1112
+ EI++ + G R ++P + L + ++ +C
Sbjct: 219 VENSEIYNYLIKGNR------------------------LKQP---PDCLEDVYELMCQC 251
Query: 1113 TEENPTERPTAGDL 1126
P RP+ L
Sbjct: 252 WSPEPKCRPSFQHL 265
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 41/154 (26%), Positives = 73/154 (47%), Gaps = 30/154 (19%)
Query: 901 IFMEYVKGGSVKNYIEKLSETGEKHVSVKL-ALFIAQDVAAALVELH-SKHIMHRDIKSE 958
I M+ ++G + + L E ++ ++ +F+ + AL LH K I+HRD+
Sbjct: 86 IVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV--QMVLALRYLHKEKRIVHRDLTPN 143
Query: 959 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV--CVGTPRWMAPE 1016
NI++ E K V + DF +A + P + VGT + PE
Sbjct: 144 NIMLG-EDDK------VTITDFG-------------LAKQKQPESKLTSVVGTILYSCPE 183
Query: 1017 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1050
+++ P YG + D+W++GC+L ++ TLQ P+
Sbjct: 184 IVKNE--P--YGEKADVWAFGCILYQMCTLQPPF 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 41/148 (27%), Positives = 66/148 (44%), Gaps = 31/148 (20%)
Query: 906 VKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965
+ GG +K +I + G + A+F A ++ L +L + I++RD+K ENIL+
Sbjct: 82 MNGGDLKFHIYNMGNPG---FDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILL--- 135
Query: 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC---VGTPRWMAPEVLRAMH 1022
D + +++ D AV IP + VGT +MAPEV+
Sbjct: 136 ----DDRGHIRISDLGLAVQ--------------IPEGETVRGRVGTVGYMAPEVI---- 173
Query: 1023 KPNLYGLEVDIWSYGCLLLELLTLQVPY 1050
Y D W GCL+ E++ Q P+
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 2e-07
Identities = 39/128 (30%), Positives = 59/128 (46%), Gaps = 33/128 (25%)
Query: 933 FIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHT 992
FI Q + L +HS +++HRD+K N+L++ AD + +K+CDF A
Sbjct: 110 FIYQ-ILCGLKYIHSANVLHRDLKPGNLLVN-----ADCE--LKICDFGLA--------- 152
Query: 993 CCIAHRGI-PAPDVCVG------TPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044
RG P G RW APE++ + Y +D+WS GC+L ELL
Sbjct: 153 -----RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQS---YTKAIDVWSVGCILAELL 204
Query: 1045 TLQVPYMG 1052
+ + G
Sbjct: 205 GRKPVFKG 212
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 50/208 (24%), Positives = 84/208 (40%), Gaps = 43/208 (20%)
Query: 858 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 917
E ++L + H V +YG +L + +E+V GG ++ +
Sbjct: 79 FSERKILNYINHPFCVNLYGSFKDESYL--------------YLVLEFVIGGEFFTFLRR 124
Query: 918 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 977
K + F A + L S +I++RD+K EN+L+D DG +K+
Sbjct: 125 -----NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLD-----KDG--FIKM 172
Query: 978 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1037
DF A + + +T C GTP ++APE+L + +G D W+ G
Sbjct: 173 TDFGFAKVVDTRTYTLC-------------GTPEYIAPEILLNVG----HGKAADWWTLG 215
Query: 1038 CLLLELLTLQVPYMGLSELEIHDLIQMG 1065
+ E+L P+ L I+ I G
Sbjct: 216 IFIYEILVGCPPFYANEPLLIYQKILEG 243
|
Length = 340 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 60/275 (21%), Positives = 106/275 (38%), Gaps = 78/275 (28%)
Query: 854 EYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKN 913
E++C VR+LG + + G P + + ME + G +K+
Sbjct: 65 EFNCHHVVRLLGVV--------------------SQGQP------TLVIMELMTRGDLKS 98
Query: 914 YIEKL-----SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 968
Y+ L + + S+K + +A ++A + L++ +HRD+ + N ++ +
Sbjct: 99 YLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF-- 156
Query: 969 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 1028
VK+ DF R T G V RWM+PE L K ++
Sbjct: 157 -----TVKIGDFGMT---RDIYETDYYRKGGKGLLPV-----RWMSPESL----KDGVFT 199
Query: 1029 LEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ 1087
D+WS+G +L E+ TL + PY G+S ++ +
Sbjct: 200 TYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV------------------------M 235
Query: 1088 SGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122
G +KP+ L ++ R C + NP RP+
Sbjct: 236 EGGLLDKPD---NCPDMLFELMRMCWQYNPKMRPS 267
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 3e-07
Identities = 54/236 (22%), Positives = 98/236 (41%), Gaps = 52/236 (22%)
Query: 901 IFMEYVKGGSVKNYIEKL-----SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 955
+ ME + G +K+Y+ L + G +++ + +A ++A + L++K +HRD+
Sbjct: 86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDL 145
Query: 956 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAP 1015
+ N ++ + VK+ DF R T G V RWMAP
Sbjct: 146 AARNCMVAHDF-------TVKIGDFGMT---RDIYETDYYRKGGKGLLPV-----RWMAP 190
Query: 1016 EVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDEL 1074
E L K ++ D+WS+G +L E+ +L + PY GLS ++ +
Sbjct: 191 ESL----KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV------------ 234
Query: 1075 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130
G ++P+ E ++ D+ R C + NP RPT ++ +
Sbjct: 235 ------------MDGGYLDQPDNCPERVT---DLMRMCWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 50/206 (24%), Positives = 83/206 (40%), Gaps = 41/206 (19%)
Query: 839 TLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQ 898
LKV GS + F + ++ L H +V++YG + D N
Sbjct: 34 VLKVLGSDHRDSLAFFET----ASLMSQLSHKHLVKLYG-------VCVRDEN------- 75
Query: 899 SAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 958
+ EYVK G + ++ + +VS+ L +A+ +A+AL L K ++H ++ +
Sbjct: 76 -IMVEEYVKFGPLDVFLHREK----NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGK 130
Query: 959 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1018
NIL+ P +KL D + + S R P W+APE +
Sbjct: 131 NILVARYGLNEGYVPFIKLSDPGIPITVLS------REERVERIP--------WIAPECI 176
Query: 1019 RAMH-KPNLYGLEVDIWSYGCLLLEL 1043
R + D WS+G LLE+
Sbjct: 177 RNGQASLTIAA---DKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 58/241 (24%), Positives = 104/241 (43%), Gaps = 44/241 (18%)
Query: 829 GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 888
G + A ++TLK G + + ++F L E ++G H I+ + G + +K+ P+
Sbjct: 30 GRKEVAVAIKTLKP-GYTEKQRQDF----LSEASIMGQFSHHNIIRLEG--VVTKFKPAM 82
Query: 889 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK 948
I EY++ G++ Y L + + S +L + + +AA + L
Sbjct: 83 ------------IITEYMENGALDKY---LRDHDGEFSSYQLVGML-RGIAAGMKYLSDM 126
Query: 949 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG-IPAPDVCV 1007
+ +HRD+ + NIL+ + K+ DF + L G IP
Sbjct: 127 NYVHRDLAARNILV-------NSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPI----- 174
Query: 1008 GTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGK 1066
RW APE + A K + D+WS+G ++ E+++ + PY +S E+ I G
Sbjct: 175 ---RWTAPEAI-AYRK---FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF 227
Query: 1067 R 1067
R
Sbjct: 228 R 228
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 42/179 (23%), Positives = 80/179 (44%), Gaps = 31/179 (17%)
Query: 901 IFMEYVKGGSVKNYIE-----------KLSETGEKHVSVKLALFIAQDVAAALVELHSKH 949
+ +EY G+++ Y+ ++ ++ ++ K + VA + L S+
Sbjct: 98 VIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK 157
Query: 950 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 1009
+HRD+ + N+L+ V+K+ DF A + + + + +P
Sbjct: 158 CIHRDLAARNVLVTENN-------VMKIADFGLARDVNNIDYYKKTTNGRLPV------- 203
Query: 1010 PRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR 1067
+WMAPE L +Y + D+WS+G L+ E+ TL PY G+ E+ L++ G R
Sbjct: 204 -KWMAPEALF----DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR 257
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 6e-07
Identities = 38/133 (28%), Positives = 54/133 (40%), Gaps = 27/133 (20%)
Query: 942 LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF--------DRAVPLRSFLHTC 993
L LH + MHRD+ NI I+ K + K+ DF S T
Sbjct: 132 LNVLHKWYFMHRDLSPANIFIN-------SKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 994 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGL 1053
V T + APE+L K Y VD+WS GC+ ELLT + + G
Sbjct: 185 QRREEMTSK----VVTLWYRAPELLMGAEK---YHFAVDMWSVGCIFAELLTGKPLFPGE 237
Query: 1054 SELEIHDLIQMGK 1066
+E++ Q+G+
Sbjct: 238 NEID-----QLGR 245
|
Length = 335 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 7e-07
Identities = 41/148 (27%), Positives = 67/148 (45%), Gaps = 30/148 (20%)
Query: 901 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960
+ ME++ +V Y++ + + L+ Q + AL +HSK I HRD+K +N+
Sbjct: 144 VVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQ-LCRALAYIHSKFICHRDLKPQNL 201
Query: 961 LIDLERKKADGKPVVKLCDFDRAVPL----RSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1016
LID +KLCDF A L RS + C +R AP++ +G
Sbjct: 202 LIDPNTH------TLKLCDFGSAKNLLAGQRSVSYICSRFYR---APELMLGATN----- 247
Query: 1017 VLRAMHKPNLYGLEVDIWSYGCLLLELL 1044
Y +D+WS GC++ E++
Sbjct: 248 ----------YTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 7e-07
Identities = 39/117 (33%), Positives = 61/117 (52%), Gaps = 20/117 (17%)
Query: 938 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 997
VA + L SK+ +HRD+ + N+L+ DG+ V K+CDF A R ++
Sbjct: 221 VAQGMDFLASKNCIHRDVAARNVLL------TDGR-VAKICDFGLA---RDIMNDSNYVV 270
Query: 998 RGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGL 1053
+G V +WMAPE + +Y ++ D+WSYG LL E+ +L + PY G+
Sbjct: 271 KGNARLPV-----KWMAPESIFDC----VYTVQSDVWSYGILLWEIFSLGKSPYPGI 318
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 9e-07
Identities = 46/156 (29%), Positives = 74/156 (47%), Gaps = 30/156 (19%)
Query: 911 VKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 970
++ Y++K+ G ++K + + L LH+ I+HRD+K ENIL+ +
Sbjct: 93 LRTYLDKVPPPGLPAETIK---DLMRQFLRGLDFLHANCIVHRDLKPENILV-----TSG 144
Query: 971 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLE 1030
G+ VKL DF A +++C +A V T + APEVL + Y
Sbjct: 145 GQ--VKLADFGLAR-----IYSCQMAL------TPVVVTLWYRAPEVLLQ----STYATP 187
Query: 1031 VDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1066
VD+WS GC+ E+ + + G SE + Q+GK
Sbjct: 188 VDMWSVGCIFAEMFRRKPLFCGNSEAD-----QLGK 218
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 57/241 (23%), Positives = 101/241 (41%), Gaps = 44/241 (18%)
Query: 829 GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 888
G + ++TLK G + + R+F L E ++G H I+ + G SK +
Sbjct: 29 GKREIPVAIKTLKA-GYTEKQRRDF----LSEASIMGQFDHPNIIHLEGVVTKSKPV--- 80
Query: 889 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK 948
I EY++ GS+ ++ K + +V + + + +A+ + L
Sbjct: 81 -----------MIVTEYMENGSLDAFLRK----HDGQFTVIQLVGMLRGIASGMKYLSDM 125
Query: 949 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG-IPAPDVCV 1007
+HRD+ + NIL++ V K+ DF + L G IP
Sbjct: 126 GYVHRDLAARNILVN-------SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI----- 173
Query: 1008 GTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGK 1066
RW APE + A K + D+WSYG ++ E+++ + PY +S ++ I+ G
Sbjct: 174 ---RWTAPEAI-AYRK---FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY 226
Query: 1067 R 1067
R
Sbjct: 227 R 227
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 1e-06
Identities = 40/126 (31%), Positives = 54/126 (42%), Gaps = 36/126 (28%)
Query: 926 VSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 985
+ + AL I + + L LH++ I+HRD+K+ENI I+ D D
Sbjct: 154 LPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIN---------------DVD---- 194
Query: 986 LRSFLHTCCIAHRG-----IPAPDV--CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1038
CI G + AP GT APEVL A K Y + DIWS G
Sbjct: 195 ------QVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVL-ARDK---YNSKADIWSAGI 244
Query: 1039 LLLELL 1044
+L E+L
Sbjct: 245 VLFEML 250
|
Length = 357 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-06
Identities = 39/132 (29%), Positives = 61/132 (46%), Gaps = 22/132 (16%)
Query: 938 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 997
+A + L K ++HRD+ + N+L+ + VK+ DF A L A
Sbjct: 118 IAKGMSYLEEKRLVHRDLAARNVLVKTPQH-------VKITDFGLA-KLLDVDEKEYHAE 169
Query: 998 RGIPAPDVCVGTP-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSE 1055
G P +WMA E + +Y + D+WSYG + EL+T PY G+
Sbjct: 170 GGK--------VPIKWMALESILH----RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA 217
Query: 1056 LEIHDLIQMGKR 1067
+EI DL++ G+R
Sbjct: 218 VEIPDLLEKGER 229
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 2e-06
Identities = 45/191 (23%), Positives = 67/191 (35%), Gaps = 61/191 (31%)
Query: 949 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIP------- 1001
I+HRD+K NIL+ D +KLCDF GI
Sbjct: 128 KIIHRDVKPSNILL-------DRNGNIKLCDF------------------GISGQLVDSI 162
Query: 1002 APDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDL 1061
A G +MAPE + + Y + D+WS G L E+ T + PY + + D
Sbjct: 163 AKTRDAGCRPYMAPERI-DPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQ 219
Query: 1062 IQM---GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1118
+ G P L + E E + S V+ C ++ +
Sbjct: 220 LTQVVKGDPPI-------LSNSEEREFSPS----------------FVNFINLCLIKDES 256
Query: 1119 ERPTAGDLYEM 1129
+RP +L E
Sbjct: 257 KRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 2e-06
Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 1/59 (1%)
Query: 212 LISLKVANNKLVELPSG-LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L SL ++NN+L +P G L L+ LDLS N LTS+ + +L++L+L N L
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 2e-06
Identities = 21/60 (35%), Positives = 29/60 (48%), Gaps = 2/60 (3%)
Query: 188 NLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKLVELPSG-LYLLQRLENLDLSNNRL 245
NL+ LDLS N++ +P L L L ++ N L + L L +LDLS N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 2e-06
Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 51/204 (25%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM-EYVKGGSVKNYIEKL 918
E +L L+H+ IV + H I H ++ + EY+ +K Y++
Sbjct: 53 EASLLKDLKHANIVTL--HDII-------------HTKKTLTLVFEYLDT-DLKQYMDDC 96
Query: 919 SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 978
G +V+L LF + L H + ++HRD+K +N+LI ER + +KL
Sbjct: 97 G-GGLSMHNVRLFLF---QLLRGLAYCHQRRVLHRDLKPQNLLIS-ERGE------LKLA 145
Query: 979 DFDRA----VPLRSFLH-TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 1033
DF A VP +++ + + +R PDV +G+ Y +D+
Sbjct: 146 DFGLARAKSVPSKTYSNEVVTLWYR---PPDVLLGSTE---------------YSTSLDM 187
Query: 1034 WSYGCLLLELLTLQVPYMGLSELE 1057
W GC+ E+ T + + G +++E
Sbjct: 188 WGVGCIFYEMATGRPLFPGSTDVE 211
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 47/169 (27%), Positives = 75/169 (44%), Gaps = 24/169 (14%)
Query: 901 IFMEYVKGGSVKNYIEKLSETGEKH-VSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959
+ + Y+K G ++N+I E H +VK + VA + L SK +HRD+ + N
Sbjct: 74 VVLPYMKHGDLRNFIRS-----ETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARN 128
Query: 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1019
++D VK+ DF A + + H G P +WMA E L+
Sbjct: 129 CMLD-------ESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP------VKWMALESLQ 175
Query: 1020 AMHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKR 1067
K + + D+WS+G LL EL+T PY + +I + G+R
Sbjct: 176 T-QK---FTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRR 220
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-06
Identities = 69/254 (27%), Positives = 111/254 (43%), Gaps = 49/254 (19%)
Query: 64 RGGDNSVEGLYLYKNVLN-LIPKSVGRYEKLRNLKFFGNE-INLFPSEVGNLLGLECLQI 121
RG ++E L L N+L+ IP +G + L+ L GN + P+ + NL LE L +
Sbjct: 136 RGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTL 195
Query: 122 KISSPGVNGFA--LNKLKGLKELELS------KVPPRPSVLTLLSEIAGLKCLTKLSVCH 173
S+ V L ++K LK + L ++P EI GL L L + +
Sbjct: 196 A-SNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIP---------YEIGGLTSLNHLDLVY 245
Query: 174 FSIR-YLPPEIGCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-------- 223
++ +P +G L NL+ L L NK+ +P I L+ LISL +++N L
Sbjct: 246 NNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVI 305
Query: 224 -----------------ELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQY 266
++P L L RL+ L L +N+ + +L +NL L+L
Sbjct: 306 QLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLST 365
Query: 267 NKLLSYCQVPSWIC 280
N L ++P +C
Sbjct: 366 NNLTG--EIPEGLC 377
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-06
Identities = 77/277 (27%), Positives = 128/277 (46%), Gaps = 23/277 (8%)
Query: 6 SVEITQKSPEG----PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESY 61
S T K P P + L +NK + E ++ ++ +V+D+S + + E
Sbjct: 317 SNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGL 376
Query: 62 GNRGGDNSVEGLYLYKNVLN-LIPKSVGRYEKLRNLKFFGNEIN-LFPSEVGNLLGLECL 119
+ G ++ L L+ N L IPKS+G LR ++ N + PSE L + L
Sbjct: 377 CSSG---NLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFL 433
Query: 120 QIKISSPGVNGFALNKLK----GLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS 175
I S+ + G +N K L+ L L+ R L + G K L L +
Sbjct: 434 DI--SNNNLQG-RINSRKWDMPSLQMLSLA----RNKFFGGLPDSFGSKRLENLDLSRNQ 486
Query: 176 IR-YLPPEIGCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLYLL 232
+P ++G LS L QL LS NK+ +P E+ K L+SL +++N+L ++P+ +
Sbjct: 487 FSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEM 546
Query: 233 QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L LDLS N+L+ +L + +L +N+ +N L
Sbjct: 547 PVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHL 583
|
Length = 968 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 3e-06
Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 37/208 (17%)
Query: 853 FEYSCLGEVRMLGALRHSCIVEMYGHKI-SSKWLPSADGNPEHHLLQSAIFMEYVKGGSV 911
F + L E+++L L+H +V + +I +K P +L+ F E+ G +
Sbjct: 54 FPITALREIKILQLLKHENVVNLI--EICRTKATPYNRYKGSFYLVFE--FCEHDLAGLL 109
Query: 912 KNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 971
N K + E +K+ L L +H I+HRD+K+ NILI DG
Sbjct: 110 SNKNVKFTL-SEIKKVMKMLL-------NGLYYIHRNKILHRDMKAANILIT-----KDG 156
Query: 972 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC---VGTPRWMAPEVLRAMHKPNLYG 1028
++KL DF A R+F + P+ V T + PE+L YG
Sbjct: 157 --ILKLADFGLA---RAF------SLSKNSKPNRYTNRVVTLWYRPPELLLGERD---YG 202
Query: 1029 LEVDIWSYGCLLLELLTLQVPYM-GLSE 1055
+D+W GC++ E+ T P M G +E
Sbjct: 203 PPIDMWGAGCIMAEMWTRS-PIMQGNTE 229
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 60/300 (20%), Positives = 118/300 (39%), Gaps = 72/300 (24%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG---HKISSKWLPSADGNPE 893
V+T+K+ + E+ +F L E + H ++ + G + S+ PS
Sbjct: 31 VKTMKIAICTRSEMEDF----LSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP----- 81
Query: 894 HHLLQSAIFMEYVKGGSVKNYI--EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIM 951
+ + ++K G + +++ +L + + + L F+ D+A+ + L SK +
Sbjct: 82 ------VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMT-DIASGMEYLSSKSFI 134
Query: 952 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS--FLHTCCIAHRGIPAPDVCVGT 1009
HRD+ + N +++ V + DF + + + + IA +
Sbjct: 135 HRDLAARNCMLNENMN-------VCVADFGLSKKIYNGDYYRQGRIAKMPV--------- 178
Query: 1010 PRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRP 1068
+W+A E L +Y + D+WS+G + E+ T Q PY G+ EI+D ++ G R
Sbjct: 179 -KWIAIESL----ADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR- 232
Query: 1069 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1128
++P + L L + C NP +RP+ L
Sbjct: 233 -----------------------LKQPP---DCLDGLYSLMSSCWLLNPKDRPSFETLRC 266
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 3e-06
Identities = 39/117 (33%), Positives = 51/117 (43%), Gaps = 31/117 (26%)
Query: 933 FIAQDVAAALVELHSKHIMHRDIKSENILI--DLERKKADGKPVVKLCDFDRAVPLRSFL 990
F+ + L +HS I+HRD+K NI + D E +K+ DF A +
Sbjct: 122 FLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE---------LKILDFGLARHTDDEM 172
Query: 991 HTCCIAHRGIPAPDVCVGTPRW-MAPEV-LRAMHKPNLYGLEVDIWSYGCLLLELLT 1045
V T RW APE+ L MH Y VDIWS GC++ ELLT
Sbjct: 173 TG-------------YVAT-RWYRAPEIMLNWMH----YNQTVDIWSVGCIMAELLT 211
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 5e-06
Identities = 54/207 (26%), Positives = 83/207 (40%), Gaps = 43/207 (20%)
Query: 840 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 899
LKV S RN+ S M+ L H +V YG + E ++Q
Sbjct: 32 LKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD---------ESIMVQ- 78
Query: 900 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959
EYVK GS+ Y++K +++ L +A+ +A AL L K + H ++ ++N
Sbjct: 79 ----EYVKFGSLDTYLKKNKNL----INISWKLEVAKQLAWALHFLEDKGLTHGNVCAKN 130
Query: 960 ILIDLERKKADGK-PVVKLCD--FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1016
+L+ E + G P +KL D V + L IP W+ PE
Sbjct: 131 VLLIREEDRKTGNPPFIKLSDPGISITVLPKEIL------LERIP----------WVPPE 174
Query: 1017 VLRAMHKPNLYGLEVDIWSYGCLLLEL 1043
+ P L D WS+G L E+
Sbjct: 175 CIE---NPQNLSLAADKWSFGTTLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 6e-06
Identities = 36/110 (32%), Positives = 49/110 (44%), Gaps = 27/110 (24%)
Query: 941 ALVELHSKHIMHRDIKSENILI----DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA 996
L +HS +++HRD+K N+L+ DL K+CDF A R
Sbjct: 118 GLKYIHSANVLHRDLKPSNLLLNTNCDL-----------KICDFGLA---RI--ADPEHD 161
Query: 997 HRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045
H G V RW APE+ M Y +DIWS GC+L E+L+
Sbjct: 162 HTGFLTEYVAT---RWYRAPEI---MLNSKGYTKAIDIWSVGCILAEMLS 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 6e-06
Identities = 60/223 (26%), Positives = 94/223 (42%), Gaps = 52/223 (23%)
Query: 914 YIEKLSETGEKHVSVK---LALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 970
Y++K+ E G ++K L D LHS ++HRD+K +NIL+ +
Sbjct: 98 YLDKVPEPGVPTETIKDMMFQLLRGLDF------LHSHRVVHRDLKPQNILV-----TSS 146
Query: 971 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLE 1030
G+ +KL DF A + SF A V T + APEVL + Y
Sbjct: 147 GQ--IKLADFGLA-RIYSFQ----------MALTSVVVTLWYRAPEVLLQ----SSYATP 189
Query: 1031 VDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE----HEVA 1086
VD+WS GC+ E+ + + G S+++ Q+GK L+ +G E +VA
Sbjct: 190 VDLWSVGCIFAEMFRRKPLFRGSSDVD-----QLGKI------LDVIGLPGEEDWPRDVA 238
Query: 1087 QSGSGFE-KPEAELETLSFLVD-----VFRRCTEENPTERPTA 1123
F K +E +D + +C NP +R +A
Sbjct: 239 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 6e-06
Identities = 33/102 (32%), Positives = 49/102 (48%), Gaps = 24/102 (23%)
Query: 946 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV 1005
H ++HRD+K +N+LI+ + +KL DF A R+F GIP
Sbjct: 117 HENRVLHRDLKPQNLLIN-------KRGELKLADFGLA---RAF---------GIPVNTF 157
Query: 1006 C--VGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045
V T + AP+VL Y +DIWS GC++ E++T
Sbjct: 158 SNEVVTLWYRAPDVLLG---SRTYSTSIDIWSVGCIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 9e-06
Identities = 57/200 (28%), Positives = 80/200 (40%), Gaps = 58/200 (29%)
Query: 938 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 997
VA + L S+ +HRD+ + NIL+ VVK+CDF A
Sbjct: 183 VARGMEFLASRKCIHRDLAARNILLSENN-------VVKICDFGLA-------------- 221
Query: 998 RGI-PAPD-VCVGTPR----WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV-PY 1050
R I PD V G+ R WMAPE + +Y + D+WS+G LL E+ +L PY
Sbjct: 222 RDIYKDPDYVRKGSARLPLKWMAPESIF----DKVYTTQSDVWSFGVLLWEIFSLGASPY 277
Query: 1051 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 1110
G+ E + Q RL D G+ PE + +
Sbjct: 278 PGVQINE--EFCQ-----RLKD----------------GTRMRAPE---NATPEIYRIML 311
Query: 1111 RCTEENPTERPTAGDLYEMF 1130
C + +P ERPT L E+
Sbjct: 312 ACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 9e-06
Identities = 39/122 (31%), Positives = 56/122 (45%), Gaps = 30/122 (24%)
Query: 938 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 997
VA + L S+ +HRD+ + NIL+ VVK+CDF +A
Sbjct: 188 VAKGMEFLASRKCIHRDLAARNILLS-------ENNVVKICDFG-------------LAR 227
Query: 998 RGIPAPD-VCVGTPR----WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV-PYM 1051
PD V G R WMAPE + +Y ++ D+WS+G LL E+ +L PY
Sbjct: 228 DIYKDPDYVRKGDARLPLKWMAPETIF----DRVYTIQSDVWSFGVLLWEIFSLGASPYP 283
Query: 1052 GL 1053
G+
Sbjct: 284 GV 285
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 53/233 (22%), Positives = 98/233 (42%), Gaps = 61/233 (26%)
Query: 901 IFMEYVKGGSVKNYIEK--LSET----GEKH-----VSVKLALFIAQDVAAALVELHSKH 949
I +EY G++ +++ K + ET ++H ++ + L A DVA + L K
Sbjct: 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ 139
Query: 950 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 1009
+HRD+ + N+L+ K+ DF + ++ +P
Sbjct: 140 FIHRDLAARNVLVG-------ENLASKIADFGLSRGEEVYVKK---TMGRLPV------- 182
Query: 1010 PRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRP 1068
RWMA E L ++Y + D+WS+G LL E+++L PY G++ E+++ + G R
Sbjct: 183 -RWMAIESLNY----SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR- 236
Query: 1069 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121
+E +C + + ++ R+C + P ERP
Sbjct: 237 -----MEKPRNCDDE---------------------VYELMRQCWRDRPYERP 263
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 1e-05
Identities = 30/101 (29%), Positives = 47/101 (46%), Gaps = 20/101 (19%)
Query: 945 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1004
+HS +++HRD+K N+L++ D +K+CDF A T +
Sbjct: 124 IHSANVLHRDLKPSNLLLN---ANCD----LKICDFGLA-------RTTSEKGDFMTE-- 167
Query: 1005 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045
V T + APE+L + Y +D+WS GC+ ELL
Sbjct: 168 -YVVTRWYRAPELLLNCSE---YTTAIDVWSVGCIFAELLG 204
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-05
Identities = 41/140 (29%), Positives = 63/140 (45%), Gaps = 26/140 (18%)
Query: 914 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 973
Y+++ + ++ A+ I + + AL LH + I+HRD+K+ENI +D +P
Sbjct: 175 YVDRSGP-----LPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLD--------EP 221
Query: 974 V-VKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 1032
L DF A L AH P GT +PE+L A+ + Y + D
Sbjct: 222 ENAVLGDFGAACKLD--------AHPDTPQCYGWSGTLETNSPELL-AL---DPYCAKTD 269
Query: 1033 IWSYGCLLLELLTLQVPYMG 1052
IWS G +L E+ V G
Sbjct: 270 IWSAGLVLFEMSVKNVTLFG 289
|
Length = 392 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 61/254 (24%), Positives = 92/254 (36%), Gaps = 57/254 (22%)
Query: 902 FMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 961
FM Y GS + ++ G + LF A L LH +HR+IK+ +IL
Sbjct: 80 FMAY---GSANSLLKTYFPEGMSEALIGNILFGA---LRGLNYLHQNGYIHRNIKASHIL 133
Query: 962 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPA------PDVCVGTPRWMAP 1015
I DG V L H + G A P W++P
Sbjct: 134 I-----SGDG-----------LVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSP 177
Query: 1016 EVLRAMHKPNLYGLEV--DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDE 1073
E+LR +LYG V DI+S G EL T +VP+ + ++ L+Q K P +
Sbjct: 178 ELLRQ----DLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPL 231
Query: 1074 LEALGSCHEHEVAQSGSGFEKPEAELETLSF---------------------LVDVFRRC 1112
C E + S SG + E + ++ C
Sbjct: 232 DITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELC 291
Query: 1113 TEENPTERPTAGDL 1126
+++P +RP+A L
Sbjct: 292 LQQDPEKRPSASSL 305
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 2e-05
Identities = 38/117 (32%), Positives = 55/117 (47%), Gaps = 19/117 (16%)
Query: 946 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV 1005
H K+ +HRDIK NIL+ + K +KL DF A R + + P +
Sbjct: 133 HKKNFLHRDIKCSNILL-------NNKGQIKLADFGLA---RLY-----NSEESRPYTNK 177
Query: 1006 CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 1062
V T + PE+L + YG +D+WS GC+L EL T + + EL +LI
Sbjct: 178 -VITLWYRPPELLLGEER---YGPAIDVWSCGCILGELFTKKPIFQANQELAQLELI 230
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-05
Identities = 34/109 (31%), Positives = 50/109 (45%), Gaps = 19/109 (17%)
Query: 934 IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC 993
+A+ + +A+ +H + I+HRDIK+EN+L+ +G + L DF A R
Sbjct: 265 VARQLLSAIDYIHGEGIIHRDIKTENVLV-------NGPEDICLGDFGAACFAR------ 311
Query: 994 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042
P GT APEVL + Y VDIWS G ++ E
Sbjct: 312 --GSWSTPFHYGIAGTVDTNAPEVLAG----DPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 60/240 (25%), Positives = 97/240 (40%), Gaps = 75/240 (31%)
Query: 901 IFMEYVKGGSVKNYIEK--LSET----GEKH-----VSVKLALFIAQDVAAALVELHSKH 949
+ +EY G++ +++ K + ET + +S + L A DVA + L K
Sbjct: 73 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ 132
Query: 950 IMHRDIKSENILI--DLERKKAD-----GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPA 1002
+HRD+ + NIL+ + K AD G+ V R +P+R
Sbjct: 133 FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR-LPVR--------------- 176
Query: 1003 PDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDL 1061
WMA E L ++Y D+WSYG LL E+++L PY G++ E+++
Sbjct: 177 ---------WMAIESLNY----SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 223
Query: 1062 IQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121
+ G R LE +C + + D+ R+C E P ERP
Sbjct: 224 LPQGYR------LEKPLNCDDE---------------------VYDLMRQCWREKPYERP 256
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 2e-05
Identities = 38/109 (34%), Positives = 53/109 (48%), Gaps = 24/109 (22%)
Query: 945 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA-VPLRSFLHTCCIAHRGIPAP 1003
LHS I+HRD+K NI++ K+D +K+ DF A SF+ T P
Sbjct: 134 LHSAGIIHRDLKPSNIVV-----KSDC--TLKILDFGLARTAGTSFMMT----------P 176
Query: 1004 DVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1052
V T + APEV+ M Y VDIWS GC++ E++ V + G
Sbjct: 177 YVV--TRYYRAPEVILGMG----YKENVDIWSVGCIMGEMIRGTVLFPG 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 57/241 (23%), Positives = 98/241 (40%), Gaps = 52/241 (21%)
Query: 901 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960
+ ME++ GS+K Y+ + + +++K L A + + L S+ +HRD+ + N+
Sbjct: 85 LIMEFLPSGSLKEYLPR----NKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNV 140
Query: 961 LIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1018
L++ E + VK+ DF +A+ +T D W APE L
Sbjct: 141 LVESEHQ-------VKIGDFGLTKAIETDKEYYT---------VKDDLDSPVFWYAPECL 184
Query: 1019 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALG 1078
+ + + D+WS+G L ELLT Y + ++M +G
Sbjct: 185 --IQSK--FYIASDVWSFGVTLYELLT----YCDSESSPMTLFLKM------------IG 224
Query: 1079 SCHEH-------EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFV 1131
H V + G +P E + L+ R+C E P++R T +L E F
Sbjct: 225 PTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLM---RKCWEFQPSKRTTFQNLIEGFE 281
Query: 1132 A 1132
A
Sbjct: 282 A 282
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 55/220 (25%), Positives = 92/220 (41%), Gaps = 47/220 (21%)
Query: 840 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 899
LKV +E ++ + E +L L+H+ IV + H I H ++
Sbjct: 35 LKVISMKTEE--GVPFTAIREASLLKGLKHANIVLL--HDII-------------HTKET 77
Query: 900 AIF-MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 958
F EY+ + I+ G H + LF+ Q + L +H +HI+HRD+K +
Sbjct: 78 LTFVFEYMHTDLAQYMIQ---HPGGLH-PYNVRLFMFQ-LLRGLAYIHGQHILHRDLKPQ 132
Query: 959 NILIDLERKKADGKPVVKLCDFD--RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1016
N+LI + +KL DF RA + S ++ + PDV +G
Sbjct: 133 NLLISYLGE-------LKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATD----- 180
Query: 1017 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL 1056
Y +DIW GC+ +E+L Q + G+S++
Sbjct: 181 ----------YSSALDIWGAGCIFIEMLQGQPAFPGVSDV 210
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-05
Identities = 38/113 (33%), Positives = 53/113 (46%), Gaps = 22/113 (19%)
Query: 945 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1004
LHS I+HRD+K NI++ K+D +K+ DF A T C P
Sbjct: 139 LHSAGIIHRDLKPSNIVV-----KSDC--TLKILDFGLA-------RTACTNFMMTPY-- 182
Query: 1005 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE 1057
V T + APEV+ M Y VDIWS GC++ EL+ V + G ++
Sbjct: 183 --VVTRYYRAPEVILGMG----YKENVDIWSVGCIMGELVKGSVIFQGTDHID 229
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 3e-05
Identities = 37/122 (30%), Positives = 55/122 (45%), Gaps = 13/122 (10%)
Query: 938 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 997
V AL H++ I+HRD+K +NI++ + +P K+ DF L
Sbjct: 88 VLDALACAHNQGIVHRDLKPQNIMV----SQTGVRPHAKVLDFGIGTLLPGVRD---ADV 140
Query: 998 RGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL 1056
+ +GTP + APE LR PN D++++G + LE LT Q G S
Sbjct: 141 ATLTRTTEVLGTPTYCAPEQLRGEPVTPN-----SDLYAWGLIFLECLTGQRVVQGASVA 195
Query: 1057 EI 1058
EI
Sbjct: 196 EI 197
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-05
Identities = 47/158 (29%), Positives = 69/158 (43%), Gaps = 36/158 (22%)
Query: 909 GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 968
G+ N I K + + HV F+ + L +HS I+HRD+K N+ ++ + +
Sbjct: 105 GADLNNIVKCQKLTDDHVQ-----FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE- 158
Query: 969 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG--TPRWM-APEV-LRAMHKP 1024
+K+ DF A HT D G RW APE+ L MH
Sbjct: 159 ------LKILDFGLA------RHT----------DDEMTGYVATRWYRAPEIMLNWMH-- 194
Query: 1025 NLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 1062
Y VDIWS GC++ ELLT + + G ++ LI
Sbjct: 195 --YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 230
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 48/212 (22%), Positives = 88/212 (41%), Gaps = 41/212 (19%)
Query: 858 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 917
L E ++ L + IV M G + W+ + ME + G + +++K
Sbjct: 44 LREANVMQQLDNPYIVRMIGICEAESWM---------------LVMELAELGPLNKFLQK 88
Query: 918 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 977
KHV+ K + V+ + L + +HRD+ + N+L+ + K+
Sbjct: 89 -----NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQH-------YAKI 136
Query: 978 CDFDRAVPLRSFL-HTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1036
DF + L + + H P +W APE + +K + + D+WS+
Sbjct: 137 SDFGLSKALGADENYYKAKTHGKWPV--------KWYAPECMN-YYK---FSSKSDVWSF 184
Query: 1037 GCLLLELLTL-QVPYMGLSELEIHDLIQMGKR 1067
G L+ E + Q PY G+ E+ +I+ G+R
Sbjct: 185 GVLMWEAFSYGQKPYKGMKGNEVTQMIESGER 216
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 5e-05
Identities = 32/88 (36%), Positives = 51/88 (57%), Gaps = 2/88 (2%)
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLL-QRLENLDLSNN 243
L L LDL+ N+++ +E+ L L SL + NN + ++P + LL L+ LDLS+N
Sbjct: 91 NLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDN 150
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
++ SL L + NL+NL+L +N L
Sbjct: 151 KIESL-PSPLRNLPNLKNLDLSFNDLSD 177
|
Length = 394 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 5e-05
Identities = 65/309 (21%), Positives = 118/309 (38%), Gaps = 75/309 (24%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
V+ L+ +S + +F EV++L L I + G L
Sbjct: 51 VKVLR-PDASDNAREDFL----KEVKILSRLSDPNIARLLGVCTVDPPL----------- 94
Query: 897 LQSAIFMEYVKGGSVKNYIEK------LSETGEKHVSVKLALFIAQDVAAALVELHSKHI 950
+ MEY++ G + +++K K +S L++A +A+ + L S +
Sbjct: 95 ---CMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNF 151
Query: 951 MHRDIKSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVG 1008
+HRD+ + N L+ +K+ DF R + + + R P P
Sbjct: 152 VHRDLATRNCLVGKNYT-------IKIADFGMSRNLYSSDY---YRVQGRA-PLP----- 195
Query: 1009 TPRWMAPE-VLRAMHKPNLYGLEVDIWSYGCLLLELLTL--QVPYMGLSELEIHDLIQ-M 1064
RWMA E VL + K + + D+W++G L E+LTL + PY L +I+
Sbjct: 196 -IRWMAWESVL--LGK---FTTKSDVWAFGVTLWEILTLCREQPY---EHLTDQQVIENA 246
Query: 1065 GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124
G R L +P + + ++ C + +RPT
Sbjct: 247 GHFFRDDGRQIYLP---------------RPPNCPKD---IYELMLECWRRDEEDRPTFR 288
Query: 1125 DLYEMFVAR 1133
+++ +F+ R
Sbjct: 289 EIH-LFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 6e-05
Identities = 37/137 (27%), Positives = 67/137 (48%), Gaps = 28/137 (20%)
Query: 932 LFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLH 991
+ I +AA + L S H++H+D+ + N+L+ K VK+ D + + +
Sbjct: 127 VHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF-------DKLNVKISDLGLFREVYAADY 179
Query: 992 TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG---LEVDIWSYGCLLLELLT--L 1046
+ + +P RWM+PE + +YG ++ DIWSYG +L E+ + L
Sbjct: 180 YKLMGNSLLPI--------RWMSPEAI-------MYGKFSIDSDIWSYGVVLWEVFSYGL 224
Query: 1047 QVPYMGLSELEIHDLIQ 1063
Q PY G S ++ ++I+
Sbjct: 225 Q-PYCGYSNQDVIEMIR 240
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 6e-05
Identities = 53/217 (24%), Positives = 94/217 (43%), Gaps = 46/217 (21%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM--EYVKGGSVKNYIEK 917
E +++ L H +V++YG +S I + E+++ G + +Y+
Sbjct: 49 EAQVMMKLSHPKLVQLYGVCTE----------------RSPICLVFEFMEHGCLSDYLR- 91
Query: 918 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 977
++ G+ S + L + DV + L S +++HRD+ + N L+ + VVK+
Sbjct: 92 -AQRGK--FSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQ-------VVKV 141
Query: 978 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1037
DF R L + G P +W +PEV + Y + D+WS+G
Sbjct: 142 SDFGMT---RFVLDDQYTSSTGTKFP------VKWSSPEVF----SFSKYSSKSDVWSFG 188
Query: 1038 CLLLELLTL-QVPYMGLSELEIHDLIQMGKR---PRL 1070
L+ E+ + + PY S E+ + I G R PRL
Sbjct: 189 VLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRL 225
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 6e-05
Identities = 37/110 (33%), Positives = 52/110 (47%), Gaps = 26/110 (23%)
Query: 941 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGI 1000
AL +H+ ++ HRD+K +NIL + AD K +K+CDF A +F T
Sbjct: 115 ALKYIHTANVFHRDLKPKNILAN-----ADCK--LKICDFGLARV--AFNDT-------- 157
Query: 1001 PAPDVCVGT----PRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045
P T RW APE+ + Y +DIWS GC+ E+LT
Sbjct: 158 --PTAIFWTDYVATRWYRAPELCGSFFSK--YTPAIDIWSIGCIFAEVLT 203
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 7e-05
Identities = 48/191 (25%), Positives = 83/191 (43%), Gaps = 49/191 (25%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
EV +L L+H+ IV + H I H + EY+ +K Y++
Sbjct: 53 EVSLLKNLKHANIVTL--HDII------------HTERCLTLVFEYLDS-DLKQYLDNCG 97
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
H +VK+ +F + L H + I+HRD+K +N+LI + K +KL D
Sbjct: 98 NLMSMH-NVKIFMF---QLLRGLSYCHKRKILHRDLKPQNLLI-------NEKGELKLAD 146
Query: 980 FD----RAVPLRSFLH-TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 1034
F ++VP +++ + + +R PDV +G+ + P +D+W
Sbjct: 147 FGLARAKSVPTKTYSNEVVTLWYR---PPDVLLGSTEYSTP---------------IDMW 188
Query: 1035 SYGCLLLELLT 1045
GC+L E+ T
Sbjct: 189 GVGCILYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 7e-05
Identities = 29/101 (28%), Positives = 49/101 (48%), Gaps = 18/101 (17%)
Query: 945 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1004
+HS +++HRD+K N+L++ +++ DF A L S H+
Sbjct: 123 IHSANVIHRDLKPSNLLVN-------EDCELRIGDFGMARGLSSS----PTEHKYFMTEY 171
Query: 1005 VCVGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044
V RW APE+L ++ + Y +D+WS GC+ E+L
Sbjct: 172 V---ATRWYRAPELLLSLPE---YTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 8e-05
Identities = 35/131 (26%), Positives = 61/131 (46%), Gaps = 20/131 (15%)
Query: 938 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 997
+A + L + ++HRD+ + N+L+ VK+ DF A L +
Sbjct: 118 IAKGMNYLEERRLVHRDLAARNVLVK-------TPQHVKITDFGLAKLLGADEKEYHAEG 170
Query: 998 RGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSEL 1056
+P +WMA E + +H+ +Y + D+WSYG + EL+T PY G+
Sbjct: 171 GKVPI--------KWMALESI--LHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 218
Query: 1057 EIHDLIQMGKR 1067
EI +++ G+R
Sbjct: 219 EISSILEKGER 229
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-04
Identities = 50/215 (23%), Positives = 97/215 (45%), Gaps = 50/215 (23%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
EV +L L+H+ IV ++ + K L + EY+ +K Y++
Sbjct: 54 EVSLLKDLKHANIVTLHDIVHTDKSL--------------TLVFEYLDK-DLKQYMDDCG 98
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
H +VK+ L+ + L H + ++HRD+K +N+LI+ ER + +KL D
Sbjct: 99 NIMSMH-NVKIFLY---QILRGLAYCHRRKVLHRDLKPQNLLIN-ERGE------LKLAD 147
Query: 980 FD----RAVPLRSFLH-TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 1034
F ++VP +++ + + +R PDV +G+ Y ++D+W
Sbjct: 148 FGLARAKSVPTKTYSNEVVTLWYR---PPDVLLGSSE---------------YSTQIDMW 189
Query: 1035 SYGCLLLELLTLQVPYMGLS-ELEIHDLIQMGKRP 1068
GC+ E+ + + + G + E E+H + ++ P
Sbjct: 190 GVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTP 224
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 1e-04
Identities = 37/146 (25%), Positives = 64/146 (43%), Gaps = 20/146 (13%)
Query: 923 EKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDR 982
+ ++ +L L +A ++ L + ++HRD+ + N+L+ VK+ DF
Sbjct: 103 KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNH-------VKITDFGL 155
Query: 983 AVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042
A L +P +WMA E + + + D+WSYG + E
Sbjct: 156 ARLLEGDEKEYNADGGKMPI--------KWMALECIHYRK----FTHQSDVWSYGVTIWE 203
Query: 1043 LLTL-QVPYMGLSELEIHDLIQMGKR 1067
L+T PY G+ EI DL++ G+R
Sbjct: 204 LMTFGGKPYDGIPTREIPDLLEKGER 229
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 1e-04
Identities = 40/133 (30%), Positives = 58/133 (43%), Gaps = 32/133 (24%)
Query: 930 LALFIAQDVAAALVELHSK-HIMHRDIKSENILIDLERKKADGKPV-----------VKL 977
LA I Q AL H++ H+MH D+K ENIL++ D PV V++
Sbjct: 233 LAQIIFQ-TGVALDYFHTELHLMHTDLKPENILMETSDTVVD--PVTNRALPPDPCRVRI 289
Query: 978 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1037
CD L CC A V T + +PEV+ + + D+WS G
Sbjct: 290 CD----------LGGCCDERHSRTA---IVSTRHYRSPEVVLGLG----WMYSTDMWSMG 332
Query: 1038 CLLLELLTLQVPY 1050
C++ EL T ++ Y
Sbjct: 333 CIIYELYTGKLLY 345
|
Length = 467 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 35/133 (26%), Positives = 60/133 (45%), Gaps = 20/133 (15%)
Query: 932 LFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLH 991
L IA +AA + L S +H+D+ + NILI + VK+ D + + S +
Sbjct: 127 LHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH-------VKISDLGLSREIYSADY 179
Query: 992 TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV-PY 1050
+P RWM PE + + + DIWS+G +L E+ + + PY
Sbjct: 180 YRVQPKSLLPI--------RWMPPEAIMY----GKFSSDSDIWSFGVVLWEIFSFGLQPY 227
Query: 1051 MGLSELEIHDLIQ 1063
G S E+ ++++
Sbjct: 228 YGFSNQEVIEMVR 240
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 55/243 (22%), Positives = 105/243 (43%), Gaps = 46/243 (18%)
Query: 829 GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 888
G + ++TLK G + + R+F L E ++G H I+ + G + +K P
Sbjct: 29 GKREIFVAIKTLKS-GYTEKQRRDF----LSEASIMGQFDHPNIIHLEG--VVTKSRPVM 81
Query: 889 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK 948
I E+++ G++ +++ + + +V + + + +AA + L
Sbjct: 82 ------------IITEFMENGALDSFLRQ----NDGQFTVIQLVGMLRGIAAGMKYLSEM 125
Query: 949 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG 1008
+ +HRD+ + NIL+ + V K+ DF L FL P +G
Sbjct: 126 NYVHRDLAARNILV-------NSNLVCKVSDFG----LSRFLED----DTSDPTYTSSLG 170
Query: 1009 TP---RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQM 1064
RW APE + A K + D+WSYG ++ E+++ + PY +S ++ + I+
Sbjct: 171 GKIPIRWTAPEAI-AYRK---FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ 226
Query: 1065 GKR 1067
R
Sbjct: 227 DYR 229
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 3e-04
Identities = 36/112 (32%), Positives = 52/112 (46%), Gaps = 20/112 (17%)
Query: 934 IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC 993
I + + A+ +H K ++HRDIK ENI ++ DGK V L DF A+P
Sbjct: 272 IMKQLLCAVEYIHDKKLIHRDIKLENIFLN-----CDGKIV--LGDFGTAMPFEK----- 319
Query: 994 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045
VGT +PE+L + Y DIWS G +LL++L+
Sbjct: 320 ----EREAFDYGWVGTVATNSPEILAG----DGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-04
Identities = 60/202 (29%), Positives = 88/202 (43%), Gaps = 39/202 (19%)
Query: 945 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA-VPLRSFLHTCCIAHRGIPAP 1003
LHS I+HRD+K NI++ K+D +K+ DF A SF+ T P
Sbjct: 142 LHSAGIIHRDLKPSNIVV-----KSDC--TLKILDFGLARTAGTSFMMT----------P 184
Query: 1004 DVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI- 1062
V T + APEV+ M Y VDIWS GC++ E++ V + G ++ + +
Sbjct: 185 YVV--TRYYRAPEVILGMG----YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI 238
Query: 1063 -QMGKR-PRLTDELEALGSCH-EHEVAQSGSGFEKPEAELETLSFLVDV-FRRCTEENPT 1118
Q+G P +L+ + E+ +G FEK DV F +E N
Sbjct: 239 EQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEK---------LFPDVLFPADSEHNKL 289
Query: 1119 ERPTAGDLY-EMFVARTSSSIS 1139
+ A DL +M V S IS
Sbjct: 290 KASQARDLLSKMLVIDASKRIS 311
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 3e-04
Identities = 32/88 (36%), Positives = 45/88 (51%), Gaps = 16/88 (18%)
Query: 897 LQSA----IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 952
LQSA + MEY+ GG VK+ + E+ +A+ +VA AL LH I+H
Sbjct: 73 LQSANNVYLVMEYLIGGDVKSLLHIYGYFDEE-----MAVKYISEVALALDYLHRHGIIH 127
Query: 953 RDIKSENILIDLERKKADGKPVVKLCDF 980
RD+K +N+LI E +KL DF
Sbjct: 128 RDLKPDNMLISNEGH-------IKLTDF 148
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-04
Identities = 50/215 (23%), Positives = 98/215 (45%), Gaps = 50/215 (23%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
EV +L L+H+ IV ++ + K L + EY+ +K Y++
Sbjct: 54 EVSLLKDLKHANIVTLHDIIHTEKSL--------------TLVFEYLDK-DLKQYLDDCG 98
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
+ H +VKL LF + L H + ++HRD+K +N+LI+ ER + +KL D
Sbjct: 99 NSINMH-NVKLFLF---QLLRGLNYCHRRKVLHRDLKPQNLLIN-ERGE------LKLAD 147
Query: 980 FD----RAVPLRSFLH-TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 1034
F +++P +++ + + +R PD+ +G+ Y ++D+W
Sbjct: 148 FGLARAKSIPTKTYSNEVVTLWYR---PPDILLGSTD---------------YSTQIDMW 189
Query: 1035 SYGCLLLELLTLQVPYMGLS-ELEIHDLIQMGKRP 1068
GC+ E+ T + + G + E ++H + ++ P
Sbjct: 190 GVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTP 224
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 4e-04
Identities = 46/204 (22%), Positives = 86/204 (42%), Gaps = 38/204 (18%)
Query: 840 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 899
LKV S R+ + M+ + H IV +YG + +++
Sbjct: 37 LKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRD--------------VEN 79
Query: 900 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959
+ E+V+ G + ++ + S+ ++ +A+ +A+AL L K ++H ++ ++N
Sbjct: 80 IMVEEFVEFGPLDLFMHRKSDV----LTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKN 135
Query: 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1019
IL+ E + P +KL D +P+ C+ IP W+APE +
Sbjct: 136 ILLAREGIDGECGPFIKLS--DPGIPITVLSRQECVER--IP----------WIAPECVE 181
Query: 1020 AMHKPNLYGLEVDIWSYGCLLLEL 1043
NL + D WS+G L E+
Sbjct: 182 --DSKNL-SIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-04
Identities = 34/109 (31%), Positives = 52/109 (47%), Gaps = 24/109 (22%)
Query: 945 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA-VPLRSFLHTCCIAHRGIPAP 1003
LHS I+HRD+K NI++ K+D +K+ DF A SF+ T + R AP
Sbjct: 135 LHSAGIIHRDLKPSNIVV-----KSDC--TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 187
Query: 1004 DVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1052
+V +G Y VDIWS GC++ E++ ++ + G
Sbjct: 188 EVILGMG----------------YKENVDIWSVGCIMGEMVRHKILFPG 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 4e-04
Identities = 57/197 (28%), Positives = 86/197 (43%), Gaps = 37/197 (18%)
Query: 904 EYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963
E+V+ G + + K E G V V + +AQ +A+AL L K+++H ++ ++NIL
Sbjct: 96 EFVEHGPLDVCLRK--EKG--RVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNIL-- 149
Query: 964 LERKK-ADG-KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 1021
L R A+G P +KL D P SF + + V W+APE +
Sbjct: 150 LARLGLAEGTSPFIKLSD-----PGVSF---------TALSREERVERIPWIAPECV--- 192
Query: 1022 HKPNLYGLE--VDIWSYGCLLLEL-LTLQVPYMGLSELEIHDLIQMGKRPRLTD----EL 1074
P L D WS+G LLE+ +VP + E + K+ RL + EL
Sbjct: 193 --PGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYE--KKHRLPEPSCKEL 248
Query: 1075 EAL-GSCHEHEVAQSGS 1090
L C +E Q S
Sbjct: 249 ATLISQCLTYEPTQRPS 265
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-04
Identities = 57/256 (22%), Positives = 107/256 (41%), Gaps = 48/256 (18%)
Query: 804 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRM 863
G S ++ G+ +++++ G + K+ LKV +E ++ + E +
Sbjct: 2 GKADSYEKLEKLGEGSYATVYK---GKSKVNGKLVALKVIRLQEEE--GTPFTAIREASL 56
Query: 864 LGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGE 923
L L+H+ IV + H I H + EYV + Y++K G
Sbjct: 57 LKGLKHANIVLL--HDII------------HTKETLTLVFEYVHT-DLCQYMDK-HPGGL 100
Query: 924 KHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFD-- 981
+VKL LF + L +H ++I+HRD+K +N+LI + +KL DF
Sbjct: 101 HPENVKLFLF---QLLRGLSYIHQRYILHRDLKPQNLLISDTGE-------LKLADFGLA 150
Query: 982 RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1041
RA + S ++ + PDV +G+ Y +D+W GC+ +
Sbjct: 151 RAKSVPSHTYSNEVVTLWYRPPDVLLGSTE---------------YSTCLDMWGVGCIFV 195
Query: 1042 ELLTLQVPYMGLSELE 1057
E++ + G+ +++
Sbjct: 196 EMIQGVAAFPGMKDIQ 211
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 6e-04
Identities = 34/113 (30%), Positives = 45/113 (39%), Gaps = 15/113 (13%)
Query: 173 HFSIRYLPPEIGCLSNLEQLDLSFNK-----MKYLPTEICYLKALISLKVANNKL----- 222
IR L + NLE LDL+ N L + LK+L L + +N L
Sbjct: 179 DAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGA 238
Query: 223 VELPSGL-YLLQRLENLDLSNNRLTSLGSLDLCL----MHNLQNLNLQYNKLL 270
L S L L L LS N +T G+ DL +L L+L+ NK
Sbjct: 239 AALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFG 291
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 6e-04
Identities = 65/265 (24%), Positives = 95/265 (35%), Gaps = 74/265 (27%)
Query: 901 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960
+ ME++ GG + + K E+ +IA+ V A + +H +HRDIK +N+
Sbjct: 78 LIMEFLPGGDMMTLLMKKDTLTEEETQ----FYIAETVLA-IDSIHQLGFIHRDIKPDNL 132
Query: 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHR---------GIPAPDV------ 1005
L+ D K VKL DF L+ AHR +P+
Sbjct: 133 LL-------DSKGHVKLSDFGLCTGLKK-------AHRTEFYRNLNHSLPSDFTFQNMNS 178
Query: 1006 -----------------CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV 1048
VGTP ++APEV Y D WS G ++ E+L
Sbjct: 179 KRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ----TGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 1049 PYMGLSELEIHDLIQMGKRPRLTDELEA----------LGSCHEHEVAQSGSGFEKPEAE 1098
P+ + E + + M + L E L C E E G E E
Sbjct: 235 PFCSETPQETYKKV-MNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVE----E 289
Query: 1099 LETLSFLVDVFRRCTEENPTERPTA 1123
++T F F E+ ERP A
Sbjct: 290 IKTNPF----FEGVDWEHIRERPAA 310
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 6e-04
Identities = 39/132 (29%), Positives = 62/132 (46%), Gaps = 22/132 (16%)
Query: 938 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 997
+A + L ++HRD+ + N+L+ VK+ DF A L T A
Sbjct: 118 IAKGMSYLEEVRLVHRDLAARNVLVKSPNH-------VKITDFGLA-RLLDIDETEYHAD 169
Query: 998 RG-IPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSE 1055
G +P +WMA E + +H+ + + D+WSYG + EL+T PY G+
Sbjct: 170 GGKVPI--------KWMALESI--LHRR--FTHQSDVWSYGVTVWELMTFGAKPYDGIPA 217
Query: 1056 LEIHDLIQMGKR 1067
EI DL++ G+R
Sbjct: 218 REIPDLLEKGER 229
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 7e-04
Identities = 41/116 (35%), Positives = 49/116 (42%), Gaps = 20/116 (17%)
Query: 932 LFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLH 991
L I + V A+ LH I+HRDIK+ENI I+ D V L DF A
Sbjct: 185 LAIERSVLRAIQYLHENRIIHRDIKAENIFIN---HPGD----VCLGDFGAA-------- 229
Query: 992 TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 1047
C GT APE+L P YG VDIWS G +L E+ T
Sbjct: 230 -CFPVDINANKYYGWAGTIATNAPELL--ARDP--YGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 7e-04
Identities = 17/37 (45%), Positives = 23/37 (62%), Gaps = 2/37 (5%)
Query: 233 QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
LE LDLSNN++T L L + NL+ L+L NK+
Sbjct: 1 TNLETLDLSNNQITDLPPL--SNLPNLETLDLSGNKI 35
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 7e-04
Identities = 36/127 (28%), Positives = 57/127 (44%), Gaps = 27/127 (21%)
Query: 933 FIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHT 992
F+ + L +H+ I+HRD+K N+ ++ + + +K+ DF A S +
Sbjct: 122 FLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCE-------LKILDFGLARQTDSEMTG 174
Query: 993 CCIAHRGIPAPDVCVGTPRWM-APEV-LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1050
+ RW APEV L MH Y VDIWS GC++ E+LT + +
Sbjct: 175 YVVT--------------RWYRAPEVILNWMH----YTQTVDIWSVGCIMAEMLTGKPLF 216
Query: 1051 MGLSELE 1057
G L+
Sbjct: 217 KGHDHLD 223
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 8e-04
Identities = 36/106 (33%), Positives = 53/106 (50%), Gaps = 11/106 (10%)
Query: 175 SIRYL---------PPEIGCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV- 223
S+RYL G + NLE LDLS N + +P +I +L L + N LV
Sbjct: 119 SLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVG 178
Query: 224 ELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
++P+ L L LE L L++N+L +L M +L+ + L YN L
Sbjct: 179 KIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNL 224
|
Length = 968 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 0.001
Identities = 64/255 (25%), Positives = 95/255 (37%), Gaps = 66/255 (25%)
Query: 839 TLKVCGSSA-DEIRNFEYSCLGEVRMLGALRHSCIVE--MYGH-KISSKWLPSADGNPEH 894
+LKV G A E+R + G + + LR + ++E H + L ADG
Sbjct: 5 SLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVV 64
Query: 895 HLLQS-------AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS 947
+ S + ME++ GG + + K E+ +IA+ V A + +H
Sbjct: 65 KMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQ----FYIAETVLA-IDAIHQ 119
Query: 948 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGI------- 1000
+HRDIK +N+L+ D K VKL DF L+ AHR
Sbjct: 120 LGFIHRDIKPDNLLL-------DAKGHVKLSDFGLCTGLKK-------AHRTEFYRNLTH 165
Query: 1001 -PAPDV------------------------CVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 1035
P D VGTP ++APEV Y D WS
Sbjct: 166 NPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG----YNKLCDWWS 221
Query: 1036 YGCLLLELLTLQVPY 1050
G ++ E+L P+
Sbjct: 222 LGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 0.001
Identities = 35/110 (31%), Positives = 50/110 (45%), Gaps = 27/110 (24%)
Query: 945 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1004
+HS I+HRD+K N+ ++ + + +K+ DF A R A
Sbjct: 133 IHSAGIIHRDLKPGNLAVNEDCE-------LKILDFGLA--------------RHADAEM 171
Query: 1005 VCVGTPRWM-APEV-LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1052
RW APEV L MH Y VDIWS GC++ E+LT + + G
Sbjct: 172 TGYVVTRWYRAPEVILNWMH----YNQTVDIWSVGCIMAEMLTGKTLFKG 217
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 0.001
Identities = 39/144 (27%), Positives = 65/144 (45%), Gaps = 28/144 (19%)
Query: 909 GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 968
G+ N I K + ++HV F+ + L +HS I+HRD+K N+ ++ + +
Sbjct: 103 GADLNNIVKCQKLSDEHVQ-----FLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCE- 156
Query: 969 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 1028
+++ DF A + T +A R AP++ +L MH Y
Sbjct: 157 ------LRILDFGLARQADDEM-TGYVATRWYRAPEI-----------MLNWMH----YN 194
Query: 1029 LEVDIWSYGCLLLELLTLQVPYMG 1052
VDIWS GC++ ELL + + G
Sbjct: 195 QTVDIWSVGCIMAELLKGKALFPG 218
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 0.001
Identities = 65/263 (24%), Positives = 96/263 (36%), Gaps = 80/263 (30%)
Query: 838 RTLKVCGSSA-DEIRNFEYSCLGEVRMLGALRHSCIVEMY-----GH---------KISS 882
T+KV G A E+R + G++ + L S EM+ H + S
Sbjct: 4 HTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKS---EMFKKDQLAHVKAERDVLAESDS 60
Query: 883 KWLPSADGNPEHHLLQSAIF----MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDV 938
W+ S ++ Q A + ME++ GG + + K E + F +
Sbjct: 61 PWVVSL-----YYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSED-----VTRFYMAEC 110
Query: 939 AAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF----------DRAV---P 985
A+ +H +HRDIK +NILID G +KL DF D A
Sbjct: 111 VLAIEAVHKLGFIHRDIKPDNILID-----RGGH--IKLSDFGLSTGFHKQHDSAYYQKL 163
Query: 986 LRSFLHTCCIAHRGIPAPDV------------------------CVGTPRWMAPEVLRAM 1021
L+ + I +R A D VGTP ++APE+
Sbjct: 164 LQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ 223
Query: 1022 HKPNLYGLEVDIWSYGCLLLELL 1044
YG E D WS G ++ E L
Sbjct: 224 G----YGQECDWWSLGAIMFECL 242
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 33/101 (32%), Positives = 48/101 (47%), Gaps = 13/101 (12%)
Query: 945 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1004
LH+ ++HRD+K NIL+ E + + VK+ D A S L + + D
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPE---RGRVKIADMGFARLFNSPL-------KPLADLD 173
Query: 1005 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045
V T + APE+L Y +DIW+ GC+ ELLT
Sbjct: 174 PVVVTFWYRAPELLLGARH---YTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.002
Identities = 33/101 (32%), Positives = 48/101 (47%), Gaps = 13/101 (12%)
Query: 945 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1004
LH+ ++HRD+K NIL+ E + + VK+ D A S L + + D
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPE---RGRVKIADMGFARLFNSPL-------KPLADLD 173
Query: 1005 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045
V T + APE+L Y +DIW+ GC+ ELLT
Sbjct: 174 PVVVTFWYRAPELLLGARH---YTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 48/210 (22%), Positives = 93/210 (44%), Gaps = 49/210 (23%)
Query: 864 LGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGE 923
+G+L H+ IV + G P A LQ + + GS+ +++ + ++
Sbjct: 63 MGSLDHAYIVRLLG------ICPGAS-------LQ--LVTQLSPLGSLLDHVRQHRDS-- 105
Query: 924 KHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA 983
+ + L +A + L ++HR++ + NIL+ K+D +V++ DF A
Sbjct: 106 --LDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILL-----KSDS--IVQIADFGVA 156
Query: 984 VPL----RSFLHTCCIAHRGIPAPDVCVGTP-RWMAPEVLRAMHKPNLYGLEVDIWSYGC 1038
L + + ++ TP +WMA L ++ Y + D+WSYG
Sbjct: 157 DLLYPDDKKYFYSE-------------HKTPIKWMA---LESILFGR-YTHQSDVWSYGV 199
Query: 1039 LLLELLTLQV-PYMGLSELEIHDLIQMGKR 1067
+ E+++ PY G+ E+ DL++ G+R
Sbjct: 200 TVWEMMSYGAEPYAGMRPHEVPDLLEKGER 229
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1142 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| PF14381 | 204 | EDR1: Ethylene-responsive protein kinase Le-CTR1 | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.98 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.98 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.93 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.92 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.89 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.86 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.84 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.84 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.83 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.83 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.83 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.82 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.82 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.81 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.78 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.77 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.76 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.76 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.75 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.74 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.74 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.73 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.72 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.72 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.7 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.69 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.68 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.68 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.68 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.65 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.65 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.64 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.63 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.63 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.63 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.6 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.59 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.58 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.53 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.5 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.5 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.47 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.46 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.45 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.41 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.33 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.17 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.16 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.15 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.14 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.12 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.12 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.11 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.11 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.1 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.1 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.08 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.07 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.06 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.05 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.04 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.03 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.02 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.0 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.96 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.9 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 98.75 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.73 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.7 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.7 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.7 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.68 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.65 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.6 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.6 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.57 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.49 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.49 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.49 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.48 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.45 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.38 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.38 | |
| PRK15386 | 426 | type III secretion protein GogB; Provisional | 98.35 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.34 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-59 Score=609.23 Aligned_cols=293 Identities=22% Similarity=0.217 Sum_probs=200.3
Q ss_pred CcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCC-ccCccccCCcCCcEE
Q 001142 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLN-LIPKSVGRYEKLRNL 96 (1142)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt-~iP~~l~~L~~L~~L 96 (1142)
.++.|.+..|++....+..|.++++|++|+|++|.+++.+|..++.+ ++|+.|+|++|.++ .+|..++.+++|+.|
T Consensus 285 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l---~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L 361 (968)
T PLN00113 285 KLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSL---PRLQVLQLWSNKFSGEIPKNLGKHNNLTVL 361 (968)
T ss_pred CcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcC---CCCCEEECcCCCCcCcCChHHhCCCCCcEE
Confidence 45555555566555555555555666666666665555555544333 55555555555554 445555555555555
Q ss_pred EccCCCCC-cCch------------------------hhcCCCCCCEEEccCCCCC-CCcccccCCCCCCEEECCCCCCC
Q 001142 97 KFFGNEIN-LFPS------------------------EVGNLLGLECLQIKISSPG-VNGFALNKLKGLKELELSKVPPR 150 (1142)
Q Consensus 97 ~Ls~N~L~-~lP~------------------------~l~~L~~L~~L~Ls~N~l~-~~~~~~~~L~~L~~L~Ls~n~~n 150 (1142)
+|++|+++ .+|. .++++++|+.|+|++|.+. ..|..+..+++|+.|++++|.+
T Consensus 362 ~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l- 440 (968)
T PLN00113 362 DLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNL- 440 (968)
T ss_pred ECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcc-
Confidence 55555554 3444 4444555555555555532 3444455555555555555332
Q ss_pred CCcccchhhhcCCCCCcEEEccCCCCC-ccCcccCCCCCCCEEEccCCCCC-ccchhhcCCCCCCEEEccCCCCC-ccCc
Q 001142 151 PSVLTLLSEIAGLKCLTKLSVCHFSIR-YLPPEIGCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-ELPS 227 (1142)
Q Consensus 151 ~~~~~lp~~l~~L~~L~~L~Ls~N~L~-~IP~~l~~L~~L~~L~Ls~N~L~-~lP~~l~~L~~L~~L~Ls~N~Ls-~IP~ 227 (1142)
.+.+|..+..+++|+.|+|++|++. .+|..+ .+++|+.|+|++|+++ .+|..+..+++|+.|+|++|+++ .+|.
T Consensus 441 --~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 517 (968)
T PLN00113 441 --QGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPD 517 (968)
T ss_pred --cCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCCh
Confidence 3334445556666666666666665 344433 4567888888888887 67888999999999999999998 7899
Q ss_pred cccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccCCCCCCCCCCCchhhccCCCCCCCCCCCCcccccccccccCC
Q 001142 228 GLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSAEMDVYEG 307 (1142)
Q Consensus 228 ~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~~n~l~~~~~~~~~~~~~~~~~~~ 307 (1142)
.+.++++|+.|+|++|.|++.+|..|..+++|+.|+|++|++++ .+|..+........+...+|.+.++.|. .
T Consensus 518 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~l~~l~~L~~l~ls~N~l~~~~p~-----~ 590 (968)
T PLN00113 518 ELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSG--EIPKNLGNVESLVQVNISHNHLHGSLPS-----T 590 (968)
T ss_pred HHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccc--cCChhHhcCcccCEEeccCCcceeeCCC-----c
Confidence 99999999999999999999999999999999999999999998 6888887776777777788888777764 3
Q ss_pred CCCCCCCCccCCCCCCC
Q 001142 308 PMLENDGNVSFSAESDA 324 (1142)
Q Consensus 308 ~~l~~~~~~sF~~n~~l 324 (1142)
..+..+...+|.||+++
T Consensus 591 ~~~~~~~~~~~~~n~~l 607 (968)
T PLN00113 591 GAFLAINASAVAGNIDL 607 (968)
T ss_pred chhcccChhhhcCCccc
Confidence 45667888999999865
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=408.34 Aligned_cols=275 Identities=23% Similarity=0.301 Sum_probs=221.8
Q ss_pred CCCCCCC-cceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeee
Q 001142 802 DPGSFPS-LSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 878 (1142)
Q Consensus 802 ~~~~~~~-y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~ 878 (1142)
.+.++.+ |.+.+.||+|+||.|-+|.. .++.+|+|++.-............ ...+.+|+++|++|+|||||+++++
T Consensus 166 ~pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~-~~~v~~EieILkkL~HP~IV~~~d~ 244 (475)
T KOG0615|consen 166 PPKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAK-TRDVQNEIEILKKLSHPNIVRIKDF 244 (475)
T ss_pred ccchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccc-hhhhHHHHHHHHhcCCCCEEEEeee
Confidence 3455555 79999999999999999976 678899999654433221111111 1124799999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 001142 879 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 958 (1142)
Q Consensus 879 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~ 958 (1142)
|+.++.. ||||||++||+|.+.+-. .+.+.+...+.+++|++.|+.|||++||+||||||+
T Consensus 245 f~~~ds~--------------YmVlE~v~GGeLfd~vv~-----nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPe 305 (475)
T KOG0615|consen 245 FEVPDSS--------------YMVLEYVEGGELFDKVVA-----NKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPE 305 (475)
T ss_pred eecCCce--------------EEEEEEecCccHHHHHHh-----ccccccchhHHHHHHHHHHHHHHHHcCcccccCCcc
Confidence 9987644 999999999999999876 457888999999999999999999999999999999
Q ss_pred CeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001142 959 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1038 (1142)
Q Consensus 959 NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGv 1038 (1142)
|||+..+ .....+||+|||+|+...... -..+.+|||.|.|||++.... ...+..++|+||+||
T Consensus 306 NILl~~~----~e~~llKItDFGlAK~~g~~s-----------fm~TlCGTpsYvAPEVl~~kg-~~~~~~kVDiWSlGc 369 (475)
T KOG0615|consen 306 NILLSND----AEDCLLKITDFGLAKVSGEGS-----------FMKTLCGTPSYVAPEVLASKG-VEYYPSKVDIWSLGC 369 (475)
T ss_pred eEEeccC----CcceEEEecccchhhccccce-----------ehhhhcCCccccChhheecCC-eecccchheeeeccc
Confidence 9999765 234789999999998764321 224678999999999997632 233456999999999
Q ss_pred HHHHHHhCCCCCCCCCHHH-HHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001142 1039 LLLELLTLQVPYMGLSELE-IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1117 (1142)
Q Consensus 1039 iL~ELLtG~~Pf~~~~~~e-l~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP 1117 (1142)
+||-+++|.+||.+..... +.++|..+.....+..+. .++++..+||.+||..||
T Consensus 370 vLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~------------------------~Iseea~dlI~~mL~VdP 425 (475)
T KOG0615|consen 370 VLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWD------------------------RISEEALDLINWMLVVDP 425 (475)
T ss_pred eEEEEeccCCCcccccCCccHHHHHhcCcccccChhhh------------------------hhhHHHHHHHHHhhEeCc
Confidence 9999999999998755444 778888887665443322 667889999999999999
Q ss_pred CCCCCHHHHHHHHHhhcCC
Q 001142 1118 TERPTAGDLYEMFVARTSS 1136 (1142)
Q Consensus 1118 ~~RPSa~EVL~~L~~~~ss 1136 (1142)
++|||++|+|+|+|++..+
T Consensus 426 ~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 426 ENRPSADEALNHPWFKDAP 444 (475)
T ss_pred ccCcCHHHHhcChhhhccc
Confidence 9999999999999999665
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=399.07 Aligned_cols=259 Identities=28% Similarity=0.427 Sum_probs=218.8
Q ss_pred CCCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001142 804 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 881 (1142)
Q Consensus 804 ~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~ 881 (1142)
.+..+++..+.||+|..|+||++++. +..+|.|+..+.. ... +++++.+|++++++.+|||||.+||.|..
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~---~~~----~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNI---DPA----LQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccC---CHH----HHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 34557889999999999999999986 5556666653321 222 33445899999999999999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCe
Q 001142 882 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENI 960 (1142)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs-~gIvHrDLKp~NI 960 (1142)
+.. ..+|+||||++|||++++.. .+++++...-+|+.+|++||.|||+ ++||||||||+||
T Consensus 149 ~~~-------------~isI~mEYMDgGSLd~~~k~-----~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNl 210 (364)
T KOG0581|consen 149 NGE-------------EISICMEYMDGGSLDDILKR-----VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNL 210 (364)
T ss_pred CCc-------------eEEeehhhcCCCCHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHe
Confidence 552 34999999999999999986 2579999999999999999999995 8999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
|++.. +.|||||||.+..+... ...+++||..|||||.+.+ ..|+.++||||||+++
T Consensus 211 LvNsk-------GeVKicDFGVS~~lvnS------------~a~tfvGT~~YMsPERi~g----~~Ys~~sDIWSLGLsl 267 (364)
T KOG0581|consen 211 LVNSK-------GEVKICDFGVSGILVNS------------IANTFVGTSAYMSPERISG----ESYSVKSDIWSLGLSL 267 (364)
T ss_pred eeccC-------CCEEeccccccHHhhhh------------hcccccccccccChhhhcC----CcCCcccceecccHHH
Confidence 99987 89999999999876542 2346789999999999987 6899999999999999
Q ss_pred HHHHhCCCCCCCC-----CHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhccc
Q 001142 1041 LELLTLQVPYMGL-----SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 1115 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~~-----~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~ 1115 (1142)
+|+++|+.||... ...+++.+|..+..|.++.. .+++++++|+..||++
T Consensus 268 lE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~--------------------------~fS~ef~~FV~~CL~K 321 (364)
T KOG0581|consen 268 LELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG--------------------------EFSPEFRSFVSCCLRK 321 (364)
T ss_pred HHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc--------------------------cCCHHHHHHHHHHhcC
Confidence 9999999999763 56677788877777665531 3677899999999999
Q ss_pred CCCCCCCHHHHHHHHHhhcCC
Q 001142 1116 NPTERPTAGDLYEMFVARTSS 1136 (1142)
Q Consensus 1116 DP~~RPSa~EVL~~L~~~~ss 1136 (1142)
||.+|||+.|+++|+|.+...
T Consensus 322 dp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 322 DPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred CcccCCCHHHHhcCHHHhhcc
Confidence 999999999999999998543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=408.68 Aligned_cols=258 Identities=26% Similarity=0.367 Sum_probs=219.6
Q ss_pred CCCCCCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeE
Q 001142 802 DPGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 879 (1142)
Q Consensus 802 ~~~~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~ 879 (1142)
++.. ..|..++.||+|+|+.+|.+++ .+..+|+|++..+... .....+ .+.+||+|.++|+|||||+++++|
T Consensus 14 D~~~-~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~-k~~~re----Kv~~EIeIHr~L~HpnIV~f~~~F 87 (592)
T KOG0575|consen 14 DPRS-KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLK-KPKQRE----KVLNEIEIHRSLKHPNIVQFYHFF 87 (592)
T ss_pred cCCc-ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhc-CcchHH----HHHHHHHHHHhcCCCcEEeeeeEe
Confidence 3444 6799999999999999999997 6788999986543221 222223 347999999999999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 001142 880 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959 (1142)
Q Consensus 880 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~N 959 (1142)
++.+++ |||.|+|+.++|..++++ ++++++.+++.+++||+.||.|||+++|+|||||..|
T Consensus 88 EDs~nV--------------YivLELC~~~sL~el~Kr-----rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGN 148 (592)
T KOG0575|consen 88 EDSNNV--------------YIVLELCHRGSLMELLKR-----RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGN 148 (592)
T ss_pred ecCCce--------------EEEEEecCCccHHHHHHh-----cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhh
Confidence 988755 999999999999999985 5689999999999999999999999999999999999
Q ss_pred eeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001142 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039 (1142)
Q Consensus 960 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGvi 1039 (1142)
+|++++ .+|||+|||+|..+.... ....+.+|||.|.|||++.. ..++..+||||+|||
T Consensus 149 lfL~~~-------~~VKIgDFGLAt~le~~~----------Erk~TlCGTPNYIAPEVl~k----~gHsfEvDiWSlGcv 207 (592)
T KOG0575|consen 149 LFLNEN-------MNVKIGDFGLATQLEYDG----------ERKKTLCGTPNYIAPEVLNK----SGHSFEVDIWSLGCV 207 (592)
T ss_pred eeecCc-------CcEEecccceeeeecCcc----------cccceecCCCcccChhHhcc----CCCCCchhhhhhhhH
Confidence 999998 889999999998776432 12346789999999999985 678899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001142 1040 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1119 (1142)
Q Consensus 1040 L~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~ 1119 (1142)
+|.||.|++||+..+..+.+..|......-. ...+.+.++||.++|+.||.+
T Consensus 208 mYtLL~G~PPFetk~vkety~~Ik~~~Y~~P----------------------------~~ls~~A~dLI~~lL~~~P~~ 259 (592)
T KOG0575|consen 208 MYTLLVGRPPFETKTVKETYNKIKLNEYSMP----------------------------SHLSAEAKDLIRKLLRPNPSE 259 (592)
T ss_pred HHhhhhCCCCcccchHHHHHHHHHhcCcccc----------------------------cccCHHHHHHHHHHhcCCccc
Confidence 9999999999998888888888865543211 045567899999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 001142 1120 RPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1120 RPSa~EVL~~L~~~ 1133 (1142)
|||+++|+.|.|+.
T Consensus 260 Rpsl~~vL~h~Ff~ 273 (592)
T KOG0575|consen 260 RPSLDEVLDHPFFK 273 (592)
T ss_pred CCCHHHHhcCHhhh
Confidence 99999999999994
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=379.14 Aligned_cols=266 Identities=27% Similarity=0.435 Sum_probs=218.1
Q ss_pred CCCCCCCcceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeee-Ee
Q 001142 802 DPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH-KI 880 (1142)
Q Consensus 802 ~~~~~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~-~~ 880 (1142)
+..+..+|++.++||+|+||+||++....+...++.+++.-........++ +..|+.+|++|+|||||+++++ +.
T Consensus 14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~----~v~Ei~lLkQL~HpNIVqYy~~~f~ 89 (375)
T KOG0591|consen 14 PQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQD----CVKEISLLKQLNHPNIVQYYAHSFI 89 (375)
T ss_pred CcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHH----HHHHHHHHHhcCCchHHHHHHHhhh
Confidence 356677899999999999999999987444333333334322223333333 3899999999999999999994 43
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh--CC--ccccCCC
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS--KH--IMHRDIK 956 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs--~g--IvHrDLK 956 (1142)
++.. -++||||||.+|+|..+|+.+.+. ...+++..+++++.|++.||.++|. .+ |+|||||
T Consensus 90 ~~~e-------------vlnivmE~c~~GDLsqmIk~~K~q-kr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIK 155 (375)
T KOG0591|consen 90 EDNE-------------VLNIVMELCDAGDLSQMIKHFKKQ-KRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIK 155 (375)
T ss_pred ccch-------------hhHHHHHhhcccCHHHHHHHHHhc-cccCchHHHHHHHHHHHHHHHHHhccccccceeeccCc
Confidence 3322 258999999999999999976544 5789999999999999999999998 45 9999999
Q ss_pred CCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHH
Q 001142 957 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1036 (1142)
Q Consensus 957 p~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSL 1036 (1142)
|.||+++.+ +.|||+|||+++.+..... .....+|||+||+||.+.+ .+|+.|+||||+
T Consensus 156 PaNIFl~~~-------gvvKLGDfGL~r~l~s~~t----------fA~S~VGTPyYMSPE~i~~----~~Y~~kSDiWsl 214 (375)
T KOG0591|consen 156 PANIFLTAN-------GVVKLGDFGLGRFLSSKTT----------FAHSLVGTPYYMSPERIHE----SGYNFKSDIWSL 214 (375)
T ss_pred chheEEcCC-------CceeeccchhHhHhcchhH----------HHHhhcCCCcccCHHHHhc----CCCCcchhHHHH
Confidence 999999988 8999999999998765332 1235689999999999987 789999999999
Q ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 001142 1037 GCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1116 (1142)
Q Consensus 1037 GviL~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~D 1116 (1142)
||++|||+.-++||.+.+..++...|.++..|++++. .++.++..||..|+..|
T Consensus 215 GCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~--------------------------~YS~~l~~li~~ci~vd 268 (375)
T KOG0591|consen 215 GCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDE--------------------------HYSTDLRELINMCIAVD 268 (375)
T ss_pred HHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHH--------------------------HhhhHHHHHHHHHccCC
Confidence 9999999999999999999999999999988776642 56778999999999999
Q ss_pred CCCCCCHHHHHHHHHh
Q 001142 1117 PTERPTAGDLYEMFVA 1132 (1142)
Q Consensus 1117 P~~RPSa~EVL~~L~~ 1132 (1142)
|+.||+.-.++..+..
T Consensus 269 ~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 269 PEQRPDTVPYVQDIQS 284 (375)
T ss_pred cccCCCcchHHHHHHH
Confidence 9999996555555444
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=396.38 Aligned_cols=265 Identities=30% Similarity=0.455 Sum_probs=217.3
Q ss_pred CCCCCCcceeeeecccCceEEEEEEECCcc-EEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001142 803 PGSFPSLSSCDEAGKSVSSSLFRCKFGSAD-AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 881 (1142)
Q Consensus 803 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~~~~-vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~ 881 (1142)
...+.++.+.+.||.|+||+||+|.|.++. +|+|++.-.. ......+. +.+|+.+|.+++|||||+++|++.+
T Consensus 37 ~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~--~~~~~~~~----f~~E~~il~~l~HpNIV~f~G~~~~ 110 (362)
T KOG0192|consen 37 EIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPD--FDDESRKA----FRREASLLSRLRHPNIVQFYGACTS 110 (362)
T ss_pred ecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchh--cChHHHHH----HHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 344556678888999999999999999998 9999864332 22222334 4899999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccCCCCCCe
Q 001142 882 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSENI 960 (1142)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~g-IvHrDLKp~NI 960 (1142)
... .++|||||+++|+|..+++.. ....+++..++.|+.|||+||+|||+++ ||||||||+||
T Consensus 111 ~~~-------------~~~iVtEy~~~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~Ni 174 (362)
T KOG0192|consen 111 PPG-------------SLCIVTEYMPGGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNI 174 (362)
T ss_pred CCC-------------ceEEEEEeCCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhE
Confidence 531 359999999999999999863 3467999999999999999999999999 99999999999
Q ss_pred eeccccccCCCCC-eEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001142 961 LIDLERKKADGKP-VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039 (1142)
Q Consensus 961 Lld~~~~~~~~~~-~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGvi 1039 (1142)
|++.+ + ++||+|||+++...... .......||+.|||||++.+. ...|+.|+||||||++
T Consensus 175 Lv~~~-------~~~~KI~DFGlsr~~~~~~----------~~~~~~~GT~~wMAPEv~~~~--~~~~~~K~DvySFgIv 235 (362)
T KOG0192|consen 175 LVDLK-------GKTLKIADFGLSREKVISK----------TSMTSVAGTYRWMAPEVLRGE--KSPYTEKSDVYSFGIV 235 (362)
T ss_pred EEcCC-------CCEEEECCCccceeecccc----------ccccCCCCCccccChhhhcCC--CCcCCccchhhhHHHH
Confidence 99987 5 99999999997654321 011235799999999999853 3679999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHH-HhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001142 1040 LLELLTLQVPYMGLSELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1118 (1142)
Q Consensus 1040 L~ELLtG~~Pf~~~~~~el~~~I-~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~ 1118 (1142)
+|||+||+.||.+....++...+ ..+.+|.++. .+++.+..++.+||..||.
T Consensus 236 lWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~---------------------------~~~~~l~~l~~~CW~~dp~ 288 (362)
T KOG0192|consen 236 LWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPK---------------------------ECPPHLSSLMERCWLVDPS 288 (362)
T ss_pred HHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCc---------------------------cCCHHHHHHHHHhCCCCCC
Confidence 99999999999998876666555 4555555443 3556799999999999999
Q ss_pred CCCCHHHHHHHHHhhcC
Q 001142 1119 ERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1119 ~RPSa~EVL~~L~~~~s 1135 (1142)
.||++.+++..+.....
T Consensus 289 ~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 289 RRPSFLEIVSRLESIMS 305 (362)
T ss_pred cCCCHHHHHHHHHHHHH
Confidence 99999999998876543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=381.53 Aligned_cols=267 Identities=25% Similarity=0.402 Sum_probs=209.3
Q ss_pred CCCCCCCcceeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeE
Q 001142 802 DPGSFPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 879 (1142)
Q Consensus 802 ~~~~~~~y~l~~~LG~GsfG~Vy~a~~~~--~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~ 879 (1142)
....+.+|.+.+.||.|+||+||+|+++. ..||||. +.+........+.+ ..|+.+|+.++|||||.+++++
T Consensus 5 ~~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~--i~~~~l~~k~~e~L----~~Ei~iLkel~H~nIV~l~d~~ 78 (429)
T KOG0595|consen 5 SMRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKC--IAKKKLNKKLVELL----LSEIKILKELKHPNIVRLLDCI 78 (429)
T ss_pred cccccccceehhhccCcceEEEEEeEeccCCceEEeee--ehhhccCHHHHHHH----HHHHHHHHhcCCcceeeEEEEE
Confidence 34557889999999999999999999854 4555554 44332233333444 7999999999999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 001142 880 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959 (1142)
Q Consensus 880 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~N 959 (1142)
.+++++ |||||||.||+|.++|+. .+.+++..++.++.||+.||++||+++||||||||+|
T Consensus 79 ~~~~~i--------------~lVMEyC~gGDLs~yi~~-----~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQN 139 (429)
T KOG0595|consen 79 EDDDFI--------------YLVMEYCNGGDLSDYIRR-----RGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQN 139 (429)
T ss_pred ecCCeE--------------EEEEEeCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcce
Confidence 987744 999999999999999987 3579999999999999999999999999999999999
Q ss_pred eeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001142 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039 (1142)
Q Consensus 960 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGvi 1039 (1142)
||++..... .....+||+|||+|+.+.... ...+.+|+|.|||||++.. ..|+.|+|+||+|+|
T Consensus 140 iLLs~~~~~-~~~~~LKIADFGfAR~L~~~~-----------~a~tlcGSplYMAPEV~~~----~~YdAKADLWSiG~I 203 (429)
T KOG0595|consen 140 ILLSTTARN-DTSPVLKIADFGFARFLQPGS-----------MAETLCGSPLYMAPEVIMS----QQYDAKADLWSIGTI 203 (429)
T ss_pred EEeccCCCC-CCCceEEecccchhhhCCchh-----------HHHHhhCCccccCHHHHHh----ccccchhhHHHHHHH
Confidence 999875221 111689999999999876422 1235679999999999975 689999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001142 1040 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1119 (1142)
Q Consensus 1040 L~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~ 1119 (1142)
+|+|++|+.||...+..++...+.++...... .+...+..+.+++...++.+|.+
T Consensus 204 lyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~-------------------------~~~~~s~~~~~Ll~~ll~~~~~~ 258 (429)
T KOG0595|consen 204 LYQCLTGKPPFDAETPKELLLYIKKGNEIVPV-------------------------LPAELSNPLRELLISLLQRNPKD 258 (429)
T ss_pred HHHHHhCCCCccccCHHHHHHHHhccccccCc-------------------------hhhhccCchhhhhhHHHhcCccc
Confidence 99999999999999999988877655431110 00122333556777777777777
Q ss_pred CCCHHHHHHHHHhhc
Q 001142 1120 RPTAGDLYEMFVART 1134 (1142)
Q Consensus 1120 RPSa~EVL~~L~~~~ 1134 (1142)
|-++.+-..+.+...
T Consensus 259 ~~~~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 259 RISFEDFFDHPFLAA 273 (429)
T ss_pred cCchHHhhhhhhccc
Confidence 777777666655543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=379.47 Aligned_cols=263 Identities=27% Similarity=0.317 Sum_probs=220.4
Q ss_pred CCCCCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001142 803 PGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 880 (1142)
Q Consensus 803 ~~~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~ 880 (1142)
....++|++.++||+|+||.||+++. .++-+|+|+.+-+..... .+.+ .+..|..||.+++||.||+++-.|+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~-~e~~----~~~~Er~IL~~v~hPFiv~l~ysFQ 95 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEK-KEVR----HTKAERNILSKIKHPFIVKLIYSFQ 95 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhh-hhHH----HHHHHHHHHHhCCCCcEeeeEEecc
Confidence 45678999999999999999999987 466678887443322222 2222 3379999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NI 960 (1142)
+... +|+|+||+.||.|..++++ ...+++..++.++..|+.||.|||++|||||||||+||
T Consensus 96 t~~k--------------LylVld~~~GGeLf~hL~~-----eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENI 156 (357)
T KOG0598|consen 96 TEEK--------------LYLVLDYLNGGELFYHLQR-----EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENI 156 (357)
T ss_pred cCCe--------------EEEEEeccCCccHHHHHHh-----cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHe
Confidence 7664 4999999999999999986 46799999999999999999999999999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
|+|.+ |+++|+|||+++..-... ....+++||+.|||||++.+ ..|+..+|+||+|+++
T Consensus 157 LLd~~-------GHi~LtDFgL~k~~~~~~----------~~t~tfcGT~eYmAPEil~~----~gy~~~vDWWsLGill 215 (357)
T KOG0598|consen 157 LLDEQ-------GHIKLTDFGLCKEDLKDG----------DATRTFCGTPEYMAPEILLG----KGYDKAVDWWSLGILL 215 (357)
T ss_pred eecCC-------CcEEEeccccchhcccCC----------CccccccCCccccChHHHhc----CCCCcccchHhHHHHH
Confidence 99998 999999999997532211 12345789999999999987 6899999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1041 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
|||++|.+||.+.+...+.+.|..+..+..+. ..+.+.++++.++|+.||++|
T Consensus 216 YeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~---------------------------~ls~~ardll~~LL~rdp~~R 268 (357)
T KOG0598|consen 216 YEMLTGKPPFYAEDVKKMYDKILKGKLPLPPG---------------------------YLSEEARDLLKKLLKRDPRQR 268 (357)
T ss_pred HHHhhCCCCCcCccHHHHHHHHhcCcCCCCCc---------------------------cCCHHHHHHHHHHhccCHHHh
Confidence 99999999999999889999987776433321 245568999999999999999
Q ss_pred C----CHHHHHHHHHhhcCCC
Q 001142 1121 P----TAGDLYEMFVARTSSS 1137 (1142)
Q Consensus 1121 P----Sa~EVL~~L~~~~ss~ 1137 (1142)
. ++.+|-+|+|+..-++
T Consensus 269 Lg~~~d~~~ik~HpfF~~inW 289 (357)
T KOG0598|consen 269 LGGPGDAEEIKRHPFFKGINW 289 (357)
T ss_pred cCCCCChHHhhcCcccccCCH
Confidence 4 7999999999976543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=364.96 Aligned_cols=282 Identities=24% Similarity=0.326 Sum_probs=215.0
Q ss_pred CCcceeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~~--~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
+.|+...++|+|+||+||+|+++. +-||+|.+ ....+. +..+. -.++|+++|++++|||+|.++++|.....
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF--~Esedd-~~VkK---IAlREIrmLKqLkH~NLVnLiEVFrrkrk 75 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKF--VESEDD-PVVKK---IALREIRMLKQLKHENLVNLIEVFRRKRK 75 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEee--ccCCcc-HHHHH---HHHHHHHHHHhcccchHHHHHHHHHhcce
Confidence 468889999999999999999854 45566554 332222 33333 35899999999999999999999986554
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
++||+|||+ .++.+-++. .+ ..++...++++++|++.|+.|+|++++|||||||+||||+.
T Consensus 76 --------------lhLVFE~~d-hTvL~eLe~---~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~ 136 (396)
T KOG0593|consen 76 --------------LHLVFEYCD-HTVLHELER---YP-NGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQ 136 (396)
T ss_pred --------------eEEEeeecc-hHHHHHHHh---cc-CCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEec
Confidence 499999998 455555554 22 35899999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||||||+|+.+...... ....+.|.+|+|||.+.+ ..+|++.+||||+||++.||+
T Consensus 137 ~-------gvvKLCDFGFAR~L~~pgd~----------YTDYVATRWYRaPELLvG---DtqYG~pVDiWAiGCv~aEl~ 196 (396)
T KOG0593|consen 137 N-------GVVKLCDFGFARTLSAPGDN----------YTDYVATRWYRAPELLVG---DTQYGKPVDIWAIGCVFAELL 196 (396)
T ss_pred C-------CcEEeccchhhHhhcCCcch----------hhhhhhhhhccChhhhcc---cCcCCCcccchhhhHHHHHHh
Confidence 8 89999999999987643221 224578999999999987 468999999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccc-ccc--ccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH-EHE--VAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~-~~~--~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
+|.+.|.+.++.+....|.......++.......... ... ..+....-..+......+.-+.+|+..||+.||++|+
T Consensus 197 ~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~ 276 (396)
T KOG0593|consen 197 TGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRL 276 (396)
T ss_pred cCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccc
Confidence 9999999988888777776555444444333322211 111 1111111111122235567789999999999999999
Q ss_pred CHHHHHHHHHhh
Q 001142 1122 TAGDLYEMFVAR 1133 (1142)
Q Consensus 1122 Sa~EVL~~L~~~ 1133 (1142)
+.+|++.|.+|.
T Consensus 277 sc~qll~H~yFd 288 (396)
T KOG0593|consen 277 SCEQLLHHPYFD 288 (396)
T ss_pred cHHHHhcChHHH
Confidence 999999999983
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=386.36 Aligned_cols=287 Identities=23% Similarity=0.279 Sum_probs=220.7
Q ss_pred CCCcceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEecCCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKW 884 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~g~~~~~~~ 884 (1142)
.++|.+.++||.|+||.||+|+.....-.|+|++++......++.-+ +||+..|+++. |||||++.+.+.+.+.
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~n-----LREvksL~kln~hpniikL~Evi~d~~~ 83 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMN-----LREVKSLRKLNPHPNIIKLKEVIRDNDR 83 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHH-----HHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence 45799999999999999999997544334555556655555554444 59999999998 9999999999887541
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
++++|||||+ .+|++++++ ++..|++..++.|+.||++||+|+|.+|+.|||+||+|||+..
T Consensus 84 -------------~L~fVfE~Md-~NLYqLmK~----R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~ 145 (538)
T KOG0661|consen 84 -------------ILYFVFEFMD-CNLYQLMKD----RNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISG 145 (538)
T ss_pred -------------eEeeeHHhhh-hhHHHHHhh----cCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecc
Confidence 4699999997 999999987 2568999999999999999999999999999999999999986
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
. ..+||+|||+|+.+.... .....+.|.+|+|||++.. ...|+.++||||+|||++|+.
T Consensus 146 ~-------~~iKiaDFGLARev~Skp-----------PYTeYVSTRWYRAPEvLLr---s~~Ys~pvD~wA~GcI~aEl~ 204 (538)
T KOG0661|consen 146 N-------DVIKIADFGLAREVRSKP-----------PYTEYVSTRWYRAPEVLLR---SGYYSSPVDMWAVGCIMAELY 204 (538)
T ss_pred c-------ceeEecccccccccccCC-----------CcchhhhcccccchHHhhh---ccccCCchHHHHHHHHHHHHH
Confidence 5 789999999998765432 2234578999999999986 468999999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhC-CCCCchhHHhh---hcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1045 TLQVPYMGLSELEIHDLIQMG-KRPRLTDELEA---LGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~-~~p~l~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
+-++.|.|.++.+.+..|... ..|... .+.. .....+..+.+.. +......-...+.++.++|.+|+.+||.+|
T Consensus 205 sLrPLFPG~sE~Dqi~KIc~VLGtP~~~-~~~eg~~La~~mnf~~P~~~-~~~l~~L~p~~s~~~~~li~~ll~WDP~kR 282 (538)
T KOG0661|consen 205 SLRPLFPGASEIDQIYKICEVLGTPDKD-SWPEGYNLASAMNFRFPQVK-PSPLKDLLPNASSEAASLIERLLAWDPDKR 282 (538)
T ss_pred HhcccCCCCcHHHHHHHHHHHhCCCccc-cchhHHHHHHHhccCCCcCC-CCChHHhCcccCHHHHHHHHHHhcCCCccC
Confidence 999999998887766666332 222221 1111 1111111111111 111111112467889999999999999999
Q ss_pred CCHHHHHHHHHhhcCCCC
Q 001142 1121 PTAGDLYEMFVARTSSSI 1138 (1142)
Q Consensus 1121 PSa~EVL~~L~~~~ss~~ 1138 (1142)
|||.|+++|+|++.....
T Consensus 283 pTA~~al~~pffq~~~~~ 300 (538)
T KOG0661|consen 283 PTASQALQHPFFQVGRAS 300 (538)
T ss_pred ccHHHHhcCccccccccc
Confidence 999999999999866444
|
|
| >PF14381 EDR1: Ethylene-responsive protein kinase Le-CTR1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=362.45 Aligned_cols=184 Identities=36% Similarity=0.523 Sum_probs=146.6
Q ss_pred ccccccccccccccccCCCCCccccCCCCC----------ccccccccccC-CCCCcceEEEEcccCCHHHHHHHHHHHH
Q 001142 521 SNASQKYSSVSFCSIEDRLPDGFYDAGRDR----------PFMQLTGYEQT-PHLDSREVILVDRKSDEELDAIALSAQA 589 (1142)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (1142)
..+|||||++|+|+|+|||||||||++++. .+-+|++++.. +.++++|||||||..|+.|++|+++|+.
T Consensus 4 e~lS~r~W~~~~L~y~dki~DGFYdi~g~~~~~~l~~~~~~~Psl~~L~~~~~~~~~~EvIlVDr~~D~~L~~L~~~a~~ 83 (204)
T PF14381_consen 4 ESLSHRYWVNGCLSYDDKIPDGFYDIYGMDCTNSLKEEFGRMPSLEDLQAVPPDDSSREVILVDRRRDPSLKELEQRAHE 83 (204)
T ss_pred HHHHHHHHHcCCCCCCCcCCCCCcccccCCCccccccccCCCCCHHHHhcCCCCCCCeeEEEEccccCHHHHHHHHHHHH
Confidence 468999999999999999999999886652 11225555543 6899999999999999999999999999
Q ss_pred HHHHhhccCCccccCcccccchHHHHHHHHHHhhhccCCCcCCcccccccccccCCCCCCCcccccCCCCCCCcchhhhH
Q 001142 590 LVLHLKQLNGLTKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTCSTGNSDSANTSQKQ 669 (1142)
Q Consensus 590 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (1142)
+...+. .+..+++.+||.+|+++|||++..++ .
T Consensus 84 ~~~~~~-------------~~~~~~v~~LA~lVa~~MGG~~~~~~----------------------------------~ 116 (204)
T PF14381_consen 84 LSKGLS-------------TNTKELVQKLAKLVADRMGGPVSDAE----------------------------------D 116 (204)
T ss_pred HHhccc-------------cCHHHHHHHHHHHHHHHhCCCCCcch----------------------------------h
Confidence 997631 13578899999999999999984432 1
Q ss_pred hhhHHHHHHhhhHHHHHHHHHhhccCceeEeccccccchhhhHHHHHHHhhhccCCCCcccccccccccCC-CccceeEE
Q 001142 670 ILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRGYLDFQP-HAWNTILV 748 (1142)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~g~~~hr~~l~k~~~d~~~~~~~~~~~~g~~~~~~-~~~~~~~~ 748 (1142)
...+ |+...+.+|. ++.+||||+|++|+|||||||||+|||+|+ ||||||||++||+. ..-+.++|
T Consensus 117 ~~~~---------w~~~s~~lk~--~s~~vplG~l~~G~~rhRALLFKvLAD~ig--lpCrLvrG~~y~g~~~~~a~~~V 183 (204)
T PF14381_consen 117 MLFR---------WELRSEKLKE--NSGVVPLGSLRIGLCRHRALLFKVLADRIG--LPCRLVRGCYYCGWDDDDASNLV 183 (204)
T ss_pred hhHH---------HHHHHHHHHh--CCCeEEEeeecccchHHHHHHHHHHHHhcC--CCceEEeeccCCccCCCCceEEE
Confidence 1113 3455555666 999999999999999999999999999999 99999999999987 33344566
Q ss_pred eeCCchhhhhhhhcC-CC
Q 001142 749 KKGDSWIRMIVDACR-PH 765 (1142)
Q Consensus 749 ~~~~~~~~~~~~~~~-~~ 765 (1142)
+.++ .+++++|.+. |+
T Consensus 184 ~~~~-~~eyiVDLm~~PG 200 (204)
T PF14381_consen 184 KFDD-GREYIVDLMGAPG 200 (204)
T ss_pred EcCC-CcEEEEEcCCCCC
Confidence 6654 5678888874 44
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=371.38 Aligned_cols=276 Identities=25% Similarity=0.374 Sum_probs=225.8
Q ss_pred CCCCCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001142 803 PGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 880 (1142)
Q Consensus 803 ~~~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~ 880 (1142)
+....+|++.++||.|..++||+|+. .+..||+|+..++..... .+.+ .+|+..|+.++||||++++..|.
T Consensus 22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~---ld~l----~kE~~~msl~~HPNIv~~~~sFv 94 (516)
T KOG0582|consen 22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND---LDAL----RKEVQTMSLIDHPNIVTYHCSFV 94 (516)
T ss_pred CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh---HHHH----HHHHHHhhhcCCCCcceEEEEEE
Confidence 34456899999999999999999998 567888998887765322 4444 79999999999999999999999
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NI 960 (1142)
.+..+ |+||.||.+||+.++++..+..+ +++..+..|++++++||.|||.+|.||||||+.||
T Consensus 95 v~~~L--------------WvVmpfMa~GS~ldIik~~~~~G---l~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnI 157 (516)
T KOG0582|consen 95 VDSEL--------------WVVMPFMAGGSLLDIIKTYYPDG---LEEASIATILREVLKALDYLHQNGHIHRDVKAGNI 157 (516)
T ss_pred eccee--------------EEeehhhcCCcHHHHHHHHcccc---ccHHHHHHHHHHHHHHHHHHHhcCceecccccccE
Confidence 87755 99999999999999999877655 99999999999999999999999999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCC-CCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAP-DVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~-~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGvi 1039 (1142)
||+.+ |.|||+|||.+..+......+ ... .+++||++|||||++... ...|+.|+||||||++
T Consensus 158 Li~~d-------G~VkLadFgvsa~l~~~G~R~-------~~rf~tfvgtp~wmAPEvl~q~--~~GYdfKaDIwSfGIT 221 (516)
T KOG0582|consen 158 LIDSD-------GTVKLADFGVSASLFDSGDRQ-------VTRFNTFVGTPCWMAPEVLMQQ--LHGYDFKADIWSFGIT 221 (516)
T ss_pred EEcCC-------CcEEEcCceeeeeecccCcee-------eEeeccccCcccccChHHhhhc--ccCccchhhhhhhhHH
Confidence 99998 899999999887654422110 111 567899999999997553 3679999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001142 1040 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1119 (1142)
Q Consensus 1040 L~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~ 1119 (1142)
..||++|..||....+.++.-.-.++.+|.+.. . ....+.....+..+++++..||+.||.+
T Consensus 222 A~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t--~----------------~~~~d~~k~~~ksf~e~i~~CL~kDP~k 283 (516)
T KOG0582|consen 222 ACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLT--S----------------GLDKDEDKKFSKSFREMIALCLVKDPSK 283 (516)
T ss_pred HHHHhcCCCCcccCChHHHHHHHhcCCCCCccc--c----------------cCChHHhhhhcHHHHHHHHHHhhcCccc
Confidence 999999999999988888765545555442220 0 0011112245568999999999999999
Q ss_pred CCCHHHHHHHHHhhcCC
Q 001142 1120 RPTAGDLYEMFVARTSS 1136 (1142)
Q Consensus 1120 RPSa~EVL~~L~~~~ss 1136 (1142)
||||+++++|.||+..-
T Consensus 284 RptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 284 RPTASKLLKHAFFKKAK 300 (516)
T ss_pred CCCHHHHhccHHHhhcc
Confidence 99999999999998653
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=389.73 Aligned_cols=259 Identities=28% Similarity=0.457 Sum_probs=217.5
Q ss_pred CCcceeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~~--~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
..|...++||+|+.|.||.|.... ..||+|.+.+... .. ++ .+..|+.+|+..+|+|||.+++.|...+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q--~~---ke---LilnEi~Vm~~~~H~NiVnfl~Sylv~d- 343 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ--PK---KE---LLLNEILVMRDLHHPNIVNFLDSYLVGD- 343 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC--Cc---hh---hhHHHHHHHHhccchHHHHHHHHhcccc-
Confidence 357888999999999999998744 4455555444432 21 12 2379999999999999999999887654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
.+|+||||++||+|.+.+.. ..+++.++..|++++++||+|||.+||+|||||.+|||++.
T Consensus 344 -------------eLWVVMEym~ggsLTDvVt~------~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~ 404 (550)
T KOG0578|consen 344 -------------ELWVVMEYMEGGSLTDVVTK------TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTM 404 (550)
T ss_pred -------------eeEEEEeecCCCchhhhhhc------ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEecc
Confidence 35999999999999999976 35999999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||+|||++..+.... ......+|||+|||||++.. ..|++|+||||||++++||+
T Consensus 405 ~-------g~vKltDFGFcaqi~~~~----------~KR~TmVGTPYWMAPEVvtr----k~YG~KVDIWSLGIMaIEMv 463 (550)
T KOG0578|consen 405 D-------GSVKLTDFGFCAQISEEQ----------SKRSTMVGTPYWMAPEVVTR----KPYGPKVDIWSLGIMAIEMV 463 (550)
T ss_pred C-------CcEEEeeeeeeecccccc----------CccccccCCCCccchhhhhh----cccCccccchhhhhHHHHHh
Confidence 8 789999999998765422 24557899999999999986 78999999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~ 1124 (1142)
-|.+||...++......|.....|.+... ...++.+++|+.+||+.||.+||+|.
T Consensus 464 eGEPPYlnE~PlrAlyLIa~ng~P~lk~~-------------------------~klS~~~kdFL~~cL~~dv~~RasA~ 518 (550)
T KOG0578|consen 464 EGEPPYLNENPLRALYLIATNGTPKLKNP-------------------------EKLSPELKDFLDRCLVVDVEQRASAK 518 (550)
T ss_pred cCCCCccCCChHHHHHHHhhcCCCCcCCc-------------------------cccCHHHHHHHHHHhhcchhcCCCHH
Confidence 99999998888877778876666654421 15677899999999999999999999
Q ss_pred HHHHHHHhhcCCCCC
Q 001142 1125 DLYEMFVARTSSSIS 1139 (1142)
Q Consensus 1125 EVL~~L~~~~ss~~s 1139 (1142)
|+|+|+|++...+.+
T Consensus 519 eLL~HpFl~~a~p~s 533 (550)
T KOG0578|consen 519 ELLEHPFLKMAKPES 533 (550)
T ss_pred HHhcChhhhhcCCHH
Confidence 999999998765543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=382.12 Aligned_cols=271 Identities=24% Similarity=0.271 Sum_probs=221.3
Q ss_pred CCCCCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeE
Q 001142 803 PGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHK 879 (1142)
Q Consensus 803 ~~~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~ 879 (1142)
..+..+|.+++.||+|+|++|++|+. .+..+|+||. .+...-.. .-...+.+|-.+|.+| .||.||++|..|
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl--~K~~Iike---~KvkYV~~Ek~~l~~L~~hPgivkLy~TF 143 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVL--DKRYIIKE---KKVKYVTREKEALTQLSGHPGIVKLYFTF 143 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhh--hHHHHHhh---cccchhhHHHHHHHHhhCCCCeEEEEEEe
Confidence 56788999999999999999999987 4667888873 32211111 1112346888999999 799999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 001142 880 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959 (1142)
Q Consensus 880 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~N 959 (1142)
.++..+ |+|+||+++|+|.++|++ .+.|++..++.++.||+.||+|||++|||||||||+|
T Consensus 144 QD~~sL--------------YFvLe~A~nGdll~~i~K-----~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPEN 204 (604)
T KOG0592|consen 144 QDEESL--------------YFVLEYAPNGDLLDLIKK-----YGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPEN 204 (604)
T ss_pred ecccce--------------EEEEEecCCCcHHHHHHH-----hCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhh
Confidence 987655 999999999999999998 3579999999999999999999999999999999999
Q ss_pred eeeccccccCCCCCeEEEeecCCcccccccccccc---cccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHH
Q 001142 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCC---IAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1036 (1142)
Q Consensus 960 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~---~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSL 1036 (1142)
||+|.+ +++||.|||.|+.+........ ...........++||..|.+||++.. ...++.+|+|||
T Consensus 205 ILLd~d-------mhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~----~~~~~~sDiWAl 273 (604)
T KOG0592|consen 205 ILLDKD-------GHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND----SPAGPSSDLWAL 273 (604)
T ss_pred eeEcCC-------CcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcC----CCCCcccchHHH
Confidence 999998 8999999999998765432211 00001111256899999999999987 677899999999
Q ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 001142 1037 GCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1116 (1142)
Q Consensus 1037 GviL~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~D 1116 (1142)
|||||+|+.|++||.+.++.-+++.|........ ...++.+++|++++|..|
T Consensus 274 GCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp----------------------------~~fp~~a~dLv~KLLv~d 325 (604)
T KOG0592|consen 274 GCILYQMLAGQPPFRAANEYLIFQKIQALDYEFP----------------------------EGFPEDARDLIKKLLVRD 325 (604)
T ss_pred HHHHHHHhcCCCCCccccHHHHHHHHHHhcccCC----------------------------CCCCHHHHHHHHHHHccC
Confidence 9999999999999999888888888765432111 144567999999999999
Q ss_pred CCCCCCHHHHHHHHHhhcCC
Q 001142 1117 PTERPTAGDLYEMFVARTSS 1136 (1142)
Q Consensus 1117 P~~RPSa~EVL~~L~~~~ss 1136 (1142)
|.+|+|+.||-+|+||..-.
T Consensus 326 p~~Rlt~~qIk~HpFF~~Vd 345 (604)
T KOG0592|consen 326 PSDRLTSQQIKAHPFFEGVD 345 (604)
T ss_pred ccccccHHHHhhCcccccCC
Confidence 99999999999999997653
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=346.78 Aligned_cols=289 Identities=21% Similarity=0.225 Sum_probs=222.0
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
.+|...++||+|+||+||+|++. ++.||+|-.++.. ..+.+...+.+|+..|+.++|+||+.++++|...+.
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~------~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~ 75 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGN------AKDGINRTALREIKLLQELKHPNIIELIDVFPHKSN 75 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccc------cccCccHHHHHHHHHHHHccCcchhhhhhhccCCCc
Confidence 46888999999999999999985 4455555444332 222333455899999999999999999999986554
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
+ .||+||++ .+|+..|++ ....++..+++.++.++++||+|||++.|+||||||.|+|++.
T Consensus 76 l--------------~lVfEfm~-tdLe~vIkd----~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~ 136 (318)
T KOG0659|consen 76 L--------------SLVFEFMP-TDLEVVIKD----KNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISS 136 (318)
T ss_pred e--------------EEEEEecc-ccHHHHhcc----cccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcC
Confidence 3 89999998 899999986 3467999999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||+|||+|+.+...... ....+-|..|+|||.+.| ...|+..+||||.|||+.||+
T Consensus 137 ~-------g~lKiADFGLAr~f~~p~~~----------~~~~V~TRWYRAPELLfG---sr~Yg~~VDmWavGCI~AELl 196 (318)
T KOG0659|consen 137 D-------GQLKIADFGLARFFGSPNRI----------QTHQVVTRWYRAPELLFG---SRQYGTGVDMWAVGCIFAELL 196 (318)
T ss_pred C-------CcEEeecccchhccCCCCcc----------cccceeeeeccChHHhcc---chhcCCcchhhhHHHHHHHHH
Confidence 8 89999999999887654322 112367999999999998 468999999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~ 1124 (1142)
-|.+-|.+.++.+....|...-..+.++.++......+....+..........-...+.++.+|+..||..||.+|+|+.
T Consensus 197 lr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~ 276 (318)
T KOG0659|consen 197 LRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITAS 276 (318)
T ss_pred ccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHH
Confidence 99998999888887777744433333333333332222221111110000001124566779999999999999999999
Q ss_pred HHHHHHHhhcCCCCCC
Q 001142 1125 DLYEMFVARTSSSISS 1140 (1142)
Q Consensus 1125 EVL~~L~~~~ss~~s~ 1140 (1142)
|+++|.||......+.
T Consensus 277 qaL~~~yf~~~P~pt~ 292 (318)
T KOG0659|consen 277 QALKHPYFKSLPLPTP 292 (318)
T ss_pred HHhcchhhhcCCCCCC
Confidence 9999999997655443
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=374.71 Aligned_cols=295 Identities=21% Similarity=0.243 Sum_probs=226.1
Q ss_pred CCCCCCCCCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccce
Q 001142 798 CSGLDPGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 875 (1142)
Q Consensus 798 ~~~~~~~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl 875 (1142)
...+.+...+.|+..++||+|+||.||+|++. +..||+|-++++... .+|...+.+||.||++|.|||||++
T Consensus 108 ~~~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~------~~~~~t~~REI~ILr~l~HpNIikL 181 (560)
T KOG0600|consen 108 LHGWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK------EGFPITAIREIKILRRLDHPNIIKL 181 (560)
T ss_pred cccccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC------CcchHHHHHHHHHHHhcCCCcccce
Confidence 34667777888999999999999999999985 445777765554321 2333445799999999999999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 001142 876 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 955 (1142)
Q Consensus 876 ~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDL 955 (1142)
.+...+... ..+|||+|||+ .+|.-++.. +...|++.+++.++.||+.||+|||.+||+||||
T Consensus 182 ~eivt~~~~------------~siYlVFeYMd-hDL~GLl~~----p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDI 244 (560)
T KOG0600|consen 182 EEIVTSKLS------------GSIYLVFEYMD-HDLSGLLSS----PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDI 244 (560)
T ss_pred eeEEEecCC------------ceEEEEEeccc-chhhhhhcC----CCcccChHHHHHHHHHHHHHHHHHhhcCeeeccc
Confidence 999887521 14599999998 888888764 4568999999999999999999999999999999
Q ss_pred CCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHH
Q 001142 956 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 1035 (1142)
Q Consensus 956 Kp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwS 1035 (1142)
|.+|||||.+ +.+||+|||+|+.+...... .....+.|.+|+|||.+.+ ...|+.++|+||
T Consensus 245 K~SNiLidn~-------G~LKiaDFGLAr~y~~~~~~---------~~T~rVvTLWYRpPELLLG---~t~Yg~aVDlWS 305 (560)
T KOG0600|consen 245 KGSNILIDNN-------GVLKIADFGLARFYTPSGSA---------PYTSRVVTLWYRPPELLLG---ATSYGTAVDLWS 305 (560)
T ss_pred cccceEEcCC-------CCEEeccccceeeccCCCCc---------ccccceEEeeccChHHhcC---Ccccccceeehh
Confidence 9999999988 89999999999876543211 1335678999999999998 468999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCC--chhhhhhHHHHHHHHHHhc
Q 001142 1036 YGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK--PEAELETLSFLVDVFRRCT 1113 (1142)
Q Consensus 1036 LGviL~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~L~dLI~~CL 1113 (1142)
.||||.||++|++.|++.++.+..+.|......+-...|... ........+....+.. .+.-...+....+|+..+|
T Consensus 306 ~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~-kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL 384 (560)
T KOG0600|consen 306 VGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS-KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLL 384 (560)
T ss_pred hhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc-cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHh
Confidence 999999999999999999888888777443322222222210 0011111111111111 1111245677899999999
Q ss_pred ccCCCCCCCHHHHHHHHHhhcC
Q 001142 1114 EENPTERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1114 ~~DP~~RPSa~EVL~~L~~~~s 1135 (1142)
..||.+|.||.++|++-||...
T Consensus 385 ~ldP~kR~tA~~aL~seyF~t~ 406 (560)
T KOG0600|consen 385 SLDPDKRGTASSALQSEYFTTE 406 (560)
T ss_pred ccCccccccHHHHhcCcccccC
Confidence 9999999999999999999544
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=369.01 Aligned_cols=264 Identities=33% Similarity=0.443 Sum_probs=206.2
Q ss_pred CCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
..+|...+.||+|+||+||++... +...|||...+.. ....+.+ .+|+.+|.+++|||||+++|......
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~----~~~~~~l----~~Ei~iL~~l~~p~IV~~~G~~~~~~ 87 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED----SPTSESL----EREIRILSRLNHPNIVQYYGSSSSRE 87 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc----chhHHHH----HHHHHHHHhCCCCCEEeeCCcccccc
Confidence 456899999999999999999985 5788999865541 1113333 79999999999999999999754322
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
. ..++++|||+++|||.+++.+ .+. .+++..++++++||+.||.|||++|||||||||+|||++
T Consensus 88 ~------------~~~~i~mEy~~~GsL~~~~~~---~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~ 151 (313)
T KOG0198|consen 88 N------------DEYNIFMEYAPGGSLSDLIKR---YGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLD 151 (313)
T ss_pred C------------eeeEeeeeccCCCcHHHHHHH---cCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEe
Confidence 1 245999999999999999987 233 699999999999999999999999999999999999999
Q ss_pred c-ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 964 L-ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 964 ~-~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
. + +.+||+|||+++...... . .........||+.|||||++.. +....+++|||||||++.|
T Consensus 152 ~~~-------~~~KlaDFG~a~~~~~~~-~------~~~~~~~~~Gtp~~maPEvi~~---g~~~~~~sDiWSlGCtVvE 214 (313)
T KOG0198|consen 152 PSN-------GDVKLADFGLAKKLESKG-T------KSDSELSVQGTPNYMAPEVIRN---GEVARRESDIWSLGCTVVE 214 (313)
T ss_pred CCC-------CeEEeccCcccccccccc-c------cccccccccCCccccCchhhcC---CCcCCccchhhhcCCEEEe
Confidence 8 4 789999999997655311 0 0112235679999999999984 1223369999999999999
Q ss_pred HHhCCCCCCCC-CHHHHHHHH-HhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1043 LLTLQVPYMGL-SELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1043 LLtG~~Pf~~~-~~~el~~~I-~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
|+||+.||... ...+..-.+ .....|.++ ...++..++|+.+|++.||++|
T Consensus 215 M~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip---------------------------~~ls~~a~~Fl~~C~~~~p~~R 267 (313)
T KOG0198|consen 215 MLTGKPPWSEFFEEAEALLLIGREDSLPEIP---------------------------DSLSDEAKDFLRKCFKRDPEKR 267 (313)
T ss_pred ccCCCCcchhhcchHHHHHHHhccCCCCCCC---------------------------cccCHHHHHHHHHHhhcCcccC
Confidence 99999999862 323222222 222222222 1456779999999999999999
Q ss_pred CCHHHHHHHHHhhcCCC
Q 001142 1121 PTAGDLYEMFVARTSSS 1137 (1142)
Q Consensus 1121 PSa~EVL~~L~~~~ss~ 1137 (1142)
|||+++|+|+|.+....
T Consensus 268 pta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 268 PTAEELLEHPFLKQNSI 284 (313)
T ss_pred cCHHHHhhChhhhcccc
Confidence 99999999999986543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=352.10 Aligned_cols=260 Identities=26% Similarity=0.342 Sum_probs=220.6
Q ss_pred CCCCCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001142 803 PGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 880 (1142)
Q Consensus 803 ~~~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~ 880 (1142)
+..+++|++.+.||.|+||.|.+++. .+..+|+|+...... ....+.+ ...+|..+|+.+.||+++++++.+.
T Consensus 40 ~~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~v-VklKQve----H~~nEk~vL~~v~~PFlv~l~~t~~ 114 (355)
T KOG0616|consen 40 PYSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKV-VKLKQVE----HTHNEKRVLKAVSHPFLVKLYGTFK 114 (355)
T ss_pred CcchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHH-HHHHHHH----HHhhHHHHHhhccCceeEEEEEeec
Confidence 47789999999999999999999987 566788887432211 1112222 3378999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NI 960 (1142)
+.+. +|+||||++||-|.+++++ ..++++..++.++.||+.||+|||+.+|++|||||+||
T Consensus 115 d~~~--------------lymvmeyv~GGElFS~Lrk-----~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENi 175 (355)
T KOG0616|consen 115 DNSN--------------LYMVMEYVPGGELFSYLRK-----SGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENL 175 (355)
T ss_pred cCCe--------------EEEEEeccCCccHHHHHHh-----cCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHe
Confidence 7664 4999999999999999987 35799999999999999999999999999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
|+|.+ |.+||.|||+|+..... + -+.+|||.|+|||++.. .+|+.++|.|||||++
T Consensus 176 LlD~~-------G~iKitDFGFAK~v~~r--T-----------~TlCGTPeYLAPEii~s----k~ynkavDWWalGVLI 231 (355)
T KOG0616|consen 176 LLDQN-------GHIKITDFGFAKRVSGR--T-----------WTLCGTPEYLAPEIIQS----KGYNKAVDWWALGVLI 231 (355)
T ss_pred eeccC-------CcEEEEeccceEEecCc--E-----------EEecCCccccChHHhhc----CCCCcchhHHHHHHHH
Confidence 99998 89999999999876543 1 24579999999999987 7899999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1041 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
|||+.|.+||...++.++++.|..+...-.. ..+.++++|+..+|+.|-.+|
T Consensus 232 YEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~----------------------------~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 232 YEMLAGYPPFYDDNPIQIYEKILEGKVKFPS----------------------------YFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred HHHHcCCCCCcCCChHHHHHHHHhCcccCCc----------------------------ccCHHHHHHHHHHHhhhhHhh
Confidence 9999999999999999999999776532111 345569999999999999999
Q ss_pred -----CCHHHHHHHHHhhcCCCC
Q 001142 1121 -----PTAGDLYEMFVARTSSSI 1138 (1142)
Q Consensus 1121 -----PSa~EVL~~L~~~~ss~~ 1138 (1142)
....+|..|+||+...+.
T Consensus 284 ~gnlknG~~dIk~H~wF~~v~W~ 306 (355)
T KOG0616|consen 284 FGNLKNGVEDIKNHPWFKGVDWE 306 (355)
T ss_pred hcCcCCCccccccCcccccccHH
Confidence 567899999999876553
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=354.50 Aligned_cols=290 Identities=25% Similarity=0.313 Sum_probs=225.0
Q ss_pred CCCCCCcceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001142 803 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 882 (1142)
Q Consensus 803 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~ 882 (1142)
..+++.|+...+|++|+||.||+|+++.+...|++++++.. .+...|....++||.+|.+++|||||.+-.++...
T Consensus 72 Crsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kme----kek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~ 147 (419)
T KOG0663|consen 72 CRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKME----KEKEGFPITSLREINILLKARHPNIVEVKEVVVGS 147 (419)
T ss_pred cccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccc----cccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecc
Confidence 46788899999999999999999999766655555555532 23445555668999999999999999999998764
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
+ ....|||||||+ .+|.+++... ..+|...+++.++.|+++|++|||.+.|+|||||++|+|+
T Consensus 148 ~------------~d~iy~VMe~~E-hDLksl~d~m----~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm 210 (419)
T KOG0663|consen 148 N------------MDKIYIVMEYVE-HDLKSLMETM----KQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLL 210 (419)
T ss_pred c------------cceeeeeHHHHH-hhHHHHHHhc----cCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheee
Confidence 4 224699999998 8999999873 2579999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
+.. |.+||+|||+|+.+...... ....+-|.+|+|||.+.+ ...|+.++|+||+|||+.|
T Consensus 211 ~~~-------G~lKiaDFGLAR~ygsp~k~----------~T~lVVTLWYRaPELLLG---~~tyst~iDMWSvGCI~aE 270 (419)
T KOG0663|consen 211 SHK-------GILKIADFGLAREYGSPLKP----------YTPLVVTLWYRAPELLLG---AKTYSTAVDMWSVGCIFAE 270 (419)
T ss_pred ccC-------CcEEecccchhhhhcCCccc----------CcceEEEeeecCHHHhcC---CcccCcchhhhhHHHHHHH
Confidence 887 89999999999987764322 234568999999999998 4679999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccc--------cccccccCCCCCCchhhhhhHHHHHHHHHHhcc
Q 001142 1043 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH--------EHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 1114 (1142)
Q Consensus 1043 LLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~ 1114 (1142)
|+++++.|.+.+..+..+.|......+....++...... ..........+.. ...++.-.+|+..+|.
T Consensus 271 ~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~----~~lse~g~~Lln~llt 346 (419)
T KOG0663|consen 271 LLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGA----LSLSEQGFDLLNKLLT 346 (419)
T ss_pred HHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccc----cccchhHHHHHHHHhc
Confidence 999999999998888777774322221111111111111 0011111111111 1145778999999999
Q ss_pred cCCCCCCCHHHHHHHHHhhcCCC
Q 001142 1115 ENPTERPTAGDLYEMFVARTSSS 1137 (1142)
Q Consensus 1115 ~DP~~RPSa~EVL~~L~~~~ss~ 1137 (1142)
+||.+|.||.|.|+|-||....-
T Consensus 347 ~dP~kR~tA~~~L~h~~F~e~P~ 369 (419)
T KOG0663|consen 347 YDPGKRITAEDGLKHEYFRETPL 369 (419)
T ss_pred cCccccccHHHhhcccccccCCC
Confidence 99999999999999999987543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=372.34 Aligned_cols=263 Identities=23% Similarity=0.274 Sum_probs=214.0
Q ss_pred CCCCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEe
Q 001142 804 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKI 880 (1142)
Q Consensus 804 ~~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~g~~~ 880 (1142)
.....|.+.+.||+|+||+|++|.+ .+..+|+|+..-+...... ......+.+|+.++++++ ||||+++++++.
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~---~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~ 90 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKS---QKLDELIKREISILRRLRSHPNIIRLLEVFA 90 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccc---cccchhhHHHHHHHHHhccCCCEeEEEEEEe
Confidence 3466899999999999999999987 5678899975433211111 122233468999999998 999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NI 960 (1142)
.... .++||||+.||+|.+++.+ ..++.+.++.++++|++.|++|||++||+||||||+||
T Consensus 91 t~~~--------------~~ivmEy~~gGdL~~~i~~-----~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENi 151 (370)
T KOG0583|consen 91 TPTK--------------IYIVMEYCSGGDLFDYIVN-----KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENI 151 (370)
T ss_pred cCCe--------------EEEEEEecCCccHHHHHHH-----cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHE
Confidence 7653 4999999999999999986 45789999999999999999999999999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
|++.+. +++||+|||++..... ........+||+.|+|||++.+.. ..-+.++||||+||+|
T Consensus 152 lld~~~------~~~Kl~DFG~s~~~~~----------~~~~l~t~cGsp~Y~aPEvl~~~~--~Y~g~~aDvWS~GViL 213 (370)
T KOG0583|consen 152 LLDGNE------GNLKLSDFGLSAISPG----------EDGLLKTFCGSPAYAAPEVLSGKG--TYSGKAADVWSLGVIL 213 (370)
T ss_pred EecCCC------CCEEEeccccccccCC----------CCCcccCCCCCcccCCHHHhCCCC--CcCCchhhhhhhHHHH
Confidence 998762 6799999999976521 111334678999999999998721 1336899999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhh-HHHHHHHHHHhcccCCCC
Q 001142 1041 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELET-LSFLVDVFRRCTEENPTE 1119 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~dLI~~CL~~DP~~ 1119 (1142)
|.|++|+.||.......++..|..+...-.. .. +.++.+++.+||..||.+
T Consensus 214 y~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~----------------------------~~~S~~~~~Li~~mL~~~P~~ 265 (370)
T KOG0583|consen 214 YVLLCGRLPFDDSNVPNLYRKIRKGEFKIPS----------------------------YLLSPEARSLIEKMLVPDPST 265 (370)
T ss_pred HHHHhCCCCCCCccHHHHHHHHhcCCccCCC----------------------------CcCCHHHHHHHHHHcCCCccc
Confidence 9999999999987777777777655432111 22 567999999999999999
Q ss_pred CCCHHHHHHHHHhhc
Q 001142 1120 RPTAGDLYEMFVART 1134 (1142)
Q Consensus 1120 RPSa~EVL~~L~~~~ 1134 (1142)
|+|+.++++|+|++.
T Consensus 266 R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 266 RITLLEILEHPWFQK 280 (370)
T ss_pred CCCHHHHhhChhhcc
Confidence 999999999999997
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=370.85 Aligned_cols=256 Identities=27% Similarity=0.394 Sum_probs=217.7
Q ss_pred CCcceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 886 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~ 886 (1142)
++|.+.+.||+|+||.||+|+.+.+...|+++.+.+......+.+.+ .+|++|+++++|||||.++++|+....
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l----~~ev~i~r~lkHpniv~m~esfEt~~~-- 75 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNL----RQEVRILRSLKHPNIVEMLESFETSAH-- 75 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHH----HHHHHHHHhcCCcchhhHHHhhcccce--
Confidence 57899999999999999999986655555555566666666677776 899999999999999999999998764
Q ss_pred CCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecccc
Q 001142 887 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 966 (1142)
Q Consensus 887 ~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~ 966 (1142)
+|+|+||+. |+|..++.. +..++++.++.|+.|++.||.|||+++|+|||+||.|||++..
T Consensus 76 ------------~~vVte~a~-g~L~~il~~-----d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~- 136 (808)
T KOG0597|consen 76 ------------LWVVTEYAV-GDLFTILEQ-----DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKG- 136 (808)
T ss_pred ------------EEEEehhhh-hhHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCC-
Confidence 499999998 599999987 5679999999999999999999999999999999999999987
Q ss_pred ccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001142 967 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1046 (1142)
Q Consensus 967 ~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG 1046 (1142)
+++|+||||+|+.+.... .......|||.|||||...+ .+|+..+|+||+|||+|||++|
T Consensus 137 ------~~~KlcdFg~Ar~m~~~t----------~vltsikGtPlYmAPElv~e----~pyd~~sDlWslGcilYE~~~G 196 (808)
T KOG0597|consen 137 ------GTLKLCDFGLARAMSTNT----------SVLTSIKGTPLYMAPELVEE----QPYDHTSDLWSLGCILYELYVG 196 (808)
T ss_pred ------CceeechhhhhhhcccCc----------eeeeeccCcccccCHHHHcC----CCccchhhHHHHHHHHHHHhcC
Confidence 899999999998765422 12234569999999999986 7899999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 001142 1047 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1126 (1142)
Q Consensus 1047 ~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EV 1126 (1142)
++||...+..++...|.....++.. ..+..+..+++..|..||.+|.|-.++
T Consensus 197 ~PPF~a~si~~Lv~~I~~d~v~~p~----------------------------~~S~~f~nfl~gLL~kdP~~RltW~~L 248 (808)
T KOG0597|consen 197 QPPFYARSITQLVKSILKDPVKPPS----------------------------TASSSFVNFLQGLLIKDPAQRLTWTDL 248 (808)
T ss_pred CCCchHHHHHHHHHHHhcCCCCCcc----------------------------cccHHHHHHHHHHhhcChhhcccHHHH
Confidence 9999887777777777554332211 455679999999999999999999999
Q ss_pred HHHHHhhcC
Q 001142 1127 YEMFVARTS 1135 (1142)
Q Consensus 1127 L~~L~~~~s 1135 (1142)
+.|+|.+..
T Consensus 249 l~HpF~k~~ 257 (808)
T KOG0597|consen 249 LGHPFWKGK 257 (808)
T ss_pred hcChHHhhh
Confidence 999887643
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=371.41 Aligned_cols=253 Identities=28% Similarity=0.438 Sum_probs=213.1
Q ss_pred CcceeeeecccCceEEEEEEECCc-cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFGSA-DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 886 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~~~-~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~ 886 (1142)
.+++.+.||+|-||.||.|.|++. +||+|..+.. . ...+.| .+|+++|++|+|+|||+++|++..++.+
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~--~---m~~~~f----~~Ea~iMk~L~H~~lV~l~gV~~~~~pi- 276 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG--S---MSPEAF----LREAQIMKKLRHEKLVKLYGVCTKQEPI- 276 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCCcccceEEecc--c---cChhHH----HHHHHHHHhCcccCeEEEEEEEecCCce-
Confidence 368999999999999999999766 8999986533 1 222344 7899999999999999999999875533
Q ss_pred CCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecccc
Q 001142 887 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 966 (1142)
Q Consensus 887 ~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~ 966 (1142)
+|||||++.|+|.++++. .....+...+.+.++.|||.|++||+++++|||||-+.||||+.+
T Consensus 277 -------------yIVtE~m~~GsLl~yLr~---~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~- 339 (468)
T KOG0197|consen 277 -------------YIVTEYMPKGSLLDYLRT---REGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDED- 339 (468)
T ss_pred -------------EEEEEecccCcHHHHhhh---cCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccC-
Confidence 999999999999999986 345679999999999999999999999999999999999999988
Q ss_pred ccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-
Q 001142 967 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT- 1045 (1142)
Q Consensus 967 ~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt- 1045 (1142)
..+||+|||+|+...+...+. ....--...|.|||.+.. ..++.|+|||||||+||||+|
T Consensus 340 ------~~vKIsDFGLAr~~~d~~Y~~---------~~~~kfPIkWtAPEa~~~----~~FS~kSDVWSFGVlL~E~fT~ 400 (468)
T KOG0197|consen 340 ------LVVKISDFGLARLIGDDEYTA---------SEGGKFPIKWTAPEALNY----GKFSSKSDVWSFGVLLWELFTY 400 (468)
T ss_pred ------ceEEEcccccccccCCCceee---------cCCCCCCceecCHHHHhh----CCcccccceeehhhhHHHHhcc
Confidence 799999999999544332211 111123457999999986 679999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001142 1046 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1125 (1142)
Q Consensus 1046 G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~E 1125 (1142)
|+.||.+.+..++.+.+.+|.+.+-+. .+++.+.+++..||+.+|++|||++.
T Consensus 401 G~~py~~msn~ev~~~le~GyRlp~P~---------------------------~CP~~vY~lM~~CW~~~P~~RPtF~~ 453 (468)
T KOG0197|consen 401 GRVPYPGMSNEEVLELLERGYRLPRPE---------------------------GCPDEVYELMKSCWHEDPEDRPTFET 453 (468)
T ss_pred CCCCCCCCCHHHHHHHHhccCcCCCCC---------------------------CCCHHHHHHHHHHhhCCcccCCCHHH
Confidence 999999999999999998887654332 67888999999999999999999998
Q ss_pred HHHHHHhh
Q 001142 1126 LYEMFVAR 1133 (1142)
Q Consensus 1126 VL~~L~~~ 1133 (1142)
+...+...
T Consensus 454 L~~~l~~~ 461 (468)
T KOG0197|consen 454 LREVLEDF 461 (468)
T ss_pred HHHHHHHh
Confidence 77665443
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=348.73 Aligned_cols=263 Identities=26% Similarity=0.341 Sum_probs=218.6
Q ss_pred CCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
+.|++.++||+|+|+.||++.+ .++.+|+|+...++.... ..+++ .+|++|++.|+|||||++.+.+.+..+
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~--~~e~l----~rEarIC~~LqHP~IvrL~~ti~~~~~ 84 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR--DFQKL----EREARICRKLQHPNIVRLHDSIQEESF 84 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc--cHHHH----HHHHHHHHhcCCCcEeehhhhhcccce
Confidence 4689999999999999999877 577888998666554333 34444 799999999999999999998887664
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
. |||+|++.|++|..-|-. +..+++..+-.+++||+.+|.|+|.+||||||+||+|+++-.
T Consensus 85 ~--------------ylvFe~m~G~dl~~eIV~-----R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLAS 145 (355)
T KOG0033|consen 85 H--------------YLVFDLVTGGELFEDIVA-----REFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLAS 145 (355)
T ss_pred e--------------EEEEecccchHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeee
Confidence 4 999999999999766544 246899999999999999999999999999999999999965
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
.. ...-+||+|||+|..+.... .-..++|||.|||||++.. .+|+..+|||+.|||||-|+
T Consensus 146 K~----~~A~vKL~~FGvAi~l~~g~-----------~~~G~~GtP~fmaPEvvrk----dpy~kpvDiW~cGViLfiLL 206 (355)
T KOG0033|consen 146 KA----KGAAVKLADFGLAIEVNDGE-----------AWHGFAGTPGYLSPEVLKK----DPYSKPVDIWACGVILYILL 206 (355)
T ss_pred cc----CCCceeecccceEEEeCCcc-----------ccccccCCCcccCHHHhhc----CCCCCcchhhhhhHHHHHHH
Confidence 42 23679999999998776322 1235689999999999986 68999999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~ 1124 (1142)
.|.+||.+.+...+++.|..+...-....++ ..+++.++|+++||..||++|.|+.
T Consensus 207 ~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~------------------------~is~~Ak~LvrrML~~dP~kRIta~ 262 (355)
T KOG0033|consen 207 VGYPPFWDEDQHRLYEQIKAGAYDYPSPEWD------------------------TVTPEAKSLIRRMLTVNPKKRITAD 262 (355)
T ss_pred hCCCCCCCccHHHHHHHHhccccCCCCcccC------------------------cCCHHHHHHHHHHhccChhhhccHH
Confidence 9999999988888999998776432221111 5567799999999999999999999
Q ss_pred HHHHHHHhhcCCC
Q 001142 1125 DLYEMFVARTSSS 1137 (1142)
Q Consensus 1125 EVL~~L~~~~ss~ 1137 (1142)
|+|+|+|......
T Consensus 263 EAL~HpWi~~r~~ 275 (355)
T KOG0033|consen 263 EALKHPWICNRER 275 (355)
T ss_pred HHhCCchhcchHH
Confidence 9999999986543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=367.61 Aligned_cols=272 Identities=23% Similarity=0.316 Sum_probs=216.2
Q ss_pred CCCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCC-ChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGS-SADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 881 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~-~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~ 881 (1142)
++++|++.++||+|+||.||+|+. .+..+|+|+. ++... ...+.+.+ +.|-.+|....+|+||++|..|.+
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~L--kKS~M~~~~Qv~hV----~aERdiL~~~ds~~vVKLyYsFQD 212 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKIL--KKSEMLKKNQVEHV----RAERDILAEVDSPWVVKLYYSFQD 212 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecc--cHHHHHhhhhHHHH----HHHHHHhhhcCCCcEEEEEEEecC
Confidence 578999999999999999999986 5666777764 33221 12233333 789999999999999999999998
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 001142 882 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 961 (1142)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NIL 961 (1142)
..++ ||||||+|||++..+|.+ ...|++..++.++.+++.|++.||+.|+|||||||+|+|
T Consensus 213 ~~~L--------------YLiMEylPGGD~mTLL~~-----~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlL 273 (550)
T KOG0605|consen 213 KEYL--------------YLIMEYLPGGDMMTLLMR-----KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLL 273 (550)
T ss_pred CCee--------------EEEEEecCCccHHHHHHh-----cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhhee
Confidence 7755 999999999999999987 457999999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCCccccccccccc---------------ccccCC----------------------CCCCC
Q 001142 962 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTC---------------CIAHRG----------------------IPAPD 1004 (1142)
Q Consensus 962 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~---------------~~~~~~----------------------~~~~~ 1004 (1142)
||.. |++||+|||++..+....... ...... .....
T Consensus 274 iD~~-------GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~ 346 (550)
T KOG0605|consen 274 IDAK-------GHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAY 346 (550)
T ss_pred ecCC-------CCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhh
Confidence 9998 999999999996432211000 000000 00111
Q ss_pred CccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCchhHHhhhcccccc
Q 001142 1005 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEH 1083 (1142)
Q Consensus 1005 ~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~Pf~~~~~~el~~~I~~~~~-p~l~~~l~~~~~~~~~ 1083 (1142)
..+|||.|||||++.+ ..|+..+|+||||||+||||.|.+||.+.++.+.+..|..... ...+
T Consensus 347 StVGTPDYiAPEVll~----kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP------------ 410 (550)
T KOG0605|consen 347 STVGTPDYIAPEVLLG----KGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFP------------ 410 (550)
T ss_pred cccCCccccchHHHhc----CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCC------------
Confidence 3589999999999997 6799999999999999999999999999999999888754321 1111
Q ss_pred cccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC---CHHHHHHHHHhhcCCCC
Q 001142 1084 EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP---TAGDLYEMFVARTSSSI 1138 (1142)
Q Consensus 1084 ~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP---Sa~EVL~~L~~~~ss~~ 1138 (1142)
.+...+++..+||.+|+. ||++|. .++||-+||||+.-.+-
T Consensus 411 -------------~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~ 454 (550)
T KOG0605|consen 411 -------------EEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWD 454 (550)
T ss_pred -------------CcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcc
Confidence 011455789999999999 999996 69999999999976553
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=372.62 Aligned_cols=261 Identities=21% Similarity=0.299 Sum_probs=220.0
Q ss_pred CCCCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001142 804 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 881 (1142)
Q Consensus 804 ~~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~ 881 (1142)
.++..|++++-||.|+.|.|-+|++ +|+.+|||+....... ... ....+.+|+.||+-+.||||+++|+.++.
T Consensus 9 ~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~-s~s----~~~~IerEIviMkLi~HpnVl~LydVwe~ 83 (786)
T KOG0588|consen 9 NTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSEL-SSS----QPAGIEREIVIMKLIEHPNVLRLYDVWEN 83 (786)
T ss_pred ccccceeccccccCCCCceehhhhcccccceeEEEeecccccc-ccc----cccchhhhhHHHHHhcCCCeeeeeeeecc
Confidence 4567899999999999999999998 6888999986544211 111 12344799999999999999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 001142 882 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 961 (1142)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NIL 961 (1142)
.. ++|+|.||++||-|++++.. .+++++.++.++++||+.|+.|+|..+|+||||||+|+|
T Consensus 84 ~~--------------~lylvlEyv~gGELFdylv~-----kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlL 144 (786)
T KOG0588|consen 84 KQ--------------HLYLVLEYVPGGELFDYLVR-----KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLL 144 (786)
T ss_pred Cc--------------eEEEEEEecCCchhHHHHHh-----hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhh
Confidence 65 45999999999999999976 468999999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001142 962 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1041 (1142)
Q Consensus 962 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ 1041 (1142)
+|.. +.+||+|||+|..-... ....+.+|+|.|.|||++.+ ....+.++||||.|||||
T Consensus 145 Ld~~-------~nIKIADFGMAsLe~~g-----------klLeTSCGSPHYA~PEIV~G---~pYdG~~sDVWSCGVILf 203 (786)
T KOG0588|consen 145 LDVK-------NNIKIADFGMASLEVPG-----------KLLETSCGSPHYAAPEIVSG---RPYDGRPSDVWSCGVILF 203 (786)
T ss_pred hhcc-------cCEeeeccceeecccCC-----------ccccccCCCcccCCchhhcC---CCCCCCccccchhHHHHH
Confidence 9988 67999999999653221 12335679999999999998 234579999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1042 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1042 ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
.||||+.||.+.+...++..++.|...- + ..++.++.+||.+||..||++|.
T Consensus 204 ALLtG~LPFdDdNir~LLlKV~~G~f~M-P---------------------------s~Is~eaQdLLr~ml~VDp~~Ri 255 (786)
T KOG0588|consen 204 ALLTGKLPFDDDNIRVLLLKVQRGVFEM-P---------------------------SNISSEAQDLLRRMLDVDPSTRI 255 (786)
T ss_pred HHHhCCCCCCCccHHHHHHHHHcCcccC-C---------------------------CcCCHHHHHHHHHHhccCccccc
Confidence 9999999999888888888888876421 1 15677899999999999999999
Q ss_pred CHHHHHHHHHhhcCCC
Q 001142 1122 TAGDLYEMFVARTSSS 1137 (1142)
Q Consensus 1122 Sa~EVL~~L~~~~ss~ 1137 (1142)
|++||++|||...-.+
T Consensus 256 T~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 256 TTEEILKHPFLSGYTS 271 (786)
T ss_pred cHHHHhhCchhhcCCC
Confidence 9999999999986533
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=360.49 Aligned_cols=278 Identities=25% Similarity=0.259 Sum_probs=215.5
Q ss_pred CCCCCCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCC-----hHHHH-HhHHhHHHHHHHHhhCCCCCcc
Q 001142 802 DPGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSS-----ADEIR-NFEYSCLGEVRMLGALRHSCIV 873 (1142)
Q Consensus 802 ~~~~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~-----~~~~~-~~~~~~~~Ei~iL~~L~HpNIV 873 (1142)
+-..+..|++.+.||+|.||.|-+|+. .++.+|+|++.-+..... ..... .--.++.+||.||++++|||||
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV 171 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV 171 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence 356688999999999999999999998 567788888532211100 00000 0012458999999999999999
Q ss_pred ceeeeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCC-CCHHHHHHHHHHHHHHHHHHHhCCccc
Q 001142 874 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKH-VSVKLALFIAQDVAAALVELHSKHIMH 952 (1142)
Q Consensus 874 kl~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~-ls~~~i~~Ia~qIa~gL~yLHs~gIvH 952 (1142)
+++++..+... ..+|||+|||..|.+..+- ...+ +++.++++|+++++.||+|||.+||||
T Consensus 172 ~LiEvLDDP~s------------~~~YlVley~s~G~v~w~p------~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiH 233 (576)
T KOG0585|consen 172 KLIEVLDDPES------------DKLYLVLEYCSKGEVKWCP------PDKPELSEQQARKYLRDVVLGLEYLHYQGIIH 233 (576)
T ss_pred EEEEeecCccc------------CceEEEEEeccCCccccCC------CCcccccHHHHHHHHHHHHHHHHHHHhcCeec
Confidence 99999876432 2569999999988865432 2344 999999999999999999999999999
Q ss_pred cCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhh
Q 001142 953 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 1032 (1142)
Q Consensus 953 rDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksD 1032 (1142)
|||||+|+|++.+ ++|||+|||.+........... .......+|||.|+|||.+.+.......+.+.|
T Consensus 234 RDIKPsNLLl~~~-------g~VKIsDFGVs~~~~~~~~~~~-----d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~D 301 (576)
T KOG0585|consen 234 RDIKPSNLLLSSD-------GTVKISDFGVSNEFPQGSDEGS-----DDQLSRTVGTPAFFAPELCSGGNSFSYSGFALD 301 (576)
T ss_pred cccchhheEEcCC-------CcEEeeccceeeecccCCcccc-----HHHHhhcCCCccccchHhhcCCCCccccchhhh
Confidence 9999999999988 8999999999976533211100 001123579999999999987544455679999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHh
Q 001142 1033 IWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 1112 (1142)
Q Consensus 1033 VwSLGviL~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~C 1112 (1142)
|||+||+||.|+.|+.||.+....++++.|....... ++. .+..+.+++||.+|
T Consensus 302 iWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~pL~f-------------------------P~~-pe~~e~~kDli~~l 355 (576)
T KOG0585|consen 302 IWALGVTLYCLLFGQLPFFDDFELELFDKIVNDPLEF-------------------------PEN-PEINEDLKDLIKRL 355 (576)
T ss_pred hhhhhhhHHHhhhccCCcccchHHHHHHHHhcCcccC-------------------------CCc-ccccHHHHHHHHHH
Confidence 9999999999999999999988888888886543211 110 14566799999999
Q ss_pred cccCCCCCCCHHHHHHHHHhhcC
Q 001142 1113 TEENPTERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1113 L~~DP~~RPSa~EVL~~L~~~~s 1135 (1142)
|.+||++|.+..+|..|+|....
T Consensus 356 L~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 356 LEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred hhcChhheeehhhheecceeccC
Confidence 99999999999999999998755
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=365.26 Aligned_cols=255 Identities=29% Similarity=0.431 Sum_probs=214.1
Q ss_pred CcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
.|+..+.||+|+||.||+|.+. ++.||+|+..++.. .++++++ .+|+.++.+++++||.++|+.+.....+
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~---~deIedi----qqei~~Ls~~~~~~it~yygsyl~g~~L 86 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA---EDEIEDI----QQEISVLSQCDSPNITEYYGSYLKGTKL 86 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhc---chhhHHH----HHHHHHHHhcCcchHHhhhhheeecccH
Confidence 4677799999999999999984 56678887666542 3445555 7899999999999999999999876544
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
|++||||.||++.+.++. ...+.+..+..|+++++.||.|||.++.+|||||+.|||+..+
T Consensus 87 --------------wiiMey~~gGsv~~lL~~-----~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~ 147 (467)
T KOG0201|consen 87 --------------WIIMEYCGGGSVLDLLKS-----GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSES 147 (467)
T ss_pred --------------HHHHHHhcCcchhhhhcc-----CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEecc
Confidence 999999999999999975 3445888999999999999999999999999999999999887
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+.|||+|||.+..+..... ...+++|||+|||||++.+ ..|+.|+||||||++.+||++
T Consensus 148 -------g~vkl~DfgVa~ql~~~~~----------rr~tfvGTPfwMAPEVI~~----~~Y~~KADIWSLGITaiEla~ 206 (467)
T KOG0201|consen 148 -------GDVKLADFGVAGQLTNTVK----------RRKTFVGTPFWMAPEVIKQ----SGYDTKADIWSLGITAIELAK 206 (467)
T ss_pred -------CcEEEEecceeeeeechhh----------ccccccccccccchhhhcc----ccccchhhhhhhhHHHHHHhc
Confidence 8899999999987655322 2357889999999999986 689999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001142 1046 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1125 (1142)
Q Consensus 1046 G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~E 1125 (1142)
|.+||....++.+...|-+..+|.+.. ..++.+++|+..||..||+.||+|.+
T Consensus 207 GePP~s~~hPmrvlflIpk~~PP~L~~---------------------------~~S~~~kEFV~~CL~k~P~~RpsA~~ 259 (467)
T KOG0201|consen 207 GEPPHSKLHPMRVLFLIPKSAPPRLDG---------------------------DFSPPFKEFVEACLDKNPEFRPSAKE 259 (467)
T ss_pred CCCCCcccCcceEEEeccCCCCCcccc---------------------------ccCHHHHHHHHHHhhcCcccCcCHHH
Confidence 999999877755544444444433322 55677999999999999999999999
Q ss_pred HHHHHHhhcCC
Q 001142 1126 LYEMFVARTSS 1136 (1142)
Q Consensus 1126 VL~~L~~~~ss 1136 (1142)
+++|.|.+..-
T Consensus 260 LLKh~FIk~a~ 270 (467)
T KOG0201|consen 260 LLKHKFIKRAK 270 (467)
T ss_pred HhhhHHHHhcC
Confidence 99999988743
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=355.93 Aligned_cols=253 Identities=27% Similarity=0.356 Sum_probs=205.3
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
++|++.+.||+|+||.||+|.+. +..+|+|+....... ..... ..+.+|+.++++++||||+++++++.+..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~----~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 74 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVI-RLKQE----QHVHNEKRVLKEVSHPFIIRLFWTEHDQR- 74 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-hhHHH----HHHHHHHHHHHhCCCCcHhhhHhhhccCC-
Confidence 46899999999999999999985 677888876433110 11112 23478999999999999999998877654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
..++||||+++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~ 136 (291)
T cd05612 75 -------------FLYMLMEYVPGGELFSYLRN-----SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDK 136 (291)
T ss_pred -------------eEEEEEeCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECC
Confidence 45999999999999999976 346899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 137 ~-------~~~kl~Dfg~~~~~~~~-------------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~il~~l~ 192 (291)
T cd05612 137 E-------GHIKLTDFGFAKKLRDR-------------TWTLCGTPEYLAPEVIQS----KGHNKAVDWWALGILIYEML 192 (291)
T ss_pred C-------CCEEEEecCcchhccCC-------------cccccCChhhcCHHHHcC----CCCCchhhHHHHHHHHHHHH
Confidence 7 78999999998754321 113458999999999875 55789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC--
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT-- 1122 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS-- 1122 (1142)
+|+.||.+....+....+..+... ++ ...+..+.+++.+||+.||.+||+
T Consensus 193 ~g~~pf~~~~~~~~~~~i~~~~~~-~~---------------------------~~~~~~~~~li~~~l~~dp~~R~~~~ 244 (291)
T cd05612 193 VGYPPFFDDNPFGIYEKILAGKLE-FP---------------------------RHLDLYAKDLIKKLLVVDRTRRLGNM 244 (291)
T ss_pred hCCCCCCCCCHHHHHHHHHhCCcC-CC---------------------------ccCCHHHHHHHHHHcCCCHHHccCCc
Confidence 999999987777766666543211 10 023456899999999999999995
Q ss_pred ---HHHHHHHHHhhcC
Q 001142 1123 ---AGDLYEMFVARTS 1135 (1142)
Q Consensus 1123 ---a~EVL~~L~~~~s 1135 (1142)
++++++|+|+...
T Consensus 245 ~~~~~~~l~h~~~~~~ 260 (291)
T cd05612 245 KNGADDVKNHRWFKSV 260 (291)
T ss_pred cCCHHHHhcCccccCC
Confidence 9999999999753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=351.85 Aligned_cols=283 Identities=21% Similarity=0.254 Sum_probs=213.2
Q ss_pred CcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
.|+-.+++|.|+||+||+|... +..+|+|-.- .. ...+ .+|+++|+.+.|||||++.-+|......
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~-~d-----~r~k------nrEl~im~~l~HpNIV~L~~~f~~~~~~ 92 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVL-QD-----KRYK------NRELQIMRKLDHPNIVRLLYFFSSSTES 92 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEec-CC-----CCcC------cHHHHHHHhcCCcCeeeEEEEEEecCCC
Confidence 4788999999999999999974 4566666432 21 1112 4799999999999999999988764311
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
...+..+||||+| .+|.++++... ..+..++...++-+.+||.+||.|||+.||+||||||+|+|+|.+
T Consensus 93 ---------d~~~lnlVleymP-~tL~~~~r~~~-~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~ 161 (364)
T KOG0658|consen 93 ---------DEVYLNLVLEYMP-ETLYRVIRHYT-RANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPD 161 (364)
T ss_pred ---------chhHHHHHHHhch-HHHHHHHHHHh-hcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCC
Confidence 1335679999998 89999998643 334678999999999999999999999999999999999999987
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
. +.+||||||.|+.+...... .....|.+|+|||.+.+ ...|+.++||||.||++.||+-
T Consensus 162 t------g~LKicDFGSAK~L~~~epn-----------iSYicSRyYRaPELifg---a~~Yt~~IDiWSaGCV~aELl~ 221 (364)
T KOG0658|consen 162 T------GVLKICDFGSAKVLVKGEPN-----------ISYICSRYYRAPELIFG---ATEYTTSIDIWSAGCVMAELLK 221 (364)
T ss_pred C------CeEEeccCCcceeeccCCCc-----------eeEEEeccccCHHHHcC---ccccCceeEEhhhhHHHHHHhc
Confidence 5 89999999999887653322 23457899999999998 4689999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHh-CCCCCchhHHhhhcc-cccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1046 LQVPYMGLSELEIHDLIQM-GKRPRLTDELEALGS-CHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1046 G~~Pf~~~~~~el~~~I~~-~~~p~l~~~l~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
|++-|.|.+..+....|.. -..|... .+..+.. +.+..+.+.....-..-.....+++..+|+.++|+++|.+|.++
T Consensus 222 g~plFpG~s~~dQL~eIik~lG~Pt~e-~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~ 300 (364)
T KOG0658|consen 222 GQPLFPGDSSVDQLVEIIKVLGTPTRE-DIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSA 300 (364)
T ss_pred CCcccCCCCHHHHHHHHHHHhCCCCHH-HHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCH
Confidence 9999999887776655533 3333322 2222211 11111111111110000112567789999999999999999999
Q ss_pred HHHHHHHHhhc
Q 001142 1124 GDLYEMFVART 1134 (1142)
Q Consensus 1124 ~EVL~~L~~~~ 1134 (1142)
.|++.|++|..
T Consensus 301 ~~~l~h~fFde 311 (364)
T KOG0658|consen 301 LEALAHPFFDE 311 (364)
T ss_pred HHHhcchhhHH
Confidence 99999999864
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=350.47 Aligned_cols=282 Identities=20% Similarity=0.226 Sum_probs=206.4
Q ss_pred CCCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001142 804 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 881 (1142)
Q Consensus 804 ~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~ 881 (1142)
..+++|++.++||+|+||+||+|+.. +..+|+|+.+...... ... .+.+|+.++++++||||+++++++.+
T Consensus 2 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~----~~~~E~~~l~~l~h~niv~~~~~~~~ 74 (288)
T cd07871 2 GKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG---APC----TAIREVSLLKNLKHANIVTLHDIIHT 74 (288)
T ss_pred CccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC---cch----hHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 35678999999999999999999874 5678888764332111 111 23689999999999999999999876
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 001142 882 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 961 (1142)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NIL 961 (1142)
.+ ..++||||++ ++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 75 ~~--------------~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil 135 (288)
T cd07871 75 ER--------------CLTLVFEYLD-SDLKQYLDNC----GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLL 135 (288)
T ss_pred CC--------------eEEEEEeCCC-cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEE
Confidence 54 3499999997 5999988652 235789999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001142 962 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1041 (1142)
Q Consensus 962 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ 1041 (1142)
++.+ +.+||+|||+++....... ......+++.|+|||++.+ ...++.++||||+||++|
T Consensus 136 ~~~~-------~~~kl~DfG~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~~l~ 195 (288)
T cd07871 136 INEK-------GELKLADFGLARAKSVPTK----------TYSNEVVTLWYRPPDVLLG---STEYSTPIDMWGVGCILY 195 (288)
T ss_pred ECCC-------CCEEECcCcceeeccCCCc----------cccCceecccccChHHhcC---CcccCcHHHHHHHHHHHH
Confidence 9887 7899999999865432111 1123458999999999864 245789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccc---cccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001142 1042 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH---EHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1118 (1142)
Q Consensus 1042 ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~ 1118 (1142)
+|++|+.||.+.+..+....+...........+....... .....+.. ...........+.++.+|+.+||+.||.
T Consensus 196 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~dll~~mL~~dp~ 274 (288)
T cd07871 196 EMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYR-AQPLINHAPRLDTDGIDLLSSLLLYETK 274 (288)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccC-CCchHHhCCCCCHHHHHHHHHhcCcCcc
Confidence 9999999998877766655553332222222221111000 00000000 0000011113456789999999999999
Q ss_pred CCCCHHHHHHHHHh
Q 001142 1119 ERPTAGDLYEMFVA 1132 (1142)
Q Consensus 1119 ~RPSa~EVL~~L~~ 1132 (1142)
+|||++|+++|+|+
T Consensus 275 ~R~t~~~~l~hp~f 288 (288)
T cd07871 275 SRISAEAALRHSYF 288 (288)
T ss_pred cCCCHHHHhcCCCC
Confidence 99999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=367.26 Aligned_cols=267 Identities=24% Similarity=0.383 Sum_probs=215.0
Q ss_pred CCCCCCcceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001142 803 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 882 (1142)
Q Consensus 803 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~ 882 (1142)
...++...+.+.||+|+||+||+|+|.| +||||+..++ ....+..+.| +.|+.++++-+|.||+-++|++..+
T Consensus 388 eIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~--~pt~~qlqaF----KnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 388 EIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVD--DPTPEQLQAF----KNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred ccCHHHhhccceeccccccceeeccccc-ceEEEEEecC--CCCHHHHHHH----HHHHHHHhhcchhhheeeehhhcCC
Confidence 3445567899999999999999999975 5799986544 5556667777 8999999999999999999999854
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
. ..||+.+|+|.||+.+++.. +..|.+...+.||+||++|+.|||.++|||||||..|||+
T Consensus 461 ~---------------~AIiTqwCeGsSLY~hlHv~----etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl 521 (678)
T KOG0193|consen 461 P---------------LAIITQWCEGSSLYTHLHVQ----ETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFL 521 (678)
T ss_pred c---------------eeeeehhccCchhhhhccch----hhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEE
Confidence 3 28999999999999999862 3579999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
.++ ++|||+|||++....... +.......-|...|||||++.. ....+|++.+||||||+++||
T Consensus 522 ~~~-------~kVkIgDFGLatvk~~w~--------g~~q~~qp~gsilwmAPEvIRm-qd~nPfS~qSDVYaFGiV~YE 585 (678)
T KOG0193|consen 522 HED-------LKVKIGDFGLATVKTRWS--------GEQQLEQPHGSLLWMAPEVIRM-QDDNPFSFQSDVYAFGIVWYE 585 (678)
T ss_pred ccC-------CcEEEecccceeeeeeec--------cccccCCCccchhhhcHHHHhh-cccCCCCcccchhhhhHHHHH
Confidence 887 789999999996543221 1112223357889999999974 446789999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCC-CCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1043 LLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1043 LLtG~~Pf~~~~~~el~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
|++|..||......+++.++-+|.. +.... ....+++++++|+..||..++++||
T Consensus 586 Lltg~lPysi~~~dqIifmVGrG~l~pd~s~------------------------~~s~~pk~mk~Ll~~C~~~~~~eRP 641 (678)
T KOG0193|consen 586 LLTGELPYSIQNRDQIIFMVGRGYLMPDLSK------------------------IRSNCPKAMKRLLSDCWKFDREERP 641 (678)
T ss_pred HHhCcCCcCCCChhheEEEecccccCccchh------------------------hhccCHHHHHHHHHHHHhcCcccCc
Confidence 9999999996665555555444421 11110 1126788999999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001142 1122 TAGDLYEMFVARTS 1135 (1142)
Q Consensus 1122 Sa~EVL~~L~~~~s 1135 (1142)
.+.+|+..+.....
T Consensus 642 ~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 642 LFPQLLSKLEELLP 655 (678)
T ss_pred cHHHHHHHHHHhhh
Confidence 99999996665443
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=360.12 Aligned_cols=258 Identities=23% Similarity=0.289 Sum_probs=208.8
Q ss_pred CCCCCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeE
Q 001142 802 DPGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 879 (1142)
Q Consensus 802 ~~~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~ 879 (1142)
....+.+|++.+.||+|+||.||+|++. +..+|+|+...... ...... ..+.+|+.++++++||||+++++++
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~----~~~~~E~~~l~~l~hp~iv~~~~~~ 87 (329)
T PTZ00263 13 SSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREI-LKMKQV----QHVAQEKSILMELSHPFIVNMMCSF 87 (329)
T ss_pred CCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhhH----HHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 3445788999999999999999999984 56788888643211 011112 2347899999999999999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 001142 880 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959 (1142)
Q Consensus 880 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~N 959 (1142)
.+.+ +.++||||+++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|
T Consensus 88 ~~~~--------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~N 148 (329)
T PTZ00263 88 QDEN--------------RVYFLLEFVVGGELFTHLRK-----AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPEN 148 (329)
T ss_pred EcCC--------------EEEEEEcCCCCChHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHH
Confidence 8655 34999999999999999976 3468999999999999999999999999999999999
Q ss_pred eeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001142 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039 (1142)
Q Consensus 960 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGvi 1039 (1142)
||++.+ +.+||+|||++....... ....||+.|+|||++.+ ..++.++|||||||+
T Consensus 149 Ill~~~-------~~~kl~Dfg~~~~~~~~~-------------~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~i 204 (329)
T PTZ00263 149 LLLDNK-------GHVKVTDFGFAKKVPDRT-------------FTLCGTPEYLAPEVIQS----KGHGKAVDWWTMGVL 204 (329)
T ss_pred EEECCC-------CCEEEeeccCceEcCCCc-------------ceecCChhhcCHHHHcC----CCCCCcceeechHHH
Confidence 999887 789999999997543211 13468999999999876 457899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001142 1040 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1119 (1142)
Q Consensus 1040 L~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~ 1119 (1142)
+|+|++|..||.+....+....+..+..+ ++. ..+..+.+|+.+||+.||.+
T Consensus 205 l~elltg~~pf~~~~~~~~~~~i~~~~~~-~p~---------------------------~~~~~~~~li~~~L~~dP~~ 256 (329)
T PTZ00263 205 LYEFIAGYPPFFDDTPFRIYEKILAGRLK-FPN---------------------------WFDGRARDLVKGLLQTDHTK 256 (329)
T ss_pred HHHHHcCCCCCCCCCHHHHHHHHhcCCcC-CCC---------------------------CCCHHHHHHHHHHhhcCHHH
Confidence 99999999999887776666666543211 110 23456899999999999999
Q ss_pred CCC-----HHHHHHHHHhhcC
Q 001142 1120 RPT-----AGDLYEMFVARTS 1135 (1142)
Q Consensus 1120 RPS-----a~EVL~~L~~~~s 1135 (1142)
||+ +++++.|+|+...
T Consensus 257 R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 257 RLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred cCCCCCCCHHHHhcCCccCCC
Confidence 997 7999999999753
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=371.18 Aligned_cols=259 Identities=27% Similarity=0.341 Sum_probs=214.9
Q ss_pred CCCCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeE
Q 001142 803 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHK 879 (1142)
Q Consensus 803 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~g~~ 879 (1142)
...+++|.+.++||+|+||+|++|... +..+|+|+.+.... ...++.+.. +.|.+|+..+. ||.++.++..|
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~I-l~~d~Ve~~----~~EkrI~~la~~HPFL~~L~~~f 438 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDI-LQRDEVESL----MCEKRIFELANRHPFLVNLFSCF 438 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccce-eccccHHHH----HHHHHHHHHhccCCeEeeccccc
Confidence 556889999999999999999999984 55678887543322 223344443 78888888774 99999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 001142 880 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959 (1142)
Q Consensus 880 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~N 959 (1142)
.+.++ +|+||||+.||++..+++ ...|++..++.++..|+.||+|||++||||||||.+|
T Consensus 439 QT~~~--------------l~fvmey~~Ggdm~~~~~------~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdN 498 (694)
T KOG0694|consen 439 QTKEH--------------LFFVMEYVAGGDLMHHIH------TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDN 498 (694)
T ss_pred ccCCe--------------EEEEEEecCCCcEEEEEe------cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhh
Confidence 98764 499999999999544433 2579999999999999999999999999999999999
Q ss_pred eeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001142 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039 (1142)
Q Consensus 960 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGvi 1039 (1142)
||+|.+ |++||+|||+++..-.. .....+++|||.|||||++.+ ..|+.++|+|||||+
T Consensus 499 iLLD~e-------Gh~kiADFGlcKe~m~~----------g~~TsTfCGTpey~aPEil~e----~~Yt~aVDWW~lGVL 557 (694)
T KOG0694|consen 499 LLLDTE-------GHVKIADFGLCKEGMGQ----------GDRTSTFCGTPEFLAPEVLTE----QSYTRAVDWWGLGVL 557 (694)
T ss_pred eEEccc-------CcEEecccccccccCCC----------CCccccccCChhhcChhhhcc----CcccchhhHHHHHHH
Confidence 999998 99999999999753211 113357789999999999987 789999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001142 1040 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1119 (1142)
Q Consensus 1040 L~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~ 1119 (1142)
||||+.|+.||.+.++.++++.|........ ...+.+...|++++|..+|++
T Consensus 558 lyeML~Gq~PF~gddEee~FdsI~~d~~~yP----------------------------~~ls~ea~~il~~ll~k~p~k 609 (694)
T KOG0694|consen 558 LYEMLVGESPFPGDDEEEVFDSIVNDEVRYP----------------------------RFLSKEAIAIMRRLLRKNPEK 609 (694)
T ss_pred HHHHHcCCCCCCCCCHHHHHHHHhcCCCCCC----------------------------CcccHHHHHHHHHHhccCccc
Confidence 9999999999999999999999876543211 145667899999999999999
Q ss_pred CCC-----HHHHHHHHHhhcC
Q 001142 1120 RPT-----AGDLYEMFVARTS 1135 (1142)
Q Consensus 1120 RPS-----a~EVL~~L~~~~s 1135 (1142)
|.. +.+|.+|+||+.-
T Consensus 610 RLG~~e~d~~~i~~hpFFr~i 630 (694)
T KOG0694|consen 610 RLGSGERDAEDIKKHPFFRSI 630 (694)
T ss_pred ccCCCCCCchhhhhCCccccC
Confidence 974 6899999999864
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=346.52 Aligned_cols=281 Identities=24% Similarity=0.265 Sum_probs=201.4
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
++|++.+.||+|+||.||+|++. +..+|+|+..... ......+ .+.+|+.++++++||||+++++++..++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~--~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 73 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSE--ENEEVKE----TTLRELKMLRTLKQENIVELKEAFRRRG- 73 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccc--ccccchh----hHHHHHHHHHhCCCccccchhhhEecCC-
Confidence 36899999999999999999985 5567777754322 1111222 3378999999999999999999987654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
..++||||++++.+..+... ...+++..+..++.||+.||.|||+.||+||||||+||+++.
T Consensus 74 -------------~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~ 135 (287)
T cd07848 74 -------------KLYLVFEYVEKNMLELLEEM-----PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISH 135 (287)
T ss_pred -------------EEEEEEecCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC
Confidence 34999999997766544332 246899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||+|||++......... ......||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 136 ~-------~~~kl~Dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~DiwslGvil~el~ 195 (287)
T cd07848 136 N-------DVLKLCDFGFARNLSEGSNA---------NYTEYVATRWYRSPELLLG----APYGKAVDMWSVGCILGELS 195 (287)
T ss_pred C-------CcEEEeeccCcccccccccc---------cccccccccccCCcHHHcC----CCCCCchhHHhHHHHHHHHH
Confidence 7 78999999999765322111 1123468999999999875 45789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccccc---ccccccCCCCC-CchhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE---HEVAQSGSGFE-KPEAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~---~~~~~~~~~~~-~~~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
+|+.||.+.+..+....+.....+.............. ........... ........+..+.+|+.+||+.||++|
T Consensus 196 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R 275 (287)
T cd07848 196 DGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDR 275 (287)
T ss_pred hCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccC
Confidence 99999987665554434433222211111111000000 00000000000 000011356779999999999999999
Q ss_pred CCHHHHHHHHHh
Q 001142 1121 PTAGDLYEMFVA 1132 (1142)
Q Consensus 1121 PSa~EVL~~L~~ 1132 (1142)
||++|+++|+|+
T Consensus 276 ~s~~~~l~hp~f 287 (287)
T cd07848 276 YLTEQCLNHPAF 287 (287)
T ss_pred CCHHHHhcCCCC
Confidence 999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=334.71 Aligned_cols=267 Identities=23% Similarity=0.339 Sum_probs=220.6
Q ss_pred CCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISS 882 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~~~~ 882 (1142)
+..|.-.+.||.|..++|-++.+ .+...|+|+..+..+....+...++.....+|+.||+++ .||+|+++.++|+.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 55688889999999999998876 567788887655443333333555656668999999999 599999999999987
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
.++ ++|+|.|+.|.|.+++.. ...++++..++|++|+..|++|||.++||||||||+|||+
T Consensus 96 sF~--------------FlVFdl~prGELFDyLts-----~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILl 156 (411)
T KOG0599|consen 96 AFV--------------FLVFDLMPRGELFDYLTS-----KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILL 156 (411)
T ss_pred chh--------------hhhhhhcccchHHHHhhh-----heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheee
Confidence 765 999999999999999976 4679999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhcccc--CCCCCCchhhHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH--KPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~--~~~~~s~ksDVwSLGviL 1040 (1142)
+++ .++||+|||+|+.+....+ ....+|||+|.|||.+.... ....|+..+|+||.|||+
T Consensus 157 ddn-------~~i~isDFGFa~~l~~Gek-----------LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVIm 218 (411)
T KOG0599|consen 157 DDN-------MNIKISDFGFACQLEPGEK-----------LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIM 218 (411)
T ss_pred ccc-------cceEEeccceeeccCCchh-----------HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHH
Confidence 988 7899999999987765332 23457999999999987633 345689999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1041 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
|.|+.|++||......-+...|..|....-.. ++. +.+...++||.+||+.||.+|
T Consensus 219 yTLLaGcpPFwHRkQmlMLR~ImeGkyqF~sp-----------------------eWa-dis~~~KdLIsrlLqVdp~~R 274 (411)
T KOG0599|consen 219 YTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSP-----------------------EWA-DISATVKDLISRLLQVDPTKR 274 (411)
T ss_pred HHHHcCCCchhHHHHHHHHHHHHhcccccCCc-----------------------chh-hccccHHHHHHHHHeeCchhc
Confidence 99999999997655555667777776432221 111 567779999999999999999
Q ss_pred CCHHHHHHHHHhh
Q 001142 1121 PTAGDLYEMFVAR 1133 (1142)
Q Consensus 1121 PSa~EVL~~L~~~ 1133 (1142)
.|++|+|+|+|+.
T Consensus 275 itake~LaHpff~ 287 (411)
T KOG0599|consen 275 ITAKEALAHPFFI 287 (411)
T ss_pred ccHHHHhcChHHH
Confidence 9999999999994
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=344.42 Aligned_cols=290 Identities=19% Similarity=0.271 Sum_probs=216.6
Q ss_pred cceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCC
Q 001142 809 LSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 888 (1142)
Q Consensus 809 y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~~ 888 (1142)
|...+.||+|+||.|+.|.+..+...|+++++..........+ +..+|+.+|+.++|+||+.+++.+..+.
T Consensus 24 y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~ak----RtlRElklLr~~~HeNIi~l~di~~p~~----- 94 (359)
T KOG0660|consen 24 YVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAK----RTLRELKLLRHLRHENIIGLLDIFRPPS----- 94 (359)
T ss_pred ecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHH----HHHHHHHHHHHhcCCCcceEEeeccccc-----
Confidence 4557999999999999999865555555555543333333333 3479999999999999999999987521
Q ss_pred CCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecccccc
Q 001142 889 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 968 (1142)
Q Consensus 889 ~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~ 968 (1142)
.......|+|+|+|+ .+|...++. ...++...+..+++||++||.|+|+.+|+||||||.|+|++.+
T Consensus 95 ----~~~f~DvYiV~elMe-tDL~~iik~-----~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~--- 161 (359)
T KOG0660|consen 95 ----RDKFNDVYLVFELME-TDLHQIIKS-----QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNAD--- 161 (359)
T ss_pred ----ccccceeEEehhHHh-hHHHHHHHc-----CccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccC---
Confidence 123346799999995 899999986 3459999999999999999999999999999999999999988
Q ss_pred CCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCC
Q 001142 969 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV 1048 (1142)
Q Consensus 969 ~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~ 1048 (1142)
..+||+|||+|+........ .--...+.|.+|+|||++.. ...|+.++||||.|||+.||++|++
T Consensus 162 ----c~lKI~DFGLAR~~~~~~~~--------~~mTeYVaTRWYRAPElll~---~~~Yt~aiDiWSvGCI~AEmL~gkp 226 (359)
T KOG0660|consen 162 ----CDLKICDFGLARYLDKFFED--------GFMTEYVATRWYRAPELLLN---SSEYTKAIDIWSVGCILAEMLTGKP 226 (359)
T ss_pred ----CCEEeccccceeeccccCcc--------cchhcceeeeeecCHHHHhc---cccccchhhhhhhhHHHHHHHcCCC
Confidence 78999999999876542111 01124568999999999876 4689999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCC---CchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001142 1049 PYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE---KPEAELETLSFLVDVFRRCTEENPTERPTAGD 1125 (1142)
Q Consensus 1049 Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~E 1125 (1142)
.|.|.+..+....|......+-...+..+.........+...... ....-....+...+|+.+||..||.+|+|++|
T Consensus 227 lFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~e 306 (359)
T KOG0660|consen 227 LFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEE 306 (359)
T ss_pred CCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHH
Confidence 999988877777774443333333333332111111111111111 11111256778999999999999999999999
Q ss_pred HHHHHHhhcC
Q 001142 1126 LYEMFVARTS 1135 (1142)
Q Consensus 1126 VL~~L~~~~s 1135 (1142)
+|+||++..-
T Consensus 307 AL~hPYl~~~ 316 (359)
T KOG0660|consen 307 ALAHPYLAPY 316 (359)
T ss_pred HhcChhhhhh
Confidence 9999998754
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=356.48 Aligned_cols=249 Identities=25% Similarity=0.348 Sum_probs=199.3
Q ss_pred eeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCCC
Q 001142 813 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADG 890 (1142)
Q Consensus 813 ~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~~~~ 890 (1142)
+.||+|+||.||+|++ .+..+|+|+.+..... ...... .+.+|+.++++++||||+++++++...+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~----~~~~e~~~l~~l~hp~i~~~~~~~~~~~------- 68 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVII-AKDEVA----HTLTESRVLQNTRHPFLTALKYSFQTHD------- 68 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhHHHH----HHHHHHHHHHhCCCCCCCCEEEEEEcCC-------
Confidence 4799999999999987 4667888886532211 111222 3378999999999999999999988655
Q ss_pred CCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccCC
Q 001142 891 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 970 (1142)
Q Consensus 891 ~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~~ 970 (1142)
..++||||+++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 69 -------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~----- 131 (323)
T cd05571 69 -------RLCFVMEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKD----- 131 (323)
T ss_pred -------EEEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC-----
Confidence 34999999999999999875 3468999999999999999999999999999999999999887
Q ss_pred CCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 001142 971 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1050 (1142)
Q Consensus 971 ~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~Pf 1050 (1142)
+.+||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 132 --~~~kl~DfG~a~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~il~elltg~~Pf 195 (323)
T cd05571 132 --GHIKITDFGLCKEGISDG----------ATMKTFCGTPEYLAPEVLED----NDYGRAVDWWGLGVVMYEMMCGRLPF 195 (323)
T ss_pred --CCEEEeeCCCCcccccCC----------CcccceecCccccChhhhcC----CCCCccccCcccchhhhhhhcCCCCC
Confidence 789999999986432111 11123469999999999875 56889999999999999999999999
Q ss_pred CCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----CHHH
Q 001142 1051 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-----TAGD 1125 (1142)
Q Consensus 1051 ~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP-----Sa~E 1125 (1142)
.+.+.......+..... .++ ...++.+.+++.+||+.||++|| ++.+
T Consensus 196 ~~~~~~~~~~~~~~~~~-~~p---------------------------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ 247 (323)
T cd05571 196 YNQDHEKLFELILMEEI-RFP---------------------------RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKE 247 (323)
T ss_pred CCCCHHHHHHHHHcCCC-CCC---------------------------CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHH
Confidence 87766665555433221 110 13456789999999999999999 8999
Q ss_pred HHHHHHhhc
Q 001142 1126 LYEMFVART 1134 (1142)
Q Consensus 1126 VL~~L~~~~ 1134 (1142)
+++|+|+..
T Consensus 248 ll~h~~f~~ 256 (323)
T cd05571 248 IMEHRFFAS 256 (323)
T ss_pred HHcCCCcCC
Confidence 999999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=350.67 Aligned_cols=292 Identities=20% Similarity=0.230 Sum_probs=204.8
Q ss_pred CcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
+|++.++||+|+||.||+|.+. +..+|+|..... ......... +.+|+.++++++||||+++++++......
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~----~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 74 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDV--FEHVSDATR----ILREIKLLRLLRHPDIVEIKHIMLPPSRR 74 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechh--hccchhHHH----HHHHHHHHHhCCCCCEeeecceEeccCCC
Confidence 4899999999999999999874 567788764322 111122223 37899999999999999999988653211
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
.....|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 75 ---------~~~~~~lv~e~~~-~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~ 139 (338)
T cd07859 75 ---------EFKDIYVVFELME-SDLHQVIKA-----NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANAD 139 (338)
T ss_pred ---------CCceEEEEEecCC-CCHHHHHHh-----cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC
Confidence 1235699999995 799998875 2468999999999999999999999999999999999999887
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+.+||+|||+++........ ........||+.|+|||++.+. ...++.++|||||||++|+|++
T Consensus 140 -------~~~kL~Dfg~~~~~~~~~~~-------~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~~DvwSlGvvl~el~t 203 (338)
T cd07859 140 -------CKLKICDFGLARVAFNDTPT-------AIFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAEVLT 203 (338)
T ss_pred -------CcEEEccCccccccccccCc-------cccccCCCCCCCcCCHHHHhcc--ccccCchhHHHHHHHHHHHHHc
Confidence 78999999999754321111 0011234689999999998642 1467899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccc---cccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1046 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEV---AQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1046 G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
|+.||.+.+.......+....................... ................++.+.+++.+||+.||++|||
T Consensus 204 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt 283 (338)
T cd07859 204 GKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPT 283 (338)
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCC
Confidence 9999987665544433322111111111111100000000 0000000000001134567899999999999999999
Q ss_pred HHHHHHHHHhhcCC
Q 001142 1123 AGDLYEMFVARTSS 1136 (1142)
Q Consensus 1123 a~EVL~~L~~~~ss 1136 (1142)
++|+++|+|+....
T Consensus 284 ~~e~l~hp~f~~~~ 297 (338)
T cd07859 284 AEEALADPYFKGLA 297 (338)
T ss_pred HHHHhcCchhhhcC
Confidence 99999999997543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=358.82 Aligned_cols=258 Identities=20% Similarity=0.280 Sum_probs=207.6
Q ss_pred CCCCCCcceeeeecccCceEEEEEEECC---ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeE
Q 001142 803 PGSFPSLSSCDEAGKSVSSSLFRCKFGS---ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 879 (1142)
Q Consensus 803 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~~---~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~ 879 (1142)
...+++|++.+.||+|+||.||+|.+.. ..+|+|+...... ......+. +.+|+.+++.++||||+++++++
T Consensus 26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~-~~~~~~~~----~~~E~~~l~~l~hp~Iv~~~~~~ 100 (340)
T PTZ00426 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKI-IKQKQVDH----VFSERKILNYINHPFCVNLYGSF 100 (340)
T ss_pred CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHh-hhhhhHHH----HHHHHHHHHhCCCCCCcceEEEE
Confidence 4567789999999999999999998643 4578887543211 11122223 37899999999999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 001142 880 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959 (1142)
Q Consensus 880 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~N 959 (1142)
.+.. ..++||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|
T Consensus 101 ~~~~--------------~~~lv~Ey~~~g~L~~~i~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~N 161 (340)
T PTZ00426 101 KDES--------------YLYLVLEFVIGGEFFTFLRR-----NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPEN 161 (340)
T ss_pred EeCC--------------EEEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHH
Confidence 8655 35999999999999999976 3468999999999999999999999999999999999
Q ss_pred eeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001142 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039 (1142)
Q Consensus 960 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGvi 1039 (1142)
||++.+ +.+||+|||++...... .....||+.|+|||++.+ ..++.++|||||||+
T Consensus 162 ILl~~~-------~~ikL~DFG~a~~~~~~-------------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlGvi 217 (340)
T PTZ00426 162 LLLDKD-------GFIKMTDFGFAKVVDTR-------------TYTLCGTPEYIAPEILLN----VGHGKAADWWTLGIF 217 (340)
T ss_pred EEECCC-------CCEEEecCCCCeecCCC-------------cceecCChhhcCHHHHhC----CCCCccccccchhhH
Confidence 999877 78999999999754321 113468999999999875 557899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001142 1040 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1119 (1142)
Q Consensus 1040 L~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~ 1119 (1142)
+|||++|..||.+.+.......+..+... .+ ...++.+.+++.+||+.||++
T Consensus 218 l~ell~G~~Pf~~~~~~~~~~~i~~~~~~-~p---------------------------~~~~~~~~~li~~~l~~dp~~ 269 (340)
T PTZ00426 218 IYEILVGCPPFYANEPLLIYQKILEGIIY-FP---------------------------KFLDNNCKHLMKKLLSHDLTK 269 (340)
T ss_pred HHHHhcCCCCCCCCCHHHHHHHHhcCCCC-CC---------------------------CCCCHHHHHHHHHHcccCHHH
Confidence 99999999999987766666665443211 00 033456889999999999999
Q ss_pred CC-----CHHHHHHHHHhhcCC
Q 001142 1120 RP-----TAGDLYEMFVARTSS 1136 (1142)
Q Consensus 1120 RP-----Sa~EVL~~L~~~~ss 1136 (1142)
|+ +++++++|+|+....
T Consensus 270 R~~~~~~~~~~~~~hp~f~~~~ 291 (340)
T PTZ00426 270 RYGNLKKGAQNVKEHPWFGNID 291 (340)
T ss_pred cCCCCCCCHHHHHcCCCcCCCC
Confidence 95 999999999997643
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=341.02 Aligned_cols=299 Identities=21% Similarity=0.245 Sum_probs=222.8
Q ss_pred CCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCC-ccceeeeEecC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSC-IVEMYGHKISS 882 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpN-IVkl~g~~~~~ 882 (1142)
...|...++||+|+||+||+|+. .+..||+|..+++... +.......+|+.+++.++|+| ||.+++++.+.
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~------EG~P~taiREisllk~L~~~~~iv~L~dv~~~~ 83 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE------EGVPSTAIREISLLKRLSHANHIVRLHDVIHTS 83 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc------cCCCchhhHHHHHHHHhCCCcceEEEEeeeeec
Confidence 55688889999999999999997 5667888887766432 112233479999999999999 99999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
+.. .....+++||||++ .+|..++....... ..++...++.+++||+.||+|||+++|+||||||+||||
T Consensus 84 ~~~--------~~~~~l~lvfe~~d-~DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi 153 (323)
T KOG0594|consen 84 NNH--------RGIGKLYLVFEFLD-RDLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLI 153 (323)
T ss_pred ccc--------cccceEEEEEEeec-ccHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEE
Confidence 521 22335799999997 89999998743221 357779999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
+.+ +.+||+|||+|+........ ....++|..|+|||++.+ ...|+...||||+|||++|
T Consensus 154 ~~~-------G~lKlaDFGlAra~~ip~~~----------yt~evvTlWYRaPEvLlG---s~~Ys~~vDiWs~GcIfaE 213 (323)
T KOG0594|consen 154 SSS-------GVLKLADFGLARAFSIPMRT----------YTPEVVTLWYRAPEVLLG---STSYSTSVDIWSLGCIFAE 213 (323)
T ss_pred CCC-------CcEeeeccchHHHhcCCccc----------ccccEEEeeccCHHHhcC---CCcCCCCcchHhHHHHHHH
Confidence 987 89999999999865543222 234578999999999998 3469999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccc--cccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1043 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEH--EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1043 LLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
|+++++.|.+.++.+....|......+-...++........ .+.+...............+...+++.+||+.+|.+|
T Consensus 214 m~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R 293 (323)
T KOG0594|consen 214 MFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKR 293 (323)
T ss_pred HHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccC
Confidence 99999999998887777666433222222222222111111 1111110111111111223578999999999999999
Q ss_pred CCHHHHHHHHHhhcCCCCCC
Q 001142 1121 PTAGDLYEMFVARTSSSISS 1140 (1142)
Q Consensus 1121 PSa~EVL~~L~~~~ss~~s~ 1140 (1142)
.||+.++.|++|......++
T Consensus 294 ~Sa~~al~h~yf~~~~~~~~ 313 (323)
T KOG0594|consen 294 ISAKGALTHPYFSELPEKSS 313 (323)
T ss_pred cCHHHHhcChhhcccccchh
Confidence 99999999999987655443
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=346.33 Aligned_cols=261 Identities=22% Similarity=0.298 Sum_probs=200.0
Q ss_pred CcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
.|++.+.||+|+||.||+|.+ .+..+|+|+...+.... ... ...+.+|+.++++++|+||+++++++.+.+
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~----~~~~~~E~~il~~l~~~~iv~~~~~~~~~~-- 73 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKG----EAMALNEKRILEKVNSRFVVSLAYAYETKD-- 73 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhh-hhh----HHHHHHHHHHHHhcCCCcEEEEEEEEccCC--
Confidence 378899999999999999987 46778888754322111 111 123378999999999999999999987655
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
..++||||+++|+|.+++... ....+++..+..++.|++.||+|||++||+||||||+|||++.+
T Consensus 74 ------------~~~lv~e~~~~g~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~ 138 (285)
T cd05631 74 ------------ALCLVLTIMNGGDLKFHIYNM---GNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDR 138 (285)
T ss_pred ------------eEEEEEEecCCCcHHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC
Confidence 349999999999999888652 23468999999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+.++|+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 139 -------~~~kl~Dfg~~~~~~~~~-----------~~~~~~g~~~y~aPE~~~~----~~~~~~~DvwslGvil~el~~ 196 (285)
T cd05631 139 -------GHIRISDLGLAVQIPEGE-----------TVRGRVGTVGYMAPEVINN----EKYTFSPDWWGLGCLIYEMIQ 196 (285)
T ss_pred -------CCEEEeeCCCcEEcCCCC-----------eecCCCCCCCccCHhhhcC----CCCCcccCchhHHHHHHHHHh
Confidence 789999999987543211 1113468999999999975 568899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC---
Q 001142 1046 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT--- 1122 (1142)
Q Consensus 1046 G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS--- 1122 (1142)
|+.||.+.........+....... ... .....+..+.+|+.+||+.||.+||+
T Consensus 197 g~~pf~~~~~~~~~~~~~~~~~~~-------------------~~~-----~~~~~s~~~~~li~~~l~~~P~~R~~~~~ 252 (285)
T cd05631 197 GQSPFRKRKERVKREEVDRRVKED-------------------QEE-----YSEKFSEDAKSICRMLLTKNPKERLGCRG 252 (285)
T ss_pred CCCCCCCCCcchhHHHHHHHhhcc-------------------ccc-----CCccCCHHHHHHHHHHhhcCHHHhcCCCC
Confidence 999998654322222221100000 000 00134567899999999999999997
Q ss_pred --HHHHHHHHHhhcCC
Q 001142 1123 --AGDLYEMFVARTSS 1136 (1142)
Q Consensus 1123 --a~EVL~~L~~~~ss 1136 (1142)
++++++|+|+....
T Consensus 253 ~~~~~~~~h~~~~~~~ 268 (285)
T cd05631 253 NGAAGVKQHPIFKNIN 268 (285)
T ss_pred CCHHHHhcCHhhcCCC
Confidence 99999999997653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=325.35 Aligned_cols=263 Identities=22% Similarity=0.256 Sum_probs=219.0
Q ss_pred CCCCCCCcceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001142 802 DPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 881 (1142)
Q Consensus 802 ~~~~~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~ 881 (1142)
...++++|++++.||+|-||.||+|+.+.....|+++.+.+. .-...+.+.++.+|++|-..|+||||+++|++|.+
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKs---qi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd 93 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKS---QILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD 93 (281)
T ss_pred cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHH---HHHHhcchhhhhheeEeecccCCccHHhhhhheec
Confidence 345688999999999999999999998655544443333321 23334556677999999999999999999999998
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 001142 882 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 961 (1142)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NIL 961 (1142)
+... ||++||.++|+|...++. ....++++.....++.|+|.||.|+|..+||||||||+|+|
T Consensus 94 ~~ri--------------yLilEya~~gel~k~L~~---~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlL 156 (281)
T KOG0580|consen 94 SKRI--------------YLILEYAPRGELYKDLQE---GRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLL 156 (281)
T ss_pred ccee--------------EEEEEecCCchHHHHHHh---cccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhc
Confidence 7644 999999999999999985 34567999999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001142 962 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1041 (1142)
Q Consensus 962 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ 1041 (1142)
++.. +.+|++|||-+..... ....+.+||..|.+||+..+ ..++..+|+|++|++.|
T Consensus 157 lg~~-------~~lkiAdfGwsV~~p~------------~kR~tlcgt~dyl~pEmv~~----~~hd~~Vd~w~lgvl~y 213 (281)
T KOG0580|consen 157 LGSA-------GELKIADFGWSVHAPS------------NKRKTLCGTLDYLPPEMVEG----RGHDKFVDLWSLGVLCY 213 (281)
T ss_pred cCCC-------CCeeccCCCceeecCC------------CCceeeecccccCCHhhcCC----CCccchhhHHHHHHHHH
Confidence 9988 7899999999865331 13346789999999999876 67889999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1042 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1042 ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
|++.|.+||......+.+..|........ ...+...+++|.+|+..+|.+|.
T Consensus 214 eflvg~ppFes~~~~etYkrI~k~~~~~p----------------------------~~is~~a~dlI~~ll~~~p~~r~ 265 (281)
T KOG0580|consen 214 EFLVGLPPFESQSHSETYKRIRKVDLKFP----------------------------STISGGAADLISRLLVKNPIERL 265 (281)
T ss_pred HHHhcCCchhhhhhHHHHHHHHHccccCC----------------------------cccChhHHHHHHHHhccCccccc
Confidence 99999999998887788888765432110 15566799999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001142 1122 TAGDLYEMFVARTS 1135 (1142)
Q Consensus 1122 Sa~EVL~~L~~~~s 1135 (1142)
+..|+++|+|....
T Consensus 266 ~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 266 ALTEVMDHPWIVAN 279 (281)
T ss_pred cHHHHhhhHHHHhc
Confidence 99999999998643
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=363.94 Aligned_cols=289 Identities=19% Similarity=0.241 Sum_probs=204.4
Q ss_pred CCCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 882 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~ 882 (1142)
.-.+|++.++||+|+||.||+|.+ .+..+|+|..... . .. ..+|+.++++++|||||++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----~----~~----~~~Ei~il~~l~h~niv~l~~~~~~~ 131 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----P----QY----KNRELLIMKNLNHINIIFLKDYYYTE 131 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----c----ch----HHHHHHHHHhcCCCCCcceeeeEeec
Confidence 345799999999999999999997 4567788764211 0 01 14799999999999999999987653
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
... .......+++||||++ ++|.+++..... ....+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 132 ~~~------~~~~~~~l~lvmE~~~-~~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl 203 (440)
T PTZ00036 132 CFK------KNEKNIFLNVVMEFIP-QTVHKYMKHYAR-NNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLI 203 (440)
T ss_pred ccc------cCCCceEEEEEEecCC-ccHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEE
Confidence 211 1112335689999997 688888765322 23578999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
+.++ +.+||+|||+|+.+.... ......||+.|+|||++.+ ...|+.++|||||||++||
T Consensus 204 ~~~~------~~vkL~DFGla~~~~~~~-----------~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwSlGvil~e 263 (440)
T PTZ00036 204 DPNT------HTLKLCDFGSAKNLLAGQ-----------RSVSYICSRFYRAPELMLG---ATNYTTHIDLWSLGCIIAE 263 (440)
T ss_pred cCCC------CceeeeccccchhccCCC-----------CcccCCCCcCccCHHHhcC---CCCCCcHHHHHHHHHHHHH
Confidence 8652 479999999997653211 1113468999999999865 2468899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHH-hCCCCCchhHHhhhcc-cccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1043 LLTLQVPYMGLSELEIHDLIQ-MGKRPRLTDELEALGS-CHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1043 LLtG~~Pf~~~~~~el~~~I~-~~~~p~l~~~l~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
|++|.+||.+....+....+. ....+... .+..... .....+............+...++++.+||.+||+.||.+|
T Consensus 264 lltG~~pf~~~~~~~~~~~i~~~~~~p~~~-~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R 342 (440)
T PTZ00036 264 MILGYPIFSGQSSVDQLVRIIQVLGTPTED-QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKR 342 (440)
T ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCCHH-HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHC
Confidence 999999998876655444442 22222211 1111100 00000000000000000011345679999999999999999
Q ss_pred CCHHHHHHHHHhhc
Q 001142 1121 PTAGDLYEMFVART 1134 (1142)
Q Consensus 1121 PSa~EVL~~L~~~~ 1134 (1142)
||+.|+++|+|+..
T Consensus 343 ~ta~e~l~hp~f~~ 356 (440)
T PTZ00036 343 LNPIEALADPFFDD 356 (440)
T ss_pred cCHHHHhCChhHHh
Confidence 99999999999864
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=342.13 Aligned_cols=284 Identities=21% Similarity=0.232 Sum_probs=202.3
Q ss_pred CCcceeeeecccCceEEEEEEEC---CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC---CCCCccceeeeEe
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG---SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL---RHSCIVEMYGHKI 880 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~---~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L---~HpNIVkl~g~~~ 880 (1142)
.+|++.+.||+|+||.||+|++. +..+|+|+......... ....+ .+|+.+++.+ .||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~----~~e~~~l~~l~~~~hpniv~~~~~~~ 74 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG--MPLST----IREVAVLRHLETFEHPNVVRLFDVCT 74 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC--chHHH----HHHHHHHHhhcccCCCCcceEEEEEe
Confidence 36899999999999999999872 45688887654332111 11122 4677776665 6999999999886
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NI 960 (1142)
..... .....++||||++ ++|.+++.. .....+++..+..++.||+.||.|||++||+||||||+||
T Consensus 75 ~~~~~---------~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Ni 141 (290)
T cd07862 75 VSRTD---------RETKLTLVFEHVD-QDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNI 141 (290)
T ss_pred cccCC---------CCCcEEEEEccCC-CCHHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHE
Confidence 43210 1234699999997 799999875 2234589999999999999999999999999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
|++.+ +.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++
T Consensus 142 l~~~~-------~~~kl~Dfg~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~----~~~~~~~DiwslG~il 199 (290)
T cd07862 142 LVTSS-------GQIKLADFGLARIYSFQM-----------ALTSVVVTLWYRAPEVLLQ----SSYATPVDLWSVGCIF 199 (290)
T ss_pred EEcCC-------CCEEEccccceEeccCCc-----------ccccccccccccChHHHhC----CCCCCccchHHHHHHH
Confidence 99887 789999999987543211 1123468999999999865 5678999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1041 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
|||++|++||.+....+....+........+..+..........+ ...............++.+.+++.+||+.||++|
T Consensus 200 ~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 278 (290)
T cd07862 200 AEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAF-HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKR 278 (290)
T ss_pred HHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhc-cCCCCCCHHHHccCCCHHHHHHHHHHhccCchhc
Confidence 999999999998777666555533222211111111000000000 0000000011112456678999999999999999
Q ss_pred CCHHHHHHHHHh
Q 001142 1121 PTAGDLYEMFVA 1132 (1142)
Q Consensus 1121 PSa~EVL~~L~~ 1132 (1142)
||+.|+++|+|+
T Consensus 279 ~s~~~~l~hp~f 290 (290)
T cd07862 279 ISAYSALSHPYF 290 (290)
T ss_pred CCHHHHhcCCCC
Confidence 999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=347.30 Aligned_cols=281 Identities=23% Similarity=0.296 Sum_probs=204.2
Q ss_pred CCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
.++|++.+.||+|+||.||+|++. +..+|+|+..... ..... ..+.+|++++++++||||+++++++...+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI---KPAIR----NQIIRELQVLHECNSPYIVGFYGAFYSDG 76 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHHH----HHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 457999999999999999999985 5567777754321 12222 33489999999999999999999987654
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCeee
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENILI 962 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~-gIvHrDLKp~NILl 962 (1142)
..++||||+++++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||+
T Consensus 77 --------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~ 137 (331)
T cd06649 77 --------------EISICMEHMDGGSLDQVLKE-----AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILV 137 (331)
T ss_pred --------------EEEEEeecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEE
Confidence 35999999999999999976 24689999999999999999999986 69999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
+.+ +.+||+|||++....... .....||+.|+|||++.+ ..++.++|||||||++||
T Consensus 138 ~~~-------~~~kl~Dfg~~~~~~~~~------------~~~~~g~~~y~aPE~~~~----~~~~~~~DiwslG~il~e 194 (331)
T cd06649 138 NSR-------GEIKLCDFGVSGQLIDSM------------ANSFVGTRSYMSPERLQG----THYSVQSDIWSMGLSLVE 194 (331)
T ss_pred cCC-------CcEEEccCcccccccccc------------cccCCCCcCcCCHhHhcC----CCCCchHhHHHHHHHHHH
Confidence 887 789999999986543211 123468999999999875 568899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCc---hhHHhhhccccccccc----------------c-cCCCCCCchhhhhhH
Q 001142 1043 LLTLQVPYMGLSELEIHDLIQMGKRPRL---TDELEALGSCHEHEVA----------------Q-SGSGFEKPEAELETL 1102 (1142)
Q Consensus 1043 LLtG~~Pf~~~~~~el~~~I~~~~~p~l---~~~l~~~~~~~~~~~~----------------~-~~~~~~~~~~~~~~~ 1102 (1142)
|++|+.||......++...+........ ................ . ..............+
T Consensus 195 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (331)
T cd06649 195 LAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFT 274 (331)
T ss_pred HHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCcccc
Confidence 9999999987665554333221100000 0000000000000000 0 000000000011356
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001142 1103 SFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1103 ~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~~s 1135 (1142)
+++.+|+.+||+.||++|||+.|+++|+|++..
T Consensus 275 ~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 275 PDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 789999999999999999999999999998754
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=344.24 Aligned_cols=285 Identities=19% Similarity=0.260 Sum_probs=201.6
Q ss_pred CCCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 882 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~ 882 (1142)
..++|++.+.||+|+||.||+|++ .+..+|+|+...... ... .. .+.+|+.+++.++||||+++++++.+.
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~-~~----~~~~E~~~l~~l~h~niv~~~~~~~~~ 75 (303)
T cd07869 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGT-PF----TAIREASLLKGLKHANIVLLHDIIHTK 75 (303)
T ss_pred ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--ccc-ch----hHHHHHHHHhhCCCCCcCeEEEEEecC
Confidence 456899999999999999999998 466788887643321 111 11 236899999999999999999998865
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
. ..++||||++ ++|.+++.. ....+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 76 ~--------------~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill 136 (303)
T cd07869 76 E--------------TLTLVFEYVH-TDLCQYMDK----HPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLI 136 (303)
T ss_pred C--------------eEEEEEECCC-cCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence 4 3499999996 788888765 12458899999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
+.+ +.+||+|||++........ ......||+.|+|||++.+ ...++.++|||||||++|+
T Consensus 137 ~~~-------~~~kl~Dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~il~~ 196 (303)
T cd07869 137 SDT-------GELKLADFGLARAKSVPSH----------TYSNEVVTLWYRPPDVLLG---STEYSTCLDMWGVGCIFVE 196 (303)
T ss_pred CCC-------CCEEECCCCcceeccCCCc----------cCCCCcccCCCCChHHHcC---CCCCCcHHHHHHHHHHHHH
Confidence 877 7899999999865332111 1123458999999999865 2457889999999999999
Q ss_pred HHhCCCCCCCCCHH-HHHHHHHh-CCCCCchhHHhhh---cccccccccccC-CCCCCchhhhhhHHHHHHHHHHhcccC
Q 001142 1043 LLTLQVPYMGLSEL-EIHDLIQM-GKRPRLTDELEAL---GSCHEHEVAQSG-SGFEKPEAELETLSFLVDVFRRCTEEN 1116 (1142)
Q Consensus 1043 LLtG~~Pf~~~~~~-el~~~I~~-~~~p~l~~~l~~~---~~~~~~~~~~~~-~~~~~~~~~~~~~~~L~dLI~~CL~~D 1116 (1142)
|++|+.||.+.... +....+.. ...+.. ..+... ............ ............++.+.+++.+||+.|
T Consensus 197 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d 275 (303)
T cd07869 197 MIQGVAAFPGMKDIQDQLERIFLVLGTPNE-DTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCF 275 (303)
T ss_pred HHhCCCCCCCCccHHHHHHHHHHHhCCCCh-hhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccC
Confidence 99999999864332 22222211 111110 000000 000000000000 000000000123467889999999999
Q ss_pred CCCCCCHHHHHHHHHhhcCC
Q 001142 1117 PTERPTAGDLYEMFVARTSS 1136 (1142)
Q Consensus 1117 P~~RPSa~EVL~~L~~~~ss 1136 (1142)
|++|||+.|+++|+|++.-.
T Consensus 276 p~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 276 PKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred chhccCHHHHhcCcccccCC
Confidence 99999999999999998643
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=352.31 Aligned_cols=260 Identities=23% Similarity=0.319 Sum_probs=207.1
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
.+|++.+.||+|+||.||+|++. +..+|+|+....... ..... ..+.+|+.++..++||||+++++++.+.+
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~----~~~~~e~~~l~~~~h~~iv~~~~~~~~~~- 74 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLF-KLNEV----RHVLTERDILTTTKSEWLVKLLYAFQDDE- 74 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhHH----HHHHHHHHHHHhCCCCCCccEEEEEEcCC-
Confidence 36899999999999999999984 567888886533211 11122 23478999999999999999999988654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
..|+||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~e~~~g~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~ 136 (333)
T cd05600 75 -------------YLYLAMEYVPGGDFRTLLNN-----LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDA 136 (333)
T ss_pred -------------EEEEEEeCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC
Confidence 35999999999999999975 346899999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||+|||++..... ......||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 137 ~-------~~~kL~Dfg~a~~~~~-------------~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~ell 192 (333)
T cd05600 137 S-------GHIKLTDFGLSKGIVT-------------YANSVVGSPDYMAPEVLRG----KGYDFTVDYWSLGCMLYEFL 192 (333)
T ss_pred C-------CCEEEEeCcCCccccc-------------ccCCcccCccccChhHhcC----CCCCCccceecchHHHhhhh
Confidence 7 7899999999975432 1123468999999999876 47889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCC-CchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRP-RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p-~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
+|..||.+.+..+....+...... ..+. ........++.+.+++.+||..+|.+||++
T Consensus 193 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~---------------------~~~~~~~~s~~~~~li~~~l~~~~~rr~s~ 251 (333)
T cd05600 193 CGFPPFSGSTPNETWENLKYWKETLQRPV---------------------YDDPRFNLSDEAWDLITKLINDPSRRFGSL 251 (333)
T ss_pred hCCCCCCCCCHHHHHHHHHhccccccCCC---------------------CCccccccCHHHHHHHHHHhhChhhhcCCH
Confidence 999999987776666555332110 0000 000001446679999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 001142 1124 GDLYEMFVARTS 1135 (1142)
Q Consensus 1124 ~EVL~~L~~~~s 1135 (1142)
.++++|+|+...
T Consensus 252 ~~ll~h~~~~~~ 263 (333)
T cd05600 252 EDIKNHPFFKEV 263 (333)
T ss_pred HHHHhCcccCCC
Confidence 999999998753
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=349.51 Aligned_cols=262 Identities=23% Similarity=0.357 Sum_probs=197.4
Q ss_pred CCCcceeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceee
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYG 877 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~-------~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g 877 (1142)
-++|++.++||+|+||.||+|.+. +..||+|+.+.. ......+.+ .+|+.++.++ +|||||++++
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~----~~E~~~l~~l~~h~niv~~~~ 78 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG---ATASEHKAL----MSELKILIHIGNHLNVVNLLG 78 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc---cchHHHHHH----HHHHHHHHHhccCcceeeEEe
Confidence 357999999999999999999752 246788875321 122223333 7999999999 8999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc------------------------------------
Q 001142 878 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET------------------------------------ 921 (1142)
Q Consensus 878 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~------------------------------------ 921 (1142)
++...+. ..++||||+++|+|.+++......
T Consensus 79 ~~~~~~~-------------~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (338)
T cd05102 79 ACTKPNG-------------PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVL 145 (338)
T ss_pred EecCCCC-------------ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCcc
Confidence 8765321 358999999999999999752110
Q ss_pred ---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccCCCCCeEEEeec
Q 001142 922 ---------------------GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF 980 (1142)
Q Consensus 922 ---------------------~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DF 980 (1142)
...++++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+||
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~-------~~~kl~Df 218 (338)
T cd05102 146 FSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSEN-------NVVKICDF 218 (338)
T ss_pred ccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCC-------CcEEEeec
Confidence 01357888999999999999999999999999999999999877 78999999
Q ss_pred CCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH-H
Q 001142 981 DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELE-I 1058 (1142)
Q Consensus 981 GlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt-G~~Pf~~~~~~e-l 1058 (1142)
|+++........ .......+++.|+|||++.+ ..++.++|||||||++|||++ |..||.+....+ .
T Consensus 219 G~a~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~ 286 (338)
T cd05102 219 GLARDIYKDPDY--------VRKGSARLPLKWMAPESIFD----KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF 286 (338)
T ss_pred ccccccccCcch--------hcccCCCCCccccCcHHhhc----CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHH
Confidence 999754321110 01123346788999999875 568899999999999999997 999998654322 2
Q ss_pred HHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001142 1059 HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1059 ~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~ 1133 (1142)
...+..+..+..+ ...++.+.+++.+||+.||.+|||+.|+++.+...
T Consensus 287 ~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 287 CQRLKDGTRMRAP---------------------------ENATPEIYRIMLACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred HHHHhcCCCCCCC---------------------------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 3333322221111 13456789999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=353.92 Aligned_cols=269 Identities=20% Similarity=0.216 Sum_probs=202.3
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
++|++.+.||+|+||+||+|.+. +..+|+|+...... ........+.+|+.++.+++||||+++++.+.+..
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~- 74 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADM-----LEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKL- 74 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHH-----HHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCC-
Confidence 47899999999999999999874 56788888642211 01111233478999999999999999999988655
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
..|+||||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~ 136 (363)
T cd05628 75 -------------NLYLIMEFLPGGDMMTLLMK-----KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDS 136 (363)
T ss_pred -------------eEEEEEcCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECC
Confidence 34999999999999999975 346899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCccccccccccccccc-------------------------CCCCCCCCccCCCcccchhhhc
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH-------------------------RGIPAPDVCVGTPRWMAPEVLR 1019 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~-------------------------~~~~~~~~~~GT~~Y~APE~l~ 1019 (1142)
+ +.+||+|||+++.+........... .........+||+.|+|||++.
T Consensus 137 ~-------~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~ 209 (363)
T cd05628 137 K-------GHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM 209 (363)
T ss_pred C-------CCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHc
Confidence 7 7899999999975432111000000 0000112347999999999987
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCchhHHhhhcccccccccccCCCCCCchhh
Q 001142 1020 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAE 1098 (1142)
Q Consensus 1020 ~~~~~~~~s~ksDVwSLGviL~ELLtG~~Pf~~~~~~el~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1142)
+ ..++.++|||||||++|||++|+.||.+....+....+..... ...+. .
T Consensus 210 ~----~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~-------------------------~ 260 (363)
T cd05628 210 Q----TGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPP-------------------------E 260 (363)
T ss_pred C----CCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCC-------------------------c
Confidence 6 5688999999999999999999999998777776666643221 11110 0
Q ss_pred hhhHHHHHHHHHHhcc--cCCCCCCCHHHHHHHHHhhcC
Q 001142 1099 LETLSFLVDVFRRCTE--ENPTERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1099 ~~~~~~L~dLI~~CL~--~DP~~RPSa~EVL~~L~~~~s 1135 (1142)
...++.+.+++.+|+. .++..||+++||++|+|+...
T Consensus 261 ~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~ 299 (363)
T cd05628 261 VPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGV 299 (363)
T ss_pred CCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCC
Confidence 1234568888888654 233356899999999999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=356.05 Aligned_cols=258 Identities=26% Similarity=0.322 Sum_probs=218.8
Q ss_pred CCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
.+.|...+++|+|+||.++++++ .+..+++|.+.+...... ..+. +.+|+.++++++|||||.+++.|.+++
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~--~r~~----A~~E~~lis~~~hP~iv~y~ds~~~~~ 76 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEP--ERRS----AIQEMDLLSKLLHPNIVEYKDSFEEDG 76 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCch--hhHH----HHHHHHHHHhccCCCeeeeccchhcCC
Confidence 46799999999999999999887 455677887666654332 2223 379999999999999999999998866
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
. ..+|||+||+||++.+.|.+. ....++++.+..|+.|++.|++|||+++|+|||||+.|||++
T Consensus 77 ~-------------~l~Ivm~Y~eGg~l~~~i~~~---k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Niflt 140 (426)
T KOG0589|consen 77 Q-------------LLCIVMEYCEGGDLAQLIKEQ---KGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLT 140 (426)
T ss_pred c-------------eEEEEEeecCCCCHHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcc
Confidence 4 259999999999999999873 246799999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ ..|+|+|||+|+.+..... .....+||+.||.||++.+ .+|+.|+|||||||++|||
T Consensus 141 k~-------~~VkLgDfGlaK~l~~~~~----------~a~tvvGTp~YmcPEil~d----~pYn~KSDiWsLGC~~yEm 199 (426)
T KOG0589|consen 141 KD-------KKVKLGDFGLAKILNPEDS----------LASTVVGTPYYMCPEILSD----IPYNEKSDIWSLGCCLYEM 199 (426)
T ss_pred cc-------CceeecchhhhhhcCCchh----------hhheecCCCcccCHHHhCC----CCCCccCcchhhcchHHHH
Confidence 88 6789999999998765321 1235789999999999987 7899999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
++-+++|.+.+...+...|..+...+++. .++.+++.++..||+.+|..||++
T Consensus 200 ~~lk~aF~a~~m~~Li~ki~~~~~~Plp~---------------------------~ys~el~~lv~~~l~~~P~~RPsa 252 (426)
T KOG0589|consen 200 CTLKPAFKASNMSELILKINRGLYSPLPS---------------------------MYSSELRSLVKSMLRKNPEHRPSA 252 (426)
T ss_pred HhcccccCccchHHHHHHHhhccCCCCCc---------------------------cccHHHHHHHHHHhhcCCccCCCH
Confidence 99999999988888888886665433332 566779999999999999999999
Q ss_pred HHHHHHHHhh
Q 001142 1124 GDLYEMFVAR 1133 (1142)
Q Consensus 1124 ~EVL~~L~~~ 1133 (1142)
.++|.++...
T Consensus 253 ~~LL~~P~l~ 262 (426)
T KOG0589|consen 253 LELLRRPHLL 262 (426)
T ss_pred HHHhhChhhh
Confidence 9999987654
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=340.76 Aligned_cols=275 Identities=25% Similarity=0.305 Sum_probs=218.8
Q ss_pred CCCCCcceeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001142 804 GSFPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 881 (1142)
Q Consensus 804 ~~~~~y~l~~~LG~GsfG~Vy~a~~~~--~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~ 881 (1142)
..+..|++.++||+|.-|+||+|+..+ ...|+||. ++.. -..+.-..+++.|-+||+.+.||.++.+|+.|+.
T Consensus 74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVm--dK~~---l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet 148 (459)
T KOG0610|consen 74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVM--DKES---LASRKKLKRAQTEREILSLLDHPFLPTLYASFET 148 (459)
T ss_pred cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEe--cHHH---HhhhhHHHHHHHHHHHHHhcCCCccchhhheeec
Confidence 345678999999999999999999866 56777774 3221 1112223456789999999999999999999998
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 001142 882 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 961 (1142)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NIL 961 (1142)
+++. |+|||||+||+|..+.++ +....+++..++.++..|+.||+|||-.|||+|||||+|||
T Consensus 149 ~~~~--------------cl~meyCpGGdL~~Lrqk---Qp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENIL 211 (459)
T KOG0610|consen 149 DKYS--------------CLVMEYCPGGDLHSLRQK---QPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENIL 211 (459)
T ss_pred ccee--------------EEEEecCCCccHHHHHhh---CCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeE
Confidence 8755 999999999999999987 55678999999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCCccccccccc---------------------cc-------c-c-----------------
Q 001142 962 IDLERKKADGKPVVKLCDFDRAVPLRSFLH---------------------TC-------C-I----------------- 995 (1142)
Q Consensus 962 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~---------------------~~-------~-~----------------- 995 (1142)
|.++ |++.|+||.++......-. .+ . .
T Consensus 212 vred-------GHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~ 284 (459)
T KOG0610|consen 212 VRED-------GHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELV 284 (459)
T ss_pred EecC-------CcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhh
Confidence 9888 9999999999864311000 00 0 0
Q ss_pred ccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHh
Q 001142 996 AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELE 1075 (1142)
Q Consensus 996 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~ 1075 (1142)
++........++||-.|.|||++.+ ...+.++|+|+|||++|||+.|+.||.+.+..+.+..|..... .++.
T Consensus 285 aep~~~RSnSFVGThEYlAPEvI~G----~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l-~Fp~--- 356 (459)
T KOG0610|consen 285 AEPTGARSNSFVGTHEYLAPEVIRG----EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPL-KFPE--- 356 (459)
T ss_pred cCCCCccccccccccccccceeeec----CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCC-cCCC---
Confidence 0011123456799999999999997 5678999999999999999999999999888877766643221 1110
Q ss_pred hhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC----HHHHHHHHHhhcCCC
Q 001142 1076 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT----AGDLYEMFVARTSSS 1137 (1142)
Q Consensus 1076 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS----a~EVL~~L~~~~ss~ 1137 (1142)
. ...+..++|||+++|.+||.+|.. |.||-+|+||+.--|
T Consensus 357 ---------------------~-~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnW 400 (459)
T KOG0610|consen 357 ---------------------E-PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNW 400 (459)
T ss_pred ---------------------C-CcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCCh
Confidence 0 145667999999999999999998 999999999987654
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=354.88 Aligned_cols=268 Identities=21% Similarity=0.254 Sum_probs=205.1
Q ss_pred CCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
++|++.+.||+|+||+||+|++ .+..+|+|+....... ..... ..+.+|+.++..++||||+++++++.+..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~- 74 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML-EKEQV----AHVRAERDILAEADNPWVVKLYYSFQDEN- 74 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHH----HHHHHHHHHHHhCCCCCCcceEEEEEcCC-
Confidence 4789999999999999999998 4667888886532111 11112 23478999999999999999999998755
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
+.++||||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~E~~~~g~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~ 136 (364)
T cd05599 75 -------------YLYLIMEYLPGGDMMTLLMK-----KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDA 136 (364)
T ss_pred -------------eEEEEECCCCCcHHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECC
Confidence 34999999999999999875 346899999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccC----------------------------CCCCCCCccCCCcccchh
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHR----------------------------GIPAPDVCVGTPRWMAPE 1016 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~----------------------------~~~~~~~~~GT~~Y~APE 1016 (1142)
+ +.++|+|||++..+............ ........+||+.|+|||
T Consensus 137 ~-------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 209 (364)
T cd05599 137 K-------GHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPE 209 (364)
T ss_pred C-------CCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHH
Confidence 7 78999999998754321110000000 000011246999999999
Q ss_pred hhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CchhHHhhhcccccccccccCCCCCCc
Q 001142 1017 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRP-RLTDELEALGSCHEHEVAQSGSGFEKP 1095 (1142)
Q Consensus 1017 ~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~Pf~~~~~~el~~~I~~~~~p-~l~~~l~~~~~~~~~~~~~~~~~~~~~ 1095 (1142)
++.. ..++.++|||||||++|||++|..||.+.+..+....+...... ..+.
T Consensus 210 ~~~~----~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~----------------------- 262 (364)
T cd05599 210 VFLQ----TGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPD----------------------- 262 (364)
T ss_pred HHcC----CCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCC-----------------------
Confidence 9875 56889999999999999999999999887776665555332210 0000
Q ss_pred hhhhhhHHHHHHHHHHhcccCCCCCCC---HHHHHHHHHhhcC
Q 001142 1096 EAELETLSFLVDVFRRCTEENPTERPT---AGDLYEMFVARTS 1135 (1142)
Q Consensus 1096 ~~~~~~~~~L~dLI~~CL~~DP~~RPS---a~EVL~~L~~~~s 1135 (1142)
....++.+.++|.+|+. +|.+|++ +.|+++|+|++..
T Consensus 263 --~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 263 --EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred --CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 01345678999999996 9999997 9999999998653
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=347.91 Aligned_cols=248 Identities=24% Similarity=0.297 Sum_probs=197.0
Q ss_pred ecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCCCCC
Q 001142 815 AGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 892 (1142)
Q Consensus 815 LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~~~~~~ 892 (1142)
||+|+||.||+|++. +..+|+|+...... ....... .+.+|+.++++++||||+++++++...+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~-~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~--------- 66 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHI-VSRSEVT----HTLAERTVLAQVNCPFIVPLKFSFQSPE--------- 66 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHH----HHHHHHHHHHhCCCCcEeceeeEEecCC---------
Confidence 799999999999984 55678887542211 1112222 3378999999999999999999987654
Q ss_pred ccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccCCCC
Q 001142 893 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 972 (1142)
Q Consensus 893 ~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~~~~ 972 (1142)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 67 -----~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~------- 129 (312)
T cd05585 67 -----KLYLVLAFINGGELFHHLQR-----EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQ------- 129 (312)
T ss_pred -----eEEEEEcCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCC-------
Confidence 34999999999999999875 3468999999999999999999999999999999999999877
Q ss_pred CeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 001142 973 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1052 (1142)
Q Consensus 973 ~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~Pf~~ 1052 (1142)
+.+||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+
T Consensus 130 ~~~kl~Dfg~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslGvil~el~tg~~pf~~ 195 (312)
T cd05585 130 GHIALCDFGLCKLNMKDD----------DKTNTFCGTPEYLAPELLLG----HGYTKAVDWWTLGVLLYEMLTGLPPFYD 195 (312)
T ss_pred CcEEEEECcccccCccCC----------CccccccCCcccCCHHHHcC----CCCCCccceechhHHHHHHHhCCCCcCC
Confidence 789999999986432211 11123468999999999876 5688999999999999999999999988
Q ss_pred CCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC---CHHHHHHH
Q 001142 1053 LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP---TAGDLYEM 1129 (1142)
Q Consensus 1053 ~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP---Sa~EVL~~ 1129 (1142)
....+....+..... .++ ...++.+.+++.+||+.||.+|| ++.|++.|
T Consensus 196 ~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 196 ENVNEMYRKILQEPL-RFP---------------------------DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CCHHHHHHHHHcCCC-CCC---------------------------CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 776666555443221 100 13456789999999999999997 68999999
Q ss_pred HHhhcC
Q 001142 1130 FVARTS 1135 (1142)
Q Consensus 1130 L~~~~s 1135 (1142)
+|+...
T Consensus 248 p~~~~~ 253 (312)
T cd05585 248 PFFSQL 253 (312)
T ss_pred CCcCCC
Confidence 998753
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=341.28 Aligned_cols=287 Identities=18% Similarity=0.237 Sum_probs=207.6
Q ss_pred CCCCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001142 803 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 880 (1142)
Q Consensus 803 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~ 880 (1142)
+..+++|++.++||+|+||.||+|++. +..+|+|..+.... . ..... +.+|+.++++++||||+++++++.
T Consensus 2 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~-~~~~~----~~~E~~~l~~l~h~~iv~~~~~~~ 74 (309)
T cd07872 2 FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--E-GAPCT----AIREVSLLKDLKHANIVTLHDIVH 74 (309)
T ss_pred CCCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--C-Ccchh----HHHHHHHHHhCCCCCcceEEEEEe
Confidence 345678999999999999999999874 55678887543321 1 11112 268999999999999999999988
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NI 960 (1142)
.++ ..++||||++ ++|.+++... ...+++..+..++.||+.||+|||++||+||||||+||
T Consensus 75 ~~~--------------~~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Ni 135 (309)
T cd07872 75 TDK--------------SLTLVFEYLD-KDLKQYMDDC----GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNL 135 (309)
T ss_pred eCC--------------eEEEEEeCCC-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 655 3499999997 5888887652 24588999999999999999999999999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
|++.+ +.+||+|||.+........ ......+|+.|+|||++.+ ...++.++|||||||++
T Consensus 136 ll~~~-------~~~kl~Dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~il 195 (309)
T cd07872 136 LINER-------GELKLADFGLARAKSVPTK----------TYSNEVVTLWYRPPDVLLG---SSEYSTQIDMWGVGCIF 195 (309)
T ss_pred EECCC-------CCEEECccccceecCCCcc----------ccccccccccccCCHHHhC---CCCCCcHHHHHHHHHHH
Confidence 99877 7899999999865432111 1123357899999999865 24578999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCC--chhhhhhHHHHHHHHHHhcccCCC
Q 001142 1041 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK--PEAELETLSFLVDVFRRCTEENPT 1118 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~L~dLI~~CL~~DP~ 1118 (1142)
|+|++|+.||.+.+..+....+...........+.................... .......++++.+++.+||+.||.
T Consensus 196 ~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~ 275 (309)
T cd07872 196 FEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESK 275 (309)
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChh
Confidence 999999999988776655544433222222211111100000000000000000 001113566789999999999999
Q ss_pred CCCCHHHHHHHHHhhcC
Q 001142 1119 ERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1119 ~RPSa~EVL~~L~~~~s 1135 (1142)
+|||+.|+++|+|++.-
T Consensus 276 ~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 276 KRISAEEAMKHAYFRSL 292 (309)
T ss_pred hCCCHHHHhcChhhhhc
Confidence 99999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=348.71 Aligned_cols=250 Identities=26% Similarity=0.324 Sum_probs=198.1
Q ss_pred eeecccCceEEEEEEE-----CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCC
Q 001142 813 DEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 887 (1142)
Q Consensus 813 ~~LG~GsfG~Vy~a~~-----~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~ 887 (1142)
++||+|+||.||+|+. .+..+|+|+............ ...+..|+.++++++||||+++++++..++
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~----~~~~~~E~~il~~l~hp~iv~~~~~~~~~~---- 73 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKD----TAHTKAERNILEAVKHPFIVDLIYAFQTGG---- 73 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhh----HHHHHHHHHHHHhCCCCchhceeeEEecCC----
Confidence 6899999999999986 356788888643211111111 123468999999999999999999988655
Q ss_pred CCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccc
Q 001142 888 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 967 (1142)
Q Consensus 888 ~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~ 967 (1142)
..|+||||+++++|.+++.. ...+.+..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 74 ----------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-- 136 (323)
T cd05584 74 ----------KLYLILEYLSGGELFMHLER-----EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQ-- 136 (323)
T ss_pred ----------eEEEEEeCCCCchHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC--
Confidence 34999999999999999875 3468889999999999999999999999999999999999887
Q ss_pred cCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCC
Q 001142 968 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 1047 (1142)
Q Consensus 968 ~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~ 1047 (1142)
+.+||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 137 -----~~~kl~Dfg~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~ell~G~ 197 (323)
T cd05584 137 -----GHVKLTDFGLCKESIHEG----------TVTHTFCGTIEYMAPEILMR----SGHGKAVDWWSLGALMYDMLTGA 197 (323)
T ss_pred -----CCEEEeeCcCCeecccCC----------CcccccCCCccccChhhccC----CCCCCcceecccHHHHHHHhcCC
Confidence 789999999986432111 01123468999999999875 45789999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----C
Q 001142 1048 VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-----T 1122 (1142)
Q Consensus 1048 ~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP-----S 1122 (1142)
.||.+.........+..+... ++ ...++.+.+++.+||+.||++|| +
T Consensus 198 ~pf~~~~~~~~~~~~~~~~~~-~~---------------------------~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 249 (323)
T cd05584 198 PPFTAENRKKTIDKILKGKLN-LP---------------------------PYLTPEARDLLKKLLKRNPSSRLGAGPGD 249 (323)
T ss_pred CCCCCCCHHHHHHHHHcCCCC-CC---------------------------CCCCHHHHHHHHHHcccCHhHcCCCCCCC
Confidence 999887766655555433211 10 13455689999999999999999 8
Q ss_pred HHHHHHHHHhhc
Q 001142 1123 AGDLYEMFVART 1134 (1142)
Q Consensus 1123 a~EVL~~L~~~~ 1134 (1142)
+.++++|+|+..
T Consensus 250 ~~~l~~h~~~~~ 261 (323)
T cd05584 250 AAEVQSHPFFRH 261 (323)
T ss_pred HHHHhcCCCcCC
Confidence 999999999864
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=349.80 Aligned_cols=249 Identities=24% Similarity=0.349 Sum_probs=197.9
Q ss_pred eeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCCC
Q 001142 813 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADG 890 (1142)
Q Consensus 813 ~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~~~~ 890 (1142)
+.||+|+||.||+|+. .+..+|+|+...... ....... .+.+|+.+++.++||||+++++++...+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-~~~~~~~----~~~~E~~~l~~l~hp~iv~~~~~~~~~~------- 68 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVI-IAKDEVA----HTLTESRVLKNTRHPFLTSLKYSFQTKD------- 68 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHH----HHHHHHHHHHhCCCCCCcceEEEEEcCC-------
Confidence 4799999999999987 466788888643221 1112222 3378999999999999999999988655
Q ss_pred CCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccCC
Q 001142 891 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 970 (1142)
Q Consensus 891 ~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~~ 970 (1142)
..++||||+++++|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 69 -------~~~lv~Ey~~~g~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~----- 131 (328)
T cd05593 69 -------RLCFVMEYVNGGELFFHLSR-----ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKD----- 131 (328)
T ss_pred -------EEEEEEeCCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCC-----
Confidence 34999999999999988865 3468999999999999999999999999999999999999877
Q ss_pred CCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 001142 971 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1050 (1142)
Q Consensus 971 ~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~Pf 1050 (1142)
+.+||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||
T Consensus 132 --~~~kL~DfG~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslGvil~elltG~~Pf 195 (328)
T cd05593 132 --GHIKITDFGLCKEGITDA----------ATMKTFCGTPEYLAPEVLED----NDYGRAVDWWGLGVVMYEMMCGRLPF 195 (328)
T ss_pred --CcEEEecCcCCccCCCcc----------cccccccCCcCccChhhhcC----CCCCccCCccccchHHHHHhhCCCCC
Confidence 789999999986432111 01123468999999999875 56789999999999999999999999
Q ss_pred CCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----CHHH
Q 001142 1051 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-----TAGD 1125 (1142)
Q Consensus 1051 ~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP-----Sa~E 1125 (1142)
.+.+..+....+..... .++ ...++.+.+++.+||+.||.+|| ++.|
T Consensus 196 ~~~~~~~~~~~~~~~~~-~~p---------------------------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ 247 (328)
T cd05593 196 YNQDHEKLFELILMEDI-KFP---------------------------RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKE 247 (328)
T ss_pred CCCCHHHHHHHhccCCc-cCC---------------------------CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHH
Confidence 87666655554432211 110 13456789999999999999997 8999
Q ss_pred HHHHHHhhc
Q 001142 1126 LYEMFVART 1134 (1142)
Q Consensus 1126 VL~~L~~~~ 1134 (1142)
+++|+|+..
T Consensus 248 il~h~~~~~ 256 (328)
T cd05593 248 IMRHSFFTG 256 (328)
T ss_pred HhcCCCcCC
Confidence 999999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=348.41 Aligned_cols=258 Identities=24% Similarity=0.271 Sum_probs=198.2
Q ss_pred CcceeeeecccCceEEEEEEE-----CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEec
Q 001142 808 SLSSCDEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 881 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~-----~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~~~ 881 (1142)
+|++.++||+|+||.||+|+. .+..+|+|+............. ..+.+|+.++.++ +||||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTV----EHTRTERNVLEHVRQSPFLVTLHYAFQT 76 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHH----HHHHHHHHHHHhccCCCCcccEEEEEec
Confidence 589999999999999999986 3567889886432111111112 2347899999999 49999999999876
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 001142 882 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 961 (1142)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NIL 961 (1142)
.+ ..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 77 ~~--------------~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil 137 (332)
T cd05614 77 EA--------------KLHLILDYVSGGEMFTHLYQ-----RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENIL 137 (332)
T ss_pred CC--------------EEEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeE
Confidence 54 34999999999999999875 346899999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001142 962 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1041 (1142)
Q Consensus 962 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ 1041 (1142)
++.+ +.+||+|||+++........ ......||+.|+|||++.+ ...++.++|||||||++|
T Consensus 138 i~~~-------~~~kl~DfG~~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~ 198 (332)
T cd05614 138 LDSE-------GHVVLTDFGLSKEFLSEEKE---------RTYSFCGTIEYMAPEIIRG---KGGHGKAVDWWSLGILIF 198 (332)
T ss_pred ECCC-------CCEEEeeCcCCccccccCCC---------ccccccCCccccCHHHhcC---CCCCCCccccccchhhhh
Confidence 9887 78999999998754321111 1123468999999999875 234678999999999999
Q ss_pred HHHhCCCCCCCCC----HHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001142 1042 ELLTLQVPYMGLS----ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1117 (1142)
Q Consensus 1042 ELLtG~~Pf~~~~----~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP 1117 (1142)
||++|+.||.... ...+...+.... +.++ ...++.+.+++.+||+.||
T Consensus 199 elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~---------------------------~~~~~~~~~li~~~l~~dp 250 (332)
T cd05614 199 ELLTGASPFTLEGERNTQSEVSRRILKCD-PPFP---------------------------SFIGPEAQDLLHKLLRKDP 250 (332)
T ss_pred hhhcCCCCCCCCCCCCCHHHHHHHHhcCC-CCCC---------------------------CCCCHHHHHHHHHHcCCCH
Confidence 9999999996432 122222222111 1100 1345668999999999999
Q ss_pred CCCC-----CHHHHHHHHHhhcC
Q 001142 1118 TERP-----TAGDLYEMFVARTS 1135 (1142)
Q Consensus 1118 ~~RP-----Sa~EVL~~L~~~~s 1135 (1142)
++|| +++++++|+|+...
T Consensus 251 ~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 251 KKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred HHcCCCCCCCHHHHHcCCCcCCC
Confidence 9999 88999999998753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=348.17 Aligned_cols=249 Identities=24% Similarity=0.350 Sum_probs=198.1
Q ss_pred eeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCCC
Q 001142 813 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADG 890 (1142)
Q Consensus 813 ~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~~~~ 890 (1142)
+.||+|+||.||+++. .+..+|+|+....... ...... .+.+|+.++++++||||+++++++...+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~----~~~~E~~~l~~l~hp~i~~~~~~~~~~~------- 68 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVII-AKDEVA----HTVTESRVLQNTRHPFLTALKYAFQTHD------- 68 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhHHHH----HHHHHHHHHHhCCCCCCcceeeEEecCC-------
Confidence 4799999999999987 4667888886533211 112222 2368999999999999999999988654
Q ss_pred CCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccCC
Q 001142 891 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 970 (1142)
Q Consensus 891 ~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~~ 970 (1142)
..++||||+++++|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 69 -------~~~lv~E~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~----- 131 (323)
T cd05595 69 -------RLCFVMEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD----- 131 (323)
T ss_pred -------EEEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCC-----
Confidence 34999999999999988865 3468999999999999999999999999999999999999887
Q ss_pred CCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 001142 971 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1050 (1142)
Q Consensus 971 ~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~Pf 1050 (1142)
+.+||+|||++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 132 --~~~kL~Dfg~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlGvil~ell~g~~Pf 195 (323)
T cd05595 132 --GHIKITDFGLCKEGISDG----------ATMKTFCGTPEYLAPEVLED----NDYGRAVDWWGLGVVMYEMMCGRLPF 195 (323)
T ss_pred --CCEEecccHHhccccCCC----------CccccccCCcCcCCcccccC----CCCCchhchhhhHHHHHHHHhCCCCC
Confidence 789999999986432111 01123468999999999875 56789999999999999999999999
Q ss_pred CCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----CHHH
Q 001142 1051 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-----TAGD 1125 (1142)
Q Consensus 1051 ~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP-----Sa~E 1125 (1142)
...+.......+..... .++ ...++.+.+++.+||+.||.+|| ++.+
T Consensus 196 ~~~~~~~~~~~~~~~~~-~~p---------------------------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ 247 (323)
T cd05595 196 YNQDHERLFELILMEEI-RFP---------------------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKE 247 (323)
T ss_pred CCCCHHHHHHHHhcCCC-CCC---------------------------CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHH
Confidence 87766665555432211 000 13456789999999999999998 9999
Q ss_pred HHHHHHhhc
Q 001142 1126 LYEMFVART 1134 (1142)
Q Consensus 1126 VL~~L~~~~ 1134 (1142)
+++|+|+..
T Consensus 248 ~l~h~~~~~ 256 (323)
T cd05595 248 VMEHRFFLS 256 (323)
T ss_pred HHcCCCcCC
Confidence 999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=354.09 Aligned_cols=248 Identities=26% Similarity=0.419 Sum_probs=202.8
Q ss_pred CCCCcceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
.|+...-.+-||.|+.|.||+|+..+..||||.++ +.+ ..+|.-|++|+||||+.|.|+|....
T Consensus 122 PFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~---------elk------ETdIKHLRkLkH~NII~FkGVCtqsP- 185 (904)
T KOG4721|consen 122 PFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVR---------ELK------ETDIKHLRKLKHPNIITFKGVCTQSP- 185 (904)
T ss_pred CHHHhhhhhhhccCcccceeeeeccCceehhHHHh---------hhh------hhhHHHHHhccCcceeeEeeeecCCc-
Confidence 34455566789999999999999999999988532 111 35788899999999999999998654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
.+|||||||+.|-|+.+++. ...++......|..+||.|+.|||.+.|||||||.-||||..
T Consensus 186 -------------cyCIiMEfCa~GqL~~VLka-----~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~ 247 (904)
T KOG4721|consen 186 -------------CYCIIMEFCAQGQLYEVLKA-----GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISY 247 (904)
T ss_pred -------------eeEEeeeccccccHHHHHhc-----cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeec
Confidence 44999999999999999986 457888999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ ..|||+|||-++...... ....++||..|||||++.. .+.+.|+||||||||||||+
T Consensus 248 ~-------d~VKIsDFGTS~e~~~~S-----------TkMSFaGTVaWMAPEvIrn----ePcsEKVDIwSfGVVLWEmL 305 (904)
T KOG4721|consen 248 D-------DVVKISDFGTSKELSDKS-----------TKMSFAGTVAWMAPEVIRN----EPCSEKVDIWSFGVVLWEML 305 (904)
T ss_pred c-------ceEEeccccchHhhhhhh-----------hhhhhhhhHhhhCHHHhhc----CCcccccceehhHHHHHHHH
Confidence 8 789999999998765532 2235789999999999987 67899999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~ 1124 (1142)
||..||.+.+... |.++.....- ....+..+++.++-|++.||+-.|..||++.
T Consensus 306 T~EiPYkdVdssA----IIwGVGsNsL----------------------~LpvPstcP~GfklL~Kqcw~sKpRNRPSFr 359 (904)
T KOG4721|consen 306 TGEIPYKDVDSSA----IIWGVGSNSL----------------------HLPVPSTCPDGFKLLLKQCWNSKPRNRPSFR 359 (904)
T ss_pred hcCCCccccchhe----eEEeccCCcc----------------------cccCcccCchHHHHHHHHHHhcCCCCCccHH
Confidence 9999998654332 2232221110 0001126778899999999999999999999
Q ss_pred HHHHHHHhhc
Q 001142 1125 DLYEMFVART 1134 (1142)
Q Consensus 1125 EVL~~L~~~~ 1134 (1142)
+++.|+....
T Consensus 360 qil~HldIa~ 369 (904)
T KOG4721|consen 360 QILLHLDIAS 369 (904)
T ss_pred HHHHHHhhcC
Confidence 9999987653
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=336.02 Aligned_cols=252 Identities=20% Similarity=0.260 Sum_probs=199.5
Q ss_pred eeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCCCCC
Q 001142 813 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 892 (1142)
Q Consensus 813 ~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~~~~~~ 892 (1142)
..||+|++|.||+|.+++..+|+|+..... ... +.+...+.+|+.+|++++|||||++++++.+..
T Consensus 26 ~~i~~g~~~~v~~~~~~~~~vavK~~~~~~--~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~--------- 91 (283)
T PHA02988 26 VLIKENDQNSIYKGIFNNKEVIIRTFKKFH--KGH---KVLIDITENEIKNLRRIDSNNILKIYGFIIDIV--------- 91 (283)
T ss_pred eEEeeCCceEEEEEEECCEEEEEEeccccc--ccc---HHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc---------
Confidence 679999999999999999999999854321 111 112223479999999999999999999987511
Q ss_pred ccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeeeccccccCCC
Q 001142 893 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILIDLERKKADG 971 (1142)
Q Consensus 893 ~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs-~gIvHrDLKp~NILld~~~~~~~~ 971 (1142)
......++||||+++|+|.+++.. ...+++.....++.|++.||.|||+ .+++||||||+|||++.+
T Consensus 92 -~~~~~~~lv~Ey~~~g~L~~~l~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~------ 159 (283)
T PHA02988 92 -DDLPRLSLILEYCTRGYLREVLDK-----EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTEN------ 159 (283)
T ss_pred -cCCCceEEEEEeCCCCcHHHHHhh-----CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCC------
Confidence 011246999999999999999975 3468899999999999999999998 499999999999999987
Q ss_pred CCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 001142 972 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM 1051 (1142)
Q Consensus 972 ~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~Pf~ 1051 (1142)
+.+||+|||+++...... ....|+..|+|||++.+. ...++.++|||||||++|||++|+.||.
T Consensus 160 -~~~kl~dfg~~~~~~~~~-------------~~~~~~~~y~aPE~~~~~--~~~~~~k~Di~SlGvil~el~~g~~Pf~ 223 (283)
T PHA02988 160 -YKLKIICHGLEKILSSPP-------------FKNVNFMVYFSYKMLNDI--FSEYTIKDDIYSLGVVLWEIFTGKIPFE 223 (283)
T ss_pred -CcEEEcccchHhhhcccc-------------ccccCcccccCHHHhhhc--cccccchhhhhHHHHHHHHHHHCCCCCC
Confidence 789999999987543211 123588999999998652 1468899999999999999999999999
Q ss_pred CCCHHHHHHHHHhC-CCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 001142 1052 GLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130 (1142)
Q Consensus 1052 ~~~~~el~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L 1130 (1142)
+.+..++...+... ..+..+ ...++.+.+++.+||+.||++|||+.|+++.+
T Consensus 224 ~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l 276 (283)
T PHA02988 224 NLTTKEIYDLIINKNNSLKLP---------------------------LDCPLEIKCIVEACTSHDSIKRPNIKEILYNL 276 (283)
T ss_pred CCCHHHHHHHHHhcCCCCCCC---------------------------CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence 87777766665322 221111 13456799999999999999999999999987
Q ss_pred Hhh
Q 001142 1131 VAR 1133 (1142)
Q Consensus 1131 ~~~ 1133 (1142)
..-
T Consensus 277 ~~~ 279 (283)
T PHA02988 277 SLY 279 (283)
T ss_pred HHH
Confidence 643
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=355.87 Aligned_cols=268 Identities=22% Similarity=0.276 Sum_probs=201.4
Q ss_pred CCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
++|++.++||+|+||.||+|++ .+..+|+|+...... ...... ..+.+|+.++++++|||||++++++.+...
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~----~~~~~E~~il~~l~hp~iv~~~~~~~~~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEM-FKKDQL----AHVKAERDVLAESDSPWVVSLYYSFQDAQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHH-HHhHHH----HHHHHHHHHHHhCCCCCcceEEEEEEcCCe
Confidence 4789999999999999999987 456788887542211 011122 234789999999999999999999987553
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
.|+||||+++|+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.
T Consensus 76 --------------~~lv~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~ 136 (377)
T cd05629 76 --------------LYLIMEFLPGGDLMTMLIK-----YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDR 136 (377)
T ss_pred --------------eEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECC
Confidence 4999999999999999875 346899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccc--------cccCC-----------------------------CCCCCCcc
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCC--------IAHRG-----------------------------IPAPDVCV 1007 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~--------~~~~~-----------------------------~~~~~~~~ 1007 (1142)
+ +.+||+|||+++.+........ ..... .......+
T Consensus 137 ~-------~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (377)
T cd05629 137 G-------GHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTV 209 (377)
T ss_pred C-------CCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccC
Confidence 7 7899999999964321100000 00000 00001246
Q ss_pred CCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCchhHHhhhccccccccc
Q 001142 1008 GTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVA 1086 (1142)
Q Consensus 1008 GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~Pf~~~~~~el~~~I~~~~-~p~l~~~l~~~~~~~~~~~~ 1086 (1142)
||+.|+|||++.+ ..++.++|||||||++|||++|..||.+....+....+.... ...++.
T Consensus 210 gt~~y~aPE~~~~----~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-------------- 271 (377)
T cd05629 210 GTPDYIAPEIFLQ----QGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPD-------------- 271 (377)
T ss_pred CCccccCHHHHcc----CCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCC--------------
Confidence 9999999999875 568899999999999999999999998777666555543221 111100
Q ss_pred ccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC---CCHHHHHHHHHhhcC
Q 001142 1087 QSGSGFEKPEAELETLSFLVDVFRRCTEENPTER---PTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1087 ~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~R---PSa~EVL~~L~~~~s 1135 (1142)
....+..+.+++.+||. +|.+| +++.|++.|+|+...
T Consensus 272 -----------~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 272 -----------DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred -----------CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 00345678999999997 66665 699999999998753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=350.86 Aligned_cols=267 Identities=24% Similarity=0.315 Sum_probs=206.8
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
++|++.+.||+|+||+||+|++. +..+|+|+........ .... ..+..|+.++..++||||+++++++.+.+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~----~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 74 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIK-RNQI----AHVRAERDILADADSPWIVKLYYSFQDEE- 74 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhh-ccHH----HHHHHHHHHHHhcCCCCccchhhheecCC-
Confidence 36899999999999999999985 7778888865332111 1122 23478999999999999999999987655
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
+.++||||+++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~ 136 (350)
T cd05573 75 -------------HLYLVMEYMPGGDLMNLLIR-----KDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDA 136 (350)
T ss_pred -------------eEEEEEcCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC
Confidence 34999999999999999976 246899999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccc-------------------cCCCCCCCCccCCCcccchhhhccccCCC
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA-------------------HRGIPAPDVCVGTPRWMAPEVLRAMHKPN 1025 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~-------------------~~~~~~~~~~~GT~~Y~APE~l~~~~~~~ 1025 (1142)
+ +.+||+|||++............. ...........||+.|+|||++.+ .
T Consensus 137 ~-------~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~ 205 (350)
T cd05573 137 D-------GHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG----T 205 (350)
T ss_pred C-------CCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcC----C
Confidence 7 789999999997654322000000 000012234569999999999976 4
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCchhHHhhhcccccccccccCCCCCCchhhhhhHHH
Q 001142 1026 LYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF 1104 (1142)
Q Consensus 1026 ~~s~ksDVwSLGviL~ELLtG~~Pf~~~~~~el~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1104 (1142)
.++.++|||||||++|||++|+.||......+....+..... ...+ . ....++.
T Consensus 206 ~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p------------------------~-~~~~~~~ 260 (350)
T cd05573 206 PYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFP------------------------P-DPPVSPE 260 (350)
T ss_pred CCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCC------------------------C-CCCCCHH
Confidence 788999999999999999999999988776655555433110 0000 0 0024667
Q ss_pred HHHHHHHhcccCCCCCCC-HHHHHHHHHhhc
Q 001142 1105 LVDVFRRCTEENPTERPT-AGDLYEMFVART 1134 (1142)
Q Consensus 1105 L~dLI~~CL~~DP~~RPS-a~EVL~~L~~~~ 1134 (1142)
+.++|.+||. ||.+||+ ++++++|+|+..
T Consensus 261 ~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~ 290 (350)
T cd05573 261 AIDLICRLLC-DPEDRLGSFEEIKSHPFFKG 290 (350)
T ss_pred HHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence 9999999997 9999999 999999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=354.73 Aligned_cols=266 Identities=22% Similarity=0.291 Sum_probs=208.4
Q ss_pred CCCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001142 804 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 881 (1142)
Q Consensus 804 ~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~ 881 (1142)
....+|++.++||+|+||.||+|++. +..+|+|+...... ......+ .+.+|+.+++.++||||+++++++.+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~----~~~~e~~il~~~~h~~iv~~~~~~~~ 114 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEM-IKRSDSA----FFWEERDIMAHANSEWIVQLHYAFQD 114 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhhHH----HHHHHHHHHHhCCCCCcceEEEEEec
Confidence 34678999999999999999999984 56788887532111 0111112 23689999999999999999999886
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 001142 882 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 961 (1142)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NIL 961 (1142)
.. +.++||||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 115 ~~--------------~~~lv~Ey~~gg~L~~~l~~------~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIL 174 (370)
T cd05596 115 DK--------------YLYMVMEYMPGGDLVNLMSN------YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNML 174 (370)
T ss_pred CC--------------EEEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence 55 35999999999999999865 35888999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001142 962 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1041 (1142)
Q Consensus 962 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ 1041 (1142)
++.+ +.+||+|||.+........ .......||+.|+|||++.+......++.++|||||||++|
T Consensus 175 l~~~-------~~~kL~DfG~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvily 238 (370)
T cd05596 175 LDKS-------GHLKLADFGTCMKMDANGM---------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLY 238 (370)
T ss_pred EcCC-------CCEEEEeccceeeccCCCc---------ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHH
Confidence 9887 7899999999875432110 11124469999999999876433345889999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCC-CCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC-
Q 001142 1042 ELLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE- 1119 (1142)
Q Consensus 1042 ELLtG~~Pf~~~~~~el~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~- 1119 (1142)
||++|+.||.+.+....+..+..... ...+. ....+..+.+++.+||+.+|.+
T Consensus 239 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~-------------------------~~~~s~~~~~li~~~L~~~p~r~ 293 (370)
T cd05596 239 EMLVGDTPFYADSLVGTYSKIMDHKNSLTFPD-------------------------DIEISKQAKDLICAFLTDREVRL 293 (370)
T ss_pred HHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCC-------------------------cCCCCHHHHHHHHHHccChhhcc
Confidence 99999999998776666655543221 11100 0134667999999999999988
Q ss_pred -CCCHHHHHHHHHhhcC
Q 001142 1120 -RPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1120 -RPSa~EVL~~L~~~~s 1135 (1142)
|||++|+++|+|++..
T Consensus 294 ~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 294 GRNGVDEIKSHPFFKND 310 (370)
T ss_pred CCCCHHHHhcCcccCCC
Confidence 9999999999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=352.74 Aligned_cols=267 Identities=22% Similarity=0.276 Sum_probs=199.5
Q ss_pred CcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
.|++.+.||+|+||+||+|++. +..+|+|+...+.. ...... ..+.+|+.++++++||||+++++++.+.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~-~~~~~~----~~~~~E~~il~~l~h~~iv~l~~~~~~~~-- 74 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDV-LNRNQV----AHVKAERDILAEADNEWVVKLYYSFQDKD-- 74 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhHHH----HHHHHHHHHHHhcCCCCeeeeEEEEecCC--
Confidence 5889999999999999999984 55678887543211 111222 23478999999999999999999998655
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
+.++||||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 75 ------------~~~lv~E~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~ 137 (381)
T cd05626 75 ------------NLYFVMDYIPGGDMMSLLIR-----MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLD 137 (381)
T ss_pred ------------EEEEEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCC
Confidence 35999999999999999876 2468999999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccc-------------------------------------cCCCCCCCCccC
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIA-------------------------------------HRGIPAPDVCVG 1008 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~-------------------------------------~~~~~~~~~~~G 1008 (1142)
+.+||+|||++..+.......... ...........|
T Consensus 138 -------~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 210 (381)
T cd05626 138 -------GHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVG 210 (381)
T ss_pred -------CCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccC
Confidence 789999999986432110000000 000001123579
Q ss_pred CCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCchhHHhhhcccccccccc
Q 001142 1009 TPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQ 1087 (1142)
Q Consensus 1009 T~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~Pf~~~~~~el~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~ 1087 (1142)
|+.|+|||++.+ ..++.++|||||||++|||++|..||......+....+... .....+.
T Consensus 211 t~~Y~aPE~~~~----~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~--------------- 271 (381)
T cd05626 211 TPNYIAPEVLLR----KGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPP--------------- 271 (381)
T ss_pred CccccCHHHHcC----CCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCC---------------
Confidence 999999999875 56889999999999999999999999876655544443221 1111110
Q ss_pred cCCCCCCchhhhhhHHHHHHHHHHhc--ccCCCCCCCHHHHHHHHHhhc
Q 001142 1088 SGSGFEKPEAELETLSFLVDVFRRCT--EENPTERPTAGDLYEMFVART 1134 (1142)
Q Consensus 1088 ~~~~~~~~~~~~~~~~~L~dLI~~CL--~~DP~~RPSa~EVL~~L~~~~ 1134 (1142)
....++++.+++.+|+ ..+|..||++.++++|+|+..
T Consensus 272 ----------~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~ 310 (381)
T cd05626 272 ----------QVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSE 310 (381)
T ss_pred ----------CCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCC
Confidence 0134567889998844 556666999999999999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=346.05 Aligned_cols=249 Identities=27% Similarity=0.361 Sum_probs=198.0
Q ss_pred eeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecCCCCCCCC
Q 001142 813 DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 889 (1142)
Q Consensus 813 ~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~~~~~~~~~~~ 889 (1142)
+.||+|+||+||+|++. +..+|+|+....... .....+. +..|+.++..+ +||||+++++++...+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~----~~~e~~~l~~~~~h~~iv~~~~~~~~~~------ 69 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVIL-QDDDVEC----TMTEKRILSLARNHPFLTQLYCCFQTPD------ 69 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-hccHHHH----HHHHHHHHHhccCCCchhceeeEEEcCC------
Confidence 47999999999999984 567888876432111 1112222 36788888877 6999999999987654
Q ss_pred CCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccC
Q 001142 890 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 969 (1142)
Q Consensus 890 ~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~ 969 (1142)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 70 --------~~~iv~Ey~~~g~L~~~i~~-----~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~---- 132 (320)
T cd05590 70 --------RLFFVMEFVNGGDLMFHIQK-----SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHE---- 132 (320)
T ss_pred --------EEEEEEcCCCCchHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC----
Confidence 35999999999999998875 3468999999999999999999999999999999999999887
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001142 970 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1049 (1142)
Q Consensus 970 ~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~P 1049 (1142)
+.+||+|||++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 133 ---~~~kL~DfG~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~el~~g~~P 195 (320)
T cd05590 133 ---GHCKLADFGMCKEGIFNG----------KTTSTFCGTPDYIAPEILQE----MLYGPSVDWWAMGVLLYEMLCGHAP 195 (320)
T ss_pred ---CcEEEeeCCCCeecCcCC----------CcccccccCccccCHHHHcC----CCCCCccchhhhHHHHHHHhhCCCC
Confidence 789999999986432111 01123468999999999875 5678999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH------
Q 001142 1050 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA------ 1123 (1142)
Q Consensus 1050 f~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa------ 1123 (1142)
|.+.+..++...+....... + ...+..+.+++.+||+.||.+||++
T Consensus 196 f~~~~~~~~~~~i~~~~~~~-~---------------------------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~ 247 (320)
T cd05590 196 FEAENEDDLFEAILNDEVVY-P---------------------------TWLSQDAVDILKAFMTKNPTMRLGSLTLGGE 247 (320)
T ss_pred CCCCCHHHHHHHHhcCCCCC-C---------------------------CCCCHHHHHHHHHHcccCHHHCCCCCCCCCH
Confidence 99877777766664432110 0 0345568999999999999999998
Q ss_pred HHHHHHHHhhc
Q 001142 1124 GDLYEMFVART 1134 (1142)
Q Consensus 1124 ~EVL~~L~~~~ 1134 (1142)
+++++|+|+..
T Consensus 248 ~~~~~h~~f~~ 258 (320)
T cd05590 248 EAILRHPFFKE 258 (320)
T ss_pred HHHHcCCCcCC
Confidence 99999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=336.69 Aligned_cols=252 Identities=24% Similarity=0.355 Sum_probs=211.2
Q ss_pred CCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
.+|++.+.||+|+||.|-+|.. .+..||+|..+.+...+. .+. -.+.+|++||..|+||||+.+|.+|+..+.
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkde-qDl----vhIRREIeIMSsLNHPhII~IyEVFENkdK 127 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDE-QDL----VHIRREIEIMSSLNHPHIIQIYEVFENKDK 127 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccH-HHH----HHHHHHHHHHhhcCCCceeehhhhhcCCce
Confidence 5799999999999999999986 467778776443322111 111 234799999999999999999999987664
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
+ .|||||..+|.|++|+.. ...+++.+++.+++||+.|+.|+|.++++|||||.+|||+|.
T Consensus 128 I--------------vivMEYaS~GeLYDYiSe-----r~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~ 188 (668)
T KOG0611|consen 128 I--------------VIVMEYASGGELYDYISE-----RGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQ 188 (668)
T ss_pred E--------------EEEEEecCCccHHHHHHH-----hccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecC
Confidence 4 999999999999999987 467999999999999999999999999999999999999999
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCC-CchhhHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~-s~ksDVwSLGviL~EL 1043 (1142)
+ +++||+|||++..+.... -..+++|+|.|.+||++.+ .+| ++.+|.|||||+||.|
T Consensus 189 N-------~NiKIADFGLSNly~~~k-----------fLqTFCGSPLYASPEIvNG----~PY~GPEVDsWsLGvLLYtL 246 (668)
T KOG0611|consen 189 N-------NNIKIADFGLSNLYADKK-----------FLQTFCGSPLYASPEIVNG----TPYKGPEVDSWSLGVLLYTL 246 (668)
T ss_pred C-------CCeeeeccchhhhhcccc-----------HHHHhcCCcccCCccccCC----CCCCCCccchhhHHHHHHHH
Confidence 8 889999999997654321 1236789999999999987 344 6899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
..|..||++.+...+..+|..+..... ..+....-||+.||..+|++|.|+
T Consensus 247 VyGtMPFDG~Dhk~lvrQIs~GaYrEP-----------------------------~~PSdA~gLIRwmLmVNP~RRATi 297 (668)
T KOG0611|consen 247 VYGTMPFDGRDHKRLVRQISRGAYREP-----------------------------ETPSDASGLIRWMLMVNPERRATI 297 (668)
T ss_pred hhcccccCCchHHHHHHHhhcccccCC-----------------------------CCCchHHHHHHHHHhcCcccchhH
Confidence 999999999888888888877764321 223346778999999999999999
Q ss_pred HHHHHHHHhh
Q 001142 1124 GDLYEMFVAR 1133 (1142)
Q Consensus 1124 ~EVL~~L~~~ 1133 (1142)
.+|..|+|.-
T Consensus 298 eDiAsHWWvN 307 (668)
T KOG0611|consen 298 EDIASHWWVN 307 (668)
T ss_pred HHHhhhheee
Confidence 9999999974
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=345.11 Aligned_cols=252 Identities=27% Similarity=0.366 Sum_probs=198.7
Q ss_pred cceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHH---hhCCCCCccceeeeEecCC
Q 001142 809 LSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRML---GALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 809 y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL---~~L~HpNIVkl~g~~~~~~ 883 (1142)
|++.+.||+|+||.||+|.+. +..+|+|+.+.... ......+ .+.+|++++ +.++||||+++++++...+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~----~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDI-IARDEVE----SLMCEKRIFETANSERHPFLVNLFACFQTED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHH----HHHHHHHHHHhccccCCCChhceeeEEEcCC
Confidence 688999999999999999884 56788888653211 1111122 235666554 5667999999999988654
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
+.|+||||+++++|..+++. ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 76 --------------~~~lv~E~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~ 135 (324)
T cd05589 76 --------------HVCFVMEYAAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLD 135 (324)
T ss_pred --------------EEEEEEcCCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC
Confidence 45999999999999888754 4689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.+||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 136 ~~-------~~~kL~Dfg~~~~~~~~~----------~~~~~~~g~~~y~aPE~~~~----~~~~~~~DiwslG~il~el 194 (324)
T cd05589 136 TE-------GFVKIADFGLCKEGMGFG----------DRTSTFCGTPEFLAPEVLTE----TSYTRAVDWWGLGVLIYEM 194 (324)
T ss_pred CC-------CcEEeCcccCCccCCCCC----------CcccccccCccccCHhHhcC----CCCCcccchhhHHHHHHHH
Confidence 87 789999999986432211 11224568999999999876 5678999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC--
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-- 1121 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP-- 1121 (1142)
++|+.||.+.+..+....+...... .+ ...++.+.+++.+||+.||.+||
T Consensus 195 ~~G~~pf~~~~~~~~~~~i~~~~~~-~p---------------------------~~~~~~~~~li~~~L~~dP~~R~~~ 246 (324)
T cd05589 195 LVGESPFPGDDEEEVFDSIVNDEVR-YP---------------------------RFLSREAISIMRRLLRRNPERRLGS 246 (324)
T ss_pred HhCCCCCCCCCHHHHHHHHHhCCCC-CC---------------------------CCCCHHHHHHHHHHhhcCHhHcCCC
Confidence 9999999987776666665443211 00 03456689999999999999999
Q ss_pred ---CHHHHHHHHHhhc
Q 001142 1122 ---TAGDLYEMFVART 1134 (1142)
Q Consensus 1122 ---Sa~EVL~~L~~~~ 1134 (1142)
++.++++|+|++.
T Consensus 247 ~~~~~~~l~~~~~f~~ 262 (324)
T cd05589 247 GEKDAEDVKKQPFFRD 262 (324)
T ss_pred CCCCHHHHhhCCCcCC
Confidence 7999999999865
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=360.50 Aligned_cols=270 Identities=24% Similarity=0.316 Sum_probs=211.6
Q ss_pred CCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
-.+|++.+.||+|+||+||+|++ .+..+|+|+...+. ........ +.+|+.++..++|+||+++++.+...+
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~--~~~~~~~~----~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEG--MSEADKNR----AQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEeccc--CCHHHHHH----HHHHHHHHhcCCCCcEEEeecceeccc
Confidence 35899999999999999999987 56788888865432 22333333 378999999999999999988776432
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
.. ........++||||+++|+|.+++..... ....+++..+..++.|++.||.|||++||+||||||+|||++
T Consensus 105 ~~------~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~-~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~ 177 (496)
T PTZ00283 105 PR------NPENVLMIALVLDYANAGDLRQEIKSRAK-TNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLC 177 (496)
T ss_pred cc------CcccceEEEEEEeCCCCCcHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEe
Confidence 11 11123346899999999999999975332 235689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.+||+|||+++.+...... .......||+.|+|||++.+ ..++.++|||||||++|||
T Consensus 178 ~~-------~~vkL~DFGls~~~~~~~~~--------~~~~~~~Gt~~Y~aPE~~~~----~~~s~k~DVwSlGvilyeL 238 (496)
T PTZ00283 178 SN-------GLVKLGDFGFSKMYAATVSD--------DVGRTFCGTPYYVAPEIWRR----KPYSKKADMFSLGVLLYEL 238 (496)
T ss_pred CC-------CCEEEEecccCeeccccccc--------cccccccCCcceeCHHHhCC----CCCCcHHHHHHHHHHHHHH
Confidence 87 78999999999765432111 11224569999999999876 5688999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
++|+.||.+....++...+..+....++ ...++.+.+++.+||+.||.+||++
T Consensus 239 ltG~~Pf~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~~L~~dP~~RPs~ 291 (496)
T PTZ00283 239 LTLKRPFDGENMEEVMHKTLAGRYDPLP---------------------------PSISPEMQEIVTALLSSDPKRRPSS 291 (496)
T ss_pred HHCCCCCCCCCHHHHHHHHhcCCCCCCC---------------------------CCCCHHHHHHHHHHcccChhhCcCH
Confidence 9999999887776666655443322211 1445679999999999999999999
Q ss_pred HHHHHHHHhhc
Q 001142 1124 GDLYEMFVART 1134 (1142)
Q Consensus 1124 ~EVL~~L~~~~ 1134 (1142)
.++++|+|.+.
T Consensus 292 ~ell~~p~~~~ 302 (496)
T PTZ00283 292 SKLLNMPICKL 302 (496)
T ss_pred HHHHhCHHHHH
Confidence 99999988653
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=344.23 Aligned_cols=254 Identities=25% Similarity=0.319 Sum_probs=200.7
Q ss_pred CcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCC-CCccceeeeEecCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH-SCIVEMYGHKISSKW 884 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H-pNIVkl~g~~~~~~~ 884 (1142)
+|++.+.||+|+||.||+|++. +..+|+|+....... .....+. +..|++++..+.| ++|+++++++.+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~~----~~~e~~~l~~~~~~~~i~~~~~~~~~~~- 74 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVII-QDDDVEC----TMVEKRVLALPGKPPFLTQLHSCFQTMD- 74 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHH----HHHHHHHHHhcCCCCceeeeEEEEEcCC-
Confidence 5899999999999999999985 456888886533211 1122222 3689999999975 56888888887654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
..|+||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~E~~~~g~L~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~ 136 (324)
T cd05587 75 -------------RLYFVMEYVNGGDLMYHIQQ-----VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDA 136 (324)
T ss_pred -------------EEEEEEcCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcC
Confidence 35999999999999999875 246899999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||+|||++....... .......||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 137 ~-------~~~kL~Dfg~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslGvil~ell 195 (324)
T cd05587 137 E-------GHIKIADFGMCKENIFGG----------KTTRTFCGTPDYIAPEIIAY----QPYGKSVDWWAFGVLLYEML 195 (324)
T ss_pred C-------CCEEEeecCcceecCCCC----------CceeeecCCccccChhhhcC----CCCCcccchhhhHHHHHHHH
Confidence 7 789999999986422111 01123468999999999876 56789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH-
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA- 1123 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa- 1123 (1142)
+|+.||.+.+..+....+..... ..+ ...+..+.+++.+||+.||.+|+++
T Consensus 196 tG~~pf~~~~~~~~~~~i~~~~~-~~~---------------------------~~~~~~~~~li~~~l~~~P~~R~~~~ 247 (324)
T cd05587 196 AGQPPFDGEDEDELFQSIMEHNV-SYP---------------------------KSLSKEAVSICKGLLTKHPAKRLGCG 247 (324)
T ss_pred hCCCCCCCCCHHHHHHHHHcCCC-CCC---------------------------CCCCHHHHHHHHHHhhcCHHHcCCCC
Confidence 99999998777766666543321 111 0345568999999999999999976
Q ss_pred ----HHHHHHHHhhc
Q 001142 1124 ----GDLYEMFVART 1134 (1142)
Q Consensus 1124 ----~EVL~~L~~~~ 1134 (1142)
+++++|+|++.
T Consensus 248 ~~~~~~~~~hp~~~~ 262 (324)
T cd05587 248 PTGERDIREHAFFRR 262 (324)
T ss_pred CCCHHHHhcCCCcCC
Confidence 89999999865
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=332.75 Aligned_cols=260 Identities=22% Similarity=0.360 Sum_probs=203.8
Q ss_pred CCCCcceeeeecccCceEEEEEEECCc-------cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceee
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKFGSA-------DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 877 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~~~~-------~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g 877 (1142)
++++|++.+.||+|+||.||+|.+... .+++|... .. ........ +.+|+.++.+++||||+++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~--~~-~~~~~~~~----~~~ei~~l~~l~h~~i~~~~~ 75 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLK--EN-AEPKVQQE----FRQEAELMSDLQHPNIVCLLG 75 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecc--cC-CCHHHHHH----HHHHHHHHHhcCCcccceEEE
Confidence 356799999999999999999987432 36666533 21 12222233 478999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCC-----------CCCCHHHHHHHHHHHHHHHHHHH
Q 001142 878 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGE-----------KHVSVKLALFIAQDVAAALVELH 946 (1142)
Q Consensus 878 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~-----------~~ls~~~i~~Ia~qIa~gL~yLH 946 (1142)
++..... .+++|||+++++|.+++........ ..+++..+..++.||+.||.|||
T Consensus 76 ~~~~~~~--------------~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH 141 (283)
T cd05048 76 VCTKEQP--------------TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS 141 (283)
T ss_pred EEcCCCc--------------eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 9876543 4999999999999999976322111 46889999999999999999999
Q ss_pred hCCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCC
Q 001142 947 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 1026 (1142)
Q Consensus 947 s~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 1026 (1142)
++||+||||||+||+++.+ +.++|+|||++......... .......+++.|+|||.+.+ ..
T Consensus 142 ~~~i~H~dlkp~Nil~~~~-------~~~~L~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~ 202 (283)
T cd05048 142 SHHFVHRDLAARNCLVGEG-------LTVKISDFGLSRDIYSADYY--------RVQSKSLLPVRWMPPEAILY----GK 202 (283)
T ss_pred hCCeeccccccceEEEcCC-------CcEEECCCcceeeccccccc--------cccCCCcccccccCHHHhcc----Cc
Confidence 9999999999999999877 78999999998754321110 01123356888999999865 46
Q ss_pred CCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHH
Q 001142 1027 YGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFL 1105 (1142)
Q Consensus 1027 ~s~ksDVwSLGviL~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 1105 (1142)
++.++|||||||++|||++ |..||.+....+....+.....+..+ ..+++.+
T Consensus 203 ~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~---------------------------~~~~~~~ 255 (283)
T cd05048 203 FTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPCP---------------------------EDCPARV 255 (283)
T ss_pred CchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCc---------------------------ccCCHHH
Confidence 7899999999999999998 99999987777776666544332211 1456779
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHH
Q 001142 1106 VDVFRRCTEENPTERPTAGDLYEMFV 1131 (1142)
Q Consensus 1106 ~dLI~~CL~~DP~~RPSa~EVL~~L~ 1131 (1142)
.+|+.+||+.||++||++.||++++.
T Consensus 256 ~~l~~~c~~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05048 256 YALMIECWNEIPARRPRFKDIHTRLR 281 (283)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHh
Confidence 99999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=344.74 Aligned_cols=249 Identities=24% Similarity=0.326 Sum_probs=198.2
Q ss_pred eeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecCCCCCCCC
Q 001142 813 DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 889 (1142)
Q Consensus 813 ~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~~~~~~~~~~~ 889 (1142)
++||+|+||.||+|++. +..+|+|+....... .....+. +..|.+++..+ +||||+++++++...+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~----~~~e~~il~~~~~hp~i~~~~~~~~~~~------ 69 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVIL-QDDDVDC----TMTEKRILALAAKHPFLTALHCCFQTKD------ 69 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhh-hhhHHHH----HHHHHHHHHhccCCCCccceeeEEEcCC------
Confidence 46999999999999985 457888886533211 1122222 36788888876 7999999999998655
Q ss_pred CCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccC
Q 001142 890 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 969 (1142)
Q Consensus 890 ~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~ 969 (1142)
..|+||||+++++|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 70 --------~~~lv~E~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~---- 132 (321)
T cd05591 70 --------RLFFVMEYVNGGDLMFQIQR-----SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAE---- 132 (321)
T ss_pred --------eEEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC----
Confidence 34999999999999998875 3468999999999999999999999999999999999999887
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001142 970 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1049 (1142)
Q Consensus 970 ~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~P 1049 (1142)
+.+||+|||++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 133 ---~~~kL~Dfg~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~el~tg~~P 195 (321)
T cd05591 133 ---GHCKLADFGMCKEGILNG----------VTTTTFCGTPDYIAPEILQE----LEYGPSVDWWALGVLMYEMMAGQPP 195 (321)
T ss_pred ---CCEEEeecccceecccCC----------ccccccccCccccCHHHHcC----CCCCCccceechhHHHHHHhcCCCC
Confidence 789999999986432211 01123468999999999875 5688999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-------C
Q 001142 1050 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-------T 1122 (1142)
Q Consensus 1050 f~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP-------S 1122 (1142)
|...+..+....+....... + ...+..+.+++.+||+.||++|| +
T Consensus 196 f~~~~~~~~~~~i~~~~~~~-p---------------------------~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~ 247 (321)
T cd05591 196 FEADNEDDLFESILHDDVLY-P---------------------------VWLSKEAVSILKAFMTKNPNKRLGCVASQGG 247 (321)
T ss_pred CCCCCHHHHHHHHHcCCCCC-C---------------------------CCCCHHHHHHHHHHhccCHHHcCCCCCCCCC
Confidence 99887777776665432110 0 02345689999999999999999 9
Q ss_pred HHHHHHHHHhhc
Q 001142 1123 AGDLYEMFVART 1134 (1142)
Q Consensus 1123 a~EVL~~L~~~~ 1134 (1142)
+.++++|+|+..
T Consensus 248 ~~~~~~hp~~~~ 259 (321)
T cd05591 248 EDAIKQHPFFKE 259 (321)
T ss_pred HHHHhcCCccCC
Confidence 999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=348.26 Aligned_cols=262 Identities=28% Similarity=0.360 Sum_probs=215.3
Q ss_pred CCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEecCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSK 883 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~g~~~~~~ 883 (1142)
..|++.+.||+|.||.||+|+. ++..+|+|+...+..... ...+.+ .+|+.+|+++. |||||.+++.|++..
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~-~~~~~v----~~Ev~il~~l~~hpniv~l~~~~e~~~ 109 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGK-EDREDV----RREVAILQQLSGHPNIVQLKDAFEDPD 109 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhcccc-ccHHHH----HHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence 3589999999999999999998 466788888643332211 122333 79999999998 999999999999876
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
. .++|||++.||.|.+.+... .+++..+..++.||+.|+.|||+.||+||||||+|+|+.
T Consensus 110 ~--------------~~lvmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~ 169 (382)
T KOG0032|consen 110 S--------------VYLVMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLA 169 (382)
T ss_pred e--------------EEEEEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeec
Confidence 4 49999999999999999872 399999999999999999999999999999999999997
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
... .+.+.+|++|||++....... .....+||+.|+|||++.. ..|+..+||||+||++|.|
T Consensus 170 ~~~---~~~~~ik~~DFGla~~~~~~~-----------~~~~~~Gtp~y~APEvl~~----~~y~~~~DiWS~Gvi~yiL 231 (382)
T KOG0032|consen 170 SKD---EGSGRIKLIDFGLAKFIKPGE-----------RLHTIVGTPEYVAPEVLGG----RPYGDEVDVWSIGVILYIL 231 (382)
T ss_pred ccc---CCCCcEEEeeCCCceEccCCc-----------eEeeecCCccccCchhhcC----CCCCcccchhHHHHHHHHH
Confidence 652 122579999999998765411 1235689999999999985 6799999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
++|..||.+.+.......|..+....... .+ ..++..+.+++++|+..||.+|+|+
T Consensus 232 L~G~~PF~~~~~~~~~~~i~~~~~~f~~~-----------------------~w-~~is~~akd~i~~ll~~dp~~R~ta 287 (382)
T KOG0032|consen 232 LSGVPPFWGETEFEIFLAILRGDFDFTSE-----------------------PW-DDISESAKDFIRKLLEFDPRKRLTA 287 (382)
T ss_pred hhCCCCCcCCChhHHHHHHHcCCCCCCCC-----------------------Cc-cccCHHHHHHHHHhcccCcccCCCH
Confidence 99999999988877777776665421111 11 1557789999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 001142 1124 GDLYEMFVARTS 1135 (1142)
Q Consensus 1124 ~EVL~~L~~~~s 1135 (1142)
.++++|||....
T Consensus 288 ~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 288 AQALQHPWIKSI 299 (382)
T ss_pred HHHhcCccccCC
Confidence 999999998864
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=347.28 Aligned_cols=250 Identities=25% Similarity=0.343 Sum_probs=197.9
Q ss_pred eeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCCC
Q 001142 813 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADG 890 (1142)
Q Consensus 813 ~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~~~~ 890 (1142)
+.||+|+||.||+|.+ .+..+|+|+....... ...... .+..|++++..++||||+++++++...+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~-~~~~~~----~~~~e~~~l~~~~hp~i~~~~~~~~~~~------- 68 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV-AKDEVA----HTLTENRVLQNSRHPFLTALKYSFQTHD------- 68 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHH----HHHHHHHHHHhCCCCCCCceEEEEEcCC-------
Confidence 4799999999999987 4667888886533211 112222 2368999999999999999999987655
Q ss_pred CCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeeeccccccC
Q 001142 891 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILIDLERKKA 969 (1142)
Q Consensus 891 ~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs-~gIvHrDLKp~NILld~~~~~~ 969 (1142)
..++||||+++++|..++.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.+
T Consensus 69 -------~~~lv~E~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~---- 132 (325)
T cd05594 69 -------RLCFVMEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD---- 132 (325)
T ss_pred -------EEEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCC----
Confidence 34999999999999988865 3468999999999999999999997 799999999999999887
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001142 970 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1049 (1142)
Q Consensus 970 ~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~P 1049 (1142)
+.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 133 ---~~~kL~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~el~tG~~P 195 (325)
T cd05594 133 ---GHIKITDFGLCKEGIKDGA----------TMKTFCGTPEYLAPEVLED----NDYGRAVDWWGLGVVMYEMMCGRLP 195 (325)
T ss_pred ---CCEEEecCCCCeecCCCCc----------ccccccCCcccCCHHHHcc----CCCCCccccccccceeeeeccCCCC
Confidence 7899999999864321110 1123469999999999875 5678999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----CHH
Q 001142 1050 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-----TAG 1124 (1142)
Q Consensus 1050 f~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP-----Sa~ 1124 (1142)
|.+....+....+..... .++ ...++.+.+++.+||+.||++|+ ++.
T Consensus 196 f~~~~~~~~~~~i~~~~~-~~p---------------------------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~ 247 (325)
T cd05594 196 FYNQDHEKLFELILMEEI-RFP---------------------------RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAK 247 (325)
T ss_pred CCCCCHHHHHHHHhcCCC-CCC---------------------------CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHH
Confidence 987766655555432221 100 13456789999999999999996 999
Q ss_pred HHHHHHHhhcC
Q 001142 1125 DLYEMFVARTS 1135 (1142)
Q Consensus 1125 EVL~~L~~~~s 1135 (1142)
++++|+|+...
T Consensus 248 ~il~h~~~~~~ 258 (325)
T cd05594 248 EIMQHKFFAGI 258 (325)
T ss_pred HHhcCCCcCCC
Confidence 99999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=351.79 Aligned_cols=260 Identities=28% Similarity=0.456 Sum_probs=217.3
Q ss_pred CcceeeeecccCceEEEEEEECCcc--EEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFGSAD--AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~~~~--vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
-|+|+..||.|+||.||+|....+. .|.|+ ++. ....+.++| +-||.||..+.||+||++++.|+.++.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKv--Iet--kseEELEDy----lVEIeILa~CdHP~ivkLl~ayy~enk- 103 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKV--IET--KSEEELEDY----LVEIEILAECDHPVIVKLLSAYYFENK- 103 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhh--hcc--cchhHHhhh----hhhhhhhhcCCChHHHHHHHHHhccCc-
Confidence 3689999999999999999876444 45555 332 244666677 789999999999999999998876554
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
+||+.|||.||-...++-.. ...+++.++..+++|++.||.|||+++|||||||+.|||++-+
T Consensus 104 -------------LwiliEFC~GGAVDaimlEL----~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~Tld 166 (1187)
T KOG0579|consen 104 -------------LWILIEFCGGGAVDAIMLEL----GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLD 166 (1187)
T ss_pred -------------eEEEEeecCCchHhHHHHHh----ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEec
Confidence 49999999999999888763 4579999999999999999999999999999999999999988
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccc-cCCCCCCchhhHHHHHHHHHHHH
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM-HKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
|.++|+|||.+...... ....+.+.|||+|||||+..+. ....+|+.++||||||++|.||.
T Consensus 167 -------GdirLADFGVSAKn~~t----------~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMA 229 (1187)
T KOG0579|consen 167 -------GDIRLADFGVSAKNKST----------RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMA 229 (1187)
T ss_pred -------CcEeeecccccccchhH----------HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHh
Confidence 88999999998643321 1234577899999999998764 34568999999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~ 1124 (1142)
.+.+|....+++.++-.|....+|.+... ...+..+.+|+.+||..||..||+++
T Consensus 230 qiEPPHhelnpMRVllKiaKSePPTLlqP-------------------------S~Ws~~F~DfLk~cL~Knp~~Rp~aa 284 (1187)
T KOG0579|consen 230 QIEPPHHELNPMRVLLKIAKSEPPTLLQP-------------------------SHWSRSFSDFLKRCLVKNPRNRPPAA 284 (1187)
T ss_pred ccCCCccccchHHHHHHHhhcCCCcccCc-------------------------chhhhHHHHHHHHHHhcCCccCCCHH
Confidence 99999999999888888877766654321 14556799999999999999999999
Q ss_pred HHHHHHHhhcC
Q 001142 1125 DLYEMFVARTS 1135 (1142)
Q Consensus 1125 EVL~~L~~~~s 1135 (1142)
++++|+|+...
T Consensus 285 qll~Hpfv~~~ 295 (1187)
T KOG0579|consen 285 QLLKHPFVQNA 295 (1187)
T ss_pred HHhhCcccccC
Confidence 99999999844
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=353.64 Aligned_cols=267 Identities=22% Similarity=0.257 Sum_probs=200.9
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
.+|++.+.||+|+||.||+|+.. +..+|+|+...... ........+.+|+.++++++||||+++++.+.+.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~-----~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~- 74 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADV-----LMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKD- 74 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHH-----HhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCC-
Confidence 36899999999999999999974 56788887532210 01111223478999999999999999999998655
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
+.++||||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~E~~~~g~L~~~i~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~ 136 (376)
T cd05598 75 -------------NLYFVMDYIPGGDMMSLLIR-----LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDR 136 (376)
T ss_pred -------------EEEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECC
Confidence 35999999999999999976 346899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccc---------------------------------cCCCCCCCCccCCCc
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA---------------------------------HRGIPAPDVCVGTPR 1011 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~---------------------------------~~~~~~~~~~~GT~~ 1011 (1142)
+ +.+||+|||+|..+.......... ...........||+.
T Consensus 137 ~-------~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 209 (376)
T cd05598 137 D-------GHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPN 209 (376)
T ss_pred C-------CCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCcc
Confidence 7 789999999985332100000000 000001123479999
Q ss_pred ccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCchhHHhhhcccccccccccCC
Q 001142 1012 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGS 1090 (1142)
Q Consensus 1012 Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~Pf~~~~~~el~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~ 1090 (1142)
|+|||++.+ ..++.++|||||||++|||++|+.||.+....+....+..... ...+
T Consensus 210 y~aPE~~~~----~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~------------------- 266 (376)
T cd05598 210 YIAPEVLLR----TGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIP------------------- 266 (376)
T ss_pred ccCHHHHcC----CCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCC-------------------
Confidence 999999875 5678999999999999999999999988776655444432111 0000
Q ss_pred CCCCchhhhhhHHHHHHHHHHhcccCCCCCC---CHHHHHHHHHhhc
Q 001142 1091 GFEKPEAELETLSFLVDVFRRCTEENPTERP---TAGDLYEMFVART 1134 (1142)
Q Consensus 1091 ~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP---Sa~EVL~~L~~~~ 1134 (1142)
.....++.+.++|.+|+ .+|.+|+ ++.++++|+|+..
T Consensus 267 ------~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 267 ------SQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred ------CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence 00134566888998876 5999999 9999999999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=354.50 Aligned_cols=279 Identities=23% Similarity=0.272 Sum_probs=213.4
Q ss_pred CcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-C-----CCccceeeeE
Q 001142 808 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-H-----SCIVEMYGHK 879 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-H-----pNIVkl~g~~ 879 (1142)
+|++.+.||+|+||.|-+|.+ ++..||+||++-+. .|..+...|+.+|..|+ | -|+|+++++|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k---------~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F 257 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK---------RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF 257 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh---------HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc
Confidence 789999999999999999998 46778888865332 22233368999999996 5 3899999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 001142 880 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959 (1142)
Q Consensus 880 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~N 959 (1142)
...+ |.|||+|.+. .+|+++++. +....++...++.|+.||+.||.+||+.||||+||||+|
T Consensus 258 ~fr~--------------HlciVfELL~-~NLYellK~---n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPEN 319 (586)
T KOG0667|consen 258 YFRN--------------HLCIVFELLS-TNLYELLKN---NKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPEN 319 (586)
T ss_pred cccc--------------ceeeeehhhh-hhHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhh
Confidence 8766 4599999996 899999987 445569999999999999999999999999999999999
Q ss_pred eeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001142 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039 (1142)
Q Consensus 960 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGvi 1039 (1142)
||+....+ ..|||+|||.|........ ....+..|+|||++.+ .+|+.++||||||||
T Consensus 320 ILL~~~~r-----~~vKVIDFGSSc~~~q~vy-------------tYiQSRfYRAPEVILG----lpY~~~IDmWSLGCI 377 (586)
T KOG0667|consen 320 ILLKDPKR-----SRIKVIDFGSSCFESQRVY-------------TYIQSRFYRAPEVILG----LPYDTAIDMWSLGCI 377 (586)
T ss_pred eeeccCCc-----CceeEEecccccccCCcce-------------eeeeccccccchhhcc----CCCCCccceeehhhh
Confidence 99976533 6899999999976544221 3457889999999998 789999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccc---ccc--cccc-----c-----------------CCCC
Q 001142 1040 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC---HEH--EVAQ-----S-----------------GSGF 1092 (1142)
Q Consensus 1040 L~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~---~~~--~~~~-----~-----------------~~~~ 1092 (1142)
++||.+|.+.|.+.++.+.+..|......+....++..... ... .... . ....
T Consensus 378 lAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~ 457 (586)
T KOG0667|consen 378 LAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLER 457 (586)
T ss_pred HHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccc
Confidence 99999999999999988877777443333333222221110 000 0000 0 0000
Q ss_pred CCc-h-------hhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001142 1093 EKP-E-------AELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1093 ~~~-~-------~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~~s 1135 (1142)
..+ . ........+.+++.+||.+||.+|+|+.|+++|+|+...
T Consensus 458 ~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 458 RGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTGT 508 (586)
T ss_pred cCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCcccccc
Confidence 001 0 111345678999999999999999999999999999854
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=352.32 Aligned_cols=264 Identities=22% Similarity=0.309 Sum_probs=205.2
Q ss_pred CCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
..+|++.+.||+|+||.||+|++. +..+|+|+...... ......+ .+.+|+.+++.++||||+++++++.+..
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~----~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEM-IKRSDSA----FFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhhHH----HHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 467999999999999999999984 56678887542111 1111122 2368999999999999999999988655
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
..++||||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 117 --------------~~~lv~Ey~~gg~L~~~l~~------~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~ 176 (370)
T cd05621 117 --------------YLYMVMEYMPGGDLVNLMSN------YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLD 176 (370)
T ss_pred --------------EEEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC
Confidence 35999999999999999865 3588999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.+||+|||+|........ .......||+.|+|||++.+......++.++|||||||++|+|
T Consensus 177 ~~-------~~~kL~DFG~a~~~~~~~~---------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyel 240 (370)
T cd05621 177 KH-------GHLKLADFGTCMKMDETGM---------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEM 240 (370)
T ss_pred CC-------CCEEEEecccceecccCCc---------eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHH
Confidence 77 7899999999976532111 1112456999999999997643334578999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCC-CCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC--C
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE--R 1120 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~--R 1120 (1142)
++|+.||.+.+.......+..... ..++. ....+..+.+++..||..++.+ |
T Consensus 241 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~-------------------------~~~~s~~~~~li~~~L~~~~~r~~R 295 (370)
T cd05621 241 LVGDTPFYADSLVGTYSKIMDHKNSLNFPE-------------------------DVEISKHAKNLICAFLTDREVRLGR 295 (370)
T ss_pred HhCCCCCCCCCHHHHHHHHHhCCcccCCCC-------------------------cccCCHHHHHHHHHHccCchhccCC
Confidence 999999988776666555543221 11110 0134567899999999865544 8
Q ss_pred CCHHHHHHHHHhhcC
Q 001142 1121 PTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1121 PSa~EVL~~L~~~~s 1135 (1142)
|++.|+++|+|++..
T Consensus 296 ~~~~e~l~hp~~~~~ 310 (370)
T cd05621 296 NGVEEIKQHPFFKND 310 (370)
T ss_pred CCHHHHhcCcccCCC
Confidence 999999999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=342.64 Aligned_cols=249 Identities=27% Similarity=0.378 Sum_probs=194.2
Q ss_pred eeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecCCCCCCCC
Q 001142 813 DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 889 (1142)
Q Consensus 813 ~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~~~~~~~~~~~ 889 (1142)
++||+|+||.||+|++. +..+|+|+.+...... ....+. +..|..++..+ +||||+++++++....
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~----~~~e~~~l~~~~~hp~i~~~~~~~~~~~------ 69 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLE-DDDVEC----TMVERRVLALAWEHPFLTHLFCTFQTKE------ 69 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhhHHH----HHHHHHHHHhccCCCCccceeeEEEcCC------
Confidence 47999999999999984 4568888765332111 111222 24677777654 7999999999987654
Q ss_pred CCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccC
Q 001142 890 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 969 (1142)
Q Consensus 890 ~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~ 969 (1142)
+.++||||+++++|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 70 --------~~~lv~e~~~gg~L~~~~~~-----~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~---- 132 (316)
T cd05592 70 --------HLFFVMEYLNGGDLMFHIQS-----SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKD---- 132 (316)
T ss_pred --------EEEEEEcCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCC----
Confidence 35999999999999999875 2468999999999999999999999999999999999999887
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001142 970 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1049 (1142)
Q Consensus 970 ~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~P 1049 (1142)
+.+||+|||++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 133 ---~~~kL~Dfg~a~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~ell~G~~P 195 (316)
T cd05592 133 ---GHIKIADFGMCKENMNGE----------GKASTFCGTPDYIAPEILKG----QKYNESVDWWSFGVLLYEMLIGQSP 195 (316)
T ss_pred ---CCEEEccCcCCeECCCCC----------CccccccCCccccCHHHHcC----CCCCCcccchhHHHHHHHHHhCCCC
Confidence 789999999986532211 11224468999999999875 5678999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH-HHHHH
Q 001142 1050 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA-GDLYE 1128 (1142)
Q Consensus 1050 f~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa-~EVL~ 1128 (1142)
|.+.+..++...+.... +..+ ...+..+.+++.+||+.||.+||++ .++++
T Consensus 196 f~~~~~~~~~~~i~~~~-~~~~---------------------------~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 196 FHGEDEDELFDSILNDR-PHFP---------------------------RWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCCHHHHHHHHHcCC-CCCC---------------------------CCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 99877766666554322 1111 1345568899999999999999986 47889
Q ss_pred HHHhhc
Q 001142 1129 MFVART 1134 (1142)
Q Consensus 1129 ~L~~~~ 1134 (1142)
|+|+..
T Consensus 248 h~~~~~ 253 (316)
T cd05592 248 HPFFRG 253 (316)
T ss_pred CcccCC
Confidence 998864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=342.88 Aligned_cols=250 Identities=25% Similarity=0.356 Sum_probs=195.8
Q ss_pred eeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecCCCCCCCC
Q 001142 813 DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 889 (1142)
Q Consensus 813 ~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~~~~~~~~~~~ 889 (1142)
++||+|+||.||+|++. +..+|+|+.+....... ..... ...|..++..+ +||||+++++++.+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~-~~~~~----~~~e~~~l~~~~~~~~i~~~~~~~~~~~------ 69 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLID-DDVEC----TMVEKRVLALAWENPFLTHLYCTFQTKE------ 69 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhc-chHHH----HHHHHHHHHhccCCCCccCeeEEEEeCC------
Confidence 47999999999999984 56788887653321111 11122 25688888765 7999999999998655
Q ss_pred CCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccC
Q 001142 890 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 969 (1142)
Q Consensus 890 ~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~ 969 (1142)
+.|+||||+++++|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 70 --------~~~lv~E~~~~g~L~~~i~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~---- 132 (316)
T cd05620 70 --------HLFFVMEFLNGGDLMFHIQD-----KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRD---- 132 (316)
T ss_pred --------EEEEEECCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC----
Confidence 45999999999999999875 2468999999999999999999999999999999999999887
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001142 970 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1049 (1142)
Q Consensus 970 ~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~P 1049 (1142)
+.++|+|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 133 ---~~~kl~Dfg~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslGvil~el~~g~~P 195 (316)
T cd05620 133 ---GHIKIADFGMCKENVFGD----------NRASTFCGTPDYIAPEILQG----LKYTFSVDWWSFGVLLYEMLIGQSP 195 (316)
T ss_pred ---CCEEeCccCCCeecccCC----------CceeccCCCcCccCHHHHcC----CCCCcccchhhhHHHHHHHHhCCCC
Confidence 789999999986422111 11224568999999999876 5688999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH-HHHHH
Q 001142 1050 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA-GDLYE 1128 (1142)
Q Consensus 1050 f~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa-~EVL~ 1128 (1142)
|.+.+..+....+..... ..+ ...+..+.+++.+||+.||.+||++ +++++
T Consensus 196 f~~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 196 FHGDDEDELFESIRVDTP-HYP---------------------------RWITKESKDILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred CCCCCHHHHHHHHHhCCC-CCC---------------------------CCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 988777666665543221 111 0234568999999999999999998 58888
Q ss_pred HHHhhcC
Q 001142 1129 MFVARTS 1135 (1142)
Q Consensus 1129 ~L~~~~s 1135 (1142)
|+|+...
T Consensus 248 h~~f~~~ 254 (316)
T cd05620 248 HPFFKTI 254 (316)
T ss_pred CCCcCCC
Confidence 9998653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=344.68 Aligned_cols=285 Identities=18% Similarity=0.216 Sum_probs=201.9
Q ss_pred CCCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 882 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~ 882 (1142)
...+|++.+.||+|+||.||+|.+ .+..+|+|+.... .........+ .+|+.+++.++||||+++++++...
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~----~~E~~~l~~l~h~niv~~~~~~~~~ 92 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP--FQNQTHAKRA----YRELVLLKCVNHKNIISLLNVFTPQ 92 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccc--ccchhHHHHH----HHHHHHHHhCCCCCEeeeeeeeccC
Confidence 357899999999999999999987 4567888875322 1222222333 6899999999999999999998754
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
... ......|+||||++ ++|...+.. .+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 93 ~~~--------~~~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~ 156 (359)
T cd07876 93 KSL--------EEFQDVYLVMELMD-ANLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 156 (359)
T ss_pred CCc--------cccceeEEEEeCCC-cCHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE
Confidence 322 12235699999997 567776643 47889999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
+.+ +.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 157 ~~~-------~~~kl~Dfg~a~~~~~~~-----------~~~~~~~t~~y~aPE~~~~----~~~~~~~DiwSlG~il~e 214 (359)
T cd07876 157 KSD-------CTLKILDFGLARTACTNF-----------MMTPYVVTRYYRAPEVILG----MGYKENVDIWSVGCIMGE 214 (359)
T ss_pred CCC-------CCEEEecCCCccccccCc-----------cCCCCcccCCCCCchhccC----CCCCcchhhHHHHHHHHH
Confidence 887 789999999986432211 1123468999999999876 568899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHH-HhCCCCCchhHHhhhc-----------ccccccccccCCCCCC---chhhhhhHHHHHH
Q 001142 1043 LLTLQVPYMGLSELEIHDLI-QMGKRPRLTDELEALG-----------SCHEHEVAQSGSGFEK---PEAELETLSFLVD 1107 (1142)
Q Consensus 1043 LLtG~~Pf~~~~~~el~~~I-~~~~~p~l~~~l~~~~-----------~~~~~~~~~~~~~~~~---~~~~~~~~~~L~d 1107 (1142)
|++|+.||.+.+.......+ .....+... ...... ........+....+.. .......++.+.+
T Consensus 215 l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (359)
T cd07876 215 LVKGSVIFQGTDHIDQWNKVIEQLGTPSAE-FMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARD 293 (359)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHhcCCCcHH-HHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHH
Confidence 99999999876654443333 222211111 000000 0000000000000000 0011123567899
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001142 1108 VFRRCTEENPTERPTAGDLYEMFVART 1134 (1142)
Q Consensus 1108 LI~~CL~~DP~~RPSa~EVL~~L~~~~ 1134 (1142)
|+.+||+.||++|||+.|+++|+|+..
T Consensus 294 li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 294 LLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHHhccCcccCCCHHHHhcCchhhh
Confidence 999999999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=357.61 Aligned_cols=258 Identities=26% Similarity=0.367 Sum_probs=205.1
Q ss_pred CCcceeeeecccCceEEEEEEEC---CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG---SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~---~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
..|.+.+.||+|++|.||+|... +..+++|..... ....... +.+|+.+++.++|||||++++++...+
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~----~~~~~~~----~~~E~~~l~~l~Hpniv~~~~~~~~~~ 138 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN----DERQAAY----ARSELHCLAACDHFGIVKHFDDFKSDD 138 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC----CHHHHHH----HHHHHHHHHhCCCCCEeEEEEEEEECC
Confidence 34999999999999999999874 345666643221 2222222 368999999999999999999998655
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
+.+|||||+++|+|.++++.... ...++++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 139 --------------~~~lv~E~~~gg~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~ 203 (478)
T PTZ00267 139 --------------KLLLIMEYGSGGDLNKQIKQRLK-EHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLM 203 (478)
T ss_pred --------------EEEEEEECCCCCCHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEEC
Confidence 45999999999999999875322 235689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.+||+|||+++.+...... .......||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 204 ~~-------~~~kL~DFgla~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slG~~l~el 264 (478)
T PTZ00267 204 PT-------GIIKLGDFGFSKQYSDSVSL--------DVASSFCGTPYYLAPELWER----KRYSKKADMWSLGVILYEL 264 (478)
T ss_pred CC-------CcEEEEeCcCceecCCcccc--------ccccccCCCccccCHhHhCC----CCCCcHHhHHHHHHHHHHH
Confidence 77 78999999999765432110 11224469999999999875 5688999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
++|+.||.+....++...+..+..+..+. ..+..+.++|.+||+.||++||++
T Consensus 265 ~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~---------------------------~~s~~~~~li~~~L~~dP~~Rps~ 317 (478)
T PTZ00267 265 LTLHRPFKGPSQREIMQQVLYGKYDPFPC---------------------------PVSSGMKALLDPLLSKNPALRPTT 317 (478)
T ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCCCc---------------------------cCCHHHHHHHHHHhccChhhCcCH
Confidence 99999998877766666655443322110 344568999999999999999999
Q ss_pred HHHHHHHHhh
Q 001142 1124 GDLYEMFVAR 1133 (1142)
Q Consensus 1124 ~EVL~~L~~~ 1133 (1142)
.+++.+.|.+
T Consensus 318 ~~~l~~~~~~ 327 (478)
T PTZ00267 318 QQLLHTEFLK 327 (478)
T ss_pred HHHHhCHHHH
Confidence 9999988765
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=346.03 Aligned_cols=261 Identities=21% Similarity=0.300 Sum_probs=198.3
Q ss_pred CCCCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001142 803 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 880 (1142)
Q Consensus 803 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~ 880 (1142)
...+.+|++.++||+|+||.||+|++. +..+|+|+..... .... ...+.+|++++++++|+||+++++++.
T Consensus 70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~ 142 (353)
T PLN00034 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH---EDTV----RRQICREIEILRDVNHPNVVKCHDMFD 142 (353)
T ss_pred CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC---cHHH----HHHHHHHHHHHHhCCCCCcceeeeEec
Confidence 344678999999999999999999984 6778888753221 1122 233479999999999999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NI 960 (1142)
+.+ ..++||||+++++|.+. ...++..+..++.||+.||+|||++||+||||||+||
T Consensus 143 ~~~--------------~~~lv~e~~~~~~L~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI 199 (353)
T PLN00034 143 HNG--------------EIQVLLEFMDGGSLEGT---------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNL 199 (353)
T ss_pred cCC--------------eEEEEEecCCCCccccc---------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHE
Confidence 654 34999999999998643 2356778889999999999999999999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhcccc-CCCCCCchhhHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCL 1039 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~s~ksDVwSLGvi 1039 (1142)
|++.+ +.+||+|||++..+..... ......||..|+|||++.... .+..++.++|||||||+
T Consensus 200 ll~~~-------~~~kL~DfG~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvi 262 (353)
T PLN00034 200 LINSA-------KNVKIADFGVSRILAQTMD----------PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVS 262 (353)
T ss_pred EEcCC-------CCEEEcccccceecccccc----------cccccccCccccCccccccccccCcCCCcchhHHHHHHH
Confidence 99887 7899999999876533211 112346899999999875422 12334579999999999
Q ss_pred HHHHHhCCCCCCCCCHHHH---HHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 001142 1040 LLELLTLQVPYMGLSELEI---HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1116 (1142)
Q Consensus 1040 L~ELLtG~~Pf~~~~~~el---~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~D 1116 (1142)
+|||++|+.||......+. ...+.....+. .....+..+.+||.+||+.|
T Consensus 263 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~~ 315 (353)
T PLN00034 263 ILEFYLGRFPFGVGRQGDWASLMCAICMSQPPE---------------------------APATASREFRHFISCCLQRE 315 (353)
T ss_pred HHHHHhCCCCCCCCCCccHHHHHHHHhccCCCC---------------------------CCCccCHHHHHHHHHHccCC
Confidence 9999999999974322221 11111111111 01144567999999999999
Q ss_pred CCCCCCHHHHHHHHHhhcCCC
Q 001142 1117 PTERPTAGDLYEMFVARTSSS 1137 (1142)
Q Consensus 1117 P~~RPSa~EVL~~L~~~~ss~ 1137 (1142)
|++|||+.|+++|+|+.....
T Consensus 316 P~~Rpt~~ell~hp~~~~~~~ 336 (353)
T PLN00034 316 PAKRWSAMQLLQHPFILRAQP 336 (353)
T ss_pred hhhCcCHHHHhcCcccccCCc
Confidence 999999999999999987643
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=344.49 Aligned_cols=286 Identities=17% Similarity=0.221 Sum_probs=202.5
Q ss_pred CCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 882 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~ 882 (1142)
..++|++.+.||+|+||.||+|.+. +..+|+|+.. ...........+ .+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~--~~~~~~~~~~~~----~~E~~~l~~l~h~niv~~~~~~~~~ 88 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS--RPFQNQTHAKRA----YRELVLMKCVNHKNIISLLNVFTPQ 88 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeC--CcccChHHHHHH----HHHHHHHHHhCCCchhceeeeeecc
Confidence 3578999999999999999999874 5667777643 222222222333 6899999999999999999998754
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
... ......++||||++ ++|...+.. .+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 89 ~~~--------~~~~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill 152 (355)
T cd07874 89 KSL--------EEFQDVYLVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 152 (355)
T ss_pred ccc--------cccceeEEEhhhhc-ccHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE
Confidence 322 12235699999997 577777653 47889999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
+.+ +.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 153 ~~~-------~~~kl~Dfg~~~~~~~~~-----------~~~~~~~t~~y~aPE~~~~----~~~~~~~DiwslG~il~e 210 (355)
T cd07874 153 KSD-------CTLKILDFGLARTAGTSF-----------MMTPYVVTRYYRAPEVILG----MGYKENVDIWSVGCIMGE 210 (355)
T ss_pred CCC-------CCEEEeeCcccccCCCcc-----------ccCCccccCCccCHHHHcC----CCCCchhhHHHHHHHHHH
Confidence 887 789999999997543211 1123468999999999875 568899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcc-----------cccccccccCCC--CC-CchhhhhhHHHHHHH
Q 001142 1043 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGS-----------CHEHEVAQSGSG--FE-KPEAELETLSFLVDV 1108 (1142)
Q Consensus 1043 LLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~-----------~~~~~~~~~~~~--~~-~~~~~~~~~~~L~dL 1108 (1142)
|++|+.||.+.+..+....+........+........ ............ +. ........+..+.+|
T Consensus 211 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 290 (355)
T cd07874 211 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDL 290 (355)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHH
Confidence 9999999987765554433322111111111000000 000000000000 00 000111235678999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhhc
Q 001142 1109 FRRCTEENPTERPTAGDLYEMFVART 1134 (1142)
Q Consensus 1109 I~~CL~~DP~~RPSa~EVL~~L~~~~ 1134 (1142)
+.+||+.||++|||+.|+++|+|+..
T Consensus 291 i~~mL~~dP~~Rps~~ell~hp~~~~ 316 (355)
T cd07874 291 LSKMLVIDPAKRISVDEALQHPYINV 316 (355)
T ss_pred HHHHhcCCchhcCCHHHHhcCcchhc
Confidence 99999999999999999999999963
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=343.85 Aligned_cols=286 Identities=17% Similarity=0.206 Sum_probs=205.2
Q ss_pred CCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 882 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~ 882 (1142)
...+|++.+.||+|+||.||+|.+. +..+|+|+.... .........+ .+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~----~~E~~~l~~l~h~~ii~~~~~~~~~ 95 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP--FQNQTHAKRA----YRELVLMKCVNHKNIIGLLNVFTPQ 95 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcc--ccCchhHHHH----HHHHHHHHhcCCCCccccceeeccc
Confidence 3578999999999999999999874 566777765322 2222222333 6899999999999999999988654
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
... ......|+||||++ ++|.+.+.. .+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus 96 ~~~--------~~~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll 159 (364)
T cd07875 96 KSL--------EEFQDVYIVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 159 (364)
T ss_pred ccc--------cccCeEEEEEeCCC-CCHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEE
Confidence 322 12235699999997 678877753 47889999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
+.+ +.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 160 ~~~-------~~~kL~DfG~a~~~~~~~-----------~~~~~~~t~~y~aPE~~~~----~~~~~~~DiwSlG~il~e 217 (364)
T cd07875 160 KSD-------CTLKILDFGLARTAGTSF-----------MMTPYVVTRYYRAPEVILG----MGYKENVDIWSVGCIMGE 217 (364)
T ss_pred CCC-------CcEEEEeCCCccccCCCC-----------cccCCcccCCcCCHHHHhC----CCCCchhhHHhHHHHHHH
Confidence 887 789999999997543211 1123468999999999876 568899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccc-----------ccccccccCCCCC---CchhhhhhHHHHHHH
Q 001142 1043 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC-----------HEHEVAQSGSGFE---KPEAELETLSFLVDV 1108 (1142)
Q Consensus 1043 LLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~-----------~~~~~~~~~~~~~---~~~~~~~~~~~L~dL 1108 (1142)
|++|+.||.+.+..+....+........+......... ......+...... ...........++++
T Consensus 218 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 297 (364)
T cd07875 218 MIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDL 297 (364)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHH
Confidence 99999999987776655555332222222111111000 0000000000000 000011234578999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhhc
Q 001142 1109 FRRCTEENPTERPTAGDLYEMFVART 1134 (1142)
Q Consensus 1109 I~~CL~~DP~~RPSa~EVL~~L~~~~ 1134 (1142)
|.+||+.||.+|||+.|+++|+|+..
T Consensus 298 l~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 298 LSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred HHHhcCcCcccCCCHHHHhcCccccc
Confidence 99999999999999999999999963
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=347.75 Aligned_cols=286 Identities=20% Similarity=0.240 Sum_probs=205.3
Q ss_pred CcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
+|++.++||+|+||.||+|.+ .+..+|+|... .........+. +.+|+.+++.++||||+++++++......
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~--~~~~~~~~~~~----~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 74 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMP--NVFQNLVSCKR----VFRELKMLCFFKHDNVLSALDILQPPHID 74 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEecc--ccccchHHHHH----HHHHHHHHHhCCCCCcCCHhheecCCCcc
Confidence 478899999999999999997 46677777642 22222222333 37899999999999999999998764311
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
.....|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 75 ---------~~~~~~lv~e~~~-~~l~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~ 139 (372)
T cd07853 75 ---------PFEEIYVVTELMQ-SDLHKIIVS-----PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSN 139 (372)
T ss_pred ---------ccceEEEEeeccc-cCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCC
Confidence 1225699999996 788887754 3468999999999999999999999999999999999999887
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+.+||+|||+++....... .......+|+.|+|||++.+ ...++.++|||||||++|||++
T Consensus 140 -------~~~kL~Dfg~a~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~il~el~~ 200 (372)
T cd07853 140 -------CVLKICDFGLARVEEPDES---------KHMTQEVVTQYYRAPEILMG---SRHYTSAVDIWSVGCIFAELLG 200 (372)
T ss_pred -------CCEEeccccceeecccCcc---------ccCCCCCcCCCcCCHHHHcC---CCCCCcHHHHHhHHHHHHHHHc
Confidence 7899999999975432111 01123357899999999875 2357899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhC-CCCCchhHHhhhcccccccccccCCCCCC-c---hhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1046 LQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEK-P---EAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1046 G~~Pf~~~~~~el~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~-~---~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
|+.||.+.+..+....+... ..+.. ..+.................... . ......++.+.+|+.+||+.||.+|
T Consensus 201 g~~pf~~~~~~~~~~~i~~~~g~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R 279 (372)
T cd07853 201 RRILFQAQSPIQQLDLITDLLGTPSL-EAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKR 279 (372)
T ss_pred CCCCCCCCCHHHHHHHHHHHcCCCCH-HHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhC
Confidence 99999987776666555332 22221 11111000000000000000000 0 0011346678999999999999999
Q ss_pred CCHHHHHHHHHhhc
Q 001142 1121 PTAGDLYEMFVART 1134 (1142)
Q Consensus 1121 PSa~EVL~~L~~~~ 1134 (1142)
||+.|+++|+|+..
T Consensus 280 ~t~~e~l~hp~~~~ 293 (372)
T cd07853 280 ISAADALAHPYLDE 293 (372)
T ss_pred cCHHHHhcCHhhCC
Confidence 99999999999876
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=344.25 Aligned_cols=249 Identities=26% Similarity=0.317 Sum_probs=194.7
Q ss_pred eeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHH-HHhhCCCCCccceeeeEecCCCCCCCC
Q 001142 813 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVR-MLGALRHSCIVEMYGHKISSKWLPSAD 889 (1142)
Q Consensus 813 ~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~-iL~~L~HpNIVkl~g~~~~~~~~~~~~ 889 (1142)
+.||+|+||+||+|++ .+..+|+|+........ ..... .+..|.. +++.++||||+++++.+.+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~----~~~~e~~~~~~~l~hp~iv~~~~~~~~~~------ 69 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILK-KKEQK----HIMAERNVLLKNVKHPFLVGLHYSFQTAD------ 69 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh-hhHHH----HHHHHHHHHHhhCCCCCCCCeeEEEEeCC------
Confidence 4799999999999998 46778888864321111 11111 2245554 457789999999999987654
Q ss_pred CCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccC
Q 001142 890 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 969 (1142)
Q Consensus 890 ~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~ 969 (1142)
..++||||+++++|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 70 --------~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~---- 132 (323)
T cd05575 70 --------KLYFVLDYVNGGELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQ---- 132 (323)
T ss_pred --------EEEEEEcCCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC----
Confidence 34999999999999999875 3468999999999999999999999999999999999999887
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001142 970 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1049 (1142)
Q Consensus 970 ~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~P 1049 (1142)
+.+||+|||++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 133 ---~~~kl~Dfg~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~ell~g~~p 195 (323)
T cd05575 133 ---GHVVLTDFGLCKEGIEHS----------KTTSTFCGTPEYLAPEVLRK----QPYDRTVDWWCLGAVLYEMLYGLPP 195 (323)
T ss_pred ---CcEEEeccCCCcccccCC----------CccccccCChhhcChhhhcC----CCCCccccccccchhhhhhhcCCCC
Confidence 789999999986432111 11123468999999999875 5688999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH----HH
Q 001142 1050 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA----GD 1125 (1142)
Q Consensus 1050 f~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa----~E 1125 (1142)
|.+.+..+....+...... +. ...+..+.+++.+||+.||.+||++ .+
T Consensus 196 f~~~~~~~~~~~i~~~~~~-~~---------------------------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (323)
T cd05575 196 FYSRDTAEMYDNILNKPLR-LK---------------------------PNISVSARHLLEGLLQKDRTKRLGAKDDFLE 247 (323)
T ss_pred CCCCCHHHHHHHHHcCCCC-CC---------------------------CCCCHHHHHHHHHHhhcCHHhCCCCCCCHHH
Confidence 9887776666655433211 00 0345668999999999999999987 69
Q ss_pred HHHHHHhhc
Q 001142 1126 LYEMFVART 1134 (1142)
Q Consensus 1126 VL~~L~~~~ 1134 (1142)
+++|+|+..
T Consensus 248 il~~~~~~~ 256 (323)
T cd05575 248 IKNHVFFSS 256 (323)
T ss_pred HHcCCCcCC
Confidence 999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=342.36 Aligned_cols=254 Identities=25% Similarity=0.326 Sum_probs=200.9
Q ss_pred CcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~~~~~~ 884 (1142)
+|++.+.||+|+||.||+|++. +..+|+|+....... .....+ ....|..++..+ +|++|+++++++.+.+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~----~~~~e~~~l~~~~~~~~i~~~~~~~~~~~- 74 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-QDDDVE----CTMVEKRVLALSGKPPFLTQLHSCFQTMD- 74 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHH----HHHHHHHHHHhccCCCeEeeEEEEEecCC-
Confidence 5889999999999999999884 457888876532211 111122 225788888777 5899999999987654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~E~~~~g~L~~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~ 136 (323)
T cd05616 75 -------------RLYFVMEYVNGGDLMYQIQQ-----VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDS 136 (323)
T ss_pred -------------EEEEEEcCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECC
Confidence 34999999999999999875 246899999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 137 ~-------~~~kL~DfG~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlGvil~ell 195 (323)
T cd05616 137 E-------GHIKIADFGMCKENMWDG----------VTTKTFCGTPDYIAPEIIAY----QPYGKSVDWWAFGVLLYEML 195 (323)
T ss_pred C-------CcEEEccCCCceecCCCC----------CccccCCCChhhcCHHHhcC----CCCCCccchhchhHHHHHHH
Confidence 7 789999999986432111 01123468999999999876 56889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC--
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT-- 1122 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS-- 1122 (1142)
+|+.||.+.+..++...+...... .+ ...+..+.+++.+||+.||.+|++
T Consensus 196 tg~~Pf~~~~~~~~~~~i~~~~~~-~p---------------------------~~~s~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05616 196 AGQAPFEGEDEDELFQSIMEHNVA-YP---------------------------KSMSKEAVAICKGLMTKHPGKRLGCG 247 (323)
T ss_pred hCCCCCCCCCHHHHHHHHHhCCCC-CC---------------------------CcCCHHHHHHHHHHcccCHHhcCCCC
Confidence 999999987777766665443211 00 034556899999999999999998
Q ss_pred ---HHHHHHHHHhhc
Q 001142 1123 ---AGDLYEMFVART 1134 (1142)
Q Consensus 1123 ---a~EVL~~L~~~~ 1134 (1142)
..++++|+|++.
T Consensus 248 ~~~~~~i~~h~~~~~ 262 (323)
T cd05616 248 PEGERDIKEHAFFRY 262 (323)
T ss_pred CCCHHHHhcCCCcCC
Confidence 489999988864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=323.55 Aligned_cols=253 Identities=24% Similarity=0.330 Sum_probs=203.5
Q ss_pred CcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
+|++.+.||+|++|.||+|.+ .+..+++|..... .......+.+ .+|++++++++||||+++++++.+.+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~----~~e~~~l~~l~h~~i~~~~~~~~~~~-- 72 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLS--KMNRREREEA----IDEARVLAKLDSSYIIRYYESFLDKG-- 72 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehh--hCCHHHHHHH----HHHHHHHHhcCCCCeehheeeeccCC--
Confidence 578999999999999999988 4566777765433 2223333344 78999999999999999999987654
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
..++||||+++++|.+++... ....+++..+..++.|++.||.|||+.||+|+||||+||+++.+
T Consensus 73 ------------~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~ 137 (256)
T cd08529 73 ------------KLNIVMEYAENGDLHKLLKMQ---RGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAY 137 (256)
T ss_pred ------------EEEEEEEeCCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCC
Confidence 359999999999999999762 23468999999999999999999999999999999999999887
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+.++|+|||.+........ ......|++.|+|||++.+ ..++.++||||||+++|+|++
T Consensus 138 -------~~~~l~df~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~l~~ 196 (256)
T cd08529 138 -------DNVKIGDLGVAKLLSDNTN----------FANTIVGTPYYLSPELCED----KPYNEKSDVWALGVVLYECCT 196 (256)
T ss_pred -------CCEEEcccccceeccCccc----------hhhccccCccccCHHHhcC----CCCCCccchHHHHHHHHHHHh
Confidence 7899999999876543211 1123357889999999875 457899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001142 1046 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1125 (1142)
Q Consensus 1046 G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~E 1125 (1142)
|+.||......+....+..+..+.... ..+..+.+++.+||+.+|++||++.+
T Consensus 197 g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~i~~~l~~~p~~Rp~~~~ 249 (256)
T cd08529 197 GKHPFDANNQGALILKIIRGVFPPVSQ---------------------------MYSQQLAQLIDQCLTKDYRQRPDTFQ 249 (256)
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCcc---------------------------ccCHHHHHHHHHHccCCcccCcCHHH
Confidence 999998777665555554443332221 34456899999999999999999999
Q ss_pred HHHHHH
Q 001142 1126 LYEMFV 1131 (1142)
Q Consensus 1126 VL~~L~ 1131 (1142)
+++++|
T Consensus 250 ll~~~~ 255 (256)
T cd08529 250 LLRNPS 255 (256)
T ss_pred HhhCCC
Confidence 999876
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=340.10 Aligned_cols=280 Identities=23% Similarity=0.310 Sum_probs=201.8
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
++|++.++||+|+||.||+|.+. +..+|+|+..... ....... +.+|++++++++||||+++++++.+.+
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~~~~~- 76 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI---KPAIRNQ----IIRELQVLHECNSPYIVGFYGAFYSDG- 76 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHHHHH----HHHHHHHHHHCCCCcccceeEEEEECC-
Confidence 57999999999999999999985 5566777654331 2222233 379999999999999999999998755
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCeeec
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENILID 963 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~-gIvHrDLKp~NILld 963 (1142)
+.++||||+++++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++
T Consensus 77 -------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~ 138 (333)
T cd06650 77 -------------EISICMEHMDGGSLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN 138 (333)
T ss_pred -------------EEEEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEc
Confidence 34999999999999999975 24588999999999999999999975 799999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.+||+|||++....... .....||..|+|||++.+ ..++.++|||||||++|+|
T Consensus 139 ~~-------~~~kL~Dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~il~~l 195 (333)
T cd06650 139 SR-------GEIKLCDFGVSGQLIDSM------------ANSFVGTRSYMSPERLQG----THYSVQSDIWSMGLSLVEM 195 (333)
T ss_pred CC-------CCEEEeeCCcchhhhhhc------------cccCCCCccccCHHHhcC----CCCCcHHHHHHHHHHHHHH
Confidence 77 789999999986543211 123458999999999875 4678999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhh-cccccccc----ccc-------------CCCCCCchhhhhhHHHH
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEAL-GSCHEHEV----AQS-------------GSGFEKPEAELETLSFL 1105 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~-~~~~~~~~----~~~-------------~~~~~~~~~~~~~~~~L 1105 (1142)
++|+.||......+....+............... ........ ... .............+.++
T Consensus 196 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (333)
T cd06650 196 AIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEF 275 (333)
T ss_pred HHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHH
Confidence 9999999865544433222110000000000000 00000000 000 00000000001245678
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001142 1106 VDVFRRCTEENPTERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1106 ~dLI~~CL~~DP~~RPSa~EVL~~L~~~~s 1135 (1142)
.+|+.+||+.||++|||+.|+++|+|++..
T Consensus 276 ~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 276 QDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred HHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 999999999999999999999999999865
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=334.45 Aligned_cols=265 Identities=20% Similarity=0.286 Sum_probs=196.0
Q ss_pred CCcceeeeecccCceEEEEEEECC------------------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFGS------------------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR 868 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~~------------------~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~ 868 (1142)
.+|++.++||+|+||.||+|.+.. ..+|+|+.... ........+ .+|+.++.+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~----~~E~~~l~~l~ 77 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD---ANKNARNDF----LKEVKILSRLK 77 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCC---CCHHHHHHH----HHHHHHHhhcC
Confidence 478999999999999999998632 24777765422 122233334 79999999999
Q ss_pred CCCccceeeeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc--------------CCCCCCHHHHHHH
Q 001142 869 HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET--------------GEKHVSVKLALFI 934 (1142)
Q Consensus 869 HpNIVkl~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~--------------~~~~ls~~~i~~I 934 (1142)
||||+++++++.+.+. .++||||+++++|.+++...... ....+++..+..+
T Consensus 78 h~niv~~~~~~~~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 143 (304)
T cd05096 78 DPNIIRLLGVCVDEDP--------------LCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHV 143 (304)
T ss_pred CCCeeEEEEEEecCCc--------------eEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHH
Confidence 9999999999986543 49999999999999998653211 1134688899999
Q ss_pred HHHHHHHHHHHHhCCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccc
Q 001142 935 AQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMA 1014 (1142)
Q Consensus 935 a~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~A 1014 (1142)
+.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++........ .......++..|+|
T Consensus 144 ~~~i~~al~~lH~~~ivH~dlkp~Nill~~~-------~~~kl~DfG~~~~~~~~~~~--------~~~~~~~~~~~y~a 208 (304)
T cd05096 144 ALQIASGMKYLSSLNFVHRDLATRNCLVGEN-------LTIKIADFGMSRNLYAGDYY--------RIQGRAVLPIRWMA 208 (304)
T ss_pred HHHHHHHHHHHHHCCccccCcchhheEEcCC-------ccEEECCCccceecccCcee--------EecCcCCCCccccC
Confidence 9999999999999999999999999999887 78999999999754322110 01123346788999
Q ss_pred hhhhccccCCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCC
Q 001142 1015 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLT--LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF 1092 (1142)
Q Consensus 1015 PE~l~~~~~~~~~s~ksDVwSLGviL~ELLt--G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~ 1092 (1142)
||++.. ..++.++||||||+++|||++ +..||.+.+..+....+...........
T Consensus 209 PE~~~~----~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~------------------- 265 (304)
T cd05096 209 WECILM----GKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQV------------------- 265 (304)
T ss_pred HHHHhc----CCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccc-------------------
Confidence 999875 568899999999999999987 5678877665554433321100000000
Q ss_pred CCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 001142 1093 EKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFV 1131 (1142)
Q Consensus 1093 ~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~ 1131 (1142)
.......++..+.+++.+||+.||.+|||+.+|.+.+.
T Consensus 266 -~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 266 -YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred -cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 00000144567999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=350.25 Aligned_cols=267 Identities=23% Similarity=0.275 Sum_probs=200.4
Q ss_pred CcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
.|++.++||+|+||+||+|++. +..+|+|+..... .........+.+|+.++++++|||||++++.+.+.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~-----~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~-- 74 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKD-----VLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD-- 74 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHH-----hhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCC--
Confidence 5899999999999999999984 5567777653221 111112233478999999999999999999998655
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
+.++||||+++|+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 75 ------------~~~lv~E~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~ 137 (382)
T cd05625 75 ------------NLYFVMDYIPGGDMMSLLIR-----MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRD 137 (382)
T ss_pred ------------EEEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 34999999999999999875 2468999999999999999999999999999999999999887
Q ss_pred cccCCCCCeEEEeecCCccccccccccccc-------------------------------------ccCCCCCCCCccC
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCI-------------------------------------AHRGIPAPDVCVG 1008 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~-------------------------------------~~~~~~~~~~~~G 1008 (1142)
+.+||+|||++..+......... ............|
T Consensus 138 -------g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 210 (382)
T cd05625 138 -------GHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVG 210 (382)
T ss_pred -------CCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhcccccccccccccc
Confidence 78999999998543211000000 0000001123469
Q ss_pred CCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCchhHHhhhcccccccccc
Q 001142 1009 TPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQ 1087 (1142)
Q Consensus 1009 T~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~Pf~~~~~~el~~~I~~~~-~p~l~~~l~~~~~~~~~~~~~ 1087 (1142)
|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+.... ....+.
T Consensus 211 t~~Y~aPE~~~~----~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~--------------- 271 (382)
T cd05625 211 TPNYIAPEVLLR----TGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPP--------------- 271 (382)
T ss_pred CcccCCHHHhcC----CCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCC---------------
Confidence 999999999875 568899999999999999999999998877665544443211 111100
Q ss_pred cCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC---HHHHHHHHHhhcC
Q 001142 1088 SGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT---AGDLYEMFVARTS 1135 (1142)
Q Consensus 1088 ~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS---a~EVL~~L~~~~s 1135 (1142)
....++++.++|.+|+ .+|.+|++ +.++++|+|++..
T Consensus 272 ----------~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 272 ----------QAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred ----------cccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence 0134566888888876 59999987 9999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=346.70 Aligned_cols=264 Identities=28% Similarity=0.390 Sum_probs=196.8
Q ss_pred CCcceeeeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~~-~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
++|.-..+||+|+||.||+|...+ ..+|||. +....... .++| .+|+.++.+++|||||+++|||.+.+.
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~--~~~~~~~~--~~eF----~~Ei~~ls~l~H~Nlv~LlGyC~e~~~- 145 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSDGTVVAVKR--LSSNSGQG--EREF----LNEVEILSRLRHPNLVKLLGYCLEGGE- 145 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECCCCEEEEEE--ecCCCCcc--hhHH----HHHHHHHhcCCCcCcccEEEEEecCCc-
Confidence 457777899999999999999865 6788884 33322221 3345 899999999999999999999987541
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCCCCeee
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK---HIMHRDIKSENILI 962 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~---gIvHrDLKp~NILl 962 (1142)
+.+||+||+++|||.+++... ... +++|..+.+||.++|+||+|||.. .||||||||+|||+
T Consensus 146 ------------~~~LVYEym~nGsL~d~L~~~--~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL 210 (361)
T KOG1187|consen 146 ------------HRLLVYEYMPNGSLEDHLHGK--KGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL 210 (361)
T ss_pred ------------eEEEEEEccCCCCHHHHhCCC--CCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE
Confidence 359999999999999999751 111 789999999999999999999975 49999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccc-cccccccccCCCCCCCCc-cCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRS-FLHTCCIAHRGIPAPDVC-VGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~-~~~~~~~~~~~~~~~~~~-~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
|.+ +++||+|||+|+.... .... ... .||..|+|||+... ...+.|+|||||||++
T Consensus 211 D~~-------~~aKlsDFGLa~~~~~~~~~~-----------~~~~~gt~gY~~PEy~~~----g~lt~KsDVySFGVvl 268 (361)
T KOG1187|consen 211 DED-------FNAKLSDFGLAKLGPEGDTSV-----------STTVMGTFGYLAPEYAST----GKLTEKSDVYSFGVVL 268 (361)
T ss_pred CCC-------CCEEccCccCcccCCccccce-----------eeecCCCCccCChhhhcc----CCcCcccccccchHHH
Confidence 988 8999999999965432 1110 111 69999999999875 5678999999999999
Q ss_pred HHHHhCCCCCCCCC---HHHHHHH----HHhCCCCCchhHHhhhcccccccccccCCC-CCCchhhhhhHHHHHHHHHHh
Q 001142 1041 LELLTLQVPYMGLS---ELEIHDL----IQMGKRPRLTDELEALGSCHEHEVAQSGSG-FEKPEAELETLSFLVDVFRRC 1112 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~~~---~~el~~~----I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~L~dLI~~C 1112 (1142)
+||+||+.|..... ...+... +..+. +.. +.++... ...+ .......+..+..+|
T Consensus 269 lElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~---~~e------------iiD~~l~~~~~~--~~~~~~~~~~~a~~C 331 (361)
T KOG1187|consen 269 LELITGRKAVDQSRPRGELSLVEWAKPLLEEGK---LRE------------IVDPRLKEGEYP--DEKEVKKLAELALRC 331 (361)
T ss_pred HHHHhCCcccCCCCCcccccHHHHHHHHHHCcc---hhh------------eeCCCccCCCCC--hHHHHHHHHHHHHHH
Confidence 99999998876432 1111221 11111 110 1111100 0011 003455688899999
Q ss_pred cccCCCCCCCHHHHHHHHHhh
Q 001142 1113 TEENPTERPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1113 L~~DP~~RPSa~EVL~~L~~~ 1133 (1142)
++.+|.+||+|.||++++...
T Consensus 332 ~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 332 LRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred cCcCCCcCcCHHHHHHHHHhh
Confidence 999999999999999988443
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=340.71 Aligned_cols=250 Identities=26% Similarity=0.350 Sum_probs=195.7
Q ss_pred eeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecCCCCCCCC
Q 001142 813 DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 889 (1142)
Q Consensus 813 ~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~~~~~~~~~~~ 889 (1142)
+.||+|+||.||+|++. +..+|+|+.+....... .... ....|..++..+ +||||+++++++.+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~----~~~~e~~~l~~~~~hp~iv~~~~~~~~~~------ 69 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMD-DDVE----CTMVEKRVLSLAWEHPFLTHLYCTFQTKE------ 69 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhc-chHH----HHHHHHHHHHhccCCCcCcceEEEEEeCC------
Confidence 47999999999999985 45688887653321111 1112 225688888765 8999999999988655
Q ss_pred CCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccC
Q 001142 890 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 969 (1142)
Q Consensus 890 ~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~ 969 (1142)
..++||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 70 --------~~~lv~ey~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~---- 132 (316)
T cd05619 70 --------NLFFVMEYLNGGDLMFHIQS-----CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTD---- 132 (316)
T ss_pred --------EEEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC----
Confidence 34999999999999999875 2468999999999999999999999999999999999999887
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001142 970 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1049 (1142)
Q Consensus 970 ~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~P 1049 (1142)
+.+||+|||++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 133 ---~~~kl~Dfg~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~el~~G~~p 195 (316)
T cd05619 133 ---GHIKIADFGMCKENMLGD----------AKTCTFCGTPDYIAPEILLG----QKYNTSVDWWSFGVLLYEMLIGQSP 195 (316)
T ss_pred ---CCEEEccCCcceECCCCC----------CceeeecCCccccCHHHHcC----CCCCchhhhhhHHHHHHHHHhCCCC
Confidence 789999999986432111 01123468999999999875 5688999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 001142 1050 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG-DLYE 1128 (1142)
Q Consensus 1050 f~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~-EVL~ 1128 (1142)
|.+.+..+....+..... ..+ ...+..+.+++.+||+.||.+||++. ++++
T Consensus 196 f~~~~~~~~~~~i~~~~~-~~~---------------------------~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 196 FHGHDEEELFQSIRMDNP-CYP---------------------------RWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CCCCCHHHHHHHHHhCCC-CCC---------------------------ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 988777666665543221 111 02345689999999999999999996 8999
Q ss_pred HHHhhcC
Q 001142 1129 MFVARTS 1135 (1142)
Q Consensus 1129 ~L~~~~s 1135 (1142)
|+|+...
T Consensus 248 h~~~~~~ 254 (316)
T cd05619 248 HPFFREI 254 (316)
T ss_pred CcccCCC
Confidence 9998653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=326.27 Aligned_cols=254 Identities=20% Similarity=0.308 Sum_probs=197.5
Q ss_pred CCCcceeeeecccCceEEEEEEEC-----CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 880 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~-----~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~ 880 (1142)
..+|++.+.||+|+||.||+|.+. +..+|+|+.+ ... .......+ .+|+.++++++||||+++++++.
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~--~~~-~~~~~~~~----~~e~~~l~~l~h~~iv~~~~~~~ 76 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLR--AGC-SDKQRRGF----LAEALTLGQFDHSNIVRLEGVIT 76 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecC--CCC-CHHHHHHH----HHHHHHHhcCCCCCcCeEEEEEe
Confidence 456899999999999999999863 3355666543 221 12222333 78999999999999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NI 960 (1142)
..+. .++||||+++++|.+++... ...+++..++.++.||+.||+|||++|++||||||+||
T Consensus 77 ~~~~--------------~~lv~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~ni 138 (266)
T cd05064 77 RGNT--------------MMIVTEYMSNGALDSFLRKH----EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKV 138 (266)
T ss_pred cCCC--------------cEEEEEeCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhE
Confidence 6543 49999999999999998751 24689999999999999999999999999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
|++.+ +.++++|||.+........ .......++..|+|||.+.+ ..++.++|||||||++
T Consensus 139 li~~~-------~~~~l~dfg~~~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l 198 (266)
T cd05064 139 LVNSD-------LVCKISGFRRLQEDKSEAI---------YTTMSGKSPVLWAAPEAIQY----HHFSSASDVWSFGIVM 198 (266)
T ss_pred EEcCC-------CcEEECCCcccccccccch---------hcccCCCCceeecCHHHHhh----CCccchhHHHHHHHHH
Confidence 99877 7899999998754321110 01112235678999999875 5688999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001142 1041 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1119 (1142)
Q Consensus 1041 ~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~ 1119 (1142)
||+++ |..||.+....+....+..+..+..+ ..++..+.+++.+||+.+|.+
T Consensus 199 ~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~c~~~~p~~ 251 (266)
T cd05064 199 WEVMSYGERPYWDMSGQDVIKAVEDGFRLPAP---------------------------RNCPNLLHQLMLDCWQKERGE 251 (266)
T ss_pred HHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCC---------------------------CCCCHHHHHHHHHHcCCCchh
Confidence 99775 99999887776666665444322111 134567999999999999999
Q ss_pred CCCHHHHHHHHH
Q 001142 1120 RPTAGDLYEMFV 1131 (1142)
Q Consensus 1120 RPSa~EVL~~L~ 1131 (1142)
||++.+|++.+.
T Consensus 252 RP~~~~i~~~l~ 263 (266)
T cd05064 252 RPRFSQIHSILS 263 (266)
T ss_pred CCCHHHHHHHHH
Confidence 999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=345.09 Aligned_cols=263 Identities=23% Similarity=0.290 Sum_probs=205.1
Q ss_pred CCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
++|++.+.||+|+||+||+|++ .+..+|+|+.+.... ...... ..+.+|+.+++.++||||+++++++.+.+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~----~~~~~e~~i~~~~~~~~i~~~~~~~~~~~- 74 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVL-LAQETV----SFFEEERDILSISNSPWIPQLQYAFQDKD- 74 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHH----HHHHHHHHHHHhCCCCCCcceeeEEecCC-
Confidence 3689999999999999999987 466788887653321 011122 23478999999999999999999887654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
..++||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~ 137 (330)
T cd05601 75 -------------NLYLVMEYQPGGDLLSLLNRY----EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDR 137 (330)
T ss_pred -------------eEEEEECCCCCCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECC
Confidence 349999999999999999762 246899999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccC--CCCCCchhhHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK--PNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~--~~~~s~ksDVwSLGviL~E 1042 (1142)
+ +.+||+|||++..+...... ......||+.|+|||++..... ...++.++|||||||++|+
T Consensus 138 ~-------~~~kL~Dfg~a~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~e 201 (330)
T cd05601 138 T-------GHIKLADFGSAARLTANKMV---------NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYE 201 (330)
T ss_pred C-------CCEEeccCCCCeECCCCCce---------eeecccCCccccCHHHhccccccccCCCCCcceeecccceeee
Confidence 7 78999999999765432111 1123468999999999864221 2457899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCC-CCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1043 LLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1043 LLtG~~Pf~~~~~~el~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
|++|+.||...........+..... ...+. ....+..+.+|+..||+ +|.+||
T Consensus 202 l~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~-------------------------~~~~~~~~~~li~~ll~-~p~~R~ 255 (330)
T cd05601 202 MIYGRSPFHEGTSAKTYNNIMNFQRFLKFPE-------------------------DPKVSSDFLDLIQSLLC-GQKERL 255 (330)
T ss_pred eccCCCCCCCCCHHHHHHHHHcCCCccCCCC-------------------------CCCCCHHHHHHHHHHcc-ChhhCC
Confidence 9999999987766655555433211 00000 01345678999999998 999999
Q ss_pred CHHHHHHHHHhhc
Q 001142 1122 TAGDLYEMFVART 1134 (1142)
Q Consensus 1122 Sa~EVL~~L~~~~ 1134 (1142)
|+.++++|+|+..
T Consensus 256 t~~~l~~h~~~~~ 268 (330)
T cd05601 256 GYEGLCCHPFFSK 268 (330)
T ss_pred CHHHHhCCCCcCC
Confidence 9999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=331.86 Aligned_cols=282 Identities=22% Similarity=0.226 Sum_probs=198.4
Q ss_pred CcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC---CCCCccceeeeEecC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL---RHSCIVEMYGHKISS 882 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L---~HpNIVkl~g~~~~~ 882 (1142)
+|++.+.||+|+||+||+|.+. +..+|+|+.+........ ... +.+|+.+++.+ .||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~--~~~----~~~e~~~l~~l~~~~h~ni~~~~~~~~~~ 74 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGL--PLS----TVREVALLKRLEAFDHPNIVRLMDVCATS 74 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCC--chH----HHHHHHHHHHhhhcCCCCeeeeeeeeccc
Confidence 4889999999999999999984 566888875543221111 111 24566666655 699999999988653
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
.. ......++||||++ ++|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 75 ~~---------~~~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili 141 (288)
T cd07863 75 RT---------DRETKVTLVFEHVD-QDLRTYLDKV---PPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV 141 (288)
T ss_pred cC---------CCCceEEEEEcccc-cCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 21 11235699999997 6899988752 23458999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
+.+ +.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 142 ~~~-------~~~kl~dfg~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~----~~~~~~~DiwslG~~l~~ 199 (288)
T cd07863 142 TSG-------GQVKLADFGLARIYSCQM-----------ALTPVVVTLWYRAPEVLLQ----STYATPVDMWSVGCIFAE 199 (288)
T ss_pred CCC-------CCEEECccCccccccCcc-----------cCCCccccccccCchHhhC----CCCCCcchhhhHHHHHHH
Confidence 877 789999999987543211 1123458899999999875 568899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhC-CCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1043 LLTLQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1043 LLtG~~Pf~~~~~~el~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
|++|++||.+....+....+... ..+. ...+..........+ ...............+..+.+++.+||+.||++||
T Consensus 200 l~~g~~~f~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 277 (288)
T cd07863 200 MFRRKPLFCGNSEADQLGKIFDLIGLPP-EDDWPRDVTLPRGAF-SPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRI 277 (288)
T ss_pred HHhCCcCcCCCCHHHHHHHHHHHhCCCC-hhhCccccccccccc-CCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCC
Confidence 99999999876665544443221 1111 001000000000000 00000000111124566789999999999999999
Q ss_pred CHHHHHHHHHh
Q 001142 1122 TAGDLYEMFVA 1132 (1142)
Q Consensus 1122 Sa~EVL~~L~~ 1132 (1142)
|+.|++.|+||
T Consensus 278 t~~~~l~hp~f 288 (288)
T cd07863 278 SAFRALQHPFF 288 (288)
T ss_pred CHHHHhcCCCC
Confidence 99999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=333.72 Aligned_cols=284 Identities=18% Similarity=0.232 Sum_probs=206.6
Q ss_pred CCCCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001142 803 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 880 (1142)
Q Consensus 803 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~ 880 (1142)
+..+++|++.++||+|+||.||+|++. +..+|+|......... . ... +.+|+.++++++||||+++++++.
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~-~~~----~~~E~~~l~~l~h~nI~~~~~~~~ 74 (301)
T cd07873 2 FGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG--A-PCT----AIREVSLLKDLKHANIVTLHDIIH 74 (301)
T ss_pred CccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC--c-hhH----HHHHHHHHHhcCCCCcceEEEEEe
Confidence 456788999999999999999999874 5667777754332111 1 112 268999999999999999999988
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NI 960 (1142)
... ..++||||++ ++|.+++... ...+++..+..++.||+.||.|||++||+|+||||+||
T Consensus 75 ~~~--------------~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Ni 135 (301)
T cd07873 75 TEK--------------SLTLVFEYLD-KDLKQYLDDC----GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNL 135 (301)
T ss_pred cCC--------------eEEEEEeccc-cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHE
Confidence 654 3499999997 6998888652 24588999999999999999999999999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
|++.+ +.++|+|||++........ ......+++.|+|||++.+ ...++.++|||||||++
T Consensus 136 l~~~~-------~~~kl~dfg~~~~~~~~~~----------~~~~~~~~~~y~~PE~~~~---~~~~~~~~Dv~slG~~l 195 (301)
T cd07873 136 LINER-------GELKLADFGLARAKSIPTK----------TYSNEVVTLWYRPPDILLG---STDYSTQIDMWGVGCIF 195 (301)
T ss_pred EECCC-------CcEEECcCcchhccCCCCC----------cccccceeecccCcHHHhC---CCCCccHHHHHHHHHHH
Confidence 99887 7899999999865432111 1112357889999999865 24577899999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccC-CCCC---CchhhhhhHHHHHHHHHHhcccC
Q 001142 1041 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG-SGFE---KPEAELETLSFLVDVFRRCTEEN 1116 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~-~~~~---~~~~~~~~~~~L~dLI~~CL~~D 1116 (1142)
|+|++|+.||.+.+..+....+...........+..... ...+.... .... ........++.+.+||.+||+.|
T Consensus 196 ~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~d 273 (301)
T cd07873 196 YEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS--NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFE 273 (301)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhc--cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCC
Confidence 999999999988776555444432221111111111000 00000000 0000 00111245677899999999999
Q ss_pred CCCCCCHHHHHHHHHhhc
Q 001142 1117 PTERPTAGDLYEMFVART 1134 (1142)
Q Consensus 1117 P~~RPSa~EVL~~L~~~~ 1134 (1142)
|.+|||+.|+++|+|++.
T Consensus 274 p~~R~t~~eil~h~~f~~ 291 (301)
T cd07873 274 GRKRISAEEAMKHPYFHC 291 (301)
T ss_pred cccCcCHHHHhcCccccc
Confidence 999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=345.17 Aligned_cols=276 Identities=23% Similarity=0.279 Sum_probs=196.6
Q ss_pred CCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
..+|++.++||+|+||.||+|.+. +..+|+|.. . ...+ .+|++++++++|||||++++++....
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~--~--------~~~~----~~E~~il~~l~HpnIv~~~~~~~~~~ 156 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAG--Q--------RGGT----ATEAHILRAINHPSIIQLKGTFTYNK 156 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEech--h--------hhhh----HHHHHHHHhCCCCCCCCEeEEEEECC
Confidence 457999999999999999999984 455666642 1 1122 68999999999999999999987654
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
. .++|||++. ++|..++.. ...+++..++.|+.||+.||.|||++||+||||||+|||++
T Consensus 157 ~--------------~~lv~e~~~-~~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~ 216 (391)
T PHA03212 157 F--------------TCLILPRYK-TDLYCYLAA-----KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFIN 216 (391)
T ss_pred e--------------eEEEEecCC-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEc
Confidence 3 499999996 789888865 24689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.+||+|||+|......... ......||+.|+|||++.+ ..++.++|||||||++|||
T Consensus 217 ~~-------~~vkL~DFG~a~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlGvil~el 276 (391)
T PHA03212 217 HP-------GDVCLGDFGAACFPVDINAN---------KYYGWAGTIATNAPELLAR----DPYGPAVDIWSAGIVLFEM 276 (391)
T ss_pred CC-------CCEEEEeCCccccccccccc---------ccccccCccCCCChhhhcC----CCCCcHHHHHHHHHHHHHH
Confidence 77 78999999998643221100 1123469999999999875 5688999999999999999
Q ss_pred HhCCCCCCCCC--------HHHHHHHHHh-CCCCC-chhHH-hhhcccccccccc-cCCCCCCc--hhhhhhHHHHHHHH
Q 001142 1044 LTLQVPYMGLS--------ELEIHDLIQM-GKRPR-LTDEL-EALGSCHEHEVAQ-SGSGFEKP--EAELETLSFLVDVF 1109 (1142)
Q Consensus 1044 LtG~~Pf~~~~--------~~el~~~I~~-~~~p~-l~~~l-~~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~~L~dLI 1109 (1142)
++|+.||.... ...+...+.. +..+. .+... ............. .......+ ......+.++.+|+
T Consensus 277 ltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li 356 (391)
T PHA03212 277 ATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLI 356 (391)
T ss_pred HHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHH
Confidence 99998875321 1122222221 11111 00000 0000000000000 00000011 11124567899999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHhhcC
Q 001142 1110 RRCTEENPTERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1110 ~~CL~~DP~~RPSa~EVL~~L~~~~s 1135 (1142)
.+||+.||.+||||.|+++|+|++.-
T Consensus 357 ~~mL~~dP~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 357 CKMLAFDAHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred HHHhcCChhhCCCHHHHhcChhhccC
Confidence 99999999999999999999999764
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=342.07 Aligned_cols=285 Identities=18% Similarity=0.226 Sum_probs=202.7
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
++|++.+.||+|+||+||+|.+. +..+|+|+.... .......+ .+.+|+.++++++||||+++++++.....
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRP--FQSLIHAR----RTYRELRLLKHMKHENVIGLLDVFTPATS 88 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCch--hhhhHHHH----HHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence 57999999999999999999874 456777764321 11112222 23689999999999999999998864321
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
. ......+++||++ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 89 ~--------~~~~~~~~~~~~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~ 153 (343)
T cd07878 89 I--------ENFNEVYLVTNLM-GADLNNIVKC------QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNE 153 (343)
T ss_pred c--------cccCcEEEEeecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECC
Confidence 1 1233569999998 6899888753 36899999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||+|||++...... .....||+.|+|||++.+ ...++.++|||||||++|+|+
T Consensus 154 ~-------~~~kl~Dfg~~~~~~~~-------------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~el~ 210 (343)
T cd07878 154 D-------CELRILDFGLARQADDE-------------MTGYVATRWYRAPEIMLN---WMHYNQTVDIWSVGCIMAELL 210 (343)
T ss_pred C-------CCEEEcCCccceecCCC-------------cCCccccccccCchHhcC---CccCCchhhhHhHHHHHHHHH
Confidence 7 78999999999754321 113468999999999865 235789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCch---hhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE---AELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
+|+.||.+....+....+.................................. ......+.+.+|+.+||+.||.+||
T Consensus 211 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~ 290 (343)
T cd07878 211 KGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRI 290 (343)
T ss_pred HCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCC
Confidence 9999998766555444442221111111111110000000000000000000 0012345688999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001142 1122 TAGDLYEMFVARTS 1135 (1142)
Q Consensus 1122 Sa~EVL~~L~~~~s 1135 (1142)
|+.|+++|+|+...
T Consensus 291 s~~ell~hp~~~~~ 304 (343)
T cd07878 291 SASEALAHPYFSQY 304 (343)
T ss_pred CHHHHhcCcchhcc
Confidence 99999999999753
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=347.38 Aligned_cols=265 Identities=21% Similarity=0.292 Sum_probs=204.8
Q ss_pred CCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 882 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~ 882 (1142)
...+|++.+.||+|+||.||+|++. +..+|+|+...... ...... ..+.+|+.+++.++||||+++++.+.+.
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~-~~~~~~----~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM-IKRSDS----AFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHh-hhhHHH----HHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 3578999999999999999999984 55677777532111 011111 2236899999999999999999998765
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
. ..++||||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 116 ~--------------~~~lv~Ey~~gg~L~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll 175 (371)
T cd05622 116 R--------------YLYMVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL 175 (371)
T ss_pred C--------------EEEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE
Confidence 4 35999999999999999875 358899999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
+.+ +.+||+|||++........ .......||+.|+|||++........++.++|||||||++||
T Consensus 176 ~~~-------~~ikL~DfG~a~~~~~~~~---------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilye 239 (371)
T cd05622 176 DKS-------GHLKLADFGTCMKMNKEGM---------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYE 239 (371)
T ss_pred CCC-------CCEEEEeCCceeEcCcCCc---------ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHH
Confidence 877 7899999999976532111 112245699999999998764333457899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCC-CCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC--
Q 001142 1043 LLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE-- 1119 (1142)
Q Consensus 1043 LLtG~~Pf~~~~~~el~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~-- 1119 (1142)
|++|+.||.+.+.......+..... ...+. ....+..+.++|..||..++.+
T Consensus 240 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~-------------------------~~~~s~~~~~li~~~L~~~~~r~~ 294 (371)
T cd05622 240 MLVGDTPFYADSLVGTYSKIMNHKNSLTFPD-------------------------DNDISKEAKNLICAFLTDREVRLG 294 (371)
T ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCcccCCC-------------------------cCCCCHHHHHHHHHHcCChhhhcC
Confidence 9999999998777666666543221 11110 0145667899999999844433
Q ss_pred CCCHHHHHHHHHhhcC
Q 001142 1120 RPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1120 RPSa~EVL~~L~~~~s 1135 (1142)
||+++++++|+|+...
T Consensus 295 r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 295 RNGVEEIKRHLFFKND 310 (371)
T ss_pred CCCHHHHhcCcccCCC
Confidence 7899999999999764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=332.15 Aligned_cols=256 Identities=21% Similarity=0.272 Sum_probs=193.7
Q ss_pred ecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCCCCC
Q 001142 815 AGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 892 (1142)
Q Consensus 815 LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~~~~~~ 892 (1142)
||+|+||+||++.+. +..+|+|........ ..... ..+..|+.++++++||||+++++++....
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~----~~~~~E~~il~~l~~~~i~~~~~~~~~~~--------- 66 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLK-KRKGY----EGAMVEKRILAKVHSRFIVSLAYAFQTKT--------- 66 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHh-hhHHH----HHHHHHHHHHHhCCCCcEeeeeEEEcCCC---------
Confidence 799999999999874 566788775322110 11111 23368999999999999999999887654
Q ss_pred ccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccCCCC
Q 001142 893 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 972 (1142)
Q Consensus 893 ~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~~~~ 972 (1142)
+.++||||+++++|..++..... ....+++..+..++.||+.||.|||++||+||||||+||+++.+
T Consensus 67 -----~~~lv~e~~~~g~L~~~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~------- 133 (280)
T cd05608 67 -----DLCLVMTIMNGGDLRYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDND------- 133 (280)
T ss_pred -----eEEEEEeCCCCCCHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-------
Confidence 35999999999999988865322 23568999999999999999999999999999999999999876
Q ss_pred CeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 001142 973 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1052 (1142)
Q Consensus 973 ~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~Pf~~ 1052 (1142)
+.++|+|||++..+..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..
T Consensus 134 ~~~~l~dfg~~~~~~~~~~----------~~~~~~g~~~y~aPE~~~~----~~~~~~~DvwslG~il~el~~g~~pf~~ 199 (280)
T cd05608 134 GNVRISDLGLAVELKDGQS----------KTKGYAGTPGFMAPELLQG----EEYDFSVDYFALGVTLYEMIAARGPFRA 199 (280)
T ss_pred CCEEEeeCccceecCCCCc----------cccccCCCcCccCHHHhcC----CCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 7899999999875433211 1123468999999999876 5678999999999999999999999975
Q ss_pred CCHHHHHHHHHh-CCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----CHHHH
Q 001142 1053 LSELEIHDLIQM-GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-----TAGDL 1126 (1142)
Q Consensus 1053 ~~~~el~~~I~~-~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP-----Sa~EV 1126 (1142)
.........+.. ...... ......+..+.+++.+||+.||++|| +++++
T Consensus 200 ~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~ 254 (280)
T cd05608 200 RGEKVENKELKQRILNDSV-------------------------TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGL 254 (280)
T ss_pred CCcchhHHHHHHhhcccCC-------------------------CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHH
Confidence 432211111111 000000 00014566799999999999999999 88999
Q ss_pred HHHHHhhcCC
Q 001142 1127 YEMFVARTSS 1136 (1142)
Q Consensus 1127 L~~L~~~~ss 1136 (1142)
++|+|+....
T Consensus 255 l~h~~~~~~~ 264 (280)
T cd05608 255 RTHPLFRDLN 264 (280)
T ss_pred hcChhhhcCC
Confidence 9999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=339.08 Aligned_cols=250 Identities=26% Similarity=0.333 Sum_probs=197.6
Q ss_pred eeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecCCCCCCCC
Q 001142 813 DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 889 (1142)
Q Consensus 813 ~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~~~~~~~~~~~ 889 (1142)
+.||+|+||+||+|.+. +..+|+|+.+..... ....... +.+|+.++..+ +||||+++++++...+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~----~~~e~~il~~~~~h~~i~~~~~~~~~~~------ 69 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVIL-QDDDVEC----TMTEKRVLALAGKHPFLTQLHSCFQTKD------ 69 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhHHHH----HHHHHHHHHhccCCCCccceeeEEEcCC------
Confidence 47999999999999984 557888876532111 1112222 36788899888 6999999999987654
Q ss_pred CCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccC
Q 001142 890 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 969 (1142)
Q Consensus 890 ~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~ 969 (1142)
+.++||||+++++|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 70 --------~~~lv~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~---- 132 (318)
T cd05570 70 --------RLFFVMEYVNGGDLMFHIQR-----SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSE---- 132 (318)
T ss_pred --------EEEEEEcCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCC----
Confidence 35999999999999998876 2468999999999999999999999999999999999999887
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001142 970 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1049 (1142)
Q Consensus 970 ~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~P 1049 (1142)
+.+||+|||++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 133 ---~~~kl~Dfg~~~~~~~~~----------~~~~~~~g~~~y~aPE~~~~----~~~~~~~DiwslGvil~~l~~G~~p 195 (318)
T cd05570 133 ---GHIKIADFGMCKEGILGG----------VTTSTFCGTPDYIAPEILSY----QPYGPAVDWWALGVLLYEMLAGQSP 195 (318)
T ss_pred ---CcEEecccCCCeecCcCC----------CcccceecCccccCHHHhcC----CCCCcchhhhhHHHHHHHHhhCCCC
Confidence 789999999986422111 01123458999999999876 5688999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH-----H
Q 001142 1050 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA-----G 1124 (1142)
Q Consensus 1050 f~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa-----~ 1124 (1142)
|.+.+..+....+..... ..+ ...++.+.+++.+||+.||.+||++ .
T Consensus 196 f~~~~~~~~~~~i~~~~~-~~~---------------------------~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~ 247 (318)
T cd05570 196 FEGDDEDELFQSILEDEV-RYP---------------------------RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQ 247 (318)
T ss_pred CCCCCHHHHHHHHHcCCC-CCC---------------------------CcCCHHHHHHHHHHccCCHHHcCCCCCCCHH
Confidence 988776666555533221 100 0345568999999999999999999 9
Q ss_pred HHHHHHHhhcC
Q 001142 1125 DLYEMFVARTS 1135 (1142)
Q Consensus 1125 EVL~~L~~~~s 1135 (1142)
++++|+|+...
T Consensus 248 ~ll~~~~~~~~ 258 (318)
T cd05570 248 DIKGHPFFREI 258 (318)
T ss_pred HHhcCCCcCCC
Confidence 99999998653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=346.52 Aligned_cols=268 Identities=20% Similarity=0.231 Sum_probs=203.5
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
++|++.+.||+|+||.||+|+.. +..+|+|+...... ........+.+|+.++..++||||+++++.+.+.+
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~- 74 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADM-----LEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKR- 74 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHH-----hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-
Confidence 46899999999999999999884 56788887642211 11112233478999999999999999999988655
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
+.++||||+++|+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~ 136 (360)
T cd05627 75 -------------NLYLIMEFLPGGDMMTLLMK-----KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDA 136 (360)
T ss_pred -------------EEEEEEeCCCCccHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECC
Confidence 34999999999999999875 346899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccc-------------------------cCCCCCCCCccCCCcccchhhhc
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA-------------------------HRGIPAPDVCVGTPRWMAPEVLR 1019 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~-------------------------~~~~~~~~~~~GT~~Y~APE~l~ 1019 (1142)
+ +.++|+|||++..+.......... ..........+||+.|+|||++.
T Consensus 137 ~-------~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~ 209 (360)
T cd05627 137 K-------GHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM 209 (360)
T ss_pred C-------CCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHc
Confidence 7 789999999987543211000000 00000111346999999999987
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCchhHHhhhcccccccccccCCCCCCchhh
Q 001142 1020 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAE 1098 (1142)
Q Consensus 1020 ~~~~~~~~s~ksDVwSLGviL~ELLtG~~Pf~~~~~~el~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1142)
+ ..++.++|||||||++|||++|+.||.+....+....+..... ...+. .
T Consensus 210 ~----~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-------------------------~ 260 (360)
T cd05627 210 Q----TGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPP-------------------------E 260 (360)
T ss_pred C----CCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCC-------------------------C
Confidence 6 5688999999999999999999999988777666655543211 10000 0
Q ss_pred hhhHHHHHHHHHHhcccCCCCCC---CHHHHHHHHHhhcC
Q 001142 1099 LETLSFLVDVFRRCTEENPTERP---TAGDLYEMFVARTS 1135 (1142)
Q Consensus 1099 ~~~~~~L~dLI~~CL~~DP~~RP---Sa~EVL~~L~~~~s 1135 (1142)
...++.+.++|.+|+. ||.+|+ +++++++|+|+...
T Consensus 261 ~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 261 VPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred CCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCC
Confidence 1245568899998774 999998 58999999998764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=343.61 Aligned_cols=248 Identities=24% Similarity=0.292 Sum_probs=197.4
Q ss_pred eeecccCceEEEEEEE-----CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCC
Q 001142 813 DEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 887 (1142)
Q Consensus 813 ~~LG~GsfG~Vy~a~~-----~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~ 887 (1142)
+.||+|+||.||+++. .+..+|+|+...... ..... .++.+|++++++++||||+++++++.+.+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 71 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL--KVRDR----VRTKMERDILAEVNHPFIVKLHYAFQTEG---- 71 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh--hhhhH----HHHHHHHHHHHhCCCCCcccEEEEEEcCC----
Confidence 6799999999999875 457788888653211 11111 23368999999999999999999988654
Q ss_pred CCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccc
Q 001142 888 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 967 (1142)
Q Consensus 888 ~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~ 967 (1142)
..|+||||+++++|.+++.+ ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 72 ----------~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-- 134 (318)
T cd05582 72 ----------KLYLILDFLRGGDLFTRLSK-----EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE-- 134 (318)
T ss_pred ----------EEEEEEcCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCC--
Confidence 34999999999999999865 3468999999999999999999999999999999999999877
Q ss_pred cCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCC
Q 001142 968 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 1047 (1142)
Q Consensus 968 ~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~ 1047 (1142)
+.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 135 -----~~~kL~Dfg~~~~~~~~~~----------~~~~~~g~~~y~aPE~~~~----~~~~~~~DiwslG~il~el~tg~ 195 (318)
T cd05582 135 -----GHIKLTDFGLSKESIDHEK----------KAYSFCGTVEYMAPEVVNR----RGHTQSADWWSFGVLMFEMLTGS 195 (318)
T ss_pred -----CcEEEeeccCCcccCCCCC----------ceecccCChhhcCHHHHcC----CCCCCccceeccceEeeeeccCC
Confidence 7899999999865432110 1123468999999999875 45789999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC-----
Q 001142 1048 VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT----- 1122 (1142)
Q Consensus 1048 ~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS----- 1122 (1142)
.||......+....+...... ++ ...++.+.+++.+||+.||.+||+
T Consensus 196 ~p~~~~~~~~~~~~i~~~~~~-~p---------------------------~~~~~~~~~li~~~l~~~P~~R~~a~~~~ 247 (318)
T cd05582 196 LPFQGKDRKETMTMILKAKLG-MP---------------------------QFLSPEAQSLLRALFKRNPANRLGAGPDG 247 (318)
T ss_pred CCCCCCCHHHHHHHHHcCCCC-CC---------------------------CCCCHHHHHHHHHHhhcCHhHcCCCCCCC
Confidence 999887766666555432211 00 034566899999999999999999
Q ss_pred HHHHHHHHHhhc
Q 001142 1123 AGDLYEMFVART 1134 (1142)
Q Consensus 1123 a~EVL~~L~~~~ 1134 (1142)
+.+++.|+|+..
T Consensus 248 ~~~~~~~~~~~~ 259 (318)
T cd05582 248 VEEIKRHPFFST 259 (318)
T ss_pred HHHHhCCCCcCC
Confidence 777999988754
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=347.77 Aligned_cols=256 Identities=27% Similarity=0.450 Sum_probs=206.6
Q ss_pred eeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCCCCC
Q 001142 813 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 892 (1142)
Q Consensus 813 ~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~~~~~~ 892 (1142)
-+||+|+||+||-|++..+.|.++|+.+...... .. .-+..||.+.++|+|.|||+++|.+-+.+++
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr--~~----QPLhEEIaLH~~LrHkNIVrYLGs~senGf~------- 647 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSR--EV----QPLHEEIALHSTLRHKNIVRYLGSVSENGFF------- 647 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccch--hh----ccHHHHHHHHHHHhhHhHHHHhhccCCCCeE-------
Confidence 4799999999999999988888888877654322 12 2336899999999999999999998766544
Q ss_pred ccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccCCCC
Q 001142 893 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 972 (1142)
Q Consensus 893 ~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~~~~ 972 (1142)
-|.||-+|||||.++++. +.+...-.+..+-.+.+||+.||.|||++.|||||||-+||||+.-.
T Consensus 648 -------kIFMEqVPGGSLSsLLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTyS------ 712 (1226)
T KOG4279|consen 648 -------KIFMEQVPGGSLSSLLRS--KWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYS------ 712 (1226)
T ss_pred -------EEEeecCCCCcHHHHHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeecc------
Confidence 899999999999999986 34433348889999999999999999999999999999999997543
Q ss_pred CeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 001142 973 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1052 (1142)
Q Consensus 973 ~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~Pf~~ 1052 (1142)
|.+||+|||-++.+.... +-..++.||..|||||++... ...|+.++|||||||++.||+||++||..
T Consensus 713 GvlKISDFGTsKRLAgin----------P~TETFTGTLQYMAPEvIDqG--~RGYG~aADIWS~GCT~vEMATGrPPF~E 780 (1226)
T KOG4279|consen 713 GVLKISDFGTSKRLAGIN----------PCTETFTGTLQYMAPEVIDQG--PRGYGKAADIWSFGCTMVEMATGRPPFVE 780 (1226)
T ss_pred ceEEecccccchhhccCC----------ccccccccchhhhChHhhccC--CcCCCchhhhhhccceeEeeccCCCCeee
Confidence 899999999998765432 223467799999999999863 46799999999999999999999999976
Q ss_pred CCHHH-HHHHH-HhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 001142 1053 LSELE-IHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130 (1142)
Q Consensus 1053 ~~~~e-l~~~I-~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L 1130 (1142)
....+ ..-.+ .....|+++ .+.+.+.+.+|.+|+.+||.+||+|.++|+.+
T Consensus 781 lgspqAAMFkVGmyKvHP~iP---------------------------eelsaeak~FilrcFepd~~~R~sA~~LL~Dp 833 (1226)
T KOG4279|consen 781 LGSPQAAMFKVGMYKVHPPIP---------------------------EELSAEAKNFILRCFEPDPCDRPSAKDLLQDP 833 (1226)
T ss_pred cCChhHhhhhhcceecCCCCc---------------------------HHHHHHHHHHHHHHcCCCcccCccHHHhccCc
Confidence 43332 11111 111222222 36677899999999999999999999999999
Q ss_pred HhhcC
Q 001142 1131 VARTS 1135 (1142)
Q Consensus 1131 ~~~~s 1135 (1142)
|.+..
T Consensus 834 Flq~~ 838 (1226)
T KOG4279|consen 834 FLQHN 838 (1226)
T ss_pred ccccC
Confidence 98866
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=341.18 Aligned_cols=249 Identities=24% Similarity=0.305 Sum_probs=192.7
Q ss_pred eeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHH-HHhhCCCCCccceeeeEecCCCCCCCC
Q 001142 813 DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVR-MLGALRHSCIVEMYGHKISSKWLPSAD 889 (1142)
Q Consensus 813 ~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~-iL~~L~HpNIVkl~g~~~~~~~~~~~~ 889 (1142)
+.||+|+||+||+|++. +..+|+|+...+.... ...... +..|.. +++.++||||+++++++.+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~----~~~e~~~~l~~~~h~~Iv~~~~~~~~~~------ 69 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILK-KKEEKH----IMSERNVLLKNVKHPFLVGLHFSFQTAD------ 69 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHh-hhHHHH----HHHHHHHHHHhCCCCCCCceeEEEEcCC------
Confidence 47999999999999984 4568888764321111 111112 234444 567789999999999988655
Q ss_pred CCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccC
Q 001142 890 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 969 (1142)
Q Consensus 890 ~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~ 969 (1142)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 70 --------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~---- 132 (325)
T cd05602 70 --------KLYFVLDYINGGELFYHLQR-----ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ---- 132 (325)
T ss_pred --------eEEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC----
Confidence 34999999999999999875 3468889999999999999999999999999999999999877
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001142 970 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1049 (1142)
Q Consensus 970 ~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~P 1049 (1142)
+.+||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 133 ---~~~kl~DfG~a~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~el~~g~~p 195 (325)
T cd05602 133 ---GHIVLTDFGLCKENIEHN----------GTTSTFCGTPEYLAPEVLHK----QPYDRTVDWWCLGAVLYEMLYGLPP 195 (325)
T ss_pred ---CCEEEccCCCCcccccCC----------CCcccccCCccccCHHHHcC----CCCCCccccccccHHHHHHhcCCCC
Confidence 789999999986432211 01224469999999999876 5688999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH----H
Q 001142 1050 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG----D 1125 (1142)
Q Consensus 1050 f~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~----E 1125 (1142)
|.+.+..+....+....... ....+..+.+++.+||+.||.+||++. +
T Consensus 196 f~~~~~~~~~~~i~~~~~~~----------------------------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 196 FYSRNTAEMYDNILNKPLQL----------------------------KPNITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred CCCCCHHHHHHHHHhCCcCC----------------------------CCCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 98877766665554321100 013456789999999999999999875 8
Q ss_pred HHHHHHhhc
Q 001142 1126 LYEMFVART 1134 (1142)
Q Consensus 1126 VL~~L~~~~ 1134 (1142)
+++|+|+..
T Consensus 248 i~~~~~~~~ 256 (325)
T cd05602 248 IKNHIFFSP 256 (325)
T ss_pred HhcCcccCC
Confidence 888888753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=333.08 Aligned_cols=260 Identities=22% Similarity=0.291 Sum_probs=199.8
Q ss_pred CcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
.|++.++||+|+||.||++.+. +..+|+|+...... .... ....+.+|+.++++++||||+++++++.+.+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 73 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI--KKRK---GEAMALNEKQILEKVNSRFVVSLAYAYETKD-- 73 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhh--hhhh---hHHHHHHHHHHHHhcCCCCEeeeeeeecCCC--
Confidence 4789999999999999999974 56788887542211 1111 1223368999999999999999999987654
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
+.++||||+++++|.+++.. .....+++..+..++.|++.||.|||++||+||||||+||+++.+
T Consensus 74 ------------~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~ 138 (285)
T cd05605 74 ------------ALCLVLTLMNGGDLKFHIYN---MGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDY 138 (285)
T ss_pred ------------eEEEEEeccCCCcHHHHHHh---cCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCC
Confidence 35999999999999988865 223468999999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+.++|+|||++....... ......|++.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 139 -------~~~~l~Dfg~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Diws~G~~l~el~~ 196 (285)
T cd05605 139 -------GHIRISDLGLAVEIPEGE-----------TIRGRVGTVGYMAPEVVKN----ERYTFSPDWWGLGCLIYEMIE 196 (285)
T ss_pred -------CCEEEeeCCCceecCCCC-----------ccccccCCCCccCcHHhcC----CCCCccccchhHHHHHHHHHH
Confidence 789999999987543211 0113368999999999875 567899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC----
Q 001142 1046 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP---- 1121 (1142)
Q Consensus 1046 G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP---- 1121 (1142)
|+.||.+.........+........ .......+..+.+|+.+||+.||++||
T Consensus 197 g~~pf~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ 252 (285)
T cd05605 197 GKSPFRQRKEKVKREEVERRVKEDQ------------------------EEYSEKFSEAARSICRQLLTKDPGFRLGCRG 252 (285)
T ss_pred CCCCCCCCchhhHHHHHHHHhhhcc------------------------cccCcccCHHHHHHHHHHccCCHHHhcCCCC
Confidence 9999987554332222211100000 000013456789999999999999999
Q ss_pred -CHHHHHHHHHhhcC
Q 001142 1122 -TAGDLYEMFVARTS 1135 (1142)
Q Consensus 1122 -Sa~EVL~~L~~~~s 1135 (1142)
+++++++|+|+...
T Consensus 253 ~~~~~l~~~~~~~~~ 267 (285)
T cd05605 253 EGAEEVKAHPFFRTA 267 (285)
T ss_pred CCHHHHhcCcCccCC
Confidence 99999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=321.94 Aligned_cols=251 Identities=25% Similarity=0.379 Sum_probs=198.0
Q ss_pred CCCcceeeeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~~-~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
..+|++.+.||+|+||.||++.+.. ..+++|... .... ...++ .+|+.++++++||||+++++++.....
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~--~~~~---~~~~~----~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAIN--EGAM---SEEDF----IEEAKVMMKLSHPKLVQLYGVCTQQKP 73 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEeccCceEEEEecc--cCCc---cHHHH----HHHHHHHHHCCCCCceeEEEEEccCCC
Confidence 3568999999999999999999854 467777643 2111 12234 689999999999999999999876543
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
.++||||+++++|.+++... ...+++..+..++.|++.||.|||++||+||||||+||+++.
T Consensus 74 --------------~~iv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~ 135 (256)
T cd05114 74 --------------LYIVTEFMENGCLLNYLRQR----QGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSS 135 (256)
T ss_pred --------------EEEEEEcCCCCcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcC
Confidence 49999999999999998751 235899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||+|||.++........ ......++..|+|||++.+ ..++.++||||||+++|+|+
T Consensus 136 ~-------~~~kl~d~g~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~s~G~~l~el~ 195 (256)
T cd05114 136 T-------GVVKVSDFGMTRYVLDDEYT---------SSSGAKFPVKWSPPEVFNF----SKYSSKSDVWSFGVLMWEVF 195 (256)
T ss_pred C-------CeEEECCCCCccccCCCcee---------ccCCCCCchhhCChhhccc----CccchhhhhHHHHHHHHHHH
Confidence 7 78999999998754321111 1112235668999999865 46789999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1045 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1045 t-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
+ |+.||...+..+....+..+..+..+. ..+..+.+++.+||+.+|.+||++
T Consensus 196 ~~g~~p~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~~~~li~~c~~~~p~~Rps~ 248 (256)
T cd05114 196 TEGKMPFEKKSNYEVVEMISRGFRLYRPK---------------------------LASMTVYEVMYSCWHEKPEGRPTF 248 (256)
T ss_pred cCCCCCCCCCCHHHHHHHHHCCCCCCCCC---------------------------CCCHHHHHHHHHHccCCcccCcCH
Confidence 9 899998877766666665543322110 234568999999999999999999
Q ss_pred HHHHHHH
Q 001142 1124 GDLYEMF 1130 (1142)
Q Consensus 1124 ~EVL~~L 1130 (1142)
.++++.+
T Consensus 249 ~~l~~~l 255 (256)
T cd05114 249 AELLRAI 255 (256)
T ss_pred HHHHHhh
Confidence 9999865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=336.96 Aligned_cols=255 Identities=24% Similarity=0.322 Sum_probs=200.4
Q ss_pred CcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEecCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKW 884 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~g~~~~~~~ 884 (1142)
+|++.+.||+|+||.||+|.+. +..+|+|+....... .....+. +..|+.++..+. |++|+++++++.+.+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~----~~~e~~~l~~~~~~~~i~~~~~~~~~~~- 74 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-QDDDVEC----TMVEKRVLALQDKPPFLTQLHSCFQTVD- 74 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHH----HHHHHHHHHhccCCCchhheeeEEecCC-
Confidence 4788999999999999999874 567888876532111 1112222 367888888885 678888998887654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
..|+||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~Ey~~~g~L~~~i~~-----~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~ 136 (323)
T cd05615 75 -------------RLYFVMEYVNGGDLMYHIQQ-----VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDS 136 (323)
T ss_pred -------------EEEEEEcCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC
Confidence 34999999999999999875 246899999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 137 ~-------~~ikL~Dfg~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslGvil~ell 195 (323)
T cd05615 137 E-------GHIKIADFGMCKEHMVDG----------VTTRTFCGTPDYIAPEIIAY----QPYGKSVDWWAYGVLLYEML 195 (323)
T ss_pred C-------CCEEEeccccccccCCCC----------ccccCccCCccccCHHHHcC----CCCCCccchhhhHHHHHHHH
Confidence 7 789999999986432211 01123458999999999875 56789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC--
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT-- 1122 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS-- 1122 (1142)
+|+.||.+.........+...... .+ ...+..+.+++.+||+.||.+|++
T Consensus 196 tG~~pf~~~~~~~~~~~i~~~~~~-~p---------------------------~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 196 AGQPPFDGEDEDELFQSIMEHNVS-YP---------------------------KSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred hCCCCCCCCCHHHHHHHHHhCCCC-CC---------------------------ccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 999999987776666665433211 00 033456899999999999999997
Q ss_pred ---HHHHHHHHHhhcC
Q 001142 1123 ---AGDLYEMFVARTS 1135 (1142)
Q Consensus 1123 ---a~EVL~~L~~~~s 1135 (1142)
..++.+|+|+...
T Consensus 248 ~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 248 PEGERDIREHAFFRRI 263 (323)
T ss_pred CCCHHHHhcCcccCCC
Confidence 5789999998754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=341.49 Aligned_cols=249 Identities=25% Similarity=0.296 Sum_probs=194.2
Q ss_pred eeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHH-HHhhCCCCCccceeeeEecCCCCCCCC
Q 001142 813 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVR-MLGALRHSCIVEMYGHKISSKWLPSAD 889 (1142)
Q Consensus 813 ~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~-iL~~L~HpNIVkl~g~~~~~~~~~~~~ 889 (1142)
+.||+|+||.||+|++ .+..+|+|+...+.... ...... +..|.. +++.++||||+++++++...+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~----~~~e~~~~l~~~~hp~iv~~~~~~~~~~------ 69 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLN-RKEQKH----IMAERNVLLKNVKHPFLVGLHYSFQTTE------ 69 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHH----HHHHHHHHHHhCCCCCCccEEEEEecCC------
Confidence 4799999999999987 46678888865332111 111122 245554 467789999999999988655
Q ss_pred CCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccC
Q 001142 890 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 969 (1142)
Q Consensus 890 ~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~ 969 (1142)
..++||||+++++|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 70 --------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~---- 132 (325)
T cd05604 70 --------KLYFVLDFVNGGELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQ---- 132 (325)
T ss_pred --------EEEEEEcCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC----
Confidence 34999999999999988865 3468999999999999999999999999999999999999887
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001142 970 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1049 (1142)
Q Consensus 970 ~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~P 1049 (1142)
+.+||+|||++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 133 ---~~~kL~DfG~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~el~~G~~p 195 (325)
T cd05604 133 ---GHVVLTDFGLCKEGIAQS----------DTTTTFCGTPEYLAPEVIRK----QPYDNTVDWWCLGAVLYEMLYGLPP 195 (325)
T ss_pred ---CCEEEeecCCcccCCCCC----------CCcccccCChhhCCHHHHcC----CCCCCcCccccccceehhhhcCCCC
Confidence 789999999986432111 11124468999999999876 5678999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH----HH
Q 001142 1050 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA----GD 1125 (1142)
Q Consensus 1050 f~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa----~E 1125 (1142)
|...+..++...+........ ...+..+.+++.+||+.||.+||++ .+
T Consensus 196 f~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 196 FYCRDVAEMYDNILHKPLVLR----------------------------PGASLTAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred CCCCCHHHHHHHHHcCCccCC----------------------------CCCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 988776666655543221100 0334568899999999999999976 58
Q ss_pred HHHHHHhhc
Q 001142 1126 LYEMFVART 1134 (1142)
Q Consensus 1126 VL~~L~~~~ 1134 (1142)
+++|+|+..
T Consensus 248 i~~h~~f~~ 256 (325)
T cd05604 248 IQEHPFFES 256 (325)
T ss_pred HhcCCCcCC
Confidence 999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=342.55 Aligned_cols=258 Identities=28% Similarity=0.450 Sum_probs=214.9
Q ss_pred cceeeeecccCceEEEEEEECCccEEEEEEecccCCCC-hHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCC
Q 001142 809 LSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSS-ADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 887 (1142)
Q Consensus 809 y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~-~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~ 887 (1142)
|.-.+.||.|+||.||-|++......|+|++....... .....++ ++|+..|.+++|||+|.+-|+|.-+.
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDI----lKEVrFL~~l~HPntieYkgCyLre~---- 99 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDI----LKEVRFLRQLRHPNTIEYKGCYLREH---- 99 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHH----HHHHHHHHhccCCCcccccceeeccc----
Confidence 56778999999999999998655555666555433221 2333344 89999999999999999999998654
Q ss_pred CCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccc
Q 001142 888 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 967 (1142)
Q Consensus 888 ~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~ 967 (1142)
..|||||||- ||-.+++.-+ .+++.+.++..|..+.+.||.|||+.+.||||||+.|||+++.
T Consensus 100 ----------TaWLVMEYCl-GSAsDlleVh----kKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~-- 162 (948)
T KOG0577|consen 100 ----------TAWLVMEYCL-GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEP-- 162 (948)
T ss_pred ----------hHHHHHHHHh-ccHHHHHHHH----hccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCC--
Confidence 3499999996 8888888653 3579999999999999999999999999999999999999887
Q ss_pred cCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCC
Q 001142 968 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 1047 (1142)
Q Consensus 968 ~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~ 1047 (1142)
+.|||+|||.|..... ...++|||+|||||++..+. .+.|+-|+||||||++..||...+
T Consensus 163 -----g~VKLaDFGSAsi~~P--------------AnsFvGTPywMAPEVILAMD-EGqYdgkvDvWSLGITCIELAERk 222 (948)
T KOG0577|consen 163 -----GLVKLADFGSASIMAP--------------ANSFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIELAERK 222 (948)
T ss_pred -----CeeeeccccchhhcCc--------------hhcccCCccccchhHheecc-ccccCCccceeeccchhhhhhhcC
Confidence 8999999999865432 24678999999999998754 568999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHH
Q 001142 1048 VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY 1127 (1142)
Q Consensus 1048 ~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL 1127 (1142)
+|+..++.+.....|.....|.+... +.++.++.|+..||+.-|.+|||.++++
T Consensus 223 PPlFnMNAMSALYHIAQNesPtLqs~--------------------------eWS~~F~~Fvd~CLqKipqeRptse~ll 276 (948)
T KOG0577|consen 223 PPLFNMNAMSALYHIAQNESPTLQSN--------------------------EWSDYFRNFVDSCLQKIPQERPTSEELL 276 (948)
T ss_pred CCccCchHHHHHHHHHhcCCCCCCCc--------------------------hhHHHHHHHHHHHHhhCcccCCcHHHHh
Confidence 99998888887778877766655421 5677899999999999999999999999
Q ss_pred HHHHhhcCCC
Q 001142 1128 EMFVARTSSS 1137 (1142)
Q Consensus 1128 ~~L~~~~ss~ 1137 (1142)
+|.|...+-+
T Consensus 277 ~H~fv~R~Rp 286 (948)
T KOG0577|consen 277 KHRFVLRERP 286 (948)
T ss_pred hcchhccCCC
Confidence 9999876543
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=343.19 Aligned_cols=260 Identities=25% Similarity=0.375 Sum_probs=196.9
Q ss_pred CCCcceeeeecccCceEEEEEEE-------CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceee
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKF-------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYG 877 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~-------~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g 877 (1142)
.++|++.++||+|+||.||+|++ .+..+|+|+.+ ... .....+. +.+|+.++..+ +|||||++++
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~--~~~-~~~~~~~----~~~Ei~il~~l~~HpnIv~l~~ 106 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLK--PSA-HLTEREA----LMSELKVLSYLGNHINIVNLLG 106 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEecc--CCc-CcHHHHH----HHHHHHHHHHhcCCcceeeeee
Confidence 45799999999999999999975 23357777643 211 1222233 37899999999 7999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc-------------------------------------
Q 001142 878 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE------------------------------------- 920 (1142)
Q Consensus 878 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~------------------------------------- 920 (1142)
++.+.+. .++||||+++|+|.++++....
T Consensus 107 ~~~~~~~--------------~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 172 (375)
T cd05104 107 ACTVGGP--------------TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMK 172 (375)
T ss_pred eeccCCc--------------ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcC
Confidence 9876553 3999999999999999975211
Q ss_pred ---------------------------------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccc
Q 001142 921 ---------------------------------TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 967 (1142)
Q Consensus 921 ---------------------------------~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~ 967 (1142)
.....+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~-- 250 (375)
T cd05104 173 PGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHG-- 250 (375)
T ss_pred CCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECC--
Confidence 012357889999999999999999999999999999999999876
Q ss_pred cCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-C
Q 001142 968 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-L 1046 (1142)
Q Consensus 968 ~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt-G 1046 (1142)
..+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|||++ |
T Consensus 251 -----~~~kl~DfG~a~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~sDi~slG~~l~ellt~g 313 (375)
T cd05104 251 -----RITKICDFGLARDIRNDSNY--------VVKGNARLPVKWMAPESIFN----CVYTFESDVWSYGILLWEIFSLG 313 (375)
T ss_pred -----CcEEEecCccceeccCcccc--------cccCCCCCCcceeChhHhcC----CCCCCCCCHHHHHHHHHHHHhcC
Confidence 78999999999765332110 01112335677999999875 568899999999999999998 8
Q ss_pred CCCCCCCCHH-HHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001142 1047 QVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1125 (1142)
Q Consensus 1047 ~~Pf~~~~~~-el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~E 1125 (1142)
..||...... .....+..+..+..+ ...+.++.+|+.+||+.||++|||+.|
T Consensus 314 ~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~cl~~dP~~RPs~~e 366 (375)
T cd05104 314 SSPYPGMPVDSKFYKMIKEGYRMLSP---------------------------ECAPSEMYDIMKSCWDADPLKRPTFKQ 366 (375)
T ss_pred CCCCCCCCchHHHHHHHHhCccCCCC---------------------------CCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 9999765433 233333332211100 023456899999999999999999999
Q ss_pred HHHHHHh
Q 001142 1126 LYEMFVA 1132 (1142)
Q Consensus 1126 VL~~L~~ 1132 (1142)
|++.++.
T Consensus 367 il~~l~~ 373 (375)
T cd05104 367 IVQLIEQ 373 (375)
T ss_pred HHHHHHh
Confidence 9998875
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=321.00 Aligned_cols=264 Identities=20% Similarity=0.331 Sum_probs=199.3
Q ss_pred cceeeeecccCceEEEEEEECCc----cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 809 LSSCDEAGKSVSSSLFRCKFGSA----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 809 y~l~~~LG~GsfG~Vy~a~~~~~----~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
|.+.++||+|+||.||+|.+... .+|+|..+.. .......+.+ .+|+.+++.++||||+++++++.....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~----~~E~~~l~~l~h~~iv~~~~~~~~~~~ 74 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIA--ICTRSEMEDF----LSEAVCMKEFDHPNVMRLIGVCLQTVE 74 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccC--cCCHHHHHHH----HHHHHHHHhCCCCCcceEEEEEccCCc
Confidence 45789999999999999998433 3666664332 2233334444 789999999999999999998754321
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~-~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
. ......++||||+++++|.+++..... .....+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 75 ~--------~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~ 146 (272)
T cd05075 75 S--------EGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLN 146 (272)
T ss_pred c--------cCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEc
Confidence 1 112345899999999999998853221 1234589999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.+||+|||+++........ .......+++.|+|||+..+ ..++.++||||||+++|||
T Consensus 147 ~~-------~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~~~~~~~~pe~~~~----~~~~~~~Di~slG~il~el 207 (272)
T cd05075 147 EN-------MNVCVADFGLSKKIYNGDYY--------RQGRIAKMPVKWIAIESLAD----RVYTTKSDVWSFGVTMWEI 207 (272)
T ss_pred CC-------CCEEECCCCcccccCcccce--------ecCCcccCCcccCCHHHccC----CCcChHHHHHHHHHHHHHH
Confidence 77 78999999999765432110 01112346778999999875 5678999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1044 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1044 Lt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
++ |+.||.+....+....+..+..+..+ ...+..+.+++.+||+.||++|||
T Consensus 208 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rps 260 (272)
T cd05075 208 ATRGQTPYPGVENSEIYDYLRQGNRLKQP---------------------------PDCLDGLYSLMSSCWLLNPKDRPS 260 (272)
T ss_pred HcCCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------CCCCHHHHHHHHHHcCCCcccCcC
Confidence 99 89999877766666665544322111 034556899999999999999999
Q ss_pred HHHHHHHHHh
Q 001142 1123 AGDLYEMFVA 1132 (1142)
Q Consensus 1123 a~EVL~~L~~ 1132 (1142)
+.++++++..
T Consensus 261 ~~~l~~~l~~ 270 (272)
T cd05075 261 FETLRCELEK 270 (272)
T ss_pred HHHHHHHHHh
Confidence 9999998753
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=357.96 Aligned_cols=268 Identities=25% Similarity=0.377 Sum_probs=218.2
Q ss_pred CCCCCCcceeeeecccCceEEEEEEEC-----CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceee
Q 001142 803 PGSFPSLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 877 (1142)
Q Consensus 803 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~-----~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g 877 (1142)
..+-.+..+.+.||+|+||.||+|+.. +....|.||.++.. ......++| ++|++++..++|||||+++|
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-a~~~~~~dF----~REaeLla~l~H~nIVrLlG 556 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-AENQARQDF----RREAELLAELQHPNIVRLLG 556 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-ccHHHHHHH----HHHHHHHHhccCCCeEEEEE
Confidence 344556789999999999999999862 34455555556642 223345566 89999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccC---------CCCCCHHHHHHHHHHHHHHHHHHHhC
Q 001142 878 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG---------EKHVSVKLALFIAQDVAAALVELHSK 948 (1142)
Q Consensus 878 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~---------~~~ls~~~i~~Ia~qIa~gL~yLHs~ 948 (1142)
.+.+.+.+ ++|+|||..|||..+++...... ..+++..+.+.||.|||.|++||-++
T Consensus 557 VC~~~~P~--------------~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~ 622 (774)
T KOG1026|consen 557 VCREGDPL--------------CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH 622 (774)
T ss_pred EEccCCee--------------EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 99987654 99999999999999998654322 22388999999999999999999999
Q ss_pred CccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCC
Q 001142 949 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 1028 (1142)
Q Consensus 949 gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s 1028 (1142)
.+|||||-..|+||.++ ..|||+|||+++..-..... . ......-...|||||.+.. ..|+
T Consensus 623 ~FVHRDLATRNCLVge~-------l~VKIsDfGLsRdiYssDYY---k-----~~~~t~lPIRWMppEsIly----~kFT 683 (774)
T KOG1026|consen 623 HFVHRDLATRNCLVGEN-------LVVKISDFGLSRDIYSSDYY---K-----VRGNTLLPIRWMPPESILY----GKFT 683 (774)
T ss_pred cccccchhhhhceeccc-------eEEEecccccchhhhhhhhh---c-----ccCCceeeeecCCHHHhhc----Cccc
Confidence 99999999999999988 89999999999864332211 1 1112234678999999987 6899
Q ss_pred chhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHH
Q 001142 1029 LEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVD 1107 (1142)
Q Consensus 1029 ~ksDVwSLGviL~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~d 1107 (1142)
.++|||||||+|||+++ |+.||.+.+..++++.|+.+....-+ ..++.++.+
T Consensus 684 teSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~lL~~P---------------------------e~CP~~vY~ 736 (774)
T KOG1026|consen 684 TESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQLLSCP---------------------------ENCPTEVYS 736 (774)
T ss_pred chhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCcccCC---------------------------CCCCHHHHH
Confidence 99999999999999999 99999999999999999887653222 278889999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001142 1108 VFRRCTEENPTERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1108 LI~~CL~~DP~~RPSa~EVL~~L~~~~s 1135 (1142)
|+..||+.+|.+||++.||-..|.....
T Consensus 737 LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 737 LMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred HHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 9999999999999999999888766543
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=339.05 Aligned_cols=248 Identities=26% Similarity=0.297 Sum_probs=192.0
Q ss_pred eeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHH-HHhhCCCCCccceeeeEecCCCCCCCC
Q 001142 813 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVR-MLGALRHSCIVEMYGHKISSKWLPSAD 889 (1142)
Q Consensus 813 ~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~-iL~~L~HpNIVkl~g~~~~~~~~~~~~ 889 (1142)
++||+|+||.||+|++ .+..+|+|+....... ..... ..+..|.. +++.++||||+++++++.+.+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~----~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~------ 69 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTIL-KKKEQ----NHIMAERNVLLKNLKHPFLVGLHYSFQTAE------ 69 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHH-HhhHH----HHHHHHHHHHHHhCCCCCccceeeEEEcCC------
Confidence 4799999999999998 4567888876432111 11111 22245554 577889999999999887654
Q ss_pred CCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccC
Q 001142 890 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 969 (1142)
Q Consensus 890 ~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~ 969 (1142)
..++||||+++++|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 70 --------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~---- 132 (321)
T cd05603 70 --------KLYFVLDYVNGGELFFHLQR-----ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQ---- 132 (321)
T ss_pred --------EEEEEEcCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC----
Confidence 34999999999999988865 3468899999999999999999999999999999999999887
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001142 970 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1049 (1142)
Q Consensus 970 ~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~P 1049 (1142)
+.+||+|||++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 133 ---~~~kl~Dfg~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~el~~g~~p 195 (321)
T cd05603 133 ---GHVVLTDFGLCKEGVEPE----------ETTSTFCGTPEYLAPEVLRK----EPYDRTVDWWCLGAVLYEMLYGLPP 195 (321)
T ss_pred ---CCEEEccCCCCccCCCCC----------CccccccCCcccCCHHHhcC----CCCCCcCcccccchhhhhhhcCCCC
Confidence 789999999986432111 01123468999999999875 5688999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH----HH
Q 001142 1050 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA----GD 1125 (1142)
Q Consensus 1050 f~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa----~E 1125 (1142)
|.+.+..+....+..... .++ ...+..+.+++.+||+.||.+||++ .+
T Consensus 196 f~~~~~~~~~~~i~~~~~-~~~---------------------------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (321)
T cd05603 196 FYSRDVSQMYDNILHKPL-QLP---------------------------GGKTVAACDLLVGLLHKDQRRRLGAKADFLE 247 (321)
T ss_pred CCCCCHHHHHHHHhcCCC-CCC---------------------------CCCCHHHHHHHHHHccCCHhhcCCCCCCHHH
Confidence 988776666655543221 100 1334568999999999999999875 58
Q ss_pred HHHHHHhh
Q 001142 1126 LYEMFVAR 1133 (1142)
Q Consensus 1126 VL~~L~~~ 1133 (1142)
+++|+|+.
T Consensus 248 ~~~~~~~~ 255 (321)
T cd05603 248 IKNHVFFS 255 (321)
T ss_pred HhCCCCcC
Confidence 99998875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=318.68 Aligned_cols=255 Identities=22% Similarity=0.324 Sum_probs=200.9
Q ss_pred CcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
+|++.+.||+|++|.||++.+. +..+++|....+. ......+.+ .+|+.++++++|||++++++.+...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~----~~e~~~l~~l~~~~i~~~~~~~~~~~-- 72 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRN--ASRRERKAA----EQEAQLLSQLKHPNIVAYRESWEGED-- 72 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhh--cCHHHHHHH----HHHHHHHHhCCCCCeeeeeeeecCCC--
Confidence 4899999999999999999874 4567777654322 122222333 78999999999999999998775322
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
...++||||+++++|.+++... ....+++.++..++.|++.|++|||++||+||||||+||+++.+
T Consensus 73 -----------~~~~lv~e~~~~~~l~~~l~~~---~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~ 138 (257)
T cd08223 73 -----------GLLYIVMGFCEGGDLYHKLKEQ---KGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRT 138 (257)
T ss_pred -----------CEEEEEecccCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecC
Confidence 1358999999999999999752 23468999999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+.++|+|||.+........ ......+++.|+|||++.+ ..++.++||||||+++++|++
T Consensus 139 -------~~~~l~df~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il~~l~~ 197 (257)
T cd08223 139 -------NIIKVGDLGIARVLENQCD----------MASTLIGTPYYMSPELFSN----KPYNYKSDVWALGCCVYEMAT 197 (257)
T ss_pred -------CcEEEecccceEEecccCC----------ccccccCCcCccChhHhcC----CCCCchhhhHHHHHHHHHHHc
Confidence 7899999999876532111 1123458899999999875 467889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001142 1046 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1125 (1142)
Q Consensus 1046 G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~E 1125 (1142)
|+.||...+.......+..+..+..+ ...++.+.+++.+||+.||.+|||+.+
T Consensus 198 g~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~~ 250 (257)
T cd08223 198 LKHAFNAKDMNSLVYRIIEGKLPPMP---------------------------KDYSPELGELIATMLSKRPEKRPSVKS 250 (257)
T ss_pred CCCCCCCCCHHHHHHHHHhcCCCCCc---------------------------cccCHHHHHHHHHHhccCcccCCCHHH
Confidence 99999876655554444433322211 134567999999999999999999999
Q ss_pred HHHHHHh
Q 001142 1126 LYEMFVA 1132 (1142)
Q Consensus 1126 VL~~L~~ 1132 (1142)
+++|+|+
T Consensus 251 ~l~~~~~ 257 (257)
T cd08223 251 ILRQPYI 257 (257)
T ss_pred HhcCCCC
Confidence 9999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=339.39 Aligned_cols=249 Identities=22% Similarity=0.341 Sum_probs=191.6
Q ss_pred eeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecCCCCCCCC
Q 001142 813 DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 889 (1142)
Q Consensus 813 ~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~~~~~~~~~~~ 889 (1142)
++||+|+||.||+|++. +..+|+|+.+..... ...... .+.+|..++.++ +||||+++++++.+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~-~~~~~~----~~~~e~~il~~~~~hp~Iv~~~~~~~~~~------ 69 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVN-DDEDID----WVQTEKHVFETASNHPFLVGLHSCFQTES------ 69 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHH----HHHHHHHHHHhccCCCCCCceEEEEEcCC------
Confidence 47999999999999984 567888876532211 111222 237899999988 6999999999988655
Q ss_pred CCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccC
Q 001142 890 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 969 (1142)
Q Consensus 890 ~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~ 969 (1142)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 70 --------~~~lv~e~~~~g~L~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~---- 132 (329)
T cd05588 70 --------RLFFVIEFVSGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAE---- 132 (329)
T ss_pred --------EEEEEEeCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC----
Confidence 34999999999999988865 2469999999999999999999999999999999999999877
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001142 970 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1049 (1142)
Q Consensus 970 ~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~P 1049 (1142)
+.+||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 133 ---~~~kL~Dfg~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~~l~el~~g~~P 195 (329)
T cd05588 133 ---GHIKLTDYGMCKEGIRPG----------DTTSTFCGTPNYIAPEILRG----EDYGFSVDWWALGVLMFEMMAGRSP 195 (329)
T ss_pred ---CCEEECcCccccccccCC----------CccccccCCccccCHHHHcC----CCCCCccceechHHHHHHHHHCCCC
Confidence 789999999986422111 11123468999999999876 5678999999999999999999999
Q ss_pred CCCCCH--------HH-HHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1050 YMGLSE--------LE-IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1050 f~~~~~--------~e-l~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
|..... .+ ..+.+.... ..+ +...+..+.+++.+||+.||.+|
T Consensus 196 f~~~~~~~~~~~~~~~~~~~~~~~~~-~~~---------------------------p~~~~~~~~~li~~~L~~dP~~R 247 (329)
T cd05588 196 FDIVGMSDNPDQNTEDYLFQVILEKQ-IRI---------------------------PRSLSVKASSVLKGFLNKDPKER 247 (329)
T ss_pred cccccccccccccchHHHHHHHHcCC-CCC---------------------------CCCCCHHHHHHHHHHhccCHHHc
Confidence 963211 11 112221111 000 01345668999999999999999
Q ss_pred CC------HHHHHHHHHhhc
Q 001142 1121 PT------AGDLYEMFVART 1134 (1142)
Q Consensus 1121 PS------a~EVL~~L~~~~ 1134 (1142)
|+ ++++++|+|+..
T Consensus 248 ~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 248 LGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred CCCCCCCCHHHHhcCCCCCC
Confidence 87 799999999974
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=334.19 Aligned_cols=290 Identities=19% Similarity=0.222 Sum_probs=199.7
Q ss_pred eeeeeccc--CceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCC
Q 001142 811 SCDEAGKS--VSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 886 (1142)
Q Consensus 811 l~~~LG~G--sfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~ 886 (1142)
+.++||+| +||+||++++. +..+|+|....+ .......+ .+.+|+.+++.++||||+++++++..++.
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~----~~~~e~~~l~~l~hpniv~~~~~~~~~~~-- 73 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLE--ACTNEMVT----FLQGELHVSKLFNHPNIVPYRATFIADNE-- 73 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechh--hccHHHHH----HHHHHHHHHHhcCCCCeeeEEEEEEECCE--
Confidence 56889999 77899999884 556677764332 22222222 34789999999999999999999987653
Q ss_pred CCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecccc
Q 001142 887 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 966 (1142)
Q Consensus 887 ~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~ 966 (1142)
.++||||+++++|.+++.... ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 74 ------------~~lv~e~~~~~~l~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~- 137 (327)
T cd08227 74 ------------LWVVTSFMAYGSAKDLICTHF---MDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD- 137 (327)
T ss_pred ------------EEEEEeccCCCcHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecC-
Confidence 499999999999999997521 2358999999999999999999999999999999999999887
Q ss_pred ccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001142 967 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1046 (1142)
Q Consensus 967 ~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG 1046 (1142)
+.++++||+.+............ .........++..|+|||++.+. ...++.++|||||||++|||++|
T Consensus 138 ------~~~~l~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~~DiwslG~il~el~~g 206 (327)
T cd08227 138 ------GKVYLSGLRSNLSMINHGQRLRV---VHDFPKYSVKVLPWLSPEVLQQN--LQGYDAKSDIYSVGITACELANG 206 (327)
T ss_pred ------CcEEEcccchhhccccccccccc---cccccccccceecccChHHhhcc--cCCCCchhhHHHHHHHHHHHHHC
Confidence 78999999876543221110000 00011233577889999998652 13578999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccc---------ccccccc------cCC---CCCCchhhhhhHHHHHHH
Q 001142 1047 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC---------HEHEVAQ------SGS---GFEKPEAELETLSFLVDV 1108 (1142)
Q Consensus 1047 ~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~---------~~~~~~~------~~~---~~~~~~~~~~~~~~L~dL 1108 (1142)
+.||......+.......+..+...+........ ....... ... ...........++.+.++
T Consensus 207 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 286 (327)
T cd08227 207 HVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHF 286 (327)
T ss_pred CCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHH
Confidence 9999865554433333322222111100000000 0000000 000 000000112346789999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001142 1109 FRRCTEENPTERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1109 I~~CL~~DP~~RPSa~EVL~~L~~~~s 1135 (1142)
+.+||+.||++|||++|+++|+|++.-
T Consensus 287 i~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 287 VEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred HHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 999999999999999999999999764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=321.02 Aligned_cols=264 Identities=28% Similarity=0.381 Sum_probs=203.3
Q ss_pred CcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCC-hHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSS-ADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~-~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
+|.+...||+|++|.||+|.+ .+..+++|.......... ......+...+.+|+.++++++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 478889999999999999987 456788887654432222 12222333456899999999999999999999886553
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
.++||||+++++|.+++.. ...+++..+..++.|++.||+|||++|++||||+|+||+++.
T Consensus 81 --------------~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~ 141 (267)
T cd06628 81 --------------LNIFLEYVPGGSVAALLNN-----YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDN 141 (267)
T ss_pred --------------cEEEEEecCCCCHHHHHHh-----ccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcC
Confidence 3999999999999999976 246889999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.++|+|||.++.......... .........|+..|+|||.+.+ ..++.++|||||||++|+|+
T Consensus 142 ~-------~~~~l~dfg~~~~~~~~~~~~~----~~~~~~~~~~~~~y~~pe~~~~----~~~~~~~Dv~slG~il~~l~ 206 (267)
T cd06628 142 K-------GGIKISDFGISKKLEANSLSTK----TNGARPSLQGSVFWMAPEVVKQ----TSYTRKADIWSLGCLVVEML 206 (267)
T ss_pred C-------CCEEecccCCCcccccccccCC----ccccccccCCCcCccChhHhcc----CCCCchhhhHHHHHHHHHHh
Confidence 7 7899999999976543111100 0011123458889999999875 45778999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~ 1124 (1142)
+|+.||...........+.....+..+ ...+..+.+++.+||+.||.+||++.
T Consensus 207 ~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~ 259 (267)
T cd06628 207 TGKHPFPDCTQLQAIFKIGENASPEIP---------------------------SNISSEAIDFLEKTFEIDHNKRPTAA 259 (267)
T ss_pred hCCCCCCCccHHHHHHHHhccCCCcCC---------------------------cccCHHHHHHHHHHccCCchhCcCHH
Confidence 999999875544333333222221111 13456789999999999999999999
Q ss_pred HHHHHHHh
Q 001142 1125 DLYEMFVA 1132 (1142)
Q Consensus 1125 EVL~~L~~ 1132 (1142)
|+++|+|+
T Consensus 260 ~il~~~~~ 267 (267)
T cd06628 260 ELLKHPFL 267 (267)
T ss_pred HHhhCCCC
Confidence 99999885
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=327.44 Aligned_cols=258 Identities=26% Similarity=0.431 Sum_probs=211.0
Q ss_pred cceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCC
Q 001142 809 LSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 888 (1142)
Q Consensus 809 y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~~ 888 (1142)
|.+.++||+|+||.||+|.++.....++++++.+. .+.+++ .+|+.||+++..|+||++||.|....
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEI----IKEISIMQQC~S~yVVKYYGSYFK~s----- 101 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEI----IKEISIMQQCKSKYVVKYYGSYFKHS----- 101 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHH----HHHHHHHHHcCCchhhhhhhhhccCC-----
Confidence 78999999999999999998655555555555442 233444 78999999999999999999877544
Q ss_pred CCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecccccc
Q 001142 889 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 968 (1142)
Q Consensus 889 ~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~ 968 (1142)
.+|||||||-.||..+.++. .++++++.++..+++..++||+|||...-||||||+.|||++.+
T Consensus 102 ---------DLWIVMEYCGAGSiSDI~R~----R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~--- 165 (502)
T KOG0574|consen 102 ---------DLWIVMEYCGAGSISDIMRA----RRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTD--- 165 (502)
T ss_pred ---------ceEeehhhcCCCcHHHHHHH----hcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEccc---
Confidence 34999999999999999985 35689999999999999999999999999999999999999888
Q ss_pred CCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCC
Q 001142 969 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV 1048 (1142)
Q Consensus 969 ~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~ 1048 (1142)
+..||+|||.|..+.+.- ...++..|||.|||||++.. -.|+.++||||||++..||..|++
T Consensus 166 ----G~AKLADFGVAGQLTDTM----------AKRNTVIGTPFWMAPEVI~E----IGY~~~ADIWSLGITaIEMAEG~P 227 (502)
T KOG0574|consen 166 ----GIAKLADFGVAGQLTDTM----------AKRNTVIGTPFWMAPEVIEE----IGYDTKADIWSLGITAIEMAEGRP 227 (502)
T ss_pred ----chhhhhhccccchhhhhH----------HhhCccccCcccccHHHHHH----hccchhhhHhhhcchhhhhhcCCC
Confidence 899999999997665421 13356789999999999986 568899999999999999999999
Q ss_pred CCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001142 1049 PYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1128 (1142)
Q Consensus 1049 Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~ 1128 (1142)
||.+..+....-.|-...+|. +..| ...+.++.++++.||...|++|-||-++++
T Consensus 228 PYsDIHPMRAIFMIPT~PPPT----------------------F~KP---E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 228 PYSDIHPMRAIFMIPTKPPPT----------------------FKKP---EEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CcccccccceeEeccCCCCCC----------------------CCCh---HhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 998766654333332222211 1121 256788999999999999999999999999
Q ss_pred HHHhhcCCCC
Q 001142 1129 MFVARTSSSI 1138 (1142)
Q Consensus 1129 ~L~~~~ss~~ 1138 (1142)
|+|.+.....
T Consensus 283 H~FiknA~g~ 292 (502)
T KOG0574|consen 283 HTFIKNAPGC 292 (502)
T ss_pred hhhhcCCCcc
Confidence 9999876554
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=342.65 Aligned_cols=261 Identities=23% Similarity=0.346 Sum_probs=196.6
Q ss_pred CCCCcceeeeecccCceEEEEEEECC-------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCcccee
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMY 876 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~~~-------~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~ 876 (1142)
..++|++.+.||+|+||.||+|.+.. ..||+|+.+.. . ....... +.+|+.+++++ +|||||+++
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~--~-~~~~~~~----~~~E~~il~~l~~h~nIv~~~ 108 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKAS--A-HTDEREA----LMSELKILSHLGQHKNIVNLL 108 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCC--C-CHHHHHH----HHHHHHHHHhhccCCceeeEe
Confidence 34579999999999999999998621 35777764322 1 2222233 47899999999 799999999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc------------------------------------
Q 001142 877 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE------------------------------------ 920 (1142)
Q Consensus 877 g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~------------------------------------ 920 (1142)
+++.+.+. .++||||+++|+|.++++....
T Consensus 109 ~~~~~~~~--------------~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (374)
T cd05106 109 GACTHGGP--------------VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFS 174 (374)
T ss_pred eEecCCCC--------------eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccc
Confidence 99876553 4999999999999999865321
Q ss_pred -----------------------------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccCCC
Q 001142 921 -----------------------------TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 971 (1142)
Q Consensus 921 -----------------------------~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~~~ 971 (1142)
....++++..+.+|+.||+.||.|||++||+||||||+|||++.+
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~------ 248 (374)
T cd05106 175 SQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDG------ 248 (374)
T ss_pred ccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCC------
Confidence 011357889999999999999999999999999999999999876
Q ss_pred CCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 001142 972 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPY 1050 (1142)
Q Consensus 972 ~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt-G~~Pf 1050 (1142)
+.+||+|||+++........ .......++..|+|||++.. ..++.++|||||||++|||++ |+.||
T Consensus 249 -~~~kL~DfGla~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~DvwSlGvil~ellt~G~~Pf 315 (374)
T cd05106 249 -RVAKICDFGLARDIMNDSNY--------VVKGNARLPVKWMAPESIFD----CVYTVQSDVWSYGILLWEIFSLGKSPY 315 (374)
T ss_pred -CeEEEeeceeeeeccCCcce--------eeccCCCCccceeCHHHhcC----CCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 78999999998754322110 01112235678999999865 568899999999999999997 99999
Q ss_pred CCCCHHHHH-HHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001142 1051 MGLSELEIH-DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1129 (1142)
Q Consensus 1051 ~~~~~~el~-~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~ 1129 (1142)
......... ..+..+..+..+ ...++++.+++.+||+.||.+|||+.+|++.
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~ 368 (374)
T cd05106 316 PGILVNSKFYKMVKRGYQMSRP---------------------------DFAPPEIYSIMKMCWNLEPTERPTFSQISQL 368 (374)
T ss_pred ccccccHHHHHHHHcccCccCC---------------------------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 765433322 222221111100 0235679999999999999999999999998
Q ss_pred HHh
Q 001142 1130 FVA 1132 (1142)
Q Consensus 1130 L~~ 1132 (1142)
+..
T Consensus 369 l~~ 371 (374)
T cd05106 369 IQR 371 (374)
T ss_pred HHH
Confidence 765
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=320.00 Aligned_cols=254 Identities=23% Similarity=0.385 Sum_probs=199.8
Q ss_pred CCCCcceeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~~-~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
+.++|++.++||+|+||.||+|.+. +..+++|..... ....+.+ .+|+.++++++||||+++++.+.+..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-----~~~~~~~----~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-----TMSVQAF----LEEANLMKTLQHDKLVRLYAVVTKEE 74 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-----chhHHHH----HHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 4567999999999999999999874 455777764321 1222334 78999999999999999999887654
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
. .++||||+++++|.+++... ....+++..+..++.|++.||+|||+.+++||||||+||+++
T Consensus 75 ~--------------~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~ 137 (261)
T cd05072 75 P--------------IYIITEYMAKGSLLDFLKSD---EGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVS 137 (261)
T ss_pred C--------------cEEEEecCCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEec
Confidence 3 39999999999999999752 234688999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.++|+|||.+......... ......++..|+|||++.. ..++.++|||||||++|+|
T Consensus 138 ~~-------~~~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~~l 197 (261)
T cd05072 138 ES-------LMCKIADFGLARVIEDNEYT---------AREGAKFPIKWTAPEAINF----GSFTIKSDVWSFGILLYEI 197 (261)
T ss_pred CC-------CcEEECCCccceecCCCcee---------ccCCCccceecCCHHHhcc----CCCChhhhhhhhHHHHHHH
Confidence 87 78999999999765432111 1112235678999999865 4578899999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1044 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1044 Lt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
++ |..||......+....+......... ...+..+.+++.+||..+|++||+
T Consensus 198 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~ 250 (261)
T cd05072 198 VTYGKIPYPGMSNSDVMSALQRGYRMPRM---------------------------ENCPDELYDIMKTCWKEKAEERPT 250 (261)
T ss_pred HccCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------CCCCHHHHHHHHHHccCCcccCcC
Confidence 98 99999876666655555433221100 134556899999999999999999
Q ss_pred HHHHHHHHH
Q 001142 1123 AGDLYEMFV 1131 (1142)
Q Consensus 1123 a~EVL~~L~ 1131 (1142)
++++.+.+.
T Consensus 251 ~~~i~~~l~ 259 (261)
T cd05072 251 FDYLQSVLD 259 (261)
T ss_pred HHHHHHHHh
Confidence 999998764
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=328.99 Aligned_cols=262 Identities=26% Similarity=0.431 Sum_probs=199.6
Q ss_pred CCCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEe
Q 001142 804 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 880 (1142)
Q Consensus 804 ~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~~ 880 (1142)
..+.+|++.+.||+|+||.||+|.+. +..++++++..+.. ........+ .+|+.++.++ +||||+++++++.
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~----~~Ei~~l~~l~~h~~iv~~~~~~~ 78 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDF----AGELEVLCKLGHHPNIINLLGACE 78 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHH----HHHHHHHHHhcCCCCcceEEEEEC
Confidence 45678999999999999999999874 34455555544321 122223333 7899999999 7999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc-----------cCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAALVELHSKH 949 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~-----------~~~~~ls~~~i~~Ia~qIa~gL~yLHs~g 949 (1142)
..+. .++||||+++++|.++++.... .....+++..++.++.||+.||+|||++|
T Consensus 79 ~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g 144 (303)
T cd05088 79 HRGY--------------LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ 144 (303)
T ss_pred CCCC--------------ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 6553 3999999999999999975321 11235889999999999999999999999
Q ss_pred ccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCc
Q 001142 950 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGL 1029 (1142)
Q Consensus 950 IvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ 1029 (1142)
|+||||||+|||++.+ +.+||+|||++....... ......++..|+|||++.+ ..++.
T Consensus 145 i~H~dlkp~Nili~~~-------~~~kl~dfg~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~----~~~~~ 202 (303)
T cd05088 145 FIHRDLAARNILVGEN-------YVAKIADFGLSRGQEVYV-----------KKTMGRLPVRWMAIESLNY----SVYTT 202 (303)
T ss_pred ccccccchheEEecCC-------CcEEeCccccCcccchhh-----------hcccCCCcccccCHHHHhc----cCCcc
Confidence 9999999999999877 789999999985321110 1112234667999998865 45789
Q ss_pred hhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHH
Q 001142 1030 EVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDV 1108 (1142)
Q Consensus 1030 ksDVwSLGviL~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dL 1108 (1142)
++|||||||++|||+| |..||......+....+.....+..+ ...+..+.++
T Consensus 203 ~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l 255 (303)
T cd05088 203 NSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP---------------------------LNCDDEVYDL 255 (303)
T ss_pred cccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCcCCCC---------------------------CCCCHHHHHH
Confidence 9999999999999998 99999876665555444322111100 1334568999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhh
Q 001142 1109 FRRCTEENPTERPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1109 I~~CL~~DP~~RPSa~EVL~~L~~~ 1133 (1142)
+.+||+.+|++||++++++.++...
T Consensus 256 i~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 256 MRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred HHHHcCCChhhCcCHHHHHHHHHHH
Confidence 9999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=338.19 Aligned_cols=250 Identities=22% Similarity=0.344 Sum_probs=190.9
Q ss_pred eeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecCCCCCCCC
Q 001142 813 DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 889 (1142)
Q Consensus 813 ~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~~~~~~~~~~~ 889 (1142)
+.||+|+||.||+|++. +..+|+|+.+..... ....... +.+|+.++.++ +||||+++++++.+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~------ 69 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVN-DDEDIDW----VQTEKHVFEQASNHPFLVGLHSCFQTES------ 69 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhc-chhHHHH----HHHHHHHHHhcCCCCcCCceeeEEEeCC------
Confidence 47999999999999974 556888876533211 1122222 36888888777 7999999999988654
Q ss_pred CCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccC
Q 001142 890 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 969 (1142)
Q Consensus 890 ~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~ 969 (1142)
..++||||+++++|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 70 --------~~~lv~E~~~~~~L~~~~~~-----~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~---- 132 (329)
T cd05618 70 --------RLFFVIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE---- 132 (329)
T ss_pred --------EEEEEEeCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC----
Confidence 35999999999999988865 3468999999999999999999999999999999999999887
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001142 970 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1049 (1142)
Q Consensus 970 ~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~P 1049 (1142)
+.+||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 133 ---~~~kL~DfG~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~el~~g~~P 195 (329)
T cd05618 133 ---GHIKLTDYGMCKEGLRPG----------DTTSTFCGTPNYIAPEILRG----EDYGFSVDWWALGVLMFEMMAGRSP 195 (329)
T ss_pred ---CCEEEeeCCccccccCCC----------CccccccCCccccCHHHHcC----CCCCCccceecccHHHHHHhhCCCC
Confidence 789999999986432111 01123468999999999876 5678999999999999999999999
Q ss_pred CCCCCH---------HHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1050 YMGLSE---------LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1050 f~~~~~---------~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
|..... ..+...+.... ..++ ...+..+.+++.+||+.||++|
T Consensus 196 f~~~~~~~~~~~~~~~~~~~~i~~~~-~~~p---------------------------~~~~~~~~~ll~~~L~~dP~~R 247 (329)
T cd05618 196 FDIVGSSDNPDQNTEDYLFQVILEKQ-IRIP---------------------------RSLSVKAASVLKSFLNKDPKER 247 (329)
T ss_pred CccCCCcCCcccccHHHHHHHHhcCC-CCCC---------------------------CCCCHHHHHHHHHHhcCCHHHc
Confidence 953110 11111111111 0000 1345668999999999999999
Q ss_pred CC------HHHHHHHHHhhcC
Q 001142 1121 PT------AGDLYEMFVARTS 1135 (1142)
Q Consensus 1121 PS------a~EVL~~L~~~~s 1135 (1142)
|+ +.++++|+|++..
T Consensus 248 ~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 248 LGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred CCCCCCCCHHHHhcCCCCCCC
Confidence 98 5899999998653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=323.93 Aligned_cols=261 Identities=22% Similarity=0.359 Sum_probs=199.7
Q ss_pred CCCCcceeeeecccCceEEEEEEE------CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeee
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKF------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 878 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~------~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~ 878 (1142)
++.+|++.++||+|+||+||+|.+ .+..+++|.. +... .......+ .+|+.++++++||||++++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~--~~~~-~~~~~~~~----~~E~~~l~~l~h~niv~~~~~ 75 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTL--KDIN-NPQQWGEF----QQEASLMAELHHPNIVCLLGV 75 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEec--cCCC-CHHHHHHH----HHHHHHHhhCCCCCeeeEEEE
Confidence 457899999999999999999985 2234555553 3221 22222334 789999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc------------cCCCCCCHHHHHHHHHHHHHHHHHHH
Q 001142 879 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE------------TGEKHVSVKLALFIAQDVAAALVELH 946 (1142)
Q Consensus 879 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~------------~~~~~ls~~~i~~Ia~qIa~gL~yLH 946 (1142)
+..... .|+||||+++++|.+++..... .....+++..+..++.|++.||.|||
T Consensus 76 ~~~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH 141 (283)
T cd05090 76 VTQEQP--------------VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS 141 (283)
T ss_pred EecCCc--------------eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH
Confidence 876543 4999999999999999864211 01234788999999999999999999
Q ss_pred hCCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCC
Q 001142 947 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 1026 (1142)
Q Consensus 947 s~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 1026 (1142)
++||+||||||+|||++.+ +.+||+|||+++........ .......++..|+|||++.+ ..
T Consensus 142 ~~~i~H~dlkp~nili~~~-------~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~ 202 (283)
T cd05090 142 SHFFVHKDLAARNILIGEQ-------LHVKISDLGLSREIYSADYY--------RVQPKSLLPIRWMPPEAIMY----GK 202 (283)
T ss_pred hcCeehhccccceEEEcCC-------CcEEeccccccccccCCcce--------ecccCCCccceecChHHhcc----CC
Confidence 9999999999999999877 78999999999764322110 01122345778999999865 45
Q ss_pred CCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHH
Q 001142 1027 YGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFL 1105 (1142)
Q Consensus 1027 ~s~ksDVwSLGviL~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 1105 (1142)
++.++|||||||++|||++ |..||.+.....+...+.....+..+ ...+..+
T Consensus 203 ~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~ 255 (283)
T cd05090 203 FSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCS---------------------------EDCPPRM 255 (283)
T ss_pred CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCC---------------------------CCCCHHH
Confidence 7899999999999999998 99999877666665555443322111 1345668
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHh
Q 001142 1106 VDVFRRCTEENPTERPTAGDLYEMFVA 1132 (1142)
Q Consensus 1106 ~dLI~~CL~~DP~~RPSa~EVL~~L~~ 1132 (1142)
.+++.+||+.||++||++.+|++++..
T Consensus 256 ~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 256 YSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=319.34 Aligned_cols=254 Identities=23% Similarity=0.401 Sum_probs=200.2
Q ss_pred CCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
..+|++.+.||+|+||.||+|.+. +..+++|+.. .. ......+ .+|++++++++||||+++++++..+.
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~--~~---~~~~~~~----~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--ED---TMEVEEF----LKEAAVMKEIKHPNLVQLLGVCTREP 75 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEec--CC---chHHHHH----HHHHHHHHhCCCCChhheEEEEcCCC
Confidence 346899999999999999999984 5667777643 21 1223334 78999999999999999999987655
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
. .++||||+++++|.+++.. .....+++..+..++.|++.||+|||++||+||||||+||+++
T Consensus 76 ~--------------~~lv~e~~~~~~L~~~~~~---~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~ 138 (263)
T cd05052 76 P--------------FYIITEFMTYGNLLDYLRE---CNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG 138 (263)
T ss_pred C--------------cEEEEEeCCCCcHHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc
Confidence 3 3999999999999999875 2234689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.+||+|||.+......... ......+++.|+|||.+.+ ..++.++|||||||++|||
T Consensus 139 ~~-------~~~kl~df~~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il~el 198 (263)
T cd05052 139 EN-------HLVKVADFGLSRLMTGDTYT---------AHAGAKFPIKWTAPESLAY----NKFSIKSDVWAFGVLLWEI 198 (263)
T ss_pred CC-------CcEEeCCCccccccccceee---------ccCCCCCccccCCHHHhcc----CCCCchhHHHHHHHHHHHH
Confidence 77 78999999999765432111 1112234667999998865 5678899999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1044 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1044 Lt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
++ |..||.+....+....+.....+..+ ...+..+.+++.+||+.||++|||
T Consensus 199 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~cl~~~p~~Rp~ 251 (263)
T cd05052 199 ATYGMSPYPGIDLSQVYELLEKGYRMERP---------------------------EGCPPKVYELMRACWQWNPSDRPS 251 (263)
T ss_pred HcCCCCCCCCCCHHHHHHHHHCCCCCCCC---------------------------CCCCHHHHHHHHHHccCCcccCCC
Confidence 98 99999877666665555433221111 134567999999999999999999
Q ss_pred HHHHHHHHHh
Q 001142 1123 AGDLYEMFVA 1132 (1142)
Q Consensus 1123 a~EVL~~L~~ 1132 (1142)
+.++++.+..
T Consensus 252 ~~~l~~~l~~ 261 (263)
T cd05052 252 FAEIHQAFET 261 (263)
T ss_pred HHHHHHHHHh
Confidence 9999998653
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=318.13 Aligned_cols=247 Identities=22% Similarity=0.342 Sum_probs=193.9
Q ss_pred eecccCceEEEEEEE----CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCC
Q 001142 814 EAGKSVSSSLFRCKF----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSAD 889 (1142)
Q Consensus 814 ~LG~GsfG~Vy~a~~----~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~~~ 889 (1142)
.||+|+||.||+|.+ .+..+|+|+.+.. .......+.+ .+|+.+++.+.||||+++++++..+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~----~~e~~~l~~l~h~~i~~~~~~~~~~------- 68 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKND--NNDPALKDEL----LREANVMQQLDNPYIVRMIGICEAE------- 68 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCC--CCcHHHHHHH----HHHHHHHHhCCCCCcceEEEEEcCC-------
Confidence 689999999999976 3466777774322 2222333334 7899999999999999999987532
Q ss_pred CCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccC
Q 001142 890 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 969 (1142)
Q Consensus 890 ~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~ 969 (1142)
..++||||+++++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+||+++.+
T Consensus 69 --------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~---- 131 (257)
T cd05116 69 --------SWMLVMELAELGPLNKFLQK-----NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQ---- 131 (257)
T ss_pred --------CcEEEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCC----
Confidence 23899999999999999865 2468999999999999999999999999999999999999877
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-CCC
Q 001142 970 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQV 1048 (1142)
Q Consensus 970 ~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt-G~~ 1048 (1142)
+.+||+|||.+.......... .......++..|+|||.+.. ..++.++|||||||++|||++ |+.
T Consensus 132 ---~~~kl~Dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~el~t~g~~ 197 (257)
T cd05116 132 ---HYAKISDFGLSKALGADENYY-------KAKTHGKWPVKWYAPECMNY----YKFSSKSDVWSFGVLMWEAFSYGQK 197 (257)
T ss_pred ---CeEEECCCccccccCCCCCee-------eecCCCCCCccccCHhHhcc----CCcCchhHHHHHHHHHHHHHhCCCC
Confidence 789999999997654321110 00112234678999998864 467789999999999999998 999
Q ss_pred CCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001142 1049 PYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1128 (1142)
Q Consensus 1049 Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~ 1128 (1142)
||......+....+..+..+..+. ..++.+.++|.+||+.||++||++++|.+
T Consensus 198 p~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 198 PYKGMKGNEVTQMIESGERMECPQ---------------------------RCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred CCCCCCHHHHHHHHHCCCCCCCCC---------------------------CCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 998877777767666544332211 34567999999999999999999999998
Q ss_pred HHH
Q 001142 1129 MFV 1131 (1142)
Q Consensus 1129 ~L~ 1131 (1142)
.|.
T Consensus 251 ~l~ 253 (257)
T cd05116 251 RLR 253 (257)
T ss_pred HHh
Confidence 874
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=330.79 Aligned_cols=285 Identities=20% Similarity=0.241 Sum_probs=189.8
Q ss_pred eeeecccCceEEEEEEEC----CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCC
Q 001142 812 CDEAGKSVSSSLFRCKFG----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 887 (1142)
Q Consensus 812 ~~~LG~GsfG~Vy~a~~~----~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~ 887 (1142)
.++||+|+||+||+|++. +..+|+|.. +..... .. +.+|+.++++++||||+++++++....
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~--~~~~~~----~~----~~~E~~~l~~l~h~niv~~~~~~~~~~---- 71 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQI--EGTGIS----MS----ACREIALLRELKHPNVISLQKVFLSHA---- 71 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEE--CCCCCc----HH----HHHHHHHHHhcCCCCCcceeeeEecCC----
Confidence 468999999999999863 345666654 322111 12 268999999999999999999886532
Q ss_pred CCCCCccccceEEEEEeccCCCCHHHHHHHHhc----cCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 888 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE----TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 888 ~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~----~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
....++||||+. ++|.+++..... .....+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 72 --------~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~ 142 (317)
T cd07868 72 --------DRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVM 142 (317)
T ss_pred --------CcEEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEe
Confidence 124699999996 789888764221 1123589999999999999999999999999999999999995
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+. ...+.+||+|||+++........ ........||+.|+|||++.+ ...++.++||||+||++|+|
T Consensus 143 ~~~---~~~~~~kl~DfG~a~~~~~~~~~-------~~~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~el 209 (317)
T cd07868 143 GEG---PERGRVKIADMGFARLFNSPLKP-------LADLDPVVVTFWYRAPELLLG---ARHYTKAIDIWAIGCIFAEL 209 (317)
T ss_pred cCC---CCcCcEEEeecCceeccCCCCcc-------ccccCCccccccccCCHHHcC---CCCcCchhhHHHHHHHHHHH
Confidence 321 12268999999999765432111 111224568999999999875 23578999999999999999
Q ss_pred HhCCCCCCCCCH---------HHHHHHHHhCCCCCchhHHhhhccccccc-----cccc-CC--CCC--CchhhhhhHHH
Q 001142 1044 LTLQVPYMGLSE---------LEIHDLIQMGKRPRLTDELEALGSCHEHE-----VAQS-GS--GFE--KPEAELETLSF 1104 (1142)
Q Consensus 1044 LtG~~Pf~~~~~---------~el~~~I~~~~~p~l~~~l~~~~~~~~~~-----~~~~-~~--~~~--~~~~~~~~~~~ 1104 (1142)
++|++||..... ......+...........+.......... .... .. ... ...........
T Consensus 210 ~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (317)
T cd07868 210 LTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSK 289 (317)
T ss_pred HhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChH
Confidence 999999964321 11122221111111111111110000000 0000 00 000 00000122345
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 001142 1105 LVDVFRRCTEENPTERPTAGDLYEMFVA 1132 (1142)
Q Consensus 1105 L~dLI~~CL~~DP~~RPSa~EVL~~L~~ 1132 (1142)
+.+++.+||+.||.+|||++|+++|+|+
T Consensus 290 ~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 290 AFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 8899999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=332.70 Aligned_cols=256 Identities=21% Similarity=0.264 Sum_probs=212.9
Q ss_pred CcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
-|.+.+.||+|.|.+|-+|++ .+..|||||. +++.........+ .+|++.|+-++|||||++|++.....
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKvi--DKTKlD~~st~hl----fqEVRCMKLVQHpNiVRLYEViDTQT-- 90 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVI--DKTKLDTLSTGHL----FQEVRCMKLVQHPNIVRLYEVIDTQT-- 90 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEe--cccccchhhhhHH----HHHHHHHHHhcCcCeeeeeehhcccc--
Confidence 488999999999999999986 7899999984 4444443333333 68999999999999999999987654
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
.+|||+|+-++|+|++||-++ ...+.+..+++++.||+.|+.|+|+..+|||||||+||.+-+.
T Consensus 91 ------------KlyLiLELGD~GDl~DyImKH----e~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEK 154 (864)
T KOG4717|consen 91 ------------KLYLILELGDGGDLFDYIMKH----EEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEK 154 (864)
T ss_pred ------------eEEEEEEecCCchHHHHHHhh----hccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeee
Confidence 459999999999999999873 3469999999999999999999999999999999999977554
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
- |-|||.|||++..+.... ...+.+|+..|-|||++.+. ....+++||||||||||.|..
T Consensus 155 l------GlVKLTDFGFSNkf~PG~-----------kL~TsCGSLAYSAPEILLGD---sYDAPAVDiWSLGVILyMLVC 214 (864)
T KOG4717|consen 155 L------GLVKLTDFGFSNKFQPGK-----------KLTTSCGSLAYSAPEILLGD---SYDAPAVDIWSLGVILYMLVC 214 (864)
T ss_pred c------CceEeeeccccccCCCcc-----------hhhcccchhhccCchhhhcC---ccCCcchhhhHHHHHHHHHHh
Confidence 2 889999999986554322 23456799999999999983 344589999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001142 1046 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1125 (1142)
Q Consensus 1046 G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~E 1125 (1142)
|++||+..+..+...+|......- +...+++.++||..||..||.+|.+.+|
T Consensus 215 Gq~PFqeANDSETLTmImDCKYtv----------------------------PshvS~eCrdLI~sMLvRdPkkRAslEe 266 (864)
T KOG4717|consen 215 GQPPFQEANDSETLTMIMDCKYTV----------------------------PSHVSKECRDLIQSMLVRDPKKRASLEE 266 (864)
T ss_pred CCCccccccchhhhhhhhcccccC----------------------------chhhhHHHHHHHHHHHhcCchhhccHHH
Confidence 999999888877777765443211 1167788999999999999999999999
Q ss_pred HHHHHHhhcC
Q 001142 1126 LYEMFVARTS 1135 (1142)
Q Consensus 1126 VL~~L~~~~s 1135 (1142)
|..+.|.+.-
T Consensus 267 I~s~~Wlq~~ 276 (864)
T KOG4717|consen 267 IVSTSWLQAG 276 (864)
T ss_pred HhccccccCC
Confidence 9999998754
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=340.47 Aligned_cols=249 Identities=25% Similarity=0.285 Sum_probs=193.2
Q ss_pred ecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC---CCCCccceeeeEecCCCCCCCC
Q 001142 815 AGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL---RHSCIVEMYGHKISSKWLPSAD 889 (1142)
Q Consensus 815 LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L---~HpNIVkl~g~~~~~~~~~~~~ 889 (1142)
||+|+||+||+|++. +..+|+|+...+.... ..... ....|..++... .||||+++++.+.+...
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-~~~~~----~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~----- 70 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVA-KKEVA----HTIGERNILVRTLLDESPFIVGLKFSFQTDSD----- 70 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhh-hhHHH----HHHHHHHHHHHhccCCCCcCcceEEEEecCCe-----
Confidence 799999999999874 6678888754221111 11111 224567777655 69999999999886553
Q ss_pred CCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccC
Q 001142 890 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 969 (1142)
Q Consensus 890 ~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~ 969 (1142)
.++||||+++++|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 71 ---------~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~---- 132 (330)
T cd05586 71 ---------LYLVTDYMSGGELFWHLQK-----EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDAT---- 132 (330)
T ss_pred ---------EEEEEcCCCCChHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC----
Confidence 4999999999999998875 3468999999999999999999999999999999999999887
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001142 970 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1049 (1142)
Q Consensus 970 ~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~P 1049 (1142)
+.+||+|||++....... .......||+.|+|||++.+ ...++.++|||||||++|+|++|+.|
T Consensus 133 ---~~~kl~Dfg~a~~~~~~~----------~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DvwslGvil~elltG~~P 196 (330)
T cd05586 133 ---GHIALCDFGLSKANLTDN----------KTTNTFCGTTEYLAPEVLLD---EKGYTKHVDFWSLGVLVFEMCCGWSP 196 (330)
T ss_pred ---CCEEEecCCcCcCCCCCC----------CCccCccCCccccCHHHHcC---CCCCCCccceeccccEEEEeccCCCC
Confidence 789999999986432211 11123469999999999865 23478999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC----CHHH
Q 001142 1050 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP----TAGD 1125 (1142)
Q Consensus 1050 f~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP----Sa~E 1125 (1142)
|.+....+....+..+.... +. ...++.+.+++.+||+.||.+|| ++.+
T Consensus 197 f~~~~~~~~~~~i~~~~~~~-~~--------------------------~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 249 (330)
T cd05586 197 FYAEDTQQMYRNIAFGKVRF-PK--------------------------NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVE 249 (330)
T ss_pred CCCCCHHHHHHHHHcCCCCC-CC--------------------------ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHH
Confidence 98877666666554332110 00 02355689999999999999998 7999
Q ss_pred HHHHHHhhc
Q 001142 1126 LYEMFVART 1134 (1142)
Q Consensus 1126 VL~~L~~~~ 1134 (1142)
+++|+|+..
T Consensus 250 ll~h~~~~~ 258 (330)
T cd05586 250 LKEHPFFAD 258 (330)
T ss_pred HhcCccccC
Confidence 999999864
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=323.89 Aligned_cols=251 Identities=29% Similarity=0.492 Sum_probs=194.1
Q ss_pred ceeeeecccCceEEEEEEEC------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 810 SSCDEAGKSVSSSLFRCKFG------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 810 ~l~~~LG~GsfG~Vy~a~~~------~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
++.+.||.|+||.||+|.+. +..|+||+.. . .......+.+ .+|++.+++++||||++++|++....
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~--~-~~~~~~~~~~----~~e~~~l~~l~h~ni~~~~g~~~~~~ 74 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILK--P-SSSEEEEEEF----LNEIQILRKLRHPNIVKLYGFCIENE 74 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEES--T-TSSHHHHHHH----HHHHHHHHTHSBTTBE-EEEEEESSS
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEec--c-ccccccceee----eecccccccccccccccccccccccc
Confidence 46789999999999999997 5567777652 2 2233334555 78999999999999999999998543
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
. .++||||+++|+|.+++... ....+++..+..|+.||+.||.|||+++|+|+||+++||+++
T Consensus 75 ~--------------~~lv~e~~~~g~L~~~L~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~ 137 (259)
T PF07714_consen 75 P--------------LFLVMEYCPGGSLDDYLKSK---NKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLD 137 (259)
T ss_dssp S--------------EEEEEE--TTEBHHHHHHHT---CTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEE
T ss_pred c--------------cccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccccccc
Confidence 2 49999999999999999872 235689999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.+||+|||++......... .......+...|+|||.+.. ..++.++||||||+++|||
T Consensus 138 ~~-------~~~Kl~~f~~~~~~~~~~~~--------~~~~~~~~~~~~~aPE~~~~----~~~~~ksDVysfG~~l~ei 198 (259)
T PF07714_consen 138 SN-------GQVKLSDFGLSRPISEKSKY--------KNDSSQQLPLRYLAPEVLKD----GEYTKKSDVYSFGMLLYEI 198 (259)
T ss_dssp TT-------TEEEEESTTTGEETTTSSSE--------EESTTSESGGGGS-HHHHHH----SEESHHHHHHHHHHHHHHH
T ss_pred cc-------cccccccccccccccccccc--------cccccccccccccccccccc----ccccccccccccccccccc
Confidence 87 89999999999765221111 01112346778999999876 4578999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1044 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1044 Lt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
++ |+.||.+....++...+..+..+..+. .++..+.+++.+||..||.+|||
T Consensus 199 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~C~~~~p~~RPs 251 (259)
T PF07714_consen 199 LTLGKFPFSDYDNEEIIEKLKQGQRLPIPD---------------------------NCPKDIYSLIQQCWSHDPEKRPS 251 (259)
T ss_dssp HTTSSGTTTTSCHHHHHHHHHTTEETTSBT---------------------------TSBHHHHHHHHHHT-SSGGGS--
T ss_pred cccccccccccccccccccccccccceecc---------------------------chhHHHHHHHHHHcCCChhhCcC
Confidence 99 789998887777777765554332221 34566899999999999999999
Q ss_pred HHHHHHHH
Q 001142 1123 AGDLYEMF 1130 (1142)
Q Consensus 1123 a~EVL~~L 1130 (1142)
+.++++.|
T Consensus 252 ~~~i~~~L 259 (259)
T PF07714_consen 252 FQEILQEL 259 (259)
T ss_dssp HHHHHHHH
T ss_pred HHHHHhcC
Confidence 99999865
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=349.28 Aligned_cols=284 Identities=20% Similarity=0.214 Sum_probs=196.2
Q ss_pred CCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC------CCCccceee
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR------HSCIVEMYG 877 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~------HpNIVkl~g 877 (1142)
-.+|++.++||+|+||+||+|.+ .+..||+|+.+... .....+ ..|+.++..++ |++|+++++
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-----~~~~~~----~~e~~~l~~l~~~~~~~~~~i~~i~~ 198 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-----KYTRDA----KIEIQFMEKVRQADPADRFPLMKIQR 198 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-----hhHHHH----HHHHHHHHHHhhcCcccCcceeeeEE
Confidence 36799999999999999999987 45668888754211 111122 45666666654 456888888
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCC
Q 001142 878 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIK 956 (1142)
Q Consensus 878 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs-~gIvHrDLK 956 (1142)
++.... .+.++|||++ +++|.+++.+ ...+++..+..|+.||+.||+|||+ .||||||||
T Consensus 199 ~~~~~~-------------~~~~iv~~~~-g~~l~~~l~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlK 259 (467)
T PTZ00284 199 YFQNET-------------GHMCIVMPKY-GPCLLDWIMK-----HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLK 259 (467)
T ss_pred EEEcCC-------------ceEEEEEecc-CCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCC
Confidence 876432 2469999998 6899998875 2468999999999999999999998 599999999
Q ss_pred CCCeeecccccc---------CCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCC
Q 001142 957 SENILIDLERKK---------ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 1027 (1142)
Q Consensus 957 p~NILld~~~~~---------~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~ 1027 (1142)
|+|||++.++.. ......+||+|||.+..... ......||+.|+|||++.+ ..|
T Consensus 260 P~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-------------~~~~~~gt~~Y~APE~~~~----~~~ 322 (467)
T PTZ00284 260 PENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH-------------SRTAIVSTRHYRSPEVVLG----LGW 322 (467)
T ss_pred HHHEEEecCCcccccccccccCCCCceEEECCCCccccCcc-------------ccccccCCccccCcHHhhc----CCC
Confidence 999999765210 00123699999998753211 1124579999999999976 568
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccccc-cccccc----CCC----------C
Q 001142 1028 GLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE-HEVAQS----GSG----------F 1092 (1142)
Q Consensus 1028 s~ksDVwSLGviL~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~-~~~~~~----~~~----------~ 1092 (1142)
+.++|||||||++|||++|+.||.+.+..+....+...... ++..+........ ..+... ... .
T Consensus 323 ~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (467)
T PTZ00284 323 MYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGR-LPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIAR 401 (467)
T ss_pred CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCC-CCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhc
Confidence 89999999999999999999999887766555444322111 1111110000000 000000 000 0
Q ss_pred CCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001142 1093 EKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1093 ~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~~s 1135 (1142)
..........+.+.+||.+||++||++|||++|+++|+|+...
T Consensus 402 ~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~ 444 (467)
T PTZ00284 402 ARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKY 444 (467)
T ss_pred ccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcccccc
Confidence 0000111234568899999999999999999999999999864
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=321.20 Aligned_cols=264 Identities=23% Similarity=0.387 Sum_probs=199.8
Q ss_pred CCCcceeeeecccCceEEEEEEECC-----ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 880 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~~-----~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~ 880 (1142)
.++|.+.+.||+|++|.||+|.+.. ..+.++++....... ......+ .+|+.++++++|+||+++++++.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~----~~e~~~l~~l~~~~i~~~~~~~~ 79 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS-EQDESDF----LMEALIMSKFNHQNIVRLIGVSF 79 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC-HHHHHHH----HHHHHHHHhCCCCCEeeEEEEEc
Confidence 4568999999999999999999855 444555544433221 2222334 78999999999999999999887
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET--GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 958 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~--~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~ 958 (1142)
+... .++||||+++++|.+++...... ....+++..+..++.||+.||+|||+++++||||||+
T Consensus 80 ~~~~--------------~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~ 145 (277)
T cd05036 80 ERLP--------------RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAAR 145 (277)
T ss_pred cCCC--------------cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchh
Confidence 6543 38999999999999999764211 1135899999999999999999999999999999999
Q ss_pred CeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001142 959 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1038 (1142)
Q Consensus 959 NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGv 1038 (1142)
||+++.++ ....+||+|||+++........ ........+..|+|||++.+ ..++.++|||||||
T Consensus 146 nil~~~~~----~~~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~DiwslG~ 209 (277)
T cd05036 146 NCLLTCKG----PGRVAKIADFGMARDIYRASYY--------RKGGRAMLPIKWMPPEAFLD----GIFTSKTDVWSFGV 209 (277)
T ss_pred eEEEeccC----CCcceEeccCccccccCCccce--------ecCCCCCccHhhCCHHHHhc----CCcCchhHHHHHHH
Confidence 99997642 1146999999999765321110 00112234567999999875 56889999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001142 1039 LLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1117 (1142)
Q Consensus 1039 iL~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP 1117 (1142)
++|||++ |..||.+....+....+.....+..+ ...+..+.+++.+||+.+|
T Consensus 210 il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~cl~~~p 262 (277)
T cd05036 210 LLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPP---------------------------KGCPGPVYRIMTDCWQHTP 262 (277)
T ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCC---------------------------CCCCHHHHHHHHHHcCCCc
Confidence 9999997 99999877666655555433221111 1345678999999999999
Q ss_pred CCCCCHHHHHHHHH
Q 001142 1118 TERPTAGDLYEMFV 1131 (1142)
Q Consensus 1118 ~~RPSa~EVL~~L~ 1131 (1142)
++|||+.+|++++.
T Consensus 263 ~~Rps~~~vl~~l~ 276 (277)
T cd05036 263 EDRPNFATILERIQ 276 (277)
T ss_pred ccCcCHHHHHHHhh
Confidence 99999999999874
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=325.07 Aligned_cols=262 Identities=29% Similarity=0.487 Sum_probs=206.7
Q ss_pred CCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
.++|++.+.||+|+||.||+|.+. +..+++|+.... .....+.+ .+|+.++++++||||+++++++....
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~----~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE----SEEELEDF----MVEIDILSECKHPNIVGLYEAYFYEN 75 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC----CHHHHHHH----HHHHHHHHhCCCCceeEEEEEEecCC
Confidence 457999999999999999999984 566777775432 22333444 78999999999999999999988654
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
..++||||+++++|.+++... ...+++..+..++.|++.||.|||++||+|+||||+||+++
T Consensus 76 --------------~~~lv~e~~~~~~L~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~ 137 (280)
T cd06611 76 --------------KLWILIEFCDGGALDSIMLEL----ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLT 137 (280)
T ss_pred --------------eEEEEeeccCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEC
Confidence 349999999999999998752 24689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhcccc-CCCCCCchhhHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~s~ksDVwSLGviL~E 1042 (1142)
.+ +.++|+|||.+........ ......+++.|+|||.+.... ....++.++||||||+++|+
T Consensus 138 ~~-------~~~~l~d~g~~~~~~~~~~----------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~ 200 (280)
T cd06611 138 LD-------GDVKLADFGVSAKNKSTLQ----------KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIE 200 (280)
T ss_pred CC-------CCEEEccCccchhhccccc----------ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHH
Confidence 77 7899999998865432111 112345889999999986321 23457789999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1043 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1043 LLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
|++|+.||......+....+..+..+.+.. ....+..+.+++.+||+.+|.+||+
T Consensus 201 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~li~~~l~~~p~~Rps 255 (280)
T cd06611 201 LAQMEPPHHELNPMRVLLKILKSEPPTLDQ-------------------------PSKWSSSFNDFLKSCLVKDPDDRPT 255 (280)
T ss_pred HHhCCCCcccCCHHHHHHHHhcCCCCCcCC-------------------------cccCCHHHHHHHHHHhccChhhCcC
Confidence 999999998766655544444333221110 0134556899999999999999999
Q ss_pred HHHHHHHHHhhcC
Q 001142 1123 AGDLYEMFVARTS 1135 (1142)
Q Consensus 1123 a~EVL~~L~~~~s 1135 (1142)
+.++++|+|+...
T Consensus 256 ~~~il~~~~~~~~ 268 (280)
T cd06611 256 AAELLKHPFVSDQ 268 (280)
T ss_pred HHHHhcChhhccc
Confidence 9999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=321.97 Aligned_cols=258 Identities=21% Similarity=0.359 Sum_probs=197.9
Q ss_pred CCcceeeeecccCceEEEEEEECC-------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeE
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 879 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~~-------~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~ 879 (1142)
++|++.+.||+|+||.||+|.+.+ ..+|+|+.. .. .......++ .+|+.+++.++||||+++++++
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~--~~-~~~~~~~~~----~~e~~~l~~l~~~~iv~~~~~~ 78 (277)
T cd05062 6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVN--EA-ASMRERIEF----LNEASVMKEFNCHHVVRLLGVV 78 (277)
T ss_pred HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecc--cc-CCHHHHHHH----HHHHHHHHhCCCCCeeeEEEEE
Confidence 468999999999999999998642 346666532 21 112222333 7899999999999999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 001142 880 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG-----EKHVSVKLALFIAQDVAAALVELHSKHIMHRD 954 (1142)
Q Consensus 880 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~-----~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrD 954 (1142)
.+.. +.++||||+++++|.++++...... ...+++..+..++.|++.||.|||+.|++|||
T Consensus 79 ~~~~--------------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~d 144 (277)
T cd05062 79 SQGQ--------------PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRD 144 (277)
T ss_pred cCCC--------------CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Confidence 7544 3499999999999999997632210 13467889999999999999999999999999
Q ss_pred CCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHH
Q 001142 955 IKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 1034 (1142)
Q Consensus 955 LKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVw 1034 (1142)
|||+||+++.+ +.++|+|||++.......... ......+++.|+|||++.+ ..++.++|||
T Consensus 145 lkp~Nil~~~~-------~~~~l~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~ 205 (277)
T cd05062 145 LAARNCMVAED-------FTVKIGDFGMTRDIYETDYYR--------KGGKGLLPVRWMSPESLKD----GVFTTYSDVW 205 (277)
T ss_pred cchheEEEcCC-------CCEEECCCCCccccCCcceee--------cCCCCccCHhhcChhHhhc----CCcCchhHHH
Confidence 99999999977 789999999987543211100 1112345778999999875 5678999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 001142 1035 SYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 1113 (1142)
Q Consensus 1035 SLGviL~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL 1113 (1142)
||||++|||++ |..||.+....+....+.....+..+ ...+..+.+++.+||
T Consensus 206 slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l 258 (277)
T cd05062 206 SFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKP---------------------------DNCPDMLFELMRMCW 258 (277)
T ss_pred HHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCC---------------------------CCCCHHHHHHHHHHc
Confidence 99999999999 78999887766666555443322111 134556899999999
Q ss_pred ccCCCCCCCHHHHHHHHH
Q 001142 1114 EENPTERPTAGDLYEMFV 1131 (1142)
Q Consensus 1114 ~~DP~~RPSa~EVL~~L~ 1131 (1142)
+.||++|||+.|+++++.
T Consensus 259 ~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 259 QYNPKMRPSFLEIISSIK 276 (277)
T ss_pred CCChhhCcCHHHHHHHhh
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=319.08 Aligned_cols=259 Identities=28% Similarity=0.437 Sum_probs=200.3
Q ss_pred CCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
++|++.+.||+|++|.||+|.. .+..+++|+...... ....... ...+.+|+.++++++||||+++++++.+..
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~--~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 77 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPD--SPETKKE-VNALECEIQLLKNLQHERIVQYYGCLRDDE- 77 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeeccc--chhhHHH-HHHHHHHHHHHHhCCCCCeeeeEEEEccCC-
Confidence 4689999999999999999986 467788887543321 1111111 123478999999999999999999998654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.||+||||+|+||+++.
T Consensus 78 -------------~~~~v~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~ 139 (263)
T cd06625 78 -------------TLSIFMEYMPGGSVKDQLKA-----YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDS 139 (263)
T ss_pred -------------eEEEEEEECCCCcHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC
Confidence 45999999999999999876 245889999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.++|+|||.+......... ........++..|+|||++.+ ..++.++||||||+++|+|+
T Consensus 140 ~-------~~~~l~dfg~~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~el~ 201 (263)
T cd06625 140 A-------GNVKLGDFGASKRLQTICSS-------GTGMKSVTGTPYWMSPEVISG----EGYGRKADVWSVGCTVVEML 201 (263)
T ss_pred C-------CCEEEeecccceeccccccc-------cccccCCCcCccccCcceecc----CCCCchhhhHHHHHHHHHHH
Confidence 7 78999999998754332111 001123457889999999876 45789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhC-CCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1045 TLQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
+|+.||...........+... ..+.. ....+..+.+++.+||..+|.+|||+
T Consensus 202 ~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~li~~~l~~~p~~Rpt~ 254 (263)
T cd06625 202 TEKPPWAEFEAMAAIFKIATQPTNPQL---------------------------PSHVSPDARNFLRRTFVENAKKRPSA 254 (263)
T ss_pred hCCCCccccchHHHHHHHhccCCCCCC---------------------------CccCCHHHHHHHHHHhhcCcccCCCH
Confidence 999999765444333222211 11110 01345668999999999999999999
Q ss_pred HHHHHHHHh
Q 001142 1124 GDLYEMFVA 1132 (1142)
Q Consensus 1124 ~EVL~~L~~ 1132 (1142)
.++++|+|+
T Consensus 255 ~~ll~~~~~ 263 (263)
T cd06625 255 EELLRHFFV 263 (263)
T ss_pred HHHhhCCCC
Confidence 999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=361.48 Aligned_cols=273 Identities=20% Similarity=0.331 Sum_probs=205.4
Q ss_pred CCCCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001142 803 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 880 (1142)
Q Consensus 803 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~ 880 (1142)
+..+.+|++.++||+|+||+||+|++. +..+++|+.... .........+ ..|+.++++++|||||+++++|.
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~--~l~e~~~~~~----~~EI~IL~~L~HPNIVrl~d~f~ 82 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYR--GLKEREKSQL----VIEVNVMRELKHKNIVRYIDRFL 82 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecc--ccCHHHHHHH----HHHHHHHHHcCCCCcCeEEEEEE
Confidence 344678999999999999999999984 445677765433 2223333333 78999999999999999999886
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-------Ccccc
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-------HIMHR 953 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~-------gIvHr 953 (1142)
.... ..+||||||+++++|.++|...... ...+++..++.|+.||+.||.|||+. +||||
T Consensus 83 de~~------------~~lyIVMEY~~gGSL~~lL~k~~~~-~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHR 149 (1021)
T PTZ00266 83 NKAN------------QKLYILMEFCDAGDLSRNIQKCYKM-FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHR 149 (1021)
T ss_pred ecCC------------CEEEEEEeCCCCCcHHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceec
Confidence 5321 2469999999999999999764332 24699999999999999999999984 59999
Q ss_pred CCCCCCeeeccccc----------cCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccC
Q 001142 954 DIKSENILIDLERK----------KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 1023 (1142)
Q Consensus 954 DLKp~NILld~~~~----------~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~ 1023 (1142)
||||+||||+.... .......+||+|||++..+.... ......||+.|+|||++.+.
T Consensus 150 DLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-----------~~~s~vGTp~YmAPEvL~ge-- 216 (1021)
T PTZ00266 150 DLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES-----------MAHSCVGTPYYWSPELLLHE-- 216 (1021)
T ss_pred cCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccc-----------cccccCCCccccCHHHHhcc--
Confidence 99999999965311 01223569999999997543211 11245699999999998652
Q ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhH
Q 001142 1024 PNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE-IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETL 1102 (1142)
Q Consensus 1024 ~~~~s~ksDVwSLGviL~ELLtG~~Pf~~~~~~e-l~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1102 (1142)
...++.++|||||||+||+|++|+.||....... +...+........ ...+
T Consensus 217 ~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~lpi----------------------------~~~S 268 (1021)
T PTZ00266 217 TKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDLPI----------------------------KGKS 268 (1021)
T ss_pred CCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCCCc----------------------------CCCC
Confidence 2457899999999999999999999997644332 3333222211000 0335
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001142 1103 SFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1103 ~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~~s 1135 (1142)
..+.+||..||+.+|.+||++.|++.|+|+...
T Consensus 269 ~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 269 KELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred HHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 679999999999999999999999999998743
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=322.29 Aligned_cols=258 Identities=32% Similarity=0.443 Sum_probs=197.7
Q ss_pred cceeeeecccCceEEEEEEECCc--cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCC
Q 001142 809 LSSCDEAGKSVSSSLFRCKFGSA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 886 (1142)
Q Consensus 809 y~l~~~LG~GsfG~Vy~a~~~~~--~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~ 886 (1142)
|++.+.||+|+||+||+++.... .+|+|+..... ....... ...+|+.++++++||||+++++++.+..
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~----~~~~e~~~~~~l~~~~i~~~~~~~~~~~--- 71 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSE--IEEEERE----ENIREIKILRRLRHPNIVQILDVFQDDN--- 71 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTT--HHHHHHH----HHHHHHHHHHHHTBTTBCHEEEEEEESS---
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccc--ccccccc----hhhhhhhccccccccccccccccccccc---
Confidence 78999999999999999999544 58888865331 1111111 1246999999999999999999998755
Q ss_pred CCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecccc
Q 001142 887 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 966 (1142)
Q Consensus 887 ~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~ 966 (1142)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+||+++.+
T Consensus 72 -----------~~~~v~~~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~- 134 (260)
T PF00069_consen 72 -----------YLYIVMEYCPGGSLQDYLQK-----NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDEN- 134 (260)
T ss_dssp -----------EEEEEEEEETTEBHHHHHHH-----HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTT-
T ss_pred -----------cccccccccccccccccccc-----ccccccccccccccccccccccccccccccccccccccccccc-
Confidence 34899999998899999983 2468999999999999999999999999999999999999977
Q ss_pred ccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001142 967 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1046 (1142)
Q Consensus 967 ~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG 1046 (1142)
+.++|+|||.+....... .......++..|+|||++.. ...++.++||||+|+++|+|++|
T Consensus 135 ------~~~~l~Dfg~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~il~~l~~~ 195 (260)
T PF00069_consen 135 ------GEVKLIDFGSSVKLSENN----------ENFNPFVGTPEYMAPEVLQQ---GKKYTRKSDIWSLGIILYELLTG 195 (260)
T ss_dssp ------SEEEESSGTTTEESTSTT----------SEBSSSSSSGGGSCHHHHTT---TSSBSTHHHHHHHHHHHHHHHHS
T ss_pred ------cccccccccccccccccc----------cccccccccccccccccccc---ccccccccccccccccccccccc
Confidence 789999999987531111 11123468999999999872 25678999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 001142 1047 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1126 (1142)
Q Consensus 1047 ~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EV 1126 (1142)
..||...........+............. ........+.+++.+||+.||++||++.++
T Consensus 196 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l 254 (260)
T PF00069_consen 196 KLPFEESNSDDQLEIIEKILKRPLPSSSQ---------------------QSREKSEELRDLIKKMLSKDPEQRPSAEEL 254 (260)
T ss_dssp SSSSTTSSHHHHHHHHHHHHHTHHHHHTT---------------------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHH
T ss_pred ccccccccchhhhhhhhhccccccccccc---------------------ccchhHHHHHHHHHHHccCChhHCcCHHHH
Confidence 99998763333333222111111100000 000223679999999999999999999999
Q ss_pred HHHHHh
Q 001142 1127 YEMFVA 1132 (1142)
Q Consensus 1127 L~~L~~ 1132 (1142)
++|+|+
T Consensus 255 ~~~~~~ 260 (260)
T PF00069_consen 255 LKHPWF 260 (260)
T ss_dssp HTSGGG
T ss_pred hcCCCC
Confidence 999996
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=322.15 Aligned_cols=259 Identities=24% Similarity=0.387 Sum_probs=202.1
Q ss_pred CCCcceeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeee
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 878 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~-------~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~ 878 (1142)
..+|.+.+.||+|+||.||+|.+. ...+|+|+.... ......+.+ .+|++++++++||||++++++
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~----~~e~~~l~~l~~~~i~~~~~~ 76 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET---ASNDARKDF----EREAELLTNFQHENIVKFYGV 76 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeeccc---CCHHHHHHH----HHHHHHHHhcCCCCchheeeE
Confidence 356899999999999999999863 245777765322 112223344 799999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHh---------ccCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 001142 879 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS---------ETGEKHVSVKLALFIAQDVAAALVELHSKH 949 (1142)
Q Consensus 879 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~---------~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~g 949 (1142)
+.... ..++||||+++++|.+++.... ......+++..+..++.|++.||.|||++|
T Consensus 77 ~~~~~--------------~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~ 142 (280)
T cd05049 77 CTEGD--------------PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH 142 (280)
T ss_pred EecCC--------------CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC
Confidence 88654 3499999999999999997632 112245789999999999999999999999
Q ss_pred ccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCc
Q 001142 950 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGL 1029 (1142)
Q Consensus 950 IvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ 1029 (1142)
|+||||||+||+++.+ +.++|+|||.+......... .......+++.|+|||++.+ ..++.
T Consensus 143 i~h~dlkp~nili~~~-------~~~kl~d~g~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~ 203 (280)
T cd05049 143 FVHRDLATRNCLVGYD-------LVVKIGDFGMSRDVYTTDYY--------RVGGHTMLPIRWMPPESIMY----RKFTT 203 (280)
T ss_pred eeccccccceEEEcCC-------CeEEECCcccceecccCcce--------ecCCCCcccceecChhhhcc----CCcch
Confidence 9999999999999887 78999999998654221100 01123346788999999876 56889
Q ss_pred hhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHH
Q 001142 1030 EVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDV 1108 (1142)
Q Consensus 1030 ksDVwSLGviL~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dL 1108 (1142)
++|||||||++|||++ |..||.+....+....+..+..+..+ ...+..+.++
T Consensus 204 ~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l 256 (280)
T cd05049 204 ESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQRP---------------------------RTCPSEVYDI 256 (280)
T ss_pred hhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcCCCC---------------------------CCCCHHHHHH
Confidence 9999999999999998 99999877766666665543322111 1345679999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHH
Q 001142 1109 FRRCTEENPTERPTAGDLYEMFV 1131 (1142)
Q Consensus 1109 I~~CL~~DP~~RPSa~EVL~~L~ 1131 (1142)
+.+||+.||++||++.||++.+.
T Consensus 257 i~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 257 MLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHcCCCcccCCCHHHHHHHhh
Confidence 99999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=322.50 Aligned_cols=262 Identities=24% Similarity=0.374 Sum_probs=201.7
Q ss_pred CCCcceeeeecccCceEEEEEEE-----CCcc--EEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeee
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKF-----GSAD--AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 878 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~-----~~~~--vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~ 878 (1142)
..+|.+.+.||+|+||.||++.. .... +++|. +... .....+.+ .+|+.++++++||||++++++
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~--~~~~--~~~~~~~~----~~e~~~l~~l~h~~i~~~~~~ 75 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKT--LKDA--SDNARKDF----HREAELLTNLQHEHIVKFYGV 75 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEe--cCCc--CHHHHHHH----HHHHHHHHhCCCCCcceEEEE
Confidence 35789999999999999999975 2223 44544 3321 22223334 789999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc--------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 001142 879 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE--------TGEKHVSVKLALFIAQDVAAALVELHSKHI 950 (1142)
Q Consensus 879 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~--------~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gI 950 (1142)
+...+. .++||||+++++|.+++..... .....+++..+..++.||+.||+|||++||
T Consensus 76 ~~~~~~--------------~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i 141 (288)
T cd05093 76 CVEGDP--------------LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHF 141 (288)
T ss_pred EecCCc--------------cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 876543 4999999999999999975321 112358999999999999999999999999
Q ss_pred cccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCch
Q 001142 951 MHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLE 1030 (1142)
Q Consensus 951 vHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~k 1030 (1142)
+||||||+|||++.+ +.++|+|||.+......... .......+++.|+|||++.+ ..++.+
T Consensus 142 ~H~dlkp~Nili~~~-------~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~ 202 (288)
T cd05093 142 VHRDLATRNCLVGEN-------LLVKIGDFGMSRDVYSTDYY--------RVGGHTMLPIRWMPPESIMY----RKFTTE 202 (288)
T ss_pred eecccCcceEEEccC-------CcEEeccCCccccccCCcee--------ecCCCCCccccccCHHHhcc----CCCCch
Confidence 999999999999877 78999999998754321110 01112346788999999875 567899
Q ss_pred hhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHH
Q 001142 1031 VDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVF 1109 (1142)
Q Consensus 1031 sDVwSLGviL~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI 1109 (1142)
+|||||||++|+|++ |..||......+....+..+..+..+. ..+..+.+|+
T Consensus 203 sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li 255 (288)
T cd05093 203 SDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPR---------------------------TCPKEVYDLM 255 (288)
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcCCCCC---------------------------CCCHHHHHHH
Confidence 999999999999998 999998777666666665543222110 3345699999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHhhcC
Q 001142 1110 RRCTEENPTERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1110 ~~CL~~DP~~RPSa~EVL~~L~~~~s 1135 (1142)
.+||+.||.+|||+.++++.+.....
T Consensus 256 ~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 256 LGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred HHHccCChhhCCCHHHHHHHHHHHHH
Confidence 99999999999999999887766543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=323.68 Aligned_cols=280 Identities=21% Similarity=0.262 Sum_probs=199.4
Q ss_pred CcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
+|++.+.||+|++|.||+|+. .+..+++|+...... .....+. +.+|+.++++++||||+++++++.++.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 72 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE--EEGVPST----AIREISLLKELQHPNIVCLQDVLMQES-- 72 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc--cCCchHH----HHHHHHHHHhcCCCCEeeeEEEEeeCC--
Confidence 588999999999999999987 466788887543321 1111122 368999999999999999999988654
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
..++||||++ ++|.+++.... ....+++..+..++.||+.||+|||++||+||||||+||+++.+
T Consensus 73 ------------~~~~v~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~ 137 (285)
T cd07861 73 ------------RLYLIFEFLS-MDLKKYLDSLP--KGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNK 137 (285)
T ss_pred ------------eEEEEEecCC-CCHHHHHhcCC--CCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCC
Confidence 3499999997 78988886522 22468999999999999999999999999999999999999887
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+.++|+|||++........ ......+++.|+|||++.+ ...++.++|||||||++|+|++
T Consensus 138 -------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~il~~l~t 197 (285)
T cd07861 138 -------GVIKLADFGLARAFGIPVR----------VYTHEVVTLWYRAPEVLLG---SPRYSTPVDIWSIGTIFAEMAT 197 (285)
T ss_pred -------CcEEECcccceeecCCCcc----------cccCCcccccccChHHhcC---CCCcCcHHHHHHHHHHHHHHHH
Confidence 7899999999865432111 1112357889999999865 2356789999999999999999
Q ss_pred CCCCCCCCCHHHHHHHH-HhCCCCCchhHHhhhccccc--ccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1046 LQVPYMGLSELEIHDLI-QMGKRPRLTDELEALGSCHE--HEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1046 G~~Pf~~~~~~el~~~I-~~~~~p~l~~~l~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
|+.||.+.........+ .....+ ....+........ ..+... ............++++.++|.+||+.||.+|||
T Consensus 198 g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt 275 (285)
T cd07861 198 KKPLFHGDSEIDQLFRIFRILGTP-TEDVWPGVTSLPDYKNTFPKW-KKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRIS 275 (285)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCC-ChhhhhcchhhHHHHhhcccc-CcchhHHhcCCCCHHHHHHHHHHhcCChhhCCC
Confidence 99999876554433222 211111 1111100000000 000000 000000011135677899999999999999999
Q ss_pred HHHHHHHHHh
Q 001142 1123 AGDLYEMFVA 1132 (1142)
Q Consensus 1123 a~EVL~~L~~ 1132 (1142)
+.+|++|+|+
T Consensus 276 ~~~ll~~~~~ 285 (285)
T cd07861 276 AKKALNHPYF 285 (285)
T ss_pred HHHHhcCCCC
Confidence 9999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=316.04 Aligned_cols=258 Identities=28% Similarity=0.420 Sum_probs=203.8
Q ss_pred CcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
+|++.+.||.|+||.||+|.+. +..+++|+... ........+.+ ..|+.++++++||||+++++++....
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~----~~e~~~l~~l~~~~i~~~~~~~~~~~-- 72 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDY--GNMTEKEKQQL----VSEVNILRELKHPNIVRYYDRIIDRS-- 72 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEec--ccCCHHHHHHH----HHHHHHHHhcCCCccceeeeeeecCC--
Confidence 4889999999999999999874 45566666432 22233333333 78999999999999999999876432
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH-----hCCccccCCCCCCe
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELH-----SKHIMHRDIKSENI 960 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLH-----s~gIvHrDLKp~NI 960 (1142)
....+++|||+++++|.+++..... ....+++..++.++.||+.||.||| +.+|+|+||||+||
T Consensus 73 ----------~~~~~~~~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~ni 141 (265)
T cd08217 73 ----------NQTLYIVMEYCEGGDLAQLIQKCKK-ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANI 141 (265)
T ss_pred ----------CCEEEEEehhccCCCHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHE
Confidence 1246999999999999999976432 2357899999999999999999999 89999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
+++.+ +.+||+|||.+......... .....+++.|+|||++.. ..++.++||||||+++
T Consensus 142 li~~~-------~~~kl~d~g~~~~~~~~~~~----------~~~~~~~~~~~~pE~~~~----~~~~~~~Dv~slG~il 200 (265)
T cd08217 142 FLDAN-------NNVKLGDFGLAKILGHDSSF----------AKTYVGTPYYMSPEQLNH----MSYDEKSDIWSLGCLI 200 (265)
T ss_pred EEecC-------CCEEEecccccccccCCccc----------ccccccCCCccChhhhcC----CCCCchhHHHHHHHHH
Confidence 99877 78999999999765432110 112358899999999875 4578999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1041 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
|+|++|+.||......+..+.+..+..+.++. ..+..+.+++.+||+.+|++|
T Consensus 201 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~~~l~~~p~~R 253 (265)
T cd08217 201 YELCALSPPFTARNQLQLASKIKEGKFRRIPY---------------------------RYSSELNEVIKSMLNVDPDKR 253 (265)
T ss_pred HHHHHCCCcccCcCHHHHHHHHhcCCCCCCcc---------------------------ccCHHHHHHHHHHccCCcccC
Confidence 99999999998776655555554443322211 345678999999999999999
Q ss_pred CCHHHHHHHHHh
Q 001142 1121 PTAGDLYEMFVA 1132 (1142)
Q Consensus 1121 PSa~EVL~~L~~ 1132 (1142)
|++.+|++|+|.
T Consensus 254 p~~~~il~~~~~ 265 (265)
T cd08217 254 PSTEELLQLPLI 265 (265)
T ss_pred CCHHHHhhCCCC
Confidence 999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=318.14 Aligned_cols=256 Identities=22% Similarity=0.355 Sum_probs=200.5
Q ss_pred CCCcceeeeecccCceEEEEEEECC-----ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 880 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~~-----~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~ 880 (1142)
.++|++.+.||+|+||+||+|.+.. ..+++|+.. ... .......+ .+|+.++++++||||+++++++.
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~--~~~-~~~~~~~~----~~e~~~l~~l~h~~i~~~~~~~~ 75 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLK--AGS-SDKQRLDF----LTEASIMGQFDHPNIIRLEGVVT 75 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcC--CCC-ChHHHHHH----HHHHHHHHhCCCCCcceEeEEEe
Confidence 4578999999999999999999842 346666543 221 22223334 78999999999999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NI 960 (1142)
+.+. .++||||+++++|.+++... ...+++..+..++.|++.||.|||+++|+||||||+||
T Consensus 76 ~~~~--------------~~iv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~ni 137 (266)
T cd05033 76 KSRP--------------VMIITEYMENGSLDKFLREN----DGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNI 137 (266)
T ss_pred cCCc--------------eEEEEEcCCCCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceE
Confidence 6543 49999999999999998752 23689999999999999999999999999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
+++.+ +.++|+|||++.......... ......++..|+|||.+.+ ..++.++||||||+++
T Consensus 138 li~~~-------~~~~l~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~~Pe~~~~----~~~~~~~Dv~slG~~l 198 (266)
T cd05033 138 LVNSN-------LVCKVSDFGLSRRLEDSEATY--------TTKGGKIPIRWTAPEAIAY----RKFTSASDVWSFGIVM 198 (266)
T ss_pred EEcCC-------CCEEECccchhhcccccccce--------eccCCCCCccccChhhhcc----CCCccccchHHHHHHH
Confidence 99887 789999999998764211110 0112235678999999875 4678999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001142 1041 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1119 (1142)
Q Consensus 1041 ~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~ 1119 (1142)
|+|++ |..||......+....+........+ ...++.+.+++.+||+.+|++
T Consensus 199 ~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~cl~~~p~~ 251 (266)
T cd05033 199 WEVMSYGERPYWDMSNQDVIKAVEDGYRLPPP---------------------------MDCPSALYQLMLDCWQKDRNE 251 (266)
T ss_pred HHHHccCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------CCCCHHHHHHHHHHcCCCccc
Confidence 99998 99999877666666665443221111 134567899999999999999
Q ss_pred CCCHHHHHHHHHh
Q 001142 1120 RPTAGDLYEMFVA 1132 (1142)
Q Consensus 1120 RPSa~EVL~~L~~ 1132 (1142)
||++.||++++..
T Consensus 252 Rp~~~ei~~~l~~ 264 (266)
T cd05033 252 RPTFSQIVSTLDK 264 (266)
T ss_pred CcCHHHHHHHHHh
Confidence 9999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=317.39 Aligned_cols=264 Identities=22% Similarity=0.363 Sum_probs=202.3
Q ss_pred cceeeeecccCceEEEEEEECC-----ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 809 LSSCDEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 809 y~l~~~LG~GsfG~Vy~a~~~~-----~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
|.+.+.||+|+||.||+|.+.. ..+|+|+.+.+ .........+ .+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~----~~e~~~l~~l~h~~iv~~~~~~~~~~ 74 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLD--IHTYSEIEEF----LSEAACMKDFDHPNVMKLIGVCFEAS 74 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccC--cCCHHHHHHH----HHHHHHHHhCCCCCeeeEEeeeccCC
Confidence 5788999999999999998732 45777775432 2223333344 78999999999999999999876543
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~-~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
.. ......++||||+++++|..++..... .....+++..+..++.|++.||.|||+++|+||||||+||++
T Consensus 75 ~~--------~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~ 146 (273)
T cd05035 75 SL--------QKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCML 146 (273)
T ss_pred cc--------ccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEE
Confidence 21 122346999999999999999865321 123468999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
+.+ +.+||+|||.++........ .......++..|+|||++.. ..++.++|||||||++||
T Consensus 147 ~~~-------~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~~~~pe~~~~----~~~~~~~Dv~SlG~il~e 207 (273)
T cd05035 147 RED-------MTVCVADFGLSKKIYSGDYY--------RQGRIAKMPVKWIAIESLAD----RVYTSKSDVWAFGVTMWE 207 (273)
T ss_pred CCC-------CeEEECCccceeeccccccc--------cccccccCCccccCHhhccc----CCCCcccchHHHHHHHHH
Confidence 877 78999999999765332110 01112235678999999865 567899999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1043 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1043 LLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
|++ |..||.+....+..+.+..+..+..+ ...+..+.+++.+||+.||.+||
T Consensus 208 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp 260 (273)
T cd05035 208 IATRGQTPYPGVENHEIYDYLRHGNRLKQP---------------------------EDCLDELYDLMYSCWRADPKDRP 260 (273)
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------cCCCHHHHHHHHHHcCCChhhCc
Confidence 999 89999887766666665544332211 13456799999999999999999
Q ss_pred CHHHHHHHHHh
Q 001142 1122 TAGDLYEMFVA 1132 (1142)
Q Consensus 1122 Sa~EVL~~L~~ 1132 (1142)
|+.|+++++..
T Consensus 261 ~~~e~~~~l~~ 271 (273)
T cd05035 261 TFTKLREVLEN 271 (273)
T ss_pred CHHHHHHHHHh
Confidence 99999998754
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=316.37 Aligned_cols=249 Identities=25% Similarity=0.399 Sum_probs=199.9
Q ss_pred CCCcceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
..+|++.+.||+|+||.||++...+..+++|..+.. ...+.+ .+|+.++++++|+||+++++++...+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~------~~~~~~----~~e~~~l~~l~~~~i~~~~~~~~~~~-- 72 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND------ATAQAF----LAEASVMTQLRHSNLVQLLGVIVEEK-- 72 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCC------chHHHH----HHHHHHHHhCCCCCeeeEEEEEEcCC--
Confidence 457899999999999999999999999999875321 122333 78999999999999999999865432
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
...++||||+++++|.++++. .....+++..+..++.||+.||+|||++||+||||||+||+++.+
T Consensus 73 -----------~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~ 138 (256)
T cd05082 73 -----------GGLYIVTEYMAKGSLVDYLRS---RGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSED 138 (256)
T ss_pred -----------CceEEEEECCCCCcHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCC
Confidence 135999999999999999875 223458899999999999999999999999999999999999887
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+.+||+|||++....... ....++..|+|||++.. ..++.++|||||||++|+|++
T Consensus 139 -------~~~kl~dfg~~~~~~~~~-------------~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~i~~~l~~ 194 (256)
T cd05082 139 -------NVAKVSDFGLTKEASSTQ-------------DTGKLPVKWTAPEALRE----KKFSTKSDVWSFGILLWEIYS 194 (256)
T ss_pred -------CcEEecCCccceeccccC-------------CCCccceeecCHHHHcc----CCCCchhhhHHHHHHHHHHHh
Confidence 789999999986533211 12234567999999865 567899999999999999997
Q ss_pred -CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001142 1046 -LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124 (1142)
Q Consensus 1046 -G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~ 1124 (1142)
|+.||......+....+..+..+..+ ...++.+.+++.+||+.+|++|||+.
T Consensus 195 ~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rpt~~ 247 (256)
T cd05082 195 FGRVPYPRIPLKDVVPRVEKGYKMDAP---------------------------DGCPPVVYDVMKQCWHLDAATRPSFL 247 (256)
T ss_pred CCCCCCCCCCHHHHHHHHhcCCCCCCC---------------------------CCCCHHHHHHHHHHhcCChhhCcCHH
Confidence 99999876666655555443222111 14456789999999999999999999
Q ss_pred HHHHHHH
Q 001142 1125 DLYEMFV 1131 (1142)
Q Consensus 1125 EVL~~L~ 1131 (1142)
++++++.
T Consensus 248 ~l~~~l~ 254 (256)
T cd05082 248 QLREQLE 254 (256)
T ss_pred HHHHHHh
Confidence 9998775
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=317.97 Aligned_cols=251 Identities=25% Similarity=0.351 Sum_probs=198.0
Q ss_pred CCCcceeeeecccCceEEEEEEECCc-cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFGSA-DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~~~-~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
..+|++.+.||+|+||+||+|++.+. .+|+|..+ ..... ...+ .+|+.++++++||||+++++++.+...
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~--~~~~~---~~~~----~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK--EGSMS---EDEF----IEEAKVMMKLSHEKLVQLYGVCTKQRP 73 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecCCCcEEEEEcC--CCccc---HHHH----HHHHHHHhcCCCCCeeeEEEEEccCCC
Confidence 45789999999999999999998544 47777643 21111 2234 789999999999999999999876543
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
.++||||+++++|.+++... ...+++..+..++.||+.||.|||+.||+|+||||+||+++.
T Consensus 74 --------------~~lv~e~~~~~~l~~~i~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~ 135 (256)
T cd05113 74 --------------IYIVTEYMSNGCLLNYLREH----GKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDD 135 (256)
T ss_pred --------------cEEEEEcCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcC
Confidence 39999999999999998752 236899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||+|||.++........ ......++..|+|||.+.+ ..++.++|||||||++|+|+
T Consensus 136 ~-------~~~kl~d~g~~~~~~~~~~~---------~~~~~~~~~~y~~pe~~~~----~~~~~~~Di~slG~~l~~l~ 195 (256)
T cd05113 136 Q-------GCVKVSDFGLSRYVLDDEYT---------SSVGSKFPVRWSPPEVLLY----SKFSSKSDVWAFGVLMWEVY 195 (256)
T ss_pred C-------CCEEECCCccceecCCCcee---------ecCCCccChhhCCHHHHhc----CcccchhHHHHHHHHHHHHh
Confidence 7 78999999998754321110 0112235678999999875 45789999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1045 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1045 t-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
+ |..||......+....+..+..+..+. ..+..+.+++.+||+.||.+||++
T Consensus 196 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~cl~~~p~~Rp~~ 248 (256)
T cd05113 196 SLGKMPYERFNNSETVEKVSQGLRLYRPH---------------------------LASEKVYAIMYSCWHEKAEERPTF 248 (256)
T ss_pred cCCCCCcCcCCHHHHHHHHhcCCCCCCCC---------------------------CCCHHHHHHHHHHcCCCcccCCCH
Confidence 8 999998776666666654443221110 234568999999999999999999
Q ss_pred HHHHHHH
Q 001142 1124 GDLYEMF 1130 (1142)
Q Consensus 1124 ~EVL~~L 1130 (1142)
.++++.+
T Consensus 249 ~~ll~~~ 255 (256)
T cd05113 249 QQLLSSI 255 (256)
T ss_pred HHHHHhh
Confidence 9999875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=320.74 Aligned_cols=262 Identities=26% Similarity=0.398 Sum_probs=198.3
Q ss_pred CcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~~~~~~ 884 (1142)
.|++.+.||+|+||.||+|.+. +..+|+|+.... .. ....+ .+|+.+++++ +||||+++++++.....
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~--~~---~~~~~----~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 77 (272)
T cd06637 7 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--GD---EEEEI----KQEINMLKKYSHHRNIATYYGAFIKKNP 77 (272)
T ss_pred hhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC--Cc---cHHHH----HHHHHHHHHhcCCCCeeeEeeEEeecCC
Confidence 5788899999999999999884 556677765432 11 11233 6899999998 69999999999875431
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
.......++||||+++++|.+++.. .....+++..+..++.|++.||+|||+++|+|+||||+||+++.
T Consensus 78 --------~~~~~~~~iv~e~~~~~~L~~~l~~---~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~ 146 (272)
T cd06637 78 --------PGMDDQLWLVMEFCGAGSVTDLIKN---TKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTE 146 (272)
T ss_pred --------CCCCcEEEEEEEcCCCCcHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECC
Confidence 1112357999999999999999875 22346899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhcccc-CCCCCCchhhHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~s~ksDVwSLGviL~EL 1043 (1142)
+ +.++|+|||++........ ......|++.|+|||++.+.. ....++.++|||||||++|||
T Consensus 147 ~-------~~~~l~Dfg~~~~~~~~~~----------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el 209 (272)
T cd06637 147 N-------AEVKLVDFGVSAQLDRTVG----------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 209 (272)
T ss_pred C-------CCEEEccCCCceecccccc----------cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHH
Confidence 7 7899999999875432111 112346899999999986421 124578899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
++|+.||...........+.....+.. .....+..+.+|+.+||..||.+|||+
T Consensus 210 ~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~ 263 (272)
T cd06637 210 AEGAPPLCDMHPMRALFLIPRNPAPRL--------------------------KSKKWSKKFQSFIESCLVKNHSQRPTT 263 (272)
T ss_pred HhCCCCccccCHHHHHHHHhcCCCCCC--------------------------CCCCcCHHHHHHHHHHcCCChhhCCCH
Confidence 999999976544333222211110000 001345578999999999999999999
Q ss_pred HHHHHHHHh
Q 001142 1124 GDLYEMFVA 1132 (1142)
Q Consensus 1124 ~EVL~~L~~ 1132 (1142)
.++++|+|+
T Consensus 264 ~~il~~~~~ 272 (272)
T cd06637 264 EQLMKHPFI 272 (272)
T ss_pred HHHhhCCCC
Confidence 999999986
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=344.83 Aligned_cols=255 Identities=23% Similarity=0.381 Sum_probs=211.5
Q ss_pred ceeeeecccCceEEEEEEECCccEEEEEE--ecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCC
Q 001142 810 SSCDEAGKSVSSSLFRCKFGSADAAAKVR--TLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 887 (1142)
Q Consensus 810 ~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~--~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~ 887 (1142)
++..+||+|+|-+||+|.+..+.+.|+.- ++..........+.| ..|+.+|+.|+|||||++|.++.+...
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~----~~Ev~lLKsL~H~NIirfy~SW~d~~n--- 115 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERL----YSEVHLLKSLKHPNIIRFYDSWVDTDN--- 115 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHH----HHHHHHHccCCCCceeeeeeheecCCC---
Confidence 77789999999999999987666666542 222222233334444 899999999999999999999987543
Q ss_pred CCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC--CccccCCCCCCeeeccc
Q 001142 888 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK--HIMHRDIKSENILIDLE 965 (1142)
Q Consensus 888 ~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~--gIvHrDLKp~NILld~~ 965 (1142)
....+|+|++..|+|..|++++ +..+.+.++.|++||++||.|||++ .|||||||.+||||+.+
T Consensus 116 ---------~~in~iTEL~TSGtLr~Y~kk~-----~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~ 181 (632)
T KOG0584|consen 116 ---------KTINFITELFTSGTLREYRKKH-----RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGN 181 (632)
T ss_pred ---------ceeeeeeecccCCcHHHHHHHh-----ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCC
Confidence 2458999999999999999884 5688999999999999999999987 69999999999999877
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
. |.|||+|+|+|+...... ...+.|||.|||||++.. .|+..+||||||+.++||+|
T Consensus 182 ~------G~VKIGDLGLAtl~r~s~------------aksvIGTPEFMAPEmYEE-----~YnE~VDVYaFGMCmLEMvT 238 (632)
T KOG0584|consen 182 L------GEVKIGDLGLATLLRKSH------------AKSVIGTPEFMAPEMYEE-----NYNELVDVYAFGMCMLEMVT 238 (632)
T ss_pred c------CceeecchhHHHHhhccc------------cceeccCccccChHHHhh-----hcchhhhhhhhhHHHHHHHh
Confidence 4 899999999998765422 124689999999999874 78999999999999999999
Q ss_pred CCCCCCC-CCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001142 1046 LQVPYMG-LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124 (1142)
Q Consensus 1046 G~~Pf~~-~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~ 1124 (1142)
+.+||.. .++.+++.++..|..|..... -..+++++||.+||.. ..+|||+.
T Consensus 239 ~eYPYsEC~n~AQIYKKV~SGiKP~sl~k--------------------------V~dPevr~fIekCl~~-~~~R~sa~ 291 (632)
T KOG0584|consen 239 SEYPYSECTNPAQIYKKVTSGIKPAALSK--------------------------VKDPEVREFIEKCLAT-KSERLSAK 291 (632)
T ss_pred ccCChhhhCCHHHHHHHHHcCCCHHHhhc--------------------------cCCHHHHHHHHHHhcC-chhccCHH
Confidence 9999965 567889999988887653221 1234699999999999 89999999
Q ss_pred HHHHHHHhhcC
Q 001142 1125 DLYEMFVARTS 1135 (1142)
Q Consensus 1125 EVL~~L~~~~s 1135 (1142)
|+|+|+|+...
T Consensus 292 eLL~d~Ff~~d 302 (632)
T KOG0584|consen 292 ELLKDPFFDED 302 (632)
T ss_pred HHhhChhhccc
Confidence 99999999865
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=327.34 Aligned_cols=257 Identities=19% Similarity=0.315 Sum_probs=198.1
Q ss_pred CCCcceeeeecccCceEEEEEEEC--Cc----cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeE
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SA----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 879 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~----~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~ 879 (1142)
..+|++.+.||+|+||.||+|.+. +. .+|+|+.. .. ......+++ .+|+.+++.++||||+++++++
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~--~~-~~~~~~~~~----~~e~~~l~~l~h~niv~~~g~~ 78 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR--EA-TSPKANKEI----LDEAYVMASVDNPHVCRLLGIC 78 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecc--cc-CCHHHHHHH----HHHHHHHHhCCCCCCCeEEEEE
Confidence 457899999999999999999873 22 25666643 21 122223333 7899999999999999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 001142 880 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959 (1142)
Q Consensus 880 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~N 959 (1142)
.... .++||||+++|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|
T Consensus 79 ~~~~---------------~~~v~e~~~~g~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~N 139 (316)
T cd05108 79 LTST---------------VQLITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARN 139 (316)
T ss_pred cCCC---------------ceeeeecCCCCCHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhh
Confidence 6532 37999999999999998752 2358899999999999999999999999999999999
Q ss_pred eeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001142 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039 (1142)
Q Consensus 960 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGvi 1039 (1142)
||++.+ +.+||+|||+++......... ......++..|+|||++.+ ..++.++|||||||+
T Consensus 140 ill~~~-------~~~kl~DfG~a~~~~~~~~~~--------~~~~~~~~~~y~apE~~~~----~~~~~~~Di~slGv~ 200 (316)
T cd05108 140 VLVKTP-------QHVKITDFGLAKLLGADEKEY--------HAEGGKVPIKWMALESILH----RIYTHQSDVWSYGVT 200 (316)
T ss_pred eEecCC-------CcEEEccccccccccCCCcce--------eccCCccceeecChHHhcc----CCCCchhhhHHHHHH
Confidence 999877 789999999998654322110 0111234678999999875 567899999999999
Q ss_pred HHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001142 1040 LLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1118 (1142)
Q Consensus 1040 L~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~ 1118 (1142)
+|||++ |..||.+....++...+.....+..+ ..++..+.+++.+||..||.
T Consensus 201 l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~cl~~~p~ 253 (316)
T cd05108 201 VWELMTFGSKPYDGIPASEISSILEKGERLPQP---------------------------PICTIDVYMIMVKCWMIDAD 253 (316)
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCC---------------------------CCCCHHHHHHHHHHccCChh
Confidence 999998 99999876665554444433221111 02345688999999999999
Q ss_pred CCCCHHHHHHHHHhhc
Q 001142 1119 ERPTAGDLYEMFVART 1134 (1142)
Q Consensus 1119 ~RPSa~EVL~~L~~~~ 1134 (1142)
+||++.+++.++....
T Consensus 254 ~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 254 SRPKFRELIIEFSKMA 269 (316)
T ss_pred hCcCHHHHHHHHHHHH
Confidence 9999999999877554
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=316.17 Aligned_cols=250 Identities=26% Similarity=0.334 Sum_probs=199.3
Q ss_pred CcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
+|++.++||+|+||.||++.+ .+..+++|..+.... ....+.+ .+|+.+++.++||||+++++.+.+.+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~----~~e~~~l~~l~h~~i~~~~~~~~~~~-- 71 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS---SSAVEDS----RKEAVLLAKMKHPNIVAFKESFEADG-- 71 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc---hHHHHHH----HHHHHHHHhCCCCCcceEEEEEEECC--
Confidence 588999999999999999987 456678887653321 2223333 68999999999999999999988655
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
+.++||||+++++|.+++.. .....+++..+..++.||+.||.|||++||+|+||||+||+++.+
T Consensus 72 ------------~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~ 136 (255)
T cd08219 72 ------------HLYIVMEYCDGGDLMQKIKL---QRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQN 136 (255)
T ss_pred ------------EEEEEEeeCCCCcHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCC
Confidence 34999999999999998865 223468999999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+.++++|||.+........ ......|++.|+|||++.+ ..++.++||||||+++|+|++
T Consensus 137 -------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~~~aPE~~~~----~~~~~~~Dv~slG~i~~~l~~ 195 (255)
T cd08219 137 -------GKVKLGDFGSARLLTSPGA----------YACTYVGTPYYVPPEIWEN----MPYNNKSDIWSLGCILYELCT 195 (255)
T ss_pred -------CcEEEcccCcceeeccccc----------ccccccCCccccCHHHHcc----CCcCchhhhhhhchhheehhh
Confidence 7899999999865433111 1123458889999999875 457899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001142 1046 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1125 (1142)
Q Consensus 1046 G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~E 1125 (1142)
|..||...+.......+..+.....+. ..+..+.+++.+||+.||++|||+.+
T Consensus 196 g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~P~~Rp~~~~ 248 (255)
T cd08219 196 LKHPFQANSWKNLILKVCQGSYKPLPS---------------------------HYSYELRSLIKQMFKRNPRSRPSATT 248 (255)
T ss_pred ccCCCCCCCHHHHHHHHhcCCCCCCCc---------------------------ccCHHHHHHHHHHHhCCcccCCCHHH
Confidence 999998776665555554443322211 23456899999999999999999999
Q ss_pred HHHH
Q 001142 1126 LYEM 1129 (1142)
Q Consensus 1126 VL~~ 1129 (1142)
++..
T Consensus 249 il~~ 252 (255)
T cd08219 249 ILSR 252 (255)
T ss_pred Hhhc
Confidence 9864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=317.27 Aligned_cols=260 Identities=25% Similarity=0.406 Sum_probs=201.1
Q ss_pred CCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
+.+|++.++||+|+||.||+|++ .+..+|+|....... ........+ .+|+.+++.++||||+++++++.+.+
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~----~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEM-MDAKARQDC----VKEIDLLKQLNHPNVIKYLDSFIEDN 75 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeecccc-CCHHHHHHH----HHHHHHHHhCCCcceeeeeeeEEECC
Confidence 35799999999999999999987 567788886543211 122222333 78999999999999999999987654
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
..++||||+++++|.+++..... ....+++..+..++.||+.||.|||++||+|+||||+||+++
T Consensus 76 --------------~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~ 140 (267)
T cd08228 76 --------------ELNIVLELADAGDLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFIT 140 (267)
T ss_pred --------------eEEEEEEecCCCcHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEc
Confidence 34999999999999999875332 234689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.++|+|||.+........ ......|++.|+|||.+.+ ..++.++||||||+++|+|
T Consensus 141 ~~-------~~~~l~d~g~~~~~~~~~~----------~~~~~~~~~~~~aPE~~~~----~~~~~~~Di~slG~~l~el 199 (267)
T cd08228 141 AT-------GVVKLGDLGLGRFFSSKTT----------AAHSLVGTPYYMSPERIHE----NGYNFKSDIWSLGCLLYEM 199 (267)
T ss_pred CC-------CCEEECccccceeccchhH----------HHhcCCCCccccChhhhcc----CCCCchhhHHHHHHHHHHH
Confidence 77 7899999999876543211 0112358889999999875 4577899999999999999
Q ss_pred HhCCCCCCCCCH--HHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1044 LTLQVPYMGLSE--LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1044 LtG~~Pf~~~~~--~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
++|+.||..... ......+.....+... ....+..+.+++.+||+.+|++||
T Consensus 200 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~li~~cl~~~p~~Rp 253 (267)
T cd08228 200 AALQSPFYGDKMNLFSLCQKIEQCDYPPLP--------------------------TEHYSEKLRELVSMCIYPDPDQRP 253 (267)
T ss_pred hcCCCCCccccccHHHHHHHHhcCCCCCCC--------------------------hhhcCHHHHHHHHHHCCCCcccCc
Confidence 999999965432 2333443332222211 013456689999999999999999
Q ss_pred CHHHHHHHHHh
Q 001142 1122 TAGDLYEMFVA 1132 (1142)
Q Consensus 1122 Sa~EVL~~L~~ 1132 (1142)
++.+|++.+..
T Consensus 254 ~~~~vl~~~~~ 264 (267)
T cd08228 254 DIGYVHQIAKQ 264 (267)
T ss_pred CHHHHHHHHHH
Confidence 99999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=324.12 Aligned_cols=280 Identities=21% Similarity=0.257 Sum_probs=198.0
Q ss_pred CcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
+|++.++||+|+||.||+|++ .+..+++|....+.. ...... .+.+|+.++++++||||+++++++.+..
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~--~~~~~~----~~~~ei~~l~~l~h~~i~~~~~~~~~~~-- 72 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPS----SALREICLLKELKHKNIVRLYDVLHSDK-- 72 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc--cccCcc----chhHHHHHHHhcCCCCeeeHHHHhccCC--
Confidence 488999999999999999998 456778877544321 111112 2368999999999999999999987654
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
..++||||++ ++|.+++... ...+++..+..++.||+.||.|||++||+||||||+||+++.+
T Consensus 73 ------------~~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~ 135 (284)
T cd07839 73 ------------KLTLVFEYCD-QDLKKYFDSC----NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKN 135 (284)
T ss_pred ------------ceEEEEecCC-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCC
Confidence 3499999997 6888887641 2468999999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+.++|+|||++......... .....+++.|+|||++.+ ...++.++|||||||++|+|++
T Consensus 136 -------~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~il~~l~t 195 (284)
T cd07839 136 -------GELKLADFGLARAFGIPVRC----------YSAEVVTLWYRPPDVLFG---AKLYSTSIDMWSAGCIFAELAN 195 (284)
T ss_pred -------CcEEECccchhhccCCCCCC----------cCCCccccCCcChHHHhC---CcccCcHHHHHHHHHHHHHHHh
Confidence 78999999998754332111 112357889999999865 2356889999999999999999
Q ss_pred CCCCC-CCCCHHHHHHHHHhCCCCCchhHHhhhccccccc-ccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1046 LQVPY-MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHE-VAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1046 G~~Pf-~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
|..|| .+.+..+....+...........+.......... .................++.+.+++.+||+.||.+|||+
T Consensus 196 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~ 275 (284)
T cd07839 196 AGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISA 275 (284)
T ss_pred cCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCH
Confidence 98885 4444444444442221111111111110000000 000000000000111356788999999999999999999
Q ss_pred HHHHHHHHh
Q 001142 1124 GDLYEMFVA 1132 (1142)
Q Consensus 1124 ~EVL~~L~~ 1132 (1142)
+++++|+|+
T Consensus 276 ~~il~h~~f 284 (284)
T cd07839 276 EEALQHPYF 284 (284)
T ss_pred HHHhcCCCC
Confidence 999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=324.08 Aligned_cols=252 Identities=22% Similarity=0.299 Sum_probs=188.7
Q ss_pred ecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCCCCC
Q 001142 815 AGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 892 (1142)
Q Consensus 815 LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~~~~~~ 892 (1142)
||+|+||.||+++.. +..+|+|....+..... .... .+..|++++++++||||+++++++....
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~-~~~~----~~~~E~~il~~l~hp~i~~~~~~~~~~~--------- 66 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKK-SGEK----MALLEKEILEKVNSPFIVNLAYAFESKT--------- 66 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcc-hhhH----HHHHHHHHHHhcCCCcEEEEEEEEecCC---------
Confidence 799999999999874 56677776432211111 1111 2256999999999999999999987654
Q ss_pred ccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccCCCC
Q 001142 893 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 972 (1142)
Q Consensus 893 ~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~~~~ 972 (1142)
+.++||||+++++|.+++.. .....+++..+..++.||+.||+|||+.||+||||||+||+++.+
T Consensus 67 -----~~~lv~e~~~g~~L~~~~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~------- 131 (277)
T cd05607 67 -----HLCLVMSLMNGGDLKYHIYN---VGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQ------- 131 (277)
T ss_pred -----eEEEEEecCCCCCHHHHHHh---ccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCC-------
Confidence 35999999999999988865 233458999999999999999999999999999999999999877
Q ss_pred CeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 001142 973 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1052 (1142)
Q Consensus 973 ~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~Pf~~ 1052 (1142)
+.++|+|||++........ .....|++.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 132 ~~~~l~Dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslGv~l~el~~g~~p~~~ 196 (277)
T cd05607 132 GNCRLSDLGLAVELKDGKT-----------ITQRAGTNGYMAPEILKE----EPYSYPVDWFAMGCSIYEMVAGRTPFKD 196 (277)
T ss_pred CCEEEeeceeeeecCCCce-----------eeccCCCCCccCHHHHcc----CCCCCchhHHHHHHHHHHHHhCCCCCCC
Confidence 7899999999875432111 112358999999999876 4588999999999999999999999975
Q ss_pred CCHHHHHHHH-HhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH----HHHH
Q 001142 1053 LSELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA----GDLY 1127 (1142)
Q Consensus 1053 ~~~~el~~~I-~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa----~EVL 1127 (1142)
.........+ ......... . .....++++.+++.+||+.||.+||++ .+++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~--------------------~----~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 197 HKEKVAKEELKRRTLEDEVK--------------------F----EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred CcchhhHHHHHHHhhccccc--------------------c----ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 4321111111 100000000 0 001345678999999999999999999 6778
Q ss_pred HHHHhhc
Q 001142 1128 EMFVART 1134 (1142)
Q Consensus 1128 ~~L~~~~ 1134 (1142)
.|+|++.
T Consensus 253 ~h~~f~~ 259 (277)
T cd05607 253 KHEFFKT 259 (277)
T ss_pred cChhhcC
Confidence 9999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=322.95 Aligned_cols=263 Identities=25% Similarity=0.408 Sum_probs=202.3
Q ss_pred cceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCC
Q 001142 809 LSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 888 (1142)
Q Consensus 809 y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~~ 888 (1142)
|++.+.||+|+||.||+|.+......++++..... .....+.+ .+|+.+++.++||||+++++++....
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~----~~e~~~l~~l~h~~ii~~~~~~~~~~----- 75 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDY----MVEIDILASCDHPNIVKLLDAFYYEN----- 75 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHH----HHHHHHHHHCCCCCeeeEEEEEeeCC-----
Confidence 68889999999999999998655444444433321 22333344 78999999999999999999987654
Q ss_pred CCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecccccc
Q 001142 889 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 968 (1142)
Q Consensus 889 ~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~ 968 (1142)
..++||||+++++|..++.. ...++++..+..++.|++.||.|||+.||+||||||+|||++.+
T Consensus 76 ---------~~~~v~e~~~~~~l~~~~~~----~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~--- 139 (282)
T cd06643 76 ---------NLWILIEFCAGGAVDAVMLE----LERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLD--- 139 (282)
T ss_pred ---------EEEEEEEecCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccC---
Confidence 34999999999999988764 13468999999999999999999999999999999999999877
Q ss_pred CCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccc-cCCCCCCchhhHHHHHHHHHHHHhCC
Q 001142 969 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM-HKPNLYGLEVDIWSYGCLLLELLTLQ 1047 (1142)
Q Consensus 969 ~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~s~ksDVwSLGviL~ELLtG~ 1047 (1142)
+.++|+|||++........ ......+++.|+|||++... .....++.++|||||||++|+|++|+
T Consensus 140 ----~~~kl~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~ 205 (282)
T cd06643 140 ----GDIKLADFGVSAKNTRTIQ----------RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIE 205 (282)
T ss_pred ----CCEEEcccccccccccccc----------ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCC
Confidence 7899999999865432111 11234588999999998532 12345778999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHH
Q 001142 1048 VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY 1127 (1142)
Q Consensus 1048 ~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL 1127 (1142)
.||...+..+....+.....+.... +...+..+.+++.+||+.||.+||++.+++
T Consensus 206 ~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 260 (282)
T cd06643 206 PPHHELNPMRVLLKIAKSEPPTLAQ-------------------------PSRWSSEFKDFLKKCLEKNVDARWTTTQLL 260 (282)
T ss_pred CCccccCHHHHHHHHhhcCCCCCCC-------------------------ccccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 9998766555444443322211110 013456799999999999999999999999
Q ss_pred HHHHhhcCCC
Q 001142 1128 EMFVARTSSS 1137 (1142)
Q Consensus 1128 ~~L~~~~ss~ 1137 (1142)
+|+|+...+.
T Consensus 261 ~~~~~~~~~~ 270 (282)
T cd06643 261 QHPFVTVNSN 270 (282)
T ss_pred cCCCEeccCC
Confidence 9999986543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=316.38 Aligned_cols=254 Identities=26% Similarity=0.385 Sum_probs=200.8
Q ss_pred CcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
+|++.+.||+|+||.||+|.. .+..+++|..... .........+ .+|+.++++++||||+++++.+...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~----~~e~~~l~~~~~~~i~~~~~~~~~~~-- 72 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVE--QMTKDERLAA----QNECQVLKLLSHPNIIEYYENFLEDK-- 72 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecc--ccccHHHHHH----HHHHHHHhhCCCCchhheeeeEecCC--
Confidence 488999999999999999987 4566777765432 2233333344 78999999999999999999887544
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
..++||||+++++|.+++... ....+++..+..++.|++.||.|||++||+|+||||+||+++.+
T Consensus 73 ------------~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~ 137 (256)
T cd08220 73 ------------ALMIVMEYAPGGTLAEYIQKR---CNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKH 137 (256)
T ss_pred ------------EEEEEEecCCCCCHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence 359999999999999999762 23458999999999999999999999999999999999999755
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
. ..++|+|||.+........ .....++..|+|||.+.+ ..++.++||||||+++|+|++
T Consensus 138 ~------~~~~l~d~~~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~~l~~l~~ 196 (256)
T cd08220 138 K------MVVKIGDFGISKILSSKSK-----------AYTVVGTPCYISPELCEG----KPYNQKSDIWALGCVLYELAS 196 (256)
T ss_pred C------CEEEEccCCCceecCCCcc-----------ccccccCCcccCchhccC----CCCCcccchHHHHHHHHHHHh
Confidence 2 5789999999976543211 113457889999999875 457789999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001142 1046 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1125 (1142)
Q Consensus 1046 G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~E 1125 (1142)
|..||...+.......+........+ ...+..+.+++.+||+.||.+|||+.|
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~~l~~~p~~Rpt~~~ 249 (256)
T cd08220 197 LKRAFEAANLPALVLKIMSGTFAPIS---------------------------DRYSPDLRQLILSMLNLDPSKRPQLSQ 249 (256)
T ss_pred CCCCcccCchHHHHHHHHhcCCCCCC---------------------------CCcCHHHHHHHHHHccCChhhCCCHHH
Confidence 99999876655554444332222111 134556899999999999999999999
Q ss_pred HHHHHHh
Q 001142 1126 LYEMFVA 1132 (1142)
Q Consensus 1126 VL~~L~~ 1132 (1142)
++.|+|+
T Consensus 250 ll~~p~~ 256 (256)
T cd08220 250 IMAQPIC 256 (256)
T ss_pred HhhCCCC
Confidence 9999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=323.10 Aligned_cols=258 Identities=25% Similarity=0.414 Sum_probs=196.5
Q ss_pred CCCcceeeeecccCceEEEEEEECCc--c--EEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEe
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFGSA--D--AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 880 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~~~--~--vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~~ 880 (1142)
+++|++.++||+|+||.||+|.+... . +++|. ++.. ......+.+ .+|+.++.++ +||||+++++++.
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~--~~~~-~~~~~~~~~----~~E~~~l~~l~~hp~iv~~~~~~~ 73 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKM--LKEF-ASENDHRDF----AGELEVLCKLGHHPNIINLLGACE 73 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCCcceeEEEE--cccc-CCHHHHHHH----HHHHHHHHhhcCCCchhheEEEEc
Confidence 46899999999999999999987432 2 34544 3321 122223334 7899999999 6999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAALVELHSKH 949 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~-----------~~~~ls~~~i~~Ia~qIa~gL~yLHs~g 949 (1142)
.... .++||||+++++|.+++...... ....+++..+..++.||+.||+|||++|
T Consensus 74 ~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ 139 (297)
T cd05089 74 NRGY--------------LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ 139 (297)
T ss_pred cCCc--------------ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 6543 39999999999999999752110 1135889999999999999999999999
Q ss_pred ccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCc
Q 001142 950 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGL 1029 (1142)
Q Consensus 950 IvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ 1029 (1142)
|+||||||+|||++.+ +.+||+|||++........ ......+..|+|||++.+ ..++.
T Consensus 140 ivH~dlkp~Nill~~~-------~~~kl~dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~ 197 (297)
T cd05089 140 FIHRDLAARNVLVGEN-------LASKIADFGLSRGEEVYVK-----------KTMGRLPVRWMAIESLNY----SVYTT 197 (297)
T ss_pred cccCcCCcceEEECCC-------CeEEECCcCCCccccceec-----------cCCCCcCccccCchhhcc----CCCCc
Confidence 9999999999999877 7899999999853221100 011123457999999865 56789
Q ss_pred hhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHH
Q 001142 1030 EVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDV 1108 (1142)
Q Consensus 1030 ksDVwSLGviL~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dL 1108 (1142)
++|||||||++|||++ |..||......+....+..+..+..+ ...+..+.+|
T Consensus 198 ~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l 250 (297)
T cd05089 198 KSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEKP---------------------------RNCDDEVYEL 250 (297)
T ss_pred hhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCC---------------------------CCCCHHHHHH
Confidence 9999999999999997 99999887776666555433221111 1345678999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhh
Q 001142 1109 FRRCTEENPTERPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1109 I~~CL~~DP~~RPSa~EVL~~L~~~ 1133 (1142)
+.+||+.+|.+||+++++++.+...
T Consensus 251 i~~~l~~~p~~Rp~~~~i~~~l~~~ 275 (297)
T cd05089 251 MRQCWRDRPYERPPFAQISVQLSRM 275 (297)
T ss_pred HHHHcCCChhhCcCHHHHHHHHHHH
Confidence 9999999999999999998886544
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=324.81 Aligned_cols=259 Identities=25% Similarity=0.434 Sum_probs=201.4
Q ss_pred CCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
..+|++.+.||+|+||.||+|.+ .+..+++|...... . ...+.+ .+|+.+++.+.||||+++++.+....
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~--~--~~~~~~----~~e~~~l~~~~h~~v~~~~~~~~~~~ 90 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--Q--PKKELI----INEILVMRENKNPNIVNYLDSYLVGD 90 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC--c--chHHHH----HHHHHHHHhCCCCCEeeEEEEEEeCC
Confidence 35799999999999999999987 45667777654322 1 122333 68999999999999999999987644
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
+.++||||+++++|.+++.. ..+++.++..++.|++.||.|||++||+||||||+|||++
T Consensus 91 --------------~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~ 150 (296)
T cd06654 91 --------------ELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG 150 (296)
T ss_pred --------------EEEEeecccCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc
Confidence 45999999999999999864 3578999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.++|+|||.+........ ......|++.|+|||.+.+ ..++.++|||||||++|+|
T Consensus 151 ~~-------~~~kl~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~s~Gvil~~l 209 (296)
T cd06654 151 MD-------GSVKLTDFGFCAQITPEQS----------KRSTMVGTPYWMAPEVVTR----KAYGPKVDIWSLGIMAIEM 209 (296)
T ss_pred CC-------CCEEECccccchhcccccc----------ccCcccCCccccCHHHHcC----CCCCccchHHHHHHHHHHH
Confidence 77 7899999999875432110 1123468899999999875 4567999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
++|+.||...........+.....+... . ....+..+.+++.+||..||++|||+
T Consensus 210 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~----------------------~---~~~~~~~l~~li~~~l~~~p~~Rpt~ 264 (296)
T cd06654 210 IEGEPPYLNENPLRALYLIATNGTPELQ----------------------N---PEKLSAIFRDFLNRCLDMDVEKRGSA 264 (296)
T ss_pred HhCCCCCCCCCHHHhHHHHhcCCCCCCC----------------------C---ccccCHHHHHHHHHHCcCCcccCcCH
Confidence 9999999866543322222111111100 0 01345668999999999999999999
Q ss_pred HHHHHHHHhhcCCCC
Q 001142 1124 GDLYEMFVARTSSSI 1138 (1142)
Q Consensus 1124 ~EVL~~L~~~~ss~~ 1138 (1142)
.++++|+|+....+.
T Consensus 265 ~eil~~~~~~~~~~~ 279 (296)
T cd06654 265 KELLQHQFLKIAKPL 279 (296)
T ss_pred HHHhhChhhhccCCc
Confidence 999999999765443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=321.97 Aligned_cols=263 Identities=24% Similarity=0.382 Sum_probs=202.4
Q ss_pred CCCcceeeeecccCceEEEEEEECC-----c--cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeee
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFGS-----A--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 878 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~~-----~--~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~ 878 (1142)
..+|.+.+.||+|+||.||+|.+.. . .+++|. .+.. .....+.+ .+|+.++++++||||++++++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~--~~~~--~~~~~~~~----~~e~~~l~~l~h~~i~~~~~~ 75 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKA--LKDP--TLAARKDF----QREAELLTNLQHEHIVKFYGV 75 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEe--cCCc--cHHHHHHH----HHHHHHHhcCCCCCcceEEEE
Confidence 4578999999999999999998532 2 244444 3321 22222334 789999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc-----------cCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 001142 879 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAALVELHS 947 (1142)
Q Consensus 879 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~-----------~~~~~ls~~~i~~Ia~qIa~gL~yLHs 947 (1142)
+.... ..++||||+++++|.+++..... .....+++..++.++.||+.||+|||+
T Consensus 76 ~~~~~--------------~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~ 141 (291)
T cd05094 76 CGDGD--------------PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS 141 (291)
T ss_pred EccCC--------------ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 87654 34999999999999999975321 112358999999999999999999999
Q ss_pred CCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCC
Q 001142 948 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 1027 (1142)
Q Consensus 948 ~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~ 1027 (1142)
+||+||||||+|||++.+ +.++|+|||++......... .......++..|+|||++.+ ..+
T Consensus 142 ~~i~H~dlkp~Nil~~~~-------~~~~l~dfg~a~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~ 202 (291)
T cd05094 142 QHFVHRDLATRNCLVGAN-------LLVKIGDFGMSRDVYSTDYY--------RVGGHTMLPIRWMPPESIMY----RKF 202 (291)
T ss_pred CCeeecccCcceEEEccC-------CcEEECCCCcccccCCCcee--------ecCCCCCcceeecChHHhcc----CCC
Confidence 999999999999999887 78999999999754332110 01123356788999999875 567
Q ss_pred CchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHH
Q 001142 1028 GLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLV 1106 (1142)
Q Consensus 1028 s~ksDVwSLGviL~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~ 1106 (1142)
+.++|||||||++|||++ |+.||...+..+....+..+..+... ...+..+.
T Consensus 203 ~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~ 255 (291)
T cd05094 203 TTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERP---------------------------RVCPKEVY 255 (291)
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCCCCCCC---------------------------ccCCHHHH
Confidence 889999999999999999 99999877766665555443322111 03355689
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 001142 1107 DVFRRCTEENPTERPTAGDLYEMFVARTSS 1136 (1142)
Q Consensus 1107 dLI~~CL~~DP~~RPSa~EVL~~L~~~~ss 1136 (1142)
+++.+||+.||.+|||+.+|++.+.....+
T Consensus 256 ~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 256 DIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=317.09 Aligned_cols=254 Identities=24% Similarity=0.359 Sum_probs=203.0
Q ss_pred CcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
+|++.+.||+|+||.||++.. .+..+++|....... .....+.+ .+|+.++++++||||+++++++.+.+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~----~~e~~~l~~l~~~~i~~~~~~~~~~~-- 72 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM--SPKEREES----RKEVAVLSNMKHPNIVQYQESFEENG-- 72 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC--ChHHHHHH----HHHHHHHHhCCCCCeeeeEeeecCCC--
Confidence 488999999999999999987 456677777543321 22233334 78999999999999999999987654
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
+.++||||+++++|.+++.. .....+++..+..++.|++.||.|||++|++|+||+|+||+++.+
T Consensus 73 ------------~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~ 137 (256)
T cd08218 73 ------------NLYIVMDYCEGGDLYKKINA---QRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD 137 (256)
T ss_pred ------------eEEEEEecCCCCcHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC
Confidence 45999999999999999875 222357899999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+.++|+|||.+........ ......|++.|+|||++.+ ..++.++|||||||++++|++
T Consensus 138 -------~~~~l~d~~~~~~~~~~~~----------~~~~~~~~~~~~~pe~~~~----~~~~~~~Dv~slG~i~~~l~~ 196 (256)
T cd08218 138 -------GTIKLGDFGIARVLNSTVE----------LARTCIGTPYYLSPEICEN----RPYNNKSDIWALGCVLYEMCT 196 (256)
T ss_pred -------CCEEEeeccceeecCcchh----------hhhhccCCccccCHHHhCC----CCCCCccchhHHHHHHHHHHc
Confidence 7899999999975533211 1123457889999999875 457789999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001142 1046 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1125 (1142)
Q Consensus 1046 G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~E 1125 (1142)
|+.||......+....+..+..+..+. ..+..+.+++.+||+.+|.+||++.+
T Consensus 197 g~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~p~~Rp~~~~ 249 (256)
T cd08218 197 LKHAFEAGNMKNLVLKIIRGSYPPVSS---------------------------HYSYDLRNLVSQLFKRNPRDRPSVNS 249 (256)
T ss_pred CCCCccCCCHHHHHHHHhcCCCCCCcc---------------------------cCCHHHHHHHHHHhhCChhhCcCHHH
Confidence 999998766666655554443322111 34556899999999999999999999
Q ss_pred HHHHHHh
Q 001142 1126 LYEMFVA 1132 (1142)
Q Consensus 1126 VL~~L~~ 1132 (1142)
|++|+|+
T Consensus 250 vl~~~~~ 256 (256)
T cd08218 250 ILEKNFI 256 (256)
T ss_pred HhhCcCC
Confidence 9999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=317.42 Aligned_cols=252 Identities=23% Similarity=0.356 Sum_probs=200.7
Q ss_pred CCcceeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~-~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
.+|++.++||.|+||.||+|.+. +..+++|+.... .......+ .+|+.+++.++||||+++++++.+...
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~----~~~~~~~~----~~e~~~l~~l~~~~i~~~~~~~~~~~~- 76 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD----DLLKQQDF----QKEVQALKRLRHKHLISLFAVCSVGEP- 76 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecCCCcEEEEecccc----chhhHHHH----HHHHHHHhcCCCcchhheeeeEecCCC-
Confidence 46899999999999999999984 466777764322 11122333 789999999999999999999876553
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
.++||||+++++|.++++. .....+++..+..++.||+.||.|||++||+|+||||+||+++.+
T Consensus 77 -------------~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~ 140 (261)
T cd05148 77 -------------VYIITELMEKGSLLAFLRS---PEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGED 140 (261)
T ss_pred -------------eEEEEeecccCCHHHHHhc---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCC
Confidence 4999999999999999975 223468999999999999999999999999999999999999887
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+.+||+|||.+........ ......++..|+|||++.. ..++.++||||||+++|+|++
T Consensus 141 -------~~~kl~d~g~~~~~~~~~~----------~~~~~~~~~~~~~PE~~~~----~~~~~~~DiwslG~~l~~l~~ 199 (261)
T cd05148 141 -------LVCKVADFGLARLIKEDVY----------LSSDKKIPYKWTAPEAASH----GTFSTKSDVWSFGILLYEMFT 199 (261)
T ss_pred -------ceEEEccccchhhcCCccc----------cccCCCCceEecCHHHHcc----CCCCchhhHHHHHHHHHHHHc
Confidence 7899999999976533211 1112235678999999865 467889999999999999998
Q ss_pred -CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001142 1046 -LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124 (1142)
Q Consensus 1046 -G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~ 1124 (1142)
|+.||......+....+..+..+..+ ...++.+.+++.+||+.||.+|||+.
T Consensus 200 ~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~~l~~~p~~Rpt~~ 252 (261)
T cd05148 200 YGQVPYPGMNNHEVYDQITAGYRMPCP---------------------------AKCPQEIYKIMLECWAAEPEDRPSFK 252 (261)
T ss_pred CCCCCCCcCCHHHHHHHHHhCCcCCCC---------------------------CCCCHHHHHHHHHHcCCCchhCcCHH
Confidence 89999877766666665433222111 14456789999999999999999999
Q ss_pred HHHHHHH
Q 001142 1125 DLYEMFV 1131 (1142)
Q Consensus 1125 EVL~~L~ 1131 (1142)
++++.|.
T Consensus 253 ~l~~~L~ 259 (261)
T cd05148 253 ALREELD 259 (261)
T ss_pred HHHHHHh
Confidence 9999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=321.73 Aligned_cols=258 Identities=28% Similarity=0.394 Sum_probs=196.2
Q ss_pred CCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
..+|++.+.||+|+||.||+|++ .+..+|+|+...+. ......+ .+|+.++++++||||+++++++....
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~----~~e~~~l~~~~h~~ii~~~~~~~~~~ 79 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP----GDDFSLI----QQEIFMVKECKHCNIVAYFGSYLSRE 79 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc----cchHHHH----HHHHHHHHhcCCCCeeeeeEEEEeCC
Confidence 45799999999999999999997 45667888764331 1122223 68999999999999999999987654
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
..++||||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++
T Consensus 80 --------------~~~iv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~ 140 (267)
T cd06646 80 --------------KLWICMEYCGGGSLQDIYHV-----TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLT 140 (267)
T ss_pred --------------EEEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC
Confidence 35999999999999999865 24689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.++|+|||++........ ......|++.|+|||.+... ....++.++|||||||++|||
T Consensus 141 ~~-------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~y~~PE~~~~~-~~~~~~~~~Dvws~G~il~el 202 (267)
T cd06646 141 DN-------GDVKLADFGVAAKITATIA----------KRKSFIGTPYWMAPEVAAVE-KNGGYNQLCDIWAVGITAIEL 202 (267)
T ss_pred CC-------CCEEECcCccceeeccccc----------ccCccccCccccCHhHcccc-cCCCCcchhhHHHHHHHHHHH
Confidence 77 7799999999976532110 11234588999999987532 124567899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
++|+.||......+....+....... + ........+..+.+++.+||+.||++|||+
T Consensus 203 ~~g~~p~~~~~~~~~~~~~~~~~~~~-~----------------------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~ 259 (267)
T cd06646 203 AELQPPMFDLHPMRALFLMSKSNFQP-P----------------------KLKDKTKWSSTFHNFVKISLTKNPKKRPTA 259 (267)
T ss_pred HhCCCCccccchhhhheeeecCCCCC-C----------------------CCccccccCHHHHHHHHHHhhCChhhCcCH
Confidence 99999996544322211111110000 0 000001345679999999999999999999
Q ss_pred HHHHHHHH
Q 001142 1124 GDLYEMFV 1131 (1142)
Q Consensus 1124 ~EVL~~L~ 1131 (1142)
+++++|+|
T Consensus 260 ~~il~~l~ 267 (267)
T cd06646 260 ERLLTHLF 267 (267)
T ss_pred HHHhcCCC
Confidence 99999886
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=322.37 Aligned_cols=289 Identities=21% Similarity=0.225 Sum_probs=206.9
Q ss_pred CcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
+|++.+.||+|++|.||+|.+. +..+++|........... ......+..|+.++++++|+||+++++++.+..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-- 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAK---DGINFTALREIKLLQELKHPNIIGLLDVFGHKS-- 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEecccccccc---chhhHHHHHHHHHHhhcCCCCChhhhheeecCC--
Confidence 4788999999999999999974 567888876543321111 112233468999999999999999999988644
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
..++||||+ +++|.+++... ...+++..+..++.||+.||.|||++||+|+||||+||+++.+
T Consensus 76 ------------~~~lv~e~~-~~~L~~~i~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~ 138 (298)
T cd07841 76 ------------NINLVFEFM-ETDLEKVIKDK----SIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASD 138 (298)
T ss_pred ------------EEEEEEccc-CCCHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCC
Confidence 349999999 89999999751 1368999999999999999999999999999999999999887
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+.++|+|||++........ ......+++.|+|||.+.+ ...++.++|||||||++|+|++
T Consensus 139 -------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~il~e~~~ 198 (298)
T cd07841 139 -------GVLKLADFGLARSFGSPNR----------KMTHQVVTRWYRAPELLFG---ARHYGVGVDMWSVGCIFAELLL 198 (298)
T ss_pred -------CCEEEccceeeeeccCCCc----------cccccccceeeeCHHHHhC---CCCCCcHHHHHHHHHHHHHHHc
Confidence 7899999999976543211 1122346888999999854 2457899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001142 1046 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1125 (1142)
Q Consensus 1046 G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~E 1125 (1142)
|.+||.+....+....+...........+...........................+..+.+++.+||+.||++|||+.|
T Consensus 199 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e 278 (298)
T cd07841 199 RVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQ 278 (298)
T ss_pred CCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHH
Confidence 98888776655544444222111111111110000000000000111101111244678999999999999999999999
Q ss_pred HHHHHHhhcCCCC
Q 001142 1126 LYEMFVARTSSSI 1138 (1142)
Q Consensus 1126 VL~~L~~~~ss~~ 1138 (1142)
+++|.|+......
T Consensus 279 ~l~~~~~~~~~~~ 291 (298)
T cd07841 279 ALEHPYFSNDPAP 291 (298)
T ss_pred HhhCccccCCCCC
Confidence 9999999876443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=333.65 Aligned_cols=265 Identities=23% Similarity=0.285 Sum_probs=201.2
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
++|++.+.||+|+||.||+++.. +..+|+|+...... ......+ .+.+|+.++..++|+||+++++++.+.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~----~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 74 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEM-LKRAETA----CFREERDVLVNGDRRWITNLHYAFQDEN- 74 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhhHH----HHHHHHHHHHhCCCCCCCceEEEEecCC-
Confidence 47999999999999999999974 56788887542110 0111222 2478999999999999999999988655
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
+.|+||||+++++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~ 137 (331)
T cd05597 75 -------------NLYLVMDYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDK 137 (331)
T ss_pred -------------eEEEEEecCCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECC
Confidence 349999999999999999752 246899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccC-CCCCCchhhHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK-PNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-~~~~s~ksDVwSLGviL~EL 1043 (1142)
+ +.+||+|||++........ .......||+.|+|||++..... ...++.++|||||||++|+|
T Consensus 138 ~-------~~~kl~Dfg~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el 201 (331)
T cd05597 138 N-------GHIRLADFGSCLRLLADGT---------VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEM 201 (331)
T ss_pred C-------CCEEEEECCceeecCCCCC---------ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHH
Confidence 7 7899999999865432111 01123468999999999874221 23578899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCC-CCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC--C
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE--R 1120 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~--R 1120 (1142)
++|+.||.+....+....+..... ..++ ......++.+.+++.+||..++.+ |
T Consensus 202 ~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~~~~~~~~li~~ll~~~~~r~~r 257 (331)
T cd05597 202 LYGETPFYAESLVETYGKIMNHKEHFQFP------------------------PDVTDVSEEAKDLIRRLICSPETRLGR 257 (331)
T ss_pred hhCCCCCCCCCHHHHHHHHHcCCCcccCC------------------------CccCCCCHHHHHHHHHHccCcccccCC
Confidence 999999987766665555432211 1100 000135667899999988654443 8
Q ss_pred CCHHHHHHHHHhhc
Q 001142 1121 PTAGDLYEMFVART 1134 (1142)
Q Consensus 1121 PSa~EVL~~L~~~~ 1134 (1142)
|++.++++|+|+..
T Consensus 258 ~~~~~~l~hp~~~~ 271 (331)
T cd05597 258 NGLQDFKDHPFFEG 271 (331)
T ss_pred CCHHHHhcCCCCCC
Confidence 89999999999864
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=314.23 Aligned_cols=254 Identities=27% Similarity=0.402 Sum_probs=202.6
Q ss_pred CcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
+|++.+.||+|+||.||.++. .+..+++|..... .......+.+ .+|++++++++|+||+++++++.+..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~----~~e~~~l~~~~h~~i~~~~~~~~~~~-- 72 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLT--RLSEKERRDA----LNEIVILSLLQHPNIIAYYNHFMDDN-- 72 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeec--ccchhHHHHH----HHHHHHHHhCCCCCeeEEEeEEecCC--
Confidence 488999999999999998887 4566777765433 2223333344 78999999999999999999998654
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
..++||||+++++|.+++... ....+++..+..++.|++.||.|||+.|++|+||+|+||+++.+
T Consensus 73 ------------~~~~~~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~ 137 (256)
T cd08221 73 ------------TLLIEMEYANGGTLYDKIVRQ---KGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKA 137 (256)
T ss_pred ------------eEEEEEEecCCCcHHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCC
Confidence 349999999999999998762 23468999999999999999999999999999999999999887
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+.+||+|||.+........ ......|++.|+|||.+.+ ..++.++||||||+++|+|++
T Consensus 138 -------~~~kl~d~~~~~~~~~~~~----------~~~~~~~~~~y~ape~~~~----~~~~~~~Dv~slG~i~~~l~~ 196 (256)
T cd08221 138 -------GLIKLGDFGISKILGSEYS----------MAETVVGTPYYMSPELCQG----VKYNFKSDIWALGCVLYELLT 196 (256)
T ss_pred -------CCEEECcCcceEEcccccc----------cccccCCCccccCHhhcCC----CCCCCcchhHHHHHHHHHHHH
Confidence 7899999999875533211 1123468999999999875 456789999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001142 1046 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1125 (1142)
Q Consensus 1046 G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~E 1125 (1142)
|..||......+....+..+..+... ...+..+.+++.+||+.+|.+||++.+
T Consensus 197 g~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~~l~~~p~~R~s~~~ 249 (256)
T cd08221 197 LKRTFDATNPLNLVVKIVQGNYTPVV---------------------------SVYSSELISLVHSLLQQDPEKRPTADE 249 (256)
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCc---------------------------cccCHHHHHHHHHHcccCcccCCCHHH
Confidence 99999876666665555443322111 134566899999999999999999999
Q ss_pred HHHHHHh
Q 001142 1126 LYEMFVA 1132 (1142)
Q Consensus 1126 VL~~L~~ 1132 (1142)
+++++|.
T Consensus 250 ll~~~~l 256 (256)
T cd08221 250 VLDQPLL 256 (256)
T ss_pred HhhCcCC
Confidence 9999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=323.89 Aligned_cols=259 Identities=23% Similarity=0.287 Sum_probs=199.0
Q ss_pred cceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCC
Q 001142 809 LSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 886 (1142)
Q Consensus 809 y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~ 886 (1142)
|+..+.||+|+||+||+|.+. +..+|+|+....... ..... ..+.+|++++++++|+||+.+++++...+
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~----~~~~~E~~il~~l~~~~i~~~~~~~~~~~--- 73 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIK-KRKGE----SMALNEKQILEKVNSQFVVNLAYAYETKD--- 73 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhh-hhhHH----HHHHHHHHHHHHcCCcCceeEEEEEecCC---
Confidence 678899999999999999984 567788875432111 11111 22368999999999999999999887654
Q ss_pred CCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecccc
Q 001142 887 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 966 (1142)
Q Consensus 887 ~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~ 966 (1142)
..++||||+++++|.+++.. .+...+++..+..++.|++.||.|||++||+||||||+||+++.+
T Consensus 74 -----------~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~- 138 (285)
T cd05632 74 -----------ALCLVLTIMNGGDLKFHIYN---MGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDY- 138 (285)
T ss_pred -----------EEEEEEEeccCccHHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCC-
Confidence 34999999999999988865 223469999999999999999999999999999999999999877
Q ss_pred ccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001142 967 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1046 (1142)
Q Consensus 967 ~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG 1046 (1142)
+.++|+|||++....... ......|+..|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 139 ------~~~kl~Dfg~~~~~~~~~-----------~~~~~~g~~~~~aPE~~~~----~~~~~~~Di~slG~~l~~l~~g 197 (285)
T cd05632 139 ------GHIRISDLGLAVKIPEGE-----------SIRGRVGTVGYMAPEVLNN----QRYTLSPDYWGLGCLIYEMIEG 197 (285)
T ss_pred ------CCEEEecCCcceecCCCC-----------cccCCCCCcCccChHHhcC----CCCCcccchHHHHHHHHHHHhC
Confidence 689999999986543211 1123468999999999875 5678999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC----
Q 001142 1047 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT---- 1122 (1142)
Q Consensus 1047 ~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS---- 1122 (1142)
..||.+.........+......... . .....+..+.+|+.+||+.||++||+
T Consensus 198 ~~P~~~~~~~~~~~~~~~~~~~~~~-------------------~-----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~ 253 (285)
T cd05632 198 QSPFRGRKEKVKREEVDRRVLETEE-------------------V-----YSAKFSEEAKSICKMLLTKDPKQRLGCQEE 253 (285)
T ss_pred CCCCCCCCHHHHHHHHHHhhhcccc-------------------c-----cCccCCHHHHHHHHHHccCCHhHcCCCccc
Confidence 9999876554333332211100000 0 00134556899999999999999999
Q ss_pred -HHHHHHHHHhhcC
Q 001142 1123 -AGDLYEMFVARTS 1135 (1142)
Q Consensus 1123 -a~EVL~~L~~~~s 1135 (1142)
+.++++|.|++..
T Consensus 254 ~~~~l~~~~~~~~~ 267 (285)
T cd05632 254 GAGEVKRHPFFRNM 267 (285)
T ss_pred ChHHHHcChhhhcC
Confidence 8999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=321.82 Aligned_cols=259 Identities=20% Similarity=0.301 Sum_probs=200.2
Q ss_pred CCCcceeeeecccCceEEEEEEECC-------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeee
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 878 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~~-------~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~ 878 (1142)
+.+|++.+.||+|+||.||+|.+.+ ..+|+|+...+ . .....+ .+.+|+.++.+++||||++++++
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~--~-~~~~~~----~~~~e~~~~~~l~h~~iv~~~~~ 76 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDK--A-EGPLRE----EFKHEAMMRSRLQHPNIVCLLGV 76 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCC--C-CHHHHH----HHHHHHHHHhcCCCCCcCeEEEE
Confidence 4568999999999999999998732 45677764322 1 122222 34789999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc-----------cCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 001142 879 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAALVELHS 947 (1142)
Q Consensus 879 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~-----------~~~~~ls~~~i~~Ia~qIa~gL~yLHs 947 (1142)
+.+... .++++||+++++|.+++..... .....+++..+..++.|++.||+|||+
T Consensus 77 ~~~~~~--------------~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~ 142 (283)
T cd05091 77 VTKEQP--------------LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS 142 (283)
T ss_pred EcCCCc--------------eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH
Confidence 876543 4899999999999999853110 112358889999999999999999999
Q ss_pred CCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCC
Q 001142 948 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 1027 (1142)
Q Consensus 948 ~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~ 1027 (1142)
+||+||||||+|||++.+ +.+||+|||+++........ .......+++.|+|||++.+ ..+
T Consensus 143 ~gi~H~dlkp~Nil~~~~-------~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~ 203 (283)
T cd05091 143 HHVVHKDLATRNVLVFDK-------LNVKISDLGLFREVYAADYY--------KLMGNSLLPIRWMSPEAIMY----GKF 203 (283)
T ss_pred cCccccccchhheEecCC-------CceEecccccccccccchhe--------eeccCccCCccccCHHHHhc----CCC
Confidence 999999999999999876 77999999998764332111 01122346788999999865 457
Q ss_pred CchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHH
Q 001142 1028 GLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLV 1106 (1142)
Q Consensus 1028 s~ksDVwSLGviL~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~ 1106 (1142)
+.++|||||||++|||++ |..||.+....+..+.+........+ ...+..+.
T Consensus 204 ~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~---------------------------~~~~~~~~ 256 (283)
T cd05091 204 SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCP---------------------------DDCPAWVY 256 (283)
T ss_pred CcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCC---------------------------CCCCHHHH
Confidence 899999999999999998 88999887777776666554332211 14556789
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHH
Q 001142 1107 DVFRRCTEENPTERPTAGDLYEMFV 1131 (1142)
Q Consensus 1107 dLI~~CL~~DP~~RPSa~EVL~~L~ 1131 (1142)
+++.+||+.+|++||++.+|+..+.
T Consensus 257 ~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 257 TLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred HHHHHHhCCCcccCCCHHHHHHHhh
Confidence 9999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=316.06 Aligned_cols=251 Identities=24% Similarity=0.373 Sum_probs=196.8
Q ss_pred CCCcceeeeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~~-~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
..+|++.+.||+|+||.||+|.+.. ..+++|+.. .... ....+ .+|+.++++++||||+++++++...+.
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~--~~~~---~~~~~----~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIR--EGAM---SEDDF----IEEAKVMMKLSHPNLVQLYGVCTKQRP 73 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEecCCccEEEEEec--cCCC---CHHHH----HHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 4568999999999999999998853 467888743 2111 11233 689999999999999999999876543
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
.++||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+||+++.
T Consensus 74 --------------~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~ 135 (256)
T cd05059 74 --------------IFIVTEYMANGCLLNYLRER----KGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGE 135 (256)
T ss_pred --------------eEEEEecCCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECC
Confidence 49999999999999998752 236899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||+|||.++........ ......++..|+|||.+.+ ..++.++||||||+++|+|+
T Consensus 136 ~-------~~~kl~dfg~~~~~~~~~~~---------~~~~~~~~~~y~~Pe~~~~----~~~~~~~Di~slG~il~~l~ 195 (256)
T cd05059 136 D-------NVVKVSDFGLARYVLDDQYT---------SSQGTKFPVKWAPPEVFDY----SRFSSKSDVWSFGVLMWEVF 195 (256)
T ss_pred C-------CcEEECCcccceeccccccc---------ccCCCCCCccccCHHHhcc----CCCCchhhHHHHHHHHHHHh
Confidence 7 78999999998754321100 0111124557999999875 56788999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1045 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1045 t-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
+ |+.||...+..+....+.....+..+ ...+..+.+++.+||..+|++|||+
T Consensus 196 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~cl~~~p~~Rpt~ 248 (256)
T cd05059 196 SEGKMPYERFSNSEVVESVSAGYRLYRP---------------------------KLAPTEVYTIMYSCWHEKPEDRPAF 248 (256)
T ss_pred ccCCCCCCCCCHHHHHHHHHcCCcCCCC---------------------------CCCCHHHHHHHHHHhcCChhhCcCH
Confidence 9 89999876666655555433221111 1345679999999999999999999
Q ss_pred HHHHHHH
Q 001142 1124 GDLYEMF 1130 (1142)
Q Consensus 1124 ~EVL~~L 1130 (1142)
.|+++.+
T Consensus 249 ~~~l~~l 255 (256)
T cd05059 249 KKLLSQL 255 (256)
T ss_pred HHHHHHh
Confidence 9999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=320.38 Aligned_cols=259 Identities=22% Similarity=0.363 Sum_probs=198.3
Q ss_pred CcceeeeecccCceEEEEEEECC-------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 880 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~~-------~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~ 880 (1142)
+|++.+.||+|+||.||+|.... ..+++|+. .... .....+.+ .+|+.+++.++||||+++++.+.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~--~~~~-~~~~~~~~----~~E~~~l~~l~h~~iv~~~~~~~ 73 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKML--KENA-SSSELRDL----LSEFNLLKQVNHPHVIKLYGACS 73 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEec--CCCC-CHHHHHHH----HHHHHHHhhCCCCCEeeEEEEEe
Confidence 47889999999999999998632 23555543 2211 12223334 78999999999999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc-------------------cCCCCCCHHHHHHHHHHHHHH
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-------------------TGEKHVSVKLALFIAQDVAAA 941 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~-------------------~~~~~ls~~~i~~Ia~qIa~g 941 (1142)
..+. .++||||+++++|.+++..... .....+++..+..++.|++.|
T Consensus 74 ~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~ 139 (290)
T cd05045 74 QDGP--------------LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRG 139 (290)
T ss_pred cCCC--------------cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHH
Confidence 6553 3999999999999999875321 112358899999999999999
Q ss_pred HHHHHhCCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccc
Q 001142 942 LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 1021 (1142)
Q Consensus 942 L~yLHs~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~ 1021 (1142)
|.|||+++|+||||||+|||++.+ +.+||+|||++......... .......++..|+|||++.+
T Consensus 140 l~~LH~~~ivH~dikp~nill~~~-------~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~apE~~~~- 203 (290)
T cd05045 140 MQYLAEMKLVHRDLAARNVLVAEG-------RKMKISDFGLSRDVYEEDSY--------VKRSKGRIPVKWMAIESLFD- 203 (290)
T ss_pred HHHHHHCCeehhhhhhheEEEcCC-------CcEEeccccccccccCccch--------hcccCCCCCccccCHHHHcc-
Confidence 999999999999999999999876 78999999998754321110 01112345678999999865
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhh
Q 001142 1022 HKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELE 1100 (1142)
Q Consensus 1022 ~~~~~~s~ksDVwSLGviL~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 1100 (1142)
..++.++||||||+++|||++ |..||.+....++...+.....+..+ ..
T Consensus 204 ---~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~ 253 (290)
T cd05045 204 ---HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRMERP---------------------------EN 253 (290)
T ss_pred ---CCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCC---------------------------CC
Confidence 567899999999999999998 99999887766665554433221111 13
Q ss_pred hHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001142 1101 TLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1101 ~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~ 1133 (1142)
.+..+.+++.+||+.+|.+||++.++++.+...
T Consensus 254 ~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 254 CSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred CCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 456799999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=316.94 Aligned_cols=264 Identities=25% Similarity=0.343 Sum_probs=201.3
Q ss_pred CcceeeeecccCceEEEEEEE-CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 886 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~-~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~ 886 (1142)
+|++.+.||+|+||.||+|.. .+..+|+|+...+.. ......+....+.+|++++++++|+||+++++++.+..
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~--~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 75 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTS--NVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDN--- 75 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCcc--chhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCC---
Confidence 478899999999999999987 556688887654422 11222222345689999999999999999999987654
Q ss_pred CCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecccc
Q 001142 887 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 966 (1142)
Q Consensus 887 ~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~ 966 (1142)
..++||||+++++|.+++.+ ...+++..+..++.|++.||+|||+.+|+|+||+|+||+++.+
T Consensus 76 -----------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~- 138 (265)
T cd06631 76 -----------TISIFMEFVPGGSISSILNR-----FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPN- 138 (265)
T ss_pred -----------eEEEEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCC-
Confidence 34999999999999999975 2458899999999999999999999999999999999999877
Q ss_pred ccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001142 967 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1046 (1142)
Q Consensus 967 ~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG 1046 (1142)
+.++|+|||.+........... .........|+..|+|||++.+ ..++.++||||||+++|+|++|
T Consensus 139 ------~~~~l~dfg~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~pe~~~~----~~~~~~~Dv~slG~~~~~l~~g 204 (265)
T cd06631 139 ------GIIKLIDFGCARRLAWVGLHGT----HSNMLKSMHGTPYWMAPEVINE----SGYGRKSDIWSIGCTVFEMATG 204 (265)
T ss_pred ------CeEEeccchhhHhhhhcccccc----ccccccccCCCccccChhhhcC----CCCcchhhHHHHHHHHHHHHhC
Confidence 7899999999875432111100 0011123458999999999875 4578999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 001142 1047 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1126 (1142)
Q Consensus 1047 ~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EV 1126 (1142)
+.||...........+....... +......+..+.+++.+||+.+|.+||++.++
T Consensus 205 ~~p~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~ 259 (265)
T cd06631 205 KPPLASMDRLAAMFYIGAHRGLM-------------------------PRLPDSFSAAAIDFVTSCLTRDQHERPSALQL 259 (265)
T ss_pred CCccccCChHHHHHHhhhccCCC-------------------------CCCCCCCCHHHHHHHHHHhcCCcccCCCHHHH
Confidence 99998655443322222111000 00011445678999999999999999999999
Q ss_pred HHHHHh
Q 001142 1127 YEMFVA 1132 (1142)
Q Consensus 1127 L~~L~~ 1132 (1142)
+.|+|+
T Consensus 260 l~~~~~ 265 (265)
T cd06631 260 LRHDFL 265 (265)
T ss_pred hcCCCC
Confidence 999985
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=323.11 Aligned_cols=259 Identities=25% Similarity=0.443 Sum_probs=204.4
Q ss_pred CCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
..+|++.+.||.|++|.||+|.+ .+..+++|...... ....+.+ .+|+.+++.++||||+++++++....
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~----~~~~~~~----~~e~~~l~~l~h~~iv~~~~~~~~~~ 89 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK----QPKKELI----INEILVMKELKNPNIVNFLDSFLVGD 89 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc----CchHHHH----HHHHHHHHhcCCCceeeeeeeEecCc
Confidence 45699999999999999999986 46678888754332 1222233 78999999999999999999987644
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
..++||||+++++|..++.. ..+++.++..++.|++.||+|||++|++||||||+||+++
T Consensus 90 --------------~~~lv~e~~~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~ 149 (296)
T cd06655 90 --------------ELFVVMEYLAGGSLTDVVTE------TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLG 149 (296)
T ss_pred --------------eEEEEEEecCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC
Confidence 45999999999999998865 3589999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.++|+|||++........ ......++..|+|||.+.+ ..++.++|||||||++|+|
T Consensus 150 ~~-------~~~kl~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slGvil~~l 208 (296)
T cd06655 150 MD-------GSVKLTDFGFCAQITPEQS----------KRSTMVGTPYWMAPEVVTR----KAYGPKVDIWSLGIMAIEM 208 (296)
T ss_pred CC-------CCEEEccCccchhcccccc----------cCCCcCCCccccCcchhcC----CCCCchhhHHHHHHHHHHH
Confidence 77 7899999999875432111 1123458889999999875 4578899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
++|+.||...+.......+.....+.+.. ....++.+.+++.+||..||.+||++
T Consensus 209 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~li~~~l~~dp~~Rpt~ 263 (296)
T cd06655 209 VEGEPPYLNENPLRALYLIATNGTPELQN-------------------------PEKLSPIFRDFLNRCLEMDVEKRGSA 263 (296)
T ss_pred HhCCCCCCCCCHHHHHHHHHhcCCcccCC-------------------------cccCCHHHHHHHHHHhhcChhhCCCH
Confidence 99999998766544333332222111100 01345678999999999999999999
Q ss_pred HHHHHHHHhhcCCCC
Q 001142 1124 GDLYEMFVARTSSSI 1138 (1142)
Q Consensus 1124 ~EVL~~L~~~~ss~~ 1138 (1142)
.++++|+|+......
T Consensus 264 ~~il~~~~~~~~~~~ 278 (296)
T cd06655 264 KELLQHPFLKLAKPL 278 (296)
T ss_pred HHHhhChHhhhcccc
Confidence 999999999875544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=318.90 Aligned_cols=256 Identities=30% Similarity=0.447 Sum_probs=205.4
Q ss_pred CCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
++|++.+.||.|++|.||+|.+ .+..+++|+..... .......+ .+|+.++++++||||+++++++.+..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~----~~e~~~l~~l~h~~i~~~~~~~~~~~- 72 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE---AEDEIEDI----QQEIQFLSQCRSPYITKYYGSFLKGS- 72 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc---cchHHHHH----HHHHHHHHHcCCCCeeeeeEEEEECC-
Confidence 3688999999999999999997 45678888765432 12223334 68999999999999999999987654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
..++||||+++++|.+++.. .++++..+..++.|++.||.|||+++|+||||+|+||+++.
T Consensus 73 -------------~~~~v~e~~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~ 133 (274)
T cd06609 73 -------------KLWIIMEYCGGGSCLDLLKP------GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSE 133 (274)
T ss_pred -------------eEEEEEEeeCCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC
Confidence 45999999999999999875 26899999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.++|+|||.++....... ......+++.|+|||++.+ ..++.++||||||+++|+|+
T Consensus 134 ~-------~~~~l~d~g~~~~~~~~~~----------~~~~~~~~~~y~~PE~~~~----~~~~~~sDv~slG~il~~l~ 192 (274)
T cd06609 134 E-------GDVKLADFGVSGQLTSTMS----------KRNTFVGTPFWMAPEVIKQ----SGYDEKADIWSLGITAIELA 192 (274)
T ss_pred C-------CCEEEcccccceeeccccc----------ccccccCCccccChhhhcc----CCCCchhhHHHHHHHHHHHH
Confidence 7 7899999999976643211 1123458889999999876 44889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~ 1124 (1142)
+|+.||...+.......+.....+.... ...+..+.+++.+||..||++|||++
T Consensus 193 tg~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~l~~~l~~~p~~Rpt~~ 246 (274)
T cd06609 193 KGEPPLSDLHPMRVLFLIPKNNPPSLEG--------------------------NKFSKPFKDFVSLCLNKDPKERPSAK 246 (274)
T ss_pred hCCCCcccCchHHHHHHhhhcCCCCCcc--------------------------cccCHHHHHHHHHHhhCChhhCcCHH
Confidence 9999998766554444443332222110 01455689999999999999999999
Q ss_pred HHHHHHHhhcCC
Q 001142 1125 DLYEMFVARTSS 1136 (1142)
Q Consensus 1125 EVL~~L~~~~ss 1136 (1142)
++++|+|+....
T Consensus 247 ~il~~~~~~~~~ 258 (274)
T cd06609 247 ELLKHKFIKKAK 258 (274)
T ss_pred HHhhChhhcCCC
Confidence 999999998654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=318.76 Aligned_cols=281 Identities=23% Similarity=0.297 Sum_probs=200.6
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
++|++.+.||+|++|.||+|.+. +..+++|+..... ......+. +.+|+.++++++||||+++++++....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~----~~~e~~~l~~~~h~~i~~~~~~~~~~~- 73 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESE--DDPVIKKI----ALREIRMLKQLKHPNLVNLIEVFRRKR- 73 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecc--cCccccHH----HHHHHHHHHhCCCCCEeeeeeEEeeCC-
Confidence 36899999999999999999984 5678888754321 11111122 368999999999999999999987654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
..++||||+++++|..++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.
T Consensus 74 -------------~~~~v~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~ 135 (286)
T cd07847 74 -------------KLHLVFEYCDHTVLNELEKN-----PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITK 135 (286)
T ss_pred -------------EEEEEEeccCccHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcC
Confidence 34999999998888777653 235899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.++|+|||++........ ......++..|+|||++.+ ...++.++||||||+++|+|+
T Consensus 136 ~-------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~i~~~l~ 195 (286)
T cd07847 136 Q-------GQIKLCDFGFARILTGPGD----------DYTDYVATRWYRAPELLVG---DTQYGPPVDVWAIGCVFAELL 195 (286)
T ss_pred C-------CcEEECccccceecCCCcc----------cccCcccccccCCHHHHhC---CCCcCchhhhHHHHHHHHHHH
Confidence 7 7899999999976543211 1112357888999999865 235778999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhc--ccc-cccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALG--SCH-EHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
+|+.||.+....+....+................ ... ....................+..+.+++.+||+.||++||
T Consensus 196 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 275 (286)
T cd07847 196 TGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERL 275 (286)
T ss_pred hCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccC
Confidence 9999998766554433332211111111000000 000 0000000000000001113467799999999999999999
Q ss_pred CHHHHHHHHHh
Q 001142 1122 TAGDLYEMFVA 1132 (1142)
Q Consensus 1122 Sa~EVL~~L~~ 1132 (1142)
++.|++.|+|+
T Consensus 276 ~~~eil~~~~f 286 (286)
T cd07847 276 SCEELLEHPYF 286 (286)
T ss_pred CHHHHhcCCCC
Confidence 99999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=316.63 Aligned_cols=258 Identities=21% Similarity=0.302 Sum_probs=198.3
Q ss_pred CCCCcceeeeecccCceEEEEEEEC--Cc----cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeee
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKFG--SA----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 878 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~----~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~ 878 (1142)
...+|++.++||+|+||+||+|++. +. .+|+|+.+.. . .....+. +.+|+.++..++||||++++++
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~--~-~~~~~~~----~~~e~~~l~~~~~~~i~~~~~~ 77 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN--T-SPKANKE----ILDEAYVMAGVGSPYVCRLLGI 77 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC--C-CHHHHHH----HHHHHHHHHhcCCCCCceEEEE
Confidence 3457899999999999999999873 32 2567764322 1 2222233 3789999999999999999998
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 001142 879 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 958 (1142)
Q Consensus 879 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~ 958 (1142)
+.... .+++|||+++|+|.+++.. ....+++..+..++.||+.||+|||+++|+||||||+
T Consensus 78 ~~~~~---------------~~l~~~~~~~g~l~~~l~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~ 138 (279)
T cd05109 78 CLTST---------------VQLVTQLMPYGCLLDYVRE----NKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAAR 138 (279)
T ss_pred EcCCC---------------cEEEEEcCCCCCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence 86422 3799999999999999875 1246899999999999999999999999999999999
Q ss_pred CeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001142 959 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1038 (1142)
Q Consensus 959 NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGv 1038 (1142)
|||++.+ +.+||+|||+++......... ......+++.|+|||...+ ..++.++|||||||
T Consensus 139 Nil~~~~-------~~~kL~dfG~~~~~~~~~~~~--------~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~slG~ 199 (279)
T cd05109 139 NVLVKSP-------NHVKITDFGLARLLDIDETEY--------HADGGKVPIKWMALESILH----RRFTHQSDVWSYGV 199 (279)
T ss_pred eEEEcCC-------CcEEECCCCceeeccccccee--------ecCCCccchhhCCHHHhcc----CCCCchhHHHHHHH
Confidence 9999876 679999999997654321110 0111235678999999865 46789999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001142 1039 LLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1117 (1142)
Q Consensus 1039 iL~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP 1117 (1142)
++|||++ |..||...........+..+..+..+ ...+..+.+++.+||+.||
T Consensus 200 ~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~dp 252 (279)
T cd05109 200 TVWELMTFGAKPYDGIPAREIPDLLEKGERLPQP---------------------------PICTIDVYMIMVKCWMIDS 252 (279)
T ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCC---------------------------ccCCHHHHHHHHHHcCCCh
Confidence 9999998 99999876665555555443322111 1345568999999999999
Q ss_pred CCCCCHHHHHHHHHhhc
Q 001142 1118 TERPTAGDLYEMFVART 1134 (1142)
Q Consensus 1118 ~~RPSa~EVL~~L~~~~ 1134 (1142)
++||++.++++.+....
T Consensus 253 ~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 253 ECRPRFRELVDEFSRMA 269 (279)
T ss_pred hhCcCHHHHHHHHHHhh
Confidence 99999999998766543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=325.31 Aligned_cols=258 Identities=26% Similarity=0.428 Sum_probs=201.3
Q ss_pred CCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
.+|++.+.||+|+||.||+|.. .+..+|+|...... ....+. +.+|+.+++.++||||+++++++...+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~----~~~e~~~l~~~~h~~i~~~~~~~~~~~- 89 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ----QPKKEL----IINEILVMRENKNPNIVNYLDSYLVGD- 89 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc----cchHHH----HHHHHHHHHhCCCCCEeeEEEEEecCC-
Confidence 5799999999999999999986 46778888754322 122222 378999999999999999999987654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
..++||||+++++|.+++.+ ..+++..+..++.|++.||.|||+.||+||||||+|||++.
T Consensus 90 -------------~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~ 150 (297)
T cd06656 90 -------------ELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGM 150 (297)
T ss_pred -------------EEEEeecccCCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC
Confidence 34999999999999999865 35789999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.++|+|||.+........ ......+++.|+|||.+.+ ..++.++|||||||++|+|+
T Consensus 151 ~-------~~~~l~Dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slGvil~~l~ 209 (297)
T cd06656 151 D-------GSVKLTDFGFCAQITPEQS----------KRSTMVGTPYWMAPEVVTR----KAYGPKVDIWSLGIMAIEMV 209 (297)
T ss_pred C-------CCEEECcCccceEccCCcc----------CcCcccCCccccCHHHHcC----CCCCcHHHHHHHHHHHHHHH
Confidence 7 7899999999865432111 1123458889999999875 55789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~ 1124 (1142)
+|..||...+.......+.....+... .....++.+.+++.+||+.||++||++.
T Consensus 210 tg~~pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~ 264 (297)
T cd06656 210 EGEPPYLNENPLRALYLIATNGTPELQ-------------------------NPERLSAVFRDFLNRCLEMDVDRRGSAK 264 (297)
T ss_pred hCCCCCCCCCcchheeeeccCCCCCCC-------------------------CccccCHHHHHHHHHHccCChhhCcCHH
Confidence 999999765433221111111111100 0113456689999999999999999999
Q ss_pred HHHHHHHhhcCCCC
Q 001142 1125 DLYEMFVARTSSSI 1138 (1142)
Q Consensus 1125 EVL~~L~~~~ss~~ 1138 (1142)
++++|+|++.....
T Consensus 265 ~il~~~~~~~~~~~ 278 (297)
T cd06656 265 ELLQHPFLKLAKPL 278 (297)
T ss_pred HHhcCchhcccccc
Confidence 99999999765443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=317.44 Aligned_cols=256 Identities=21% Similarity=0.289 Sum_probs=195.8
Q ss_pred CCCcceeeeecccCceEEEEEEEC--Ccc----EEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeE
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SAD----AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 879 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~----vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~ 879 (1142)
..+|++.+.||+|+||+||+|.+. +.. +++|.. ... .......+ +..|+.+++++.||||+++++++
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~--~~~-~~~~~~~~----~~~~~~~l~~l~h~~iv~~~~~~ 78 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTI--QDR-SGRQTFQE----ITDHMLAMGSLDHAYIVRLLGIC 78 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeec--ccc-cchHHHHH----HHHHHHHHhcCCCCCcceEEEEE
Confidence 457899999999999999999983 333 344432 211 11122223 36788899999999999999987
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 001142 880 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959 (1142)
Q Consensus 880 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~N 959 (1142)
... ..++||||+++|+|.+++... ...+++..+..|+.||+.||.|||++|++||||||+|
T Consensus 79 ~~~---------------~~~~i~e~~~~gsL~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~n 139 (279)
T cd05111 79 PGA---------------SLQLVTQLSPLGSLLDHVRQH----RDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARN 139 (279)
T ss_pred CCC---------------ccEEEEEeCCCCcHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcce
Confidence 432 237999999999999999751 2468999999999999999999999999999999999
Q ss_pred eeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001142 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039 (1142)
Q Consensus 960 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGvi 1039 (1142)
||++.+ +.+||+|||.++........ .......++..|+|||.+.+ ..++.++|||||||+
T Consensus 140 ili~~~-------~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~~pE~~~~----~~~~~~~Dv~slG~i 200 (279)
T cd05111 140 ILLKSD-------SIVQIADFGVADLLYPDDKK--------YFYSEHKTPIKWMALESILF----GRYTHQSDVWSYGVT 200 (279)
T ss_pred EEEcCC-------CcEEEcCCccceeccCCCcc--------cccCCCCCcccccCHHHhcc----CCcCchhhHHHHHHH
Confidence 999877 78999999999754322111 01123346778999999875 468899999999999
Q ss_pred HHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001142 1040 LLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1118 (1142)
Q Consensus 1040 L~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~ 1118 (1142)
+|||++ |+.||.+.......+.+..+..+..+. .++..+.+++.+||..||+
T Consensus 201 l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~c~~~~p~ 253 (279)
T cd05111 201 VWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQ---------------------------ICTIDVYMVMVKCWMIDEN 253 (279)
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCC---------------------------CCCHHHHHHHHHHcCCCcc
Confidence 999998 999998876665555554443322110 2234578899999999999
Q ss_pred CCCCHHHHHHHHHhh
Q 001142 1119 ERPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1119 ~RPSa~EVL~~L~~~ 1133 (1142)
+|||+.|+++.+...
T Consensus 254 ~Rps~~el~~~l~~~ 268 (279)
T cd05111 254 VRPTFKELANEFTRM 268 (279)
T ss_pred cCcCHHHHHHHHHHH
Confidence 999999999987654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=334.35 Aligned_cols=265 Identities=23% Similarity=0.289 Sum_probs=201.6
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
++|++.++||+|+||.||++++. +..+|+|+...... ...... ..+..|+.++..++|+||+++++++.+.+
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~----~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 74 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM-LKRAET----ACFREERDVLVNGDNQWITTLHYAFQDEN- 74 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHH-HHhhHH----HHHHHHHHHHhhCCCCCEeeEEEEEecCC-
Confidence 47899999999999999999985 45577776532110 011111 22478999999999999999999987654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
..++||||+++|+|.+++.+. ...+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~ey~~~g~L~~~l~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~ 137 (332)
T cd05623 75 -------------NLYLVMDYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDM 137 (332)
T ss_pred -------------EEEEEEeccCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECC
Confidence 359999999999999999752 246899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhcccc-CCCCCCchhhHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~s~ksDVwSLGviL~EL 1043 (1142)
+ +.+||+|||++........ .......||+.|+|||++.... ....++.++|||||||++|||
T Consensus 138 ~-------~~~kL~DfG~a~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~el 201 (332)
T cd05623 138 N-------GHIRLADFGSCLKLMEDGT---------VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEM 201 (332)
T ss_pred C-------CCEEEeecchheecccCCc---------ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHH
Confidence 7 7899999999865432111 1112346999999999986422 124578999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCC-CCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC--C
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE--R 1120 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~--R 1120 (1142)
++|+.||...+..+....+..... ...+ ......++.+.+++.+|+..++.+ |
T Consensus 202 l~g~~Pf~~~~~~~~~~~i~~~~~~~~~p------------------------~~~~~~s~~~~~li~~ll~~~~~r~~r 257 (332)
T cd05623 202 LYGETPFYAESLVETYGKIMNHKERFQFP------------------------AQVTDVSEDAKDLIRRLICSREHRLGQ 257 (332)
T ss_pred hcCCCCCCCCCHHHHHHHHhCCCccccCC------------------------CccccCCHHHHHHHHHHccChhhhcCC
Confidence 999999998777666665543221 1100 000145667899999998665544 7
Q ss_pred CCHHHHHHHHHhhc
Q 001142 1121 PTAGDLYEMFVART 1134 (1142)
Q Consensus 1121 PSa~EVL~~L~~~~ 1134 (1142)
++++|+++|+|+..
T Consensus 258 ~~~~~~~~h~~f~~ 271 (332)
T cd05623 258 NGIEDFKQHPFFTG 271 (332)
T ss_pred CCHHHHhCCCCcCC
Confidence 89999999999875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=312.49 Aligned_cols=249 Identities=26% Similarity=0.408 Sum_probs=201.3
Q ss_pred CCCcceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
..+|++.+.||+|+||.||+|...+..+++|...... ...+.+ .+|+.++++++|+||+++++++.+..
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~-----~~~~~~----~~e~~~l~~l~~~~i~~~~~~~~~~~-- 73 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDS-----TAAQAF----LAEASVMTTLRHPNLVQLLGVVLQGN-- 73 (256)
T ss_pred hhhccceeeeecCCCceEEEEEecCcEEEEEEeccch-----hHHHHH----HHHHHHHHhcCCcceeeeEEEEcCCC--
Confidence 4578999999999999999999999999999864331 123333 78999999999999999999987644
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
..++||||+++++|.+++.. .....+++..+..++.|++.||.|||++||+||||||+||+++.+
T Consensus 74 ------------~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~ 138 (256)
T cd05039 74 ------------PLYIVTEYMAKGSLVDYLRS---RGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSED 138 (256)
T ss_pred ------------CeEEEEEecCCCcHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCC
Confidence 34999999999999999976 222368999999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+.++|+|||.+....... ....++..|+|||++.. ..++.++||||||+++|+|++
T Consensus 139 -------~~~~l~d~g~~~~~~~~~-------------~~~~~~~~~~ape~~~~----~~~~~~~Di~slG~il~~l~~ 194 (256)
T cd05039 139 -------LVAKVSDFGLAKEASQGQ-------------DSGKLPVKWTAPEALRE----KKFSTKSDVWSFGILLWEIYS 194 (256)
T ss_pred -------CCEEEccccccccccccc-------------ccCCCcccccCchhhcC----CcCCcHHHHHHHHHHHHHHHh
Confidence 789999999997653211 01224567999999865 467889999999999999997
Q ss_pred -CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001142 1046 -LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124 (1142)
Q Consensus 1046 -G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~ 1124 (1142)
|..||......++...+.....+..+ ...++.+.+++.+||..+|.+|||+.
T Consensus 195 ~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~ 247 (256)
T cd05039 195 FGRVPYPRIPLKDVVPHVEKGYRMEAP---------------------------EGCPPEVYKVMKDCWELDPAKRPTFK 247 (256)
T ss_pred cCCCCCCCCCHHHHHHHHhcCCCCCCc---------------------------cCCCHHHHHHHHHHhccChhhCcCHH
Confidence 99999877666655554433221111 13456789999999999999999999
Q ss_pred HHHHHHH
Q 001142 1125 DLYEMFV 1131 (1142)
Q Consensus 1125 EVL~~L~ 1131 (1142)
++++.+.
T Consensus 248 ~l~~~l~ 254 (256)
T cd05039 248 QLREQLA 254 (256)
T ss_pred HHHHHHh
Confidence 9999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=316.75 Aligned_cols=259 Identities=23% Similarity=0.367 Sum_probs=200.6
Q ss_pred CCCcceeeeecccCceEEEEEEECC-------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeee
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 878 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~~-------~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~ 878 (1142)
.++|++.+.||+|+||.||+|.+.. ..+++|... .. ........+ .+|+.+++.++||||++++++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~--~~-~~~~~~~~~----~~e~~~l~~~~~~~i~~~~~~ 77 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN--EN-ASMRERIEF----LNEASVMKEFNCHHVVRLLGV 77 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecC--Cc-cCHHHHHHH----HHHHHHHHhCCCCceeEEEEE
Confidence 3578999999999999999998743 457777642 21 122222333 789999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 001142 879 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----GEKHVSVKLALFIAQDVAAALVELHSKHIMHR 953 (1142)
Q Consensus 879 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~-----~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHr 953 (1142)
+..... .++||||+++++|.+++...... ....+++..+..++.||+.||.|||+++|+||
T Consensus 78 ~~~~~~--------------~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~ 143 (277)
T cd05032 78 VSTGQP--------------TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHR 143 (277)
T ss_pred EcCCCC--------------cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Confidence 876543 39999999999999999753221 12347889999999999999999999999999
Q ss_pred CCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhH
Q 001142 954 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 1033 (1142)
Q Consensus 954 DLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDV 1033 (1142)
||||+|||++.+ +.+||+|||.++........ .......++..|+|||.+.. ..++.++||
T Consensus 144 di~p~nill~~~-------~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di 204 (277)
T cd05032 144 DLAARNCMVAED-------LTVKIGDFGMTRDIYETDYY--------RKGGKGLLPVRWMAPESLKD----GVFTTKSDV 204 (277)
T ss_pred ccChheEEEcCC-------CCEEECCcccchhhccCccc--------ccCCCCCccccccCHHHHhc----CCCCcccch
Confidence 999999999887 78999999998754332110 01123346788999999865 457899999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHh
Q 001142 1034 WSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 1112 (1142)
Q Consensus 1034 wSLGviL~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~C 1112 (1142)
|||||++|||++ |..||.+.+..+....+..+..+..+. ..+..+.+++.+|
T Consensus 205 ~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~ 257 (277)
T cd05032 205 WSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLPE---------------------------NCPDKLLELMRMC 257 (277)
T ss_pred HHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCCCCC---------------------------CCCHHHHHHHHHH
Confidence 999999999998 999998777766665554333222111 3356789999999
Q ss_pred cccCCCCCCCHHHHHHHHH
Q 001142 1113 TEENPTERPTAGDLYEMFV 1131 (1142)
Q Consensus 1113 L~~DP~~RPSa~EVL~~L~ 1131 (1142)
|+.+|++|||+.++++.+.
T Consensus 258 l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 258 WQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred cCCChhhCCCHHHHHHHhc
Confidence 9999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=316.38 Aligned_cols=269 Identities=25% Similarity=0.363 Sum_probs=205.3
Q ss_pred CCCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEe
Q 001142 804 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 880 (1142)
Q Consensus 804 ~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~~ 880 (1142)
...++|++.+.||+|++|.||+|.+. +..+++|+..... ...+.+ .+|+.+++++ .||||+++++++.
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~----~~e~~~l~~~~~h~~i~~~~~~~~ 73 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-----DEEEEI----KEEYNILRKYSNHPNIATFYGAFI 73 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-----hhHHHH----HHHHHHHHHhcCCCChheEEEEEE
Confidence 34578999999999999999999984 4567777754321 122334 7899999999 6999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NI 960 (1142)
..... ....+.++||||+++++|.+++...... ...+++..+..++.|++.||.|||++|++|+||+|+||
T Consensus 74 ~~~~~--------~~~~~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni 144 (275)
T cd06608 74 KKNPP--------GNDDQLWLVMELCGGGSVTDLVKGLRKK-GKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNI 144 (275)
T ss_pred ecCCC--------CcceEEEEEEEcCCCCcHHHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHE
Confidence 64420 1233579999999999999998764322 35689999999999999999999999999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhcccc-CCCCCCchhhHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCL 1039 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~s~ksDVwSLGvi 1039 (1142)
+++.+ +.++|+|||.+........ ......|++.|+|||++.... ....++.++|||||||+
T Consensus 145 ~~~~~-------~~~~l~d~~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~i 207 (275)
T cd06608 145 LLTKN-------AEVKLVDFGVSAQLDSTLG----------RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGIT 207 (275)
T ss_pred EEccC-------CeEEECCCccceecccchh----------hhcCccccccccCHhHhcccccccCCccccccHHHhHHH
Confidence 99887 7899999999865432111 112345899999999986422 23457789999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001142 1040 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1119 (1142)
Q Consensus 1040 L~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~ 1119 (1142)
+|+|++|+.||...........+.....+... .....+..+.+++.+||..||.+
T Consensus 208 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~l~~dp~~ 262 (275)
T cd06608 208 AIELADGKPPLCDMHPMRALFKIPRNPPPTLK-------------------------SPENWSKKFNDFISECLIKNYEQ 262 (275)
T ss_pred HHHHHhCCCCccccchHHHHHHhhccCCCCCC-------------------------chhhcCHHHHHHHHHHhhcChhh
Confidence 99999999999765444433333322211111 00134567999999999999999
Q ss_pred CCCHHHHHHHHHh
Q 001142 1120 RPTAGDLYEMFVA 1132 (1142)
Q Consensus 1120 RPSa~EVL~~L~~ 1132 (1142)
|||+.++++|+|.
T Consensus 263 Rpt~~~ll~~~~~ 275 (275)
T cd06608 263 RPFMEELLEHPFI 275 (275)
T ss_pred CcCHHHHhcCCCC
Confidence 9999999999984
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=351.60 Aligned_cols=268 Identities=23% Similarity=0.340 Sum_probs=202.8
Q ss_pred CcceeeeecccCceEEEEEEEC-C-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeee-EecCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFG-S-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGH-KISSK 883 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~-~-~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~g~-~~~~~ 883 (1142)
++++.++|.+|||+.||+|... + ..+|+|..... .....+.+ .+||.+|++|+ |+|||.+++. .....
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~----de~~L~~v----~~EI~~MK~L~gh~nIV~yidss~~~~~ 109 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN----DEEALNAV----KREIDIMKLLSGHKNIVSYIDSSAINRS 109 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC----CHHHHHHH----HHHHHHHHHhcCCCceeeEecccccccc
Confidence 4699999999999999999984 3 67888865433 33444444 89999999997 9999999994 32211
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCee
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENIL 961 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~g--IvHrDLKp~NIL 961 (1142)
......++.|.||||+||+|-+++..... ..|++.++++|++|+++|+.+||..+ |||||||-+|||
T Consensus 110 --------~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq---~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvL 178 (738)
T KOG1989|consen 110 --------SNNGVWEVLLLMEYCKGGSLVDFMNTRLQ---TRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVL 178 (738)
T ss_pred --------CCCceeEEEeehhhccCCcHHHHHHHHHh---ccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheE
Confidence 11124578999999999999999986332 34999999999999999999999886 999999999999
Q ss_pred eccccccCCCCCeEEEeecCCcccccccc-ccc--ccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001142 962 IDLERKKADGKPVVKLCDFDRAVPLRSFL-HTC--CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1038 (1142)
Q Consensus 962 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~-~~~--~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGv 1038 (1142)
|..+ +.+||||||.|....... ... ...+. .-....|+.|+|||++.-+ .+...++|+|||||||
T Consensus 179 ls~~-------g~~KLCDFGSatt~~~~~~~~~e~~~ve~----eI~k~TTp~YRsPEMIDly-sg~pI~eKsDIWALGc 246 (738)
T KOG1989|consen 179 LSAD-------GNYKLCDFGSATTKILSPTSAQEVNYVEE----EIEKYTTPQYRSPEMIDLY-SGLPIGEKSDIWALGC 246 (738)
T ss_pred EcCC-------CCEEeCcccccccccCCCccHHHHHHHHH----HHHhhCCccccChHHHhhh-cCCCCcchhHHHHHHH
Confidence 9988 789999999996422111 000 00000 0122479999999998643 3567899999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001142 1039 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1118 (1142)
Q Consensus 1039 iL~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~ 1118 (1142)
+||.|+..+.||.+..... |..+.. ..|.. ..+++.+.+||+.||+.||.
T Consensus 247 lLYkLCy~t~PFe~sg~la----Ilng~Y-------------------------~~P~~-p~ys~~l~~LI~~mL~~nP~ 296 (738)
T KOG1989|consen 247 LLYKLCYFTTPFEESGKLA----ILNGNY-------------------------SFPPF-PNYSDRLKDLIRTMLQPNPD 296 (738)
T ss_pred HHHHHHHhCCCcCcCccee----EEeccc-------------------------cCCCC-ccHHHHHHHHHHHHhccCcc
Confidence 9999999999998653322 222211 01111 16778899999999999999
Q ss_pred CCCCHHHHHHHHHhhcCC
Q 001142 1119 ERPTAGDLYEMFVARTSS 1136 (1142)
Q Consensus 1119 ~RPSa~EVL~~L~~~~ss 1136 (1142)
+||++.+|+.+++.....
T Consensus 297 ~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 297 ERPNIYQVLEEIFELANK 314 (738)
T ss_pred cCCCHHHHHHHHHHHhcC
Confidence 999999999998876543
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=323.94 Aligned_cols=259 Identities=22% Similarity=0.309 Sum_probs=196.3
Q ss_pred CcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
.|+..++||+|+||.||+|.+. +..+|+|....... ... .....+.+|+.++++++|+||+.+++.+.+.+
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~--~~~---~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-- 73 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI--KKR---KGESMALNEKQILEKVNSRFVVSLAYAYETKD-- 73 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhc--cch---HHHHHHHHHHHHHHhCCCCCeeeeeEEEecCC--
Confidence 3778899999999999999985 55677776432211 111 11122368999999999999999999987654
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
..++||||+++++|.+++... +...+++..+..++.|++.||.|||+.||+||||||+||+++.+
T Consensus 74 ------------~~~lv~e~~~g~~L~~~l~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~ 138 (285)
T cd05630 74 ------------ALCLVLTLMNGGDLKFHIYHM---GEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDH 138 (285)
T ss_pred ------------EEEEEEEecCCCcHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC
Confidence 349999999999999988652 23458999999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+.++|+|||++....... ......|+..|+|||++.+ ..++.++|||||||++|+|++
T Consensus 139 -------~~~~l~Dfg~~~~~~~~~-----------~~~~~~g~~~y~aPE~~~~----~~~~~~~DiwslG~~l~~l~~ 196 (285)
T cd05630 139 -------GHIRISDLGLAVHVPEGQ-----------TIKGRVGTVGYMAPEVVKN----ERYTFSPDWWALGCLLYEMIA 196 (285)
T ss_pred -------CCEEEeeccceeecCCCc-----------cccCCCCCccccChHHHcC----CCCCCccccHHHHHHHHHHHh
Confidence 779999999986543211 0112368999999999875 567899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC---
Q 001142 1046 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT--- 1122 (1142)
Q Consensus 1046 G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS--- 1122 (1142)
|+.||................. .... .. ....++.+.+|+.+||+.||.+|||
T Consensus 197 g~~Pf~~~~~~~~~~~~~~~~~-~~~~------------------~~-----~~~~~~~~~~li~~~l~~~p~~R~s~~~ 252 (285)
T cd05630 197 GQSPFQQRKKKIKREEVERLVK-EVQE------------------EY-----SEKFSPDARSLCKMLLCKDPKERLGCQG 252 (285)
T ss_pred CCCCCCCCCccchHHHHHhhhh-hhhh------------------hc-----CccCCHHHHHHHHHHhhcCHHHccCCCC
Confidence 9999986432111111110000 0000 00 0134566899999999999999999
Q ss_pred --HHHHHHHHHhhc
Q 001142 1123 --AGDLYEMFVART 1134 (1142)
Q Consensus 1123 --a~EVL~~L~~~~ 1134 (1142)
+.|+++|+|+..
T Consensus 253 ~~~~~~~~h~~~~~ 266 (285)
T cd05630 253 GGAREVKEHPLFKQ 266 (285)
T ss_pred CchHHHHcChhhhc
Confidence 999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=319.06 Aligned_cols=268 Identities=26% Similarity=0.384 Sum_probs=200.1
Q ss_pred CCCCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEe
Q 001142 804 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 880 (1142)
Q Consensus 804 ~~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~~ 880 (1142)
...++|++.+.||+|+||.||+|.+ .+..+++|+.... ......+ ..|+.+++++ +||||+++++++.
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-----~~~~~~~----~~e~~~l~~l~~h~~i~~~~~~~~ 85 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-----HDIDEEI----EAEYNILKALSDHPNVVKFYGMYY 85 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-----cchHHHH----HHHHHHHHHHhcCCCeeeeeeeee
Confidence 3467899999999999999999987 4567788864311 1111233 6799999999 6999999999876
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NI 960 (1142)
.... ......++||||+++++|.+++...... ...+++..+..++.|++.||.|||+++|+||||||+||
T Consensus 86 ~~~~---------~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~ni 155 (286)
T cd06638 86 KKDV---------KNGDQLWLVLELCNGGSVTDLVKGFLKR-GERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNI 155 (286)
T ss_pred eccc---------CCCCeEEEEEeecCCCCHHHHHHHhhcc-CccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhE
Confidence 4221 0123569999999999999988753222 34689999999999999999999999999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhcccc-CCCCCCchhhHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCL 1039 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~s~ksDVwSLGvi 1039 (1142)
+++.+ +.++|+|||++........ ......|++.|+|||++.... ....++.++|||||||+
T Consensus 156 li~~~-------~~~kl~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi 218 (286)
T cd06638 156 LLTTE-------GGVKLVDFGVSAQLTSTRL----------RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGIT 218 (286)
T ss_pred EECCC-------CCEEEccCCceeecccCCC----------ccccccCCCcccChhhhchhhhccccccchhhhhhHHHH
Confidence 99887 6799999999876532110 112345899999999985321 12457889999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001142 1040 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1119 (1142)
Q Consensus 1040 L~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~ 1119 (1142)
+|+|++|+.||...........+.....+... .+ ...+..+.+++.+||+.||++
T Consensus 219 ~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------------------~~---~~~~~~~~~li~~~l~~~p~~ 273 (286)
T cd06638 219 AIELGDGDPPLADLHPMRALFKIPRNPPPTLH----------------------QP---ELWSNEFNDFIRKCLTKDYEK 273 (286)
T ss_pred HHHHhcCCCCCCCCchhHHHhhccccCCCccc----------------------CC---CCcCHHHHHHHHHHccCCccc
Confidence 99999999999865543322222111111100 00 023456899999999999999
Q ss_pred CCCHHHHHHHHHh
Q 001142 1120 RPTAGDLYEMFVA 1132 (1142)
Q Consensus 1120 RPSa~EVL~~L~~ 1132 (1142)
|||+.|+++|+|+
T Consensus 274 Rps~~ell~~~~~ 286 (286)
T cd06638 274 RPTVSDLLQHVFI 286 (286)
T ss_pred CCCHHHHhhcccC
Confidence 9999999999985
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=332.01 Aligned_cols=250 Identities=22% Similarity=0.339 Sum_probs=191.3
Q ss_pred eeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecCCCCCCCC
Q 001142 813 DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 889 (1142)
Q Consensus 813 ~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~~~~~~~~~~~ 889 (1142)
+.||+|+||.||+|+.. +..+|+|+...+... .....+ .+.+|+.++.++ +||||+++++++.+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~----~~~~e~~~~~~~~~~~~i~~~~~~~~~~~------ 69 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVH-DDEDID----WVQTEKHVFEQASSNPFLVGLHSCFQTTS------ 69 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHH----HHHHHHHHHHhhcCCCCEeeEEEEEEeCC------
Confidence 47999999999999874 566788876432211 112222 237899999888 5999999999987654
Q ss_pred CCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccC
Q 001142 890 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 969 (1142)
Q Consensus 890 ~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~ 969 (1142)
+.++||||+++++|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 70 --------~~~lv~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~---- 132 (327)
T cd05617 70 --------RLFLVIEYVNGGDLMFHMQR-----QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDAD---- 132 (327)
T ss_pred --------EEEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCC----
Confidence 35999999999999998865 2469999999999999999999999999999999999999887
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001142 970 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1049 (1142)
Q Consensus 970 ~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~P 1049 (1142)
+.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus 133 ---~~~kl~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslGvil~ell~g~~p 195 (327)
T cd05617 133 ---GHIKLTDYGMCKEGLGPGD----------TTSTFCGTPNYIAPEILRG----EEYGFSVDWWALGVLMFEMMAGRSP 195 (327)
T ss_pred ---CCEEEeccccceeccCCCC----------ceecccCCcccCCHHHHCC----CCCCchheeehhHHHHHHHHhCCCC
Confidence 7899999999864221110 1123468999999999875 5678999999999999999999999
Q ss_pred CCCCC------HH-HHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1050 YMGLS------EL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1050 f~~~~------~~-el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
|.... .. .....+... ...++ ...+..+.+++.+||+.||.+|++
T Consensus 196 f~~~~~~~~~~~~~~~~~~~~~~-~~~~p---------------------------~~~~~~~~~li~~~L~~dP~~R~~ 247 (327)
T cd05617 196 FDIITDNPDMNTEDYLFQVILEK-PIRIP---------------------------RFLSVKASHVLKGFLNKDPKERLG 247 (327)
T ss_pred CCccCCCcccccHHHHHHHHHhC-CCCCC---------------------------CCCCHHHHHHHHHHhccCHHHcCC
Confidence 96321 11 122222111 11111 134556899999999999999998
Q ss_pred ------HHHHHHHHHhhcC
Q 001142 1123 ------AGDLYEMFVARTS 1135 (1142)
Q Consensus 1123 ------a~EVL~~L~~~~s 1135 (1142)
+.++++|+|+..-
T Consensus 248 ~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 248 CQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred CCCCCCHHHHHcCCCCCCC
Confidence 5799999998753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=321.08 Aligned_cols=251 Identities=25% Similarity=0.420 Sum_probs=193.9
Q ss_pred CCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
++|++.++||+|+||.||+|.+ .+..+|+|+..... .....+.+ .+|+.+++++.||||+++++++...+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~----~~E~~~l~~l~h~~iv~~~~~~~~~~- 72 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI---TVELQKQI----MSELEILYKCDSPYIIGFYGAFFVEN- 72 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC---ChHHHHHH----HHHHHHHHhCCCCCeeeEEEEEEECC-
Confidence 3678999999999999999987 45667777754321 22222333 78999999999999999999998755
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
..++||||+++++|..+. .+++..+..++.|++.||.|||+.||+|+||||+|||++.
T Consensus 73 -------------~~~lv~e~~~~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~ 130 (279)
T cd06619 73 -------------RISICTEFMDGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNT 130 (279)
T ss_pred -------------EEEEEEecCCCCChHHhh---------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECC
Confidence 348999999999986542 3688899999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.++|+|||++....... .....||..|+|||++.+ ..++.++||||||+++|+|+
T Consensus 131 ~-------~~~~l~dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~~l~~l~ 187 (279)
T cd06619 131 R-------GQVKLCDFGVSTQLVNSI------------AKTYVGTNAYMAPERISG----EQYGIHSDVWSLGISFMELA 187 (279)
T ss_pred C-------CCEEEeeCCcceeccccc------------ccCCCCChhhcCceeecC----CCCCCcchHHHHHHHHHHHH
Confidence 7 789999999986543211 123468999999999875 45789999999999999999
Q ss_pred hCCCCCCCCCHH-------HHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001142 1045 TLQVPYMGLSEL-------EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1117 (1142)
Q Consensus 1045 tG~~Pf~~~~~~-------el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP 1117 (1142)
+|+.||...... .....+.....+.. .....++.+.+++.+||+.||
T Consensus 188 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~li~~~l~~~P 241 (279)
T cd06619 188 LGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVL--------------------------PVGQFSEKFVHFITQCMRKQP 241 (279)
T ss_pred hCCCCchhhcccccccchHHHHHHHhccCCCCC--------------------------CCCcCCHHHHHHHHHHhhCCh
Confidence 999999642211 11111111100000 001345678999999999999
Q ss_pred CCCCCHHHHHHHHHhhcCC
Q 001142 1118 TERPTAGDLYEMFVARTSS 1136 (1142)
Q Consensus 1118 ~~RPSa~EVL~~L~~~~ss 1136 (1142)
++||+++|+++|+|+....
T Consensus 242 ~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 242 KERPAPENLMDHPFIVQYN 260 (279)
T ss_pred hhCCCHHHHhcCccccccc
Confidence 9999999999999987553
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=315.10 Aligned_cols=265 Identities=24% Similarity=0.394 Sum_probs=204.3
Q ss_pred CCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
++|++.+.||.|+||+||+|.+ .+..+++|+...... . ...+.+ .+|+.+++.++|+||+++++.+....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~-~~~~~~----~~e~~~l~~l~~~~i~~~~~~~~~~~- 72 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC--Q-TSVDEL----RKEVQAMSQCNHPNVVKYYTSFVVGD- 72 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc--c-hHHHHH----HHHHHHHHhcCCCCEEEEEEEEeeCC-
Confidence 4689999999999999999987 455677776543221 1 133344 78999999999999999999887654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
..++||||+++++|.++++.... ...+++..+..++.|++.||.|||++||+||||||+||+++.
T Consensus 73 -------------~~~iv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~ 137 (267)
T cd06610 73 -------------ELWLVMPYLSGGSLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGE 137 (267)
T ss_pred -------------EEEEEEeccCCCcHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcC
Confidence 35999999999999999976321 245899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.++|+|||++..+....... ........|+..|+|||++... ..++.++|||||||++|+|+
T Consensus 138 ~-------~~~~l~df~~~~~~~~~~~~~------~~~~~~~~~~~~y~~Pe~~~~~---~~~~~~~Dv~slG~i~~~l~ 201 (267)
T cd06610 138 D-------GSVKIADFGVSASLADGGDRT------RKVRKTFVGTPCWMAPEVMEQV---HGYDFKADIWSFGITAIELA 201 (267)
T ss_pred C-------CCEEEcccchHHHhccCcccc------ccccccccCChhhcChHHHccc---cCcCcccchHhHhHHHHHHH
Confidence 7 789999999987654422110 0112344689999999998752 35789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~ 1124 (1142)
+|+.||...+..+....+.....+..... ......+..+.+++.+||+.||++||++.
T Consensus 202 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 259 (267)
T cd06610 202 TGAAPYSKYPPMKVLMLTLQNDPPSLETG----------------------ADYKKYSKSFRKMISLCLQKDPSKRPTAE 259 (267)
T ss_pred hCCCCccccChhhhHHHHhcCCCCCcCCc----------------------cccccccHHHHHHHHHHcCCChhhCcCHH
Confidence 99999987665544444333222111100 00114566789999999999999999999
Q ss_pred HHHHHHHh
Q 001142 1125 DLYEMFVA 1132 (1142)
Q Consensus 1125 EVL~~L~~ 1132 (1142)
++++|+|+
T Consensus 260 ~ll~~p~~ 267 (267)
T cd06610 260 ELLKHKFF 267 (267)
T ss_pred HHhhCCCC
Confidence 99999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=319.93 Aligned_cols=263 Identities=25% Similarity=0.407 Sum_probs=199.4
Q ss_pred CCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSK 883 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~~~~~ 883 (1142)
..|++.+.||+|+||.||+|.+ .+..+++|+.... ......+ ..|+.+++++ +||||+++++++....
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-----~~~~~~~----~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-----EDEEEEI----KLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-----hHHHHHH----HHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 5789999999999999999998 4566777775432 1222233 6899999998 6999999999986432
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
........++||||+++++|.+++... ....+++..+..++.||+.||.|||++||+|+||||+||+++
T Consensus 87 --------~~~~~~~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~ 155 (282)
T cd06636 87 --------PPGHDDQLWLVMEFCGAGSVTDLVKNT---KGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLT 155 (282)
T ss_pred --------ccCCCCEEEEEEEeCCCCcHHHHHHHc---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC
Confidence 111233679999999999999998752 234588889999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhcccc-CCCCCCchhhHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~s~ksDVwSLGviL~E 1042 (1142)
.+ +.++|+|||.+........ ......|++.|+|||++.... ....++.++|||||||++|+
T Consensus 156 ~~-------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~e 218 (282)
T cd06636 156 EN-------AEVKLVDFGVSAQLDRTVG----------RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIE 218 (282)
T ss_pred CC-------CCEEEeeCcchhhhhcccc----------CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHH
Confidence 77 7799999999865432110 122346899999999975321 12457889999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1043 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1043 LLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
|++|..||...........+.....+... ....+..+.++|.+||+.||.+|||
T Consensus 219 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~li~~cl~~~p~~Rp~ 272 (282)
T cd06636 219 MAEGAPPLCDMHPMRALFLIPRNPPPKLK--------------------------SKKWSKKFIDFIEGCLVKNYLSRPS 272 (282)
T ss_pred HHhCCCCccccCHHhhhhhHhhCCCCCCc--------------------------ccccCHHHHHHHHHHhCCChhhCcC
Confidence 99999999765543333222211111100 0134567999999999999999999
Q ss_pred HHHHHHHHHh
Q 001142 1123 AGDLYEMFVA 1132 (1142)
Q Consensus 1123 a~EVL~~L~~ 1132 (1142)
+.|+++|+|+
T Consensus 273 ~~ell~~~~~ 282 (282)
T cd06636 273 TEQLLKHPFI 282 (282)
T ss_pred HHHHhcCCCC
Confidence 9999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=320.78 Aligned_cols=291 Identities=18% Similarity=0.220 Sum_probs=202.1
Q ss_pred CCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEecCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSK 883 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~g~~~~~~ 883 (1142)
++|++.+.||+|+||.||+|.+ .+..+++|+...... ....... +.+|+.+++++. ||||+++++++....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~--~~~~~~~----~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 74 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD--EEGIPPT----ALREISLLQMLSESIYIVRLLDVEHVEE 74 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc--ccCCchH----HHHHHHHHHHccCCCCccceeeeEeecC
Confidence 3689999999999999999997 456788887544321 1111122 368999999995 799999999887644
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
.. .....|+||||++ ++|.+++..........+++..+..++.||+.||.|||++||+||||||+||+++
T Consensus 75 ~~---------~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~ 144 (295)
T cd07837 75 KN---------GKPSLYLVFEYLD-SDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVD 144 (295)
T ss_pred CC---------CCceEEEEeeccC-cCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEe
Confidence 21 1234699999998 5899988764332235689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+. +.+||+|||.+........ ......+++.|+|||++.+ ...++.++||||||+++|+|
T Consensus 145 ~~~------~~~kl~dfg~~~~~~~~~~----------~~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~~l~~l 205 (295)
T cd07837 145 KQK------GLLKIADLGLGRAFSIPVK----------SYTHEIVTLWYRAPEVLLG---STHYSTPVDIWSVGCIFAEM 205 (295)
T ss_pred cCC------CeEEEeecccceecCCCcc----------ccCCcccccCCCChHHhhC---CCCCCchHHHHHHHHHHHHH
Confidence 721 7899999999875432111 1112246888999999864 24578999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHh-CCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1044 LTLQVPYMGLSELEIHDLIQM-GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~-~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
++|..||.+.+..+....+.. ...+.. ..+...........................+..+.++|.+||+.||.+||+
T Consensus 206 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~ 284 (295)
T cd07837 206 SRKQPLFPGDSELQQLLHIFKLLGTPTE-QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRIS 284 (295)
T ss_pred HcCCCCCCCCCHHHHHHHHHHHhCCCCh-hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCC
Confidence 999999987665554333322 111110 000000000000000000000000011145677999999999999999999
Q ss_pred HHHHHHHHHhh
Q 001142 1123 AGDLYEMFVAR 1133 (1142)
Q Consensus 1123 a~EVL~~L~~~ 1133 (1142)
+.|++.|+|+.
T Consensus 285 ~~eil~~~~~~ 295 (295)
T cd07837 285 AKAALTHPYFD 295 (295)
T ss_pred HHHHhcCCCcC
Confidence 99999999974
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=312.85 Aligned_cols=258 Identities=27% Similarity=0.410 Sum_probs=201.5
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
++|++.+.||+|+||.||+|.+. +..+++|+...... ...+.+ .+|+.++++++||||+++++++....
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~----~~~~~~----~~e~~~l~~~~h~~i~~~~~~~~~~~- 73 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG----DDFEII----QQEISMLKECRHPNIVAYFGSYLRRD- 73 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch----hhHHHH----HHHHHHHHhCCCCChhceEEEEEeCC-
Confidence 57999999999999999999973 56788888654321 123333 78999999999999999999987654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
..+++|||+++++|.+++... ...+++..+..++.|++.||.|||++||+|+||||+||+++.
T Consensus 74 -------------~~~l~~e~~~~~~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~ 136 (262)
T cd06613 74 -------------KLWIVMEYCGGGSLQDIYQVT----RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTE 136 (262)
T ss_pred -------------EEEEEEeCCCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECC
Confidence 359999999999999998752 246899999999999999999999999999999999999997
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.++|+|||.+........ ......++..|+|||.+.... ...++.++||||||+++|+|+
T Consensus 137 ~-------~~~~l~d~g~~~~~~~~~~----------~~~~~~~~~~y~~Pe~~~~~~-~~~~~~~~Di~slG~~l~~~~ 198 (262)
T cd06613 137 D-------GDVKLADFGVSAQLTATIA----------KRKSFIGTPYWMAPEVAAVER-KGGYDGKCDIWALGITAIELA 198 (262)
T ss_pred C-------CCEEECccccchhhhhhhh----------ccccccCCccccCchhhcccc-cCCcCchhhhHHHHHHHHHHH
Confidence 7 7899999999875443211 112345888999999986521 136778999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~ 1124 (1142)
+|+.||...........+......... .......+..+.+++.+||..||.+|||+.
T Consensus 199 tg~~p~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~ 255 (262)
T cd06613 199 ELQPPMFDLHPMRALFLISKSNFPPPK-----------------------LKDKEKWSPVFHDFIKKCLTKDPKKRPTAT 255 (262)
T ss_pred hCCCCCCCCCHHHHHHHHHhccCCCcc-----------------------ccchhhhhHHHHHHHHHHcCCChhhCCCHH
Confidence 999999876655444333222111000 000114566799999999999999999999
Q ss_pred HHHHHHH
Q 001142 1125 DLYEMFV 1131 (1142)
Q Consensus 1125 EVL~~L~ 1131 (1142)
+|+.|.|
T Consensus 256 ~il~~~~ 262 (262)
T cd06613 256 KLLQHPF 262 (262)
T ss_pred HHhcCCC
Confidence 9999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=356.22 Aligned_cols=268 Identities=25% Similarity=0.399 Sum_probs=214.6
Q ss_pred CCCCCCCcceeeeecccCceEEEEEEEC---Cc--cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCcccee
Q 001142 802 DPGSFPSLSSCDEAGKSVSSSLFRCKFG---SA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMY 876 (1142)
Q Consensus 802 ~~~~~~~y~l~~~LG~GsfG~Vy~a~~~---~~--~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~ 876 (1142)
+.......++.+.||+|+||.||.|.+. +. ++.|++|.++... ...+..+| ++|..+|+++.|||||+++
T Consensus 687 p~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-~~~~~~~F----l~Ea~~m~~f~HpNiv~li 761 (1025)
T KOG1095|consen 687 PEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-SEQEVSDF----LKEALLMSKFDHPNIVSLI 761 (1025)
T ss_pred ccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-CHHHHHHH----HHHHHHHhcCCCcceeeEE
Confidence 3345556789999999999999999872 22 5667777676532 34455566 8999999999999999999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 001142 877 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG--EKHVSVKLALFIAQDVAAALVELHSKHIMHRD 954 (1142)
Q Consensus 877 g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~--~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrD 954 (1142)
|.+.+... .+|++|||+||+|..+|++.+... ...++..+.+.++.|||+|+.||+++++||||
T Consensus 762 Gv~l~~~~--------------~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRD 827 (1025)
T KOG1095|consen 762 GVCLDSGP--------------PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRD 827 (1025)
T ss_pred EeecCCCC--------------cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcc
Confidence 99987543 399999999999999999753221 34689999999999999999999999999999
Q ss_pred CCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHH
Q 001142 955 IKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 1034 (1142)
Q Consensus 955 LKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVw 1034 (1142)
|-+.|+|++.. .+|||+|||+|+.+-..... ... ....-...|||||.+.. ..++.|+|||
T Consensus 828 LAaRNCLL~~~-------r~VKIaDFGlArDiy~~~yy---r~~-----~~a~lPvkWm~PEsl~d----~iFtskSDvW 888 (1025)
T KOG1095|consen 828 LAARNCLLDER-------RVVKIADFGLARDIYDKDYY---RKH-----GEAMLPVKWMPPESLKD----GIFTSKSDVW 888 (1025)
T ss_pred hhhhheeeccc-------CcEEEcccchhHhhhhchhe---ecc-----CccccceecCCHHHHhh----cccccccchh
Confidence 99999999987 89999999999843322211 111 11123467999999986 6789999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 001142 1035 SYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 1113 (1142)
Q Consensus 1035 SLGviL~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL 1113 (1142)
||||++||++| |..||.+.+..++...+..+.+...+. .+++.+.+++..||
T Consensus 889 sFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~---------------------------~CP~~ly~lM~~CW 941 (1025)
T KOG1095|consen 889 SFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPS---------------------------YCPEKLYQLMLQCW 941 (1025)
T ss_pred hhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCC---------------------------CCChHHHHHHHHHc
Confidence 99999999999 899999988888887665554332221 67778999999999
Q ss_pred ccCCCCCCCHHHHHHHHHhhc
Q 001142 1114 EENPTERPTAGDLYEMFVART 1134 (1142)
Q Consensus 1114 ~~DP~~RPSa~EVL~~L~~~~ 1134 (1142)
+.+|++||++..|++.+....
T Consensus 942 ~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 942 KHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred cCChhhCccHHHHHhhhhhhh
Confidence 999999999999999765543
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=321.01 Aligned_cols=261 Identities=28% Similarity=0.448 Sum_probs=201.5
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
+.|++.++||+|+||.||+|++. +..+++|+.... .....+.+ .+|+.++++++||||+++++.+..+.
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~----~~~~~~~~----~~e~~~l~~l~h~~i~~~~~~~~~~~- 82 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELEDY----MVEIEILATCNHPYIVKLLGAFYWDG- 82 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC----CHHHHHHH----HHHHHHHHhCCCCcEeeeEEEEEeCC-
Confidence 56899999999999999999984 456666664322 22333444 78999999999999999999987654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
..++||||+++++|..++.+. ...+++..+..++.|++.||.|||++||+||||||+||+++.
T Consensus 83 -------------~~~lv~e~~~~~~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~ 145 (292)
T cd06644 83 -------------KLWIMIEFCPGGAVDAIMLEL----DRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTL 145 (292)
T ss_pred -------------eEEEEEecCCCCcHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcC
Confidence 349999999999998887642 245899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhcccc-CCCCCCchhhHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~s~ksDVwSLGviL~EL 1043 (1142)
+ +.++|+|||.+........ ......+++.|+|||++.+.. ....++.++|||||||++|+|
T Consensus 146 ~-------~~~kl~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el 208 (292)
T cd06644 146 D-------GDIKLADFGVSAKNVKTLQ----------RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208 (292)
T ss_pred C-------CCEEEccCccceecccccc----------ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHH
Confidence 6 7899999998864322110 112345788999999985421 234578899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
++|..||...........+.....+.... ....+..+.+++.+||+.||++||++
T Consensus 209 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~li~~~l~~~p~~Rp~~ 263 (292)
T cd06644 209 AQIEPPHHELNPMRVLLKIAKSEPPTLSQ-------------------------PSKWSMEFRDFLKTALDKHPETRPSA 263 (292)
T ss_pred hcCCCCCccccHHHHHHHHhcCCCccCCC-------------------------CcccCHHHHHHHHHHhcCCcccCcCH
Confidence 99999998765544443433222211110 01344568999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 001142 1124 GDLYEMFVARTS 1135 (1142)
Q Consensus 1124 ~EVL~~L~~~~s 1135 (1142)
.++++|+|+..-
T Consensus 264 ~~il~~~~~~~~ 275 (292)
T cd06644 264 AQLLEHPFVSSV 275 (292)
T ss_pred HHHhcCcccccc
Confidence 999999998753
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=313.91 Aligned_cols=252 Identities=23% Similarity=0.389 Sum_probs=197.5
Q ss_pred CCcceeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~-~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
.+|++.+.||+|++|.||+|.+. +..+++|..+ .... ..+++ .+|+.++++++||||+++++++...+.
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~--~~~~---~~~~~----~~e~~~l~~l~h~~i~~~~~~~~~~~~- 75 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLK--PGTM---DPKDF----LAEAQIMKKLRHPKLIQLYAVCTLEEP- 75 (261)
T ss_pred hheeeEEEecccCCccEEEEEecCCeEEEEEeeC--CCcc---cHHHH----HHHHHHHHHCCCCCccceeEEEecCCC-
Confidence 46899999999999999999874 4457777643 2111 12334 789999999999999999999876543
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
.++||||+++++|.+++... ....+++..+..++.|++.||.|||++||+||||||+||+++.+
T Consensus 76 -------------~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~ 139 (261)
T cd05068 76 -------------IYIVTELMKYGSLLEYLQGG---AGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGEN 139 (261)
T ss_pred -------------eeeeeecccCCcHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCC
Confidence 49999999999999999752 23468999999999999999999999999999999999999887
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+.++|+|||++......... .......+..|+|||++.+ ..++.++||||||+++|||++
T Consensus 140 -------~~~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~el~t 199 (261)
T cd05068 140 -------NICKVADFGLARVIKEDIYE---------AREGAKFPIKWTAPEAALY----NRFSIKSDVWSFGILLTEIVT 199 (261)
T ss_pred -------CCEEECCcceEEEccCCccc---------ccCCCcCceeccCcccccc----CCCCchhhHHHHHHHHHHHHh
Confidence 78999999999765421110 0011123457999998865 567899999999999999999
Q ss_pred -CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001142 1046 -LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124 (1142)
Q Consensus 1046 -G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~ 1124 (1142)
|+.||.+.........+........+ ...+..+.+++.+||+.+|.+||++.
T Consensus 200 ~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~P~~Rp~~~ 252 (261)
T cd05068 200 YGRMPYPGMTNAEVLQQVDQGYRMPCP---------------------------PGCPKELYDIMLDCWKEDPDDRPTFE 252 (261)
T ss_pred cCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------CcCCHHHHHHHHHHhhcCcccCCCHH
Confidence 99999887766665555433211110 13456799999999999999999999
Q ss_pred HHHHHHH
Q 001142 1125 DLYEMFV 1131 (1142)
Q Consensus 1125 EVL~~L~ 1131 (1142)
++++.+.
T Consensus 253 ~l~~~l~ 259 (261)
T cd05068 253 TLQWKLE 259 (261)
T ss_pred HHHHHHh
Confidence 9998764
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=330.09 Aligned_cols=261 Identities=24% Similarity=0.373 Sum_probs=197.4
Q ss_pred CCcceeeeecccCceEEEEEEECC-------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeee
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGH 878 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~~-------~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~ 878 (1142)
++|++.++||+|+||.||+|.+.+ ..+|+|+++.. ......+.+ .+|+.++.++ +||||++++++
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~~----~~E~~~~~~l~~h~niv~~~~~ 79 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEG---ATASEYKAL----MTELKILIHIGHHLNVVNLLGA 79 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCC---CCHHHHHHH----HHHHHHHHhhccCcchhheeee
Confidence 479999999999999999997532 46888875422 122223333 6899999999 79999999998
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc-------------------------------------
Q 001142 879 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET------------------------------------- 921 (1142)
Q Consensus 879 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~------------------------------------- 921 (1142)
+...+. ..++||||+++++|.+++......
T Consensus 80 ~~~~~~-------------~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (337)
T cd05054 80 CTKPGG-------------PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSG 146 (337)
T ss_pred EecCCC-------------CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccc
Confidence 865331 358999999999999998642110
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccCCCCCeEEEeecCC
Q 001142 922 -------------------GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDR 982 (1142)
Q Consensus 922 -------------------~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGl 982 (1142)
....+++..+..++.||+.||+|||++||+||||||+|||++.+ +.++|+|||+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~-------~~vkL~DfG~ 219 (337)
T cd05054 147 FIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSEN-------NVVKICDFGL 219 (337)
T ss_pred cccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCC-------CcEEEecccc
Confidence 01368999999999999999999999999999999999999876 7899999999
Q ss_pred cccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH-HHH
Q 001142 983 AVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELE-IHD 1060 (1142)
Q Consensus 983 A~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt-G~~Pf~~~~~~e-l~~ 1060 (1142)
+..+...... .......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+....+ ...
T Consensus 220 a~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~ 287 (337)
T cd05054 220 ARDIYKDPDY--------VRKGDARLPLKWMAPESIFD----KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCR 287 (337)
T ss_pred chhcccCcch--------hhccCCCCCccccCcHHhcC----CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHH
Confidence 9765321110 01123346778999999876 568899999999999999998 999997643332 222
Q ss_pred HHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001142 1061 LIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1061 ~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~ 1133 (1142)
.+..+..+..+ ...++.+.+++.+||+.+|++||++.|+++++...
T Consensus 288 ~~~~~~~~~~~---------------------------~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 288 RLKEGTRMRAP---------------------------EYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred HHhccCCCCCC---------------------------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 33222211110 13445689999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=324.23 Aligned_cols=279 Identities=23% Similarity=0.303 Sum_probs=199.5
Q ss_pred CCcceeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~~--~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
++|++.++||+|+||.||++.+.. ..+++|+...+ ..... ...+.+|++++.+++||||+++++++.+++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~---~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 72 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE---IKPAI----RNQIIRELKVLHECNSPYIVGFYGAFYSDG- 72 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc---cCHHH----HHHHHHHHHHHHhCCCCCCCeEEEEEeeCC-
Confidence 368999999999999999999854 44555553322 11222 223478999999999999999999998655
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeeec
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILID 963 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs-~gIvHrDLKp~NILld 963 (1142)
+.++||||+++++|.++++. ...+++..+..++.||+.||.|||+ .+++||||||+|||++
T Consensus 73 -------------~~~lv~ey~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~ 134 (308)
T cd06615 73 -------------EISICMEHMDGGSLDQVLKK-----AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVN 134 (308)
T ss_pred -------------EEEEEeeccCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEe
Confidence 34999999999999999976 2468999999999999999999997 5999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.+||+|||.+...... ......|++.|+|||.+.+ ..++.++||||||+++|+|
T Consensus 135 ~~-------~~~~l~dfg~~~~~~~~------------~~~~~~~~~~~~aPE~~~~----~~~~~~~DiwslG~~l~~l 191 (308)
T cd06615 135 SR-------GEIKLCDFGVSGQLIDS------------MANSFVGTRSYMSPERLQG----THYTVQSDIWSLGLSLVEM 191 (308)
T ss_pred cC-------CcEEEccCCCccccccc------------ccccCCCCcCccChhHhcC----CCCCccchHHHHHHHHHHH
Confidence 77 78999999998644221 1123468899999999865 4578899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHh--hhccc-cc-------cccccc-CCCCCCchhhhhhHHHHHHHHHHh
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELE--ALGSC-HE-------HEVAQS-GSGFEKPEAELETLSFLVDVFRRC 1112 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~--~~~~~-~~-------~~~~~~-~~~~~~~~~~~~~~~~L~dLI~~C 1112 (1142)
++|+.||...........+..... ....... ..... .. ....+. .............+.++.+++.+|
T Consensus 192 ~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 270 (308)
T cd06615 192 AIGRYPIPPPDAKELEAMFGRPVS-EGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKC 270 (308)
T ss_pred HhCCCCCCCcchhhHHHhhcCccc-cccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHH
Confidence 999999976554433333221110 0000000 00000 00 000000 000000000012466799999999
Q ss_pred cccCCCCCCCHHHHHHHHHhhcC
Q 001142 1113 TEENPTERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1113 L~~DP~~RPSa~EVL~~L~~~~s 1135 (1142)
|..||++|||+.+|++|+|+...
T Consensus 271 l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 271 LKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred ccCChhhCcCHHHHhcChhhhhc
Confidence 99999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=319.48 Aligned_cols=261 Identities=24% Similarity=0.379 Sum_probs=201.3
Q ss_pred CCCcceeeeecccCceEEEEEEECC-------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceee
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYG 877 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~~-------~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g 877 (1142)
..+|++.+.||+|+||.||++.+.+ ..+++|+.... ........+ .+|+.+++++ +||||+++++
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~---~~~~~~~~~----~~E~~~l~~l~~h~~i~~~~~ 83 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD---ATEKDLSDL----VSEMEMMKMIGKHKNIINLLG 83 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCC---CCHHHHHHH----HHHHHHHHhhcCCCCeeeEEE
Confidence 3568999999999999999998743 34666664321 122222333 7899999999 7999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc-----------cCCCCCCHHHHHHHHHHHHHHHHHHH
Q 001142 878 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAALVELH 946 (1142)
Q Consensus 878 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~-----------~~~~~ls~~~i~~Ia~qIa~gL~yLH 946 (1142)
++..... .++||||+++++|.++++.... .....+++..+..++.|++.||+|||
T Consensus 84 ~~~~~~~--------------~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH 149 (293)
T cd05053 84 VCTQEGP--------------LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA 149 (293)
T ss_pred EEcCCCC--------------eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH
Confidence 9876543 4999999999999999975310 22356899999999999999999999
Q ss_pred hCCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCC
Q 001142 947 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 1026 (1142)
Q Consensus 947 s~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 1026 (1142)
+++|+||||||+||+++.+ +.+||+|||.++.+...... .......++..|+|||++.+ ..
T Consensus 150 ~~~ivH~dlkp~Nil~~~~-------~~~kL~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~ 210 (293)
T cd05053 150 SKKCIHRDLAARNVLVTED-------HVMKIADFGLARDIHHIDYY--------RKTTNGRLPVKWMAPEALFD----RV 210 (293)
T ss_pred HCCccccccceeeEEEcCC-------CeEEeCccccccccccccce--------eccCCCCCCccccCHHHhcc----CC
Confidence 9999999999999999877 78999999999765432110 00111234677999999865 56
Q ss_pred CCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHH
Q 001142 1027 YGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFL 1105 (1142)
Q Consensus 1027 ~s~ksDVwSLGviL~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 1105 (1142)
++.++|||||||++|||++ |..||.+....+....+..+..+..+ ...+..+
T Consensus 211 ~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~ 263 (293)
T cd05053 211 YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYRMEKP---------------------------QNCTQEL 263 (293)
T ss_pred cCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCC---------------------------CCCCHHH
Confidence 7899999999999999998 99999887766666655443322111 1345568
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001142 1106 VDVFRRCTEENPTERPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1106 ~dLI~~CL~~DP~~RPSa~EVL~~L~~~ 1133 (1142)
.+|+.+||..||.+|||+.|+++++...
T Consensus 264 ~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 264 YHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred HHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 9999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=316.52 Aligned_cols=281 Identities=20% Similarity=0.245 Sum_probs=203.1
Q ss_pred CcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
+|++.+.||+|+||.||+|.+ .+..+++|+...... .....+.+ .+|+.++++++||||+++++++....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~--~~~~~~~~----~~e~~~l~~~~~~~i~~~~~~~~~~~-- 72 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL--EGGIPNQA----LREIKALQACQHPYVVKLLDVFPHGS-- 72 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc--cchhhHHH----HHHHHHHHhCCCCCCcceeeEEecCC--
Confidence 588999999999999999997 466788887654321 12222333 78999999999999999999987654
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
..++||||+ +++|.+++... ...+++..+..++.||+.||+|||++||+|+||||+||+++.+
T Consensus 73 ------------~~~~v~e~~-~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~ 135 (286)
T cd07832 73 ------------GFVLVMEYM-PSDLSEVLRDE----ERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISAD 135 (286)
T ss_pred ------------eeEEEeccc-CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCC
Confidence 349999999 99999998752 2468999999999999999999999999999999999999886
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+.++|+|||.+........ .......|+..|+|||++.+ ...++.++||||+|+++|+|++
T Consensus 136 -------~~~~l~dfg~~~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~~l~~l~t 196 (286)
T cd07832 136 -------GVLKIADFGLARLFSEEEP---------RLYSHQVATRWYRAPELLYG---ARKYDPGVDLWAVGCIFAELLN 196 (286)
T ss_pred -------CcEEEeeeeecccccCCCC---------CccccccCcccccCceeeec---cccCCchhHHHHHHHHHHHHHc
Confidence 7899999999876543211 01123458899999999764 2456899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccccc--ccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1046 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE--HEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1046 G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
|.+||.+.........+...........+........ ...................+..+.+++.+||+.||.+|||+
T Consensus 197 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~ 276 (286)
T cd07832 197 GSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSA 276 (286)
T ss_pred CCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCH
Confidence 9988887665554444322111111111111000000 00000000000000111345789999999999999999999
Q ss_pred HHHHHHHHh
Q 001142 1124 GDLYEMFVA 1132 (1142)
Q Consensus 1124 ~EVL~~L~~ 1132 (1142)
++++.|+|+
T Consensus 277 ~~~l~h~~~ 285 (286)
T cd07832 277 AEALRHPYF 285 (286)
T ss_pred HHHhhCcCc
Confidence 999999997
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=319.15 Aligned_cols=258 Identities=26% Similarity=0.396 Sum_probs=197.2
Q ss_pred CCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
.++|++.+.||+|+||.||+|++ .+..+++|+.+... ......+ .+|+.+++.++||||+++++.+...+
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~----~~e~~~~~~l~h~~ii~~~~~~~~~~ 79 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP----GEDFAVV----QQEIIMMKDCKHSNIVAYFGSYLRRD 79 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc----hhHHHHH----HHHHHHHHhCCCCCeeeEEEEEEeCC
Confidence 34789999999999999999987 46677888754331 1222223 68999999999999999999987654
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
..++||||+++++|.+++.. ...+++..+..++.|++.||.|||++||+|+||||+||+++
T Consensus 80 --------------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~ 140 (267)
T cd06645 80 --------------KLWICMEFCGGGSLQDIYHV-----TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLT 140 (267)
T ss_pred --------------EEEEEEeccCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC
Confidence 34999999999999999875 24689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.++|+|||.+....... .......|+..|+|||++... ....++.++|||||||++|+|
T Consensus 141 ~~-------~~~~l~dfg~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~-~~~~~~~~~DvwSlG~il~~l 202 (267)
T cd06645 141 DN-------GHVKLADFGVSAQITATI----------AKRKSFIGTPYWMAPEVAAVE-RKGGYNQLCDIWAVGITAIEL 202 (267)
T ss_pred CC-------CCEEECcceeeeEccCcc----------cccccccCcccccChhhhccc-cCCCCCchhhhHHHHHHHHHH
Confidence 77 789999999986543211 111234689999999997421 124578899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
++|..||...........+....... + .. ......+..+.+++.+||+.+|++||++
T Consensus 203 ~~~~~p~~~~~~~~~~~~~~~~~~~~-~-~~---------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~ 259 (267)
T cd06645 203 AELQPPMFDLHPMRALFLMTKSNFQP-P-KL---------------------KDKMKWSNSFHHFVKMALTKNPKKRPTA 259 (267)
T ss_pred hcCCCCcccccchhhHHhhhccCCCC-C-cc---------------------cccCCCCHHHHHHHHHHccCCchhCcCH
Confidence 99999997544333222221111000 0 00 0001334568999999999999999999
Q ss_pred HHHHHHHH
Q 001142 1124 GDLYEMFV 1131 (1142)
Q Consensus 1124 ~EVL~~L~ 1131 (1142)
+++++|+|
T Consensus 260 ~~ll~~~~ 267 (267)
T cd06645 260 EKLLQHPF 267 (267)
T ss_pred HHHhcCCC
Confidence 99999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=332.97 Aligned_cols=265 Identities=22% Similarity=0.288 Sum_probs=201.5
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
++|++.+.||+|+||.||++++. +..+|+|+...... ...... ..+..|+.++..++|+||+++++++.+.+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~----~~~~~e~~~l~~~~~~~i~~l~~~~~~~~- 74 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEM-LKRAET----ACFREERNVLVNGDCQWITTLHYAFQDEN- 74 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHH-HhhHHH----HHHHHHHHHHHhCCCCCEeeEEEEEEcCC-
Confidence 47999999999999999999984 45678877532110 011112 22468899999999999999999998655
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
..|+||||++||+|.+++... ...+++..+..++.|++.||+|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~Ey~~gg~L~~~l~~~----~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~ 137 (331)
T cd05624 75 -------------YLYLVMDYYVGGDLLTLLSKF----EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDM 137 (331)
T ss_pred -------------EEEEEEeCCCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcC
Confidence 349999999999999999752 246899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCC-CCCCchhhHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP-NLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~-~~~s~ksDVwSLGviL~EL 1043 (1142)
+ +.+||+|||++......... ......||+.|+|||++.+.... ..++.++|||||||++|+|
T Consensus 138 ~-------~~~kl~DfG~a~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~el 201 (331)
T cd05624 138 N-------GHIRLADFGSCLKMNQDGTV---------QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEM 201 (331)
T ss_pred C-------CCEEEEeccceeeccCCCce---------eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhh
Confidence 7 78999999998754321110 11234699999999998652211 3567899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCC-CCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC--C
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE--R 1120 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~--R 1120 (1142)
++|+.||...+..+....+.... ...++. .....++.+.+++.+|+..++.+ |
T Consensus 202 l~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~------------------------~~~~~~~~~~~li~~ll~~~~~~~~~ 257 (331)
T cd05624 202 LYGETPFYAESLVETYGKIMNHEERFQFPS------------------------HITDVSEEAKDLIQRLICSRERRLGQ 257 (331)
T ss_pred hhCCCCccCCCHHHHHHHHHcCCCcccCCC------------------------ccccCCHHHHHHHHHHccCchhhcCC
Confidence 99999998777666555553321 111110 00134567999999999876655 5
Q ss_pred CCHHHHHHHHHhhc
Q 001142 1121 PTAGDLYEMFVART 1134 (1142)
Q Consensus 1121 PSa~EVL~~L~~~~ 1134 (1142)
++++++++|+|+..
T Consensus 258 ~~~~~~~~h~~f~~ 271 (331)
T cd05624 258 NGIEDFKKHAFFEG 271 (331)
T ss_pred CCHHHHhcCCCcCC
Confidence 79999999999865
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=313.23 Aligned_cols=253 Identities=26% Similarity=0.411 Sum_probs=200.0
Q ss_pred CCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
.++|++.+.||+|+||.||+|.+. +..+++|..... ...+.+ .+|++++++++||||+++++++.+..
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~------~~~~~~----~~e~~~~~~l~~~~i~~~~~~~~~~~ 71 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE------EDLQEI----IKEISILKQCDSPYIVKYYGSYFKNT 71 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH------HHHHHH----HHHHHHHHhCCCCcEeeeeeeeecCC
Confidence 357999999999999999999985 466777765422 113344 79999999999999999999988654
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
+.+++|||+++++|.+++.. ....+++..+..++.|++.||.|||+.+|+||||+|+||+++
T Consensus 72 --------------~~~l~~e~~~~~~L~~~l~~----~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~ 133 (256)
T cd06612 72 --------------DLWIVMEYCGAGSVSDIMKI----TNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLN 133 (256)
T ss_pred --------------cEEEEEecCCCCcHHHHHHh----CccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEC
Confidence 34999999999999999865 134689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.++|+|||.+........ ......++..|+|||++.+ ..++.++||||||+++|+|
T Consensus 134 ~~-------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~s~G~il~~l 192 (256)
T cd06612 134 EE-------GQAKLADFGVSGQLTDTMA----------KRNTVIGTPFWMAPEVIQE----IGYNNKADIWSLGITAIEM 192 (256)
T ss_pred CC-------CcEEEcccccchhcccCcc----------ccccccCCccccCHHHHhc----CCCCchhhHHHHHHHHHHH
Confidence 87 7899999999876543211 1123457889999999876 4678999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
++|+.||...........+.....+... .....+..+.+++.+||+.||.+|||+
T Consensus 193 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~i~~~l~~~P~~Rps~ 247 (256)
T cd06612 193 AEGKPPYSDIHPMRAIFMIPNKPPPTLS-------------------------DPEKWSPEFNDFVKKCLVKDPEERPSA 247 (256)
T ss_pred HhCCCCCCCcchhhhhhhhccCCCCCCC-------------------------chhhcCHHHHHHHHHHHhcChhhCcCH
Confidence 9999999865544332222111111000 011345678999999999999999999
Q ss_pred HHHHHHHHh
Q 001142 1124 GDLYEMFVA 1132 (1142)
Q Consensus 1124 ~EVL~~L~~ 1132 (1142)
.|+++|+|+
T Consensus 248 ~~il~~~~~ 256 (256)
T cd06612 248 IQLLQHPFI 256 (256)
T ss_pred HHHhcCCCC
Confidence 999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=335.03 Aligned_cols=271 Identities=19% Similarity=0.217 Sum_probs=190.0
Q ss_pred CCcceeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~~--~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
.+|++.+.||+|+||.||+|++.+ ..+|+|+. ... .. ..|+.++++++||||+++++++.....
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~--~~~--------~~----~~E~~~l~~l~h~~iv~~~~~~~~~~~ 131 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIG--QKG--------TT----LIEAMLLQNVNHPSVIRMKDTLVSGAI 131 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeC--Ccc--------cc----HHHHHHHHhCCCCCCcChhheEEeCCe
Confidence 469999999999999999999854 45666652 110 11 469999999999999999999886543
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
.++||||+. ++|.+++.. ....+++..+..|+.||+.||.|||++||+||||||+|||++.
T Consensus 132 --------------~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~ 192 (357)
T PHA03209 132 --------------TCMVLPHYS-SDLYTYLTK----RSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIND 192 (357)
T ss_pred --------------eEEEEEccC-CcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC
Confidence 499999996 788888864 2356899999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 193 ~-------~~~kl~DfG~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlGvvl~ell 250 (357)
T PHA03209 193 V-------DQVCIGDLGAAQFPVVAP-----------AFLGLAGTVETNAPEVLAR----DKYNSKADIWSAGIVLFEML 250 (357)
T ss_pred C-------CCEEEecCccccccccCc-----------ccccccccccccCCeecCC----CCCCchhhHHHHHHHHHHHH
Confidence 7 789999999986432111 1113458999999999875 56889999999999999999
Q ss_pred hCCCCC-CCCCH----------HHHHHHHHhCC-CC-Cch-----hHHhhhcccccccccccCCCCCCchhhhhhHHHHH
Q 001142 1045 TLQVPY-MGLSE----------LEIHDLIQMGK-RP-RLT-----DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLV 1106 (1142)
Q Consensus 1045 tG~~Pf-~~~~~----------~el~~~I~~~~-~p-~l~-----~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~ 1106 (1142)
++..|+ ..... ..+...+.... .+ .++ ......... ..........+ ........+..+.
T Consensus 251 ~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~ 328 (357)
T PHA03209 251 AYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEY-ASLERQPYTRY-PCFQRVNLPIDGE 328 (357)
T ss_pred HcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhh-cccCCCccccc-HHHhccCCCchHH
Confidence 865554 32111 11112221111 11 000 000000000 00000000000 0000113455678
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001142 1107 DVFRRCTEENPTERPTAGDLYEMFVART 1134 (1142)
Q Consensus 1107 dLI~~CL~~DP~~RPSa~EVL~~L~~~~ 1134 (1142)
++|.+||+.||.+||||.|+++|+|++.
T Consensus 329 ~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 329 FLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred HHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 8999999999999999999999999974
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=314.47 Aligned_cols=259 Identities=24% Similarity=0.342 Sum_probs=186.2
Q ss_pred eeecccCceEEEEEEEC-C---ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCC
Q 001142 813 DEAGKSVSSSLFRCKFG-S---ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 888 (1142)
Q Consensus 813 ~~LG~GsfG~Vy~a~~~-~---~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~~ 888 (1142)
+.||+|+||.||+|... . ..+++|. +... ........ +.+|+.+++.++||||+++++.+.....
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~--~~~~-~~~~~~~~----~~~e~~~~~~l~h~nii~~~~~~~~~~~---- 69 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKE--LRAS-ATPDEQLL----FLQEVQPYRELNHPNVLQCLGQCIESIP---- 69 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEee--cCcc-CChHHHHH----HHHHHHHHHhCCCCCcceEEEEECCCCc----
Confidence 46999999999999752 2 2344443 2221 12222233 3789999999999999999999876543
Q ss_pred CCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecccccc
Q 001142 889 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 968 (1142)
Q Consensus 889 ~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~ 968 (1142)
.++||||+++++|.+++...........++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 70 ----------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~--- 136 (269)
T cd05042 70 ----------YLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTAD--- 136 (269)
T ss_pred ----------eEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCC---
Confidence 4999999999999999976432222345778889999999999999999999999999999999887
Q ss_pred CCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhcccc---CCCCCCchhhHHHHHHHHHHHHh
Q 001142 969 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH---KPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 969 ~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~---~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+.+||+|||++......... .......+++.|+|||++.... ....++.++|||||||++|||++
T Consensus 137 ----~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~ 204 (269)
T cd05042 137 ----LSVKIGDYGLALEQYPEDYY--------ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204 (269)
T ss_pred ----CcEEEeccccccccccchhe--------eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHh
Confidence 78999999998643221100 0112234677899999975421 12456889999999999999999
Q ss_pred -CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001142 1046 -LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124 (1142)
Q Consensus 1046 -G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~ 1124 (1142)
|..||......+....+.......++. +......+..+.+++..|| .||++|||++
T Consensus 205 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~ 261 (269)
T cd05042 205 AADQPYPDLSDEQVLKQVVREQDIKLPK----------------------PQLDLKYSDRWYEVMQFCW-LDPETRPTAE 261 (269)
T ss_pred CCCCCCCcCCHHHHHHHHhhccCccCCC----------------------CcccccCCHHHHHHHHHHh-cCcccccCHH
Confidence 788998766555444433222221111 0011144566788999998 5999999999
Q ss_pred HHHHHH
Q 001142 1125 DLYEMF 1130 (1142)
Q Consensus 1125 EVL~~L 1130 (1142)
+|++.+
T Consensus 262 ~v~~~l 267 (269)
T cd05042 262 EVHELL 267 (269)
T ss_pred HHHHHh
Confidence 999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=310.52 Aligned_cols=248 Identities=26% Similarity=0.391 Sum_probs=190.5
Q ss_pred eeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCCC
Q 001142 813 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADG 890 (1142)
Q Consensus 813 ~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~~~~ 890 (1142)
++||+|+||.||+|++ .++.+|+|... .. ....... .+.+|++++++++||||+++++++.....
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~--~~-~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------ 67 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCR--ET-LPPDLKA----KFLQEARILKQYSHPNIVRLIGVCTQKQP------ 67 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecC--cc-CCHHHHH----HHHHHHHHHHhCCCCCcceEEEEEcCCCC------
Confidence 4799999999999987 46667777643 11 1222223 34789999999999999999999876543
Q ss_pred CCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccCC
Q 001142 891 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 970 (1142)
Q Consensus 891 ~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~~ 970 (1142)
.++||||+++++|.+++.. ....+++..+..++.|++.||.|||++||+||||||+|||++.+
T Consensus 68 --------~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~----- 130 (252)
T cd05084 68 --------IYIVMELVQGGDFLTFLRT----EGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEK----- 130 (252)
T ss_pred --------eEEEEeeccCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCC-----
Confidence 4999999999999999865 12458999999999999999999999999999999999999877
Q ss_pred CCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-CCCC
Q 001142 971 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVP 1049 (1142)
Q Consensus 971 ~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt-G~~P 1049 (1142)
+.+||+|||.+......... . ......++..|+|||.+.+ ..++.++||||||+++|||++ |..|
T Consensus 131 --~~~kl~dfg~~~~~~~~~~~---~-----~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il~e~~~~~~~p 196 (252)
T cd05084 131 --NVLKISDFGMSREEEDGVYA---S-----TGGMKQIPVKWTAPEALNY----GRYSSESDVWSFGILLWEAFSLGAVP 196 (252)
T ss_pred --CcEEECccccCccccccccc---c-----cCCCCCCceeecCchhhcC----CCCChHHHHHHHHHHHHHHHhCCCCC
Confidence 78999999998754321100 0 0011123457999999865 457899999999999999998 8999
Q ss_pred CCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001142 1050 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1129 (1142)
Q Consensus 1050 f~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~ 1129 (1142)
|...........+.....+..+ ...+..+.+++.+||+.+|++|||+.++++.
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~ 249 (252)
T cd05084 197 YANLSNQQTREAIEQGVRLPCP---------------------------ELCPDAVYRLMERCWEYDPGQRPSFSTVHQE 249 (252)
T ss_pred ccccCHHHHHHHHHcCCCCCCc---------------------------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9766655544444332221111 1345578999999999999999999999987
Q ss_pred HH
Q 001142 1130 FV 1131 (1142)
Q Consensus 1130 L~ 1131 (1142)
+.
T Consensus 250 l~ 251 (252)
T cd05084 250 LQ 251 (252)
T ss_pred Hh
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=316.02 Aligned_cols=253 Identities=28% Similarity=0.410 Sum_probs=201.8
Q ss_pred CcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
.|+..++||+|+||.||+|.+ .+..+|+|+..... .......+ .+|+.+++++.||||+++++++.+..
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~----~~e~~~l~~l~h~~i~~~~~~~~~~~-- 75 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE---AEDEIEDI----QQEITVLSQCDSPYVTKYYGSYLKGT-- 75 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc---cHHHHHHH----HHHHHHHHhCCCCCEeeEEEEEEECC--
Confidence 478889999999999999987 45678888755332 12223333 78999999999999999999988654
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
..++||||+++++|.+++.. .++++..+..++.|++.||+|||+.+++|+||+|+||+++.+
T Consensus 76 ------------~~~lv~e~~~~~~L~~~i~~------~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~ 137 (277)
T cd06640 76 ------------KLWIIMEYLGGGSALDLLRA------GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQ 137 (277)
T ss_pred ------------EEEEEEecCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCC
Confidence 35999999999999998864 358899999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+.++|+|||++........ ......++..|+|||++.+ ..++.++|||||||++|||++
T Consensus 138 -------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~y~apE~~~~----~~~~~~~Dv~slG~il~el~t 196 (277)
T cd06640 138 -------GDVKLADFGVAGQLTDTQI----------KRNTFVGTPFWMAPEVIQQ----SAYDSKADIWSLGITAIELAK 196 (277)
T ss_pred -------CCEEEcccccceeccCCcc----------ccccccCcccccCHhHhcc----CCCccHHHHHHHHHHHHHHHH
Confidence 7899999999865432110 1112357889999999865 457899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001142 1046 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1125 (1142)
Q Consensus 1046 G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~E 1125 (1142)
|+.||...........+.....+... ...+..+.+++.+||+.+|++||++.+
T Consensus 197 g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~~ 249 (277)
T cd06640 197 GEPPNSDMHPMRVLFLIPKNNPPTLT---------------------------GEFSKPFKEFIDACLNKDPSFRPTAKE 249 (277)
T ss_pred CCCCCCCcChHhHhhhhhcCCCCCCc---------------------------hhhhHHHHHHHHHHcccCcccCcCHHH
Confidence 99999876655444333222222111 145667899999999999999999999
Q ss_pred HHHHHHhhcC
Q 001142 1126 LYEMFVARTS 1135 (1142)
Q Consensus 1126 VL~~L~~~~s 1135 (1142)
+++|+|+...
T Consensus 250 il~~~~~~~~ 259 (277)
T cd06640 250 LLKHKFIVKN 259 (277)
T ss_pred HHhChHhhhc
Confidence 9999998654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=311.80 Aligned_cols=252 Identities=26% Similarity=0.394 Sum_probs=197.0
Q ss_pred CCCcceeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~-~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
.++|++.++||+|+||.||+|.+. +..+++|...... .. .+.+ .+|+.++++++||||+++++++...
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~--~~---~~~~----~~E~~~l~~l~~~~i~~~~~~~~~~-- 73 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT--MS---PESF----LEEAQIMKKLRHDKLVQLYAVVSEE-- 73 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCC--CC---HHHH----HHHHHHHHhcCCCceEEEEeEECCC--
Confidence 457899999999999999999874 4567777654221 11 1233 7899999999999999999887432
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
..++||||+++++|.+++.. .....+++..+..++.|++.||.|||++||+||||||+||+++.
T Consensus 74 -------------~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~ 137 (260)
T cd05070 74 -------------PIYIVTEYMSKGSLLDFLKD---GEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGD 137 (260)
T ss_pred -------------CcEEEEEecCCCcHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeC
Confidence 23899999999999999975 22345899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.++|+|||.+......... ......++..|+|||++.+ ..++.++||||||+++|+|+
T Consensus 138 ~-------~~~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~~l~ 197 (260)
T cd05070 138 G-------LVCKIADFGLARLIEDNEYT---------ARQGAKFPIKWTAPEAALY----GRFTIKSDVWSFGILLTELV 197 (260)
T ss_pred C-------ceEEeCCceeeeeccCcccc---------cccCCCCCccccChHHHhc----CCCcchhhhHHHHHHHHHHH
Confidence 7 78999999999765332111 1112235667999998865 46789999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1045 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1045 t-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
+ |..||.+....+....+.....+..+ ...+..+.+++.+||..||.+|||+
T Consensus 198 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rpt~ 250 (260)
T cd05070 198 TKGRVPYPGMNNREVLEQVERGYRMPCP---------------------------QDCPISLHELMLQCWKKDPEERPTF 250 (260)
T ss_pred hcCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------CcCCHHHHHHHHHHcccCcccCcCH
Confidence 9 89999877666655555433222111 1345679999999999999999999
Q ss_pred HHHHHHHH
Q 001142 1124 GDLYEMFV 1131 (1142)
Q Consensus 1124 ~EVL~~L~ 1131 (1142)
+++.+.+.
T Consensus 251 ~~l~~~l~ 258 (260)
T cd05070 251 EYLQSFLE 258 (260)
T ss_pred HHHHHHHh
Confidence 99998764
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=321.58 Aligned_cols=263 Identities=24% Similarity=0.369 Sum_probs=201.5
Q ss_pred CCCcceeeeecccCceEEEEEEECC---------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccce
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFGS---------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 875 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~~---------~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl 875 (1142)
.++|.+.+.||+|+||.||+|.+.+ ..+|+|+.... ........+ .+|+.+++++ +||||+++
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~----~~e~~~l~~l~~h~~i~~~ 89 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD---ATEKDLSDL----ISEMEMMKMIGKHKNIINL 89 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCC---CChHHHHHH----HHHHHHHHHhcCCCCEeeE
Confidence 3679999999999999999998632 34777765322 122223333 6899999999 79999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc-----------CCCCCCHHHHHHHHHHHHHHHHH
Q 001142 876 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAALVE 944 (1142)
Q Consensus 876 ~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~-----------~~~~ls~~~i~~Ia~qIa~gL~y 944 (1142)
++++...+. .++||||+++++|.+++...... ....+++..+..++.|++.||+|
T Consensus 90 ~~~~~~~~~--------------~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~ 155 (307)
T cd05098 90 LGACTQDGP--------------LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEY 155 (307)
T ss_pred EEEEecCCc--------------eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHH
Confidence 999876543 49999999999999999763211 12358899999999999999999
Q ss_pred HHhCCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCC
Q 001142 945 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 1024 (1142)
Q Consensus 945 LHs~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~ 1024 (1142)
||++|++||||||+||+++.+ +.+||+|||.+.......... ......+++.|+|||++.+
T Consensus 156 lH~~gi~H~dlkp~Nill~~~-------~~~kL~dfg~a~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~---- 216 (307)
T cd05098 156 LASKKCIHRDLAARNVLVTED-------NVMKIADFGLARDIHHIDYYK--------KTTNGRLPVKWMAPEALFD---- 216 (307)
T ss_pred HHHCCcccccccHHheEEcCC-------CcEEECCCcccccccccchhh--------ccccCCCccceeChHHhcc----
Confidence 999999999999999999877 789999999987543211100 0011224568999999875
Q ss_pred CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHH
Q 001142 1025 NLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLS 1103 (1142)
Q Consensus 1025 ~~~s~ksDVwSLGviL~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1103 (1142)
..++.++|||||||++|+|++ |..||.+....++...+.....+..+ ...+.
T Consensus 217 ~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~ 269 (307)
T cd05098 217 RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKP---------------------------SNCTN 269 (307)
T ss_pred CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcCCCCCCC---------------------------CcCCH
Confidence 467899999999999999998 89999877666666555443322111 13456
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001142 1104 FLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1104 ~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~~s 1135 (1142)
.+.+++.+||+.+|.+|||+.++++++.....
T Consensus 270 ~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 270 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred HHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 78999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=337.21 Aligned_cols=278 Identities=20% Similarity=0.257 Sum_probs=196.7
Q ss_pred CCcceeeeecccCceEEEEEEECC----ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFGS----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 882 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~~----~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~ 882 (1142)
.+|++.+.||+|+||.||+|...+ ..+++|... .. ... .+|+.++++++|||||++++++...
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~--~~-------~~~----~~E~~il~~l~h~~iv~~~~~~~~~ 158 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVT--GG-------KTP----GREIDILKTISHRAIINLIHAYRWK 158 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecc--cc-------ccH----HHHHHHHHhcCCCCccceeeeEeeC
Confidence 469999999999999999997632 345555432 11 111 5799999999999999999988764
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
. ..++||||+. ++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||+
T Consensus 159 ~--------------~~~lv~e~~~-~~l~~~l~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill 218 (392)
T PHA03207 159 S--------------TVCMVMPKYK-CDLFTYVDR-----SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFL 218 (392)
T ss_pred C--------------EEEEEehhcC-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE
Confidence 4 3499999996 789888854 3568999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
+.+ +.++|+|||++......... .......||+.|+|||++.+ ..++.++|||||||++||
T Consensus 219 ~~~-------~~~~l~DfG~a~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslGvil~e 279 (392)
T PHA03207 219 DEP-------ENAVLGDFGAACKLDAHPDT--------PQCYGWSGTLETNSPELLAL----DPYCAKTDIWSAGLVLFE 279 (392)
T ss_pred cCC-------CCEEEccCccccccCccccc--------ccccccccccCccCHhHhcC----CCCCchhhHHHHHHHHHH
Confidence 887 78999999999755432111 11224569999999999875 568899999999999999
Q ss_pred HHhCCCCCCCCCH----HHHHHHHHhCCCCCc--hhHH-hhhcccccccccccCCCCCCch--hhhhhHHHHHHHHHHhc
Q 001142 1043 LLTLQVPYMGLSE----LEIHDLIQMGKRPRL--TDEL-EALGSCHEHEVAQSGSGFEKPE--AELETLSFLVDVFRRCT 1113 (1142)
Q Consensus 1043 LLtG~~Pf~~~~~----~el~~~I~~~~~p~l--~~~l-~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~L~dLI~~CL 1113 (1142)
|++|+.||.+... ..+...+........ +... .................+..+. .....+.++.++|.+||
T Consensus 280 l~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml 359 (392)
T PHA03207 280 MSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKML 359 (392)
T ss_pred HHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHh
Confidence 9999999976432 122222211111110 0000 0000000000000000010110 01134567889999999
Q ss_pred ccCCCCCCCHHHHHHHHHhhcCC
Q 001142 1114 EENPTERPTAGDLYEMFVARTSS 1136 (1142)
Q Consensus 1114 ~~DP~~RPSa~EVL~~L~~~~ss 1136 (1142)
+.||.+|||+.|++.|+|+....
T Consensus 360 ~~dp~~Rpsa~e~l~~p~f~~~~ 382 (392)
T PHA03207 360 TFDQEFRPSAQDILSLPLFTKEP 382 (392)
T ss_pred ccChhhCCCHHHHhhCchhhccc
Confidence 99999999999999999998654
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=334.32 Aligned_cols=261 Identities=25% Similarity=0.345 Sum_probs=197.4
Q ss_pred CCCcceeeeecccCceEEEEEEECC-------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceee
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYG 877 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~~-------~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~g 877 (1142)
-++|++.++||+|+||.||+|++.+ ..+|+|+.+.. ......+. +.+|+.+++++. |||||++++
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~---~~~~~~~~----~~~Ei~~l~~l~~HpnIv~l~~ 108 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT---ARSSEKQA----LMSELKIMTHLGPHLNIVNLLG 108 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC---CChHHHHH----HHHHHHHHHhcCCCCCeeeEEE
Confidence 3468999999999999999998632 24777764322 12222233 379999999996 999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc------------------------------------
Q 001142 878 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET------------------------------------ 921 (1142)
Q Consensus 878 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~------------------------------------ 921 (1142)
++.+... .++||||+++|+|.+++......
T Consensus 109 ~~~~~~~--------------~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (400)
T cd05105 109 ACTKSGP--------------IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENK 174 (400)
T ss_pred EEccCCc--------------eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccc
Confidence 9976543 49999999999999998753210
Q ss_pred -------------------------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHH
Q 001142 922 -------------------------------------------------------GEKHVSVKLALFIAQDVAAALVELH 946 (1142)
Q Consensus 922 -------------------------------------------------------~~~~ls~~~i~~Ia~qIa~gL~yLH 946 (1142)
....+++..+..++.||+.||+|||
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH 254 (400)
T cd05105 175 GDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA 254 (400)
T ss_pred ccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 1134788889999999999999999
Q ss_pred hCCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCC
Q 001142 947 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 1026 (1142)
Q Consensus 947 s~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 1026 (1142)
+++|+||||||+|||++.+ +.+||+|||+++........ .......+++.|+|||.+.+ ..
T Consensus 255 ~~~ivH~dikp~Nill~~~-------~~~kL~DfGla~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~ 315 (400)
T cd05105 255 SKNCVHRDLAARNVLLAQG-------KIVKICDFGLARDIMHDSNY--------VSKGSTFLPVKWMAPESIFD----NL 315 (400)
T ss_pred hCCeeCCCCChHhEEEeCC-------CEEEEEeCCcceeccccccc--------cccCCcCCCcceEChhhhcC----CC
Confidence 9999999999999999887 78999999999754321110 11123356788999999875 56
Q ss_pred CCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH-HHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHH
Q 001142 1027 YGLEVDIWSYGCLLLELLT-LQVPYMGLSELE-IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF 1104 (1142)
Q Consensus 1027 ~s~ksDVwSLGviL~ELLt-G~~Pf~~~~~~e-l~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1104 (1142)
++.++|||||||++|||++ |..||....... ....+..+..+..+ ...+..
T Consensus 316 ~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~ 368 (400)
T cd05105 316 YTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKP---------------------------DHATQE 368 (400)
T ss_pred CCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCCCC---------------------------ccCCHH
Confidence 7899999999999999997 999997643332 22333322211110 144567
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001142 1105 LVDVFRRCTEENPTERPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1105 L~dLI~~CL~~DP~~RPSa~EVL~~L~~~ 1133 (1142)
+.+++.+||+.||++|||+.+|.+.+...
T Consensus 369 l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 369 VYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred HHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 99999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=311.89 Aligned_cols=247 Identities=26% Similarity=0.403 Sum_probs=198.7
Q ss_pred CCCcceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
+.+|++.+.||+|+||.||++...+..+++|+.... ...+.+ .+|+.++++++||||+++++++....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~------~~~~~~----~~e~~~l~~~~~~~i~~~~~~~~~~~-- 72 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCD------VTAQAF----LEETAVMTKLHHKNLVRLLGVILHNG-- 72 (254)
T ss_pred HHHceeeeeeccCCCCceEecccCCCceEEEeecCc------chHHHH----HHHHHHHHhCCCCCcCeEEEEEcCCC--
Confidence 467999999999999999999998888999986432 112233 78999999999999999999876422
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
.++||||+++++|.+++.. .....+++..+..++.|++.||.|||++|++||||||+||+++.+
T Consensus 73 -------------~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~ 136 (254)
T cd05083 73 -------------LYIVMELMSKGNLVNFLRT---RGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSED 136 (254)
T ss_pred -------------cEEEEECCCCCCHHHHHHh---cCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCC
Confidence 3899999999999999976 223458999999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+.+||+|||.+....... .....+..|+|||++.+ ..++.++||||||+++|+|++
T Consensus 137 -------~~~kl~Dfg~~~~~~~~~-------------~~~~~~~~y~~pe~~~~----~~~~~~~Dv~slG~~l~el~~ 192 (254)
T cd05083 137 -------GVAKVSDFGLARVGSMGV-------------DNSKLPVKWTAPEALKH----KKFSSKSDVWSYGVLLWEVFS 192 (254)
T ss_pred -------CcEEECCCccceeccccC-------------CCCCCCceecCHHHhcc----CCcCchhhHHHHHHHHHHHHh
Confidence 789999999986532210 11224567999999865 567899999999999999998
Q ss_pred -CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001142 1046 -LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124 (1142)
Q Consensus 1046 -G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~ 1124 (1142)
|+.||......+....+..+..+... ...+..+.+++.+||+.+|.+||+++
T Consensus 193 ~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~ 245 (254)
T cd05083 193 YGRAPYPKMSLKEVKECVEKGYRMEPP---------------------------EGCPADVYVLMTSCWETEPKKRPSFH 245 (254)
T ss_pred CCCCCCccCCHHHHHHHHhCCCCCCCC---------------------------CcCCHHHHHHHHHHcCCChhhCcCHH
Confidence 99999877766655555443222111 13456789999999999999999999
Q ss_pred HHHHHHH
Q 001142 1125 DLYEMFV 1131 (1142)
Q Consensus 1125 EVL~~L~ 1131 (1142)
++++.+.
T Consensus 246 ~l~~~l~ 252 (254)
T cd05083 246 KLREKLE 252 (254)
T ss_pred HHHHHHc
Confidence 9998764
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=313.71 Aligned_cols=260 Identities=26% Similarity=0.424 Sum_probs=199.3
Q ss_pred CCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
+++|++.+.||+|++|.||+|.+ .+..+++|....... ........ +.+|+.+++.++||||+++++++.+.+
T Consensus 1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~----~~~e~~~l~~~~h~~i~~~~~~~~~~~ 75 (267)
T cd08229 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDL-MDAKARAD----CIKEIDLLKQLNHPNVIKYYASFIEDN 75 (267)
T ss_pred CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhh-hhHHHHHH----HHHHHHHHHHccCCchhhhhheeEeCC
Confidence 46789999999999999999996 566777776432211 11122233 478999999999999999999988655
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
. .++||||+++++|.+++..... ....+++..+..++.||+.||.|||++||+|+||||+||+++
T Consensus 76 ~--------------~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~ 140 (267)
T cd08229 76 E--------------LNIVLELADAGDLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT 140 (267)
T ss_pred e--------------EEEEEEecCCCCHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc
Confidence 3 4999999999999999875322 235689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.++|+|||++........ ......|+..|+|||++.+ ..++.++||||||+++|+|
T Consensus 141 ~~-------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~~~ape~~~~----~~~~~~~Dv~slG~il~~l 199 (267)
T cd08229 141 AT-------GVVKLGDLGLGRFFSSKTT----------AAHSLVGTPYYMSPERIHE----NGYNFKSDIWSLGCLLYEM 199 (267)
T ss_pred CC-------CCEEECcchhhhccccCCc----------ccccccCCcCccCHHHhcC----CCccchhhHHHHHHHHHHH
Confidence 77 7899999999865432111 1123358889999999865 4578899999999999999
Q ss_pred HhCCCCCCCCCHH--HHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1044 LTLQVPYMGLSEL--EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~--el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
++|..||.+.... .....+.....+..+ ....+..+.+++.+||+.||.+||
T Consensus 200 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~li~~~l~~~p~~Rp 253 (267)
T cd08229 200 AALQSPFYGDKMNLYSLCKKIEQCDYPPLP--------------------------SDHYSEELRQLVNMCINPDPEKRP 253 (267)
T ss_pred HhCCCCcccccchHHHHhhhhhcCCCCCCC--------------------------cccccHHHHHHHHHhcCCCcccCC
Confidence 9999999754322 222332222211111 013556799999999999999999
Q ss_pred CHHHHHHHHHh
Q 001142 1122 TAGDLYEMFVA 1132 (1142)
Q Consensus 1122 Sa~EVL~~L~~ 1132 (1142)
|+.+|++.+..
T Consensus 254 t~~~i~~~~~~ 264 (267)
T cd08229 254 DITYVYDVAKR 264 (267)
T ss_pred CHHHHHHHHhh
Confidence 99999887654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=313.54 Aligned_cols=259 Identities=28% Similarity=0.425 Sum_probs=196.1
Q ss_pred CcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCC-hHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSS-ADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~-~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
+|+..+.||+|+||.||+|.. .+..+++|+......... .... ..+.+|+.++++++||||+++++++.+..
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 77 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEV----SALECEIQLLKNLQHERIVQYYGCLRDRA- 77 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHH----HHHHHHHHHHHHcCCCCeeeEEEEEEcCC-
Confidence 688999999999999999987 456778776543321111 1122 23478999999999999999999886532
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
....+++|||+++++|.+++.. ...+++..+..++.|++.||.|||+++|+||||||+||+++.
T Consensus 78 -----------~~~~~l~~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~ 141 (266)
T cd06651 78 -----------EKTLTIFMEYMPGGSVKDQLKA-----YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDS 141 (266)
T ss_pred -----------CCEEEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECC
Confidence 1245899999999999999975 235889999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.++|+|||++.......... .......++..|+|||++.+ ..++.++|||||||++|+|+
T Consensus 142 ~-------~~~~l~dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~i~~el~ 203 (266)
T cd06651 142 A-------GNVKLGDFGASKRLQTICMSG-------TGIRSVTGTPYWMSPEVISG----EGYGRKADVWSLGCTVVEML 203 (266)
T ss_pred C-------CCEEEccCCCccccccccccC-------CccccCCccccccCHHHhCC----CCCCchhhhHHHHHHHHHHH
Confidence 7 789999999987553211110 01123457889999999875 45788999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHH-hCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1045 TLQVPYMGLSELEIHDLIQ-MGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~-~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
+|+.||......+....+. ....+.++ ...++.+.+++ +||..+|++||++
T Consensus 204 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li-~~~~~~p~~Rp~~ 255 (266)
T cd06651 204 TEKPPWAEYEAMAAIFKIATQPTNPQLP---------------------------SHISEHARDFL-GCIFVEARHRPSA 255 (266)
T ss_pred HCCCCccccchHHHHHHHhcCCCCCCCc---------------------------hhcCHHHHHHH-HHhcCChhhCcCH
Confidence 9999998654433322221 11111111 13345577788 6888899999999
Q ss_pred HHHHHHHHhh
Q 001142 1124 GDLYEMFVAR 1133 (1142)
Q Consensus 1124 ~EVL~~L~~~ 1133 (1142)
+||++|+|+.
T Consensus 256 ~eil~hp~~~ 265 (266)
T cd06651 256 EELLRHPFAQ 265 (266)
T ss_pred HHHhcCcccc
Confidence 9999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=312.32 Aligned_cols=251 Identities=26% Similarity=0.374 Sum_probs=195.6
Q ss_pred CCcceeeeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~~-~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
.+|++.++||+|+||.||+|++.+ ..+++|+.. ..... .+.+ .+|++++++++||||+++++++.+.
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~--~~~~~---~~~~----~~E~~~l~~l~~~~i~~~~~~~~~~--- 73 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMS---PEAF----LQEAQVMKKLRHEKLVQLYAVVSEE--- 73 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecc--cCccC---HHHH----HHHHHHHHhCCCCCcceEEEEECCC---
Confidence 569999999999999999998844 356666643 21111 1233 7899999999999999999886432
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
..++||||+++++|.+++... ....+++..+..++.|++.||+|||+.+|+||||||+||+++.+
T Consensus 74 ------------~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~ 138 (262)
T cd05071 74 ------------PIYIVTEYMSKGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN 138 (262)
T ss_pred ------------CcEEEEEcCCCCcHHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCC
Confidence 238999999999999999752 22457899999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+.++|+|||.+......... ......++..|+|||+... ..++.++||||||+++|+|++
T Consensus 139 -------~~~~L~dfg~~~~~~~~~~~---------~~~~~~~~~~y~~PE~~~~----~~~~~~~DvwslG~~l~ellt 198 (262)
T cd05071 139 -------LVCKVADFGLARLIEDNEYT---------ARQGAKFPIKWTAPEAALY----GRFTIKSDVWSFGILLTELTT 198 (262)
T ss_pred -------CcEEeccCCceeeccccccc---------cccCCcccceecCHhHhcc----CCCCchhhHHHHHHHHHHHHc
Confidence 78999999999755432111 1112346778999998765 467899999999999999999
Q ss_pred -CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001142 1046 -LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124 (1142)
Q Consensus 1046 -G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~ 1124 (1142)
|..||.+....+....+......... ...+..+.+++.+||+.||++||++.
T Consensus 199 ~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~~l~~~p~~Rp~~~ 251 (262)
T cd05071 199 KGRVPYPGMVNREVLDQVERGYRMPCP---------------------------PECPESLHDLMCQCWRKEPEERPTFE 251 (262)
T ss_pred CCCCCCCCCChHHHHHHHhcCCCCCCc---------------------------cccCHHHHHHHHHHccCCcccCCCHH
Confidence 88899876666555554332211110 14456789999999999999999999
Q ss_pred HHHHHHH
Q 001142 1125 DLYEMFV 1131 (1142)
Q Consensus 1125 EVL~~L~ 1131 (1142)
++++.+.
T Consensus 252 ~~~~~l~ 258 (262)
T cd05071 252 YLQAFLE 258 (262)
T ss_pred HHHHHHH
Confidence 9998765
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=339.94 Aligned_cols=276 Identities=18% Similarity=0.270 Sum_probs=195.0
Q ss_pred CCcceeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~~--~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
..|.+.+.||+|+||.||+|.+.. ..||+|.... .. +.+|++++++++|||||++++++...+
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~----------~~----~~~E~~iL~~L~HpnIv~l~~~~~~~~- 233 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY----------AS----SVHEARLLRRLSHPAVLALLDVRVVGG- 233 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc----------cC----HHHHHHHHHHCCCCCCCcEEEEEEECC-
Confidence 469999999999999999999854 4566663210 11 258999999999999999999987654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
..++|||++. ++|.+++.. ....+++..++.|+.||+.||.|||++||+||||||+|||++.
T Consensus 234 -------------~~~lv~e~~~-~~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~ 295 (461)
T PHA03211 234 -------------LTCLVLPKYR-SDLYTYLGA----RLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNG 295 (461)
T ss_pred -------------EEEEEEEccC-CCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECC
Confidence 3499999995 789888864 1236899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 296 ~-------~~vkL~DFGla~~~~~~~~~--------~~~~~~~GT~~Y~APE~~~~----~~~~~~sDvwSlGviL~El~ 356 (461)
T PHA03211 296 P-------EDICLGDFGAACFARGSWST--------PFHYGIAGTVDTNAPEVLAG----DPYTPSVDIWSAGLVIFEAA 356 (461)
T ss_pred C-------CCEEEcccCCceeccccccc--------ccccccCCCcCCcCHHHHcC----CCCCchHHHHHHHHHHHHHH
Confidence 7 78999999999764321111 11123469999999999876 56889999999999999999
Q ss_pred hCCCCCCCC--------CHHHHHHHHHhCCCC--CchhHH-h-hhcccccccccccCCCCCCchh--hhhhHHHHHHHHH
Q 001142 1045 TLQVPYMGL--------SELEIHDLIQMGKRP--RLTDEL-E-ALGSCHEHEVAQSGSGFEKPEA--ELETLSFLVDVFR 1110 (1142)
Q Consensus 1045 tG~~Pf~~~--------~~~el~~~I~~~~~p--~l~~~l-~-~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~L~dLI~ 1110 (1142)
+|..|+... ...++...+...... .++... . ...................+.+ .......+.+||.
T Consensus 357 ~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~ 436 (461)
T PHA03211 357 VHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVC 436 (461)
T ss_pred HcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHH
Confidence 987655321 123344444332211 110000 0 0000000000000000001100 0133456899999
Q ss_pred HhcccCCCCCCCHHHHHHHHHhhc
Q 001142 1111 RCTEENPTERPTAGDLYEMFVART 1134 (1142)
Q Consensus 1111 ~CL~~DP~~RPSa~EVL~~L~~~~ 1134 (1142)
+||+.||.+|||+.|+|+|+||+.
T Consensus 437 ~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 437 RALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred HHcccChhhCcCHHHHhhCcccCC
Confidence 999999999999999999999974
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=310.56 Aligned_cols=249 Identities=24% Similarity=0.367 Sum_probs=192.3
Q ss_pred eeecccCceEEEEEEECC-----ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCC
Q 001142 813 DEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 887 (1142)
Q Consensus 813 ~~LG~GsfG~Vy~a~~~~-----~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~ 887 (1142)
++||+|+||.||+|.+.. ..+++|+.. ..... ...+. +.+|+.+++++.||||+++++++...
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~--~~~~~-~~~~~----~~~e~~~l~~l~h~~iv~~~~~~~~~----- 68 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLK--QEHIA-AGKKE----FLREASVMAQLDHPCIVRLIGVCKGE----- 68 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecc--cccch-HHHHH----HHHHHHHHHhcCCCCeeeEEEEEcCC-----
Confidence 479999999999998733 346666543 22111 22233 37899999999999999999986532
Q ss_pred CCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccc
Q 001142 888 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 967 (1142)
Q Consensus 888 ~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~ 967 (1142)
..++||||+++++|.+++.. ...+++..+..++.|++.||+|||.++++||||||+|||++.+
T Consensus 69 ----------~~~~v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~-- 131 (257)
T cd05060 69 ----------PLMLVMELAPLGPLLKYLKK-----RREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNR-- 131 (257)
T ss_pred ----------ceEEEEEeCCCCcHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCC--
Confidence 24899999999999999976 2368999999999999999999999999999999999999887
Q ss_pred cCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-C
Q 001142 968 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-L 1046 (1142)
Q Consensus 968 ~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt-G 1046 (1142)
+.+||+|||.++......... .......++..|+|||.+.+ ..++.++||||||+++|+|++ |
T Consensus 132 -----~~~kl~df~~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~~~~~~g 195 (257)
T cd05060 132 -----HQAKISDFGMSRALGAGSDYY-------RATTAGRWPLKWYAPECINY----GKFSSKSDVWSYGVTLWEAFSYG 195 (257)
T ss_pred -----CcEEeccccccceeecCCccc-------ccccCccccccccCHHHhcC----CCCCccchHHHHHHHHHHHHcCC
Confidence 789999999997654322110 01111224567999999865 568899999999999999998 9
Q ss_pred CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 001142 1047 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1126 (1142)
Q Consensus 1047 ~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EV 1126 (1142)
..||...+..+....+........+ ...+..+.+++.+||..+|.+||++.++
T Consensus 196 ~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~cl~~~p~~Rp~~~~l 248 (257)
T cd05060 196 AKPYGEMKGAEVIAMLESGERLPRP---------------------------EECPQEIYSIMLSCWKYRPEDRPTFSEL 248 (257)
T ss_pred CCCcccCCHHHHHHHHHcCCcCCCC---------------------------CCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 9999877766666655443321111 1345678999999999999999999999
Q ss_pred HHHHHhh
Q 001142 1127 YEMFVAR 1133 (1142)
Q Consensus 1127 L~~L~~~ 1133 (1142)
++.+...
T Consensus 249 ~~~l~~~ 255 (257)
T cd05060 249 ESTFRRD 255 (257)
T ss_pred HHHHHhc
Confidence 9987653
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=336.19 Aligned_cols=257 Identities=28% Similarity=0.473 Sum_probs=206.2
Q ss_pred CcceeeeecccCceEEEEEEECC-----cc-EEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFGS-----AD-AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 881 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~~-----~~-vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~ 881 (1142)
+-.+.++||+|+||.||+|++.. .. ||+|..+.+ .........+| .+|+++|++++|||||++||+...
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~-~~~~~~~~~e~----m~EArvMr~l~H~NVVr~yGVa~~ 232 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGS-SELTKEQIKEF----MKEARVMRQLNHPNVVRFYGVAVL 232 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeeccc-ccccHHHHHHH----HHHHHHHHhCCCCCEEEEEEEEcC
Confidence 34677999999999999998731 12 566665432 12344556666 899999999999999999999887
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 001142 882 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 961 (1142)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NIL 961 (1142)
...+ ++|||+|+||+|.+++++. + ..++..+...++.+.|.||+|||++++|||||-+.|+|
T Consensus 233 ~~Pl--------------~ivmEl~~gGsL~~~L~k~---~-~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL 294 (474)
T KOG0194|consen 233 EEPL--------------MLVMELCNGGSLDDYLKKN---K-KSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCL 294 (474)
T ss_pred CCcc--------------EEEEEecCCCcHHHHHHhC---C-CCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHhe
Confidence 6654 9999999999999999872 2 25999999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001142 962 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1041 (1142)
Q Consensus 962 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ 1041 (1142)
++.+ ..+||+|||+++.-..... .....--...|+|||.+.. ..|++++|||||||++|
T Consensus 295 ~~~~-------~~vKISDFGLs~~~~~~~~----------~~~~~klPirWLAPEtl~~----~~~s~kTDV~sfGV~~~ 353 (474)
T KOG0194|consen 295 YSKK-------GVVKISDFGLSRAGSQYVM----------KKFLKKLPIRWLAPETLNT----GIFSFKTDVWSFGVLLW 353 (474)
T ss_pred ecCC-------CeEEeCccccccCCcceee----------ccccccCcceecChhhhcc----CccccccchhheeeeEE
Confidence 9987 6789999999865431110 0111224567999999986 58999999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHH-HhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001142 1042 ELLT-LQVPYMGLSELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1119 (1142)
Q Consensus 1042 ELLt-G~~Pf~~~~~~el~~~I-~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~ 1119 (1142)
|+.+ |..||.+....++...| ..+.+...+. ..+..+..++.+||..||++
T Consensus 354 Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~---------------------------~~p~~~~~~~~~c~~~~p~~ 406 (474)
T KOG0194|consen 354 EIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPS---------------------------KTPKELAKVMKQCWKKDPED 406 (474)
T ss_pred eeeccCCCCCCCCCHHHHHHHHHhcCccCCCCC---------------------------CCHHHHHHHHHHhccCChhh
Confidence 9999 88999999998888888 4444433221 44567888999999999999
Q ss_pred CCCHHHHHHHHHhhcC
Q 001142 1120 RPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1120 RPSa~EVL~~L~~~~s 1135 (1142)
||+|.++.+.+.....
T Consensus 407 R~tm~~i~~~l~~~~~ 422 (474)
T KOG0194|consen 407 RPTMSTIKKKLEALEK 422 (474)
T ss_pred ccCHHHHHHHHHHHHh
Confidence 9999999887766543
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=321.24 Aligned_cols=270 Identities=25% Similarity=0.306 Sum_probs=205.4
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
.+|++.+.||+|++|.||+|... +..+++|....... ...... ..+..|+++++.++||||+++++.+.+..
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 74 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEM-IKRNKV----KRVLTEQEILATLDHPFLPTLYASFQTET- 74 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEecccc-chHHHH----HHHHHHHHHHHhCCCCCchhheeeeecCC-
Confidence 36899999999999999999984 56778887543211 111122 23478999999999999999999987654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
..++||||+.+++|.+++.. .....+++..+..++.||+.||+|||+.||+|+||||+||+++.
T Consensus 75 -------------~~~lv~e~~~~~~L~~~~~~---~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~ 138 (316)
T cd05574 75 -------------YLCLVMDYCPGGELFRLLQR---QPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHE 138 (316)
T ss_pred -------------EEEEEEEecCCCCHHHHHHh---CCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcC
Confidence 35999999999999999875 22356899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccc-------------------cCCCCCCCCccCCCcccchhhhccccCCC
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA-------------------HRGIPAPDVCVGTPRWMAPEVLRAMHKPN 1025 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~-------------------~~~~~~~~~~~GT~~Y~APE~l~~~~~~~ 1025 (1142)
+ +.++|+|||++............. ...........||..|+|||++.+ .
T Consensus 139 ~-------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~ 207 (316)
T cd05574 139 S-------GHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG----D 207 (316)
T ss_pred C-------CCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC----C
Confidence 7 789999999987543221110000 000011224468999999999875 4
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHH
Q 001142 1026 LYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFL 1105 (1142)
Q Consensus 1026 ~~s~ksDVwSLGviL~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 1105 (1142)
.++.++||||||+++|+|++|+.||.+.+.......+..... ..+ . ....+..+
T Consensus 208 ~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~----------------------~---~~~~~~~~ 261 (316)
T cd05574 208 GHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEV-TFP----------------------G---SPPVSSSA 261 (316)
T ss_pred CCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCc-cCC----------------------C---ccccCHHH
Confidence 578999999999999999999999987665544433322111 000 0 00246679
Q ss_pred HHHHHHhcccCCCCCCC----HHHHHHHHHhhcC
Q 001142 1106 VDVFRRCTEENPTERPT----AGDLYEMFVARTS 1135 (1142)
Q Consensus 1106 ~dLI~~CL~~DP~~RPS----a~EVL~~L~~~~s 1135 (1142)
.+++.+||+.||++||| ++|+++|+|+...
T Consensus 262 ~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~ 295 (316)
T cd05574 262 RDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV 295 (316)
T ss_pred HHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence 99999999999999999 9999999999765
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=312.68 Aligned_cols=259 Identities=24% Similarity=0.338 Sum_probs=186.6
Q ss_pred eeecccCceEEEEEEECC----ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCC
Q 001142 813 DEAGKSVSSSLFRCKFGS----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 888 (1142)
Q Consensus 813 ~~LG~GsfG~Vy~a~~~~----~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~~ 888 (1142)
+.||+|+||.||+|.+.+ ..+++|. ++.... ......+ .+|+.++++++||||+++++++.+...
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~--~~~~~~-~~~~~~~----~~E~~~l~~l~h~~iv~~~~~~~~~~~---- 69 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKE--LRVSAS-VQEQMKF----LEEAQPYRSLQHSNLLQCLGQCTEVTP---- 69 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEe--cCCCCC-hHHHHHH----HHHHHHHHhCCCCCEeeEEEEEcCCCC----
Confidence 469999999999998642 2355554 332221 2222233 789999999999999999999876543
Q ss_pred CCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecccccc
Q 001142 889 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 968 (1142)
Q Consensus 889 ~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~ 968 (1142)
.++||||+++++|.+++...........++..+..++.|++.||+|||+++++|+||||+||+++.+
T Consensus 70 ----------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~--- 136 (269)
T cd05087 70 ----------YLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTAD--- 136 (269)
T ss_pred ----------cEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCC---
Confidence 3999999999999999976433333456778889999999999999999999999999999999876
Q ss_pred CCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccC---CCCCCchhhHHHHHHHHHHHHh
Q 001142 969 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK---PNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 969 ~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~---~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+++||+|||.+......... .......++..|+|||++.+... ...++.++||||||+++|||++
T Consensus 137 ----~~~kL~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~ 204 (269)
T cd05087 137 ----LTVKIGDYGLSHNKYKEDYY--------VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFE 204 (269)
T ss_pred ----CcEEECCccccccccCccee--------ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHh
Confidence 78999999998643221100 01123357788999999864211 1235789999999999999996
Q ss_pred -CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001142 1046 -LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124 (1142)
Q Consensus 1046 -G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~ 1124 (1142)
|..||......+.............. .+......++.+.+++.+|+ .+|++|||++
T Consensus 205 ~g~~p~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~ 261 (269)
T cd05087 205 LGSQPYRHLSDEQVLTYTVREQQLKLP----------------------KPRLKLPLSDRWYEVMQFCW-LQPEQRPSAE 261 (269)
T ss_pred CCCCCCCCCChHHHHHHHhhcccCCCC----------------------CCccCCCCChHHHHHHHHHh-cCcccCCCHH
Confidence 99999876555443322211111111 00011134456889999999 6899999999
Q ss_pred HHHHHH
Q 001142 1125 DLYEMF 1130 (1142)
Q Consensus 1125 EVL~~L 1130 (1142)
||++.|
T Consensus 262 ~l~~~l 267 (269)
T cd05087 262 EVHLLL 267 (269)
T ss_pred HHHHHh
Confidence 999865
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=321.56 Aligned_cols=259 Identities=26% Similarity=0.418 Sum_probs=201.7
Q ss_pred CcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
.|.....||+|+||.||++.. .+..+++|..... .....+. +.+|+.++++++||||+++++.+...+
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~----~~~e~~~l~~l~h~~ii~~~~~~~~~~-- 92 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR----KQQRREL----LFNEVVIMRDYHHENVVDMYNSYLVGD-- 92 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc----hHHHHHH----HHHHHHHHHhCCCCcHHHHHHheecCC--
Confidence 356678899999999999987 4566777764322 1222233 378999999999999999999987644
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
..++||||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.+
T Consensus 93 ------------~~~lv~e~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~ 154 (292)
T cd06658 93 ------------ELWVVMEFLEGGALTDIVTH------TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSD 154 (292)
T ss_pred ------------eEEEEEeCCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC
Confidence 34999999999999998854 358899999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+.++|+|||++........ ......|+..|+|||.+.+ ..++.++||||||+++|||++
T Consensus 155 -------~~~kL~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slGvil~el~~ 213 (292)
T cd06658 155 -------GRIKLSDFGFCAQVSKEVP----------KRKSLVGTPYWMAPEVISR----LPYGTEVDIWSLGIMVIEMID 213 (292)
T ss_pred -------CCEEEccCcchhhcccccc----------cCceeecCccccCHHHHcc----CCCCchhhHHHHHHHHHHHHh
Confidence 7899999999865432111 1123458899999999865 467899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001142 1046 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1125 (1142)
Q Consensus 1046 G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~E 1125 (1142)
|+.||......+....+.....+.... ....+..+.+++.+||..||.+|||+.+
T Consensus 214 g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 268 (292)
T cd06658 214 GEPPYFNEPPLQAMRRIRDNLPPRVKD-------------------------SHKVSSVLRGFLDLMLVREPSQRATAQE 268 (292)
T ss_pred CCCCCCCCCHHHHHHHHHhcCCCcccc-------------------------ccccCHHHHHHHHHHccCChhHCcCHHH
Confidence 999998766555444433222111110 0134456889999999999999999999
Q ss_pred HHHHHHhhcCCCCCC
Q 001142 1126 LYEMFVARTSSSISS 1140 (1142)
Q Consensus 1126 VL~~L~~~~ss~~s~ 1140 (1142)
+++|+|+......++
T Consensus 269 il~~~~~~~~~~~~~ 283 (292)
T cd06658 269 LLQHPFLKLAGPPSC 283 (292)
T ss_pred HhhChhhhccCCccc
Confidence 999999997655443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=314.47 Aligned_cols=263 Identities=22% Similarity=0.357 Sum_probs=199.3
Q ss_pred CCCcceeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeee
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 878 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~-------~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~ 878 (1142)
.++|++.++||+|+||.||+|.+. +..+|+|.. +.. ........+ .+|+.++++++||||++++++
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~--~~~-~~~~~~~~~----~~e~~~l~~l~~~~i~~~~~~ 77 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV--NES-ASLRERIEF----LNEASVMKGFTCHHVVRLLGV 77 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEEC--CCc-CCHHHHHHH----HHHHHHHHhCCCCCeeeEEEE
Confidence 457999999999999999999753 224666653 221 112222233 689999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 001142 879 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----GEKHVSVKLALFIAQDVAAALVELHSKHIMHR 953 (1142)
Q Consensus 879 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~-----~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHr 953 (1142)
+.+... .++||||+++|+|.++++..... +...+++..+..++.||+.||.|||+++|+||
T Consensus 78 ~~~~~~--------------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~ 143 (288)
T cd05061 78 VSKGQP--------------TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHR 143 (288)
T ss_pred EcCCCC--------------cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCC
Confidence 876543 39999999999999999763211 12345778899999999999999999999999
Q ss_pred CCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhH
Q 001142 954 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 1033 (1142)
Q Consensus 954 DLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDV 1033 (1142)
||||+||+++.+ +.++|+|||+++........ .......++..|+|||.+.+ ..++.++||
T Consensus 144 dikp~nili~~~-------~~~~L~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~~pE~~~~----~~~~~~~Dv 204 (288)
T cd05061 144 DLAARNCMVAHD-------FTVKIGDFGMTRDIYETDYY--------RKGGKGLLPVRWMAPESLKD----GVFTTSSDM 204 (288)
T ss_pred CCChheEEEcCC-------CcEEECcCCccccccccccc--------cccCCCcccccccCHHHhcc----CCCChHhHH
Confidence 999999999877 78999999998754321110 01112235678999999875 467899999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHh
Q 001142 1034 WSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 1112 (1142)
Q Consensus 1034 wSLGviL~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~C 1112 (1142)
|||||++|||++ |..||.+....+....+..+..+..+ ...++.+.+++.+|
T Consensus 205 wslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~ 257 (288)
T cd05061 205 WSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQP---------------------------DNCPERVTDLMRMC 257 (288)
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------CCCCHHHHHHHHHH
Confidence 999999999998 78999877766665555433322111 03345799999999
Q ss_pred cccCCCCCCCHHHHHHHHHhhcC
Q 001142 1113 TEENPTERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1113 L~~DP~~RPSa~EVL~~L~~~~s 1135 (1142)
|+.||++|||+.++++.+.....
T Consensus 258 l~~~p~~Rps~~~ll~~l~~~~~ 280 (288)
T cd05061 258 WQFNPKMRPTFLEIVNLLKDDLH 280 (288)
T ss_pred cCCChhHCcCHHHHHHHHHhhcC
Confidence 99999999999999997665433
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=317.91 Aligned_cols=252 Identities=28% Similarity=0.425 Sum_probs=198.0
Q ss_pred CcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
.|+..+.||+|+||.||+|.+. +..+|+|+..... .....+. +.+|+.++++++||||+++++++....
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 75 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE---AEDEIED----IQQEITVLSQCDSPYITRYYGSYLKGT-- 75 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc---chHHHHH----HHHHHHHHHcCCCCccHhhhcccccCC--
Confidence 4778899999999999999874 5567777654221 1222233 378999999999999999999987654
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
..++||||+++++|.+++.. ..+++..+..++.||+.|+.|||++|++|+||+|+||+++.+
T Consensus 76 ------------~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~ 137 (277)
T cd06642 76 ------------KLWIIMEYLGGGSALDLLKP------GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQ 137 (277)
T ss_pred ------------ceEEEEEccCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCC
Confidence 34999999999999998854 358999999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+.++|+|||++..+..... ......|+..|+|||++.+ ..++.++|||||||++|||++
T Consensus 138 -------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il~el~t 196 (277)
T cd06642 138 -------GDVKLADFGVAGQLTDTQI----------KRNTFVGTPFWMAPEVIKQ----SAYDFKADIWSLGITAIELAK 196 (277)
T ss_pred -------CCEEEccccccccccCcch----------hhhcccCcccccCHHHhCc----CCCchhhhHHHHHHHHHHHHh
Confidence 7899999999875543211 1112357889999999875 457889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001142 1046 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1125 (1142)
Q Consensus 1046 G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~E 1125 (1142)
|+.||...........+.....+.+ ....+..+.+++.+||+.+|++||++.+
T Consensus 197 g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 249 (277)
T cd06642 197 GEPPNSDLHPMRVLFLIPKNSPPTL---------------------------EGQYSKPFKEFVEACLNKDPRFRPTAKE 249 (277)
T ss_pred CCCCCcccchhhHHhhhhcCCCCCC---------------------------CcccCHHHHHHHHHHccCCcccCcCHHH
Confidence 9999976544433333222211111 0134566899999999999999999999
Q ss_pred HHHHHHhhc
Q 001142 1126 LYEMFVART 1134 (1142)
Q Consensus 1126 VL~~L~~~~ 1134 (1142)
+++|+|+..
T Consensus 250 il~~~~~~~ 258 (277)
T cd06642 250 LLKHKFITR 258 (277)
T ss_pred HHHhHHHHH
Confidence 999999864
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=311.75 Aligned_cols=255 Identities=26% Similarity=0.383 Sum_probs=198.7
Q ss_pred CcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
+|++.+.||+|+||.||+|.+. +..+++|...... ......+. +.+|+.++++++|+||+++++.+....
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~----~~~E~~~l~~~~h~~i~~~~~~~~~~~-- 72 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTK--MPVKEKEA----SKKEVILLAKMKHPNIVTFFASFQENG-- 72 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhh--ccchhhHH----HHHHHHHHHhCCCCChhhhhheeccCC--
Confidence 4889999999999999999984 5667777654331 11122223 378999999999999999999887654
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
..++||||+++++|.+++.. .....+++..+..++.|++.||.|||+++|+|+||||+||+++.+
T Consensus 73 ------------~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~ 137 (257)
T cd08225 73 ------------RLFIVMEYCDGGDLMKRINR---QRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKN 137 (257)
T ss_pred ------------eEEEEEecCCCCcHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCC
Confidence 34999999999999999875 223457999999999999999999999999999999999999876
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
. ..++|+|||.+........ ......|++.|+|||++.. ..++.++||||||+++|+|++
T Consensus 138 ~------~~~~l~d~~~~~~~~~~~~----------~~~~~~~~~~~~ape~~~~----~~~~~~~Dv~slG~il~~l~~ 197 (257)
T cd08225 138 G------MVAKLGDFGIARQLNDSME----------LAYTCVGTPYYLSPEICQN----RPYNNKTDIWSLGCVLYELCT 197 (257)
T ss_pred C------CeEEecccccchhccCCcc----------cccccCCCccccCHHHHcC----CCCCchhhHHHHHHHHHHHHh
Confidence 2 3579999999875533111 1123458899999999865 457899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001142 1046 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1125 (1142)
Q Consensus 1046 G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~E 1125 (1142)
|..||......+....+.....+... ...+..+.+++.+||..+|++|||+.+
T Consensus 198 g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~~l~~~p~~Rpt~~~ 250 (257)
T cd08225 198 LKHPFEGNNLHQLVLKICQGYFAPIS---------------------------PNFSRDLRSLISQLFKVSPRDRPSITS 250 (257)
T ss_pred CCCCCCCccHHHHHHHHhcccCCCCC---------------------------CCCCHHHHHHHHHHhccChhhCcCHHH
Confidence 99999876555444333222211100 133456999999999999999999999
Q ss_pred HHHHHHh
Q 001142 1126 LYEMFVA 1132 (1142)
Q Consensus 1126 VL~~L~~ 1132 (1142)
+++|+|+
T Consensus 251 ll~~~~~ 257 (257)
T cd08225 251 ILKRPFL 257 (257)
T ss_pred HhhCCCC
Confidence 9999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=317.61 Aligned_cols=266 Identities=22% Similarity=0.317 Sum_probs=198.5
Q ss_pred CCCcceeeeecccCceEEEEEEECC------------------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFGS------------------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL 867 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~~------------------~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L 867 (1142)
..+|++.++||+|+||.||+|.+.. ..+++|+..... .....+.+ .+|+++++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~----~~e~~~l~~l 76 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA---SDNAREDF----LKEVKILSRL 76 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc---CHHHHHHH----HHHHHHHHhc
Confidence 4579999999999999999998643 235666643221 12233334 7899999999
Q ss_pred CCCCccceeeeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc------CCCCCCHHHHHHHHHHHHHH
Q 001142 868 RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET------GEKHVSVKLALFIAQDVAAA 941 (1142)
Q Consensus 868 ~HpNIVkl~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~------~~~~ls~~~i~~Ia~qIa~g 941 (1142)
+||||+++++++..+.. .++||||+++++|.+++...... ....+++..+..++.|++.|
T Consensus 77 ~~~~i~~~~~~~~~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~a 142 (296)
T cd05051 77 SDPNIARLLGVCTVDPP--------------LCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASG 142 (296)
T ss_pred CCCCEeEEEEEEecCCC--------------cEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHH
Confidence 99999999999876543 39999999999999999764311 12268999999999999999
Q ss_pred HHHHHhCCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccc
Q 001142 942 LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 1021 (1142)
Q Consensus 942 L~yLHs~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~ 1021 (1142)
|.|||++||+||||||+||+++.+ +.++|+|||.+......... .......+++.|+|||++.+
T Consensus 143 l~~LH~~~i~H~dlkp~Nili~~~-------~~~~l~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~- 206 (296)
T cd05051 143 MRYLESLNFVHRDLATRNCLVGKN-------YTIKIADFGMSRNLYSSDYY--------RVQGRAPLPIRWMAWESVLL- 206 (296)
T ss_pred HHHHHHcCccccccchhceeecCC-------CceEEccccceeecccCcce--------eecCcCCCCceecCHHHhhc-
Confidence 999999999999999999999887 78999999998754322110 01123346788999999875
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhh
Q 001142 1022 HKPNLYGLEVDIWSYGCLLLELLT--LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 1099 (1142)
Q Consensus 1022 ~~~~~~s~ksDVwSLGviL~ELLt--G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 1099 (1142)
..++.++|||||||++|||++ +..||...+..+....+......... .. ......
T Consensus 207 ---~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~---------------~~-----~~~~~~ 263 (296)
T cd05051 207 ---GKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGR---------------QI-----YLPRPP 263 (296)
T ss_pred ---CCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccc---------------cc-----cCCCcc
Confidence 467899999999999999998 77888766655554443221100000 00 000001
Q ss_pred hhHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 001142 1100 ETLSFLVDVFRRCTEENPTERPTAGDLYEMFV 1131 (1142)
Q Consensus 1100 ~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~ 1131 (1142)
..+.++.+++.+||+.||.+|||+.||++.|.
T Consensus 264 ~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 264 NCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred CCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 34567999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=316.13 Aligned_cols=263 Identities=24% Similarity=0.338 Sum_probs=197.7
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHH-HhhCCCCCccceeeeEecCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRM-LGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~i-L~~L~HpNIVkl~g~~~~~~ 883 (1142)
++|++.+.||+|+||.||+|.+. +..+|+|..... ...... ..+ ..|+.+ ++.++||||+++++++..++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~-~~~----~~e~~~~~~~~~~~~iv~~~~~~~~~~ 73 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRAT--VNSQEQ-KRL----LMDLDISMRSVDCPYTVTFYGALFREG 73 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecC--CCcHHH-HHH----HHHHHHHHHHcCCCCeeeeeEEEecCC
Confidence 46899999999999999999984 567777765432 222222 222 456665 55668999999999987654
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCeee
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENILI 962 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~-gIvHrDLKp~NILl 962 (1142)
. .++||||++ ++|.++++..... ...+++..+..++.||+.||+|||++ +++||||||+||++
T Consensus 74 ~--------------~~lv~e~~~-~~l~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~ 137 (283)
T cd06617 74 D--------------VWICMEVMD-TSLDKFYKKVYDK-GLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLI 137 (283)
T ss_pred c--------------EEEEhhhhc-ccHHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE
Confidence 3 499999997 7999988764332 35789999999999999999999997 99999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
+.+ +.+||+|||.+....... ......++..|+|||.+.+......++.++|||||||++|+
T Consensus 138 ~~~-------~~~kl~dfg~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~ 199 (283)
T cd06617 138 NRN-------GQVKLCDFGISGYLVDSV-----------AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIE 199 (283)
T ss_pred CCC-------CCEEEeeccccccccccc-----------ccccccCCccccChhhcCCcccccccCccccchhhHHHHHH
Confidence 887 789999999987543211 11123578899999998653333457889999999999999
Q ss_pred HHhCCCCCCCCC-HHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1043 LLTLQVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1043 LLtG~~Pf~~~~-~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
|++|+.||.... ..+....+.....+..+. ...+..+.+++.+||..+|.+||
T Consensus 200 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~l~~li~~~l~~~p~~Rp 253 (283)
T cd06617 200 LATGRFPYDSWKTPFQQLKQVVEEPSPQLPA--------------------------EKFSPEFQDFVNKCLKKNYKERP 253 (283)
T ss_pred HHhCCCCCCccccCHHHHHHHHhcCCCCCCc--------------------------cccCHHHHHHHHHHccCChhhCc
Confidence 999999996422 122222222221111110 13456799999999999999999
Q ss_pred CHHHHHHHHHhhcCC
Q 001142 1122 TAGDLYEMFVARTSS 1136 (1142)
Q Consensus 1122 Sa~EVL~~L~~~~ss 1136 (1142)
++.++++|+|+....
T Consensus 254 ~~~~il~~~~~~~~~ 268 (283)
T cd06617 254 NYPELLQHPFFELHL 268 (283)
T ss_pred CHHHHhcCchhhhcc
Confidence 999999999998764
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=311.45 Aligned_cols=259 Identities=27% Similarity=0.391 Sum_probs=197.0
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCC-hHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSS-ADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~-~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
.+|++.+.||+|+||.||+|.+. +..+++|....+..... ....+. +.+|+.++++++||||+++++++.+..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~----~~~E~~~l~~l~h~~i~~~~~~~~~~~ 77 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNA----LECEIQLLKNLLHERIVQYYGCLRDPM 77 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHH----HHHHHHHHHhcCCCCeeeEEeEeccCC
Confidence 46899999999999999999874 56678876544322211 122233 378999999999999999999876532
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
. ...++||||+++++|.+++.. ...+++..+..++.|++.||+|||+++|+|+||||+||+++
T Consensus 78 ~------------~~~~~v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~ 140 (265)
T cd06652 78 E------------RTLSIFMEHMPGGSIKDQLKS-----YGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRD 140 (265)
T ss_pred C------------ceEEEEEEecCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEec
Confidence 1 245899999999999999875 23578899999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.++|+|||.+.......... .......|+..|+|||++.+ ..++.++|||||||++|+|
T Consensus 141 ~~-------~~~~l~Dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il~el 202 (265)
T cd06652 141 SV-------GNVKLGDFGASKRLQTICLSG-------TGMKSVTGTPYWMSPEVISG----EGYGRKADIWSVGCTVVEM 202 (265)
T ss_pred CC-------CCEEECcCccccccccccccc-------cccccCCCCccccChhhhcC----CCCCcchhHHHHHHHHHHH
Confidence 77 789999999987543211100 01122358889999999875 4578999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCC-CCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
++|+.||...........+.... .+.. +...+..+.+++.+|+. +|++||+
T Consensus 203 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~i~~~l~-~p~~Rp~ 254 (265)
T cd06652 203 LTEKPPWAEFEAMAAIFKIATQPTNPVL---------------------------PPHVSDHCRDFLKRIFV-EAKLRPS 254 (265)
T ss_pred hhCCCCCCccchHHHHHHHhcCCCCCCC---------------------------chhhCHHHHHHHHHHhc-ChhhCCC
Confidence 99999998654443332222111 1111 11345568899999995 9999999
Q ss_pred HHHHHHHHHh
Q 001142 1123 AGDLYEMFVA 1132 (1142)
Q Consensus 1123 a~EVL~~L~~ 1132 (1142)
++++++|+|.
T Consensus 255 ~~~il~~~~~ 264 (265)
T cd06652 255 ADELLRHTFV 264 (265)
T ss_pred HHHHhcCccc
Confidence 9999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=319.65 Aligned_cols=288 Identities=21% Similarity=0.224 Sum_probs=208.0
Q ss_pred CCCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 882 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~ 882 (1142)
++++|++.+.||+|+||.||+|.+ .+..+|+|+.+.+..... ... .+.+|+.++++++|+||+++++++...
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~--~~~----~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDG--IPI----SSLREITLLLNLRHPNIVELKEVVVGK 78 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCC--Ccc----hhhHHHHHHHhCCCCCCcceEEEEecC
Confidence 567899999999999999999998 467788887654432111 111 225799999999999999999998753
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
.. ...++||||+. ++|.+++... ...+++..+..++.||+.||.|||++||+||||||+||++
T Consensus 79 ~~------------~~~~lv~e~~~-~~l~~~l~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~ 141 (309)
T cd07845 79 HL------------DSIFLVMEYCE-QDLASLLDNM----PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLL 141 (309)
T ss_pred CC------------CeEEEEEecCC-CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 21 14599999997 6898888752 2468999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
+.+ +.+||+|||.+........ ......+++.|+|||.+.+ ...++.++|||||||++|+
T Consensus 142 ~~~-------~~~kL~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~---~~~~~~~~DvwslG~il~e 201 (309)
T cd07845 142 TDK-------GCLKIADFGLARTYGLPAK----------PMTPKVVTLWYRAPELLLG---CTTYTTAIDMWAVGCILAE 201 (309)
T ss_pred CCC-------CCEEECccceeeecCCccC----------CCCcccccccccChhhhcC---CCCcCchHHHHHHHHHHHH
Confidence 877 7899999999976543211 1112245788999999865 2457899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccc-cccccCCCCCCc-hhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1043 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEH-EVAQSGSGFEKP-EAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1043 LLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
|++|+.||.+.+..+....+...........+......... .+.......... ......++.+.++|.+||+.||.+|
T Consensus 202 l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R 281 (309)
T cd07845 202 LLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKR 281 (309)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhC
Confidence 99999999887777666655432221111111100000000 000000000000 0001246678999999999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 001142 1121 PTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1121 PSa~EVL~~L~~~~s 1135 (1142)
||+.+++.|+|++..
T Consensus 282 ~t~~~il~h~~f~~~ 296 (309)
T cd07845 282 ATAEEALESSYFKEK 296 (309)
T ss_pred cCHHHHhcChhhccC
Confidence 999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=308.50 Aligned_cols=260 Identities=27% Similarity=0.408 Sum_probs=201.2
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
++|++.+.||+|+||.||+|... +..+++|..+..... .....+. +.+|++++++++|+||+++++++.+.+
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~----~~~ei~~l~~~~~~~i~~~~~~~~~~~- 75 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMM-DAKARQD----CLKEIDLLKQLDHPNVIKYLASFIENN- 75 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeeccccc-chhhHHH----HHHHHHHHHhCCCCCeeeeeeeeecCC-
Confidence 57999999999999999999984 677888875432211 1122233 378999999999999999999988654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
..++||||+++++|.+++..... ....+++..+..++.|++.||.|||+.||+||||||+||+++.
T Consensus 76 -------------~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~ 141 (267)
T cd08224 76 -------------ELNIVLELADAGDLSRMIKHFKK-QKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITA 141 (267)
T ss_pred -------------eEEEEEecCCCCCHHHHHHHhcc-cCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECC
Confidence 34999999999999999976432 2346899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.++|+|||.+........ ......+++.|+|||.+.+ ..++.++|||||||++|+|+
T Consensus 142 ~-------~~~~l~d~~~~~~~~~~~~----------~~~~~~~~~~y~apE~~~~----~~~~~~~Di~slG~il~~l~ 200 (267)
T cd08224 142 T-------GVVKLGDLGLGRFFSSKTT----------AAHSLVGTPYYMSPERIHE----NGYNFKSDIWSLGCLLYEMA 200 (267)
T ss_pred C-------CcEEEeccceeeeccCCCc----------ccceecCCccccCHHHhcc----CCCCchhcHHHHHHHHHHHH
Confidence 7 7899999999875432111 1112357889999999875 56788999999999999999
Q ss_pred hCCCCCCCCC--HHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1045 TLQVPYMGLS--ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1045 tG~~Pf~~~~--~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
+|+.||.... ..+..+.+..+..+..+. ...+..+.+++.+||..+|.+|||
T Consensus 201 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~i~~cl~~~p~~Rp~ 254 (267)
T cd08224 201 ALQSPFYGDKMNLYSLCKKIEKCDYPPLPA--------------------------DHYSEELRDLVSRCINPDPEKRPD 254 (267)
T ss_pred HCCCCcccCCccHHHHHhhhhcCCCCCCCh--------------------------hhcCHHHHHHHHHHcCCCcccCCC
Confidence 9999996533 222333333222221110 134556899999999999999999
Q ss_pred HHHHHHHHHhh
Q 001142 1123 AGDLYEMFVAR 1133 (1142)
Q Consensus 1123 a~EVL~~L~~~ 1133 (1142)
+.+|++.+...
T Consensus 255 ~~~il~~~~~~ 265 (267)
T cd08224 255 ISYVLQVAKEM 265 (267)
T ss_pred HHHHHHHHHHh
Confidence 99999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=319.05 Aligned_cols=262 Identities=22% Similarity=0.357 Sum_probs=201.1
Q ss_pred CCCcceeeeecccCceEEEEEEEC---------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccce
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG---------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 875 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~---------~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl 875 (1142)
.++|.+.+.||+|+||.||+|++. ...+++|+.... ......+.+ .+|+.+++.+ +||||+++
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~----~~E~~~l~~l~~h~~i~~~ 86 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD---ATEKDLSDL----VSEMEMMKMIGKHKNIINL 86 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc---cchHHHHHH----HHHHHHHHhhccCCCchhe
Confidence 456899999999999999999752 124666654311 112223334 7899999999 79999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc-----------CCCCCCHHHHHHHHHHHHHHHHH
Q 001142 876 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAALVE 944 (1142)
Q Consensus 876 ~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~-----------~~~~ls~~~i~~Ia~qIa~gL~y 944 (1142)
++++..... .++||||+++++|.+++...... ....+++..+..++.||+.||.|
T Consensus 87 ~~~~~~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~ 152 (304)
T cd05101 87 LGACTQDGP--------------LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEY 152 (304)
T ss_pred eEEEecCCc--------------eEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHH
Confidence 999876543 49999999999999999763211 12357888999999999999999
Q ss_pred HHhCCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCC
Q 001142 945 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 1024 (1142)
Q Consensus 945 LHs~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~ 1024 (1142)
||++||+||||||+||+++.+ +.+||+|||.++......... ......+++.|+|||++.+
T Consensus 153 LH~~givH~dlkp~Nili~~~-------~~~kl~D~g~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~---- 213 (304)
T cd05101 153 LASQKCIHRDLAARNVLVTEN-------NVMKIADFGLARDVNNIDYYK--------KTTNGRLPVKWMAPEALFD---- 213 (304)
T ss_pred HHHCCeeecccccceEEEcCC-------CcEEECCCccceecccccccc--------cccCCCCCceeeCchhhcc----
Confidence 999999999999999999876 789999999997654321110 0112235678999999865
Q ss_pred CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHH
Q 001142 1025 NLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLS 1103 (1142)
Q Consensus 1025 ~~~s~ksDVwSLGviL~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1103 (1142)
..++.++||||||+++|+|++ |..||.+.+..++...+........+ ...+.
T Consensus 214 ~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~ 266 (304)
T cd05101 214 RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKP---------------------------ANCTN 266 (304)
T ss_pred CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCC---------------------------CCCCH
Confidence 567899999999999999998 78899887777766665443322111 13456
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001142 1104 FLVDVFRRCTEENPTERPTAGDLYEMFVART 1134 (1142)
Q Consensus 1104 ~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~~ 1134 (1142)
.+.+++.+||+.+|.+|||+.|+++.+....
T Consensus 267 ~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~ 297 (304)
T cd05101 267 ELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297 (304)
T ss_pred HHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence 7899999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=321.30 Aligned_cols=284 Identities=19% Similarity=0.257 Sum_probs=188.4
Q ss_pred eeeecccCceEEEEEEECC----ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCC
Q 001142 812 CDEAGKSVSSSLFRCKFGS----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 887 (1142)
Q Consensus 812 ~~~LG~GsfG~Vy~a~~~~----~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~ 887 (1142)
..+||+|+||.||+|++.. ..+|+|.. +.... ... +.+|+.++++++||||+++++++.....
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~--~~~~~----~~~----~~~E~~~l~~l~h~niv~~~~~~~~~~~--- 72 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQI--EGTGI----SMS----ACREIALLRELKHPNVIALQKVFLSHSD--- 72 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEe--cCCCC----cHH----HHHHHHHHHhCCCCCeeeEEEEEeccCC---
Confidence 3689999999999999632 45666653 32111 112 2689999999999999999999864321
Q ss_pred CCCCCccccceEEEEEeccCCCCHHHHHHHHhc----cCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 888 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE----TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 888 ~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~----~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
...++||||++ ++|.+++..... .....+++..+..++.||+.||.|||++||+||||||+|||+.
T Consensus 73 ---------~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~ 142 (317)
T cd07867 73 ---------RKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVM 142 (317)
T ss_pred ---------CeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEc
Confidence 24699999996 688888754221 1123588999999999999999999999999999999999995
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+. ...+.+||+|||+++........ ........||+.|+|||++.+ ...++.++|||||||++|||
T Consensus 143 ~~~---~~~~~~kl~DfG~a~~~~~~~~~-------~~~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwSlG~il~el 209 (317)
T cd07867 143 GEG---PERGRVKIADMGFARLFNSPLKP-------LADLDPVVVTFWYRAPELLLG---ARHYTKAIDIWAIGCIFAEL 209 (317)
T ss_pred cCC---CCCCcEEEeeccceeccCCCccc-------ccccCcceecccccCcHHhcC---CCccCcHHHHHhHHHHHHHH
Confidence 331 12268999999999765432111 011223468999999999865 24578999999999999999
Q ss_pred HhCCCCCCCCCHH----------HHHHHHHhCCCCCchhHHhhhcccccccc-cc--cCCCCC-------CchhhhhhHH
Q 001142 1044 LTLQVPYMGLSEL----------EIHDLIQMGKRPRLTDELEALGSCHEHEV-AQ--SGSGFE-------KPEAELETLS 1103 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~----------el~~~I~~~~~p~l~~~l~~~~~~~~~~~-~~--~~~~~~-------~~~~~~~~~~ 1103 (1142)
+||++||...... +....+.....+. ...+........... .. ...... ..........
T Consensus 210 ~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (317)
T cd07867 210 LTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPA-DKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDS 288 (317)
T ss_pred HhCCCCcccccccccccccccHHHHHHHHHhcCCCC-hhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCCh
Confidence 9999999743211 1111111111111 001110000000000 00 000000 0000112345
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 001142 1104 FLVDVFRRCTEENPTERPTAGDLYEMFVA 1132 (1142)
Q Consensus 1104 ~L~dLI~~CL~~DP~~RPSa~EVL~~L~~ 1132 (1142)
.+.+|+.+||+.||.+|||+.|+++|+|+
T Consensus 289 ~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 289 KVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 68899999999999999999999999996
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=320.44 Aligned_cols=262 Identities=23% Similarity=0.367 Sum_probs=201.2
Q ss_pred CCCcceeeeecccCceEEEEEEEC---------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccce
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG---------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 875 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~---------~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl 875 (1142)
.++|.+.++||+|+||.||+|++. ...+|+|+.. .. ........+ .+|+.+++++ +||||+++
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~--~~-~~~~~~~~~----~~E~~~l~~l~~h~~iv~~ 83 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLK--DN-ATDKDLADL----ISEMELMKLIGKHKNIINL 83 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecC--CC-CChHHHHHH----HHHHHHHHhccCCCCeeeE
Confidence 457899999999999999999752 2346777643 21 122333334 7899999999 59999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc-----------cCCCCCCHHHHHHHHHHHHHHHHH
Q 001142 876 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAALVE 944 (1142)
Q Consensus 876 ~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~-----------~~~~~ls~~~i~~Ia~qIa~gL~y 944 (1142)
++++..... .++||||+++++|.+++..... .....+++..+..++.||+.||.|
T Consensus 84 ~~~~~~~~~--------------~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~ 149 (314)
T cd05099 84 LGVCTQEGP--------------LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEY 149 (314)
T ss_pred EEEEccCCc--------------eEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHH
Confidence 999876543 4999999999999999976321 112458999999999999999999
Q ss_pred HHhCCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCC
Q 001142 945 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 1024 (1142)
Q Consensus 945 LHs~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~ 1024 (1142)
||++||+||||||+|||++.+ +.+||+|||.++......... ......++..|+|||++.+
T Consensus 150 lH~~gi~H~dlkp~Nill~~~-------~~~kL~Dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~---- 210 (314)
T cd05099 150 LESRRCIHRDLAARNVLVTED-------NVMKIADFGLARGVHDIDYYK--------KTSNGRLPVKWMAPEALFD---- 210 (314)
T ss_pred HHHCCeeeccccceeEEEcCC-------CcEEEcccccccccccccccc--------ccccCCCCccccCHHHHcc----
Confidence 999999999999999999877 789999999997653321100 0111124567999999865
Q ss_pred CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHH
Q 001142 1025 NLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLS 1103 (1142)
Q Consensus 1025 ~~~s~ksDVwSLGviL~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1103 (1142)
..++.++|||||||++|+|++ |..||.+....+....+..+..+..+ ...+.
T Consensus 211 ~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~ 263 (314)
T cd05099 211 RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHRMDKP---------------------------SNCTH 263 (314)
T ss_pred CCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------CCCCH
Confidence 567899999999999999999 89999887776666665443321111 13455
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001142 1104 FLVDVFRRCTEENPTERPTAGDLYEMFVART 1134 (1142)
Q Consensus 1104 ~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~~ 1134 (1142)
.+.+++.+||+.||++|||+.++++.+....
T Consensus 264 ~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 264 ELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 6899999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=317.57 Aligned_cols=254 Identities=26% Similarity=0.365 Sum_probs=203.4
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
++|++.+.||+|+||.||++.+. +..+|+|+...... ...... ..+.+|++++++++||||+++++++.+..
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 74 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKI-VKLKQV----EHVLNEKRILQSIRHPFLVNLYGSFQDDS- 74 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHh-hhhhHH----HHHHHHHHHHHhCCCCCccceeeEEEcCC-
Confidence 36899999999999999999984 56788887542211 011112 23478999999999999999999987654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+|+||+|.||+++.
T Consensus 75 -------------~~~~v~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~ 136 (290)
T cd05580 75 -------------NLYLVMEYVPGGELFSHLRK-----SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDS 136 (290)
T ss_pred -------------eEEEEEecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECC
Confidence 34999999999999999976 246899999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||+|||++...... .....+++.|+|||.+.+ ..++.++||||||+++|+|+
T Consensus 137 ~-------~~~kl~dfg~~~~~~~~-------------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~l~ 192 (290)
T cd05580 137 D-------GYIKITDFGFAKRVKGR-------------TYTLCGTPEYLAPEIILS----KGYGKAVDWWALGILIYEML 192 (290)
T ss_pred C-------CCEEEeeCCCccccCCC-------------CCCCCCCccccChhhhcC----CCCCccccHHHHHHHHHHHH
Confidence 7 78999999998754321 113358899999999865 45678999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC---
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP--- 1121 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP--- 1121 (1142)
+|+.||......+....+..+.. .++. ..+..+.+++.+||..||.+||
T Consensus 193 ~g~~p~~~~~~~~~~~~~~~~~~-~~~~---------------------------~~~~~l~~li~~~l~~~p~~R~~~~ 244 (290)
T cd05580 193 AGYPPFFDDNPIQIYEKILEGKV-RFPS---------------------------FFSPDAKDLIRNLLQVDLTKRLGNL 244 (290)
T ss_pred hCCCCCCCCCHHHHHHHHhcCCc-cCCc---------------------------cCCHHHHHHHHHHccCCHHHccCcc
Confidence 99999987665555554443221 1110 2345689999999999999999
Q ss_pred --CHHHHHHHHHhhcCC
Q 001142 1122 --TAGDLYEMFVARTSS 1136 (1142)
Q Consensus 1122 --Sa~EVL~~L~~~~ss 1136 (1142)
+++|+++|+|+....
T Consensus 245 ~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 245 KNGVNDIKNHPWFAGID 261 (290)
T ss_pred cCCHHHHHcCcccccCC
Confidence 999999999987654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=310.79 Aligned_cols=257 Identities=22% Similarity=0.359 Sum_probs=197.7
Q ss_pred CCCcceeeeecccCceEEEEEEEC---Cc--cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG---SA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 880 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~---~~--~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~ 880 (1142)
..+|++.+.||+|+||.||+|.+. +. .+++|. ++... .....+.+ .+|+.++++++||||+++++++.
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~--~~~~~-~~~~~~~~----~~e~~~l~~l~h~~i~~~~~~~~ 75 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKT--LKAGY-TEKQRRDF----LSEASIMGQFDHPNIIHLEGVVT 75 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEE--CCCCC-CHHHHHHH----HHHHHHHHhCCCCCcceEEEEEe
Confidence 357899999999999999999873 22 355554 43321 22333344 78999999999999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NI 960 (1142)
..+. .++||||+++++|.+++... ...+++..+..++.|++.||.|||++|++||||||+||
T Consensus 76 ~~~~--------------~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~ni 137 (267)
T cd05066 76 KSKP--------------VMIVTEYMENGSLDAFLRKH----DGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNI 137 (267)
T ss_pred cCCc--------------cEEEEEcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcE
Confidence 6553 39999999999999999751 24689999999999999999999999999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
|++.+ +.++|+|||.+.......... .......++..|+|||.+.+ ..++.++||||||+++
T Consensus 138 li~~~-------~~~~l~dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~~pe~~~~----~~~~~~~Dv~slG~~l 199 (267)
T cd05066 138 LVNSN-------LVCKVSDFGLSRVLEDDPEAA-------YTTRGGKIPIRWTAPEAIAY----RKFTSASDVWSYGIVM 199 (267)
T ss_pred EECCC-------CeEEeCCCCccccccccccee-------eecCCCccceeecCHhHhcc----CccCchhhhHHHHHHH
Confidence 99877 789999999997654321110 00011223567999999875 4678999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001142 1041 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1119 (1142)
Q Consensus 1041 ~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~ 1119 (1142)
|++++ |..||......+....+..+..+..+ ...++.+.+++.+||+.+|.+
T Consensus 200 ~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~ 252 (267)
T cd05066 200 WEVMSYGERPYWEMSNQDVIKAIEEGYRLPAP---------------------------MDCPAALHQLMLDCWQKDRNE 252 (267)
T ss_pred HHHhcCCCCCcccCCHHHHHHHHhCCCcCCCC---------------------------CCCCHHHHHHHHHHcccCchh
Confidence 99887 99999876666655555443221110 134567899999999999999
Q ss_pred CCCHHHHHHHHHh
Q 001142 1120 RPTAGDLYEMFVA 1132 (1142)
Q Consensus 1120 RPSa~EVL~~L~~ 1132 (1142)
||++.++++.+..
T Consensus 253 Rp~~~~i~~~l~~ 265 (267)
T cd05066 253 RPKFEQIVSILDK 265 (267)
T ss_pred CCCHHHHHHHHHh
Confidence 9999999987653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=316.51 Aligned_cols=260 Identities=25% Similarity=0.359 Sum_probs=201.0
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
++|++.+.||+|+||.||+|.+. +..+|+|..+.+. .......+ .+|+.++++++||||+++++.+...+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~----~~e~~~l~~~~~~~i~~~~~~~~~~~- 72 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL---DESKFNQI----IMELDILHKAVSPYIVDFYGAFFIEG- 72 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc---CHHHHHHH----HHHHHHHHhcCCCcHHhhhhheecCC-
Confidence 46899999999999999999985 6677777654321 22222333 78999999999999999999887654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeeec
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILID 963 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs-~gIvHrDLKp~NILld 963 (1142)
..++||||+++++|..++... .....+++..+..++.||+.||.|||+ .||+||||||+||+++
T Consensus 73 -------------~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~ 137 (286)
T cd06622 73 -------------AVYMCMEYMDAGSLDKLYAGG--VATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVN 137 (286)
T ss_pred -------------eEEEEEeecCCCCHHHHHHhc--cccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEEC
Confidence 349999999999999988752 112368999999999999999999997 5999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhcccc--CCCCCCchhhHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH--KPNLYGLEVDIWSYGCLLL 1041 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~--~~~~~s~ksDVwSLGviL~ 1041 (1142)
.+ +.++|+|||.+..+.... .....+++.|+|||.+.+.. ....++.++|||||||++|
T Consensus 138 ~~-------~~~~l~dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~ 198 (286)
T cd06622 138 GN-------GQVKLCDFGVSGNLVASL------------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSIL 198 (286)
T ss_pred CC-------CCEEEeecCCcccccCCc------------cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHH
Confidence 86 789999999986543211 11235788999999986522 1234678999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHH---HhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001142 1042 ELLTLQVPYMGLSELEIHDLI---QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1118 (1142)
Q Consensus 1042 ELLtG~~Pf~~~~~~el~~~I---~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~ 1118 (1142)
+|++|+.||...........+ ..+..+..+ ...++.+.+++.+||+.+|.
T Consensus 199 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~ 251 (286)
T cd06622 199 EMALGRYPYPPETYANIFAQLSAIVDGDPPTLP---------------------------SGYSDDAQDFVAKCLNKIPN 251 (286)
T ss_pred HHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCC---------------------------cccCHHHHHHHHHHcccCcc
Confidence 999999999765443333322 222211111 13556789999999999999
Q ss_pred CCCCHHHHHHHHHhhcC
Q 001142 1119 ERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1119 ~RPSa~EVL~~L~~~~s 1135 (1142)
+||++.+++.|+|+...
T Consensus 252 ~Rp~~~~l~~~~~~~~~ 268 (286)
T cd06622 252 RRPTYAQLLEHPWLVKY 268 (286)
T ss_pred cCCCHHHHhcChhhhhc
Confidence 99999999999998654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=324.89 Aligned_cols=285 Identities=17% Similarity=0.203 Sum_probs=203.3
Q ss_pred CCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
..+|++.+.||+|+||.||+|.. .+..+|+|+.. ...........+ .+|+.++++++||||+++++++....
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~--~~~~~~~~~~~~----~~E~~~l~~l~h~~iv~~~~~~~~~~ 88 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLS--RPFQNVTHAKRA----YRELVLMKLVNHKNIIGLLNVFTPQK 88 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecC--ccccChhHHHHH----HHHHHHHHhcCCCCCcceeeeeccCC
Confidence 46799999999999999999997 45667777643 222222222333 68999999999999999999987543
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
.. ......|+||||+. ++|.+.+.. .++...+..++.|++.||+|||++||+||||||+||+++
T Consensus 89 ~~--------~~~~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~ 152 (353)
T cd07850 89 SL--------EEFQDVYLVMELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 152 (353)
T ss_pred Cc--------cccCcEEEEEeccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC
Confidence 22 12235699999996 688888764 288999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.+||+|||.+....... ......+++.|+|||++.+ ..++.++|||||||++|+|
T Consensus 153 ~~-------~~~kL~Dfg~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~~l~~l 210 (353)
T cd07850 153 SD-------CTLKILDFGLARTAGTSF-----------MMTPYVVTRYYRAPEVILG----MGYKENVDIWSVGCIMGEM 210 (353)
T ss_pred CC-------CCEEEccCccceeCCCCC-----------CCCCCcccccccCHHHHhC----CCCCCchhhHhHHHHHHHH
Confidence 87 789999999997543311 1123357889999999876 5688999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccc-----------cccccccCCCCC----CchhhhhhHHHHHHH
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH-----------EHEVAQSGSGFE----KPEAELETLSFLVDV 1108 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~-----------~~~~~~~~~~~~----~~~~~~~~~~~L~dL 1108 (1142)
++|+.||...+.......+................... ...+.+...... ........++.+.++
T Consensus 211 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 290 (353)
T cd07850 211 IRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDL 290 (353)
T ss_pred HHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHH
Confidence 99999998766555444442211111111111000000 000000000000 000011346678999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhhc
Q 001142 1109 FRRCTEENPTERPTAGDLYEMFVART 1134 (1142)
Q Consensus 1109 I~~CL~~DP~~RPSa~EVL~~L~~~~ 1134 (1142)
+.+||+.||++|||+.|+++|+|++.
T Consensus 291 i~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 291 LSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred HHHHcCCChhhCcCHHHHhcChhHhh
Confidence 99999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=310.67 Aligned_cols=251 Identities=24% Similarity=0.415 Sum_probs=197.6
Q ss_pred CCcceeeeecccCceEEEEEEE-CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~-~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
++|++.++||+|+||.||+|.. .+..+|+|..... ... .+.+ .+|+.++++++||||+++++++.. +
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~--~~~---~~~~----~~E~~~l~~l~h~~i~~~~~~~~~-~-- 73 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQG--SMS---PEAF----LAEANLMKQLQHPRLVRLYAVVTQ-E-- 73 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCceEEEEEecCC--CCc---HHHH----HHHHHHHHhcCCcCeeeEEEEEcc-C--
Confidence 4689999999999999999987 4567888865422 111 2234 789999999999999999988643 2
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
..++||||+++++|.+++.. .....+++..+..++.|++.||+|||+.|++||||||+||+++.+
T Consensus 74 ------------~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~ 138 (260)
T cd05067 74 ------------PIYIITEYMENGSLVDFLKT---PEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSET 138 (260)
T ss_pred ------------CcEEEEEcCCCCCHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCC
Confidence 24999999999999999865 233568999999999999999999999999999999999999887
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+.++|+|||.+......... ......++..|+|||++.. ..++.++||||||+++|||++
T Consensus 139 -------~~~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~~pe~~~~----~~~~~~~Di~slG~~l~el~~ 198 (260)
T cd05067 139 -------LCCKIADFGLARLIEDNEYT---------AREGAKFPIKWTAPEAINY----GTFTIKSDVWSFGILLTEIVT 198 (260)
T ss_pred -------CCEEEccCcceeecCCCCcc---------cccCCcccccccCHHHhcc----CCcCcccchHHHHHHHHHHHh
Confidence 78999999998765421110 1112345678999999865 457889999999999999999
Q ss_pred -CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001142 1046 -LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124 (1142)
Q Consensus 1046 -G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~ 1124 (1142)
|+.||.+.+..+....+..+..+..+ ...+..+.+++.+||..+|++|||++
T Consensus 199 ~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~ 251 (260)
T cd05067 199 YGRIPYPGMTNPEVIQNLERGYRMPRP---------------------------DNCPEELYELMRLCWKEKPEERPTFE 251 (260)
T ss_pred CCCCCCCCCChHHHHHHHHcCCCCCCC---------------------------CCCCHHHHHHHHHHccCChhhCCCHH
Confidence 99999877766665555433222111 13345699999999999999999999
Q ss_pred HHHHHHH
Q 001142 1125 DLYEMFV 1131 (1142)
Q Consensus 1125 EVL~~L~ 1131 (1142)
+++..+.
T Consensus 252 ~l~~~l~ 258 (260)
T cd05067 252 YLRSVLE 258 (260)
T ss_pred HHHHHhh
Confidence 9998764
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=306.96 Aligned_cols=251 Identities=27% Similarity=0.439 Sum_probs=198.2
Q ss_pred eeecccCceEEEEEEEC-----CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCC
Q 001142 813 DEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 887 (1142)
Q Consensus 813 ~~LG~GsfG~Vy~a~~~-----~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~ 887 (1142)
+.||+|+||.||+|.+. +..+++|+.... ... ...+.+ .+|+.++..++|+||+++++++.+...
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~--~~~-~~~~~~----~~e~~~l~~~~~~~i~~~~~~~~~~~~--- 70 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKED--ASE-EERKDF----LKEARVMKKLGHPNVVRLLGVCTEEEP--- 70 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccc--cch-hHHHHH----HHHHHHHhhcCCCChheeeeeecCCCc---
Confidence 47999999999999985 556777765422 111 123344 789999999999999999999886443
Q ss_pred CCCCCccccceEEEEEeccCCCCHHHHHHHHhcc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 888 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET----GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 888 ~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~----~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
.++||||+++++|.+++...... ....+++..+..++.|++.||+|||++||+||||||+||+++
T Consensus 71 -----------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~ 139 (262)
T cd00192 71 -----------LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVG 139 (262)
T ss_pred -----------eEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEEC
Confidence 49999999999999999862110 025689999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.++|+|||.+......... .......+++.|+|||.+.. ..++.++||||||+++|+|
T Consensus 140 ~~-------~~~~l~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~l 200 (262)
T cd00192 140 ED-------LVVKISDFGLSRDVYDDDYY--------RKKTGGKLPIRWMAPESLKD----GIFTSKSDVWSFGVLLWEI 200 (262)
T ss_pred CC-------CcEEEccccccccccccccc--------ccccCCCcCccccCHHHhcc----CCcchhhccHHHHHHHHHH
Confidence 87 78999999999765432210 11123457889999999876 4678999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1044 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1044 Lt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
++ |..||......+....+..+.....+ ...+..+.+++.+||+.||.+|||
T Consensus 201 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rps 253 (262)
T cd00192 201 FTLGATPYPGLSNEEVLEYLRKGYRLPKP---------------------------EYCPDELYELMLSCWQLDPEDRPT 253 (262)
T ss_pred HhcCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------ccCChHHHHHHHHHccCCcccCcC
Confidence 99 69999887776666665543222111 134567999999999999999999
Q ss_pred HHHHHHHH
Q 001142 1123 AGDLYEMF 1130 (1142)
Q Consensus 1123 a~EVL~~L 1130 (1142)
+.|+++++
T Consensus 254 ~~~l~~~l 261 (262)
T cd00192 254 FSELVERL 261 (262)
T ss_pred HHHHHHhh
Confidence 99999876
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=313.39 Aligned_cols=266 Identities=27% Similarity=0.381 Sum_probs=199.9
Q ss_pred CcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
+|+..+.||+|++|.||+|.. .+..+++|+........ .........+.+|+.++++++||||+++++++.+.+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 76 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTS--SEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDS-- 76 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCc--hhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCC--
Confidence 478889999999999999986 56778888765332211 111222344589999999999999999999987654
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
+.++||||+++++|.+++.+ ..++++..+..++.||+.||.|||++|++|+||||+||+++.+
T Consensus 77 ------------~~~~v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~ 139 (268)
T cd06630 77 ------------HFNLFVEWMAGGSVSHLLSK-----YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDST 139 (268)
T ss_pred ------------eEEEEEeccCCCcHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence 34999999999999999975 2468999999999999999999999999999999999999765
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+ ..++|+|||.+......... .........++..|+|||.+.+ ..++.++||||+|+++++|++
T Consensus 140 ~------~~~~l~dfg~~~~~~~~~~~------~~~~~~~~~~~~~~~~PE~~~~----~~~~~~~Dv~slG~~l~~l~~ 203 (268)
T cd06630 140 G------QRLRIADFGAAARLAAKGTG------AGEFQGQLLGTIAFMAPEVLRG----EQYGRSCDVWSVGCVIIEMAT 203 (268)
T ss_pred C------CEEEEccccccccccccccc------CCccccccccccceeCHhHhcc----CCCCcccchHHHHHHHHHHHh
Confidence 2 46999999998765432111 0011223458899999999865 457899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001142 1046 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1125 (1142)
Q Consensus 1046 G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~E 1125 (1142)
|..||...........+...... ...+......++.+.+++.+||..+|.+||++.+
T Consensus 204 g~~p~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ 260 (268)
T cd06630 204 AKPPWNAEKHSNHLALIFKIASA-----------------------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRE 260 (268)
T ss_pred CCCCCCCCCCcchHHHHHHHhcc-----------------------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHH
Confidence 99999754322211111110000 0000111145567999999999999999999999
Q ss_pred HHHHHHhh
Q 001142 1126 LYEMFVAR 1133 (1142)
Q Consensus 1126 VL~~L~~~ 1133 (1142)
+++|+|++
T Consensus 261 ll~~~~~~ 268 (268)
T cd06630 261 LLKHPVFR 268 (268)
T ss_pred HhcCcccC
Confidence 99999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=314.16 Aligned_cols=259 Identities=24% Similarity=0.378 Sum_probs=198.7
Q ss_pred CCCcceeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeee
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 878 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~-------~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~ 878 (1142)
..+|++.+.||+|+||.||+|.+. ...+|+|+.... ........+ .+|+.+++++.||||++++++
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~----~~ei~~l~~l~h~~iv~~~~~ 76 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE---ASADMQADF----QREAALMAEFDHPNIVKLLGV 76 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCC---cCHHHHHHH----HHHHHHHHhcCCCchheEEEE
Confidence 457899999999999999999863 356677764321 122223334 789999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc-----------------cCCCCCCHHHHHHHHHHHHHH
Q 001142 879 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------------TGEKHVSVKLALFIAQDVAAA 941 (1142)
Q Consensus 879 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~-----------------~~~~~ls~~~i~~Ia~qIa~g 941 (1142)
+.+... .++||||+++++|.+++..... .....+++..+..++.||+.|
T Consensus 77 ~~~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~a 142 (288)
T cd05050 77 CAVGKP--------------MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAG 142 (288)
T ss_pred EcCCCc--------------cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHH
Confidence 876543 3999999999999999975311 112357888999999999999
Q ss_pred HHHHHhCCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccc
Q 001142 942 LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 1021 (1142)
Q Consensus 942 L~yLHs~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~ 1021 (1142)
|.|||+++++||||||+||+++.+ +.++|+|||.+......... .......+++.|+|||.+.+
T Consensus 143 L~~lH~~~i~H~dl~p~nil~~~~-------~~~~l~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~- 206 (288)
T cd05050 143 MAYLSERKFVHRDLATRNCLVGEN-------MVVKIADFGLSRNIYSADYY--------KASENDAIPIRWMPPESIFY- 206 (288)
T ss_pred HHHHHhCCeecccccHhheEecCC-------CceEECccccceecccCccc--------cccCCCccChhhcCHHHHhc-
Confidence 999999999999999999999877 78999999998654321110 01112234667999999875
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhh
Q 001142 1022 HKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELE 1100 (1142)
Q Consensus 1022 ~~~~~~s~ksDVwSLGviL~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 1100 (1142)
..++.++|||||||++|||++ |..||.+....+....+..+.....+ ..
T Consensus 207 ---~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~ 256 (288)
T cd05050 207 ---NRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVLSCP---------------------------DN 256 (288)
T ss_pred ---CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCC---------------------------CC
Confidence 568899999999999999997 88899877766665555443322111 03
Q ss_pred hHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 001142 1101 TLSFLVDVFRRCTEENPTERPTAGDLYEMFV 1131 (1142)
Q Consensus 1101 ~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~ 1131 (1142)
.+..+.+++.+||+.||.+|||+.|+++.|.
T Consensus 257 ~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 257 CPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 4566999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=308.98 Aligned_cols=248 Identities=21% Similarity=0.330 Sum_probs=190.8
Q ss_pred eecccCceEEEEEEEC--C--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCC
Q 001142 814 EAGKSVSSSLFRCKFG--S--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSAD 889 (1142)
Q Consensus 814 ~LG~GsfG~Vy~a~~~--~--~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~~~ 889 (1142)
.||+|+||.||+|.+. + ..+|+|+.... . .....+. +.+|+.++++++||||+++++++...
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~--~-~~~~~~~----~~~E~~~l~~l~h~~ii~~~~~~~~~------- 67 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE--N-EKSVRDE----MMREAEIMHQLDNPYIVRMIGVCEAE------- 67 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccc--c-ChHHHHH----HHHHHHHHHhcCCCCeEEEEEEEcCC-------
Confidence 4899999999999873 2 34666664322 1 1222233 47999999999999999999987532
Q ss_pred CCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccC
Q 001142 890 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 969 (1142)
Q Consensus 890 ~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~ 969 (1142)
..++||||+++++|.+++.. ....+++..+.+++.||+.||.|||++|++||||||+|||++.+
T Consensus 68 --------~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~---- 131 (257)
T cd05115 68 --------ALMLVMEMASGGPLNKFLSG----KKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQ---- 131 (257)
T ss_pred --------CeEEEEEeCCCCCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCC----
Confidence 24899999999999999864 13468999999999999999999999999999999999999877
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-CCC
Q 001142 970 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQV 1048 (1142)
Q Consensus 970 ~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt-G~~ 1048 (1142)
+.+||+|||.+.......... .......++..|+|||++.. ..++.++|||||||++|+|++ |..
T Consensus 132 ---~~~kl~dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~el~~~g~~ 197 (257)
T cd05115 132 ---HYAKISDFGLSKALGADDSYY-------KARSAGKWPLKWYAPECINF----RKFSSRSDVWSYGITMWEAFSYGQK 197 (257)
T ss_pred ---CcEEeccCCccccccCCccce-------eccCCCCCCcccCCHHHHcc----CCCCchhhHHHHHHHHHHHhcCCCC
Confidence 789999999987543321110 00111224578999999865 457889999999999999996 999
Q ss_pred CCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001142 1049 PYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1128 (1142)
Q Consensus 1049 Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~ 1128 (1142)
||.+....+....+..+..+..+ ...++++.+++.+||..||++||++.+|.+
T Consensus 198 p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 198 PYKKMKGPEVMSFIEQGKRLDCP---------------------------AECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred CcCcCCHHHHHHHHHCCCCCCCC---------------------------CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99887776666665554432211 134567999999999999999999999998
Q ss_pred HHHh
Q 001142 1129 MFVA 1132 (1142)
Q Consensus 1129 ~L~~ 1132 (1142)
.+..
T Consensus 251 ~l~~ 254 (257)
T cd05115 251 RMRT 254 (257)
T ss_pred HHhh
Confidence 7753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=315.26 Aligned_cols=267 Identities=25% Similarity=0.350 Sum_probs=202.0
Q ss_pred CCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISS 882 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~~~~ 882 (1142)
.++|++.+.||+|+||.||+|.. .+..+++|+.... ...... +.+|+.++.++ +||||+++++++...
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~-----~~~~~~----~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-----SDVDEE----IEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc-----ccHHHH----HHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 56799999999999999999997 4566777775321 111122 36899999999 799999999998754
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
+.. .....++||||+++++|.++++..... ...+++..+..++.|++.||+|||++||+||||||+||++
T Consensus 92 ~~~---------~~~~~~lv~ey~~~~sL~~~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili 161 (291)
T cd06639 92 DKL---------VGGQLWLVLELCNGGSVTELVKGLLIC-GQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILL 161 (291)
T ss_pred ccc---------CCCeeEEEEEECCCCcHHHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE
Confidence 321 122469999999999999998753222 3468999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhcccc-CCCCCCchhhHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLL 1041 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~s~ksDVwSLGviL~ 1041 (1142)
+.+ +.+||+|||.+........ ......|+..|+|||.+.... ....++.++|||||||++|
T Consensus 162 ~~~-------~~~kl~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~ 224 (291)
T cd06639 162 TTE-------GGVKLVDFGVSAQLTSTRL----------RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAI 224 (291)
T ss_pred cCC-------CCEEEeecccchhcccccc----------cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHH
Confidence 877 6799999999875433111 112335888999999976421 1123678999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1042 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1042 ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
+|++|+.||...........+.....+.... + ......+.+++.+||+.+|++||
T Consensus 225 el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----------------------~---~~~~~~l~~li~~~l~~~p~~Rp 279 (291)
T cd06639 225 ELGDGDPPLFDMHPVKTLFKIPRNPPPTLLH----------------------P---EKWCRSFNHFISQCLIKDFEARP 279 (291)
T ss_pred HHhhCCCCCCCCcHHHHHHHHhcCCCCCCCc----------------------c---cccCHHHHHHHHHHhhcChhhCc
Confidence 9999999998765544433333322211110 0 12345689999999999999999
Q ss_pred CHHHHHHHHHhh
Q 001142 1122 TAGDLYEMFVAR 1133 (1142)
Q Consensus 1122 Sa~EVL~~L~~~ 1133 (1142)
++.|+++|+|++
T Consensus 280 s~~~il~~~~~~ 291 (291)
T cd06639 280 SVTHLLEHPFIK 291 (291)
T ss_pred CHHHHhcCcccC
Confidence 999999999974
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=316.17 Aligned_cols=278 Identities=20% Similarity=0.266 Sum_probs=198.4
Q ss_pred CcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
+|++.+.||.|++|.||+|++ .+..+++|....+.. ....... +.+|++++++++||||+++++++.+.+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~----~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 72 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE--TEGVPST----AIREISLLKELNHPNIVKLLDVIHTEN-- 72 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc--ccccchH----HHHHHHHHHhcCCCCCcchhhhcccCC--
Confidence 488999999999999999988 456677776543321 1111122 378999999999999999999987654
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
..++||||+. ++|.+++.. .....+++..+..++.||+.||+|||++|++||||+|+||+++.+
T Consensus 73 ------------~~~~v~e~~~-~~l~~~~~~---~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~ 136 (284)
T cd07860 73 ------------KLYLVFEFLH-QDLKKFMDA---SPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE 136 (284)
T ss_pred ------------cEEEEeeccc-cCHHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC
Confidence 3499999996 689988865 233568999999999999999999999999999999999999887
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+.+||+|||.+........ ......+++.|+|||++.+ ...++.++||||||+++|+|+|
T Consensus 137 -------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~il~~l~t 196 (284)
T cd07860 137 -------GAIKLADFGLARAFGVPVR----------TYTHEVVTLWYRAPEILLG---CKYYSTAVDIWSLGCIFAEMVT 196 (284)
T ss_pred -------CCEEEeeccchhhcccCcc----------ccccccccccccCCeEEec---CCCCCcHHHHHHHHHHHHHHHH
Confidence 7899999999865432111 1112346888999998765 2346789999999999999999
Q ss_pred CCCCCCCCCHHHHHHHH-HhCCCCCchhHHhh---hcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1046 LQVPYMGLSELEIHDLI-QMGKRPRLTDELEA---LGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1046 G~~Pf~~~~~~el~~~I-~~~~~p~l~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
|+.||.+.+.......+ .....+. ...+.. ..... ..+.... ...........+..+.++|.+||+.||.+||
T Consensus 197 g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 273 (284)
T cd07860 197 RRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSLPDYK-PSFPKWA-RQDFSKVVPPLDEDGRDLLSQMLHYDPNKRI 273 (284)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCC-hhhhhhhhHHHHHH-hhccccc-ccCHHHHcccCCHHHHHHHHHhcCCCcccCC
Confidence 99999876654433332 2222221 110000 00000 0000000 0000000113456789999999999999999
Q ss_pred CHHHHHHHHHh
Q 001142 1122 TAGDLYEMFVA 1132 (1142)
Q Consensus 1122 Sa~EVL~~L~~ 1132 (1142)
|+.++++|+||
T Consensus 274 t~~~~l~~~~f 284 (284)
T cd07860 274 SAKAALAHPFF 284 (284)
T ss_pred CHHHHhcCCCC
Confidence 99999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=316.67 Aligned_cols=281 Identities=23% Similarity=0.288 Sum_probs=199.2
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
++|++.++||+|+||.||+|.+. +..+|+|+.... .......+. +.+|+++++.++||||+++++++....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~--~~~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~- 73 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLES--EDDKMVKKI----AMREIRMLKQLRHENLVNLIEVFRRKK- 73 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhc--cCcchhhHH----HHHHHHHHHhcCCcchhhHHHhcccCC-
Confidence 36899999999999999999984 567777764322 111112223 368999999999999999999987654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
..++||||+++++|..+... ...+++..+..++.||+.||.|||++||+|+||+|+||+++.
T Consensus 74 -------------~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~ 135 (286)
T cd07846 74 -------------RLYLVFEFVDHTVLDDLEKY-----PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQ 135 (286)
T ss_pred -------------eEEEEEecCCccHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC
Confidence 34999999998888877653 235899999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.++|+|||++........ ......++..|+|||++.+ ...++.++||||||+++|||+
T Consensus 136 ~-------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~~l~el~ 195 (286)
T cd07846 136 S-------GVVKLCDFGFARTLAAPGE----------VYTDYVATRWYRAPELLVG---DTKYGRAVDIWAVGCLVTEML 195 (286)
T ss_pred C-------CcEEEEeeeeeeeccCCcc----------ccCcccceeeccCcHHhcc---ccccCchHhHHHHHHHHHHHH
Confidence 7 7899999999875433211 1123457889999999864 234678999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccc---ccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC---HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
+|+.||......+....+.................. .....................+..+.+++.+||+.+|++||
T Consensus 196 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 275 (286)
T cd07846 196 TGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRP 275 (286)
T ss_pred cCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccch
Confidence 999999866554433333211111000000000000 00000000000000000114567799999999999999999
Q ss_pred CHHHHHHHHHh
Q 001142 1122 TAGDLYEMFVA 1132 (1142)
Q Consensus 1122 Sa~EVL~~L~~ 1132 (1142)
++.++++|+|+
T Consensus 276 ~~~~il~~~~~ 286 (286)
T cd07846 276 SSSQLLHHEFF 286 (286)
T ss_pred hHHHHhcCCCC
Confidence 99999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=308.75 Aligned_cols=251 Identities=24% Similarity=0.360 Sum_probs=195.4
Q ss_pred CCcceeeeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~~-~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
++|.+.+.||+|++|.||+|.+.+ ..+++|... ... ...+. +.+|+.++++++|||++++++++.. +
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~--~~~---~~~~~----~~~E~~~l~~l~h~~i~~~~~~~~~-~-- 73 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLK--PGT---MMPEA----FLQEAQIMKKLRHDKLVPLYAVVSE-E-- 73 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcc--cCC---ccHHH----HHHHHHHHHhCCCCCeeeEEEEEcC-C--
Confidence 468999999999999999998854 356666532 211 11123 3789999999999999999988743 2
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
..++||||+++++|.++++. .....+++..+..++.|++.||.|||+.||+|+||||+||+++.+
T Consensus 74 ------------~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~ 138 (260)
T cd05069 74 ------------PIYIVTEFMGKGSLLDFLKE---GDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDN 138 (260)
T ss_pred ------------CcEEEEEcCCCCCHHHHHhh---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCC
Confidence 23899999999999999975 223458899999999999999999999999999999999999887
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+.++|+|||.+......... ......++..|+|||...+ ..++.++||||||+++|+|++
T Consensus 139 -------~~~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~~Pe~~~~----~~~~~~~Di~slG~~l~el~t 198 (260)
T cd05069 139 -------LVCKIADFGLARLIEDNEYT---------ARQGAKFPIKWTAPEAALY----GRFTIKSDVWSFGILLTELVT 198 (260)
T ss_pred -------CeEEECCCccceEccCCccc---------ccCCCccchhhCCHHHhcc----CCcChHHHHHHHHHHHHHHHh
Confidence 78999999999754321111 1112245678999998865 457899999999999999999
Q ss_pred -CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001142 1046 -LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124 (1142)
Q Consensus 1046 -G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~ 1124 (1142)
|..||.+....+....+.....+..+ ...+..+.+++.+||+.||.+||+++
T Consensus 199 ~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~ 251 (260)
T cd05069 199 KGRVPYPGMVNREVLEQVERGYRMPCP---------------------------QGCPESLHELMKLCWKKDPDERPTFE 251 (260)
T ss_pred CCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------cccCHHHHHHHHHHccCCcccCcCHH
Confidence 99999877666655555433221111 13456799999999999999999999
Q ss_pred HHHHHHH
Q 001142 1125 DLYEMFV 1131 (1142)
Q Consensus 1125 EVL~~L~ 1131 (1142)
++++.+.
T Consensus 252 ~i~~~l~ 258 (260)
T cd05069 252 YIQSFLE 258 (260)
T ss_pred HHHHHHh
Confidence 9998765
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=313.28 Aligned_cols=258 Identities=24% Similarity=0.363 Sum_probs=197.7
Q ss_pred CCCcceeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeee
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 878 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~-------~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~ 878 (1142)
+.+|.+.++||+|+||.||++... +..+++|. .+.. .......+ .+|+++++.++||||++++++
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~--~~~~--~~~~~~~~----~~e~~~l~~l~h~~i~~~~~~ 75 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKA--LKEA--SESARQDF----QREAELLTVLQHQHIVRFYGV 75 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEe--cCcC--CHHHHHHH----HHHHHHHhcCCCCCCceEEEE
Confidence 457889999999999999999742 23455554 3321 22333344 789999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc----------CCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 001142 879 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET----------GEKHVSVKLALFIAQDVAAALVELHSK 948 (1142)
Q Consensus 879 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~----------~~~~ls~~~i~~Ia~qIa~gL~yLHs~ 948 (1142)
+.+... .++||||+++++|.+++...... ....+++..+..++.||+.||+|||++
T Consensus 76 ~~~~~~--------------~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~ 141 (280)
T cd05092 76 CTEGRP--------------LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL 141 (280)
T ss_pred EecCCc--------------eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC
Confidence 876543 49999999999999999763210 113588999999999999999999999
Q ss_pred CccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCC
Q 001142 949 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 1028 (1142)
Q Consensus 949 gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s 1028 (1142)
||+||||||+|||++.+ +.+||+|||++......... .......+++.|+|||.+.+ ..++
T Consensus 142 ~i~H~dlkp~nil~~~~-------~~~kL~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~ 202 (280)
T cd05092 142 HFVHRDLATRNCLVGQG-------LVVKIGDFGMSRDIYSTDYY--------RVGGRTMLPIRWMPPESILY----RKFT 202 (280)
T ss_pred CeecccccHhhEEEcCC-------CCEEECCCCceeEcCCCcee--------ecCCCccccccccCHHHhcc----CCcC
Confidence 99999999999999876 78999999998654321100 01112345788999999875 4678
Q ss_pred chhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHH
Q 001142 1029 LEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVD 1107 (1142)
Q Consensus 1029 ~ksDVwSLGviL~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~d 1107 (1142)
.++|||||||++|||++ |.+||......+....+..+..+..+ ..+++.+.+
T Consensus 203 ~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~ 255 (280)
T cd05092 203 TESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELERP---------------------------RTCPPEVYA 255 (280)
T ss_pred chhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCccCCCC---------------------------CCCCHHHHH
Confidence 99999999999999998 99999876666655555443322111 134566899
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHH
Q 001142 1108 VFRRCTEENPTERPTAGDLYEMFV 1131 (1142)
Q Consensus 1108 LI~~CL~~DP~~RPSa~EVL~~L~ 1131 (1142)
++.+||+.||.+||++.+|++.+.
T Consensus 256 li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 256 IMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHHccCChhhCCCHHHHHHHHh
Confidence 999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=318.40 Aligned_cols=285 Identities=21% Similarity=0.283 Sum_probs=203.2
Q ss_pred CCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 882 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~ 882 (1142)
.+++|++.+.||+|+||.||+|.+. +..+++|..+.... . +.+...+.+|+.++++++||||+++++++...
T Consensus 3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~----~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 76 (293)
T cd07843 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKE--K----EGFPITSLREINILLKLQHPNIVTVKEVVVGS 76 (293)
T ss_pred chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccc--c----ccchhhHHHHHHHHHhcCCCCEEEEEEEEEec
Confidence 3568999999999999999999985 45566666543321 1 11222336899999999999999999998754
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
+. ...++||||++ ++|.+++... ...+++..+..++.||+.||+|||++||+|+||||+||++
T Consensus 77 ~~------------~~~~lv~e~~~-~~L~~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili 139 (293)
T cd07843 77 NL------------DKIYMVMEYVE-HDLKSLMETM----KQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL 139 (293)
T ss_pred CC------------CcEEEEehhcC-cCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE
Confidence 21 24599999997 6999988752 2368999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
+.+ +.++|+|||.+........ ......+++.|+|||.+.+. ..++.++||||||+++|+
T Consensus 140 ~~~-------~~~~l~d~g~~~~~~~~~~----------~~~~~~~~~~~~aPE~~~~~---~~~~~~~Di~slG~~l~~ 199 (293)
T cd07843 140 NNR-------GILKICDFGLAREYGSPLK----------PYTQLVVTLWYRAPELLLGA---KEYSTAIDMWSVGCIFAE 199 (293)
T ss_pred CCC-------CcEEEeecCceeeccCCcc----------ccccccccccccCchhhcCC---ccccchhhHHHHHHHHHH
Confidence 887 7899999999876543211 11223578899999998652 346789999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccc---ccccccccCCCCCCchhhh-hhHHHHHHHHHHhcccCCC
Q 001142 1043 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC---HEHEVAQSGSGFEKPEAEL-ETLSFLVDVFRRCTEENPT 1118 (1142)
Q Consensus 1043 LLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~---~~~~~~~~~~~~~~~~~~~-~~~~~L~dLI~~CL~~DP~ 1118 (1142)
|++|..||......+....+...........+...... ................... ..++.+.+++.+||+.||+
T Consensus 200 l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 279 (293)
T cd07843 200 LLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPA 279 (293)
T ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCcc
Confidence 99999999877666655554322211111111111000 0000000000000000000 1467789999999999999
Q ss_pred CCCCHHHHHHHHHh
Q 001142 1119 ERPTAGDLYEMFVA 1132 (1142)
Q Consensus 1119 ~RPSa~EVL~~L~~ 1132 (1142)
+|||+.|+++|+|+
T Consensus 280 ~R~t~~ell~~~~f 293 (293)
T cd07843 280 KRISAEDALKHPYF 293 (293)
T ss_pred ccCCHHHHhcCCCC
Confidence 99999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=314.28 Aligned_cols=257 Identities=32% Similarity=0.495 Sum_probs=200.4
Q ss_pred CcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC---CCCccceeeeEecC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR---HSCIVEMYGHKISS 882 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~---HpNIVkl~g~~~~~ 882 (1142)
.|++.+.||+|+||.||+|.+ .+..+++|+..... .....+.+ .+|+.++++++ ||||+++++++.+.
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~----~~e~~~l~~l~~~~~~~vi~~~~~~~~~ 74 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT---PDDDVSDI----QREVALLSQLRQSQPPNITKYYGSYLKG 74 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC---CchhHHHH----HHHHHHHHHhccCCCCCeeeEeeeeeeC
Confidence 478889999999999999997 45678888754321 12223334 68999999986 99999999998754
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
. ..++||||+++++|.++++. ..+++..+..++.|++.||.|||+.||+|+||+|+||++
T Consensus 75 ~--------------~~~lv~e~~~~~~L~~~~~~------~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i 134 (277)
T cd06917 75 P--------------RLWIIMEYAEGGSVRTLMKA------GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILV 134 (277)
T ss_pred C--------------EEEEEEecCCCCcHHHHHHc------cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEE
Confidence 4 35999999999999998864 268999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
+.+ +.++|+|||.+........ ......|+..|+|||.+.+ +..++.++|||||||++|+
T Consensus 135 ~~~-------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~~l~~ 194 (277)
T cd06917 135 TNT-------GNVKLCDFGVAALLNQNSS----------KRSTFVGTPYWMAPEVITE---GKYYDTKADIWSLGITIYE 194 (277)
T ss_pred cCC-------CCEEEccCCceeecCCCcc----------ccccccCCcceeCHHHhcc---CCccccchhHHHHHHHHHH
Confidence 886 7899999999876543211 1123358899999999864 2456789999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1043 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1043 LLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
|++|..||.+.........+.....+.+.. ...+.++.+++.+||+.||++||+
T Consensus 195 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~i~~~l~~~p~~R~~ 248 (277)
T cd06917 195 MATGNPPYSDVDAFRAMMLIPKSKPPRLED--------------------------NGYSKLLREFVAACLDEEPKERLS 248 (277)
T ss_pred HHhCCCCCCCCChhhhhhccccCCCCCCCc--------------------------ccCCHHHHHHHHHHcCCCcccCcC
Confidence 999999998755443332222211111100 024567899999999999999999
Q ss_pred HHHHHHHHHhhcCCC
Q 001142 1123 AGDLYEMFVARTSSS 1137 (1142)
Q Consensus 1123 a~EVL~~L~~~~ss~ 1137 (1142)
+.++++|.|++....
T Consensus 249 ~~~il~~~~~~~~~~ 263 (277)
T cd06917 249 AEELLKSKWIKAHSK 263 (277)
T ss_pred HHHHhhChHhhcccc
Confidence 999999999976543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=317.25 Aligned_cols=255 Identities=28% Similarity=0.406 Sum_probs=198.5
Q ss_pred CCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
.++|++.+.||+|+||+||++.+. +..+|+|+..... .....+ .+.+|+++++.++||||+++++++....
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~----~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 76 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA---KSSVRK----QILRELQIMHECRSPYIVSFYGAFLNEN 76 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC---cchHHH----HHHHHHHHHHHcCCCCcceEeeeEecCC
Confidence 357899999999999999999985 6677888754321 112222 3479999999999999999999988654
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeee
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILI 962 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs-~gIvHrDLKp~NILl 962 (1142)
..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+ ++++||||||+||++
T Consensus 77 --------------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~ 137 (284)
T cd06620 77 --------------NICMCMEFMDCGSLDRIYKK-----GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILV 137 (284)
T ss_pred --------------EEEEEEecCCCCCHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEE
Confidence 45999999999999999875 2468999999999999999999997 699999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
+.+ +.++|+|||++....... .....|+..|+|||++.+ ..++.++|||||||++|+
T Consensus 138 ~~~-------~~~~l~d~gl~~~~~~~~------------~~~~~~~~~~~aPE~~~~----~~~~~~~Di~slG~~l~~ 194 (284)
T cd06620 138 NSR-------GQIKLCDFGVSGELINSI------------ADTFVGTSTYMSPERIQG----GKYTVKSDVWSLGISIIE 194 (284)
T ss_pred CCC-------CcEEEccCCcccchhhhc------------cCccccCcccCCHHHHcc----CCCCccchHHHHHHHHHH
Confidence 877 789999999886432211 113468999999999865 467889999999999999
Q ss_pred HHhCCCCCCCCCHHH-----------HHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHH
Q 001142 1043 LLTLQVPYMGLSELE-----------IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRR 1111 (1142)
Q Consensus 1043 LLtG~~Pf~~~~~~e-----------l~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~ 1111 (1142)
|++|+.||......+ ....+.....+.++ ....+..+.+++.+
T Consensus 195 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~li~~ 248 (284)
T cd06620 195 LALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLP--------------------------SSDFPEDLRDFVDA 248 (284)
T ss_pred HHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCC--------------------------chhcCHHHHHHHHH
Confidence 999999997543321 11111111111000 01245678999999
Q ss_pred hcccCCCCCCCHHHHHHHHHhhcC
Q 001142 1112 CTEENPTERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1112 CL~~DP~~RPSa~EVL~~L~~~~s 1135 (1142)
||+.||++|||+.|+++|+|+...
T Consensus 249 ~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 249 CLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred HhcCCcccCcCHHHHhcCcccccc
Confidence 999999999999999999988654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=312.47 Aligned_cols=266 Identities=25% Similarity=0.420 Sum_probs=199.8
Q ss_pred CcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCCh--HHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSA--DEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~--~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
.|.+.+.||+|+||.||+|.. .+..+|+|..+........ .........+.+|+.++++++||||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 478899999999999999986 4567888875443221111 112222334578999999999999999999987654
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
..++||||+++++|.++++.. ..+++..+..++.||+.||.|||+++++||||+|+||+++
T Consensus 82 --------------~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~ 142 (272)
T cd06629 82 --------------YLSIFLEYVPGGSIGSCLRTY-----GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVD 142 (272)
T ss_pred --------------ceEEEEecCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEc
Confidence 349999999999999999762 4689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.++|+|||.+......... .......|+..|+|||.+.... ..++.++||||||+++|+|
T Consensus 143 ~~-------~~~~l~d~~~~~~~~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~--~~~~~~~Dv~slG~~l~~l 205 (272)
T cd06629 143 AD-------GICKISDFGISKKSDDIYDN--------DQNMSMQGSVFWMAPEVIHSYS--QGYSAKVDIWSLGCVVLEM 205 (272)
T ss_pred CC-------CeEEEeeccccccccccccc--------cccccccCCccccCHHHhcccc--CCCCccchhHHHHHHHHHH
Confidence 77 78999999998754321100 0112335788999999987521 2478899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHH-hCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1044 LTLQVPYMGLSELEIHDLIQ-MGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~-~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
++|..||......+....+. ....+..+. ......+..+.+++.+||..||.+|||
T Consensus 206 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps 262 (272)
T cd06629 206 FAGRRPWSDEEAIAAMFKLGNKRSAPPIPP-----------------------DVSMNLSPVALDFLNACFTINPDNRPT 262 (272)
T ss_pred HhCCCCCcCcchHHHHHHhhccccCCcCCc-----------------------cccccCCHHHHHHHHHHhcCChhhCCC
Confidence 99999997544433222221 111111110 001144667999999999999999999
Q ss_pred HHHHHHHHHh
Q 001142 1123 AGDLYEMFVA 1132 (1142)
Q Consensus 1123 a~EVL~~L~~ 1132 (1142)
++++++|+|+
T Consensus 263 ~~~il~~~~~ 272 (272)
T cd06629 263 ARELLQHPFI 272 (272)
T ss_pred HHHHhhCCCC
Confidence 9999999984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=312.41 Aligned_cols=271 Identities=22% Similarity=0.297 Sum_probs=194.0
Q ss_pred Cc-ceeeeecccCceEEEEEEE------CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001142 808 SL-SSCDEAGKSVSSSLFRCKF------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 880 (1142)
Q Consensus 808 ~y-~l~~~LG~GsfG~Vy~a~~------~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~ 880 (1142)
+| ++.+.||+|+||+||++.+ .+..+|+|+..... .......+ .+|++++++++||||+++++++.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~----~~E~~~l~~l~h~~i~~~~~~~~ 76 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC---GQQNTSGW----KKEINILKTLYHENIVKYKGCCS 76 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc---ChHHHHHH----HHHHHHHHhCCCCCEeeEEEEEe
Confidence 44 8999999999999998764 34567888754321 11222333 78999999999999999999876
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NI 960 (1142)
.... ...++||||+++++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||
T Consensus 77 ~~~~------------~~~~lv~e~~~~~~l~~~~~~------~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Ni 138 (283)
T cd05080 77 EQGG------------KGLQLIMEYVPLGSLRDYLPK------HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNV 138 (283)
T ss_pred cCCC------------ceEEEEecCCCCCCHHHHHHH------cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheE
Confidence 5321 245899999999999999875 3589999999999999999999999999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
|++.+ +.++|+|||++.......... .......++..|+|||++.+ ..++.++||||||+++
T Consensus 139 li~~~-------~~~~l~dfg~~~~~~~~~~~~-------~~~~~~~~~~~~~~PE~~~~----~~~~~~~Di~slG~~l 200 (283)
T cd05080 139 LLDND-------RLVKIGDFGLAKAVPEGHEYY-------RVREDGDSPVFWYAVECLKE----NKFSYASDVWSFGVTL 200 (283)
T ss_pred EEcCC-------CcEEEeecccccccCCcchhh-------ccCCCCCCCceeeCHhHhcc----cCCCcccccHHHHHHH
Confidence 99877 789999999987654321110 01112235677999999865 4678999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1041 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
|||++|+.||...... ....+............... ...... .......+..+.+++.+||+.||++|
T Consensus 201 ~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~--------~~~~~~---~~~~~~~~~~~~~li~~cl~~~p~~R 268 (283)
T cd05080 201 YELLTHCDSKQSPPKK-FEEMIGPKQGQMTVVRLIEL--------LERGMR---LPCPKNCPQEVYILMKNCWETEAKFR 268 (283)
T ss_pred HHHHhCCCCCCCCcch-hhhhhcccccccchhhhhhh--------hhcCCC---CCCCCCCCHHHHHHHHHHhccChhhC
Confidence 9999999998653321 11111110000000000000 000000 00112456789999999999999999
Q ss_pred CCHHHHHHHHHhh
Q 001142 1121 PTAGDLYEMFVAR 1133 (1142)
Q Consensus 1121 PSa~EVL~~L~~~ 1133 (1142)
||++++++.+...
T Consensus 269 ps~~~i~~~l~~~ 281 (283)
T cd05080 269 PTFRSLIPILKEM 281 (283)
T ss_pred CCHHHHHHHHHHh
Confidence 9999999987654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=309.99 Aligned_cols=259 Identities=20% Similarity=0.333 Sum_probs=197.5
Q ss_pred CCCcceeeeecccCceEEEEEEECC-----ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 880 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~~-----~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~ 880 (1142)
..+|++.+.||+|+||.||+|.+.. ..+++|+.... ......+.+ ..|+.++++++||||+++++++.
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~----~~e~~~l~~l~h~ni~~~~~~~~ 75 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG---YTEKQRRDF----LSEASIMGQFDHPNIIHLEGVVT 75 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC---CCHHHHHHH----HHHHHHHHhCCCcCcceEEEEEC
Confidence 4568999999999999999998742 24777764321 123333444 78999999999999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NI 960 (1142)
+... .++||||+++++|.+++... ...+++..+..++.|++.||.|||++|++|+||||+||
T Consensus 76 ~~~~--------------~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~ni 137 (269)
T cd05065 76 KSRP--------------VMIITEFMENGALDSFLRQN----DGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNI 137 (269)
T ss_pred CCCc--------------eEEEEecCCCCcHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheE
Confidence 6543 49999999999999998751 24689999999999999999999999999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
+++.+ +.++|+|||.+.......... ..........+..|+|||++.+ ..++.++|||||||++
T Consensus 138 li~~~-------~~~kl~dfg~~~~~~~~~~~~-----~~~~~~~~~~~~~y~~PE~~~~----~~~~~~~DvwslG~~l 201 (269)
T cd05065 138 LVNSN-------LVCKVSDFGLSRFLEDDTSDP-----TYTSSLGGKIPIRWTAPEAIAY----RKFTSASDVWSYGIVM 201 (269)
T ss_pred EEcCC-------CcEEECCCccccccccCcccc-----ccccccCCCcceeecCHhHhcc----CcccchhhhhhhHHHH
Confidence 99876 789999999987543321110 0000011112457999999875 5678999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001142 1041 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1119 (1142)
Q Consensus 1041 ~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~ 1119 (1142)
|||++ |..||......+....+........+ ...+..+.+++.+||+.+|.+
T Consensus 202 ~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~ 254 (269)
T cd05065 202 WEVMSYGERPYWDMSNQDVINAIEQDYRLPPP---------------------------MDCPTALHQLMLDCWQKDRNA 254 (269)
T ss_pred HHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCc---------------------------ccCCHHHHHHHHHHcCCChhh
Confidence 99886 99999877666665555432211110 134566899999999999999
Q ss_pred CCCHHHHHHHHHh
Q 001142 1120 RPTAGDLYEMFVA 1132 (1142)
Q Consensus 1120 RPSa~EVL~~L~~ 1132 (1142)
||++.+|+..+..
T Consensus 255 Rp~~~~i~~~l~~ 267 (269)
T cd05065 255 RPKFGQIVSTLDK 267 (269)
T ss_pred CcCHHHHHHHHHh
Confidence 9999999987653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=307.39 Aligned_cols=251 Identities=23% Similarity=0.364 Sum_probs=197.0
Q ss_pred CCCcceeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~-~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
..+|++.+.||+|+||.||+|.+. +..+++|+.. ..... ...+ .+|+++++++.||||+++++++....
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~--~~~~~---~~~~----~~e~~~l~~l~~~~i~~~~~~~~~~~- 72 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIR--EGAMS---EEDF----IEEAQVMMKLSHPKLVQLYGVCTERS- 72 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECC--CCCCC---HHHH----HHHHHHHHhCCCCCeeeEEEEEccCC-
Confidence 457899999999999999999885 5667777643 22111 2234 68999999999999999999987544
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
..++||||+++++|.+++.. ....+++..+..++.|++.||+|||+++++|+||||+||+++.
T Consensus 73 -------------~~~~v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~ 135 (256)
T cd05112 73 -------------PICLVFEFMEHGCLSDYLRA----QRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGE 135 (256)
T ss_pred -------------ceEEEEEcCCCCcHHHHHHh----CccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcC
Confidence 34999999999999999875 1235889999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.++|+|||.+......... ......++..|+|||.+.+ ..++.++||||||+++|||+
T Consensus 136 ~-------~~~~l~d~g~~~~~~~~~~~---------~~~~~~~~~~~~aPe~~~~----~~~~~~~Dv~slG~~l~el~ 195 (256)
T cd05112 136 N-------QVVKVSDFGMTRFVLDDQYT---------SSTGTKFPVKWSSPEVFSF----SKYSSKSDVWSFGVLMWEVF 195 (256)
T ss_pred C-------CeEEECCCcceeecccCccc---------ccCCCccchhhcCHhHhcc----CCcChHHHHHHHHHHHHHHH
Confidence 6 78999999998754321100 1112235678999999875 46788999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1045 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1045 t-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
+ |..||...........+..+..+..+ ...++.+.+|+.+||+.+|++|||+
T Consensus 196 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~~~l~~~p~~Rp~~ 248 (256)
T cd05112 196 SEGKTPYENRSNSEVVETINAGFRLYKP---------------------------RLASQSVYELMQHCWKERPEDRPSF 248 (256)
T ss_pred cCCCCCCCcCCHHHHHHHHhCCCCCCCC---------------------------CCCCHHHHHHHHHHcccChhhCCCH
Confidence 8 99999876666666555433221111 0234569999999999999999999
Q ss_pred HHHHHHH
Q 001142 1124 GDLYEMF 1130 (1142)
Q Consensus 1124 ~EVL~~L 1130 (1142)
.++++++
T Consensus 249 ~~~l~~l 255 (256)
T cd05112 249 SLLLHQL 255 (256)
T ss_pred HHHHHhh
Confidence 9999875
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=304.33 Aligned_cols=247 Identities=26% Similarity=0.387 Sum_probs=191.0
Q ss_pred eeecccCceEEEEEEE-CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCCCC
Q 001142 813 DEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGN 891 (1142)
Q Consensus 813 ~~LG~GsfG~Vy~a~~-~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~~~~~ 891 (1142)
++||+|+||.||+|.. .+..+|+|+.. ... ...... .+.+|+.++++++||||+++++++.....
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~--~~~-~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------- 66 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCK--EDL-PQELKI----KFLSEARILKQYDHPNIVKLIGVCTQRQP------- 66 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecC--CcC-CHHHHH----HHHHHHHHHHhCCCCCcCeEEEEEecCCc-------
Confidence 4799999999999986 34567777643 211 122222 34789999999999999999999876543
Q ss_pred CccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccCCC
Q 001142 892 PEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 971 (1142)
Q Consensus 892 ~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~~~ 971 (1142)
.++||||+++++|.+++... ...+++..+..++.|++.||.|||++|++||||||+||+++.+
T Consensus 67 -------~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~------ 129 (250)
T cd05085 67 -------IYIVMELVPGGDFLSFLRKK----KDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGEN------ 129 (250)
T ss_pred -------cEEEEECCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCC------
Confidence 39999999999999998651 2357899999999999999999999999999999999999877
Q ss_pred CCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 001142 972 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPY 1050 (1142)
Q Consensus 972 ~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt-G~~Pf 1050 (1142)
+.+||+|||++........ .......+++.|+|||++.. ..++.++||||||+++|++++ |..||
T Consensus 130 -~~~~l~d~g~~~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~ll~~~~~~g~~p~ 195 (250)
T cd05085 130 -NVLKISDFGMSRQEDDGIY---------SSSGLKQIPIKWTAPEALNY----GRYSSESDVWSYGILLWETFSLGVCPY 195 (250)
T ss_pred -CeEEECCCccceecccccc---------ccCCCCCCcccccCHHHhcc----CCCCchhHHHHHHHHHHHHhcCCCCCC
Confidence 7899999999865332110 01112234677999999865 457889999999999999998 99999
Q ss_pred CCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 001142 1051 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130 (1142)
Q Consensus 1051 ~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L 1130 (1142)
...........+..+.....+ ...+..+.+++.+||..+|.+||++.|+++.+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l 248 (250)
T cd05085 196 PGMTNQQAREQVEKGYRMSCP---------------------------QKCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248 (250)
T ss_pred CCCCHHHHHHHHHcCCCCCCC---------------------------CCCCHHHHHHHHHHcccCcccCCCHHHHHHHh
Confidence 877665555554433221111 13456799999999999999999999999876
Q ss_pred H
Q 001142 1131 V 1131 (1142)
Q Consensus 1131 ~ 1131 (1142)
.
T Consensus 249 ~ 249 (250)
T cd05085 249 A 249 (250)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=328.47 Aligned_cols=263 Identities=22% Similarity=0.338 Sum_probs=199.1
Q ss_pred CCcceeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~-~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~g~~~~~~~ 884 (1142)
..|++.++||.||.+.||++... .+.+|+|.+.+. .........| ..|+..|.+|+ |.+||++|+|-..+++
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~--~~D~qtl~gy----~nEI~lL~KLkg~~~IIqL~DYEv~d~~ 434 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLL--EADNQTLDGY----RNEIALLNKLKGHDKIIQLYDYEVTDGY 434 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHh--hcCHHHHHHH----HHHHHHHHHhcCCceEEEEeeeeccCce
Confidence 35999999999999999999874 344555433222 2234445556 89999999996 9999999999887765
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
+ ||||||-+ .+|..++++. ....+...++.+..||+.|+.++|.+||||.||||.|+|+-.
T Consensus 435 l--------------YmvmE~Gd-~DL~kiL~k~----~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk 495 (677)
T KOG0596|consen 435 L--------------YMVMECGD-IDLNKILKKK----KSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK 495 (677)
T ss_pred E--------------EEEeeccc-ccHHHHHHhc----cCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe
Confidence 4 99999986 8999999872 223343488899999999999999999999999999998854
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCC-------CCCCchhhHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP-------NLYGLEVDIWSYG 1037 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~-------~~~s~ksDVwSLG 1037 (1142)
|.+||+|||.|..+...... ......+||+.||+||.+..+... -..+.++||||+|
T Consensus 496 --------G~LKLIDFGIA~aI~~DTTs--------I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLG 559 (677)
T KOG0596|consen 496 --------GRLKLIDFGIANAIQPDTTS--------IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLG 559 (677)
T ss_pred --------eeEEeeeechhcccCccccc--------eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhh
Confidence 78999999999876543211 233456899999999999875432 1267899999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001142 1038 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1117 (1142)
Q Consensus 1038 viL~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP 1117 (1142)
||||+|+.|+.||... ...+..+.....|... .+.+.. ....++.+++..||+.||
T Consensus 560 CILYqMvYgktPf~~~--~n~~aKl~aI~~P~~~--------------------Iefp~~--~~~~~li~~mK~CL~rdP 615 (677)
T KOG0596|consen 560 CILYQMVYGKTPFGQI--INQIAKLHAITDPNHE--------------------IEFPDI--PENDELIDVMKCCLARDP 615 (677)
T ss_pred hHHHHHHhcCCchHHH--HHHHHHHHhhcCCCcc--------------------ccccCC--CCchHHHHHHHHHHhcCc
Confidence 9999999999999743 2233333333322211 111111 112238999999999999
Q ss_pred CCCCCHHHHHHHHHhhc
Q 001142 1118 TERPTAGDLYEMFVART 1134 (1142)
Q Consensus 1118 ~~RPSa~EVL~~L~~~~ 1134 (1142)
.+|||+.|+|+|+|...
T Consensus 616 kkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 616 KKRWSIPELLQHPFLQI 632 (677)
T ss_pred ccCCCcHHHhcCccccc
Confidence 99999999999999875
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=315.87 Aligned_cols=295 Identities=17% Similarity=0.202 Sum_probs=202.7
Q ss_pred CCCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 882 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~ 882 (1142)
.+++|++.++||+|+||.||+|.. .+..+|+|....... ... +...+.+|+.++++++||||+++++++...
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 83 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE--KEG----FPITALREIKILQLLKHENVVNLIEICRTK 83 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC--cCC----chhHHHHHHHHHHhCCCCCccceEEEEecc
Confidence 456899999999999999999998 466788887543321 111 112235799999999999999999998764
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
... ........++||||+. ++|.+++.. ....+++..+..++.||+.||+|||++||+|+||||+||++
T Consensus 84 ~~~------~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~ 152 (310)
T cd07865 84 ATP------YNRYKGSFYLVFEFCE-HDLAGLLSN----KNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILI 152 (310)
T ss_pred ccc------ccCCCceEEEEEcCCC-cCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence 321 1112335699999996 688888764 22368999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
+.+ +.+||+|||.+.......... ........++..|+|||.+.+ ...++.++||||||+++|+
T Consensus 153 ~~~-------~~~kl~dfg~~~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~~l~e 216 (310)
T cd07865 153 TKD-------GILKLADFGLARAFSLSKNSK------PNRYTNRVVTLWYRPPELLLG---ERDYGPPIDMWGAGCIMAE 216 (310)
T ss_pred CCC-------CcEEECcCCCcccccCCcccC------CCCccCcccCccccCcHHhcC---CcccCchhhhHHHHHHHHH
Confidence 877 789999999997654322110 011123357889999999865 2346789999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccccccc-ccccCCCCCCch---hhhhhHHHHHHHHHHhcccCCC
Q 001142 1043 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHE-VAQSGSGFEKPE---AELETLSFLVDVFRRCTEENPT 1118 (1142)
Q Consensus 1043 LLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~-~~~~~~~~~~~~---~~~~~~~~L~dLI~~CL~~DP~ 1118 (1142)
|++|..||.+.........+........+..++......... ............ .....+..+.++|.+||..||.
T Consensus 217 l~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~ 296 (310)
T cd07865 217 MWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPA 296 (310)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChh
Confidence 999999998776655444442211111000000000000000 000000000000 0001245678999999999999
Q ss_pred CCCCHHHHHHHHHh
Q 001142 1119 ERPTAGDLYEMFVA 1132 (1142)
Q Consensus 1119 ~RPSa~EVL~~L~~ 1132 (1142)
+|||++|+++|+|+
T Consensus 297 ~R~t~~e~l~h~~f 310 (310)
T cd07865 297 KRIDADTALNHDFF 310 (310)
T ss_pred hccCHHHHhcCCCC
Confidence 99999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=309.98 Aligned_cols=252 Identities=27% Similarity=0.454 Sum_probs=189.4
Q ss_pred eeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecCCCCCCCC
Q 001142 813 DEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 889 (1142)
Q Consensus 813 ~~LG~GsfG~Vy~a~~~~--~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~~~~~~~~~~~ 889 (1142)
+.||+|+||.||+|.+.. ..+.++++..+... .....+.+ .+|+.++.++ +||||+++++++.....
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~----~~E~~~l~~l~~h~~iv~~~~~~~~~~~----- 70 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDF----AGELEVLCKLGHHPNIINLLGACEHRGY----- 70 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC-CHHHHHHH----HHHHHHHHhhccCCCeeeEEEEEecCCC-----
Confidence 468999999999999743 33334444333211 12222333 7899999999 79999999999886553
Q ss_pred CCCccccceEEEEEeccCCCCHHHHHHHHhc-----------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 001142 890 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 958 (1142)
Q Consensus 890 ~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~-----------~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~ 958 (1142)
.++||||+++++|.+++..... .....+++..+..++.|++.||+|||++|++||||||+
T Consensus 71 ---------~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~ 141 (270)
T cd05047 71 ---------LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAAR 141 (270)
T ss_pred ---------ceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccc
Confidence 3999999999999999975321 11235789999999999999999999999999999999
Q ss_pred CeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001142 959 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1038 (1142)
Q Consensus 959 NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGv 1038 (1142)
||+++.+ +.+||+|||++....... .......+..|+|||++.. ..++.++|||||||
T Consensus 142 nili~~~-------~~~kl~dfgl~~~~~~~~-----------~~~~~~~~~~y~apE~~~~----~~~~~~~Di~slG~ 199 (270)
T cd05047 142 NILVGEN-------YVAKIADFGLSRGQEVYV-----------KKTMGRLPVRWMAIESLNY----SVYTTNSDVWSYGV 199 (270)
T ss_pred eEEEcCC-------CeEEECCCCCccccchhh-----------hccCCCCccccCChHHHcc----CCCCchhhHHHHHH
Confidence 9999887 789999999985322100 0111224567999999865 56789999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001142 1039 LLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1117 (1142)
Q Consensus 1039 iL~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP 1117 (1142)
++|||++ |..||.+.+..+....+........+ ...+..+.+++.+||+.||
T Consensus 200 il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p 252 (270)
T cd05047 200 LLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP---------------------------LNCDDEVYDLMRQCWREKP 252 (270)
T ss_pred HHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCC---------------------------CcCCHHHHHHHHHHcccCh
Confidence 9999997 99999876665555554332211110 1334568999999999999
Q ss_pred CCCCCHHHHHHHHHh
Q 001142 1118 TERPTAGDLYEMFVA 1132 (1142)
Q Consensus 1118 ~~RPSa~EVL~~L~~ 1132 (1142)
.+|||+.++++.+..
T Consensus 253 ~~Rps~~~il~~l~~ 267 (270)
T cd05047 253 YERPSFAQILVSLNR 267 (270)
T ss_pred hhCCCHHHHHHHHHH
Confidence 999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=361.95 Aligned_cols=265 Identities=28% Similarity=0.430 Sum_probs=212.8
Q ss_pred CcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
++.-...||.|.||.||-|... +...|+|-.++. .......+.. .+|+.++..++|||+|++||+-...+.
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq--~~~~k~~~~i----~eEm~vlE~lnHpNlV~YyGVEvHRek- 1308 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQ--DSDHKTFKLI----AEEMKVLEGLNHPNLVRYYGVEVHREK- 1308 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcC--ccccccCcch----HHHHHHHHhccCccccccCceeecHHH-
Confidence 3567789999999999999974 445555543333 2222333333 789999999999999999998766543
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
.+|.||||++|+|.++++. ....++.....+..|++.|+.|||++|||||||||.||+++.+
T Consensus 1309 -------------v~IFMEyC~~GsLa~ll~~-----gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~ 1370 (1509)
T KOG4645|consen 1309 -------------VYIFMEYCEGGSLASLLEH-----GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFN 1370 (1509)
T ss_pred -------------HHHHHHHhccCcHHHHHHh-----cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecC
Confidence 3899999999999999986 3457888888899999999999999999999999999999988
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+.+|++|||.|..+.....+.. ......+||+.|||||++.+... ....-+.||||+|||+.||+|
T Consensus 1371 -------g~iK~~DFGsa~ki~~~~~~~~------~el~~~~GT~~YMAPEvit~t~~-kG~~~A~DiWslGCVVlEM~t 1436 (1509)
T KOG4645|consen 1371 -------GLIKYGDFGSAVKIKNNAQTMP------GELQSMMGTPMYMAPEVITGTKG-KGHGGAADIWSLGCVVLEMAT 1436 (1509)
T ss_pred -------CcEEeecccceeEecCchhcCC------HHHHhhcCCchhcCchhhccccc-CCCCcchhhhcccceEEEeec
Confidence 8999999999988765432221 22345689999999999987442 345678999999999999999
Q ss_pred CCCCCCCC-CHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001142 1046 LQVPYMGL-SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124 (1142)
Q Consensus 1046 G~~Pf~~~-~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~ 1124 (1142)
|+.||... +..++...+..|..|.++.. .+.+-+++|.+||+.||++|+++.
T Consensus 1437 GkrPW~~~dne~aIMy~V~~gh~Pq~P~~---------------------------ls~~g~dFle~Cl~~dP~~Rw~~~ 1489 (1509)
T KOG4645|consen 1437 GKRPWAELDNEWAIMYHVAAGHKPQIPER---------------------------LSSEGRDFLEHCLEQDPKMRWTAS 1489 (1509)
T ss_pred CCCchhhccchhHHHhHHhccCCCCCchh---------------------------hhHhHHHHHHHHHhcCchhhhHHH
Confidence 99999764 34566777788888777653 455689999999999999999999
Q ss_pred HHHHHHHhhcCCCC
Q 001142 1125 DLYEMFVARTSSSI 1138 (1142)
Q Consensus 1125 EVL~~L~~~~ss~~ 1138 (1142)
|+++|-|-+...+.
T Consensus 1490 qlle~~f~~~~~d~ 1503 (1509)
T KOG4645|consen 1490 QLLEHAFGKSCTDE 1503 (1509)
T ss_pred HHHHhhcccccccc
Confidence 99999888765443
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=312.42 Aligned_cols=245 Identities=22% Similarity=0.350 Sum_probs=181.2
Q ss_pred eecccCceEEEEEEEC------------------------C--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC
Q 001142 814 EAGKSVSSSLFRCKFG------------------------S--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL 867 (1142)
Q Consensus 814 ~LG~GsfG~Vy~a~~~------------------------~--~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L 867 (1142)
.||+|+||.||+|.+. + ..+++|+ ++.. ... ....+.+|+.+++.+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~--~~~~--~~~----~~~~~~~~~~~~~~l 73 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKV--LDPS--HRD----IALAFFETASLMSQV 73 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEe--cChH--HHH----HHHHHHHHHHHHhcC
Confidence 6999999999998752 1 1244444 3211 111 122346889999999
Q ss_pred CCCCccceeeeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 001142 868 RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS 947 (1142)
Q Consensus 868 ~HpNIVkl~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs 947 (1142)
+||||+++++++..... .++||||+++++|..++.. ....+++..+..++.||+.||+|||+
T Consensus 74 ~h~niv~~~~~~~~~~~--------------~~lv~ey~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~ 135 (274)
T cd05076 74 SHIHLAFVHGVCVRGSE--------------NIMVEEFVEHGPLDVCLRK----EKGRVPVAWKITVAQQLASALSYLED 135 (274)
T ss_pred CCCCeeeEEEEEEeCCc--------------eEEEEecCCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHc
Confidence 99999999999886553 3999999999999998864 23468899999999999999999999
Q ss_pred CCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCC
Q 001142 948 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 1027 (1142)
Q Consensus 948 ~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~ 1027 (1142)
+||+||||||+|||++..+........+|++|||.+...... ....++..|+|||.+.+ ...+
T Consensus 136 ~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~--------------~~~~~~~~~~aPe~~~~---~~~~ 198 (274)
T cd05076 136 KNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR--------------EERVERIPWIAPECVPG---GNSL 198 (274)
T ss_pred CCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc--------------cccccCCcccCchhhcC---CCCC
Confidence 999999999999999865322222346899999987532211 12247788999998865 2457
Q ss_pred CchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHH
Q 001142 1028 GLEVDIWSYGCLLLELL-TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLV 1106 (1142)
Q Consensus 1028 s~ksDVwSLGviL~ELL-tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~ 1106 (1142)
+.++|||||||++|||+ +|+.||......+....+..... .+ . ...+.+.
T Consensus 199 ~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~----------------------~-----~~~~~~~ 249 (274)
T cd05076 199 STAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEKKHR--LP----------------------E-----PSCKELA 249 (274)
T ss_pred CcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHHhccC--CC----------------------C-----CCChHHH
Confidence 89999999999999985 69999986554443222211100 00 0 1234589
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHH
Q 001142 1107 DVFRRCTEENPTERPTAGDLYEMF 1130 (1142)
Q Consensus 1107 dLI~~CL~~DP~~RPSa~EVL~~L 1130 (1142)
+++.+||+.+|++|||+.++++++
T Consensus 250 ~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 250 TLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHHHcccChhhCcCHHHHHHhh
Confidence 999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=313.91 Aligned_cols=282 Identities=19% Similarity=0.247 Sum_probs=198.3
Q ss_pred CCCCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001142 804 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 881 (1142)
Q Consensus 804 ~~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~ 881 (1142)
..+++|++.+.||+|++|.||+|.. .+..+++|......... .... +.+|+.++++++||||+++++++.+
T Consensus 2 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~---~~~~----~~~E~~~l~~l~h~~i~~~~~~~~~ 74 (291)
T cd07844 2 GKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG---APFT----AIREASLLKDLKHANIVTLHDIIHT 74 (291)
T ss_pred CCccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC---Cchh----HHHHHHHHhhCCCcceeeEEEEEec
Confidence 3467899999999999999999987 45678888754332111 1112 2589999999999999999999876
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 001142 882 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 961 (1142)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NIL 961 (1142)
.+ +.++||||++ ++|.+++.+. ...+++..+..++.||+.||.|||++||+||||||+||+
T Consensus 75 ~~--------------~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil 135 (291)
T cd07844 75 KK--------------TLTLVFEYLD-TDLKQYMDDC----GGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLL 135 (291)
T ss_pred CC--------------eEEEEEecCC-CCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEE
Confidence 54 3499999998 5999988752 236899999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001142 962 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1041 (1142)
Q Consensus 962 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ 1041 (1142)
++.+ +.+||+|||.++........ .....++..|+|||++.+ ...++.++||||||+++|
T Consensus 136 ~~~~-------~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~---~~~~~~~~Dv~slG~il~ 195 (291)
T cd07844 136 ISER-------GELKLADFGLARAKSVPSKT----------YSNEVVTLWYRPPDVLLG---STEYSTSLDMWGVGCIFY 195 (291)
T ss_pred EcCC-------CCEEECccccccccCCCCcc----------ccccccccccCCcHHhhc---CcccCcHHHHHHHHHHHH
Confidence 9887 78999999998653221110 112246788999999865 235788999999999999
Q ss_pred HHHhCCCCCCCCC-HHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCch-----hhhhhHHHHHHHHHHhccc
Q 001142 1042 ELLTLQVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE-----AELETLSFLVDVFRRCTEE 1115 (1142)
Q Consensus 1042 ELLtG~~Pf~~~~-~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~L~dLI~~CL~~ 1115 (1142)
+|++|+.||.+.. ..+....+...........+.............. ....... ........+.+++.+||+.
T Consensus 196 ~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 274 (291)
T cd07844 196 EMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSF-PFYPPRPLINHAPRLDRIPHGEELALKFLQY 274 (291)
T ss_pred HHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccc-cccCChhHHHhCcCCCCchhHHHHHHHHhcc
Confidence 9999999997654 2222222211111111111111100000000000 0000000 0011226788999999999
Q ss_pred CCCCCCCHHHHHHHHHh
Q 001142 1116 NPTERPTAGDLYEMFVA 1132 (1142)
Q Consensus 1116 DP~~RPSa~EVL~~L~~ 1132 (1142)
+|.+|||+.|++.|+||
T Consensus 275 ~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 275 EPKKRISAAEAMKHPYF 291 (291)
T ss_pred CcccccCHHHHhcCCCC
Confidence 99999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=308.97 Aligned_cols=254 Identities=22% Similarity=0.334 Sum_probs=196.7
Q ss_pred CCcceeeeecccCceEEEEEEECCc-----cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFGSA-----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 881 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~~~-----~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~ 881 (1142)
.+|.+.++||+|+||.||+|.+... .+++|..... . .....+.+ .+|+.++++++||||+++++++.+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~--~-~~~~~~~~----~~e~~~l~~~~h~~i~~~~~~~~~ 78 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC--T-SPSVREKF----LQEAYIMRQFDHPHIVKLIGVITE 78 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCc--C-CHHHHHHH----HHHHHHHHhCCCCchhceeEEEcC
Confidence 4588999999999999999987432 4555654322 1 12223334 789999999999999999998764
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 001142 882 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 961 (1142)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NIL 961 (1142)
. ..++||||+++++|.+++... ...+++..+..++.|++.||+|||++|++||||||+||+
T Consensus 79 ~---------------~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nil 139 (270)
T cd05056 79 N---------------PVWIVMELAPLGELRSYLQVN----KYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVL 139 (270)
T ss_pred C---------------CcEEEEEcCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEE
Confidence 2 238999999999999999751 235899999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001142 962 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1041 (1142)
Q Consensus 962 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ 1041 (1142)
++.+ +.++|+|||++......... ......++..|+|||.+.. ..++.++||||||+++|
T Consensus 140 i~~~-------~~~~l~d~g~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~ 199 (270)
T cd05056 140 VSSP-------DCVKLGDFGLSRYLEDESYY---------KASKGKLPIKWMAPESINF----RRFTSASDVWMFGVCMW 199 (270)
T ss_pred EecC-------CCeEEccCceeeecccccce---------ecCCCCccccccChhhhcc----CCCCchhhhHHHHHHHH
Confidence 9877 78999999998765432110 0011234567999998865 46789999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1042 ELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1042 ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
||++ |..||.+....+....+..+..+..+ ...+..+.+++.+|+..+|.+|
T Consensus 200 el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~P~~R 252 (270)
T cd05056 200 EILMLGVKPFQGVKNNDVIGRIENGERLPMP---------------------------PNCPPTLYSLMTKCWAYDPSKR 252 (270)
T ss_pred HHHHcCCCCCCCCCHHHHHHHHHcCCcCCCC---------------------------CCCCHHHHHHHHHHcCCChhhC
Confidence 9986 99999877666655555444322211 1345679999999999999999
Q ss_pred CCHHHHHHHHHhh
Q 001142 1121 PTAGDLYEMFVAR 1133 (1142)
Q Consensus 1121 PSa~EVL~~L~~~ 1133 (1142)
||+.++++.+...
T Consensus 253 pt~~~~~~~l~~~ 265 (270)
T cd05056 253 PRFTELKAQLSDI 265 (270)
T ss_pred cCHHHHHHHHHHH
Confidence 9999999987654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=307.27 Aligned_cols=254 Identities=25% Similarity=0.388 Sum_probs=198.5
Q ss_pred CCCCcceeeeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~~~-~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
.-++|++.++||+|+||.||+|.+.+ ..+++|... .... ..+++ .+|+.++++++||||+++++++....
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~--~~~~---~~~~~----~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLK--PGTM---SPEAF----LQEAQIMKKLRHDKLVQLYAVCSEEE 74 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEec--CCcc---CHHHH----HHHHHHHhhCCCCCEeeeeeeeecCC
Confidence 34679999999999999999998743 456776643 2111 12334 78999999999999999999987644
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
. .++||||+++++|.+++.. .....+++..+..++.||+.||.|||++||+|+||||+||+++
T Consensus 75 ~--------------~~~v~e~~~~~~L~~~i~~---~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~ 137 (261)
T cd05034 75 P--------------IYIVTEYMSKGSLLDFLKS---GEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVG 137 (261)
T ss_pred c--------------eEEEEeccCCCCHHHHHhc---cccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEc
Confidence 3 4999999999999999975 2234689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.++|+|||.+......... ......++..|+|||.+.+ ..++.++||||||+++|+|
T Consensus 138 ~~-------~~~~l~d~g~~~~~~~~~~~---------~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~slG~il~~l 197 (261)
T cd05034 138 EN-------LVCKIADFGLARLIEDDEYT---------AREGAKFPIKWTAPEAANY----GRFTIKSDVWSFGILLTEI 197 (261)
T ss_pred CC-------CCEEECccccceeccchhhh---------hhhccCCCccccCHHHhcc----CCcCchhHHHHHHHHHHHH
Confidence 87 78999999998765431110 0112234568999999875 4578999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1044 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1044 Lt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
++ |+.||.+.........+..+.....+ ...+..+.+++.+||+.+|.+||+
T Consensus 198 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~~l~~~p~~Rp~ 250 (261)
T cd05034 198 VTYGRVPYPGMTNREVLEQVERGYRMPRP---------------------------PNCPEELYDLMLQCWDKDPEERPT 250 (261)
T ss_pred HhCCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------CCCCHHHHHHHHHHcccCcccCCC
Confidence 98 99999877666666555433221111 023556899999999999999999
Q ss_pred HHHHHHHHH
Q 001142 1123 AGDLYEMFV 1131 (1142)
Q Consensus 1123 a~EVL~~L~ 1131 (1142)
++++.+.+.
T Consensus 251 ~~~l~~~l~ 259 (261)
T cd05034 251 FEYLQSFLE 259 (261)
T ss_pred HHHHHHHHh
Confidence 999998654
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=311.10 Aligned_cols=267 Identities=29% Similarity=0.443 Sum_probs=202.3
Q ss_pred CCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
++|+..++||.|++|.||+|.+ .+..+++|+..... ....... +.+|++++++++||||+++++++.+...
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~----~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 73 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP---NPDLQKQ----ILRELEINKSCKSPYIVKYYGAFLDESS 73 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC---chHHHHH----HHHHHHHHHhCCCCCeeeeeeEEEccCC
Confidence 3688999999999999999998 45677777754321 1122233 3789999999999999999999865321
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
...++||||+++++|.+++..... ....+++..+..++.||+.||.|||+.|++|+||+|+||+++.
T Consensus 74 ------------~~~~lv~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~ 140 (287)
T cd06621 74 ------------SSIGIAMEYCEGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTR 140 (287)
T ss_pred ------------CeEEEEEEecCCCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEec
Confidence 246999999999999998875433 2356899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.++|+|||++....... .....++..|+|||.+.+ ..++.++||||||+++|+|+
T Consensus 141 ~-------~~~~l~dfg~~~~~~~~~------------~~~~~~~~~y~~pE~~~~----~~~~~~~Dv~slG~il~~l~ 197 (287)
T cd06621 141 K-------GQVKLCDFGVSGELVNSL------------AGTFTGTSFYMAPERIQG----KPYSITSDVWSLGLTLLEVA 197 (287)
T ss_pred C-------CeEEEeeccccccccccc------------cccccCCccccCHHHhcC----CCCCchhhHHHHHHHHHHHH
Confidence 7 789999999986543211 112347888999999875 46788999999999999999
Q ss_pred hCCCCCCCCC-----HHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001142 1045 TLQVPYMGLS-----ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1119 (1142)
Q Consensus 1045 tG~~Pf~~~~-----~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~ 1119 (1142)
+|+.||.... ..+....+.....+.+... +......++.+.+++.+||+.+|.+
T Consensus 198 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~li~~~l~~~p~~ 256 (287)
T cd06621 198 QNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDE---------------------PGNGIKWSEEFKDFIKQCLEKDPTR 256 (287)
T ss_pred hCCCCCCcccCCCCChHHHHHHHhcCCchhhccC---------------------CCCCCchHHHHHHHHHHHcCCCccc
Confidence 9999997542 2223333222111111100 0000134567999999999999999
Q ss_pred CCCHHHHHHHHHhhcCCC
Q 001142 1120 RPTAGDLYEMFVARTSSS 1137 (1142)
Q Consensus 1120 RPSa~EVL~~L~~~~ss~ 1137 (1142)
|||+.|+++|+|++....
T Consensus 257 Rpt~~eil~~~~~~~~~~ 274 (287)
T cd06621 257 RPTPWDMLEHPWIKAQMK 274 (287)
T ss_pred CCCHHHHHhCcccccccc
Confidence 999999999999975543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=310.27 Aligned_cols=262 Identities=24% Similarity=0.331 Sum_probs=201.1
Q ss_pred CCCcceeeeecccCceEEEEEEECC------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeE
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFGS------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 879 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~~------~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~ 879 (1142)
-++|++.+.||+|+||.||+|.+.. ..+++|+. .. .......+.+ .+|+.++++++||||+++++++
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~--~~-~~~~~~~~~~----~~e~~~l~~l~h~ni~~~~~~~ 77 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTV--KD-HASEIQVTLL----LQESCLLYGLSHQNILPILHVC 77 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEc--cC-CCCHHHHHHH----HHHHHHHHhCCCCCCCeEEEEE
Confidence 4578999999999999999999854 55666653 22 1223333333 7899999999999999999987
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 001142 880 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET---GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956 (1142)
Q Consensus 880 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~---~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLK 956 (1142)
...+. ..++++||+++++|.+++...... ....+++..+..++.||+.||+|||+++++|||||
T Consensus 78 ~~~~~-------------~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~ 144 (280)
T cd05043 78 IEDGE-------------PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIA 144 (280)
T ss_pred ecCCC-------------CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccC
Confidence 65321 248999999999999999763221 11468999999999999999999999999999999
Q ss_pred CCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHH
Q 001142 957 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1036 (1142)
Q Consensus 957 p~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSL 1036 (1142)
|+||+++.+ +.+||+|||+++.+....... ......++..|+|||++.+ ..++.++|||||
T Consensus 145 p~nil~~~~-------~~~kl~d~g~~~~~~~~~~~~--------~~~~~~~~~~y~apE~~~~----~~~~~~~Di~sl 205 (280)
T cd05043 145 ARNCVIDEE-------LQVKITDNALSRDLFPMDYHC--------LGDNENRPVKWMALESLVN----KEYSSASDVWSF 205 (280)
T ss_pred HhhEEEcCC-------CcEEECCCCCcccccCCceEE--------eCCCCCcchhccCHHHHhc----CCCCchhhHHHh
Confidence 999999877 789999999997543321110 0112245678999999875 467899999999
Q ss_pred HHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhccc
Q 001142 1037 GCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 1115 (1142)
Q Consensus 1037 GviL~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~ 1115 (1142)
|+++||+++ |+.||......+....+..+..+... ...++.+.+++.+||..
T Consensus 206 G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~ 258 (280)
T cd05043 206 GVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQP---------------------------INCPDELFAVMACCWAL 258 (280)
T ss_pred HHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCC---------------------------CcCCHHHHHHHHHHcCC
Confidence 999999999 99999877666655554433221110 13456789999999999
Q ss_pred CCCCCCCHHHHHHHHHhh
Q 001142 1116 NPTERPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1116 DP~~RPSa~EVL~~L~~~ 1133 (1142)
||++|||+.++++.+...
T Consensus 259 ~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 259 DPEERPSFSQLVQCLTDF 276 (280)
T ss_pred ChhhCCCHHHHHHHHHHH
Confidence 999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=306.45 Aligned_cols=252 Identities=22% Similarity=0.390 Sum_probs=197.1
Q ss_pred CCCcceeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~-~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
-++|++.++||+|+||.||+|.+. +..+++|.... .....+.+ .+|+.++++++|+||+++++++.. .
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~-----~~~~~~~~----~~e~~~l~~l~~~~i~~~~~~~~~-~- 73 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP-----GSMSVEAF----LAEANVMKTLQHDKLVKLHAVVTK-E- 73 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCC-----ChhHHHHH----HHHHHHHHhcCCCCcceEEEEEcC-C-
Confidence 457899999999999999999874 45577775431 12223334 789999999999999999998765 2
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
..++||||+++++|.+++.. .....+++..+..++.|++.||.|||+.|++|+||||+||+++.
T Consensus 74 -------------~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~ 137 (260)
T cd05073 74 -------------PIYIITEFMAKGSLLDFLKS---DEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSA 137 (260)
T ss_pred -------------CeEEEEEeCCCCcHHHHHHh---CCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcC
Confidence 24899999999999999976 22346788999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||+|||.+......... ......++..|+|||++.. ..++.++|||||||++|+++
T Consensus 138 ~-------~~~~l~d~~~~~~~~~~~~~---------~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~slG~~l~~l~ 197 (260)
T cd05073 138 S-------LVCKIADFGLARVIEDNEYT---------AREGAKFPIKWTAPEAINF----GSFTIKSDVWSFGILLMEIV 197 (260)
T ss_pred C-------CcEEECCCcceeeccCCCcc---------cccCCcccccccCHhHhcc----CCcCccccchHHHHHHHHHH
Confidence 7 78999999998754331111 1112235677999999865 46788999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1045 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1045 t-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
+ |..||.+.+..+....+..+...... ...+..+.+++.+||+.+|++||++
T Consensus 198 t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~~l~~~p~~Rp~~ 250 (260)
T cd05073 198 TYGRIPYPGMSNPEVIRALERGYRMPRP---------------------------ENCPEELYNIMMRCWKNRPEERPTF 250 (260)
T ss_pred hcCCCCCCCCCHHHHHHHHhCCCCCCCc---------------------------ccCCHHHHHHHHHHcccCcccCcCH
Confidence 9 99999877666555555433221110 1345569999999999999999999
Q ss_pred HHHHHHHH
Q 001142 1124 GDLYEMFV 1131 (1142)
Q Consensus 1124 ~EVL~~L~ 1131 (1142)
.++++.|.
T Consensus 251 ~~l~~~L~ 258 (260)
T cd05073 251 EYIQSVLD 258 (260)
T ss_pred HHHHHHHh
Confidence 99998764
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=320.30 Aligned_cols=260 Identities=23% Similarity=0.375 Sum_probs=200.1
Q ss_pred CcceeeeecccCceEEEEEEECC---------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceee
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFGS---------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYG 877 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~~---------~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g 877 (1142)
+|++.+.||+|+||.||+|.+.+ ..+|+|+.... ......+.+ .+|+.+++++ +||||+++++
T Consensus 13 ~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~----~~E~~~l~~l~~h~~iv~~~~ 85 (334)
T cd05100 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD---ATDKDLSDL----VSEMEMMKMIGKHKNIINLLG 85 (334)
T ss_pred HeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc---cCHHHHHHH----HHHHHHHHhhcCCCCeeeeeE
Confidence 58999999999999999998621 24666654321 122233344 7899999999 7999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc-----------cCCCCCCHHHHHHHHHHHHHHHHHHH
Q 001142 878 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAALVELH 946 (1142)
Q Consensus 878 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~-----------~~~~~ls~~~i~~Ia~qIa~gL~yLH 946 (1142)
++...+. .++||||+++++|.+++..... .....+++..+..++.||+.||.|||
T Consensus 86 ~~~~~~~--------------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH 151 (334)
T cd05100 86 ACTQDGP--------------LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA 151 (334)
T ss_pred EEccCCc--------------eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH
Confidence 9876543 4999999999999999975321 11235788999999999999999999
Q ss_pred hCCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCC
Q 001142 947 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 1026 (1142)
Q Consensus 947 s~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 1026 (1142)
++||+||||||+|||++.+ +.+||+|||.++......... ......++..|+|||++.+ ..
T Consensus 152 ~~givH~dlkp~Nill~~~-------~~~kL~Dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~~ 212 (334)
T cd05100 152 SQKCIHRDLAARNVLVTED-------NVMKIADFGLARDVHNIDYYK--------KTTNGRLPVKWMAPEALFD----RV 212 (334)
T ss_pred HCCeeccccccceEEEcCC-------CcEEECCcccceecccccccc--------cccCCCcCceEcCHHHhcc----CC
Confidence 9999999999999999877 789999999997654321110 0111234567999999875 56
Q ss_pred CCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHH
Q 001142 1027 YGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFL 1105 (1142)
Q Consensus 1027 ~s~ksDVwSLGviL~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 1105 (1142)
++.++||||||+++|||++ |..||.+.+..+....+.....+..+ ...+..+
T Consensus 213 ~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l 265 (334)
T cd05100 213 YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKP---------------------------ANCTHEL 265 (334)
T ss_pred cCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------CCCCHHH
Confidence 7899999999999999998 88999887776666655443222111 1334568
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001142 1106 VDVFRRCTEENPTERPTAGDLYEMFVART 1134 (1142)
Q Consensus 1106 ~dLI~~CL~~DP~~RPSa~EVL~~L~~~~ 1134 (1142)
.+++.+||+.+|.+|||+.|+++++....
T Consensus 266 ~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 266 YMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred HHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 99999999999999999999999988665
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=306.59 Aligned_cols=256 Identities=21% Similarity=0.348 Sum_probs=196.6
Q ss_pred CCcceeeeecccCceEEEEEEEC--Cc---cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SA---DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 881 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~---~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~ 881 (1142)
.+|+..+.||+|+||.||+|+.. +. .+++|.. +... .....+.+ ..|++++++++||||+++++++.+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~--~~~~-~~~~~~~~----~~e~~~l~~l~h~~i~~~~~~~~~ 77 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTL--KPGY-TEKQRQDF----LSEASIMGQFSHHNIIRLEGVVTK 77 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEec--cccC-CHHHHHHH----HHHHHHHhcCCCCCeeEEEEEEcc
Confidence 46889999999999999999873 22 3555543 3221 22233334 789999999999999999999876
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 001142 882 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 961 (1142)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NIL 961 (1142)
.+. .++||||+++++|.+++.. ....+++..+..++.|++.||+|||+.||+||||||+||+
T Consensus 78 ~~~--------------~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil 139 (268)
T cd05063 78 FKP--------------AMIITEYMENGALDKYLRD----HDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNIL 139 (268)
T ss_pred CCC--------------cEEEEEcCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEE
Confidence 543 4999999999999999875 1246899999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001142 962 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1041 (1142)
Q Consensus 962 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ 1041 (1142)
++.+ +.+||+|||++.......... ........+..|+|||++.. ..++.++|||||||++|
T Consensus 140 i~~~-------~~~kl~dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~~PE~~~~----~~~~~~~Dv~slG~il~ 201 (268)
T cd05063 140 VNSN-------LECKVSDFGLSRVLEDDPEGT-------YTTSGGKIPIRWTAPEAIAY----RKFTSASDVWSFGIVMW 201 (268)
T ss_pred EcCC-------CcEEECCCccceecccccccc-------eeccCCCcCceecCHHHhhc----CCcChHhHHHHHHHHHH
Confidence 9876 789999999987553321110 00011123457999999875 45789999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1042 ELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1042 ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
||++ |..||......+....+..+...... ...+..+.+++.+||+.+|.+|
T Consensus 202 ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~---------------------------~~~~~~~~~li~~c~~~~p~~R 254 (268)
T cd05063 202 EVMSFGERPYWDMSNHEVMKAINDGFRLPAP---------------------------MDCPSAVYQLMLQCWQQDRARR 254 (268)
T ss_pred HHHhCCCCCCCcCCHHHHHHHHhcCCCCCCC---------------------------CCCCHHHHHHHHHHcCCCcccC
Confidence 9997 99999876666666665433221110 1345668999999999999999
Q ss_pred CCHHHHHHHHHh
Q 001142 1121 PTAGDLYEMFVA 1132 (1142)
Q Consensus 1121 PSa~EVL~~L~~ 1132 (1142)
|++.+|++.+..
T Consensus 255 p~~~~i~~~l~~ 266 (268)
T cd05063 255 PRFVDIVNLLDK 266 (268)
T ss_pred cCHHHHHHHHHh
Confidence 999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=316.00 Aligned_cols=300 Identities=20% Similarity=0.213 Sum_probs=205.7
Q ss_pred CCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 882 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~ 882 (1142)
.+++|++.++||+|+||.||+|.+. +..+++|+......... .... +.+|++++++++||||+++++++.+.
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~--~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG--FPIT----ALREIKILKKLKHPNVVPLIDMAVER 79 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC--cchh----HHHHHHHHHhcCCCCccchhhheecc
Confidence 4688999999999999999999984 56677877544322111 1112 25899999999999999999987654
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
... ........++||||+. ++|...+.. ....+++..+..++.||+.||.|||++||+|+||||+||++
T Consensus 80 ~~~------~~~~~~~~~lv~~~~~-~~l~~~~~~----~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~ 148 (311)
T cd07866 80 PDK------SKRKRGSVYMVTPYMD-HDLSGLLEN----PSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILI 148 (311)
T ss_pred ccc------ccccCceEEEEEecCC-cCHHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 321 0112336799999997 677777653 23469999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCccccccccccccccc-CCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH-RGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1041 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~-~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ 1041 (1142)
+.+ +.++|+|||++.............. ..........+++.|+|||.+.+ ...++.++|||||||++|
T Consensus 149 ~~~-------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~il~ 218 (311)
T cd07866 149 DNQ-------GILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLG---ERRYTTAVDIWGIGCVFA 218 (311)
T ss_pred CCC-------CCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhC---CCccCchhHhHHHHHHHH
Confidence 887 7899999999976543221111000 00111223457889999998765 235788999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhh---hcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001142 1042 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEA---LGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1118 (1142)
Q Consensus 1042 ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~ 1118 (1142)
+|++|++||.+.+.......+........+..+.. ......... ................+.+.+++.+||+.||.
T Consensus 219 el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 297 (311)
T cd07866 219 EMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHS-FTNYPRTLEERFGKLGPEGLDLLSKLLSLDPY 297 (311)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhccccccccc-CCCCCccHHHHcccCChhHHHHHHHHcccCcc
Confidence 99999999987776655544422211111111110 000000000 00000000000112346789999999999999
Q ss_pred CCCCHHHHHHHHHh
Q 001142 1119 ERPTAGDLYEMFVA 1132 (1142)
Q Consensus 1119 ~RPSa~EVL~~L~~ 1132 (1142)
+|||+.|++.|+|+
T Consensus 298 ~R~t~~ell~~~~f 311 (311)
T cd07866 298 KRLTASDALEHPYF 311 (311)
T ss_pred cCcCHHHHhcCCCC
Confidence 99999999999986
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=308.39 Aligned_cols=246 Identities=20% Similarity=0.356 Sum_probs=181.8
Q ss_pred eeecccCceEEEEEEECCc--------------cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeee
Q 001142 813 DEAGKSVSSSLFRCKFGSA--------------DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 878 (1142)
Q Consensus 813 ~~LG~GsfG~Vy~a~~~~~--------------~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~ 878 (1142)
+.||+|+||.||+|.+... .+++|+. ... ... ....+..|+.+++.++||||++++++
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~--~~~--~~~----~~~~~~~~~~~l~~l~hp~iv~~~~~ 72 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVL--DPS--HRD----ISLAFFETASMMRQVSHKHIVLLYGV 72 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeec--Chh--hhh----HHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 4689999999999986321 2444442 211 111 22234788999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 001142 879 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 958 (1142)
Q Consensus 879 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~ 958 (1142)
+...... ++||||+++++|..++.. ....+++..+..++.||+.||+|||++||+||||||+
T Consensus 73 ~~~~~~~--------------~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 134 (262)
T cd05077 73 CVRDVEN--------------IMVEEFVEFGPLDLFMHR----KSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTK 134 (262)
T ss_pred EecCCCC--------------EEEEecccCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcc
Confidence 8765433 899999999999988764 2246899999999999999999999999999999999
Q ss_pred CeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001142 959 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1038 (1142)
Q Consensus 959 NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGv 1038 (1142)
|||++.++........++++|||.+..... .....++..|+|||.+.. ...++.++|||||||
T Consensus 135 Nill~~~~~~~~~~~~~~l~d~g~~~~~~~--------------~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~ 197 (262)
T cd05077 135 NILLAREGIDGECGPFIKLSDPGIPITVLS--------------RQECVERIPWIAPECVED---SKNLSIAADKWSFGT 197 (262)
T ss_pred cEEEecCCccCCCCceeEeCCCCCCccccC--------------cccccccccccChhhhcC---CCCCCchhHHHHHHH
Confidence 999976532222234599999998864321 113457888999998763 246789999999999
Q ss_pred HHHHHH-hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001142 1039 LLLELL-TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1117 (1142)
Q Consensus 1039 iL~ELL-tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP 1117 (1142)
++|||+ +|..||......+.... ....... . ....+.+.+|+.+||+.||
T Consensus 198 ~l~el~~~~~~p~~~~~~~~~~~~-~~~~~~~-----------------------~-----~~~~~~~~~li~~cl~~dp 248 (262)
T cd05077 198 TLWEICYNGEIPLKDKTLAEKERF-YEGQCML-----------------------V-----TPSCKELADLMTHCMNYDP 248 (262)
T ss_pred HHHHHHhCCCCCCCCcchhHHHHH-HhcCccC-----------------------C-----CCChHHHHHHHHHHcCCCh
Confidence 999998 58888876443332211 1111000 0 0234568999999999999
Q ss_pred CCCCCHHHHHHHH
Q 001142 1118 TERPTAGDLYEMF 1130 (1142)
Q Consensus 1118 ~~RPSa~EVL~~L 1130 (1142)
.+||++.+|++++
T Consensus 249 ~~Rp~~~~il~~~ 261 (262)
T cd05077 249 NQRPFFRAIMRDI 261 (262)
T ss_pred hhCcCHHHHHHhc
Confidence 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=316.25 Aligned_cols=294 Identities=21% Similarity=0.236 Sum_probs=200.5
Q ss_pred CcceeeeecccCceEEEEEEE----CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKF----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~----~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
.|++.+.||+|+||.||+|.+ .+..+|+|+....... ...+...+.+|+.++++++||||+++++++.+..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQ-----YTGISQSACREIALLRELKHENVVSLVEVFLEHA 75 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEecccccc-----ccCccHHHHHHHHHHHhcCCCCccceEEEEeCCC
Confidence 478999999999999999998 3577888886543210 0111122368999999999999999999987642
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
. ...++||||++ ++|.+++..........+++..+..++.||+.||.|||+++|+||||||+||+++
T Consensus 76 ~------------~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~ 142 (316)
T cd07842 76 D------------KSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVM 142 (316)
T ss_pred C------------ceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEc
Confidence 1 24699999997 6788887654443334789999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.++ ...+.+||+|||++......... ........+++.|+|||++.+ ...++.++|||||||++++|
T Consensus 143 ~~~---~~~~~~kl~Dfg~~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~~l~~l 209 (316)
T cd07842 143 GEG---PERGVVKIGDLGLARLFNAPLKP-------LADLDPVVVTIWYRAPELLLG---ARHYTKAIDIWAIGCIFAEL 209 (316)
T ss_pred CCC---CccceEEECCCccccccCCCccc-------ccccCCccccccccCHHHHhC---CCCCCcHHHHHHHHHHHHHH
Confidence 721 11288999999999765432110 111223467899999998765 23578899999999999999
Q ss_pred HhCCCCCCCCCHHH---------HHHHHHhCCCCCchhHHhhhcccccccc---cccCCCCCCch----hhh--hhHHHH
Q 001142 1044 LTLQVPYMGLSELE---------IHDLIQMGKRPRLTDELEALGSCHEHEV---AQSGSGFEKPE----AEL--ETLSFL 1105 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~e---------l~~~I~~~~~p~l~~~l~~~~~~~~~~~---~~~~~~~~~~~----~~~--~~~~~L 1105 (1142)
++|+.||.+..... ....+...................+... ......+.... .+. ..+..+
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (316)
T cd07842 210 LTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQG 289 (316)
T ss_pred HhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHH
Confidence 99999997543221 1111111110111110000000000000 00000000000 011 345678
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHh
Q 001142 1106 VDVFRRCTEENPTERPTAGDLYEMFVA 1132 (1142)
Q Consensus 1106 ~dLI~~CL~~DP~~RPSa~EVL~~L~~ 1132 (1142)
.+++.+||+.||++|||+.|+++|+||
T Consensus 290 ~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 290 FDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=322.54 Aligned_cols=262 Identities=24% Similarity=0.369 Sum_probs=195.5
Q ss_pred CCCcceeeeecccCceEEEEEEE-------CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceee
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKF-------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYG 877 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~-------~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g 877 (1142)
.++|++.++||+|+||.||+|.+ .+..+|+|+.+... .......+ .+|+.++.++ +||||+++++
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~----~~E~~~l~~l~~h~niv~~~~ 78 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRAL----MSELKILIHIGHHLNVVNLLG 78 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC---ChHHHHHH----HHHHHHHHhccCCccHhhhcc
Confidence 35799999999999999999975 24567888754221 22223333 7899999999 6899999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc------------------------------------
Q 001142 878 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET------------------------------------ 921 (1142)
Q Consensus 878 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~------------------------------------ 921 (1142)
++...+. ..++||||+++|+|.+++......
T Consensus 79 ~~~~~~~-------------~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (343)
T cd05103 79 ACTKPGG-------------PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQ 145 (343)
T ss_pred eeecCCC-------------ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhcccccccc
Confidence 8765331 348999999999999998752100
Q ss_pred --------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccCCCCCeE
Q 001142 922 --------------------------GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 975 (1142)
Q Consensus 922 --------------------------~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~~~~~~v 975 (1142)
....+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~-------~~~ 218 (343)
T cd05103 146 SSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEN-------NVV 218 (343)
T ss_pred ccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCC-------CcE
Confidence 01247888899999999999999999999999999999999876 789
Q ss_pred EEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 001142 976 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLS 1054 (1142)
Q Consensus 976 KL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt-G~~Pf~~~~ 1054 (1142)
||+|||++......... .......++..|+|||++.+ ..++.++||||||+++|+|++ |..||....
T Consensus 219 kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 286 (343)
T cd05103 219 KICDFGLARDIYKDPDY--------VRKGDARLPLKWMAPETIFD----RVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 286 (343)
T ss_pred EEEecccccccccCcch--------hhcCCCCCCcceECcHHhcC----CCCCchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence 99999998754321110 01112335678999999865 567899999999999999997 999997643
Q ss_pred HH-HHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001142 1055 EL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1055 ~~-el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~ 1133 (1142)
.. .....+..+..+..+. ..++.+.+++.+||+.||.+|||+.||++++...
T Consensus 287 ~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 287 IDEEFCRRLKEGTRMRAPD---------------------------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred ccHHHHHHHhccCCCCCCC---------------------------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 32 2223333222211110 2334689999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=305.38 Aligned_cols=254 Identities=29% Similarity=0.435 Sum_probs=198.1
Q ss_pred CcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCC-ChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGS-SADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~-~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
+|+..+.||+|++|.||+|.. .+..+++|+........ .....+. +.+|+.++++++||||+++++++.+..
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~----~~~e~~~l~~~~h~~i~~~~~~~~~~~- 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQ----LEQEIALLSKLQHPNIVQYLGTEREED- 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHH----HHHHHHHHHhcCCCCchheeeeEecCC-
Confidence 477889999999999999987 46778888764432211 1222233 478999999999999999999887654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.||+|+||+|+||+++.
T Consensus 76 -------------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~ 137 (258)
T cd06632 76 -------------NLYIFLELVPGGSLAKLLKK-----YGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDT 137 (258)
T ss_pred -------------eEEEEEEecCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC
Confidence 34999999999999999976 235889999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||+|||.+....... ......|+..|+|||.+... ..++.++|+||||+++|+|+
T Consensus 138 ~-------~~~kl~d~~~~~~~~~~~-----------~~~~~~~~~~y~~pe~~~~~---~~~~~~~D~~slG~~l~~l~ 196 (258)
T cd06632 138 N-------GVVKLADFGMAKQVVEFS-----------FAKSFKGSPYWMAPEVIAQQ---GGYGLAADIWSLGCTVLEMA 196 (258)
T ss_pred C-------CCEEEccCccceeccccc-----------cccccCCCcceeCHHHhcCC---CCCCchhhhHHHHHHHHHHH
Confidence 7 789999999987543321 11234588999999998651 23789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHh-CCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1045 TLQVPYMGLSELEIHDLIQM-GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~-~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
+|+.||......+....+.. ...+.. ....++.+.+++.+||+.+|.+||++
T Consensus 197 ~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~li~~~l~~~p~~Rp~~ 249 (258)
T cd06632 197 TGKPPWSQLEGVAAVFKIGRSKELPPI---------------------------PDHLSDEAKDFILKCLQRDPSLRPTA 249 (258)
T ss_pred hCCCCcccCcHHHHHHHHHhcccCCCc---------------------------CCCcCHHHHHHHHHHhhcCcccCcCH
Confidence 99999976554333322221 111111 01345678999999999999999999
Q ss_pred HHHHHHHHh
Q 001142 1124 GDLYEMFVA 1132 (1142)
Q Consensus 1124 ~EVL~~L~~ 1132 (1142)
.+++.|+|+
T Consensus 250 ~~~l~~~~~ 258 (258)
T cd06632 250 AELLEHPFV 258 (258)
T ss_pred HHHhcCCCC
Confidence 999999874
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=320.47 Aligned_cols=290 Identities=19% Similarity=0.237 Sum_probs=203.1
Q ss_pred CCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
++|++.++||+|+||.||+|.+ .+..+|+|+.. .... ..... .+.+|+.++++++||||+++++++.....
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~--~~~~-~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 77 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKIS--PFEH-QTFCQ----RTLREIKILRRFKHENIIGILDIIRPPSF 77 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEec--cccc-chhHH----HHHHHHHHHHhCCCCCcCchhheeecccc
Confidence 5799999999999999999987 45667777643 1111 11222 23689999999999999999998765432
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
. .....++||||++ ++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 78 ~---------~~~~~~lv~e~~~-~~l~~~~~~------~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~ 141 (336)
T cd07849 78 E---------SFNDVYIVQELME-TDLYKLIKT------QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 141 (336)
T ss_pred c---------ccceEEEEehhcc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECC
Confidence 1 1235699999997 688887753 46899999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||+|||++......... ........||+.|+|||.+.+ ...++.++|||||||++|+|+
T Consensus 142 ~-------~~~kl~dfg~~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~DvwslGvil~el~ 204 (336)
T cd07849 142 N-------CDLKICDFGLARIADPEHDH-------TGFLTEYVATRWYRAPEIMLN---SKGYTKAIDIWSVGCILAEML 204 (336)
T ss_pred C-------CCEEECcccceeeccccccc-------cCCcCCcCcCCCccChHHhhC---CCCCCcHHHHHHHHHHHHHHH
Confidence 7 78999999998754332111 001123468999999998754 245789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccc---cCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ---SGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
+|+.||.+.+.......+...........+............. ..............+..+.+++.+||+.||++||
T Consensus 205 ~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp 284 (336)
T cd07849 205 SNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRI 284 (336)
T ss_pred hCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCc
Confidence 9999998765544333332211111111111110000000000 0000000001113466799999999999999999
Q ss_pred CHHHHHHHHHhhcCC
Q 001142 1122 TAGDLYEMFVARTSS 1136 (1142)
Q Consensus 1122 Sa~EVL~~L~~~~ss 1136 (1142)
|+.|+++|+|+..-.
T Consensus 285 t~~e~l~hp~~~~~~ 299 (336)
T cd07849 285 TVEEALAHPYLEQYH 299 (336)
T ss_pred CHHHHhcCccccccC
Confidence 999999999997553
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=315.41 Aligned_cols=269 Identities=22% Similarity=0.269 Sum_probs=202.0
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
++|++.+.||+|+||.||++.+. +..+++|....... ...... ..+.+|+.+++.++||||+++++.+...+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~----~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 74 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNL-ILRNQI----QQVFVERDILTFAENPFVVSMFCSFETKR- 74 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhh-hhHHHH----HHHHHHHHHHHhCCCCCeeeeEEEEecCC-
Confidence 36899999999999999999985 45677776432210 011112 23478999999999999999999987654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
+.++||||++|++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.
T Consensus 75 -------------~~~lv~e~~~g~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~ 136 (305)
T cd05609 75 -------------HLCMVMEYVEGGDCATLLKN-----IGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITS 136 (305)
T ss_pred -------------EEEEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECC
Confidence 34999999999999999976 246899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccc-----cCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA-----HRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~-----~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGvi 1039 (1142)
+ +.++|+|||.++............ ...........++..|+|||.+.. ..++.++|||||||+
T Consensus 137 ~-------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~v 205 (305)
T cd05609 137 M-------GHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR----QGYGKPVDWWAMGII 205 (305)
T ss_pred C-------CCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccC----CCCCchhhHHHHHHH
Confidence 7 789999999986421110000000 000001112357889999999865 467899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001142 1040 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1119 (1142)
Q Consensus 1040 L~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~ 1119 (1142)
+|||++|..||.+....++...+.....+... .....+..+.+++.+||+.||++
T Consensus 206 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~l~~~P~~ 260 (305)
T cd05609 206 LYEFLVGCVPFFGDTPEELFGQVISDDIEWPE-------------------------GDEALPADAQDLISRLLRQNPLE 260 (305)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC-------------------------ccccCCHHHHHHHHHHhccChhh
Confidence 99999999999877666655554433211100 00134566899999999999999
Q ss_pred CCC---HHHHHHHHHhhcC
Q 001142 1120 RPT---AGDLYEMFVARTS 1135 (1142)
Q Consensus 1120 RPS---a~EVL~~L~~~~s 1135 (1142)
||+ +.++++|+|+...
T Consensus 261 R~~~~~~~~ll~~~~~~~~ 279 (305)
T cd05609 261 RLGTGGAFEVKQHRFFLGL 279 (305)
T ss_pred ccCccCHHHHHhCccccCC
Confidence 998 7999999998654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=311.52 Aligned_cols=286 Identities=21% Similarity=0.254 Sum_probs=200.6
Q ss_pred CCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
+++|++.+.||+|++|+||+|.+. +..+++|...... ......+.+ .+|+.++++++||||+++++++.+..
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~----~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQ--EDEGVPSTA----IREISLLKEMQHGNIVRLQDVVHSEK 74 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcc--ccccchHHH----HHHHHHHHhccCCCEeeEEEEEecCC
Confidence 367999999999999999999974 5567887654322 111112223 68999999999999999999988654
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
+.++||||++ ++|.+++.. .....+++..+..++.||+.||+|||++||+|+||+|+||+++
T Consensus 75 --------------~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~ 136 (294)
T PLN00009 75 --------------RLYLVFEYLD-LDLKKHMDS---SPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLID 136 (294)
T ss_pred --------------eEEEEEeccc-ccHHHHHHh---CCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEE
Confidence 3599999996 688888754 2233468889999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.++ +.+||+|||++........ ......+++.|+|||++.+ ...++.++|||||||++|+|
T Consensus 137 ~~~------~~~kl~dfg~~~~~~~~~~----------~~~~~~~~~~y~~PE~~~~---~~~~~~~~Dv~slG~i~~~l 197 (294)
T PLN00009 137 RRT------NALKLADFGLARAFGIPVR----------TFTHEVVTLWYRAPEILLG---SRHYSTPVDIWSVGCIFAEM 197 (294)
T ss_pred CCC------CEEEEcccccccccCCCcc----------ccccCceeecccCHHHHhC---CCCCCcHHHHHHHHHHHHHH
Confidence 542 5799999999965432111 1112357889999999865 23578899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHh-CCCCCchhHHhhhcccccccccccC-CCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1044 LTLQVPYMGLSELEIHDLIQM-GKRPRLTDELEALGSCHEHEVAQSG-SGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~-~~~p~l~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
+||+.||......+....+.. ...+ ....+............... ............++.+.+++.+||+.+|++||
T Consensus 198 ~tg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp 276 (294)
T PLN00009 198 VNQKPLFPGDSEIDELFKIFRILGTP-NEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRI 276 (294)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCC-ChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCc
Confidence 999999987655444333321 1111 11111000000000000000 00000001114566789999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001142 1122 TAGDLYEMFVARTS 1135 (1142)
Q Consensus 1122 Sa~EVL~~L~~~~s 1135 (1142)
++.++++|+|+...
T Consensus 277 s~~~~l~~~~~~~~ 290 (294)
T PLN00009 277 TARAALEHEYFKDL 290 (294)
T ss_pred CHHHHhcCchHhHH
Confidence 99999999999854
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=326.01 Aligned_cols=347 Identities=22% Similarity=0.261 Sum_probs=252.0
Q ss_pred hhhhHHHHHHHhhhccCCCCcccccccccc-cCCCccceeEEeeCCchhhhhhhhcCCCCCCCCCCccchhhcccccccc
Q 001142 708 VCRHRAVLLKYLCDRVEPPVPCELVRGYLD-FQPHAWNTILVKKGDSWIRMIVDACRPHDIREEADPEYFIRYIPLYRTI 786 (1142)
Q Consensus 708 ~~~hr~~l~k~~~d~~~~~~~~~~~~g~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 786 (1142)
.++-|.++-.+|....-..+||=-.++..- ++.|....+.-.--....+.+...++..++....+..||.++..|.+.
T Consensus 99 ~~~~~~i~~~~l~~~~~~~~~~~s~~~~v~~~~~~l~~~~~~~lf~~~~~~~~~~L~~~pF~~f~~S~yf~rFlQWK~l- 177 (591)
T KOG0986|consen 99 KDKARQILDAYLMKELLACLPQFSSKDLVTHVQEHLLEKPPKDLFQPLARAICAYLRGDPFQEFLESDYFTRFLQWKWL- 177 (591)
T ss_pred hhhHHHHHHHHhhccccccCCCcchhhhhHHHhhhccccCchhhhHHHHHHHHHHhccchHhHhHHHHHHHHHHHHHHH-
Confidence 356677777777766544444322111111 111111110000011234666777889999999999999999999886
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHH
Q 001142 787 APFSTESDHSPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRML 864 (1142)
Q Consensus 787 ~~~~~~~~~~~~~~~~~~~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL 864 (1142)
+..|.+.+.|+..++||+|+||.||-++. ++.-+|.|. +++..... +.-+...+.|-.||
T Consensus 178 -------------E~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKk--L~KKRiKk---r~ge~maLnEk~iL 239 (591)
T KOG0986|consen 178 -------------ELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKK--LDKKRIKK---RKGETMALNEKQIL 239 (591)
T ss_pred -------------HhhhccccceeeeEEEecccccceeEEEEecchhhHHHHH--HHHHHHHH---hhhhHHhhHHHHHH
Confidence 33677778899999999999999998875 455555554 22211111 11123347899999
Q ss_pred hhCCCCCccceeeeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHH
Q 001142 865 GALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVE 944 (1142)
Q Consensus 865 ~~L~HpNIVkl~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~y 944 (1142)
.+++.+.||.+--.|++.+.+ |+||..|.||+|.-+|.. .+...|++..++.++.+|+.||+|
T Consensus 240 ~kV~s~FiVslaYAfeTkd~L--------------ClVLtlMNGGDLkfHiyn---~g~~gF~e~ra~FYAAEi~cGLeh 302 (591)
T KOG0986|consen 240 EKVSSPFIVSLAYAFETKDAL--------------CLVLTLMNGGDLKFHIYN---HGNPGFDEQRARFYAAEIICGLEH 302 (591)
T ss_pred HHhccCcEEEEeeeecCCCce--------------EEEEEeecCCceeEEeec---cCCCCCchHHHHHHHHHHHhhHHH
Confidence 999999999998888877654 999999999999999876 344679999999999999999999
Q ss_pred HHhCCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCC
Q 001142 945 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 1024 (1142)
Q Consensus 945 LHs~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~ 1024 (1142)
||+.+||+|||||+|||+|+. |+|.|+|+|+|..+..... ....+||.+|||||++..
T Consensus 303 lH~~~iVYRDLKPeNILLDd~-------GhvRISDLGLAvei~~g~~-----------~~~rvGT~GYMAPEvl~n---- 360 (591)
T KOG0986|consen 303 LHRRRIVYRDLKPENILLDDH-------GHVRISDLGLAVEIPEGKP-----------IRGRVGTVGYMAPEVLQN---- 360 (591)
T ss_pred HHhcceeeccCChhheeeccC-------CCeEeeccceEEecCCCCc-----------cccccCcccccCHHHHcC----
Confidence 999999999999999999988 8999999999987765321 224489999999999987
Q ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHH
Q 001142 1025 NLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF 1104 (1142)
Q Consensus 1025 ~~~s~ksDVwSLGviL~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1104 (1142)
..|+...|.||+||+||||+.|+.||.......-.+.+.+.... .. ..-....+++
T Consensus 361 e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~-------------------~~-----~ey~~kFS~e 416 (591)
T KOG0986|consen 361 EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE-------------------DP-----EEYSDKFSEE 416 (591)
T ss_pred CcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc-------------------ch-----hhcccccCHH
Confidence 55999999999999999999999999754332222222111000 00 0001256778
Q ss_pred HHHHHHHhcccCCCCCC-----CHHHHHHHHHhhcCC
Q 001142 1105 LVDVFRRCTEENPTERP-----TAGDLYEMFVARTSS 1136 (1142)
Q Consensus 1105 L~dLI~~CL~~DP~~RP-----Sa~EVL~~L~~~~ss 1136 (1142)
+++|.+..|+.||.+|. .+++|-+|++|+.-.
T Consensus 417 akslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ln 453 (591)
T KOG0986|consen 417 AKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLN 453 (591)
T ss_pred HHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCC
Confidence 99999999999999985 678999999998643
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=328.75 Aligned_cols=260 Identities=24% Similarity=0.330 Sum_probs=197.8
Q ss_pred CCCcceeeeecccCceEEEEEEECC-------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceee
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYG 877 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~~-------~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~g 877 (1142)
.++|.+.++||+|+||.||+|++.+ ..+|+|+.+.. . .....+. +.+|+.++.++. |||||++++
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~--~-~~~~~~~----~~~E~~~l~~l~~H~niv~~~~ 108 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKST--A-RSSEKQA----LMSELKIMSHLGPHLNIVNLLG 108 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCC--C-ChhHHHH----HHHHHHHHHhcCCCCCeEEEEE
Confidence 4568899999999999999999743 45788875422 1 1222223 378999999997 999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc-------------------------------------
Q 001142 878 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE------------------------------------- 920 (1142)
Q Consensus 878 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~------------------------------------- 920 (1142)
++..... .++||||+++|+|.++++....
T Consensus 109 ~~~~~~~--------------~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (401)
T cd05107 109 ACTKGGP--------------IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSES 174 (401)
T ss_pred EEccCCC--------------cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhcc
Confidence 9876543 3999999999999999975321
Q ss_pred --------------------------------------------------------cCCCCCCHHHHHHHHHHHHHHHHH
Q 001142 921 --------------------------------------------------------TGEKHVSVKLALFIAQDVAAALVE 944 (1142)
Q Consensus 921 --------------------------------------------------------~~~~~ls~~~i~~Ia~qIa~gL~y 944 (1142)
.....+++..+..|+.||+.||+|
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~ 254 (401)
T cd05107 175 DGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEF 254 (401)
T ss_pred CccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHH
Confidence 011246788899999999999999
Q ss_pred HHhCCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCC
Q 001142 945 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 1024 (1142)
Q Consensus 945 LHs~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~ 1024 (1142)
||+++|+||||||+|||++.+ +.+||+|||+++........ .......++..|+|||.+.+
T Consensus 255 LH~~~ivHrdlkp~NiLl~~~-------~~~kL~DfGla~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~---- 315 (401)
T cd05107 255 LASKNCVHRDLAARNVLICEG-------KLVKICDFGLARDIMRDSNY--------ISKGSTFLPLKWMAPESIFN---- 315 (401)
T ss_pred HhcCCcCcccCCcceEEEeCC-------CEEEEEecCcceeccccccc--------ccCCCcCCCCceeChHHhcC----
Confidence 999999999999999999876 78999999999754321110 01122356788999999875
Q ss_pred CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH-HHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhH
Q 001142 1025 NLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIH-DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETL 1102 (1142)
Q Consensus 1025 ~~~s~ksDVwSLGviL~ELLt-G~~Pf~~~~~~el~-~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1102 (1142)
..++.++|||||||++|||++ |..||......+.. ..+..+..+..+ ...+
T Consensus 316 ~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p---------------------------~~~~ 368 (401)
T cd05107 316 NLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKP---------------------------AHAS 368 (401)
T ss_pred CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCCC---------------------------CCCC
Confidence 567899999999999999998 89999765444432 333332221111 1345
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 001142 1103 SFLVDVFRRCTEENPTERPTAGDLYEMFVA 1132 (1142)
Q Consensus 1103 ~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~ 1132 (1142)
..+.+|+.+||..+|.+||++++|++.|..
T Consensus 369 ~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 398 (401)
T cd05107 369 DEIYEIMQKCWEEKFEIRPDFSQLVHLVGD 398 (401)
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 679999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=316.31 Aligned_cols=260 Identities=26% Similarity=0.438 Sum_probs=202.0
Q ss_pred CCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
..+|++.+.||+|+||.||++.. .+..+++|...... ....+.+ .+|+.++++++||||+++++.+....
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~----~~e~~~l~~l~hp~i~~~~~~~~~~~ 89 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ----QPKKELI----INEILVMRENKHPNIVNYLDSYLVGD 89 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc----chHHHHH----HHHHHHHhhcCCCCeeehhheeeeCC
Confidence 46899999999999999999986 45667888754321 1222333 78999999999999999999987654
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
..++||||+++++|.+++.+ ..+++..+..++.|++.||.|||++|++|+||||+||+++
T Consensus 90 --------------~~~lv~e~~~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~ 149 (293)
T cd06647 90 --------------ELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG 149 (293)
T ss_pred --------------cEEEEEecCCCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEc
Confidence 34999999999999999875 3578999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.++|+|||.+........ ......|++.|+|||.+.. ..++.++||||||+++|++
T Consensus 150 ~~-------~~~kL~dfg~~~~~~~~~~----------~~~~~~~~~~y~~PE~~~~----~~~~~~~Dv~slG~ll~~l 208 (293)
T cd06647 150 MD-------GSVKLTDFGFCAQITPEQS----------KRSTMVGTPYWMAPEVVTR----KAYGPKVDIWSLGIMAIEM 208 (293)
T ss_pred CC-------CCEEEccCcceeccccccc----------ccccccCChhhcCchhhcc----CCCCchhhHHHHHHHHHHH
Confidence 77 7899999998865432211 1123458889999999865 4578899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
++|+.||...........+.....+... .....+..+.+++.+||..+|.+||++
T Consensus 209 l~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~l~~li~~~l~~~p~~Rp~~ 263 (293)
T cd06647 209 VEGEPPYLNENPLRALYLIATNGTPELQ-------------------------NPEKLSAIFRDFLNRCLEMDVEKRGSA 263 (293)
T ss_pred HhCCCCCCCCChhhheeehhcCCCCCCC-------------------------CccccCHHHHHHHHHHccCChhhCcCH
Confidence 9999999865543322222111111100 001345568999999999999999999
Q ss_pred HHHHHHHHhhcCCCCC
Q 001142 1124 GDLYEMFVARTSSSIS 1139 (1142)
Q Consensus 1124 ~EVL~~L~~~~ss~~s 1139 (1142)
.+++.|.|++..-..+
T Consensus 264 ~~il~h~~~~~~~~~~ 279 (293)
T cd06647 264 KELLQHPFLKIAKPLS 279 (293)
T ss_pred HHHhcCHHHhcCcccc
Confidence 9999999998665443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=303.85 Aligned_cols=253 Identities=24% Similarity=0.357 Sum_probs=187.7
Q ss_pred eeecccCceEEEEEEECC-----ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCC
Q 001142 813 DEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 887 (1142)
Q Consensus 813 ~~LG~GsfG~Vy~a~~~~-----~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~ 887 (1142)
+.||+|+||.||+|.+.. ..+|+|. .... ......+.+ .+|+.+++.++||||+++++++...+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~--~~~~-~~~~~~~~~----~~e~~~l~~l~h~~iv~~~~~~~~~~~--- 70 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKS--LNRI-TDLEEVEQF----LKEGIIMKDFSHPNVLSLLGICLPSEG--- 70 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEe--cCcc-CCHHHHHHH----HHHHHHHccCCCCCcceEEEEeecCCC---
Confidence 468999999999998632 2455554 3221 122223333 789999999999999999997654221
Q ss_pred CCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccc
Q 001142 888 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 967 (1142)
Q Consensus 888 ~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~ 967 (1142)
..++||||+++++|.+++... ....++..+..++.||+.||.|||+.+|+||||||+|||++.+
T Consensus 71 ----------~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~-- 134 (262)
T cd05058 71 ----------SPLVVLPYMKHGDLRNFIRSE----THNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDES-- 134 (262)
T ss_pred ----------CcEEEEecCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCC--
Confidence 238999999999999999752 2346778889999999999999999999999999999999877
Q ss_pred cCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-C
Q 001142 968 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-L 1046 (1142)
Q Consensus 968 ~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt-G 1046 (1142)
+.+||+|||+++......... ........++..|+|||.+.. ..++.++|||||||++|||++ |
T Consensus 135 -----~~~kl~dfg~~~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~el~~~~ 199 (262)
T cd05058 135 -----FTVKVADFGLARDIYDKEYYS------VHNHTGAKLPVKWMALESLQT----QKFTTKSDVWSFGVLLWELMTRG 199 (262)
T ss_pred -----CcEEECCccccccccCCccee------ecccccCcCCccccChhHhcc----CccchHHHHHHHHHHHHHHHcCC
Confidence 789999999987543211100 001112346778999999865 467899999999999999999 5
Q ss_pred CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 001142 1047 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1126 (1142)
Q Consensus 1047 ~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EV 1126 (1142)
.+||......+....+..+..+..+ ...++.+.+++.+||+.+|++||++.++
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i 252 (262)
T cd05058 200 APPYPDVDSFDITVYLLQGRRLLQP---------------------------EYCPDPLYEVMLSCWHPKPEMRPTFSEL 252 (262)
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCCC---------------------------CcCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 6677766555555444333222111 0334568999999999999999999999
Q ss_pred HHHHHhh
Q 001142 1127 YEMFVAR 1133 (1142)
Q Consensus 1127 L~~L~~~ 1133 (1142)
++.+...
T Consensus 253 l~~l~~~ 259 (262)
T cd05058 253 VSRIEQI 259 (262)
T ss_pred HHHHHHH
Confidence 9987654
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=343.28 Aligned_cols=292 Identities=18% Similarity=0.205 Sum_probs=192.0
Q ss_pred CCCcceeeeecccCceEEEEEEECCc---cEEEEEEeccc---------CCCChHHHHHhHHhHHHHHHHHhhCCCCCcc
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFGSA---DAAAKVRTLKV---------CGSSADEIRNFEYSCLGEVRMLGALRHSCIV 873 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~~~---~vAvKi~~l~~---------~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV 873 (1142)
..+|++.++||+|+||+||+|.+... ..+.|...... ..............+.+|+.++++++|||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 46799999999999999999876321 11111000000 0000000111223457999999999999999
Q ss_pred ceeeeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 001142 874 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 953 (1142)
Q Consensus 874 kl~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHr 953 (1142)
++++++...+. .|+|||++. ++|..++...............+..|+.||+.||.|||++|||||
T Consensus 227 ~l~~~~~~~~~--------------~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHr 291 (501)
T PHA03210 227 KIEEILRSEAN--------------TYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHR 291 (501)
T ss_pred cEeEEEEECCe--------------eEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 99999987553 399999996 788887754221112234567788999999999999999999999
Q ss_pred CCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhH
Q 001142 954 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 1033 (1142)
Q Consensus 954 DLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDV 1033 (1142)
||||+|||++.+ +.+||+|||+++.+...... ......||+.|+|||++.+ ..++.++||
T Consensus 292 DLKP~NILl~~~-------~~vkL~DFGla~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~----~~~~~~~Di 351 (501)
T PHA03210 292 DIKLENIFLNCD-------GKIVLGDFGTAMPFEKEREA---------FDYGWVGTVATNSPEILAG----DGYCEITDI 351 (501)
T ss_pred CCCHHHEEECCC-------CCEEEEeCCCceecCccccc---------ccccccCCcCCCCchhhcC----CCCCcHHHH
Confidence 999999999887 78999999999765432111 1123469999999999876 568899999
Q ss_pred HHHHHHHHHHHhCCCC-CCCC--CH-HHHHHHHHhCCC-----CCchhH-HhhhcccccccccccCCCCCCchhhhhhHH
Q 001142 1034 WSYGCLLLELLTLQVP-YMGL--SE-LEIHDLIQMGKR-----PRLTDE-LEALGSCHEHEVAQSGSGFEKPEAELETLS 1103 (1142)
Q Consensus 1034 wSLGviL~ELLtG~~P-f~~~--~~-~el~~~I~~~~~-----p~l~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1103 (1142)
|||||++|||++|..+ |... .. .++.+.+..... +..... +.... ..............-.....+.
T Consensus 352 wSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~---~~~~~~~~~~~~~~~~~~~~~~ 428 (501)
T PHA03210 352 WSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYID---SAEIDHAGHSVPPLIRNLGLPA 428 (501)
T ss_pred HHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhh---hhhcccCccchhhHHHhcCCCh
Confidence 9999999999998754 4322 12 223333322111 110000 00000 0000000000000001113456
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001142 1104 FLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1104 ~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~~s 1135 (1142)
.+.+++.+||+.||.+|||+.|++.|+||...
T Consensus 429 ~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 429 DFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 68889999999999999999999999999754
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=313.74 Aligned_cols=267 Identities=21% Similarity=0.297 Sum_probs=195.1
Q ss_pred CCCCcceeeeecccCceEEEEEEECC--------------c--cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKFGS--------------A--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR 868 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~~~--------------~--~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~ 868 (1142)
...+|++.++||+|+||.||+|.+.+ . .+|+|+.. .. ........+ .+|++++++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~--~~-~~~~~~~~~----~~ei~~l~~l~ 75 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLR--AD-VTKTARNDF----LKEIKIMSRLK 75 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecC--CC-CCHHHHHHH----HHHHHHHHhCC
Confidence 34589999999999999999987632 2 25565533 21 122223334 78999999999
Q ss_pred CCCccceeeeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc-------CCCCCCHHHHHHHHHHHHHH
Q 001142 869 HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-------GEKHVSVKLALFIAQDVAAA 941 (1142)
Q Consensus 869 HpNIVkl~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~-------~~~~ls~~~i~~Ia~qIa~g 941 (1142)
||||+++++++..... .++||||+++++|.+++...... ....+++..+..++.|++.|
T Consensus 76 h~~i~~~~~~~~~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~a 141 (295)
T cd05097 76 NPNIIRLLGVCVSDDP--------------LCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASG 141 (295)
T ss_pred CCCcCeEEEEEcCCCc--------------cEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHH
Confidence 9999999999876543 49999999999999998652110 11246888999999999999
Q ss_pred HHHHHhCCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccc
Q 001142 942 LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 1021 (1142)
Q Consensus 942 L~yLHs~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~ 1021 (1142)
|+|||++|++||||||+||+++.+ +.+||+|||++......... .......++..|+|||++..
T Consensus 142 l~~lH~~~i~H~dlkp~Nill~~~-------~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~- 205 (295)
T cd05097 142 MKYLASLNFVHRDLATRNCLVGNH-------YTIKIADFGMSRNLYSGDYY--------RIQGRAVLPIRWMAWESILL- 205 (295)
T ss_pred HHHHHhcCeeccccChhhEEEcCC-------CcEEecccccccccccCcce--------eccCcCcCceeecChhhhcc-
Confidence 999999999999999999999876 78999999998754321110 01122345778999999875
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhh
Q 001142 1022 HKPNLYGLEVDIWSYGCLLLELLT--LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 1099 (1142)
Q Consensus 1022 ~~~~~~s~ksDVwSLGviL~ELLt--G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 1099 (1142)
..++.++|||||||++|+|++ +..||......+....+......... .. ......
T Consensus 206 ---~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~---------------~~-----~~~~~~ 262 (295)
T cd05097 206 ---GKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGR---------------QI-----YLSQTP 262 (295)
T ss_pred ---CCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccc---------------cc-----cCCCCC
Confidence 457899999999999999988 67888766655544333211000000 00 000001
Q ss_pred hhHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 001142 1100 ETLSFLVDVFRRCTEENPTERPTAGDLYEMFV 1131 (1142)
Q Consensus 1100 ~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~ 1131 (1142)
..++.+.+|+.+||+.||++|||+++|++.+.
T Consensus 263 ~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 263 LCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 34567999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=314.16 Aligned_cols=259 Identities=24% Similarity=0.374 Sum_probs=196.5
Q ss_pred CCCCCcceeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccce
Q 001142 804 GSFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 875 (1142)
Q Consensus 804 ~~~~~y~l~~~LG~GsfG~Vy~a~~~-------~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl 875 (1142)
...++|.+.+.||+|+||.||+|.+. ...+|+|+.+ ... .....+.+ .+|+.+++++ +||||+++
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~--~~~-~~~~~~~~----~~E~~~l~~l~~h~~iv~~ 104 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLK--PTA-HSSEREAL----MSELKIMSHLGNHENIVNL 104 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecC--ccC-ChHHHHHH----HHHHHHHHhccCCCCcceE
Confidence 44567999999999999999999752 2246666533 211 12222333 7899999999 79999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 001142 876 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 955 (1142)
Q Consensus 876 ~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDL 955 (1142)
++++...+. .++||||+++++|.++++. .....+++..+..++.||+.||+|||+++|+|+||
T Consensus 105 ~~~~~~~~~--------------~~lv~e~~~~~~L~~~i~~---~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dl 167 (302)
T cd05055 105 LGACTIGGP--------------ILVITEYCCYGDLLNFLRR---KRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDL 167 (302)
T ss_pred EEEEecCCc--------------eEEEEEcCCCCcHHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhh
Confidence 999876543 4999999999999999975 22234899999999999999999999999999999
Q ss_pred CCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHH
Q 001142 956 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 1035 (1142)
Q Consensus 956 Kp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwS 1035 (1142)
||+|||++.+ +.++|+|||.+......... .......++..|+|||.+.+ ..++.++||||
T Consensus 168 kp~Nil~~~~-------~~~~l~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Diws 228 (302)
T cd05055 168 AARNVLLTHG-------KIVKICDFGLARDIMNDSNY--------VVKGNARLPVKWMAPESIFN----CVYTFESDVWS 228 (302)
T ss_pred ccceEEEcCC-------CeEEECCCcccccccCCCce--------eecCCCCcccccCCHhhhcc----CCCCcHhHHHH
Confidence 9999999876 78999999999755332111 01112346788999999875 45789999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCHHHHH-HHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 001142 1036 YGCLLLELLT-LQVPYMGLSELEIH-DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 1113 (1142)
Q Consensus 1036 LGviL~ELLt-G~~Pf~~~~~~el~-~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL 1113 (1142)
|||++|+|++ |..||......+.. ..+..+..+..+ ...++.+.+++.+||
T Consensus 229 lGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~cl 281 (302)
T cd05055 229 YGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQP---------------------------EHAPAEIYDIMKTCW 281 (302)
T ss_pred HHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCC---------------------------CCCCHHHHHHHHHHc
Confidence 9999999998 99999875544333 222222111100 023456999999999
Q ss_pred ccCCCCCCCHHHHHHHHHh
Q 001142 1114 EENPTERPTAGDLYEMFVA 1132 (1142)
Q Consensus 1114 ~~DP~~RPSa~EVL~~L~~ 1132 (1142)
..+|++|||+.|+++.+..
T Consensus 282 ~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 282 DADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred CCCchhCcCHHHHHHHHHh
Confidence 9999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=307.83 Aligned_cols=261 Identities=22% Similarity=0.332 Sum_probs=185.4
Q ss_pred eeecccCceEEEEEEE-CCccEEEEEEe-cccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCCC
Q 001142 813 DEAGKSVSSSLFRCKF-GSADAAAKVRT-LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADG 890 (1142)
Q Consensus 813 ~~LG~GsfG~Vy~a~~-~~~~vAvKi~~-l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~~~~ 890 (1142)
+.||+|+||.||+|.+ ....++.++.+ ++. .......+. +.+|+.+++.++||||+++++.+.+...
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~----~~~e~~~~~~l~h~~iv~~~~~~~~~~~------ 69 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKA-NASSKEQNE----FLQQGDPYRILQHPNILQCLGQCVEAIP------ 69 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecC-CCChHHHHH----HHHHHHHHhccCCcchhheEEEecCCCc------
Confidence 4699999999999975 33333322222 222 112222333 3799999999999999999999876543
Q ss_pred CCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccCC
Q 001142 891 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 970 (1142)
Q Consensus 891 ~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~~ 970 (1142)
.++||||+++++|.++++.... ....+++..+..++.||+.||+|||+++|+||||||+|||++.+
T Consensus 70 --------~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~----- 135 (268)
T cd05086 70 --------YLLVFEYCELGDLKSYLSQEQW-HRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSD----- 135 (268)
T ss_pred --------cEEEEecCCCCcHHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCC-----
Confidence 4999999999999999976321 12356777889999999999999999999999999999999877
Q ss_pred CCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhcccc---CCCCCCchhhHHHHHHHHHHHHh-C
Q 001142 971 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH---KPNLYGLEVDIWSYGCLLLELLT-L 1046 (1142)
Q Consensus 971 ~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~---~~~~~s~ksDVwSLGviL~ELLt-G 1046 (1142)
+.++|+|||.+........ ........++..|+|||++.... ....++.++|||||||++|||++ +
T Consensus 136 --~~~~l~Dfg~~~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~ 205 (268)
T cd05086 136 --LTVKVGDYGIGPSRYKEDY--------IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENA 205 (268)
T ss_pred --ccEEecccccccccCcchh--------hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCC
Confidence 7899999998753221100 00112345788999999975321 12345789999999999999997 5
Q ss_pred CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 001142 1047 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1126 (1142)
Q Consensus 1047 ~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EV 1126 (1142)
..||......+....+.......+.. +......++.+.+++..|| .+|++||++++|
T Consensus 206 ~~p~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i 262 (268)
T cd05086 206 AQPYSHLSDREVLNHVIKDQQVKLFK----------------------PQLELPYSERWYEVLQFCW-LSPEKRATAEEV 262 (268)
T ss_pred CCCCCCCCHHHHHHHHHhhcccccCC----------------------CccCCCCcHHHHHHHHHHh-hCcccCCCHHHH
Confidence 77887766655554443222111110 0001134566888999999 679999999999
Q ss_pred HHHHH
Q 001142 1127 YEMFV 1131 (1142)
Q Consensus 1127 L~~L~ 1131 (1142)
++.+.
T Consensus 263 ~~~l~ 267 (268)
T cd05086 263 HRLLT 267 (268)
T ss_pred HHHhc
Confidence 98763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=311.67 Aligned_cols=282 Identities=25% Similarity=0.310 Sum_probs=199.0
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
.+|++.+.||+|++|.||+|.+. +..+++|+.+... .... ....+.+|++++++++|+||+++++++...+
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~--~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 73 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESE--DDED----VKKTALREVKVLRQLRHENIVNLKEAFRRKG- 73 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhc--cccc----chhHHHHHHHHHHhcCCCCeeehhheEEECC-
Confidence 36899999999999999999984 5567777643322 1111 2233478999999999999999999987644
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
..++||||++++.+..+... ...+++..+..++.||+.||.|||++||+|+||+|+||+++.
T Consensus 74 -------------~~~iv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~ 135 (288)
T cd07833 74 -------------RLYLVFEYVERTLLELLEAS-----PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSE 135 (288)
T ss_pred -------------EEEEEEecCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC
Confidence 35999999997666655543 245899999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||+|||.+........ .......++..|+|||++.+. ..++.++||||||+++|+|+
T Consensus 136 ~-------~~~kl~d~g~~~~~~~~~~---------~~~~~~~~~~~~~~PE~~~~~---~~~~~~~Dv~slG~~l~~l~ 196 (288)
T cd07833 136 S-------GVLKLCDFGFARALRARPA---------SPLTDYVATRWYRAPELLVGD---TNYGKPVDVWAIGCIMAELL 196 (288)
T ss_pred C-------CCEEEEeeecccccCCCcc---------ccccCcccccCCcCCchhcCC---CCcCchhhHHHHHHHHHHHH
Confidence 7 7899999999876543221 011234578899999998761 26789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccc---cccccCCCCCCc-hhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEH---EVAQSGSGFEKP-EAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~---~~~~~~~~~~~~-~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
+|+.||.+....+....+........+............ ............ ......+..+.+++.+||..+|++|
T Consensus 197 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 276 (288)
T cd07833 197 DGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKER 276 (288)
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhc
Confidence 999999876554433333221111111100000000000 000000000000 0001236779999999999999999
Q ss_pred CCHHHHHHHHHh
Q 001142 1121 PTAGDLYEMFVA 1132 (1142)
Q Consensus 1121 PSa~EVL~~L~~ 1132 (1142)
||++++++|+|+
T Consensus 277 ps~~~il~~~~f 288 (288)
T cd07833 277 LTCDELLQHPYF 288 (288)
T ss_pred ccHHHHhcCCCC
Confidence 999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=309.53 Aligned_cols=254 Identities=30% Similarity=0.424 Sum_probs=199.3
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
++|++.+.||+|++|.||+|.+. +..+++|..... .. ....+. +.+|+.++++++||||+++++.+....
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~-~~~~~~----~~~e~~~l~~~~~~~i~~~~~~~~~~~- 72 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLE--IN-EAIQKQ----ILRELDILHKCNSPYIVGFYGAFYNNG- 72 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecc--cC-hHHHHH----HHHHHHHHHHCCCCchhhhheeeecCC-
Confidence 36888999999999999999985 566777765432 11 222233 378999999999999999999987654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeeec
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILID 963 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs-~gIvHrDLKp~NILld 963 (1142)
..++||||+++++|.+++... ...+++..+..++.|++.||+|||+ .|++|+||||+||+++
T Consensus 73 -------------~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~ 135 (265)
T cd06605 73 -------------DISICMEYMDGGSLDKILKEV----QGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVN 135 (265)
T ss_pred -------------EEEEEEEecCCCcHHHHHHHc----cCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEEC
Confidence 459999999999999999762 1568999999999999999999999 9999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.++|+|||.+........ ....++..|+|||.+.+ ..++.++||||||+++|+|
T Consensus 136 ~~-------~~~~l~d~g~~~~~~~~~~------------~~~~~~~~y~~PE~~~~----~~~~~~~Dv~slG~~l~~l 192 (265)
T cd06605 136 SR-------GQIKLCDFGVSGQLVNSLA------------KTFVGTSSYMAPERIQG----NDYSVKSDIWSLGLSLIEL 192 (265)
T ss_pred CC-------CCEEEeecccchhhHHHHh------------hcccCChhccCHHHHcC----CCCCchhhHHHHHHHHHHH
Confidence 87 7899999999865432110 11457889999999876 4678999999999999999
Q ss_pred HhCCCCCCCCC-----HHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001142 1044 LTLQVPYMGLS-----ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1118 (1142)
Q Consensus 1044 LtG~~Pf~~~~-----~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~ 1118 (1142)
++|+.||.... ..+..+.+.....+..+. ...+..+.++|.+||..||+
T Consensus 193 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~li~~~l~~~p~ 246 (265)
T cd06605 193 ATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPS--------------------------GKFSPDFQDFVNLCLIKDPR 246 (265)
T ss_pred HhCCCCCCccccccccHHHHHHHHhcCCCCCCCh--------------------------hhcCHHHHHHHHHHcCCCch
Confidence 99999996532 122222222222211110 02456799999999999999
Q ss_pred CCCCHHHHHHHHHhhc
Q 001142 1119 ERPTAGDLYEMFVART 1134 (1142)
Q Consensus 1119 ~RPSa~EVL~~L~~~~ 1134 (1142)
+|||+.+++.|+|++.
T Consensus 247 ~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 247 ERPSYKELLEHPFIKK 262 (265)
T ss_pred hCcCHHHHhhCchhhc
Confidence 9999999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=305.89 Aligned_cols=261 Identities=29% Similarity=0.473 Sum_probs=200.1
Q ss_pred CcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
+|.+.+.||+|+||.||+|.. .+..+++|+...... .....+ .+..|+.++++++|+||+++++.+...+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~----~~~~e~~~~~~l~~~~i~~~~~~~~~~~-- 72 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN--DPKTIK----EIADEMKVLELLKHPNLVKYYGVEVHRE-- 72 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc--chHHHH----HHHHHHHHHHhCCCCChhheeeeEecCC--
Confidence 588999999999999999987 456788887654322 222333 3489999999999999999999876544
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.||+|+||+|+||+++.+
T Consensus 73 ------------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~ 135 (264)
T cd06626 73 ------------KVYIFMEYCSGGTLEELLEH-----GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHN 135 (264)
T ss_pred ------------EEEEEEecCCCCcHHHHHhh-----cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC
Confidence 35999999999999999875 2357899999999999999999999999999999999999886
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+.+||+|||.+........... .......+++.|+|||++.+.. ...++.++||||||+++|+|++
T Consensus 136 -------~~~kl~d~g~~~~~~~~~~~~~------~~~~~~~~~~~~~~PE~~~~~~-~~~~~~~~Dv~s~G~il~~l~~ 201 (264)
T cd06626 136 -------GVIKLGDFGCAVKLKNNTTTMG------EEVQSLAGTPAYMAPEVITGGK-GKGHGRAADIWSLGCVVLEMAT 201 (264)
T ss_pred -------CCEEEcccccccccCCCCCccc------ccccCCcCCcCccChhhccCCC-CCCCCcccchHHHHHHHHHHHh
Confidence 7899999999876543221110 0011245788999999987522 1237899999999999999999
Q ss_pred CCCCCCCCCH-HHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001142 1046 LQVPYMGLSE-LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124 (1142)
Q Consensus 1046 G~~Pf~~~~~-~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~ 1124 (1142)
|+.||..... ......+.....+.++.. ...+..+.+++.+||+.+|.+|||+.
T Consensus 202 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~li~~~l~~~p~~R~~~~ 256 (264)
T cd06626 202 GKRPWSELDNEFQIMFHVGAGHKPPIPDS-------------------------LQLSPEGKDFLDRCLESDPKKRPTAS 256 (264)
T ss_pred CCCCccCCcchHHHHHHHhcCCCCCCCcc-------------------------cccCHHHHHHHHHHccCCcccCCCHH
Confidence 9999976432 222222222222221110 13356688999999999999999999
Q ss_pred HHHHHHHh
Q 001142 1125 DLYEMFVA 1132 (1142)
Q Consensus 1125 EVL~~L~~ 1132 (1142)
+++.|+|.
T Consensus 257 ~i~~~~~~ 264 (264)
T cd06626 257 ELLQHPFV 264 (264)
T ss_pred HHhcCCCC
Confidence 99999884
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=309.19 Aligned_cols=272 Identities=24% Similarity=0.372 Sum_probs=194.1
Q ss_pred CCcceeeeecccCceEEEEEEE------CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKF------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 880 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~------~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~ 880 (1142)
.+|++.+.||+|+||.||+|.+ .+..+++|..... .....+.+ .+|++++++++||||+++++++.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~----~~~~~~~~----~~e~~~l~~l~h~~iv~~~~~~~ 75 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS----TAEHLRDF----EREIEILKSLQHDNIVKYKGVCY 75 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC----CHHHHHHH----HHHHHHHHhCCCCCeeEEEEEEc
Confidence 3689999999999999999975 2456777764321 22333344 78999999999999999999875
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NI 960 (1142)
..+. ...++||||+++++|.+++... ...+++..+..++.|++.||+|||++||+||||||+||
T Consensus 76 ~~~~------------~~~~lv~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~ni 139 (284)
T cd05081 76 SAGR------------RNLRLVMEYLPYGSLRDYLQKH----RERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNI 139 (284)
T ss_pred cCCC------------CceEEEEEecCCCCHHHHHHhc----CcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhE
Confidence 4321 1359999999999999999751 23589999999999999999999999999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
+++.+ +.+||+|||++........... ......++..|+|||++.+ ..++.++|||||||++
T Consensus 140 li~~~-------~~~~l~dfg~~~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l 201 (284)
T cd05081 140 LVESE-------NRVKIGDFGLTKVLPQDKEYYK-------VREPGESPIFWYAPESLTE----SKFSVASDVWSFGVVL 201 (284)
T ss_pred EECCC-------CeEEECCCcccccccCCCccee-------ecCCCCCceEeeCHHHhcc----CCcChHHHHHHHHHHH
Confidence 99877 7899999999976543211100 0111124456999999865 5678999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCC-CCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001142 1041 LELLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1119 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~~~~~el~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~ 1119 (1142)
|||++|..|+.... ......+..... +.....+... ....... ......+..+.+++.+||..+|++
T Consensus 202 ~el~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~ 269 (284)
T cd05081 202 YELFTYSDKSCSPP-AEFMRMMGNDKQGQMIVYHLIEL--------LKNNGRL---PAPPGCPAEIYAIMKECWNNDPSQ 269 (284)
T ss_pred HHHhhcCCcCCCcc-hhhhhhcccccccccchHHHHHH--------HhcCCcC---CCCCCCCHHHHHHHHHHccCChhh
Confidence 99999987765432 122222211111 1111111000 0000000 011245667999999999999999
Q ss_pred CCCHHHHHHHHHh
Q 001142 1120 RPTAGDLYEMFVA 1132 (1142)
Q Consensus 1120 RPSa~EVL~~L~~ 1132 (1142)
|||+.||++.+..
T Consensus 270 Rpt~~ei~~~l~~ 282 (284)
T cd05081 270 RPSFSELALQVEA 282 (284)
T ss_pred CCCHHHHHHHHHh
Confidence 9999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=307.64 Aligned_cols=257 Identities=23% Similarity=0.355 Sum_probs=198.4
Q ss_pred CCCCcceeeeecccCceEEEEEEECC--c----cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeee
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKFGS--A----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 878 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~~~--~----~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~ 878 (1142)
...+|++.+.||+|+||.||+|.+.. . .+++|+. +... .......+ .+|+.++++++||||++++++
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~--~~~~-~~~~~~~~----~~e~~~l~~l~h~~i~~~~~~ 77 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVL--REET-SPKANKEI----LDEAYVMASVDHPHVVRLLGI 77 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEec--cCCC-CHHHHHHH----HHHHHHHHhCCCCCcceEEEE
Confidence 34678999999999999999998732 2 3555543 2221 12222333 789999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 001142 879 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 958 (1142)
Q Consensus 879 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~ 958 (1142)
+.. . ..++||||+++++|.+++.. ....+++..+..++.||+.||+|||++||+||||||+
T Consensus 78 ~~~-~--------------~~~~v~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~ 138 (279)
T cd05057 78 CLS-S--------------QVQLITQLMPLGCLLDYVRN----HKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAAR 138 (279)
T ss_pred Eec-C--------------ceEEEEecCCCCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcc
Confidence 875 2 34999999999999999875 1235899999999999999999999999999999999
Q ss_pred CeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001142 959 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1038 (1142)
Q Consensus 959 NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGv 1038 (1142)
||+++.+ +.+||+|||.++......... ......++..|+|||.+.. ..++.++||||||+
T Consensus 139 nil~~~~-------~~~kL~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~slG~ 199 (279)
T cd05057 139 NVLVKTP-------QHVKITDFGLAKLLDVDEKEY--------HAEGGKVPIKWMALESILH----RIYTHKSDVWSYGV 199 (279)
T ss_pred eEEEcCC-------CeEEECCCcccccccCcccce--------ecCCCcccccccCHHHhhc----CCcCchhhHHHHHH
Confidence 9999876 789999999997654322110 0111224568999998864 56789999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001142 1039 LLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1117 (1142)
Q Consensus 1039 iL~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP 1117 (1142)
++||+++ |+.||.+....++...+..+.....+. ..+..+.+++.+||..||
T Consensus 200 ~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~l~~~p 252 (279)
T cd05057 200 TVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPP---------------------------ICTIDVYMVLVKCWMIDA 252 (279)
T ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCC---------------------------CCCHHHHHHHHHHcCCCh
Confidence 9999998 999998877766666655433221110 233458899999999999
Q ss_pred CCCCCHHHHHHHHHhh
Q 001142 1118 TERPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1118 ~~RPSa~EVL~~L~~~ 1133 (1142)
.+||++.++++.+...
T Consensus 253 ~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 253 ESRPTFKELINEFSKM 268 (279)
T ss_pred hhCCCHHHHHHHHHHH
Confidence 9999999999877653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=304.55 Aligned_cols=255 Identities=27% Similarity=0.450 Sum_probs=202.7
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
.+|++.+.||+|++|.||+|++. +..+++|+..... .. .....+ .+|+.++.+++||||+++++++....
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~--~~-~~~~~~----~~e~~~l~~l~~~~i~~~~~~~~~~~- 72 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDG--DE-EFRKQL----LRELKTLRSCESPYVVKCYGAFYKEG- 72 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCc--ch-HHHHHH----HHHHHHHHhcCCCCeeeEEEEEccCC-
Confidence 36889999999999999999984 6677777754332 11 223333 79999999999999999999987654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeeec
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILID 963 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs-~gIvHrDLKp~NILld 963 (1142)
..++||||+++++|.+++.. ...+++..+..++.|++.||+|||+ .|++||||+|+||+++
T Consensus 73 -------------~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~ 134 (264)
T cd06623 73 -------------EISIVLEYMDGGSLADLLKK-----VGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLIN 134 (264)
T ss_pred -------------eEEEEEEecCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEEC
Confidence 45999999999999999976 2568999999999999999999999 9999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.++|+|||.+......... .....++..|+|||.+.. ..++.++||||||+++|+|
T Consensus 135 ~~-------~~~~l~df~~~~~~~~~~~~----------~~~~~~~~~y~~pE~~~~----~~~~~~~Dv~slG~il~~l 193 (264)
T cd06623 135 SK-------GEVKIADFGISKVLENTLDQ----------CNTFVGTVTYMSPERIQG----ESYSYAADIWSLGLTLLEC 193 (264)
T ss_pred CC-------CCEEEccCccceecccCCCc----------ccceeecccccCHhhhCC----CCCCchhhHHHHHHHHHHH
Confidence 87 78999999998765432111 113357889999999865 4678999999999999999
Q ss_pred HhCCCCCCCCC---HHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhh-hHHHHHHHHHHhcccCCCC
Q 001142 1044 LTLQVPYMGLS---ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELE-TLSFLVDVFRRCTEENPTE 1119 (1142)
Q Consensus 1044 LtG~~Pf~~~~---~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~L~dLI~~CL~~DP~~ 1119 (1142)
++|+.||.... ..+....+.....+... .. .+..+.+++.+||..+|++
T Consensus 194 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~l~~li~~~l~~~p~~ 246 (264)
T cd06623 194 ALGKFPFLPPGQPSFFELMQAICDGPPPSLP---------------------------AEEFSPEFRDFISACLQKDPKK 246 (264)
T ss_pred HhCCCCCccccccCHHHHHHHHhcCCCCCCC---------------------------cccCCHHHHHHHHHHccCChhh
Confidence 99999997653 33333333322211111 02 5567999999999999999
Q ss_pred CCCHHHHHHHHHhhcC
Q 001142 1120 RPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1120 RPSa~EVL~~L~~~~s 1135 (1142)
||++.++++|+|++.-
T Consensus 247 R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 247 RPSAAELLQHPFIKKA 262 (264)
T ss_pred CCCHHHHHhCHHHHhc
Confidence 9999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=315.55 Aligned_cols=254 Identities=28% Similarity=0.463 Sum_probs=199.2
Q ss_pred cceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCC
Q 001142 809 LSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 886 (1142)
Q Consensus 809 y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~ 886 (1142)
|.....||+|+||.||+|.. .+..+++|+...... ...+. +.+|+.+++.+.||||+++++++...+
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~----~~~e~~~l~~l~hp~i~~~~~~~~~~~--- 91 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ----QRREL----LFNEVVIMRDYQHQNVVEMYKSYLVGE--- 91 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc----chHHH----HHHHHHHHHhCCCCchhhhhhheeeCC---
Confidence 45566899999999999987 467788887643321 11222 368999999999999999999987654
Q ss_pred CCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecccc
Q 001142 887 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 966 (1142)
Q Consensus 887 ~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~ 966 (1142)
..++||||+++++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.+
T Consensus 92 -----------~~~iv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~- 153 (297)
T cd06659 92 -----------ELWVLMEFLQGGALTDIVSQ------TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLD- 153 (297)
T ss_pred -----------eEEEEEecCCCCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccC-
Confidence 34999999999999998754 358999999999999999999999999999999999999887
Q ss_pred ccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001142 967 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1046 (1142)
Q Consensus 967 ~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG 1046 (1142)
+.++|+|||++........ ......|+..|+|||++.+ ..++.++|||||||++|||++|
T Consensus 154 ------~~~kL~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il~el~~g 213 (297)
T cd06659 154 ------GRVKLSDFGFCAQISKDVP----------KRKSLVGTPYWMAPEVISR----TPYGTEVDIWSLGIMVIEMVDG 213 (297)
T ss_pred ------CcEEEeechhHhhcccccc----------cccceecCccccCHHHHcc----CCCCchhhHHHHHHHHHHHHhC
Confidence 7899999999865432111 1123468899999999875 4578999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 001142 1047 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1126 (1142)
Q Consensus 1047 ~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EV 1126 (1142)
+.||......+....+.....+... .....+..+.+++.+||+.+|.+||++.++
T Consensus 214 ~~p~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~l~~~i~~~l~~~P~~Rps~~~l 268 (297)
T cd06659 214 EPPYFSDSPVQAMKRLRDSPPPKLK-------------------------NAHKISPVLRDFLERMLTREPQERATAQEL 268 (297)
T ss_pred CCCCCCCCHHHHHHHHhccCCCCcc-------------------------ccCCCCHHHHHHHHHHhcCCcccCcCHHHH
Confidence 9999876655544443322111100 001344568999999999999999999999
Q ss_pred HHHHHhhcCC
Q 001142 1127 YEMFVARTSS 1136 (1142)
Q Consensus 1127 L~~L~~~~ss 1136 (1142)
++|+|+....
T Consensus 269 l~~~~~~~~~ 278 (297)
T cd06659 269 LDHPFLLQTG 278 (297)
T ss_pred hhChhhccCC
Confidence 9999987653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=302.37 Aligned_cols=256 Identities=29% Similarity=0.430 Sum_probs=204.3
Q ss_pred CcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
+|++.+.||.|+||.||++.+. +..+++|+.... .......+.+ .+|++++++++|||++++++.+....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~----~~e~~~l~~l~~~~~~~~~~~~~~~~-- 72 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLS--NMSEKEREDA----LNEVKILKKLNHPNIIKYYESFEEKG-- 72 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecc--cCChHHHHHH----HHHHHHHHhcCCCChhheEEEEecCC--
Confidence 5889999999999999999985 667777775433 2222333333 78999999999999999999987643
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
..++||||+++++|.+++..... ....+++..+..++.|++.||.|||++|++|+||+|+||+++.+
T Consensus 73 ------------~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~ 139 (258)
T cd08215 73 ------------KLCIVMEYADGGDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSN 139 (258)
T ss_pred ------------EEEEEEEecCCCcHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCC
Confidence 45999999999999999986322 23579999999999999999999999999999999999999876
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+.++|+|||.+....... .......|++.|+|||.+.+ ..++.++||||+|+++++|++
T Consensus 140 -------~~~~l~d~~~~~~~~~~~----------~~~~~~~~~~~y~~pe~~~~----~~~~~~~Dv~slG~~~~~l~~ 198 (258)
T cd08215 140 -------GLVKLGDFGISKVLSSTV----------DLAKTVVGTPYYLSPELCQN----KPYNYKSDIWSLGCVLYELCT 198 (258)
T ss_pred -------CcEEECCccceeecccCc----------ceecceeeeecccChhHhcc----CCCCccccHHHHHHHHHHHHc
Confidence 789999999997654321 01123458889999999765 457889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001142 1046 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1125 (1142)
Q Consensus 1046 G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~E 1125 (1142)
|+.||......+....+.....+.++. ..+..+.+++.+||..+|++|||+.+
T Consensus 199 g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~i~~~l~~~p~~Rp~~~~ 251 (258)
T cd08215 199 LKHPFEGENLLELALKILKGQYPPIPS---------------------------QYSSELRNLVSSLLQKDPEERPSIAQ 251 (258)
T ss_pred CCCCCCCCcHHHHHHHHhcCCCCCCCC---------------------------CCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 999998766655555543333222111 34456899999999999999999999
Q ss_pred HHHHHHh
Q 001142 1126 LYEMFVA 1132 (1142)
Q Consensus 1126 VL~~L~~ 1132 (1142)
+++|+|+
T Consensus 252 ll~~~~~ 258 (258)
T cd08215 252 ILQSPFI 258 (258)
T ss_pred HhcCCCC
Confidence 9999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=309.02 Aligned_cols=252 Identities=29% Similarity=0.419 Sum_probs=199.5
Q ss_pred cceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCC
Q 001142 809 LSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 886 (1142)
Q Consensus 809 y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~ 886 (1142)
|++.++||+|+||.||+|.+ .+..+|+|+..... .....+.+ .+|+.++++++||||+++++++....
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~----~~e~~~l~~l~h~~iv~~~~~~~~~~--- 75 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE---AEDEIEDI----QQEITVLSQCDSPYVTKYYGSYLKDT--- 75 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc---chHHHHHH----HHHHHHHHhcCCCCEeEEEEEEEeCC---
Confidence 67889999999999999987 45667887653221 11222333 78999999999999999999998655
Q ss_pred CCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecccc
Q 001142 887 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 966 (1142)
Q Consensus 887 ~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~ 966 (1142)
..++||||+++++|.+++.. ..+++..+..++.|++.|+.|||++|++|+||||+||+++.+
T Consensus 76 -----------~~~lv~e~~~~~~l~~~i~~------~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~- 137 (277)
T cd06641 76 -----------KLWIIMEYLGGGSALDLLEP------GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH- 137 (277)
T ss_pred -----------eEEEEEEeCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCC-
Confidence 34999999999999999864 358999999999999999999999999999999999999877
Q ss_pred ccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001142 967 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1046 (1142)
Q Consensus 967 ~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG 1046 (1142)
+.++|+|||++..+..... ......++..|+|||.+.+ ..++.++|||||||++|+|++|
T Consensus 138 ------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~y~~PE~~~~----~~~~~~~Dv~slG~~l~~l~~g 197 (277)
T cd06641 138 ------GEVKLADFGVAGQLTDTQI----------KRNTFVGTPFWMAPEVIKQ----SAYDSKADIWSLGITAIELAKG 197 (277)
T ss_pred ------CCEEEeecccceecccchh----------hhccccCCccccChhhhcc----CCCCchhhHHHHHHHHHHHHcC
Confidence 7899999999865433111 1112357889999999865 4567899999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 001142 1047 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1126 (1142)
Q Consensus 1047 ~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EV 1126 (1142)
..||...........+.....+.+. ...+..+.+++.+||+.+|.+||++.++
T Consensus 198 ~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~~l~~~p~~Rp~~~~~ 250 (277)
T cd06641 198 EPPHSELHPMKVLFLIPKNNPPTLE---------------------------GNYSKPLKEFVEACLNKEPSFRPTAKEL 250 (277)
T ss_pred CCCCCccchHHHHHHHhcCCCCCCC---------------------------cccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 9999876555444444332221111 1345668999999999999999999999
Q ss_pred HHHHHhhcC
Q 001142 1127 YEMFVARTS 1135 (1142)
Q Consensus 1127 L~~L~~~~s 1135 (1142)
++|+|+...
T Consensus 251 l~~~~~~~~ 259 (277)
T cd06641 251 LKHKFIVRF 259 (277)
T ss_pred HhCHHHhhh
Confidence 999998753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=307.17 Aligned_cols=278 Identities=23% Similarity=0.269 Sum_probs=196.1
Q ss_pred cceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEecCCCC
Q 001142 809 LSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 809 y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~g~~~~~~~~ 885 (1142)
|++.++||+|+||.||+|.. .+..+|+|+.... ......... .+|+.++.++. ||||+++++++.+...
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~--~~~~~~~~~-----~~e~~~l~~l~~h~~i~~~~~~~~~~~~- 72 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKH--FKSLEQVNN-----LREIQALRRLSPHPNILRLIEVLFDRKT- 72 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhc--cCCchhhhH-----HHHHHHHhhcCCCCCccceEEEEecCCC-
Confidence 67899999999999999987 4566777764322 122222222 47999999985 9999999999876411
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
...++||||++ ++|.+.+... ...+++..+..++.||+.||+|||+.||+||||||+||+++.
T Consensus 73 -----------~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~- 135 (282)
T cd07831 73 -----------GRLALVFELMD-MNLYELIKGR----KRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD- 135 (282)
T ss_pred -----------CcEEEEEecCC-ccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-
Confidence 14599999997 6888887651 246899999999999999999999999999999999999975
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+.+||+|||.+....... ......++..|+|||++.. ...++.++|||||||++|||++
T Consensus 136 -------~~~kl~dfg~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slGv~l~el~~ 194 (282)
T cd07831 136 -------DILKLADFGSCRGIYSKP-----------PYTEYISTRWYRAPECLLT---DGYYGPKMDIWAVGCVFFEILS 194 (282)
T ss_pred -------CCeEEEecccccccccCC-----------CcCCCCCCcccCChhHhhc---CCCCCcchhHHHHHHHHHHHHc
Confidence 479999999997543211 1112357889999998654 2456789999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccc-cccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001142 1046 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEV-AQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124 (1142)
Q Consensus 1046 G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~ 1124 (1142)
|+.||.+.+..+....+....................... ................+..+.+++.+||+.+|++||++.
T Consensus 195 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 274 (282)
T cd07831 195 LFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAK 274 (282)
T ss_pred CCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHH
Confidence 9999988776655544432211111100000000000000 000000000011124578899999999999999999999
Q ss_pred HHHHHHHh
Q 001142 1125 DLYEMFVA 1132 (1142)
Q Consensus 1125 EVL~~L~~ 1132 (1142)
++++|+|+
T Consensus 275 ~~l~~~~~ 282 (282)
T cd07831 275 QALRHPYF 282 (282)
T ss_pred HHhhCCCC
Confidence 99999985
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=306.90 Aligned_cols=257 Identities=26% Similarity=0.408 Sum_probs=192.7
Q ss_pred eeecccCceEEEEEEECC--------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 813 DEAGKSVSSSLFRCKFGS--------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 813 ~~LG~GsfG~Vy~a~~~~--------~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
+.||+|+||.||+|++.. ..+++|..... ........+ .+|+.+++.++||||+++++++.....
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~----~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG---ATDQEKKEF----LKEAHLMSNFNHPNIVKLLGVCLLNEP 73 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcc---cchhhHHHH----HHHHHHHHhcCCCCeeeEeeeecCCCC
Confidence 469999999999998743 34666653211 111223333 789999999999999999999876543
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET--GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~--~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
.++||||+++++|.+++...... ....+++..+..++.||+.||.|||+.+++|+||||+||++
T Consensus 74 --------------~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~ 139 (269)
T cd05044 74 --------------QYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLV 139 (269)
T ss_pred --------------eEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEE
Confidence 49999999999999999763221 22357899999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
+.+.. .....++|+|||++......... .......++..|+|||++.+ ..++.++|||||||++|+
T Consensus 140 ~~~~~--~~~~~~~l~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il~e 205 (269)
T cd05044 140 SEKGY--DADRVVKIGDFGLARDIYKSDYY--------RKEGEGLLPVRWMAPESLLD----GKFTTQSDVWSFGVLMWE 205 (269)
T ss_pred ecCCC--CCCcceEECCccccccccccccc--------ccCcccCCCccccCHHHHcc----CCcccchhHHHHHHHHHH
Confidence 87620 11237999999998754322110 01112345778999999875 467899999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1043 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1043 LLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
|++ |..||......+....+.....+..+ ...+..+.+++.+||..+|.+||
T Consensus 206 llt~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp 258 (269)
T cd05044 206 ILTLGQQPYPALNNQEVLQHVTAGGRLQKP---------------------------ENCPDKIYQLMTNCWAQDPSERP 258 (269)
T ss_pred HHHcCCCCCcccCHHHHHHHHhcCCccCCc---------------------------ccchHHHHHHHHHHcCCCcccCC
Confidence 998 99999876665555544332221111 13456789999999999999999
Q ss_pred CHHHHHHHHH
Q 001142 1122 TAGDLYEMFV 1131 (1142)
Q Consensus 1122 Sa~EVL~~L~ 1131 (1142)
++.++++.+.
T Consensus 259 ~~~~i~~~l~ 268 (269)
T cd05044 259 TFDRIQEILQ 268 (269)
T ss_pred CHHHHHHHHh
Confidence 9999998764
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=313.36 Aligned_cols=258 Identities=27% Similarity=0.406 Sum_probs=200.3
Q ss_pred CCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
..|.+.+.||+|+||.||+|.+ .+..+++|+..... .......+.+ .+|+.+++.++||||+++++++.+.+.
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~----~~Ei~~l~~l~h~niv~~~~~~~~~~~ 89 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSG-KQSNEKWQDI----IKEVRFLQQLRHPNTIEYKGCYLREHT 89 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccc-cCcHHHHHHH----HHHHHHHHhCCCCCEEEEEEEEEeCCe
Confidence 3488999999999999999987 46678888753221 1122222333 789999999999999999999886543
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
.++||||++ |+|.+++... ...+++..+..++.||+.||.|||++||+||||+|+||+++.
T Consensus 90 --------------~~lv~e~~~-g~l~~~~~~~----~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~ 150 (307)
T cd06607 90 --------------AWLVMEYCL-GSASDILEVH----KKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTE 150 (307)
T ss_pred --------------EEEEHHhhC-CCHHHHHHHc----ccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECC
Confidence 499999997 7887777541 246899999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.++|+|||++...... ....+++.|+|||++.+.. ...++.++||||||+++|||+
T Consensus 151 ~-------~~~kL~dfg~~~~~~~~--------------~~~~~~~~y~aPE~~~~~~-~~~~~~~sDv~s~G~il~el~ 208 (307)
T cd06607 151 P-------GTVKLADFGSASLVSPA--------------NSFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIELA 208 (307)
T ss_pred C-------CCEEEeecCcceecCCC--------------CCccCCccccCceeeeccC-CCCCCcccchHHHHHHHHHHH
Confidence 7 78999999988643221 1335788999999875321 245788999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~ 1124 (1142)
+|+.||.+.........+.....+... ....+..+.+++.+||..||++||++.
T Consensus 209 tg~~p~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~ 262 (307)
T cd06607 209 ERKPPLFNMNAMSALYHIAQNDSPTLS--------------------------SNDWSDYFRNFVDSCLQKIPQDRPSSE 262 (307)
T ss_pred cCCCCCCCccHHHHHHHHhcCCCCCCC--------------------------chhhCHHHHHHHHHHhcCChhhCcCHH
Confidence 999999876655443333322222111 013456799999999999999999999
Q ss_pred HHHHHHHhhcCC
Q 001142 1125 DLYEMFVARTSS 1136 (1142)
Q Consensus 1125 EVL~~L~~~~ss 1136 (1142)
+++.|+|+....
T Consensus 263 ~il~~~~~~~~~ 274 (307)
T cd06607 263 ELLKHRFVLRER 274 (307)
T ss_pred HHhcChhhcccC
Confidence 999999997643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=306.14 Aligned_cols=252 Identities=27% Similarity=0.398 Sum_probs=188.5
Q ss_pred ceeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCC
Q 001142 810 SSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 887 (1142)
Q Consensus 810 ~l~~~LG~GsfG~Vy~a~~~~--~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~ 887 (1142)
.....||+|+||.||+|++.. ..+++|... .. .....+.+ .+|+.++++++|+||+++++++...+
T Consensus 11 ~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~--~~--~~~~~~~~----~~e~~~l~~l~h~~iv~~~~~~~~~~---- 78 (268)
T cd06624 11 GERVVLGKGTYGIVYAARDLSTQVRIAIKEIP--ER--DSRYVQPL----HEEIALHSYLKHRNIVQYLGSDSENG---- 78 (268)
T ss_pred CceEEEecCCceEEEEeEecCCCcEEEEEEec--CC--CHHHHHHH----HHHHHHHHhcCCCCeeeeeeeeccCC----
Confidence 444689999999999999754 446666533 21 22233344 78999999999999999999987654
Q ss_pred CCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCC--CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 888 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHV--SVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 888 ~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~l--s~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
..++||||+++++|.+++... ...+ ++..+..++.||+.||+|||++||+||||||+||+++.+
T Consensus 79 ----------~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~ 144 (268)
T cd06624 79 ----------FFKIFMEQVPGGSLSALLRSK----WGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTY 144 (268)
T ss_pred ----------EEEEEEecCCCCCHHHHHHHh----cccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC
Confidence 349999999999999999752 1234 788899999999999999999999999999999999763
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
. +.++|+|||.+........ ......|++.|+|||++... ...++.++||||||+++|+|++
T Consensus 145 ~------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~~~aPE~~~~~--~~~~~~~~Dv~slGvvl~~l~~ 206 (268)
T cd06624 145 S------GVVKISDFGTSKRLAGINP----------CTETFTGTLQYMAPEVIDKG--PRGYGAPADIWSLGCTIVEMAT 206 (268)
T ss_pred C------CeEEEecchhheecccCCC----------ccccCCCCccccChhhhccc--cccCCchhhhHHHHHHHHHHHh
Confidence 2 6799999999865432111 11123478899999998652 1347789999999999999999
Q ss_pred CCCCCCCCCHHHH-HHHH-HhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1046 LQVPYMGLSELEI-HDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1046 G~~Pf~~~~~~el-~~~I-~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
|..||........ .... .....+.+ +...++.+.+++.+||+.+|.+|||+
T Consensus 207 g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~li~~~l~~~p~~Rpt~ 259 (268)
T cd06624 207 GKPPFIELGEPQAAMFKVGMFKIHPEI---------------------------PESLSAEAKNFILRCFEPDPDKRASA 259 (268)
T ss_pred CCCCCccccChhhhHhhhhhhccCCCC---------------------------CcccCHHHHHHHHHHcCCCchhCCCH
Confidence 9999975332211 1111 00111110 11345678999999999999999999
Q ss_pred HHHHHHHHh
Q 001142 1124 GDLYEMFVA 1132 (1142)
Q Consensus 1124 ~EVL~~L~~ 1132 (1142)
.|++.|+|+
T Consensus 260 ~~ll~~~~~ 268 (268)
T cd06624 260 HDLLQDPFL 268 (268)
T ss_pred HHHHhCCCC
Confidence 999999985
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=310.47 Aligned_cols=255 Identities=27% Similarity=0.431 Sum_probs=200.4
Q ss_pred CcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
.|...+.||+|++|.||++.+ .+..+++|..... .....+. +.+|+.+++.++||||+++++++...+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~----~~~e~~~l~~~~h~~vv~~~~~~~~~~-- 89 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR----KQQRREL----LFNEVVIMRDYQHPNIVEMYSSYLVGD-- 89 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc----chhHHHH----HHHHHHHHHHcCCCChheEEEEEEcCC--
Confidence 355668999999999999987 3566777764322 1122223 378999999999999999999987644
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
+.++||||+++++|.+++.. ..+++..+..++.|++.||+|||++||+||||+|+||+++.+
T Consensus 90 ------------~~~~v~e~~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~ 151 (285)
T cd06648 90 ------------ELWVVMEFLEGGALTDIVTH------TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSD 151 (285)
T ss_pred ------------eEEEEEeccCCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCC
Confidence 34999999999999999875 358999999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+.++|+|||.+....... .......|++.|+|||.+.+ ..++.++|||||||++|+|++
T Consensus 152 -------~~~~l~d~g~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slGv~l~ell~ 210 (285)
T cd06648 152 -------GRVKLSDFGFCAQVSKEV----------PRRKSLVGTPYWMAPEVISR----LPYGTEVDIWSLGIMVIEMVD 210 (285)
T ss_pred -------CcEEEcccccchhhccCC----------cccccccCCccccCHHHhcC----CCCCCcccHHHHHHHHHHHHh
Confidence 789999999886443211 11123458899999999865 457899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001142 1046 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1125 (1142)
Q Consensus 1046 G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~E 1125 (1142)
|+.||...+.......+.....+.... ....+..+.+++.+||+.+|.+||++.+
T Consensus 211 g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 265 (285)
T cd06648 211 GEPPYFNEPPLQAMKRIRDNLPPKLKN-------------------------LHKVSPRLRSFLDRMLVRDPAQRATAAE 265 (285)
T ss_pred CCCCCcCCCHHHHHHHHHhcCCCCCcc-------------------------cccCCHHHHHHHHHHcccChhhCcCHHH
Confidence 999998766655555544332211110 0024567999999999999999999999
Q ss_pred HHHHHHhhcCC
Q 001142 1126 LYEMFVARTSS 1136 (1142)
Q Consensus 1126 VL~~L~~~~ss 1136 (1142)
+++|+|+...-
T Consensus 266 il~~~~~~~~~ 276 (285)
T cd06648 266 LLNHPFLAKAG 276 (285)
T ss_pred HccCcccccCC
Confidence 99999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=344.61 Aligned_cols=270 Identities=24% Similarity=0.300 Sum_probs=195.0
Q ss_pred CCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
+.+|++.++||+|+||.||+|.+. +..+|+|+..... ... .....++.+|++++++++||||+++++++.+.+
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l--~~~---e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~ 75 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDL--SEN---PLLKKRFLREAKIAADLIHPGIVPVYSICSDGD 75 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECccc--ccC---HHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC
Confidence 468999999999999999999984 5677887754221 111 122334589999999999999999999987654
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccC------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG------EKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 957 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~------~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp 957 (1142)
..++||||++|++|.+++....... ...+++..+..++.||+.||+|||++||+||||||
T Consensus 76 --------------~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKP 141 (932)
T PRK13184 76 --------------PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKP 141 (932)
T ss_pred --------------EEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCch
Confidence 3499999999999999997532211 23456778899999999999999999999999999
Q ss_pred CCeeeccccccCCCCCeEEEeecCCccccccccccc---c-----cccCCCCCCCCccCCCcccchhhhccccCCCCCCc
Q 001142 958 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC---C-----IAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGL 1029 (1142)
Q Consensus 958 ~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~---~-----~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ 1029 (1142)
+|||++.+ +.++|+|||+++......... . .............||+.|+|||++.+ ..++.
T Consensus 142 eNILLd~d-------g~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g----~~~S~ 210 (932)
T PRK13184 142 DNILLGLF-------GEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG----VPASE 210 (932)
T ss_pred heEEEcCC-------CCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC----CCCCc
Confidence 99999887 789999999997652111000 0 00001112234579999999999876 56789
Q ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHH
Q 001142 1030 EVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVF 1109 (1142)
Q Consensus 1030 ksDVwSLGviL~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI 1109 (1142)
++|||||||++|||+||+.||.............. ..+. .. ......++.+.+++
T Consensus 211 kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~i-~~P~---~~---------------------~p~~~iP~~L~~LI 265 (932)
T PRK13184 211 STDIYALGVILYQMLTLSFPYRRKKGRKISYRDVI-LSPI---EV---------------------APYREIPPFLSQIA 265 (932)
T ss_pred HhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhhc-cChh---hc---------------------cccccCCHHHHHHH
Confidence 99999999999999999999976443322211000 0000 00 00014556789999
Q ss_pred HHhcccCCCCCCCH-HHHHHHH
Q 001142 1110 RRCTEENPTERPTA-GDLYEMF 1130 (1142)
Q Consensus 1110 ~~CL~~DP~~RPSa-~EVL~~L 1130 (1142)
.+||+.||++||+. +++++.+
T Consensus 266 ~rcL~~DP~kR~ss~eeLl~~L 287 (932)
T PRK13184 266 MKALAVDPAERYSSVQELKQDL 287 (932)
T ss_pred HHHccCChhhCcCHHHHHHHHH
Confidence 99999999999755 4454443
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=313.30 Aligned_cols=266 Identities=24% Similarity=0.318 Sum_probs=196.7
Q ss_pred CCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEecC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISS 882 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~g~~~~~ 882 (1142)
.++|+..++||+|+||.||++.+. +..+|+|..... ... ..... +.+|+.++.++. ||||+++++++..+
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~--~~~-~~~~~----~~~e~~~l~~~~~~~~iv~~~~~~~~~ 75 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRST--VDE-KEQKR----LLMDLDVVMRSSDCPYIVKFYGALFRE 75 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhc--cCh-HHHHH----HHHHHHHHHHhcCCCCEeeeeeEEecC
Confidence 356788899999999999999984 566777764322 112 22223 378999999996 99999999988764
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENIL 961 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~-gIvHrDLKp~NIL 961 (1142)
. ..+++|||+. ++|.++...........+++..+..++.|++.||+|||+. +|+||||||+||+
T Consensus 76 ~--------------~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil 140 (288)
T cd06616 76 G--------------DCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNIL 140 (288)
T ss_pred C--------------cEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEE
Confidence 4 3489999996 6777665433223335799999999999999999999975 9999999999999
Q ss_pred eccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001142 962 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1041 (1142)
Q Consensus 962 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ 1041 (1142)
++.+ +.++|+|||++....... ......|++.|+|||++.... ...++.++|||||||++|
T Consensus 141 ~~~~-------~~~kl~dfg~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~-~~~~~~~~Di~slG~il~ 201 (288)
T cd06616 141 LDRN-------GNIKLCDFGISGQLVDSI-----------AKTRDAGCRPYMAPERIDPSA-RDGYDVRSDVWSLGITLY 201 (288)
T ss_pred EccC-------CcEEEeecchhHHhccCC-----------ccccccCccCccCHHHhcccc-ccCCcchhhhhHHHHHHH
Confidence 9876 789999999986543211 111235788999999987521 136789999999999999
Q ss_pred HHHhCCCCCCCCCH-HHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1042 ELLTLQVPYMGLSE-LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1042 ELLtG~~Pf~~~~~-~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
+|++|+.||..... .+....+.....+.+.. ......+..+.+|+.+||+.||++|
T Consensus 202 el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~l~~li~~~l~~~p~~R 258 (288)
T cd06616 202 EVATGKFPYPKWNSVFDQLTQVVKGDPPILSN-----------------------SEEREFSPSFVNFINLCLIKDESKR 258 (288)
T ss_pred HHHhCCCCchhcchHHHHHhhhcCCCCCcCCC-----------------------cCCCccCHHHHHHHHHHccCChhhC
Confidence 99999999975431 11111111111111110 0001456679999999999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 001142 1121 PTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1121 PSa~EVL~~L~~~~s 1135 (1142)
||+.+|++|+|++..
T Consensus 259 pt~~~i~~~~~~~~~ 273 (288)
T cd06616 259 PKYKELLEHPFIKDY 273 (288)
T ss_pred cCHHHHhcChhhhch
Confidence 999999999999754
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=308.53 Aligned_cols=279 Identities=18% Similarity=0.245 Sum_probs=201.7
Q ss_pred CcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
+|++.++||+|++|.||+|++. +..+++|+....... ..... +.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~----~~~E~~~l~~l~h~~i~~~~~~~~~~~~- 72 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE---GTPST----AIREISLMKELKHENIVRLHDVIHTENK- 72 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc---cchHH----HHHHHHHHHhhcCCCEeeeeeeEeeCCc-
Confidence 5889999999999999999984 566788875543211 11122 3689999999999999999999987553
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
.++||||++ ++|.+++.... ....+++..+..++.||+.||.|||++||+||||||+||+++.+
T Consensus 73 -------------~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~ 136 (284)
T cd07836 73 -------------LMLVFEYMD-KDLKKYMDTHG--VRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKR 136 (284)
T ss_pred -------------EEEEEecCC-ccHHHHHHhcC--CCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC
Confidence 499999998 58998886522 22468999999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+.++|+|||.+........ ......++..|+|||++.+ ...++.++|||||||++|+|++
T Consensus 137 -------~~~~l~d~g~~~~~~~~~~----------~~~~~~~~~~y~~PE~~~~---~~~~~~~~Dv~slG~~l~~l~~ 196 (284)
T cd07836 137 -------GELKLADFGLARAFGIPVN----------TFSNEVVTLWYRAPDVLLG---SRTYSTSIDIWSVGCIMAEMIT 196 (284)
T ss_pred -------CcEEEeecchhhhhcCCcc----------ccccccccccccChHHhcC---CCCCCcHHHHHHHHHHHHHHHh
Confidence 7899999999865432111 1112347889999999865 2356789999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCC---chhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1046 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK---PEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1046 G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
|+.||.+.+..+....+...........+....... ........... .......+..+.+++.+||+.||.+||+
T Consensus 197 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~ 274 (284)
T cd07836 197 GRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLP--EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRIS 274 (284)
T ss_pred CCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCc--hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCC
Confidence 999998776655544442222111111111111000 00000000000 0011134567899999999999999999
Q ss_pred HHHHHHHHHh
Q 001142 1123 AGDLYEMFVA 1132 (1142)
Q Consensus 1123 a~EVL~~L~~ 1132 (1142)
+.++++|+|+
T Consensus 275 ~~~~l~~~~f 284 (284)
T cd07836 275 AHDALQHPWF 284 (284)
T ss_pred HHHHhcCCCC
Confidence 9999999986
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=302.19 Aligned_cols=249 Identities=25% Similarity=0.364 Sum_probs=191.9
Q ss_pred eeecccCceEEEEEEECC---c--cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCC
Q 001142 813 DEAGKSVSSSLFRCKFGS---A--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 887 (1142)
Q Consensus 813 ~~LG~GsfG~Vy~a~~~~---~--~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~ 887 (1142)
++||+|++|.||+|.+.. . .+|+|+.... ... ...+. +.+|+.++++++||||+++++++.+ .
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~--~~~-~~~~~----~~~e~~~l~~l~h~~iv~~~~~~~~-~---- 68 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSD--KLS-DIMDD----FLKEAAIMHSLDHENLIRLYGVVLT-H---- 68 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCc--ccH-HHHHH----HHHHHHHHhhcCCCCccceeEEEcC-C----
Confidence 478999999999998732 2 3566654322 111 22333 4799999999999999999999875 3
Q ss_pred CCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccc
Q 001142 888 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 967 (1142)
Q Consensus 888 ~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~ 967 (1142)
..++||||+++++|.+++... ....+++..+..++.|++.||+|||++|++|+||||+||+++.+
T Consensus 69 ----------~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~-- 133 (257)
T cd05040 69 ----------PLMMVTELAPLGSLLDRLRKD---ALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASD-- 133 (257)
T ss_pred ----------eEEEEEEecCCCcHHHHHHhc---ccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecC--
Confidence 349999999999999999762 11468999999999999999999999999999999999999987
Q ss_pred cCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-C
Q 001142 968 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-L 1046 (1142)
Q Consensus 968 ~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt-G 1046 (1142)
+.+||+|||++..+....... .......++..|+|||++.. ..++.++|||||||++|+|++ |
T Consensus 134 -----~~~kl~dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~~pE~~~~----~~~~~~~Di~slG~~l~el~t~g 197 (257)
T cd05040 134 -----DKVKIGDFGLMRALPQNEDHY-------VMEEHLKVPFAWCAPESLRT----RTFSHASDVWMFGVTLWEMFTYG 197 (257)
T ss_pred -----CEEEeccccccccccccccce-------ecccCCCCCceecCHHHhcc----cCcCchhhhHHHHHHHHHHHhCC
Confidence 789999999997654322110 01113347788999999875 567899999999999999998 9
Q ss_pred CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 001142 1047 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1126 (1142)
Q Consensus 1047 ~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EV 1126 (1142)
..||...+..+....+..... ... . ....+..+.+++.+||+.+|++|||+.++
T Consensus 198 ~~p~~~~~~~~~~~~~~~~~~-~~~----------------------~---~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 251 (257)
T cd05040 198 EEPWAGLSGSQILKKIDKEGE-RLE----------------------R---PEACPQDIYNVMLQCWAHNPADRPTFAAL 251 (257)
T ss_pred CCCCCCCCHHHHHHHHHhcCC-cCC----------------------C---CccCCHHHHHHHHHHCCCCcccCCCHHHH
Confidence 999987766665555432110 000 0 01345679999999999999999999999
Q ss_pred HHHH
Q 001142 1127 YEMF 1130 (1142)
Q Consensus 1127 L~~L 1130 (1142)
++.+
T Consensus 252 ~~~l 255 (257)
T cd05040 252 REFL 255 (257)
T ss_pred HHHh
Confidence 9875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=302.15 Aligned_cols=253 Identities=27% Similarity=0.401 Sum_probs=201.9
Q ss_pred CcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
+|++.++||+|+||.||++.+. +..+++|..... .........+ .+|+.++++++||||+++++++.+..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~----~~e~~~l~~l~~~~i~~~~~~~~~~~-- 72 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLG--SMSQKEREDA----VNEIRILASVNHPNIISYKEAFLDGN-- 72 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehh--hccHHHHHHH----HHHHHHHHhCCCCCchhhhhhhccCC--
Confidence 4889999999999999999874 456777765432 2222333333 68999999999999999999887543
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
+.++||||+++++|.+++.+.. .....+++..+..++.|++.||.|||+.|++|+||+|+||+++.+
T Consensus 73 ------------~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~ 139 (256)
T cd08530 73 ------------KLCIVMEYAPFGDLSKAISKRK-KKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAN 139 (256)
T ss_pred ------------EEEEEehhcCCCCHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecC
Confidence 4599999999999999987633 223568999999999999999999999999999999999999886
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+.+||+|||.+....... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++
T Consensus 140 -------~~~kl~d~g~~~~~~~~~------------~~~~~~~~~~~~Pe~~~~----~~~~~~~D~~slG~~~~~l~~ 196 (256)
T cd08530 140 -------DLVKIGDLGISKVLKKNM------------AKTQIGTPHYMAPEVWKG----RPYSYKSDIWSLGCLLYEMAT 196 (256)
T ss_pred -------CcEEEeeccchhhhccCC------------cccccCCccccCHHHHCC----CCCCchhhHHHHHHHHHHHHh
Confidence 789999999997654321 112347889999999875 567889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001142 1046 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1125 (1142)
Q Consensus 1046 G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~E 1125 (1142)
|+.||...+..+....+.....+..+. ..+.++.+++.+||+.+|++||++.+
T Consensus 197 g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~p~~Rp~~~~ 249 (256)
T cd08530 197 FAPPFEARSMQDLRYKVQRGKYPPIPP---------------------------IYSQDLQNFIRSMLQVKPKLRPNCDK 249 (256)
T ss_pred CCCCCCCCCHHHHHHHHhcCCCCCCch---------------------------hhCHHHHHHHHHHcCCCcccCCCHHH
Confidence 999998777665555544433322211 34566999999999999999999999
Q ss_pred HHHHHH
Q 001142 1126 LYEMFV 1131 (1142)
Q Consensus 1126 VL~~L~ 1131 (1142)
+++||+
T Consensus 250 ~l~~p~ 255 (256)
T cd08530 250 ILASPA 255 (256)
T ss_pred HhcCCC
Confidence 999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=306.15 Aligned_cols=257 Identities=25% Similarity=0.354 Sum_probs=196.1
Q ss_pred CcceeeeecccCceEEEEEEECCc--cEEEEEEec-ccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFGSA--DAAAKVRTL-KVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~~~--~vAvKi~~l-~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
+|.+.++||+|+||.||++.+... .+++|+.+. ............ +..|+.++++++||||+++++++.+..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~- 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQ----ANQEAQLLSKLDHPAIVKFHASFLERD- 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHH----HHHHHHHHHhCCCCcHHHHHHHHhcCC-
Confidence 488999999999999999988543 345555321 111111111222 257999999999999999999987544
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
..++||||+++++|.+++...... ...+++..++.++.|++.||.|||++|++|+||||+||+++.
T Consensus 76 -------------~~~lv~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~ 141 (260)
T cd08222 76 -------------AFCIITEYCEGRDLDCKLEELKHT-GKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN 141 (260)
T ss_pred -------------ceEEEEEeCCCCCHHHHHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec
Confidence 349999999999999998764322 356899999999999999999999999999999999999964
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+.++|+|||.+........ ......|++.|+|||.+.+ ..++.++||||||+++|+|+
T Consensus 142 --------~~~~l~d~g~~~~~~~~~~----------~~~~~~~~~~~~~pe~~~~----~~~~~~~Dv~slG~~~~~l~ 199 (260)
T cd08222 142 --------NLLKIGDFGVSRLLMGSCD----------LATTFTGTPYYMSPEALKH----QGYDSKSDIWSLGCILYEMC 199 (260)
T ss_pred --------CCEeecccCceeecCCCcc----------cccCCCCCcCccCHHHHcc----CCCCchhhHHHHHHHHHHHH
Confidence 4599999999865432111 1123457889999999865 45678999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~ 1124 (1142)
+|..||...........+..+..+..+ ...+.++.+++.+||+.+|++||++.
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~ 252 (260)
T cd08222 200 CLAHAFEGQNFLSVVLRIVEGPTPSLP---------------------------ETYSRQLNSIMQSMLNKDPSLRPSAA 252 (260)
T ss_pred hCCCCCCCccHHHHHHHHHcCCCCCCc---------------------------chhcHHHHHHHHHHhcCChhhCcCHH
Confidence 999999765554444444333222211 14456789999999999999999999
Q ss_pred HHHHHHHh
Q 001142 1125 DLYEMFVA 1132 (1142)
Q Consensus 1125 EVL~~L~~ 1132 (1142)
++++|+|+
T Consensus 253 ~il~~~~~ 260 (260)
T cd08222 253 EILRNPFI 260 (260)
T ss_pred HHhhCCCC
Confidence 99999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=306.38 Aligned_cols=258 Identities=22% Similarity=0.348 Sum_probs=195.7
Q ss_pred CCcceeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeE
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 879 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~-------~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~ 879 (1142)
.+|++.+.||+|+||.||+|++. ...+++|... .. ......+.+ .+|++++++++||||+++++++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~--~~-~~~~~~~~~----~~E~~~l~~l~h~~iv~~~~~~ 77 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQ--KT-KDENLQSEF----RRELDMFRKLSHKNVVRLLGLC 77 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccC--Cc-cchHHHHHH----HHHHHHHHhcCCcceeeeEEEE
Confidence 46889999999999999999963 2346666532 11 111123334 7899999999999999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccC----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 001142 880 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG----EKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 955 (1142)
Q Consensus 880 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~----~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDL 955 (1142)
.+... .++||||+++++|.+++....... ...+++..+..++.||+.||+|||+++|+||||
T Consensus 78 ~~~~~--------------~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl 143 (275)
T cd05046 78 REAEP--------------HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDL 143 (275)
T ss_pred CCCCc--------------ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcC
Confidence 76543 399999999999999997632110 125899999999999999999999999999999
Q ss_pred CCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHH
Q 001142 956 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 1035 (1142)
Q Consensus 956 Kp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwS 1035 (1142)
||+||+++.+ +.++++|||++........ .......+++.|+|||.+.+ ..++.++||||
T Consensus 144 kp~Nili~~~-------~~~~l~~~~~~~~~~~~~~---------~~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~s 203 (275)
T cd05046 144 AARNCLVSSQ-------REVKVSLLSLSKDVYNSEY---------YKLRNALIPLRWLAPEAVQE----DDFSTKSDVWS 203 (275)
T ss_pred ccceEEEeCC-------CcEEEcccccccccCcccc---------cccCCceeEEeecChhhhcc----CCCCchhhHHH
Confidence 9999999887 7899999999864322110 01122346778999998865 45678999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcc
Q 001142 1036 YGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 1114 (1142)
Q Consensus 1036 LGviL~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~ 1114 (1142)
||+++|+|++ |..||...........+..+.... . . ....+..+.+++.+||+
T Consensus 204 lG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~-~----------------------~---~~~~~~~l~~~i~~~l~ 257 (275)
T cd05046 204 FGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL-P----------------------V---PEGCPSRLYKLMTRCWA 257 (275)
T ss_pred HHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCC-C----------------------C---CCCCCHHHHHHHHHHcC
Confidence 9999999998 888997665555444443222110 0 0 01345679999999999
Q ss_pred cCCCCCCCHHHHHHHHH
Q 001142 1115 ENPTERPTAGDLYEMFV 1131 (1142)
Q Consensus 1115 ~DP~~RPSa~EVL~~L~ 1131 (1142)
.||.+|||+.|+++++.
T Consensus 258 ~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 258 VNPKDRPSFSELVSALG 274 (275)
T ss_pred CCcccCCCHHHHHHHhc
Confidence 99999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=300.53 Aligned_cols=248 Identities=27% Similarity=0.431 Sum_probs=192.2
Q ss_pred eeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCCCC
Q 001142 813 DEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGN 891 (1142)
Q Consensus 813 ~~LG~GsfG~Vy~a~~~-~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~~~~~ 891 (1142)
++||+|+||.||+|.+. +..+++|+..... . ....+.+ .+|+.+++++.||||+++++++.+...
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~--~-~~~~~~~----~~e~~~l~~l~~~~i~~~~~~~~~~~~------- 66 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTL--P-PDLKRKF----LQEAEILKQYDHPNIVKLIGVCVQKQP------- 66 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccC--C-HHHHHHH----HHHHHHHHhCCCCCeEEEEEEEecCCC-------
Confidence 47999999999999975 6778888654322 1 1223333 789999999999999999999876553
Q ss_pred CccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccCCC
Q 001142 892 PEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 971 (1142)
Q Consensus 892 ~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~~~ 971 (1142)
.++||||+++++|.+++... ...+++..+..++.|++.||.|||+++++||||||+||+++.+
T Consensus 67 -------~~~v~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~------ 129 (251)
T cd05041 67 -------IYIVMELVPGGSLLTFLRKK----KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGEN------ 129 (251)
T ss_pred -------eEEEEEcCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCC------
Confidence 49999999999999998752 2357899999999999999999999999999999999999877
Q ss_pred CCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 001142 972 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPY 1050 (1142)
Q Consensus 972 ~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt-G~~Pf 1050 (1142)
+.++|+|||.+......... .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||
T Consensus 130 -~~~~l~d~g~~~~~~~~~~~--------~~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~slG~i~~~l~t~~~~p~ 196 (251)
T cd05041 130 -NVLKISDFGMSREEEGGIYT--------VSDGLKQIPIKWTAPEALNY----GRYTSESDVWSYGILLWETFSLGDTPY 196 (251)
T ss_pred -CcEEEeeccccccccCCcce--------eccccCcceeccCChHhhcc----CCCCcchhHHHHHHHHHHHHhccCCCC
Confidence 78999999998754321110 00111234567999999865 467899999999999999999 88999
Q ss_pred CCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 001142 1051 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130 (1142)
Q Consensus 1051 ~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L 1130 (1142)
...........+........+ ...+..+.+++.+||+.+|.+|||+.|+++.+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l 249 (251)
T cd05041 197 PGMSNQQTRERIESGYRMPAP---------------------------QLCPEEIYRLMLQCWAYDPENRPSFSEIYNEL 249 (251)
T ss_pred ccCCHHHHHHHHhcCCCCCCC---------------------------ccCCHHHHHHHHHHhccChhhCcCHHHHHHHh
Confidence 876655555444332211110 13456799999999999999999999999876
Q ss_pred H
Q 001142 1131 V 1131 (1142)
Q Consensus 1131 ~ 1131 (1142)
.
T Consensus 250 ~ 250 (251)
T cd05041 250 Q 250 (251)
T ss_pred h
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=319.74 Aligned_cols=255 Identities=24% Similarity=0.424 Sum_probs=214.7
Q ss_pred CcceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 887 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~ 887 (1142)
+.+..++||-|-||.||.|.|+.-...|+|+.++.. ..+.++| +.|+.+|+.++|||+|+++|+|..+..+
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED---tMeveEF----LkEAAvMKeikHpNLVqLLGVCT~EpPF-- 338 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEF----LKEAAVMKEIKHPNLVQLLGVCTHEPPF-- 338 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhc---chhHHHH----HHHHHHHHhhcCccHHHHhhhhccCCCe--
Confidence 357889999999999999999877767776666642 3456667 8999999999999999999999865543
Q ss_pred CCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccc
Q 001142 888 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 967 (1142)
Q Consensus 888 ~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~ 967 (1142)
|||+|||..|+|.+|++.+. +..++.-..+.|+.||..|++||..+++|||||-+.|.|+.++
T Consensus 339 ------------YIiTEfM~yGNLLdYLRecn---r~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEn-- 401 (1157)
T KOG4278|consen 339 ------------YIITEFMCYGNLLDYLRECN---RSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-- 401 (1157)
T ss_pred ------------EEEEecccCccHHHHHHHhc---hhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccccc--
Confidence 99999999999999999853 3457888899999999999999999999999999999999988
Q ss_pred cCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-C
Q 001142 968 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-L 1046 (1142)
Q Consensus 968 ~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt-G 1046 (1142)
..||++|||+++.+.....+ ++.+ .--...|.|||-+.. ..++.|+|||+|||+|||+.| |
T Consensus 402 -----hiVKvADFGLsRlMtgDTYT---AHAG------AKFPIKWTAPEsLAy----NtFSiKSDVWAFGVLLWEIATYG 463 (1157)
T KOG4278|consen 402 -----HIVKVADFGLSRLMTGDTYT---AHAG------AKFPIKWTAPESLAY----NTFSIKSDVWAFGVLLWEIATYG 463 (1157)
T ss_pred -----ceEEeeccchhhhhcCCcee---cccC------ccCcccccCcccccc----cccccchhhHHHHHHHHHHHhcC
Confidence 78999999999987664432 1211 123567999999875 678899999999999999999 8
Q ss_pred CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 001142 1047 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1126 (1142)
Q Consensus 1047 ~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EV 1126 (1142)
..||.+.+..+++..+..+.+..-+ ..+++.+.+|++.||++.|.+||+++|+
T Consensus 464 MsPYPGidlSqVY~LLEkgyRM~~P---------------------------eGCPpkVYeLMraCW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 464 MSPYPGIDLSQVYGLLEKGYRMDGP---------------------------EGCPPKVYELMRACWNWSPSDRPSFAEI 516 (1157)
T ss_pred CCCCCCccHHHHHHHHhccccccCC---------------------------CCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence 9999999999999888777653322 1778889999999999999999999999
Q ss_pred HHHHHhh
Q 001142 1127 YEMFVAR 1133 (1142)
Q Consensus 1127 L~~L~~~ 1133 (1142)
-+.++-.
T Consensus 517 HqafEtm 523 (1157)
T KOG4278|consen 517 HQAFETM 523 (1157)
T ss_pred HHHHHHH
Confidence 8776654
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=310.21 Aligned_cols=265 Identities=21% Similarity=0.322 Sum_probs=193.2
Q ss_pred CCcceeeeecccCceEEEEEEECC------------------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFGS------------------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR 868 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~~------------------~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~ 868 (1142)
.+|++.++||+|+||.||++.+.+ ..+|+|+.... ........+ .+|+.++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~----~~E~~~l~~l~ 77 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED---ANKNARNDF----LKEIKIMSRLK 77 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc---CCHHHHHHH----HHHHHHHHhCC
Confidence 468999999999999999986532 23566654321 112222334 78999999999
Q ss_pred CCCccceeeeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc------CCCCCCHHHHHHHHHHHHHHH
Q 001142 869 HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET------GEKHVSVKLALFIAQDVAAAL 942 (1142)
Q Consensus 869 HpNIVkl~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~------~~~~ls~~~i~~Ia~qIa~gL 942 (1142)
||||+++++++...+. .++||||+++++|.+++...... ....+++..+..++.||+.||
T Consensus 78 ~~~i~~~~~~~~~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al 143 (296)
T cd05095 78 DPNIIRLLAVCITSDP--------------LCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGM 143 (296)
T ss_pred CCCcceEEEEEecCCc--------------cEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHH
Confidence 9999999999876553 39999999999999999763211 112477889999999999999
Q ss_pred HHHHhCCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhcccc
Q 001142 943 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1022 (1142)
Q Consensus 943 ~yLHs~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~ 1022 (1142)
+|||++||+||||||+|||++.+ +.++|+|||++..+...... .......+++.|+|||...+
T Consensus 144 ~~lH~~~i~H~dlkp~Nili~~~-------~~~~l~dfg~~~~~~~~~~~--------~~~~~~~~~~~~~~pe~~~~-- 206 (296)
T cd05095 144 KYLSSLNFVHRDLATRNCLVGKN-------YTIKIADFGMSRNLYSGDYY--------RIQGRAVLPIRWMSWESILL-- 206 (296)
T ss_pred HHHHHCCeecccCChheEEEcCC-------CCEEeccCcccccccCCcce--------eccCcCcCccccCCHHHHhc--
Confidence 99999999999999999999876 78999999998754321110 01112235678999998765
Q ss_pred CCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhh
Q 001142 1023 KPNLYGLEVDIWSYGCLLLELLT--LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELE 1100 (1142)
Q Consensus 1023 ~~~~~s~ksDVwSLGviL~ELLt--G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 1100 (1142)
..++.++|||||||++|||++ |..||...+..+............. . ...... ...
T Consensus 207 --~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~----------------~-~~~~~~---~~~ 264 (296)
T cd05095 207 --GKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQG----------------R-QVYLPK---PAL 264 (296)
T ss_pred --CCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhcc----------------c-cccCCC---CCC
Confidence 468899999999999999998 7789976655544332211000000 0 000000 013
Q ss_pred hHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 001142 1101 TLSFLVDVFRRCTEENPTERPTAGDLYEMFV 1131 (1142)
Q Consensus 1101 ~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~ 1131 (1142)
+++.+.+++.+||+.||.+||++.+|++.+.
T Consensus 265 ~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 265 CPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred CCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 4567999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=318.62 Aligned_cols=290 Identities=17% Similarity=0.222 Sum_probs=204.2
Q ss_pred CCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
.+|++.+.||+|++|.||+|.. .+..+++|+...+ .......+. +.+|+.++++++||||+++++++.....
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~--~~~~~~~~~----~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 78 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHA--FDVPTLAKR----TLRELKILRHFKHDNIIAIRDILRPPGA 78 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccc--cccccchHH----HHHHHHHHHhcCCCCccCHHHhccccCC
Confidence 5689999999999999999987 4667787765322 111122222 3689999999999999999998764321
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
.....++||||+. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.
T Consensus 79 ----------~~~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~ 142 (334)
T cd07855 79 ----------DFKDVYVVMDLME-SDLHHIIHS-----DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNE 142 (334)
T ss_pred ----------CCceEEEEEehhh-hhHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC
Confidence 1235699999996 688888764 345899999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||+|||++......... .........|+..|+|||++.. ...++.++|||||||++|+|+
T Consensus 143 ~-------~~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~~~~y~~PE~~~~---~~~~~~~~Di~slG~~l~el~ 206 (334)
T cd07855 143 D-------CELRIGDFGMARGLSSSPTE------HKYFMTEYVATRWYRAPELLLS---LPEYTTAIDMWSVGCIFAEML 206 (334)
T ss_pred C-------CcEEecccccceeecccCcC------CCcccccccccccccChHHhcC---CcccccccchHHHHHHHHHHH
Confidence 7 78999999998754332111 0011123468899999999864 235789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHh-CCCCCchhHHhhhcccccccc---cccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1045 TLQVPYMGLSELEIHDLIQM-GKRPRLTDELEALGSCHEHEV---AQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~-~~~p~l~~~l~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
+|+.||.+.+.......+.. ...+. ...+........... ................+..+.++|.+||+.||.+|
T Consensus 207 ~g~~pf~~~~~~~~~~~~~~~~g~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 285 (334)
T cd07855 207 GRRQLFPGKNYVHQLKLILSVLGSPS-EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEER 285 (334)
T ss_pred cCCCccCCCChHHHHHHHHHHhCCCh-hHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhC
Confidence 99999987665544443322 11111 100100000000000 00000000001112456789999999999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 001142 1121 PTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1121 PSa~EVL~~L~~~~s 1135 (1142)
||+.+++.|+|+..-
T Consensus 286 pt~~~~l~~~~~~~~ 300 (334)
T cd07855 286 ITVEQALQHPFLAQY 300 (334)
T ss_pred cCHHHHHhChhhhhc
Confidence 999999999999644
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=308.26 Aligned_cols=278 Identities=21% Similarity=0.258 Sum_probs=198.6
Q ss_pred cceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCC
Q 001142 809 LSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 886 (1142)
Q Consensus 809 y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~ 886 (1142)
|++.+.||.|++|.||+|.+ .+..+++|+...+.. .....+.+ .+|+.++++++||||+++++++.+.+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~----~~E~~~l~~l~~~~iv~~~~~~~~~~--- 71 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE--DEGVPSTA----IREISLLKELNHPNIVRLLDVVHSEN--- 71 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc--cccchhHH----HHHHHHHHhcCCCCccCHhheeccCC---
Confidence 67889999999999999987 467788887654321 11111223 68999999999999999999987654
Q ss_pred CCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecccc
Q 001142 887 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 966 (1142)
Q Consensus 887 ~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~ 966 (1142)
..++||||++ ++|.+++... ....+++..+..++.|++.||+|||+++++||||+|+||+++.+
T Consensus 72 -----------~~~iv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~- 135 (283)
T cd07835 72 -----------KLYLVFEFLD-LDLKKYMDSS---PLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDRE- 135 (283)
T ss_pred -----------eEEEEEeccC-cCHHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCC-
Confidence 3499999995 7999998752 22368999999999999999999999999999999999999886
Q ss_pred ccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001142 967 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1046 (1142)
Q Consensus 967 ~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG 1046 (1142)
+.++|+|||.+........ ......+++.|+|||++.+ ...++.++||||||+++|+|++|
T Consensus 136 ------~~~~l~df~~~~~~~~~~~----------~~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~~l~~l~~g 196 (283)
T cd07835 136 ------GALKLADFGLARAFGVPVR----------TYTHEVVTLWYRAPEILLG---SRQYSTPVDIWSIGCIFAEMVNR 196 (283)
T ss_pred ------CcEEEeecccccccCCCcc----------ccCccccccCCCCCceeec---CcccCcHHHHHHHHHHHHHHHhC
Confidence 7899999999865432111 1112246888999998765 23567899999999999999999
Q ss_pred CCCCCCCCHHHHHHHH-HhCCCCCchhHHhhhcccc--cccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1047 QVPYMGLSELEIHDLI-QMGKRPRLTDELEALGSCH--EHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1047 ~~Pf~~~~~~el~~~I-~~~~~p~l~~~l~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
+.||...+.......+ .....+. ...+....... ...+... ............+..+.+++.+||+.||.+|||+
T Consensus 197 ~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~ 274 (283)
T cd07835 197 RPLFPGDSEIDQLFRIFRTLGTPD-EDVWPGVTSLPDYKPTFPKW-ARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISA 274 (283)
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCC-hHHhhhhhhchhhhhhcccc-cccchhhhcCCCCHHHHHHHHHHhcCChhhCcCH
Confidence 9999876654433333 2211111 11110000000 0000000 0000011112455779999999999999999999
Q ss_pred HHHHHHHHh
Q 001142 1124 GDLYEMFVA 1132 (1142)
Q Consensus 1124 ~EVL~~L~~ 1132 (1142)
.|+++|+|+
T Consensus 275 ~~il~~~~~ 283 (283)
T cd07835 275 KAALQHPYF 283 (283)
T ss_pred HHHhcCCCC
Confidence 999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=307.75 Aligned_cols=270 Identities=23% Similarity=0.334 Sum_probs=191.5
Q ss_pred cceeeeecccCceEEEEEEE------CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001142 809 LSSCDEAGKSVSSSLFRCKF------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 882 (1142)
Q Consensus 809 y~l~~~LG~GsfG~Vy~a~~------~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~ 882 (1142)
|++.+.||+|+||.||+|++ .+..+++|... ... ....... +.+|+.++++++||||+++++++...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~--~~~-~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (284)
T cd05079 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK--PES-GGNHIAD----LKKEIEILRNLYHENIVKYKGICTED 78 (284)
T ss_pred hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcC--ccc-cHHHHHH----HHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 68899999999999999985 24557777643 221 1222233 47999999999999999999988754
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
+. ...++||||+++++|.+++... ...+++..+..++.||+.||+|||++||+||||||+||++
T Consensus 79 ~~------------~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~ 142 (284)
T cd05079 79 GG------------NGIKLIMEFLPSGSLKEYLPRN----KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV 142 (284)
T ss_pred CC------------CceEEEEEccCCCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEE
Confidence 21 1348999999999999998651 2358999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
+.+ +.++|+|||++..+...... ........++..|+|||++.+ ..++.++|||||||++|+
T Consensus 143 ~~~-------~~~~l~dfg~~~~~~~~~~~-------~~~~~~~~~~~~y~apE~~~~----~~~~~~~Di~slG~il~e 204 (284)
T cd05079 143 ESE-------HQVKIGDFGLTKAIETDKEY-------YTVKDDLDSPVFWYAPECLIQ----SKFYIASDVWSFGVTLYE 204 (284)
T ss_pred cCC-------CCEEECCCccccccccCccc-------eeecCCCCCCccccCHHHhcc----CCCCccccchhhhhhhhh
Confidence 877 78999999999765432111 001123456778999999865 467899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhC-CCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1043 LLTLQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1043 LLtG~~Pf~~~~~~el~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
|++++.|+..... ......... ............ ....... .....+..+.+|+.+||+.||.+||
T Consensus 205 llt~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp 271 (284)
T cd05079 205 LLTYCDSESSPMT-LFLKMIGPTHGQMTVTRLVRVL---------EEGKRLP---RPPNCPEEVYQLMRKCWEFQPSKRT 271 (284)
T ss_pred hhcCCCCCccccc-hhhhhcccccccccHHHHHHHH---------HcCccCC---CCCCCCHHHHHHHHHHccCCcccCc
Confidence 9998776542111 011100000 000000000000 0000000 0114567899999999999999999
Q ss_pred CHHHHHHHHHh
Q 001142 1122 TAGDLYEMFVA 1132 (1142)
Q Consensus 1122 Sa~EVL~~L~~ 1132 (1142)
|+.++++.+..
T Consensus 272 t~~~il~~l~~ 282 (284)
T cd05079 272 TFQNLIEGFEA 282 (284)
T ss_pred CHHHHHHHHHh
Confidence 99999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=310.39 Aligned_cols=258 Identities=21% Similarity=0.336 Sum_probs=196.4
Q ss_pred CCCCcceeeeecccCceEEEEEEEC--Cc----cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeee
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKFG--SA----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 878 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~----~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~ 878 (1142)
...+|+..+.||+|+||.||+|.+. +. .+++|+. ... ........ +.+|+.++++++||||++++++
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~--~~~-~~~~~~~~----~~~e~~~~~~l~h~niv~~~~~ 77 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKIL--NET-TGPKANVE----FMDEALIMASMDHPHLVRLLGV 77 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEec--ccc-CCHHHHHH----HHHHHHHHHhCCCCCcccEEEE
Confidence 3457889999999999999999873 33 2455543 221 11222223 3789999999999999999998
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 001142 879 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 958 (1142)
Q Consensus 879 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~ 958 (1142)
+.... .++||||+++|+|.+++.. ....+++..+..++.||+.||.|||++||+||||||+
T Consensus 78 ~~~~~---------------~~~v~e~~~~g~l~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~ 138 (303)
T cd05110 78 CLSPT---------------IQLVTQLMPHGCLLDYVHE----HKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAAR 138 (303)
T ss_pred EcCCC---------------ceeeehhcCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccc
Confidence 86432 2799999999999999875 1235889999999999999999999999999999999
Q ss_pred CeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001142 959 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1038 (1142)
Q Consensus 959 NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGv 1038 (1142)
||+++.+ +.+||+|||+++........ .......++..|+|||.+.+ ..++.++|||||||
T Consensus 139 Nill~~~-------~~~kL~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~~PE~~~~----~~~~~~~DiwslG~ 199 (303)
T cd05110 139 NVLVKSP-------NHVKITDFGLARLLEGDEKE--------YNADGGKMPIKWMALECIHY----RKFTHQSDVWSYGV 199 (303)
T ss_pred eeeecCC-------CceEEccccccccccCcccc--------cccCCCccccccCCHHHhcc----CCCChHHHHHHHHH
Confidence 9999876 67999999999765432111 01112345778999999865 56789999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001142 1039 LLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1117 (1142)
Q Consensus 1039 iL~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP 1117 (1142)
++|||++ |+.||.+....+....+..+..+..+ ...+..+.+++.+||..+|
T Consensus 200 ~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~c~~~~p 252 (303)
T cd05110 200 TIWELMTFGGKPYDGIPTREIPDLLEKGERLPQP---------------------------PICTIDVYMVMVKCWMIDA 252 (303)
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCC---------------------------CCCCHHHHHHHHHHcCCCh
Confidence 9999997 89999876655555554433322111 0234568999999999999
Q ss_pred CCCCCHHHHHHHHHhhc
Q 001142 1118 TERPTAGDLYEMFVART 1134 (1142)
Q Consensus 1118 ~~RPSa~EVL~~L~~~~ 1134 (1142)
++||++.++++.+....
T Consensus 253 ~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 253 DSRPKFKELAAEFSRMA 269 (303)
T ss_pred hhCcCHHHHHHHHHHHH
Confidence 99999999999887653
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=300.55 Aligned_cols=250 Identities=28% Similarity=0.467 Sum_probs=196.3
Q ss_pred cceeeeecccCceEEEEEEECC------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001142 809 LSSCDEAGKSVSSSLFRCKFGS------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 882 (1142)
Q Consensus 809 y~l~~~LG~GsfG~Vy~a~~~~------~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~ 882 (1142)
+++.+.||+|+||.||++.+.. ..+|+|+.... . .....+.+ ..|+.++..++|+||+++++++.+.
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~--~-~~~~~~~~----~~e~~~l~~l~~~~i~~~~~~~~~~ 73 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKED--A-DEQQIEEF----LREARIMRKLDHPNIVKLLGVCTEE 73 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCC--C-ChHHHHHH----HHHHHHHHhcCCCchheEEEEEcCC
Confidence 3678899999999999999865 55777765322 1 11133344 7899999999999999999998865
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
+ ..++||||+++++|.+++.... ...+++..+..++.|++.||+|||+.|++|+||||+||++
T Consensus 74 ~--------------~~~~i~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~ 136 (258)
T smart00219 74 E--------------PLMIVMEYMEGGDLLDYLRKNR---PKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV 136 (258)
T ss_pred C--------------eeEEEEeccCCCCHHHHHHhhh---hccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEE
Confidence 4 3499999999999999997621 1128999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
+.+ +.++|+|||.+......... ......+++.|+|||.+.. ..++.++||||+|+++++
T Consensus 137 ~~~-------~~~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~~Pe~~~~----~~~~~~~Di~slG~i~~~ 196 (258)
T smart00219 137 GEN-------LVVKISDFGLSRDLYDDDYY---------KKKGGKLPIRWMAPESLKD----GKFTSKSDVWSFGVLLWE 196 (258)
T ss_pred ccC-------CeEEEcccCCceeccccccc---------ccccCCCcccccChHHhcc----CCCCcchhHHHHHHHHHH
Confidence 887 78999999999765432111 0001226788999999854 567899999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1043 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1043 LLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
|++ |..||...........+.....+..+. ..+..+.+++.+||..||.+||
T Consensus 197 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~i~~~l~~~p~~Rp 249 (258)
T smart00219 197 IFTLGESPYPGMSNEEVLEYLKKGYRLPKPE---------------------------NCPPEIYKLMLQCWAEDPEDRP 249 (258)
T ss_pred HHhCCCCCCCCCCHHHHHHHHhcCCCCCCCC---------------------------cCCHHHHHHHHHHCcCChhhCc
Confidence 998 889998766666666655443322110 3456799999999999999999
Q ss_pred CHHHHHHH
Q 001142 1122 TAGDLYEM 1129 (1142)
Q Consensus 1122 Sa~EVL~~ 1129 (1142)
|+.|+++.
T Consensus 250 t~~~ll~~ 257 (258)
T smart00219 250 TFSELVEI 257 (258)
T ss_pred CHHHHHhh
Confidence 99999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=303.39 Aligned_cols=247 Identities=27% Similarity=0.318 Sum_probs=195.4
Q ss_pred ecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCCCCC
Q 001142 815 AGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 892 (1142)
Q Consensus 815 LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~~~~~~ 892 (1142)
||.|++|.||+|++. +..+++|+....... ..... ..+.+|+.+++.++||||+++++.+.+...
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-------- 67 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIV-ETGQQ----EHIFSEKEILEECNHPFIVKLYRTFKDKKY-------- 67 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcch-hhhHH----HHHHHHHHHHHhCCCCCEeeeeeeEEcCCc--------
Confidence 799999999999986 677888876432211 11222 234799999999999999999999876553
Q ss_pred ccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccCCCC
Q 001142 893 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 972 (1142)
Q Consensus 893 ~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~~~~ 972 (1142)
.++||||+++++|.+++.+ ...+++..+..++.||+.||.|||+++++|+||+|+||+++.+
T Consensus 68 ------~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~------- 129 (262)
T cd05572 68 ------IYMLMEYCLGGELWTILRD-----RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSN------- 129 (262)
T ss_pred ------cEEEEecCCCCcHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCC-------
Confidence 4999999999999999976 2458999999999999999999999999999999999999887
Q ss_pred CeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 001142 973 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1052 (1142)
Q Consensus 973 ~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~Pf~~ 1052 (1142)
+.++|+|||.+....... ......+++.|+|||.+.. ..++.++|+||||+++|+|++|..||..
T Consensus 130 ~~~~l~df~~~~~~~~~~-----------~~~~~~~~~~~~~PE~~~~----~~~~~~~Di~slG~il~~l~~g~~p~~~ 194 (262)
T cd05572 130 GYVKLVDFGFAKKLKSGQ-----------KTWTFCGTPEYVAPEIILN----KGYDFSVDYWSLGILLYELLTGRPPFGE 194 (262)
T ss_pred CCEEEeeCCcccccCccc-----------ccccccCCcCccChhHhcC----CCCCChhhhhhhHHHHHHHHhCCCCcCC
Confidence 789999999987654321 1113357889999999865 4578999999999999999999999986
Q ss_pred CC--HHHHHHHHHhCC-CCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC-----HH
Q 001142 1053 LS--ELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT-----AG 1124 (1142)
Q Consensus 1053 ~~--~~el~~~I~~~~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS-----a~ 1124 (1142)
.. ..+....+..+. .+..+ ...++.+.+++.+||+.+|++||+ +.
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~ 247 (262)
T cd05572 195 DDEDPMEIYNDILKGNGKLEFP---------------------------NYIDKAAKDLIKQLLRRNPEERLGNLKGGIK 247 (262)
T ss_pred CCCCHHHHHHHHhccCCCCCCC---------------------------cccCHHHHHHHHHHccCChhhCcCCcccCHH
Confidence 55 444444433211 11100 022557999999999999999999 99
Q ss_pred HHHHHHHhhc
Q 001142 1125 DLYEMFVART 1134 (1142)
Q Consensus 1125 EVL~~L~~~~ 1134 (1142)
|+++|+|+..
T Consensus 248 ~l~~~~~~~~ 257 (262)
T cd05572 248 DIKKHKWFNG 257 (262)
T ss_pred HHhcChhhhC
Confidence 9999999974
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=309.44 Aligned_cols=282 Identities=21% Similarity=0.240 Sum_probs=195.8
Q ss_pred CCCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 882 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~ 882 (1142)
...+|.+.+.||+|+||.||+|.. .+..+++|+...+... ..... +.+|+.+++.++|+||+++++++...
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~----~~~e~~~l~~l~h~ni~~~~~~~~~~ 75 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE---GVPFT----AIREASLLKGLKHANIVLLHDIIHTK 75 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC---CCcHH----HHHHHHHHHhcCCCCEeEEEEEEecC
Confidence 346799999999999999999986 4677888876443211 11112 26899999999999999999998764
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
. ..++||||+. ++|.+++.. ....+++..+..++.||+.||.|||++||+|+||||+|||+
T Consensus 76 ~--------------~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~ 136 (291)
T cd07870 76 E--------------TLTFVFEYMH-TDLAQYMIQ----HPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI 136 (291)
T ss_pred C--------------eEEEEEeccc-CCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE
Confidence 4 3499999996 788777654 12357888899999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
+.+ +.++|+|||+++........ .....+++.|+|||++.+ ...++.++|||||||++|+
T Consensus 137 ~~~-------~~~~l~Dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~~l~~ 196 (291)
T cd07870 137 SYL-------GELKLADFGLARAKSIPSQT----------YSSEVVTLWYRPPDVLLG---ATDYSSALDIWGAGCIFIE 196 (291)
T ss_pred cCC-------CcEEEeccccccccCCCCCC----------CCCccccccccCCceeec---CCCCCcHHHHHHHHHHHHH
Confidence 877 78999999998654321111 122347889999999864 2346789999999999999
Q ss_pred HHhCCCCCCCCCHH-HHHHHH-HhCCCCCch--hHHhhhcccccccccc-cCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001142 1043 LLTLQVPYMGLSEL-EIHDLI-QMGKRPRLT--DELEALGSCHEHEVAQ-SGSGFEKPEAELETLSFLVDVFRRCTEENP 1117 (1142)
Q Consensus 1043 LLtG~~Pf~~~~~~-el~~~I-~~~~~p~l~--~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP 1117 (1142)
|++|+.||.+.... +....+ .....|... ................ ..............+..+.+++.+|++.||
T Consensus 197 l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp 276 (291)
T cd07870 197 MLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFP 276 (291)
T ss_pred HHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCc
Confidence 99999999765432 222222 111111100 0000000000000000 000000000011235678999999999999
Q ss_pred CCCCCHHHHHHHHHh
Q 001142 1118 TERPTAGDLYEMFVA 1132 (1142)
Q Consensus 1118 ~~RPSa~EVL~~L~~ 1132 (1142)
.+|||+.|++.|+|+
T Consensus 277 ~~R~t~~~~l~h~~~ 291 (291)
T cd07870 277 KDRISAQDALLHPYF 291 (291)
T ss_pred ccCcCHHHHhcCCCC
Confidence 999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=308.65 Aligned_cols=249 Identities=21% Similarity=0.261 Sum_probs=185.4
Q ss_pred eecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHH---HHhhCCCCCccceeeeEecCCCCCCC
Q 001142 814 EAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVR---MLGALRHSCIVEMYGHKISSKWLPSA 888 (1142)
Q Consensus 814 ~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~---iL~~L~HpNIVkl~g~~~~~~~~~~~ 888 (1142)
.||+|+||.||++.+. +..+|+|+...+....... ...+ .+|.. ++....||||+.+++++...+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~---- 71 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-ETLA----LNERIMLSLVSTGDCPFIVCMTYAFHTPDK---- 71 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchH-HHHH----HHHHHHHHHHhhCCCCcEeEEEEEEecCCe----
Confidence 4899999999999874 5678888754332211111 1111 23433 3334479999999999876543
Q ss_pred CCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecccccc
Q 001142 889 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 968 (1142)
Q Consensus 889 ~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~ 968 (1142)
.++||||+++++|.+++.. ...+++..+..++.|++.||+|||+++|+||||||+|||++.+
T Consensus 72 ----------~~lv~e~~~~~~L~~~i~~-----~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~--- 133 (279)
T cd05633 72 ----------LCFILDLMNGGDLHYHLSQ-----HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEH--- 133 (279)
T ss_pred ----------EEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCC---
Confidence 4999999999999998875 2469999999999999999999999999999999999999877
Q ss_pred CCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCC
Q 001142 969 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV 1048 (1142)
Q Consensus 969 ~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~ 1048 (1142)
+.++|+|||++....... .....||+.|+|||.+.. +..++.++|||||||++|+|++|..
T Consensus 134 ----~~~~l~dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~~l~~l~~g~~ 194 (279)
T cd05633 134 ----GHVRISDLGLACDFSKKK------------PHASVGTHGYMAPEVLQK---GTAYDSSADWFSLGCMLFKLLRGHS 194 (279)
T ss_pred ----CCEEEccCCcceeccccC------------ccCcCCCcCccCHHHhcC---CCCCCchhhhHHHHHHHHHHHhCCC
Confidence 789999999986443211 112358999999999753 2457899999999999999999999
Q ss_pred CCCCCCHHH--HHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----
Q 001142 1049 PYMGLSELE--IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP----- 1121 (1142)
Q Consensus 1049 Pf~~~~~~e--l~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP----- 1121 (1142)
||....... ............ .....++.+.+++.+||+.||.+||
T Consensus 195 pf~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~ 247 (279)
T cd05633 195 PFRQHKTKDKHEIDRMTLTVNVE---------------------------LPDSFSPELKSLLEGLLQRDVSKRLGCLGR 247 (279)
T ss_pred CcCCCCCcCHHHHHHHhhcCCcC---------------------------CccccCHHHHHHHHHHhcCCHHHhcCCCCC
Confidence 997532211 111111000000 0114556799999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001142 1122 TAGDLYEMFVARTS 1135 (1142)
Q Consensus 1122 Sa~EVL~~L~~~~s 1135 (1142)
|+.|+++|+|++.-
T Consensus 248 ~~~~~~~h~~~~~~ 261 (279)
T cd05633 248 GAQEVKEHVFFKGI 261 (279)
T ss_pred CHHHHHhCccccCC
Confidence 69999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=302.00 Aligned_cols=269 Identities=24% Similarity=0.340 Sum_probs=209.5
Q ss_pred cce-eeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEecCCC
Q 001142 809 LSS-CDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKW 884 (1142)
Q Consensus 809 y~l-~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~g~~~~~~~ 884 (1142)
|.+ .+.||+|+|+.|--+.. .+..+||||. ++. .+... .++.+|++++.+.+ |+||++++++|+++..
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKii--dKq-~gHsR-----~RvfREVe~f~~Cqgh~nilqLiefFEdd~~ 150 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKII--DKQ-PGHSR-----SRVFREVETFYQCQGHKNILQLIEFFEDDTR 150 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhh--hcC-CchHH-----HHHHHHHHHHHHhcCCccHHHHHHHhcccce
Confidence 443 47899999999988875 6788999984 433 22222 23369999999996 9999999999998775
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
+ |||||-+.||+|..+|++ ...|++.++.++.++|+.||.|||.+||.||||||+|||...
T Consensus 151 F--------------YLVfEKm~GGplLshI~~-----~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~ 211 (463)
T KOG0607|consen 151 F--------------YLVFEKMRGGPLLSHIQK-----RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCES 211 (463)
T ss_pred E--------------EEEEecccCchHHHHHHH-----hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecC
Confidence 5 999999999999999987 467999999999999999999999999999999999999965
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhcccc-CCCCCCchhhHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ ...-||||||.++.-+...... .....+..-+.+|+..|||||+..-.. ....|+.+.|.||||||+|-|
T Consensus 212 pn----~vsPvKiCDfDLgSg~k~~~~~---spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYIm 284 (463)
T KOG0607|consen 212 PN----KVSPVKICDFDLGSGIKLNNDC---SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIM 284 (463)
T ss_pred CC----CcCceeeeccccccccccCCCC---CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHH
Confidence 42 2345999999988654332211 112233445668999999999875322 235789999999999999999
Q ss_pred HhCCCCCCCCC---------------HHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHH
Q 001142 1044 LTLQVPYMGLS---------------ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDV 1108 (1142)
Q Consensus 1044 LtG~~Pf~~~~---------------~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dL 1108 (1142)
++|.+||.+.- ...+++.|+.+........| ..++.+..++
T Consensus 285 LsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdW------------------------ahIS~eakdl 340 (463)
T KOG0607|consen 285 LSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDW------------------------AHISSEAKDL 340 (463)
T ss_pred HhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhh------------------------HHhhHHHHHH
Confidence 99999997631 23356666666542222111 1677889999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001142 1109 FRRCTEENPTERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1109 I~~CL~~DP~~RPSa~EVL~~L~~~~s 1135 (1142)
+..+|..|+.+|.++.+++.|||+..-
T Consensus 341 isnLlvrda~~rlsa~~vlnhPw~~~~ 367 (463)
T KOG0607|consen 341 ISNLLVRDAKQRLSAAQVLNHPWVQRC 367 (463)
T ss_pred HHHHHhccHHhhhhhhhccCCcccccc
Confidence 999999999999999999999999754
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=302.29 Aligned_cols=258 Identities=26% Similarity=0.404 Sum_probs=197.6
Q ss_pred CCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCC-ChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGS-SADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~-~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
.+|++.+.||+|+||.||+|.+ .+..+++|+........ ...... .+.+|+.++++++||||+++++++.+..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~----~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 77 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVN----ALECEIQLLKNLRHDRIVQYYGCLRDPE 77 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHH----HHHHHHHHHHHcCCCCcceEEEEEEcCC
Confidence 4689999999999999999987 46678888754332111 112222 3478999999999999999999986532
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
. ...++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+||+++
T Consensus 78 ~------------~~~~~v~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~ 140 (264)
T cd06653 78 E------------KKLSIFVEYMPGGSIKDQLKA-----YGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRD 140 (264)
T ss_pred C------------CEEEEEEEeCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc
Confidence 1 245899999999999999875 23588999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.++|+|||.+......... . .......++..|+|||.+.+ ..++.++|||||||++|+|
T Consensus 141 ~~-------~~~~l~dfg~~~~~~~~~~~------~-~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~l 202 (264)
T cd06653 141 SA-------GNVKLGDFGASKRIQTICMS------G-TGIKSVTGTPYWMSPEVISG----EGYGRKADVWSVACTVVEM 202 (264)
T ss_pred CC-------CCEEECcccccccccccccc------C-ccccccCCcccccCHhhhcC----CCCCccccHHHHHHHHHHH
Confidence 77 78999999999764321100 0 01123458899999999875 4577899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhC-CCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
++|+.||...........+... ..+.++ ...++.+.+++.+||+ +|..||+
T Consensus 203 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p---------------------------~~~~~~~~~~i~~~l~-~~~~r~~ 254 (264)
T cd06653 203 LTEKPPWAEYEAMAAIFKIATQPTKPMLP---------------------------DGVSDACRDFLKQIFV-EEKRRPT 254 (264)
T ss_pred HhCCCCCCccCHHHHHHHHHcCCCCCCCC---------------------------cccCHHHHHHHHHHhc-CcccCcc
Confidence 9999999875544433332211 111111 1455679999999999 5799999
Q ss_pred HHHHHHHHH
Q 001142 1123 AGDLYEMFV 1131 (1142)
Q Consensus 1123 a~EVL~~L~ 1131 (1142)
+.+++.|+|
T Consensus 255 ~~~~~~~~~ 263 (264)
T cd06653 255 AEFLLRHPF 263 (264)
T ss_pred HHHHhcCCC
Confidence 999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=316.05 Aligned_cols=288 Identities=18% Similarity=0.215 Sum_probs=202.7
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
.+|.+.+.||+|+||+||+|++. +..+++|..... .........+ .+|+.+++.++||||+++++++.....
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~----~~E~~~l~~l~h~ni~~~~~~~~~~~~ 78 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANA--FDNRIDAKRT----LREIKLLRHLDHENVIAIKDIMPPPHR 78 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccc--ccccchhHHH----HHHHHHHHhcCCCCccchHHheecccc
Confidence 46899999999999999999974 566777764322 1111122222 689999999999999999998765321
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
. .....++||||+. ++|.+++.. ...+++..+..++.||+.||.|||+++++||||||+||+++.
T Consensus 79 ~---------~~~~~~lv~e~~~-~~L~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~ 143 (337)
T cd07858 79 E---------AFNDVYIVYELMD-TDLHQIIRS-----SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA 143 (337)
T ss_pred c---------ccCcEEEEEeCCC-CCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC
Confidence 1 1234699999996 789888864 346999999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||+|||++........ ......++..|+|||.+... ..++.++|||||||++|+|+
T Consensus 144 ~-------~~~kL~Dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~il~~l~ 203 (337)
T cd07858 144 N-------CDLKICDFGLARTTSEKGD----------FMTEYVVTRWYRAPELLLNC---SEYTTAIDVWSVGCIFAELL 203 (337)
T ss_pred C-------CCEEECcCccccccCCCcc----------cccccccccCccChHHHhcC---CCCCCcccHHHHHHHHHHHH
Confidence 7 7899999999975432110 11133578899999997641 34789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCC---CCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS---GFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
+|+.||.+.+.......+...........+............+... ...........++.+.+++.+||+.||++||
T Consensus 204 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 283 (337)
T cd07858 204 GRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRI 283 (337)
T ss_pred cCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhcc
Confidence 9999998765544443332211111111111000000000000000 0000011124567899999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001142 1122 TAGDLYEMFVARTS 1135 (1142)
Q Consensus 1122 Sa~EVL~~L~~~~s 1135 (1142)
|+.++++|+|+..-
T Consensus 284 s~~ell~h~~~~~~ 297 (337)
T cd07858 284 TVEEALAHPYLASL 297 (337)
T ss_pred CHHHHHcCcchhhh
Confidence 99999999999753
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=297.14 Aligned_cols=251 Identities=29% Similarity=0.491 Sum_probs=199.1
Q ss_pred CcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
+|++.+.||+|++|.||++.+. +..+++|+...... .....+ .+|+.++++++||||+++++++....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~----~~e~~~l~~l~~~~i~~~~~~~~~~~-- 70 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK----EKKEKI----INEIQILKKCKHPNIVKYYGSYLKKD-- 70 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch----hHHHHH----HHHHHHHHhCCCCCEeEEEEEEecCC--
Confidence 5889999999999999999985 56677777543221 223333 78999999999999999999987654
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
..+++|||+++++|.+++... ...+++..+..++.|++.||.|||++|++||||+|+||+++.+
T Consensus 71 ------------~~~l~~e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~ 134 (253)
T cd05122 71 ------------ELWIVMEFCSGGSLKDLLKST----NQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSD 134 (253)
T ss_pred ------------eEEEEEecCCCCcHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccC
Confidence 349999999999999998762 1468999999999999999999999999999999999999887
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+.++|+|||.+........ .....++..|+|||.+.+ ..++.++||||||+++++|++
T Consensus 135 -------~~~~l~d~~~~~~~~~~~~-----------~~~~~~~~~~~~PE~~~~----~~~~~~~Dv~slG~il~~l~~ 192 (253)
T cd05122 135 -------GEVKLIDFGLSAQLSDTKA-----------RNTMVGTPYWMAPEVING----KPYDYKADIWSLGITAIELAE 192 (253)
T ss_pred -------CeEEEeecccccccccccc-----------ccceecCCcccCHHHHcC----CCCCccccHHHHHHHHHHHHh
Confidence 7899999999876543210 123468889999999876 347889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001142 1046 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1125 (1142)
Q Consensus 1046 G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~E 1125 (1142)
|+.||...+.......+.....+..... ...+..+.+++.+||+.||.+|||+.+
T Consensus 193 g~~p~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~i~~~l~~~p~~R~t~~~ 247 (253)
T cd05122 193 GKPPYSELPPMKALFKIATNGPPGLRNP-------------------------EKWSDEFKDFLKKCLQKNPEKRPTAEQ 247 (253)
T ss_pred CCCCCCCCchHHHHHHHHhcCCCCcCcc-------------------------cccCHHHHHHHHHHccCChhhCCCHHH
Confidence 9999987655444433332222111100 023567999999999999999999999
Q ss_pred HHHHHH
Q 001142 1126 LYEMFV 1131 (1142)
Q Consensus 1126 VL~~L~ 1131 (1142)
+++|+|
T Consensus 248 ~l~~~~ 253 (253)
T cd05122 248 LLKHPF 253 (253)
T ss_pred HhcCCC
Confidence 999986
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=316.43 Aligned_cols=291 Identities=23% Similarity=0.253 Sum_probs=205.1
Q ss_pred CCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEec
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 881 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~~~ 881 (1142)
-.++|++.+.||+|+||.||+|.+. +..+++|... ...........+ .+|+.+++++ +||||+++++++..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~--~~~~~~~~~~~~----~~E~~~l~~l~~h~ni~~~~~~~~~ 78 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIF--DAFRNATDAQRT----FREIMFLQELGDHPNIVKLLNVIKA 78 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeec--cccCcchhhhhh----hHHHHHHHHhcCCCCccceeeeecc
Confidence 3467999999999999999999874 5567777542 211122222233 6899999999 99999999998865
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 001142 882 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 961 (1142)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NIL 961 (1142)
.+. ...++||||++ ++|..++.. ..+++..+..++.||+.||.|||+.||+||||||+||+
T Consensus 79 ~~~------------~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nil 139 (337)
T cd07852 79 END------------KDIYLVFEYME-TDLHAVIRA------NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNIL 139 (337)
T ss_pred CCC------------ceEEEEecccc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEE
Confidence 321 24699999997 699988864 26788999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001142 962 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1041 (1142)
Q Consensus 962 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ 1041 (1142)
++.+ +.+||+|||.+.......... .........||..|+|||++.+ ...++.++||||||+++|
T Consensus 140 l~~~-------~~~kl~d~g~~~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~sDi~slG~~l~ 204 (337)
T cd07852 140 LNSD-------CRVKLADFGLARSLSELEENP-----ENPVLTDYVATRWYRAPEILLG---STRYTKGVDMWSVGCILG 204 (337)
T ss_pred EcCC-------CcEEEeeccchhccccccccc-----cCcchhcccccccccCceeeec---cccccccchHHHHHHHHH
Confidence 9987 789999999997654322110 0112223468999999998764 245678999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccc---cCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001142 1042 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ---SGSGFEKPEAELETLSFLVDVFRRCTEENPT 1118 (1142)
Q Consensus 1042 ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~ 1118 (1142)
+|++|+.||.+....+....+...........+............. ..............+..+.+++.+||+.||.
T Consensus 205 el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~ 284 (337)
T cd07852 205 EMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPN 284 (337)
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcc
Confidence 9999999998766655444442222111111111110000000000 0000000111113567899999999999999
Q ss_pred CCCCHHHHHHHHHhhcC
Q 001142 1119 ERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1119 ~RPSa~EVL~~L~~~~s 1135 (1142)
+|||+.++++|+|+..-
T Consensus 285 ~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 285 KRLTAEEALEHPYVAQF 301 (337)
T ss_pred cccCHHHHhhChhhhhh
Confidence 99999999999988643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=294.10 Aligned_cols=275 Identities=23% Similarity=0.244 Sum_probs=201.8
Q ss_pred CCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
.+|++.++||+|+|+.||+++. ++..+|+|..... ...+.+.. ++|++..++++||||++++++...+..
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~----~~~~~e~~----~rEid~~rkf~s~~vl~l~dh~l~~~~ 92 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH----SQEDIEEA----LREIDNHRKFNSPNVLRLVDHQLREEK 92 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeecc----chHHHHHH----HHHHHHHHhhCCcchHHHHHHHHHhhc
Confidence 4799999999999999999985 5566777764332 23333443 799999999999999999998764321
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCeee
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENILI 962 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~g--IvHrDLKp~NILl 962 (1142)
| .....||+++|+..|||.+.++.....+ ..+++.+++.|+.+|++||++||+.. +.||||||.|||+
T Consensus 93 ----D-----~~~~~yll~Pyy~~Gsl~d~i~~~k~kg-~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILl 162 (302)
T KOG2345|consen 93 ----D-----GKHEAYLLLPYYKRGSLLDEIERLKIKG-NFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILL 162 (302)
T ss_pred ----c-----CceeEEEEeehhccccHHHHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEe
Confidence 1 2235799999999999999998765443 57999999999999999999999998 9999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
.+. +.++|.|||.++...........+.+-... .....|..|+|||.+.-. .....+.++|||||||+||+
T Consensus 163 s~~-------~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~-a~e~Ct~pyRAPELf~vk-~~~ti~ertDIWSLGCtLYa 233 (302)
T KOG2345|consen 163 SDS-------GLPVLMDLGSATQAPIQIEGSRQALRLQEW-AEERCTIPYRAPELFNVK-SHCTITERTDIWSLGCTLYA 233 (302)
T ss_pred cCC-------CceEEEeccCccccceEeechHHHHHHHHH-HHHhCCCcccCchheecc-cCcccccccchhhhhHHHHH
Confidence 886 789999999997654322221111110000 012368999999998653 34567899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1043 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1043 LLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
|+.|..||... + .+|....+.- . ......|.. ..+++.+.++|..||+.||.+||+
T Consensus 234 ~mf~~sPfe~~-----~---~~GgSlaLAv-------~--------n~q~s~P~~-~~yse~l~~lik~mlqvdP~qRP~ 289 (302)
T KOG2345|consen 234 MMFGESPFERI-----Y---QQGGSLALAV-------Q--------NAQISIPNS-SRYSEALHQLIKSMLQVDPNQRPT 289 (302)
T ss_pred HHHcCCcchHH-----h---hcCCeEEEee-------e--------ccccccCCC-CCccHHHHHHHHHHhcCCcccCCC
Confidence 99999999631 1 1121111000 0 000001111 136778999999999999999999
Q ss_pred HHHHHHHHHh
Q 001142 1123 AGDLYEMFVA 1132 (1142)
Q Consensus 1123 a~EVL~~L~~ 1132 (1142)
+.+++.++..
T Consensus 290 i~~ll~~~d~ 299 (302)
T KOG2345|consen 290 IPELLSKLDD 299 (302)
T ss_pred HHHHHHHHHh
Confidence 9999987653
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=306.92 Aligned_cols=257 Identities=28% Similarity=0.460 Sum_probs=204.4
Q ss_pred CCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
...|++.+.||+|++|.||+|.+. +..+++|+...... ..+.+ .+|++++++++|+||+++++++....
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----~~~~~----~~e~~~l~~l~~~~i~~~~~~~~~~~ 88 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-----NKELI----INEILIMKDCKHPNIVDYYDSYLVGD 88 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-----hHHHH----HHHHHHHHHCCCCCeeEEEEEEEECC
Confidence 445889999999999999999985 67788887653321 22333 78999999999999999999988654
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.||+|+||+|+||+++
T Consensus 89 --------------~~~lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~ 150 (286)
T cd06614 89 --------------ELWVVMEYMDGGSLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLS 150 (286)
T ss_pred --------------EEEEEEeccCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEc
Confidence 3599999999999999998621 3689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.++|+|||.+........ ......++..|+|||++.+ ..++.++|||||||++|+|
T Consensus 151 ~~-------~~~~l~d~~~~~~~~~~~~----------~~~~~~~~~~y~~PE~~~~----~~~~~~~Dv~slGvil~~l 209 (286)
T cd06614 151 KD-------GSVKLADFGFAAQLTKEKS----------KRNSVVGTPYWMAPEVIKR----KDYGPKVDIWSLGIMCIEM 209 (286)
T ss_pred CC-------CCEEECccchhhhhccchh----------hhccccCCcccCCHhHhcC----CCCCCccccHHHHHHHHHH
Confidence 77 7899999998865432111 1123347889999999865 4578999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
++|+.||...........+.....+.... ....+..+.+++.+||+.+|.+||++
T Consensus 210 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~l~~li~~~l~~~p~~Rpt~ 264 (286)
T cd06614 210 AEGEPPYLREPPLRALFLITTKGIPPLKN-------------------------PEKWSPEFKDFLNKCLVKDPEKRPSA 264 (286)
T ss_pred HhCCCCCCCCCHHHHHHHHHhcCCCCCcc-------------------------hhhCCHHHHHHHHHHhccChhhCcCH
Confidence 99999998766554444433222211110 01245679999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 001142 1124 GDLYEMFVARTS 1135 (1142)
Q Consensus 1124 ~EVL~~L~~~~s 1135 (1142)
.++++|+|+...
T Consensus 265 ~~il~~~~~~~~ 276 (286)
T cd06614 265 EELLQHPFLKKA 276 (286)
T ss_pred HHHhhChHhhcc
Confidence 999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=323.83 Aligned_cols=261 Identities=23% Similarity=0.355 Sum_probs=211.5
Q ss_pred CCCCcceeeeecccCceEEEEEEEC---Cc--cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeE
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKFG---SA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 879 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~~---~~--~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~ 879 (1142)
..++..+.++||+|.||+|++|.|+ ++ .||||+. +..... ....+| ++|+.+|.+|+|||+|++||.+
T Consensus 108 pee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKcl--r~d~l~-~~mddf----lrEas~M~~L~H~hliRLyGvV 180 (1039)
T KOG0199|consen 108 PEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCL--RDDSLN-AIMDDF----LREASHMLKLQHPHLIRLYGVV 180 (1039)
T ss_pred cHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEec--cCCccc-hhHHHH----HHHHHHHHhccCcceeEEeeee
Confidence 3456788999999999999999994 33 4566664 332222 245566 8999999999999999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 001142 880 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959 (1142)
Q Consensus 880 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~N 959 (1142)
.+.. ..+|||+++.|||.+++++ .....|.....-.++.|||.||.||..+++|||||-..|
T Consensus 181 l~qp---------------~mMV~ELaplGSLldrLrk---a~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARN 242 (1039)
T KOG0199|consen 181 LDQP---------------AMMVFELAPLGSLLDRLRK---AKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARN 242 (1039)
T ss_pred ccch---------------hhHHhhhcccchHHHHHhh---ccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhh
Confidence 8632 3799999999999999987 334578889999999999999999999999999999999
Q ss_pred eeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001142 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039 (1142)
Q Consensus 960 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGvi 1039 (1142)
+|+-.. .+|||+|||+.+.+......+... ....-...|+|||.+.. ..++.++|||+|||+
T Consensus 243 lllasp-------rtVKI~DFGLmRaLg~ned~Yvm~-------p~rkvPfAWCaPEsLrh----~kFShaSDvWmyGVT 304 (1039)
T KOG0199|consen 243 LLLASP-------RTVKICDFGLMRALGENEDMYVMA-------PQRKVPFAWCAPESLRH----RKFSHASDVWMYGVT 304 (1039)
T ss_pred heeccc-------ceeeeecccceeccCCCCcceEec-------CCCcCcccccCHhHhcc----ccccccchhhhhhhh
Confidence 999765 689999999999887654332111 11224567999999986 678999999999999
Q ss_pred HHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001142 1040 LLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1118 (1142)
Q Consensus 1040 L~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~ 1118 (1142)
||||+| |..||.+....++.+.|..+.+..-+ ..+++++.+++..||...|+
T Consensus 305 iWEMFtyGEePW~G~~g~qIL~~iD~~erLpRP---------------------------k~csedIY~imk~cWah~pa 357 (1039)
T KOG0199|consen 305 IWEMFTYGEEPWVGCRGIQILKNIDAGERLPRP---------------------------KYCSEDIYQIMKNCWAHNPA 357 (1039)
T ss_pred HHhhhccCCCCCCCCCHHHHHHhccccccCCCC---------------------------CCChHHHHHHHHHhccCCcc
Confidence 999999 89999999998888887654432211 16788899999999999999
Q ss_pred CCCCHHHHHHHHHhhcC
Q 001142 1119 ERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1119 ~RPSa~EVL~~L~~~~s 1135 (1142)
+||||..|.+.+..+..
T Consensus 358 DRptFsair~~~~l~ea 374 (1039)
T KOG0199|consen 358 DRPTFSAIREDLVLAEA 374 (1039)
T ss_pred ccccHHHHHHhHHHHhc
Confidence 99999999876665543
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=300.66 Aligned_cols=264 Identities=20% Similarity=0.335 Sum_probs=198.4
Q ss_pred cceeeeecccCceEEEEEEEC-----CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 809 LSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 809 y~l~~~LG~GsfG~Vy~a~~~-----~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
|.+.+.||+|+||.||+|.+. +..+|+|+...+. ......+++ .+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~----~~E~~~l~~l~h~~i~~~~~~~~~~~ 74 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI--FSSSDIEEF----LREAACMKEFDHPNVIKLIGVSLRSR 74 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc--CChHHHHHH----HHHHHHHhcCCCCCcceEEEEEccCC
Confidence 678899999999999999863 4567888764332 222333344 78999999999999999999886532
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~-~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
.. ......++++||+++++|.+++...... ....+++..+..++.||+.||+|||++||+||||||+||++
T Consensus 75 ~~--------~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili 146 (273)
T cd05074 75 AK--------GRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCML 146 (273)
T ss_pred CC--------CcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEE
Confidence 11 1122457899999999999887542211 12357899999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
+.+ +.+||+|||.++........ .......+++.|++||.+.. ..++.++|||||||++|+
T Consensus 147 ~~~-------~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~~~~pe~~~~----~~~~~~sDi~slG~il~e 207 (273)
T cd05074 147 NEN-------MTVCVADFGLSKKIYSGDYY--------RQGCASKLPVKWLALESLAD----NVYTTHSDVWAFGVTMWE 207 (273)
T ss_pred cCC-------CCEEECcccccccccCCcce--------ecCCCccCchhhcCHhHHhc----CccchhhhhHHHHHHHHH
Confidence 876 78999999998764321110 01112235678999999865 457789999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1043 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1043 LLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
|++ |+.||.+....+....+......... ...+..+.+++.+||+.+|++||
T Consensus 208 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~~~l~~~p~~Rp 260 (273)
T cd05074 208 IMTRGQTPYAGVENSEIYNYLIKGNRLKQP---------------------------PDCLEDVYELMCQCWSPEPKCRP 260 (273)
T ss_pred HhhCCCCCCCCCCHHHHHHHHHcCCcCCCC---------------------------CCCCHHHHHHHHHHcCCChhhCc
Confidence 999 89999877666555554433221110 13455799999999999999999
Q ss_pred CHHHHHHHHHh
Q 001142 1122 TAGDLYEMFVA 1132 (1142)
Q Consensus 1122 Sa~EVL~~L~~ 1132 (1142)
|+.++++.+..
T Consensus 261 s~~~~~~~l~~ 271 (273)
T cd05074 261 SFQHLRDQLEL 271 (273)
T ss_pred CHHHHHHHHHh
Confidence 99999998764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=297.87 Aligned_cols=252 Identities=30% Similarity=0.435 Sum_probs=199.2
Q ss_pred CcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
+|++.+.||+|++|.||++.+. +..+++|..... .......+.+ .+|++++.+++|||++++++++.+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~----~~e~~~l~~l~~~~i~~~~~~~~~~~-- 72 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLE--KIKEEALKSI----MQEIDLLKNLKHPNIVKYIGSIETSD-- 72 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccc--ccCHHHHHHH----HHHHHHHHhCCCCCccEEEEEEEeCC--
Confidence 4889999999999999999874 556788875433 2222333334 89999999999999999999987654
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+||+++.+
T Consensus 73 ------------~~~~v~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~ 135 (254)
T cd06627 73 ------------SLYIILEYAENGSLRQIIKK-----FGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKD 135 (254)
T ss_pred ------------EEEEEEecCCCCcHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCC
Confidence 34999999999999999876 2468999999999999999999999999999999999999876
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+.++|+|||.+........ ......++..|+|||...+ ..++.++||||+|+++|+|++
T Consensus 136 -------~~~~l~d~~~~~~~~~~~~----------~~~~~~~~~~y~~pe~~~~----~~~~~~~Dv~~lG~~l~~l~~ 194 (254)
T cd06627 136 -------GVVKLADFGVATKLNDVSK----------DDASVVGTPYWMAPEVIEM----SGASTASDIWSLGCTVIELLT 194 (254)
T ss_pred -------CCEEEeccccceecCCCcc----------cccccccchhhcCHhhhcC----CCCCcchhHHHHHHHHHHHHh
Confidence 7899999999976543211 1123457889999999865 347789999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001142 1046 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1125 (1142)
Q Consensus 1046 G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~E 1125 (1142)
|..||...........+.....+..+ ...+..+.+++.+||..+|++|||+.+
T Consensus 195 g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~~l~~~p~~R~~~~~ 247 (254)
T cd06627 195 GNPPYYDLNPMAALFRIVQDDHPPLP---------------------------EGISPELKDFLMQCFQKDPNLRPTAKQ 247 (254)
T ss_pred CCCCCCCccHHHHHHHHhccCCCCCC---------------------------CCCCHHHHHHHHHHHhCChhhCcCHHH
Confidence 99999765543333332222111111 134567899999999999999999999
Q ss_pred HHHHHHh
Q 001142 1126 LYEMFVA 1132 (1142)
Q Consensus 1126 VL~~L~~ 1132 (1142)
++.++|+
T Consensus 248 ~l~~~~~ 254 (254)
T cd06627 248 LLKHPWI 254 (254)
T ss_pred HhcCCCC
Confidence 9998875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=304.89 Aligned_cols=299 Identities=19% Similarity=0.252 Sum_probs=214.5
Q ss_pred CCCCCcceeeeecccCceEEEEEEEC------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceee
Q 001142 804 GSFPSLSSCDEAGKSVSSSLFRCKFG------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 877 (1142)
Q Consensus 804 ~~~~~y~l~~~LG~GsfG~Vy~a~~~------~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g 877 (1142)
..+..|+....||+|+||.||+|... ...+|+|.++..+... .+.....+|+.+++.++|||||.+..
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t------GiS~SAcREiaL~REl~h~nvi~Lv~ 94 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT------GISMSACREIALLRELKHPNVISLVK 94 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC------CcCHHHHHHHHHHHHhcCCcchhHHH
Confidence 34567999999999999999999642 2255666544332211 22233469999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 001142 878 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 957 (1142)
Q Consensus 878 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp 957 (1142)
++...+ ...++++||.+ .+|...|+-++......++...++.|+.||+.|+.|||++=|+||||||
T Consensus 95 Vfl~~d-------------~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKP 160 (438)
T KOG0666|consen 95 VFLSHD-------------KKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKP 160 (438)
T ss_pred HHhccC-------------ceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCc
Confidence 887522 24699999998 8999999877666667899999999999999999999999999999999
Q ss_pred CCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHH
Q 001142 958 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1037 (1142)
Q Consensus 958 ~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLG 1037 (1142)
.||||..++. .+|.|||+|||+++.+........ ..+..+.|..|+|||.+.+ ...|++++||||.|
T Consensus 161 aNIlvmgdgp---erG~VKIaDlGlaR~~~~plkpl~-------s~d~VVVTiWYRAPELLLG---a~hYT~AiDvWAiG 227 (438)
T KOG0666|consen 161 ANILVMGDGP---ERGRVKIADLGLARLFNNPLKPLA-------SLDPVVVTIWYRAPELLLG---ARHYTKAIDVWAIG 227 (438)
T ss_pred ceEEEeccCC---ccCeeEeecccHHHHhhccccccc-------cCCceEEEEEecChHHhcc---cccccchhhhHHHH
Confidence 9999987743 358999999999998776554321 2345678999999999998 45799999999999
Q ss_pred HHHHHHHhCCCCCCCCCH---------HHHHHHHHhCCCCCchhHHhhhcccccccc--cccC-CCCCC---chh---hh
Q 001142 1038 CLLLELLTLQVPYMGLSE---------LEIHDLIQMGKRPRLTDELEALGSCHEHEV--AQSG-SGFEK---PEA---EL 1099 (1142)
Q Consensus 1038 viL~ELLtG~~Pf~~~~~---------~el~~~I~~~~~p~l~~~l~~~~~~~~~~~--~~~~-~~~~~---~~~---~~ 1099 (1142)
||+.||+|-.+.|.+... .+..+.|......+....++......+... .... ..+.. ... ..
T Consensus 228 CIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k 307 (438)
T KOG0666|consen 228 CIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHK 307 (438)
T ss_pred HHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhc
Confidence 999999999888865221 122333422221111112222211111100 0000 00000 000 00
Q ss_pred hhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001142 1100 ETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1100 ~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~~s 1135 (1142)
..++...+|+.+||++||.+|.|++++++|++|...
T Consensus 308 ~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d 343 (438)
T KOG0666|consen 308 VKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTED 343 (438)
T ss_pred CCCchHHHHHHHHhccCchhhccHHHHhcccccccC
Confidence 123447899999999999999999999999999876
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=309.97 Aligned_cols=291 Identities=19% Similarity=0.214 Sum_probs=202.1
Q ss_pred cceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCC
Q 001142 809 LSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 888 (1142)
Q Consensus 809 y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~~ 888 (1142)
|.+++.+|.|+++.||++...+..+|+|+..... ......+.+ .+|+.++++++||||+++++++.+.+.
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~----~~Ei~~l~~l~h~~i~~~~~~~~~~~~---- 73 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDS--CSKEDLKLL----QQEIITSRQLQHPNILPYVTSFIVDSE---- 73 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccc--cchhHHHHH----HHHHHHHHhcCCcchhhhhheeecCCe----
Confidence 4566667777777777777778889999865431 122333334 799999999999999999999886553
Q ss_pred CCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecccccc
Q 001142 889 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 968 (1142)
Q Consensus 889 ~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~ 968 (1142)
.+++|||+++++|.+++.... ...+++..+..++.|++.||+|||+++|+||||||+||+++.+
T Consensus 74 ----------~~~~~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~--- 137 (314)
T cd08216 74 ----------LYVVSPLMAYGSCEDLLKTHF---PEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGD--- 137 (314)
T ss_pred ----------EEEEEeccCCCCHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecC---
Confidence 499999999999999998632 2358899999999999999999999999999999999999877
Q ss_pred CCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCC
Q 001142 969 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV 1048 (1142)
Q Consensus 969 ~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~ 1048 (1142)
+.+||+|||.+........... ..........++..|+|||++.... ..++.++|||||||++|||++|+.
T Consensus 138 ----~~~kl~d~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~~~Diws~G~il~el~~g~~ 208 (314)
T cd08216 138 ----GKVVLSGLRYSVSMIKHGKRQR---VVHDFPKSSVKNLPWLSPEVLQQNL--QGYNEKSDIYSVGITACELANGHV 208 (314)
T ss_pred ----CceEEecCccceeecccccccc---ccccccccccccccccCHHHhcCCC--CCCCcchhHHHHHHHHHHHHhCCC
Confidence 7899999999875532211100 0011122345788899999986521 347889999999999999999999
Q ss_pred CCCCCCHHHHH-HHHHhCCCCCchhHH--hhhccccccc---ccccCCCC-CCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1049 PYMGLSELEIH-DLIQMGKRPRLTDEL--EALGSCHEHE---VAQSGSGF-EKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1049 Pf~~~~~~el~-~~I~~~~~p~l~~~l--~~~~~~~~~~---~~~~~~~~-~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
||......... +.+. +..+.+.... .......... ........ .........+..+.+++.+||+.||++||
T Consensus 209 pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 287 (314)
T cd08216 209 PFKDMPATQMLLEKVR-GTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRP 287 (314)
T ss_pred CCCCCCHHHHHHHHHh-ccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCc
Confidence 99875544332 2222 1111110000 0000000000 00000000 00011124467789999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001142 1122 TAGDLYEMFVARTS 1135 (1142)
Q Consensus 1122 Sa~EVL~~L~~~~s 1135 (1142)
|+.++++|+|++..
T Consensus 288 t~~~ll~~p~~~~~ 301 (314)
T cd08216 288 SASQLLNHSFFKQC 301 (314)
T ss_pred CHHHHhcCchHhhh
Confidence 99999999999854
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=332.52 Aligned_cols=260 Identities=22% Similarity=0.387 Sum_probs=216.1
Q ss_pred CCcceeeeecccCceEEEEEEE---CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKF---GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~---~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
....+.++||.|-||.|++|+. ....+.|+||.++... ...+..+| +.|+.||.++.||||+++.|++....
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy-tekqrrdF----L~EAsIMGQFdHPNIIrLEGVVTks~ 703 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY-TEKQRRDF----LSEASIMGQFDHPNIIRLEGVVTKSK 703 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc-cHHHHhhh----hhhhhhcccCCCCcEEEEEEEEecCc
Confidence 3458999999999999999997 3455666666676532 34455566 99999999999999999999998665
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
.. +||+|||++|+|+.+++.. +..|++.+..-|+++|+.|+.||-+.++|||||-+.|||++
T Consensus 704 Pv--------------MIiTEyMENGsLDsFLR~~----DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVN 765 (996)
T KOG0196|consen 704 PV--------------MIITEYMENGSLDSFLRQN----DGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVN 765 (996)
T ss_pred ee--------------EEEhhhhhCCcHHHHHhhc----CCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeec
Confidence 43 9999999999999999872 35699999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ -.+|++|||+++.+.+.......+.++ --...|.|||.+.. ..++.++||||||+++||.
T Consensus 766 sn-------LvCKVsDFGLSRvledd~~~~ytt~GG-------KIPiRWTAPEAIa~----RKFTsASDVWSyGIVmWEV 827 (996)
T KOG0196|consen 766 SN-------LVCKVSDFGLSRVLEDDPEAAYTTLGG-------KIPIRWTAPEAIAY----RKFTSASDVWSYGIVMWEV 827 (996)
T ss_pred cc-------eEEEeccccceeecccCCCccccccCC-------ccceeecChhHhhh----cccCchhhccccceEEEEe
Confidence 88 899999999999776543222111111 12357999999986 6789999999999999998
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1044 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1044 Lt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
++ |..||.+.+..+++..|..+.+.+.+ .+++..|.+|+..||++|-.+||.
T Consensus 828 mSyGERPYWdmSNQdVIkaIe~gyRLPpP---------------------------mDCP~aL~qLMldCWqkdR~~RP~ 880 (996)
T KOG0196|consen 828 MSYGERPYWDMSNQDVIKAIEQGYRLPPP---------------------------MDCPAALYQLMLDCWQKDRNRRPK 880 (996)
T ss_pred cccCCCcccccchHHHHHHHHhccCCCCC---------------------------CCCcHHHHHHHHHHHHHHhhcCCC
Confidence 87 99999999999999999887654322 278888999999999999999999
Q ss_pred HHHHHHHHHhhc
Q 001142 1123 AGDLYEMFVART 1134 (1142)
Q Consensus 1123 a~EVL~~L~~~~ 1134 (1142)
+.||+.+|-+..
T Consensus 881 F~qiV~~lDklI 892 (996)
T KOG0196|consen 881 FAQIVSTLDKLI 892 (996)
T ss_pred HHHHHHHHHHHh
Confidence 999999887643
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=315.51 Aligned_cols=285 Identities=20% Similarity=0.214 Sum_probs=201.7
Q ss_pred CCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
.+|.+.+.||+|+||.||+|.+ .+..+|+|+..... .... +...+.+|+.++++++||||+++++++.....
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 88 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF--QSEI----FAKRAYRELTLLKHMQHENVIGLLDVFTSAVS 88 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcc--cccc----chhHHHHHHHHHHhcCCCCccchhheeccccc
Confidence 4789999999999999999987 46678888653221 1111 11223789999999999999999999875432
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
. ......++||||+. .+|..++. ..+++..+..++.|++.||+|||++||+||||||+||+++.
T Consensus 89 ~--------~~~~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~ 152 (342)
T cd07879 89 G--------DEFQDFYLVMPYMQ-TDLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNE 152 (342)
T ss_pred C--------CCCceEEEEecccc-cCHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC
Confidence 1 12235699999996 57766542 35899999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||+|||+++..... .....+++.|+|||++.+ ...++.++|||||||++|||+
T Consensus 153 ~-------~~~kL~dfg~~~~~~~~-------------~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slGvil~el~ 209 (342)
T cd07879 153 D-------CELKILDFGLARHADAE-------------MTGYVVTRWYRAPEVILN---WMHYNQTVDIWSVGCIMAEML 209 (342)
T ss_pred C-------CCEEEeeCCCCcCCCCC-------------CCCceeeecccChhhhcC---ccccCchHHHHHHHHHHHHHH
Confidence 7 78999999998653221 112357889999999864 235788999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchh---hhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA---ELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
+|+.||.+.+.......+........+.......................... ....++.+.+++.+||+.||.+||
T Consensus 210 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~ 289 (342)
T cd07879 210 TGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRL 289 (342)
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCc
Confidence 99999988765555444433222221111111100000000000000000000 013456789999999999999999
Q ss_pred CHHHHHHHHHhhcCC
Q 001142 1122 TAGDLYEMFVARTSS 1136 (1142)
Q Consensus 1122 Sa~EVL~~L~~~~ss 1136 (1142)
++.+++.|+|+..--
T Consensus 290 ~~~e~l~h~~f~~~~ 304 (342)
T cd07879 290 TATEALEHPYFDSFR 304 (342)
T ss_pred CHHHHhcCcchhhcc
Confidence 999999999997643
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=301.97 Aligned_cols=250 Identities=23% Similarity=0.274 Sum_probs=191.0
Q ss_pred eeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHH-hhCCCCCccceeeeEecCCCCCCCC
Q 001142 813 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRML-GALRHSCIVEMYGHKISSKWLPSAD 889 (1142)
Q Consensus 813 ~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL-~~L~HpNIVkl~g~~~~~~~~~~~~ 889 (1142)
+.||+|+||.||+|.+ .+..+|+|+...... ........ +..|..++ ....||||+++++++...+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~----~~~e~~~~~~~~~~~~i~~~~~~~~~~~------ 70 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDM-IAKNQVTN----VKAERAIMMIQGESPYVAKLYYSFQSKD------ 70 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhh-hHHHHHHH----HHHHHHHHhhcCCCCCeeeeeeeEEcCC------
Confidence 5799999999999988 456788887532110 01111111 24555544 4458999999999998654
Q ss_pred CCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccC
Q 001142 890 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 969 (1142)
Q Consensus 890 ~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~ 969 (1142)
..++||||+++++|.++++. ...+++..+..++.||+.||.|||+.+|+||||+|+||+++.+
T Consensus 71 --------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~---- 133 (260)
T cd05611 71 --------YLYLVMEYLNGGDCASLIKT-----LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQT---- 133 (260)
T ss_pred --------eEEEEEeccCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC----
Confidence 34999999999999999975 2468999999999999999999999999999999999999876
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001142 970 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1049 (1142)
Q Consensus 970 ~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~P 1049 (1142)
+.++|+|||.+..... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..|
T Consensus 134 ---~~~~l~dfg~~~~~~~--------------~~~~~~~~~y~~pe~~~~----~~~~~~~Dv~slG~il~~l~~g~~p 192 (260)
T cd05611 134 ---GHLKLTDFGLSRNGLE--------------NKKFVGTPDYLAPETILG----VGDDKMSDWWSLGCVIFEFLFGYPP 192 (260)
T ss_pred ---CcEEEeecccceeccc--------------cccCCCCcCccChhhhcC----CCCcchhhhHHHHHHHHHHHHCCCC
Confidence 7899999998864322 113357889999999875 3478999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC---HHHH
Q 001142 1050 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT---AGDL 1126 (1142)
Q Consensus 1050 f~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS---a~EV 1126 (1142)
|......+....+....... +. ......++.+.+++.+||+.||++||+ ++|+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~-~~-----------------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~ 248 (260)
T cd05611 193 FHAETPDAVFDNILSRRINW-PE-----------------------EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEI 248 (260)
T ss_pred CCCCCHHHHHHHHHhcccCC-CC-----------------------cccccCCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence 98776666555543322110 00 000134567999999999999999995 5799
Q ss_pred HHHHHhhcC
Q 001142 1127 YEMFVARTS 1135 (1142)
Q Consensus 1127 L~~L~~~~s 1135 (1142)
+.|+|++..
T Consensus 249 l~~~~~~~~ 257 (260)
T cd05611 249 KSHPFFKSI 257 (260)
T ss_pred HcChHhhcC
Confidence 999999754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=304.88 Aligned_cols=246 Identities=22% Similarity=0.382 Sum_probs=181.2
Q ss_pred eeecccCceEEEEEEECCc---------cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 813 DEAGKSVSSSLFRCKFGSA---------DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 813 ~~LG~GsfG~Vy~a~~~~~---------~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
+.||+|+||.||+|.+... .+++|+.. .. .....+ .+..|+.+++.+.||||+++++++....
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~--~~--~~~~~~----~~~~e~~~l~~~~h~~iv~~~~~~~~~~ 72 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLD--KS--HRNYSE----SFFEAASMMSQLSHKHLVLNYGVCVCGD 72 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhc--ch--hHHHHH----HHHHHHHHHHhCCCCChhheeeEEEeCC
Confidence 4799999999999987321 24444421 11 111122 3368999999999999999999988654
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
. .++||||+++|+|.++++.. ...+++..+..++.||+.||+|||++||+||||||+||+++
T Consensus 73 ~--------------~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~ 134 (258)
T cd05078 73 E--------------SIMVQEYVKFGSLDTYLKKN----KNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLI 134 (258)
T ss_pred C--------------cEEEEecCCCCcHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEe
Confidence 3 38999999999999998751 23589999999999999999999999999999999999998
Q ss_pred ccccc-CCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 964 LERKK-ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 964 ~~~~~-~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
.++.. ....+.++++|||.+..... .....+++.|+|||++.+ ...++.++||||||+++|+
T Consensus 135 ~~~~~~~~~~~~~~l~d~g~~~~~~~--------------~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~~l~~ 197 (258)
T cd05078 135 REEDRKTGNPPFIKLSDPGISITVLP--------------KEILLERIPWVPPECIEN---PQNLSLAADKWSFGTTLWE 197 (258)
T ss_pred cccccccCCCceEEecccccccccCC--------------chhccccCCccCchhccC---CCCCCchhhHHHHHHHHHH
Confidence 76321 12234589999998854321 113457888999999875 2346789999999999999
Q ss_pred HHhC-CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1043 LLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1043 LLtG-~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
|++| ..||.............. ...++ ......+.+++.+||+.||++||
T Consensus 198 l~~g~~~~~~~~~~~~~~~~~~~--~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp 248 (258)
T cd05078 198 IFSGGDKPLSALDSQKKLQFYED--RHQLP---------------------------APKWTELANLINQCMDYEPDFRP 248 (258)
T ss_pred HHcCCCCChhhccHHHHHHHHHc--cccCC---------------------------CCCcHHHHHHHHHHhccChhhCC
Confidence 9998 466655443332221111 11100 02234689999999999999999
Q ss_pred CHHHHHHHH
Q 001142 1122 TAGDLYEMF 1130 (1142)
Q Consensus 1122 Sa~EVL~~L 1130 (1142)
|++++++.+
T Consensus 249 s~~~il~~l 257 (258)
T cd05078 249 SFRAIIRDL 257 (258)
T ss_pred CHHHHHHhc
Confidence 999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=299.92 Aligned_cols=245 Identities=23% Similarity=0.375 Sum_probs=182.6
Q ss_pred eeecccCceEEEEEEECCcc------------EEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001142 813 DEAGKSVSSSLFRCKFGSAD------------AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 880 (1142)
Q Consensus 813 ~~LG~GsfG~Vy~a~~~~~~------------vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~ 880 (1142)
+.||+|+||.||+|.+.... +++|+.... ......+ .+|+.++++++||||+++++++.
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~-----~~~~~~~----~~e~~~l~~l~h~~i~~~~~~~~ 71 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSD-----HRDSLAF----FETASLMSQLSHKHLVKLYGVCV 71 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccc-----hhhHHHH----HHHHHHHHcCCCcchhheeeEEe
Confidence 47999999999999985433 444443211 1112333 78999999999999999999887
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NI 960 (1142)
. .. .++||||+++++|.+++... ...+++..+..++.||+.||+|||++||+||||||+||
T Consensus 72 ~-~~--------------~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Ni 132 (259)
T cd05037 72 R-DE--------------NIMVEEYVKFGPLDVFLHRE----KNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNI 132 (259)
T ss_pred c-CC--------------cEEEEEcCCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceE
Confidence 5 32 38999999999999999762 12689999999999999999999999999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
|++.+.........+||+|||++..... .....++..|+|||++.+.. ..++.++||||||+++
T Consensus 133 ll~~~~~~~~~~~~~kl~Dfg~a~~~~~--------------~~~~~~~~~y~aPE~~~~~~--~~~~~~~Di~slG~~~ 196 (259)
T cd05037 133 LVARYGLNEGYVPFIKLSDPGIPITVLS--------------REERVERIPWIAPECIRNGQ--ASLTIAADKWSFGTTL 196 (259)
T ss_pred EEecCccccCCceeEEeCCCCccccccc--------------ccccccCCCccChhhhcCCC--CCcchhhHHHHHHHHH
Confidence 9987632112234799999999875432 11234677899999987621 3678999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001142 1041 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1119 (1142)
Q Consensus 1041 ~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~ 1119 (1142)
|+|++ |..||......+........... .. .....+.+++.+||..+|.+
T Consensus 197 ~~l~~~~~~p~~~~~~~~~~~~~~~~~~~------------------------~~-----~~~~~~~~li~~~l~~~p~~ 247 (259)
T cd05037 197 LEICSNGEEPLSTLSSSEKERFYQDQHRL------------------------PM-----PDCAELANLINQCWTYDPTK 247 (259)
T ss_pred HHHHhCCCCCcccCCchhHHHHHhcCCCC------------------------CC-----CCchHHHHHHHHHhccChhh
Confidence 99999 57888765433322222111000 00 11256899999999999999
Q ss_pred CCCHHHHHHHH
Q 001142 1120 RPTAGDLYEMF 1130 (1142)
Q Consensus 1120 RPSa~EVL~~L 1130 (1142)
|||+.++++.+
T Consensus 248 Rpt~~~il~~l 258 (259)
T cd05037 248 RPSFRAILRDL 258 (259)
T ss_pred CCCHHHHHHhc
Confidence 99999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=302.25 Aligned_cols=261 Identities=23% Similarity=0.341 Sum_probs=198.3
Q ss_pred CcceeeeecccCceEEEEEEECC---ccEEEEEEecccCCCCh--HHHHHhHHhHHHHHHHHhh-CCCCCccceeeeEec
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFGS---ADAAAKVRTLKVCGSSA--DEIRNFEYSCLGEVRMLGA-LRHSCIVEMYGHKIS 881 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~~---~~vAvKi~~l~~~~~~~--~~~~~~~~~~~~Ei~iL~~-L~HpNIVkl~g~~~~ 881 (1142)
.|++.+.||+|+||.||+|.+.. ..+++|........... .........+.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47889999999999999999844 66888875443221110 0011111223678888875 689999999999876
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCe
Q 001142 882 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENI 960 (1142)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs-~gIvHrDLKp~NI 960 (1142)
.+ ..++||||+++++|.+++...... ...+++..++.++.|++.||.|||+ .+|+|+||||+||
T Consensus 81 ~~--------------~~~lv~e~~~~~~l~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~ni 145 (269)
T cd08528 81 ND--------------RLYIVMDLIEGAPLGEHFNSLKEK-KQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNI 145 (269)
T ss_pred CC--------------eEEEEEecCCCCcHHHHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHE
Confidence 54 349999999999999998754333 3568999999999999999999996 7899999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
+++.+ +.++|+|||.+....... ......|+..|+|||.+.+ ..++.++||||||+++
T Consensus 146 l~~~~-------~~~~l~dfg~~~~~~~~~-----------~~~~~~~~~~~~~Pe~~~~----~~~~~~~Dv~slG~ll 203 (269)
T cd08528 146 MLGED-------DKVTITDFGLAKQKQPES-----------KLTSVVGTILYSCPEIVKN----EPYGEKADVWAFGCIL 203 (269)
T ss_pred EECCC-------CcEEEecccceeeccccc-----------ccccccCcccCcChhhhcC----CCCchHHHHHHHHHHH
Confidence 99887 789999999997543321 1123458889999999875 4578999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1041 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
|+|++|+.||...........+......... ....++.+.+++.+||+.||++|
T Consensus 204 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~l~~li~~cl~~~p~~R 257 (269)
T cd08528 204 YQMCTLQPPFYSTNMLSLATKIVEAVYEPLP--------------------------EGMYSEDVTDVITSCLTPDAEAR 257 (269)
T ss_pred HHHHhCCCcccccCHHHHHHHHhhccCCcCC--------------------------cccCCHHHHHHHHHHCCCCCccC
Confidence 9999999999876555544444332221110 01335679999999999999999
Q ss_pred CCHHHHHHHHH
Q 001142 1121 PTAGDLYEMFV 1131 (1142)
Q Consensus 1121 PSa~EVL~~L~ 1131 (1142)
|++.|+..++.
T Consensus 258 p~~~e~~~~~~ 268 (269)
T cd08528 258 PDIIQVSAMIS 268 (269)
T ss_pred CCHHHHHHHhc
Confidence 99999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=305.60 Aligned_cols=282 Identities=22% Similarity=0.262 Sum_probs=200.6
Q ss_pred cceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCC
Q 001142 809 LSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 886 (1142)
Q Consensus 809 y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~ 886 (1142)
|++.+.||+|+||.||+|.+. +..+++|+..... ........ +.+|+.++++++||||+++++++....
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~--~~~~~~~~----~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 71 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN--EKEGFPIT----AIREIKLLQKLRHPNIVRLKEIVTSKG--- 71 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc--ccccchHH----HHHHHHHHHhccCCCeeeheeeEecCC---
Confidence 678999999999999999985 4678888765432 11122223 368999999999999999999987641
Q ss_pred CCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecccc
Q 001142 887 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 966 (1142)
Q Consensus 887 ~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~ 966 (1142)
....++||||++ ++|.+++.. ....+++..+..++.||+.||+|||++|++|+||||+||+++.+
T Consensus 72 ---------~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~- 136 (287)
T cd07840 72 ---------KGSIYMVFEYMD-HDLTGLLDS----PEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINND- 136 (287)
T ss_pred ---------CCcEEEEecccc-ccHHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCC-
Confidence 114599999997 589888864 12468999999999999999999999999999999999999987
Q ss_pred ccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001142 967 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1046 (1142)
Q Consensus 967 ~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG 1046 (1142)
+.++|+|||.+......... ......++..|+|||.+.+ ...++.++||||||+++|+|++|
T Consensus 137 ------~~~~l~d~g~~~~~~~~~~~---------~~~~~~~~~~y~~PE~~~~---~~~~~~~~Dv~slG~~l~el~t~ 198 (287)
T cd07840 137 ------GVLKLADFGLARPYTKRNSA---------DYTNRVITLWYRPPELLLG---ATRYGPEVDMWSVGCILAELFLG 198 (287)
T ss_pred ------CCEEEccccceeeccCCCcc---------cccccccccccCCceeeEc---cccCChHHHHHHHHHHHHHHHhC
Confidence 78999999999765432110 1112346788999998764 23578999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCC--Cchhhhh-hHHHHHHHHHHhcccCCCCCCCH
Q 001142 1047 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE--KPEAELE-TLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1047 ~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~--~~~~~~~-~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
+.||...........+...........+................... ..+.... .+..+.+++.+||..+|.+||++
T Consensus 199 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~ 278 (287)
T cd07840 199 KPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISA 278 (287)
T ss_pred CCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCH
Confidence 99998776655554443222111111111000000000000000000 0000011 26779999999999999999999
Q ss_pred HHHHHHHHh
Q 001142 1124 GDLYEMFVA 1132 (1142)
Q Consensus 1124 ~EVL~~L~~ 1132 (1142)
.++++++|+
T Consensus 279 ~~~l~~~~~ 287 (287)
T cd07840 279 DQALQHEYF 287 (287)
T ss_pred HHHhhCcCC
Confidence 999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=304.63 Aligned_cols=251 Identities=26% Similarity=0.340 Sum_probs=197.9
Q ss_pred CcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
+|++.+.||+|+||.||+|.+. +..+++|+...+.. ......+. +.+|++++++++||||+++++.+.+..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 73 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKC-VEKGSVRN----VLNERRILQELNHPFLVNLWYSFQDEE-- 73 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhh-cchhHHHH----HHHHHHHHHhCCCCChHHHHHhhcCCC--
Confidence 4889999999999999999984 67788887643221 11122233 478999999999999999999887544
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+|+||+|+||+++.+
T Consensus 74 ------------~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~ 136 (258)
T cd05578 74 ------------NMYLVVDLLLGGDLRYHLSQ-----KVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQ 136 (258)
T ss_pred ------------eEEEEEeCCCCCCHHHHHHh-----cCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCC
Confidence 45999999999999999876 2468999999999999999999999999999999999999887
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+.++|+|||.+....... ......|+..|+|||.+.. ..++.++||||||+++|+|++
T Consensus 137 -------~~~~l~d~~~~~~~~~~~-----------~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~slG~~l~~l~~ 194 (258)
T cd05578 137 -------GHVHITDFNIATKVTPDT-----------LTTSTSGTPGYMAPEVLCR----QGYSVAVDWWSLGVTAYECLR 194 (258)
T ss_pred -------CCEEEeecccccccCCCc-----------cccccCCChhhcCHHHHcc----cCCCCcccchhhHHHHHHHHh
Confidence 789999999987543321 1123457889999999875 447899999999999999999
Q ss_pred CCCCCCCCCH---HHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1046 LQVPYMGLSE---LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1046 G~~Pf~~~~~---~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
|..||..... ......... ..+.. ....+..+.+++.+||+.||.+||+
T Consensus 195 g~~p~~~~~~~~~~~~~~~~~~-~~~~~---------------------------~~~~~~~~~~~i~~~l~~~p~~R~~ 246 (258)
T cd05578 195 GKRPYRGHSRTIRDQIRAKQET-ADVLY---------------------------PATWSTEAIDAINKLLERDPQKRLG 246 (258)
T ss_pred CCCCCCCCCccHHHHHHHHhcc-ccccC---------------------------cccCcHHHHHHHHHHccCChhHcCC
Confidence 9999986553 222222111 11110 0134567999999999999999999
Q ss_pred H--HHHHHHHHh
Q 001142 1123 A--GDLYEMFVA 1132 (1142)
Q Consensus 1123 a--~EVL~~L~~ 1132 (1142)
+ .|+++|+|+
T Consensus 247 ~~~~~l~~~~~~ 258 (258)
T cd05578 247 DNLKDLKNHPYF 258 (258)
T ss_pred ccHHHHhcCCCC
Confidence 9 999999885
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=313.25 Aligned_cols=285 Identities=20% Similarity=0.209 Sum_probs=202.8
Q ss_pred CCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
++|++.+.||+|+||.||+|.+ .+..+|+|+.... ....... ..+.+|+.++++++||||+++++++.....
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRP--FQSELFA----KRAYRELRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccc--ccchHHH----HHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence 4699999999999999999987 4566777764322 1111222 234789999999999999999999875432
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
. ......++||||+ +++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+||+++.
T Consensus 89 ~--------~~~~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~ 153 (343)
T cd07880 89 L--------DRFHDFYLVMPFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNE 153 (343)
T ss_pred c--------cccceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC
Confidence 2 1223468999999 6899888753 36899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.++|+|||++...... .....+++.|+|||.+.+ ...++.++||||||+++|+|+
T Consensus 154 ~-------~~~kl~dfg~~~~~~~~-------------~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~ll~~l~ 210 (343)
T cd07880 154 D-------CELKILDFGLARQTDSE-------------MTGYVVTRWYRAPEVILN---WMHYTQTVDIWSVGCIMAEML 210 (343)
T ss_pred C-------CCEEEeecccccccccC-------------ccccccCCcccCHHHHhC---CCCCCcHHHHHHHHHHHHHHH
Confidence 7 78999999998654321 112357889999999864 134778999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCC---chhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK---PEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
+|..||.+.........+................................ .......++.+.+++.+||+.||.+||
T Consensus 211 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~ 290 (343)
T cd07880 211 TGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRI 290 (343)
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCC
Confidence 99999987665444433322221111111110000000000000000000 011124566789999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001142 1122 TAGDLYEMFVARTS 1135 (1142)
Q Consensus 1122 Sa~EVL~~L~~~~s 1135 (1142)
|+.+++.|+|++..
T Consensus 291 t~~~~l~~~~~~~~ 304 (343)
T cd07880 291 TAAEALAHPYFEEF 304 (343)
T ss_pred CHHHHhcCccHhhh
Confidence 99999999999864
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=314.93 Aligned_cols=299 Identities=17% Similarity=0.203 Sum_probs=203.2
Q ss_pred CCcc-eeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChH------HHHHhHHhHHHHHHHHhhCCCCCccceee
Q 001142 807 PSLS-SCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSAD------EIRNFEYSCLGEVRMLGALRHSCIVEMYG 877 (1142)
Q Consensus 807 ~~y~-l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~------~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g 877 (1142)
.+|. +.+.||+|+||+||+|.+ .+..+|+|+.+......... ....+...+.+|+.++++++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4564 567899999999999986 46678888764332211000 00011123478999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 001142 878 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 957 (1142)
Q Consensus 878 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp 957 (1142)
++...+. .++||||++ ++|.+++.. ...+++..+..++.|++.||+|||++||+||||||
T Consensus 88 ~~~~~~~--------------~~lv~e~~~-~~l~~~l~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~ 147 (335)
T PTZ00024 88 VYVEGDF--------------INLVMDIMA-SDLKKVVDR-----KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSP 147 (335)
T ss_pred EEecCCc--------------EEEEEeccc-cCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccH
Confidence 9876553 499999997 799998865 34689999999999999999999999999999999
Q ss_pred CCeeeccccccCCCCCeEEEeecCCccccccccccccccc----CCCCCCCCccCCCcccchhhhccccCCCCCCchhhH
Q 001142 958 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH----RGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 1033 (1142)
Q Consensus 958 ~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~----~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDV 1033 (1142)
+||+++.+ +.++|+|||.+.............. ..........+++.|+|||.+.+ ...++.++||
T Consensus 148 ~nill~~~-------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv 217 (335)
T PTZ00024 148 ANIFINSK-------GICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMG---AEKYHFAVDM 217 (335)
T ss_pred HHeEECCC-------CCEEECCccceeecccccccccccccccccccccccccccccCCCCChhccc---CCCCCcHHHH
Confidence 99999877 7899999999976541110000000 00011122346889999999865 2346899999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 001142 1034 WSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 1113 (1142)
Q Consensus 1034 wSLGviL~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL 1113 (1142)
|||||++|+|++|+.||.+.+..+....+...........+...........................++.+.+++.+||
T Consensus 218 ~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 297 (335)
T PTZ00024 218 WSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLL 297 (335)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHc
Confidence 99999999999999999877766554444221111111000000000000000000000000011134567899999999
Q ss_pred ccCCCCCCCHHHHHHHHHhhcC
Q 001142 1114 EENPTERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1114 ~~DP~~RPSa~EVL~~L~~~~s 1135 (1142)
+.||++|||++|++.|+|++..
T Consensus 298 ~~~P~~R~s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 298 KLNPLERISAKEALKHEYFKSD 319 (335)
T ss_pred CCCchhccCHHHHhcCcccCCC
Confidence 9999999999999999999865
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=313.95 Aligned_cols=284 Identities=19% Similarity=0.232 Sum_probs=201.0
Q ss_pred CCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
++|++.+.||+|+||.||+|.. .+..+|+|+.. .........+ .+.+|+.++++++||||+++++++.....
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~--~~~~~~~~~~----~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~ 90 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAK----RTYRELRLLKHMKHENVIGLLDVFTPARS 90 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEec--CcchhhHHHH----HHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence 6799999999999999999986 45567777543 2111112222 23689999999999999999998865432
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
. ......+++++++ +++|.++++. ..+++..+..++.||+.||+|||++||+||||||+||+++.
T Consensus 91 ~--------~~~~~~~lv~~~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~ 155 (345)
T cd07877 91 L--------EEFNDVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 155 (345)
T ss_pred c--------cccccEEEEehhc-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcC
Confidence 1 1122458899987 6899888764 35899999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||+|||++...... .....++..|+|||.+.+ ...++.++|||||||++|+|+
T Consensus 156 ~-------~~~kl~dfg~~~~~~~~-------------~~~~~~~~~y~aPE~~~~---~~~~~~~~DvwslG~il~el~ 212 (345)
T cd07877 156 D-------CELKILDFGLARHTDDE-------------MTGYVATRWYRAPEIMLN---WMHYNQTVDIWSVGCIMAELL 212 (345)
T ss_pred C-------CCEEEeccccccccccc-------------ccccccCCCccCHHHHhC---ccCCCchhhHHHHHHHHHHHH
Confidence 7 78999999998653221 112357889999999764 235778999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccccccccccc---CCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS---GSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
+|+.||...........+........+...............+. .......+.....++.+.++|.+||+.||.+||
T Consensus 213 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~ 292 (345)
T cd07877 213 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 292 (345)
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcC
Confidence 99999987665554444432222111111111100000000000 000000011113456789999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 001142 1122 TAGDLYEMFVART 1134 (1142)
Q Consensus 1122 Sa~EVL~~L~~~~ 1134 (1142)
++.+++.|+|+..
T Consensus 293 t~~e~l~h~~f~~ 305 (345)
T cd07877 293 TAAQALAHAYFAQ 305 (345)
T ss_pred CHHHHhcChhhhh
Confidence 9999999999974
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=305.99 Aligned_cols=254 Identities=24% Similarity=0.321 Sum_probs=191.7
Q ss_pred ecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCCCCC
Q 001142 815 AGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 892 (1142)
Q Consensus 815 LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~~~~~~ 892 (1142)
||+|+||+||+|.+. +..+++|+...... ... .....+..|+.++++++||||+++++.+...+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~--~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--------- 66 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRL--KKR---KGEQMALNEKKILEKVSSRFIVSLAYAFETKD--------- 66 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhh--hhh---hhhHHHHHHHHHHHhCCCCCEeeeeeEEecCC---------
Confidence 699999999999874 66778877542211 111 11223368999999999999999999987654
Q ss_pred ccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccCCCC
Q 001142 893 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 972 (1142)
Q Consensus 893 ~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~~~~ 972 (1142)
..|+||||+++++|.+++... ....+++..+..++.|++.||.|||+.||+||||+|+||+++.+
T Consensus 67 -----~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~------- 131 (277)
T cd05577 67 -----DLCLVMTLMNGGDLKYHIYNV---GEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDH------- 131 (277)
T ss_pred -----eEEEEEecCCCCcHHHHHHHc---CcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-------
Confidence 349999999999999998762 22468999999999999999999999999999999999999887
Q ss_pred CeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 001142 973 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1052 (1142)
Q Consensus 973 ~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~Pf~~ 1052 (1142)
+.++|+|||.+....... ......++..|+|||++.+ ..++.++||||||+++|+|++|+.||..
T Consensus 132 ~~~~l~dfg~~~~~~~~~-----------~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~slG~il~~l~~g~~p~~~ 196 (277)
T cd05577 132 GNVRISDLGLAVELKGGK-----------KIKGRAGTPGYMAPEVLQG----EVYDFSVDWFALGCTLYEMIAGRSPFRQ 196 (277)
T ss_pred CCEEEccCcchhhhccCC-----------ccccccCCCCcCCHHHhcC----CCCCchhhhHHHHHHHHHHhhCCCCCCC
Confidence 789999999986543211 1123357889999999875 4478899999999999999999999976
Q ss_pred CCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----CHHHHH
Q 001142 1053 LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-----TAGDLY 1127 (1142)
Q Consensus 1053 ~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP-----Sa~EVL 1127 (1142)
.........+....... . . ......++.+.+++.+||+.||.+|| ++.+++
T Consensus 197 ~~~~~~~~~~~~~~~~~-~------------------~-----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll 252 (277)
T cd05577 197 RKEKVEKEELKRRTLEM-A------------------V-----EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVR 252 (277)
T ss_pred CcccccHHHHHhccccc-c------------------c-----cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHH
Confidence 43311111111111000 0 0 00013456789999999999999999 899999
Q ss_pred HHHHhhcCC
Q 001142 1128 EMFVARTSS 1136 (1142)
Q Consensus 1128 ~~L~~~~ss 1136 (1142)
.|+|+..-.
T Consensus 253 ~h~~~~~~~ 261 (277)
T cd05577 253 EHPLFKDLN 261 (277)
T ss_pred hChhhhcCC
Confidence 999996543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=308.77 Aligned_cols=259 Identities=26% Similarity=0.401 Sum_probs=199.5
Q ss_pred CcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
.|...+.||+|+||.||+|++. +..+++|+..... ......... +.+|++++++++|||++++++++.+...
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~-~~~~~~~~~----~~~e~~~l~~l~h~~iv~~~~~~~~~~~- 99 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSG-KQSNEKWQD----IIKEVKFLQRIKHPNSIEYKGCYLREHT- 99 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCC-CCchHHHHH----HHHHHHHHHhCCCCCEEEEEEEEeeCCe-
Confidence 3788999999999999999974 5567777643221 111222223 4789999999999999999999886543
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
.++||||++ |+|.+++... ..++++..+..++.||+.||.|||++||+||||+|+||+++.+
T Consensus 100 -------------~~lv~e~~~-g~l~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~ 161 (317)
T cd06635 100 -------------AWLVMEYCL-GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP 161 (317)
T ss_pred -------------EEEEEeCCC-CCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCC
Confidence 499999997 6888877541 3468999999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+.++|+|||++..... .....|++.|+|||++.... ...++.++|||||||++|+|++
T Consensus 162 -------~~~kl~dfg~~~~~~~--------------~~~~~~~~~y~aPE~~~~~~-~~~~~~~~Dv~slGvil~el~~ 219 (317)
T cd06635 162 -------GQVKLADFGSASIASP--------------ANSFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIELAE 219 (317)
T ss_pred -------CCEEEecCCCccccCC--------------cccccCCccccChhhhhcCC-CCCCCccccHHHHHHHHHHHHh
Confidence 7899999998854322 11235788999999975321 2457889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001142 1046 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1125 (1142)
Q Consensus 1046 G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~E 1125 (1142)
|+.||...........+.....+... ....++.+.+++.+||+.+|.+||++.+
T Consensus 220 g~~p~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 273 (317)
T cd06635 220 RKPPLFNMNAMSALYHIAQNESPTLQ--------------------------SNEWSDYFRNFVDSCLQKIPQDRPTSEE 273 (317)
T ss_pred CCCCCCCccHHHHHHHHHhccCCCCC--------------------------CccccHHHHHHHHHHccCCcccCcCHHH
Confidence 99999876555544444333221111 0134556899999999999999999999
Q ss_pred HHHHHHhhcCCCC
Q 001142 1126 LYEMFVARTSSSI 1138 (1142)
Q Consensus 1126 VL~~L~~~~ss~~ 1138 (1142)
+++|+|+......
T Consensus 274 il~~~~~~~~~~~ 286 (317)
T cd06635 274 LLKHMFVLRERPE 286 (317)
T ss_pred HHhChhhhccCcc
Confidence 9999998765543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=307.90 Aligned_cols=293 Identities=20% Similarity=0.190 Sum_probs=201.6
Q ss_pred CCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
.++|++.+.||+|+||.||+|.+. +..+++|+.+...... ... ..+.+|++++++++||||+++++++.+..
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~--~~~----~~~~~e~~~~~~l~h~~i~~~~~~~~~~~ 79 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE--GFP----ITAIREIKILRQLNHRNIVNLKEIVTDKQ 79 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc--Cch----HHHHHHHHHHHhCCCCCeeeeeheecCcc
Confidence 567999999999999999999984 5677888765432211 111 22368999999999999999999987643
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
.... ........++||||++ +++...+.. ....+++..+..++.||+.||+|||+.||+|+||||+||+++
T Consensus 80 ~~~~----~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~ 150 (302)
T cd07864 80 DALD----FKKDKGAFYLVFEYMD-HDLMGLLES----GLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLN 150 (302)
T ss_pred hhhh----ccccCCcEEEEEcccC-ccHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence 1000 0011225799999998 477777654 134689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.+||+|||.+......... ......++..|+|||.+.+ ...++.++|||||||++|+|
T Consensus 151 ~~-------~~~kl~dfg~~~~~~~~~~~---------~~~~~~~~~~y~~PE~~~~---~~~~~~~~Di~slG~~~~el 211 (302)
T cd07864 151 NK-------GQIKLADFGLARLYNSEESR---------PYTNKVITLWYRPPELLLG---EERYGPAIDVWSCGCILGEL 211 (302)
T ss_pred CC-------CcEEeCcccccccccCCccc---------ccccceeccCccChHHhcC---CCCCCchhHHHHHHHHHHHH
Confidence 87 78999999998765432110 1112246778999998864 23467899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccccccccc--ccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVA--QSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
++|++||......+....+........+..+............ +..............+..+.+++.+||+.||.+||
T Consensus 212 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 291 (302)
T cd07864 212 FTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRC 291 (302)
T ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCC
Confidence 9999999876655544444332111111111110000000000 00000000000013467799999999999999999
Q ss_pred CHHHHHHHHHh
Q 001142 1122 TAGDLYEMFVA 1132 (1142)
Q Consensus 1122 Sa~EVL~~L~~ 1132 (1142)
++.+++.|+|+
T Consensus 292 ~~~~il~~~~~ 302 (302)
T cd07864 292 TAEEALNSPWL 302 (302)
T ss_pred CHHHHhcCCCC
Confidence 99999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=313.76 Aligned_cols=297 Identities=22% Similarity=0.249 Sum_probs=202.9
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
.+|++.+.||+|+||.||+|... +..+++|....+.. ...+.+ .+|++++++++||||+++++++.....
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~----~~~~~~----~~Ei~~l~~l~h~~i~~~~~~~~~~~~ 76 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP----QSVKHA----LREIKIIRRLDHDNIVKVYEVLGPSGS 76 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC----chHHHH----HHHHHHHHhcCCCcchhhHhhhccccc
Confidence 57999999999999999999884 55677776543321 222233 689999999999999999988765331
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
....+-.........++||||++ ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.
T Consensus 77 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~ 149 (342)
T cd07854 77 DLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ------GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINT 149 (342)
T ss_pred ccccccccccccceEEEEeeccc-ccHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcC
Confidence 10000001112335799999997 688887753 35899999999999999999999999999999999999975
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
++ ..++|+|||.+......... ........++..|+|||.+.. ...++.++|||||||++|+|+
T Consensus 150 ~~------~~~kl~dfg~~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwSlGvil~el~ 213 (342)
T cd07854 150 ED------LVLKIGDFGLARIVDPHYSH-------KGYLSEGLVTKWYRSPRLLLS---PNNYTKAIDMWAAGCIFAEML 213 (342)
T ss_pred CC------ceEEECCcccceecCCcccc-------ccccccccccccccCHHHHhC---ccccCchhhHHHHHHHHHHHH
Confidence 42 57999999998754322111 001112357889999998754 245788999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCC--CCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSG--FEKPEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
+|+.||.+....+....+........................+.... ..........+.++.+++.+||+.||.+|||
T Consensus 214 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 293 (342)
T cd07854 214 TGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLT 293 (342)
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccC
Confidence 99999987766555444432221111111100000000000000000 0000011135567899999999999999999
Q ss_pred HHHHHHHHHhhc
Q 001142 1123 AGDLYEMFVART 1134 (1142)
Q Consensus 1123 a~EVL~~L~~~~ 1134 (1142)
+.+++.|+|++.
T Consensus 294 ~~ell~h~~~~~ 305 (342)
T cd07854 294 AEEALMHPYMSC 305 (342)
T ss_pred HHHHhCCCcccc
Confidence 999999999973
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=303.71 Aligned_cols=263 Identities=24% Similarity=0.313 Sum_probs=202.6
Q ss_pred CCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEecCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSK 883 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~g~~~~~~ 883 (1142)
++|.+.+.||+|++|.||+|.. .+..+++|+...... ......+ .+.+|+.+++++. ||||+++++++...+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~----~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQL-IKEKKVK----YVKIEKEVLTRLNGHPGIIKLYYTFQDEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhc-cchHHHH----HHHHHHHHHHhcccCCCchhHHHHhcCCc
Confidence 3689999999999999999998 567788887643211 1112122 3478999999998 999999999887654
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
..++||||+++++|.+++.+ ...+++..+..|+.|++.||.|||+.|++|+||+|+||+++
T Consensus 76 --------------~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~ 136 (280)
T cd05581 76 --------------NLYFVLEYAPNGELLQYIRK-----YGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLD 136 (280)
T ss_pred --------------eEEEEEcCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC
Confidence 34999999999999999976 23699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccc----------cccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCC----------IAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 1033 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~----------~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDV 1033 (1142)
.+ +.++|+|||++........... .............++..|+|||+... ..++.++||
T Consensus 137 ~~-------~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~----~~~~~~~Di 205 (280)
T cd05581 137 KD-------MHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE----KPAGKSSDL 205 (280)
T ss_pred CC-------CCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCC----CCCChhhhH
Confidence 77 7899999999976543221000 00001112234568899999999875 457889999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 001142 1034 WSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 1113 (1142)
Q Consensus 1034 wSLGviL~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL 1113 (1142)
||||++++++++|..||...........+...... .+ ...++.+.+++.+||
T Consensus 206 ~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~---------------------------~~~~~~~~~li~~~l 257 (280)
T cd05581 206 WALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYS-FP---------------------------PNFPPDAKDLIEKLL 257 (280)
T ss_pred HHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCCC-CC---------------------------CccCHHHHHHHHHHh
Confidence 99999999999999999876654444443321110 00 033556899999999
Q ss_pred ccCCCCCCCH----HHHHHHHHh
Q 001142 1114 EENPTERPTA----GDLYEMFVA 1132 (1142)
Q Consensus 1114 ~~DP~~RPSa----~EVL~~L~~ 1132 (1142)
+.||.+||++ +++++|+|+
T Consensus 258 ~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 258 VLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred cCCHhhCCCcccCHHHHhcCCCC
Confidence 9999999999 999999985
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-32 Score=310.26 Aligned_cols=288 Identities=19% Similarity=0.234 Sum_probs=200.7
Q ss_pred CcceeeeecccCceEEEEEEEC----CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFG----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISS 882 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~----~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~~~~ 882 (1142)
+|++.+.||+|+||.||++++. +..+|+|..... .......+. +.+|+.+++++ +||||++++++....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~----~~~E~~~l~~l~~h~~iv~~~~~~~~~ 74 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNV--FSKKILAKR----ALRELKLLRHFRGHKNITCLYDMDIVF 74 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccc--cccchhHHH----HHHHHHHHHHhcCCCChheeeeeeeec
Confidence 4789999999999999999985 446777764322 111122222 36899999999 599999999875432
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
. ......+++|||+. ++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 75 ~----------~~~~~~~~~~e~~~-~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili 138 (332)
T cd07857 75 P----------GNFNELYLYEELME-ADLHQIIRS-----GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV 138 (332)
T ss_pred c----------ccCCcEEEEEeccc-CCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEE
Confidence 1 01224589999996 799988864 3468999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
+.+ +.+||+|||.+......... .........||+.|+|||++.+ ...++.++|||||||++|+
T Consensus 139 ~~~-------~~~kl~Dfg~a~~~~~~~~~------~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~~Di~slGv~l~~ 202 (332)
T cd07857 139 NAD-------CELKICDFGLARGFSENPGE------NAGFMTEYVATRWYRAPEIMLS---FQSYTKAIDVWSVGCILAE 202 (332)
T ss_pred cCC-------CCEEeCcCCCceeccccccc------ccccccCcccCccccCcHHHhC---CCCCCcHHHHHHHHHHHHH
Confidence 887 78999999999765432111 0011123468999999998764 2457899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccccccccccc---CCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001142 1043 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS---GSGFEKPEAELETLSFLVDVFRRCTEENPTE 1119 (1142)
Q Consensus 1043 LLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~ 1119 (1142)
|++|+.||...+.......+...........+.............. .............+..+.+++.+||+.||.+
T Consensus 203 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 282 (332)
T cd07857 203 LLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTK 282 (332)
T ss_pred HHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCccc
Confidence 9999999987665555444432221111111111100000000000 0000000111134567999999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 001142 1120 RPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1120 RPSa~EVL~~L~~~ 1133 (1142)
|||+.++++|+|++
T Consensus 283 R~t~~~ll~~~~~~ 296 (332)
T cd07857 283 RISVEEALEHPYLA 296 (332)
T ss_pred CCCHHHHhcChhhh
Confidence 99999999999986
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=307.08 Aligned_cols=258 Identities=26% Similarity=0.419 Sum_probs=200.2
Q ss_pred cceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCC
Q 001142 809 LSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 886 (1142)
Q Consensus 809 y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~ 886 (1142)
|....+||+|+||.||++... +..+++|..... ....... +.+|+.+++.++||||+++++++...+
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~----~~~e~~~l~~l~h~~iv~~~~~~~~~~--- 90 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR----KQQRREL----LFNEVVIMRDYQHENVVEMYNSYLVGD--- 90 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc----chhHHHH----HHHHHHHHHhcCCcchhheeeEEEeCC---
Confidence 345578999999999999884 566777764322 1122223 478999999999999999999988654
Q ss_pred CCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecccc
Q 001142 887 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 966 (1142)
Q Consensus 887 ~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~ 966 (1142)
+.++||||+++++|.+++.. ..+++..+..++.|++.||+|||++|++||||+|+||+++.+
T Consensus 91 -----------~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~- 152 (292)
T cd06657 91 -----------ELWVVMEFLEGGALTDIVTH------TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHD- 152 (292)
T ss_pred -----------EEEEEEecCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-
Confidence 35999999999999988753 358999999999999999999999999999999999999877
Q ss_pred ccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001142 967 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1046 (1142)
Q Consensus 967 ~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG 1046 (1142)
+.++|+|||.+........ ......|++.|+|||.+.+ ..++.++||||||+++|+|++|
T Consensus 153 ------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~y~~pE~~~~----~~~~~~~Dv~slGvil~el~tg 212 (292)
T cd06657 153 ------GRVKLSDFGFCAQVSKEVP----------RRKSLVGTPYWMAPELISR----LPYGPEVDIWSLGIMVIEMVDG 212 (292)
T ss_pred ------CCEEEcccccceecccccc----------cccccccCccccCHHHhcC----CCCCchhhHHHHHHHHHHHHhC
Confidence 7899999998865432110 1123458899999998865 4567899999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 001142 1047 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1126 (1142)
Q Consensus 1047 ~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EV 1126 (1142)
+.||.+....+....+.....+.+.. ....+..+.+++.+||+.||.+||++.++
T Consensus 213 ~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~l~~li~~~l~~~P~~R~~~~~l 267 (292)
T cd06657 213 EPPYFNEPPLKAMKMIRDNLPPKLKN-------------------------LHKVSPSLKGFLDRLLVRDPAQRATAAEL 267 (292)
T ss_pred CCCCCCCCHHHHHHHHHhhCCcccCC-------------------------cccCCHHHHHHHHHHHhCCcccCcCHHHH
Confidence 99998766555444443322111100 00345568899999999999999999999
Q ss_pred HHHHHhhcCCCCCC
Q 001142 1127 YEMFVARTSSSISS 1140 (1142)
Q Consensus 1127 L~~L~~~~ss~~s~ 1140 (1142)
++|+|+......++
T Consensus 268 l~~~~~~~~~~~~~ 281 (292)
T cd06657 268 LKHPFLAKAGPPSC 281 (292)
T ss_pred hcChHHhccCCCcc
Confidence 99999987765544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=344.44 Aligned_cols=266 Identities=23% Similarity=0.307 Sum_probs=215.6
Q ss_pred CCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCC-hHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSS-ADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 882 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~-~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~ 882 (1142)
-++|++.++||+|+||.|.++++. ++.+|+|+ +.+...- ..+..- |..|-.+|.....+-||.++-.|.++
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~--lnK~eMlKr~~tA~----F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKI--LNKWEMLKRAETAC----FREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHH--hhHHHHhhchhHHH----HHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 357999999999999999999985 45566665 3321111 111222 36788899888999999999999987
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
.++ |+|||||+||+|-.++.++ .++++..++.++..|+.||.-||+.|+|||||||+|||+
T Consensus 148 ~~L--------------YlVMdY~pGGDlltLlSk~-----~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLl 208 (1317)
T KOG0612|consen 148 RYL--------------YLVMDYMPGGDLLTLLSKF-----DRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLL 208 (1317)
T ss_pred cce--------------EEEEecccCchHHHHHhhc-----CCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEe
Confidence 755 9999999999999999873 369999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCC-CCCCchhhHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP-NLYGLEVDIWSYGCLLL 1041 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~-~~~s~ksDVwSLGviL~ 1041 (1142)
|.. |++||+|||.+..+... |.......+|||.|.+||++..+..+ +.|++.+|+||+||++|
T Consensus 209 d~~-------GHikLADFGsClkm~~d---------G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~Y 272 (1317)
T KOG0612|consen 209 DKS-------GHIKLADFGSCLKMDAD---------GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMY 272 (1317)
T ss_pred ccc-------CcEeeccchhHHhcCCC---------CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHH
Confidence 998 99999999999776542 22344567899999999999887766 78999999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1042 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1042 ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
||+.|..||...+..+.+..|..... .+..| .+..+++.+++||.+.+. +|+.|.
T Consensus 273 EMlyG~TPFYadslveTY~KIm~hk~-----------------------~l~FP-~~~~VSeeakdLI~~ll~-~~e~RL 327 (1317)
T KOG0612|consen 273 EMLYGETPFYADSLVETYGKIMNHKE-----------------------SLSFP-DETDVSEEAKDLIEALLC-DREVRL 327 (1317)
T ss_pred HHHcCCCcchHHHHHHHHHHHhchhh-----------------------hcCCC-cccccCHHHHHHHHHHhc-Chhhhc
Confidence 99999999998888787777743311 11122 122578889999998875 678888
Q ss_pred C---HHHHHHHHHhhcCCC
Q 001142 1122 T---AGDLYEMFVARTSSS 1137 (1142)
Q Consensus 1122 S---a~EVL~~L~~~~ss~ 1137 (1142)
. ++++-.||||..-.|
T Consensus 328 grngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 328 GRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred ccccHHHHHhCccccCCCh
Confidence 7 999999999987655
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-32 Score=301.08 Aligned_cols=282 Identities=22% Similarity=0.214 Sum_probs=200.5
Q ss_pred cceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC---CCCCccceeeeEecCC
Q 001142 809 LSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL---RHSCIVEMYGHKISSK 883 (1142)
Q Consensus 809 y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L---~HpNIVkl~g~~~~~~ 883 (1142)
|++.+.||+|+||.||+|++. +..+|+|+.+..... ......+ .+|+.+++++ .||||+++++++...+
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~----~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 74 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE--EGIPLST----LREIALLKQLESFEHPNIVRLLDVCHGPR 74 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEecccccc--chhhhhH----HHHHHHHHHhhccCCCCcceEEEEEeecc
Confidence 678999999999999999984 677888886544321 1111222 5677777666 5999999999988654
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
.. .....+++|||++ ++|.+++... ....+++..+..++.||+.||.|||+++++|+||+|+||+++
T Consensus 75 ~~---------~~~~~~l~~e~~~-~~l~~~l~~~---~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~ 141 (287)
T cd07838 75 TD---------RELKLTLVFEHVD-QDLATYLSKC---PKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVT 141 (287)
T ss_pred CC---------CCceeEEEehhcc-cCHHHHHHHc---cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEc
Confidence 21 2234699999997 6899988752 223589999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.++|+|||.+....... ......++..|+|||++.+ ..++.++|||||||++|+|
T Consensus 142 ~~-------~~~~l~dfg~~~~~~~~~-----------~~~~~~~~~~~~~PE~~~~----~~~~~~~Di~s~G~~l~~l 199 (287)
T cd07838 142 SD-------GQVKIADFGLARIYSFEM-----------ALTSVVVTLWYRAPEVLLQ----SSYATPVDMWSVGCIFAEL 199 (287)
T ss_pred cC-------CCEEEeccCcceeccCCc-----------ccccccccccccChHHhcc----CCCCCcchhhhHHHHHHHH
Confidence 87 789999999987653321 1112347888999999875 4678899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
++|++||.+....+....+...........+... .......................++.+.+++.+||+.||.+||++
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~ 278 (287)
T cd07838 200 FRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRN-VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISA 278 (287)
T ss_pred HhCCCcccCCChHHHHHHHHHHcCCCChHhcCCC-cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCH
Confidence 9999999887766655444221111100000000 000000000000001111112456778999999999999999999
Q ss_pred HHHHHHHHh
Q 001142 1124 GDLYEMFVA 1132 (1142)
Q Consensus 1124 ~EVL~~L~~ 1132 (1142)
.+++.|+|+
T Consensus 279 ~~il~~~~~ 287 (287)
T cd07838 279 FEALQHPYF 287 (287)
T ss_pred HHHhcCcCC
Confidence 999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=310.10 Aligned_cols=287 Identities=18% Similarity=0.259 Sum_probs=197.7
Q ss_pred eeeccc--CceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCC
Q 001142 813 DEAGKS--VSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 888 (1142)
Q Consensus 813 ~~LG~G--sfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~~ 888 (1142)
..||+| +||+||+|++ .+..||+|+..... ......+. +.+|+.+++.++||||+++++++...+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~----~~~e~~~~~~l~h~niv~~~~~~~~~~~---- 73 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLEN--CTEEHLKA----LQNEVVLSHFFRHPNIMTSWTVFTTGSW---- 73 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEecccc--CCHHHHHH----HHHHHHHHHhCCCCCcceEeeeEecCCc----
Confidence 466777 9999999988 57889999865432 22233333 3789999999999999999999987553
Q ss_pred CCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecccccc
Q 001142 889 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 968 (1142)
Q Consensus 889 ~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~ 968 (1142)
.++||||+++++|.+++.... ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 74 ----------~~~v~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~--- 137 (328)
T cd08226 74 ----------LWVISPFMAYGSANSLLKTYF---PEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGD--- 137 (328)
T ss_pred ----------eEEEEecccCCCHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCC---
Confidence 499999999999999987632 2358999999999999999999999999999999999999877
Q ss_pred CCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCC
Q 001142 969 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV 1048 (1142)
Q Consensus 969 ~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~ 1048 (1142)
+.++++||+.+............ .........++..|+|||++.+. ...++.++|||||||++|+|++|+.
T Consensus 138 ----~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~~DiwslG~~l~el~~g~~ 208 (328)
T cd08226 138 ----GLVSLSGLSHLYSLVRNGQKAKV---VYDFPQFSTSVLPWLSPELLRQD--LYGYNVKSDIYSVGITACELATGRV 208 (328)
T ss_pred ----CcEEEechHHHhhhhccCccccc---cccccccccCccCccChhhhcCC--CCCCCchhhHHHHHHHHHHHHhCCC
Confidence 78999999865432211100000 00011123456779999998652 1347899999999999999999999
Q ss_pred CCCCCCHHHHHHHHHhCCCCCchhHHh-------hhcc---ccc----cccc------ccCCCCCCchhhhhhHHHHHHH
Q 001142 1049 PYMGLSELEIHDLIQMGKRPRLTDELE-------ALGS---CHE----HEVA------QSGSGFEKPEAELETLSFLVDV 1108 (1142)
Q Consensus 1049 Pf~~~~~~el~~~I~~~~~p~l~~~l~-------~~~~---~~~----~~~~------~~~~~~~~~~~~~~~~~~L~dL 1108 (1142)
||......+.......... ..+.... .... ... .... ...............++.+.+|
T Consensus 209 p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 287 (328)
T cd08226 209 PFQDMLRTQMLLQKLKGPP-YSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNL 287 (328)
T ss_pred CCCCcChHHHHHHHhcCCC-CCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHH
Confidence 9987654443322222111 0000000 0000 000 0000 0000000111122467789999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001142 1109 FRRCTEENPTERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1109 I~~CL~~DP~~RPSa~EVL~~L~~~~s 1135 (1142)
+.+||+.||++|||+.|+++|+|+...
T Consensus 288 i~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 288 VELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred HHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 999999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=304.79 Aligned_cols=251 Identities=21% Similarity=0.255 Sum_probs=186.6
Q ss_pred eecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCCCC
Q 001142 814 EAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGN 891 (1142)
Q Consensus 814 ~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~~~~~ 891 (1142)
.||+|+||.||+|.+ .+..+|+|+...+........ ..+ ......+.+++...||||+++++++...+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~i~~~~~~~~~~~-------- 70 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE-TLA-LNERIMLSLVSTGDCPFIVCMSYAFHTPD-------- 70 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhH-HHH-HHHHHHHHHHHhCCCCcEeeeeeeeecCC--------
Confidence 489999999999987 456788887543321111111 111 00012234455567999999999988654
Q ss_pred CccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccCCC
Q 001142 892 PEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 971 (1142)
Q Consensus 892 ~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~~~ 971 (1142)
..++||||++|++|..++.. ...+++..+..++.|++.||.|||+++|+||||||+||+++.+
T Consensus 71 ------~~~~v~e~~~g~~L~~~l~~-----~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~------ 133 (278)
T cd05606 71 ------KLSFILDLMNGGDLHYHLSQ-----HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH------ 133 (278)
T ss_pred ------EEEEEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCC------
Confidence 34999999999999988865 2468999999999999999999999999999999999999877
Q ss_pred CCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 001142 972 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM 1051 (1142)
Q Consensus 972 ~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~Pf~ 1051 (1142)
+.++|+|||++....... .....|+..|+|||++.+ +..++.++||||+||++|+|++|+.||.
T Consensus 134 -~~~kl~dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~s~G~~l~~l~~g~~p~~ 197 (278)
T cd05606 134 -GHVRISDLGLACDFSKKK------------PHASVGTHGYMAPEVLQK---GVAYDSSADWFSLGCMLFKLLRGHSPFR 197 (278)
T ss_pred -CCEEEccCcCccccCccC------------CcCcCCCcCCcCcHHhcC---CCCCCcccchHhHHHHHHHHHhCCCCCC
Confidence 789999999986543211 113468999999999864 2357899999999999999999999997
Q ss_pred CCCHH---HHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----CH
Q 001142 1052 GLSEL---EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-----TA 1123 (1142)
Q Consensus 1052 ~~~~~---el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP-----Sa 1123 (1142)
+.... .....+. ...+.++ ...+..+.+++.+||..+|.+|| ++
T Consensus 198 ~~~~~~~~~~~~~~~-~~~~~~~---------------------------~~~s~~~~~li~~~l~~~p~~R~~~~~~~~ 249 (278)
T cd05606 198 QHKTKDKHEIDRMTL-TMAVELP---------------------------DSFSPELRSLLEGLLQRDVNRRLGCLGRGA 249 (278)
T ss_pred CCCccchHHHHHHhh-ccCCCCC---------------------------CcCCHHHHHHHHHHhhcCHHhccCCCCCCH
Confidence 64221 1111111 1111110 13456799999999999999999 99
Q ss_pred HHHHHHHHhhcC
Q 001142 1124 GDLYEMFVARTS 1135 (1142)
Q Consensus 1124 ~EVL~~L~~~~s 1135 (1142)
.++++|+|++.-
T Consensus 250 ~~ll~~~~~~~~ 261 (278)
T cd05606 250 QEVKEHPFFRSL 261 (278)
T ss_pred HHHHhCccccCC
Confidence 999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=299.57 Aligned_cols=258 Identities=26% Similarity=0.333 Sum_probs=197.8
Q ss_pred ecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCCCCC
Q 001142 815 AGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 892 (1142)
Q Consensus 815 LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~~~~~~ 892 (1142)
||+|+||.||++.+. +..+++|+..... . ..+.....+.+|++++++++||||+++++.+....
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~--~---~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--------- 66 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKAD--M---IRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKK--------- 66 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchh--h---hhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCc---------
Confidence 689999999999985 6778888753221 1 11122234478999999999999999999887544
Q ss_pred ccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccCCCC
Q 001142 893 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 972 (1142)
Q Consensus 893 ~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~~~~ 972 (1142)
..++||||+++++|.+++.+. ..+++..+..++.||+.||+|||++|++|+||+|+||+++.+
T Consensus 67 -----~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~------- 129 (265)
T cd05579 67 -----NLYLVMEYLPGGDLASLLENV-----GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSN------- 129 (265)
T ss_pred -----EEEEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCC-------
Confidence 459999999999999999762 368999999999999999999999999999999999999987
Q ss_pred CeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 001142 973 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1052 (1142)
Q Consensus 973 ~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~Pf~~ 1052 (1142)
+.++|+|||++.......... . ...........++..|+|||.... ..++.++||||||+++|+|++|..||..
T Consensus 130 ~~~~l~dfg~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~Pe~~~~----~~~~~~~Dv~slG~~~~~l~~g~~p~~~ 203 (265)
T cd05579 130 GHLKLTDFGLSKVGLVRRQIN-L-NDDEKEDKRIVGTPDYIAPEVILG----QGHSKTVDWWSLGCILYEFLVGIPPFHG 203 (265)
T ss_pred CCEEEEecccchhcccCcccc-c-ccccccccCcccCccccCHHHhcC----CCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 789999999986533211100 0 000111223457889999999875 3477899999999999999999999987
Q ss_pred CCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH---HHHHHH
Q 001142 1053 LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA---GDLYEM 1129 (1142)
Q Consensus 1053 ~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa---~EVL~~ 1129 (1142)
....+....+..+.... +.. ...+..+.+++.+||+.+|.+|||+ .++++|
T Consensus 204 ~~~~~~~~~~~~~~~~~-~~~-------------------------~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 204 ETPEEIFQNILNGKIEW-PED-------------------------VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred CCHHHHHHHHhcCCcCC-Ccc-------------------------ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 77666665554322111 000 0235678999999999999999999 999999
Q ss_pred HHhhcC
Q 001142 1130 FVARTS 1135 (1142)
Q Consensus 1130 L~~~~s 1135 (1142)
+|+..-
T Consensus 258 ~~~~~~ 263 (265)
T cd05579 258 PFFKGI 263 (265)
T ss_pred ccccCC
Confidence 999743
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=294.49 Aligned_cols=264 Identities=22% Similarity=0.383 Sum_probs=208.0
Q ss_pred CCCCCCcceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEec
Q 001142 803 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKIS 881 (1142)
Q Consensus 803 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~g~~~~ 881 (1142)
..++.+.+....||.|+.|+||++++..+...++|+....+.. .++.++ ++..+.++.+-+ .|+||+.+|+|..
T Consensus 88 ~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~N-kee~kR----ILmDldvv~~s~dcpyIV~c~GyFi~ 162 (391)
T KOG0983|consen 88 QADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGN-KEENKR----ILMDLDVVLKSHDCPYIVQCFGYFIT 162 (391)
T ss_pred ccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCC-HHHHHH----HHHhhhHHhhccCCCeeeeeeeEEee
Confidence 4567778899999999999999999977555555544554433 233333 478898887775 9999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCe
Q 001142 882 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENI 960 (1142)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs-~gIvHrDLKp~NI 960 (1142)
+... ++.||.|. .-++.++++. ..++++..+-++..-+++||.||-+ +||+|||+||+||
T Consensus 163 n~dV--------------~IcMelMs-~C~ekLlkri----k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNI 223 (391)
T KOG0983|consen 163 NTDV--------------FICMELMS-TCAEKLLKRI----KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNI 223 (391)
T ss_pred CchH--------------HHHHHHHH-HHHHHHHHHh----cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccce
Confidence 6543 88999984 5556666552 4579999999999999999999985 6999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
|+|+. |++||||||.+..+.+.. ......|-+.|||||.+.-. ....|+-++||||||+.+
T Consensus 224 LlDe~-------GniKlCDFGIsGrlvdSk-----------AhtrsAGC~~YMaPERidp~-~~~kYDiRaDVWSlGITl 284 (391)
T KOG0983|consen 224 LLDER-------GNIKLCDFGISGRLVDSK-----------AHTRSAGCAAYMAPERIDPP-DKPKYDIRADVWSLGITL 284 (391)
T ss_pred EEccC-------CCEEeecccccceeeccc-----------ccccccCCccccCccccCCC-CCCccchhhhhhhhccch
Confidence 99988 899999999997765432 12234688999999998653 246789999999999999
Q ss_pred HHHHhCCCCCCCC-CHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001142 1041 LELLTLQVPYMGL-SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1119 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~~-~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~ 1119 (1142)
+||+||+.||.+. .+.++...+....+|.++... ..++.+.+++..||+.|+.+
T Consensus 285 veLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~-------------------------gFSp~F~~fv~~CL~kd~r~ 339 (391)
T KOG0983|consen 285 VELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHM-------------------------GFSPDFQSFVKDCLTKDHRK 339 (391)
T ss_pred hhhhcccCCCCCCCccHHHHHHHHhcCCCCCCccc-------------------------CcCHHHHHHHHHHhhcCccc
Confidence 9999999999873 345666677665555444211 35678999999999999999
Q ss_pred CCCHHHHHHHHHhhc
Q 001142 1120 RPTAGDLYEMFVART 1134 (1142)
Q Consensus 1120 RPSa~EVL~~L~~~~ 1134 (1142)
||...++++|+|...
T Consensus 340 RP~Y~~Ll~h~Fi~~ 354 (391)
T KOG0983|consen 340 RPKYNKLLEHPFIKR 354 (391)
T ss_pred CcchHHHhcCcceee
Confidence 999999999998764
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-32 Score=294.92 Aligned_cols=256 Identities=32% Similarity=0.492 Sum_probs=199.2
Q ss_pred CcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
+|.+.+.||+|++|.||+|... +..+++|+..... ......+.+ .+|+.++++++||||+++++.+.+..
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~----~~e~~~l~~l~~~~i~~~~~~~~~~~-- 72 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSG--DSEEELEAL----EREIRILSSLQHPNIVRYYGSERDEE-- 72 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccc--cchHHHHHH----HHHHHHHHHcCCCCEeeEEEEEecCC--
Confidence 4788999999999999999985 6677887754332 222333344 79999999999999999999987641
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
....++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.+
T Consensus 73 ----------~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~ 137 (260)
T cd06606 73 ----------KNTLNIFLEYVSGGSLSSLLKK-----FGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSD 137 (260)
T ss_pred ----------CCeEEEEEEecCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCC
Confidence 1245999999999999999976 2378999999999999999999999999999999999999886
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+.++|+|||.+......... .......++..|+|||.+.. ..++.++||||||+++++|++
T Consensus 138 -------~~~~l~d~~~~~~~~~~~~~--------~~~~~~~~~~~y~~pE~~~~----~~~~~~~Dv~slG~il~~l~~ 198 (260)
T cd06606 138 -------GVVKLADFGCAKRLGDIETG--------EGTGSVRGTPYWMAPEVIRG----EEYGRAADIWSLGCTVIEMAT 198 (260)
T ss_pred -------CCEEEcccccEEeccccccc--------ccccCCCCCccccCHhhhcC----CCCCchhhHHHHHHHHHHHHh
Confidence 78999999998765442210 00123458889999999876 347899999999999999999
Q ss_pred CCCCCCCCC-HHHHHHHHHh-CCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1046 LQVPYMGLS-ELEIHDLIQM-GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1046 G~~Pf~~~~-~~el~~~I~~-~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
|..||.... .......+.. ...+.+ ....+..+.+++.+||+.||.+||++
T Consensus 199 g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~l~~~i~~~l~~~p~~Rp~~ 251 (260)
T cd06606 199 GKPPWSELGNPMAALYKIGSSGEPPEI---------------------------PEHLSEEAKDFLRKCLRRDPKKRPTA 251 (260)
T ss_pred CCCCCCCCCchHHHHHhccccCCCcCC---------------------------CcccCHHHHHHHHHhCcCChhhCCCH
Confidence 999998654 1222211111 011110 01335679999999999999999999
Q ss_pred HHHHHHHHh
Q 001142 1124 GDLYEMFVA 1132 (1142)
Q Consensus 1124 ~EVL~~L~~ 1132 (1142)
.++++|+|+
T Consensus 252 ~~ll~~~~~ 260 (260)
T cd06606 252 DELLQHPFL 260 (260)
T ss_pred HHHhhCCCC
Confidence 999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=302.08 Aligned_cols=278 Identities=23% Similarity=0.286 Sum_probs=199.4
Q ss_pred cceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCC
Q 001142 809 LSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 886 (1142)
Q Consensus 809 y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~ 886 (1142)
|++.+.||+|++|.||+|... +..+++|...... ....... .+.+|+.++++++||||+++++++....
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~----~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 71 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRF--ESEGIPK----TALREIKLLKELNHPNIIKLLDVFRHKG--- 71 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccc--ccchhHH----HHHHHHHHHHHhcCCCcchHHHhhccCC---
Confidence 677899999999999999974 5567777643322 1111122 3378999999999999999999987654
Q ss_pred CCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecccc
Q 001142 887 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 966 (1142)
Q Consensus 887 ~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~ 966 (1142)
..++||||++ ++|.+++... ...+++..+..++.||+.||.|||+++|+|+||||+||+++.+
T Consensus 72 -----------~~~~v~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~- 134 (283)
T cd05118 72 -----------DLYLVFEFMD-TDLYKLIKDR----QRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTE- 134 (283)
T ss_pred -----------CEEEEEeccC-CCHHHHHHhh----cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCC-
Confidence 3499999997 5888887651 2468999999999999999999999999999999999999877
Q ss_pred ccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001142 967 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1046 (1142)
Q Consensus 967 ~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG 1046 (1142)
+.++|+|||.+........ ......++..|+|||.+.+ ...++.++||||||+++|+|++|
T Consensus 135 ------~~~~l~df~~~~~~~~~~~----------~~~~~~~~~~~~~PE~~~~---~~~~~~~~Di~slG~~l~~l~tg 195 (283)
T cd05118 135 ------GVLKLADFGLARSFGSPVR----------PYTHYVVTRWYRAPELLLG---DKGYSTPVDIWSVGCIFAELLSR 195 (283)
T ss_pred ------CcEEEeeeeeeEecCCCcc----------cccCccCcccccCcHHHhc---CCCCCchhHHHHHHHHHHHHHhC
Confidence 7899999999876543210 1112357888999999875 23578999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccc---ccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1047 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC---HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1047 ~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
+.||...+..+....+........+..+...... ....... .............+..+.+++.+||+.||.+||++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~ 274 (283)
T cd05118 196 RPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPK-KAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITA 274 (283)
T ss_pred CCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhcc-ccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCH
Confidence 9999876665544433221111111111110000 0000000 00000111122457789999999999999999999
Q ss_pred HHHHHHHHh
Q 001142 1124 GDLYEMFVA 1132 (1142)
Q Consensus 1124 ~EVL~~L~~ 1132 (1142)
.+++.|+|+
T Consensus 275 ~~ll~~~~~ 283 (283)
T cd05118 275 EQALAHPYF 283 (283)
T ss_pred HHHhhCCCC
Confidence 999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=301.65 Aligned_cols=273 Identities=23% Similarity=0.357 Sum_probs=194.8
Q ss_pred CCcceeeeecccCceEEEEEEEC------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 880 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~------~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~ 880 (1142)
..|++.+.||+|+||.||+|++. +..+|+|+..... .. ...+.+ .+|+.+++++.||||+++++++.
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~--~~-~~~~~~----~~ei~~l~~l~~~~i~~~~~~~~ 76 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSG--EE-QHRSDF----EREIEILRTLDHENIVKYKGVCE 76 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEecccc--ch-HHHHHH----HHHHHHHHhCCCCChheEEeeee
Confidence 45788899999999999999874 4567888754221 11 223334 89999999999999999999886
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NI 960 (1142)
... ....++||||+++++|.+++... ...+++..+..++.|++.||+|||++||+|+||||+||
T Consensus 77 ~~~------------~~~~~lv~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni 140 (284)
T cd05038 77 KPG------------GRSLRLIMEYLPSGSLRDYLQRH----RDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNI 140 (284)
T ss_pred cCC------------CCceEEEEecCCCCCHHHHHHhC----ccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhE
Confidence 532 12459999999999999999752 23589999999999999999999999999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
+++.+ +.++|+|||.+.......... .......++..|+|||.+.+ ..++.++||||||+++
T Consensus 141 l~~~~-------~~~~l~dfg~~~~~~~~~~~~-------~~~~~~~~~~~~~~Pe~~~~----~~~~~~~Di~slG~~l 202 (284)
T cd05038 141 LVESE-------DLVKISDFGLAKVLPEDKDYY-------YVKEPGESPIFWYAPECLRT----SKFSSASDVWSFGVTL 202 (284)
T ss_pred EEcCC-------CCEEEcccccccccccCCcce-------eccCCCCCcccccCcHHHcc----CCCCcccchHHHhhhh
Confidence 99887 789999999997654221110 00111235567999999865 4678899999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1041 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
|||++|..|+........................... ........ ...++..+.+++.+||+.+|.+|
T Consensus 203 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~R 270 (284)
T cd05038 203 YELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL---------KEGERLPR---PPSCPDEVYDLMKLCWEAEPQDR 270 (284)
T ss_pred heeeccCCCcccccchhccccccccccccHHHHHHHH---------HcCCcCCC---CccCCHHHHHHHHHHhccChhhC
Confidence 9999999998653221110000000000000000000 00000000 11345679999999999999999
Q ss_pred CCHHHHHHHHHh
Q 001142 1121 PTAGDLYEMFVA 1132 (1142)
Q Consensus 1121 PSa~EVL~~L~~ 1132 (1142)
||+.||++.+..
T Consensus 271 pt~~ei~~~l~~ 282 (284)
T cd05038 271 PSFADLILIVDR 282 (284)
T ss_pred CCHHHHHHHHhh
Confidence 999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=311.63 Aligned_cols=290 Identities=19% Similarity=0.213 Sum_probs=207.1
Q ss_pred CcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
+|++.+.||+|++|.||+|++. +..+++|... .........+. +.+|+.++++++||||+++++++.....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~--~~~~~~~~~~~----~~~e~~~l~~l~~~~i~~~~~~~~~~~~- 73 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKIS--NVFDDLIDAKR----ILREIKLLRHLRHENIIGLLDILRPPSP- 73 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeec--cccccchhhhh----HHHHHHHHHhcCCcchhhhhhhhcccCc-
Confidence 4889999999999999999974 5667777643 22111222233 3789999999999999999999876431
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
......|+||||++ ++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 74 --------~~~~~~~lv~e~~~-~~l~~~l~~-----~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~ 139 (330)
T cd07834 74 --------EDFNDVYIVTELME-TDLHKVIKS-----PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSN 139 (330)
T ss_pred --------ccccceEEEecchh-hhHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence 11224699999997 688888864 2379999999999999999999999999999999999999887
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+.++|+|||.+......... ........+++.|+|||++.+. ..++.++||||||+++|+|++
T Consensus 140 -------~~~~L~dfg~~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~---~~~~~~sDi~slG~il~~l~~ 202 (330)
T cd07834 140 -------CDLKICDFGLARGVDPDEDE-------KGFLTEYVVTRWYRAPELLLSS---SRYTKAIDIWSVGCIFAELLT 202 (330)
T ss_pred -------CCEEEcccCceEeecccccc-------cccccccccccCcCCceeeecc---cCCCcchhHHHHHHHHHHHHc
Confidence 78999999999765432210 0011234578899999998762 267899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccc-cccccccc--CCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1046 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC-HEHEVAQS--GSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1046 G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~-~~~~~~~~--~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
|+.||.+.+..+....+...........+...... ........ .............+..+.+++.+||+.+|.+|||
T Consensus 203 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt 282 (330)
T cd07834 203 RKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRIT 282 (330)
T ss_pred CCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCC
Confidence 99999887776655555332222111111100000 00000000 0000000011135677999999999999999999
Q ss_pred HHHHHHHHHhhcC
Q 001142 1123 AGDLYEMFVARTS 1135 (1142)
Q Consensus 1123 a~EVL~~L~~~~s 1135 (1142)
+.+++.|+|+..-
T Consensus 283 ~~~ll~~~~~~~~ 295 (330)
T cd07834 283 ADEALAHPYLAQL 295 (330)
T ss_pred HHHHHhCccHHhh
Confidence 9999999999754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-32 Score=301.21 Aligned_cols=277 Identities=24% Similarity=0.265 Sum_probs=196.9
Q ss_pred cceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEecCCCC
Q 001142 809 LSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 809 y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~g~~~~~~~~ 885 (1142)
|++.+.||+|++|+||+|... +..+++|....+ ........ ..+|+..+++++ ||||+++++++.+.+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~-----~~~e~~~l~~~~~h~~i~~~~~~~~~~~-- 71 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKK--FYSWEECM-----NLREVKSLRKLNEHPNIVKLKEVFREND-- 71 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhh--ccchhHHH-----HHHHHHHHHhccCCCCchhHHHHhhcCC--
Confidence 678899999999999999984 456777764322 11112111 247999999998 999999999987644
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
..++||||+ +++|.+++... ....+++..+..++.|++.||.|||++|++|+||+|+||+++.+
T Consensus 72 ------------~~~lv~e~~-~~~l~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~ 135 (283)
T cd07830 72 ------------ELYFVFEYM-EGNLYQLMKDR---KGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGP 135 (283)
T ss_pred ------------cEEEEEecC-CCCHHHHHHhc---ccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC
Confidence 349999999 68999988752 12468999999999999999999999999999999999999987
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+.++|+|||.+....... ......++..|+|||++.. ...++.++||||||+++++|++
T Consensus 136 -------~~~~l~d~~~~~~~~~~~-----------~~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~s~G~~l~el~~ 194 (283)
T cd07830 136 -------EVVKIADFGLAREIRSRP-----------PYTDYVSTRWYRAPEILLR---STSYSSPVDIWALGCIMAELYT 194 (283)
T ss_pred -------CCEEEeecccceeccCCC-----------CcCCCCCcccccCceeeec---CcCcCCccchhhHHHHHHHHHh
Confidence 789999999987543211 1123457889999998754 2457889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhh---cccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1046 LQVPYMGLSELEIHDLIQMGKRPRLTDELEAL---GSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1046 G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
|+.||......+....+...........+... .......... .............+..+.+++.+||+.||++|||
T Consensus 195 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt 273 (283)
T cd07830 195 LRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQ-FAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPT 273 (283)
T ss_pred CCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccc-cccccHHHHcccCCHHHHHHHHHhcccCcccCCC
Confidence 99999876655444333222111111111000 0000000000 0000000000122567999999999999999999
Q ss_pred HHHHHHHHHh
Q 001142 1123 AGDLYEMFVA 1132 (1142)
Q Consensus 1123 a~EVL~~L~~ 1132 (1142)
+.|++.|+|+
T Consensus 274 ~~ei~~~~~~ 283 (283)
T cd07830 274 ASQALQHPYF 283 (283)
T ss_pred HHHHhhCCCC
Confidence 9999999885
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=316.72 Aligned_cols=251 Identities=22% Similarity=0.393 Sum_probs=207.5
Q ss_pred cceeeeecccCceEEEEEEE----CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 809 LSSCDEAGKSVSSSLFRCKF----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 809 y~l~~~LG~GsfG~Vy~a~~----~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
.++.+.||.|-||.||.|.+ ++...||+|+..+... ..+..+.| +.|..+|+.+.|||||+++|.+.+..
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekf----lqEa~iMrnfdHphIikLIGv~~e~P- 464 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKF----LQEASIMRNFDHPHIIKLIGVCVEQP- 464 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC-ChhhHHHH----HHHHHHHHhCCCcchhheeeeeeccc-
Confidence 36678999999999999997 3556777776665433 33445556 89999999999999999999998643
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
.|||||+++-|.|..+++. ....++......++.||..||.|||+.+.|||||-..|||+..
T Consensus 465 --------------~WivmEL~~~GELr~yLq~----nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsS 526 (974)
T KOG4257|consen 465 --------------MWIVMELAPLGELREYLQQ----NKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSS 526 (974)
T ss_pred --------------eeEEEecccchhHHHHHHh----ccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecC
Confidence 3999999999999999986 2346899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
. ..|||+|||+++.+.+..... + ....-...|||||.+.. ..++.++|||-|||.+||++
T Consensus 527 p-------~CVKLaDFGLSR~~ed~~yYk--a-------S~~kLPIKWmaPESINf----RrFTtASDVWMFgVCmWEIl 586 (974)
T KOG4257|consen 527 P-------QCVKLADFGLSRYLEDDAYYK--A-------SRGKLPIKWMAPESINF----RRFTTASDVWMFGVCMWEIL 586 (974)
T ss_pred c-------ceeeecccchhhhccccchhh--c-------cccccceeecCccccch----hcccchhhHHHHHHHHHHHH
Confidence 7 689999999999876643221 1 11124567999999875 57899999999999999998
Q ss_pred h-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1045 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1045 t-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
. |..||++....+++..+.+|.+++.+. .+++.+..|+.+||.+||.+||.+
T Consensus 587 ~lGvkPfqgvkNsDVI~~iEnGeRlP~P~---------------------------nCPp~LYslmskcWayeP~kRPrf 639 (974)
T KOG4257|consen 587 SLGVKPFQGVKNSDVIGHIENGERLPCPP---------------------------NCPPALYSLMSKCWAYEPSKRPRF 639 (974)
T ss_pred HhcCCccccccccceEEEecCCCCCCCCC---------------------------CCChHHHHHHHHHhccCcccCCcH
Confidence 7 999999987777777777777665442 677889999999999999999999
Q ss_pred HHHHHHH
Q 001142 1124 GDLYEMF 1130 (1142)
Q Consensus 1124 ~EVL~~L 1130 (1142)
.|+...+
T Consensus 640 tei~~~l 646 (974)
T KOG4257|consen 640 TEIKAIL 646 (974)
T ss_pred HHHHHHH
Confidence 9887654
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-32 Score=304.39 Aligned_cols=264 Identities=23% Similarity=0.358 Sum_probs=198.3
Q ss_pred CCCCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeE
Q 001142 803 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHK 879 (1142)
Q Consensus 803 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~g~~ 879 (1142)
...+++|++.+.||+|+||.||+|.+. +..+|+|+.... .. ......+ ..|+.++.+.. ||||+++++++
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~--~~-~~~~~~~----~~e~~~~~~~~~~~~i~~~~~~~ 83 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRT--GN-KEENKRI----LMDLDVVLKSHDCPYIVKCYGYF 83 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEecc--CC-hHHHHHH----HHHHHHHHhccCCCchHhhheee
Confidence 456788999999999999999999986 677888875422 11 1222223 56777777775 99999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCC
Q 001142 880 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSE 958 (1142)
Q Consensus 880 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs-~gIvHrDLKp~ 958 (1142)
.+... .++||||++ ++|.+++... ...+++..+..++.||+.||+|||+ .||+||||+|+
T Consensus 84 ~~~~~--------------~~~v~e~~~-~~l~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~ 144 (296)
T cd06618 84 ITDSD--------------VFICMELMS-TCLDKLLKRI----QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPS 144 (296)
T ss_pred ecCCe--------------EEEEeeccC-cCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHH
Confidence 86553 499999995 6888877652 2368999999999999999999997 59999999999
Q ss_pred CeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001142 959 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1038 (1142)
Q Consensus 959 NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGv 1038 (1142)
||+++.+ +.+||+|||++..+..... .....++..|+|||.+.+......++.++||||||+
T Consensus 145 nill~~~-------~~~kL~dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~ 206 (296)
T cd06618 145 NILLDAS-------GNVKLCDFGISGRLVDSKA-----------KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGI 206 (296)
T ss_pred HEEEcCC-------CCEEECccccchhccCCCc-----------ccCCCCCccccCHhhcCCCCCccccccchhHHHHHH
Confidence 9999876 7899999999865432111 112247888999999875322245788999999999
Q ss_pred HHHHHHhCCCCCCCCCH-HHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001142 1039 LLLELLTLQVPYMGLSE-LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1117 (1142)
Q Consensus 1039 iL~ELLtG~~Pf~~~~~-~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP 1117 (1142)
++|+|++|+.||..... .+....+.....+..+. ....+..+.+++.+||..||
T Consensus 207 il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~l~~li~~~l~~~p 261 (296)
T cd06618 207 SLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPP-------------------------NEGFSPDFCSFVDLCLTKDH 261 (296)
T ss_pred HHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCC-------------------------CCCCCHHHHHHHHHHccCCh
Confidence 99999999999975322 22232322222111110 00345679999999999999
Q ss_pred CCCCCHHHHHHHHHhhcC
Q 001142 1118 TERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1118 ~~RPSa~EVL~~L~~~~s 1135 (1142)
.+||++.++++|+|+...
T Consensus 262 ~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 262 RKRPKYRELLQHPFIRRY 279 (296)
T ss_pred hhCCCHHHHhcChhhhcc
Confidence 999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=320.83 Aligned_cols=258 Identities=25% Similarity=0.359 Sum_probs=212.0
Q ss_pred CCCCCCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeE
Q 001142 802 DPGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 879 (1142)
Q Consensus 802 ~~~~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~ 879 (1142)
....+..|.+.+.||+|.|+.|.+|++ .+..||+|+ ++++.........+ .+|+++|+.+.|||||+++.+.
T Consensus 51 ~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~--idkt~ln~~~~~k~----~rev~imk~l~HPnIvkl~~v~ 124 (596)
T KOG0586|consen 51 DSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKI--IDKTQLNPSKRQKL----GREVDIMKSLNHPNIVKLFSVI 124 (596)
T ss_pred ccccccceeeeeeeccceeEEEEeeEecCCCceEEEEE--ehhcccChHHHHHH----HHHHHHHHhcCCcceeeeeeee
Confidence 345567799999999999999999998 567777776 55554444433333 6999999999999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 001142 880 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959 (1142)
Q Consensus 880 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~N 959 (1142)
.....+ |+||||+.+|.+++++.+ ..++.+..+..++.|+++|++|||+++|||||||++|
T Consensus 125 ~t~~~l--------------ylV~eya~~ge~~~yl~~-----~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eN 185 (596)
T KOG0586|consen 125 ETEATL--------------YLVMEYASGGELFDYLVK-----HGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAEN 185 (596)
T ss_pred eeccee--------------EEEEEeccCchhHHHHHh-----cccchhhhhhhhhHHHHHHHHHHhhcceeccccchhh
Confidence 876644 999999999999999987 3457779999999999999999999999999999999
Q ss_pred eeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001142 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039 (1142)
Q Consensus 960 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGvi 1039 (1142)
||++.+ .++||+|||++..+.... .....+|++.|.|||++.+. ...++.+|+||+|++
T Consensus 186 ilL~~~-------mnikIaDfgfS~~~~~~~-----------~lqt~cgsppyAaPEl~~g~---~y~gpe~D~Wslgvv 244 (596)
T KOG0586|consen 186 ILLDEN-------MNIKIADFGFSTFFDYGL-----------MLQTFCGSPPYAAPELFNGK---KYDGPEVDIWSLGVV 244 (596)
T ss_pred cccccc-------cceeeeccccceeecccc-----------cccccCCCCCccChHhhcCc---ccCCcceehhhhhhh
Confidence 999988 779999999998765422 23466899999999999873 355799999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001142 1040 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1119 (1142)
Q Consensus 1040 L~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~ 1119 (1142)
+|-|+.|..||++....++...+..+... ++ ...+.++.++|+++|..+|.+
T Consensus 245 ly~LV~GsLPFDG~~lk~Lr~rvl~gk~r-Ip---------------------------~~ms~dce~lLrk~lvl~Psk 296 (596)
T KOG0586|consen 245 LYALVEGSLPFDGQNLKELRPRVLRGKYR-IP---------------------------FYMSCDCEDLLRKFLVLNPSK 296 (596)
T ss_pred heeeeecccccCCcccccccchheeeeec-cc---------------------------ceeechhHHHHHHhhccCccc
Confidence 99999999999987666655444333210 00 033456889999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 001142 1120 RPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1120 RPSa~EVL~~L~~~ 1133 (1142)
|++.+++.+|.|.-
T Consensus 297 r~~~dqim~~~W~n 310 (596)
T KOG0586|consen 297 RGPCDQIMKDRWRN 310 (596)
T ss_pred cCCHHHhhhhcccc
Confidence 99999999999864
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=303.83 Aligned_cols=260 Identities=22% Similarity=0.260 Sum_probs=196.5
Q ss_pred CcceeeeecccCceEEEEEEE-----CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEec
Q 001142 808 SLSSCDEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 881 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~-----~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~~~ 881 (1142)
+|++.+.||+|+||.||+|.. .+..+|+|+.+......... ....+.+|+.++.++ +|+||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAK----TTEHTRTERQVLEHIRQSPFLVTLHYAFQT 76 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcch----HHHHHHHHHHHHHhcccCCChhceeeEeec
Confidence 478999999999999999986 45678888764321111111 122337899999999 59999999998876
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 001142 882 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 961 (1142)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NIL 961 (1142)
+. ..++||||+++++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||
T Consensus 77 ~~--------------~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil 137 (290)
T cd05613 77 DT--------------KLHLILDYINGGELFTHLSQ-----RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENIL 137 (290)
T ss_pred CC--------------eEEEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeE
Confidence 54 34899999999999999875 246889999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001142 962 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1041 (1142)
Q Consensus 962 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ 1041 (1142)
++.+ +.+||+|||++........ .......|+..|+|||.+... ...++.++||||||+++|
T Consensus 138 ~~~~-------~~~kl~dfg~~~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~--~~~~~~~~Dv~slG~~l~ 199 (290)
T cd05613 138 LDSN-------GHVVLTDFGLSKEFHEDEV---------ERAYSFCGTIEYMAPDIVRGG--DGGHDKAVDWWSMGVLMY 199 (290)
T ss_pred ECCC-------CCEEEeeCccceecccccc---------cccccccCCcccCChhhccCC--CCCCCccccHHHHHHHHH
Confidence 9877 7899999999875432110 011134588899999998642 134678999999999999
Q ss_pred HHHhCCCCCCCCCH----HHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001142 1042 ELLTLQVPYMGLSE----LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1117 (1142)
Q Consensus 1042 ELLtG~~Pf~~~~~----~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP 1117 (1142)
+|++|..||..... ..+...+..... ..+ ...++.+.+++.+||+.||
T Consensus 200 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~ll~~~l~~~p 251 (290)
T cd05613 200 ELLTGASPFTVDGEKNSQAEISRRILKSEP-PYP---------------------------QEMSALAKDIIQRLLMKDP 251 (290)
T ss_pred HHhcCCCCCCcCCccccHHHHHHHhhccCC-CCC---------------------------ccCCHHHHHHHHHHhcCCH
Confidence 99999999964222 112222211111 000 1345568999999999999
Q ss_pred CCCC-----CHHHHHHHHHhhcCC
Q 001142 1118 TERP-----TAGDLYEMFVARTSS 1136 (1142)
Q Consensus 1118 ~~RP-----Sa~EVL~~L~~~~ss 1136 (1142)
++|| ++.+++.|+|+....
T Consensus 252 ~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 252 KKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred HHhcCCCCCCHHHHHcCcccccCC
Confidence 9997 899999999987543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=303.16 Aligned_cols=273 Identities=18% Similarity=0.223 Sum_probs=185.9
Q ss_pred CCcceeeeecccCceEEEEEEECCc-----cEEEEEEecccCCCChHHH--HH-hHHhHHHHHHHHhhCCCCCccceeee
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFGSA-----DAAAKVRTLKVCGSSADEI--RN-FEYSCLGEVRMLGALRHSCIVEMYGH 878 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~~~-----~vAvKi~~l~~~~~~~~~~--~~-~~~~~~~Ei~iL~~L~HpNIVkl~g~ 878 (1142)
.+|.+.++||+|+||+||+|.+.+. .+++|+............. .. .......+...+..+.|+||++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 4699999999999999999998543 5566654333211100000 00 00111234455667789999999997
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 001142 879 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 958 (1142)
Q Consensus 879 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~ 958 (1142)
+..... .....+++||++. .++.+.+... ...++..+..|+.|++.||+|||+++|+||||||+
T Consensus 92 ~~~~~~----------~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~ 155 (294)
T PHA02882 92 GSFKRC----------RMYYRFILLEKLV-ENTKEIFKRI-----KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPE 155 (294)
T ss_pred eeEecC----------CceEEEEEEehhc-cCHHHHHHhh-----ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 654321 1234578999885 6777777641 23578889999999999999999999999999999
Q ss_pred CeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001142 959 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1038 (1142)
Q Consensus 959 NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGv 1038 (1142)
|||++.+ +.++|+|||+|+.+......... .........||+.|+|||+..+ ..++.++|||||||
T Consensus 156 Nill~~~-------~~~~l~DFGla~~~~~~~~~~~~---~~~~~~~~~gt~~y~ape~~~~----~~~~~~~DiwSlG~ 221 (294)
T PHA02882 156 NIMVDGN-------NRGYIIDYGIASHFIIHGKHIEY---SKEQKDLHRGTLYYAGLDAHNG----ACVTRRGDLESLGY 221 (294)
T ss_pred HEEEcCC-------CcEEEEEcCCceeeccCCccccc---ccccccccCCCccccCHHHhCC----CCCCcHHHHHHHHH
Confidence 9999876 78999999999765432111000 0111223469999999999876 56889999999999
Q ss_pred HHHHHHhCCCCCCCCCH-HHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001142 1039 LLLELLTLQVPYMGLSE-LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1117 (1142)
Q Consensus 1039 iL~ELLtG~~Pf~~~~~-~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP 1117 (1142)
++|||++|+.||.+... ........... .... .+.. ... ...++.+.+++..|+..+|
T Consensus 222 ~l~el~~g~~P~~~~~~~~~~~~~~~~~~-------~~~~--------~~~~--~~~----~~~~~~~~~~~~~~~~~~~ 280 (294)
T PHA02882 222 CMLKWAGIKLPWKGFGHNGNLIHAAKCDF-------IKRL--------HEGK--IKI----KNANKFIYDFIECVTKLSY 280 (294)
T ss_pred HHHHHHhCCCCCCccccchHHHHHhHHHH-------HHHh--------hhhh--hcc----CCCCHHHHHHHHHHHhCCC
Confidence 99999999999986532 22221111000 0000 0000 000 1345679999999999999
Q ss_pred CCCCCHHHHHHHH
Q 001142 1118 TERPTAGDLYEMF 1130 (1142)
Q Consensus 1118 ~~RPSa~EVL~~L 1130 (1142)
++||++.++++.+
T Consensus 281 ~~rp~~~~l~~~~ 293 (294)
T PHA02882 281 EEKPDYDALIKIF 293 (294)
T ss_pred CCCCCHHHHHHhh
Confidence 9999999998854
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-32 Score=312.20 Aligned_cols=286 Identities=20% Similarity=0.227 Sum_probs=204.7
Q ss_pred CCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
.++|++.+.||+|++|.||+|++. +..+++|+.... .......+. +.+|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRP--FQSAIHAKR----TYRELRLLKHMDHENVIGLLDVFTPAS 87 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccc--cchhhHHHH----HHHHHHHHHhccCCCHHHHHHHhhccc
Confidence 457999999999999999999984 566777764321 111122222 368999999999999999998876543
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
.. ......++||||+ +++|.+++.. ..+++..+..++.||+.||+|||+.||+||||||+||+++
T Consensus 88 ~~--------~~~~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~ 152 (343)
T cd07851 88 SL--------EDFQDVYLVTHLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 152 (343)
T ss_pred cc--------cccccEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC
Confidence 21 1223469999999 5799998864 4689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.++|+|||.+...... .....++..|+|||.+.+ ...++.++|||||||++|+|
T Consensus 153 ~~-------~~~kL~dfg~~~~~~~~-------------~~~~~~~~~y~aPE~~~~---~~~~~~~~DvwslGv~l~el 209 (343)
T cd07851 153 ED-------CELKILDFGLARHTDDE-------------MTGYVATRWYRAPEIMLN---WMHYNQTVDIWSVGCIMAEL 209 (343)
T ss_pred CC-------CCEEEcccccccccccc-------------ccCCcccccccCHHHHhC---CCCCCchHhHHHHHHHHHHH
Confidence 87 78999999998754321 112357888999999864 13567899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCC---chhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK---PEAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
++|+.||.+....+....+........+.............+......... .......++.+.+++.+||+.||.+|
T Consensus 210 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~R 289 (343)
T cd07851 210 LTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKR 289 (343)
T ss_pred HhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhC
Confidence 999999987666555555433222211111111100000000000000000 01111346789999999999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 001142 1121 PTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1121 PSa~EVL~~L~~~~s 1135 (1142)
||+.+|++|+|+..-
T Consensus 290 pt~~ell~h~~~~~~ 304 (343)
T cd07851 290 ITAAEALAHPYLAEY 304 (343)
T ss_pred CCHHHHhcCCCcccc
Confidence 999999999999754
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=300.78 Aligned_cols=264 Identities=22% Similarity=0.338 Sum_probs=215.9
Q ss_pred CCCCCCCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeee
Q 001142 801 LDPGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 878 (1142)
Q Consensus 801 ~~~~~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~ 878 (1142)
..-.+.++|.+.++||+|.||.|-+++- .+..+|+||.+.++.....+ ...- +.|-++|+..+||.+..+--.
T Consensus 162 ~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdE-VAHT----lTE~RVL~~~~HPFLt~LKYs 236 (516)
T KOG0690|consen 162 KNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDE-VAHT----LTENRVLQNCRHPFLTSLKYS 236 (516)
T ss_pred cceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHH-hhhh----hhHHHHHHhccCcHHHHhhhh
Confidence 3456788999999999999999999986 56788999865544333322 2222 589999999999999988777
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 001142 879 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 958 (1142)
Q Consensus 879 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~ 958 (1142)
|...+ ++|+||||..||.|.-++.+ ...+++...+.+...|+.||.|||+++||+||||.+
T Consensus 237 FQt~d--------------rlCFVMeyanGGeLf~HLsr-----er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLE 297 (516)
T KOG0690|consen 237 FQTQD--------------RLCFVMEYANGGELFFHLSR-----ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLE 297 (516)
T ss_pred hccCc--------------eEEEEEEEccCceEeeehhh-----hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhh
Confidence 77655 45999999999999988876 457999999999999999999999999999999999
Q ss_pred CeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001142 959 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1038 (1142)
Q Consensus 959 NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGv 1038 (1142)
|.|+|.+ |++||.|||+++.--... .....++|||.|.|||++.. ..|+.++|.|.+||
T Consensus 298 NLlLDkD-------GHIKitDFGLCKE~I~~g----------~t~kTFCGTPEYLAPEVleD----nDYgraVDWWG~GV 356 (516)
T KOG0690|consen 298 NLLLDKD-------GHIKITDFGLCKEEIKYG----------DTTKTFCGTPEYLAPEVLED----NDYGRAVDWWGVGV 356 (516)
T ss_pred hheeccC-------CceEeeecccchhccccc----------ceeccccCChhhcCchhhcc----ccccceeehhhhhH
Confidence 9999998 899999999997532211 12346789999999999986 78999999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001142 1039 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1118 (1142)
Q Consensus 1039 iL~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~ 1118 (1142)
++|||+.|+.||...+...+++.|..... .++ ...+++.+.|+..+|..||.
T Consensus 357 VMYEMmCGRLPFyn~dh~kLFeLIl~ed~-kFP---------------------------r~ls~eAktLLsGLL~kdP~ 408 (516)
T KOG0690|consen 357 VMYEMMCGRLPFYNKDHEKLFELILMEDL-KFP---------------------------RTLSPEAKTLLSGLLKKDPK 408 (516)
T ss_pred HHHHHHhccCcccccchhHHHHHHHhhhc-cCC---------------------------ccCCHHHHHHHHHHhhcChH
Confidence 99999999999998777777777643321 001 14566789999999999999
Q ss_pred CCC-----CHHHHHHHHHhhcCCC
Q 001142 1119 ERP-----TAGDLYEMFVARTSSS 1137 (1142)
Q Consensus 1119 ~RP-----Sa~EVL~~L~~~~ss~ 1137 (1142)
+|. .|.||.+|.||..-.+
T Consensus 409 kRLGgGpdDakEi~~h~FF~~v~W 432 (516)
T KOG0690|consen 409 KRLGGGPDDAKEIMRHRFFASVDW 432 (516)
T ss_pred hhcCCCchhHHHHHhhhhhccCCH
Confidence 994 6899999999876543
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=274.29 Aligned_cols=283 Identities=20% Similarity=0.252 Sum_probs=211.5
Q ss_pred CcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
.|.-.++||+|+||+||+|+.. ...||+|..+++....+ .....++|+-+++.++|.|||++++....+..
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddeg------vpssalreicllkelkhknivrl~dvlhsdkk- 75 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEG------VPSSALREICLLKELKHKNIVRLHDVLHSDKK- 75 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCC------CcHHHHHHHHHHHHhhhcceeehhhhhccCce-
Confidence 5777899999999999999974 45567776666644333 23344799999999999999999999877664
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
+.+|+|||. .+|..+... -++.++.+.++.++.|+++||.|+|++++.||||||+|.||+.+
T Consensus 76 -------------ltlvfe~cd-qdlkkyfds----lng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~n 137 (292)
T KOG0662|consen 76 -------------LTLVFEFCD-QDLKKYFDS----LNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRN 137 (292)
T ss_pred -------------eEEeHHHhh-HHHHHHHHh----cCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccC
Confidence 489999996 677777665 34679999999999999999999999999999999999999988
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+.+|++|||+++.+....... ...+.|..|++|.++.+ ..-|+..+|+||.|||+.|+..
T Consensus 138 -------gelkladfglarafgipvrcy----------saevvtlwyrppdvlfg---akly~tsidmwsagcifaelan 197 (292)
T KOG0662|consen 138 -------GELKLADFGLARAFGIPVRCY----------SAEVVTLWYRPPDVLFG---AKLYSTSIDMWSAGCIFAELAN 197 (292)
T ss_pred -------CcEEecccchhhhcCCceEee----------eceeeeeeccCcceeee---eehhccchHhhhcchHHHHHhh
Confidence 899999999998776543221 12357999999999987 4678999999999999999987
Q ss_pred -CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccc---cccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1046 -LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEH---EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1046 -G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
|.+.|.+.+..+....|.+.......+.++........ +.......+ ..........-++++++.|.-+|.+|.
T Consensus 198 agrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattsw--sqivp~lns~grdllqkll~cnp~qri 275 (292)
T KOG0662|consen 198 AGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSW--SQIVPKLNSTGRDLLQKLLKCNPAQRI 275 (292)
T ss_pred cCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchH--HHHhhhhcchhHHHHHHHhccCccccc
Confidence 77778888777766666443322222222211111100 000000000 001113334468999999999999999
Q ss_pred CHHHHHHHHHhhcCCC
Q 001142 1122 TAGDLYEMFVARTSSS 1137 (1142)
Q Consensus 1122 Sa~EVL~~L~~~~ss~ 1137 (1142)
+|+++++|++|...++
T Consensus 276 saeaalqhpyf~d~s~ 291 (292)
T KOG0662|consen 276 SAEAALQHPYFSDFSP 291 (292)
T ss_pred CHHHHhcCccccccCC
Confidence 9999999999987654
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-31 Score=304.25 Aligned_cols=255 Identities=27% Similarity=0.409 Sum_probs=196.3
Q ss_pred cceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCC
Q 001142 809 LSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 886 (1142)
Q Consensus 809 y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~ 886 (1142)
|...+.||+|+||+||+|++ .+..+++|+...... ......+.+ .+|+.+++.++|||++++++++.+..
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~----~~E~~~l~~l~h~~iv~~~~~~~~~~--- 94 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGK-QTNEKWQDI----IKEVKFLQQLKHPNTIEYKGCYLKEH--- 94 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEecccc-CchHHHHHH----HHHHHHHHhCCCCCCccEEEEEEeCC---
Confidence 67778899999999999987 455677776533211 122222333 78999999999999999999988654
Q ss_pred CCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecccc
Q 001142 887 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 966 (1142)
Q Consensus 887 ~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~ 966 (1142)
..++||||+. ++|.+++.. ....+++..+..++.||+.||.|||++||+|+||||+||+++.+
T Consensus 95 -----------~~~lv~e~~~-~~l~~~l~~----~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~- 157 (313)
T cd06633 95 -----------TAWLVMEYCL-GSASDLLEV----HKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP- 157 (313)
T ss_pred -----------EEEEEEecCC-CCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCC-
Confidence 3499999996 688887764 13468999999999999999999999999999999999999877
Q ss_pred ccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001142 967 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1046 (1142)
Q Consensus 967 ~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG 1046 (1142)
+.+||+|||.+..... .....|+..|+|||++.... ...++.++|||||||++|+|++|
T Consensus 158 ------~~~kL~dfg~~~~~~~--------------~~~~~~~~~y~aPE~~~~~~-~~~~~~~sDv~slGvil~el~~g 216 (313)
T cd06633 158 ------GQVKLADFGSASKSSP--------------ANSFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIELAER 216 (313)
T ss_pred ------CCEEEeecCCCcccCC--------------CCCccccccccChhhccccC-CCCCCchhhHHHHHHHHHHHHhC
Confidence 7899999998853211 12345888999999975321 24578899999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 001142 1047 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1126 (1142)
Q Consensus 1047 ~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EV 1126 (1142)
..||...........+.....+.... ...+..+.+++.+||+.+|.+||++.++
T Consensus 217 ~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~l~~li~~~l~~~P~~Rp~~~~~ 270 (313)
T cd06633 217 KPPLFNMNAMSALYHIAQNDSPTLQS--------------------------NEWTDSFRGFVDYCLQKIPQERPASAEL 270 (313)
T ss_pred CCCCCCCChHHHHHHHHhcCCCCCCc--------------------------cccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 99998765544444433222211110 1334568999999999999999999999
Q ss_pred HHHHHhhcC
Q 001142 1127 YEMFVARTS 1135 (1142)
Q Consensus 1127 L~~L~~~~s 1135 (1142)
+.|+|++..
T Consensus 271 l~~~~~~~~ 279 (313)
T cd06633 271 LRHDFVRRD 279 (313)
T ss_pred hcCcccCCC
Confidence 999999754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=298.27 Aligned_cols=279 Identities=23% Similarity=0.264 Sum_probs=200.8
Q ss_pred cceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCC
Q 001142 809 LSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 886 (1142)
Q Consensus 809 y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~ 886 (1142)
|++.+.||+|++|.||+|+.. +..+++|+..... ......+. +..|+.++++++||||+++++++.+..
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~--~~~~~~~~----~~~e~~~l~~~~~~~i~~~~~~~~~~~--- 71 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN--EEEGIPST----ALREISLLKELKHPNIVKLLDVIHTER--- 71 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc--ccccccHH----HHHHHHHHHhcCCCCHHHHHhhhhcCC---
Confidence 677899999999999999984 6778888765432 11111222 368999999999999999999987654
Q ss_pred CCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecccc
Q 001142 887 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 966 (1142)
Q Consensus 887 ~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~ 966 (1142)
..++||||++ ++|.+++... ...+++..+..++.|++.||.|||++||+||||+|+||+++.+
T Consensus 72 -----------~~~~v~e~~~-~~l~~~i~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~- 134 (282)
T cd07829 72 -----------KLYLVFEYCD-MDLKKYLDKR----PGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRD- 134 (282)
T ss_pred -----------ceEEEecCcC-cCHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCC-
Confidence 3499999997 6999999862 1468999999999999999999999999999999999999887
Q ss_pred ccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001142 967 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1046 (1142)
Q Consensus 967 ~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG 1046 (1142)
+.++|+|||.+........ ......++..|+|||.+.+ ...++.++|||||||++|||++|
T Consensus 135 ------~~~~l~d~g~~~~~~~~~~----------~~~~~~~~~~~~aPE~~~~---~~~~~~~~Dv~slG~~l~~l~~~ 195 (282)
T cd07829 135 ------GVLKLADFGLARAFGIPLR----------TYTHEVVTLWYRAPEILLG---SKHYSTAVDIWSVGCIFAEMITG 195 (282)
T ss_pred ------CCEEEecCCcccccCCCcc----------ccCccccCcCcCChHHhcC---CcCCCccccHHHHHHHHHHHHhC
Confidence 7899999999876433211 1112345778999999865 23678899999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccc-cccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001142 1047 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH-EHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1125 (1142)
Q Consensus 1047 ~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~E 1125 (1142)
..||......+....+...........+....... ....................+..+.+++.+||..||.+||++.+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ 275 (282)
T cd07829 196 KPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKE 275 (282)
T ss_pred CCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHH
Confidence 99998766555444443222111111111111100 00000000000000011133667999999999999999999999
Q ss_pred HHHHHHh
Q 001142 1126 LYEMFVA 1132 (1142)
Q Consensus 1126 VL~~L~~ 1132 (1142)
++.|+|+
T Consensus 276 ~l~~p~~ 282 (282)
T cd07829 276 ALKHPYF 282 (282)
T ss_pred HhhCcCC
Confidence 9999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=324.30 Aligned_cols=264 Identities=24% Similarity=0.374 Sum_probs=216.9
Q ss_pred CCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSK 883 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~~~~~ 883 (1142)
+.|++.++||+|.+|.||+++. .++.+|+||+.... +..+++ +.|.++++.. .|||++.+||+|.-.+
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-----d~deEi----E~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-----DEEEEI----ELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-----cccHHH----HHHHHHHHhccCCCCcceEEEEEEEec
Confidence 4589999999999999999875 68889999865432 222222 4688999888 5999999999988654
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
.. ...++|||||||.|||..++++.+. ...+.|..+..|++.++.|+.|||.+.++|||||-.|||++
T Consensus 90 ~~---------~~DqLWLVMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT 157 (953)
T KOG0587|consen 90 PG---------NGDQLWLVMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLT 157 (953)
T ss_pred CC---------CCCeEEEEeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEe
Confidence 31 3458899999999999999999864 46799999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhcccc-CCCCCCchhhHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~s~ksDVwSLGviL~E 1042 (1142)
.+ +.|||+|||.+..+.... ....++.|||+|||||++.+.. ....|+..+|+||||++..|
T Consensus 158 ~e-------~~VKLvDFGvSaQldsT~----------grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIE 220 (953)
T KOG0587|consen 158 EN-------AEVKLVDFGVSAQLDSTV----------GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIE 220 (953)
T ss_pred cc-------CcEEEeeeeeeeeeeccc----------ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeeh
Confidence 98 789999999997765422 2345788999999999998743 23457889999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1043 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1043 LLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
|..|.+|+.++.+....-.|-...+|.+... ...++.+.++|..||..|-++||+
T Consensus 221 ladG~PPl~DmHPmraLF~IpRNPPPkLkrp-------------------------~kWs~~FndFIs~cL~Kd~e~RP~ 275 (953)
T KOG0587|consen 221 MAEGAPPLCDMHPMRALFLIPRNPPPKLKRP-------------------------KKWSKKFNDFISTCLVKDYEQRPS 275 (953)
T ss_pred hcCCCCCccCcchhhhhccCCCCCCccccch-------------------------hhHHHHHHHHHHHHHhhccccCcc
Confidence 9999999988777665545444444433211 156778999999999999999999
Q ss_pred HHHHHHHHHhh
Q 001142 1123 AGDLYEMFVAR 1133 (1142)
Q Consensus 1123 a~EVL~~L~~~ 1133 (1142)
+.++++|+|..
T Consensus 276 ~~~ll~hpFi~ 286 (953)
T KOG0587|consen 276 TEELLKHPFIT 286 (953)
T ss_pred hhhhccCCccc
Confidence 99999999876
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=303.01 Aligned_cols=258 Identities=27% Similarity=0.407 Sum_probs=197.9
Q ss_pred CcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
.|+..+.||+|+||.||+|++ .+..+++|....... ........+ .+|+.+++.++|+|++++++++....
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~----~~e~~~l~~l~h~~i~~~~~~~~~~~-- 88 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDI----IKEVRFLQKLRHPNTIQYRGCYLREH-- 88 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccc-cChHHHHHH----HHHHHHHHhCCCCCcccEEEEEEcCC--
Confidence 377889999999999999997 455677776542211 112222333 68999999999999999999988654
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
..++||||+. ++|.+++.. ....+++..+..++.|++.||.|||+++++||||||+||+++.+
T Consensus 89 ------------~~~lv~e~~~-~~l~~~~~~----~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~ 151 (308)
T cd06634 89 ------------TAWLVMEYCL-GSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP 151 (308)
T ss_pred ------------eeEEEEEccC-CCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCC
Confidence 3499999997 688887754 12458999999999999999999999999999999999999876
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+.++|+|||++...... ....+++.|+|||.+.... ...++.++|||||||++|+|++
T Consensus 152 -------~~~kl~dfg~~~~~~~~--------------~~~~~~~~y~aPE~~~~~~-~~~~~~~~Di~slG~il~el~~ 209 (308)
T cd06634 152 -------GLVKLGDFGSASIMAPA--------------NXFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIELAE 209 (308)
T ss_pred -------CcEEECCcccceeecCc--------------ccccCCccccCHHHHhhcc-cCCCCcccchHHHHHHHHHHHc
Confidence 78999999998654321 1235788999999975321 2356789999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001142 1046 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1125 (1142)
Q Consensus 1046 G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~E 1125 (1142)
|+.||......+....+.....+... ....+..+.++|.+||+.+|.+||++.+
T Consensus 210 g~~p~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~li~~cl~~~P~~Rp~~~~ 263 (308)
T cd06634 210 RKPPLFNMNAMSALYHIAQNESPALQ--------------------------SGHWSEYFRNFVDSCLQKIPQDRPTSEV 263 (308)
T ss_pred CCCCCccccHHHHHHHHhhcCCCCcC--------------------------cccccHHHHHHHHHHhhCCcccCCCHHH
Confidence 99999765544433333332222111 0134566899999999999999999999
Q ss_pred HHHHHHhhcCCC
Q 001142 1126 LYEMFVARTSSS 1137 (1142)
Q Consensus 1126 VL~~L~~~~ss~ 1137 (1142)
+++|+|+.....
T Consensus 264 ll~~~~~~~~~~ 275 (308)
T cd06634 264 LLKHRFVLRERP 275 (308)
T ss_pred HhhCccccccCC
Confidence 999999876543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=294.14 Aligned_cols=262 Identities=25% Similarity=0.286 Sum_probs=203.6
Q ss_pred CCCcce-eeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEec
Q 001142 806 FPSLSS-CDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 881 (1142)
Q Consensus 806 ~~~y~l-~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~~~ 881 (1142)
.++|.+ .++||-|-.|.|-.+.+ .+..+|+|+. .. ... ..+|+++.-.. .|||||.++++|..
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL--~D---s~K--------ARrEVeLHw~~s~h~~iV~IidVyeN 126 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVL--LD---SPK--------ARREVELHWMASGHPHIVSIIDVYEN 126 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHH--hc---CHH--------HHhHhhhhhhhcCCCceEEeehhhhh
Confidence 356743 47899999999999887 4666777763 21 111 15788877665 59999999999875
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 001142 882 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 961 (1142)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NIL 961 (1142)
.-. ....+.+|||.++||.|.+.|++ .+...|++.++-.|++||..|+.|||+.+|.||||||+|+|
T Consensus 127 s~~----------~rkcLLiVmE~meGGeLfsriq~---~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLL 193 (400)
T KOG0604|consen 127 SYQ----------GRKCLLIVMECMEGGELFSRIQD---RGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLL 193 (400)
T ss_pred hcc----------CceeeEeeeecccchHHHHHHHH---cccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhhee
Confidence 321 13356899999999999999987 55677999999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001142 962 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1041 (1142)
Q Consensus 962 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ 1041 (1142)
.... .....+||+|||+|+.-.... ...+.+-||+|.|||++.. ..|+...|+||+||++|
T Consensus 194 yt~t----~~na~lKLtDfGFAK~t~~~~-----------~L~TPc~TPyYvaPevlg~----eKydkscdmwSlgVimY 254 (400)
T KOG0604|consen 194 YTTT----SPNAPLKLTDFGFAKETQEPG-----------DLMTPCFTPYYVAPEVLGP----EKYDKSCDMWSLGVIMY 254 (400)
T ss_pred eecC----CCCcceEecccccccccCCCc-----------cccCCcccccccCHHHhCc----hhcCCCCCccchhHHHH
Confidence 9765 233789999999997543211 1234568999999999865 56999999999999999
Q ss_pred HHHhCCCCCCCCCH----HHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001142 1042 ELLTLQVPYMGLSE----LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1117 (1142)
Q Consensus 1042 ELLtG~~Pf~~~~~----~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP 1117 (1142)
-|+.|.+||....- ..+...|..+... |..+++. ..+++.+++|+.+|..+|
T Consensus 255 IlLCGyPPFYS~hg~aispgMk~rI~~gqy~-----------------------FP~pEWs-~VSe~aKdlIR~LLkt~P 310 (400)
T KOG0604|consen 255 ILLCGYPPFYSNHGLAISPGMKRRIRTGQYE-----------------------FPEPEWS-CVSEAAKDLIRKLLKTEP 310 (400)
T ss_pred HhhcCCCcccccCCccCChhHHhHhhccCcc-----------------------CCChhHh-HHHHHHHHHHHHHhcCCc
Confidence 99999999975322 1234455444432 1222222 778899999999999999
Q ss_pred CCCCCHHHHHHHHHhhcCC
Q 001142 1118 TERPTAGDLYEMFVARTSS 1136 (1142)
Q Consensus 1118 ~~RPSa~EVL~~L~~~~ss 1136 (1142)
.+|.|+.+++.|+|..+..
T Consensus 311 teRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 311 TERLTIEEVMDHPWINQYE 329 (400)
T ss_pred hhheeHHHhhcCchhcccc
Confidence 9999999999999987653
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.8e-32 Score=299.28 Aligned_cols=244 Identities=21% Similarity=0.265 Sum_probs=183.7
Q ss_pred Ccceeeee--cccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecC
Q 001142 808 SLSSCDEA--GKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISS 882 (1142)
Q Consensus 808 ~y~l~~~L--G~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~~~~ 882 (1142)
.|++.+.+ |+|+||.||++.. .+..+++|+..... ... .|+.....+ +||||+++++.+...
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~-----------~e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKN--FNA-----------IEPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhh--cch-----------hhHHHHHHhhcCCCEEEEEEEEecC
Confidence 45565555 9999999999987 45567777754221 111 122222222 699999999999865
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
+ ..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+||++
T Consensus 82 ~--------------~~~iv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~ 142 (267)
T PHA03390 82 K--------------GHVLIMDYIKDGDLFDLLKK-----EGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLY 142 (267)
T ss_pred C--------------eeEEEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE
Confidence 5 34999999999999999976 2378999999999999999999999999999999999999
Q ss_pred ccccccCCCCC-eEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001142 963 DLERKKADGKP-VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1041 (1142)
Q Consensus 963 d~~~~~~~~~~-~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ 1041 (1142)
+.+ + .++|+|||.+...... ....++..|+|||++.+ ..++.++||||||+++|
T Consensus 143 ~~~-------~~~~~l~dfg~~~~~~~~--------------~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~il~ 197 (267)
T PHA03390 143 DRA-------KDRIYLCDYGLCKIIGTP--------------SCYDGTLDYFSPEKIKG----HNYDVSFDWWAVGVLTY 197 (267)
T ss_pred eCC-------CCeEEEecCccceecCCC--------------ccCCCCCcccChhhhcC----CCCCchhhHHHHHHHHH
Confidence 877 4 8999999998654321 12357889999999875 56789999999999999
Q ss_pred HHHhCCCCCCCCCHHHH-HHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1042 ELLTLQVPYMGLSELEI-HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1042 ELLtG~~Pf~~~~~~el-~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
+|++|+.||........ ...+........ ......++.+.+++.+||+.||.+|
T Consensus 198 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~l~~~p~~R 252 (267)
T PHA03390 198 ELLTGKHPFKEDEDEELDLESLLKRQQKKL-------------------------PFIKNVSKNANDFVQSMLKYNINYR 252 (267)
T ss_pred HHHHCCCCCCCCCcchhhHHHHHHhhcccC-------------------------CcccccCHHHHHHHHHHhccChhhC
Confidence 99999999975433221 111111000000 0001456679999999999999999
Q ss_pred CC-HHHHHHHHHhh
Q 001142 1121 PT-AGDLYEMFVAR 1133 (1142)
Q Consensus 1121 PS-a~EVL~~L~~~ 1133 (1142)
|+ ++++++|+|+.
T Consensus 253 ~~~~~~~l~h~~~~ 266 (267)
T PHA03390 253 LTNYNEIIKHPFLK 266 (267)
T ss_pred CchHHHHhcCCccc
Confidence 96 69999999985
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-33 Score=294.22 Aligned_cols=297 Identities=18% Similarity=0.246 Sum_probs=213.3
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
..|+-..+||+|.||.||+|+.. +..||+|.+-.+ .+.+.|.....+|+.+|..++|+|++.+++.+.....
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlme------neKeGfpitalreikiL~~lkHenv~nliEic~tk~T 90 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLME------NEKEGFPITALREIKILQLLKHENVVNLIEICRTKAT 90 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHh------ccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccC
Confidence 45888899999999999999874 455676654332 2223344444799999999999999999988765332
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
- ..+....+|+||.+|+ .+|..++.+ ...+++..++.+++.++..||.|+|.+.|+|||+||.|+||+.
T Consensus 91 p------~~r~r~t~ylVf~~ce-hDLaGlLsn----~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~ 159 (376)
T KOG0669|consen 91 P------TNRDRATFYLVFDFCE-HDLAGLLSN----RKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITK 159 (376)
T ss_pred C------cccccceeeeeHHHhh-hhHHHHhcC----ccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcC
Confidence 1 1112235799999997 899888864 3467999999999999999999999999999999999999999
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +++||+|||+++.+....... .+.....+.|..|++||.+.+. ..|+++.|||+.|||+.||+
T Consensus 160 d-------gilklADFGlar~fs~~~n~~------kprytnrvvTLwYrppEllLG~---r~yg~~iDiWgAgCimaeMw 223 (376)
T KOG0669|consen 160 D-------GILKLADFGLARAFSTSKNVV------KPRYTNRVVTLWYRPPELLLGD---REYGPPIDIWGAGCIMAEMW 223 (376)
T ss_pred C-------ceEEeeccccccceecccccC------CCCcccceeeeecCCHHHhhcc---cccCCcchhHhHHHHHHHHH
Confidence 8 899999999998765433221 1123355679999999999984 57899999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccc------cccccccCC-CCCCchhhhhhHHHHHHHHHHhcccCC
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH------EHEVAQSGS-GFEKPEAELETLSFLVDVFRRCTEENP 1117 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~------~~~~~~~~~-~~~~~~~~~~~~~~L~dLI~~CL~~DP 1117 (1142)
|+.+-+++.+..+....|..-.....++.++...... ..+..+... ..+....+....++..+|+..++..||
T Consensus 224 trspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP 303 (376)
T KOG0669|consen 224 TRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDP 303 (376)
T ss_pred ccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCc
Confidence 9999999888777666664322211111111110000 000000000 000000001223467899999999999
Q ss_pred CCCCCHHHHHHHHHhhcCC
Q 001142 1118 TERPTAGDLYEMFVARTSS 1136 (1142)
Q Consensus 1118 ~~RPSa~EVL~~L~~~~ss 1136 (1142)
.+|+++++++.|.||....
T Consensus 304 ~kR~~ad~alnh~~F~kdp 322 (376)
T KOG0669|consen 304 TKRIDADQALNHDFFWKDP 322 (376)
T ss_pred ccCcchHhhhchhhhhcCC
Confidence 9999999999999987553
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=299.72 Aligned_cols=260 Identities=24% Similarity=0.254 Sum_probs=193.8
Q ss_pred CcceeeeecccCceEEEEEEE-----CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEec
Q 001142 808 SLSSCDEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 881 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~-----~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~~~ 881 (1142)
+|++.+.||+|++|.||++++ .+..+|+|+.+.... .........+.+|+.++.++ +||||+++++.+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~----~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~ 76 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATI----VQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT 76 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHH----HhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec
Confidence 478999999999999999985 346688887542211 11111122347899999999 59999999998875
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 001142 882 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 961 (1142)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NIL 961 (1142)
.. ..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++||||||+||+
T Consensus 77 ~~--------------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil 137 (288)
T cd05583 77 DT--------------KLHLILDYVNGGELFTHLYQ-----REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENIL 137 (288)
T ss_pred CC--------------EEEEEEecCCCCcHHHHHhh-----cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeE
Confidence 44 34899999999999999865 246899999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001142 962 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1041 (1142)
Q Consensus 962 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ 1041 (1142)
++.+ +.++|+|||++......... ......|+..|+|||.+.+.. ..++.++||||||+++|
T Consensus 138 ~~~~-------~~~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~--~~~~~~~Dv~slG~il~ 199 (288)
T cd05583 138 LDSE-------GHVVLTDFGLSKEFLAEEEE---------RAYSFCGTIEYMAPEVIRGGS--GGHDKAVDWWSLGVLTF 199 (288)
T ss_pred ECCC-------CCEEEEECcccccccccccc---------ccccccCCccccCHHHhcCCC--CCCcchhhhHHHHHHHH
Confidence 9877 78999999998654322110 111235788999999986521 23678999999999999
Q ss_pred HHHhCCCCCCCCCH----HHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001142 1042 ELLTLQVPYMGLSE----LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1117 (1142)
Q Consensus 1042 ELLtG~~Pf~~~~~----~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP 1117 (1142)
+|++|..||..... .+....+..... ..+ ...+..+.+++.+||+.||
T Consensus 200 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~l~~li~~~l~~~p 251 (288)
T cd05583 200 ELLTGASPFTVDGEQNSQSEISRRILKSKP-PFP---------------------------KTMSAEARDFIQKLLEKDP 251 (288)
T ss_pred HHHhCCCCcccCcccchHHHHHHHHHccCC-CCC---------------------------cccCHHHHHHHHHHhcCCH
Confidence 99999999964321 112122111110 000 1344568999999999999
Q ss_pred CCCCC---HHHHHHHHHhhcCC
Q 001142 1118 TERPT---AGDLYEMFVARTSS 1136 (1142)
Q Consensus 1118 ~~RPS---a~EVL~~L~~~~ss 1136 (1142)
++||| +.++++|+|++.-.
T Consensus 252 ~~R~t~~~~~~~l~~~~~~~~~ 273 (288)
T cd05583 252 KKRLGANGADEIKNHPFFQGID 273 (288)
T ss_pred hhccCcchHHHHhcCcccccCC
Confidence 99998 46779999987643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-31 Score=332.32 Aligned_cols=149 Identities=26% Similarity=0.282 Sum_probs=125.8
Q ss_pred CCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 882 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~ 882 (1142)
++++|.+.++||+|+||.||+|.+. +..||+|+.+.... ..... ...+..|+.+++.++||||+++++++...
T Consensus 2 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~-~~~~~----~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~ 76 (669)
T cd05610 2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADM-INKNM----VHQVQAERDALALSKSPFIVHLYYSLQSA 76 (669)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhc-cCHHH----HHHHHHHHHHHHhcCCCCcCeEEEEEEEC
Confidence 3678999999999999999999985 77889998653221 11122 22347899999999999999999888765
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
. +.|+||||+++++|.+++.. ...+++..++.|+.||+.||.|||.+||+||||||+|||+
T Consensus 77 ~--------------~~~lVmEy~~g~~L~~li~~-----~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl 137 (669)
T cd05610 77 N--------------NVYLVMEYLIGGDVKSLLHI-----YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLI 137 (669)
T ss_pred C--------------EEEEEEeCCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEE
Confidence 4 45999999999999999975 2458899999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcc
Q 001142 963 DLERKKADGKPVVKLCDFDRAV 984 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~ 984 (1142)
+.+ +.+||+|||+++
T Consensus 138 ~~~-------g~vkL~DFGls~ 152 (669)
T cd05610 138 SNE-------GHIKLTDFGLSK 152 (669)
T ss_pred cCC-------CCEEEEeCCCCc
Confidence 877 789999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-32 Score=301.02 Aligned_cols=262 Identities=25% Similarity=0.318 Sum_probs=210.2
Q ss_pred CCCCCCCcceeeeecccCceEEEEEEECCc--cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeee
Q 001142 802 DPGSFPSLSSCDEAGKSVSSSLFRCKFGSA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGH 878 (1142)
Q Consensus 802 ~~~~~~~y~l~~~LG~GsfG~Vy~a~~~~~--~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~ 878 (1142)
+.....+|.+..+||+|+||.|.+|..+++ .+|+||.+.++.... ++.+-- +.|-++|.-. +-|.+++++.+
T Consensus 344 d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQd-DDvect----m~EKrvLAL~~kppFL~qlHSc 418 (683)
T KOG0696|consen 344 DRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQD-DDVECT----MVEKRVLALPGKPPFLVQLHSC 418 (683)
T ss_pred cceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeec-Ccccce----ehhhhheecCCCCchHHHHHHH
Confidence 345567899999999999999999988654 578887543332211 212111 4577777666 48899999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 001142 879 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 958 (1142)
Q Consensus 879 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~ 958 (1142)
|.+.+.+ |+||||+.||+|...|++. ..+.+..+..+|..|+-||-+||++|||+||||.+
T Consensus 419 FQTmDRL--------------yFVMEyvnGGDLMyhiQQ~-----GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLD 479 (683)
T KOG0696|consen 419 FQTMDRL--------------YFVMEYVNGGDLMYHIQQV-----GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLD 479 (683)
T ss_pred hhhhhhe--------------eeEEEEecCchhhhHHHHh-----cccCCchhhhhhHHHHHHhhhhhcCCeeeeecccc
Confidence 9876654 9999999999999999873 56889999999999999999999999999999999
Q ss_pred CeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001142 959 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1038 (1142)
Q Consensus 959 NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGv 1038 (1142)
|||++.+ +++||.|||+++.--.. .....+++|||.|+|||++.. .+|+..+|+|||||
T Consensus 480 NvmLd~e-------GHiKi~DFGmcKEni~~----------~~TTkTFCGTPdYiAPEIi~Y----qPYgksvDWWa~GV 538 (683)
T KOG0696|consen 480 NVMLDSE-------GHIKIADFGMCKENIFD----------GVTTKTFCGTPDYIAPEIIAY----QPYGKSVDWWAFGV 538 (683)
T ss_pred ceEeccC-------CceEeeecccccccccC----------CcceeeecCCCcccccceEEe----cccccchhHHHHHH
Confidence 9999998 89999999999753221 123346789999999999986 68999999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001142 1039 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1118 (1142)
Q Consensus 1039 iL~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~ 1118 (1142)
+||||+.|++||.+.++.++++.|....... + ...+.+..+++...|...|.
T Consensus 539 LLyEmlaGQpPFdGeDE~elF~aI~ehnvsy-P---------------------------KslSkEAv~ickg~ltK~P~ 590 (683)
T KOG0696|consen 539 LLYEMLAGQPPFDGEDEDELFQAIMEHNVSY-P---------------------------KSLSKEAVAICKGLLTKHPG 590 (683)
T ss_pred HHHHHHcCCCCCCCCCHHHHHHHHHHccCcC-c---------------------------ccccHHHHHHHHHHhhcCCc
Confidence 9999999999999999999998885432211 0 04566788899999999999
Q ss_pred CCCCH-----HHHHHHHHhhcCC
Q 001142 1119 ERPTA-----GDLYEMFVARTSS 1136 (1142)
Q Consensus 1119 ~RPSa-----~EVL~~L~~~~ss 1136 (1142)
+|... .+|-.|++++.-.
T Consensus 591 kRLGcg~~ge~di~~H~FFR~iD 613 (683)
T KOG0696|consen 591 KRLGCGPEGERDIREHPFFRRID 613 (683)
T ss_pred cccCCCCccccchhhCcchhhcc
Confidence 99543 6788888887543
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-31 Score=303.79 Aligned_cols=280 Identities=20% Similarity=0.237 Sum_probs=196.9
Q ss_pred CCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
-++|++.+.||+|+||.||+|... +..+++|...... ......+.+ .+|+.++++++||||+++++++....
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~----~~E~~~l~~l~hpniv~~~~~~~~~~ 82 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF--STPVLAKRT----YRELKLLKHLRHENIISLSDIFISPL 82 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccc--cccchhHHH----HHHHHHHHhcCCCCeeeEeeeEecCC
Confidence 356999999999999999999874 5567777643221 111222333 68999999999999999999886532
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
. ..++||||+ +++|.++++. ..+++..+..++.||+.||.|||++||+||||+|+||+++
T Consensus 83 ~-------------~~~lv~e~~-~~~L~~~~~~------~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~ 142 (328)
T cd07856 83 E-------------DIYFVTELL-GTDLHRLLTS------RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILIN 142 (328)
T ss_pred C-------------cEEEEeehh-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeEC
Confidence 1 358999999 5789888763 3578889999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.++|+|||.+...... .....++..|+|||++.+ ...++.++||||||+++|+|
T Consensus 143 ~~-------~~~~l~dfg~~~~~~~~-------------~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~il~el 199 (328)
T cd07856 143 EN-------CDLKICDFGLARIQDPQ-------------MTGYVSTRYYRAPEIMLT---WQKYDVEVDIWSAGCIFAEM 199 (328)
T ss_pred CC-------CCEEeCccccccccCCC-------------cCCCcccccccCceeeec---cCCcCcHHHHHHHHHHHHHH
Confidence 76 78999999998643221 112357888999998754 24578999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccc-ccc--CCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEV-AQS--GSGFEKPEAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
++|+.||...........+......................+ ... .............++.+.+++.+||+.+|++|
T Consensus 200 ~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 279 (328)
T cd07856 200 LEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKR 279 (328)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhC
Confidence 999999987655443333221111110100000000000000 000 00000001111346789999999999999999
Q ss_pred CCHHHHHHHHHhhc
Q 001142 1121 PTAGDLYEMFVART 1134 (1142)
Q Consensus 1121 PSa~EVL~~L~~~~ 1134 (1142)
||+++++.|+|+..
T Consensus 280 ~t~~ell~~~~~~~ 293 (328)
T cd07856 280 ISAAEALAHPYLAP 293 (328)
T ss_pred CCHHHHhcCCcccc
Confidence 99999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-32 Score=330.59 Aligned_cols=282 Identities=25% Similarity=0.341 Sum_probs=197.6
Q ss_pred CCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
+.+|+..+.||+||||.||+++. ++..+|+|-..++. ..... ..+.+|+..+++|+|||||++|..+.+..
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~---s~~~~----skI~rEVk~LArLnHpNVVRYysAWVEs~ 550 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA---SDKLY----SKILREVKLLARLNHPNVVRYYSAWVEST 550 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch---HHHHH----HHHHHHHHHHhhcCCcceeeeehhhhccC
Confidence 45679999999999999999997 68888888755442 11222 33479999999999999999997765321
Q ss_pred CC-C--------------C----------------------------------C---------------------CC---
Q 001142 884 WL-P--------------S----------------------------------A---------------------DG--- 890 (1142)
Q Consensus 884 ~~-~--------------~----------------------------------~---------------------~~--- 890 (1142)
.- + . . ++
T Consensus 551 ~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~ 630 (1351)
T KOG1035|consen 551 AELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNL 630 (1351)
T ss_pred CccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccc
Confidence 10 0 0 0 00
Q ss_pred --------------------------C-Cc-----cccceEEEEEeccCCCCHHHHHHHHhccCCCCC-CHHHHHHHHHH
Q 001142 891 --------------------------N-PE-----HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHV-SVKLALFIAQD 937 (1142)
Q Consensus 891 --------------------------~-~~-----~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~l-s~~~i~~Ia~q 937 (1142)
+ .+ .....+||-||||+..+|.+++++ +... .....++++++
T Consensus 631 S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~-----N~~~~~~d~~wrLFre 705 (1351)
T KOG1035|consen 631 SNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRR-----NHFNSQRDEAWRLFRE 705 (1351)
T ss_pred ccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHh-----cccchhhHHHHHHHHH
Confidence 0 00 012458999999997777777765 1222 47889999999
Q ss_pred HHHHHHHHHhCCccccCCCCCCeeeccccccCCCCCeEEEeecCCccccc----c---cccccccccC-CCCCCCCccCC
Q 001142 938 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR----S---FLHTCCIAHR-GIPAPDVCVGT 1009 (1142)
Q Consensus 938 Ia~gL~yLHs~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~----~---~~~~~~~~~~-~~~~~~~~~GT 1009 (1142)
|+.||.|+|++|||||||||.||+++.+ ..|||+|||+|+... . ....+..... ........+||
T Consensus 706 IlEGLaYIH~~giIHRDLKP~NIFLd~~-------~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGT 778 (1351)
T KOG1035|consen 706 ILEGLAYIHDQGIIHRDLKPRNIFLDSR-------NSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGT 778 (1351)
T ss_pred HHHHHHHHHhCceeeccCCcceeEEcCC-------CCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccce
Confidence 9999999999999999999999999977 789999999998722 0 0010111111 11134567899
Q ss_pred CcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccC
Q 001142 1010 PRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG 1089 (1142)
Q Consensus 1010 ~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~ 1089 (1142)
..|+|||++.+... ..|+.|+|+||+|||++||+ +||. +.++....+..-+.+.++..
T Consensus 779 alYvAPEll~~~~~-~~Yn~KiDmYSLGIVlFEM~---yPF~--TsMERa~iL~~LR~g~iP~~---------------- 836 (1351)
T KOG1035|consen 779 ALYVAPELLSDTSS-NKYNSKIDMYSLGIVLFEML---YPFG--TSMERASILTNLRKGSIPEP---------------- 836 (1351)
T ss_pred eeeecHHHhccccc-ccccchhhhHHHHHHHHHHh---ccCC--chHHHHHHHHhcccCCCCCC----------------
Confidence 99999999987432 47999999999999999998 4565 33443333333333333221
Q ss_pred CCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001142 1090 SGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1090 ~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~ 1133 (1142)
++......+.-..+|++|++.||.+||||.|+|++=++-
T Consensus 837 -----~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 837 -----ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred -----cccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 000112333457789999999999999999999876554
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=288.69 Aligned_cols=245 Identities=30% Similarity=0.358 Sum_probs=193.7
Q ss_pred ecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCCCCC
Q 001142 815 AGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 892 (1142)
Q Consensus 815 LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~~~~~~ 892 (1142)
||+|+||.||++.+. +..+++|+....... .......+ ..|+.++++++||||+++++.+....
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~----~~e~~~l~~l~h~~i~~~~~~~~~~~--------- 66 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKII-KRKEVEHT----LTERNILSRINHPFIVKLHYAFQTEE--------- 66 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhc-chHHHHHH----HHHHHHHHHcCCCcHHHHHHHeecCC---------
Confidence 799999999999984 667788875433211 11223333 78999999999999999999887654
Q ss_pred ccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccCCCC
Q 001142 893 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 972 (1142)
Q Consensus 893 ~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~~~~ 972 (1142)
..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.+
T Consensus 67 -----~~~~v~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~------- 129 (250)
T cd05123 67 -----KLYLVLEYAPGGELFSHLSK-----EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDAD------- 129 (250)
T ss_pred -----eeEEEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCC-------
Confidence 34999999999999999976 2368999999999999999999999999999999999999887
Q ss_pred CeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 001142 973 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1052 (1142)
Q Consensus 973 ~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~Pf~~ 1052 (1142)
+.++|+|||.+....... .......++..|+|||...+ ..++.++|+||||+++|+|++|+.||..
T Consensus 130 ~~~~l~d~~~~~~~~~~~----------~~~~~~~~~~~~~~Pe~~~~----~~~~~~~D~~slG~~~~~l~~g~~p~~~ 195 (250)
T cd05123 130 GHIKLTDFGLAKELSSEG----------SRTNTFCGTPEYLAPEVLLG----KGYGKAVDWWSLGVLLYEMLTGKPPFYA 195 (250)
T ss_pred CcEEEeecCcceecccCC----------CcccCCcCCccccChHHhCC----CCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 789999999987643321 01123457889999999875 4467899999999999999999999987
Q ss_pred CCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH---HHHHHH
Q 001142 1053 LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA---GDLYEM 1129 (1142)
Q Consensus 1053 ~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa---~EVL~~ 1129 (1142)
.+..+....+.... ...+ ...+..+.+++.+||..||++||++ .++++|
T Consensus 196 ~~~~~~~~~~~~~~-~~~~---------------------------~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~ 247 (250)
T cd05123 196 EDRKEIYEKILKDP-LRFP---------------------------EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAH 247 (250)
T ss_pred CCHHHHHHHHhcCC-CCCC---------------------------CCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence 66555544443321 1111 0235568999999999999999999 899999
Q ss_pred HHh
Q 001142 1130 FVA 1132 (1142)
Q Consensus 1130 L~~ 1132 (1142)
+||
T Consensus 248 ~~f 250 (250)
T cd05123 248 PFF 250 (250)
T ss_pred CCC
Confidence 986
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=310.25 Aligned_cols=254 Identities=24% Similarity=0.312 Sum_probs=203.8
Q ss_pred eeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCC
Q 001142 812 CDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSAD 889 (1142)
Q Consensus 812 ~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~~~ 889 (1142)
.++||.|-||+||-|++ .++.||||+.. +..........+ ..|++||.+++||.||.+...|++.+.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvId--KlrFp~kqesql----R~EVaILq~l~HPGiV~le~M~ET~er----- 637 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVID--KLRFPTKQESQL----RNEVAILQNLHHPGIVNLECMFETPER----- 637 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeee--cccCCCchHHHH----HHHHHHHHhcCCCCeeEEEEeecCCce-----
Confidence 48899999999999987 57888998843 333333333344 799999999999999999999987664
Q ss_pred CCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccC
Q 001142 890 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 969 (1142)
Q Consensus 890 ~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~ 969 (1142)
.++|||-+. |+...+|-. ....++++...+.++.||+.||.|||-++|+|+||||+|||+...
T Consensus 638 ---------vFVVMEKl~-GDMLEMILS---sEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~---- 700 (888)
T KOG4236|consen 638 ---------VFVVMEKLH-GDMLEMILS---SEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASA---- 700 (888)
T ss_pred ---------EEEEehhhc-chHHHHHHH---hhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccC----
Confidence 499999997 555555533 234679999999999999999999999999999999999999765
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001142 970 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1049 (1142)
Q Consensus 970 ~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~P 1049 (1142)
....++||||||+|+.+.+.. -....+|||.|.|||++.. ..|+..-|+||.|||+|--++|..|
T Consensus 701 ~~FPQvKlCDFGfARiIgEks-----------FRrsVVGTPAYLaPEVLrn----kGyNrSLDMWSVGVIiYVsLSGTFP 765 (888)
T KOG4236|consen 701 SPFPQVKLCDFGFARIIGEKS-----------FRRSVVGTPAYLAPEVLRN----KGYNRSLDMWSVGVIIYVSLSGTFP 765 (888)
T ss_pred CCCCceeeccccceeecchhh-----------hhhhhcCCccccCHHHHhh----ccccccccceeeeEEEEEEeccccc
Confidence 344789999999999876532 1235689999999999987 6789999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001142 1050 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1129 (1142)
Q Consensus 1050 f~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~ 1129 (1142)
|... .++.++|+.......+..|. ++++...+||..+|+..-.+|.|.+..+.|
T Consensus 766 FNEd--EdIndQIQNAaFMyPp~PW~------------------------eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 766 FNED--EDINDQIQNAAFMYPPNPWS------------------------EISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred CCCc--cchhHHhhccccccCCCchh------------------------hcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 9743 34566665443322221111 566779999999999999999999999999
Q ss_pred HHhhc
Q 001142 1130 FVART 1134 (1142)
Q Consensus 1130 L~~~~ 1134 (1142)
+|.+.
T Consensus 820 ~Wlq~ 824 (888)
T KOG4236|consen 820 PWLQD 824 (888)
T ss_pred hhhhc
Confidence 99874
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=298.33 Aligned_cols=266 Identities=27% Similarity=0.389 Sum_probs=201.4
Q ss_pred CcceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhh--CCCCCccceeeeEecCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGA--LRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~--L~HpNIVkl~g~~~~~~~~ 885 (1142)
+..+.+.||+|.||.||+|+|.+..||||+|.-. ++ + ++.+|.+|... |+|+||..|++.-..+.
T Consensus 212 qI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~sr------dE-~----SWfrEtEIYqTvmLRHENILgFIaaD~~~~-- 278 (513)
T KOG2052|consen 212 QIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSR------DE-R----SWFRETEIYQTVMLRHENILGFIAADNKDN-- 278 (513)
T ss_pred eeEEEEEecCccccceeeccccCCceEEEEeccc------ch-h----hhhhHHHHHHHHHhccchhhhhhhccccCC--
Confidence 4689999999999999999999999999998522 11 1 22466666654 59999999998755432
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CccccCCCC
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK--------HIMHRDIKS 957 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~--------gIvHrDLKp 957 (1142)
....++|||++|.+.|||+|++.+ ..++....++++..+|.||+|||.. .|.|||||+
T Consensus 279 --------gs~TQLwLvTdYHe~GSL~DyL~r------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKS 344 (513)
T KOG2052|consen 279 --------GSWTQLWLVTDYHEHGSLYDYLNR------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKS 344 (513)
T ss_pred --------CceEEEEEeeecccCCcHHHHHhh------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccccc
Confidence 235689999999999999999986 4689999999999999999999952 499999999
Q ss_pred CCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCC--CchhhHHH
Q 001142 958 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY--GLEVDIWS 1035 (1142)
Q Consensus 958 ~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~--s~ksDVwS 1035 (1142)
.||||..+ +++-|+|+|+|......... -....+..+||..|||||++........+ -..+||||
T Consensus 345 KNILVKkn-------~~C~IADLGLAv~h~~~t~~------idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYa 411 (513)
T KOG2052|consen 345 KNILVKKN-------GTCCIADLGLAVRHDSDTDT------IDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYA 411 (513)
T ss_pred ccEEEccC-------CcEEEeeceeeEEecccCCc------ccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHH
Confidence 99999988 89999999999876554322 11234567899999999999764322222 25799999
Q ss_pred HHHHHHHHHhC----------CCCCCC-----CCHHHHHHHH-HhCCCCCchhHHhhhcccccccccccCCCCCCchhhh
Q 001142 1036 YGCLLLELLTL----------QVPYMG-----LSELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 1099 (1142)
Q Consensus 1036 LGviL~ELLtG----------~~Pf~~-----~~~~el~~~I-~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 1099 (1142)
||.|+||++-+ +.||.+ .+..++.+.+ .+..+|.++..+. ..
T Consensus 412 fgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~----------------------s~ 469 (513)
T KOG2052|consen 412 FGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWK----------------------SD 469 (513)
T ss_pred HHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccc----------------------cC
Confidence 99999999853 567754 2233343333 2233343332221 22
Q ss_pred hhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001142 1100 ETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1100 ~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~~s 1135 (1142)
+....+.++++.||..+|..|-||--+-+.+-...+
T Consensus 470 ~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 470 PALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred HHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 666778999999999999999999888777766553
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=310.39 Aligned_cols=267 Identities=25% Similarity=0.299 Sum_probs=223.1
Q ss_pred CCCCCCCCCcceeeeecccCceEEEEEEECCcc--EEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceee
Q 001142 800 GLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSAD--AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 877 (1142)
Q Consensus 800 ~~~~~~~~~y~l~~~LG~GsfG~Vy~a~~~~~~--vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g 877 (1142)
.+....+.+++....||-|+||.|-++..+.+. .|+|+.+.+...+. .+.+. +..|-.||...+.|.||++|.
T Consensus 413 e~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdt-kQqeH----v~sEr~Im~~~~s~fIvrLYr 487 (732)
T KOG0614|consen 413 EFAQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDT-KQQEH----VFSERNIMMECRSDFIVRLYR 487 (732)
T ss_pred hhcccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccch-hHHHH----HHhHHHHHHhcCchHHHHHHH
Confidence 445667788899999999999999999887665 57776433322222 22222 258999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 001142 878 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 957 (1142)
Q Consensus 878 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp 957 (1142)
.|.++.++ |++||-|-||.|+..+++ ++.|+...++.++..++.|++|||++|||+|||||
T Consensus 488 Tfrd~kyv--------------YmLmEaClGGElWTiLrd-----Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKP 548 (732)
T KOG0614|consen 488 TFRDSKYV--------------YMLMEACLGGELWTILRD-----RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKP 548 (732)
T ss_pred Hhccchhh--------------hhhHHhhcCchhhhhhhh-----cCCcccchhhhhHHHHHHHHHHHHhcCceeccCCh
Confidence 99887755 999999999999999987 46899999999999999999999999999999999
Q ss_pred CCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHH
Q 001142 958 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1037 (1142)
Q Consensus 958 ~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLG 1037 (1142)
+|.|++.+ |.+||.|||+|+.+....+++ +++|||.|.|||++.. ...+.++|.||||
T Consensus 549 ENllLd~~-------Gy~KLVDFGFAKki~~g~KTw-----------TFcGTpEYVAPEIILn----KGHD~avDyWaLG 606 (732)
T KOG0614|consen 549 ENLLLDNR-------GYLKLVDFGFAKKIGSGRKTW-----------TFCGTPEYVAPEIILN----KGHDRAVDYWALG 606 (732)
T ss_pred hheeeccC-------CceEEeehhhHHHhccCCcee-----------eecCCcccccchhhhc----cCcchhhHHHHHH
Confidence 99999988 899999999999887766554 6789999999999987 5567999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001142 1038 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1117 (1142)
Q Consensus 1038 viL~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP 1117 (1142)
+++|||++|.+||.+.+++..+..|..+.... . .+..+.....++++++...+|
T Consensus 607 Ili~ELL~G~pPFs~~dpmktYn~ILkGid~i-----~---------------------~Pr~I~k~a~~Lik~LCr~~P 660 (732)
T KOG0614|consen 607 ILIYELLTGSPPFSGVDPMKTYNLILKGIDKI-----E---------------------FPRRITKTATDLIKKLCRDNP 660 (732)
T ss_pred HHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh-----h---------------------cccccchhHHHHHHHHHhcCc
Confidence 99999999999999999999988887664211 0 011455668899999999999
Q ss_pred CCCCC-----HHHHHHHHHhhcCCCC
Q 001142 1118 TERPT-----AGDLYEMFVARTSSSI 1138 (1142)
Q Consensus 1118 ~~RPS-----a~EVL~~L~~~~ss~~ 1138 (1142)
.+|.. +.+|-+|-||..-.+.
T Consensus 661 ~ERLG~~~~gI~DIkkH~Wf~gfdwe 686 (732)
T KOG0614|consen 661 TERLGYQKGGINDIKKHRWFEGFDWE 686 (732)
T ss_pred HhhhccccCChHHHHhhhhhhcCChh
Confidence 99975 8999999999876543
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=305.62 Aligned_cols=264 Identities=22% Similarity=0.331 Sum_probs=203.9
Q ss_pred CCcceeeeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~~-~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
..+.+.++||+|-||.|.++...+ ..||||+.+-.. ......+| .+|+++|.+++|||||+++|+|..++.+
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a---~~~~r~~F----~kEIkiLsqLkhPNIveLvGVC~~DePi 610 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA---TKNARNDF----LKEIKILSRLKHPNIVELLGVCVQDDPL 610 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCccc---chhHHHHH----HHHHHHHhccCCCCeeEEEeeeecCCch
Confidence 446899999999999999999865 788888754221 22333445 8999999999999999999999987755
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
++||||+++|+|.+++..... ..........|+.||+.|++||.+-++|||||.+.|+|++.+
T Consensus 611 --------------cmI~EYmEnGDLnqFl~ahea---pt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e 673 (807)
T KOG1094|consen 611 --------------CMITEYMENGDLNQFLSAHEL---PTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGE 673 (807)
T ss_pred --------------HHHHHHHhcCcHHHHHHhccC---cccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCc
Confidence 999999999999999987321 124556677899999999999999999999999999999988
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+++||+|||+++.+-..... ......+-...|||||.+.- ..++.++|||+||+++||+++
T Consensus 674 -------~~iKiadfgmsR~lysg~yy--------~vqgr~vlpiRwmawEsill----gkFttaSDvWafgvTlwE~~~ 734 (807)
T KOG1094|consen 674 -------FTIKIADFGMSRNLYSGDYY--------RVQGRAVLPIRWMAWESILL----GKFTTASDVWAFGVTLWEVFM 734 (807)
T ss_pred -------ccEEecCcccccccccCCce--------eeecceeeeeeehhHHHHHh----ccccchhhhhhhHHHHHHHHH
Confidence 89999999999865432211 11223456788999999876 678999999999999999877
Q ss_pred --CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1046 --LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1046 --G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
...||......++.+.....-...-.. + ....+.-++..+.+++.+||..|-.+||++
T Consensus 735 ~C~e~Py~~lt~e~vven~~~~~~~~~~~------------~--------~l~~P~~cp~~lyelml~Cw~~es~~RPsF 794 (807)
T KOG1094|consen 735 LCREQPYSQLTDEQVVENAGEFFRDQGRQ------------V--------VLSRPPACPQGLYELMLRCWRRESEQRPSF 794 (807)
T ss_pred HHhhCchhhhhHHHHHHhhhhhcCCCCcc------------e--------eccCCCcCcHHHHHHHHHHhchhhhcCCCH
Confidence 678998777766655432211100000 0 001112567789999999999999999999
Q ss_pred HHHHHHHHhh
Q 001142 1124 GDLYEMFVAR 1133 (1142)
Q Consensus 1124 ~EVL~~L~~~ 1133 (1142)
+++..++...
T Consensus 795 e~lh~~lq~~ 804 (807)
T KOG1094|consen 795 EQLHLFLQED 804 (807)
T ss_pred HHHHHHHHHh
Confidence 9998877643
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=293.96 Aligned_cols=268 Identities=22% Similarity=0.335 Sum_probs=200.2
Q ss_pred CCCcceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHh--hCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLG--ALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~--~L~HpNIVkl~g~~~~~~ 883 (1142)
.....+.++||+|.||.||+|...++.||||++.. .+.+.| ..|-+|.+ .++|+||++|+++-....
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~-------~~kqs~----~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t 277 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPE-------QEKQSF----QNEKNIYSLPGMKHENILQFIGAEKRGT 277 (534)
T ss_pred CCchhhHHHhhcCccceeehhhccCceeEEEecCH-------HHHHHH----HhHHHHHhccCccchhHHHhhchhccCC
Confidence 45678899999999999999999999999999753 334444 55655554 557999999998754321
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CccccC
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK---------HIMHRD 954 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~---------gIvHrD 954 (1142)
. ....++||+||.+.|||.+++.. ..++|....+|+..|++||+|||+. .|+|||
T Consensus 278 ---------~-~~~eywLVt~fh~kGsL~dyL~~------ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRD 341 (534)
T KOG3653|consen 278 ---------A-DRMEYWLVTEFHPKGSLCDYLKA------NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRD 341 (534)
T ss_pred ---------c-cccceeEEeeeccCCcHHHHHHh------ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCcccccc
Confidence 1 13467999999999999999986 4699999999999999999999962 699999
Q ss_pred CCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCC--CCCchhh
Q 001142 955 IKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN--LYGLEVD 1032 (1142)
Q Consensus 955 LKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~--~~s~ksD 1032 (1142)
||+.||||..+ .++.|+|||+|..+...... ......+||..|||||++.+...-. ..=.++|
T Consensus 342 lkSkNVLvK~D-------lTccIaDFGLAl~~~p~~~~--------~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~D 406 (534)
T KOG3653|consen 342 LKSKNVLVKND-------LTCCIADFGLALRLEPGKPQ--------GDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRID 406 (534)
T ss_pred ccccceEEccC-------CcEEeeccceeEEecCCCCC--------cchhhhhhhhhhcCHHHHhhhcccccHHHHHHHH
Confidence 99999999988 89999999999887643211 1112358999999999998743211 1115699
Q ss_pred HHHHHHHHHHHHhCCCCCC-C----------------CCHHHHHHHH-HhCCCCCchhHHhhhcccccccccccCCCCCC
Q 001142 1033 IWSYGCLLLELLTLQVPYM-G----------------LSELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEK 1094 (1142)
Q Consensus 1033 VwSLGviL~ELLtG~~Pf~-~----------------~~~~el~~~I-~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~ 1094 (1142)
|||+|.|||||+++..-+. + .+..++...+ ....+|.+++.+..
T Consensus 407 vYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~------------------ 468 (534)
T KOG3653|consen 407 VYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRK------------------ 468 (534)
T ss_pred HHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhc------------------
Confidence 9999999999998754332 1 1222333333 44445555543321
Q ss_pred chhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCC
Q 001142 1095 PEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSS 1137 (1142)
Q Consensus 1095 ~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~~ss~ 1137 (1142)
......+.+.+..||..||+.|.||.=|-+.++.....+
T Consensus 469 ----h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 469 ----HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred ----CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 144567899999999999999999988877776654433
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-32 Score=288.50 Aligned_cols=266 Identities=24% Similarity=0.318 Sum_probs=204.6
Q ss_pred CCcceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecCCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~~~~~~~ 885 (1142)
++++-...||.|+||+|++..++.....++++++..... ..+. .+++.|.+...+- +.||||++||....++
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq----~rll~e~d~~mks~~cp~IVkfyGa~F~EG-- 136 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQ----KRLLMEHDTVMKSSNCPNIVKFYGALFSEG-- 136 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHH----HHHHHHHHHHHhhcCCcHHHHHhhhhhcCC--
Confidence 445667889999999999999876555555555554333 2222 3447888776655 6999999999977554
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeeecc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILIDL 964 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs-~gIvHrDLKp~NILld~ 964 (1142)
..||.||+|+ .||..+.+..+.-....+++...-.|+.-.+.||.||-. ..|||||+||+|||++.
T Consensus 137 ------------dcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr 203 (361)
T KOG1006|consen 137 ------------DCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDR 203 (361)
T ss_pred ------------ceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEec
Confidence 2499999997 888887766555555679999999999999999999985 58999999999999998
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
. |.|||||||.+..+..... ...-+|-..|||||.+.... ..|+-++||||||++|||++
T Consensus 204 ~-------G~vKLCDFGIcGqLv~SiA-----------kT~daGCrpYmAPERi~p~~--~gyDiRSDvWSLGITL~EvA 263 (361)
T KOG1006|consen 204 H-------GDVKLCDFGICGQLVDSIA-----------KTVDAGCRPYMAPERIDPSD--KGYDIRSDVWSLGITLYEVA 263 (361)
T ss_pred C-------CCEeeecccchHhHHHHHH-----------hhhccCCccccChhccCCcc--CCcchhhhhhhhcceEeeee
Confidence 8 8899999999976544221 12336888899999987633 46899999999999999999
Q ss_pred hCCCCCCCCC-HHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1045 TLQVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1045 tG~~Pf~~~~-~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
||..|+.+.+ ..+....+..+.+|.+...... .+.+..+..+|..||..|-..||..
T Consensus 264 tG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~----------------------~~~s~~~~~fintCl~Kd~~~Rpky 321 (361)
T KOG1006|consen 264 TGNFPYRKWDSVFEQLCQVVIGDPPILLFDKEC----------------------VHYSFSMVRFINTCLIKDRSDRPKY 321 (361)
T ss_pred cCCCCcchHHHHHHHHHHHHcCCCCeecCcccc----------------------cccCHHHHHHHHHHhhcccccCcch
Confidence 9999998643 2334455566665554332211 2567789999999999999999999
Q ss_pred HHHHHHHHhhc
Q 001142 1124 GDLYEMFVART 1134 (1142)
Q Consensus 1124 ~EVL~~L~~~~ 1134 (1142)
.++.+++|-+.
T Consensus 322 ~~Lk~~~fyr~ 332 (361)
T KOG1006|consen 322 DDLKKFPFYRM 332 (361)
T ss_pred hhhhcCchhhh
Confidence 99999988653
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=312.07 Aligned_cols=212 Identities=25% Similarity=0.368 Sum_probs=169.3
Q ss_pred CCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
..|..-+.||+||||.||++++ .|..+|||.++.. ....+ .+ +..+|+++|++++|||||++++.-++...
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~--~~~r~-~e----~~~~EieilkKLnh~NIVk~f~iee~~~~ 85 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKE--SSLRP-RE----RWCREIEILKKLNHPNIVKLFDIEETKFL 85 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhh--cccch-HH----HHHHHHHHHHHcCchhhhhhcccCCcccc
Confidence 4467789999999999999997 5677888875432 22212 12 23689999999999999999987654321
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
+.-.....+|||||.||||...+++ ......+++.+.+.++.++..||.|||++|||||||||.||++..
T Consensus 86 --------~~~~~~~vlvmEyC~gGsL~~~L~~--PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~ 155 (732)
T KOG4250|consen 86 --------GLVTRLPVLVMEYCSGGSLRKVLNS--PENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQI 155 (732)
T ss_pred --------CcccccceEEEeecCCCcHHHHhcC--cccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEee
Confidence 0112245899999999999999986 334457999999999999999999999999999999999998854
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
.. ++.-..||+|||+|+.+.+... -...+||+.|.+||.+.. ...|+..+|.|||||++|+++
T Consensus 156 Ge---dgq~IyKLtDfG~Arel~d~s~-----------~~S~vGT~~YLhPel~E~---q~~y~~tVDLWS~GvtlY~ca 218 (732)
T KOG4250|consen 156 GE---DGQSIYKLTDFGAARELDDNSL-----------FTSLVGTEEYLHPELYER---QKKYTATVDLWSFGVTLYECA 218 (732)
T ss_pred cC---CCceEEeeecccccccCCCCCe-----------eeeecCchhhcChHHHhh---ccCcCceeehhhhhhHHHHHh
Confidence 31 2446789999999998776432 235689999999999874 367899999999999999999
Q ss_pred hCCCCCCC
Q 001142 1045 TLQVPYMG 1052 (1142)
Q Consensus 1045 tG~~Pf~~ 1052 (1142)
||..||..
T Consensus 219 TG~lPF~p 226 (732)
T KOG4250|consen 219 TGELPFIP 226 (732)
T ss_pred ccCCCCCc
Confidence 99999953
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=306.48 Aligned_cols=242 Identities=26% Similarity=0.267 Sum_probs=193.5
Q ss_pred CCCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEec
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 881 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~~~ 881 (1142)
..+.|++...+|.|+|+.|-.+.+ .+...+||+..-. .... .+|+.++... +||||+++.+.+.+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~--~~~~----------~~e~~~~~~~~~h~niv~~~~v~~~ 387 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR--ADDN----------QDEIPISLLVRDHPNIVKSHDVYED 387 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc--cccc----------ccccchhhhhcCCCcceeecceecC
Confidence 456799999999999999999987 4566788875322 1111 3677777666 69999999999886
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 001142 882 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 961 (1142)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NIL 961 (1142)
.. +.|+|||++.|+-+.+.+.. .+.....+..|+++|+.|+.|||++|||||||||+|||
T Consensus 388 ~~--------------~~~~v~e~l~g~ell~ri~~------~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL 447 (612)
T KOG0603|consen 388 GK--------------EIYLVMELLDGGELLRRIRS------KPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNIL 447 (612)
T ss_pred Cc--------------eeeeeehhccccHHHHHHHh------cchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhhee
Confidence 54 45999999999888777765 12333778889999999999999999999999999999
Q ss_pred ec-cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 962 ID-LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 962 ld-~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
++ .. ++++|+|||.++..... ....+-|..|.|||++.. ..|++++||||||++|
T Consensus 448 ~~~~~-------g~lrltyFG~a~~~~~~-------------~~tp~~t~~y~APEvl~~----~~yt~acD~WSLGvlL 503 (612)
T KOG0603|consen 448 LDGSA-------GHLRLTYFGFWSELERS-------------CDTPALTLQYVAPEVLAI----QEYTEACDWWSLGVLL 503 (612)
T ss_pred ecCCC-------CcEEEEEechhhhCchh-------------hcccchhhcccChhhhcc----CCCCcchhhHHHHHHH
Confidence 95 44 88999999999765542 113346889999999874 6899999999999999
Q ss_pred HHHHhCCCCCCCCCHH-HHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001142 1041 LELLTLQVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1119 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~~~~~-el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~ 1119 (1142)
|+|++|+.||...... ++...+..+.. . ...++..++|++.||+.||.+
T Consensus 504 y~ML~G~tp~~~~P~~~ei~~~i~~~~~---s---------------------------~~vS~~AKdLl~~LL~~dP~~ 553 (612)
T KOG0603|consen 504 YEMLTGRTLFAAHPAGIEIHTRIQMPKF---S---------------------------ECVSDEAKDLLQQLLQVDPAL 553 (612)
T ss_pred HHHHhCCCccccCCchHHHHHhhcCCcc---c---------------------------cccCHHHHHHHHHhccCChhh
Confidence 9999999999865443 44444433221 1 266778999999999999999
Q ss_pred CCCHHHHHHHHHh
Q 001142 1120 RPTAGDLYEMFVA 1132 (1142)
Q Consensus 1120 RPSa~EVL~~L~~ 1132 (1142)
||++.++..|+|+
T Consensus 554 Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 554 RLGADEIGAHPWF 566 (612)
T ss_pred CcChhhhccCcch
Confidence 9999999999999
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=292.60 Aligned_cols=285 Identities=20% Similarity=0.234 Sum_probs=203.3
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-C-CC----ccceeee
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-H-SC----IVEMYGH 878 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-H-pN----IVkl~g~ 878 (1142)
.+|.+...+|+|+||.|-.+.+. +..+|+||.+ ....+....+-|++++.++. + |+ +|++.++
T Consensus 89 ~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik---------~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w 159 (415)
T KOG0671|consen 89 NRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIK---------NVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDW 159 (415)
T ss_pred cceehhhhhcCCcccceEEEeecCCCceehHHHHH---------HHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence 57999999999999999999874 4567777632 12223333467999999994 2 33 6777777
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 001142 879 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 958 (1142)
Q Consensus 879 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~ 958 (1142)
|.-.+ +.|||+|.+ |-|+.+++.. ++..+++...++.|++|++.+++|||+.+++|.||||+
T Consensus 160 Fdyrg--------------hiCivfell-G~S~~dFlk~---N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPE 221 (415)
T KOG0671|consen 160 FDYRG--------------HICIVFELL-GLSTFDFLKE---NNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPE 221 (415)
T ss_pred hhccC--------------ceEEEEecc-ChhHHHHhcc---CCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChh
Confidence 76544 459999999 5799999976 56678999999999999999999999999999999999
Q ss_pred Ceeeccccc-------------cCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCC
Q 001142 959 NILIDLERK-------------KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 1025 (1142)
Q Consensus 959 NILld~~~~-------------~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~ 1025 (1142)
|||+..... .......|+++|||.|+..... ....+.|..|+|||++.+ -
T Consensus 222 NILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-------------hs~iVsTRHYRAPEViLg----L 284 (415)
T KOG0671|consen 222 NILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH-------------HSTIVSTRHYRAPEVILG----L 284 (415)
T ss_pred eEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccC-------------cceeeeccccCCchheec----c
Confidence 998854320 1122467999999999754331 124578999999999997 6
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhh-cc---------ccc-------cccccc
Q 001142 1026 LYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEAL-GS---------CHE-------HEVAQS 1088 (1142)
Q Consensus 1026 ~~s~ksDVwSLGviL~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~-~~---------~~~-------~~~~~~ 1088 (1142)
.++.++||||+||||.|+.||...|+..+..+-...+.....|......... .. |.+ ..+.+.
T Consensus 285 GwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ 364 (415)
T KOG0671|consen 285 GWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEP 364 (415)
T ss_pred CcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcC
Confidence 7899999999999999999999999876655533333332222222211111 00 000 000000
Q ss_pred CCCCCC-chhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001142 1089 GSGFEK-PEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1089 ~~~~~~-~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~~s 1135 (1142)
..+... ..........|.+|+++||..||.+|+|+.|++.|+||...
T Consensus 365 ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 365 CKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARL 412 (415)
T ss_pred CccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcC
Confidence 000000 00112344569999999999999999999999999999864
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=310.16 Aligned_cols=292 Identities=14% Similarity=0.103 Sum_probs=177.8
Q ss_pred CCCCCcceeeeecccCceEEEEEEEC------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceee
Q 001142 804 GSFPSLSSCDEAGKSVSSSLFRCKFG------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 877 (1142)
Q Consensus 804 ~~~~~y~l~~~LG~GsfG~Vy~a~~~------~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g 877 (1142)
...++|++.++||+|+||.||+|++. +..+|+|.. ... ... +.. ..| .+....+.+++.++.
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~--~~~--~~~--e~~----~~e--~l~~~~~~~~~~~~~ 196 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKA--TEY--GAV--EIW----MNE--RVRRACPNSCADFVY 196 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEe--ccc--chh--HHH----HHH--HHHhhchhhHHHHHH
Confidence 45678999999999999999999984 446777753 221 111 111 111 122223344444333
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc---------------CCCCCCHHHHHHHHHHHHHHH
Q 001142 878 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET---------------GEKHVSVKLALFIAQDVAAAL 942 (1142)
Q Consensus 878 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~---------------~~~~ls~~~i~~Ia~qIa~gL 942 (1142)
.+..... .......++||||+++++|.++++..... .........+..|+.||+.||
T Consensus 197 ~~~~~~~--------~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL 268 (566)
T PLN03225 197 GFLEPVS--------SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFAL 268 (566)
T ss_pred hhhcccc--------cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHH
Confidence 3221110 01223569999999999999998752100 001122345678999999999
Q ss_pred HHHHhCCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhcccc
Q 001142 943 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1022 (1142)
Q Consensus 943 ~yLHs~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~ 1022 (1142)
.|||+++|+||||||+|||++.+. +.+||+|||+|+.+..... .......+|+.|+|||.+....
T Consensus 269 ~yLH~~gIiHRDLKP~NILl~~~~------~~~KL~DFGlA~~l~~~~~---------~~~~~~~~t~~Y~APE~~~~~~ 333 (566)
T PLN03225 269 DGLHSTGIVHRDVKPQNIIFSEGS------GSFKIIDLGAAADLRVGIN---------YIPKEFLLDPRYAAPEQYIMST 333 (566)
T ss_pred HHHHHCCEEeCcCCHHHEEEeCCC------CcEEEEeCCCccccccccc---------cCCcccccCCCccChHHhhccC
Confidence 999999999999999999998542 6799999999975433211 1223456899999999764321
Q ss_pred CC------------------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccccccc
Q 001142 1023 KP------------------NLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHE 1084 (1142)
Q Consensus 1023 ~~------------------~~~s~ksDVwSLGviL~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~ 1084 (1142)
.. ..++.++|||||||++|||+++..|+.. ........+.........+. .... ...
T Consensus 334 ~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~-~~~~~~~~l~~~~~~~~~~~-~~~~---~~~ 408 (566)
T PLN03225 334 QTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDS-NLIQFNRQLKRNDYDLVAWR-KLVE---PRA 408 (566)
T ss_pred CCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCch-HHHHHHHHHHhcCCcHHHHH-Hhhc---ccc
Confidence 10 1244577999999999999997766542 12222223322221111100 0000 000
Q ss_pred ccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCCC
Q 001142 1085 VAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSSI 1138 (1142)
Q Consensus 1085 ~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~~ss~~ 1138 (1142)
.......+... ........+|+.+||+.||.+|||+.|+++|+|+......
T Consensus 409 ~~~~~~~~~~~---d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~~~ 459 (566)
T PLN03225 409 SPDLRRGFEVL---DLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDREGLL 459 (566)
T ss_pred chhhhhhhhhc---cccchHHHHHHHHHccCCcccCCCHHHHhCCcCcCCCCcc
Confidence 00000000000 0123346789999999999999999999999999876554
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-30 Score=300.35 Aligned_cols=253 Identities=23% Similarity=0.318 Sum_probs=204.7
Q ss_pred cceeeeecccCceEEEEEEEC------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001142 809 LSSCDEAGKSVSSSLFRCKFG------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 882 (1142)
Q Consensus 809 y~l~~~LG~GsfG~Vy~a~~~------~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~ 882 (1142)
....++||+|+||+||+|.|- +.+||+|++.-. .......++ ++|+.+|.++.||||++++|++..+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~---t~~~~s~e~----LdeAl~masldHpnl~RLLgvc~~s 770 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF---TSPKASIEL----LDEALRMASLDHPNLLRLLGVCMLS 770 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeecc---CCchhhHHH----HHHHHHHhcCCCchHHHHhhhcccc
Confidence 467799999999999999982 346777765322 222333444 7999999999999999999998754
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
. +.||++|+|.|+|.++++.. +..+-.+..+.|..|||+||.|||.+++|||||-+.||||
T Consensus 771 ~---------------~qlvtq~mP~G~LlDyvr~h----r~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLV 831 (1177)
T KOG1025|consen 771 T---------------LQLVTQLMPLGCLLDYVREH----RDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLV 831 (1177)
T ss_pred h---------------HHHHHHhcccchHHHHHHHh----hccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheee
Confidence 3 37999999999999999863 3568889999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
..- ..+|+.|||+|+.+......... ....-.+.|||-|.+.. ..|+.++|||||||++||
T Consensus 832 ksP-------~hvkitdfgla~ll~~d~~ey~~--------~~gK~pikwmale~i~~----~~~thqSDVWsfGVtiWE 892 (1177)
T KOG1025|consen 832 KSP-------NHVKITDFGLAKLLAPDEKEYSA--------PGGKVPIKWMALESIRI----RKYTHQSDVWSFGVTIWE 892 (1177)
T ss_pred cCC-------CeEEEEecchhhccCcccccccc--------cccccCcHHHHHHHhhc----cCCCchhhhhhhhhhHHH
Confidence 876 78999999999887654432211 11123566999998875 689999999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1043 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1043 LLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
++| |..|+.+.+..++.+.+..+.+..-+ ..++.++..++.+||..|+..||
T Consensus 893 lmTFGa~Py~gi~~~eI~dlle~geRLsqP---------------------------piCtiDVy~~mvkCwmid~~~rp 945 (1177)
T KOG1025|consen 893 LMTFGAKPYDGIPAEEIPDLLEKGERLSQP---------------------------PICTIDVYMVMVKCWMIDADSRP 945 (1177)
T ss_pred HHhcCCCccCCCCHHHhhHHHhccccCCCC---------------------------CCccHHHHHHHHHHhccCcccCc
Confidence 999 99999999999888888776652211 15566789999999999999999
Q ss_pred CHHHHHHHHHhh
Q 001142 1122 TAGDLYEMFVAR 1133 (1142)
Q Consensus 1122 Sa~EVL~~L~~~ 1133 (1142)
+|+++...+-..
T Consensus 946 ~fkel~~~fs~~ 957 (1177)
T KOG1025|consen 946 TFKELAEEFSRM 957 (1177)
T ss_pred cHHHHHHHHHHH
Confidence 999998866544
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-30 Score=278.00 Aligned_cols=227 Identities=20% Similarity=0.144 Sum_probs=172.8
Q ss_pred cCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCCCCCccc
Q 001142 818 SVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHH 895 (1142)
Q Consensus 818 GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~~~~~~~~~ 895 (1142)
|.+|.||+|++ .+..+|+|..... . .+ .+|...+....||||+++++++.+..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~--~-------~~----~~~~~~~~~~~~~~i~~~~~~~~~~~------------ 58 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKS--S-------EY----SRERLTIIPHCVPNMVCLHKYIVSED------------ 58 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecch--h-------hh----hhHHHHHHhcCCCceeehhhheecCC------------
Confidence 89999999998 4556777764321 1 11 24555555667999999999987644
Q ss_pred cceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccCCCCCeE
Q 001142 896 LLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 975 (1142)
Q Consensus 896 ~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~~~~~~v 975 (1142)
..++||||+++++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+||+++.+ +.+
T Consensus 59 --~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~-------~~~ 124 (237)
T cd05576 59 --SVFLVLQHAEGGKLWSHISK-----FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDR-------GHI 124 (237)
T ss_pred --eEEEEEecCCCCCHHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCC-------CCE
Confidence 34999999999999999875 2358999999999999999999999999999999999999887 789
Q ss_pred EEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 001142 976 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSE 1055 (1142)
Q Consensus 976 KL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~Pf~~~~~ 1055 (1142)
+++|||.+....... ....++..|+|||++.. ..++.++||||+|+++|||++|..|+.....
T Consensus 125 ~l~df~~~~~~~~~~-------------~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~il~el~~g~~~~~~~~~ 187 (237)
T cd05576 125 QLTYFSRWSEVEDSC-------------DGEAVENMYCAPEVGGI----SEETEACDWWSLGAILFELLTGKTLVECHPS 187 (237)
T ss_pred EEecccchhcccccc-------------ccCCcCccccCCcccCC----CCCCchhhHHHHHHHHHHHHHCcchhhcCch
Confidence 999999875443211 11235677999998764 4578899999999999999999988753211
Q ss_pred HHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH-----HHHHHHH
Q 001142 1056 LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA-----GDLYEMF 1130 (1142)
Q Consensus 1056 ~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa-----~EVL~~L 1130 (1142)
. +....... .+...++.+.+++.+||+.||++||++ +++++|+
T Consensus 188 -~----~~~~~~~~---------------------------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~ 235 (237)
T cd05576 188 -G----INTHTTLN---------------------------IPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHP 235 (237)
T ss_pred -h----cccccccC---------------------------CcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCC
Confidence 0 00000000 001345668999999999999999996 9999998
Q ss_pred Hh
Q 001142 1131 VA 1132 (1142)
Q Consensus 1131 ~~ 1132 (1142)
|+
T Consensus 236 ~~ 237 (237)
T cd05576 236 FF 237 (237)
T ss_pred CC
Confidence 85
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=288.35 Aligned_cols=280 Identities=21% Similarity=0.224 Sum_probs=214.8
Q ss_pred CCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
++|-+.++||+|+|+.||+|.+ ....|||||-.+.+.. ..+..+++..-..+|.+|.+.|.||.||++|++|.-+..
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~W-rdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNW-RDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccch-hhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 3589999999999999999987 5778999997766432 223344566667899999999999999999999875432
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC--CccccCCCCCCeee
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK--HIMHRDIKSENILI 962 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~--gIvHrDLKp~NILl 962 (1142)
.+|-|+|||+|.+|.-|++. ...+++++++.|+.||+.||.||.+. .|||-||||.|||+
T Consensus 542 -------------sFCTVLEYceGNDLDFYLKQ-----hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILL 603 (775)
T KOG1151|consen 542 -------------SFCTVLEYCEGNDLDFYLKQ-----HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILL 603 (775)
T ss_pred -------------cceeeeeecCCCchhHHHHh-----hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEE
Confidence 24999999999999999987 35789999999999999999999975 79999999999988
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
-... ..|.+||.|||+++.+...... ...+........||.+|.+||.+.-.......+.|+||||.|||+|.
T Consensus 604 v~Gt----acGeIKITDFGLSKIMdddSy~---~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQ 676 (775)
T KOG1151|consen 604 VNGT----ACGEIKITDFGLSKIMDDDSYN---SVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQ 676 (775)
T ss_pred ecCc----ccceeEeeecchhhhccCCccC---cccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhh
Confidence 5432 2378999999999987664432 22344455667899999999998765555678999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1043 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1043 LLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
.+.|+.||......+ +.+......... +...|.. ...+.+..+||++||++.-++|..
T Consensus 677 ClYGrKPFGhnqsQQ--dILqeNTIlkAt-------------------EVqFP~K-PvVsseAkaFIRRCLaYRKeDR~D 734 (775)
T KOG1151|consen 677 CLYGRKPFGHNQSQQ--DILQENTILKAT-------------------EVQFPPK-PVVSSEAKAFIRRCLAYRKEDRID 734 (775)
T ss_pred hhccCCCCCCchhHH--HHHhhhchhcce-------------------eccCCCC-CccCHHHHHHHHHHHHhhhhhhhh
Confidence 999999996532211 111111100000 0001110 145667899999999999999999
Q ss_pred HHHHHHHHHhhc
Q 001142 1123 AGDLYEMFVART 1134 (1142)
Q Consensus 1123 a~EVL~~L~~~~ 1134 (1142)
..++..++++..
T Consensus 735 V~qLA~dpyllP 746 (775)
T KOG1151|consen 735 VQQLACDPYLLP 746 (775)
T ss_pred HHHHccCccccc
Confidence 999999988754
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-29 Score=306.16 Aligned_cols=259 Identities=25% Similarity=0.410 Sum_probs=201.7
Q ss_pred CcceeeeecccCceEEEEEEEC----C---ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeE
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFG----S---ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHK 879 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~----~---~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~g~~ 879 (1142)
+..+.+.||+|+||.|++|... . ..+.|+++.++..... .+.+.+ ..|+.+|+.+. ||||+.++|++
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~----~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDL----MSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHH----HHHHHHHHHhcCCcchhhheeee
Confidence 3467779999999999999742 1 1333444434443333 445555 89999999995 99999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHh---------ccCC--CCCCHHHHHHHHHHHHHHHHHHHhC
Q 001142 880 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS---------ETGE--KHVSVKLALFIAQDVAAALVELHSK 948 (1142)
Q Consensus 880 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~---------~~~~--~~ls~~~i~~Ia~qIa~gL~yLHs~ 948 (1142)
.....+ ++|+||+..|+|.++++..+ .... ..++..+...++.|||.|++||++.
T Consensus 372 t~~~~~--------------~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~ 437 (609)
T KOG0200|consen 372 TQDGPL--------------YVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV 437 (609)
T ss_pred ccCCce--------------EEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC
Confidence 875533 99999999999999998754 1111 1389999999999999999999999
Q ss_pred CccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccC--CCcccchhhhccccCCCC
Q 001142 949 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG--TPRWMAPEVLRAMHKPNL 1026 (1142)
Q Consensus 949 gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~G--T~~Y~APE~l~~~~~~~~ 1026 (1142)
++|||||-+.|||+..+ ..+||+|||+|+.......... ....| ...|||||.+.. ..
T Consensus 438 ~~vHRDLAaRNVLi~~~-------~~~kIaDFGlar~~~~~~~y~~---------~~~~~~LP~kWmApEsl~~----~~ 497 (609)
T KOG0200|consen 438 PCVHRDLAARNVLITKN-------KVIKIADFGLARDHYNKDYYRT---------KSSAGTLPVKWMAPESLFD----RV 497 (609)
T ss_pred CccchhhhhhhEEecCC-------CEEEEccccceeccCCCCceEe---------cCCCCccceeecCHHHhcc----Cc
Confidence 99999999999999987 7899999999985433221100 01112 334999999986 67
Q ss_pred CCchhhHHHHHHHHHHHHh-CCCCCCCCC-HHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHH
Q 001142 1027 YGLEVDIWSYGCLLLELLT-LQVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF 1104 (1142)
Q Consensus 1027 ~s~ksDVwSLGviL~ELLt-G~~Pf~~~~-~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1104 (1142)
|+.++|||||||+|||++| |..||.+.. ..++.+.+..|.+...+. .+.++
T Consensus 498 ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~r~~~P~---------------------------~c~~e 550 (609)
T KOG0200|consen 498 FTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGNRMEQPE---------------------------HCSDE 550 (609)
T ss_pred ccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCCCCCCCC---------------------------CCCHH
Confidence 9999999999999999999 899998755 556666777776644332 55677
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 001142 1105 LVDVFRRCTEENPTERPTAGDLYEMFVA 1132 (1142)
Q Consensus 1105 L~dLI~~CL~~DP~~RPSa~EVL~~L~~ 1132 (1142)
+.+++..||+.+|++||++.++.+.+..
T Consensus 551 iY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 551 IYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred HHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 8999999999999999999999887655
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-30 Score=264.00 Aligned_cols=280 Identities=20% Similarity=0.275 Sum_probs=205.1
Q ss_pred CCCCCCCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceee
Q 001142 801 LDPGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYG 877 (1142)
Q Consensus 801 ~~~~~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~g 877 (1142)
++-+..++|++.+++|+|-|+.||.|.. +...+.+|+.+ +-..+.+ .+|+.||..|. ||||+++++
T Consensus 32 i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK-------PVkkkKI----kREikIL~nL~gg~NIi~L~D 100 (338)
T KOG0668|consen 32 IDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILK-------PVKKKKI----KREIKILQNLRGGPNIIKLLD 100 (338)
T ss_pred eeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeec-------hHHHHHH----HHHHHHHHhccCCCCeeehhh
Confidence 3445678999999999999999999985 66778888743 1222333 79999999996 999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 001142 878 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 957 (1142)
Q Consensus 878 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp 957 (1142)
...+...- ...||+||+.+.+...+... ++...++.++.+++.||.|+|++||+|||+||
T Consensus 101 iV~Dp~Sk------------tpaLiFE~v~n~Dfk~ly~t--------l~d~dIryY~~elLkALdyCHS~GImHRDVKP 160 (338)
T KOG0668|consen 101 IVKDPESK------------TPSLIFEYVNNTDFKQLYPT--------LTDYDIRYYIYELLKALDYCHSMGIMHRDVKP 160 (338)
T ss_pred hhcCcccc------------CchhHhhhhccccHHHHhhh--------hchhhHHHHHHHHHHHHhHHHhcCcccccCCc
Confidence 98875422 34899999998887776543 78889999999999999999999999999999
Q ss_pred CCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHH
Q 001142 958 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1037 (1142)
Q Consensus 958 ~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLG 1037 (1142)
+|+|||... -.++|+|+|+|........ .+..+.+.+|.-||.+... ..|+..-|+||||
T Consensus 161 hNvmIdh~~------rkLrlIDWGLAEFYHp~~e-----------YnVRVASRyfKGPELLVdy---~~YDYSLD~WS~G 220 (338)
T KOG0668|consen 161 HNVMIDHEL------RKLRLIDWGLAEFYHPGKE-----------YNVRVASRYFKGPELLVDY---QMYDYSLDMWSLG 220 (338)
T ss_pred ceeeechhh------ceeeeeecchHhhcCCCce-----------eeeeeehhhcCCchheeec---hhccccHHHHHHH
Confidence 999998764 5799999999976543221 2345678889999998873 4678899999999
Q ss_pred HHHHHHHhCCCCCC-CCCHHHHHHHHHh-CCCCC-----------chhHHhhhcccccccccccCCCCCCchhhhhhHHH
Q 001142 1038 CLLLELLTLQVPYM-GLSELEIHDLIQM-GKRPR-----------LTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF 1104 (1142)
Q Consensus 1038 viL~ELLtG~~Pf~-~~~~~el~~~I~~-~~~p~-----------l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1104 (1142)
|++..|+..+.||. +.+..+..-.|.. -.... ++..+..+- .....+....+...+...-.+++
T Consensus 221 cmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~---~~~~rk~w~~Fi~~~n~hl~~pe 297 (338)
T KOG0668|consen 221 CMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDIL---GRHSRKPWSRFINSENQHLVSPE 297 (338)
T ss_pred HHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHh---hccccccHHHhCCccccccCChH
Confidence 99999999999984 3332222222211 11111 111111110 01111122222222222334578
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001142 1105 LVDVFRRCTEENPTERPTAGDLYEMFVART 1134 (1142)
Q Consensus 1105 L~dLI~~CL~~DP~~RPSa~EVL~~L~~~~ 1134 (1142)
..+|+.+.|..|..+|+||.|++.|++|..
T Consensus 298 aiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 298 AIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred HHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 999999999999999999999999999974
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=262.50 Aligned_cols=241 Identities=33% Similarity=0.423 Sum_probs=187.9
Q ss_pred CceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCCCCCcccc
Q 001142 819 VSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896 (1142)
Q Consensus 819 sfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~~~~~~~~~~ 896 (1142)
+||.||+|.+. +..+++|+...... ... .+.+ .+|++.+++++|+||+++++++....
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~--~~~-~~~~----~~e~~~~~~l~~~~i~~~~~~~~~~~------------- 60 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKI--KKK-RERI----LREISILKKLKHPNIVRLYDVFEDED------------- 60 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEeccccc--ccH-HHHH----HHHHHHHHhCCCCcHHHHHhheeeCC-------------
Confidence 58999999985 46788887543321 111 3344 78999999999999999999987643
Q ss_pred ceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccCCCCCeEE
Q 001142 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 976 (1142)
Q Consensus 897 ~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~~~~~~vK 976 (1142)
..++||||+++++|.+++... ..+++..+..++.+++.++.|||+.+|+|+||+|.||+++.+ +.++
T Consensus 61 -~~~l~~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~-------~~~~ 127 (244)
T smart00220 61 -KLYLVMEYCDGGDLFDLLKKR-----GRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDED-------GHVK 127 (244)
T ss_pred -EEEEEEeCCCCCCHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCC-------CcEE
Confidence 459999999988999998761 238999999999999999999999999999999999999887 7899
Q ss_pred EeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCH
Q 001142 977 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG-LSE 1055 (1142)
Q Consensus 977 L~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~Pf~~-~~~ 1055 (1142)
|+|||.+....... ......++..|++||.... ..++.++||||||+++++|++|..||.. ...
T Consensus 128 l~d~~~~~~~~~~~-----------~~~~~~~~~~~~~pE~~~~----~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~ 192 (244)
T smart00220 128 LADFGLARQLDPGG-----------LLTTFVGTPEYMAPEVLLG----KGYGKAVDVWSLGVILYELLTGKPPFPGDDQL 192 (244)
T ss_pred Eccccceeeecccc-----------ccccccCCcCCCCHHHHcc----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 99999997654321 1123457889999999874 5677899999999999999999999976 344
Q ss_pred HHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 001142 1056 LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVA 1132 (1142)
Q Consensus 1056 ~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~ 1132 (1142)
....+.+.......... ....+..+.+++.+||..+|++||++.++++|+|+
T Consensus 193 ~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 193 LELFKKIGKPKPPFPPP-------------------------EWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred HHHHHHHhccCCCCccc-------------------------cccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 44444433322211000 00145679999999999999999999999999875
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=287.22 Aligned_cols=268 Identities=22% Similarity=0.257 Sum_probs=197.0
Q ss_pred cceeeeecccCceEEEEEEECCc--cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCC
Q 001142 809 LSSCDEAGKSVSSSLFRCKFGSA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 886 (1142)
Q Consensus 809 y~l~~~LG~GsfG~Vy~a~~~~~--~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~ 886 (1142)
|..++.||-|+||.|.+++..++ .+|.|. +++.. .-.++--.-+..|-.||.....+-||++|-.|.+.+.+
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKT--LrKaD---Vl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnL- 704 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKT--LRKAD---VLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL- 704 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhh--hHHHH---HHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCce-
Confidence 57889999999999999986443 455554 33211 11111112336788999999999999999999987755
Q ss_pred CCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecccc
Q 001142 887 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 966 (1142)
Q Consensus 887 ~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~ 966 (1142)
|+||+|++||++.+++-+ .+.|++..++.++..+..|+++.|..|+|||||||+|||||.+
T Consensus 705 -------------YFVMdYIPGGDmMSLLIr-----mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrd- 765 (1034)
T KOG0608|consen 705 -------------YFVMDYIPGGDMMSLLIR-----MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRD- 765 (1034)
T ss_pred -------------EEEEeccCCccHHHHHHH-----hccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccC-
Confidence 999999999999999876 3579999999999999999999999999999999999999998
Q ss_pred ccCCCCCeEEEeecCCcccccccccccccccCC--------------------------------CCCCCCccCCCcccc
Q 001142 967 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--------------------------------IPAPDVCVGTPRWMA 1014 (1142)
Q Consensus 967 ~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~--------------------------------~~~~~~~~GT~~Y~A 1014 (1142)
|++||.|||+++-+.......++..+. .......+||+.|+|
T Consensus 766 ------GHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyia 839 (1034)
T KOG0608|consen 766 ------GHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIA 839 (1034)
T ss_pred ------CceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccC
Confidence 999999999997554322211111100 001124589999999
Q ss_pred hhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhCCCCCchhHHhhhcccccccccccCCCCC
Q 001142 1015 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFE 1093 (1142)
Q Consensus 1015 PE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~Pf~~~~~~el~~~I-~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~ 1093 (1142)
||++.. ..|+..+|+||.|||||||+.|++||....+.+....| .+.....++.
T Consensus 840 pevl~r----~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~--------------------- 894 (1034)
T KOG0608|consen 840 PEVLAR----TGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPY--------------------- 894 (1034)
T ss_pred hHHhcc----cCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhcccccc---------------------
Confidence 999986 67899999999999999999999999876665543332 2222211111
Q ss_pred CchhhhhhHHHHHHHHHHhcccCCCCCC---CHHHHHHHHHhhcCCC
Q 001142 1094 KPEAELETLSFLVDVFRRCTEENPTERP---TAGDLYEMFVARTSSS 1137 (1142)
Q Consensus 1094 ~~~~~~~~~~~L~dLI~~CL~~DP~~RP---Sa~EVL~~L~~~~ss~ 1137 (1142)
....+++..++|.++.. +++.|. -++||-.|+||+.-..
T Consensus 895 ----~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgIDf 936 (1034)
T KOG0608|consen 895 ----QGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGIDF 936 (1034)
T ss_pred ----ccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccccch
Confidence 11455667777765442 455664 5778999999986543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-30 Score=302.75 Aligned_cols=260 Identities=26% Similarity=0.329 Sum_probs=192.5
Q ss_pred cceeeeecccCceE-EEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecCCCCC
Q 001142 809 LSSCDEAGKSVSSS-LFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLP 886 (1142)
Q Consensus 809 y~l~~~LG~GsfG~-Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~~~~~~~~ 886 (1142)
|.-.+.+|.|+.|+ ||+|.+.++.||||.+. .++...+.+|+..|+.- .|||||++|+.-.++.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll-----------~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~q--- 576 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLL-----------EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQ--- 576 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCCceehHHHHh-----------hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCc---
Confidence 45668899999987 89999999988888642 12222347999999888 4999999998766555
Q ss_pred CCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecccc
Q 001142 887 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 966 (1142)
Q Consensus 887 ~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~ 966 (1142)
+.||..|+|. .+|.++++... ...........+.++.|++.||+|||+-+||||||||+||||+...
T Consensus 577 -----------F~YIalELC~-~sL~dlie~~~-~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~ 643 (903)
T KOG1027|consen 577 -----------FLYIALELCA-CSLQDLIESSG-LDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPS 643 (903)
T ss_pred -----------eEEEEehHhh-hhHHHHHhccc-cchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccC
Confidence 4599999997 99999998631 1111111144577899999999999999999999999999998641
Q ss_pred ccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001142 967 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1046 (1142)
Q Consensus 967 ~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG 1046 (1142)
..+...++|+|||+++.+....... .......||-+|+|||++.... -+.++||||+||++|+.++|
T Consensus 644 --~~~~~ra~iSDfglsKkl~~~~sS~-------~r~s~~sGt~GW~APE~L~~~~----~~~avDiFslGCvfyYvltg 710 (903)
T KOG1027|consen 644 --ADGTLRAKISDFGLSKKLAGGKSSF-------SRLSGGSGTSGWQAPEQLREDR----KTQAVDIFSLGCVFYYVLTG 710 (903)
T ss_pred --CCcceeEEecccccccccCCCcchh-------hcccCCCCcccccCHHHHhccc----cCcccchhhcCceEEEEecC
Confidence 2334789999999999876543221 1234567999999999998733 35699999999999999995
Q ss_pred -CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001142 1047 -QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1125 (1142)
Q Consensus 1047 -~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~E 1125 (1142)
.+||... .+....|..+...... . ....++ ...+||.+|+.+||..||+|.+
T Consensus 711 G~HpFGd~--~~R~~NIl~~~~~L~~----------------L-------~~~~d~--eA~dLI~~ml~~dP~~RPsa~~ 763 (903)
T KOG1027|consen 711 GSHPFGDS--LERQANILTGNYTLVH----------------L-------EPLPDC--EAKDLISRMLNPDPQLRPSATD 763 (903)
T ss_pred CccCCCch--HHhhhhhhcCccceee----------------e-------ccCchH--HHHHHHHHhcCCCcccCCCHHH
Confidence 9999742 2222333333221100 0 000011 6899999999999999999999
Q ss_pred HHHHHHhhcC
Q 001142 1126 LYEMFVARTS 1135 (1142)
Q Consensus 1126 VL~~L~~~~s 1135 (1142)
|+.||+|..+
T Consensus 764 VL~HPlFW~~ 773 (903)
T KOG1027|consen 764 VLNHPLFWDS 773 (903)
T ss_pred HhCCCccCCh
Confidence 9999998755
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-29 Score=267.06 Aligned_cols=259 Identities=22% Similarity=0.334 Sum_probs=199.1
Q ss_pred CCCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEe
Q 001142 804 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 880 (1142)
Q Consensus 804 ~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~~ 880 (1142)
..+.+|.+.++||+|+|..|.+++.. .+-+|+|+.+.+.. +.++.- .+++.|-.+..+. +||.+|-++.+|.
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~--nddedi---dwvqtek~vfe~asn~pflvglhscfq 321 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELV--NDDEDI---DWVQTEKHVFEQASNNPFLVGLHSCFQ 321 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhc--CCcccc---hhHHhhHHHHHhccCCCeEEehhhhhc
Confidence 34778999999999999999999875 45567776443322 222211 2346788888777 5999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NI 960 (1142)
++..+ ++|.||++||+|.-++++ ...++++.++.+...|..||.|||++|||+||||.+||
T Consensus 322 tesrl--------------ffvieyv~ggdlmfhmqr-----qrklpeeharfys~ei~lal~flh~rgiiyrdlkldnv 382 (593)
T KOG0695|consen 322 TESRL--------------FFVIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNV 382 (593)
T ss_pred ccceE--------------EEEEEEecCcceeeehhh-----hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccce
Confidence 77644 999999999999888876 35699999999999999999999999999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
|+|.+ +++||.|+|+++.--.. .....+++|||.|.|||++.+ ..|+..+|+|++||++
T Consensus 383 lldae-------ghikltdygmcke~l~~----------gd~tstfcgtpnyiapeilrg----eeygfsvdwwalgvlm 441 (593)
T KOG0695|consen 383 LLDAE-------GHIKLTDYGMCKEGLGP----------GDTTSTFCGTPNYIAPEILRG----EEYGFSVDWWALGVLM 441 (593)
T ss_pred EEccC-------CceeecccchhhcCCCC----------CcccccccCCCcccchhhhcc----cccCceehHHHHHHHH
Confidence 99998 89999999999753221 123346789999999999987 6899999999999999
Q ss_pred HHHHhCCCCCCC-------CCHHH-HHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHh
Q 001142 1041 LELLTLQVPYMG-------LSELE-IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 1112 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~-------~~~~e-l~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~C 1112 (1142)
+||+.|+.||.- .+..+ +++.|.. ....++. ..+-....+++.-
T Consensus 442 femmagrspfdivgm~n~d~ntedylfqvile-kqiripr---------------------------slsvkas~vlkgf 493 (593)
T KOG0695|consen 442 FEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE-KQIRIPR---------------------------SLSVKASHVLKGF 493 (593)
T ss_pred HHHHcCCCCcceecCCCcccchhHHHHHHHhh-hcccccc---------------------------eeehhhHHHHHHh
Confidence 999999999952 11122 2232211 1111111 2233456778899
Q ss_pred cccCCCCCC------CHHHHHHHHHhhcC
Q 001142 1113 TEENPTERP------TAGDLYEMFVARTS 1135 (1142)
Q Consensus 1113 L~~DP~~RP------Sa~EVL~~L~~~~s 1135 (1142)
|..||.+|. .++++-.|.||+.-
T Consensus 494 lnkdp~erlgc~~~~g~~dik~h~ffr~i 522 (593)
T KOG0695|consen 494 LNKDPKERLGCRPQTGFSDIKSHAFFRSI 522 (593)
T ss_pred hcCCcHHhcCCCcccchhhhhcchhhhhC
Confidence 999999984 46888888888743
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=251.96 Aligned_cols=224 Identities=25% Similarity=0.364 Sum_probs=177.4
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSK 883 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~~~~~ 883 (1142)
+++.-...||+|+||.|-+.++. +.-.|+|- +..+..... +.+.++|+.+..+. .+|.+|.+||.+....
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKr--i~~tvn~q~-----q~r~L~dldi~~r~~~CPf~V~FyGa~~reg 118 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKR--IRATVNSQE-----QKRLLMDLDIIMRTVDCPFTVHFYGALFREG 118 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEee--ehhhcChHH-----HHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence 45677889999999998887774 55555554 444333322 23447899887665 6999999999876554
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCeee
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENILI 962 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~-gIvHrDLKp~NILl 962 (1142)
. .|+.||.|+ .||..+-++....+ ..+++..+-+|+..|++||.|||++ .|||||+||+||||
T Consensus 119 d--------------vwIcME~M~-tSldkfy~~v~~~g-~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLI 182 (282)
T KOG0984|consen 119 D--------------VWICMELMD-TSLDKFYRKVLKKG-GTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILI 182 (282)
T ss_pred c--------------EEEeHHHhh-hhHHHHHHHHHhcC-CcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEE
Confidence 3 499999997 89988887766554 6789999999999999999999986 89999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
+.+ ++||+||||.+-.+.+.... ....|-..|||||.+........|+-|+||||||+.+.|
T Consensus 183 n~~-------GqVKiCDFGIsG~L~dSiAk-----------t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiE 244 (282)
T KOG0984|consen 183 NYD-------GQVKICDFGISGYLVDSIAK-----------TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIE 244 (282)
T ss_pred ccC-------CcEEEcccccceeehhhhHH-----------HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhh
Confidence 998 89999999999776543221 123577889999999877666789999999999999999
Q ss_pred HHhCCCCCCC-CCHHHHHHHHHhCCCCCch
Q 001142 1043 LLTLQVPYMG-LSELEIHDLIQMGKRPRLT 1071 (1142)
Q Consensus 1043 LLtG~~Pf~~-~~~~el~~~I~~~~~p~l~ 1071 (1142)
|+++++||.. .++.+...++.....|.++
T Consensus 245 lA~lr~PY~~w~tpF~qLkqvVeep~P~Lp 274 (282)
T KOG0984|consen 245 MAILRFPYESWGTPFQQLKQVVEEPSPQLP 274 (282)
T ss_pred hhhccccccccCCHHHHHHHHhcCCCCCCc
Confidence 9999999964 4566777777666666554
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-28 Score=271.81 Aligned_cols=136 Identities=21% Similarity=0.275 Sum_probs=112.4
Q ss_pred CCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-----C---CCcccee
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-----H---SCIVEMY 876 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-----H---pNIVkl~ 876 (1142)
.+|.+.++||-|.|++||+|.+ ..+.||+||.+.. +.+.+..+.||.+|++++ | .+||+++
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---------qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~Ll 148 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---------QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLL 148 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---------hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeee
Confidence 5799999999999999999988 4677899886522 122233479999999984 2 3699999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCC
Q 001142 877 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDI 955 (1142)
Q Consensus 877 g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~-gIvHrDL 955 (1142)
++|...+ ....|+|+|+|++ |.+|..+|... ....++...++.|++||+.||.|||.. ||||-||
T Consensus 149 D~FkhsG----------pNG~HVCMVfEvL-GdnLLklI~~s---~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDl 214 (590)
T KOG1290|consen 149 DHFKHSG----------PNGQHVCMVFEVL-GDNLLKLIKYS---NYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDL 214 (590)
T ss_pred ccceecC----------CCCcEEEEEehhh-hhHHHHHHHHh---CCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCC
Confidence 9998643 3567999999999 78999999874 345699999999999999999999965 9999999
Q ss_pred CCCCeeeccc
Q 001142 956 KSENILIDLE 965 (1142)
Q Consensus 956 Kp~NILld~~ 965 (1142)
||+|||+...
T Consensus 215 KPENvLl~~~ 224 (590)
T KOG1290|consen 215 KPENVLLCST 224 (590)
T ss_pred Ccceeeeecc
Confidence 9999998543
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-28 Score=288.07 Aligned_cols=290 Identities=18% Similarity=0.186 Sum_probs=185.5
Q ss_pred CCCCcceeeeecccCceEEEEEEE------------------CCccEEEEEEecccCCCChHHHHHh----------HHh
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKF------------------GSADAAAKVRTLKVCGSSADEIRNF----------EYS 856 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~------------------~~~~vAvKi~~l~~~~~~~~~~~~~----------~~~ 856 (1142)
+.++|++.++||+|+||+||+|.+ .+..||||....... ...++| ...
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~----~~~~~fl~e~~~~~~~~e~ 218 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQ----GVRQDFLKTGTLAKGSAET 218 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccch----hhHHHHHhhhhhhhcccch
Confidence 466899999999999999999964 224577776543211 111111 112
Q ss_pred HHHHHHHHhhCCCCCc-----cceeeeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc----------
Q 001142 857 CLGEVRMLGALRHSCI-----VEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET---------- 921 (1142)
Q Consensus 857 ~~~Ei~iL~~L~HpNI-----Vkl~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~---------- 921 (1142)
...|+.++.+++|.++ +++++++..... ++ .......++||||+++++|.++++.....
T Consensus 219 ~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~----~g--~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~ 292 (507)
T PLN03224 219 GMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTA----DG--AFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMM 292 (507)
T ss_pred hHHHHHHHHHhhcccchhhhhhhhhhhcccccc----cc--cccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHh
Confidence 2467888888876554 677777754211 01 01122469999999999999998742100
Q ss_pred ---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccc
Q 001142 922 ---------GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHT 992 (1142)
Q Consensus 922 ---------~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~ 992 (1142)
....+++..++.++.|++.||.|||+++|+||||||+|||++.+ +.+||+|||++.........
T Consensus 293 ~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~-------~~~kL~DFGla~~~~~~~~~ 365 (507)
T PLN03224 293 AGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVD-------GQVKIIDFGAAVDMCTGINF 365 (507)
T ss_pred cCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCC-------CcEEEEeCcCccccccCCcc
Confidence 11235678899999999999999999999999999999999877 78999999998654321110
Q ss_pred cccccCCCCCCCCccCCCcccchhhhccccCCC----------------CC--CchhhHHHHHHHHHHHHhCCC-CCCCC
Q 001142 993 CCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN----------------LY--GLEVDIWSYGCLLLELLTLQV-PYMGL 1053 (1142)
Q Consensus 993 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~----------------~~--s~ksDVwSLGviL~ELLtG~~-Pf~~~ 1053 (1142)
......+|+.|+|||.+....... .| ..+.||||+||++++|+++.. ||.+.
T Consensus 366 ---------~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~ 436 (507)
T PLN03224 366 ---------NPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANI 436 (507)
T ss_pred ---------CccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccch
Confidence 111223588999999975421000 01 235799999999999999875 66532
Q ss_pred CHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC---CCCCCHHHHHHHH
Q 001142 1054 SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP---TERPTAGDLYEMF 1130 (1142)
Q Consensus 1054 ~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP---~~RPSa~EVL~~L 1130 (1142)
.... ..+...... . ..+... ......+. .....++..++|+.+||..+| .+|+|++|+++|+
T Consensus 437 ~~f~--~~~~~~~~~-~-~~~r~~--------~~~~~~~~---~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp 501 (507)
T PLN03224 437 RLFN--TELRQYDND-L-NRWRMY--------KGQKYDFS---LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHR 501 (507)
T ss_pred hhhh--hHHhhccch-H-HHHHhh--------cccCCCcc---cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCC
Confidence 1111 111100000 0 000000 00000011 111456779999999999766 6899999999999
Q ss_pred HhhcC
Q 001142 1131 VARTS 1135 (1142)
Q Consensus 1131 ~~~~s 1135 (1142)
|+...
T Consensus 502 ~f~~~ 506 (507)
T PLN03224 502 FFLPE 506 (507)
T ss_pred CcCCC
Confidence 99753
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-29 Score=265.85 Aligned_cols=284 Identities=19% Similarity=0.282 Sum_probs=201.8
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
.+.+--+.||.|+||+||.+++. ++.++.| ++.........-+ ++-+|+.+|..++|.|++..++...-...
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalk--K~pnvfq~L~s~k----rvFre~kmLcfFkHdNVLSaLDILQPph~ 126 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALK--KMPNVFQNLASCK----RVFREIKMLSSFRHDNVLSLLDILQPANP 126 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHh--hcchHHHHHHHHH----HHHHHHHHHHhhccccHHHHHHhcCCCCc
Confidence 34566789999999999999884 4444444 3332222222223 33699999999999999999887654321
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
......|+|+|++. .+|...|-. ...++.+.++-+++||++||.|||+.+|.||||||.|.|++.
T Consensus 127 ---------dfFqEiYV~TELmQ-SDLHKIIVS-----PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNS 191 (449)
T KOG0664|consen 127 ---------SFFQELYVLTELMQ-SDLHKIIVS-----PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNS 191 (449)
T ss_pred ---------hHHHHHHHHHHHHH-hhhhheecc-----CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEecc
Confidence 11234688999996 788888764 357999999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ ..+||||||+|+........ .....+.|.+|+|||++.+ ...|+.++||||.|||+.||+
T Consensus 192 N-------CvLKICDFGLARvee~d~~~---------hMTqEVVTQYYRAPEiLMG---aRhYs~AvDiWSVGCIFaELL 252 (449)
T KOG0664|consen 192 N-------CILKICDFGLARTWDQRDRL---------NMTHEVVTQYYRAPELLMG---ARRYTGAVDIWSVGCIFAELL 252 (449)
T ss_pred C-------ceEEecccccccccchhhhh---------hhHHHHHHHHhccHHHhhc---chhhcCccceehhhHHHHHHH
Confidence 8 89999999999864332211 1112356889999999998 357899999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHh-CCCCCchhHHhhhcccccccccccCCCCCCchh--------hhhhHHHHHHHHHHhccc
Q 001142 1045 TLQVPYMGLSELEIHDLIQM-GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA--------ELETLSFLVDVFRRCTEE 1115 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~-~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~L~dLI~~CL~~ 1115 (1142)
.++..|+..++.+..+.|.. -..|.... +..........+... ....+.. ......+...++..++..
T Consensus 253 gRrILFQAq~PiqQL~lItdLLGTPs~Ea-Mr~ACEGAk~H~LR~--~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~ 329 (449)
T KOG0664|consen 253 QRKILFQAAGPIEQLQMIIDLLGTPSQEA-MKYACEGAKNHVLRA--GLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHF 329 (449)
T ss_pred hhhhhhhccChHHHHHHHHHHhCCCcHHH-HHHHhhhhHHHhhcc--CCCCCCccceeeecCCcccchHHHHHHHHHhCC
Confidence 99999998888877777633 23333322 211111111111110 0001100 112234467788899999
Q ss_pred CCCCCCCHHHHHHHHHhh
Q 001142 1116 NPTERPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1116 DP~~RPSa~EVL~~L~~~ 1133 (1142)
||++|.+.++.+.|++..
T Consensus 330 d~dkris~~~A~~~~~~~ 347 (449)
T KOG0664|consen 330 DPDKRISVEEALQHRYLE 347 (449)
T ss_pred CCcccccHhhhccccccc
Confidence 999999999999998764
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-29 Score=290.64 Aligned_cols=262 Identities=27% Similarity=0.394 Sum_probs=211.6
Q ss_pred CCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
-++|++.+++|.|+||.||+|++ .+..+|+|+++++.. +..... .+|+-+++..+|||||.++|.+...+
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~----dd~~~i----qqei~~~~dc~h~nivay~gsylr~d 85 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG----DDFSGI----QQEIGMLRDCRHPNIVAYFGSYLRRD 85 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCC----cccccc----ccceeeeecCCCcChHHHHhhhhhhc
Confidence 45799999999999999999997 577899999887743 333333 68999999999999999999887655
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
.+ |+.||||.||+|++.-+- ..++++.++..+.+..++||+|||++|-+|||||-.||+++
T Consensus 86 kl--------------wicMEycgggslQdiy~~-----TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanillt 146 (829)
T KOG0576|consen 86 KL--------------WICMEYCGGGSLQDIYHV-----TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLT 146 (829)
T ss_pred Cc--------------EEEEEecCCCcccceeee-----cccchhHHHHHHHhhhhccchhhhcCCcccccccccceeec
Confidence 44 999999999999987654 46899999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
+. +.+|+.|||.+..+.... .....+.||++|||||+-.- .+...|.+++|||+.|+...|+
T Consensus 147 d~-------gDvklaDfgvsaqitati----------~KrksfiGtpywmapEvaav-erkggynqlcdiwa~gitAiel 208 (829)
T KOG0576|consen 147 DE-------GDVKLADFGVSAQITATI----------AKRKSFIGTPYWMAPEVAAV-ERKGGYNQLCDIWALGITAIEL 208 (829)
T ss_pred cc-------CceeecccCchhhhhhhh----------hhhhcccCCccccchhHHHH-Hhcccccccccccccccchhhh
Confidence 88 889999999987654422 23346789999999998643 3346799999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
..-++|.....+.+...........+... + ......+.+.+|++.++..+|++||++
T Consensus 209 ~eLqpplfdlhpmr~l~LmTkS~~qpp~l--------------k---------Dk~kws~~fh~fvK~altknpKkRpta 265 (829)
T KOG0576|consen 209 GELQPPLFDLHPMRALFLMTKSGFQPPTL--------------K---------DKTKWSEFFHNFVKGALTKNPKKRPTA 265 (829)
T ss_pred hhcCCcccccchHHHHHHhhccCCCCCcc--------------c---------CCccchHHHHHHHHHHhcCCCccCCCh
Confidence 99999977666666555543222111110 0 001456679999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 001142 1124 GDLYEMFVARTS 1135 (1142)
Q Consensus 1124 ~EVL~~L~~~~s 1135 (1142)
+.++.|++....
T Consensus 266 eklL~h~fvs~~ 277 (829)
T KOG0576|consen 266 EKLLQHPFVSQT 277 (829)
T ss_pred hhheeceeeccc
Confidence 999999887654
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-28 Score=263.62 Aligned_cols=282 Identities=20% Similarity=0.217 Sum_probs=199.5
Q ss_pred CCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
.+|.-.+.+|.|+- .|-.|.+ .+..|++|. +..........+ +..+|...+..+.|+||++++.+|.-...
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk--~~~pf~n~~~ak----ra~rel~l~~~v~~~nii~l~n~ftP~~~ 89 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKK--LSRPFQNQTHAK----RAYRELKLMKCVNHKNIISLLNVFTPQKT 89 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhh--hcCccccCccch----hhhhhhhhhhhhcccceeeeeeccCcccc
Confidence 45777788899988 6666655 355555554 322222222222 23699999999999999999999876443
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
. ......|+||||+. .+|...+.- .++-..+..|+.|++.|++|||+.||+||||||+||++..
T Consensus 90 l--------~~~~e~y~v~e~m~-~nl~~vi~~-------elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~ 153 (369)
T KOG0665|consen 90 L--------EEFQEVYLVMELMD-ANLCQVILM-------ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNS 153 (369)
T ss_pred H--------HHHHhHHHHHHhhh-hHHHHHHHH-------hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecc
Confidence 2 23345799999997 899998873 4777899999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +++||.|||+|+..... ......+.|.+|.|||++.+ ..|...+||||.||++.||+
T Consensus 154 ~-------~~lKi~dfg~ar~e~~~-----------~~mtpyVvtRyyrapevil~----~~~ke~vdiwSvGci~gEli 211 (369)
T KOG0665|consen 154 D-------CTLKILDFGLARTEDTD-----------FMMTPYVVTRYYRAPEVILG----MGYKENVDIWSVGCIMGELI 211 (369)
T ss_pred h-------hheeeccchhhcccCcc-----------cccCchhheeeccCchheec----cCCcccchhhhhhhHHHHHh
Confidence 8 89999999999754322 01224568999999999987 34889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHH-HhCCCCCchh--HHhhhccccc--------ccccccCCCCCCc---hhhhhhHHHHHHHHH
Q 001142 1045 TLQVPYMGLSELEIHDLI-QMGKRPRLTD--ELEALGSCHE--------HEVAQSGSGFEKP---EAELETLSFLVDVFR 1110 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I-~~~~~p~l~~--~l~~~~~~~~--------~~~~~~~~~~~~~---~~~~~~~~~L~dLI~ 1110 (1142)
+|+..|.+.+..+.+.++ ..-..|.... .+......+- ..+...-+....+ +.+......+++++.
T Consensus 212 ~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~ 291 (369)
T KOG0665|consen 212 LGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLS 291 (369)
T ss_pred hceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHH
Confidence 999999887665544443 3333332221 1111110000 0000000000000 001133566899999
Q ss_pred HhcccCCCCCCCHHHHHHHHHhh
Q 001142 1111 RCTEENPTERPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1111 ~CL~~DP~~RPSa~EVL~~L~~~ 1133 (1142)
+||..||++|.+++++|.||+++
T Consensus 292 ~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 292 KMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HhhccChhhcccHHHHhcCCeee
Confidence 99999999999999999999986
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-28 Score=274.98 Aligned_cols=277 Identities=22% Similarity=0.296 Sum_probs=208.8
Q ss_pred CCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC------CCCccceeee
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR------HSCIVEMYGH 878 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~------HpNIVkl~g~ 878 (1142)
.+|.+....|+|-|++|-+|.+ .+..|||||.+-.. ...... ++|++||++|. --|+++++..
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE----~M~KtG-----l~EleiLkKL~~AD~Edk~Hclrl~r~ 502 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE----VMHKTG-----LKELEILKKLNDADPEDKFHCLRLFRH 502 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch----HHhhhh-----hHHHHHHHHhhccCchhhhHHHHHHHH
Confidence 3589999999999999999987 46689999865321 111122 58999999995 2478999988
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 001142 879 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 958 (1142)
Q Consensus 879 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~ 958 (1142)
|...+ |+|||+|-+. .+|.++++++.. ...|....+..++.|+..||.+|-..||+|.||||+
T Consensus 503 F~hkn--------------HLClVFE~Ls-lNLRevLKKyG~--nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPD 565 (752)
T KOG0670|consen 503 FKHKN--------------HLCLVFEPLS-LNLREVLKKYGR--NVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPD 565 (752)
T ss_pred hhhcc--------------eeEEEehhhh-chHHHHHHHhCc--ccceeehHHHHHHHHHHHHHHHHHhcCeeecccCcc
Confidence 87554 5699999996 899999998643 346889999999999999999999999999999999
Q ss_pred CeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001142 959 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1038 (1142)
Q Consensus 959 NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGv 1038 (1142)
|||++... ..+||||||.|.......-+ ....+..|.|||++.+ -+|+...|+||.||
T Consensus 566 NiLVNE~k------~iLKLCDfGSA~~~~eneit------------PYLVSRFYRaPEIiLG----~~yd~~iD~WSvgc 623 (752)
T KOG0670|consen 566 NILVNESK------NILKLCDFGSASFASENEIT------------PYLVSRFYRAPEIILG----LPYDYPIDTWSVGC 623 (752)
T ss_pred ceEeccCc------ceeeeccCcccccccccccc------------HHHHHHhccCcceeec----CcccCCccceeece
Confidence 99998764 78999999999765543222 2235678999999998 67999999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHH--HhCCCCCchhHHhhhccccccc--------------c-----------cccCC-
Q 001142 1039 LLLELLTLQVPYMGLSELEIHDLI--QMGKRPRLTDELEALGSCHEHE--------------V-----------AQSGS- 1090 (1142)
Q Consensus 1039 iL~ELLtG~~Pf~~~~~~el~~~I--~~~~~p~l~~~l~~~~~~~~~~--------------~-----------~~~~~- 1090 (1142)
.||||.||+..|.+.+..+++... ..|..|.-. -.-+.+.+.. + .++..
T Consensus 624 tLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Km---lRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkd 700 (752)
T KOG0670|consen 624 TLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKM---LRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKD 700 (752)
T ss_pred eeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHH---hhhcchhhhhcccccceEEEeccccccceeEEEecccCcchh
Confidence 999999999999998877766554 333333211 1001110000 0 00000
Q ss_pred -------CCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001142 1091 -------GFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1134 (1142)
Q Consensus 1091 -------~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~~ 1134 (1142)
.-..++.+......+.+|+..||..||++|.|..++|+|||+..
T Consensus 701 l~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 701 LGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred HHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence 00023333466788999999999999999999999999999864
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-29 Score=290.03 Aligned_cols=277 Identities=25% Similarity=0.287 Sum_probs=176.8
Q ss_pred CcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCC--CCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcE
Q 001142 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTV--DFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRN 95 (1142)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L--~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~ 95 (1142)
.++.|.++.|+|..+. +.++.|+.|+.+++..|+| +|++++.| .|..|+.||||+|+|+++|..+..-+++-+
T Consensus 56 kLEHLs~~HN~L~~vh-GELs~Lp~LRsv~~R~N~LKnsGiP~diF----~l~dLt~lDLShNqL~EvP~~LE~AKn~iV 130 (1255)
T KOG0444|consen 56 KLEHLSMAHNQLISVH-GELSDLPRLRSVIVRDNNLKNSGIPTDIF----RLKDLTILDLSHNQLREVPTNLEYAKNSIV 130 (1255)
T ss_pred hhhhhhhhhhhhHhhh-hhhccchhhHHHhhhccccccCCCCchhc----ccccceeeecchhhhhhcchhhhhhcCcEE
Confidence 5677778888887775 5677788888888888877 34444433 347778888888888888877777777778
Q ss_pred EEccCCCCCcCchh-hcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCC----------------------
Q 001142 96 LKFFGNEINLFPSE-VGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPS---------------------- 152 (1142)
Q Consensus 96 L~Ls~N~L~~lP~~-l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~---------------------- 152 (1142)
|+||+|+|.+||.. |-+|+.|-.|||++|++..+|+....|..|++|.|++|+++..
T Consensus 131 LNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRT 210 (1255)
T KOG0444|consen 131 LNLSYNNIETIPNSLFINLTDLLFLDLSNNRLEMLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRT 210 (1255)
T ss_pred EEcccCccccCCchHHHhhHhHhhhccccchhhhcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccch
Confidence 88888888878776 4467777788888888777777777777777777777764321
Q ss_pred cccchhhhcCCCCCcEEEccCCCCCccCcccCCCCCCCEEEccCCCCCc-----------------------cchhhcCC
Q 001142 153 VLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKY-----------------------LPTEICYL 209 (1142)
Q Consensus 153 ~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~-----------------------lP~~l~~L 209 (1142)
...+|.++..|.+|..++|+.|.+..+|+.+.++.+|+.|+||+|+|++ +|+.++.|
T Consensus 211 l~N~Ptsld~l~NL~dvDlS~N~Lp~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt~LP~avcKL 290 (1255)
T KOG0444|consen 211 LDNIPTSLDDLHNLRDVDLSENNLPIVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLTVLPDAVCKL 290 (1255)
T ss_pred hhcCCCchhhhhhhhhccccccCCCcchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhccchHHHhhh
Confidence 1224555556666666677777766666666666666666666555554 44445555
Q ss_pred CCCCEEEccCCCCC--ccCccccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccCCCCCCCCCCCchhhccCCCCC
Q 001142 210 KALISLKVANNKLV--ELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNG 287 (1142)
Q Consensus 210 ~~L~~L~Ls~N~Ls--~IP~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~~n~ 287 (1142)
+.|+.|.+.+|+|+ .||++++.|.+|+.+..++|.|.-+ |+.++.+..|+.|.|+.|+|-. +|..+.+......
T Consensus 291 ~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LElV-PEglcRC~kL~kL~L~~NrLiT---LPeaIHlL~~l~v 366 (1255)
T KOG0444|consen 291 TKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLELV-PEGLCRCVKLQKLKLDHNRLIT---LPEAIHLLPDLKV 366 (1255)
T ss_pred HHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccccC-chhhhhhHHHHHhcccccceee---chhhhhhcCCcce
Confidence 55555555555444 4555555555555555555555433 3456666666666666666655 6666665555555
Q ss_pred CCCC-CCCccccccccc
Q 001142 288 KDSS-NDDFISSSAEMD 303 (1142)
Q Consensus 288 l~~~-~~~~~~~~~~~~ 303 (1142)
++.- ++++..+..|.+
T Consensus 367 LDlreNpnLVMPPKP~d 383 (1255)
T KOG0444|consen 367 LDLRENPNLVMPPKPND 383 (1255)
T ss_pred eeccCCcCccCCCCcch
Confidence 5442 334444444433
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-26 Score=252.01 Aligned_cols=258 Identities=22% Similarity=0.322 Sum_probs=203.3
Q ss_pred CcceeeeecccCceEEEEEEECCc-------cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFGSA-------DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 880 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~~~-------~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~ 880 (1142)
++++..++-+|.||.||+|.|... .+.||. ++. ....-+.. .++.|.-.+..+.|||+..+.+...
T Consensus 285 Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKT--vk~-~AS~iQv~----~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 285 RVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKT--VKQ-HASQIQVN----LLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred heechhhhhcCchhheeeeeecccCCcchHHHHHHHH--HHh-cccHHHHH----HHHHHHHHHhcCcCCCccceeEEEe
Confidence 367788899999999999987432 233332 222 11222233 3478888889999999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE---TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 957 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~---~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp 957 (1142)
++.. ..+.++.+..-|+|..+++.++. .....++..+...++.|++.|++|||++||||.||-+
T Consensus 358 e~~~-------------~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAa 424 (563)
T KOG1024|consen 358 EDYA-------------TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAA 424 (563)
T ss_pred eccC-------------cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhh
Confidence 6432 34889999988999999985432 2334577788899999999999999999999999999
Q ss_pred CCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHH
Q 001142 958 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1037 (1142)
Q Consensus 958 ~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLG 1037 (1142)
.|.+|++. -.|||+|=.+++.+......+- .. .......||+||.+.. ..|+.++||||||
T Consensus 425 RNCvIdd~-------LqVkltDsaLSRDLFP~DYhcL-GD-------nEnRPvkWMslEal~n----~~yssasDvWsfG 485 (563)
T KOG1024|consen 425 RNCVIDDQ-------LQVKLTDSALSRDLFPGDYHCL-GD-------NENRPVKWMSLEALQN----SHYSSASDVWSFG 485 (563)
T ss_pred hcceehhh-------eeEEeccchhccccCccccccc-CC-------CCCCcccccCHHHHhh----hhhcchhhhHHHH
Confidence 99999987 7899999999987655443321 11 1124567999999987 6799999999999
Q ss_pred HHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 001142 1038 CLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1116 (1142)
Q Consensus 1038 viL~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~D 1116 (1142)
|++|||+| |+.|+...++.++...+..|.+..-+ .++++++..++.-||..+
T Consensus 486 VllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP---------------------------~NCPDeLf~vMacCWall 538 (563)
T KOG1024|consen 486 VLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQP---------------------------FNCPDELFTVMACCWALL 538 (563)
T ss_pred HHHHHHHhcCCCCccccCHHHHHHHHhccceecCC---------------------------CCCcHHHHHHHHHHHhcC
Confidence 99999999 99999999999999888877653211 178899999999999999
Q ss_pred CCCCCCHHHHHHHHH
Q 001142 1117 PTERPTAGDLYEMFV 1131 (1142)
Q Consensus 1117 P~~RPSa~EVL~~L~ 1131 (1142)
|++||+++|++.-+-
T Consensus 539 peeRPsf~Qlv~cLs 553 (563)
T KOG1024|consen 539 PEERPSFSQLVICLS 553 (563)
T ss_pred cccCCCHHHHHHHHH
Confidence 999999999987653
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-27 Score=268.83 Aligned_cols=208 Identities=25% Similarity=0.358 Sum_probs=165.8
Q ss_pred CCCCCCcceeeeecccCceEEEEEEECCccEEEEEEecccCCCCh---HHHHHhHHhHHHHHHHHhhCC---CCCcccee
Q 001142 803 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSA---DEIRNFEYSCLGEVRMLGALR---HSCIVEMY 876 (1142)
Q Consensus 803 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~---~~~~~~~~~~~~Ei~iL~~L~---HpNIVkl~ 876 (1142)
+..+.+|+..+.+|+|+||.|++|.++...+.|-+|.+.+...-. -..+.+ -.+-.|++||..++ |+||++++
T Consensus 557 ~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkL-GtVp~EIqIla~l~~~sH~NIlKlL 635 (772)
T KOG1152|consen 557 YKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKL-GTVPSEIQILATLNKHSHENILKLL 635 (772)
T ss_pred ecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhccccc-CccchhHHHHHHhhhcCccchhhhh
Confidence 556788999999999999999999996554444443333221100 011111 11246999999997 99999999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEecc-CCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 001142 877 GHKISSKWLPSADGNPEHHLLQSAIFMEYV-KGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 955 (1142)
Q Consensus 877 g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~-~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDL 955 (1142)
++|++++++ ||+||-. +|.+|.++|.. ...+++.++..|++||+.|++|||++|||||||
T Consensus 636 dfFEddd~y--------------yl~te~hg~gIDLFd~IE~-----kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdi 696 (772)
T KOG1152|consen 636 DFFEDDDYY--------------YLETEVHGEGIDLFDFIEF-----KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDI 696 (772)
T ss_pred heeecCCee--------------EEEecCCCCCcchhhhhhc-----cCccchHHHHHHHHHHHhccccccccCceeccc
Confidence 999998765 9999975 45699999976 467999999999999999999999999999999
Q ss_pred CCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHH
Q 001142 956 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 1035 (1142)
Q Consensus 956 Kp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwS 1035 (1142)
|-+||.++.+ |-+||+|||.|...... .-..++||..|.|||++.+ ....+..-||||
T Consensus 697 kdenvivd~~-------g~~klidfgsaa~~ksg------------pfd~f~gtv~~aapevl~g---~~y~gk~qdiwa 754 (772)
T KOG1152|consen 697 KDENVIVDSN-------GFVKLIDFGSAAYTKSG------------PFDVFVGTVDYAAPEVLGG---EKYLGKPQDIWA 754 (772)
T ss_pred ccccEEEecC-------CeEEEeeccchhhhcCC------------CcceeeeeccccchhhhCC---CccCCCcchhhh
Confidence 9999999988 89999999998654321 1236789999999999987 234578899999
Q ss_pred HHHHHHHHHhCCCCCCC
Q 001142 1036 YGCLLLELLTLQVPYMG 1052 (1142)
Q Consensus 1036 LGviL~ELLtG~~Pf~~ 1052 (1142)
+|++||.++....||..
T Consensus 755 lgillytivykenpyyn 771 (772)
T KOG1152|consen 755 LGILLYTIVYKENPYYN 771 (772)
T ss_pred hhheeeEEEeccCCCcC
Confidence 99999999988888863
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=299.86 Aligned_cols=255 Identities=24% Similarity=0.307 Sum_probs=206.0
Q ss_pred CCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCC-ccCccccCCcCCcE
Q 001142 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLN-LIPKSVGRYEKLRN 95 (1142)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt-~iP~~l~~L~~L~~ 95 (1142)
..|..|.+..|++++..+. ..+++|++|||++|.+++.+|..++.+ ++|++|+|++|.++ .+|..|.++++|++
T Consensus 118 ~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l---~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 192 (968)
T PLN00113 118 SSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSF---SSLKVLDLGGNVLVGKIPNSLTNLTSLEF 192 (968)
T ss_pred CCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcC---CCCCEEECccCcccccCChhhhhCcCCCe
Confidence 4678888888888765443 457888888888888888888776554 88888888888876 67888888888888
Q ss_pred EEccCCCCC-cCchhhcCCCCCCEEEccCCCCC-CCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccC
Q 001142 96 LKFFGNEIN-LFPSEVGNLLGLECLQIKISSPG-VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCH 173 (1142)
Q Consensus 96 L~Ls~N~L~-~lP~~l~~L~~L~~L~Ls~N~l~-~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~ 173 (1142)
|+|++|.++ .+|..++++++|+.|+|++|.+. .+|..+..+++|++|++++|. ..+.+|..+.++++|+.|++++
T Consensus 193 L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~---l~~~~p~~l~~l~~L~~L~L~~ 269 (968)
T PLN00113 193 LTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNN---LTGPIPSSLGNLKNLQYLFLYQ 269 (968)
T ss_pred eeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCce---eccccChhHhCCCCCCEEECcC
Confidence 888888887 67888888888888888888854 577778888888888888843 4456777888888888888888
Q ss_pred CCCC-ccCcccCCCCCCCEEEccCCCCC-ccchhhcCCCCCCEEEccCCCCC-ccCccccCCCCCCEEeCcCCcCCCCCc
Q 001142 174 FSIR-YLPPEIGCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRLENLDLSNNRLTSLGS 250 (1142)
Q Consensus 174 N~L~-~IP~~l~~L~~L~~L~Ls~N~L~-~lP~~l~~L~~L~~L~Ls~N~Ls-~IP~~l~~L~~L~~L~Ls~N~Ls~~~p 250 (1142)
|.++ .+|..+.++++|+.|+|++|+++ .+|..+..+++|+.|+|++|.++ .+|..+..+++|+.|+|++|.+++.+|
T Consensus 270 n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p 349 (968)
T PLN00113 270 NKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIP 349 (968)
T ss_pred CeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCC
Confidence 8887 67888888888888888888887 67888888888888888888887 678888888888888888888888888
Q ss_pred ccccCCCCCCEEEccCCCCCCCCCCCchhhc
Q 001142 251 LDLCLMHNLQNLNLQYNKLLSYCQVPSWICC 281 (1142)
Q Consensus 251 ~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~ 281 (1142)
..+..+++|+.|+|++|++++ .+|.+++.
T Consensus 350 ~~l~~~~~L~~L~Ls~n~l~~--~~p~~~~~ 378 (968)
T PLN00113 350 KNLGKHNNLTVLDLSTNNLTG--EIPEGLCS 378 (968)
T ss_pred hHHhCCCCCcEEECCCCeeEe--eCChhHhC
Confidence 788888888888888888876 46665553
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-26 Score=257.37 Aligned_cols=288 Identities=23% Similarity=0.320 Sum_probs=195.2
Q ss_pred CCCcceeeeecccCceEEEEEEEC-----CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeE
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHK 879 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~-----~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~g~~ 879 (1142)
...|..+++||+|+|++||+|... ...+|+|- +..+.... ++..|+++|..+. +.||+++.+++
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~--i~~ts~p~--------ri~~El~~L~~~gG~~ni~~~~~~~ 104 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKA--IYRTSSPS--------RILNELEMLYRLGGSDNIIKLNGCF 104 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeee--cccccCch--------HHHHHHHHHHHhccchhhhcchhhh
Confidence 346899999999999999999863 34455554 44333222 2478999999995 99999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 001142 880 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959 (1142)
Q Consensus 880 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~N 959 (1142)
...+ +..+||||++.....++... ++..++..+++.++.||.|+|.+|||||||||+|
T Consensus 105 rnnd--------------~v~ivlp~~~H~~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsN 162 (418)
T KOG1167|consen 105 RNND--------------QVAIVLPYFEHDRFRDLYRS--------LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSN 162 (418)
T ss_pred ccCC--------------eeEEEecccCccCHHHHHhc--------CCHHHHHHHHHHHHHHhhhhhccCccccCCCccc
Confidence 7655 45999999998888888765 7789999999999999999999999999999999
Q ss_pred eeeccccccCCCCCeEEEeecCCcccccccc-cccccc---------------------------------cCCCCCCCC
Q 001142 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFL-HTCCIA---------------------------------HRGIPAPDV 1005 (1142)
Q Consensus 960 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~-~~~~~~---------------------------------~~~~~~~~~ 1005 (1142)
+|.+... +.-.|+|||+|....... ...... .........
T Consensus 163 FL~n~~t------~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~an 236 (418)
T KOG1167|consen 163 FLYNRRT------QRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERAN 236 (418)
T ss_pred ccccccc------CCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecc
Confidence 9998764 567899999997211100 000000 000111234
Q ss_pred ccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HH-HHHH--------H-----HhCC----
Q 001142 1006 CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSE-LE-IHDL--------I-----QMGK---- 1066 (1142)
Q Consensus 1006 ~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~Pf~~~~~-~e-l~~~--------I-----~~~~---- 1066 (1142)
..||++|+|||++... ..-++++||||.|||++-++++.+||..... .. +.+. + ..+.
T Consensus 237 rAGT~GfRaPEvL~k~---~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~ 313 (418)
T KOG1167|consen 237 RAGTPGFRAPEVLFRC---PRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLW 313 (418)
T ss_pred cCCCCCCCchHHHhhc---cCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeee
Confidence 5799999999999863 3456899999999999999999999964211 11 1111 0 1111
Q ss_pred ----CCCchhHHhhhcccccccccccCCC-CCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001142 1067 ----RPRLTDELEALGSCHEHEVAQSGSG-FEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1134 (1142)
Q Consensus 1067 ----~p~l~~~l~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~~ 1134 (1142)
.+.++..........-..+.+.... ..........+..+.+++.+|+..||.+|.||+++|+|+||..
T Consensus 314 ~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 314 QKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred ccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 0000000000000000000110000 0111122244557999999999999999999999999999863
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-27 Score=271.95 Aligned_cols=273 Identities=22% Similarity=0.279 Sum_probs=167.6
Q ss_pred CcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccC-ccccCCcCCcEE
Q 001142 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIP-KSVGRYEKLRNL 96 (1142)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP-~~l~~L~~L~~L 96 (1142)
.+++|.+..|.|+.+....++-++.|++||||.|.|+.+....|..- .+|++|+|++|.|+.+- ..|.+|.+|..|
T Consensus 126 hl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~---~ni~~L~La~N~It~l~~~~F~~lnsL~tl 202 (873)
T KOG4194|consen 126 HLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAK---VNIKKLNLASNRITTLETGHFDSLNSLLTL 202 (873)
T ss_pred ceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCC---CCceEEeeccccccccccccccccchheee
Confidence 56666666666666666666667777777777777766655544432 46777777777777663 356666677777
Q ss_pred EccCCCCCcCchh-hcCCCCCCEEEccCCCCCCC-cccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCC
Q 001142 97 KFFGNEINLFPSE-VGNLLGLECLQIKISSPGVN-GFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHF 174 (1142)
Q Consensus 97 ~Ls~N~L~~lP~~-l~~L~~L~~L~Ls~N~l~~~-~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N 174 (1142)
.|+.|.|+.+|.. |.+|++|+.|+|..|++... +..|..|.+|+.|.|..|.+..+. -+.|..|..+++|+|..|
T Consensus 203 kLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~---DG~Fy~l~kme~l~L~~N 279 (873)
T KOG4194|consen 203 KLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLD---DGAFYGLEKMEHLNLETN 279 (873)
T ss_pred ecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCccccc---Ccceeeecccceeecccc
Confidence 7777777777655 44477777777777776665 456666777776666664443322 224555666666666666
Q ss_pred CCCccCc-ccCCCCCCCEEEccCCCCCcc-chhhcCCCCCCEEEccCCCCCccCc-cccCCCCCCEEeCcCCcCCCCCcc
Q 001142 175 SIRYLPP-EIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPS-GLYLLQRLENLDLSNNRLTSLGSL 251 (1142)
Q Consensus 175 ~L~~IP~-~l~~L~~L~~L~Ls~N~L~~l-P~~l~~L~~L~~L~Ls~N~Ls~IP~-~l~~L~~L~~L~Ls~N~Ls~~~p~ 251 (1142)
+++.+-. ++.+|+.|+.|+||+|.|..| +++....++|++|+|++|+|+.+|+ ++..|..|+.|+|++|+|+.+-..
T Consensus 280 ~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~ 359 (873)
T KOG4194|consen 280 RLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEG 359 (873)
T ss_pred hhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhh
Confidence 6665533 456666666666666666655 4555556666666666666666643 344466666666666666666666
Q ss_pred cccCCCCCCEEEccCCCCCC--------CCCCCchhhccCCCCCCCCCCCCcc
Q 001142 252 DLCLMHNLQNLNLQYNKLLS--------YCQVPSWICCNLEGNGKDSSNDDFI 296 (1142)
Q Consensus 252 ~l~~L~~L~~L~Ls~N~L~~--------~~~iP~~~~~~l~~n~l~~~~~~~~ 296 (1142)
.|..+++|+.|||++|.|+. +..+|..-.+.+.+|.+.......+
T Consensus 360 af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAf 412 (873)
T KOG4194|consen 360 AFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAF 412 (873)
T ss_pred HHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhh
Confidence 66666666666666666544 1124444445555555544444333
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-24 Score=226.72 Aligned_cols=212 Identities=34% Similarity=0.506 Sum_probs=173.1
Q ss_pred ecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCCCCC
Q 001142 815 AGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 892 (1142)
Q Consensus 815 LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~~~~~~ 892 (1142)
||+|++|.||++... +..+++|++..... .. ..+. +.+|+..++.+.|++|+++++++....
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~--~~-~~~~----~~~e~~~~~~l~~~~i~~~~~~~~~~~--------- 64 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDS--SS-LLEE----LLREIEILKKLNHPNIVKLYGVFEDEN--------- 64 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccc--hh-HHHH----HHHHHHHHHhcCCCCeeeEeeeeecCC---------
Confidence 689999999999986 77888888653321 10 1223 379999999999999999999987643
Q ss_pred ccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc-ccccCCC
Q 001142 893 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL-ERKKADG 971 (1142)
Q Consensus 893 ~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~-~~~~~~~ 971 (1142)
..+++|||+++++|.+++... ...+++..+..++.+++.++.|||++|++|+||+|.||+++. +
T Consensus 65 -----~~~~~~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~------ 129 (215)
T cd00180 65 -----HLYLVMEYCEGGSLKDLLKEN----EGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDN------ 129 (215)
T ss_pred -----eEEEEEecCCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCC------
Confidence 459999999999999998762 136899999999999999999999999999999999999987 5
Q ss_pred CCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 001142 972 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM 1051 (1142)
Q Consensus 972 ~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~Pf~ 1051 (1142)
..++|+|||.+........ ......+...|++||..... ..++.+.|+|++|+++++|
T Consensus 130 -~~~~l~d~~~~~~~~~~~~----------~~~~~~~~~~~~~pe~~~~~---~~~~~~~D~~~lg~~~~~l-------- 187 (215)
T cd00180 130 -GKVKLADFGLSKLLTSDKS----------LLKTIVGTPAYMAPEVLLGK---GYYSEKSDIWSLGVILYEL-------- 187 (215)
T ss_pred -CcEEEecCCceEEccCCcc----------hhhcccCCCCccChhHhccc---CCCCchhhhHHHHHHHHHH--------
Confidence 6899999999976543210 01223578889999998652 2667899999999999999
Q ss_pred CCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 001142 1052 GLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130 (1142)
Q Consensus 1052 ~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L 1130 (1142)
..+.+++..|++.||.+||++.++++++
T Consensus 188 ---------------------------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ---------------------------------------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ---------------------------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 0267889999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.2e-26 Score=240.86 Aligned_cols=264 Identities=18% Similarity=0.252 Sum_probs=190.4
Q ss_pred CCCCCC-CcceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeee-
Q 001142 802 DPGSFP-SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGH- 878 (1142)
Q Consensus 802 ~~~~~~-~y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~g~- 878 (1142)
.-.++. .|.+.+.||+|.||.+-+|+++++...+.++.+.. .....++| .+|...--.|. |.||+.-|+.
T Consensus 18 ~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~---p~tt~~dF----~rEfhY~~~Ls~H~hIi~tY~va 90 (378)
T KOG1345|consen 18 KKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR---PQTTQADF----VREFHYSFFLSPHQHIIDTYEVA 90 (378)
T ss_pred cccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc---chhhHHHH----HHHhccceeeccchhhhHHHHHH
Confidence 333443 49999999999999999999977666665554443 34455666 78887766774 9999988875
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 001142 879 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 958 (1142)
Q Consensus 879 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~ 958 (1142)
|+..+. +.++|||+|.|+|.+-+.. ..+.+...++++.|+++|+.|||++++||||||.+
T Consensus 91 Fqt~d~--------------YvF~qE~aP~gdL~snv~~------~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~e 150 (378)
T KOG1345|consen 91 FQTSDA--------------YVFVQEFAPRGDLRSNVEA------AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAE 150 (378)
T ss_pred hhcCce--------------EEEeeccCccchhhhhcCc------ccccHHHHHHHHHHHHHHHHHhhccchhhcccccc
Confidence 444443 3899999999999988764 34888999999999999999999999999999999
Q ss_pred CeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCC-CCCCchhhHHHHH
Q 001142 959 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP-NLYGLEVDIWSYG 1037 (1142)
Q Consensus 959 NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~-~~~s~ksDVwSLG 1037 (1142)
||||-..+ ...|||||||..+....... ..--+..|.|||.......+ -...+.+|||.||
T Consensus 151 NiLif~~d-----f~rvKlcDFG~t~k~g~tV~-------------~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfG 212 (378)
T KOG1345|consen 151 NILIFDAD-----FYRVKLCDFGLTRKVGTTVK-------------YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFG 212 (378)
T ss_pred eEEEecCC-----ccEEEeeecccccccCceeh-------------hhhhhcccCCcHHHhhccccceEecccccchhee
Confidence 99995431 26899999999875443221 11235569999987653211 2346889999999
Q ss_pred HHHHHHHhCCCCCCCCCHHH----HHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 001142 1038 CLLLELLTLQVPYMGLSELE----IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 1113 (1142)
Q Consensus 1038 viL~ELLtG~~Pf~~~~~~e----l~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL 1113 (1142)
++++.++||++||+.....+ -+.+...+..+.++..+. ..++.+..+.++-|
T Consensus 213 Ii~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~------------------------~fs~~a~r~Fkk~l 268 (378)
T KOG1345|consen 213 IIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFN------------------------PFSEKALRLFKKSL 268 (378)
T ss_pred eeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhc------------------------ccCHHHHHHHHHhc
Confidence 99999999999998432221 112223333333333221 33455777888999
Q ss_pred ccCCCCC---CCHHHHHHHHHhhc
Q 001142 1114 EENPTER---PTAGDLYEMFVART 1134 (1142)
Q Consensus 1114 ~~DP~~R---PSa~EVL~~L~~~~ 1134 (1142)
..+|++| .++....+.+|...
T Consensus 269 t~~~~drcki~~~kk~rk~~w~E~ 292 (378)
T KOG1345|consen 269 TPRFKDRCKIWTAKKMRKCLWKEK 292 (378)
T ss_pred CCcccccchhHHHHHHHHHHHHHh
Confidence 9999999 66666666677643
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.8e-27 Score=267.44 Aligned_cols=286 Identities=21% Similarity=0.213 Sum_probs=234.2
Q ss_pred cchhhcccCCCCCCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccC
Q 001142 5 NSVEITQKSPEGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIP 84 (1142)
Q Consensus 5 ~~v~~~~~~~~~~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP 84 (1142)
.||+..+.+--+ .++.++++.|.|+.|+..+|..-.++++|+|++|.|+.+-...|..+ .+|..|.|++|+|+++|
T Consensus 138 ~sv~se~L~~l~-alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~l---nsL~tlkLsrNrittLp 213 (873)
T KOG4194|consen 138 SSVTSEELSALP-ALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSL---NSLLTLKLSRNRITTLP 213 (873)
T ss_pred ccccHHHHHhHh-hhhhhhhhhchhhcccCCCCCCCCCceEEeecccccccccccccccc---chheeeecccCcccccC
Confidence 345544444444 78899999999999999999999999999999999999887777666 89999999999999998
Q ss_pred c-cccCCcCCcEEEccCCCCCcC-chhhcCCCCCCEEEccCCCCCCC-cccccCCCCCCEEECCCCCCCCCcccchhhhc
Q 001142 85 K-SVGRYEKLRNLKFFGNEINLF-PSEVGNLLGLECLQIKISSPGVN-GFALNKLKGLKELELSKVPPRPSVLTLLSEIA 161 (1142)
Q Consensus 85 ~-~l~~L~~L~~L~Ls~N~L~~l-P~~l~~L~~L~~L~Ls~N~l~~~-~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~ 161 (1142)
. .|.+|++|+.|+|..|+|..+ --.|.+|.+|+.|.|..|.+.-+ ...|..|.++++|+|..|++.. .--.++.
T Consensus 214 ~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~---vn~g~lf 290 (873)
T KOG4194|consen 214 QRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQA---VNEGWLF 290 (873)
T ss_pred HHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhh---hhccccc
Confidence 6 577799999999999999866 44588899999999999996654 4689999999999999965533 3345778
Q ss_pred CCCCCcEEEccCCCCCcc-CcccCCCCCCCEEEccCCCCCccc-hhhcCCCCCCEEEccCCCCCccCcccc-CCCCCCEE
Q 001142 162 GLKCLTKLSVCHFSIRYL-PPEIGCLSNLEQLDLSFNKMKYLP-TEICYLKALISLKVANNKLVELPSGLY-LLQRLENL 238 (1142)
Q Consensus 162 ~L~~L~~L~Ls~N~L~~I-P~~l~~L~~L~~L~Ls~N~L~~lP-~~l~~L~~L~~L~Ls~N~Ls~IP~~l~-~L~~L~~L 238 (1142)
+|+.|+.|+|+.|.|..| ++.+.-.++|++|+|++|+|+.+| .+|..|.+|+.|+|++|.++.|-+..+ .+++|+.|
T Consensus 291 gLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~L 370 (873)
T KOG4194|consen 291 GLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKL 370 (873)
T ss_pred ccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhh
Confidence 999999999999999977 677888899999999999999995 678889999999999999998865544 48999999
Q ss_pred eCcCCcCCCCCcc---cccCCCCCCEEEccCCCCCCC-----CCCCchhhccCCCCCCCCCCCCccc
Q 001142 239 DLSNNRLTSLGSL---DLCLMHNLQNLNLQYNKLLSY-----CQVPSWICCNLEGNGKDSSNDDFIS 297 (1142)
Q Consensus 239 ~Ls~N~Ls~~~p~---~l~~L~~L~~L~Ls~N~L~~~-----~~iP~~~~~~l~~n~l~~~~~~~~~ 297 (1142)
||++|.|+..+.+ .|..|++|+.|+|.||+|..+ ..+|..-.+++..|.+-....+.|.
T Consensus 371 dLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe 437 (873)
T KOG4194|consen 371 DLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFE 437 (873)
T ss_pred cCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccc
Confidence 9999999987754 378899999999999999862 2345555566666665555444443
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.7e-24 Score=227.03 Aligned_cols=215 Identities=32% Similarity=0.451 Sum_probs=170.6
Q ss_pred cceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCC
Q 001142 809 LSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 886 (1142)
Q Consensus 809 y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~ 886 (1142)
|.+.+.||+|++|.||++... +..+++|+...... . ...+. +.+|++.+.+++|+|++++++++....
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~-~~~~~----~~~e~~~~~~~~~~~i~~~~~~~~~~~--- 70 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKT--E-KQREE----FLREIRILKKLKHPNIVKLYGVFEDPE--- 70 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccc--h-HHHHH----HHHHHHHHHhCCCCChhhheeeeecCC---
Confidence 578899999999999999985 46788887543321 1 12333 478999999999999999999987654
Q ss_pred CCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCC-CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 887 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKH-VSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 887 ~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~-ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
..+++|||+++++|.+++... .. +++..+..++.+++.++.|||+++++|+||+|+||+++.+
T Consensus 71 -----------~~~~v~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~ 134 (225)
T smart00221 71 -----------PLYLVMEYCEGGDLFDYLRKK-----GGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMD 134 (225)
T ss_pred -----------ceEEEEeccCCCCHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence 349999999988999999762 22 7899999999999999999999999999999999999887
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+.++|+|||.+........ .......++..|++||.+. ....++.++|||+||+++++|++
T Consensus 135 -------~~~~l~d~g~~~~~~~~~~---------~~~~~~~~~~~~~~pe~~~---~~~~~~~~~Dv~~lG~~~~~l~~ 195 (225)
T smart00221 135 -------GLVKLADFGLARFIHRDLA---------ALLKTVKGTPFYLAPEVLL---GGKGYGEAVDIWSLGVILYELLW 195 (225)
T ss_pred -------CCEEEeeCceeeEecCccc---------ccccceeccCCcCCHhHhc---CCCCCCchhhHHHHHHHHHHHHH
Confidence 7899999999876543210 0112345788899999984 23567789999999999999999
Q ss_pred CCCCCCC-CC-HHHHHHHHHhCCCC
Q 001142 1046 LQVPYMG-LS-ELEIHDLIQMGKRP 1068 (1142)
Q Consensus 1046 G~~Pf~~-~~-~~el~~~I~~~~~p 1068 (1142)
|+.||.. .. ..++.+.+..+..+
T Consensus 196 g~~pf~~~~~~~~~~~~~~~~~~~~ 220 (225)
T smart00221 196 GPEPFSGEGEFTSLLSDVWSFGVPL 220 (225)
T ss_pred CCCCccccchhHHHHHHHHhcCCcc
Confidence 9999976 33 33566777666543
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.1e-25 Score=281.62 Aligned_cols=225 Identities=12% Similarity=0.118 Sum_probs=149.8
Q ss_pred hhCCC-CCccceeeeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHH
Q 001142 865 GALRH-SCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALV 943 (1142)
Q Consensus 865 ~~L~H-pNIVkl~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~ 943 (1142)
+.+.| +||+++++++..... + +......+++|||+. ++|.+++.. ....+++.+++.|++||+.||.
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~----~---~~~~~~~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~ 94 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNL----D---GLDDDSIVRALECED-VSLRQWLDN----PDRSVDAFECFHVFRQIVEIVN 94 (793)
T ss_pred chhhHHHHHHHhhcccCCccc----c---ccccchhhhhhccCC-ccHHHHHhc----ccccccHHHHHHHHHHHHHHHH
Confidence 35556 688888888743210 0 011223578899884 799999964 2346999999999999999999
Q ss_pred HHHhCCccccCCCCCCeeecccccc------------CCCCCeEEEeecCCcccccccccc---cccccCC---CCCCCC
Q 001142 944 ELHSKHIMHRDIKSENILIDLERKK------------ADGKPVVKLCDFDRAVPLRSFLHT---CCIAHRG---IPAPDV 1005 (1142)
Q Consensus 944 yLHs~gIvHrDLKp~NILld~~~~~------------~~~~~~vKL~DFGlA~~l~~~~~~---~~~~~~~---~~~~~~ 1005 (1142)
|||++||+||||||+||||+..+.. ....+.+|++|||+++........ ......+ ......
T Consensus 95 ~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (793)
T PLN00181 95 AAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQIL 174 (793)
T ss_pred HHHhCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccc
Confidence 9999999999999999999653110 011256777777777543211000 0000000 001122
Q ss_pred ccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccc
Q 001142 1006 CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEV 1085 (1142)
Q Consensus 1006 ~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~ 1085 (1142)
..||+.|||||++.+ ..|+.++|||||||+||||++|..|+... ......+.....+..
T Consensus 175 ~~gt~~Y~APE~~~~----~~~~~~sDVwSlGviL~ELl~~~~~~~~~--~~~~~~~~~~~~~~~--------------- 233 (793)
T PLN00181 175 AMEMSWYTSPEEDNG----SSSNCASDVYRLGVLLFELFCPVSSREEK--SRTMSSLRHRVLPPQ--------------- 233 (793)
T ss_pred cCCCcceEChhhhcc----CCCCchhhhhhHHHHHHHHhhCCCchhhH--HHHHHHHHHhhcChh---------------
Confidence 468999999999876 56899999999999999999998887532 112222211111100
Q ss_pred cccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001142 1086 AQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1134 (1142)
Q Consensus 1086 ~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~~ 1134 (1142)
.........+++.+||+.||.+||++.|+++|+|+..
T Consensus 234 ------------~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~ 270 (793)
T PLN00181 234 ------------ILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINE 270 (793)
T ss_pred ------------hhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhh
Confidence 0011223567889999999999999999999999864
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-25 Score=257.72 Aligned_cols=161 Identities=28% Similarity=0.356 Sum_probs=127.4
Q ss_pred CchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCcccCC
Q 001142 106 FPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGC 185 (1142)
Q Consensus 106 lP~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~ 185 (1142)
||.++..|.+|..+||+.|++...|..+..+.+|+.|+||+|.+.. +--..+.+.+|+.|+|++|+++.+|..+..
T Consensus 214 ~Ptsld~l~NL~dvDlS~N~Lp~vPecly~l~~LrrLNLS~N~ite----L~~~~~~W~~lEtLNlSrNQLt~LP~avcK 289 (1255)
T KOG0444|consen 214 IPTSLDDLHNLRDVDLSENNLPIVPECLYKLRNLRRLNLSGNKITE----LNMTEGEWENLETLNLSRNQLTVLPDAVCK 289 (1255)
T ss_pred CCCchhhhhhhhhccccccCCCcchHHHhhhhhhheeccCcCceee----eeccHHHHhhhhhhccccchhccchHHHhh
Confidence 3444444555555555555555555555556666666666644332 222334556777888888888889999999
Q ss_pred CCCCCEEEccCCCCC--ccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEE
Q 001142 186 LSNLEQLDLSFNKMK--YLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLN 263 (1142)
Q Consensus 186 L~~L~~L~Ls~N~L~--~lP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~ 263 (1142)
|++|+.|++.+|+|+ .||+.|+.|.+|+.+.+++|.|.-+|.++..|..|+.|.|++|+|-.+|. .+.-|+.|+.||
T Consensus 290 L~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LElVPEglcRC~kL~kL~L~~NrLiTLPe-aIHlL~~l~vLD 368 (1255)
T KOG0444|consen 290 LTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLELVPEGLCRCVKLQKLKLDHNRLITLPE-AIHLLPDLKVLD 368 (1255)
T ss_pred hHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccccCchhhhhhHHHHHhcccccceeechh-hhhhcCCcceee
Confidence 999999999999998 89999999999999999999999999999999999999999999998764 899999999999
Q ss_pred ccCCCCCC
Q 001142 264 LQYNKLLS 271 (1142)
Q Consensus 264 Ls~N~L~~ 271 (1142)
|..|+=--
T Consensus 369 lreNpnLV 376 (1255)
T KOG0444|consen 369 LRENPNLV 376 (1255)
T ss_pred ccCCcCcc
Confidence 99998544
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.3e-23 Score=214.64 Aligned_cols=168 Identities=24% Similarity=0.307 Sum_probs=126.3
Q ss_pred CCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccc
Q 001142 909 GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS 988 (1142)
Q Consensus 909 gSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~ 988 (1142)
|||.++++.. ...+++..++.|+.||+.||.|||+++ ||+|||++.+ +.+|+ ||.+.....
T Consensus 1 GsL~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~-------~~~~~--fG~~~~~~~ 61 (176)
T smart00750 1 VSLADILEVR----GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWD-------GLLKL--DGSVAFKTP 61 (176)
T ss_pred CcHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCc-------cceee--ccceEeecc
Confidence 6899999752 346999999999999999999999998 9999999887 77888 999865432
Q ss_pred cccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCC
Q 001142 989 FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL-EIHDLIQMGKR 1067 (1142)
Q Consensus 989 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~Pf~~~~~~-el~~~I~~~~~ 1067 (1142)
. ...||+.|||||++.+ ..++.++|||||||++|||++|+.||...... .....+.....
T Consensus 62 ~---------------~~~g~~~y~aPE~~~~----~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 122 (176)
T smart00750 62 E---------------QSRVDPYFMAPEVIQG----QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMP 122 (176)
T ss_pred c---------------cCCCcccccChHHhcC----CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhc
Confidence 1 1248899999999976 56889999999999999999999999754322 22222222111
Q ss_pred CCchhHHhhhcccccccccccCCCCCCchhhhhhHH--HHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001142 1068 PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLS--FLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1068 p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~~s 1135 (1142)
+..+.. .. ....... .+.+++.+||..||.+||++.|+++|+|....
T Consensus 123 ~~~~~~--------------------~~-~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 123 ADDPRD--------------------RS-NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred cCCccc--------------------cc-cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 110000 00 0012222 68999999999999999999999999998754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.4e-26 Score=250.15 Aligned_cols=243 Identities=27% Similarity=0.359 Sum_probs=184.6
Q ss_pred CcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEE
Q 001142 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLK 97 (1142)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~ 97 (1142)
.++++.+..|.+..+. ..+.++..|.+|++++|+++..+|. + +.+..++.|+.++|++.++|++++.+.+|..|+
T Consensus 46 ~l~~lils~N~l~~l~-~dl~nL~~l~vl~~~~n~l~~lp~a-i---g~l~~l~~l~vs~n~ls~lp~~i~s~~~l~~l~ 120 (565)
T KOG0472|consen 46 DLQKLILSHNDLEVLR-EDLKNLACLTVLNVHDNKLSQLPAA-I---GELEALKSLNVSHNKLSELPEQIGSLISLVKLD 120 (565)
T ss_pred chhhhhhccCchhhcc-HhhhcccceeEEEeccchhhhCCHH-H---HHHHHHHHhhcccchHhhccHHHhhhhhhhhhh
Confidence 3677888999999886 4678999999999999999977665 4 444889999999999999999999999999999
Q ss_pred ccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCC
Q 001142 98 FFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIR 177 (1142)
Q Consensus 98 Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~ 177 (1142)
.++|.+.++|++++.+..|..|+..+|++...|..+..+.+|..|++.+|.+ ..+|+..-+++.|+.|+..+|-++
T Consensus 121 ~s~n~~~el~~~i~~~~~l~dl~~~~N~i~slp~~~~~~~~l~~l~~~~n~l----~~l~~~~i~m~~L~~ld~~~N~L~ 196 (565)
T KOG0472|consen 121 CSSNELKELPDSIGRLLDLEDLDATNNQISSLPEDMVNLSKLSKLDLEGNKL----KALPENHIAMKRLKHLDCNSNLLE 196 (565)
T ss_pred ccccceeecCchHHHHhhhhhhhccccccccCchHHHHHHHHHHhhccccch----hhCCHHHHHHHHHHhcccchhhhh
Confidence 9999999999999999999999999999999998888888888888887443 334444444666677777777777
Q ss_pred ccCcccCCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCcccc-CCCCCCEEeCcCCcCCCCCcccccCC
Q 001142 178 YLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLY-LLQRLENLDLSNNRLTSLGSLDLCLM 256 (1142)
Q Consensus 178 ~IP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~-~L~~L~~L~Ls~N~Ls~~~p~~l~~L 256 (1142)
.+|+.++.|.+|..|||.+|+|..+| +|..+..|.+|+++.|+|+.+|.+.. +|.+|..|||..|+|+..|. .++.+
T Consensus 197 tlP~~lg~l~~L~~LyL~~Nki~~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklke~Pd-e~clL 274 (565)
T KOG0472|consen 197 TLPPELGGLESLELLYLRRNKIRFLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLKEVPD-EICLL 274 (565)
T ss_pred cCChhhcchhhhHHHHhhhcccccCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccccCch-HHHHh
Confidence 77777777777777777777776666 56666666666666666666666655 46666666666666666543 55666
Q ss_pred CCCCEEEccCCCCCC
Q 001142 257 HNLQNLNLQYNKLLS 271 (1142)
Q Consensus 257 ~~L~~L~Ls~N~L~~ 271 (1142)
.+|..||+|+|.+++
T Consensus 275 rsL~rLDlSNN~is~ 289 (565)
T KOG0472|consen 275 RSLERLDLSNNDISS 289 (565)
T ss_pred hhhhhhcccCCcccc
Confidence 666666666666665
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-24 Score=238.47 Aligned_cols=123 Identities=20% Similarity=0.255 Sum_probs=83.6
Q ss_pred cccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCcccc-CCcCCcEEE
Q 001142 19 KEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVG-RYEKLRNLK 97 (1142)
Q Consensus 19 l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~-~L~~L~~L~ 97 (1142)
+++|+...|-++.++ ..++++..|..|||.+|+|...+ + | .++..|.+|++..|.|..+|.+.. +|.+|.+||
T Consensus 185 L~~ld~~~N~L~tlP-~~lg~l~~L~~LyL~~Nki~~lP-e-f---~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLD 258 (565)
T KOG0472|consen 185 LKHLDCNSNLLETLP-PELGGLESLELLYLRRNKIRFLP-E-F---PGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLD 258 (565)
T ss_pred HHhcccchhhhhcCC-hhhcchhhhHHHHhhhcccccCC-C-C---CccHHHHHHHhcccHHHhhHHHHhcccccceeee
Confidence 455555555555554 35666667777777777766433 2 3 344667777777777777776644 677777777
Q ss_pred ccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCC
Q 001142 98 FFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVP 148 (1142)
Q Consensus 98 Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~ 148 (1142)
|..|+|+++|.++.-|.+|.+||+++|.++.+|..+++| .|+.|.+.+|+
T Consensus 259 LRdNklke~Pde~clLrsL~rLDlSNN~is~Lp~sLgnl-hL~~L~leGNP 308 (565)
T KOG0472|consen 259 LRDNKLKEVPDEICLLRSLERLDLSNNDISSLPYSLGNL-HLKFLALEGNP 308 (565)
T ss_pred ccccccccCchHHHHhhhhhhhcccCCccccCCcccccc-eeeehhhcCCc
Confidence 777777777777777777777777777777777777777 77777777665
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.6e-20 Score=215.69 Aligned_cols=270 Identities=21% Similarity=0.212 Sum_probs=188.2
Q ss_pred CcceeeeecccCceEEEEEEECCc---cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCC----CCccceeeeEe
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFGSA---DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH----SCIVEMYGHKI 880 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~~~---~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H----pNIVkl~g~~~ 880 (1142)
.|.+.++||+|+||.||+|..... .+|+|+.......... . +..|+.++..+.. +++..+++.+.
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~----~----l~~E~~vl~~l~~~~~~~~~~~~~~~G~ 90 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS----V----LKIEIQVLKKLEKKNGPSHFPKLLDHGR 90 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc----c----chhHHHHHHHHhhhcCCCCCCEEEEecc
Confidence 899999999999999999998554 5788875433221111 1 2568888888762 58888888874
Q ss_pred -cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 001142 881 -SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959 (1142)
Q Consensus 881 -~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~N 959 (1142)
... ..++||+.+ |.+|.++.... +...++...+.+|+.|++.+|++||+.|++||||||.|
T Consensus 91 ~~~~--------------~~~iVM~l~-G~sL~dl~~~~---~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N 152 (322)
T KOG1164|consen 91 STED--------------FNFIVMSLL-GPSLEDLRKRN---PPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPEN 152 (322)
T ss_pred CCCc--------------eeEEEEecc-CccHHHHHHhC---CCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHH
Confidence 333 239999999 79999988652 24679999999999999999999999999999999999
Q ss_pred eeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001142 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039 (1142)
Q Consensus 960 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGvi 1039 (1142)
+++.... ......+.|.|||+|+.....................+.||..|+++.+..+ ...+.+.|+||++.+
T Consensus 153 ~~~g~~~--~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~----~e~~r~DDles~~Y~ 226 (322)
T KOG1164|consen 153 FVVGQSS--RSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG----IEQGRRDDLESLFYM 226 (322)
T ss_pred eeecCCC--CcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCC----CccCCchhhhhHHHH
Confidence 9997652 0111469999999998433211111000011111345669999999999876 567899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001142 1040 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1119 (1142)
Q Consensus 1040 L~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~ 1119 (1142)
+.|+..|..||.+.........+........... .....+..+.++...+-..+...
T Consensus 227 l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~ 283 (322)
T KOG1164|consen 227 LLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDR-----------------------FGDLKPEEFAKILEYIDSLDYED 283 (322)
T ss_pred HHHHhcCCCCCccccccchHHHHHHHhhhhcccc-----------------------ccCCChHHHHHHHHHhhccCCcC
Confidence 9999999999976543222222211110000000 00023445677777777789999
Q ss_pred CCCHHHHHHHHHh
Q 001142 1120 RPTAGDLYEMFVA 1132 (1142)
Q Consensus 1120 RPSa~EVL~~L~~ 1132 (1142)
+|....+...+..
T Consensus 284 ~Pdy~~~~~~l~~ 296 (322)
T KOG1164|consen 284 KPDYEKLAELLKD 296 (322)
T ss_pred CCCHHHHHHHHHH
Confidence 9999888776544
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.4e-23 Score=232.33 Aligned_cols=270 Identities=22% Similarity=0.273 Sum_probs=220.1
Q ss_pred CCCCCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEee-cCCCCccCc-cccCCc
Q 001142 14 PEGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLY-KNVLNLIPK-SVGRYE 91 (1142)
Q Consensus 14 ~~~~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls-~N~Lt~iP~-~l~~L~ 91 (1142)
+-|+.+..|.++.|.|+.|++++|+.+++|+.||||+|+|+.+-|..|..+ .+|..|-|. +|+|+.||. .|.+|.
T Consensus 64 ~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL---~~l~~Lvlyg~NkI~~l~k~~F~gL~ 140 (498)
T KOG4237|consen 64 NLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGL---ASLLSLVLYGNNKITDLPKGAFGGLS 140 (498)
T ss_pred cCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhh---HhhhHHHhhcCCchhhhhhhHhhhHH
Confidence 345568889999999999999999999999999999999999999887655 777777665 599999996 699999
Q ss_pred CCcEEEccCCCCCcCc-hhhcCCCCCCEEEccCCCCCCCcc-cccCCCCCCEEECCCCCCC---C------Ccccchhhh
Q 001142 92 KLRNLKFFGNEINLFP-SEVGNLLGLECLQIKISSPGVNGF-ALNKLKGLKELELSKVPPR---P------SVLTLLSEI 160 (1142)
Q Consensus 92 ~L~~L~Ls~N~L~~lP-~~l~~L~~L~~L~Ls~N~l~~~~~-~~~~L~~L~~L~Ls~n~~n---~------~~~~lp~~l 160 (1142)
+|+.|.|.-|++.-++ ..|..|++|..|.|..|.+..+.. +|..+..++.|.+..|++- + .....|..+
T Consensus 141 slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~iet 220 (498)
T KOG4237|consen 141 SLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIET 220 (498)
T ss_pred HHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhc
Confidence 9999999999999665 458889999999999999888875 8999999999999887721 1 111223333
Q ss_pred cCCCCCcEEEccC--------------------------CCCCccCc-ccCCCCCCCEEEccCCCCCcc-chhhcCCCCC
Q 001142 161 AGLKCLTKLSVCH--------------------------FSIRYLPP-EIGCLSNLEQLDLSFNKMKYL-PTEICYLKAL 212 (1142)
Q Consensus 161 ~~L~~L~~L~Ls~--------------------------N~L~~IP~-~l~~L~~L~~L~Ls~N~L~~l-P~~l~~L~~L 212 (1142)
+......-..+.+ +....-|. .|..|++|+.|+|++|+|+.| +.+|..+..|
T Consensus 221 sgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l 300 (498)
T KOG4237|consen 221 SGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAEL 300 (498)
T ss_pred ccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhh
Confidence 3332222222222 22222344 578899999999999999988 7889999999
Q ss_pred CEEEccCCCCCccCcccc-CCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccCCCCCCCCCCCchhhccCCCC
Q 001142 213 ISLKVANNKLVELPSGLY-LLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGN 286 (1142)
Q Consensus 213 ~~L~Ls~N~Ls~IP~~l~-~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~~n 286 (1142)
+.|.|..|+|..+-..++ ++..|+.|+|.+|+|+.+.|..|..+.+|..|+|-.|+|.|.|.+-+.-.|+-...
T Consensus 301 ~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~ 375 (498)
T KOG4237|consen 301 QELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKS 375 (498)
T ss_pred hhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhCC
Confidence 999999999998866655 59999999999999999999999999999999999999999999887766765544
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.5e-20 Score=202.80 Aligned_cols=217 Identities=22% Similarity=0.278 Sum_probs=171.4
Q ss_pred CcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEecCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKW 884 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~g~~~~~~~ 884 (1142)
.|+++++||+|+||+++.|+. ++..||+|....+. ..+ ++ ..|.+..+.|. .+.|..+|-+..+..
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS---~AP---QL----rdEYr~YKlL~g~~GIP~vYYFGqeG~- 97 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS---EAP---QL----RDEYRTYKLLGGTEGIPQVYYFGQEGK- 97 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccC---Ccc---hH----HHHHHHHHHHcCCCCCCceeeeccccc-
Confidence 589999999999999999986 78899999754332 222 22 56888888884 789998887665433
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
+-.||||++ |.||++++.-+ +..|+.+.+..||.|++.-++|+|++.+|+|||||+|+||..
T Consensus 98 -------------~NiLVidLL-GPSLEDLFD~C----gR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGr 159 (449)
T KOG1165|consen 98 -------------YNILVIDLL-GPSLEDLFDLC----GRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGR 159 (449)
T ss_pred -------------hhhhhhhhh-CcCHHHHHHHh----cCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecC
Confidence 238999999 79999998763 467999999999999999999999999999999999999976
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
.+ ......+.++|||+|+.+.+.... .+.+........||..||+-....+ ..-+.+-|+-|+|.++...|
T Consensus 160 p~--~k~~n~IhiiDFGmAK~YrDp~Tk---qHIPYrE~KSLsGTARYMSINTHlG----rEQSRRDDLEaLGHvFmYFL 230 (449)
T KOG1165|consen 160 PG--TKDANVIHIIDFGMAKEYRDPKTK---QHIPYREHKSLSGTARYMSINTHLG----REQSRRDDLEALGHVFMYFL 230 (449)
T ss_pred CC--CCCCceEEEEeccchhhhcCcccc---ccCccccccccccceeeeEeecccc----chhhhhhhHHHhhhhhhhhc
Confidence 53 233467999999999987765432 2333334456679999999888776 45578999999999999999
Q ss_pred hCCCCCCCCC---HHHHHHHH
Q 001142 1045 TLQVPYMGLS---ELEIHDLI 1062 (1142)
Q Consensus 1045 tG~~Pf~~~~---~~el~~~I 1062 (1142)
-|..||++.. ..+-++.|
T Consensus 231 RGsLPWQGLKA~tnK~kYeKI 251 (449)
T KOG1165|consen 231 RGSLPWQGLKADTNKEKYEKI 251 (449)
T ss_pred cCCCccccccCcchHHHHHHh
Confidence 9999999753 34445555
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-19 Score=199.94 Aligned_cols=273 Identities=31% Similarity=0.396 Sum_probs=196.1
Q ss_pred cceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCC-CccceeeeEecCCCCCC
Q 001142 809 LSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS-CIVEMYGHKISSKWLPS 887 (1142)
Q Consensus 809 y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp-NIVkl~g~~~~~~~~~~ 887 (1142)
|.+.+.||.|+||.||++.+. ..+++|+...... ... .....+.+|+.++..+.|+ +|+++++++....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~--~~~---~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~---- 71 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLE--SKS---KEVERFLREIQILASLNHPPNIVKLYDFFQDEG---- 71 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhc--cch---hHHHHHHHHHHHHHHccCCcceeeEEEEEecCC----
Confidence 788999999999999999988 6667776543322 111 1223348999999999977 7999999985433
Q ss_pred CCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccc
Q 001142 888 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 967 (1142)
Q Consensus 888 ~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~ 967 (1142)
..+++++|+.++++.+++...... ..++...+..++.|++.++.|+|+.+++|||+||+||+++..
T Consensus 72 ----------~~~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~-- 137 (384)
T COG0515 72 ----------SLYLVMEYVDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRD-- 137 (384)
T ss_pred ----------EEEEEEecCCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCC--
Confidence 259999999999999777652111 268999999999999999999999999999999999999876
Q ss_pred cCCCCC-eEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001142 968 KADGKP-VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1046 (1142)
Q Consensus 968 ~~~~~~-~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG 1046 (1142)
. .++++|||.+............ ........||..|+|||.+.+.. ...+....|+||+|++++++++|
T Consensus 138 -----~~~~~l~dfg~~~~~~~~~~~~~~----~~~~~~~~~t~~~~~pe~~~~~~-~~~~~~~~D~~s~g~~~~~~~~~ 207 (384)
T COG0515 138 -----GRVVKLIDFGLAKLLPDPGSTSSI----PALPSTSVGTPGYMAPEVLLGLS-LAYASSSSDIWSLGITLYELLTG 207 (384)
T ss_pred -----CCeEEEeccCcceecCCCCccccc----cccccccccccccCCHHHhcCCC-CCCCCchHhHHHHHHHHHHHHhC
Confidence 4 6999999999754432211000 01224567999999999987521 13567899999999999999999
Q ss_pred CCCCCCCCH----HHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1047 QVPYMGLSE----LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1047 ~~Pf~~~~~----~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
..||..... ......+.....+....... ... . ......+.+++..|+..+|..|.+
T Consensus 208 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~--~---~~~~~~~~~~~~~~~~~~~~~r~~ 268 (384)
T COG0515 208 LPPFEGEKNSSATSQTLKIILELPTPSLASPLS--------------PSN--P---ELISKAASDLLKKLLAKDPKNRLS 268 (384)
T ss_pred CCCCCCCCccccHHHHHHHHHhcCCcccccccC--------------ccc--c---chhhHHHHHHHHHHHhcCchhcCC
Confidence 999876542 34444443333220000000 000 0 122356889999999999999999
Q ss_pred HHHHHHHHHhhc
Q 001142 1123 AGDLYEMFVART 1134 (1142)
Q Consensus 1123 a~EVL~~L~~~~ 1134 (1142)
+.+...+.+...
T Consensus 269 ~~~~~~~~~~~~ 280 (384)
T COG0515 269 SSSDLSHDLLAH 280 (384)
T ss_pred HHHHhhchHhhC
Confidence 998887755443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.5e-22 Score=242.41 Aligned_cols=270 Identities=19% Similarity=0.204 Sum_probs=190.4
Q ss_pred CCc-ceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 807 PSL-SSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 807 ~~y-~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
+.| ....++|.|++|.|+.+.. .....+.|.++++ .. .......+...+..|+-+-..++|||++..+..+.+..
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~-~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~ 394 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VK-PTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID 394 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcc-cC-CcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc
Confidence 445 6788999999998877764 2222334433322 11 22233333333577888888999999988877766533
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
.. .-+||||++ +|..++.. ...++..++..++.|++.|++|||..||.|||||++|+++.
T Consensus 395 ~~--------------~~~mE~~~~-Dlf~~~~~-----~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~ 454 (601)
T KOG0590|consen 395 GI--------------LQSMEYCPY-DLFSLVMS-----NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVT 454 (601)
T ss_pred cc--------------hhhhhcccH-HHHHHHhc-----ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEe
Confidence 22 334999998 99999976 24688999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCC-CchhhHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~-s~ksDVwSLGviL~E 1042 (1142)
.. +.+||+|||.+......... ........+|+..|+|||++.+ ..| ....||||.|+++..
T Consensus 455 ~~-------g~lki~Dfg~~~vf~~~~e~------~~~~~~g~~gS~pY~apE~~~~----~~ydpr~vDiwS~~ii~~~ 517 (601)
T KOG0590|consen 455 EN-------GILKIIDFGAASVFRYPWEK------NIHESSGIVGSDPYLAPEVLTG----KEYDPRAVDVWSCGIIYIC 517 (601)
T ss_pred cC-------CceEEeecCcceeeccCcch------hhhhhcCcccCCcCcCcccccc----cccCcchhhhhhccceEEE
Confidence 88 79999999999765433221 0112335679999999999886 344 467999999999999
Q ss_pred HHhCCCCCCCCCHHHHH-HHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1043 LLTLQVPYMGLSELEIH-DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1043 LLtG~~Pf~~~~~~el~-~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
|++|+.||......+.. ............ ..........+...+.+|.+||++||.+|.
T Consensus 518 m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ 577 (601)
T KOG0590|consen 518 MILGRFPWKVAKKSDNSFKTNNYSDQRNIF--------------------EGPNRLLSLLPRETRIIIYRMLQLDPTKRI 577 (601)
T ss_pred EecCCCccccccccccchhhhccccccccc--------------------cChHHHHHhchhhHHHHHHHHccCChhhee
Confidence 99999999743222111 010000000000 000111125566788999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001142 1122 TAGDLYEMFVARTS 1135 (1142)
Q Consensus 1122 Sa~EVL~~L~~~~s 1135 (1142)
|+++|++..|++.-
T Consensus 578 ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 578 TIEQILNDEWIRSI 591 (601)
T ss_pred cHHHHhhChHhhhc
Confidence 99999999999853
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.9e-21 Score=239.79 Aligned_cols=223 Identities=22% Similarity=0.265 Sum_probs=170.7
Q ss_pred cccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEEc
Q 001142 19 KEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKF 98 (1142)
Q Consensus 19 l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~L 98 (1142)
...|.+..+.|+.++.. + .++|+.|+|++|+|+.++...+ ++|++|+|++|+|+.||..+.. +|+.|+|
T Consensus 180 ~~~L~L~~~~LtsLP~~-I--p~~L~~L~Ls~N~LtsLP~~l~------~nL~~L~Ls~N~LtsLP~~l~~--~L~~L~L 248 (754)
T PRK15370 180 KTELRLKILGLTTIPAC-I--PEQITTLILDNNELKSLPENLQ------GNIKTLYANSNQLTSIPATLPD--TIQEMEL 248 (754)
T ss_pred ceEEEeCCCCcCcCCcc-c--ccCCcEEEecCCCCCcCChhhc------cCCCEEECCCCccccCChhhhc--cccEEEC
Confidence 45677778888877643 2 2478899999999886543322 5789999999999988876643 7889999
Q ss_pred cCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCc
Q 001142 99 FGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRY 178 (1142)
Q Consensus 99 s~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~ 178 (1142)
++|+|+.||..+. ++|+.|+|++|++..+|..+. .+|+.|+|++|.+.. +|..+. ++|+.|++++|+|+.
T Consensus 249 s~N~L~~LP~~l~--s~L~~L~Ls~N~L~~LP~~l~--~sL~~L~Ls~N~Lt~----LP~~lp--~sL~~L~Ls~N~Lt~ 318 (754)
T PRK15370 249 SINRITELPERLP--SALQSLDLFHNKISCLPENLP--EELRYLSVYDNSIRT----LPAHLP--SGITHLNVQSNSLTA 318 (754)
T ss_pred cCCccCcCChhHh--CCCCEEECcCCccCccccccC--CCCcEEECCCCcccc----Ccccch--hhHHHHHhcCCcccc
Confidence 9999998888775 578899999888887776543 478999998876653 343332 367788888998888
Q ss_pred cCcccCCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeCcCCcCCCCCcccccCCCC
Q 001142 179 LPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHN 258 (1142)
Q Consensus 179 IP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~ 258 (1142)
+|..+. ++|+.|++++|.|+.||..+. ++|+.|+|++|+|+.||..+. ++|+.|+|++|+|+.+|+. +. ..
T Consensus 319 LP~~l~--~sL~~L~Ls~N~Lt~LP~~l~--~sL~~L~Ls~N~L~~LP~~lp--~~L~~LdLs~N~Lt~LP~~-l~--~s 389 (754)
T PRK15370 319 LPETLP--PGLKTLEAGENALTSLPASLP--PELQVLDVSKNQITVLPETLP--PTITTLDVSRNALTNLPEN-LP--AA 389 (754)
T ss_pred CCcccc--ccceeccccCCccccCChhhc--CcccEEECCCCCCCcCChhhc--CCcCEEECCCCcCCCCCHh-HH--HH
Confidence 887543 678888999999888887664 688899999999888887664 5788999999998887663 32 36
Q ss_pred CCEEEccCCCCCC
Q 001142 259 LQNLNLQYNKLLS 271 (1142)
Q Consensus 259 L~~L~Ls~N~L~~ 271 (1142)
|+.|++++|+|+.
T Consensus 390 L~~LdLs~N~L~~ 402 (754)
T PRK15370 390 LQIMQASRNNLVR 402 (754)
T ss_pred HHHHhhccCCccc
Confidence 8888899998886
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-20 Score=233.65 Aligned_cols=213 Identities=25% Similarity=0.213 Sum_probs=120.5
Q ss_pred ccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEEcc
Q 001142 20 EKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFF 99 (1142)
Q Consensus 20 ~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls 99 (1142)
..|.+..|+|+.++.. +. ++|+.|+|++|+|+.+ |.. +++|++|+|++|+|+.||.. .++|+.|+|+
T Consensus 204 ~~LdLs~~~LtsLP~~-l~--~~L~~L~L~~N~Lt~L-P~l------p~~Lk~LdLs~N~LtsLP~l---p~sL~~L~Ls 270 (788)
T PRK15387 204 AVLNVGESGLTTLPDC-LP--AHITTLVIPDNNLTSL-PAL------PPELRTLEVSGNQLTSLPVL---PPGLLELSIF 270 (788)
T ss_pred cEEEcCCCCCCcCCcc-hh--cCCCEEEccCCcCCCC-CCC------CCCCcEEEecCCccCcccCc---ccccceeecc
Confidence 3456666666666542 22 3567777777777653 321 25667777777777766643 2356667777
Q ss_pred CCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCcc
Q 001142 100 GNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYL 179 (1142)
Q Consensus 100 ~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~I 179 (1142)
+|.|+.+|..+ ++|+.|+|++|++..+|.. +++|+.|+|++|.+.. +|.. ..+|+.|++++|+|+.|
T Consensus 271 ~N~L~~Lp~lp---~~L~~L~Ls~N~Lt~LP~~---p~~L~~LdLS~N~L~~----Lp~l---p~~L~~L~Ls~N~L~~L 337 (788)
T PRK15387 271 SNPLTHLPALP---SGLCKLWIFGNQLTSLPVL---PPGLQELSVSDNQLAS----LPAL---PSELCKLWAYNNQLTSL 337 (788)
T ss_pred CCchhhhhhch---hhcCEEECcCCcccccccc---ccccceeECCCCcccc----CCCC---cccccccccccCccccc
Confidence 77766666532 4566666666666655532 3556666666654432 2221 12345556666666666
Q ss_pred CcccCCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeCcCCcCCCCCcccccCCCCC
Q 001142 180 PPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNL 259 (1142)
Q Consensus 180 P~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L 259 (1142)
|.. ..+|+.|+|++|+|+.||.. ..+|+.|++++|+|+.||... .+|+.|+|++|+|+++++ . .++|
T Consensus 338 P~l---p~~Lq~LdLS~N~Ls~LP~l---p~~L~~L~Ls~N~L~~LP~l~---~~L~~LdLs~N~Lt~LP~-l---~s~L 404 (788)
T PRK15387 338 PTL---PSGLQELSVSDNQLASLPTL---PSELYKLWAYNNRLTSLPALP---SGLKELIVSGNRLTSLPV-L---PSEL 404 (788)
T ss_pred ccc---ccccceEecCCCccCCCCCC---CcccceehhhccccccCcccc---cccceEEecCCcccCCCC-c---ccCC
Confidence 541 23566666666666666542 234555666666666665432 345666666666665443 1 2456
Q ss_pred CEEEccCCCCCC
Q 001142 260 QNLNLQYNKLLS 271 (1142)
Q Consensus 260 ~~L~Ls~N~L~~ 271 (1142)
+.|+|++|+|+.
T Consensus 405 ~~LdLS~N~Lss 416 (788)
T PRK15387 405 KELMVSGNRLTS 416 (788)
T ss_pred CEEEccCCcCCC
Confidence 666666666655
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=9e-21 Score=236.51 Aligned_cols=225 Identities=19% Similarity=0.247 Sum_probs=96.0
Q ss_pred cccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEEc
Q 001142 19 KEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKF 98 (1142)
Q Consensus 19 l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~L 98 (1142)
+..|.+..|+|+.++...+ ++|++|+|++|+|+.+ |..+. .+|+.|+|++|.|+.||..+. .+|+.|+|
T Consensus 201 L~~L~Ls~N~LtsLP~~l~---~nL~~L~Ls~N~LtsL-P~~l~-----~~L~~L~Ls~N~L~~LP~~l~--s~L~~L~L 269 (754)
T PRK15370 201 ITTLILDNNELKSLPENLQ---GNIKTLYANSNQLTSI-PATLP-----DTIQEMELSINRITELPERLP--SALQSLDL 269 (754)
T ss_pred CcEEEecCCCCCcCChhhc---cCCCEEECCCCccccC-Chhhh-----ccccEEECcCCccCcCChhHh--CCCCEEEC
Confidence 4444444444444443322 2444455555544432 22111 234445555554444444432 24445555
Q ss_pred cCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCc
Q 001142 99 FGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRY 178 (1142)
Q Consensus 99 s~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~ 178 (1142)
++|+|+.||..+. .+|+.|+|++|++..+|..+. .+|+.|++++|.+.. +|..+ .++|+.|++++|.|+.
T Consensus 270 s~N~L~~LP~~l~--~sL~~L~Ls~N~Lt~LP~~lp--~sL~~L~Ls~N~Lt~----LP~~l--~~sL~~L~Ls~N~Lt~ 339 (754)
T PRK15370 270 FHNKISCLPENLP--EELRYLSVYDNSIRTLPAHLP--SGITHLNVQSNSLTA----LPETL--PPGLKTLEAGENALTS 339 (754)
T ss_pred cCCccCccccccC--CCCcEEECCCCccccCcccch--hhHHHHHhcCCcccc----CCccc--cccceeccccCCcccc
Confidence 5555544444332 244445554444444433221 234444444433321 22211 1344444455554444
Q ss_pred cCcccCCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeCcCCcCCCCCc---ccccC
Q 001142 179 LPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGS---LDLCL 255 (1142)
Q Consensus 179 IP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls~N~Ls~~~p---~~l~~ 255 (1142)
+|..+. ++|+.|+|++|+|+.+|..+. ++|+.|+|++|+|+.||..+. ..|+.|++++|+|++++. ..+..
T Consensus 340 LP~~l~--~sL~~L~Ls~N~L~~LP~~lp--~~L~~LdLs~N~Lt~LP~~l~--~sL~~LdLs~N~L~~LP~sl~~~~~~ 413 (754)
T PRK15370 340 LPASLP--PELQVLDVSKNQITVLPETLP--PTITTLDVSRNALTNLPENLP--AALQIMQASRNNLVRLPESLPHFRGE 413 (754)
T ss_pred CChhhc--CcccEEECCCCCCCcCChhhc--CCcCEEECCCCcCCCCCHhHH--HHHHHHhhccCCcccCchhHHHHhhc
Confidence 444332 344455555555444444332 344455555555544444433 134444455555443321 11222
Q ss_pred CCCCCEEEccCCCCC
Q 001142 256 MHNLQNLNLQYNKLL 270 (1142)
Q Consensus 256 L~~L~~L~Ls~N~L~ 270 (1142)
++.+..|+|.+|+|+
T Consensus 414 ~~~l~~L~L~~Npls 428 (754)
T PRK15370 414 GPQPTRIIVEYNPFS 428 (754)
T ss_pred CCCccEEEeeCCCcc
Confidence 344444555555443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.5e-21 Score=201.79 Aligned_cols=259 Identities=25% Similarity=0.337 Sum_probs=197.8
Q ss_pred CCCCCCCCCCcceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeee
Q 001142 799 SGLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 878 (1142)
Q Consensus 799 ~~~~~~~~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~ 878 (1142)
..+...++.++.+.-+|.+...|..|+|+|.+.++++|+..+.. ......++| ..|.-.|+-+.||||..++|.
T Consensus 182 sr~~gid~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~--~t~risrdf----neefp~lrifshpnilpvlga 255 (448)
T KOG0195|consen 182 SRYTGIDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVRE--VTARISRDF----NEEFPALRIFSHPNILPVLGA 255 (448)
T ss_pred ccccCcchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhh--cchhhcchh----hhhCcceeeecCCchhhhhhh
Confidence 34445567778889999999999999999999999999865443 333334455 678888888899999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-C-ccccCCC
Q 001142 879 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-H-IMHRDIK 956 (1142)
Q Consensus 879 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~-g-IvHrDLK 956 (1142)
+.... ++.++..|++.|||+..++. ......+..++.+++.+|++|++|||+. . |.---|.
T Consensus 256 cnspp--------------nlv~isq~mp~gslynvlhe---~t~vvvd~sqav~faldiargmaflhslep~ipr~~ln 318 (448)
T KOG0195|consen 256 CNSPP--------------NLVIISQYMPFGSLYNVLHE---QTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLN 318 (448)
T ss_pred ccCCC--------------CceEeeeeccchHHHHHHhc---CccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcc
Confidence 97643 45999999999999999986 3445678899999999999999999986 3 4445688
Q ss_pred CCCeeeccccccCCCCCeEEE--eecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHH
Q 001142 957 SENILIDLERKKADGKPVVKL--CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 1034 (1142)
Q Consensus 957 p~NILld~~~~~~~~~~~vKL--~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVw 1034 (1142)
+..|+||++ .+.+| +|--++.. .....-.|.||+||.++.... ..--.++|+|
T Consensus 319 s~hvmided-------ltarismad~kfsfq-----------------e~gr~y~pawmspealqrkpe-d~n~raadmw 373 (448)
T KOG0195|consen 319 SKHVMIDED-------LTARISMADTKFSFQ-----------------EVGRAYSPAWMSPEALQRKPE-DLNIRAADMW 373 (448)
T ss_pred cceEEecch-------hhhheecccceeeee-----------------ccccccCcccCCHHHHhcCch-hcchhhhhHH
Confidence 999999987 44443 33222210 112235788999999976321 1223689999
Q ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 001142 1035 SYGCLLLELLTLQVPYMGLSELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 1113 (1142)
Q Consensus 1035 SLGviL~ELLtG~~Pf~~~~~~el~~~I-~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL 1113 (1142)
||.+++|||.|...||...++.+.--.| ..+.++.++. ..+..+..|+.-|+
T Consensus 374 sfaillwel~trevpfadlspmecgmkialeglrv~ipp---------------------------gis~hm~klm~icm 426 (448)
T KOG0195|consen 374 SFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPP---------------------------GISRHMNKLMNICM 426 (448)
T ss_pred HHHHHHHHhhccccccccCCchhhhhhhhhccccccCCC---------------------------CccHHHHHHHHHHh
Confidence 9999999999999999988888765444 4454444331 55667899999999
Q ss_pred ccCCCCCCCHHHHHHHHHh
Q 001142 1114 EENPTERPTAGDLYEMFVA 1132 (1142)
Q Consensus 1114 ~~DP~~RPSa~EVL~~L~~ 1132 (1142)
..||.+||.++.|+-.++.
T Consensus 427 nedpgkrpkfdmivpilek 445 (448)
T KOG0195|consen 427 NEDPGKRPKFDMIVPILEK 445 (448)
T ss_pred cCCCCcCCCcceehhhHHH
Confidence 9999999999998877654
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.2e-23 Score=204.38 Aligned_cols=164 Identities=25% Similarity=0.364 Sum_probs=122.0
Q ss_pred CCCCccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECC
Q 001142 66 GDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELS 145 (1142)
Q Consensus 66 ~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls 145 (1142)
.+.+++.|.||+|+|+.+|+.|..|.+|+.|++++|+|+.+|..++.|++|+.|+++.|++...|..|+.++.|+.|||.
T Consensus 31 ~~s~ITrLtLSHNKl~~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~~lprgfgs~p~levldlt 110 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLTVVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLNILPRGFGSFPALEVLDLT 110 (264)
T ss_pred chhhhhhhhcccCceeecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhhcCccccCCCchhhhhhcc
Confidence 45789999999999999999999999999999999999999999999999999999999888888777777777777776
Q ss_pred CCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCcccCCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCcc
Q 001142 146 KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVEL 225 (1142)
Q Consensus 146 ~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~I 225 (1142)
+|.++. ..+|..|..++.|+.|+|+.|.+..+|..+++|++|+.|.|.+|.|-++|.+++.|++|++|++.+|+|+.+
T Consensus 111 ynnl~e--~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll~lpkeig~lt~lrelhiqgnrl~vl 188 (264)
T KOG0617|consen 111 YNNLNE--NSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLLSLPKEIGDLTRLRELHIQGNRLTVL 188 (264)
T ss_pred cccccc--ccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchhhCcHHHHHHHHHHHHhcccceeeec
Confidence 655432 235555555666666666666666666666666666666666666666666666666666666666666666
Q ss_pred CccccC
Q 001142 226 PSGLYL 231 (1142)
Q Consensus 226 P~~l~~ 231 (1142)
|+++++
T Consensus 189 ppel~~ 194 (264)
T KOG0617|consen 189 PPELAN 194 (264)
T ss_pred Chhhhh
Confidence 655554
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.7e-19 Score=188.92 Aligned_cols=211 Identities=18% Similarity=0.228 Sum_probs=162.4
Q ss_pred CCCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCC-CCccceeeeEec
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH-SCIVEMYGHKIS 881 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H-pNIVkl~g~~~~ 881 (1142)
-...|.++++||.|+||.+|+|.. .+..||+|+..-+. ..+ . +..|..+...|+| ..|..+..++.+
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a---~hp---q----L~yEskvY~iL~~g~GiP~i~~y~~e 82 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA---KHP---Q----LLYESKVYRILQGGVGIPHIRHYGTE 82 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC---CCc---c----hhHHHHHHHHhccCCCCchhhhhccc
Confidence 356799999999999999999987 67889999754322 122 1 2578888888864 556666556555
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 001142 882 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 961 (1142)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NIL 961 (1142)
..+- .+||+++ |.||++++.-+ ...++..+++.++-|++.-++|+|.+++|||||||+|+|
T Consensus 83 ~~yn--------------vlVMdLL-GPsLEdLfnfC----~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFL 143 (341)
T KOG1163|consen 83 KDYN--------------VLVMDLL-GPSLEDLFNFC----SRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFL 143 (341)
T ss_pred cccc--------------eeeeecc-CccHHHHHHHH----hhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCcccee
Confidence 4432 8999999 79999998753 356999999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001142 962 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1041 (1142)
Q Consensus 962 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ 1041 (1142)
..-+ .....+.++|||+|+.+.+..... +-+........||..|.+-....+ ..-+.+.|+-|+|.+|.
T Consensus 144 MGlg----rh~~kl~LIDFGLaKky~d~~t~~---HIpyre~r~ltGTaRYASinAh~g----~eqSRRDDmeSvgYvLm 212 (341)
T KOG1163|consen 144 MGLG----RHCNKLYLIDFGLAKKYRDIRTRQ---HIPYREDRNLTGTARYASINAHLG----IEQSRRDDMESVGYVLM 212 (341)
T ss_pred eccc----cccceEEEEeccchhhhccccccc---cCccccCCccceeeeehhhhhhhh----hhhhhhhhhhhhcceee
Confidence 8654 122568999999998876543222 222233445679999998877665 33467899999999999
Q ss_pred HHHhCCCCCCCCCH
Q 001142 1042 ELLTLQVPYMGLSE 1055 (1142)
Q Consensus 1042 ELLtG~~Pf~~~~~ 1055 (1142)
.+.-|..||++...
T Consensus 213 YfnrG~LPWQglka 226 (341)
T KOG1163|consen 213 YFNRGSLPWQGLKA 226 (341)
T ss_pred eeecCCCcccccch
Confidence 99999999998654
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.6e-20 Score=212.59 Aligned_cols=172 Identities=20% Similarity=0.174 Sum_probs=121.5
Q ss_pred CCCcceeeeecccCceEEEEEEEC---CccEEEEEEecccCC-CChHHHHHhHHhHHHHHHHHhhCCCCCccc-eeeeEe
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG---SADAAAKVRTLKVCG-SSADEIRNFEYSCLGEVRMLGALRHSCIVE-MYGHKI 880 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~---~~~vAvKi~~l~~~~-~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVk-l~g~~~ 880 (1142)
...|.+.++||+|+||+||+|.+. +..+|+|+....... ...... ..+.+|+++|++++|+|++. ++++
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~----~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLAR----HLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHH----HHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 356999999999999999999873 455677764311100 011122 23489999999999999985 4332
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC-CCCC
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI-KSEN 959 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDL-Kp~N 959 (1142)
+ ..|+||||++|++|.. +.. .. ...++.|++.||.|||++||+|||| ||+|
T Consensus 91 --~--------------~~~LVmE~~~G~~L~~-~~~--------~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~N 142 (365)
T PRK09188 91 --G--------------KDGLVRGWTEGVPLHL-ARP--------HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQN 142 (365)
T ss_pred --C--------------CcEEEEEccCCCCHHH-hCc--------cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcce
Confidence 1 2399999999999962 211 11 1467899999999999999999999 9999
Q ss_pred eeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhcc
Q 001142 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1020 (1142)
Q Consensus 960 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~ 1020 (1142)
||++.+ +.+||+|||+|+.+.......... .........+++.|+|||++..
T Consensus 143 ILv~~~-------~~ikLiDFGlA~~~~~~~~~~~~~--~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 143 WLMGPD-------GEAAVIDFQLASVFRRRGALYRIA--AYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred EEEcCC-------CCEEEEECccceecccCcchhhhh--hhhhhhhhhccCccCCcccCCh
Confidence 999766 679999999998765432111100 0011125568889999999864
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=5e-20 Score=228.64 Aligned_cols=239 Identities=23% Similarity=0.184 Sum_probs=164.6
Q ss_pred CCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEE
Q 001142 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNL 96 (1142)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L 96 (1142)
+.+..|.+..|+|+.++.. .++|++|+|++|+|+.+ |..+ ++|+.|+|++|.|+.+|..+ ++|+.|
T Consensus 222 ~~L~~L~L~~N~Lt~LP~l----p~~Lk~LdLs~N~LtsL-P~lp------~sL~~L~Ls~N~L~~Lp~lp---~~L~~L 287 (788)
T PRK15387 222 AHITTLVIPDNNLTSLPAL----PPELRTLEVSGNQLTSL-PVLP------PGLLELSIFSNPLTHLPALP---SGLCKL 287 (788)
T ss_pred cCCCEEEccCCcCCCCCCC----CCCCcEEEecCCccCcc-cCcc------cccceeeccCCchhhhhhch---hhcCEE
Confidence 4688899999999998752 58999999999999965 4322 57889999999998888633 467788
Q ss_pred EccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCC
Q 001142 97 KFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSI 176 (1142)
Q Consensus 97 ~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L 176 (1142)
+|++|+|+.+|.. +++|+.|+|++|.+..+|..+ .+|+.|++++|.+. .+|.. ..+|+.|+|++|+|
T Consensus 288 ~Ls~N~Lt~LP~~---p~~L~~LdLS~N~L~~Lp~lp---~~L~~L~Ls~N~L~----~LP~l---p~~Lq~LdLS~N~L 354 (788)
T PRK15387 288 WIFGNQLTSLPVL---PPGLQELSVSDNQLASLPALP---SELCKLWAYNNQLT----SLPTL---PSGLQELSVSDNQL 354 (788)
T ss_pred ECcCCcccccccc---ccccceeECCCCccccCCCCc---ccccccccccCccc----ccccc---ccccceEecCCCcc
Confidence 8889988888863 467888888888877776533 34667777775553 23321 13677888888888
Q ss_pred CccCcccCCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeCcCCcCCCCCcccccCC
Q 001142 177 RYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLM 256 (1142)
Q Consensus 177 ~~IP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L 256 (1142)
+.+|.. ..+|+.|++++|+|+.||... .+|+.|+|++|+|+.+|... ++|+.|+|++|+|++++. . .
T Consensus 355 s~LP~l---p~~L~~L~Ls~N~L~~LP~l~---~~L~~LdLs~N~Lt~LP~l~---s~L~~LdLS~N~LssIP~-l---~ 421 (788)
T PRK15387 355 ASLPTL---PSELYKLWAYNNRLTSLPALP---SGLKELIVSGNRLTSLPVLP---SELKELMVSGNRLTSLPM-L---P 421 (788)
T ss_pred CCCCCC---CcccceehhhccccccCcccc---cccceEEecCCcccCCCCcc---cCCCEEEccCCcCCCCCc-c---h
Confidence 877753 245667777777777776532 45777777777777776532 457777777777776543 2 2
Q ss_pred CCCCEEEccCCCCCCCCCCCchhhccCCCCCCCCCCCCcccc
Q 001142 257 HNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISS 298 (1142)
Q Consensus 257 ~~L~~L~Ls~N~L~~~~~iP~~~~~~l~~n~l~~~~~~~~~~ 298 (1142)
.+|+.|+|++|+|+. ||..++-......+...+|.+.+.
T Consensus 422 ~~L~~L~Ls~NqLt~---LP~sl~~L~~L~~LdLs~N~Ls~~ 460 (788)
T PRK15387 422 SGLLSLSVYRNQLTR---LPESLIHLSSETTVNLEGNPLSER 460 (788)
T ss_pred hhhhhhhhccCcccc---cChHHhhccCCCeEECCCCCCCch
Confidence 356667777777764 666555444444444455544433
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.1e-22 Score=238.08 Aligned_cols=244 Identities=25% Similarity=0.276 Sum_probs=171.2
Q ss_pred CCCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcE
Q 001142 16 GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRN 95 (1142)
Q Consensus 16 ~~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~ 95 (1142)
++.+..|....|-|..+ ....--.+|+++|+|+|++++.+ +|++.+ .+|+.|...+|+|+.+|..+..+++|+.
T Consensus 218 g~~l~~L~a~~n~l~~~--~~~p~p~nl~~~dis~n~l~~lp-~wi~~~---~nle~l~~n~N~l~~lp~ri~~~~~L~~ 291 (1081)
T KOG0618|consen 218 GPSLTALYADHNPLTTL--DVHPVPLNLQYLDISHNNLSNLP-EWIGAC---ANLEALNANHNRLVALPLRISRITSLVS 291 (1081)
T ss_pred CcchheeeeccCcceee--ccccccccceeeecchhhhhcch-HHHHhc---ccceEecccchhHHhhHHHHhhhhhHHH
Confidence 34555566666666522 22223347778888888887655 777655 7788888888888878877777778888
Q ss_pred EEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccC--------------------------CCCCCEEECCCCCC
Q 001142 96 LKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNK--------------------------LKGLKELELSKVPP 149 (1142)
Q Consensus 96 L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~~~~~~--------------------------L~~L~~L~Ls~n~~ 149 (1142)
|.+.+|.++.+|+.+..++.|++|+|..|++...|..+-. ++.|+.|++.+|.+
T Consensus 292 l~~~~nel~yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~L 371 (1081)
T KOG0618|consen 292 LSAAYNELEYIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHL 371 (1081)
T ss_pred HHhhhhhhhhCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcc
Confidence 8888888888877777788888888887777776653211 12234445555444
Q ss_pred CCCcccchhhhcCCCCCcEEEccCCCCCccCcc-cCCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCcc
Q 001142 150 RPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPE-IGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG 228 (1142)
Q Consensus 150 n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~-l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~IP~~ 228 (1142)
+... ...|.+..+|+.|+|++|+|..+|+. +.+|..|+.|+||+|+|+.||..+.++..|+.|..-+|+|..+| +
T Consensus 372 td~c---~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~~Lp~tva~~~~L~tL~ahsN~l~~fP-e 447 (1081)
T KOG0618|consen 372 TDSC---FPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLTTLPDTVANLGRLHTLRAHSNQLLSFP-E 447 (1081)
T ss_pred cccc---hhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhhhhhHHHHhhhhhHHHhhcCCceeech-h
Confidence 3322 22455667788888888888888874 57788888888888888888888888888888888888888888 7
Q ss_pred ccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccCCCC
Q 001142 229 LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269 (1142)
Q Consensus 229 l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L 269 (1142)
+.+++.|+.+|||.|+|+...-..-..-++|++|||+||..
T Consensus 448 ~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 448 LAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred hhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 88888888888888888755432322336888888888874
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.1e-20 Score=226.18 Aligned_cols=258 Identities=19% Similarity=0.190 Sum_probs=182.7
Q ss_pred CcceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 887 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~ 887 (1142)
+|...+.||.+.|=.|.+|++.+..+.|||+..+..........+ + +.|++ .+.++|||++.+.-....+..
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~q---r-L~~ik-~~l~~~pn~lPfqk~~~t~kA--- 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQ---R-LEEIK-FALMKAPNCLPFQKVLVTDKA--- 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHH---H-HHHHH-HHhhcCCcccchHHHHHhhHH---
Confidence 688999999999999999999888899999865543333333332 2 45666 566789999988776554432
Q ss_pred CCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccc
Q 001142 888 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 967 (1142)
Q Consensus 888 ~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~ 967 (1142)
.|||-+|+. .+|+|.+.. +.-+...+.+.|+.|++.||..+|..||+|||||.+||||+..
T Consensus 96 -----------AylvRqyvk-hnLyDRlST-----RPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSW-- 156 (1431)
T KOG1240|consen 96 -----------AYLVRQYVK-HNLYDRLST-----RPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSW-- 156 (1431)
T ss_pred -----------HHHHHHHHh-hhhhhhhcc-----chHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeee--
Confidence 388889996 899998865 3457888899999999999999999999999999999999987
Q ss_pred cCCCCCeEEEeecCCcccc--cccccccccccCCCCCCCCccCCCcccchhhhcccc------CCCC-CCchhhHHHHHH
Q 001142 968 KADGKPVVKLCDFDRAVPL--RSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH------KPNL-YGLEVDIWSYGC 1038 (1142)
Q Consensus 968 ~~~~~~~vKL~DFGlA~~l--~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~------~~~~-~s~ksDVwSLGv 1038 (1142)
..+.|.||..-+.. ...........-+ +...-..|.|||.+.... .... .+++.||||+||
T Consensus 157 -----NW~~LtDFAsFKPtYLPeDNPadf~fFFD-----TSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GC 226 (1431)
T KOG1240|consen 157 -----NWLYLTDFASFKPTYLPEDNPADFTFFFD-----TSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGC 226 (1431)
T ss_pred -----chhhhhcccccCCccCCCCCcccceEEEe-----cCCceeeecChHhhhccccccccCCcccccChhhhhhhhhH
Confidence 67999999987542 1111110000000 111234599999876421 1112 578999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001142 1039 LLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1117 (1142)
Q Consensus 1039 iL~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP 1117 (1142)
+++||++ |++||. ..+++.. +.+.......-++. -....++.++..|++.||
T Consensus 227 ViaELf~Eg~PlF~---LSQL~aY-r~~~~~~~e~~Le~-----------------------Ied~~~Rnlil~Mi~rdP 279 (1431)
T KOG1240|consen 227 VIAELFLEGRPLFT---LSQLLAY-RSGNADDPEQLLEK-----------------------IEDVSLRNLILSMIQRDP 279 (1431)
T ss_pred HHHHHHhcCCCccc---HHHHHhH-hccCccCHHHHHHh-----------------------CcCccHHHHHHHHHccCc
Confidence 9999998 688885 2333322 22221111111111 112358999999999999
Q ss_pred CCCCCHHHHHHH
Q 001142 1118 TERPTAGDLYEM 1129 (1142)
Q Consensus 1118 ~~RPSa~EVL~~ 1129 (1142)
.+|.+|++.|+.
T Consensus 280 s~RlSAedyL~~ 291 (1431)
T KOG1240|consen 280 SKRLSAEDYLQK 291 (1431)
T ss_pred hhccCHHHHHHh
Confidence 999999999985
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2e-19 Score=199.32 Aligned_cols=216 Identities=23% Similarity=0.317 Sum_probs=150.0
Q ss_pred CCCCccceeeeEecCCC-CCCCC------------CCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHH
Q 001142 868 RHSCIVEMYGHKISSKW-LPSAD------------GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFI 934 (1142)
Q Consensus 868 ~HpNIVkl~g~~~~~~~-~~~~~------------~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~I 934 (1142)
+|||||+++++|.++-. +|+.- .....+...+|+||.-++ .+|..++.. ...+.....-|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~------~~~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT------RHRSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc------CCCchHHHHHH
Confidence 59999999999876421 11110 012234556899999997 899999875 34677888889
Q ss_pred HHHHHHHHHHHHhCCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccc
Q 001142 935 AQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMA 1014 (1142)
Q Consensus 935 a~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~A 1014 (1142)
+.|+++|+.|||.+||.|||+|++|||+.-+ ++....+.++|||++-.-....-.-... ...-...|...-||
T Consensus 347 laQlLEav~hL~~hgvAhRDlKSDNiL~Eld---dD~~P~LVvaDFGCcLAd~~hGlqlpy~----S~~Vd~GGNa~lmA 419 (598)
T KOG4158|consen 347 LAQLLEAVTHLHKHGVAHRDLKSDNILLELD---DDEIPQLVVADFGCCLADDNHGLQLPYE----SDEVDLGGNAKLMA 419 (598)
T ss_pred HHHHHHHHHHHHHccchhhcccccceEEEec---CCCCcEEEEcccceeeeccccccccccc----cccccCCCcceecc
Confidence 9999999999999999999999999999654 2345788999999985322210000000 01112347778999
Q ss_pred hhhhccccCCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhCCCCCchhHHhhhcccccccccccCCC
Q 001142 1015 PEVLRAMHKPNL--YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIH-DLIQMGKRPRLTDELEALGSCHEHEVAQSGSG 1091 (1142)
Q Consensus 1015 PE~l~~~~~~~~--~s~ksDVwSLGviL~ELLtG~~Pf~~~~~~el~-~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~ 1091 (1142)
||+.....+... --.|+|.|+.|.+.||+++...||.+.....+. ...++.+.|.++
T Consensus 420 PEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp-------------------- 479 (598)
T KOG4158|consen 420 PEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALP-------------------- 479 (598)
T ss_pred hhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCc--------------------
Confidence 999876432221 236899999999999999999999864333221 112222333222
Q ss_pred CCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001142 1092 FEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124 (1142)
Q Consensus 1092 ~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~ 1124 (1142)
..+++.+++++...|+.||.+|++..
T Consensus 480 -------~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 480 -------SRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred -------ccCChHHHHHHHHHhcCCccccCCcc
Confidence 25667799999999999999999864
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=6.6e-21 Score=229.30 Aligned_cols=263 Identities=21% Similarity=0.250 Sum_probs=210.4
Q ss_pred CcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEE
Q 001142 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLK 97 (1142)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~ 97 (1142)
+++.|..+.|+|..+.. ..++|+.|+.++|-|+...+... -.+|+++++++|+++.+|.+++.+.+|+.|+
T Consensus 200 ~l~~l~c~rn~ls~l~~----~g~~l~~L~a~~n~l~~~~~~p~-----p~nl~~~dis~n~l~~lp~wi~~~~nle~l~ 270 (1081)
T KOG0618|consen 200 NLEVLHCERNQLSELEI----SGPSLTALYADHNPLTTLDVHPV-----PLNLQYLDISHNNLSNLPEWIGACANLEALN 270 (1081)
T ss_pred chhhhhhhhcccceEEe----cCcchheeeeccCcceeeccccc-----cccceeeecchhhhhcchHHHHhcccceEec
Confidence 55555555555555543 23578888888888875443311 2579999999999999999999999999999
Q ss_pred ccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccc----hh---------------
Q 001142 98 FFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTL----LS--------------- 158 (1142)
Q Consensus 98 Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~l----p~--------------- 158 (1142)
..+|+|+.+|..+..+++|+.|.+.+|.+..+|.....++.|++|+|..|.+..+.... +.
T Consensus 271 ~n~N~l~~lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~l 350 (1081)
T KOG0618|consen 271 ANHNRLVALPLRISRITSLVSLSAAYNELEYIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTL 350 (1081)
T ss_pred ccchhHHhhHHHHhhhhhHHHHHhhhhhhhhCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhcccccc
Confidence 99999999999999999999999999999999999999999999999986653221110 00
Q ss_pred -hh--cCCCCCcEEEccCCCCC-ccCcccCCCCCCCEEEccCCCCCccch-hhcCCCCCCEEEccCCCCCccCccccCCC
Q 001142 159 -EI--AGLKCLTKLSVCHFSIR-YLPPEIGCLSNLEQLDLSFNKMKYLPT-EICYLKALISLKVANNKLVELPSGLYLLQ 233 (1142)
Q Consensus 159 -~l--~~L~~L~~L~Ls~N~L~-~IP~~l~~L~~L~~L~Ls~N~L~~lP~-~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~ 233 (1142)
.+ .....|+.|++.+|.|+ ..=+.+-++..|+.|+|++|+|.++|+ .+.+|..|+.|+||+|+|+.||.++.++.
T Consensus 351 p~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~~Lp~tva~~~ 430 (1081)
T KOG0618|consen 351 PSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLTTLPDTVANLG 430 (1081)
T ss_pred ccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhhhhhHHHHhhh
Confidence 00 11234677888899988 333446788999999999999999995 47889999999999999999999999999
Q ss_pred CCCEEeCcCCcCCCCCcccccCCCCCCEEEccCCCCCCCC---CC--CchhhccCCCCCCCCC
Q 001142 234 RLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYC---QV--PSWICCNLEGNGKDSS 291 (1142)
Q Consensus 234 ~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~~~---~i--P~~~~~~l~~n~l~~~ 291 (1142)
.|+.|...+|+|...| .+..+++|+.+|||.|+|+... .. |..-.+++++|..+..
T Consensus 431 ~L~tL~ahsN~l~~fP--e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~~ 491 (1081)
T KOG0618|consen 431 RLHTLRAHSNQLLSFP--ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRLVF 491 (1081)
T ss_pred hhHHHhhcCCceeech--hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCccccc
Confidence 9999999999999887 6899999999999999998732 12 4444578888875443
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.4e-21 Score=192.42 Aligned_cols=190 Identities=22% Similarity=0.315 Sum_probs=170.3
Q ss_pred ccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhc
Q 001142 82 LIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIA 161 (1142)
Q Consensus 82 ~iP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~ 161 (1142)
++| .+.++.+.+.|.||+|+|+.+|+.+.+|.+|+.|++.+|++..+|..++.|+.|+.|+++-|.+ ..+|..|+
T Consensus 25 ~~~-gLf~~s~ITrLtLSHNKl~~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl----~~lprgfg 99 (264)
T KOG0617|consen 25 ELP-GLFNMSNITRLTLSHNKLTVVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRL----NILPRGFG 99 (264)
T ss_pred hcc-cccchhhhhhhhcccCceeecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhh----hcCccccC
Confidence 444 3667889999999999999999999999999999999999999999999999999999998554 46788999
Q ss_pred CCCCCcEEEccCCCCC--ccCcccCCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEe
Q 001142 162 GLKCLTKLSVCHFSIR--YLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLD 239 (1142)
Q Consensus 162 ~L~~L~~L~Ls~N~L~--~IP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~ 239 (1142)
.++.|+.|||..|++. .+|..|..|+.|+.|+|++|.+..+|..+++|++|+.|.|..|.|-++|.+++.|++|+.|.
T Consensus 100 s~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll~lpkeig~lt~lrelh 179 (264)
T KOG0617|consen 100 SFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLLSLPKEIGDLTRLRELH 179 (264)
T ss_pred CCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchhhCcHHHHHHHHHHHHh
Confidence 9999999999999998 68999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcCCcCCCCCcccccCCC---CCCEEEccCCCCCCCCCCCchh
Q 001142 240 LSNNRLTSLGSLDLCLMH---NLQNLNLQYNKLLSYCQVPSWI 279 (1142)
Q Consensus 240 Ls~N~Ls~~~p~~l~~L~---~L~~L~Ls~N~L~~~~~iP~~~ 279 (1142)
+.+|+|+-+|| .++++. +=+.+.+.+|+|.. +|...+
T Consensus 180 iqgnrl~vlpp-el~~l~l~~~k~v~r~E~NPwv~--pIaeQf 219 (264)
T KOG0617|consen 180 IQGNRLTVLPP-ELANLDLVGNKQVMRMEENPWVN--PIAEQF 219 (264)
T ss_pred cccceeeecCh-hhhhhhhhhhHHHHhhhhCCCCC--hHHHHH
Confidence 99999999998 566654 33567788898865 444433
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=3e-18 Score=182.17 Aligned_cols=145 Identities=14% Similarity=0.090 Sum_probs=107.1
Q ss_pred eeeecccCceEEEEEEE-CCccEEEEEEecccCCCChH--------H----------HHHhHHhHHHHHHHHhhCCCCCc
Q 001142 812 CDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSAD--------E----------IRNFEYSCLGEVRMLGALRHSCI 872 (1142)
Q Consensus 812 ~~~LG~GsfG~Vy~a~~-~~~~vAvKi~~l~~~~~~~~--------~----------~~~~~~~~~~Ei~iL~~L~HpNI 872 (1142)
...||+|++|.||+|.. .+..||+|+.+......... . .+........|++++.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 46899999999999987 57889999876443211110 0 00112234569999999988877
Q ss_pred cceeeeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHH-HhCCcc
Q 001142 873 VEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVEL-HSKHIM 951 (1142)
Q Consensus 873 Vkl~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yL-Hs~gIv 951 (1142)
.....+... ..+|||||++|+++...+.. ...++...+..++.|++.+|.|+ |+.||+
T Consensus 82 ~~p~~~~~~----------------~~~iVmE~i~g~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~l~H~~gii 140 (190)
T cd05147 82 PCPEPILLK----------------SHVLVMEFIGDDGWAAPRLK-----DAPLSESKARELYLQVIQIMRILYQDCRLV 140 (190)
T ss_pred CCCcEEEec----------------CCEEEEEEeCCCCCcchhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 543332211 12899999998777654322 24688999999999999999999 699999
Q ss_pred ccCCCCCCeeeccccccCCCCCeEEEeecCCccc
Q 001142 952 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 985 (1142)
Q Consensus 952 HrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~ 985 (1142)
||||||+|||++. +.++|+|||+|..
T Consensus 141 HrDlkP~NIli~~--------~~v~LiDFG~a~~ 166 (190)
T cd05147 141 HADLSEYNLLYHD--------GKLYIIDVSQSVE 166 (190)
T ss_pred cCCCCHHHEEEEC--------CcEEEEEcccccc
Confidence 9999999999973 4699999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.6e-18 Score=193.05 Aligned_cols=255 Identities=20% Similarity=0.225 Sum_probs=155.6
Q ss_pred CcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC----------CCCccce
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR----------HSCIVEM 875 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~----------HpNIVkl 875 (1142)
.+...+.||.|+++.||.+++. ++.+|+|++.... .......+++ .+|.-....+. |-.++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~-~~~~~~~~~~----~~e~l~~~~~~~~~~p~~a~~~~r~l~P 87 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA-DASANEYEQL----KEEQLAITLFPGVKNPKEAYRHLRFLVP 87 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS-TTHTTHHHHH----HHHHHGGGGSTT--SHHHHHHHH-B---
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEeccc-ccchHHHHHH----HHHHHHhhhhccCCCHHHHHHhceEEee
Confidence 3578899999999999999995 5889999987765 2223344444 44443333332 2233333
Q ss_pred eeeEecCCCCCCCCCCCc---cccceEEEEEeccCCCCHHHHHHHHhccCCC--CCCHHHHHHHHHHHHHHHHHHHhCCc
Q 001142 876 YGHKISSKWLPSADGNPE---HHLLQSAIFMEYVKGGSVKNYIEKLSETGEK--HVSVKLALFIAQDVAAALVELHSKHI 950 (1142)
Q Consensus 876 ~g~~~~~~~~~~~~~~~~---~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~--~ls~~~i~~Ia~qIa~gL~yLHs~gI 950 (1142)
++.....+.-+....... ......+++|+-+. ++|.+++.-.+..... .+.......+..|+++.+++||..||
T Consensus 88 ~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~Gl 166 (288)
T PF14531_consen 88 LDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGL 166 (288)
T ss_dssp SEEEEETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred eEEEEEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcce
Confidence 443332211100111111 11224578999885 8999987755444322 23344556677999999999999999
Q ss_pred cccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhcccc----CCCC
Q 001142 951 MHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH----KPNL 1026 (1142)
Q Consensus 951 vHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~----~~~~ 1026 (1142)
+|+||||+|++++.+ |.++|+||+........... ...+..|.+||...... ....
T Consensus 167 VHgdi~~~nfll~~~-------G~v~Lg~F~~~~r~g~~~~~-------------~~~~~~~~PPe~~~~~~~~~~~~~~ 226 (288)
T PF14531_consen 167 VHGDIKPENFLLDQD-------GGVFLGDFSSLVRAGTRYRC-------------SEFPVAFTPPELESCAGQFGQNNAP 226 (288)
T ss_dssp EEST-SGGGEEE-TT-------S-EEE--GGGEEETTEEEEG-------------GGS-TTTS-HHHHHHHTSCHHSEEE
T ss_pred EecccceeeEEEcCC-------CCEEEcChHHHeecCceeec-------------cCCCcccCChhhhhhhcccCcccce
Confidence 999999999999998 89999999988654432110 12456799999875421 1235
Q ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHH
Q 001142 1027 YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLV 1106 (1142)
Q Consensus 1027 ~s~ksDVwSLGviL~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~ 1106 (1142)
++.+.|.|++|+++|.|+.+..||........... . ...+. +.++.++
T Consensus 227 ~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~-----------~--------------------f~~C~-~~Pe~v~ 274 (288)
T PF14531_consen 227 YTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW-----------D--------------------FSRCR-DMPEPVQ 274 (288)
T ss_dssp E-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG-----------G--------------------GTTSS----HHHH
T ss_pred eeeccCHHHHHHHHHHHHHccCCCCCCCccccccc-----------c--------------------chhcC-CcCHHHH
Confidence 78999999999999999999999975422111000 0 11122 5677799
Q ss_pred HHHHHhcccCCCCC
Q 001142 1107 DVFRRCTEENPTER 1120 (1142)
Q Consensus 1107 dLI~~CL~~DP~~R 1120 (1142)
.||..+|+.+|.+|
T Consensus 275 ~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 275 FLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHT-SSGGGS
T ss_pred HHHHHHccCCcccC
Confidence 99999999999988
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.9e-18 Score=183.98 Aligned_cols=184 Identities=13% Similarity=0.126 Sum_probs=131.1
Q ss_pred CCcceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHh--HHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNF--EYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~--~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
.+|++.++||.|+||.||++...+..+++|++.-+... .......| ...+.+|+..+.++.||+|..+.+++.....
T Consensus 31 ~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~-~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~ 109 (232)
T PRK10359 31 YNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKR-TERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER 109 (232)
T ss_pred CceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCc-hHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence 46899999999999999998887888999997533221 11111111 0114789999999999999999988765321
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
. ........+|||||++|.+|.++.. +++ ....+++.+|..+|..|++|||+||+||+++.
T Consensus 110 ~------~~~~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~ 170 (232)
T PRK10359 110 K------TLRYAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSK 170 (232)
T ss_pred c------cccccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeC
Confidence 1 0011234699999999999987632 232 24568999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ + ++|+|||.......... ...+... ..|+.++|+|+||+++..+.
T Consensus 171 ~-------g-i~liDfg~~~~~~e~~a----------------------~d~~vle----r~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 171 N-------G-LRIIDLSGKRCTAQRKA----------------------KDRIDLE----RHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred C-------C-EEEEECCCcccccchhh----------------------HHHHHHH----hHhcccccccceeEeehHHH
Confidence 6 6 99999998754322100 0012222 34667999999999987543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.6e-19 Score=208.25 Aligned_cols=237 Identities=23% Similarity=0.278 Sum_probs=180.3
Q ss_pred eecccCceEEEEEEE-----CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEecCCCCCC
Q 001142 814 EAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWLPS 887 (1142)
Q Consensus 814 ~LG~GsfG~Vy~a~~-----~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~g~~~~~~~~~~ 887 (1142)
++|+|+||.|++++. .+.-+|.|+.+.......... ....|..++...+ ||.+|++.-.+..+...
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~------~t~~er~il~~~~~~~f~v~lhyafqt~~kl-- 72 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT------HTKQERIILAFVHNTPFLVKLHYAFQTDGKL-- 72 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc------ccccHHHHHhhccCCCceeeeeeeeccccch--
Confidence 479999999998753 455566666332211111111 1146778888887 99999999988876644
Q ss_pred CCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccc
Q 001142 888 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 967 (1142)
Q Consensus 888 ~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~ 967 (1142)
+++++|..||.|...+.. ...+++.....+...++-+++++|+.+|+|||+|++||+++.+
T Consensus 73 ------------~l~ld~~rgg~lft~l~~-----~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~-- 133 (612)
T KOG0603|consen 73 ------------YLILDFLRGGDLFTRLSK-----EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLE-- 133 (612)
T ss_pred ------------hHhhhhcccchhhhcccc-----CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeeccc--
Confidence 999999999999887754 4567888888889999999999999999999999999999988
Q ss_pred cCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCC
Q 001142 968 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 1047 (1142)
Q Consensus 968 ~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~ 1047 (1142)
|++++.|||.++..-... ..+||..|||||++.+ ....+|.||||++.+||+||.
T Consensus 134 -----Ghi~~tdfglske~v~~~--------------~~cgt~eymApEI~~g------h~~a~D~ws~gvl~felltg~ 188 (612)
T KOG0603|consen 134 -----GHIKLTDFGLSKEAVKEK--------------IACGTYEYRAPEIING------HLSAADWWSFGVLAFELLTGT 188 (612)
T ss_pred -----CccccCCchhhhHhHhhh--------------hcccchhhhhhHhhhc------cCCcccchhhhhhHHHHhhCC
Confidence 899999999997654321 1168999999999874 358899999999999999999
Q ss_pred CCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC-----
Q 001142 1048 VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT----- 1122 (1142)
Q Consensus 1048 ~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS----- 1122 (1142)
.||.. +....|.....+ .+ ......+.+++..++..+|..|--
T Consensus 189 ~pf~~----~~~~~Il~~~~~-~p---------------------------~~l~~~a~~~~~~l~~r~p~nrLg~~~~~ 236 (612)
T KOG0603|consen 189 LPFGG----DTMKRILKAELE-MP---------------------------RELSAEARSLFRQLFKRNPENRLGAGPDG 236 (612)
T ss_pred CCCch----HHHHHHhhhccC-Cc---------------------------hhhhHHHHHHHHHHHhhCHHHHhccCcch
Confidence 99986 344444332211 11 145566888999999999999954
Q ss_pred HHHHHHHHHhhc
Q 001142 1123 AGDLYEMFVART 1134 (1142)
Q Consensus 1123 a~EVL~~L~~~~ 1134 (1142)
+.|+.+|.++..
T Consensus 237 ~~eik~h~f~~~ 248 (612)
T KOG0603|consen 237 VDEIKQHEFFQS 248 (612)
T ss_pred hHHHhccchhee
Confidence 467777776653
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.5e-17 Score=176.67 Aligned_cols=146 Identities=14% Similarity=0.133 Sum_probs=108.9
Q ss_pred eeeecccCceEEEEEEEC-CccEEEEEEecccCCCChH------------------HHHHhHHhHHHHHHHHhhCCCCCc
Q 001142 812 CDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSAD------------------EIRNFEYSCLGEVRMLGALRHSCI 872 (1142)
Q Consensus 812 ~~~LG~GsfG~Vy~a~~~-~~~vAvKi~~l~~~~~~~~------------------~~~~~~~~~~~Ei~iL~~L~HpNI 872 (1142)
.+.||+|++|.||+|.+. +..+|+|+.+......... ........+.+|.+.+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 578999999999999974 8899999976542211000 001112234689999999999987
Q ss_pred cceeeeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHH-HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCc
Q 001142 873 VEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY-IEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHI 950 (1142)
Q Consensus 873 Vkl~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~-l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs-~gI 950 (1142)
.....+.... .+|||||++|+++... +.. ..++...+..++.|++.++.++|. +||
T Consensus 82 ~~p~~~~~~~----------------~~lVmE~~~g~~~~~~~l~~------~~~~~~~~~~i~~~l~~~l~~lH~~~gi 139 (190)
T cd05145 82 PVPEPILLKK----------------NVLVMEFIGDDGSPAPRLKD------VPLEEEEAEELYEQVVEQMRRLYQEAGL 139 (190)
T ss_pred CCceEEEecC----------------CEEEEEEecCCCchhhhhhh------ccCCHHHHHHHHHHHHHHHHHHHHhCCE
Confidence 5544443221 2899999998755433 332 357888999999999999999999 999
Q ss_pred cccCCCCCCeeeccccccCCCCCeEEEeecCCccccc
Q 001142 951 MHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR 987 (1142)
Q Consensus 951 vHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~ 987 (1142)
+||||||+|||++ + +.++|+|||++....
T Consensus 140 vHrDlkP~NIll~-~-------~~~~liDFG~a~~~~ 168 (190)
T cd05145 140 VHGDLSEYNILYH-D-------GKPYIIDVSQAVELD 168 (190)
T ss_pred ecCCCChhhEEEE-C-------CCEEEEEcccceecC
Confidence 9999999999998 4 679999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.73 E-value=7.5e-17 Score=213.42 Aligned_cols=241 Identities=23% Similarity=0.241 Sum_probs=163.3
Q ss_pred CcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecC-CCCccCccccCCcCCcEE
Q 001142 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKN-VLNLIPKSVGRYEKLRNL 96 (1142)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N-~Lt~iP~~l~~L~~L~~L 96 (1142)
+|..|.+..|+|..+.. .+..+++|++|||++|+..+.+|. +..+++|+.|+|++| .+..+|..|.+|++|+.|
T Consensus 612 ~L~~L~L~~s~l~~L~~-~~~~l~~Lk~L~Ls~~~~l~~ip~----ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L 686 (1153)
T PLN03210 612 NLVKLQMQGSKLEKLWD-GVHSLTGLRNIDLRGSKNLKEIPD----LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDL 686 (1153)
T ss_pred CCcEEECcCcccccccc-ccccCCCCCEEECCCCCCcCcCCc----cccCCcccEEEecCCCCccccchhhhccCCCCEE
Confidence 55666666666665543 346667777777776654344443 234467777777664 455677777777777777
Q ss_pred EccCC-CCCcCchhhcCCCCCCEEEccCCC-CCCCcccccCCCCCCEEECCCCCCCCCcccchhh---------------
Q 001142 97 KFFGN-EINLFPSEVGNLLGLECLQIKISS-PGVNGFALNKLKGLKELELSKVPPRPSVLTLLSE--------------- 159 (1142)
Q Consensus 97 ~Ls~N-~L~~lP~~l~~L~~L~~L~Ls~N~-l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~--------------- 159 (1142)
+|++| .++.+|..+ ++++|+.|+|++|. +..+|. ...+|+.|+|++|.+. .+|..
T Consensus 687 ~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~---~~~nL~~L~L~~n~i~----~lP~~~~l~~L~~L~l~~~~ 758 (1153)
T PLN03210 687 DMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPD---ISTNISWLDLDETAIE----EFPSNLRLENLDELILCEMK 758 (1153)
T ss_pred eCCCCCCcCccCCcC-CCCCCCEEeCCCCCCcccccc---ccCCcCeeecCCCccc----cccccccccccccccccccc
Confidence 77764 456666655 56667777666654 333332 2345566666654432 22221
Q ss_pred ---------------hcCCCCCcEEEccCCC-CCccCcccCCCCCCCEEEccCC-CCCccchhhcCCCCCCEEEccCC-C
Q 001142 160 ---------------IAGLKCLTKLSVCHFS-IRYLPPEIGCLSNLEQLDLSFN-KMKYLPTEICYLKALISLKVANN-K 221 (1142)
Q Consensus 160 ---------------l~~L~~L~~L~Ls~N~-L~~IP~~l~~L~~L~~L~Ls~N-~L~~lP~~l~~L~~L~~L~Ls~N-~ 221 (1142)
+...++|+.|+|++|. +..+|..+++|++|+.|+|++| ++..+|..+ ++++|+.|+|++| .
T Consensus 759 ~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~ 837 (1153)
T PLN03210 759 SEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSR 837 (1153)
T ss_pred hhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCc
Confidence 1123578888998885 4489999999999999999986 578999877 7899999999997 4
Q ss_pred CCccCccccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccC-CCCCCCCCCCchh
Q 001142 222 LVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQY-NKLLSYCQVPSWI 279 (1142)
Q Consensus 222 Ls~IP~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~-N~L~~~~~iP~~~ 279 (1142)
+..+|.. .++|+.|+|++|.|+.+| .++..+++|+.|+|++ |+|.+ +|..+
T Consensus 838 L~~~p~~---~~nL~~L~Ls~n~i~~iP-~si~~l~~L~~L~L~~C~~L~~---l~~~~ 889 (1153)
T PLN03210 838 LRTFPDI---STNISDLNLSRTGIEEVP-WWIEKFSNLSFLDMNGCNNLQR---VSLNI 889 (1153)
T ss_pred ccccccc---ccccCEeECCCCCCccCh-HHHhcCCCCCEEECCCCCCcCc---cCccc
Confidence 5577753 367899999999999765 4889999999999998 66766 55443
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.7e-16 Score=210.07 Aligned_cols=235 Identities=22% Similarity=0.229 Sum_probs=139.3
Q ss_pred CcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecC-CCCccCccccCCcCCcEE
Q 001142 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKN-VLNLIPKSVGRYEKLRNL 96 (1142)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N-~Lt~iP~~l~~L~~L~~L 96 (1142)
.+..|.+..+.++.++.. | ...+|+.|+|++|+|... +..+ ..+++|+.|+|++| .++.+|. +..+++|+.|
T Consensus 590 ~Lr~L~~~~~~l~~lP~~-f-~~~~L~~L~L~~s~l~~L-~~~~---~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L 662 (1153)
T PLN03210 590 KLRLLRWDKYPLRCMPSN-F-RPENLVKLQMQGSKLEKL-WDGV---HSLTGLRNIDLRGSKNLKEIPD-LSMATNLETL 662 (1153)
T ss_pred ccEEEEecCCCCCCCCCc-C-CccCCcEEECcCcccccc-cccc---ccCCCCCEEECCCCCCcCcCCc-cccCCcccEE
Confidence 455566666666666543 3 456788888888877643 3323 34577888888765 4667764 6777788888
Q ss_pred EccCCC-CCcCchhhcCCCCCCEEEccCCC-CCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCC
Q 001142 97 KFFGNE-INLFPSEVGNLLGLECLQIKISS-PGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHF 174 (1142)
Q Consensus 97 ~Ls~N~-L~~lP~~l~~L~~L~~L~Ls~N~-l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N 174 (1142)
+|++|. +..+|..+.+|++|+.|++++|. +..+|..+ ++++|+.|++++|. ....+|.. +.+|+.|+|++|
T Consensus 663 ~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~---~L~~~p~~---~~nL~~L~L~~n 735 (1153)
T PLN03210 663 KLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCS---RLKSFPDI---STNISWLDLDET 735 (1153)
T ss_pred EecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCC---Cccccccc---cCCcCeeecCCC
Confidence 887754 56778888888888888887754 66666544 67788888887743 33344432 356778888888
Q ss_pred CCCccCcccCCCC-------------------------------CCCEEEccCCCC-CccchhhcCCCCCCEEEccCC-C
Q 001142 175 SIRYLPPEIGCLS-------------------------------NLEQLDLSFNKM-KYLPTEICYLKALISLKVANN-K 221 (1142)
Q Consensus 175 ~L~~IP~~l~~L~-------------------------------~L~~L~Ls~N~L-~~lP~~l~~L~~L~~L~Ls~N-~ 221 (1142)
.+..+|..+ .++ +|+.|+|++|.. ..+|.+++++++|+.|+|++| .
T Consensus 736 ~i~~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~ 814 (1153)
T PLN03210 736 AIEEFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCIN 814 (1153)
T ss_pred ccccccccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCC
Confidence 888777653 233 344444444432 245555555555555555543 3
Q ss_pred CCccCccccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccCCCCCC
Q 001142 222 LVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 222 Ls~IP~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1142)
|+.||..+ ++++|+.|+|++|..-...|. ...+|+.|+|++|.++.
T Consensus 815 L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~---~~~nL~~L~Ls~n~i~~ 860 (1153)
T PLN03210 815 LETLPTGI-NLESLESLDLSGCSRLRTFPD---ISTNISDLNLSRTGIEE 860 (1153)
T ss_pred cCeeCCCC-CccccCEEECCCCCccccccc---cccccCEeECCCCCCcc
Confidence 44455443 445555555555432222221 12345555555555543
|
syringae 6; Provisional |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.4e-17 Score=172.10 Aligned_cols=201 Identities=13% Similarity=0.049 Sum_probs=136.7
Q ss_pred ceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEecCCCCCCC
Q 001142 810 SSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWLPSA 888 (1142)
Q Consensus 810 ~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~g~~~~~~~~~~~ 888 (1142)
.+...|++|+||+||.+...+..++.+-+... ......-+...+.+|+++|++|. |++|++++++.
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~----~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~--------- 71 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAA----PWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD--------- 71 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccc----hhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc---------
Confidence 56789999999999988876666655443221 11111111223589999999995 68899998862
Q ss_pred CCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC-CCCCeeeccccc
Q 001142 889 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI-KSENILIDLERK 967 (1142)
Q Consensus 889 ~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDL-Kp~NILld~~~~ 967 (1142)
..+++|||+.|.+|...+.. . ...++.|++.+|.++|++||+|||| ||+|||++.+
T Consensus 72 ---------~~~lvmeyI~G~~L~~~~~~-----------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~-- 128 (218)
T PRK12274 72 ---------GRHLDRSYLAGAAMYQRPPR-----------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQED-- 128 (218)
T ss_pred ---------CEEEEEeeecCccHHhhhhh-----------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCC--
Confidence 13899999999898654321 1 1347789999999999999999999 7999999876
Q ss_pred cCCCCCeEEEeecCCcccccccccccc-cccCCC--CCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 968 KADGKPVVKLCDFDRAVPLRSFLHTCC-IAHRGI--PAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 968 ~~~~~~~vKL~DFGlA~~l~~~~~~~~-~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+.++|+|||+|........... ...++. ........++.|+.|+...-.. ..--...+.++-|+-+|.++
T Consensus 129 -----g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~--~~~~~~~~w~~~g~~~~~~~ 201 (218)
T PRK12274 129 -----GSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLK--RTSWIRELWFATGKPVYRFV 201 (218)
T ss_pred -----CCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhc--cchhHHHHHHHhcchHHHHH
Confidence 7799999999975432211000 000000 0011223678899998654311 11226678999999999999
Q ss_pred hCCCCCCCC
Q 001142 1045 TLQVPYMGL 1053 (1142)
Q Consensus 1045 tG~~Pf~~~ 1053 (1142)
|+..|+.+.
T Consensus 202 ~~~~~~~~~ 210 (218)
T PRK12274 202 TRRVLHWED 210 (218)
T ss_pred hccCCcccc
Confidence 999887543
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.1e-19 Score=197.26 Aligned_cols=224 Identities=21% Similarity=0.228 Sum_probs=168.7
Q ss_pred CCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCcc-CccccCCcCCcEEEccC-CCCCcCchh-hcCCCCCCE
Q 001142 42 DDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLI-PKSVGRYEKLRNLKFFG-NEINLFPSE-VGNLLGLEC 118 (1142)
Q Consensus 42 ~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~i-P~~l~~L~~L~~L~Ls~-N~L~~lP~~-l~~L~~L~~ 118 (1142)
.-..|+|..|+|+.+++..|+.+ ++|++|||++|+|+.| |.+|.+|.+|..|-+.+ |+|+.||.. |++|..|+.
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l---~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqr 144 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTL---HRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQR 144 (498)
T ss_pred cceEEEeccCCcccCChhhccch---hhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHH
Confidence 55678888999988888777655 8889999999999888 77888888877766665 888888876 677888888
Q ss_pred EEccCCCCCCCc-ccccCCCCCCEEECCCCCCCCCcccchh-hhcCCCCCcEEEccCCCCC---c----------cCccc
Q 001142 119 LQIKISSPGVNG-FALNKLKGLKELELSKVPPRPSVLTLLS-EIAGLKCLTKLSVCHFSIR---Y----------LPPEI 183 (1142)
Q Consensus 119 L~Ls~N~l~~~~-~~~~~L~~L~~L~Ls~n~~n~~~~~lp~-~l~~L~~L~~L~Ls~N~L~---~----------IP~~l 183 (1142)
|.+.-|++.-+. ..|..|++|..|.+.+|.+ ..++. .|..+..++.+.+..|.+- . .|..+
T Consensus 145 LllNan~i~Cir~~al~dL~~l~lLslyDn~~----q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~iet 220 (498)
T KOG4237|consen 145 LLLNANHINCIRQDALRDLPSLSLLSLYDNKI----QSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIET 220 (498)
T ss_pred HhcChhhhcchhHHHHHHhhhcchhcccchhh----hhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhc
Confidence 888888865544 6788888888888887444 33343 5677788888888877722 1 12222
Q ss_pred CCCCCCCEEEc--------------------------cCCCCCccc-hhhcCCCCCCEEEccCCCCCcc-CccccCCCCC
Q 001142 184 GCLSNLEQLDL--------------------------SFNKMKYLP-TEICYLKALISLKVANNKLVEL-PSGLYLLQRL 235 (1142)
Q Consensus 184 ~~L~~L~~L~L--------------------------s~N~L~~lP-~~l~~L~~L~~L~Ls~N~Ls~I-P~~l~~L~~L 235 (1142)
+...-..-..| ..+.....| ..|..|++|+.|+|++|+|+.| +.+|..+..|
T Consensus 221 sgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l 300 (498)
T KOG4237|consen 221 SGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAEL 300 (498)
T ss_pred ccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhh
Confidence 22221111111 122222334 3577899999999999999988 6677789999
Q ss_pred CEEeCcCCcCCCCCcccccCCCCCCEEEccCCCCCCC
Q 001142 236 ENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSY 272 (1142)
Q Consensus 236 ~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~~ 272 (1142)
+.|.|..|+|..+....|.++..|+.|+|.+|+|+++
T Consensus 301 ~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~ 337 (498)
T KOG4237|consen 301 QELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTV 337 (498)
T ss_pred hhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEE
Confidence 9999999999999998999999999999999999984
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.5e-17 Score=201.54 Aligned_cols=163 Identities=28% Similarity=0.314 Sum_probs=124.2
Q ss_pred HHHHHHHHhCCccccCCCCCCeeeccccccCCCCCeEEEeecCCccccccccccccccc-----CCCCCCCCccCCCccc
Q 001142 939 AAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH-----RGIPAPDVCVGTPRWM 1013 (1142)
Q Consensus 939 a~gL~yLHs~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~-----~~~~~~~~~~GT~~Y~ 1013 (1142)
+.+++|||+.||+|||+||+|.+|+.- +++|+.|||+.+.......++.++. .........+||+.|+
T Consensus 153 vla~Eylh~ygivhrdlkpdnllIT~m-------GhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyi 225 (1205)
T KOG0606|consen 153 VLAVEYLHSYGIVHRDLKPDNLLITSM-------GHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYI 225 (1205)
T ss_pred hHHhHhhccCCeecCCCCCCcceeeec-------ccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCcccc
Confidence 788999999999999999999999887 8999999999975322211111110 0111234557999999
Q ss_pred chhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCC
Q 001142 1014 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE 1093 (1142)
Q Consensus 1014 APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~ 1093 (1142)
|||++.. ..|+..+|+|++|+|+||.+.|+.||.+..+.+++..+.......
T Consensus 226 aPeVilr----qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~w------------------------ 277 (1205)
T KOG0606|consen 226 APEVILR----QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW------------------------ 277 (1205)
T ss_pred Chhhhhh----hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccc------------------------
Confidence 9999986 579999999999999999999999999999998887664332111
Q ss_pred CchhhhhhHHHHHHHHHHhcccCCCCC---CCHHHHHHHHHhhcCCC
Q 001142 1094 KPEAELETLSFLVDVFRRCTEENPTER---PTAGDLYEMFVARTSSS 1137 (1142)
Q Consensus 1094 ~~~~~~~~~~~L~dLI~~CL~~DP~~R---PSa~EVL~~L~~~~ss~ 1137 (1142)
++.+...++++++++.++|+.+|..| +.+-+|.+|-+|+.-.+
T Consensus 278 -pE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw 323 (1205)
T KOG0606|consen 278 -PEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDW 323 (1205)
T ss_pred -cccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeeccc
Confidence 11122556779999999999999999 57778888887765443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.3e-16 Score=188.12 Aligned_cols=215 Identities=25% Similarity=0.339 Sum_probs=159.1
Q ss_pred HhhCCCCCccceeeeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHH
Q 001142 864 LGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALV 943 (1142)
Q Consensus 864 L~~L~HpNIVkl~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~ 943 (1142)
|+.+.|.|+.+++|.+.+.. ..++|.+||..|+|.+.+.. ....+++.....++++|+.||+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~--------------~~~~i~~~c~rGsl~D~i~~----~~~~~d~~F~~s~~rdi~~Gl~ 62 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGP--------------EMIVIWEYCSRGSLLDILSN----EDIKLDYFFILSFIRDISKGLA 62 (484)
T ss_pred CcccchhhhhhheeeEecCC--------------ceEEEEeeecCccHHhHHhc----cccCccHHHHHHHHHHHHHHHH
Confidence 45788999999999998654 45999999999999999975 3456888999999999999999
Q ss_pred HHHhCCc-cccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhcccc
Q 001142 944 ELHSKHI-MHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1022 (1142)
Q Consensus 944 yLHs~gI-vHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~ 1022 (1142)
|||...| .|+.+++.|.+++.. +.+||.|||+.......... . ......-..-|.|||.+.+..
T Consensus 63 ylh~s~i~~hg~l~s~nClvd~~-------w~lklt~~Gl~~~~~~~~~~---~-----~~~~~~~~~lw~aPellr~~~ 127 (484)
T KOG1023|consen 63 YLHNSPIGYHGALKSSNCLVDSR-------WVLKLTDFGLNSLLEETAEP---E-----AHHPIRKALLWTAPELLRGAL 127 (484)
T ss_pred HHhcCcceeeeeeccccceeeee-------EEEEechhhhcccccccccc---c-----ccchhHHHHhccCHHHhcccc
Confidence 9998766 999999999999988 99999999998765421000 0 001112345699999998743
Q ss_pred CCCC---CCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHh-CCCCCchhHHhhhcccccccccccCCCCCC
Q 001142 1023 KPNL---YGLEVDIWSYGCLLLELLTLQVPYMGL----SELEIHDLIQM-GKRPRLTDELEALGSCHEHEVAQSGSGFEK 1094 (1142)
Q Consensus 1023 ~~~~---~s~ksDVwSLGviL~ELLtG~~Pf~~~----~~~el~~~I~~-~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~ 1094 (1142)
.... .+++.||||||++++|+++.+.||... .+.++...+.. +..+..+....
T Consensus 128 ~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~------------------- 188 (484)
T KOG1023|consen 128 SQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIEL------------------- 188 (484)
T ss_pred cccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhh-------------------
Confidence 2222 578899999999999999999999752 23345555544 22222111110
Q ss_pred chhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001142 1095 PEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1095 ~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~ 1133 (1142)
. ....+.+..++.+||..+|.+||++++|-..+...
T Consensus 189 --~-~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 189 --L-NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred --h-hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 0 03334688999999999999999999987655443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=4.2e-16 Score=167.42 Aligned_cols=142 Identities=20% Similarity=0.234 Sum_probs=111.5
Q ss_pred eeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCCCCC
Q 001142 813 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 892 (1142)
Q Consensus 813 ~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~~~~~~ 892 (1142)
+.||+|++|.||+|.+.+..+++|+...+..............++.+|+.++..+.|++|+....++.+...
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~-------- 73 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPEN-------- 73 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCC--------
Confidence 679999999999999988999999865332211111111122345789999999999998777666554332
Q ss_pred ccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccCCCC
Q 001142 893 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 972 (1142)
Q Consensus 893 ~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~~~~ 972 (1142)
.++||||++|++|.+++.. ... .+..++.+++.+|.++|+.|++|||++|.|||++ +
T Consensus 74 ------~~lv~e~~~G~~L~~~~~~--------~~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~------- 130 (211)
T PRK14879 74 ------FIIVMEYIEGEPLKDLINS--------NGM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-G------- 130 (211)
T ss_pred ------CEEEEEEeCCcCHHHHHHh--------ccH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-C-------
Confidence 3899999999999999865 112 7889999999999999999999999999999998 4
Q ss_pred CeEEEeecCCccc
Q 001142 973 PVVKLCDFDRAVP 985 (1142)
Q Consensus 973 ~~vKL~DFGlA~~ 985 (1142)
+.++|+|||.+..
T Consensus 131 ~~~~liDf~~a~~ 143 (211)
T PRK14879 131 GKIYLIDFGLAEF 143 (211)
T ss_pred CCEEEEECCcccC
Confidence 6799999998853
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.9e-16 Score=169.21 Aligned_cols=144 Identities=14% Similarity=0.129 Sum_probs=103.0
Q ss_pred ceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-----CCCCccceeeeEecCCC
Q 001142 810 SSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-----RHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 810 ~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-----~HpNIVkl~g~~~~~~~ 884 (1142)
.-.+.||+|+||.||. .-.....++|+...... ...+. +.+|+.+++++ .||||++++|++.++..
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k~IKv~~~~~~----~~~~~----~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g 75 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQRCIKIVYHRGD----GGDKE----IRRELKYYAHLSRRLIDWSGIPRYYGTVETDCG 75 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCeEEEEEecccc----chHHH----HHHHHHHHHHhhccCCCCcccceeeEEEEeCCC
Confidence 4468899999999996 21223346776543211 12223 37999999999 57999999999987531
Q ss_pred CCCCCCCCccccceEEEEEec--cCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHH-HHHHhCCccccCCCCCCee
Q 001142 885 LPSADGNPEHHLLQSAIFMEY--VKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAAL-VELHSKHIMHRDIKSENIL 961 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy--~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL-~yLHs~gIvHrDLKp~NIL 961 (1142)
. .....+|||| +++++|.+++++ ..+++. ..++.|++.++ +|||+++|+||||||+|||
T Consensus 76 ~----------g~v~~~I~e~~G~~~~tL~~~l~~------~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NIL 137 (210)
T PRK10345 76 T----------GYVYDVIADFDGKPSITLTEFAEQ------CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNIL 137 (210)
T ss_pred C----------eEEEEEEecCCCCcchhHHHHHHc------ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEE
Confidence 0 1123489999 667999999965 235555 35678888887 9999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCCc
Q 001142 962 IDLERKKADGKPVVKLCDFDRA 983 (1142)
Q Consensus 962 ld~~~~~~~~~~~vKL~DFGlA 983 (1142)
++..+ .+...++|+||+.+
T Consensus 138 l~~~~---~~~~~~~LiDg~G~ 156 (210)
T PRK10345 138 CQRIS---ESEVIPVVCDNIGE 156 (210)
T ss_pred EeccC---CCCCcEEEEECCCC
Confidence 97542 12258999995444
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.3e-15 Score=162.12 Aligned_cols=138 Identities=21% Similarity=0.267 Sum_probs=104.7
Q ss_pred eecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCCCCCc
Q 001142 814 EAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 893 (1142)
Q Consensus 814 ~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~~~~~~~ 893 (1142)
.||+|++|.||+|.+.+..+++|++..+.......+...-..++.+|++++..+.|+++.....++.....
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~--------- 71 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDN--------- 71 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCC---------
Confidence 48999999999999999999999864332111111111112345789999999998876544444443322
Q ss_pred cccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccCCCCC
Q 001142 894 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 973 (1142)
Q Consensus 894 ~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~~~~~ 973 (1142)
.++||||++|++|.+++... .. .++.|++.+|.+||+.|++|||++|.||+++ + +
T Consensus 72 -----~~lv~e~~~g~~l~~~~~~~-----~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~-------~ 126 (199)
T TIGR03724 72 -----KTIVMEYIEGKPLKDVIEEG-----ND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-D-------D 126 (199)
T ss_pred -----CEEEEEEECCccHHHHHhhc-----HH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-C-------C
Confidence 38999999999999887541 11 7899999999999999999999999999998 4 6
Q ss_pred eEEEeecCCccc
Q 001142 974 VVKLCDFDRAVP 985 (1142)
Q Consensus 974 ~vKL~DFGlA~~ 985 (1142)
.++++|||.+..
T Consensus 127 ~~~liDfg~a~~ 138 (199)
T TIGR03724 127 KLYLIDFGLGKY 138 (199)
T ss_pred cEEEEECCCCcC
Confidence 799999998854
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.65 E-value=6.9e-16 Score=193.09 Aligned_cols=201 Identities=18% Similarity=0.234 Sum_probs=148.4
Q ss_pred CCCcceeeeecccCceEEEEEEE-CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC---CCCccceeeeEec
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR---HSCIVEMYGHKIS 881 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~-~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~---HpNIVkl~g~~~~ 881 (1142)
-..|.|.+.||+|+||.||+|.. ++..+|+|+-+-.. ... | .--.+++.+|+ -+.|..+..++.-
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~--~WE-----f----YI~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPN--PWE-----F----YICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCC--cee-----e----eehHHHHHhhchhhhcchHHHHHHHcc
Confidence 45689999999999999999987 56778888743211 111 1 11122334444 2344455444332
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 001142 882 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 961 (1142)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NIL 961 (1142)
.+ ..+||+||.+.|+|.+++.. .+.+++..+..+..|++..+++||..+||||||||+|+|
T Consensus 766 ~~--------------~S~lv~ey~~~Gtlld~~N~-----~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfl 826 (974)
T KOG1166|consen 766 QN--------------ASVLVSEYSPYGTLLDLINT-----NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFL 826 (974)
T ss_pred CC--------------cceeeeeccccccHHHhhcc-----CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeE
Confidence 22 23899999999999999973 567999999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001142 962 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1041 (1142)
Q Consensus 962 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ 1041 (1142)
|......+.+...++|+|||.+..+.-..... .-...++|-.+-.+|+..+ .+++..+|.|.|..+++
T Consensus 827 l~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~--------~F~~~~~td~f~C~EM~~g----rpWtYq~DyfGlAa~~h 894 (974)
T KOG1166|consen 827 LRREICADSDSKGLYLIDFGRSIDMKLFPDGT--------KFKAVWHTDLFDCIEMREG----RPWTYQIDYFGLAATVH 894 (974)
T ss_pred eecccCCCCcccceEEEecccceeeeEcCCCc--------EEeeeeccccchhHHHhcC----CCCchhhhhHHHHHHHH
Confidence 96654333445679999999997654322110 1123457888999999876 78999999999999999
Q ss_pred HHHhCCC
Q 001142 1042 ELLTLQV 1048 (1142)
Q Consensus 1042 ELLtG~~ 1048 (1142)
-|+.|++
T Consensus 895 ~mLFG~y 901 (974)
T KOG1166|consen 895 VMLFGKY 901 (974)
T ss_pred HHHHHHH
Confidence 9999864
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.4e-15 Score=186.45 Aligned_cols=145 Identities=20% Similarity=0.224 Sum_probs=112.3
Q ss_pred CCCcceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
...|...+.||+|+||+||++.+.+..+++|++..+..............++.+|++++.+++|++++..+.+..+...
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~- 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE- 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC-
Confidence 3445778999999999999999988777777654332211111111222455899999999999999887766654332
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
.++||||++|++|.+++. ....++.|++.+|.|||+.||+||||||+|||++ +
T Consensus 411 -------------~~lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~ 463 (535)
T PRK09605 411 -------------KTIVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-D 463 (535)
T ss_pred -------------CEEEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-C
Confidence 389999999999998875 2357899999999999999999999999999994 3
Q ss_pred cccCCCCCeEEEeecCCccc
Q 001142 966 RKKADGKPVVKLCDFDRAVP 985 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~ 985 (1142)
+.++|+|||+++.
T Consensus 464 -------~~~~liDFGla~~ 476 (535)
T PRK09605 464 -------DRLYLIDFGLGKY 476 (535)
T ss_pred -------CcEEEEeCccccc
Confidence 5799999999864
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.63 E-value=6.6e-17 Score=184.21 Aligned_cols=251 Identities=22% Similarity=0.192 Sum_probs=179.1
Q ss_pred cccCCCCCCcccC-CCCCCCCCCCCEEEccCCCCCCCCcccc-cCCCCCCCccEEEeecCCCCc-------cCccccCCc
Q 001142 21 KLPSEANKINNEK-NGSVNDDDDDSVIDVSGKTVDFPLIESY-GNRGGDNSVEGLYLYKNVLNL-------IPKSVGRYE 91 (1142)
Q Consensus 21 ~L~~~~N~i~~l~-~~~f~~l~~L~~LdLs~N~L~~~~p~~~-~~l~~L~~L~~L~Ls~N~Lt~-------iP~~l~~L~ 91 (1142)
.|.+..++++.-. ...|..+.+|+.|+|+++.++..-...+ ..+...++|++|+++.|.+.. ++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 4666777776333 3456677789999999999865311111 123344779999999888773 234567788
Q ss_pred CCcEEEccCCCCC-cCchhhcCCCC---CCEEEccCCCCCC-----CcccccCC-CCCCEEECCCCCCCCC-cccchhhh
Q 001142 92 KLRNLKFFGNEIN-LFPSEVGNLLG---LECLQIKISSPGV-----NGFALNKL-KGLKELELSKVPPRPS-VLTLLSEI 160 (1142)
Q Consensus 92 ~L~~L~Ls~N~L~-~lP~~l~~L~~---L~~L~Ls~N~l~~-----~~~~~~~L-~~L~~L~Ls~n~~n~~-~~~lp~~l 160 (1142)
+|+.|+|++|.+. ..+..+..+.+ |+.|++++|.+.. +...+..+ ++|+.|++++|.+... ...++..+
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~ 161 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL 161 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHH
Confidence 9999999999997 45555655555 9999999988653 22345566 8899999999776532 12345567
Q ss_pred cCCCCCcEEEccCCCCC-----ccCcccCCCCCCCEEEccCCCCC-----ccchhhcCCCCCCEEEccCCCCCc-cCccc
Q 001142 161 AGLKCLTKLSVCHFSIR-----YLPPEIGCLSNLEQLDLSFNKMK-----YLPTEICYLKALISLKVANNKLVE-LPSGL 229 (1142)
Q Consensus 161 ~~L~~L~~L~Ls~N~L~-----~IP~~l~~L~~L~~L~Ls~N~L~-----~lP~~l~~L~~L~~L~Ls~N~Ls~-IP~~l 229 (1142)
..+++|+.|++++|.++ .++..+..+++|+.|+|++|.++ .++..+..+++|+.|+|++|.++. .+..+
T Consensus 162 ~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l 241 (319)
T cd00116 162 RANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAAL 241 (319)
T ss_pred HhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHH
Confidence 77888999999999987 24455666789999999999987 244566778899999999999873 12222
Q ss_pred c-----CCCCCCEEeCcCCcCCC--C--CcccccCCCCCCEEEccCCCCCC
Q 001142 230 Y-----LLQRLENLDLSNNRLTS--L--GSLDLCLMHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 230 ~-----~L~~L~~L~Ls~N~Ls~--~--~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1142)
. ..++|+.|++++|.++. . ....+..+++|+.|++++|+++.
T Consensus 242 ~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~ 292 (319)
T cd00116 242 ASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGE 292 (319)
T ss_pred HHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcH
Confidence 2 24789999999999872 1 22345567899999999999875
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.63 E-value=2e-17 Score=190.78 Aligned_cols=217 Identities=28% Similarity=0.333 Sum_probs=169.5
Q ss_pred EEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEccCC
Q 001142 45 VIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKIS 124 (1142)
Q Consensus 45 ~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N 124 (1142)
.|.|++-++...+-..+. -.|...+..||+.|++.++|..+..+..|+.|.|++|.|..||..+++|..|++|||+.|
T Consensus 54 ~l~Ls~rrlk~fpr~a~~--~~ltdt~~aDlsrNR~~elp~~~~~f~~Le~liLy~n~~r~ip~~i~~L~~lt~l~ls~N 131 (722)
T KOG0532|consen 54 RLLLSGRRLKEFPRGAAS--YDLTDTVFADLSRNRFSELPEEACAFVSLESLILYHNCIRTIPEAICNLEALTFLDLSSN 131 (722)
T ss_pred ccccccchhhcCCCcccc--ccccchhhhhccccccccCchHHHHHHHHHHHHHHhccceecchhhhhhhHHHHhhhccc
Confidence 456666666654433332 345666777888888888887777777788888888888888888888888877777776
Q ss_pred CCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCcccCCCCCCCEEEccCCCCCccch
Q 001142 125 SPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPT 204 (1142)
Q Consensus 125 ~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~lP~ 204 (1142)
++..+| ..++.|+ |+.|-+++|+++.+|+.++.+..|..||.+.|.|.++|.
T Consensus 132 qlS~lp---------------------------~~lC~lp-Lkvli~sNNkl~~lp~~ig~~~tl~~ld~s~nei~slps 183 (722)
T KOG0532|consen 132 QLSHLP---------------------------DGLCDLP-LKVLIVSNNKLTSLPEEIGLLPTLAHLDVSKNEIQSLPS 183 (722)
T ss_pred hhhcCC---------------------------hhhhcCc-ceeEEEecCccccCCcccccchhHHHhhhhhhhhhhchH
Confidence 655444 4455555 788899999999999999988899999999999999999
Q ss_pred hhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccCCCCCCCCCCCchhhccCC
Q 001142 205 EICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLE 284 (1142)
Q Consensus 205 ~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~ 284 (1142)
.+++|.+|+.|.+..|++..+|.++..|+ |..||+|+|+++.+| ..|.+|..|++|-|.+|+|+. -|..+|..=.
T Consensus 184 ql~~l~slr~l~vrRn~l~~lp~El~~Lp-Li~lDfScNkis~iP-v~fr~m~~Lq~l~LenNPLqS---PPAqIC~kGk 258 (722)
T KOG0532|consen 184 QLGYLTSLRDLNVRRNHLEDLPEELCSLP-LIRLDFSCNKISYLP-VDFRKMRHLQVLQLENNPLQS---PPAQICEKGK 258 (722)
T ss_pred HhhhHHHHHHHHHhhhhhhhCCHHHhCCc-eeeeecccCceeecc-hhhhhhhhheeeeeccCCCCC---ChHHHHhccc
Confidence 99999999999999999999999999764 899999999998875 489999999999999999987 7888886544
Q ss_pred CCCCCCCCCCcc
Q 001142 285 GNGKDSSNDDFI 296 (1142)
Q Consensus 285 ~n~l~~~~~~~~ 296 (1142)
...+.++.-..|
T Consensus 259 VHIFKyL~~qA~ 270 (722)
T KOG0532|consen 259 VHIFKYLSTQAC 270 (722)
T ss_pred eeeeeeecchhc
Confidence 444444444444
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.4e-15 Score=167.26 Aligned_cols=146 Identities=14% Similarity=0.159 Sum_probs=107.8
Q ss_pred cceeeeecccCceEEEEEE---ECCccEEEEEEecccCCCCh----------------HHHHHhHHhHHHHHHHHhhCCC
Q 001142 809 LSSCDEAGKSVSSSLFRCK---FGSADAAAKVRTLKVCGSSA----------------DEIRNFEYSCLGEVRMLGALRH 869 (1142)
Q Consensus 809 y~l~~~LG~GsfG~Vy~a~---~~~~~vAvKi~~l~~~~~~~----------------~~~~~~~~~~~~Ei~iL~~L~H 869 (1142)
|++.+.||+|++|.||+|. ..+..+|+|+.+........ ...+.....+.+|+.++.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 6888999999999999998 36789999987644211000 0011122345789999999975
Q ss_pred C--CccceeeeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 001142 870 S--CIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS 947 (1142)
Q Consensus 870 p--NIVkl~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs 947 (1142)
. .+.+++++ . ..++||||++|.+|...... ...+....+..++.||+.++.+||.
T Consensus 110 ~~i~~p~~~~~---~---------------~~~lV~E~~~g~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~ 166 (237)
T smart00090 110 AGVPVPKPIAW---R---------------RNVLVMEFIGGDGLPAPRLK-----DVEPEEEEEFELYDDILEEMRKLYK 166 (237)
T ss_pred cCCCCCeeeEe---c---------------CceEEEEEecCCcccccccc-----cCCcchHHHHHHHHHHHHHHHHHHh
Confidence 3 23344432 1 12899999998888665422 2345666778999999999999999
Q ss_pred CC-ccccCCCCCCeeeccccccCCCCCeEEEeecCCccc
Q 001142 948 KH-IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 985 (1142)
Q Consensus 948 ~g-IvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~ 985 (1142)
+| |+||||||+||+++ + +.++|+|||.+..
T Consensus 167 ~g~iiH~Dikp~NIli~-~-------~~i~LiDFg~a~~ 197 (237)
T smart00090 167 EGELVHGDLSEYNILVH-D-------GKVVIIDVSQSVE 197 (237)
T ss_pred cCCEEeCCCChhhEEEE-C-------CCEEEEEChhhhc
Confidence 99 99999999999998 4 6799999999854
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.60 E-value=5.4e-16 Score=179.65 Aligned_cols=187 Identities=22% Similarity=0.283 Sum_probs=137.0
Q ss_pred cceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccCCCCCeE
Q 001142 896 LLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 975 (1142)
Q Consensus 896 ~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~~~~~~v 975 (1142)
..++||.|++|...+|.+++.+. ......++...+.++.|++.|++| ++.+|+|+||.||++..+ ..+
T Consensus 328 ~~~lyI~Mn~c~~~tledWl~rr--~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d-------~q~ 395 (516)
T KOG1033|consen 328 KVYLYIQMNLCEKETLEDWLRRR--RTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDD-------DQL 395 (516)
T ss_pred ccchhhhhhhhhhhhHHHHhhCC--CcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccc-------hhh
Confidence 34579999999999999999752 223457888999999999999999 999999999999999777 679
Q ss_pred EEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCC
Q 001142 976 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLS 1054 (1142)
Q Consensus 976 KL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG-~~Pf~~~~ 1054 (1142)
||+|||+...........+ ........+||..||+||.+.+ ..|+.|+||||||+||+|++.- ..+|.
T Consensus 396 kIgDFgl~ts~~~~~~~~~----~~a~~t~~~gt~~YmsPEQi~g----~~y~~kvdIyaLGlil~EL~~~f~T~~e--- 464 (516)
T KOG1033|consen 396 KIGDFGLVTSQDKDETVAP----AAASHTQQVGTLLYMSPEQIRG----QQYSEKVDIYALGLILAELLIQFSTQFE--- 464 (516)
T ss_pred hhhhhhheeecccCCcccc----hhhhhhhcccccccCCHHHHhh----hhhhhhcchhhHHHHHHHHHHHhccHHH---
Confidence 9999999976544321000 0112334579999999999987 6899999999999999999973 22221
Q ss_pred HHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 001142 1055 ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVA 1132 (1142)
Q Consensus 1055 ~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~ 1132 (1142)
.......+..+..|+... .+. +.-..|+.+++.+.|.+||++.+..-|.|.
T Consensus 465 r~~t~~d~r~g~ip~~~~--------------------------~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 465 RIATLTDIRDGIIPPEFL--------------------------QDY-PEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred HHHhhhhhhcCCCChHHh--------------------------hcC-cHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 111233344443332111 011 224678999999999999988887777664
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.59 E-value=3.8e-16 Score=177.98 Aligned_cols=223 Identities=23% Similarity=0.233 Sum_probs=172.8
Q ss_pred EEEccCCCCCC-CCcccccCCCCCCCccEEEeecCCCC-----ccCccccCCcCCcEEEccCCCCCc-------Cchhhc
Q 001142 45 VIDVSGKTVDF-PLIESYGNRGGDNSVEGLYLYKNVLN-----LIPKSVGRYEKLRNLKFFGNEINL-------FPSEVG 111 (1142)
Q Consensus 45 ~LdLs~N~L~~-~~p~~~~~l~~L~~L~~L~Ls~N~Lt-----~iP~~l~~L~~L~~L~Ls~N~L~~-------lP~~l~ 111 (1142)
.|+|..+.+++ .....+..+ .+|+.|+|+++.++ .++..+...++|++|++++|.+.. ++..+.
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l---~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~ 78 (319)
T cd00116 2 QLSLKGELLKTERATELLPKL---LCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLT 78 (319)
T ss_pred ccccccCcccccchHHHHHHH---hhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHH
Confidence 57899999883 344444444 78999999999995 466677888899999999998873 345677
Q ss_pred CCCCCCEEEccCCCCC-CCcccccCCCC---CCEEECCCCCCCC-CcccchhhhcCC-CCCcEEEccCCCCC-----ccC
Q 001142 112 NLLGLECLQIKISSPG-VNGFALNKLKG---LKELELSKVPPRP-SVLTLLSEIAGL-KCLTKLSVCHFSIR-----YLP 180 (1142)
Q Consensus 112 ~L~~L~~L~Ls~N~l~-~~~~~~~~L~~---L~~L~Ls~n~~n~-~~~~lp~~l~~L-~~L~~L~Ls~N~L~-----~IP 180 (1142)
++++|+.|+|++|.+. ..+..+..+.. |++|++++|.+.. ....+...+..+ ++|+.|++++|.++ .++
T Consensus 79 ~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~ 158 (319)
T cd00116 79 KGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALA 158 (319)
T ss_pred hcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHH
Confidence 8999999999999865 34445555555 9999999976642 122334556677 89999999999998 345
Q ss_pred cccCCCCCCCEEEccCCCCC-----ccchhhcCCCCCCEEEccCCCCC-----ccCccccCCCCCCEEeCcCCcCCCCCc
Q 001142 181 PEIGCLSNLEQLDLSFNKMK-----YLPTEICYLKALISLKVANNKLV-----ELPSGLYLLQRLENLDLSNNRLTSLGS 250 (1142)
Q Consensus 181 ~~l~~L~~L~~L~Ls~N~L~-----~lP~~l~~L~~L~~L~Ls~N~Ls-----~IP~~l~~L~~L~~L~Ls~N~Ls~~~p 250 (1142)
..+..+.+|+.|+|++|.|+ .++..+..+++|+.|+|++|.++ .++..+..+++|+.|+|++|.++....
T Consensus 159 ~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~ 238 (319)
T cd00116 159 KALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGA 238 (319)
T ss_pred HHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHH
Confidence 56677889999999999998 34566777789999999999997 345566778999999999999996433
Q ss_pred ccccC-----CCCCCEEEccCCCCC
Q 001142 251 LDLCL-----MHNLQNLNLQYNKLL 270 (1142)
Q Consensus 251 ~~l~~-----L~~L~~L~Ls~N~L~ 270 (1142)
..+.. .+.|+.|++++|.++
T Consensus 239 ~~l~~~~~~~~~~L~~L~l~~n~i~ 263 (319)
T cd00116 239 AALASALLSPNISLLTLSLSCNDIT 263 (319)
T ss_pred HHHHHHHhccCCCceEEEccCCCCC
Confidence 33332 479999999999997
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=7.9e-15 Score=156.64 Aligned_cols=143 Identities=17% Similarity=0.163 Sum_probs=105.5
Q ss_pred cceeeeecccCceEEEEEEE-CCccEEEEEEecccCCCChH--------------HHHHhHHhHHHHHHHHhhCCCCC--
Q 001142 809 LSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSAD--------------EIRNFEYSCLGEVRMLGALRHSC-- 871 (1142)
Q Consensus 809 y~l~~~LG~GsfG~Vy~a~~-~~~~vAvKi~~l~~~~~~~~--------------~~~~~~~~~~~Ei~iL~~L~HpN-- 871 (1142)
|.+.+.||+|+||.||++.+ .+..+|||+........... ..........+|+.++.++.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 67789999999999999988 57889999866432111000 00011123468999999998774
Q ss_pred ccceeeeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 001142 872 IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIM 951 (1142)
Q Consensus 872 IVkl~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIv 951 (1142)
+...++. . ..++||||++|++|...... .....++.+++.++.++|+.||+
T Consensus 97 v~~~~~~----~--------------~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~~gi~ 147 (198)
T cd05144 97 VPKPIDW----N--------------RHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYKHGII 147 (198)
T ss_pred CCceeec----C--------------CceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHHCCCC
Confidence 3443321 1 12899999999998765321 23467889999999999999999
Q ss_pred ccCCCCCCeeeccccccCCCCCeEEEeecCCccccc
Q 001142 952 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR 987 (1142)
Q Consensus 952 HrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~ 987 (1142)
||||||+||+++.+ +.++|+|||.+....
T Consensus 148 H~Dl~p~Nill~~~-------~~~~liDfg~~~~~~ 176 (198)
T cd05144 148 HGDLSEFNILVDDD-------EKIYIIDWPQMVSTD 176 (198)
T ss_pred cCCCCcccEEEcCC-------CcEEEEECCccccCC
Confidence 99999999999876 789999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.53 E-value=4.4e-16 Score=179.86 Aligned_cols=205 Identities=28% Similarity=0.402 Sum_probs=164.3
Q ss_pred cccccCCCCCCcccCCCCCC-CCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEE
Q 001142 19 KEKLPSEANKINNEKNGSVN-DDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLK 97 (1142)
Q Consensus 19 l~~L~~~~N~i~~l~~~~f~-~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~ 97 (1142)
.+.|.+.+-+++..+.+.+. ++..-...||+.|++..+ |..+..| ..|+.|.|++|.+..||..+.+|..|++||
T Consensus 52 sg~l~Ls~rrlk~fpr~a~~~~ltdt~~aDlsrNR~~el-p~~~~~f---~~Le~liLy~n~~r~ip~~i~~L~~lt~l~ 127 (722)
T KOG0532|consen 52 SGRLLLSGRRLKEFPRGAASYDLTDTVFADLSRNRFSEL-PEEACAF---VSLESLILYHNCIRTIPEAICNLEALTFLD 127 (722)
T ss_pred hcccccccchhhcCCCccccccccchhhhhccccccccC-chHHHHH---HHHHHHHHHhccceecchhhhhhhHHHHhh
Confidence 45666777777777765544 666777899999999865 4445555 789999999999999999999999999999
Q ss_pred ccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCC
Q 001142 98 FFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIR 177 (1142)
Q Consensus 98 Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~ 177 (1142)
|+.|+++.+|..++.| -|+.|-+++|+++.+| ..++.+..|..|+.+.|.|.
T Consensus 128 ls~NqlS~lp~~lC~l-pLkvli~sNNkl~~lp---------------------------~~ig~~~tl~~ld~s~nei~ 179 (722)
T KOG0532|consen 128 LSSNQLSHLPDGLCDL-PLKVLIVSNNKLTSLP---------------------------EEIGLLPTLAHLDVSKNEIQ 179 (722)
T ss_pred hccchhhcCChhhhcC-cceeEEEecCccccCC---------------------------cccccchhHHHhhhhhhhhh
Confidence 9999999999998876 4777777766655544 45556667778888888888
Q ss_pred ccCcccCCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeCcCCcCCCCCcccccCCC
Q 001142 178 YLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMH 257 (1142)
Q Consensus 178 ~IP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~ 257 (1142)
.+|..++.+.+|+.|.+..|++..+|.+++.| .|..||+|.|+++.||-.|.+|+.|++|-|.+|.|+..+. .++...
T Consensus 180 slpsql~~l~slr~l~vrRn~l~~lp~El~~L-pLi~lDfScNkis~iPv~fr~m~~Lq~l~LenNPLqSPPA-qIC~kG 257 (722)
T KOG0532|consen 180 SLPSQLGYLTSLRDLNVRRNHLEDLPEELCSL-PLIRLDFSCNKISYLPVDFRKMRHLQVLQLENNPLQSPPA-QICEKG 257 (722)
T ss_pred hchHHhhhHHHHHHHHHhhhhhhhCCHHHhCC-ceeeeecccCceeecchhhhhhhhheeeeeccCCCCCChH-HHHhcc
Confidence 88888888888888888888888888888865 4888888888888888888888888888888888886543 555443
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.5e-13 Score=151.33 Aligned_cols=146 Identities=15% Similarity=0.185 Sum_probs=105.1
Q ss_pred eeeec-ccCceEEEEEEECCccEEEEEEecccC-----CCChHHHHHhHHhHHHHHHHHhhCCCCCc--cceeeeEecCC
Q 001142 812 CDEAG-KSVSSSLFRCKFGSADAAAKVRTLKVC-----GSSADEIRNFEYSCLGEVRMLGALRHSCI--VEMYGHKISSK 883 (1142)
Q Consensus 812 ~~~LG-~GsfG~Vy~a~~~~~~vAvKi~~l~~~-----~~~~~~~~~~~~~~~~Ei~iL~~L~HpNI--Vkl~g~~~~~~ 883 (1142)
...|| .|+.|+||.+...+..+++|.+..... ............++.+|++++.++.|++| ++.+++.....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred CceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 45687 888899999988888999998642110 00000001112345789999999998775 67777644322
Q ss_pred CCCCCCCCCccccceEEEEEeccCC-CCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKG-GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~g-gSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
. .....++||||++| .+|.+++.. ..++.. .+.||+.+|.+||++||+||||||.|||+
T Consensus 116 ~----------~~~~~~lV~e~l~G~~~L~~~l~~------~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv 175 (239)
T PRK01723 116 G----------LFYRADILIERIEGARDLVALLQE------APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILL 175 (239)
T ss_pred C----------cceeeeEEEEecCCCCCHHHHHhc------CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEE
Confidence 1 12234799999997 699988764 235543 35789999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcc
Q 001142 963 DLERKKADGKPVVKLCDFDRAV 984 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~ 984 (1142)
+.+ +.++|+|||.+.
T Consensus 176 ~~~-------~~v~LIDfg~~~ 190 (239)
T PRK01723 176 DPD-------GKFWLIDFDRGE 190 (239)
T ss_pred cCC-------CCEEEEECCCcc
Confidence 876 679999999874
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.8e-14 Score=170.14 Aligned_cols=194 Identities=34% Similarity=0.428 Sum_probs=105.5
Q ss_pred EEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCc-CCcEEEccCCCCCcCchhhcCCCCCCEEEccC
Q 001142 45 VIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYE-KLRNLKFFGNEINLFPSEVGNLLGLECLQIKI 123 (1142)
Q Consensus 45 ~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~-~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~ 123 (1142)
.|+++.|.+...+.. +..++.++.|++.+|.++.||.....+. +|+.|++++|+|..+|..+.++++|+.|++++
T Consensus 97 ~l~~~~~~~~~~~~~----~~~~~~l~~L~l~~n~i~~i~~~~~~~~~nL~~L~l~~N~i~~l~~~~~~l~~L~~L~l~~ 172 (394)
T COG4886 97 SLDLNLNRLRSNISE----LLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSF 172 (394)
T ss_pred eeeccccccccCchh----hhcccceeEEecCCcccccCccccccchhhcccccccccchhhhhhhhhccccccccccCC
Confidence 355555555333322 1222455666666666666655555553 56666666666665555555555555555555
Q ss_pred CCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCcccCCCCCCCEEEccCCCCCccc
Q 001142 124 SSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLP 203 (1142)
Q Consensus 124 N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~lP 203 (1142)
|++..++.... .++.|+.|++++|+++.+|..+..+..|+.|.+++|.+..++
T Consensus 173 N~l~~l~~~~~---------------------------~~~~L~~L~ls~N~i~~l~~~~~~~~~L~~l~~~~N~~~~~~ 225 (394)
T COG4886 173 NDLSDLPKLLS---------------------------NLSNLNNLDLSGNKISDLPPEIELLSALEELDLSNNSIIELL 225 (394)
T ss_pred chhhhhhhhhh---------------------------hhhhhhheeccCCccccCchhhhhhhhhhhhhhcCCcceecc
Confidence 55554443333 445555555555555555554444444555555555555555
Q ss_pred hhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccCCCCCC
Q 001142 204 TEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 204 ~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1142)
..+..+.++..|.+++|++..+|..++.+++|+.|++++|+++.+.+ +..+.+|+.|++++|.+..
T Consensus 226 ~~~~~~~~l~~l~l~~n~~~~~~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~ 291 (394)
T COG4886 226 SSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSN 291 (394)
T ss_pred hhhhhcccccccccCCceeeeccchhccccccceecccccccccccc--ccccCccCEEeccCccccc
Confidence 55555555555555555555555555555555555555555555544 5555555555555555544
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.8e-15 Score=185.95 Aligned_cols=266 Identities=23% Similarity=0.233 Sum_probs=191.8
Q ss_pred CCCcceeeeecccCceEEEEEEE-CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~-~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~g~~~~~~ 883 (1142)
...|.+.+.||+|+|+.|-.+.. .....+++.+.+.......... .++..|..+-+.+. |+|++.+++......
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~----~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~ 94 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSS----EHIDTETDIQKKLSKHSNTVHMIEPSSSPR 94 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchh----hhcCccccccccccccccccccCCccCCCc
Confidence 45688888999999999988765 3444555554444433222222 22356888888886 999999999887655
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCCeee
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELH-SKHIMHRDIKSENILI 962 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLH-s~gIvHrDLKp~NILl 962 (1142)
.. +++++|..|+++.+.+.. ......+...+..++.|+..++.|+| ..++.|+||||+|.++
T Consensus 95 ~~--------------~~~~~~s~g~~~f~~i~~---~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l 157 (601)
T KOG0590|consen 95 SY--------------LLSLSYSDGGSLFSKISH---PDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLL 157 (601)
T ss_pred cc--------------ccccCccccccccccccc---CCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchh
Confidence 43 899999999999888731 12225677788899999999999999 9999999999999999
Q ss_pred ccccccCCCCC-eEEEeecCCcccccccccccccccCCCCCCCCccC-CCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 963 DLERKKADGKP-VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG-TPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 963 d~~~~~~~~~~-~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~G-T~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
+.. + ..++.|||+|..+..... ........+| ++.|+|||...+. ....+..|+||.|+++
T Consensus 158 ~~s-------~~~l~~~df~~At~~~~~~g-------~~~~~~~~~g~s~~y~a~E~~~~~---~~~~~~~d~~S~g~~l 220 (601)
T KOG0590|consen 158 DES-------GSALKIADFGLATAYRNKNG-------AERSLKDRCGSSPPYGAPEHLSGK---AYRGPSVDVWSLGIVL 220 (601)
T ss_pred ccC-------CCcccCCCchhhccccccCC-------cceeeecccCCCCCCCCcccccch---hhcCCCcccccccccc
Confidence 887 5 799999999987654211 1112234457 9999999998762 3446889999999999
Q ss_pred HHHHhCCCCCCCCCHHHHH--HHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001142 1041 LELLTLQVPYMGLSELEIH--DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1118 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~~~~~el~--~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~ 1118 (1142)
.-+++|..||......... ..+...... ....+ ........+++.+++..+|.
T Consensus 221 ~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~------~~~~~~~~~~l~k~l~~~~~ 275 (601)
T KOG0590|consen 221 SAMLTGELPWDFPSRKDGRYSSWKSNKGRF-------------------TQLPW------NSISDQAHDLLHKILKENPS 275 (601)
T ss_pred cccccCCCCccccccccccceeeccccccc-------------------ccCcc------ccCChhhhhcccccccCCch
Confidence 9999999999754332210 000000000 00000 13445578889999999999
Q ss_pred CCCCHHHHHHHHHhhc
Q 001142 1119 ERPTAGDLYEMFVART 1134 (1142)
Q Consensus 1119 ~RPSa~EVL~~L~~~~ 1134 (1142)
.|.+.+++..+.|...
T Consensus 276 ~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 276 NRLSIEELKLDNWLSS 291 (601)
T ss_pred hccccccccccccccc
Confidence 9999999999999876
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.46 E-value=3.5e-13 Score=141.98 Aligned_cols=140 Identities=16% Similarity=0.233 Sum_probs=94.5
Q ss_pred eeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHh------------------HHhHHHHHHHHhhCCCCC-
Q 001142 812 CDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNF------------------EYSCLGEVRMLGALRHSC- 871 (1142)
Q Consensus 812 ~~~LG~GsfG~Vy~a~~~-~~~vAvKi~~l~~~~~~~~~~~~~------------------~~~~~~Ei~iL~~L~HpN- 871 (1142)
.+.||+|+||+||+|... +..+|+|+.+....... ....+ ......|...+.++.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFK--KRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchh--hhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 578999999999999985 78899998654322111 11110 011134566666664332
Q ss_pred -ccceeeeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHH-HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-C
Q 001142 872 -IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKN-YIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-K 948 (1142)
Q Consensus 872 -IVkl~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~-~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs-~ 948 (1142)
+.+.+++. ..++||||++++++.. .+... ... ..+..++.+++.++.++|. +
T Consensus 80 ~~~~~~~~~------------------~~~lv~e~~~g~~~~~~~l~~~------~~~-~~~~~~~~~~~~~l~~lh~~~ 134 (187)
T cd05119 80 PVPKPIDLN------------------RHVLVMEFIGGDGIPAPRLKDV------RLL-EDPEELYDQILELMRKLYREA 134 (187)
T ss_pred CCCceEecC------------------CCEEEEEEeCCCCccChhhhhh------hhc-ccHHHHHHHHHHHHHHHhhcc
Confidence 33333321 2389999999854321 12210 011 6678899999999999999 9
Q ss_pred CccccCCCCCCeeeccccccCCCCCeEEEeecCCcccc
Q 001142 949 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPL 986 (1142)
Q Consensus 949 gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l 986 (1142)
||+||||||+||+++ + +.++|+|||.+...
T Consensus 135 ~ivH~Dl~p~Nili~-~-------~~~~liDfg~a~~~ 164 (187)
T cd05119 135 GLVHGDLSEYNILVD-D-------GKVYIIDVPQAVEI 164 (187)
T ss_pred CcCcCCCChhhEEEE-C-------CcEEEEECcccccc
Confidence 999999999999998 5 68999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.45 E-value=7.6e-14 Score=164.74 Aligned_cols=191 Identities=34% Similarity=0.376 Sum_probs=142.2
Q ss_pred EEEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCC-CCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccC
Q 001142 95 NLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLK-GLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCH 173 (1142)
Q Consensus 95 ~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~-~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~ 173 (1142)
.|+++.|.+..-+..+..++.++.|++.+|.+..++.....+. +|+.|++++|.+ ..+|..+..+++|+.|++++
T Consensus 97 ~l~~~~~~~~~~~~~~~~~~~l~~L~l~~n~i~~i~~~~~~~~~nL~~L~l~~N~i----~~l~~~~~~l~~L~~L~l~~ 172 (394)
T COG4886 97 SLDLNLNRLRSNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKI----ESLPSPLRNLPNLKNLDLSF 172 (394)
T ss_pred eeeccccccccCchhhhcccceeEEecCCcccccCccccccchhhcccccccccch----hhhhhhhhccccccccccCC
Confidence 4555555553333334444555555555555555555555553 666666665332 34445678899999999999
Q ss_pred CCCCccCcccCCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeCcCCcCCCCCcccc
Q 001142 174 FSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDL 253 (1142)
Q Consensus 174 N~L~~IP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls~N~Ls~~~p~~l 253 (1142)
|+++.+|...+.+++|+.|++++|+++.+|..+..+..|+.|.+++|.+..+|..+.++.++..|.+++|++...+ ..+
T Consensus 173 N~l~~l~~~~~~~~~L~~L~ls~N~i~~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~~~~-~~~ 251 (394)
T COG4886 173 NDLSDLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLEDLP-ESI 251 (394)
T ss_pred chhhhhhhhhhhhhhhhheeccCCccccCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceeeecc-chh
Confidence 9999999987799999999999999999999887788899999999988888889999999999999999998763 478
Q ss_pred cCCCCCCEEEccCCCCCCCC---CCCchhhccCCCCCCCC
Q 001142 254 CLMHNLQNLNLQYNKLLSYC---QVPSWICCNLEGNGKDS 290 (1142)
Q Consensus 254 ~~L~~L~~L~Ls~N~L~~~~---~iP~~~~~~l~~n~l~~ 290 (1142)
..++.|+.|++++|.++.+. .+..+..+.++.|.+..
T Consensus 252 ~~l~~l~~L~~s~n~i~~i~~~~~~~~l~~L~~s~n~~~~ 291 (394)
T COG4886 252 GNLSNLETLDLSNNQISSISSLGSLTNLRELDLSGNSLSN 291 (394)
T ss_pred ccccccceeccccccccccccccccCccCEEeccCccccc
Confidence 89999999999999998732 22333345555555543
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.41 E-value=9.4e-13 Score=131.41 Aligned_cols=132 Identities=20% Similarity=0.228 Sum_probs=104.2
Q ss_pred eeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCC--CCccceeeeEecCCCCCCC
Q 001142 811 SCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH--SCIVEMYGHKISSKWLPSA 888 (1142)
Q Consensus 811 l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H--pNIVkl~g~~~~~~~~~~~ 888 (1142)
+.+.||+|.++.||++...+..+++|+..... . ...+ .+|+.++..++| .++++++++....+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~--~----~~~~----~~e~~~~~~l~~~~~~~p~~~~~~~~~~----- 66 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSRE--K----GADR----EREVAILQLLARKGLPVPKVLASGESDG----- 66 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCC--c----hhHH----HHHHHHHHHHHHcCCCCCeEEEEcCCCC-----
Confidence 45789999999999999988888888753221 1 2233 689999999975 58888887765432
Q ss_pred CCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCCCCeeeccc
Q 001142 889 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK---HIMHRDIKSENILIDLE 965 (1142)
Q Consensus 889 ~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~---gIvHrDLKp~NILld~~ 965 (1142)
..+++|||++++.+..+ +......++.+++.++.++|.. +++|+|++|.||+++..
T Consensus 67 ---------~~~~v~e~~~g~~~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~ 125 (155)
T cd05120 67 ---------WSYLLMEWIEGETLDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG 125 (155)
T ss_pred ---------ccEEEEEecCCeecccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECC
Confidence 34999999997766533 4456677899999999999984 79999999999999875
Q ss_pred cccCCCCCeEEEeecCCccc
Q 001142 966 RKKADGKPVVKLCDFDRAVP 985 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~ 985 (1142)
+.++++|||.+..
T Consensus 126 -------~~~~l~Df~~~~~ 138 (155)
T cd05120 126 -------KILGIIDWEYAGY 138 (155)
T ss_pred -------cEEEEEecccccC
Confidence 6899999998853
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.33 E-value=2.8e-12 Score=159.77 Aligned_cols=90 Identities=29% Similarity=0.442 Sum_probs=63.0
Q ss_pred CCEEEccCCCCC-ccchhhcCCCCCCEEEccCCCCC-ccCccccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccC
Q 001142 189 LEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQY 266 (1142)
Q Consensus 189 L~~L~Ls~N~L~-~lP~~l~~L~~L~~L~Ls~N~Ls-~IP~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~ 266 (1142)
++.|+|++|.|+ .+|..++.+++|+.|+|++|.|+ .+|..++.+++|+.|+|++|+|+|.+|..+++|++|+.|+|++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 566777777776 66777777777777777777776 6676777777777777777777777776677777777777777
Q ss_pred CCCCCCCCCCchhh
Q 001142 267 NKLLSYCQVPSWIC 280 (1142)
Q Consensus 267 N~L~~~~~iP~~~~ 280 (1142)
|+|++ .+|..+.
T Consensus 500 N~l~g--~iP~~l~ 511 (623)
T PLN03150 500 NSLSG--RVPAALG 511 (623)
T ss_pred Ccccc--cCChHHh
Confidence 77766 5665554
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.17 E-value=3.6e-11 Score=131.99 Aligned_cols=214 Identities=21% Similarity=0.232 Sum_probs=144.8
Q ss_pred HHHhhCCCCCccceeeeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHH
Q 001142 862 RMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAA 941 (1142)
Q Consensus 862 ~iL~~L~HpNIVkl~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~g 941 (1142)
.-+.++-|.|||+++.|+.+..+- ..+...++.||+..|++..++++..... ..+......+|+-||+.|
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~---------e~~rviFiteymssgs~~~fLkrt~~~~-~a~~~~~wkkw~tqIlsa 188 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYE---------EKPRVIFITEYMSSGSLKQFLKRTKKNQ-KALFQKAWKKWCTQILSA 188 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccc---------cccceEEEEecccchhHHHHHHHHHHhh-hhhhHHHHHHHHHHHHhh
Confidence 345566799999999999875532 3456789999999999999999876654 578888999999999999
Q ss_pred HHHHHhC--CccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhc
Q 001142 942 LVELHSK--HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1019 (1142)
Q Consensus 942 L~yLHs~--gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~ 1019 (1142)
|.|||+. .|+|+++...-|++..+ +-+|++- +.-............ .......+-++|.|||.-.
T Consensus 189 l~yLhs~~PpiihgnlTc~tifiq~n-------gLIkig~-~ap~s~h~s~~~~~~-----~Ek~~~~~~~g~~a~~sg~ 255 (458)
T KOG1266|consen 189 LSYLHSCDPPIIHGNLTCDTIFIQHN-------GLIKIGS-VAPDSTHPSVNSTRE-----AEKSVNTSLPGFSAPESGT 255 (458)
T ss_pred hhhhhccCCccccCCcchhheeecCC-------ceEEecc-cCccccchhhhhhhH-----hhhhccccCCccccCCcCc
Confidence 9999975 69999999999999876 5566542 211111110011000 0111224677899999743
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhh
Q 001142 1020 AMHKPNLYGLEVDIWSYGCLLLELLTLQVP-YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 1098 (1142)
Q Consensus 1020 ~~~~~~~~s~ksDVwSLGviL~ELLtG~~P-f~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1142)
. ...+.++|||+||....||..+..- -.+.+..+....+...... .
T Consensus 256 ~----tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~-----------------------l------ 302 (458)
T KOG1266|consen 256 T----TNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIG-----------------------L------ 302 (458)
T ss_pred c----cccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheee-----------------------c------
Confidence 2 3456789999999999999887543 2222222222222111100 0
Q ss_pred hhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001142 1099 LETLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1099 ~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~ 1133 (1142)
..+.-++++..|++..|..||+|.+++.|+...
T Consensus 303 --en~lqr~~i~kcl~~eP~~rp~ar~llfHpllf 335 (458)
T KOG1266|consen 303 --ENGLQRGSITKCLEGEPNGRPDARLLLFHPLLF 335 (458)
T ss_pred --cCccccCcCcccccCCCCCCcchhhhhcCceee
Confidence 000124568899999999999999999997654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.6e-10 Score=121.42 Aligned_cols=143 Identities=14% Similarity=0.108 Sum_probs=102.3
Q ss_pred eeeecccCceEEEEEEEC--------CccEEEEEEecccCCCC------------------hHHHHHhHHhHHHHHHHHh
Q 001142 812 CDEAGKSVSSSLFRCKFG--------SADAAAKVRTLKVCGSS------------------ADEIRNFEYSCLGEVRMLG 865 (1142)
Q Consensus 812 ~~~LG~GsfG~Vy~a~~~--------~~~vAvKi~~l~~~~~~------------------~~~~~~~~~~~~~Ei~iL~ 865 (1142)
...||.|--+.||.|... +..+|+|+++....... ....+.+..+..+|++.|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 357899999999999754 36899999764322111 0112233445569999999
Q ss_pred hCC--CCCccceeeeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHH-HHHHHhccCCCCCCHHHHHHHHHHHHHHH
Q 001142 866 ALR--HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKN-YIEKLSETGEKHVSVKLALFIAQDVAAAL 942 (1142)
Q Consensus 866 ~L~--HpNIVkl~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~-~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL 942 (1142)
++. .-++.+.+++. . -+|||||+.+..+.. .+++ ..++......+..+++.+|
T Consensus 82 rl~~~Gv~vP~pi~~~--~----------------~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l 137 (197)
T cd05146 82 RMQKAGIPCPEVVVLK--K----------------HVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMM 137 (197)
T ss_pred HHHHcCCCCCeEEEec--C----------------CEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHH
Confidence 995 35666777642 1 189999997654422 2222 2355566778889999999
Q ss_pred HHH-HhCCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccc
Q 001142 943 VEL-HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPL 986 (1142)
Q Consensus 943 ~yL-Hs~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l 986 (1142)
..| |..|||||||++.|||++. +.++|+|||.+...
T Consensus 138 ~~l~H~~glVHGDLs~~NIL~~~--------~~v~iIDF~qav~~ 174 (197)
T cd05146 138 KQLYKECNLVHADLSEYNMLWHD--------GKVWFIDVSQSVEP 174 (197)
T ss_pred HHHHHhCCeecCCCCHHHEEEEC--------CcEEEEECCCceeC
Confidence 999 8999999999999999964 46999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=3e-12 Score=152.42 Aligned_cols=218 Identities=27% Similarity=0.248 Sum_probs=99.8
Q ss_pred CCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCE
Q 001142 39 DDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLEC 118 (1142)
Q Consensus 39 ~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~ 118 (1142)
.+..++.++|..|.|.... ..+..+.+|+.|+|.+|.|..|...+..+++|++|+|++|+|+.+. .+..++.|+.
T Consensus 70 ~l~~l~~l~l~~n~i~~~~----~~l~~~~~l~~l~l~~n~i~~i~~~l~~~~~L~~L~ls~N~I~~i~-~l~~l~~L~~ 144 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIAKIL----NHLSKLKSLEALDLYDNKIEKIENLLSSLVNLQVLDLSFNKITKLE-GLSTLTLLKE 144 (414)
T ss_pred HhHhHHhhccchhhhhhhh----cccccccceeeeeccccchhhcccchhhhhcchheecccccccccc-chhhccchhh
Confidence 4445555556666555411 1133345666666666666666444555666666666666666553 2444555666
Q ss_pred EEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCcccCCCCCCCEEEccCCC
Q 001142 119 LQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNK 198 (1142)
Q Consensus 119 L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~ 198 (1142)
|++.+|.+..+.. +..+..|+.|++++|.+...... . +..+.+|+.+.+.+|.+..+ ..+..+..+..+++..|.
T Consensus 145 L~l~~N~i~~~~~-~~~l~~L~~l~l~~n~i~~ie~~--~-~~~~~~l~~l~l~~n~i~~i-~~~~~~~~l~~~~l~~n~ 219 (414)
T KOG0531|consen 145 LNLSGNLISDISG-LESLKSLKLLDLSYNRIVDIEND--E-LSELISLEELDLGGNSIREI-EGLDLLKKLVLLSLLDNK 219 (414)
T ss_pred heeccCcchhccC-CccchhhhcccCCcchhhhhhhh--h-hhhccchHHHhccCCchhcc-cchHHHHHHHHhhccccc
Confidence 6666665444332 22244444455544333211110 0 23344444445555544433 222223333333444444
Q ss_pred CCccchhhcCCCC--CCEEEccCCCCCccCccccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccCCCC
Q 001142 199 MKYLPTEICYLKA--LISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269 (1142)
Q Consensus 199 L~~lP~~l~~L~~--L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L 269 (1142)
++.+- .+..+.. |+.|++++|.+..+|..+..+.++..|++++|++...-. +.....+..+.+..|++
T Consensus 220 i~~~~-~l~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~l~~l~~~~n~~~~~~~--~~~~~~~~~~~~~~~~~ 289 (414)
T KOG0531|consen 220 ISKLE-GLNELVMLHLRELYLSGNRISRSPEGLENLKNLPVLDLSSNRISNLEG--LERLPKLSELWLNDNKL 289 (414)
T ss_pred ceecc-CcccchhHHHHHHhcccCccccccccccccccccccchhhcccccccc--ccccchHHHhccCcchh
Confidence 44331 1111122 445555555555444444444445555555555443322 33334444444444444
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.14 E-value=7e-11 Score=140.02 Aligned_cols=257 Identities=22% Similarity=0.194 Sum_probs=176.3
Q ss_pred cceeeeecc--cCceEEEEEEE----CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEec
Q 001142 809 LSSCDEAGK--SVSSSLFRCKF----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKIS 881 (1142)
Q Consensus 809 y~l~~~LG~--GsfG~Vy~a~~----~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~g~~~~ 881 (1142)
+.+.+.+|. |.+|.||.+.. ....+|+|.-+.... ........ .+|+....+++ |+|.|+.+..+..
T Consensus 116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s-~p~~~~~k-----~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFS-PPLDSKRK-----LREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred cccccccccCCCCCceeecccCCcccCCcccccccccCCCC-Cccccccc-----cchhhcccccCccccccccCccccc
Confidence 467788999 99999999876 344556654222211 11122222 47877777885 9999998888877
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHH----HHHHHHhCCccccCCCC
Q 001142 882 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAA----ALVELHSKHIMHRDIKS 957 (1142)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~----gL~yLHs~gIvHrDLKp 957 (1142)
.+.. ++-+|++. .+|.++.+. ....++...++.++.+... ||.++|..+|+|-|+||
T Consensus 190 ~~~l--------------fiqtE~~~-~sl~~~~~~----~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp 250 (524)
T KOG0601|consen 190 SGIL--------------FIQTELCG-ESLQSYCHT----PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKP 250 (524)
T ss_pred CCcc--------------eeeecccc-chhHHhhhc----ccccCCchhhhhHHhhhhhcccccccccCCCcccccccch
Confidence 6644 88999995 788887765 2334778888888888888 99999999999999999
Q ss_pred CCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHH
Q 001142 958 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1037 (1142)
Q Consensus 958 ~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLG 1037 (1142)
.||+...+. ...+++|||....+....-..... ......|...|++||...+ .++.+.|||++|
T Consensus 251 ~~i~~~~~~------~s~~~~df~~v~~i~~~~~~~~~~-----~~~r~~~~~~Y~~ke~~~~-----l~~~~~di~sl~ 314 (524)
T KOG0601|consen 251 ANIFTTSDW------TSCKLTDFGLVSKISDGNFSSVFK-----VSKRPEGDCIYAAKELLNG-----LATFASDIFSLG 314 (524)
T ss_pred hheeccccc------ceeecCCcceeEEccCCcccccee-----eeecCCCCceEeChhhhcc-----ccchHhhhcchh
Confidence 999997662 568999999988765533111100 0111246778999999875 678999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001142 1038 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1117 (1142)
Q Consensus 1038 viL~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP 1117 (1142)
.++.+..++..++...-. .....+..+. ++ .+.-...+.++...+..|++.+|
T Consensus 315 ev~l~~~l~~~~~~~g~~-~~W~~~r~~~---ip-----------------------~e~~~~~s~~l~~~~~~~~d~~~ 367 (524)
T KOG0601|consen 315 EVILEAILGSHLPSVGKN-SSWSQLRQGY---IP-----------------------LEFCEGGSSSLRSVTSQMLDEDP 367 (524)
T ss_pred hhhHhhHhhcccccCCCC-CCcccccccc---Cc-----------------------hhhhcCcchhhhhHHHHhcCcch
Confidence 999999888665542100 0011111111 11 01101223445568899999999
Q ss_pred CCCCCHHHHHHHHHhh
Q 001142 1118 TERPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1118 ~~RPSa~EVL~~L~~~ 1133 (1142)
..|++++.+.++....
T Consensus 368 ~~~~~~q~~~~l~~i~ 383 (524)
T KOG0601|consen 368 RLRLTAQILTALNVIH 383 (524)
T ss_pred hhhhHHHHHhcccccc
Confidence 9999999998876554
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.12 E-value=3.6e-11 Score=125.60 Aligned_cols=129 Identities=20% Similarity=0.177 Sum_probs=38.7
Q ss_pred CCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhc-CCCC
Q 001142 37 VNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVG-NLLG 115 (1142)
Q Consensus 37 f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~l~-~L~~ 115 (1142)
+.+...++.|+|++|+|+.+- .++. .+.+|+.|+|++|.|+.|+ .+..|++|++|+|++|.|+.+++.+. .+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~~Ie--~L~~--~l~~L~~L~Ls~N~I~~l~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQISTIE--NLGA--TLDKLEVLDLSNNQITKLE-GLPGLPRLKTLDLSNNRISSISEGLDKNLPN 89 (175)
T ss_dssp -----------------------S--T--T-TT--EEE-TTS--S--T-T----TT--EEE--SS---S-CHHHHHH-TT
T ss_pred ccccccccccccccccccccc--chhh--hhcCCCEEECCCCCCcccc-CccChhhhhhcccCCCCCCccccchHHhCCc
Confidence 445556777777777776532 1221 3467777777777777774 46667777777777777777765553 5777
Q ss_pred CCEEEccCCCCCCCcc--cccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEE
Q 001142 116 LECLQIKISSPGVNGF--ALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLS 170 (1142)
Q Consensus 116 L~~L~Ls~N~l~~~~~--~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~ 170 (1142)
|+.|+|++|++..+.. .+..+++|+.|+|.+|++.....--...+..+++|+.||
T Consensus 90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEET
T ss_pred CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeC
Confidence 7777777777554442 244455555555555444322221222234444554444
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=8.6e-12 Score=148.51 Aligned_cols=238 Identities=23% Similarity=0.203 Sum_probs=183.2
Q ss_pred ccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEEcc
Q 001142 20 EKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFF 99 (1142)
Q Consensus 20 ~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls 99 (1142)
+.+.+..|.|..+ ...+..+.+|..|+|..|+|..+... +..+.+|++|+|++|.|+.|. .+..++.|+.|+++
T Consensus 75 ~~l~l~~n~i~~~-~~~l~~~~~l~~l~l~~n~i~~i~~~----l~~~~~L~~L~ls~N~I~~i~-~l~~l~~L~~L~l~ 148 (414)
T KOG0531|consen 75 KELNLRQNLIAKI-LNHLSKLKSLEALDLYDNKIEKIENL----LSSLVNLQVLDLSFNKITKLE-GLSTLTLLKELNLS 148 (414)
T ss_pred Hhhccchhhhhhh-hcccccccceeeeeccccchhhcccc----hhhhhcchheecccccccccc-chhhccchhhheec
Confidence 3444555666652 34578889999999999999875531 345599999999999999984 46777789999999
Q ss_pred CCCCCcCchhhcCCCCCCEEEccCCCCCCCccc-ccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCc
Q 001142 100 GNEINLFPSEVGNLLGLECLQIKISSPGVNGFA-LNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRY 178 (1142)
Q Consensus 100 ~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~~~-~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~ 178 (1142)
+|.|+.++. +..++.|+.+++++|.+..+... ...+.+|+.|++.+|.+.... .+..+..+..+++..|.++.
T Consensus 149 ~N~i~~~~~-~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~~i~-----~~~~~~~l~~~~l~~n~i~~ 222 (414)
T KOG0531|consen 149 GNLISDISG-LESLKSLKLLDLSYNRIVDIENDELSELISLEELDLGGNSIREIE-----GLDLLKKLVLLSLLDNKISK 222 (414)
T ss_pred cCcchhccC-CccchhhhcccCCcchhhhhhhhhhhhccchHHHhccCCchhccc-----chHHHHHHHHhhccccccee
Confidence 999998864 66699999999999998777654 588899999999986653322 33444556666899999986
Q ss_pred cCcccCCCCC--CCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeCcCCcCCCC---Cccc-
Q 001142 179 LPPEIGCLSN--LEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSL---GSLD- 252 (1142)
Q Consensus 179 IP~~l~~L~~--L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls~N~Ls~~---~p~~- 252 (1142)
+- .+..+.. |+.|++++|.+..++..+..+.++..|++++|+++.+. .+.....+..+.++.|.+... ....
T Consensus 223 ~~-~l~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~l~~l~~~~n~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (414)
T KOG0531|consen 223 LE-GLNELVMLHLRELYLSGNRISRSPEGLENLKNLPVLDLSSNRISNLE-GLERLPKLSELWLNDNKLALSEAISQEYI 300 (414)
T ss_pred cc-CcccchhHHHHHHhcccCccccccccccccccccccchhhccccccc-cccccchHHHhccCcchhcchhhhhcccc
Confidence 62 2333444 89999999999998888889999999999999998663 344566778888888887632 2222
Q ss_pred ccCCCCCCEEEccCCCCCC
Q 001142 253 LCLMHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 253 l~~L~~L~~L~Ls~N~L~~ 271 (1142)
....+.+..+.+.+|++..
T Consensus 301 ~~~~~~~~~~~~~~~~~~~ 319 (414)
T KOG0531|consen 301 TSAAPTLVTLTLELNPIRK 319 (414)
T ss_pred ccccccccccccccCcccc
Confidence 5677899999999999876
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.8e-11 Score=138.89 Aligned_cols=203 Identities=19% Similarity=0.146 Sum_probs=114.5
Q ss_pred CCCccEEEeecCCCCccCc--cccCCcCCcEEEccCCCCCcCc---hhhcCCCCCCEEEccCCCCCCCc--ccccCCCCC
Q 001142 67 DNSVEGLYLYKNVLNLIPK--SVGRYEKLRNLKFFGNEINLFP---SEVGNLLGLECLQIKISSPGVNG--FALNKLKGL 139 (1142)
Q Consensus 67 L~~L~~L~Ls~N~Lt~iP~--~l~~L~~L~~L~Ls~N~L~~lP---~~l~~L~~L~~L~Ls~N~l~~~~--~~~~~L~~L 139 (1142)
+.+|+...|.+....-++. ....|++++.||||.|-|..+- .-...|++|+.|+|+.|.+...- ..-..+..|
T Consensus 120 ~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~l 199 (505)
T KOG3207|consen 120 LKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHL 199 (505)
T ss_pred HHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhh
Confidence 3555555555555544432 3445555666666666555321 12334566666666655532211 122245566
Q ss_pred CEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCcc-CcccCCCCCCCEEEccCCCCCccc--hhhcCCCCCCEEE
Q 001142 140 KELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYL-PPEIGCLSNLEQLDLSFNKMKYLP--TEICYLKALISLK 216 (1142)
Q Consensus 140 ~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~I-P~~l~~L~~L~~L~Ls~N~L~~lP--~~l~~L~~L~~L~ 216 (1142)
+.|.|+.+.++ ...+-..+..+++|+.|+|..|..-.+ -.....+..|+.|||++|++-.++ ..++.++.|..|+
T Consensus 200 K~L~l~~CGls--~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Ln 277 (505)
T KOG3207|consen 200 KQLVLNSCGLS--WKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLN 277 (505)
T ss_pred heEEeccCCCC--HHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhh
Confidence 66666665443 122222344567777777777742211 122344566777777777777666 5567777777777
Q ss_pred ccCCCCC--ccCcc-----ccCCCCCCEEeCcCCcCCCCCc-ccccCCCCCCEEEccCCCCCC
Q 001142 217 VANNKLV--ELPSG-----LYLLQRLENLDLSNNRLTSLGS-LDLCLMHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 217 Ls~N~Ls--~IP~~-----l~~L~~L~~L~Ls~N~Ls~~~p-~~l~~L~~L~~L~Ls~N~L~~ 271 (1142)
++.+.+. .+|+. ...+++|++|+++.|++..... ..+..+++|+.|.+..|+|+.
T Consensus 278 ls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 278 LSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK 340 (505)
T ss_pred ccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence 7777776 34554 3446777777777777754322 124455666777777777764
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.8e-11 Score=132.46 Aligned_cols=131 Identities=31% Similarity=0.299 Sum_probs=81.5
Q ss_pred CCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCcccCCCCCCCEEEccCCCCCccchhhcCCCCCCE
Q 001142 135 KLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALIS 214 (1142)
Q Consensus 135 ~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~ 214 (1142)
.+.-|++||||+|.+ ..+-+++.-++.++.|++++|.|..+-. +..|++|+.||||+|.|+.+-.+-..|.+++.
T Consensus 282 TWq~LtelDLS~N~I----~~iDESvKL~Pkir~L~lS~N~i~~v~n-La~L~~L~~LDLS~N~Ls~~~Gwh~KLGNIKt 356 (490)
T KOG1259|consen 282 TWQELTELDLSGNLI----TQIDESVKLAPKLRRLILSQNRIRTVQN-LAELPQLQLLDLSGNLLAECVGWHLKLGNIKT 356 (490)
T ss_pred hHhhhhhccccccch----hhhhhhhhhccceeEEeccccceeeehh-hhhcccceEeecccchhHhhhhhHhhhcCEee
Confidence 344566666666433 2333344445666677777777665533 66666777777777777766555555666677
Q ss_pred EEccCCCCCccCccccCCCCCCEEeCcCCcCCCCCcc-cccCCCCCCEEEccCCCCCC
Q 001142 215 LKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSL-DLCLMHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 215 L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls~N~Ls~~~p~-~l~~L~~L~~L~Ls~N~L~~ 271 (1142)
|.|++|.|..+ +++..|-+|..||+++|+|...... .+++|+-|+.|.|.+|+|..
T Consensus 357 L~La~N~iE~L-SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 357 LKLAQNKIETL-SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred eehhhhhHhhh-hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence 77777776665 3566666677777777776644321 36667777777777777765
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=2e-11 Score=150.53 Aligned_cols=274 Identities=21% Similarity=0.230 Sum_probs=183.0
Q ss_pred CCCCCcceeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001142 804 GSFPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 881 (1142)
Q Consensus 804 ~~~~~y~l~~~LG~GsfG~Vy~a~~~~--~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~ 881 (1142)
.+++.+.+.+-+-.|+++.++.+.-.+ ...+.|+..+.... ...+.+.. ..+-.++...+||-++...--+..
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i-~~~~~~s~----r~~s~~~i~p~~P~v~~~~~s~~~ 875 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKI-RTNDYESI----RSKSNILITPRSPAVVRSFPSFPC 875 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhh-cccccccc----CCccCccccCCCCceecccCCCCC
Confidence 467788999999999999999876432 22333332211100 00111111 233333334455666654433222
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 001142 882 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 961 (1142)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NIL 961 (1142)
.. -.+|||+|+.+++|...++.. ...+..-++.....+..+++|||...+.|+|++|.|++
T Consensus 876 rs--------------P~~L~~~~~~~~~~~Skl~~~-----~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l 936 (1205)
T KOG0606|consen 876 RS--------------PLPLVGHYLNGGDLPSKLHNS-----GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLL 936 (1205)
T ss_pred CC--------------CcchhhHHhccCCchhhhhcC-----CCcccccccchhHHHHhhhhccccchhhcccccccchh
Confidence 11 248999999999999998862 24566666667777899999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCCcccccccccccc---------------------cccCCCCCCCCccCCCcccchhhhcc
Q 001142 962 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCC---------------------IAHRGIPAPDVCVGTPRWMAPEVLRA 1020 (1142)
Q Consensus 962 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~---------------------~~~~~~~~~~~~~GT~~Y~APE~l~~ 1020 (1142)
+..+ +..++.|||............. .............||+.|.+||...+
T Consensus 937 ~~~~-------gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg 1009 (1205)
T KOG0606|consen 937 IAYD-------GHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG 1009 (1205)
T ss_pred hccc-------CCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc
Confidence 9877 7899999984432211100000 00000112345679999999999987
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhh
Q 001142 1021 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELE 1100 (1142)
Q Consensus 1021 ~~~~~~~s~ksDVwSLGviL~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 1100 (1142)
...+..+|+|++|++++|.++|.+||....+.++++.+..+..+... ....
T Consensus 1010 ----~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~-------------------------g~~~ 1060 (1205)
T KOG0606|consen 1010 ----RRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPE-------------------------GPEE 1060 (1205)
T ss_pred ----ccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCC-------------------------Cccc
Confidence 44568899999999999999999999988888877776554433211 1124
Q ss_pred hHHHHHHHHHHhcccCCCCCCCHH---HHHHHHHhhcCCC
Q 001142 1101 TLSFLVDVFRRCTEENPTERPTAG---DLYEMFVARTSSS 1137 (1142)
Q Consensus 1101 ~~~~L~dLI~~CL~~DP~~RPSa~---EVL~~L~~~~ss~ 1137 (1142)
.+....+++...+..+|.+|-.|. ++-.|.+++...+
T Consensus 1061 ~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~ 1100 (1205)
T KOG0606|consen 1061 GSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDW 1100 (1205)
T ss_pred cChhhhhhhhhhhccCchhccCcccccccccCCccCCCCc
Confidence 455688899999999999998776 7777777765543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.10 E-value=2.1e-10 Score=137.23 Aligned_cols=149 Identities=15% Similarity=0.163 Sum_probs=95.9
Q ss_pred eeecccCceEEEEEEE-CCccEEEEEEecccCCC--------------------------ChHHHHHhHHh------HHH
Q 001142 813 DEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGS--------------------------SADEIRNFEYS------CLG 859 (1142)
Q Consensus 813 ~~LG~GsfG~Vy~a~~-~~~~vAvKi~~l~~~~~--------------------------~~~~~~~~~~~------~~~ 859 (1142)
+.||.|++|.||+|+. .++.||||+.+-..... ...-.+++... +.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 6799999999999997 68899999864221000 00111222222 244
Q ss_pred HHHHHhhCC----CCCccceeeeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHH
Q 001142 860 EVRMLGALR----HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 935 (1142)
Q Consensus 860 Ei~iL~~L~----HpNIVkl~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia 935 (1142)
|++.+.+++ |.+-+.+-..+.+- ....+|||||++|++|.++.... .. .. ....++
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~-------------~~~~vLvmE~i~G~~L~~~~~~~-~~---~~---~~~~ia 262 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDR-------------TSERVLTMEWIDGIPLSDIAALD-EA---GL---DRKALA 262 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhh-------------cCCceEEEEeECCcccccHHHHH-hc---CC---CHHHHH
Confidence 555555552 22222222222210 01238999999999998876531 11 12 234566
Q ss_pred HHHHH-HHHHHHhCCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccc
Q 001142 936 QDVAA-ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS 988 (1142)
Q Consensus 936 ~qIa~-gL~yLHs~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~ 988 (1142)
.+++. .+..+|..|++|+|+||.||+++.+ +.++++|||++..+..
T Consensus 263 ~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~-------g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 263 ENLARSFLNQVLRDGFFHADLHPGNIFVLKD-------GKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHHHHHHHHHhCCceeCCCCcccEEECCC-------CcEEEEeCCCeeECCH
Confidence 66666 4788999999999999999999877 7899999999976543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.5e-10 Score=140.36 Aligned_cols=166 Identities=14% Similarity=0.180 Sum_probs=97.6
Q ss_pred CCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccC--------------------------CCChHHHHHhHHhH
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVC--------------------------GSSADEIRNFEYSC 857 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~--------------------------~~~~~~~~~~~~~~ 857 (1142)
+.+|+. +.||.|++|.||+|+.. ++.||||+.+-... .....-.+++...+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345666 78999999999999983 78999999652210 00112233555555
Q ss_pred HHHHHHHhhCCCCCccceeeeEecCCCC--CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCC--CCCCHHHHHH
Q 001142 858 LGEVRMLGALRHSCIVEMYGHKISSKWL--PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGE--KHVSVKLALF 933 (1142)
Q Consensus 858 ~~Ei~iL~~L~HpNIVkl~g~~~~~~~~--~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~--~~ls~~~i~~ 933 (1142)
.+|+...... +|+.++...+.+...+ |.... ......+|||||++|+.+.++..- ...+. ..+....+..
T Consensus 198 ~~ElD~~~Ea--~N~~~~~~~f~~~~~v~VP~v~~---d~st~~VLvmE~i~G~~l~d~~~l-~~~g~d~~~la~~~v~~ 271 (537)
T PRK04750 198 HDELDLMREA--ANASQLRRNFEDSDMLYVPEVYW---DYCSETVMVMERMYGIPVSDVAAL-RAAGTDMKLLAERGVEV 271 (537)
T ss_pred HHhhCHHHHH--HHHHHHHHHccCCCCeecceeec---ccCCCceEEEeeecCccHHhHHHH-HhcCCCHHHHHHHHHHH
Confidence 5666555444 3444444433322111 00000 001234799999999999875321 11110 1122333333
Q ss_pred HHHHHHHHHHHHHhCCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccc
Q 001142 934 IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS 988 (1142)
Q Consensus 934 Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~ 988 (1142)
++.| ++..|++|+|+||.||+++.++. ..+.++++|||++..+..
T Consensus 272 ~~~Q-------if~~GffHaDpHPGNIlv~~~g~---~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 272 FFTQ-------VFRDGFFHADMHPGNIFVSYDPP---ENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHH-------HHhCCeeeCCCChHHeEEecCCC---CCCeEEEEecceEEECCH
Confidence 3333 44699999999999999987621 124899999999987654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.07 E-value=5e-10 Score=115.71 Aligned_cols=127 Identities=16% Similarity=0.196 Sum_probs=91.8
Q ss_pred eeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCc-cceeeeEecCCCCCCCCC
Q 001142 812 CDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCI-VEMYGHKISSKWLPSADG 890 (1142)
Q Consensus 812 ~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNI-Vkl~g~~~~~~~~~~~~~ 890 (1142)
.+.|+.|.++.||+++..+..+++|+..... .....+ .+|+.+++.+.+.++ .+++.+..+
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~-----~~~~~~----~~E~~~l~~l~~~~~~P~~~~~~~~--------- 64 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGT-----ELLINR----ENEAENSKLAAEAGIGPKLYYFDPE--------- 64 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCc-----ccccCH----HHHHHHHHHHHHhCCCCceEEEeCC---------
Confidence 4678999999999999988889999753221 011122 578999988865444 345544321
Q ss_pred CCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----cccCCCCCCeeeccc
Q 001142 891 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHI-----MHRDIKSENILIDLE 965 (1142)
Q Consensus 891 ~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gI-----vHrDLKp~NILld~~ 965 (1142)
..++||||++|.++... . .....++.+++.+|..||+.++ +|+|++|.||+++ +
T Consensus 65 -------~~~lv~e~i~G~~l~~~--~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~ 123 (170)
T cd05151 65 -------TGVLITEFIEGSELLTE--D-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-D 123 (170)
T ss_pred -------CCeEEEEecCCCccccc--c-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-C
Confidence 12799999998876542 0 0113456789999999999885 9999999999998 3
Q ss_pred cccCCCCCeEEEeecCCcc
Q 001142 966 RKKADGKPVVKLCDFDRAV 984 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~ 984 (1142)
+.++++|||.+.
T Consensus 124 -------~~~~liDf~~a~ 135 (170)
T cd05151 124 -------GRLWLIDWEYAG 135 (170)
T ss_pred -------CeEEEEeccccc
Confidence 568999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.7e-10 Score=136.79 Aligned_cols=254 Identities=22% Similarity=0.160 Sum_probs=175.1
Q ss_pred CCCCcceeeeecccCceEEEEEEEC-CccEEEEEEecccCCCCh-HHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEec
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSA-DEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKIS 881 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~~-~~~vAvKi~~l~~~~~~~-~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~g~~~~ 881 (1142)
...+|..+..||.|.|+.|+.+..+ ...+.++++.+....... .++.. ..|+.+...+. |.+++.++..+..
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~s-----l~ev~l~~~l~~~~~~~g~~~~W~~ 337 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFS-----LGEVILEAILGSHLPSVGKNSSWSQ 337 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcc-----hhhhhHhhHhhcccccCCCCCCccc
Confidence 3567889999999999999998764 344444444343332222 22222 57888888875 9999988777665
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 001142 882 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 961 (1142)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NIL 961 (1142)
.. +.|+--|||+++++...+.- ...+++...+++..|++.++.++|+..++|+|+||+||+
T Consensus 338 ~r--------------~~~ip~e~~~~~s~~l~~~~-----~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~ 398 (524)
T KOG0601|consen 338 LR--------------QGYIPLEFCEGGSSSLRSVT-----SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNIL 398 (524)
T ss_pred cc--------------cccCchhhhcCcchhhhhHH-----HHhcCcchhhhhHHHHHhccccccchhhhccccccccee
Confidence 33 23688899999987766532 235788899999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCccc-chhhhccccCCCCCCchhhHHHHHHHH
Q 001142 962 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 962 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~-APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
+..++ +..+++|||.++.+..... ...+.-.++ ..|++.. ...+..+.|++|||.-+
T Consensus 399 i~~~~------~~~~~~~~~~~t~~~~~~~-------------~~~~~~r~~p~~~~~~e---~~~~~~~~~~~sl~~~~ 456 (524)
T KOG0601|consen 399 ISNDG------FFSKLGDFGCWTRLAFSSG-------------VFHHIDRLYPIAEILLE---DYPHLSKADIFSLGLSV 456 (524)
T ss_pred eccch------hhhhccccccccccceecc-------------cccccccccccchhhcc---ccccccccccccccccc
Confidence 97752 5688999999865332111 112233344 3555543 25677999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1041 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
.+.+++..--... .....+..+..+..+ .....+..+...+...++..|
T Consensus 457 ~e~~~~~~ls~~~---~~~~~i~~~~~p~~~----------------------------~~~~~~q~~~kv~~~~~~~~~ 505 (524)
T KOG0601|consen 457 DEAITGSPLSESG---VQSLTIRSGDTPNLP----------------------------GLKLQLQVLLKVMINPDRKRR 505 (524)
T ss_pred cccccCcccCccc---ccceeeecccccCCC----------------------------chHHhhhhhhhhhcCCccccc
Confidence 9999885422111 112233333333322 222457778889999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 001142 1121 PTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1121 PSa~EVL~~L~~~~s 1135 (1142)
|.+.++..|..+...
T Consensus 506 ~l~~~l~~~~~~~~~ 520 (524)
T KOG0601|consen 506 PSAVELSLHSEFYRD 520 (524)
T ss_pred hhhhhhcccchhhhh
Confidence 999999888766543
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.2e-09 Score=110.44 Aligned_cols=153 Identities=22% Similarity=0.239 Sum_probs=108.5
Q ss_pred eeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCCC
Q 001142 811 SCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADG 890 (1142)
Q Consensus 811 l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~~~~ 890 (1142)
....|-||+-+.|+++.+.++...+|-...+.-..+.-+.+--..+..+|++++.++.--.|.-..=++.+..
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~------- 83 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY------- 83 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC-------
Confidence 5678889999999999999999888876544333333333334567789999999886333332222233221
Q ss_pred CCccccceEEEEEeccCC-CCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccC
Q 001142 891 NPEHHLLQSAIFMEYVKG-GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 969 (1142)
Q Consensus 891 ~~~~~~~~~~LVmEy~~g-gSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~ 969 (1142)
.-.|+|||++| .++.+++...-... ........++.+|-..+.-||.++||||||..+||++..++
T Consensus 84 -------~~~i~ME~~~g~~~vk~~i~~~~~~~---~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~--- 150 (229)
T KOG3087|consen 84 -------GGQIYMEFIDGASTVKDFILSTMEDE---SEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDG--- 150 (229)
T ss_pred -------CCeEEEEeccchhHHHHHHHHHccCc---ccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCC---
Confidence 11799999985 38888887643221 22233367888889999999999999999999999997663
Q ss_pred CCCCeEEEeecCCcc
Q 001142 970 DGKPVVKLCDFDRAV 984 (1142)
Q Consensus 970 ~~~~~vKL~DFGlA~ 984 (1142)
....+.++|||++.
T Consensus 151 -~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 151 -NQITPILIDFGLSS 164 (229)
T ss_pred -CcCceEEEeecchh
Confidence 23667999999984
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.04 E-value=6.8e-11 Score=128.01 Aligned_cols=136 Identities=24% Similarity=0.284 Sum_probs=113.7
Q ss_pred cchhhhcCCCCCcEEEccCCCCCccCcccCCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCC
Q 001142 155 TLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQR 234 (1142)
Q Consensus 155 ~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~ 234 (1142)
.....+..+..|+.|||++|.|+.|.+++.-++.++.|+||+|.|..+-. +..|++|+.||||+|.|+.+-.+-..|-+
T Consensus 275 ~~~~~~dTWq~LtelDLS~N~I~~iDESvKL~Pkir~L~lS~N~i~~v~n-La~L~~L~~LDLS~N~Ls~~~Gwh~KLGN 353 (490)
T KOG1259|consen 275 SALVSADTWQELTELDLSGNLITQIDESVKLAPKLRRLILSQNRIRTVQN-LAELPQLQLLDLSGNLLAECVGWHLKLGN 353 (490)
T ss_pred ceEEecchHhhhhhccccccchhhhhhhhhhccceeEEeccccceeeehh-hhhcccceEeecccchhHhhhhhHhhhcC
Confidence 33344555678999999999999999999999999999999999998854 88999999999999999998777777889
Q ss_pred CCEEeCcCCcCCCCCcccccCCCCCCEEEccCCCCCC------CCCCCchhhccCCCCCCCCCCC
Q 001142 235 LENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS------YCQVPSWICCNLEGNGKDSSND 293 (1142)
Q Consensus 235 L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~------~~~iP~~~~~~l~~n~l~~~~~ 293 (1142)
++.|.|+.|.|..+. .+..|-+|..||+++|++.. +..+|-.-...+..|++.....
T Consensus 354 IKtL~La~N~iE~LS--GL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 354 IKTLKLAQNKIETLS--GLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred EeeeehhhhhHhhhh--hhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence 999999999998774 47889999999999999865 4467766666666666655443
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.7e-09 Score=110.52 Aligned_cols=135 Identities=20% Similarity=0.276 Sum_probs=97.9
Q ss_pred eeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHh-HHhHHHHHHHHhhCCCCCc--cceeeeEecCCCCCCCC
Q 001142 813 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNF-EYSCLGEVRMLGALRHSCI--VEMYGHKISSKWLPSAD 889 (1142)
Q Consensus 813 ~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~-~~~~~~Ei~iL~~L~HpNI--Vkl~g~~~~~~~~~~~~ 889 (1142)
..+++|+-+.||.+.|.+..+.+|... ++....+.-.+.+ ..+..+|+.++.+++--.| ..++++ +.+
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri-~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv--D~~------ 72 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERI-PKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV--DPD------ 72 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeec-CcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE--cCC------
Confidence 468899999999999988788888753 3333333222222 4567899999999864333 334433 222
Q ss_pred CCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccC
Q 001142 890 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 969 (1142)
Q Consensus 890 ~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~ 969 (1142)
...|+|||++|..|.+.+... . ..++..|-.-+.-||..||+|+||.++||++..+
T Consensus 73 --------~~~I~me~I~G~~lkd~l~~~--------~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~---- 128 (204)
T COG3642 73 --------NGLIVMEYIEGELLKDALEEA--------R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG---- 128 (204)
T ss_pred --------CCEEEEEEeCChhHHHHHHhc--------c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC----
Confidence 227999999988888888761 1 3455566666778999999999999999999764
Q ss_pred CCCCeEEEeecCCcc
Q 001142 970 DGKPVVKLCDFDRAV 984 (1142)
Q Consensus 970 ~~~~~vKL~DFGlA~ 984 (1142)
.+.++|||++.
T Consensus 129 ----~i~~IDfGLg~ 139 (204)
T COG3642 129 ----RIYFIDFGLGE 139 (204)
T ss_pred ----cEEEEECCccc
Confidence 49999999985
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.02 E-value=2e-10 Score=120.09 Aligned_cols=109 Identities=30% Similarity=0.388 Sum_probs=41.6
Q ss_pred cCCCCCcEEEccCCCCCccCcccC-CCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCcccc-CCCCCCEE
Q 001142 161 AGLKCLTKLSVCHFSIRYLPPEIG-CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLY-LLQRLENL 238 (1142)
Q Consensus 161 ~~L~~L~~L~Ls~N~L~~IP~~l~-~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~-~L~~L~~L 238 (1142)
.+...++.|+|.+|.|+.|. .++ .+.+|+.|+|++|.|+.|+ .+..+++|+.|+|++|+|+.|+..+. .+++|+.|
T Consensus 16 ~n~~~~~~L~L~~n~I~~Ie-~L~~~l~~L~~L~Ls~N~I~~l~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L 93 (175)
T PF14580_consen 16 NNPVKLRELNLRGNQISTIE-NLGATLDKLEVLDLSNNQITKLE-GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQEL 93 (175)
T ss_dssp ---------------------S--TT-TT--EEE-TTS--S--T-T----TT--EEE--SS---S-CHHHHHH-TT--EE
T ss_pred cccccccccccccccccccc-chhhhhcCCCEEECCCCCCcccc-CccChhhhhhcccCCCCCCccccchHHhCCcCCEE
Confidence 44556788888888888773 455 5788888888888888875 57778888888888888888876664 57888888
Q ss_pred eCcCCcCCCCCc-ccccCCCCCCEEEccCCCCCC
Q 001142 239 DLSNNRLTSLGS-LDLCLMHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 239 ~Ls~N~Ls~~~p-~~l~~L~~L~~L~Ls~N~L~~ 271 (1142)
+|++|+|..+.. ..+..+++|+.|+|.+||++.
T Consensus 94 ~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~ 127 (175)
T PF14580_consen 94 YLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCE 127 (175)
T ss_dssp E-TTS---SCCCCGGGGG-TT--EEE-TT-GGGG
T ss_pred ECcCCcCCChHHhHHHHcCCCcceeeccCCcccc
Confidence 888888876543 246778888888888888875
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.00 E-value=5.3e-11 Score=135.07 Aligned_cols=206 Identities=21% Similarity=0.190 Sum_probs=145.6
Q ss_pred CCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCcc-C--ccccCCcCCcEEEccCCCCCcCchh--hcC
Q 001142 38 NDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLI-P--KSVGRYEKLRNLKFFGNEINLFPSE--VGN 112 (1142)
Q Consensus 38 ~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~i-P--~~l~~L~~L~~L~Ls~N~L~~lP~~--l~~ 112 (1142)
++++.|+.+.|.+..+.-...+ +....|++++.|||+.|.|... | .-...|++|+.|+|+.|.+...-++ -..
T Consensus 118 sn~kkL~~IsLdn~~V~~~~~~--~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~ 195 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVEDAGIE--EYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLL 195 (505)
T ss_pred hhHHhhhheeecCccccccchh--hhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhh
Confidence 3566788888888776543332 3345568888889988888755 2 2346788888899988888643222 235
Q ss_pred CCCCCEEEccCCCCCC--CcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccC--cccCCCCC
Q 001142 113 LLGLECLQIKISSPGV--NGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLP--PEIGCLSN 188 (1142)
Q Consensus 113 L~~L~~L~Ls~N~l~~--~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP--~~l~~L~~ 188 (1142)
+++|+.|.|+.+.++. +......+++|+.|+|..|. +-.....+ ...+..|+.|+|++|++-..+ ...+.|+.
T Consensus 196 l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~-~~~~~~~~--~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~ 272 (505)
T KOG3207|consen 196 LSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANE-IILIKATS--TKILQTLQELDLSNNNLIDFDQGYKVGTLPG 272 (505)
T ss_pred hhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhccc-ccceecch--hhhhhHHhhccccCCcccccccccccccccc
Confidence 7788888888777653 22346678888888888864 11222222 234567888999999988776 45688999
Q ss_pred CCEEEccCCCCCcc--chh-----hcCCCCCCEEEccCCCCCccC--ccccCCCCCCEEeCcCCcCCCC
Q 001142 189 LEQLDLSFNKMKYL--PTE-----ICYLKALISLKVANNKLVELP--SGLYLLQRLENLDLSNNRLTSL 248 (1142)
Q Consensus 189 L~~L~Ls~N~L~~l--P~~-----l~~L~~L~~L~Ls~N~Ls~IP--~~l~~L~~L~~L~Ls~N~Ls~~ 248 (1142)
|..|+++.+.|.+| |+. ...+++|++|+++.|++..++ ..+..+.+|+.|....|.|+..
T Consensus 273 L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~e 341 (505)
T KOG3207|consen 273 LNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNKE 341 (505)
T ss_pred hhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccccccccc
Confidence 99999999999844 554 345789999999999997665 3455577888888888888754
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=5e-11 Score=132.33 Aligned_cols=232 Identities=19% Similarity=0.174 Sum_probs=135.4
Q ss_pred CCCCCCCEEEccCCCCCCCCcccccC-CCCCCCccEEEeecCCCC----ccCcc-------ccCCcCCcEEEccCCCCC-
Q 001142 38 NDDDDDSVIDVSGKTVDFPLIESYGN-RGGDNSVEGLYLYKNVLN----LIPKS-------VGRYEKLRNLKFFGNEIN- 104 (1142)
Q Consensus 38 ~~l~~L~~LdLs~N~L~~~~p~~~~~-l~~L~~L~~L~Ls~N~Lt----~iP~~-------l~~L~~L~~L~Ls~N~L~- 104 (1142)
.....++.|+||+|.|...-..+++. +...++|+.-++++=-.+ +||+. +-..+.|++||||.|.|+
T Consensus 27 ~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~ 106 (382)
T KOG1909|consen 27 EPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGP 106 (382)
T ss_pred cccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCc
Confidence 34556777788888775433332221 233356677776654222 45543 234457777888888776
Q ss_pred cCchh----hcCCCCCCEEEccCCCCCCCccc--------------ccCCCCCCEEECCCCCCCCCccc-chhhhcCCCC
Q 001142 105 LFPSE----VGNLLGLECLQIKISSPGVNGFA--------------LNKLKGLKELELSKVPPRPSVLT-LLSEIAGLKC 165 (1142)
Q Consensus 105 ~lP~~----l~~L~~L~~L~Ls~N~l~~~~~~--------------~~~L~~L~~L~Ls~n~~n~~~~~-lp~~l~~L~~ 165 (1142)
.-+.. +..++.|+.|+|.+|.++..+.. ...-+.|+.+....|.+-+.... +-..|...+.
T Consensus 107 ~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~ 186 (382)
T KOG1909|consen 107 KGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPT 186 (382)
T ss_pred cchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhccc
Confidence 32322 45567777777777665544321 12334566676666655433322 2233555567
Q ss_pred CcEEEccCCCCCc--c---CcccCCCCCCCEEEccCCCCC-----ccchhhcCCCCCCEEEccCCCCC-----ccCcccc
Q 001142 166 LTKLSVCHFSIRY--L---PPEIGCLSNLEQLDLSFNKMK-----YLPTEICYLKALISLKVANNKLV-----ELPSGLY 230 (1142)
Q Consensus 166 L~~L~Ls~N~L~~--I---P~~l~~L~~L~~L~Ls~N~L~-----~lP~~l~~L~~L~~L~Ls~N~Ls-----~IP~~l~ 230 (1142)
|+.+.+..|.|.. + -..|..+++|+.|||.+|-|+ .+-..+..+++|+.|+++.+.|+ .+-..+.
T Consensus 187 leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~ 266 (382)
T KOG1909|consen 187 LEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALK 266 (382)
T ss_pred cceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHh
Confidence 7777777777651 1 234566777777777777776 23455666777777777777775 2223333
Q ss_pred C-CCCCCEEeCcCCcCCCC----CcccccCCCCCCEEEccCCCC
Q 001142 231 L-LQRLENLDLSNNRLTSL----GSLDLCLMHNLQNLNLQYNKL 269 (1142)
Q Consensus 231 ~-L~~L~~L~Ls~N~Ls~~----~p~~l~~L~~L~~L~Ls~N~L 269 (1142)
. .++|++|.|.+|.|+.- +...+...+.|..|+|++|.|
T Consensus 267 ~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 267 ESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred ccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 2 56777777777777632 122344567777777777777
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.3e-10 Score=129.09 Aligned_cols=230 Identities=18% Similarity=0.174 Sum_probs=175.4
Q ss_pred CCcccccCCCCCCcccCC----CCCCCCCCCCEEEccCC---CCCCCCcccc----cCCCCCCCccEEEeecCCCC-c-c
Q 001142 17 PIKEKLPSEANKINNEKN----GSVNDDDDDSVIDVSGK---TVDFPLIESY----GNRGGDNSVEGLYLYKNVLN-L-I 83 (1142)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~----~~f~~l~~L~~LdLs~N---~L~~~~p~~~----~~l~~L~~L~~L~Ls~N~Lt-~-i 83 (1142)
..+.+|.+++|.+..--. ..+.+.++|+..++|+= ++...+|+.+ ..+-+.++|++|+||.|-|+ . +
T Consensus 30 ~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g~ 109 (382)
T KOG1909|consen 30 DSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKGI 109 (382)
T ss_pred CceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccch
Confidence 377889999998865432 45667789999999874 2333344432 22345579999999999998 3 3
Q ss_pred Cc---cccCCcCCcEEEccCCCCCcCc--------------hhhcCCCCCCEEEccCCCCCCCcc-----cccCCCCCCE
Q 001142 84 PK---SVGRYEKLRNLKFFGNEINLFP--------------SEVGNLLGLECLQIKISSPGVNGF-----ALNKLKGLKE 141 (1142)
Q Consensus 84 P~---~l~~L~~L~~L~Ls~N~L~~lP--------------~~l~~L~~L~~L~Ls~N~l~~~~~-----~~~~L~~L~~ 141 (1142)
+. -|.++..|++|+|.||.++..- .-++.-++|+++....|++..-+. .|...+.|+.
T Consensus 110 ~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~lee 189 (382)
T KOG1909|consen 110 RGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEE 189 (382)
T ss_pred HHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhccccce
Confidence 32 3567889999999999987331 123556789999999999887763 5778899999
Q ss_pred EECCCCCCCCCcc-cchhhhcCCCCCcEEEccCCCCCc-----cCcccCCCCCCCEEEccCCCCCc-----cchhhc-CC
Q 001142 142 LELSKVPPRPSVL-TLLSEIAGLKCLTKLSVCHFSIRY-----LPPEIGCLSNLEQLDLSFNKMKY-----LPTEIC-YL 209 (1142)
Q Consensus 142 L~Ls~n~~n~~~~-~lp~~l~~L~~L~~L~Ls~N~L~~-----IP~~l~~L~~L~~L~Ls~N~L~~-----lP~~l~-~L 209 (1142)
+.+..|.+..... .+-..|..+++|++|+|..|-|+. +...+..+++|+.|+++++.|+. +-..+. ..
T Consensus 190 vr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~ 269 (382)
T KOG1909|consen 190 VRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESA 269 (382)
T ss_pred EEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhccC
Confidence 9999988754443 455678899999999999999983 35567888999999999999982 334443 37
Q ss_pred CCCCEEEccCCCCC-----ccCccccCCCCCCEEeCcCCcCC
Q 001142 210 KALISLKVANNKLV-----ELPSGLYLLQRLENLDLSNNRLT 246 (1142)
Q Consensus 210 ~~L~~L~Ls~N~Ls-----~IP~~l~~L~~L~~L~Ls~N~Ls 246 (1142)
++|+.|.|.+|.++ .+-..+...+.|..|+|++|+|.
T Consensus 270 p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 270 PSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred CCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 89999999999997 33456677899999999999993
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.7e-08 Score=126.21 Aligned_cols=111 Identities=23% Similarity=0.358 Sum_probs=101.0
Q ss_pred CCcEEEccCCCCC-ccCcccCCCCCCCEEEccCCCCC-ccchhhcCCCCCCEEEccCCCCC-ccCccccCCCCCCEEeCc
Q 001142 165 CLTKLSVCHFSIR-YLPPEIGCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRLENLDLS 241 (1142)
Q Consensus 165 ~L~~L~Ls~N~L~-~IP~~l~~L~~L~~L~Ls~N~L~-~lP~~l~~L~~L~~L~Ls~N~Ls-~IP~~l~~L~~L~~L~Ls 241 (1142)
.++.|+|++|.++ .+|..++.|++|+.|+|++|+|+ .+|..++.+++|+.|+|++|+|+ .+|..+++|++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 3788999999998 78999999999999999999998 89999999999999999999998 899999999999999999
Q ss_pred CCcCCCCCcccccCC-CCCCEEEccCCCCCCCCCCCc
Q 001142 242 NNRLTSLGSLDLCLM-HNLQNLNLQYNKLLSYCQVPS 277 (1142)
Q Consensus 242 ~N~Ls~~~p~~l~~L-~~L~~L~Ls~N~L~~~~~iP~ 277 (1142)
+|+|+|.+|..+..+ .++..+++.+|+..| .+|.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc--~~p~ 533 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLC--GIPG 533 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCcccc--CCCC
Confidence 999999999888764 477899999998765 4553
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.73 E-value=8.5e-08 Score=115.14 Aligned_cols=142 Identities=18% Similarity=0.255 Sum_probs=108.0
Q ss_pred HHHHHHHhhCCCCCccceeeeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHH
Q 001142 858 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQD 937 (1142)
Q Consensus 858 ~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~q 937 (1142)
.+-+.-|+.++||||+++++.++.++. .|||+|-+. -|..+++. +....+...+.|
T Consensus 57 ~~A~k~lKtlRHP~Il~yL~t~e~~~~--------------~ylvTErV~--Pl~~~lk~--------l~~~~v~~Gl~q 112 (690)
T KOG1243|consen 57 KRAVKRLKTLRHPNILSYLDTTEEEGT--------------LYLVTERVR--PLETVLKE--------LGKEEVCLGLFQ 112 (690)
T ss_pred HHHHHHhhhccCchhhhhhhhhcccCc--------------eEEEeeccc--cHHHHHHH--------hHHHHHHHHHHH
Confidence 567788999999999999999887664 499999984 67888876 335667778899
Q ss_pred HHHHHHHHH-hCCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchh
Q 001142 938 VAAALVELH-SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1016 (1142)
Q Consensus 938 Ia~gL~yLH-s~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE 1016 (1142)
|+.||.||| ..+++|++|.-.-|+|+.. |..||++|..+........ ......---.|..|+
T Consensus 113 Il~AL~FL~~d~~lvHgNv~~~SVfVn~~-------GeWkLggle~v~~~~~~~~----------~~~~~~~~~s~~~P~ 175 (690)
T KOG1243|consen 113 ILAALSFLNDDCNLVHGNVCKDSVFVNES-------GEWKLGGLELVSKASGFNA----------PAKSLYLIESFDDPE 175 (690)
T ss_pred HHHHHHHHhccCCeeeccEeeeeEEEcCC-------CcEEEeeeEEEeccccCCc----------ccccchhhhcccChh
Confidence 999999998 5689999999999999988 8899999998854332211 000111122356666
Q ss_pred hhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001142 1017 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1046 (1142)
Q Consensus 1017 ~l~~~~~~~~~s~ksDVwSLGviL~ELLtG 1046 (1142)
.+.. -+...|.|-||++++|++.|
T Consensus 176 ~~~~------s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 176 EIDP------SEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hcCc------cccchhhhhHHHHHHHHhCc
Confidence 5432 11457999999999999998
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.70 E-value=2.8e-07 Score=103.28 Aligned_cols=151 Identities=16% Similarity=0.131 Sum_probs=98.0
Q ss_pred CceEEEEEEECCccEEEEEEecccCCCChHHHHHh-----H-HhHHHHHHHHhhCCCC--CccceeeeEecCCCCCCCCC
Q 001142 819 VSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNF-----E-YSCLGEVRMLGALRHS--CIVEMYGHKISSKWLPSADG 890 (1142)
Q Consensus 819 sfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~-----~-~~~~~Ei~iL~~L~Hp--NIVkl~g~~~~~~~~~~~~~ 890 (1142)
....|+++.+.+..+.+|...... .....+.+ . ..+.+|...+.++..- .+.+.+++......
T Consensus 34 ~~rrvvr~~~~g~~~~vKr~~~~~---~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~------ 104 (268)
T PRK15123 34 EGRRTLRFELAGKSYFLKWHRGTG---WGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSN------ 104 (268)
T ss_pred CCceEEEEEECCEEEEEEEecCCc---HHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCC------
Confidence 334466788888888888653211 00001110 0 0246888888887432 33444555543110
Q ss_pred CCccccceEEEEEeccCCC-CHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccC
Q 001142 891 NPEHHLLQSAIFMEYVKGG-SVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 969 (1142)
Q Consensus 891 ~~~~~~~~~~LVmEy~~gg-SL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~ 969 (1142)
......+||||++++. +|.+++.... ....+......++.+++..+.-||..||+|+|++++|||++.+....
T Consensus 105 ---~~~~~s~LVte~l~~~~sL~~~~~~~~---~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~ 178 (268)
T PRK15123 105 ---PATRTSFIITEDLAPTISLEDYCADWA---TNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGR 178 (268)
T ss_pred ---CccceeEEEEeeCCCCccHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCC
Confidence 0122468999999875 8999986421 13456677889999999999999999999999999999997520001
Q ss_pred CCCCeEEEeecCCcc
Q 001142 970 DGKPVVKLCDFDRAV 984 (1142)
Q Consensus 970 ~~~~~vKL~DFGlA~ 984 (1142)
.+...+.|+||+.+.
T Consensus 179 ~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 179 EEDLKLSVIDLHRAQ 193 (268)
T ss_pred CCCceEEEEECCccc
Confidence 123689999999874
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.70 E-value=5.7e-08 Score=103.12 Aligned_cols=131 Identities=21% Similarity=0.243 Sum_probs=82.8
Q ss_pred EEEEEEE-CCccEEEEEEecccCCCCh------------------HHHHHhHHhHHHHHHHHhhCCCC--CccceeeeEe
Q 001142 822 SLFRCKF-GSADAAAKVRTLKVCGSSA------------------DEIRNFEYSCLGEVRMLGALRHS--CIVEMYGHKI 880 (1142)
Q Consensus 822 ~Vy~a~~-~~~~vAvKi~~l~~~~~~~------------------~~~~~~~~~~~~Ei~iL~~L~Hp--NIVkl~g~~~ 880 (1142)
.||.|.. .+..+|+|+.+........ ........++.+|+++|.++..- ++.+++++..
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~~ 80 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYNR 80 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEET
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEeC
Confidence 3899887 5778999998754332211 11222245678999999999754 5667765532
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccC--CCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHH-HHhCCccccCCCC
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVK--GGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVE-LHSKHIMHRDIKS 957 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~--ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~y-LHs~gIvHrDLKp 957 (1142)
+ +|||||++ |..+..+... .++......++.+++..+.. +|..||+||||.+
T Consensus 81 --~----------------~ivME~I~~~G~~~~~l~~~-------~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~ 135 (188)
T PF01163_consen 81 --N----------------VIVMEYIGEDGVPLPRLKDV-------DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSE 135 (188)
T ss_dssp --T----------------EEEEE--EETTEEGGCHHHC-------GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-ST
T ss_pred --C----------------EEEEEecCCCccchhhHHhc-------cccchhHHHHHHHHHHHHHHHHHhcCceecCCCh
Confidence 1 89999998 6555443321 12234556777888886655 5799999999999
Q ss_pred CCeeeccccccCCCCCeEEEeecCCccc
Q 001142 958 ENILIDLERKKADGKPVVKLCDFDRAVP 985 (1142)
Q Consensus 958 ~NILld~~~~~~~~~~~vKL~DFGlA~~ 985 (1142)
.|||++.+ .+.++|||.+..
T Consensus 136 ~NIlv~~~--------~~~iIDf~qav~ 155 (188)
T PF01163_consen 136 YNILVDDG--------KVYIIDFGQAVD 155 (188)
T ss_dssp TSEEEETT--------CEEE--GTTEEE
T ss_pred hhEEeecc--------eEEEEecCccee
Confidence 99999864 699999998864
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.70 E-value=5.8e-08 Score=104.42 Aligned_cols=143 Identities=19% Similarity=0.191 Sum_probs=97.0
Q ss_pred eeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCC--CCccceeeeEecCCCCCCCC
Q 001142 813 DEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH--SCIVEMYGHKISSKWLPSAD 889 (1142)
Q Consensus 813 ~~LG~GsfG~Vy~a~~~~-~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H--pNIVkl~g~~~~~~~~~~~~ 889 (1142)
+.|+.|.++.||+++..+ ..+++|+....... ..... +.+|+++++.+.+ .++.+++.+......
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~---~~~~~----~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~----- 71 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL---PSAHD----VAREYRVLRALAGTGVPVPKVLALCEDPSV----- 71 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC---ccccc----HHHHHHHHHHhhCCCCCCCCEEEECCCCCc-----
Confidence 678999999999998865 78888874322110 11122 3689999999965 445667766543210
Q ss_pred CCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh----------------------
Q 001142 890 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS---------------------- 947 (1142)
Q Consensus 890 ~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs---------------------- 947 (1142)
....++||||++|.++.+.+.. ..++......++.+++++|.+||+
T Consensus 72 ------~~~~~~v~e~i~G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~ 139 (223)
T cd05154 72 ------LGTPFYVMERVDGRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQV 139 (223)
T ss_pred ------cCCceEEEEEeCCEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHH
Confidence 0123899999998877654321 135666666667777777777763
Q ss_pred ----------------------------------CCccccCCCCCCeeeccccccCCCCCeEEEeecCCcc
Q 001142 948 ----------------------------------KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 984 (1142)
Q Consensus 948 ----------------------------------~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~ 984 (1142)
..++|+|+.|.||+++.+. ...+.|+||+.+.
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~-----~~~~~iID~e~~~ 205 (223)
T cd05154 140 ARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDE-----PRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCC-----CcEEEEEeccccc
Confidence 2469999999999998721 0568999999874
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.1e-08 Score=130.83 Aligned_cols=198 Identities=22% Similarity=0.242 Sum_probs=131.6
Q ss_pred ccccCCCCCCcccCCCCCCCCCCCCEEEccCCC--CCCCCcccccCCCCCCCccEEEeecC-CCCccCccccCCcCCcEE
Q 001142 20 EKLPSEANKINNEKNGSVNDDDDDSVIDVSGKT--VDFPLIESYGNRGGDNSVEGLYLYKN-VLNLIPKSVGRYEKLRNL 96 (1142)
Q Consensus 20 ~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~--L~~~~p~~~~~l~~L~~L~~L~Ls~N-~Lt~iP~~l~~L~~L~~L 96 (1142)
..+.+..|++..+... ...+.|++|-+..|. +.....+.|..+ +.|..|||++| .++++|..|+.|-+|++|
T Consensus 526 rr~s~~~~~~~~~~~~--~~~~~L~tLll~~n~~~l~~is~~ff~~m---~~LrVLDLs~~~~l~~LP~~I~~Li~LryL 600 (889)
T KOG4658|consen 526 RRMSLMNNKIEHIAGS--SENPKLRTLLLQRNSDWLLEISGEFFRSL---PLLRVLDLSGNSSLSKLPSSIGELVHLRYL 600 (889)
T ss_pred eEEEEeccchhhccCC--CCCCccceEEEeecchhhhhcCHHHHhhC---cceEEEECCCCCccCcCChHHhhhhhhhcc
Confidence 4455556666655432 234478899999986 554555445444 89999999976 567899999999999999
Q ss_pred EccCCCCCcCchhhcCCCCCCEEEccCCC-CCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCC
Q 001142 97 KFFGNEINLFPSEVGNLLGLECLQIKISS-PGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS 175 (1142)
Q Consensus 97 ~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~-l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~ 175 (1142)
+|++..|+.+|..+.+|..|.+|++..+. +..++.....|.+|++|.+-.-. .........++.+|.+|+.|......
T Consensus 601 ~L~~t~I~~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~-~~~~~~~l~el~~Le~L~~ls~~~~s 679 (889)
T KOG4658|consen 601 DLSDTGISHLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA-LSNDKLLLKELENLEHLENLSITISS 679 (889)
T ss_pred cccCCCccccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccc-cccchhhHHhhhcccchhhheeecch
Confidence 99999999999999999999999998777 55566677779999999887633 12233334455666777666664444
Q ss_pred CCccCcccCCCCCCC----EEEccCCCCCccchhhcCCCCCCEEEccCCCCCc
Q 001142 176 IRYLPPEIGCLSNLE----QLDLSFNKMKYLPTEICYLKALISLKVANNKLVE 224 (1142)
Q Consensus 176 L~~IP~~l~~L~~L~----~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~ 224 (1142)
. .+-..+..+++|. .+.+..+.....+..+..+.+|+.|.+.+..+++
T Consensus 680 ~-~~~e~l~~~~~L~~~~~~l~~~~~~~~~~~~~~~~l~~L~~L~i~~~~~~e 731 (889)
T KOG4658|consen 680 V-LLLEDLLGMTRLRSLLQSLSIEGCSKRTLISSLGSLGNLEELSILDCGISE 731 (889)
T ss_pred h-HhHhhhhhhHHHHHHhHhhhhcccccceeecccccccCcceEEEEcCCCch
Confidence 3 1112222222222 3333334444556667777777777777776653
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.65 E-value=9.6e-09 Score=131.32 Aligned_cols=251 Identities=23% Similarity=0.211 Sum_probs=153.4
Q ss_pred CCCcccccCCCCC--CcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCC
Q 001142 16 GPIKEKLPSEANK--INNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKL 93 (1142)
Q Consensus 16 ~~~l~~L~~~~N~--i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L 93 (1142)
.+.+.+|-+-.|. +..+....|..++.|++||||+|.=-+.+|+.++.+ -+|++|+|++..++.+|..|.+|..|
T Consensus 544 ~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~L---i~LryL~L~~t~I~~LP~~l~~Lk~L 620 (889)
T KOG4658|consen 544 NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGEL---VHLRYLDLSDTGISHLPSGLGNLKKL 620 (889)
T ss_pred CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhh---hhhhcccccCCCccccchHHHHHHhh
Confidence 3367777777886 888888889999999999999987667788877665 89999999999999999999999999
Q ss_pred cEEEccCCCCC-cCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCc----E
Q 001142 94 RNLKFFGNEIN-LFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLT----K 168 (1142)
Q Consensus 94 ~~L~Ls~N~L~-~lP~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~----~ 168 (1142)
.+|++..+.-- .+|..+..|++|++|.+...........+..+.+|++|..-....... .+...+..+..|. .
T Consensus 621 ~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~--~~~e~l~~~~~L~~~~~~ 698 (889)
T KOG4658|consen 621 IYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSV--LLLEDLLGMTRLRSLLQS 698 (889)
T ss_pred heeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchh--HhHhhhhhhHHHHHHhHh
Confidence 99999988754 555656679999999996655333333344444444444333221111 1111222222222 3
Q ss_pred EEccCCCCCccCcccCCCCCCCEEEccCCCCCccch-hhcC------CCCCCEEEccCCCCCccCccccCCCCCCEEeCc
Q 001142 169 LSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPT-EICY------LKALISLKVANNKLVELPSGLYLLQRLENLDLS 241 (1142)
Q Consensus 169 L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~lP~-~l~~------L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls 241 (1142)
+.+..+.....+..+..+.+|+.|.+.+..+.++.. .... +++|..+...+...-..+.+.--.++|+.|.+.
T Consensus 699 l~~~~~~~~~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~~~~r~l~~~~f~~~L~~l~l~ 778 (889)
T KOG4658|consen 699 LSIEGCSKRTLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNCHMLRDLTWLLFAPHLTSLSLV 778 (889)
T ss_pred hhhcccccceeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhccccccccchhhccCcccEEEEe
Confidence 333334444556667777888888887777764321 1111 111222211111111223333334667777776
Q ss_pred CCcCCCCCcccccCCCCCCEEEccCCCCCC
Q 001142 242 NNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 242 ~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1142)
.......+......+..+..+-+..+.+.+
T Consensus 779 ~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~ 808 (889)
T KOG4658|consen 779 SCRLLEDIIPKLKALLELKELILPFNKLEG 808 (889)
T ss_pred cccccccCCCHHHHhhhcccEEeccccccc
Confidence 555444433344455555544454454444
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.60 E-value=4.5e-10 Score=133.39 Aligned_cols=179 Identities=27% Similarity=0.293 Sum_probs=120.1
Q ss_pred CccccCCcCCcEEEccCCCCCcCchhhcCC-CCCCEEEccCCCCCCCccccc----------CCCCCCEEECCCCCCCCC
Q 001142 84 PKSVGRYEKLRNLKFFGNEINLFPSEVGNL-LGLECLQIKISSPGVNGFALN----------KLKGLKELELSKVPPRPS 152 (1142)
Q Consensus 84 P~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L-~~L~~L~Ls~N~l~~~~~~~~----------~L~~L~~L~Ls~n~~n~~ 152 (1142)
|-.|..+.+|++|.|.+..|+..- .+..| ..|+.|-. .|.+..+...|. ....|...+.+.|.+
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~~~-GL~~lr~qLe~LIC-~~Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L--- 176 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLSTAK-GLQELRHQLEKLIC-HNSLDALRHVFASCGGDISNSPVWNKLATASFSYNRL--- 176 (1096)
T ss_pred CceeccccceeeEEecCcchhhhh-hhHHHHHhhhhhhh-hccHHHHHHHHHHhccccccchhhhhHhhhhcchhhH---
Confidence 445666667777777777765421 11111 12333321 122221111111 122344555555433
Q ss_pred cccchhhhcCCCCCcEEEccCCCCCccCcccCCCCCCCEEEccCCCCCccch-hhcCCCCCCEEEccCCCCCccCccccC
Q 001142 153 VLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPT-EICYLKALISLKVANNKLVELPSGLYL 231 (1142)
Q Consensus 153 ~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~lP~-~l~~L~~L~~L~Ls~N~Ls~IP~~l~~ 231 (1142)
..+-..+.-++.|+.|+|++|+++.+- .+..|+.|++|||+.|+|..+|. ....+. |+.|.|++|.++++ .++.+
T Consensus 177 -~~mD~SLqll~ale~LnLshNk~~~v~-~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~tL-~gie~ 252 (1096)
T KOG1859|consen 177 -VLMDESLQLLPALESLNLSHNKFTKVD-NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALTTL-RGIEN 252 (1096)
T ss_pred -HhHHHHHHHHHHhhhhccchhhhhhhH-HHHhcccccccccccchhccccccchhhhh-heeeeecccHHHhh-hhHHh
Confidence 233345566788999999999999874 78889999999999999999984 333444 99999999999987 47889
Q ss_pred CCCCCEEeCcCCcCCCCCcc-cccCCCCCCEEEccCCCCCC
Q 001142 232 LQRLENLDLSNNRLTSLGSL-DLCLMHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 232 L~~L~~L~Ls~N~Ls~~~p~-~l~~L~~L~~L~Ls~N~L~~ 271 (1142)
|.+|+.|||++|-|.+.-.. .+..|..|..|+|.||++.|
T Consensus 253 LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 253 LKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred hhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence 99999999999998865432 25677889999999999988
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.60 E-value=3e-09 Score=104.30 Aligned_cols=115 Identities=22% Similarity=0.214 Sum_probs=88.2
Q ss_pred chhhhcCCCCCcEEEccCCCCCccCcccC-CCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCC
Q 001142 156 LLSEIAGLKCLTKLSVCHFSIRYLPPEIG-CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQR 234 (1142)
Q Consensus 156 lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~-~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~ 234 (1142)
.+..+.....|+..+|++|.|..+|+.|. .++.++.|+|++|.|+.+|.++..++.|+.|+++.|.|...|.-+..|.+
T Consensus 45 avy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neisdvPeE~Aam~aLr~lNl~~N~l~~~p~vi~~L~~ 124 (177)
T KOG4579|consen 45 AVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEISDVPEELAAMPALRSLNLRFNPLNAEPRVIAPLIK 124 (177)
T ss_pred HHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhhhchHHHhhhHHhhhcccccCccccchHHHHHHHh
Confidence 34445556677778888888888888774 45578888888888888888888888888888888888888888888888
Q ss_pred CCEEeCcCCcCCCCCcccccCCCCCCEEEccCCCCCC
Q 001142 235 LENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 235 L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1142)
|.+|+..+|.+..++-+ +..-..+...++.+|+|.+
T Consensus 125 l~~Lds~~na~~eid~d-l~~s~~~al~~lgnepl~~ 160 (177)
T KOG4579|consen 125 LDMLDSPENARAEIDVD-LFYSSLPALIKLGNEPLGD 160 (177)
T ss_pred HHHhcCCCCccccCcHH-HhccccHHHHHhcCCcccc
Confidence 88888888888877664 3333444455667777776
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.57 E-value=2.6e-08 Score=85.88 Aligned_cols=59 Identities=46% Similarity=0.591 Sum_probs=35.8
Q ss_pred CCCEEEccCCCCCccCc-cccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccCCCC
Q 001142 211 ALISLKVANNKLVELPS-GLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269 (1142)
Q Consensus 211 ~L~~L~Ls~N~Ls~IP~-~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L 269 (1142)
+|+.|+|++|+|+.||. .+..+++|+.|+|++|+|+.+++..|..+++|+.|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 45666666666666653 334466666666666666666666666666666666666653
|
... |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.49 E-value=4.8e-06 Score=95.11 Aligned_cols=273 Identities=17% Similarity=0.144 Sum_probs=156.9
Q ss_pred ceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecCCCCCCC
Q 001142 810 SSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSA 888 (1142)
Q Consensus 810 ~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~~~~~~~~~~ 888 (1142)
...+.||+|+.+.+|-.-.-. +.+.||+-.. ....+ .+-++.|.+. .||-+-.-+.+=.. .-+
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~-d~VAKIYh~P-----ppa~~------aqk~a~la~~p~~p~~~~rvaWPqa-~L~--- 77 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVR-DQVAKIYHAP-----PPAAQ------AQKVAELAATPDAPLLNYRVAWPQA-TLH--- 77 (637)
T ss_pred CCCccccCCccceeeecchhh-chhheeecCC-----CchHH------HHHHHHhccCCCCcchhhhhcccHH-Hhh---
Confidence 466889999999999643322 2345664211 11111 1233445454 57755432222111 000
Q ss_pred CCCCccccceEEEEEeccCCCC-HHHHHH-HHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecccc
Q 001142 889 DGNPEHHLLQSAIFMEYVKGGS-VKNYIE-KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 966 (1142)
Q Consensus 889 ~~~~~~~~~~~~LVmEy~~ggS-L~~~l~-~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~ 966 (1142)
..+......+.|+.++|.- ...+.. .++........|...+++++.++.+.+-||+.|.+-||+.++|+|+.++
T Consensus 78 ---G~~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~- 153 (637)
T COG4248 78 ---GGRRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDD- 153 (637)
T ss_pred ---CCCccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecC-
Confidence 1111223689999998641 111111 1112233467899999999999999999999999999999999999887
Q ss_pred ccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhc-cccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 967 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR-AMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 967 ~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~-~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
..|.|.|=..-..-.... ...-.+|...|.+||... ....+..-+...|.|.||+++++++.
T Consensus 154 ------~~V~LVdsDsfqi~~ng~-----------~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ 216 (637)
T COG4248 154 ------SKVVLVDSDSFQINANGT-----------LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLF 216 (637)
T ss_pred ------ceEEEEcccceeeccCCc-----------eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHh
Confidence 678888744322111100 111336899999999865 22222334577899999999999998
Q ss_pred C-CCCCCCCCHH-----HHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhh-hhhHHHHHHHHHHhccc--C
Q 001142 1046 L-QVPYMGLSEL-----EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE-LETLSFLVDVFRRCTEE--N 1116 (1142)
Q Consensus 1046 G-~~Pf~~~~~~-----el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~L~dLI~~CL~~--D 1116 (1142)
| ++||.+.... .....|..+.....++ ...+........+ .-.++++..+..+|+.. .
T Consensus 217 ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~-------------~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~ 283 (637)
T COG4248 217 GGRHPYSGIPLISDAPNPLETDIAHGRFAYASD-------------QRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGV 283 (637)
T ss_pred cCCCCCCcccccCCCCCcchhhhhcceeeechh-------------ccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCC
Confidence 6 9999863210 0111222222111110 0000000000000 13456788889999865 3
Q ss_pred CCCCCCHHHHHHHHHh
Q 001142 1117 PTERPTAGDLYEMFVA 1132 (1142)
Q Consensus 1117 P~~RPSa~EVL~~L~~ 1132 (1142)
+.-|||++..+..+-.
T Consensus 284 ~~~RP~a~aW~aAl~a 299 (637)
T COG4248 284 ATPRPTAKAWVAALDA 299 (637)
T ss_pred CCCCCCHHHHHHHHHH
Confidence 5679999887765543
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.49 E-value=7.4e-08 Score=83.04 Aligned_cols=58 Identities=26% Similarity=0.320 Sum_probs=26.2
Q ss_pred CCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccC-ccccCCcCCcEEEccCCC
Q 001142 42 DDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIP-KSVGRYEKLRNLKFFGNE 102 (1142)
Q Consensus 42 ~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP-~~l~~L~~L~~L~Ls~N~ 102 (1142)
+|++|+|++|+|+.+.+.+|..+ ++|++|+|++|.|+.+| ..|.++++|++|+|++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l---~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNL---PNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTG---TTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCC---CCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 34444444444444444333322 44444444444444443 234444444444444444
|
... |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.49 E-value=8.8e-07 Score=95.62 Aligned_cols=111 Identities=23% Similarity=0.237 Sum_probs=84.9
Q ss_pred hHHHHHHHHhhCC--CCCccceeeeEecCCCCCCCCCCCccccceEEEEEeccCCC-CHHHHHHHHhccCCCCCCHHHHH
Q 001142 856 SCLGEVRMLGALR--HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGG-SVKNYIEKLSETGEKHVSVKLAL 932 (1142)
Q Consensus 856 ~~~~Ei~iL~~L~--HpNIVkl~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gg-SL~~~l~~~~~~~~~~ls~~~i~ 932 (1142)
++.+|...+..+. .=.+.+.+++.+..... ....++|||++++. +|.+++... ...+.....
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~----------~~~s~lite~l~~~~~L~~~~~~~-----~~~~~~~~~ 121 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGG----------GYRSYLITEALPGAQDLRDLLQQW-----EQLDPSQRR 121 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCC----------ceeEEEEEEeCCCcccHHHHHHhh-----cccchhhHH
Confidence 3468888887774 34456777776653211 14568999999974 899998762 125667788
Q ss_pred HHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccCCCCCeEEEeecCCccc
Q 001142 933 FIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 985 (1142)
Q Consensus 933 ~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~ 985 (1142)
.++.+++..+.-||.+||+|+|+++.|||++.+. +...+.++||+.++.
T Consensus 122 ~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~----~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 122 ELLRALARLIAKLHDAGIYHGDLNPSNILVDPDD----GQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCC----CceeEEEEcchhcee
Confidence 9999999999999999999999999999998772 235799999998753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.48 E-value=5.1e-06 Score=97.28 Aligned_cols=223 Identities=16% Similarity=0.109 Sum_probs=143.2
Q ss_pred ceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCCCCCccccceE
Q 001142 820 SSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 899 (1142)
Q Consensus 820 fG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~~~~~~~~~~~~~ 899 (1142)
..+.|++...-...++-.+++......... +. ..=+++++++.|+|||++.+++....+. ..-+
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n-k~-----t~lve~wkkl~h~NvV~frevf~t~tF~----------D~Sl 352 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTN-KD-----TSLVEAWKKLCHTNVVPFREVFLTYTFG----------DLSL 352 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcc-cc-----hHHHHHHHHhccCceeehhhhhhhhccC----------cceE
Confidence 356788887433334444444211111110 11 2457788999999999999998854322 2356
Q ss_pred EEEEeccCC-CCHHHHHHHHh----------ccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecccccc
Q 001142 900 AIFMEYVKG-GSVKNYIEKLS----------ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 968 (1142)
Q Consensus 900 ~LVmEy~~g-gSL~~~l~~~~----------~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~ 968 (1142)
++|++|+|+ ++|.++.-... ...+...++..++.++.|+..||.++|+.|+.-+-|.+.+|+++.+
T Consensus 353 vlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~--- 429 (655)
T KOG3741|consen 353 VLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGK--- 429 (655)
T ss_pred EEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCc---
Confidence 999999986 36766542211 1223457889999999999999999999999999999999999876
Q ss_pred CCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCC
Q 001142 969 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV 1048 (1142)
Q Consensus 969 ~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~ 1048 (1142)
..++|.-.|....+.... . |.+.. -++-|.-.||.+++.|.||..
T Consensus 430 ----~RIriS~C~i~Dvl~~d~----------------------~--~~le~-------~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 430 ----MRIRISGCGIMDVLQEDP----------------------T--EPLES-------QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred ----ceEEEecccceeeecCCC----------------------C--cchhH-------HhhhhHHHHHHHHHHHhhccc
Confidence 567777666543222100 0 11111 156799999999999999954
Q ss_pred C-CCCCCHHHH-HHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 001142 1049 P-YMGLSELEI-HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1126 (1142)
Q Consensus 1049 P-f~~~~~~el-~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EV 1126 (1142)
- +......+. .+.|. ..++.++++++.-....++++ -++.++
T Consensus 475 ns~~~d~~~~s~~~~I~-----------------------------------~~yS~D~rn~v~yl~s~~~~~-ksI~~l 518 (655)
T KOG3741|consen 475 NSNRTDSTQSSHLTRIT-----------------------------------TTYSTDLRNVVEYLESLNFRE-KSIQDL 518 (655)
T ss_pred ccccccchHHHHHHHhh-----------------------------------hhhhHHHHHHHHHHHhcCccc-ccHHHH
Confidence 3 222222221 11111 145666778888877777776 677777
Q ss_pred HHHHHh
Q 001142 1127 YEMFVA 1132 (1142)
Q Consensus 1127 L~~L~~ 1132 (1142)
+.+...
T Consensus 519 lp~~~~ 524 (655)
T KOG3741|consen 519 LPMIGS 524 (655)
T ss_pred HHHHHH
Confidence 776544
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.45 E-value=4.8e-08 Score=117.59 Aligned_cols=163 Identities=19% Similarity=0.202 Sum_probs=112.3
Q ss_pred HHHHHHHHHHhC-CccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccch
Q 001142 937 DVAAALVELHSK-HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAP 1015 (1142)
Q Consensus 937 qIa~gL~yLHs~-gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~AP 1015 (1142)
+++.|+.|+|.. ++||++|.|++|.++.. +.+||+.|+++........ +.........+-...-...|.||
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~-------~~wkl~Gf~f~v~~~~~~~-~p~~~yd~~lp~~~~~~~~f~ap 178 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNAN-------GDWKLAGFSFCVNANGPTE-YPFSEYDPPLPLLLQPHLNFLAP 178 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccC-------cceeeccchhhhccCCCCc-cccccCCCCCChhhccCcccccc
Confidence 345999999965 89999999999999988 7899999999876544322 11222233344455667889999
Q ss_pred hhhccccCCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCC
Q 001142 1016 EVLRAMHKPNLYGLEVDIWSYGCLLLELL-TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK 1094 (1142)
Q Consensus 1016 E~l~~~~~~~~~s~ksDVwSLGviL~ELL-tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~ 1094 (1142)
|++.. ...+.++|+||+|+++|.+. .|+.-+....... ......... ... .. ...
T Consensus 179 E~~~~----~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~-~~~~~~~~~-~~~-------------~~----~~s- 234 (700)
T KOG2137|consen 179 EYLLG----TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL-SYSFSRNLL-NAG-------------AF----GYS- 234 (700)
T ss_pred hhhcc----ccccccccceeeeeEEEEEecCCcchhhccCCcc-hhhhhhccc-ccc-------------cc----ccc-
Confidence 99986 45679999999999999988 4655554332221 111111110 000 00 000
Q ss_pred chhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001142 1095 PEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1095 ~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~~s 1135 (1142)
-..+.++++=+.+++..++..||++.++...+++...
T Consensus 235 ----~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~ 271 (700)
T KOG2137|consen 235 ----NNLPSELRESLKKLLNGDSAVRPTLDLLLSIPFFSDP 271 (700)
T ss_pred ----ccCcHHHHHHHHHHhcCCcccCcchhhhhcccccCCc
Confidence 1566778889999999999999999998888877654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.38 E-value=4.9e-06 Score=89.29 Aligned_cols=148 Identities=15% Similarity=0.107 Sum_probs=100.7
Q ss_pred cccCceEEEEEEECCccEEEEEEecccCCC-C-hHHHHHhHHhHHHHHHHHhhCC--CCCccceeeeEecCCCCCCCCCC
Q 001142 816 GKSVSSSLFRCKFGSADAAAKVRTLKVCGS-S-ADEIRNFEYSCLGEVRMLGALR--HSCIVEMYGHKISSKWLPSADGN 891 (1142)
Q Consensus 816 G~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~-~-~~~~~~~~~~~~~Ei~iL~~L~--HpNIVkl~g~~~~~~~~~~~~~~ 891 (1142)
|+|+-+.|++....+..+-+|.-....... . +-... .+.+|+..+.++. .-.+.++. ++....
T Consensus 27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~p----tf~rE~~~L~~L~~~GvPVP~pv-f~~~~k-------- 93 (216)
T PRK09902 27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRP----TIVREVAVIKELERAGVIVPKIV-FGEAVK-------- 93 (216)
T ss_pred CCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCch----HHHHHHHHHHHHHHcCCCCCccc-eeeeec--------
Confidence 568888899988877766666532111111 0 11222 3478999998885 23355555 322111
Q ss_pred CccccceEEEEEeccCC-CCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccCC
Q 001142 892 PEHHLLQSAIFMEYVKG-GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 970 (1142)
Q Consensus 892 ~~~~~~~~~LVmEy~~g-gSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~~ 970 (1142)
.....+.+||+|-++| .||.+++.+ ....+.+......++.+++..+.-||..|+.|+|+.+.||+++.++
T Consensus 94 -~~~~~rA~LVTe~L~g~~~L~~~l~~---~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g---- 165 (216)
T PRK09902 94 -IEGEWRALLVTEDMAGFISIADWYAQ---HAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG---- 165 (216)
T ss_pred -cCCceEEEEEEEeCCCCccHHHHHhc---CCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC----
Confidence 1124567999998764 489888764 2223567788889999999999999999999999999999998552
Q ss_pred CCCeEEEeecCCccc
Q 001142 971 GKPVVKLCDFDRAVP 985 (1142)
Q Consensus 971 ~~~~vKL~DFGlA~~ 985 (1142)
...+.++||.-++.
T Consensus 166 -~~~v~lIDlEk~r~ 179 (216)
T PRK09902 166 -KAEAGFLDLEKSRR 179 (216)
T ss_pred -CeeEEEEEhhccch
Confidence 15699999997753
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.8e-08 Score=98.95 Aligned_cols=86 Identities=24% Similarity=0.307 Sum_probs=67.7
Q ss_pred CCcEEEccCCCCCccCcccCCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeCcCCc
Q 001142 165 CLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNR 244 (1142)
Q Consensus 165 ~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls~N~ 244 (1142)
.++.|+|++|.|+.+|.++..++.|+.|+++.|.|...|..|..|.+|-.|+..+|.+..||-.+.--+++-..+|.+|.
T Consensus 78 t~t~lNl~~neisdvPeE~Aam~aLr~lNl~~N~l~~~p~vi~~L~~l~~Lds~~na~~eid~dl~~s~~~al~~lgnep 157 (177)
T KOG4579|consen 78 TATTLNLANNEISDVPEELAAMPALRSLNLRFNPLNAEPRVIAPLIKLDMLDSPENARAEIDVDLFYSSLPALIKLGNEP 157 (177)
T ss_pred hhhhhhcchhhhhhchHHHhhhHHhhhcccccCccccchHHHHHHHhHHHhcCCCCccccCcHHHhccccHHHHHhcCCc
Confidence 46678888888888888888888999999999999888888888888888998889888888765544444455666776
Q ss_pred CCCCCc
Q 001142 245 LTSLGS 250 (1142)
Q Consensus 245 Ls~~~p 250 (1142)
+.+--+
T Consensus 158 l~~~~~ 163 (177)
T KOG4579|consen 158 LGDETK 163 (177)
T ss_pred ccccCc
Confidence 665544
|
|
| >PRK15386 type III secretion protein GogB; Provisional | Back alignment and domain information |
|---|
Probab=98.35 E-value=4.7e-07 Score=105.52 Aligned_cols=136 Identities=20% Similarity=0.239 Sum_probs=70.1
Q ss_pred CCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeec-CCCCccCccccCCcCCcEEEccCC-CCCcCchhhcCCC
Q 001142 37 VNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYK-NVLNLIPKSVGRYEKLRNLKFFGN-EINLFPSEVGNLL 114 (1142)
Q Consensus 37 f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~-N~Lt~iP~~l~~L~~L~~L~Ls~N-~L~~lP~~l~~L~ 114 (1142)
+..+.+++.|++++|.|+..+ ... .+|+.|.+++ +.|+.+|..+. .+|+.|+|++| .|..+|..
T Consensus 48 ~~~~~~l~~L~Is~c~L~sLP-~LP------~sLtsL~Lsnc~nLtsLP~~LP--~nLe~L~Ls~Cs~L~sLP~s----- 113 (426)
T PRK15386 48 IEEARASGRLYIKDCDIESLP-VLP------NELTEITIENCNNLTTLPGSIP--EGLEKLTVCHCPEISGLPES----- 113 (426)
T ss_pred HHHhcCCCEEEeCCCCCcccC-CCC------CCCcEEEccCCCCcccCCchhh--hhhhheEccCcccccccccc-----
Confidence 444556666666666655442 211 3466666654 45555555442 35666666665 45455432
Q ss_pred CCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCC-C--CccCcccCCCCCCCE
Q 001142 115 GLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS-I--RYLPPEIGCLSNLEQ 191 (1142)
Q Consensus 115 ~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~-L--~~IP~~l~~L~~L~~ 191 (1142)
|+.|+++.|. . ..++.+|.. |+.|.+.+++ . ..+|.. -.++|++
T Consensus 114 -Le~L~L~~n~-----------------------~-~~L~~LPss------Lk~L~I~~~n~~~~~~lp~~--LPsSLk~ 160 (426)
T PRK15386 114 -VRSLEIKGSA-----------------------T-DSIKNVPNG------LTSLSINSYNPENQARIDNL--ISPSLKT 160 (426)
T ss_pred -cceEEeCCCC-----------------------C-cccccCcch------Hhheeccccccccccccccc--cCCcccE
Confidence 3333333332 1 122334433 3344443322 1 122211 1246888
Q ss_pred EEccCCCCCccchhhcCCCCCCEEEccCCC
Q 001142 192 LDLSFNKMKYLPTEICYLKALISLKVANNK 221 (1142)
Q Consensus 192 L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~ 221 (1142)
|++++|....+|..+. .+|+.|+++.|.
T Consensus 161 L~Is~c~~i~LP~~LP--~SLk~L~ls~n~ 188 (426)
T PRK15386 161 LSLTGCSNIILPEKLP--ESLQSITLHIEQ 188 (426)
T ss_pred EEecCCCcccCccccc--ccCcEEEecccc
Confidence 8888887766665554 478888888774
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.34 E-value=2.1e-06 Score=94.22 Aligned_cols=141 Identities=18% Similarity=0.188 Sum_probs=100.8
Q ss_pred ceeeeecccCceEEEEEEE-CCccEEEEEEecccCCCChH--------------HHHHhHHhHHHHHHHHhhCCCC--Cc
Q 001142 810 SSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSAD--------------EIRNFEYSCLGEVRMLGALRHS--CI 872 (1142)
Q Consensus 810 ~l~~~LG~GsfG~Vy~a~~-~~~~vAvKi~~l~~~~~~~~--------------~~~~~~~~~~~Ei~iL~~L~Hp--NI 872 (1142)
.++..||-|--+.||.|.. .+.++++|.-++-.++.... ...--...+++|.++|.+|.-. .|
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 6789999999999999998 48899999866543322110 0001122457899999999644 66
Q ss_pred cceeeeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 001142 873 VEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 952 (1142)
Q Consensus 873 Vkl~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvH 952 (1142)
.+.+++- .-++||||++|--|... +++......++..|+.-+..+-..||||
T Consensus 174 P~P~~~n------------------RHaVvMe~ieG~eL~~~----------r~~~en~~~il~~il~~~~~~~~~GiVH 225 (304)
T COG0478 174 PKPIAWN------------------RHAVVMEYIEGVELYRL----------RLDVENPDEILDKILEEVRKAYRRGIVH 225 (304)
T ss_pred CCccccc------------------cceeeeehcccceeecc----------cCcccCHHHHHHHHHHHHHHHHHcCccc
Confidence 6666542 22899999997555432 2234455566666676666666899999
Q ss_pred cCCCCCCeeeccccccCCCCCeEEEeecCCccc
Q 001142 953 RDIKSENILIDLERKKADGKPVVKLCDFDRAVP 985 (1142)
Q Consensus 953 rDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~ 985 (1142)
+|+.+-||+++.+ +.+.++||--+..
T Consensus 226 GDlSefNIlV~~d-------g~~~vIDwPQ~v~ 251 (304)
T COG0478 226 GDLSEFNILVTED-------GDIVVIDWPQAVP 251 (304)
T ss_pred cCCchheEEEecC-------CCEEEEeCccccc
Confidence 9999999999988 7899999987753
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1142 | ||||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-18 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 9e-18 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-17 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-17 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-17 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-17 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-16 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-15 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-15 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 9e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-14 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-14 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-14 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-14 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-14 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-14 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-14 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-14 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-14 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 8e-14 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 9e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-13 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-13 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-13 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-13 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-13 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-13 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 9e-13 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 9e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-12 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-12 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-12 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-12 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-12 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-12 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 7e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-12 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 8e-12 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-11 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-11 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-11 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-11 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-11 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-11 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-11 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-11 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-11 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-11 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-11 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-11 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-11 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-11 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-11 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 8e-11 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 9e-11 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 9e-11 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 9e-11 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-10 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-10 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-10 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-10 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-10 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-10 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-10 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-10 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-10 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-10 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-10 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-10 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-10 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-10 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-10 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-10 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-10 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-10 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-10 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-10 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-10 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-10 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-10 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-10 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 8e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-10 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 8e-10 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 9e-10 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 9e-10 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-09 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-09 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-09 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-09 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-09 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-09 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-09 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-09 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-09 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-09 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-09 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-09 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-09 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-09 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-09 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-09 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-09 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-09 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-09 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-09 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-09 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-09 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-09 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-09 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 6e-09 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-09 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-09 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-09 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 8e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 8e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-09 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 9e-09 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 9e-09 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 9e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 9e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-08 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-08 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-08 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-08 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-08 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-08 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-08 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-08 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-08 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-08 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-08 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-08 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-08 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-08 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-08 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-08 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-08 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-08 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-08 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-08 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-08 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-08 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-08 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-08 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-08 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-08 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-08 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-08 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-08 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-08 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-08 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-08 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-08 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-08 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-08 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-08 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-08 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-08 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-08 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-08 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-08 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-08 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-08 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-08 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-08 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-08 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 5e-08 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-08 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-08 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-08 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-08 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-08 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-08 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-08 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-08 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-08 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-08 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-08 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-08 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-08 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-08 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-08 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-08 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-08 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-08 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-08 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-08 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 7e-08 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-08 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 7e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-08 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-08 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-08 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 8e-08 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 8e-08 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 8e-08 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 8e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 8e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 8e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-07 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-07 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-07 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-07 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-07 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-07 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-07 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-07 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-07 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-07 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-07 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-07 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-07 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-07 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-07 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-07 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-07 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-07 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-07 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-07 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-07 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-07 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-07 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-07 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-07 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-07 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-07 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-07 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-07 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-07 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-07 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-07 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-07 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-07 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-07 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 5e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-07 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-07 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 6e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-07 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 7e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-07 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 7e-07 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-07 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-07 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-06 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-06 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-06 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-06 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-06 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-06 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-06 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-06 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-06 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-06 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-06 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-06 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-06 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 3e-06 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-06 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-06 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-06 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-06 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-06 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-06 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-06 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-06 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-06 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-06 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-06 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-06 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-06 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-06 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-06 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-06 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-06 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-06 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-06 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-06 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-06 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-06 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-06 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-06 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-06 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-06 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-06 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-06 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-06 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-06 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-06 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-06 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-06 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-06 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-06 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-06 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-06 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-06 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-06 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-06 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-06 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-06 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-06 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-06 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-06 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-06 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-06 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 7e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 7e-06 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-06 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 8e-06 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-06 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 8e-06 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 9e-06 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 9e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 9e-06 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 9e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 9e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 9e-06 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-05 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-05 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-05 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-05 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-05 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-05 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-05 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-05 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-05 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-05 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-05 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-05 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-05 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-05 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-05 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-05 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-05 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-05 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-05 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-05 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-05 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-05 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-05 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-05 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-05 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-05 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-05 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-05 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-05 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-05 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-05 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-05 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-05 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-05 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-05 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-05 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-05 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-05 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-05 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-05 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-05 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-05 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-05 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-05 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-05 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-05 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-05 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-05 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 5e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 5e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 5e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 5e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 5e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-05 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 6e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 6e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 6e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-05 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 7e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 7e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-05 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 8e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 8e-05 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 8e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-05 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 9e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 9e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-04 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-04 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-04 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-04 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-04 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-04 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-04 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-04 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-04 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-04 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-04 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-04 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-04 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 1e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-04 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 1e-04 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-04 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-04 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-04 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-04 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-04 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-04 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-04 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-04 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-04 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-04 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-04 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-04 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-04 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-04 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-04 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-04 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-04 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-04 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-04 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-04 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-04 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-04 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-04 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-04 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-04 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-04 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-04 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-04 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-04 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-04 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-04 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-04 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-04 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-04 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-04 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-04 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-04 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-04 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-04 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-04 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 3e-04 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-04 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-04 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-04 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-04 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-04 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-04 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-04 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-04 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-04 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-04 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-04 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-04 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-04 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-04 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-04 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-04 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-04 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-04 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-04 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-04 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 3e-04 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 3e-04 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-04 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-04 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-04 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-04 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-04 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-04 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-04 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-04 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-04 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-04 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 4e-04 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-04 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 4e-04 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 4e-04 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 4e-04 |
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-43
Identities = 67/311 (21%), Positives = 111/311 (35%), Gaps = 76/311 (24%)
Query: 816 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 875
++ S L++ ++ D KV LKV S + R+F E L H ++ +
Sbjct: 19 NENHSGELWKGRWQGNDIVVKV--LKVRDWSTRKSRDF----NEECPRLRIFSHPNVLPV 72
Query: 876 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 935
G + P H + ++ GS+ N L E V A+ A
Sbjct: 73 LG---------ACQSPPAPHP---TLITHWMPYGSLYNV---LHEGTNFVVDQSQAVKFA 117
Query: 936 QDVAAALVELHSKH--IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC 993
D+A + LH+ I + S +++ID + ++ D SF
Sbjct: 118 LDMARGMAFLHTLEPLIPRHALNSRSVMIDEDM-------TARISMADVK---FSFQSP- 166
Query: 994 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP-NLYGLEVDIWSYGCLLLELLTLQVPYMG 1052
+ P W+APE L+ KP + D+WS+ LL EL+T +VP+
Sbjct: 167 -----------GRMYAPAWVAPEALQ--KKPEDTNRRSADMWSFAVLLWELVTREVPFAD 213
Query: 1053 LSELEI-HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRR 1111
LS +EI + G RP + H + + +
Sbjct: 214 LSNMEIGMKVALEGLRPTIPP------GISPH---------------------VSKLMKI 246
Query: 1112 CTEENPTERPT 1122
C E+P +RP
Sbjct: 247 CMNEDPAKRPK 257
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 6e-41
Identities = 55/291 (18%), Positives = 98/291 (33%), Gaps = 66/291 (22%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
+R + + + D+++ F EV RH +V G A +P H
Sbjct: 60 IRLIDIERDNEDQLKAF----KREVMAYRQTRHENVVLFMG----------ACMSPPHL- 104
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
AI KG ++ + + + + V IAQ++ + LH+K I+H+D+K
Sbjct: 105 ---AIITSLCKGRTLYSVVRD----AKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLK 157
Query: 957 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1016
S+N+ D V + DF L S R G +APE
Sbjct: 158 SKNVFYD--------NGKVVITDFG----LFSISGVLQAGRREDKLRIQN-GWLCHLAPE 204
Query: 1017 VLRAMHKPNL-----YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLT 1071
++R + + D+++ G + EL + P+ I + G +P
Sbjct: 205 IIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP--- 261
Query: 1072 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122
+++ + D+ C ERPT
Sbjct: 262 -----------------------NLSQIGMGKEISDILLFCWAFEQEERPT 289
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 6e-41
Identities = 53/268 (19%), Positives = 103/268 (38%), Gaps = 69/268 (25%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
EV ++ L H IV++YG + + ME+V G + + + +
Sbjct: 73 EVFIMSNLNHPNIVKLYG--LMHNPP--------------RMVMEFVPCGDLYHRLLDKA 116
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENILIDLERKKADGKPVVKL 977
+ + L + D+A + + +++ I+HRD++S NI + + A K+
Sbjct: 117 ----HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAP--VCAKV 170
Query: 978 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1037
DF + + +H+ +G +WMAPE + A + Y + D +S+
Sbjct: 171 ADFGLS---QQSVHSV----------SGLLGNFQWMAPETIGAEEES--YTEKADTYSFA 215
Query: 1038 CLLLELLTLQVPYMGLSELEI---HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK 1094
+L +LT + P+ S +I + + + G RP + + C
Sbjct: 216 MILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPE------DCPPR----------- 258
Query: 1095 PEAELETLSFLVDVFRRCTEENPTERPT 1122
L +V C +P +RP
Sbjct: 259 ----------LRNVIELCWSGDPKKRPH 276
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 65/312 (20%), Positives = 108/312 (34%), Gaps = 72/312 (23%)
Query: 816 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 875
G ++R + + A K + I N E ++ L+H I+ +
Sbjct: 16 GIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENV----RQEAKLFAMLKHPNIIAL 71
Query: 876 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 935
G + + ME+ +GG + + K + + + A
Sbjct: 72 RG----------VCLKEPNL----CLVMEFARGGPLNRVLSG------KRIPPDILVNWA 111
Query: 936 QDVAAALVELHSKH---IMHRDIKSENILIDLERKKAD-GKPVVKLCDFDRAVPLRSFLH 991
+A + LH + I+HRD+KS NILI + + D ++K+ DF
Sbjct: 112 VQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG---------- 161
Query: 992 TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM 1051
HR G WMAPEV+R + D+WSYG LL ELLT +VP+
Sbjct: 162 LAREWHRT--TKMSAAGAYAWMAPEVIR--ASM--FSKGSDVWSYGVLLWELLTGEVPFR 215
Query: 1052 GLSELEI-HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 1110
G+ L + + + + +C E +
Sbjct: 216 GIDGLAVAYGVAMNKLALPIPS------TCPEP---------------------FAKLME 248
Query: 1111 RCTEENPTERPT 1122
C +P RP+
Sbjct: 249 DCWNPDPHSRPS 260
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-40
Identities = 75/310 (24%), Positives = 125/310 (40%), Gaps = 73/310 (23%)
Query: 816 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 875
G ++ R ++ +D A K+ L A+ + F L EV ++ LRH IV
Sbjct: 46 GAGSFGTVHRAEWHGSDVAVKI--LMEQDFHAERVNEF----LREVAIMKRLRHPNIVLF 99
Query: 876 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 935
G A P + +I EY+ GS+ + K + + + L +A
Sbjct: 100 MG----------AVTQPPNL----SIVTEYLSRGSLYRLLHK--SGAREQLDERRRLSMA 143
Query: 936 QDVAAALVELHSKH--IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC 993
DVA + LH+++ I+HR++KS N+L+D K VK+CDF +
Sbjct: 144 YDVAKGMNYLHNRNPPIVHRNLKSPNLLVD-------KKYTVKVCDFGLS---------- 186
Query: 994 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGL 1053
+ + GTP WMAPEVLR +P + D++S+G +L EL TLQ P+ L
Sbjct: 187 RLKASTFLSSKSAAGTPEWMAPEVLR--DEP--SNEKSDVYSFGVILWELATLQQPWGNL 242
Query: 1054 SELEI-HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 1112
+ ++ + KR + + + + + C
Sbjct: 243 NPAQVVAAVGFKCKRLEIPR------NLNPQ---------------------VAAIIEGC 275
Query: 1113 TEENPTERPT 1122
P +RP+
Sbjct: 276 WTNEPWKRPS 285
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 5e-40
Identities = 66/288 (22%), Positives = 114/288 (39%), Gaps = 65/288 (22%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
V+ L V + +++ F EV +L RH I+ G S+ L
Sbjct: 51 VKMLNVTAPTPQQLQAF----KNEVGVLRKTRHVNILLFMG--YSTA----------PQL 94
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
AI ++ +G S+ +++ E +K + IA+ A + LH+K I+HRD+K
Sbjct: 95 ---AIVTQWCEGSSLYHHLHAS----ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLK 147
Query: 957 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1016
S NI + VK+ DF A + G+ WMAPE
Sbjct: 148 SNNIFL-------HEDNTVKIGDFGLA---TEKSRWSGSHQFEQLS-----GSILWMAPE 192
Query: 1017 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE--IHDLIQMGKRPRLTDEL 1074
V+R M N Y + D++++G +L EL+T Q+PY ++ + I + + P L
Sbjct: 193 VIR-MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDL---S 248
Query: 1075 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122
+ +C + + + C ++ ERP+
Sbjct: 249 KVRSNCPKR---------------------MKRLMAECLKKKRDERPS 275
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-39
Identities = 66/312 (21%), Positives = 120/312 (38%), Gaps = 83/312 (26%)
Query: 816 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 875
G+ + + K+ + D A K ++ S E + F E+R L + H IV++
Sbjct: 17 GRGAFGVVCKAKWRAKDVAIKQ--IE----SESERKAFI----VELRQLSRVNHPNIVKL 66
Query: 876 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 935
YG + + MEY +GGS+ N + + + A+
Sbjct: 67 YG--ACLNPV--------------CLVMEYAEGGSLYNVLHGAEPL--PYYTAAHAMSWC 108
Query: 936 QDVAAALVELHS---KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHT 992
+ + LHS K ++HRD+K N+L+ G V+K+CDF A +++ +
Sbjct: 109 LQCSQGVAYLHSMQPKALIHRDLKPPNLLLV------AGGTVLKICDFGTACDIQTHMTN 162
Query: 993 CCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1052
G+ WMAPEV Y + D++S+G +L E++T + P+
Sbjct: 163 NK-------------GSAAWMAPEVFE--GSN--YSEKCDVFSWGIILWEVITRRKPFDE 205
Query: 1053 LS--ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 1110
+ I + G RP L + + + +
Sbjct: 206 IGGPAFRIMWAVHNGTRPPLIK------NLPKP---------------------IESLMT 238
Query: 1111 RCTEENPTERPT 1122
RC ++P++RP+
Sbjct: 239 RCWSKDPSQRPS 250
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-37
Identities = 66/276 (23%), Positives = 102/276 (36%), Gaps = 64/276 (23%)
Query: 856 SCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 915
C+ E+ +L L H +++ Y I L I +E G + I
Sbjct: 78 DCIKEIDLLKQLNHPNVIKYYASFIEDNEL--------------NIVLELADAGDLSRMI 123
Query: 916 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 975
+ + + + + + +AL +HS+ +MHRDIK N+ I A G VV
Sbjct: 124 KHFKKQK-RLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT-----ATG--VV 175
Query: 976 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 1035
KL D R F AH VGTP +M+PE + Y + DIWS
Sbjct: 176 KLGDLGLG---RFFSSKTTAAH-------SLVGTPYYMSPERIH--ENG--YNFKSDIWS 221
Query: 1036 YGCLLLELLTLQVPYMG--LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE 1093
GCLL E+ LQ P+ G ++ + I+ P L + S
Sbjct: 222 LGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSD------------HYS----- 264
Query: 1094 KPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1129
L + C +P +RP +Y++
Sbjct: 265 ---------EELRQLVNMCINPDPEKRPDVTYVYDV 291
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 6e-37
Identities = 56/296 (18%), Positives = 101/296 (34%), Gaps = 60/296 (20%)
Query: 849 EIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSA--IFMEYV 906
++ EV+ L L H IV G + P I ME+
Sbjct: 43 RVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFC 102
Query: 907 KGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 966
G+++ +IEK + + LAL + + + + +HSK +++RD+K NI +
Sbjct: 103 DKGTLEQWIEK---RRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV--- 156
Query: 967 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 1026
VK+ DF L++ GT R+M+PE + +
Sbjct: 157 --DTK--QVKIGDFGLVTSLKNDGKRTRS-----------KGTLRYMSPEQIS--SQD-- 197
Query: 1027 YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVA 1086
YG EVD+++ G +L ELL + E + ++D
Sbjct: 198 YGKEVDLYALGLILAELLHVCDTAF-----ETSKFFTDLRDGIISDIF------------ 240
Query: 1087 QSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM-FVARTSSSISSR 1141
+ ++ + P +RP ++ V + S + R
Sbjct: 241 -DKK--------------EKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNER 281
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 9e-37
Identities = 61/290 (21%), Positives = 107/290 (36%), Gaps = 71/290 (24%)
Query: 840 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 899
L+ + E + F+ E ML L+H IV Y W + G + ++
Sbjct: 59 LQDRKLTKSERQRFK----EEAEMLKGLQHPNIVRFYDS-----WESTVKG--KKCIV-- 105
Query: 900 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKS 957
+ E + G++K Y+++ K + + + L LH++ I+HRD+K
Sbjct: 106 -LVTELMTSGTLKTYLKRFKVMKIKVLRS-----WCRQILKGLQFLHTRTPPIIHRDLKC 159
Query: 958 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 1017
+NI I G VK+ D + +GTP +MAPE+
Sbjct: 160 DNIFIT----GPTG--SVKIGDL------------GLATLKRASFAKAVIGTPEFMAPEM 201
Query: 1018 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL-EIHDLIQMGKRPRLTDELEA 1076
Y VD++++G +LE+ T + PY +I+ + G +P D++
Sbjct: 202 YE-----EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 256
Query: 1077 LGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1126
PE + + C +N ER + DL
Sbjct: 257 ------------------PEVK----EII----EGCIRQNKDERYSIKDL 280
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-36
Identities = 56/314 (17%), Positives = 108/314 (34%), Gaps = 68/314 (21%)
Query: 823 LFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 882
+ ++ L + R F L EV+++ L H +++ G +
Sbjct: 26 AIKVTHRETGEVMVMKELI--RFDEETQRTF----LKEVKVMRCLEHPNVLKFIG--VLY 77
Query: 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAAL 942
K + L EY+KGG+++ I+ + + A+D+A+ +
Sbjct: 78 K---------DKRL---NFITEYIKGGTLRGIIKS----MDSQYPWSQRVSFAKDIASGM 121
Query: 943 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGI 1000
LHS +I+HRD+ S N L+ + V + DF R + + +
Sbjct: 122 AYLHSMNIIHRDLNSHNCLVRENK-------NVVVADFGLARLMVDEKTQPEGLRSLKKP 174
Query: 1001 PAPDV--CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY--MGLSEL 1056
VG P WMAPE++ + Y +VD++S+G +L E++ +
Sbjct: 175 DRKKRYTVVGNPYWMAPEMIN--GRS--YDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM 230
Query: 1057 EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1116
+ ++ +C + RC + +
Sbjct: 231 DFGLNVRGFLDR------YCPPNCPPS---------------------FFPITVRCCDLD 263
Query: 1117 PTERPTAGDLYEMF 1130
P +RP+ L
Sbjct: 264 PEKRPSFVKLEHWL 277
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-36
Identities = 56/286 (19%), Positives = 93/286 (32%), Gaps = 75/286 (26%)
Query: 854 EYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVK 912
E + L EV L +HS +V + W + H+L I EY GGS+
Sbjct: 54 EQNALREVYAHAVLGQHSHVVRYFSA-----WAE------DDHML---IQNEYCNGGSLA 99
Query: 913 NYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID--------- 963
+ I + + + V L +HS ++H DIK NI I
Sbjct: 100 DAISENYRIM-SYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAAS 158
Query: 964 ---LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1020
E A K + K+ D + S P V G R++A EVL+
Sbjct: 159 EEGDEDDWASNKVMFKIGDLGHVTRISS--------------PQVEEGDSRFLANEVLQ- 203
Query: 1021 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC 1080
+ + + DI++ ++ + + I+ G+ PR+ L
Sbjct: 204 ENYT--HLPKADIFALALTVVCAAGAEPLPRNGDQWHE---IRQGRLPRIPQVL------ 252
Query: 1081 HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1126
S ++ + +P RP+A L
Sbjct: 253 -------SQE--------------FTELLKVMIHPDPERRPSAMAL 277
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-36
Identities = 58/268 (21%), Positives = 92/268 (34%), Gaps = 61/268 (22%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
E+ L IV +YG W+ IFME ++GGS+ I+++
Sbjct: 100 ELVACAGLSSPRIVPLYGAVREGPWV--------------NIFMELLEGGSLGQLIKQMG 145
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
E L LH++ I+H D+K++N+L+ +DG LCD
Sbjct: 146 CLPEDRALY-----YLGQALEGLEYLHTRRILHGDVKADNVLLS-----SDGS-RAALCD 194
Query: 980 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039
F A+ L+ + D GT MAPEV+ +VDIWS C+
Sbjct: 195 FGHALCLQPDGLGKSLLTG-----DYIPGTETHMAPEVVMG----KPCDAKVDIWSSCCM 245
Query: 1040 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 1099
+L +L P+ + I P E P
Sbjct: 246 MLHMLNGCHPWTQYFRGPLCLKIASEPPPIR----------------------EIP---- 279
Query: 1100 ETLS-FLVDVFRRCTEENPTERPTAGDL 1126
+ + + + P R +A +L
Sbjct: 280 PSCAPLTAQAIQEGLRKEPVHRASAMEL 307
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-36
Identities = 69/288 (23%), Positives = 107/288 (37%), Gaps = 66/288 (22%)
Query: 856 SCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 915
EV +L ++H IV+ + L I M+Y +GG + I
Sbjct: 69 ESRREVAVLANMKHPNIVQYRESFEENGSL--------------YIVMDYCEGGDLFKRI 114
Query: 916 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 975
L + AL +H + I+HRDIKS+NI + DG V
Sbjct: 115 NA---QKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT-----KDG--TV 164
Query: 976 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 1035
+L DF A R T +A C+GTP +++PE+ +KP Y + DIW+
Sbjct: 165 QLGDFGIA---RVLNSTVELAR-------ACIGTPYYLSPEICE--NKP--YNNKSDIWA 210
Query: 1036 YGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKP 1095
GC+L EL TL+ + S + I G P ++ S
Sbjct: 211 LGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHY----S---------------- 250
Query: 1096 EAELETLSFLVDVFRRCTEENPTERPTAGDLYEM-FVARTSSSISSRS 1142
L + + + NP +RP+ + E F+A+ S
Sbjct: 251 -------YDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQ 291
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-36
Identities = 72/279 (25%), Positives = 106/279 (37%), Gaps = 66/279 (23%)
Query: 856 SCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 915
+ EV +L L+H IV Y I L I MEY +GG + + I
Sbjct: 51 MLVSEVNLLRELKHPNIVRYYDRIIDRT---------NTTLY---IVMEYCEGGDLASVI 98
Query: 916 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-----IMHRDIKSENILIDLERKKAD 970
K ++ +++ + L + + AL E H + ++HRD+K N+ +D
Sbjct: 99 TKGTKER-QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD------- 150
Query: 971 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLE 1030
GK VKL DF A R H A VGTP +M+PE + Y +
Sbjct: 151 GKQNVKLGDFGLA---RILNHDTSFAK-------TFVGTPYYMSPEQMN--RMS--YNEK 196
Query: 1031 VDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS 1090
DIWS GCLL EL L P+ S+ E+ I+ GK R+ S
Sbjct: 197 SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY----S----------- 241
Query: 1091 GFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1129
L ++ R RP+ ++ E
Sbjct: 242 ------------DELNEIITRMLNLKDYHRPSVEEILEN 268
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-36
Identities = 56/276 (20%), Positives = 99/276 (35%), Gaps = 55/276 (19%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSA----IFMEYVKGGSVKNYI 915
EV +L +L H +V Y WL + ++ I MEY + G++ + I
Sbjct: 52 EVMLLASLNHQYVVRYYAA-----WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI 106
Query: 916 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 975
+ + + + AL +HS+ I+HRD+K NI ID V
Sbjct: 107 HS----ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFID-----ESRN--V 155
Query: 976 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDV----CVGTPRWMAPEVLRAMHKPNLYGLEV 1031
K+ DF A + L + + +P +GT ++A EVL + Y ++
Sbjct: 156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG--TGH-YNEKI 212
Query: 1032 DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSG 1091
D++S G + E++ G+ + I ++
Sbjct: 213 DMYSLGIIFFEMIYP--FSTGMERVNILKKLRSVS------------------------- 245
Query: 1092 FEKPEAELETLS-FLVDVFRRCTEENPTERPTAGDL 1126
E P + + R + +P +RP A L
Sbjct: 246 IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTL 281
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-35
Identities = 61/274 (22%), Positives = 96/274 (35%), Gaps = 48/274 (17%)
Query: 856 SCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 915
+ EV+ L L H IV + + + L I M+ + ++K+++
Sbjct: 49 KVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYL--YIQMQLCRKENLKDWM 106
Query: 916 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 975
+ + L I +A A+ LHSK +MHRD+K NI D VV
Sbjct: 107 NG--RCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT-----MDD--VV 157
Query: 976 KLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 1033
K+ DF A+ T VGT +M+PE + Y +VDI
Sbjct: 158 KVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS----YSHKVDI 213
Query: 1034 WSYGCLLLELLTLQVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF 1092
+S G +L ELL P+ E ++ K P L
Sbjct: 214 FSLGLILFELLY---PFSTQMERVRTLTDVRNLKFPPL---------------------- 248
Query: 1093 EKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1126
+ +V + +P ERP A ++
Sbjct: 249 --FTQKYPCEYVMV---QDMLSPSPMERPEAINI 277
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 61/285 (21%), Positives = 101/285 (35%), Gaps = 53/285 (18%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
E+ LRH I+ +D H Q + Y + GS+ +Y++
Sbjct: 52 ELYNTVMLRHENILGFIA----------SDMTSRHSSTQLWLITHYHEMGSLYDYLQL-- 99
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKH--------IMHRDIKSENILIDLERKKADG 971
+ L I +A+ L LH + I HRD+KS+NIL+ +G
Sbjct: 100 ----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK-----KNG 150
Query: 972 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLE- 1030
+ D AV + + + VGT R+MAPEVL + +
Sbjct: 151 --QCCIADLGLAVMHSQSTNQLDVGNNPR------VGTKRYMAPEVLD--ETIQVDCFDS 200
Query: 1031 ---VDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ 1087
VDIW++G +L E+ V + + + + P D + V
Sbjct: 201 YKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKV--------VCV 252
Query: 1088 SGS--GFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130
TL+ L + + C +NP+ R TA + +
Sbjct: 253 DQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-35
Identities = 53/220 (24%), Positives = 86/220 (39%), Gaps = 19/220 (8%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KISS-PGV 128
L L L P R L+++ + P + GLE L + + + P
Sbjct: 86 LELRSVPLPQFPDQAFRLSHLQHMTIDAAGLMELPDTMQQFAGLETLTLARNPLRALPA- 144
Query: 129 NGFALNKLKGLKELELS------KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPE 182
++ L L+EL + ++P + E GL L L + IR LP
Sbjct: 145 ---SIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPAS 201
Query: 183 IGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVA-NNKLVELPSGLYLLQRLENLDLS 241
I L NL+ L + + + L I +L L L + L P L+ L L
Sbjct: 202 IANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILK 261
Query: 242 N-NRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC 280
+ + L +L LD+ + L+ L+L+ LS ++PS I
Sbjct: 262 DCSNLLTL-PLDIHRLTQLEKLDLRGCVNLS--RLPSLIA 298
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 7e-27
Identities = 36/198 (18%), Positives = 67/198 (33%), Gaps = 18/198 (9%)
Query: 93 LRNLKFFG-NEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRP 151
NL F G + + + N + ++ +
Sbjct: 14 RENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQ-IETRTGRALKATA 72
Query: 152 SVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKA 211
+L + L + + P + LS+L+ + + + LP +
Sbjct: 73 DLLEDAT----QPGRVALELRSVPLPQFPDQAFRLSHLQHMTIDAAGLMELPDTMQQFAG 128
Query: 212 LISLKVANNKLVELPSGLYLLQRLENLDLS-NNRLTSL--------GSLDLCLMHNLQNL 262
L +L +A N L LP+ + L RL L + LT L S + + NLQ+L
Sbjct: 129 LETLTLARNPLRALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSL 188
Query: 263 NLQYNKLLSYCQVPSWIC 280
L++ + S +P+ I
Sbjct: 189 RLEWTGIRS---LPASIA 203
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 6e-20
Identities = 35/185 (18%), Positives = 63/185 (34%), Gaps = 43/185 (23%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGV 128
+++ L L + +P S+ + L++LK + ++ + +L LE L
Sbjct: 184 NLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEEL--------- 234
Query: 129 NGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS-IRYLPPEIGCLS 187
L+G L G L +L + S + LP +I L+
Sbjct: 235 ------DLRGCTALR-----------NYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLT 277
Query: 188 NLEQLDLSFNKM-KYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLT 246
LE+LDL LP+ I L A + V + +L +R
Sbjct: 278 QLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQ---------------HRPV 322
Query: 247 SLGSL 251
+ +
Sbjct: 323 ARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 5e-08
Identities = 9/93 (9%), Positives = 19/93 (20%), Gaps = 5/93 (5%)
Query: 179 LPPEIGCLSNLEQLDLS-FNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLEN 237
S E L ++ + + A+ +
Sbjct: 4 SHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQ---RHYNADRNRWHSAWRQANSNNPQI 60
Query: 238 LDLSNNRLTSL-GSLDLCLMHNLQNLNLQYNKL 269
+ L + L+ L L+ L
Sbjct: 61 ETRTGRALKATADLLEDATQPGRVALELRSVPL 93
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-34
Identities = 68/286 (23%), Positives = 110/286 (38%), Gaps = 64/286 (22%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
E+ + L+H IV+ G + IFME V GGS+ +
Sbjct: 69 EIALHKHLKHKNIVQYLGSFSE-----------NGFIK---IFMEQVPGGSLSALLRSKW 114
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
+ + + + Q + L LH I+HRDIK +N+LI+ G V+K+ D
Sbjct: 115 GPLKDNEQT-IGFYTKQ-ILEGLKYLHDNQIVHRDIKGDNVLINTY----SG--VLKISD 166
Query: 980 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039
F + L P + GT ++MAPE++ P YG DIWS GC
Sbjct: 167 FGTSKRLAGI----------NPCTETFTGTLQYMAPEIID--KGPRGYGKAADIWSLGCT 214
Query: 1040 LLELLTLQVPYMGLSE-LEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEA 1097
++E+ T + P+ L E + M K P + + + A
Sbjct: 215 IIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEA------------------- 255
Query: 1098 ELETLSFLVDVFRRCTEENPTERPTAGDLYE-MFVARTSSSISSRS 1142
+F+ +C E +P +R A DL F+ +S ++
Sbjct: 256 ----KAFI----LKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQP 293
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 60/299 (20%), Positives = 106/299 (35%), Gaps = 81/299 (27%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
EV L ++H I++ G A+ + + + + GS+ ++++
Sbjct: 68 EVYSLPGMKHENILQFIG----------AEKRGTSVDVDLWLITAFHEKGSLSDFLKA-- 115
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSK----------HIMHRDIKSENILIDLERKKA 969
VS IA+ +A L LH I HRDIKS+N+L+
Sbjct: 116 ----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK-----N 166
Query: 970 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR-AMHKPNLYG 1028
+ + DF A+ + + VGT R+MAPEVL A++
Sbjct: 167 NL--TACIADFGLALKFEAGKSAGDTHGQ--------VGTRRYMAPEVLEGAINFQRDAF 216
Query: 1029 LEVDIWSYGCLLLELLTLQVPYMGL----------------SELEIHDLI-QMGKRPRLT 1071
L +D+++ G +L EL + G S ++ +++ KRP L
Sbjct: 217 LRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLR 276
Query: 1072 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130
D +H ++ L + C + + R +AG + E
Sbjct: 277 D------YWQKHAG----------------MAMLCETIEECWDHDAEARLSAGCVGERI 313
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-34
Identities = 64/281 (22%), Positives = 96/281 (34%), Gaps = 75/281 (26%)
Query: 856 SCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY 914
L EV + +H C V + W +G L + E G S++ +
Sbjct: 102 RKLAEVGSHEKVGQHPCCVRLEQA-----W---EEGG---ILY---LQTELC-GPSLQQH 146
Query: 915 IEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 974
E + +D AL LHS+ ++H D+K NI + G
Sbjct: 147 CEAWG----ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLG-----PRG--R 195
Query: 975 VKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 1034
KL DF V L + +V G PR+MAPE+L+ YG D++
Sbjct: 196 CKLGDFGLLVELGTAGAG-----------EVQEGDPRYMAPELLQ-----GSYGTAADVF 239
Query: 1035 SYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE 1093
S G +LE+ +++P+ G L Q P T L S
Sbjct: 240 SLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGL----S-------------- 278
Query: 1094 KPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM-FVAR 1133
E L V E +P R TA L + + +
Sbjct: 279 -SE--------LRSVLVMMLEPDPKLRATAEALLALPVLRQ 310
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-33
Identities = 44/228 (19%), Positives = 82/228 (35%), Gaps = 28/228 (12%)
Query: 857 CLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 916
E M H I+ + + + + +H + + + K G++ N IE
Sbjct: 73 AQREADMHRLFNHPNILRLVAYCLRER-------GAKHEAW---LLLPFFKRGTLWNEIE 122
Query: 917 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 976
+L + G ++ L++ + L +H+K HRD+K NIL+ +G
Sbjct: 123 RLKDKGN-FLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLG-----DEG--QPV 174
Query: 977 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL-YGLEVDIWS 1035
L D + A T + APE+ + + D+WS
Sbjct: 175 LMDLGSMNQACIHVEGSRQALTLQDWAAQR-CTISYRAPELFSV--QSHCVIDERTDVWS 231
Query: 1036 YGCLLLELLTLQVPYMGLSE-LEIHDLIQMGKR-----PRLTDELEAL 1077
GC+L ++ + PY + + + L + PR + L L
Sbjct: 232 LGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQL 279
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 49/288 (17%), Positives = 101/288 (35%), Gaps = 82/288 (28%)
Query: 856 SCLGEVRMLGALRHSC--IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKN 913
S E+ L L+ I+ +Y ++I+ +++ + ME + +
Sbjct: 72 SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI--------------YMVMECG-NIDLNS 116
Query: 914 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 973
+++K +K + +++ A+ +H I+H D+K N LI
Sbjct: 117 WLKK-----KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV--------DG 163
Query: 974 VVKLCDFDRAVPLRS-----FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM------- 1021
++KL DF A ++ + GT +M PE ++ M
Sbjct: 164 MLKLIDFGIANQMQPDTTSVVKDSQV-------------GTVNYMPPEAIKDMSSSRENG 210
Query: 1022 HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH 1081
+ + D+WS GC+L + + P+ + +++ L
Sbjct: 211 KSKSKISPKSDVWSLGCILYYMTYGKTPFQQ-----------------IINQISKL---- 249
Query: 1082 EHEVAQSGSGFEKPEAELETLSF-LVDVFRRCTEENPTERPTAGDLYE 1128
H + E P + L DV + C + +P +R + +L
Sbjct: 250 -HAIIDPNHEIEFP----DIPEKDLQDVLKCCLKRDPKQRISIPELLA 292
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 50/277 (18%), Positives = 90/277 (32%), Gaps = 37/277 (13%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
E +L L H IV+++ + + H +L ME+ GS+ +E+ S
Sbjct: 57 EFEVLKKLNHKNIVKLFAIE--------EETTTRHKVL----IMEFCPCGSLYTVLEEPS 104
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
+ L + +DV + L I+HR+IK NI+ DG+ V KL D
Sbjct: 105 NAYG--LPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRV---IGEDGQSVYKLTD 159
Query: 980 F--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL----YGLEVDI 1033
F R + + GT ++ P++ YG VD+
Sbjct: 160 FGAARELEDDEQFVSLY-------------GTEEYLHPDMYERAVLRKDHQKKYGATVDL 206
Query: 1034 WSYGCLLLELLTLQVPYMGLSELEIH-DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF 1092
WS G T +P+ + +++ + + + + + SG
Sbjct: 207 WSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMP 266
Query: 1093 EKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1129
L V E + + +
Sbjct: 267 VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-33
Identities = 49/288 (17%), Positives = 101/288 (35%), Gaps = 82/288 (28%)
Query: 856 SCLGEVRMLGALRHSC--IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKN 913
S E+ L L+ I+ +Y ++I+ +++ + ME + +
Sbjct: 53 SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI--------------YMVMECG-NIDLNS 97
Query: 914 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 973
+++K +K + +++ A+ +H I+H D+K N LI
Sbjct: 98 WLKK-----KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV--------DG 144
Query: 974 VVKLCDFDRAVPLRS-----FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM------- 1021
++KL DF A ++ + GT +M PE ++ M
Sbjct: 145 MLKLIDFGIANQMQPDTTSVVKDSQV-------------GTVNYMPPEAIKDMSSSRENG 191
Query: 1022 HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH 1081
+ + D+WS GC+L + + P+ + +++ L
Sbjct: 192 KSKSKISPKSDVWSLGCILYYMTYGKTPFQQ-----------------IINQISKL---- 230
Query: 1082 EHEVAQSGSGFEKPEAELETLSF-LVDVFRRCTEENPTERPTAGDLYE 1128
H + E P + L DV + C + +P +R + +L
Sbjct: 231 -HAIIDPNHEIEFP----DIPEKDLQDVLKCCLKRDPKQRISIPELLA 273
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 78/316 (24%), Positives = 115/316 (36%), Gaps = 79/316 (25%)
Query: 825 RCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG--HKISS 882
C A K L+ C +S DE+ E++ + H IV Y
Sbjct: 35 YCAPKKEKVAIKRINLEKCQTSMDELLK-------EIQAMSQCHHPNIVSYYTSFVVKDE 87
Query: 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG--------EKHVSVKLALFI 934
W + M+ + GGSV + I+ + G E ++ I
Sbjct: 88 LW----------------LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIAT-----I 126
Query: 935 AQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCC 994
++V L LH +HRD+K+ NIL+ DG V++ DF + L +
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLG-----EDGS--VQIADFGVSAFLATGGDITR 179
Query: 995 IAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLS 1054
R VGTP WMAPEV M + Y + DIWS+G +EL T PY
Sbjct: 180 NKVR-----KTFVGTPCWMAPEV---MEQVRGYDFKADIWSFGITAIELATGAAPYHKYP 231
Query: 1055 ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR---- 1110
+++ L P L E + E L FR
Sbjct: 232 PMKVLMLTLQNDPPSL----------------------ETGVQDKEMLKKYGKSFRKMIS 269
Query: 1111 RCTEENPTERPTAGDL 1126
C +++P +RPTA +L
Sbjct: 270 LCLQKDPEKRPTAAEL 285
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-33
Identities = 61/283 (21%), Positives = 97/283 (34%), Gaps = 49/283 (17%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
E+ +RH I+ AD Q + +Y + GS+ +Y++
Sbjct: 81 EIYQTVLMRHENILGFIA----------ADIKGTGSWTQLYLITDYHENGSLYDYLKS-- 128
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSK--------HIMHRDIKSENILIDLERKKADG 971
+ K L +A + L LH++ I HRD+KS+NIL+
Sbjct: 129 ----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK-------K 177
Query: 972 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL--YGL 1029
+ D AV S + I VGT R+M PEVL N +
Sbjct: 178 NGTCCIADLGLAVKFISDTNEVDIPPNTR------VGTKRYMPPEVLDESLNRNHFQSYI 231
Query: 1030 EVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG 1089
D++S+G +L E+ V + E ++ + P D E V
Sbjct: 232 MADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREI--------VCIKK 283
Query: 1090 S--GFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130
F + E L + + C NP R TA + +
Sbjct: 284 LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 8e-33
Identities = 48/288 (16%), Positives = 100/288 (34%), Gaps = 82/288 (28%)
Query: 856 SCLGEVRMLGALRHSC--IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKN 913
S E+ L L+ I+ +Y ++I+ +++ + ME + +
Sbjct: 100 SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI--------------YMVMECG-NIDLNS 144
Query: 914 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 973
+++K +K + +++ A+ +H I+H D+K N LI
Sbjct: 145 WLKK-----KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV--------DG 191
Query: 974 VVKLCDFDRAVPLRS-----FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM------- 1021
++KL DF A ++ + G +M PE ++ M
Sbjct: 192 MLKLIDFGIANQMQPDTTSVVKDSQV-------------GAVNYMPPEAIKDMSSSRENG 238
Query: 1022 HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH 1081
+ + D+WS GC+L + + P+ + +++ L
Sbjct: 239 KSKSKISPKSDVWSLGCILYYMTYGKTPFQQ-----------------IINQISKL---- 277
Query: 1082 EHEVAQSGSGFEKPEAELETLSF-LVDVFRRCTEENPTERPTAGDLYE 1128
H + E P + L DV + C + +P +R + +L
Sbjct: 278 -HAIIDPNHEIEFP----DIPEKDLQDVLKCCLKRDPKQRISIPELLA 320
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 3e-32
Identities = 50/277 (18%), Positives = 90/277 (32%), Gaps = 37/277 (13%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
E +L L H IV+++ + + H +L ME+ GS+ +E+ S
Sbjct: 57 EFEVLKKLNHKNIVKLFAIE--------EETTTRHKVL----IMEFCPCGSLYTVLEEPS 104
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
+ L + +DV + L I+HR+IK NI+ DG+ V KL D
Sbjct: 105 NAYG--LPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRV---IGEDGQSVYKLTD 159
Query: 980 F--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL----YGLEVDI 1033
F R + + GT ++ P++ YG VD+
Sbjct: 160 FGAARELEDDEQFVSLY-------------GTEEYLHPDMYERAVLRKDHQKKYGATVDL 206
Query: 1034 WSYGCLLLELLTLQVPYMGLSELEIH-DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF 1092
WS G T +P+ + +++ + + + + + SG
Sbjct: 207 WSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMP 266
Query: 1093 EKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1129
L V E + + +
Sbjct: 267 VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-32
Identities = 63/323 (19%), Positives = 102/323 (31%), Gaps = 59/323 (18%)
Query: 825 RCKFGSADAAAKVRTLKVC-GSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883
R K + L+ C ++ E+ + H IV I+
Sbjct: 47 RYKPTGEYVTVRRINLEACSNEMVTFLQG-------ELHVSKLFNHPNIVPYRATFIADN 99
Query: 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG--EKHVSVKLALFIAQDVAAA 941
L + ++ GS K+ I G E ++ +I Q V A
Sbjct: 100 EL--------------WVVTSFMAYGSAKDLICTHFMDGMNELAIA-----YILQGVLKA 140
Query: 942 LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIP 1001
L +H +HR +K+ +ILI DGK V L S +
Sbjct: 141 LDYIHHMGYVHRSVKASHILIS-----VDGK--VYLSGLRSN---LSMISHGQRQRVVHD 190
Query: 1002 APDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDL 1061
P V W++PEVL+ + Y + DI+S G EL VP+ + ++
Sbjct: 191 FPKYSVKVLPWLSPEVLQQNLQG--YDAKSDIYSVGITACELANGHVPFKDMPATQMLLE 248
Query: 1062 IQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLV--------------D 1107
G P L D ++S + ++ +
Sbjct: 249 KLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSP 308
Query: 1108 VFR----RCTEENPTERPTAGDL 1126
F +C + NP RP+A L
Sbjct: 309 HFHHFVEQCLQRNPDARPSASTL 331
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 6e-32
Identities = 66/299 (22%), Positives = 103/299 (34%), Gaps = 81/299 (27%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
E+ LRH I+ AD Q + +Y + GS+ +Y+ + +
Sbjct: 86 EIYQTVMLRHENILGFIA----------ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT 135
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKH--------IMHRDIKSENILIDLERKKADG 971
V+V+ + +A A+ L LH + I HRD+KS+NIL+
Sbjct: 136 ------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-------K 182
Query: 972 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR----AMHKPNLY 1027
+ D AV S T IA VGT R+MAPEVL H
Sbjct: 183 NGTCCIADLGLAVRHDSATDTIDIAPNHR------VGTKRYMAPEVLDDSINMKHFE--S 234
Query: 1028 GLEVDIWSYGCLLLELLTL----------QVPYMGL-----SELEIHDLI-QMGKRPRLT 1071
DI++ G + E+ Q+PY L S E+ ++ + RP +
Sbjct: 235 FKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIP 294
Query: 1072 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130
+ + E L + + R C N R TA + +
Sbjct: 295 NRWQ----------------------SCEALRVMAKIMRECWYANGAARLTALRIKKTL 331
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-30
Identities = 51/301 (16%), Positives = 97/301 (32%), Gaps = 76/301 (25%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
+ + + H I + ++ + MEY GS+ Y+
Sbjct: 57 NIYRVPLMEHDNIARFIV---------GDERVTADGRMEYLLVMEYYPNGSLXKYLSL-- 105
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKH---------IMHRDIKSENILIDLERKKAD 970
+ +A V L LH++ I HRD+ S N+L+ D
Sbjct: 106 ----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK-----ND 156
Query: 971 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR---AMHKPNLY 1027
G + DF ++ L +V GT R+MAPEVL +
Sbjct: 157 G--TCVISDFGLSMRLTGNRLVRPGEEDNAAISEV--GTIRYMAPEVLEGAVNLRDXESA 212
Query: 1028 GLEVDIWSYGCLLLELLT-------------LQVPYMGL-----SELEIHDLI-QMGKRP 1068
+VD+++ G + E+ Q+ + + ++ L+ + +RP
Sbjct: 213 LKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRP 272
Query: 1069 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1128
+ + + E+ +A + L + C +++ R TA E
Sbjct: 273 KFPE------AWKENSLA---------------VRSLKETIEDCWDQDAEARLTAQXAEE 311
Query: 1129 M 1129
Sbjct: 312 R 312
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 70/270 (25%), Positives = 107/270 (39%), Gaps = 72/270 (26%)
Query: 860 EVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 917
E+ ++ ++ IV W + MEY+ GGS+ + + +
Sbjct: 67 EILVMRENKNPNIVNYLDSYLVGDELW----------------VVMEYLAGGSLTDVVTE 110
Query: 918 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 977
+ E ++ + ++ AL LHS ++HRDIKS+NIL+ DG VKL
Sbjct: 111 -TCMDEGQIAA-----VCRECLQALEFLHSNQVIHRDIKSDNILLG-----MDGS--VKL 157
Query: 978 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1037
DF + T + R VGTP WMAPEV+ YG +VDIWS G
Sbjct: 158 TDFGFCAQI-----TPEQSKR-----STMVGTPYWMAPEVV----TRKAYGPKVDIWSLG 203
Query: 1038 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 1097
+ +E++ + PY+ + L LI P L +
Sbjct: 204 IMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP------------------------ 239
Query: 1098 ELETLS-FLVDVFRRCTEENPTERPTAGDL 1126
E LS D RC E + +R +A +L
Sbjct: 240 --EKLSAIFRDFLNRCLEMDVEKRGSAKEL 267
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-30
Identities = 69/270 (25%), Positives = 115/270 (42%), Gaps = 72/270 (26%)
Query: 860 EVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 917
EV ++ +H +VEMY W + ME+++GG++ + + +
Sbjct: 92 EVVIMRDYQHFNVVEMYKSYLVGEELW----------------VLMEFLQGGALTDIVSQ 135
Query: 918 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 977
+ E+ ++ + + V AL LH++ ++HRDIKS++IL+ L DG+ VKL
Sbjct: 136 VRLN-EEQIAT-----VCEAVLQALAYLHAQGVIHRDIKSDSILLTL-----DGR--VKL 182
Query: 978 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1037
DF + + + R VGTP WMAPEV+ Y EVDIWS G
Sbjct: 183 SDFGFCAQI-----SKDVPKR-----KSLVGTPYWMAPEVISRSL----YATEVDIWSLG 228
Query: 1038 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 1097
+++E++ + PY S ++ ++ P+L +
Sbjct: 229 IMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNS------------------------ 264
Query: 1098 ELETLS-FLVDVFRRCTEENPTERPTAGDL 1126
+S L D R +P ER TA +L
Sbjct: 265 --HKVSPVLRDFLERMLVRDPQERATAQEL 292
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 7e-30
Identities = 78/311 (25%), Positives = 121/311 (38%), Gaps = 80/311 (25%)
Query: 833 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG--HKISSKWLPSADG 890
A K+ L+ ++I+ E+ +L + + YG K + W
Sbjct: 50 VAIKIIDLEEAEDEIEDIQQ-------EITVLSQCDSPYVTKYYGSYLKDTKLW------ 96
Query: 891 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHI 950
I MEY+ GGS + + + E ++ I +++ L LHS+
Sbjct: 97 ----------IIMEYLGGGSALD-LLEPGPLDETQIAT-----ILREILKGLDYLHSEKK 140
Query: 951 MHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP 1010
+HRDIK+ N+L+ G+ VKL DF A L T R + VGTP
Sbjct: 141 IHRDIKAANVLLS-----EHGE--VKLADFGVAGQL-----TDTQIKR-----NTFVGTP 183
Query: 1011 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL 1070
WMAPEV+ K + Y + DIWS G +EL + P+ L +++ LI P L
Sbjct: 184 FWMAPEVI----KQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTL 239
Query: 1071 TDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM- 1129
+ KP L + C + P+ RPTA +L +
Sbjct: 240 EGN------------------YSKP---------LKEFVEACLNKEPSFRPTAKELLKHK 272
Query: 1130 FVARTSSSISS 1140
F+ R + S
Sbjct: 273 FILRNAKKTSY 283
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 8e-30
Identities = 65/291 (22%), Positives = 106/291 (36%), Gaps = 64/291 (21%)
Query: 840 LKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHHLLQ 898
+KV + DE + E+ ML H I YG ++ + L
Sbjct: 54 IKVMDVTGDEEEEIKQ----EINMLKKYSHHRNIATYYGA-----FIKKNPPGMDDQLW- 103
Query: 899 SAIFMEYVKGGSVKNYIEKLSETG--EKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
+ ME+ GSV + I+ E+ ++ +I +++ L LH ++HRDIK
Sbjct: 104 --LVMEFCGAGSVTDLIKNTKGNTLKEEWIA-----YICREILRGLSHLHQHKVIHRDIK 156
Query: 957 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1016
+N+L+ + + VKL DF + L + R + +GTP WMAPE
Sbjct: 157 GQNVLLT-----ENAE--VKLVDFGVSAQL-----DRTVGRR-----NTFIGTPYWMAPE 199
Query: 1017 VLRAMHKPNL-YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELE 1075
V+ P+ Y + D+WS G +E+ P + + LI PRL
Sbjct: 200 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL----- 254
Query: 1076 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1126
+ K C +N ++RP L
Sbjct: 255 ------------KSKKWSKK---------FQSFIESCLVKNHSQRPATEQL 284
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-29
Identities = 73/298 (24%), Positives = 117/298 (39%), Gaps = 75/298 (25%)
Query: 833 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG--HKISSKWLPSADG 890
AAAKV K S +E+ ++ E+ +L H IV++ G + W
Sbjct: 47 AAAKVIETK----SEEELEDYI----VEIEILATCDHPYIVKLLGAYYHDGKLW------ 92
Query: 891 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-GEKHVSVKLALFIAQDVAAALVELHSKH 949
I +E+ GG+V + +L E + + + + AL LHSK
Sbjct: 93 ----------IMIEFCPGGAVDAIMLELDRGLTEPQIQ-----VVCRQMLEALNFLHSKR 137
Query: 950 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 1009
I+HRD+K+ N+L+ +G ++L DF + L R D +GT
Sbjct: 138 IIHRDLKAGNVLMT-----LEGD--IRLADFGVSAKNLKTL-----QKR-----DSFIGT 180
Query: 1010 PRWMAPEV-LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRP 1068
P WMAPEV + K Y + DIWS G L+E+ ++ P+ L+ + + I P
Sbjct: 181 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPP 240
Query: 1069 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1126
L + S + D + ++NP RP+A L
Sbjct: 241 TL----------------LTPSKWSVE---------FRDFLKIALDKNPETRPSAAQL 273
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-29
Identities = 49/210 (23%), Positives = 85/210 (40%), Gaps = 48/210 (22%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 917
EV + LRH I+ +YG+ + ++ +EY G+V ++K
Sbjct: 59 EVEIQSHLRHPNILRLYGYFHDAT----------------RVYLILEYAPLGTVYRELQK 102
Query: 918 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 977
+ ++A AL HSK ++HRDIK EN+L+ + G+ +K+
Sbjct: 103 -----LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG-----SAGE--LKI 150
Query: 978 CDFDRAVPLRS-FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1036
DF +V S C GT ++ PE++ ++ +VD+WS
Sbjct: 151 ADFGWSVHAPSSRRTDLC-------------GTLDYLPPEMIEG----RMHDEKVDLWSL 193
Query: 1037 GCLLLELLTLQVPYMGLSELEIHDLIQMGK 1066
G L E L + P+ + E + I +
Sbjct: 194 GVLCYEFLVGKPPFEANTYQETYKRISRVE 223
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 68/271 (25%), Positives = 100/271 (36%), Gaps = 72/271 (26%)
Query: 860 EVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 917
E+ ++ +V+ YG K + W I MEY GSV + I
Sbjct: 74 EISIMQQCDSPHVVKYYGSYFKNTDLW----------------IVMEYCGAGSVSDIIRL 117
Query: 918 LSET-GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 976
++T E ++ I Q L LH +HRDIK+ NIL++ +G K
Sbjct: 118 RNKTLTEDEIAT-----ILQSTLKGLEYLHFMRKIHRDIKAGNILLN-----TEGH--AK 165
Query: 977 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1036
L DF A L T +A R + +GTP WMAPEV+ + Y DIWS
Sbjct: 166 LADFGVAGQL-----TDTMAKR-----NTVIGTPFWMAPEVI----QEIGYNCVADIWSL 211
Query: 1037 GCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE 1096
G +E+ + PY + + +I P
Sbjct: 212 GITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKP----------------------- 248
Query: 1097 AELETLS-FLVDVFRRCTEENPTERPTAGDL 1126
E S D ++C ++P +R TA L
Sbjct: 249 ---ELWSDNFTDFVKQCLVKSPEQRATATQL 276
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-28
Identities = 54/274 (19%), Positives = 107/274 (39%), Gaps = 55/274 (20%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 917
E++++ +++ + G I++ ++ EY++ S+ + E
Sbjct: 93 ELQIITDIKNEYCLTCEGI-ITNY---------------DEVYIIYEYMENDSILKFDEY 136
Query: 918 ---LSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILIDLERKKADGKP 973
L + + +++ I + V + +H+ K+I HRD+K NIL+D +G+
Sbjct: 137 FFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD-----KNGR- 190
Query: 974 VVKLCDFDRAVPLR-SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 1032
VKL DF + + + GT +M PE ++ + G +VD
Sbjct: 191 -VKLSDFGESEYMVDKKIKGSR-------------GTYEFMPPEFF--SNESSYNGAKVD 234
Query: 1033 IWSYGCLLLELLTLQVPYMG-LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSG 1091
IWS G L + VP+ +S +E+ + I+ + ++ + +
Sbjct: 235 IWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKN-IEYPLDRNHFLYPLTNKKSTCSNN 293
Query: 1092 FEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1125
F E D + +NP ER T+ D
Sbjct: 294 FLSNEDI--------DFLKLFLRKNPAERITSED 319
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 1e-28
Identities = 33/303 (10%), Positives = 69/303 (22%), Gaps = 56/303 (18%)
Query: 840 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH----------KISSKWLPSAD 889
LKV A+ R+ L E + S+ +
Sbjct: 92 LKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQL 151
Query: 890 GNPEHHLLQSAIF--MEYVKGGSVKNYIEKLSETGEKH--VSVKLALFIAQDVAAALVEL 945
+ + M ++ L + + + L
Sbjct: 152 SPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANL 210
Query: 946 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV 1005
SK ++H +N+ I DG+ + L D + +
Sbjct: 211 QSKGLVHGHFTPDNLFIM-----PDGR--LMLGDVSALWKVGTRGPASS----------- 252
Query: 1006 CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMG 1065
+ E L + ++ W G + + L +P+ ++ +
Sbjct: 253 --VPVTYAPREFLN--ASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPS 308
Query: 1066 KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1125
R TD L + + + R + R +
Sbjct: 309 LRVPGTDSLAFGSCTPLPDFVK-------------------TLIGRFLNFDRRRRLLPLE 349
Query: 1126 LYE 1128
E
Sbjct: 350 AME 352
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-28
Identities = 51/219 (23%), Positives = 84/219 (38%), Gaps = 29/219 (13%)
Query: 67 DNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSP 126
D L L L+ +P+ L +L N + P +L L + +
Sbjct: 70 DRQAHELELNNLGLSSLPELPP---HLESLVASCNSLTELPELPQSLKSLLVDNNNLKA- 125
Query: 127 GVNGFALNKL-KGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGC 185
L+ L L+ L +S L L E+ L + V + S++ LP
Sbjct: 126 ------LSDLPPLLEYLGVSNNQ-----LEKLPELQNSSFLKIIDVDNNSLKKLPDLPP- 173
Query: 186 LSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRL 245
+LE + N+++ LP E+ L L ++ NN L +LP L LE++ NN L
Sbjct: 174 --SLEFIAAGNNQLEELP-ELQNLPFLTAIYADNNSLKKLPD---LPLSLESIVAGNNIL 227
Query: 246 TSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLE 284
L +L + L + N L + +P +LE
Sbjct: 228 EELP--ELQNLPFLTTIYADNNLLKT---LPDLP-PSLE 260
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-24
Identities = 49/234 (20%), Positives = 83/234 (35%), Gaps = 41/234 (17%)
Query: 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPG 127
+E L + N L +P + L+ + N + P +L + ++
Sbjct: 131 PLLEYLGVSNNQLEKLP-ELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEEL- 188
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLTLLSEI-AGLKCLTKLSVCHFSIRYLPPEIGCL 186
L L L + L ++ L + + + LP E+ L
Sbjct: 189 ---PELQNLPFLTAIYADN--------NSLKKLPDLPLSLESIVAGNNILEELP-ELQNL 236
Query: 187 SNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLT 246
L + N +K LP L+ +L V +N L +LP L Q L LD+S N +
Sbjct: 237 PFLTTIYADNNLLKTLPDLPPSLE---ALNVRDNYLTDLPE---LPQSLTFLDVSENIFS 290
Query: 247 -------SLGSLDLC---------LMHNLQNLNLQYNKLLSYCQVPSWICCNLE 284
+L L+ L +L+ LN+ NKL+ +P+ LE
Sbjct: 291 GLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE---LPALP-PRLE 340
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-24
Identities = 41/233 (17%), Positives = 76/233 (32%), Gaps = 29/233 (12%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFA 132
+Y N+L +P L L N + P +L L+ + S
Sbjct: 242 IYADNNLLKTLPDLPP---SLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPN 298
Query: 133 LNKLKGLKELELSKVPPRPSVLT-------LLSEI-AGLKCLTKLSVCHFSIRYLPPEIG 184
L L E+ + P L L E+ A L +L + +P
Sbjct: 299 LYYLN-ASSNEIRSLCDLPPSLEELNVSNNKLIELPALPPRLERLIASFNHLAEVPELPQ 357
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNR 244
NL+QL + +N ++ P ++ L N+ L E+P L Q L+ L + N
Sbjct: 358 ---NLKQLHVEYNPLREFPDIPESVEDLRM----NSHLAEVPE---LPQNLKQLHVETNP 407
Query: 245 LTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFIS 297
L + ++++L + +++ + + D
Sbjct: 408 LREFPDI----PESVEDLRMNSERVV---DPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-22
Identities = 39/199 (19%), Positives = 66/199 (33%), Gaps = 31/199 (15%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEI-NLFPSEVGNLLGLECLQIKISSPGVNGF 131
+ + L +P + +E P G + +++
Sbjct: 16 PLRHSSNLTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRD-------- 67
Query: 132 ALNKLKGLKELELSKVPPRPSVLTLLSEI-AGLKCLTKLSVCHFSIRYLPPEIGCLSNLE 190
+ ELEL+ LS + L L S+ LP L +L
Sbjct: 68 --CLDRQAHELELNN--------LGLSSLPELPPHLESLVASCNSLTELPELPQSLKSLL 117
Query: 191 QLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGS 250
+ + + LP L L V+NN+L +LP L L+ +D+ NN L L
Sbjct: 118 VDNNNLKALSDLP------PLLEYLGVSNNQLEKLPE-LQNSSFLKIIDVDNNSLKKLPD 170
Query: 251 LDLCLMHNLQNLNLQYNKL 269
L +L+ + N+L
Sbjct: 171 ----LPPSLEFIAAGNNQL 185
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 3e-16
Identities = 38/208 (18%), Positives = 73/208 (35%), Gaps = 42/208 (20%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGV 128
S+E L + N L +P+ L L N + NL L +I S
Sbjct: 258 SLEALNVRDNYLTDLPELPQ---SLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSL-- 312
Query: 129 NGFALNKLKGLKELELS-----KVPPRPSVLT-------LLSEI-AGLKCLTKLSVCHFS 175
+ L+EL +S ++P P L L+E+ + L +L V +
Sbjct: 313 ----CDLPPSLEELNVSNNKLIELPALPPRLERLIASFNHLAEVPELPQNLKQLHVEYNP 368
Query: 176 IRYLPPEIGCL----------------SNLEQLDLSFNKMKYLPTEICYLKALISLKVAN 219
+R P + NL+QL + N ++ P ++ L++ +
Sbjct: 369 LREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLREFPDIPESVE---DLRMNS 425
Query: 220 NKLVELPSGLY-LLQRLENLDLSNNRLT 246
++V+ + +LE+ ++
Sbjct: 426 ERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-10
Identities = 20/106 (18%), Positives = 40/106 (37%), Gaps = 18/106 (16%)
Query: 178 YLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLV-ELPSGLY------ 230
++ P + L++ + + +P E +K+ A ++ P G
Sbjct: 2 FINPRNVSNTFLQEPLRHSSNLTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 231 -------LLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L ++ L+L+N L+SL L +L++L N L
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLSSLPE----LPPHLESLVASCNSL 103
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-28
Identities = 69/303 (22%), Positives = 111/303 (36%), Gaps = 74/303 (24%)
Query: 860 EVRMLGALRHSCIVEMYG-----HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY 914
E+++L IV YG +IS I ME++ GGS+
Sbjct: 81 ELQVLHECNSPYIVGFYGAFYSDGEIS-------------------ICMEHMDGGSLDQV 121
Query: 915 IEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSENILIDLERKKADGKP 973
++K E+ + ++ V L L KH IMHRD+K NIL++ +
Sbjct: 122 LKKAGRIPEQILGK-----VSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE------ 170
Query: 974 VVKLCDFDRAVPL-RSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 1032
+KLCDF + L S ++ VGT +M+PE L + Y ++ D
Sbjct: 171 -IKLCDFGVSGQLIDSMANS-------------FVGTRSYMSPERL----QGTHYSVQSD 212
Query: 1033 IWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF 1092
IWS G L+E+ + P E+ + + + + + G
Sbjct: 213 IWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT-PGRPLNKFGMDS 271
Query: 1093 EKPEAELETLSFLV-----------------DVFRRCTEENPTERPTAGDLYEM-FVART 1134
P A E L ++V D +C +NP ER L F+ R+
Sbjct: 272 RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331
Query: 1135 SSS 1137
+
Sbjct: 332 DAE 334
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 7e-28
Identities = 59/276 (21%), Positives = 96/276 (34%), Gaps = 56/276 (20%)
Query: 860 EVRMLGALR-HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKL 918
EV + L H IV+ K + L + E KG V +++K+
Sbjct: 75 EVCFMKKLSGHPNIVQFCSAASIGK---EESDTGQAEFL---LLTELCKGQLV-EFLKKM 127
Query: 919 SETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENILIDLERKKADGKPVVK 976
G +S L I A+ +H + I+HRD+K EN+L+ G +K
Sbjct: 128 ESRG--PLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS-----NQG--TIK 178
Query: 977 LCDFDRAVPLRSFLHTCCIAHRGIPAPDV--CVGTPRWMAPEVLRAM-HKPNLYGLEVDI 1033
LCDF A + + A R + TP + PE++ + P G + DI
Sbjct: 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFP--IGEKQDI 236
Query: 1034 WSYGCLLLELLTLQVPYMGLSELEI-HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF 1092
W+ GC+L L Q P+ ++L I + + +L
Sbjct: 237 WALGCILYLLCFRQHPFEDGAKLRIVNGKYSIPPHDTQYTVFHSL--------------- 281
Query: 1093 EKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1128
R + NP ER + ++
Sbjct: 282 ----------------IRAMLQVNPEERLSIAEVVH 301
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-28
Identities = 46/210 (21%), Positives = 78/210 (37%), Gaps = 48/210 (22%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 917
E+ + LRH I+ MY + + I+ +E+ G + ++K
Sbjct: 64 EIEIQSHLRHPNILRMYNY-FHDR---------------KRIYLMLEFAPRGELYKELQK 107
Query: 918 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 977
+ + +++A AL H + ++HRDIK EN+L+ G +K+
Sbjct: 108 -----HGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMG-----YKG--ELKI 155
Query: 978 CDFDRAV-PLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1036
DF +V T C GT ++ PE++ + +VD+W
Sbjct: 156 ADFGWSVHAPSLRRRTMC-------------GTLDYLPPEMIEG----KTHDEKVDLWCA 198
Query: 1037 GCLLLELLTLQVPYMGLSELEIHDLIQMGK 1066
G L E L P+ S E H I
Sbjct: 199 GVLCYEFLVGMPPFDSPSHTETHRRIVNVD 228
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-27
Identities = 66/295 (22%), Positives = 108/295 (36%), Gaps = 70/295 (23%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
V++ + D F L E R+L H IV + G + ++ P +
Sbjct: 144 VKSCR-ETLPPDLKAKF----LQEARILKQYSHPNIVRLIG--VCTQKQP---------I 187
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
I ME V+GG ++ + VK L + D AA + L SK +HRD+
Sbjct: 188 Y---IVMELVQGGDFLTFLRT----EGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLA 240
Query: 957 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1016
+ N L+ + V+K+ DF + ++ R +P +W APE
Sbjct: 241 ARNCLVTEKN-------VLKISDFGMSREEADGVYAASGGLRQVPV--------KWTAPE 285
Query: 1017 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELE 1075
L Y E D+WS+G LL E +L PY LS + + ++ G R L
Sbjct: 286 ALNY----GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGR------LP 335
Query: 1076 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130
C + + + +C P +RP+ +Y+
Sbjct: 336 CPELCPDA---------------------VFRLMEQCWAYEPGQRPSFSTIYQEL 369
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-27
Identities = 28/218 (12%), Positives = 76/218 (34%), Gaps = 27/218 (12%)
Query: 71 EGLYLYKNVLN-LIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI-------K 122
Y+ + E + + + NL L +++ K
Sbjct: 209 RQFYMGNSPFVAENICEAWENENSEYAQQYKT----EDLKWDNLKDLTDVEVYNCPNLTK 264
Query: 123 ISSPGVNGFALNKLKGLKELELS-----KVPPRPSVLTLLSEIAGLKCLTKLSV--CHFS 175
+ + L L ++ + ++ L++ + + + + +
Sbjct: 265 LPT------FLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK 318
Query: 176 IRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGL-YLLQR 234
+ + + L L+ +N+++ L SL +A N++ E+P+ ++
Sbjct: 319 TFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQ 378
Query: 235 LENLDLSNNRLTSL-GSLDLCLMHNLQNLNLQYNKLLS 271
+ENL ++N+L + D + + ++ YN++ S
Sbjct: 379 VENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGS 416
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-25
Identities = 43/241 (17%), Positives = 76/241 (31%), Gaps = 37/241 (15%)
Query: 68 NSVEGLYLYKNVLNLIPK--SVGRYEKLRNLKFFGNEINLF--------PSEVGNLLGLE 117
VE L N L IP + + F NEI + +
Sbjct: 377 EQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVS 436
Query: 118 CL-----QIKISSPGVNGFALNKLKGLKELELS----KVPPRPSVLTLLSEIAGLKCLTK 168
+ QI + + L + L P+ S+ LT
Sbjct: 437 SINLSNNQISKFPKEL----FSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTS 492
Query: 169 LSVCHFSIRYLPPEI--GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLV--- 223
+ + + L + L L +DLS+N PT+ L + N +
Sbjct: 493 IDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQRDAQGN 552
Query: 224 ----ELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWI 279
E P G+ L L L + +N + ++ + N+ L+++ N +S S++
Sbjct: 553 RTLREWPEGITLCPSLTQLQIGSNDIR---KVNEKITPNISVLDIKDNPNISI--DLSYV 607
Query: 280 C 280
C
Sbjct: 608 C 608
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-25
Identities = 37/235 (15%), Positives = 75/235 (31%), Gaps = 38/235 (16%)
Query: 69 SVEGLYLYKNVLNL-IPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KIS 124
+ + + I KS K + N I V L L +
Sbjct: 160 DLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFV 219
Query: 125 SPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS-IRYLPPEI 183
N + + + + K + LK LT + V + + LP +
Sbjct: 220 --AENICEAWENENSEYAQQYKTED--------LKWDNLKDLTDVEVYNCPNLTKLPTFL 269
Query: 184 GCLSNLEQLDLSFNKMKYLP---------TEICYLKALISLKVANNKLVEL--PSGLYLL 232
L ++ ++++ N+ + + + + + N L + L +
Sbjct: 270 KALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKM 329
Query: 233 QRLENLDLSNNRLT----SLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNL 283
++L L+ N+L + GS L +LNL YN++ +P+ C
Sbjct: 330 KKLGMLECLYNQLEGKLPAFGSE-----IKLASLNLAYNQITE---IPANFCGFT 376
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-21
Identities = 31/239 (12%), Positives = 77/239 (32%), Gaps = 46/239 (19%)
Query: 75 LYKNVLNLIPKSVGRYEKLRNLKFFGNEINL---FPSEVGNLLGLECLQI---------K 122
Y + L +++ + P+ + L ++ + + +
Sbjct: 233 EYAQQYKTEDLKWDNLKDLTDVEVYNC--PNLTKLPTFLKALPEMQLINVACNRGISGEQ 290
Query: 123 ISSPGVNGFALNKLKGLKELELSK-----VPPRPSV-----LTLLS-----------EIA 161
+ + ++ + + P S+ L +L
Sbjct: 291 LKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFG 350
Query: 162 GLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLP--TEICYLKALISLKVA 218
L L++ + I +P G +E L + NK+KY+P + + + ++ +
Sbjct: 351 SEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFS 410
Query: 219 NNKL--------VELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
N++ L + + +++LSNN+++ L ++NL N L
Sbjct: 411 YNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNML 469
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 5e-20
Identities = 33/213 (15%), Positives = 71/213 (33%), Gaps = 30/213 (14%)
Query: 78 NVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEV-GNLLGLECLQI---KISSPGVNGF-- 131
+ + + + + ++ N+I+ FP E+ L + + ++ N
Sbjct: 420 KNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKD 479
Query: 132 ---ALNKLKGLKELELS-----KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEI 183
L ++L K+ TL L + LS FS P +
Sbjct: 480 ENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPY----LVGID-LSYNSFS--KFPTQP 532
Query: 184 GCLSNLEQLDLSFNK-------MKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLE 236
S L+ + + ++ P I +L L++ +N + ++ + +
Sbjct: 533 LNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKI--TPNIS 590
Query: 237 NLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
LD+ +N S+ +C L Y+K
Sbjct: 591 VLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKT 623
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 8e-16
Identities = 31/203 (15%), Positives = 63/203 (31%), Gaps = 25/203 (12%)
Query: 69 SVEGLYLYKNVLN-LIPKSVGRYEKLRNLKFFGNEI--------NLFPSEVGNLLGLECL 119
+V + L N ++ + L ++ GN + N L +
Sbjct: 434 NVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSI 493
Query: 120 QI---KISS-PGVNGFALNKLKGLKELELS-----KVPPRPSVLTLLSEIAGLKCLTKLS 170
+ K++ + F L L ++LS K P +P + L
Sbjct: 494 DLRFNKLTKLS--DDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQR-DAQ 550
Query: 171 VCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELP-SGL 229
R P I +L QL + N ++ + +I + L + +N + + S +
Sbjct: 551 GNRTL-REWPEGITLCPSLTQLQIGSNDIRKVNEKI--TPNISVLDIKDNPNISIDLSYV 607
Query: 230 YLLQRLENLDLSNNRLTSLGSLD 252
L ++ + D
Sbjct: 608 CPYIEAGMYMLFYDKTQDIRGCD 630
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 3e-12
Identities = 25/247 (10%), Positives = 65/247 (26%), Gaps = 75/247 (30%)
Query: 65 GGDNSVEGLYLYKNVLN-LIPKSVGRYEKLRNL-----KFFGNEINLFPSEVGNLLGLEC 118
+ V GL L + +P ++G+ +L L NE P + + E
Sbjct: 78 NSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ 137
Query: 119 LQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRY 178
Q + + + S + + S+ +
Sbjct: 138 KQK-----MRMHYQKTFVDYDPREDFSDL----IKDCINSD--------------PQQKS 174
Query: 179 LPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENL 238
+ Q+ +N + + + L +L
Sbjct: 175 IKKSSRITLKDTQIGQL-----------------------SNNITFVSKAVMRLTKLRQF 211
Query: 239 DLSNNRLTS-----------------LGSLDLCL--MHNLQNLNLQYNKLLSYCQVPSWI 279
+ N+ + + DL + +L ++ + L+ ++P+++
Sbjct: 212 YMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLT--KLPTFL 269
Query: 280 --CCNLE 284
++
Sbjct: 270 KALPEMQ 276
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 6e-12
Identities = 28/192 (14%), Positives = 59/192 (30%), Gaps = 32/192 (16%)
Query: 124 SSPGVNGFALNKLKGLKELELS------KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIR 177
+ PGV +LN + L L +VP I L L L++ +
Sbjct: 71 AQPGV---SLNSNGRVTGLSLEGFGASGRVPD---------AIGQLTELEVLALGSHGEK 118
Query: 178 -----YLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKL------VELP 226
+ P I + EQ Y T + Y + + + +
Sbjct: 119 VNERLFGPKGISANMSDEQKQKMRMH--YQKTFVDYDPREDFSDLIKDCINSDPQQKSIK 176
Query: 227 SGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGN 286
+ + + +N +T + S + + L+ + + ++ +W N E
Sbjct: 177 KSSRITLKDTQIGQLSNNITFV-SKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYA 235
Query: 287 GKDSSNDDFISS 298
+ + D +
Sbjct: 236 QQYKTEDLKWDN 247
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-27
Identities = 32/200 (16%), Positives = 66/200 (33%), Gaps = 40/200 (20%)
Query: 855 YSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY 914
Y + L ++ Y + S + E G++ N
Sbjct: 112 YIGTQLMERLKPSMQHMFMKFYSAHLFQN--------------GSVLVGELYSYGTLLNA 157
Query: 915 IEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI----DLERKKAD 970
I T EK + L + A + + ++H I+H DIK +N ++ + + D
Sbjct: 158 INLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDD 217
Query: 971 GKPVVKLCDFDRAVPLRSF-----LHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 1025
+ L D +++ ++ F C T + E+L +KP
Sbjct: 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKC-------------ETSGFQCVEMLS--NKP- 261
Query: 1026 LYGLEVDIWSYGCLLLELLT 1045
+ ++D + + +L
Sbjct: 262 -WNYQIDYFGVAATVYCMLF 280
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-27
Identities = 34/210 (16%), Positives = 72/210 (34%), Gaps = 21/210 (10%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFA 132
+ N + I K++ R KL+ + F + V + + + +
Sbjct: 430 IGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEEL---S 486
Query: 133 LNKLKGLKELELSKVPPRPSVLTLL-SEIAGLKCLTKLSVCH----------FSIRYLPP 181
+ LK L ++EL +T L + L L L++ L
Sbjct: 487 WSNLKDLTDVELY----NCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLAD 542
Query: 182 EIGCLSNLEQLDLSFNKMKYLPTE--ICYLKALISLKVANNKLVELPSGLYLLQRLENLD 239
+ ++ + +N ++ P + + L L +NK+ L + +L +L
Sbjct: 543 DEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRHLEA-FGTNVKLTDLK 601
Query: 240 LSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L N++ + ++ L +NKL
Sbjct: 602 LDYNQIEEIPEDFCAFTDQVEGLGFSHNKL 631
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-25
Identities = 38/239 (15%), Positives = 75/239 (31%), Gaps = 36/239 (15%)
Query: 73 LYLY-KNVLNLIPKSVGRYEKLRNLKFFGNEI----------NLFPSEVGNLLGLECLQI 121
+ LY + +P + +L++L N + ++ +
Sbjct: 496 VELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYM 555
Query: 122 ---KISSPGVNGFALNKLKGLKELELS--KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSI 176
+ + L K+ L L+ K + L LT L + + I
Sbjct: 556 GYNNLEEFPASAS-LQKMVKLGLLDCVHNK-------VRHLEAFGTNVKLTDLKLDYNQI 607
Query: 177 RYLPPEIG-CLSNLEQLDLSFNKMKYLP--TEICYLKALISLKVANNKLVELPSGL---- 229
+P + +E L S NK+KY+P + + S+ + NK+ +
Sbjct: 608 EEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSM 667
Query: 230 --YLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGN 286
Y + LS N + + + + L N + S +P +GN
Sbjct: 668 DDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTS---IPENSLKPKDGN 723
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 6e-24
Identities = 38/242 (15%), Positives = 75/242 (30%), Gaps = 41/242 (16%)
Query: 73 LYLYKNVLNLIPKSVGRY-EKLRNLKFFGNEINLFPS--EVGNLLGLECLQI---KISSP 126
L L N + IP+ + +++ L F N++ P+ ++ + + KI S
Sbjct: 600 LKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSE 659
Query: 127 GVNGFALNKLKGLKELE--------LSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRY 178
G N + K P A ++ + + + +
Sbjct: 660 GRNISCSMDDYKGINASTVTLSYNEIQKFPT--------ELFATGSPISTIILSNNLMTS 711
Query: 179 LPPE--------IGCLSNLEQLDLSFNKMKYLPTEI--CYLKALISLKVANNKLVELPSG 228
+P L +DL FNK+ L + L L ++ V+ N P+
Sbjct: 712 IPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSSFPTQ 771
Query: 229 LYLLQRLENLDLSNNRLTS----LGSL--DLCLMHNLQNLNLQYNKLLSYCQVPSWICCN 282
+L+ + + R L + +L L + N + V +
Sbjct: 772 PLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK---VDEKLTPQ 828
Query: 283 LE 284
L
Sbjct: 829 LY 830
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 3e-21
Identities = 45/264 (17%), Positives = 82/264 (31%), Gaps = 55/264 (20%)
Query: 68 NSVEGLYLYKNVLNLIPK--SVGRYEKLRNLKFFGNEINLFPSEVG------NLLGLECL 119
+ VEGL N L IP + + ++ F N+I + + +
Sbjct: 619 DQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTV 678
Query: 120 QI---KISSPGVNGFAL-----------NKLKGLKELELSKVPPRPSVLTLLSE------ 159
+ +I FA N + + E L LL+
Sbjct: 679 TLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFN 738
Query: 160 ----------IAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKM-------KYL 202
L L+ + V + P + S L+ + + +
Sbjct: 739 KLTSLSDDFRATTLPYLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQW 798
Query: 203 PTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNL 262
PT I +LI L++ +N + ++ L +L LD+++N S+ +C
Sbjct: 799 PTGITTCPSLIQLQIGSNDIRKVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMY 856
Query: 263 NLQYNKLLSYCQVPSWIC-CNLEG 285
L Y+K I C+ G
Sbjct: 857 VLLYDKT-------QDIRGCDALG 873
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 4e-20
Identities = 32/218 (14%), Positives = 74/218 (33%), Gaps = 19/218 (8%)
Query: 65 GGDNSVEGLYLYKNVL-NLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNL---LGLECLQ 120
+ V GL L +P ++G+ +L+ L F + + G+ + +
Sbjct: 320 DNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEER 379
Query: 121 IKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLT-------KLSVCH 173
L+ + L +L + + E+ +K + ++
Sbjct: 380 KHRIRMHYKKMFLDYDQRLNLSDLLQ-----DAINRNPEMKPIKKDSRISLKDTQIGNLT 434
Query: 174 FSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQ 233
I ++ I L+ L+ + + + Y + + A + L+
Sbjct: 435 NRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDY---AKQYENEELSWSNLK 491
Query: 234 RLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
L +++L N + L + LQ+LN+ N+ +S
Sbjct: 492 DLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGIS 529
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 2e-11
Identities = 24/191 (12%), Positives = 56/191 (29%), Gaps = 30/191 (15%)
Query: 114 LGLECLQIKISSPGVNGFALNKLKGLKELELS----KVPPRPSVLTLLSEIAGLKCLTKL 169
L L K P A+ +L LK L V R L+ + ++
Sbjct: 328 LSLAGFGAKGRVPD----AIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRI 383
Query: 170 SVCHFS-IRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG 228
+ + + L+ +MK + + + N++ +
Sbjct: 384 RMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKA 443
Query: 229 LYLLQRLENLDLSNNRLTSLGSLDLCL-------------------MHNLQNLNLQYNKL 269
+ L +L+ + +N+ T + +L ++ L
Sbjct: 444 IQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPN 503
Query: 270 LSYCQVPSWIC 280
++ Q+P ++
Sbjct: 504 MT--QLPDFLY 512
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 2e-09
Identities = 19/165 (11%), Positives = 44/165 (26%), Gaps = 34/165 (20%)
Query: 166 LTKLSVCHFSIRY-LPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLK-------- 216
+T LS+ F + +P IG L+ L+ L + + +
Sbjct: 325 VTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIR 384
Query: 217 ------------------------VANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLD 252
N ++ + + + + NR+T +
Sbjct: 385 MHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISK-A 443
Query: 253 LCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFIS 297
+ + LQ + + W N + + + + S
Sbjct: 444 IQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWS 488
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 59/261 (22%), Positives = 93/261 (35%), Gaps = 44/261 (16%)
Query: 868 RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVS 927
+ V++ S P + I M+ + ++K+++ + +
Sbjct: 105 MDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNR--RCSLEDRE 162
Query: 928 VKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF--DRAVP 985
+ L I +A A+ LHSK +MHRD+K NI D VVK+ DF A+
Sbjct: 163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT-----MDD--VVKVGDFGLVTAMD 215
Query: 986 LRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045
T VGT +M+PE + + Y +VDI+S G +L ELL
Sbjct: 216 QDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNN----YSHKVDIFSLGLILFELLY 271
Query: 1046 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFL 1105
M + I D+ K P L + +
Sbjct: 272 SFSTQMERVRI-ITDVRN-LKFPLL------------------------FTQKYPQEHMM 305
Query: 1106 VDVFRRCTEENPTERPTAGDL 1126
V + +PTERP A D+
Sbjct: 306 V---QDMLSPSPTERPEATDI 323
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-27
Identities = 49/233 (21%), Positives = 82/233 (35%), Gaps = 53/233 (22%)
Query: 901 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960
I +E +++ Y+E+ + + + Q + L LHS +I+HRD+K NI
Sbjct: 95 IAIELC-AATLQEYVEQ----KDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNI 149
Query: 961 LIDLERKKADGKPVVKLCDF------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMA 1014
LI A GK + DF S GT W+A
Sbjct: 150 LIS--MPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP-------------GTEGWIA 194
Query: 1015 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 1073
PE+L K N VDI+S GC+ +++ P+ + + + L+ L E
Sbjct: 195 PEMLSEDCKEN-PTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPE 253
Query: 1074 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1126
E A ++ + +P +RP+A +
Sbjct: 254 KH-----------------EDVIAR--------ELIEKMIAMDPQKRPSAKHV 281
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-27
Identities = 66/273 (24%), Positives = 100/273 (36%), Gaps = 79/273 (28%)
Query: 860 EVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 917
EVR L LRH ++ G + + W + MEY GS + +E
Sbjct: 104 EVRFLQKLRHPNTIQYRGCYLREHTAW----------------LVMEYC-LGSASDLLEV 146
Query: 918 LSET-GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 976
+ E ++ + L LHS +++HRD+K+ NIL+ G VK
Sbjct: 147 HKKPLQEVEIAA-----VTHGALQGLAYLHSHNMIHRDVKAGNILLS-----EPGL--VK 194
Query: 977 LCDFDRAVPL---RSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 1033
L DF A + SF VGTP WMAPEV+ AM Y +VD+
Sbjct: 195 LGDFGSASIMAPANSF-----------------VGTPYWMAPEVILAM-DEGQYDGKVDV 236
Query: 1034 WSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE 1093
WS G +EL + P ++ + I + P L +
Sbjct: 237 WSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQS-----------------GHWS 279
Query: 1094 KPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1126
+ + C ++ P +RPT+ L
Sbjct: 280 EY---------FRNFVDSCLQKIPQDRPTSEVL 303
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 9e-27
Identities = 38/256 (14%), Positives = 78/256 (30%), Gaps = 31/256 (12%)
Query: 834 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP- 892
V ++ I+ + + +R+L +++ +++ I L
Sbjct: 107 EVHVPY-FTERPPSNAIKQMK-EEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKK 164
Query: 893 --------EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKH--VSVKLALFIAQDVAAAL 942
+ S F+ +++ + E L H + L + V L
Sbjct: 165 MIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLL 224
Query: 943 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPA 1002
LH ++H ++ +I++D G V L F+ V + +
Sbjct: 225 ASLHHYGLVHTYLRPVDIVLD-----QRGG--VFLTGFEHLVRDGASAVSPI-------- 269
Query: 1003 PDVCVGTPRWMAPEVLRAM-HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDL 1061
P A +L H P L D W+ G + + +P + L +
Sbjct: 270 -GRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEW 328
Query: 1062 IQMGKRPRLTDELEAL 1077
I + + AL
Sbjct: 329 I-FRSCKNIPQPVRAL 343
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-26
Identities = 44/212 (20%), Positives = 80/212 (37%), Gaps = 33/212 (15%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
E++++ L H +V + L D + MEY +GG ++ Y+ +
Sbjct: 62 EIQIMKKLNHPNVVSAREVPDGLQKLAPND--------LPLLAMEYCEGGDLRKYLNQFE 113
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
+ + D+++AL LH I+HRD+K ENI++ + + K+ D
Sbjct: 114 NCCG--LKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPG----PQRLIHKIID 167
Query: 980 F--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1037
+ + GT +++APE+L Y + VD WS+G
Sbjct: 168 LGYAKELDQGELCTEFV-------------GTLQYLAPELLEQ----KKYTVTVDYWSFG 210
Query: 1038 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPR 1069
L E +T P++ + K
Sbjct: 211 TLAFECITGFRPFLPNWQPVQWHGKVREKSNE 242
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 58/234 (24%), Positives = 83/234 (35%), Gaps = 52/234 (22%)
Query: 901 IFMEYVKGGSVKNYIEKLSETG----EKHVSVKLALFIAQDVAAALVELHSKH-IMHRDI 955
I ME + K Y S E+ + I AL L I+HRDI
Sbjct: 98 ICMELMSTSFDKFYKYVYSVLDDVIPEEILGK-----ITLATVKALNHLKENLKIIHRDI 152
Query: 956 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAP 1015
K NIL+D G +KLCDF + L IA G +MAP
Sbjct: 153 KPSNILLD-----RSGN--IKLCDFGISGQL-----VDSIAKT------RDAGCRPYMAP 194
Query: 1016 EVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGL-SELEIHDLIQMGKRPRLTDEL 1074
E + Y + D+WS G L EL T + PY S + + G P+L++
Sbjct: 195 ERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSE 254
Query: 1075 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1128
E S P +F+ C ++ ++RP +L +
Sbjct: 255 EREFS---------------PSFI----NFV----NLCLTKDESKRPKYKELLK 285
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-26
Identities = 51/236 (21%), Positives = 98/236 (41%), Gaps = 41/236 (17%)
Query: 834 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 893
A ++ + + + + + E+ +L L H CI+++ + +
Sbjct: 164 AIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA----------ED 213
Query: 894 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 953
++++ +E ++GG + + + G K + + A+ LH I+HR
Sbjct: 214 YYIV-----LELMEGGELFDKV-----VGNKRLKEATCKLYFYQMLLAVQYLHENGIIHR 263
Query: 954 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPR 1011
D+K EN+L+ + + +K+ DF + L S + T C GTP
Sbjct: 264 DLKPENVLLSSQEEDCL----IKITDFGHSKILGETSLMRTLC-------------GTPT 306
Query: 1012 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP-YMGLSELEIHDLIQMGK 1066
++APEVL ++ Y VD WS G +L L+ P +++ + D I GK
Sbjct: 307 YLAPEVLVSVGTAG-YNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 361
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 57/302 (18%), Positives = 113/302 (37%), Gaps = 72/302 (23%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
V+ LK ++ +I F L E + H + ++ G +S + L
Sbjct: 56 VKMLKADIIASSDIEEF----LREAACMKEFDHPHVAKLVG--VSL------RSRAKGRL 103
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKH-VSVKLALFIAQDVAAALVELHSKHIMHRDI 955
+ + ++K G + ++ + ++ + D+A + L S++ +HRD+
Sbjct: 104 PIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDL 163
Query: 956 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV-CVGT----P 1010
+ N ++ + V + DF + R I + D G P
Sbjct: 164 AARNCMLAEDM-------TVCVADFGLS--------------RKIYSGDYYRQGCASKLP 202
Query: 1011 -RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRP 1068
+W+A E L NLY + D+W++G + E++T Q PY G+ EI++ + G R
Sbjct: 203 VKWLALESLAD----NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR- 257
Query: 1069 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1128
++P E + + D+ +C +P +RP+ L
Sbjct: 258 -----------------------LKQPP---ECMEEVYDLMYQCWSADPKQRPSFTCLRM 291
Query: 1129 MF 1130
Sbjct: 292 EL 293
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 44/191 (23%), Positives = 76/191 (39%), Gaps = 49/191 (25%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 917
EV++ L+H I+E+Y + + ++ +E G + Y++
Sbjct: 61 EVKIHCQLKHPSILELYNY-FEDS---------------NYVYLVLEMCHNGEMNRYLKN 104
Query: 918 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 977
K S A + ++ LHS I+HRD+ N+L+ +K+
Sbjct: 105 RV----KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMN-------IKI 153
Query: 978 CDFDRAVPLR---SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 1034
DF A L+ +T C GTP +++PE+ + +GLE D+W
Sbjct: 154 ADFGLATQLKMPHEKHYTLC-------------GTPNYISPEIATR----SAHGLESDVW 196
Query: 1035 SYGCLLLELLT 1045
S GC+ LL
Sbjct: 197 SLGCMFYTLLI 207
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-26
Identities = 62/302 (20%), Positives = 115/302 (38%), Gaps = 73/302 (24%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
V+T+K+ SS EI F L E + H ++ + G + + P
Sbjct: 67 VKTMKLDNSSQREIEEF----LSEAACMKDFSHPNVIRLLG--VCIEMSSQGIPKP---- 116
Query: 897 LQSAIFMEYVKGGSVKNYI-EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 955
+ + ++K G + Y+ ETG KH+ ++ L D+A + L +++ +HRD+
Sbjct: 117 ---MVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDL 173
Query: 956 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV-CVGTP---- 1010
+ N ++ + V + DF + + I + D G
Sbjct: 174 AARNCMLRDDM-------TVCVADFGLS--------------KKIYSGDYYRQGRIAKMP 212
Query: 1011 -RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRP 1068
+W+A E L +Y + D+W++G + E+ T PY G+ E++D + G R
Sbjct: 213 VKWIAIESLAD----RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR- 267
Query: 1069 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1128
++PE + L L ++ C +P +RPT L
Sbjct: 268 -----------------------LKQPE---DCLDELYEIMYSCWRTDPLDRPTFSVLRL 301
Query: 1129 MF 1130
Sbjct: 302 QL 303
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 110 bits (275), Expect = 8e-26
Identities = 33/236 (13%), Positives = 73/236 (30%), Gaps = 40/236 (16%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNP---------EHHLLQSAIFMEYVKGGS 910
+R+L +++ +++ I L + S F+ +
Sbjct: 126 RLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSN 185
Query: 911 VKNYIEKLSETGEKH--VSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 968
++ + E L H + L + V L LH ++H ++ +I++D
Sbjct: 186 LQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD----- 240
Query: 969 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL-------RAM 1021
G V L F+ V + + + + + PE+
Sbjct: 241 QRGG--VFLTGFEHLVRDGARVVSS--------------VSRGFEPPELEARRATISYHR 284
Query: 1022 HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEAL 1077
+ L D W+ G ++ + +P + L + I + + AL
Sbjct: 285 DRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWI-FRSCKNIPQPVRAL 339
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 40/191 (20%), Positives = 71/191 (37%), Gaps = 50/191 (26%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 917
E+ + +L H +V +G +F +E + S+ ++
Sbjct: 65 EISIHRSLAHQHVVGFHGF-FEDN---------------DFVFVVLELCRRRSLLELHKR 108
Query: 918 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 977
K ++ A + + + LH ++HRD+K N+ ++ D + VK+
Sbjct: 109 -----RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN-----EDLE--VKI 156
Query: 978 CDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 1034
DF + C GTP ++APEVL + EVD+W
Sbjct: 157 GDFGLATKVEYDGERKKVLC-------------GTPNYIAPEVLSK----KGHSFEVDVW 199
Query: 1035 SYGCLLLELLT 1045
S GC++ LL
Sbjct: 200 SIGCIMYTLLV 210
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 59/233 (25%), Positives = 93/233 (39%), Gaps = 54/233 (23%)
Query: 901 IFMEYVKGGSVKNYIEKLSETG---EKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIK 956
I ME + K Y + + + E + IA + AL LHSK ++HRD+K
Sbjct: 83 ICMELMDTSLDKFYKQVIDKGQTIPEDILGK-----IAVSIVKALEHLHSKLSVIHRDVK 137
Query: 957 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1016
N+LI+ A G+ VK+CDF + L + A D+ G +MAPE
Sbjct: 138 PSNVLIN-----ALGQ--VKMCDFGISGYLVDDV-----------AKDIDAGCKPYMAPE 179
Query: 1017 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGL-SELEIHDLIQMGKRPRLTDELE 1075
+ Y ++ DIWS G ++EL L+ PY + + + P+L +
Sbjct: 180 RINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD-- 237
Query: 1076 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1128
F E + F +C ++N ERPT +L +
Sbjct: 238 ---------------KFSA-----EFVDFT----SQCLKKNSKERPTYPELMQ 266
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-25
Identities = 47/241 (19%), Positives = 88/241 (36%), Gaps = 54/241 (22%)
Query: 901 IFMEYVKGGSVKNYIEK--LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 958
I +E ++++ +E +S+ K + + + +A+ + LHS I+HRD+K +
Sbjct: 86 IALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQ 144
Query: 959 NILIDLERKKADGKPV------VKLCDF-------DRAVPLRSFLHTCCIAHRGIPAPDV 1005
NIL+ + + + + DF R+ L+
Sbjct: 145 NILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS----------- 193
Query: 1006 CVGTPRWMAPEVLRAMHKPNL---YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 1062
GT W APE+L + +DI+S GC+ +L+ G + I
Sbjct: 194 --GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG-DKYSRESNI 250
Query: 1063 QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122
G L+ + H+ + EA D+ + + +P +RPT
Sbjct: 251 IRGIF-----SLDEMKCLHDRSLI--------AEAT--------DLISQMIDHDPLKRPT 289
Query: 1123 A 1123
A
Sbjct: 290 A 290
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 40/191 (20%), Positives = 71/191 (37%), Gaps = 50/191 (26%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 917
E+ + +L H +V +G +F +E + S+ ++
Sbjct: 91 EISIHRSLAHQHVVGFHGF-FEDN---------------DFVFVVLELCRRRSLLELHKR 134
Query: 918 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 977
K ++ A + + + LH ++HRD+K N+ ++ D + VK+
Sbjct: 135 -----RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN-----EDLE--VKI 182
Query: 978 CDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 1034
DF + C GTP ++APEVL + EVD+W
Sbjct: 183 GDFGLATKVEYDGERKKVLC-------------GTPNYIAPEVLSK----KGHSFEVDVW 225
Query: 1035 SYGCLLLELLT 1045
S GC++ LL
Sbjct: 226 SIGCIMYTLLV 236
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-25
Identities = 43/202 (21%), Positives = 78/202 (38%), Gaps = 16/202 (7%)
Query: 71 EGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KISSPG 127
L L N + L L +++ + NL L L + +I
Sbjct: 135 YSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVT-PIANLTDLYSLSLNYNQIEDIS 193
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLS 187
L L L + +T ++ +A + L L + + I L P + LS
Sbjct: 194 ----PLASLTSLHYFTAYV-----NQITDITPVANMTRLNSLKIGNNKITDLSP-LANLS 243
Query: 188 NLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTS 247
L L++ N++ + + L L L V +N++ ++ L L +L +L L+NN+L +
Sbjct: 244 QLTWLEIGTNQISDIN-AVKDLTKLKMLNVGSNQISDISV-LNNLSQLNSLFLNNNQLGN 301
Query: 248 LGSLDLCLMHNLQNLNLQYNKL 269
+ + NL L L N +
Sbjct: 302 EDMEVIGGLTNLTTLFLSQNHI 323
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-24
Identities = 37/207 (17%), Positives = 78/207 (37%), Gaps = 24/207 (11%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KISS 125
L K + + + E + L G ++ + L LE L + +I+
Sbjct: 23 EGIRAVLQKASVTDVV-TQEELESITKLVVAGEKVASIQ-GIEYLTNLEYLNLNGNQITD 80
Query: 126 PGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS---IRYLPPE 182
L+ L L L + +++I+ L+ LT L + + I + P
Sbjct: 81 IS----PLSNLVKLTNLYIGT--------NKITDISALQNLTNLRELYLNEDNISDISP- 127
Query: 183 IGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSN 242
+ L+ + L+L N + + + L L V +K+ ++ + L L +L L+
Sbjct: 128 LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVT-PIANLTDLYSLSLNY 186
Query: 243 NRLTSLGSLDLCLMHNLQNLNLQYNKL 269
N++ + L + +L N++
Sbjct: 187 NQIEDISPLA--SLTSLHYFTAYVNQI 211
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 3e-22
Identities = 39/203 (19%), Positives = 79/203 (38%), Gaps = 19/203 (9%)
Query: 71 EGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KISSPG 127
L + ++ + + + L +L N+I S + +L L +I+
Sbjct: 158 NYLTVTESKVKDVT-PIANLTDLYSLSLNYNQIE-DISPLASLTSLHYFTAYVNQITDIT 215
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLS 187
+ + L L++ + +T LS +A L LT L + I + + L+
Sbjct: 216 ----PVANMTRLNSLKIGN-----NKITDLSPLANLSQLTWLEIGTNQISDINA-VKDLT 265
Query: 188 NLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVEL-PSGLYLLQRLENLDLSNNRLT 246
L+ L++ N++ + + L L SL + NN+L + L L L LS N +T
Sbjct: 266 KLKMLNVGSNQISDIS-VLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHIT 324
Query: 247 SLGSLDLCLMHNLQNLNLQYNKL 269
+ L + + + + +
Sbjct: 325 DIRPLA--SLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 4e-20
Identities = 35/141 (24%), Positives = 63/141 (44%), Gaps = 10/141 (7%)
Query: 131 FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLE 190
F L L K + +T + L+ +TKL V + + I L+NLE
Sbjct: 16 FPDADLAEGIRAVLQK-----ASVTDVVTQEELESITKLVVAGEKVASIQG-IEYLTNLE 69
Query: 191 QLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGS 250
L+L+ N++ + + L L +L + NK+ ++ + L L L L L+ + ++ +
Sbjct: 70 YLNLNGNQITDIS-PLSNLVKLTNLYIGTNKITDISA-LQNLTNLRELYLNEDNISDISP 127
Query: 251 LDLCLMHNLQNLNLQYNKLLS 271
L + + +LNL N LS
Sbjct: 128 LAN--LTKMYSLNLGANHNLS 146
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 2e-16
Identities = 39/180 (21%), Positives = 70/180 (38%), Gaps = 21/180 (11%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECL-----QIKISSPG 127
L L N + I + L + N+I V N+ L L +I SP
Sbjct: 182 LSLNYNQIEDIS-PLASLTSLHYFTAYVNQITDITP-VANMTRLNSLKIGNNKITDLSP- 238
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLS 187
L L L LE+ + ++ ++ + L L L+V I + + LS
Sbjct: 239 -----LANLSQLTWLEIGT-----NQISDINAVKDLTKLKMLNVGSNQISDISV-LNNLS 287
Query: 188 NLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLT 246
L L L+ N++ I L L +L ++ N + ++ L L ++++ D +N +
Sbjct: 288 QLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP-LASLSKMDSADFANQVIK 346
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 54/231 (23%), Positives = 81/231 (35%), Gaps = 51/231 (22%)
Query: 901 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSEN 959
I ME + + K E+ + + + AL L KH ++HRD+K N
Sbjct: 101 IAMELMGTCAEKLKKRMQGPIPERILGK-----MTVAIVKALYYLKEKHGVIHRDVKPSN 155
Query: 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1019
IL+D G+ +KLCDF + L A D G +MAPE +
Sbjct: 156 ILLD-----ERGQ--IKLCDFGISGRLVDDK-----------AKDRSAGCAAYMAPERID 197
Query: 1020 AMHKPNL-YGLEVDIWSYGCLLLELLTLQVPYMGL-SELEIHDLIQMGKRPRLTDELEAL 1077
Y + D+WS G L+EL T Q PY ++ E+ + + P L
Sbjct: 198 PPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGH---- 253
Query: 1078 GSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1128
GF + C ++ +RP L E
Sbjct: 254 ------------MGFSGD---------FQSFVKDCLTKDHRKRPKYNKLLE 283
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 3e-25
Identities = 48/222 (21%), Positives = 81/222 (36%), Gaps = 33/222 (14%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISS-PGVNGF 131
L+++ N L +P L+ L N++ P+ L L +++S P
Sbjct: 126 LWIFGNQLTSLPVLPP---GLQELSVSDNQLASLPALPSELCKLWAYNNQLTSLP----- 177
Query: 132 ALNKLKGLKELELSK-----VPPRPSVLTLLSEI--------AGLKCLTKLSVCHFSIRY 178
GL+EL +S +P PS L L A L +L V +
Sbjct: 178 --MLPSGLQELSVSDNQLASLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTS 235
Query: 179 LPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENL 238
LP L++L +S N++ LP L+SL V N+L LP L L +
Sbjct: 236 LPVLPS---ELKELMVSGNRLTSLPMLPS---GLLSLSVYRNQLTRLPESLIHLSSETTV 289
Query: 239 DLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC 280
+L N L+ L + + + ++ + +
Sbjct: 290 NLEGNPLS---ERTLQALREITSAPGYSGPIIRFDMAGASAP 328
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 3e-24
Identities = 50/218 (22%), Positives = 79/218 (36%), Gaps = 34/218 (15%)
Query: 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISS-P 126
N L + ++ L +P + + L N + P+ L LE +++S P
Sbjct: 40 NGNAVLNVGESGLTTLPDCLPA--HITTLVIPDNNLTSLPALPPELRTLEVSGNQLTSLP 97
Query: 127 GVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCL 186
L L LT L + L KL + + LP
Sbjct: 98 V----LPPGLLELSIFSNP--------LTHLPAL--PSGLCKLWIFGNQLTSLPVLPP-- 141
Query: 187 SNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLT 246
L++L +S N++ LP L L NN+L LP L L+ L +S+N+L
Sbjct: 142 -GLQELSVSDNQLASLPALPSELC---KLWAYNNQLTSLPM---LPSGLQELSVSDNQLA 194
Query: 247 SLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLE 284
SL + L L L N+L +P+ L+
Sbjct: 195 SLPT----LPSELYKLWAYNNRL---TSLPALP-SGLK 224
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 1e-20
Identities = 37/198 (18%), Positives = 64/198 (32%), Gaps = 26/198 (13%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISS-PGVNGF 131
L+ Y N L +P L+ L N++ P+ L L +++S P
Sbjct: 166 LWAYNNQLTSLPMLPS---GLQELSVSDNQLASLPTLPSELYKLWAYNNRLTSLP----- 217
Query: 132 ALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQ 191
GLKEL +S LT L L +L V + LP L
Sbjct: 218 --ALPSGLKELIVSGNR-----LTSLPV--LPSELKELMVSGNRLTSLPMLPS---GLLS 265
Query: 192 LDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSL 251
L + N++ LP + +L + ++ + N L E + + + + +
Sbjct: 266 LSVYRNQLTRLPESLIHLSSETTVNLEGNPLSERTLQAL--REITSAPGYSGPIIRFDMA 323
Query: 252 D---LCLMHNLQNLNLQY 266
L +
Sbjct: 324 GASAPRETRALHLAAADW 341
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 87.3 bits (216), Expect = 1e-17
Identities = 38/145 (26%), Positives = 56/145 (38%), Gaps = 22/145 (15%)
Query: 136 LKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLS 195
G L + + S LT L + +T L + ++ LP L L++S
Sbjct: 39 NNGNAVLNVGE-----SGLTTLPD-CLPAHITTLVIPDNNLTSLPALPP---ELRTLEVS 89
Query: 196 FNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCL 255
N++ LP L L L LPSG L L + N+LTSL L
Sbjct: 90 GNQLTSLPVLPPGLLELSIFSNPLTHLPALPSG------LCKLWIFGNQLTSLPV----L 139
Query: 256 MHNLQNLNLQYNKLLSYCQVPSWIC 280
LQ L++ N+L S +P+
Sbjct: 140 PPGLQELSVSDNQLAS---LPALPS 161
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 4e-07
Identities = 18/65 (27%), Positives = 26/65 (40%), Gaps = 6/65 (9%)
Query: 205 EICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNL 264
C L V + L LP L + L + +N LTSL + L L+ L +
Sbjct: 35 RACLNNGNAVLNVGESGLTTLPDC--LPAHITTLVIPDNNLTSLPA----LPPELRTLEV 88
Query: 265 QYNKL 269
N+L
Sbjct: 89 SGNQL 93
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 52/235 (22%), Positives = 97/235 (41%), Gaps = 61/235 (25%)
Query: 901 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960
+ MEY++G ++ YIE +SV A+ + + H I+HRDIK +NI
Sbjct: 88 LVMEYIEGPTLSEYIES-----HGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNI 142
Query: 961 LIDLERKKADGKPVVKLCDFD--RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1018
LID ++ +K+ DF +A+ + + + +GT ++ +PE
Sbjct: 143 LID-----SNKT--LKIFDFGIAKAL-----------SETSLTQTNHVLGTVQYFSPEQA 184
Query: 1019 RAMHKPNLYGLEV----DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDEL 1074
+ G DI+S G +L E+L + P+ G + + I I+ + D +
Sbjct: 185 K--------GEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI--AIK-----HIQDSV 229
Query: 1075 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-TAGDLYE 1128
+ + ++ QS L +V R TE++ R T ++ +
Sbjct: 230 PNVTTDVRKDIPQS----------------LSNVILRATEKDKANRYKTIQEMKD 268
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-25
Identities = 52/236 (22%), Positives = 98/236 (41%), Gaps = 41/236 (17%)
Query: 834 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 893
A K+ + + + + + E+ +L L H CI+++ + +
Sbjct: 39 AIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA----------ED 88
Query: 894 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 953
++++ +E ++GG + + + G K + + A+ LH I+HR
Sbjct: 89 YYIV-----LELMEGGELFDKV-----VGNKRLKEATCKLYFYQMLLAVQYLHENGIIHR 138
Query: 954 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPR 1011
D+K EN+L+ + + +K+ DF + L S + T C GTP
Sbjct: 139 DLKPENVLLSSQEEDCL----IKITDFGHSKILGETSLMRTLC-------------GTPT 181
Query: 1012 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP-YMGLSELEIHDLIQMGK 1066
++APEVL ++ Y VD WS G +L L+ P +++ + D I GK
Sbjct: 182 YLAPEVLVSVGTAG-YNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 236
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 8e-25
Identities = 41/203 (20%), Positives = 74/203 (36%), Gaps = 15/203 (7%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KISSPGVN 129
L L N + + + L N I+ G G + + + KI+ +
Sbjct: 85 LDLNNNYVQELLVG----PSIETLHAANNNISRVSCSRGQ--GKKNIYLANNKITM--LR 136
Query: 130 GFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNL 189
++ L+L + A L L++ + I + ++ + L
Sbjct: 137 DLDEGCRSRVQYLDLKL--NEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQV-VFAKL 193
Query: 190 EQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLG 249
+ LDLS NK+ ++ E + + + NNKLV + L Q LE+ DL N
Sbjct: 194 KTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGT 253
Query: 250 SLDLCLMHN-LQNLNLQYNKLLS 271
D + +Q + Q K L+
Sbjct: 254 LRDFFSKNQRVQTVAKQTVKKLT 276
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-18
Identities = 26/116 (22%), Positives = 46/116 (39%), Gaps = 9/116 (7%)
Query: 157 LSEIAG-LKCLTKLSVCHFSIRYLPPEIG-CLSNLEQLDLSFNKMKYLPTE-ICYLKALI 213
+ EI V S++ + N+++LDLS N + + + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 214 SLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L +++N L E L L L LDL+NN + L +++ L+ N +
Sbjct: 62 LLNLSSNVLYETLD-LESLSTLRTLDLNNNYVQELLVG-----PSIETLHAANNNI 111
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 51/296 (17%), Positives = 97/296 (32%), Gaps = 72/296 (24%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
++ L + +F M+ L H +V YG + +
Sbjct: 45 LKVLDKA--HRNYSESF----FEAASMMSKLSHKHLVLNYG--VCVCGDENI-------- 88
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
+ E+VK GS+ Y++K + +++ L +A+ +AAA+ L ++H ++
Sbjct: 89 ----LVQEFVKFGSLDTYLKK----NKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVC 140
Query: 957 SENILIDLERKKADGKP-VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAP 1015
++NIL+ E + G P +KL D + + D+ W+ P
Sbjct: 141 AKNILLIREEDRKTGNPPFIKLSDPGIS--------------ITVLPKDILQERIPWVPP 186
Query: 1016 EVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDEL 1074
E + P L D WS+G L E+ + P L + + L
Sbjct: 187 E---CIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQ------L 237
Query: 1075 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130
A + ++ C + P RP+ +
Sbjct: 238 PAPKAAELA-----------------------NLINNCMDYEPDHRPSFRAIIRDL 270
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-24
Identities = 47/169 (27%), Positives = 74/169 (43%), Gaps = 23/169 (13%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
MEY GG + + K + + ++A F ++ A+ +H +HRDIK +NIL+
Sbjct: 140 MEYYVGGDLLTLLSKF----GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL 195
Query: 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM- 1021
D G ++L DF + LR+ V VGTP +++PE+L+A+
Sbjct: 196 D-----RCGH--IRLADFGSCLKLRADGTVRS---------LVAVGTPDYLSPEILQAVG 239
Query: 1022 --HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRP 1068
YG E D W+ G E+ Q P+ S E + I K
Sbjct: 240 GGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH 288
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-24
Identities = 53/215 (24%), Positives = 83/215 (38%), Gaps = 44/215 (20%)
Query: 858 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF----MEYVKGGSVKN 913
E ++ +V++ + Q + MEY+ GG
Sbjct: 117 WEERDIMAFANSPWVVQL------------------FYAFQDDRYLYMVMEYMPGG---- 154
Query: 914 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 973
+ ++ V K A F +V AL +HS +HRD+K +N+L+D G
Sbjct: 155 --DLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD-----KSGH- 206
Query: 974 VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 1033
+KL DF + + C D VGTP +++PEVL++ YG E D
Sbjct: 207 -LKLADFGTCMKMNKEGMVRC---------DTAVGTPDYISPEVLKSQGGDGYYGRECDW 256
Query: 1034 WSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRP 1068
WS G L E+L P+ S + + I K
Sbjct: 257 WSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS 291
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 56/255 (21%), Positives = 92/255 (36%), Gaps = 39/255 (15%)
Query: 834 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG--------------- 877
A K+ K+ + ++ + EVR++ L H I +Y
Sbjct: 55 AIKIMNKNKIRQINPKDVERIK----TEVRLMKKLHHPNIARLYEVYEDEQYICLVMELC 110
Query: 878 ------HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLA 931
K++ S + ++ I E+ + KL
Sbjct: 111 HGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLI 170
Query: 932 LFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLH 991
I + + +AL LH++ I HRDIK EN L + +KL DF + +
Sbjct: 171 SNIMRQIFSALHYLHNQGICHRDIKPENFLFS-----TNKSFEIKLVDFGLSKEFYKLNN 225
Query: 992 TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM 1051
GTP ++APEVL ++ YG + D WS G LL LL VP+
Sbjct: 226 GEYYGMTTK------AGTPYFVAPEVLNTTNES--YGPKCDAWSAGVLLHLLLMGAVPFP 277
Query: 1052 GLSELEIHDLIQMGK 1066
G+++ + + K
Sbjct: 278 GVNDADTISQVLNKK 292
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 2e-24
Identities = 53/275 (19%), Positives = 88/275 (32%), Gaps = 88/275 (32%)
Query: 860 EVRMLGALRHSCIVEMY--GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 917
E + L + H IV+++ G+P + I MEYV G S+K +
Sbjct: 129 ERQFLAEVVHPSIVQIFNFVEH------TDRHGDPVGY-----IVMEYVGGQSLKRSKGQ 177
Query: 918 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 977
+ V A+ ++ AL LHS +++ D+K ENI++ E+ +KL
Sbjct: 178 -------KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ--------LKL 222
Query: 978 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV---DIW 1034
D I + GTP + APE++R DI+
Sbjct: 223 IDLG-------------AV-SRINSFGYLYGTPGFQAPEIVR--------TGPTVATDIY 260
Query: 1035 SYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK 1094
+ G L L G + + + D L
Sbjct: 261 TVGRTLAALTLDLPTRNGRYVDGLPEDDP---VLKTYDSYGRL----------------- 300
Query: 1095 PEAELETLSFLVDVFRRCTEENPTERP-TAGDLYE 1128
RR + +P +R TA ++
Sbjct: 301 --------------LRRAIDPDPRQRFTTAEEMSA 321
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 2e-24
Identities = 42/234 (17%), Positives = 83/234 (35%), Gaps = 30/234 (12%)
Query: 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISS-P 126
N L L + L+ +P ++ ++ L+ N + P +L L+ ++S+ P
Sbjct: 59 NQFSELQLNRLNLSSLPDNLPP--QITVLEITQNALISLPELPASLEYLDACDNRLSTLP 116
Query: 127 GVNGFALNKLKGLKELELS-----KVPPRPSVLTLLS-------EI-AGLKCLTKLSVCH 173
LK L++ +P P++L ++ + L LSV +
Sbjct: 117 -------ELPASLKHLDVDNNQLTMLPELPALLEYINADNNQLTMLPELPTSLEVLSVRN 169
Query: 174 FSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKAL----ISLKVANNKLVELPSGL 229
+ +LP +LE LD+S N ++ LP I + N++ +P +
Sbjct: 170 NQLTFLPELPE---SLEALDVSTNLLESLPAVPVRNHHSEETEIFFRCRENRITHIPENI 226
Query: 230 YLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNL 283
L + L +N L+S L + + + + L
Sbjct: 227 LSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPL 280
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 94.7 bits (235), Expect = 5e-20
Identities = 33/208 (15%), Positives = 63/208 (30%), Gaps = 24/208 (11%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISS-PG 127
S+E L N L+ +P+ L++L N++ + P L + +++ P
Sbjct: 101 SLEYLDACDNRLSTLPELPA---SLKHLDVDNNQLTMLPELPALLEYINADNNQLTMLP- 156
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLS 187
L+ L + LT L E + L L V + LP
Sbjct: 157 ------ELPTSLEVLSVRNNQ-----LTFLPE--LPESLEALDVSTNLLESLPAVPVRNH 203
Query: 188 NLEQ----LDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNN 243
+ E+ N++ ++P I L ++ + +N L L + +
Sbjct: 204 HSEETEIFFRCRENRITHIPENILSLDPTCTIILEDNPLSSRIR--ESLSQQTAQPDYHG 261
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
D + L
Sbjct: 262 PRIYFSMSDGQQNTLHRPLADAVTAWFP 289
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 90.4 bits (224), Expect = 1e-18
Identities = 36/153 (23%), Positives = 65/153 (42%), Gaps = 21/153 (13%)
Query: 132 ALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQ 191
A +K + + R ++LL E + ++L + ++ LP + +
Sbjct: 32 AWDKWEKQALPGEN----RNEAVSLLKECL-INQFSELQLNRLNLSSLPDNLP--PQITV 84
Query: 192 LDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSL 251
L+++ N + LP L+ L +N+L LP L L++LD+ NN+LT L
Sbjct: 85 LEITQNALISLPELPASLE---YLDACDNRLSTLPE---LPASLKHLDVDNNQLTMLPE- 137
Query: 252 DLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLE 284
L L+ +N N+L +P +LE
Sbjct: 138 ---LPALLEYINADNNQL---TMLPELP-TSLE 163
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 49.2 bits (117), Expect = 7e-06
Identities = 18/96 (18%), Positives = 32/96 (33%), Gaps = 10/96 (10%)
Query: 192 LDLSFNKMKYLPTEIC-YLKALISLKVANNKLVELPSGL--YLLQRLENLDLSNNRLTSL 248
+ +N + + + E S L L+ + L L+ L+SL
Sbjct: 15 QNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLSSL 74
Query: 249 GSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLE 284
L + L + N L+S +P +LE
Sbjct: 75 PD---NLPPQITVLEITQNALIS---LPELP-ASLE 103
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-24
Identities = 44/222 (19%), Positives = 81/222 (36%), Gaps = 33/222 (14%)
Query: 73 LYLYKNVLNLIPKSVGRY-EKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KISSPGV 128
L + N L I + L+NL+ N + + L + +S+
Sbjct: 146 LSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDL--SLIPSLFHANVSYNLLST--- 200
Query: 129 NGFALNKLKGLKELELS-----KVPPRPSV-----------LTLLSEIAGLKCLTKLSVC 172
L ++EL+ S V +V LT + + L ++ +
Sbjct: 201 ----LAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTDTAWLLNYPGLVEVDLS 256
Query: 173 HFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYL 231
+ + + + LE+L +S N++ L + L L +++N L+ +
Sbjct: 257 YNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLLHVERNQPQ 316
Query: 232 LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYC 273
RLENL L +N + +L L H L+NL L +N
Sbjct: 317 FDRLENLYLDHNSIV---TLKLSTHHTLKNLTLSHNDWDCNS 355
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 3e-20
Identities = 38/176 (21%), Positives = 66/176 (37%), Gaps = 11/176 (6%)
Query: 102 EINLFPSEVGNLLGLECLQIKISSPGV-NGFALNKLKGLKELELSKVPPRPSVLTLLSE- 159
E S + + I + + V GF L K + S + L
Sbjct: 9 EYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKN-----STMRKLPAA 63
Query: 160 -IAGLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLK 216
+ + + L++ I + +++L + FN ++YLP + + L L
Sbjct: 64 LLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 123
Query: 217 VANNKLVELPSGLYL-LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
+ N L LP G++ +L L +SNN L + +LQNL L N+L
Sbjct: 124 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH 179
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 9e-18
Identities = 45/189 (23%), Positives = 79/189 (41%), Gaps = 24/189 (12%)
Query: 95 NLKFFGNEINLFPSEVG------NLLGLECLQI---KISSPGVNGFALNKLKGLKELELS 145
+ F+ I++ +V L + + + + L+ + ++ L L+
Sbjct: 20 DCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK--LPAALLDSFRQVELLNLN 77
Query: 146 KVPPRPSVLTLLSEIA--GLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYL 202
+ + A + KL + +IRYLPP + + L L L N + L
Sbjct: 78 D-----LQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSL 132
Query: 203 PTEI-CYLKALISLKVANNKLVELPSGLYL-LQRLENLDLSNNRLTSLGSLDLCLMHNLQ 260
P I L +L ++NN L + + L+NL LS+NRLT +DL L+ +L
Sbjct: 133 PRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT---HVDLSLIPSLF 189
Query: 261 NLNLQYNKL 269
+ N+ YN L
Sbjct: 190 HANVSYNLL 198
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 66/297 (22%), Positives = 105/297 (35%), Gaps = 77/297 (25%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
V+ +K S DE F E + + L H +V+ YG + SK P +
Sbjct: 37 VKMIKEGSMSEDE---F----FQEAQTMMKLSHPKLVKFYG--VCSK------EYPIY-- 79
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
I EY+ G + NY+ K + L + DV + L S +HRD+
Sbjct: 80 ----IVTEYISNGCLLNYLRS----HGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLA 131
Query: 957 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1014
+ N L+D + VK+ DF R L ++ G P +W A
Sbjct: 132 ARNCLVDRDL-------CVKVSDFGMT---RYVLDDQYVSSVGTKFPV--------KWSA 173
Query: 1015 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 1073
PEV Y + D+W++G L+ E+ +L ++PY + E+ + G R
Sbjct: 174 PEVFHY----FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHR------ 223
Query: 1074 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130
L + + + C E P +RPT L
Sbjct: 224 LYRPHLA--------------SDT-------IYQIMYSCWHELPEKRPTFQQLLSSI 259
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 49/188 (26%), Positives = 75/188 (39%), Gaps = 41/188 (21%)
Query: 901 IFMEYVKGGSVKNYIEK--LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 958
+ E V G V LSE A F QD+ + LH + I+HRDIK
Sbjct: 115 MVFELVNQGPVMEVPTLKPLSE--------DQARFYFQDLIKGIEYLHYQKIIHRDIKPS 166
Query: 959 NILIDLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAP 1015
N+L+ DG +K+ DF + + L GTP +MAP
Sbjct: 167 NLLVG-----EDG--HIKIADFGVSNEFKGSDALLSNTV-------------GTPAFMAP 206
Query: 1016 EVLRAMHKPNLY-GLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK-----RPR 1069
E L K + G +D+W+ G L + Q P+M + +H I+ +P
Sbjct: 207 ESLSETRKI--FSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPD 264
Query: 1070 LTDELEAL 1077
+ ++L+ L
Sbjct: 265 IAEDLKDL 272
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 59/297 (19%), Positives = 106/297 (35%), Gaps = 76/297 (25%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
++T K +S F L E + H IV++ G + ++ NP
Sbjct: 48 IKTCKN-CTSDSVREKF----LQEALTMRQFDHPHIVKLIG--VITE-------NP---- 89
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
I ME G ++++++ + + + + A ++ AL L SK +HRDI
Sbjct: 90 --VWIIMELCTLGELRSFLQV----RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIA 143
Query: 957 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1014
+ N+L+ VKL DF + R + +P +WMA
Sbjct: 144 ARNVLVSSND-------CVKLGDFGLS---RYMEDSTYYKASKGKLPI--------KWMA 185
Query: 1015 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 1073
PE + + D+W +G + E+L P+ G+ ++ I+ G+R
Sbjct: 186 PESINF----RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER------ 235
Query: 1074 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130
L +C P L + +C +P+ RP +L
Sbjct: 236 LPMPPNC--------------PPT-------LYSLMTKCWAYDPSRRPRFTELKAQL 271
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-24
Identities = 66/270 (24%), Positives = 113/270 (41%), Gaps = 39/270 (14%)
Query: 860 EVRMLGALR-HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKL 918
EV ML + H ++E+ + +L+ E ++GGS+ ++I K
Sbjct: 60 EVEMLYQCQGHRNVLELIE---------FFEEEDRFYLV-----FEKMRGGSILSHIHK- 104
Query: 919 SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 978
+H + A + QDVA+AL LH+K I HRD+K ENIL E VK+C
Sbjct: 105 ----RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENIL--CEHPNQVSP--VKIC 156
Query: 979 DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM-HKPNLYGLEVDIWSYG 1037
DFD ++ I+ + P G+ +MAPEV+ A + ++Y D+WS G
Sbjct: 157 DFDLGSGIKLNGDCSPISTPELLTP---CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLG 213
Query: 1038 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 1097
+L LL+ P++G + E++ +E P+
Sbjct: 214 VILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGK----------YEFPDK 263
Query: 1098 ELETLSFLV-DVFRRCTEENPTERPTAGDL 1126
+ +S D+ + + +R +A +
Sbjct: 264 DWAHISCAAKDLISKLLVRDAKQRLSAAQV 293
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 8e-24
Identities = 61/239 (25%), Positives = 95/239 (39%), Gaps = 56/239 (23%)
Query: 834 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 892
AAK+ T K+ ++ E R+ L+H IV ++ S
Sbjct: 35 AAKIINTKKLSARDFQKLER-------EARICRKLQHPNIVRLHD---------SIQEES 78
Query: 893 EHHLLQSAIFMEYVKGGSVKNYI---EKLSETGEKHVSVKLALFIAQDVAAALVELHSKH 949
H+L+ + V GG + I E SE A Q + ++ HS
Sbjct: 79 FHYLV-----FDLVTGGELFEDIVAREFYSE--------ADASHCIQQILESIAYCHSNG 125
Query: 950 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCV 1007
I+HR++K EN+L+ KA G VKL DF A+ + H
Sbjct: 126 IVHRNLKPENLLLA---SKAKGAA-VKLADFGLAIEVNDSEAWHGFA------------- 168
Query: 1008 GTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1066
GTP +++PEVL+ + Y VDIW+ G +L LL P+ + ++ I+ G
Sbjct: 169 GTPGYLSPEVLKK----DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA 223
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 9e-24
Identities = 60/242 (24%), Positives = 99/242 (40%), Gaps = 51/242 (21%)
Query: 834 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGN 891
A K+ SA+E++ + L EV +L + H I+++ + + N
Sbjct: 46 AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD---------TYETN 96
Query: 892 PEHHLLQSAIFMEYVKGGSVKNYI---EKLSETGEKHVSVKLALFIAQDVAAALVELHSK 948
L+ + +K G + +Y+ LSE K I + + + LH
Sbjct: 97 TFFFLV-----FDLMKKGELFDYLTEKVTLSE--------KETRKIMRALLEVICALHKL 143
Query: 949 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVC 1006
+I+HRD+K ENIL+ D +KL DF + L L C
Sbjct: 144 NIVHRDLKPENILL-------DDDMNIKLTDFGFSCQLDPGEKLREVC------------ 184
Query: 1007 VGTPRWMAPEVLRAMHKPNL--YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 1064
GTP ++APE++ N YG EVD+WS G ++ LL P+ ++ + +I
Sbjct: 185 -GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 243
Query: 1065 GK 1066
G
Sbjct: 244 GN 245
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-23
Identities = 51/301 (16%), Positives = 107/301 (35%), Gaps = 83/301 (27%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
++ L+ +S + L E ++ ++ + + + G I +
Sbjct: 49 IKELRE-ATSPKANKEI----LDEAYVMASVDNPHVCRLLG--ICLT-------ST---- 90
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
+Q + + + G + +Y+ + + ++ + L +A + L + ++HRD+
Sbjct: 91 VQ--LITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLA 144
Query: 957 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP------ 1010
+ N+L+ + VK+ DF A + + A +
Sbjct: 145 ARNVLVKTPQ-------HVKITDFGLA--------------KLLGAEEKEYHAEGGKVPI 183
Query: 1011 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPR 1069
+WMA E + +Y + D+WSYG + EL+T PY G+ EI +++ G+R
Sbjct: 184 KWMALESILH----RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-- 237
Query: 1070 LTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1129
L C + + R+C + RP +L
Sbjct: 238 ----LPQPPIC--------------TID-------VYMIMRKCWMIDADSRPKFRELIIE 272
Query: 1130 F 1130
F
Sbjct: 273 F 273
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 55/297 (18%), Positives = 105/297 (35%), Gaps = 77/297 (25%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
++T++ S ++ F + E ++ L H +V++YG + + P
Sbjct: 37 IKTIREGAMSEED---F----IEEAEVMMKLSHPKLVQLYG--VCLEQAPIC-------- 79
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
+ E+++ G + +Y+ + + L + DV + L ++HRD+
Sbjct: 80 ----LVTEFMEHGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLA 131
Query: 957 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1014
+ N L+ + V+K+ DF R L + G P +W +
Sbjct: 132 ARNCLVGENQ-------VIKVSDFGMT---RFVLDDQYTSSTGTKFPV--------KWAS 173
Query: 1015 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 1073
PEV + Y + D+WS+G L+ E+ + ++PY S E+ + I G R
Sbjct: 174 PEVFSF----SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR------ 223
Query: 1074 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130
L + + C E P +RP L
Sbjct: 224 LYKPRLA--------------STH-------VYQIMNHCWRERPEDRPAFSRLLRQL 259
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 66/297 (22%), Positives = 119/297 (40%), Gaps = 77/297 (25%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
V++LK S D F L E ++ L+H +V +Y + ++ P +
Sbjct: 42 VKSLKQGSMSPDA---F----LAEANLMKQLQHQRLVRLYA--VVTQ-------EPIY-- 83
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
I EY++ GS+ ++ L +++ L +A +A + + ++ +HRD++
Sbjct: 84 ----IITEYMENGSLVDF---LKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLR 136
Query: 957 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1014
+ NIL+ K+ DF A R A G P +W A
Sbjct: 137 AANILVSDTL-------SCKIADFGLA---RLIEDNEYTAREGAKFPI--------KWTA 178
Query: 1015 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 1073
PE + + ++ D+WS+G LL E++T ++PY G++ E+ ++ G R
Sbjct: 179 PEAINY----GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR------ 228
Query: 1074 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130
+ +C PE L + R C +E P +RPT L +
Sbjct: 229 MVRPDNC--------------PEE-------LYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 59/300 (19%), Positives = 105/300 (35%), Gaps = 82/300 (27%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
V+T K + D F + E ++ L H IV++ G I + P
Sbjct: 45 VKTCKK-DCTLDNKEKF----MSEAVIMKNLDHPHIVKLIG--IIEE-------EP---- 86
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
+ I ME G + +Y+E+ + + V + + + A+ L S + +HRDI
Sbjct: 87 --TWIIMELYPYGELGHYLER----NKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIA 140
Query: 957 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1014
NIL+ VKL DF + R +P +WM+
Sbjct: 141 VRNILVASPE-------CVKLGDFGLS---RYIEDEDYYKASVTRLPI--------KWMS 182
Query: 1015 PEVLRAMHKPNLYG---LEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRL 1070
PE + + D+W + + E+L+ + P+ L ++ +++ G R
Sbjct: 183 PESI-------NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDR--- 232
Query: 1071 TDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130
L C P L + RC + +P++RP +L
Sbjct: 233 ---LPKPDLC--------------PPV-------LYTLMTRCWDYDPSDRPRFTELVCSL 268
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 52/237 (21%), Positives = 80/237 (33%), Gaps = 71/237 (29%)
Query: 901 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960
+ M + G + + + + ++ A+ I + + +AL H+ HRD+K ENI
Sbjct: 111 VDMRLINGVDLAAMLRR-----QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENI 165
Query: 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHR----GIPAPDVCVGTPRWMAPE 1016
L+ AD L DF IA + VGT +MAPE
Sbjct: 166 LVS-----ADDF--AYLVDFG-------------IASATTDEKLTQLGNTVGTLYYMAPE 205
Query: 1017 VLRAMHKPNLYGLEV----DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTD 1072
DI++ C+L E LT PY G D + +
Sbjct: 206 RFS--------ESHATYRADIYALTCVLYECLTGSPPYQG-------DQLSV-------- 242
Query: 1073 ELEALGSCHEHEVAQSGSGFEKPE--AELETLSFLVDVFRRCTEENPTER-PTAGDL 1126
H ++ S +P + V R +NP +R T GDL
Sbjct: 243 ---MGA--HINQAIPRPSTV-RPGIPVAFD------AVIARGMAKNPEDRYVTCGDL 287
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-23
Identities = 50/167 (29%), Positives = 78/167 (46%), Gaps = 21/167 (12%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
M+Y GG + + K E + ++A F ++ A+ +H H +HRDIK +NIL+
Sbjct: 153 MDYYVGGDLLTLLSKF----EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM 208
Query: 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1022
D +G ++L DF + L G V VGTP +++PE+L+AM
Sbjct: 209 D-----MNGH--IRLADFGSCLKLME---------DGTVQSSVAVGTPDYISPEILQAME 252
Query: 1023 KPNL-YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRP 1068
YG E D WS G + E+L + P+ S +E + I K
Sbjct: 253 GGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER 299
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 54/233 (23%), Positives = 93/233 (39%), Gaps = 56/233 (24%)
Query: 901 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960
I MEYV G ++++ + E ++ K A+ + D AL H I+HRD+K NI
Sbjct: 93 IVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANI 147
Query: 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1020
+I A VK+ DF A + ++ + +GT ++++PE R
Sbjct: 148 MIS-----ATNA--VKVMDFGIARAIADSGNS-------VTQTAAVIGTAQYLSPEQAR- 192
Query: 1021 MHKPNLYGLEV----DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEA 1076
G V D++S GC+L E+LT + P+ G S + + Q + ++
Sbjct: 193 -------GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV--AYQ-----HVREDPIP 238
Query: 1077 LGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-TAGDLYE 1128
S ++ L V + +NP R TA ++
Sbjct: 239 P-SARHEGLSAD----------------LDAVVLKALAKNPENRYQTAAEMRA 274
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 66/303 (21%), Positives = 110/303 (36%), Gaps = 77/303 (25%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
V+TL S + +F L E ++ H IV G +S + LP
Sbjct: 65 VKTLPE-VCSEQDELDF----LMEALIISKFNHQNIVRCIG--VSLQSLP---------R 108
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLA--LFIAQDVAAALVELHSKHIMHRD 954
I ME + GG +K+++ + + S+ + L +A+D+A L H +HRD
Sbjct: 109 F---ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRD 165
Query: 955 IKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP---- 1010
I + N L+ G+ V K+ DF A R I
Sbjct: 166 IAARNCLLT---CPGPGR-VAKIGDFGMA--------------RDIYRASYYRKGGCAML 207
Query: 1011 --RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR 1067
+WM PE ++ + D WS+G LL E+ +L +PY S E+ + + G R
Sbjct: 208 PVKWMPPEAF----MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 263
Query: 1068 PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY 1127
++ +C P + + +C + P +RP +
Sbjct: 264 ------MDPPKNC--------------PGP-------VYRIMTQCWQHQPEDRPNFAIIL 296
Query: 1128 EMF 1130
E
Sbjct: 297 ERI 299
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-23
Identities = 68/299 (22%), Positives = 113/299 (37%), Gaps = 77/299 (25%)
Query: 834 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 892
A K+ R V SS ++ EV +L L H I+++Y +
Sbjct: 66 AIKIIRKTSVSTSSNSKLLE-------EVAVLKLLDHPNIMKLYDFFEDKR--------- 109
Query: 893 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 952
++L+ ME KGG + + I + A I + V + + LH +I+H
Sbjct: 110 NYYLV-----MECYKGGELFDEIIH-----RMKFNEVDAAVIIKQVLSGVTYLHKHNIVH 159
Query: 953 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTP 1010
RD+K EN+L LE K+ D +K+ DF + + GT
Sbjct: 160 RDLKPENLL--LESKEKDAL--IKIVDFGLSAVFENQKKMKERL-------------GTA 202
Query: 1011 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL 1070
++APEVLR Y + D+WS G +L LL P+ G ++ EI ++ GK
Sbjct: 203 YYIAPEVLRKK-----YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGK---- 253
Query: 1071 TDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLV-DVFRRCTEENPTERPTAGDLYE 1128
+ E + +S D+ ++ + + R +A E
Sbjct: 254 ---------------------YTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 57/236 (24%), Positives = 96/236 (40%), Gaps = 51/236 (21%)
Query: 834 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 892
A KV I EV +L L H I++++ + +
Sbjct: 51 AVKVINKASAKNKDTSTILR-------EVELLKKLDHPNIMKLFE---------ILEDSS 94
Query: 893 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 952
+++ E GG + + I K K S A I + V + + +H +I+H
Sbjct: 95 SFYIV-----GELYTGGELFDEIIK-----RKRFSEHDAARIIKQVFSGITYMHKHNIVH 144
Query: 953 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTP 1010
RD+K ENIL++ + K D +K+ DF + + + + GT
Sbjct: 145 RDLKPENILLESKEKDCD----IKIIDFGLSTCFQQNTKMKDRI-------------GTA 187
Query: 1011 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1066
++APEVLR Y + D+WS G +L LL+ P+ G +E +I ++ GK
Sbjct: 188 YYIAPEVLR---GT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK 238
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 4e-23
Identities = 68/297 (22%), Positives = 111/297 (37%), Gaps = 77/297 (25%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
++ +K S DE F + E +++ L H +V++YG + +K P
Sbjct: 53 IKMIKEGSMSEDE---F----IEEAKVMMNLSHEKLVQLYG--VCTK------QRPIF-- 95
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
I EY+ G + NY+ + + L + +DV A+ L SK +HRD+
Sbjct: 96 ----IITEYMANGCLLNYLRE----MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLA 147
Query: 957 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1014
+ N L++ + VVK+ DF + R L + G P RW
Sbjct: 148 ARNCLVNDQG-------VVKVSDFGLS---RYVLDDEYTSSVGSKFPV--------RWSP 189
Query: 1015 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 1073
PEVL + + + DIW++G L+ E+ +L ++PY + E + I G R
Sbjct: 190 PEVLMY----SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR------ 239
Query: 1074 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130
L E + + C E ERPT L
Sbjct: 240 LYRPHLA--------------SEK-------VYTIMYSCWHEKADERPTFKILLSNI 275
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-23
Identities = 53/209 (25%), Positives = 90/209 (43%), Gaps = 43/209 (20%)
Query: 858 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 917
L E R+L A+ +V++ + L +++ MEYV GG + +++ +
Sbjct: 89 LNEKRILQAVNFPFLVKLEFSFKDNSNL---------YMV-----MEYVAGGEMFSHLRR 134
Query: 918 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 977
S A F A + LHS +++RD+K EN+LID G +++
Sbjct: 135 -----IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-----QQGY--IQV 182
Query: 978 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1037
DF A ++ T C GTP +APE++ + K Y VD W+ G
Sbjct: 183 TDFGFAKRVKGRTWTLC-------------GTPEALAPEII--LSKG--YNKAVDWWALG 225
Query: 1038 CLLLELLTLQVPYMGLSELEIHDLIQMGK 1066
L+ E+ P+ ++I++ I GK
Sbjct: 226 VLIYEMAAGYPPFFADQPIQIYEKIVSGK 254
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-23
Identities = 66/299 (22%), Positives = 115/299 (38%), Gaps = 77/299 (25%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
++TLK G + + +F LGE ++G H I+ + G + SK+ P
Sbjct: 78 IKTLKA-GYTEKQRVDF----LGEAGIMGQFSHHNIIRLEG--VISKYKPMM-------- 122
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
I EY++ G++ ++ + + SV + + + +AA + L + + +HRD+
Sbjct: 123 ----IITEYMENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLA 174
Query: 957 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG-IPAPDVCVGTPRWMAP 1015
+ NIL++ V K+ DF + L G IP RW AP
Sbjct: 175 ARNILVNSNL-------VCKVSDFGLSRVLEDDPEATYTTSGGKIPI--------RWTAP 219
Query: 1016 EVLRAMHKPNLYGL---EVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLT 1071
E + Y D+WS+G ++ E++T + PY LS E+ I G R
Sbjct: 220 EAI-------SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR---- 268
Query: 1072 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130
L C P A + + +C ++ RP D+ +
Sbjct: 269 --LPTPMDC--------------PSA-------IYQLMMQCWQQERARRPKFADIVSIL 304
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 6e-23
Identities = 68/297 (22%), Positives = 129/297 (43%), Gaps = 76/297 (25%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
V+TLK +E F L E ++ ++H +V++ G + ++ P +
Sbjct: 43 VKTLKEDTMEVEE---F----LKEAAVMKEIKHPNLVQLLG--VCTR------EPPFY-- 85
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
I E++ G++ +Y L E + VS + L++A +++A+ L K+ +HRD+
Sbjct: 86 ----IITEFMTYGNLLDY---LRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLA 138
Query: 957 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1014
+ N L+ +VK+ DF + R AH G P +W A
Sbjct: 139 ARNCLVGENH-------LVKVADFGLS---RLMTGDTYTAHAGAKFPI--------KWTA 180
Query: 1015 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 1073
PE L N + ++ D+W++G LL E+ T PY G+ ++++L++ R
Sbjct: 181 PESLAY----NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR------ 230
Query: 1074 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130
+E C PE + ++ R C + NP++RP+ ++++ F
Sbjct: 231 MERPEGC--------------PEK-------VYELMRACWQWNPSDRPSFAEIHQAF 266
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 7e-23
Identities = 46/218 (21%), Positives = 80/218 (36%), Gaps = 56/218 (25%)
Query: 858 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF----MEYVKGGSVKN 913
E ++ L H V++Y Q + Y K G +
Sbjct: 78 TRERDVMSRLDHPFFVKLYFT------------------FQDDEKLYFGLSYAKNGELLK 119
Query: 914 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 973
YI K F ++ +AL LH K I+HRD+K ENIL++ D
Sbjct: 120 YIRK-----IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN-----EDMH- 168
Query: 974 VVKLCDFDRA-----VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 1028
+++ DF A ++ ++ GT ++++PE+L K
Sbjct: 169 -IQITDFGTAKVLSPESKQARANSFV-------------GTAQYVSPELLT--EKS--AC 210
Query: 1029 LEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1066
D+W+ GC++ +L+ P+ +E I I +
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 248
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 8e-23
Identities = 68/295 (23%), Positives = 114/295 (38%), Gaps = 73/295 (24%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
++TLK S + L E +++ LRH +V++Y
Sbjct: 213 IKTLKPGTMSPEAF-------LQEAQVMKKLRHEKLVQLYAVVSEEPIY----------- 254
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
I EY+ GS+ ++ L K++ + + +A +A+ + + + +HRD++
Sbjct: 255 ----IVTEYMSKGSLLDF---LKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR 307
Query: 957 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1016
+ NIL+ V K+ DF A R A +G P +W APE
Sbjct: 308 AANILVGENL-------VCKVADFGLA---RLIEDNEYTARQGAKFP------IKWTAPE 351
Query: 1017 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELE 1075
+ ++ D+WS+G LL EL T +VPY G+ E+ D ++ G R +
Sbjct: 352 AALY----GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR------MP 401
Query: 1076 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130
C PE+ L D+ +C + P ERPT L
Sbjct: 402 CPPEC--------------PES-------LHDLMCQCWRKEPEERPTFEYLQAFL 435
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-23
Identities = 60/236 (25%), Positives = 95/236 (40%), Gaps = 51/236 (21%)
Query: 834 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 892
A KV I EV +L L H I++++ S
Sbjct: 51 AVKVINKASAKNKDTSTILR-------EVELLKKLDHPNIMKLFEILEDSS--------- 94
Query: 893 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 952
+++ E GG + + I K K S A I + V + + +H +I+H
Sbjct: 95 SFYIV-----GELYTGGELFDEIIK-----RKRFSEHDAARIIKQVFSGITYMHKHNIVH 144
Query: 953 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTP 1010
RD+K ENIL LE K+ D +K+ DF + + + + GT
Sbjct: 145 RDLKPENIL--LESKEKDCD--IKIIDFGLSTCFQQNTKMKDRI-------------GTA 187
Query: 1011 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1066
++APEVLR Y + D+WS G +L LL+ P+ G +E +I ++ GK
Sbjct: 188 YYIAPEVLR---GT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK 238
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 9e-23
Identities = 64/446 (14%), Positives = 129/446 (28%), Gaps = 54/446 (12%)
Query: 73 LYLYKNVLNLIPKSVGRY-EKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KISSPGV 128
L + N L I + L+NL+ N + + L + +S+
Sbjct: 152 LSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDL--SLIPSLFHANVSYNLLST--- 206
Query: 129 NGFALNKLKGLKELELS-----KVPPRPSV-----------LTLLSEIAGLKCLTKLSVC 172
L ++EL+ S V +V LT + + L ++ +
Sbjct: 207 ----LAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTDTAWLLNYPGLVEVDLS 262
Query: 173 HFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYL 231
+ + + + LE+L +S N++ L + L L +++N L+ +
Sbjct: 263 YNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLLHVERNQPQ 322
Query: 232 LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQV---PSWICCNLEGNGK 288
RLENL L +N + +L L H L+NL L +N + ++ +
Sbjct: 323 FDRLENLYLDHNSIV---TLKLSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQ 379
Query: 289 DSSNDDFISSSAEMDVYEGPMLE------NDGNVSFSAESDAGSRHTSSSISTVSSSNSR 342
D + + P L+ +V + G + +I++V S +
Sbjct: 380 HCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHY 439
Query: 343 SLTARKSSKQWKRHHLQQRARQERLNNSRKWRGEGHAQTSMKEGQRYKSGNLDALASETP 402
Q + + Q + L L +E
Sbjct: 440 ITQQGGVPLQGNEQLEAEVNELRAEVQ------------QLTNEQIQQEQLLQGLHAEID 487
Query: 403 SEEASDIIGLDDDDKQLLSPEAESENLLFSVEDDKIRSGTGLHVENCSCAGLESTGKEGN 462
+ + D + + +L + + E +E
Sbjct: 488 TNLRRYRLPKDGLARSSDNLNKVFTHLKERQAFKLRETQARRTEADAKQKETEDLEQENI 547
Query: 463 DECSKHDSSSLSTANGATEQDEGSSS 488
+ D+ A E
Sbjct: 548 ALEKQLDNKRAKQAELRQETSLKRQK 573
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 89.6 bits (222), Expect = 2e-18
Identities = 38/179 (21%), Positives = 67/179 (37%), Gaps = 17/179 (9%)
Query: 102 EINLFPSEVGNLLGLECLQIKISSPGV-NGFALNKLKGLKELELS-----KVPPRPSVLT 155
E S + + I + + V GF L K + K+P
Sbjct: 15 EYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPA------ 68
Query: 156 LLSEIAGLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEI-CYLKALI 213
+ + + + L++ I + +++L + FN ++YLP + + L
Sbjct: 69 --ALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLT 126
Query: 214 SLKVANNKLVELPSGLYL-LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
L + N L LP G++ +L L +SNN L + +LQNL L N+L
Sbjct: 127 VLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH 185
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 48/170 (28%), Positives = 73/170 (42%), Gaps = 31/170 (18%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
E +KGG + + I + +K S + A + + + LH++ ++HRD+K NIL
Sbjct: 95 TELMKGGELLDKILR-----QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILY 149
Query: 963 DLERKKADGKPVVKLCDFDRAVPLR---SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1019
++ +++CDF A LR L T C T ++APEVL
Sbjct: 150 ---VDESGNPESIRICDFGFAKQLRAENGLLMTPC-------------YTANFVAPEVL- 192
Query: 1020 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGL---SELEIHDLIQMGK 1066
+ Y DIWS G LL +LT P+ + EI I GK
Sbjct: 193 ---ERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGK 239
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 1e-22
Identities = 58/267 (21%), Positives = 101/267 (37%), Gaps = 69/267 (25%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
E+ ++ +L H I+ +Y + + +L+ ME GG + +
Sbjct: 56 EIEIMKSLDHPNIIRLYETFEDNT---------DIYLV-----MELCTGGELFERVVH-- 99
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
++ A I +DV +A+ H ++ HRD+K EN L + + +KL D
Sbjct: 100 ---KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSP----LKLID 152
Query: 980 FDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1037
F A + + T GTP +++P+VL LYG E D WS G
Sbjct: 153 FGLAARFKPGKMMRTKV-------------GTPYYVSPQVLE-----GLYGPECDEWSAG 194
Query: 1038 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 1097
++ LL P+ ++ E+ I+ G F PE
Sbjct: 195 VMMYVLLCGYPPFSAPTDSEVMLKIREGT-------------------------FTFPEK 229
Query: 1098 ELETLSFLV-DVFRRCTEENPTERPTA 1123
+ +S + RR ++P +R T+
Sbjct: 230 DWLNVSPQAESLIRRLLTKSPKQRITS 256
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 68/313 (21%), Positives = 121/313 (38%), Gaps = 89/313 (28%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
V++LK S + I + E+ +L L H IV+ G I ++ GN
Sbjct: 55 VKSLKP-ESGGNHIADL----KKEIEILRNLYHENIVKYKG--ICTE----DGGNG---- 99
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
++ + ME++ GS+K Y+ K + +++K L A + + L S+ +HRD+
Sbjct: 100 IK--LIMEFLPSGSLKEYLPK----NKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLA 153
Query: 957 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 1012
+ N+L++ E VK+ DF +A+ +T P W
Sbjct: 154 ARNVLVESEH-------QVKIGDFGLTKAIETDKEYYT---VKDDRDSPV--------FW 195
Query: 1013 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL---------------QVPYMGLSELE 1057
APE L + + + D+WS+G L ELLT + ++
Sbjct: 196 YAPECLMQ----SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251
Query: 1058 IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1117
+ + ++ GKR L +C P+ + + R+C E P
Sbjct: 252 LVNTLKEGKR------LPCPPNC--------------PDE-------VYQLMRKCWEFQP 284
Query: 1118 TERPTAGDLYEMF 1130
+ R + +L E F
Sbjct: 285 SNRTSFQNLIEGF 297
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-22
Identities = 59/296 (19%), Positives = 110/296 (37%), Gaps = 71/296 (23%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
++ LK G + + R+F L E ++G H I+ + G + ++ G
Sbjct: 82 IKALKA-GYTERQRRDF----LSEASIMGQFDHPNIIRLEG--VVTR------GRLAM-- 126
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
I EY++ GS+ ++ + ++ + + + V A + L +HRD+
Sbjct: 127 ----IVTEYMENGSLDTFLRT----HDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLA 178
Query: 957 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG-IPAPDVCVGTPRWMAP 1015
+ N+L+D V K+ DF + L G IP RW AP
Sbjct: 179 ARNVLVDSNL-------VCKVSDFGLSRVLEDDPDAAYTTTGGKIPI--------RWTAP 223
Query: 1016 EVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDEL 1074
E + A + D+WS+G ++ E+L + PY ++ ++ ++ G R L
Sbjct: 224 EAI-AFRT---FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYR------L 273
Query: 1075 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130
A C P A L + C ++ +RP + +
Sbjct: 274 PAPMGC--------------PHA-------LHQLMLDCWHKDRAQRPRFSQIVSVL 308
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-22
Identities = 66/295 (22%), Positives = 127/295 (43%), Gaps = 72/295 (24%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
V+TLK +E L E ++ ++H +V++ G + ++ E
Sbjct: 250 VKTLKEDTMEVEEF-------LKEAAVMKEIKHPNLVQLLG--VCTR---------EPPF 291
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
I E++ G++ +Y L E + VS + L++A +++A+ L K+ +HR++
Sbjct: 292 Y---IITEFMTYGNLLDY---LRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLA 345
Query: 957 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1016
+ N L+ +VK+ DF + R AH G P +W APE
Sbjct: 346 ARNCLVGENH-------LVKVADFGLS---RLMTGDTYTAHAGAKFP------IKWTAPE 389
Query: 1017 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELE 1075
L N + ++ D+W++G LL E+ T PY G+ ++++L++ R +E
Sbjct: 390 SLAY----NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR------ME 439
Query: 1076 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130
C PE + ++ R C + NP++RP+ ++++ F
Sbjct: 440 RPEGC--------------PEK-------VYELMRACWQWNPSDRPSFAEIHQAF 473
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 49/209 (23%), Positives = 83/209 (39%), Gaps = 39/209 (18%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
E+ +L +L H I++++ +++ ME +GG + I
Sbjct: 70 EIEVLKSLDHPNIIKIFEVFEDYH---------NMYIV-----METCEGGELLERIVSAQ 115
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
G K +S + + + AL HS+H++H+D+K ENIL + +K+ D
Sbjct: 116 ARG-KALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENIL--FQDTSPHSP--IKIID 170
Query: 980 FDRAVPLRS--FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1037
F A +S GT +MAPEV + + DIWS G
Sbjct: 171 FGLAELFKSDEHSTNAA-------------GTALYMAPEVFK-----RDVTFKCDIWSAG 212
Query: 1038 CLLLELLTLQVPYMGLSELEIHDLIQMGK 1066
++ LLT +P+ G S E+ +
Sbjct: 213 VVMYFLLTGCLPFTGTSLEEVQQKATYKE 241
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-22
Identities = 50/213 (23%), Positives = 87/213 (40%), Gaps = 50/213 (23%)
Query: 858 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSA----IFMEYVKGGSVKN 913
E++++ L H +V ++ Q + ++ + GG ++
Sbjct: 63 FKELQIMQGLEHPFLVNLWYS------------------FQDEEDMFMVVDLLLGGDLRY 104
Query: 914 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 973
++++ E+ V LFI + + AL L ++ I+HRD+K +NIL+D G
Sbjct: 105 HLQQNVHFKEETV----KLFICE-LVMALDYLQNQRIIHRDMKPDNILLD-----EHGH- 153
Query: 974 VVKLCDFDRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 1031
V + DF+ A +P + + T GT +MAPE+ K Y V
Sbjct: 154 -VHITDFNIAAMLPRETQITTMA-------------GTKPYMAPEMFS-SRKGAGYSFAV 198
Query: 1032 DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 1064
D WS G ELL + PY S +++
Sbjct: 199 DWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT 231
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 61/314 (19%), Positives = 111/314 (35%), Gaps = 91/314 (28%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
V+ L+ S+ + +R+F E+ +L +L+H IV+ G S+
Sbjct: 44 VKKLQH--STEEHLRDF----EREIEILKSLQHDNIVKYKGVCYSAGRRN---------- 87
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
L+ + MEY+ GS+++Y++K ++ + L + + L +K +HRD+
Sbjct: 88 LK--LIMEYLPYGSLRDYLQK----HKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLA 141
Query: 957 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 1012
+ NIL++ E VK+ DF + +P P W
Sbjct: 142 TRNILVENEN-------RVKIGDFGLTKVLPQDKEFFK---VKEPGESPI--------FW 183
Query: 1013 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL----------------QVPYMGLSEL 1056
APE L + + + D+WS+G +L EL T +
Sbjct: 184 YAPESLTE----SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239
Query: 1057 EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1116
+ +L++ R L C P+ + + C N
Sbjct: 240 HLIELLKNNGR------LPRPDGC--------------PDE-------IYMIMTECWNNN 272
Query: 1117 PTERPTAGDLYEMF 1130
+RP+ DL
Sbjct: 273 VNQRPSFRDLALRV 286
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-22
Identities = 60/239 (25%), Positives = 95/239 (39%), Gaps = 56/239 (23%)
Query: 834 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 892
AAK+ T K+ ++ E R+ L+H IV ++ S
Sbjct: 58 AAKIINTKKLSARDFQKLER-------EARICRKLQHPNIVRLHD---------SIQEES 101
Query: 893 EHHLLQSAIFMEYVKGGSVKNYI---EKLSETGEKHVSVKLALFIAQDVAAALVELHSKH 949
H+L+ + V GG + I E SE A Q + ++ HS
Sbjct: 102 FHYLV-----FDLVTGGELFEDIVAREFYSE--------ADASHCIQQILESIAYCHSNG 148
Query: 950 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCV 1007
I+HR++K EN+L+ + K A VKL DF A+ + H
Sbjct: 149 IVHRNLKPENLLLASKAKGAA----VKLADFGLAIEVNDSEAWHGFA------------- 191
Query: 1008 GTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1066
GTP +++PEVL+ + Y VDIW+ G +L LL P+ + ++ I+ G
Sbjct: 192 GTPGYLSPEVLKK----DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA 246
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 59/297 (19%), Positives = 107/297 (36%), Gaps = 71/297 (23%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
+++L + ++ F L E ++ L H ++ + G I
Sbjct: 54 IKSLSR-ITEMQQVEAF----LREGLLMRGLNHPNVLALIG--IMLPPEGLP-------- 98
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
+ + Y+ G + +I +++ +VK + VA + L + +HRD+
Sbjct: 99 ---HVLLPYMCHGDLLQFIRS----PQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLA 151
Query: 957 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1014
+ N ++D VK+ DF A + + HR +P +W A
Sbjct: 152 ARNCMLDESF-------TVKVADFGLARDILDREYYSVQQHRHARLPV--------KWTA 196
Query: 1015 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 1073
E L + + + D+WS+G LL ELLT PY + ++ + G+R
Sbjct: 197 LESL----QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR------ 246
Query: 1074 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130
L C P++ L V ++C E +P RPT L
Sbjct: 247 LPQPEYC--------------PDS-------LYQVMQQCWEADPAVRPTFRVLVGEV 282
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 3e-22
Identities = 55/241 (22%), Positives = 98/241 (40%), Gaps = 50/241 (20%)
Query: 834 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWLPSADGNP 892
A K+ + S +++ + E +L + H I+ + S + +
Sbjct: 123 AVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID---------SYESSS 173
Query: 893 EHHLLQSAIFMEYVKGGSVKNYI---EKLSETGEKHVSVKLALFIAQDVAAALVELHSKH 949
L+ + ++ G + +Y+ LSE K I + + A+ LH+ +
Sbjct: 174 FMFLV-----FDLMRKGELFDYLTEKVALSE--------KETRSIMRSLLEAVSFLHANN 220
Query: 950 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCV 1007
I+HRD+K ENIL+ D ++L DF + L L C
Sbjct: 221 IVHRDLKPENILL-------DDNMQIRLSDFGFSCHLEPGEKLRELC------------- 260
Query: 1008 GTPRWMAPEVLRAMHKPNL--YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMG 1065
GTP ++APE+L+ YG EVD+W+ G +L LL P+ ++ + +I G
Sbjct: 261 GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEG 320
Query: 1066 K 1066
+
Sbjct: 321 Q 321
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-22
Identities = 51/209 (24%), Positives = 89/209 (42%), Gaps = 43/209 (20%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
EV++L L H I+++Y + +L+ E GG + + I
Sbjct: 76 EVQLLKQLDHPNIMKLYE---------FFEDKGYFYLV-----GEVYTGGELFDEIIS-- 119
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
K S A I + V + + +H I+HRD+K EN+L++ + K A+ +++ D
Sbjct: 120 ---RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDAN----IRIID 172
Query: 980 FDRAVPLRS--FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1037
F + + + GT ++APEVL Y + D+WS G
Sbjct: 173 FGLSTHFEASKKMKDKI-------------GTAYYIAPEVLH-----GTYDEKCDVWSTG 214
Query: 1038 CLLLELLTLQVPYMGLSELEIHDLIQMGK 1066
+L LL+ P+ G +E +I ++ GK
Sbjct: 215 VILYILLSGCPPFNGANEYDILKKVEKGK 243
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 4e-22
Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 43/209 (20%)
Query: 858 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 917
E ML + H I+ M+G ++ + ++ M+Y++GG + + + K
Sbjct: 54 NDERLMLSIVTHPFIIRMWGTFQDAQQI---------FMI-----MDYIEGGELFSLLRK 99
Query: 918 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 977
+ +A F A +V AL LHSK I++RD+K ENIL+D +G +K+
Sbjct: 100 -----SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD-----KNGH--IKI 147
Query: 978 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1037
DF A + +T C GTP ++APEV+ KP Y +D WS+G
Sbjct: 148 TDFGFAKYVPDVTYTLC-------------GTPDYIAPEVVS--TKP--YNKSIDWWSFG 190
Query: 1038 CLLLELLTLQVPYMGLSELEIHDLIQMGK 1066
L+ E+L P+ + ++ ++ I +
Sbjct: 191 ILIYEMLAGYTPFYDSNTMKTYEKILNAE 219
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 4e-22
Identities = 64/303 (21%), Positives = 108/303 (35%), Gaps = 77/303 (25%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
V+TL S + +F L E ++ H IV G +S + LP
Sbjct: 106 VKTLPE-VCSEQDELDF----LMEALIISKFNHQNIVRCIG--VSLQSLP---------R 149
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLA--LFIAQDVAAALVELHSKHIMHRD 954
I +E + GG +K+++ + + S+ + L +A+D+A L H +HRD
Sbjct: 150 F---ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRD 206
Query: 955 IKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP---- 1010
I + N L+ G+ V K+ DF A R I
Sbjct: 207 IAARNCLLT---CPGPGR-VAKIGDFGMA--------------RDIYRAGYYRKGGCAML 248
Query: 1011 --RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR 1067
+WM PE ++ + D WS+G LL E+ +L +PY S E+ + + G R
Sbjct: 249 PVKWMPPEAF----MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 304
Query: 1068 PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY 1127
+ P+ + + +C + P +RP +
Sbjct: 305 ------------------------MDPPK---NCPGPVYRIMTQCWQHQPEDRPNFAIIL 337
Query: 1128 EMF 1130
E
Sbjct: 338 ERI 340
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 4e-22
Identities = 55/215 (25%), Positives = 94/215 (43%), Gaps = 56/215 (26%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYI-- 915
EVR++ L H IV+++ I ++ ++ MEY GG V +Y+
Sbjct: 64 EVRIMKILNHPNIVKLF-EVIETE---------------KTLYLIMEYASGGEVFDYLVA 107
Query: 916 -EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 974
++ E K A + + +A+ H K I+HRD+K+EN+L+D +
Sbjct: 108 HGRMKE--------KEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN------- 152
Query: 975 VKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLEV 1031
+K+ DF + L C G P + APE+ + Y G EV
Sbjct: 153 IKIADFGFSNEFTVGGKLDAFC-------------GAPPYAAPELFQG----KKYDGPEV 195
Query: 1032 DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1066
D+WS G +L L++ +P+ G + E+ + + GK
Sbjct: 196 DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 230
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 4e-22
Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 47/211 (22%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI---E 916
E+ +L ++H IV + S+ ++L M+ V GG + + I
Sbjct: 56 EIAVLKKIKHENIVTLEDIYESTT---------HYYL-----VMQLVSGGELFDRILERG 101
Query: 917 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 976
+E K A + Q V +A+ LH I+HRD+K EN+L + + K +
Sbjct: 102 VYTE--------KDASLVIQQVLSAVKYLHENGIVHRDLKPENLL--YLTPEENSK--IM 149
Query: 977 LCDFDRAVPLR-SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 1035
+ DF + + + T C GTP ++APEVL KP Y VD WS
Sbjct: 150 ITDFGLSKMEQNGIMSTAC-------------GTPGYVAPEVLA--QKP--YSKAVDCWS 192
Query: 1036 YGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1066
G + LL P+ +E ++ + I+ G
Sbjct: 193 IGVITYILLCGYPPFYEETESKLFEKIKEGY 223
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 4e-22
Identities = 62/297 (20%), Positives = 113/297 (38%), Gaps = 71/297 (23%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
V++L + E+ F L E ++ H ++ + G I + ++G+P
Sbjct: 58 VKSLNR-ITDIGEVSQF----LTEGIIMKDFSHPNVLSLLG--ICLR----SEGSP---- 102
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
+ + Y+K G ++N+I + +VK + VA + L SK +HRD+
Sbjct: 103 ---LVVLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLA 155
Query: 957 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMA 1014
+ N ++D + VK+ DF R + + + +P +WMA
Sbjct: 156 ARNCMLDEKF-------TVKVADFGLARDMYDKEYYSVHNKTGAKLPV--------KWMA 200
Query: 1015 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 1073
E L+ + + D+WS+G LL EL+T PY ++ +I + G+R
Sbjct: 201 LESLQT----QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR------ 250
Query: 1074 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130
L C P+ L +V +C RP+ +L
Sbjct: 251 LLQPEYC--------------PDP-------LYEVMLKCWHPKAEMRPSFSELVSRI 286
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 5e-22
Identities = 64/296 (21%), Positives = 113/296 (38%), Gaps = 71/296 (23%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
++TLKV G + + R+F LGE ++G H I+ + G + +K P
Sbjct: 78 IKTLKV-GYTEKQRRDF----LGEASIMGQFDHPNIIRLEG--VVTKSKPVM-------- 122
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
I EY++ GS+ +++ K + +V + + + +A+ + L +HRD+
Sbjct: 123 ----IVTEYMENGSLDSFLRK----HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLA 174
Query: 957 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG-IPAPDVCVGTPRWMAP 1015
+ NILI+ V K+ DF L G IP RW +P
Sbjct: 175 ARNILINSNL-------VCKVSDFGLGRVLEDDPEAAYTTRGGKIPI--------RWTSP 219
Query: 1016 EVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDEL 1074
E + + D+WSYG +L E+++ + PY +S ++ + G R L
Sbjct: 220 EAI----AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR------L 269
Query: 1075 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130
C P A L + C +++ RP + +
Sbjct: 270 PPPMDC--------------PAA-------LYQLMLDCWQKDRNNRPKFEQIVSIL 304
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 6e-22
Identities = 61/314 (19%), Positives = 112/314 (35%), Gaps = 91/314 (28%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
V+ L+ S+ + +R+F E+ +L +L+H IV+ G S+
Sbjct: 75 VKKLQH--STEEHLRDF----EREIEILKSLQHDNIVKYKGVCYSAGRRN---------- 118
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
L+ + MEY+ GS+++Y++K ++ + L + + L +K +HRD+
Sbjct: 119 LK--LIMEYLPYGSLRDYLQK----HKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLA 172
Query: 957 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 1012
+ NIL++ E VK+ DF + +P + P W
Sbjct: 173 TRNILVENEN-------RVKIGDFGLTKVLPQDKEYYK---VKEPGESPI--------FW 214
Query: 1013 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL----------------QVPYMGLSEL 1056
APE L + + + D+WS+G +L EL T +
Sbjct: 215 YAPESLTE----SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 270
Query: 1057 EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1116
+ +L++ R L C P+ + + C N
Sbjct: 271 HLIELLKNNGR------LPRPDGC--------------PDE-------IYMIMTECWNNN 303
Query: 1117 PTERPTAGDLYEMF 1130
+RP+ DL
Sbjct: 304 VNQRPSFRDLALRV 317
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 6e-22
Identities = 46/221 (20%), Positives = 76/221 (34%), Gaps = 24/221 (10%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKFF---GNEINLFPSEVGNLLGLECLQI---K 122
S+ L L +N L+ +L+ N + + L L+ L
Sbjct: 351 SLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHST 410
Query: 123 ISSPGVNGFALNKLKGLKELELSK-----VPPRPSVLTLLSEIAGLKCLTKLSVCHFSIR 177
+ A L+ L L++S GL L L + S +
Sbjct: 411 LKRVTEFS-AFLSLEKLLYLDISYTNTKIDFD--------GIFLGLTSLNTLKMAGNSFK 461
Query: 178 YLPPE--IGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLYL-LQ 233
+NL LDLS +++ + + L L L +++N L+ L S Y L
Sbjct: 462 DNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLY 521
Query: 234 RLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQ 274
L LD S NR+ + + +L NL N + C+
Sbjct: 522 SLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICE 562
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-19
Identities = 46/225 (20%), Positives = 80/225 (35%), Gaps = 33/225 (14%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFP-----------------SEVGNLLG 115
+ L + + + K ++L ++ FP S +
Sbjct: 290 MSLAGVSIKYLEDVPKHF-KWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVA 348
Query: 116 LECLQI------KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKL 169
L L +S G ++ L+ L+LS + + + GL+ L L
Sbjct: 349 LPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLS----FNGAIIMSANFMGLEELQHL 404
Query: 170 SVCHFSIRYLPPE--IGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVE-- 224
H +++ + L L LD+S+ K I L +L +LK+A N +
Sbjct: 405 DFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNT 464
Query: 225 LPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L + L LDLS +L + +H LQ LN+ +N L
Sbjct: 465 LSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNL 509
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 4e-16
Identities = 35/151 (23%), Positives = 60/151 (39%), Gaps = 21/151 (13%)
Query: 132 ALNKLKGLKELELS-----KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPE-IGC 185
+ + L+ L+LS + GL L+ L + I+ P
Sbjct: 51 SFSNFSELQWLDLSRCEIETIED--------KAWHGLHHLSNLILTGNPIQSFSPGSFSG 102
Query: 186 LSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKL--VELPSGLYLLQRLENLDLSN 242
L++LE L K+ L + I L L L VA+N + +LP+ L L ++DLS
Sbjct: 103 LTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSY 162
Query: 243 NRLTSLGSLDLCLMHNLQN----LNLQYNKL 269
N + ++ DL + L++ N +
Sbjct: 163 NYIQTITVNDLQFLRENPQVNLSLDMSLNPI 193
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 5e-16
Identities = 25/107 (23%), Positives = 46/107 (42%), Gaps = 3/107 (2%)
Query: 166 LTKLSVCHFSIRYLPPE-IGCLSNLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKLV 223
+ + ++ L S L+ LDLS +++ + + + L L +L + N +
Sbjct: 34 TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93
Query: 224 ELPSG-LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
G L LENL +L SL S + + L+ LN+ +N +
Sbjct: 94 SFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFI 140
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-12
Identities = 38/219 (17%), Positives = 73/219 (33%), Gaps = 28/219 (12%)
Query: 73 LYLYKNVL-NLIPKSVGRYEKLRNLKFFGNEINLFPSEV-GNLLGLECLQI---KISSPG 127
L L N + + P S L NL ++ S G L+ L+ L + I S
Sbjct: 85 LILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCK 144
Query: 128 VNGFALNKLKGLKELELS-----KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPE 182
+ + + L L ++LS + + L L E + L + I ++ +
Sbjct: 145 LPAY-FSNLTNLVHVDLSYNYIQTITV--NDLQFLRENPQV--NLSLDMSLNPIDFIQDQ 199
Query: 183 IGCLSNLEQLDLSFNKM--KYLPTEICYLKALISLKVANNKLVELPS----------GLY 230
L +L L N + T + L L ++ + + + GL
Sbjct: 200 AFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLC 259
Query: 231 LLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
+ E L+ S + + N+ ++L +
Sbjct: 260 DVTIDE-FRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI 297
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 4e-12
Identities = 33/212 (15%), Positives = 67/212 (31%), Gaps = 30/212 (14%)
Query: 68 NSVEGLYLYKNVLNLIPKSV-----GRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIK 122
++ + L N + I + + +L N I+ + + L L ++
Sbjct: 153 TNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLR 212
Query: 123 --ISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLP 180
+S + L L GL L L E + L
Sbjct: 213 GNFNSSNIMKTCLQNLAGLHVHRLI-----------LGEFKDERNLEIFEPSIM------ 255
Query: 181 PEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSGLYLLQRLENLD 239
E C +++ L++ + L + ++ +A + L + ++L
Sbjct: 256 -EGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFK-WQSLS 313
Query: 240 LSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
+ +L +LDL L++L L NK
Sbjct: 314 IIRCQLKQFPTLDL---PFLKSLTLTMNKGSI 342
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 3e-10
Identities = 23/94 (24%), Positives = 40/94 (42%), Gaps = 4/94 (4%)
Query: 179 LPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG-LYLLQRLEN 237
L P I + N+ K+ +P +I + ++ ++ N L L S L+
Sbjct: 4 LNPCIEVVPNIT-YQCMDQKLSKVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSELQW 60
Query: 238 LDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
LDLS + ++ +H+L NL L N + S
Sbjct: 61 LDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQS 94
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 7e-22
Identities = 57/297 (19%), Positives = 102/297 (34%), Gaps = 76/297 (25%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
++T K +S F L E + H IV++ G +
Sbjct: 423 IKTCKN-CTSDSVREKF----LQEALTMRQFDHPHIVKLIGVITENPVW----------- 466
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
I ME G ++++++ + + + + A ++ AL L SK +HRDI
Sbjct: 467 ----IIMELCTLGELRSFLQV----RKFSLDLASLILYAYQLSTALAYLESKRFVHRDIA 518
Query: 957 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1014
+ N+L+ VKL DF + R + +P +WMA
Sbjct: 519 ARNVLVSSND-------CVKLGDFGLS---RYMEDSTYYKASKGKLPI--------KWMA 560
Query: 1015 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 1073
PE + + D+W +G + E+L P+ G+ ++ I+ G+R
Sbjct: 561 PESINF----RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER------ 610
Query: 1074 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130
L +C P L + +C +P+ RP +L
Sbjct: 611 LPMPPNC--------------PPT-------LYSLMTKCWAYDPSRRPRFTELKAQL 646
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 7e-22
Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KIS 124
N++ + N L I + KL ++ N+I + NL L L + +I+
Sbjct: 68 NNLTQINFSNNQLTDIT-PLKNLTKLVDILMNNNQIADIT-PLANLTNLTGLTLFNNQIT 125
Query: 125 SPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIG 184
L L L LELS ++ +S ++GL L +LS + + L P +
Sbjct: 126 DI----DPLKNLTNLNRLELSSNT-----ISDISALSGLTSLQQLSFGN-QVTDLKP-LA 174
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNR 244
L+ LE+LD+S NK+ + + L L SL NN++ ++ L +L L+ L L+ N+
Sbjct: 175 NLTTLERLDISSNKVSDIS-VLAKLTNLESLIATNNQISDIT-PLGILTNLDELSLNGNQ 232
Query: 245 LTSLGSLDLCLMHNLQNLNLQYNKL 269
L +G+L NL +L+L N++
Sbjct: 233 LKDIGTLASL--TNLTDLDLANNQI 255
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 3e-20
Identities = 49/216 (22%), Positives = 91/216 (42%), Gaps = 21/216 (9%)
Query: 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KIS 124
+++ L L N L I ++ L +L N+I+ + L L L++ +IS
Sbjct: 221 TNLDELSLNGNQLKDIG-TLASLTNLTDLDLANNQISNLA-PLSGLTKLTELKLGANQIS 278
Query: 125 SPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIG 184
+ L L L LEL++ L +S I+ LK LT L++ +I + P +
Sbjct: 279 NI----SPLAGLTALTNLELNENQ-----LEDISPISNLKNLTYLTLYFNNISDISP-VS 328
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNR 244
L+ L++L NK+ + + L + L +N++ +L L L R+ L L++
Sbjct: 329 SLTKLQRLFFYNNKVSDVS-SLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQA 386
Query: 245 LTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC 280
T+ ++ ++ N L P+ I
Sbjct: 387 WTNA-PVNYKANVSIPNTVKNVTGALI---APATIS 418
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-19
Identities = 32/181 (17%), Positives = 72/181 (39%), Gaps = 17/181 (9%)
Query: 91 EKLRNLKFFGNEINLFP--SEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVP 148
+ + +++ + L+ ++ I S + L L ++ S
Sbjct: 24 AEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSID----GVEYLNNLTQINFSN-- 77
Query: 149 PRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICY 208
+ LT ++ + L L + + + I + P + L+NL L L N++ + +
Sbjct: 78 ---NQLTDITPLKNLTKLVDILMNNNQIADITP-LANLTNLTGLTLFNNQITDIDP-LKN 132
Query: 209 LKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNK 268
L L L++++N + ++ + L L L+ L N L + L+ L++ NK
Sbjct: 133 LTNLNRLELSSNTISDISA-LSGLTSLQQLSFGNQVTDLKP---LANLTTLERLDISSNK 188
Query: 269 L 269
+
Sbjct: 189 V 189
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 4e-19
Identities = 33/139 (23%), Positives = 59/139 (42%), Gaps = 10/139 (7%)
Query: 131 FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLE 190
F L + L K + +T L +T L I+ + + L+NL
Sbjct: 18 FTDTALAEKMKTVLGK-----TNVTDTVSQTDLDQVTTLQADRLGIKSIDG-VEYLNNLT 71
Query: 191 QLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGS 250
Q++ S N++ + + L L+ + + NN++ ++ L L L L L NN++T +
Sbjct: 72 QINFSNNQLTDIT-PLKNLTKLVDILMNNNQIADIT-PLANLTNLTGLTLFNNQITDI-- 127
Query: 251 LDLCLMHNLQNLNLQYNKL 269
L + NL L L N +
Sbjct: 128 DPLKNLTNLNRLELSSNTI 146
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 4e-14
Identities = 34/201 (16%), Positives = 66/201 (32%), Gaps = 16/201 (7%)
Query: 71 EGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KISSPG 127
L L N ++ I + L NL+ N++ + NL L L + IS
Sbjct: 268 TELKLGANQISNIS-PLAGLTALTNLELNENQLEDIS-PISNLKNLTYLTLYFNNISDIS 325
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLS 187
++ L L+ L + ++ +S +A L + LS H I L P + L+
Sbjct: 326 ----PVSSLTKLQRLFFYN-----NKVSDVSSLANLTNINWLSAGHNQISDLTP-LANLT 375
Query: 188 NLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTS 247
+ QL L+ P ++ + + P+ + D++ N +
Sbjct: 376 RITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPSY 435
Query: 248 LGSLDLCLMHNLQNLNLQYNK 268
+ +
Sbjct: 436 TNEVS-YTFSQPVTIGKGTTT 455
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 3e-11
Identities = 29/182 (15%), Positives = 57/182 (31%), Gaps = 14/182 (7%)
Query: 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KIS 124
++ L L +N L I + + L L + N I+ S V +L L+ L K+S
Sbjct: 287 TALTNLELNENQLEDIS-PISNLKNLTYLTLYFNNISDI-SPVSSLTKLQRLFFYNNKVS 344
Query: 125 SPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIG 184
+L L + L ++ L+ +A L +T+L + + P
Sbjct: 345 DVS----SLANLTNINWLSAGHNQ-----ISDLTPLANLTRITQLGLNDQAWTNAPVNYK 395
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNR 244
++ + P I + + N Y + +
Sbjct: 396 ANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPSYTNEVSYTFSQPVTIGKGTTT 455
Query: 245 LT 246
+
Sbjct: 456 FS 457
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 8e-11
Identities = 16/95 (16%), Positives = 37/95 (38%), Gaps = 5/95 (5%)
Query: 175 SIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQR 234
I + L+ + L + + L + +L+ + + G+ L
Sbjct: 13 PINQIFT-DTALAEKMKTVLGKTNVTDTVS-QTDLDQVTTLQADRLGIKSI-DGVEYLNN 69
Query: 235 LENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L ++ SNN+LT + L + L ++ + N++
Sbjct: 70 LTQINFSNNQLTDITPLK--NLTKLVDILMNNNQI 102
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 9e-22
Identities = 54/240 (22%), Positives = 95/240 (39%), Gaps = 53/240 (22%)
Query: 834 AAKV---RTLKVCGSSAD--EIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 888
AAK R + EI EV +L + H ++ ++
Sbjct: 41 AAKFIKKRQSRASRRGVSREEIER-------EVSILRQVLHHNVITLHD---------VY 84
Query: 889 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK 948
+ + L+ +E V GG + +++ ++ +S + A + + + LH+K
Sbjct: 85 ENRTDVVLI-----LELVSGGELFDFL-----AQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 949 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPL--RSFLHTCCIAHRGIPAPDVC 1006
I H D+K ENI++ K P +KL DF A +
Sbjct: 135 KIAHFDLKPENIML---LDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF------------ 179
Query: 1007 VGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1066
GTP ++APE++ ++P GLE D+WS G + LL+ P++G ++ E I
Sbjct: 180 -GTPEFVAPEIVN--YEP--LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVS 234
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 1e-21
Identities = 66/234 (28%), Positives = 95/234 (40%), Gaps = 18/234 (7%)
Query: 58 IESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLE 117
IE + + + L L P + + L+ L F N+ SEV +L LE
Sbjct: 294 IERVKDFSYNFGWQHLELVNCKFGQFPT--LKLKSLKRLTFTSNKGGNAFSEV-DLPSLE 350
Query: 118 CLQI---KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHF 174
L + +S G + LK L+LS V+T+ S GL+ L L H
Sbjct: 351 FLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS----FNGVITMSSNFLGLEQLEHLDFQHS 406
Query: 175 SIRYLPPEI--GCLSNLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKLVE--LPSGL 229
+++ + L NL LD+S + I L +L LK+A N E LP
Sbjct: 407 NLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIF 466
Query: 230 YLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNL 283
L+ L LDLS +L L + +LQ LN+ N+L S VP I L
Sbjct: 467 TELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKS---VPDGIFDRL 517
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-21
Identities = 37/208 (17%), Positives = 70/208 (33%), Gaps = 15/208 (7%)
Query: 69 SVEGLYLYKN--VLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSP 126
++E L L+ I + + I N G + L++ +
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNF-GWQHLEL--VNC 314
Query: 127 GVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYL---PPEI 183
F KLK LK L + + L L L + + +
Sbjct: 315 KFGQFPTLKLKSLKRLTFTS-----NKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSD 369
Query: 184 GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG--LYLLQRLENLDLS 241
++L+ LDLSFN + + + L+ L L ++ L ++ L+ L LD+S
Sbjct: 370 FGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS 429
Query: 242 NNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
+ + + +L+ L + N
Sbjct: 430 HTHTRVAFNGIFNGLSSLEVLKMAGNSF 457
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 4e-17
Identities = 51/230 (22%), Positives = 87/230 (37%), Gaps = 32/230 (13%)
Query: 68 NSVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEV-GNLLGLECL-----Q 120
S + L L N L + + +L+ L EI +L L L
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 121 IKISSPGVNGFALNKLKGLKELELS-----KVPPRPSVLTLLSEIAGLKCLTKLSVCHFS 175
I+ + G A + L L++L + P I LK L +L+V H
Sbjct: 88 IQSLALG----AFSGLSSLQKLVAVETNLASLENFP--------IGHLKTLKELNVAHNL 135
Query: 176 IRYL--PPEIGCLSNLEQLDLSFNKMKYLPTE-ICYLKAL----ISLKVANNKLVELPSG 228
I+ P L+NLE LDLS NK++ + + L + +SL ++ N + + G
Sbjct: 136 IQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPG 195
Query: 229 LYLLQRLENLDLSNNRLT-SLGSLDLCLMHNLQNLNLQYNKLLSYCQVPS 277
+ RL L L NN + ++ + + L+ L + + +
Sbjct: 196 AFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEK 245
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 1e-16
Identities = 46/212 (21%), Positives = 79/212 (37%), Gaps = 19/212 (8%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEI--NLFPSEVGNLLGLECLQI--------- 121
L L N +N I + +L L N N+ + + L GLE ++
Sbjct: 182 LDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEG 241
Query: 122 KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP 181
+ + ++E L+ + + L L ++ S+ +I +
Sbjct: 242 NLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFN--CLTNVSSFSLVSVTIERVKD 299
Query: 182 EIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLS 241
+ L+L K PT LK+L L +NK S + L LE LDLS
Sbjct: 300 FSY-NFGWQHLELVNCKFGQFPT--LKLKSLKRLTFTSNKGGNAFSEVDL-PSLEFLDLS 355
Query: 242 NNRLTSLG--SLDLCLMHNLQNLNLQYNKLLS 271
N L+ G S +L+ L+L +N +++
Sbjct: 356 RNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT 387
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 3e-14
Identities = 48/192 (25%), Positives = 74/192 (38%), Gaps = 24/192 (12%)
Query: 69 SVEGLYLYKNVLNLI---PKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---- 121
S+E L L +N L+ +S L+ L N + S L LE L
Sbjct: 348 SLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSN 407
Query: 122 --KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSE--IAGLKCLTKLSVCHFSI- 176
++S V L+ L L++S + GL L L + S
Sbjct: 408 LKQMSEFSV----FLSLRNLIYLDISHTH-----TRVAFNGIFNGLSSLEVLKMAGNSFQ 458
Query: 177 RYLPPEI-GCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLY-LLQ 233
P+I L NL LDLS +++ L L +L L +A+N+L +P G++ L
Sbjct: 459 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLT 518
Query: 234 RLENLDLSNNRL 245
L+ + L N
Sbjct: 519 SLQKIWLHTNPW 530
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 1e-21
Identities = 68/295 (23%), Positives = 114/295 (38%), Gaps = 73/295 (24%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
++TLK S + L E +++ LRH +V++Y
Sbjct: 296 IKTLKPGTMSPEAF-------LQEAQVMKKLRHEKLVQLYAVVSEEPIY----------- 337
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
I EY+ GS+ ++ L K++ + + +A +A+ + + + +HRD++
Sbjct: 338 ----IVTEYMSKGSLLDF---LKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR 390
Query: 957 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1016
+ NIL+ V K+ DF A R A +G P +W APE
Sbjct: 391 AANILVGENL-------VCKVADFGLA---RLIEDNEYTARQGAKFP------IKWTAPE 434
Query: 1017 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELE 1075
+ ++ D+WS+G LL EL T +VPY G+ E+ D ++ G R +
Sbjct: 435 AALY----GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR------MP 484
Query: 1076 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130
C PE+ L D+ +C + P ERPT L
Sbjct: 485 CPPEC--------------PES-------LHDLMCQCWRKEPEERPTFEYLQAFL 518
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-21
Identities = 63/318 (19%), Positives = 113/318 (35%), Gaps = 83/318 (26%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
++T+ +S E F L E ++ +V + G + S+ P
Sbjct: 60 IKTVNE-AASMRERIEF----LNEASVMKEFNCHHVVRLLG--VVSQGQP---------T 103
Query: 897 LQSAIFMEYVKGGSVKNYI-----EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIM 951
L + ME + G +K+Y+ + S+ + +A ++A + L++ +
Sbjct: 104 L---VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFV 160
Query: 952 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT-- 1009
HRD+ + N ++ + VK+ DF R I D
Sbjct: 161 HRDLAARNCMVAEDF-------TVKIGDFGMT--------------RDIYETDYYRKGGK 199
Query: 1010 ---P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQM 1064
P RWM+PE L K ++ D+WS+G +L E+ TL + PY GLS ++ +
Sbjct: 200 GLLPVRWMSPESL----KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255
Query: 1065 GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124
G +KP+ L ++ R C + NP RP+
Sbjct: 256 GGL------------------------LDKPD---NCPDMLFELMRMCWQYNPKMRPSFL 288
Query: 1125 DLYEMFVARTSSSISSRS 1142
++ S
Sbjct: 289 EIISSIKEEMEPGFREVS 306
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-21
Identities = 52/211 (24%), Positives = 92/211 (43%), Gaps = 24/211 (11%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEV-GNLLGLECLQI---KISSPGV 128
LYL KN L +P+ + + L+ L+ NEI V L + +++ + S G+
Sbjct: 105 LYLSKNQLKELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 162
Query: 129 NGFALNKLKGLKELELSKVPPRPSVLTLLSEIAG--LKCLTKLSVCHFSIRYLPPEI-GC 185
A +K L + ++ T ++ I LT+L + I +
Sbjct: 163 ENGAFQGMKKLSYIRIAD--------TNITTIPQGLPPSLTELHLDGNKITKVDAASLKG 214
Query: 186 LSNLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKLVELPSGLYLLQRLENLDLSNNR 244
L+NL +L LSFN + + L L + NNKLV++P GL + ++ + L NN
Sbjct: 215 LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNN 274
Query: 245 LTSLGSLDLCL------MHNLQNLNLQYNKL 269
++++GS D C + ++L N +
Sbjct: 275 ISAIGSNDFCPPGYNTKKASYSGVSLFSNPV 305
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 5e-17
Identities = 48/207 (23%), Positives = 83/207 (40%), Gaps = 24/207 (11%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEI-NLFPSEVGNLLGLECLQI---KISSPGV 128
+ L +PK + L N+I + + NL L L + KIS +
Sbjct: 36 VQCSDLGLEKVPKDLPPD--TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK--I 91
Query: 129 NGFALNKLKGLKELELSKVPPRPSVLTLLSEIAG--LKCLTKLSVCHFSIRYLPPEI-GC 185
+ A L L+ L LSK L E+ K L +L V I + +
Sbjct: 92 SPGAFAPLVKLERLYLSK--------NQLKELPEKMPKTLQELRVHENEITKVRKSVFNG 143
Query: 186 LSNLEQLDLSFNKMK--YLPTEI-CYLKALISLKVANNKLVELPSGLYLLQRLENLDLSN 242
L+ + ++L N +K + +K L +++A+ + +P G L L L L
Sbjct: 144 LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQG--LPPSLTELHLDG 201
Query: 243 NRLTSLGSLDLCLMHNLQNLNLQYNKL 269
N++T + + L ++NL L L +N +
Sbjct: 202 NKITKVDAASLKGLNNLAKLGLSFNSI 228
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 7e-13
Identities = 23/87 (26%), Positives = 38/87 (43%), Gaps = 3/87 (3%)
Query: 186 LSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNR 244
L NL L L NK+ + L L L ++ N+L ELP + + L+ L + N
Sbjct: 75 LKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKM--PKTLQELRVHENE 132
Query: 245 LTSLGSLDLCLMHNLQNLNLQYNKLLS 271
+T + ++ + + L N L S
Sbjct: 133 ITKVRKSVFNGLNQMIVVELGTNPLKS 159
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 6e-08
Identities = 21/87 (24%), Positives = 39/87 (44%), Gaps = 3/87 (3%)
Query: 184 GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSN 242
C +L + S ++ +P ++ L + NNK+ E+ G L+ L L L N
Sbjct: 28 RCQCHLRVVQCSDLGLEKVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILIN 85
Query: 243 NRLTSLGSLDLCLMHNLQNLNLQYNKL 269
N+++ + + L+ L L N+L
Sbjct: 86 NKISKISPGAFAPLVKLERLYLSKNQL 112
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 3e-04
Identities = 23/140 (16%), Positives = 44/140 (31%), Gaps = 20/140 (14%)
Query: 73 LYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEV-GNLLGLECLQI---KISS-P 126
L+L N + + + L L N I+ + N L L + K+ P
Sbjct: 197 LHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVP 256
Query: 127 GVNGFALNKLKGLKELEL-----SKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRY--L 179
G L K ++ + L S + + + +S+ ++Y +
Sbjct: 257 G----GLADHKYIQVVYLHNNNISAIGS--NDFCPPGYNTKKASYSGVSLFSNPVQYWEI 310
Query: 180 PPEI-GCLSNLEQLDLSFNK 198
P C+ + L K
Sbjct: 311 QPSTFRCVYVRAAVQLGNYK 330
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 49/195 (25%), Positives = 75/195 (38%), Gaps = 55/195 (28%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE--- 916
E+ + L H +V+ YGH + +F+EY GG + + IE
Sbjct: 55 EICINKMLNHENVVKFYGH-RREG----------NIQ---YLFLEYCSGGELFDRIEPDI 100
Query: 917 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 976
+ E A + A +V LH I HRDIK EN+L+ D + +K
Sbjct: 101 GMPE--------PDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL-------DERDNLK 145
Query: 977 LCDF-----DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLE 1030
+ DF R L+ C GT ++APE+L+ +
Sbjct: 146 ISDFGLATVFRYNNRERLLNKMC-------------GTLPYVAPELLKR----REFHAEP 188
Query: 1031 VDIWSYGCLLLELLT 1045
VD+WS G +L +L
Sbjct: 189 VDVWSCGIVLTAMLA 203
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 1e-21
Identities = 61/243 (25%), Positives = 96/243 (39%), Gaps = 59/243 (24%)
Query: 834 AAKV---RTLKVCGSSAD--EIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 888
AAK R L EI EV +L +RH I+ ++
Sbjct: 34 AAKFIKKRRLSSSRRGVSREEIER-------EVNILREIRHPNIITLHD---------IF 77
Query: 889 DGNPEHHLLQSAIFMEYVKGGSVKNYI---EKLSETGEKHVSVKLALFIAQDVAAALVEL 945
+ + L+ +E V GG + +++ E L+E A + + + L
Sbjct: 78 ENKTDVVLI-----LELVSGGELFDFLAEKESLTE--------DEATQFLKQILDGVHYL 124
Query: 946 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAP 1003
HSK I H D+K ENI+ L K P +KL DF A + +
Sbjct: 125 HSKRIAHFDLKPENIM--LLDKNVPN-PRIKLIDFGIAHKIEAGNEFKNIF--------- 172
Query: 1004 DVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQ 1063
GTP ++APE++ ++P GLE D+WS G + LL+ P++G ++ E I
Sbjct: 173 ----GTPEFVAPEIVN--YEP--LGLEADMWSIGVITYILLSGASPFLGETKQETLTNIS 224
Query: 1064 MGK 1066
Sbjct: 225 AVN 227
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-21
Identities = 68/315 (21%), Positives = 118/315 (37%), Gaps = 96/315 (30%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
V+ LK + ++F E +L L+H IV+ YG + P L
Sbjct: 50 VKALK--DPTLAARKDF----QREAELLTNLQHEHIVKFYG--VCGDGDP---------L 92
Query: 897 LQSAIFMEYVKGGSVKNY-----------IEKLSETGEKHVSVKLALFIAQDVAAALVEL 945
+ + EY+K G + + ++ + + + L IA +A+ +V L
Sbjct: 93 I---MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL 149
Query: 946 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV 1005
S+H +HRD+ + N L+ +VK+ DF + R + + D
Sbjct: 150 ASQHFVHRDLATRNCLVGANL-------LVKIGDFGMS--------------RDVYSTDY 188
Query: 1006 CVGT-----P-RWMAPEVLRAMHKPNLYG---LEVDIWSYGCLLLELLTL-QVPYMGLSE 1055
P RWM PE + +Y E D+WS+G +L E+ T + P+ LS
Sbjct: 189 YRVGGHTMLPIRWMPPESI-------MYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN 241
Query: 1056 LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 1115
E+ + I G+ LE C P+ + DV C +
Sbjct: 242 TEVIECITQGRV------LERPRVC--------------PKE-------VYDVMLGCWQR 274
Query: 1116 NPTERPTAGDLYEMF 1130
P +R ++Y++
Sbjct: 275 EPQQRLNIKEIYKIL 289
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-21
Identities = 55/299 (18%), Positives = 102/299 (34%), Gaps = 78/299 (26%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
V+ LK + L E ++ L + IV M G I E +
Sbjct: 49 VKILKNEANDPALKDEL----LAEANVMQQLDNPYIVRMIG--ICEA---------ESWM 93
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
+ ME + G + Y+++ +HV K + + V+ + L + +HRD+
Sbjct: 94 ----LVMEMAELGPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLA 144
Query: 957 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 1012
+ N+L+ + K+ DF +A+ + A P +W
Sbjct: 145 ARNVLLVTQH-------YAKISDFGLSKALRADENYYK---AQTHGKWPV--------KW 186
Query: 1013 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLT 1071
APE + + + D+WS+G L+ E + Q PY G+ E+ +++ G+R
Sbjct: 187 YAPECINY----YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER---- 238
Query: 1072 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130
+ C P + D+ C + RP +
Sbjct: 239 --MGCPAGC--------------PRE-------MYDLMNLCWTYDVENRPGFAAVELRL 274
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 2e-21
Identities = 53/167 (31%), Positives = 78/167 (46%), Gaps = 32/167 (19%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
MEY+ GG + +I+ + A F A ++ L LHSK I++RD+K +NIL+
Sbjct: 97 MEYLNGGDLMYHIQS-----CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL 151
Query: 963 DLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1019
D DG +K+ DF + + +T C GTP ++APE+L
Sbjct: 152 D-----KDGH--IKIADFGMCKENMLGDAKTNTFC-------------GTPDYIAPEILL 191
Query: 1020 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1066
Y VD WS+G LL E+L Q P+ G E E+ I+M
Sbjct: 192 GQK----YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN 234
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 2e-21
Identities = 47/174 (27%), Positives = 76/174 (43%), Gaps = 46/174 (26%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
+++++GG + + K E + + F ++A AL LHS I++RD+K ENIL+
Sbjct: 105 LDFLRGGDLFTRLSK-----EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL 159
Query: 963 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 1012
D +G +KL DF +A ++ C GT +
Sbjct: 160 D-----EEGH--IKLTDFGLSKESIDHEKKA-------YSFC-------------GTVEY 192
Query: 1013 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1066
MAPEV+ + D WS+G L+ E+LT +P+ G E +I K
Sbjct: 193 MAPEVVNRRG----HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK 242
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 62/313 (19%), Positives = 114/313 (36%), Gaps = 90/313 (28%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
V+ L+ G D+ R+F E+++L AL IV+ G
Sbjct: 57 VKQLQHSGP--DQQRDF----QREIQILKALHSDFIVKYRGVSYGPGRQS---------- 100
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
L+ + MEY+ G +++++++ + L + + + L S+ +HRD+
Sbjct: 101 LR--LVMEYLPSGCLRDFLQR----HRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLA 154
Query: 957 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 1012
+ NIL++ E VK+ DF + +PL + P W
Sbjct: 155 ARNILVESEA-------HVKIADFGLAKLLPLDKDYYV---VREPGQSPI--------FW 196
Query: 1013 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSEL--------------E 1057
APE L N++ + D+WS+G +L EL T +E
Sbjct: 197 YAPESLSD----NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252
Query: 1058 IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1117
+ +L++ G+R L A +C P + ++ + C +P
Sbjct: 253 LLELLEEGQR------LPAPPAC--------------PAE-------VHELMKLCWAPSP 285
Query: 1118 TERPTAGDLYEMF 1130
+RP+ L
Sbjct: 286 QDRPSFSALGPQL 298
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 98.7 bits (245), Expect = 3e-21
Identities = 49/236 (20%), Positives = 88/236 (37%), Gaps = 22/236 (9%)
Query: 54 DFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNL 113
P G +S + L K+ + E+L + + + SE+ +
Sbjct: 312 QLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKSTVLQSELESC 371
Query: 114 LGLECLQIKISSPGVNGFA-----------------LNKLKGLKELELSKVPPRPSVLTL 156
L+ L+ + + + LK + + + + S L
Sbjct: 372 KELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLL 431
Query: 157 LSEIAG--LKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALIS 214
+ + + L + H + L + L + LDLS N+++ LP + L+ L
Sbjct: 432 ENSVLKMEYADVRVLHLAHKDLTVLC-HLEQLLLVTHLDLSHNRLRALPPALAALRCLEV 490
Query: 215 LKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLD-LCLMHNLQNLNLQYNKL 269
L+ ++N L + G+ L RL+ L L NNRL ++ L L LNLQ N L
Sbjct: 491 LQASDNALENVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 48.2 bits (114), Expect = 1e-05
Identities = 26/219 (11%), Positives = 61/219 (27%), Gaps = 3/219 (1%)
Query: 72 GLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGF 131
L +++ E+ F + + LL ++ + + +G
Sbjct: 234 WLLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGR 293
Query: 132 ALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQ 191
L +L + + + T G + + + L +
Sbjct: 294 NRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFR 353
Query: 192 LDLSFNKMKYLPTEICYLKALISLKVANN-KLVELPSGLYLLQRLENLDLSNNRLTSLGS 250
+LS K L +E+ K L L+ N L+ + + L L + ++L +
Sbjct: 354 CELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKA 413
Query: 251 LDLC--LMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNG 287
+D + + + +L
Sbjct: 414 VDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKD 452
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-21
Identities = 49/301 (16%), Positives = 105/301 (34%), Gaps = 83/301 (27%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
++ L+ +S + L E ++ ++ + + + G ++S
Sbjct: 49 IKELRE-ATSPKANKEI----LDEAYVMASVDNPHVCRLLGICLTSTVQ----------- 92
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
+ + + G + +Y+ + + ++ + L +A + L + ++HRD+
Sbjct: 93 ----LITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLA 144
Query: 957 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP------ 1010
+ N+L+ + VK+ DF A + + A +
Sbjct: 145 ARNVLVKTPQ-------HVKITDFGLA--------------KLLGAEEKEYHAEGGKVPI 183
Query: 1011 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPR 1069
+WMA E + +Y + D+WSYG + EL+T PY G+ EI +++ G+R
Sbjct: 184 KWMALESILH----RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-- 237
Query: 1070 LTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1129
L C + + +C + RP +L
Sbjct: 238 ----LPQPPIC--------------TID-------VYMIMVKCWMIDADSRPKFRELIIE 272
Query: 1130 F 1130
F
Sbjct: 273 F 273
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-21
Identities = 55/272 (20%), Positives = 100/272 (36%), Gaps = 69/272 (25%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
E+ +L +L H I++++ K +L+ E+ +GG + I
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKK---------YFYLV-----TEFYEGGELFEQIIN-- 139
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
A I + + + + LH +I+HRDIK ENIL LE K + +K+ D
Sbjct: 140 ---RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENIL--LENKNSLLN--IKIVD 192
Query: 980 FDRAVPLRS--FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1037
F + L GT ++APEVL+ Y + D+WS G
Sbjct: 193 FGLSSFFSKDYKLRDRL-------------GTAYYIAPEVLK-----KKYNEKCDVWSCG 234
Query: 1038 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 1097
++ LL P+ G ++ +I ++ GK +
Sbjct: 235 VIMYILLCGYPPFGGQNDQDIIKKVEKGK-------------------------YYFDFN 269
Query: 1098 ELETLSFLV-DVFRRCTEENPTERPTAGDLYE 1128
+ + +S ++ + + +R TA +
Sbjct: 270 DWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 3e-21
Identities = 62/297 (20%), Positives = 117/297 (39%), Gaps = 77/297 (25%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
V+T+K S + L E ++ L+H +V+++ + +K P +
Sbjct: 217 VKTMKPGSMSVEAF-------LAEANVMKTLQHDKLVKLHA--VVTK-------EPIY-- 258
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
I E++ GS+ ++ L + + + +A + + ++ +HRD++
Sbjct: 259 ----IITEFMAKGSLLDF---LKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLR 311
Query: 957 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1014
+ NIL+ V K+ DF A R A G P +W A
Sbjct: 312 AANILVSASL-------VCKIADFGLA---RVIEDNEYTAREGAKFPI--------KWTA 353
Query: 1015 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 1073
PE + + ++ D+WS+G LL+E++T ++PY G+S E+ ++ G R
Sbjct: 354 PEAINF----GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR------ 403
Query: 1074 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130
+ +C PE L ++ RC + P ERPT + +
Sbjct: 404 MPRPENC--------------PEE-------LYNIMMRCWKNRPEERPTFEYIQSVL 439
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 4e-21
Identities = 47/174 (27%), Positives = 78/174 (44%), Gaps = 46/174 (26%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
MEY GG + ++ + E+ + + A F ++ +AL LHS+ +++RDIK EN+++
Sbjct: 84 MEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML 138
Query: 963 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 1012
D DG +K+ DF T C GTP +
Sbjct: 139 D-----KDGH--IKITDFGLCKEGISDGATM-------KTFC-------------GTPEY 171
Query: 1013 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1066
+APEVL N YG VD W G ++ E++ ++P+ + +LI M +
Sbjct: 172 LAPEVLED----NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 221
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 4e-21
Identities = 49/174 (28%), Positives = 73/174 (41%), Gaps = 46/174 (26%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
+EY+ GG + +E+ E A F +++ AL LH K I++RD+K ENI++
Sbjct: 100 LEYLSGGELFMQLER-----EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML 154
Query: 963 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 1012
+ G VKL DF HT C GT +
Sbjct: 155 N-----HQGH--VKLTDFGLCKESIHDGTVT-------HTFC-------------GTIEY 187
Query: 1013 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1066
MAPE+L + + VD WS G L+ ++LT P+ G + + D I K
Sbjct: 188 MAPEILMR----SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK 237
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 55/299 (18%), Positives = 100/299 (33%), Gaps = 78/299 (26%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
++ LK G+ + + E +++ L + IV + G + +
Sbjct: 42 IKVLKQ-GTEKADTEEM----MREAQIMHQLDNPYIVRLIGVCQAEALM----------- 85
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
+ ME GG + ++ + + V + V+ + L K+ +HRD+
Sbjct: 86 ----LVMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLA 137
Query: 957 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 1012
+ N+L+ K+ DF +A+ +T A P +W
Sbjct: 138 ARNVLLVNRH-------YAKISDFGLSKALGADDSYYT---ARSAGKWPL--------KW 179
Query: 1013 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLT 1071
APE + K + D+WSYG + E L+ Q PY + E+ I+ GKR
Sbjct: 180 YAPECI-NFRK---FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR---- 231
Query: 1072 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130
+E C P L + C +RP + +
Sbjct: 232 --MECPPEC--------------PPE-------LYALMSDCWIYKWEDRPDFLTVEQRM 267
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 4e-21
Identities = 25/205 (12%), Positives = 64/205 (31%), Gaps = 12/205 (5%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEV-GNLLGLECLQI---KIS 124
S+E L+ N ++ + S G+ +N+ N+I + G ++ L + +I
Sbjct: 100 SIETLHAANNNISRVSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157
Query: 125 SPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIG 184
+ L+ L L + + + L L + + ++ PE
Sbjct: 158 TVNFAEL-AASSDTLEHLNLQY-----NFIYDVKGQVVFAKLKTLDLSSNKLAFMGPEFQ 211
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNR 244
+ + + L NK+ + + + + L + N + + ++
Sbjct: 212 SAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQT 271
Query: 245 LTSLGSLDLCLMHNLQNLNLQYNKL 269
+ L + +
Sbjct: 272 VKKLTGQNEEECTVPTLGHYGAYCC 296
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 3e-17
Identities = 26/116 (22%), Positives = 46/116 (39%), Gaps = 9/116 (7%)
Query: 157 LSEIAG-LKCLTKLSVCHFSIRYLPPEIG-CLSNLEQLDLSFNKMKYLPTE-ICYLKALI 213
+ EI V S++ + N+++LDLS N + + + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 214 SLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L +++N L E L L L LDL+NN + L +++ L+ N +
Sbjct: 62 LLNLSSNVLYETLD-LESLSTLRTLDLNNNYVQELLVG-----PSIETLHAANNNI 111
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 2e-16
Identities = 27/140 (19%), Positives = 52/140 (37%), Gaps = 19/140 (13%)
Query: 133 LNKLKGLK--ELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPE-IGCLSNL 189
N+ K K + L + S + +L + + + + + L
Sbjct: 9 GNRYKIEKVTDSSLKQALA--------SLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 190 EQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLG 249
E L+LS N + ++ L L +L + NN + EL +E L +NN ++
Sbjct: 61 ELLNLSSNVLYETL-DLESLSTLRTLDLNNNYVQELLV----GPSIETLHAANNNIS--- 112
Query: 250 SLDLCLMHNLQNLNLQYNKL 269
+ +N+ L NK+
Sbjct: 113 RVSCSRGQGKKNIYLANNKI 132
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 2e-14
Identities = 33/251 (13%), Positives = 73/251 (29%), Gaps = 32/251 (12%)
Query: 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KIS 124
+++E L L N + + V + KL+ L N++ E + G+ + + K+
Sbjct: 169 DTLEHLNLQYNFIYDVKGQVV-FAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV 227
Query: 125 S-PGVNGFALNKLKGLKELELS----KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYL 179
AL + L+ +L + + +V +++ L
Sbjct: 228 LIEK----ALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV--------QTVAKQTVKKL 275
Query: 180 PPEIG-CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLV--------ELPSGLY 230
+ + + LP + LI+LK + L+ L
Sbjct: 276 TGQNEEECTVPTLGHYGAYCCEDLPAP--FADRLIALKRKEHALLSGQGSETERLECERE 333
Query: 231 LLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDS 290
R +D + ++ L + L L+G + +
Sbjct: 334 NQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQA 393
Query: 291 SNDDFISSSAE 301
+ + E
Sbjct: 394 VGQIELQHATE 404
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 4e-21
Identities = 57/219 (26%), Positives = 86/219 (39%), Gaps = 13/219 (5%)
Query: 58 IESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVG--NLLG 115
IE + + + L L P + L+ L F N+ SEV +L
Sbjct: 294 IERVKDFSYNFGWQHLELVNCKFGQFPTLKLK--SLKRLTFTSNKGGNAFSEVDLPSLEF 351
Query: 116 LECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS 175
L+ + +S G + LK L+LS V+T+ S GL+ L L H +
Sbjct: 352 LDLSRNGLSFKGCCSQSDFGTTSLKYLDLS----FNGVITMSSNFLGLEQLEHLDFQHSN 407
Query: 176 IRYLPPE--IGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVE--LPSGLY 230
++ + L NL LD+S + L +L LK+A N E LP
Sbjct: 408 LKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 467
Query: 231 LLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L+ L LDLS +L L + +LQ LN+ +N
Sbjct: 468 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNF 506
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-19
Identities = 55/219 (25%), Positives = 81/219 (36%), Gaps = 29/219 (13%)
Query: 69 SVEGLYLYKNVLN---LIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECL-----Q 120
S+E L L +N L+ +S L+ L N + S L LE L
Sbjct: 348 SLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSN 407
Query: 121 IKISSPGVNGFALNKLKGLKELELS-----KVPPRPSVLTLLSEIAGLKCLT--KLSVCH 173
+K S L+ L L++S GL L K++
Sbjct: 408 LKQMSEFS---VFLSLRNLIYLDISHTHTRVAFN--------GIFNGLSSLEVLKMAGNS 456
Query: 174 FSIRYLPPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSG-LYL 231
F +LP L NL LDLS +++ L PT L +L L +++N L +
Sbjct: 457 FQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKC 516
Query: 232 LQRLENLDLSNNRLTSLGSLDLC-LMHNLQNLNLQYNKL 269
L L+ LD S N + + +L +L LNL N
Sbjct: 517 LNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 555
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-18
Identities = 35/197 (17%), Positives = 67/197 (34%), Gaps = 13/197 (6%)
Query: 80 LNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGL 139
L+ I + + I + G + L++ + F KLK L
Sbjct: 271 LDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLEL--VNCKFGQFPTLKLKSL 327
Query: 140 KELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYL---PPEIGCLSNLEQLDLSF 196
K L + + L L L + + + ++L+ LDLSF
Sbjct: 328 KRLTFTS-----NKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSF 382
Query: 197 NKMKYLPTEICYLKALISLKVANNKLVEL--PSGLYLLQRLENLDLSNNRLTSLGSLDLC 254
N + + + L+ L L ++ L ++ S L+ L LD+S+ +
Sbjct: 383 NGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN 442
Query: 255 LMHNLQNLNLQYNKLLS 271
+ +L+ L + N
Sbjct: 443 GLSSLEVLKMAGNSFQE 459
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-17
Identities = 56/238 (23%), Positives = 94/238 (39%), Gaps = 32/238 (13%)
Query: 68 NSVEGLYLYKNVL-NLIPKSVGRYEKLRNLKFFGNEIN-LFPSEVGNLLGLECL-----Q 120
S + L L N L +L S + +L+ L EI + +L L L
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 121 IKISSPGVNGFALNKLKGLKELELS-----KVPPRPSVLTLLSEIAGLKCLTKLSV--CH 173
I+ + G A + L L++L + P I LK L +L+V
Sbjct: 88 IQSLALG----AFSGLSSLQKLVAVETNLASLENFP--------IGHLKTLKELNVAHNL 135
Query: 174 FSIRYLPPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKAL----ISLKVANNKLVELPSG 228
LP L+NLE LDLS NK++ + T++ L + +SL ++ N + + G
Sbjct: 136 IQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPG 195
Query: 229 LYLLQRLENLDLSNNRLT-SLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEG 285
+ RL L L NN + ++ + + L+ L + + + + LEG
Sbjct: 196 AFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEG 253
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-16
Identities = 44/251 (17%), Positives = 85/251 (33%), Gaps = 32/251 (12%)
Query: 73 LYLYKNVL-NLIPKSVGRYEKLRNLKFF-------GNEINLFPSEVGNLLGLECLQIK-- 122
L L N + ++ + L + N +N + L L ++
Sbjct: 154 LDLSSNKIQSIYCTDLR---VLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNN 210
Query: 123 ISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYL--- 179
S V + L GL+ L R + + L+ L L++ F + YL
Sbjct: 211 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYY 270
Query: 180 ----PPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRL 235
CL+N+ L ++ + + Y L++ N K + P+ L+ L
Sbjct: 271 LDDIIDLFNCLTNVSSFSLVSVTIERVK-DFSYNFGWQHLELVNCKFGQFPTLK--LKSL 327
Query: 236 ENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICC-------NLEGNGK 288
+ L ++N+ + S +L+ L+L N L +L NG
Sbjct: 328 KRLTFTSNKGGNAFSEVDL--PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGV 385
Query: 289 DSSNDDFISSS 299
+ + +F+
Sbjct: 386 ITMSSNFLGLE 396
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 8e-13
Identities = 22/99 (22%), Positives = 39/99 (39%), Gaps = 4/99 (4%)
Query: 173 HFSIRYLPPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSG-LY 230
+ +P + + + LDLSFN +++L L L ++ ++ + G
Sbjct: 16 ELNFYKIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQ 73
Query: 231 LLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L L L L+ N + SL + +LQ L L
Sbjct: 74 SLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNL 112
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 2e-06
Identities = 16/53 (30%), Positives = 23/53 (43%), Gaps = 2/53 (3%)
Query: 219 NNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
++P L +NLDLS N L LGS LQ L+L ++ +
Sbjct: 16 ELNFYKIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-21
Identities = 49/195 (25%), Positives = 75/195 (38%), Gaps = 55/195 (28%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE--- 916
E+ + L H +V+ YGH + +F+EY GG + + IE
Sbjct: 55 EICINKMLNHENVVKFYGH-RREG----------NIQ---YLFLEYCSGGELFDRIEPDI 100
Query: 917 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 976
+ E A + A +V LH I HRDIK EN+L+ D + +K
Sbjct: 101 GMPE--------PDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL-------DERDNLK 145
Query: 977 LCDF-----DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLE 1030
+ DF R L+ C GT ++APE+L+ +
Sbjct: 146 ISDFGLATVFRYNNRERLLNKMC-------------GTLPYVAPELLKR----REFHAEP 188
Query: 1031 VDIWSYGCLLLELLT 1045
VD+WS G +L +L
Sbjct: 189 VDVWSCGIVLTAMLA 203
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 5e-21
Identities = 51/240 (21%), Positives = 97/240 (40%), Gaps = 53/240 (22%)
Query: 834 AAKV---RTLKVCGSSAD--EIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 888
AAK R K +I EV +L ++H ++ ++
Sbjct: 40 AAKFIKKRRTKSSRRGVSREDIER-------EVSILKEIQHPNVITLHE---------VY 83
Query: 889 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK 948
+ + L+ +E V GG + +++ + ++ ++ + A + + + LHS
Sbjct: 84 ENKTDVILI-----LELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLHSL 133
Query: 949 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVC 1006
I H D+K ENI+ L + P +K+ DF A + +
Sbjct: 134 QIAHFDLKPENIM--LLDRNVPK-PRIKIIDFGLAHKIDFGNEFKNIF------------ 178
Query: 1007 VGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1066
GTP ++APE++ ++P GLE D+WS G + LL+ P++G ++ E +
Sbjct: 179 -GTPEFVAPEIVN--YEP--LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN 233
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 5e-21
Identities = 61/297 (20%), Positives = 110/297 (37%), Gaps = 80/297 (26%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
V+ +K ++A L E ++ LRHS +V++ G + +
Sbjct: 49 VKCIK-NDATAQAF-------LAEASVMTQLRHSNLVQLLG--VIVEEKGGL-------- 90
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
I EY+ GS+ +Y L G + L + DV A+ L + +HRD+
Sbjct: 91 ---YIVTEYMAKGSLVDY---LRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLA 144
Query: 957 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1014
+ N+L+ + V K+ DF + + +P +W A
Sbjct: 145 ARNVLVSEDN-------VAKVSDFGLT---KE-ASS---TQDTGKLPV--------KWTA 182
Query: 1015 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 1073
PE LR + + D+WS+G LL E+ + +VPY + ++ ++ G +
Sbjct: 183 PEALRE----KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK------ 232
Query: 1074 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130
++A C P A + +V + C + RP+ L E
Sbjct: 233 MDAPDGC--------------PPA-------VYEVMKNCWHLDAAMRPSFLQLREQL 268
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 6e-21
Identities = 66/313 (21%), Positives = 118/313 (37%), Gaps = 90/313 (28%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 895
V+ LK ++ ++ + + E+ M+ + +H I+ + G P +
Sbjct: 72 VKMLK-DDATEKDLSDL----VSEMEMMKMIGKHKNIINLLGA--------CTQDGPLY- 117
Query: 896 LLQSAIFMEYVKGGSVKNY-----------IEKLSETGEKHVSVKLALFIAQDVAAALVE 944
+ +EY G+++ Y ++ E+ ++ K + +A +
Sbjct: 118 -----VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 172
Query: 945 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1004
L S+ +HRD+ + N+L+ + V+K+ DF A R I D
Sbjct: 173 LASQKCIHRDLAARNVLV------TENN-VMKIADFGLA--------------RDINNID 211
Query: 1005 VCVGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELE 1057
T P +WMAPE L +Y + D+WS+G L+ E+ TL PY G+ E
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFD----RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267
Query: 1058 IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1117
+ L++ G R +KP + L + R C P
Sbjct: 268 LFKLLKEGHR------------------------MDKPA---NCTNELYMMMRDCWHAVP 300
Query: 1118 TERPTAGDLYEMF 1130
++RPT L E
Sbjct: 301 SQRPTFKQLVEDL 313
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 6e-21
Identities = 46/179 (25%), Positives = 72/179 (40%), Gaps = 49/179 (27%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
++Y+ GG + ++ + + + ++ AL LH I++RDIK ENIL+
Sbjct: 138 LDYINGGELFTHLSQ-----RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL 192
Query: 963 DLERKKADGKPVVKLCDF-----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR 1011
D ++G V L DF +RA + C GT
Sbjct: 193 D-----SNGH--VVLTDFGLSKEFVADETERA-------YDFC-------------GTIE 225
Query: 1012 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSE----LEIHDLIQMGK 1066
+MAP+++R + VD WS G L+ ELLT P+ E EI I +
Sbjct: 226 YMAPDIVRGGDSG--HDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 282
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 6e-21
Identities = 71/311 (22%), Positives = 115/311 (36%), Gaps = 89/311 (28%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
V+ LK S ++F E +L L+H IV +G + ++ P L
Sbjct: 76 VKALKEA--SESARQDF----QREAELLTMLQHQHIVRFFG--VCTEGRP---------L 118
Query: 897 LQSAIFMEYVKGGSVKNY----------IEKLSETGEKHVSVKLALFIAQDVAAALVELH 946
L + EY++ G + + + + + + L +A VAA +V L
Sbjct: 119 L---MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA 175
Query: 947 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC 1006
H +HRD+ + N L+ VVK+ DF + R I + D
Sbjct: 176 GLHFVHRDLATRNCLVGQGL-------VVKIGDFGMS--------------RDIYSTDYY 214
Query: 1007 -VGT----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIH 1059
VG P RWM PE + + E D+WS+G +L E+ T + P+ LS E
Sbjct: 215 RVGGRTMLPIRWMPPESI----LYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI 270
Query: 1060 DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1119
D I G+ LE +C P + + R C + P +
Sbjct: 271 DCITQGRE------LERPRAC--------------PPE-------VYAIMRGCWQREPQQ 303
Query: 1120 RPTAGDLYEMF 1130
R + D++
Sbjct: 304 RHSIKDVHARL 314
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 6e-21
Identities = 57/223 (25%), Positives = 88/223 (39%), Gaps = 47/223 (21%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
ME ++GG + ++ E G++ + + A I +D+ A+ LHS +I HRD+K EN+L
Sbjct: 105 MECMEGGEL---FSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLL- 160
Query: 963 DLERKKADGKPVVKLCDFDRAVPLRS-FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 1021
K+ D V+KL DF A L T C TP ++APEVL
Sbjct: 161 -YTSKEKD--AVLKLTDFGFAKETTQNALQTPC-------------YTPYYVAPEVLGPE 204
Query: 1022 HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH 1081
Y D+WS G ++ LL P+ + I + +
Sbjct: 205 K----YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM-----------KRRIRLGQ 249
Query: 1082 EHEVAQSGSGFEKPEAELETLSFLV-DVFRRCTEENPTERPTA 1123
+ P E +S + R + +PTER T
Sbjct: 250 ----------YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTI 282
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 6e-21
Identities = 67/320 (20%), Positives = 125/320 (39%), Gaps = 97/320 (30%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
V+ LK +S E+R+ L E +L + H ++++YG + P L
Sbjct: 58 VKMLKE-NASPSELRDL----LSEFNVLKQVNHPHVIKLYGA--------CSQDGP---L 101
Query: 897 LQSAIFMEYVKGGSVKNY-------------------IEKLSETGEKHVSVKLALFIAQD 937
L + +EY K GS++ + L E+ +++ + A
Sbjct: 102 L---LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQ 158
Query: 938 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 997
++ + L ++HRD+ + NIL+ A+G+ +K+ DF +
Sbjct: 159 ISQGMQYLAEMKLVHRDLAARNILV------AEGR-KMKISDFGLS-------------- 197
Query: 998 RGIPAPDVCVGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPY 1050
R + D V P +WMA E L ++Y + D+WS+G LL E++TL PY
Sbjct: 198 RDVYEEDSYVKRSQGRIPVKWMAIESLFD----HIYTTQSDVWSFGVLLWEIVTLGGNPY 253
Query: 1051 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 1110
G+ + +L++ G R E+P+ + +
Sbjct: 254 PGIPPERLFNLLKTGHR------------------------MERPD---NCSEEMYRLML 286
Query: 1111 RCTEENPTERPTAGDLYEMF 1130
+C ++ P +RP D+ +
Sbjct: 287 QCWKQEPDKRPVFADISKDL 306
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 7e-21
Identities = 48/174 (27%), Positives = 73/174 (41%), Gaps = 36/174 (20%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
ME + GG + I+K +KH S A +I + + +A+ +H ++HRD+K EN+L
Sbjct: 85 MELLNGGELFERIKK-----KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLF 139
Query: 963 DLERKKADGKPVVKLCDFDRAVPLR---SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1019
+ +K+ DF A L T C T + APE+L
Sbjct: 140 ----TDENDNLEIKIIDFGFARLKPPDNQPLKTPC-------------FTLHYAAPELLN 182
Query: 1020 AMHKPNLYGLEVDIWSYGCLLLELLTLQVP-------YMGLSELEIHDLIQMGK 1066
N Y D+WS G +L +L+ QVP S +EI I+ G
Sbjct: 183 Q----NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD 232
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 7e-21
Identities = 64/297 (21%), Positives = 109/297 (36%), Gaps = 80/297 (26%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
V+ +K ++A L E ++ LRHS +V++ G + +
Sbjct: 221 VKCIK-NDATAQAF-------LAEASVMTQLRHSNLVQLLG--VIVEEKGGL-------- 262
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
I EY+ GS+ +Y L G + L + DV A+ L + +HRD+
Sbjct: 263 ---YIVTEYMAKGSLVDY---LRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLA 316
Query: 957 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1014
+ N+L+ + V K+ DF S +P +W A
Sbjct: 317 ARNVLVSEDN-------VAKVSDFGLTKEASS-------TQDTGKLPV--------KWTA 354
Query: 1015 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 1073
PE LR + + D+WS+G LL E+ + +VPY + ++ ++ G +
Sbjct: 355 PEALRE----KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK------ 404
Query: 1074 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130
++A C P A + DV + C + RPT L E
Sbjct: 405 MDAPDGC--------------PPA-------VYDVMKNCWHLDAATRPTFLQLREQL 440
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-20
Identities = 58/243 (23%), Positives = 95/243 (39%), Gaps = 59/243 (24%)
Query: 834 AAKV---RTLKVCGSSAD--EIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 888
AAK R + EI EV +L + H I+ ++
Sbjct: 41 AAKFIKKRQSRASRRGVCREEIER-------EVSILRQVLHPNIITLHD---------VY 84
Query: 889 DGNPEHHLLQSAIFMEYVKGGSVKNYI---EKLSETGEKHVSVKLALFIAQDVAAALVEL 945
+ + L+ +E V GG + +++ E LSE + A + + + L
Sbjct: 85 ENRTDVVLI-----LELVSGGELFDFLAQKESLSE--------EEATSFIKQILDGVNYL 131
Query: 946 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPL--RSFLHTCCIAHRGIPAP 1003
H+K I H D+K ENI++ K P +KL DF A +
Sbjct: 132 HTKKIAHFDLKPENIML---LDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF--------- 179
Query: 1004 DVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQ 1063
GTP ++APE++ ++P GLE D+WS G + LL+ P++G ++ E I
Sbjct: 180 ----GTPEFVAPEIVN--YEP--LGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT 231
Query: 1064 MGK 1066
Sbjct: 232 AVS 234
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 1e-20
Identities = 63/297 (21%), Positives = 112/297 (37%), Gaps = 71/297 (23%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
V++L + E+ F L E ++ H ++ + G I + ++G+P
Sbjct: 122 VKSLNR-ITDIGEVSQF----LTEGIIMKDFSHPNVLSLLG--ICLR----SEGSP---- 166
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
+ + Y+K G ++N+I + +VK + VA + L SK +HRD+
Sbjct: 167 ---LVVLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLA 219
Query: 957 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1014
+ N ++D + VK+ DF A + G +P +WMA
Sbjct: 220 ARNCMLDEKF-------TVKVADFGLARDMYDKEFDSVHNKTGAKLPV--------KWMA 264
Query: 1015 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 1073
E L+ + + D+WS+G LL EL+T PY ++ +I + G+R
Sbjct: 265 LESLQT----QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR------ 314
Query: 1074 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130
L C P+ L +V +C RP+ +L
Sbjct: 315 LLQPEYC--------------PDP-------LYEVMLKCWHPKAEMRPSFSELVSRI 350
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-20
Identities = 67/313 (21%), Positives = 114/313 (36%), Gaps = 91/313 (29%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
V+ LK + + E+ +L L H I++ G A
Sbjct: 65 VKALKA-DAGPQHRSGW----KQEIDILRTLYHEHIIKYKG--CCED----AGAAS---- 109
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
LQ + MEYV GS+++Y+ + + + L AQ + + LH++H +HRD+
Sbjct: 110 LQ--LVMEYVPLGSLRDYLPR------HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLA 161
Query: 957 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 1012
+ N+L+D +R +VK+ DF +AVP + P W
Sbjct: 162 ARNVLLDNDR-------LVKIGDFGLAKAVPEGHEYYR---VREDGDSPV--------FW 203
Query: 1013 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL---------------QVPYMGLSELE 1057
APE L+ + D+WS+G L ELLT + ++ L
Sbjct: 204 YAPECLKE----YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR 259
Query: 1058 IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1117
+ +L++ G+R L C P + + + C E
Sbjct: 260 LTELLERGER------LPRPDKC--------------PAE-------VYHLMKNCWETEA 292
Query: 1118 TERPTAGDLYEMF 1130
+ RPT +L +
Sbjct: 293 SFRPTFENLIPIL 305
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 1e-20
Identities = 72/313 (23%), Positives = 120/313 (38%), Gaps = 90/313 (28%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 895
V+ LK ++ ++ + + E+ M+ + +H I+ + G ++ +
Sbjct: 106 VKMLK-SDATEKDLSDL----ISEMEMMKMIGKHKNIINLLG--ACTQ---------DGP 149
Query: 896 LLQSAIFMEYVKGGSVKNY-----------IEKLSETGEKHVSVKLALFIAQDVAAALVE 944
L + +EY G+++ Y S E+ +S K + A VA +
Sbjct: 150 LY---VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 206
Query: 945 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1004
L SK +HRD+ + N+L+ + V+K+ DF A R I D
Sbjct: 207 LASKKCIHRDLAARNVLVTEDN-------VMKIADFGLA--------------RDIHHID 245
Query: 1005 VCVGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELE 1057
T P +WMAPE L +Y + D+WS+G LL E+ TL PY G+ E
Sbjct: 246 YYKKTTNGRLPVKWMAPEAL----FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301
Query: 1058 IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1117
+ L++ G R +KP + L + R C P
Sbjct: 302 LFKLLKEGHR------------------------MDKPS---NCTNELYMMMRDCWHAVP 334
Query: 1118 TERPTAGDLYEMF 1130
++RPT L E
Sbjct: 335 SQRPTFKQLVEDL 347
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-20
Identities = 65/227 (28%), Positives = 95/227 (41%), Gaps = 29/227 (12%)
Query: 71 EGLYLYKNVLN-LIPKSV-GRYEKLRNLKFFGNEIN-LFPSEVGNLLG-LECLQI---KI 123
E L L N + +P + L+ L NE + P + NL L L +
Sbjct: 321 ESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNF 380
Query: 124 SSPGVNGFALNKLKGLKELELS------KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIR 177
S P + N L+EL L K+PP S + L + LS + S
Sbjct: 381 SGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLH-------LSFNYLSGT 433
Query: 178 YLPPEIGCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRL 235
+P +G LS L L L N ++ +P E+ Y+K L +L + N L E+PSGL L
Sbjct: 434 -IPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNL 492
Query: 236 ENLDLSNNRLTSLGSL--DLCLMHNLQNLNLQYNKLLSYCQVPSWIC 280
+ LSNNRLT G + + + NL L L N +P+ +
Sbjct: 493 NWISLSNNRLT--GEIPKWIGRLENLAILKLSNNSF--SGNIPAELG 535
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-17
Identities = 46/211 (21%), Positives = 80/211 (37%), Gaps = 27/211 (12%)
Query: 73 LYLYKNVLN-LIPKSVGRYEKLRNLKFFGNEIN-LFPSEVGNLLGLECLQIKISSPGVNG 130
L L N + IP +G L L N N P+ + G + + G
Sbjct: 519 LKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK--IAANFIA-GKRY 575
Query: 131 FALNKLKGLKELELSKVPPRPSVLTLLSEI-AGLKCLTKLSVCHFSIRYL----PPEIGC 185
+ KE + ++L L L+ + C+ + R P
Sbjct: 576 VYIKNDGMKKECHGAG-----NLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDN 630
Query: 186 LSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRLENLDLSNN 243
++ LD+S+N + Y+P EI + L L + +N + +P + L+ L LDLS+N
Sbjct: 631 NGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSN 690
Query: 244 RLT-----SLGSLDLCLMHNLQNLNLQYNKL 269
+L ++ +L L ++L N L
Sbjct: 691 KLDGRIPQAMSAL-----TMLTEIDLSNNNL 716
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 3e-16
Identities = 50/233 (21%), Positives = 86/233 (36%), Gaps = 26/233 (11%)
Query: 68 NSVEGLYLYKNVLNL----IPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI-- 121
+ V + L LN+ + S+ L +L + IN S L L +
Sbjct: 50 DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSR 109
Query: 122 -KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYL- 179
+S P +L GLK L +S + L +++G L L V S +
Sbjct: 110 NSLSGPVTTLTSLGSCSGLKFLNVSS-----NTLDFPGKVSGGLKLNSLEVLDLSANSIS 164
Query: 180 ---PPEI---GCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLYL 231
L+ L +S NK+ + + L L V++N +P L
Sbjct: 165 GANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGD 221
Query: 232 LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLE 284
L++LD+S N+L+ S + L+ LN+ N+ +P +L+
Sbjct: 222 CSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQF--VGPIPPLPLKSLQ 272
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 8e-15
Identities = 54/237 (22%), Positives = 84/237 (35%), Gaps = 51/237 (21%)
Query: 69 SVEGLYLYKNVLN-LIPKSVGRYEKLRNLKFF---GNEIN-LFPSEVGNLLGLECLQIKI 123
S+E L L N ++ + LK GN+I+ V + LE L +
Sbjct: 152 SLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDV-- 207
Query: 124 SSPGVNGF-----ALNKLKGLKELELS------KVPPRPSVLTLLSEIAGLKCLTKL--S 170
N F L L+ L++S I+ L L S
Sbjct: 208 ---SSNNFSTGIPFLGDCSALQHLDISGNKLSGDFSR---------AISTCTELKLLNIS 255
Query: 171 VCHFS--IRYLPPEIGCLSNLEQLDLSFNKMK-YLPTEICY-LKALISLKVANNKLV-EL 225
F I PP L +L+ L L+ NK +P + L L ++ N +
Sbjct: 256 SNQFVGPI---PPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAV 310
Query: 226 PSGLYLLQRLENLDLSNNRLTSLGSL---DLCLMHNLQNLNLQYNKLLSYCQVPSWI 279
P LE+L LS+N + G L L M L+ L+L +N+ ++P +
Sbjct: 311 PPFFGSCSLLESLALSSNNFS--GELPMDTLLKMRGLKVLDLSFNEFSG--ELPESL 363
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-14
Identities = 38/220 (17%), Positives = 72/220 (32%), Gaps = 45/220 (20%)
Query: 73 LYLYKNVLN-LIPKSVGRYEKLRNLKFFGNEIN-LFPSEVGNLLGLECLQIKISSPGVNG 130
L L N L IP + L + N + P +G L L L++ S+ N
Sbjct: 471 LILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKL--SN---NS 525
Query: 131 F------ALNKLKGLKELELS------KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRY 178
F L + L L+L+ +P + + K K++ + +
Sbjct: 526 FSGNIPAELGDCRSLIWLDLNTNLFNGTIP---------AAMF--KQSGKIAANFIAGK- 573
Query: 179 LPPEIGCLSNLEQLDLSFNKMKY---LPTEICYLKALISLKVANNKLV-ELPSGLYLLQR 234
I ++ + N +++ ++ L + +
Sbjct: 574 RYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGS 633
Query: 235 LENLDLSNNRLT-----SLGSLDLCLMHNLQNLNLQYNKL 269
+ LD+S N L+ +GS+ L LNL +N +
Sbjct: 634 MMFLDMSYNMLSGYIPKEIGSM-----PYLFILNLGHNDI 668
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 7e-14
Identities = 47/220 (21%), Positives = 75/220 (34%), Gaps = 43/220 (19%)
Query: 73 LYLYKNVLNL-IPKSVG-RYEKLRNLKFFGNEIN-LFPSEV---GNLLGLECLQIKISSP 126
L + N L+ S G + L L N I+ L+ L I
Sbjct: 131 LNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAI----- 185
Query: 127 GVNGFA----LNKLKGLKELELS------KVPPRPSVLTLLSEIAGLKCLTK--LSVCHF 174
N + +++ L+ L++S +P + L +S
Sbjct: 186 SGNKISGDVDVSRCVNLEFLDVSSNNFSTGIP----------FLGDCSALQHLDISGNKL 235
Query: 175 SIRYLPPEIGCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLY-L 231
S I + L+ L++S N+ +P LK+L L +A NK E+P L
Sbjct: 236 SGD-FSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGA 292
Query: 232 LQRLENLDLSNNRLTSLGSL--DLCLMHNLQNLNLQYNKL 269
L LDLS N G++ L++L L N
Sbjct: 293 CDTLTGLDLSGNHFY--GAVPPFFGSCSLLESLALSSNNF 330
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-11
Identities = 51/243 (20%), Positives = 79/243 (32%), Gaps = 59/243 (24%)
Query: 69 SVEGLYLYKNVLN-LIPKSVGRYEKLRNLKFFGNEIN-LFPSEVGNLLGLECLQIKISSP 126
+ L+L N L+ IP S+G KLR+LK + N + P E+ + LE L +
Sbjct: 419 ELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLIL----- 473
Query: 127 GVNGF------ALNKLKGLKELELS------KVPPRPSVLTLLSEIAGLKCLTKLSV--C 172
N L+ L + LS ++P I L+ L L +
Sbjct: 474 DFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIP---------KWIGRLENLAILKLSNN 524
Query: 173 HFS--IRYLPPEIGCLSNLEQLDLSFNK---------------MKY------LPTEICYL 209
FS I P E+G +L LDL+ N + I
Sbjct: 525 SFSGNI---PAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKND 581
Query: 210 KALISLKVANNKLV---ELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQY 266
A N L L L ++++ S ++ L++ Y
Sbjct: 582 GMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSY 641
Query: 267 NKL 269
N L
Sbjct: 642 NML 644
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 3e-08
Identities = 35/187 (18%), Positives = 55/187 (29%), Gaps = 36/187 (19%)
Query: 65 GGDNSVEGLYLYKNVLNL---IPKSVGRYEKLRNLKFFGNEIN-LFPSEVGNLLGLECLQ 120
D + + N+L + + R N + L
Sbjct: 579 KNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLD 638
Query: 121 IKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS--IRY 178
+ S N L G + P + + + L L S I
Sbjct: 639 M--SY--------NMLSG----YI------PKEIGSMPYLFILN----LGHNDISGSI-- 672
Query: 179 LPPEIGCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRLE 236
P E+G L L LDLS NK+ +P + L L + ++NN L +P +
Sbjct: 673 -PDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMG-QFETFP 730
Query: 237 NLDLSNN 243
NN
Sbjct: 731 PAKFLNN 737
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-20
Identities = 45/198 (22%), Positives = 74/198 (37%), Gaps = 53/198 (26%)
Query: 860 EVRMLGALRHSC--IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKG-GSVKNYIE 916
EV +L + ++ + W D + + +E + + ++I
Sbjct: 96 EVVLLKKVSSGFSGVIRLLD------WFERPD-----SFV---LILERPEPVQDLFDFIT 141
Query: 917 ---KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 973
L E +LA V A+ H+ ++HRDIK ENILIDL R +
Sbjct: 142 ERGALQE--------ELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE----- 188
Query: 974 VVKLCDFD-RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLEV 1031
+KL DF A+ + GT + PE +R + Y G
Sbjct: 189 -LKLIDFGSGALLKDTVYTDFD-------------GTRVYSPPEWIRY----HRYHGRSA 230
Query: 1032 DIWSYGCLLLELLTLQVP 1049
+WS G LL +++ +P
Sbjct: 231 AVWSLGILLYDMVCGDIP 248
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 2e-20
Identities = 51/174 (29%), Positives = 79/174 (45%), Gaps = 46/174 (26%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
MEYV GG + +I+++ E H A+F A ++A L L SK I++RD+K +N+++
Sbjct: 100 MEYVNGGDLMYHIQQVGRFKEPH-----AVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML 154
Query: 963 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 1012
D ++G +K+ DF T C GTP +
Sbjct: 155 D-----SEGH--IKIADFGMCKENIWDGVTT-------KTFC-------------GTPDY 187
Query: 1013 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1066
+APE++ YG VD W++G LL E+L Q P+ G E E+ I
Sbjct: 188 IAPEIIAYQP----YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN 237
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 2e-20
Identities = 66/313 (21%), Positives = 118/313 (37%), Gaps = 90/313 (28%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 895
V+ LK ++ ++ + + E+ M+ + +H I+ + G P +
Sbjct: 118 VKMLKD-DATEKDLSDL----VSEMEMMKMIGKHKNIINLLGA--------CTQDGPLY- 163
Query: 896 LLQSAIFMEYVKGGSVKNY-----------IEKLSETGEKHVSVKLALFIAQDVAAALVE 944
+ +EY G+++ Y ++ E+ ++ K + +A +
Sbjct: 164 -----VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 218
Query: 945 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1004
L S+ +HRD+ + N+L+ + V+K+ DF A R I D
Sbjct: 219 LASQKCIHRDLAARNVLV------TENN-VMKIADFGLA--------------RDINNID 257
Query: 1005 VCVGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELE 1057
T P +WMAPE L +Y + D+WS+G L+ E+ TL PY G+ E
Sbjct: 258 YYKKTTNGRLPVKWMAPEALFD----RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 313
Query: 1058 IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1117
+ L++ G R +KP + L + R C P
Sbjct: 314 LFKLLKEGHR------------------------MDKPA---NCTNELYMMMRDCWHAVP 346
Query: 1118 TERPTAGDLYEMF 1130
++RPT L E
Sbjct: 347 SQRPTFKQLVEDL 359
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-20
Identities = 50/174 (28%), Positives = 78/174 (44%), Gaps = 46/174 (26%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
ME+V GG + +I+K + A F A ++ +AL+ LH K I++RD+K +N+L+
Sbjct: 103 MEFVNGGDLMFHIQK-----SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL 157
Query: 963 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 1012
D +G KL DF T C GTP +
Sbjct: 158 D-----HEGH--CKLADFGMCKEGICNGVTT-------ATFC-------------GTPDY 190
Query: 1013 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1066
+APE+L+ M YG VD W+ G LL E+L P+ +E ++ + I +
Sbjct: 191 IAPEILQEML----YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE 240
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 47/216 (21%), Positives = 83/216 (38%), Gaps = 24/216 (11%)
Query: 69 SVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI------ 121
S L L N L +P V + +L L N ++ + G L+
Sbjct: 29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFN 88
Query: 122 KISS-PGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEI---AGLKCLTKLSVCHFSIR 177
+ + L+ L+ L+ L +SE L+ L L + H R
Sbjct: 89 GVITMSS----NFLGLEQLEHLDFQHSN-----LKQMSEFSVFLSLRNLIYLDISHTHTR 139
Query: 178 YLPPEI-GCLSNLEQLDLSFNKM-KYLPTEI-CYLKALISLKVANNKLVELPSGLYL-LQ 233
I LS+LE L ++ N + +I L+ L L ++ +L +L + L
Sbjct: 140 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLS 199
Query: 234 RLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L+ L++S+N SL + +++LQ L+ N +
Sbjct: 200 SLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI 235
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 51/188 (27%), Positives = 76/188 (40%), Gaps = 13/188 (6%)
Query: 93 LRNLKFFGNEI-NLFPSEVGNLLGLECLQI---KISSPGVNGFALNKLKGLKELELSKVP 148
L+ N++ +L L L L + +S G + LK L+LS
Sbjct: 30 ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS--- 86
Query: 149 PRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPE--IGCLSNLEQLDLSFNKMKYLPTEI 206
V+T+ S GL+ L L H +++ + L NL LD+S + I
Sbjct: 87 -FNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 145
Query: 207 CY-LKALISLKVANNKLVE--LPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLN 263
L +L LK+A N E LP L+ L LDLS +L L + +LQ LN
Sbjct: 146 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 205
Query: 264 LQYNKLLS 271
+ +N S
Sbjct: 206 MSHNNFFS 213
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 53/235 (22%), Positives = 79/235 (33%), Gaps = 41/235 (17%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKF---FGNEINLFPSEVGNLLGLECL-----Q 120
+ L L N L+ +LK+ N + S L LE L
Sbjct: 53 QLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSN 112
Query: 121 IK-ISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEI-----AGLKCLTKLSVCH- 173
+K +S L+ L L++S T GL L L +
Sbjct: 113 LKQMSEFS----VFLSLRNLIYLDISH--------THTRVAFNGIFNGLSSLEVLKMAGN 160
Query: 174 FSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLYL 231
P+I L NL LDLS +++ L L +L L +++N L + Y
Sbjct: 161 SFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYK 220
Query: 232 -LQRLENLDLSNNRLTSLGSLDLC-LMHNLQNLNLQYNKLLSYCQVPSWIC-CNL 283
L L+ LD S N + + +L +L LNL N + C C
Sbjct: 221 CLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN---------DFACTCEH 266
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 25/117 (21%), Positives = 47/117 (40%), Gaps = 5/117 (4%)
Query: 161 AGLKCLTKLSVCHFSIRYLPPEIGC---LSNLEQLDLSFNKMKYLPTEICYLKALISLKV 217
L LTKLS+ + + ++L+ LDLSFN + + + L+ L L
Sbjct: 49 DKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDF 108
Query: 218 ANNKLVELPSG--LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSY 272
++ L ++ L+ L LD+S+ + + +L+ L + N
Sbjct: 109 QHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN 165
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 3e-20
Identities = 53/205 (25%), Positives = 83/205 (40%), Gaps = 57/205 (27%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--ME-YVKGGSVKNYIE 916
E+ +L + H+ I+++ ++ ME + G + +I+
Sbjct: 79 EIAILSRVEHANIIKVL-DIFENQ---------------GFFQLVMEKHGSGLDLFAFID 122
Query: 917 ---KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 973
+L E LA +I + + +A+ L K I+HRDIK ENI+I
Sbjct: 123 RHPRLDE--------PLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI-------AEDF 167
Query: 974 VVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLE 1030
+KL DF A L +T C GT + APEVL N Y G E
Sbjct: 168 TIKLIDFGSAAYLERGKLFYTFC-------------GTIEYCAPEVLMG----NPYRGPE 210
Query: 1031 VDIWSYGCLLLELLTLQVPYMGLSE 1055
+++WS G L L+ + P+ L E
Sbjct: 211 LEMWSLGVTLYTLVFEENPFCELEE 235
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 3e-20
Identities = 47/219 (21%), Positives = 82/219 (37%), Gaps = 18/219 (8%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRY-EKLRNLKFFGNEI-NLFPSEVGNLLGLECLQI----- 121
V+ + + + + L+P S ++ + L L N + + LQ
Sbjct: 311 KVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQ 370
Query: 122 -KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLP 180
+ S G L LK L L++S R + + + + L++ IR +
Sbjct: 371 NHLRSMQKTGEILLTLKNLTSLDIS----RNTFHPMPDSCQWPEKMRFLNLSSTGIRVVK 426
Query: 181 PEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDL 240
I LE LD+S N + +L L L ++ NKL LP L L + +
Sbjct: 427 TCI--PQTLEVLDVSNNNLDSFSL---FLPRLQELYISRNKLKTLPDAS-LFPVLLVMKI 480
Query: 241 SNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWI 279
S N+L S+ + +LQ + L N C ++
Sbjct: 481 SRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYL 519
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 4e-20
Identities = 47/214 (21%), Positives = 84/214 (39%), Gaps = 17/214 (7%)
Query: 67 DNSVEGLYLYKNVLNLIPKSVGRYE--KLRNLKFFGNEINLFPSEV-GNLLGLECLQI-- 121
D ++ GL + + + +G+ E +R L + S V L ++ + +
Sbjct: 260 DCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVEN 319
Query: 122 -KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLP 180
K+ V LK L+ L+LS+ L + L L + +R +
Sbjct: 320 SKVFL--VPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQ 377
Query: 181 PEIG---CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLEN 237
L NL LD+S N +P + + + L +++ + + + + Q LE
Sbjct: 378 KTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIRVVKTC--IPQTLEV 435
Query: 238 LDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
LD+SNN L S + LQ L + NKL +
Sbjct: 436 LDVSNNNLDSFSL----FLPRLQELYISRNKLKT 465
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 2e-16
Identities = 37/242 (15%), Positives = 80/242 (33%), Gaps = 17/242 (7%)
Query: 69 SVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEV-GNLLGLECLQI---KI 123
+++ L L N + I L+ L + IN + +L LE L + +
Sbjct: 27 AMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHL 86
Query: 124 SSPGVNGFALNKLKGLKELELS--KVPPRPSVLTLLSEIAGLKCLTKLSVCHF-SIRYLP 180
SS ++ L LK L L L + S L L L + + + +
Sbjct: 87 SS--LSSSWFGPLSSLKYLNLMGNPY----QTLGVTSLFPNLTNLQTLRIGNVETFSEIR 140
Query: 181 PE-IGCLSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKLVELPSGLY-LLQRLEN 237
L++L +L++ ++ ++ + ++ + L + ++ L +L +
Sbjct: 141 RIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRY 200
Query: 238 LDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFIS 297
L+L + L L + + + L + S +F
Sbjct: 201 LELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDD 260
Query: 298 SS 299
+
Sbjct: 261 CT 262
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 9e-15
Identities = 27/152 (17%), Positives = 52/152 (34%), Gaps = 18/152 (11%)
Query: 139 LKELELSKVPPR-PSVLTLL------------SEIAGLKCLTKLSVCHFSIRYLPPEI-G 184
+ + +P + + L ++ L L + I + +
Sbjct: 12 GRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFY 71
Query: 185 CLSNLEQLDLSFNKMKYLPTEIC-YLKALISLKVANNKLVELPSGLYL--LQRLENLDLS 241
L +LE LDLS N + L + L +L L + N L L L+ L +
Sbjct: 72 SLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIG 131
Query: 242 -NNRLTSLGSLDLCLMHNLQNLNLQYNKLLSY 272
+ + +D + +L L ++ L +Y
Sbjct: 132 NVETFSEIRRIDFAGLTSLNELEIKALSLRNY 163
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-20
Identities = 56/301 (18%), Positives = 103/301 (34%), Gaps = 83/301 (27%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
++ ++ S + + +G+L H+ IV + G S
Sbjct: 47 IKVIED-KSGRQSFQAV----TDHMLAIGSLDHAHIVRLLGLCPGSSLQ----------- 90
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
+ +Y+ GS+ +++ + + +L L +A + L ++HR++
Sbjct: 91 ----LVTQYLPLGSLLDHVRQ----HRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLA 142
Query: 957 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP------ 1010
+ N+L+ V++ DF A +P D +
Sbjct: 143 ARNVLLKSPS-------QVQVADFGVA--------------DLLPPDDKQLLYSEAKTPI 181
Query: 1011 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPR 1069
+WMA E + Y + D+WSYG + EL+T PY GL E+ DL++ G+R
Sbjct: 182 KWMALESIHF----GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER-- 235
Query: 1070 LTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1129
L C + V +C + RPT +L
Sbjct: 236 ----LAQPQIC--------------TID-------VYMVMVKCWMIDENIRPTFKELANE 270
Query: 1130 F 1130
F
Sbjct: 271 F 271
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-20
Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 29/213 (13%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI------KISSP 126
LY+ KN L IP ++ L L+ N I P G GL + + +
Sbjct: 107 LYISKNHLVEIPPNL--PSSLVELRIHDNRIRKVPK--GVFSGLRNMNCIEMGGNPLENS 162
Query: 127 GVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAG--LKCLTKLSVCHFSIRYLPPEI- 183
G A + LK L L +S+ L+ I + L +L + H I+ + E
Sbjct: 163 GFEPGAFDGLK-LNYLRISE--------AKLTGIPKDLPETLNELHLDHNKIQAIELEDL 213
Query: 184 GCLSNLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKLVELPSGLYLLQRLENLDLSN 242
S L +L L N+++ + L L L + NNKL +P+GL L+ L+ + L
Sbjct: 214 LRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHT 273
Query: 243 NRLTSLGSLDLCLMH------NLQNLNLQYNKL 269
N +T +G D C + ++L N +
Sbjct: 274 NNITKVGVNDFCPVGFGVKRAYYNGISLFNNPV 306
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 5e-18
Identities = 47/233 (20%), Positives = 89/233 (38%), Gaps = 49/233 (21%)
Query: 69 SVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPG 127
L L N ++ + K + L L N+I+ +
Sbjct: 55 DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEK------------------ 96
Query: 128 VNGFALNKLKGLKELELSK-----VPPR-PSVLTLL-------SEI-----AGLKCLTKL 169
A + L+ L++L +SK +PP PS L L ++ +GL+ + +
Sbjct: 97 ----AFSPLRKLQKLYISKNHLVEIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCI 152
Query: 170 SVCHFSIRYLPPEIGCLS--NLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPS 227
+ + E G L L +S K+ +P ++ + L L + +NK+ +
Sbjct: 153 EMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDL--PETLNELHLDHNKIQAIEL 210
Query: 228 G-LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWI 279
L +L L L +N++ + + L + L+ L+L NKL VP+ +
Sbjct: 211 EDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSR---VPAGL 260
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 24/97 (24%), Positives = 45/97 (46%), Gaps = 7/97 (7%)
Query: 175 SIRYLPPEIGCLSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKLVELPSG-LYLL 232
++ +P EI + LDL N + L + L+ L +L + NNK+ ++ L
Sbjct: 44 GLKAVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPL 101
Query: 233 QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
++L+ L +S N L + L +L L + N++
Sbjct: 102 RKLQKLYISKNHLVEIPPN---LPSSLVELRIHDNRI 135
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 25/87 (28%), Positives = 37/87 (42%), Gaps = 3/87 (3%)
Query: 184 GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSN 242
GC +L + S +K +P EI L + NN + EL LQ L L L N
Sbjct: 30 GCHCHLRVVQCSDLGLKAVPKEI--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVN 87
Query: 243 NRLTSLGSLDLCLMHNLQNLNLQYNKL 269
N+++ + + LQ L + N L
Sbjct: 88 NKISKIHEKAFSPLRKLQKLYISKNHL 114
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-20
Identities = 55/237 (23%), Positives = 93/237 (39%), Gaps = 51/237 (21%)
Query: 834 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 892
AA + T K+ ++ E R+ L+H IV ++
Sbjct: 40 AAMIINTKKLSARDHQKLER-------EARICRLLKHPNIVRLHDSISEEG--------- 83
Query: 893 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 952
H+L+ + V GG + I ++ S A Q + A++ H ++H
Sbjct: 84 HHYLI-----FDLVTGGELFEDIVA-----REYYSEADASHCIQQILEAVLHCHQMGVVH 133
Query: 953 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS---FLHTCCIAHRGIPAPDVCVGT 1009
R++K EN+L+ + K A VKL DF A+ + GT
Sbjct: 134 RNLKPENLLLASKLKGAA----VKLADFGLAIEVEGEQQAWFGFA-------------GT 176
Query: 1010 PRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1066
P +++PEVLR + YG VD+W+ G +L LL P+ + ++ I+ G
Sbjct: 177 PGYLSPEVLRK----DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGA 229
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 4e-20
Identities = 52/210 (24%), Positives = 83/210 (39%), Gaps = 40/210 (19%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
E + L+H IVE+ S +++ E++ G + I K
Sbjct: 76 EASICHMLKHPHIVELLETYSSDG---------MLYMV-----FEFMDGADLCFEIVK-R 120
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
S +A + + AL H +I+HRD+K +L+ K + P VKL
Sbjct: 121 ADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLA---SKENSAP-VKLGG 176
Query: 980 FDRAVPLR---SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1036
F A+ L GTP +MAPEV++ YG VD+W
Sbjct: 177 FGVAIQLGESGLVAGGRV-------------GTPHFMAPEVVKR----EPYGKPVDVWGC 219
Query: 1037 GCLLLELLTLQVPYMGLSELEIHDLIQMGK 1066
G +L LL+ +P+ G ++ + + I GK
Sbjct: 220 GVILFILLSGCLPFYG-TKERLFEGIIKGK 248
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 5e-20
Identities = 49/242 (20%), Positives = 87/242 (35%), Gaps = 59/242 (24%)
Query: 834 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS-CIVEMYGHKISSKWLPSADGN 891
AAK + + EI + E+ +L + ++ ++ +
Sbjct: 58 AAKFLKKRRRGQDCRAEILH-------EIAVLELAKSCPRVINLHE---------VYENT 101
Query: 892 PEHHLLQSAIFMEYVKGGS-----VKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELH 946
E L+ +EY GG + E +SE + + + + + LH
Sbjct: 102 SEIILI-----LEYAAGGEIFSLCLPELAEMVSE--------NDVIRLIKQILEGVYYLH 148
Query: 947 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPD 1004
+I+H D+K +NIL L G +K+ DF + + L
Sbjct: 149 QNNIVHLDLKPQNIL--LSSIYPLGD--IKIVDFGMSRKIGHACELREIM---------- 194
Query: 1005 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 1064
GTP ++APE+L + P D+W+ G + LLT P++G E + I
Sbjct: 195 ---GTPEYLAPEILN--YDP--ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQ 247
Query: 1065 GK 1066
Sbjct: 248 VN 249
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 6e-20
Identities = 45/214 (21%), Positives = 80/214 (37%), Gaps = 15/214 (7%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRY-EKLRNLKFFGNEI-NLFPSEVGNLLGLECLQI----- 121
++E LYL N ++ I G EKL+ L F N I L ++ +L L +
Sbjct: 130 TLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGN 189
Query: 122 KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP 181
I+ F + L + L + ++ L + + P
Sbjct: 190 DIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNST----IQSLWLGTFEDMDDEDISP 245
Query: 182 EI---GCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLYLLQRLEN 237
+ C ++E ++L + + + L L + L ELPSGL L L+
Sbjct: 246 AVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKK 305
Query: 238 LDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
L LS N+ +L + +L +L+++ N
Sbjct: 306 LVLSANKFENLCQISASNFPSLTHLSIKGNTKRL 339
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-18
Identities = 41/211 (19%), Positives = 75/211 (35%), Gaps = 36/211 (17%)
Query: 68 NSVEGLYLYKNVL-NLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KI 123
SVE + L K+ N+ + + L+ L ++ PS + L L+ L + K
Sbjct: 254 MSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKF 313
Query: 124 SSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEI 183
+ + + L L + + +
Sbjct: 314 E--NLCQISASNFPSLTHLSIKG-------------------------NTKRLELGTGCL 346
Query: 184 GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKV---ANNKLVELPSG-LYLLQRLENLD 239
L NL +LDLS + ++ L+ L L+ + N+ + L + +LE LD
Sbjct: 347 ENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLD 406
Query: 240 LSNNRLTSLGSLD-LCLMHNLQNLNLQYNKL 269
L+ RL + +H L+ LNL ++ L
Sbjct: 407 LAFTRLKVKDAQSPFQNLHLLKVLNLSHSLL 437
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-17
Identities = 45/223 (20%), Positives = 82/223 (36%), Gaps = 24/223 (10%)
Query: 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLK---FFGNEINLFPSEV-GNLLGLECL---- 119
++ L L + + + L +L+ NE +E LE L
Sbjct: 350 ENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAF 409
Query: 120 -QIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSE--IAGLKCLTKLSVCHFSI 176
++K+ L LK L LS S+L + SE GL L L++
Sbjct: 410 TRLKVKDAQS---PFQNLHLLKVLNLSH-----SLLDISSEQLFDGLPALQHLNLQGNHF 461
Query: 177 RYLPPE----IGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLYL 231
+ + L LE L LSF + + LK + + +++N+L
Sbjct: 462 PKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALS 521
Query: 232 LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQ 274
+ L+L++N ++ + L ++ + +NL+ N L C
Sbjct: 522 HLKGIYLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS 564
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-15
Identities = 20/107 (18%), Positives = 42/107 (39%), Gaps = 3/107 (2%)
Query: 166 LTKLSVCHFSIRYLPPE-IGCLSNLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKLV 223
L + + L NL LDL+ ++ ++ + L +L + N L+
Sbjct: 35 TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI 94
Query: 224 ELPSG-LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
+ L + L++L ++S+ + L L++L L N +
Sbjct: 95 FMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHI 141
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 6e-15
Identities = 42/213 (19%), Positives = 63/213 (29%), Gaps = 38/213 (17%)
Query: 68 NSVEGLYLYKNVL-NLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSP 126
NS E L NVL + + R L L +I +
Sbjct: 33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHED----------------- 75
Query: 127 GVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIA--GLKCLTKLSVCHFSIRYLPPE-I 183
L L L+ + L ++E A G K L L I + +
Sbjct: 76 -----TFQSQHRLDTLVLTA-----NPLIFMAETALSGPKALKHLFFIQTGISSIDFIPL 125
Query: 184 GCLSNLEQLDLSFNKMKYLP-TEICYLKALISLKVANNKLVELP----SGLYLLQRLENL 238
LE L L N + + + + L L NN + L S L L L
Sbjct: 126 HNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLS-L 184
Query: 239 DLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
+L+ N + + Q+LN + L
Sbjct: 185 NLNGNDIAGIEPGAFDSAV-FQSLNFGGTQNLL 216
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-09
Identities = 15/88 (17%), Positives = 30/88 (34%), Gaps = 3/88 (3%)
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSNN 243
+ + + +P + + L+ + N L + + L L LDL+
Sbjct: 10 EKEVNKTYNCENLGLNEIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRC 67
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
++ + H L L L N L+
Sbjct: 68 QIYWIHEDTFQSQHRLDTLVLTANPLIF 95
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 6e-20
Identities = 48/174 (27%), Positives = 75/174 (43%), Gaps = 46/174 (26%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
++Y+ GG + ++++ E+ A F A ++A+AL LHS +I++RD+K ENIL+
Sbjct: 118 LDYINGGELFYHLQR-----ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL 172
Query: 963 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 1012
D + G + L DF T C GTP +
Sbjct: 173 D-----SQGH--IVLTDFGLCKENIEHNSTT-------STFC-------------GTPEY 205
Query: 1013 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1066
+APEVL Y VD W G +L E+L P+ + E++D I
Sbjct: 206 LAPEVLHKQP----YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP 255
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 7e-20
Identities = 50/190 (26%), Positives = 76/190 (40%), Gaps = 48/190 (25%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI---E 916
E+ +L L H I+++ + E L+ +E V GG + + I
Sbjct: 98 EIGVLLRLSHPNIIKLKE------IFETPT---EISLV-----LELVTGGELFDRIVEKG 143
Query: 917 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 976
SE + A + + A+ LH I+HRD+K EN+L D +K
Sbjct: 144 YYSE--------RDAADAVKQILEAVAYLHENGIVHRDLKPENLL--YATPAPDAP--LK 191
Query: 977 LCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 1034
+ DF + + + T C GTP + APE+LR YG EVD+W
Sbjct: 192 IADFGLSKIVEHQVLMKTVC-------------GTPGYCAPEILRGCA----YGPEVDMW 234
Query: 1035 SYGCLLLELL 1044
S G + LL
Sbjct: 235 SVGIITYILL 244
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 7e-20
Identities = 68/314 (21%), Positives = 119/314 (37%), Gaps = 90/314 (28%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 895
V+ LK G++ E R + E+++L + H +V + G +K P
Sbjct: 62 VKMLKE-GATHSEHRAL----MSELKILIHIGHHLNVVNLLG--ACTK--------PGGP 106
Query: 896 LLQSAIFMEYVKGGSVKNY-----------IEKLSETGEKHVSVKLALFIAQDVAAALVE 944
L+ + +E+ K G++ Y + + ++++ + + VA +
Sbjct: 107 LM---VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEF 163
Query: 945 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1004
L S+ +HRD+ + NIL+ ++ VVK+CDF A R I
Sbjct: 164 LASRKCIHRDLAARNILL------SEKN-VVKICDFGLA--------------RDIYKDP 202
Query: 1005 VCVGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSE-L 1056
V P +WMAPE + +Y ++ D+WS+G LL E+ +L PY G+
Sbjct: 203 DYVRKGDARLPLKWMAPETIFD----RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 258
Query: 1057 EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1116
E ++ G R P+ T + C
Sbjct: 259 EFCRRLKEGTR------------------------MRAPD---YTTPEMYQTMLDCWHGE 291
Query: 1117 PTERPTAGDLYEMF 1130
P++RPT +L E
Sbjct: 292 PSQRPTFSELVEHL 305
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 8e-20
Identities = 50/221 (22%), Positives = 83/221 (37%), Gaps = 34/221 (15%)
Query: 73 LYLYKNVLN-LIPKSVGRYEKLRNLKFFGNEI--NLFPSEVGNLLGLECL-----QIKIS 124
L L KN ++ + + L L NEI L E L + + +
Sbjct: 386 LNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQL 445
Query: 125 SPGVNGFALNKLKGLKELELSK-----VPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYL 179
+ + + L+ L L + V PS L+ LT L + + +I +
Sbjct: 446 TRN----SFALVPSLQRLMLRRVALKNVDSSPSPFQ------PLRNLTILDLSNNNIANI 495
Query: 180 PPE-IGCLSNLEQLDLSFNKMKYLPTEICY---------LKALISLKVANNKLVELPSGL 229
+ + L LE LDL N + L L L L + +N E+P +
Sbjct: 496 NDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEV 555
Query: 230 YL-LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
+ L L+ +DL N L +L + +L++LNLQ N +
Sbjct: 556 FKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLI 596
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 4e-19
Identities = 54/233 (23%), Positives = 87/233 (37%), Gaps = 33/233 (14%)
Query: 73 LYLYKNVLN-LIPKSVGRYEKLRNLKFFGNEIN-LFPSEVGNLLGLECL-------QIKI 123
L L N LN + S +L N I LF + L + L + I
Sbjct: 253 LDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSI 312
Query: 124 SS---PGVNGFALNKLKGLKELELSK-----VPPRPSVLTLLSEIAGLKCLTK--LSVCH 173
S P ++ F+ LK L+ L + + + GL L LS
Sbjct: 313 SLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKS--------NMFTGLINLKYLSLSNSF 364
Query: 174 FSIRYLPPEIG---CLSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKLVELPSG- 228
S+R L E S L L+L+ NK+ + ++ +L L L + N++ + +G
Sbjct: 365 TSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQ 424
Query: 229 -LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC 280
L+ + + LS N+ L L+ +LQ L L+ L + PS
Sbjct: 425 EWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQ 477
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 7e-19
Identities = 53/227 (23%), Positives = 81/227 (35%), Gaps = 37/227 (16%)
Query: 68 NSVEGLYLYKNVL-NLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSP 126
++ L L N L L + RY +L +L N I+ E
Sbjct: 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPE----------------- 67
Query: 127 GVNGFALNKLKGLKELELSKVPPRPSVLTLLSE--IAGLKCLTKLSVCHFSIRYLPPE-I 183
KL LK L L L+ LS+ A LT+L + SI+ +
Sbjct: 68 -----LCQKLPMLKVLNLQHNE-----LSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPF 117
Query: 184 GCLSNLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKLVELPS---GLYLLQRLENLD 239
NL LDLS N + L+ L L ++NNK+ L S ++ L+ L+
Sbjct: 118 VKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLE 177
Query: 240 LSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGN 286
LS+N++ + L L L +L + +C L
Sbjct: 178 LSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGP--SLTEKLCLELANT 222
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-18
Identities = 45/218 (20%), Positives = 79/218 (36%), Gaps = 21/218 (9%)
Query: 67 DNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEIN-LFPSEVGNLLGLECL-----Q 120
+ + ++ + S + L +L N+I + + L+ L+ L
Sbjct: 305 RSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSF 364
Query: 121 IKISSPGVNGFALNKLKGLKELELSK-----VPPRPSVLTLLSEIAGLKCLTKLSVCHFS 175
+ + F L L L+K + S + L+ L L +
Sbjct: 365 TSLRTLTNETFVSLAHSPLHILNLTKNKISKIESD-----AFSWLGHLEVL-DLGLNEIG 418
Query: 176 IRYLPPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKL---VELPSGLYL 231
E L N+ ++ LS+NK L + +L L + L PS
Sbjct: 419 QELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQP 478
Query: 232 LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L+ L LDLSNN + ++ L + L+ L+LQ+N L
Sbjct: 479 LRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNL 516
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-17
Identities = 44/230 (19%), Positives = 78/230 (33%), Gaps = 36/230 (15%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGV 128
+++ L L N + + +LK ++ L N QIK SPG
Sbjct: 146 NLQELLLSNNKIQALKSEELDIFANSSLK----KLELS----SN-------QIKEFSPG- 189
Query: 129 NGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIG---C 185
+ + L L L+ V PS+ L + LS+ + +
Sbjct: 190 ---CFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLK 246
Query: 186 LSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSG----------LYLLQR 234
+NL LDLS+N + + +L L + N + L S L L +
Sbjct: 247 WTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRS 306
Query: 235 LENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLE 284
+S L + + L++LN++ N + + S + L
Sbjct: 307 FTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPG---IKSNMFTGLI 353
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 7e-17
Identities = 54/250 (21%), Positives = 87/250 (34%), Gaps = 27/250 (10%)
Query: 45 VIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFF---GN 101
+ ++ + L E + S+ L L + L+ + K NL N
Sbjct: 199 GLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYN 258
Query: 102 EIN-LFPSEVGNLLGLECL-----QIKISSPGVNGFALNKLKGLKELELS----KVPPRP 151
+N + L LE I+ +L+ L ++ L L K
Sbjct: 259 NLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSH----SLHGLFNVRYLNLKRSFTKQSISL 314
Query: 152 SVLTLL--SEIAGLKCLTKLSVCHFSIRYLPPEIGC-LSNLEQLDLSFNKMK--YLPTEI 206
+ L + LKCL L++ I + + L NL+ L LS + L E
Sbjct: 315 ASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNET 374
Query: 207 CYLKALISLKV---ANNKLVELPSG-LYLLQRLENLDLSNNRLT-SLGSLDLCLMHNLQN 261
A L + NK+ ++ S L LE LDL N + L + + N+
Sbjct: 375 FVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFE 434
Query: 262 LNLQYNKLLS 271
+ L YNK L
Sbjct: 435 IYLSYNKYLQ 444
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-16
Identities = 47/216 (21%), Positives = 78/216 (36%), Gaps = 28/216 (12%)
Query: 73 LYLYKNVL-NLIPKSVGRYEKLRNLKFFGNEI-NLFPSEVGNLLGLECLQI---KISSPG 127
L L N L L K+ L L N I + + L L + +SS
Sbjct: 78 LNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSS-- 135
Query: 128 VNGFALNKLKGLKELELS-----KVPPRP-SVLTLLSEIAGLKCLTKLSVCHFSIRYLPP 181
+L+ L+EL LS + + S L KL + I+ P
Sbjct: 136 TKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSS-------LKKLELSSNQIKEFSP 188
Query: 182 E-IGCLSNLEQLDLSFNKMKYLPTEI----CYLKALISLKVANNKLVELPSGLYL---LQ 233
+ L L L+ ++ TE ++ +L ++N++L + +L
Sbjct: 189 GCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWT 248
Query: 234 RLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L LDLS N L +G+ + L+ L+YN +
Sbjct: 249 NLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNI 284
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-14
Identities = 39/147 (26%), Positives = 64/147 (43%), Gaps = 16/147 (10%)
Query: 139 LKELELSKVPPR-PSVLTLL------------SEIAGLKCLTKLSVCHFSIRYLPPE-IG 184
L+L++VP P+ +T+L + LT L V +I L PE
Sbjct: 11 CSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQ 70
Query: 185 CLSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSN 242
L L+ L+L N++ L + + L L + +N + ++ + + L LDLS+
Sbjct: 71 KLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSH 130
Query: 243 NRLTSLGSLDLCLMHNLQNLNLQYNKL 269
N L+S + NLQ L L NK+
Sbjct: 131 NGLSSTKLGTQVQLENLQELLLSNNKI 157
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 7e-12
Identities = 23/86 (26%), Positives = 42/86 (48%), Gaps = 3/86 (3%)
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSNN 243
C + E D S K+ +P ++ + L + +N+L LP+ +L +LD+ N
Sbjct: 2 CTVSHEVADCSHLKLTQVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFN 59
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKL 269
++ L + L+ LNLQ+N+L
Sbjct: 60 TISKLEPELCQKLPMLKVLNLQHNEL 85
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 1e-19
Identities = 56/192 (29%), Positives = 75/192 (39%), Gaps = 50/192 (26%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI---E 916
E+ +LRH IV I + HL AI MEY GG + I
Sbjct: 66 EIINHRSLRHPNIVRFK-EVILTP----------THL---AIIMEYASGGELYERICNAG 111
Query: 917 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 976
+ SE A F Q + + + HS I HRD+K EN L+D P +K
Sbjct: 112 RFSE--------DEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLD-----GSPAPRLK 158
Query: 977 LCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLEVDI 1033
+CDF ++ L S + GTP ++APEVL Y G D+
Sbjct: 159 ICDFGYSKSSVLHSQPKSTV-------------GTPAYIAPEVLLR----QEYDGKIADV 201
Query: 1034 WSYGCLLLELLT 1045
WS G L +L
Sbjct: 202 WSCGVTLYVMLV 213
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 65/310 (20%), Positives = 115/310 (37%), Gaps = 75/310 (24%)
Query: 837 VRTLKV-CGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHH 895
V+ LK S + + +F + EV + +L H ++ +YG + P
Sbjct: 51 VKCLKPDVLSQPEAMDDF----IREVNAMHSLDHRNLIRLYG--VVL-------TPP--- 94
Query: 896 LLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 955
++ + E GS+ + + K + H + A VA + L SK +HRD+
Sbjct: 95 -MK--MVTELAPLGSLLDRLRK----HQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDL 147
Query: 956 KSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 1013
+ N+L+ + +VK+ DF RA+P + P W
Sbjct: 148 AARNLLL-------ATRDLVKIGDFGLMRALPQND---DHYVMQEHRKVP------FAWC 191
Query: 1014 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLI-QMGKRPRLT 1071
APE L+ + D W +G L E+ T Q P++GL+ +I I + G+R
Sbjct: 192 APESLKT----RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER---- 243
Query: 1072 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFV 1131
L C P+ + +V +C P +RPT L + +
Sbjct: 244 --LPRPEDC--------------PQD-------IYNVMVQCWAHKPEDRPTFVALRDFLL 280
Query: 1132 ARTSSSISSR 1141
+ + +
Sbjct: 281 EAQPTDMRAE 290
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 56/194 (28%), Positives = 83/194 (42%), Gaps = 56/194 (28%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYI-- 915
E++ L RH I+++Y IS+ + F MEYV GG + +YI
Sbjct: 61 EIQNLKLFRHPHIIKLY-QVISTP---------------TDFFMVMEYVSGGELFDYICK 104
Query: 916 -EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 974
++ E A + Q + +A+ H ++HRD+K EN+L+D
Sbjct: 105 HGRVEE--------MEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMN------- 149
Query: 975 VKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLEV 1031
K+ DF + + FL T C G+P + APEV+ LY G EV
Sbjct: 150 AKIADFGLSNMMSDGEFLRTSC-------------GSPNYAAPEVISG----RLYAGPEV 192
Query: 1032 DIWSYGCLLLELLT 1045
DIWS G +L LL
Sbjct: 193 DIWSCGVILYALLC 206
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 1e-19
Identities = 49/170 (28%), Positives = 75/170 (44%), Gaps = 30/170 (17%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
ME + GG + ++ + G++ + + A I + + A+ LHS +I HRD+K EN+L
Sbjct: 138 MECLDGGEL---FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLY 194
Query: 963 DLERKKADGKPVVKLCDFDRAVPLRS--FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1020
+R A +KL DF A S L T C TP ++APEVL
Sbjct: 195 TSKRPNAI----LKLTDFGFAKETTSHNSLTTPC-------------YTPYYVAPEVL-- 235
Query: 1021 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG----LSELEIHDLIQMGK 1066
P Y D+WS G ++ LL P+ + I+MG+
Sbjct: 236 --GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 283
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 40/155 (25%), Positives = 59/155 (38%), Gaps = 37/155 (23%)
Query: 901 IFMEY-VKGGSVKNYIE---KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
+ +E + + +YI L E + V AA+ HS+ ++HRDIK
Sbjct: 115 LVLERPLPAQDLFDYITEKGPLGE--------GPSRCFFGQVVAAIQHCHSRGVVHRDIK 166
Query: 957 SENILIDLERKKADGKPVVKLCDFD-RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAP 1015
ENILIDL R KL DF A+ GT + P
Sbjct: 167 DENILIDLRRGC------AKLIDFGSGALLHDEPYTDFD-------------GTRVYSPP 207
Query: 1016 EVLRAMHKPNLY-GLEVDIWSYGCLLLELLTLQVP 1049
E + + Y L +WS G LL +++ +P
Sbjct: 208 EWISR----HQYHALPATVWSLGILLYDMVCGDIP 238
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 2e-19
Identities = 52/227 (22%), Positives = 88/227 (38%), Gaps = 46/227 (20%)
Query: 851 RNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGS 910
R E L E ++L + +V + A + L + + GG
Sbjct: 225 RKGEAMALNEKQILEKVNSRFVVSLA----------YAYETKDALCL----VLTLMNGGD 270
Query: 911 VKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 970
+K +I + G+ A+F A ++ L +LH + I++RD+K ENIL+D
Sbjct: 271 LKFHIYHM---GQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLD-----DH 322
Query: 971 GKPVVKLCDFDRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 1028
G +++ D A VP + GT +MAPEV++ Y
Sbjct: 323 GH--IRISDLGLAVHVPEGQTIKGRV-------------GTVGYMAPEVVKNER----YT 363
Query: 1029 LEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELE 1075
D W+ GCLL E++ Q P+ + + + +R E
Sbjct: 364 FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV---ERLVKEVPEE 407
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 93.2 bits (231), Expect = 2e-19
Identities = 51/174 (29%), Positives = 79/174 (45%), Gaps = 46/174 (26%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
MEYV GG + +I+++ E H A+F A ++A L L SK I++RD+K +N+++
Sbjct: 421 MEYVNGGDLMYHIQQVGRFKEPH-----AVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML 475
Query: 963 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 1012
D ++G +K+ DF T C GTP +
Sbjct: 476 D-----SEGH--IKIADFGMCKENIWDGVTT-------KTFC-------------GTPDY 508
Query: 1013 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1066
+APE++ YG VD W++G LL E+L Q P+ G E E+ I
Sbjct: 509 IAPEIIAYQP----YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN 558
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 68/320 (21%), Positives = 113/320 (35%), Gaps = 97/320 (30%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
V+ LK +SAD +F E ++ + IV++ G A G P +
Sbjct: 82 VKMLKE-EASADMQADF----QREAALMAEFDNPNIVKLLG--------VCAVGKP---M 125
Query: 897 LQSAIFMEYVKGGSVKNY-------------------IEKLSETGEKHVSVKLALFIAQD 937
+ EY+ G + + ++S G +S L IA+
Sbjct: 126 C---LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQ 182
Query: 938 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 997
VAA + L + +HRD+ + N L+ VVK+ DF +
Sbjct: 183 VAAGMAYLSERKFVHRDLATRNCLVGENM-------VVKIADFGLS-------------- 221
Query: 998 RGIPAPDVCVGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPY 1050
R I + D P RWM PE + N Y E D+W+YG +L E+ + PY
Sbjct: 222 RNIYSADYYKADGNDAIPIRWMPPESI----FYNRYTTESDVWAYGVVLWEIFSYGLQPY 277
Query: 1051 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 1110
G++ E+ ++ G PE L ++ R
Sbjct: 278 YGMAHEEVIYYVRDGNI------------------------LACPE---NCPLELYNLMR 310
Query: 1111 RCTEENPTERPTAGDLYEMF 1130
C + P +RP+ ++ +
Sbjct: 311 LCWSKLPADRPSFCSIHRIL 330
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 3e-19
Identities = 60/314 (19%), Positives = 107/314 (34%), Gaps = 95/314 (30%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
++TLK + F E + L+H +V + G + +K P
Sbjct: 44 IKTLKD-KAEGPLREEF----RHEAMLRARLQHPNVVCLLG--VVTK------DQP---- 86
Query: 897 LQSAIFMEYVKGGSVKNY-----------IEKLSETGEKHVSVKLALFIAQDVAAALVEL 945
++ Y G + + T + + + + +AA + L
Sbjct: 87 --LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL 144
Query: 946 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV 1005
S H++H+D+ + N+L+ + VK+ D R + A D
Sbjct: 145 SSHHVVHKDLATRNVLVYDKL-------NVKISDLGLF--------------REVYAADY 183
Query: 1006 CVGT-----P-RWMAPEVLRAMHKPNLYG---LEVDIWSYGCLLLELLTL-QVPYMGLSE 1055
P RWMAPE + +YG ++ DIWSYG +L E+ + PY G S
Sbjct: 184 YKLLGNSLLPIRWMAPEAI-------MYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 236
Query: 1056 LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 1115
++ ++I+ + L C P + + C E
Sbjct: 237 QDVVEMIRNRQV------LPCPDDC--------------PAW-------VYALMIECWNE 269
Query: 1116 NPTERPTAGDLYEM 1129
P+ RP D++
Sbjct: 270 FPSRRPRFKDIHSR 283
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 3e-19
Identities = 50/233 (21%), Positives = 98/233 (42%), Gaps = 47/233 (20%)
Query: 834 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 893
AK +KV G+ ++ E+ +L RH I+ ++ S + E
Sbjct: 34 MAKF--VKVKGTDQVLVKK-------EISILNIARHRNILHLHE---------SFESMEE 75
Query: 894 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 953
++ E++ G + E+++ + + ++ ++ Q V AL LHS +I H
Sbjct: 76 LVMI-----FEFISGLDI---FERINTSAFELNEREIVSYVHQ-VCEALQFLHSHNIGHF 126
Query: 954 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 1013
DI+ ENI+ + +++ +K+ +F +A L+ G + P +
Sbjct: 127 DIRPENII--YQTRRSS---TIKIIEFGQARQLKP----------GDNFRLLF-TAPEYY 170
Query: 1014 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1066
APEV + H D+WS G L+ LL+ P++ + +I + I +
Sbjct: 171 APEVHQ--HDV--VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAE 219
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 52/233 (22%), Positives = 87/233 (37%), Gaps = 38/233 (16%)
Query: 69 SVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEV-GNLLGLECL------Q 120
+ + ++L+ N ++ +P + L L N + + L LE L Q
Sbjct: 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92
Query: 121 IKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEI-----AGLKCLTKLSVCHFS 175
++ P + L L L L + L E+ GL L L + +
Sbjct: 93 LRSVDPA----TFHGLGRLHTLHLDR--------CGLQELGPGLFRGLAALQYLYLQDNA 140
Query: 176 IRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLYL-L 232
++ LP + L NL L L N++ +P L +L L + N++ + + L
Sbjct: 141 LQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDL 200
Query: 233 QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC-CNLE 284
RL L L N L++L + L + LQ L L N W+C C
Sbjct: 201 GRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN---------PWVCDCRAR 244
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 23/98 (23%), Positives = 44/98 (44%), Gaps = 5/98 (5%)
Query: 175 SIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSG-LYLL 232
++ +P I + +++ L N++ ++P + L L + +N L + + L
Sbjct: 22 GLQAVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGL 79
Query: 233 QRLENLDLSNN-RLTSLGSLDLCLMHNLQNLNLQYNKL 269
LE LDLS+N +L S+ + L L+L L
Sbjct: 80 ALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL 117
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 4e-06
Identities = 15/82 (18%), Positives = 31/82 (37%), Gaps = 3/82 (3%)
Query: 192 LDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSNNRLTSLGS 250
++ +P I A + + N++ +P+ + L L L +N L + +
Sbjct: 16 TSCPQQGLQAVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDA 73
Query: 251 LDLCLMHNLQNLNLQYNKLLSY 272
+ L+ L+L N L
Sbjct: 74 AAFTGLALLEQLDLSDNAQLRS 95
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 4e-19
Identities = 47/168 (27%), Positives = 81/168 (48%), Gaps = 33/168 (19%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSENIL 961
MEY GG + ++ + E+ S A F ++ +AL LHS+ +++RD+K EN++
Sbjct: 227 MEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLM 281
Query: 962 IDLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1018
+D DG +K+ DF + + + T C GTP ++APEVL
Sbjct: 282 LD-----KDGH--IKITDFGLCKEGIKDGATMKTFC-------------GTPEYLAPEVL 321
Query: 1019 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1066
N YG VD W G ++ E++ ++P+ ++ +LI M +
Sbjct: 322 ED----NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE 365
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 4e-19
Identities = 48/243 (19%), Positives = 75/243 (30%), Gaps = 26/243 (10%)
Query: 64 RGGDNSVEGLYLYKNVL--NLIPKSVGRYEKLRNLKFFGNEIN-------LFPSEVGNLL 114
GG S+E L + + + L+ L I L + L
Sbjct: 39 YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQ 98
Query: 115 GLECLQIKISSPGVNGFALNKLKGLKELELSKV--PPRPSVLTLLSEIAGLKCLTKLSVC 172
L ++++ L L L V R + L L + L LS+
Sbjct: 99 ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPG-LKVLSIA 157
Query: 173 HFSIRYLP-PEIGCLSNLEQLDLSFNKM---KYLPTEICY--LKALISLKVANNKLVELP 226
++ L LDLS N + L + +C L L + N +
Sbjct: 158 QAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPS 217
Query: 227 ----SGLYLLQRLENLDLSNNRLTSLGSLDLCL-MHNLQNLNLQYNKLLSYCQVPSWICC 281
+ +L+ LDLS+N L C L +LNL + L VP +
Sbjct: 218 GVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ---VPKGLPA 274
Query: 282 NLE 284
L
Sbjct: 275 KLS 277
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 4e-19
Identities = 44/190 (23%), Positives = 73/190 (38%), Gaps = 20/190 (10%)
Query: 93 LRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGF---ALNKLKGLKELELSK--- 146
LRN+ + + + +E+ L + I+ F + L L+LS
Sbjct: 128 LRNVSW--ATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPE 185
Query: 147 VPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCL----SNLEQLDLSFNKMKYL 202
+ R + L L L++ + + L L+ LDLS N ++
Sbjct: 186 LGERGLISALCPL--KFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDA 243
Query: 203 PTEI--CYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQ 260
+ L SL ++ L ++P GL +L LDLS NRL S D + +
Sbjct: 244 AGAPSCDWPSQLNSLNLSFTGLKQVPKGL--PAKLSVLDLSYNRLDRNPSPD--ELPQVG 299
Query: 261 NLNLQYNKLL 270
NL+L+ N L
Sbjct: 300 NLSLKGNPFL 309
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 4e-19
Identities = 51/245 (20%), Positives = 92/245 (37%), Gaps = 27/245 (11%)
Query: 68 NSVEGLYLYKNVLNLIPK---SVGRYEKLRNLKFFGNEINLFPS----EVGNLLGLECLQ 120
NS++ + N + L+ + + + L N + S + N L+
Sbjct: 148 NSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLE 207
Query: 121 -IKISSPG----VNGFALNKLKGLKELELSKVPPRPSVLTL----LSEI-----AGLKC- 165
+ +S G + G N + + L + + AGL
Sbjct: 208 ILDVSGNGWTVDITGNFSNAISKSQAFSLIL-AHHIMGAGFGFHNIKDPDQNTFAGLARS 266
Query: 166 -LTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKL 222
+ L + H + L + L +L+ L+L++NK+ + E L L L ++ N L
Sbjct: 267 SVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL 326
Query: 223 VELPSG-LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICC 281
EL S Y L ++ +DL N + + + LQ L+L+ N L + +PS
Sbjct: 327 GELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDI 386
Query: 282 NLEGN 286
L GN
Sbjct: 387 FLSGN 391
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 1e-16
Identities = 52/213 (24%), Positives = 86/213 (40%), Gaps = 21/213 (9%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRY-EKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPG 127
V + L KN + +I ++ EKL+ L N + + ++ + K+ +
Sbjct: 339 KVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHF-IPSIPDIFLSGNKLVTLP 397
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGC-- 185
N + L E L + L + + L L + +
Sbjct: 398 KINLTANLIH-LSENRLENLDI-------LYFLLRVPHLQILILNQNRFSSCSGDQTPSE 449
Query: 186 LSNLEQLDLSFNKMKYLP-TEIC-----YLKALISLKVANNKLVELPSGLYL-LQRLENL 238
+LEQL L N ++ TE+C L L L + +N L LP G++ L L L
Sbjct: 450 NPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGL 509
Query: 239 DLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
L++NRLT L D L NL+ L++ N+LL+
Sbjct: 510 SLNSNRLTVLSHND--LPANLEILDISRNQLLA 540
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 1e-15
Identities = 41/240 (17%), Positives = 77/240 (32%), Gaps = 49/240 (20%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKFF---GNEINLFPSEV-GNLLGLECLQI--- 121
++ L L N +N I + L NL+ N + S L + + +
Sbjct: 291 DLKVLNLAYNKINKIADEA--FYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKN 348
Query: 122 KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP 181
I+ + L+ L+ L+L L+ I + + + + + LP
Sbjct: 349 HIAI--IQDQTFKFLEKLQTLDLRD--------NALTTIHFIPSIPDIFLSGNKLVTLPK 398
Query: 182 E----------------------IGCLSNLEQLDLSFNKMKYLPTE--ICYLKALISLKV 217
+ + +L+ L L+ N+ + +L L +
Sbjct: 399 INLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFL 458
Query: 218 ANNKLVEL------PSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
N L L L+ L L++N L SL + L+ L+L N+L
Sbjct: 459 GENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTV 518
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 3e-14
Identities = 47/194 (24%), Positives = 75/194 (38%), Gaps = 17/194 (8%)
Query: 112 NLLGLECLQI---KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEI-AGLKCLT 167
L E L + I + V + L+ L+ LEL + + LT+ E L L
Sbjct: 22 VLNTTERLLLSFNYIRT--VTASSFPFLEQLQLLELGS---QYTPLTIDKEAFRNLPNLR 76
Query: 168 KLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYL---PTEICYLKALISLKVANNKLV 223
L + I +L P+ L +L +L L F + LKAL L ++ N++
Sbjct: 77 ILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIR 136
Query: 224 ELPSGLYL--LQRLENLDLSNNRLTSLGSLDLCLMH--NLQNLNLQYNKLLSYCQVPSWI 279
L L L+++D S+N++ + +L + L +L N L S V
Sbjct: 137 SLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGK 196
Query: 280 CCNLEGNGKDSSND 293
C N N D
Sbjct: 197 CMNPFRNMVLEILD 210
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 1e-12
Identities = 25/123 (20%), Positives = 52/123 (42%), Gaps = 8/123 (6%)
Query: 165 CLTKLSVCHF-SIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKL 222
+++ F ++ +P L+ E+L LSFN ++ + +L+ L L++ +
Sbjct: 4 FDGRIAFYRFCNLTQVPQV---LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYT 60
Query: 223 -VELPSGLYL-LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC 280
+ + + L L LDL ++++ L + +L L L + LS +
Sbjct: 61 PLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCG-LSDAVLKDGYF 119
Query: 281 CNL 283
NL
Sbjct: 120 RNL 122
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 5e-19
Identities = 55/225 (24%), Positives = 101/225 (44%), Gaps = 26/225 (11%)
Query: 69 SVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEV-GNLLGLECLQI---KI 123
+E L L +N + I L L+ F N + P+ L L+ L + I
Sbjct: 89 HLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPI 148
Query: 124 SSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIA--GLKCLTKLSVCHFSIRYLPP 181
S + +A N++ L+ L+L ++ L+ +SE A GL L L++ ++R +P
Sbjct: 149 ES--IPSYAFNRIPSLRRLDLGELKR----LSYISEGAFEGLSNLRYLNLAMCNLREIP- 201
Query: 182 EIGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLYL-LQRLENLD 239
+ L L++LDLS N + + L L L + +++ + + LQ L ++
Sbjct: 202 NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEIN 261
Query: 240 LSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC-CNL 283
L++N LT L +H+L+ ++L +N W C C++
Sbjct: 262 LAHNNLTLLPHDLFTPLHHLERIHLHHN---------PWNCNCDI 297
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 2e-17
Identities = 44/216 (20%), Positives = 81/216 (37%), Gaps = 28/216 (12%)
Query: 69 SVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI------ 121
+ L L++N + +I + L L+ N I G GL L
Sbjct: 65 NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEI--GAFNGLANLNTLELFDN 122
Query: 122 KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEI-----AGLKCLTKLSVCHF-S 175
++++ + A L LKEL L + I + L +L +
Sbjct: 123 RLTT--IPNGAFVYLSKLKELWLRN--------NPIESIPSYAFNRIPSLRRLDLGELKR 172
Query: 176 IRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG-LYLLQ 233
+ Y+ LSNL L+L+ ++ +P + L L L ++ N L + G L
Sbjct: 173 LSYISEGAFEGLSNLRYLNLAMCNLREIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLM 231
Query: 234 RLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L+ L + +++ + + +L +NL +N L
Sbjct: 232 HLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNL 267
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 6e-16
Identities = 51/217 (23%), Positives = 85/217 (39%), Gaps = 29/217 (13%)
Query: 67 DNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEI-NLFPSEVGNLLGLECL-----Q 120
N + + L +P + R L N+I + + +L LE L
Sbjct: 42 SNQFSKVICVRKNLREVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99
Query: 121 IKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEI-----AGLKCLTKLSVCHFS 175
I+ G A N L L LEL L+ I L L +L + +
Sbjct: 100 IRTIEIG----AFNGLANLNTLELFD--------NRLTTIPNGAFVYLSKLKELWLRNNP 147
Query: 176 IRYLPPEI-GCLSNLEQLDLS-FNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLYLL 232
I +P + +L +LDL ++ Y+ L L L +A L E+P+ L L
Sbjct: 148 IESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIPN-LTPL 206
Query: 233 QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
+L+ LDLS N L+++ + +LQ L + +++
Sbjct: 207 IKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQI 243
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 91.5 bits (227), Expect = 6e-19
Identities = 38/163 (23%), Positives = 67/163 (41%), Gaps = 29/163 (17%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
++ + GG + ++ + S F A ++ L +H++ +++RD+K NIL+
Sbjct: 271 LDLMNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL 325
Query: 963 DLERKKADGKPVVKLCDFDRAVPLRSFL-HTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 1021
D G V++ D A H GT +MAPEVL+
Sbjct: 326 D-----EHGH--VRISDLGLACDFSKKKPHASV-------------GTHGYMAPEVLQKG 365
Query: 1022 HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 1064
Y D +S GC+L +LL P+ + H++ +M
Sbjct: 366 VA---YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 405
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 90.8 bits (225), Expect = 8e-19
Identities = 53/299 (17%), Positives = 99/299 (33%), Gaps = 78/299 (26%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
++ LK G+ + + E +++ L + IV + G + +
Sbjct: 368 IKVLKQ-GTEKADTEEM----MREAQIMHQLDNPYIVRLIGVCQAEALM----------- 411
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
+ ME GG + ++ + + V + V+ + L K+ +HR++
Sbjct: 412 ----LVMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLA 463
Query: 957 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 1012
+ N+L+ K+ DF +A+ +T A P +W
Sbjct: 464 ARNVLLVNRH-------YAKISDFGLSKALGADDSYYT---ARSAGKWPL--------KW 505
Query: 1013 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLT 1071
APE + + D+WSYG + E L+ Q PY + E+ I+ GKR
Sbjct: 506 YAPECINF----RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR---- 557
Query: 1072 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130
+E C P L + C +RP + +
Sbjct: 558 --MECPPEC--------------PPE-------LYALMSDCWIYKWEDRPDFLTVEQRM 593
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 9e-19
Identities = 72/316 (22%), Positives = 115/316 (36%), Gaps = 93/316 (29%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 895
V+ LK + E + E+++L L H IV + G G P
Sbjct: 58 VKMLKP-SAHLTEREAL----MSELKVLSYLGNHMNIVNLLGA--------CTIGGP--- 101
Query: 896 LLQSAIFMEYVKGGSVKNY-------------IEKLSETGEKHVSVKLALFIAQDVAAAL 942
L + EY G + N+ + E E + ++ L + VA +
Sbjct: 102 TL---VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGM 158
Query: 943 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPA 1002
L SK+ +HRD+ + NIL+ R + K+CDF A R I
Sbjct: 159 AFLASKNCIHRDLAARNILLTHGR-------ITKICDFGLA--------------RDIKN 197
Query: 1003 PDVCVGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSE 1055
V P +WMAPE + +Y E D+WSYG L EL +L PY G+
Sbjct: 198 DSNYVVKGNARLPVKWMAPESI----FNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253
Query: 1056 -LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 1114
+ + +I+ G R PE + + D+ + C +
Sbjct: 254 DSKFYKMIKEGFR------------------------MLSPE---HAPAEMYDIMKTCWD 286
Query: 1115 ENPTERPTAGDLYEMF 1130
+P +RPT + ++
Sbjct: 287 ADPLKRPTFKQIVQLI 302
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 9e-19
Identities = 49/210 (23%), Positives = 84/210 (40%), Gaps = 23/210 (10%)
Query: 73 LYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEV-GNLLGLECLQI---KISSPG 127
L L N L LIP V L L N+I + + +L L+ L++ +
Sbjct: 85 LGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVY-- 142
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLTLLSEI-----AGLKCLTKLSVCHFSIRYLPPE 182
++ A + L L++L L K L+ I + L L L + H +I +
Sbjct: 143 ISHRAFSGLNSLEQLTLEK--------CNLTSIPTEALSHLHGLIVLRLRHLNINAIRDY 194
Query: 183 I-GCLSNLEQLDLSFNK-MKYLPTEICYLKALISLKVANNKLVELPSG-LYLLQRLENLD 239
L L+ L++S + + Y L SL + + L +P + L L L+
Sbjct: 195 SFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLN 254
Query: 240 LSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
LS N ++++ L + LQ + L +L
Sbjct: 255 LSYNPISTIEGSMLHELLRLQEIQLVGGQL 284
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 1e-18
Identities = 54/229 (23%), Positives = 93/229 (40%), Gaps = 31/229 (13%)
Query: 69 SVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEV-GNLLGLECLQI---KI 123
+++ L + N L I L L + P+E +L GL L++ I
Sbjct: 129 NLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNI 188
Query: 124 SSPGVNGFALNKLKGLKELELSKVP----PRPSVLTLLSEIAGLKCLTKLSVCHFSIRYL 179
++ + ++ +L LK LE+S P P+ L L+ LT LS+ H ++ +
Sbjct: 189 NA--IRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLN-------LTSLSITHCNLTAV 239
Query: 180 PPE-IGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSG-LYLLQRLE 236
P + L L L+LS+N + + + L L +++ +L + L L
Sbjct: 240 PYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLR 299
Query: 237 NLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC-CNLE 284
L++S N+LT+L + NL+ L L N C C L
Sbjct: 300 VLNVSGNQLTTLEESVFHSVGNLETLILDSN---------PLACDCRLL 339
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 5e-18
Identities = 48/204 (23%), Positives = 74/204 (36%), Gaps = 22/204 (10%)
Query: 93 LRNLKFFGNEI-NLFPSEVGNLLGLECLQI---KISSPGVNGFALNKLKGLKELELSKVP 148
R L N I L E + LE L++ +S+ V A N L L+ L L
Sbjct: 34 TRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSA--VEPGAFNNLFNLRTLGLRS-- 89
Query: 149 PRPSVLTLLSEI-----AGLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYL 202
L I GL LTKL + I L + L NL+ L++ N + Y+
Sbjct: 90 ------NRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYI 143
Query: 203 PTEI-CYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQ 260
L +L L + L +P+ L L L L L + + ++ ++ L+
Sbjct: 144 SHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLK 203
Query: 261 NLNLQYNKLLSYCQVPSWICCNLE 284
L + + L NL
Sbjct: 204 VLEISHWPYLDTMTPNCLYGLNLT 227
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 5e-11
Identities = 24/97 (24%), Positives = 39/97 (40%), Gaps = 4/97 (4%)
Query: 175 SIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSG-LYLL 232
+P I + LDL N++K L + L L++ N + + G L
Sbjct: 22 RFVAVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNL 79
Query: 233 QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L L L +NRL + + NL L++ NK+
Sbjct: 80 FNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKI 116
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 4e-05
Identities = 13/51 (25%), Positives = 22/51 (43%), Gaps = 2/51 (3%)
Query: 219 NNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
+ V +P G+ LDL NR+ +L + +L+ L L N +
Sbjct: 20 RKRFVAVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIV 68
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 9e-19
Identities = 45/162 (27%), Positives = 81/162 (50%), Gaps = 34/162 (20%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
+EYV GG + ++++ + E+H A F + +++ AL LH + I++RD+K +N+L+
Sbjct: 89 IEYVNGGDLMFHMQRQRKLPEEH-----ARFYSAEISLALNYLHERGIIYRDLKLDNVLL 143
Query: 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV----CVGTPRWMAPEVL 1018
D ++G +KL D+ + G+ D C GTP ++APE+L
Sbjct: 144 D-----SEGH--IKLTDY-------------GMCKEGLRPGDTTSTFC-GTPNYIAPEIL 182
Query: 1019 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHD 1060
R YG VD W+ G L+ E++ + P+ + + D
Sbjct: 183 RG----EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 220
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-18
Identities = 68/312 (21%), Positives = 112/312 (35%), Gaps = 89/312 (28%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 895
V+ LK + ADE + E++++ L +H IV + G G P
Sbjct: 81 VKMLKS-TAHADEKEAL----MSELKIMSHLGQHENIVNLLGA--------CTHGGP--- 124
Query: 896 LLQSAIFMEYVKGGSVKNY---------IEKLSETGEKHVSVKLALFIAQDVAAALVELH 946
+L + EY G + N+ + S + L + VA + L
Sbjct: 125 VL---VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA 181
Query: 947 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC 1006
SK+ +HRD+ + N+L+ +G V K+ DF A R I
Sbjct: 182 SKNCIHRDVAARNVLL------TNGH-VAKIGDFGLA--------------RDIMNDSNY 220
Query: 1007 VGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMG-LSELEI 1058
+ P +WMAPE + +Y ++ D+WSYG LL E+ +L PY G L +
Sbjct: 221 IVKGNARLPVKWMAPESI----FDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 276
Query: 1059 HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1118
+ L++ G + +P + + + C PT
Sbjct: 277 YKLVKDGYQ------------------------MAQPA---FAPKNIYSIMQACWALEPT 309
Query: 1119 ERPTAGDLYEMF 1130
RPT +
Sbjct: 310 HRPTFQQICSFL 321
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 2e-18
Identities = 42/171 (24%), Positives = 71/171 (41%), Gaps = 32/171 (18%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
M + GG ++ +I + E A+F + + L LH ++I++RD+K EN+L+
Sbjct: 264 MTIMNGGDIRYHIYNVDE-DNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL 322
Query: 963 DLERKKADGKPVVKLCDFDRAVPLRSF---LHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1019
D DG V++ D AV L++ GTP +MAPE+L
Sbjct: 323 D-----DDGN--VRISDLGLAVELKAGQTKTKGYA-------------GTPGFMAPELLL 362
Query: 1020 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL----EIHDLIQMGK 1066
Y VD ++ G L E++ + P+ E E+ +
Sbjct: 363 GEE----YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA 409
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-18
Identities = 43/217 (19%), Positives = 68/217 (31%), Gaps = 38/217 (17%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFP-SEVGNLLGLECLQIKISSPGVNGF 131
L N L + V + L L N + S L L+C K +
Sbjct: 111 LNCDTNKLTKLD--VSQNPLLTYLNCARNTLTEIDVSHNTQLTELDCHLNKKITKL---- 164
Query: 132 ALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQ 191
+ L L+ S + +T L +++ K L +L+ +I L + L
Sbjct: 165 DVTPQTQLTTLDCSF-----NKITEL-DVSQNKLLNRLNCDTNNITKLD--LNQNIQLTF 216
Query: 192 LDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSL--- 248
LD S NK+ + + L L + N L EL L +L L L +
Sbjct: 217 LDCSSNKLTEID--VTPLTQLTYFDCSVNPLTELDVST--LSKLTTLHCIQTDLLEIDLT 272
Query: 249 ----------------GSLDLCLMHNLQNLNLQYNKL 269
LD+ L L+ Q +
Sbjct: 273 HNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGI 309
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 4e-17
Identities = 39/171 (22%), Positives = 65/171 (38%), Gaps = 18/171 (10%)
Query: 101 NEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEI 160
+ + FP + N ++ + + + +L L L+ S +T ++ I
Sbjct: 10 SFNDWFPDD--NFASEVAAAFEMQA--TDTISEEQLATLTSLDCHN-----SSITDMTGI 60
Query: 161 AGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANN 220
L LTKL +I L + +NL L NK+ L + L L L N
Sbjct: 61 EKLTGLTKLICTSNNITTLD--LSQNTNLTYLACDSNKLTNLD--VTPLTKLTYLNCDTN 116
Query: 221 KLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
KL +L L L+ + N LT +D+ L L+ NK ++
Sbjct: 117 KLTKLDVSQ--NPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKIT 162
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 1e-16
Identities = 37/221 (16%), Positives = 74/221 (33%), Gaps = 32/221 (14%)
Query: 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KIS 124
+ L N + + V + + L L N I + + L L K++
Sbjct: 170 TQLTTLDCSFNKITELD--VSQNKLLNRLNCDTNNITKLD--LNQNIQLTFLDCSSNKLT 225
Query: 125 SPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKC----LTKLSVCHF-SIRYL 179
+ L L + S P ++ LS++ L C L ++ + H + Y
Sbjct: 226 E-----IDVTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYF 280
Query: 180 ---------PPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLY 230
++ + L LD + L + L+ L + N +L EL +
Sbjct: 281 QAEGCRKIKELDVTHNTQLYLLDCQAAGITELD--LSQNPKLVYLYLNNTELTELD--VS 336
Query: 231 LLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
+L++L N + S + + L N + ++
Sbjct: 337 HNTKLKSLSCVNAHIQDFSS--VGKIPALNNNFEAEGQTIT 375
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 7e-07
Identities = 27/194 (13%), Positives = 61/194 (31%), Gaps = 25/194 (12%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEI-NLFPSEVGNLLGLECLQIKISSPGVNGF 131
N L + S KL L ++ + + L+ + +
Sbjct: 238 FDCSVNPLTELDVS--TLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKEL---- 291
Query: 132 ALNKLKGLKELELSK-------VPPRPSVLTL------LSEI--AGLKCLTKLSVCHFSI 176
+ L L+ + P ++ L L+E+ + L LS + I
Sbjct: 292 DVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTELDVSHNTKLKSLSCVNAHI 351
Query: 177 RYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLE 236
+ +G + L + + +P E +L ++ V+ + L + + + +
Sbjct: 352 QDFSS-VGKIPALNNNFEAEGQTITMPKETLTNNSL-TIAVSPDLLDQFGNPMNIEPGDG 409
Query: 237 N-LDLSNNRLTSLG 249
D + N +T
Sbjct: 410 GVYDQATNTITWEN 423
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 2e-18
Identities = 56/227 (24%), Positives = 95/227 (41%), Gaps = 30/227 (13%)
Query: 69 SVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI------ 121
+E L L +N + I L L+ F N + + PS L L+
Sbjct: 100 HLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGA--FEYLSKLRELWLRNN 157
Query: 122 KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIA--GLKCLTKLSVCHFSIRYL 179
I S + +A N++ L L+L ++ L +SE A GL L L++ +I+ +
Sbjct: 158 PIES--IPSYAFNRVPSLMRLDLGELKK----LEYISEGAFEGLFNLKYLNLGMCNIKDM 211
Query: 180 PPEIGCLSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKLVELPSG-LYLLQRLEN 237
P + L LE+L++S N + L +L L V N+++ + L L
Sbjct: 212 P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVE 270
Query: 238 LDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC-CNL 283
L+L++N L+SL + L L+L +N W C C++
Sbjct: 271 LNLAHNNLSSLPHDLFTPLRYLVELHLHHN---------PWNCDCDI 308
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 3e-17
Identities = 44/214 (20%), Positives = 81/214 (37%), Gaps = 24/214 (11%)
Query: 69 SVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEV-GNLLGLECLQI---KI 123
+ L L +N + +I L L+ N I L L L++ +
Sbjct: 76 NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL 135
Query: 124 SSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEI-----AGLKCLTKLSVCHF-SIR 177
+ + A L L+EL L + I + L +L + +
Sbjct: 136 TV--IPSGAFEYLSKLRELWLRN--------NPIESIPSYAFNRVPSLMRLDLGELKKLE 185
Query: 178 YLPPEI-GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYL-LQRL 235
Y+ L NL+ L+L +K +P + L L L+++ N E+ G + L L
Sbjct: 186 YISEGAFEGLFNLKYLNLGMCNIKDMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSL 244
Query: 236 ENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
+ L + N++++ + + +L LNL +N L
Sbjct: 245 KKLWVMNSQVSLIERNAFDGLASLVELNLAHNNL 278
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 9e-12
Identities = 24/97 (24%), Positives = 44/97 (45%), Gaps = 4/97 (4%)
Query: 175 SIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSG-LYLL 232
+ +P I SN L+L N ++ + + +L L L++ N + ++ G L
Sbjct: 65 GLSEVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGL 122
Query: 233 QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L L+L +N LT + S + L+ L L+ N +
Sbjct: 123 ASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPI 159
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 3e-18
Identities = 42/259 (16%), Positives = 97/259 (37%), Gaps = 24/259 (9%)
Query: 16 GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYL 75
GP+ + + I + DD+ + + + + NS++ +
Sbjct: 1 GPLGSETITVPTPIKQIFS-------DDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIA 53
Query: 76 YKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KISSPGVNGFA 132
+ + + + + + L GN++ + NL L L + K+ ++
Sbjct: 54 NNSDIKSV-QGIQYLPNVTKLFLNGNKLTDI-KPLANLKNLGWLFLDENKVKD--LSS-- 107
Query: 133 LNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQL 192
L LK LK L L + ++ ++ + L L L + + I + + L+ L+ L
Sbjct: 108 LKDLKKLKSLSLEH-----NGISDINGLVHLPQLESLYLGNNKITDITV-LSRLTKLDTL 161
Query: 193 DLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLD 252
L N++ + + L L +L ++ N + +L L L+ L+ L+L + +
Sbjct: 162 SLEDNQISDIV-PLAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQECLNKPINH 219
Query: 253 LCLMHNLQNLNLQYNKLLS 271
+ + L++
Sbjct: 220 QSNLVVPNTVKNTDGSLVT 238
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 3e-18
Identities = 68/307 (22%), Positives = 117/307 (38%), Gaps = 81/307 (26%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 895
++ +K +S D+ R+F GE+ +L L H I+ + G +
Sbjct: 57 IKRMKE-YASKDDHRDF----AGELEVLCKLGHHPNIINLLGA--------CEHRGYLY- 102
Query: 896 LLQSAIFMEYVKGGSVKNY-----------IEKLSETGEKHVSVKLALFIAQDVAAALVE 944
+ +EY G++ ++ ++ + +S + L A DVA +
Sbjct: 103 -----LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDY 157
Query: 945 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1004
L K +HRD+ + NIL+ V K+ DF + R +P
Sbjct: 158 LSQKQFIHRDLAARNILVGENY-------VAKIADFGLS---RGQEVYVKKTMGRLPV-- 205
Query: 1005 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQ 1063
RWMA E L ++Y D+WSYG LL E+++L PY G++ E+++ +
Sbjct: 206 ------RWMAIESLNY----SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 255
Query: 1064 MGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123
G R LE +C + + D+ R+C E P ERP+
Sbjct: 256 QGYR------LEKPLNC--------------DDE-------VYDLMRQCWREKPYERPSF 288
Query: 1124 GDLYEMF 1130
+
Sbjct: 289 AQILVSL 295
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 6e-18
Identities = 49/236 (20%), Positives = 74/236 (31%), Gaps = 51/236 (21%)
Query: 62 GNRGGDNSVEGLYLYKNVLN---LIPKSVGRYEKLRNLKFFGNEINLF----PSEVGNLL 114
V L L L IP S+ L L G N P + L
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGI--NNLVGPIPPAIAKLT 101
Query: 115 GLECLQIKISSPGVNGF------ALNKLKGLKELELS------KVPPRPSVLTLLSEIAG 162
L L I L+++K L L+ S +PP S L L I
Sbjct: 102 QLHYLYI-----THTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT- 155
Query: 163 LKCLTKLSVCHFS--IRYLPPEIGCLSNLEQ-LDLSFNKMK-YLPTEICYLKALISLKVA 218
S I P G S L + +S N++ +P L L + ++
Sbjct: 156 ------FDGNRISGAI---PDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLS 205
Query: 219 NNKLV-ELPSGLYLLQRLENLDLSNNRLT----SLGSLDLCLMHNLQNLNLQYNKL 269
N L + + + + L+ N L +G NL L+L+ N++
Sbjct: 206 RNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLS-----KNLNGLDLRNNRI 256
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 3e-17
Identities = 47/202 (23%), Positives = 75/202 (37%), Gaps = 49/202 (24%)
Query: 83 IPKSVGRYEKLRNLKFFGNEIN---LFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGL 139
+ + + ++ NL G + PS + NL L L I +N L G
Sbjct: 42 LCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYI---------GGINNLVG- 91
Query: 140 KELELSKVPPRPSVLTLLSEIAGLKCLTKL--SVCHFS--IRYLPPEIGCLSNLEQLDLS 195
+PP IA L L L + + S I P + + L LD S
Sbjct: 92 ------PIPP---------AIAKLTQLHYLYITHTNVSGAI---PDFLSQIKTLVTLDFS 133
Query: 196 FNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRL-ENLDLSNNRLT-----S 247
+N + LP I L L+ + N++ +P +L ++ +S NRLT +
Sbjct: 134 YNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPT 193
Query: 248 LGSLDLCLMHNLQNLNLQYNKL 269
+L NL ++L N L
Sbjct: 194 FANL------NLAFVDLSRNML 209
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 8e-15
Identities = 51/211 (24%), Positives = 75/211 (35%), Gaps = 47/211 (22%)
Query: 73 LYLYKNVLN-LIPKSVGRYEKLRNLKFFGNEIN-LFPSEVGNLLGLECLQIKISSPGVNG 130
L N L+ +P S+ L + F GN I+ P G+ L + IS
Sbjct: 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLF-TSMTISR----- 183
Query: 131 FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTK--LSVCHFS--IRYLPPEIGCL 186
N+L G K+PP A L L LS G
Sbjct: 184 ---NRLTG-------KIPP---------TFANLN-LAFVDLSRNMLEGDA---SVLFGSD 220
Query: 187 SNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRLENLDLSNNR 244
N +++ L+ N + L ++ K L L + NN++ LP GL L+ L +L++S N
Sbjct: 221 KNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNN 279
Query: 245 LT----SLGSLDLCLMHNLQNLNLQYNKLLS 271
L G+L NK L
Sbjct: 280 LCGEIPQGGNLQ-----RFDVSAYANNKCLC 305
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 2e-04
Identities = 40/202 (19%), Positives = 68/202 (33%), Gaps = 55/202 (27%)
Query: 69 SVEGLYLYKNVLN-LIPKSVGRYEKL-RNLKFFGNEIN-LFPSEVGNLLGLECLQI---- 121
++ G+ N ++ IP S G + KL ++ N + P NL L + +
Sbjct: 150 NLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNM 208
Query: 122 ---KISSPGVNGFALNKLKGLKELELSKVPPRPSVLT-LLSEIAGLKCLTKLSVCH--FS 175
S K +++ L+K + L L ++ K L L + +
Sbjct: 209 LEGDASV------LFGSDKNTQKIHLAK-----NSLAFDLGKVGLSKNLNGLDLRNNRIY 257
Query: 176 --IRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLV-ELPSGLYLL 232
+ P + L L L++SF N L E+P G L
Sbjct: 258 GTL---PQGLTQLKFLHSLNVSF-----------------------NNLCGEIPQGG-NL 290
Query: 233 QRLENLDLSNNRLTSLGSLDLC 254
QR + +NN+ L C
Sbjct: 291 QRFDVSAYANNKCLCGSPLPAC 312
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 7e-18
Identities = 45/168 (26%), Positives = 79/168 (47%), Gaps = 46/168 (27%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
+EYV GG + ++++ + E+H A F + +++ AL LH + I++RD+K +N+L+
Sbjct: 132 IEYVNGGDLMFHMQRQRKLPEEH-----ARFYSAEISLALNYLHERGIIYRDLKLDNVLL 186
Query: 963 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 1012
D ++G +KL D+ D T C GTP +
Sbjct: 187 D-----SEGH--IKLTDYGMCKEGLRPGDTT-------STFC-------------GTPNY 219
Query: 1013 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHD 1060
+APE+LR YG VD W+ G L+ E++ + P+ + + D
Sbjct: 220 IAPEILRGED----YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 263
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 8e-18
Identities = 46/207 (22%), Positives = 82/207 (39%), Gaps = 38/207 (18%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
E+ ++ L H ++ ++ + + E L +E++ GG + ++++
Sbjct: 98 EISIMNQLHHPKLINLHD---------AFEDKYEMVL-----ILEFLSGGEL---FDRIA 140
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
K ++ ++ Q L +H I+H DIK ENI+ E KKA VK+ D
Sbjct: 141 AEDYKMSEAEVINYMRQ-ACEGLKHMHEHSIVHLDIKPENIM--CETKKAS---SVKIID 194
Query: 980 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039
F A L T + APE++ +P G D+W+ G L
Sbjct: 195 FGLATKLNP----------DEIVKVTT-ATAEFAAPEIVD--REP--VGFYTDMWAIGVL 239
Query: 1040 LLELLTLQVPYMGLSELEIHDLIQMGK 1066
LL+ P+ G +LE ++
Sbjct: 240 GYVLLSGLSPFAGEDDLETLQNVKRCD 266
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 8e-18
Identities = 46/207 (22%), Positives = 79/207 (38%), Gaps = 38/207 (18%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
E++ + LRH +V ++ + + + E ++ E++ GG + +
Sbjct: 204 EIQTMSVLRHPTLVNLHD---------AFEDDNEMVMI-----YEFMSGGELFEKV--AD 247
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
E +S A+ + V L +H + +H D+K ENI+ +R +KL D
Sbjct: 248 EHN--KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNE-----LKLID 300
Query: 980 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039
F L GT + APEV KP G D+WS G L
Sbjct: 301 FGLTAHLDP----------KQSVKVTT-GTAEFAAPEVAE--GKP--VGYYTDMWSVGVL 345
Query: 1040 LLELLTLQVPYMGLSELEIHDLIQMGK 1066
LL+ P+ G ++ E ++
Sbjct: 346 SYILLSGLSPFGGENDDETLRNVKSCD 372
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 1e-17
Identities = 54/242 (22%), Positives = 86/242 (35%), Gaps = 58/242 (23%)
Query: 849 EIRNFEYSCLGEVRMLGALRHSCIVEMY----GHKISSKWLPSADGNPEHHLLQSAIFME 904
E S E+ +L L+H ++ + H WL +
Sbjct: 57 EGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL----------------LFD 100
Query: 905 YVKGGSVKNYIEKLSETGEKHVSVKLAL-----FIAQDVAAALVELHSKHIMHRDIKSEN 959
Y + + + I+ + V+L + Q + + LH+ ++HRD+K N
Sbjct: 101 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ-ILDGIHYLHANWVLHRDLKPAN 158
Query: 960 ILIDLERKKADGKPVVKLCDFDRA----VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-A 1014
IL+ E + VK+ D A PL+ D V T W A
Sbjct: 159 ILVMGE---GPERGRVKIADMGFARLFNSPLKPLAD-----------LDPVVVT-FWYRA 203
Query: 1015 PEVL-RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDE 1073
PE+L A H Y +DIW+ GC+ ELLT + + E P D+
Sbjct: 204 PELLLGARH----YTKAIDIWAIGCIFAELLTSEPIFHCRQE------DIKTSNPYHHDQ 253
Query: 1074 LE 1075
L+
Sbjct: 254 LD 255
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 44/204 (21%), Positives = 82/204 (40%), Gaps = 17/204 (8%)
Query: 71 EGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KISSPG 127
GL L N + + + K+ L+ GN + S + L ++ L + +I+
Sbjct: 66 IGLELKDNQITDLA-PLKNLTKITELELSGNPLKNV-SAIAGLQSIKTLDLTSTQITDV- 122
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLS 187
L L L+ L L + +T +S +AGL L LS+ + + L P + LS
Sbjct: 123 ---TPLAGLSNLQVLYLDL-----NQITNISPLAGLTNLQYLSIGNAQVSDLTP-LANLS 173
Query: 188 NLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTS 247
L L NK+ + + L LI + + NN++ ++ S L L + L+N +T+
Sbjct: 174 KLTTLKADDNKISDIS-PLASLPNLIEVHLKNNQISDV-SPLANTSNLFIVTLTNQTITN 231
Query: 248 LGSLDLCLMHNLQNLNLQYNKLLS 271
+ + ++
Sbjct: 232 QPVFYNNNLVVPNVVKGPSGAPIA 255
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 35/139 (25%), Positives = 63/139 (45%), Gaps = 10/139 (7%)
Query: 131 FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLE 190
F L ++ K S +T A L +T LS + + + L+NL
Sbjct: 13 FPDPALANAIKIAAGK-----SNVTDTVTQADLDGITTLSAFGTGVTTIEG-VQYLNNLI 66
Query: 191 QLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGS 250
L+L N++ L + L + L+++ N L + S + LQ ++ LDL++ ++T +
Sbjct: 67 GLELKDNQITDLA-PLKNLTKITELELSGNPLKNV-SAIAGLQSIKTLDLTSTQITDVT- 123
Query: 251 LDLCLMHNLQNLNLQYNKL 269
L + NLQ L L N++
Sbjct: 124 -PLAGLSNLQVLYLDLNQI 141
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 1e-17
Identities = 58/194 (29%), Positives = 84/194 (43%), Gaps = 56/194 (28%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYI-- 915
E++ L RH I+++Y IS+ S IF MEYV GG + +YI
Sbjct: 66 EIQNLKLFRHPHIIKLY-QVISTP---------------SDIFMVMEYVSGGELFDYICK 109
Query: 916 -EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 974
+L E K + + Q + + + H ++HRD+K EN+L+D
Sbjct: 110 NGRLDE--------KESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMN------- 154
Query: 975 VKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLEV 1031
K+ DF + + FL T C G+P + APEV+ LY G EV
Sbjct: 155 AKIADFGLSNMMSDGEFLRTSC-------------GSPNYAAPEVISG----RLYAGPEV 197
Query: 1032 DIWSYGCLLLELLT 1045
DIWS G +L LL
Sbjct: 198 DIWSSGVILYALLC 211
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-17
Identities = 53/194 (27%), Positives = 83/194 (42%), Gaps = 57/194 (29%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYI-- 915
E+ L LRH I+++Y I++ + I +EY GG + +YI
Sbjct: 59 EISYLKLLRHPHIIKLY-DVITTP---------------TDIVMVIEYA-GGELFDYIVE 101
Query: 916 -EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 974
++++E Q + A+ H I+HRD+K EN+L+D
Sbjct: 102 KKRMTE--------DEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLN------- 146
Query: 975 VKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLEV 1031
VK+ DF + + +FL T C G+P + APEV+ LY G EV
Sbjct: 147 VKIADFGLSNIMTDGNFLKTSC-------------GSPNYAAPEVING----KLYAGPEV 189
Query: 1032 DIWSYGCLLLELLT 1045
D+WS G +L +L
Sbjct: 190 DVWSCGIVLYVMLV 203
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 4e-17
Identities = 30/182 (16%), Positives = 72/182 (39%), Gaps = 14/182 (7%)
Query: 91 EKLRNLKFFGNEI-NLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPP 149
+ N + N+ +++ +L + I ++ + G + +K+L ++
Sbjct: 23 KAYLNGLLGQSSTANITEAQMNSLTYITLANINVTD--LTG--IEYAHNIKDLTINN--- 75
Query: 150 RPSVLTLLSEIAGLKCLTKLSVCHFSIR-YLPPEIGCLSNLEQLDLSFNKMK-YLPTEIC 207
T + I+GL L +L + + P + L++L LD+S + + T+I
Sbjct: 76 --IHATNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 208 YLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYN 267
L + S+ ++ N + L L L++L++ + + ++ L L
Sbjct: 134 TLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHDYRGIE--DFPKLNQLYAFSQ 191
Query: 268 KL 269
+
Sbjct: 192 TI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 9e-14
Identities = 24/148 (16%), Positives = 53/148 (35%), Gaps = 9/148 (6%)
Query: 125 SPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIG 184
S + K L + S + A + LT +++ + ++ L I
Sbjct: 11 SQDNVNIPDSTFKAYLNGLLGQ----SSTANI--TEAQMNSLTYITLANINVTDLTG-IE 63
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRLENLDLSNN 243
N++ L ++ I L L L++ + + L L L LD+S++
Sbjct: 64 YAHNIKDLTINNIHATNY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHS 122
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
+ + + +++L YN ++
Sbjct: 123 AHDDSILTKINTLPKVNSIDLSYNGAIT 150
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 1e-12
Identities = 28/184 (15%), Positives = 62/184 (33%), Gaps = 23/184 (12%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECL-----QIKISSPG 127
L ++ I ++ + L + + + + ++ L +P
Sbjct: 28 GLLGQSSTANITEA--QMNSLTYITLANINVTDL-TGIEYAHNIKDLTINNIHATNYNP- 83
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLT--LLSEIAGLKCLTKLSVCHFSIRYLPPE-IG 184
++ L L+ L + +T + ++GL LT L + H + I
Sbjct: 84 -----ISGLSNLERLRIMG-----KDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNR 244
L + +DLS+N + L L SL + + + + G+ +L L +
Sbjct: 134 TLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHDY-RGIEDFPKLNQLYAFSQT 192
Query: 245 LTSL 248
+
Sbjct: 193 IGGK 196
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 4e-17
Identities = 47/213 (22%), Positives = 85/213 (39%), Gaps = 50/213 (23%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI---- 915
E+ ++ L H+ ++++Y + + + L MEYV GG + + I
Sbjct: 136 EISVMNQLDHANLIQLYD---------AFESKNDIVL-----VMEYVDGGELFDRIIDES 181
Query: 916 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 975
L+E + + + + +H +I+H D+K ENIL + A +
Sbjct: 182 YNLTE--------LDTILFMKQICEGIRHMHQMYILHLDLKPENIL--CVNRDAK---QI 228
Query: 976 KLCDFDRAVPL--RSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 1033
K+ DF A R L GTP ++APEV+ + D+
Sbjct: 229 KIIDFGLARRYKPREKLKVNF-------------GTPEFLAPEVVN--YDF--VSFPTDM 271
Query: 1034 WSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1066
WS G + LL+ P++G ++ E + I +
Sbjct: 272 WSVGVIAYMLLSGLSPFLGDNDAETLNNILACR 304
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 6e-17
Identities = 36/151 (23%), Positives = 52/151 (34%), Gaps = 33/151 (21%)
Query: 901 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960
+ MEY G E L EK V A + L LHS+ I+H+DIK N+
Sbjct: 85 MVMEYCVCGMQ----EMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNL 140
Query: 961 LIDLERKKADGKPVVKLCDF-----DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAP 1015
L+ +K+ T G+P + P
Sbjct: 141 LLTTGGT-------LKISALGVAEALHPFAADDTCRTSQ-------------GSPAFQPP 180
Query: 1016 EVLRAMHKPNLY-GLEVDIWSYGCLLLELLT 1045
E+ + + G +VDIWS G L + T
Sbjct: 181 EIANGLD---TFSGFKVDIWSAGVTLYNITT 208
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 84.4 bits (208), Expect = 9e-17
Identities = 42/267 (15%), Positives = 96/267 (35%), Gaps = 19/267 (7%)
Query: 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KIS 124
NS++ + + + + + + + L GN++ + NL L L + KI
Sbjct: 43 NSIDQIIANNSDIKSV-QGIQYLPNVTKLFLNGNKLTDI-KPLTNLKNLGWLFLDENKIK 100
Query: 125 SPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIG 184
++ L LK LK L L + ++ ++ + L L L + + I + +
Sbjct: 101 D--LSS--LKDLKKLKSLSLEH-----NGISDINGLVHLPQLESLYLGNNKITDITV-LS 150
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNR 244
L+ L+ L L N++ + + L L +L ++ N + +L L L+ L+ L+L +
Sbjct: 151 RLTKLDTLSLEDNQISDIV-PLAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQE 208
Query: 245 LTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSAEMDV 304
+ + + L++ + + E +F + + +
Sbjct: 209 CLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS--DDGDYEKPNVKWHLPEFTNEVSFIFY 266
Query: 305 YEGPMLENDGNVSFSAESDAGSRHTSS 331
+ + +T S
Sbjct: 267 QPVTIGKAKARFHGRVTQPLKEVYTVS 293
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 73.2 bits (179), Expect = 3e-13
Identities = 25/117 (21%), Positives = 53/117 (45%), Gaps = 6/117 (5%)
Query: 155 TLLSEIAGLKCLTKLSVCHFSIRYL--PPEIGCLSNLEQLDLSFNKMKYLPTEICYLKAL 212
T + +I + + + + L++++Q+ + + +K + I YL +
Sbjct: 9 TPIKQIFPDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSV-QGIQYLPNV 67
Query: 213 ISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L + NKL ++ L L+ L L L N++ L SL L++L+L++N +
Sbjct: 68 TKLFLNGNKLTDI-KPLTNLKNLGWLFLDENKIKDLSSLKDL--KKLKSLSLEHNGI 121
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 51.3 bits (122), Expect = 1e-06
Identities = 11/81 (13%), Positives = 27/81 (33%), Gaps = 4/81 (4%)
Query: 189 LEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSL 248
+ + +K + I + + + L ++ + +N+ + S+
Sbjct: 1 MGETITVSTPIKQIFP-DDAFAETIKDNLKKKSVTDA-VTQNELNSIDQIIANNSDIKSV 58
Query: 249 GSLDLCLMHNLQNLNLQYNKL 269
+ N+ L L NKL
Sbjct: 59 QGIQYL--PNVTKLFLNGNKL 77
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-16
Identities = 69/324 (21%), Positives = 112/324 (34%), Gaps = 104/324 (32%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 895
V+ LK + + E + E++M+ L H IV + G P
Sbjct: 80 VKMLKE-KADSSEREAL----MSELKMMTQLGSHENIVNLLGA--------CTLSGP--- 123
Query: 896 LLQSAIFMEYVKGGSVKNY------------------IEKLSETGEKHVSVKLALFIAQD 937
+ + EY G + NY E ++ + L A
Sbjct: 124 IY---LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQ 180
Query: 938 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 997
VA + L K +HRD+ + N+L+ + VVK+CDF A
Sbjct: 181 VAKGMEFLEFKSCVHRDLAARNVLVTHGK-------VVKICDFGLA-------------- 219
Query: 998 RGIPAPDVCVGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPY 1050
R I + V P +WMAPE L +Y ++ D+WSYG LL E+ +L PY
Sbjct: 220 RDIMSDSNYVVRGNARLPVKWMAPESLFE----GIYTIKSDVWSYGILLWEIFSLGVNPY 275
Query: 1051 MGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE---AELETLSFLV 1106
G+ + + LIQ G + ++P E+
Sbjct: 276 PGIPVDANFYKLIQNGFK------------------------MDQPFYATEEIY------ 305
Query: 1107 DVFRRCTEENPTERPTAGDLYEMF 1130
+ + C + +RP+ +L
Sbjct: 306 IIMQSCWAFDSRKRPSFPNLTSFL 329
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 2e-16
Identities = 51/203 (25%), Positives = 86/203 (42%), Gaps = 45/203 (22%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
EV +L L+H I+E+ + HH + + EY + +K Y++K
Sbjct: 83 EVSLLKELQHRNIIEL--KSV------------IHHNHRLHLIFEYAEN-DLKKYMDKNP 127
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
+ + + F+ Q + + HS+ +HRD+K +N+L+ + V+K+ D
Sbjct: 128 DVSMRVI----KSFLYQ-LINGVNFCHSRRCLHRDLKPQNLLLSVSDASETP--VLKIGD 180
Query: 980 F--DRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIW 1034
F RA +P+R F H + T W PE+L Y VDIW
Sbjct: 181 FGLARAFGIPIRQFTHE--------------IIT-LWYRPPEILLGSRH---YSTSVDIW 222
Query: 1035 SYGCLLLELLTLQVPYMGLSELE 1057
S C+ E+L + G SE++
Sbjct: 223 SIACIWAEMLMKTPLFPGDSEID 245
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 53/207 (25%), Positives = 82/207 (39%), Gaps = 57/207 (27%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM--EYVKGGSVKNYIEK 917
E+RML L+H +V + + + + EY +V + +++
Sbjct: 52 EIRMLKQLKHPNLVNLL--------------EVFRR--KRRLHLVFEYCDH-TVLHELDR 94
Query: 918 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 977
+H+ VK Q A+ H + +HRD+K ENILI V+KL
Sbjct: 95 YQRGVPEHL-VKS--ITWQ-TLQAVNFCHKHNCIHRDVKPENILIT-----KHS--VIKL 143
Query: 978 CDFD--RA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVL-RAMHKPNLYGLEV 1031
CDF R P + V T RW +PE+L YG V
Sbjct: 144 CDFGFARLLTGPSDYYDDE--------------VAT-RWYRSPELLVGDTQ----YGPPV 184
Query: 1032 DIWSYGCLLLELLTLQVPYM-GLSELE 1057
D+W+ GC+ ELL+ P G S+++
Sbjct: 185 DVWAIGCVFAELLSGV-PLWPGKSDVD 210
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 3e-16
Identities = 57/207 (27%), Positives = 89/207 (42%), Gaps = 57/207 (27%)
Query: 860 EVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 917
E+++L LRH +V + K +L +F E+V ++ + +E
Sbjct: 74 EIKLLKQLRHENLVNLLEVCKKKKRWYL---------------VF-EFVDH-TILDDLEL 116
Query: 918 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 977
+ V V+ ++ Q + + HS +I+HRDIK ENIL+ G VVKL
Sbjct: 117 FPNGLDYQV-VQK--YLFQ-IINGIGFCHSHNIIHRDIKPENILVS-----QSG--VVKL 165
Query: 978 CDF--DRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVL-RAMHKPNLYGLEV 1031
CDF R P + V T RW APE+L + YG V
Sbjct: 166 CDFGFARTLAAPGEVYDD--------------EVAT-RWYRAPELLVGDVK----YGKAV 206
Query: 1032 DIWSYGCLLLELLTLQVPYM-GLSELE 1057
D+W+ GCL+ E+ + P G S+++
Sbjct: 207 DVWAIGCLVTEMFMGE-PLFPGDSDID 232
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 4e-16
Identities = 52/162 (32%), Positives = 69/162 (42%), Gaps = 15/162 (9%)
Query: 114 LGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCH 173
L L + S L L +L L + + LT L L L L + H
Sbjct: 36 LHLSENLLYTFSLA----TLMPYTRLTQLNLDR-----AELTKLQVDGTLPVLGTLDLSH 86
Query: 174 FSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLY-L 231
++ LP L L LD+SFN++ LP L L L + N+L LP GL
Sbjct: 87 NQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTP 146
Query: 232 LQRLENLDLSNNRLTSL--GSLDLCLMHNLQNLNLQYNKLLS 271
+LE L L+NN LT L G L+ + NL L LQ N L +
Sbjct: 147 TPKLEKLSLANNNLTELPAGLLN--GLENLDTLLLQENSLYT 186
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 55/222 (24%), Positives = 78/222 (35%), Gaps = 47/222 (21%)
Query: 69 SVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPG 127
L+L +N+L + Y +L L E+
Sbjct: 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ-------------------- 71
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEI-GCL 186
L L L+LS + +L L LT L V + LP L
Sbjct: 72 ----VDGTLPVLGTLDLS----HNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGL 123
Query: 187 SNLEQLDLSFNKMKYLPTEIC-YLKALISLKVANNKLVELPSGLYL-LQRLENLDLSNNR 244
L++L L N++K LP + L L +ANN L ELP+GL L+ L+ L L N
Sbjct: 124 GELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS 183
Query: 245 LTSL--GSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC-CNL 283
L ++ G H L L N P W+C C +
Sbjct: 184 LYTIPKGFFGS---HLLPFAFLHGN--------P-WLCNCEI 213
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 9e-08
Identities = 19/88 (21%), Positives = 36/88 (40%), Gaps = 5/88 (5%)
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYL-LQRLENLDLSNN 243
+++ +++ + LP ++ K L ++ N L + RL L+L
Sbjct: 8 KVASHLEVNCDKRNLTALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
LT L + L L+L +N+L S
Sbjct: 66 ELTKLQVDG--TLPVLGTLDLSHNQLQS 91
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 78.7 bits (195), Expect = 6e-16
Identities = 48/206 (23%), Positives = 82/206 (39%), Gaps = 54/206 (26%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 917
E+ +L L+H IV ++ + H + E+ +K Y +
Sbjct: 51 EICLLKELKHKNIVRLH--------------DVLHS--DKKLTLVFEFCDQ-DLKKYFDS 93
Query: 918 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 977
+ + + VK F+ Q + L HS++++HRD+K +N+LI+ +G +KL
Sbjct: 94 CNGDLDPEI-VKS--FLFQ-LLKGLGFCHSRNVLHRDLKPQNLLIN-----RNG--ELKL 142
Query: 978 CDF--DRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVD 1032
+F RA +P+R + V T W P+VL Y +D
Sbjct: 143 ANFGLARAFGIPVRCYSA--------------EVVT-LWYRPPDVLFGAKL---YSTSID 184
Query: 1033 IWSYGCLLLELLTLQVPYM-GLSELE 1057
+WS GC+ EL P G +
Sbjct: 185 MWSAGCIFAELANAGRPLFPGNDVDD 210
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 9e-16
Identities = 27/113 (23%), Positives = 51/113 (45%), Gaps = 6/113 (5%)
Query: 157 LSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLK 216
+ GL K ++ S+ L LS ++ + + ++ L + + L L
Sbjct: 12 VFPDPGLANAVKQNLGKQSVTDLVS-QKELSGVQNFNGDNSNIQSL-AGMQFFTNLKELH 69
Query: 217 VANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
+++N++ +L S L L +LE L ++ NRL +L + L L L N+L
Sbjct: 70 LSHNQISDL-SPLKDLTKLEELSVNRNRLKNLNGIPSA---CLSRLFLDNNEL 118
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 40/202 (19%), Positives = 77/202 (38%), Gaps = 29/202 (14%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECL-----QIKISSPG 127
L K + + S ++N + I + + L+ L QI SP
Sbjct: 24 QNLGKQSVTDL-VSQKELSGVQNFNGDNSNIQSL-AGMQFFTNLKELHLSHNQISDLSP- 80
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKC--LTKLSVCHFSIRYLPPEIGC 185
L L L+EL +++ L + G+ L++L + + +R +
Sbjct: 81 -----LKDLTKLEELSVNR--------NRLKNLNGIPSACLSRLFLDNNELRDTDS-LIH 126
Query: 186 LSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRL 245
L NLE L + NK+K + + +L L L + N++ GL L+++ +DL+ +
Sbjct: 127 LKNLEILSIRNNKLKSIV-MLGFLSKLEVLDLHGNEITNT-GGLTRLKKVNWIDLTGQKC 184
Query: 246 TSLGSLDLCLMHNLQNLNLQYN 267
+ + L N +
Sbjct: 185 V---NEPVKYQPELYITNTVKD 203
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 5e-15
Identities = 36/137 (26%), Positives = 63/137 (45%), Gaps = 11/137 (8%)
Query: 133 LNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQL 192
+L G++ S + L+ + L +L + H I L P + L+ LE+L
Sbjct: 37 QKELSGVQNFNGDN-----SNIQSLAGMQFFTNLKELHLSHNQISDLSP-LKDLTKLEEL 90
Query: 193 DLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLD 252
++ N++K L L L + NN+L + L L+ LE L + NN+L S+ L
Sbjct: 91 SVNRNRLKNL--NGIPSACLSRLFLDNNELRDT-DSLIHLKNLEILSIRNNKLKSIVMLG 147
Query: 253 LCLMHNLQNLNLQYNKL 269
+ L+ L+L N++
Sbjct: 148 --FLSKLEVLDLHGNEI 162
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-15
Identities = 46/193 (23%), Positives = 84/193 (43%), Gaps = 40/193 (20%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
E++++ ++H +V++ + + D E L + +EYV +V +
Sbjct: 82 ELQIMRIVKHPNVVDLKAF-----FYSNGDKKDEVFLN---LVLEYV-PETVYRASRHYA 132
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
+ + + + L++ Q + +L +HS I HRDIK +N+L+D V+KL D
Sbjct: 133 KLKQTMPMLLIKLYMYQ-LLRSLAYIHSIGICHRDIKPQNLLLDPP------SGVLKLID 185
Query: 980 FDRA---VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEV-LRAMHKPNLYGLEVDIW 1034
F A + + +C R+ APE+ A + Y +DIW
Sbjct: 186 FGSAKILIAGEPNVS------------YICS---RYYRAPELIFGATN----YTTNIDIW 226
Query: 1035 SYGCLLLELLTLQ 1047
S GC++ EL+ Q
Sbjct: 227 STGCVMAELMQGQ 239
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 2e-15
Identities = 66/286 (23%), Positives = 111/286 (38%), Gaps = 67/286 (23%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
E++++ +H +VE+ G S+DG+ L ++ Y+ GS+ + +
Sbjct: 80 EIKVMAKCQHENLVELLGF--------SSDGD--DLCL---VY-VYMPNGSLLDRL--SC 123
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
G +S + IAQ A + LH H +HRDIKS NIL+D K+ D
Sbjct: 124 LDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLD-----EAFTA--KISD 176
Query: 980 FD--RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1037
F RA + + R + VGT +MAPE LR + + DI+S+G
Sbjct: 177 FGLARASEKFAQTV---MTSR------I-VGTTAYMAPEALRG----EIT-PKSDIYSFG 221
Query: 1038 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDE--LEA-----LGSCHEHEVAQSGS 1090
+LLE++T + L+ + K +E +E + V
Sbjct: 222 VVLLEIITGLPA-VDEHREP-QLLLDI-KEEIEDEEKTIEDYIDKKMNDADSTSVEA--- 275
Query: 1091 GFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSS 1136
+ V +C E +RP + ++ T+S
Sbjct: 276 --------------MYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-15
Identities = 37/151 (24%), Positives = 64/151 (42%), Gaps = 30/151 (19%)
Query: 900 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959
A+ E+V K + L++ + ++ + + AL HS IMHRD+K N
Sbjct: 109 ALVFEHVNNTDFKQLYQTLTD---YDI----RFYMYE-ILKALDYCHSMGIMHRDVKPHN 160
Query: 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVL 1018
++ID E +K ++L D+ A + R V + R+ PE+L
Sbjct: 161 VMIDHEHRK------LRLIDWGLA---EFYHPGQEYNVR--------VAS-RYFKGPELL 202
Query: 1019 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1049
Y +D+WS GC+L ++ + P
Sbjct: 203 VDYQM---YDYSLDMWSLGCMLASMIFRKEP 230
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 4e-15
Identities = 42/238 (17%), Positives = 76/238 (31%), Gaps = 50/238 (21%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKF---FGNEI-NLFPSEVGNLLG-------LECLQI 121
L L N L+ + S ++ L +L F GN L + + + L
Sbjct: 105 LDLSYNYLSNLSSSW--FKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTF 162
Query: 122 KISSPGVNGFALNKLKGLKELELS-----KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSI 176
L L+ELE+ P L ++ ++ L +
Sbjct: 163 TKIQRK----DFAGLTFLEELEIDASDLQSYEP--KSL------KSIQNVSHLILHMKQH 210
Query: 177 RYLPPEI-GCLSNLEQLDLSFNKMKYLP-TEIC--------YLKALISLKVANNKLVELP 226
L S++E L+L + +E+ ++K+ + L ++
Sbjct: 211 ILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVM 270
Query: 227 SGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC-CNL 283
L + L L+ S N+L S+ + +LQ + L N W C C
Sbjct: 271 KLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTN---------PWDCSCPR 319
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 30/115 (26%), Positives = 49/115 (42%), Gaps = 6/115 (5%)
Query: 161 AGLKCLTKLSV-CHF-SIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKV 217
A L C S+ +P + ++ LDLS N++ Y+ L +L +
Sbjct: 26 ASLSCDRNGICKGSSGSLNSIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVL 83
Query: 218 ANNKLVELPSGL-YLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
+N + + L LE+LDLS N L++L S + +L LNL N +
Sbjct: 84 TSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKT 138
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 7e-15
Identities = 52/218 (23%), Positives = 85/218 (38%), Gaps = 31/218 (14%)
Query: 69 SVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEV-GNLLGLECL-----QI 121
S + L L N L + + +L+ L EI +L L L I
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 122 KISSPGVNGFALNKLKGLKELEL-----SKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSI 176
+ + G + L L++L + + P I LK L +L+V H I
Sbjct: 89 QSLALGA----FSGLSSLQKLVAVETNLASLENFP--------IGHLKTLKELNVAHNLI 136
Query: 177 RYLPPEIGC--LSNLEQLDLSFNKMKYLPTEI-CYLKAL----ISLKVANNKLVELPSGL 229
+ L+NLE LDLS NK++ + L + +SL ++ N + + G
Sbjct: 137 QSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGA 196
Query: 230 YLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYN 267
+ RL+ L L N+L S+ + +LQ + L N
Sbjct: 197 FKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 5e-13
Identities = 26/113 (23%), Positives = 48/113 (42%), Gaps = 4/113 (3%)
Query: 161 AGLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVA 218
L L + I+ + LS+L L L+ N ++ L L +L L
Sbjct: 49 FSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108
Query: 219 NNKLVELPSGLYL-LQRLENLDLSNNRLTSLGSLDLCL-MHNLQNLNLQYNKL 269
L L + L+ L+ L++++N + S + + NL++L+L NK+
Sbjct: 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 161
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 6e-12
Identities = 24/100 (24%), Positives = 44/100 (44%), Gaps = 3/100 (3%)
Query: 176 IRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKLVELPSGLYL-L 232
+R+L L+ LDLS +++ + L L +L + N + L G + L
Sbjct: 40 LRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGL 99
Query: 233 QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSY 272
L+ L L SL + + + L+ LN+ +N + S+
Sbjct: 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 24/89 (26%), Positives = 39/89 (43%), Gaps = 6/89 (6%)
Query: 187 SNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLYL-LQRLENLDLSNNR 244
+ + LDLSFN +++L + L L ++ ++ + G Y L L L L+ N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 245 LTSL--GSLDLCLMHNLQNLNLQYNKLLS 271
+ SL G+ +LQ L L S
Sbjct: 88 IQSLALGAFSGL--SSLQKLVAVETNLAS 114
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 7e-15
Identities = 52/206 (25%), Positives = 86/206 (41%), Gaps = 46/206 (22%)
Query: 850 IRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGG 909
+ + E++++ L H IV + + S + E +L + ++YV
Sbjct: 87 VLQDKRFKNRELQIMRKLDHCNIVRLRYF-----FYSSGEKKDEVYL---NLVLDYV-PE 137
Query: 910 SVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 969
+V S + + + L++ Q + +L +HS I HRDIK +N+L+D +
Sbjct: 138 TVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSLAYIHSFGICHRDIKPQNLLLDPD---- 192
Query: 970 DGKPVVKLCDF------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEV-LRAM 1021
V+KLCDF R P S+ +C R+ APE+ A
Sbjct: 193 --TAVLKLCDFGSAKQLVRGEPNVSY---------------ICS---RYYRAPELIFGAT 232
Query: 1022 HKPNLYGLEVDIWSYGCLLLELLTLQ 1047
Y +D+WS GC+L ELL Q
Sbjct: 233 D----YTSSIDVWSAGCVLAELLLGQ 254
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 50/203 (24%), Positives = 88/203 (43%), Gaps = 49/203 (24%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
E+ +L L+HS IV++Y + H + + E++ +K ++
Sbjct: 50 EISILKELKHSNIVKLY--------------DVIHTKKRLVLVFEHLDQ-DLKKLLDVCE 94
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
E K F+ Q + + H + ++HRD+K +N+LI+ +G +K+ D
Sbjct: 95 GGLESVT-AKS--FLLQ-LLNGIAYCHDRRVLHRDLKPQNLLIN-----REG--ELKIAD 143
Query: 980 F--DRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIW 1034
F RA +P+R + H + T W AP+VL K Y +DIW
Sbjct: 144 FGLARAFGIPVRKYTH--------------EIVT-LWYRAPDVLMGSKK---YSTTIDIW 185
Query: 1035 SYGCLLLELLTLQVPYMGLSELE 1057
S GC+ E++ + G+SE +
Sbjct: 186 SVGCIFAEMVNGTPLFPGVSEAD 208
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 2e-14
Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 53/205 (25%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 917
E+ +L L H IV + + H + + E+++ +K +++
Sbjct: 69 EISLLKELHHPNIVSLI--------------DVIHS--ERCLTLVFEFMEK-DLKKVLDE 111
Query: 918 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 977
+ +K+ ++ Q + + H I+HRD+K +N+LI+ +DG +KL
Sbjct: 112 NKTGLQDSQ-IKI--YLYQ-LLRGVAHCHQHRILHRDLKPQNLLIN-----SDG--ALKL 160
Query: 978 CDF--DRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVD 1032
DF RA +P+RS+ H V T W AP+VL K Y VD
Sbjct: 161 ADFGLARAFGIPVRSYTH--------------EVVT-LWYRAPDVLMGSKK---YSTSVD 202
Query: 1033 IWSYGCLLLELLTLQVPYMGLSELE 1057
IWS GC+ E++T + + G+++ +
Sbjct: 203 IWSIGCIFAEMITGKPLFPGVTDDD 227
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 27/195 (13%), Positives = 43/195 (22%), Gaps = 73/195 (37%)
Query: 860 EVRMLGALRHSCIVEMY--GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 917
L + + + H + E+++GGS
Sbjct: 81 RTLRLSRIDKPGVARVLDVVH---------TRAGG-------LVVAEWIRGGS------- 117
Query: 918 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 977
L E + S A+ Q +AAA H + + + DG V
Sbjct: 118 LQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVS-----IDGDVV--- 169
Query: 978 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1037
+ P M + DI G
Sbjct: 170 -----------------------------LAYPATMPDANPQD-----------DIRGIG 189
Query: 1038 CLLLELLTLQVPYMG 1052
L LL + P
Sbjct: 190 ASLYALLVNRWPLPE 204
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 2e-14
Identities = 45/126 (35%), Positives = 65/126 (51%), Gaps = 38/126 (30%)
Query: 941 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFD--RA--VPLRSFLHTCCIA 996
L LH I+HRD+K N+L+D +G V+KL DF ++ P R++ H
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLD-----ENG--VLKLADFGLAKSFGSPNRAYTH----- 171
Query: 997 HRGIPAPDVCVGTPRWM-APEVL---RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM- 1051
V T RW APE+L R YG+ VD+W+ GC+L ELL +VP++
Sbjct: 172 ---------QVVT-RWYRAPELLFGARM------YGVGVDMWAVGCILAELLL-RVPFLP 214
Query: 1052 GLSELE 1057
G S+L+
Sbjct: 215 GDSDLD 220
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 7e-14
Identities = 51/203 (25%), Positives = 85/203 (41%), Gaps = 49/203 (24%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
EV +L L+H+ IV + H I H + EY+ +K Y++
Sbjct: 50 EVSLLKDLKHANIVTL--HDI------------IHTEKSLTLVFEYLDK-DLKQYLDDCG 94
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
H VKL F+ Q + L H + ++HRD+K +N+LI+ G +KL D
Sbjct: 95 NIINMHN-VKL--FLFQ-LLRGLAYCHRQKVLHRDLKPQNLLIN-----ERG--ELKLAD 143
Query: 980 F--DRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIW 1034
F RA +P +++ + V T W P++L Y ++D+W
Sbjct: 144 FGLARAKSIPTKTYDN--------------EVVT-LWYRPPDILLGSTD---YSTQIDMW 185
Query: 1035 SYGCLLLELLTLQVPYMGLSELE 1057
GC+ E+ T + + G + E
Sbjct: 186 GVGCIFYEMATGRPLFPGSTVEE 208
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 7e-14
Identities = 48/164 (29%), Positives = 67/164 (40%), Gaps = 44/164 (26%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
E+V ++ Y++K G ++K + Q L LH+ I+HRD+K ENIL+
Sbjct: 98 FEHVDQ-DLRTYLDKAPPPGLPAETIKD--LMRQ-FLRGLDFLHANCIVHRDLKPENILV 153
Query: 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP----RWM-APEV 1017
+ G VKL DF A R + TP W APEV
Sbjct: 154 T-----SGG--TVKLADFGLA---RIY---------SYQMA----LTPVVVTLWYRAPEV 190
Query: 1018 LRAMHKPNL---YGLEVDIWSYGCLLLELLTLQVPYM-GLSELE 1057
L L Y VD+WS GC+ E+ + P G SE +
Sbjct: 191 L-------LQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNSEAD 226
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 8e-14
Identities = 54/216 (25%), Positives = 86/216 (39%), Gaps = 56/216 (25%)
Query: 850 IRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGG 909
IR E + L R L H +V + + + + E L + E+V
Sbjct: 59 IR--EVAVL---RHLETFEHPNVVRL--FDV----CTVSRTDRETKLT---LVFEHVDQ- 103
Query: 910 SVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 969
+ Y++K+ E G ++K + Q + L LHS ++HRD+K +NIL+ +
Sbjct: 104 DLTTYLDKVPEPGVPTETIKD--MMFQ-LLRGLDFLHSHRVVHRDLKPQNILVT-----S 155
Query: 970 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP----RWM-APEVLRAMHKP 1024
G +KL DF A R + T W APEVL
Sbjct: 156 SG--QIKLADFGLA---RIY---------SFQMA----LTSVVVTLWYRAPEVL------ 191
Query: 1025 NL---YGLEVDIWSYGCLLLELLTLQVPYMGLSELE 1057
L Y VD+WS GC+ E+ + + G S+++
Sbjct: 192 -LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD 226
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 73.4 bits (180), Expect = 8e-14
Identities = 51/229 (22%), Positives = 85/229 (37%), Gaps = 60/229 (26%)
Query: 910 SVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 969
S E + + ++++ + + VA + L S+ +HRD+ + NIL+ +
Sbjct: 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN--- 230
Query: 970 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT-----P-RWMAPEVLRAMHK 1023
VVK+CDF A R I V P +WMAPE +
Sbjct: 231 ----VVKICDFGLA--------------RDIYKDPDYVRKGDARLPLKWMAPETIFD--- 269
Query: 1024 PNLYGLEVDIWSYGCLLLELLTL-QVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCH 1081
+Y ++ D+WS+G LL E+ +L PY G+ + E ++ G R + A
Sbjct: 270 -RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR------MRAPDYTT 322
Query: 1082 EHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130
+ C P++RPT +L E
Sbjct: 323 PE---------------------MYQTMLDCWHGEPSQRPTFSELVEHL 350
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 8e-14
Identities = 51/212 (24%), Positives = 84/212 (39%), Gaps = 55/212 (25%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVK---GGSVKNYIE 916
E+++L L+H +V + +K P +L+ ++ + G + N +
Sbjct: 66 EIKILQLLKHENVVNLIE-ICRTKASPYNRCKGSIYLV-----FDFCEHDLAGLLSNVLV 119
Query: 917 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 976
K + + K + + L +H I+HRD+K+ N+LI DG V+K
Sbjct: 120 KFTLSEIKR-------VMQM-LLNGLYYIHRNKILHRDMKAANVLIT-----RDG--VLK 164
Query: 977 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG-TPR----WM-APEVLRAMHKPNL---- 1026
L DF A R+F + T R W PE+L L
Sbjct: 165 LADFGLA---RAF---------SLAKNSQPNRYTNRVVTLWYRPPELL-------LGERD 205
Query: 1027 YGLEVDIWSYGCLLLELLTLQVPYM-GLSELE 1057
YG +D+W GC++ E+ T P M G +E
Sbjct: 206 YGPPIDLWGAGCIMAEMWTRS-PIMQGNTEQH 236
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 8e-14
Identities = 51/207 (24%), Positives = 85/207 (41%), Gaps = 52/207 (25%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
E+ ++ L+H IV + + + H + + E++ +K Y++ +
Sbjct: 53 EISLMKELKHENIVRL--YDV------------IHTENKLTLVFEFMDN-DLKKYMDSRT 97
Query: 920 ETGEKH----VSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 975
VK F Q + L H I+HRD+K +N+LI+ G +
Sbjct: 98 VGNTPRGLELNLVKY--FQWQ-LLQGLAFCHENKILHRDLKPQNLLIN-----KRG--QL 147
Query: 976 KLCDF--DRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLE 1030
KL DF RA +P+ +F V T W AP+VL Y
Sbjct: 148 KLGDFGLARAFGIPVNTFSS--------------EVVT-LWYRAPDVLMGSRT---YSTS 189
Query: 1031 VDIWSYGCLLLELLTLQVPYMGLSELE 1057
+DIWS GC+L E++T + + G ++ E
Sbjct: 190 IDIWSCGCILAEMITGKPLFPGTNDEE 216
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 1e-13
Identities = 53/241 (21%), Positives = 82/241 (34%), Gaps = 53/241 (21%)
Query: 916 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 975
E + + + S+ L A + L LH I+H D+K ENIL+ K G+ +
Sbjct: 187 ELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILL-----KQQGRSGI 241
Query: 976 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 1035
K+ DF + ++T I R AP+V +G YG+ +D+WS
Sbjct: 242 KVIDFGSSCYEHQRVYT-YIQSRFYRAPEVILGAR----------------YGMPIDMWS 284
Query: 1036 YGCLLLELLTLQVPYMGLSELEI------------HDLIQMGKRPRLTDELEALGSCHEH 1083
GC+L ELLT G E + L+ KR + +
Sbjct: 285 LGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTV 344
Query: 1084 EVAQSGSGFEKP-------------------EAELETLSFLVDVFRRCTEENPTERPTAG 1124
GS + +D ++C E +P R T G
Sbjct: 345 TTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG 404
Query: 1125 D 1125
Sbjct: 405 Q 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 2e-13
Identities = 42/242 (17%), Positives = 78/242 (32%), Gaps = 36/242 (14%)
Query: 68 NSVEGLYLYKNVLNLIPKSVGRYEK---------LRNLKFFGNEINLFPSEV----GNLL 114
L L L + + +EK + L GN ++
Sbjct: 180 KHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGT 239
Query: 115 GLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRP-SVLTL----LSEI-----AGLK 164
++ L + S + F K + L + + +
Sbjct: 240 KIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFT 299
Query: 165 CLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKL 222
L +L++ I + L++L +L+LS N + + + + L L L ++ N +
Sbjct: 300 DLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHI 359
Query: 223 VELPSGLYL-LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC- 280
L +L L L+ L L N+L S+ + +LQ + L N W C
Sbjct: 360 RALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN---------PWDCS 410
Query: 281 CN 282
C
Sbjct: 411 CP 412
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 2e-11
Identities = 33/232 (14%), Positives = 69/232 (29%), Gaps = 31/232 (13%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKF---FGNEI-NLFPSEV-GNLLGLECL---- 119
++E L L + L+ S ++ L +L+ N I + P+ N+ L
Sbjct: 104 NLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTF 163
Query: 120 -QIKISSPGV-NGFALNKLKGLK--ELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS 175
++K F L+ + L + +T L +
Sbjct: 164 NKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNG 223
Query: 176 IRYLPPEI----GCLSNLEQL----------DLSFNKMKYLPTEICY---LKALISLKVA 218
+ + + ++ L K + + ++
Sbjct: 224 FKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLS 283
Query: 219 NNKLVELPSGLYL-LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
+K+ L ++ LE L L+ N + + + +L LNL N L
Sbjct: 284 KSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFL 335
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 2e-11
Identities = 30/150 (20%), Positives = 60/150 (40%), Gaps = 14/150 (9%)
Query: 132 ALNKLKGLKELELSKVPPRPSVLTLLSEIA--GLKCLTKLSVCHFSIRYLPPEI-GCLSN 188
+ ++L+ L+ L++ + + ++ GL L L + + L L+N
Sbjct: 49 SFSRLQDLQFLKVEQQ----TPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLAN 104
Query: 189 LEQLDLSFNKMK--YLPTEI-CYLKALISLKVANNKLVEL-PSGL-YLLQRLENLDLSNN 243
LE L L+ + L L +L L + +N + ++ P+ ++R LDL+ N
Sbjct: 105 LEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFN 164
Query: 244 RLTSL--GSLDLCLMHNLQNLNLQYNKLLS 271
++ S+ L + L L L
Sbjct: 165 KVKSICEEDLLNFQGKHFTLLRLSSITLQD 194
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 4e-10
Identities = 35/149 (23%), Positives = 56/149 (37%), Gaps = 19/149 (12%)
Query: 144 LSKVPPRPSVLTLL-------SEI-----AGLKCLTKLSVCHFSIRYLPPEIGC--LSNL 189
L +VP P+ + + +E+ + L+ L L V + + LS+L
Sbjct: 22 LHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSL 81
Query: 190 EQLDLSFNKMKYLPTEICY-LKALISLKVANNKL--VELPSGLYL-LQRLENLDLSNNRL 245
L L +N+ L T L L L + L L + L LE L L +N +
Sbjct: 82 IILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNI 141
Query: 246 TSLGSLDL-CLMHNLQNLNLQYNKLLSYC 273
+ M L+L +NK+ S C
Sbjct: 142 KKIQPASFFLNMRRFHVLDLTFNKVKSIC 170
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 43/243 (17%), Positives = 72/243 (29%), Gaps = 52/243 (21%)
Query: 73 LYLYKNVLNL-IPKSVGRY-EKLRNLKFFGNEINLFPSEV-GNLLGLECLQI---KISSP 126
L + + L I + R L LK N+ + L LE L + +
Sbjct: 59 LKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGA 118
Query: 127 GVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEI--G 184
++G L L+ L L +I+ + P
Sbjct: 119 VLSGNFFKPLTSLEMLVLRDN---------------------------NIKKIQPASFFL 151
Query: 185 CLSNLEQLDLSFNKMKYLPTEICY---LKALISLKVANNKLVELPSGLYL---------L 232
+ LDL+FNK+K + E K L++++ L ++
Sbjct: 152 NMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKN 211
Query: 233 QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSN 292
+ LDLS N + + +Q L + + S N KD N
Sbjct: 212 TSITTLDLSGNGFKESMAKRFF--DAIAGTKIQSLILSNSYNMGSSFGHT---NFKDPDN 266
Query: 293 DDF 295
F
Sbjct: 267 FTF 269
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-13
Identities = 47/251 (18%), Positives = 84/251 (33%), Gaps = 66/251 (26%)
Query: 916 EKLSETGEKHVSVKLALFIAQDVAAALVELHSK--HIMHRDIKSENILIDLERKKADGKP 973
+ L T + VS+ L AQ + AL+ L + I+H D+K ENIL+ +
Sbjct: 144 DLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILL-----CNPKRS 198
Query: 974 VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 1033
+K+ DF + L ++ I R +P+V +G P Y L +D+
Sbjct: 199 AIKIVDFGSSCQLGQRIYQY-IQSRFYRSPEVLLGMP----------------YDLAIDM 241
Query: 1034 WSYGCLLLELLTLQVPYMGLSELEI------------HDLIQMGKR-------------- 1067
WS GC+L+E+ T + + G +E++ ++ +
Sbjct: 242 WSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWN 301
Query: 1068 -------------PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 1114
P LG + + + D+ R +
Sbjct: 302 LKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAG---ESGHTVADYLKFKDLILRMLD 358
Query: 1115 ENPTERPTAGD 1125
+P R
Sbjct: 359 YDPKTRIQPYY 369
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-13
Identities = 57/288 (19%), Positives = 99/288 (34%), Gaps = 67/288 (23%)
Query: 858 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 917
L ++ L L H IV++ + + +L + MEYV ++
Sbjct: 67 LQIMQDLAVLHHPNIVQLQ-SYFYT---LGERDRRDIYL---NVVMEYV-PDTLHRCCRN 118
Query: 918 LSETGEKHVSVKLALFIAQDVAAALVELH--SKHIMHRDIKSENILIDLERKKADGKPVV 975
+ + +F+ Q + ++ LH S ++ HRDIK N+L++ +ADG +
Sbjct: 119 YYRRQVAPPPILIKVFLFQ-LIRSIGCLHLPSVNVCHRDIKPHNVLVN----EADG--TL 171
Query: 976 KLCDFDRA---VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEV-LRAMHKPNLYGLE 1030
KLCDF A P + C + R+ APE+ H Y
Sbjct: 172 KLCDFGSAKKLSPSEPNVAYIC--------------S-RYYRAPELIFGNQH----YTTA 212
Query: 1031 VDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS 1090
VDIWS GC+ E++ + + G + I + LG + +
Sbjct: 213 VDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEI-----------VRVLGCPSREVLRKLNP 261
Query: 1091 G-------------FEK--PEAELETLSFLVDVFRRCTEENPTERPTA 1123
+ + L+ D+ + P ER
Sbjct: 262 SHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKP 309
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 4e-13
Identities = 33/127 (25%), Positives = 56/127 (44%), Gaps = 13/127 (10%)
Query: 161 AGLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEICY-LKALISLKVA 218
+ K L ++ + + I L P+ L +L L L NK+ LP + L +L L +
Sbjct: 53 SPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLN 112
Query: 219 NNKLVELPSGLYL-LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPS 277
NK+ L + L L L L +N+L ++ + +Q ++L N P
Sbjct: 113 ANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN--------P- 163
Query: 278 WIC-CNL 283
+IC C+L
Sbjct: 164 FICDCHL 170
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 23/87 (26%), Positives = 41/87 (47%), Gaps = 2/87 (2%)
Query: 187 SNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLYL-LQRLENLDLSNNR 244
+ ++ L N +K +P K L + ++NN++ EL + L+ L +L L N+
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91
Query: 245 LTSLGSLDLCLMHNLQNLNLQYNKLLS 271
+T L + +LQ L L NK+
Sbjct: 92 ITELPKSLFEGLFSLQLLLLNANKINC 118
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 6e-13
Identities = 29/138 (21%), Positives = 65/138 (47%), Gaps = 17/138 (12%)
Query: 152 SVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEICY-L 209
+VL L L K++ + I + S + ++ L+ N+++ + ++ L
Sbjct: 45 TVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGL 104
Query: 210 KALISLKVANNKLVELPSGLYL-LQRLENLDLSNNRLTSL--GSLDLCLMHNLQNLNLQY 266
++L +L + +N++ + + ++ L + L L +N++T++ G+ D +H+L LNL
Sbjct: 105 ESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFD--TLHSLSTLNLLA 162
Query: 267 NKLLSYCQVPSWIC-CNL 283
N + C C L
Sbjct: 163 N---------PFNCNCYL 171
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 4e-10
Identities = 18/88 (20%), Positives = 40/88 (45%), Gaps = 3/88 (3%)
Query: 187 SNLEQLDLSFNKMKYLPTEICY--LKALISLKVANNKLVELPSGLYL-LQRLENLDLSNN 243
+L L+ N+ L + L L + +NNK+ ++ G + + + L++N
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
RL ++ + +L+ L L+ N++
Sbjct: 92 RLENVQHKMFKGLESLKTLMLRSNRITC 119
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 6e-13
Identities = 38/168 (22%), Positives = 63/168 (37%), Gaps = 47/168 (27%)
Query: 903 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962
ME + GG + ++ + G++ + + A I + + A+ LHS +I HRD+K EN+L
Sbjct: 94 MECLDGGEL---FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL- 149
Query: 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1022
K+ + +KL DF G A E
Sbjct: 150 -YTSKRPNAI--LKLTDF------------------GF-------------AKETTG--- 172
Query: 1023 KPNLYGLEVDIWSYGCLLLELLTLQVPYMG----LSELEIHDLIQMGK 1066
Y D+WS G ++ LL P+ + I+MG+
Sbjct: 173 --EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 218
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 8e-13
Identities = 41/209 (19%), Positives = 71/209 (33%), Gaps = 64/209 (30%)
Query: 945 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1004
LHS I+HRD+K NI++ +D +K+ DF A R
Sbjct: 143 LHSAGIIHRDLKPSNIVVK-----SDCT--LKILDFGLA--------------RTAGTSF 181
Query: 1005 VC---VGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHD 1060
+ V T R+ APEV+ M Y VDIWS GC++ E++ V + G ++ +
Sbjct: 182 MMTPYVVT-RYYRAPEVILGMG----YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWN 236
Query: 1061 LI------------------------QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE 1096
+ K + E L + + +
Sbjct: 237 KVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYS--FEKLFPDVLFPADSEHNKLKASQ 294
Query: 1097 AELETLSFLVDVFRRCTEENPTERPTAGD 1125
A D+ + + ++R + +
Sbjct: 295 A--------RDLLSKMLVIDASKRISVDE 315
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 8e-13
Identities = 49/192 (25%), Positives = 77/192 (40%), Gaps = 32/192 (16%)
Query: 945 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1004
LH +++HRD+K N+LI+ ++ +K+CDF A R +
Sbjct: 128 LHGSNVIHRDLKPSNLLIN-----SNCD--LKVCDFGLA---RIIDESAADNSEPTGQQS 177
Query: 1005 VC---VGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHD 1060
V T RW APEV+ K Y +D+WS GC+L EL + + G
Sbjct: 178 GMVEFVAT-RWYRAPEVMLTSAK---YSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLL 233
Query: 1061 LI--QMGKRPRLTDELEALGSCHEHEVAQSGSGFEK-------PEAELETLSFLVDVFRR 1111
LI +G P ++L + S E +S + P + + L +R
Sbjct: 234 LIFGIIGT-PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLL----QR 288
Query: 1112 CTEENPTERPTA 1123
+P +R TA
Sbjct: 289 MLVFDPAKRITA 300
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 9e-13
Identities = 43/216 (19%), Positives = 78/216 (36%), Gaps = 21/216 (9%)
Query: 69 SVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEI-NLFPSEV-GNLLGLECLQI---- 121
+ L L +I K + L ++ N++ + ++V NL L ++I
Sbjct: 31 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 90
Query: 122 KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIA--GLKCLTKLSVCH-FSIRY 178
+ +N A L L+ L +S + + L ++ L + +I
Sbjct: 91 NLLY--INPEAFQNLPNLQYLLISN-----TGIKHLPDVHKIHSLQKVLLDIQDNINIHT 143
Query: 179 LPPEI--GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKV-ANNKLVELPSG-LYLLQR 234
+ G L L+ N ++ + L L + NN L ELP+ +
Sbjct: 144 IERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASG 203
Query: 235 LENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLL 270
LD+S R+ SL S L + L+ + K L
Sbjct: 204 PVILDISRTRIHSLPSYGLENLKKLRARSTYNLKKL 239
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 19/112 (16%), Positives = 45/112 (40%), Gaps = 5/112 (4%)
Query: 166 LTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNK-MKYLPTEI-CYLKALISLKVAN-NK 221
+L +R + +LE++++S N ++ + ++ L L +++ N
Sbjct: 32 AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANN 91
Query: 222 LVELPSGLYL-LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSY 272
L+ + + L L+ L +SN + L + L++Q N +
Sbjct: 92 LLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHT 143
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 10/54 (18%), Positives = 21/54 (38%), Gaps = 2/54 (3%)
Query: 219 NNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSY 272
+K+ E+PS L + L +L + +L+ + + N +L
Sbjct: 18 ESKVTEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEV 69
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-12
Identities = 53/318 (16%), Positives = 110/318 (34%), Gaps = 85/318 (26%)
Query: 850 IRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSA--------- 900
+ E+ ++ L H I+++ + ++ P +
Sbjct: 40 VLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNH 99
Query: 901 ---------------IFMEYVKGGSVKNYIEKLSETG----EKHVSVKLALFIAQDVAAA 941
+ MEYV ++ ++ +G +S ++I Q + A
Sbjct: 100 HKSVIVNPSQNKYLNVIMEYV-PDTLHKVLKSFIRSGRSIPMNLIS----IYIYQ-LFRA 153
Query: 942 LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA---VPLRSFLHTCCIAHR 998
+ +HS I HRDIK +N+L++ + D +KLCDF A +P + C
Sbjct: 154 VGFIHSLGICHRDIKPQNLLVNSK----DN--TLKLCDFGSAKKLIPSEPSVAYIC---- 203
Query: 999 GIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE 1057
+ R+ APE+ M Y +D+WS GC+ EL+ + + G + ++
Sbjct: 204 ----------S-RFYRAPEL---MLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSID 249
Query: 1058 IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF------EKPEAELETL------SFL 1105
I ++ +G+ + ++ + + + + S
Sbjct: 250 QLVRI-----------IQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLA 298
Query: 1106 VDVFRRCTEENPTERPTA 1123
+D+ + P R
Sbjct: 299 IDLLEQILRYEPDLRINP 316
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-12
Identities = 36/237 (15%), Positives = 66/237 (27%), Gaps = 71/237 (29%)
Query: 934 IAQDVAAALVELHSKHIMHRDIKSENILI------------------DLERKKADGKPVV 975
++ AL L + H D+K ENIL+ + +
Sbjct: 142 YCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI 201
Query: 976 KLCDFDRAVPLRSFLHTCCIAHRGIP---------APDVCVGTPRWMAPEVLRAMHKPNL 1026
KL DF A AP+V +
Sbjct: 202 KLIDFGCA----------TFKSDYHGSIINTRQYRAPEVILNLG---------------- 235
Query: 1027 YGLEVDIWSYGCLLLELLTLQVPYMGLSELEI------------HDLIQMGKRPR----L 1070
+ + D+WS+GC+L EL T + + +E +++ + +
Sbjct: 236 WDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYV 295
Query: 1071 TDELEALGSCHEHEVAQSGSGFE--KPEAELETLSFLVDVFRRCTEENPTERPTAGD 1125
+ L S + P ++ D + +PT RP+ +
Sbjct: 296 NKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAE 352
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-12
Identities = 32/117 (27%), Positives = 52/117 (44%), Gaps = 6/117 (5%)
Query: 156 LLSEIAGLKCLTK---LSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKAL 212
L+ + A + L + + I + L + +D S N+++ L L+ L
Sbjct: 8 LIEQAAQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLDG-FPLLRRL 66
Query: 213 ISLKVANNKLVELPSGL-YLLQRLENLDLSNNRLTSLGSLD-LCLMHNLQNLNLQYN 267
+L V NN++ + GL L L L L+NN L LG LD L + +L L + N
Sbjct: 67 KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 22/89 (24%), Positives = 41/89 (46%), Gaps = 1/89 (1%)
Query: 181 PEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDL 240
+ +LDL K+ + L ++ ++N++ +L G LL+RL+ L +
Sbjct: 13 AQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLV 71
Query: 241 SNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
+NNR+ +G + +L L L N L
Sbjct: 72 NNNRICRIGEGLDQALPDLTELILTNNSL 100
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 28/137 (20%), Positives = 48/137 (35%), Gaps = 16/137 (11%)
Query: 133 LNKLKGLKELELSKVPPRPSVLTLLSEIAGL----KCLTKLSVCHFSIRYLPPEIGCLSN 188
+EL+L + I L + IR L L
Sbjct: 15 YTNAVRDRELDLRG--------YKIPVIENLGATLDQFDAIDFSDNEIRKLDG-FPLLRR 65
Query: 189 LEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSGLYL--LQRLENLDLSNNRL 245
L+ L ++ N++ + L L L + NN LVEL L L+ L L + N +
Sbjct: 66 LKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPV 125
Query: 246 TSLGSLDLCLMHNLQNL 262
T+ L +++ + +
Sbjct: 126 TNKKHYRLYVIYKVPQV 142
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 58/278 (20%), Positives = 101/278 (36%), Gaps = 69/278 (24%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
E+ L RH +V + G + N +L I+ +Y++ G++K ++ S
Sbjct: 85 EIETLSFCRHPHLVSLIGF--------CDERN--EMIL---IY-KYMENGNLKRHLYG-S 129
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
+ +S + L I A L LH++ I+HRD+KS NIL+ D V K+ D
Sbjct: 130 DLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL-------DENFVPKITD 182
Query: 980 FD--RAVPLRSFLH--TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV--DI 1033
F + H T V GT ++ PE L D+
Sbjct: 183 FGISKKGTELDQTHLST------------VVKGTLGYIDPEYFIKGR------LTEKSDV 224
Query: 1034 WSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEAL------GSCHEHEVAQ 1087
+S+G +L E+L + + E+ +L + +LE + + +
Sbjct: 225 YSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRK 284
Query: 1088 SGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1125
D +C + +RP+ GD
Sbjct: 285 -----------------FGDTAVKCLALSSEDRPSMGD 305
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 26/130 (20%), Positives = 53/130 (40%), Gaps = 15/130 (11%)
Query: 166 LTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKV---ANNKL 222
+L I + + L + L LS N + +I L + +L++ N +
Sbjct: 27 KVELHGMIPPIEKMDATLSTLKACKHLALSTNNI----EKISSLSGMENLRILSLGRNLI 82
Query: 223 VELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQV------P 276
++ + + LE L +S N++ SL ++ NL+ L + NK+ ++ ++
Sbjct: 83 KKIENLDAVADTLEELWISYNQIASLSGIEKL--VNLRVLYMSNNKITNWGEIDKLAALD 140
Query: 277 SWICCNLEGN 286
L GN
Sbjct: 141 KLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 5e-10
Identities = 36/138 (26%), Positives = 61/138 (44%), Gaps = 30/138 (21%)
Query: 133 LNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQL 192
L+ LK K L LS + + +S ++G++ L LS+ I+ + LE+L
Sbjct: 44 LSTLKACKHLALST-----NNIEKISSLSGMENLRILSLGRNLIKKIENLDAVADTLEEL 98
Query: 193 DLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLD 252
+S+N++ L SG+ L L L +SNN++T+ G +D
Sbjct: 99 WISYNQIASL------------------------SGIEKLVNLRVLYMSNNKITNWGEID 134
Query: 253 -LCLMHNLQNLNLQYNKL 269
L + L++L L N L
Sbjct: 135 KLAALDKLEDLLLAGNPL 152
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 4e-12
Identities = 33/112 (29%), Positives = 48/112 (42%), Gaps = 21/112 (18%)
Query: 945 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPA 1002
LHS ++HRD+K NIL++ A+ VK+ DF R+ +
Sbjct: 125 LHSGGLLHRDMKPSNILLN-----AECH--VKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 1003 PDVCVGTP--------RWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045
+ P RW APE+L K Y +D+WS GC+L E+L
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTK---YTKGIDMWSLGCILGEILC 226
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 7e-12
Identities = 46/200 (23%), Positives = 77/200 (38%), Gaps = 56/200 (28%)
Query: 945 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1004
+HS +++HRD+K N+ I+ E +K+ DF A R +
Sbjct: 136 IHSANVLHRDLKPANLFINTEDLV------LKIGDFGLA--------------RIMDPHY 175
Query: 1005 VC-------VGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL 1056
+ T +W +P +L + + Y +D+W+ GC+ E+LT + + G EL
Sbjct: 176 SHKGHLSEGLVT-KWYRSPRLLLSPNN---YTKAIDMWAAGCIFAEMLTGKTLFAGAHEL 231
Query: 1057 EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF--------EKPEAELETL-----S 1103
E LI LE++ HE + + S +P L L
Sbjct: 232 EQMQLI-----------LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISR 280
Query: 1104 FLVDVFRRCTEENPTERPTA 1123
VD + +P +R TA
Sbjct: 281 EAVDFLEQILTFSPMDRLTA 300
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 9e-12
Identities = 43/224 (19%), Positives = 73/224 (32%), Gaps = 53/224 (23%)
Query: 934 IAQDVAAALVELHSKHIMHRDIKSENILI------------DLERKKADGKPVVKLCDFD 981
+A + AL LH + H D+K ENIL +K+ +++ DF
Sbjct: 128 MAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187
Query: 982 RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1041
A HT +A R P+V + + D+WS GC+L
Sbjct: 188 SATFDHEH-HTTIVATRHYRPPEVILELG----------------WAQPCDVWSIGCILF 230
Query: 1042 ELLTLQVPYMGLSELEI------------HDLIQMGKRPRLTDELEALGSCHEHEVAQSG 1089
E + E +I ++ + + G E + G
Sbjct: 231 EYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYK----GGLVWDENSSDG 286
Query: 1090 SGFEKPEAELETL--------SFLVDVFRRCTEENPTERPTAGD 1125
++ L++ L D+ RR E +P +R T +
Sbjct: 287 RYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAE 330
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 9e-12
Identities = 39/223 (17%), Positives = 77/223 (34%), Gaps = 36/223 (16%)
Query: 73 LYLYKNVLNLIPKSVGRY-EKLRNLKFFGNEINLFPSEV-GNLLGLECL-----QIKISS 125
++ V +++ ++ ++ + L S
Sbjct: 310 EHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSV 369
Query: 126 PGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAG----LKCLTKLSVCHFSIRYLPP 181
+ LK L+ L L + L ++A + L L V S+
Sbjct: 370 FQG----CSTLKRLQTLILQRNG-----LKNFFKVALMTKNMSSLETLDVSLNSLNSHAY 420
Query: 182 EIGC--LSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLD 239
+ C ++ L+LS N + C + L + NN+++ +P + LQ L+ L+
Sbjct: 421 DRTCAWAESILVLNLSSNMLTGSVFR-CLPPKVKVLDLHNNRIMSIPKDVTHLQALQELN 479
Query: 240 LSNNRLTSL--GSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC 280
+++N+L S+ G D +LQ + L N W C
Sbjct: 480 VASNQLKSVPDGVFDRL--TSLQYIWLHDNP---------WDC 511
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 2e-11
Identities = 33/157 (21%), Positives = 54/157 (34%), Gaps = 5/157 (3%)
Query: 162 GLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANN 220
L L L + H IR L + +LE LD+S N+++ + + +L L ++ N
Sbjct: 74 FLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNISCCP--MASLRHLDLSFN 131
Query: 221 KLVELPSGLYL--LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSW 278
LP L +L L LS + L L + +H L + + + S
Sbjct: 132 DFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESL 191
Query: 279 ICCNLEGNGKDSSNDDFISSSAEMDVYEGPMLENDGN 315
N + S M V L+
Sbjct: 192 QIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNI 228
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 4e-11
Identities = 24/92 (26%), Positives = 45/92 (48%), Gaps = 9/92 (9%)
Query: 184 GCLSNLEQLDLSFNKMKYLPTEIC-YLKALISLKVANNKLVELPSGLYL-LQRLENLDLS 241
+ L LS N + L +L L L++++N++ L ++L Q LE LD+S
Sbjct: 49 DLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVS 108
Query: 242 NNRLTSL--GSLDLCLMHNLQNLNLQYNKLLS 271
+NRL ++ + +L++L+L +N
Sbjct: 109 HNRLQNISCCPMA-----SLRHLDLSFNDFDV 135
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 6e-08
Identities = 37/182 (20%), Positives = 68/182 (37%), Gaps = 35/182 (19%)
Query: 69 SVEGLYLYKNVL-NLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNL-----LGLECLQIK 122
S L +NV + + + ++L+ L N + F L + +
Sbjct: 354 SFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLN 413
Query: 123 ISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPE 182
+ + + L LS L+ F R LPP
Sbjct: 414 SLNSHAYDRTCAWAESILVLNLSS--------------------NMLTGSVF--RCLPP- 450
Query: 183 IGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLY-LLQRLENLDLS 241
++ LDL N++ +P ++ +L+AL L VA+N+L +P G++ L L+ + L
Sbjct: 451 -----KVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLH 505
Query: 242 NN 243
+N
Sbjct: 506 DN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 3e-06
Identities = 28/232 (12%), Positives = 66/232 (28%), Gaps = 21/232 (9%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKF---FGNEINLFPSEVGNLLGLECLQIKISSPGVN 129
L L N +++P + L L F + L L C+ + + S +
Sbjct: 126 LDLSFNDFDVLPVC-KEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIK 184
Query: 130 GFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKC----LTKLSVCHFSIRYLPPEIGC 185
G L+ L V S+ ++ ++ L+ + + + + L +
Sbjct: 185 GGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSE 244
Query: 186 LS-NLEQLDLSFNKMKYLPTEIC------YLKALISLKVANNKLVELPSGLYL------L 232
L+ L+++ ++ + + + L + N + E L
Sbjct: 245 LTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETAL 304
Query: 233 QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLE 284
+ L + N + + L + V +
Sbjct: 305 KSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFT 356
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 5e-04
Identities = 15/51 (29%), Positives = 25/51 (49%), Gaps = 2/51 (3%)
Query: 219 NNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
N L +P L R + L LS N ++ L D+ + L+ L L +N++
Sbjct: 40 NRNLTHVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRI 88
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 1e-11
Identities = 46/197 (23%), Positives = 75/197 (38%), Gaps = 52/197 (26%)
Query: 945 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1004
+HS ++HRD+K N+ ++ D + +K+ DF A R +
Sbjct: 142 IHSAGVVHRDLKPGNLAVN-----EDCE--LKILDFGLA--------------RHA-DAE 179
Query: 1005 VC--VGTPRW-MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDL 1061
+ V T RW APEV+ + Y VDIWS GC++ E+LT + + G L+
Sbjct: 180 MTGYVVT-RWYRAPEVILSWMH---YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ 235
Query: 1062 I--QMGKRPRLTDELEALGSCHEHEVAQSGSGFEK-----------PEAELETLSFLVDV 1108
I G + ++ L QS + P+A D+
Sbjct: 236 ILKVTGVPGT--EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQA--------ADL 285
Query: 1109 FRRCTEENPTERPTAGD 1125
+ E + +R TA
Sbjct: 286 LEKMLELDVDKRLTAAQ 302
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-11
Identities = 40/224 (17%), Positives = 73/224 (32%), Gaps = 53/224 (23%)
Query: 934 IAQDVAAALVELHSKHIMHRDIKSENILI------------DLERKKADGKPVVKLCDFD 981
+A + ++ LHS + H D+K ENIL ++ P +K+ DF
Sbjct: 123 MAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182
Query: 982 RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1041
A T ++ R AP+V + + D+WS GC+L+
Sbjct: 183 SATYDDEHHST-LVSTRHYRAPEVILALG----------------WSQPCDVWSIGCILI 225
Query: 1042 ELLTLQVPYMGLSELEI------------HDLIQMGKRPRLTDELEALGSCHEHEVAQSG 1089
E + E +IQ ++ + E + +G
Sbjct: 226 EYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHH----DRLDWDEHSSAG 281
Query: 1090 SGFEKPEAELETL--------SFLVDVFRRCTEENPTERPTAGD 1125
+ L+ L D+ ++ E +P +R T +
Sbjct: 282 RYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLRE 325
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 1e-11
Identities = 43/209 (20%), Positives = 72/209 (34%), Gaps = 64/209 (30%)
Query: 945 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1004
LHS I+HRD+K NI++ +D +K+ DF A R
Sbjct: 180 LHSAGIIHRDLKPSNIVVK-----SDCT--LKILDFGLA--------------RTAGTSF 218
Query: 1005 VC---VGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHD 1060
+ V T R+ APEV+ M Y VDIWS GC++ E++ ++ + G ++ +
Sbjct: 219 MMTPYVVT-RYYRAPEVILGMG----YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 273
Query: 1061 LI------------------------QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE 1096
+ K LT L + + +
Sbjct: 274 KVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLT--FPKLFPDSLFPADSEHNKLKASQ 331
Query: 1097 AELETLSFLVDVFRRCTEENPTERPTAGD 1125
A D+ + +P +R + D
Sbjct: 332 A--------RDLLSKMLVIDPAKRISVDD 352
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 27/86 (31%), Positives = 38/86 (44%), Gaps = 3/86 (3%)
Query: 187 SNLEQLDLSFNKMKYLPTEI--CYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSNN 243
S LDLS N + L E L L SL +++N L + S + L LDLS+N
Sbjct: 39 SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKL 269
L +L + L+ L L N +
Sbjct: 99 HLHTLDEFLFSDLQALEVLLLYNNHI 124
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 38/165 (23%), Positives = 57/165 (34%), Gaps = 25/165 (15%)
Query: 130 GFALNKLKGLKELELSKVPPRPSVLTLLSEIA--GLKCLTKLSVCHFSIRYLPPEI-GCL 186
+ +L L L LS + L +S A + L L + + L + L
Sbjct: 57 EWTPTRLTNLHSLLLSH-----NHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDL 111
Query: 187 SNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSG----LYLLQRLENLDLS 241
LE L L N + + + L L ++ N++ P L +L LDLS
Sbjct: 112 QALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLS 171
Query: 242 NNRLTSLGSLDLCLMHNL--QNLNLQYNKLLSYCQVPSWIC-CNL 283
+N+L L DL + L L N C C L
Sbjct: 172 SNKLKKLPLTDLQKLPAWVKNGLYLHNN---------PLECDCKL 207
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 48/195 (24%), Positives = 75/195 (38%), Gaps = 48/195 (24%)
Query: 945 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1004
+HS I+HRD+K N+ ++ D + +K+ DF A +
Sbjct: 148 IHSADIIHRDLKPSNLAVN-----EDCE--LKILDFGLARHTADEM-------------T 187
Query: 1005 VCVGTPRW-MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI- 1062
V T RW APE++ Y VDIWS GC++ ELLT + + G ++ LI
Sbjct: 188 GYVAT-RWYRAPEIMLNWMH---YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 243
Query: 1063 -QMGKRPRLTDELEALGSCHEHEVAQSGSGFEK-----------PEAELETLSFLVDVFR 1110
+G + L+ + S QS + K P A VD+
Sbjct: 244 RLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLA--------VDLLE 293
Query: 1111 RCTEENPTERPTAGD 1125
+ + +R TA
Sbjct: 294 KMLVLDSDKRITAAQ 308
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 47/195 (24%), Positives = 77/195 (39%), Gaps = 48/195 (24%)
Query: 945 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1004
+H+ I+HRD+K N+ ++ D + +K+ DF A S +
Sbjct: 144 IHAAGIIHRDLKPGNLAVN-----EDCE--LKILDFGLARQADSEMTG------------ 184
Query: 1005 VCVGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI- 1062
V T RW APEV+ + Y VDIWS GC++ E++T + + G L+ I
Sbjct: 185 -YVVT-RWYRAPEVILNWMR---YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM 239
Query: 1063 -QMGKRPRLTDELEALGSCHEHEVAQSGSGFEK-----------PEAELETLSFLVDVFR 1110
G P + ++ L S + EK P A V++
Sbjct: 240 KVTGTPPA--EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLA--------VNLLE 289
Query: 1111 RCTEENPTERPTAGD 1125
+ + +R TAG+
Sbjct: 290 KMLVLDAEQRVTAGE 304
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 3e-11
Identities = 26/111 (23%), Positives = 48/111 (43%), Gaps = 4/111 (3%)
Query: 159 EIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVA 218
A ++ L L C + + NLE L L + + + L L L+++
Sbjct: 22 TPAAVRELV-LDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSN-LPKLPKLKKLELS 79
Query: 219 NNKLVELPSGLY-LLQRLENLDLSNNRLTSLGSLD-LCLMHNLQNLNLQYN 267
N++ L L L +L+LS N+L + +L+ L + L++L+L
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-09
Identities = 26/109 (23%), Positives = 41/109 (37%), Gaps = 9/109 (8%)
Query: 186 LSNLEQLDLSFNKMKYLPTE--ICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNN 243
+ + +L L K E L L + N L+ + S L L +L+ L+LS N
Sbjct: 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSEN 81
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICC------NLEGN 286
R+ + + NL +LNL NKL + +L
Sbjct: 82 RIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 2e-06
Identities = 32/131 (24%), Positives = 56/131 (42%), Gaps = 8/131 (6%)
Query: 136 LKGLKELELSKVP-PRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDL 194
++EL L + L +E L LS+ + + + + L L++L+L
Sbjct: 23 PAAVRELVLDNCKSNDGKIEGLTAE---FVNLEFLSLINVGLISVSN-LPKLPKLKKLEL 78
Query: 195 SFNK-MKYLPTEICYLKALISLKVANNKLVELPSGLYL--LQRLENLDLSNNRLTSLGSL 251
S N+ L L L L ++ NKL ++ + L L+ L++LDL N +T+L
Sbjct: 79 SENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDY 138
Query: 252 DLCLMHNLQNL 262
+ L L
Sbjct: 139 RESVFKLLPQL 149
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 3e-11
Identities = 28/117 (23%), Positives = 43/117 (36%), Gaps = 22/117 (18%)
Query: 945 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPA 1002
+H I+HRD+K N L++ D VK+CDF R + +
Sbjct: 145 IHESGIIHRDLKPANCLLN-----QDCS--VKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 1003 PDVCVGTPRWM----------APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1049
+ + APE++ Y +DIWS GC+ ELL +
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQEN---YTKSIDIWSTGCIFAELLNMLQS 251
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 3e-11
Identities = 45/232 (19%), Positives = 72/232 (31%), Gaps = 65/232 (28%)
Query: 945 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFD--RAVPLRSFLHTCCIAHRGIPA 1002
+HS I+HRD+K N L++ D VK+CDF R V ++
Sbjct: 172 VHSAGILHRDLKPANCLVN-----QDCS--VKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 1003 PDVCVGTP--------------RWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 1047
++ RW APE++ Y +D+WS GC+ ELL +
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQEN---YTEAIDVWSIGCIFAELLNMI 281
Query: 1048 VP----------------YMGLSELEIHDLIQMGKRPRLTDEL----EALGSCHEHEVAQ 1087
LS + D+L LG+ E ++
Sbjct: 282 KENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEA 341
Query: 1088 SGSGFEKPEAELETLSF-----LVDVFRRCTEE-----------NPTERPTA 1123
E + + L + F + + NP +R T
Sbjct: 342 LEK--EDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITI 391
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 3e-11
Identities = 25/99 (25%), Positives = 50/99 (50%), Gaps = 7/99 (7%)
Query: 175 SIRYLPPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSGLYL-L 232
+ ++P ++ L++S N + L ++I L L L +++N++ L ++
Sbjct: 11 GLIHVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFN 68
Query: 233 QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
Q LE LDLS+N+L + NL++L+L +N +
Sbjct: 69 QELEYLDLSHNKLVKISCHPT---VNLKHLDLSFNAFDA 104
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 2e-10
Identities = 40/179 (22%), Positives = 75/179 (41%), Gaps = 13/179 (7%)
Query: 73 LYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEV-GNLLGLECLQI---KISSPG 127
+ ++ + +L F N + E G+L LE L + ++
Sbjct: 305 KNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELS 364
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEI-GCL 186
++K L++L++S+ ++ + L + S L I CL
Sbjct: 365 KIAEMTTQMKSLQQLDISQNS-----VSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL 419
Query: 187 -SNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLY-LLQRLENLDLSNN 243
++ LDL NK+K +P ++ L+AL L VA+N+L +P G++ L L+ + L N
Sbjct: 420 PPRIKVLDLHSNKIKSIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 8e-09
Identities = 42/226 (18%), Positives = 70/226 (30%), Gaps = 36/226 (15%)
Query: 69 SVEGLYLYKNVL-NLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPG 127
L + +N + L + KLR L N I V
Sbjct: 22 KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISV----------------- 64
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP--EIGC 185
+ L+ L+LS + L +S L L + + LP E G
Sbjct: 65 -----FKFNQELEYLDLSH-----NKLVKIS-CHPTVNLKHLDLSFNAFDALPICKEFGN 113
Query: 186 LSNLEQLDLSFNKMKYLP-TEICYLKALISLKVANNKLVELPSGLYL----LQRLENLDL 240
+S L+ L LS ++ I +L L V E L + L +
Sbjct: 114 MSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFP 173
Query: 241 SNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGN 286
+N + + + + NL+ N++ + C I L+ N
Sbjct: 174 TNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTN 219
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 4e-08
Identities = 36/241 (14%), Positives = 73/241 (30%), Gaps = 44/241 (18%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGF- 131
L L L + + + E + L + I P F
Sbjct: 120 LGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFH 179
Query: 132 -----ALNKLKGLKELELSKVPPR---PSVLTLLSEIAGLKCLTKLSVCHFSIRYL---- 179
++ + L+ + V L++L+++ L+ L++ + +
Sbjct: 180 FILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIR 239
Query: 180 PPEIGCLSNLEQLDLSFNKMKYLPTEI------CYLKALISLKVANNKLVELPSGLYL-- 231
++ + + +S K++ LKAL +V ++ S +Y
Sbjct: 240 ILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIF 299
Query: 232 -----------------------LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNK 268
+ +LD SNN LT + + L+ L LQ N+
Sbjct: 300 SNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQ 359
Query: 269 L 269
L
Sbjct: 360 L 360
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 1e-04
Identities = 13/51 (25%), Positives = 28/51 (54%), Gaps = 2/51 (3%)
Query: 219 NNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
N L+ +P L Q+ L++S N ++ L + D+ + L+ L + +N++
Sbjct: 9 KNGLIHVPKDL--SQKTTILNISQNYISELWTSDILSLSKLRILIISHNRI 57
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 49/203 (24%), Positives = 85/203 (41%), Gaps = 37/203 (18%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFA 132
L L N L+ +P + +L L+ L L +++ G+ F
Sbjct: 42 LDLQSNKLSSLPSKA--FHRLTKLRL---------------LYLNDNKLQTLPAGI--F- 81
Query: 133 LNKLKGLKELELS-----KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEI-GCL 186
+LK L+ L ++ +P L L +L + ++ LPP + L
Sbjct: 82 -KELKNLETLWVTDNKLQALPIG--------VFDQLVNLAELRLDRNQLKSLPPRVFDSL 132
Query: 187 SNLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKLVELPSGLY-LLQRLENLDLSNNR 244
+ L L L +N+++ LP + L +L L++ NN+L +P G + L L+ L L NN+
Sbjct: 133 TKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQ 192
Query: 245 LTSLGSLDLCLMHNLQNLNLQYN 267
L + + L+ L LQ N
Sbjct: 193 LKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 30/87 (34%), Positives = 50/87 (57%), Gaps = 2/87 (2%)
Query: 187 SNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLYL-LQRLENLDLSNNR 244
++ ++LDL NK+ LP++ L L L + +NKL LP+G++ L+ LE L +++N+
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNK 96
Query: 245 LTSLGSLDLCLMHNLQNLNLQYNKLLS 271
L +L + NL L L N+L S
Sbjct: 97 LQALPIGVFDQLVNLAELRLDRNQLKS 123
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 5e-11
Identities = 27/105 (25%), Positives = 42/105 (40%), Gaps = 29/105 (27%)
Query: 945 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1004
LH ++HRD+ NIL+ + + +CDF+ A R A
Sbjct: 150 LHEAGVVHRDLHPGNILLA-----DNND--ITICDFNLA--------------REDTADA 188
Query: 1005 VC---VGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045
V RW APE++ + VD+WS GC++ E+
Sbjct: 189 NKTHYVTH-RWYRAPELVMQFKG---FTKLVDMWSAGCVMAEMFN 229
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 6e-11
Identities = 45/226 (19%), Positives = 74/226 (32%), Gaps = 49/226 (21%)
Query: 927 SVKLALFIAQDVAAALVELHSK-HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 985
+ I++ + L +H + I+H DIK EN+L+++ + +K+ D A
Sbjct: 129 PLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV-DSPENLIQIKIADLGNA-- 185
Query: 986 LRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045
C + T + +PEVL +G DIWS CL+ EL+T
Sbjct: 186 --------CWYDEHYTNS---IQTREYRSPEVLLGAP----WGCGADIWSTACLIFELIT 230
Query: 1046 LQVPYMGLSELEI------------------HDLIQMGKRPRL--TDELEALGSCHE--- 1082
+ L++ GK R
Sbjct: 231 GDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFW 290
Query: 1083 --HEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1126
+V F K EA+ + D + +P +R AG L
Sbjct: 291 PLEDVLTEKYKFSKDEAKE-----ISDFLSPMLQLDPRKRADAGGL 331
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 32/207 (15%), Positives = 71/207 (34%), Gaps = 25/207 (12%)
Query: 93 LRNLKFFGNEINLFPSEV-GNLLGLECLQI----KISSPGVNGFALNKLKGLKELELSKV 147
+ LK + PS NL + + + + + + L + +E+
Sbjct: 33 TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQ--LESHSFYNLSKVTHIEIRNT 90
Query: 148 PPRPSVLTLLSEIA--GLKCLTKLSVCHFSIRYLPPEIGC--LSNLEQLDLSFN-KMKYL 202
LT + A L L L + + ++ P L+++ N M +
Sbjct: 91 RN----LTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSI 146
Query: 203 PTEICY--LKALISLKVANNKLVELPSGLYLLQRLENLDLS-NNRLTSL--GSLDLCLMH 257
P ++LK+ NN + + +L+ + L+ N LT + + +
Sbjct: 147 PVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFG-GVYS 205
Query: 258 NLQNLNLQYNKLLSYCQVPSWICCNLE 284
L++ + + +PS +L+
Sbjct: 206 GPSLLDVSQTSVTA---LPSKGLEHLK 229
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 20/110 (18%), Positives = 44/110 (40%), Gaps = 7/110 (6%)
Query: 166 LTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVA-NNKLV 223
V I+ +P + + L L ++ +P+ L + + V+ + L
Sbjct: 13 EEDFRVTCKDIQRIP---SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQ 69
Query: 224 ELPSGLYL-LQRLENLDLSNNR-LTSLGSLDLCLMHNLQNLNLQYNKLLS 271
+L S + L ++ ++++ N R LT + L + L+ L + L
Sbjct: 70 QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM 119
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-10
Identities = 45/196 (22%), Positives = 75/196 (38%), Gaps = 48/196 (24%)
Query: 945 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1004
+HS +++HRD+K N+L++ +K+CDF A R
Sbjct: 144 IHSANVLHRDLKPSNLLLN-----TTCD--LKICDFGLA--------------RVADPDH 182
Query: 1005 VC-------VGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL 1056
V T RW APE++ Y +DIWS GC+L E+L+ + + G L
Sbjct: 183 DHTGFLTEYVAT-RWYRAPEIMLNSKG---YTKSIDIWSVGCILAEMLSNRPIFPGKHYL 238
Query: 1057 EIHDLI--QMGKRPRLTDELEALGSCHEHEVAQSGSGFEK-------PEAELETLSFLVD 1107
+ + I +G + ++L + + S K P A+ + L L
Sbjct: 239 DQLNHILGILGSPSQ--EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLL-- 294
Query: 1108 VFRRCTEENPTERPTA 1123
+ NP +R
Sbjct: 295 --DKMLTFNPHKRIEV 308
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-10
Identities = 23/107 (21%), Positives = 45/107 (42%), Gaps = 4/107 (3%)
Query: 163 LKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKL 222
+K L L + L LE L + + + L L L++++N++
Sbjct: 19 VKELV-LDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRV 76
Query: 223 VELPSGLY-LLQRLENLDLSNNRLTSLGSLD-LCLMHNLQNLNLQYN 267
L L +L+LS N++ L +++ L + NL++L+L
Sbjct: 77 SGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 4e-10
Identities = 23/86 (26%), Positives = 41/86 (47%), Gaps = 3/86 (3%)
Query: 186 LSNLEQLDLSFNKMKYLPTE--ICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNN 243
S++++L L ++ E + L L N L + + L L +L+ L+LS+N
Sbjct: 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDN 74
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKL 269
R++ + NL +LNL NK+
Sbjct: 75 RVSGGLEVLAEKCPNLTHLNLSGNKI 100
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-06
Identities = 31/127 (24%), Positives = 56/127 (44%), Gaps = 6/127 (4%)
Query: 139 LKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNK 198
+KEL L R + L + L LS + + + + L+ L++L+LS N+
Sbjct: 19 VKELVLDNS--RSNEGKLEGLTDEFEELEFLSTINVGLTSIAN-LPKLNKLKKLELSDNR 75
Query: 199 MKYLPTEIC-YLKALISLKVANNKLVELPSGLYL--LQRLENLDLSNNRLTSLGSLDLCL 255
+ + L L ++ NK+ +L + L L+ L++LDL N +T+L +
Sbjct: 76 VSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENV 135
Query: 256 MHNLQNL 262
L L
Sbjct: 136 FKLLPQL 142
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 6e-10
Identities = 42/125 (33%), Positives = 68/125 (54%), Gaps = 9/125 (7%)
Query: 154 LTLLSEIA--GLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEI-CYL 209
L LS+ GL LT L++ + ++ L + L+ L L L+ N++ LP + +L
Sbjct: 47 LATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHL 106
Query: 210 KALISLKVANNKLVELPSGLY-LLQRLENLDLSNNRLTSL--GSLDLCLMHNLQNLNLQY 266
L L + N+L LPSG++ L +L+ L L+ N+L S+ G+ D + NLQ L+L
Sbjct: 107 TQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFD--KLTNLQTLSLST 164
Query: 267 NKLLS 271
N+L S
Sbjct: 165 NQLQS 169
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 40/165 (24%), Positives = 64/165 (38%), Gaps = 26/165 (15%)
Query: 116 LECLQIKISS-PGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKC----LTKLS 170
+ ++ N ++ V L + L L +S
Sbjct: 24 ANLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQY----LPNVRYLALGGNKLHDIS 79
Query: 171 VCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKLVELPSGL 229
L+NL L L+ N+++ LP + L L L + N+L LP G+
Sbjct: 80 ALK-----------ELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGV 128
Query: 230 Y-LLQRLENLDLSNNRLTSL--GSLDLCLMHNLQNLNLQYNKLLS 271
+ L L L+L++N+L SL G D + NL L+L YN+L S
Sbjct: 129 FDKLTNLTYLNLAHNQLQSLPKGVFD--KLTNLTELDLSYNQLQS 171
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 18/88 (20%), Positives = 36/88 (40%), Gaps = 4/88 (4%)
Query: 184 GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNN 243
+ + +L + T+ L ++ + N+ + + G+ L + L L N
Sbjct: 16 DAFAETIKANLKKKSVTDAVTQN-ELNSIDQIIANNSDIKSVQ-GIQYLPNVRYLALGGN 73
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
+L + +L + NL L L N+L S
Sbjct: 74 KLHDISALK--ELTNLTYLILTGNQLQS 99
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 45/203 (22%), Positives = 80/203 (39%), Gaps = 24/203 (11%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPS--EVGNLLGLECLQIKISSP 126
L K + + + + ++I + N+ L K+
Sbjct: 20 ETIKANLKKKSVTDAV-TQNELNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGNKLHDI 78
Query: 127 GVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIA--GLKCLTKLSVCHFSIRYLPPEI- 183
L +L L L L+ + L L L L +L + ++ LP +
Sbjct: 79 SA----LKELTNLTYLILTG-----NQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVF 129
Query: 184 GCLSNLEQLDLSFNKMKYLPTEIC-YLKALISLKVANNKLVELPSGLY-LLQRLENLDLS 241
L+NL L+L+ N+++ LP + L L L ++ N+L LP G++ L +L++L L
Sbjct: 130 DKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLY 189
Query: 242 NNRLTSL--GSLDLCLMHNLQNL 262
N+L S+ G D L +L
Sbjct: 190 QNQLKSVPDGVFD-----RLTSL 207
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 2e-09
Identities = 50/254 (19%), Positives = 72/254 (28%), Gaps = 64/254 (25%)
Query: 930 LALFIAQDVAAALVELHSK-HIMHRDIKSENILIDLE-----------------RKKADG 971
I Q V L LH+K I+H DIK ENIL+ +
Sbjct: 147 CVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPS 206
Query: 972 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV------------CVGTPRWMAPEVLR 1019
V L + L + D+ + T ++ + EVL
Sbjct: 207 GSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLI 266
Query: 1020 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHD----LIQM----GKRP--- 1068
Y DIWS C+ EL T + S E + + GK P
Sbjct: 267 GSG----YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKL 322
Query: 1069 ----RLTDE----------LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 1114
+ + E + L EV + + EA D E
Sbjct: 323 IVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAG-----FTDFLLPMLE 377
Query: 1115 ENPTERPTAGDLYE 1128
P +R TA +
Sbjct: 378 LIPEKRATAAECLR 391
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 2e-09
Identities = 22/88 (25%), Positives = 44/88 (50%), Gaps = 5/88 (5%)
Query: 187 SNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLY-LLQRLENLDLSNNRL 245
++ +L L N+ +P E+ K L + ++NN++ L + + + +L L LS NRL
Sbjct: 31 RDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL 90
Query: 246 TSL--GSLDLCLMHNLQNLNLQYNKLLS 271
+ + D + +L+ L+L N +
Sbjct: 91 RCIPPRTFD--GLKSLRLLSLHGNDISV 116
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 27/111 (24%), Positives = 52/111 (46%), Gaps = 8/111 (7%)
Query: 167 TKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEIC-YLKALISLKVANNKLVEL 225
T+L + +P E+ +L +DLS N++ L + + L++L ++ N+L +
Sbjct: 34 TELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCI 93
Query: 226 PSGLY-LLQRLENLDLSNNRLTSL--GSLDLCLMHNLQNLNLQYNKLLSYC 273
P + L+ L L L N ++ + G+ + L +L + N L YC
Sbjct: 94 PPRTFDGLKSLRLLSLHGNDISVVPEGAFNDL--SALSHLAIGANPL--YC 140
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 6e-09
Identities = 74/314 (23%), Positives = 113/314 (35%), Gaps = 88/314 (28%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
V+ LK + E F EV M+ H ++ + G L
Sbjct: 59 VKRLKEERTQGGE-LQF----QTEVEMISMAVHRNLLRLRGF--------CMTPT--ERL 103
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK---HIMHR 953
L ++ Y+ GSV + + + E + + IA A L LH I+HR
Sbjct: 104 L---VY-PYMANGSVASCLRERPE-SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHR 158
Query: 954 DIKSENILID--LERKKAD-GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP 1010
D+K+ NIL+D E D G + KL D+ + + T V GT
Sbjct: 159 DVKAANILLDEEFEAVVGDFG--LAKLMDYK-----DTHVTT-----------AV-RGTI 199
Query: 1011 RWMAPEVLRAMH-----KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHD----- 1060
+APE K D++ YG +LLEL+T Q + D
Sbjct: 200 GHIAPEY--LSTGKSSEK-------TDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250
Query: 1061 ----LIQMGKRPRLTD-ELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 1115
L++ K L D +L+ G+ + EV Q L+ V CT+
Sbjct: 251 WVKGLLKEKKLEALVDVDLQ--GNYKDEEVEQ-----------------LIQVALLCTQS 291
Query: 1116 NPTERPTAGDLYEM 1129
+P ERP ++ M
Sbjct: 292 SPMERPKMSEVVRM 305
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 9e-09
Identities = 39/168 (23%), Positives = 67/168 (39%), Gaps = 24/168 (14%)
Query: 916 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 975
E L + + SVK A+ + A + +H K +++RDIK +N LI K +
Sbjct: 93 EDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANM--I 150
Query: 976 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC--VGTPRWMAPEVLRAMHKPNLYGLEV-- 1031
+ DF + + H IP + GT R+M+ H G E
Sbjct: 151 YVVDFGMV---KFYRDPVTKQH--IPYREKKNLSGTARYMS----INTHL----GREQSR 197
Query: 1032 --DIWSYGCLLLELLTLQVPYMGL---SELEIHDLIQMGKRPRLTDEL 1074
D+ + G + + L +P+ GL + + ++ I K+ EL
Sbjct: 198 RDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 245
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 39/169 (23%), Positives = 72/169 (42%), Gaps = 28/169 (16%)
Query: 916 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 975
E L + S+K L +A + + + +HSK+ +HRD+K +N L+ L +K +V
Sbjct: 92 EDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKK----GNLV 147
Query: 976 KLCDFDRA---VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV- 1031
+ DF A R+ H ++ + GT R+ + H G+E
Sbjct: 148 YIIDFGLAKKYRDARTHQHIPYRENKNL------TGTARYAS----INTHL----GIEQS 193
Query: 1032 ---DIWSYGCLLLELLTLQVPYMGL---SELEIHDLIQMGKRPRLTDEL 1074
D+ S G +L+ +P+ GL ++ + ++ I K + L
Sbjct: 194 RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-08
Identities = 45/212 (21%), Positives = 76/212 (35%), Gaps = 36/212 (16%)
Query: 93 LRNLKFFGNEIN------LFPSEVGNLLGLECLQI---KISSPGVN--GFALNKLKGLKE 141
L+ L N + L + LE LQ+ +S+ L KE
Sbjct: 115 LQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKE 174
Query: 142 LELSKVPPRPSVLTLLSEI-----AGLKCLTKLSVCHFS---IRYLPPEIGCLSNLEQLD 193
L +S + + +L + L+ L KL C + R L + ++L +L
Sbjct: 175 LTVSNNDINEAGVRVLCQGLKDSPCQLEAL-KLESCGVTSDNCRDLCGIVASKASLRELA 233
Query: 194 LSFNK-----MKYL-PTEICYLKALISLKVANNKL-----VELPSGLYLLQRLENLDLSN 242
L NK M L P + L +L + + +L L + L+ L L+
Sbjct: 234 LGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAG 293
Query: 243 NRLTSLGSLDLC--LMHN---LQNLNLQYNKL 269
N L G+ LC L+ L++L ++
Sbjct: 294 NELGDEGARLLCETLLEPGCQLESLWVKSCSF 325
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 7e-07
Identities = 34/162 (20%), Positives = 59/162 (36%), Gaps = 25/162 (15%)
Query: 132 ALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKL--------SVCHFSIRYLPPEI 183
L L L+EL LS + L LL E L +L S+ S L +
Sbjct: 108 TLRTLPTLQELHLSDNLLGDAGLQLLCE-GLLDPQCRLEKLQLEYCSLSAASCEPLASVL 166
Query: 184 GCLSNLEQLDLSFNK-----MKYLPTEICYLKA-LISLKVANNKL-----VELPSGLYLL 232
+ ++L +S N ++ L + L +LK+ + + +L +
Sbjct: 167 RAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASK 226
Query: 233 QRLENLDLSNNRLTSLGSLDLCLM-----HNLQNLNLQYNKL 269
L L L +N+L +G +LC L+ L + +
Sbjct: 227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGI 268
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 8e-06
Identities = 38/168 (22%), Positives = 55/168 (32%), Gaps = 33/168 (19%)
Query: 130 GFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKC----LTKLSVCHFSI-----RYLP 180
L + LKEL L+ LL E L L L V S +
Sbjct: 277 CRVLRAKESLKELSLAGNELGDEGARLLCE--TLLEPGCQLESLWVKSCSFTAACCSHFS 334
Query: 181 PEIGCLSNLEQLDLSFNKM---------KYLPTEICYLKALISLKVANNKLVE-----LP 226
+ L +L +S N++ + L L+ L +A+ + + L
Sbjct: 335 SVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLR---VLWLADCDVSDSSCSSLA 391
Query: 227 SGLYLLQRLENLDLSNNRLTSLGSLDLC--LMHN---LQNLNLQYNKL 269
+ L L LDLSNN L G L L + L+ L L
Sbjct: 392 ATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYW 439
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 4e-05
Identities = 25/144 (17%), Positives = 47/144 (32%), Gaps = 36/144 (25%)
Query: 139 LKELELSKVP-PRPSVLTLLSEIAGLKCLTKLSVCHFS---IRYLPPEIGCLSNLEQLDL 194
++ L++ LL + + + +L C + + + + L +L+L
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVV-RLDDCGLTEARCKDISSALRVNPALAELNL 63
Query: 195 SFNK-----MKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLG 249
N+ + + L L+ + K+ + L L N LT G
Sbjct: 64 RSNELGDVGVHCV---------LQGLQTPSCKI-------------QKLSLQNCCLTGAG 101
Query: 250 SLDLCLM----HNLQNLNLQYNKL 269
L LQ L+L N L
Sbjct: 102 CGVLSSTLRTLPTLQELHLSDNLL 125
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 1e-04
Identities = 19/95 (20%), Positives = 40/95 (42%), Gaps = 12/95 (12%)
Query: 187 SNLEQLDLSFNKMKYLP-TEIC-YLKALISLKVANNKL-----VELPSGLYLLQRLENLD 239
+++ LD+ ++ E+ L+ +++ + L ++ S L + L L+
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 240 LSNNRLTSLGSLDLC--LMHN---LQNLNLQYNKL 269
L +N L +G + L +Q L+LQ L
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 97
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 55.9 bits (134), Expect = 3e-08
Identities = 29/162 (17%), Positives = 54/162 (33%), Gaps = 9/162 (5%)
Query: 150 RPSVLTLLSEIAGLKCLTKLSVCHF-SIRYLPPE-IGCLSNLEQLDLSFNKMKYLPTEI- 206
R L L + G + LT+L + + +++L + L L L + + ++++ +
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76
Query: 207 CYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQY 266
+ L L ++ N L L L+ L LS N L C + LQ +
Sbjct: 77 HFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH----CS-CALRWLQRWEEEG 131
Query: 267 NKLLSYCQVPSWICCNLEGNGKDS-SNDDFISSSAEMDVYEG 307
+ ++ L S V G
Sbjct: 132 LGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVG 173
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.4 bits (135), Expect = 6e-08
Identities = 92/647 (14%), Positives = 172/647 (26%), Gaps = 209/647 (32%)
Query: 394 LDALASETPSEEASDIIGLDDDDKQLLSPEAESENLLFSVEDDKIRSGTGLHVENCSCAG 453
D S EE II D L LF
Sbjct: 39 QDMPKSILSKEEIDHIIMSKDAVSGTL--------RLFWT-------------------- 70
Query: 454 LESTGKEGNDECSKHDSSSLSTANGATEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKS 513
L S +E + + K + + +
Sbjct: 71 LLSKQEEMVQK----------FVEEVLRINYKFLMSPIKTEQR-----QPSMMTRMYIEQ 115
Query: 514 RKSMGENSNASQKYSSVSFCSIEDRLPDGFYDAGRDRPFMQLTG--YEQTPHLDSREVIL 571
R + N +Q ++ Y+ R +P+++L E P + +L
Sbjct: 116 RDRL---YNDNQVFAK--------------YNVSRLQPYLKLRQALLELRPA----KNVL 154
Query: 572 VDR-----KSDEELDAIALSAQALV---------LHLKQLNGLTKDGVIEPVDNLQIALL 617
+D K+ + + + L+LK N + + V+E + L
Sbjct: 155 IDGVLGSGKT--WVALDVCLSYKVQCKMDFKIFWLNLKNCN--SPETVLEMLQKL----- 205
Query: 618 LALFVSDHFGGSDRSG--------IVERTRKTVSGSNYRKPFVCTCSTGNSDSANTSQKQ 669
L + SD S I R+ + Y +
Sbjct: 206 LYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLL----------------- 248
Query: 670 ILDAVEDI-VLS--DL-C-------EKSLRSIKSKRNSVVVPIGSVQFGVCRH--RAVLL 716
+L V++ + +L C K + S + + + + +++LL
Sbjct: 249 VLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLL 308
Query: 717 KYLCDRVE--PPVPC-----------ELVRGYLD-FQPHAWNTILVKKGDSWIRMIVDAC 762
KYL R + P E +R L + W + K + I ++
Sbjct: 309 KYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDN--WKHVNCDKLTTIIESSLNVL 366
Query: 763 RPHDIREEADPEYFIRYIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDE--AGKSVS 820
P + R+ ++ ++ F S H P L F + S K
Sbjct: 367 EPAEYRK------------MFDRLSVFP-PSAHIPTILLSLIWFDVIKSDVMVVVNKLHK 413
Query: 821 SSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 880
SL + K T+ + + E + H IV+ Y I
Sbjct: 414 YSL-------VEKQPKESTISI----PSIYLELKVKLENEYAL-----HRSIVDHY--NI 455
Query: 881 SSKWLPSADGNPE----------HHLLQ----------SAIFMEYVKGGSVKNYIE-KLS 919
+ P HHL +F+++ ++E K+
Sbjct: 456 PKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDF-------RFLEQKIR 508
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 966
+ L Q ++ + +I D K E ++ +
Sbjct: 509 HDSTAWNASGSILNTLQQ-----LKFYKPYICDNDPKYERLVNAILD 550
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.9 bits (118), Expect = 5e-06
Identities = 103/648 (15%), Positives = 190/648 (29%), Gaps = 212/648 (32%)
Query: 174 FSIRYLPPEIGCLSNLEQLDLSFNKM-KYLPTEICYLKALISLKVANNKLVELPSGLYLL 232
P + +EQ D +N + + L+ + L+ L+EL +L
Sbjct: 98 IKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLR---QALLELRPAKNVL 154
Query: 233 QRLENLDLSNNRLTSLGS------LDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGN 286
++ + LGS LD+CL + +Q ++ W+ NL
Sbjct: 155 --IDGV---------LGSGKTWVALDVCLSYKVQCKM--------DFKI-FWL--NL--- 189
Query: 287 GKDSSNDDFISSSAEMDVYEGPMLEN-----DGNVSFSAESDAGSRHTSSSISTVSSSNS 341
+S + + ML+ D N + ++ + + SI
Sbjct: 190 KNCNSPETVLE-----------MLQKLLYQIDPNWTSRSDHSSNIKLRIHSI-------- 230
Query: 342 RSLTARKSSKQWKRHHLQQRARQERL------NNSRKWRG-EGHAQ---TSMKEGQRYKS 391
+ R L+ + + L N++ W + T+ R+K
Sbjct: 231 ---------QAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTT-----RFKQ 276
Query: 392 GNLDALASETPSEEASDIIGLDDDDKQLLSPEAESENLLFSVEDDKIRSGTGLHVENCSC 451
D L++ T + I LD L E ++LL D + + L E +
Sbjct: 277 -VTDFLSAATTTH-----ISLDHHSMTLT--PDEVKSLLLKYLDCRPQD---LPREVLTT 325
Query: 452 AGLESTGKEGNDECSKHDSSSLSTANGATEQDEGSSSENSKAV-CKTKRHS-DRDLDNPK 509
LS + +D ++ +N K V C + L+ +
Sbjct: 326 NPR-----------------RLSII-AESIRDGLATWDNWKHVNCDKLTTIIESSLNVLE 367
Query: 510 PCKSRKSMGENSNASQKYSSVSFCSIEDRLPDGFYDAGRDRPFMQLTGY-EQTPHLDSRE 568
P + R + + S+ P A P + L+ D
Sbjct: 368 PAEYR----------KMFDR---LSV---FPP---SA--HIPTILLSLIWFDVIKSDVMV 406
Query: 569 VI-------LVDRKSDEE--------LDAIALSAQALVLH---LKQLNGLTK----DGVI 606
V+ LV+++ E L+ LH + N D +
Sbjct: 407 VVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIP 466
Query: 607 EPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCT--CSTGNSDSAN 664
+D + H + + R ++R F+ + +A+
Sbjct: 467 PYLDQY-----FYSHIGHHLKNIEHPERMTLFRMVFL--DFR--FLEQKIRHDSTAWNAS 517
Query: 665 TSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVE 724
S IL+ ++ L+ K Y+CD
Sbjct: 518 GS---ILNTLQQ----------LKFYK-------------------------PYICD--N 537
Query: 725 PPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDACRPHD-IREEA 771
P LV LDF P ++ K +R+ + A + I EEA
Sbjct: 538 DPKYERLVNAILDFLPKIEENLICSKYTDLLRIALMA--EDEAIFEEA 583
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.2 bits (111), Expect = 3e-05
Identities = 69/519 (13%), Positives = 139/519 (26%), Gaps = 179/519 (34%)
Query: 577 DEELDAIALSAQALVLHLKQLNGLTKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVE 636
D E + ++ + + + V ++ ++L + D V
Sbjct: 8 DFETGEHQYQYKDILSVFED--AFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDA---VS 62
Query: 637 RTRKTVSGSNYRKPFVCTCSTGNSDSANTSQKQILDAVEDIVLSD---LCEKSLRSIKSK 693
T + F S + VE+++ + L IK++
Sbjct: 63 GTLRL---------FWTLLSKQEE--------MVQKFVEEVLRINYKFLMSP----IKTE 101
Query: 694 RNSVVVPIGSVQFGVCRHRA-----VLLKYLCDRVEPPVPCELVRGYLDFQPHAWNTILV 748
+ + + + R R V KY R++P + +L + L+ +P +L+
Sbjct: 102 QRQPSMM--TRMYIEQRDRLYNDNQVFAKYNVSRLQPYL--KLRQALLELRPAKN--VLI 155
Query: 749 K----KGDSWIRMIVDACRPHDIREEADPEYFIRYIPLYRTIAP---------FSTESDH 795
G +W + +D C + ++ + D + F ++ L +P + D
Sbjct: 156 DGVLGSGKTW--VALDVCLSYKVQCKMDFKIF--WLNLKNCNSPETVLEMLQKLLYQIDP 211
Query: 796 SPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTL----KVCGSSADEIR 851
+ S D S L + ++ L + K L V +A
Sbjct: 212 NWTSRSDHSSNIKLRI--HSIQAELRRLLKSK-------PYENCLLVLLNVQ--NAKAWN 260
Query: 852 NFEYSCLGEVRML--------------GALRHSCIVEM-------YGHKISSKW------ 884
F SC ++L H + + K+
Sbjct: 261 AFNLSC----KILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQ 316
Query: 885 -LPS--ADGNPEHHLLQSAIFMEYVKGG-----------------SVKNYIEKLSETGEK 924
LP NP + +I E ++ G +++ + L +
Sbjct: 317 DLPREVLTTNP----RRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYR 372
Query: 925 HVSVKLALF-----I----------------AQDVAAALV-------------------- 943
+ +L++F I V L
Sbjct: 373 KMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIY 432
Query: 944 -----------ELHSKHIMHRDIKSENILIDLERKKADG 971
LH + H +I DL D
Sbjct: 433 LELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQ 471
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 8e-08
Identities = 38/110 (34%), Positives = 62/110 (56%), Gaps = 7/110 (6%)
Query: 167 TKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEIC-YLKALISLKVANNKLVE 224
T L + S++ LP + L++L QL L NK++ LP + L +L L ++ N+L
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQS 90
Query: 225 LPSGLY-LLQRLENLDLSNNRLTSL--GSLDLCLMHNLQNLNLQYNKLLS 271
LP+G++ L +L+ L L+ N+L SL G D + L++L L N+L S
Sbjct: 91 LPNGVFDKLTQLKELALNTNQLQSLPDGVFDK--LTQLKDLRLYQNQLKS 138
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 35/111 (31%), Positives = 59/111 (53%), Gaps = 7/111 (6%)
Query: 162 GLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEIC-YLKALISLKVAN 219
L LT+L + ++ LP + L++L L+LS N+++ LP + L L L +
Sbjct: 50 ELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNT 109
Query: 220 NKLVELPSGLY-LLQRLENLDLSNNRLTSL--GSLDLCLMHNLQNLNLQYN 267
N+L LP G++ L +L++L L N+L S+ G D + +LQ + L N
Sbjct: 110 NQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFD--RLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 7e-07
Identities = 35/96 (36%), Positives = 48/96 (50%), Gaps = 8/96 (8%)
Query: 180 PPEIGCLSNLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKLVELPSGLY-LLQRLEN 237
P I + LDL N +K LP + L +L L + NKL LP+G++ L L
Sbjct: 23 PTGIP--AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTY 80
Query: 238 LDLSNNRLTSL--GSLDLCLMHNLQNLNLQYNKLLS 271
L+LS N+L SL G D + L+ L L N+L S
Sbjct: 81 LNLSTNQLQSLPNGVFDK--LTQLKELALNTNQLQS 114
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 8e-08
Identities = 17/87 (19%), Positives = 40/87 (45%), Gaps = 7/87 (8%)
Query: 190 EQLDLSFNKMKYLPTEICY--LKALISLKVANNKLVELPSGLY-LLQRLENLDLSNNRLT 246
+L L+ N++ + ++ + L L+ L++ N+L + + ++ L L N++
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK 91
Query: 247 SL--GSLDLCLMHNLQNLNLQYNKLLS 271
+ +H L+ LNL N++
Sbjct: 92 EISNKMFL--GLHQLKTLNLYDNQISC 116
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 9e-08
Identities = 42/168 (25%), Positives = 72/168 (42%), Gaps = 24/168 (14%)
Query: 916 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 975
E L + ++ S+K L IA + + + +HSK++++RD+K EN LI K +
Sbjct: 92 EDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQV--I 149
Query: 976 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC--VGTPRWMAPEVLRAMHKPNLYGLEV-- 1031
+ DF A + ++ H IP + GT R+M+ H G E
Sbjct: 150 HIIDFALA---KEYIDPETKKH--IPYREHKSLTGTARYMS----INTHL----GKEQSR 196
Query: 1032 --DIWSYGCLLLELLTLQVPYMGL---SELEIHDLIQMGKRPRLTDEL 1074
D+ + G + + L +P+ GL + E + I KR + L
Sbjct: 197 RDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVL 244
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 41/169 (24%), Positives = 71/169 (42%), Gaps = 28/169 (16%)
Query: 916 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 975
E L + +S+K L +A + + +HSK +HRDIK +N L+ L R+ V
Sbjct: 90 EDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR----ANQV 145
Query: 976 KLCDFDRAVPLR---SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV- 1031
+ DF A R + H ++ + GT R+ + H G+E
Sbjct: 146 YIIDFGLAKKYRDTSTHQHIPYRENKNL------TGTARYAS----VNTHL----GIEQS 191
Query: 1032 ---DIWSYGCLLLELLTLQVPYMGL---SELEIHDLIQMGKRPRLTDEL 1074
D+ S G +L+ L +P+ GL ++ + ++ I K + L
Sbjct: 192 RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL 240
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 35/110 (31%), Positives = 53/110 (48%), Gaps = 6/110 (5%)
Query: 162 GLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEIC-YLKALISLKVAN 219
L L +L + + LP + L+ L LDL N++ LP+ + L L L +
Sbjct: 62 SLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCC 121
Query: 220 NKLVELPSGLYLLQRLENLDLSNNRLTSL--GSLDLCLMHNLQNLNLQYN 267
NKL ELP G+ L L +L L N+L S+ G+ D + +L + L N
Sbjct: 122 NKLTELPRGIERLTHLTHLALDQNQLKSIPHGAFD--RLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 30/96 (31%), Positives = 45/96 (46%), Gaps = 8/96 (8%)
Query: 180 PPEIGCLSNLEQLDLSFNKMKYLP-TEICYLKALISLKVANNKLVELPSGLY-LLQRLEN 237
P I +N + L L N++ L L L L + +N+L LP G++ L +L
Sbjct: 35 PAGI--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTV 92
Query: 238 LDLSNNRLTSL--GSLDLCLMHNLQNLNLQYNKLLS 271
LDL N+LT L D + +L+ L + NKL
Sbjct: 93 LDLGTNQLTVLPSAVFDR--LVHLKELFMCCNKLTE 126
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 7e-07
Identities = 31/169 (18%), Positives = 60/169 (35%), Gaps = 27/169 (15%)
Query: 915 IEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 974
++K+ E K S K L ++ + L +H +H DIK+ N+L++ +
Sbjct: 138 LQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD-----Q 192
Query: 975 VKLCDFDRAVPLRSFLHTCCIAHRGIP-APDVC-VGTPRWMAPEVLRAMHKPNLYGLEV- 1031
V L D+ A + H+ P C GT + + H G+
Sbjct: 193 VYLVDYGLA---YRYCPEGV--HKAYAADPKRCHDGTIEFTS----IDAHN----GVAPS 239
Query: 1032 ---DIWSYGCLLLELLTLQVPYMGL---SELEIHDLIQMGKRPRLTDEL 1074
D+ G +++ LT +P+ + I+ + +
Sbjct: 240 RRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDK 288
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 9e-07
Identities = 30/168 (17%), Positives = 61/168 (36%), Gaps = 31/168 (18%)
Query: 918 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 977
L + + +S + L +A + AL LH +H ++ +ENI +D E + V L
Sbjct: 148 LDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQS-----QVTL 202
Query: 978 CDFDRAVPLRSFLHTCCIAHRGIPAPDVC----VGTPRWMAPEVLRAMHKPNLYGLEV-- 1031
+ A + C + + + + G +++ +HK G
Sbjct: 203 AGYGFA---FRY----CPSGKHVAYVEGSRSPHEGDLEFIS----MDLHK----GCGPSR 247
Query: 1032 --DIWSYGCLLLELLTLQVPYMGL---SELEIHDLIQMGKRPRLTDEL 1074
D+ S G +L+ L +P+ +E + + +P
Sbjct: 248 RSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGP 295
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 30/89 (33%), Positives = 47/89 (52%), Gaps = 6/89 (6%)
Query: 187 SNLEQLDLSFNKMKYLPTEIC-YLKALISLKVANNKLVELPSGLY-LLQRLENLDLSNNR 244
S+ +L+L NK++ LP + L L L ++ N++ LP G++ L +L L L N+
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENK 87
Query: 245 LTSL--GSLDLCLMHNLQNLNLQYNKLLS 271
L SL G D + L+ L L N+L S
Sbjct: 88 LQSLPNGVFDK--LTQLKELALDTNQLKS 114
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 2e-05
Identities = 30/86 (34%), Positives = 47/86 (54%), Gaps = 6/86 (6%)
Query: 186 LSNLEQLDLSFNKMKYLPTEIC-YLKALISLKVANNKLVELPSGLY-LLQRLENLDLSNN 243
L+ L +L LS N+++ LP + L L L + NKL LP+G++ L +L+ L L N
Sbjct: 51 LTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTN 110
Query: 244 RLTSL--GSLDLCLMHNLQNLNLQYN 267
+L S+ G D + +LQ + L N
Sbjct: 111 QLKSVPDGIFD--RLTSLQKIWLHTN 134
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 45/238 (18%), Positives = 75/238 (31%), Gaps = 49/238 (20%)
Query: 68 NSVEGLYLYKNVLN-----LIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIK 122
+SV+ + L N + + +++ + L +F E+ L L
Sbjct: 32 DSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEI--PEALRLL--- 86
Query: 123 ISSPGVNGFALNKLKGLKELELS--KVPPRPSVLTLLSEIAGLKCLTKLSVCH------- 173
AL K L + LS P + L+ ++ L L + +
Sbjct: 87 -------LQALLKCPKLHTVRLSDNAFGPT-AQEPLIDFLSKHTPLEHLYLHNNGLGPQA 138
Query: 174 -------FSIRYLPPEIGCLSNLEQLDLSFNK-----MKYLPTEICYLKALISLKVANNK 221
+ + L + N+ MK + L ++K+ N
Sbjct: 139 GAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNG 198
Query: 222 L------VELPSGLYLLQRLENLDLSNNRLTSLGSLDLC--LMHN--LQNLNLQYNKL 269
+ L GL Q L+ LDL +N T LGS L L L+ L L L
Sbjct: 199 IRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLL 256
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 19/100 (19%), Positives = 28/100 (28%), Gaps = 17/100 (17%)
Query: 187 SNLEQLDLSFNK-----MKYLPTEICYLKALISLKVANNKL-----VELPSGLYLL--QR 234
L+ LDL N L + L L + + L + L
Sbjct: 216 QELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIG 275
Query: 235 LENLDLSNNRLTSLGSLDLC--LMHN---LQNLNLQYNKL 269
L+ L L N + L + L L L N+
Sbjct: 276 LQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 25/134 (18%), Positives = 45/134 (33%), Gaps = 26/134 (19%)
Query: 927 SVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF---DRA 983
L + + L +H +H DIK+ N+L+ + V L D+ R
Sbjct: 149 KKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD-----QVYLADYGLSYRY 203
Query: 984 VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV----DIWSYGCL 1039
P + +G GT + + HK G+ + D+ G
Sbjct: 204 CPNGNHKQYQENPRKGH------NGTIEFTS----LDAHK----GVALSRRSDVEILGYC 249
Query: 1040 LLELLTLQVPYMGL 1053
+L L ++P+
Sbjct: 250 MLRWLCGKLPWEQN 263
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 46.9 bits (110), Expect = 3e-05
Identities = 34/168 (20%), Positives = 63/168 (37%), Gaps = 24/168 (14%)
Query: 110 VGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKL 169
+ + L L+IK ++ LK LE+ SV+ + + L L KL
Sbjct: 168 LDAMPLLNNLKIKGTNNL--SIGKKPRPNLKSLEIISGGLPDSVVEDILG-SDLPNLEKL 224
Query: 170 SVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLV-ELPSG 228
+ Y G ++ F+K + L L + + + +
Sbjct: 225 VLYVGVEDY-----GFDGDMNVFRPLFSKDR--------FPNLKWLGIVDAEEQNVVVEM 271
Query: 229 LY---LLQRLENLDLSNNRLTSLGSLDLC----LMHNLQNLNLQYNKL 269
+L +LE +D+S LT G+ L + +L+ +N++YN L
Sbjct: 272 FLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL 319
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Length = 267 | Back alignment and structure |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 24/95 (25%), Positives = 36/95 (37%), Gaps = 5/95 (5%)
Query: 192 LDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSL 251
LDL + + L + L + L +L+LSNNRL L +
Sbjct: 132 LDLKGLRSDPDLVA---QNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDM 188
Query: 252 DLCL--MHNLQNLNLQYNKLLSYCQVPSWICCNLE 284
+ NL+ LNL N+L S ++ LE
Sbjct: 189 SSIVQKAPNLKILNLSGNELKSERELDKIKGLKLE 223
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1142 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.98 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.98 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.96 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.96 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.96 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.96 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.96 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.95 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.95 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.95 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.95 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.95 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.95 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.95 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.95 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.95 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.95 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.95 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.95 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.95 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.95 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.95 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.95 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.95 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.94 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.94 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.94 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.94 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.94 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.94 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.94 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.94 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.94 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.94 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.94 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.93 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.93 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.93 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.93 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.93 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.93 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.93 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.93 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.93 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.93 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.92 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.92 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.92 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.92 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.92 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.92 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.92 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.91 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.91 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.91 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.9 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.9 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.9 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.9 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.88 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.87 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.87 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.87 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.87 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.87 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.87 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.86 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.85 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.84 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.84 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.83 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.83 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.83 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.83 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.82 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.82 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.82 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.82 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.81 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.81 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.8 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.79 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.79 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.79 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.78 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.78 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.78 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.78 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.77 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.77 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.77 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.75 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.74 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.74 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.73 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.73 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.73 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.72 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.72 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.71 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.7 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.7 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.64 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.64 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.64 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.63 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.6 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.6 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.58 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.57 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.56 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.56 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.55 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.55 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.54 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.52 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.51 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.51 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.5 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.5 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.5 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.49 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.48 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.47 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.47 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.45 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.43 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.37 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.31 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.29 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.18 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.17 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.06 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.03 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.95 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 98.91 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 98.82 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.82 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.8 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.76 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.74 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.73 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.64 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.61 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.4 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.36 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.35 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.29 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.22 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.2 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 98.02 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.98 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.92 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.64 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.49 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.46 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.35 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.16 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.77 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.74 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.65 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.65 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.5 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 96.37 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.11 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 95.98 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 95.79 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 95.66 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.47 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.24 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 94.98 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 94.62 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 94.19 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 93.96 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 93.17 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 92.74 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 92.7 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 87.08 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 83.06 | |
| 3isr_A | 293 | Transglutaminase-like enzymes, putative cysteine; | 80.29 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=465.69 Aligned_cols=261 Identities=25% Similarity=0.333 Sum_probs=214.7
Q ss_pred CCCCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001142 803 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 880 (1142)
Q Consensus 803 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~ 880 (1142)
+.++++|++.++||+|+||+||+|++. +..||+|+.... .......+.+ .+|+.+|++++|||||++++++.
T Consensus 20 f~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~~~~----~~E~~il~~l~HpnIV~~~~~~~ 93 (350)
T 4b9d_A 20 FQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINIS--RMSSKEREES----RREVAVLANMKHPNIVQYRESFE 93 (350)
T ss_dssp CSCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECT--TSCHHHHHHH----HHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CCcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehH--HCCHHHHHHH----HHHHHHHHHCCCCCCCcEEEEEE
Confidence 446789999999999999999999984 677888886433 2333334444 89999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NI 960 (1142)
+++ .+|||||||+||+|.+++.. .+...+++..++.|+.||+.||+|||++|||||||||+||
T Consensus 94 ~~~--------------~~yiVmEy~~gg~L~~~i~~---~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NI 156 (350)
T 4b9d_A 94 ENG--------------SLYIVMDYCEGGDLFKRINA---QKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNI 156 (350)
T ss_dssp ETT--------------EEEEEEECCTTCBHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGE
T ss_pred ECC--------------EEEEEEeCCCCCcHHHHHHH---cCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHE
Confidence 765 35999999999999999976 3345689999999999999999999999999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
|++.+ +.+||+|||+|+.+...... ....+||+.|||||++.+ ..|+.++|||||||++
T Consensus 157 Ll~~~-------g~vKl~DFGla~~~~~~~~~----------~~~~~GT~~YmAPE~l~~----~~y~~~~DiwSlGvil 215 (350)
T 4b9d_A 157 FLTKD-------GTVQLGDFGIARVLNSTVEL----------ARACIGTPYYLSPEICEN----KPYNNKSDIWALGCVL 215 (350)
T ss_dssp EECTT-------CCEEECSTTEESCCCHHHHH----------HHHHHSCCTTCCHHHHTT----CCCCHHHHHHHHHHHH
T ss_pred EECCC-------CCEEEcccccceeecCCccc----------ccccCCCccccCHHHHCC----CCCCcHHHHHHHHHHH
Confidence 99887 78999999999876432211 123579999999999986 6799999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1041 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
|||++|+.||.+.+..++...+..+..+..+. ..++++.+||.+||+.||++|
T Consensus 216 yemltG~~PF~~~~~~~~~~~i~~~~~~~~~~---------------------------~~s~~~~~li~~~L~~dP~~R 268 (350)
T 4b9d_A 216 YELCTLKHAFEAGSMKNLVLKIISGSFPPVSL---------------------------HYSYDLRSLVSQLFKRNPRDR 268 (350)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCT---------------------------TSCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCc---------------------------cCCHHHHHHHHHHccCChhHC
Confidence 99999999999988888888887665543321 456679999999999999999
Q ss_pred CCHHHHHHHHHhhc
Q 001142 1121 PTAGDLYEMFVART 1134 (1142)
Q Consensus 1121 PSa~EVL~~L~~~~ 1134 (1142)
||++|+++|+|++.
T Consensus 269 ~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 269 PSVNSILEKGFIAK 282 (350)
T ss_dssp CCHHHHHTSHHHHT
T ss_pred cCHHHHhcCHHhhc
Confidence 99999999999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=461.67 Aligned_cols=257 Identities=26% Similarity=0.422 Sum_probs=216.9
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
..|++.++||+|+||+||+|++. +..||+|+...... ...+.+ .+|+.+|++++|||||++++++.+.+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~----~~~~~~----~~Ei~il~~l~HpnIV~l~~~~~~~~- 144 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ----QRRELL----FNEVVIMRDYQHENVVEMYNSYLVGD- 144 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC----SSGGGG----HHHHHHHHHCCCTTBCCEEEEEEETT-
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch----hHHHHH----HHHHHHHHhCCCCCCCcEEEEEEECC-
Confidence 45999999999999999999984 67789988654422 112233 79999999999999999999998765
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
++|||||||+||+|.+++.. ..+++.++..|+.||+.||+|||++|||||||||+|||++.
T Consensus 145 -------------~~~ivmEy~~gg~L~~~l~~------~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 205 (346)
T 4fih_A 145 -------------ELWVVMEFLEGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTH 205 (346)
T ss_dssp -------------EEEEEECCCTTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT
T ss_pred -------------EEEEEEeCCCCCcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECC
Confidence 35999999999999999975 35999999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||+|||+|+.+..... .....+||+.|||||++.+ ..|+.++|||||||++|||+
T Consensus 206 ~-------g~vKl~DFGla~~~~~~~~----------~~~~~~GTp~YmAPEvl~~----~~y~~~~DiWSlGvilyeml 264 (346)
T 4fih_A 206 D-------GRVKLSDFGFCAQVSKEVP----------RRKSLVGTPYWMAPELISR----LPYGPEVDIWSLGIMVIEMV 264 (346)
T ss_dssp T-------CCEEECCCTTCEECCSSSC----------CBCCCCSCGGGCCHHHHTT----CCBCTHHHHHHHHHHHHHHH
T ss_pred C-------CCEEEecCcCceecCCCCC----------cccccccCcCcCCHHHHCC----CCCCcHHHHHHHHHHHHHHH
Confidence 7 7899999999986543211 1235679999999999876 57899999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~ 1124 (1142)
+|+.||.+.+..+....+.....+.+... ...++++.+||.+||+.||++|||++
T Consensus 265 ~G~~PF~~~~~~~~~~~i~~~~~~~~~~~-------------------------~~~s~~~~dli~~~L~~dP~~R~ta~ 319 (346)
T 4fih_A 265 DGEPPYFNEPPLKAMKMIRDNLPPRLKNL-------------------------HKVSPSLKGFLDRLLVRDPAQRATAA 319 (346)
T ss_dssp HSSCTTTTSCHHHHHHHHHHSSCCCCSCG-------------------------GGSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred HCCCCCCCcCHHHHHHHHHcCCCCCCCcc-------------------------ccCCHHHHHHHHHHcCCChhHCcCHH
Confidence 99999999888888887766544332210 14567899999999999999999999
Q ss_pred HHHHHHHhhcCCC
Q 001142 1125 DLYEMFVARTSSS 1137 (1142)
Q Consensus 1125 EVL~~L~~~~ss~ 1137 (1142)
|+++|+|++...+
T Consensus 320 e~l~Hp~~~~~~~ 332 (346)
T 4fih_A 320 ELLKHPFLAKAGP 332 (346)
T ss_dssp HHTTCGGGGGCCC
T ss_pred HHhcCHhhcCCCC
Confidence 9999999987643
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=440.45 Aligned_cols=258 Identities=23% Similarity=0.298 Sum_probs=200.1
Q ss_pred CCCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 882 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~ 882 (1142)
.+++|++.+.||+|+||+||+|++ .+..||+|+...... .. .+...++.+|+.+|++++|||||++++++.++
T Consensus 11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~ 85 (275)
T 3hyh_A 11 HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVL--AK---SDMQGRIEREISYLRLLRHPHIIKLYDVIKSK 85 (275)
T ss_dssp ---CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC-----------CHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred EeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHc--CC---HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC
Confidence 467899999999999999999997 467889988643321 11 12223458999999999999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
+ ..|+||||+ +|+|.+++.+ ...+++.+++.++.||+.||+|||++||+||||||+|||+
T Consensus 86 ~--------------~~~ivmEy~-~g~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl 145 (275)
T 3hyh_A 86 D--------------EIIMVIEYA-GNELFDYIVQ-----RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL 145 (275)
T ss_dssp S--------------EEEEEEECC-CEEHHHHHHH-----SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE
T ss_pred C--------------EEEEEEeCC-CCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEE
Confidence 5 359999999 6899999976 3579999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
+.+ +.+||+|||+|+...... .....+||+.|||||++.+ ...++.++||||+||++|+
T Consensus 146 ~~~-------~~vkl~DFGla~~~~~~~-----------~~~~~~GT~~Y~APE~~~~---~~y~~~~~DiwSlGvily~ 204 (275)
T 3hyh_A 146 DEH-------LNVKIADFGLSNIMTDGN-----------FLKTSCGSPNYAAPEVISG---KLYAGPEVDVWSCGVILYV 204 (275)
T ss_dssp CTT-------CCEEECCSSCC--------------------------CTTSCHHHHSS---SSCCCTHHHHHHHHHHHHH
T ss_pred CCC-------CCEEEeecCCCeecCCCC-----------ccCCeeECcccCChhhhcC---CCCCCChhhhHHHHHHHHH
Confidence 887 789999999997654321 1224579999999999976 2234689999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1043 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1043 LLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
|++|+.||.+.+..++...+..+..+ ++ ...++++.+||.+||+.||++|||
T Consensus 205 lltg~~PF~~~~~~~~~~~i~~~~~~-~p---------------------------~~~s~~~~~li~~~L~~dP~~R~s 256 (275)
T 3hyh_A 205 MLCRRLPFDDESIPVLFKNISNGVYT-LP---------------------------KFLSPGAAGLIKRMLIVNPLNRIS 256 (275)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHTCCC-CC---------------------------TTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred HHHCCCCCCCCCHHHHHHHHHcCCCC-CC---------------------------CCCCHHHHHHHHHHccCChhHCcC
Confidence 99999999988888877777655422 11 034567899999999999999999
Q ss_pred HHHHHHHHHhhcCC
Q 001142 1123 AGDLYEMFVARTSS 1136 (1142)
Q Consensus 1123 a~EVL~~L~~~~ss 1136 (1142)
++|+++|+|++..-
T Consensus 257 ~~eil~hpw~k~~~ 270 (275)
T 3hyh_A 257 IHEIMQDDWFKVDL 270 (275)
T ss_dssp HHHHHHCHHHHTTC
T ss_pred HHHHHcCcccccCC
Confidence 99999999998653
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=450.72 Aligned_cols=262 Identities=21% Similarity=0.254 Sum_probs=216.6
Q ss_pred CCCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 882 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~ 882 (1142)
..++|++.++||+|+||+||+|++ .+..+|+|+...... ........+.+|+++|++++|||||++++++.++
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~-----~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 104 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI-----IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD 104 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHC-----CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence 456899999999999999999998 467789988643211 1111223458999999999999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
+. .|||||||+||+|.+++++ ...+++..++.|+.||+.||+|||++||+||||||+|||+
T Consensus 105 ~~--------------~yivmEy~~gG~L~~~i~~-----~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl 165 (311)
T 4aw0_A 105 EK--------------LYFGLSYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL 165 (311)
T ss_dssp SE--------------EEEEECCCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred CE--------------EEEEEecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEE
Confidence 53 4999999999999999986 2469999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
+.+ +.+||+|||+|+.+...... ......+||+.|||||++.+ ..|+.++||||+||++||
T Consensus 166 ~~~-------g~vKl~DFGla~~~~~~~~~--------~~~~~~~GTp~YmAPEvl~~----~~y~~~~DiWSlGvilye 226 (311)
T 4aw0_A 166 NED-------MHIQITDFGTAKVLSPESKQ--------ARANSFVGTAQYVSPELLTE----KSACKSSDLWALGCIIYQ 226 (311)
T ss_dssp CTT-------SCEEECCCTTCEECCTTTTC--------CCBCCCCSCGGGCCHHHHHH----SCBCHHHHHHHHHHHHHH
T ss_pred cCC-------CCEEEEEcCCceecCCCCCc--------ccccCcccCcccCCHHHHcC----CCCCcHHHHHHHHHHHHH
Confidence 887 88999999999876432111 12235679999999999987 678999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1043 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1043 LLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
|++|+.||.+.+..++...|..+... ++. ..++++++||.+||+.||++|||
T Consensus 227 ml~G~~PF~~~~~~~~~~~i~~~~~~-~p~---------------------------~~s~~~~dli~~lL~~dp~~R~t 278 (311)
T 4aw0_A 227 LVAGLPPFRAGNEGLIFAKIIKLEYD-FPE---------------------------KFFPKARDLVEKLLVLDATKRLG 278 (311)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHTCCC-CCT---------------------------TCCHHHHHHHHHHSCSSGGGSTT
T ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCC-CCc---------------------------ccCHHHHHHHHHHccCCHhHCcC
Confidence 99999999998888888887665421 110 34567999999999999999999
Q ss_pred HHH------HHHHHHhhcCCC
Q 001142 1123 AGD------LYEMFVARTSSS 1137 (1142)
Q Consensus 1123 a~E------VL~~L~~~~ss~ 1137 (1142)
++| |++|+||+.-.+
T Consensus 279 ~~e~~~~~~i~~Hp~F~~idw 299 (311)
T 4aw0_A 279 CEEMEGYGPLKAHPFFESVTW 299 (311)
T ss_dssp SGGGTCHHHHHTSGGGTTCCC
T ss_pred hHHHcCCHHHHCCCCcCCCCH
Confidence 987 588899876543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=444.28 Aligned_cols=259 Identities=24% Similarity=0.348 Sum_probs=202.9
Q ss_pred cceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCC
Q 001142 809 LSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 888 (1142)
Q Consensus 809 y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~~ 888 (1142)
|++.++||+|+||+||+|.+..+...|+++.+..........+.| .+|+.+|++++|||||++++++.+...
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~----~~E~~il~~l~HpnIV~~~~~~~~~~~---- 99 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRF----KEEAEMLKGLQHPNIVRFYDSWESTVK---- 99 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHH----HHHHHHHHTCCCTTBCCEEEEEEEEET----
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHH----HHHHHHHHhCCCCCCCcEEEEEeeccC----
Confidence 378889999999999999996544444443344333334444444 899999999999999999999875211
Q ss_pred CCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCeeecccc
Q 001142 889 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENILIDLER 966 (1142)
Q Consensus 889 ~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~g--IvHrDLKp~NILld~~~ 966 (1142)
....+|||||||+||+|.+++++ ...+++..+..|+.||+.||+|||++| ||||||||+|||++...
T Consensus 100 ------~~~~~~lvmEy~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~ 168 (290)
T 3fpq_A 100 ------GKKCIVLVTELMTSGTLKTYLKR-----FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPT 168 (290)
T ss_dssp ------TEEEEEEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTT
T ss_pred ------CCcEEEEEEeCCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCC
Confidence 12356999999999999999986 246999999999999999999999998 99999999999997521
Q ss_pred ccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001142 967 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1046 (1142)
Q Consensus 967 ~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG 1046 (1142)
+.+||+|||+|+..... .....+||+.|||||++.+ .|+.++|||||||++|||+||
T Consensus 169 ------g~vKl~DFGla~~~~~~------------~~~~~~GTp~YmAPE~~~~-----~y~~~~DiwSlGvilyelltg 225 (290)
T 3fpq_A 169 ------GSVKIGDLGLATLKRAS------------FAKAVIGTPEFMAPEMYEE-----KYDESVDVYAFGMCMLEMATS 225 (290)
T ss_dssp ------SCEEECCTTGGGGCCTT------------SBEESCSSCCCCCGGGGGT-----CCCTHHHHHHHHHHHHHHHHS
T ss_pred ------CCEEEEeCcCCEeCCCC------------ccCCcccCccccCHHHcCC-----CCCcHHHHHHHHHHHHHHHHC
Confidence 78999999999753321 1124579999999999864 589999999999999999999
Q ss_pred CCCCCCCC-HHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001142 1047 QVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1125 (1142)
Q Consensus 1047 ~~Pf~~~~-~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~E 1125 (1142)
+.||.+.. ...+...+..+..|... +...++++.+||.+||+.||++|||++|
T Consensus 226 ~~Pf~~~~~~~~~~~~i~~~~~~~~~--------------------------~~~~~~~~~~li~~~L~~dP~~R~s~~e 279 (290)
T 3fpq_A 226 EYPYSECQNAAQIYRRVTSGVKPASF--------------------------DKVAIPEVKEIIEGCIRQNKDERYSIKD 279 (290)
T ss_dssp SCTTTTCSSHHHHHHHHTTTCCCGGG--------------------------GGCCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCCCCCCcHHHHHHHHHcCCCCCCC--------------------------CccCCHHHHHHHHHHccCChhHCcCHHH
Confidence 99997644 44455555544332211 1134557999999999999999999999
Q ss_pred HHHHHHhhcC
Q 001142 1126 LYEMFVARTS 1135 (1142)
Q Consensus 1126 VL~~L~~~~s 1135 (1142)
+++|+|++..
T Consensus 280 ~l~Hp~~~~~ 289 (290)
T 3fpq_A 280 LLNHAFFQEE 289 (290)
T ss_dssp HHTSGGGC--
T ss_pred HhcCccccCC
Confidence 9999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=441.57 Aligned_cols=266 Identities=24% Similarity=0.372 Sum_probs=207.7
Q ss_pred CCCCCcceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 804 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 804 ~~~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
.+.+++++.++||+|+||+||+|++.+ .+|||+++ .........+.| .+|+.+|++++|||||+++|++.++
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~--~~~~~~~~~~~f----~~E~~il~~l~HpNIV~l~g~~~~~- 104 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILK--VVDPTPEQFQAF----RNEVAVLRKTRHVNILLFMGYMTKD- 104 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECC--CSSCCHHHHHHH----HHHHHHHTTCCCTTBCCEEEEECSS-
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEE--ecCCCHHHHHHH----HHHHHHHHhCCCCCEeeEEEEEECC-
Confidence 345678999999999999999999865 58888754 333344444555 8999999999999999999987542
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
..+||||||+||+|.++++. ....+++.++..|+.||+.||+|||+++||||||||+|||++
T Consensus 105 --------------~~~iVmEy~~gGsL~~~l~~----~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~ 166 (307)
T 3omv_A 105 --------------NLAIVTQWCEGSSLYKHLHV----QETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLH 166 (307)
T ss_dssp --------------SCEEEEECCSSCBHHHHHHT----SCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEE
T ss_pred --------------eEEEEEEcCCCCCHHHHHhh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEEC
Confidence 23899999999999999975 235699999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +++||+|||+|+........ ......+||+.|||||++.+.. ...|+.++|||||||++|||
T Consensus 167 ~~-------~~~Ki~DFGla~~~~~~~~~--------~~~~~~~GT~~ymAPE~l~~~~-~~~y~~ksDVwS~Gvvl~El 230 (307)
T 3omv_A 167 EG-------LTVKIGDFGLATVKSRWSGS--------QQVEQPTGSVLWMAPEVIRMQD-NNPFSFQSDVYSYGIVLYEL 230 (307)
T ss_dssp TT-------EEEEECCCSSCBC--------------------CCCCTTSCCHHHHHCCS-SCCCCHHHHHHHHHHHHHHH
T ss_pred CC-------CcEEEeeccCceecccCCcc--------eeecccccCCCccCHHHhhccC-CCCCCcHHHhHhHHHHHHHH
Confidence 87 88999999999765432111 1123457999999999997522 24689999999999999999
Q ss_pred HhCCCCCCCCCHHH-HHHHHHhCCCC-CchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1044 LTLQVPYMGLSELE-IHDLIQMGKRP-RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~e-l~~~I~~~~~p-~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
+||+.||.+.+... +...+..+..+ .... ....+++.+.+|+.+||+.||++||
T Consensus 231 ltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~------------------------~~~~~~~~l~~li~~cl~~dP~~RP 286 (307)
T 3omv_A 231 MTGELPYSHINNRDQIIFMVGRGYASPDLSK------------------------LYKNCPKAMKRLVADCVKKVKEERP 286 (307)
T ss_dssp HHSSCTTTTCCCHHHHHHHHHTTCCCCCSTT------------------------SCTTSCHHHHHHHHHHTCSSSTTSC
T ss_pred HHCCCCCCCCChHHHHHHHHhcCCCCCCccc------------------------ccccchHHHHHHHHHHcCCCHhHCc
Confidence 99999998765544 33444443321 1110 1115667899999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001142 1122 TAGDLYEMFVARTS 1135 (1142)
Q Consensus 1122 Sa~EVL~~L~~~~s 1135 (1142)
||.||+++++....
T Consensus 287 s~~ei~~~Le~l~~ 300 (307)
T 3omv_A 287 LFPQILSSIELLQH 300 (307)
T ss_dssp CHHHHHHHHHHHHT
T ss_pred CHHHHHHHHHHHhc
Confidence 99999999886543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=463.37 Aligned_cols=257 Identities=26% Similarity=0.429 Sum_probs=216.6
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
..|++.++||+|+||+||+|++. +..||+|+...... ...+. +.+|+.+|++++|||||+++++|.+.+
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~----~~~~~----~~~Ei~il~~l~HpnIV~l~~~~~~~~- 221 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ----QRREL----LFNEVVIMRDYQHENVVEMYNSYLVGD- 221 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC----SSGGG----HHHHHHHHHHCCCTTBCCEEEEEEETT-
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch----hHHHH----HHHHHHHHHhCCCCCCCceEEEEEECC-
Confidence 45999999999999999999984 67788888654321 11222 479999999999999999999998765
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
++|||||||+||+|.++++. ..+++.++..|+.||+.||+|||++|||||||||+||||+.
T Consensus 222 -------------~~~iVmEy~~gG~L~~~i~~------~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~ 282 (423)
T 4fie_A 222 -------------ELWVVMEFLEGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTH 282 (423)
T ss_dssp -------------EEEEEEECCTTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECT
T ss_pred -------------EEEEEEeCCCCCcHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcC
Confidence 35999999999999999975 35999999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||+|||+|+.+.... ......+||+.|||||++.+ ..|+.++|||||||++|||+
T Consensus 283 ~-------g~vKl~DFGla~~~~~~~----------~~~~~~~GTp~YmAPEvl~~----~~y~~~~DiWSlGvilyeml 341 (423)
T 4fie_A 283 D-------GRVKLSDFGFCAQVSKEV----------PRRKSLVGTPYWMAPELISR----LPYGPEVDIWSLGIMVIEMV 341 (423)
T ss_dssp T-------CCEEECCCTTCEECCSSC----------CCBCCCEECTTTCCHHHHTT----CCBCTHHHHHHHHHHHHHHH
T ss_pred C-------CCEEEecCccceECCCCC----------ccccccccCcCcCCHHHHCC----CCCCcHHHHHHHHHHHHHHH
Confidence 7 789999999998654321 11235679999999999976 67899999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~ 1124 (1142)
+|+.||.+.+..+....|.....+.+... ...++.+.+||.+||+.||++|||+.
T Consensus 342 ~G~~PF~~~~~~~~~~~i~~~~~~~~~~~-------------------------~~~s~~~~dli~~~L~~dP~~R~ta~ 396 (423)
T 4fie_A 342 DGEPPYFNEPPLKAMKMIRDNLPPRLKNL-------------------------HKVSPSLKGFLDRLLVRDPAQRATAA 396 (423)
T ss_dssp HSSCTTTTSCHHHHHHHHHHSCCCCCSCT-------------------------TSSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred HCCCCCCCcCHHHHHHHHHcCCCCCCccc-------------------------ccCCHHHHHHHHHHcCCChhHCcCHH
Confidence 99999999888888888766544332210 14567799999999999999999999
Q ss_pred HHHHHHHhhcCCC
Q 001142 1125 DLYEMFVARTSSS 1137 (1142)
Q Consensus 1125 EVL~~L~~~~ss~ 1137 (1142)
|+++|+|++....
T Consensus 397 ell~Hp~~~~~~~ 409 (423)
T 4fie_A 397 ELLKHPFLAKAGP 409 (423)
T ss_dssp HHTTCGGGGGCCC
T ss_pred HHhcCHHhcCCCC
Confidence 9999999987643
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=440.98 Aligned_cols=260 Identities=24% Similarity=0.353 Sum_probs=212.3
Q ss_pred CCCcceeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeee
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 878 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~-------~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~ 878 (1142)
-++|.+.++||+|+||+||+|++. +..||||+. +. ......++| .+|+++|++++|||||+++|+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l--~~--~~~~~~~~f----~~E~~il~~l~HpnIV~l~g~ 83 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTL--KD--ASDNARKDF----HREAELLTNLQHEHIVKFYGV 83 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEE--CS--CCHHHHHHH----HHHHHHHTTCCCTTBCCEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEe--CC--CChHHHHHH----HHHHHHHHhCCCCCCccEEEE
Confidence 457899999999999999999873 445777764 32 233344444 899999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHh--------ccCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 001142 879 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS--------ETGEKHVSVKLALFIAQDVAAALVELHSKHI 950 (1142)
Q Consensus 879 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~--------~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gI 950 (1142)
+.+.+. .+||||||++|+|.++++... ......+++.++..|+.||+.||+|||+++|
T Consensus 84 ~~~~~~--------------~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~i 149 (299)
T 4asz_A 84 CVEGDP--------------LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHF 149 (299)
T ss_dssp ECSSSS--------------EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EeeCCE--------------EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 987653 499999999999999998632 1223579999999999999999999999999
Q ss_pred cccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCch
Q 001142 951 MHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLE 1030 (1142)
Q Consensus 951 vHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~k 1030 (1142)
|||||||+|||++.+ +++||+|||+|+......... ......||+.|||||++.+ ..|+.+
T Consensus 150 iHRDlKp~NILl~~~-------~~~Ki~DFGla~~~~~~~~~~--------~~~~~~gt~~ymAPE~~~~----~~~~~k 210 (299)
T 4asz_A 150 VHRDLATRNCLVGEN-------LLVKIGDFGMSRDVYSTDYYR--------VGGHTMLPIRWMPPESIMY----RKFTTE 210 (299)
T ss_dssp CCSCCSGGGEEECGG-------GCEEECCCSCHHHHTGGGCEE--------ETTTEEECGGGCCHHHHHH----CCCCHH
T ss_pred ccCccCHhhEEECCC-------CcEEECCcccceecCCCCcee--------ecCceecChhhcCHHHHcC----CCCCch
Confidence 999999999999988 789999999998654322110 1123468999999999986 679999
Q ss_pred hhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHH
Q 001142 1031 VDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVF 1109 (1142)
Q Consensus 1031 sDVwSLGviL~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI 1109 (1142)
+|||||||++|||+| |+.||.+.+..++...+..+..+..+. .+++++.+|+
T Consensus 211 ~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~---------------------------~~~~~~~~li 263 (299)
T 4asz_A 211 SDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPR---------------------------TCPQEVYELM 263 (299)
T ss_dssp HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCCCCCT---------------------------TCCHHHHHHH
T ss_pred hhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------cchHHHHHHH
Confidence 999999999999999 899999988888888887776544331 4566799999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHhh
Q 001142 1110 RRCTEENPTERPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1110 ~~CL~~DP~~RPSa~EVL~~L~~~ 1133 (1142)
.+||+.||++||||.||++.|...
T Consensus 264 ~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 264 LGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHcCCChhHCcCHHHHHHHHHHH
Confidence 999999999999999998877654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=443.62 Aligned_cols=263 Identities=24% Similarity=0.346 Sum_probs=209.5
Q ss_pred CCCCcceeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceee
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 877 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~~-------~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g 877 (1142)
...+|.+.++||+|+||+||+|++. +..||||+.+ . ......++| .+|+++|++++|||||+++|
T Consensus 39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~--~--~~~~~~~~f----~~E~~il~~l~HpnIV~l~g 110 (329)
T 4aoj_A 39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK--E--ASESARQDF----QREAELLTMLQHQHIVRFFG 110 (329)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEES--C--CSHHHHHHH----HHHHHHHTTCCCTTBCCEEE
T ss_pred CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEEC--c--CCHHHHHHH----HHHHHHHHhCCCCCCCcEEE
Confidence 3457899999999999999999974 4567777743 2 233444445 89999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc----------cCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 001142 878 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE----------TGEKHVSVKLALFIAQDVAAALVELHS 947 (1142)
Q Consensus 878 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~----------~~~~~ls~~~i~~Ia~qIa~gL~yLHs 947 (1142)
++.+.+. .+||||||++|+|.++++.... ....++++.++..|+.||+.||+|||+
T Consensus 111 ~~~~~~~--------------~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~ 176 (329)
T 4aoj_A 111 VCTEGRP--------------LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG 176 (329)
T ss_dssp EECSSSS--------------EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEECCE--------------EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc
Confidence 9987553 4999999999999999975321 112469999999999999999999999
Q ss_pred CCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCC
Q 001142 948 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 1027 (1142)
Q Consensus 948 ~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~ 1027 (1142)
++||||||||+|||++.+ +++||+|||+|+........ .......||+.|||||++.+ ..|
T Consensus 177 ~~iiHRDLKp~NILl~~~-------~~~Ki~DFGla~~~~~~~~~--------~~~~~~~gt~~ymAPE~~~~----~~~ 237 (329)
T 4aoj_A 177 LHFVHRDLATRNCLVGQG-------LVVKIGDFGMSRDIYSTDYY--------RVGGRTMLPIRWMPPESILY----RKF 237 (329)
T ss_dssp TTCCCSCCCGGGEEEETT-------TEEEECCCC------------------------CCCCGGGCCHHHHTT----CCC
T ss_pred CCeecccccHhhEEECCC-------CcEEEcccccceeccCCCcc--------eecCcccccccccChhhhcC----CCC
Confidence 999999999999999987 89999999999865432111 11224569999999999986 678
Q ss_pred CchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHH
Q 001142 1028 GLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLV 1106 (1142)
Q Consensus 1028 s~ksDVwSLGviL~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~ 1106 (1142)
+.++|||||||++|||+| |+.||.+.+..++...+..+.++..+. .+++++.
T Consensus 238 ~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~~~~p~---------------------------~~~~~~~ 290 (329)
T 4aoj_A 238 TTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPR---------------------------ACPPEVY 290 (329)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCCCCCCT---------------------------TCCHHHH
T ss_pred CccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCcc---------------------------cccHHHH
Confidence 999999999999999999 899999988888888887766544321 4566799
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001142 1107 DVFRRCTEENPTERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1107 dLI~~CL~~DP~~RPSa~EVL~~L~~~~s 1135 (1142)
+|+.+||+.||++||||.||+++|.....
T Consensus 291 ~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 291 AIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 99999999999999999999999877543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=440.55 Aligned_cols=264 Identities=21% Similarity=0.325 Sum_probs=215.0
Q ss_pred CCCCCCcceeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccce
Q 001142 803 PGSFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 875 (1142)
Q Consensus 803 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~-------~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl 875 (1142)
..++.++++.++||+|+||+||+|++. +..||||+. +.... ....++| .+|+.++++++|||||++
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l--~~~~~-~~~~~~f----~~E~~il~~l~HpNIV~l 94 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL--KDKAE-GPLREEF----RHEAMLRARLQHPNVVCL 94 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEEC--CC-CC-C-CHHHH----HHHHHHHHHCCCTTBCCE
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEE--CcccC-hHHHHHH----HHHHHHHHhCCCCCCCCc
Confidence 345667899999999999999999973 345777764 32221 2223344 899999999999999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc-----------CCCCCCHHHHHHHHHHHHHHHHH
Q 001142 876 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAALVE 944 (1142)
Q Consensus 876 ~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~-----------~~~~ls~~~i~~Ia~qIa~gL~y 944 (1142)
+|++.+++.+ +||||||++|+|.+++...... ....+++..+..|+.||+.||+|
T Consensus 95 ~g~~~~~~~~--------------~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~y 160 (308)
T 4gt4_A 95 LGVVTKDQPL--------------SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEY 160 (308)
T ss_dssp EEEECSSSSC--------------EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHH
T ss_pred ceEEEECCEE--------------EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHH
Confidence 9999876544 9999999999999999752211 12468999999999999999999
Q ss_pred HHhCCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCC
Q 001142 945 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 1024 (1142)
Q Consensus 945 LHs~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~ 1024 (1142)
||+++||||||||+|||++.+ +++||+|||+|+........ .......||+.|||||++.+
T Consensus 161 LH~~~iiHRDLK~~NILl~~~-------~~~Ki~DFGlar~~~~~~~~--------~~~~~~~gt~~ymAPE~l~~---- 221 (308)
T 4gt4_A 161 LSSHHVVHKDLATRNVLVYDK-------LNVKISDLGLFREVYAADYY--------KLLGNSLLPIRWMAPEAIMY---- 221 (308)
T ss_dssp HHHTTCCCSCCSGGGEEECGG-------GCEEECCSCCBCGGGGGGCB--------CSSSSSCBCGGGCCHHHHHH----
T ss_pred HHhCCCCCCCccccceEECCC-------CCEEECCcccceeccCCCce--------eEecccccCCcccCHHHHhC----
Confidence 999999999999999999988 78999999999865432211 12234579999999999986
Q ss_pred CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHH
Q 001142 1025 NLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLS 1103 (1142)
Q Consensus 1025 ~~~s~ksDVwSLGviL~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1103 (1142)
..|+.++|||||||++|||+| |+.||.+.+..++...+..+..++.+. .+++
T Consensus 222 ~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~---------------------------~~~~ 274 (308)
T 4gt4_A 222 GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCPD---------------------------DCPA 274 (308)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTCCCCCCT---------------------------TCCH
T ss_pred CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCcc---------------------------cchH
Confidence 579999999999999999999 899999998888888887665543321 4566
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001142 1104 FLVDVFRRCTEENPTERPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1104 ~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~ 1133 (1142)
.+.+|+.+||+.||++||||.||+++|...
T Consensus 275 ~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 275 WVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 799999999999999999999999998764
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=446.82 Aligned_cols=257 Identities=24% Similarity=0.261 Sum_probs=207.7
Q ss_pred CCCCcceeeeecccCceEEEEEEE-----CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeE
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 879 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~-----~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~ 879 (1142)
+.++|++.+.||+|+||+||+|++ .+..||+|+...... ....... +.+|+++|++++|||||++++++
T Consensus 22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~----~~~E~~il~~l~HpnIv~l~~~~ 95 (304)
T 3ubd_A 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATL--KVRDRVR----TKMERDILVEVNHPFIVKLHYAF 95 (304)
T ss_dssp CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEE--EEEECC----------CCCCCCCCTTEECEEEEE
T ss_pred CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHc--ChHHHHH----HHHHHHHHHHCCCCCCCeEEEEE
Confidence 346899999999999999999987 245689998643221 1111122 37899999999999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 001142 880 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959 (1142)
Q Consensus 880 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~N 959 (1142)
.+++ ..|||||||+||+|.+++++ ...+++.++..|+.||+.||+|||++||+||||||+|
T Consensus 96 ~~~~--------------~~~ivmEy~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N 156 (304)
T 3ubd_A 96 QTEG--------------KLYLILDFLRGGDLFTRLSK-----EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPEN 156 (304)
T ss_dssp EETT--------------EEEEEECCCTTCEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGG
T ss_pred EECC--------------EEEEEEEcCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHH
Confidence 8765 34999999999999999986 2469999999999999999999999999999999999
Q ss_pred eeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001142 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039 (1142)
Q Consensus 960 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGvi 1039 (1142)
||++.+ +.+||+|||+|+...... ......+||+.|||||++.+ ..|+.++|||||||+
T Consensus 157 ILl~~~-------g~vKl~DFGla~~~~~~~----------~~~~~~~GT~~YmAPE~~~~----~~y~~~~DiwSlGvi 215 (304)
T 3ubd_A 157 ILLDEE-------GHIKLTDFGLSKESIDHE----------KKAYSFCGTVEYMAPEVVNR----RGHTQSADWWSFGVL 215 (304)
T ss_dssp EEECTT-------SCEEEESSEEEEC---------------CCCCSCCCCGGGCCHHHHHT----SCCCTHHHHHHHHHH
T ss_pred eEEcCC-------CCEEecccccceeccCCC----------ccccccccCcccCCHHHhcc----CCCCCCCcccchHHH
Confidence 999987 789999999997543311 11234679999999999976 678999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001142 1040 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1119 (1142)
Q Consensus 1040 L~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~ 1119 (1142)
+|||+||+.||.+.+..++...+..+..+. + ...++++.+||.+||+.||++
T Consensus 216 lyemltG~~PF~~~~~~~~~~~i~~~~~~~-p---------------------------~~~s~~~~~li~~~L~~dP~~ 267 (304)
T 3ubd_A 216 MFEMLTGTLPFQGKDRKETMTMILKAKLGM-P---------------------------QFLSPEAQSLLRMLFKRNPAN 267 (304)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-C---------------------------TTSCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHhCCCCCCCcCHHHHHHHHHcCCCCC-C---------------------------CcCCHHHHHHHHHHcccCHHH
Confidence 999999999999988888888876554321 1 034567999999999999999
Q ss_pred CCC-----HHHHHHHHHhhcC
Q 001142 1120 RPT-----AGDLYEMFVARTS 1135 (1142)
Q Consensus 1120 RPS-----a~EVL~~L~~~~s 1135 (1142)
||| ++|+++|+|++.-
T Consensus 268 R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 268 RLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp STTCSTTTHHHHHTSGGGTTC
T ss_pred CCCCCcCCHHHHHcCccccCC
Confidence 998 5899999999753
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=442.43 Aligned_cols=254 Identities=24% Similarity=0.322 Sum_probs=204.5
Q ss_pred CCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
++.|++.++||+|+||+||+|++. +..||+|+.+.+.. . .+|+.+|++++|||||++++++.+.+
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~---------~----~~E~~il~~l~HpnIV~l~~~~~~~~ 123 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF---------R----VEELVACAGLSSPRIVPLYGAVREGP 123 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---------C----THHHHTTTTCCCTTBCCEEEEEEETT
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh---------H----HHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 456899999999999999999984 67788888654321 1 37999999999999999999998765
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
.+|||||||+||+|.+++++ ...+++..+..|+.||+.||+|||++|||||||||+|||++
T Consensus 124 --------------~~~ivmEy~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 184 (336)
T 4g3f_A 124 --------------WVNIFMELLEGGSLGQLIKQ-----MGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS 184 (336)
T ss_dssp --------------EEEEEECCCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEC
T ss_pred --------------EEEEEEeccCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEe
Confidence 34999999999999999986 24699999999999999999999999999999999999998
Q ss_pred cccccCCCCC-eEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 964 LERKKADGKP-VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 964 ~~~~~~~~~~-~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
.+ + .+||+|||+|+.+....... ........+||+.|||||++.+ ..|+.++|||||||++||
T Consensus 185 ~~-------g~~vKl~DFGla~~~~~~~~~~-----~~~~~~~~~GT~~YmAPE~~~~----~~y~~~~DiwSlGvilye 248 (336)
T 4g3f_A 185 SD-------GSRAALCDFGHALCLQPDGLGK-----SLLTGDYIPGTETHMAPEVVMG----KPCDAKVDIWSSCCMMLH 248 (336)
T ss_dssp TT-------SCCEEECCCTTCEEC-----------------CCCCCCGGGCCHHHHTT----CCCCTHHHHHHHHHHHHH
T ss_pred CC-------CCEEEEeeCCCCeEccCCCccc-----ceecCCccccCccccCHHHHCC----CCCCcHHHHHHHHHHHHH
Confidence 76 4 69999999998764322110 0112234579999999999986 678999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1043 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1043 LLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
|++|+.||.+.+..++...+.....+.. .....+++.+.+||.+||+.||.+|||
T Consensus 249 mltG~~Pf~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s 303 (336)
T 4g3f_A 249 MLNGCHPWTQYFRGPLCLKIASEPPPIR-------------------------EIPPSCAPLTAQAIQEGLRKEPVHRAS 303 (336)
T ss_dssp HHHSSCSSTTTCCSCCHHHHHHSCCGGG-------------------------GSCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHCcCCCCCCCHHHHHHHHHcCCCCch-------------------------hcCccCCHHHHHHHHHHccCCHhHCcC
Confidence 9999999988766666666654432110 001155678999999999999999999
Q ss_pred HHHHHHHHHh
Q 001142 1123 AGDLYEMFVA 1132 (1142)
Q Consensus 1123 a~EVL~~L~~ 1132 (1142)
+.|+++++..
T Consensus 304 a~el~~~l~~ 313 (336)
T 4g3f_A 304 AMELRRKVGK 313 (336)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999877654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=436.83 Aligned_cols=292 Identities=16% Similarity=0.204 Sum_probs=214.3
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
++|++.++||+|+||+||+|++. +..||+|+.+ .........+. +.+|+.+|++++|||||++++++.....
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~--~~~~~~~~~~~----~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 127 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIP--NAFDVVTNAKR----TLRELKILKHFKHDNIIAIKDILRPTVP 127 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEET--TTTSSHHHHHH----HHHHHHHHHHCCCTTBCCEEEECCCSSC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEEC--ccccchHHHHH----HHHHHHHHHhcCCCCcceEeeeeecccc
Confidence 46999999999999999999984 6678888753 33333333333 4799999999999999999999876432
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
+ ....++|||||||+ |+|.+++.. ...+++..++.|++||+.||+|||++|||||||||+|||++.
T Consensus 128 ~--------~~~~~~~ivmE~~~-g~L~~~i~~-----~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~ 193 (398)
T 4b99_A 128 Y--------GEFKSVYVVLDLME-SDLHQIIHS-----SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNE 193 (398)
T ss_dssp T--------TTCCCEEEEEECCS-EEHHHHHTS-----SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT
T ss_pred c--------ccCCEEEEEEeCCC-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCC
Confidence 2 12236799999996 789999864 357999999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||+|||+|+.+...... ........+||+.|||||++.+ ...|+.++||||+||++|||+
T Consensus 194 ~-------~~~Ki~DFGla~~~~~~~~~------~~~~~~~~~GT~~Y~APEv~~~---~~~~~~~~DiWSlG~il~ell 257 (398)
T 4b99_A 194 N-------CELKIGDFGMARGLCTSPAE------HQYFMTEYVATRWYRAPELMLS---LHEYTQAIDLWSVGCIFGEML 257 (398)
T ss_dssp T-------CCEEECCCTTCBCC-------------CCCCCSSCCCCTTCCHHHHTT---CSCCCTHHHHHHHHHHHHHHH
T ss_pred C-------CCEEEeecceeeecccCccc------cccccccceeChHhcCHHHhcC---CCCCCChhheehhHHHHHHHH
Confidence 7 88999999999865432111 1112335689999999999876 245789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCC---chhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK---PEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
+|++||.+.+..+....|...........+.................... .......++++.+||.+||+.||.+||
T Consensus 258 ~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ 337 (398)
T 4b99_A 258 ARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARI 337 (398)
T ss_dssp HTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSC
T ss_pred HCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCc
Confidence 99999999888887777743322111111111000000000000000000 011114567899999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 001142 1122 TAGDLYEMFVART 1134 (1142)
Q Consensus 1122 Sa~EVL~~L~~~~ 1134 (1142)
||.|+++|+|++.
T Consensus 338 ta~e~L~Hp~f~~ 350 (398)
T 4b99_A 338 SAAAALRHPFLAK 350 (398)
T ss_dssp CHHHHTTSGGGTT
T ss_pred CHHHHhcCHhhCc
Confidence 9999999999975
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=421.33 Aligned_cols=277 Identities=24% Similarity=0.285 Sum_probs=192.9
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
.+|++.+.||+|+||+||+|++. +..||+|+..... .....+ ++.+|+.+|++++|||||++++++.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~----~~~~E~~il~~l~HpnIV~~~~~~~~~~~ 77 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELARE----KVMREVKALAKLEHPGIVRYFNAWLEKNT 77 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS---SHHHHH----HHHHHHHHHTTCCCTTBCCEEEEEEEEC-
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC---CHHHHH----HHHHHHHHHHhCCCCCCCeEEEEEEecCc
Confidence 46899999999999999999984 6678888764332 222233 34899999999999999999999876442
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
.... .......++|+|||||++|+|.++++.. ......++..++.|+.||+.||+|||++|||||||||+|||++.
T Consensus 78 ~~~~--~~~~~~~~l~ivmE~~~gg~L~~~l~~~--~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~ 153 (299)
T 4g31_A 78 TEKL--QPSSPKVYLYIQMQLCRKENLKDWMNGR--CTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTM 153 (299)
T ss_dssp -----------CEEEEEEEECCCSCCHHHHHHTC--CSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT
T ss_pred cccc--cccCCCcEEEEEEecCCCCcHHHHHHhc--CCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECC
Confidence 1000 0011223579999999999999999752 11123566778999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccc--cCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA--HRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~--~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
+ +.+||+|||+|+.+.......... ..........+||+.|||||++.+ ..|+.++|||||||++||
T Consensus 154 ~-------~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~----~~y~~~~DiwSlGvilye 222 (299)
T 4g31_A 154 D-------DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG----NSYSHKVDIFSLGLILFE 222 (299)
T ss_dssp T-------CCEEECCCCCC--------------------------CCCTTSCHHHHTT----CCCCTHHHHHHHHHHHHH
T ss_pred C-------CcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcC----CCCCCHHHHHHHHHHHHH
Confidence 7 789999999998765432111000 000111234579999999999986 679999999999999999
Q ss_pred HHhCCCCCCCCCHH-HHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1043 LLTLQVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1043 LLtG~~Pf~~~~~~-el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
|++ ||.+.... .....+.....|.. ....++.+.+||.+||+.||++||
T Consensus 223 ll~---Pf~~~~~~~~~~~~~~~~~~p~~---------------------------~~~~~~~~~~li~~~L~~dP~~Rp 272 (299)
T 4g31_A 223 LLY---PFSTQMERVRTLTDVRNLKFPPL---------------------------FTQKYPCEYVMVQDMLSPSPMERP 272 (299)
T ss_dssp HHS---CCSSHHHHHHHHHHHHTTCCCHH---------------------------HHHHCHHHHHHHHHHTCSSGGGSC
T ss_pred Hcc---CCCCccHHHHHHHHHhcCCCCCC---------------------------CcccCHHHHHHHHHHcCCChhHCc
Confidence 996 78642211 12222332222211 113345578899999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001142 1122 TAGDLYEMFVARTS 1135 (1142)
Q Consensus 1122 Sa~EVL~~L~~~~s 1135 (1142)
|+.|+++|+|++.-
T Consensus 273 s~~eil~h~~~~~~ 286 (299)
T 4g31_A 273 EAINIIENAVFEDL 286 (299)
T ss_dssp CHHHHHTSGGGCCC
T ss_pred CHHHHhcCHhhCCC
Confidence 99999999999854
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-46 Score=419.43 Aligned_cols=266 Identities=25% Similarity=0.296 Sum_probs=199.2
Q ss_pred CcceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 887 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~ 887 (1142)
+|.+.++||+|+||+||+|+++++.||||+...+ ..+.+ ....|+..+.+++|||||++++++.+++.
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~-------~~~~~--~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~--- 71 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR-------EERSW--FREAEIYQTVMLRHENILGFIAADNKDNG--- 71 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTEEEEEEEECGG-------GHHHH--HHHHHHHTSTTCCCTTBCCEEEEEEEECS---
T ss_pred EEEEEEEEeeCCCeEEEEEEECCEEEEEEEECcc-------chhhH--HHHHHHHHHhcCCCCCCCcEEEEEEecCC---
Confidence 5889999999999999999999999999986422 11122 12456777778999999999999986432
Q ss_pred CCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CccccCCCCCC
Q 001142 888 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK--------HIMHRDIKSEN 959 (1142)
Q Consensus 888 ~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~--------gIvHrDLKp~N 959 (1142)
...++|||||||++|+|.++++. ..+++..+.+|+.|++.||+|||++ +||||||||+|
T Consensus 72 -------~~~~~~lV~Ey~~~gsL~~~l~~------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~N 138 (303)
T 3hmm_A 72 -------TWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKN 138 (303)
T ss_dssp -------SSEEEEEEEECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGG
T ss_pred -------CceEEEEEecCCCCCcHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCccc
Confidence 12357999999999999999976 3589999999999999999999987 99999999999
Q ss_pred eeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccC--CCCCCchhhHHHHH
Q 001142 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK--PNLYGLEVDIWSYG 1037 (1142)
Q Consensus 960 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~--~~~~s~ksDVwSLG 1037 (1142)
||++.+ +++||+|||+|+......... .......+||+.|||||++.+... ...|+.++||||||
T Consensus 139 ILl~~~-------~~~Ki~DFGla~~~~~~~~~~------~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~G 205 (303)
T 3hmm_A 139 ILVKKN-------GTCCIADLGLAVRHDSATDTI------DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG 205 (303)
T ss_dssp EEECTT-------SCEEECCCTTCEEEETTTTEE------SCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHH
T ss_pred EEECCC-------CCEEEEeCCCCccccCCCCce------eeecccccccccccCHHHhcccccccCCccChhHhhhhHH
Confidence 999988 889999999998654432211 011234579999999999975321 12467899999999
Q ss_pred HHHHHHHhCCCCCCCC---------------CHHHHHHHH-HhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhh
Q 001142 1038 CLLLELLTLQVPYMGL---------------SELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELET 1101 (1142)
Q Consensus 1038 viL~ELLtG~~Pf~~~---------------~~~el~~~I-~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1101 (1142)
|++|||+||..||... ...++...+ ....+|.++... ...+.
T Consensus 206 vvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~----------------------~~~~~ 263 (303)
T 3hmm_A 206 LVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRW----------------------QSCEA 263 (303)
T ss_dssp HHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGG----------------------GSSHH
T ss_pred HHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccc----------------------cchHH
Confidence 9999999997766321 112222222 122223222211 11155
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001142 1102 LSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1102 ~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~ 1133 (1142)
++.+.+|+.+||+.||++||||.||+++|...
T Consensus 264 ~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 264 LRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp HHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 67899999999999999999999999998764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=427.55 Aligned_cols=262 Identities=23% Similarity=0.365 Sum_probs=208.1
Q ss_pred CCCcceeeeecccCceEEEEEEECC-------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceee
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYG 877 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~~-------~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~g 877 (1142)
.++|++.++||+|+||+||+|++.+ +.||||+.. .. ......+.| .+|+.+|+++. |||||+++|
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~--~~-~~~~~~~~~----~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK--EG-ATHSEHRAL----MSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEEC--TT-CCHHHHHHH----HHHHHHHHHHCCCTTBCCEEE
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEc--cc-cChHHHHHH----HHHHHHHHHcCCCCcEEEEEE
Confidence 4679999999999999999999743 346666643 21 223334444 89999999996 599999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc-----------CCCCCCHHHHHHHHHHHHHHHHHHH
Q 001142 878 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAALVELH 946 (1142)
Q Consensus 878 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~-----------~~~~ls~~~i~~Ia~qIa~gL~yLH 946 (1142)
++.+++. .++||||||++|+|.++++..... ....+++..+..|+.|||.||+|||
T Consensus 136 ~~~~~~~-------------~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH 202 (353)
T 4ase_A 136 ACTKPGG-------------PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA 202 (353)
T ss_dssp EECCTTS-------------CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEecCC-------------EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh
Confidence 9865321 249999999999999999864321 1245899999999999999999999
Q ss_pred hCCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCC
Q 001142 947 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 1026 (1142)
Q Consensus 947 s~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 1026 (1142)
+++||||||||+|||++.+ +++||+|||+|+.+...... .......||+.|||||++.+ ..
T Consensus 203 ~~~iiHRDLK~~NILl~~~-------~~vKi~DFGlar~~~~~~~~--------~~~~~~~gt~~ymAPE~l~~----~~ 263 (353)
T 4ase_A 203 SRKCIHRDLAARNILLSEK-------NVVKICDFGLARDIYKDPDY--------VRKGDARLPLKWMAPETIFD----RV 263 (353)
T ss_dssp HTTCCCSCCSGGGEEECGG-------GCEEECCCGGGSCTTTCTTS--------EEETTEEECGGGCCHHHHHH----CC
T ss_pred hCCeecCccCccceeeCCC-------CCEEECcchhhhhcccCCCc--------eeeccccccccccCHHHHhc----CC
Confidence 9999999999999999988 78999999999865432211 01124568999999999987 67
Q ss_pred CCchhhHHHHHHHHHHHHh-CCCCCCCCCH-HHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHH
Q 001142 1027 YGLEVDIWSYGCLLLELLT-LQVPYMGLSE-LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF 1104 (1142)
Q Consensus 1027 ~s~ksDVwSLGviL~ELLt-G~~Pf~~~~~-~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1104 (1142)
|+.++|||||||++|||+| |+.||.+... ..+...+..+.++..+. .++++
T Consensus 264 y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~---------------------------~~~~~ 316 (353)
T 4ase_A 264 YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD---------------------------YTTPE 316 (353)
T ss_dssp CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCT---------------------------TCCHH
T ss_pred CCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCCc---------------------------cCCHH
Confidence 9999999999999999998 8999987653 44556666665544332 44567
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001142 1105 LVDVFRRCTEENPTERPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1105 L~dLI~~CL~~DP~~RPSa~EVL~~L~~~ 1133 (1142)
+.+++.+||+.||++||||.||++||...
T Consensus 317 ~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 317 MYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 99999999999999999999999998653
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=415.34 Aligned_cols=286 Identities=19% Similarity=0.165 Sum_probs=198.0
Q ss_pred CCcceeeeecccCceEEEEEEEC-----CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEe
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 880 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~-----~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~~ 880 (1142)
+.|++.++||+|+||+||+|++. +..||+|+. .... ... ++.+|+++|+.+ +|||||++++++.
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i--~~~~----~~~----~~~~E~~~l~~~~~h~nIv~l~~~~~ 90 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHL--IPTS----HPI----RIAAELQCLTVAGGQDNVMGVKYCFR 90 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEE--CTTS----CHH----HHHHHHHHHHHTCSBTTBCCCSEEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEE--cccc----CHH----HHHHHHHHHHHhcCCCCCceEEEEEE
Confidence 46999999999999999999862 345777754 2211 111 237899999998 6999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NI 960 (1142)
+.+ +.|+||||++||+|.++++ .+++.+++.++.||+.||+|||++||+||||||+||
T Consensus 91 ~~~--------------~~~lvmE~~~g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNi 148 (361)
T 4f9c_A 91 KND--------------HVVIAMPYLEHESFLDILN--------SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNF 148 (361)
T ss_dssp ETT--------------EEEEEEECCCCCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred ECC--------------EEEEEEeCCCcccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHe
Confidence 765 4599999999999999884 389999999999999999999999999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCccccccccccccc------------------ccCCCCCCCCccCCCcccchhhhcccc
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI------------------AHRGIPAPDVCVGTPRWMAPEVLRAMH 1022 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~------------------~~~~~~~~~~~~GT~~Y~APE~l~~~~ 1022 (1142)
|++.+. +.+||+|||+|+........... ...........+||+.|||||++.+
T Consensus 149 Ll~~~~------~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-- 220 (361)
T 4f9c_A 149 LYNRRL------KKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTK-- 220 (361)
T ss_dssp EEETTT------TEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTT--
T ss_pred EEeCCC------CeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcC--
Confidence 997652 68999999999764332110000 0000011234579999999999876
Q ss_pred CCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhCCC-CCc----------------------hhHHhhhc
Q 001142 1023 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGL-SELEIHDLIQMGKR-PRL----------------------TDELEALG 1078 (1142)
Q Consensus 1023 ~~~~~s~ksDVwSLGviL~ELLtG~~Pf~~~-~~~el~~~I~~~~~-p~l----------------------~~~l~~~~ 1078 (1142)
...|+.++||||+||++|||++|+.||... +..+....|..... +.. ........
T Consensus 221 -~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 299 (361)
T 4f9c_A 221 -CPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLR 299 (361)
T ss_dssp -CSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC
T ss_pred -CCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhc
Confidence 245889999999999999999999999643 34444444321100 000 00000000
Q ss_pred ccccccccccC----CCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001142 1079 SCHEHEVAQSG----SGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1134 (1142)
Q Consensus 1079 ~~~~~~~~~~~----~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~~ 1134 (1142)
. ......... ............++++.+||.+||+.||++||||+|+++|+|++.
T Consensus 300 ~-~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 300 G-MDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp -----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred c-ccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 0 000000000 000000011245678999999999999999999999999999974
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=436.16 Aligned_cols=261 Identities=21% Similarity=0.261 Sum_probs=215.6
Q ss_pred CCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
+++|++.+.||+|+||+||+|++ .+..+|+|+.... .....+. +.+|+.+|++++|||||+++++|.+..
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~----~~~~~~~----~~~Ei~il~~l~hpnIv~l~~~~~~~~ 227 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKET----VRKEIQTMSVLRHPTLVNLHDAFEDDN 227 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SHHHHHH----HHHHHHHHHHTCCTTBCCEEEEEECSS
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc----chhhHHH----HHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 46899999999999999999998 4667888875432 2233333 479999999999999999999998765
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
++|||||||+||+|.+++.. ....+++.++..|+.||+.||+|||++||+||||||+|||++
T Consensus 228 --------------~~~iv~E~~~gg~L~~~i~~----~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~ 289 (573)
T 3uto_A 228 --------------EMVMIYEFMSGGELFEKVAD----EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFT 289 (573)
T ss_dssp --------------EEEEEEECCCCCBHHHHHTC----TTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES
T ss_pred --------------EEEEEEeecCCCcHHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhcccc
Confidence 45999999999999999853 234699999999999999999999999999999999999997
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+. .+.+||+|||+|+.+...... ...+||+.|||||++.+ ..|+.++|||||||++|||
T Consensus 290 ~~~-----~~~vKl~DFG~a~~~~~~~~~-----------~~~~GT~~y~APEv~~~----~~y~~~~DiWSlGvilyem 349 (573)
T 3uto_A 290 TKR-----SNELKLIDFGLTAHLDPKQSV-----------KVTTGTAEFAAPEVAEG----KPVGYYTDMWSVGVLSYIL 349 (573)
T ss_dssp SSS-----CCCEEECCCSSCEECCTTSEE-----------EEECSSGGGCCHHHHTT----CCBCHHHHHHHHHHHHHHH
T ss_pred CCC-----CCCEEEeeccceeEccCCCce-----------eeeEECccccCHHHhCC----CCCCcHHHHHHHHHHHHHH
Confidence 542 268999999999876542211 24479999999999986 6789999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
++|+.||.+.+..+.+..|........... ....++.+.+||.+||+.||.+|||+
T Consensus 350 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~------------------------~~~~s~~~~dli~~~L~~dp~~R~t~ 405 (573)
T 3uto_A 350 LSGLSPFGGENDDETLRNVKSCDWNMDDSA------------------------FSGISEDGKDFIRKLLLADPNTRMTI 405 (573)
T ss_dssp HHSCCSSCCSSHHHHHHHHHTTCCCCCSGG------------------------GTTSCHHHHHHHHTTSCSSGGGSCCH
T ss_pred HHCCCCCCCcCHHHHHHHHHhCCCCCCccc------------------------ccCCCHHHHHHHHHHccCChhHCcCH
Confidence 999999999888888888765543211110 01456779999999999999999999
Q ss_pred HHHHHHHHhhcCC
Q 001142 1124 GDLYEMFVARTSS 1136 (1142)
Q Consensus 1124 ~EVL~~L~~~~ss 1136 (1142)
.|+++|+|++...
T Consensus 406 ~e~l~Hpw~~~~~ 418 (573)
T 3uto_A 406 HQALEHPWLTPGN 418 (573)
T ss_dssp HHHHHSTTTSCCC
T ss_pred HHHhcCcCcCCCC
Confidence 9999999998653
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=438.08 Aligned_cols=262 Identities=20% Similarity=0.238 Sum_probs=207.4
Q ss_pred CCCCCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001142 803 PGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 880 (1142)
Q Consensus 803 ~~~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~ 880 (1142)
+.++++|++.++||+|+||+||+|++ .+..+|+|+.......... ..........++.+++.++|||||+++++|.
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~--~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~ 262 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--GETLALNERIMLSLVSTGDCPFIVCMSYAFH 262 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTT--CHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhh--hHHHHHHHHHHHHHHhhCCCCCEeEEEEEEE
Confidence 56789999999999999999999998 4677888886432110000 0111011134567778889999999999999
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NI 960 (1142)
+.+. +|||||||+||+|.+++.+ ...+++..++.|+.||+.||+|||++|||||||||+||
T Consensus 263 ~~~~--------------lylVmEy~~GGdL~~~l~~-----~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNI 323 (689)
T 3v5w_A 263 TPDK--------------LSFILDLMNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANI 323 (689)
T ss_dssp CSSE--------------EEEEECCCCSCBHHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGE
T ss_pred ECCE--------------EEEEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHe
Confidence 7664 5999999999999999986 24699999999999999999999999999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
|++.+ +++||+|||+|+.+... .....+||+.|||||++.. +..|+.++|||||||++
T Consensus 324 Lld~~-------G~vKL~DFGlA~~~~~~------------~~~t~~GTp~YmAPEvl~~---~~~y~~~vDiWSLGvil 381 (689)
T 3v5w_A 324 LLDEH-------GHVRISDLGLACDFSKK------------KPHASVGTHGYMAPEVLQK---GVAYDSSADWFSLGCML 381 (689)
T ss_dssp EECTT-------SCEEECCCTTCEECSSC------------CCCSCCSCGGGCCHHHHST---TCCCCTHHHHHHHHHHH
T ss_pred EEeCC-------CCEEecccceeeecCCC------------CCCCccCCcCccCHHHHhC---CCCCCcHHHHHHHHHHH
Confidence 99987 89999999999765431 1234579999999999864 24689999999999999
Q ss_pred HHHHhCCCCCCCC---CHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001142 1041 LELLTLQVPYMGL---SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1117 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~~---~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP 1117 (1142)
|||++|++||.+. ...++...+..... .++ ...++++.+||.+||+.||
T Consensus 382 YEmLtG~~PF~~~~~~~~~~i~~~i~~~~~-~~p---------------------------~~~S~~a~dLI~~lL~~dP 433 (689)
T 3v5w_A 382 FKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-ELP---------------------------DSFSPELRSLLEGLLQRDV 433 (689)
T ss_dssp HHHHHSSCTTCGGGCCCHHHHHHHHHHCCC-CCC---------------------------TTSCHHHHHHHHHHTCSCG
T ss_pred HHHHhCCCCCCCCChHHHHHHHHhhcCCCC-CCC---------------------------ccCCHHHHHHHHHHccCCH
Confidence 9999999999753 22333444333221 111 1456679999999999999
Q ss_pred CCCCC-----HHHHHHHHHhhcC
Q 001142 1118 TERPT-----AGDLYEMFVARTS 1135 (1142)
Q Consensus 1118 ~~RPS-----a~EVL~~L~~~~s 1135 (1142)
.+|++ ++||++|+||+.-
T Consensus 434 ~~Rl~~~~~ga~ei~~HpfF~~i 456 (689)
T 3v5w_A 434 NRRLGCLGRGAQEVKESPFFRSL 456 (689)
T ss_dssp GGCTTCSSSTHHHHTTSGGGTTC
T ss_pred hHCCCCCCCCHHHHhcCccccCC
Confidence 99998 8999999999754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=380.19 Aligned_cols=260 Identities=25% Similarity=0.431 Sum_probs=212.2
Q ss_pred CCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
..+|++.++||+|+||+||+|.+ .+..+|+|+....... ..+. +.+|+.++++++||||+++++++...+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~----~~~E~~~l~~l~hp~iv~~~~~~~~~~ 90 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP----KKEL----IINEILVMRENKNPNIVNYLDSYLVGD 90 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS----CHHH----HHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc----HHHH----HHHHHHHHhcCCCCCCCeEeEEEEECC
Confidence 45799999999999999999986 5677888886544321 1222 378999999999999999999998655
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
..++||||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 91 --------------~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~ 150 (297)
T 3fxz_A 91 --------------ELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG 150 (297)
T ss_dssp --------------EEEEEEECCTTCBHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred --------------EEEEEEECCCCCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEC
Confidence 34999999999999999976 3589999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 151 ~~-------~~~kl~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~el 209 (297)
T 3fxz_A 151 MD-------GSVKLTDFGFCAQITPEQS----------KRSTMVGTPYWMAPEVVTR----KAYGPKVDIWSLGIMAIEM 209 (297)
T ss_dssp TT-------CCEEECCCTTCEECCSTTC----------CBCCCCSCGGGCCHHHHHC----SCBCTHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEeeCCCceecCCccc----------ccCCccCCcCccChhhhcC----CCCCcHHHHHHHHHHHHHH
Confidence 87 7899999999876543211 1224569999999999876 5688999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
++|+.||.+.........+.....+.... ....++.+.+++.+||+.||++|||+
T Consensus 210 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~li~~~l~~dp~~Rps~ 264 (297)
T 3fxz_A 210 IEGEPPYLNENPLRALYLIATNGTPELQN-------------------------PEKLSAIFRDFLNRCLEMDVEKRGSA 264 (297)
T ss_dssp HHSSCTTTTSCHHHHHHHHHHHCSCCCSC-------------------------GGGSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCCCC-------------------------ccccCHHHHHHHHHHccCChhHCcCH
Confidence 99999998877766555543332222110 11456679999999999999999999
Q ss_pred HHHHHHHHhhcCCCCC
Q 001142 1124 GDLYEMFVARTSSSIS 1139 (1142)
Q Consensus 1124 ~EVL~~L~~~~ss~~s 1139 (1142)
.|+++|+|++...+.+
T Consensus 265 ~ell~h~~~~~~~~~~ 280 (297)
T 3fxz_A 265 KELLQHQFLKIAKPLS 280 (297)
T ss_dssp HHHTTCGGGGGCCCGG
T ss_pred HHHhhChhhcccCccc
Confidence 9999999999765543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=384.28 Aligned_cols=258 Identities=24% Similarity=0.350 Sum_probs=213.0
Q ss_pred CCCCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001142 804 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 881 (1142)
Q Consensus 804 ~~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~ 881 (1142)
..+.+|++.+.||+|+||.||+|++ .+..||+|+.... .......+.+ .+|+.++++++||||+++++++.+
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~----~~E~~~l~~l~hpnIv~l~~~~~~ 85 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKT--QLNPTSLQKL----FREVRIMKILNHPNIVKLFEVIET 85 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGG--GSCHHHHHHH----HHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhh--cCCHHHHHHH----HHHHHHHHhCCCCCEeeEEEEEEE
Confidence 3467899999999999999999998 5678888886433 2233333333 799999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 001142 882 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 961 (1142)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NIL 961 (1142)
.+ ..++||||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 86 ~~--------------~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIl 146 (328)
T 3fe3_A 86 EK--------------TLYLIMEYASGGEVFDYLVAH-----GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLL 146 (328)
T ss_dssp SS--------------EEEEEECCCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred CC--------------EEEEEEECCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEE
Confidence 55 359999999999999999762 46999999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001142 962 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1041 (1142)
Q Consensus 962 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ 1041 (1142)
++.+ +.+||+|||++........ .....||+.|+|||++.+. ...+.++|||||||++|
T Consensus 147 l~~~-------~~~kl~DFG~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~ 205 (328)
T 3fe3_A 147 LDAD-------MNIKIADFGFSNEFTVGGK-----------LDAFCGAPPYAAPELFQGK---KYDGPEVDVWSLGVILY 205 (328)
T ss_dssp ECTT-------SCEEECSTTCCGGGSSSCG-----------GGTTSSSGGGCCHHHHHTC---CCCSHHHHHHHHHHHHH
T ss_pred EcCC-------CCEEEeeccCceecCCCCc-----------cccccCCcceeCcccccCC---CcCCchhhhhhhHHHHH
Confidence 9887 7899999999975543211 1244699999999999762 23358999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1042 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1042 ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
+|++|+.||.+.+..++...+..+.... + ...++.+.+|+.+||+.||.+||
T Consensus 206 ell~g~~pf~~~~~~~~~~~i~~~~~~~-p---------------------------~~~s~~~~~li~~~L~~dP~~R~ 257 (328)
T 3fe3_A 206 TLVSGSLPFDGQNLKELRERVLRGKYRI-P---------------------------FYMSTDCENLLKRFLVLNPIKRG 257 (328)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHCCCCC-C---------------------------TTSCHHHHHHHHHHCCSSTTTSC
T ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCC-C---------------------------CCCCHHHHHHHHHHCCCChhHCc
Confidence 9999999999988887777775543211 1 03456689999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001142 1122 TAGDLYEMFVARTS 1135 (1142)
Q Consensus 1122 Sa~EVL~~L~~~~s 1135 (1142)
|++|+++|+|+...
T Consensus 258 t~~eil~h~~~~~~ 271 (328)
T 3fe3_A 258 TLEQIMKDRWINAG 271 (328)
T ss_dssp CHHHHTTCTTTTTT
T ss_pred CHHHHhcCHhhcCC
Confidence 99999999999754
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=378.16 Aligned_cols=259 Identities=21% Similarity=0.277 Sum_probs=211.8
Q ss_pred CCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
.++|++.+.||+|+||+||+|.+. +..+|+|+.... ...... +.+|+.+++.++||||+++++++.+.+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-----~~~~~~----~~~E~~~l~~l~hpnIv~~~~~~~~~~ 74 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-----GTDQVL----VKKEISILNIARHRNILHLHESFESME 74 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-----THHHHH----HHHHHHHHHHSCCTTBCCEEEEEEETT
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-----cccHHH----HHHHHHHHHhCCCCCCCeEeEEEecCC
Confidence 457999999999999999999985 566777775422 222233 379999999999999999999998655
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
..++||||+++++|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 75 --------------~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~ 136 (321)
T 1tki_A 75 --------------ELVMIFEFISGLDIFERINT----SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQ 136 (321)
T ss_dssp --------------EEEEEECCCCCCBHHHHHTS----SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES
T ss_pred --------------EEEEEEEeCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEc
Confidence 35999999999999999854 234699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+. .+.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 137 ~~~-----~~~~kl~Dfg~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~~l 196 (321)
T 1tki_A 137 TRR-----SSTIKIIEFGQARQLKPGDN-----------FRLLFTAPEYYAPEVHQH----DVVSTATDMWSLGTLVYVL 196 (321)
T ss_dssp SSS-----CCCEEECCCTTCEECCTTCE-----------EEEEESCGGGSCHHHHTT----CEECHHHHHHHHHHHHHHH
T ss_pred cCC-----CCCEEEEECCCCeECCCCCc-----------cccccCChhhcCcHHhcC----CCCCchhhHHHHHHHHHHH
Confidence 631 17899999999976543211 123468999999999876 4578999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
++|..||.+....+....+...........+ ...++.+.+++.+||..||.+|||+
T Consensus 197 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~------------------------~~~s~~~~~li~~~L~~dp~~Rpt~ 252 (321)
T 1tki_A 197 LSGINPFLAETNQQIIENIMNAEYTFDEEAF------------------------KEISIEAMDFVDRLLVKERKSRMTA 252 (321)
T ss_dssp HHSSCTTCCSSHHHHHHHHHHTCCCCCHHHH------------------------TTSCHHHHHHHHTTSCSSGGGSCCH
T ss_pred HhCCCCCcCCCHHHHHHHHHcCCCCCChhhh------------------------ccCCHHHHHHHHHHcCCChhHCcCH
Confidence 9999999988887777777655433222111 1456679999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 001142 1124 GDLYEMFVARTS 1135 (1142)
Q Consensus 1124 ~EVL~~L~~~~s 1135 (1142)
.|+++|+|++..
T Consensus 253 ~e~l~hp~~~~~ 264 (321)
T 1tki_A 253 SEALQHPWLKQK 264 (321)
T ss_dssp HHHHHSHHHHSC
T ss_pred HHHhcChhhccC
Confidence 999999999864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=385.15 Aligned_cols=265 Identities=22% Similarity=0.276 Sum_probs=212.5
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
+.|++.+.||+|+||+||+|++. +..+|+|+........... ......+.+|+.++++++||||+++++++.+..
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~- 88 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRR--GVCREEIEREVSILRQVLHPNIITLHDVYENRT- 88 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSS--SBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccc--hhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC-
Confidence 45999999999999999999984 6778999865443221110 001123479999999999999999999998654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
..++||||++|++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 89 -------------~~~lv~e~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~ 150 (361)
T 2yab_A 89 -------------DVVLILELVSGGELFDFLAQ-----KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLD 150 (361)
T ss_dssp -------------EEEEEEECCCSCBHHHHHTT-----CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESC
T ss_pred -------------EEEEEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeC
Confidence 45999999999999999864 357999999999999999999999999999999999999976
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
++. ....+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 151 ~~~---~~~~vkl~DFG~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslGvil~~ll 212 (361)
T 2yab_A 151 KNI---PIPHIKLIDFGLAHEIEDGV-----------EFKNIFGTPEFVAPEIVNY----EPLGLEADMWSIGVITYILL 212 (361)
T ss_dssp TTS---SSCCEEECCCSSCEECCTTC-----------CCCCCCSCGGGCCHHHHTT----CCCCTHHHHHHHHHHHHHHH
T ss_pred CCC---CccCEEEEecCCceEcCCCC-----------ccccCCCCccEECchHHcC----CCCCccccHHHHHHHHHHHH
Confidence 520 11279999999997654321 1124469999999999875 56899999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~ 1124 (1142)
+|..||.+.+..+....+..+........+ ...++.+.+||.+||..||.+|||+.
T Consensus 213 ~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~------------------------~~~s~~~~~li~~~L~~dP~~R~t~~ 268 (361)
T 2yab_A 213 SGASPFLGDTKQETLANITAVSYDFDEEFF------------------------SQTSELAKDFIRKLLVKETRKRLTIQ 268 (361)
T ss_dssp HSCCSSCCSSHHHHHHHHHTTCCCCCHHHH------------------------TTSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred hCCCCCCCCCHHHHHHHHHhcCCCCCchhc------------------------cCCCHHHHHHHHHHCCCChhHCcCHH
Confidence 999999988888777777655432211111 14566799999999999999999999
Q ss_pred HHHHHHHhhc
Q 001142 1125 DLYEMFVART 1134 (1142)
Q Consensus 1125 EVL~~L~~~~ 1134 (1142)
|+++|+|+..
T Consensus 269 e~l~hp~~~~ 278 (361)
T 2yab_A 269 EALRHPWITP 278 (361)
T ss_dssp HHHTSTTTSC
T ss_pred HHhcCcCcCC
Confidence 9999999974
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=383.49 Aligned_cols=260 Identities=24% Similarity=0.296 Sum_probs=208.1
Q ss_pred CCCCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeE
Q 001142 803 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHK 879 (1142)
Q Consensus 803 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~ 879 (1142)
...+++|++.++||+|+||.||+|++. +..+|+|+.+... .........+.+|..++..+ +||||+++++++
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~-----~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~ 93 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDV-----ILQDDDVECTMTEKRILSLARNHPFLTQLFCCF 93 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHH-----HHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHH-----hcchhHHHHHHHHHHHHHhccCCCceeeEEEEE
Confidence 456789999999999999999999984 6678888865321 11111123347899999988 699999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 001142 880 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959 (1142)
Q Consensus 880 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~N 959 (1142)
.+.+ ..|+||||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|
T Consensus 94 ~~~~--------------~~~lv~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~N 154 (353)
T 3txo_A 94 QTPD--------------RLFFVMEFVNGGDLMFHIQK-----SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDN 154 (353)
T ss_dssp ECSS--------------EEEEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGG
T ss_pred EeCC--------------EEEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHH
Confidence 8755 35999999999999999976 2469999999999999999999999999999999999
Q ss_pred eeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001142 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039 (1142)
Q Consensus 960 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGvi 1039 (1142)
||++.+ +.+||+|||+|+...... ......+||+.|+|||++.+ ..|+.++|||||||+
T Consensus 155 ILl~~~-------g~ikL~DFG~a~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~i 213 (353)
T 3txo_A 155 VLLDHE-------GHCKLADFGMCKEGICNG----------VTTATFCGTPDYIAPEILQE----MLYGPAVDWWAMGVL 213 (353)
T ss_dssp EEECTT-------SCEEECCCTTCBCSCC-------------------CCGGGCCHHHHHH----HHCTTHHHHHHHHHH
T ss_pred EEECCC-------CCEEEccccceeecccCC----------ccccccCCCcCeEChhhcCC----CCcCCccCCCcchHH
Confidence 999887 789999999997532211 11234579999999999976 468899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001142 1040 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1119 (1142)
Q Consensus 1040 L~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~ 1119 (1142)
+|||++|+.||.+.+..++...+....... + ...++.+.++|.+||+.||.+
T Consensus 214 l~ell~G~~Pf~~~~~~~~~~~i~~~~~~~-p---------------------------~~~~~~~~~li~~lL~~dP~~ 265 (353)
T 3txo_A 214 LYEMLCGHAPFEAENEDDLFEAILNDEVVY-P---------------------------TWLHEDATGILKSFMTKNPTM 265 (353)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-C---------------------------TTSCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCC-C---------------------------CCCCHHHHHHHHHHhhhCHHH
Confidence 999999999999988888887776543211 1 034556899999999999999
Q ss_pred CCCH------HHHHHHHHhhcC
Q 001142 1120 RPTA------GDLYEMFVARTS 1135 (1142)
Q Consensus 1120 RPSa------~EVL~~L~~~~s 1135 (1142)
||++ .|+++|+|++.-
T Consensus 266 R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 266 RLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp STTSGGGTCTHHHHTSGGGTTC
T ss_pred ccCCcccCCHHHHhhCCcccCC
Confidence 9999 999999999753
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=378.08 Aligned_cols=258 Identities=22% Similarity=0.313 Sum_probs=210.7
Q ss_pred CCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 882 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~ 882 (1142)
++++|++.+.||+|+||.||+|++. +..+|+|+...... ........+.+|+.++++++||||+++++++.+.
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~ 77 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI-----IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH 77 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHh-----hhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC
Confidence 4678999999999999999999984 67788888643211 0111122347899999999999999999999875
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
+ ..++||||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 78 ~--------------~~~lv~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll 138 (337)
T 1o6l_A 78 D--------------RLCFVMEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML 138 (337)
T ss_dssp S--------------EEEEEEECCTTCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE
T ss_pred C--------------EEEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEE
Confidence 5 35999999999999999976 2468999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
+.+ +.+||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||++||
T Consensus 139 ~~~-------g~vkL~DFG~a~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~e 197 (337)
T 1o6l_A 139 DKD-------GHIKITDFGLCKEGISDG----------ATMKTFCGTPEYLAPEVLED----NDYGRAVDWWGLGVVMYE 197 (337)
T ss_dssp CTT-------SCEEECCCTTCBCSCCTT----------CCBCCCEECGGGCCGGGGSS----SCBCTTHHHHHHHHHHHH
T ss_pred CCC-------CCEEEeeccchhhcccCC----------CcccccccChhhCChhhhcC----CCCCchhhcccchhHHHH
Confidence 887 789999999997532211 11224579999999999875 568899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-
Q 001142 1043 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP- 1121 (1142)
Q Consensus 1043 LLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP- 1121 (1142)
|++|+.||.+.+..++...+...... ++ ...++.+.++|.+||+.||.+||
T Consensus 198 ll~g~~Pf~~~~~~~~~~~i~~~~~~-~p---------------------------~~~s~~~~~li~~lL~~dP~~R~g 249 (337)
T 1o6l_A 198 MMCGRLPFYNQDHERLFELILMEEIR-FP---------------------------RTLSPEAKSLLAGLLKKDPKQRLG 249 (337)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHCCCC-CC---------------------------TTSCHHHHHHHHHHTCSSTTTSTT
T ss_pred HhcCCCCCCCCCHHHHHHHHHcCCCC-CC---------------------------CCCCHHHHHHHHHHhhcCHHHhcC
Confidence 99999999988777777666543221 11 03456799999999999999999
Q ss_pred ----CHHHHHHHHHhhcC
Q 001142 1122 ----TAGDLYEMFVARTS 1135 (1142)
Q Consensus 1122 ----Sa~EVL~~L~~~~s 1135 (1142)
+++|+++|+|+..-
T Consensus 250 ~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 250 GGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp CSTTTHHHHHTSGGGTTC
T ss_pred CCCCCHHHHHcCCCcCCC
Confidence 99999999999643
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=371.87 Aligned_cols=289 Identities=19% Similarity=0.226 Sum_probs=208.2
Q ss_pred CCCCCcceeeeecccCceEEEEEEE-CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001142 804 GSFPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 882 (1142)
Q Consensus 804 ~~~~~y~l~~~LG~GsfG~Vy~a~~-~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~ 882 (1142)
.-.++|++.++||+|+||+||+|++ .+..+|+|+...... ... ....+.+|+.++++++||||+++++++.+.
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 91 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE--DEG----IPSTAIREISLLKELHHPNIVSLIDVIHSE 91 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC--------C----HHHHHHHHHHHHHHCCCTTBCCEEEEECCS
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccc--cch----hhHHHHHHHHHHHHcCCCCEeeeeeEEccC
Confidence 3457899999999999999999998 567788888653321 111 122347999999999999999999999765
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
. ..++||||++ ++|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 92 ~--------------~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~ 152 (311)
T 3niz_A 92 R--------------CLTLVFEFME-KDLKKVLDE----NKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI 152 (311)
T ss_dssp S--------------CEEEEEECCS-EEHHHHHHT----CTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred C--------------EEEEEEcCCC-CCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEE
Confidence 5 3499999998 688888764 23469999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
+.+ +.+||+|||+++....... ......||+.|+|||++.+ ...++.++|||||||++|+
T Consensus 153 ~~~-------~~~kl~Dfg~a~~~~~~~~----------~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~~ 212 (311)
T 3niz_A 153 NSD-------GALKLADFGLARAFGIPVR----------SYTHEVVTLWYRAPDVLMG---SKKYSTSVDIWSIGCIFAE 212 (311)
T ss_dssp CTT-------CCEEECCCTTCEETTSCCC-------------CCCCCCTTCCHHHHTT---CCSCCTHHHHHHHHHHHHH
T ss_pred CCC-------CCEEEccCcCceecCCCcc----------cccCCcccCCcCCHHHhcC---CCCCCchHHhHHHHHHHHH
Confidence 887 7899999999976543211 1123468999999999865 2467899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccccc--ccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1043 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE--HEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1043 LLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
|++|+.||.+....+....+........+..+........ ...................++++.+||.+||+.||.+|
T Consensus 213 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 292 (311)
T 3niz_A 213 MITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKR 292 (311)
T ss_dssp HHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTS
T ss_pred HHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHC
Confidence 9999999987665554444422111111111110000000 00000000000011112456789999999999999999
Q ss_pred CCHHHHHHHHHhhcCCC
Q 001142 1121 PTAGDLYEMFVARTSSS 1137 (1142)
Q Consensus 1121 PSa~EVL~~L~~~~ss~ 1137 (1142)
||++|+++|+|++.-.+
T Consensus 293 pt~~ell~hp~f~~~~~ 309 (311)
T 3niz_A 293 ISARDAMNHPYFKDLDP 309 (311)
T ss_dssp CCHHHHHTSGGGTTSCT
T ss_pred CCHHHHhcCcccccCCc
Confidence 99999999999986543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=369.93 Aligned_cols=262 Identities=28% Similarity=0.459 Sum_probs=204.7
Q ss_pred CCCCCcceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 804 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 804 ~~~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
....+|++.+.||+|+||+||+|++.+..+|+|+.... .......+.+ .+|+.++++++||||+++++++.+..
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~--~~~~~~~~~~----~~E~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQ--DFHAERVNEF----LREVAIMKRLRHPNIVLFMGAVTQPP 107 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCC--CCSHHHHHHH----HHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred CChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCC--CCCHHHHHHH----HHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 34568999999999999999999999999999986433 2233434444 79999999999999999999998655
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCee
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENIL 961 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~g--IvHrDLKp~NIL 961 (1142)
.. ++||||+++++|.+++.... ....+++..+..++.||+.||+|||++| |+||||||+|||
T Consensus 108 ~~--------------~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIl 171 (309)
T 3p86_A 108 NL--------------SIVTEYLSRGSLYRLLHKSG--AREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLL 171 (309)
T ss_dssp CC--------------EEEEECCTTCBHHHHHHSTT--HHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEE
T ss_pred ce--------------EEEEecCCCCcHHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEE
Confidence 43 99999999999999997521 1124899999999999999999999999 999999999999
Q ss_pred eccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001142 962 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1041 (1142)
Q Consensus 962 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ 1041 (1142)
++.+ +.+||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|
T Consensus 172 l~~~-------~~~kL~Dfg~a~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~ 230 (309)
T 3p86_A 172 VDKK-------YTVKVCDFGLSRLKASTF----------LSSKSAAGTPEWMAPEVLRD----EPSNEKSDVYSFGVILW 230 (309)
T ss_dssp ECTT-------CCEEECCCC---------------------------CCTTSCHHHHTT----CCCCTTHHHHHHHHHHH
T ss_pred EeCC-------CcEEECCCCCCccccccc----------cccccCCCCccccChhhhcC----CCCCchhhHHHHHHHHH
Confidence 9887 789999999997543211 11224569999999999876 56789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhC-CCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1042 ELLTLQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1042 ELLtG~~Pf~~~~~~el~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
+|++|+.||.+....+....+... .....+ ...++.+.+|+.+||+.||.+|
T Consensus 231 elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~~l~~dP~~R 283 (309)
T 3p86_A 231 ELATLQQPWGNLNPAQVVAAVGFKCKRLEIP---------------------------RNLNPQVAAIIEGCWTNEPWKR 283 (309)
T ss_dssp HHHHCCCTTTTSCHHHHHHHHHHSCCCCCCC---------------------------TTSCHHHHHHHHHHTCSSGGGS
T ss_pred HHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC---------------------------ccCCHHHHHHHHHHccCChhhC
Confidence 999999999988777766555322 211111 1455679999999999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 001142 1121 PTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1121 PSa~EVL~~L~~~~s 1135 (1142)
||+.++++.+.....
T Consensus 284 ps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 284 PSFATIMDLLRPLIK 298 (309)
T ss_dssp CCHHHHHHHHHHHHC
T ss_pred cCHHHHHHHHHHHHH
Confidence 999999998766544
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=372.89 Aligned_cols=256 Identities=24% Similarity=0.324 Sum_probs=211.2
Q ss_pred CCCCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001142 804 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 881 (1142)
Q Consensus 804 ~~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~ 881 (1142)
.++++|++.+.||+|+||.||+|++ .+..+|+|+...... ........+.+|+.+++.++||||+++++++.+
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~ 77 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV-----VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD 77 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-----hhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe
Confidence 4567899999999999999999998 467788888643211 011111234789999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 001142 882 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 961 (1142)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NIL 961 (1142)
.. ..++||||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 78 ~~--------------~~~lv~e~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIl 138 (318)
T 1fot_A 78 AQ--------------QIFMIMDYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENIL 138 (318)
T ss_dssp SS--------------EEEEEECCCCSCBHHHHHHH-----TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEE
T ss_pred CC--------------EEEEEEeCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEE
Confidence 55 45999999999999999986 346899999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001142 962 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1041 (1142)
Q Consensus 962 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ 1041 (1142)
++.+ +.+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|
T Consensus 139 l~~~-------g~~kL~Dfg~a~~~~~~-------------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~ 194 (318)
T 1fot_A 139 LDKN-------GHIKITDFGFAKYVPDV-------------TYTLCGTPDYIAPEVVST----KPYNKSIDWWSFGILIY 194 (318)
T ss_dssp ECTT-------SCEEECCCSSCEECSSC-------------BCCCCSCTTTCCHHHHTT----CCBCTTHHHHHHHHHHH
T ss_pred EcCC-------CCEEEeecCcceecCCc-------------cccccCCccccCHhHhcC----CCCCcccchhhhHHHHH
Confidence 9887 78999999999764321 123469999999999876 56889999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1042 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1042 ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
||++|+.||.+.+..+....+...... .+ ...++.+.+++.+||+.||.+||
T Consensus 195 ell~g~~pf~~~~~~~~~~~i~~~~~~-~p---------------------------~~~~~~~~~li~~lL~~dp~~R~ 246 (318)
T 1fot_A 195 EMLAGYTPFYDSNTMKTYEKILNAELR-FP---------------------------PFFNEDVKDLLSRLITRDLSQRL 246 (318)
T ss_dssp HHHHSSCTTCCSSHHHHHHHHHHCCCC-CC---------------------------TTSCHHHHHHHHHHTCSCTTTCT
T ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCC-CC---------------------------CCCCHHHHHHHHHHhccCHHHcC
Confidence 999999999988877777766544321 11 03456789999999999999999
Q ss_pred -----CHHHHHHHHHhhcC
Q 001142 1122 -----TAGDLYEMFVARTS 1135 (1142)
Q Consensus 1122 -----Sa~EVL~~L~~~~s 1135 (1142)
+++|+++|+|++..
T Consensus 247 ~~~~~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 247 GNLQNGTEDVKNHPWFKEV 265 (318)
T ss_dssp TSSTTTTHHHHTSGGGSSC
T ss_pred CCcCCCHHHHhcCccccCC
Confidence 99999999999753
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=379.21 Aligned_cols=260 Identities=25% Similarity=0.316 Sum_probs=212.1
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
++|++.+.||+|+||.||+|.+. +..+|+|+...+ .......+.+ .+|+.++++++|||||++++++.+.+
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~----~~E~~il~~l~hpnIv~~~~~~~~~~- 101 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTK--KLSARDFQKL----EREARICRKLQHPNIVRLHDSIQEES- 101 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETT--TCCHHHHHHH----HHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcc--cCCHHHHHHH----HHHHHHHHhCCCCCCCeEEEEEEeCC-
Confidence 46999999999999999999984 667888886533 2233333444 79999999999999999999998655
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 102 -------------~~~lv~e~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~ 163 (362)
T 2bdw_A 102 -------------FHYLVFDLVTGGELFEDIVA-----REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLAS 163 (362)
T ss_dssp -------------EEEEEECCCCSCBHHHHHTT-----CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESC
T ss_pred -------------EEEEEEecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEec
Confidence 34999999999999998864 356899999999999999999999999999999999999976
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+. ..+.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 164 ~~----~~~~~kl~DfG~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~~ll 224 (362)
T 2bdw_A 164 KA----KGAAVKLADFGLAIEVNDSE-----------AWHGFAGTPGYLSPEVLKK----DPYSKPVDIWACGVILYILL 224 (362)
T ss_dssp SS----TTCCEEECCCTTCBCCTTCC-----------SCCCSCSCTTTCCHHHHTT----CCCCTHHHHHHHHHHHHHHH
T ss_pred CC----CCCCEEEeecCcceEecCCc-----------ccccCCCCccccCHHHHcc----CCCCchhhHHHHHHHHHHHH
Confidence 52 12569999999997654311 1123569999999999875 56889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~ 1124 (1142)
+|..||.+.+..++...+..+........+ ...++.+.+||.+||+.||.+|||+.
T Consensus 225 ~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~------------------------~~~~~~~~~li~~~L~~dP~~R~t~~ 280 (362)
T 2bdw_A 225 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEW------------------------DTVTPEAKSLIDSMLTVNPKKRITAD 280 (362)
T ss_dssp HSSCSSCCSSHHHHHHHHHHTCCCCCTTGG------------------------GGSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred HCCCCCCCCCHHHHHHHHHhCCCCCCcccc------------------------cCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 999999988877777777655432111100 14566799999999999999999999
Q ss_pred HHHHHHHhhc
Q 001142 1125 DLYEMFVART 1134 (1142)
Q Consensus 1125 EVL~~L~~~~ 1134 (1142)
|+++|+|+..
T Consensus 281 e~l~hp~~~~ 290 (362)
T 2bdw_A 281 QALKVPWICN 290 (362)
T ss_dssp HHTTSHHHHT
T ss_pred HHhcCcccCC
Confidence 9999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=364.57 Aligned_cols=285 Identities=19% Similarity=0.236 Sum_probs=207.2
Q ss_pred CCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
+++|++.++||+|+||+||+|++. +..+|+|+...... .......+ .+|+.++++++||||+++++++.+.+
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~----~~E~~~l~~l~h~~iv~~~~~~~~~~ 74 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSA----LREICLLKELKHKNIVRLHDVLHSDK 74 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS--STTHHHHH----HHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC--cCCcchHH----HHHHHHHhcCCCCCEeeEEeEEEeCC
Confidence 468999999999999999999984 56788888654432 22222333 78999999999999999999998755
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
..++||||++ ++|.+.+.. ....+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 75 --------------~~~lv~e~~~-~~l~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~ 135 (292)
T 3o0g_A 75 --------------KLTLVFEFCD-QDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN 135 (292)
T ss_dssp --------------EEEEEEECCS-EEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred --------------EEEEEEecCC-CCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc
Confidence 3599999997 577776654 235699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.+||+|||++........ ......||+.|+|||++.+ ...++.++|||||||++|+|
T Consensus 136 ~~-------~~~kl~Dfg~~~~~~~~~~----------~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~~l 195 (292)
T 3o0g_A 136 RN-------GELKLANFGLARAFGIPVR----------CYSAEVVTLWYRPPDVLFG---AKLYSTSIDMWSAGCIFAEL 195 (292)
T ss_dssp TT-------SCEEECCCTTCEECCSCCS----------CCCSCCSCGGGCCHHHHTT---CSCCCTHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEeecccceecCCccc----------cccCCccccCCcChHHHcC---CCCcCchHHHHHHHHHHHHH
Confidence 87 7899999999976543211 1224468999999999875 23478999999999999999
Q ss_pred HhCCCC-CCCCCHHHHHHHHHhCCCCCchhHHhhhccccc-ccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1044 LTLQVP-YMGLSELEIHDLIQMGKRPRLTDELEALGSCHE-HEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1044 LtG~~P-f~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
++|..| |.+.+..+....+...........+........ ...................++.+.+|+.+||+.||++||
T Consensus 196 ~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 275 (292)
T 3o0g_A 196 ANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI 275 (292)
T ss_dssp TTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSC
T ss_pred HHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCC
Confidence 988777 455555555555432111111111110000000 000000000011111224667899999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001142 1122 TAGDLYEMFVARTS 1135 (1142)
Q Consensus 1122 Sa~EVL~~L~~~~s 1135 (1142)
|++|+++|+|+..-
T Consensus 276 t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 276 SAEEALQHPYFSDF 289 (292)
T ss_dssp CHHHHHTSGGGTTC
T ss_pred CHHHHhcCcccccC
Confidence 99999999999853
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=388.64 Aligned_cols=262 Identities=25% Similarity=0.314 Sum_probs=211.1
Q ss_pred CCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
++|++.+.||+|+||+||+|.+ .+..+|+|+...+. ......+. +.+|+.++++++|||||++++++.+.+
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~--~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~- 83 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKK--LSARDHQK----LEREARICRLLKHPNIVRLHDSISEEG- 83 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCS--CHHHHHHH----HHHHHHHHHHCCBTTBCCEEEEEECSS-
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEccc--CCHHHHHH----HHHHHHHHHhCCCcCCCeEEEEEEECC-
Confidence 4689999999999999999987 46678888765332 22233333 489999999999999999999998755
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
..++||||++||+|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 84 -------------~~~lv~E~~~gg~L~~~i~~-----~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~ 145 (444)
T 3soa_A 84 -------------HHYLIFDLVTGGELFEDIVA-----REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLAS 145 (444)
T ss_dssp -------------EEEEEECCCBCCBHHHHHHH-----CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESB
T ss_pred -------------EEEEEEEeCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEec
Confidence 34999999999999999976 356999999999999999999999999999999999999985
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+. ..+.+||+|||++........ ......||+.|+|||++.+ ..|+.++|||||||++|+|+
T Consensus 146 ~~----~~~~vkL~DFG~a~~~~~~~~----------~~~~~~gt~~Y~APE~l~~----~~~~~~~DIwSlGvilyell 207 (444)
T 3soa_A 146 KL----KGAAVKLADFGLAIEVEGEQQ----------AWFGFAGTPGYLSPEVLRK----DPYGKPVDLWACGVILYILL 207 (444)
T ss_dssp SS----TTCCEEECCCSSCBCCCTTCC----------BCCCSCSCGGGCCHHHHTT----CCBCTHHHHHHHHHHHHHHH
T ss_pred cC----CCCcEEEccCceeEEecCCCc----------eeecccCCcccCCHHHhcC----CCCCCccccHHHHHHHHHHH
Confidence 31 126899999999976543211 1123569999999999875 56889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~ 1124 (1142)
+|..||.+.+..+....+..+........+ ...++.+.+||.+||+.||.+|||+.
T Consensus 208 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~------------------------~~~s~~~~~li~~~L~~dP~~Rpta~ 263 (444)
T 3soa_A 208 VGYPPFWDEDQHRLYQQIKAGAYDFPSPEW------------------------DTVTPEAKDLINKMLTINPSKRITAA 263 (444)
T ss_dssp HSSCSCCCSSHHHHHHHHHHTCCCCCTTTT------------------------TTSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred hCCCCCCCccHHHHHHHHHhCCCCCCcccc------------------------ccCCHHHHHHHHHHcCCChhHCCCHH
Confidence 999999988888888777665432211100 14566799999999999999999999
Q ss_pred HHHHHHHhhcC
Q 001142 1125 DLYEMFVARTS 1135 (1142)
Q Consensus 1125 EVL~~L~~~~s 1135 (1142)
|+++|+|+...
T Consensus 264 e~L~hp~~~~~ 274 (444)
T 3soa_A 264 EALKHPWISHR 274 (444)
T ss_dssp HHHHSCTTHHH
T ss_pred HHhcCccccCC
Confidence 99999999643
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=373.04 Aligned_cols=261 Identities=25% Similarity=0.273 Sum_probs=203.8
Q ss_pred CCCCCCcceeeeecccCceEEEEEEE-----CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceee
Q 001142 803 PGSFPSLSSCDEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 877 (1142)
Q Consensus 803 ~~~~~~y~l~~~LG~GsfG~Vy~a~~-----~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g 877 (1142)
....++|++.+.||+|+||.||+|++ .+..+|+|+............... +.+|+.++++++||||+++++
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~----~~~E~~~l~~l~hp~iv~~~~ 88 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAH----TKAERNILEEVKHPFIVDLIY 88 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC------------------HHHHHHHCCCTTBCCEEE
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHH----HHHHHHHHHhCCCCCccceeE
Confidence 34467899999999999999999987 466788888643221111122222 378999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 001142 878 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 957 (1142)
Q Consensus 878 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp 957 (1142)
++...+. .++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||
T Consensus 89 ~~~~~~~--------------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp 149 (327)
T 3a62_A 89 AFQTGGK--------------LYLILEYLSGGELFMQLER-----EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKP 149 (327)
T ss_dssp EEECSSC--------------EEEEEECCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCT
T ss_pred EEEcCCE--------------EEEEEeCCCCCcHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCH
Confidence 9987553 4999999999999999976 24689999999999999999999999999999999
Q ss_pred CCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHH
Q 001142 958 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1037 (1142)
Q Consensus 958 ~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLG 1037 (1142)
+|||++.+ +.+||+|||+++....... ......||+.|+|||++.+ ..++.++||||||
T Consensus 150 ~Nill~~~-------~~~kl~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG 208 (327)
T 3a62_A 150 ENIMLNHQ-------GHVKLTDFGLCKESIHDGT----------VTHTFCGTIEYMAPEILMR----SGHNRAVDWWSLG 208 (327)
T ss_dssp TTEEECTT-------SCEEECCCSCC--------------------CTTSSCCTTSCHHHHTT----SCCCTHHHHHHHH
T ss_pred HHeEECCC-------CcEEEEeCCcccccccCCc----------cccccCCCcCccCHhhCcC----CCCCCcccchhHH
Confidence 99999887 7899999999875332110 1124469999999999875 5678999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001142 1038 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1117 (1142)
Q Consensus 1038 viL~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP 1117 (1142)
|++|+|++|+.||.+.+..+....+...... ++ ...++.+.+++.+||+.||
T Consensus 209 ~il~el~~g~~pf~~~~~~~~~~~i~~~~~~-~p---------------------------~~~~~~~~~li~~~L~~dp 260 (327)
T 3a62_A 209 ALMYDMLTGAPPFTGENRKKTIDKILKCKLN-LP---------------------------PYLTQEARDLLKKLLKRNA 260 (327)
T ss_dssp HHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-CC---------------------------TTSCHHHHHHHHHHSCSCG
T ss_pred HHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC-CC---------------------------CCCCHHHHHHHHHHHhcCH
Confidence 9999999999999988777776666543321 10 0345678999999999999
Q ss_pred CCCC-----CHHHHHHHHHhhcC
Q 001142 1118 TERP-----TAGDLYEMFVARTS 1135 (1142)
Q Consensus 1118 ~~RP-----Sa~EVL~~L~~~~s 1135 (1142)
.+|| ++.|+++|+|++.-
T Consensus 261 ~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 261 ASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp GGSTTSSTTTHHHHHHSGGGSSC
T ss_pred hhccCCCCCCHHHHHcCCcccCC
Confidence 9999 89999999999753
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=361.94 Aligned_cols=260 Identities=25% Similarity=0.284 Sum_probs=209.9
Q ss_pred CCCCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001142 803 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 880 (1142)
Q Consensus 803 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~ 880 (1142)
...+++|++.+.||+|+||.||+|.+. +..+|+|+.... ..........+.+|+.++++++||||+++++++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 79 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-----QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 79 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHH-----HHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEecc-----ccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe
Confidence 345778999999999999999999985 446888876422 1122223345589999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NI 960 (1142)
+.. ..++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||
T Consensus 80 ~~~--------------~~~lv~e~~~~~~l~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Ni 140 (279)
T 3fdn_A 80 DAT--------------RVYLILEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENL 140 (279)
T ss_dssp CSS--------------EEEEEECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGE
T ss_pred cCC--------------EEEEEEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhE
Confidence 654 359999999999999999762 4689999999999999999999999999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
|++.+ +.+||+|||++....... .....||+.|+|||++.+ ..++.++||||||+++
T Consensus 141 li~~~-------~~~~l~Dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il 197 (279)
T 3fdn_A 141 LLGSA-------GELKIADFGWSVHAPSSR------------RTDLCGTLDYLPPEMIEG----RMHDEKVDLWSLGVLC 197 (279)
T ss_dssp EECTT-------SCEEECSCCEESCC--------------------CCCCTTCCHHHHTT----CCCCTTHHHHHHHHHH
T ss_pred EEcCC-------CCEEEEeccccccCCccc------------ccccCCCCCccCHhHhcc----CCCCccchhHhHHHHH
Confidence 99887 789999999885433211 123468999999999876 5678999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1041 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
|+|++|..||......+....+....... + ...++.+.+|+.+||+.||.+|
T Consensus 198 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~---------------------------~~~~~~~~~li~~~l~~~p~~R 249 (279)
T 3fdn_A 198 YEFLVGKPPFEANTYQETYKRISRVEFTF-P---------------------------DFVTEGARDLISRLLKHNPSQR 249 (279)
T ss_dssp HHHHHSSCTTCCSSHHHHHHHHHHTCCCC-C---------------------------TTSCHHHHHHHHHHCCSSGGGS
T ss_pred HHHHHCCCCCCCCcHHHHHHHHHhCCCCC-C---------------------------CcCCHHHHHHHHHHhccChhhC
Confidence 99999999999877777666654433211 0 1345668999999999999999
Q ss_pred CCHHHHHHHHHhhcCCC
Q 001142 1121 PTAGDLYEMFVARTSSS 1137 (1142)
Q Consensus 1121 PSa~EVL~~L~~~~ss~ 1137 (1142)
||+.|+++|+|+...+.
T Consensus 250 ps~~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 250 PMLREVLEHPWITANSS 266 (279)
T ss_dssp CCHHHHHHCHHHHHHCS
T ss_pred CCHHHHhhCccccCCcc
Confidence 99999999999986544
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=375.52 Aligned_cols=266 Identities=25% Similarity=0.314 Sum_probs=209.1
Q ss_pred CCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCC-ChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGS-SADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~-~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
+.|++.+.||+|+||+||+|.+ .+..+|+|+........ .....+. +.+|+.++++++||||+++++++.+.+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~----~~~E~~~l~~l~hpnIv~~~~~~~~~~ 99 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTED----LKREASICHMLKHPHIVELLETYSSDG 99 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHH----HHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHH----HHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 3599999999999999999998 46788999865432111 0111223 379999999999999999999998755
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
..++||||+++++|.+++..... ....+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 100 --------------~~~lv~e~~~g~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~ 164 (351)
T 3c0i_A 100 --------------MLYMVFEFMDGADLCFEIVKRAD-AGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLA 164 (351)
T ss_dssp --------------EEEEEEECCSSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred --------------EEEEEEeCCCCCCHHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEe
Confidence 35999999999999988875332 234689999999999999999999999999999999999997
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+. ....+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 165 ~~~----~~~~vkl~Dfg~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~~l 226 (351)
T 3c0i_A 165 SKE----NSAPVKLGGFGVAIQLGESGL----------VAGGRVGTPHFMAPEVVKR----EPYGKPVDVWGCGVILFIL 226 (351)
T ss_dssp SSS----TTCCEEECCCTTCEECCTTSC----------BCCCCCSCGGGCCHHHHTT----CCBCTHHHHHHHHHHHHHH
T ss_pred cCC----CCCcEEEecCcceeEecCCCe----------eecCCcCCcCccCHHHHcC----CCCCchHhhHHHHHHHHHH
Confidence 652 125699999999976543211 1123469999999999876 5688999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
++|+.||.+. ..+....+..+.....+..+ ...++.+.+||.+||+.||++|||+
T Consensus 227 l~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~------------------------~~~s~~~~~li~~~L~~dP~~R~s~ 281 (351)
T 3c0i_A 227 LSGCLPFYGT-KERLFEGIIKGKYKMNPRQW------------------------SHISESAKDLVRRMLMLDPAERITV 281 (351)
T ss_dssp HHSSCSSCSS-HHHHHHHHHHTCCCCCHHHH------------------------TTSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHCCCCCCCc-HHHHHHHHHcCCCCCCcccc------------------------ccCCHHHHHHHHHHCCCChhHCcCH
Confidence 9999999874 44455555444332221111 1456679999999999999999999
Q ss_pred HHHHHHHHhhc
Q 001142 1124 GDLYEMFVART 1134 (1142)
Q Consensus 1124 ~EVL~~L~~~~ 1134 (1142)
.|+++|+|+..
T Consensus 282 ~e~l~hp~~~~ 292 (351)
T 3c0i_A 282 YEALNHPWLKE 292 (351)
T ss_dssp HHHHTSHHHHT
T ss_pred HHHhcChhhcC
Confidence 99999999974
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=366.06 Aligned_cols=283 Identities=19% Similarity=0.244 Sum_probs=205.6
Q ss_pred CCCcceeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~-~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
+++|++.+.||+|+||+||+|++. +..+|+|+...... ... ....+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~--~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 74 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE--DEG----IPSTTIREISILKELKHSNIVKLYDVIHTKKR 74 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG--GGC----CCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred CccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccc--ccc----cchhHHHHHHHHHhcCCCCEeeeeeEEccCCe
Confidence 468999999999999999999984 67788887654321 111 11233789999999999999999999986553
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
.++||||++ ++|.+++.. ....+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 75 --------------~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~ 135 (288)
T 1ob3_A 75 --------------LVLVFEHLD-QDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINR 135 (288)
T ss_dssp --------------EEEEEECCS-EEHHHHHHT----STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred --------------EEEEEEecC-CCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC
Confidence 499999998 599998864 2346899999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||+|||++........ ......||+.|+|||++.+ ...++.++|||||||++|+|+
T Consensus 136 ~-------~~~kl~Dfg~~~~~~~~~~----------~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~~l~ 195 (288)
T 1ob3_A 136 E-------GELKIADFGLARAFGIPVR----------KYTHEIVTLWYRAPDVLMG---SKKYSTTIDIWSVGCIFAEMV 195 (288)
T ss_dssp T-------SCEEECCTTHHHHHCC-------------------CCCTTCCHHHHTT---CCSCCTHHHHHHHHHHHHHHH
T ss_pred C-------CCEEEeECccccccCcccc----------ccccccccccccCchheeC---CCCCCcHHHHHHHHHHHHHHH
Confidence 7 7899999999976532111 1123468999999999865 245789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhC-CCCCchhHHhhhccccc-ccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1045 TLQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHE-HEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~-~~p~l~~~l~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
+|+.||.+....+....+... ..+... .+........ ...................++.+.+|+.+||+.||++|||
T Consensus 196 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 274 (288)
T 1ob3_A 196 NGTPLFPGVSEADQLMRIFRILGTPNSK-NWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT 274 (288)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCTT-TSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCC
T ss_pred hCCCCCCCCCHHHHHHHHHHHHCCCChh-hchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCC
Confidence 999999987776655444221 111100 0000000000 0000000000001111245678999999999999999999
Q ss_pred HHHHHHHHHhhc
Q 001142 1123 AGDLYEMFVART 1134 (1142)
Q Consensus 1123 a~EVL~~L~~~~ 1134 (1142)
+.|+++|+|++.
T Consensus 275 ~~e~l~hp~f~~ 286 (288)
T 1ob3_A 275 AKQALEHAYFKE 286 (288)
T ss_dssp HHHHHTSGGGGC
T ss_pred HHHHhcCcchhh
Confidence 999999999975
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=372.81 Aligned_cols=263 Identities=22% Similarity=0.293 Sum_probs=210.6
Q ss_pred CcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCCh--HHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSA--DEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~--~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
.|++.+.||+|+||.||+|.+. +..+|+|+.......... ...+. +.+|+.++++++||||+++++++.+..
T Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~----~~~E~~~l~~l~hp~iv~~~~~~~~~~ 87 (326)
T 2y0a_A 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED----IEREVSILKEIQHPNVITLHEVYENKT 87 (326)
T ss_dssp HEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHH----HHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred ceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHH----HHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 5899999999999999999984 677888886544322111 11233 379999999999999999999998654
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 88 --------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~ 148 (326)
T 2y0a_A 88 --------------DVILILELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLL 148 (326)
T ss_dssp --------------EEEEEEECCCSCBHHHHHTT-----SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES
T ss_pred --------------EEEEEEEcCCCCCHHHHHHh-----cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEe
Confidence 45999999999999999864 35699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.++ .....+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 149 ~~~---~~~~~~kl~Dfg~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~~l 210 (326)
T 2y0a_A 149 DRN---VPKPRIKIIDFGLAHKIDFGN-----------EFKNIFGTPEFVAPEIVNY----EPLGLEADMWSIGVITYIL 210 (326)
T ss_dssp CSS---SSSCCEEECCCTTCEECCTTS-----------CCCCCCSCTTTCCHHHHTT----CCCCTHHHHHHHHHHHHHH
T ss_pred cCC---CCCCCEEEEECCCCeECCCCC-----------ccccccCCcCcCCceeecC----CCCCcHHHHHHHHHHHHHH
Confidence 762 011379999999997654321 1123469999999999875 5688999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
++|..||.+....+....+........... ....+..+.+|+.+||+.||.+|||+
T Consensus 211 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~li~~~L~~dP~~Rpt~ 266 (326)
T 2y0a_A 211 LSGASPFLGDTKQETLANVSAVNYEFEDEY------------------------FSNTSALAKDFIRRLLVKDPKKRMTI 266 (326)
T ss_dssp HHSCCSSCCSSHHHHHHHHHHTCCCCCHHH------------------------HTTSCHHHHHHHHHHSCSSGGGSCCH
T ss_pred HHCcCCCCCCCHHHHHHHHHhcCCCcCccc------------------------cccCCHHHHHHHHHHccCChhhCCCH
Confidence 999999998877776666654432221111 01445678999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 001142 1124 GDLYEMFVARTS 1135 (1142)
Q Consensus 1124 ~EVL~~L~~~~s 1135 (1142)
.|+++|+|++..
T Consensus 267 ~e~l~hp~~~~~ 278 (326)
T 2y0a_A 267 QDSLQHPWIKPK 278 (326)
T ss_dssp HHHHHSTTTSCC
T ss_pred HHHhcCCCccCC
Confidence 999999999754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=369.35 Aligned_cols=254 Identities=28% Similarity=0.467 Sum_probs=209.2
Q ss_pred cceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCC
Q 001142 809 LSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 886 (1142)
Q Consensus 809 y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~ 886 (1142)
|...++||+|+||.||+|++ .+..||||+...... ...+.+ .+|+.++++++||||+++++++...+
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~----~~~~~~----~~E~~~l~~l~h~niv~~~~~~~~~~--- 115 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ----QRRELL----FNEVVIMRDYQHFNVVEMYKSYLVGE--- 115 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CSHHHH----HHHHHHHTTCCCTTBCCEEEEEEETT---
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch----hHHHHH----HHHHHHHHhCCCCCcceEEEEEEECC---
Confidence 67888999999999999998 477899998654321 122233 78999999999999999999998654
Q ss_pred CCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecccc
Q 001142 887 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 966 (1142)
Q Consensus 887 ~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~ 966 (1142)
..++||||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 116 -----------~~~lv~e~~~~~~L~~~l~~------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~- 177 (321)
T 2c30_A 116 -----------ELWVLMEFLQGGALTDIVSQ------VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLD- 177 (321)
T ss_dssp -----------EEEEEECCCCSCBHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-
T ss_pred -----------EEEEEEecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-
Confidence 35999999999999998853 368999999999999999999999999999999999999877
Q ss_pred ccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001142 967 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1046 (1142)
Q Consensus 967 ~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG 1046 (1142)
+.+||+|||++........ ......||+.|+|||++.+ ..++.++||||||+++|+|++|
T Consensus 178 ------~~~kl~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slG~il~el~~g 237 (321)
T 2c30_A 178 ------GRVKLSDFGFCAQISKDVP----------KRKSLVGTPYWMAPEVISR----SLYATEVDIWSLGIMVIEMVDG 237 (321)
T ss_dssp ------CCEEECCCTTCEECCSSSC----------CBCCCCSCGGGCCHHHHTT----CCBCTHHHHHHHHHHHHHHHHS
T ss_pred ------CcEEEeeeeeeeecccCcc----------ccccccCCccccCHhhhcC----CCCCchhhHHHHHHHHHHHHhC
Confidence 7899999999976543211 1124469999999999875 5688999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 001142 1047 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1126 (1142)
Q Consensus 1047 ~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EV 1126 (1142)
+.||......+....+.....+.... ....++.+.+++.+||+.||++|||+.|+
T Consensus 238 ~~pf~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~el 292 (321)
T 2c30_A 238 EPPYFSDSPVQAMKRLRDSPPPKLKN-------------------------SHKVSPVLRDFLERMLVRDPQERATAQEL 292 (321)
T ss_dssp SCTTTTSCHHHHHHHHHHSSCCCCTT-------------------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCcCc-------------------------cccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 99999877777666665544332211 01445679999999999999999999999
Q ss_pred HHHHHhhcCC
Q 001142 1127 YEMFVARTSS 1136 (1142)
Q Consensus 1127 L~~L~~~~ss 1136 (1142)
++|+|+....
T Consensus 293 l~hp~~~~~~ 302 (321)
T 2c30_A 293 LDHPFLLQTG 302 (321)
T ss_dssp HTSGGGGGCC
T ss_pred hcChhhccCC
Confidence 9999998654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=374.93 Aligned_cols=257 Identities=23% Similarity=0.289 Sum_probs=213.0
Q ss_pred CCCCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001142 803 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 880 (1142)
Q Consensus 803 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~ 880 (1142)
...+++|++.+.||+|+||.||+|++. +..+|+|+..... .........+.+|+.++++++||||+++++++.
T Consensus 37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 111 (350)
T 1rdq_E 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK-----VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHH-----hccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 345788999999999999999999984 6778888864321 111111233478999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NI 960 (1142)
+.. ..|+||||++|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||
T Consensus 112 ~~~--------------~~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NI 172 (350)
T 1rdq_E 112 DNS--------------NLYMVMEYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENL 172 (350)
T ss_dssp CSS--------------EEEEEEECCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred cCC--------------EEEEEEcCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceE
Confidence 655 459999999999999999862 4689999999999999999999999999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
|++.+ +.+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++
T Consensus 173 ll~~~-------g~~kL~DFg~a~~~~~~-------------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il 228 (350)
T 1rdq_E 173 LIDQQ-------GYIQVTDFGFAKRVKGR-------------TWTLCGTPEALAPEIILS----KGYNKAVDWWALGVLI 228 (350)
T ss_dssp EECTT-------SCEEECCCTTCEECSSC-------------BCCCEECGGGCCHHHHTT----CCBCTHHHHHHHHHHH
T ss_pred EECCC-------CCEEEcccccceeccCC-------------cccccCCccccCHHHhcC----CCCCCcCCEecccHhH
Confidence 99887 78999999999765321 123469999999999876 5688999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1041 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
|||++|..||.+.+..+....+..+... ++ ...++.+.++|.+||+.||.+|
T Consensus 229 ~ell~g~~Pf~~~~~~~~~~~i~~~~~~-~p---------------------------~~~~~~~~~li~~lL~~dp~~R 280 (350)
T 1rdq_E 229 YEMAAGYPPFFADQPIQIYEKIVSGKVR-FP---------------------------SHFSSDLKDLLRNLLQVDLTKR 280 (350)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHCCCC-CC---------------------------TTCCHHHHHHHHHHSCSCTTTC
T ss_pred hHHhhCCCCCCCCCHHHHHHHHHcCCCC-CC---------------------------CCCCHHHHHHHHHHhhcCHHhc
Confidence 9999999999988888777777654321 11 0345679999999999999999
Q ss_pred CC-----HHHHHHHHHhhcC
Q 001142 1121 PT-----AGDLYEMFVARTS 1135 (1142)
Q Consensus 1121 PS-----a~EVL~~L~~~~s 1135 (1142)
|+ ++||++|+|+...
T Consensus 281 ~~~~~~~~~ei~~h~~f~~~ 300 (350)
T 1rdq_E 281 FGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp TTSSTTTTHHHHTSGGGTTC
T ss_pred cCCccCCHHHHHhCcCcCCC
Confidence 98 9999999999753
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=358.68 Aligned_cols=265 Identities=25% Similarity=0.301 Sum_probs=214.1
Q ss_pred CCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
.++|++.+.||+|+||.||+|.+. +..+|+|+..... ......+.+ .+|+.++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~----~~e~~~l~~l~h~~i~~~~~~~~~~~ 78 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK--LSARDFQKL----EREARICRKLQHPNIVRLHDSIQEES 78 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG--CCHHHHHHH----HHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeeccc--CCHHHHHHH----HHHHHHHHHcCCCCcCeEEEEEEcCC
Confidence 357999999999999999999984 6678888865442 233333444 79999999999999999999998654
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++
T Consensus 79 --------------~~~~v~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~ 139 (284)
T 3kk8_A 79 --------------FHYLVFDLVTGGELFEDIVA-----REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLA 139 (284)
T ss_dssp --------------EEEEEECCCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEES
T ss_pred --------------EEEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEe
Confidence 34999999999999998876 24689999999999999999999999999999999999997
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.++ ..+.+||+|||.+........ .....||+.|+|||++.+ ..++.++||||||+++|+|
T Consensus 140 ~~~----~~~~~kl~Dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~~l 200 (284)
T 3kk8_A 140 SKA----KGAAVKLADFGLAIEVNDSEA-----------WHGFAGTPGYLSPEVLKK----DPYSKPVDIWACGVILYIL 200 (284)
T ss_dssp SSS----TTCCEEECCCTTCEECCSSCB-----------CCCSCSCGGGCCHHHHTT----CCBCTHHHHHHHHHHHHHH
T ss_pred cCC----CCCcEEEeeceeeEEcccCcc-----------ccCCCCCcCCcCchhhcC----CCCCcccchHHHHHHHHHH
Confidence 652 125699999999976543211 123468999999999876 5678999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
++|..||.+....+....+..+........ ....++.+.+++.+||+.||.+|||+
T Consensus 201 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~li~~~l~~dp~~Rps~ 256 (284)
T 3kk8_A 201 LVGYPPFWDEDQHRLYAQIKAGAYDYPSPE------------------------WDTVTPEAKSLIDSMLTVNPKKRITA 256 (284)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHTCCCCCTTT------------------------TTTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred HHCCCCCCCCchhHHHHHHHhccccCCchh------------------------hcccCHHHHHHHHHHcccChhhCCCH
Confidence 999999998887777776655433211100 01445679999999999999999999
Q ss_pred HHHHHHHHhhcCCCC
Q 001142 1124 GDLYEMFVARTSSSI 1138 (1142)
Q Consensus 1124 ~EVL~~L~~~~ss~~ 1138 (1142)
.|+++|+|+......
T Consensus 257 ~~~l~h~~~~~~~~~ 271 (284)
T 3kk8_A 257 DQALKVPWICNRERV 271 (284)
T ss_dssp HHHTTSHHHHSCCCG
T ss_pred HHHhcCccccCChhH
Confidence 999999999876544
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=376.81 Aligned_cols=259 Identities=25% Similarity=0.321 Sum_probs=209.7
Q ss_pred CCCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEe
Q 001142 804 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 880 (1142)
Q Consensus 804 ~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~~ 880 (1142)
..+++|++.+.||+|+||.||+|++. +..+|+|+...... ........+..|..++..+ +||||+++++++.
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~ 88 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV-----LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ 88 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHh-----hhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEE
Confidence 45789999999999999999999984 56788887643211 0011112336899999877 8999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NI 960 (1142)
+.+ ..|+||||++||+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+||
T Consensus 89 ~~~--------------~~~lv~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NI 149 (345)
T 1xjd_A 89 TKE--------------NLFFVMEYLNGGDLMYHIQS-----CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNI 149 (345)
T ss_dssp CSS--------------EEEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGE
T ss_pred eCC--------------EEEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhE
Confidence 755 35999999999999999986 24689999999999999999999999999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
|++.+ +.+||+|||+++...... ......+||+.|+|||++.+ ..++.++|||||||++
T Consensus 150 ll~~~-------g~vkL~DFG~a~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il 208 (345)
T 1xjd_A 150 LLDKD-------GHIKIADFGMCKENMLGD----------AKTNTFCGTPDYIAPEILLG----QKYNHSVDWWSFGVLL 208 (345)
T ss_dssp EECTT-------SCEEECCCTTCBCCCCTT----------CCBCCCCSCGGGCCHHHHTT----CCBCTHHHHHHHHHHH
T ss_pred EECCC-------CCEEEeEChhhhhcccCC----------CcccCCCCCcccCChhhhcC----CCCCChhhhHHHHHHH
Confidence 99887 789999999997532211 11234579999999999976 5688999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1041 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
|||++|+.||.+.+..++...+...... .+ ...++.+.++|.+||+.||.+|
T Consensus 209 ~ell~g~~Pf~~~~~~~~~~~i~~~~~~-~p---------------------------~~~s~~~~~li~~lL~~dp~~R 260 (345)
T 1xjd_A 209 YEMLIGQSPFHGQDEEELFHSIRMDNPF-YP---------------------------RWLEKEAKDLLVKLFVREPEKR 260 (345)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHCCCC-CC---------------------------TTSCHHHHHHHHHHSCSSGGGS
T ss_pred HHHhcCCCCCCCCCHHHHHHHHHhCCCC-CC---------------------------cccCHHHHHHHHHHhcCCHhHc
Confidence 9999999999988887777777554321 11 0345678999999999999999
Q ss_pred CCHH-HHHHHHHhhcC
Q 001142 1121 PTAG-DLYEMFVARTS 1135 (1142)
Q Consensus 1121 PSa~-EVL~~L~~~~s 1135 (1142)
|++. ++++|+|++.-
T Consensus 261 ~~~~~~i~~hp~f~~~ 276 (345)
T 1xjd_A 261 LGVRGDIRQHPLFREI 276 (345)
T ss_dssp BTTBSCGGGSGGGTTC
T ss_pred CCChHHHHcCccccCC
Confidence 9998 99999999753
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=371.44 Aligned_cols=261 Identities=22% Similarity=0.352 Sum_probs=206.6
Q ss_pred CCCCCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeee
Q 001142 802 DPGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGH 878 (1142)
Q Consensus 802 ~~~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~ 878 (1142)
.+..+.+|++.+.||+|+||.||+|++. +..+|+|+...... ......+. +.+|+.++.++ +||||++++++
T Consensus 4 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~----~~~E~~~l~~~~~hp~iv~l~~~ 78 (345)
T 3a8x_A 4 DPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELV-NDDEDIDW----VQTEKHVFEQASNHPFLVGLHSC 78 (345)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGS-CSHHHHHH----HHHHHHHHHHTTTCTTBCCEEEE
T ss_pred CCCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHh-cchHHHHH----HHHHHHHHHhcCCCCccCeEEEE
Confidence 3456788999999999999999999985 56788887653322 12222333 37899999988 79999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 001142 879 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 958 (1142)
Q Consensus 879 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~ 958 (1142)
+.+.. ..|+||||+++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+
T Consensus 79 ~~~~~--------------~~~lv~e~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~ 139 (345)
T 3a8x_A 79 FQTES--------------RLFFVIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLD 139 (345)
T ss_dssp EECSS--------------EEEEEECCCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGG
T ss_pred EEeCC--------------EEEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHH
Confidence 98655 45999999999999999976 246999999999999999999999999999999999
Q ss_pred CeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001142 959 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1038 (1142)
Q Consensus 959 NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGv 1038 (1142)
|||++.+ +.+||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||
T Consensus 140 NIll~~~-------g~~kL~DFG~a~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~ 198 (345)
T 3a8x_A 140 NVLLDSE-------GHIKLTDYGMCKEGLRPG----------DTTSTFCGTPNYIAPEILRG----EDYGFSVDWWALGV 198 (345)
T ss_dssp GEEECTT-------SCEEECCGGGCBCSCCTT----------CCBCCCCSCGGGCCHHHHTT----CCBCTHHHHHHHHH
T ss_pred HEEECCC-------CCEEEEeccccccccCCC----------CcccccCCCccccCccccCC----CCCChHHhHHHHHH
Confidence 9999887 789999999997532211 11224579999999999976 56889999999999
Q ss_pred HHHHHHhCCCCCCCC---------CHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHH
Q 001142 1039 LLLELLTLQVPYMGL---------SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVF 1109 (1142)
Q Consensus 1039 iL~ELLtG~~Pf~~~---------~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI 1109 (1142)
++|||++|+.||... ....+...+..... .++ ...+..+.++|
T Consensus 199 il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~~p---------------------------~~~s~~~~~li 250 (345)
T 3a8x_A 199 LMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RIP---------------------------RSLSVKAASVL 250 (345)
T ss_dssp HHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC-CCC---------------------------TTSCHHHHHHH
T ss_pred HHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC-CCC---------------------------CCCCHHHHHHH
Confidence 999999999999642 12223333322211 110 14456799999
Q ss_pred HHhcccCCCCCCCH------HHHHHHHHhhcC
Q 001142 1110 RRCTEENPTERPTA------GDLYEMFVARTS 1135 (1142)
Q Consensus 1110 ~~CL~~DP~~RPSa------~EVL~~L~~~~s 1135 (1142)
.+||+.||.+||++ .|+++|+|++.-
T Consensus 251 ~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 251 KSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282 (345)
T ss_dssp HHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred HHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence 99999999999995 899999999753
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=362.45 Aligned_cols=285 Identities=22% Similarity=0.283 Sum_probs=206.5
Q ss_pred CCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
+++|++.++||+|+||+||+|++. +..+|+|+.... .......+. +.+|+.++++++||||+++++++.+.+
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~----~~~E~~~l~~l~h~~i~~~~~~~~~~~ 75 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLES--EDDPVIKKI----ALREIRMLKQLKHPNLVNLLEVFRRKR 75 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCC--CC-HHHHHH----HHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecc--ccchHHHHH----HHHHHHHHHhCCCCCccchhheeecCC
Confidence 468999999999999999999985 667888875322 222222333 478999999999999999999998655
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 76 --------------~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~ 136 (311)
T 4agu_A 76 --------------RLHLVFEYCDHTVLHELDRY-----QRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILIT 136 (311)
T ss_dssp --------------EEEEEEECCSEEHHHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred --------------eEEEEEEeCCCchHHHHHhh-----hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEc
Confidence 34999999999999888764 34689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.+||+|||.+........ ......||+.|+|||++.+ ...++.++||||||+++|+|
T Consensus 137 ~~-------~~~kl~Dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~il~~l 196 (311)
T 4agu_A 137 KH-------SVIKLCDFGFARLLTGPSD----------YYDDEVATRWYRSPELLVG---DTQYGPPVDVWAIGCVFAEL 196 (311)
T ss_dssp TT-------SCEEECCCTTCEECC----------------------GGGCCHHHHHT---CSCCCTHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEeeCCCchhccCccc----------ccCCCcCCccccChHHHhc---CCCCCcchhhHHHHHHHHHH
Confidence 77 7899999999976543211 1123468999999999875 24678999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccc---cccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH---EHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
++|+.||.+....+....+........+.......... ....................++.+.+|+.+||+.||.+|
T Consensus 197 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 276 (311)
T 4agu_A 197 LSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTER 276 (311)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTS
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhc
Confidence 99999999877766555543322222221111110000 000000000000000112456779999999999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 001142 1121 PTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1121 PSa~EVL~~L~~~~s 1135 (1142)
||++|+++|+|++.-
T Consensus 277 pt~~ell~hp~f~~~ 291 (311)
T 4agu_A 277 LTCEQLLHHPYFENI 291 (311)
T ss_dssp CCHHHHHTSGGGTTC
T ss_pred CCHHHHhcChHHHhc
Confidence 999999999999864
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=377.81 Aligned_cols=259 Identities=21% Similarity=0.278 Sum_probs=203.6
Q ss_pred CCCCCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001142 803 PGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 880 (1142)
Q Consensus 803 ~~~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~ 880 (1142)
...+.+|++.+.||+|+||.||+|.+ .+..||+|+..... ....+...++.+|+.+++.++||||+++++++.
T Consensus 5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 79 (336)
T 3h4j_B 5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQL-----LKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT 79 (336)
T ss_dssp CSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHH-----HHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHH-----ccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 34577899999999999999999998 56778888864221 111122234589999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NI 960 (1142)
+.. ..++||||+ +|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 80 ~~~--------------~~~lv~E~~-~g~l~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NI 139 (336)
T 3h4j_B 80 TPT--------------DIVMVIEYA-GGELFDYIVE-----KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENL 139 (336)
T ss_dssp CSS--------------EEEEEECCC-CEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTE
T ss_pred eCC--------------EEEEEEECC-CCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhE
Confidence 755 359999999 6899998876 24699999999999999999999999999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
|++.+ +.+||+|||++....... ......||+.|+|||++.+. ..+++++|||||||++
T Consensus 140 ll~~~-------~~~kl~DFG~s~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il 198 (336)
T 3h4j_B 140 LLDDN-------LNVKIADFGLSNIMTDGN-----------FLKTSCGSPNYAAPEVINGK---LYAGPEVDVWSCGIVL 198 (336)
T ss_dssp EECTT-------CCEEECCSSCTBTTTTSB-----------TTCCCTTSTTTSCGGGSCCS---GGGCHHHHHHHHHHHH
T ss_pred EEcCC-------CCEEEEEeccceeccCCc-----------ccccccCCcCcCCHHHHcCC---CCCCCccchhHHHHHH
Confidence 99887 789999999997544321 11244699999999998751 2237899999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1041 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
|+|++|+.||.+.........+..+. .. .+...++.+.+|+.+||+.||.+|
T Consensus 199 ~~ll~g~~Pf~~~~~~~~~~~i~~~~-------------------------~~---~p~~~s~~~~~li~~~L~~dP~~R 250 (336)
T 3h4j_B 199 YVMLVGRLPFDDEFIPNLFKKVNSCV-------------------------YV---MPDFLSPGAQSLIRRMIVADPMQR 250 (336)
T ss_dssp HHHHHSSCSSBCSSSTTCBCCCCSSC-------------------------CC---CCTTSCHHHHHHHHTTSCSSGGGS
T ss_pred HHHHhCCCCCCCccHHHHHHHHHcCC-------------------------CC---CcccCCHHHHHHHHHHcCCChhHC
Confidence 99999999997643221111110000 00 011456679999999999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 001142 1121 PTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1121 PSa~EVL~~L~~~~s 1135 (1142)
||++|+++|+|+...
T Consensus 251 pt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 251 ITIQEIRRDPWFNVN 265 (336)
T ss_dssp CCHHHHTTCHHHHTT
T ss_pred cCHHHHHhChhhccC
Confidence 999999999999864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=379.32 Aligned_cols=260 Identities=21% Similarity=0.335 Sum_probs=204.1
Q ss_pred CCCCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeE
Q 001142 803 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHK 879 (1142)
Q Consensus 803 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~ 879 (1142)
...+.+|++.++||+|+||.||+|++. +..+|+|+.+..... .....+. +.+|..++.++ +|||||++++++
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~-~~~~~~~----~~~E~~il~~~~~hp~Iv~l~~~~ 122 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVN-DDEDIDW----VQTEKHVFEQASNHPFLVGLHSCF 122 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC-----CCH----HHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc-CHHHHHH----HHHHHHHHHhcCCCCCcCeeEEEE
Confidence 345778999999999999999999985 556888886533221 1122222 36899999887 799999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 001142 880 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959 (1142)
Q Consensus 880 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~N 959 (1142)
.+.. ..++||||++||+|..++.. ...+++..++.++.||+.||+|||++||+||||||+|
T Consensus 123 ~~~~--------------~~~lV~E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~N 183 (396)
T 4dc2_A 123 QTES--------------RLFFVIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDN 183 (396)
T ss_dssp ECSS--------------EEEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGG
T ss_pred EECC--------------EEEEEEEcCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHH
Confidence 8755 35999999999999999986 2469999999999999999999999999999999999
Q ss_pred eeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001142 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039 (1142)
Q Consensus 960 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGvi 1039 (1142)
||++.+ +.+||+|||+|+...... ......+||+.|+|||++.+ ..|+.++|||||||+
T Consensus 184 ILl~~~-------g~ikL~DFGla~~~~~~~----------~~~~~~~gt~~Y~aPE~l~~----~~~~~~~DiwslGvl 242 (396)
T 4dc2_A 184 VLLDSE-------GHIKLTDYGMCKEGLRPG----------DTTSTFCGTPNYIAPEILRG----EDYGFSVDWWALGVL 242 (396)
T ss_dssp EEECTT-------SCEEECCCTTCBCCCCTT----------CCBCCCCBCGGGCCHHHHTT----CCBCTHHHHHHHHHH
T ss_pred EEECCC-------CCEEEeecceeeecccCC----------CccccccCCcccCCchhhcC----CCCChHHHHHHHHHH
Confidence 999887 889999999997532211 11234579999999999976 568999999999999
Q ss_pred HHHHHhCCCCCCCCC---------HHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHH
Q 001142 1040 LLELLTLQVPYMGLS---------ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 1110 (1142)
Q Consensus 1040 L~ELLtG~~Pf~~~~---------~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~ 1110 (1142)
+|||++|+.||.... ...+...+..... .++ ...++.+.+||.
T Consensus 243 lyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~~p---------------------------~~~s~~~~~li~ 294 (396)
T 4dc2_A 243 MFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RIP---------------------------RSLSVKAASVLK 294 (396)
T ss_dssp HHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC-CCC---------------------------TTSCHHHHHHHH
T ss_pred HHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc-CCC---------------------------CcCCHHHHHHHH
Confidence 999999999996422 1223333332211 111 134567999999
Q ss_pred HhcccCCCCCCCH------HHHHHHHHhhcC
Q 001142 1111 RCTEENPTERPTA------GDLYEMFVARTS 1135 (1142)
Q Consensus 1111 ~CL~~DP~~RPSa------~EVL~~L~~~~s 1135 (1142)
+||+.||.+||++ +||++|+|++.-
T Consensus 295 ~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 295 SFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp HHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred HHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence 9999999999985 899999999753
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=356.69 Aligned_cols=262 Identities=24% Similarity=0.293 Sum_probs=209.0
Q ss_pred CCcceeeeecccCceEEEEEEECCc--cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFGSA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~~~--~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
++|++.+.||+|+||.||+|.+... .+|+|+..... .. ..+.+ .+|+.++++++||||+++++++.+..
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~--~~~~~----~~E~~~l~~l~h~~i~~~~~~~~~~~- 79 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF--VE--DVDRF----KQEIEIMKSLDHPNIIRLYETFEDNT- 79 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG--CS--CHHHH----HHHHHHHHTCCCTTBCCEEEEEECSS-
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhc--cc--hHHHH----HHHHHHHHhCCCCCEeeEEEEEecCC-
Confidence 3589999999999999999998554 56666643221 11 12233 78999999999999999999998654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+..
T Consensus 80 -------------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~ 141 (277)
T 3f3z_A 80 -------------DIYLVMELCTGGELFERVVH-----KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLT 141 (277)
T ss_dssp -------------EEEEEEECCCSCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESS
T ss_pred -------------eEEEEEeccCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEec
Confidence 35999999999999999876 246899999999999999999999999999999999999932
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ ...+.+||+|||++....... ......||+.|+|||++.+ .++.++||||||+++|+|+
T Consensus 142 ~----~~~~~~~l~Dfg~~~~~~~~~-----------~~~~~~~t~~y~aPE~~~~-----~~~~~~Di~slG~~l~~l~ 201 (277)
T 3f3z_A 142 D----SPDSPLKLIDFGLAARFKPGK-----------MMRTKVGTPYYVSPQVLEG-----LYGPECDEWSAGVMMYVLL 201 (277)
T ss_dssp S----STTCCEEECCCTTCEECCTTS-----------CBCCCCSCTTTCCHHHHTT-----CBCTTHHHHHHHHHHHHHH
T ss_pred C----CCCCcEEEEecccceeccCcc-----------chhccCCCCCccChHHhcc-----cCCchhhehhHHHHHHHHH
Confidence 2 112789999999997654321 1123468999999999864 4789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~ 1124 (1142)
+|+.||......+....+..+......... ...++.+.+++.+||+.||.+|||+.
T Consensus 202 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~li~~~l~~dp~~R~s~~ 257 (277)
T 3f3z_A 202 CGYPPFSAPTDSEVMLKIREGTFTFPEKDW------------------------LNVSPQAESLIRRLLTKSPKQRITSL 257 (277)
T ss_dssp HSSCSSCCSSHHHHHHHHHHCCCCCCHHHH------------------------TTSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HCCCCCCCCCHHHHHHHHHhCCCCCCchhh------------------------hcCCHHHHHHHHHHccCChhhCcCHH
Confidence 999999988877777776655433222111 14456799999999999999999999
Q ss_pred HHHHHHHhhcCCCCC
Q 001142 1125 DLYEMFVARTSSSIS 1139 (1142)
Q Consensus 1125 EVL~~L~~~~ss~~s 1139 (1142)
++++|+|++.....+
T Consensus 258 ~~l~h~~~~~~~~~~ 272 (277)
T 3f3z_A 258 QALEHEWFEKQLSSS 272 (277)
T ss_dssp HHTTSHHHHHHHCCS
T ss_pred HHhcCHHHhcccccc
Confidence 999999998654443
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=358.62 Aligned_cols=262 Identities=24% Similarity=0.319 Sum_probs=203.3
Q ss_pred CCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
++|++.+.||+|+||.||+|++ .+..+|+|+...... ......+. +.+|+.++++++||||+++++++.+.+
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~----~~~e~~~l~~l~hp~iv~~~~~~~~~~- 84 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPR-EKEETLKR----FEREVHNSSQLSHQNIVSMIDVDEEDD- 84 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSS-CCHHHHHH----HHHHHHHHTTCCBTTBCCEEEEEECSS-
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCcc-ccHHHHHH----HHHHHHHHhcCCCCCCceEEEeeeeCC-
Confidence 5799999999999999999997 466788887643321 22233333 489999999999999999999988655
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 85 -------------~~~lv~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~ 146 (294)
T 4eqm_A 85 -------------CYYLVMEYIEGPTLSEYIESH-----GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDS 146 (294)
T ss_dssp -------------EEEEEEECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT
T ss_pred -------------eEEEEEeCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC
Confidence 359999999999999999762 46899999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||+|||++........ .......||+.|+|||++.+ ..++.++||||||+++|+|+
T Consensus 147 ~-------~~~kl~Dfg~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~~l~~ll 206 (294)
T 4eqm_A 147 N-------KTLKIFDFGIAKALSETSL---------TQTNHVLGTVQYFSPEQAKG----EATDECTDIYSIGIVLYEML 206 (294)
T ss_dssp T-------SCEEECCCSSSTTC----------------------CCSSCCHHHHHT----CCCCTTHHHHHHHHHHHHHH
T ss_pred C-------CCEEEEeCCCccccccccc---------cccCccccCccccCHhHhcC----CCCCchHhHHHHHHHHHHHH
Confidence 7 7899999999976543211 11224469999999999876 56789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-CH
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-TA 1123 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP-Sa 1123 (1142)
+|+.||.+...............+...... ....++.+.+++.+||+.||.+|| ++
T Consensus 207 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~l~~li~~~l~~dp~~R~~~~ 263 (294)
T 4eqm_A 207 VGEPPFNGETAVSIAIKHIQDSVPNVTTDV-----------------------RKDIPQSLSNVILRATEKDKANRYKTI 263 (294)
T ss_dssp HSSCSSCSSCHHHHHHHHHSSCCCCHHHHS-----------------------CTTSCHHHHHHHHHHSCSSGGGSCSSH
T ss_pred hCCCCCCCCChHHHHHHHhhccCCCcchhc-----------------------ccCCCHHHHHHHHHHhcCCHhHccccH
Confidence 999999987776655444443333322111 014567799999999999999999 77
Q ss_pred HHHHHHHHhhcC
Q 001142 1124 GDLYEMFVARTS 1135 (1142)
Q Consensus 1124 ~EVL~~L~~~~s 1135 (1142)
+++.+.+.....
T Consensus 264 ~~l~~~l~~~~~ 275 (294)
T 4eqm_A 264 QEMKDDLSSVLH 275 (294)
T ss_dssp HHHHHHHHTSSS
T ss_pred HHHHHHHHHHHh
Confidence 777776665433
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=383.49 Aligned_cols=265 Identities=22% Similarity=0.288 Sum_probs=211.1
Q ss_pred CCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
.++|++.++||+|+||+||+|++. +..+|+|+..... .........+.+|+.+++.++|||||++++++.+..
T Consensus 68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~-----~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFE-----MIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-----HHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhh-----hhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 567999999999999999999984 5678888754211 011111123478999999999999999999998755
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
+.|+||||++||+|.++++. ..+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 143 --------------~~~lV~E~~~gg~L~~~l~~------~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~ 202 (410)
T 3v8s_A 143 --------------YLYMVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD 202 (410)
T ss_dssp --------------EEEEEECCCTTEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred --------------EEEEEEeCCCCCcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeEC
Confidence 35999999999999999975 3589999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.+||+|||+|+........ .....+||+.|+|||++.+......|+.++|||||||++|||
T Consensus 203 ~~-------g~ikL~DFG~a~~~~~~~~~---------~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyel 266 (410)
T 3v8s_A 203 KS-------GHLKLADFGTCMKMNKEGMV---------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 266 (410)
T ss_dssp TT-------SCEEECCCTTCEECCTTSEE---------ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEeccceeEeeccCCcc---------cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHH
Confidence 87 78999999999765432111 112457999999999998633223378999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCC-CCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC--C
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE--R 1120 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~--R 1120 (1142)
++|+.||.+.+..+....+..... ...+. ....++.+.+||.+||+.+|.+ |
T Consensus 267 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~-------------------------~~~~s~~~~~li~~lL~~~~~rlgR 321 (410)
T 3v8s_A 267 LVGDTPFYADSLVGTYSKIMNHKNSLTFPD-------------------------DNDISKEAKNLICAFLTDREVRLGR 321 (410)
T ss_dssp HHSSCTTCCSSHHHHHHHHHTHHHHCCCCT-------------------------TCCCCHHHHHHHHHHSSCGGGCTTS
T ss_pred HhCCCCCCCCChhhHHHHHHhccccccCCC-------------------------cccccHHHHHHHHHHccChhhhCCC
Confidence 999999998888777776643210 00000 0135567999999999999988 9
Q ss_pred CCHHHHHHHHHhhcCC
Q 001142 1121 PTAGDLYEMFVARTSS 1136 (1142)
Q Consensus 1121 PSa~EVL~~L~~~~ss 1136 (1142)
|+++||++|+|++...
T Consensus 322 ~~~~ei~~Hp~f~~~~ 337 (410)
T 3v8s_A 322 NGVEEIKRHLFFKNDQ 337 (410)
T ss_dssp SCHHHHHTSGGGCCSS
T ss_pred CCHHHHhcCccccCCC
Confidence 9999999999998653
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=366.52 Aligned_cols=264 Identities=20% Similarity=0.328 Sum_probs=209.8
Q ss_pred CCCCcceeeeecccCceEEEEEEEC-----CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeE
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 879 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~~-----~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~ 879 (1142)
...+|++.+.||+|+||.||+|.+. +..+|+|+.... ......+.+ .+|+.++++++||||+++++++
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~----~~E~~~l~~l~h~~iv~~~~~~ 119 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG---YTERQRRDF----LSEASIMGQFDHPNIIRLEGVV 119 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT---CCHHHHHHH----HHHHHHHTTCCCTTBCCEEEEE
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC---CCHHHHHHH----HHHHHHHHhCCCCCCCcEEEEE
Confidence 3467999999999999999999983 234777775422 123333344 8999999999999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 001142 880 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959 (1142)
Q Consensus 880 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~N 959 (1142)
.+.+.. ++||||+++++|.++++. ....+++..+..|+.||+.||.|||++||+||||||+|
T Consensus 120 ~~~~~~--------------~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~N 181 (325)
T 3kul_A 120 TRGRLA--------------MIVTEYMENGSLDTFLRT----HDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARN 181 (325)
T ss_dssp CGGGCC--------------EEEEECCTTCBHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred EeCCcc--------------EEEeeCCCCCcHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcce
Confidence 765543 999999999999999964 23469999999999999999999999999999999999
Q ss_pred eeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001142 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039 (1142)
Q Consensus 960 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGvi 1039 (1142)
||++.+ +.+||+|||+++.......... ......+|+.|+|||++.+ ..++.++|||||||+
T Consensus 182 Ill~~~-------~~~kl~Dfg~a~~~~~~~~~~~-------~~~~~~~t~~y~aPE~~~~----~~~~~~~Di~slG~i 243 (325)
T 3kul_A 182 VLVDSN-------LVCKVSDFGLSRVLEDDPDAAY-------TTTGGKIPIRWTAPEAIAF----RTFSSASDVWSFGVV 243 (325)
T ss_dssp EEECTT-------CCEEECCCSSCEECC----CCE-------ECC---CCGGGSCHHHHHH----CEECHHHHHHHHHHH
T ss_pred EEECCC-------CCEEECCCCcccccccCcccee-------eccCCCCcccccCHhHhcC----CCCCcHHHHHHHHHH
Confidence 999877 7899999999986543221110 1112346788999999976 568899999999999
Q ss_pred HHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001142 1040 LLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1118 (1142)
Q Consensus 1040 L~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~ 1118 (1142)
+|+|++ |..||.+....+....+..+..+..+. .+++.+.+|+.+||+.||.
T Consensus 244 l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~dp~ 296 (325)
T 3kul_A 244 MWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPM---------------------------GCPHALHQLMLDCWHKDRA 296 (325)
T ss_dssp HHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGG
T ss_pred HHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCC---------------------------CcCHHHHHHHHHHccCChh
Confidence 999999 999999888877777766554332211 4556799999999999999
Q ss_pred CCCCHHHHHHHHHhhcCCCC
Q 001142 1119 ERPTAGDLYEMFVARTSSSI 1138 (1142)
Q Consensus 1119 ~RPSa~EVL~~L~~~~ss~~ 1138 (1142)
+|||+.+|++.+........
T Consensus 297 ~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 297 QRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp GSCCHHHHHHHHHHHHHSCC
T ss_pred hCcCHHHHHHHHHHHHhCcc
Confidence 99999999999887654443
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=363.97 Aligned_cols=291 Identities=21% Similarity=0.223 Sum_probs=207.5
Q ss_pred CCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC---CCCCccceeeeEe
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL---RHSCIVEMYGHKI 880 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L---~HpNIVkl~g~~~ 880 (1142)
..+|++.++||+|+||+||+|++ .+..+|+|+........... .....+.+|+.+++++ +||||+++++++.
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGG---GLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSS---CCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEeccccccccc---ccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 45799999999999999999996 56788999876443211110 1111225677777666 4999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NI 960 (1142)
.... ......++||||+. ++|.+++.. .....+++..+..|+.||+.||+|||++||+||||||+||
T Consensus 85 ~~~~---------~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Ni 151 (308)
T 3g33_A 85 TSRT---------DREIKVTLVFEHVD-QDLRTYLDK---APPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENI 151 (308)
T ss_dssp ECCS---------SSEEEEEEEEECCC-CBHHHHHHT---CCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTE
T ss_pred ccCC---------CCceeEEEEehhhh-cCHHHHHhh---ccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence 6431 12335799999997 699999875 2334499999999999999999999999999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
|++.+ +.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++
T Consensus 152 l~~~~-------~~~kl~Dfg~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il 209 (308)
T 3g33_A 152 LVTSG-------GTVKLADFGLARIYSYQM-----------ALTPVVVTLWYRAPEVLLQ----STYATPVDMWSVGCIF 209 (308)
T ss_dssp EECTT-------SCEEECSCSCTTTSTTCC-----------CSGGGGCCCSSCCHHHHHT----SCCCSTHHHHHHHHHH
T ss_pred EEcCC-------CCEEEeeCccccccCCCc-----------ccCCccccccccCchHHcC----CCCCchHHHHHHHHHH
Confidence 99887 789999999997543211 1224568999999999976 5688999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1041 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
|+|++|+.||.+....+....+...........+....... ...................++.+.+||.+||+.||++|
T Consensus 210 ~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 288 (308)
T 3g33_A 210 AEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLP-RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKR 288 (308)
T ss_dssp HHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSC-GGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTS
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhcc-ccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccC
Confidence 99999999999888777665553221111111000000000 00000000000111112456789999999999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 001142 1121 PTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1121 PSa~EVL~~L~~~~s 1135 (1142)
||+.|+++|+|+...
T Consensus 289 ~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 289 ISAFRALQHSYLHKD 303 (308)
T ss_dssp CCHHHHHTSTTC---
T ss_pred CCHHHHhcCccccCC
Confidence 999999999999864
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=372.47 Aligned_cols=262 Identities=23% Similarity=0.372 Sum_probs=208.4
Q ss_pred CCCCcceeeeecccCceEEEEEEEC---------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccc
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKFG---------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVE 874 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~~---------~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVk 874 (1142)
..++|++.+.||+|+||.||+|++. +..+|+|+.+ .. ......+.+ .+|+.+++++ +||||++
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~--~~-~~~~~~~~~----~~E~~~l~~l~~hpnIv~ 151 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK--DD-ATEKDLSDL----VSEMEMMKMIGKHKNIIN 151 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECC--TT-CBHHHHHHH----HHHHHHHHHSCCCTTBCC
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEec--CC-cCHHHHHHH----HHHHHHHHHhcCCCCEee
Confidence 3467999999999999999999863 2246777643 21 222333344 8999999999 8999999
Q ss_pred eeeeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc-----------CCCCCCHHHHHHHHHHHHHHHH
Q 001142 875 MYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAALV 943 (1142)
Q Consensus 875 l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~-----------~~~~ls~~~i~~Ia~qIa~gL~ 943 (1142)
+++++.+.+.+ |+||||+++|+|.+++...... ....+++..+..++.||+.||+
T Consensus 152 ~~~~~~~~~~~--------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~ 217 (370)
T 2psq_A 152 LLGACTQDGPL--------------YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGME 217 (370)
T ss_dssp EEEEECSSSSC--------------EEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHH
T ss_pred EEEEEccCCCE--------------EEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHH
Confidence 99999876544 9999999999999999863211 1235899999999999999999
Q ss_pred HHHhCCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccC
Q 001142 944 ELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 1023 (1142)
Q Consensus 944 yLHs~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~ 1023 (1142)
|||++||+||||||+|||++.+ +.+||+|||+++........ .......+|+.|+|||++.+
T Consensus 218 ~LH~~~ivHrDlkp~NIll~~~-------~~~kl~DFG~a~~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~--- 279 (370)
T 2psq_A 218 YLASQKCIHRDLAARNVLVTEN-------NVMKIADFGLARDINNIDYY--------KKTTNGRLPVKWMAPEALFD--- 279 (370)
T ss_dssp HHHHTTEECSCCCGGGEEECTT-------CCEEECCCSSCEETTCCCTT--------CTTTTTTSCGGGCCHHHHHT---
T ss_pred HHHhCCeeccccchhhEEECCC-------CCEEEccccCCcccCcccce--------ecccCCCcccceECHhHhcC---
Confidence 9999999999999999999887 78999999999765432111 11123357889999999876
Q ss_pred CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhH
Q 001142 1024 PNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETL 1102 (1142)
Q Consensus 1024 ~~~~s~ksDVwSLGviL~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1102 (1142)
..++.++|||||||++|||++ |..||.+....++...+..+..+..+. .++
T Consensus 280 -~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~ 331 (370)
T 2psq_A 280 -RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPA---------------------------NCT 331 (370)
T ss_dssp -CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCT---------------------------TSC
T ss_pred -CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCC---------------------------CCC
Confidence 568999999999999999999 999999877777666665554332221 445
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001142 1103 SFLVDVFRRCTEENPTERPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1103 ~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~ 1133 (1142)
+.+.+++.+||+.||.+|||+.|+++++...
T Consensus 332 ~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 332 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 6799999999999999999999999998764
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=371.12 Aligned_cols=261 Identities=24% Similarity=0.278 Sum_probs=203.4
Q ss_pred CCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 882 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~ 882 (1142)
.+++|++.+.||+|+||+||+|.+. +..+|+|+...+.. ....+. +.+|+.+++.++||||+++++++.+.
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~----~~~E~~~l~~l~hpnIv~~~~~~~~~ 77 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPEN----IKKEICINKMLNHENVVKFYGHRREG 77 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------C----HHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc---cchHHH----HHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 3578999999999999999999984 67788888654321 111223 37899999999999999999999865
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
+ ..++||||+++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 78 ~--------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll 138 (323)
T 3tki_A 78 N--------------IQYLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL 138 (323)
T ss_dssp S--------------EEEEEEECCTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred C--------------eEEEEEEcCCCCcHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEE
Confidence 5 34999999999999988854 3569999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
+.+ +.+||+|||++..+...... .......||+.|+|||++.+ ...++.++|||||||++|+
T Consensus 139 ~~~-------~~~kl~Dfg~a~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~~ 200 (323)
T 3tki_A 139 DER-------DNLKISDFGLATVFRYNNRE--------RLLNKMCGTLPYVAPELLKR---REFHAEPVDVWSCGIVLTA 200 (323)
T ss_dssp CTT-------CCEEECCCTTCEECEETTEE--------CCBCSCCSCGGGSCHHHHHC---SSBCHHHHHHHHHHHHHHH
T ss_pred eCC-------CCEEEEEeeccceeccCCcc--------cccCCCccCcCccCcHHhcc---CCCCCCcccHHHHHHHHHH
Confidence 887 78999999999765432211 11124569999999999876 2334789999999999999
Q ss_pred HHhCCCCCCCCCHHH-HHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1043 LLTLQVPYMGLSELE-IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1043 LLtG~~Pf~~~~~~e-l~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
|++|+.||....... ............. .....++.+.+|+.+||+.||.+||
T Consensus 201 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~li~~~L~~dP~~R~ 254 (323)
T 3tki_A 201 MLAGELPWDQPSDSCQEYSDWKEKKTYLN--------------------------PWKKIDSAPLALLHKILVENPSARI 254 (323)
T ss_dssp HHHSSCSCSSSCTTSHHHHHHHTTCTTST--------------------------TGGGSCHHHHHHHHHHSCSSTTTSC
T ss_pred HHhCCCCCCCCchHHHHHHHHhcccccCC--------------------------ccccCCHHHHHHHHHHccCChhhCc
Confidence 999999997654321 2222211111000 0114566789999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001142 1122 TAGDLYEMFVARTS 1135 (1142)
Q Consensus 1122 Sa~EVL~~L~~~~s 1135 (1142)
|+.|+++|+|+...
T Consensus 255 t~~eil~h~~~~~~ 268 (323)
T 3tki_A 255 TIPDIKKDRWYNKP 268 (323)
T ss_dssp CHHHHTTCTTTTCC
T ss_pred CHHHHhhChhhccc
Confidence 99999999999754
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=371.46 Aligned_cols=259 Identities=24% Similarity=0.291 Sum_probs=209.2
Q ss_pred CCCCCCcceeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeE
Q 001142 803 PGSFPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHK 879 (1142)
Q Consensus 803 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~~--~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~ 879 (1142)
...+.+|++.+.||+|+||.||+|++.. ..+|+|+...... ........+..|..++..+ +||||+++++++
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~-----~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~ 90 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV-----IQDDDVECTMVEKRVLALPGKPPFLTQLHSCF 90 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-----hcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE
Confidence 4567899999999999999999999864 5678887543211 0111122347899999988 799999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 001142 880 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959 (1142)
Q Consensus 880 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~N 959 (1142)
.+.+ ..|+||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|
T Consensus 91 ~~~~--------------~~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~N 151 (353)
T 2i0e_A 91 QTMD--------------RLYFVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDN 151 (353)
T ss_dssp ECSS--------------EEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGG
T ss_pred EcCC--------------EEEEEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHH
Confidence 8755 459999999999999999862 469999999999999999999999999999999999
Q ss_pred eeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001142 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039 (1142)
Q Consensus 960 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGvi 1039 (1142)
||++.+ +.+||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||+
T Consensus 152 Ill~~~-------g~vkL~DFG~a~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~i 210 (353)
T 2i0e_A 152 VMLDSE-------GHIKIADFGMCKENIWDG----------VTTKTFCGTPDYIAPEIIAY----QPYGKSVDWWAFGVL 210 (353)
T ss_dssp EEECTT-------SCEEECCCTTCBCCCCTT----------CCBCCCCSCGGGCCHHHHTT----CCBSTHHHHHHHHHH
T ss_pred EEEcCC-------CcEEEEeCCcccccccCC----------cccccccCCccccChhhhcC----CCcCCcccccchHHH
Confidence 999887 789999999997532211 11234579999999999876 568899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001142 1040 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1119 (1142)
Q Consensus 1040 L~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~ 1119 (1142)
+|||++|+.||.+.+..++...+...... .+ ...++.+.+||.+||+.||.+
T Consensus 211 l~ell~G~~Pf~~~~~~~~~~~i~~~~~~-~p---------------------------~~~s~~~~~li~~lL~~dP~~ 262 (353)
T 2i0e_A 211 LYEMLAGQAPFEGEDEDELFQSIMEHNVA-YP---------------------------KSMSKEAVAICKGLMTKHPGK 262 (353)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHCCCC-CC---------------------------TTSCHHHHHHHHHHTCSCTTS
T ss_pred HHHHHcCCCCCCCCCHHHHHHHHHhCCCC-CC---------------------------CCCCHHHHHHHHHHhhcCHHH
Confidence 99999999999988888877777554321 11 034567999999999999999
Q ss_pred CC-----CHHHHHHHHHhhc
Q 001142 1120 RP-----TAGDLYEMFVART 1134 (1142)
Q Consensus 1120 RP-----Sa~EVL~~L~~~~ 1134 (1142)
|| +++++++|+|++.
T Consensus 263 R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 263 RLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp CTTCSTTHHHHHHTSGGGTT
T ss_pred cCCCCCCCHHHHhcCccccC
Confidence 99 4799999999974
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=368.69 Aligned_cols=293 Identities=20% Similarity=0.248 Sum_probs=204.7
Q ss_pred CCCCCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001142 803 PGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 880 (1142)
Q Consensus 803 ~~~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~ 880 (1142)
...+++|++.++||+|+||+||+|.+ .+..+|+|+.... .......+.+ .+|+.++++++||||+++++++.
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~----~~E~~~l~~l~h~~iv~~~~~~~ 103 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLE--HEEEGVPGTA----IREVSLLKELQHRNIIELKSVIH 103 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCC--C--------C----HHHHHHGGGCCCTTBCCEEEEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccc--ccccccchhH----HHHHHHHHHcCCCCcceEEEEEe
Confidence 44567899999999999999999987 4667777775432 2222222333 78999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NI 960 (1142)
+.. ..++||||++ ++|.+++.. ...+++..+..|+.||+.||.|||++||+||||||+||
T Consensus 104 ~~~--------------~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NI 163 (329)
T 3gbz_A 104 HNH--------------RLHLIFEYAE-NDLKKYMDK-----NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNL 163 (329)
T ss_dssp ETT--------------EEEEEEECCS-EEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred cCC--------------EEEEEEecCC-CCHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHE
Confidence 755 3599999998 699999976 34699999999999999999999999999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
|++.++ ....+.+||+|||++........ ......||+.|+|||++.+ ...++.++|||||||++
T Consensus 164 ll~~~~--~~~~~~~kl~Dfg~a~~~~~~~~----------~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il 228 (329)
T 3gbz_A 164 LLSVSD--ASETPVLKIGDFGLARAFGIPIR----------QFTHEIITLWYRPPEILLG---SRHYSTSVDIWSIACIW 228 (329)
T ss_dssp EEEC-------CCEEEECCTTHHHHHC---------------------CCTTCCHHHHTT---CCCCCTHHHHHHHHHHH
T ss_pred EEecCC--CCccceEEECcCCCccccCCccc----------ccCCCcCCccccCHHHhcC---CCCCCcHHHHHHHHHHH
Confidence 996441 11226799999999976543211 1123468999999999875 23578999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhC-CCCCchhHHhhhccccc--ccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001142 1041 LELLTLQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHE--HEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1117 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~~~~~el~~~I~~~-~~p~l~~~l~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP 1117 (1142)
|+|++|+.||.+....+....+... ..+... .+........ ...................++.+.+||.+||+.||
T Consensus 229 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 307 (329)
T 3gbz_A 229 AEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDT-TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDP 307 (329)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT-TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSG
T ss_pred HHHHHCCCCcCCCCHHHHHHHHHHHhCCCchh-hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCCh
Confidence 9999999999987776655544221 111111 0000000000 00000000000001112356789999999999999
Q ss_pred CCCCCHHHHHHHHHhhcCCC
Q 001142 1118 TERPTAGDLYEMFVARTSSS 1137 (1142)
Q Consensus 1118 ~~RPSa~EVL~~L~~~~ss~ 1137 (1142)
.+|||+.|+++|+|+....+
T Consensus 308 ~~R~t~~e~l~hp~f~~~~~ 327 (329)
T 3gbz_A 308 VKRISAKNALEHPYFSHNDF 327 (329)
T ss_dssp GGSCCHHHHHTSGGGSSSCS
T ss_pred hhCCCHHHHhCCcccCCCCC
Confidence 99999999999999987643
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=364.62 Aligned_cols=289 Identities=21% Similarity=0.295 Sum_probs=197.8
Q ss_pred CCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 882 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~ 882 (1142)
+..+|++.+.||+|+||.||+|.+. +..+|+|+....... ...+. +.+|+.++++++||||+++++++.+.
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~----~~~E~~~l~~l~hp~iv~~~~~~~~~ 75 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE---GTPST----AIREISLMKELKHENIVRLYDVIHTE 75 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCSTT---CSCHH----HHHHHHHHTTCCBTTBCCEEEEECCT
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc---ccHHH----HHHHHHHHHhcCCCCcceEEEEEEEC
Confidence 3568999999999999999999874 677888886543211 11122 36899999999999999999998765
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 961 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~-~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NIL 961 (1142)
+ ..++||||++ ++|.+++...... ....+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 76 ~--------------~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl 140 (317)
T 2pmi_A 76 N--------------KLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLL 140 (317)
T ss_dssp T--------------EEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred C--------------eEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeE
Confidence 4 4599999998 6999998764321 2235899999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001142 962 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1041 (1142)
Q Consensus 962 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ 1041 (1142)
++.+ +.+||+|||+++....... ......||+.|+|||++.+ ...++.++|||||||++|
T Consensus 141 ~~~~-------~~~kl~Dfg~~~~~~~~~~----------~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~ 200 (317)
T 2pmi_A 141 INKR-------GQLKLGDFGLARAFGIPVN----------TFSSEVVTLWYRAPDVLMG---SRTYSTSIDIWSCGCILA 200 (317)
T ss_dssp ECTT-------CCEEECCCSSCEETTSCCC----------CCCCCCSCCTTCCHHHHTT---CCCCCTHHHHHHHHHHHH
T ss_pred EcCC-------CCEEECcCccceecCCCcc----------cCCCCcccccccCchHhhC---CCCCCcHHHHHHHHHHHH
Confidence 9887 7899999999976543211 1123468999999999875 245789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHh--CCCCCc-hhHHhhhcccccccccccCCCCCC-----chhhhhhHHHHHHHHHHhc
Q 001142 1042 ELLTLQVPYMGLSELEIHDLIQM--GKRPRL-TDELEALGSCHEHEVAQSGSGFEK-----PEAELETLSFLVDVFRRCT 1113 (1142)
Q Consensus 1042 ELLtG~~Pf~~~~~~el~~~I~~--~~~p~l-~~~l~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~L~dLI~~CL 1113 (1142)
+|++|+.||.+....+....+.. +..+.. ........... ...... ..... +......+..+.+|+.+||
T Consensus 201 el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~L 278 (317)
T 2pmi_A 201 EMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYN-PNIQQR-PPRDLRQVLQPHTKEPLDGNLMDFLHGLL 278 (317)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCC-TTCCCC-CCCCSHHHHGGGCSSCCCHHHHHHHHHHS
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcc-cccccc-cchhHHHhhcccccccCCHHHHHHHHHHC
Confidence 99999999998877766655532 111111 00000000000 000000 00000 0001135668999999999
Q ss_pred ccCCCCCCCHHHHHHHHHhhcCCC
Q 001142 1114 EENPTERPTAGDLYEMFVARTSSS 1137 (1142)
Q Consensus 1114 ~~DP~~RPSa~EVL~~L~~~~ss~ 1137 (1142)
+.||++|||+.|+++|+|+.....
T Consensus 279 ~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 279 QLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp CSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred CCCcccCCCHHHHhCChhhhcccc
Confidence 999999999999999999986543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=354.36 Aligned_cols=256 Identities=21% Similarity=0.352 Sum_probs=209.3
Q ss_pred CCCcceeeeecccCceEEEEEEE-CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~-~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
.++|++.+.||+|+||.||+|.+ .+..+|+|+.... ... .+.+ .+|+.++++++||||+++++++.+...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~---~~~~----~~E~~~l~~l~h~~i~~~~~~~~~~~~ 79 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG--AMS---EEDF----IEEAEVMMKLSHPKLVQLYGVCLEQAP 79 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTT--SBC---HHHH----HHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccc--ccC---HHHH----HHHHHHHHhCCCCCEeeEEEEEecCCc
Confidence 45799999999999999999998 5667888876422 111 2233 789999999999999999999886553
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
.++||||+++++|.+++.. ....+++..+..++.|++.||.|||++||+||||||+||+++.
T Consensus 80 --------------~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~ 141 (269)
T 4hcu_A 80 --------------ICLVFEFMEHGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE 141 (269)
T ss_dssp --------------EEEEEECCTTCBHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG
T ss_pred --------------eEEEEEeCCCCcHHHHHHh----cCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcC
Confidence 4999999999999999965 2346899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||+|||++......... ......+|+.|+|||++.+ ..++.++||||||+++|+|+
T Consensus 142 ~-------~~~kl~Dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~~ll 201 (269)
T 4hcu_A 142 N-------QVIKVSDFGMTRFVLDDQYT---------SSTGTKFPVKWASPEVFSF----SRYSSKSDVWSFGVLMWEVF 201 (269)
T ss_dssp G-------GCEEECCTTGGGGBCCHHHH---------STTSTTCCGGGCCHHHHHH----CCCCHHHHHHHHHHHHHHHH
T ss_pred C-------CCEEeccccccccccccccc---------cccCcccccccCCHHHhcC----CCCCchhhhHHHHHHHHHHh
Confidence 7 78999999999765432211 1123357888999999976 56889999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1045 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1045 t-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
+ |+.||......+....+..+..+..+. ..++.+.+++.+||+.||.+|||+
T Consensus 202 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~p~~Rps~ 254 (269)
T 4hcu_A 202 SEGKIPYENRSNSEVVEDISTGFRLYKPR---------------------------LASTHVYQIMNHCWRERPEDRPAF 254 (269)
T ss_dssp TTSCCTTTTCCHHHHHHHHHTTCCCCCCT---------------------------TSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred cCCCCCCCCCCHHHHHHHHhcCccCCCCC---------------------------cCCHHHHHHHHHHccCCcccCcCH
Confidence 9 999999888877777765543322211 345669999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 001142 1124 GDLYEMFVARTS 1135 (1142)
Q Consensus 1124 ~EVL~~L~~~~s 1135 (1142)
.++++++.....
T Consensus 255 ~~ll~~l~~l~~ 266 (269)
T 4hcu_A 255 SRLLRQLAEIAE 266 (269)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHH
Confidence 999999987644
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=354.76 Aligned_cols=261 Identities=25% Similarity=0.424 Sum_probs=198.8
Q ss_pred CCCCcceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
.+.+|++.+.||+|+||.||+|.+.+..+|+|+.+........... ..+.+|+.+++.++||||+++++++.+.+.
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTI----ENVRQEAKLFAMLKHPNIIALRGVCLKEPN 80 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CH----HHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred chhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHH----HHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 4678999999999999999999999999999986543221111222 334799999999999999999999986553
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCCCCee
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH---IMHRDIKSENIL 961 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~g---IvHrDLKp~NIL 961 (1142)
.++||||+++++|.+++.. ..+++..+..++.||+.||.|||++| |+||||||+|||
T Consensus 81 --------------~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil 140 (271)
T 3dtc_A 81 --------------LCLVMEFARGGPLNRVLSG------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNIL 140 (271)
T ss_dssp --------------CEEEEECCTTEEHHHHHTS------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEE
T ss_pred --------------eEEEEEcCCCCCHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEE
Confidence 3999999999999998853 46999999999999999999999999 999999999999
Q ss_pred ecccccc-CCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 962 IDLERKK-ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 962 ld~~~~~-~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
++..... ....+.+||+|||.+....... .....||+.|+|||++.+ ..++.++||||||+++
T Consensus 141 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l 204 (271)
T 3dtc_A 141 ILQKVENGDLSNKILKITDFGLAREWHRTT------------KMSAAGAYAWMAPEVIRA----SMFSKGSDVWSYGVLL 204 (271)
T ss_dssp ESSCCSSSCCSSCCEEECCCCC-------------------------CCGGGSCHHHHHH----CCCSHHHHHHHHHHHH
T ss_pred EecccccccccCcceEEccCCccccccccc------------ccCCCCccceeCHHHhcc----CCCCchhhHHHHHHHH
Confidence 9863110 1113789999999997543321 113468999999999876 5688999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCC-CchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001142 1041 LELLTLQVPYMGLSELEIHDLIQMGKRP-RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1119 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~~~~~el~~~I~~~~~p-~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~ 1119 (1142)
|+|++|+.||.+.........+...... ..+ ...++.+.+++.+||+.||.+
T Consensus 205 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~ 257 (271)
T 3dtc_A 205 WELLTGEVPFRGIDGLAVAYGVAMNKLALPIP---------------------------STCPEPFAKLMEDCWNPDPHS 257 (271)
T ss_dssp HHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCC---------------------------TTCCHHHHHHHHHHTCSSGGG
T ss_pred HHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCC---------------------------cccCHHHHHHHHHHhcCCccc
Confidence 9999999999987766655444332211 110 144567999999999999999
Q ss_pred CCCHHHHHHHHHh
Q 001142 1120 RPTAGDLYEMFVA 1132 (1142)
Q Consensus 1120 RPSa~EVL~~L~~ 1132 (1142)
|||+.|+++++..
T Consensus 258 Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 258 RPSFTNILDQLTT 270 (271)
T ss_dssp SCCHHHHHHHHHC
T ss_pred CcCHHHHHHHHhc
Confidence 9999999999853
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=368.63 Aligned_cols=283 Identities=19% Similarity=0.251 Sum_probs=209.1
Q ss_pred CCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-----CCCccceeeeE
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-----HSCIVEMYGHK 879 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-----HpNIVkl~g~~ 879 (1142)
++|++.++||+|+||+||+|++ .+..+|+|+... .....+.+ ..|+.+++++. |||||++++++
T Consensus 35 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~----~~e~~~l~~l~~~~~~h~~iv~~~~~~ 105 (360)
T 3llt_A 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-----IKKYTRSA----KIEADILKKIQNDDINNNNIVKYHGKF 105 (360)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-----CHHHHHHH----HHHHHHHHHTCCCSTTGGGBCCEEEEE
T ss_pred CEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-----chhhhhhh----HHHHHHHHHhcccCCCCCCeeccccee
Confidence 5799999999999999999998 566788887541 12222333 67999999986 99999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 001142 880 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959 (1142)
Q Consensus 880 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~N 959 (1142)
...+ +.++||||+ +++|.+++.. .....+++..+..++.||+.||+|||++||+||||||+|
T Consensus 106 ~~~~--------------~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 167 (360)
T 3llt_A 106 MYYD--------------HMCLIFEPL-GPSLYEIITR---NNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPEN 167 (360)
T ss_dssp EETT--------------EEEEEECCC-CCBHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred eECC--------------eeEEEEcCC-CCCHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCccc
Confidence 8654 459999999 8999999986 233458999999999999999999999999999999999
Q ss_pred eeecccccc------------------CCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccc
Q 001142 960 ILIDLERKK------------------ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 1021 (1142)
Q Consensus 960 ILld~~~~~------------------~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~ 1021 (1142)
||++..... ....+.+||+|||+++..... .....||+.|+|||++.+
T Consensus 168 Ill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-------------~~~~~gt~~y~aPE~~~~- 233 (360)
T 3llt_A 168 ILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-------------HGSIINTRQYRAPEVILN- 233 (360)
T ss_dssp EEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-------------CCSCCSCGGGCCHHHHTT-
T ss_pred EEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-------------CcCccCcccccCcHHHcC-
Confidence 999752000 001278999999999753321 123468999999999976
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccccccccccc------CCCC---
Q 001142 1022 HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS------GSGF--- 1092 (1142)
Q Consensus 1022 ~~~~~~s~ksDVwSLGviL~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~------~~~~--- 1092 (1142)
..++.++|||||||++|+|++|+.||.+....+....+.....+.................... ....
T Consensus 234 ---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 310 (360)
T 3llt_A 234 ---LGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASS 310 (360)
T ss_dssp ---CCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSC
T ss_pred ---CCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccc
Confidence 5689999999999999999999999998877776666644433333222211111000000000 0000
Q ss_pred ---------CCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001142 1093 ---------EKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1093 ---------~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~ 1133 (1142)
..+.......+.+.+|+.+||+.||++|||+.|+++|+|++
T Consensus 311 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 311 INSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred hhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 00111112236788999999999999999999999999985
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=364.99 Aligned_cols=284 Identities=21% Similarity=0.264 Sum_probs=205.1
Q ss_pred CCCCcceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
...+|++.++||+|+||+||+|++.+..||+|++... ......+ .+|+.++++++|||||++++++.....
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~-----~~~~~~~----~~E~~~l~~l~hpniv~~~~~~~~~~~ 92 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQ-----DKQSWQN----EYEVYSLPGMKHENILQFIGAEKRGTS 92 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGG-----GHHHHHH----HHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred chhhchhhheecccCceEEEEEEECCCEEEEEEeecC-----chHHHHH----HHHHHHHhcCCCCCchhhcceeccCCC
Confidence 3467999999999999999999999999999986432 1222222 579999999999999999999986432
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CccccC
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK----------HIMHRD 954 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~----------gIvHrD 954 (1142)
. ..+.++||||+++|+|.++++. ..+++..+..|+.||+.||.|||+. ||+|||
T Consensus 93 ~----------~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~D 156 (322)
T 3soc_A 93 V----------DVDLWLITAFHEKGSLSDFLKA------NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRD 156 (322)
T ss_dssp S----------SEEEEEEEECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSC
T ss_pred C----------CceEEEEEecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCC
Confidence 1 2356999999999999999976 3599999999999999999999999 999999
Q ss_pred CCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccC-CCCCCchhhH
Q 001142 955 IKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK-PNLYGLEVDI 1033 (1142)
Q Consensus 955 LKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-~~~~s~ksDV 1033 (1142)
|||+|||++.+ +.+||+|||+++........ .......||+.|+|||++.+... ...++.++||
T Consensus 157 lkp~Nill~~~-------~~~kL~DFg~a~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Di 221 (322)
T 3soc_A 157 IKSKNVLLKNN-------LTACIADFGLALKFEAGKSA--------GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDM 221 (322)
T ss_dssp CSGGGEEECTT-------CCEEECCCTTCEEECTTSCC--------CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHH
T ss_pred CChHhEEECCC-------CeEEEccCCcccccccccCc--------cccccCccCccccCHhhcccccccCcCCCccchh
Confidence 99999999877 78999999999765432211 11223569999999999875211 1245678999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHh
Q 001142 1034 WSYGCLLLELLTLQVPYMGLSELEIHD-LIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 1112 (1142)
Q Consensus 1034 wSLGviL~ELLtG~~Pf~~~~~~el~~-~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~C 1112 (1142)
|||||++|||++|+.||.+........ .......+........... ................++.+.+|+.+|
T Consensus 222 wslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~l~~li~~c 295 (322)
T 3soc_A 222 YAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVH------KKKRPVLRDYWQKHAGMAMLCETIEEC 295 (322)
T ss_dssp HHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTT------SCCCCCCCGGGGSSHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhc------ccCCCCccccccccchHHHHHHHHHHH
Confidence 999999999999999997532210000 0000111111110000000 000000000001124567799999999
Q ss_pred cccCCCCCCCHHHHHHHHHhhc
Q 001142 1113 TEENPTERPTAGDLYEMFVART 1134 (1142)
Q Consensus 1113 L~~DP~~RPSa~EVL~~L~~~~ 1134 (1142)
|+.||++|||+.||++.+....
T Consensus 296 l~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 296 WDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccCChhhCcCHHHHHHHHHHHH
Confidence 9999999999999999987653
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=363.67 Aligned_cols=268 Identities=24% Similarity=0.246 Sum_probs=203.0
Q ss_pred CCCCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCCh------------------HHHHHhHHhHHHHHHH
Q 001142 804 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSA------------------DEIRNFEYSCLGEVRM 863 (1142)
Q Consensus 804 ~~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~------------------~~~~~~~~~~~~Ei~i 863 (1142)
..+++|++.+.||+|+||.||+|++ .+..+|+|+.......... .........+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 3467899999999999999999987 4667888886533211100 0000111234799999
Q ss_pred HhhCCCCCccceeeeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHH
Q 001142 864 LGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALV 943 (1142)
Q Consensus 864 L~~L~HpNIVkl~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~ 943 (1142)
+++++||||+++++++.+.. ....++||||+++++|.+++. ...+++..+..++.||+.||+
T Consensus 90 l~~l~h~~iv~~~~~~~~~~------------~~~~~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~~~qi~~~l~ 151 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPN------------EDHLYMVFELVNQGPVMEVPT------LKPLSEDQARFYFQDLIKGIE 151 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSS------------SSEEEEEEECCTTCBSCCSSC------SSCCCHHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCeEEEEEEcCC------------CCEEEEEEecCCCCcHHHHhh------cCCCCHHHHHHHHHHHHHHHH
Confidence 99999999999999987632 125699999999999877542 246999999999999999999
Q ss_pred HHHhCCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccC
Q 001142 944 ELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 1023 (1142)
Q Consensus 944 yLHs~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~ 1023 (1142)
|||++||+||||||+|||++.+ +.+||+|||++......... .....||+.|+|||++.+..
T Consensus 152 ~lH~~~ivH~Dlkp~Nil~~~~-------~~~kl~Dfg~~~~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~- 213 (298)
T 2zv2_A 152 YLHYQKIIHRDIKPSNLLVGED-------GHIKIADFGVSNEFKGSDAL----------LSNTVGTPAFMAPESLSETR- 213 (298)
T ss_dssp HHHHTTEECCCCCGGGEEECTT-------SCEEECCCTTCEECSSSSCE----------ECCCCSCGGGCCGGGCCTTC-
T ss_pred HHHHCCeeccCCCHHHEEECCC-------CCEEEecCCCcccccccccc----------ccCCcCCccccChhhhccCC-
Confidence 9999999999999999999887 78999999999765432111 12346999999999987521
Q ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHH
Q 001142 1024 PNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLS 1103 (1142)
Q Consensus 1024 ~~~~s~ksDVwSLGviL~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1103 (1142)
...++.++|||||||++|+|++|+.||.+.........+......... ....++
T Consensus 214 ~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~ 267 (298)
T 2zv2_A 214 KIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPD--------------------------QPDIAE 267 (298)
T ss_dssp CCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS--------------------------SSCCCH
T ss_pred CCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcccCCCCC--------------------------ccccCH
Confidence 112478999999999999999999999887766665555433211100 013456
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001142 1104 FLVDVFRRCTEENPTERPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1104 ~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~ 1133 (1142)
.+.+++.+||+.||++|||+.|+++|+|+.
T Consensus 268 ~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 268 DLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 799999999999999999999999999985
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=356.32 Aligned_cols=261 Identities=22% Similarity=0.289 Sum_probs=204.2
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
++|.+.++||+|+||.||+|++. +..+|+|+........ ..+.+ .+|++++++++||||+++++++.+..
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~----~~E~~~l~~l~hp~iv~~~~~~~~~~- 93 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV---PMEQI----EAEIEVLKSLDHPNIIKIFEVFEDYH- 93 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCS---CHHHH----HHHHHHHHTCCCTTBCCEEEEEECSS-
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccch---hHHHH----HHHHHHHHhCCCchHHhHHHheecCC-
Confidence 46999999999999999999984 5677888765433211 12233 78999999999999999999998654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
..++||||+++++|.+++...... ...+++..+..|+.||+.||+|||++||+||||||+|||++.
T Consensus 94 -------------~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~ 159 (285)
T 3is5_A 94 -------------NMYIVMETCEGGELLERIVSAQAR-GKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQD 159 (285)
T ss_dssp -------------EEEEEECCCSCCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESS
T ss_pred -------------eEEEEEEeCCCCcHHHHHHhhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEec
Confidence 359999999999999999764332 356999999999999999999999999999999999999964
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+. ..+.+||+|||++....... ......||+.|+|||++.+ .++.++||||||+++|+|+
T Consensus 160 ~~----~~~~~kl~Dfg~a~~~~~~~-----------~~~~~~~t~~y~aPE~~~~-----~~~~~~Di~slG~il~~ll 219 (285)
T 3is5_A 160 TS----PHSPIKIIDFGLAELFKSDE-----------HSTNAAGTALYMAPEVFKR-----DVTFKCDIWSAGVVMYFLL 219 (285)
T ss_dssp SS----TTCCEEECCCCCCCC---------------------CTTGGGCCHHHHTT-----CCCHHHHHHHHHHHHHHHH
T ss_pred CC----CCCCEEEEeeecceecCCcc-----------cCcCcccccCcCChHHhcc-----CCCcccCeehHHHHHHHHH
Confidence 31 12679999999997544321 1123468999999999853 5789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~ 1124 (1142)
+|+.||.+....+....+.......... ....++.+.+++.+||+.||.+|||+.
T Consensus 220 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~ 274 (285)
T 3is5_A 220 TGCLPFTGTSLEEVQQKATYKEPNYAVE-------------------------CRPLTPQAVDLLKQMLTKDPERRPSAA 274 (285)
T ss_dssp HSSCSSCCSSHHHHHHHHHHCCCCCCC---------------------------CCCCHHHHHHHHHHTCSCTTTSCCHH
T ss_pred hCCCCCCCCCHHHHHhhhccCCcccccc-------------------------cCcCCHHHHHHHHHHccCChhhCcCHH
Confidence 9999999877766655554332211100 002456789999999999999999999
Q ss_pred HHHHHHHhhc
Q 001142 1125 DLYEMFVART 1134 (1142)
Q Consensus 1125 EVL~~L~~~~ 1134 (1142)
|+++|+|++.
T Consensus 275 e~l~hp~f~~ 284 (285)
T 3is5_A 275 QVLHHEWFKQ 284 (285)
T ss_dssp HHHTSGGGGC
T ss_pred HHhcCHHhhc
Confidence 9999999975
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=369.24 Aligned_cols=266 Identities=25% Similarity=0.358 Sum_probs=217.1
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSK 883 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~~~~~ 883 (1142)
++|++.+.||+|+||.||+|++. +..||||+...............+...+.+|+.+++++ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 45899999999999999999984 77899999765544444455555666678999999999 7999999999988654
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 174 --------------~~~lv~e~~~g~~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~ 234 (365)
T 2y7j_A 174 --------------FMFLVFDLMRKGELFDYLTE-----KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLD 234 (365)
T ss_dssp --------------EEEEEECCCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred --------------EEEEEEEeCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence 45999999999999999976 24689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhcccc--CCCCCCchhhHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH--KPNLYGLEVDIWSYGCLLL 1041 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~--~~~~~s~ksDVwSLGviL~ 1041 (1142)
.+ +.+||+|||++..+..... .....||+.|+|||++.+.. ....++.++|||||||++|
T Consensus 235 ~~-------~~ikl~DfG~~~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ 296 (365)
T 2y7j_A 235 DN-------MQIRLSDFGFSCHLEPGEK-----------LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILF 296 (365)
T ss_dssp TT-------CCEEECCCTTCEECCTTCC-----------BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHH
T ss_pred CC-------CCEEEEecCcccccCCCcc-----------cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHH
Confidence 87 7899999999976543211 12346999999999987532 1235789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1042 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1042 ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
+|++|..||.+.........+..+........+ ...+..+.+++.+||+.||++||
T Consensus 297 ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~------------------------~~~~~~~~~li~~~L~~dP~~Rp 352 (365)
T 2y7j_A 297 TLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEW------------------------DDRSSTVKDLISRLLQVDPEARL 352 (365)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHH------------------------SSSCHHHHHHHHHHSCSSTTTSC
T ss_pred HHHHCCCCCCCCCHHHHHHHHHhCCCCCCCccc------------------------ccCCHHHHHHHHHHcCCChhHCc
Confidence 999999999887777666666554432211111 13456799999999999999999
Q ss_pred CHHHHHHHHHhh
Q 001142 1122 TAGDLYEMFVAR 1133 (1142)
Q Consensus 1122 Sa~EVL~~L~~~ 1133 (1142)
|+.|+++|+|++
T Consensus 353 s~~ell~hp~f~ 364 (365)
T 2y7j_A 353 TAEQALQHPFFE 364 (365)
T ss_dssp CHHHHHHSGGGC
T ss_pred CHHHHhcCcccC
Confidence 999999999986
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=376.90 Aligned_cols=260 Identities=21% Similarity=0.278 Sum_probs=209.5
Q ss_pred CCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
.+.|++.+.||+|+||.||+|.+. +..+|+|+.... ....... +.+|+.++++++||||+++++++.+..
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~----~~~E~~il~~l~hpnIv~~~~~~~~~~ 121 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKYT----VKNEISIMNQLHHPKLINLHDAFEDKY 121 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SHHHHHH----HHHHHHHHTTCCSTTBCCEEEEEECSS
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc----chhhHHH----HHHHHHHHHhCCCcCCCeEEEEEEeCC
Confidence 457999999999999999999984 566788875422 1222233 479999999999999999999998654
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
..++||||+++++|.+++.. ....+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 122 --------------~~~lv~E~~~gg~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~ 183 (387)
T 1kob_A 122 --------------EMVLILEFLSGGELFDRIAA----EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCE 183 (387)
T ss_dssp --------------EEEEEEECCCCCBHHHHTTC----TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES
T ss_pred --------------EEEEEEEcCCCCcHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEe
Confidence 45999999999999998863 234699999999999999999999999999999999999997
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+. .+.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 184 ~~~-----~~~vkL~DFG~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~il~el 243 (387)
T 1kob_A 184 TKK-----ASSVKIIDFGLATKLNPDEI-----------VKVTTATAEFAAPEIVDR----EPVGFYTDMWAIGVLGYVL 243 (387)
T ss_dssp STT-----CCCEEECCCTTCEECCTTSC-----------EEEECSSGGGCCHHHHTT----CCBCHHHHHHHHHHHHHHH
T ss_pred cCC-----CCceEEEecccceecCCCcc-----------eeeeccCCCccCchhccC----CCCCCcccEeeHhHHHHHH
Confidence 542 16799999999976543211 113468999999999876 5688999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
++|..||.+....+....+.......... .....++.+.+||.+||+.||.+|||+
T Consensus 244 ltg~~Pf~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~ 299 (387)
T 1kob_A 244 LSGLSPFAGEDDLETLQNVKRCDWEFDED------------------------AFSSVSPEAKDFIKNLLQKEPRKRLTV 299 (387)
T ss_dssp HHSCCSSCCSSHHHHHHHHHHCCCCCCSS------------------------TTTTSCHHHHHHHHTTSCSSGGGSCCH
T ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCCcc------------------------ccccCCHHHHHHHHHHcCCChhHCcCH
Confidence 99999999887777666665433211100 001456679999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 001142 1124 GDLYEMFVARTS 1135 (1142)
Q Consensus 1124 ~EVL~~L~~~~s 1135 (1142)
.|+++|+|+...
T Consensus 300 ~ell~hp~~~~~ 311 (387)
T 1kob_A 300 HDALEHPWLKGD 311 (387)
T ss_dssp HHHHTSTTTSSC
T ss_pred HHHhhCccccCC
Confidence 999999999865
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=375.06 Aligned_cols=296 Identities=19% Similarity=0.215 Sum_probs=209.5
Q ss_pred CCCCcceeeeeccc--CceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001142 805 SFPSLSSCDEAGKS--VSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 880 (1142)
Q Consensus 805 ~~~~y~l~~~LG~G--sfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~ 880 (1142)
...+|++.++||+| +||.||+|++. +..||+|+..... ......+. +.+|+.++++++|||||++++++.
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~----~~~E~~~l~~l~h~niv~~~~~~~ 96 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEA--CSNEMVTF----LQGELHVSKLFNHPNIVPYRATFI 96 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGG--SCHHHHHH----HHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccc--cChHHHHH----HHHHHHHHHhCCCCCCCcEeEEEE
Confidence 35679999999999 99999999985 6778888865442 23333333 478999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NI 960 (1142)
+.+ ..++||||+++++|.+++... ....+++..+..|+.||+.||+|||++||+||||||+||
T Consensus 97 ~~~--------------~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NI 159 (389)
T 3gni_B 97 ADN--------------ELWVVTSFMAYGSAKDLICTH---FMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHI 159 (389)
T ss_dssp ETT--------------EEEEEEECCTTCBHHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred ECC--------------EEEEEEEccCCCCHHHHHhhh---cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 755 359999999999999999762 234699999999999999999999999999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
|++.+ +.+||+|||.+............ .........||+.|+|||++.+. ...++.++|||||||++
T Consensus 160 ll~~~-------~~~kl~dfg~~~~~~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~DiwslG~il 227 (389)
T 3gni_B 160 LISVD-------GKVYLSGLRSNLSMISHGQRQRV---VHDFPKYSVKVLPWLSPEVLQQN--LQGYDAKSDIYSVGITA 227 (389)
T ss_dssp EECTT-------CCEEECCGGGCEECEETTEECSC---BCCCCTTCTTTGGGSCHHHHSTT--SSCBCTHHHHHHHHHHH
T ss_pred EEcCC-------CCEEEcccccceeeccccccccc---cccccccccccccccCHHHHhcc--CCCCCcHhHHHHHHHHH
Confidence 99877 78999999998754332211100 11122345799999999998752 14688999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccc---------c----cccccc-----cCCCCCCchhhhhhH
Q 001142 1041 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC---------H----EHEVAQ-----SGSGFEKPEAELETL 1102 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~---------~----~~~~~~-----~~~~~~~~~~~~~~~ 1102 (1142)
|+|++|+.||.+....+....+..+..+............ . ...... ..............+
T Consensus 228 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 307 (389)
T 3gni_B 228 CELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFS 307 (389)
T ss_dssp HHHHHSSCTTTTCCSTTHHHHC--------------------------------------------------------CC
T ss_pred HHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccC
Confidence 9999999999876554433332222221111000000000 0 000000 000000001112456
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001142 1103 SFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1103 ~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~~s 1135 (1142)
+.+.+||.+||+.||++|||+.|+++|+|++.-
T Consensus 308 ~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~ 340 (389)
T 3gni_B 308 PHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 340 (389)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred HHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHH
Confidence 789999999999999999999999999999854
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=383.06 Aligned_cols=284 Identities=17% Similarity=0.239 Sum_probs=205.5
Q ss_pred CCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
..+|++.++||+|+||+||+|.+. +..||+|+.... .......+. +.+|+.+++.++|||||++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~--~~~~~~~~~----~~~E~~~l~~l~hpnIv~l~~~~~~~~ 134 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP--FQNQTHAKR----AYRELVLMKCVNHKNIISLLNVFTPQK 134 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESG--GGSHHHHHH----HHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcc--ccChHHHHH----HHHHHHHHHhCCCCCCCcEEEEEccCC
Confidence 468999999999999999999884 566777775422 222233333 479999999999999999999997654
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
.. ....+.|+||||++ ++|.+.+.. .+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 135 ~~--------~~~~~~~lv~E~~~-~~l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~ 198 (464)
T 3ttj_A 135 TL--------EEFQDVYLVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 198 (464)
T ss_dssp ST--------TTCCEEEEEEECCS-EEHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred cc--------ccCCeEEEEEeCCC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEe
Confidence 22 12346799999997 567666632 489999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.+||+|||+|+...... ......||+.|+|||++.+ ..|+.++|||||||++|||
T Consensus 199 ~~-------~~~kl~DFG~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~il~el 256 (464)
T 3ttj_A 199 SD-------CTLKILDFGLARTAGTSF-----------MMTPYVVTRYYRAPEVILG----MGYKENVDIWSVGCIMGEM 256 (464)
T ss_dssp TT-------SCEEECCCCCC-----CC-----------CC----CCCTTCCHHHHTT----CCCCTTHHHHHHHHHHHHH
T ss_pred CC-------CCEEEEEEEeeeecCCCc-----------ccCCCcccccccCHHHHcC----CCCCHHHHHHHHHHHHHHH
Confidence 87 789999999997643311 1224579999999999986 5689999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCC---------------CchhhhhhHHHHHHH
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE---------------KPEAELETLSFLVDV 1108 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~L~dL 1108 (1142)
++|+.||.+.+..+....+........+..+....... ........... ........++.+.+|
T Consensus 257 l~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 335 (464)
T 3ttj_A 257 VRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV-RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDL 335 (464)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHH-HHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHH
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhh-hhHhhcccccCCCChHHhCcccccccccccccccCHHHHHH
Confidence 99999999988777666653322222221111110000 00000000000 011112336789999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhhc
Q 001142 1109 FRRCTEENPTERPTAGDLYEMFVART 1134 (1142)
Q Consensus 1109 I~~CL~~DP~~RPSa~EVL~~L~~~~ 1134 (1142)
|.+||+.||.+|||++|+++|+|+..
T Consensus 336 l~~mL~~dP~~R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 336 LSKMLVIDPAKRISVDDALQHPYINV 361 (464)
T ss_dssp HHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred HHHHcCCChhhCCCHHHHhcChhhhh
Confidence 99999999999999999999999974
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=355.00 Aligned_cols=261 Identities=21% Similarity=0.254 Sum_probs=210.8
Q ss_pred CCCCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001142 803 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 880 (1142)
Q Consensus 803 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~ 880 (1142)
...+++|++.+.||+|+||.||+|++. +..+|+|+..... .........+.+|+.++++++||||+++++++.
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 84 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQ-----LEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH 84 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccc-----cchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE
Confidence 345678999999999999999999985 4567888754221 111122334589999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NI 960 (1142)
+.+ ..++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||
T Consensus 85 ~~~--------------~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Ni 145 (284)
T 2vgo_A 85 DRK--------------RIYLMLEFAPRGELYKELQKH-----GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENL 145 (284)
T ss_dssp CSS--------------EEEEEECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGE
T ss_pred cCC--------------EEEEEEEeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHE
Confidence 654 459999999999999999762 3689999999999999999999999999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
+++.+ +.+||+|||++....... .....||+.|+|||++.+ ..++.++||||||+++
T Consensus 146 l~~~~-------~~~kl~Dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il 202 (284)
T 2vgo_A 146 LMGYK-------GELKIADFGWSVHAPSLR------------RRTMCGTLDYLPPEMIEG----KTHDEKVDLWCAGVLC 202 (284)
T ss_dssp EECTT-------CCEEECCCTTCEECSSSC------------BCCCCSCGGGCCHHHHTT----CCBCTTHHHHHHHHHH
T ss_pred EEcCC-------CCEEEecccccccCcccc------------cccccCCCCcCCHHHhcc----CCCCcccchhhHHHHH
Confidence 99877 789999999986543211 123468999999999876 5678999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1041 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
|+|++|..||......+....+...... .+ ...++.+.+++.+||+.||.+|
T Consensus 203 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~---------------------------~~~~~~~~~li~~~l~~~p~~R 254 (284)
T 2vgo_A 203 YEFLVGMPPFDSPSHTETHRRIVNVDLK-FP---------------------------PFLSDGSKDLISKLLRYHPPQR 254 (284)
T ss_dssp HHHHHSSCTTCCSSHHHHHHHHHTTCCC-CC---------------------------TTSCHHHHHHHHHHSCSSGGGS
T ss_pred HHHHHCCCCCCCCCHhHHHHHHhccccC-CC---------------------------CcCCHHHHHHHHHHhhcCHhhC
Confidence 9999999999887766665555433211 00 1345678999999999999999
Q ss_pred CCHHHHHHHHHhhcCCCC
Q 001142 1121 PTAGDLYEMFVARTSSSI 1138 (1142)
Q Consensus 1121 PSa~EVL~~L~~~~ss~~ 1138 (1142)
||+.++++|+|++.....
T Consensus 255 ps~~~ll~h~~~~~~~~~ 272 (284)
T 2vgo_A 255 LPLKGVMEHPWVKANSRR 272 (284)
T ss_dssp CCHHHHHTCHHHHHHCCC
T ss_pred CCHHHHhhCHHHHhhccc
Confidence 999999999999865443
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=366.53 Aligned_cols=276 Identities=23% Similarity=0.241 Sum_probs=207.9
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCC-CChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCG-SSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~-~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
.+|++.+.||+|+||+||+|.+. +..+|+|+....... ......+ .+.+|+.++++++||||+++++++.+.+
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~----~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVE----RIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHH----HHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHH----HHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 35999999999999999999984 556788876433211 1112223 3489999999999999999999998654
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc-----------------------------------cCCCCCCH
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------------------------------TGEKHVSV 928 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~-----------------------------------~~~~~ls~ 928 (1142)
..++||||+++++|.+++..... .....+++
T Consensus 102 --------------~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (345)
T 3hko_A 102 --------------YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQRE 167 (345)
T ss_dssp --------------EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHH
T ss_pred --------------eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccH
Confidence 35999999999999998842111 01223467
Q ss_pred HHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccC
Q 001142 929 KLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG 1008 (1142)
Q Consensus 929 ~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~G 1008 (1142)
..+..|+.||+.||+|||++||+||||||+|||++.+.. +.+||+|||++..+...... .........|
T Consensus 168 ~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~-----~~~kl~Dfg~a~~~~~~~~~------~~~~~~~~~g 236 (345)
T 3hko_A 168 KLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKS-----FEIKLVDFGLSKEFYKLNNG------EYYGMTTKAG 236 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSS-----CCEEECCCTTCEEGGGTTCC--------------CC
T ss_pred HHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCC-----ceEEEeeccccccccccCcc------ccccccccCC
Confidence 889999999999999999999999999999999986521 48999999999765432211 0111224569
Q ss_pred CCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccccccccccc
Q 001142 1009 TPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS 1088 (1142)
Q Consensus 1009 T~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~ 1088 (1142)
|+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+....+....+..........
T Consensus 237 t~~y~aPE~~~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------------- 298 (345)
T 3hko_A 237 TPYFVAPEVLNTT--NESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENP---------------- 298 (345)
T ss_dssp CGGGCCHHHHTCS--SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSG----------------
T ss_pred CccccCchhhccC--CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCc----------------
Confidence 9999999998642 2468899999999999999999999999887777666654433221110
Q ss_pred CCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCC
Q 001142 1089 GSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSS 1137 (1142)
Q Consensus 1089 ~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~~ss~ 1137 (1142)
.....++.+.+||.+||+.||.+|||+.|+++|+|+..-+.
T Consensus 299 --------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 299 --------NYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339 (345)
T ss_dssp --------GGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred --------ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChH
Confidence 00135667999999999999999999999999999986644
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=373.96 Aligned_cols=293 Identities=19% Similarity=0.254 Sum_probs=201.3
Q ss_pred CCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEecC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISS 882 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~g~~~~~ 882 (1142)
..+|++.+.||+|+||.||+|.+. +..||+|+.. .........+.+ .+|+.+++++. ||||+++++++...
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~--~~~~~~~~~~~~----~~E~~~l~~l~~h~niv~l~~~~~~~ 81 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF--DAFQNSTDAQRT----FREIMILTELSGHENIVNLLNVLRAD 81 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEEC--C--CCHHHHHHH----HHHHHHHHHTTTCTTBCCEEEEEECT
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEec--ccccChHHHHHH----HHHHHHHHhccCCCCCCeeeeEEecC
Confidence 467999999999999999999884 6677887643 222233333333 79999999997 99999999998754
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
+. ...|+||||++ ++|..+++. ..+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 82 ~~------------~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll 142 (388)
T 3oz6_A 82 ND------------RDVYLVFDYME-TDLHAVIRA------NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL 142 (388)
T ss_dssp TS------------SCEEEEEECCS-EEHHHHHHH------TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred CC------------CEEEEEecccC-cCHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEE
Confidence 31 24699999997 799999875 368999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCccccccccccccc-----------ccCCCCCCCCccCCCcccchhhhccccCCCCCCchh
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI-----------AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 1031 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~-----------~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ks 1031 (1142)
+.+ +.+||+|||+|+........... ...........+||+.|+|||++.+ ...|+.++
T Consensus 143 ~~~-------~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~ 212 (388)
T 3oz6_A 143 NAE-------CHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG---STKYTKGI 212 (388)
T ss_dssp CTT-------CCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTT---CCCCCTHH
T ss_pred cCC-------CCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcC---CCCCCChh
Confidence 887 78999999999865331110000 0001112234579999999999875 24688999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-CCCCCchhHHhhhcccccccc----cc----cCCCCCC--ch----
Q 001142 1032 DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM-GKRPRLTDELEALGSCHEHEV----AQ----SGSGFEK--PE---- 1096 (1142)
Q Consensus 1032 DVwSLGviL~ELLtG~~Pf~~~~~~el~~~I~~-~~~p~l~~~l~~~~~~~~~~~----~~----~~~~~~~--~~---- 1096 (1142)
|||||||++|||++|++||.+.+..+....+.. ...|.. ..+........... .. ....... +.
T Consensus 213 DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (388)
T 3oz6_A 213 DMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSN-EDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNL 291 (388)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH-HHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH-HHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhh
Confidence 999999999999999999998887776666532 222221 11111000000000 00 0000000 00
Q ss_pred -----hhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001142 1097 -----AELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1134 (1142)
Q Consensus 1097 -----~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~~ 1134 (1142)
.....++.+.+|+.+||+.||++|||++|+++|+|+..
T Consensus 292 ~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~ 334 (388)
T 3oz6_A 292 LLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSI 334 (388)
T ss_dssp HHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTT
T ss_pred cccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHH
Confidence 00134667999999999999999999999999999864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=362.62 Aligned_cols=267 Identities=23% Similarity=0.270 Sum_probs=203.9
Q ss_pred CCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
.++|++.+.||+|+||.||+|++ .+..+|+|+...... ...... ..+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~----~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 85 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLA-RDPSFY----LRFRREAQNAAALNHPAIVAVYDTGEAET 85 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTT-TSHHHH----HHHHHHHTTCCCCCCTTBCCEEEEEEEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCcccc-CCHHHH----HHHHHHHHHHHcCCCCCcceEEEeeeccC
Confidence 45799999999999999999997 466788887643321 122222 33489999999999999999999987643
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
.. ....++||||+++++|.++++. ...+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 86 ~~----------~~~~~lv~e~~~g~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~ 150 (311)
T 3ork_A 86 PA----------GPLPYIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS 150 (311)
T ss_dssp TT----------EEEEEEEEECCCEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE
T ss_pred CC----------CcccEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEc
Confidence 21 2245999999999999999976 24689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.+||+|||++......... ........||+.|+|||++.+ ..++.++||||||+++|+|
T Consensus 151 ~~-------~~~kl~Dfg~a~~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~~l~~l 212 (311)
T 3ork_A 151 AT-------NAVKVMDFGIARAIADSGNS-------VTQTAAVIGTAQYLSPEQARG----DSVDARSDVYSLGCVLYEV 212 (311)
T ss_dssp TT-------SCEEECCCSCC-------------------------CCTTCCHHHHHT----CCCCHHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEeeccCcccccccccc-------cccccccCcCcccCCHHHhcC----CCCCchHhHHHHHHHHHHH
Confidence 87 78999999999765432111 011223468999999999976 5688999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
++|+.||.+....+....+.......... .....++.+.+++.+||+.||.+||++
T Consensus 213 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~l~~li~~~l~~dP~~R~~~ 268 (311)
T 3ork_A 213 LTGEPPFTGDSPVSVAYQHVREDPIPPSA------------------------RHEGLSADLDAVVLKALAKNPENRYQT 268 (311)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHCCCCCHHH------------------------HSTTCCHHHHHHHHHHTCSSGGGSCSS
T ss_pred HhCCCCCCCCChHHHHHHHhcCCCCCccc------------------------ccCCCCHHHHHHHHHHHhcCHhhChhh
Confidence 99999999877766655443332221110 001456779999999999999999999
Q ss_pred HHHHHHHHhhc
Q 001142 1124 GDLYEMFVART 1134 (1142)
Q Consensus 1124 ~EVL~~L~~~~ 1134 (1142)
.+++.+.|++.
T Consensus 269 ~~~l~~~l~~~ 279 (311)
T 3ork_A 269 AAEMRADLVRV 279 (311)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99999988864
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=355.11 Aligned_cols=257 Identities=24% Similarity=0.356 Sum_probs=200.8
Q ss_pred CcceeeeecccCceEEEEEEECCcc--EEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFGSAD--AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~~~~--vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
.|++.+.||+|+||.||+|.+.... +|+|+. ..........+.+ .+|+.++++++||||+++++++.....
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~--~~~~~~~~~~~~~----~~e~~~l~~l~h~~iv~~~~~~~~~~~- 99 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCEL--QDRKLTKSERQRF----KEEAEMLKGLQHPNIVRFYDSWESTVK- 99 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEE--EGGGSCHHHHHHH----HHHHHHHTTCCCTTBCCEEEEEEEESS-
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEe--cchhhCHHHHHHH----HHHHHHHHhCCCCCeeeeeeeeccccC-
Confidence 4799999999999999999986544 555554 3333333444444 799999999999999999999875321
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCeeec
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENILID 963 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~g--IvHrDLKp~NILld 963 (1142)
.....++||||+++++|.+++... ..+++..+..|+.||+.||.|||++| |+||||||+|||++
T Consensus 100 ---------~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~ 165 (290)
T 1t4h_A 100 ---------GKKCIVLVTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT 165 (290)
T ss_dssp ---------SCEEEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES
T ss_pred ---------CCceEEEEEEecCCCCHHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEE
Confidence 123569999999999999999762 46899999999999999999999999 99999999999997
Q ss_pred -cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 964 -LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 964 -~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
.+ +.+||+|||++....... .....||+.|+|||++.+ .++.++||||||+++|+
T Consensus 166 ~~~-------~~~kl~Dfg~~~~~~~~~------------~~~~~~t~~y~aPE~~~~-----~~~~~~Di~slG~~l~~ 221 (290)
T 1t4h_A 166 GPT-------GSVKIGDLGLATLKRASF------------AKAVIGTPEFMAPEMYEE-----KYDESVDVYAFGMCMLE 221 (290)
T ss_dssp STT-------SCEEECCTTGGGGCCTTS------------BEESCSSCCCCCGGGGGT-----CCCTHHHHHHHHHHHHH
T ss_pred CCC-------CCEEEeeCCCcccccccc------------cccccCCcCcCCHHHHhc-----cCCCcchHHHHHHHHHH
Confidence 44 789999999986433211 123468999999998864 47899999999999999
Q ss_pred HHhCCCCCCCCCH-HHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1043 LLTLQVPYMGLSE-LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1043 LLtG~~Pf~~~~~-~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
|++|+.||..... ......+..+..+.. .....++.+.+++.+||+.||.+||
T Consensus 222 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~l~~li~~~l~~dp~~Rp 275 (290)
T 1t4h_A 222 MATSEYPYSECQNAAQIYRRVTSGVKPAS--------------------------FDKVAIPEVKEIIEGCIRQNKDERY 275 (290)
T ss_dssp HHHSSCTTTTCSSHHHHHHHHTTTCCCGG--------------------------GGGCCCHHHHHHHHHHSCSSGGGSC
T ss_pred HHhCCCCCCCcCcHHHHHHHHhccCCccc--------------------------cCCCCCHHHHHHHHHHccCChhhCC
Confidence 9999999987443 334444433322111 1113345799999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001142 1122 TAGDLYEMFVARTS 1135 (1142)
Q Consensus 1122 Sa~EVL~~L~~~~s 1135 (1142)
|+.|+++|+|++..
T Consensus 276 s~~ell~h~~f~~~ 289 (290)
T 1t4h_A 276 SIKDLLNHAFFQEE 289 (290)
T ss_dssp CHHHHHTSGGGC--
T ss_pred CHHHHhhCcccccC
Confidence 99999999999753
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=373.29 Aligned_cols=260 Identities=23% Similarity=0.283 Sum_probs=204.1
Q ss_pred CCCCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHH-HhhCCCCCccceeeeE
Q 001142 803 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRM-LGALRHSCIVEMYGHK 879 (1142)
Q Consensus 803 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~i-L~~L~HpNIVkl~g~~ 879 (1142)
.....+|++.+.||+|+||.||+|++. +..+|+|+........ ...... +.+|..+ ++.++|||||++++++
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~-~~~~~~----~~~e~~~ll~~~~hp~Iv~l~~~~ 108 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILK-KKEEKH----IMSERNVLLKNVKHPFLVGLHFSF 108 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC------------------CCBCCCCCTTBCCEEEEE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhh-hHHHHH----HHHHHHHHHHhCCCCCCCCEEEEE
Confidence 345678999999999999999999984 5567888865432211 112222 2567776 4678999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 001142 880 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959 (1142)
Q Consensus 880 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~N 959 (1142)
.+.+ ..|+||||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|
T Consensus 109 ~~~~--------------~~~lv~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~N 169 (373)
T 2r5t_A 109 QTAD--------------KLYFVLDYINGGELFYHLQR-----ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPEN 169 (373)
T ss_dssp ECSS--------------EEEEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred EeCC--------------EEEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHH
Confidence 8755 45999999999999999976 2468999999999999999999999999999999999
Q ss_pred eeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001142 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039 (1142)
Q Consensus 960 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGvi 1039 (1142)
||++.+ +.+||+|||+++...... ......+||+.|+|||++.+ ..++.++|||||||+
T Consensus 170 Ill~~~-------g~ikL~DFG~a~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~i 228 (373)
T 2r5t_A 170 ILLDSQ-------GHIVLTDFGLCKENIEHN----------STTSTFCGTPEYLAPEVLHK----QPYDRTVDWWCLGAV 228 (373)
T ss_dssp EEECTT-------SCEEECCCCBCGGGBCCC----------CCCCSBSCCCCCCCHHHHTT----CCCCTHHHHHHHHHH
T ss_pred EEECCC-------CCEEEeeCccccccccCC----------CccccccCCccccCHHHhCC----CCCCchhhhHHHHHH
Confidence 999887 789999999997532211 12235579999999999876 568999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001142 1040 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1119 (1142)
Q Consensus 1040 L~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~ 1119 (1142)
+|||++|..||.+.+..++...+...... ++ ...+..+.+||.+||+.||.+
T Consensus 229 l~ell~G~~Pf~~~~~~~~~~~i~~~~~~-~~---------------------------~~~~~~~~~li~~lL~~dp~~ 280 (373)
T 2r5t_A 229 LYEMLYGLPPFYSRNTAEMYDNILNKPLQ-LK---------------------------PNITNSARHLLEGLLQKDRTK 280 (373)
T ss_dssp HHHHHHSSCTTCCSBHHHHHHHHHHSCCC-CC---------------------------SSSCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHcCCCCCCCCCHHHHHHHHHhcccC-CC---------------------------CCCCHHHHHHHHHHcccCHHh
Confidence 99999999999988887777776543211 00 034567899999999999999
Q ss_pred CCCH----HHHHHHHHhhcC
Q 001142 1120 RPTA----GDLYEMFVARTS 1135 (1142)
Q Consensus 1120 RPSa----~EVL~~L~~~~s 1135 (1142)
||++ .++++|+|++.-
T Consensus 281 R~~~~~~~~~i~~h~~f~~~ 300 (373)
T 2r5t_A 281 RLGAKDDFMEIKSHVFFSLI 300 (373)
T ss_dssp STTTTTTHHHHHTSGGGTTC
T ss_pred CCCCCCCHHHHhCCccccCC
Confidence 9986 699999999753
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=383.80 Aligned_cols=259 Identities=24% Similarity=0.322 Sum_probs=204.5
Q ss_pred CCCCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001142 804 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 881 (1142)
Q Consensus 804 ~~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~ 881 (1142)
...++|++.++||+|+||.||+|++ .+..||+|+....... ....... +.+|+.++++++||||+++++++.+
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~----~~~e~~~l~~l~h~~iv~l~~~~~~ 219 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV-AKDEVAH----TLTENRVLQNSRHPFLTALKYSFQT 219 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC------------------CCCCCSCTTSCCEEEEEEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhh-hhHHHHH----HHHHHHHHHhCCCCeEeeEEEEEee
Confidence 3467899999999999999999998 4667888886533211 1112222 3689999999999999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCe
Q 001142 882 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENI 960 (1142)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs-~gIvHrDLKp~NI 960 (1142)
.+ ..++||||+++++|.+++.. ...+++..+..++.||+.||+|||+ +||+||||||+||
T Consensus 220 ~~--------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NI 280 (446)
T 4ejn_A 220 HD--------------RLCFVMEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENL 280 (446)
T ss_dssp TT--------------EEEEEECCCSSCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGE
T ss_pred CC--------------EEEEEEeeCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHE
Confidence 55 35999999999999999976 2468999999999999999999998 9999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
|++.+ +.+||+|||+|+...... .......||+.|+|||++.+ ..|+.++|||||||++
T Consensus 281 ll~~~-------~~~kl~DFG~a~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il 339 (446)
T 4ejn_A 281 MLDKD-------GHIKITDFGLCKEGIKDG----------ATMKTFCGTPEYLAPEVLED----NDYGRAVDWWGLGVVM 339 (446)
T ss_dssp EECSS-------SCEEECCCCCCCTTCC---------------CCSSSCGGGCCHHHHHT----SCCCTHHHHHHHHHHH
T ss_pred EECCC-------CCEEEccCCCceeccCCC----------cccccccCCccccCHhhcCC----CCCCCccchhhhHHHH
Confidence 99887 789999999997532211 11224579999999999876 5789999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1041 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
|||++|+.||.+.+..+....+...... ++ ...++.+.+||.+||+.||.+|
T Consensus 340 ~ell~g~~Pf~~~~~~~~~~~i~~~~~~-~p---------------------------~~~~~~~~~li~~~L~~dP~~R 391 (446)
T 4ejn_A 340 YEMMCGRLPFYNQDHEKLFELILMEEIR-FP---------------------------RTLGPEAKSLLSGLLKKDPKQR 391 (446)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHCCCC-CC---------------------------TTSCHHHHHHHHHHTCSSTTTS
T ss_pred HHHhhCCCCCCCCCHHHHHHHHHhCCCC-CC---------------------------ccCCHHHHHHHHHHcccCHHHh
Confidence 9999999999988877777666543321 11 0345679999999999999999
Q ss_pred C-----CHHHHHHHHHhhcC
Q 001142 1121 P-----TAGDLYEMFVARTS 1135 (1142)
Q Consensus 1121 P-----Sa~EVL~~L~~~~s 1135 (1142)
| +++|+++|+|+..-
T Consensus 392 ~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 392 LGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp TTCSTTTHHHHHTSGGGTTC
T ss_pred CCCCCCCHHHHHhCccccCC
Confidence 9 99999999999753
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=366.05 Aligned_cols=261 Identities=25% Similarity=0.283 Sum_probs=187.9
Q ss_pred Cccee---eeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEec
Q 001142 808 SLSSC---DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKIS 881 (1142)
Q Consensus 808 ~y~l~---~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~g~~~~ 881 (1142)
+|++. ++||+|+||+||+|.+. +..+|+|+.... .... +.+|+.+++++. ||||+++++++.+
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~----~~~e~~~l~~l~~h~niv~~~~~~~~ 77 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-------MEAN----TQKEITALKLCEGHPNIVKLHEVFHD 77 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-------GHHH----HHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-------hhhh----HHHHHHHHHHhcCCCCeeEEEEEEEc
Confidence 35553 78999999999999984 667888875321 1122 368999999997 9999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 001142 882 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 961 (1142)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NIL 961 (1142)
.. ..++||||+++++|.+++.. ...+++..+..|+.||+.||+|||++||+||||||+|||
T Consensus 78 ~~--------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl 138 (325)
T 3kn6_A 78 QL--------------HTFLVMELLNGGELFERIKK-----KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLL 138 (325)
T ss_dssp SS--------------EEEEEECCCCSCBHHHHHHH-----CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred CC--------------EEEEEEEccCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEE
Confidence 54 35999999999999999986 357999999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001142 962 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1041 (1142)
Q Consensus 962 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ 1041 (1142)
++.++ ....+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|
T Consensus 139 l~~~~----~~~~~kl~Dfg~a~~~~~~~~----------~~~~~~~t~~y~aPE~~~~----~~~~~~~DiwslG~il~ 200 (325)
T 3kn6_A 139 FTDEN----DNLEIKIIDFGFARLKPPDNQ----------PLKTPCFTLHYAAPELLNQ----NGYDESCDLWSLGVILY 200 (325)
T ss_dssp EEC--------CEEEECCCTTCEECCC------------------------------------CCCCHHHHHHHHHHHHH
T ss_pred EecCC----CcccEEEeccccceecCCCCC----------cccccCCCcCccCHHHhcC----CCCCCccchHHHHHHHH
Confidence 97652 114799999999975433211 1123468999999999875 56899999999999999
Q ss_pred HHHhCCCCCCCCCH-------HHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcc
Q 001142 1042 ELLTLQVPYMGLSE-------LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 1114 (1142)
Q Consensus 1042 ELLtG~~Pf~~~~~-------~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~ 1114 (1142)
+|++|+.||.+... .+....+..+....... .....++.+.+||.+||+
T Consensus 201 ~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~s~~~~~li~~~L~ 256 (325)
T 3kn6_A 201 TMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGE------------------------AWKNVSQEAKDLIQGLLT 256 (325)
T ss_dssp HHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSH------------------------HHHTSCHHHHHHHHHHHC
T ss_pred HHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcc------------------------cccCCCHHHHHHHHHHCC
Confidence 99999999976332 33444444333221111 112456789999999999
Q ss_pred cCCCCCCCHHHHHHHHHhhcCCCCCC
Q 001142 1115 ENPTERPTAGDLYEMFVARTSSSISS 1140 (1142)
Q Consensus 1115 ~DP~~RPSa~EVL~~L~~~~ss~~s~ 1140 (1142)
.||.+|||+.|+++|+|++.....++
T Consensus 257 ~dP~~Rpt~~ell~h~w~~~~~~~~~ 282 (325)
T 3kn6_A 257 VDPNKRLKMSGLRYNEWLQDGSQLSS 282 (325)
T ss_dssp CCTTTCCCTTTSTTCGGGCTTCCCCC
T ss_pred CChhHCCCHHHHhcChhhccCccCCC
Confidence 99999999999999999987655443
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=371.32 Aligned_cols=255 Identities=20% Similarity=0.309 Sum_probs=200.5
Q ss_pred ceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCC
Q 001142 810 SSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 887 (1142)
Q Consensus 810 ~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~ 887 (1142)
...+.||+|+||.||+|.+ .+..+|+|+.... .....+.+ .+|+.++++++||||+++++++.+.+
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~----~~~~~~~~----~~E~~~l~~l~hpnIv~~~~~~~~~~---- 159 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR----GMKDKEEV----KNEISVMNQLDHANLIQLYDAFESKN---- 159 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECC----SHHHHHHH----HHHHHHHTTCCCTTBCCEEEEEECSS----
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEccc----ccccHHHH----HHHHHHHHhCCCCCCCeEEEEEEECC----
Confidence 4477899999999999997 4667888886532 22333344 79999999999999999999998654
Q ss_pred CCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccc
Q 001142 888 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 967 (1142)
Q Consensus 888 ~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~ 967 (1142)
..++||||+++++|.+++.. ....+++..+..++.||+.||+|||++||+||||||+|||+..+.
T Consensus 160 ----------~~~lv~E~~~~~~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~- 224 (373)
T 2x4f_A 160 ----------DIVLVMEYVDGGELFDRIID----ESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRD- 224 (373)
T ss_dssp ----------EEEEEEECCTTCEEHHHHHH----TGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETT-
T ss_pred ----------EEEEEEeCCCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCC-
Confidence 35999999999999998875 124689999999999999999999999999999999999995331
Q ss_pred cCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCC
Q 001142 968 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 1047 (1142)
Q Consensus 968 ~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~ 1047 (1142)
.+.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 225 ----~~~~kl~DFG~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~elltg~ 285 (373)
T 2x4f_A 225 ----AKQIKIIDFGLARRYKPREK-----------LKVNFGTPEFLAPEVVNY----DFVSFPTDMWSVGVIAYMLLSGL 285 (373)
T ss_dssp ----TTEEEECCCSSCEECCTTCB-----------CCCCCSSCTTCCHHHHTT----CBCCHHHHHHHHHHHHHHHHHSS
T ss_pred ----CCcEEEEeCCCceecCCccc-----------cccccCCCcEeChhhccC----CCCCcHHhHHHHHHHHHHHHhCC
Confidence 17899999999976543211 123469999999999875 56889999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHH
Q 001142 1048 VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY 1127 (1142)
Q Consensus 1048 ~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL 1127 (1142)
.||.+....+....+........... ....++.+.+||.+||+.||.+|||+.|++
T Consensus 286 ~pf~~~~~~~~~~~i~~~~~~~~~~~------------------------~~~~~~~~~~li~~~L~~dp~~Rps~~e~l 341 (373)
T 2x4f_A 286 SPFLGDNDAETLNNILACRWDLEDEE------------------------FQDISEEAKEFISKLLIKEKSWRISASEAL 341 (373)
T ss_dssp CTTCCSSHHHHHHHHHHTCCCSCSGG------------------------GTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred CCCCCCCHHHHHHHHHhccCCCChhh------------------------hccCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 99998887777666654432111100 014566799999999999999999999999
Q ss_pred HHHHhhc
Q 001142 1128 EMFVART 1134 (1142)
Q Consensus 1128 ~~L~~~~ 1134 (1142)
+|+|+..
T Consensus 342 ~hp~~~~ 348 (373)
T 2x4f_A 342 KHPWLSD 348 (373)
T ss_dssp HSHHHHC
T ss_pred cCcCcCC
Confidence 9999874
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=362.48 Aligned_cols=264 Identities=22% Similarity=0.268 Sum_probs=210.9
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCCh--HHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSA--DEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 882 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~--~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~ 882 (1142)
+.|++.+.||+|+||.||+|++. +..+|+|+.......... ...+. +.+|+.++++++||||+++++++.+.
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~~~~ 87 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE----IEREVSILRQVLHHNVITLHDVYENR 87 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHH----HHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHH----HHHHHHHHHhCCCCCcceEEEEEecC
Confidence 35899999999999999999984 667899886544322111 11233 37999999999999999999999865
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
. ..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 88 ~--------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~ 148 (321)
T 2a2a_A 88 T--------------DVVLILELVSGGELFDFLAQ-----KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIML 148 (321)
T ss_dssp S--------------EEEEEECCCCSCBHHHHHHT-----CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred C--------------EEEEEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEE
Confidence 4 35999999999999999975 3568999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
+.++. ....+||+|||++....... ......||+.|+|||++.+ ..++.++||||||+++|+
T Consensus 149 ~~~~~---~~~~~kl~Dfg~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il~~ 210 (321)
T 2a2a_A 149 LDKNI---PIPHIKLIDFGLAHEIEDGV-----------EFKNIFGTPEFVAPEIVNY----EPLGLEADMWSIGVITYI 210 (321)
T ss_dssp SCTTS---SSCCEEECCCTTCEECCTTC-----------CCCCCCSCGGGCCHHHHTT----CCCCTHHHHHHHHHHHHH
T ss_pred ecCCC---CcCCEEEccCccceecCccc-----------cccccCCCCCccCcccccC----CCCCCccccHHHHHHHHH
Confidence 87621 11279999999997654321 1123468999999999875 568899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1043 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1043 LLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
|++|..||.+....+....+........... ....++.+.+++.+||+.||.+|||
T Consensus 211 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~------------------------~~~~~~~~~~li~~~l~~dp~~Rps 266 (321)
T 2a2a_A 211 LLSGASPFLGDTKQETLANITSVSYDFDEEF------------------------FSHTSELAKDFIRKLLVKETRKRLT 266 (321)
T ss_dssp HHHSCCSSCCSSHHHHHHHHHTTCCCCCHHH------------------------HTTCCHHHHHHHHTTSCSSTTTSCC
T ss_pred HHHCCCCCCCCCHHHHHHHHHhcccccChhh------------------------hcccCHHHHHHHHHHcCCChhhCcC
Confidence 9999999998877777666654432211110 1144567999999999999999999
Q ss_pred HHHHHHHHHhhcC
Q 001142 1123 AGDLYEMFVARTS 1135 (1142)
Q Consensus 1123 a~EVL~~L~~~~s 1135 (1142)
+.|+++|+|+...
T Consensus 267 ~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 267 IQEALRHPWITPV 279 (321)
T ss_dssp HHHHHHSTTTSCS
T ss_pred HHHHhcCccccCC
Confidence 9999999999753
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=373.03 Aligned_cols=262 Identities=23% Similarity=0.300 Sum_probs=207.6
Q ss_pred CCCCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001142 803 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 880 (1142)
Q Consensus 803 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~ 880 (1142)
...+++|++.+.||+|+||.||+|++. +..+|+|+...... ........+.+|+.++++++|||||++++++.
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~-----~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 85 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKC-----VERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ 85 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhc-----ccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 455788999999999999999999984 55688887643211 11111233478999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NI 960 (1142)
+.. ..++||||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 86 ~~~--------------~~~lv~e~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NI 146 (384)
T 4fr4_A 86 DEE--------------DMFMVVDLLLGGDLRYHLQQ-----NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNI 146 (384)
T ss_dssp CSS--------------EEEEEECCCTTEEHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred eCC--------------EEEEEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHe
Confidence 755 35999999999999999975 35699999999999999999999999999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
|++.+ +.+||+|||+++...... ......||+.|+|||++... .+..|+.++|||||||++
T Consensus 147 ll~~~-------g~vkL~DFG~a~~~~~~~-----------~~~~~~gt~~Y~aPE~~~~~-~~~~~~~~~DiwSlG~il 207 (384)
T 4fr4_A 147 LLDEH-------GHVHITDFNIAAMLPRET-----------QITTMAGTKPYMAPEMFSSR-KGAGYSFAVDWWSLGVTA 207 (384)
T ss_dssp EECTT-------SCEEECCCTTCEECCTTC-----------CBCCCCSCGGGCCGGGTCCC-SSCCBCTTHHHHHHHHHH
T ss_pred EECCC-------CCEEEeccceeeeccCCC-----------ceeccCCCccccCCeeeccC-CCCCCCccceeechHHHH
Confidence 99887 789999999997654321 12245799999999998642 124588999999999999
Q ss_pred HHHHhCCCCCCCCC---HHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001142 1041 LELLTLQVPYMGLS---ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1117 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~~~---~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP 1117 (1142)
|+|++|+.||.... ..+....+...... .+ ...++.+.+||.+||+.||
T Consensus 208 ~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~-~p---------------------------~~~s~~~~~li~~lL~~dP 259 (384)
T 4fr4_A 208 YELLRGRRPYHIRSSTSSKEIVHTFETTVVT-YP---------------------------SAWSQEMVSLLKKLLEPNP 259 (384)
T ss_dssp HHHHHSSCSSCCCTTSCHHHHHHHHHHCCCC-CC---------------------------TTSCHHHHHHHHHHSCSSG
T ss_pred HHHHhCCCCCCCCCCccHHHHHHHHhhcccC-CC---------------------------CcCCHHHHHHHHHHhcCCH
Confidence 99999999997432 33333333322211 00 1445679999999999999
Q ss_pred CCCCC-HHHHHHHHHhhcC
Q 001142 1118 TERPT-AGDLYEMFVARTS 1135 (1142)
Q Consensus 1118 ~~RPS-a~EVL~~L~~~~s 1135 (1142)
.+||+ ++++++|+|+..-
T Consensus 260 ~~R~s~~~~l~~hp~f~~~ 278 (384)
T 4fr4_A 260 DQRFSQLSDVQNFPYMNDI 278 (384)
T ss_dssp GGSCCSHHHHHTSGGGTTC
T ss_pred hHhcccHHHHHcChhhhcC
Confidence 99998 9999999999753
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=368.41 Aligned_cols=289 Identities=22% Similarity=0.236 Sum_probs=205.2
Q ss_pred CCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
..+|++.+.||+|+||.||+|++. +..+|+|+....... .........+.+|+.++++++||||+++++++.+..
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRS---EAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC---------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcc---hhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 567999999999999999999984 667888875432211 111122233479999999999999999999997655
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
.. ++||||++ ++|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 86 ~~--------------~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~ 146 (346)
T 1ua2_A 86 NI--------------SLVFDFME-TDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD 146 (346)
T ss_dssp CC--------------EEEEECCS-EEHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred ce--------------EEEEEcCC-CCHHHHHHh----cCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEc
Confidence 33 99999998 588888764 234689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.+||+|||+++....... ......||+.|+|||++.+ ...++.++|||||||++|+|
T Consensus 147 ~~-------~~~kl~Dfg~a~~~~~~~~----------~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~el 206 (346)
T 1ua2_A 147 EN-------GVLKLADFGLAKSFGSPNR----------AYTHQVVTRWYRAPELLFG---ARMYGVGVDMWAVGCILAEL 206 (346)
T ss_dssp TT-------CCEEECCCGGGSTTTSCCC----------CCCCSCCCCTTCCHHHHTT---CSCCCHHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEEecccceeccCCcc----------cCCcccccccccCchHhhC---CCCCCchhhhHhHHHHHHHH
Confidence 87 7899999999976543211 1224468999999999865 24578999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
++|.+||.+....+....+...........+...........................++.+.+||.+||+.||.+|||+
T Consensus 207 l~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 286 (346)
T 1ua2_A 207 LLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA 286 (346)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCH
T ss_pred HHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCH
Confidence 99999999887776665553321111111110000000000000000000001112456789999999999999999999
Q ss_pred HHHHHHHHhhcCC
Q 001142 1124 GDLYEMFVARTSS 1136 (1142)
Q Consensus 1124 ~EVL~~L~~~~ss 1136 (1142)
.|+++|+|+....
T Consensus 287 ~ell~h~~f~~~~ 299 (346)
T 1ua2_A 287 TQALKMKYFSNRP 299 (346)
T ss_dssp HHHHTSGGGTSSS
T ss_pred HHHhcChhhhcCC
Confidence 9999999998653
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=363.23 Aligned_cols=279 Identities=24% Similarity=0.279 Sum_probs=200.5
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
.+|++.+.||+|+||.||+|++. +..+|+|+..... .....+. +.+|+.++++++|||||++++++.+...
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~----~~~E~~~l~~l~hpniv~~~~~~~~~~~ 78 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREK----VMREVKALAKLEHPGIVRYFNAWLETPP 78 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS---TTTHHHH----HHHHHHHHTSCCCTTBCCEEEEEEECCS
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC---chhHHHH----HHHHHHHHHhCCCCCEeeEEEEEEEecc
Confidence 46899999999999999999984 6778998865432 1222233 3799999999999999999999865431
Q ss_pred CC-----------C--------------------------------CCCCCccccceEEEEEeccCCCCHHHHHHHHhcc
Q 001142 885 LP-----------S--------------------------------ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET 921 (1142)
Q Consensus 885 ~~-----------~--------------------------------~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~ 921 (1142)
.. . ............++||||+++++|.+++... .
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~ 156 (332)
T 3qd2_B 79 EKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR--C 156 (332)
T ss_dssp CHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTC--C
T ss_pred chhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcc--c
Confidence 00 0 0000011223479999999999999999762 2
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccc--cCC
Q 001142 922 GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA--HRG 999 (1142)
Q Consensus 922 ~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~--~~~ 999 (1142)
.....++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++............ ...
T Consensus 157 ~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-------~~~kL~DfG~a~~~~~~~~~~~~~~~~~~ 229 (332)
T 3qd2_B 157 SLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD-------DVVKVGDFGLVTAMDQDEEEQTVLTPMPA 229 (332)
T ss_dssp SGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-------CCEEECCCTTCEECSCC------------
T ss_pred CccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCC-------CCEEEeecCcccccccchhhccccccccc
Confidence 22345777899999999999999999999999999999999877 789999999998765432110000 000
Q ss_pred CCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcc
Q 001142 1000 IPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGS 1079 (1142)
Q Consensus 1000 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~ 1079 (1142)
........||+.|+|||++.+ ..++.++|||||||++|+|++|..|+.. .......+.....+.
T Consensus 230 ~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~---------- 293 (332)
T 3qd2_B 230 YATHTGQVGTKLYMSPEQIHG----NNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPL---------- 293 (332)
T ss_dssp --CCCSCC-CGGGSCHHHHHC----CCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCH----------
T ss_pred cccccccCCCcCccChHHhcC----CCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCc----------
Confidence 112234569999999999876 5689999999999999999998766531 122223333222211
Q ss_pred cccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001142 1080 CHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1134 (1142)
Q Consensus 1080 ~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~~ 1134 (1142)
.....++.+.+++.+||+.||.+|||+.|+++|+|++.
T Consensus 294 -----------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 294 -----------------LFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp -----------------HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred -----------------ccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 11144566899999999999999999999999999864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=362.50 Aligned_cols=265 Identities=23% Similarity=0.372 Sum_probs=211.1
Q ss_pred CCCCcceeeeecccCceEEEEEEECC-------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceee
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 877 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~~~-------~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g 877 (1142)
..++|++.+.||+|+||.||+|++.+ ..+|+|+.... ......+. +.+|+.++++++||||+++++
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~----~~~E~~~l~~l~hp~iv~~~~ 117 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE---ASADMQAD----FQREAALMAEFDNPNIVKLLG 117 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT---CCHHHHHH----HHHHHHHHHTCCCTTBCCEEE
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccc---cCHHHHHH----HHHHHHHHHhCCCCCEEEEEE
Confidence 34679999999999999999999853 56788774321 12233333 489999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc-------------------CCCCCCHHHHHHHHHHH
Q 001142 878 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-------------------GEKHVSVKLALFIAQDV 938 (1142)
Q Consensus 878 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~-------------------~~~~ls~~~i~~Ia~qI 938 (1142)
++.+.+.. ++||||+++++|.+++...... ....+++..++.|+.||
T Consensus 118 ~~~~~~~~--------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 183 (343)
T 1luf_A 118 VCAVGKPM--------------CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQV 183 (343)
T ss_dssp EECSSSSC--------------EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHH
T ss_pred EEccCCce--------------EEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHH
Confidence 99865543 9999999999999999863211 12568999999999999
Q ss_pred HHHHHHHHhCCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhh
Q 001142 939 AAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1018 (1142)
Q Consensus 939 a~gL~yLHs~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l 1018 (1142)
+.||.|||++||+||||||+|||++.+ +.+||+|||++......... .......+|+.|+|||++
T Consensus 184 ~~~l~~LH~~~ivH~Dlkp~NIl~~~~-------~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~~t~~y~aPE~~ 248 (343)
T 1luf_A 184 AAGMAYLSERKFVHRDLATRNCLVGEN-------MVVKIADFGLSRNIYSADYY--------KADGNDAIPIRWMPPESI 248 (343)
T ss_dssp HHHHHHHHHTTCCCSCCSGGGEEECGG-------GCEEECCCSCHHHHTGGGCB--------C----CCBCGGGCCHHHH
T ss_pred HHHHHHHHhCCeecCCCCcceEEECCC-------CeEEEeecCCCcccccCccc--------cccCCCcccceecChhhh
Confidence 999999999999999999999999887 78999999999765432111 111234578999999998
Q ss_pred ccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchh
Q 001142 1019 RAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 1097 (1142)
Q Consensus 1019 ~~~~~~~~~s~ksDVwSLGviL~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~ 1097 (1142)
.+ ..++.++||||||+++|+|++ |..||.+....+....+..+..+..+.
T Consensus 249 ~~----~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~------------------------- 299 (343)
T 1luf_A 249 FY----NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPE------------------------- 299 (343)
T ss_dssp HH----CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCT-------------------------
T ss_pred cc----CCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCcCCCCC-------------------------
Confidence 76 568899999999999999999 999999888777777766554332221
Q ss_pred hhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 001142 1098 ELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSS 1136 (1142)
Q Consensus 1098 ~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~~ss 1136 (1142)
.+++.+.+++.+||+.||.+|||+.++++++......
T Consensus 300 --~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 300 --NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp --TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred --CCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 4456799999999999999999999999998876543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=370.91 Aligned_cols=269 Identities=21% Similarity=0.341 Sum_probs=213.0
Q ss_pred CCCCCCcceeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccce
Q 001142 803 PGSFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 875 (1142)
Q Consensus 803 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~-------~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl 875 (1142)
.....+|++.++||+|+||+||+|++. +..||+|+.. .. ........+ .+|+.++++++|||||++
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~--~~-~~~~~~~~~----~~E~~~l~~l~hpnIv~~ 139 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP--EV-CSEQDELDF----LMEALIISKFNHQNIVRC 139 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECC--SS-CCHHHHHHH----HHHHHHHHHCCCTTBCCE
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecc--cc-cChhhHHHH----HHHHHHHHhCCCCCCCeE
Confidence 344567999999999999999999963 3357777643 21 223333334 789999999999999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 001142 876 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET--GEKHVSVKLALFIAQDVAAALVELHSKHIMHR 953 (1142)
Q Consensus 876 ~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~--~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHr 953 (1142)
++++.+.... ++||||+++|+|.+++...... ....+++..++.|+.||+.||+|||++||+||
T Consensus 140 ~~~~~~~~~~--------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr 205 (367)
T 3l9p_A 140 IGVSLQSLPR--------------FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHR 205 (367)
T ss_dssp EEEECSSSSC--------------EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EEEEecCCCC--------------EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCC
Confidence 9999865543 9999999999999999874321 12458999999999999999999999999999
Q ss_pred CCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhH
Q 001142 954 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 1033 (1142)
Q Consensus 954 DLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDV 1033 (1142)
||||+|||++.++ ....+||+|||+++....... ........||+.|+|||++.+ ..++.++||
T Consensus 206 Dlkp~NIll~~~~----~~~~~kL~DFG~a~~~~~~~~--------~~~~~~~~~t~~y~aPE~~~~----~~~~~~~Dv 269 (367)
T 3l9p_A 206 DIAARNCLLTCPG----PGRVAKIGDFGMARDIYRAGY--------YRKGGCAMLPVKWMPPEAFME----GIFTSKTDT 269 (367)
T ss_dssp CCCGGGEEESCSS----TTCCEEECCCHHHHHHHHHSS--------CTTCCGGGSCGGGCCHHHHHH----CCCCHHHHH
T ss_pred CCChhhEEEecCC----CCceEEECCCccccccccccc--------cccCCCcCCcccEECHHHhcC----CCCCcHHHH
Confidence 9999999998542 115699999999975432211 111224468999999999876 568999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHh
Q 001142 1034 WSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 1112 (1142)
Q Consensus 1034 wSLGviL~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~C 1112 (1142)
|||||++|||++ |..||.+....++...+..+..+..+. ..++.+.+|+.+|
T Consensus 270 wslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~~ 322 (367)
T 3l9p_A 270 WSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK---------------------------NCPGPVYRIMTQC 322 (367)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------cCCHHHHHHHHHH
Confidence 999999999998 999999888888777776654432221 3456699999999
Q ss_pred cccCCCCCCCHHHHHHHHHhhcC
Q 001142 1113 TEENPTERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1113 L~~DP~~RPSa~EVL~~L~~~~s 1135 (1142)
|+.||.+|||+.+|+++++....
T Consensus 323 l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 323 WQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCHhHCcCHHHHHHHHHHHhh
Confidence 99999999999999999988643
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=349.03 Aligned_cols=261 Identities=23% Similarity=0.363 Sum_probs=209.1
Q ss_pred CCCCCCcceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001142 803 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 882 (1142)
Q Consensus 803 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~ 882 (1142)
...+++|++.+.||+|+||.||+|++.+..+|+|++... .......+.+ .+|+.++++++||||+++++++.+.
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~--~~~~~~~~~~----~~E~~~l~~l~h~~iv~~~~~~~~~ 79 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVR--DWSTRKSRDF----NEECPRLRIFSHPNVLPVLGACQSP 79 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCT--TCCHHHHHHH----HHHGGGGCCCSCTTEECEEEEECTT
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEeccc--ccCHHHHHHH----HHHHHHHHhcCCCchhheEEEEccC
Confidence 345678999999999999999999999999999987543 2233434444 8999999999999999999998764
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCe
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENI 960 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~g--IvHrDLKp~NI 960 (1142)
.. .+.++||||+++++|.+++.. .....+++..+..|+.||+.||.|||++| |+||||||+||
T Consensus 80 ~~------------~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Ni 144 (271)
T 3kmu_A 80 PA------------PHPTLITHWMPYGSLYNVLHE---GTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSV 144 (271)
T ss_dssp TS------------SSCEEEEECCTTCBHHHHHHS---CSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGE
T ss_pred CC------------CCeEeeecccCCCcHHHHHhh---cccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceE
Confidence 21 134999999999999999975 23336899999999999999999999999 99999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
|++.+ +.++|+|||++..... ....||+.|+|||++.+.. ...++.++||||||+++
T Consensus 145 l~~~~-------~~~~l~~~~~~~~~~~---------------~~~~~t~~y~aPE~~~~~~-~~~~~~~~Di~slG~il 201 (271)
T 3kmu_A 145 MIDED-------MTARISMADVKFSFQS---------------PGRMYAPAWVAPEALQKKP-EDTNRRSADMWSFAVLL 201 (271)
T ss_dssp EECTT-------SCEEEEGGGSCCTTSC---------------TTCBSCGGGSCHHHHHSCG-GGSCHHHHHHHHHHHHH
T ss_pred EEcCC-------cceeEEeccceeeecc---------------cCccCCccccChhhhccCC-CCCCCchhhHHHHHHHH
Confidence 99877 7899999888753221 1335899999999987521 12344589999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHh-CCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001142 1041 LELLTLQVPYMGLSELEIHDLIQM-GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1119 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~~~~~el~~~I~~-~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~ 1119 (1142)
|+|++|+.||.+....+....+.. ...+..+ ...++.+.+++.+||+.||.+
T Consensus 202 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~ 254 (271)
T 3kmu_A 202 WELVTREVPFADLSNMEIGMKVALEGLRPTIP---------------------------PGISPHVSKLMKICMNEDPAK 254 (271)
T ss_dssp HHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCC---------------------------TTCCHHHHHHHHHHTCSSGGG
T ss_pred HHHHhCCCCccccChHHHHHHHHhcCCCCCCC---------------------------CCCCHHHHHHHHHHcCCChhh
Confidence 999999999998777666554432 2222211 145567999999999999999
Q ss_pred CCCHHHHHHHHHhhc
Q 001142 1120 RPTAGDLYEMFVART 1134 (1142)
Q Consensus 1120 RPSa~EVL~~L~~~~ 1134 (1142)
|||+.++++.+....
T Consensus 255 Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 255 RPKFDMIVPILEKMQ 269 (271)
T ss_dssp SCCHHHHHHHHHHHC
T ss_pred CcCHHHHHHHHHHhh
Confidence 999999999887653
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=383.36 Aligned_cols=268 Identities=22% Similarity=0.287 Sum_probs=211.3
Q ss_pred CCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCC-----hHHHHHhHHhHHHHHHHHhhCCCCCccceeee
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSS-----ADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 878 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~-----~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~ 878 (1142)
..+|++.++||+|+||+||+|++. +..+|+|+......... ....+.....+.+|+.++++++|||||+++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 357999999999999999999984 56788888653321110 01112233455899999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 001142 879 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 958 (1142)
Q Consensus 879 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~ 958 (1142)
+.+.. ..++||||+++|+|.+++.. ...+++..+..|+.||+.||.|||++||+||||||+
T Consensus 115 ~~~~~--------------~~~lv~e~~~gg~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~ 175 (504)
T 3q5i_A 115 FEDKK--------------YFYLVTEFYEGGELFEQIIN-----RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPE 175 (504)
T ss_dssp EECSS--------------EEEEEEECCTTCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred EEcCC--------------EEEEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHH
Confidence 98655 45999999999999999876 246999999999999999999999999999999999
Q ss_pred CeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001142 959 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1038 (1142)
Q Consensus 959 NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGv 1038 (1142)
|||++.++ ....+||+|||++....... ......||+.|+|||++.+ .++.++|||||||
T Consensus 176 Nil~~~~~----~~~~~kl~Dfg~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~ 235 (504)
T 3q5i_A 176 NILLENKN----SLLNIKIVDFGLSSFFSKDY-----------KLRDRLGTAYYIAPEVLKK-----KYNEKCDVWSCGV 235 (504)
T ss_dssp GEEESSTT----CCSSEEECCCTTCEECCTTS-----------CBCCCCSCTTTCCHHHHTT-----CBCTHHHHHHHHH
T ss_pred HEEEecCC----CCccEEEEECCCCEEcCCCC-----------ccccccCCcCCCCHHHhcc-----CCCchHHHHHHHH
Confidence 99998652 12469999999997654321 1123469999999999864 5789999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001142 1039 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1118 (1142)
Q Consensus 1039 iL~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~ 1118 (1142)
++|+|++|..||.+.+..++...+..+........+ ...++.+.+||.+||+.||.
T Consensus 236 il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~------------------------~~~s~~~~~li~~~L~~dp~ 291 (504)
T 3q5i_A 236 IMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDW------------------------KNISDEAKELIKLMLTYDYN 291 (504)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH------------------------TTSCHHHHHHHHHHTCSSTT
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccc------------------------CCCCHHHHHHHHHHcCCChh
Confidence 999999999999998888888887666543221111 14566799999999999999
Q ss_pred CCCCHHHHHHHHHhhcCC
Q 001142 1119 ERPTAGDLYEMFVARTSS 1136 (1142)
Q Consensus 1119 ~RPSa~EVL~~L~~~~ss 1136 (1142)
+|||+.|+++|+|++...
T Consensus 292 ~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 292 KRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp TSCCHHHHHTSHHHHHTC
T ss_pred HCCCHHHHhcCHhhhhch
Confidence 999999999999998654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=366.48 Aligned_cols=291 Identities=22% Similarity=0.266 Sum_probs=211.2
Q ss_pred CCCCCCCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceee
Q 001142 800 GLDPGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 877 (1142)
Q Consensus 800 ~~~~~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g 877 (1142)
.+....+++|++.+.||+|+||.||+|++. +..+|+|+.... .......+. +.+|+.++++++||||+++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~----~~~E~~~l~~l~h~~iv~~~~ 91 (331)
T 4aaa_A 18 NLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLES--DDDKMVKKI----AMREIKLLKQLRHENLVNLLE 91 (331)
T ss_dssp -CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESC--SSCHHHHHH----HHHHHHHHHHCCCTTBCCEEE
T ss_pred hhhhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecC--CCchHHHHH----HHHHHHHHhhCCCCCEeeEEE
Confidence 455667889999999999999999999985 667888875422 223232333 378999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 001142 878 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 957 (1142)
Q Consensus 878 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp 957 (1142)
++.+.+ ..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||
T Consensus 92 ~~~~~~--------------~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp 152 (331)
T 4aaa_A 92 VCKKKK--------------RWYLVFEFVDHTILDDLELF-----PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKP 152 (331)
T ss_dssp EEEETT--------------EEEEEEECCSEEHHHHHHHS-----TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred EeecCC--------------EEEEEEecCCcchHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcCh
Confidence 998655 34999999998888887653 34699999999999999999999999999999999
Q ss_pred CCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHH
Q 001142 958 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1037 (1142)
Q Consensus 958 ~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLG 1037 (1142)
+|||++.+ +.+||+|||++........ ......||+.|+|||++.+ ...++.++||||||
T Consensus 153 ~Nil~~~~-------~~~kl~Dfg~~~~~~~~~~----------~~~~~~~t~~y~aPE~~~~---~~~~~~~~Di~slG 212 (331)
T 4aaa_A 153 ENILVSQS-------GVVKLCDFGFARTLAAPGE----------VYDDEVATRWYRAPELLVG---DVKYGKAVDVWAIG 212 (331)
T ss_dssp GGEEECTT-------SCEEECCCTTC----------------------CCCCCTTCCHHHHTT---CTTCCTHHHHHHHH
T ss_pred heEEEcCC-------CcEEEEeCCCceeecCCcc----------ccCCCcCCccccCcccccC---CCCcchHHHHHHHH
Confidence 99999887 7899999999976543211 1123468999999999875 23678999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHh---hhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcc
Q 001142 1038 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELE---ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 1114 (1142)
Q Consensus 1038 viL~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~ 1114 (1142)
|++|+|++|+.||.+....+....+........+.... ..........................++.+.+|+.+||+
T Consensus 213 ~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 292 (331)
T 4aaa_A 213 CLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLH 292 (331)
T ss_dssp HHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTC
T ss_pred HHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhc
Confidence 99999999999999877766554443221111111111 000000000000000000111112457789999999999
Q ss_pred cCCCCCCCHHHHHHHHHhhcC
Q 001142 1115 ENPTERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1115 ~DP~~RPSa~EVL~~L~~~~s 1135 (1142)
.||++|||+.|+++|+|++..
T Consensus 293 ~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 293 IDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp SSGGGSCCGGGGGGSHHHHGG
T ss_pred cCcccCCCHHHHhcCchhccC
Confidence 999999999999999999754
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=368.79 Aligned_cols=286 Identities=19% Similarity=0.219 Sum_probs=205.1
Q ss_pred CCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
..+|++.+.||+|+||.||+|.+. +..||+|+. ..........+ ++.+|+.++++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~--~~~~~~~~~~~----~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 97 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL--YRPFQSELFAK----RAYRELRLLKHMRHENVIGLLDVFTPDE 97 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEEC--SSTTSSHHHHH----HHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEe--CccccCHHHHH----HHHHHHHHHHhCCCcCCCCceeeEecCC
Confidence 357999999999999999999984 566777763 33222333233 3489999999999999999999987653
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
.. ......|+||||+ +++|.++++. ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 98 ~~--------~~~~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~ 162 (367)
T 1cm8_A 98 TL--------DDFTDFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN 162 (367)
T ss_dssp ST--------TTCCCCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred cc--------ccCceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEc
Confidence 22 1123459999999 7999999875 3589999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.+||+|||+++..... .....||+.|+|||++.+ ...++.++|||||||++|||
T Consensus 163 ~~-------~~~kl~Dfg~a~~~~~~-------------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~el 219 (367)
T 1cm8_A 163 ED-------CELKILDFGLARQADSE-------------MTGYVVTRWYRAPEVILN---WMRYTQTVDIWSVGCIMAEM 219 (367)
T ss_dssp TT-------CCEEECCCTTCEECCSS-------------CCSSCSCGGGCCTHHHHT---TTCCCTTHHHHHHHHHHHHH
T ss_pred CC-------CCEEEEeeecccccccc-------------cCcCcCCCCcCCHHHHhC---CCCCChhhhHHHHHHHHHHH
Confidence 87 78999999999764321 123468999999999875 24688999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccccccccccc---CCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS---GSGFEKPEAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
++|+.||.+.+..+....+......................+... .............++.+.+|+.+||+.||.+|
T Consensus 220 l~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R 299 (367)
T 1cm8_A 220 ITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQR 299 (367)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTS
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHC
Confidence 999999998877766665533221111111111100000000000 00000011112456789999999999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 001142 1121 PTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1121 PSa~EVL~~L~~~~s 1135 (1142)
||+.|+++|+|+..-
T Consensus 300 ~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 300 VTAGEALAHPYFESL 314 (367)
T ss_dssp CCHHHHHHSGGGTTT
T ss_pred CCHHHHhcChHHHhh
Confidence 999999999999754
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=365.79 Aligned_cols=285 Identities=19% Similarity=0.212 Sum_probs=204.7
Q ss_pred CCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
+++|++.++||+|+||+||+|++. +..+|+|+...... ......+ .+|+.++++++||||+++++++.+.+
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~----~~E~~~l~~l~h~~iv~~~~~~~~~~ 73 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE---EGAPCTA----IREVSLLKDLKHANIVTLHDIIHTEK 73 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC---------CCCC----CCCHHHHSCCCCTTBCCEEEEEECSS
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc---cccchhH----HHHHHHHHhcCCCCCCeeeeEEeeCC
Confidence 468999999999999999999984 66788887643321 1111122 57999999999999999999998655
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
. .++||||++ ++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 74 ~--------------~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~ 134 (324)
T 3mtl_A 74 S--------------LTLVFEYLD-KDLKQYLDDC----GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLIN 134 (324)
T ss_dssp C--------------EEEEEECCS-EEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEEC
T ss_pred E--------------EEEEecccc-cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEEC
Confidence 3 499999997 6999998762 34689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.+||+|||++........ ......||+.|+|||++.+ ...++.++|||||||++|+|
T Consensus 135 ~~-------~~~kl~Dfg~a~~~~~~~~----------~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~~l 194 (324)
T 3mtl_A 135 ER-------GELKLADFGLARAKSIPTK----------TYDNEVVTLWYRPPDILLG---STDYSTQIDMWGVGCIFYEM 194 (324)
T ss_dssp TT-------CCEEECSSSEEECC----------------------CGGGCCHHHHTT---CCCCCTHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEccCcccccccCCcc----------ccccccCcccccChhhhcC---CCCCCcHHHHHHHHHHHHHH
Confidence 87 7899999999975432211 1123468999999999875 24678999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccccccccccc-C-CCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS-G-SGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
++|+.||.+.+..+....+...........+.............. . ............++.+.+|+.+||+.||.+||
T Consensus 195 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 274 (324)
T 3mtl_A 195 ATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRI 274 (324)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSC
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCC
Confidence 999999998887776655533211111111110000000000000 0 00000111124567799999999999999999
Q ss_pred CHHHHHHHHHhhcCC
Q 001142 1122 TAGDLYEMFVARTSS 1136 (1142)
Q Consensus 1122 Sa~EVL~~L~~~~ss 1136 (1142)
|++|+++|+|+....
T Consensus 275 t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 275 SAEDAMKHPFFLSLG 289 (324)
T ss_dssp CHHHHTTSGGGGGGC
T ss_pred CHHHHhcChhhhhcc
Confidence 999999999997653
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=383.91 Aligned_cols=258 Identities=24% Similarity=0.341 Sum_probs=205.8
Q ss_pred CcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
.|++.++||+|+||+||+|++. +..+|+|+...... ....... +.+|+.+++.++|||||++++++.+..
T Consensus 38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~----~~~E~~~l~~l~hpniv~~~~~~~~~~-- 109 (494)
T 3lij_A 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSV--STSSNSK----LLEEVAVLKLLDHPNIMKLYDFFEDKR-- 109 (494)
T ss_dssp HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-------CTTHH----HHHHHHHHTTCCCTTBCCEEEEEECSS--
T ss_pred CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEecccc--CchHHHH----HHHHHHHHHhCCCCCCCeEEEEEEeCC--
Confidence 5999999999999999999984 56788887653321 1111223 378999999999999999999998654
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
..++||||+++|+|.+++.. ...+++..+..|+.||+.||.|||++||+||||||+|||++..
T Consensus 110 ------------~~~lv~e~~~~g~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~ 172 (494)
T 3lij_A 110 ------------NYYLVMECYKGGELFDEIIH-----RMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESK 172 (494)
T ss_dssp ------------EEEEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCS
T ss_pred ------------EEEEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCC
Confidence 35999999999999998876 2468999999999999999999999999999999999999764
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
. ..+.+||+|||++....... ......||+.|+|||++.+ .|+.++|||||||++|+|++
T Consensus 173 ~----~~~~~kl~DfG~a~~~~~~~-----------~~~~~~gt~~y~aPE~l~~-----~~~~~~DiwslG~il~~ll~ 232 (494)
T 3lij_A 173 E----KDALIKIVDFGLSAVFENQK-----------KMKERLGTAYYIAPEVLRK-----KYDEKCDVWSIGVILFILLA 232 (494)
T ss_dssp S----TTCCEEECCCTTCEECBTTB-----------CBCCCCSCTTTCCHHHHTT-----CBCTHHHHHHHHHHHHHHHH
T ss_pred C----CCCcEEEEECCCCeECCCCc-----------cccccCCCcCeeCHHHHcc-----cCCCchhHHHHHHHHHHHHh
Confidence 2 12679999999997654321 1123469999999999863 58899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001142 1046 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1125 (1142)
Q Consensus 1046 G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~E 1125 (1142)
|..||.+....++...+..+........+ ...++.+.+||.+||+.||.+|||+.|
T Consensus 233 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~------------------------~~~s~~~~~li~~~L~~dp~~R~s~~e 288 (494)
T 3lij_A 233 GYPPFGGQTDQEILRKVEKGKYTFDSPEW------------------------KNVSEGAKDLIKQMLQFDSQRRISAQQ 288 (494)
T ss_dssp SSCSSCCSSHHHHHHHHHHTCCCCCSGGG------------------------TTSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred CCCCCCCCCHHHHHHHHHhCCCCCCchhc------------------------ccCCHHHHHHHHHHCCCChhhCccHHH
Confidence 99999998888888777665433211111 145567999999999999999999999
Q ss_pred HHHHHHhhc
Q 001142 1126 LYEMFVART 1134 (1142)
Q Consensus 1126 VL~~L~~~~ 1134 (1142)
+++|+|++.
T Consensus 289 ~l~hp~~~~ 297 (494)
T 3lij_A 289 ALEHPWIKE 297 (494)
T ss_dssp HHTCHHHHH
T ss_pred HhcCccccc
Confidence 999999974
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=354.57 Aligned_cols=265 Identities=26% Similarity=0.360 Sum_probs=211.6
Q ss_pred CCCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001142 804 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 881 (1142)
Q Consensus 804 ~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~ 881 (1142)
...++|++.+.||+|+||.||+|++. +..+|+|+.... .......+.+ .+|+.++++++||||+++++++.+
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~----~~e~~~l~~l~h~~i~~~~~~~~~ 76 (279)
T 2w5a_A 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYG--SMTEAEKQML----VSEVNLLRELKHPNIVRYYDRIID 76 (279)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECT--TCCHHHHHHH----HHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred CchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcc--cCCHHHHHHH----HHHHHHHHhcCCCCCCeEEEEEec
Confidence 34678999999999999999999984 566788875433 2233333344 899999999999999999998764
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccCCC
Q 001142 882 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-----IMHRDIK 956 (1142)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~g-----IvHrDLK 956 (1142)
.. ....++||||+++++|.+++..... ....+++..+..++.||+.||+|||++| |+|||||
T Consensus 77 ~~------------~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~ 143 (279)
T 2w5a_A 77 RT------------NTTLYIVMEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLK 143 (279)
T ss_dssp GG------------GTEEEEEEECCTTEEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCS
T ss_pred CC------------CceEEEEEeCCCCCCHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccc
Confidence 32 1246999999999999999986432 2346999999999999999999999999 9999999
Q ss_pred CCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHH
Q 001142 957 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1036 (1142)
Q Consensus 957 p~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSL 1036 (1142)
|+|||++.+ +.+||+|||.+......... .....||+.|+|||++.+ ..++.++|||||
T Consensus 144 p~NIl~~~~-------~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~sl 202 (279)
T 2w5a_A 144 PANVFLDGK-------QNVKLGDFGLARILNHDTSF----------AKTFVGTPYYMSPEQMNR----MSYNEKSDIWSL 202 (279)
T ss_dssp GGGEEECSS-------SCEEECCCCHHHHC---CHH----------HHHHHSCCTTCCHHHHHC----C-CCHHHHHHHH
T ss_pred hhhEEEcCC-------CCEEEecCchheeecccccc----------ccccCCCccccChHHhcc----CCCCchhhHHHH
Confidence 999999877 78999999999765432110 012358999999999876 468899999999
Q ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 001142 1037 GCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1116 (1142)
Q Consensus 1037 GviL~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~D 1116 (1142)
|+++|+|++|+.||......++...+..+..+.++. ..++.+.+++.+||+.|
T Consensus 203 G~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~ 255 (279)
T 2w5a_A 203 GCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY---------------------------RYSDELNEIITRMLNLK 255 (279)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCT---------------------------TSCHHHHHHHHHHTCSS
T ss_pred HHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCc---------------------------ccCHHHHHHHHHHcCCC
Confidence 999999999999999887777777766655433221 34567999999999999
Q ss_pred CCCCCCHHHHHHHHHhhcC
Q 001142 1117 PTERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1117 P~~RPSa~EVL~~L~~~~s 1135 (1142)
|.+|||+.|+++++|+...
T Consensus 256 p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 256 DYHRPSVEEILENPLILEH 274 (279)
T ss_dssp GGGSCCHHHHHTSTTCCGG
T ss_pred cccCCCHHHHHhChhhhhh
Confidence 9999999999999998754
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=367.08 Aligned_cols=258 Identities=24% Similarity=0.273 Sum_probs=193.2
Q ss_pred CCCCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001142 804 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 881 (1142)
Q Consensus 804 ~~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~ 881 (1142)
...++|++.+.||+|+||+||+|++ .+..+|+|+..... .. .+. +.+|+.++++++||||+++++++.+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~---~~~----~~~E~~~l~~l~hpniv~~~~~~~~ 87 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA--AI---DEN----VQREIINHRSLRHPNIVRFKEVILT 87 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST--TS---CHH----HHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc--cc---cHH----HHHHHHHHHhCCCCCCCcEEEEEee
Confidence 3457899999999999999999998 46678888764221 11 122 3689999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 001142 882 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 961 (1142)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NIL 961 (1142)
.. ..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 88 ~~--------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nil 148 (361)
T 3uc3_A 88 PT--------------HLAIIMEYASGGELYERICN-----AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTL 148 (361)
T ss_dssp SS--------------EEEEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEE
T ss_pred CC--------------EEEEEEEeCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence 55 35999999999999999976 246999999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCC-chhhHHHHHHHH
Q 001142 962 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG-LEVDIWSYGCLL 1040 (1142)
Q Consensus 962 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s-~ksDVwSLGviL 1040 (1142)
++.+.. +.+||+|||+++...... ......||+.|+|||++.+ ..++ .++|||||||++
T Consensus 149 l~~~~~-----~~~kl~Dfg~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il 208 (361)
T 3uc3_A 149 LDGSPA-----PRLKICDFGYSKSSVLHS-----------QPKSTVGTPAYIAPEVLLR----QEYDGKIADVWSCGVTL 208 (361)
T ss_dssp ECSSSS-----CCEEECCCCCC--------------------------CTTSCHHHHHC----SSCCHHHHHHHHHHHHH
T ss_pred EcCCCC-----ceEEEeecCccccccccC-----------CCCCCcCCCCcCChhhhcC----CCCCCCeeeeehhHHHH
Confidence 986521 459999999986432211 1123469999999999876 3444 459999999999
Q ss_pred HHHHhCCCCCCCCCH----HHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 001142 1041 LELLTLQVPYMGLSE----LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1116 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~~~~----~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~D 1116 (1142)
|+|++|+.||.+... ......+...... .+ .....++.+.+||.+||+.|
T Consensus 209 ~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~-------------------------~~~~~s~~~~~li~~~L~~d 262 (361)
T 3uc3_A 209 YVMLVGAYPFEDPEEPRDYRKTIQRILSVKYS-IP-------------------------DDIRISPECCHLISRIFVAD 262 (361)
T ss_dssp HHHHHSSCSCC----CCCHHHHHHHHHTTCCC-CC-------------------------TTSCCCHHHHHHHHHHSCSC
T ss_pred HHHHhCCCCCCCCccHHHHHHHHHHHhcCCCC-CC-------------------------CcCCCCHHHHHHHHHHccCC
Confidence 999999999976432 2222222221110 00 00134567999999999999
Q ss_pred CCCCCCHHHHHHHHHhhcC
Q 001142 1117 PTERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1117 P~~RPSa~EVL~~L~~~~s 1135 (1142)
|.+|||+.|+++|+|+...
T Consensus 263 P~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 263 PATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp TTTSCCHHHHHTSHHHHTT
T ss_pred hhHCcCHHHHHhCcchhcC
Confidence 9999999999999999654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=383.14 Aligned_cols=263 Identities=27% Similarity=0.326 Sum_probs=212.2
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
++|++.++||+|+||+||+|++. +..+|+|+........ .... .+.+|+.++++++|||||++++++.+..
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~----~~~~E~~~l~~l~hpniv~~~~~~~~~~- 94 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN--KDTS----TILREVELLKKLDHPNIMKLFEILEDSS- 94 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC--SCHH----HHHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc--hHHH----HHHHHHHHHHhCCCCCcCeEEEEEEcCC-
Confidence 45999999999999999999984 6778999864322111 1122 3379999999999999999999998655
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
..++||||+++++|.+++.. ...+++..+..|+.||+.||.|||++||+||||||+|||++.
T Consensus 95 -------------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~ 156 (486)
T 3mwu_A 95 -------------SFYIVGELYTGGELFDEIIK-----RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLES 156 (486)
T ss_dssp -------------EEEEEECCCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESS
T ss_pred -------------EEEEEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEec
Confidence 35999999999999999876 246999999999999999999999999999999999999965
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
.. ..+.+||+|||+++...... ......||+.|+|||++.+ .|+.++|||||||++|+|+
T Consensus 157 ~~----~~~~~kl~Dfg~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~il~~ll 216 (486)
T 3mwu_A 157 KE----KDCDIKIIDFGLSTCFQQNT-----------KMKDRIGTAYYIAPEVLRG-----TYDEKCDVWSAGVILYILL 216 (486)
T ss_dssp SS----TTCCEEECSCSCTTTBCCC---------------CCTTGGGGCCGGGGGS-----CCCHHHHHHHHHHHHHHHH
T ss_pred CC----CCCCEEEEECCcCeECCCCC-----------ccCCCcCCCCCCCHHHhCC-----CCCchhhHHHHHHHHHHHH
Confidence 31 12679999999997554321 1123469999999999874 4889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~ 1124 (1142)
+|..||.+....++...+..+........+ ...++.+.+||.+||+.||.+|||+.
T Consensus 217 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~------------------------~~~s~~~~~li~~~L~~dp~~R~t~~ 272 (486)
T 3mwu_A 217 SGTPPFYGKNEYDILKRVETGKYAFDLPQW------------------------RTISDDAKDLIRKMLTFHPSLRITAT 272 (486)
T ss_dssp HSSCSSCCSSHHHHHHHHHHTCCCSCSGGG------------------------GGSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCCCccc------------------------CCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 999999998888887777655432211110 14567799999999999999999999
Q ss_pred HHHHHHHhhcCCCC
Q 001142 1125 DLYEMFVARTSSSI 1138 (1142)
Q Consensus 1125 EVL~~L~~~~ss~~ 1138 (1142)
|+++|+|++.....
T Consensus 273 ~~l~hp~~~~~~~~ 286 (486)
T 3mwu_A 273 QCLEHPWIQKYSSE 286 (486)
T ss_dssp HHHHCHHHHHTCCC
T ss_pred HHhcCHhhccCccc
Confidence 99999999876543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=364.22 Aligned_cols=299 Identities=17% Similarity=0.203 Sum_probs=210.8
Q ss_pred CCCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 882 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~ 882 (1142)
.+.+|++.++||+|+||.||+|++ .+..+|+|+..... ........ +.+|+.++++++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~~~~ 88 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN--EKEGFPIT----ALREIKILQLLKHENVVNLIEICRTK 88 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSS--CSSSSCHH----HHHHHHHHHHCCCTTBCCEEEEEEEC
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccc--ccccchHH----HHHHHHHHHhccCCCcccHhheeecc
Confidence 467899999999999999999998 45678888754332 12111222 36899999999999999999998864
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
... ........++||||++ ++|.+.+.. ....+++..+..|+.||+.||.|||++||+||||||+|||+
T Consensus 89 ~~~------~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~ 157 (351)
T 3mi9_A 89 ASP------YNRCKGSIYLVFDFCE-HDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI 157 (351)
T ss_dssp --------------CEEEEEEECCS-EEHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred ccc------cccCCceEEEEEeccC-CCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE
Confidence 321 0111235799999997 688887754 23469999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
+.+ +.+||+|||+++........ .........||+.|+|||++.+ ...++.++|||||||++|+
T Consensus 158 ~~~-------~~~kl~Dfg~a~~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~e 221 (351)
T 3mi9_A 158 TRD-------GVLKLADFGLARAFSLAKNS------QPNRYTNRVVTLWYRPPELLLG---ERDYGPPIDLWGAGCIMAE 221 (351)
T ss_dssp CTT-------SCEEECCCTTCEECCCCSSS------SCCCCCSSCSCGGGCCHHHHTT---CCSCCTHHHHHHHHHHHHH
T ss_pred cCC-------CCEEEccchhcccccccccc------cccccCCcccccCccCchhhcC---CCCCCcHhHHHHHHHHHHH
Confidence 887 78999999999765432211 1112234568999999999875 2457899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCC-CCCchh---hhhhHHHHHHHHHHhcccCCC
Q 001142 1043 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSG-FEKPEA---ELETLSFLVDVFRRCTEENPT 1118 (1142)
Q Consensus 1043 LLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~-~~~~~~---~~~~~~~L~dLI~~CL~~DP~ 1118 (1142)
|++|+.||.+.........+........+..+................. ...... ....++.+.+||.+||+.||+
T Consensus 222 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 301 (351)
T 3mi9_A 222 MWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPA 301 (351)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGG
T ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChh
Confidence 9999999998877766655533211111111111100000000000000 000000 011256689999999999999
Q ss_pred CCCCHHHHHHHHHhhcCC
Q 001142 1119 ERPTAGDLYEMFVARTSS 1136 (1142)
Q Consensus 1119 ~RPSa~EVL~~L~~~~ss 1136 (1142)
+|||++|+++|+|+....
T Consensus 302 ~R~t~~e~l~hp~f~~~~ 319 (351)
T 3mi9_A 302 QRIDSDDALNHDFFWSDP 319 (351)
T ss_dssp GSCCHHHHHTSGGGGSSS
T ss_pred hCCCHHHHhCCCCcCCCC
Confidence 999999999999998653
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=350.01 Aligned_cols=256 Identities=23% Similarity=0.312 Sum_probs=207.6
Q ss_pred CCCcceeeeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~~-~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
.++|++.+.||+|+||.||+|++.+ ..+|+|+.... ... .+.+ .+|+.++++++||||+++++++.+...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~---~~~~----~~E~~~l~~l~h~~i~~~~~~~~~~~~ 77 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG--SMS---EDEF----FQEAQTMMKLSHPKLVKFYGVCSKEYP 77 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBT--TBC---HHHH----HHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccC--CCc---HHHH----HHHHHHHHhCCCCCEeeEEEEEccCCc
Confidence 4579999999999999999999854 46888876432 111 2233 789999999999999999999876543
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
.++||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+||+++.
T Consensus 78 --------------~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~ 139 (268)
T 3sxs_A 78 --------------IYIVTEYISNGCLLNYLRSH----GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDR 139 (268)
T ss_dssp --------------EEEEEECCTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECT
T ss_pred --------------eEEEEEccCCCcHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECC
Confidence 49999999999999999763 235899999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||+|||.+......... ......+|+.|+|||++.+ ..++.++||||||+++|+|+
T Consensus 140 ~-------~~~~l~Dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~l~ 199 (268)
T 3sxs_A 140 D-------LCVKVSDFGMTRYVLDDQYV---------SSVGTKFPVKWSAPEVFHY----FKYSSKSDVWAFGILMWEVF 199 (268)
T ss_dssp T-------CCEEECCTTCEEECCTTCEE---------ECCSCCCCGGGCCHHHHHH----SEEETTHHHHHHHHHHHHHH
T ss_pred C-------CCEEEccCccceecchhhhh---------cccCCCcCcccCCHHHHhc----cCCchhhhhHHHHHHHHHHH
Confidence 7 78999999999765432211 1112346788999999876 45789999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1045 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1045 t-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
+ |..||......+....+..+.....+. ..++.+.+++.+||+.||.+|||+
T Consensus 200 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~p~~Rps~ 252 (268)
T 3sxs_A 200 SLGKMPYDLYTNSEVVLKVSQGHRLYRPH---------------------------LASDTIYQIMYSCWHELPEKRPTF 252 (268)
T ss_dssp TTTCCTTTTSCHHHHHHHHHTTCCCCCCT---------------------------TSCHHHHHHHHHTTCSSGGGSCCH
T ss_pred cCCCCCccccChHHHHHHHHcCCCCCCCC---------------------------cChHHHHHHHHHHcCCChhhCcCH
Confidence 9 999999887777666665544322211 334569999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 001142 1124 GDLYEMFVARTS 1135 (1142)
Q Consensus 1124 ~EVL~~L~~~~s 1135 (1142)
.|+++++.....
T Consensus 253 ~~ll~~L~~l~~ 264 (268)
T 3sxs_A 253 QQLLSSIEPLRE 264 (268)
T ss_dssp HHHHHHHGGGCC
T ss_pred HHHHHHHHHhhh
Confidence 999999987543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=368.04 Aligned_cols=259 Identities=24% Similarity=0.274 Sum_probs=193.9
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
+.|++.+.||+|+||.||+|++. +..+|+|+.... ...+.+ .+|+.++++++||||+++++++.+..
T Consensus 53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~----~~E~~~l~~l~h~niv~~~~~~~~~~- 121 (349)
T 2w4o_A 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT------VDKKIV----RTEIGVLLRLSHPNIIKLKEIFETPT- 121 (349)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------------CHHHHHCCCTTBCCEEEEEECSS-
T ss_pred CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc------hhHHHH----HHHHHHHHhCCCCCCcceeeeEecCC-
Confidence 45999999999999999999985 456888875422 112233 68999999999999999999998654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 122 -------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~ 183 (349)
T 2w4o_A 122 -------------EISLVLELVTGGELFDRIVE-----KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYAT 183 (349)
T ss_dssp -------------EEEEEECCCCSCBHHHHHTT-----CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESS
T ss_pred -------------eEEEEEEeCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEec
Confidence 35999999999999999864 346899999999999999999999999999999999999975
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
. ...+.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 184 ~----~~~~~~kl~Dfg~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~ell 244 (349)
T 2w4o_A 184 P----APDAPLKIADFGLSKIVEHQV-----------LMKTVCGTPGYCAPEILRG----CAYGPEVDMWSVGIITYILL 244 (349)
T ss_dssp S----STTCCEEECCCC---------------------------CGGGSCHHHHTT----CCCCTHHHHHHHHHHHHHHH
T ss_pred C----CCCCCEEEccCccccccCccc-----------ccccccCCCCccCHHHhcC----CCCCcccchHHHHHHHHHHH
Confidence 2 112789999999997543211 1123468999999999876 56889999999999999999
Q ss_pred hCCCCCCCCCHHH-HHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1045 TLQVPYMGLSELE-IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1045 tG~~Pf~~~~~~e-l~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
+|..||......+ ....+.......... .....+..+.+||.+||+.||++|||+
T Consensus 245 ~g~~pf~~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~ 300 (349)
T 2w4o_A 245 CGFEPFYDERGDQFMFRRILNCEYYFISP------------------------WWDEVSLNAKDLVRKLIVLDPKKRLTT 300 (349)
T ss_dssp HSSCTTCCTTCHHHHHHHHHTTCCCCCTT------------------------TTTTSCHHHHHHHHTTSCSSGGGSCCH
T ss_pred hCCCCCCCCcccHHHHHHHHhCCCccCCc------------------------hhhhCCHHHHHHHHHHccCChhhCcCH
Confidence 9999997655443 444444333211110 001456679999999999999999999
Q ss_pred HHHHHHHHhhcCCC
Q 001142 1124 GDLYEMFVARTSSS 1137 (1142)
Q Consensus 1124 ~EVL~~L~~~~ss~ 1137 (1142)
.|+++|+|+.....
T Consensus 301 ~e~l~hp~~~~~~~ 314 (349)
T 2w4o_A 301 FQALQHPWVTGKAA 314 (349)
T ss_dssp HHHHHSTTTTSTTC
T ss_pred HHHhcCcccCCCcc
Confidence 99999999986543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=382.16 Aligned_cols=259 Identities=23% Similarity=0.276 Sum_probs=211.5
Q ss_pred CCCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001142 804 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 881 (1142)
Q Consensus 804 ~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~ 881 (1142)
..+.+|.+.+.||+|+||.||+|++. +..||+|+..... ....+....+.+|+.+++.++||||+++++++.+
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~-----~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~ 87 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQK-----IRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST 87 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHH-----HHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhh-----ccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 45678999999999999999999984 7788999864321 1111122345899999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 001142 882 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 961 (1142)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NIL 961 (1142)
.+ ..++||||+++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 88 ~~--------------~~~lv~E~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIl 148 (476)
T 2y94_A 88 PS--------------DIFMVMEYVSGGELFDYICK-----NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVL 148 (476)
T ss_dssp SS--------------EEEEEEECCSSEEHHHHTTS-----SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEE
T ss_pred CC--------------EEEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEE
Confidence 54 35999999999999999864 356999999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001142 962 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1041 (1142)
Q Consensus 962 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ 1041 (1142)
++.+ +.+||+|||++....... ......||+.|+|||++.+. ..++.++|||||||++|
T Consensus 149 l~~~-------~~vkL~DFG~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwSlGvil~ 207 (476)
T 2y94_A 149 LDAH-------MNAKIADFGLSNMMSDGE-----------FLRTSCGSPNYAAPEVISGR---LYAGPEVDIWSSGVILY 207 (476)
T ss_dssp ECTT-------CCEEECCCSSCEECCTTC-----------CBCCCCSCSTTCCHHHHTTC---CBCSHHHHHHHHHHHHH
T ss_pred EecC-------CCeEEEeccchhhccccc-----------cccccCCCcCeEChhhccCC---CCCCCcceehhhHHHHH
Confidence 9887 789999999997654311 11234699999999998762 23478999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1042 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1042 ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
+|++|+.||.+.........+..+.... + ...++.+.+||.+||+.||.+||
T Consensus 208 elltG~~Pf~~~~~~~~~~~i~~~~~~~-p---------------------------~~~s~~~~~Li~~~L~~dP~~Rp 259 (476)
T 2y94_A 208 ALLCGTLPFDDDHVPTLFKKICDGIFYT-P---------------------------QYLNPSVISLLKHMLQVDPMKRA 259 (476)
T ss_dssp HHHHSSCSSCCSSSHHHHHHHHTTCCCC-C---------------------------TTCCHHHHHHHHHHTCSSTTTSC
T ss_pred HHhhCCCCCCCCCHHHHHHHHhcCCcCC-C---------------------------ccCCHHHHHHHHHHcCCCchhCc
Confidence 9999999999877777776665443211 0 03455689999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001142 1122 TAGDLYEMFVARTS 1135 (1142)
Q Consensus 1122 Sa~EVL~~L~~~~s 1135 (1142)
|+.|+++|+|+...
T Consensus 260 t~~eil~hp~~~~~ 273 (476)
T 2y94_A 260 TIKDIREHEWFKQD 273 (476)
T ss_dssp CHHHHHTCHHHHTT
T ss_pred CHHHHHhCHHhhhc
Confidence 99999999999864
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=377.31 Aligned_cols=298 Identities=18% Similarity=0.199 Sum_probs=194.4
Q ss_pred CCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
.++|++.++||+|+||+||+|++. +..||+|+. ..........+.+ .+|+.+|++++|||||++++++....
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i--~~~~~~~~~~~~~----~~E~~~l~~l~h~niv~l~~~~~~~~ 125 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI--LRVFEDLIDCKRI----LREIAILNRLNHDHVVKVLDIVIPKD 125 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEE--CSTTSSHHHHHHH----HHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEe--chhhcCHHHHHHH----HHHHHHHHhCCCCCCCceEEEEecCC
Confidence 367999999999999999999874 566777764 3323333333444 89999999999999999999986533
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
. ......|+||||+. ++|.+++.. ...+++..++.|+.||+.||+|||++||+||||||+|||++
T Consensus 126 ~---------~~~~~~~lv~e~~~-~~L~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~ 190 (458)
T 3rp9_A 126 V---------EKFDELYVVLEIAD-SDFKKLFRT-----PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVN 190 (458)
T ss_dssp T---------TTCCCEEEEECCCS-EEHHHHHHS-----SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC
T ss_pred c---------ccCceEEEEEeccc-cchhhhccc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEEC
Confidence 1 12235799999985 899999864 35699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccc-----------------cCCCCCCCCccCCCcccchhhhccccCCCC
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA-----------------HRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 1026 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~-----------------~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 1026 (1142)
.+ +.+||+|||+|+............ ..........+||+.|+|||++.. ...
T Consensus 191 ~~-------~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~ 260 (458)
T 3rp9_A 191 QD-------CSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL---QEN 260 (458)
T ss_dssp TT-------CCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTT---CCC
T ss_pred CC-------CCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhC---CCC
Confidence 87 789999999998754321110000 000011234578999999998753 256
Q ss_pred CCchhhHHHHHHHHHHHHh-----------CCCCCCCCCH--------------------HHHHHHHH-hCCCCCchhHH
Q 001142 1027 YGLEVDIWSYGCLLLELLT-----------LQVPYMGLSE--------------------LEIHDLIQ-MGKRPRLTDEL 1074 (1142)
Q Consensus 1027 ~s~ksDVwSLGviL~ELLt-----------G~~Pf~~~~~--------------------~el~~~I~-~~~~p~l~~~l 1074 (1142)
|+.++|||||||++|||++ |+++|.+.+. .+....+. ....+. ...+
T Consensus 261 ~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~-~~~~ 339 (458)
T 3rp9_A 261 YTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPS-EEDI 339 (458)
T ss_dssp CCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCC-HHHH
T ss_pred CCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCC-HHHH
Confidence 8999999999999999999 6777765431 11122221 111111 1111
Q ss_pred hhhcccccccccc---cCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001142 1075 EALGSCHEHEVAQ---SGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1075 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~~s 1135 (1142)
............. ..............++.+.+||.+||+.||++|||++|+++|+|++.-
T Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 340 EALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp HTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence 1100000000000 000001111112456789999999999999999999999999999864
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=379.15 Aligned_cols=268 Identities=23% Similarity=0.270 Sum_probs=210.5
Q ss_pred CCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
.++|++.++||+|+||+||+|++. +..+|+|+..... ...+.....+.+|+.++..++||||+++++++.+.+
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~-----~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 147 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWE-----MLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN 147 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHH-----HHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHH-----hhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence 457999999999999999999985 4567888754211 111111122478999999999999999999998755
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
..|+||||++||+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 148 --------------~~~lV~Ey~~gg~L~~~l~~----~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~ 209 (437)
T 4aw2_A 148 --------------NLYLVMDYYVGGDLLTLLSK----FEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD 209 (437)
T ss_dssp --------------EEEEEECCCTTCBHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred --------------EEEEEEecCCCCcHHHHHHH----ccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEc
Confidence 35999999999999999975 134699999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhcccc-CCCCCCchhhHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~s~ksDVwSLGviL~E 1042 (1142)
.+ +.+||+|||+|+........ .....+||+.|+|||++.... ....|+.++|||||||++||
T Consensus 210 ~~-------g~vkL~DFGla~~~~~~~~~---------~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~e 273 (437)
T 4aw2_A 210 MN-------GHIRLADFGSCLKLMEDGTV---------QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYE 273 (437)
T ss_dssp TT-------SCEEECCCTTCEECCTTSCE---------ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHH
T ss_pred CC-------CCEEEcchhhhhhcccCCCc---------ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHH
Confidence 87 78999999999765432111 112357999999999987321 12468899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCC-CCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC--
Q 001142 1043 LLTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE-- 1119 (1142)
Q Consensus 1043 LLtG~~Pf~~~~~~el~~~I~~~~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~-- 1119 (1142)
|++|+.||.+.+..+....+.... ...++ ......++.+.+||.+||..+|++
T Consensus 274 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p------------------------~~~~~~s~~~~dLi~~lL~~~~~r~~ 329 (437)
T 4aw2_A 274 MLYGETPFYAESLVETYGKIMNHKERFQFP------------------------TQVTDVSENAKDLIRRLICSREHRLG 329 (437)
T ss_dssp HHHSSCTTCCSSHHHHHHHHHTHHHHCCCC------------------------SSCCCSCHHHHHHHHTTSSCGGGCTT
T ss_pred HHhCCCCCCCCChhHHHHhhhhccccccCC------------------------cccccCCHHHHHHHHHHhcccccccC
Confidence 999999999888877776664311 00000 000135667999999999988888
Q ss_pred CCCHHHHHHHHHhhcCC
Q 001142 1120 RPTAGDLYEMFVARTSS 1136 (1142)
Q Consensus 1120 RPSa~EVL~~L~~~~ss 1136 (1142)
||+++|+++|+|++.-.
T Consensus 330 r~~~~eil~Hpff~~i~ 346 (437)
T 4aw2_A 330 QNGIEDFKKHPFFSGID 346 (437)
T ss_dssp TTTTHHHHTSGGGTTCC
T ss_pred CCCHHHHhCCCccCCCC
Confidence 99999999999998643
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=366.37 Aligned_cols=256 Identities=24% Similarity=0.264 Sum_probs=203.3
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSK 883 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~~~~~ 883 (1142)
++|++.+.||+|+||.||+|.+. +..+|+|+..... . .. .+|++++.++ +||||+++++++.+..
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~------~~----~~E~~~l~~~~~hp~iv~~~~~~~~~~ 89 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK--R------DP----TEEIEILLRYGQHPNIITLKDVYDDGK 89 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT--C------CC----HHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc--C------Ch----HHHHHHHHHhcCCCCcCeEEEEEEcCC
Confidence 46999999999999999999984 6678888764221 1 11 4688888888 7999999999998655
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
..|+||||++||+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+.
T Consensus 90 --------------~~~lv~E~~~gg~L~~~i~~-----~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~ 150 (342)
T 2qr7_A 90 --------------YVYVVTELMKGGELLDKILR-----QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYV 150 (342)
T ss_dssp --------------EEEEEECCCCSCBHHHHHHT-----CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEES
T ss_pred --------------EEEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEe
Confidence 45999999999999999875 34699999999999999999999999999999999999985
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+. ...+.+||+|||+++....... ......||+.|+|||++.+ ..|+.++|||||||++|+|
T Consensus 151 ~~~---~~~~~~kl~Dfg~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~el 213 (342)
T 2qr7_A 151 DES---GNPESIRICDFGFAKQLRAENG----------LLMTPCYTANFVAPEVLER----QGYDAACDIWSLGVLLYTM 213 (342)
T ss_dssp SSS---CSGGGEEECCCTTCEECBCTTC----------CBCCSSCCSSCCCHHHHHH----HHHHHHHHHHHHHHHHHHH
T ss_pred cCC---CCcCeEEEEECCCcccCcCCCC----------ceeccCCCccccCHHHhcC----CCCCCccCeeeHhHHHHHH
Confidence 431 1124699999999976543211 1123468999999999876 4577899999999999999
Q ss_pred HhCCCCCCC---CCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1044 LTLQVPYMG---LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1044 LtG~~Pf~~---~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
++|..||.+ ....++...+..+........ ....++.+.+||.+||+.||++|
T Consensus 214 l~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~------------------------~~~~s~~~~~li~~~L~~dP~~R 269 (342)
T 2qr7_A 214 LTGYTPFANGPDDTPEEILARIGSGKFSLSGGY------------------------WNSVSDTAKDLVSKMLHVDPHQR 269 (342)
T ss_dssp HHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTT------------------------TTTSCHHHHHHHHHHTCSSTTTS
T ss_pred hcCCCCCCCCCcCCHHHHHHHHccCCcccCccc------------------------cccCCHHHHHHHHHHCCCChhHC
Confidence 999999975 345556666655443211100 01456679999999999999999
Q ss_pred CCHHHHHHHHHhhc
Q 001142 1121 PTAGDLYEMFVART 1134 (1142)
Q Consensus 1121 PSa~EVL~~L~~~~ 1134 (1142)
||+.|+++|+|+..
T Consensus 270 ~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 270 LTAALVLRHPWIVH 283 (342)
T ss_dssp CCHHHHTTSHHHHT
T ss_pred cCHHHHhcCCeecC
Confidence 99999999999964
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=350.90 Aligned_cols=263 Identities=24% Similarity=0.310 Sum_probs=208.1
Q ss_pred CcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCCh--HHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSA--DEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~--~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
+|++.+.||+|+||.||+|++. +..+|+|+.......... ...+. +.+|+.++++++||||+++++++.+..
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~----~~~E~~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T 3bhy_A 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREE----IEREVNILREIRHPNIITLHDIFENKT 81 (283)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHH----HHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHH----HHHHHHHHHhCCCCCeeehhheecCCC
Confidence 5899999999999999999984 678899986544322111 11233 379999999999999999999998654
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++
T Consensus 82 --------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~ 142 (283)
T 3bhy_A 82 --------------DVVLILELVSGGELFDFLAE-----KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLL 142 (283)
T ss_dssp --------------EEEEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEES
T ss_pred --------------eEEEEEeecCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEe
Confidence 35999999999999999976 24689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.++ .....+||+|||.+........ .....||+.|+|||++.+ ..++.++||||||+++|+|
T Consensus 143 ~~~---~~~~~~kl~dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~l 204 (283)
T 3bhy_A 143 DKN---VPNPRIKLIDFGIAHKIEAGNE-----------FKNIFGTPEFVAPEIVNY----EPLGLEADMWSIGVITYIL 204 (283)
T ss_dssp CSS---SSSCCEEECCCTTCEECC-------------------CCCGGGCCHHHHTT----CCCCTHHHHHHHHHHHHHH
T ss_pred cCC---CCCCceEEEecccceeccCCCc-----------ccccCCCcCccCcceecC----CCCCcchhhhhHHHHHHHH
Confidence 762 1123799999999976543211 123458999999999875 5688999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
++|..||.+....+....+........... ....++.+.+++.+||+.||.+|||+
T Consensus 205 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~li~~~l~~dp~~Rps~ 260 (283)
T 3bhy_A 205 LSGASPFLGETKQETLTNISAVNYDFDEEY------------------------FSNTSELAKDFIRRLLVKDPKRRMTI 260 (283)
T ss_dssp HHSSCTTCCSSHHHHHHHHHTTCCCCCHHH------------------------HTTCCHHHHHHHHTTSCSSGGGSCCH
T ss_pred HHCCCCCCCcchHHHHHHhHhcccCCcchh------------------------cccCCHHHHHHHHHHccCCHhHCcCH
Confidence 999999998777766666554432211110 11445679999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 001142 1124 GDLYEMFVARTS 1135 (1142)
Q Consensus 1124 ~EVL~~L~~~~s 1135 (1142)
.|+++|+|++..
T Consensus 261 ~~~l~h~~~~~~ 272 (283)
T 3bhy_A 261 AQSLEHSWIKAI 272 (283)
T ss_dssp HHHHHCHHHHHH
T ss_pred HHHHhCHHHHHH
Confidence 999999998753
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=351.55 Aligned_cols=255 Identities=25% Similarity=0.353 Sum_probs=204.8
Q ss_pred CCCCcceeeeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~~~-~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
...+|++.+.||+|+||+||+|.+.+ ..+|+|+.... ... .+++ .+|+.++++++||||+++++++.+..
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~---~~~~----~~E~~~l~~l~h~~i~~~~~~~~~~~ 92 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG--SMS---EDEF----IEEAKVMMNLSHEKLVQLYGVCTKQR 92 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTT--SBC---HHHH----HHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCC--CCC---HHHH----HHHHHHHhcCCCCCEeeEEEEEecCC
Confidence 45579999999999999999999854 46888876422 111 1233 78999999999999999999997654
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
. .++||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 93 ~--------------~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~ 154 (283)
T 3gen_A 93 P--------------IFIITEYMANGCLLNYLREM----RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN 154 (283)
T ss_dssp S--------------EEEEECCCTTCBHHHHHHCG----GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEEC
T ss_pred C--------------eEEEEeccCCCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEc
Confidence 3 49999999999999999752 24589999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.+||+|||++......... ......+|+.|+|||++.+ ..++.++||||||+++|+|
T Consensus 155 ~~-------~~~kl~Dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~~l~~l 214 (283)
T 3gen_A 155 DQ-------GVVKVSDFGLSRYVLDDEYT---------SSVGSKFPVRWSPPEVLMY----SKFSSKSDIWAFGVLMWEI 214 (283)
T ss_dssp TT-------SCEEECSTTGGGGBCCHHHH---------STTSTTSCGGGCCHHHHHH----CCCSHHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEccccccccccccccc---------cccCCccCcccCCHHHhcc----CCCCchhhHHHHHHHHHHH
Confidence 77 78999999999765432211 1123347888999999986 4688999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1044 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1044 Lt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
++ |+.||......+....+..+.....+. ..++.+.+++.+||+.||.+|||
T Consensus 215 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~p~~Rps 267 (283)
T 3gen_A 215 YSLGKMPYERFTNSETAEHIAQGLRLYRPH---------------------------LASEKVYTIMYSCWHEKADERPT 267 (283)
T ss_dssp HTTTCCTTTTSCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHTTCSSGGGSCC
T ss_pred HhCCCCCccccChhHHHHHHhcccCCCCCC---------------------------cCCHHHHHHHHHHccCChhHCcC
Confidence 98 999999888777777666554322211 33456899999999999999999
Q ss_pred HHHHHHHHHhh
Q 001142 1123 AGDLYEMFVAR 1133 (1142)
Q Consensus 1123 a~EVL~~L~~~ 1133 (1142)
+.++++++...
T Consensus 268 ~~~ll~~L~~~ 278 (283)
T 3gen_A 268 FKILLSNILDV 278 (283)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99999998764
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=352.44 Aligned_cols=260 Identities=21% Similarity=0.280 Sum_probs=210.7
Q ss_pred CCCCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001142 803 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 880 (1142)
Q Consensus 803 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~ 880 (1142)
+....+|++.+.||+|+||.||+|.+. +..+|+|+...... ......+. +.+|+.++++++||||+++++++.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~----~~~e~~~l~~l~h~~iv~~~~~~~ 85 (294)
T 2rku_A 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL-LKPHQREK----MSMEISIHRSLAHQHVVGFHGFFE 85 (294)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CSHHHHHH----HHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhc-cCHHHHHH----HHHHHHHHHhCCCCCEeeeeeeec
Confidence 455678999999999999999999985 56788887653321 12233333 378999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NI 960 (1142)
+.+ ..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 86 ~~~--------------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Ni 146 (294)
T 2rku_A 86 DND--------------FVFVVLELCRRRSLLELHKR-----RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNL 146 (294)
T ss_dssp CSS--------------EEEEEEECCTTCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred cCC--------------EEEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhE
Confidence 654 35999999999999999876 24689999999999999999999999999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
|++.+ +.+||+|||.+........ ......||+.|+|||++.+ ..++.++||||||+++
T Consensus 147 l~~~~-------~~~kl~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l 205 (294)
T 2rku_A 147 FLNED-------LEVKIGDFGLATKVEYDGE----------RKKVLCGTPNYIAPEVLSK----KGHSFEVDVWSIGCIM 205 (294)
T ss_dssp EECTT-------CCEEECCCTTCEECCSTTC----------CBCCCCSCCSSCCHHHHTT----SCBCTHHHHHHHHHHH
T ss_pred EEcCC-------CCEEEEeccCceecccCcc----------ccccccCCCCcCCcchhcc----CCCCchhhHHHHHHHH
Confidence 99877 7899999999976542111 1123468999999999875 5678999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1041 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
|+|++|+.||......+....+...... .+ ...++.+.+++.+||+.||++|
T Consensus 206 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~---------------------------~~~~~~~~~li~~~l~~~p~~R 257 (294)
T 2rku_A 206 YTLLVGKPPFETSCLKETYLRIKKNEYS-IP---------------------------KHINPVAASLIQKMLQTDPTAR 257 (294)
T ss_dssp HHHHHSSCTTCCSSHHHHHHHHHTTCCC-CC---------------------------TTSCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHhCCCCCCCCCHHHHHHHHhhccCC-Cc---------------------------cccCHHHHHHHHHHcccChhhC
Confidence 9999999999987766655555433211 00 0344568999999999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 001142 1121 PTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1121 PSa~EVL~~L~~~~s 1135 (1142)
||++|+++|+|+...
T Consensus 258 ps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 258 PTINELLNDEFFTSG 272 (294)
T ss_dssp CCGGGGGGSHHHHTS
T ss_pred cCHHHHhhChheecC
Confidence 999999999999754
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=382.48 Aligned_cols=261 Identities=24% Similarity=0.324 Sum_probs=211.7
Q ss_pred CCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
++|++.++||+|+||.||+|++ .+..+|+|+........ ....+.+ .+|+.++++++|||||++++++.+..
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~----~~E~~~l~~l~hpniv~~~~~~~~~~- 99 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ-KTDKESL----LREVQLLKQLDHPNIMKLYEFFEDKG- 99 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCB-SSCHHHH----HHHHHHHTTCCCTTBCCEEEEEECSS-
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhccc-chHHHHH----HHHHHHHHhCCCCCCCcEEEEEEeCC-
Confidence 4699999999999999999998 46778998865332211 1222333 79999999999999999999998755
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
..++||||+++++|.+++.. ...+++..+..|+.||+.||.|||++||+||||||+|||++.
T Consensus 100 -------------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~ 161 (484)
T 3nyv_A 100 -------------YFYLVGEVYTGGELFDEIIS-----RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLES 161 (484)
T ss_dssp -------------EEEEEECCCCSCBHHHHHHT-----CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESS
T ss_pred -------------EEEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEec
Confidence 35999999999999999865 356999999999999999999999999999999999999954
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
.. ..+.+||+|||++........ .....||+.|+|||++.+ .|+.++|||||||++|+|+
T Consensus 162 ~~----~~~~~kl~Dfg~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~il~~ll 221 (484)
T 3nyv_A 162 KS----KDANIRIIDFGLSTHFEASKK-----------MKDKIGTAYYIAPEVLHG-----TYDEKCDVWSTGVILYILL 221 (484)
T ss_dssp SS----TTCCEEECCTTHHHHBCCCCS-----------HHHHTTGGGTCCHHHHHT-----CCCTHHHHHHHHHHHHHHH
T ss_pred CC----CCCcEEEEeeeeeEEcccccc-----------cccCCCCccccCceeecC-----CCCCcceeHHHHHHHHHHH
Confidence 21 127899999999976543211 123469999999999864 5889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~ 1124 (1142)
+|..||.+.+..+....+..+........+ ...++.+.+||.+||+.||.+|||+.
T Consensus 222 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~------------------------~~~s~~~~~li~~~L~~dp~~R~s~~ 277 (484)
T 3nyv_A 222 SGCPPFNGANEYDILKKVEKGKYTFELPQW------------------------KKVSESAKDLIRKMLTYVPSMRISAR 277 (484)
T ss_dssp HSSCSSCCSSHHHHHHHHHHCCCCCCSGGG------------------------GGSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HCCCCCCCCCHHHHHHHHHcCCCCCCCccc------------------------ccCCHHHHHHHHHHCCCChhHCcCHH
Confidence 999999998888888777665432211100 14567799999999999999999999
Q ss_pred HHHHHHHhhcC
Q 001142 1125 DLYEMFVARTS 1135 (1142)
Q Consensus 1125 EVL~~L~~~~s 1135 (1142)
|+++|+|++..
T Consensus 278 e~l~h~~~~~~ 288 (484)
T 3nyv_A 278 DALDHEWIQTY 288 (484)
T ss_dssp HHHTSHHHHHH
T ss_pred HHhhChhhccc
Confidence 99999999754
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=351.84 Aligned_cols=264 Identities=24% Similarity=0.331 Sum_probs=193.5
Q ss_pred CCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
.++|++.+.||+|+||+||+|++ .+..+|+|+.... .......+. +..+...++.++||||+++++++.+.+
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~----~~~~~~~~~~~~h~~iv~~~~~~~~~~ 79 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT--VNSQEQKRL----LMDLDISMRTVDCPFTVTFYGALFREG 79 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC-----CHHHHHHH----HHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecc--cCcHHHHHH----HHHHHHHHHhCCCCeEEEEeeeeeccC
Confidence 46799999999999999999998 5677888875422 111222222 244555578889999999999998655
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCeee
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENILI 962 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~-gIvHrDLKp~NILl 962 (1142)
. .++||||++ ++|.+++...... ...+++..+..|+.||+.||.|||++ ||+||||||+|||+
T Consensus 80 ~--------------~~lv~e~~~-~~l~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~ 143 (290)
T 3fme_A 80 D--------------VWICMELMD-TSLDKFYKQVIDK-GQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLI 143 (290)
T ss_dssp S--------------EEEEEECCS-EEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEE
T ss_pred C--------------EEEEEehhc-cchHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE
Confidence 3 499999997 6998888764333 35799999999999999999999998 99999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
+.+ +.+||+|||++....... ......||+.|+|||++........++.++||||||+++|+
T Consensus 144 ~~~-------~~~kl~Dfg~~~~~~~~~-----------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~ 205 (290)
T 3fme_A 144 NAL-------GQVKMCDFGISGYLVDDV-----------AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIE 205 (290)
T ss_dssp CTT-------CCEEBCCC--------------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHH
T ss_pred CCC-------CCEEEeecCCcccccccc-----------cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHH
Confidence 887 789999999997654321 11233689999999997533234578899999999999999
Q ss_pred HHhCCCCCCCC-CHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1043 LLTLQVPYMGL-SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1043 LLtG~~Pf~~~-~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
|++|+.||... ..............+.... ...++.+.+++.+||+.||.+||
T Consensus 206 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~li~~~l~~~p~~Rp 259 (290)
T 3fme_A 206 LAILRFPYDSWGTPFQQLKQVVEEPSPQLPA--------------------------DKFSAEFVDFTSQCLKKNSKERP 259 (290)
T ss_dssp HHHTSCSSCCCSCHHHHHHHHHHSCCCCCCT--------------------------TTSCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHCCCCccccCchHHHHHHHhccCCCCccc--------------------------ccCCHHHHHHHHHHhhcChhhCc
Confidence 99999999753 3333333332222221110 14456799999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001142 1122 TAGDLYEMFVARTS 1135 (1142)
Q Consensus 1122 Sa~EVL~~L~~~~s 1135 (1142)
|+.|+++|+|+...
T Consensus 260 t~~e~l~hp~f~~~ 273 (290)
T 3fme_A 260 TYPELMQHPFFTLH 273 (290)
T ss_dssp CHHHHTTSHHHHHH
T ss_pred CHHHHHhCcccccC
Confidence 99999999999754
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=373.78 Aligned_cols=269 Identities=24% Similarity=0.259 Sum_probs=211.2
Q ss_pred CCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 882 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~ 882 (1142)
..++|++.++||+|+||.||+|++. +..+|+|+..... .........+.+|..++.+++||||+++++++.+.
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~-----~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 133 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWD-----MLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE 133 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH-----HHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHH-----hhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence 3568999999999999999999984 6778888864211 11111123347899999999999999999999875
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
+ +.|+||||++||+|.+++.+. ...+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 134 ~--------------~~~lVmE~~~gg~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl 195 (412)
T 2vd5_A 134 N--------------YLYLVMEYYVGGDLLTLLSKF----GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL 195 (412)
T ss_dssp S--------------EEEEEECCCCSCBHHHHHHHH----SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred C--------------EEEEEEcCCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeee
Confidence 5 359999999999999999762 2369999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhcccc---CCCCCCchhhHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH---KPNLYGLEVDIWSYGCL 1039 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~---~~~~~s~ksDVwSLGvi 1039 (1142)
+.+ +.+||+|||+++........ .....+||+.|+|||++.... ....|+.++|||||||+
T Consensus 196 d~~-------g~vkL~DFGla~~~~~~~~~---------~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvi 259 (412)
T 2vd5_A 196 DRC-------GHIRLADFGSCLKLRADGTV---------RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVF 259 (412)
T ss_dssp CTT-------SCEEECCCTTCEECCTTSCE---------ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHH
T ss_pred cCC-------CCEEEeechhheeccCCCcc---------ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHH
Confidence 987 88999999999765432111 112457999999999987321 12467899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001142 1040 LLELLTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1118 (1142)
Q Consensus 1040 L~ELLtG~~Pf~~~~~~el~~~I~~~~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~ 1118 (1142)
+|||++|+.||.+.+..+....+.... .... +......++.+.+||.+||. +|.
T Consensus 260 lyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~------------------------p~~~~~~s~~~~dli~~lL~-~p~ 314 (412)
T 2vd5_A 260 AYEMFYGQTPFYADSTAETYGKIVHYKEHLSL------------------------PLVDEGVPEEARDFIQRLLC-PPE 314 (412)
T ss_dssp HHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC------------------------C----CCCHHHHHHHHTTSS-CGG
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhcccCcCC------------------------CccccCCCHHHHHHHHHHcC-Chh
Confidence 999999999999888877776664311 0000 00011456679999999999 999
Q ss_pred CC---CCHHHHHHHHHhhcCCC
Q 001142 1119 ER---PTAGDLYEMFVARTSSS 1137 (1142)
Q Consensus 1119 ~R---PSa~EVL~~L~~~~ss~ 1137 (1142)
+| |+++|+++|+|++.-.+
T Consensus 315 ~Rlgr~~~~ei~~Hpff~~i~w 336 (412)
T 2vd5_A 315 TRLGRGGAGDFRTHPFFFGLDW 336 (412)
T ss_dssp GCTTTTTHHHHHTSGGGTTCCS
T ss_pred hcCCCCCHHHHhcCCCcCCCCH
Confidence 98 69999999999986544
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=356.45 Aligned_cols=286 Identities=20% Similarity=0.231 Sum_probs=206.7
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
.+|++.++||+|+||+||+|++. +..+|+|+...... ....+. +.+|++++++++||||+++++++.....
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 81 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF---LRPVDV----QMREFEVLKKLNHKNIVKLFAIEEETTT 81 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG---GSCHHH----HHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc---cchHHH----HHHHHHHHHhcCCCCcceEEEEeecCCC
Confidence 46999999999999999999985 67788888643221 111222 3689999999999999999999876431
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee--
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI-- 962 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl-- 962 (1142)
...++||||+++++|.+++.... ....+++..++.|+.||+.||+|||++||+||||||+|||+
T Consensus 82 ------------~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~ 147 (319)
T 4euu_A 82 ------------RHKVLIMEFCPCGSLYTVLEEPS--NAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVI 147 (319)
T ss_dssp ------------CCEEEEEECCTTCBHHHHHHSGG--GTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE
T ss_pred ------------ceEEEEEeCCCCCCHHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEec
Confidence 24599999999999999997632 22348999999999999999999999999999999999998
Q ss_pred --ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhcccc----CCCCCCchhhHHHH
Q 001142 963 --DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH----KPNLYGLEVDIWSY 1036 (1142)
Q Consensus 963 --d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~----~~~~~s~ksDVwSL 1036 (1142)
+.+ +.+||+|||+++....... .....||+.|+|||++.... ....++.++|||||
T Consensus 148 ~~~~~-------~~~kL~Dfg~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Diwsl 209 (319)
T 4euu_A 148 GEDGQ-------SVYKLTDFGAARELEDDEQ-----------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSI 209 (319)
T ss_dssp CTTSC-------EEEEECCCTTCEECCTTCC-----------BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHH
T ss_pred cCCCC-------ceEEEccCCCceecCCCCc-----------eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHH
Confidence 443 7899999999976543211 12346899999999986311 12567899999999
Q ss_pred HHHHHHHHhCCCCCCCCC----HHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHh
Q 001142 1037 GCLLLELLTLQVPYMGLS----ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 1112 (1142)
Q Consensus 1037 GviL~ELLtG~~Pf~~~~----~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~C 1112 (1142)
||++|||++|+.||.... ..+....+..+..+............ ...+.. ... .........++.+.+++.+|
T Consensus 210 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~-~~~~~~-~~~-~~~~~~~~~~~~l~~ll~~~ 286 (319)
T 4euu_A 210 GVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENG-PIDWSG-DMP-VSCSLSRGLQVLLTPVLANI 286 (319)
T ss_dssp HHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTC-CEEEES-SCC-TTCSSCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCC-ccccCc-cCC-cccccchhHHHHhHHHHHHh
Confidence 999999999999996422 23344444333332211111000000 000000 000 01112236778899999999
Q ss_pred cccCCCCCCCHHHHHHHHHhhc
Q 001142 1113 TEENPTERPTAGDLYEMFVART 1134 (1142)
Q Consensus 1113 L~~DP~~RPSa~EVL~~L~~~~ 1134 (1142)
|+.||++|||++|+++|+.-..
T Consensus 287 L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 287 LEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp SCCCTTTSCCHHHHHHHHHHHT
T ss_pred ccCChhhhccHHHhhhccHHHh
Confidence 9999999999999999987543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=347.98 Aligned_cols=259 Identities=23% Similarity=0.263 Sum_probs=202.6
Q ss_pred CCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 882 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~ 882 (1142)
...+|++.+.||+|+||.||+|.+. +..+|+|+..... .........+.+|+.++++++||||+++++++...
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 83 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQK-----IRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP 83 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEecccc-----ccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 4578999999999999999999984 6788888864321 11112223457999999999999999999998865
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
+ ..++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||++
T Consensus 84 ~--------------~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~ 144 (276)
T 2h6d_A 84 T--------------DFFMVMEYVSGGELFDYICKH-----GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL 144 (276)
T ss_dssp S--------------EEEEEEECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEE
T ss_pred C--------------eEEEEEeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEE
Confidence 4 459999999999999999762 368999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
+.+ +.+||+|||.+....... ......||+.|+|||++.+. ...+.++||||||+++|+
T Consensus 145 ~~~-------~~~~l~dfg~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~---~~~~~~~Di~slG~~l~~ 203 (276)
T 2h6d_A 145 DAH-------MNAKIADFGLSNMMSDGE-----------FLRTSCGSPNYAAPEVISGR---LYAGPEVDIWSCGVILYA 203 (276)
T ss_dssp CTT-------SCEEECCCCGGGCCCC------------------------CCTGGGTTS---CCCHHHHHHHHHHHHHHH
T ss_pred CCC-------CCEEEeecccccccCCCc-----------ceecccCCccccCHHHHcCC---CCCCccchHHHHHHHHHH
Confidence 877 789999999987654321 11234689999999998751 233689999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1043 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1043 LLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
|++|+.||......+....+..+.... + ...+..+.+++.+||+.||.+|||
T Consensus 204 l~~g~~p~~~~~~~~~~~~~~~~~~~~-~---------------------------~~~~~~l~~li~~~l~~~p~~Rps 255 (276)
T 2h6d_A 204 LLCGTLPFDDEHVPTLFKKIRGGVFYI-P---------------------------EYLNRSVATLLMHMLQVDPLKRAT 255 (276)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHCCCCC-C---------------------------TTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHhCCCCCCCCcHHHHHHHhhcCcccC-c---------------------------hhcCHHHHHHHHHHccCChhhCCC
Confidence 999999998877766666655433211 0 033456899999999999999999
Q ss_pred HHHHHHHHHhhcCC
Q 001142 1123 AGDLYEMFVARTSS 1136 (1142)
Q Consensus 1123 a~EVL~~L~~~~ss 1136 (1142)
+.|+++|+|++...
T Consensus 256 ~~~~l~h~~~~~~~ 269 (276)
T 2h6d_A 256 IKDIREHEWFKQDL 269 (276)
T ss_dssp HHHHHHSHHHHTTC
T ss_pred HHHHHhChhhccCc
Confidence 99999999998654
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=349.79 Aligned_cols=262 Identities=22% Similarity=0.235 Sum_probs=200.3
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSK 883 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~~~~~ 883 (1142)
.+|++.+.||+|+||+||+|.+. +..+|+|+.... .........+ .+|+.++.++ +||||+++++++.+.+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~----~~e~~~~~~l~~h~~iv~~~~~~~~~~ 84 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKP--LAGSVDEQNA----LREVYAHAVLGQHSHVVRYFSAWAEDD 84 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--CTTSHHHHHH----HHHHHHHHHSCSCTTBCCEEEEEEETT
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccc--ccccHHHHHH----HHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence 46899999999999999999984 777888876533 2222333333 7899999999 8999999999998655
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
..++||||+++++|.+++...... ...+++..+..|+.||+.||.|||++||+||||||+|||++
T Consensus 85 --------------~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~ 149 (289)
T 1x8b_A 85 --------------HMLIQNEYCNGGSLADAISENYRI-MSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFIS 149 (289)
T ss_dssp --------------EEEEEEECCTTCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred --------------eEEEEEEecCCCcHHHHHHhhccc-ccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEc
Confidence 459999999999999999864332 24689999999999999999999999999999999999998
Q ss_pred ccccc------------CCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchh
Q 001142 964 LERKK------------ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 1031 (1142)
Q Consensus 964 ~~~~~------------~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ks 1031 (1142)
.++.. ......+||+|||.+...... ....||+.|+|||++.+ ...++.++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--------------~~~~gt~~y~aPE~~~~---~~~~~~~~ 212 (289)
T 1x8b_A 150 RTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP--------------QVEEGDSRFLANEVLQE---NYTHLPKA 212 (289)
T ss_dssp --------------------CCCEEECCCTTCEETTCS--------------CCCCCCGGGCCHHHHTT---CCTTHHHH
T ss_pred CCCCCcccccccccccccCCceEEEEcccccccccCCc--------------cccCCCccccChhHhcC---CCCCCchh
Confidence 54200 012357999999998764321 12358999999999875 23566899
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHH
Q 001142 1032 DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRR 1111 (1142)
Q Consensus 1032 DVwSLGviL~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~ 1111 (1142)
|||||||++|+|++|.+|+.... ....+..+..+.++. ..++.+.+++.+
T Consensus 213 Di~slG~il~~l~~~~~~~~~~~---~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~ 262 (289)
T 1x8b_A 213 DIFALALTVVCAAGAEPLPRNGD---QWHEIRQGRLPRIPQ---------------------------VLSQEFTELLKV 262 (289)
T ss_dssp HHHHHHHHHHHHTTCCCCCSSSH---HHHHHHTTCCCCCSS---------------------------CCCHHHHHHHHH
T ss_pred hHHHHHHHHHHHhcCCCCCcchh---HHHHHHcCCCCCCCc---------------------------ccCHHHHHHHHH
Confidence 99999999999999988775432 233343333322211 345679999999
Q ss_pred hcccCCCCCCCHHHHHHHHHhhcCC
Q 001142 1112 CTEENPTERPTAGDLYEMFVARTSS 1136 (1142)
Q Consensus 1112 CL~~DP~~RPSa~EVL~~L~~~~ss 1136 (1142)
||+.||++|||+.|+++|+|+...+
T Consensus 263 ~l~~dp~~Rps~~~ll~h~~~~~~~ 287 (289)
T 1x8b_A 263 MIHPDPERRPSAMALVKHSVLLSAS 287 (289)
T ss_dssp HTCSSGGGSCCHHHHHTCTTC----
T ss_pred HhCCCcccCCCHHHHhhChHhhhhc
Confidence 9999999999999999999998654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=364.98 Aligned_cols=262 Identities=24% Similarity=0.385 Sum_probs=210.9
Q ss_pred CCCcceeeeecccCceEEEEEEECC---------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccce
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFGS---------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 875 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~~---------~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl 875 (1142)
.++|.+.++||+|+||.||+|++.+ ..+|+|+.... ......+.+ .+|+++++++ +|||||++
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~----~~E~~~l~~l~~hpnIv~~ 140 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD---ATEKDLSDL----ISEMEMMKMIGKHKNIINL 140 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT---CCHHHHHHH----HHHHHHHHHHCCCTTBCCE
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc---cCHHHHHHH----HHHHHHHHHhcCCchhhhh
Confidence 3579999999999999999999632 35788875422 223333344 7999999999 89999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc-----------CCCCCCHHHHHHHHHHHHHHHHH
Q 001142 876 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAALVE 944 (1142)
Q Consensus 876 ~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~-----------~~~~ls~~~i~~Ia~qIa~gL~y 944 (1142)
++++.+.+.. ++||||+++++|.+++...... ....+++..++.|+.||+.||.|
T Consensus 141 ~~~~~~~~~~--------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 206 (382)
T 3tt0_A 141 LGACTQDGPL--------------YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 206 (382)
T ss_dssp EEEECSSSSC--------------EEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHH
T ss_pred eeeeccCCce--------------EEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHH
Confidence 9999876544 9999999999999999873211 12459999999999999999999
Q ss_pred HHhCCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCC
Q 001142 945 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 1024 (1142)
Q Consensus 945 LHs~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~ 1024 (1142)
||++||+||||||+|||++.+ +.+||+|||+++........ .......+|+.|+|||++.+
T Consensus 207 LH~~~ivH~Dlkp~NIll~~~-------~~~kL~DFG~a~~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~---- 267 (382)
T 3tt0_A 207 LASKKCIHRDLAARNVLVTED-------NVMKIADFGLARDIHHIDYY--------KKTTNGRLPVKWMAPEALFD---- 267 (382)
T ss_dssp HHHTTCCCSCCCGGGEEECTT-------CCEEECSCSCCCCSSCCCTT--------CCCTTCCCGGGGSCHHHHHS----
T ss_pred HHhCCEecCCCCcceEEEcCC-------CcEEEcccCccccccccccc--------ccccCCCCCcceeCHHHhcC----
Confidence 999999999999999999887 78999999999765432111 11223457889999999876
Q ss_pred CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHH
Q 001142 1025 NLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLS 1103 (1142)
Q Consensus 1025 ~~~s~ksDVwSLGviL~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1103 (1142)
..++.++|||||||++|+|++ |..||.+....++...+..+..+..+. ..++
T Consensus 268 ~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~ 320 (382)
T 3tt0_A 268 RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPS---------------------------NCTN 320 (382)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCS---------------------------SCCH
T ss_pred CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------cCCH
Confidence 568899999999999999999 999999888877777776554332211 4456
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001142 1104 FLVDVFRRCTEENPTERPTAGDLYEMFVART 1134 (1142)
Q Consensus 1104 ~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~~ 1134 (1142)
.+.+|+.+||+.||++|||+.||++++....
T Consensus 321 ~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 351 (382)
T 3tt0_A 321 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351 (382)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 7999999999999999999999999987653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=349.36 Aligned_cols=255 Identities=22% Similarity=0.333 Sum_probs=193.6
Q ss_pred CCCcceeeeecccCceEEEEEEECC-----ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 880 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~~-----~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~ 880 (1142)
..+|++.+.||+|+||.||+|.+.. ..+|+|+ .+.. ......+. +.+|+.++++++||||+++++++.
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~--~~~~-~~~~~~~~----~~~e~~~l~~l~h~~iv~~~~~~~ 86 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKT--CKNC-TSDSVREK----FLQEALTMRQFDHPHIVKLIGVIT 86 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEE--CTTT-TSHHHHHH----HHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEe--cccc-CCHHHHHH----HHHHHHHHHhCCCCccceEEEEEc
Confidence 4579999999999999999999843 2355554 3321 12222333 489999999999999999999975
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NI 960 (1142)
+. ..++||||+++++|.+++.. ....+++..+..++.||+.||.|||++||+||||||+||
T Consensus 87 ~~---------------~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 147 (281)
T 1mp8_A 87 EN---------------PVWIIMELCTLGELRSFLQV----RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNV 147 (281)
T ss_dssp SS---------------SCEEEEECCTTEEHHHHHHH----TTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred cC---------------ccEEEEecCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHE
Confidence 32 23899999999999999975 234689999999999999999999999999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
|++.+ +.+||+|||+++........ ......+|+.|+|||++.+ ..++.++||||||+++
T Consensus 148 l~~~~-------~~~kl~Dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l 207 (281)
T 1mp8_A 148 LVSSN-------DCVKLGDFGLSRYMEDSTYY---------KASKGKLPIKWMAPESINF----RRFTSASDVWMFGVCM 207 (281)
T ss_dssp EEEET-------TEEEECC----------------------------CCGGGCCHHHHHH----CCCSHHHHHHHHHHHH
T ss_pred EECCC-------CCEEECccccccccCccccc---------ccccCCCcccccChhhccc----CCCCCccCchHHHHHH
Confidence 99987 78999999999765432111 1123357789999999876 5688999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001142 1041 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1119 (1142)
Q Consensus 1041 ~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~ 1119 (1142)
|||++ |..||.+....+....+..+..+..+ ...++.+.+++.+||+.||++
T Consensus 208 ~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~---------------------------~~~~~~l~~li~~~l~~~p~~ 260 (281)
T 1mp8_A 208 WEILMHGVKPFQGVKNNDVIGRIENGERLPMP---------------------------PNCPPTLYSLMTKCWAYDPSR 260 (281)
T ss_dssp HHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC---------------------------TTCCHHHHHHHHHHTCSSGGG
T ss_pred HHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCC---------------------------CCCCHHHHHHHHHHccCChhh
Confidence 99997 99999887766666666554332221 145567999999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 001142 1120 RPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1120 RPSa~EVL~~L~~~ 1133 (1142)
|||+.|+++++...
T Consensus 261 Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 261 RPRFTELKAQLSTI 274 (281)
T ss_dssp SCCHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHH
Confidence 99999999998764
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=361.84 Aligned_cols=258 Identities=27% Similarity=0.403 Sum_probs=206.6
Q ss_pred CcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
.|++.+.||+|+||+||+|++ .+..||+|+...... ......+. +.+|+.++++++||||+++++++.+.+
T Consensus 55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~----~~~E~~~l~~l~hpniv~~~~~~~~~~-- 127 (348)
T 1u5q_A 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQD----IIKEVRFLQKLRHPNTIQYRGCYLREH-- 127 (348)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSS-CHHHHHHH----HHHHHHHHHHCCCTTBCCEEEEEEETT--
T ss_pred heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccc-cchHHHHH----HHHHHHHHHhCCCCCEeeEEEEEEECC--
Confidence 489999999999999999997 466778887543211 11222233 479999999999999999999998654
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
..++||||++ |+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 128 ------------~~~lv~e~~~-g~l~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~ 190 (348)
T 1u5q_A 128 ------------TAWLVMEYCL-GSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP 190 (348)
T ss_dssp ------------EEEEEEECCS-EEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT
T ss_pred ------------eEEEEEecCC-CCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC
Confidence 3599999997 7888888642 3468999999999999999999999999999999999999887
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+.+||+|||++...... ....||+.|+|||++.+.. ...++.++|||||||++|||++
T Consensus 191 -------~~~kL~DfG~a~~~~~~--------------~~~~gt~~y~aPE~~~~~~-~~~~~~~~DiwslG~il~ell~ 248 (348)
T 1u5q_A 191 -------GLVKLGDFGSASIMAPA--------------NSFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIELAE 248 (348)
T ss_dssp -------TEEEECCCTTCBSSSSB--------------CCCCSCGGGCCHHHHHTTS-SCCBCTHHHHHHHHHHHHHHHH
T ss_pred -------CCEEEeeccCceecCCC--------------CcccCCcceeCHhhhcccc-CCCCCcHHHHHHHHHHHHHHHh
Confidence 78999999999654321 1346899999999986321 2467899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001142 1046 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1125 (1142)
Q Consensus 1046 G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~E 1125 (1142)
|+.||.+.........+.....+.... ...++.+.+|+.+||+.||.+|||+++
T Consensus 249 g~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~l~~li~~~l~~dP~~Rps~~~ 302 (348)
T 1u5q_A 249 RKPPLFNMNAMSALYHIAQNESPALQS--------------------------GHWSEYFRNFVDSCLQKIPQDRPTSEV 302 (348)
T ss_dssp SSCTTTTSCHHHHHHHHHHSCCCCCCC--------------------------TTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCCCCChHHHHHHHHhcCCCCCCC--------------------------CCCCHHHHHHHHHHcccChhhCcCHHH
Confidence 999998877766555554443322110 134567899999999999999999999
Q ss_pred HHHHHHhhcCCC
Q 001142 1126 LYEMFVARTSSS 1137 (1142)
Q Consensus 1126 VL~~L~~~~ss~ 1137 (1142)
+++|+|+.....
T Consensus 303 ll~h~~~~~~~~ 314 (348)
T 1u5q_A 303 LLKHRFVLRERP 314 (348)
T ss_dssp HTTCHHHHSCCC
T ss_pred HhhChhhhccCC
Confidence 999999986543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=354.84 Aligned_cols=261 Identities=22% Similarity=0.334 Sum_probs=185.0
Q ss_pred CCCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 882 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~ 882 (1142)
.+++|++.+.||+|+||.||+|++ .+..+|+|+..... .........+.+|+.++++++||||+++++++.+.
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 83 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKA-----MYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDS 83 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECS
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhh-----hhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccC
Confidence 456899999999999999999997 56778998864321 11112223458999999999999999999999865
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
+ ..++||||+++++|.+++.. ....+++..+..++.||+.||.|||++||+||||||+||++
T Consensus 84 ~--------------~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili 145 (278)
T 3cok_A 84 N--------------YVYLVLEMCHNGEMNRYLKN----RVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLL 145 (278)
T ss_dssp S--------------EEEEEEECCTTEEHHHHHHT----CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEE
T ss_pred C--------------eEEEEEecCCCCcHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence 4 35999999999999999874 23568999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
+.+ +.+||+|||.+........ ......||+.|+|||++.+ ..++.++||||||+++|+
T Consensus 146 ~~~-------~~~kl~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~ 204 (278)
T 3cok_A 146 TRN-------MNIKIADFGLATQLKMPHE----------KHYTLCGTPNYISPEIATR----SAHGLESDVWSLGCMFYT 204 (278)
T ss_dssp CTT-------CCEEECCCTTCEECC------------------------------------------CTHHHHHHHHHHH
T ss_pred cCC-------CCEEEEeecceeeccCCCC----------cceeccCCCCcCCcchhcC----CCCCchhhHHHHHHHHHH
Confidence 877 7899999999976542211 1123468999999999875 567899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1043 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1043 LLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
|++|+.||......+....+.... ... +...+..+.+++.+||+.||++|||
T Consensus 205 l~~g~~p~~~~~~~~~~~~~~~~~-------------------------~~~---~~~~~~~~~~li~~~l~~dp~~Rps 256 (278)
T 3cok_A 205 LLIGRPPFDTDTVKNTLNKVVLAD-------------------------YEM---PSFLSIEAKDLIHQLLRRNPADRLS 256 (278)
T ss_dssp HHHSSCSSCCCSCC-----CCSSC-------------------------CCC---CTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred HHhCCCCCCChhHHHHHHHHhhcc-------------------------cCC---ccccCHHHHHHHHHHcccCHhhCCC
Confidence 999999997654332222111100 000 0134567899999999999999999
Q ss_pred HHHHHHHHHhhcCCC
Q 001142 1123 AGDLYEMFVARTSSS 1137 (1142)
Q Consensus 1123 a~EVL~~L~~~~ss~ 1137 (1142)
++++++|+|+.....
T Consensus 257 ~~~~l~h~~~~~~~~ 271 (278)
T 3cok_A 257 LSSVLDHPFMSRNSS 271 (278)
T ss_dssp HHHHTTSTTTC----
T ss_pred HHHHhcCccccCCCC
Confidence 999999999986543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=367.40 Aligned_cols=295 Identities=18% Similarity=0.187 Sum_probs=207.7
Q ss_pred CCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
..+|++.+.||+|+||+||+|.+ .+..+|+|+...... .. .+|+.+++.++|||||++++++....
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~--------~~----~~E~~il~~l~hpnIv~l~~~~~~~~ 73 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR--------YK----NRELDIMKVLDHVNIIKLVDYFYTTG 73 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT--------SC----CHHHHHHTTCCCTTBCCEEEEEEEC-
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc--------hH----HHHHHHHHHcCCCCccchhheeeecC
Confidence 45799999999999999999988 567788887542211 11 37999999999999999999986532
Q ss_pred CCCCC-----------CC-------------CCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHH
Q 001142 884 WLPSA-----------DG-------------NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVA 939 (1142)
Q Consensus 884 ~~~~~-----------~~-------------~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa 939 (1142)
..... .+ .......+.++||||++ ++|.+.+...... ...+++..+..++.||+
T Consensus 74 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~ 151 (383)
T 3eb0_A 74 DEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRS-GRSIPMNLISIYIYQLF 151 (383)
T ss_dssp ------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHT-TCCCCHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhc-CCCCCHHHHHHHHHHHH
Confidence 10000 00 00012335789999998 6999888764433 35799999999999999
Q ss_pred HHHHHHHhCCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhc
Q 001142 940 AALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1019 (1142)
Q Consensus 940 ~gL~yLHs~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~ 1019 (1142)
.||.|||++||+||||||+|||++... +.+||+|||+|+...... ......||+.|+|||++.
T Consensus 152 ~aL~~LH~~gi~H~Dikp~Nil~~~~~------~~~kl~Dfg~a~~~~~~~-----------~~~~~~~t~~y~aPE~~~ 214 (383)
T 3eb0_A 152 RAVGFIHSLGICHRDIKPQNLLVNSKD------NTLKLCDFGSAKKLIPSE-----------PSVAYICSRFYRAPELML 214 (383)
T ss_dssp HHHHHHHTTTEECSCCCGGGEEEETTT------TEEEECCCTTCEECCTTS-----------CCCCCCCCSSCCCHHHHT
T ss_pred HHHHHHHHCcCccCccCHHHEEEcCCC------CcEEEEECCCCcccCCCC-----------CCcCcccCCCccCHHHhc
Confidence 999999999999999999999997431 789999999997653321 112346899999999987
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhCCCCCchhHHhhhcccccccccccCCCCCCchhh
Q 001142 1020 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 1098 (1142)
Q Consensus 1020 ~~~~~~~~s~ksDVwSLGviL~ELLtG~~Pf~~~~~~el~~~I-~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1142)
+ ...++.++|||||||++|||++|+.||.+.+..+....+ .....+................+.......-.....
T Consensus 215 ~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (383)
T 3eb0_A 215 G---ATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILP 291 (383)
T ss_dssp T---CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSC
T ss_pred C---CCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCC
Confidence 5 245889999999999999999999999988777665555 333333222111111000000000000000000011
Q ss_pred hhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001142 1099 LETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1134 (1142)
Q Consensus 1099 ~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~~ 1134 (1142)
...++.+.+|+.+||+.||.+|||+.|+++|+|+..
T Consensus 292 ~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 292 EGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH 327 (383)
T ss_dssp TTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHH
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHH
Confidence 145677999999999999999999999999999963
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=377.72 Aligned_cols=268 Identities=20% Similarity=0.281 Sum_probs=199.5
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
++|.+.+.||+|+||+||+|.+. +..+|+|+...+...............+.+|+.++++++|||||++++++...
T Consensus 135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-- 212 (419)
T 3i6u_A 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-- 212 (419)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS--
T ss_pred ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC--
Confidence 57999999999999999999984 56889998765432222211111122347999999999999999999998642
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
..++||||+++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 213 -------------~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~ 274 (419)
T 3i6u_A 213 -------------DYYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSS 274 (419)
T ss_dssp -------------EEEEEEECCTTCBGGGGTSS-----SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESS
T ss_pred -------------ceEEEEEcCCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEec
Confidence 24899999999999888753 357999999999999999999999999999999999999975
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
++ ....+||+|||+++...... ......||+.|+|||++.+.. ...++.++|||||||++|+|+
T Consensus 275 ~~----~~~~~kl~DFG~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~DiwslG~il~~ll 338 (419)
T 3i6u_A 275 QE----EDCLIKITDFGHSKILGETS-----------LMRTLCGTPTYLAPEVLVSVG-TAGYNRAVDCWSLGVILFICL 338 (419)
T ss_dssp SS----SSCCEEECCSSTTTSCC----------------------CTTCCTTTTC-----CTTHHHHHHHHHHHHHHHHH
T ss_pred CC----CcceEEEeecccceecCCCc-----------cccccCCCCCccCceeeecCC-CCCCCchhhhHhHHHHHHHHH
Confidence 42 12569999999997654321 112456999999999985321 246789999999999999999
Q ss_pred hCCCCCCCCCHH-HHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1045 TLQVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1045 tG~~Pf~~~~~~-el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
+|+.||...... .....+..+.....+..+ ...++.+.+|+.+||+.||.+|||+
T Consensus 339 tg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~------------------------~~~~~~~~~li~~~L~~dP~~Rps~ 394 (419)
T 3i6u_A 339 SGYPPFSEHRTQVSLKDQITSGKYNFIPEVW------------------------AEVSEKALDLVKKLLVVDPKARFTT 394 (419)
T ss_dssp HSSCSSCCCSSSCCHHHHHHTTCCCCCHHHH------------------------TTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred HCCCCCCCCcchHHHHHHHhcCCCCCCchhh------------------------cccCHHHHHHHHHHccCChhHCcCH
Confidence 999999764322 234444444333222211 1456679999999999999999999
Q ss_pred HHHHHHHHhhc
Q 001142 1124 GDLYEMFVART 1134 (1142)
Q Consensus 1124 ~EVL~~L~~~~ 1134 (1142)
+|+++|+|++.
T Consensus 395 ~e~l~hp~~~~ 405 (419)
T 3i6u_A 395 EEALRHPWLQD 405 (419)
T ss_dssp HHHHHSGGGCC
T ss_pred HHHhCCcccCC
Confidence 99999999974
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=351.96 Aligned_cols=266 Identities=24% Similarity=0.357 Sum_probs=199.3
Q ss_pred CCCcceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhh--CCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGA--LRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~--L~HpNIVkl~g~~~~~~ 883 (1142)
.++|++.+.||+|+||+||+|++.+..+|+|++... ....+ .+|.+++.. ++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-------~~~~~----~~e~~~~~~~~l~h~niv~~~~~~~~~~ 75 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR-------DEKSW----FRETELYNTVMLRHENILGFIASDMTSR 75 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGG-------GHHHH----HHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccc-------cchhh----HHHHHHHHHhhccCcCeeeEEEeecccc
Confidence 457999999999999999999999999999986422 11222 456666655 78999999999876532
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCccccCC
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELH--------SKHIMHRDI 955 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLH--------s~gIvHrDL 955 (1142)
. .....++||||+++|+|.++++. ..+++..+..|+.||+.||+||| ++||+||||
T Consensus 76 ~----------~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dl 139 (301)
T 3q4u_A 76 H----------SSTQLWLITHYHEMGSLYDYLQL------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDL 139 (301)
T ss_dssp T----------TEEEEEEEECCCTTCBHHHHHTT------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCC
T ss_pred C----------CCceeEEehhhccCCCHHHHHhh------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCC
Confidence 1 12356999999999999999953 46999999999999999999999 999999999
Q ss_pred CCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCC--CCCchhhH
Q 001142 956 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN--LYGLEVDI 1033 (1142)
Q Consensus 956 Kp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~--~~s~ksDV 1033 (1142)
||+|||++.+ +.+||+|||+++.......... .......||+.|+|||++.+..... .++.++||
T Consensus 140 kp~Nill~~~-------~~~kl~Dfg~a~~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Dv 206 (301)
T 3q4u_A 140 KSKNILVKKN-------GQCCIADLGLAVMHSQSTNQLD------VGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDI 206 (301)
T ss_dssp CGGGEEECTT-------SCEEECCCTTCEEEETTTTEEE------CCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHH
T ss_pred ChHhEEEcCC-------CCEEEeeCCCeeeccccccccc------ccccccccccceeChhhhcCcCCCCcccCCchhhH
Confidence 9999999877 7899999999976543221110 0122346999999999997632111 34579999
Q ss_pred HHHHHHHHHHHhC----------CCCCCCCC-----HHHHHHHHH-hCCCCCchhHHhhhcccccccccccCCCCCCchh
Q 001142 1034 WSYGCLLLELLTL----------QVPYMGLS-----ELEIHDLIQ-MGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 1097 (1142)
Q Consensus 1034 wSLGviL~ELLtG----------~~Pf~~~~-----~~el~~~I~-~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~ 1097 (1142)
|||||++|||++| +.||.... .......+. ....+..+. ...
T Consensus 207 wslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~ 264 (301)
T 3q4u_A 207 WAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPN----------------------RWF 264 (301)
T ss_dssp HHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCG----------------------GGG
T ss_pred HHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCCh----------------------hhc
Confidence 9999999999999 88885421 122222221 111221111 011
Q ss_pred hhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001142 1098 ELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1098 ~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~ 1133 (1142)
....++.+.+|+.+||+.||.+|||+.||++.+...
T Consensus 265 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 265 SDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp GSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 125678899999999999999999999999988653
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=353.32 Aligned_cols=275 Identities=23% Similarity=0.331 Sum_probs=198.8
Q ss_pred CCCcceeeeecccCceEEEEEEE------CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeE
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKF------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 879 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~------~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~ 879 (1142)
-.+|++.++||+|+||+||+|++ .+..+|+|+... ......+.+ .+|+.++++++||||+++++++
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~----~~E~~~l~~l~h~~iv~~~~~~ 80 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH----STEEHLRDF----EREIEILKSLQHDNIVKYKGVC 80 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESC----CCHHHHHHH----HHHHHHHHTCCCTTBCCEEEEE
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEccc----CCHHHHHHH----HHHHHHHHhCCCCCEeeEEEEE
Confidence 45799999999999999999985 456788887532 123333444 7999999999999999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 001142 880 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959 (1142)
Q Consensus 880 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~N 959 (1142)
...+. ...++||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|
T Consensus 81 ~~~~~------------~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~N 144 (295)
T 3ugc_A 81 YSAGR------------RNLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRN 144 (295)
T ss_dssp CHHHH------------TSCEEEEECCTTCBHHHHHHHC----GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred ecCCC------------CceEEEEEeCCCCCHHHHHHhc----ccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhh
Confidence 65321 1349999999999999999862 2358999999999999999999999999999999999
Q ss_pred eeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001142 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039 (1142)
Q Consensus 960 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGvi 1039 (1142)
||++.+ +.+||+|||++......... ........+|..|+|||++.+ ..++.++||||||++
T Consensus 145 il~~~~-------~~~kl~Dfg~~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~ 206 (295)
T 3ugc_A 145 ILVENE-------NRVKIGDFGLTKVLPQDKEF-------FKVKEPGESPIFWYAPESLTE----SKFSVASDVWSFGVV 206 (295)
T ss_dssp EEEEET-------TEEEECCCCSCC--------------------CTTCGGGGCCHHHHHH----CCCCHHHHHHHHHHH
T ss_pred EEEcCC-------CeEEEccCcccccccCCcce-------eeeccCCCCccceeCcHHhcC----CCCChHHHHHHHHHH
Confidence 999987 78999999999765432211 011223357788999999976 568899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001142 1040 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1119 (1142)
Q Consensus 1040 L~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~ 1119 (1142)
+|+|++|..||... ..+....+......... ..... .......... ....+++.+.+++.+||+.||++
T Consensus 207 l~~l~~g~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~------~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~ 275 (295)
T 3ugc_A 207 LYELFTYIEKSKSP-PAEFMRMIGNDKQGQMI-VFHLI------ELLKNNGRLP---RPDGCPDEIYMIMTECWNNNVNQ 275 (295)
T ss_dssp HHHHHHTTCTTCSH-HHHHHHHHCTTCCTHHH-HHHHH------HHHHTTCCCC---CCTTCCHHHHHHHHHHSCSSGGG
T ss_pred HHHHHhcccccCCC-hHHHHhhhcCccccchh-HHHHH------HHHhccCcCC---CCcCcCHHHHHHHHHHcCCChhh
Confidence 99999999998742 22222222111110000 00000 0000000000 11256678999999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 001142 1120 RPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1120 RPSa~EVL~~L~~~ 1133 (1142)
|||+.|+++.+...
T Consensus 276 Rps~~el~~~L~~l 289 (295)
T 3ugc_A 276 RPSFRDLALRVDQI 289 (295)
T ss_dssp SCCHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHH
Confidence 99999999988764
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=355.22 Aligned_cols=273 Identities=26% Similarity=0.326 Sum_probs=198.0
Q ss_pred CCCccee-eeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEec
Q 001142 806 FPSLSSC-DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 881 (1142)
Q Consensus 806 ~~~y~l~-~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~~~ 881 (1142)
-+.|++. +.||+|+||.||+|.+ .+..+|+|+..... . ...+. +.+|+.++.++ +||||+++++++.+
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~--~~~~~----~~~E~~~l~~~~~h~~i~~~~~~~~~ 82 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--G--HIRSR----VFREVEMLYQCQGHRNVLELIEFFEE 82 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--S--CCHHH----HHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--c--hhHHH----HHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 3568885 7899999999999987 46788888864321 1 11222 37899999985 79999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 001142 882 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 961 (1142)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NIL 961 (1142)
.+ ..++||||+++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 83 ~~--------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil 143 (316)
T 2ac3_A 83 ED--------------RFYLVFEKMRGGSILSHIHK-----RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENIL 143 (316)
T ss_dssp TT--------------EEEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred CC--------------EEEEEEEcCCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEE
Confidence 55 45999999999999999976 246899999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhcccc-CCCCCCchhhHHHHHHHH
Q 001142 962 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 962 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~s~ksDVwSLGviL 1040 (1142)
++.++ ....+||+|||++............ .........||+.|+|||++.+.. ....++.++|||||||++
T Consensus 144 ~~~~~----~~~~~kl~Dfg~~~~~~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il 216 (316)
T 2ac3_A 144 CEHPN----QVSPVKICDFDLGSGIKLNGDCSPI---STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216 (316)
T ss_dssp ESCSS----SSCSEEECCTTCCC----------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHH
T ss_pred EccCC----CcCceEEEEccCccccccCCccccc---cccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHH
Confidence 98762 1134999999999765322111000 011122346999999999986411 012467899999999999
Q ss_pred HHHHhCCCCCCCCCH---------------HHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHH
Q 001142 1041 LELLTLQVPYMGLSE---------------LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFL 1105 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~~~~---------------~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 1105 (1142)
|+|++|+.||.+... ..+...+..+....... .....++.+
T Consensus 217 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~~~~~ 272 (316)
T 2ac3_A 217 YILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDK------------------------DWAHISCAA 272 (316)
T ss_dssp HHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHH------------------------HHTTSCHHH
T ss_pred HHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcccCch------------------------hcccCCHHH
Confidence 999999999976431 22333443332211110 001456679
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 001142 1106 VDVFRRCTEENPTERPTAGDLYEMFVARTSS 1136 (1142)
Q Consensus 1106 ~dLI~~CL~~DP~~RPSa~EVL~~L~~~~ss 1136 (1142)
.+|+.+||+.||.+|||+.|+++|+|++...
T Consensus 273 ~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 273 KDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred HHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 9999999999999999999999999998653
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=352.76 Aligned_cols=267 Identities=21% Similarity=0.276 Sum_probs=207.2
Q ss_pred CCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
+.+|++.+.||+|+||.||+|.+ .+..+|+|+............ ...+.+|+.++++++||||+++++++....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNG----EANVKKEIQLLRRLRHKNVIQLVDVLYNEE 79 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTH----HHHHHHHHHHHTTCCCTTBCCEEEEEECC-
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchh----HHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence 46899999999999999999998 456788888653321111111 234489999999999999999999986422
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
....++||||++++ |.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 80 ------------~~~~~lv~e~~~~~-l~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~ 143 (305)
T 2wtk_C 80 ------------KQKMYMVMEYCVCG-MQEMLDSV---PEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLT 143 (305)
T ss_dssp --------------CEEEEEECCSEE-HHHHHHHS---TTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred ------------CCeEEEEehhccCC-HHHHHHhC---cccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEc
Confidence 12459999999855 88887652 345799999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.+||+|||.+......... .......||+.|+|||++.+. ...++.++||||||+++|+|
T Consensus 144 ~~-------~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~--~~~~~~~~Di~slG~il~~l 206 (305)
T 2wtk_C 144 TG-------GTLKISALGVAEALHPFAAD--------DTCRTSQGSPAFQPPEIANGL--DTFSGFKVDIWSAGVTLYNI 206 (305)
T ss_dssp TT-------CCEEECCCTTCEECCTTCSS--------CEECCCCSCGGGCCHHHHTCC--SCEESHHHHHHHHHHHHHHH
T ss_pred CC-------CcEEeeccccccccCccccc--------cccccCCCCCCCcChhhccCc--ccCCcchhhHHHHHHHHHHH
Confidence 77 78999999999765432111 011234589999999998752 12346899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
++|+.||.+....+....+..+.... + ...++.+.+++.+||+.||.+|||+
T Consensus 207 ~~g~~p~~~~~~~~~~~~i~~~~~~~-~---------------------------~~~~~~l~~li~~~l~~dp~~Rps~ 258 (305)
T 2wtk_C 207 TTGLYPFEGDNIYKLFENIGKGSYAI-P---------------------------GDCGPPLSDLLKGMLEYEPAKRFSI 258 (305)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHCCCCC-C---------------------------SSSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred HhCCCCCCCchHHHHHHHHhcCCCCC-C---------------------------CccCHHHHHHHHHHccCChhhCCCH
Confidence 99999999877777666665443211 0 0345678999999999999999999
Q ss_pred HHHHHHHHhhcCCC
Q 001142 1124 GDLYEMFVARTSSS 1137 (1142)
Q Consensus 1124 ~EVL~~L~~~~ss~ 1137 (1142)
.|+++|+|++....
T Consensus 259 ~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 259 RQIRQHSWFRKKHP 272 (305)
T ss_dssp HHHHHSHHHHSCCC
T ss_pred HHHhcCcccccCCC
Confidence 99999999986544
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=368.83 Aligned_cols=257 Identities=25% Similarity=0.386 Sum_probs=207.2
Q ss_pred CCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
.++|++.+.||+|+||.||+|++. +..||+|+.+ .. ......+.+ .+|+.++++++|||||++++++...+
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~--~~-~~~~~~~~~----~~E~~~l~~l~hpniv~~~~~~~~~~ 185 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR--ET-LPPDLKAKF----LQEARILKQYSHPNIVRLIGVCTQKQ 185 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECC--TT-SCHHHHTTT----THHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcc--cc-CCHHHHHHH----HHHHHHHHhCCCCCEEEEEEEEecCC
Confidence 457999999999999999999995 6677887643 21 223333344 79999999999999999999997655
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
.. ++||||+++|+|.++++.. ...+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 186 ~~--------------~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~ 247 (377)
T 3cbl_A 186 PI--------------YIVMELVQGGDFLTFLRTE----GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVT 247 (377)
T ss_dssp SC--------------EEEEECCTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred Cc--------------EEEEEcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEc
Confidence 43 9999999999999999762 23589999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.+||+|||+++........ .......+++.|+|||++.+ ..++.++|||||||++|||
T Consensus 248 ~~-------~~~kl~DfG~s~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~il~el 308 (377)
T 3cbl_A 248 EK-------NVLKISDFGMSREEADGVYA--------ASGGLRQVPVKWTAPEALNY----GRYSSESDVWSFGILLWET 308 (377)
T ss_dssp TT-------CCEEECCGGGCEECTTSEEE--------CCSSCCEEEGGGSCHHHHHH----CEEEHHHHHHHHHHHHHHH
T ss_pred CC-------CcEEECcCCCceecCCCcee--------ecCCCCCCCcCcCCHhHhcc----CCCCchhhHHHHHHHHHHH
Confidence 77 78999999999754332111 01112235778999999876 4678999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1044 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1044 Lt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
++ |..||.+....+....+..+..+..+. .+++.+.+|+.+||+.||++|||
T Consensus 309 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~cl~~dP~~Rps 361 (377)
T 3cbl_A 309 FSLGASPYPNLSNQQTREFVEKGGRLPCPE---------------------------LCPDAVFRLMEQCWAYEPGQRPS 361 (377)
T ss_dssp HTTSCCSSTTSCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HhCCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHcCCCchhCcC
Confidence 98 999999888777776665554332221 34567999999999999999999
Q ss_pred HHHHHHHHHhh
Q 001142 1123 AGDLYEMFVAR 1133 (1142)
Q Consensus 1123 a~EVL~~L~~~ 1133 (1142)
+.++++.+...
T Consensus 362 ~~~i~~~L~~i 372 (377)
T 3cbl_A 362 FSTIYQELQSI 372 (377)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99999988654
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=352.94 Aligned_cols=259 Identities=24% Similarity=0.243 Sum_probs=207.0
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
.+|++.+.||+|+||.||+|++. +..+|+|+..... ....+. +.+|+.++++++||||+++++++.+..
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~- 79 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP----AFRDSS----LENEIAVLKKIKHENIVTLEDIYESTT- 79 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC----------H----HHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc----ccchHH----HHHHHHHHHhCCCCCeeehhhhcccCC-
Confidence 36899999999999999999984 6778888865321 111223 378999999999999999999988654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||++..
T Consensus 80 -------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~ 141 (304)
T 2jam_A 80 -------------HYYLVMQLVSGGELFDRILE-----RGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLT 141 (304)
T ss_dssp -------------EEEEEECCCCSCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESS
T ss_pred -------------EEEEEEEcCCCccHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEec
Confidence 45999999999999999876 246899999999999999999999999999999999999932
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
. ...+.+||+|||.+...... ......||+.|+|||++.+ ..++.++||||||+++|+|+
T Consensus 142 ~----~~~~~~kl~Dfg~~~~~~~~------------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~l~ 201 (304)
T 2jam_A 142 P----EENSKIMITDFGLSKMEQNG------------IMSTACGTPGYVAPEVLAQ----KPYSKAVDCWSIGVITYILL 201 (304)
T ss_dssp S----STTCCEEBCSCSTTCCCCCB------------TTHHHHSCCCBCCTTTBSS----CSCCHHHHHHHHHHHHHHHH
T ss_pred C----CCCCCEEEccCCcceecCCC------------ccccccCCCCccChHHhcc----CCCCchhhHHHHHHHHHHHH
Confidence 1 11278999999998653321 1123458999999999875 56889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~ 1124 (1142)
+|..||.+....+....+..+....... .....++.+.+++.+||+.||.+|||+.
T Consensus 202 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ 257 (304)
T 2jam_A 202 CGYPPFYEETESKLFEKIKEGYYEFESP------------------------FWDDISESAKDFICHLLEKDPNERYTCE 257 (304)
T ss_dssp HSSCTTTTSCHHHHHHHHHHCCCCCCTT------------------------TTTTSCHHHHHHHHHHHCSSTTTSCCHH
T ss_pred HCCCCCCCCCHHHHHHHHHcCCCCCCcc------------------------ccccCCHHHHHHHHHHcCCChhHCcCHH
Confidence 9999999887777777765543221100 0014566799999999999999999999
Q ss_pred HHHHHHHhhcCC
Q 001142 1125 DLYEMFVARTSS 1136 (1142)
Q Consensus 1125 EVL~~L~~~~ss 1136 (1142)
|+++|+|+....
T Consensus 258 ~~l~h~~~~~~~ 269 (304)
T 2jam_A 258 KALSHPWIDGNT 269 (304)
T ss_dssp HHHTSHHHHSSC
T ss_pred HHhcCccccCCC
Confidence 999999998654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=362.31 Aligned_cols=284 Identities=17% Similarity=0.225 Sum_probs=204.0
Q ss_pred CCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
..+|++.+.||+|+||.||+|.+. +..+|+|+.... .......+.+ .+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~----~~E~~~l~~l~hpniv~~~~~~~~~~ 97 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP--FQNQTHAKRA----YRELVLMKCVNHKNIIGLLNVFTPQK 97 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECT--TSSHHHHHHH----HHHHHHHHHCCCTTBCCEEEEECSCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccc--cCChHHHHHH----HHHHHHHHhcCCCCccceEEeecccc
Confidence 468999999999999999999874 667888875422 2233333333 79999999999999999999987644
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
.. ......++||||++ ++|.+++.. .+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 98 ~~--------~~~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~ 161 (371)
T 2xrw_A 98 SL--------EEFQDVYIVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 161 (371)
T ss_dssp ST--------TTCCEEEEEEECCS-EEHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred cc--------ccccceEEEEEcCC-CCHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc
Confidence 22 12336799999997 688888752 489999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 162 ~~-------~~~kl~Dfg~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~el 219 (371)
T 2xrw_A 162 SD-------CTLKILDFGLARTAGTSF-----------MMTPYVVTRYYRAPEVILG----MGYKENVDIWSVGCIMGEM 219 (371)
T ss_dssp TT-------SCEEECCCCC---------------------------CTTCCHHHHTT----CCCCTTHHHHHHHHHHHHH
T ss_pred CC-------CCEEEEEeeccccccccc-----------ccCCceecCCccCHHHhcC----CCCCchHhHHHHHHHHHHH
Confidence 87 789999999997543211 1123468999999999976 5688999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCC---------------CCchhhhhhHHHHHHH
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF---------------EKPEAELETLSFLVDV 1108 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~L~dL 1108 (1142)
++|+.||.+.+..+....+........+........... ........+ .........+..+.+|
T Consensus 220 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 298 (371)
T 2xrw_A 220 IKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR-TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDL 298 (371)
T ss_dssp HHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHH-HHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHH
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHH-HHHhhCccccccchhhhcccccCcccccccccccHHHHHH
Confidence 999999998887776666644433322221111100000 000000000 0011112346789999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhhc
Q 001142 1109 FRRCTEENPTERPTAGDLYEMFVART 1134 (1142)
Q Consensus 1109 I~~CL~~DP~~RPSa~EVL~~L~~~~ 1134 (1142)
|.+||+.||.+|||++|+++|+|+..
T Consensus 299 i~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 299 LSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp HHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred HHHHCcCChhhCCCHHHHhCCcchhh
Confidence 99999999999999999999999974
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=351.78 Aligned_cols=261 Identities=21% Similarity=0.355 Sum_probs=207.7
Q ss_pred CCCcceeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeee
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 878 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~-------~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~ 878 (1142)
..+|++.+.||+|+||.||+|.+. +..+|+|+.. .. ......+.+ .+|+.++++++||||++++++
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~--~~-~~~~~~~~~----~~E~~~l~~l~hp~iv~~~~~ 94 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK--EN-ASPSELRDL----LSEFNVLKQVNHPHVIKLYGA 94 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECC--TT-CCHHHHHHH----HHHHHHHTTCCCTTBCCEEEE
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEecc--CC-CCHHHHHHH----HHHHHHHhhCCCCceeeEEEE
Confidence 457999999999999999999872 2567777643 21 223333444 799999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc-------------------CCCCCCHHHHHHHHHHHH
Q 001142 879 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-------------------GEKHVSVKLALFIAQDVA 939 (1142)
Q Consensus 879 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~-------------------~~~~ls~~~i~~Ia~qIa 939 (1142)
+.+.+.. ++||||+++++|.+++...... ....+++..++.++.||+
T Consensus 95 ~~~~~~~--------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 160 (314)
T 2ivs_A 95 CSQDGPL--------------LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQIS 160 (314)
T ss_dssp ECSSSSC--------------EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHH
T ss_pred EecCCce--------------EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHH
Confidence 9765543 9999999999999999863221 123489999999999999
Q ss_pred HHHHHHHhCCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhc
Q 001142 940 AALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1019 (1142)
Q Consensus 940 ~gL~yLHs~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~ 1019 (1142)
.||.|||++||+||||||+|||++.+ +.+||+|||++.......... ......+|+.|+|||++.
T Consensus 161 ~~l~~lH~~~ivH~dikp~NIli~~~-------~~~kl~Dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~ 225 (314)
T 2ivs_A 161 QGMQYLAEMKLVHRDLAARNILVAEG-------RKMKISDFGLSRDVYEEDSYV--------KRSQGRIPVKWMAIESLF 225 (314)
T ss_dssp HHHHHHHHTTEECCCCSGGGEEEETT-------TEEEECCCTTCEECTTTSCEE--------CSSCCCSCGGGCCHHHHH
T ss_pred HHHHHHHHCCCcccccchheEEEcCC-------CCEEEccccccccccccccce--------eccCCCCcccccChhhhc
Confidence 99999999999999999999999877 789999999997654322110 112335788999999987
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhh
Q 001142 1020 AMHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 1098 (1142)
Q Consensus 1020 ~~~~~~~~s~ksDVwSLGviL~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1142)
+ ..++.++||||||+++|+|++ |..||.+....++...+..+..+..+
T Consensus 226 ~----~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------------------- 274 (314)
T 2ivs_A 226 D----HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERP--------------------------- 274 (314)
T ss_dssp H----CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCC---------------------------
T ss_pred C----CCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCcCCCC---------------------------
Confidence 6 567899999999999999999 99999887776666666554432221
Q ss_pred hhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001142 1099 LETLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1099 ~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~ 1133 (1142)
...++.+.+++.+||+.||.+|||+.++++++...
T Consensus 275 ~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 275 DNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 14456799999999999999999999999998764
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=354.71 Aligned_cols=257 Identities=28% Similarity=0.407 Sum_probs=210.1
Q ss_pred CCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
-+.|++.+.||+|+||.||+|.+ .+..+|+|+...... ....+.+ .+|+.++++++||||+++++++.+..
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~----~~e~~~l~~l~h~~i~~~~~~~~~~~ 93 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA---EDEIEDI----QQEITVLSQCDSPYVTKYYGSYLKDT 93 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC---STTHHHH----HHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc---HHHHHHH----HHHHHHHHhCCCCCEeEEEEEEecCC
Confidence 34699999999999999999987 466788888654422 1222333 78999999999999999999988654
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
..++||||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++
T Consensus 94 --------------~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~ 153 (303)
T 3a7i_A 94 --------------KLWIIMEYLGGGSALDLLEP------GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS 153 (303)
T ss_dssp --------------EEEEEEECCTTEEHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred --------------eEEEEEEeCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEEC
Confidence 35999999999999999853 4689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.+||+|||++........ ......||+.|+|||++.+ ..++.++||||||+++|+|
T Consensus 154 ~~-------~~~kl~Dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~l 212 (303)
T 3a7i_A 154 EH-------GEVKLADFGVAGQLTDTQI----------KRNTFVGTPFWMAPEVIKQ----SAYDSKADIWSLGITAIEL 212 (303)
T ss_dssp TT-------SCEEECCCTTCEECBTTBC----------CBCCCCSCGGGCCHHHHTT----CCBCTHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEeecccceecCcccc----------ccCccCCCcCccCHHHHhc----CCCCchhhhHHHHHHHHHH
Confidence 77 7899999999976543211 1123468999999999875 5678999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
++|+.||...........+.....+... ...+..+.+++.+||+.||.+|||+
T Consensus 213 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~~l~~dp~~Rps~ 265 (303)
T 3a7i_A 213 ARGEPPHSELHPMKVLFLIPKNNPPTLE---------------------------GNYSKPLKEFVEACLNKEPSFRPTA 265 (303)
T ss_dssp HHSSCTTTTSCHHHHHHHHHHSCCCCCC---------------------------SSCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred ccCCCCCCCcCHHHHHHHhhcCCCCCCc---------------------------cccCHHHHHHHHHHcCCChhhCcCH
Confidence 9999999887776666555444332221 1345669999999999999999999
Q ss_pred HHHHHHHHhhcCCC
Q 001142 1124 GDLYEMFVARTSSS 1137 (1142)
Q Consensus 1124 ~EVL~~L~~~~ss~ 1137 (1142)
.++++|+|+.....
T Consensus 266 ~~ll~~~~~~~~~~ 279 (303)
T 3a7i_A 266 KELLKHKFILRNAK 279 (303)
T ss_dssp HHHTTCHHHHHHCC
T ss_pred HHHhhChhhhcCCC
Confidence 99999999975543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=362.94 Aligned_cols=280 Identities=23% Similarity=0.307 Sum_probs=206.8
Q ss_pred CCCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001142 804 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 881 (1142)
Q Consensus 804 ~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~ 881 (1142)
...++|++.+.||+|+||.||+|.+. +..+|+|+..... .....+. +.+|+.++++++||||+++++++.+
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~---~~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~~~ 102 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQ----IIRELQVLHECNSPYIVGFYGAFYS 102 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC---CHHHHHH----HHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc---CHHHHHH----HHHHHHHHHHCCCCCEEEEeEEEEE
Confidence 33567999999999999999999985 6678888765331 2233333 4899999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCe
Q 001142 882 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENI 960 (1142)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~-gIvHrDLKp~NI 960 (1142)
.+ ..++||||+++++|.+++... ..+++..+..++.||+.||.|||++ ||+||||||+||
T Consensus 103 ~~--------------~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Ni 163 (360)
T 3eqc_A 103 DG--------------EISICMEHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 163 (360)
T ss_dssp TT--------------EEEEEECCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGE
T ss_pred CC--------------EEEEEEECCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHE
Confidence 55 359999999999999999762 4689999999999999999999996 999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
|++.+ +.+||+|||++....... .....||+.|+|||++.+ ..++.++|||||||++
T Consensus 164 l~~~~-------~~~kl~Dfg~~~~~~~~~------------~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il 220 (360)
T 3eqc_A 164 LVNSR-------GEIKLCDFGVSGQLIDSM------------ANSFVGTRSYMSPERLQG----THYSVQSDIWSMGLSL 220 (360)
T ss_dssp EECTT-------CCEEECCCCCCHHHHHHC----------------CCCCTTCCHHHHTT----CCCSHHHHHHHHHHHH
T ss_pred EECCC-------CCEEEEECCCCccccccc------------ccCCCCCCCeECHHHHcC----CCCCchhhHHHHHHHH
Confidence 99887 789999999996543211 123468999999999876 5688999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCC---CCCchhHHhhhcccc----------------cccccccCCCCCCchhhhhh
Q 001142 1041 LELLTLQVPYMGLSELEIHDLIQMGK---RPRLTDELEALGSCH----------------EHEVAQSGSGFEKPEAELET 1101 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~~~~~el~~~I~~~~---~p~l~~~l~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~ 1101 (1142)
|+|++|+.||......+....+.... ....+.......... ........ . ........
T Consensus 221 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~ 297 (360)
T 3eqc_A 221 VEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEP-P--PKLPSGVF 297 (360)
T ss_dssp HHHHHTSCCSSCCCHHHHHHHHC------------------------------CCCHHHHHHHHHHSC-C--CCCCTTTS
T ss_pred HHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccC-C--CCCCcccc
Confidence 99999999998876655433321110 000000000000000 00000000 0 00011135
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001142 1102 LSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1102 ~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~~s 1135 (1142)
+..+.+|+.+||+.||++|||++|+++|+|++..
T Consensus 298 ~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 298 SLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp CHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 6789999999999999999999999999999754
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=358.32 Aligned_cols=260 Identities=21% Similarity=0.283 Sum_probs=211.0
Q ss_pred CCCCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001142 803 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 880 (1142)
Q Consensus 803 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~ 880 (1142)
+....+|.+.+.||+|+||.||+|.+. +..+|+|+...... ......+.+ .+|+.++++++||||+++++++.
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~----~~E~~~l~~l~h~~iv~~~~~~~ 111 (335)
T 2owb_A 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL-LKPHQREKM----SMEISIHRSLAHQHVVGFHGFFE 111 (335)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CSHHHHHHH----HHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhh-cCHHHHHHH----HHHHHHHHhCCCCCCCeEEEEEe
Confidence 445667999999999999999999984 56788887653321 222333333 78999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NI 960 (1142)
+.+ ..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 112 ~~~--------------~~~lv~e~~~~~~L~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NI 172 (335)
T 2owb_A 112 DND--------------FVFVVLELCRRRSLLELHKR-----RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNL 172 (335)
T ss_dssp CSS--------------EEEEEECCCTTCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred cCC--------------eEEEEEecCCCCCHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhE
Confidence 654 35999999999999999876 24689999999999999999999999999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
|++.+ +.+||+|||++........ ......||+.|+|||++.+ ..++.++||||||+++
T Consensus 173 l~~~~-------~~~kl~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il 231 (335)
T 2owb_A 173 FLNED-------LEVKIGDFGLATKVEYDGE----------RKKVLCGTPNYIAPEVLSK----KGHSFEVDVWSIGCIM 231 (335)
T ss_dssp EECTT-------CCEEECCCTTCEECCSTTC----------CBCCCCSCCSSCCHHHHHT----SCBCTHHHHHHHHHHH
T ss_pred EEcCC-------CCEEEeeccCceecccCcc----------cccccCCCccccCHHHhcc----CCCCchhhHHHHHHHH
Confidence 99887 7899999999976542111 1123468999999999876 5678999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1041 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
|+|++|+.||......+....+...... ++ ...++.+.+|+.+||+.||.+|
T Consensus 232 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~---------------------------~~~~~~~~~li~~~l~~dp~~R 283 (335)
T 2owb_A 232 YTLLVGKPPFETSCLKETYLRIKKNEYS-IP---------------------------KHINPVAASLIQKMLQTDPTAR 283 (335)
T ss_dssp HHHHHSSCTTCCSSHHHHHHHHHHTCCC-CC---------------------------TTSCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHCcCCCCCCCHHHHHHHHhcCCCC-CC---------------------------ccCCHHHHHHHHHHccCChhHC
Confidence 9999999999887766665555433211 00 0344568999999999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 001142 1121 PTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1121 PSa~EVL~~L~~~~s 1135 (1142)
||+.|+++|+|+...
T Consensus 284 ps~~ell~~~~~~~~ 298 (335)
T 2owb_A 284 PTINELLNDEFFTSG 298 (335)
T ss_dssp CCGGGGGGSHHHHTS
T ss_pred cCHHHHhcCccccCC
Confidence 999999999999754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=362.50 Aligned_cols=263 Identities=23% Similarity=0.363 Sum_probs=203.7
Q ss_pred CCCCcceeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCcccee
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMY 876 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~~-------~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~ 876 (1142)
..++|++.+.||+|+||.||+|++. +..||+|+.... ......+.+ .+|++++.++ +|||||+++
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~----~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG---ATHSEHRAL----MSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT---CCHHHHHHH----HHHHHHHHHHCCCTTBCCEE
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc---CCHHHHHHH----HHHHHHHHhhcCCcceeeee
Confidence 3467999999999999999999852 256788875321 223333344 8999999999 799999999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccC----------------------------------
Q 001142 877 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG---------------------------------- 922 (1142)
Q Consensus 877 g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~---------------------------------- 922 (1142)
+++.+.+. ..++||||+++|+|.++++......
T Consensus 93 ~~~~~~~~-------------~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (359)
T 3vhe_A 93 GACTKPGG-------------PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSS 159 (359)
T ss_dssp EEECSTTS-------------CCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------
T ss_pred eeeecCCC-------------ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcc
Confidence 99876432 2499999999999999997632100
Q ss_pred ---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccCCCCCeE
Q 001142 923 ---------------------------EKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 975 (1142)
Q Consensus 923 ---------------------------~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~~~~~~v 975 (1142)
...+++..+..|+.||+.||.|||++||+||||||+|||++.+ +.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~-------~~~ 232 (359)
T 3vhe_A 160 QSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK-------NVV 232 (359)
T ss_dssp ------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-------GCE
T ss_pred ccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC-------CcE
Confidence 1228999999999999999999999999999999999999877 789
Q ss_pred EEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 001142 976 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLS 1054 (1142)
Q Consensus 976 KL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt-G~~Pf~~~~ 1054 (1142)
||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++ |..||.+..
T Consensus 233 kl~Dfg~a~~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~----~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 300 (359)
T 3vhe_A 233 KICDFGLARDIYKDPDY--------VRKGDARLPLKWMAPETIFD----RVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 300 (359)
T ss_dssp EECCCGGGSCTTSCTTC--------EEC--CEECGGGCCHHHHHH----CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred EEEeccceeeecccccc--------hhccccCCCceeEChhhhcC----CCCCchhhhhhHHHHHHHHHhcCCCCCCccc
Confidence 99999999765332111 11224468899999999876 568899999999999999998 999998755
Q ss_pred HHH-HHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001142 1055 ELE-IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1055 ~~e-l~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~ 1133 (1142)
..+ ....+..+..+..+. ..++.+.+++.+||+.||.+|||+.|+++|+...
T Consensus 301 ~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 301 IDEEFCRRLKEGTRMRAPD---------------------------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp CSHHHHHHHHHTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hhHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 333 334444433322211 3456799999999999999999999999998764
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=343.35 Aligned_cols=256 Identities=21% Similarity=0.354 Sum_probs=208.0
Q ss_pred CCCcceeeeecccCceEEEEEEE-CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~-~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
..+|++.+.||+|+||.||+|.+ .+..+|+|+..... .. .+.+ .+|+.++++++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--~~---~~~~----~~e~~~l~~l~h~~i~~~~~~~~~~~~ 77 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MS---EEDF----IEEAEVMMKLSHPKLVQLYGVCLEQAP 77 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT--BC---HHHH----HHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC--CC---HHHH----HHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 45799999999999999999998 45678888764321 11 1233 789999999999999999999986553
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
. ++||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+||+++.
T Consensus 78 ~--------------~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~ 139 (267)
T 3t9t_A 78 I--------------CLVTEFMEHGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE 139 (267)
T ss_dssp C--------------EEEECCCTTCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECG
T ss_pred e--------------EEEEeCCCCCcHHHHHhhC----cccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECC
Confidence 3 9999999999999999762 246899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||+|||.+......... ......+|+.|+|||++.+ ..++.++||||||+++|+|+
T Consensus 140 ~-------~~~kl~dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~l~ 199 (267)
T 3t9t_A 140 N-------QVIKVSDFGMTRFVLDDQYT---------SSTGTKFPVKWASPEVFSF----SRYSSKSDVWSFGVLMWEVF 199 (267)
T ss_dssp G-------GCEEECCTTGGGGBCCHHHH---------STTSTTCCGGGCCHHHHHH----CCCCHHHHHHHHHHHHHHHH
T ss_pred C-------CCEEEccccccccccccccc---------ccccccccccccChhhhcC----CCccchhchhhhHHHHHHHh
Confidence 7 78999999999765332111 1123357889999999876 56789999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1045 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1045 t-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
+ |+.||......+....+..+..+..+. ..++.+.+++.+||+.||.+|||+
T Consensus 200 ~~g~~p~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~p~~Rps~ 252 (267)
T 3t9t_A 200 SEGKIPYENRSNSEVVEDISTGFRLYKPR---------------------------LASTHVYQIMNHCWRERPEDRPAF 252 (267)
T ss_dssp TTSCCTTTTCCHHHHHHHHHTTCCCCCCT---------------------------TSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred ccCCCCCCCCCHHHHHHHHhcCCcCCCCc---------------------------cCcHHHHHHHHHHccCChhhCcCH
Confidence 9 899999877777776665543322111 345568999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 001142 1124 GDLYEMFVARTS 1135 (1142)
Q Consensus 1124 ~EVL~~L~~~~s 1135 (1142)
.++++++.....
T Consensus 253 ~~ll~~L~~l~~ 264 (267)
T 3t9t_A 253 SRLLRQLAEIAE 264 (267)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHh
Confidence 999999876543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=374.78 Aligned_cols=254 Identities=25% Similarity=0.395 Sum_probs=208.2
Q ss_pred CCCCcceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
...+|++.+.||+|+||.||+|.+.+..||||+.+... ..+.+ .+|+.+|++++|||||++++++.+...
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~------~~~~~----~~E~~~l~~l~h~niv~~~~~~~~~~~ 260 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA------TAQAF----LAEASVMTQLRHSNLVQLLGVIVEEKG 260 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT------TSHHH----HHHHHHHHTCCCTTBCCEEEEEECTTS
T ss_pred ChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch------HHHHH----HHHHHHHHhccCCCEEEEEEEEEcCCC
Confidence 35679999999999999999999999999999864221 22334 799999999999999999999875431
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
..++||||+++|+|.++++.. +...+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 261 -------------~~~iv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~ 324 (450)
T 1k9a_A 261 -------------GLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSE 324 (450)
T ss_dssp -------------CEEEEEECCTTCBHHHHHHHH---CTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT
T ss_pred -------------ceEEEEEecCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECC
Confidence 359999999999999999862 3345799999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||+|||+++...... ....+++.|+|||++.+ ..++.++|||||||++|||+
T Consensus 325 ~-------~~~kl~DfG~a~~~~~~~-------------~~~~~~~~y~aPE~~~~----~~~~~~sDvwslG~~l~el~ 380 (450)
T 1k9a_A 325 D-------NVAKVSDFGLTKEASSTQ-------------DTGKLPVKWTAPEALRE----KKFSTKSDVWSFGILLWEIY 380 (450)
T ss_dssp T-------SCEEECCCTTCEECC-------------------CCCTTTSCHHHHHS----SCCCHHHHHHHHHHHHHHHH
T ss_pred C-------CCEEEeeCCCcccccccc-------------cCCCCCcceeCHHHhcC----CCCCcHHHHHHHHHHHHHHH
Confidence 7 789999999997433211 12247889999999976 56899999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1045 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1045 t-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
+ |+.||.+....++...+..+..+..+. .+++.+.+|+.+||+.||.+|||+
T Consensus 381 t~g~~P~~~~~~~~~~~~i~~~~~~~~p~---------------------------~~~~~l~~li~~cl~~dp~~Rpt~ 433 (450)
T 1k9a_A 381 SFGRVPYPRIPLKDVVPRVEKGYKMDAPD---------------------------GCPPAVYDVMKNCWHLDAATRPTF 433 (450)
T ss_dssp TTTCCSSTTSCTTTHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred hCCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------cCCHHHHHHHHHHcCCChhHCcCH
Confidence 8 999998877666666665554332211 456679999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 001142 1124 GDLYEMFVARTS 1135 (1142)
Q Consensus 1124 ~EVL~~L~~~~s 1135 (1142)
.++++.+.....
T Consensus 434 ~~l~~~L~~i~~ 445 (450)
T 1k9a_A 434 LQLREQLEHIRT 445 (450)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHH
Confidence 999998876543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=370.87 Aligned_cols=282 Identities=23% Similarity=0.267 Sum_probs=206.0
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
.+|++.++||+|+||.||+|++. +..||+|+..... ... .+|++++++++|||||++++++.....
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~--------~~~----~~E~~il~~l~hpniv~l~~~~~~~~~ 121 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK--------RFK----NRELQIMRKLDHCNIVRLRYFFYSSGE 121 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT--------TSC----CHHHHHHHTCCCTTBCCEEEEEEEEET
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc--------hhH----HHHHHHHHHcCCCCccceeeEEeccCC
Confidence 35999999999999999999984 6778888753221 111 479999999999999999999865321
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
. ....+.++||||++ ++|.+.+..... ....+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 122 ~--------~~~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~ 191 (420)
T 1j1b_A 122 K--------KDEVYLNLVLDYVP-ETVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP 191 (420)
T ss_dssp T--------TTEEEEEEEEECCC-EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEET
T ss_pred C--------CcceeEEeehhccc-ccHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeC
Confidence 1 12335689999998 578777765332 2357999999999999999999999999999999999999986
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+. +.+||+|||+++.+.... ......||+.|+|||++.+ ...|+.++|||||||++|||+
T Consensus 192 ~~------~~~kl~DFG~a~~~~~~~-----------~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwSlG~il~ell 251 (420)
T 1j1b_A 192 DT------AVLKLCDFGSAKQLVRGE-----------PNVSYICSRYYRAPELIFG---ATDYTSSIDVWSAGCVLAELL 251 (420)
T ss_dssp TT------TEEEECCCTTCEECCTTC-----------CCCSCCSCTTSCCHHHHTT---CSSCCTHHHHHHHHHHHHHHH
T ss_pred CC------CeEEeccchhhhhcccCC-----------CceeeeeCCCcCCHHHHcC---CCCCCchhhhHHHHHHHHHHH
Confidence 52 578999999997653311 1123468999999999875 246889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHH-HhCCCCCchhHHhhhcc-cccccccccCCCCCCch---hhhhhHHHHHHHHHHhcccCCCC
Q 001142 1045 TLQVPYMGLSELEIHDLI-QMGKRPRLTDELEALGS-CHEHEVAQSGSGFEKPE---AELETLSFLVDVFRRCTEENPTE 1119 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I-~~~~~p~l~~~l~~~~~-~~~~~~~~~~~~~~~~~---~~~~~~~~L~dLI~~CL~~DP~~ 1119 (1142)
+|+.||.+.+..+....+ .....+.. ..+..... .....+.... ..+. .....++.+.+||.+||+.||.+
T Consensus 252 ~G~~pf~~~~~~~~l~~i~~~lg~p~~-~~~~~~~~~~~~~~~p~~~---~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~ 327 (420)
T 1j1b_A 252 LGQPIFPGDSGVDQLVEIIKVLGTPTR-EQIREMNPNYTEFKFPQIK---AHPWTKVFRPRTPPEAIALCSRLLEYTPTA 327 (420)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCSCCH-HHHHHHCSCCCCCCCCCCC---CCCHHHHSCTTSCHHHHHHHHHHSCSSGGG
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCCH-HHHHhhChhhhhhccCccC---CCCHHHhcCCCCCHHHHHHHHHhccCChhH
Confidence 999999987766655444 32222221 11111100 0000000000 0000 01134678999999999999999
Q ss_pred CCCHHHHHHHHHhhc
Q 001142 1120 RPTAGDLYEMFVART 1134 (1142)
Q Consensus 1120 RPSa~EVL~~L~~~~ 1134 (1142)
|||+.|+++|+|+..
T Consensus 328 R~t~~e~l~hp~f~~ 342 (420)
T 1j1b_A 328 RLTPLEACAHSFFDE 342 (420)
T ss_dssp SCCHHHHHTSGGGGG
T ss_pred CCCHHHHhCCHhhcc
Confidence 999999999999964
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=359.84 Aligned_cols=260 Identities=21% Similarity=0.301 Sum_probs=196.4
Q ss_pred CCcceeeeecccCceEEEEEEE-CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCC--CCccceeeeEecCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH--SCIVEMYGHKISSK 883 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~-~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H--pNIVkl~g~~~~~~ 883 (1142)
..|++.+.||+|+||.||+|.+ .+..+|+|+.... .......+.+ .+|+.++.+++| |||+++++++.+..
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~----~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 82 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLE--EADNQTLDSY----RNEIAYLNKLQQHSDKIIRLYDYEITDQ 82 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECT--TCCHHHHHHH----HHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeecc--ccchHHHHHH----HHHHHHHHhhhhcCCceEEEeeeEeeCC
Confidence 4599999999999999999987 4566888886543 2233333444 799999999976 99999999998655
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
..++|||| .+++|.+++.. ...+++..+..|+.||+.||.|||++||+||||||+|||++
T Consensus 83 --------------~~~lv~e~-~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~ 142 (343)
T 3dbq_A 83 --------------YIYMVMEC-GNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV 142 (343)
T ss_dssp --------------EEEEEECC-CSEEHHHHHHH-----SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE
T ss_pred --------------EEEEEEeC-CCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE
Confidence 45999995 47899999986 35689999999999999999999999999999999999996
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhcccc-------CCCCCCchhhHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-------KPNLYGLEVDIWSY 1036 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-------~~~~~s~ksDVwSL 1036 (1142)
. +.+||+|||+++........ .......||+.|+|||++.+.. ....++.++|||||
T Consensus 143 ~--------~~~kl~DFG~a~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Diwsl 206 (343)
T 3dbq_A 143 D--------GMLKLIDFGIANQMQPDTTS--------VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 206 (343)
T ss_dssp T--------TEEEECCCSSSCCC--------------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHH
T ss_pred C--------CcEEEeecccccccCccccc--------ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHH
Confidence 3 67999999999765432111 1122456999999999986421 12467899999999
Q ss_pred HHHHHHHHhCCCCCCCCCHH-HHHHHHHh-CCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcc
Q 001142 1037 GCLLLELLTLQVPYMGLSEL-EIHDLIQM-GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 1114 (1142)
Q Consensus 1037 GviL~ELLtG~~Pf~~~~~~-el~~~I~~-~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~ 1114 (1142)
||++|+|++|+.||...... .....+.. ......+ ...+..+.+|+.+||+
T Consensus 207 G~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~~L~ 259 (343)
T 3dbq_A 207 GCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP---------------------------DIPEKDLQDVLKCCLK 259 (343)
T ss_dssp HHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCC---------------------------CCSCHHHHHHHHHHTC
T ss_pred HHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCc---------------------------ccCCHHHHHHHHHHcC
Confidence 99999999999999764322 22222211 1111000 0234568999999999
Q ss_pred cCCCCCCCHHHHHHHHHhhcC
Q 001142 1115 ENPTERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1115 ~DP~~RPSa~EVL~~L~~~~s 1135 (1142)
.||.+|||+.|+++|+|+...
T Consensus 260 ~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 260 RDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp SSTTTSCCHHHHHTSHHHHSC
T ss_pred CChhHCCCHHHHHhCcccccc
Confidence 999999999999999999754
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=354.57 Aligned_cols=251 Identities=26% Similarity=0.278 Sum_probs=194.9
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSK 883 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~~~~~ 883 (1142)
++|++.++||+|+||+||+|++. +..||+|+.. ...........+ ..|+..+.++ +||||+++++++.+.+
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~~~~~~~~~----~~e~~~~~~~~~h~~iv~l~~~~~~~~ 130 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSM--SPFRGPKDRARK----LAEVGSHEKVGQHPCCVRLEQAWEEGG 130 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEES--SSCCSHHHHHHH----HHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEec--ccccChHHHHHH----HHHHHHHHHhcCCCcEEEEEEEEEeCC
Confidence 45899999999999999999984 6678888743 222233332222 4666666655 8999999999998655
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
..++||||+ +++|.+++... ...+++..++.|+.||+.||+|||++||+||||||+|||++
T Consensus 131 --------------~~~lv~e~~-~~~L~~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~ 191 (311)
T 3p1a_A 131 --------------ILYLQTELC-GPSLQQHCEAW----GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLG 191 (311)
T ss_dssp --------------EEEEEEECC-CCBHHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred --------------EEEEEEecc-CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC
Confidence 359999999 58999998763 34699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.+||+|||++....... ......||+.|+|||++.+ .++.++|||||||++|||
T Consensus 192 ~~-------~~~kl~DFG~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~il~el 248 (311)
T 3p1a_A 192 PR-------GRCKLGDFGLLVELGTAG-----------AGEVQEGDPRYMAPELLQG-----SYGTAADVFSLGLTILEV 248 (311)
T ss_dssp GG-------GCEEECCCTTCEECC-----------------CCCCCGGGCCGGGGGT-----CCSTHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEccceeeeecccCC-----------CCcccCCCccccCHhHhcC-----CCCchhhHHHHHHHHHHH
Confidence 87 789999999987654321 1123459999999999864 578999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
++|..|+.+. .....+..+..+ +......++.+.+++.+||+.||++|||+
T Consensus 249 ~~g~~~~~~~---~~~~~~~~~~~~--------------------------~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 299 (311)
T 3p1a_A 249 ACNMELPHGG---EGWQQLRQGYLP--------------------------PEFTAGLSSELRSVLVMMLEPDPKLRATA 299 (311)
T ss_dssp HHTCCCCSSH---HHHHHHTTTCCC--------------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred HhCCCCCCCc---cHHHHHhccCCC--------------------------cccccCCCHHHHHHHHHHcCCChhhCcCH
Confidence 9997766542 222333222211 11112456779999999999999999999
Q ss_pred HHHHHHHHhhc
Q 001142 1124 GDLYEMFVART 1134 (1142)
Q Consensus 1124 ~EVL~~L~~~~ 1134 (1142)
.|+++|+|++.
T Consensus 300 ~ell~hp~~~~ 310 (311)
T 3p1a_A 300 EALLALPVLRQ 310 (311)
T ss_dssp HHHHTSGGGSC
T ss_pred HHHHhCccccC
Confidence 99999999975
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=347.87 Aligned_cols=272 Identities=24% Similarity=0.339 Sum_probs=216.1
Q ss_pred CCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCC-CChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEe
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCG-SSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKI 880 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~-~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~g~~~ 880 (1142)
..++|++.+.||+|+||.||+|.+. +..+|+|+....... ......+.....+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3678999999999999999999984 567888886544321 122333444556689999999996 999999999997
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NI 960 (1142)
... ..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 95 ~~~--------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Ni 155 (298)
T 1phk_A 95 TNT--------------FFFLVFDLMKKGELFDYLTE-----KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENI 155 (298)
T ss_dssp CSS--------------EEEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred cCC--------------eEEEEEeccCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceE
Confidence 654 45999999999999999976 24689999999999999999999999999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhcccc--CCCCCCchhhHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH--KPNLYGLEVDIWSYGC 1038 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~--~~~~~s~ksDVwSLGv 1038 (1142)
+++.+ +.+||+|||.+....... ......||+.|+|||++.+.. ....++.++||||||+
T Consensus 156 l~~~~-------~~~kl~dfg~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~ 217 (298)
T 1phk_A 156 LLDDD-------MNIKLTDFGFSCQLDPGE-----------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 217 (298)
T ss_dssp EECTT-------CCEEECCCTTCEECCTTC-----------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHH
T ss_pred EEcCC-------CcEEEecccchhhcCCCc-----------ccccccCCccccCHHHhccccccccccCCcccccHhHHH
Confidence 99887 789999999997654321 112346899999999986321 1245789999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001142 1039 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1118 (1142)
Q Consensus 1039 iL~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~ 1118 (1142)
++|+|++|..||...........+..+....... .....+..+.+++.+||+.||.
T Consensus 218 ~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~l~~li~~~l~~dp~ 273 (298)
T 1phk_A 218 IMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP------------------------EWDDYSDTVKDLVSRFLVVQPQ 273 (298)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT------------------------TGGGSCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcc------------------------cccccCHHHHHHHHHHccCCcc
Confidence 9999999999998877776666665443221110 0014566799999999999999
Q ss_pred CCCCHHHHHHHHHhhcCCC
Q 001142 1119 ERPTAGDLYEMFVARTSSS 1137 (1142)
Q Consensus 1119 ~RPSa~EVL~~L~~~~ss~ 1137 (1142)
+|||+.|+++|+|++....
T Consensus 274 ~Rps~~~ll~h~~~~~~~~ 292 (298)
T 1phk_A 274 KRYTAEEALAHPFFQQYVV 292 (298)
T ss_dssp GSCCHHHHTTSGGGCTTC-
T ss_pred cCCCHHHHHhChHhhhccc
Confidence 9999999999999986543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=355.34 Aligned_cols=267 Identities=20% Similarity=0.327 Sum_probs=192.1
Q ss_pred CCCCcceeeeecccCceEEEEEEECCc-----cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeE
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKFGSA-----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 879 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~~~~-----~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~ 879 (1142)
...+|++.+.||+|+||.||+|++... .+|+|+.... .......+.+ .+|+.++++++||||+++++++
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~----~~E~~~l~~l~h~~iv~~~~~~ 94 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKAD--IIASSDIEEF----LREAACMKEFDHPHVAKLVGVS 94 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC--------CHHHHHH----HHHHHHHTTCCCTTBCCCCEEE
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccc--ccCHHHHHHH----HHHHHHHHHCCCCceehhhcee
Confidence 345799999999999999999987433 5777775322 2222333444 8999999999999999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 001142 880 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 958 (1142)
Q Consensus 880 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~-~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~ 958 (1142)
...... ......++||||+++++|.+++...... ....+++..+..|+.||+.||.|||++||+||||||+
T Consensus 95 ~~~~~~--------~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~ 166 (323)
T 3qup_A 95 LRSRAK--------GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAAR 166 (323)
T ss_dssp ECC---------------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred eccccc--------cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcc
Confidence 864421 1123458999999999999999764321 1235899999999999999999999999999999999
Q ss_pred CeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001142 959 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1038 (1142)
Q Consensus 959 NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGv 1038 (1142)
|||++.+ +.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||
T Consensus 167 NIli~~~-------~~~kl~Dfg~a~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~ 227 (323)
T 3qup_A 167 NCMLAED-------MTVCVADFGLSRKIYSGDYY--------RQGCASKLPVKWLALESLAD----NLYTVHSDVWAFGV 227 (323)
T ss_dssp GEEECTT-------SCEEECCCCC-------------------------CCGGGCCHHHHHH----CCCCHHHHHHHHHH
T ss_pred eEEEcCC-------CCEEEeeccccccccccccc--------cccccccCcccccCchhhcC----CCCCCccchhhHHH
Confidence 9999877 78999999999765432111 11123347889999999876 56889999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001142 1039 LLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1117 (1142)
Q Consensus 1039 iL~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP 1117 (1142)
++|+|++ |+.||.+....+....+..+..+..+ ...++.+.+++.+||+.||
T Consensus 228 il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~~l~~dp 280 (323)
T 3qup_A 228 TMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQP---------------------------PECMEEVYDLMYQCWSADP 280 (323)
T ss_dssp HHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC---------------------------TTCCHHHHHHHHHTTCSSG
T ss_pred HHHHHHhCCCCCccccChHHHHHHHhcCCCCCCC---------------------------CccCHHHHHHHHHHccCCh
Confidence 9999999 99999987777666666544432211 1445679999999999999
Q ss_pred CCCCCHHHHHHHHH
Q 001142 1118 TERPTAGDLYEMFV 1131 (1142)
Q Consensus 1118 ~~RPSa~EVL~~L~ 1131 (1142)
.+|||+.++++.+.
T Consensus 281 ~~Rps~~~l~~~l~ 294 (323)
T 3qup_A 281 KQRPSFTCLRMELE 294 (323)
T ss_dssp GGSCCHHHHHHHHH
T ss_pred hhCcCHHHHHHHHH
Confidence 99999555544433
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=366.33 Aligned_cols=285 Identities=22% Similarity=0.245 Sum_probs=204.2
Q ss_pred CCcceeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~-~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
.+|++.++||+|+||+||+|++. ...+|+|...-+.. .. .+|+.+++.++||||+++++++......
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~--------~~----~~E~~il~~l~h~niv~l~~~~~~~~~~ 107 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR--------FK----NRELQIMRIVKHPNVVDLKAFFYSNGDK 107 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT--------SC----CHHHHHHHTCCCTTBCCEEEEEEEESSS
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc--------hH----HHHHHHHHhCCCCCcceEEEEEEecCCC
Confidence 46999999999999999999984 44566665432110 11 3799999999999999999998764321
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec-c
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID-L 964 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld-~ 964 (1142)
......++||||+++ ++...+..... ....+++..++.++.||+.||+|||++||+||||||+|||++ .
T Consensus 108 --------~~~~~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~ 177 (394)
T 4e7w_A 108 --------KDEVFLNLVLEYVPE-TVYRASRHYAK-LKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPP 177 (394)
T ss_dssp --------SSCEEEEEEEECCSE-EHHHHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETT
T ss_pred --------CCceEEEEEeeccCc-cHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCC
Confidence 123356899999984 55555543222 235799999999999999999999999999999999999998 4
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||+|||+|+...... ......||+.|+|||++.+ ...|+.++|||||||++|||+
T Consensus 178 ~-------~~~kL~DFG~a~~~~~~~-----------~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwSlG~il~ell 236 (394)
T 4e7w_A 178 S-------GVLKLIDFGSAKILIAGE-----------PNVSYICSRYYRAPELIFG---ATNYTTNIDIWSTGCVMAELM 236 (394)
T ss_dssp T-------TEEEECCCTTCEECCTTC-----------CCCSSCSCGGGCCHHHHTT---CSSCCTHHHHHHHHHHHHHHH
T ss_pred C-------CcEEEeeCCCcccccCCC-----------CCcccccCcCccCHHHHcC---CCCCCcHHHHHHHHHHHHHHH
Confidence 5 789999999997653321 1123468999999999865 245889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHh-CCCCCchhHHhhhc-ccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1045 TLQVPYMGLSELEIHDLIQM-GKRPRLTDELEALG-SCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~-~~~p~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
+|+.||.+.+..+....+.. ...+... .+.... ......+.......-........++.+.+|+.+||+.||.+|||
T Consensus 237 ~g~~pf~~~~~~~~l~~i~~~~g~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 315 (394)
T 4e7w_A 237 QGQPLFPGESGIDQLVEIIKVLGTPSRE-QIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLT 315 (394)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCCCCHH-HHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCCHH-HHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCC
Confidence 99999998877665555432 2222222 111110 00000000000000000001135678999999999999999999
Q ss_pred HHHHHHHHHhhcC
Q 001142 1123 AGDLYEMFVARTS 1135 (1142)
Q Consensus 1123 a~EVL~~L~~~~s 1135 (1142)
+.|+++|+|+..-
T Consensus 316 ~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 316 AIEALCHPFFDEL 328 (394)
T ss_dssp HHHHHTSGGGSTT
T ss_pred HHHHhcChhhhhh
Confidence 9999999999753
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=369.88 Aligned_cols=298 Identities=18% Similarity=0.224 Sum_probs=201.6
Q ss_pred CCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
.++|++.+.||+|+||.||+|.+. +..||+|+. ..........+.+ .+|+.++++++||||+++++++....
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~--~~~~~~~~~~~~~----~~E~~~l~~l~h~nIv~l~~~~~~~~ 98 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV--NRMFEDLIDCKRI----LREITILNRLKSDYIIRLYDLIIPDD 98 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEE--CSTTTSHHHHHHH----HHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEe--CchhcChHHHHHH----HHHHHHHHHcCCCCcceEEEEEecCC
Confidence 357999999999999999999985 455777764 3333333333344 89999999999999999999987643
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
.. .....|+||||++ ++|.++++. ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 99 ~~---------~~~~~~lv~e~~~-~~L~~~~~~-----~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~ 163 (432)
T 3n9x_A 99 LL---------KFDELYIVLEIAD-SDLKKLFKT-----PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLN 163 (432)
T ss_dssp TT---------TCCCEEEEEECCS-EEHHHHHHS-----SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred CC---------cCCeEEEEEecCC-cCHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEEC
Confidence 21 1235799999996 799999864 35699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccc------------cCCCCCCCCccCCCcccchhhhccccCCCCCCchh
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA------------HRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 1031 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~------------~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ks 1031 (1142)
.+ +.+||+|||+|+............ ..........+||+.|+|||++.. ...|+.++
T Consensus 164 ~~-------~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~---~~~~~~~~ 233 (432)
T 3n9x_A 164 QD-------CSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL---QENYTKSI 233 (432)
T ss_dssp TT-------CCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTT---CSCCCTHH
T ss_pred CC-------CCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhc---CCCCCccc
Confidence 87 789999999998754322110000 000011235579999999998754 25689999
Q ss_pred hHHHHHHHHHHHHhCC-----------CCCCCCC-----------------HHHHHHHH-HhCCCCCchhHHhhhccccc
Q 001142 1032 DIWSYGCLLLELLTLQ-----------VPYMGLS-----------------ELEIHDLI-QMGKRPRLTDELEALGSCHE 1082 (1142)
Q Consensus 1032 DVwSLGviL~ELLtG~-----------~Pf~~~~-----------------~~el~~~I-~~~~~p~l~~~l~~~~~~~~ 1082 (1142)
|||||||++|||++|. ++|.+.+ ..+....+ .....|... .+........
T Consensus 234 DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~-~~~~~~~~~~ 312 (432)
T 3n9x_A 234 DIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTED-DLKNINKPEV 312 (432)
T ss_dssp HHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHH-HHHTCCCHHH
T ss_pred ccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHH-HHHhccCHHH
Confidence 9999999999999854 4443322 11122222 111222111 1111000000
Q ss_pred cccccc---CCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001142 1083 HEVAQS---GSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1083 ~~~~~~---~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~~s 1135 (1142)
...... .............++.+.+||.+||+.||++|||++|+++|+|+..-
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 368 (432)
T 3n9x_A 313 IKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDV 368 (432)
T ss_dssp HHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTT
T ss_pred HHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhc
Confidence 000000 00000001112457789999999999999999999999999999864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=357.89 Aligned_cols=257 Identities=19% Similarity=0.322 Sum_probs=199.9
Q ss_pred CCCCcceeeeecccCceEEEEEEEC--CccE----EEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeee
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKFG--SADA----AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 878 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~v----AvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~ 878 (1142)
...+|++.++||+|+||+||+|++. +..+ |+|. +... ......+ .+.+|+.++++++||||++++++
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~--~~~~-~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~ 85 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREA-TSPKANK----EILDEAYVMASVDNPHVCRLLGI 85 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEE--C--------CHH----HHHHHHHHHHHCCBTTBCCEEEE
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEee--cccc-cCHHHHH----HHHHHHHHHHhCCCCCEeEEEEE
Confidence 3457999999999999999999984 3333 4443 2211 1112222 34799999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 001142 879 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 958 (1142)
Q Consensus 879 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~ 958 (1142)
+.+.. .++||||+++|+|.+++.. ....+++..++.|+.||+.||.|||++||+||||||+
T Consensus 86 ~~~~~---------------~~~v~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~ 146 (327)
T 3poz_A 86 CLTST---------------VQLITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAAR 146 (327)
T ss_dssp EESSS---------------EEEEEECCTTCBHHHHHHH----STTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred EecCC---------------eEEEEEecCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChh
Confidence 98533 3899999999999999976 2346999999999999999999999999999999999
Q ss_pred CeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001142 959 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1038 (1142)
Q Consensus 959 NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGv 1038 (1142)
|||++.+ +.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||
T Consensus 147 NIll~~~-------~~~kl~Dfg~a~~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~----~~~~~~~Di~slG~ 207 (327)
T 3poz_A 147 NVLVKTP-------QHVKITDFGLAKLLGAEEKE--------YHAEGGKVPIKWMALESILH----RIYTHQSDVWSYGV 207 (327)
T ss_dssp GEEEEET-------TEEEECCTTHHHHHTTTCC---------------CCCGGGSCHHHHHH----CCCCHHHHHHHHHH
T ss_pred eEEECCC-------CCEEEccCcceeEccCCccc--------ccccCCCccccccChHHhcc----CCCCchhhhhhhHH
Confidence 9999887 78999999999765432211 11123357889999999986 57899999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001142 1039 LLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1117 (1142)
Q Consensus 1039 iL~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP 1117 (1142)
++|||++ |+.||.+....++...+..+.....+ ...+..+.+++.+||+.||
T Consensus 208 il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p 260 (327)
T 3poz_A 208 TVWELMTFGSKPYDGIPASEISSILEKGERLPQP---------------------------PICTIDVYMIMVKCWMIDA 260 (327)
T ss_dssp HHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC---------------------------TTBCHHHHHHHHHHTCSCG
T ss_pred HHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCC---------------------------ccCCHHHHHHHHHHcCCCh
Confidence 9999999 99999987776666666554432211 1345679999999999999
Q ss_pred CCCCCHHHHHHHHHhh
Q 001142 1118 TERPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1118 ~~RPSa~EVL~~L~~~ 1133 (1142)
.+|||+.|+++++...
T Consensus 261 ~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 261 DSRPKFRELIIEFSKM 276 (327)
T ss_dssp GGSCCHHHHHHHHHHH
T ss_pred hhCCCHHHHHHHHHHH
Confidence 9999999999998654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=355.25 Aligned_cols=269 Identities=25% Similarity=0.404 Sum_probs=207.8
Q ss_pred CCCCCCCCCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccc
Q 001142 798 CSGLDPGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVE 874 (1142)
Q Consensus 798 ~~~~~~~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVk 874 (1142)
...++...+.+|++.+.||+|+||.||+|++. +..+.++++.++... .....+.+ .+|+.+++++ +||||++
T Consensus 16 ~~~~p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~----~~E~~~l~~l~~hp~iv~ 90 (327)
T 1fvr_A 16 PTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDF----AGELEVLCKLGHHPNIIN 90 (327)
T ss_dssp CCCSSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHH----HHHHHHHTTCCCCTTBCC
T ss_pred CcccccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHH----HHHHHHHHhccCCCchhh
Confidence 34566777889999999999999999999874 444433443333221 12223333 7899999999 8999999
Q ss_pred eeeeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHh-----------ccCCCCCCHHHHHHHHHHHHHHHH
Q 001142 875 MYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS-----------ETGEKHVSVKLALFIAQDVAAALV 943 (1142)
Q Consensus 875 l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~-----------~~~~~~ls~~~i~~Ia~qIa~gL~ 943 (1142)
+++++.+.+ ..++||||+++++|.+++.... ......+++..++.++.||+.||.
T Consensus 91 ~~~~~~~~~--------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~ 156 (327)
T 1fvr_A 91 LLGACEHRG--------------YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMD 156 (327)
T ss_dssp EEEEEEETT--------------EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHH
T ss_pred hceeeeeCC--------------ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHH
Confidence 999998655 3599999999999999997521 011246899999999999999999
Q ss_pred HHHhCCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccC
Q 001142 944 ELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 1023 (1142)
Q Consensus 944 yLHs~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~ 1023 (1142)
|||++||+||||||+|||++.+ +.+||+|||+++...... ......+++.|+|||++.+
T Consensus 157 ~LH~~~ivH~dlkp~NIl~~~~-------~~~kL~Dfg~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~--- 215 (327)
T 1fvr_A 157 YLSQKQFIHRDLAARNILVGEN-------YVAKIADFGLSRGQEVYV-----------KKTMGRLPVRWMAIESLNY--- 215 (327)
T ss_dssp HHHHTTEECSCCSGGGEEECGG-------GCEEECCTTCEESSCEEC-----------CC----CCTTTCCHHHHHH---
T ss_pred HHHhCCccCCCCccceEEEcCC-------CeEEEcccCcCccccccc-----------cccCCCCCccccChhhhcc---
Confidence 9999999999999999999887 789999999986432211 1123357889999999876
Q ss_pred CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhH
Q 001142 1024 PNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETL 1102 (1142)
Q Consensus 1024 ~~~~s~ksDVwSLGviL~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1102 (1142)
..++.++||||||+++|+|++ |..||.+....+....+..+..+..+ ...+
T Consensus 216 -~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~ 267 (327)
T 1fvr_A 216 -SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP---------------------------LNCD 267 (327)
T ss_dssp -CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCCCC---------------------------TTBC
T ss_pred -ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCCCCCC---------------------------CCCC
Confidence 467899999999999999998 99999988777766665444322111 1445
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001142 1103 SFLVDVFRRCTEENPTERPTAGDLYEMFVART 1134 (1142)
Q Consensus 1103 ~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~~ 1134 (1142)
+.+.+++.+||+.||.+|||+.|+++++....
T Consensus 268 ~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 299 (327)
T 1fvr_A 268 DEVYDLMRQCWREKPYERPSFAQILVSLNRML 299 (327)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 67999999999999999999999999987653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=365.70 Aligned_cols=259 Identities=22% Similarity=0.363 Sum_probs=195.8
Q ss_pred CCCCcceeeeecccCceEEEEEEEC-----CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeE
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 879 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~~-----~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~ 879 (1142)
...+|++.+.||+|+||.||+|++. +..+|+|+.+.. ......+.+ .+|+.++++++||||+++++++
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~----~~E~~~l~~l~h~niv~~~~~~ 115 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG---YTEKQRRDF----LGEASIMGQFDHPNIIRLEGVV 115 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT---CCHHHHHHH----HHHHHHHTTCCCTTBCCEEEEE
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc---cCHHHHHHH----HHHHHHHHhCCCCCCCeEEEEE
Confidence 3457999999999999999999864 445788774322 123333344 8999999999999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 001142 880 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959 (1142)
Q Consensus 880 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~N 959 (1142)
.+.... ++||||+++++|.++++. ....+++..+..|+.||+.||+|||++||+||||||+|
T Consensus 116 ~~~~~~--------------~lv~e~~~~~sL~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 177 (373)
T 2qol_A 116 TKSKPV--------------MIVTEYMENGSLDSFLRK----HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARN 177 (373)
T ss_dssp CSSSSC--------------EEEEECCTTCBHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred eeCCce--------------EEEEeCCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcce
Confidence 865543 999999999999999975 23469999999999999999999999999999999999
Q ss_pred eeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001142 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039 (1142)
Q Consensus 960 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGvi 1039 (1142)
||++.+ +.+||+|||+++......... .......+|+.|+|||++.+ ..++.++|||||||+
T Consensus 178 Ill~~~-------~~~kl~Dfg~a~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~SlG~i 239 (373)
T 2qol_A 178 ILINSN-------LVCKVSDFGLGRVLEDDPEAA-------YTTRGGKIPIRWTSPEAIAY----RKFTSASDVWSYGIV 239 (373)
T ss_dssp EEECTT-------CCEEECCC-----------------------------CTTSCHHHHHH----CCCCHHHHHHHHHHH
T ss_pred EEEcCC-------CCEEECcCccccccccCCccc-------eeccCCCcCCCccChhhhcc----CCcCchhcHHHHHHH
Confidence 999887 789999999997654321110 01112235778999999976 568899999999999
Q ss_pred HHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001142 1040 LLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1118 (1142)
Q Consensus 1040 L~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~ 1118 (1142)
+|||++ |+.||.+....++...+..+.....+ ...+..+.+++.+||+.||.
T Consensus 240 l~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~---------------------------~~~~~~l~~li~~cl~~dp~ 292 (373)
T 2qol_A 240 LWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPP---------------------------MDCPAALYQLMLDCWQKDRN 292 (373)
T ss_dssp HHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCC---------------------------TTCBHHHHHHHHHHTCSSGG
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------ccccHHHHHHHHHHhCcChh
Confidence 999998 99999988777776666543221111 14456799999999999999
Q ss_pred CCCCHHHHHHHHHhh
Q 001142 1119 ERPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1119 ~RPSa~EVL~~L~~~ 1133 (1142)
+||++.+|++.+...
T Consensus 293 ~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 293 NRPKFEQIVSILDKL 307 (373)
T ss_dssp GSCCHHHHHHHHHHH
T ss_pred hCcCHHHHHHHHHHH
Confidence 999999999987654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=370.88 Aligned_cols=262 Identities=24% Similarity=0.266 Sum_probs=194.5
Q ss_pred CCCccee-eeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhh-CCCCCccceeeeEec
Q 001142 806 FPSLSSC-DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGA-LRHSCIVEMYGHKIS 881 (1142)
Q Consensus 806 ~~~y~l~-~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~-L~HpNIVkl~g~~~~ 881 (1142)
+++|.+. ++||+|+||+||+|.+. +..+|+|+.... ..+ .+|+.++.+ .+||||+++++++..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~---------~~~----~~E~~~~~~~~~hp~iv~l~~~~~~ 126 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKA----RREVELHWRASQCPHIVRIVDVYEN 126 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------HHH----HHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc---------hhH----HHHHHHHHHhcCCCCcceEeEEEee
Confidence 5678776 78999999999999984 567888875311 122 578888754 589999999999864
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 001142 882 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 961 (1142)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NIL 961 (1142)
.. ....+.|+||||++||+|.+++.. .+...+++..+..|+.||+.||.|||++||+||||||+|||
T Consensus 127 ~~----------~~~~~~~lv~E~~~gg~L~~~l~~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nil 193 (400)
T 1nxk_A 127 LY----------AGRKCLLIVMECLDGGELFSRIQD---RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 193 (400)
T ss_dssp EE----------TTEEEEEEEEECCCSEEHHHHHHC---C---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred cc----------cCCcEEEEEEEeCCCCcHHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEE
Confidence 11 012256999999999999999975 22346999999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001142 962 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1041 (1142)
Q Consensus 962 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ 1041 (1142)
++... ..+.+||+|||+++...... ......||+.|+|||++.+ ..|+.++|||||||++|
T Consensus 194 l~~~~----~~~~~kl~DFG~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~ 254 (400)
T 1nxk_A 194 YTSKR----PNAILKLTDFGFAKETTSHN-----------SLTTPCYTPYYVAPEVLGP----EKYDKSCDMWSLGVIMY 254 (400)
T ss_dssp ESSSS----TTCCEEECCCTTCEECC----------------------CTTCCGGGSCC----CCSSSHHHHHHHHHHHH
T ss_pred EecCC----CCccEEEEecccccccCCCC-----------ccccCCCCCCccCHhhcCC----CCCCCcccHHHHHHHHH
Confidence 98631 12789999999997543211 1124468999999999865 57889999999999999
Q ss_pred HHHhCCCCCCCCCHHH----HHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001142 1042 ELLTLQVPYMGLSELE----IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1117 (1142)
Q Consensus 1042 ELLtG~~Pf~~~~~~e----l~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP 1117 (1142)
+|++|..||.+..... ....+..+..... .+. ....++.+.+||.+||+.||
T Consensus 255 ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~-----------------------~~~-~~~~s~~~~~li~~~L~~dP 310 (400)
T 1nxk_A 255 ILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP-----------------------NPE-WSEVSEEVKMLIRNLLKTEP 310 (400)
T ss_dssp HHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCC-----------------------TTT-TTTSCHHHHHHHHTTSCSSG
T ss_pred HHHhCCCCCCCCccccccHHHHHHHHcCcccCC-----------------------Ccc-cccCCHHHHHHHHHHCCCCh
Confidence 9999999997643221 2233322221100 000 01456779999999999999
Q ss_pred CCCCCHHHHHHHHHhhcCC
Q 001142 1118 TERPTAGDLYEMFVARTSS 1136 (1142)
Q Consensus 1118 ~~RPSa~EVL~~L~~~~ss 1136 (1142)
.+|||+.|+++|+|+....
T Consensus 311 ~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 311 TQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp GGSCCHHHHHHSHHHHTTT
T ss_pred hHCcCHHHHhcCccccCCC
Confidence 9999999999999998654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=358.61 Aligned_cols=289 Identities=18% Similarity=0.210 Sum_probs=210.1
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
.+|++.+.||+|+||.||+|.+. +..+|+|+.. . .......+. +.+|+.++++++||||+++++++.....
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~--~-~~~~~~~~~----~~~E~~~l~~l~h~niv~~~~~~~~~~~ 99 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS--P-FEHQTYCQR----TLREIKILLRFRHENIIGINDIIRAPTI 99 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC--C-TTCHHHHHH----HHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEec--c-ccCcHHHHH----HHHHHHHHHhcCCCCCccceeEEecCCc
Confidence 47999999999999999999985 5567777643 2 112232233 4799999999999999999999875431
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
. .....++||||++ ++|.++++. ..+++..+..|+.||+.||.|||++||+||||||+|||++.
T Consensus 100 ~---------~~~~~~iv~e~~~-~~L~~~l~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~ 163 (364)
T 3qyz_A 100 E---------QMKDVYIVQDLME-TDLYKLLKT------QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 163 (364)
T ss_dssp T---------TCCCEEEEEECCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT
T ss_pred c---------ccceEEEEEcccC-cCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECC
Confidence 1 2235699999997 699999875 35999999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||+|||++......... ........||+.|+|||++.+ ...++.++|||||||++|+|+
T Consensus 164 ~-------~~~kl~Dfg~a~~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~ell 226 (364)
T 3qyz_A 164 T-------CDLKICDFGLARVADPDHDH-------TGFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEML 226 (364)
T ss_dssp T-------CCEEECCCTTCEECCGGGCB-------CCTTCCCCSCGGGCCHHHHHT---BCSCSTHHHHHHHHHHHHHHH
T ss_pred C-------CCEEEEeCcceEecCCCCCc-------cccccccccccCCCCCHHhcC---CCCCCcchhHHHHHHHHHHHH
Confidence 7 78999999999765432211 011224579999999998765 245789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccc-ccc--CCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEV-AQS--GSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
+|+.||.+....+....+...........+........... ... .............++.+.+||.+||+.||.+||
T Consensus 227 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 306 (364)
T 3qyz_A 227 SNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI 306 (364)
T ss_dssp HSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSC
T ss_pred HCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCC
Confidence 99999988776665555532221111111111000000000 000 000000111124567799999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001142 1122 TAGDLYEMFVARTS 1135 (1142)
Q Consensus 1122 Sa~EVL~~L~~~~s 1135 (1142)
|+.|+++|+|+...
T Consensus 307 t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 307 EVEQALAHPYLEQY 320 (364)
T ss_dssp CHHHHHTSGGGTTT
T ss_pred CHHHHhcCcchhhc
Confidence 99999999999864
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=348.26 Aligned_cols=300 Identities=21% Similarity=0.238 Sum_probs=206.4
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
.+|++.+.||+|+||.||+|.+. +..+|+|+.... .....+.+ .+|+.++++++||||+++++++.....
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~----~~e~~~l~~l~h~~iv~~~~~~~~~~~ 82 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT----DPQSVKHA----LREIKIIRRLDHDNIVKVFEILGPSGS 82 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC----SHHHHHHH----HHHHHHHHTCCCTTBCCEEEEECTTSC
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC----ChHHHHHH----HHHHHHHHhcCCCCeeEEEEecccccc
Confidence 57999999999999999999985 667888875432 23333444 799999999999999999999865321
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
....+..........++||||++ ++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 83 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~ 155 (320)
T 2i6l_A 83 QLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT 155 (320)
T ss_dssp BCCC----CCSCSEEEEEEECCS-EEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET
T ss_pred ccccccccccccCceeEEeeccC-CCHHHHhhc------CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC
Confidence 10000001122346799999998 699998853 46899999999999999999999999999999999999974
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
++ +.+||+|||++......... ........+|+.|+|||++.+ ...++.++||||||+++|+|+
T Consensus 156 ~~------~~~kl~Dfg~~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~il~el~ 219 (320)
T 2i6l_A 156 ED------LVLKIGDFGLARIMDPHYSH-------KGHLSEGLVTKWYRSPRLLLS---PNNYTKAIDMWAAGCIFAEML 219 (320)
T ss_dssp TT------TEEEECCCTTCBCC---------------CCCGGGSCCTTCCHHHHHC---TTCCCHHHHHHHHHHHHHHHH
T ss_pred CC------CeEEEccCccccccCCCccc-------ccccccccccccccCcHHhcC---cccCCchhhhHhHHHHHHHHH
Confidence 32 68999999999765432110 011223457999999999864 246889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCC-C-CCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS-G-FEKPEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
+|+.||.+....+....+............................ . ..........+..+.+++.+||+.||.+|||
T Consensus 220 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 299 (320)
T 2i6l_A 220 TGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLT 299 (320)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCC
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCC
Confidence 9999999887776666554433222211111110000000000000 0 0000111245778999999999999999999
Q ss_pred HHHHHHHHHhhcCCC
Q 001142 1123 AGDLYEMFVARTSSS 1137 (1142)
Q Consensus 1123 a~EVL~~L~~~~ss~ 1137 (1142)
+.|+++|+|+...+.
T Consensus 300 ~~ell~hp~~~~~~~ 314 (320)
T 2i6l_A 300 AEEALSHPYMSIYSF 314 (320)
T ss_dssp HHHHHTSHHHHTTCC
T ss_pred HHHHhCCcccccccC
Confidence 999999999986543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=351.42 Aligned_cols=260 Identities=25% Similarity=0.381 Sum_probs=204.2
Q ss_pred CCCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001142 804 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 881 (1142)
Q Consensus 804 ~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~ 881 (1142)
...++|++.+.||+|+||.||+|.+. +..+|+|+..... ..+.+ .+|+.++++++||||+++++++..
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~----~~e~~~l~~l~h~~i~~~~~~~~~ 95 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES------DLQEI----IKEISIMQQCDSPHVVKYYGSYFK 95 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS------CCHHH----HHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH------HHHHH----HHHHHHHHhCCCCCCccEEEEEEe
Confidence 34567999999999999999999985 6778888765321 11233 789999999999999999999886
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 001142 882 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 961 (1142)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NIL 961 (1142)
.. ..++||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+||+
T Consensus 96 ~~--------------~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil 157 (314)
T 3com_A 96 NT--------------DLWIVMEYCGAGSVSDIIRLR----NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNIL 157 (314)
T ss_dssp TT--------------EEEEEEECCTTEEHHHHHHHH----TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred CC--------------EEEEEeecCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEE
Confidence 54 359999999999999999741 346899999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001142 962 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1041 (1142)
Q Consensus 962 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ 1041 (1142)
++.+ +.+||+|||.+........ ......||+.|+|||++.+ ..++.++||||||+++|
T Consensus 158 ~~~~-------~~~kl~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~ 216 (314)
T 3com_A 158 LNTE-------GHAKLADFGVAGQLTDTMA----------KRNTVIGTPFWMAPEVIQE----IGYNCVADIWSLGITAI 216 (314)
T ss_dssp ECTT-------CCEEECCCTTCEECBTTBS----------CBCCCCSCGGGCCHHHHSS----SCBCTTHHHHHHHHHHH
T ss_pred ECCC-------CCEEEeecccchhhhhhcc----------ccCccCCCCCccChhhcCC----CCCCccccHHHHHHHHH
Confidence 9877 7899999999976543211 1123468999999999876 46789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1042 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1042 ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
+|++|+.||...........+.....+.... ....++.+.+++.+||+.||.+||
T Consensus 217 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~l~~li~~~l~~dp~~Rp 271 (314)
T 3com_A 217 EMAEGKPPYADIHPMRAIFMIPTNPPPTFRK-------------------------PELWSDNFTDFVKQCLVKSPEQRA 271 (314)
T ss_dssp HHHHSSCTTTTSCHHHHHHHHHHSCCCCCSS-------------------------GGGSCHHHHHHHHHHTCSCTTTSC
T ss_pred HHHhCCCCCCCCChHHHHHHHhcCCCcccCC-------------------------cccCCHHHHHHHHHHccCChhhCc
Confidence 9999999998776665544443333222110 113456799999999999999999
Q ss_pred CHHHHHHHHHhhcCCC
Q 001142 1122 TAGDLYEMFVARTSSS 1137 (1142)
Q Consensus 1122 Sa~EVL~~L~~~~ss~ 1137 (1142)
|+.++++|+|+.....
T Consensus 272 t~~~ll~~~~~~~~~~ 287 (314)
T 3com_A 272 TATQLLQHPFVRSAKG 287 (314)
T ss_dssp CHHHHTTSHHHHTCCC
T ss_pred CHHHHHhCHHHhcCCc
Confidence 9999999999986643
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=351.46 Aligned_cols=270 Identities=25% Similarity=0.343 Sum_probs=205.1
Q ss_pred cceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCC
Q 001142 809 LSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 888 (1142)
Q Consensus 809 y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~~ 888 (1142)
|...+.||+|+||.||+|.+.+..+|+|+.............+. +.+|+.++++++||||+++++++.+.+..
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~----~~~E~~~l~~l~h~~i~~~~~~~~~~~~~--- 105 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQ----FDQEIKVMAKCQHENLVELLGFSSDGDDL--- 105 (307)
T ss_dssp TTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHH----HHHHHHHHHHCCCTTBCCEEEEECSSSSC---
T ss_pred cccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHH----HHHHHHHHHhcCCCCeEEEEEEEecCCce---
Confidence 56679999999999999999999999998653322222222333 48999999999999999999999865543
Q ss_pred CCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecccccc
Q 001142 889 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 968 (1142)
Q Consensus 889 ~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~ 968 (1142)
++||||+++++|.+++.... ....+++..+..++.||+.||.|||++||+||||||+||+++.+
T Consensus 106 -----------~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~--- 169 (307)
T 2nru_A 106 -----------CLVYVYMPNGSLLDRLSCLD--GTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEA--- 169 (307)
T ss_dssp -----------EEEEECCTTCBHHHHHHTGG--GCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT---
T ss_pred -----------EEEEEecCCCcHHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCC---
Confidence 99999999999999997532 23468999999999999999999999999999999999999877
Q ss_pred CCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCC
Q 001142 969 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV 1048 (1142)
Q Consensus 969 ~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~ 1048 (1142)
+.+||+|||++......... .......||+.|+|||++.+ .++.++||||||+++|+|++|..
T Consensus 170 ----~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~g~~~y~aPE~~~~-----~~~~~~Dv~slG~il~~l~~g~~ 232 (307)
T 2nru_A 170 ----FTAKISDFGLARASEKFAQT--------VMTSRIVGTTAYMAPEALRG-----EITPKSDIYSFGVVLLEIITGLP 232 (307)
T ss_dssp ----CCEEECCCTTCEECCSCSSC--------EECSSCCSCGGGCCHHHHTT-----EECTHHHHHHHHHHHHHHHHCCC
T ss_pred ----CcEEEeeccccccccccccc--------ccccccCCCcCcCChHHhcC-----CCCccchhHHHHHHHHHHHHCCC
Confidence 78999999999765432111 01123468999999999864 46799999999999999999999
Q ss_pred CCCCCCHHH----HHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001142 1049 PYMGLSELE----IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124 (1142)
Q Consensus 1049 Pf~~~~~~e----l~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~ 1124 (1142)
||......+ +...+... ...+.... ... ........++.+.+++.+||+.||.+|||+.
T Consensus 233 p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~------------~~~----~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 295 (307)
T 2nru_A 233 AVDEHREPQLLLDIKEEIEDE-EKTIEDYI------------DKK----MNDADSTSVEAMYSVASQCLHEKKNKRPDIK 295 (307)
T ss_dssp SBCTTBSSSBTTHHHHHHHTT-SCCHHHHS------------CSS----CSCCCHHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred CcccCcchHHHHHHHHHhhhh-hhhhhhhc------------ccc----ccccchHHHHHHHHHHHHHcCCCcccCcCHH
Confidence 997643322 12222111 11111100 000 0111235677899999999999999999999
Q ss_pred HHHHHHHhhcC
Q 001142 1125 DLYEMFVARTS 1135 (1142)
Q Consensus 1125 EVL~~L~~~~s 1135 (1142)
++++++.....
T Consensus 296 ~l~~~L~~l~~ 306 (307)
T 2nru_A 296 KVQQLLQEMTA 306 (307)
T ss_dssp HHHHHHHHHC-
T ss_pred HHHHHHHHHhc
Confidence 99999987654
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=365.06 Aligned_cols=264 Identities=22% Similarity=0.270 Sum_probs=203.9
Q ss_pred CCCCCCcceeeeecccCceEEEEEEE-----CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCcccee
Q 001142 803 PGSFPSLSSCDEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMY 876 (1142)
Q Consensus 803 ~~~~~~y~l~~~LG~GsfG~Vy~a~~-----~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~ 876 (1142)
...+.+|++.+.||+|+||.||+|++ .+..+|+|+.+...........+.+ .+|+.+++++ +||||++++
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~----~~E~~~l~~l~~h~~iv~~~ 125 (355)
T 1vzo_A 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHT----RTERQVLEHIRQSPFLVTLH 125 (355)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGC----CCHHHHHHHHHTCTTBCCEE
T ss_pred cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHH----HHHHHHHHHccCCCceeEEE
Confidence 44567899999999999999999998 5678999986432111111112223 5799999999 699999999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 001142 877 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956 (1142)
Q Consensus 877 g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLK 956 (1142)
+++.... ..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+|||||
T Consensus 126 ~~~~~~~--------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlk 186 (355)
T 1vzo_A 126 YAFQTET--------------KLHLILDYINGGELFTHLSQ-----RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIK 186 (355)
T ss_dssp EEEEETT--------------EEEEEECCCCSCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred EEEeeCc--------------eEEEEeecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 9998654 34999999999999999976 2468999999999999999999999999999999
Q ss_pred CCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHH
Q 001142 957 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1036 (1142)
Q Consensus 957 p~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSL 1036 (1142)
|+|||++.+ +.+||+|||+++........ ......||+.|+|||++.+. ...++.++|||||
T Consensus 187 p~NIll~~~-------~~~kl~DfG~a~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~--~~~~~~~~Dvwsl 248 (355)
T 1vzo_A 187 LENILLDSN-------GHVVLTDFGLSKEFVADETE---------RAYDFCGTIEYMAPDIVRGG--DSGHDKAVDWWSL 248 (355)
T ss_dssp GGGEEECTT-------SCEEESCSSEEEECCGGGGG---------GGCGGGSCCTTCCHHHHTTC--C---CTHHHHHHH
T ss_pred HHHEEECCC-------CcEEEeeCCCCeecccCCCC---------cccCcccCcCccChhhhcCC--CCCCCchhhHHHH
Confidence 999999887 78999999999765332111 11234699999999998752 2357899999999
Q ss_pred HHHHHHHHhCCCCCCCCC----HHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHh
Q 001142 1037 GCLLLELLTLQVPYMGLS----ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 1112 (1142)
Q Consensus 1037 GviL~ELLtG~~Pf~~~~----~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~C 1112 (1142)
||++|||++|+.||.... ...+...+.....+ .+ ...+..+.+||.+|
T Consensus 249 G~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~---------------------------~~~~~~~~~li~~~ 300 (355)
T 1vzo_A 249 GVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP-YP---------------------------QEMSALAKDLIQRL 300 (355)
T ss_dssp HHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCC-CC---------------------------TTSCHHHHHHHHHH
T ss_pred HHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCC-CC---------------------------cccCHHHHHHHHHH
Confidence 999999999999997432 22333333222111 10 14456689999999
Q ss_pred cccCCCCCC-----CHHHHHHHHHhhcC
Q 001142 1113 TEENPTERP-----TAGDLYEMFVARTS 1135 (1142)
Q Consensus 1113 L~~DP~~RP-----Sa~EVL~~L~~~~s 1135 (1142)
|+.||.+|| +++|+++|+|+...
T Consensus 301 L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 301 LMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp TCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred hhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 999999999 99999999999753
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=364.77 Aligned_cols=285 Identities=20% Similarity=0.233 Sum_probs=193.7
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
.+|++.+.||+|+||.||+|.+. +..||+|+ +..........+.+ .+|+.++++++||||+++++++.....
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~--~~~~~~~~~~~~~~----~~E~~~l~~l~hpnIv~~~~~~~~~~~ 102 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKK--LSRPFQSIIHAKRT----YRELRLLKHMKHENVIGLLDVFTPARS 102 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEE--CSSTTSSHHHHHHH----HHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEE--eCccccCHHHHHHH----HHHHHHHHhCCCCCCCcEEEEEecCCc
Confidence 67999999999999999999874 55677776 33322233333333 799999999999999999999875432
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
. ......++||||+ +++|.++++. ..+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 103 ~--------~~~~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~ 167 (367)
T 2fst_X 103 L--------EEFNDVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 167 (367)
T ss_dssp G--------GGCCCCEEEEECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT
T ss_pred c--------ccCCeEEEEeccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECC
Confidence 1 1123459999999 6899998864 46999999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||+|||+++..... .....||+.|+|||++.+ ...++.++|||||||++|||+
T Consensus 168 ~-------~~~kL~DFG~a~~~~~~-------------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~ell 224 (367)
T 2fst_X 168 D-------CELKILDFGLARHTADE-------------MTGYVATRWYRAPEIMLN---WMHYNQTVDIWSVGCIMAELL 224 (367)
T ss_dssp T-------CCEEECC----------------------------CCCTTCCHHHHTT---CCSCCTTHHHHHHHHHHHHHH
T ss_pred C-------CCEEEeecccccccccc-------------CCCcCcCcCccChHHHcC---CcCCCchhhHHHHHHHHHHHH
Confidence 7 78999999999754321 123468999999999875 246889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCC---CCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS---GFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
+|+.||.+.+..+....+...........+..........+.+... ...........++.+.+||.+||+.||.+||
T Consensus 225 ~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~ 304 (367)
T 2fst_X 225 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 304 (367)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSC
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCc
Confidence 9999999888776666553322111111111110000000000000 0000111124467799999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001142 1122 TAGDLYEMFVARTS 1135 (1142)
Q Consensus 1122 Sa~EVL~~L~~~~s 1135 (1142)
|+.|+++|+|+..-
T Consensus 305 t~~e~L~hp~~~~~ 318 (367)
T 2fst_X 305 TAAQALAHAYFAQY 318 (367)
T ss_dssp CHHHHHTSGGGTTT
T ss_pred CHHHHhcChhhhhc
Confidence 99999999999753
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=382.65 Aligned_cols=260 Identities=23% Similarity=0.321 Sum_probs=208.1
Q ss_pred CCCCCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001142 803 PGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 880 (1142)
Q Consensus 803 ~~~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~ 880 (1142)
+....+|++.++||+|+||.||+|++ .+..+|+|+...... ........+.+|+.++++++|||||++++++.
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~-----~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~ 254 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI-----KKRKGEAMALNEKQILEKVNSRFVVSLAYAYE 254 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhh-----hhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEe
Confidence 34567899999999999999999998 467788888643211 11111233478999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NI 960 (1142)
+.+ ..|+||||++||+|.+++.. .+...+++..++.++.||+.||+|||++||+||||||+||
T Consensus 255 ~~~--------------~l~lVmEy~~gg~L~~~l~~---~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNI 317 (576)
T 2acx_A 255 TKD--------------ALCLVLTLMNGGDLKFHIYH---MGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENI 317 (576)
T ss_dssp CSS--------------EEEEEECCCCSCBHHHHHHS---SSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred eCC--------------EEEEEEEcCCCCcHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheE
Confidence 655 45999999999999999875 2334599999999999999999999999999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
|++.+ +.+||+|||+++....... .....||+.|+|||++.+ ..|+.++|||||||++
T Consensus 318 Lld~~-------g~vKL~DFGla~~~~~~~~-----------~~~~~GT~~Y~APEvl~~----~~~~~~~DiwSLGvil 375 (576)
T 2acx_A 318 LLDDH-------GHIRISDLGLAVHVPEGQT-----------IKGRVGTVGYMAPEVVKN----ERYTFSPDWWALGCLL 375 (576)
T ss_dssp EECTT-------SCEEECCCTTCEECCTTCC-----------EECCCSCGGGCCHHHHTT----CEESSHHHHHHHHHHH
T ss_pred EEeCC-------CCeEEEecccceecccCcc-----------ccccCCCccccCHHHHcC----CCCCccchHHHHHHHH
Confidence 99887 7899999999976543211 113469999999999976 5688999999999999
Q ss_pred HHHHhCCCCCCCCC----HHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 001142 1041 LELLTLQVPYMGLS----ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1116 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~~~----~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~D 1116 (1142)
|||++|+.||.+.. ..++...+..... .++ ...++.+.+||.+||+.|
T Consensus 376 yeLltG~~PF~~~~~~~~~~~i~~~i~~~~~-~~p---------------------------~~~s~~~~dLI~~lL~~d 427 (576)
T 2acx_A 376 YEMIAGQSPFQQRKKKIKREEVERLVKEVPE-EYS---------------------------ERFSPQARSLCSQLLCKD 427 (576)
T ss_dssp HHHHHSSCSSSCSSSCCCHHHHHHHHHHCCC-CCC---------------------------TTSCHHHHHHHHHHTCSS
T ss_pred HHHHhCCCCCcccccchhHHHHHHHhhcccc-cCC---------------------------ccCCHHHHHHHHHhccCC
Confidence 99999999998643 2334444432211 110 145567999999999999
Q ss_pred CCCCC-----CHHHHHHHHHhhc
Q 001142 1117 PTERP-----TAGDLYEMFVART 1134 (1142)
Q Consensus 1117 P~~RP-----Sa~EVL~~L~~~~ 1134 (1142)
|.+|| +++||++|+|++.
T Consensus 428 P~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 428 PAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp GGGSTTCSSSHHHHHHTSGGGTT
T ss_pred HHHcCCCCCCCHHHHHhChhhcc
Confidence 99999 8999999999985
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=369.70 Aligned_cols=283 Identities=21% Similarity=0.234 Sum_probs=203.1
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC------CCCCccceeee
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL------RHSCIVEMYGH 878 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L------~HpNIVkl~g~ 878 (1142)
.+|++.++||+|+||+||+|.+. +..||+|+.... ....+. +.+|+.+++.+ .|+||++++++
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-----~~~~~~----~~~E~~~l~~l~~~~~~~~~~iv~~~~~ 167 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-----KRFHRQ----AAEEIRILEHLRKQDKDNTMNVIHMLEN 167 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHH----HHHHHHHHHHHHTTCTTSCSCBCCEEEE
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-----cchHHH----HHHHHHHHHHHhhccccCCcCEEEEEee
Confidence 46999999999999999999984 567788875321 222222 36788877776 57899999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 001142 879 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 958 (1142)
Q Consensus 879 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~ 958 (1142)
+.... +.++||||+. ++|.+++.. .....+++..++.|+.||+.||+|||++||+||||||+
T Consensus 168 ~~~~~--------------~~~lv~e~~~-~~L~~~l~~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~ 229 (429)
T 3kvw_A 168 FTFRN--------------HICMTFELLS-MNLYELIKK---NKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPE 229 (429)
T ss_dssp EEETT--------------EEEEEECCCC-CBHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGG
T ss_pred cccCC--------------eEEEEEeccC-CCHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHH
Confidence 98654 4599999996 799999986 23345899999999999999999999999999999999
Q ss_pred CeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001142 959 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1038 (1142)
Q Consensus 959 NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGv 1038 (1142)
|||++.++. ..+||+|||++...... .....||+.|+|||++.+ ..++.++|||||||
T Consensus 230 NILl~~~~~-----~~vkL~DFG~a~~~~~~-------------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~ 287 (429)
T 3kvw_A 230 NILLKQQGR-----SGIKVIDFGSSCYEHQR-------------VYTYIQSRFYRAPEVILG----ARYGMPIDMWSLGC 287 (429)
T ss_dssp GEEESSTTS-----CCEEECCCTTCEETTCC-------------CCSSCSCGGGCCHHHHHT----BCCCTHHHHHHHHH
T ss_pred HeEEccCCC-----cceEEeecccceecCCc-------------ccccCCCCCccChHHHhC----CCCCchHHHHhHHH
Confidence 999987621 33999999999653321 123468999999999986 56899999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccc---cc-cccc--------------------cc---CCC
Q 001142 1039 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC---HE-HEVA--------------------QS---GSG 1091 (1142)
Q Consensus 1039 iL~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~---~~-~~~~--------------------~~---~~~ 1091 (1142)
++|||++|..||.+.+..+....+...........+...... .. .... .. ...
T Consensus 288 il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (429)
T 3kvw_A 288 ILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGP 367 (429)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECS
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCC
Confidence 999999999999988877766555332211111111100000 00 0000 00 000
Q ss_pred CCCch----hhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCCC
Q 001142 1092 FEKPE----AELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSSI 1138 (1142)
Q Consensus 1092 ~~~~~----~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~~ss~~ 1138 (1142)
..... .....++.+.+||.+||+.||++|||+.|+++|+|++...+.
T Consensus 368 ~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~~~~ 418 (429)
T 3kvw_A 368 PESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPK 418 (429)
T ss_dssp TTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC-----
T ss_pred ccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccCCCC
Confidence 00000 001235679999999999999999999999999999876443
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=353.81 Aligned_cols=269 Identities=24% Similarity=0.372 Sum_probs=204.4
Q ss_pred CCCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEec
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 881 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~~~ 881 (1142)
...+|++.+.||+|+||.||+|++ .+..+|+|+..... . ..+.+ .+|+.+++++ +||||+++++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~---~~~~~----~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--D---EEEEI----KQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--S---TTHHH----HHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc--c---cHHHH----HHHHHHHHhccCCCCeeeeeeEEee
Confidence 356799999999999999999998 56778888865331 1 12233 7899999999 79999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 001142 882 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 961 (1142)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NIL 961 (1142)
.... ......++||||+++++|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 93 ~~~~--------~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl 161 (326)
T 2x7f_A 93 KNPP--------GMDDQLWLVMEFCGAGSVTDLIKNT---KGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVL 161 (326)
T ss_dssp CC----------CCCCEEEEEEECCTTEEHHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEE
T ss_pred ccCc--------cccceEEEEEEcCCCCcHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEE
Confidence 4310 1123579999999999999999862 2246899999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhcccc-CCCCCCchhhHHHHHHHH
Q 001142 962 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 962 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~s~ksDVwSLGviL 1040 (1142)
++.+ +.+||+|||++........ ......||+.|+|||++.... ....++.++|||||||++
T Consensus 162 ~~~~-------~~~kl~Dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il 224 (326)
T 2x7f_A 162 LTEN-------AEVKLVDFGVSAQLDRTVG----------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITA 224 (326)
T ss_dssp ECTT-------CCEEECCCTTTC-----------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHH
T ss_pred EcCC-------CCEEEeeCcCceecCcCcc----------ccccccCCccccChhhhccccccCcCCCccchHHHHHHHH
Confidence 9877 7899999999876533111 112346899999999986321 124678999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1041 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
|+|++|..||.+.........+.....+... ....++.+.++|.+||..||.+|
T Consensus 225 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~l~~li~~~l~~dp~~R 278 (326)
T 2x7f_A 225 IEMAEGAPPLCDMHPMRALFLIPRNPAPRLK--------------------------SKKWSKKFQSFIESCLVKNHSQR 278 (326)
T ss_dssp HHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS--------------------------CSCSCHHHHHHHHHHCCSSGGGS
T ss_pred HHHHhCCCCCCCCcHHHHHHHhhcCccccCC--------------------------ccccCHHHHHHHHHHhccChhhC
Confidence 9999999999887766655544433322211 01345679999999999999999
Q ss_pred CCHHHHHHHHHhhcCC
Q 001142 1121 PTAGDLYEMFVARTSS 1136 (1142)
Q Consensus 1121 PSa~EVL~~L~~~~ss 1136 (1142)
||+.++++|+|++...
T Consensus 279 ps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 279 PATEQLMKHPFIRDQP 294 (326)
T ss_dssp CCHHHHHTSHHHHCCT
T ss_pred CCHHHHhhChHHhhCc
Confidence 9999999999998643
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=349.46 Aligned_cols=262 Identities=21% Similarity=0.323 Sum_probs=208.1
Q ss_pred CCCcceeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeee
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 878 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~-------~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~ 878 (1142)
..+|++.+.||+|+||.||+|.+. +..+|+|+.. .. ........ +.+|+.++++++||||++++++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~--~~-~~~~~~~~----~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--EA-ASMRERIE----FLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECC--TT-SCHHHHHH----HHHHHHHGGGCCCTTBCCEEEE
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecc--cc-cCHHHHHH----HHHHHHHHHhcCCCCEeeeEEE
Confidence 457999999999999999999864 3557777643 21 12233333 3799999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 001142 879 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----GEKHVSVKLALFIAQDVAAALVELHSKHIMHR 953 (1142)
Q Consensus 879 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~-----~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHr 953 (1142)
+.+.+.. ++||||+++++|.+++...... ....+++..+..++.||+.||.|||++||+||
T Consensus 97 ~~~~~~~--------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~ 162 (322)
T 1p4o_A 97 VSQGQPT--------------LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHR 162 (322)
T ss_dssp ECSSSSC--------------EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCS
T ss_pred EccCCcc--------------EEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccC
Confidence 9765543 9999999999999999764321 12457999999999999999999999999999
Q ss_pred CCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhH
Q 001142 954 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 1033 (1142)
Q Consensus 954 DLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDV 1033 (1142)
||||+|||++.+ +.+||+|||++.......... ......+|+.|+|||++.+ ..++.++||
T Consensus 163 dikp~NIli~~~-------~~~kl~Dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di 223 (322)
T 1p4o_A 163 DLAARNCMVAED-------FTVKIGDFGMTRDIYETDYYR--------KGGKGLLPVRWMSPESLKD----GVFTTYSDV 223 (322)
T ss_dssp CCSGGGEEECTT-------CCEEECCTTCCCGGGGGGCEE--------GGGSSEECGGGCCHHHHHH----CCCCHHHHH
T ss_pred CCccceEEEcCC-------CeEEECcCccccccccccccc--------cccCCCCCCCccChhhhcc----CCCCchhhH
Confidence 999999999887 789999999997654322110 1113357889999999876 568899999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHh
Q 001142 1034 WSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 1112 (1142)
Q Consensus 1034 wSLGviL~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~C 1112 (1142)
||||+++|+|++ |..||.+....+....+..+..+..+ ...++.+.+++.+|
T Consensus 224 ~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~~ 276 (322)
T 1p4o_A 224 WSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP---------------------------DNCPDMLFELMRMC 276 (322)
T ss_dssp HHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCC---------------------------TTCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcCCCC---------------------------CCCCHHHHHHHHHH
Confidence 999999999999 89999988777777666554432211 14456799999999
Q ss_pred cccCCCCCCCHHHHHHHHHhhc
Q 001142 1113 TEENPTERPTAGDLYEMFVART 1134 (1142)
Q Consensus 1113 L~~DP~~RPSa~EVL~~L~~~~ 1134 (1142)
|+.||.+|||+.|+++++....
T Consensus 277 l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 277 WQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp TCSSGGGSCCHHHHHHHHGGGS
T ss_pred cCCCcccCcCHHHHHHHHHHhh
Confidence 9999999999999999987653
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=372.31 Aligned_cols=256 Identities=22% Similarity=0.372 Sum_probs=208.1
Q ss_pred CCCcceeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~-~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
.++|++.++||+|+||.||+|.+. +..||+|+.+.. . ...+.+ .+|+.+|++++|||||++++++.. .
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~--~---~~~~~~----~~E~~~l~~l~h~~iv~l~~~~~~-~- 255 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG--S---MSVEAF----LAEANVMKTLQHDKLVKLHAVVTK-E- 255 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTT--S---BCHHHH----HHHHHHHTTCCCTTBCCEEEEECS-S-
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCC--C---ccHHHH----HHHHHHHhhCCCCCEeeEEEEEeC-C-
Confidence 457899999999999999999985 567888875422 1 123344 799999999999999999999863 2
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
..++||||+++|+|.++++... ...+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 256 -------------~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~ 319 (454)
T 1qcf_A 256 -------------PIYIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSA 319 (454)
T ss_dssp -------------SCEEEECCCTTCBHHHHHHSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECT
T ss_pred -------------ccEEEEeecCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECC
Confidence 2399999999999999997421 135889999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||+|||+++........ ......+|+.|+|||++.. ..++.++|||||||++|||+
T Consensus 320 ~-------~~~kl~DFG~a~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~~l~el~ 379 (454)
T 1qcf_A 320 S-------LVCKIADFGLARVIEDNEYT---------AREGAKFPIKWTAPEAINF----GSFTIKSDVWSFGILLMEIV 379 (454)
T ss_dssp T-------CCEEECSTTGGGGBCCHHHH---------TTCSSSSCGGGSCHHHHHH----CCCCHHHHHHHHHHHHHHHH
T ss_pred C-------CcEEEeeCCCceEcCCCcee---------ccCCCcccccccCHHHhcc----CCCCcHHHHHhHHHHHHHHH
Confidence 7 78999999999765432111 1112346788999999976 56889999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1045 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1045 t-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
+ |+.||.+....++...+..+.....+ ..+++.+.+|+.+||+.||++|||+
T Consensus 380 t~g~~P~~~~~~~~~~~~i~~~~~~~~~---------------------------~~~~~~l~~li~~cl~~dp~~RPt~ 432 (454)
T 1qcf_A 380 TYGRIPYPGMSNPEVIRALERGYRMPRP---------------------------ENCPEELYNIMMRCWKNRPEERPTF 432 (454)
T ss_dssp TTSCCSSTTCCHHHHHHHHHHTCCCCCC---------------------------TTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred hCCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------CCCCHHHHHHHHHHccCChhHCcCH
Confidence 9 99999988888877777655433221 1456679999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 001142 1124 GDLYEMFVARTS 1135 (1142)
Q Consensus 1124 ~EVL~~L~~~~s 1135 (1142)
.+|++.+.....
T Consensus 433 ~~i~~~L~~~~~ 444 (454)
T 1qcf_A 433 EYIQSVLDDFYT 444 (454)
T ss_dssp HHHHHHHHTSSS
T ss_pred HHHHHHHHHHHh
Confidence 999999887644
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=392.30 Aligned_cols=260 Identities=23% Similarity=0.288 Sum_probs=211.3
Q ss_pred CCCCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeE
Q 001142 803 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHK 879 (1142)
Q Consensus 803 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~ 879 (1142)
...+.+|++.++||+|+||.||+|++. +..+|+|+.+.... ........+..|..++..+ +||||+++++++
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~-----~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~ 411 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV-----IQDDDVECTMVEKRVLALPGKPPFLTQLHSCF 411 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHH-----HHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEecccc-----ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE
Confidence 345788999999999999999999984 45688888653211 0111122346899999988 699999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 001142 880 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959 (1142)
Q Consensus 880 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~N 959 (1142)
.+.+ .+||||||++||+|.++++.. ..+++..++.|+.||+.||+|||++||+||||||+|
T Consensus 412 ~~~~--------------~~~lV~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~N 472 (674)
T 3pfq_A 412 QTMD--------------RLYFVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDN 472 (674)
T ss_dssp BCSS--------------EEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTT
T ss_pred EeCC--------------EEEEEEeCcCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhh
Confidence 8655 459999999999999999862 469999999999999999999999999999999999
Q ss_pred eeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001142 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039 (1142)
Q Consensus 960 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGvi 1039 (1142)
||++.+ +.+||+|||+|+...... .......||+.|+|||++.+ ..|+.++|||||||+
T Consensus 473 ILl~~~-------g~ikL~DFGla~~~~~~~----------~~~~~~~GT~~Y~APE~l~~----~~~~~~~DvwSlGvi 531 (674)
T 3pfq_A 473 VMLDSE-------GHIKIADFGMCKENIWDG----------VTTKTFCGTPDYIAPEIIAY----QPYGKSVDWWAFGVL 531 (674)
T ss_dssp EEECSS-------SCEEECCCTTCEECCCTT----------CCBCCCCSCSSSCCHHHHTC----CCBSTHHHHHHHHHH
T ss_pred EEEcCC-------CcEEEeecceeeccccCC----------cccccccCCCcccCHhhhcC----CCCCccceEechHHH
Confidence 999987 889999999997532211 11234579999999999976 578999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001142 1040 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1119 (1142)
Q Consensus 1040 L~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~ 1119 (1142)
+|||++|+.||.+.+..++...|...... ++ ...++++.+||.+||+.||.+
T Consensus 532 lyelltG~~Pf~~~~~~~~~~~i~~~~~~-~p---------------------------~~~s~~~~~li~~lL~~dP~~ 583 (674)
T 3pfq_A 532 LYEMLAGQAPFEGEDEDELFQSIMEHNVA-YP---------------------------KSMSKEAVAICKGLMTKHPGK 583 (674)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHSSCCC-CC---------------------------TTSCHHHHHHHHHHSCSSSTT
T ss_pred HHHHHcCCCCCCCCCHHHHHHHHHhCCCC-CC---------------------------ccCCHHHHHHHHHHccCCHHH
Confidence 99999999999998888888877654321 11 144567999999999999999
Q ss_pred CCCH-----HHHHHHHHhhcC
Q 001142 1120 RPTA-----GDLYEMFVARTS 1135 (1142)
Q Consensus 1120 RPSa-----~EVL~~L~~~~s 1135 (1142)
||++ +||++|+||+.-
T Consensus 584 R~~~~~~~~~ei~~h~ff~~i 604 (674)
T 3pfq_A 584 RLGCGPEGERDIKEHAFFRYI 604 (674)
T ss_dssp CTTCSTTHHHHHHSSGGGSSC
T ss_pred CCCCCCCcHHHHhcCccccCC
Confidence 9997 999999999753
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=345.50 Aligned_cols=256 Identities=21% Similarity=0.342 Sum_probs=200.8
Q ss_pred CCCCcceeeeecccCceEEEEEEECC---c--cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeE
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKFGS---A--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 879 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~~~---~--~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~ 879 (1142)
...+|++.+.||+|+||.||+|.+.. . .+|+|+. ... ......+.+ .+|+.++++++||||+++++++
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~--~~~-~~~~~~~~~----~~E~~~l~~l~h~~i~~~~~~~ 82 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC--KKD-CTLDNKEKF----MSEAVIMKNLDHPHIVKLIGII 82 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEEC--CTT-SCHHHHHHH----HHHHHHHHHHCCTTBCCEEEEE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEec--ccc-cCchHHHHH----HHHHHHHHhCCCCCcceEEEEE
Confidence 45679999999999999999998732 2 2666653 322 122333334 8999999999999999999997
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 001142 880 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959 (1142)
Q Consensus 880 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~N 959 (1142)
.+.. .++||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|
T Consensus 83 ~~~~---------------~~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~N 143 (281)
T 3cc6_A 83 EEEP---------------TWIIMELYPYGELGHYLERN----KNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRN 143 (281)
T ss_dssp CSSS---------------CEEEEECCTTCBHHHHHHHH----TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGG
T ss_pred cCCC---------------CEEEEecCCCCCHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccce
Confidence 6432 28999999999999999762 2458999999999999999999999999999999999
Q ss_pred eeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001142 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039 (1142)
Q Consensus 960 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGvi 1039 (1142)
|+++.+ +.+||+|||.+......... ......+|+.|+|||++.+ ..++.++||||||++
T Consensus 144 il~~~~-------~~~kl~Dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~i 203 (281)
T 3cc6_A 144 ILVASP-------ECVKLGDFGLSRYIEDEDYY---------KASVTRLPIKWMSPESINF----RRFTTASDVWMFAVC 203 (281)
T ss_dssp EEEEET-------TEEEECCCCGGGCC------------------CCCCCGGGCCHHHHHH----CCCCHHHHHHHHHHH
T ss_pred EEECCC-------CcEEeCccCCCccccccccc---------ccccCCCCcceeCchhhcc----CCCCchhccHHHHHH
Confidence 999887 78999999999765432111 1123357889999999875 568899999999999
Q ss_pred HHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001142 1040 LLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1118 (1142)
Q Consensus 1040 L~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~ 1118 (1142)
+|+|++ |+.||......+....+..+..+..+. ..++.+.+++.+||+.||.
T Consensus 204 l~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~p~ 256 (281)
T 3cc6_A 204 MWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPD---------------------------LCPPVLYTLMTRCWDYDPS 256 (281)
T ss_dssp HHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGG
T ss_pred HHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCC---------------------------CCCHHHHHHHHHHccCCch
Confidence 999998 999998766666555554443322111 3456699999999999999
Q ss_pred CCCCHHHHHHHHHhh
Q 001142 1119 ERPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1119 ~RPSa~EVL~~L~~~ 1133 (1142)
+|||+.|+++++...
T Consensus 257 ~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 257 DRPRFTELVCSLSDV 271 (281)
T ss_dssp GSCCHHHHHHHHHHH
T ss_pred hCcCHHHHHHHHHHH
Confidence 999999999998654
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=349.10 Aligned_cols=263 Identities=21% Similarity=0.331 Sum_probs=197.4
Q ss_pred CCCCcceeeeecccCceEEEEEEECC---------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccce
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKFGS---------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 875 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~~~---------~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl 875 (1142)
..++|++.+.||+|+||+||+|.+.. ..+|+|+.... ..... ..+.+|+.++++++||||+++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~----~~~~~----~~~~~E~~~l~~l~h~~iv~~ 77 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA----HRNYS----ESFFEAASMMSKLSHKHLVLN 77 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG----GGGGH----HHHHHHHHHHHTSCCTTBCCE
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc----cHHHH----HHHHHHHHHHHhCCCCCEeEE
Confidence 34679999999999999999998743 34777775322 11222 234899999999999999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 001142 876 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 955 (1142)
Q Consensus 876 ~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDL 955 (1142)
++++.+.+.. ++||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||
T Consensus 78 ~~~~~~~~~~--------------~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dl 139 (289)
T 4fvq_A 78 YGVCVCGDEN--------------ILVQEFVKFGSLDTYLKKN----KNCINILWKLEVAKQLAAAMHFLEENTLIHGNV 139 (289)
T ss_dssp EEEECCTTCC--------------EEEEECCTTCBHHHHHHHT----GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred EEEEEeCCCC--------------EEEEECCCCCCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCc
Confidence 9999875533 8999999999999999862 234899999999999999999999999999999
Q ss_pred CCCCeeecccccc-CCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHH
Q 001142 956 KSENILIDLERKK-ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 1034 (1142)
Q Consensus 956 Kp~NILld~~~~~-~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVw 1034 (1142)
||+|||++.+... ....+.+||+|||.+...... ....||+.|+|||++.+ ...++.++|||
T Consensus 140 kp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--------------~~~~~~~~y~aPE~~~~---~~~~~~~~Diw 202 (289)
T 4fvq_A 140 CAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK--------------DILQERIPWVPPECIEN---PKNLNLATDKW 202 (289)
T ss_dssp CGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH--------------HHHHHTTTTSCHHHHHC---GGGCCHHHHHH
T ss_pred CcceEEEecCCcccccccceeeeccCcccccccCc--------------cccCCcCcccCHHHhCC---CCCCCchhHHH
Confidence 9999999877310 111233999999998654321 12347888999999875 24578999999
Q ss_pred HHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 001142 1035 SYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 1113 (1142)
Q Consensus 1035 SLGviL~ELLtG-~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL 1113 (1142)
|||+++|+|++| .+||................. .+. ..++.+.+++.+||
T Consensus 203 slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~--~~~---------------------------~~~~~l~~li~~~l 253 (289)
T 4fvq_A 203 SFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQ--LPA---------------------------PKAAELANLINNCM 253 (289)
T ss_dssp HHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC--CCC---------------------------CSSCTTHHHHHHHS
T ss_pred HHHHHHHHHHcCCCCCccccchHHHHHHhhccCC--CCC---------------------------CCCHHHHHHHHHHc
Confidence 999999999995 555555444433333222111 000 12334889999999
Q ss_pred ccCCCCCCCHHHHHHHHHhhcCCCCC
Q 001142 1114 EENPTERPTAGDLYEMFVARTSSSIS 1139 (1142)
Q Consensus 1114 ~~DP~~RPSa~EVL~~L~~~~ss~~s 1139 (1142)
+.||.+|||+.|+++++....++..+
T Consensus 254 ~~dp~~Rps~~~ll~~l~~l~~p~~~ 279 (289)
T 4fvq_A 254 DYEPDHRPSFRAIIRDLNSLFTPDLV 279 (289)
T ss_dssp CSSGGGSCCHHHHHHHHHTCC-----
T ss_pred CCChhHCcCHHHHHHHHHHhcCCCCC
Confidence 99999999999999999987765543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=345.41 Aligned_cols=258 Identities=22% Similarity=0.307 Sum_probs=206.3
Q ss_pred CCCcceee-eecccCceEEEEEEE----CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001142 806 FPSLSSCD-EAGKSVSSSLFRCKF----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 880 (1142)
Q Consensus 806 ~~~y~l~~-~LG~GsfG~Vy~a~~----~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~ 880 (1142)
.++|.+.+ .||+|+||.||+|.+ .+..+|+|+.... ......+.+ .+|+.++++++||||+++++++.
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~----~~E~~~l~~l~h~~i~~~~~~~~ 80 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG---TEKADTEEM----MREAQIMHQLDNPYIVRLIGVCQ 80 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS---CCHHHHHHH----HHHHHHHHHCCCTTBCCEEEEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc---cchhHHHHH----HHHHHHHHhCCCCCEeEEEEEec
Confidence 34577776 999999999999986 3556777775422 223333444 79999999999999999999984
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NI 960 (1142)
.. ..++||||+++++|.+++.. ....+++..+..++.||+.||.|||++||+||||||+||
T Consensus 81 ~~---------------~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 141 (287)
T 1u59_A 81 AE---------------ALMLVMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNV 141 (287)
T ss_dssp SS---------------SEEEEEECCTTEEHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred CC---------------CcEEEEEeCCCCCHHHHHHh----CCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheE
Confidence 32 24999999999999999864 234699999999999999999999999999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
+++.+ +.+||+|||++.......... .......+|+.|+|||++.+ ..++.++||||||+++
T Consensus 142 li~~~-------~~~kl~Dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il 203 (287)
T 1u59_A 142 LLVNR-------HYAKISDFGLSKALGADDSYY-------TARSAGKWPLKWYAPECINF----RKFSSRSDVWSYGVTM 203 (287)
T ss_dssp EEEET-------TEEEECCCTTCEECTTCSCEE-------CCCCSSCCCGGGCCHHHHHH----CEECHHHHHHHHHHHH
T ss_pred EEcCC-------CCEEECcccceeeeccCccee-------eccccccccccccCHHHhcc----CCCCchhhHHHHHHHH
Confidence 99877 789999999997654322110 11123357899999999875 4678999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001142 1041 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1119 (1142)
Q Consensus 1041 ~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~ 1119 (1142)
|+|++ |+.||......+....+..+..+..+. ..++.+.+++.+||+.||.+
T Consensus 204 ~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~p~~ 256 (287)
T 1u59_A 204 WEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP---------------------------ECPPELYALMSDCWIYKWED 256 (287)
T ss_dssp HHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHTTCSSGGG
T ss_pred HHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCC---------------------------CcCHHHHHHHHHHcCCChhh
Confidence 99998 999998877777776666554332221 45567999999999999999
Q ss_pred CCCHHHHHHHHHhhc
Q 001142 1120 RPTAGDLYEMFVART 1134 (1142)
Q Consensus 1120 RPSa~EVL~~L~~~~ 1134 (1142)
||++.+++++++...
T Consensus 257 Rps~~~l~~~l~~~~ 271 (287)
T 1u59_A 257 RPDFLTVEQRMRACY 271 (287)
T ss_dssp SCCHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHHH
Confidence 999999999988753
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=355.82 Aligned_cols=259 Identities=22% Similarity=0.301 Sum_probs=201.8
Q ss_pred CCCCCcceeeeecccCceEEEEEEEC--Ccc----EEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceee
Q 001142 804 GSFPSLSSCDEAGKSVSSSLFRCKFG--SAD----AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 877 (1142)
Q Consensus 804 ~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~----vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g 877 (1142)
....+|++.++||+|+||+||+|++. +.. +++|+.... . .......+ .+|+.++++++||||+++++
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~--~-~~~~~~~~----~~e~~~l~~l~h~~iv~~~~ 82 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK--S-GRQSFQAV----TDHMLAIGSLDHAHIVRLLG 82 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCT--T-SCSCBCSC----CHHHHHHHTCCCTTBCCEEE
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccc--c-cHHHHHHH----HHHHHHHhcCCCCCcCeEEE
Confidence 34568999999999999999999984 333 555543211 1 11112233 68999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 001142 878 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 957 (1142)
Q Consensus 878 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp 957 (1142)
++.+. ..++||||+++++|.+++.. ....+++..+..|+.||+.||.|||++||+||||||
T Consensus 83 ~~~~~---------------~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp 143 (325)
T 3kex_A 83 LCPGS---------------SLQLVTQYLPLGSLLDHVRQ----HRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAA 143 (325)
T ss_dssp EECBS---------------SEEEEEECCTTCBSHHHHHS----SGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSS
T ss_pred EEcCC---------------ccEEEEEeCCCCCHHHHHHH----ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccch
Confidence 88532 24899999999999999874 124689999999999999999999999999999999
Q ss_pred CCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHH
Q 001142 958 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1037 (1142)
Q Consensus 958 ~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLG 1037 (1142)
+|||++.+ +.+||+|||+++........ .......||+.|+|||++.+ ..++.++||||||
T Consensus 144 ~Nil~~~~-------~~~kl~Dfg~a~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG 204 (325)
T 3kex_A 144 RNVLLKSP-------SQVQVADFGVADLLPPDDKQ--------LLYSEAKTPIKWMALESIHF----GKYTHQSDVWSYG 204 (325)
T ss_dssp TTEEESSS-------SCEEECSCSGGGGSCCCTTC--------CC-----CCTTTSCHHHHHH----CCCCHHHHHHHHH
T ss_pred heEEECCC-------CeEEECCCCcccccCccccc--------ccccCCCCcccccChHHhcc----CCCChhhHhHHhH
Confidence 99999877 78999999999865432211 11224468889999999976 5688999999999
Q ss_pred HHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 001142 1038 CLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1116 (1142)
Q Consensus 1038 viL~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~D 1116 (1142)
|++|+|++ |..||.+....+....+..+..+..+. ..+..+.+++.+||+.|
T Consensus 205 ~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~d 257 (325)
T 3kex_A 205 VTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQ---------------------------ICTIDVYMVMVKCWMID 257 (325)
T ss_dssp HHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCT---------------------------TBCTTTTHHHHHHTCSC
T ss_pred HHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCC---------------------------cCcHHHHHHHHHHcCCC
Confidence 99999999 999999877666666665544332221 22334788999999999
Q ss_pred CCCCCCHHHHHHHHHhhc
Q 001142 1117 PTERPTAGDLYEMFVART 1134 (1142)
Q Consensus 1117 P~~RPSa~EVL~~L~~~~ 1134 (1142)
|.+|||+.++++++....
T Consensus 258 p~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 258 ENIRPTFKELANEFTRMA 275 (325)
T ss_dssp TTTSCCHHHHHHHHHHHT
T ss_pred hhhCcCHHHHHHHHHHHH
Confidence 999999999999987643
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=344.91 Aligned_cols=267 Identities=21% Similarity=0.307 Sum_probs=203.0
Q ss_pred CCCCCCCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeee
Q 001142 801 LDPGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 878 (1142)
Q Consensus 801 ~~~~~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~ 878 (1142)
++.....+|++.+.||+|+||+||+|++ .+..+|+|+............. .....+.+|+.++++++||||++++++
T Consensus 13 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~ 91 (287)
T 4f0f_A 13 LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI-EKFQEFQREVFIMSNLNHPNIVKLYGL 91 (287)
T ss_dssp CCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHH-CCSHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHH-HHHHHHHHHHHHHHhCCCCCchhhhee
Confidence 3344557899999999999999999998 4667888875443322222211 111345899999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCC
Q 001142 879 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIK 956 (1142)
Q Consensus 879 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~g--IvHrDLK 956 (1142)
+.+.. ++||||+++++|.+++.. ....+++..+..++.||+.||+|||++| |+|||||
T Consensus 92 ~~~~~----------------~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dik 151 (287)
T 4f0f_A 92 MHNPP----------------RMVMEFVPCGDLYHRLLD----KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLR 151 (287)
T ss_dssp ETTTT----------------EEEEECCTTCBHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCS
T ss_pred ecCCC----------------eEEEEecCCCCHHHHHhc----ccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCC
Confidence 86432 799999999999998864 2357999999999999999999999999 9999999
Q ss_pred CCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHH
Q 001142 957 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1036 (1142)
Q Consensus 957 p~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSL 1036 (1142)
|+|||++.++ ......+||+|||+++..... .....||+.|+|||++... ...++.++|||||
T Consensus 152 p~Nil~~~~~--~~~~~~~kl~Dfg~~~~~~~~-------------~~~~~g~~~y~aPE~~~~~--~~~~~~~~Di~sl 214 (287)
T 4f0f_A 152 SPNIFLQSLD--ENAPVCAKVADFGLSQQSVHS-------------VSGLLGNFQWMAPETIGAE--EESYTEKADTYSF 214 (287)
T ss_dssp GGGEEESCCC--TTCSCCEEECCCTTCBCCSSC-------------EECCCCCCTTSCGGGSSCS--SCEECHHHHHHHH
T ss_pred cceEEEeccC--CCCceeEEeCCCCcccccccc-------------ccccCCCccccCchhhccC--CCCcCchhhHHHH
Confidence 9999997652 112245999999999643321 1234689999999998431 2457899999999
Q ss_pred HHHHHHHHhCCCCCCCCCHHH--HHHHHHh-CCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 001142 1037 GCLLLELLTLQVPYMGLSELE--IHDLIQM-GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 1113 (1142)
Q Consensus 1037 GviL~ELLtG~~Pf~~~~~~e--l~~~I~~-~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL 1113 (1142)
||++|+|++|+.||....... ....+.. ...+..+ ...++.+.+++.+||
T Consensus 215 G~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~~l 267 (287)
T 4f0f_A 215 AMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIP---------------------------EDCPPRLRNVIELCW 267 (287)
T ss_dssp HHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCC---------------------------TTSCHHHHHHHHHHT
T ss_pred HHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCC---------------------------cccCHHHHHHHHHHh
Confidence 999999999999997654332 2333322 2111111 145667999999999
Q ss_pred ccCCCCCCCHHHHHHHHHh
Q 001142 1114 EENPTERPTAGDLYEMFVA 1132 (1142)
Q Consensus 1114 ~~DP~~RPSa~EVL~~L~~ 1132 (1142)
+.||.+|||+.|+++.+..
T Consensus 268 ~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 268 SGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp CSSGGGSCCHHHHHHHHHT
T ss_pred cCChhhCcCHHHHHHHHHh
Confidence 9999999999999998753
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=347.65 Aligned_cols=263 Identities=24% Similarity=0.410 Sum_probs=195.1
Q ss_pred CCCcceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
-.+|++.++||+|+||+||+|++.+ .+|+|+.+.. .......+.+ .+|+.++++++||||++++++....
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~--~~~~~~~~~~----~~E~~~l~~l~h~~iv~~~~~~~~~--- 92 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVT--APTPQQLQAF----KNEVGVLRKTRHVNILLFMGYSTAP--- 92 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCS--SCCHHHHHHH----HHHHHHHTTCCCTTBCCEEEEECSS---
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEecc--CCCHHHHHHH----HHHHHHHHhCCCCcEEEEEeeccCC---
Confidence 4569999999999999999999865 4888886543 3334444444 8999999999999999999975432
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
..++||||+++++|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 93 ------------~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~ 156 (289)
T 3og7_A 93 ------------QLAIVTQWCEGSSLYHHLHA----SETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHED 156 (289)
T ss_dssp ------------SCEEEEECCCEEEHHHHHTT----C---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT
T ss_pred ------------ccEEEEEecCCCcHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCC
Confidence 23899999999999999854 23568999999999999999999999999999999999999887
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+.+||+|||++......... .......||+.|+|||++... ....++.++||||||+++|+|++
T Consensus 157 -------~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~Di~slG~il~el~~ 220 (289)
T 3og7_A 157 -------NTVKIGDFGLATEKSRWSGS--------HQFEQLSGSILWMAPEVIRMQ-DSNPYSFQSDVYAFGIVLYELMT 220 (289)
T ss_dssp -------TEEEECCCC--------------------------CCCTTCCHHHHC-----CCSCHHHHHHHHHHHHHHHHH
T ss_pred -------CCEEEccceecccccccccc--------ccccccCCCccccCchhhccc-CCCCCCcccchHHHHHHHHHHHH
Confidence 78999999999754331111 112234689999999998632 12567889999999999999999
Q ss_pred CCCCCCCCCHHH-HHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001142 1046 LQVPYMGLSELE-IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124 (1142)
Q Consensus 1046 G~~Pf~~~~~~e-l~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~ 1124 (1142)
|+.||.+....+ ....+..+....... .....+++.+.+++.+||+.||.+|||+.
T Consensus 221 g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 277 (289)
T 3og7_A 221 GQLPYSNINNRDQIIEMVGRGSLSPDLS-----------------------KVRSNCPKRMKRLMAECLKKKRDERPSFP 277 (289)
T ss_dssp SSCTTSSCCCHHHHHHHHHHTSCCCCTT-----------------------SSCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCccccchHHHHHHHhcccccCcchh-----------------------hccccCCHHHHHHHHHHccCChhhCCCHH
Confidence 999998754433 444444333221110 00114567799999999999999999999
Q ss_pred HHHHHHHhh
Q 001142 1125 DLYEMFVAR 1133 (1142)
Q Consensus 1125 EVL~~L~~~ 1133 (1142)
++++.+...
T Consensus 278 ell~~L~~l 286 (289)
T 3og7_A 278 RILAEIEEL 286 (289)
T ss_dssp HHHHHHHHT
T ss_pred HHHHHHHHH
Confidence 999988764
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=351.24 Aligned_cols=253 Identities=25% Similarity=0.467 Sum_probs=195.7
Q ss_pred CCCCCCcceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001142 803 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 882 (1142)
Q Consensus 803 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~ 882 (1142)
..+..+|++.+.||+|+||.||+|++.+..+|+|+.. . ....+.+ .+|+.++++++||||+++++++.+.
T Consensus 4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~--~----~~~~~~~----~~E~~~l~~l~hp~iv~~~~~~~~~ 73 (307)
T 2eva_A 4 MIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIE--S----ESERKAF----IVELRQLSRVNHPNIVKLYGACLNP 73 (307)
T ss_dssp BCCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECS--S----TTHHHHH----HHHHHHHHHCCCTTBCCEEEBCTTT
T ss_pred cCCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEec--C----hhHHHHH----HHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 3456789999999999999999999999999998743 1 1223334 7999999999999999999987532
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCCCC
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS---KHIMHRDIKSEN 959 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs---~gIvHrDLKp~N 959 (1142)
.++||||+++++|.+++... .....+++..+..++.||+.||.|||+ +||+||||||+|
T Consensus 74 ----------------~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~N 135 (307)
T 2eva_A 74 ----------------VCLVMEYAEGGSLYNVLHGA--EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPN 135 (307)
T ss_dssp ----------------TEEEEECCTTCBHHHHHHCS--SSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGG
T ss_pred ----------------cEEEEEcCCCCCHHHHHhcc--CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhH
Confidence 28999999999999999752 112247899999999999999999999 899999999999
Q ss_pred eeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001142 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039 (1142)
Q Consensus 960 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGvi 1039 (1142)
||++.++ ..+||+|||++...... .....||+.|+|||++.+ ..++.++||||||++
T Consensus 136 Ill~~~~------~~~kl~Dfg~~~~~~~~-------------~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~i 192 (307)
T 2eva_A 136 LLLVAGG------TVLKICDFGTACDIQTH-------------MTNNKGSAAWMAPEVFEG----SNYSEKCDVFSWGII 192 (307)
T ss_dssp EEEETTT------TEEEECCCCC-------------------------CCTTSSCHHHHTC----CCCCTHHHHHHHHHH
T ss_pred EEEeCCC------CEEEEcccccccccccc-------------cccCCCCCceEChhhhCC----CCCCcHHHHHHHHHH
Confidence 9998762 34899999999654321 112358999999999875 568899999999999
Q ss_pred HHHHHhCCCCCCCCC--HHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001142 1040 LLELLTLQVPYMGLS--ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1117 (1142)
Q Consensus 1040 L~ELLtG~~Pf~~~~--~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP 1117 (1142)
+|+|++|+.||.... .......+..+..+... ...++.+.+++.+||+.||
T Consensus 193 l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~~l~~dp 245 (307)
T 2eva_A 193 LWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLI---------------------------KNLPKPIESLMTRCWSKDP 245 (307)
T ss_dssp HHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCB---------------------------TTCCHHHHHHHHHHTCSSG
T ss_pred HHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcc---------------------------cccCHHHHHHHHHHhcCCh
Confidence 999999999997533 22233333333322211 1445679999999999999
Q ss_pred CCCCCHHHHHHHHHhh
Q 001142 1118 TERPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1118 ~~RPSa~EVL~~L~~~ 1133 (1142)
.+|||+.++++++...
T Consensus 246 ~~Rps~~ell~~L~~~ 261 (307)
T 2eva_A 246 SQRPSMEEIVKIMTHL 261 (307)
T ss_dssp GGSCCHHHHHHHHHHH
T ss_pred hhCcCHHHHHHHHHHH
Confidence 9999999999988764
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=356.37 Aligned_cols=268 Identities=21% Similarity=0.278 Sum_probs=200.9
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
++|++.+.||+|+||.||+|.+. +..+|+|+...................+.+|+.++++++||||+++++++....
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 36899999999999999999984 567888876433211111111111223479999999999999999999986432
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
.++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 89 --------------~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~ 149 (322)
T 2ycf_A 89 --------------YYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSS 149 (322)
T ss_dssp --------------EEEEEECCTTEETHHHHST-----TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESS
T ss_pred --------------eEEEEecCCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEec
Confidence 4999999999999998854 357999999999999999999999999999999999999986
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
++ ....+||+|||++......... ....||+.|+|||++... ....++.++|||||||++|+|+
T Consensus 150 ~~----~~~~~kl~Dfg~~~~~~~~~~~-----------~~~~gt~~y~aPE~~~~~-~~~~~~~~~Di~slG~il~~l~ 213 (322)
T 2ycf_A 150 QE----EDCLIKITDFGHSKILGETSLM-----------RTLCGTPTYLAPEVLVSV-GTAGYNRAVDCWSLGVILFICL 213 (322)
T ss_dssp SS----SSCCEEECCCTTCEECCCCHHH-----------HHHHSCCTTCCHHHHHHT-TTTTCTTHHHHHHHHHHHHHHH
T ss_pred CC----CCCeEEEccCccceeccccccc-----------ccccCCcCccCchhhccC-CCCCCCchhhHHHHHHHHHHHH
Confidence 52 1246999999999765432110 123589999999997531 1246789999999999999999
Q ss_pred hCCCCCCCCCHH-HHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1045 TLQVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1045 tG~~Pf~~~~~~-el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
+|..||...... .+...+..+.....+.. ....++.+.+++.+||+.||.+|||+
T Consensus 214 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~li~~~l~~dP~~Rps~ 269 (322)
T 2ycf_A 214 SGYPPFSEHRTQVSLKDQITSGKYNFIPEV------------------------WAEVSEKALDLVKKLLVVDPKARFTT 269 (322)
T ss_dssp HSSCSSCSTTCSSCHHHHHHHTCCCCCHHH------------------------HTTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred hCCCCCcccchHHHHHHHHHhCccccCchh------------------------hhhcCHHHHHHHHHHcccCHhhCCCH
Confidence 999999754322 23344444333222211 11456679999999999999999999
Q ss_pred HHHHHHHHhhc
Q 001142 1124 GDLYEMFVART 1134 (1142)
Q Consensus 1124 ~EVL~~L~~~~ 1134 (1142)
.++++|+|+..
T Consensus 270 ~~~l~h~~~~~ 280 (322)
T 2ycf_A 270 EEALRHPWLQD 280 (322)
T ss_dssp HHHHTSGGGCC
T ss_pred HHHhhCcCcCC
Confidence 99999999864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=364.14 Aligned_cols=260 Identities=21% Similarity=0.299 Sum_probs=197.5
Q ss_pred CCcceeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC--CCCccceeeeEecCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR--HSCIVEMYGHKISSK 883 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~-~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~--HpNIVkl~g~~~~~~ 883 (1142)
..|++.+.||+|+||.||+|.+. +..+|+|+..... ......+.+ .+|+.++++++ |||||++++++...+
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~--~~~~~~~~~----~~Ei~~l~~l~~~~~~iv~~~~~~~~~~ 129 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE--ADNQTLDSY----RNEIAYLNKLQQHSDKIIRLYDYEITDQ 129 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTT--CCHHHHHHH----HHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEeccc--ccHHHHHHH----HHHHHHHHHcccCCCeEEEEEEEEecCC
Confidence 35999999999999999999874 5678888865432 233333444 89999999996 599999999988655
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
..++|||+ .+++|.+++.. ...+++..+..|+.||+.||.|||++||+||||||+|||++
T Consensus 130 --------------~~~lv~E~-~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~ 189 (390)
T 2zmd_A 130 --------------YIYMVMEC-GNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV 189 (390)
T ss_dssp --------------EEEEEEEC-CSEEHHHHHHH-----CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES
T ss_pred --------------EEEEEEec-CCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE
Confidence 35999994 57999999986 34689999999999999999999999999999999999995
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhcccc-------CCCCCCchhhHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-------KPNLYGLEVDIWSY 1036 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-------~~~~~s~ksDVwSL 1036 (1142)
. +.+||+|||+++.+...... .......||+.|+|||++.+.. ....++.++|||||
T Consensus 190 ~--------~~~kl~DFG~a~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSl 253 (390)
T 2zmd_A 190 D--------GMLKLIDFGIANQMQPDTTS--------VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 253 (390)
T ss_dssp S--------SCEEECCCSSSCCC-----------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHH
T ss_pred C--------CeEEEEecCccccccCCCcc--------ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHH
Confidence 3 67999999999765432111 1122456999999999987521 11368899999999
Q ss_pred HHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCC-CCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcc
Q 001142 1037 GCLLLELLTLQVPYMGLSE-LEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 1114 (1142)
Q Consensus 1037 GviL~ELLtG~~Pf~~~~~-~el~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~ 1114 (1142)
||++|||++|+.||..... ......+..... ...+ ...+..+.+||.+||+
T Consensus 254 Gvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~L~ 306 (390)
T 2zmd_A 254 GCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP---------------------------DIPEKDLQDVLKCCLK 306 (390)
T ss_dssp HHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCC---------------------------CCSCHHHHHHHHHHTC
T ss_pred HHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCC---------------------------ccchHHHHHHHHHHcc
Confidence 9999999999999976432 222333222111 0000 0224568999999999
Q ss_pred cCCCCCCCHHHHHHHHHhhcC
Q 001142 1115 ENPTERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1115 ~DP~~RPSa~EVL~~L~~~~s 1135 (1142)
.||.+|||+.|+++|+|+...
T Consensus 307 ~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 307 RDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp SSTTTSCCHHHHHTSHHHHSC
T ss_pred cChhhCCCHHHHhhCcCcccc
Confidence 999999999999999999754
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=351.02 Aligned_cols=263 Identities=28% Similarity=0.441 Sum_probs=205.8
Q ss_pred CCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
.+.|++.+.||+|+||.||+|++. +..+|+|+..... ....+.+ .+|+.++++++||||+++++++...+
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~----~~e~~~l~~l~h~~i~~~~~~~~~~~ 89 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS----EEELEDY----IVEIEILATCDHPYIVKLLGAYYHDG 89 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC--------CCHHHH----HHHHHHHHHCCCTTBCCEEEEEECC-
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC----HHHHHHH----HHHHHHHhcCCCCCEeeeeeeeeeCC
Confidence 457999999999999999999985 5677888754221 1222333 78999999999999999999998654
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
..++||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+||+++
T Consensus 90 --------------~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~ 151 (302)
T 2j7t_A 90 --------------KLWIMIEFCPGGAVDAIMLEL----DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMT 151 (302)
T ss_dssp --------------CEEEEEECCTTEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC
T ss_pred --------------eEEEEEEeCCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEC
Confidence 349999999999999998752 24689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhcccc-CCCCCCchhhHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~s~ksDVwSLGviL~E 1042 (1142)
.+ +.+||+|||++........ ......||+.|+|||++.... ....++.++||||||+++|+
T Consensus 152 ~~-------~~~kl~Dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~ 214 (302)
T 2j7t_A 152 LE-------GDIRLADFGVSAKNLKTLQ----------KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIE 214 (302)
T ss_dssp TT-------SCEEECCCHHHHHHHHHHH----------C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHH
T ss_pred CC-------CCEEEEECCCCcccccccc----------ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHH
Confidence 77 7899999998754322110 112346899999999985211 13567899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1043 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1043 LLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
|++|..||...+.......+.....+.... ....+..+.+++.+||+.||.+|||
T Consensus 215 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~l~~li~~~l~~dp~~Rps 269 (302)
T 2j7t_A 215 MAQIEPPHHELNPMRVLLKIAKSDPPTLLT-------------------------PSKWSVEFRDFLKIALDKNPETRPS 269 (302)
T ss_dssp HHHSSCTTTTSCHHHHHHHHHHSCCCCCSS-------------------------GGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred HhcCCCCCccCCHHHHHHHHhccCCcccCC-------------------------ccccCHHHHHHHHHHcccChhhCCC
Confidence 999999999877766665554443322110 1144567999999999999999999
Q ss_pred HHHHHHHHHhhcCC
Q 001142 1123 AGDLYEMFVARTSS 1136 (1142)
Q Consensus 1123 a~EVL~~L~~~~ss 1136 (1142)
+.++++|+|+....
T Consensus 270 ~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 270 AAQLLEHPFVSSIT 283 (302)
T ss_dssp HHHHTTSTTTTTCC
T ss_pred HHHHhcChHHhhhc
Confidence 99999999998543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=351.43 Aligned_cols=260 Identities=22% Similarity=0.351 Sum_probs=201.5
Q ss_pred CCCCCcceeeeecccCceEEEEEEECCc------cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceee
Q 001142 804 GSFPSLSSCDEAGKSVSSSLFRCKFGSA------DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 877 (1142)
Q Consensus 804 ~~~~~y~l~~~LG~GsfG~Vy~a~~~~~------~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g 877 (1142)
....+|++.+.||+|+||.||+|.+... .+|+|+.... ........+ .+|+.++++++||||+++++
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~----~~E~~~l~~l~h~~iv~~~~ 113 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG---YTEKQRVDF----LGEAGIMGQFSHHNIIRLEG 113 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT---CCHHHHHHH----HHHHHHHHTCCCTTBCCEEE
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCC---CCHHHHHHH----HHHHHHHHhCCCCCCCcEEE
Confidence 3456799999999999999999987432 3777775422 122333334 79999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 001142 878 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 957 (1142)
Q Consensus 878 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp 957 (1142)
++.+.+ ..++||||+++++|.+++.. ....+++..+..++.||+.||.|||++||+||||||
T Consensus 114 ~~~~~~--------------~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp 175 (333)
T 1mqb_A 114 VISKYK--------------PMMIITEYMENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAA 175 (333)
T ss_dssp EECSSS--------------SEEEEEECCTTEEHHHHHHH----TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred EEecCC--------------CcEEEEeCCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCh
Confidence 987654 34999999999999999975 234689999999999999999999999999999999
Q ss_pred CCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHH
Q 001142 958 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1037 (1142)
Q Consensus 958 ~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLG 1037 (1142)
+|||++.+ +.+||+|||++.......... .......+|+.|+|||++.+ ..++.++||||||
T Consensus 176 ~NIl~~~~-------~~~kl~Dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG 237 (333)
T 1mqb_A 176 RNILVNSN-------LVCKVSDFGLSRVLEDDPEAT-------YTTSGGKIPIRWTAPEAISY----RKFTSASDVWSFG 237 (333)
T ss_dssp GGEEECTT-------CCEEECCCCC------------------------CCCGGGSCHHHHHS----CCCCHHHHHHHHH
T ss_pred heEEECCC-------CcEEECCCCcchhhccccccc-------cccCCCCccccccCchhccc----CCCCchhhhHHHH
Confidence 99999877 789999999997654321110 01112346888999999875 5688999999999
Q ss_pred HHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 001142 1038 CLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1116 (1142)
Q Consensus 1038 viL~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~D 1116 (1142)
+++|||++ |..||.+....++...+..+..+..+ ...++.+.+++.+||+.|
T Consensus 238 ~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~~l~~~ 290 (333)
T 1mqb_A 238 IVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP---------------------------MDCPSAIYQLMMQCWQQE 290 (333)
T ss_dssp HHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC---------------------------TTCBHHHHHHHHHHTCSS
T ss_pred HHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCc---------------------------ccCCHHHHHHHHHHcCCC
Confidence 99999999 99999888777777766554332211 134567999999999999
Q ss_pred CCCCCCHHHHHHHHHhh
Q 001142 1117 PTERPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1117 P~~RPSa~EVL~~L~~~ 1133 (1142)
|.+||++.++++++...
T Consensus 291 p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 291 RARRPKFADIVSILDKL 307 (333)
T ss_dssp TTTSCCHHHHHHHHHHH
T ss_pred hhhCcCHHHHHHHHHHH
Confidence 99999999999988754
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=351.67 Aligned_cols=263 Identities=21% Similarity=0.218 Sum_probs=199.8
Q ss_pred CCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSK 883 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~~~~~ 883 (1142)
.+|++.+.||+|+||.||+|++ .+..||+|+...+.. .+.+ .+|+.+++++ +||||+++++++...+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~----~~E~~~l~~l~~h~~i~~~~~~~~~~~ 78 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR------APQL----HLEYRFYKQLGSGDGIPQVYYFGPCGK 78 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS------SCCH----HHHHHHHHHHCSCTTSCCEEEEEEETT
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc------hHHH----HHHHHHHHHhhCCCCCCEEEEEEecCC
Confidence 5799999999999999999996 577788888653321 1223 7899999999 8999999999988654
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
..++||||+ +++|.+++... ...+++..+..|+.||+.||+|||++||+||||||+|||++
T Consensus 79 --------------~~~lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~ 139 (330)
T 2izr_A 79 --------------YNAMVLELL-GPSLEDLFDLC----DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIG 139 (330)
T ss_dssp --------------EEEEEEECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred --------------ccEEEEEeC-CCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec
Confidence 349999999 89999999862 34799999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.++. .....+||+|||+++.......... ..........||+.|+|||++.+ ..++.++|||||||++|||
T Consensus 140 ~~~~--~~~~~~kl~DFg~a~~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il~el 210 (330)
T 2izr_A 140 RPGN--KTQQVIHIIDFALAKEYIDPETKKH---IPYREHKSLTGTARYMSINTHLG----KEQSRRDDLEALGHMFMYF 210 (330)
T ss_dssp CGGG--TCTTSEEECCCTTCEESBCTTTCCB---CCCCCCCCCCSCTTTCCHHHHTT----CCCCHHHHHHHHHHHHHHH
T ss_pred cCCC--CCCceEEEEEcccceeeecCCCCcc---ccccccCCcCCCccccChHHHcC----CCCCchhHHHHHHHHHHHH
Confidence 7721 1112399999999986543221110 01112235679999999999876 5688999999999999999
Q ss_pred HhCCCCCCCCC---HHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1044 LTLQVPYMGLS---ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1044 LtG~~Pf~~~~---~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
++|+.||.+.. ..+....+.....+..... .....+ .+.+++..||+.||.+|
T Consensus 211 l~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~-----------------------~~~~~p-~~~~li~~~l~~~p~~R 266 (330)
T 2izr_A 211 LRGSLPWQGLKADTLKERYQKIGDTKRATPIEV-----------------------LCENFP-EMATYLRYVRRLDFFEK 266 (330)
T ss_dssp HHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHH-----------------------HTTTCH-HHHHHHHHHHHCCTTCC
T ss_pred hcCCCCccccccccHHHHHHHHHhhhccCCHHH-----------------------HhccCh-HHHHHHHHHHhCCCCCC
Confidence 99999998743 2333333322111100000 000234 79999999999999999
Q ss_pred CCHHHHHHHHH
Q 001142 1121 PTAGDLYEMFV 1131 (1142)
Q Consensus 1121 PSa~EVL~~L~ 1131 (1142)
|++++|++.+.
T Consensus 267 P~~~~l~~~l~ 277 (330)
T 2izr_A 267 PDYDYLRKLFT 277 (330)
T ss_dssp CCHHHHHHHHH
T ss_pred CCHHHHHHHHH
Confidence 99999988765
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=354.72 Aligned_cols=293 Identities=19% Similarity=0.186 Sum_probs=200.1
Q ss_pred CCCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001142 804 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 881 (1142)
Q Consensus 804 ~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~ 881 (1142)
..+++|++.+.||+|+||.||+|++. +..+|+|+....... ... ..+|+..+..++||||+++++++..
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~----~~~~~~~l~~l~h~niv~~~~~~~~ 90 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF-----RNR----ELQIMQDLAVLHHPNIVQLQSYFYT 90 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC-----CCH----HHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc-----cHH----HHHHHHHHHhcCCCCcccHHHhhhc
Confidence 34678999999999999999999984 667888875422111 111 2578888889999999999999876
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH--hCCccccCCCCCC
Q 001142 882 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELH--SKHIMHRDIKSEN 959 (1142)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLH--s~gIvHrDLKp~N 959 (1142)
.... .......++||||++ ++|...+..... ....+++..+..++.||+.||.||| ++||+||||||+|
T Consensus 91 ~~~~-------~~~~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~N 161 (360)
T 3e3p_A 91 LGER-------DRRDIYLNVVMEYVP-DTLHRCCRNYYR-RQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHN 161 (360)
T ss_dssp ECSS-------CTTCEEEEEEEECCS-CBHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGG
T ss_pred cccc-------cccceeEEEEeeccc-ccHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHH
Confidence 4321 112335789999998 577666654332 3457899999999999999999999 9999999999999
Q ss_pred eeecc-ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001142 960 ILIDL-ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1038 (1142)
Q Consensus 960 ILld~-~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGv 1038 (1142)
||++. + +.+||+|||++....... ......||+.|+|||++.+ ...++.++|||||||
T Consensus 162 Ill~~~~-------~~~kl~Dfg~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~~---~~~~~~~~Di~slG~ 220 (360)
T 3e3p_A 162 VLVNEAD-------GTLKLCDFGSAKKLSPSE-----------PNVAYICSRYYRAPELIFG---NQHYTTAVDIWSVGC 220 (360)
T ss_dssp EEEETTT-------TEEEECCCTTCBCCCTTS-----------CCCSTTSCGGGCCHHHHTT---CSSCCTHHHHHHHHH
T ss_pred EEEeCCC-------CcEEEeeCCCceecCCCC-----------CcccccCCcceeCHHHHcC---CCCCCcHHHHHHHHH
Confidence 99986 4 789999999997654321 1123468999999999865 245789999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccc-cccccccc-CCCCC--CchhhhhhHHHHHHHHHHhcc
Q 001142 1039 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC-HEHEVAQS-GSGFE--KPEAELETLSFLVDVFRRCTE 1114 (1142)
Q Consensus 1039 iL~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~-~~~~~~~~-~~~~~--~~~~~~~~~~~L~dLI~~CL~ 1114 (1142)
++|+|++|+.||.+.+.......+...........+...... ........ ...+. .+......++.+.+|+.+||+
T Consensus 221 il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 300 (360)
T 3e3p_A 221 IFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQ 300 (360)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTC
T ss_pred HHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhc
Confidence 999999999999988777666555332221111111111000 00000000 00000 000011357789999999999
Q ss_pred cCCCCCCCHHHHHHHHHhhcC
Q 001142 1115 ENPTERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1115 ~DP~~RPSa~EVL~~L~~~~s 1135 (1142)
.||.+|||+.|+++|+|+...
T Consensus 301 ~dP~~Rpt~~e~l~hp~f~~~ 321 (360)
T 3e3p_A 301 YLPEERMKPYEALCHPYFDEL 321 (360)
T ss_dssp SSGGGSCCHHHHTTSGGGGGG
T ss_pred cCccccCCHHHHhcCcccccc
Confidence 999999999999999999865
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=347.26 Aligned_cols=267 Identities=22% Similarity=0.308 Sum_probs=198.4
Q ss_pred CCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 882 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~ 882 (1142)
..++|++.++||+|+||+||+|.+. +..+|+|+.. . ......+.+ .+|+.++++++||||+++++++.+.
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~--~--~~~~~~~~~----~~E~~~l~~l~hp~iv~~~~~~~~~ 79 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELI--R--FDEETQRTF----LKEVKVMRCLEHPNVLKFIGVLYKD 79 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEES--C--CCHHHHHHH----HHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEec--c--CCHHHHHHH----HHHHHHHHhCCCcCcccEEEEEecC
Confidence 3467999999999999999999985 5667777642 1 233444444 8999999999999999999999865
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
. ..++||||+++++|.++++. ....+++..+..|+.||+.||+|||++||+||||||+|||+
T Consensus 80 ~--------------~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~ 141 (310)
T 3s95_A 80 K--------------RLNFITEYIKGGTLRGIIKS----MDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV 141 (310)
T ss_dssp T--------------EEEEEEECCTTCBHHHHHHH----CCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE
T ss_pred C--------------eeEEEEEecCCCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEE
Confidence 4 35999999999999999976 23569999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCccccccccccccc----ccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI----AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1038 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~----~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGv 1038 (1142)
+.+ +.+||+|||++............ ............||+.|+|||++.+ ..++.++||||||+
T Consensus 142 ~~~-------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~ 210 (310)
T 3s95_A 142 REN-------KNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING----RSYDEKVDVFSFGI 210 (310)
T ss_dssp CTT-------SCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTT----CCCCTHHHHHHHHH
T ss_pred CCC-------CCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcC----CCCCcHHHHHHHHH
Confidence 887 78999999999865432211000 0000011124579999999999976 57889999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001142 1039 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1118 (1142)
Q Consensus 1039 iL~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~ 1118 (1142)
++|+|++|..||......... ............ ....+++.+.+++.+||+.||+
T Consensus 211 ~l~el~~g~~~~~~~~~~~~~------~~~~~~~~~~~~-------------------~~~~~~~~l~~li~~~l~~dP~ 265 (310)
T 3s95_A 211 VLCEIIGRVNADPDYLPRTMD------FGLNVRGFLDRY-------------------CPPNCPPSFFPITVRCCDLDPE 265 (310)
T ss_dssp HHHHHHHTCCSSTTTSCBCTT------SSBCHHHHHHHT-------------------CCTTCCTTHHHHHHHHTCSSGG
T ss_pred HHHHHhcCCCCCcchhhhHHH------Hhhhhhcccccc-------------------CCCCCCHHHHHHHHHHccCChh
Confidence 999999999998643211000 000000000000 0013445689999999999999
Q ss_pred CCCCHHHHHHHHHhh
Q 001142 1119 ERPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1119 ~RPSa~EVL~~L~~~ 1133 (1142)
+|||+.++++.+...
T Consensus 266 ~Rps~~~l~~~L~~l 280 (310)
T 3s95_A 266 KRPSFVKLEHWLETL 280 (310)
T ss_dssp GSCCHHHHHHHHHHH
T ss_pred hCcCHHHHHHHHHHH
Confidence 999999999887653
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=354.11 Aligned_cols=297 Identities=20% Similarity=0.217 Sum_probs=207.8
Q ss_pred CCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
.++|++.+.||+|+||.||+|++. +..+|+|+.. . ......... +.+|+.++++++||||+++++++....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~--~-~~~~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~~~~~ 82 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE--P-FDKPLFALR----TLREIKILKHFKHENIITIFNIQRPDS 82 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC--C-CSSHHHHHH----HHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeec--c-cccchHHHH----HHHHHHHHHhCcCCCcCCeeeeecccc
Confidence 467999999999999999999985 6667887753 2 122222333 379999999999999999999876532
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
.. .....++||||+. ++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 83 ~~---------~~~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~ 146 (353)
T 2b9h_A 83 FE---------NFNEVYIIQELMQ-TDLHRVIST------QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLIN 146 (353)
T ss_dssp ST---------TCCCEEEEECCCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred cC---------ccceEEEEEeccC-ccHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEc
Confidence 11 1235699999997 799999875 3689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.+||+|||++........................||+.|+|||++.. ...++.++|||||||++|+|
T Consensus 147 ~~-------~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~Di~slG~il~~l 216 (353)
T 2b9h_A 147 SN-------CDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT---SAKYSRAMDVWSCGCILAEL 216 (353)
T ss_dssp TT-------CCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHS---CCCCCHHHHHHHHHHHHHHH
T ss_pred CC-------CcEEEEecccccccccccccccCccccccchhhccccccccCCeeecc---CCCccchhhHHHHHHHHHHH
Confidence 87 789999999998754322111000000111223468999999998764 24688999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHh-CCCCCchhHHhhhcccccccccccCCCCC---CchhhhhhHHHHHHHHHHhcccCCCC
Q 001142 1044 LTLQVPYMGLSELEIHDLIQM-GKRPRLTDELEALGSCHEHEVAQSGSGFE---KPEAELETLSFLVDVFRRCTEENPTE 1119 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~-~~~p~l~~~l~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~L~dLI~~CL~~DP~~ 1119 (1142)
++|+.||.+.+..+....+.. ...+......................... ........++.+.+|+.+||+.||.+
T Consensus 217 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 296 (353)
T 2b9h_A 217 FLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAK 296 (353)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGG
T ss_pred HhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCccc
Confidence 999999998776655444321 11111110000000000000000000000 00111255678999999999999999
Q ss_pred CCCHHHHHHHHHhhcC
Q 001142 1120 RPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1120 RPSa~EVL~~L~~~~s 1135 (1142)
|||+.|+++|+|++..
T Consensus 297 Rpt~~ell~hp~~~~~ 312 (353)
T 2b9h_A 297 RITAKEALEHPYLQTY 312 (353)
T ss_dssp SCCHHHHHTSGGGTTT
T ss_pred CCCHHHHhcCcccccc
Confidence 9999999999999864
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=350.29 Aligned_cols=277 Identities=20% Similarity=0.234 Sum_probs=202.1
Q ss_pred CCCCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEe
Q 001142 804 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKI 880 (1142)
Q Consensus 804 ~~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~g~~~ 880 (1142)
...++|++.+.||+|+||+||+|++ .+..+|+|+.... . .+.+ .+|+.++++++ ||||+++++++.
T Consensus 33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~---~~~~----~~E~~~l~~l~~~~~i~~~~~~~~ 101 (330)
T 3nsz_A 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----K---KKKI----KREIKILENLRGGPNIITLADIVK 101 (330)
T ss_dssp EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----C---HHHH----HHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc----c---hHHH----HHHHHHHHHcCCCCCEEEeeeeec
Confidence 3456799999999999999999987 5677888875311 1 1233 78999999997 999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NI 960 (1142)
+... ...++||||+++++|.++++ .+++..+..++.||+.||+|||++||+||||||+||
T Consensus 102 ~~~~------------~~~~lv~e~~~~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Ni 161 (330)
T 3nsz_A 102 DPVS------------RTPALVFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNV 161 (330)
T ss_dssp CTTT------------CCEEEEEECCCCCCHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred cCCC------------CceEEEEeccCchhHHHHHH--------hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHE
Confidence 6321 24599999999999998874 388999999999999999999999999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
|++.++ ..+||+|||+++...... ......||+.|+|||++.+ ...++.++|||||||++
T Consensus 162 l~~~~~------~~~kl~Dfg~a~~~~~~~-----------~~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~il 221 (330)
T 3nsz_A 162 MIDHEH------RKLRLIDWGLAEFYHPGQ-----------EYNVRVASRYFKGPELLVD---YQMYDYSLDMWSLGCML 221 (330)
T ss_dssp EEETTT------TEEEECCCTTCEECCTTC-----------CCCSCCSCGGGCCHHHHTT---CCCCCTHHHHHHHHHHH
T ss_pred EEcCCC------CEEEEEeCCCceEcCCCC-----------ccccccccccccChhhhcC---CCcCCchhhHHHHHHHH
Confidence 998662 389999999997654321 1123468999999999865 24688999999999999
Q ss_pred HHHHhCCCCCCCC-CHHHHHHHH-------------HhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHH
Q 001142 1041 LELLTLQVPYMGL-SELEIHDLI-------------QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLV 1106 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~~-~~~el~~~I-------------~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~ 1106 (1142)
|+|++|+.||... ...+....+ ........+.............+. ...........++.+.
T Consensus 222 ~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~ 297 (330)
T 3nsz_A 222 ASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWE----RFVHSENQHLVSPEAL 297 (330)
T ss_dssp HHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGG----GGCCTTTGGGCCHHHH
T ss_pred HHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchh----hhccccccccCCHHHH
Confidence 9999999999543 222222221 111110000000000000000000 0001111224678899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001142 1107 DVFRRCTEENPTERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1107 dLI~~CL~~DP~~RPSa~EVL~~L~~~~s 1135 (1142)
+||.+||+.||.+|||++|+++|+|+...
T Consensus 298 ~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 298 DFLDKLLRYDHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred HHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence 99999999999999999999999999854
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=346.39 Aligned_cols=254 Identities=23% Similarity=0.397 Sum_probs=205.6
Q ss_pred CCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
..+|++.+.||+|+||.||+|.+. +..+|+|+.... ....+.+ .+|+.++++++||||+++++++.+..
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~----~~E~~~l~~l~h~~i~~~~~~~~~~~ 82 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEF----LKEAAVMKEIKHPNLVQLLGVCTREP 82 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-----STHHHHH----HHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-----HHHHHHH----HHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 457999999999999999999986 556777765321 1223344 78999999999999999999987654
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
. .++||||+++++|.+++.. .....+++..+..++.||+.||.|||++||+||||||+||+++
T Consensus 83 ~--------------~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~ 145 (288)
T 3kfa_A 83 P--------------FYIITEFMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG 145 (288)
T ss_dssp S--------------EEEEEECCTTEEHHHHHHH---CCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEEC
T ss_pred C--------------EEEEEEcCCCCcHHHHHHh---cccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEc
Confidence 3 4999999999999999976 3345699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.+||+|||.+......... ......+|+.|+|||++.+ ..++.++||||||+++|+|
T Consensus 146 ~~-------~~~~l~Dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~l 205 (288)
T 3kfa_A 146 EN-------HLVKVADFGLSRLMTGDTYT---------AHAGAKFPIKWTAPESLAY----NKFSIKSDVWAFGVLLWEI 205 (288)
T ss_dssp GG-------GCEEECCCCGGGTSCSSSSE---------EETTEEECGGGCCHHHHHH----CCCCHHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEccCccceeccCCccc---------cccCCccccCcCChhhhcc----CCCCchhhHHHHHHHHHHH
Confidence 87 78999999999765432211 1123357888999999976 5688999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1044 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1044 Lt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
++ |..||.+....+....+.....+..+ ...++.+.+++.+||+.||.+|||
T Consensus 206 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~~l~~dp~~Rps 258 (288)
T 3kfa_A 206 ATYGMSPYPGIDLSQVYELLEKDYRMERP---------------------------EGCPEKVYELMRACWQWNPSDRPS 258 (288)
T ss_dssp HTTSCCSSTTCCGGGHHHHHHTTCCCCCC---------------------------TTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HhCCCCCCCCCCHHHHHHHHhccCCCCCC---------------------------CCCCHHHHHHHHHHhCCChhhCcC
Confidence 99 99999887766666665544322211 144567999999999999999999
Q ss_pred HHHHHHHHHh
Q 001142 1123 AGDLYEMFVA 1132 (1142)
Q Consensus 1123 a~EVL~~L~~ 1132 (1142)
+.++++.+..
T Consensus 259 ~~~~~~~l~~ 268 (288)
T 3kfa_A 259 FAEIHQAFET 268 (288)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999988754
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=353.51 Aligned_cols=261 Identities=19% Similarity=0.325 Sum_probs=199.5
Q ss_pred CCCCCcceeeeecccCceEEEEEEEC--CccEEEEE--EecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeE
Q 001142 804 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKV--RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 879 (1142)
Q Consensus 804 ~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi--~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~ 879 (1142)
....+|++.++||+|+||.||+|.+. +..+++|+ +.+.... .....+. +.+|+.++++++||||+++++++
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~----~~~E~~~l~~l~hp~iv~~~~~~ 86 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKE----ILDEAYVMASVDNPHVCRLLGIC 86 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHH----HHHHHHHHTTCCBTTBCCCCEEE
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHH----HHHHHHHHHhCCCCCeeEEEEEE
Confidence 34567999999999999999999983 44443332 2222111 1122233 37899999999999999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 001142 880 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959 (1142)
Q Consensus 880 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~N 959 (1142)
.... .++||||+++++|.+++... ...+++..+..|+.||+.||.|||++||+||||||+|
T Consensus 87 ~~~~---------------~~~v~~~~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~N 147 (327)
T 3lzb_A 87 LTST---------------VQLITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARN 147 (327)
T ss_dssp ESSS---------------EEEEECCCSSCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred ecCC---------------ceEEEEecCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHH
Confidence 7543 38999999999999999762 3468999999999999999999999999999999999
Q ss_pred eeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001142 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039 (1142)
Q Consensus 960 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGvi 1039 (1142)
||++.+ +.+||+|||+++......... ......+|+.|+|||++.+ ..++.++|||||||+
T Consensus 148 Il~~~~-------~~~kL~DfG~a~~~~~~~~~~--------~~~~~~~t~~y~aPE~~~~----~~~~~~~Di~slG~i 208 (327)
T 3lzb_A 148 VLVKTP-------QHVKITDFGLAKLLGAEEKEY--------HAEGGKVPIKWMALESILH----RIYTHQSDVWSYGVT 208 (327)
T ss_dssp EEEEET-------TEEEECCTTC------------------------CCCGGGSCHHHHHH----CCCCHHHHHHHHHHH
T ss_pred EEEcCC-------CCEEEccCcceeEccCccccc--------cccCCCccccccCHHHHcC----CCCChHHHHHHHHHH
Confidence 999887 789999999997654322111 1123347889999999986 568899999999999
Q ss_pred HHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001142 1040 LLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1118 (1142)
Q Consensus 1040 L~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~ 1118 (1142)
+|+|++ |..||.+....++...+..+..+..+. ..+..+.+++.+||+.||.
T Consensus 209 l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~dp~ 261 (327)
T 3lzb_A 209 VWELMTFGSKPYDGIPASEISSILEKGERLPQPP---------------------------ICTIDVYMIMRKCWMIDAD 261 (327)
T ss_dssp HHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCT---------------------------TBCHHHHHHHHHHTCSSGG
T ss_pred HHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------cCCHHHHHHHHHHcCCChh
Confidence 999999 999999877776666665544322211 3456799999999999999
Q ss_pred CCCCHHHHHHHHHhhc
Q 001142 1119 ERPTAGDLYEMFVART 1134 (1142)
Q Consensus 1119 ~RPSa~EVL~~L~~~~ 1134 (1142)
+|||+.|+++.+....
T Consensus 262 ~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 262 SRPKFRELIIEFSKMA 277 (327)
T ss_dssp GSCCHHHHHHHHHHHH
T ss_pred HCcCHHHHHHHHHHHH
Confidence 9999999999887653
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=377.51 Aligned_cols=263 Identities=21% Similarity=0.285 Sum_probs=208.8
Q ss_pred CCCCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001142 803 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 880 (1142)
Q Consensus 803 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~ 880 (1142)
+...++|++.++||+|+||.||+|++. +..+|+|+...... ........+.+|+.++++++||||+++++++.
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~-----~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~ 255 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRL-----KKRKGYQGAMVEKKILAKVHSRFIVSLAYAFE 255 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHh-----hhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 345678999999999999999999984 67788888643211 11111233478999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NI 960 (1142)
+.. ..|+||||++||+|.+++.... .....+++..++.++.||+.||.|||++||+||||||+||
T Consensus 256 ~~~--------------~l~lVmE~~~gg~L~~~l~~~~-~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NI 320 (543)
T 3c4z_A 256 TKT--------------DLCLVMTIMNGGDIRYHIYNVD-EDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENV 320 (543)
T ss_dssp CSS--------------EEEEEECCCTTCBHHHHHHTSS-TTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred eCC--------------EEEEEEEeccCCCHHHHHHHhh-cccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHE
Confidence 655 3599999999999999987522 1234699999999999999999999999999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
|++.+ +.+||+|||+++....... ......||+.|+|||++.+ ..|+.++|||||||++
T Consensus 321 Ll~~~-------g~vkL~DFGla~~~~~~~~----------~~~~~~GT~~Y~APE~l~~----~~~~~~~DiwSlGvil 379 (543)
T 3c4z_A 321 LLDDD-------GNVRISDLGLAVELKAGQT----------KTKGYAGTPGFMAPELLLG----EEYDFSVDYFALGVTL 379 (543)
T ss_dssp EECTT-------SCEEECCCTTCEECCTTCC----------CBCCCCSCTTTSCHHHHTT----CCBCTHHHHHHHHHHH
T ss_pred EEeCC-------CCEEEeecceeeeccCCCc----------ccccccCCccccChhhhcC----CCCChHHhcCcchHHH
Confidence 99887 7899999999976543211 1123479999999999976 5688999999999999
Q ss_pred HHHHhCCCCCCCCC----HHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 001142 1041 LELLTLQVPYMGLS----ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1116 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~~~----~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~D 1116 (1142)
|||++|+.||.+.. ..++...+...... .+ ...++.+.+||.+||+.|
T Consensus 380 yelltG~~PF~~~~~~~~~~~~~~~i~~~~~~-~p---------------------------~~~s~~~~~li~~lL~~d 431 (543)
T 3c4z_A 380 YEMIAARGPFRARGEKVENKELKQRVLEQAVT-YP---------------------------DKFSPASKDFCEALLQKD 431 (543)
T ss_dssp HHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCC-CC---------------------------TTSCHHHHHHHHHHSCSS
T ss_pred HHHHhCCCCCCCCccchhHHHHHHHHhhcccC-CC---------------------------cccCHHHHHHHHHhccCC
Confidence 99999999997642 34444444332211 00 145567999999999999
Q ss_pred CCCCCC-----HHHHHHHHHhhc
Q 001142 1117 PTERPT-----AGDLYEMFVART 1134 (1142)
Q Consensus 1117 P~~RPS-----a~EVL~~L~~~~ 1134 (1142)
|.+||+ +++|++|+|++.
T Consensus 432 P~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 432 PEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp GGGSCCCBTTBSHHHHTSGGGTT
T ss_pred HhHCCCCcccCHHHHHcCccccC
Confidence 999996 589999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=356.28 Aligned_cols=264 Identities=25% Similarity=0.345 Sum_probs=202.5
Q ss_pred CCCCcceeeeecccCceEEEEEEE-------CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCcccee
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKF-------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMY 876 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~-------~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~ 876 (1142)
...+|++.+.||+|+||.||+|++ .+..+|+|+..... .....+ .+.+|+.+++++ +||||++++
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~----~~~~E~~~l~~l~~hp~iv~~~ 115 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSERE----ALMSELKMMTQLGSHENIVNLL 115 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CH----HHHHHHHHHHHHCCCTTBCCEE
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc---CHHHHH----HHHHHHHHHHhhcCCCCeeeEE
Confidence 346799999999999999999997 23457888754221 112222 347999999999 899999999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc------------------CCCCCCHHHHHHHHHHH
Q 001142 877 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET------------------GEKHVSVKLALFIAQDV 938 (1142)
Q Consensus 877 g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~------------------~~~~ls~~~i~~Ia~qI 938 (1142)
+++...+.. ++||||+++++|.+++...... ....+++..+..++.||
T Consensus 116 ~~~~~~~~~--------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 181 (344)
T 1rjb_A 116 GACTLSGPI--------------YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQV 181 (344)
T ss_dssp EEECSSSSC--------------EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHH
T ss_pred EEEeeCCcc--------------EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHH
Confidence 999875543 9999999999999999752110 01347999999999999
Q ss_pred HHHHHHHHhCCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhh
Q 001142 939 AAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1018 (1142)
Q Consensus 939 a~gL~yLHs~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l 1018 (1142)
+.||.|||++||+||||||+|||++.+ +.+||+|||++......... .......||+.|+|||++
T Consensus 182 ~~aL~~LH~~~ivH~Dikp~NIll~~~-------~~~kL~Dfg~~~~~~~~~~~--------~~~~~~~~t~~y~aPE~~ 246 (344)
T 1rjb_A 182 AKGMEFLEFKSCVHRDLAARNVLVTHG-------KVVKICDFGLARDIMSDSNY--------VVRGNARLPVKWMAPESL 246 (344)
T ss_dssp HHHHHHHHHTTEEETTCSGGGEEEETT-------TEEEECCCGGGSCGGGCTTS--------EEETTEEECGGGCCHHHH
T ss_pred HHHHHHHHhCCcccCCCChhhEEEcCC-------CcEEeCCCccCcccccCccc--------eeccCccCccCccCHHHh
Confidence 999999999999999999999999887 78999999999765432211 011234578899999998
Q ss_pred ccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH-HHHHHhCCCCCchhHHhhhcccccccccccCCCCCCch
Q 001142 1019 RAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEI-HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE 1096 (1142)
Q Consensus 1019 ~~~~~~~~~s~ksDVwSLGviL~ELLt-G~~Pf~~~~~~el-~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~ 1096 (1142)
.+ ..++.++||||||+++|+|++ |..||.+...... ...+..+..+..+
T Consensus 247 ~~----~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~------------------------- 297 (344)
T 1rjb_A 247 FE----GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQP------------------------- 297 (344)
T ss_dssp HH----CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCC-------------------------
T ss_pred cc----CCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCCC-------------------------
Confidence 76 568899999999999999998 9999987654333 3333333222111
Q ss_pred hhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001142 1097 AELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1097 ~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~~s 1135 (1142)
...++.+.+|+.+||+.||.+|||+.++++++.....
T Consensus 298 --~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 298 --FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp --TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred --CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 1345679999999999999999999999999987654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=374.25 Aligned_cols=256 Identities=23% Similarity=0.392 Sum_probs=207.3
Q ss_pred CCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
..+|++.++||+|+||.||+|.+. +..||+|+. +.... ..+.+ .+|+.+|++++|||||++++++....
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~--~~~~~---~~~~~----~~E~~~l~~l~hpniv~l~~~~~~~~ 289 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTM---EVEEF----LKEAAVMKEIKHPNLVQLLGVCTREP 289 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEEC--CSSSS---CHHHH----HHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEe--cCccc---chHHH----HHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 456899999999999999999996 456677664 33221 22344 79999999999999999999998655
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
.+ ++||||+++|+|.++++. .....+++..+..|+.||+.||+|||++||+||||||+|||++
T Consensus 290 ~~--------------~lv~E~~~~g~L~~~l~~---~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~ 352 (495)
T 1opk_A 290 PF--------------YIITEFMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVG 352 (495)
T ss_dssp SC--------------EEEEECCTTCBHHHHHHH---SCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred cE--------------EEEEEccCCCCHHHHHHh---cCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEC
Confidence 43 999999999999999986 2335689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.+||+|||+++........ ......+++.|+|||++.. ..++.++|||||||++|||
T Consensus 353 ~~-------~~~kl~DFG~a~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~sDvwSlG~~l~el 412 (495)
T 1opk_A 353 EN-------HLVKVADFGLSRLMTGDTYT---------AHAGAKFPIKWTAPESLAY----NKFSIKSDVWAFGVLLWEI 412 (495)
T ss_dssp GG-------GCEEECCTTCEECCTTCCEE---------CCTTCCCCGGGCCHHHHHH----CEECHHHHHHHHHHHHHHH
T ss_pred CC-------CcEEEeecccceeccCCcee---------ecCCCcCCcceeCHhHHhc----CCCCcHHhHHhHHHHHHHH
Confidence 87 78999999999765432111 1123346788999999876 5688999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1044 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1044 Lt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
++ |..||.+.+..++...+..+.....+ ..+++.+.+|+.+||+.||.+|||
T Consensus 413 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~cl~~dP~~RPs 465 (495)
T 1opk_A 413 ATYGMSPYPGIDLSQVYELLEKDYRMERP---------------------------EGCPEKVYELMRACWQWNPSDRPS 465 (495)
T ss_dssp HTTSCCSSTTCCGGGHHHHHHTTCCCCCC---------------------------TTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HhCCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------CCCCHHHHHHHHHHcCcChhHCcC
Confidence 99 99999987776666666544332211 145567999999999999999999
Q ss_pred HHHHHHHHHhhc
Q 001142 1123 AGDLYEMFVART 1134 (1142)
Q Consensus 1123 a~EVL~~L~~~~ 1134 (1142)
+.+|++.+....
T Consensus 466 ~~el~~~L~~~~ 477 (495)
T 1opk_A 466 FAEIHQAFETMF 477 (495)
T ss_dssp HHHHHHHHHTSC
T ss_pred HHHHHHHHHHHH
Confidence 999999887653
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=345.99 Aligned_cols=262 Identities=24% Similarity=0.294 Sum_probs=204.1
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
++|++.+.||+|+||.||+|.+. +..+|+|+...... ....+. +.+|+.+++.++||||+++++++.+.+
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~- 78 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPEN----IKKEICINKMLNHENVVKFYGHRREGN- 78 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC---TTHHHH----HHHHHHHHHTCCCTTBCCEEEEEEETT-
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc---hhhhHH----HHHHHHHHHhcCCCCceeeeeEEEcCC-
Confidence 56999999999999999999984 67788888654432 122233 378999999999999999999988654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.
T Consensus 79 -------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~ 140 (276)
T 2yex_A 79 -------------IQYLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDE 140 (276)
T ss_dssp -------------EEEEEEECCTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred -------------EEEEEEEecCCCcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEcc
Confidence 34999999999999988753 356899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||+|||.+......... .......||+.|+|||++.+ ...++.++||||||+++|+|+
T Consensus 141 ~-------~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~il~~l~ 202 (276)
T 2yex_A 141 R-------DNLKISDFGLATVFRYNNRE--------RLLNKMCGTLPYVAPELLKR---REFHAEPVDVWSCGIVLTAML 202 (276)
T ss_dssp T-------CCEEECCCTTCEECEETTEE--------CCBCCCCSCGGGCCGGGGTC---SSBCHHHHHHHHHHHHHHHHH
T ss_pred C-------CCEEEeeCCCccccCCCcch--------hcccCCccccCccChHHHhc---CCCCCCcchHHHHHHHHHHHH
Confidence 7 78999999999765432111 01123468999999999875 123468999999999999999
Q ss_pred hCCCCCCCCCHH-HHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1045 TLQVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1045 tG~~Pf~~~~~~-el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
+|+.||...... .....+...... .. .....++.+.+++.+||+.||.+|||+
T Consensus 203 ~g~~p~~~~~~~~~~~~~~~~~~~~-~~-------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~ 256 (276)
T 2yex_A 203 AGELPWDQPSDSCQEYSDWKEKKTY-LN-------------------------PWKKIDSAPLALLHKILVENPSARITI 256 (276)
T ss_dssp HSSCCCSCSCTTSHHHHHHHTTCTT-ST-------------------------TGGGSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred hCCCCCCCCchHHHHHHHhhhcccc-cC-------------------------chhhcCHHHHHHHHHHCCCCchhCCCH
Confidence 999999765432 122222211110 00 001456678999999999999999999
Q ss_pred HHHHHHHHhhcCCCC
Q 001142 1124 GDLYEMFVARTSSSI 1138 (1142)
Q Consensus 1124 ~EVL~~L~~~~ss~~ 1138 (1142)
.|+++|+|+......
T Consensus 257 ~~il~~~~~~~~~~~ 271 (276)
T 2yex_A 257 PDIKKDRWYNKPLKK 271 (276)
T ss_dssp HHHTTCTTTTCCCC-
T ss_pred HHHhcCccccChhhc
Confidence 999999999866544
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=348.02 Aligned_cols=263 Identities=24% Similarity=0.376 Sum_probs=204.5
Q ss_pred CCCcceeeeecccCceEEEEEEE-------CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceee
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKF-------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYG 877 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~-------~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g 877 (1142)
..+|++.+.||+|+||.||+|++ .+..+|+|+.... ......+.+ .+|+.+++++ +||||+++++
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~----~~E~~~l~~l~~h~~i~~~~~ 94 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS---AHLTEREAL----MSELKVLSYLGNHMNIVNLLG 94 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT---CCHHHHHHH----HHHHHHHHHHCCCTTBCCEEE
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc---hhHHHHHHH----HHHHHHHhhcccCCCeeeEEE
Confidence 45799999999999999999986 2356788875422 222333334 8999999999 8999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc-------------cCCCCCCHHHHHHHHHHHHHHHHH
Q 001142 878 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-------------TGEKHVSVKLALFIAQDVAAALVE 944 (1142)
Q Consensus 878 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~-------------~~~~~ls~~~i~~Ia~qIa~gL~y 944 (1142)
++.+.+.. ++||||+++++|.+++..... .....+++..+..++.||+.||.|
T Consensus 95 ~~~~~~~~--------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~ 160 (313)
T 1t46_A 95 ACTIGGPT--------------LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAF 160 (313)
T ss_dssp EECSSSSC--------------EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHH
T ss_pred EEecCCCc--------------EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHH
Confidence 99875543 999999999999999986321 112358999999999999999999
Q ss_pred HHhCCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCC
Q 001142 945 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 1024 (1142)
Q Consensus 945 LHs~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~ 1024 (1142)
||++||+||||||+|||++.+ +.+||+|||++......... .......||+.|+|||++.+
T Consensus 161 lH~~~i~H~dlkp~Nil~~~~-------~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~---- 221 (313)
T 1t46_A 161 LASKNCIHRDLAARNILLTHG-------RITKICDFGLARDIKNDSNY--------VVKGNARLPVKWMAPESIFN---- 221 (313)
T ss_dssp HHHTTCCCSCCSGGGEEEETT-------TEEEECCCGGGSCTTSCTTS--------EECSSSEECGGGCCHHHHHH----
T ss_pred HHHCCeecCCCccceEEEcCC-------CCEEEccccccccccccccc--------eeccCCCCcceeeChHHhcC----
Confidence 999999999999999999877 78999999999765432211 01223457889999999876
Q ss_pred CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH-HHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhH
Q 001142 1025 NLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELE-IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETL 1102 (1142)
Q Consensus 1025 ~~~s~ksDVwSLGviL~ELLt-G~~Pf~~~~~~e-l~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1102 (1142)
..++.++||||||+++|+|++ |..||.+..... ....+.....+..+ ...+
T Consensus 222 ~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~ 274 (313)
T 1t46_A 222 CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSP---------------------------EHAP 274 (313)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCC---------------------------TTSC
T ss_pred CCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCCCc---------------------------ccCC
Confidence 568899999999999999999 999998755433 33333332221111 1445
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001142 1103 SFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1103 ~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~~s 1135 (1142)
+.+.+++.+||+.||.+|||+.|+++++.....
T Consensus 275 ~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 275 AEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 679999999999999999999999999876543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=357.78 Aligned_cols=261 Identities=20% Similarity=0.246 Sum_probs=204.1
Q ss_pred ccee-eeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEecCCC
Q 001142 809 LSSC-DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKW 884 (1142)
Q Consensus 809 y~l~-~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~g~~~~~~~ 884 (1142)
|.+. +.||+|+||.||+|.+. +..+|+|+...... ....... +.+|+.++.++. ||||+++++++.+..
T Consensus 30 y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~----~~~e~~~l~~l~~~~~iv~~~~~~~~~~- 102 (327)
T 3lm5_A 30 YILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR--GQDCRAE----ILHEIAVLELAKSCPRVINLHEVYENTS- 102 (327)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET--TEECHHH----HHHHHHHHHHTTTCTTBCCEEEEEECSS-
T ss_pred EeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHH----HHHHHHHHHhccCCCCEEEEEEEEEeCC-
Confidence 6666 89999999999999984 67889988654321 2222223 378999999995 799999999998654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
..++||||+++++|.+++.. .....+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 103 -------------~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~ 166 (327)
T 3lm5_A 103 -------------EIILILEYAAGGEIFSLCLP---ELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSS 166 (327)
T ss_dssp -------------EEEEEEECCTTEEGGGGGSS---CC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESC
T ss_pred -------------eEEEEEEecCCCcHHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEec
Confidence 35999999999999988743 22356999999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
.. ..+.+||+|||++........ .....||+.|+|||++.+ ..++.++||||||+++|+|+
T Consensus 167 ~~----~~~~~kL~Dfg~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~~ll 227 (327)
T 3lm5_A 167 IY----PLGDIKIVDFGMSRKIGHACE-----------LREIMGTPEYLAPEILNY----DPITTATDMWNIGIIAYMLL 227 (327)
T ss_dssp BT----TBCCEEECCGGGCEEC--------------------CCCGGGCCHHHHTT----CCCCTHHHHHHHHHHHHHHH
T ss_pred CC----CCCcEEEeeCccccccCCccc-----------cccccCCcCccCCeeecC----CCCCchhhHHHHHHHHHHHH
Confidence 21 116899999999976543211 123469999999999875 56889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~ 1124 (1142)
+|+.||.+....+....+.......... .....++.+.+++.+||+.||.+|||++
T Consensus 228 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 283 (327)
T 3lm5_A 228 THTSPFVGEDNQETYLNISQVNVDYSEE------------------------TFSSVSQLATDFIQSLLVKNPEKRPTAE 283 (327)
T ss_dssp HSSCSSCCSSHHHHHHHHHHTCCCCCTT------------------------TTTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred hCCCCCCCCCchHHHHHHHhcccccCch------------------------hhcccCHHHHHHHHHHcCCChhhCcCHH
Confidence 9999999887777666654433221110 0014566799999999999999999999
Q ss_pred HHHHHHHhhcC
Q 001142 1125 DLYEMFVARTS 1135 (1142)
Q Consensus 1125 EVL~~L~~~~s 1135 (1142)
|+++|+|++..
T Consensus 284 ~ll~h~~~~~~ 294 (327)
T 3lm5_A 284 ICLSHSWLQQW 294 (327)
T ss_dssp HHTTCGGGCCC
T ss_pred HHhCCHhhccc
Confidence 99999999754
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=346.40 Aligned_cols=253 Identities=24% Similarity=0.362 Sum_probs=200.1
Q ss_pred CCCCCcceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 804 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 804 ~~~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
....+|++.+.||+|+||.||+|++.+..+|+|+.... ...+.+ .+|+.++++++||||+++++++.+..
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~------~~~~~~----~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND------ATAQAF----LAEASVMTQLRHSNLVQLLGVIVEEK 87 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCC------C--HHH----HHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred CChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecch------hHHHHH----HHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 34678999999999999999999999999999985421 122333 78999999999999999999876432
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
...++||||+++++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+||+++
T Consensus 88 -------------~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~ 151 (278)
T 1byg_A 88 -------------GGLYIVTEYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS 151 (278)
T ss_dssp --------------CCEEEECCCTTEEHHHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred -------------CceEEEEecCCCCCHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEe
Confidence 12499999999999999997632 12478999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.+||+|||++....... ....+++.|+|||++.+ ..++.++||||||+++|+|
T Consensus 152 ~~-------~~~~l~Dfg~~~~~~~~~-------------~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~l 207 (278)
T 1byg_A 152 ED-------NVAKVSDFGLTKEASSTQ-------------DTGKLPVKWTAPEALRE----KKFSTKSDVWSFGILLWEI 207 (278)
T ss_dssp TT-------SCEEECCCCC-------------------------CCTTTSCHHHHHH----CCCCHHHHHHHHHHHHHHH
T ss_pred CC-------CcEEEeeccccccccccc-------------cCCCccccccCHHHhCC----CCCCchhcHHHHHHHHHHH
Confidence 77 789999999987543211 12357889999999876 5688999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1044 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1044 Lt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
++ |..||......+....+..+..+..+ ...++.+.+++.+||+.||.+|||
T Consensus 208 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~~l~~~p~~Rps 260 (278)
T 1byg_A 208 YSFGRVPYPRIPLKDVVPRVEKGYKMDAP---------------------------DGCPPAVYEVMKNCWHLDAAMRPS 260 (278)
T ss_dssp HTTSCCSCTTSCGGGHHHHHTTTCCCCCC---------------------------TTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HhCCCCCCCCCCHHHHHHHHhcCCCCCCc---------------------------ccCCHHHHHHHHHHhcCChhhCCC
Confidence 98 99999877666655555443322211 145567999999999999999999
Q ss_pred HHHHHHHHHhh
Q 001142 1123 AGDLYEMFVAR 1133 (1142)
Q Consensus 1123 a~EVL~~L~~~ 1133 (1142)
+.|+++.+...
T Consensus 261 ~~~l~~~L~~i 271 (278)
T 1byg_A 261 FLQLREQLEHI 271 (278)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99999988764
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=344.91 Aligned_cols=263 Identities=22% Similarity=0.346 Sum_probs=200.5
Q ss_pred CCcceeeeecccCceEEEEEEEC---CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG---SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~---~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
..|++.++||+|+||+||+|++. +..++++++.++.. ......+.+ .+|+.++++++||||+++++++...+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~----~~E~~~l~~l~h~~iv~~~~~~~~~~ 99 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQF----LTEGIIMKDFSHPNVLSLLGICLRSE 99 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHH----HHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHH----HHHHHHHHhCCCCCEeeeeeEEEcCC
Confidence 46899999999999999999863 33334444444432 223333444 79999999999999999999865432
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
. ..++||||+++++|.++++. ....+++..+..|+.||+.||.|||++||+||||||+|||++
T Consensus 100 ~-------------~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~ 162 (298)
T 3f66_A 100 G-------------SPLVVLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD 162 (298)
T ss_dssp S-------------CCEEEEECCTTCBHHHHHHC----TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred C-------------ceEEEEeCCCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEC
Confidence 1 24899999999999999964 235689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.+||+|||+++......... ........||+.|+|||++.+ ..++.++||||||+++|+|
T Consensus 163 ~~-------~~~kl~Dfg~a~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~l 225 (298)
T 3f66_A 163 EK-------FTVKVADFGLARDMYDKEYYS------VHNKTGAKLPVKWMALESLQT----QKFTTKSDVWSFGVLLWEL 225 (298)
T ss_dssp TT-------CCEEECSCGGGCCCSCGGGCB------C-----CCBCGGGSCHHHHHH----CCCCHHHHHHHHHHHHHHH
T ss_pred CC-------CCEEECcccccccccccchhc------cccccCCCCCccccChHHhcC----CCCChHHHHHHHHHHHHHH
Confidence 77 789999999997654322111 111223457889999999976 5688999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1044 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1044 Lt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
++ +.+||.+....+....+..+..+..+. ..++.+.+++.+||+.||.+|||
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~p~~Rps 278 (298)
T 3f66_A 226 MTRGAPPYPDVNTFDITVYLLQGRRLLQPE---------------------------YCPDPLYEVMLKCWHPKAEMRPS 278 (298)
T ss_dssp HTTSCCSSTTSCTTTHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HhCCCCCCccCCHHHHHHHHhcCCCCCCCc---------------------------cCCHHHHHHHHHHcCCChhhCcC
Confidence 99 677777665555555554443322111 34567999999999999999999
Q ss_pred HHHHHHHHHhhcC
Q 001142 1123 AGDLYEMFVARTS 1135 (1142)
Q Consensus 1123 a~EVL~~L~~~~s 1135 (1142)
+.|+++.+.....
T Consensus 279 ~~ell~~L~~~~~ 291 (298)
T 3f66_A 279 FSELVSRISAIFS 291 (298)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHH
Confidence 9999998876543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=346.83 Aligned_cols=267 Identities=22% Similarity=0.346 Sum_probs=200.8
Q ss_pred CCCcceeeeecccCceEEEEEEECC-----ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 880 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~~-----~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~ 880 (1142)
..+|++.+.||+|+||.||+|.+.. ..+|+|+.. .........+.+ .+|+.++++++||||+++++++.
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~----~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMK--LDNSSQREIEEF----LSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC-----CCCHHHHHHH----HHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEe--ccccchhHHHHH----HHHHHHHhcCCCCCeeeeeEEEe
Confidence 3569999999999999999998732 257777643 223333444444 79999999999999999999988
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~-~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~N 959 (1142)
+.... .....++||||+++++|.+++..... .....+++..++.++.||+.||.|||++||+||||||+|
T Consensus 107 ~~~~~---------~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~N 177 (313)
T 3brb_A 107 EMSSQ---------GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARN 177 (313)
T ss_dssp C----------------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGG
T ss_pred ecccc---------CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcce
Confidence 64321 12346999999999999999965321 233569999999999999999999999999999999999
Q ss_pred eeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001142 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039 (1142)
Q Consensus 960 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGvi 1039 (1142)
||++.+ +.+||+|||++......... .......+++.|+|||++.+ ..++.++||||||++
T Consensus 178 Ili~~~-------~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~i 238 (313)
T 3brb_A 178 CMLRDD-------MTVCVADFGLSKKIYSGDYY--------RQGRIAKMPVKWIAIESLAD----RVYTSKSDVWAFGVT 238 (313)
T ss_dssp EEECTT-------SCEEECSCSCC------------------------CCGGGSCHHHHHS----SCCCHHHHHHHHHHH
T ss_pred EEEcCC-------CcEEEeecCcceeccccccc--------CcccccCCCccccCchhhcC----CCccchhhhHHHHHH
Confidence 999887 78999999999765432111 11223457889999999876 568899999999999
Q ss_pred HHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001142 1040 LLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1118 (1142)
Q Consensus 1040 L~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~ 1118 (1142)
+|+|++ |..||.+....+....+..+..+..+. ..++.+.+++.+||+.||.
T Consensus 239 l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~dp~ 291 (313)
T 3brb_A 239 MWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPE---------------------------DCLDELYEIMYSCWRTDPL 291 (313)
T ss_dssp HHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCBT---------------------------TCCHHHHHHHHHTTCSSGG
T ss_pred HHHHHhcCCCCCccCCHHHHHHHHHcCCCCCCCc---------------------------cccHHHHHHHHHHcCCChh
Confidence 999999 899998877766666665544332211 4456799999999999999
Q ss_pred CCCCHHHHHHHHHhh
Q 001142 1119 ERPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1119 ~RPSa~EVL~~L~~~ 1133 (1142)
+|||+.++++++...
T Consensus 292 ~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 292 DRPTFSVLRLQLEKL 306 (313)
T ss_dssp GSCCHHHHHHHHHHH
T ss_pred hCcCHHHHHHHHHHH
Confidence 999999999998764
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=341.40 Aligned_cols=266 Identities=17% Similarity=0.187 Sum_probs=202.7
Q ss_pred CCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSK 883 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~~~~~ 883 (1142)
.+|++.+.||+|+||.||+|.+ .+..+|+|+..... ..+.+ .+|+.+++++ +|+|++++++++.+..
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~----~~e~~~~~~l~~~~~i~~~~~~~~~~~ 79 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS------DAPQL----RDEYRTYKLLAGCTGIPNVYYFGQEGL 79 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT------TSCCH----HHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC------ccHHH----HHHHHHHHHHhcCCCCCeEEeecCCCc
Confidence 4699999999999999999996 57788888754221 11223 6899999999 7999999999987654
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
..++||||+ +++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 80 --------------~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~ 140 (298)
T 1csn_A 80 --------------HNVLVIDLL-GPSLEDLLDLC----GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIG 140 (298)
T ss_dssp --------------EEEEEEECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC
T ss_pred --------------eeEEEEEec-CCCHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEec
Confidence 459999999 89999999862 24699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.++. .....+||+|||++........... ..........||+.|+|||++.+ ..++.++||||||+++|+|
T Consensus 141 ~~~~--~~~~~~kl~Dfg~~~~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il~el 211 (298)
T 1csn_A 141 RPNS--KNANMIYVVDFGMVKFYRDPVTKQH---IPYREKKNLSGTARYMSINTHLG----REQSRRDDLEALGHVFMYF 211 (298)
T ss_dssp CSSS--TTTTCEEECCCTTCEESBCTTTCCB---CCCCCCCCCCSCTTTCCHHHHTT----CCCCHHHHHHHHHHHHHHH
T ss_pred cCCC--CCCCeEEEEECcccccccccccccc---ccccCccCCCCCcccCCchhhcC----CCCChHHHHHHHHHHHHHH
Confidence 7621 1224599999999987654321110 01112345579999999999876 5688999999999999999
Q ss_pred HhCCCCCCCCC---HHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1044 LTLQVPYMGLS---ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1044 LtG~~Pf~~~~---~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
++|+.||.+.. ..+....+.....+.... ......++.+.+++.+||+.||++|
T Consensus 212 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~l~~li~~~l~~dp~~R 268 (298)
T 1csn_A 212 LRGSLPWQGLKAATNKQKYERIGEKKQSTPLR-----------------------ELCAGFPEEFYKYMHYARNLAFDAT 268 (298)
T ss_dssp HHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH-----------------------HHTTTSCHHHHHHHHHHHHCCTTCC
T ss_pred HcCCCCcchhhccccHHHHHHHHhhccCccHH-----------------------HHHhhCcHHHHHHHHHHhcCCcccC
Confidence 99999998642 333333332211100000 0011456779999999999999999
Q ss_pred CCHHHHHHHHHhh
Q 001142 1121 PTAGDLYEMFVAR 1133 (1142)
Q Consensus 1121 PSa~EVL~~L~~~ 1133 (1142)
||+++|++.+...
T Consensus 269 P~~~~l~~~l~~~ 281 (298)
T 1csn_A 269 PDYDYLQGLFSKV 281 (298)
T ss_dssp CCHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHH
Confidence 9999999887654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=360.83 Aligned_cols=251 Identities=22% Similarity=0.267 Sum_probs=198.7
Q ss_pred CCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCC----hHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSS----ADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 880 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~----~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~ 880 (1142)
.+|++.+.||+|+||.||+|.+ .+..+|+|+......... ......+ .+|+.++++++||||+++++++.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~----~~E~~~l~~l~h~~Iv~~~~~~~ 99 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKV----TLEIAILSRVEHANIIKVLDIFE 99 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEE----EHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHH----HHHHHHHHhCCCCCEeeEEEEEe
Confidence 4699999999999999999987 466788887654322111 0122233 68999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCC-CHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGG-SVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gg-SL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~N 959 (1142)
+.+ ..++||||+.+| +|.+++.. ...+++..+..|+.||+.||.|||++||+||||||+|
T Consensus 100 ~~~--------------~~~lv~e~~~~g~~l~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~N 160 (335)
T 3dls_A 100 NQG--------------FFQLVMEKHGSGLDLFAFIDR-----HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDEN 160 (335)
T ss_dssp CSS--------------EEEEEEECCTTSCBHHHHHHT-----CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred eCC--------------EEEEEEEeCCCCccHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHH
Confidence 655 349999999766 99999875 3469999999999999999999999999999999999
Q ss_pred eeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001142 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039 (1142)
Q Consensus 960 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGvi 1039 (1142)
||++.+ +.+||+|||++....... ......||+.|+|||++.+ ...++.++|||||||+
T Consensus 161 Ill~~~-------~~~kL~Dfg~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~i 219 (335)
T 3dls_A 161 IVIAED-------FTIKLIDFGSAAYLERGK-----------LFYTFCGTIEYCAPEVLMG---NPYRGPELEMWSLGVT 219 (335)
T ss_dssp EEECTT-------SCEEECCCTTCEECCTTC-----------CBCEECSCGGGCCHHHHTT---CCBCSHHHHHHHHHHH
T ss_pred EEEcCC-------CcEEEeecccceECCCCC-----------ceeccCCCccccChhhhcC---CCCCCCcccchhHHHH
Confidence 999887 789999999997654321 1123469999999999876 2234789999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001142 1040 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1119 (1142)
Q Consensus 1040 L~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~ 1119 (1142)
+|+|++|..||..... .+..... . ....++.+.+|+.+||+.||.+
T Consensus 220 l~el~~g~~pf~~~~~-----~~~~~~~--------------------------~---~~~~~~~l~~li~~~L~~dP~~ 265 (335)
T 3dls_A 220 LYTLVFEENPFCELEE-----TVEAAIH--------------------------P---PYLVSKELMSLVSGLLQPVPER 265 (335)
T ss_dssp HHHHHHSSCSCSSGGG-----GTTTCCC--------------------------C---SSCCCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHhCCCchhhHHH-----HHhhccC--------------------------C---CcccCHHHHHHHHHHccCChhh
Confidence 9999999999975211 0000000 0 0134567999999999999999
Q ss_pred CCCHHHHHHHHHhhcC
Q 001142 1120 RPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1120 RPSa~EVL~~L~~~~s 1135 (1142)
|||+.++++|+|+...
T Consensus 266 Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 266 RTTLEKLVTDPWVTQP 281 (335)
T ss_dssp SCCHHHHHHCTTTTCC
T ss_pred CcCHHHHhcCccccCC
Confidence 9999999999998753
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=350.49 Aligned_cols=261 Identities=23% Similarity=0.370 Sum_probs=206.7
Q ss_pred CCCcceeeeecccCceEEEEEEEC---------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccce
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG---------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 875 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~---------~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl 875 (1142)
.++|++.+.||+|+||.||+|++. +..+|+|+.. .. ......+.+ .+|+.+++++ +||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~--~~-~~~~~~~~~----~~E~~~l~~l~~hp~iv~~ 106 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK--DD-ATEKDLSDL----VSEMEMMKMIGKHKNIINL 106 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECC--TT-CCHHHHHHH----HHHHHHHHHHCCCTTBCCE
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeec--cC-CcHHHHHHH----HHHHHHHHHhhcCCCEeeE
Confidence 467999999999999999999973 3457777643 21 223333344 7999999999 89999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc-----------CCCCCCHHHHHHHHHHHHHHHHH
Q 001142 876 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAALVE 944 (1142)
Q Consensus 876 ~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~-----------~~~~ls~~~i~~Ia~qIa~gL~y 944 (1142)
++++.+.+.. ++||||+++++|.+++...... ....+++..++.++.||+.||.|
T Consensus 107 ~~~~~~~~~~--------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~ 172 (334)
T 2pvf_A 107 LGACTQDGPL--------------YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 172 (334)
T ss_dssp EEEECSSSCC--------------EEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHH
T ss_pred EEEEccCCce--------------EEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHH
Confidence 9999865543 9999999999999999753211 12348999999999999999999
Q ss_pred HHhCCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCC
Q 001142 945 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 1024 (1142)
Q Consensus 945 LHs~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~ 1024 (1142)
||++||+||||||+|||++.+ +.+||+|||++.......... ......+|+.|+|||++.+
T Consensus 173 LH~~~ivH~Dlkp~NIll~~~-------~~~kL~Dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~---- 233 (334)
T 2pvf_A 173 LASQKCIHRDLAARNVLVTEN-------NVMKIADFGLARDINNIDYYK--------KTTNGRLPVKWMAPEALFD---- 233 (334)
T ss_dssp HHHTTEECSCCSGGGEEECTT-------CCEEECCCTTCEECTTTSSEE--------CCSCCCCCGGGCCHHHHHH----
T ss_pred HHhCCeeCCCCccceEEEcCC-------CCEEEcccccccccccccccc--------ccCCCCcccceeChHHhcC----
Confidence 999999999999999999877 789999999997654322110 1123357889999999876
Q ss_pred CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHH
Q 001142 1025 NLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLS 1103 (1142)
Q Consensus 1025 ~~~s~ksDVwSLGviL~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1103 (1142)
..++.++||||||+++|+|++ |..||.+....++...+..+..+..+. ..+.
T Consensus 234 ~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~ 286 (334)
T 2pvf_A 234 RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPA---------------------------NCTN 286 (334)
T ss_dssp CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCT---------------------------TCCH
T ss_pred CCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCCCCCCc---------------------------cCCH
Confidence 467899999999999999999 999999888777776665544332211 4456
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001142 1104 FLVDVFRRCTEENPTERPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1104 ~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~ 1133 (1142)
.+.+++.+||+.||.+|||+.|+++++...
T Consensus 287 ~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 287 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 799999999999999999999999988754
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=349.21 Aligned_cols=285 Identities=20% Similarity=0.221 Sum_probs=205.4
Q ss_pred CCCcceeeeecccCceEEEEEEE---CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCC------Ccccee
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKF---GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS------CIVEMY 876 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~---~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp------NIVkl~ 876 (1142)
..+|++.+.||+|+||.||+|.+ .+..+|+|+... .....+. +.+|+.+++.++|+ +|++++
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~-----~~~~~~~----~~~e~~~l~~l~~~~~~~~~~i~~~~ 83 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN-----VDRYCEA----ARSEIQVLEHLNTTDPNSTFRCVQML 83 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS-----SHHHHHH----HHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec-----CCchhHH----HHHHHHHHHHhhhcCCCCceeeEeee
Confidence 35799999999999999999987 456788888531 1222233 37899998888655 499999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 001142 877 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956 (1142)
Q Consensus 877 g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLK 956 (1142)
+++...+ +.++||||+ +++|.+++.. .+...+++..+..++.||+.||+|||++||+|||||
T Consensus 84 ~~~~~~~--------------~~~lv~e~~-~~~l~~~l~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlk 145 (339)
T 1z57_A 84 EWFEHHG--------------HICIVFELL-GLSTYDFIKE---NGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLK 145 (339)
T ss_dssp EEEEETT--------------EEEEEEECC-CCBHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred cccccCC--------------cEEEEEcCC-CCCHHHHHHh---cCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCC
Confidence 9988655 459999999 7999999976 233468999999999999999999999999999999
Q ss_pred CCCeeecccccc------------CCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCC
Q 001142 957 SENILIDLERKK------------ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 1024 (1142)
Q Consensus 957 p~NILld~~~~~------------~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~ 1024 (1142)
|+|||++..... ....+.+||+|||.+...... .....||+.|+|||++.+
T Consensus 146 p~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-------------~~~~~gt~~y~aPE~~~~---- 208 (339)
T 1z57_A 146 PENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-------------HSTLVSTRHYRAPEVILA---- 208 (339)
T ss_dssp GGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC-------------CCSSCSCGGGCCHHHHTT----
T ss_pred HHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc-------------cccccCCccccChHHhhC----
Confidence 999999763100 000267999999999753321 123468999999999876
Q ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccccc---cc------------ccccC
Q 001142 1025 NLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE---HE------------VAQSG 1089 (1142)
Q Consensus 1025 ~~~s~ksDVwSLGviL~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~---~~------------~~~~~ 1089 (1142)
..++.++|||||||++|||++|..||...+..+....+.....+.............. .. .....
T Consensus 209 ~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (339)
T 1z57_A 209 LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRAC 288 (339)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHC
T ss_pred CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcC
Confidence 5688999999999999999999999998777665554433222111111110000000 00 00000
Q ss_pred CCC-CCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001142 1090 SGF-EKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1134 (1142)
Q Consensus 1090 ~~~-~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~~ 1134 (1142)
... .........++.+.+|+.+||+.||.+|||+.|+++|+|+..
T Consensus 289 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 334 (339)
T 1z57_A 289 KPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDL 334 (339)
T ss_dssp CCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGG
T ss_pred cchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHH
Confidence 000 000011245778999999999999999999999999999975
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=357.79 Aligned_cols=283 Identities=19% Similarity=0.186 Sum_probs=205.2
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
.+|.+.+.||+|+||.||+|.+. +..+|+|+.. .........+. +.+|+.++++++||||+++++++.....
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~--~~~~~~~~~~~----~~~E~~~l~~l~h~niv~~~~~~~~~~~ 115 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS--RPFQSEIFAKR----AYRELLLLKHMQHENVIGLLDVFTPASS 115 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC--STTSSHHHHHH----HHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEec--ccccchhHHHH----HHHHHHHHHhcCCCCchhhhhheeccCC
Confidence 47999999999999999999984 6677888754 22223333333 4799999999999999999999986543
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
. ......++||||+. ++|.+++. ..+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 116 ~--------~~~~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~ 179 (371)
T 4exu_A 116 L--------RNFYDFYLVMPFMQ-TDLQKIMG-------MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNE 179 (371)
T ss_dssp S--------TTCCCCEEEEECCC-EEHHHHTT-------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred c--------ccceeEEEEEcccc-ccHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECC
Confidence 2 12334599999997 78887763 34999999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||+|||+++..... .....||+.|+|||++.+ ...++.++|||||||++|+|+
T Consensus 180 ~-------~~~kL~Dfg~a~~~~~~-------------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~el~ 236 (371)
T 4exu_A 180 D-------CELKILDFGLARHADAE-------------MTGYVVTRWYRAPEVILS---WMHYNQTVDIWSVGCIMAEML 236 (371)
T ss_dssp T-------CCEEECSTTCC---------------------CTTCCCTTSCHHHHSC---CSCCCTTHHHHHHHHHHHHHH
T ss_pred C-------CCEEEEecCcccccccC-------------cCCcccCccccCHHHhcC---CCCCCcHHhHHHHHHHHHHHH
Confidence 7 78999999999754321 123468999999999875 246789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccC---CCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG---SGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
+|+.||.+.+..+....+........................+.. ............++.+.+||.+||+.||.+||
T Consensus 237 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 316 (371)
T 4exu_A 237 TGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRL 316 (371)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSC
T ss_pred hCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcC
Confidence 999999988777666555322111111111100000000000000 00000111124567899999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 001142 1122 TAGDLYEMFVART 1134 (1142)
Q Consensus 1122 Sa~EVL~~L~~~~ 1134 (1142)
|+.|+++|+|+..
T Consensus 317 t~~ell~hp~f~~ 329 (371)
T 4exu_A 317 TAAQALTHPFFEP 329 (371)
T ss_dssp CHHHHHTSGGGTT
T ss_pred CHHHHhcCccccc
Confidence 9999999999974
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=343.12 Aligned_cols=256 Identities=21% Similarity=0.320 Sum_probs=202.4
Q ss_pred CCCcceee-eecccCceEEEEEEE----CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001142 806 FPSLSSCD-EAGKSVSSSLFRCKF----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 880 (1142)
Q Consensus 806 ~~~y~l~~-~LG~GsfG~Vy~a~~----~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~ 880 (1142)
..+|++.+ .||+|+||+||+|.+ .+..+|+|+.... .......+. +.+|+.++++++||||+++++++.
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~ 88 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE--ANDPALKDE----LLAEANVMQQLDNPYIVRMIGICE 88 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHH----HHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccc--ccCHHHHHH----HHHHHHHHHhCCCCCEEEEEEEEC
Confidence 45688888 999999999999965 2456788875432 112222333 489999999999999999999984
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NI 960 (1142)
. + ..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 89 ~-~--------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Ni 148 (291)
T 1xbb_A 89 A-E--------------SWMLVMEMAELGPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNV 148 (291)
T ss_dssp S-S--------------SEEEEEECCTTEEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred C-C--------------CcEEEEEeCCCCCHHHHHHh-----CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceE
Confidence 3 2 24899999999999999986 34689999999999999999999999999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
|++.+ +.+||+|||++........... ......+|+.|+|||++.+ ..++.++||||||+++
T Consensus 149 l~~~~-------~~~kl~Dfg~~~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il 210 (291)
T 1xbb_A 149 LLVTQ-------HYAKISDFGLSKALRADENYYK-------AQTHGKWPVKWYAPECINY----YKFSSKSDVWSFGVLM 210 (291)
T ss_dssp EEEET-------TEEEECCCTTCEECCTTCSEEE-------C----CCCGGGCCHHHHHH----CEEEHHHHHHHHHHHH
T ss_pred EEeCC-------CcEEEccCCcceeeccCCCccc-------ccccCCCCceeeChHHhcc----CCCChhhhHHHHHHHH
Confidence 99887 7899999999976543221100 1112346788999999876 4578999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001142 1041 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1119 (1142)
Q Consensus 1041 ~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~ 1119 (1142)
|+|++ |+.||.+....+....+..+..+..+. ..++.+.+++.+||+.||.+
T Consensus 211 ~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~dp~~ 263 (291)
T 1xbb_A 211 WEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA---------------------------GCPREMYDLMNLCWTYDVEN 263 (291)
T ss_dssp HHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSTTT
T ss_pred HHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHcCCChhh
Confidence 99999 999999888777777766554332221 44567999999999999999
Q ss_pred CCCHHHHHHHHHh
Q 001142 1120 RPTAGDLYEMFVA 1132 (1142)
Q Consensus 1120 RPSa~EVL~~L~~ 1132 (1142)
|||+.++++.+..
T Consensus 264 Rps~~~l~~~L~~ 276 (291)
T 1xbb_A 264 RPGFAAVELRLRN 276 (291)
T ss_dssp SCCHHHHHHHHHH
T ss_pred CcCHHHHHHHHHH
Confidence 9999999987754
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=358.18 Aligned_cols=270 Identities=23% Similarity=0.292 Sum_probs=203.9
Q ss_pred CCCCcceeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~~-~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
...+|++.+.||+|+||.||+|++. +..+|+|+.... .....+.+ .+|+.++++++||||+++++++.+.+
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~----~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE----SSQGIEEF----ETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSC----CSSHHHHH----HHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred HHhccCccceeecCCCeeEEEEEECCCCEEEEEEeccc----ChHHHHHH----HHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 4567999999999999999999974 677888864322 12223344 79999999999999999999987655
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
. .++||||+++++|.+++... ......+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 109 ~--------------~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~ 173 (321)
T 2qkw_B 109 E--------------MILIYKYMENGNLKRHLYGS-DLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLD 173 (321)
T ss_dssp C--------------CEEEEECCTTCBTGGGSSSS-CCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEEC
T ss_pred e--------------EEEEEEcCCCCcHHHHHhcc-CCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEEC
Confidence 3 39999999999999988642 11224689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.+||+|||++......... .......||+.|+|||++.+ ..++.++||||||+++|||
T Consensus 174 ~~-------~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il~el 234 (321)
T 2qkw_B 174 EN-------FVPKITDFGISKKGTELDQT--------HLSTVVKGTLGYIDPEYFIK----GRLTEKSDVYSFGVVLFEV 234 (321)
T ss_dssp TT-------CCEEECCCTTCEECSSSSCC--------CCBCCCEEETTTCCHHHHHH----CBCCTHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEeeccccccccccccc--------ccccccCCCccccCHHHhcC----CCCCcccchHhHHHHHHHH
Confidence 77 78999999999754322111 11123458999999999876 5688999999999999999
Q ss_pred HhCCCCCCCCCHHHHHH-------HHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 001142 1044 LTLQVPYMGLSELEIHD-------LIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1116 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~-------~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~D 1116 (1142)
++|+.||.+....+... ....+.... ..... .........+..+.+++.+||+.|
T Consensus 235 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~---~~~~~~~~~~~~l~~li~~~l~~d 296 (321)
T 2qkw_B 235 LCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ---------------IVDPN---LADKIRPESLRKFGDTAVKCLALS 296 (321)
T ss_dssp HHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCS---------------SSSSS---CTTCSCHHHHHHHHHHHHHHTCSS
T ss_pred HhCCCcccccCcHHHHHHHHHhhhccccccHHH---------------hcChh---hccccCHHHHHHHHHHHHHHcCCC
Confidence 99999997543221110 000000000 00000 001112367788999999999999
Q ss_pred CCCCCCHHHHHHHHHhhc
Q 001142 1117 PTERPTAGDLYEMFVART 1134 (1142)
Q Consensus 1117 P~~RPSa~EVL~~L~~~~ 1134 (1142)
|++|||+.|++++++...
T Consensus 297 P~~Rps~~ell~~L~~~l 314 (321)
T 2qkw_B 297 SEDRPSMGDVLWKLEYAL 314 (321)
T ss_dssp GGGSCCHHHHHHHHHHHH
T ss_pred cccCcCHHHHHHHHHHHh
Confidence 999999999999998654
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=354.67 Aligned_cols=294 Identities=16% Similarity=0.168 Sum_probs=206.3
Q ss_pred CCcceeeeecccCceEEEEEEE-CCccEEEEEEecccCCCCh---HHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSA---DEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 882 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~-~~~~vAvKi~~l~~~~~~~---~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~ 882 (1142)
.+|++.+.||+|+||.||+|.+ .+..+|+|+.......... .........+.+|+.++++++||||+++++++...
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 101 (362)
T 3pg1_A 22 SPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHF 101 (362)
T ss_dssp CSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEEC
T ss_pred cceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEec
Confidence 5799999999999999999987 5677888876433221110 11112223458999999999999999999998653
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
.. ......++||||++ ++|.+++.. ....+++..+..|+.||+.||.|||++||+||||||+|||+
T Consensus 102 ~~---------~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 102 EE---------PAMHKLYLVTELMR-TDLAQVIHD----QRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL 167 (362)
T ss_dssp CT---------TTCCEEEEEEECCS-EEHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred cC---------CCcceEEEEEccCC-CCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEE
Confidence 21 12336799999998 788888864 23469999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
+.+ +.+||+|||++....... ......||+.|+|||++.+ ...++.++|||||||++|+
T Consensus 168 ~~~-------~~~kl~Dfg~~~~~~~~~-----------~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~~ 226 (362)
T 3pg1_A 168 ADN-------NDITICDFNLAREDTADA-----------NKTHYVTHRWYRAPELVMQ---FKGFTKLVDMWSAGCVMAE 226 (362)
T ss_dssp CTT-------CCEEECCTTC--------------------------CGGGCCHHHHTT---CTTCCTHHHHHHHHHHHHH
T ss_pred cCC-------CCEEEEecCccccccccc-----------ccceecccceecCcHHhcC---CCCCCcHhHHHhHHHHHHH
Confidence 877 789999999997433211 1123468999999999875 2457899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHH-HhCCCCCchhHHhhhcccccccccccCCCC---CCchhhhhhHHHHHHHHHHhcccCCC
Q 001142 1043 LLTLQVPYMGLSELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGF---EKPEAELETLSFLVDVFRRCTEENPT 1118 (1142)
Q Consensus 1043 LLtG~~Pf~~~~~~el~~~I-~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~L~dLI~~CL~~DP~ 1118 (1142)
|++|+.||.+....+....+ .....+........................ .........++.+.+|+.+||+.||.
T Consensus 227 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 306 (362)
T 3pg1_A 227 MFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQ 306 (362)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGG
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChh
Confidence 99999999988777666555 323333322111000000000000000000 00111124567799999999999999
Q ss_pred CCCCHHHHHHHHHhhcC
Q 001142 1119 ERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1119 ~RPSa~EVL~~L~~~~s 1135 (1142)
+|||+.|+++|+|++.-
T Consensus 307 ~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 307 RRISTEQALRHPYFESL 323 (362)
T ss_dssp GSCCHHHHHTSGGGTTT
T ss_pred hCCCHHHHHcCchhhhc
Confidence 99999999999999854
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=346.07 Aligned_cols=267 Identities=25% Similarity=0.406 Sum_probs=199.2
Q ss_pred CCCCCCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeE
Q 001142 802 DPGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 879 (1142)
Q Consensus 802 ~~~~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~ 879 (1142)
....+.+|++.+.||+|+||.||+|.+ .+..+|+|+...... ......+.+ .+|+.++++++||||+++++++
T Consensus 27 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~----~~E~~~l~~l~h~~i~~~~~~~ 101 (310)
T 2wqm_A 27 GYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDL-MDAKARADC----IKEIDLLKQLNHPNVIKYYASF 101 (310)
T ss_dssp TTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSS-CCHHHHHHH----HHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhc-cCHHHHHHH----HHHHHHHHhCCCCCEeeEEEEE
Confidence 445677899999999999999999997 467788887643221 222333334 7999999999999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 001142 880 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959 (1142)
Q Consensus 880 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~N 959 (1142)
...+ ..++||||+++++|.+++..... ....+++..+..++.||+.||.|||++||+||||||+|
T Consensus 102 ~~~~--------------~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~N 166 (310)
T 2wqm_A 102 IEDN--------------ELNIVLELADAGDLSRMIKHFKK-QKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPAN 166 (310)
T ss_dssp EETT--------------EEEEEEECCCSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred EcCC--------------cEEEEEecCCCCCHHHHHHHhcc-cccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHH
Confidence 8654 34999999999999999976433 23568999999999999999999999999999999999
Q ss_pred eeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001142 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039 (1142)
Q Consensus 960 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGvi 1039 (1142)
|+++.+ +.+||+|||++........ ......||+.|+|||++.+ ..++.++||||||++
T Consensus 167 Il~~~~-------~~~kl~Dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~i 225 (310)
T 2wqm_A 167 VFITAT-------GVVKLGDLGLGRFFSSKTT----------AAHSLVGTPYYMSPERIHE----NGYNFKSDIWSLGCL 225 (310)
T ss_dssp EEECTT-------SCEEECCC----------------------------CCSSCCHHHHTT----CCCCHHHHHHHHHHH
T ss_pred EEEcCC-------CCEEEEeccceeeecCCCc----------cccccCCCeeEeChHHhCC----CCCCchhhHHHHHHH
Confidence 999877 7899999999875433211 1123468999999999875 568899999999999
Q ss_pred HHHHHhCCCCCCCC--CHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001142 1040 LLELLTLQVPYMGL--SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1117 (1142)
Q Consensus 1040 L~ELLtG~~Pf~~~--~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP 1117 (1142)
+|+|++|+.||.+. ........+.....+.... ...++.+.+++.+||+.||
T Consensus 226 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~l~~li~~~l~~dp 279 (310)
T 2wqm_A 226 LYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPS--------------------------DHYSEELRQLVNMCINPDP 279 (310)
T ss_dssp HHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCT--------------------------TTSCHHHHHHHHHHTCSSG
T ss_pred HHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcc--------------------------cccCHHHHHHHHHHcCCCh
Confidence 99999999999753 2233444444333222110 1445679999999999999
Q ss_pred CCCCCHHHHHHHHHhhcC
Q 001142 1118 TERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1118 ~~RPSa~EVL~~L~~~~s 1135 (1142)
.+|||+.+|++++.....
T Consensus 280 ~~Rps~~~il~~l~~l~~ 297 (310)
T 2wqm_A 280 EKRPDVTYVYDVAKRMHA 297 (310)
T ss_dssp GGSCCHHHHHHHHHHHHH
T ss_pred hhCCCHHHHHHHHHHHHH
Confidence 999999999998877654
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=344.65 Aligned_cols=261 Identities=26% Similarity=0.325 Sum_probs=209.5
Q ss_pred CCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
.+|++.+.||+|+||.||+|++ .+..+|+|+....... ....+.+ .+|+.++++++||||+++++++.+..
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~--~~~~~~~----~~e~~~l~~l~h~~i~~~~~~~~~~~- 94 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK--NKDTSTI----LREVELLKKLDHPNIMKLFEILEDSS- 94 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS--SSCHHHH----HHHHHHHHTCCCTTBCCEEEEEECSS-
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc--hHHHHHH----HHHHHHHHhccCCCccEEEEEEeCCC-
Confidence 4699999999999999999998 4677899886543221 1222333 78999999999999999999988654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.
T Consensus 95 -------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~ 156 (287)
T 2wei_A 95 -------------SFYIVGELYTGGELFDEIIK-----RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLES 156 (287)
T ss_dssp -------------EEEEEECCCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESC
T ss_pred -------------eEEEEEEccCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEec
Confidence 35999999999999998875 246899999999999999999999999999999999999976
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
++ ....+||+|||++....... ......||+.|+|||++.+ .++.++||||||+++|+|+
T Consensus 157 ~~----~~~~~kL~Dfg~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~-----~~~~~~Di~slG~~l~~l~ 216 (287)
T 2wei_A 157 KE----KDCDIKIIDFGLSTCFQQNT-----------KMKDRIGTAYYIAPEVLRG-----TYDEKCDVWSAGVILYILL 216 (287)
T ss_dssp SS----TTCCEEECSTTGGGTBCCCS-----------SCSCHHHHHTTCCHHHHTT-----CCCTHHHHHHHHHHHHHHH
T ss_pred CC----CcccEEEeccCcceeecCCC-----------ccccccCcccccChHHhcC-----CCCCchhhHhHHHHHHHHH
Confidence 42 12579999999987543321 1123458899999999864 4789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~ 1124 (1142)
+|..||.+....+....+..+........ ....++.+.+++.+||+.||.+|||+.
T Consensus 217 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~li~~~l~~dp~~Rps~~ 272 (287)
T 2wei_A 217 SGTPPFYGKNEYDILKRVETGKYAFDLPQ------------------------WRTISDDAKDLIRKMLTFHPSLRITAT 272 (287)
T ss_dssp HSSCSSCCSSHHHHHHHHHHCCCCCCSGG------------------------GTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCCchh------------------------hhhcCHHHHHHHHHHcccChhhCcCHH
Confidence 99999998877777766655443211100 014456799999999999999999999
Q ss_pred HHHHHHHhhcCC
Q 001142 1125 DLYEMFVARTSS 1136 (1142)
Q Consensus 1125 EVL~~L~~~~ss 1136 (1142)
|+++|+|++...
T Consensus 273 ell~hp~~~~~~ 284 (287)
T 2wei_A 273 QCLEHPWIQKYS 284 (287)
T ss_dssp HHHHSHHHHHHC
T ss_pred HHhcCHHHhccc
Confidence 999999998644
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=351.52 Aligned_cols=274 Identities=21% Similarity=0.247 Sum_probs=203.1
Q ss_pred CCCcceeeeecccCceEEEEEEE-CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~-~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
.++|++.+.||+|+||.||+|++ .+..+|+|+...... ..... .+.+|+.++++++||||+++++++.+...
T Consensus 29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 101 (326)
T 3uim_A 29 SDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERT---QGGEL----QFQTEVEMISMAVHRNLLRLRGFCMTPTE 101 (326)
T ss_dssp TTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC--------CCC----HHHHHHHGGGTCCCTTBCCCCEEECCSSC
T ss_pred hhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccC---chHHH----HHHHHHHHHHhccCCCccceEEEEecCCc
Confidence 46799999999999999999987 467789988543211 11111 23789999999999999999999986553
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCCCCee
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK---HIMHRDIKSENIL 961 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~---gIvHrDLKp~NIL 961 (1142)
. ++||||+++++|.+++.... .....+++..+..|+.||+.||.|||++ ||+||||||+|||
T Consensus 102 ~--------------~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil 166 (326)
T 3uim_A 102 R--------------LLVYPYMANGSVASCLRERP-ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANIL 166 (326)
T ss_dssp C--------------EEEEECCTTCBHHHHHHCCS-TTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEE
T ss_pred e--------------EEEEEeccCCCHHHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEE
Confidence 3 89999999999999997522 2234599999999999999999999999 9999999999999
Q ss_pred eccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001142 962 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1041 (1142)
Q Consensus 962 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ 1041 (1142)
++.+ +.+||+|||++......... ......||+.|+|||++.+ ..++.++|||||||++|
T Consensus 167 ~~~~-------~~~kl~Dfg~~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il~ 226 (326)
T 3uim_A 167 LDEE-------FEAVVGDFGLAKLMDYKDTH---------VTTAVRGTIGHIAPEYLST----GKSSEKTDVFGYGVMLL 226 (326)
T ss_dssp ECTT-------CCEEECCCSSCEECCSSSSC---------EECCCCSCGGGCCHHHHHH----SEECHHHHHHHHHHHHH
T ss_pred ECCC-------CCEEeccCccccccCccccc---------ccccccCCcCccCHHHhcc----CCCCccccchhHHHHHH
Confidence 9887 78999999999765432111 1123458999999999876 45789999999999999
Q ss_pred HHHhCCCCCCCC-----CHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 001142 1042 ELLTLQVPYMGL-----SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1116 (1142)
Q Consensus 1042 ELLtG~~Pf~~~-----~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~D 1116 (1142)
+|++|+.||... ........+........ .................+..+.+++.+||+.|
T Consensus 227 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 292 (326)
T 3uim_A 227 ELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK--------------LEALVDVDLQGNYKDEEVEQLIQVALLCTQSS 292 (326)
T ss_dssp HHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCC--------------STTSSCTTCTTSCCHHHHHHHHHHHHHHTCSC
T ss_pred HHHhCCCcccccccccccchhHHHHHHHHhhchh--------------hhhhcChhhccccCHHHHHHHHHHHHHHhCcC
Confidence 999999999521 00001111111000000 00000000011122366788999999999999
Q ss_pred CCCCCCHHHHHHHHHhhcC
Q 001142 1117 PTERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1117 P~~RPSa~EVL~~L~~~~s 1135 (1142)
|.+|||+.||+++|+....
T Consensus 293 P~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 293 PMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp GGGSCCHHHHHHHHHTSSC
T ss_pred CccCCCHHHHHHHhcCcch
Confidence 9999999999999987543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=350.03 Aligned_cols=271 Identities=22% Similarity=0.347 Sum_probs=209.2
Q ss_pred CCCCCCCCCcceeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCc
Q 001142 800 GLDPGSFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCI 872 (1142)
Q Consensus 800 ~~~~~~~~~y~l~~~LG~GsfG~Vy~a~~~-------~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNI 872 (1142)
.+......+|++.+.||+|+||.||+|++. +..+|+|+.. .. ........+ .+|+.++++++||||
T Consensus 23 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~--~~-~~~~~~~~~----~~E~~~l~~l~h~~i 95 (327)
T 2yfx_A 23 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP--EV-CSEQDELDF----LMEALIISKFNHQNI 95 (327)
T ss_dssp GSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECC--SS-CCHHHHHHH----HHHHHHHHHCCCTTB
T ss_pred hcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEec--cc-cchhhHHHH----HHHHHHHhhCCCCCC
Confidence 344455678999999999999999999852 3457888743 21 223333334 789999999999999
Q ss_pred cceeeeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 001142 873 VEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET--GEKHVSVKLALFIAQDVAAALVELHSKHI 950 (1142)
Q Consensus 873 Vkl~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~--~~~~ls~~~i~~Ia~qIa~gL~yLHs~gI 950 (1142)
+++++++.+.... ++||||+++++|.+++...... ....+++..+..++.||+.||.|||++||
T Consensus 96 v~~~~~~~~~~~~--------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i 161 (327)
T 2yfx_A 96 VRCIGVSLQSLPR--------------FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHF 161 (327)
T ss_dssp CCEEEEECSSSSC--------------EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CeEEEEEcCCCCc--------------EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCe
Confidence 9999999865533 9999999999999999873221 11358999999999999999999999999
Q ss_pred cccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCch
Q 001142 951 MHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLE 1030 (1142)
Q Consensus 951 vHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~k 1030 (1142)
+||||||+|||++.++ ....+||+|||++......... .......||+.|+|||++.+ ..++.+
T Consensus 162 ~H~dlkp~NIli~~~~----~~~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~ 225 (327)
T 2yfx_A 162 IHRDIAARNCLLTCPG----PGRVAKIGDFGMARDIYRASYY--------RKGGCAMLPVKWMPPEAFME----GIFTSK 225 (327)
T ss_dssp CCSCCCGGGEEESCSS----TTCCEEECCCHHHHHHHC--------------CCGGGSCGGGCCHHHHHH----CCCCHH
T ss_pred ecCcCCHhHEEEecCC----CcceEEECcccccccccccccc--------ccCCCcCCCcceeCHhHhcC----CCCCch
Confidence 9999999999998541 1257999999999754332111 11223468899999999876 568899
Q ss_pred hhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHH
Q 001142 1031 VDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVF 1109 (1142)
Q Consensus 1031 sDVwSLGviL~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI 1109 (1142)
+||||||+++|+|++ |..||......+....+..+..+..+. ..++.+.+++
T Consensus 226 ~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li 278 (327)
T 2yfx_A 226 TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK---------------------------NCPGPVYRIM 278 (327)
T ss_dssp HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHH
T ss_pred hhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCCCCC---------------------------CCCHHHHHHH
Confidence 999999999999998 999999877777776665554332211 3456799999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHhhc
Q 001142 1110 RRCTEENPTERPTAGDLYEMFVART 1134 (1142)
Q Consensus 1110 ~~CL~~DP~~RPSa~EVL~~L~~~~ 1134 (1142)
.+||+.||.+|||+.++++++|...
T Consensus 279 ~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 279 TQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhcCChhhCcCHHHHHHHHHHHh
Confidence 9999999999999999999999764
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=370.65 Aligned_cols=270 Identities=14% Similarity=0.125 Sum_probs=191.6
Q ss_pred CCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHH---HHHhhCCCCCcccee----
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEV---RMLGALRHSCIVEMY---- 876 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei---~iL~~L~HpNIVkl~---- 876 (1142)
..+|++.+.||+|+||.||+|++ .+..+|+|+....... .....+.+ .+|+ .++++++|||||+++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~-~~~~~~~~----~~E~~~l~~l~~l~hpniv~~~~~~~ 146 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERP-PSNAIKQM----KEEVLRLRLLRGIKNQKQAKVHLRFI 146 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-C-CTTHHHHH----HHHHHGGGGSTTCCSHHHHHHHHCBC
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeecccc-chHHHHHH----HHHHHHHHhccccCCHHHHHHHhhhh
Confidence 35799999999999999999996 4778999987543221 22233334 7899 455556799999999
Q ss_pred ---eeEecCCCCC---CCCCCCccccceEEEEEeccCCCCHHHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC
Q 001142 877 ---GHKISSKWLP---SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG--EKHVSVKLALFIAQDVAAALVELHSK 948 (1142)
Q Consensus 877 ---g~~~~~~~~~---~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~--~~~ls~~~i~~Ia~qIa~gL~yLHs~ 948 (1142)
+++.+.+... ...+.........++||||+ +|+|.+++....... ...+++..+..|+.||+.||+|||++
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 225 (377)
T 3byv_A 147 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY 225 (377)
T ss_dssp CCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred hhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC
Confidence 5544332100 00000111122468999999 589999998632211 12345688889999999999999999
Q ss_pred CccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhcccc------
Q 001142 949 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH------ 1022 (1142)
Q Consensus 949 gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~------ 1022 (1142)
||+||||||+|||++.+ +.+||+|||+++...... ....| +.|+|||++.+..
T Consensus 226 ~ivHrDikp~NIll~~~-------~~~kL~DFG~a~~~~~~~-------------~~~~g-~~y~aPE~~~~~~~~~~~~ 284 (377)
T 3byv_A 226 GLVHTYLRPVDIVLDQR-------GGVFLTGFEHLVRDGARV-------------VSSVS-RGFEPPELEARRATISYHR 284 (377)
T ss_dssp TEECSCCCGGGEEECTT-------CCEEECCGGGCEETTCEE-------------ECCCC-TTCCCHHHHHHHTSTHHHH
T ss_pred CeecCCCCHHHEEEcCC-------CCEEEEechhheecCCcc-------------cCCCC-cCccChhhhcccccccccc
Confidence 99999999999999977 789999999997533211 13357 8999999998620
Q ss_pred -CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhh
Q 001142 1023 -KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELET 1101 (1142)
Q Consensus 1023 -~~~~~s~ksDVwSLGviL~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1101 (1142)
....++.++|||||||++|||++|+.||.+.........+.. .. ...
T Consensus 285 ~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~~-----------------------~~---------~~~ 332 (377)
T 3byv_A 285 DRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFR-----------------------SC---------KNI 332 (377)
T ss_dssp CCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGGS-----------------------SC---------CCC
T ss_pred cccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhhh-----------------------hc---------cCC
Confidence 001688999999999999999999999975432211111100 00 144
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001142 1102 LSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1134 (1142)
Q Consensus 1102 ~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~~ 1134 (1142)
++.+.+|+.+||+.||++|||+.|+++|+|+..
T Consensus 333 ~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 333 PQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp CHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred CHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 567999999999999999999999999999874
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=367.20 Aligned_cols=256 Identities=26% Similarity=0.369 Sum_probs=203.0
Q ss_pred CCCcceeeeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~~-~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
..+|++.++||+|+||.||+|.+.+ ..||+|+.+ ..... .+.+ .+|+.+|++++||||+++++++.+ .
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~--~~~~~---~~~~----~~E~~~l~~l~hp~iv~~~~~~~~-~- 251 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMS---PEAF----LQEAQVMKKLRHEKLVQLYAVVSE-E- 251 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECC--TTSSC---HHHH----HHHHHHHHHCCCTTBCCEEEEECS-S-
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEec--cCCCC---HHHH----HHHHHHHHhCCCCCEeeEEEEEcC-C-
Confidence 3568999999999999999999965 467887743 22211 2334 799999999999999999999864 2
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
..++||||+++|+|.++++... ...+++..+..|+.||+.||+|||++||+||||||+|||++.
T Consensus 252 -------------~~~iv~e~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~ 315 (452)
T 1fmk_A 252 -------------PIYIVTEYMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE 315 (452)
T ss_dssp -------------SCEEEECCCTTCBHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred -------------ceEEEehhhcCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECC
Confidence 2389999999999999997521 235899999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||+|||+++........ ......+|+.|+|||++.. ..++.++|||||||++|||+
T Consensus 316 ~-------~~~kl~DfG~a~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~sDvwslG~~l~el~ 375 (452)
T 1fmk_A 316 N-------LVCKVADFGLARLIEDNEYT---------ARQGAKFPIKWTAPEAALY----GRFTIKSDVWSFGILLTELT 375 (452)
T ss_dssp G-------GCEEECCCCTTC-----------------------CCGGGSCHHHHHH----CCCCHHHHHHHHHHHHHHHH
T ss_pred C-------CCEEECCCccceecCCCcee---------cccCCcccccccCHhHHhc----CCCCccccHHhHHHHHHHHH
Confidence 7 78999999999765432111 1123347888999999876 56889999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1045 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1045 t-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
+ |+.||.+....++...+..+..+..+. .+++.+.+++.+||+.||++|||+
T Consensus 376 t~g~~P~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~cl~~dP~~Rpt~ 428 (452)
T 1fmk_A 376 TKGRVPYPGMVNREVLDQVERGYRMPCPP---------------------------ECPESLHDLMCQCWRKEPEERPTF 428 (452)
T ss_dssp TTTCCSSTTCCHHHHHHHHHTTCCCCCCT---------------------------TSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred hCCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHccCChhhCcCH
Confidence 9 999999888877777776554332211 455679999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 001142 1124 GDLYEMFVARTS 1135 (1142)
Q Consensus 1124 ~EVL~~L~~~~s 1135 (1142)
+++++.+.....
T Consensus 429 ~~l~~~L~~~~~ 440 (452)
T 1fmk_A 429 EYLQAFLEDYFT 440 (452)
T ss_dssp HHHHHHHHTTTS
T ss_pred HHHHHHHHHHhc
Confidence 999998876543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=349.65 Aligned_cols=277 Identities=23% Similarity=0.351 Sum_probs=192.9
Q ss_pred CCCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 882 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~ 882 (1142)
...+|++.+.||+|+||.||+|.+ .+..+|+|+...... ....+. +.+|+.++++++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~ 85 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC---QTSMDE----LLKEIQAMSQCHHPNIVSYYTSFVVK 85 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------------CCCCCCCTTBCCEEEEEESS
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc---chhHHH----HHHHHHHHhhcCCCCEeeEEEEEeec
Confidence 356899999999999999999987 466778776432211 112223 37899999999999999999999865
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET---GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~---~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~N 959 (1142)
+. .++||||+++++|.+++...... ....+++..+..++.||+.||.|||++||+||||||+|
T Consensus 86 ~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~N 151 (303)
T 2vwi_A 86 DE--------------LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGN 151 (303)
T ss_dssp SC--------------EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGG
T ss_pred CC--------------cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhh
Confidence 53 49999999999999999764322 23468999999999999999999999999999999999
Q ss_pred eeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001142 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039 (1142)
Q Consensus 960 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGvi 1039 (1142)
|+++.+ +.+||+|||++.......... .........||+.|+|||++.+. ..++.++||||||++
T Consensus 152 il~~~~-------~~~kl~dfg~~~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~Di~slG~i 216 (303)
T 2vwi_A 152 ILLGED-------GSVQIADFGVSAFLATGGDIT-----RNKVRKTFVGTPCWMAPEVMEQV---RGYDFKADIWSFGIT 216 (303)
T ss_dssp EEECTT-------CCEEECCCHHHHHCC--------------------CCCTTCCHHHHHHH---HCCCTHHHHHHHHHH
T ss_pred EEEcCC-------CCEEEEeccchheeccCCCcc-----chhhhcccCCCccccCHHHhccc---cCCCchhhHHHHHHH
Confidence 999877 789999999987654321110 00112245699999999998642 347899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001142 1040 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1119 (1142)
Q Consensus 1040 L~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~ 1119 (1142)
+|+|++|+.||.................+........ .......++.+.+++.+||+.||.+
T Consensus 217 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~li~~~l~~dp~~ 278 (303)
T 2vwi_A 217 AIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQD------------------KEMLKKYGKSFRKMISLCLQKDPEK 278 (303)
T ss_dssp HHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----------------------CCCCCCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHHhCCCCCccCchhhHHHHHhccCCCcccccccc------------------chhhhhhhHHHHHHHHHHccCChhh
Confidence 9999999999987665554433333332222111100 0000144567999999999999999
Q ss_pred CCCHHHHHHHHHhhcC
Q 001142 1120 RPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1120 RPSa~EVL~~L~~~~s 1135 (1142)
|||+.++++|+|+...
T Consensus 279 Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 279 RPTAAELLRHKFFQKA 294 (303)
T ss_dssp SCCHHHHHTSTTC---
T ss_pred CcCHHHHhhChhhhcC
Confidence 9999999999999754
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=345.47 Aligned_cols=267 Identities=24% Similarity=0.364 Sum_probs=195.7
Q ss_pred CCcceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC--CCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL--RHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L--~HpNIVkl~g~~~~~~~ 884 (1142)
++|++.++||+|+||.||+|++.+..+|+|+.... . ...+ .+|.+++..+ +||||+++++++.....
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~------~-~~~~----~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTT------E-EASW----FRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGG------G-HHHH----HHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred cceEEEeEeecCCCeEEEEEEECCceEEEEEEecc------c-cchh----hhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 46999999999999999999999999999986422 1 1112 3566666554 89999999999876421
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CccccCCC
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK--------HIMHRDIK 956 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~--------gIvHrDLK 956 (1142)
.....++||||+++++|.++++. ..+++..+..++.|++.||.|||++ ||+|||||
T Consensus 106 ----------~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dik 169 (337)
T 3mdy_A 106 ----------SWTQLYLITDYHENGSLYDYLKS------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLK 169 (337)
T ss_dssp ----------GGCEEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCC
T ss_pred ----------CCCceEEEEeccCCCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccc
Confidence 12356999999999999999976 3599999999999999999999998 99999999
Q ss_pred CCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCC--CCchhhHH
Q 001142 957 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL--YGLEVDIW 1034 (1142)
Q Consensus 957 p~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~--~s~ksDVw 1034 (1142)
|+|||++.+ +.+||+|||+++......... ........||+.|+|||++.+...... ++.++|||
T Consensus 170 p~Nill~~~-------~~~kl~Dfg~a~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Diw 236 (337)
T 3mdy_A 170 SKNILVKKN-------GTCCIADLGLAVKFISDTNEV------DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMY 236 (337)
T ss_dssp GGGEEECTT-------SCEEECCCTTCEECC---------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHH
T ss_pred hHHEEECCC-------CCEEEEeCCCceeeccccccc------cCCCCCCccCcceeChhhcccccCCccccCccccchH
Confidence 999999877 789999999997654322110 011224579999999999876221111 11249999
Q ss_pred HHHHHHHHHHhC----------CCCCCCCC-----HHHHHHHHH-hCCCCCchhHHhhhcccccccccccCCCCCCchhh
Q 001142 1035 SYGCLLLELLTL----------QVPYMGLS-----ELEIHDLIQ-MGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 1098 (1142)
Q Consensus 1035 SLGviL~ELLtG----------~~Pf~~~~-----~~el~~~I~-~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1142)
||||++|||++| +.||.... .......+. ....+..+.. ...
T Consensus 237 slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~ 294 (337)
T 3mdy_A 237 SFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNR----------------------WSS 294 (337)
T ss_dssp HHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGG----------------------GGG
T ss_pred HHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCcccccc----------------------chh
Confidence 999999999999 66665321 112222221 1111111111 111
Q ss_pred hhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001142 1099 LETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1099 ~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~~s 1135 (1142)
..+++.+.+|+.+||+.||.+|||+.||++++.....
T Consensus 295 ~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 295 DECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp SHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 2677889999999999999999999999999887643
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=342.88 Aligned_cols=279 Identities=23% Similarity=0.334 Sum_probs=200.4
Q ss_pred CCCCCCC--CcceeeeecccCceEEEEEEE------CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCc
Q 001142 801 LDPGSFP--SLSSCDEAGKSVSSSLFRCKF------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCI 872 (1142)
Q Consensus 801 ~~~~~~~--~y~l~~~LG~GsfG~Vy~a~~------~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNI 872 (1142)
+++..+. .|++.+.||+|+||.||+|++ .+..+|+|+..... .....+. +.+|+.++++++||||
T Consensus 13 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~----~~~E~~~l~~l~h~~i 85 (302)
T 4e5w_A 13 VDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES---GGNHIAD----LKKEIEILRNLYHENI 85 (302)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC--------CCHHH----HHHHHHHHHTCCCTTB
T ss_pred cChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc---cchhHHH----HHHHHHHHHhCCCCCe
Confidence 3444443 489999999999999999995 46778888864332 1112223 3799999999999999
Q ss_pred cceeeeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 001142 873 VEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 952 (1142)
Q Consensus 873 Vkl~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvH 952 (1142)
+++++++.+.+. ...++||||+++++|.+++... ...+++..+..++.||+.||+|||++||+|
T Consensus 86 ~~~~~~~~~~~~------------~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H 149 (302)
T 4e5w_A 86 VKYKGICTEDGG------------NGIKLIMEFLPSGSLKEYLPKN----KNKINLKQQLKYAVQICKGMDYLGSRQYVH 149 (302)
T ss_dssp CCEEEEEEC---------------CCEEEEEECCTTCBHHHHHHHH----TTTCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred eeeeeEEecCCC------------ceEEEEEEeCCCCcHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHhhcCCccc
Confidence 999999886421 1459999999999999999652 246899999999999999999999999999
Q ss_pred cCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhh
Q 001142 953 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 1032 (1142)
Q Consensus 953 rDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksD 1032 (1142)
|||||+|||++.+ +.+||+|||++.......... .......||..|+|||++.+ ..++.++|
T Consensus 150 ~dikp~Nil~~~~-------~~~kl~Dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~D 211 (302)
T 4e5w_A 150 RDLAARNVLVESE-------HQVKIGDFGLTKAIETDKEYY-------TVKDDRDSPVFWYAPECLMQ----SKFYIASD 211 (302)
T ss_dssp SCCSGGGEEEEET-------TEEEECCCTTCEECCTTCCEE-------ECCCCTTCCGGGCCHHHHHH----CEEEHHHH
T ss_pred CCCchheEEEcCC-------CCEEECcccccccccCCCcce-------eccCCCCCCccccCCeeecC----CCCCcchh
Confidence 9999999999887 789999999997654422110 11223468889999999876 46779999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHh
Q 001142 1033 IWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 1112 (1142)
Q Consensus 1033 VwSLGviL~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~C 1112 (1142)
|||||+++|+|++|..|+.. .............. ........ .......... .....++.+.+++.+|
T Consensus 212 i~slG~il~~l~~g~~p~~~--~~~~~~~~~~~~~~--~~~~~~~~-----~~~~~~~~~~---~~~~~~~~l~~li~~~ 279 (302)
T 4e5w_A 212 VWSFGVTLHELLTYCDSDSS--PMALFLKMIGPTHG--QMTVTRLV-----NTLKEGKRLP---CPPNCPDEVYQLMRKC 279 (302)
T ss_dssp HHHHHHHHHHHHTTTCGGGS--HHHHHHHHHCSCCG--GGHHHHHH-----HHHHTTCCCC---CCTTCCHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHccCCCcc--hhhHHhhccCCccc--ccCHHHHH-----HHHhccCCCC---CCCCCCHHHHHHHHHH
Confidence 99999999999999998753 22111111111000 00000000 0000000000 1115567899999999
Q ss_pred cccCCCCCCCHHHHHHHHHh
Q 001142 1113 TEENPTERPTAGDLYEMFVA 1132 (1142)
Q Consensus 1113 L~~DP~~RPSa~EVL~~L~~ 1132 (1142)
|+.||.+|||+.++++.+..
T Consensus 280 l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 280 WEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp TCSSGGGSCCHHHHHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHH
Confidence 99999999999999998764
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=340.08 Aligned_cols=253 Identities=24% Similarity=0.395 Sum_probs=202.9
Q ss_pred CCCcceeeeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~~-~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
.++|++.+.||+|+||.||+|.+.+ ..+|+|+.... ... .+.+ .+|++++++++||||+++++++.+..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~---~~~~----~~E~~~l~~l~h~~i~~~~~~~~~~~- 81 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG--SMS---PDAF----LAEANLMKQLQHQRLVRLYAVVTQEP- 81 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT--SSC---HHHH----HHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCC--ccc---HHHH----HHHHHHHHhCCCcCcceEEEEEcCCC-
Confidence 3579999999999999999999854 46888875422 111 2233 78999999999999999999876322
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
.++||||+++++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+||+++.
T Consensus 82 --------------~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~ 144 (279)
T 1qpc_A 82 --------------IYIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSD 144 (279)
T ss_dssp --------------CEEEEECCTTCBHHHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred --------------cEEEEecCCCCCHHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcC
Confidence 389999999999999986421 125899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||+|||.+......... ......+++.|+|||++.+ ..++.++||||||+++|+|+
T Consensus 145 ~-------~~~kl~Dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~el~ 204 (279)
T 1qpc_A 145 T-------LSCKIADFGLARLIEDNEYT---------AREGAKFPIKWTAPEAINY----GTFTIKSDVWSFGILLTEIV 204 (279)
T ss_dssp T-------SCEEECCCTTCEECSSSCEE---------CCTTCCCCTTTSCHHHHHH----CEECHHHHHHHHHHHHHHHH
T ss_pred C-------CCEEECCCcccccccCcccc---------cccCCCCccCccChhhhcc----CCCCchhhhHHHHHHHHHHH
Confidence 7 78999999999765432211 1123357889999999875 46789999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1045 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1045 t-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
+ |+.||.+....+....+..+..+..+ ...++.+.+++.+||+.||++|||+
T Consensus 205 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~~l~~~p~~Rps~ 257 (279)
T 1qpc_A 205 THGRIPYPGMTNPEVIQNLERGYRMVRP---------------------------DNCPEELYQLMRLCWKERPEDRPTF 257 (279)
T ss_dssp TTTCCSSTTCCHHHHHHHHHTTCCCCCC---------------------------TTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred hCCCCCCcccCHHHHHHHHhcccCCCCc---------------------------ccccHHHHHHHHHHhccChhhCCCH
Confidence 9 99999987777776666544322211 1445679999999999999999999
Q ss_pred HHHHHHHHh
Q 001142 1124 GDLYEMFVA 1132 (1142)
Q Consensus 1124 ~EVL~~L~~ 1132 (1142)
.++++.+..
T Consensus 258 ~~l~~~l~~ 266 (279)
T 1qpc_A 258 DYLRSVLED 266 (279)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 999987654
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=349.26 Aligned_cols=275 Identities=24% Similarity=0.358 Sum_probs=202.0
Q ss_pred CCCcceeeeecccCceEEEEEEE------CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeE
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKF------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 879 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~------~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~ 879 (1142)
-.+|++.+.||+|+||.||+|++ .+..+|+|+.... .....+.+ .+|+.++++++||||+++++++
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~----~~E~~~l~~l~h~~i~~~~~~~ 93 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS----GPDQQRDF----QREIQILKALHSDFIVKYRGVS 93 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC----CHHHHHHH----HHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC----CHHHHHHH----HHHHHHHHhcCCCceeEEEEEE
Confidence 45799999999999999999995 4566788875322 23333334 8999999999999999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 001142 880 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959 (1142)
Q Consensus 880 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~N 959 (1142)
...+. ...++||||+++++|.+++... ...+++..+..|+.||+.||+|||++||+||||||+|
T Consensus 94 ~~~~~------------~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~N 157 (327)
T 3lxl_A 94 YGPGR------------QSLRLVMEYLPSGCLRDFLQRH----RARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARN 157 (327)
T ss_dssp ECSSS------------CEEEEEEECCTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred ecCCC------------ceEEEEEeecCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhh
Confidence 75321 2469999999999999999763 2358999999999999999999999999999999999
Q ss_pred eeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001142 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039 (1142)
Q Consensus 960 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGvi 1039 (1142)
||++.+ +.+||+|||++........... ......||+.|+|||++.+ ..++.++||||||++
T Consensus 158 Il~~~~-------~~~kl~Dfg~~~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~i 219 (327)
T 3lxl_A 158 ILVESE-------AHVKIADFGLAKLLPLDKDYYV-------VREPGQSPIFWYAPESLSD----NIFSRQSDVWSFGVV 219 (327)
T ss_dssp EEEEET-------TEEEECCGGGCEECCTTCSEEE-------CSSCCCSCGGGSCHHHHHH----CEEEHHHHHHHHHHH
T ss_pred EEECCC-------CCEEEcccccceecccCCccce-------eeccCCccccccCHHHhcc----CCCChHHhHHHHHHH
Confidence 999887 7899999999986543221110 1123458889999999876 457899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHH-hCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001142 1040 LLELLTLQVPYMGLSELEIHDLIQ-MGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1118 (1142)
Q Consensus 1040 L~ELLtG~~Pf~~~~~~el~~~I~-~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~ 1118 (1142)
+|+|++|+.||...... ...... ....+......... ...... ......++.+.+|+.+||+.||.
T Consensus 220 l~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~---------~~~~~~---~~~~~~~~~l~~li~~~l~~dP~ 286 (327)
T 3lxl_A 220 LYELFTYCDKSCSPSAE-FLRMMGCERDVPALSRLLELL---------EEGQRL---PAPPACPAEVHELMKLCWAPSPQ 286 (327)
T ss_dssp HHHHHTTTCGGGSHHHH-HHHHCC----CCHHHHHHHHH---------HTTCCC---CCCTTCCHHHHHHHHHHTCSSGG
T ss_pred HHHHHhCCCCCccccch-hhhhcccccccccHHHHHHHh---------hcccCC---CCCCcccHHHHHHHHHHcCCChh
Confidence 99999999999753221 111110 00111000000000 000000 01125667899999999999999
Q ss_pred CCCCHHHHHHHHHhhcC
Q 001142 1119 ERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1119 ~RPSa~EVL~~L~~~~s 1135 (1142)
+|||+.|+++++.....
T Consensus 287 ~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 287 DRPSFSALGPQLDMLWS 303 (327)
T ss_dssp GSCCHHHHHHHHHHC--
T ss_pred hCcCHHHHHHHHHHHHh
Confidence 99999999998876533
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=360.73 Aligned_cols=291 Identities=20% Similarity=0.250 Sum_probs=186.8
Q ss_pred cce-eeeecccCceEEEEEEEC----CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 809 LSS-CDEAGKSVSSSLFRCKFG----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 809 y~l-~~~LG~GsfG~Vy~a~~~----~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
|++ .++||+|+||+||+|++. +..+|+|+.. ..... .. +.+|+.++++++|||||++++++....
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~--~~~~~----~~----~~~E~~~l~~l~hpniv~~~~~~~~~~ 91 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE--GTGIS----MS----ACREIALLRELKHPNVISLQKVFLSHA 91 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECS--SSSCC----HH----HHHHHHHHHHCCCTTBCCCCEEEEETT
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEEC--CCCCC----HH----HHHHHHHHHhcCCCCeeeEeeEEecCC
Confidence 555 568999999999999964 5568888743 22111 12 368999999999999999999986532
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET----GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~----~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~N 959 (1142)
. ...++||||++ ++|.+++...... ....+++..++.|+.||+.||.|||++||+||||||+|
T Consensus 92 ~------------~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~N 158 (405)
T 3rgf_A 92 D------------RKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPAN 158 (405)
T ss_dssp T------------TEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred C------------CeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHH
Confidence 1 25699999997 6898888653321 12358999999999999999999999999999999999
Q ss_pred eeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001142 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039 (1142)
Q Consensus 960 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGvi 1039 (1142)
||+..+. ...+.+||+|||+|+........ ........||+.|+|||++.+ ...++.++|||||||+
T Consensus 159 Ill~~~~---~~~~~~kl~Dfg~a~~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwSlG~i 225 (405)
T 3rgf_A 159 ILVMGEG---PERGRVKIADMGFARLFNSPLKP-------LADLDPVVVTFWYRAPELLLG---ARHYTKAIDIWAIGCI 225 (405)
T ss_dssp EEECCSS---TTTTCEEECCTTCCC-----------------------CCCTTCCHHHHTT---CCSCCHHHHHHHHHHH
T ss_pred eEEecCC---CCCCcEEEEECCCceecCCCCcc-------cccCCCceecCcccCchhhcC---CCcccchhhhHHHHHH
Confidence 9994320 11278999999999765432111 011224579999999999875 2358899999999999
Q ss_pred HHHHHhCCCCCCCCCHH---------HHHHHH-HhCCCCCchhHHhhhccccccc-cc-ccC-CCCCCch-------hhh
Q 001142 1040 LLELLTLQVPYMGLSEL---------EIHDLI-QMGKRPRLTDELEALGSCHEHE-VA-QSG-SGFEKPE-------AEL 1099 (1142)
Q Consensus 1040 L~ELLtG~~Pf~~~~~~---------el~~~I-~~~~~p~l~~~l~~~~~~~~~~-~~-~~~-~~~~~~~-------~~~ 1099 (1142)
+|+|++|+.||.+.... +....+ .....+... .+.......... .. ... ..+.... ...
T Consensus 226 l~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (405)
T 3rgf_A 226 FAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADK-DWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV 304 (405)
T ss_dssp HHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTT-TCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTC
T ss_pred HHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChh-hcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCC
Confidence 99999999999764431 222222 221111111 000000000000 00 000 0000000 000
Q ss_pred hhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 001142 1100 ETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSS 1136 (1142)
Q Consensus 1100 ~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~~ss 1136 (1142)
..++.+.+||.+||+.||.+|||++|+++|+|+....
T Consensus 305 ~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~ 341 (405)
T 3rgf_A 305 KPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDP 341 (405)
T ss_dssp CTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSS
T ss_pred CCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCC
Confidence 1245689999999999999999999999999998653
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=348.52 Aligned_cols=262 Identities=23% Similarity=0.344 Sum_probs=203.1
Q ss_pred CCCCcceeeeecccCceEEEEEEECC-------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCcccee
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMY 876 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~~~-------~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~ 876 (1142)
...+|++.+.||+|+||.||+|.+.+ ..+|+|+.... ......+.+ .+|+.+++++ +||||++++
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~----~~E~~~l~~l~~h~~iv~~~ 116 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST---AHADEKEAL----MSELKIMSHLGQHENIVNLL 116 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTT---CCHHHHHHH----HHHHHHHHHHCCCTTBCCEE
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccc---cChHHHHHH----HHHHHHHHhhcCCCCeeeEE
Confidence 35679999999999999999999843 25777775322 122333334 7999999999 899999999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc---------CCCCCCHHHHHHHHHHHHHHHHHHHh
Q 001142 877 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET---------GEKHVSVKLALFIAQDVAAALVELHS 947 (1142)
Q Consensus 877 g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~---------~~~~ls~~~i~~Ia~qIa~gL~yLHs 947 (1142)
+++.+.+.. ++||||+++|+|.+++...... ....+++..+..++.||+.||.|||+
T Consensus 117 ~~~~~~~~~--------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~ 182 (333)
T 2i1m_A 117 GACTHGGPV--------------LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS 182 (333)
T ss_dssp EEECSSSSC--------------EEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEecCCce--------------EEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc
Confidence 999865543 9999999999999999764321 12458999999999999999999999
Q ss_pred CCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCC
Q 001142 948 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 1027 (1142)
Q Consensus 948 ~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~ 1027 (1142)
+||+||||||+|||++.+ +.+||+|||++......... .......||+.|+|||++.+ ..+
T Consensus 183 ~~ivH~Dlkp~NIl~~~~-------~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~ 243 (333)
T 2i1m_A 183 KNCIHRDVAARNVLLTNG-------HVAKIGDFGLARDIMNDSNY--------IVKGNARLPVKWMAPESIFD----CVY 243 (333)
T ss_dssp TTEECSCCSGGGCEEEGG-------GEEEBCCCGGGCCGGGCTTS--------EECSSCEECGGGSCHHHHHH----CCC
T ss_pred CCcccCCcccceEEECCC-------CeEEECccccccccccccce--------eecCCCCCCccccCHHHhcc----CCC
Confidence 999999999999999887 78999999999765432111 01223457889999999876 568
Q ss_pred CchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH-HHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHH
Q 001142 1028 GLEVDIWSYGCLLLELLT-LQVPYMGLSELEIH-DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFL 1105 (1142)
Q Consensus 1028 s~ksDVwSLGviL~ELLt-G~~Pf~~~~~~el~-~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 1105 (1142)
+.++||||||+++|+|++ |..||.+....... ..+.....+..+ ...++.+
T Consensus 244 ~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l 296 (333)
T 2i1m_A 244 TVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQP---------------------------AFAPKNI 296 (333)
T ss_dssp CHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCCCC---------------------------TTCCHHH
T ss_pred ChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCCCC---------------------------CCCCHHH
Confidence 899999999999999998 99999875443332 333322221111 1345678
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001142 1106 VDVFRRCTEENPTERPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1106 ~dLI~~CL~~DP~~RPSa~EVL~~L~~~ 1133 (1142)
.+++.+||+.||.+|||+.|+++++...
T Consensus 297 ~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 297 YSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 9999999999999999999999988754
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=342.57 Aligned_cols=264 Identities=25% Similarity=0.354 Sum_probs=199.3
Q ss_pred CCCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001142 804 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 881 (1142)
Q Consensus 804 ~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~ 881 (1142)
+.+++|.....||+|+||.||+|.+. +..||+|+.... . ....+.+ .+|+.++++++||||+++++++..
T Consensus 19 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~--~~~~~~~----~~e~~~l~~l~h~~iv~~~~~~~~ 90 (295)
T 2clq_A 19 YEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER--D--SRYSQPL----HEEIALHKHLKHKNIVQYLGSFSE 90 (295)
T ss_dssp ECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC--C--C---HHH----HHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred ccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC--c--hHHHHHH----HHHHHHHHhCCCCCEeeEeeEEEe
Confidence 33455667779999999999999984 556777765422 1 1222333 789999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 001142 882 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 961 (1142)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NIL 961 (1142)
.+ ..++||||+++++|.+++... .....+++..+..++.||+.||.|||++||+||||||+||+
T Consensus 91 ~~--------------~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil 154 (295)
T 2clq_A 91 NG--------------FIKIFMEQVPGGSLSALLRSK--WGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVL 154 (295)
T ss_dssp TT--------------EEEEEEECCSEEEHHHHHHHT--TCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred CC--------------cEEEEEEeCCCCCHHHHHHhh--ccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEE
Confidence 54 349999999999999999762 22345789999999999999999999999999999999999
Q ss_pred ecc-ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 962 IDL-ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 962 ld~-~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
++. + +.+||+|||.+........ ......||+.|+|||++.+.. ..++.++||||||+++
T Consensus 155 ~~~~~-------~~~kl~Dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~--~~~~~~~Di~slG~il 215 (295)
T 2clq_A 155 INTYS-------GVLKISDFGTSKRLAGINP----------CTETFTGTLQYMAPEIIDKGP--RGYGKAADIWSLGCTI 215 (295)
T ss_dssp EETTT-------CCEEECCTTTCEESCC---------------CCCCCCGGGCCHHHHHHGG--GGCSHHHHHHHHHHHH
T ss_pred EECCC-------CCEEEeecccccccCCCCC----------cccccCCCccccChhhhcCCC--CCCCcHHHHHHHHHHH
Confidence 986 4 7899999999976543211 112346899999999987521 2378999999999999
Q ss_pred HHHHhCCCCCCCCCHHHH--HHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001142 1041 LELLTLQVPYMGLSELEI--HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1118 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~~~~~el--~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~ 1118 (1142)
|+|++|+.||........ .........+.++ ...++.+.+++.+||+.||+
T Consensus 216 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~dp~ 268 (295)
T 2clq_A 216 IEMATGKPPFYELGEPQAAMFKVGMFKVHPEIP---------------------------ESMSAEAKAFILKCFEPDPD 268 (295)
T ss_dssp HHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCC---------------------------TTSCHHHHHHHHHTTCSSTT
T ss_pred HHHHHCCCCccCCCchhHHHHhhcccccccccc---------------------------ccCCHHHHHHHHHHccCChh
Confidence 999999999975432221 1111111111111 14556799999999999999
Q ss_pred CCCCHHHHHHHHHhhcCCC
Q 001142 1119 ERPTAGDLYEMFVARTSSS 1137 (1142)
Q Consensus 1119 ~RPSa~EVL~~L~~~~ss~ 1137 (1142)
+|||+.++++|+|++....
T Consensus 269 ~Rps~~~ll~~~~~~~~~~ 287 (295)
T 2clq_A 269 KRACANDLLVDEFLKVSSK 287 (295)
T ss_dssp TSCCHHHHHTSGGGCC---
T ss_pred hCCCHHHHhcChhhhhccc
Confidence 9999999999999986643
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=358.82 Aligned_cols=262 Identities=23% Similarity=0.344 Sum_probs=193.3
Q ss_pred CcceeeeecccCceEEEEEEEC---CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFG---SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~---~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
.|++.++||+|+||+||+|++. +..+.++++.++... .....+.+ .+|+.++++++||||+++++++...+.
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~----~~E~~il~~l~hpnIv~~~~~~~~~~~ 164 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQF----LTEGIIMKDFSHPNVLSLLGICLRSEG 164 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHH----HHHHTTSTTCCCTTBCCCCEEECCCSS
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHH----HHHHHHHHhCCCCCcceEEEEEEcCCC
Confidence 4789999999999999999873 233444444444322 22333444 799999999999999999998754321
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
..++||||+++++|.++++. ....+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 165 -------------~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~ 227 (373)
T 3c1x_A 165 -------------SPLVVLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDE 227 (373)
T ss_dssp -------------CCEEEEECCTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred -------------CeEEEEECCCCCCHHHHHhh----cccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECC
Confidence 23899999999999999964 2346899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||+|||+++........ .........+|+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 228 ~-------~~~kL~DFG~a~~~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~DvwSlG~il~ell 290 (373)
T 3c1x_A 228 K-------FTVKVADFGLARDMYDKEFD------SVHNKTGAKLPVKWMALESLQT----QKFTTKSDVWSFGVLLWELM 290 (373)
T ss_dssp T-------CCEEECCC---------------------------CCGGGSCHHHHHH----CCCCHHHHHHHHHHHHHHHH
T ss_pred C-------CCEEEeeccccccccccccc------cccccCCCCCcccccChHHhcC----CCCCcHHHHHHHHHHHHHHH
Confidence 7 78999999999765332111 0011123457889999999876 56889999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1045 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1045 t-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
+ |.+||.+....+....+..+..+..+ ..+++.+.+++.+||+.||++|||+
T Consensus 291 t~~~~p~~~~~~~~~~~~~~~~~~~~~p---------------------------~~~~~~l~~li~~cl~~dp~~RPs~ 343 (373)
T 3c1x_A 291 TRGAPPYPDVNTFDITVYLLQGRRLLQP---------------------------EYCPDPLYEVMLKCWHPKAEMRPSF 343 (373)
T ss_dssp TTSCCSCTTSCSSCHHHHHHTTCCCCCC---------------------------TTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred hCcCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------CCCCHHHHHHHHHHcCCChhhCcCH
Confidence 9 78888766555555555444332211 1345679999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 001142 1124 GDLYEMFVARTS 1135 (1142)
Q Consensus 1124 ~EVL~~L~~~~s 1135 (1142)
.|+++++.....
T Consensus 344 ~ell~~L~~i~~ 355 (373)
T 3c1x_A 344 SELVSRISAIFS 355 (373)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHH
Confidence 999999877543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=355.19 Aligned_cols=284 Identities=24% Similarity=0.257 Sum_probs=200.6
Q ss_pred CCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC--------CCCccce
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR--------HSCIVEM 875 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~--------HpNIVkl 875 (1142)
..+|++.++||+|+||+||+|++. +..||+|+... .....+. +.+|+.++++++ ||||+++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~----~~~E~~~l~~l~~~~~~~~~~~~iv~~ 106 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS-----AEHYTET----ALDEIRLLKSVRNSDPNDPNREMVVQL 106 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-----CHHHHHH----HHHHHHHHHHHHHSCTTCGGGGGBCCE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec-----CCcchHH----HHHHHHHHHHHhhcCCCCCCcceeeee
Confidence 357999999999999999999874 56788887531 1222233 378999999885 7889999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccC
Q 001142 876 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRD 954 (1142)
Q Consensus 876 ~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~-gIvHrD 954 (1142)
++++..... ...+.++||||+ +++|.+.+.. .....+++..++.|+.||+.||.|||++ ||+|||
T Consensus 107 ~~~~~~~~~----------~~~~~~lv~e~~-~~~l~~~~~~---~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrD 172 (397)
T 1wak_A 107 LDDFKISGV----------NGTHICMVFEVL-GHHLLKWIIK---SNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTD 172 (397)
T ss_dssp EEEEEEEET----------TEEEEEEEECCC-CCBHHHHHHH---TTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCC
T ss_pred ecceeecCC----------CCceEEEEEecc-CccHHHHHHh---cccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCC
Confidence 999874221 123569999999 5777777765 2235699999999999999999999998 999999
Q ss_pred CCCCCeeeccccc------------------------------------------cCCCCCeEEEeecCCcccccccccc
Q 001142 955 IKSENILIDLERK------------------------------------------KADGKPVVKLCDFDRAVPLRSFLHT 992 (1142)
Q Consensus 955 LKp~NILld~~~~------------------------------------------~~~~~~~vKL~DFGlA~~l~~~~~~ 992 (1142)
|||+|||++.++. .......+||+|||.+......
T Consensus 173 ikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--- 249 (397)
T 1wak_A 173 IKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--- 249 (397)
T ss_dssp CSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---
T ss_pred CCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---
Confidence 9999999986520 0001137999999999765321
Q ss_pred cccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHH-H-h
Q 001142 993 CCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLS------ELEIHDLI-Q-M 1064 (1142)
Q Consensus 993 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~Pf~~~~------~~el~~~I-~-~ 1064 (1142)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+ .......+ . .
T Consensus 250 ----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 315 (397)
T 1wak_A 250 ----------FTEDIQTRQYRSLEVLIG----SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELL 315 (397)
T ss_dssp ----------SCSCCSCGGGCCHHHHHT----SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHH
T ss_pred ----------CccCCCCCcccCChhhcC----CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhc
Confidence 123468999999999986 568899999999999999999999997543 22222222 1 1
Q ss_pred CCCCCchhHHhhhccccccccccc------CCCCCC----------chhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001142 1065 GKRPRLTDELEALGSCHEHEVAQS------GSGFEK----------PEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1128 (1142)
Q Consensus 1065 ~~~p~l~~~l~~~~~~~~~~~~~~------~~~~~~----------~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~ 1128 (1142)
+..+. ........ ...+... ...... .......++.+.+||.+||+.||++|||+.|+++
T Consensus 316 ~~~p~---~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 316 GKVPR---KLIVAGKY-SKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CSCCH---HHHHHCTT-GGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CCCCh---HHhhcccc-cccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 11111 00000000 0000000 000000 0112356778999999999999999999999999
Q ss_pred HHHhh
Q 001142 1129 MFVAR 1133 (1142)
Q Consensus 1129 ~L~~~ 1133 (1142)
|+|+.
T Consensus 392 hp~~~ 396 (397)
T 1wak_A 392 HPWLN 396 (397)
T ss_dssp SGGGG
T ss_pred Ccccc
Confidence 99986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=337.96 Aligned_cols=262 Identities=22% Similarity=0.289 Sum_probs=201.0
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
.+|++.+.||+|+||.||+|.+. +..+|+|+..... +.+ .+|+.++++++||||+++++++.....
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~----~~e~~~l~~l~h~~i~~~~~~~~~~~~ 78 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--------EKA----EREVKALAKLDHVNIVHYNGCWDGFDY 78 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS--------GGG----HHHHHHHHHCCCTTBCCEEEEEEEEEE
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc--------HHH----HHHHHHHHhCCCCCEEEEeeeEecccc
Confidence 46899999999999999999985 7778888765321 123 689999999999999999998865221
Q ss_pred CCCCC--CCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 885 LPSAD--GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 885 ~~~~~--~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
.+... ..........++||||+++++|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 155 (284)
T 2a19_B 79 DPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR---RGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFL 155 (284)
T ss_dssp C---------CCEEEEEEEEECCCCSCBHHHHHHHG---GGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred CcccccccccccCcceEEEEEeccCCCCHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEE
Confidence 10000 00011233579999999999999999863 22468999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
+.+ +.+||+|||++....... ......||+.|+|||++.+ ..++.++||||||+++|+
T Consensus 156 ~~~-------~~~kl~Dfg~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~ 213 (284)
T 2a19_B 156 VDT-------KQVKIGDFGLVTSLKNDG-----------KRTRSKGTLRYMSPEQISS----QDYGKEVDLYALGLILAE 213 (284)
T ss_dssp EET-------TEEEECCCTTCEESSCCS-----------CCCCCCSCCTTSCHHHHHC----SCCCTHHHHHHHHHHHHH
T ss_pred cCC-------CCEEECcchhheeccccc-----------cccccCCcccccChhhhcc----CCCcchhhhHHHHHHHHH
Confidence 887 789999999997654321 1123458999999999876 567899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1043 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1043 LLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
|++|..||.. .......+.....+ ...+..+.+++.+||+.||.+|||
T Consensus 214 l~~~~~~~~~--~~~~~~~~~~~~~~------------------------------~~~~~~~~~li~~~l~~dp~~Rps 261 (284)
T 2a19_B 214 LLHVCDTAFE--TSKFFTDLRDGIIS------------------------------DIFDKKEKTLLQKLLSKKPEDRPN 261 (284)
T ss_dssp HHSCCSSHHH--HHHHHHHHHTTCCC------------------------------TTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHhcCCcchh--HHHHHHHhhccccc------------------------------ccCCHHHHHHHHHHccCChhhCcC
Confidence 9999988742 22222222221110 033456899999999999999999
Q ss_pred HHHHHHHHHhhcCCC
Q 001142 1123 AGDLYEMFVARTSSS 1137 (1142)
Q Consensus 1123 a~EVL~~L~~~~ss~ 1137 (1142)
+.|++++++....+.
T Consensus 262 ~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 262 TSEILRTLTVWKKSP 276 (284)
T ss_dssp HHHHHHHHHHHTC--
T ss_pred HHHHHHHHHHHhhCC
Confidence 999999999886654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=345.23 Aligned_cols=262 Identities=23% Similarity=0.370 Sum_probs=202.6
Q ss_pred CCCcceeeeecccCceEEEEEEE-------CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceee
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKF-------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYG 877 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~-------~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g 877 (1142)
.++|++.+.||+|+||+||+|++ .+..+|+|+.... ......+.+ .+|+.++.++ +||||+++++
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~----~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG---ATHSEHRAL----MSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT---CCHHHHHHH----HHHHHHHHHHCCCTTBCCEEE
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC---CCcHHHHHH----HHHHHHHHhcccCCCeeeEEE
Confidence 45799999999999999999985 2356888875422 223333334 7999999999 6999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc-----------CCCCCCHHHHHHHHHHHHHHHHHHH
Q 001142 878 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAALVELH 946 (1142)
Q Consensus 878 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~-----------~~~~ls~~~i~~Ia~qIa~gL~yLH 946 (1142)
++...+. ..++||||+++++|.+++...... ....+++..+..++.||+.||.|||
T Consensus 99 ~~~~~~~-------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH 165 (316)
T 2xir_A 99 ACTKPGG-------------PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA 165 (316)
T ss_dssp EECCTTS-------------CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH
T ss_pred EEecCCC-------------ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH
Confidence 9875432 249999999999999999752110 0123899999999999999999999
Q ss_pred hCCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCC
Q 001142 947 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 1026 (1142)
Q Consensus 947 s~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 1026 (1142)
++||+||||||+|||++.+ +.+||+|||+++........ .......||+.|+|||++.+ ..
T Consensus 166 ~~~i~H~dikp~Nil~~~~-------~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~----~~ 226 (316)
T 2xir_A 166 SRKCIHRDLAARNILLSEK-------NVVKICDFGLARDIYKDPDY--------VRKGDARLPLKWMAPETIFD----RV 226 (316)
T ss_dssp HTTCCCSCCSGGGEEECGG-------GCEEECCCGGGSCTTTCTTS--------EEETTEEECGGGCCHHHHHH----CC
T ss_pred hCCcccccCccceEEECCC-------CCEEECCCccccccccCccc--------eeccCCCcceeecCchhhcc----cc
Confidence 9999999999999999877 78999999999765332111 01123457889999999876 56
Q ss_pred CCchhhHHHHHHHHHHHHh-CCCCCCCCCHH-HHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHH
Q 001142 1027 YGLEVDIWSYGCLLLELLT-LQVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF 1104 (1142)
Q Consensus 1027 ~s~ksDVwSLGviL~ELLt-G~~Pf~~~~~~-el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1104 (1142)
++.++||||||+++|+|++ |..||.+.... .....+..+..+..+. ..++.
T Consensus 227 ~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~ 279 (316)
T 2xir_A 227 YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD---------------------------YTTPE 279 (316)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCT---------------------------TCCHH
T ss_pred ccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccCCCCC---------------------------CCCHH
Confidence 8899999999999999998 99999875433 3334444433222111 34567
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001142 1105 LVDVFRRCTEENPTERPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1105 L~dLI~~CL~~DP~~RPSa~EVL~~L~~~ 1133 (1142)
+.+++.+||+.||.+|||+.|+++++...
T Consensus 280 l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 280 MYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 99999999999999999999999998764
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=345.60 Aligned_cols=286 Identities=21% Similarity=0.241 Sum_probs=206.9
Q ss_pred CCcceeeeecccCceEEEEEEEC---CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC---CCCCccceeeeEe
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG---SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL---RHSCIVEMYGHKI 880 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~---~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L---~HpNIVkl~g~~~ 880 (1142)
.+|++.+.||+|+||.||+|++. +..+|+|+......... ....+ .+|+.+++.+ +||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~----~~e~~~l~~l~~~~h~~i~~~~~~~~ 84 (326)
T 1blx_A 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG--MPLST----IREVAVLRHLETFEHPNVVRLFDVCT 84 (326)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS--CBCTH----HHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc--CCchh----hHHHHHHHhhhccCCCCeEeeeeeee
Confidence 57999999999999999999983 56788998654432111 11122 5677776665 8999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NI 960 (1142)
.... ......++||||++ ++|.+++.. .....+++..+..++.||+.||.|||++||+||||||+||
T Consensus 85 ~~~~---------~~~~~~~lv~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Ni 151 (326)
T 1blx_A 85 VSRT---------DRETKLTLVFEHVD-QDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNI 151 (326)
T ss_dssp EEEC---------SSEEEEEEEEECCS-CBHHHHHHH---SCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred eccc---------CCCceEEEEEecCC-CCHHHHHHh---cccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHe
Confidence 3210 01235699999998 799999976 2334589999999999999999999999999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
|++.+ +.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++
T Consensus 152 li~~~-------~~~kl~Dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il 209 (326)
T 1blx_A 152 LVTSS-------GQIKLADFGLARIYSFQMA-----------LTSVVVTLWYRAPEVLLQ----SSYATPVDLWSVGCIF 209 (326)
T ss_dssp EECTT-------CCEEECSCCSCCCCCGGGG-----------GCCCCCCCTTCCHHHHTT----CCCCTHHHHHHHHHHH
T ss_pred EEcCC-------CCEEEecCcccccccCCCC-----------ccccccccceeCHHHHhc----CCCCcchhHHHHHHHH
Confidence 99887 7899999999976543211 123468999999999876 5688999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhC-CCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001142 1041 LELLTLQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1119 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~~~~~el~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~ 1119 (1142)
|+|++|+.||.+....+....+... ..+.. ..+......... .................+..+.+|+.+||+.||.+
T Consensus 210 ~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 287 (326)
T 1blx_A 210 AEMFRRKPLFRGSSDVDQLGKILDVIGLPGE-EDWPRDVALPRQ-AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAK 287 (326)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG-GGSCTTCSSCGG-GSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTT
T ss_pred HHHHcCCCCCCCCCHHHHHHHHHHHcCCCCc-ccCccccccchh-hhcccCcchhhhccccCCHHHHHHHHHHcCCCccc
Confidence 9999999999987776665555321 11111 000000000000 00000000011111246678999999999999999
Q ss_pred CCCHHHHHHHHHhhcC
Q 001142 1120 RPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1120 RPSa~EVL~~L~~~~s 1135 (1142)
|||+.|+++|+|+...
T Consensus 288 Rpt~~e~l~hp~~~~~ 303 (326)
T 1blx_A 288 RISAYSALSHPYFQDL 303 (326)
T ss_dssp SCCHHHHHTSGGGTTC
T ss_pred CCCHHHHhcCcccccc
Confidence 9999999999999754
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=337.26 Aligned_cols=259 Identities=22% Similarity=0.326 Sum_probs=200.8
Q ss_pred CcceeeeecccCceEEEEEEEC--Cc---cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFG--SA---DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 882 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~--~~---~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~ 882 (1142)
.|.+.++||+|+||+||+|.+. .. .+|+|+. .. .......+.+ .+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~--~~-~~~~~~~~~~----~~E~~~l~~l~h~~iv~~~~~~~~~ 94 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL--SR-ITEMQQVEAF----LREGLLMRGLNHPNVLALIGIMLPP 94 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEE--TT-CCSHHHHHHH----HHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeec--cc-cccHHHHHHH----HHHHHHHHhCCCCCeeeEEEEEecC
Confidence 4677899999999999999872 22 4666654 32 2223333444 7999999999999999999998754
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
+. ..++||||+.+++|.+++.. ....+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 95 ~~-------------~~~~v~e~~~~~~L~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili 157 (298)
T 3pls_A 95 EG-------------LPHVLLPYMCHGDLLQFIRS----PQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML 157 (298)
T ss_dssp SS-------------CCEEEECCCTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CC-------------CcEEEEecccCCCHHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE
Confidence 32 23899999999999999964 23568999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
+.+ +.+||+|||+++........ .........+|+.|+|||.+.+ ..++.++||||||+++|+
T Consensus 158 ~~~-------~~~kl~Dfg~~~~~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~ 220 (298)
T 3pls_A 158 DES-------FTVKVADFGLARDILDREYY------SVQQHRHARLPVKWTALESLQT----YRFTTKSDVWSFGVLLWE 220 (298)
T ss_dssp CTT-------CCEEECCTTSSCTTTTGGGG------CSCCSSCTTCGGGGSCHHHHTT----CCCCHHHHHHHHHHHHHH
T ss_pred cCC-------CcEEeCcCCCcccccCCccc------ccccCcCCCCCccccChhhhcc----CCCChhhchhhHHHHHHH
Confidence 877 78999999999765432211 1112234468899999999876 568899999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1043 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1043 LLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
|++ +.+||......+....+.....+..+ ...++.+.+++.+||+.||.+||
T Consensus 221 l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~~l~~~p~~Rp 273 (298)
T 3pls_A 221 LLTRGAPPYRHIDPFDLTHFLAQGRRLPQP---------------------------EYCPDSLYQVMQQCWEADPAVRP 273 (298)
T ss_dssp HHHTSCCTTTTSCGGGHHHHHHTTCCCCCC---------------------------TTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HhhCCCCCCccCCHHHHHHHhhcCCCCCCC---------------------------ccchHHHHHHHHHHccCChhhCc
Confidence 999 55556655555555555544432211 13456799999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 001142 1122 TAGDLYEMFVART 1134 (1142)
Q Consensus 1122 Sa~EVL~~L~~~~ 1134 (1142)
|+.++++.+....
T Consensus 274 s~~~ll~~l~~~~ 286 (298)
T 3pls_A 274 TFRVLVGEVEQIV 286 (298)
T ss_dssp CHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHH
Confidence 9999999887653
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=346.33 Aligned_cols=295 Identities=19% Similarity=0.211 Sum_probs=198.3
Q ss_pred CCCCCCCcceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001142 802 DPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 881 (1142)
Q Consensus 802 ~~~~~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~ 881 (1142)
+...+++|++.+.||+|+||.||+|++.+..+|+|+..... ...+ ....|+..+..++||||+++++.+..
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-------~~~~--~~e~~~~~~~~~~h~~i~~~~~~~~~ 78 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN-------RQNF--INEKNIYRVPLMEHDNIARFIVGDER 78 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG-------HHHH--HHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred CCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc-------hhhH--HHHHHHHHHHhccCcchhhheecccc
Confidence 34567899999999999999999999999999999975321 1122 01234444556899999999987654
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---------Cccc
Q 001142 882 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK---------HIMH 952 (1142)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~---------gIvH 952 (1142)
.... .....++||||+++|+|.+++.. ...++..+..|+.||+.||.|||++ ||+|
T Consensus 79 ~~~~---------~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH 143 (336)
T 3g2f_A 79 VTAD---------GRMEYLLVMEYYPNGSLXKYLSL------HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISH 143 (336)
T ss_dssp ECTT---------SCEEEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEEC
T ss_pred cccC---------CCceEEEEEecCCCCcHHHHHhh------cccchhHHHHHHHHHHHHHHHHHhhhccccccccceee
Confidence 2211 12356899999999999999976 3468999999999999999999999 9999
Q ss_pred cCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCC---CCCCc
Q 001142 953 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP---NLYGL 1029 (1142)
Q Consensus 953 rDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~---~~~s~ 1029 (1142)
|||||+|||++.+ +.+||+|||+++.+........ ...........||+.|+|||++.+.... ..++.
T Consensus 144 ~Dikp~Nill~~~-------~~~kL~DFG~a~~~~~~~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 214 (336)
T 3g2f_A 144 RDLNSRNVLVKND-------GTCVISDFGLSMRLTGNRLVRP--GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALK 214 (336)
T ss_dssp SSCSGGGEEECTT-------SCEEECCCTTCEECSSSSCC-----------CCTTSCGGGCCHHHHTTCCCGGGHHHHHH
T ss_pred cccccceEEEcCC-------CcEEEeeccceeecccccccCc--cccccccccCCCccceeCchhhcCCccccccccccc
Confidence 9999999999887 7899999999986543211100 0001112244699999999998752110 24567
Q ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCH-HHH--HHHHHhCCCCCchhHHhhhcccccccccccCCCCCC-chhhhhhHHHH
Q 001142 1030 EVDIWSYGCLLLELLTLQVPYMGLSE-LEI--HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK-PEAELETLSFL 1105 (1142)
Q Consensus 1030 ksDVwSLGviL~ELLtG~~Pf~~~~~-~el--~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~L 1105 (1142)
++|||||||++|||++|..||..... .+. .........+............ .....+.. .......++.+
T Consensus 215 ~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~l 288 (336)
T 3g2f_A 215 QVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSRE------KQRPKFPEAWKENSLAVRSL 288 (336)
T ss_dssp HHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTS------CCCCCCCTTCCCCSHHHHHH
T ss_pred ccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhccc------ccCCCCCcccccccchHHHH
Confidence 89999999999999999776643211 000 0000111111111100000000 00000000 00012467789
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001142 1106 VDVFRRCTEENPTERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1106 ~dLI~~CL~~DP~~RPSa~EVL~~L~~~~s 1135 (1142)
.+||.+||+.||++|||+.|+++.+.....
T Consensus 289 ~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 289 KETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 999999999999999999999988776543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=345.51 Aligned_cols=270 Identities=22% Similarity=0.321 Sum_probs=198.1
Q ss_pred cceeeeecccCceEEEEEEE------CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001142 809 LSSCDEAGKSVSSSLFRCKF------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 882 (1142)
Q Consensus 809 y~l~~~LG~GsfG~Vy~a~~------~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~ 882 (1142)
|++.++||+|+||+||++.+ .+..+|+|+.... ......+.+ .+|+.++++++||||+++++++.+.
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~----~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD---AGPQHRSGW----KQEIDILRTLYHEHIIKYKGCCEDA 105 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT---CCHHHHHHH----HHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc---cChHHHHHH----HHHHHHHHhCCCcchhhEEEEEecC
Confidence 49999999999999999876 4667888886432 222333334 8999999999999999999999864
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
+. ...++||||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 106 ~~------------~~~~lv~e~~~~~~L~~~l~~------~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~ 167 (318)
T 3lxp_A 106 GA------------ASLQLVMEYVPLGSLRDYLPR------HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLL 167 (318)
T ss_dssp TT------------TEEEEEECCCTTCBHHHHGGG------SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred CC------------ceEEEEEecccCCcHHHHHhh------CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE
Confidence 31 256999999999999999864 348999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
+.+ +.+||+|||++.......... .......+|+.|+|||++.+ ..++.++||||||+++|+
T Consensus 168 ~~~-------~~~kl~Dfg~a~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~ 229 (318)
T 3lxp_A 168 DND-------RLVKIGDFGLAKAVPEGHEYY-------RVREDGDSPVFWYAPECLKE----YKFYYASDVWSFGVTLYE 229 (318)
T ss_dssp CTT-------CCEEECCGGGCEECCTTCSEE-------EC---CCCCGGGCCHHHHHH----CEEEHHHHHHHHHHHHHH
T ss_pred cCC-------CCEEECCcccccccccccccc-------ccccCCCCCceeeChHHhcC----CCCCcHHHHHHHHHHHHH
Confidence 887 789999999998654422110 01223458889999999976 467799999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1043 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1043 LLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
|++|+.||...... ...... ... ........ .......... ......++.+.+|+.+||+.||.+|||
T Consensus 230 ll~g~~p~~~~~~~-~~~~~~-~~~--~~~~~~~~-----~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps 297 (318)
T 3lxp_A 230 LLTHCDSSQSPPTK-FLELIG-IAQ--GQMTVLRL-----TELLERGERL---PRPDKCPAEVYHLMKNCWETEASFRPT 297 (318)
T ss_dssp HHTTTCGGGSHHHH-HHHHHC-SCC--HHHHHHHH-----HHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHhCCCcccccchh-hhhhhc-ccc--cchhHHHH-----HHHHhcccCC---CCCccccHHHHHHHHHHcCCCcccCcC
Confidence 99999999752211 111110 000 00000000 0000000000 011155678999999999999999999
Q ss_pred HHHHHHHHHhh
Q 001142 1123 AGDLYEMFVAR 1133 (1142)
Q Consensus 1123 a~EVL~~L~~~ 1133 (1142)
+.|+++.+...
T Consensus 298 ~~ell~~L~~l 308 (318)
T 3lxp_A 298 FENLIPILKTV 308 (318)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99999887654
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=338.33 Aligned_cols=278 Identities=20% Similarity=0.283 Sum_probs=196.3
Q ss_pred CCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
++|++.+.||+|+||.||+|++ .+..+|+|+.... ....+. +.+|+.++++++||||+++++++.+...
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~----~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 76 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-----EEKLST----ILSEVMLLASLNHQYVVRYYAAWLERRN 76 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-----HHHHHH----HHHHHHHHTTCCCTTBCCEEEEEEECCC
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-----HHHHHH----HHHHHHHHHhcCchHHHHHHHHHHhhcc
Confidence 3689999999999999999997 4677888876421 223333 3799999999999999999999876432
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
+... -.........++||||+++++|.+++.. ....+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 77 ~~~~-~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~ 151 (303)
T 1zy4_A 77 FVKP-MTAVKKKSTLFIQMEYCENGTLYDLIHS----ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDE 151 (303)
T ss_dssp CCC-------CEEEEEEEEECCCSCBHHHHHHH----SCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred hhhh-hcccccCCceEEEEecCCCCCHHHhhhc----cccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcC
Confidence 1000 0011123467999999999999999986 2346888999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccc----cCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA----HRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~----~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
+ +.+||+|||.+............. ...........||+.|+|||++.+ ...++.++|||||||++
T Consensus 152 ~-------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~il 221 (303)
T 1zy4_A 152 S-------RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG---TGHYNEKIDMYSLGIIF 221 (303)
T ss_dssp T-------SCEEECCCCCCSCTTC-------------------------CTTSCHHHHTS---CSCCCTHHHHHHHHHHH
T ss_pred C-------CCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccC---CCCCcchhhHHHHHHHH
Confidence 7 789999999997654321100000 000111234568999999999875 23678999999999999
Q ss_pred HHHHhCCCCCCCC-CHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001142 1041 LELLTLQVPYMGL-SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1119 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~~-~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~ 1119 (1142)
|+|++ ||... ...+....+..... ..+. ......++.+.+++.+||+.||.+
T Consensus 222 ~~l~~---p~~~~~~~~~~~~~~~~~~~-~~~~-----------------------~~~~~~~~~~~~li~~~l~~dp~~ 274 (303)
T 1zy4_A 222 FEMIY---PFSTGMERVNILKKLRSVSI-EFPP-----------------------DFDDNKMKVEKKIIRLLIDHDPNK 274 (303)
T ss_dssp HHHHS---CCSSHHHHHHHHHHHHSTTC-CCCT-----------------------TCCTTTSHHHHHHHHHHTCSSGGG
T ss_pred HHHHh---ccCCchhHHHHHHhcccccc-ccCc-----------------------cccccchHHHHHHHHHHHhcCccc
Confidence 99998 56432 12223333332211 1110 011144567899999999999999
Q ss_pred CCCHHHHHHHHHhhcC
Q 001142 1120 RPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1120 RPSa~EVL~~L~~~~s 1135 (1142)
|||+.++++|+|+...
T Consensus 275 Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 275 RPGARTLLNSGWLPVK 290 (303)
T ss_dssp SCCHHHHHHSSCSCCC
T ss_pred CcCHHHHhCCCCcCCC
Confidence 9999999999999753
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=355.71 Aligned_cols=283 Identities=19% Similarity=0.221 Sum_probs=211.1
Q ss_pred CCCCcceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHH---------HHHhHHhHHHHHHHHhhCCCCCccce
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADE---------IRNFEYSCLGEVRMLGALRHSCIVEM 875 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~---------~~~~~~~~~~Ei~iL~~L~HpNIVkl 875 (1142)
.+.+|++.+.||+|+||.||+|.+.+..+|+|+............ .......+.+|+.++++++||||+++
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 457899999999999999999999889999998764422111000 00000234799999999999999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHH------HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-C
Q 001142 876 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY------IEKLSETGEKHVSVKLALFIAQDVAAALVELHS-K 948 (1142)
Q Consensus 876 ~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~------l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs-~ 948 (1142)
++++.+.+ ..++||||+++++|.++ +.. .....+++..+..++.||+.||.|||+ +
T Consensus 109 ~~~~~~~~--------------~~~lv~e~~~~~~L~~~~~~~~~l~~---~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 171 (348)
T 2pml_X 109 EGIITNYD--------------EVYIIYEYMENDSILKFDEYFFVLDK---NYTCFIPIQVIKCIIKSVLNSFSYIHNEK 171 (348)
T ss_dssp SEEEESSS--------------EEEEEEECCTTCBSSEESSSEESSCS---SSCCCCCHHHHHHHHHHHHHHHHHHHHTS
T ss_pred EEEEeeCC--------------eEEEEEeccCCCcHHHHHHHhhhhhh---ccccCCCHHHHHHHHHHHHHHHHHHhccC
Confidence 99998654 45999999999999988 432 224579999999999999999999999 9
Q ss_pred CccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCC
Q 001142 949 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 1028 (1142)
Q Consensus 949 gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s 1028 (1142)
||+||||||+|||++.+ +.+||+|||.+....... .....||+.|+|||++.+. ..++
T Consensus 172 ~i~H~dl~p~Nil~~~~-------~~~kl~dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~~---~~~~ 229 (348)
T 2pml_X 172 NICHRDVKPSNILMDKN-------GRVKLSDFGESEYMVDKK------------IKGSRGTYEFMPPEFFSNE---SSYN 229 (348)
T ss_dssp CEECCCCCGGGEEECTT-------SCEEECCCTTCEECBTTE------------ECSSCSCGGGCCGGGGSSC---CCEE
T ss_pred CEeecCCChHhEEEcCC-------CcEEEecccccccccccc------------ccCCCCCcCccCchhhcCC---CCCC
Confidence 99999999999999887 789999999997653321 1234689999999998762 2455
Q ss_pred c-hhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHH
Q 001142 1029 L-EVDIWSYGCLLLELLTLQVPYMGLSE-LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLV 1106 (1142)
Q Consensus 1029 ~-ksDVwSLGviL~ELLtG~~Pf~~~~~-~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~ 1106 (1142)
. ++||||||+++|+|++|..||..... .+....+..+.... +..... .................++.+.
T Consensus 230 ~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~-~~~~~~--------~~~~~~~~~~~~~~~~~~~~l~ 300 (348)
T 2pml_X 230 GAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEY-PLDRNH--------FLYPLTNKKSTCSNNFLSNEDI 300 (348)
T ss_dssp HHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCC-CCSSSS--------STTTTCC--------CCCHHHH
T ss_pred cchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCC-ccchhh--------hhccccccccccchhhcCHHHH
Confidence 5 99999999999999999999987655 55666665443221 100000 0000000000011125567899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001142 1107 DVFRRCTEENPTERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1107 dLI~~CL~~DP~~RPSa~EVL~~L~~~~s 1135 (1142)
+|+.+||+.||.+|||+.|+++|+|+...
T Consensus 301 ~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 301 DFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred HHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 99999999999999999999999999754
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=349.37 Aligned_cols=269 Identities=22% Similarity=0.307 Sum_probs=205.7
Q ss_pred CCCCCCcceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001142 803 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 882 (1142)
Q Consensus 803 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~ 882 (1142)
.....+|++.+.||+|+||.||+|++.+ .+++|+..... ......+.+ .+|+.++++++||||+++++++.+.
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~--~~~~~~~~~----~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIER--DNEDQLKAF----KREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCS--CCCCCCCCC----CTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCC--CCHHHHHHH----HHHHHHHhcCCCCCEeEEEEEEecC
Confidence 3456789999999999999999999875 58888755432 222222334 6899999999999999999999865
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
.. .++||||+++++|.+++.. ....+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 102 ~~--------------~~iv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~ 163 (319)
T 2y4i_B 102 PH--------------LAIITSLCKGRTLYSVVRD----AKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY 163 (319)
T ss_dssp SC--------------EEEECBCCCSEEHHHHTTS----SCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEE
T ss_pred Cc--------------eEEEeecccCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEE
Confidence 53 4999999999999999864 23468999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhcccc-----CCCCCCchhhHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-----KPNLYGLEVDIWSYG 1037 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-----~~~~~s~ksDVwSLG 1037 (1142)
+ + +.+||+|||++......... ..........||+.|+|||++.+.. ....++.++||||||
T Consensus 164 ~-~-------~~~~l~Dfg~~~~~~~~~~~-----~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG 230 (319)
T 2y4i_B 164 D-N-------GKVVITDFGLFSISGVLQAG-----RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALG 230 (319)
T ss_dssp C----------CCEECCCSCCC---------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHH
T ss_pred e-C-------CCEEEeecCCcccccccccc-----ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHH
Confidence 7 3 57999999998754322111 0111223445899999999987522 123578999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001142 1038 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1117 (1142)
Q Consensus 1038 viL~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP 1117 (1142)
+++|+|++|+.||...........+..+..+.... ...+..+.+++.+||..||
T Consensus 231 ~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~l~~li~~~l~~~p 284 (319)
T 2y4i_B 231 TIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQ--------------------------IGMGKEISDILLFCWAFEQ 284 (319)
T ss_dssp HHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCCC--------------------------SSCCTTHHHHHHHHHCSST
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCCc--------------------------CCCCHHHHHHHHHHhcCCh
Confidence 99999999999999887777766665554433211 0233458999999999999
Q ss_pred CCCCCHHHHHHHHHhhcC
Q 001142 1118 TERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1118 ~~RPSa~EVL~~L~~~~s 1135 (1142)
.+|||+.++++.+.....
T Consensus 285 ~~Rpt~~~l~~~l~~l~~ 302 (319)
T 2y4i_B 285 EERPTFTKLMDMLEKLPK 302 (319)
T ss_dssp TTSCCHHHHHHHHTTC--
T ss_pred hhCcCHHHHHHHHHHHHH
Confidence 999999999999876544
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=351.56 Aligned_cols=283 Identities=19% Similarity=0.197 Sum_probs=204.4
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
.+|.+.+.||+|+||.||+|.+. +..||+|+.. .........+. +.+|+.++++++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~--~~~~~~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 97 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS--RPFQSEIFAKR----AYRELLLLKHMQHENVIGLLDVFTPASS 97 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEES--STTSSHHHHHH----HHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEec--ccccchHHHHH----HHHHHHHHHhcCCCCcccHhheEecccc
Confidence 57999999999999999999984 6677777753 22223332333 4799999999999999999999876542
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
. ......++||||++ ++|.+++. ..+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 98 ~--------~~~~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~ 161 (353)
T 3coi_A 98 L--------RNFYDFYLVMPFMQ-TDLQKIMG-------LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNE 161 (353)
T ss_dssp G--------GGCCCCEEEEECCS-EEGGGTTT-------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECT
T ss_pred c--------ccceeEEEEecccc-CCHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECC
Confidence 2 12234599999997 68877653 25899999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||+|||++...... .....||+.|+|||++.+ ...++.++|||||||++|+|+
T Consensus 162 ~-------~~~kl~Dfg~~~~~~~~-------------~~~~~~t~~y~aPE~~~~---~~~~~~~~Di~slG~il~el~ 218 (353)
T 3coi_A 162 D-------CELKILDFGLARHADAE-------------MTGYVVTRWYRAPEVILS---WMHYNQTVDIWSVGCIMAEML 218 (353)
T ss_dssp T-------CCEEECSTTCTTC---------------------CCSBCCSCHHHHSC---CSCCCTTHHHHHHHHHHHHHH
T ss_pred C-------CcEEEeecccccCCCCC-------------ccccccCcCcCCHHHHhC---cCCCCchhhHHHHHHHHHHHH
Confidence 7 78999999999754321 123468999999999865 246789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhC-CCCCchhHHhhhcccccccccc---cCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1045 TLQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQ---SGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
+|+.||.+.+..+....+... ..+. ................+ ..............++.+.+|+.+||+.||++|
T Consensus 219 ~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R 297 (353)
T 3coi_A 219 TGKTLFKGKDYLDQLTQILKVTGVPG-TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKR 297 (353)
T ss_dssp HSSCSSBSSCHHHHHHHHHHHHCBCC-HHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTS
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCC-HHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccC
Confidence 999999987776655554321 1111 11110000000000000 000000011112457789999999999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 001142 1121 PTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1121 PSa~EVL~~L~~~~s 1135 (1142)
||+.|+++|+|+...
T Consensus 298 pt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 298 LTAAQALTHPFFEPF 312 (353)
T ss_dssp CCHHHHHTSGGGTTT
T ss_pred CCHHHHhcCcchhhc
Confidence 999999999999743
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=353.62 Aligned_cols=281 Identities=14% Similarity=0.133 Sum_probs=199.3
Q ss_pred CCCcceeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHh----HHhHHHHHHHHhhCCCCCccc
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNF----EYSCLGEVRMLGALRHSCIVE 874 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~-------~~~vAvKi~~l~~~~~~~~~~~~~----~~~~~~Ei~iL~~L~HpNIVk 874 (1142)
-.+|++.++||+|+||.||+|.+. +..+|+|+....... ...+.+.+ ...+..|+..+..++||||++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGP-LFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHH-HHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchh-HHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 347999999999999999999884 357899986433110 00011101 112346777788889999999
Q ss_pred eeeeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 001142 875 MYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRD 954 (1142)
Q Consensus 875 l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrD 954 (1142)
+++++..... ...+.++||||+ +++|.+++.. ....+++..+..|+.||+.||+|||++||+|||
T Consensus 113 ~~~~~~~~~~----------~~~~~~lv~e~~-g~~L~~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrD 177 (364)
T 3op5_A 113 YWGSGLHDKN----------GKSYRFMIMDRF-GSDLQKIYEA----NAKRFSRKTVLQLSLRILDILEYIHEHEYVHGD 177 (364)
T ss_dssp EEEEEEEEET----------TEEEEEEEEECE-EEEHHHHHHH----TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred EEeeeeeccC----------CcceEEEEEeCC-CCCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEec
Confidence 9999876321 123569999999 8999999976 235699999999999999999999999999999
Q ss_pred CCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHH
Q 001142 955 IKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 1034 (1142)
Q Consensus 955 LKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVw 1034 (1142)
|||+|||++.+. .+.+||+|||+++.+........ ..........||+.|+|||++.+ ..++.++|||
T Consensus 178 lkp~Nill~~~~-----~~~~kl~DFG~a~~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~ 245 (364)
T 3op5_A 178 IKASNLLLNYKN-----PDQVYLVDYGLAYRYCPEGVHKA---YAADPKRCHDGTIEFTSIDAHNG----VAPSRRGDLE 245 (364)
T ss_dssp CCGGGEEEESSC-----TTCEEECCCTTCEESSGGGCCCC---SSCCSSCCCCCCTTTCCHHHHTT----CCCCHHHHHH
T ss_pred CCHHHEEEecCC-----CCeEEEEECCcceecccCCcccc---cccCcccccCCCCCccCHHHhCC----CCCCchhhHH
Confidence 999999998321 17899999999987654321110 01111234569999999999876 5689999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 001142 1035 SYGCLLLELLTLQVPYMGLSE-LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 1113 (1142)
Q Consensus 1035 SLGviL~ELLtG~~Pf~~~~~-~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL 1113 (1142)
||||++|||++|+.||.+... ............+.+....... .. ....++.+.+++..||
T Consensus 246 slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~----------~~~~~~~~~~li~~cl 307 (364)
T 3op5_A 246 ILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKC--------FP----------AANAPGEIAKYMETVK 307 (364)
T ss_dssp HHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHH--------SC----------TTCCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHh--------cc----------cccCHHHHHHHHHHHh
Confidence 999999999999999985322 2222211111111111111000 00 0144677999999999
Q ss_pred ccCCCCCCCHHHHHHHHHh
Q 001142 1114 EENPTERPTAGDLYEMFVA 1132 (1142)
Q Consensus 1114 ~~DP~~RPSa~EVL~~L~~ 1132 (1142)
+.||.+||++.+|++.+..
T Consensus 308 ~~~p~~RP~~~~l~~~l~~ 326 (364)
T 3op5_A 308 LLDYTEKPLYENLRDILLQ 326 (364)
T ss_dssp TCCTTCCCCHHHHHHHHHH
T ss_pred cCCCCCCCCHHHHHHHHHH
Confidence 9999999999999987754
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=339.08 Aligned_cols=263 Identities=22% Similarity=0.324 Sum_probs=197.1
Q ss_pred CCCcceeeeecccCceEEEEEEEC---Cc--cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG---SA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 880 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~---~~--~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~ 880 (1142)
..+|++.+.||+|+||+||+|++. +. .+|+|+....... .....+. +.+|+.++++++||||+++++++.
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~ 91 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS-QPEAMDD----FIREVNAMHSLDHRNLIRLYGVVL 91 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHH----HHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccC-CHHHHHH----HHHHHHHHHhCCCCCcccEEEEEc
Confidence 457999999999999999999862 23 3566654322111 1122333 489999999999999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NI 960 (1142)
+.. .++||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 92 ~~~---------------~~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Ni 152 (291)
T 1u46_A 92 TPP---------------MKMVTELAPLGSLLDRLRKH----QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNL 152 (291)
T ss_dssp SSS---------------CEEEEECCTTCBHHHHHHHH----GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred cCC---------------ceeeEecccCCCHHHHHHhc----cCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheE
Confidence 533 38999999999999999763 24589999999999999999999999999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
|++.+ +.+||+|||++.......... .......+|+.|+|||++.+ ..++.++||||||+++
T Consensus 153 li~~~-------~~~kl~Dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il 214 (291)
T 1u46_A 153 LLATR-------DLVKIGDFGLMRALPQNDDHY-------VMQEHRKVPFAWCAPESLKT----RTFSHASDTWMFGVTL 214 (291)
T ss_dssp EEEET-------TEEEECCCTTCEECCC-CCEE-------EC-----CCGGGCCHHHHHH----CEEEHHHHHHHHHHHH
T ss_pred EEcCC-------CCEEEccccccccccccccch-------hhhccCCCCceeeCchhhcC----CCCCchhhHHHHHHHH
Confidence 99887 789999999997654322110 01123457889999999876 4578999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001142 1041 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1119 (1142)
Q Consensus 1041 ~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~ 1119 (1142)
|+|++ |+.||.+....+....+......... ....+..+.+++.+||+.||.+
T Consensus 215 ~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~l~~li~~~l~~~p~~ 268 (291)
T 1u46_A 215 WEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--------------------------PEDCPQDIYNVMVQCWAHKPED 268 (291)
T ss_dssp HHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC--------------------------CTTCCHHHHHHHHHHTCSSGGG
T ss_pred HHHHhCCCCCcccCCHHHHHHHHHccCCCCCC--------------------------CcCcCHHHHHHHHHHccCCccc
Confidence 99999 99999988777766665433211100 0145567999999999999999
Q ss_pred CCCHHHHHHHHHhhcCC
Q 001142 1120 RPTAGDLYEMFVARTSS 1136 (1142)
Q Consensus 1120 RPSa~EVL~~L~~~~ss 1136 (1142)
|||+.++++++......
T Consensus 269 Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 269 RPTFVALRDFLLEAQPT 285 (291)
T ss_dssp SCCHHHHHHHHHHHC--
T ss_pred CcCHHHHHHHHHHhCcc
Confidence 99999999998876543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=352.68 Aligned_cols=281 Identities=20% Similarity=0.242 Sum_probs=203.8
Q ss_pred CCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CC-----Cccceee
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HS-----CIVEMYG 877 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-Hp-----NIVkl~g 877 (1142)
.++|++.+.||+|+||+||+|.+. +..||+|+... ....... +.+|+.+++.+. |+ +|+++++
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~~----~~~e~~~l~~l~~~~~~~~~~iv~~~~ 123 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN-----KKAFLNQ----AQIEVRLLELMNKHDTEMKYYIVHLKR 123 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS-----SHHHHHH----HHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec-----cHHHHHH----HHHHHHHHHHHHhcccccceeEEEeee
Confidence 568999999999999999999984 56688887542 1222223 367888888885 55 4899999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH--hCCccccCC
Q 001142 878 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELH--SKHIMHRDI 955 (1142)
Q Consensus 878 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLH--s~gIvHrDL 955 (1142)
++...+ +.++||||++ ++|.+++... ....+++..+..++.||+.||.||| +.||+||||
T Consensus 124 ~~~~~~--------------~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDl 185 (382)
T 2vx3_A 124 HFMFRN--------------HLCLVFEMLS-YNLYDLLRNT---NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDL 185 (382)
T ss_dssp EEEETT--------------EEEEEEECCC-CBHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCC
T ss_pred eeccCC--------------ceEEEEecCC-CCHHHHHhhc---CcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCC
Confidence 988654 4599999996 6999999862 2245899999999999999999999 579999999
Q ss_pred CCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHH
Q 001142 956 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 1035 (1142)
Q Consensus 956 Kp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwS 1035 (1142)
||+|||++.+.. +.+||+|||+++..... .....||+.|+|||++.+ ..++.++||||
T Consensus 186 kp~NIll~~~~~-----~~~kL~DFG~a~~~~~~-------------~~~~~~t~~y~aPE~~~~----~~~~~~~DiwS 243 (382)
T 2vx3_A 186 KPENILLCNPKR-----SAIKIVDFGSSCQLGQR-------------IYQYIQSRFYRSPEVLLG----MPYDLAIDMWS 243 (382)
T ss_dssp SGGGEEESSTTS-----CCEEECCCTTCEETTCC-------------CCSSCSCGGGCCHHHHTT----CCCCTHHHHHH
T ss_pred CcccEEEecCCC-----CcEEEEeccCceecccc-------------cccccCCccccChHHHcC----CCCCcHHHHHH
Confidence 999999964321 78999999999765321 123468999999999976 56899999999
Q ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcc-------ccccccc-----ccCCCCCC---------
Q 001142 1036 YGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGS-------CHEHEVA-----QSGSGFEK--------- 1094 (1142)
Q Consensus 1036 LGviL~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~-------~~~~~~~-----~~~~~~~~--------- 1094 (1142)
|||++|||++|+.||.+.+..+....+................. .....+. .....+..
T Consensus 244 lG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 323 (382)
T 2vx3_A 244 LGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNI 323 (382)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHH
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHH
Confidence 99999999999999998887776666543222211111110000 0000000 00000000
Q ss_pred ---------------chhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001142 1095 ---------------PEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1095 ---------------~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~~s 1135 (1142)
........+.+.+||.+||+.||++|||++|+++|+|++..
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 324 LGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp HTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred hhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccC
Confidence 00011234579999999999999999999999999999754
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=343.01 Aligned_cols=266 Identities=26% Similarity=0.365 Sum_probs=203.0
Q ss_pred CCcceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhh--CCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGA--LRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~--L~HpNIVkl~g~~~~~~~ 884 (1142)
++|++.+.||+|+||.||+|++.+..+|+|+.... ....+ .+|++++.. ++||||+++++++.....
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~-------~~~~~----~~e~~~~~~~~l~h~ni~~~~~~~~~~~~ 110 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR-------EERSW----FREAEIYQTVMLRHENILGFIAADNKDNG 110 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG-------GHHHH----HHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred ccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch-------hHHHH----HHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence 46899999999999999999999999999986421 12233 678888877 689999999999876431
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCccccCCC
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELH--------SKHIMHRDIK 956 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLH--------s~gIvHrDLK 956 (1142)
.....++||||+++++|.+++.. ..+++..+..++.||+.||.||| ++||+|||||
T Consensus 111 ----------~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlk 174 (342)
T 1b6c_B 111 ----------TWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLK 174 (342)
T ss_dssp ----------SCCCEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCS
T ss_pred ----------ccceeEEEEeecCCCcHHHHHhc------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCC
Confidence 12256999999999999999976 35899999999999999999999 8999999999
Q ss_pred CCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCC--CCCchhhHH
Q 001142 957 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN--LYGLEVDIW 1034 (1142)
Q Consensus 957 p~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~--~~s~ksDVw 1034 (1142)
|+|||++.+ +.+||+|||++........... .......||+.|+|||++.+..... .++.++|||
T Consensus 175 p~NIll~~~-------~~~kL~Dfg~~~~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~ 241 (342)
T 1b6c_B 175 SKNILVKKN-------GTCCIADLGLAVRHDSATDTID------IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIY 241 (342)
T ss_dssp GGGEEECTT-------SCEEECCCTTCEEEETTTTEEE------ECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHH
T ss_pred HHHEEECCC-------CCEEEEECCCceeccccccccc------cccccCCcCcccCCHhhhcccccccccccCCcccHH
Confidence 999999887 7899999999976543221100 0122446999999999987632111 234789999
Q ss_pred HHHHHHHHHHhC----------CCCCCCCC-----HHHHHHHHHh-CCCCCchhHHhhhcccccccccccCCCCCCchhh
Q 001142 1035 SYGCLLLELLTL----------QVPYMGLS-----ELEIHDLIQM-GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 1098 (1142)
Q Consensus 1035 SLGviL~ELLtG----------~~Pf~~~~-----~~el~~~I~~-~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1142)
||||++|||++| ..||.... ...+...+.. ...+.++..+ ..
T Consensus 242 slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~ 299 (342)
T 1b6c_B 242 AMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRW----------------------QS 299 (342)
T ss_dssp HHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGG----------------------GT
T ss_pred HHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccc----------------------cc
Confidence 999999999999 78886532 2333333322 2222222111 11
Q ss_pred hhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001142 1099 LETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1134 (1142)
Q Consensus 1099 ~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~~ 1134 (1142)
...++.+.+|+.+||+.||++|||+.+|++++....
T Consensus 300 ~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 300 CEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp SHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 256778999999999999999999999999987654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=370.47 Aligned_cols=256 Identities=26% Similarity=0.370 Sum_probs=207.5
Q ss_pred CCCcceeeeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~~-~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
.++|++.++||+|+||.||+|.+.+ ..||+|+.+.. ... .+.| .+|+.+|++++|||||++++++.+ .
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~---~~~~----~~E~~~l~~l~hpniv~~~~~~~~-~- 334 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMS---PEAF----LQEAQVMKKLRHEKLVQLYAVVSE-E- 334 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTT--SSC---HHHH----HHHHHHHHHCCCTTBCCEEEEECS-S-
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCC--CCC---HHHH----HHHHHHHHhCCCCCEeeEEEEEee-c-
Confidence 4568999999999999999999964 56888875432 111 2334 799999999999999999999864 2
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
..+|||||+++|+|.++++... ...+++..+..|+.||+.||+|||++||+||||||+|||++.
T Consensus 335 -------------~~~lv~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~ 398 (535)
T 2h8h_A 335 -------------PIYIVTEYMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE 398 (535)
T ss_dssp -------------SCEEEECCCTTEEHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred -------------cceEeeehhcCCcHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcC
Confidence 2399999999999999997521 235899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||+|||+++........ ......++..|+|||++.. ..++.++|||||||++|||+
T Consensus 399 ~-------~~~kl~DFG~a~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~sDvwSlGv~l~el~ 458 (535)
T 2h8h_A 399 N-------LVCKVADFGLARLIEDNEYT---------ARQGAKFPIKWTAPEAALY----GRFTIKSDVWSFGILLTELT 458 (535)
T ss_dssp G-------GCEEECCTTSTTTCCCHHHH---------TTCSTTSCGGGSCHHHHHH----CCCCHHHHHHHHHHHHHHHT
T ss_pred C-------CcEEEcccccceecCCCcee---------cccCCcCcccccCHHHhcc----CCCCchhhHHHHHHHHHHHH
Confidence 7 78999999999765432111 1112346788999999876 56889999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1045 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1045 t-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
+ |+.||.+....++...+..+.....+. .+++.+.+||.+||+.||++|||+
T Consensus 459 t~g~~P~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~cl~~dP~~RPt~ 511 (535)
T 2h8h_A 459 TKGRVPYPGMVNREVLDQVERGYRMPCPP---------------------------ECPESLHDLMCQCWRKEPEERPTF 511 (535)
T ss_dssp TTTCCSSTTCCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred hCCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHcCCChhHCcCH
Confidence 9 999999888877777776554322211 455679999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 001142 1124 GDLYEMFVARTS 1135 (1142)
Q Consensus 1124 ~EVL~~L~~~~s 1135 (1142)
++|++.|.....
T Consensus 512 ~~l~~~L~~~~~ 523 (535)
T 2h8h_A 512 EYLQAFLEDYFT 523 (535)
T ss_dssp HHHHHHHHTSSC
T ss_pred HHHHHHHHHHhh
Confidence 999998876543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=342.60 Aligned_cols=264 Identities=24% Similarity=0.260 Sum_probs=195.8
Q ss_pred CCCCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001142 803 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 880 (1142)
Q Consensus 803 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~ 880 (1142)
...+.+|++.+.||+|+||.||+|.+. +..+|+|+..... .. .......+.+|+.++++++||||+++++++.
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~---~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~ 104 (309)
T 2h34_A 30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETL--SS---DPVFRTRMQREARTAGRLQEPHVVPIHDFGE 104 (309)
T ss_dssp ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGG--GG---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCccc--cc---CHHHHHHHHHHHHHHhhcCCCCeeEEEEEEe
Confidence 345788999999999999999999974 5667887753221 11 1122234589999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NI 960 (1142)
..+ ..++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||
T Consensus 105 ~~~--------------~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NI 165 (309)
T 2h34_A 105 IDG--------------QLYVDMRLINGVDLAAMLRRQ-----GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENI 165 (309)
T ss_dssp ETT--------------EEEEEEECCCCEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred eCC--------------eEEEEEEecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHE
Confidence 654 359999999999999999862 4689999999999999999999999999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
|++.+ +.+||+|||++......... ......||+.|+|||++.+ ..++.++||||||+++
T Consensus 166 l~~~~-------~~~kl~Dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il 225 (309)
T 2h34_A 166 LVSAD-------DFAYLVDFGIASATTDEKLT---------QLGNTVGTLYYMAPERFSE----SHATYRADIYALTCVL 225 (309)
T ss_dssp EECTT-------SCEEECSCCC-------------------------CCGGGCCGGGTCC--------CCCHHHHHHHHH
T ss_pred EEcCC-------CCEEEecCccCccccccccc---------cccccCCCcCccCHHHHcC----CCCCchHhHHHHHHHH
Confidence 99877 78999999998754432111 1123468999999999875 5678999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1041 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
|+|++|+.||.+.....+...+.... +.... .....++.+.+++.+||+.||++|
T Consensus 226 ~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~------------------------~~~~~~~~l~~li~~~l~~dP~~R 280 (309)
T 2h34_A 226 YECLTGSPPYQGDQLSVMGAHINQAI-PRPST------------------------VRPGIPVAFDAVIARGMAKNPEDR 280 (309)
T ss_dssp HHHHHSSCSSCSCHHHHHHHHHHSCC-CCGGG------------------------TSTTCCTHHHHHHHHHTCSSGGGS
T ss_pred HHHHHCCCCCCCchHHHHHHHhccCC-CCccc------------------------cCCCCCHHHHHHHHHhccCCHHHH
Confidence 99999999998765543333333221 11100 001445679999999999999999
Q ss_pred C-CHHHHHHHHHhhcC
Q 001142 1121 P-TAGDLYEMFVARTS 1135 (1142)
Q Consensus 1121 P-Sa~EVL~~L~~~~s 1135 (1142)
| +++++++.+.....
T Consensus 281 p~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 281 YVTCGDLSAAAHAALA 296 (309)
T ss_dssp CSSHHHHHHHHHHTCC
T ss_pred HHhHHHHHHHHHHHHH
Confidence 9 99999998876544
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=345.41 Aligned_cols=284 Identities=18% Similarity=0.184 Sum_probs=203.1
Q ss_pred CCCcceeeeecccCceEEEEEEEC---CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCC------cccee
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG---SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSC------IVEMY 876 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~---~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpN------IVkl~ 876 (1142)
.++|++.+.||+|+||+||+|.+. +..+|+|+... .....+. +.+|+.++++++|++ ++.++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~-----~~~~~~~----~~~E~~~l~~l~~~~~~~~~~~~~~~ 88 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN-----VGKYREA----ARLEINVLKKIKEKDKENKFLCVLMS 88 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS-----CHHHHHH----HHHHHHHHHHHHHHCTTSCSCBCCEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc-----cccchhH----HHHHHHHHHHHhhcCCCCceeEEEee
Confidence 367999999999999999999984 25688888531 1222233 378999999887655 88888
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 001142 877 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956 (1142)
Q Consensus 877 g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLK 956 (1142)
+++...+ +.++||||+ +++|.+++.. .....+++..+..|+.||+.||.|||++||+|||||
T Consensus 89 ~~~~~~~--------------~~~lv~e~~-~~~l~~~l~~---~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlk 150 (355)
T 2eu9_A 89 DWFNFHG--------------HMCIAFELL-GKNTFEFLKE---NNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLK 150 (355)
T ss_dssp EEEEETT--------------EEEEEEECC-CCBHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCC
T ss_pred eeeeeCC--------------eEEEEEecc-CCChHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 8887654 459999999 5788887765 233469999999999999999999999999999999
Q ss_pred CCCeeeccccc------------cCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCC
Q 001142 957 SENILIDLERK------------KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 1024 (1142)
Q Consensus 957 p~NILld~~~~------------~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~ 1024 (1142)
|+|||++.... .....+.+||+|||+++..... .....||+.|+|||++.+
T Consensus 151 p~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-------------~~~~~gt~~y~aPE~~~~---- 213 (355)
T 2eu9_A 151 PENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-------------HTTIVATRHYRPPEVILE---- 213 (355)
T ss_dssp GGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC-------------CCSSCSCGGGCCHHHHTT----
T ss_pred HHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc-------------ccCCcCCCcccCCeeeec----
Confidence 99999943210 0012278999999999753321 123468999999999976
Q ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCC-----------
Q 001142 1025 NLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE----------- 1093 (1142)
Q Consensus 1025 ~~~s~ksDVwSLGviL~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~----------- 1093 (1142)
..++.++|||||||++|||++|..||......+....+.....+........... ...+......+.
T Consensus 214 ~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 291 (355)
T 2eu9_A 214 LGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRK--QKYFYKGGLVWDENSSDGRYVKE 291 (355)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSC--GGGEETTEECCCTTSHHHHHHHH
T ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccc--hhhhcccccccccccchhccccc
Confidence 5688999999999999999999999998776665544433222111111110000 000000000000
Q ss_pred -------CchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001142 1094 -------KPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1094 -------~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~~s 1135 (1142)
........+..+.+|+.+||+.||++|||+.|+++|+|+..-
T Consensus 292 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 292 NCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGL 340 (355)
T ss_dssp HCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGC
T ss_pred cCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCC
Confidence 000011446689999999999999999999999999999854
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=333.86 Aligned_cols=263 Identities=17% Similarity=0.164 Sum_probs=194.7
Q ss_pred CCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
-++|++.+.||+|+||.||+|++ .+..+|+|+...... ...+ .+|+.+++.++|++++..+..+....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~----~~e~~~l~~l~~~~~i~~~~~~~~~~ 77 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HPQL----HIESKIYKMMQGGVGIPTIRWCGAEG 77 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---------CCCH----HHHHHHHHHHTTSTTCCCEEEEEEET
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc------chHH----HHHHHHHHHhcCCCCCCeeeeecCCC
Confidence 35799999999999999999996 567788887543321 1123 68999999999888887777665422
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee-
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI- 962 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl- 962 (1142)
...++||||+ +++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 78 -------------~~~~lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~ 139 (296)
T 4hgt_A 78 -------------DYNVMVMELL-GPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMG 139 (296)
T ss_dssp -------------TEEEEEEECC-CCBHHHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred -------------CceEEEEEcc-CCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeee
Confidence 1459999999 89999999752 3469999999999999999999999999999999999999
Q ss_pred --ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 963 --DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 963 --d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
+.+ +.+||+|||+++.......... ..........||+.|+|||++.+ ..++.++|||||||++
T Consensus 140 ~~~~~-------~~~kL~Dfg~a~~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il 205 (296)
T 4hgt_A 140 LGKKG-------NLVYIIDFGLAKKYRDARTHQH---IPYRENKNLTGTARYASINTHLG----IEQSRRDDLESLGYVL 205 (296)
T ss_dssp CGGGT-------TCEEECCCTTCEECBCTTTCCB---CCCCCSCCCCSCGGGCCHHHHTT----CCCCHHHHHHHHHHHH
T ss_pred ccCCC-------CeEEEecCccceeccCcccCcc---CCCCcccccCCCccccchHHhcC----CCCCchhHHHHHHHHH
Confidence 444 7899999999987654322110 01112335579999999999876 5688999999999999
Q ss_pred HHHHhCCCCCCCCCHH---HHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001142 1041 LELLTLQVPYMGLSEL---EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1117 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~~~~~---el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP 1117 (1142)
|+|++|+.||.+.... +....+.....+... +......++.+.+++.+||+.||
T Consensus 206 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~l~~li~~~l~~~p 262 (296)
T 4hgt_A 206 MYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-----------------------EVLCKGYPSEFATYLNFCRSLRF 262 (296)
T ss_dssp HHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-----------------------HHHTTTSCHHHHHHHHHHHTSCT
T ss_pred HHHhcCCCCCcccchhhhhhhhhhhhcccccchh-----------------------hhhhccCCHHHHHHHHHHHhcCC
Confidence 9999999999764321 112111111000000 00001446679999999999999
Q ss_pred CCCCCHHHHHHHHHhh
Q 001142 1118 TERPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1118 ~~RPSa~EVL~~L~~~ 1133 (1142)
++|||+.++++.+...
T Consensus 263 ~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 263 DDKPDYSYLRQLFRNL 278 (296)
T ss_dssp TCCCCHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHH
Confidence 9999999999876553
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=335.01 Aligned_cols=263 Identities=17% Similarity=0.162 Sum_probs=197.6
Q ss_pred CCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
-++|++.+.||+|+||.||+|++ .+..+|+|+...... .+.+ .+|+.++++++|++++..+.++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~----~~e~~~l~~l~~~~~i~~~~~~~~~~ 77 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HPQL----HIESKIYKMMQGGVGIPTIRWCGAEG 77 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS------CCHH----HHHHHHHHHHTTSTTCCCEEEEEEET
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc------hhHH----HHHHHHHHHhhcCCCCCccccccCCC
Confidence 35799999999999999999996 577888887653321 1123 68999999999888877776664422
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
...++||||+ +++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 78 -------------~~~~lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~ 139 (296)
T 3uzp_A 78 -------------DYNVMVMELL-GPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMG 139 (296)
T ss_dssp -------------TEEEEEEECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred -------------CceEEEEEec-CCCHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEe
Confidence 2459999999 89999999752 34699999999999999999999999999999999999995
Q ss_pred ---cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 964 ---LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 964 ---~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
.+ +.+||+|||++........... ..........||+.|+|||++.+ ..++.++|||||||++
T Consensus 140 ~~~~~-------~~~kl~Dfg~~~~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il 205 (296)
T 3uzp_A 140 LGKKG-------NLVYIIDFGLAKKYRDARTHQH---IPYRENKNLTGTARYASINTHLG----IEQSRRDDLESLGYVL 205 (296)
T ss_dssp CGGGT-------TCEEECCCTTCEECBCTTTCCB---CCCCCSCCCCSCTTTCCHHHHTT----CCCCHHHHHHHHHHHH
T ss_pred cCCCC-------CeEEEeeCCCcccccccccccc---cccccccccccccccCChhhhcC----CCCCcchhhHHHHHHH
Confidence 33 7899999999987554322110 01112235579999999999876 5688999999999999
Q ss_pred HHHHhCCCCCCCCCH---HHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001142 1041 LELLTLQVPYMGLSE---LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1117 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~~~~---~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP 1117 (1142)
|+|++|+.||.+... .+....+......... +......++.+.+++.+||+.||
T Consensus 206 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~l~~li~~~l~~dp 262 (296)
T 3uzp_A 206 MYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-----------------------EVLCKGYPSEFATYLNFCRSLRF 262 (296)
T ss_dssp HHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-----------------------HHHTTTSCHHHHHHHHHHHTSCT
T ss_pred HHHHhCCCCCCCcCchhhhhhhhhhcccccCCch-----------------------HHHHhhCCHHHHHHHHHHHhcCc
Confidence 999999999976322 1122222111000000 00001456779999999999999
Q ss_pred CCCCCHHHHHHHHHhh
Q 001142 1118 TERPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1118 ~~RPSa~EVL~~L~~~ 1133 (1142)
.+|||+.++++.+...
T Consensus 263 ~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 263 DDKPDYSYLRQLFRNL 278 (296)
T ss_dssp TCCCCHHHHHHHHHHH
T ss_pred CcCCCHHHHHHHHHHH
Confidence 9999999999887654
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=346.57 Aligned_cols=268 Identities=23% Similarity=0.325 Sum_probs=183.7
Q ss_pred CCCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHH-HHhhCCCCCccceeeeEe
Q 001142 804 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVR-MLGALRHSCIVEMYGHKI 880 (1142)
Q Consensus 804 ~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~-iL~~L~HpNIVkl~g~~~ 880 (1142)
...++|++.+.||+|+||.||+|.+. +..+|+|+.... . .......+ ..|+. +++.++||||+++++++.
T Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~-~~~~~~~~----~~e~~~~~~~~~h~niv~~~~~~~ 91 (327)
T 3aln_A 19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST--V-DEKEQKQL----LMDLDVVMRSSDCPYIVQFYGALF 91 (327)
T ss_dssp CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECC--C-CHHHHHHH----HHHHHHHHSSCCCTTBCCEEEEEE
T ss_pred cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecc--c-CchHHHHH----HHHHHHHHHcCCCCcEeeeeeEEE
Confidence 34678999999999999999999985 677888876432 1 22222222 46665 667789999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCC
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSEN 959 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~-gIvHrDLKp~N 959 (1142)
+.+ ..++||||++ ++|.+++..........+++..+..++.|++.||.|||++ ||+||||||+|
T Consensus 92 ~~~--------------~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~N 156 (327)
T 3aln_A 92 REG--------------DCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSN 156 (327)
T ss_dssp CSS--------------EEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGG
T ss_pred eCC--------------ceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHH
Confidence 654 3599999998 6898888765444456799999999999999999999999 99999999999
Q ss_pred eeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001142 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039 (1142)
Q Consensus 960 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGvi 1039 (1142)
||++.+ +.+||+|||++....... ......||+.|+|||++........++.++||||||++
T Consensus 157 Ill~~~-------~~~kl~Dfg~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~i 218 (327)
T 3aln_A 157 ILLDRS-------GNIKLCDFGISGQLVDSI-----------AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGIT 218 (327)
T ss_dssp EEEETT-------TEEEECCCSSSCC-----------------------------------------CCSHHHHHHHHHH
T ss_pred EEEcCC-------CCEEEccCCCceeccccc-----------ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHH
Confidence 999887 789999999997654321 11123689999999998532223568899999999999
Q ss_pred HHHHHhCCCCCCCCCHH-HHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001142 1040 LLELLTLQVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1118 (1142)
Q Consensus 1040 L~ELLtG~~Pf~~~~~~-el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~ 1118 (1142)
+|+|++|+.||.+.... +....+..+..+.+.. ......++.+.+|+.+||+.||+
T Consensus 219 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~l~~li~~~l~~dp~ 275 (327)
T 3aln_A 219 LYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSN-----------------------SEEREFSPSFINFVNLCLTKDES 275 (327)
T ss_dssp HHHHHHSCCCSSCC-------CCCCCSCCCCCCC-----------------------CSSCCCCHHHHHHHHHHTCSSGG
T ss_pred HHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCC-----------------------cccccCCHHHHHHHHHHhhCChh
Confidence 99999999999764321 1111111111111100 00014566799999999999999
Q ss_pred CCCCHHHHHHHHHhhc
Q 001142 1119 ERPTAGDLYEMFVART 1134 (1142)
Q Consensus 1119 ~RPSa~EVL~~L~~~~ 1134 (1142)
+|||+.++++|+|+..
T Consensus 276 ~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 276 KRPKYKELLKHPFILM 291 (327)
T ss_dssp GSCCHHHHTTSHHHHH
T ss_pred hCcCHHHHHhChHHHH
Confidence 9999999999999964
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=369.57 Aligned_cols=254 Identities=22% Similarity=0.315 Sum_probs=198.0
Q ss_pred CCcceee-eecccCceEEEEEEEC----CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001142 807 PSLSSCD-EAGKSVSSSLFRCKFG----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 881 (1142)
Q Consensus 807 ~~y~l~~-~LG~GsfG~Vy~a~~~----~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~ 881 (1142)
.++.+.+ .||+|+||.||+|.+. +..||+|+. +... .....+.+ .+|+.+|++++|||||++++++..
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~--~~~~-~~~~~~~~----~~E~~il~~l~hpniv~l~~~~~~ 407 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGT-EKADTEEM----MREAQIMHQLDNPYIVRLIGVCQA 407 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEEC--CCCC-SSTTHHHH----HHHHHHHTTCCCTTBCCEEEEEES
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEc--CCCC-ChHHHHHH----HHHHHHHHhCCCCCEeeEEEEecc
Confidence 3455555 8999999999999873 334677764 3221 12223344 799999999999999999999874
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 001142 882 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 961 (1142)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NIL 961 (1142)
+ ..++||||+++|+|.+++.. ....+++..+..|+.||+.||+|||++||+||||||+|||
T Consensus 408 ~---------------~~~lv~E~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIL 468 (613)
T 2ozo_A 408 E---------------ALMLVMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVL 468 (613)
T ss_dssp S---------------SEEEEEECCTTCBHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred C---------------CeEEEEEeCCCCcHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEE
Confidence 2 24999999999999999864 2356999999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001142 962 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1041 (1142)
Q Consensus 962 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ 1041 (1142)
++.+ +.+||+|||+++......... .......+|+.|+|||++.+ ..++.++|||||||++|
T Consensus 469 l~~~-------~~vkL~DFGla~~~~~~~~~~-------~~~~~~~~~~~y~APE~~~~----~~~~~~sDvwSlGv~l~ 530 (613)
T 2ozo_A 469 LVNR-------HYAKISDFGLSKALGADDSYY-------TARSAGKWPLKWYAPECINF----RKFSSRSDVWSYGVTMW 530 (613)
T ss_dssp EEET-------TEEEECCCSTTTTCC---------------------CCTTSCHHHHHH----CCCCHHHHHHHHHHHHH
T ss_pred EcCC-------CcEEEeeccCcccccCCCcee-------eeccCCCCccceeCHhhhcC----CCCCcHHHHHHHHHHHH
Confidence 9987 789999999997654321110 01112346788999999976 57899999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1042 ELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1042 ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
||++ |+.||.+....++...+..+..+..+. .+++.+.+|+.+||+.||++|
T Consensus 531 ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~---------------------------~~~~~l~~li~~cl~~dP~~R 583 (613)
T 2ozo_A 531 EALSYGQKPYKKMKGPEVMAFIEQGKRMECPP---------------------------ECPPELYALMSDCWIYKWEDR 583 (613)
T ss_dssp HHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHTTCSSTTTS
T ss_pred HHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------cCCHHHHHHHHHHcCCChhHC
Confidence 9998 999999888878777776665433221 456679999999999999999
Q ss_pred CCHHHHHHHHH
Q 001142 1121 PTAGDLYEMFV 1131 (1142)
Q Consensus 1121 PSa~EVL~~L~ 1131 (1142)
|++.+|++.+.
T Consensus 584 Ps~~~l~~~L~ 594 (613)
T 2ozo_A 584 PDFLTVEQRMR 594 (613)
T ss_dssp CCHHHHHHHHH
T ss_pred cCHHHHHHHHH
Confidence 99999966543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=346.73 Aligned_cols=287 Identities=19% Similarity=0.252 Sum_probs=202.7
Q ss_pred CCCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-----------CCC
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-----------HSC 871 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-----------HpN 871 (1142)
...+|++.+.||+|+||+||+|++ .+..+|+|+... .....+.+ .+|+.+++++. |||
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~~~----~~e~~~l~~l~~~~~~~~~~~~~~~ 87 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-----DKVYTEAA----EDEIKLLQRVNDADNTKEDSMGANH 87 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-----CHHHHHHH----HHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-----Cccchhhh----hHHHHHHHHhhcccccchhccccch
Confidence 456899999999999999999997 567788887542 12222333 78999988876 899
Q ss_pred ccceeeeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-Cc
Q 001142 872 IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HI 950 (1142)
Q Consensus 872 IVkl~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~-gI 950 (1142)
|+++++++...+. .....++||||+ +++|.+++... ....+++..+..|+.||+.||+|||++ ||
T Consensus 88 i~~~~~~~~~~~~----------~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~~i 153 (373)
T 1q8y_A 88 ILKLLDHFNHKGP----------NGVHVVMVFEVL-GENLLALIKKY---EHRGIPLIYVKQISKQLLLGLDYMHRRCGI 153 (373)
T ss_dssp BCCCCEEEEEEET----------TEEEEEEEECCC-CEEHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHHHTTCE
T ss_pred HHHHHHHhhccCC----------CCceEEEEEecC-CCCHHHHHHHh---hccCCcHHHHHHHHHHHHHHHHHHHhcCCE
Confidence 9999999876331 123569999999 79999999862 234589999999999999999999998 99
Q ss_pred cccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCch
Q 001142 951 MHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLE 1030 (1142)
Q Consensus 951 vHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~k 1030 (1142)
+||||||+|||++.++. ....+.+||+|||++...... .....||+.|+|||++.+ ..++.+
T Consensus 154 vH~Dikp~NIll~~~~~-~~~~~~~kl~Dfg~a~~~~~~-------------~~~~~~t~~y~aPE~~~~----~~~~~~ 215 (373)
T 1q8y_A 154 IHTDIKPENVLMEIVDS-PENLIQIKIADLGNACWYDEH-------------YTNSIQTREYRSPEVLLG----APWGCG 215 (373)
T ss_dssp ECSCCSGGGEEEEEEET-TTTEEEEEECCCTTCEETTBC-------------CCSCCSCGGGCCHHHHHT----CCCCTH
T ss_pred EecCCChHHeEEeccCC-CcCcceEEEcccccccccCCC-------------CCCCCCCccccCcHHHhC----CCCCch
Confidence 99999999999965421 012258999999999765431 123468999999999986 568899
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHH-Hh-CCCCCchhHHhhhcccc-----cccccccCCCCC----
Q 001142 1031 VDIWSYGCLLLELLTLQVPYMGLSE------LEIHDLI-QM-GKRPRLTDELEALGSCH-----EHEVAQSGSGFE---- 1093 (1142)
Q Consensus 1031 sDVwSLGviL~ELLtG~~Pf~~~~~------~el~~~I-~~-~~~p~l~~~l~~~~~~~-----~~~~~~~~~~~~---- 1093 (1142)
+|||||||++|||++|+.||.+... .+....+ .. +..|. .+....... ............
T Consensus 216 ~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (373)
T 1q8y_A 216 ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPS---YLLRNGKYTRTFFNSRGLLRNISKLKFWPL 292 (373)
T ss_dssp HHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCH---HHHHHCTTHHHHBCC--CBSSCCCCCBCCH
T ss_pred HhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCH---HHHhccchhhhhcCCcchhcccccccccch
Confidence 9999999999999999999975431 2222222 11 11111 100000000 000000000000
Q ss_pred ------CchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001142 1094 ------KPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1094 ------~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~~s 1135 (1142)
........++.+.+||.+||+.||++|||+.|+++|+|++..
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 340 (373)
T 1q8y_A 293 EDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 340 (373)
T ss_dssp HHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred hhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhcc
Confidence 000112567889999999999999999999999999999865
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=339.01 Aligned_cols=262 Identities=21% Similarity=0.295 Sum_probs=195.9
Q ss_pred CCcceeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC--CCCccceeeeEecCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR--HSCIVEMYGHKISSK 883 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~-~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~--HpNIVkl~g~~~~~~ 883 (1142)
.+|++.+.||+|+||.||+|.+. +..+|+|+..... ......+.+ .+|+.++.+++ ||||+++++++....
T Consensus 28 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~----~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 101 (313)
T 3cek_A 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE--ADNQTLDSY----RNEIAYLNKLQQHSDKIIRLYDYEITDQ 101 (313)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSS--CCHHHHHHH----HHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred ceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEecccc--ccccchHHH----HHHHHHHHhccccCCceEEEEEEeecCC
Confidence 45999999999999999999874 5668888865432 233334444 79999999996 599999999988654
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
..++|||+ .+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 102 --------------~~~lv~e~-~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~ 161 (313)
T 3cek_A 102 --------------YIYMVMEC-GNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV 161 (313)
T ss_dssp --------------EEEEEECC-CSEEHHHHHHH-----CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE
T ss_pred --------------EEEEEEec-CCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE
Confidence 35999995 57999999986 34689999999999999999999999999999999999995
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhcccc-------CCCCCCchhhHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-------KPNLYGLEVDIWSY 1036 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-------~~~~~s~ksDVwSL 1036 (1142)
. +.+||+|||++......... .......||+.|+|||++.+.. ....++.++|||||
T Consensus 162 ~--------~~~kL~Dfg~~~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~sl 225 (313)
T 3cek_A 162 D--------GMLKLIDFGIANQMQPDTTS--------VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 225 (313)
T ss_dssp T--------TEEEECCCSSSCC----------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHH
T ss_pred C--------CeEEEeeccccccccCcccc--------ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHH
Confidence 3 68999999999765432111 1112346899999999986521 11367899999999
Q ss_pred HHHHHHHHhCCCCCCCCCHH-HHHHHHHhC-CCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcc
Q 001142 1037 GCLLLELLTLQVPYMGLSEL-EIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 1114 (1142)
Q Consensus 1037 GviL~ELLtG~~Pf~~~~~~-el~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~ 1114 (1142)
|+++|+|++|+.||...... .....+... .....+ ...+..+.+++.+||+
T Consensus 226 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~~l~ 278 (313)
T 3cek_A 226 GCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP---------------------------DIPEKDLQDVLKCCLK 278 (313)
T ss_dssp HHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCC---------------------------CCSCHHHHHHHHHHTC
T ss_pred HHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCc---------------------------ccchHHHHHHHHHHcc
Confidence 99999999999999764322 222222111 110000 0234568999999999
Q ss_pred cCCCCCCCHHHHHHHHHhhcCCC
Q 001142 1115 ENPTERPTAGDLYEMFVARTSSS 1137 (1142)
Q Consensus 1115 ~DP~~RPSa~EVL~~L~~~~ss~ 1137 (1142)
.||.+|||+.|+++|+|+.....
T Consensus 279 ~dp~~Rps~~ell~h~~~~~~~~ 301 (313)
T 3cek_A 279 RDPKQRISIPELLAHPYVQIQTH 301 (313)
T ss_dssp SSTTTSCCHHHHHTSHHHHCC--
T ss_pred CCcccCcCHHHHhcCccccCCCC
Confidence 99999999999999999986543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=353.25 Aligned_cols=290 Identities=20% Similarity=0.236 Sum_probs=206.2
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
.+|++.++||+|+||+||+|++. +..+|+|+...... ....+. +.+|++++++++||||+++++++.+...
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~----~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 81 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF---LRPVDV----QMREFEVLKKLNHKNIVKLFAIEEETTT 81 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG---GSCHHH----HHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc---cchHHH----HHHHHHHHHhcCCCCCCeEEEeeccCCC
Confidence 46999999999999999999985 67788888643221 111222 3689999999999999999999876431
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
...++||||+++++|.+++.... ....+++..++.|+.||+.||+|||++||+||||||+|||+..
T Consensus 82 ------------~~~~lv~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 147 (396)
T 4eut_A 82 ------------RHKVLIMEFCPCGSLYTVLEEPS--NAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVI 147 (396)
T ss_dssp ------------CCEEEEECCCTTEEHHHHTTSGG--GTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEE
T ss_pred ------------CeeEEEEecCCCCCHHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEee
Confidence 24599999999999999987522 2234899999999999999999999999999999999999821
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccC----CCCCCchhhHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK----PNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~----~~~~s~ksDVwSLGviL 1040 (1142)
. ....+.+||+|||+++....... .....||+.|+|||++.+... ...++.++|||||||++
T Consensus 148 ~---~~~~~~~kL~DFG~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il 213 (396)
T 4eut_A 148 G---EDGQSVYKLTDFGAARELEDDEQ-----------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213 (396)
T ss_dssp C---TTSCEEEEECCGGGCEECCCGGG-----------SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHH
T ss_pred c---CCCceeEEEecCCCceEccCCCc-----------cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHH
Confidence 1 01126799999999976543221 123469999999999864110 02467899999999999
Q ss_pred HHHHhCCCCCCCC----CHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 001142 1041 LELLTLQVPYMGL----SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1116 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~~----~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~D 1116 (1142)
|||++|+.||... ...+....+..+..+............ ...+.. ... .........++.+.+++.+||+.|
T Consensus 214 ~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~-~~~~~~-~~~-~~~~l~~~~~~~l~~ll~~~L~~d 290 (396)
T 4eut_A 214 YHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENG-PIDWSG-DMP-VSCSLSRGLQVLLTPVLANILEAD 290 (396)
T ss_dssp HHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTC-CEEEES-SCC-TTCSSCHHHHHHHHHHHHHHSCCC
T ss_pred HHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCC-CcccCc-cCC-cccccchHHHhhchHHHHHhhccC
Confidence 9999999999642 223444555444433222111100000 000000 000 011112367788999999999999
Q ss_pred CCCCCCHHHHHHHHHhhc
Q 001142 1117 PTERPTAGDLYEMFVART 1134 (1142)
Q Consensus 1117 P~~RPSa~EVL~~L~~~~ 1134 (1142)
|++|||+.|+++++....
T Consensus 291 P~~R~s~~e~l~~l~~il 308 (396)
T 4eut_A 291 QEKCWGFDQFFAETSDIL 308 (396)
T ss_dssp TTTSCCHHHHHHHHHHHH
T ss_pred hhhhccHHHHHHHHHHHh
Confidence 999999999999887653
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=372.65 Aligned_cols=249 Identities=21% Similarity=0.332 Sum_probs=198.6
Q ss_pred eeecccCceEEEEEEE----CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCC
Q 001142 813 DEAGKSVSSSLFRCKF----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 888 (1142)
Q Consensus 813 ~~LG~GsfG~Vy~a~~----~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~~ 888 (1142)
++||+|+||.||+|.+ .+..+|||+.+.. .......+. +.+|+.++++++|||||++++++...
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~------ 442 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE--ANDPALKDE----LLAEANVMQQLDNPYIVRMIGICEAE------ 442 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGG--GGCGGGHHH----HHHHHHHHHHCCCTTBCCEEEEEESS------
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccc--cCCHHHHHH----HHHHHHHHHhCCCCCEeeEEEEEecC------
Confidence 4899999999999976 2356888875432 122222333 48999999999999999999998643
Q ss_pred CCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecccccc
Q 001142 889 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 968 (1142)
Q Consensus 889 ~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~ 968 (1142)
..++||||+++|+|.++++. ...+++..+..|+.||+.||+|||++||+||||||+|||++.+
T Consensus 443 ---------~~~lv~E~~~~g~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~--- 505 (635)
T 4fl3_A 443 ---------SWMLVMEMAELGPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ--- 505 (635)
T ss_dssp ---------SEEEEEECCTTEEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET---
T ss_pred ---------CEEEEEEccCCCCHHHHHhh-----CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCC---
Confidence 24899999999999999976 3568999999999999999999999999999999999999987
Q ss_pred CCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-CC
Q 001142 969 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQ 1047 (1142)
Q Consensus 969 ~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt-G~ 1047 (1142)
+.+||+|||+++.+....... .......+|+.|+|||++.+ ..++.++|||||||++|||++ |+
T Consensus 506 ----~~~kL~DFGla~~~~~~~~~~-------~~~~~~~~t~~y~APE~~~~----~~~~~~sDvwSlGv~l~ellt~G~ 570 (635)
T 4fl3_A 506 ----HYAKISDFGLSKALRADENYY-------KAQTHGKWPVKWYAPECINY----YKFSSKSDVWSFGVLMWEAFSYGQ 570 (635)
T ss_dssp ----TEEEECCTTHHHHTTC--------------------CGGGSCHHHHHH----CCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred ----CCEEEEEcCCccccccCcccc-------ccccCCCCceeeeChhhhcC----CCCCcHHHHHHHHHHHHHHHhCCC
Confidence 789999999997654322110 11123346889999999976 568999999999999999998 99
Q ss_pred CCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHH
Q 001142 1048 VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY 1127 (1142)
Q Consensus 1048 ~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL 1127 (1142)
.||.+....++...+..+..+..+. .+++.+.+||.+||+.||++|||+.+|+
T Consensus 571 ~Pf~~~~~~~~~~~i~~~~~~~~p~---------------------------~~~~~l~~li~~cl~~dP~~RPs~~~l~ 623 (635)
T 4fl3_A 571 KPYRGMKGSEVTAMLEKGERMGCPA---------------------------GCPREMYDLMNLCWTYDVENRPGFAAVE 623 (635)
T ss_dssp CSSTTCCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 9999988888887777665443221 4556799999999999999999999999
Q ss_pred HHHHh
Q 001142 1128 EMFVA 1132 (1142)
Q Consensus 1128 ~~L~~ 1132 (1142)
+.+..
T Consensus 624 ~~L~~ 628 (635)
T 4fl3_A 624 LRLRN 628 (635)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 88754
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=340.80 Aligned_cols=272 Identities=21% Similarity=0.286 Sum_probs=183.8
Q ss_pred CcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEecCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKW 884 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~g~~~~~~~ 884 (1142)
+|++.++||+|+||.||+|++ .+..+|+|+.... .....+.+ .+|+.+++++. ||||+++++++.....
T Consensus 29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~----~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 100 (337)
T 3ll6_A 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN----EEEKNRAI----IQEVCFMKKLSGHPNIVQFCSAASIGKE 100 (337)
T ss_dssp EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES----SHHHHHHH----HHHHHHHHHHTTSTTBCCEEEEEEECTT
T ss_pred eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC----chHHHHHH----HHHHHHHHHhccCCChhhcccccccccc
Confidence 699999999999999999998 5677888875322 22333333 79999999996 9999999999865332
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCeee
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENILI 962 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~g--IvHrDLKp~NILl 962 (1142)
. ........++||||+. |+|.+++..... ...+++..++.|+.||+.||.|||++| |+||||||+|||+
T Consensus 101 ~------~~~~~~~~~lv~e~~~-g~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~ 171 (337)
T 3ll6_A 101 E------SDTGQAEFLLLTELCK-GQLVEFLKKMES--RGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL 171 (337)
T ss_dssp T------STTSSEEEEEEEECCS-EEHHHHHHHHHT--TCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEE
T ss_pred c------cccCCceEEEEEEecC-CCHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEE
Confidence 1 1122345799999996 899999976432 346999999999999999999999999 9999999999999
Q ss_pred ccccccCCCCCeEEEeecCCccccccccccccccc--CCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH--RGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~--~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
+.+ +.+||+|||++.............. ..........||+.|+|||++... ....++.++|||||||++
T Consensus 172 ~~~-------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~~~Dv~slG~il 243 (337)
T 3ll6_A 172 SNQ-------GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLY-SNFPIGEKQDIWALGCIL 243 (337)
T ss_dssp CTT-------SCEEBCCCTTCBCCSSCC-------------------------------CC-TTSCSSHHHHHHHHHHHH
T ss_pred CCC-------CCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhcc-ccCCCChHHhHHHHHHHH
Confidence 887 7899999999986543221100000 000111234589999999998421 135678999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1041 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
|+|++|+.||............ ..... ....+..+.+|+.+||+.||.+|
T Consensus 244 ~el~~g~~p~~~~~~~~~~~~~---~~~~~---------------------------~~~~~~~~~~li~~~l~~~p~~R 293 (337)
T 3ll6_A 244 YLLCFRQHPFEDGAKLRIVNGK---YSIPP---------------------------HDTQYTVFHSLIRAMLQVNPEER 293 (337)
T ss_dssp HHHHHSSCCC---------------CCCCT---------------------------TCCSSGGGHHHHHHHSCSSGGGS
T ss_pred HHHHhCCCCCcchhHHHhhcCc---ccCCc---------------------------ccccchHHHHHHHHHccCChhhC
Confidence 9999999999754332221110 00000 00223348899999999999999
Q ss_pred CCHHHHHHHHHhhc
Q 001142 1121 PTAGDLYEMFVART 1134 (1142)
Q Consensus 1121 PSa~EVL~~L~~~~ 1134 (1142)
||+.|++++++...
T Consensus 294 ps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 294 LSIAEVVHQLQEIA 307 (337)
T ss_dssp CCHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHH
Confidence 99999999988754
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=338.36 Aligned_cols=263 Identities=24% Similarity=0.375 Sum_probs=187.1
Q ss_pred CCCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001142 804 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 881 (1142)
Q Consensus 804 ~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~ 881 (1142)
..+.+|++.+.||+|+||.||+|.+. +..+|+|+.... . .......+ +..+..+++.++||||+++++++.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~-~~~~~~~~---~~~~~~~~~~~~h~~i~~~~~~~~~ 95 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS--G-NKEENKRI---LMDLDVVLKSHDCPYIVQCFGTFIT 95 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETT--S-CHHHHHHH---HHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccc--c-cchHHHHH---HHHHHHHHHhcCCCceeeEEEEEec
Confidence 34678999999999999999999984 677888886432 1 12222222 2445556788899999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCe
Q 001142 882 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENI 960 (1142)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~-gIvHrDLKp~NI 960 (1142)
.+ ..++||||+ ++.+..+.... ...+++..+..++.||+.||.|||++ ||+||||||+||
T Consensus 96 ~~--------------~~~lv~e~~-~~~~~~l~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Ni 156 (318)
T 2dyl_A 96 NT--------------DVFIAMELM-GTCAEKLKKRM----QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNI 156 (318)
T ss_dssp SS--------------EEEEEECCC-SEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGE
T ss_pred CC--------------cEEEEEecc-CCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHE
Confidence 54 459999999 56666665542 34689999999999999999999995 999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhcccc-CCCCCCchhhHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCL 1039 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~s~ksDVwSLGvi 1039 (1142)
|++.+ +.+||+|||++....... ......||+.|+|||++.... ....++.++||||||++
T Consensus 157 l~~~~-------~~~kl~dfg~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~i 218 (318)
T 2dyl_A 157 LLDER-------GQIKLCDFGISGRLVDDK-----------AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGIS 218 (318)
T ss_dssp EECTT-------SCEEECCCTTC-------------------------CCTTCCHHHHC--------CCTHHHHHHHHHH
T ss_pred EECCC-------CCEEEEECCCchhccCCc-----------cccccCCCccccChhhcccccccccCCccccchhhHHHH
Confidence 99887 789999999996543321 112346899999999985321 12467899999999999
Q ss_pred HHHHHhCCCCCCCC-CHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001142 1040 LLELLTLQVPYMGL-SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1118 (1142)
Q Consensus 1040 L~ELLtG~~Pf~~~-~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~ 1118 (1142)
+|+|++|+.||... ...+....+.....+..+.. ...++.+.+++.+||+.||.
T Consensus 219 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~l~~li~~~l~~dp~ 273 (318)
T 2dyl_A 219 LVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGH-------------------------MGFSGDFQSFVKDCLTKDHR 273 (318)
T ss_dssp HHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSS-------------------------SCCCHHHHHHHHHHTCSCTT
T ss_pred HHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCcc-------------------------CCCCHHHHHHHHHHccCChh
Confidence 99999999999863 34445555544433322110 03456799999999999999
Q ss_pred CCCCHHHHHHHHHhhc
Q 001142 1119 ERPTAGDLYEMFVART 1134 (1142)
Q Consensus 1119 ~RPSa~EVL~~L~~~~ 1134 (1142)
+|||+.++++|+|++.
T Consensus 274 ~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 274 KRPKYNKLLEHSFIKR 289 (318)
T ss_dssp TSCCHHHHTTSHHHHH
T ss_pred HCcCHHHHhhCHHHHh
Confidence 9999999999999864
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=347.09 Aligned_cols=280 Identities=13% Similarity=0.098 Sum_probs=196.2
Q ss_pred CCCcceeeeecccCceEEEEEEEC-----CccEEEEEEecccCCCCh-HHHHHh----HHhHHHHHHHHhhCCCCCccce
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSA-DEIRNF----EYSCLGEVRMLGALRHSCIVEM 875 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~-----~~~vAvKi~~l~~~~~~~-~~~~~~----~~~~~~Ei~iL~~L~HpNIVkl 875 (1142)
-.+|++.+.||+|+||.||+|.+. +..+|+|+..... ... .+.+.+ ...+.+|+.+++.++||||+++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN--GPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC---CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCC--cchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 357999999999999999999984 4567888754321 111 111111 1234688999999999999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 001142 876 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 955 (1142)
Q Consensus 876 ~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDL 955 (1142)
++++..... .....++||||+ +++|.+++.. ...+++..++.|+.||+.||+|||++||+||||
T Consensus 114 ~~~~~~~~~----------~~~~~~lv~e~~-~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dl 177 (345)
T 2v62_A 114 YGSGLTEFK----------GRSYRFMVMERL-GIDLQKISGQ-----NGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDI 177 (345)
T ss_dssp EEEEEEESS----------SCEEEEEEEECE-EEEHHHHCBG-----GGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred ecccccccC----------CCcEEEEEEecc-CCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCc
Confidence 999876210 123569999999 8999999865 237999999999999999999999999999999
Q ss_pred CCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHH
Q 001142 956 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 1035 (1142)
Q Consensus 956 Kp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwS 1035 (1142)
||+|||++.+.. +.+||+|||+++.+........ ..........||+.|+|||++.+ ..++.++||||
T Consensus 178 kp~NIll~~~~~-----~~~kL~Dfg~a~~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~s 245 (345)
T 2v62_A 178 KAANLLLGYKNP-----DQVYLADYGLSYRYCPNGNHKQ---YQENPRKGHNGTIEFTSLDAHKG----VALSRRSDVEI 245 (345)
T ss_dssp SGGGEEEESSST-----TSEEECCCTTCEESSGGGCCCC---CCCCGGGCSCSCTTTCCHHHHHT----CCCCHHHHHHH
T ss_pred CHHHEEEccCCC-----CcEEEEeCCCceeccccccccc---chhccccccCCCccccCHHHhcC----CCCCchhhHHH
Confidence 999999987621 3899999999987643221100 00111134579999999999886 56899999999
Q ss_pred HHHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 001142 1036 YGCLLLELLTLQVPYMGL--SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 1113 (1142)
Q Consensus 1036 LGviL~ELLtG~~Pf~~~--~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL 1113 (1142)
|||++|||++|+.||.+. ......... ....+.++...... . .....++.+.+++.+||
T Consensus 246 lG~il~ell~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~-----------~-------~~~~~~~~l~~li~~~l 306 (345)
T 2v62_A 246 LGYCMLRWLCGKLPWEQNLKDPVAVQTAK-TNLLDELPQSVLKW-----------A-------PSGSSCCEIAQFLVCAH 306 (345)
T ss_dssp HHHHHHHHHHSSCTTGGGTTCHHHHHHHH-HHHHHTTTHHHHHH-----------S-------CTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCccccccccHHHHHHH-HhhcccccHHHHhh-----------c-------cccccHHHHHHHHHHHh
Confidence 999999999999999642 222222111 11111111111100 0 00145567999999999
Q ss_pred ccCCCCCCCHHHHHHHHHhhc
Q 001142 1114 EENPTERPTAGDLYEMFVART 1134 (1142)
Q Consensus 1114 ~~DP~~RPSa~EVL~~L~~~~ 1134 (1142)
+.||++|||+.+|++.+....
T Consensus 307 ~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 307 SLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp TCCTTCCCCHHHHHHHHCTTC
T ss_pred hcCcccCCCHHHHHHHHhccC
Confidence 999999999999999987654
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=345.66 Aligned_cols=265 Identities=14% Similarity=0.112 Sum_probs=197.0
Q ss_pred CCCcceeeeecccCceEEEEEEEC----------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccce
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG----------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 875 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~----------~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl 875 (1142)
-.+|++.+.||+|+||.||+|++. +..+|+|+.... +.+ .+|+.++++++||||+++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---------~~~----~~E~~~l~~l~h~niv~~ 107 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---------GRL----FNEQNFFQRAAKPLQVNK 107 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---------STH----HHHHHHHHHHCCHHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---------chH----HHHHHHHHHhcccchhhh
Confidence 367999999999999999999984 567899886422 123 689999999999999984
Q ss_pred ---------------eeeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHH
Q 001142 876 ---------------YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAA 940 (1142)
Q Consensus 876 ---------------~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~ 940 (1142)
++++... ....++||||+ +++|.+++... ....+++..+..|+.||+.
T Consensus 108 ~~~~~~~~~~~i~~~~~~~~~~-------------~~~~~lv~e~~-~~~L~~~l~~~---~~~~l~~~~~~~i~~qi~~ 170 (352)
T 2jii_A 108 WKKLYSTPLLAIPTCMGFGVHQ-------------DKYRFLVLPSL-GRSLQSALDVS---PKHVLSERSVLQVACRLLD 170 (352)
T ss_dssp HHHHTTCTTCSCCCCCEEEEET-------------TTEEEEEEECC-CEEHHHHHHHS---GGGCCCHHHHHHHHHHHHH
T ss_pred hhhhccCCccCccchhhccccC-------------CcEEEEEecCC-CcCHHHHHHhC---CcCCCCHHHHHHHHHHHHH
Confidence 4444331 12569999999 89999999862 1246999999999999999
Q ss_pred HHHHHHhCCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhcc
Q 001142 941 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1020 (1142)
Q Consensus 941 gL~yLHs~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~ 1020 (1142)
||.|||++||+||||||+|||++.++. ..+||+|||+++.+......... .........||+.|+|||++.+
T Consensus 171 ~L~~LH~~~ivH~Dikp~NIl~~~~~~-----~~~kl~Dfg~a~~~~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~ 242 (352)
T 2jii_A 171 ALEFLHENEYVHGNVTAENIFVDPEDQ-----SQVTLAGYGFAFRYCPSGKHVAY---VEGSRSPHEGDLEFISMDLHKG 242 (352)
T ss_dssp HHHHHHHTTCBCSCCCGGGEEEETTEE-----EEEEECCGGGCBCSSGGGCCCCC---CTTSSCTTCSCTTTCCHHHHTT
T ss_pred HHHHHHhCCccCCCCCHHHEEEcCCCC-----ceEEEecCcceeeccCCCccccc---cccccccccCCccccCHHHHcc
Confidence 999999999999999999999987621 28999999999866543211100 0111234479999999999876
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHH--hCCCCCchhHHhhhcccccccccccCCCCCCch
Q 001142 1021 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLS--ELEIHDLIQ--MGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE 1096 (1142)
Q Consensus 1021 ~~~~~~~s~ksDVwSLGviL~ELLtG~~Pf~~~~--~~el~~~I~--~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~ 1096 (1142)
..++.++|||||||++|+|++|+.||.... ...+..... ....+.+... . .
T Consensus 243 ----~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~------~ 297 (352)
T 2jii_A 243 ----CGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGP---------------C------G 297 (352)
T ss_dssp ----CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECT---------------T------S
T ss_pred ----CCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhh---------------c------c
Confidence 568899999999999999999999997643 322322221 1111111000 0 0
Q ss_pred hhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001142 1097 AELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1097 ~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~ 1133 (1142)
.....++.+.+++.+||+.||.+|||++++++.+...
T Consensus 298 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 334 (352)
T 2jii_A 298 HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL 334 (352)
T ss_dssp CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence 0013456799999999999999999999999987654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-36 Score=336.23 Aligned_cols=277 Identities=18% Similarity=0.176 Sum_probs=201.3
Q ss_pred CCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
-.+|++.+.||+|+||.||+|++ .+..+|+|+.... .....+.+ .+|+.++++++||||+++++++....
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~----~~E~~~l~~l~h~~iv~~~~~~~~~~ 99 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH----EQQDREEA----QREADMHRLFNHPNILRLVAYCLRER 99 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES----SHHHHHHH----HHHHHHHHTCCCTTBCCCCEEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC----CHHHHHHH----HHHHHHHhhcCCCCeeeEEEEEEecc
Confidence 45799999999999999999997 5677888876432 23333344 79999999999999999999987422
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
. .....++||||+++++|.+++...... ...+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 100 ~----------~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~ 168 (317)
T 2buj_A 100 G----------AKHEAWLLLPFFKRGTLWNEIERLKDK-GNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLG 168 (317)
T ss_dssp T----------TEEEEEEEEECCTTCBHHHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred C----------CCceeEEEEEeCCCCcHHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc
Confidence 1 123569999999999999999874332 35799999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.+||+|||.+.............. .........||+.|+|||++.+.. ...++.++||||||+++|+|
T Consensus 169 ~~-------~~~kl~dfg~~~~~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~Di~slG~il~el 239 (317)
T 2buj_A 169 DE-------GQPVLMDLGSMNQACIHVEGSRQAL-TLQDWAAQRCTISYRAPELFSVQS-HCVIDERTDVWSLGCVLYAM 239 (317)
T ss_dssp TT-------SCEEECCCSSCEESCEEEESHHHHH-HHHHHHHHHSCGGGCCGGGSSCCS-EEEECTHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEEecCcchhcccccccccccc-cccccccccCCcccCCHhHhccCC-CcCCCchhhHHHHHHHHHHH
Confidence 77 7899999999875432110000000 000001234799999999986421 12367899999999999999
Q ss_pred HhCCCCCCCCCH--HHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1044 LTLQVPYMGLSE--LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1044 LtG~~Pf~~~~~--~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
++|+.||..... ......+....... . ....+..+.+++.+||+.||.+||
T Consensus 240 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------------------~---~~~~~~~l~~li~~~l~~dp~~Rp 292 (317)
T 2buj_A 240 MFGEGPYDMVFQKGDSVALAVQNQLSIP------------------------Q---SPRHSSALWQLLNSMMTVDPHQRP 292 (317)
T ss_dssp HHSSCTTHHHHHTTSCHHHHHHCC--CC------------------------C---CTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred HhCCCChhhhhcccchhhHHhhccCCCC------------------------c---cccCCHHHHHHHHHHhhcChhhCC
Confidence 999999953100 00111111110000 0 014456799999999999999999
Q ss_pred CHHHHHHHHHhhcCCC
Q 001142 1122 TAGDLYEMFVARTSSS 1137 (1142)
Q Consensus 1122 Sa~EVL~~L~~~~ss~ 1137 (1142)
|+.++++++.......
T Consensus 293 s~~~ll~~L~~~~~~~ 308 (317)
T 2buj_A 293 HIPLLLSQLEALQPPA 308 (317)
T ss_dssp CHHHHHHHHHHTCCCC
T ss_pred CHHHHHHHhhhcCCCC
Confidence 9999999998875543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=337.57 Aligned_cols=274 Identities=23% Similarity=0.319 Sum_probs=199.4
Q ss_pred CCCcceeeeecccCceEEEEEEE------CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeE
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKF------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 879 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~------~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~ 879 (1142)
..+|++.+.||+|+||.||+|++ .+..+|+|+.... .....+.+ .+|+.++++++||||+++++++
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~----~~E~~~l~~l~h~~iv~~~~~~ 111 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDF----EREIEILKSLQHDNIVKYKGVC 111 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC----CSHHHHHH----HHHHHHHHTCCCTTBCCEEEEE
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC----CHHHHHHH----HHHHHHHHhCCCCCeeeEEEEE
Confidence 45699999999999999999985 4567888875421 22333344 7999999999999999999988
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 001142 880 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959 (1142)
Q Consensus 880 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~N 959 (1142)
...+. ...++||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|
T Consensus 112 ~~~~~------------~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~N 175 (326)
T 2w1i_A 112 YSAGR------------RNLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRN 175 (326)
T ss_dssp CC----------------CCEEEECCCTTCBHHHHHHHS----TTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred EecCC------------CceEEEEECCCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcce
Confidence 65331 1349999999999999999762 2468999999999999999999999999999999999
Q ss_pred eeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001142 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039 (1142)
Q Consensus 960 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGvi 1039 (1142)
||++.+ +.+||+|||++........... ......++..|+|||++.+ ..++.++||||||++
T Consensus 176 Ili~~~-------~~~kL~Dfg~~~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~i 237 (326)
T 2w1i_A 176 ILVENE-------NRVKIGDFGLTKVLPQDKEYYK-------VKEPGESPIFWYAPESLTE----SKFSVASDVWSFGVV 237 (326)
T ss_dssp EEEEET-------TEEEECCCTTCEECCSSCSEEE-------CSSCCSCCGGGCCHHHHHH----CEEEHHHHHHHHHHH
T ss_pred EEEcCC-------CcEEEecCcchhhccccccccc-------cccCCCCceeEECchhhcC----CCCCchhhHHHHHHH
Confidence 999887 7899999999976543221100 1123357888999999876 457899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCch-hHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001142 1040 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLT-DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1118 (1142)
Q Consensus 1040 L~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~ 1118 (1142)
+|+|++|..||... ..+....+......... ..+.. .......... ...+++.+.+++.+||+.||.
T Consensus 238 l~el~tg~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~ 305 (326)
T 2w1i_A 238 LYELFTYIEKSKSP-PAEFMRMIGNDKQGQMIVFHLIE--------LLKNNGRLPR---PDGCPDEIYMIMTECWNNNVN 305 (326)
T ss_dssp HHHHHHTTCGGGSH-HHHHHHHHCTTCCTHHHHHHHHH--------HHHTTCCCCC---CTTCCHHHHHHHHHHSCSSGG
T ss_pred HHHHHhcCCCCCCC-HHHHHHhhccccchhhhHHHHHH--------HhhcCCCCCC---CCcccHHHHHHHHHHcCCChh
Confidence 99999999998642 12222221111100000 00000 0000000000 114567899999999999999
Q ss_pred CCCCHHHHHHHHHhh
Q 001142 1119 ERPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1119 ~RPSa~EVL~~L~~~ 1133 (1142)
+|||+.|+++.+...
T Consensus 306 ~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 306 QRPSFRDLALRVDQI 320 (326)
T ss_dssp GSCCHHHHHHHHHHH
T ss_pred hCcCHHHHHHHHHHH
Confidence 999999999987654
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=350.16 Aligned_cols=277 Identities=14% Similarity=0.082 Sum_probs=182.2
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC--CCCCcccee------
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL--RHSCIVEMY------ 876 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L--~HpNIVkl~------ 876 (1142)
..|++.+.||+|+||+||+|++. +..+|+|+...... ......+. +.+|+.+++.+ +||||++++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~----~~~E~~~~~~l~~~hp~iv~~~~~~~~p 136 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAE-NSRSELER----LHEATFAAARLLGESPEEARDRRRLLLP 136 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCST-THHHHHHH----HHHHHHHHHHHHC----------CBCCC
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEeccc-ccccHHHH----HHHHHHHHHHhcccChhhhhhceeEEee
Confidence 35899999999999999999984 66788888654321 11122223 36775444444 699988765
Q ss_pred -eeEecCCCCC---CCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHH------HHHHHHHHHHHHHHH
Q 001142 877 -GHKISSKWLP---SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLA------LFIAQDVAAALVELH 946 (1142)
Q Consensus 877 -g~~~~~~~~~---~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i------~~Ia~qIa~gL~yLH 946 (1142)
+++...+.-. ..++.........++||||++ ++|.+++.... ..+++..+ ..++.||+.||+|||
T Consensus 137 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~vk~~i~~qi~~aL~~LH 211 (371)
T 3q60_A 137 SDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD----FVYVFRGDEGILALHILTAQLIRLAANLQ 211 (371)
T ss_dssp CEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH----HSCCCCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc----cccchhhhhhhhhHHHHHHHHHHHHHHHH
Confidence 3443322100 000000111245799999998 89999998632 12444455 677899999999999
Q ss_pred hCCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCC
Q 001142 947 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 1026 (1142)
Q Consensus 947 s~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 1026 (1142)
++||+||||||+|||++.+ +.+||+|||+++....... ...+|+.|+|||++.+. ...
T Consensus 212 ~~~ivHrDikp~NIll~~~-------~~~kL~DFG~a~~~~~~~~-------------~~~~t~~y~aPE~~~~~--~~~ 269 (371)
T 3q60_A 212 SKGLVHGHFTPDNLFIMPD-------GRLMLGDVSALWKVGTRGP-------------ASSVPVTYAPREFLNAS--TAT 269 (371)
T ss_dssp HTTEEETTCSGGGEEECTT-------SCEEECCGGGEEETTCEEE-------------GGGSCGGGCCHHHHTCS--EEE
T ss_pred HCCCccCcCCHHHEEECCC-------CCEEEEecceeeecCCCcc-------------CccCCcCCcChhhccCC--CCC
Confidence 9999999999999999887 7899999999976543210 23467999999998641 246
Q ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHH
Q 001142 1027 YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLV 1106 (1142)
Q Consensus 1027 ~s~ksDVwSLGviL~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~ 1106 (1142)
++.++|||||||++|||++|+.||.+....... .. ..... ..........+. ....++.+.
T Consensus 270 ~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~-~~---~~~~~--------------~~~~~~~~~~~~-~~~~~~~~~ 330 (371)
T 3q60_A 270 FTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG-SW---KRPSL--------------RVPGTDSLAFGS-CTPLPDFVK 330 (371)
T ss_dssp CCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTT-CC---CBCCT--------------TSCCCCSCCCTT-SSCCCHHHH
T ss_pred cCccccHHHHHHHHHHHHhCCCCCCCcCccccc-ch---hhhhh--------------hhccccccchhh-ccCCCHHHH
Confidence 889999999999999999999999865321100 00 00000 000000000110 115567899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001142 1107 DVFRRCTEENPTERPTAGDLYEMFVART 1134 (1142)
Q Consensus 1107 dLI~~CL~~DP~~RPSa~EVL~~L~~~~ 1134 (1142)
+|+.+||+.||++|||+.|+++|+|+..
T Consensus 331 ~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 331 TLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp HHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred HHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 9999999999999999999999999974
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=346.23 Aligned_cols=264 Identities=25% Similarity=0.279 Sum_probs=176.4
Q ss_pred CCCcceee-eecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHH-HHHhhCCCCCccceeeeEec
Q 001142 806 FPSLSSCD-EAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEV-RMLGALRHSCIVEMYGHKIS 881 (1142)
Q Consensus 806 ~~~y~l~~-~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei-~iL~~L~HpNIVkl~g~~~~ 881 (1142)
.++|.+.+ +||+|+||+||+|.+. +..+|+|+.... ... .+|+ ..++.++||||+++++++..
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~--------~~e~~~~~~~~~h~~i~~~~~~~~~ 93 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKA--------RQEVDHHWQASGGPHIVCILDVYEN 93 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHH--------HHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHH--------HHHHHHHHHhcCCCChHHHHHHHhh
Confidence 35798854 6999999999999985 678888885321 111 2333 33566789999999999875
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 001142 882 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 961 (1142)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NIL 961 (1142)
... .....++||||+++++|.+++.. .....+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 94 ~~~----------~~~~~~lv~e~~~gg~L~~~l~~---~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIl 160 (336)
T 3fhr_A 94 MHH----------GKRCLLIIMECMEGGELFSRIQE---RGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLL 160 (336)
T ss_dssp EET----------TEEEEEEEEECCTTEEHHHHHHT---C-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred ccC----------CCceEEEEEeccCCCCHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 221 12246999999999999999975 23346999999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001142 962 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1041 (1142)
Q Consensus 962 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ 1041 (1142)
++.++ ..+.+||+|||++....... .....||+.|+|||++.+ ..++.++||||||+++|
T Consensus 161 l~~~~----~~~~~kl~Dfg~~~~~~~~~------------~~~~~~t~~y~aPE~~~~----~~~~~~~Di~slG~il~ 220 (336)
T 3fhr_A 161 YTSKE----KDAVLKLTDFGFAKETTQNA------------LQTPCYTPYYVAPEVLGP----EKYDKSCDMWSLGVIMY 220 (336)
T ss_dssp ESCSS----TTCCEEECCCTTCEEC--------------------------------------CHHHHHHHHHHHHHHHH
T ss_pred EEecC----CCceEEEeccccceeccccc------------cccCCCCcCccChhhhCC----CCCCchhhHHHHHHHHH
Confidence 97641 12679999999997543211 123468999999999865 56789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1042 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1042 ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
+|++|..||.................. . ......+ .....++.+.+|+.+||+.||.+||
T Consensus 221 ~l~~g~~pf~~~~~~~~~~~~~~~~~~----~---------------~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rp 280 (336)
T 3fhr_A 221 ILLCGFPPFYSNTGQAISPGMKRRIRL----G---------------QYGFPNP-EWSEVSEDAKQLIRLLLKTDPTERL 280 (336)
T ss_dssp HHHHSSCCC----------------------------------------CCCTT-TSTTCCHHHHHHHHHHSCSSGGGSC
T ss_pred HHHHCCCCCCCccchhhhhhHHHhhhc----c---------------ccccCch-hhccCCHHHHHHHHHHCCCChhHCc
Confidence 999999999764433221111000000 0 0000000 0014567799999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001142 1122 TAGDLYEMFVARTS 1135 (1142)
Q Consensus 1122 Sa~EVL~~L~~~~s 1135 (1142)
|+.|+++|+|+...
T Consensus 281 t~~ell~hp~~~~~ 294 (336)
T 3fhr_A 281 TITQFMNHPWINQS 294 (336)
T ss_dssp CHHHHHHSHHHHTG
T ss_pred CHHHHhcCcccccc
Confidence 99999999999865
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=337.63 Aligned_cols=253 Identities=22% Similarity=0.260 Sum_probs=190.5
Q ss_pred CCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC----CCCCccceeeeE
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL----RHSCIVEMYGHK 879 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L----~HpNIVkl~g~~ 879 (1142)
..+|++.+.||+|+||.||+|++ .+..+|+|+...... ...........+.+|+.++.++ +||||+++++++
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRV--LGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTT--C--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccc--cccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 35699999999999999999987 456788887543221 1110000111236799999888 899999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEec-cCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 001142 880 ISSKWLPSADGNPEHHLLQSAIFMEY-VKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 958 (1142)
Q Consensus 880 ~~~~~~~~~~~~~~~~~~~~~LVmEy-~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~ 958 (1142)
...+.. ++|||| +.+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+
T Consensus 108 ~~~~~~--------------~~v~e~~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~ 168 (312)
T 2iwi_A 108 ETQEGF--------------MLVLERPLPAQDLFDYITE-----KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDE 168 (312)
T ss_dssp -----C--------------EEEEECCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGG
T ss_pred ecCCeE--------------EEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChh
Confidence 765533 999999 788999999986 236899999999999999999999999999999999
Q ss_pred Ceeec-cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHH
Q 001142 959 NILID-LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1037 (1142)
Q Consensus 959 NILld-~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLG 1037 (1142)
||+++ .+ +.+||+|||++....... .....||+.|+|||++.+. ..++.++||||||
T Consensus 169 Nil~~~~~-------~~~kl~dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~~---~~~~~~~Di~slG 226 (312)
T 2iwi_A 169 NILIDLRR-------GCAKLIDFGSGALLHDEP------------YTDFDGTRVYSPPEWISRH---QYHALPATVWSLG 226 (312)
T ss_dssp GEEEETTT-------TEEEECCCSSCEECCSSC------------BCCCCSCTTTSCHHHHHHS---CBCHHHHHHHHHH
T ss_pred hEEEeCCC-------CeEEEEEcchhhhcccCc------------ccccCCcccccCceeeecC---CCCCccchHHHHH
Confidence 99998 44 789999999997654321 1234589999999998751 2335689999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001142 1038 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1117 (1142)
Q Consensus 1038 viL~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP 1117 (1142)
+++|+|++|+.||... .+ +..... ..+ ...+..+.+++.+||+.||
T Consensus 227 ~il~~l~~g~~pf~~~--~~----~~~~~~-~~~---------------------------~~~~~~~~~li~~~l~~~p 272 (312)
T 2iwi_A 227 ILLYDMVCGDIPFERD--QE----ILEAEL-HFP---------------------------AHVSPDCCALIRRCLAPKP 272 (312)
T ss_dssp HHHHHHHHSSCSCCSH--HH----HHHTCC-CCC---------------------------TTSCHHHHHHHHHHTCSST
T ss_pred HHHHHHHHCCCCCCCh--HH----Hhhhcc-CCc---------------------------ccCCHHHHHHHHHHccCCh
Confidence 9999999999999742 11 111110 000 1345678999999999999
Q ss_pred CCCCCHHHHHHHHHhhcC
Q 001142 1118 TERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1118 ~~RPSa~EVL~~L~~~~s 1135 (1142)
++|||+.|+++|+|++..
T Consensus 273 ~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 273 SSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp TTSCCHHHHHHSTTTCC-
T ss_pred hhCcCHHHHhcChhhcCc
Confidence 999999999999999865
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=342.13 Aligned_cols=251 Identities=21% Similarity=0.231 Sum_probs=197.5
Q ss_pred CCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCCh--HHHHHhHHhHHHHHHHHhhCC--CCCccceeeeE
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSA--DEIRNFEYSCLGEVRMLGALR--HSCIVEMYGHK 879 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~--~~~~~~~~~~~~Ei~iL~~L~--HpNIVkl~g~~ 879 (1142)
..+|++.+.||+|+||.||+|.+ .+..+|+|+.......... ...+.+ .+|+.++++++ ||||+++++++
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~----~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV----PMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEE----EHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHH----HHHHHHHHhhccCCCCceEEEEEE
Confidence 45799999999999999999988 4667888886544321100 111223 68999999996 69999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCC-CCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 001142 880 ISSKWLPSADGNPEHHLLQSAIFMEYVKG-GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 958 (1142)
Q Consensus 880 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~g-gSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~ 958 (1142)
...+ ..++||||+.+ ++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+
T Consensus 118 ~~~~--------------~~~lv~e~~~~~~~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~ 178 (320)
T 3a99_A 118 ERPD--------------SFVLILERPEPVQDLFDFITE-----RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDE 178 (320)
T ss_dssp ECSS--------------EEEEEEECCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred ecCC--------------cEEEEEEcCCCCccHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHH
Confidence 8654 34999999976 899999976 246899999999999999999999999999999999
Q ss_pred Ceeec-cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHH
Q 001142 959 NILID-LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1037 (1142)
Q Consensus 959 NILld-~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLG 1037 (1142)
|||++ .+ +.+||+|||++....... .....||+.|+|||++.+ ...++.++||||||
T Consensus 179 NIll~~~~-------~~~kL~Dfg~~~~~~~~~------------~~~~~gt~~y~aPE~~~~---~~~~~~~~Di~slG 236 (320)
T 3a99_A 179 NILIDLNR-------GELKLIDFGSGALLKDTV------------YTDFDGTRVYSPPEWIRY---HRYHGRSAAVWSLG 236 (320)
T ss_dssp GEEEETTT-------TEEEECCCTTCEECCSSC------------BCCCCSCGGGSCHHHHHH---SCBCHHHHHHHHHH
T ss_pred HEEEeCCC-------CCEEEeeCcccccccccc------------ccCCCCCccCCChHHhcc---CCCCCccchHHhHH
Confidence 99998 44 789999999997654321 113458999999999876 23346889999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001142 1038 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1117 (1142)
Q Consensus 1038 viL~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP 1117 (1142)
+++|||++|+.||... .. +...... . ....++.+.+|+.+||+.||
T Consensus 237 ~il~el~~g~~pf~~~--~~----~~~~~~~-~---------------------------~~~~~~~~~~li~~~l~~dp 282 (320)
T 3a99_A 237 ILLYDMVCGDIPFEHD--EE----IIRGQVF-F---------------------------RQRVSSECQHLIRWCLALRP 282 (320)
T ss_dssp HHHHHHHHSSCSCCSH--HH----HHHCCCC-C---------------------------SSCCCHHHHHHHHHHTCSSG
T ss_pred HHHHHHHHCCCCCCCh--hh----hhccccc-c---------------------------cccCCHHHHHHHHHHccCCh
Confidence 9999999999999752 11 1111100 0 01345679999999999999
Q ss_pred CCCCCHHHHHHHHHhhcC
Q 001142 1118 TERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1118 ~~RPSa~EVL~~L~~~~s 1135 (1142)
++|||++|+++|+|+...
T Consensus 283 ~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 283 SDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp GGSCCHHHHHTSGGGSSC
T ss_pred hhCcCHHHHhcCHhhcCc
Confidence 999999999999999754
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=366.47 Aligned_cols=257 Identities=21% Similarity=0.339 Sum_probs=202.2
Q ss_pred CCCcceeeeecccCceEEEEEEECC---ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFGS---ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 882 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~~---~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~ 882 (1142)
..+|++.+.||+|+||.||+|.+.. ...+++++..+.. ......+. +.+|+.++++++||||+++++++.+
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~----~~~E~~~l~~l~HpnIv~l~~~~~~- 462 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREK----FLQEALTMRQFDHPHIVKLIGVITE- 462 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHH----HHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHH----HHHHHHHHHhCCCCCCCeEEEEEec-
Confidence 3569999999999999999999842 2233444434322 22232333 4899999999999999999999853
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
+ ..++||||+++|+|.++++. ....+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 463 ~--------------~~~lv~E~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl 524 (656)
T 2j0j_A 463 N--------------PVWIIMELCTLGELRSFLQV----RKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV 524 (656)
T ss_dssp S--------------SCEEEEECCTTCBHHHHHHH----TTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred C--------------ceEEEEEcCCCCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEE
Confidence 2 23899999999999999975 23468999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
+.+ +.+||+|||+++........ ......+|+.|+|||++.+ ..++.++|||||||++||
T Consensus 525 ~~~-------~~vkL~DFG~a~~~~~~~~~---------~~~~~~~t~~y~aPE~~~~----~~~~~~~DiwSlG~il~e 584 (656)
T 2j0j_A 525 SSN-------DCVKLGDFGLSRYMEDSTYY---------KASKGKLPIKWMAPESINF----RRFTSASDVWMFGVCMWE 584 (656)
T ss_dssp EET-------TEEEECCCCCCCSCCC-------------------CCGGGCCHHHHHH----CCCCHHHHHHHHHHHHHH
T ss_pred eCC-------CCEEEEecCCCeecCCCcce---------eccCCCCCcceeCHHHhcC----CCCCchhhHHHHHHHHHH
Confidence 987 78999999999765432111 1123357889999999976 568899999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1043 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1043 LLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
|++ |..||.+....+....+..+..+..+. .+++.+.+++.+||+.||.+||
T Consensus 585 llt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~dP~~RP 637 (656)
T 2j0j_A 585 ILMHGVKPFQGVKNNDVIGRIENGERLPMPP---------------------------NCPPTLYSLMTKCWAYDPSRRP 637 (656)
T ss_dssp HHTTSCCTTTTCCHHHHHHHHHHTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHcCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------cccHHHHHHHHHHcCCChhHCc
Confidence 997 999999888877777776554433221 4456799999999999999999
Q ss_pred CHHHHHHHHHhh
Q 001142 1122 TAGDLYEMFVAR 1133 (1142)
Q Consensus 1122 Sa~EVL~~L~~~ 1133 (1142)
|+.++++++...
T Consensus 638 s~~el~~~L~~i 649 (656)
T 2j0j_A 638 RFTELKAQLSTI 649 (656)
T ss_dssp CHHHHHHHHHHH
T ss_pred CHHHHHHHHHHH
Confidence 999999987654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=343.83 Aligned_cols=256 Identities=14% Similarity=0.145 Sum_probs=191.2
Q ss_pred CCCcceeeeecccCceEEEEEE-------ECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC---CCCccce
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCK-------FGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR---HSCIVEM 875 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~-------~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~---HpNIVkl 875 (1142)
-.+|++.++||+|+||+||+|. ..+..+|+|+.... . ..++ .+|+.++..++ |+||+++
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~---~~~~----~~e~~~~~~l~~~~~~~iv~~ 132 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA----N---PWEF----YIGTQLMERLKPSMQHMFMKF 132 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC----C---HHHH----HHHHHHHHHSCGGGGGGBCCE
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC----C---hhHH----HHHHHHHHHhhhhhhhhhhhh
Confidence 3569999999999999999994 25678899985321 1 1223 57888888886 9999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 001142 876 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 955 (1142)
Q Consensus 876 ~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDL 955 (1142)
++++...+. .++||||+++|+|.+++..........+++..+..|+.||+.||+|||++||+||||
T Consensus 133 ~~~~~~~~~--------------~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDi 198 (365)
T 3e7e_A 133 YSAHLFQNG--------------SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDI 198 (365)
T ss_dssp EEEEECSSC--------------EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCC
T ss_pred heeeecCCC--------------cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCC
Confidence 999987653 499999999999999998755444567999999999999999999999999999999
Q ss_pred CCCCeeeccccc----cCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchh
Q 001142 956 KSENILIDLERK----KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 1031 (1142)
Q Consensus 956 Kp~NILld~~~~----~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ks 1031 (1142)
||+|||++.... .....+.+||+|||+|+.+....... ......||+.|+|||++.+ ..|+.++
T Consensus 199 Kp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~----~~~~~~~ 266 (365)
T 3e7e_A 199 KPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT--------IFTAKCETSGFQCVEMLSN----KPWNYQI 266 (365)
T ss_dssp SGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTE--------EECCSSCTTSCCCHHHHTT----CCBSTHH
T ss_pred CHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCc--------eeeeecCCCCCCChHHhcC----CCCCccc
Confidence 999999987100 00112789999999997654221110 1123469999999999976 5689999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHH
Q 001142 1032 DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRR 1111 (1142)
Q Consensus 1032 DVwSLGviL~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~ 1111 (1142)
|||||||++|||++|+.||........ ........ ....+.+.+++..
T Consensus 267 DiwslG~il~elltg~~pf~~~~~~~~-------------------------~~~~~~~~-------~~~~~~~~~~~~~ 314 (365)
T 3e7e_A 267 DYFGVAATVYCMLFGTYMKVKNEGGEC-------------------------KPEGLFRR-------LPHLDMWNEFFHV 314 (365)
T ss_dssp HHHHHHHHHHHHHHSSCCCEEEETTEE-------------------------EECSCCTT-------CSSHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHhCCCccccCCCCce-------------------------eechhccc-------cCcHHHHHHHHHH
Confidence 999999999999999999964211000 00000000 0235568899999
Q ss_pred hcccCCCCCC-CHHHHHHHH
Q 001142 1112 CTEENPTERP-TAGDLYEMF 1130 (1142)
Q Consensus 1112 CL~~DP~~RP-Sa~EVL~~L 1130 (1142)
||+.+|.+|+ ++.++.+.+
T Consensus 315 ~l~~~p~~r~~~~~~l~~~l 334 (365)
T 3e7e_A 315 MLNIPDCHHLPSLDLLRQKL 334 (365)
T ss_dssp HHCCCCTTCCCCHHHHHHHH
T ss_pred HcCCCCCCcchHHHHHHHHH
Confidence 9999999995 666555433
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-36 Score=353.39 Aligned_cols=262 Identities=22% Similarity=0.299 Sum_probs=190.7
Q ss_pred CcceeeeecccCceE-EEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecCCCC
Q 001142 808 SLSSCDEAGKSVSSS-LFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~-Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~~~~~~~ 885 (1142)
+|.+.++||+|+||+ ||++.+.+..||||+..... ...+ .+|+.+++++ +|||||++++++.+..
T Consensus 25 ~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~-------~~~~----~~E~~~l~~l~~HpnIv~l~~~~~~~~-- 91 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC-------FSFA----DREVQLLRESDEHPNVIRYFCTEKDRQ-- 91 (432)
T ss_dssp EEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT-------EEEC----HHHHHHHHHSCCCTTBCCEEEEEEETT--
T ss_pred EEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH-------HHHH----HHHHHHHHhccCCCCcCeEEEEEecCC--
Confidence 489999999999998 55666788899999863211 1122 5899999999 7999999999988655
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
..|+||||++ |+|.+++.. ....+.+..+..|+.||+.||.|||++||+||||||+|||++.+
T Consensus 92 ------------~~~lv~E~~~-g~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~ 154 (432)
T 3p23_A 92 ------------FQYIAIELCA-ATLQEYVEQ----KDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMP 154 (432)
T ss_dssp ------------EEEEEEECCS-EEHHHHHHS----SSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCC
T ss_pred ------------EEEEEEECCC-CCHHHHHHh----cCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecC
Confidence 3499999997 799999875 22345555678999999999999999999999999999999643
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+ ..+...+||+|||+|+........ ........||+.|+|||++.+.. ...++.++|||||||++|||++
T Consensus 155 ~--~~~~~~~kL~DFG~a~~~~~~~~~-------~~~~~~~~gt~~y~APE~l~~~~-~~~~t~~~DiwSlG~il~ellt 224 (432)
T 3p23_A 155 N--AHGKIKAMISDFGLCKKLAVGRHS-------FSRRSGVPGTEGWIAPEMLSEDC-KENPTYTVDIFSAGCVFYYVIS 224 (432)
T ss_dssp B--TTTBCCEEECCTTEEECC-------------------CCSCTTSCCGGGTSCC----CCCTHHHHHHHHHHHHHHHT
T ss_pred C--CCCceeEEEecccceeeccCCCcc-------eeeccccCCCcCccChhhhhccc-ccCCCcHHHHHHHHHHHHHHHc
Confidence 1 122357899999999765432111 01122456999999999987421 2456789999999999999999
Q ss_pred -CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001142 1046 -LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124 (1142)
Q Consensus 1046 -G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~ 1124 (1142)
|..||...........+....... .......+..+.+||.+||+.||.+|||+.
T Consensus 225 ~g~~pf~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ 279 (432)
T 3p23_A 225 EGSHPFGKSLQRQANILLGACSLDC-------------------------LHPEKHEDVIARELIEKMIAMDPQKRPSAK 279 (432)
T ss_dssp TSCBTTBSTTTHHHHHHTTCCCCTT-------------------------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CCCCCcchhhHHHHHHHhccCCccc-------------------------cCccccccHHHHHHHHHHHhCCHhhCCCHH
Confidence 999997544333222211111000 000114456689999999999999999999
Q ss_pred HHHHHHHhhc
Q 001142 1125 DLYEMFVART 1134 (1142)
Q Consensus 1125 EVL~~L~~~~ 1134 (1142)
||++|+|+..
T Consensus 280 evl~hp~f~~ 289 (432)
T 3p23_A 280 HVLKHPFFWS 289 (432)
T ss_dssp HHHTSTTTCC
T ss_pred HHHhCccccC
Confidence 9999999853
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=347.05 Aligned_cols=261 Identities=18% Similarity=0.213 Sum_probs=195.7
Q ss_pred CCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCC-CccceeeeEecC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS-CIVEMYGHKISS 882 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp-NIVkl~g~~~~~ 882 (1142)
.++|++.++||+|+||.||+|++. +..||||+...+... ..+ .+|+.+++.++|+ +|..+..++...
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------~~~----~~E~~il~~L~~~~~i~~i~~~~~~~ 75 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH------PQL----LYESKIYRILQGGTGIPNVRWFGVEG 75 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS------CCH----HHHHHHHHHTTTSTTCCCEEEEEEET
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc------HHH----HHHHHHHHHhcCCCCCCeEEEEEeeC
Confidence 467999999999999999999974 778899986544221 123 6899999999865 455554444433
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
. ..+|||||+ +++|.+++... ...+++..++.|+.||+.||+|||++||+||||||+||||
T Consensus 76 ~--------------~~~lvme~~-g~sL~~ll~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl 136 (483)
T 3sv0_A 76 D--------------YNVLVMDLL-GPSLEDLFNFC----SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 136 (483)
T ss_dssp T--------------EEEEEEECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred C--------------EEEEEEECC-CCCHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEE
Confidence 3 459999999 89999999752 3469999999999999999999999999999999999999
Q ss_pred c---cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001142 963 D---LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039 (1142)
Q Consensus 963 d---~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGvi 1039 (1142)
+ .+ +.+||+|||+++.+........ ..........||+.|+|||++.+ ..++.++|||||||+
T Consensus 137 ~~~~~~-------~~vkL~DFGla~~~~~~~~~~~---~~~~~~~~~~gt~~Y~aPE~~~~----~~~s~~sDvwSlGvi 202 (483)
T 3sv0_A 137 GLGRRA-------NQVYIIDFGLAKKYRDTSTHQH---IPYRENKNLTGTARYASVNTHLG----IEQSRRDDLESLGYV 202 (483)
T ss_dssp CCGGGT-------TCEEECCCTTCEECBCTTTCCB---CCCCCCCCCCSCTTTCCHHHHTT----CCCCHHHHHHHHHHH
T ss_pred ecCCCC-------CeEEEEeCCcceeccCCccccc---cccccccccCCCccccCHHHhcC----CCCChHHHHHHHHHH
Confidence 4 44 7899999999987654321110 01112335679999999999886 568899999999999
Q ss_pred HHHHHhCCCCCCCCCH---HHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 001142 1040 LLELLTLQVPYMGLSE---LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1116 (1142)
Q Consensus 1040 L~ELLtG~~Pf~~~~~---~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~D 1116 (1142)
+|||++|+.||.+... .+.+..+.......... .....+++++.+|+..||+.|
T Consensus 203 l~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~-----------------------~l~~~~p~~l~~li~~cl~~d 259 (483)
T 3sv0_A 203 LMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE-----------------------ALCRGYPTEFASYFHYCRSLR 259 (483)
T ss_dssp HHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH-----------------------HHHTTSCHHHHHHHHHHHTCC
T ss_pred HHHHHhCCCCCccccchhHHHHHHHHhhccccccHH-----------------------HHhcCCcHHHHHHHHHHhcCC
Confidence 9999999999986433 22333322111000000 001145677999999999999
Q ss_pred CCCCCCHHHHHHHHHh
Q 001142 1117 PTERPTAGDLYEMFVA 1132 (1142)
Q Consensus 1117 P~~RPSa~EVL~~L~~ 1132 (1142)
|++||++.+|++.+..
T Consensus 260 P~~RPs~~el~~~L~~ 275 (483)
T 3sv0_A 260 FDDKPDYSYLKRLFRD 275 (483)
T ss_dssp TTCCCCHHHHHHHHHH
T ss_pred hhhCcCHHHHHHHHHH
Confidence 9999999999887654
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=348.14 Aligned_cols=270 Identities=21% Similarity=0.271 Sum_probs=188.1
Q ss_pred cceeeeecccCceEEEEE-EECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecCCCCC
Q 001142 809 LSSCDEAGKSVSSSLFRC-KFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLP 886 (1142)
Q Consensus 809 y~l~~~LG~GsfG~Vy~a-~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~~~~~~~~ 886 (1142)
|.+.+.||+|+||+||.+ ...+..||||+...+. .+. +.+|+.+++++ +|||||++++++.+..
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~-------~~~----~~~E~~~l~~l~~HpnIv~~~~~~~~~~--- 82 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-------CDI----ALMEIKLLTESDDHPNVIRYYCSETTDR--- 82 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG-------HHH----HHHHHHHHHHHTTSTTBCCEEEEEECSS---
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH-------HHH----HHHHHHHHHhccCCCCcCeEEEEEecCC---
Confidence 567899999999999654 4578889999864321 122 36899999876 8999999999987654
Q ss_pred CCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 887 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGE--KHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 887 ~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~--~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
..++||||+. |+|.+++........ ...++..+..|+.||+.||+|||++||+||||||+|||++.
T Consensus 83 -----------~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~ 150 (434)
T 2rio_A 83 -----------FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVST 150 (434)
T ss_dssp -----------EEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEC
T ss_pred -----------eEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEec
Confidence 4599999996 799999975211110 01133356789999999999999999999999999999976
Q ss_pred ccc------cCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhcccc---CCCCCCchhhHHH
Q 001142 965 ERK------KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH---KPNLYGLEVDIWS 1035 (1142)
Q Consensus 965 ~~~------~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~---~~~~~s~ksDVwS 1035 (1142)
++. .......+||+|||+++......... ........||+.|+|||++.+.. ....++.++||||
T Consensus 151 ~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwS 224 (434)
T 2rio_A 151 SSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF------RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFS 224 (434)
T ss_dssp CHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHH
T ss_pred CcccccccccCCCceEEEEcccccceecCCCCccc------eeeecCCCCCCCccCHHHhccccccccccCcchhhhhHh
Confidence 420 01223689999999998754322110 00112346999999999986521 1246889999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcc
Q 001142 1036 YGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 1114 (1142)
Q Consensus 1036 LGviL~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~ 1114 (1142)
|||++|||++ |+.||......+ ..+..+...... . ........++.+.+++.+||+
T Consensus 225 lG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~~--------------------~-~~~~~~~~~~~~~~li~~~L~ 281 (434)
T 2rio_A 225 MGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDE--------------------M-KCLHDRSLIAEATDLISQMID 281 (434)
T ss_dssp HHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCCCC--------------------C-TTCCCHHHHHHHHHHHHHHTC
T ss_pred HHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCccc--------------------c-cccccccchHHHHHHHHHHhh
Confidence 9999999999 999997644332 122221110000 0 000012567789999999999
Q ss_pred cCCCCCCCHHHHHHHHHhh
Q 001142 1115 ENPTERPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1115 ~DP~~RPSa~EVL~~L~~~ 1133 (1142)
.||.+|||+.||++|+|+.
T Consensus 282 ~dP~~Rps~~eil~hp~f~ 300 (434)
T 2rio_A 282 HDPLKRPTAMKVLRHPLFW 300 (434)
T ss_dssp SSGGGSCCHHHHHTSGGGS
T ss_pred CChhhCCCHHHHHhCCccC
Confidence 9999999999999999985
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=322.78 Aligned_cols=245 Identities=22% Similarity=0.241 Sum_probs=181.8
Q ss_pred CCCccee-eeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHH-hhCCCCCccceeeeEec
Q 001142 806 FPSLSSC-DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRML-GALRHSCIVEMYGHKIS 881 (1142)
Q Consensus 806 ~~~y~l~-~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL-~~L~HpNIVkl~g~~~~ 881 (1142)
+++|.+. +.||+|+||.||+|.+ .+..+|+|+.... ..+ .+|+.++ +.++||||+++++++..
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~----~~e~~~~~~~~~h~~i~~~~~~~~~ 82 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKA----RREVELHWRASQCPHIVRIVDVYEN 82 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------HHH----HHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc---------HHH----HHHHHHHHHhccCCCchhHHhhhhh
Confidence 5678887 7899999999999998 4667888875311 122 5788888 55689999999999875
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 001142 882 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 961 (1142)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NIL 961 (1142)
.. ......++||||+++++|.+++.. .....+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 83 ~~----------~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil 149 (299)
T 3m2w_A 83 LY----------AGRKCLLIVMECLDGGELFSRIQD---RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 149 (299)
T ss_dssp EE----------TTEEEEEEEECCCCSCBHHHHHHH---CTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred hc----------CCCceEEEEEeecCCCcHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEE
Confidence 11 012256999999999999999986 23346999999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001142 962 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1041 (1142)
Q Consensus 962 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ 1041 (1142)
++.+. ..+.+||+|||++..... ..++.++|||||||++|
T Consensus 150 ~~~~~----~~~~~kl~Dfg~a~~~~~------------------------------------~~~~~~~DiwslG~il~ 189 (299)
T 3m2w_A 150 YTSKR----PNAILKLTDFGFAKETTG------------------------------------EKYDKSCDMWSLGVIMY 189 (299)
T ss_dssp ESSSS----TTCCEEECCCTTCEECTT------------------------------------CGGGGHHHHHHHHHHHH
T ss_pred EecCC----CCCcEEEecccccccccc------------------------------------ccCCchhhHHHHHHHHH
Confidence 98731 127899999999853210 23458999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCc-hhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1042 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKP-EAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1042 ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
+|++|+.||.+.........+.... . . .....+ ......++.+.+++.+||+.||.+|
T Consensus 190 el~tg~~pf~~~~~~~~~~~~~~~~----~---------------~--~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R 248 (299)
T 3m2w_A 190 ILLCGYPPFYSNHGLAISPGMKTRI----R---------------M--GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQR 248 (299)
T ss_dssp HHHHSSCSCCC-------CCSCCSS----C---------------T--TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTS
T ss_pred HHHHCCCCCCCCcchhhhHHHHHHH----h---------------h--ccccCCchhcccCCHHHHHHHHHHcccChhhC
Confidence 9999999997644322111100000 0 0 000001 0112567789999999999999999
Q ss_pred CCHHHHHHHHHhhcCCC
Q 001142 1121 PTAGDLYEMFVARTSSS 1137 (1142)
Q Consensus 1121 PSa~EVL~~L~~~~ss~ 1137 (1142)
||+.|+++|+|+.....
T Consensus 249 ps~~e~l~hp~~~~~~~ 265 (299)
T 3m2w_A 249 MTITEFMNHPWIMQSTK 265 (299)
T ss_dssp CCHHHHHTSHHHHTGGG
T ss_pred CCHHHHhcChhhccccc
Confidence 99999999999986643
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=336.26 Aligned_cols=270 Identities=17% Similarity=0.118 Sum_probs=185.7
Q ss_pred CCCcceeeeecccCceEEEEEEECCccEEEEEEecccCCC----ChHHHHHhHHhHHHHHHHHhhCC---------CCCc
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGS----SADEIRNFEYSCLGEVRMLGALR---------HSCI 872 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~----~~~~~~~~~~~~~~Ei~iL~~L~---------HpNI 872 (1142)
..+|++.++||+|+||+||+|++.+..||+|+........ .....+. +.+|+.+++.++ ||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~----~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEE----ILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHH----HHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred cccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHH----HHHHHHHHHHHHHhhccccccCCch
Confidence 3569999999999999999999999999999976543211 1111123 368888888775 6666
Q ss_pred cceeeeE-----------------ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHH
Q 001142 873 VEMYGHK-----------------ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 935 (1142)
Q Consensus 873 Vkl~g~~-----------------~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia 935 (1142)
|++++.+ .+.... ..+........+.|+||||+++|++.+.+.+ ..+++..++.|+
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~-~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~ 167 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGS-ANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSIL 167 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCC-SSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccc-cccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHH
Confidence 6665543 321000 0000000012367999999999976655532 458999999999
Q ss_pred HHHHHHHHHHH-hCCccccCCCCCCeeecccccc-------------CCCCCeEEEeecCCcccccccccccccccCCCC
Q 001142 936 QDVAAALVELH-SKHIMHRDIKSENILIDLERKK-------------ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIP 1001 (1142)
Q Consensus 936 ~qIa~gL~yLH-s~gIvHrDLKp~NILld~~~~~-------------~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~ 1001 (1142)
.||+.||+||| ++||+||||||+|||++.++.. ......+||+|||+|+.....
T Consensus 168 ~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------------ 235 (336)
T 2vuw_A 168 HQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------------ 235 (336)
T ss_dssp HHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------------
T ss_pred HHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------------
Confidence 99999999999 9999999999999999876200 000128999999999765421
Q ss_pred CCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH-HHHHHhCCCCCCCCCH-HHHHHHHHhC-CCCCchhHHhhhc
Q 001142 1002 APDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL-LLELLTLQVPYMGLSE-LEIHDLIQMG-KRPRLTDELEALG 1078 (1142)
Q Consensus 1002 ~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGvi-L~ELLtG~~Pf~~~~~-~el~~~I~~~-~~p~l~~~l~~~~ 1078 (1142)
...||+.|+|||++.+ .. +.++||||+|++ .+++++|..||.+... ......+... ....
T Consensus 236 ---~~~gt~~y~aPE~~~g----~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------- 298 (336)
T 2vuw_A 236 ---IVVFCDVSMDEDLFTG----DG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKT--------- 298 (336)
T ss_dssp ---EEECCCCTTCSGGGCC----CS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSS---------
T ss_pred ---cEEEeecccChhhhcC----CC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCc---------
Confidence 3469999999999976 22 789999998777 7778889998853111 1122222211 1100
Q ss_pred ccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHH-HHHHhh
Q 001142 1079 SCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY-EMFVAR 1133 (1142)
Q Consensus 1079 ~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL-~~L~~~ 1133 (1142)
..........++++.+||.+||+.| ||+|++ +|+|++
T Consensus 299 -------------~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 299 -------------KCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp -------------CCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred -------------ccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 0011122367888999999999976 999999 999984
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-35 Score=358.51 Aligned_cols=290 Identities=19% Similarity=0.188 Sum_probs=199.0
Q ss_pred CCCCCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001142 803 PGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 880 (1142)
Q Consensus 803 ~~~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~ 880 (1142)
...+.+|++.++||+|+||+||+|.+ .+..||+|+.... ......+.+ .+|+.++++++||||+++++++.
T Consensus 10 g~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~---~~~~~~~~~----~~Ei~iL~~L~HpnIV~l~~v~~ 82 (676)
T 3qa8_A 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE---LSPKNRERW----CLEIQIMKKLNHPNVVSAREVPD 82 (676)
T ss_dssp -------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC---CCHHHHHHH----HHHHHHHHHCCBTTBCCEEECCT
T ss_pred CCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc---CCHHHHHHH----HHHHHHHHhCCCCCCCceeeeec
Confidence 44567899999999999999999987 4677888874321 223333344 79999999999999999999876
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NI 960 (1142)
..... ......++||||+++++|.+++... .....+++..+..|+.||+.||.|||++||+||||||+||
T Consensus 83 ~~~~~--------~~~~~~~LVmEy~~ggsL~~~L~~~--~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NI 152 (676)
T 3qa8_A 83 GLQKL--------APNDLPLLAMEYCEGGDLRKYLNQF--ENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENI 152 (676)
T ss_dssp TTCCC--------CTTSSCCCEEECCSSCBHHHHHHSS--SCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTE
T ss_pred ccccc--------cCCCeEEEEEEeCCCCCHHHHHHhc--ccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHe
Confidence 52211 1122458999999999999999752 2223689999999999999999999999999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
|++.++ ....+||+|||.+....... ......||+.|+|||++.+ ..++.++|||||||++
T Consensus 153 Ll~~~g----~~~~vKL~DFG~a~~~~~~~-----------~~~~~~gt~~Y~APE~l~~----~~~s~ksDIwSLGviL 213 (676)
T 3qa8_A 153 VLQPGP----QRLIHKIIDLGYAKELDQGE-----------LCTEFVGTLQYLAPELLEQ----KKYTVTVDYWSFGTLA 213 (676)
T ss_dssp EEECCS----SSCEEEECSCCCCCBTTSCC-----------CCCCCCSCCTTCSSCSSCC----SCCSTTHHHHHHHHHH
T ss_pred EeecCC----CceeEEEccccccccccccc-----------ccccccCCcccCChHHhcc----CCCCchhHHHHHHHHH
Confidence 998652 12469999999997654321 1123468999999999875 5788999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHH-HHHHhCCCCCchhHHhhhcccccccccccCCCCC-CchhhhhhHHHHHHHHHHhcccCCC
Q 001142 1041 LELLTLQVPYMGLSELEIH-DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE-KPEAELETLSFLVDVFRRCTEENPT 1118 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~~~~~el~-~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~L~dLI~~CL~~DP~ 1118 (1142)
|+|++|..||.+....... ..+........ ................. ........++.+.+++.+||..||+
T Consensus 214 yeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~------~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~ 287 (676)
T 3qa8_A 214 FECITGFRPFLPNWQPVQWHGKVREKSNEHI------VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQR 287 (676)
T ss_dssp HHHHSSCSSCCSSCHHHHSSTTCC------C------CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC
T ss_pred HHHHHCCCCCCcccchhhhhhhhhcccchhh------hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHh
Confidence 9999999999764332110 00000000000 00000000000000000 1112235788899999999999999
Q ss_pred CCCCHHHHHHHHHhhc
Q 001142 1119 ERPTAGDLYEMFVART 1134 (1142)
Q Consensus 1119 ~RPSa~EVL~~L~~~~ 1134 (1142)
+|||+.|+++|+|+..
T Consensus 288 kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 288 QRGTDPQNPNVGCFQA 303 (676)
T ss_dssp ---CCTTCCCCTTHHH
T ss_pred hCcCHHHHhcCHHHHH
Confidence 9999999999998753
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=340.31 Aligned_cols=270 Identities=14% Similarity=0.118 Sum_probs=188.5
Q ss_pred CCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCC-CCcccee------
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH-SCIVEMY------ 876 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H-pNIVkl~------ 876 (1142)
...|.+.++||+|+||+||+|++. +..||||+...... ......+. +.+|+.+++.++| +|...++
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~-~~~~~~~~----~~~E~~~~~~l~~~~~~~~~~~~~~~~ 151 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER-PPSNAIKQ----MKEEVLRLRLLRGIKNQKQAKVHLRFI 151 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC-----CCHH----HHHHHHGGGGSTTCCSHHHHHHHTCBC
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCC-ccHHHHHH----HHHHHHHHHhhccCCCHHHHHHhcccc
Confidence 345889999999999999999985 78899998653321 11122233 4799999999977 4332221
Q ss_pred ---eeEecCCCC---CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 001142 877 ---GHKISSKWL---PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE--TGEKHVSVKLALFIAQDVAAALVELHSK 948 (1142)
Q Consensus 877 ---g~~~~~~~~---~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~--~~~~~ls~~~i~~Ia~qIa~gL~yLHs~ 948 (1142)
+.....+.. ....+.........+++|+++ +++|.++++.... .....+++..+..|+.||+.||+|||++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 230 (413)
T 3dzo_A 152 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY 230 (413)
T ss_dssp CCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred cchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 111111000 000000111234568888887 5899999964421 2234678889999999999999999999
Q ss_pred CccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhcccc------
Q 001142 949 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH------ 1022 (1142)
Q Consensus 949 gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~------ 1022 (1142)
||+||||||+|||++.+ +.+||+|||+++..... .....| +.|+|||++.+..
T Consensus 231 ~iiHrDiKp~NILl~~~-------~~~kL~DFG~a~~~~~~-------------~~~~~g-~~y~aPE~~~~~~~~~~~~ 289 (413)
T 3dzo_A 231 GLVHTYLRPVDIVLDQR-------GGVFLTGFEHLVRDGAS-------------AVSPIG-RGFAPPETTAERMLPFGQH 289 (413)
T ss_dssp TEECSCCCGGGEEECTT-------CCEEECCGGGCEETTEE-------------ECCCCC-TTTCCHHHHHHHTSTTGGG
T ss_pred CcccCCcccceEEEecC-------CeEEEEeccceeecCCc-------------cccCCC-CceeCchhhhccccccccc
Confidence 99999999999999987 77999999998764432 113357 9999999984321
Q ss_pred CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhH
Q 001142 1023 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETL 1102 (1142)
Q Consensus 1023 ~~~~~s~ksDVwSLGviL~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1102 (1142)
....++.++|||||||++|||++|+.||......+....+. ... ...+
T Consensus 290 ~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~-----------------------~~~---------~~~~ 337 (413)
T 3dzo_A 290 HPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIF-----------------------RSC---------KNIP 337 (413)
T ss_dssp CCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGG-----------------------SSC---------CCCC
T ss_pred cCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHH-----------------------hhc---------ccCC
Confidence 23567889999999999999999999997643221111100 000 0344
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001142 1103 SFLVDVFRRCTEENPTERPTAGDLYEMFVART 1134 (1142)
Q Consensus 1103 ~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~~ 1134 (1142)
+.+.+|+.+||+.||++|||+.++++|+|++.
T Consensus 338 ~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 338 QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 67999999999999999999999999999853
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-33 Score=309.76 Aligned_cols=230 Identities=14% Similarity=0.081 Sum_probs=176.5
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
.+|++.+.||+|+||.||+|++. +..||+|+...... ......+.+ .+|+.++.+++||||+++++++.+.+
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~-~~~~~~~~~----~~e~~~l~~l~hp~iv~~~~~~~~~~- 104 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGV-LPDDVLQET----LSRTLRLSRIDKPGVARVLDVVHTRA- 104 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCC-SCHHHHHHH----HHHHHHHHTCCCTTBCCEEEEEEETT-
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccc-cCHHHHHHH----HHHHHHHhcCCCCCcceeeEEEEECC-
Confidence 56999999999999999999985 67788887542211 122223334 79999999999999999999998755
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
..|+||||++|++|.++++. .....++..|+.||+.||+|||++||+||||||+|||++.
T Consensus 105 -------------~~~lv~e~~~g~~L~~~l~~-------~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~ 164 (286)
T 3uqc_A 105 -------------GGLVVAEWIRGGSLQEVADT-------SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSI 164 (286)
T ss_dssp -------------EEEEEEECCCEEEHHHHHTT-------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEET
T ss_pred -------------cEEEEEEecCCCCHHHHHhc-------CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcC
Confidence 35999999999999999853 1356678899999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||+++| |++ .++.++|||||||++|||+
T Consensus 165 ~-------g~~kl~~~~------------------------------~~~-----------~~~~~~Di~slG~il~ell 196 (286)
T 3uqc_A 165 D-------GDVVLAYPA------------------------------TMP-----------DANPQDDIRGIGASLYALL 196 (286)
T ss_dssp T-------SCEEECSCC------------------------------CCT-----------TCCHHHHHHHHHHHHHHHH
T ss_pred C-------CCEEEEecc------------------------------ccC-----------CCCchhHHHHHHHHHHHHH
Confidence 7 778887544 222 2468999999999999999
Q ss_pred hCCCCCCCCCHHHHHH---HHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1045 TLQVPYMGLSELEIHD---LIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~---~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
+|+.||.+.+..+... .......+. ........++.+.+++.+||+.||.+|
T Consensus 197 tg~~Pf~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~l~~li~~~l~~dP~~R- 251 (286)
T 3uqc_A 197 VNRWPLPEAGVRSGLAPAERDTAGQPIE------------------------PADIDRDIPFQISAVAARSVQGDGGIR- 251 (286)
T ss_dssp HSEECSCCCSBCCCSEECCBCTTSCBCC------------------------HHHHCTTSCHHHHHHHHHHHCTTSSCC-
T ss_pred HCCCCCCcCCcchhhHHHHHHhccCCCC------------------------hhhcccCCCHHHHHHHHHHcccCCccC-
Confidence 9999998644321100 000000000 001112566789999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001142 1122 TAGDLYEMFVARTS 1135 (1142)
Q Consensus 1122 Sa~EVL~~L~~~~s 1135 (1142)
|+.|+++.+.....
T Consensus 252 s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 252 SASTLLNLMQQATA 265 (286)
T ss_dssp CHHHHHHHHHHHHC
T ss_pred CHHHHHHHHHHHhc
Confidence 99999999887544
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.4e-32 Score=344.17 Aligned_cols=242 Identities=22% Similarity=0.246 Sum_probs=186.5
Q ss_pred CCcceeeeecccCceEEEEEEEC---CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG---SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~---~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
.+|++.+.||+|+||.||+|.+. +..||+|+.. .. ........ +.+|+.++++++|||||++++++...+
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~--~~-~~~~~~~~----~~~E~~~l~~l~hp~iv~~~~~~~~~~ 152 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLV--HS-GDAEAQAM----AMAERQFLAEVVHPSIVQIFNFVEHTD 152 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESC--SS-CCHHHHHH----HHHHHGGGGGCCCTTBCCEEEEEEEEC
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeC--cc-CCHHHHHH----HHHHHHHHHhcCCCCcCeEeeeEeecC
Confidence 67999999999999999999983 5678888642 21 12232333 479999999999999999999998654
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
.. .....||||||++|++|.+++.. .+++..++.|+.||+.||.|||++||+||||||+|||++
T Consensus 153 ~~---------~~~~~~lv~E~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~ 216 (681)
T 2pzi_A 153 RH---------GDPVGYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT 216 (681)
T ss_dssp TT---------SCEEEEEEEECCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred CC---------CCceeEEEEEeCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEe
Confidence 21 12235999999999999887642 689999999999999999999999999999999999997
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ .+||+|||+++..... ....||+.|+|||++.+ .++.++|||||||++|+|
T Consensus 217 ~~--------~~kl~DFG~a~~~~~~--------------~~~~gt~~y~aPE~~~~-----~~~~~sDi~slG~~l~~l 269 (681)
T 2pzi_A 217 EE--------QLKLIDLGAVSRINSF--------------GYLYGTPGFQAPEIVRT-----GPTVATDIYTVGRTLAAL 269 (681)
T ss_dssp SS--------CEEECCCTTCEETTCC--------------SCCCCCTTTSCTTHHHH-----CSCHHHHHHHHHHHHHHH
T ss_pred CC--------cEEEEecccchhcccC--------------CccCCCccccCHHHHcC-----CCCCceehhhhHHHHHHH
Confidence 63 6999999999764321 23469999999999875 247899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
++|..||.+.... ..+. .......++.+.+||.+||+.||.+||++
T Consensus 270 ~~g~~~~~~~~~~---------~~~~-------------------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~ 315 (681)
T 2pzi_A 270 TLDLPTRNGRYVD---------GLPE-------------------------DDPVLKTYDSYGRLLRRAIDPDPRQRFTT 315 (681)
T ss_dssp HSCCCEETTEECS---------SCCT-------------------------TCHHHHHCHHHHHHHHHHTCSSGGGSCSS
T ss_pred HhCCCCCcccccc---------cccc-------------------------cccccccCHHHHHHHhhhccCChhhCCCH
Confidence 9999888642100 0000 00111344678999999999999999987
Q ss_pred HHHHHHHHh
Q 001142 1124 GDLYEMFVA 1132 (1142)
Q Consensus 1124 ~EVL~~L~~ 1132 (1142)
.+.+.+.|.
T Consensus 316 ~~~l~~~l~ 324 (681)
T 2pzi_A 316 AEEMSAQLT 324 (681)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 777766654
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=8.3e-32 Score=341.46 Aligned_cols=296 Identities=21% Similarity=0.203 Sum_probs=221.3
Q ss_pred CcccccCCCCCCcccCCCCCCC--CCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCC-ccCccccCCcCCc
Q 001142 18 IKEKLPSEANKINNEKNGSVND--DDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLN-LIPKSVGRYEKLR 94 (1142)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~--l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt-~iP~~l~~L~~L~ 94 (1142)
.++.|.+..|++++..+..+.. +++|++|+|++|++++.+|..++.+ ++|++|+|++|.++ .+|..|..+++|+
T Consensus 369 ~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l---~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 445 (768)
T 3rgz_A 369 SLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNC---SELVSLHLSFNYLSGTIPSSLGSLSKLR 445 (768)
T ss_dssp TCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGC---TTCCEEECCSSEEESCCCGGGGGCTTCC
T ss_pred CCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcC---CCCCEEECcCCcccCcccHHHhcCCCCC
Confidence 4555555555555444444444 5667777777777766666666544 77777777777776 5577777777777
Q ss_pred EEEccCCCCC-cCchhhcCCCCCCEEEccCCCCC-CCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEcc
Q 001142 95 NLKFFGNEIN-LFPSEVGNLLGLECLQIKISSPG-VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVC 172 (1142)
Q Consensus 95 ~L~Ls~N~L~-~lP~~l~~L~~L~~L~Ls~N~l~-~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls 172 (1142)
+|+|++|.++ .+|..+.++++|+.|+|++|.+. .+|..+..+++|++|+|++|. +.+.+|.+++.+++|+.|+|+
T Consensus 446 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~---l~~~~p~~~~~l~~L~~L~L~ 522 (768)
T 3rgz_A 446 DLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNR---LTGEIPKWIGRLENLAILKLS 522 (768)
T ss_dssp EEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSC---CCSCCCGGGGGCTTCCEEECC
T ss_pred EEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCc---cCCcCChHHhcCCCCCEEECC
Confidence 7777777776 66777777777777777777754 566777777777777777743 344567777777778888888
Q ss_pred CCCCC-ccCcccCCCCCCCEEEccCCCCC-ccchhh--------------------------------------------
Q 001142 173 HFSIR-YLPPEIGCLSNLEQLDLSFNKMK-YLPTEI-------------------------------------------- 206 (1142)
Q Consensus 173 ~N~L~-~IP~~l~~L~~L~~L~Ls~N~L~-~lP~~l-------------------------------------------- 206 (1142)
+|+++ .+|..++.+++|++|+|++|+++ .+|..+
T Consensus 523 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 602 (768)
T 3rgz_A 523 NNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSE 602 (768)
T ss_dssp SSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGG
T ss_pred CCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccch
Confidence 88777 66777777788888888877776 555443
Q ss_pred --------------------------cCCCCCCEEEccCCCCC-ccCccccCCCCCCEEeCcCCcCCCCCcccccCCCCC
Q 001142 207 --------------------------CYLKALISLKVANNKLV-ELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNL 259 (1142)
Q Consensus 207 --------------------------~~L~~L~~L~Ls~N~Ls-~IP~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L 259 (1142)
+.+++|+.|+|++|+|+ .||.+++++++|+.|+|++|+|+|.+|..|+++++|
T Consensus 603 ~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L 682 (768)
T 3rgz_A 603 QLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGL 682 (768)
T ss_dssp GGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTC
T ss_pred hhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCC
Confidence 33567888888888888 788888888888888888888888888888888888
Q ss_pred CEEEccCCCCCCCCCCCchhhccCCCCCCCCCCCCcccccccccccCCCCCCCCCCccCCCCCCC-CC
Q 001142 260 QNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSAEMDVYEGPMLENDGNVSFSAESDA-GS 326 (1142)
Q Consensus 260 ~~L~Ls~N~L~~~~~iP~~~~~~l~~n~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~sF~~n~~l-g~ 326 (1142)
+.|||++|+|++ .+|..+........+...+|.+.+..|. ..++.+|...+|.||+++ |.
T Consensus 683 ~~LdLs~N~l~g--~ip~~l~~l~~L~~L~ls~N~l~g~iP~-----~~~~~~~~~~~~~gN~~Lcg~ 743 (768)
T 3rgz_A 683 NILDLSSNKLDG--RIPQAMSALTMLTEIDLSNNNLSGPIPE-----MGQFETFPPAKFLNNPGLCGY 743 (768)
T ss_dssp CEEECCSSCCEE--CCCGGGGGCCCCSEEECCSSEEEEECCS-----SSSGGGSCGGGGCSCTEEEST
T ss_pred CEEECCCCcccC--cCChHHhCCCCCCEEECcCCcccccCCC-----chhhccCCHHHhcCCchhcCC
Confidence 888888888887 6888888777777788888888877774 467888999999999987 64
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=330.99 Aligned_cols=274 Identities=20% Similarity=0.232 Sum_probs=243.2
Q ss_pred CCCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCC-ccCccccCCcCCc
Q 001142 16 GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLN-LIPKSVGRYEKLR 94 (1142)
Q Consensus 16 ~~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt-~iP~~l~~L~~L~ 94 (1142)
.+.++.|.+..|++++..+..|.++++|++|||++|++++.+|..++.+ ++|+.|+|++|.++ .+|..+..+++|+
T Consensus 393 ~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l---~~L~~L~L~~n~l~~~~p~~~~~l~~L~ 469 (768)
T 3rgz_A 393 KNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSL---SKLRDLKLWLNMLEGEIPQELMYVKTLE 469 (768)
T ss_dssp TCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGC---TTCCEEECCSSCCCSCCCGGGGGCTTCC
T ss_pred cCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcC---CCCCEEECCCCcccCcCCHHHcCCCCce
Confidence 3479999999999999999999999999999999999999999888766 99999999999999 7799999999999
Q ss_pred EEEccCCCCC-cCchhhcCCCCCCEEEccCCCCC-CCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEcc
Q 001142 95 NLKFFGNEIN-LFPSEVGNLLGLECLQIKISSPG-VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVC 172 (1142)
Q Consensus 95 ~L~Ls~N~L~-~lP~~l~~L~~L~~L~Ls~N~l~-~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls 172 (1142)
+|+|++|+++ .+|..+.++++|+.|+|++|.+. .+|..+..+++|++|+|++| .+.+.+|..+.++++|+.|+++
T Consensus 470 ~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N---~l~~~~p~~l~~l~~L~~L~Ls 546 (768)
T 3rgz_A 470 TLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNN---SFSGNIPAELGDCRSLIWLDLN 546 (768)
T ss_dssp EEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSS---CCEEECCGGGGGCTTCCEEECC
T ss_pred EEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCC---cccCcCCHHHcCCCCCCEEECC
Confidence 9999999998 78999999999999999999966 78889999999999999994 5567889999999999999999
Q ss_pred CCCCC-ccCccc--------------------------------------------------------------------
Q 001142 173 HFSIR-YLPPEI-------------------------------------------------------------------- 183 (1142)
Q Consensus 173 ~N~L~-~IP~~l-------------------------------------------------------------------- 183 (1142)
+|.++ .+|..+
T Consensus 547 ~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~ 626 (768)
T 3rgz_A 547 TNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSP 626 (768)
T ss_dssp SSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCC
T ss_pred CCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCch
Confidence 99987 666543
Q ss_pred --CCCCCCCEEEccCCCCC-ccchhhcCCCCCCEEEccCCCCC-ccCccccCCCCCCEEeCcCCcCCCCCcccccCCCCC
Q 001142 184 --GCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNL 259 (1142)
Q Consensus 184 --~~L~~L~~L~Ls~N~L~-~lP~~l~~L~~L~~L~Ls~N~Ls-~IP~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L 259 (1142)
+.+++|+.|+|++|+|+ .+|..|+.+++|+.|+|++|+|+ .||..++++++|+.|||++|+|+|.+|..+..+++|
T Consensus 627 ~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L 706 (768)
T 3rgz_A 627 TFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTML 706 (768)
T ss_dssp SCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCC
T ss_pred hhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCC
Confidence 34578999999999999 89999999999999999999999 999999999999999999999999999999999999
Q ss_pred CEEEccCCCCCCCCCCCchhhccCCCCCCCCCCCCccc
Q 001142 260 QNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFIS 297 (1142)
Q Consensus 260 ~~L~Ls~N~L~~~~~iP~~~~~~l~~n~l~~~~~~~~~ 297 (1142)
+.|+|++|+|+| .||....+..-.......++++|+
T Consensus 707 ~~L~ls~N~l~g--~iP~~~~~~~~~~~~~~gN~~Lcg 742 (768)
T 3rgz_A 707 TEIDLSNNNLSG--PIPEMGQFETFPPAKFLNNPGLCG 742 (768)
T ss_dssp SEEECCSSEEEE--ECCSSSSGGGSCGGGGCSCTEEES
T ss_pred CEEECcCCcccc--cCCCchhhccCCHHHhcCCchhcC
Confidence 999999999999 788654433222222334445554
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=285.19 Aligned_cols=271 Identities=20% Similarity=0.203 Sum_probs=231.9
Q ss_pred ccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCcc---CccccCCcCCcEE
Q 001142 20 EKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLI---PKSVGRYEKLRNL 96 (1142)
Q Consensus 20 ~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~i---P~~l~~L~~L~~L 96 (1142)
..+....++|+.++...+ ++|++|+|++|+|+...+..|+ ++++|++|+|++|.|+.+ |..+..+++|++|
T Consensus 10 ~~l~c~~~~l~~ip~~~~---~~l~~L~L~~n~l~~i~~~~~~---~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L 83 (306)
T 2z66_A 10 TEIRCNSKGLTSVPTGIP---SSATRLELESNKLQSLPHGVFD---KLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYL 83 (306)
T ss_dssp TEEECCSSCCSSCCSCCC---TTCCEEECCSSCCCCCCTTTTT---TCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEE
T ss_pred CEEEcCCCCcccCCCCCC---CCCCEEECCCCccCccCHhHhh---ccccCCEEECCCCccCcccCcccccccccccCEE
Confidence 357788888999887543 6899999999999977665555 459999999999999866 6778889999999
Q ss_pred EccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcc--cccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCC
Q 001142 97 KFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGF--ALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHF 174 (1142)
Q Consensus 97 ~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~~--~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N 174 (1142)
+|++|.|+.+|..+.++++|+.|+|++|.+...+. .+..+++|++|++++|. .....+..+..+++|+.|++++|
T Consensus 84 ~Ls~n~i~~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~---l~~~~~~~~~~l~~L~~L~l~~n 160 (306)
T 2z66_A 84 DLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH---TRVAFNGIFNGLSSLEVLKMAGN 160 (306)
T ss_dssp ECCSCSEEEEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSC---CEECSTTTTTTCTTCCEEECTTC
T ss_pred ECCCCccccChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCc---CCccchhhcccCcCCCEEECCCC
Confidence 99999999999999999999999999999777664 78999999999999954 44556777899999999999999
Q ss_pred CCCc--cCcccCCCCCCCEEEccCCCCCcc-chhhcCCCCCCEEEccCCCCCccCc-cccCCCCCCEEeCcCCcCCCCCc
Q 001142 175 SIRY--LPPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPS-GLYLLQRLENLDLSNNRLTSLGS 250 (1142)
Q Consensus 175 ~L~~--IP~~l~~L~~L~~L~Ls~N~L~~l-P~~l~~L~~L~~L~Ls~N~Ls~IP~-~l~~L~~L~~L~Ls~N~Ls~~~p 250 (1142)
.++. +|..+..+++|++|+|++|+|+.+ |..+..+++|+.|+|++|+|+.+|. .+..+++|+.|+|++|+|++.+|
T Consensus 161 ~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 240 (306)
T 2z66_A 161 SFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKK 240 (306)
T ss_dssp EEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSS
T ss_pred ccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCH
Confidence 9985 789999999999999999999977 7889999999999999999998765 67889999999999999999999
Q ss_pred ccccCCC-CCCEEEccCCCCCCCCCCCchhhccCCCCCCCCCCCCccccc
Q 001142 251 LDLCLMH-NLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSS 299 (1142)
Q Consensus 251 ~~l~~L~-~L~~L~Ls~N~L~~~~~iP~~~~~~l~~n~l~~~~~~~~~~~ 299 (1142)
..+..++ +|+.|+|++|+|+|.|+++.+..|......+....+.+.|..
T Consensus 241 ~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~ 290 (306)
T 2z66_A 241 QELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECAT 290 (306)
T ss_dssp SSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEE
T ss_pred HHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCC
Confidence 9999985 999999999999998888776666555544444444444443
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-28 Score=279.00 Aligned_cols=245 Identities=22% Similarity=0.313 Sum_probs=182.3
Q ss_pred CCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEE
Q 001142 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNL 96 (1142)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L 96 (1142)
+.++.|.+..|+|+.+.+..|.++++|++|+|++|+|++..|..|+.+ ++|++|+|++|.|+.+|..+. ++|++|
T Consensus 52 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l---~~L~~L~Ls~n~l~~l~~~~~--~~L~~L 126 (330)
T 1xku_A 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPL---VKLERLYLSKNQLKELPEKMP--KTLQEL 126 (330)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTC---TTCCEEECCSSCCSBCCSSCC--TTCCEE
T ss_pred CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCC---CCCCEEECCCCcCCccChhhc--ccccEE
Confidence 467778888888888877778888888888888888887777665444 788888888888888777655 578888
Q ss_pred EccCCCCCcCch-hhcCCCCCCEEEccCCCCC---CCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEcc
Q 001142 97 KFFGNEINLFPS-EVGNLLGLECLQIKISSPG---VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVC 172 (1142)
Q Consensus 97 ~Ls~N~L~~lP~-~l~~L~~L~~L~Ls~N~l~---~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls 172 (1142)
+|++|.|+.++. .|.++++|+.|+|++|.+. ..+..+..+++|++|++++|.+.. +|..+. ++|+.|+++
T Consensus 127 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~----l~~~~~--~~L~~L~l~ 200 (330)
T 1xku_A 127 RVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT----IPQGLP--PSLTELHLD 200 (330)
T ss_dssp ECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS----CCSSCC--TTCSEEECT
T ss_pred ECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc----CCcccc--ccCCEEECC
Confidence 888888876654 3677888888888887765 445567778888888888765543 343332 677888888
Q ss_pred CCCCCcc-CcccCCCCCCCEEEccCCCCCccc-hhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeCcCCcCCCCCc
Q 001142 173 HFSIRYL-PPEIGCLSNLEQLDLSFNKMKYLP-TEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGS 250 (1142)
Q Consensus 173 ~N~L~~I-P~~l~~L~~L~~L~Ls~N~L~~lP-~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls~N~Ls~~~p 250 (1142)
+|+++.+ |..|..+++|+.|+|++|+|+.++ ..+..+++|+.|+|++|+|+.+|.++..+++|+.|+|++|+|+++++
T Consensus 201 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~L~~L~l~~N~i~~~~~ 280 (330)
T 1xku_A 201 GNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGS 280 (330)
T ss_dssp TSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEECCSSCCCCCCT
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCccCChhhccCCCcCEEECCCCcCCccCh
Confidence 8888755 556777888888888888888664 46777888888888888888888778778888888888888888777
Q ss_pred ccccCC------CCCCEEEccCCCCCCC
Q 001142 251 LDLCLM------HNLQNLNLQYNKLLSY 272 (1142)
Q Consensus 251 ~~l~~L------~~L~~L~Ls~N~L~~~ 272 (1142)
..|+.. ..|+.|+|++|++..+
T Consensus 281 ~~f~~~~~~~~~~~l~~l~l~~N~~~~~ 308 (330)
T 1xku_A 281 NDFCPPGYNTKKASYSGVSLFSNPVQYW 308 (330)
T ss_dssp TSSSCSSCCTTSCCCSEEECCSSSSCGG
T ss_pred hhcCCcccccccccccceEeecCccccc
Confidence 666543 6777888888887653
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.96 E-value=6.1e-30 Score=290.17 Aligned_cols=229 Identities=21% Similarity=0.251 Sum_probs=163.1
Q ss_pred CCCCEEEccCCCCCC--CCcccccCCCCCCCccEEEeec-CCCC-ccCccccCCcCCcEEEccCCCCC-cCchhhcCCCC
Q 001142 41 DDDSVIDVSGKTVDF--PLIESYGNRGGDNSVEGLYLYK-NVLN-LIPKSVGRYEKLRNLKFFGNEIN-LFPSEVGNLLG 115 (1142)
Q Consensus 41 ~~L~~LdLs~N~L~~--~~p~~~~~l~~L~~L~~L~Ls~-N~Lt-~iP~~l~~L~~L~~L~Ls~N~L~-~lP~~l~~L~~ 115 (1142)
..++.|+|++|+|++ .+|..++.+ ++|++|+|++ |.++ .+|..|.++++|++|+|++|.|+ .+|..|.++++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l---~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~ 126 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANL---PYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKT 126 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGC---TTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTT
T ss_pred ceEEEEECCCCCccCCcccChhHhCC---CCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCC
Confidence 467777777777777 666655544 7777777773 6666 56777777777777777777776 66777777777
Q ss_pred CCEEEccCCCCC-CCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCC-CCcEEEccCCCCC-ccCcccCCCCCCCEE
Q 001142 116 LECLQIKISSPG-VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLK-CLTKLSVCHFSIR-YLPPEIGCLSNLEQL 192 (1142)
Q Consensus 116 L~~L~Ls~N~l~-~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~-~L~~L~Ls~N~L~-~IP~~l~~L~~L~~L 192 (1142)
|++|+|++|.+. .+|..+..+++|++|+|++| .+.+.+|..+..++ +|+.|++++|+++ .+|..+..++ |+.|
T Consensus 127 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N---~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L 202 (313)
T 1ogq_A 127 LVTLDFSYNALSGTLPPSISSLPNLVGITFDGN---RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFV 202 (313)
T ss_dssp CCEEECCSSEEESCCCGGGGGCTTCCEEECCSS---CCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEE
T ss_pred CCEEeCCCCccCCcCChHHhcCCCCCeEECcCC---cccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEE
Confidence 777777777755 56667777777777777773 33446666777776 7777777777777 5677776666 7777
Q ss_pred EccCCCCC-ccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccCCCCCC
Q 001142 193 DLSFNKMK-YLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 193 ~Ls~N~L~-~lP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1142)
+|++|+|+ .+|..+..+++|+.|+|++|.++..++.+..+++|+.|+|++|+|++.+|..|..+++|+.|+|++|++++
T Consensus 203 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 282 (313)
T 1ogq_A 203 DLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282 (313)
T ss_dssp ECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEE
T ss_pred ECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCcccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccc
Confidence 77777777 45666777777777777777777554456667777777777777777777777777777777777777775
Q ss_pred CCCCCch
Q 001142 272 YCQVPSW 278 (1142)
Q Consensus 272 ~~~iP~~ 278 (1142)
.+|..
T Consensus 283 --~ip~~ 287 (313)
T 1ogq_A 283 --EIPQG 287 (313)
T ss_dssp --ECCCS
T ss_pred --cCCCC
Confidence 35554
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-28 Score=289.99 Aligned_cols=253 Identities=20% Similarity=0.190 Sum_probs=164.4
Q ss_pred CCCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCc-ccccCCCCCCCccEEEeecCCCCcc-CccccCCcCC
Q 001142 16 GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLI-ESYGNRGGDNSVEGLYLYKNVLNLI-PKSVGRYEKL 93 (1142)
Q Consensus 16 ~~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p-~~~~~l~~L~~L~~L~Ls~N~Lt~i-P~~l~~L~~L 93 (1142)
++.++.|.+..|+|+.+.+..|.++++|++|+|++|.+.+.++ ..| .++++|++|+|++|.++.+ |..|.++++|
T Consensus 29 ~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~---~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L 105 (455)
T 3v47_A 29 PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTF---RGLSSLIILKLDYNQFLQLETGAFNGLANL 105 (455)
T ss_dssp CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTT---TTCTTCCEEECTTCTTCEECTTTTTTCTTC
T ss_pred CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccc---cccccCCEEeCCCCccCccChhhccCcccC
Confidence 3568888888888888888888888888888888888875553 334 4458888888888888866 6678888888
Q ss_pred cEEEccCCCCCc-Cchh--hcCCCCCCEEEccCCCCCCC-ccc-ccCCCCCCEEECCCCCCCCCccc-------------
Q 001142 94 RNLKFFGNEINL-FPSE--VGNLLGLECLQIKISSPGVN-GFA-LNKLKGLKELELSKVPPRPSVLT------------- 155 (1142)
Q Consensus 94 ~~L~Ls~N~L~~-lP~~--l~~L~~L~~L~Ls~N~l~~~-~~~-~~~L~~L~~L~Ls~n~~n~~~~~------------- 155 (1142)
++|+|++|+|+. +|.. |.++++|++|+|++|.+... |.. +..+++|++|++++|.+......
T Consensus 106 ~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L 185 (455)
T 3v47_A 106 EVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLL 185 (455)
T ss_dssp CEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEE
T ss_pred CEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhcccccccccc
Confidence 888888888874 4444 77788888888888886655 433 67778888888877654332111
Q ss_pred ------------------------------------------chhhhc--------------------------------
Q 001142 156 ------------------------------------------LLSEIA-------------------------------- 161 (1142)
Q Consensus 156 ------------------------------------------lp~~l~-------------------------------- 161 (1142)
.|..+.
T Consensus 186 ~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~ 265 (455)
T 3v47_A 186 RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPD 265 (455)
T ss_dssp ECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCC
T ss_pred ccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCc
Confidence 000000
Q ss_pred -------CCCCCcEEEccCCCCCc-cCcccCCCCCCCEEEccCCCCCcc-chhhcCCCCCCEEEccCCCCCcc-CccccC
Q 001142 162 -------GLKCLTKLSVCHFSIRY-LPPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVEL-PSGLYL 231 (1142)
Q Consensus 162 -------~L~~L~~L~Ls~N~L~~-IP~~l~~L~~L~~L~Ls~N~L~~l-P~~l~~L~~L~~L~Ls~N~Ls~I-P~~l~~ 231 (1142)
..++|+.|++++|.++. +|..+..+++|+.|+|++|+|+.+ |..|..+++|+.|+|++|+|+.+ |..+..
T Consensus 266 ~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 345 (455)
T 3v47_A 266 NFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFEN 345 (455)
T ss_dssp TTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTT
T ss_pred ccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcC
Confidence 01234444444444442 244556666666666666666644 44566666666666666666644 444555
Q ss_pred CCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccCCCCCC
Q 001142 232 LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 232 L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1142)
+++|+.|+|++|+|++++|..|..+++|+.|+|++|++++
T Consensus 346 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 385 (455)
T 3v47_A 346 LDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKS 385 (455)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSC
T ss_pred cccCCEEECCCCcccccChhhccccccccEEECCCCcccc
Confidence 6666666666666666666566666666666666666655
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.8e-28 Score=287.96 Aligned_cols=255 Identities=20% Similarity=0.281 Sum_probs=224.1
Q ss_pred cccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccC-ccccCCcCCcEEE
Q 001142 19 KEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIP-KSVGRYEKLRNLK 97 (1142)
Q Consensus 19 l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP-~~l~~L~~L~~L~ 97 (1142)
...+....++|+.++.... +++++|+|++|+|++..+..|..+ ++|++|+|++|.|+.++ ..|.++++|++|+
T Consensus 45 ~~~v~c~~~~l~~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l---~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~ 118 (440)
T 3zyj_A 45 FSKVICVRKNLREVPDGIS---TNTRLLNLHENQIQIIKVNSFKHL---RHLEILQLSRNHIRTIEIGAFNGLANLNTLE 118 (440)
T ss_dssp SCEEECCSCCCSSCCSCCC---TTCSEEECCSCCCCEECTTTTSSC---SSCCEEECCSSCCCEECGGGGTTCSSCCEEE
T ss_pred CCEEEeCCCCcCcCCCCCC---CCCcEEEccCCcCCeeCHHHhhCC---CCCCEEECCCCcCCccChhhccCCccCCEEE
Confidence 4567778888998886544 689999999999999888777555 99999999999999886 5799999999999
Q ss_pred ccCCCCCcCch-hhcCCCCCCEEEccCCCCCCCcc-cccCCCCCCEEECCCCCCCCCcccch-hhhcCCCCCcEEEccCC
Q 001142 98 FFGNEINLFPS-EVGNLLGLECLQIKISSPGVNGF-ALNKLKGLKELELSKVPPRPSVLTLL-SEIAGLKCLTKLSVCHF 174 (1142)
Q Consensus 98 Ls~N~L~~lP~-~l~~L~~L~~L~Ls~N~l~~~~~-~~~~L~~L~~L~Ls~n~~n~~~~~lp-~~l~~L~~L~~L~Ls~N 174 (1142)
|++|+|+.+|. .|.++++|+.|+|++|.+..++. .|..+++|++|+|++| +....++ ..|.++++|+.|+|++|
T Consensus 119 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~---~~l~~i~~~~~~~l~~L~~L~L~~n 195 (440)
T 3zyj_A 119 LFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGEL---KRLSYISEGAFEGLSNLRYLNLAMC 195 (440)
T ss_dssp CCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCC---TTCCEECTTTTTTCSSCCEEECTTS
T ss_pred CCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCC---CCcceeCcchhhcccccCeecCCCC
Confidence 99999999876 58899999999999999877664 7899999999999984 3344444 46889999999999999
Q ss_pred CCCccCcccCCCCCCCEEEccCCCCCcc-chhhcCCCCCCEEEccCCCCCcc-CccccCCCCCCEEeCcCCcCCCCCccc
Q 001142 175 SIRYLPPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVEL-PSGLYLLQRLENLDLSNNRLTSLGSLD 252 (1142)
Q Consensus 175 ~L~~IP~~l~~L~~L~~L~Ls~N~L~~l-P~~l~~L~~L~~L~Ls~N~Ls~I-P~~l~~L~~L~~L~Ls~N~Ls~~~p~~ 252 (1142)
+|+.+|. +..+++|+.|+|++|+|+.+ |..|..+++|+.|+|++|+|+.+ |..+.++++|+.|+|++|+|+++++..
T Consensus 196 ~l~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 274 (440)
T 3zyj_A 196 NLREIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDL 274 (440)
T ss_dssp CCSSCCC-CTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTT
T ss_pred cCccccc-cCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhH
Confidence 9999985 78999999999999999977 78899999999999999999966 567788999999999999999999989
Q ss_pred ccCCCCCCEEEccCCCCCCCCCCCchhhccC
Q 001142 253 LCLMHNLQNLNLQYNKLLSYCQVPSWICCNL 283 (1142)
Q Consensus 253 l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l 283 (1142)
|..+++|+.|+|++|+|.|.|.+-+...|..
T Consensus 275 ~~~l~~L~~L~L~~Np~~CdC~l~~l~~~~~ 305 (440)
T 3zyj_A 275 FTPLHHLERIHLHHNPWNCNCDILWLSWWIK 305 (440)
T ss_dssp TSSCTTCCEEECCSSCEECSSTTHHHHHHHH
T ss_pred hccccCCCEEEcCCCCccCCCCchHHHHHHH
Confidence 9999999999999999999999765555543
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-28 Score=299.52 Aligned_cols=131 Identities=16% Similarity=0.100 Sum_probs=114.0
Q ss_pred CCCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCcCCc
Q 001142 16 GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLR 94 (1142)
Q Consensus 16 ~~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~-~l~~L~~L~ 94 (1142)
+++++.|++..|+|+.+.+.+|.++++|++|||++|+|+++.+..|+.+ ++|++|+|++|+|+.+|. .|.+|++|+
T Consensus 51 p~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L---~~L~~L~Ls~N~l~~l~~~~f~~L~~L~ 127 (635)
T 4g8a_A 51 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSL---SHLSTLILTGNPIQSLALGAFSGLSSLQ 127 (635)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTC---TTCCEEECTTCCCCEECGGGGTTCTTCC
T ss_pred CcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCC---CCCCEEEccCCcCCCCCHHHhcCCCCCC
Confidence 3568999999999999999999999999999999999999888766544 999999999999999975 589999999
Q ss_pred EEEccCCCCCcCchh-hcCCCCCCEEEccCCCCCC--CcccccCCCCCCEEECCCCCC
Q 001142 95 NLKFFGNEINLFPSE-VGNLLGLECLQIKISSPGV--NGFALNKLKGLKELELSKVPP 149 (1142)
Q Consensus 95 ~L~Ls~N~L~~lP~~-l~~L~~L~~L~Ls~N~l~~--~~~~~~~L~~L~~L~Ls~n~~ 149 (1142)
+|+|++|+|+.+|.. |+++++|++|+|++|.+.. .|..+..+++|++|+|++|.+
T Consensus 128 ~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l 185 (635)
T 4g8a_A 128 KLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 185 (635)
T ss_dssp EEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCC
T ss_pred EEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccc
Confidence 999999999988764 8899999999999998764 456788888999888887653
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-28 Score=278.35 Aligned_cols=241 Identities=21% Similarity=0.317 Sum_probs=133.9
Q ss_pred CcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEE
Q 001142 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLK 97 (1142)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~ 97 (1142)
.++.|.+..|+|+.+.+..|.++++|++|+|++|+|++..|..|+.+ ++|++|+|++|.|+.+|..+. ++|++|+
T Consensus 55 ~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l---~~L~~L~L~~n~l~~l~~~~~--~~L~~L~ 129 (332)
T 2ft3_A 55 DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPL---RKLQKLYISKNHLVEIPPNLP--SSLVELR 129 (332)
T ss_dssp TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTC---TTCCEEECCSSCCCSCCSSCC--TTCCEEE
T ss_pred CCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCc---CCCCEEECCCCcCCccCcccc--ccCCEEE
Confidence 45555555566665555556666666666666666655555444333 556666666666665555443 4566666
Q ss_pred ccCCCCCcCchh-hcCCCCCCEEEccCCCCC---CCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccC
Q 001142 98 FFGNEINLFPSE-VGNLLGLECLQIKISSPG---VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCH 173 (1142)
Q Consensus 98 Ls~N~L~~lP~~-l~~L~~L~~L~Ls~N~l~---~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~ 173 (1142)
|++|+|+.+|.. |.++++|+.|+|++|.+. ..+..+..+ +|++|++++|.+.. +|..+. ++|+.|++++
T Consensus 130 l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~----l~~~~~--~~L~~L~l~~ 202 (332)
T 2ft3_A 130 IHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG----IPKDLP--ETLNELHLDH 202 (332)
T ss_dssp CCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS----CCSSSC--SSCSCCBCCS
T ss_pred CCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc----cCcccc--CCCCEEECCC
Confidence 666666555443 555566666666655543 333444444 55556665544332 333222 4555566666
Q ss_pred CCCCccC-cccCCCCCCCEEEccCCCCCccc-hhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeCcCCcCCCCCcc
Q 001142 174 FSIRYLP-PEIGCLSNLEQLDLSFNKMKYLP-TEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSL 251 (1142)
Q Consensus 174 N~L~~IP-~~l~~L~~L~~L~Ls~N~L~~lP-~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls~N~Ls~~~p~ 251 (1142)
|.++.++ ..+..+++|+.|+|++|+|+.++ ..+..+++|+.|+|++|+|+.||.++..+++|+.|+|++|+|+++++.
T Consensus 203 n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~L~~L~l~~N~l~~~~~~ 282 (332)
T 2ft3_A 203 NKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTNNITKVGVN 282 (332)
T ss_dssp SCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCCBCCTTGGGCTTCCEEECCSSCCCBCCTT
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCeecChhhhcCccCCEEECCCCCCCccChh
Confidence 6665443 34555666666666666666443 345556666666666666666666565666666666666666665555
Q ss_pred cccCC------CCCCEEEccCCCCC
Q 001142 252 DLCLM------HNLQNLNLQYNKLL 270 (1142)
Q Consensus 252 ~l~~L------~~L~~L~Ls~N~L~ 270 (1142)
.|..+ ..|+.|++++|++.
T Consensus 283 ~~~~~~~~~~~~~l~~L~l~~N~~~ 307 (332)
T 2ft3_A 283 DFCPVGFGVKRAYYNGISLFNNPVP 307 (332)
T ss_dssp SSSCSSCCSSSCCBSEEECCSSSSC
T ss_pred HccccccccccccccceEeecCccc
Confidence 54432 34556666666655
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=8.4e-28 Score=285.97 Aligned_cols=254 Identities=20% Similarity=0.253 Sum_probs=222.7
Q ss_pred cccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccC-ccccCCcCCcEEE
Q 001142 19 KEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIP-KSVGRYEKLRNLK 97 (1142)
Q Consensus 19 l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP-~~l~~L~~L~~L~ 97 (1142)
...+....++++.++.... ++|++|+|++|+|++..+..|+.+ ++|+.|+|++|.|+.++ ..|.++++|++|+
T Consensus 56 ~~~v~c~~~~l~~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l---~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 129 (452)
T 3zyi_A 56 FSKVVCTRRGLSEVPQGIP---SNTRYLNLMENNIQMIQADTFRHL---HHLEVLQLGRNSIRQIEVGAFNGLASLNTLE 129 (452)
T ss_dssp SCEEECCSSCCSSCCSCCC---TTCSEEECCSSCCCEECTTTTTTC---TTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred CcEEEECCCCcCccCCCCC---CCccEEECcCCcCceECHHHcCCC---CCCCEEECCCCccCCcChhhccCcccCCEEE
Confidence 4567777888888875443 689999999999999888877555 99999999999999885 6799999999999
Q ss_pred ccCCCCCcCchh-hcCCCCCCEEEccCCCCCCCcc-cccCCCCCCEEECCCCCCCCCcccchh-hhcCCCCCcEEEccCC
Q 001142 98 FFGNEINLFPSE-VGNLLGLECLQIKISSPGVNGF-ALNKLKGLKELELSKVPPRPSVLTLLS-EIAGLKCLTKLSVCHF 174 (1142)
Q Consensus 98 Ls~N~L~~lP~~-l~~L~~L~~L~Ls~N~l~~~~~-~~~~L~~L~~L~Ls~n~~n~~~~~lp~-~l~~L~~L~~L~Ls~N 174 (1142)
|++|+|+.+|.. |.++++|+.|+|++|.+..++. .|..+++|++|++++| +....++. .|.++++|+.|+|++|
T Consensus 130 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~---~~l~~i~~~~~~~l~~L~~L~L~~n 206 (452)
T 3zyi_A 130 LFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGEL---KKLEYISEGAFEGLFNLKYLNLGMC 206 (452)
T ss_dssp CCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCC---TTCCEECTTTTTTCTTCCEEECTTS
T ss_pred CCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCC---CCccccChhhccCCCCCCEEECCCC
Confidence 999999988766 7889999999999999887664 7899999999999983 33444443 5889999999999999
Q ss_pred CCCccCcccCCCCCCCEEEccCCCCCcc-chhhcCCCCCCEEEccCCCCCcc-CccccCCCCCCEEeCcCCcCCCCCccc
Q 001142 175 SIRYLPPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVEL-PSGLYLLQRLENLDLSNNRLTSLGSLD 252 (1142)
Q Consensus 175 ~L~~IP~~l~~L~~L~~L~Ls~N~L~~l-P~~l~~L~~L~~L~Ls~N~Ls~I-P~~l~~L~~L~~L~Ls~N~Ls~~~p~~ 252 (1142)
+|+.+|. +..+++|+.|+|++|+|+.+ |..|..+++|+.|+|++|+|+.+ |..+..+++|+.|+|++|+|+++++..
T Consensus 207 ~l~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 285 (452)
T 3zyi_A 207 NIKDMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDL 285 (452)
T ss_dssp CCSSCCC-CTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTS
T ss_pred ccccccc-ccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHH
Confidence 9999874 78999999999999999976 78899999999999999999966 667888999999999999999999988
Q ss_pred ccCCCCCCEEEccCCCCCCCCCCCchhhcc
Q 001142 253 LCLMHNLQNLNLQYNKLLSYCQVPSWICCN 282 (1142)
Q Consensus 253 l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~ 282 (1142)
|..+++|+.|+|++|+|.|.|++-....|.
T Consensus 286 ~~~l~~L~~L~L~~Np~~CdC~~~~l~~~l 315 (452)
T 3zyi_A 286 FTPLRYLVELHLHHNPWNCDCDILWLAWWL 315 (452)
T ss_dssp STTCTTCCEEECCSSCEECSTTTHHHHHHH
T ss_pred hccccCCCEEEccCCCcCCCCCchHHHHHH
Confidence 999999999999999999999876554443
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=279.99 Aligned_cols=247 Identities=17% Similarity=0.183 Sum_probs=225.3
Q ss_pred CCcccccCCCCCCcc--cCCCCCCCCCCCCEEEccC-CCCCCCCcccccCCCCCCCccEEEeecCCCC-ccCccccCCcC
Q 001142 17 PIKEKLPSEANKINN--EKNGSVNDDDDDSVIDVSG-KTVDFPLIESYGNRGGDNSVEGLYLYKNVLN-LIPKSVGRYEK 92 (1142)
Q Consensus 17 ~~l~~L~~~~N~i~~--l~~~~f~~l~~L~~LdLs~-N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt-~iP~~l~~L~~ 92 (1142)
..+..|.+..|+|++ ..+..|.++++|++|+|++ |++++.+|..|+.+ ++|++|+|++|.|+ .+|..|.++++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l---~~L~~L~Ls~n~l~~~~p~~~~~l~~ 126 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKL---TQLHYLYITHTNVSGAIPDFLSQIKT 126 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGC---TTCSEEEEEEECCEEECCGGGGGCTT
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcC---CCCCEEECcCCeeCCcCCHHHhCCCC
Confidence 368889999999998 6678999999999999995 99999999888665 99999999999999 78999999999
Q ss_pred CcEEEccCCCCC-cCchhhcCCCCCCEEEccCCCCC-CCcccccCCC-CCCEEECCCCCCCCCcccchhhhcCCCCCcEE
Q 001142 93 LRNLKFFGNEIN-LFPSEVGNLLGLECLQIKISSPG-VNGFALNKLK-GLKELELSKVPPRPSVLTLLSEIAGLKCLTKL 169 (1142)
Q Consensus 93 L~~L~Ls~N~L~-~lP~~l~~L~~L~~L~Ls~N~l~-~~~~~~~~L~-~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L 169 (1142)
|++|+|++|.|+ .+|..|.++++|++|+|++|.+. .+|..+..++ +|++|++++| .+.+.+|..+..++ |+.|
T Consensus 127 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N---~l~~~~~~~~~~l~-L~~L 202 (313)
T 1ogq_A 127 LVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN---RLTGKIPPTFANLN-LAFV 202 (313)
T ss_dssp CCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSS---EEEEECCGGGGGCC-CSEE
T ss_pred CCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCC---eeeccCChHHhCCc-ccEE
Confidence 999999999998 78999999999999999999987 7888999998 9999999994 45567888898887 9999
Q ss_pred EccCCCCC-ccCcccCCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCC-ccCccccCCCCCCEEeCcCCcCCC
Q 001142 170 SVCHFSIR-YLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRLENLDLSNNRLTS 247 (1142)
Q Consensus 170 ~Ls~N~L~-~IP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls-~IP~~l~~L~~L~~L~Ls~N~Ls~ 247 (1142)
++++|.++ .+|..|..+++|+.|+|++|+|+..+..+..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++
T Consensus 203 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 282 (313)
T 1ogq_A 203 DLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282 (313)
T ss_dssp ECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEE
T ss_pred ECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCcccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccc
Confidence 99999999 5677889999999999999999966666889999999999999999 889999999999999999999999
Q ss_pred CCcccccCCCCCCEEEccCCCCCC
Q 001142 248 LGSLDLCLMHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 248 ~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1142)
.+|.. ..+++|+.|++++|+.-|
T Consensus 283 ~ip~~-~~l~~L~~l~l~~N~~lc 305 (313)
T 1ogq_A 283 EIPQG-GNLQRFDVSAYANNKCLC 305 (313)
T ss_dssp ECCCS-TTGGGSCGGGTCSSSEEE
T ss_pred cCCCC-ccccccChHHhcCCCCcc
Confidence 99854 899999999999999544
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.2e-28 Score=289.89 Aligned_cols=256 Identities=21% Similarity=0.253 Sum_probs=165.4
Q ss_pred CCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCcc-CccccCCcCCcE
Q 001142 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLI-PKSVGRYEKLRN 95 (1142)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~i-P~~l~~L~~L~~ 95 (1142)
+.++.|.+..|+|+.+.+..|.++++|++|+|++|+|++.++..|+. +++|++|+|++|.++.+ |..|..+++|++
T Consensus 56 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~---l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 132 (477)
T 2id5_A 56 PHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTG---LSNLTKLDISENKIVILLDYMFQDLYNLKS 132 (477)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTT---CTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred CCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccC---CCCCCEEECCCCccccCChhHccccccCCE
Confidence 47788888888888888888888888888888888888766655543 47788888888887765 456777777888
Q ss_pred EEccCCCCCcC-chhhcCCCCCCEEEccCCCCCCCcc-cccCCCCCCEEECCCCCCCC---------------------C
Q 001142 96 LKFFGNEINLF-PSEVGNLLGLECLQIKISSPGVNGF-ALNKLKGLKELELSKVPPRP---------------------S 152 (1142)
Q Consensus 96 L~Ls~N~L~~l-P~~l~~L~~L~~L~Ls~N~l~~~~~-~~~~L~~L~~L~Ls~n~~n~---------------------~ 152 (1142)
|+|++|.|+.+ |..|.++++|+.|+|++|.+..++. .+..+++|+.|+|++|.+.. .
T Consensus 133 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~ 212 (477)
T 2id5_A 133 LEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPY 212 (477)
T ss_dssp EEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTT
T ss_pred EECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCcc
Confidence 88887777755 4457777777777777777665553 46667777777777654432 1
Q ss_pred cccchhhhcCCCCCcEEEccCCCCCccCc-ccCCCCCCCEEEccCCCCCccc-hhhcCCCCCCEEEccCCCCCcc-Cccc
Q 001142 153 VLTLLSEIAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFNKMKYLP-TEICYLKALISLKVANNKLVEL-PSGL 229 (1142)
Q Consensus 153 ~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~Ls~N~L~~lP-~~l~~L~~L~~L~Ls~N~Ls~I-P~~l 229 (1142)
...+|..+....+|+.|+|++|+|+.+|. .+..+++|+.|+|++|.|+.++ ..|..+++|+.|+|++|+|+.+ |..+
T Consensus 213 ~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 292 (477)
T 2id5_A 213 LDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAF 292 (477)
T ss_dssp CCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTB
T ss_pred ccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHh
Confidence 22223333333355555555555555553 4556666666666666666543 3455566666666666666643 4555
Q ss_pred cCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccCCCCCCCCCC
Q 001142 230 YLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQV 275 (1142)
Q Consensus 230 ~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~~~~i 275 (1142)
..+++|+.|+|++|+|+++++..|..+++|+.|+|++|+|.|.|.+
T Consensus 293 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~ 338 (477)
T 2id5_A 293 RGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRL 338 (477)
T ss_dssp TTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGG
T ss_pred cCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccch
Confidence 5566666666666666666665566666666666666666665543
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.2e-28 Score=286.92 Aligned_cols=272 Identities=20% Similarity=0.192 Sum_probs=219.6
Q ss_pred CCCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCcCCc
Q 001142 16 GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLR 94 (1142)
Q Consensus 16 ~~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~-~l~~L~~L~ 94 (1142)
++.+..|.+..|+|+.+.+..|.++++|++|+|++|+|++..|..|+.+ ++|++|+|++|.|+.+|. .|.++++|+
T Consensus 31 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l---~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 107 (477)
T 2id5_A 31 PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNL---FNLRTLGLRSNRLKLIPLGVFTGLSNLT 107 (477)
T ss_dssp CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTC---TTCCEEECCSSCCCSCCTTSSTTCTTCC
T ss_pred CCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCC---ccCCEEECCCCcCCccCcccccCCCCCC
Confidence 3568999999999999999999999999999999999999888777554 999999999999999986 578999999
Q ss_pred EEEccCCCCCcC-chhhcCCCCCCEEEccCCCCCCC-cccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEcc
Q 001142 95 NLKFFGNEINLF-PSEVGNLLGLECLQIKISSPGVN-GFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVC 172 (1142)
Q Consensus 95 ~L~Ls~N~L~~l-P~~l~~L~~L~~L~Ls~N~l~~~-~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls 172 (1142)
+|+|++|+|+.+ |..|.++++|+.|+|++|.+..+ +..|..+++|+.|+|++|.+.. ..+..|.++++|+.|+|+
T Consensus 108 ~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~---~~~~~l~~l~~L~~L~l~ 184 (477)
T 2id5_A 108 KLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTS---IPTEALSHLHGLIVLRLR 184 (477)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSS---CCHHHHTTCTTCCEEEEE
T ss_pred EEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcc---cChhHhcccCCCcEEeCC
Confidence 999999999965 66789999999999999997654 4689999999999999965543 334568899999999999
Q ss_pred CCCCCccCc-ccCCCCCCCEEEccCCCCC-ccchhhcCCCCCCEEEccCCCCCccCc-cccCCCCCCEEeCcCCcCCCCC
Q 001142 173 HFSIRYLPP-EIGCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLVELPS-GLYLLQRLENLDLSNNRLTSLG 249 (1142)
Q Consensus 173 ~N~L~~IP~-~l~~L~~L~~L~Ls~N~L~-~lP~~l~~L~~L~~L~Ls~N~Ls~IP~-~l~~L~~L~~L~Ls~N~Ls~~~ 249 (1142)
+|.++.++. .|..+++|+.|+|++|.+. .+|..+....+|+.|+|++|+|+.+|. .+..+++|+.|+|++|+|++++
T Consensus 185 ~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~ 264 (477)
T 2id5_A 185 HLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIE 264 (477)
T ss_dssp SCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEEC
T ss_pred CCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccC
Confidence 999997754 6788888888888887654 677666666678888888888887773 5667788888888888888877
Q ss_pred cccccCCCCCCEEEccCCCCCCC-----CCCCchhhccCCCCCCCCCCC
Q 001142 250 SLDLCLMHNLQNLNLQYNKLLSY-----CQVPSWICCNLEGNGKDSSND 293 (1142)
Q Consensus 250 p~~l~~L~~L~~L~Ls~N~L~~~-----~~iP~~~~~~l~~n~l~~~~~ 293 (1142)
+..|..+++|+.|+|++|++++. ..+|....++++.|.+...+.
T Consensus 265 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 313 (477)
T 2id5_A 265 GSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEE 313 (477)
T ss_dssp TTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCG
T ss_pred hhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCH
Confidence 77777888888888888877662 123333334555555544433
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.9e-28 Score=275.85 Aligned_cols=224 Identities=19% Similarity=0.174 Sum_probs=194.7
Q ss_pred CCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCEE
Q 001142 40 DDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECL 119 (1142)
Q Consensus 40 l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L 119 (1142)
...++.|||++|+|+. +|..++. +++|++|+|++|.|+.+|..|+++++|++|+|++|.|+.+|..++++++|++|
T Consensus 80 ~~~l~~L~L~~n~l~~-lp~~l~~---l~~L~~L~L~~n~l~~lp~~~~~l~~L~~L~Ls~n~l~~lp~~l~~l~~L~~L 155 (328)
T 4fcg_A 80 QPGRVALELRSVPLPQ-FPDQAFR---LSHLQHMTIDAAGLMELPDTMQQFAGLETLTLARNPLRALPASIASLNRLREL 155 (328)
T ss_dssp STTCCEEEEESSCCSS-CCSCGGG---GTTCSEEEEESSCCCCCCSCGGGGTTCSEEEEESCCCCCCCGGGGGCTTCCEE
T ss_pred ccceeEEEccCCCchh-cChhhhh---CCCCCEEECCCCCccchhHHHhccCCCCEEECCCCccccCcHHHhcCcCCCEE
Confidence 4789999999999984 5555554 48999999999999999999999999999999999999999999999999999
Q ss_pred EccCCC-CCCCcccccC---------CCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCcccCCCCCC
Q 001142 120 QIKISS-PGVNGFALNK---------LKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNL 189 (1142)
Q Consensus 120 ~Ls~N~-l~~~~~~~~~---------L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L 189 (1142)
+|++|+ ++.+|..+.. +++|++|+|++|.+. .+|..+..+++|+.|+|++|.++.+|..++.+++|
T Consensus 156 ~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~----~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L 231 (328)
T 4fcg_A 156 SIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR----SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKL 231 (328)
T ss_dssp EEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC----CCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTC
T ss_pred ECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC----cchHhhcCCCCCCEEEccCCCCCcCchhhccCCCC
Confidence 999865 7777766554 889999999986543 67778888999999999999999888888889999
Q ss_pred CEEEccCCCCC-ccchhhcCCCCCCEEEccCCCCC-ccCccccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccCC
Q 001142 190 EQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYN 267 (1142)
Q Consensus 190 ~~L~Ls~N~L~-~lP~~l~~L~~L~~L~Ls~N~Ls-~IP~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N 267 (1142)
++|+|++|++. .+|..++.+++|+.|+|++|.+. .+|..+.++++|+.|+|++|++.+.+|..+.++++|+.+++..|
T Consensus 232 ~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~ 311 (328)
T 4fcg_A 232 EELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH 311 (328)
T ss_dssp CEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGG
T ss_pred CEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHH
Confidence 99999998877 77888889999999999998776 88888888999999999999999988889999999999999888
Q ss_pred CCCC
Q 001142 268 KLLS 271 (1142)
Q Consensus 268 ~L~~ 271 (1142)
.+..
T Consensus 312 ~~~~ 315 (328)
T 4fcg_A 312 LQAQ 315 (328)
T ss_dssp GSCC
T ss_pred HHHH
Confidence 7765
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-27 Score=276.24 Aligned_cols=246 Identities=19% Similarity=0.160 Sum_probs=178.7
Q ss_pred CCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCcc-ccCCcCCcE
Q 001142 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKS-VGRYEKLRN 95 (1142)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~-l~~L~~L~~ 95 (1142)
+.++.|.+..|+|+.+.+..|.++++|++|+|++|+|++.+|..|+.+ ++|++|+|++|.|+.+|.. |.++++|++
T Consensus 69 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l---~~L~~L~L~~n~l~~l~~~~~~~l~~L~~ 145 (390)
T 3o6n_A 69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNV---PLLTVLVLERNDLSSLPRGIFHNTPKLTT 145 (390)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC---TTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred ccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCC---CCCCEEECCCCccCcCCHHHhcCCCCCcE
Confidence 467778888888888887788888888888888888887777665444 7888888888888888765 577888888
Q ss_pred EEccCCCCCcCc-hhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCC---------------cccchhh
Q 001142 96 LKFFGNEINLFP-SEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPS---------------VLTLLSE 159 (1142)
Q Consensus 96 L~Ls~N~L~~lP-~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~---------------~~~lp~~ 159 (1142)
|+|++|.|+.++ ..|.++++|+.|+|++|.+...+ +..+++|+.|++++|.+... ...+|..
T Consensus 146 L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~L~~L~l~~n~l~~~~~~ 223 (390)
T 3o6n_A 146 LSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD--LSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGP 223 (390)
T ss_dssp EECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC--GGGCTTCSEEECCSSCCSEEECCSSCSEEECCSSCCCEEECC
T ss_pred EECCCCccCccChhhccCCCCCCEEECCCCcCCccc--cccccccceeecccccccccCCCCcceEEECCCCeeeecccc
Confidence 888888887664 44777888888888888766553 44455555555554432211 1111211
Q ss_pred hcCCCCCcEEEccCCCCCccCcccCCCCCCCEEEccCCCCCcc-chhhcCCCCCCEEEccCCCCCccCccccCCCCCCEE
Q 001142 160 IAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSGLYLLQRLENL 238 (1142)
Q Consensus 160 l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~l-P~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L 238 (1142)
..++|+.|++++|.++.+ ..+..+++|+.|+|++|.|+.+ |..+..+++|+.|+|++|+|+.+|..+..+++|+.|
T Consensus 224 --~~~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L 300 (390)
T 3o6n_A 224 --VNVELTILKLQHNNLTDT-AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVL 300 (390)
T ss_dssp --CCSSCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCEEECSSSCCTTCCEE
T ss_pred --ccccccEEECCCCCCccc-HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcccCcccCCCCCCCEE
Confidence 235677888888888765 4577788888888888888855 677888888888888888888887777778888888
Q ss_pred eCcCCcCCCCCcccccCCCCCCEEEccCCCCCC
Q 001142 239 DLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 239 ~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1142)
+|++|+|+++++ .+..+++|+.|+|++|+++.
T Consensus 301 ~L~~n~l~~~~~-~~~~l~~L~~L~L~~N~i~~ 332 (390)
T 3o6n_A 301 DLSHNHLLHVER-NQPQFDRLENLYLDHNSIVT 332 (390)
T ss_dssp ECCSSCCCCCGG-GHHHHTTCSEEECCSSCCCC
T ss_pred ECCCCcceecCc-cccccCcCCEEECCCCccce
Confidence 888888887654 56777888888888888876
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.7e-28 Score=300.02 Aligned_cols=251 Identities=17% Similarity=0.193 Sum_probs=157.9
Q ss_pred CCCCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCC-CCC-CCcccccCC---CCCCCccEEEeecCCCCccCc--cc
Q 001142 15 EGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKT-VDF-PLIESYGNR---GGDNSVEGLYLYKNVLNLIPK--SV 87 (1142)
Q Consensus 15 ~~~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~-L~~-~~p~~~~~l---~~L~~L~~L~Ls~N~Lt~iP~--~l 87 (1142)
.-+.++.|.+..|++.+..+..|.++++|++|+|++|+ |++ .+|..++.+ ..+++|++|+|++|.|+.||. .|
T Consensus 247 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~~ip~~~~l 326 (636)
T 4eco_A 247 NLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSL 326 (636)
T ss_dssp GCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCSSCCCHHHH
T ss_pred ccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCCccCchhhh
Confidence 44578899999999999888999999999999999998 998 777766542 233678888888888888887 78
Q ss_pred cCCcCCcEEEccCCCCC-cCchhhcCCCCCCEEEccCCCCCCCcccccCCCC-CCEEECCCCCCCCCcccchhhhcCCC-
Q 001142 88 GRYEKLRNLKFFGNEIN-LFPSEVGNLLGLECLQIKISSPGVNGFALNKLKG-LKELELSKVPPRPSVLTLLSEIAGLK- 164 (1142)
Q Consensus 88 ~~L~~L~~L~Ls~N~L~-~lP~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~-L~~L~Ls~n~~n~~~~~lp~~l~~L~- 164 (1142)
+++++|++|+|++|+|+ .+| .++++++|+.|+|++|.+..+|..+..+++ |++|++++|.+. .+|..+..+.
T Consensus 327 ~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~~L~~L~Ls~N~l~----~lp~~~~~~~l 401 (636)
T 4eco_A 327 QKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK----YIPNIFDAKSV 401 (636)
T ss_dssp TTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEEECCTTSEEECTTCCEEECCSSCCS----SCCSCCCTTCS
T ss_pred ccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccccccHhhhhhcccCcEEEccCCcCc----ccchhhhhccc
Confidence 88888888888888887 777 677777777777777776666666777777 777777775443 3444443332
Q ss_pred -CCcEEEccCCCCC-ccCcccC-------CCCCCCEEEccCCCCCccchhhc-CCCCCCEEEccCCCCCccCccccCCC-
Q 001142 165 -CLTKLSVCHFSIR-YLPPEIG-------CLSNLEQLDLSFNKMKYLPTEIC-YLKALISLKVANNKLVELPSGLYLLQ- 233 (1142)
Q Consensus 165 -~L~~L~Ls~N~L~-~IP~~l~-------~L~~L~~L~Ls~N~L~~lP~~l~-~L~~L~~L~Ls~N~Ls~IP~~l~~L~- 233 (1142)
+|+.|++++|.++ .+|..|. .+++|+.|+|++|+|+.+|..+. .+++|+.|+|++|+|+.||..+....
T Consensus 402 ~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~ 481 (636)
T 4eco_A 402 SVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDEN 481 (636)
T ss_dssp SCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETT
T ss_pred CccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhcccc
Confidence 4555555555554 2344444 44455555555555554444332 24445555555554444444333211
Q ss_pred -------CCCEEeCcCCcCCCCCccccc--CCCCCCEEEccCCCCCC
Q 001142 234 -------RLENLDLSNNRLTSLGSLDLC--LMHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 234 -------~L~~L~Ls~N~Ls~~~p~~l~--~L~~L~~L~Ls~N~L~~ 271 (1142)
+|+.|+|++|+|+.+++ .+. .+++|+.|+|++|++++
T Consensus 482 ~~~~~l~~L~~L~Ls~N~l~~lp~-~~~~~~l~~L~~L~Ls~N~l~~ 527 (636)
T 4eco_A 482 ENFKNTYLLTSIDLRFNKLTKLSD-DFRATTLPYLVGIDLSYNSFSK 527 (636)
T ss_dssp EECTTGGGCCEEECCSSCCCBCCG-GGSTTTCTTCCEEECCSSCCSS
T ss_pred ccccccCCccEEECcCCcCCccCh-hhhhccCCCcCEEECCCCCCCC
Confidence 44444444444443322 332 44444444444444443
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.5e-28 Score=298.94 Aligned_cols=240 Identities=17% Similarity=0.143 Sum_probs=146.1
Q ss_pred CCCcccccCCCCC-Ccc-cCCCCCCCC------CCCCEEEccCCCCCCCCcc--cccCCCCCCCccEEEeecCCCC-ccC
Q 001142 16 GPIKEKLPSEANK-INN-EKNGSVNDD------DDDSVIDVSGKTVDFPLIE--SYGNRGGDNSVEGLYLYKNVLN-LIP 84 (1142)
Q Consensus 16 ~~~l~~L~~~~N~-i~~-l~~~~f~~l------~~L~~LdLs~N~L~~~~p~--~~~~l~~L~~L~~L~Ls~N~Lt-~iP 84 (1142)
-+.++.|.+..|+ |++ ..+..+..+ ++|++|+|++|+|+ .+|. .++.+ ++|++|+|++|.++ .+|
T Consensus 272 l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l---~~L~~L~L~~N~l~g~ip 347 (636)
T 4eco_A 272 LPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKM---KKLGMLECLYNQLEGKLP 347 (636)
T ss_dssp CSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTC---TTCCEEECCSCCCEEECC
T ss_pred CCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccC---CCCCEEeCcCCcCccchh
Confidence 3466667777776 665 333344433 66777777777776 4454 45433 66777777777776 666
Q ss_pred ccccCCcCCcEEEccCCCCCcCchhhcCCCC-CCEEEccCCCCCCCcccccCCC--CCCEEECCCCCCCCCcccchhhhc
Q 001142 85 KSVGRYEKLRNLKFFGNEINLFPSEVGNLLG-LECLQIKISSPGVNGFALNKLK--GLKELELSKVPPRPSVLTLLSEIA 161 (1142)
Q Consensus 85 ~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~-L~~L~Ls~N~l~~~~~~~~~L~--~L~~L~Ls~n~~n~~~~~lp~~l~ 161 (1142)
.|..+++|++|+|++|+|+.+|..++++++ |+.|+|++|.+..+|..+..+. +|++|++++|.+ .+.+|..|.
T Consensus 348 -~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~~L~~L~Ls~N~l~~lp~~~~~~~l~~L~~L~Ls~N~l---~~~~p~~l~ 423 (636)
T 4eco_A 348 -AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEI---GSVDGKNFD 423 (636)
T ss_dssp -CCEEEEEESEEECCSSEEEECCTTSEEECTTCCEEECCSSCCSSCCSCCCTTCSSCEEEEECCSSCT---TTTTTCSSC
T ss_pred -hhCCCCCCCEEECCCCccccccHhhhhhcccCcEEEccCCcCcccchhhhhcccCccCEEECcCCcC---CCcchhhhc
Confidence 666666777777777777666666666666 7777777776666665555543 666666666433 233344444
Q ss_pred -------CCCCCcEEEccCCCCCccCccc-CCCCCCCEEEccCCCCCccchhhcC-C-------CCCCEEEccCCCCCcc
Q 001142 162 -------GLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEICY-L-------KALISLKVANNKLVEL 225 (1142)
Q Consensus 162 -------~L~~L~~L~Ls~N~L~~IP~~l-~~L~~L~~L~Ls~N~L~~lP~~l~~-L-------~~L~~L~Ls~N~Ls~I 225 (1142)
.+++|+.|+|++|.|+.+|..+ ..+++|+.|+|++|+|+.+|..+.. + ++|+.|+|++|+|+.|
T Consensus 424 ~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l 503 (636)
T 4eco_A 424 PLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKL 503 (636)
T ss_dssp TTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCCBC
T ss_pred ccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCCcCCcc
Confidence 5556666666666666665543 3466666666666666666544332 1 1566666666666666
Q ss_pred Ccccc--CCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEc
Q 001142 226 PSGLY--LLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNL 264 (1142)
Q Consensus 226 P~~l~--~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~L 264 (1142)
|..++ .+++|+.|+|++|+|++ +|..+..+++|+.|+|
T Consensus 504 p~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~L 543 (636)
T 4eco_A 504 SDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGI 543 (636)
T ss_dssp CGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEEC
T ss_pred ChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEEC
Confidence 66665 56666666666666666 3445556666666666
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-26 Score=262.82 Aligned_cols=242 Identities=19% Similarity=0.230 Sum_probs=212.9
Q ss_pred CcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCcc-CccccCCcCCcEE
Q 001142 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLI-PKSVGRYEKLRNL 96 (1142)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~i-P~~l~~L~~L~~L 96 (1142)
.+..+....+.++.++.... ++|++|+|++|+|++..+..|+. +++|++|+|++|.|+.+ |..|.++++|++|
T Consensus 32 ~l~~l~~~~~~l~~lp~~~~---~~l~~L~L~~n~i~~~~~~~~~~---l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (330)
T 1xku_A 32 HLRVVQCSDLGLEKVPKDLP---PDTALLDLQNNKITEIKDGDFKN---LKNLHTLILINNKISKISPGAFAPLVKLERL 105 (330)
T ss_dssp ETTEEECTTSCCCSCCCSCC---TTCCEEECCSSCCCCBCTTTTTT---CTTCCEEECCSSCCCCBCTTTTTTCTTCCEE
T ss_pred CCeEEEecCCCccccCccCC---CCCeEEECCCCcCCEeChhhhcc---CCCCCEEECCCCcCCeeCHHHhcCCCCCCEE
Confidence 56778888899998875433 68999999999999988766654 49999999999999988 7889999999999
Q ss_pred EccCCCCCcCchhhcCCCCCCEEEccCCCCCCCc-ccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCC
Q 001142 97 KFFGNEINLFPSEVGNLLGLECLQIKISSPGVNG-FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS 175 (1142)
Q Consensus 97 ~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~-~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~ 175 (1142)
+|++|+|+.+|..+. ++|+.|++++|.+..++ ..+..+++|+.|++++|.+.. .+..+..+.++++|+.|++++|.
T Consensus 106 ~Ls~n~l~~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~~~l~~L~~L~l~~n~ 182 (330)
T 1xku_A 106 YLSKNQLKELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKS-SGIENGAFQGMKKLSYIRIADTN 182 (330)
T ss_dssp ECCSSCCSBCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCG-GGBCTTGGGGCTTCCEEECCSSC
T ss_pred ECCCCcCCccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCc-cCcChhhccCCCCcCEEECCCCc
Confidence 999999999998876 89999999999977666 468999999999999976532 33567788999999999999999
Q ss_pred CCccCcccCCCCCCCEEEccCCCCCcc-chhhcCCCCCCEEEccCCCCCccC-ccccCCCCCCEEeCcCCcCCCCCcccc
Q 001142 176 IRYLPPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELP-SGLYLLQRLENLDLSNNRLTSLGSLDL 253 (1142)
Q Consensus 176 L~~IP~~l~~L~~L~~L~Ls~N~L~~l-P~~l~~L~~L~~L~Ls~N~Ls~IP-~~l~~L~~L~~L~Ls~N~Ls~~~p~~l 253 (1142)
++.+|..+. ++|+.|+|++|+|+.+ |..+..+++|+.|+|++|.|+.++ ..+..+++|+.|+|++|+|+.++. .+
T Consensus 183 l~~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~-~l 259 (330)
T 1xku_A 183 ITTIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPG-GL 259 (330)
T ss_dssp CCSCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCT-TT
T ss_pred cccCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCccCCh-hh
Confidence 999998765 8999999999999976 688999999999999999999775 478889999999999999997654 79
Q ss_pred cCCCCCCEEEccCCCCCC
Q 001142 254 CLMHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 254 ~~L~~L~~L~Ls~N~L~~ 271 (1142)
..+++|+.|+|++|+|+.
T Consensus 260 ~~l~~L~~L~l~~N~i~~ 277 (330)
T 1xku_A 260 ADHKYIQVVYLHNNNISA 277 (330)
T ss_dssp TTCSSCCEEECCSSCCCC
T ss_pred ccCCCcCEEECCCCcCCc
Confidence 999999999999999987
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=305.10 Aligned_cols=246 Identities=16% Similarity=0.152 Sum_probs=167.3
Q ss_pred CCCCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCC-CCC-CCcccccCC----CCCCCccEEEeecCCCCccCc--c
Q 001142 15 EGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKT-VDF-PLIESYGNR----GGDNSVEGLYLYKNVLNLIPK--S 86 (1142)
Q Consensus 15 ~~~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~-L~~-~~p~~~~~l----~~L~~L~~L~Ls~N~Lt~iP~--~ 86 (1142)
.-+.|+.|.+..|++.+..+..|.++++|++|+|++|+ |++ .+|..++.+ ..+++|+.|+|++|.|+.||. .
T Consensus 489 ~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~ip~~~~ 568 (876)
T 4ecn_A 489 NLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASAS 568 (876)
T ss_dssp GCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCBCCCHHH
T ss_pred cCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCCccCChhh
Confidence 34578899999999888888999999999999999998 988 777766533 355689999999999999998 8
Q ss_pred ccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCC-CCEEECCCCCCCCCcccchhhhcCCCC
Q 001142 87 VGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKG-LKELELSKVPPRPSVLTLLSEIAGLKC 165 (1142)
Q Consensus 87 l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~-L~~L~Ls~n~~n~~~~~lp~~l~~L~~ 165 (1142)
|.++++|++|+|++|+|+.|| .|+++++|+.|+|++|.+..+|..+..+++ |+.|+|++|.+. .+|..+..++.
T Consensus 569 l~~L~~L~~L~Ls~N~l~~lp-~~~~L~~L~~L~Ls~N~l~~lp~~l~~l~~~L~~L~Ls~N~L~----~lp~~~~~~~~ 643 (876)
T 4ecn_A 569 LQKMVKLGLLDCVHNKVRHLE-AFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLK----YIPNIFNAKSV 643 (876)
T ss_dssp HTTCTTCCEEECTTSCCCBCC-CCCTTSEESEEECCSSCCSCCCTTSCEECTTCCEEECCSSCCC----SCCSCCCTTCS
T ss_pred hhcCCCCCEEECCCCCcccch-hhcCCCcceEEECcCCccccchHHHhhccccCCEEECcCCCCC----cCchhhhcccc
Confidence 999999999999999999888 888899999999999988888888888888 888888886654 34444443332
Q ss_pred --CcEEEccCCCC-----------------------------CccCccc-CCCCCCCEEEccCCCCCccchhhcCCC---
Q 001142 166 --LTKLSVCHFSI-----------------------------RYLPPEI-GCLSNLEQLDLSFNKMKYLPTEICYLK--- 210 (1142)
Q Consensus 166 --L~~L~Ls~N~L-----------------------------~~IP~~l-~~L~~L~~L~Ls~N~L~~lP~~l~~L~--- 210 (1142)
|+.|+|++|+| +.+|..+ ..+++|+.|+|++|+|+.+|..+....
T Consensus 644 ~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~ 723 (876)
T 4ecn_A 644 YVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGN 723 (876)
T ss_dssp SCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTSC
T ss_pred CCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCCccChHHhcccccc
Confidence 45555555554 4444433 244455555555555554444333211
Q ss_pred -----CCCEEEccCCCCCccCcccc--CCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccC
Q 001142 211 -----ALISLKVANNKLVELPSGLY--LLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQY 266 (1142)
Q Consensus 211 -----~L~~L~Ls~N~Ls~IP~~l~--~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~ 266 (1142)
+|+.|+|++|+|+.||..++ .+++|+.|+|++|+|+++ |..+..+++|+.|+|++
T Consensus 724 l~nl~~L~~L~Ls~N~L~~lp~~l~~~~l~~L~~L~Ls~N~L~~l-p~~l~~L~~L~~L~Ls~ 785 (876)
T 4ecn_A 724 YKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSSF-PTQPLNSSQLKAFGIRH 785 (876)
T ss_dssp CTTGGGCCEEECCSSCCCCCCGGGSTTTCTTCCEEECCSSCCSSC-CCGGGGCTTCCEEECCC
T ss_pred ccccCCccEEECCCCCCccchHHhhhccCCCcCEEEeCCCCCCcc-chhhhcCCCCCEEECCC
Confidence 45555555555555555444 455555555555555553 23444555555555543
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-27 Score=302.31 Aligned_cols=262 Identities=17% Similarity=0.207 Sum_probs=191.4
Q ss_pred CCcccccCCCCCCcccCC-CCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcC-Cc
Q 001142 17 PIKEKLPSEANKINNEKN-GSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEK-LR 94 (1142)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~-~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~-L~ 94 (1142)
+.++.|.+..|+|+.++. ..|.++++|++|+|++|+|+ .+| .| +++++|+.|+|++|.|+.+|..|.++++ |+
T Consensus 548 ~~L~~L~Ls~N~L~~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~---~~L~~L~~L~Ls~N~l~~lp~~l~~l~~~L~ 622 (876)
T 4ecn_A 548 PKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLE-AF---GTNVKLTDLKLDYNQIEEIPEDFCAFTDQVE 622 (876)
T ss_dssp TTCCEEECCSSCCCBCCCHHHHTTCTTCCEEECTTSCCC-BCC-CC---CTTSEESEEECCSSCCSCCCTTSCEECTTCC
T ss_pred CCccEEEeeCCcCCccCChhhhhcCCCCCEEECCCCCcc-cch-hh---cCCCcceEEECcCCccccchHHHhhccccCC
Confidence 356666666666664433 25666666666666666666 444 33 3446666666666666666666666666 66
Q ss_pred EEEccCCCCCcCchhhcCCCC--CCEEEccCCCCCCCccc----cc--CCCCCCEEECCCCCCCCCcccchhhh-cCCCC
Q 001142 95 NLKFFGNEINLFPSEVGNLLG--LECLQIKISSPGVNGFA----LN--KLKGLKELELSKVPPRPSVLTLLSEI-AGLKC 165 (1142)
Q Consensus 95 ~L~Ls~N~L~~lP~~l~~L~~--L~~L~Ls~N~l~~~~~~----~~--~L~~L~~L~Ls~n~~n~~~~~lp~~l-~~L~~ 165 (1142)
.|+|++|.|+.+|..+..++. |+.|+|++|.+...... +. .+.+|+.|+|++|.+. .+|..+ ..+++
T Consensus 623 ~L~Ls~N~L~~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~----~lp~~~~~~l~~ 698 (876)
T 4ecn_A 623 GLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ----KFPTELFATGSP 698 (876)
T ss_dssp EEECCSSCCCSCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC----SCCHHHHHTTCC
T ss_pred EEECcCCCCCcCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC----ccCHHHHccCCC
Confidence 667766666666666655443 66666666664432211 11 2346777777775543 456555 48899
Q ss_pred CcEEEccCCCCCccCcccCCC--------CCCCEEEccCCCCCccchhhc--CCCCCCEEEccCCCCCccCccccCCCCC
Q 001142 166 LTKLSVCHFSIRYLPPEIGCL--------SNLEQLDLSFNKMKYLPTEIC--YLKALISLKVANNKLVELPSGLYLLQRL 235 (1142)
Q Consensus 166 L~~L~Ls~N~L~~IP~~l~~L--------~~L~~L~Ls~N~L~~lP~~l~--~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L 235 (1142)
|+.|+|++|+|+.+|..+... ++|+.|+|++|+|+.+|..+. .+++|+.|+|++|+|+.||..++.+++|
T Consensus 699 L~~L~Ls~N~L~~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~~lp~~l~~~~l~~L~~L~Ls~N~L~~lp~~l~~L~~L 778 (876)
T 4ecn_A 699 ISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSSFPTQPLNSSQL 778 (876)
T ss_dssp CSEEECCSCCCSCCCTTSSSCTTSCCTTGGGCCEEECCSSCCCCCCGGGSTTTCTTCCEEECCSSCCSSCCCGGGGCTTC
T ss_pred CCEEECCCCcCCccChHHhccccccccccCCccEEECCCCCCccchHHhhhccCCCcCEEEeCCCCCCccchhhhcCCCC
Confidence 999999999999999876543 389999999999999999998 8999999999999999999999999999
Q ss_pred CEEeCcC------CcCCCCCcccccCCCCCCEEEccCCCCCCCCCCCchhh-----ccCCCCCCCC
Q 001142 236 ENLDLSN------NRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC-----CNLEGNGKDS 290 (1142)
Q Consensus 236 ~~L~Ls~------N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~-----~~l~~n~l~~ 290 (1142)
+.|+|++ |++.+.+|..|..+++|+.|+|++|+|.. ||..+. ++++.|.+..
T Consensus 779 ~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L~~---Ip~~l~~~L~~LdLs~N~l~~ 841 (876)
T 4ecn_A 779 KAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK---VDEKLTPQLYILDIADNPNIS 841 (876)
T ss_dssp CEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCCCB---CCSCCCSSSCEEECCSCTTCE
T ss_pred CEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCCCc---cCHhhcCCCCEEECCCCCCCc
Confidence 9999976 88999999999999999999999999954 776543 4444444433
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.6e-27 Score=290.59 Aligned_cols=246 Identities=19% Similarity=0.169 Sum_probs=182.3
Q ss_pred CCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCcc-ccCCcCCcE
Q 001142 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKS-VGRYEKLRN 95 (1142)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~-l~~L~~L~~ 95 (1142)
+.+..|.+..|+|+.+.+..|.++++|++|+|++|.|++.+|..|+.+ ++|++|+|++|.|+.+|.. |.++++|++
T Consensus 75 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l---~~L~~L~L~~n~l~~l~~~~~~~l~~L~~ 151 (597)
T 3oja_B 75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNV---PLLTVLVLERNDLSSLPRGIFHNTPKLTT 151 (597)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC---TTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred CCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCC---CCCCEEEeeCCCCCCCCHHHhccCCCCCE
Confidence 357777777778887777778888888888888888877777655444 7788888888888777665 577778888
Q ss_pred EEccCCCCCcCc-hhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCC---------------cccchhh
Q 001142 96 LKFFGNEINLFP-SEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPS---------------VLTLLSE 159 (1142)
Q Consensus 96 L~Ls~N~L~~lP-~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~---------------~~~lp~~ 159 (1142)
|+|++|.|+.++ ..|+++++|+.|+|++|.+..++ +..+++|+.|++++|.+... +..+|..
T Consensus 152 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~l~~L~~L~l~~n~l~~l~~~~~L~~L~ls~n~l~~~~~~ 229 (597)
T 3oja_B 152 LSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD--LSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGP 229 (597)
T ss_dssp EECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC--GGGCTTCSEEECCSSCCSEEECCTTCSEEECCSSCCCEEECS
T ss_pred EEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC--hhhhhhhhhhhcccCccccccCCchhheeeccCCcccccccc
Confidence 888888877554 35777788888888777766554 44455555555555433211 0111111
Q ss_pred hcCCCCCcEEEccCCCCCccCcccCCCCCCCEEEccCCCCCcc-chhhcCCCCCCEEEccCCCCCccCccccCCCCCCEE
Q 001142 160 IAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSGLYLLQRLENL 238 (1142)
Q Consensus 160 l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~l-P~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L 238 (1142)
+ .++|+.|+|++|.++.+ ..++.+++|+.|+|++|.|+.+ |..|+.+++|+.|+|++|.|+.+|..+..+++|+.|
T Consensus 230 ~--~~~L~~L~L~~n~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L 306 (597)
T 3oja_B 230 V--NVELTILKLQHNNLTDT-AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVL 306 (597)
T ss_dssp C--CSCCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCEEECSSSCCTTCCEE
T ss_pred c--CCCCCEEECCCCCCCCC-hhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCCCCcccccCCCCcEE
Confidence 1 24677777888877764 5678889999999999999855 788889999999999999999888888888999999
Q ss_pred eCcCCcCCCCCcccccCCCCCCEEEccCCCCCC
Q 001142 239 DLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 239 ~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1142)
+|++|.|+++++ .+..+++|+.|+|++|+|+.
T Consensus 307 ~Ls~N~l~~i~~-~~~~l~~L~~L~L~~N~l~~ 338 (597)
T 3oja_B 307 DLSHNHLLHVER-NQPQFDRLENLYLDHNSIVT 338 (597)
T ss_dssp ECCSSCCCCCGG-GHHHHTTCSEEECCSSCCCC
T ss_pred ECCCCCCCccCc-ccccCCCCCEEECCCCCCCC
Confidence 999999997654 67888999999999999887
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-26 Score=285.87 Aligned_cols=250 Identities=18% Similarity=0.178 Sum_probs=212.8
Q ss_pred CCCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCcc-CccccCCcCCc
Q 001142 16 GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLI-PKSVGRYEKLR 94 (1142)
Q Consensus 16 ~~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~i-P~~l~~L~~L~ 94 (1142)
++.++.|.+..|+|+.+.+..|.++++|++|||++|+|++..|..|+.+ ++|++|+|++|.++.+ |..|.++++|+
T Consensus 32 ~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l---~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 108 (606)
T 3t6q_A 32 PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQ---HRLDTLVLTANPLIFMAETALSGPKALK 108 (606)
T ss_dssp CTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTC---TTCCEEECTTCCCSEECTTTTSSCTTCC
T ss_pred CCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCc---cccCeeeCCCCcccccChhhhccccccc
Confidence 4468999999999999999999999999999999999999888877655 9999999999999977 67899999999
Q ss_pred EEEccCCCCCcC-chhhcCCCCCCEEEccCCCCCCCc-ccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCc--EEE
Q 001142 95 NLKFFGNEINLF-PSEVGNLLGLECLQIKISSPGVNG-FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLT--KLS 170 (1142)
Q Consensus 95 ~L~Ls~N~L~~l-P~~l~~L~~L~~L~Ls~N~l~~~~-~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~--~L~ 170 (1142)
+|+|++|.|+.+ |..++++++|++|+|++|.+..++ ..+..+++|++|++++|.+. ...|..|..+++|+ .|+
T Consensus 109 ~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~---~~~~~~~~~l~~L~~l~L~ 185 (606)
T 3t6q_A 109 HLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIH---YLSKEDMSSLQQATNLSLN 185 (606)
T ss_dssp EEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCC---EECHHHHHTTTTCCSEEEE
T ss_pred EeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCccc---ccChhhhhhhcccceeEEe
Confidence 999999999987 667999999999999999987753 45556999999999996543 44566788888888 899
Q ss_pred ccCCCCCccCcccCCCC----------------------------------------------------CCCEEEccCCC
Q 001142 171 VCHFSIRYLPPEIGCLS----------------------------------------------------NLEQLDLSFNK 198 (1142)
Q Consensus 171 Ls~N~L~~IP~~l~~L~----------------------------------------------------~L~~L~Ls~N~ 198 (1142)
+++|.++.+++...... +|+.|+|++|.
T Consensus 186 l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~ 265 (606)
T 3t6q_A 186 LNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHY 265 (606)
T ss_dssp CTTCCCCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCC
T ss_pred cCCCccCccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCc
Confidence 99999986654322211 57778888888
Q ss_pred CCccch-hhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccCCCCCC
Q 001142 199 MKYLPT-EICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 199 L~~lP~-~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1142)
++.+|. .|..+++|+.|+|++|+++.+|..+..+++|+.|+|++|++++.+|..+..+++|+.|++++|.+.+
T Consensus 266 l~~~~~~~~~~l~~L~~L~l~~n~l~~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~ 339 (606)
T 3t6q_A 266 FFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRL 339 (606)
T ss_dssp CSSCCTTTTTTCTTCSEEECTTSCCSCCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCC
T ss_pred cCccCHHHhccccCCCEEeccCCccCCCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCccc
Confidence 887754 4888889999999999999898888888999999999999998888888888999999999988764
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-27 Score=270.95 Aligned_cols=212 Identities=24% Similarity=0.255 Sum_probs=197.3
Q ss_pred CCccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCC
Q 001142 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKV 147 (1142)
Q Consensus 68 ~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n 147 (1142)
.+++.|+|++|.|+.||..++++++|++|+|++|.|+.+|..++++++|++|+|++|.+..+|..+..+++|++|+|++|
T Consensus 81 ~~l~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~n~l~~lp~~~~~l~~L~~L~Ls~n~l~~lp~~l~~l~~L~~L~L~~n 160 (328)
T 4fcg_A 81 PGRVALELRSVPLPQFPDQAFRLSHLQHMTIDAAGLMELPDTMQQFAGLETLTLARNPLRALPASIASLNRLRELSIRAC 160 (328)
T ss_dssp TTCCEEEEESSCCSSCCSCGGGGTTCSEEEEESSCCCCCCSCGGGGTTCSEEEEESCCCCCCCGGGGGCTTCCEEEEEEE
T ss_pred cceeEEEccCCCchhcChhhhhCCCCCEEECCCCCccchhHHHhccCCCCEEECCCCccccCcHHHhcCcCCCEEECCCC
Confidence 78999999999999999999999999999999999999999999999999999999999999999999999999999994
Q ss_pred CCCCCcccchhhhc---------CCCCCcEEEccCCCCCccCcccCCCCCCCEEEccCCCCCccchhhcCCCCCCEEEcc
Q 001142 148 PPRPSVLTLLSEIA---------GLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVA 218 (1142)
Q Consensus 148 ~~n~~~~~lp~~l~---------~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls 218 (1142)
+..+.+|..+. ++++|+.|+|++|+|+.+|..++.+++|+.|+|++|+|+.+|..++.+++|+.|+|+
T Consensus 161 ---~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L~Ls 237 (328)
T 4fcg_A 161 ---PELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLR 237 (328)
T ss_dssp ---TTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCCCCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTCCEEECT
T ss_pred ---CCccccChhHhhccchhhhccCCCCCEEECcCCCcCcchHhhcCCCCCCEEEccCCCCCcCchhhccCCCCCEEECc
Confidence 44556666654 499999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCC-ccCccccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccCCCCCCCCCCCchhhccCC
Q 001142 219 NNKLV-ELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLE 284 (1142)
Q Consensus 219 ~N~Ls-~IP~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~ 284 (1142)
+|.+. .+|..++.+++|+.|+|++|++.+.+|..+..+++|+.|+|++|++.+ .+|.++.-...
T Consensus 238 ~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~--~iP~~l~~L~~ 302 (328)
T 4fcg_A 238 GCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLS--RLPSLIAQLPA 302 (328)
T ss_dssp TCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCC--CCCGGGGGSCT
T ss_pred CCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchh--hccHHHhhccC
Confidence 99887 889999999999999999999999999999999999999999999988 79988765443
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.9e-27 Score=265.18 Aligned_cols=241 Identities=18% Similarity=0.238 Sum_probs=210.7
Q ss_pred CcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCcc-CccccCCcCCcEE
Q 001142 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLI-PKSVGRYEKLRNL 96 (1142)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~i-P~~l~~L~~L~~L 96 (1142)
.+..+.+..++++.++...+ ++|++|+|++|+|++..|..|+.+ ++|++|+|++|.|+.+ |..|.++++|++|
T Consensus 34 ~l~~l~~~~~~l~~ip~~~~---~~l~~L~l~~n~i~~~~~~~~~~l---~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 107 (332)
T 2ft3_A 34 HLRVVQCSDLGLKAVPKEIS---PDTTLLDLQNNDISELRKDDFKGL---QHLYALVLVNNKISKIHEKAFSPLRKLQKL 107 (332)
T ss_dssp ETTEEECCSSCCSSCCSCCC---TTCCEEECCSSCCCEECTTTTTTC---TTCCEEECCSSCCCEECGGGSTTCTTCCEE
T ss_pred cCCEEECCCCCccccCCCCC---CCCeEEECCCCcCCccCHhHhhCC---CCCcEEECCCCccCccCHhHhhCcCCCCEE
Confidence 47788888999998876543 689999999999998887766544 9999999999999987 6789999999999
Q ss_pred EccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcc-cccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCC
Q 001142 97 KFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGF-ALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS 175 (1142)
Q Consensus 97 ~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~~-~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~ 175 (1142)
+|++|+|+.+|..+. ++|++|+|++|.+..++. .+..+++|+.|++++|.+.. .+..|..+..+ +|+.|++++|+
T Consensus 108 ~L~~n~l~~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~~~l-~L~~L~l~~n~ 183 (332)
T 2ft3_A 108 YISKNHLVEIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLEN-SGFEPGAFDGL-KLNYLRISEAK 183 (332)
T ss_dssp ECCSSCCCSCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBG-GGSCTTSSCSC-CCSCCBCCSSB
T ss_pred ECCCCcCCccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCcccc-CCCCcccccCC-ccCEEECcCCC
Confidence 999999999998876 899999999999887764 58999999999999976532 23556777777 89999999999
Q ss_pred CCccCcccCCCCCCCEEEccCCCCCccc-hhhcCCCCCCEEEccCCCCCccCc-cccCCCCCCEEeCcCCcCCCCCcccc
Q 001142 176 IRYLPPEIGCLSNLEQLDLSFNKMKYLP-TEICYLKALISLKVANNKLVELPS-GLYLLQRLENLDLSNNRLTSLGSLDL 253 (1142)
Q Consensus 176 L~~IP~~l~~L~~L~~L~Ls~N~L~~lP-~~l~~L~~L~~L~Ls~N~Ls~IP~-~l~~L~~L~~L~Ls~N~Ls~~~p~~l 253 (1142)
++.+|..+. ++|+.|+|++|+|+.++ ..+..+++|+.|+|++|+|+.++. .+..+++|+.|+|++|+|+.+++ .+
T Consensus 184 l~~l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~-~l 260 (332)
T 2ft3_A 184 LTGIPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPA-GL 260 (332)
T ss_dssp CSSCCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCCBCCT-TG
T ss_pred CCccCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCeecCh-hh
Confidence 999998765 79999999999999775 789999999999999999997754 78889999999999999997654 79
Q ss_pred cCCCCCCEEEccCCCCCC
Q 001142 254 CLMHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 254 ~~L~~L~~L~Ls~N~L~~ 271 (1142)
..+++|+.|+|++|+++.
T Consensus 261 ~~l~~L~~L~l~~N~l~~ 278 (332)
T 2ft3_A 261 PDLKLLQVVYLHTNNITK 278 (332)
T ss_dssp GGCTTCCEEECCSSCCCB
T ss_pred hcCccCCEEECCCCCCCc
Confidence 999999999999999987
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-27 Score=275.73 Aligned_cols=245 Identities=18% Similarity=0.197 Sum_probs=140.5
Q ss_pred ccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccC-ccccCCcCCcEEEccC
Q 001142 22 LPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIP-KSVGRYEKLRNLKFFG 100 (1142)
Q Consensus 22 L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP-~~l~~L~~L~~L~Ls~ 100 (1142)
.....|+|+.++...+ ++|++|+|++|+|++..+..|+ ++++|++|+|++|.|+.++ ..|.++++|++|+|++
T Consensus 36 c~~~~~~l~~iP~~~~---~~L~~L~l~~n~i~~~~~~~~~---~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 109 (353)
T 2z80_A 36 CKGSSGSLNSIPSGLT---EAVKSLDLSNNRITYISNSDLQ---RCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSY 109 (353)
T ss_dssp EECCSTTCSSCCTTCC---TTCCEEECTTSCCCEECTTTTT---TCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred eeCCCCCccccccccc---ccCcEEECCCCcCcccCHHHhc---cCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCC
Confidence 4444555555544322 2455555555555544443332 2255555555555555442 3455555555555555
Q ss_pred CCCCcCchh-hcCCCCCCEEEccCCCCCCCcc--cccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCC
Q 001142 101 NEINLFPSE-VGNLLGLECLQIKISSPGVNGF--ALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIR 177 (1142)
Q Consensus 101 N~L~~lP~~-l~~L~~L~~L~Ls~N~l~~~~~--~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~ 177 (1142)
|+|+.+|.. |.++++|++|+|++|.+..++. .+..+++|++|++++|. ......+..|.++++|+.|++++|+++
T Consensus 110 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~--~~~~~~~~~~~~l~~L~~L~l~~n~l~ 187 (353)
T 2z80_A 110 NYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMD--TFTKIQRKDFAGLTFLEELEIDASDLQ 187 (353)
T ss_dssp SCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESS--SCCEECTTTTTTCCEEEEEEEEETTCC
T ss_pred CcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCc--cccccCHHHccCCCCCCEEECCCCCcC
Confidence 555555444 4555555555555555444443 45555555555555531 011112334455555555555555555
Q ss_pred cc-CcccCCCCCCCEEEccCCCCCccchhh-cCCCCCCEEEccCCCCCc-------------------------------
Q 001142 178 YL-PPEIGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVE------------------------------- 224 (1142)
Q Consensus 178 ~I-P~~l~~L~~L~~L~Ls~N~L~~lP~~l-~~L~~L~~L~Ls~N~Ls~------------------------------- 224 (1142)
.+ |..+..+++|++|+|++|+++.+|..+ ..+++|+.|+|++|.++.
T Consensus 188 ~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~ 267 (353)
T 2z80_A 188 SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF 267 (353)
T ss_dssp EECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHH
T ss_pred ccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchh
Confidence 33 445555555555555555555554332 234555555555555543
Q ss_pred -cCccccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccCCCCCCCCC
Q 001142 225 -LPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQ 274 (1142)
Q Consensus 225 -IP~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~~~~ 274 (1142)
+|..+..+++|+.|+|++|+|+.+++..|..+++|+.|+|++|+|.|.|+
T Consensus 268 ~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 268 QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp HHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred hhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 56678889999999999999998887667999999999999999999553
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.5e-27 Score=284.36 Aligned_cols=126 Identities=20% Similarity=0.168 Sum_probs=107.7
Q ss_pred CCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEE
Q 001142 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNL 96 (1142)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L 96 (1142)
+.++.|.+..|+|+.+.+..|.++++|++|+|++|+|++..|..|+.+ ++|++|+|++|.|+.||.. .+++|++|
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l---~~L~~L~Ls~N~l~~lp~~--~l~~L~~L 126 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFN---QDLEYLDVSHNRLQNISCC--PMASLRHL 126 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTC---TTCCEEECTTSCCCEECSC--CCTTCSEE
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCC---CCCCEEECCCCcCCccCcc--ccccCCEE
Confidence 579999999999999999999999999999999999999888776544 9999999999999999987 89999999
Q ss_pred EccCCCCCcC--chhhcCCCCCCEEEccCCCCCCCcccccCCCCC--CEEECCCCCC
Q 001142 97 KFFGNEINLF--PSEVGNLLGLECLQIKISSPGVNGFALNKLKGL--KELELSKVPP 149 (1142)
Q Consensus 97 ~Ls~N~L~~l--P~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L--~~L~Ls~n~~ 149 (1142)
+|++|+|+.+ |..|+++++|++|+|++|.+.. ..+..+++| +.|++++|.+
T Consensus 127 ~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~--~~~~~l~~L~L~~L~L~~n~l 181 (562)
T 3a79_B 127 DLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ--LDLLPVAHLHLSCILLDLVSY 181 (562)
T ss_dssp ECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCT--TTTGGGTTSCEEEEEEEESSC
T ss_pred ECCCCCccccCchHhhcccCcccEEecCCCcccc--CchhhhhhceeeEEEeecccc
Confidence 9999999876 4789999999999999998664 235555555 7777777654
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5e-27 Score=283.45 Aligned_cols=126 Identities=17% Similarity=0.112 Sum_probs=107.1
Q ss_pred CCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEE
Q 001142 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNL 96 (1142)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L 96 (1142)
+.++.|.+..|+|+.+.+..|.++++|++|+|++|+|++..|..|+.+ ++|++|+|++|.|+.||.. .+++|++|
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l---~~L~~L~Ls~N~l~~lp~~--~l~~L~~L 95 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFN---QELEYLDLSHNKLVKISCH--PTVNLKHL 95 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTC---TTCCEEECCSSCCCEEECC--CCCCCSEE
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcc---cCCCEEecCCCceeecCcc--ccCCccEE
Confidence 689999999999999998999999999999999999999888877655 9999999999999999887 89999999
Q ss_pred EccCCCCCc--CchhhcCCCCCCEEEccCCCCCCCcccccCCCCC--CEEECCCCCC
Q 001142 97 KFFGNEINL--FPSEVGNLLGLECLQIKISSPGVNGFALNKLKGL--KELELSKVPP 149 (1142)
Q Consensus 97 ~Ls~N~L~~--lP~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L--~~L~Ls~n~~ 149 (1142)
+|++|+|+. +|..|+++++|++|+|++|.+.. ..+..+++| +.|++++|.+
T Consensus 96 ~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~--~~~~~l~~L~L~~L~l~~n~l 150 (520)
T 2z7x_B 96 DLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK--SSVLPIAHLNISKVLLVLGET 150 (520)
T ss_dssp ECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG--GGGGGGTTSCEEEEEEEECTT
T ss_pred eccCCccccccchhhhccCCcceEEEecCcccch--hhccccccceeeEEEeecccc
Confidence 999999985 57899999999999999988653 334555555 5555555443
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.8e-27 Score=282.87 Aligned_cols=82 Identities=16% Similarity=0.111 Sum_probs=60.2
Q ss_pred CCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCc--cCccccCCcCCc
Q 001142 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNL--IPKSVGRYEKLR 94 (1142)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~--iP~~l~~L~~L~ 94 (1142)
+.++.|.+..|+|+.+.+..|.++++|++|||++|+|+. +|.. .+++|++|+|++|.|+. +|..|+++++|+
T Consensus 45 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~-----~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~ 118 (520)
T 2z7x_B 45 SKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVK-ISCH-----PTVNLKHLDLSFNAFDALPICKEFGNMSQLK 118 (520)
T ss_dssp TTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCE-EECC-----CCCCCSEEECCSSCCSSCCCCGGGGGCTTCC
T ss_pred ccccEEecCCCccCCcChHHhhcccCCCEEecCCCceee-cCcc-----ccCCccEEeccCCccccccchhhhccCCcce
Confidence 467888888888888877888888888888888888874 3332 34777777777777775 456777777777
Q ss_pred EEEccCCCCC
Q 001142 95 NLKFFGNEIN 104 (1142)
Q Consensus 95 ~L~Ls~N~L~ 104 (1142)
+|+|++|.|+
T Consensus 119 ~L~L~~n~l~ 128 (520)
T 2z7x_B 119 FLGLSTTHLE 128 (520)
T ss_dssp EEEEEESSCC
T ss_pred EEEecCcccc
Confidence 7777776653
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.9e-27 Score=272.85 Aligned_cols=265 Identities=18% Similarity=0.186 Sum_probs=216.9
Q ss_pred CCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccC-ccccCCcCCcE
Q 001142 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIP-KSVGRYEKLRN 95 (1142)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP-~~l~~L~~L~~ 95 (1142)
+.+..+.+..|.|+.++...|..+++|++|+|++|.|++..+..|+. +++|++|+|++|.++.+| ..|.++++|++
T Consensus 45 ~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~---l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 121 (390)
T 3o6n_A 45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAY---AHTIQKLYMGFNAIRYLPPHVFQNVPLLTV 121 (390)
T ss_dssp CCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTT---CTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred CCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccC---CCCcCEEECCCCCCCcCCHHHhcCCCCCCE
Confidence 46788889999999999988999999999999999999888776654 499999999999999885 46899999999
Q ss_pred EEccCCCCCcCchh-hcCCCCCCEEEccCCCCCCCc-ccccCCCCCCEEECCCCCCCCCcccchhh-------------h
Q 001142 96 LKFFGNEINLFPSE-VGNLLGLECLQIKISSPGVNG-FALNKLKGLKELELSKVPPRPSVLTLLSE-------------I 160 (1142)
Q Consensus 96 L~Ls~N~L~~lP~~-l~~L~~L~~L~Ls~N~l~~~~-~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~-------------l 160 (1142)
|+|++|.|+.+|.. |.++++|++|+|++|.+..++ ..+..+++|++|++++|.+.......... +
T Consensus 122 L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n~l~~~ 201 (390)
T 3o6n_A 122 LVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTL 201 (390)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCGGGCTTCSEEECCSSCCSEE
T ss_pred EECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccccccccccceeeccccccccc
Confidence 99999999999887 588999999999999976654 56999999999999998765432111100 1
Q ss_pred cCCCCCcEEEccCCCCCccCcccCCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCcc-CccccCCCCCCEEe
Q 001142 161 AGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVEL-PSGLYLLQRLENLD 239 (1142)
Q Consensus 161 ~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~I-P~~l~~L~~L~~L~ 239 (1142)
....+|+.|++++|.++.+|.. .+++|+.|+|++|+|+.+ ..+..+++|+.|+|++|.|+.+ |..+..+++|+.|+
T Consensus 202 ~~~~~L~~L~l~~n~l~~~~~~--~~~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 278 (390)
T 3o6n_A 202 AIPIAVEELDASHNSINVVRGP--VNVELTILKLQHNNLTDT-AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLY 278 (390)
T ss_dssp ECCSSCSEEECCSSCCCEEECC--CCSSCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEE
T ss_pred CCCCcceEEECCCCeeeecccc--ccccccEEECCCCCCccc-HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEE
Confidence 2224466666666666666543 347899999999999987 4789999999999999999955 88899999999999
Q ss_pred CcCCcCCCCCcccccCCCCCCEEEccCCCCCCCCCCCchhh-------ccCCCCCCCCC
Q 001142 240 LSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC-------CNLEGNGKDSS 291 (1142)
Q Consensus 240 Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~-------~~l~~n~l~~~ 291 (1142)
|++|+|++++. .+..+++|+.|+|++|+++. +|..+. +.++.|.+...
T Consensus 279 L~~n~l~~~~~-~~~~l~~L~~L~L~~n~l~~---~~~~~~~l~~L~~L~L~~N~i~~~ 333 (390)
T 3o6n_A 279 ISNNRLVALNL-YGQPIPTLKVLDLSHNHLLH---VERNQPQFDRLENLYLDHNSIVTL 333 (390)
T ss_dssp CCSSCCCEEEC-SSSCCTTCCEEECCSSCCCC---CGGGHHHHTTCSEEECCSSCCCCC
T ss_pred CCCCcCcccCc-ccCCCCCCCEEECCCCccee---cCccccccCcCCEEECCCCcccee
Confidence 99999999754 67889999999999999986 665544 45555555443
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.7e-27 Score=284.27 Aligned_cols=83 Identities=20% Similarity=0.117 Sum_probs=70.7
Q ss_pred CCCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccC--ccccCCcCC
Q 001142 16 GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIP--KSVGRYEKL 93 (1142)
Q Consensus 16 ~~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP--~~l~~L~~L 93 (1142)
-+.++.|.+..|+|+.+.+..|.++++|++|||++|+|+.. |.. .+++|++|+|++|.|+.+| ..|.++++|
T Consensus 75 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l-p~~-----~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L 148 (562)
T 3a79_B 75 LSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNI-SCC-----PMASLRHLDLSFNDFDVLPVCKEFGNLTKL 148 (562)
T ss_dssp CTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCEE-CSC-----CCTTCSEEECCSSCCSBCCCCGGGGGCTTC
T ss_pred CCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCcc-Ccc-----ccccCCEEECCCCCccccCchHhhcccCcc
Confidence 34889999999999999999999999999999999999854 432 4589999999999998764 678888889
Q ss_pred cEEEccCCCCC
Q 001142 94 RNLKFFGNEIN 104 (1142)
Q Consensus 94 ~~L~Ls~N~L~ 104 (1142)
++|+|++|+|+
T Consensus 149 ~~L~L~~n~l~ 159 (562)
T 3a79_B 149 TFLGLSAAKFR 159 (562)
T ss_dssp CEEEEECSBCC
T ss_pred cEEecCCCccc
Confidence 88888888765
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=284.83 Aligned_cols=252 Identities=17% Similarity=0.189 Sum_probs=175.1
Q ss_pred CCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCcc-CccccCCcCCcE
Q 001142 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLI-PKSVGRYEKLRN 95 (1142)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~i-P~~l~~L~~L~~ 95 (1142)
+.+..|.+..|+|+.+.+..|.++++|++|||++|+|++..|..|+.+ ++|++|+|++|.|+.+ |..|.++++|++
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l---~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 108 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGL---HHLSNLILTGNPIQSFSPGSFSGLTSLEN 108 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTC---TTCCEEECTTCCCCCCCTTSSTTCTTCCE
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhch---hhcCEeECCCCcccccChhhcCCcccCCE
Confidence 467778888888888887788888888888888888887777665444 7888888888888766 667788888888
Q ss_pred EEccCCCCCcCc-hhhcCCCCCCEEEccCCCCCC--CcccccCCCCCCEEECCCCCCCCCccc-----------------
Q 001142 96 LKFFGNEINLFP-SEVGNLLGLECLQIKISSPGV--NGFALNKLKGLKELELSKVPPRPSVLT----------------- 155 (1142)
Q Consensus 96 L~Ls~N~L~~lP-~~l~~L~~L~~L~Ls~N~l~~--~~~~~~~L~~L~~L~Ls~n~~n~~~~~----------------- 155 (1142)
|+|++|.|+.+| ..++++++|++|+|++|.+.. +|..+..+++|++|++++|.+......
T Consensus 109 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l 188 (606)
T 3vq2_A 109 LVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDM 188 (606)
T ss_dssp EECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEEC
T ss_pred EEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeec
Confidence 888888887665 557778888888888877653 567777788888777777654321100
Q ss_pred -------chh----------------------------------------------------------------------
Q 001142 156 -------LLS---------------------------------------------------------------------- 158 (1142)
Q Consensus 156 -------lp~---------------------------------------------------------------------- 158 (1142)
++.
T Consensus 189 ~~n~l~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l 268 (606)
T 3vq2_A 189 SLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRL 268 (606)
T ss_dssp TTCCCCEECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEE
T ss_pred cCCCcceeCcccccCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheec
Confidence 000
Q ss_pred ---------------------------------hhcCCCCCcEEEccCCCCCccCc--------------------ccCC
Q 001142 159 ---------------------------------EIAGLKCLTKLSVCHFSIRYLPP--------------------EIGC 185 (1142)
Q Consensus 159 ---------------------------------~l~~L~~L~~L~Ls~N~L~~IP~--------------------~l~~ 185 (1142)
.+..+++|+.|++++|.++.+|. .+..
T Consensus 269 ~~~~~~~~~~~~~~~l~~L~~L~l~~~~~~~l~~l~~~~~L~~L~l~~n~l~~lp~~~l~~L~~L~l~~n~~~~~~~~~~ 348 (606)
T 3vq2_A 269 TYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVA 348 (606)
T ss_dssp CCCTTCCGGGGSCGGGTTCSEEEEESCCCCCCCCCCTTCCCSEEEEESCCCSSCCCCCCSSCCEEEEESCSSCEECCCCC
T ss_pred cccccccccccccccCCCCCEEEecCccchhhhhccccccCCEEEcccccCcccccCCCCccceeeccCCcCccchhhcc
Confidence 12223344455555555444441 1334
Q ss_pred CCCCCEEEccCCCCCcc---chhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeCcCCcCCCCCc-ccccCCCCCCE
Q 001142 186 LSNLEQLDLSFNKMKYL---PTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGS-LDLCLMHNLQN 261 (1142)
Q Consensus 186 L~~L~~L~Ls~N~L~~l---P~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls~N~Ls~~~p-~~l~~L~~L~~ 261 (1142)
+++|++|+|++|+++.+ |..+..+++|+.|+|++|.++.+|..+..+++|+.|+|++|++++.+| ..+..+++|+.
T Consensus 349 l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~ 428 (606)
T 3vq2_A 349 LPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLY 428 (606)
T ss_dssp CTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEEECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCE
T ss_pred CCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccccchhhccCCCCCCeeECCCCccCCccChhhhhccccCCE
Confidence 56677777777777644 677777778888888888777777777777777777777777777766 56777777777
Q ss_pred EEccCCCCCC
Q 001142 262 LNLQYNKLLS 271 (1142)
Q Consensus 262 L~Ls~N~L~~ 271 (1142)
|++++|++++
T Consensus 429 L~l~~n~l~~ 438 (606)
T 3vq2_A 429 LDISYTNTKI 438 (606)
T ss_dssp EECTTSCCEE
T ss_pred EECcCCCCCc
Confidence 7777777765
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7e-27 Score=287.28 Aligned_cols=247 Identities=20% Similarity=0.189 Sum_probs=163.2
Q ss_pred CCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCC-ccCc-cccCCcCCc
Q 001142 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLN-LIPK-SVGRYEKLR 94 (1142)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt-~iP~-~l~~L~~L~ 94 (1142)
+.++.|.+..|+|+.++. .|.++++|++|+|++|.+++..|..++.+ ++|++|+|++|.++ .+|. .+..+++|+
T Consensus 278 ~~L~~L~l~~n~l~~lp~-~l~~l~~L~~L~l~~n~l~~~~~~~~~~l---~~L~~L~l~~n~~~~~~~~~~~~~l~~L~ 353 (606)
T 3t6q_A 278 SGLQELDLTATHLSELPS-GLVGLSTLKKLVLSANKFENLCQISASNF---PSLTHLSIKGNTKRLELGTGCLENLENLR 353 (606)
T ss_dssp TTCSEEECTTSCCSCCCS-SCCSCTTCCEEECTTCCCSBGGGGCGGGC---TTCSEEECCSCSSCCBCCSSTTTTCTTCC
T ss_pred cCCCEEeccCCccCCCCh-hhcccccCCEEECccCCcCcCchhhhhcc---CcCCEEECCCCCcccccchhhhhccCcCC
Confidence 477888888888886643 57778888888888888887777666544 77777777777766 5654 367777777
Q ss_pred EEEccCCCCCcC---chhhcCCCCCCEEEccCCCCCC-CcccccCCCCCCEEECCCCCCCCCcccch-hhhcCCCCCcEE
Q 001142 95 NLKFFGNEINLF---PSEVGNLLGLECLQIKISSPGV-NGFALNKLKGLKELELSKVPPRPSVLTLL-SEIAGLKCLTKL 169 (1142)
Q Consensus 95 ~L~Ls~N~L~~l---P~~l~~L~~L~~L~Ls~N~l~~-~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp-~~l~~L~~L~~L 169 (1142)
+|+|++|.++.+ |..+.++++|+.|+|++|.+.. .+..+..+++|++|++++|.+. ...| ..+.++++|+.|
T Consensus 354 ~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~---~~~~~~~~~~l~~L~~L 430 (606)
T 3t6q_A 354 ELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLK---VKDAQSPFQNLHLLKVL 430 (606)
T ss_dssp EEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEE---CCTTCCTTTTCTTCCEE
T ss_pred EEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCC---CcccchhhhCcccCCEE
Confidence 777777777644 4556777777777777776443 3456666777777777764432 2222 235666666677
Q ss_pred EccCCCCCcc-CcccCCCCCCCEEEccCCCCCc--cc--hhhcCCCCCCEEEccCCCCCcc-CccccCCCCCCEEeCcCC
Q 001142 170 SVCHFSIRYL-PPEIGCLSNLEQLDLSFNKMKY--LP--TEICYLKALISLKVANNKLVEL-PSGLYLLQRLENLDLSNN 243 (1142)
Q Consensus 170 ~Ls~N~L~~I-P~~l~~L~~L~~L~Ls~N~L~~--lP--~~l~~L~~L~~L~Ls~N~Ls~I-P~~l~~L~~L~~L~Ls~N 243 (1142)
++++|.++.+ |..+..+++|++|+|++|+|+. +| ..+..+++|+.|+|++|+++.+ |..+..+++|+.|+|++|
T Consensus 431 ~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 510 (606)
T 3t6q_A 431 NLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHN 510 (606)
T ss_dssp ECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred ECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCC
Confidence 7777666643 4456666666666666666653 22 4466666666666666666644 455666666666666666
Q ss_pred cCCCCCcccccCCCCCCEEEccCCCCCC
Q 001142 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 244 ~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1142)
+|++.+|..+..++.| .|+|++|++++
T Consensus 511 ~l~~~~~~~l~~l~~L-~L~L~~N~l~~ 537 (606)
T 3t6q_A 511 RLTSSSIEALSHLKGI-YLNLASNHISI 537 (606)
T ss_dssp CCCGGGGGGGTTCCSC-EEECCSSCCCC
T ss_pred ccCcCChhHhCccccc-EEECcCCcccc
Confidence 6666666666666666 66666666665
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-26 Score=257.16 Aligned_cols=230 Identities=21% Similarity=0.220 Sum_probs=188.0
Q ss_pred CEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCcCCcEEEccCCCCCcC-chhhcCCCCCCEEEc
Q 001142 44 SVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLRNLKFFGNEINLF-PSEVGNLLGLECLQI 121 (1142)
Q Consensus 44 ~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~-~l~~L~~L~~L~Ls~N~L~~l-P~~l~~L~~L~~L~L 121 (1142)
+++++++++++.++.. + .++|++|+|++|.|+.+|. .|..+++|++|+|++|.|+.+ |..|.++++|++|+|
T Consensus 14 ~~~~c~~~~l~~ip~~-~-----~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 87 (285)
T 1ozn_A 14 VTTSCPQQGLQAVPVG-I-----PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDL 87 (285)
T ss_dssp CEEECCSSCCSSCCTT-C-----CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred eEEEcCcCCcccCCcC-C-----CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeC
Confidence 5778888877765432 1 2577888888888887753 577788888888888888766 666777888888888
Q ss_pred cCCC-CCCC-cccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCc-ccCCCCCCCEEEccCCC
Q 001142 122 KISS-PGVN-GFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFNK 198 (1142)
Q Consensus 122 s~N~-l~~~-~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~Ls~N~ 198 (1142)
++|. +..+ +..+..+++|++|++++|.+. ...|..|.++++|+.|++++|+++.+|. .|..+++|+.|+|++|+
T Consensus 88 ~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~---~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 164 (285)
T 1ozn_A 88 SDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ---ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNR 164 (285)
T ss_dssp CSCTTCCCCCTTTTTTCTTCCEEECTTSCCC---CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CCCCCccccCHHHhcCCcCCCEEECCCCcCC---EECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCc
Confidence 8886 6655 566778888888888885543 3345678889999999999999998876 47899999999999999
Q ss_pred CCccch-hhcCCCCCCEEEccCCCCCcc-CccccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccCCCCCCCCCCC
Q 001142 199 MKYLPT-EICYLKALISLKVANNKLVEL-PSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVP 276 (1142)
Q Consensus 199 L~~lP~-~l~~L~~L~~L~Ls~N~Ls~I-P~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP 276 (1142)
|+.+|. .+..+++|+.|+|++|.|+.+ |..+..+++|+.|+|++|+|+++++..+..+++|+.|+|++|+|.|.|++.
T Consensus 165 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~ 244 (285)
T 1ozn_A 165 ISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR 244 (285)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH
T ss_pred ccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH
Confidence 998875 588999999999999999965 888999999999999999999999888999999999999999999988776
Q ss_pred chhhcc
Q 001142 277 SWICCN 282 (1142)
Q Consensus 277 ~~~~~~ 282 (1142)
+...|.
T Consensus 245 ~~~~~l 250 (285)
T 1ozn_A 245 PLWAWL 250 (285)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 554443
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=8.3e-27 Score=287.33 Aligned_cols=265 Identities=19% Similarity=0.192 Sum_probs=215.9
Q ss_pred CcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCcCCcEE
Q 001142 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLRNL 96 (1142)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~-~l~~L~~L~~L 96 (1142)
.+..+.+..|.++.+++..|.++++|++|+|++|.|++.+|..|+.+ ++|++|+|++|.|+.+|+ .|+++++|++|
T Consensus 52 ~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l---~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 128 (597)
T 3oja_B 52 NQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYA---HTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 128 (597)
T ss_dssp CCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTC---TTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCC---CCCCEEECCCCcCCCCCHHHHcCCCCCCEE
Confidence 46777888999999999899999999999999999999888766544 999999999999998865 57999999999
Q ss_pred EccCCCCCcCchh-hcCCCCCCEEEccCCCCCCCc-ccccCCCCCCEEECCCCCCCCCcccch-------------hhhc
Q 001142 97 KFFGNEINLFPSE-VGNLLGLECLQIKISSPGVNG-FALNKLKGLKELELSKVPPRPSVLTLL-------------SEIA 161 (1142)
Q Consensus 97 ~Ls~N~L~~lP~~-l~~L~~L~~L~Ls~N~l~~~~-~~~~~L~~L~~L~Ls~n~~n~~~~~lp-------------~~l~ 161 (1142)
+|++|.|+.+|.. |+++++|++|+|++|.+..++ ..|..+++|++|+|++|.+........ ..+.
T Consensus 129 ~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n~l~~l~ 208 (597)
T 3oja_B 129 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLA 208 (597)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGCTTCSEEECCSSCCSEEE
T ss_pred EeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChhhhhhhhhhhcccCcccccc
Confidence 9999999999887 589999999999999976654 579999999999999987654321110 0112
Q ss_pred CCCCCcEEEccCCCCCccCcccCCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCcc-CccccCCCCCCEEeC
Q 001142 162 GLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVEL-PSGLYLLQRLENLDL 240 (1142)
Q Consensus 162 ~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~I-P~~l~~L~~L~~L~L 240 (1142)
...+|+.|++++|.++.+|..+ .++|+.|+|++|.|+.+ ..++.+++|+.|+|++|.|+.+ |..++.+++|+.|+|
T Consensus 209 ~~~~L~~L~ls~n~l~~~~~~~--~~~L~~L~L~~n~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 285 (597)
T 3oja_B 209 IPIAVEELDASHNSINVVRGPV--NVELTILKLQHNNLTDT-AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYI 285 (597)
T ss_dssp CCTTCSEEECCSSCCCEEECSC--CSCCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEEC
T ss_pred CCchhheeeccCCccccccccc--CCCCCEEECCCCCCCCC-hhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEEC
Confidence 2344566666666666555433 36899999999999875 6789999999999999999955 888999999999999
Q ss_pred cCCcCCCCCcccccCCCCCCEEEccCCCCCCCCCCCchhh-------ccCCCCCCCCCC
Q 001142 241 SNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC-------CNLEGNGKDSSN 292 (1142)
Q Consensus 241 s~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~-------~~l~~n~l~~~~ 292 (1142)
++|+|+++++ .+..+++|+.|+|++|+++. +|..+. ++++.|.+...+
T Consensus 286 s~N~l~~l~~-~~~~l~~L~~L~Ls~N~l~~---i~~~~~~l~~L~~L~L~~N~l~~~~ 340 (597)
T 3oja_B 286 SNNRLVALNL-YGQPIPTLKVLDLSHNHLLH---VERNQPQFDRLENLYLDHNSIVTLK 340 (597)
T ss_dssp TTSCCCEEEC-SSSCCTTCCEEECCSSCCCC---CGGGHHHHTTCSEEECCSSCCCCCC
T ss_pred CCCCCCCCCc-ccccCCCCcEEECCCCCCCc---cCcccccCCCCCEEECCCCCCCCcC
Confidence 9999999754 67889999999999999986 665554 455666655443
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.3e-27 Score=300.40 Aligned_cols=261 Identities=19% Similarity=0.166 Sum_probs=187.0
Q ss_pred CCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCcc-CccccCCcCCcE
Q 001142 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLI-PKSVGRYEKLRN 95 (1142)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~i-P~~l~~L~~L~~ 95 (1142)
+.++.|.+..|+|..+.+..|..+++|++|+|++|+|++..|..|+. +++|++|+|++|.|+.+ |..|..+++|++
T Consensus 266 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~---l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 342 (844)
T 3j0a_A 266 SSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYG---LDNLQVLNLSYNLLGELYSSNFYGLPKVAY 342 (844)
T ss_dssp SCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTT---CSSCCEEEEESCCCSCCCSCSCSSCTTCCE
T ss_pred CCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcC---CCCCCEEECCCCCCCccCHHHhcCCCCCCE
Confidence 47888999999999999999999999999999999999888876654 48999999999999977 668999999999
Q ss_pred EEccCCCCCcCch-hhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcc------------------cc
Q 001142 96 LKFFGNEINLFPS-EVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVL------------------TL 156 (1142)
Q Consensus 96 L~Ls~N~L~~lP~-~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~------------------~l 156 (1142)
|+|++|.|+.++. .|.++++|+.|+|++|.+..++. +++|+.|++++|.+..... ..
T Consensus 343 L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~----~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~ 418 (844)
T 3j0a_A 343 IDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHF----IPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDI 418 (844)
T ss_dssp EECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSS----CCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTT
T ss_pred EECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccC----CCCcchhccCCCCcccccccccccceeecccCccccCch
Confidence 9999999997765 48889999999999988765442 3333333333332221100 00
Q ss_pred hhhhcCCCCCcEEEccCCCCCcc-------------------------------CcccCCCCCCCEEEccCCCCCccc-h
Q 001142 157 LSEIAGLKCLTKLSVCHFSIRYL-------------------------------PPEIGCLSNLEQLDLSFNKMKYLP-T 204 (1142)
Q Consensus 157 p~~l~~L~~L~~L~Ls~N~L~~I-------------------------------P~~l~~L~~L~~L~Ls~N~L~~lP-~ 204 (1142)
+..+.++++|+.|+|++|+++.+ |..|..+++|+.|+|++|+|+.+| .
T Consensus 419 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 498 (844)
T 3j0a_A 419 LYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPG 498 (844)
T ss_dssp HHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTT
T ss_pred hhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChh
Confidence 11223444444444444444432 223556677777777777777654 4
Q ss_pred hhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccCCCCCCCCCCCchhhccCC
Q 001142 205 EICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLE 284 (1142)
Q Consensus 205 ~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~ 284 (1142)
.|..+++|+.|+|++|+|+.+|+.... ++|+.|+|++|+|++.+|..| .+|+.|+|++|++.|.|++.....|...
T Consensus 499 ~~~~l~~L~~L~Ls~N~l~~l~~~~~~-~~L~~L~Ls~N~l~~~~~~~~---~~L~~l~l~~Np~~C~c~~~~f~~~~~~ 574 (844)
T 3j0a_A 499 VFSHLTALRGLSLNSNRLTVLSHNDLP-ANLEILDISRNQLLAPNPDVF---VSLSVLDITHNKFICECELSTFINWLNH 574 (844)
T ss_dssp SSSSCCSCSEEEEESCCCSSCCCCCCC-SCCCEEEEEEECCCCCCSCCC---SSCCEEEEEEECCCCSSSCCSHHHHHHH
T ss_pred HccchhhhheeECCCCCCCccChhhhh-ccccEEECCCCcCCCCChhHh---CCcCEEEecCCCcccccccHHHHHHHHh
Confidence 467788888888888888877665544 678888888888888877554 4778888888888888887776666544
Q ss_pred CCCC
Q 001142 285 GNGK 288 (1142)
Q Consensus 285 ~n~l 288 (1142)
.+..
T Consensus 575 ~~~~ 578 (844)
T 3j0a_A 575 TNVT 578 (844)
T ss_dssp TTTT
T ss_pred cCcc
Confidence 4433
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.4e-26 Score=285.25 Aligned_cols=253 Identities=23% Similarity=0.195 Sum_probs=135.4
Q ss_pred CCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCC--CcccccCCCCCCCccEEEeecCCCCcc-CccccCCcCC
Q 001142 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFP--LIESYGNRGGDNSVEGLYLYKNVLNLI-PKSVGRYEKL 93 (1142)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~--~p~~~~~l~~L~~L~~L~Ls~N~Lt~i-P~~l~~L~~L 93 (1142)
+.++.|.+..|+|+.+.+..|.++++|++|+|++|.++.. ....|..+ ..++|+.|+|++|.++.+ |..|..+++|
T Consensus 329 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~-~~~~L~~L~L~~n~l~~~~~~~~~~l~~L 407 (680)
T 1ziw_A 329 KCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSL-AHSPLHILNLTKNKISKIESDAFSWLGHL 407 (680)
T ss_dssp TTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGG-TTSCCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred CCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhccc-ccCcCceEECCCCCCCeEChhhhhCCCCC
Confidence 4788888888999988888888888888888887764332 11122211 113566666666666654 4456666666
Q ss_pred cEEEccCCCCC-cCc-hhhcCCCCCCEEEccCCCCC-CCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEE
Q 001142 94 RNLKFFGNEIN-LFP-SEVGNLLGLECLQIKISSPG-VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLS 170 (1142)
Q Consensus 94 ~~L~Ls~N~L~-~lP-~~l~~L~~L~~L~Ls~N~l~-~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~ 170 (1142)
++|+|++|.++ .+| ..+.++++|+.|+|++|.+. ..+..|..+++|+.|++++|.+.. .+.+|..|.++++|+.|+
T Consensus 408 ~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~-~~~~p~~~~~l~~L~~L~ 486 (680)
T 1ziw_A 408 EVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKN-VDSSPSPFQPLRNLTILD 486 (680)
T ss_dssp CEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBC-TTCSSCTTTTCTTCCEEE
T ss_pred CEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccc-cccCCcccccCCCCCEEE
Confidence 66666666665 344 34556666666666666532 223344455555555555543321 123444445555555555
Q ss_pred ccCCCCCccCc-ccCCCCCCCEEEccCCCCCccch---------hhcCCCCCCEEEccCCCCCccCcc-ccCCCCCCEEe
Q 001142 171 VCHFSIRYLPP-EIGCLSNLEQLDLSFNKMKYLPT---------EICYLKALISLKVANNKLVELPSG-LYLLQRLENLD 239 (1142)
Q Consensus 171 Ls~N~L~~IP~-~l~~L~~L~~L~Ls~N~L~~lP~---------~l~~L~~L~~L~Ls~N~Ls~IP~~-l~~L~~L~~L~ 239 (1142)
|++|+|+.+|. .|..+++|++|+|++|+|+.++. .+..+++|+.|+|++|+|+.||.. +.++++|+.|+
T Consensus 487 Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~ 566 (680)
T 1ziw_A 487 LSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIID 566 (680)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeE
Confidence 55555554433 24445555555555555443311 134444455555555555444432 33444455555
Q ss_pred CcCCcCCCCCcccccCCCCCCEEEccCCCCCC
Q 001142 240 LSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 240 Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1142)
|++|+|+++++..|..+++|+.|+|++|+|++
T Consensus 567 Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ 598 (680)
T 1ziw_A 567 LGLNNLNTLPASVFNNQVSLKSLNLQKNLITS 598 (680)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECTTSCCCB
T ss_pred CCCCCCCcCCHhHhCCCCCCCEEECCCCcCCc
Confidence 55555554444444444444444444444444
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-26 Score=284.18 Aligned_cols=258 Identities=21% Similarity=0.138 Sum_probs=172.7
Q ss_pred CcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCccc-----------------ccCCCCCCCccEEEeecCCC
Q 001142 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIES-----------------YGNRGGDNSVEGLYLYKNVL 80 (1142)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~-----------------~~~l~~L~~L~~L~Ls~N~L 80 (1142)
.++.|.+..|.++.++ .|..+++|++|+|++|.+ +.+|.. ...++.+++|++|+|++|.+
T Consensus 286 ~L~~L~l~~~~~~~l~--~l~~~~~L~~L~l~~n~l-~~lp~~~l~~L~~L~l~~n~~~~~~~~~~l~~L~~L~ls~n~l 362 (606)
T 3vq2_A 286 NVSAMSLAGVSIKYLE--DVPKHFKWQSLSIIRCQL-KQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNAL 362 (606)
T ss_dssp TCSEEEEESCCCCCCC--CCCTTCCCSEEEEESCCC-SSCCCCCCSSCCEEEEESCSSCEECCCCCCTTCCEEECCSSCE
T ss_pred CCCEEEecCccchhhh--hccccccCCEEEcccccC-cccccCCCCccceeeccCCcCccchhhccCCCCCEEECcCCcc
Confidence 4555666666665554 556666666666666666 333321 00223446667777777766
Q ss_pred Ccc---CccccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCc--ccccCCCCCCEEECCCCCCCCCccc
Q 001142 81 NLI---PKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNG--FALNKLKGLKELELSKVPPRPSVLT 155 (1142)
Q Consensus 81 t~i---P~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~--~~~~~L~~L~~L~Ls~n~~n~~~~~ 155 (1142)
+.+ |..+..+++|++|+|++|.++.+|..+.++++|+.|++++|.+...+ ..+..+++|++|++++|. ....
T Consensus 363 ~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~---l~~~ 439 (606)
T 3vq2_A 363 SFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTN---TKID 439 (606)
T ss_dssp EEEEECCHHHHCCSCCCEEECCSCSEEEECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSC---CEEC
T ss_pred CCCcchhhhhccCCcccEeECCCCccccchhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCC---CCcc
Confidence 654 55667777777777777777777766777777777777777744433 356777777777777743 3445
Q ss_pred chhhhcCCCCCcEEEccCCCCCc--cCcccCCCCCCCEEEccCCCCCcc-chhhcCCCCCCEEEccCCCCCcc-CccccC
Q 001142 156 LLSEIAGLKCLTKLSVCHFSIRY--LPPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVEL-PSGLYL 231 (1142)
Q Consensus 156 lp~~l~~L~~L~~L~Ls~N~L~~--IP~~l~~L~~L~~L~Ls~N~L~~l-P~~l~~L~~L~~L~Ls~N~Ls~I-P~~l~~ 231 (1142)
.|..+.++++|+.|++++|.++. +|..++.+++|+.|+|++|+|+.+ |..+..+++|+.|+|++|+|+.+ |..+..
T Consensus 440 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 519 (606)
T 3vq2_A 440 FDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQ 519 (606)
T ss_dssp CTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTT
T ss_pred chhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccC
Confidence 56667777777777777777774 566777777777777777777754 56677777777777777777744 667777
Q ss_pred CCCCCEEeCcCCcCCCCCcccccCCC-CCCEEEccCCCCCCCCCCCchhhcc
Q 001142 232 LQRLENLDLSNNRLTSLGSLDLCLMH-NLQNLNLQYNKLLSYCQVPSWICCN 282 (1142)
Q Consensus 232 L~~L~~L~Ls~N~Ls~~~p~~l~~L~-~L~~L~Ls~N~L~~~~~iP~~~~~~ 282 (1142)
+++|+.|+|++|+|+.+++ .+..++ +|+.|++++|+|.|.|++.+...|.
T Consensus 520 l~~L~~L~l~~N~l~~~p~-~~~~l~~~L~~l~l~~N~~~c~c~~~~~~~~l 570 (606)
T 3vq2_A 520 LYSLSTLDCSFNRIETSKG-ILQHFPKSLAFFNLTNNSVACICEHQKFLQWV 570 (606)
T ss_dssp CTTCCEEECTTSCCCCEES-CGGGSCTTCCEEECCSCCCCCSSTTHHHHTTT
T ss_pred CCcCCEEECCCCcCcccCH-hHhhhcccCcEEEccCCCcccCCccHHHHHHH
Confidence 7777777777777776554 466765 4777777777777777665444443
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-26 Score=279.69 Aligned_cols=131 Identities=23% Similarity=0.279 Sum_probs=98.9
Q ss_pred cCCCCCcEEEccCCCCCc-cC---cccCCCCCCCEEEccCCCCCccc---hhhcCCCCCCEEEccCCCCCccCccccCCC
Q 001142 161 AGLKCLTKLSVCHFSIRY-LP---PEIGCLSNLEQLDLSFNKMKYLP---TEICYLKALISLKVANNKLVELPSGLYLLQ 233 (1142)
Q Consensus 161 ~~L~~L~~L~Ls~N~L~~-IP---~~l~~L~~L~~L~Ls~N~L~~lP---~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~ 233 (1142)
.++++|+.|++++|+++. +| ..++.+++|++|+|++|+|+.+| ..+..+++|+.|+|++|+|+.+|..+..++
T Consensus 331 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~~~ 410 (549)
T 2z81_A 331 QHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPE 410 (549)
T ss_dssp HHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCCCCCSCCCCCT
T ss_pred hcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCccCChhhcccc
Confidence 358889999999999984 43 34678889999999999998775 357888999999999999998988888888
Q ss_pred CCCEEeCcCCcCCCCCccc-----------------ccCCCCCCEEEccCCCCCCCCCCCch------hhccCCCCCCCC
Q 001142 234 RLENLDLSNNRLTSLGSLD-----------------LCLMHNLQNLNLQYNKLLSYCQVPSW------ICCNLEGNGKDS 290 (1142)
Q Consensus 234 ~L~~L~Ls~N~Ls~~~p~~-----------------l~~L~~L~~L~Ls~N~L~~~~~iP~~------~~~~l~~n~l~~ 290 (1142)
+|+.|+|++|+|++++... +..+++|+.|+|++|+|+. ||.. ..++++.|.+..
T Consensus 411 ~L~~L~Ls~N~l~~l~~~~~~~L~~L~Ls~N~l~~~~~~l~~L~~L~Ls~N~l~~---ip~~~~l~~L~~L~Ls~N~l~~ 487 (549)
T 2z81_A 411 KMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLKT---LPDASLFPVLLVMKISRNQLKS 487 (549)
T ss_dssp TCCEEECTTSCCSCCCTTSCTTCSEEECCSSCCSCCCCCCTTCCEEECCSSCCSS---CCCGGGCTTCCEEECCSSCCCC
T ss_pred cccEEECCCCCcccccchhcCCceEEECCCCChhhhcccCChhcEEECCCCccCc---CCCcccCccCCEEecCCCccCC
Confidence 8888888888877654321 1368899999999999986 5543 224555555554
Q ss_pred CCCC
Q 001142 291 SNDD 294 (1142)
Q Consensus 291 ~~~~ 294 (1142)
..+.
T Consensus 488 ~~~~ 491 (549)
T 2z81_A 488 VPDG 491 (549)
T ss_dssp CCTT
T ss_pred cCHH
Confidence 4443
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.7e-28 Score=295.24 Aligned_cols=193 Identities=15% Similarity=0.095 Sum_probs=128.3
Q ss_pred eeeeecccCceEEEEEEE--CCccEEEEEEecccCCC--ChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecCCCC
Q 001142 811 SCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGS--SADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 811 l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~--~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~~~~~~~ 885 (1142)
.....+.|+.|.+..++. -+..+++|++....... .....+.-.+.+.+|+++|+++ .|+||++++++++++..
T Consensus 238 w~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~- 316 (569)
T 4azs_A 238 WQNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQS- 316 (569)
T ss_dssp EECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSE-
T ss_pred hhhccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCE-
Confidence 344567777777666543 58889999976543222 1222222234568999999999 69999999999998664
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
.||||||++|++|.++|.+ ..+++.. +|+.||+.||+|+|++|||||||||+|||++.+
T Consensus 317 -------------~yLVMEyv~G~~L~d~i~~-----~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~d 375 (569)
T 4azs_A 317 -------------GWLVMEKLPGRLLSDMLAA-----GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDAR 375 (569)
T ss_dssp -------------EEEEEECCCSEEHHHHHHT-----TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTT
T ss_pred -------------EEEEEecCCCCcHHHHHHh-----CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCC
Confidence 4999999999999999975 3456654 588999999999999999999999999999887
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+.+||+|||+|+....... .....+||+.|||||++.+ .+..++|+||+|+++++|.+
T Consensus 376 -------g~vKL~DFGlAr~~~~~~~----------~~~t~vGTp~YmAPE~l~g-----~~~~~~d~~s~g~~~~~l~~ 433 (569)
T 4azs_A 376 -------QHARLIDFGSIVTTPQDCS----------WPTNLVQSFFVFVNELFAE-----NKSWNGFWRSAPVHPFNLPQ 433 (569)
T ss_dssp -------SCEEECCCTTEESCC---C----------CSHHHHHHHHHHHHHHC----------------------CCCCT
T ss_pred -------CCEEEeecccCeeCCCCCc----------cccCceechhhccHHHhCC-----CCCCcccccccccchhhhcc
Confidence 7899999999976543211 1234579999999999875 35678999999999887765
Q ss_pred CC
Q 001142 1046 LQ 1047 (1142)
Q Consensus 1046 G~ 1047 (1142)
+.
T Consensus 434 ~~ 435 (569)
T 4azs_A 434 PW 435 (569)
T ss_dssp TH
T ss_pred cc
Confidence 53
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.7e-25 Score=254.02 Aligned_cols=237 Identities=19% Similarity=0.217 Sum_probs=175.3
Q ss_pred CCCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcE
Q 001142 16 GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRN 95 (1142)
Q Consensus 16 ~~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~ 95 (1142)
-+.++.|.+..|+|+.+.. |..+++|++|+|++|.++.. + . +.++++|++|+|++|.++.+|. +..+++|++
T Consensus 65 ~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~-~-~---~~~l~~L~~L~l~~n~i~~~~~-~~~l~~L~~ 136 (347)
T 4fmz_A 65 LTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI-S-A---LQNLTNLRELYLNEDNISDISP-LANLTKMYS 136 (347)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC-G-G---GTTCTTCSEEECTTSCCCCCGG-GTTCTTCCE
T ss_pred cCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCc-h-H---HcCCCcCCEEECcCCcccCchh-hccCCceeE
Confidence 4578999999999998876 89999999999999999874 2 2 4556999999999999998876 888899999
Q ss_pred EEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCC
Q 001142 96 LKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS 175 (1142)
Q Consensus 96 L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~ 175 (1142)
|+|++|.....+..+.++++|+.|++++|.+...+. +..+++|+.|++++|.+... +. +..+++|+.|++++|.
T Consensus 137 L~l~~n~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~-~~~l~~L~~L~l~~n~l~~~----~~-~~~l~~L~~L~l~~n~ 210 (347)
T 4fmz_A 137 LNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTP-IANLTDLYSLSLNYNQIEDI----SP-LASLTSLHYFTAYVNQ 210 (347)
T ss_dssp EECTTCTTCCCCGGGTTCTTCCEEECCSSCCCCCGG-GGGCTTCSEEECTTSCCCCC----GG-GGGCTTCCEEECCSSC
T ss_pred EECCCCCCcccccchhhCCCCcEEEecCCCcCCchh-hccCCCCCEEEccCCccccc----cc-ccCCCccceeecccCC
Confidence 999999655444458888889999998888776665 77888888888888665432 22 5566677777777777
Q ss_pred CCccCcccCCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeCcCCcCCCCCcccccC
Q 001142 176 IRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCL 255 (1142)
Q Consensus 176 L~~IP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~ 255 (1142)
++.++. +..+++|+.|+|++|+++.+|. +..+++|+.|+|++|.++.++ .+..+++|+.|+|++|+|+++ + .+..
T Consensus 211 l~~~~~-~~~~~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~-~~~~l~~L~~L~l~~n~l~~~-~-~~~~ 285 (347)
T 4fmz_A 211 ITDITP-VANMTRLNSLKIGNNKITDLSP-LANLSQLTWLEIGTNQISDIN-AVKDLTKLKMLNVGSNQISDI-S-VLNN 285 (347)
T ss_dssp CCCCGG-GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCCC-G-GGGG
T ss_pred CCCCch-hhcCCcCCEEEccCCccCCCcc-hhcCCCCCEEECCCCccCCCh-hHhcCCCcCEEEccCCccCCC-h-hhcC
Confidence 665544 5666677777777777766655 666667777777777666653 466666677777777766665 2 4666
Q ss_pred CCCCCEEEccCCCCCC
Q 001142 256 MHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 256 L~~L~~L~Ls~N~L~~ 271 (1142)
+++|+.|+|++|++++
T Consensus 286 l~~L~~L~L~~n~l~~ 301 (347)
T 4fmz_A 286 LSQLNSLFLNNNQLGN 301 (347)
T ss_dssp CTTCSEEECCSSCCCG
T ss_pred CCCCCEEECcCCcCCC
Confidence 6667777777776654
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-25 Score=274.32 Aligned_cols=130 Identities=16% Similarity=0.111 Sum_probs=103.9
Q ss_pred CCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccC-ccccCCcCCcE
Q 001142 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIP-KSVGRYEKLRN 95 (1142)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP-~~l~~L~~L~~ 95 (1142)
+.+..|.+..|+|+.+.+.+|.++++|++|||++|+|++..+..|+. +++|++|+|++|.++.+| ..|.++++|++
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~---l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 104 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQS---LSHLSTLILTGNPIQSLALGAFSGLSSLQK 104 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTT---CTTCCEEECTTCCCCEECTTTTTTCTTCCE
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccC---chhCCEEeCcCCcCCccCHhhhcCcccccc
Confidence 46888888888888888888888888888888888888877766544 488888888888888775 56888888888
Q ss_pred EEccCCCCCcCch-hhcCCCCCCEEEccCCCCCC--CcccccCCCCCCEEECCCCCC
Q 001142 96 LKFFGNEINLFPS-EVGNLLGLECLQIKISSPGV--NGFALNKLKGLKELELSKVPP 149 (1142)
Q Consensus 96 L~Ls~N~L~~lP~-~l~~L~~L~~L~Ls~N~l~~--~~~~~~~L~~L~~L~Ls~n~~ 149 (1142)
|+|++|+|+.+|. .++++++|++|+|++|.+.. +|..+..+++|++|++++|.+
T Consensus 105 L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l 161 (570)
T 2z63_A 105 LVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 161 (570)
T ss_dssp EECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCC
T ss_pred ccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCcc
Confidence 8888888887765 57788888888888888664 467788888888888877654
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-25 Score=265.40 Aligned_cols=241 Identities=18% Similarity=0.186 Sum_probs=175.8
Q ss_pred cccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCC-ccC-ccccCCcCCcEEEc
Q 001142 21 KLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLN-LIP-KSVGRYEKLRNLKF 98 (1142)
Q Consensus 21 ~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt-~iP-~~l~~L~~L~~L~L 98 (1142)
.+....++++.++. +. ++|++|||++|+|++..|..|+.+ ++|++|+|++|.++ .+| ..|.++++|++|+|
T Consensus 14 ~~~c~~~~l~~lp~--l~--~~l~~L~Ls~n~i~~~~~~~~~~l---~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~L 86 (455)
T 3v47_A 14 NAICINRGLHQVPE--LP--AHVNYVDLSLNSIAELNETSFSRL---QDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKL 86 (455)
T ss_dssp EEECCSSCCSSCCC--CC--TTCCEEECCSSCCCEECTTTTSSC---TTCCEEECCCCSTTCEECTTTTTTCTTCCEEEC
T ss_pred ccCcCCCCcccCCC--CC--CccCEEEecCCccCcCChhHhccC---ccccEEECcCCcccceECcccccccccCCEEeC
Confidence 46677788888876 22 789999999999999888777655 99999999999997 674 57999999999999
Q ss_pred cCCCCCcC-chhhcCCCCCCEEEccCCCCCC-Ccc--cccCCCCCCEEECCCCCCCCCcccchhh-hcCCCCCcEEEccC
Q 001142 99 FGNEINLF-PSEVGNLLGLECLQIKISSPGV-NGF--ALNKLKGLKELELSKVPPRPSVLTLLSE-IAGLKCLTKLSVCH 173 (1142)
Q Consensus 99 s~N~L~~l-P~~l~~L~~L~~L~Ls~N~l~~-~~~--~~~~L~~L~~L~Ls~n~~n~~~~~lp~~-l~~L~~L~~L~Ls~ 173 (1142)
++|.|+.+ |..|+++++|++|+|++|.+.. .+. .+..+++|++|+|++|.+.. ..|.. +.++++|+.|++++
T Consensus 87 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~---~~~~~~~~~l~~L~~L~L~~ 163 (455)
T 3v47_A 87 DYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKK---IQPASFFLNMRRFHVLDLTF 163 (455)
T ss_dssp TTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCS---CCCCGGGGGCTTCCEEECTT
T ss_pred CCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCc---cCcccccCCCCcccEEeCCC
Confidence 99999966 7789999999999999999764 333 38899999999999966543 33544 78899999999999
Q ss_pred CCCCcc-CcccCCC----------------------------------CCCCEEEccCCCCC------------------
Q 001142 174 FSIRYL-PPEIGCL----------------------------------SNLEQLDLSFNKMK------------------ 200 (1142)
Q Consensus 174 N~L~~I-P~~l~~L----------------------------------~~L~~L~Ls~N~L~------------------ 200 (1142)
|.++.+ |..+..+ ++|+.|+|++|+++
T Consensus 164 n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~ 243 (455)
T 3v47_A 164 NKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQS 243 (455)
T ss_dssp CCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEE
T ss_pred CcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceee
Confidence 998855 4333322 44555555555543
Q ss_pred ---------------------------------------------c-cchhhcCCCCCCEEEccCCCCCcc-CccccCCC
Q 001142 201 ---------------------------------------------Y-LPTEICYLKALISLKVANNKLVEL-PSGLYLLQ 233 (1142)
Q Consensus 201 ---------------------------------------------~-lP~~l~~L~~L~~L~Ls~N~Ls~I-P~~l~~L~ 233 (1142)
. +|..++.+++|+.|+|++|+|+.+ |..+..++
T Consensus 244 L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~ 323 (455)
T 3v47_A 244 LILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLT 323 (455)
T ss_dssp EECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCT
T ss_pred EeeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcc
Confidence 2 244455556666666666666543 44555566
Q ss_pred CCCEEeCcCCcCCCCCcccccCCCCCCEEEccCCCCCC
Q 001142 234 RLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 234 ~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1142)
+|+.|+|++|+|++++|..|..+++|+.|+|++|+++.
T Consensus 324 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 361 (455)
T 3v47_A 324 HLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRA 361 (455)
T ss_dssp TCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCE
T ss_pred cCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccc
Confidence 66666666666666655556666666666666666554
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.3e-25 Score=263.68 Aligned_cols=227 Identities=19% Similarity=0.154 Sum_probs=191.4
Q ss_pred CCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEE
Q 001142 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNL 96 (1142)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L 96 (1142)
+.++.|.+..|+|++++ .|..+++|++|+|++|+|++. | ++.+++|++|+|++|.|+.+| ++++++|++|
T Consensus 42 ~~L~~L~Ls~n~l~~~~--~l~~l~~L~~L~Ls~n~l~~~-~-----~~~l~~L~~L~Ls~N~l~~~~--~~~l~~L~~L 111 (457)
T 3bz5_A 42 ATLTSLDCHNSSITDMT--GIEKLTGLTKLICTSNNITTL-D-----LSQNTNLTYLACDSNKLTNLD--VTPLTKLTYL 111 (457)
T ss_dssp TTCCEEECCSSCCCCCT--TGGGCTTCSEEECCSSCCSCC-C-----CTTCTTCSEEECCSSCCSCCC--CTTCTTCCEE
T ss_pred CCCCEEEccCCCcccCh--hhcccCCCCEEEccCCcCCeE-c-----cccCCCCCEEECcCCCCceee--cCCCCcCCEE
Confidence 46788999999999884 689999999999999999985 2 345689999999999999886 8899999999
Q ss_pred EccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCC
Q 001142 97 KFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSI 176 (1142)
Q Consensus 97 ~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L 176 (1142)
+|++|+|+.+| ++++++|+.|++++|.+..++ +..+++|++|++++|. ..+.+ .+..+++|+.|++++|+|
T Consensus 112 ~L~~N~l~~l~--~~~l~~L~~L~l~~N~l~~l~--l~~l~~L~~L~l~~n~---~~~~~--~~~~l~~L~~L~ls~n~l 182 (457)
T 3bz5_A 112 NCDTNKLTKLD--VSQNPLLTYLNCARNTLTEID--VSHNTQLTELDCHLNK---KITKL--DVTPQTQLTTLDCSFNKI 182 (457)
T ss_dssp ECCSSCCSCCC--CTTCTTCCEEECTTSCCSCCC--CTTCTTCCEEECTTCS---CCCCC--CCTTCTTCCEEECCSSCC
T ss_pred ECCCCcCCeec--CCCCCcCCEEECCCCccceec--cccCCcCCEEECCCCC---ccccc--ccccCCcCCEEECCCCcc
Confidence 99999999886 889999999999999987764 7889999999999864 33333 477889999999999999
Q ss_pred CccCcccCCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeCcCCcCCCCCcccccCC
Q 001142 177 RYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLM 256 (1142)
Q Consensus 177 ~~IP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L 256 (1142)
+.+| ++.+++|+.|+|++|+|+.++ ++.+++|+.|+|++|+|+.+| +..+++|+.|+|++|+|+++++. .+
T Consensus 183 ~~l~--l~~l~~L~~L~l~~N~l~~~~--l~~l~~L~~L~Ls~N~l~~ip--~~~l~~L~~L~l~~N~l~~~~~~---~l 253 (457)
T 3bz5_A 183 TELD--VSQNKLLNRLNCDTNNITKLD--LNQNIQLTFLDCSSNKLTEID--VTPLTQLTYFDCSVNPLTELDVS---TL 253 (457)
T ss_dssp CCCC--CTTCTTCCEEECCSSCCSCCC--CTTCTTCSEEECCSSCCSCCC--CTTCTTCSEEECCSSCCSCCCCT---TC
T ss_pred ceec--cccCCCCCEEECcCCcCCeec--cccCCCCCEEECcCCcccccC--ccccCCCCEEEeeCCcCCCcCHH---HC
Confidence 9987 788999999999999999884 888999999999999999988 88899999999999999998754 45
Q ss_pred CCCCEEEccCCCCCC
Q 001142 257 HNLQNLNLQYNKLLS 271 (1142)
Q Consensus 257 ~~L~~L~Ls~N~L~~ 271 (1142)
++|+.|++++|+|..
T Consensus 254 ~~L~~L~l~~n~L~~ 268 (457)
T 3bz5_A 254 SKLTTLHCIQTDLLE 268 (457)
T ss_dssp TTCCEEECTTCCCSC
T ss_pred CCCCEEeccCCCCCE
Confidence 555555555555443
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=287.84 Aligned_cols=272 Identities=19% Similarity=0.206 Sum_probs=179.7
Q ss_pred CCCCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCC-cccccCCCCCCCccEEEeecCCCCcc-CccccCCcC
Q 001142 15 EGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPL-IESYGNRGGDNSVEGLYLYKNVLNLI-PKSVGRYEK 92 (1142)
Q Consensus 15 ~~~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~-p~~~~~l~~L~~L~~L~Ls~N~Lt~i-P~~l~~L~~ 92 (1142)
.++.+..|.+..|+|+.+.+.+|.++++|++|||++|.+.+.+ |..|+ ++++|++|+|++|.|+.+ |..|.++++
T Consensus 22 lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~---~L~~L~~L~Ls~N~l~~~~p~~~~~l~~ 98 (844)
T 3j0a_A 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFR---NLPNLRILDLGSSKIYFLHPDAFQGLFH 98 (844)
T ss_dssp SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTS---SCTTCCEEECTTCCCCEECTTSSCSCSS
T ss_pred CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhc---CCCCCCEEECCCCcCcccCHhHccCCcc
Confidence 3457889999999999999889999999999999999666555 55554 448899999999988876 778888999
Q ss_pred CcEEEccCCCCCc-Cchh--hcCCCCCCEEEccCCCCCCCc--ccccCCCCCCEEECCCCCCCCCccc------------
Q 001142 93 LRNLKFFGNEINL-FPSE--VGNLLGLECLQIKISSPGVNG--FALNKLKGLKELELSKVPPRPSVLT------------ 155 (1142)
Q Consensus 93 L~~L~Ls~N~L~~-lP~~--l~~L~~L~~L~Ls~N~l~~~~--~~~~~L~~L~~L~Ls~n~~n~~~~~------------ 155 (1142)
|++|+|++|.|+. +|.. |.++++|+.|+|++|.+...+ ..|.++++|++|+|++|.+......
T Consensus 99 L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~ 178 (844)
T 3j0a_A 99 LFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSF 178 (844)
T ss_dssp CCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCC
T ss_pred cCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccce
Confidence 9999999998874 5555 888899999999888866543 4688888888888888765432111
Q ss_pred -----------chhhhcCC-------------------------------------------------------------
Q 001142 156 -----------LLSEIAGL------------------------------------------------------------- 163 (1142)
Q Consensus 156 -----------lp~~l~~L------------------------------------------------------------- 163 (1142)
.|..+..+
T Consensus 179 L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~ 258 (844)
T 3j0a_A 179 FSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQN 258 (844)
T ss_dssp CEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGT
T ss_pred EECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChh
Confidence 11111111
Q ss_pred -------CCCcEEEccCCCCCcc-CcccCCCCCCCEEEccCCCCCcc-chhhcCCCCCCEEEccCCCCCcc-CccccCCC
Q 001142 164 -------KCLTKLSVCHFSIRYL-PPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVEL-PSGLYLLQ 233 (1142)
Q Consensus 164 -------~~L~~L~Ls~N~L~~I-P~~l~~L~~L~~L~Ls~N~L~~l-P~~l~~L~~L~~L~Ls~N~Ls~I-P~~l~~L~ 233 (1142)
++|+.|+|++|.+..+ |..|..+++|+.|+|++|+|+.+ |..|..+++|+.|+|++|.|+.+ |..+..++
T Consensus 259 ~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 338 (844)
T 3j0a_A 259 TFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLP 338 (844)
T ss_dssp TTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCT
T ss_pred hhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCC
Confidence 3445555555555533 33455556666666666666544 44555566666666666666544 44555566
Q ss_pred CCCEEeCcCCcCCCCCcccccCCCCCCEEEccCCCCCCCCCCCchhhccCCCCCCC
Q 001142 234 RLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKD 289 (1142)
Q Consensus 234 ~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~~n~l~ 289 (1142)
+|+.|+|++|+|+++++..|..+++|+.|+|++|.++.+..+|....+.++.|.+.
T Consensus 339 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~ 394 (844)
T 3j0a_A 339 KVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLV 394 (844)
T ss_dssp TCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCC
T ss_pred CCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCCcc
Confidence 66666666666666665556666666666666666655444444444444444444
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.93 E-value=6.7e-25 Score=250.78 Aligned_cols=254 Identities=19% Similarity=0.256 Sum_probs=213.0
Q ss_pred CCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEE
Q 001142 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNL 96 (1142)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L 96 (1142)
+.+..|.+..|+++.++ .|..+++|++|+|++|++++..+ + .++++|++|+|++|.++.+| .|..+++|++|
T Consensus 44 ~~L~~L~l~~~~i~~~~--~~~~~~~L~~L~l~~n~i~~~~~--~---~~l~~L~~L~L~~n~i~~~~-~~~~l~~L~~L 115 (347)
T 4fmz_A 44 ESITKLVVAGEKVASIQ--GIEYLTNLEYLNLNGNQITDISP--L---SNLVKLTNLYIGTNKITDIS-ALQNLTNLREL 115 (347)
T ss_dssp TTCSEEECCSSCCCCCT--TGGGCTTCCEEECCSSCCCCCGG--G---TTCTTCCEEECCSSCCCCCG-GGTTCTTCSEE
T ss_pred ccccEEEEeCCccccch--hhhhcCCccEEEccCCccccchh--h---hcCCcCCEEEccCCcccCch-HHcCCCcCCEE
Confidence 46788999999999885 48889999999999999987654 4 45599999999999999986 58999999999
Q ss_pred EccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCC
Q 001142 97 KFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSI 176 (1142)
Q Consensus 97 ~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L 176 (1142)
+|++|.|+.+|. +.++++|+.|++++|........+..+++|++|++++|.+.... . +..+++|+.|++++|.+
T Consensus 116 ~l~~n~i~~~~~-~~~l~~L~~L~l~~n~~~~~~~~~~~l~~L~~L~l~~~~~~~~~----~-~~~l~~L~~L~l~~n~l 189 (347)
T 4fmz_A 116 YLNEDNISDISP-LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVT----P-IANLTDLYSLSLNYNQI 189 (347)
T ss_dssp ECTTSCCCCCGG-GTTCTTCCEEECTTCTTCCCCGGGTTCTTCCEEECCSSCCCCCG----G-GGGCTTCSEEECTTSCC
T ss_pred ECcCCcccCchh-hccCCceeEEECCCCCCcccccchhhCCCCcEEEecCCCcCCch----h-hccCCCCCEEEccCCcc
Confidence 999999998887 88999999999999974444445899999999999996654332 2 78899999999999999
Q ss_pred CccCcccCCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeCcCCcCCCCCcccccCC
Q 001142 177 RYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLM 256 (1142)
Q Consensus 177 ~~IP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L 256 (1142)
+.++. +..+++|+.|++++|.++.++. +..+++|+.|+|++|.++.+|. +..+++|+.|+|++|.++++ + .+..+
T Consensus 190 ~~~~~-~~~l~~L~~L~l~~n~l~~~~~-~~~~~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~-~-~~~~l 264 (347)
T 4fmz_A 190 EDISP-LASLTSLHYFTAYVNQITDITP-VANMTRLNSLKIGNNKITDLSP-LANLSQLTWLEIGTNQISDI-N-AVKDL 264 (347)
T ss_dssp CCCGG-GGGCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCC-G-GGTTC
T ss_pred ccccc-ccCCCccceeecccCCCCCCch-hhcCCcCCEEEccCCccCCCcc-hhcCCCCCEEECCCCccCCC-h-hHhcC
Confidence 98876 8889999999999999998866 8889999999999999998877 88899999999999999986 3 68899
Q ss_pred CCCCEEEccCCCCCCCC---CCCchhhccCCCCCCC
Q 001142 257 HNLQNLNLQYNKLLSYC---QVPSWICCNLEGNGKD 289 (1142)
Q Consensus 257 ~~L~~L~Ls~N~L~~~~---~iP~~~~~~l~~n~l~ 289 (1142)
++|+.|++++|+++.+. .+|....+.++.|.+.
T Consensus 265 ~~L~~L~l~~n~l~~~~~~~~l~~L~~L~L~~n~l~ 300 (347)
T 4fmz_A 265 TKLKMLNVGSNQISDISVLNNLSQLNSLFLNNNQLG 300 (347)
T ss_dssp TTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCC
T ss_pred CCcCEEEccCCccCCChhhcCCCCCCEEECcCCcCC
Confidence 99999999999998731 2233333455555444
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-26 Score=280.67 Aligned_cols=154 Identities=20% Similarity=0.203 Sum_probs=125.4
Q ss_pred CCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCcc-ccCCcCCcE
Q 001142 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKS-VGRYEKLRN 95 (1142)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~-l~~L~~L~~ 95 (1142)
+.++.|.+..|+|+.+.+..|.++++|++|+|++|+|++.+|..|+. +++|++|+|++|.|+.+|+. |+++++|++
T Consensus 26 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~---l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~ 102 (549)
T 2z81_A 26 AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYS---LGSLEHLDLSDNHLSSLSSSWFGPLSSLKY 102 (549)
T ss_dssp TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTT---CTTCCEEECTTSCCCSCCHHHHTTCTTCCE
T ss_pred CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccc---cccCCEEECCCCccCccCHHHhccCCCCcE
Confidence 57999999999999999999999999999999999999988876654 49999999999999988764 999999999
Q ss_pred EEccCCCCCc--CchhhcCCCCCCEEEccCCC-CCCCc-ccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEc
Q 001142 96 LKFFGNEINL--FPSEVGNLLGLECLQIKISS-PGVNG-FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSV 171 (1142)
Q Consensus 96 L~Ls~N~L~~--lP~~l~~L~~L~~L~Ls~N~-l~~~~-~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~L 171 (1142)
|+|++|.|+. +|..++++++|++|+|++|. ++.++ ..+..+++|++|++++|.+. +..|..+..+++|+.|++
T Consensus 103 L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~---~~~~~~l~~l~~L~~L~l 179 (549)
T 2z81_A 103 LNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR---NYQSQSLKSIRDIHHLTL 179 (549)
T ss_dssp EECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCC---EECTTTTTTCSEEEEEEE
T ss_pred EECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCccc---ccChhhhhccccCceEec
Confidence 9999999984 47789999999999999998 66665 57889999999999986543 334445544444444443
Q ss_pred cCCCC
Q 001142 172 CHFSI 176 (1142)
Q Consensus 172 s~N~L 176 (1142)
+.|.+
T Consensus 180 ~~n~~ 184 (549)
T 2z81_A 180 HLSES 184 (549)
T ss_dssp ECSBS
T ss_pred ccCcc
Confidence 33333
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-25 Score=272.77 Aligned_cols=251 Identities=20% Similarity=0.210 Sum_probs=167.3
Q ss_pred CCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCcCCcE
Q 001142 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLRN 95 (1142)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~-~l~~L~~L~~ 95 (1142)
+.++.|.+..|+|+.+.+..|.++++|++|+|++|++++.+|..|+.+ ++|++|+|++|.++.+|. .|+++++|++
T Consensus 52 ~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l---~~L~~L~L~~n~l~~l~~~~~~~l~~L~~ 128 (570)
T 2z63_A 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGL---SSLQKLVAVETNLASLENFPIGHLKTLKE 128 (570)
T ss_dssp SSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTC---TTCCEEECTTSCCCCSTTCSCTTCTTCCE
T ss_pred CCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCc---cccccccccccccccCCCccccccccccE
Confidence 467888888888888888888888888888888888887776655443 777777777777777654 5677777777
Q ss_pred EEccCCCCCc--CchhhcCCCCCCEEEccCCCCCCCc-ccc---------------------------------------
Q 001142 96 LKFFGNEINL--FPSEVGNLLGLECLQIKISSPGVNG-FAL--------------------------------------- 133 (1142)
Q Consensus 96 L~Ls~N~L~~--lP~~l~~L~~L~~L~Ls~N~l~~~~-~~~--------------------------------------- 133 (1142)
|+|++|.|+. +|..|+++++|+.|++++|.+..++ ..+
T Consensus 129 L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~~L~~L~l~ 208 (570)
T 2z63_A 129 LNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLR 208 (570)
T ss_dssp EECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEE
T ss_pred EecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCCceecCHHHhccCcceeEecc
Confidence 7777777763 5677777777777777666543221 111
Q ss_pred --------------------------------------------------------------------------------
Q 001142 134 -------------------------------------------------------------------------------- 133 (1142)
Q Consensus 134 -------------------------------------------------------------------------------- 133 (1142)
T Consensus 209 ~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~ 288 (570)
T 2z63_A 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFS 288 (570)
T ss_dssp SCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEE
T ss_pred cccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEE
Confidence
Q ss_pred -------------------------------------------------------cCCCCCCEEECCCCCCCCCcccchh
Q 001142 134 -------------------------------------------------------NKLKGLKELELSKVPPRPSVLTLLS 158 (1142)
Q Consensus 134 -------------------------------------------------------~~L~~L~~L~Ls~n~~n~~~~~lp~ 158 (1142)
..+++|++|++++|.+.. ....|.
T Consensus 289 l~~~~l~~l~~~~~~~~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~~~~~~L~~L~l~~n~l~~-~~~~~~ 367 (570)
T 2z63_A 289 LVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSF-KGCCSQ 367 (570)
T ss_dssp EESCEECSCCBCCSCCCCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCCCBCTTCCEEECCSSCCBE-EEEEEH
T ss_pred ecCccchhhhhhhccCCccEEeeccCcccccCcccccccCEEeCcCCccccccccccCCCCCEEeCcCCccCc-cccccc
Confidence 112233333333322210 011145
Q ss_pred hhcCCCCCcEEEccCCCCCccCcccCCCCCCCEEEccCCCCCccc--hhhcCCCCCCEEEccCCCCC-ccCccccCCCCC
Q 001142 159 EIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLP--TEICYLKALISLKVANNKLV-ELPSGLYLLQRL 235 (1142)
Q Consensus 159 ~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~lP--~~l~~L~~L~~L~Ls~N~Ls-~IP~~l~~L~~L 235 (1142)
.+.++++|+.|++++|.++.+|..+..+++|+.|+|++|.++.++ ..+..+++|+.|+|++|.++ .+|..+..+++|
T Consensus 368 ~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 447 (570)
T 2z63_A 368 SDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL 447 (570)
T ss_dssp HHHTCSCCCEEECCSCSEEEEEEEEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTC
T ss_pred cccccCccCEEECCCCccccccccccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcC
Confidence 566777888888888887777666777777777777777777543 35667777777777777776 345566667777
Q ss_pred CEEeCcCCcCC-CCCcccccCCCCCCEEEccCCCCCC
Q 001142 236 ENLDLSNNRLT-SLGSLDLCLMHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 236 ~~L~Ls~N~Ls-~~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1142)
+.|+|++|+++ +.+|..+..+++|+.|+|++|++++
T Consensus 448 ~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~ 484 (570)
T 2z63_A 448 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ 484 (570)
T ss_dssp CEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCE
T ss_pred cEEECcCCcCccccchhhhhcccCCCEEECCCCcccc
Confidence 77777777776 4555567777777777777777765
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-24 Score=271.23 Aligned_cols=276 Identities=22% Similarity=0.173 Sum_probs=190.6
Q ss_pred CcccccCCCCCCcccCCCCCCCCCC--CCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCcc-CccccCCcCCc
Q 001142 18 IKEKLPSEANKINNEKNGSVNDDDD--DSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLI-PKSVGRYEKLR 94 (1142)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l~~--L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~i-P~~l~~L~~L~ 94 (1142)
.++.|.+..|+++.+.+..|.+++. |++|||++|++++..|..|+.+ ++|++|+|++|.++.+ |..|..+++|+
T Consensus 223 ~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l---~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 299 (680)
T 1ziw_A 223 SIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWL---PQLEYFFLEYNNIQHLFSHSLHGLFNVR 299 (680)
T ss_dssp CCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTC---TTCCEEECCSCCBSEECTTTTTTCTTCC
T ss_pred cccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcccccCc---ccccEeeCCCCccCccChhhhcCCCCcc
Confidence 5666777777777777777766644 7777777777776666555433 6777777777777654 44566666666
Q ss_pred EEEccCCCCC------cCch----hhcCCCCCCEEEccCCCCCCC-cccccCCCCCCEEECCCCCC--------------
Q 001142 95 NLKFFGNEIN------LFPS----EVGNLLGLECLQIKISSPGVN-GFALNKLKGLKELELSKVPP-------------- 149 (1142)
Q Consensus 95 ~L~Ls~N~L~------~lP~----~l~~L~~L~~L~Ls~N~l~~~-~~~~~~L~~L~~L~Ls~n~~-------------- 149 (1142)
+|+|++|... .+|. .|..+++|+.|+|++|.+..+ +..|..+++|++|++++|.+
T Consensus 300 ~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~ 379 (680)
T 1ziw_A 300 YLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLA 379 (680)
T ss_dssp EEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGT
T ss_pred EEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccc
Confidence 6666655433 3332 455666666666666664433 33456666666666655431
Q ss_pred -----------CCCcccchhhhcCCCCCcEEEccCCCCC-ccC-cccCCCCCCCEEEccCCCCCcc-chhhcCCCCCCEE
Q 001142 150 -----------RPSVLTLLSEIAGLKCLTKLSVCHFSIR-YLP-PEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISL 215 (1142)
Q Consensus 150 -----------n~~~~~lp~~l~~L~~L~~L~Ls~N~L~-~IP-~~l~~L~~L~~L~Ls~N~L~~l-P~~l~~L~~L~~L 215 (1142)
|.+....|..|..+++|+.|+|++|.++ .+| ..|..+++|++|+|++|++..+ |..+..+++|+.|
T Consensus 380 ~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L 459 (680)
T 1ziw_A 380 HSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRL 459 (680)
T ss_dssp TSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEE
T ss_pred cCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccc
Confidence 2233444667888888888888888887 465 4678888888888888888855 5677778888888
Q ss_pred EccCCCCC---ccCccccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccCCCCCCC-------------CCCCchh
Q 001142 216 KVANNKLV---ELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSY-------------CQVPSWI 279 (1142)
Q Consensus 216 ~Ls~N~Ls---~IP~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~~-------------~~iP~~~ 279 (1142)
+|++|.++ .+|..+..+++|+.|+|++|+|+++++..|..+++|+.|+|++|+++.+ ..++...
T Consensus 460 ~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~ 539 (680)
T 1ziw_A 460 MLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLH 539 (680)
T ss_dssp ECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCC
T ss_pred hhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCC
Confidence 88888875 5688888889999999999999998888888899999999999988752 2334444
Q ss_pred hccCCCCCCCCCCCCcc
Q 001142 280 CCNLEGNGKDSSNDDFI 296 (1142)
Q Consensus 280 ~~~l~~n~l~~~~~~~~ 296 (1142)
.+.++.|.+...+...+
T Consensus 540 ~L~L~~N~l~~i~~~~~ 556 (680)
T 1ziw_A 540 ILNLESNGFDEIPVEVF 556 (680)
T ss_dssp EEECCSSCCCCCCTTTT
T ss_pred EEECCCCCCCCCCHHHc
Confidence 56666776665555433
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.93 E-value=6.9e-27 Score=264.65 Aligned_cols=245 Identities=21% Similarity=0.178 Sum_probs=198.4
Q ss_pred CcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCC-CCCccccc----CCCCCCCccEEEeecCCCC-ccCccc--cC
Q 001142 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVD-FPLIESYG----NRGGDNSVEGLYLYKNVLN-LIPKSV--GR 89 (1142)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~-~~~p~~~~----~l~~L~~L~~L~Ls~N~Lt-~iP~~l--~~ 89 (1142)
.++.+.+..|++ .++. .+... |+.|+|++|+|+ ..+|..+. .+.++++|++|+|++|.|+ .+|..+ ..
T Consensus 44 ~L~~l~l~~n~l-~~p~-~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~ 119 (312)
T 1wwl_A 44 SLEYLLKRVDTE-ADLG-QFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEAT 119 (312)
T ss_dssp ECTTHHHHCCTT-CCCH-HHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSCC
T ss_pred CceeEeeccccc-ccHH-HHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHhc
Confidence 467777778888 4443 22222 888899999984 44555443 0013489999999999998 678876 88
Q ss_pred CcCCcEEEccCCCCCcCchhhcCC-----CCCCEEEccCCCCCCCc-ccccCCCCCCEEECCCCCCCCCcccchhhh--c
Q 001142 90 YEKLRNLKFFGNEINLFPSEVGNL-----LGLECLQIKISSPGVNG-FALNKLKGLKELELSKVPPRPSVLTLLSEI--A 161 (1142)
Q Consensus 90 L~~L~~L~Ls~N~L~~lP~~l~~L-----~~L~~L~Ls~N~l~~~~-~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l--~ 161 (1142)
+++|++|+|++|+|+.+|..++++ ++|++|+|++|.+..++ ..+..+++|++|+|++|.+.... .+|..+ .
T Consensus 120 l~~L~~L~Ls~N~l~~~~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~~~~ 198 (312)
T 1wwl_A 120 GPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGER-GLISALCPL 198 (312)
T ss_dssp SCCCSEEEEESCBCSSSSSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHH-HHHHHSCTT
T ss_pred CCCccEEEccCCCCcchhHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcch-HHHHHHHhc
Confidence 999999999999999888888777 99999999999977766 78999999999999996643221 134444 8
Q ss_pred CCCCCcEEEccCCCCCccC---cc-cCCCCCCCEEEccCCCCCccc--hhhcCCCCCCEEEccCCCCCccCccccCCCCC
Q 001142 162 GLKCLTKLSVCHFSIRYLP---PE-IGCLSNLEQLDLSFNKMKYLP--TEICYLKALISLKVANNKLVELPSGLYLLQRL 235 (1142)
Q Consensus 162 ~L~~L~~L~Ls~N~L~~IP---~~-l~~L~~L~~L~Ls~N~L~~lP--~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L 235 (1142)
.+++|+.|+|++|+|+.+| .. +..+++|++|+|++|+|+.++ ..+..+++|+.|+|++|+|+.||..+. ++|
T Consensus 199 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~ip~~~~--~~L 276 (312)
T 1wwl_A 199 KFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLP--AKL 276 (312)
T ss_dssp SCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCSSCCSSCC--SEE
T ss_pred cCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccChhhhhcc--CCc
Confidence 8999999999999999543 33 368899999999999999654 456678999999999999999999888 889
Q ss_pred CEEeCcCCcCCCCCcccccCCCCCCEEEccCCCCCC
Q 001142 236 ENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 236 ~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1142)
+.|+|++|+|+++ |. +..+++|+.|+|++|+|++
T Consensus 277 ~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 277 SVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp EEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred eEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 9999999999998 43 8999999999999999986
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-24 Score=260.11 Aligned_cols=237 Identities=22% Similarity=0.270 Sum_probs=171.9
Q ss_pred CCCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcE
Q 001142 16 GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRN 95 (1142)
Q Consensus 16 ~~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~ 95 (1142)
-+.++.|.+..|+|+.+.+ |.++++|++|+|++|.+++..+ + +++++|++|+|++|.++.+|. +.++++|++
T Consensus 67 l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~---~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~ 138 (466)
T 1o6v_A 67 LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--L---ANLTNLTGLTLFNNQITDIDP-LKNLTNLNR 138 (466)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--G---TTCTTCCEEECCSSCCCCCGG-GTTCTTCSE
T ss_pred hcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--h---cCCCCCCEEECCCCCCCCChH-HcCCCCCCE
Confidence 3478888888898888876 8888888888888888887665 4 445888888888888888865 778888888
Q ss_pred EEccCCCCCcCch--------------------hhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCccc
Q 001142 96 LKFFGNEINLFPS--------------------EVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLT 155 (1142)
Q Consensus 96 L~Ls~N~L~~lP~--------------------~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~ 155 (1142)
|+|++|.++.+|. .+.++++|+.|++++|.+..++ .+..+++|++|++++|.+....
T Consensus 139 L~l~~n~l~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~-~l~~l~~L~~L~l~~n~l~~~~-- 215 (466)
T 1o6v_A 139 LELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDIS-VLAKLTNLESLIATNNQISDIT-- 215 (466)
T ss_dssp EEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCG-GGGGCTTCSEEECCSSCCCCCG--
T ss_pred EECCCCccCCChhhccCCcccEeecCCcccCchhhccCCCCCEEECcCCcCCCCh-hhccCCCCCEEEecCCcccccc--
Confidence 8888887766542 2556777888888888876664 3777888888888886554332
Q ss_pred chhhhcCCCCCcEEEccCCCCCccCcccCCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCC
Q 001142 156 LLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRL 235 (1142)
Q Consensus 156 lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L 235 (1142)
| +..+++|+.|++++|+++.++ .+..+++|+.|+|++|.++.++. +..+++|+.|+|++|.++.+|. +..+++|
T Consensus 216 -~--~~~l~~L~~L~l~~n~l~~~~-~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L 289 (466)
T 1o6v_A 216 -P--LGILTNLDELSLNGNQLKDIG-TLASLTNLTDLDLANNQISNLAP-LSGLTKLTELKLGANQISNISP-LAGLTAL 289 (466)
T ss_dssp -G--GGGCTTCCEEECCSSCCCCCG-GGGGCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCCCCGG-GTTCTTC
T ss_pred -c--ccccCCCCEEECCCCCcccch-hhhcCCCCCEEECCCCccccchh-hhcCCCCCEEECCCCccCcccc-ccCCCcc
Confidence 1 556677777777777777663 45667777777777777776654 6667777777777777776655 6667777
Q ss_pred CEEeCcCCcCCCCCcccccCCCCCCEEEccCCCCCC
Q 001142 236 ENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 236 ~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1142)
+.|+|++|+++++++ +..+++|+.|+|++|++++
T Consensus 290 ~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~ 323 (466)
T 1o6v_A 290 TNLELNENQLEDISP--ISNLKNLTYLTLYFNNISD 323 (466)
T ss_dssp SEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSC
T ss_pred CeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCC
Confidence 777777777776654 5666777777777777665
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.5e-26 Score=260.63 Aligned_cols=238 Identities=17% Similarity=0.139 Sum_probs=195.3
Q ss_pred cccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEEc
Q 001142 19 KEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKF 98 (1142)
Q Consensus 19 l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~L 98 (1142)
++.+.+..+++.......+..+++|++|||++|+|++..|..|+.+ ++|++|+|++|.++.+++ |..+++|++|+|
T Consensus 12 l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l---~~L~~L~Ls~n~l~~~~~-~~~l~~L~~L~L 87 (317)
T 3o53_A 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPF---TKLELLNLSSNVLYETLD-LESLSTLRTLDL 87 (317)
T ss_dssp EEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTC---TTCCEEECTTSCCEEEEE-ETTCTTCCEEEC
T ss_pred eeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCC---CcCCEEECCCCcCCcchh-hhhcCCCCEEEC
Confidence 4445566677776666677788899999999999999888777655 899999999999987765 888999999999
Q ss_pred cCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCc
Q 001142 99 FGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRY 178 (1142)
Q Consensus 99 s~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~ 178 (1142)
++|+|+.+|. +++|+.|++++|.+..++. ..+++|++|++++|.+.. ..+..+..+++|+.|+|++|.|+.
T Consensus 88 s~n~l~~l~~----~~~L~~L~l~~n~l~~~~~--~~~~~L~~L~l~~N~l~~---~~~~~~~~l~~L~~L~Ls~N~l~~ 158 (317)
T 3o53_A 88 NNNYVQELLV----GPSIETLHAANNNISRVSC--SRGQGKKNIYLANNKITM---LRDLDEGCRSRVQYLDLKLNEIDT 158 (317)
T ss_dssp CSSEEEEEEE----CTTCCEEECCSSCCSEEEE--CCCSSCEEEECCSSCCCS---GGGBCTGGGSSEEEEECTTSCCCE
T ss_pred cCCccccccC----CCCcCEEECCCCccCCcCc--cccCCCCEEECCCCCCCC---ccchhhhccCCCCEEECCCCCCCc
Confidence 9999987763 3889999999998776653 457889999999866543 334467788899999999999996
Q ss_pred c-Cccc-CCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeCcCCcCCCCCcccccCC
Q 001142 179 L-PPEI-GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLM 256 (1142)
Q Consensus 179 I-P~~l-~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L 256 (1142)
+ |..+ ..+++|++|+|++|+|+.+|... .+++|+.|+|++|+|+.+|..+..+++|+.|+|++|+|+++++ .+..+
T Consensus 159 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~~l~~-~~~~l 236 (317)
T 3o53_A 159 VNFAELAASSDTLEHLNLQYNFIYDVKGQV-VFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVLIEK-ALRFS 236 (317)
T ss_dssp EEGGGGGGGTTTCCEEECTTSCCCEEECCC-CCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCEECT-TCCCC
T ss_pred ccHHHHhhccCcCCEEECCCCcCccccccc-ccccCCEEECCCCcCCcchhhhcccCcccEEECcCCcccchhh-HhhcC
Confidence 5 4455 47899999999999999886543 4889999999999999998888889999999999999998654 68889
Q ss_pred CCCCEEEccCCCCCC
Q 001142 257 HNLQNLNLQYNKLLS 271 (1142)
Q Consensus 257 ~~L~~L~Ls~N~L~~ 271 (1142)
++|+.|+|++|+++|
T Consensus 237 ~~L~~L~l~~N~~~~ 251 (317)
T 3o53_A 237 QNLEHFDLRGNGFHC 251 (317)
T ss_dssp TTCCEEECTTCCCBH
T ss_pred CCCCEEEccCCCccC
Confidence 999999999999984
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.7e-24 Score=256.78 Aligned_cols=184 Identities=19% Similarity=0.112 Sum_probs=127.3
Q ss_pred CCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEE
Q 001142 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNL 96 (1142)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L 96 (1142)
+.++.|.+..|+|+.++ |..+++|++|+|++|+|++. + ++++++|++|+|++|.|+.+| +..+++|++|
T Consensus 64 ~~L~~L~Ls~n~l~~~~---~~~l~~L~~L~Ls~N~l~~~-~-----~~~l~~L~~L~L~~N~l~~l~--~~~l~~L~~L 132 (457)
T 3bz5_A 64 TGLTKLICTSNNITTLD---LSQNTNLTYLACDSNKLTNL-D-----VTPLTKLTYLNCDTNKLTKLD--VSQNPLLTYL 132 (457)
T ss_dssp TTCSEEECCSSCCSCCC---CTTCTTCSEEECCSSCCSCC-C-----CTTCTTCCEEECCSSCCSCCC--CTTCTTCCEE
T ss_pred CCCCEEEccCCcCCeEc---cccCCCCCEEECcCCCCcee-e-----cCCCCcCCEEECCCCcCCeec--CCCCCcCCEE
Confidence 47888999999999874 88899999999999999885 2 345689999999999999886 8888899999
Q ss_pred EccCCCCCcCchhhcCCCCCCEEEccCCC-CCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCC
Q 001142 97 KFFGNEINLFPSEVGNLLGLECLQIKISS-PGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS 175 (1142)
Q Consensus 97 ~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~-l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~ 175 (1142)
+|++|+|+.+| ++++++|+.|++++|. ++.+ .+..+++|++|++++|.+.. +| +..+++|+.|++++|+
T Consensus 133 ~l~~N~l~~l~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~----l~--l~~l~~L~~L~l~~N~ 202 (457)
T 3bz5_A 133 NCARNTLTEID--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE----LD--VSQNKLLNRLNCDTNN 202 (457)
T ss_dssp ECTTSCCSCCC--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC----CC--CTTCTTCCEEECCSSC
T ss_pred ECCCCccceec--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce----ec--cccCCCCCEEECcCCc
Confidence 99999998775 6777777777777774 4444 35666777777777655433 22 4455555555555555
Q ss_pred CCccCcccCCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCcc
Q 001142 176 IRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVEL 225 (1142)
Q Consensus 176 L~~IP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~I 225 (1142)
|+.++ ++.+++|+.|+|++|+|+.+| ++.+++|+.|+|++|+|+.+
T Consensus 203 l~~~~--l~~l~~L~~L~Ls~N~l~~ip--~~~l~~L~~L~l~~N~l~~~ 248 (457)
T 3bz5_A 203 ITKLD--LNQNIQLTFLDCSSNKLTEID--VTPLTQLTYFDCSVNPLTEL 248 (457)
T ss_dssp CSCCC--CTTCTTCSEEECCSSCCSCCC--CTTCTTCSEEECCSSCCSCC
T ss_pred CCeec--cccCCCCCEEECcCCcccccC--ccccCCCCEEEeeCCcCCCc
Confidence 55442 455555555555555555554 44555555555555555433
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.2e-25 Score=248.44 Aligned_cols=219 Identities=21% Similarity=0.265 Sum_probs=195.7
Q ss_pred CCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCcc-ccCCcCCcEEEccCCCCCcC---chhhcCCCCCCE
Q 001142 43 DSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKS-VGRYEKLRNLKFFGNEINLF---PSEVGNLLGLEC 118 (1142)
Q Consensus 43 L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~-l~~L~~L~~L~Ls~N~L~~l---P~~l~~L~~L~~ 118 (1142)
-+.+++++++++..+...+ ++|++|+|++|.|+.+|.. |.++++|++|+|++|.|+.+ |..+..+++|++
T Consensus 9 ~~~l~c~~~~l~~ip~~~~------~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~ 82 (306)
T 2z66_A 9 GTEIRCNSKGLTSVPTGIP------SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKY 82 (306)
T ss_dssp TTEEECCSSCCSSCCSCCC------TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCE
T ss_pred CCEEEcCCCCcccCCCCCC------CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCE
Confidence 3589999999987654322 6899999999999999875 78999999999999999865 678889999999
Q ss_pred EEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccch--hhhcCCCCCcEEEccCCCCCcc-CcccCCCCCCCEEEcc
Q 001142 119 LQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLL--SEIAGLKCLTKLSVCHFSIRYL-PPEIGCLSNLEQLDLS 195 (1142)
Q Consensus 119 L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp--~~l~~L~~L~~L~Ls~N~L~~I-P~~l~~L~~L~~L~Ls 195 (1142)
|+|++|.+..++..+..+++|++|++++|.+. .++ ..+..+++|+.|++++|.++.+ |..+..+++|++|+|+
T Consensus 83 L~Ls~n~i~~l~~~~~~l~~L~~L~l~~n~l~----~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 158 (306)
T 2z66_A 83 LDLSFNGVITMSSNFLGLEQLEHLDFQHSNLK----QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMA 158 (306)
T ss_dssp EECCSCSEEEEEEEEETCTTCCEEECTTSEEE----SSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECT
T ss_pred EECCCCccccChhhcCCCCCCCEEECCCCccc----ccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECC
Confidence 99999998888888999999999999995543 333 4688999999999999999954 6678999999999999
Q ss_pred CCCCCc--cchhhcCCCCCCEEEccCCCCCcc-CccccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccCCCCCC
Q 001142 196 FNKMKY--LPTEICYLKALISLKVANNKLVEL-PSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 196 ~N~L~~--lP~~l~~L~~L~~L~Ls~N~Ls~I-P~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1142)
+|.++. +|..+..+++|+.|+|++|+|+.+ |..+..+++|+.|+|++|+|+++++..+..+++|+.|+|++|++++
T Consensus 159 ~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 237 (306)
T 2z66_A 159 GNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT 237 (306)
T ss_dssp TCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCB
T ss_pred CCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcc
Confidence 999985 799999999999999999999976 7788899999999999999999999889999999999999999988
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.7e-26 Score=276.23 Aligned_cols=219 Identities=18% Similarity=0.165 Sum_probs=172.6
Q ss_pred CCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCC
Q 001142 38 NDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLE 117 (1142)
Q Consensus 38 ~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~ 117 (1142)
...++|++|||++|+|++.+|..|+.+ ++|++|+|++|.|+.+++ |..+++|++|+|++|.|+.+|.. ++|+
T Consensus 31 ~~~~~L~~L~Ls~n~l~~~~~~~~~~l---~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~l~~l~~~----~~L~ 102 (487)
T 3oja_A 31 QSAWNVKELDLSGNPLSQISAADLAPF---TKLELLNLSSNVLYETLD-LESLSTLRTLDLNNNYVQELLVG----PSIE 102 (487)
T ss_dssp TTGGGCCEEECCSSCCCCCCGGGGTTC---TTCCEEECTTSCCEEEEE-CTTCTTCCEEECCSSEEEEEEEC----TTCC
T ss_pred ccCCCccEEEeeCCcCCCCCHHHHhCC---CCCCEEEeeCCCCCCCcc-cccCCCCCEEEecCCcCCCCCCC----CCcC
Confidence 345588888888888888877766544 888888888888886654 88888888888888888877643 7888
Q ss_pred EEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCc-cCcccC-CCCCCCEEEcc
Q 001142 118 CLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRY-LPPEIG-CLSNLEQLDLS 195 (1142)
Q Consensus 118 ~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~-IP~~l~-~L~~L~~L~Ls 195 (1142)
.|+|++|.+..++. ..+++|+.|+|++|.+. +..|..++.+++|+.|+|++|.|+. +|..+. .+++|+.|+|+
T Consensus 103 ~L~L~~N~l~~~~~--~~l~~L~~L~L~~N~l~---~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls 177 (487)
T 3oja_A 103 TLHAANNNISRVSC--SRGQGKKNIYLANNKIT---MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ 177 (487)
T ss_dssp EEECCSSCCCCEEE--CCCSSCEEEECCSSCCC---SGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECT
T ss_pred EEECcCCcCCCCCc--cccCCCCEEECCCCCCC---CCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecC
Confidence 88888888776653 35678888888885543 3445567778888888888888885 466664 78888888888
Q ss_pred CCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccCCCCCC
Q 001142 196 FNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 196 ~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1142)
+|.|+.+|.. ..+++|+.|+|++|.|+.+|+.+..+++|+.|+|++|.|+++++ .+..+++|+.|+|++|++.|
T Consensus 178 ~N~l~~~~~~-~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~lp~-~l~~l~~L~~L~l~~N~l~c 251 (487)
T 3oja_A 178 YNFIYDVKGQ-VVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVLIEK-ALRFSQNLEHFDLRGNGFHC 251 (487)
T ss_dssp TSCCCEEECC-CCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCEECT-TCCCCTTCCEEECTTCCBCH
T ss_pred CCcccccccc-ccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCCcCcccch-hhccCCCCCEEEcCCCCCcC
Confidence 8888877543 35888888888888888888888888888888888888888655 68888888888888888874
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-24 Score=258.91 Aligned_cols=254 Identities=23% Similarity=0.281 Sum_probs=214.8
Q ss_pred CcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEE
Q 001142 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLK 97 (1142)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~ 97 (1142)
.+..|.+..+.++.++ .+..+++|++|||++|.+++..+ + +++++|++|+|++|.++.+|. +.++++|++|+
T Consensus 47 ~l~~L~l~~~~i~~l~--~~~~l~~L~~L~Ls~n~l~~~~~--~---~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~ 118 (466)
T 1o6v_A 47 QVTTLQADRLGIKSID--GVEYLNNLTQINFSNNQLTDITP--L---KNLTKLVDILMNNNQIADITP-LANLTNLTGLT 118 (466)
T ss_dssp TCCEEECCSSCCCCCT--TGGGCTTCCEEECCSSCCCCCGG--G---TTCTTCCEEECCSSCCCCCGG-GTTCTTCCEEE
T ss_pred cccEEecCCCCCccCc--chhhhcCCCEEECCCCccCCchh--h---hccccCCEEECCCCccccChh-hcCCCCCCEEE
Confidence 5778889999999876 48889999999999999998765 4 455999999999999999877 99999999999
Q ss_pred ccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcc--------------------cccCCCCCCEEECCCCCCCCCcccch
Q 001142 98 FFGNEINLFPSEVGNLLGLECLQIKISSPGVNGF--------------------ALNKLKGLKELELSKVPPRPSVLTLL 157 (1142)
Q Consensus 98 Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~~--------------------~~~~L~~L~~L~Ls~n~~n~~~~~lp 157 (1142)
|++|.|+.+|. +.++++|+.|+|++|.+..++. .+..+++|+.|++++|.+...
T Consensus 119 L~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~----- 192 (466)
T 1o6v_A 119 LFNNQITDIDP-LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDI----- 192 (466)
T ss_dssp CCSSCCCCCGG-GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCC-----
T ss_pred CCCCCCCCChH-HcCCCCCCEEECCCCccCCChhhccCCcccEeecCCcccCchhhccCCCCCEEECcCCcCCCC-----
Confidence 99999999876 8999999999999998665542 256778899999998766443
Q ss_pred hhhcCCCCCcEEEccCCCCCccCcccCCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCE
Q 001142 158 SEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLEN 237 (1142)
Q Consensus 158 ~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~ 237 (1142)
..+..+++|+.|++++|.++.++. ++.+++|+.|+|++|+++.++ .+..+++|+.|+|++|.++.++. +..+++|+.
T Consensus 193 ~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~-~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~ 269 (466)
T 1o6v_A 193 SVLAKLTNLESLIATNNQISDITP-LGILTNLDELSLNGNQLKDIG-TLASLTNLTDLDLANNQISNLAP-LSGLTKLTE 269 (466)
T ss_dssp GGGGGCTTCSEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCCG-GGGGCTTCSEEECCSSCCCCCGG-GTTCTTCSE
T ss_pred hhhccCCCCCEEEecCCccccccc-ccccCCCCEEECCCCCcccch-hhhcCCCCCEEECCCCccccchh-hhcCCCCCE
Confidence 247889999999999999997765 788999999999999999885 68899999999999999998876 888999999
Q ss_pred EeCcCCcCCCCCcccccCCCCCCEEEccCCCCCCCC---CCCchhhccCCCCCCCC
Q 001142 238 LDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYC---QVPSWICCNLEGNGKDS 290 (1142)
Q Consensus 238 L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~~~---~iP~~~~~~l~~n~l~~ 290 (1142)
|+|++|+++++++ +..+++|+.|+|++|++++.. .+|....+.++.|.+..
T Consensus 270 L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~L~~n~l~~ 323 (466)
T 1o6v_A 270 LKLGANQISNISP--LAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISD 323 (466)
T ss_dssp EECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSCCSC
T ss_pred EECCCCccCcccc--ccCCCccCeEEcCCCcccCchhhcCCCCCCEEECcCCcCCC
Confidence 9999999999876 889999999999999998732 13333335555555443
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.5e-25 Score=244.66 Aligned_cols=208 Identities=26% Similarity=0.260 Sum_probs=143.4
Q ss_pred CccEEEeecCCCCccCc-cccCCcCCcEEEccCCCCCcCch-hhcCCCCCCEEEccCCCCCCCc-ccccCCCCCCEEECC
Q 001142 69 SVEGLYLYKNVLNLIPK-SVGRYEKLRNLKFFGNEINLFPS-EVGNLLGLECLQIKISSPGVNG-FALNKLKGLKELELS 145 (1142)
Q Consensus 69 ~L~~L~Ls~N~Lt~iP~-~l~~L~~L~~L~Ls~N~L~~lP~-~l~~L~~L~~L~Ls~N~l~~~~-~~~~~L~~L~~L~Ls 145 (1142)
+|++|+|++|.|+.+|. .|.++++|++|+|++|+|+.++. .|.++++|++|+|++|.+..++ ..+..+++|++|+++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 108 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence 34444444444444432 34444444444444444444332 3444444444444444433322 334455555555555
Q ss_pred CCCCCCCcccchhhhcCCCCCcEEEccCCCCCc--cCcccCCCCCCCEEEccCCCCCccc-hhhcCCCCCC----EEEcc
Q 001142 146 KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRY--LPPEIGCLSNLEQLDLSFNKMKYLP-TEICYLKALI----SLKVA 218 (1142)
Q Consensus 146 ~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~--IP~~l~~L~~L~~L~Ls~N~L~~lP-~~l~~L~~L~----~L~Ls 218 (1142)
+|.+... .+..+.++++|+.|++++|.++. +|..+..+++|+.|+|++|+|+.+| ..+..+++|+ .|+|+
T Consensus 109 ~n~l~~~---~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls 185 (276)
T 2z62_A 109 ETNLASL---ENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLS 185 (276)
T ss_dssp TSCCCCS---TTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECC
T ss_pred CCCcccc---CchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecC
Confidence 5333221 12246778889999999999986 6889999999999999999999775 5666666666 89999
Q ss_pred CCCCCccCccccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccCCCCCCCCCCCchh
Q 001142 219 NNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWI 279 (1142)
Q Consensus 219 ~N~Ls~IP~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~ 279 (1142)
+|.|+.+|.......+|+.|+|++|+|+++++..|..+++|+.|+|++|+|+|.|+.-.++
T Consensus 186 ~n~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~l~~l 246 (276)
T 2z62_A 186 LNPMNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYL 246 (276)
T ss_dssp SSCCCEECTTSSCSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTTTHHH
T ss_pred CCcccccCccccCCCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCchHHH
Confidence 9999999888888779999999999999999988899999999999999999977533333
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-26 Score=263.55 Aligned_cols=241 Identities=17% Similarity=0.126 Sum_probs=211.5
Q ss_pred CCCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcE
Q 001142 16 GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRN 95 (1142)
Q Consensus 16 ~~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~ 95 (1142)
.+.++.|.+..|+|+.+.+..|.++++|++|+|++|+|++.++ + .++++|++|+|++|.|+.+|. +++|++
T Consensus 33 ~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~---~~l~~L~~L~Ls~n~l~~l~~----~~~L~~ 103 (317)
T 3o53_A 33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--L---ESLSTLRTLDLNNNYVQELLV----GPSIET 103 (317)
T ss_dssp GGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--E---TTCTTCCEEECCSSEEEEEEE----CTTCCE
T ss_pred CCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--h---hhcCCCCEEECcCCccccccC----CCCcCE
Confidence 4579999999999999998999999999999999999987665 4 455999999999999998863 379999
Q ss_pred EEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCc-ccccCCCCCCEEECCCCCCCCCcccchhhh-cCCCCCcEEEccC
Q 001142 96 LKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNG-FALNKLKGLKELELSKVPPRPSVLTLLSEI-AGLKCLTKLSVCH 173 (1142)
Q Consensus 96 L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~-~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l-~~L~~L~~L~Ls~ 173 (1142)
|+|++|+|+.++.. .+++|+.|+|++|.+..++ ..+..+++|++|+|++|.+. ...|..+ ..+++|+.|+|++
T Consensus 104 L~l~~n~l~~~~~~--~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~---~~~~~~~~~~l~~L~~L~L~~ 178 (317)
T 3o53_A 104 LHAANNNISRVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID---TVNFAELAASSDTLEHLNLQY 178 (317)
T ss_dssp EECCSSCCSEEEEC--CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCC---EEEGGGGGGGTTTCCEEECTT
T ss_pred EECCCCccCCcCcc--ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCC---cccHHHHhhccCcCCEEECCC
Confidence 99999999987654 4789999999999987765 47889999999999996554 3345555 4789999999999
Q ss_pred CCCCccCcccCCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeCcCCcCC-CCCccc
Q 001142 174 FSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLT-SLGSLD 252 (1142)
Q Consensus 174 N~L~~IP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls~N~Ls-~~~p~~ 252 (1142)
|.|+.+|.. ..+++|++|+|++|+|+.+|..+..+++|+.|+|++|+|+.||..+..+++|+.|+|++|.++ +.++.+
T Consensus 179 N~l~~~~~~-~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~ 257 (317)
T 3o53_A 179 NFIYDVKGQ-VVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTLRDF 257 (317)
T ss_dssp SCCCEEECC-CCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCCBHHHHHHH
T ss_pred CcCcccccc-cccccCCEEECCCCcCCcchhhhcccCcccEEECcCCcccchhhHhhcCCCCCEEEccCCCccCcCHHHH
Confidence 999988654 459999999999999999998899999999999999999999999999999999999999999 778888
Q ss_pred ccCCCCCCEEEccCC-CCCC
Q 001142 253 LCLMHNLQNLNLQYN-KLLS 271 (1142)
Q Consensus 253 l~~L~~L~~L~Ls~N-~L~~ 271 (1142)
+..+++|+.|++++| .+++
T Consensus 258 ~~~~~~L~~l~l~~~~~l~~ 277 (317)
T 3o53_A 258 FSKNQRVQTVAKQTVKKLTG 277 (317)
T ss_dssp HHTCHHHHHHHHHHHHHHHS
T ss_pred HhccccceEEECCCchhccC
Confidence 999999999999954 4544
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=8.1e-26 Score=259.83 Aligned_cols=228 Identities=18% Similarity=0.162 Sum_probs=202.2
Q ss_pred CCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCcc-ccCCcCCcE
Q 001142 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKS-VGRYEKLRN 95 (1142)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~-l~~L~~L~~ 95 (1142)
+.++.|.+..|+|+.+....|.++++|++|+|++|+|++..|..|+.+ ++|++|+|++|.|+.+|.. |.++++|++
T Consensus 52 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l---~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~ 128 (353)
T 2z80_A 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSL---GSLEHLDLSYNYLSNLSSSWFKPLSSLTF 128 (353)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTC---TTCCEEECCSSCCSSCCHHHHTTCTTCSE
T ss_pred ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCC---CCCCEEECCCCcCCcCCHhHhCCCccCCE
Confidence 479999999999999999999999999999999999999888766544 9999999999999999876 899999999
Q ss_pred EEccCCCCCcCch--hhcCCCCCCEEEccCCC-CCCC-cccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEc
Q 001142 96 LKFFGNEINLFPS--EVGNLLGLECLQIKISS-PGVN-GFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSV 171 (1142)
Q Consensus 96 L~Ls~N~L~~lP~--~l~~L~~L~~L~Ls~N~-l~~~-~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~L 171 (1142)
|+|++|+|+.+|. .+.++++|+.|++++|. +..+ +..+..+++|++|++++|.+ ....|..+..+++|+.|++
T Consensus 129 L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l---~~~~~~~l~~l~~L~~L~l 205 (353)
T 2z80_A 129 LNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDL---QSYEPKSLKSIQNVSHLIL 205 (353)
T ss_dssp EECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTC---CEECTTTTTTCSEEEEEEE
T ss_pred EECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCc---CccCHHHHhccccCCeecC
Confidence 9999999999987 68899999999999995 6555 46789999999999999554 4456788999999999999
Q ss_pred cCCCCCccCccc-CCCCCCCEEEccCCCCCc--------------------------------cchhhcCCCCCCEEEcc
Q 001142 172 CHFSIRYLPPEI-GCLSNLEQLDLSFNKMKY--------------------------------LPTEICYLKALISLKVA 218 (1142)
Q Consensus 172 s~N~L~~IP~~l-~~L~~L~~L~Ls~N~L~~--------------------------------lP~~l~~L~~L~~L~Ls 218 (1142)
++|.++.+|..+ ..+++|+.|+|++|+|+. +|..+..+++|+.|+|+
T Consensus 206 ~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls 285 (353)
T 2z80_A 206 HMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFS 285 (353)
T ss_dssp ECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECC
T ss_pred CCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECC
Confidence 999999887754 568899999999999875 45567889999999999
Q ss_pred CCCCCccCccc-cCCCCCCEEeCcCCcCCCCCc
Q 001142 219 NNKLVELPSGL-YLLQRLENLDLSNNRLTSLGS 250 (1142)
Q Consensus 219 ~N~Ls~IP~~l-~~L~~L~~L~Ls~N~Ls~~~p 250 (1142)
+|+|+.||..+ ..+++|+.|+|++|.+++..|
T Consensus 286 ~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 286 RNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCCCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 99999999886 689999999999999998765
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.7e-25 Score=245.69 Aligned_cols=249 Identities=20% Similarity=0.193 Sum_probs=206.9
Q ss_pred ccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCcc-CccccCCcCCcEEEc
Q 001142 20 EKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLI-PKSVGRYEKLRNLKF 98 (1142)
Q Consensus 20 ~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~i-P~~l~~L~~L~~L~L 98 (1142)
..+....+.|+.++... .++|++|+|++|+|++..+..|+.+ ++|++|+|++|.|+.+ |..|..+++|++|+|
T Consensus 14 ~~~~c~~~~l~~ip~~~---~~~l~~L~l~~n~i~~~~~~~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 87 (285)
T 1ozn_A 14 VTTSCPQQGLQAVPVGI---PAASQRIFLHGNRISHVPAASFRAC---RNLTILWLHSNVLARIDAAAFTGLALLEQLDL 87 (285)
T ss_dssp CEEECCSSCCSSCCTTC---CTTCSEEECTTSCCCEECTTTTTTC---TTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred eEEEcCcCCcccCCcCC---CCCceEEEeeCCcCCccCHHHcccC---CCCCEEECCCCccceeCHhhcCCccCCCEEeC
Confidence 45778888898886533 4689999999999999887766554 9999999999999988 678999999999999
Q ss_pred cCCC-CCcC-chhhcCCCCCCEEEccCCCCCCC-cccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCC
Q 001142 99 FGNE-INLF-PSEVGNLLGLECLQIKISSPGVN-GFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS 175 (1142)
Q Consensus 99 s~N~-L~~l-P~~l~~L~~L~~L~Ls~N~l~~~-~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~ 175 (1142)
++|. ++.+ |..|.++++|++|+|++|.+..+ +..+..+++|++|++++|.+.. ..+..|..+++|+.|+|++|+
T Consensus 88 ~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~---~~~~~~~~l~~L~~L~l~~n~ 164 (285)
T 1ozn_A 88 SDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA---LPDDTFRDLGNLTHLFLHGNR 164 (285)
T ss_dssp CSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCC---CCTTTTTTCTTCCEEECCSSC
T ss_pred CCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccc---cCHhHhccCCCccEEECCCCc
Confidence 9997 8877 66789999999999999997765 5678999999999999966542 334458899999999999999
Q ss_pred CCccCc-ccCCCCCCCEEEccCCCCCcc-chhhcCCCCCCEEEccCCCCCccCc-cccCCCCCCEEeCcCCcCCCCCccc
Q 001142 176 IRYLPP-EIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPS-GLYLLQRLENLDLSNNRLTSLGSLD 252 (1142)
Q Consensus 176 L~~IP~-~l~~L~~L~~L~Ls~N~L~~l-P~~l~~L~~L~~L~Ls~N~Ls~IP~-~l~~L~~L~~L~Ls~N~Ls~~~p~~ 252 (1142)
|+.+|. .|..+++|+.|+|++|+|+.+ |..+..+++|+.|+|++|+|+.+|. .+..+++|+.|+|++|.++...+..
T Consensus 165 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~ 244 (285)
T 1ozn_A 165 ISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR 244 (285)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH
T ss_pred ccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH
Confidence 998877 589999999999999999966 8899999999999999999998875 4888999999999999998755421
Q ss_pred ccCCCCCCEEEccCCCCCCCCCCCchhh
Q 001142 253 LCLMHNLQNLNLQYNKLLSYCQVPSWIC 280 (1142)
Q Consensus 253 l~~L~~L~~L~Ls~N~L~~~~~iP~~~~ 280 (1142)
.-+..|+.+..+.|.+.| ..|..+.
T Consensus 245 -~~~~~l~~~~~~~~~~~c--~~p~~l~ 269 (285)
T 1ozn_A 245 -PLWAWLQKFRGSSSEVPC--SLPQRLA 269 (285)
T ss_dssp -HHHHHHHHCCSEECCCBE--EESGGGT
T ss_pred -HHHHHHHhcccccCcccc--CCchHhC
Confidence 112234555677788776 5665543
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.3e-24 Score=254.15 Aligned_cols=220 Identities=21% Similarity=0.215 Sum_probs=195.2
Q ss_pred CCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccC-ccccCCcCCcEEEccCCCCCcCc-hhhcCCCCCCEE
Q 001142 42 DDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIP-KSVGRYEKLRNLKFFGNEINLFP-SEVGNLLGLECL 119 (1142)
Q Consensus 42 ~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP-~~l~~L~~L~~L~Ls~N~L~~lP-~~l~~L~~L~~L 119 (1142)
....+++++++|+.++.... ++++.|+|++|.|+.++ ..|.++++|++|+|++|+|+.++ ..|.++++|+.|
T Consensus 44 ~~~~v~c~~~~l~~iP~~~~------~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L 117 (440)
T 3zyj_A 44 QFSKVICVRKNLREVPDGIS------TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTL 117 (440)
T ss_dssp TSCEEECCSCCCSSCCSCCC------TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEE
T ss_pred CCCEEEeCCCCcCcCCCCCC------CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEE
Confidence 46789999999997654322 68999999999999885 67999999999999999999775 568999999999
Q ss_pred EccCCCCCCCcc-cccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccC-CCCCccCc-ccCCCCCCCEEEccC
Q 001142 120 QIKISSPGVNGF-ALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCH-FSIRYLPP-EIGCLSNLEQLDLSF 196 (1142)
Q Consensus 120 ~Ls~N~l~~~~~-~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~-N~L~~IP~-~l~~L~~L~~L~Ls~ 196 (1142)
+|++|.+..++. .|..+++|++|+|++|.+. ...+..|.++++|+.|+|++ |.++.+|. .|..+++|++|+|++
T Consensus 118 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~---~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~ 194 (440)
T 3zyj_A 118 ELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE---SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAM 194 (440)
T ss_dssp ECCSSCCSSCCTTTSCSCSSCCEEECCSCCCC---EECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTT
T ss_pred ECCCCcCCeeCHhHhhccccCceeeCCCCccc---ccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCC
Confidence 999999887775 6999999999999996653 33345788999999999999 56777766 689999999999999
Q ss_pred CCCCccchhhcCCCCCCEEEccCCCCCcc-CccccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccCCCCCC
Q 001142 197 NKMKYLPTEICYLKALISLKVANNKLVEL-PSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 197 N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~I-P~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1142)
|+|+.+|. +..+++|+.|+|++|+|+.+ |..+..+++|+.|+|++|+|+++++..|..+++|+.|+|++|+|+.
T Consensus 195 n~l~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 269 (440)
T 3zyj_A 195 CNLREIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTL 269 (440)
T ss_dssp SCCSSCCC-CTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCC
T ss_pred CcCccccc-cCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCc
Confidence 99999984 88999999999999999966 7788899999999999999999999999999999999999999997
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.9e-25 Score=268.85 Aligned_cols=240 Identities=17% Similarity=0.121 Sum_probs=206.3
Q ss_pred ccCCCCCCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCC
Q 001142 11 QKSPEGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRY 90 (1142)
Q Consensus 11 ~~~~~~~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L 90 (1142)
...+..+.+..|.+..|+|+.+.+..|.++++|++|+|++|.|++.+| ++.+++|++|+|++|.|+.+|..
T Consensus 28 ~l~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-----l~~l~~L~~L~Ls~N~l~~l~~~---- 98 (487)
T 3oja_A 28 SLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD-----LESLSTLRTLDLNNNYVQELLVG---- 98 (487)
T ss_dssp TTSTTGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE-----CTTCTTCCEEECCSSEEEEEEEC----
T ss_pred HhcccCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc-----cccCCCCCEEEecCCcCCCCCCC----
Confidence 334455589999999999999999999999999999999999988665 45569999999999999988743
Q ss_pred cCCcEEEccCCCCCcCchhhcCCCCCCEEEccCCCCCCC-cccccCCCCCCEEECCCCCCCCCcccchhhhc-CCCCCcE
Q 001142 91 EKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVN-GFALNKLKGLKELELSKVPPRPSVLTLLSEIA-GLKCLTK 168 (1142)
Q Consensus 91 ~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~-~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~-~L~~L~~ 168 (1142)
++|++|+|++|.|+.+|.. .+++|+.|+|++|.+... |..+..+++|++|+|++|.+ .+..|..+. .+++|+.
T Consensus 99 ~~L~~L~L~~N~l~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l---~~~~~~~l~~~l~~L~~ 173 (487)
T 3oja_A 99 PSIETLHAANNNISRVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEI---DTVNFAELAASSDTLEH 173 (487)
T ss_dssp TTCCEEECCSSCCCCEEEC--CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCC---CEEEGGGGGGGTTTCCE
T ss_pred CCcCEEECcCCcCCCCCcc--ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCC---CCcChHHHhhhCCcccE
Confidence 7899999999999987653 468999999999997765 56788999999999999554 444566765 7899999
Q ss_pred EEccCCCCCccCcccCCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeCcCCcCC-C
Q 001142 169 LSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLT-S 247 (1142)
Q Consensus 169 L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls~N~Ls-~ 247 (1142)
|+|++|.|+.+|.. ..+++|+.|+|++|+|+.+|..+..+++|+.|+|++|.|+.||..+..+++|+.|+|++|.++ +
T Consensus 174 L~Ls~N~l~~~~~~-~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~l~~N~l~c~ 252 (487)
T 3oja_A 174 LNLQYNFIYDVKGQ-VVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCG 252 (487)
T ss_dssp EECTTSCCCEEECC-CCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCBCHH
T ss_pred EecCCCcccccccc-ccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCCcCcccchhhccCCCCCEEEcCCCCCcCc
Confidence 99999999988653 468999999999999999988899999999999999999999999999999999999999998 6
Q ss_pred CCcccccCCCCCCEEEcc
Q 001142 248 LGSLDLCLMHNLQNLNLQ 265 (1142)
Q Consensus 248 ~~p~~l~~L~~L~~L~Ls 265 (1142)
.+|.++..++.|+.|+++
T Consensus 253 ~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 253 TLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp HHHHHHTTCHHHHHHHHH
T ss_pred chHHHHHhCCCCcEEecc
Confidence 667788888888888887
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.9e-24 Score=257.14 Aligned_cols=224 Identities=21% Similarity=0.236 Sum_probs=199.2
Q ss_pred CCCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCcCCc
Q 001142 16 GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLR 94 (1142)
Q Consensus 16 ~~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~-~l~~L~~L~ 94 (1142)
++.+..|.+..|+|+.+.+..|.++++|++|+|++|+|++..+..|.. +++|++|+|++|.|+.+|. .|..+++|+
T Consensus 74 ~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~---l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 150 (452)
T 3zyi_A 74 PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNG---LASLNTLELFDNWLTVIPSGAFEYLSKLR 150 (452)
T ss_dssp CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTT---CTTCCEEECCSSCCSBCCTTTSSSCTTCC
T ss_pred CCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccC---cccCCEEECCCCcCCccChhhhcccCCCC
Confidence 357999999999999999999999999999999999999988876654 5999999999999999976 488999999
Q ss_pred EEEccCCCCCcCch-hhcCCCCCCEEEccCCC-CCCCcc-cccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEc
Q 001142 95 NLKFFGNEINLFPS-EVGNLLGLECLQIKISS-PGVNGF-ALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSV 171 (1142)
Q Consensus 95 ~L~Ls~N~L~~lP~-~l~~L~~L~~L~Ls~N~-l~~~~~-~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~L 171 (1142)
+|+|++|+|+.+|. .|.++++|+.|+|++|+ ++.++. .|..+++|++|+|++|.+.. +| .+..+++|+.|+|
T Consensus 151 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~----~~-~~~~l~~L~~L~L 225 (452)
T 3zyi_A 151 ELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD----MP-NLTPLVGLEELEM 225 (452)
T ss_dssp EEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS----CC-CCTTCTTCCEEEC
T ss_pred EEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc----cc-cccccccccEEEC
Confidence 99999999998876 58899999999999854 666664 68999999999999977653 33 5788999999999
Q ss_pred cCCCCCcc-CcccCCCCCCCEEEccCCCCCcc-chhhcCCCCCCEEEccCCCCCccCcc-ccCCCCCCEEeCcCCcCCC
Q 001142 172 CHFSIRYL-PPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSNNRLTS 247 (1142)
Q Consensus 172 s~N~L~~I-P~~l~~L~~L~~L~Ls~N~L~~l-P~~l~~L~~L~~L~Ls~N~Ls~IP~~-l~~L~~L~~L~Ls~N~Ls~ 247 (1142)
++|.|+.+ |..|..+++|+.|+|++|+|+.+ |..|..+++|+.|+|++|+|+.+|.. +..+++|+.|+|++|.+..
T Consensus 226 s~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C 304 (452)
T 3zyi_A 226 SGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNC 304 (452)
T ss_dssp TTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEEC
T ss_pred cCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCC
Confidence 99999976 66899999999999999999966 67899999999999999999988765 5669999999999998764
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-25 Score=253.65 Aligned_cols=226 Identities=19% Similarity=0.103 Sum_probs=190.4
Q ss_pred cccccCCCCCCcccCCCC-CC-------CCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCC
Q 001142 19 KEKLPSEANKINNEKNGS-VN-------DDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRY 90 (1142)
Q Consensus 19 l~~L~~~~N~i~~l~~~~-f~-------~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L 90 (1142)
++.|.+..|+|+.+.... +. ++++|++|+|++|+|++.+|..+. ++.+++|++|+|++|.|+.+|..+..+
T Consensus 65 L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~l 143 (312)
T 1wwl_A 65 IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLL-EATGPDLNILNLRNVSWATRDAWLAEL 143 (312)
T ss_dssp HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSS-SCCSCCCSEEEEESCBCSSSSSHHHHH
T ss_pred HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHH-HhcCCCccEEEccCCCCcchhHHHHHH
Confidence 778899999997654433 22 689999999999999998887541 245699999999999999888888877
Q ss_pred -----cCCcEEEccCCCCCcCc-hhhcCCCCCCEEEccCCCCCC---Cccc--ccCCCCCCEEECCCCCCCCCcccchhh
Q 001142 91 -----EKLRNLKFFGNEINLFP-SEVGNLLGLECLQIKISSPGV---NGFA--LNKLKGLKELELSKVPPRPSVLTLLSE 159 (1142)
Q Consensus 91 -----~~L~~L~Ls~N~L~~lP-~~l~~L~~L~~L~Ls~N~l~~---~~~~--~~~L~~L~~L~Ls~n~~n~~~~~lp~~ 159 (1142)
++|++|+|++|+|+.+| ..|+++++|+.|+|++|.+.. .+.. +..+++|++|+|++|.+..........
T Consensus 144 ~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 223 (312)
T 1wwl_A 144 QQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSAL 223 (312)
T ss_dssp HTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHH
T ss_pred HHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHH
Confidence 89999999999999776 779999999999999998543 1223 389999999999998775332222234
Q ss_pred hcCCCCCcEEEccCCCCCccC--cccCCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCE
Q 001142 160 IAGLKCLTKLSVCHFSIRYLP--PEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLEN 237 (1142)
Q Consensus 160 l~~L~~L~~L~Ls~N~L~~IP--~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~ 237 (1142)
+.++++|+.|+|++|+|+.++ ..+..+++|++|+|++|+|+.+|..+. ++|+.|+|++|+|+.+|. +..+++|+.
T Consensus 224 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~ip~~~~--~~L~~L~Ls~N~l~~~p~-~~~l~~L~~ 300 (312)
T 1wwl_A 224 AAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLP--AKLSVLDLSYNRLDRNPS-PDELPQVGN 300 (312)
T ss_dssp HHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCSSCCSSCC--SEEEEEECCSSCCCSCCC-TTTSCEEEE
T ss_pred HhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccChhhhhcc--CCceEEECCCCCCCCChh-HhhCCCCCE
Confidence 568899999999999999654 456778999999999999999999887 899999999999999987 889999999
Q ss_pred EeCcCCcCCCC
Q 001142 238 LDLSNNRLTSL 248 (1142)
Q Consensus 238 L~Ls~N~Ls~~ 248 (1142)
|+|++|+|++.
T Consensus 301 L~L~~N~l~~~ 311 (312)
T 1wwl_A 301 LSLKGNPFLDS 311 (312)
T ss_dssp EECTTCTTTCC
T ss_pred EeccCCCCCCC
Confidence 99999999864
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.92 E-value=5.9e-24 Score=253.60 Aligned_cols=234 Identities=26% Similarity=0.258 Sum_probs=153.4
Q ss_pred CCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEE
Q 001142 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNL 96 (1142)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L 96 (1142)
+.++.|.+..|+|+.++ .|.++++|++|+|++|++++ +|..+ .+|++|+|++|.++.+| .+.++++|++|
T Consensus 131 ~~L~~L~L~~n~l~~lp--~~~~l~~L~~L~l~~N~l~~-lp~~~------~~L~~L~L~~n~l~~l~-~~~~l~~L~~L 200 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEKLP--ELQNSSFLKIIDVDNNSLKK-LPDLP------PSLEFIAAGNNQLEELP-ELQNLPFLTAI 200 (454)
T ss_dssp TTCCEEECCSSCCSSCC--CCTTCTTCCEEECCSSCCSC-CCCCC------TTCCEEECCSSCCSSCC-CCTTCTTCCEE
T ss_pred CCCCEEECcCCCCCCCc--ccCCCCCCCEEECCCCcCcc-cCCCc------ccccEEECcCCcCCcCc-cccCCCCCCEE
Confidence 35666666666666654 46677777777777777665 33322 35666666666666666 46666666666
Q ss_pred EccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCC
Q 001142 97 KFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSI 176 (1142)
Q Consensus 97 ~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L 176 (1142)
+|++|+|+.+|... ++|+.|++++|.+..+| .+..+++|++|++++|.+.. +|.. +++|+.|++++|++
T Consensus 201 ~l~~N~l~~l~~~~---~~L~~L~l~~n~l~~lp-~~~~l~~L~~L~l~~N~l~~----l~~~---~~~L~~L~l~~N~l 269 (454)
T 1jl5_A 201 YADNNSLKKLPDLP---LSLESIVAGNNILEELP-ELQNLPFLTTIYADNNLLKT----LPDL---PPSLEALNVRDNYL 269 (454)
T ss_dssp ECCSSCCSSCCCCC---TTCCEEECCSSCCSSCC-CCTTCTTCCEEECCSSCCSS----CCSC---CTTCCEEECCSSCC
T ss_pred ECCCCcCCcCCCCc---CcccEEECcCCcCCccc-ccCCCCCCCEEECCCCcCCc----cccc---ccccCEEECCCCcc
Confidence 66666666665432 46666666666666555 36667777777777755432 2221 24556666666666
Q ss_pred CccCcccCCCCCCCEEEccCCCCCccc---hhhc-------------CC-CCCCEEEccCCCCCccCccccCCCCCCEEe
Q 001142 177 RYLPPEIGCLSNLEQLDLSFNKMKYLP---TEIC-------------YL-KALISLKVANNKLVELPSGLYLLQRLENLD 239 (1142)
Q Consensus 177 ~~IP~~l~~L~~L~~L~Ls~N~L~~lP---~~l~-------------~L-~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~ 239 (1142)
+.+|.. +++|+.|+|++|+|+.+| ..+. .+ ++|+.|+|++|+|+.+|.. +++|+.|+
T Consensus 270 ~~l~~~---~~~L~~L~ls~N~l~~l~~~~~~L~~L~l~~N~l~~i~~~~~~L~~L~Ls~N~l~~lp~~---~~~L~~L~ 343 (454)
T 1jl5_A 270 TDLPEL---PQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIELPAL---PPRLERLI 343 (454)
T ss_dssp SCCCCC---CTTCCEEECCSSCCSEESCCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCSCCCCC---CTTCCEEE
T ss_pred cccCcc---cCcCCEEECcCCccCcccCcCCcCCEEECcCCcCCcccCCcCcCCEEECCCCcccccccc---CCcCCEEE
Confidence 655543 245666666666665432 2211 22 5888999999999888865 47899999
Q ss_pred CcCCcCCCCCcccccCCCCCCEEEccCCCCCCCCCCCchhhc
Q 001142 240 LSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICC 281 (1142)
Q Consensus 240 Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~ 281 (1142)
|++|+|+++++ .+++|+.|+|++|+++++..+|.++..
T Consensus 344 L~~N~l~~lp~----~l~~L~~L~L~~N~l~~l~~ip~~l~~ 381 (454)
T 1jl5_A 344 ASFNHLAEVPE----LPQNLKQLHVEYNPLREFPDIPESVED 381 (454)
T ss_dssp CCSSCCSCCCC----CCTTCCEEECCSSCCSSCCCCCTTCCE
T ss_pred CCCCccccccc----hhhhccEEECCCCCCCcCCCChHHHHh
Confidence 99999998665 478999999999999987667776653
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-23 Score=233.16 Aligned_cols=201 Identities=26% Similarity=0.362 Sum_probs=156.0
Q ss_pred CCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCcCCcEEEccCCCCCcCchh-hcCCCCCCEE
Q 001142 42 DDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLRNLKFFGNEINLFPSE-VGNLLGLECL 119 (1142)
Q Consensus 42 ~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~-~l~~L~~L~~L~Ls~N~L~~lP~~-l~~L~~L~~L 119 (1142)
+++++|+++|+|+.++ ..+. ++|+.|+|++|.|+.+|. .|.++++|++|+|++|.|+.+|.. |.++++|++|
T Consensus 17 ~~~~l~~~~~~l~~ip-~~~~-----~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L 90 (270)
T 2o6q_A 17 NKNSVDCSSKKLTAIP-SNIP-----ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETL 90 (270)
T ss_dssp TTTEEECTTSCCSSCC-SCCC-----TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEE
T ss_pred CCCEEEccCCCCCccC-CCCC-----CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEE
Confidence 4567777777777533 2221 456777777777776654 566777777777777777766654 3556666666
Q ss_pred EccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCc-ccCCCCCCCEEEccCCC
Q 001142 120 QIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFNK 198 (1142)
Q Consensus 120 ~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~Ls~N~ 198 (1142)
+|++|.+..++ +..|.++++|+.|+|++|+++.+|. .|..+++|++|+|++|+
T Consensus 91 ~l~~n~l~~~~--------------------------~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 144 (270)
T 2o6q_A 91 WVTDNKLQALP--------------------------IGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNE 144 (270)
T ss_dssp ECCSSCCCCCC--------------------------TTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred ECCCCcCCcCC--------------------------HhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCc
Confidence 66655543322 2345678889999999999997765 57899999999999999
Q ss_pred CCccchh-hcCCCCCCEEEccCCCCCccCcc-ccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccCCCCCCCCC
Q 001142 199 MKYLPTE-ICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQ 274 (1142)
Q Consensus 199 L~~lP~~-l~~L~~L~~L~Ls~N~Ls~IP~~-l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~~~~ 274 (1142)
|+.+|.. |..+++|+.|+|++|+|+.+|.. +..+++|+.|+|++|+|+++++..|..+++|+.|+|++|+|.|.|.
T Consensus 145 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 145 LQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred CCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence 9988754 78899999999999999988764 6789999999999999999999889999999999999999999886
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.9e-23 Score=258.02 Aligned_cols=214 Identities=26% Similarity=0.227 Sum_probs=99.9
Q ss_pred CcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEE
Q 001142 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLK 97 (1142)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~ 97 (1142)
.+..|.+..|+|+.++. .+++|++|||++|+|+++++ .+++|++|+|++|.|+.+|. .+++|+.|+
T Consensus 62 ~L~~L~L~~N~l~~lp~----~l~~L~~L~Ls~N~l~~lp~-------~l~~L~~L~Ls~N~l~~l~~---~l~~L~~L~ 127 (622)
T 3g06_A 62 HITTLVIPDNNLTSLPA----LPPELRTLEVSGNQLTSLPV-------LPPGLLELSIFSNPLTHLPA---LPSGLCKLW 127 (622)
T ss_dssp TCSEEEECSCCCSCCCC----CCTTCCEEEECSCCCSCCCC-------CCTTCCEEEECSCCCCCCCC---CCTTCCEEE
T ss_pred CCcEEEecCCCCCCCCC----cCCCCCEEEcCCCcCCcCCC-------CCCCCCEEECcCCcCCCCCC---CCCCcCEEE
Confidence 44444444444444433 23444555555554443221 12444555555554444444 233444555
Q ss_pred ccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCC
Q 001142 98 FFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIR 177 (1142)
Q Consensus 98 Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~ 177 (1142)
|++|+|+.+|.. +++|+.|+|++|.+..+|. .+.+|+.|++++|.+.. +| ..+++|+.|++++|.|+
T Consensus 128 L~~N~l~~lp~~---l~~L~~L~Ls~N~l~~l~~---~~~~L~~L~L~~N~l~~----l~---~~~~~L~~L~Ls~N~l~ 194 (622)
T 3g06_A 128 IFGNQLTSLPVL---PPGLQELSVSDNQLASLPA---LPSELCKLWAYNNQLTS----LP---MLPSGLQELSVSDNQLA 194 (622)
T ss_dssp CCSSCCSCCCCC---CTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCCSC----CC---CCCTTCCEEECCSSCCS
T ss_pred CCCCCCCcCCCC---CCCCCEEECcCCcCCCcCC---ccCCCCEEECCCCCCCC----Cc---ccCCCCcEEECCCCCCC
Confidence 555555444432 2444555555554444332 12334444444433221 22 22345555555555555
Q ss_pred ccCcccCCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeCcCCcCCCCCcccccCCC
Q 001142 178 YLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMH 257 (1142)
Q Consensus 178 ~IP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~ 257 (1142)
.+|.. +++|+.|+|++|.|+.+|.. +++|+.|+|++|+|+.|| ..+++|+.|+|++|+|+++++ .++
T Consensus 195 ~l~~~---~~~L~~L~L~~N~l~~l~~~---~~~L~~L~Ls~N~L~~lp---~~l~~L~~L~Ls~N~L~~lp~----~~~ 261 (622)
T 3g06_A 195 SLPTL---PSELYKLWAYNNRLTSLPAL---PSGLKELIVSGNRLTSLP---VLPSELKELMVSGNRLTSLPM----LPS 261 (622)
T ss_dssp CCCCC---CTTCCEEECCSSCCSSCCCC---CTTCCEEECCSSCCSCCC---CCCTTCCEEECCSSCCSCCCC----CCT
T ss_pred CCCCc---cchhhEEECcCCcccccCCC---CCCCCEEEccCCccCcCC---CCCCcCcEEECCCCCCCcCCc----ccc
Confidence 55442 24455555555555554432 245555555555555555 233455555555555554433 345
Q ss_pred CCCEEEccCCCCCC
Q 001142 258 NLQNLNLQYNKLLS 271 (1142)
Q Consensus 258 ~L~~L~Ls~N~L~~ 271 (1142)
+|+.|+|++|+|+.
T Consensus 262 ~L~~L~Ls~N~L~~ 275 (622)
T 3g06_A 262 GLLSLSVYRNQLTR 275 (622)
T ss_dssp TCCEEECCSSCCCS
T ss_pred cCcEEeCCCCCCCc
Confidence 55555555555553
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.1e-23 Score=257.51 Aligned_cols=227 Identities=22% Similarity=0.172 Sum_probs=196.6
Q ss_pred CCCCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCc
Q 001142 15 EGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLR 94 (1142)
Q Consensus 15 ~~~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~ 94 (1142)
..++++.|.+..|+|+.++. .+++|++|+|++|+|++..+ .+++|+.|+|++|+|+.||.. +++|+
T Consensus 79 ~l~~L~~L~Ls~N~l~~lp~----~l~~L~~L~Ls~N~l~~l~~-------~l~~L~~L~L~~N~l~~lp~~---l~~L~ 144 (622)
T 3g06_A 79 LPPELRTLEVSGNQLTSLPV----LPPGLLELSIFSNPLTHLPA-------LPSGLCKLWIFGNQLTSLPVL---PPGLQ 144 (622)
T ss_dssp CCTTCCEEEECSCCCSCCCC----CCTTCCEEEECSCCCCCCCC-------CCTTCCEEECCSSCCSCCCCC---CTTCC
T ss_pred cCCCCCEEEcCCCcCCcCCC----CCCCCCEEECcCCcCCCCCC-------CCCCcCEEECCCCCCCcCCCC---CCCCC
Confidence 45689999999999999876 78999999999999998654 237899999999999999975 47899
Q ss_pred EEEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCC
Q 001142 95 NLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHF 174 (1142)
Q Consensus 95 ~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N 174 (1142)
+|+|++|+|+.+|.. +.+|+.|+|++|.+..+| ..+++|+.|++++|.+.. +|. .+++|+.|++++|
T Consensus 145 ~L~Ls~N~l~~l~~~---~~~L~~L~L~~N~l~~l~---~~~~~L~~L~Ls~N~l~~----l~~---~~~~L~~L~L~~N 211 (622)
T 3g06_A 145 ELSVSDNQLASLPAL---PSELCKLWAYNNQLTSLP---MLPSGLQELSVSDNQLAS----LPT---LPSELYKLWAYNN 211 (622)
T ss_dssp EEECCSSCCSCCCCC---CTTCCEEECCSSCCSCCC---CCCTTCCEEECCSSCCSC----CCC---CCTTCCEEECCSS
T ss_pred EEECcCCcCCCcCCc---cCCCCEEECCCCCCCCCc---ccCCCCcEEECCCCCCCC----CCC---ccchhhEEECcCC
Confidence 999999999999863 578999999999988887 567899999999977654 333 2478999999999
Q ss_pred CCCccCcccCCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeCcCCcCCCCCccccc
Q 001142 175 SIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLC 254 (1142)
Q Consensus 175 ~L~~IP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~ 254 (1142)
.|+.+|.. +++|+.|+|++|+|+.+| ..+++|+.|+|++|+|+.||. .+++|+.|+|++|+|+.++ ..|.
T Consensus 212 ~l~~l~~~---~~~L~~L~Ls~N~L~~lp---~~l~~L~~L~Ls~N~L~~lp~---~~~~L~~L~Ls~N~L~~lp-~~l~ 281 (622)
T 3g06_A 212 RLTSLPAL---PSGLKELIVSGNRLTSLP---VLPSELKELMVSGNRLTSLPM---LPSGLLSLSVYRNQLTRLP-ESLI 281 (622)
T ss_dssp CCSSCCCC---CTTCCEEECCSSCCSCCC---CCCTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCCCSCC-GGGG
T ss_pred cccccCCC---CCCCCEEEccCCccCcCC---CCCCcCcEEECCCCCCCcCCc---ccccCcEEeCCCCCCCcCC-HHHh
Confidence 99999864 588999999999999999 456899999999999999998 6788999999999999765 5799
Q ss_pred CCCCCCEEEccCCCCCCCCCCCchhh
Q 001142 255 LMHNLQNLNLQYNKLLSYCQVPSWIC 280 (1142)
Q Consensus 255 ~L~~L~~L~Ls~N~L~~~~~iP~~~~ 280 (1142)
.+++|+.|+|++|+|++ .+|..+.
T Consensus 282 ~l~~L~~L~L~~N~l~~--~~~~~l~ 305 (622)
T 3g06_A 282 HLSSETTVNLEGNPLSE--RTLQALR 305 (622)
T ss_dssp GSCTTCEEECCSCCCCH--HHHHHHH
T ss_pred hccccCEEEecCCCCCC--cCHHHHH
Confidence 99999999999999998 4555444
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=7e-24 Score=238.05 Aligned_cols=211 Identities=25% Similarity=0.257 Sum_probs=153.9
Q ss_pred CCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCcc-CccccCCcCCcEEEccCCCCCcCchhhcCCCC
Q 001142 37 VNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLI-PKSVGRYEKLRNLKFFGNEINLFPSEVGNLLG 115 (1142)
Q Consensus 37 f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~i-P~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~ 115 (1142)
+.++++++.|++++|+|+.+++..+ ++|+.|+|++|.|+.+ |..|..+++|++|+|++|.|+.+|.. +.+++
T Consensus 6 ~~~l~~l~~l~~~~~~l~~ip~~~~------~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-~~l~~ 78 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLTALPPDLP------KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD-GTLPV 78 (290)
T ss_dssp EECSTTCCEEECTTSCCSSCCSCCC------TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC-SCCTT
T ss_pred ccccCCccEEECCCCCCCcCCCCCC------CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC-CCCCc
Confidence 4555666666666666665433221 4566666666666655 34566666666666666666655443 44555
Q ss_pred CCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCc-ccCCCCCCCEEEc
Q 001142 116 LECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDL 194 (1142)
Q Consensus 116 L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~L 194 (1142)
|+.|+|++|.+. .+|..+..+++|+.|+|++|+|+.+|. .|..+++|++|+|
T Consensus 79 L~~L~Ls~N~l~---------------------------~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L 131 (290)
T 1p9a_G 79 LGTLDLSHNQLQ---------------------------SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYL 131 (290)
T ss_dssp CCEEECCSSCCS---------------------------SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEEC
T ss_pred CCEEECCCCcCC---------------------------cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEEC
Confidence 555555544433 345556778888999999999998864 6899999999999
Q ss_pred cCCCCCccchh-hcCCCCCCEEEccCCCCCccCccc-cCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccCCCCCCC
Q 001142 195 SFNKMKYLPTE-ICYLKALISLKVANNKLVELPSGL-YLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSY 272 (1142)
Q Consensus 195 s~N~L~~lP~~-l~~L~~L~~L~Ls~N~Ls~IP~~l-~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~~ 272 (1142)
++|+|+.+|.. |..+++|+.|+|++|+|+.+|..+ ..+++|+.|+|++|+|+.+++ .+..+.+|+.|+|++|+|.|.
T Consensus 132 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~-~~~~~~~L~~l~L~~Np~~C~ 210 (290)
T 1p9a_G 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPK-GFFGSHLLPFAFLHGNPWLCN 210 (290)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCT-TTTTTCCCSEEECCSCCBCCS
T ss_pred CCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCCccCh-hhcccccCCeEEeCCCCccCc
Confidence 99999988654 678999999999999999998765 569999999999999997765 677788999999999999998
Q ss_pred CCCCchhhcc
Q 001142 273 CQVPSWICCN 282 (1142)
Q Consensus 273 ~~iP~~~~~~ 282 (1142)
|.+.....|.
T Consensus 211 c~~~~l~~wl 220 (290)
T 1p9a_G 211 CEILYFRRWL 220 (290)
T ss_dssp GGGHHHHHHH
T ss_pred CccHHHHHHH
Confidence 8765544443
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.8e-23 Score=254.86 Aligned_cols=147 Identities=17% Similarity=0.111 Sum_probs=120.1
Q ss_pred cCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCcCCcEEEccCC
Q 001142 23 PSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLRNLKFFGN 101 (1142)
Q Consensus 23 ~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~-~l~~L~~L~~L~Ls~N 101 (1142)
.-..-+|+.++.+ + -+++++|||++|+|+++.+..|..+ ++|++|+|++|.|+.||+ .|.+|++|++|+|++|
T Consensus 37 ~c~~~~l~~vP~~-l--p~~~~~LdLs~N~i~~l~~~~f~~l---~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N 110 (635)
T 4g8a_A 37 QCMELNFYKIPDN-L--PFSTKNLDLSFNPLRHLGSYSFFSF---PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 110 (635)
T ss_dssp ECTTSCCSSCCSS-S--CTTCCEEECTTSCCCEECTTTTTTC---TTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred ECCCCCcCccCCC-C--CcCCCEEEeeCCCCCCCCHHHHhCC---CCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCC
Confidence 3445567777643 1 1479999999999999888777655 999999999999999965 6999999999999999
Q ss_pred CCCcCchh-hcCCCCCCEEEccCCCCCCCcc-cccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCC
Q 001142 102 EINLFPSE-VGNLLGLECLQIKISSPGVNGF-ALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIR 177 (1142)
Q Consensus 102 ~L~~lP~~-l~~L~~L~~L~Ls~N~l~~~~~-~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~ 177 (1142)
+|+.+|.. |.+|++|++|+|++|++..++. .|..+++|++|+|++|.+... .+|..+..+++|+.|+|++|+|+
T Consensus 111 ~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~--~~~~~~~~l~~L~~L~L~~N~l~ 186 (635)
T 4g8a_A 111 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF--KLPEYFSNLTNLEHLDLSSNKIQ 186 (635)
T ss_dssp CCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCC--CCCGGGGGCTTCCEEECCSSCCC
T ss_pred cCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccC--CCchhhccchhhhhhcccCcccc
Confidence 99998764 8899999999999999887764 699999999999999766432 34556677777777777777654
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.3e-22 Score=241.95 Aligned_cols=218 Identities=22% Similarity=0.168 Sum_probs=111.0
Q ss_pred ccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEEcc
Q 001142 20 EKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFF 99 (1142)
Q Consensus 20 ~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls 99 (1142)
..|.+..|+|++++.. .++|++|+|++|++++ +|..+ ++|++|+|++|.++.+|... ++|++|+|+
T Consensus 74 ~~L~l~~~~l~~lp~~----~~~L~~L~l~~n~l~~-lp~~~------~~L~~L~l~~n~l~~l~~~~---~~L~~L~L~ 139 (454)
T 1jl5_A 74 HELELNNLGLSSLPEL----PPHLESLVASCNSLTE-LPELP------QSLKSLLVDNNNLKALSDLP---PLLEYLGVS 139 (454)
T ss_dssp SEEECTTSCCSCCCSC----CTTCSEEECCSSCCSS-CCCCC------TTCCEEECCSSCCSCCCSCC---TTCCEEECC
T ss_pred CEEEecCCccccCCCC----cCCCCEEEccCCcCCc-ccccc------CCCcEEECCCCccCcccCCC---CCCCEEECc
Confidence 4555555655555431 2455666666666655 33211 45555555555555554321 355555555
Q ss_pred CCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCcc
Q 001142 100 GNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYL 179 (1142)
Q Consensus 100 ~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~I 179 (1142)
+|+|+.+| .|+++++|++|++++|.+..+|.. ..+|++|++++|.+.. +| .+.++++|+.|++++|+++.+
T Consensus 140 ~n~l~~lp-~~~~l~~L~~L~l~~N~l~~lp~~---~~~L~~L~L~~n~l~~----l~-~~~~l~~L~~L~l~~N~l~~l 210 (454)
T 1jl5_A 140 NNQLEKLP-ELQNSSFLKIIDVDNNSLKKLPDL---PPSLEFIAAGNNQLEE----LP-ELQNLPFLTAIYADNNSLKKL 210 (454)
T ss_dssp SSCCSSCC-CCTTCTTCCEEECCSSCCSCCCCC---CTTCCEEECCSSCCSS----CC-CCTTCTTCCEEECCSSCCSSC
T ss_pred CCCCCCCc-ccCCCCCCCEEECCCCcCcccCCC---cccccEEECcCCcCCc----Cc-cccCCCCCCEEECCCCcCCcC
Confidence 55555555 355555555555555554444432 2355555555543322 23 345555555555555555555
Q ss_pred CcccCCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeCcCCcCCCCCcccccCCCCC
Q 001142 180 PPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNL 259 (1142)
Q Consensus 180 P~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L 259 (1142)
|... ++|++|+|++|+++.+|. ++.+++|+.|+|++|+|+.+|.. +++|+.|+|++|+|++++. . +++|
T Consensus 211 ~~~~---~~L~~L~l~~n~l~~lp~-~~~l~~L~~L~l~~N~l~~l~~~---~~~L~~L~l~~N~l~~l~~-~---~~~L 279 (454)
T 1jl5_A 211 PDLP---LSLESIVAGNNILEELPE-LQNLPFLTTIYADNNLLKTLPDL---PPSLEALNVRDNYLTDLPE-L---PQSL 279 (454)
T ss_dssp CCCC---TTCCEEECCSSCCSSCCC-CTTCTTCCEEECCSSCCSSCCSC---CTTCCEEECCSSCCSCCCC-C---CTTC
T ss_pred CCCc---CcccEEECcCCcCCcccc-cCCCCCCCEEECCCCcCCccccc---ccccCEEECCCCcccccCc-c---cCcC
Confidence 4422 355555555555555552 55555555555555555555532 2445555555555555332 1 2445
Q ss_pred CEEEccCCCCCC
Q 001142 260 QNLNLQYNKLLS 271 (1142)
Q Consensus 260 ~~L~Ls~N~L~~ 271 (1142)
+.|++++|++++
T Consensus 280 ~~L~ls~N~l~~ 291 (454)
T 1jl5_A 280 TFLDVSENIFSG 291 (454)
T ss_dssp CEEECCSSCCSE
T ss_pred CEEECcCCccCc
Confidence 555555555554
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.90 E-value=4.9e-23 Score=231.18 Aligned_cols=197 Identities=19% Similarity=0.228 Sum_probs=166.1
Q ss_pred CcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEE
Q 001142 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLK 97 (1142)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~ 97 (1142)
.+..+.+..|+|+.++...+ +++++|+|++|+|++..+..|..+ ++|++|+|++|.|+.+|.. ..+++|++|+
T Consensus 11 ~l~~l~~~~~~l~~ip~~~~---~~l~~L~L~~N~l~~~~~~~~~~l---~~L~~L~L~~n~l~~~~~~-~~l~~L~~L~ 83 (290)
T 1p9a_G 11 SHLEVNCDKRNLTALPPDLP---KDTTILHLSENLLYTFSLATLMPY---TRLTQLNLDRAELTKLQVD-GTLPVLGTLD 83 (290)
T ss_dssp TCCEEECTTSCCSSCCSCCC---TTCCEEECTTSCCSEEEGGGGTTC---TTCCEEECTTSCCCEEECC-SCCTTCCEEE
T ss_pred CccEEECCCCCCCcCCCCCC---CCCCEEEcCCCcCCccCHHHhhcC---CCCCEEECCCCccCcccCC-CCCCcCCEEE
Confidence 68889999999999986654 689999999999999888777655 9999999999999999765 7899999999
Q ss_pred ccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCC
Q 001142 98 FFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIR 177 (1142)
Q Consensus 98 Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~ 177 (1142)
|++|+|+.+|..+.++++|+.|+|++|.++.++ |..|.++++|+.|+|++|+|+
T Consensus 84 Ls~N~l~~l~~~~~~l~~L~~L~l~~N~l~~l~--------------------------~~~~~~l~~L~~L~L~~N~l~ 137 (290)
T 1p9a_G 84 LSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLP--------------------------LGALRGLGELQELYLKGNELK 137 (290)
T ss_dssp CCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCC--------------------------SSTTTTCTTCCEEECTTSCCC
T ss_pred CCCCcCCcCchhhccCCCCCEEECCCCcCcccC--------------------------HHHHcCCCCCCEEECCCCCCC
Confidence 999999999998988999999999888765544 234566777888888888888
Q ss_pred ccCcc-cCCCCCCCEEEccCCCCCccchh-hcCCCCCCEEEccCCCCCccCccccCCCCCCEEeCcCCcCCC
Q 001142 178 YLPPE-IGCLSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTS 247 (1142)
Q Consensus 178 ~IP~~-l~~L~~L~~L~Ls~N~L~~lP~~-l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls~N~Ls~ 247 (1142)
.+|.. |..+++|+.|+|++|+|+.+|.. +..+++|+.|+|++|+|+.||..++.+.+|+.|+|++|.+..
T Consensus 138 ~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 138 TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp CCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCC
T ss_pred ccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccC
Confidence 77654 57888888888888888888754 467888888999888888888888888888999999888764
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=5.9e-23 Score=227.61 Aligned_cols=221 Identities=19% Similarity=0.175 Sum_probs=183.0
Q ss_pred ccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCcCCcEEEccC
Q 001142 22 LPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLRNLKFFG 100 (1142)
Q Consensus 22 L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~-~l~~L~~L~~L~Ls~ 100 (1142)
+.....+++.++.... ++|++|+|++|+|++..+..|+. +++|++|+|++|.|+.+|. .|.++++|++|+|++
T Consensus 12 ~~c~~~~l~~ip~~l~---~~l~~L~ls~n~l~~~~~~~~~~---l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~ 85 (276)
T 2z62_A 12 YQCMELNFYKIPDNLP---FSTKNLDLSFNPLRHLGSYSFFS---FPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTG 85 (276)
T ss_dssp EECTTSCCSSCCSSSC---TTCCEEECTTCCCCEECTTTTTT---CTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTT
T ss_pred EEecCCCccccCCCCC---CCccEEECCCCcccccCHhHhcc---ccCCcEEECCCCcCCccCHHHccCCcCCCEEECCC
Confidence 4445566666665321 57999999999999887766654 4899999999999998865 789999999999999
Q ss_pred CCCCcCc-hhhcCCCCCCEEEccCCCCCCCcc-cccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCc
Q 001142 101 NEINLFP-SEVGNLLGLECLQIKISSPGVNGF-ALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRY 178 (1142)
Q Consensus 101 N~L~~lP-~~l~~L~~L~~L~Ls~N~l~~~~~-~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~ 178 (1142)
|.|+.++ ..|.++++|+.|++++|.+..++. .+..+++|++|++++|.+... .+|..+.++++|+.|+|++|+++.
T Consensus 86 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~--~l~~~~~~l~~L~~L~Ls~N~l~~ 163 (276)
T 2z62_A 86 NPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF--KLPEYFSNLTNLEHLDLSSNKIQS 163 (276)
T ss_dssp CCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCC--CCCGGGGGCTTCCEEECCSSCCCE
T ss_pred CccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCcccee--cCchhhccCCCCCEEECCCCCCCc
Confidence 9999775 568899999999999999776654 688999999999999665432 357789999999999999999998
Q ss_pred cCc-ccCCCCCCC----EEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccc-cCCCCCCEEeCcCCcCCCCCc
Q 001142 179 LPP-EIGCLSNLE----QLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGL-YLLQRLENLDLSNNRLTSLGS 250 (1142)
Q Consensus 179 IP~-~l~~L~~L~----~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~IP~~l-~~L~~L~~L~Ls~N~Ls~~~p 250 (1142)
+|. .+..+++|+ .|+|++|.|+.+|..+....+|+.|+|++|+|+.+|..+ ..+++|+.|+|++|.+++..+
T Consensus 164 ~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 164 IYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp ECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred CCHHHhhhhhhccccceeeecCCCcccccCccccCCCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence 764 666666666 899999999999877777779999999999999988764 679999999999999986543
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.90 E-value=3.9e-23 Score=233.74 Aligned_cols=195 Identities=22% Similarity=0.286 Sum_probs=123.7
Q ss_pred CCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCC
Q 001142 37 VNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGL 116 (1142)
Q Consensus 37 f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L 116 (1142)
+.++++|++|+|++|+++.. + .+ ..+++|++|+|++|.++.+|. +..+++|++|+|++|.|+.+| .+.++++|
T Consensus 37 ~~~l~~L~~L~l~~~~i~~l-~-~~---~~l~~L~~L~L~~n~i~~~~~-~~~l~~L~~L~L~~n~l~~~~-~~~~l~~L 109 (308)
T 1h6u_A 37 QADLDGITTLSAFGTGVTTI-E-GV---QYLNNLIGLELKDNQITDLAP-LKNLTKITELELSGNPLKNVS-AIAGLQSI 109 (308)
T ss_dssp HHHHHTCCEEECTTSCCCCC-T-TG---GGCTTCCEEECCSSCCCCCGG-GTTCCSCCEEECCSCCCSCCG-GGTTCTTC
T ss_pred HHHcCCcCEEEeeCCCccCc-h-hh---hccCCCCEEEccCCcCCCChh-HccCCCCCEEEccCCcCCCch-hhcCCCCC
Confidence 44556666666666666543 2 22 233666666666666666655 666666666666666666554 35556666
Q ss_pred CEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCcccCCCCCCCEEEccC
Q 001142 117 ECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSF 196 (1142)
Q Consensus 117 ~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~ 196 (1142)
+.|+|++|.+..++ .+..+++|+.|++++|.++.+|. +..+++|+.|+|++
T Consensus 110 ~~L~l~~n~l~~~~----------------------------~l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~ 160 (308)
T 1h6u_A 110 KTLDLTSTQITDVT----------------------------PLAGLSNLQVLYLDLNQITNISP-LAGLTNLQYLSIGN 160 (308)
T ss_dssp CEEECTTSCCCCCG----------------------------GGTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCS
T ss_pred CEEECCCCCCCCch----------------------------hhcCCCCCCEEECCCCccCcCcc-ccCCCCccEEEccC
Confidence 66665555544332 25556666666666666666654 66667777777777
Q ss_pred CCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccCCCCCC
Q 001142 197 NKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 197 N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1142)
|+|+.+|. +..+++|+.|+|++|+|+.+|. +..+++|+.|+|++|+|+++++ +..+++|+.|+|++|++++
T Consensus 161 n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 161 AQVSDLTP-LANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp SCCCCCGG-GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred CcCCCChh-hcCCCCCCEEECCCCccCcChh-hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeec
Confidence 77776655 6667777777777777776654 6666777777777777776654 6677777777777777765
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.2e-24 Score=261.15 Aligned_cols=201 Identities=19% Similarity=0.176 Sum_probs=144.6
Q ss_pred ceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCC
Q 001142 810 SSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSAD 889 (1142)
Q Consensus 810 ~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~~~ 889 (1142)
...++||+|+||.||+|.+.+..+++|....+..............++.+|++++++++||||+++..++...+..
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~---- 414 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNK---- 414 (540)
T ss_dssp ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTT----
T ss_pred CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCcc----
Confidence 4567999999999999998899999998655432222222223345568999999999999999655555443322
Q ss_pred CCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccccccC
Q 001142 890 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 969 (1142)
Q Consensus 890 ~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~~ 969 (1142)
+|||||+++++|.++++. +..|+.||+.||+|||++||+||||||+|||++.
T Consensus 415 ----------~lVmE~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~----- 466 (540)
T 3en9_A 415 ----------RIMMSYINGKLAKDVIED-------------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK----- 466 (540)
T ss_dssp ----------EEEEECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS-----
T ss_pred ----------EEEEECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC-----
Confidence 999999999999998753 5689999999999999999999999999999975
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001142 970 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1049 (1142)
Q Consensus 970 ~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~P 1049 (1142)
.+||+|||+++............ ........||+.|||||++.... ..|+..+|+|+..+-..+.+.++.+
T Consensus 467 ----~~kL~DFGla~~~~~~~~~~~~~---~~~~~~~~GT~~y~APEv~~~~~--~~Y~~~~d~ws~vl~~l~~v~~r~r 537 (540)
T 3en9_A 467 ----DLYIIDFGLGKISNLDEDKAVDL---IVFKKAVLSTHHEKFDEIWERFL--EGYKSVYDRWEIILELMKDVERRAR 537 (540)
T ss_dssp ----SEEECCCTTCEECCCHHHHHHHH---HHHHHHHHHHCGGGHHHHHHHHH--HHHHHHCTTHHHHHHHHHHHHTCSC
T ss_pred ----eEEEEECccCEECCCccccccch---hhhhhhhcCCCCcCCHHHHHHHH--HHHHHHHhHHHHHHHHHHHHHhccc
Confidence 49999999998765422110000 00012456999999999997532 3467888999999988888877766
Q ss_pred CC
Q 001142 1050 YM 1051 (1142)
Q Consensus 1050 f~ 1051 (1142)
|.
T Consensus 538 Y~ 539 (540)
T 3en9_A 538 YV 539 (540)
T ss_dssp CC
T ss_pred cC
Confidence 63
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=4.6e-23 Score=232.91 Aligned_cols=228 Identities=19% Similarity=0.123 Sum_probs=182.1
Q ss_pred CCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCC-ccCccc--cCCcCCcEEEccCCCCCc-Cc----hhhc
Q 001142 40 DDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLN-LIPKSV--GRYEKLRNLKFFGNEINL-FP----SEVG 111 (1142)
Q Consensus 40 l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt-~iP~~l--~~L~~L~~L~Ls~N~L~~-lP----~~l~ 111 (1142)
...++.|++.++.++...-..+.....+++|++|+|++|.++ .+|..+ ..+++|++|+|++|.|+. +| ..+.
T Consensus 63 ~~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~ 142 (310)
T 4glp_A 63 ALRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQW 142 (310)
T ss_dssp SCCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTT
T ss_pred hcceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhh
Confidence 335788999988876421111111123367999999999998 457777 889999999999999984 33 3456
Q ss_pred CCCCCCEEEccCCCCCCCc-ccccCCCCCCEEECCCCCCCCCcccc-hhhhcCCCCCcEEEccCCCCCccCcc----cCC
Q 001142 112 NLLGLECLQIKISSPGVNG-FALNKLKGLKELELSKVPPRPSVLTL-LSEIAGLKCLTKLSVCHFSIRYLPPE----IGC 185 (1142)
Q Consensus 112 ~L~~L~~L~Ls~N~l~~~~-~~~~~L~~L~~L~Ls~n~~n~~~~~l-p~~l~~L~~L~~L~Ls~N~L~~IP~~----l~~ 185 (1142)
.+++|++|+|++|.+...+ ..+..+++|++|+|++|.+....+.. +..+..+++|++|+|++|+|+.+|.. +..
T Consensus 143 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~ 222 (310)
T 4glp_A 143 LKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAA 222 (310)
T ss_dssp BCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHH
T ss_pred hccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhc
Confidence 7999999999999976655 67889999999999997653221111 22246889999999999999877653 478
Q ss_pred CCCCCEEEccCCCCCcc-chhhcCC---CCCCEEEccCCCCCccCccccCCCCCCEEeCcCCcCCCCCcccccCCCCCCE
Q 001142 186 LSNLEQLDLSFNKMKYL-PTEICYL---KALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQN 261 (1142)
Q Consensus 186 L~~L~~L~Ls~N~L~~l-P~~l~~L---~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~ 261 (1142)
+++|++|+|++|+|+.+ |..++.+ ++|+.|+|++|+|+.||..+. ++|+.|+|++|+|++++. +..+++|+.
T Consensus 223 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~--~~L~~L~Ls~N~l~~~~~--~~~l~~L~~ 298 (310)
T 4glp_A 223 GVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQVPKGLP--AKLRVLDLSSNRLNRAPQ--PDELPEVDN 298 (310)
T ss_dssp TCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCCSCCSCCC--SCCSCEECCSCCCCSCCC--TTSCCCCSC
T ss_pred CCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCCchhhhhc--CCCCEEECCCCcCCCCch--hhhCCCccE
Confidence 89999999999999966 8888776 699999999999999999886 799999999999999743 788999999
Q ss_pred EEccCCCCCC
Q 001142 262 LNLQYNKLLS 271 (1142)
Q Consensus 262 L~Ls~N~L~~ 271 (1142)
|+|++|+|+.
T Consensus 299 L~L~~N~l~~ 308 (310)
T 4glp_A 299 LTLDGNPFLV 308 (310)
T ss_dssp EECSSTTTSC
T ss_pred EECcCCCCCC
Confidence 9999999975
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.88 E-value=8e-22 Score=218.27 Aligned_cols=200 Identities=23% Similarity=0.294 Sum_probs=164.1
Q ss_pred CcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCcc-ccCCcCCcEE
Q 001142 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKS-VGRYEKLRNL 96 (1142)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~-l~~L~~L~~L 96 (1142)
....+.+..++|+.++.... ++|++|+|++|+|++..+..|+. +++|++|+|++|.|+.+|.. |.++++|++|
T Consensus 17 ~~~~l~~~~~~l~~ip~~~~---~~l~~L~l~~n~l~~~~~~~~~~---l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L 90 (270)
T 2o6q_A 17 NKNSVDCSSKKLTAIPSNIP---ADTKKLDLQSNKLSSLPSKAFHR---LTKLRLLYLNDNKLQTLPAGIFKELKNLETL 90 (270)
T ss_dssp TTTEEECTTSCCSSCCSCCC---TTCSEEECCSSCCSCCCTTSSSS---CTTCCEEECCSSCCSCCCTTTTSSCTTCCEE
T ss_pred CCCEEEccCCCCCccCCCCC---CCCCEEECcCCCCCeeCHHHhcC---CCCCCEEECCCCccCeeChhhhcCCCCCCEE
Confidence 45679999999999876433 68999999999999888766654 49999999999999999875 6889999999
Q ss_pred EccCCCCCcCchh-hcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCC
Q 001142 97 KFFGNEINLFPSE-VGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS 175 (1142)
Q Consensus 97 ~Ls~N~L~~lP~~-l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~ 175 (1142)
+|++|.|+.+|.. |.++++|+.|+|++|.+..++ +..|..+++|+.|+|++|.
T Consensus 91 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~--------------------------~~~~~~l~~L~~L~Ls~n~ 144 (270)
T 2o6q_A 91 WVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLP--------------------------PRVFDSLTKLTYLSLGYNE 144 (270)
T ss_dssp ECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCC--------------------------TTTTTTCTTCCEEECCSSC
T ss_pred ECCCCcCCcCCHhHcccccCCCEEECCCCccCeeC--------------------------HHHhCcCcCCCEEECCCCc
Confidence 9999999988765 677888888888887755433 2345667788888888888
Q ss_pred CCccCcc-cCCCCCCCEEEccCCCCCccch-hhcCCCCCCEEEccCCCCCccCcc-ccCCCCCCEEeCcCCcCCCCC
Q 001142 176 IRYLPPE-IGCLSNLEQLDLSFNKMKYLPT-EICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSNNRLTSLG 249 (1142)
Q Consensus 176 L~~IP~~-l~~L~~L~~L~Ls~N~L~~lP~-~l~~L~~L~~L~Ls~N~Ls~IP~~-l~~L~~L~~L~Ls~N~Ls~~~ 249 (1142)
|+.+|.. |..+++|+.|+|++|+|+.+|. .|..+++|+.|+|++|+|+.+|.. +..+++|+.|+|++|.+...-
T Consensus 145 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 221 (270)
T 2o6q_A 145 LQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTC 221 (270)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSS
T ss_pred CCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCC
Confidence 8877764 6888899999999999988764 577889999999999999888765 566889999999999886543
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.88 E-value=7.8e-23 Score=231.29 Aligned_cols=194 Identities=19% Similarity=0.216 Sum_probs=146.2
Q ss_pred CCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEE
Q 001142 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNL 96 (1142)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L 96 (1142)
+.+..|.+..|+|+.+. .|..+++|++|+|++|+|++..+ + .++++|++|+|++|.|+.+| .+..+++|++|
T Consensus 41 ~~L~~L~l~~~~i~~l~--~~~~l~~L~~L~L~~n~i~~~~~--~---~~l~~L~~L~L~~n~l~~~~-~~~~l~~L~~L 112 (308)
T 1h6u_A 41 DGITTLSAFGTGVTTIE--GVQYLNNLIGLELKDNQITDLAP--L---KNLTKITELELSGNPLKNVS-AIAGLQSIKTL 112 (308)
T ss_dssp HTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCGG--G---TTCCSCCEEECCSCCCSCCG-GGTTCTTCCEE
T ss_pred CCcCEEEeeCCCccCch--hhhccCCCCEEEccCCcCCCChh--H---ccCCCCCEEEccCCcCCCch-hhcCCCCCCEE
Confidence 36888999999999885 68999999999999999998765 4 45599999999999999986 68999999999
Q ss_pred EccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCC
Q 001142 97 KFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSI 176 (1142)
Q Consensus 97 ~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L 176 (1142)
+|++|+|+.+|. +.++++|+.|+|++|.+..++. + ..+++|+.|+|++|++
T Consensus 113 ~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~-l---------------------------~~l~~L~~L~l~~n~l 163 (308)
T 1h6u_A 113 DLTSTQITDVTP-LAGLSNLQVLYLDLNQITNISP-L---------------------------AGLTNLQYLSIGNAQV 163 (308)
T ss_dssp ECTTSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG-G---------------------------GGCTTCCEEECCSSCC
T ss_pred ECCCCCCCCchh-hcCCCCCCEEECCCCccCcCcc-c---------------------------cCCCCccEEEccCCcC
Confidence 999999999876 8999999999999888665543 3 3455555566666666
Q ss_pred CccCcccCCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeCcCCcCCCCCc
Q 001142 177 RYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGS 250 (1142)
Q Consensus 177 ~~IP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls~N~Ls~~~p 250 (1142)
+.+|. +..+++|+.|+|++|+|+.+|. +..+++|+.|+|++|+|+.+|+ +..+++|+.|+|++|.|++.+.
T Consensus 164 ~~~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~l~~N~i~~~~~ 234 (308)
T 1h6u_A 164 SDLTP-LANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQISDVSP-LANTSNLFIVTLTNQTITNQPV 234 (308)
T ss_dssp CCCGG-GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECTTSCCCBCGG-GTTCTTCCEEEEEEEEEECCCE
T ss_pred CCChh-hcCCCCCCEEECCCCccCcChh-hcCCCCCCEEEccCCccCcccc-ccCCCCCCEEEccCCeeecCCe
Confidence 65544 5666666666666666665554 5566666666666666665553 5666666666666666665443
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.1e-21 Score=214.83 Aligned_cols=180 Identities=21% Similarity=0.284 Sum_probs=139.3
Q ss_pred CccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCch-hhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCC
Q 001142 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPS-EVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKV 147 (1142)
Q Consensus 69 ~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~-~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n 147 (1142)
+.+++++++|.++.+|..+. ++|+.|+|++|.|+.++. .|.++++|++|+|++|.+..+
T Consensus 15 ~~~~l~~~~~~l~~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~------------------ 74 (251)
T 3m19_A 15 GKKEVDCQGKSLDSVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTL------------------ 74 (251)
T ss_dssp GGTEEECTTCCCSSCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCC------------------
T ss_pred CCeEEecCCCCccccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCcc------------------
Confidence 45667777777777776654 367777777777775543 466666666666665553322
Q ss_pred CCCCCcccchhhhcCCCCCcEEEccCCCCCccCc-ccCCCCCCCEEEccCCCCCccchh-hcCCCCCCEEEccCCCCCcc
Q 001142 148 PPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKLVEL 225 (1142)
Q Consensus 148 ~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~Ls~N~L~~lP~~-l~~L~~L~~L~Ls~N~Ls~I 225 (1142)
.+..|.++++|+.|+|++|+|+.+|. .|..+++|++|+|++|+|+.+|.. |..+++|+.|+|++|+|+.+
T Consensus 75 --------~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 146 (251)
T 3m19_A 75 --------SAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSI 146 (251)
T ss_dssp --------CTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred --------CHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCcc
Confidence 23346667788888888888887765 568899999999999999988754 67899999999999999988
Q ss_pred Cc-cccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccCCCCCCC-CCCC
Q 001142 226 PS-GLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSY-CQVP 276 (1142)
Q Consensus 226 P~-~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~~-~~iP 276 (1142)
|. .+..+++|+.|+|++|+|+++++..|..+++|+.|+|++|+|.|. |++.
T Consensus 147 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~~ 199 (251)
T 3m19_A 147 PAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCSRCEIL 199 (251)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTTSTTHH
T ss_pred CHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCCccccH
Confidence 76 577899999999999999999998899999999999999999986 5543
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.87 E-value=1e-23 Score=245.36 Aligned_cols=237 Identities=19% Similarity=0.164 Sum_probs=193.9
Q ss_pred CCCCCCCCCCEEEccCCCCCCCCccccc-CCCCCCCccEEEeecCCCC----ccCccc-------cCCcCCcEEEccCCC
Q 001142 35 GSVNDDDDDSVIDVSGKTVDFPLIESYG-NRGGDNSVEGLYLYKNVLN----LIPKSV-------GRYEKLRNLKFFGNE 102 (1142)
Q Consensus 35 ~~f~~l~~L~~LdLs~N~L~~~~p~~~~-~l~~L~~L~~L~Ls~N~Lt----~iP~~l-------~~L~~L~~L~Ls~N~ 102 (1142)
..+..+++|++|+|++|+|+...+..++ .+..+++|++|+|++|.+. .+|..+ ..+++|++|+|++|.
T Consensus 26 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~ 105 (386)
T 2ca6_A 26 AVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNA 105 (386)
T ss_dssp HHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCC
T ss_pred HHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCc
Confidence 3456788999999999999887554432 2456699999999997665 345444 688999999999999
Q ss_pred CCc-----CchhhcCCCCCCEEEccCCCCCCCc-----ccccCC---------CCCCEEECCCCCCC-CCcccchhhhcC
Q 001142 103 INL-----FPSEVGNLLGLECLQIKISSPGVNG-----FALNKL---------KGLKELELSKVPPR-PSVLTLLSEIAG 162 (1142)
Q Consensus 103 L~~-----lP~~l~~L~~L~~L~Ls~N~l~~~~-----~~~~~L---------~~L~~L~Ls~n~~n-~~~~~lp~~l~~ 162 (1142)
|+. +|..+.++++|+.|+|++|.++..+ ..+..+ ++|++|+|++|.+. .....+...+..
T Consensus 106 l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~ 185 (386)
T 2ca6_A 106 FGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 185 (386)
T ss_dssp CCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHh
Confidence 986 7888999999999999999975332 233344 89999999997765 223333367788
Q ss_pred CCCCcEEEccCCCCC------ccCcccCCCCCCCEEEccCCCC-----CccchhhcCCCCCCEEEccCCCCCc-----cC
Q 001142 163 LKCLTKLSVCHFSIR------YLPPEIGCLSNLEQLDLSFNKM-----KYLPTEICYLKALISLKVANNKLVE-----LP 226 (1142)
Q Consensus 163 L~~L~~L~Ls~N~L~------~IP~~l~~L~~L~~L~Ls~N~L-----~~lP~~l~~L~~L~~L~Ls~N~Ls~-----IP 226 (1142)
+++|+.|+|++|+|+ -+|..+..+++|+.|+|++|.| ..+|..+..+++|+.|+|++|.|+. +|
T Consensus 186 ~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~ 265 (386)
T 2ca6_A 186 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVV 265 (386)
T ss_dssp CTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHH
T ss_pred CCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHH
Confidence 999999999999998 2455888999999999999999 5689999999999999999999983 57
Q ss_pred ccc--cCCCCCCEEeCcCCcCCC----CCcccc-cCCCCCCEEEccCCCCCC
Q 001142 227 SGL--YLLQRLENLDLSNNRLTS----LGSLDL-CLMHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 227 ~~l--~~L~~L~~L~Ls~N~Ls~----~~p~~l-~~L~~L~~L~Ls~N~L~~ 271 (1142)
..+ +.+++|+.|+|++|.|++ .+|..+ .++++|+.|+|++|++++
T Consensus 266 ~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~ 317 (386)
T 2ca6_A 266 DAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 317 (386)
T ss_dssp HHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred HHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCc
Confidence 777 448999999999999998 355556 678999999999999987
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=7e-22 Score=214.46 Aligned_cols=193 Identities=15% Similarity=0.132 Sum_probs=134.8
Q ss_pred CCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCC-CCccCc-cccCCcCCcEEEccC-CCCCcCch-hhcCCCCCC
Q 001142 42 DDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNV-LNLIPK-SVGRYEKLRNLKFFG-NEINLFPS-EVGNLLGLE 117 (1142)
Q Consensus 42 ~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~-Lt~iP~-~l~~L~~L~~L~Ls~-N~L~~lP~-~l~~L~~L~ 117 (1142)
+|++|+|++|+|++..+..|+. +++|++|+|++|. ++.+|. .|.++++|++|+|++ |+|+.+|. .|.++++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~---l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~ 108 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSN---LPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLK 108 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTT---CTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCC
T ss_pred cccEEEEeCCcceEECHHHccC---CCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCC
Confidence 6666777777666665544433 3666677776665 666654 566666677777766 66666653 355666666
Q ss_pred EEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCc---EEEccCC-CCCccCc-ccCCCCCCC-E
Q 001142 118 CLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLT---KLSVCHF-SIRYLPP-EIGCLSNLE-Q 191 (1142)
Q Consensus 118 ~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~---~L~Ls~N-~L~~IP~-~l~~L~~L~-~ 191 (1142)
.|+|++|.+..+| . |..+++|+ .|++++| .++.+|. .|..+++|+ .
T Consensus 109 ~L~l~~n~l~~lp---------------------------~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~ 160 (239)
T 2xwt_C 109 FLGIFNTGLKMFP---------------------------D-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLT 160 (239)
T ss_dssp EEEEEEECCCSCC---------------------------C-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEE
T ss_pred EEeCCCCCCcccc---------------------------c-cccccccccccEEECCCCcchhhcCcccccchhcceeE
Confidence 6666655544333 2 44455555 8888888 8887766 478888888 8
Q ss_pred EEccCCCCCccchhhcCCCCCCEEEccCCC-CCccCc-cccCC-CCCCEEeCcCCcCCCCCcccccCCCCCCEEEccCCC
Q 001142 192 LDLSFNKMKYLPTEICYLKALISLKVANNK-LVELPS-GLYLL-QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNK 268 (1142)
Q Consensus 192 L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~-Ls~IP~-~l~~L-~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~ 268 (1142)
|+|++|+|+.+|......++|+.|+|++|+ |+.+|. .+..+ ++|+.|+|++|+|+++++. .+++|+.|++++|.
T Consensus 161 L~l~~n~l~~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~~ 237 (239)
T 2xwt_C 161 LKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNTW 237 (239)
T ss_dssp EECCSCCCCEECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC-
T ss_pred EEcCCCCCcccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCcc
Confidence 999888888888765555788899999994 888754 45667 8899999999999887764 56788888888763
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=2.9e-22 Score=226.31 Aligned_cols=203 Identities=17% Similarity=0.129 Sum_probs=169.4
Q ss_pred CCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCcc-C----ccccCCcCCcEEEccCCCCCcCc-hhhcCC
Q 001142 40 DDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLI-P----KSVGRYEKLRNLKFFGNEINLFP-SEVGNL 113 (1142)
Q Consensus 40 l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~i-P----~~l~~L~~L~~L~Ls~N~L~~lP-~~l~~L 113 (1142)
+++|++|+|++|++++..|..+.. ..+++|++|+|++|.++.. | ..+..+++|++|+|++|.|+.+| ..|.++
T Consensus 90 ~~~L~~L~l~~n~l~~~~~~~~~~-~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l 168 (310)
T 4glp_A 90 YSRLKELTLEDLKITGTMPPLPLE-ATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAF 168 (310)
T ss_dssp HSCCCEEEEESCCCBSCCCCCSSS-CCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCC
T ss_pred cCceeEEEeeCCEeccchhhhhhh-ccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccC
Confidence 456999999999999998876511 4559999999999999953 3 34567899999999999999765 568899
Q ss_pred CCCCEEEccCCCCCC---C--cccccCCCCCCEEECCCCCCCCCcccchhh-hcCCCCCcEEEccCCCCCcc-CcccCCC
Q 001142 114 LGLECLQIKISSPGV---N--GFALNKLKGLKELELSKVPPRPSVLTLLSE-IAGLKCLTKLSVCHFSIRYL-PPEIGCL 186 (1142)
Q Consensus 114 ~~L~~L~Ls~N~l~~---~--~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~-l~~L~~L~~L~Ls~N~L~~I-P~~l~~L 186 (1142)
++|++|+|++|.+.. + +..+..+++|++|+|++|.+.... ..+.. +..+++|+.|+|++|+|+.+ |..+..+
T Consensus 169 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~-~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 247 (310)
T 4glp_A 169 PALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPT-GVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRC 247 (310)
T ss_dssp TTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHH-HHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSC
T ss_pred CCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchH-HHHHHHHhcCCCCCEEECCCCCCCccchhhHHhc
Confidence 999999999998543 2 223478999999999997764322 22333 57889999999999999966 8888776
Q ss_pred ---CCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeCcCCcCCC
Q 001142 187 ---SNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTS 247 (1142)
Q Consensus 187 ---~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls~N~Ls~ 247 (1142)
++|++|+|++|+|+.+|..+. ++|+.|+|++|+|+.+|. +..+++|+.|+|++|+|+.
T Consensus 248 ~~~~~L~~L~Ls~N~l~~lp~~~~--~~L~~L~Ls~N~l~~~~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 248 MWSSALNSLNLSFAGLEQVPKGLP--AKLRVLDLSSNRLNRAPQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp CCCTTCCCEECCSSCCCSCCSCCC--SCCSCEECCSCCCCSCCC-TTSCCCCSCEECSSTTTSC
T ss_pred cCcCcCCEEECCCCCCCchhhhhc--CCCCEEECCCCcCCCCch-hhhCCCccEEECcCCCCCC
Confidence 699999999999999998885 799999999999999876 7789999999999999984
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.87 E-value=3.3e-22 Score=221.81 Aligned_cols=197 Identities=24% Similarity=0.289 Sum_probs=96.8
Q ss_pred CCccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcc-cccCCCCCCEEECCC
Q 001142 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGF-ALNKLKGLKELELSK 146 (1142)
Q Consensus 68 ~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~~-~~~~L~~L~~L~Ls~ 146 (1142)
++|+.|++++|.++.++ .+..+++|++|+|++|.|+.++ .+.++++|++|+|++|.+..++. .+..+++|++|+|++
T Consensus 41 ~~L~~L~l~~~~i~~~~-~l~~l~~L~~L~l~~n~l~~~~-~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 118 (272)
T 3rfs_A 41 NSIDQIIANNSDIKSVQ-GIQYLPNVRYLALGGNKLHDIS-ALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVE 118 (272)
T ss_dssp TTCCEEECTTSCCCCCT-TGGGCTTCCEEECTTSCCCCCG-GGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred cceeeeeeCCCCccccc-ccccCCCCcEEECCCCCCCCch-hhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCC
Confidence 45555555555555443 2445555555555555555443 34455555555555554333222 233334444444443
Q ss_pred CCCCCCcccchhhhcCCCCCcEEEccCCCCCccCcc-cCCCCCCCEEEccCCCCCccch-hhcCCCCCCEEEccCCCCCc
Q 001142 147 VPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPE-IGCLSNLEQLDLSFNKMKYLPT-EICYLKALISLKVANNKLVE 224 (1142)
Q Consensus 147 n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~-l~~L~~L~~L~Ls~N~L~~lP~-~l~~L~~L~~L~Ls~N~Ls~ 224 (1142)
|.+. ...+..|..+++|+.|+|++|+|+.+|.. +..+++|+.|+|++|+|+.+|. .+..+++|+.|+|++|+|+.
T Consensus 119 n~l~---~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 195 (272)
T 3rfs_A 119 NQLQ---SLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKS 195 (272)
T ss_dssp SCCC---CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred CcCC---ccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCc
Confidence 2221 11122344555555555555555554432 3555555555555555554433 24555555555555555554
Q ss_pred cCcc-ccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccCCCCCCCCCCCch
Q 001142 225 LPSG-LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSW 278 (1142)
Q Consensus 225 IP~~-l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~ 278 (1142)
+|+. +..+++|+.|+|++|.+.+. ++.|++|++++|.+++ .+|.+
T Consensus 196 ~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g--~ip~~ 241 (272)
T 3rfs_A 196 VPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSG--VVRNS 241 (272)
T ss_dssp CCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGG--GBBCT
T ss_pred cCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCC--cccCc
Confidence 4332 34455555555555555432 2345555555555555 34443
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.87 E-value=6.9e-22 Score=219.20 Aligned_cols=214 Identities=21% Similarity=0.192 Sum_probs=181.3
Q ss_pred CCccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCC
Q 001142 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKV 147 (1142)
Q Consensus 68 ~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n 147 (1142)
..+..+++..+.++.+ ..+..+++|+.|++++|.++.++ .+..+++|++|+|++|.+..++ .+..+++|++|+|++|
T Consensus 19 ~~l~~l~l~~~~~~~~-~~~~~l~~L~~L~l~~~~i~~~~-~l~~l~~L~~L~l~~n~l~~~~-~l~~l~~L~~L~L~~n 95 (272)
T 3rfs_A 19 AETIKANLKKKSVTDA-VTQNELNSIDQIIANNSDIKSVQ-GIQYLPNVRYLALGGNKLHDIS-ALKELTNLTYLILTGN 95 (272)
T ss_dssp HHHHHHHHTCSCTTSE-ECHHHHTTCCEEECTTSCCCCCT-TGGGCTTCCEEECTTSCCCCCG-GGTTCTTCCEEECTTS
T ss_pred HHHHHHHhcCcccccc-cccccccceeeeeeCCCCccccc-ccccCCCCcEEECCCCCCCCch-hhcCCCCCCEEECCCC
Confidence 4566777888877765 23667889999999999999886 4889999999999999987765 7889999999999996
Q ss_pred CCCCCcccchhhhcCCCCCcEEEccCCCCCccCcc-cCCCCCCCEEEccCCCCCccch-hhcCCCCCCEEEccCCCCCcc
Q 001142 148 PPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPE-IGCLSNLEQLDLSFNKMKYLPT-EICYLKALISLKVANNKLVEL 225 (1142)
Q Consensus 148 ~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~-l~~L~~L~~L~Ls~N~L~~lP~-~l~~L~~L~~L~Ls~N~Ls~I 225 (1142)
.+. ...+..|.++++|+.|+|++|+++.+|.. |..+++|++|+|++|+|+.+|. .+..+++|+.|+|++|+|+.+
T Consensus 96 ~l~---~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 172 (272)
T 3rfs_A 96 QLQ---SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSL 172 (272)
T ss_dssp CCC---CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred ccC---ccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCcc
Confidence 554 33445678999999999999999988664 7899999999999999998865 468899999999999999988
Q ss_pred Ccc-ccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccCCCCCCCCCCCchhhccCCCCCCC
Q 001142 226 PSG-LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKD 289 (1142)
Q Consensus 226 P~~-l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~~n~l~ 289 (1142)
|.. +..+++|+.|+|++|+|+++++..+..+++|+.|+|++|++.| .+|....+.+..|.+.
T Consensus 173 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~--~~~~l~~l~~~~n~~~ 235 (272)
T 3rfs_A 173 PEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC--TCPGIRYLSEWINKHS 235 (272)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC--CTTTTHHHHHHHHHTG
T ss_pred CHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccc--cCcHHHHHHHHHHhCC
Confidence 665 5779999999999999999999889999999999999999998 4665555555444444
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.2e-21 Score=212.74 Aligned_cols=180 Identities=17% Similarity=0.206 Sum_probs=143.4
Q ss_pred CccEEEeecCCCCccCc-cccCCcCCcEEEccCCC-CCcCch-hhcCCCCCCEEEccC-CCCCCCcccccCCCCCCEEEC
Q 001142 69 SVEGLYLYKNVLNLIPK-SVGRYEKLRNLKFFGNE-INLFPS-EVGNLLGLECLQIKI-SSPGVNGFALNKLKGLKELEL 144 (1142)
Q Consensus 69 ~L~~L~Ls~N~Lt~iP~-~l~~L~~L~~L~Ls~N~-L~~lP~-~l~~L~~L~~L~Ls~-N~l~~~~~~~~~L~~L~~L~L 144 (1142)
+|++|+|++|.|+.+|. .|.++++|++|+|++|. |+.+|. .|.++++|+.|+|++ |.+..++
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~-------------- 97 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYID-------------- 97 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEEC--------------
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcC--------------
Confidence 56666776666666654 56666666667776665 666654 455566666666655 4433222
Q ss_pred CCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCcccCCCCCCC---EEEccCC-CCCccch-hhcCCCCCC-EEEcc
Q 001142 145 SKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLE---QLDLSFN-KMKYLPT-EICYLKALI-SLKVA 218 (1142)
Q Consensus 145 s~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~---~L~Ls~N-~L~~lP~-~l~~L~~L~-~L~Ls 218 (1142)
+..|.++++|+.|++++|.++.+|. +..+++|+ +|+|++| +|+.+|. .|..+++|+ .|+|+
T Consensus 98 ------------~~~f~~l~~L~~L~l~~n~l~~lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~ 164 (239)
T 2xwt_C 98 ------------PDALKELPLLKFLGIFNTGLKMFPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLY 164 (239)
T ss_dssp ------------TTSEECCTTCCEEEEEEECCCSCCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECC
T ss_pred ------------HHHhCCCCCCCEEeCCCCCCccccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcC
Confidence 3457788999999999999999988 88889998 9999999 9998875 588999999 99999
Q ss_pred CCCCCccCccccCCCCCCEEeCcCCc-CCCCCcccccCC-CCCCEEEccCCCCCCCCCCCch
Q 001142 219 NNKLVELPSGLYLLQRLENLDLSNNR-LTSLGSLDLCLM-HNLQNLNLQYNKLLSYCQVPSW 278 (1142)
Q Consensus 219 ~N~Ls~IP~~l~~L~~L~~L~Ls~N~-Ls~~~p~~l~~L-~~L~~L~Ls~N~L~~~~~iP~~ 278 (1142)
+|+|+.||...+..++|+.|+|++|+ |+++++..|..+ ++|+.|+|++|+++. +|..
T Consensus 165 ~n~l~~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~---l~~~ 223 (239)
T 2xwt_C 165 NNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA---LPSK 223 (239)
T ss_dssp SCCCCEECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCC---CCCT
T ss_pred CCCCcccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCcccc---CChh
Confidence 99999999887777899999999995 999999889999 999999999999987 6654
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.1e-21 Score=239.71 Aligned_cols=178 Identities=20% Similarity=0.239 Sum_probs=95.6
Q ss_pred CCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEc
Q 001142 42 DDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI 121 (1142)
Q Consensus 42 ~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~L 121 (1142)
+|+.|+|++|+|++ +|..+ + ++|++|+|++|.|+.|| ..+++|++|+|++|+|+.||. +.+ +|+.|+|
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l--~---~~L~~L~Ls~N~l~~ip---~~l~~L~~L~Ls~N~l~~ip~-l~~--~L~~L~L 127 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNL--P---PQITVLEITQNALISLP---ELPASLEYLDACDNRLSTLPE-LPA--SLKHLDV 127 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCC--C---TTCSEEECCSSCCSCCC---CCCTTCCEEECCSSCCSCCCC-CCT--TCCEEEC
T ss_pred CccEEEeCCCCCCc-cCHhH--c---CCCCEEECcCCCCcccc---cccCCCCEEEccCCCCCCcch-hhc--CCCEEEC
Confidence 66777777777766 33322 1 56677777777777666 335667777777777766666 544 6666666
Q ss_pred cCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCcccCCCCCCCEEEccCCCCCc
Q 001142 122 KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKY 201 (1142)
Q Consensus 122 s~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~ 201 (1142)
++|.++.+|. .+++| +.|+|++|.|+.||. .+++|+.|+|++|+|+.
T Consensus 128 s~N~l~~lp~---~l~~L---------------------------~~L~Ls~N~l~~lp~---~l~~L~~L~Ls~N~L~~ 174 (571)
T 3cvr_A 128 DNNQLTMLPE---LPALL---------------------------EYINADNNQLTMLPE---LPTSLEVLSVRNNQLTF 174 (571)
T ss_dssp CSSCCSCCCC---CCTTC---------------------------CEEECCSSCCSCCCC---CCTTCCEEECCSSCCSC
T ss_pred CCCcCCCCCC---cCccc---------------------------cEEeCCCCccCcCCC---cCCCcCEEECCCCCCCC
Confidence 6666555443 34444 445555555544444 34445555555555555
Q ss_pred cchhhcCCCCCCEEEccCCCCCccCccccCCCCC-------CEEeCcCCcCCCCCcccccCCCCCCEEEccCCCCCC
Q 001142 202 LPTEICYLKALISLKVANNKLVELPSGLYLLQRL-------ENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 202 lP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L-------~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1142)
+|. |. ++|+.|+|++|+|+.||. +.. +| +.|+|++|+|+.+++ .+..+++|+.|+|++|+|++
T Consensus 175 lp~-l~--~~L~~L~Ls~N~L~~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~~lp~-~l~~l~~L~~L~L~~N~l~~ 244 (571)
T 3cvr_A 175 LPE-LP--ESLEALDVSTNLLESLPA-VPV--RNHHSEETEIFFRCRENRITHIPE-NILSLDPTCTIILEDNPLSS 244 (571)
T ss_dssp CCC-CC--TTCCEEECCSSCCSSCCC-CC----------CCEEEECCSSCCCCCCG-GGGGSCTTEEEECCSSSCCH
T ss_pred cch-hh--CCCCEEECcCCCCCchhh-HHH--hhhcccccceEEecCCCcceecCH-HHhcCCCCCEEEeeCCcCCC
Confidence 544 33 455555555555555544 332 34 555555555554333 33345555555555555544
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.85 E-value=4.9e-21 Score=233.93 Aligned_cols=181 Identities=22% Similarity=0.219 Sum_probs=134.7
Q ss_pred CCcEEEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEc
Q 001142 92 KLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSV 171 (1142)
Q Consensus 92 ~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~L 171 (1142)
+|+.|+|++|.|+.||..+. ++|+.|+|++|.+..+| ..+++|++|+|++|.+.. +|. +.+ +|+.|+|
T Consensus 60 ~L~~L~Ls~n~L~~lp~~l~--~~L~~L~Ls~N~l~~ip---~~l~~L~~L~Ls~N~l~~----ip~-l~~--~L~~L~L 127 (571)
T 3cvr_A 60 QFSELQLNRLNLSSLPDNLP--PQITVLEITQNALISLP---ELPASLEYLDACDNRLST----LPE-LPA--SLKHLDV 127 (571)
T ss_dssp TCSEEECCSSCCSCCCSCCC--TTCSEEECCSSCCSCCC---CCCTTCCEEECCSSCCSC----CCC-CCT--TCCEEEC
T ss_pred CccEEEeCCCCCCccCHhHc--CCCCEEECcCCCCcccc---cccCCCCEEEccCCCCCC----cch-hhc--CCCEEEC
Confidence 56666666666666665543 55666666666655555 345666677777654433 344 443 8999999
Q ss_pred cCCCCCccCcccCCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeCcCCcCCCCCcc
Q 001142 172 CHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSL 251 (1142)
Q Consensus 172 s~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls~N~Ls~~~p~ 251 (1142)
++|.|+.||. .+++|+.|+|++|+|+.||. .+++|+.|+|++|+|+.||. +. ++|+.|+|++|+|+.+++
T Consensus 128 s~N~l~~lp~---~l~~L~~L~Ls~N~l~~lp~---~l~~L~~L~Ls~N~L~~lp~-l~--~~L~~L~Ls~N~L~~lp~- 197 (571)
T 3cvr_A 128 DNNQLTMLPE---LPALLEYINADNNQLTMLPE---LPTSLEVLSVRNNQLTFLPE-LP--ESLEALDVSTNLLESLPA- 197 (571)
T ss_dssp CSSCCSCCCC---CCTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCCSCCCC-CC--TTCCEEECCSSCCSSCCC-
T ss_pred CCCcCCCCCC---cCccccEEeCCCCccCcCCC---cCCCcCEEECCCCCCCCcch-hh--CCCCEEECcCCCCCchhh-
Confidence 9999999988 68999999999999999987 67899999999999999998 66 899999999999997765
Q ss_pred cccCCCCC-------CEEEccCCCCCCCCCCCchhhccCCCCCCCCCCCCcccccc
Q 001142 252 DLCLMHNL-------QNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSA 300 (1142)
Q Consensus 252 ~l~~L~~L-------~~L~Ls~N~L~~~~~iP~~~~~~l~~n~l~~~~~~~~~~~~ 300 (1142)
|.. +| +.|+|++|+|+. ||..+........+...+|.+.+..+
T Consensus 198 -~~~--~L~~~~~~L~~L~Ls~N~l~~---lp~~l~~l~~L~~L~L~~N~l~~~~p 247 (571)
T 3cvr_A 198 -VPV--RNHHSEETEIFFRCRENRITH---IPENILSLDPTCTIILEDNPLSSRIR 247 (571)
T ss_dssp -CC----------CCEEEECCSSCCCC---CCGGGGGSCTTEEEECCSSSCCHHHH
T ss_pred -HHH--hhhcccccceEEecCCCccee---cCHHHhcCCCCCEEEeeCCcCCCcCH
Confidence 544 77 999999999996 88877665555556666665554443
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.84 E-value=3.8e-22 Score=232.05 Aligned_cols=235 Identities=15% Similarity=0.123 Sum_probs=192.9
Q ss_pred CCCcccccCCCCCCcccCC----CCCCCCCCCCEEEccCCC---CCCCCccccc----CCCCCCCccEEEeecCCCCc--
Q 001142 16 GPIKEKLPSEANKINNEKN----GSVNDDDDDSVIDVSGKT---VDFPLIESYG----NRGGDNSVEGLYLYKNVLNL-- 82 (1142)
Q Consensus 16 ~~~l~~L~~~~N~i~~l~~----~~f~~l~~L~~LdLs~N~---L~~~~p~~~~----~l~~L~~L~~L~Ls~N~Lt~-- 82 (1142)
.+.++.|.+..|+|+.... ..|..+++|++|+|++|. +++.+|..+. .+..+++|++|+|++|.|+.
T Consensus 31 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~ 110 (386)
T 2ca6_A 31 DDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTA 110 (386)
T ss_dssp CSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTT
T ss_pred CCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHH
Confidence 3478999999999988754 348899999999999964 4555565442 12456999999999999996
Q ss_pred ---cCccccCCcCCcEEEccCCCCCc-----CchhhcCC---------CCCCEEEccCCCCC--CCc---ccccCCCCCC
Q 001142 83 ---IPKSVGRYEKLRNLKFFGNEINL-----FPSEVGNL---------LGLECLQIKISSPG--VNG---FALNKLKGLK 140 (1142)
Q Consensus 83 ---iP~~l~~L~~L~~L~Ls~N~L~~-----lP~~l~~L---------~~L~~L~Ls~N~l~--~~~---~~~~~L~~L~ 140 (1142)
+|..+..+++|++|+|++|.|+. ++..+..+ ++|+.|+|++|.++ .++ ..+..+++|+
T Consensus 111 ~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~ 190 (386)
T 2ca6_A 111 QEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLH 190 (386)
T ss_dssp HHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCC
T ss_pred HHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcC
Confidence 78889999999999999999973 34445445 99999999999976 333 3567899999
Q ss_pred EEECCCCCCCC--CcccchhhhcCCCCCcEEEccCCCC-----CccCcccCCCCCCCEEEccCCCCCc-----cchhh--
Q 001142 141 ELELSKVPPRP--SVLTLLSEIAGLKCLTKLSVCHFSI-----RYLPPEIGCLSNLEQLDLSFNKMKY-----LPTEI-- 206 (1142)
Q Consensus 141 ~L~Ls~n~~n~--~~~~lp~~l~~L~~L~~L~Ls~N~L-----~~IP~~l~~L~~L~~L~Ls~N~L~~-----lP~~l-- 206 (1142)
+|+|++|.+.. .....|..+..+++|+.|+|++|.| ..+|..+..+++|+.|+|++|.|+. +|..+
T Consensus 191 ~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~ 270 (386)
T 2ca6_A 191 TVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSK 270 (386)
T ss_dssp EEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHT
T ss_pred EEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhh
Confidence 99999976641 1123444788999999999999999 4578889999999999999999984 57777
Q ss_pred cCCCCCCEEEccCCCCCc-----cCccc-cCCCCCCEEeCcCCcCCCCCc
Q 001142 207 CYLKALISLKVANNKLVE-----LPSGL-YLLQRLENLDLSNNRLTSLGS 250 (1142)
Q Consensus 207 ~~L~~L~~L~Ls~N~Ls~-----IP~~l-~~L~~L~~L~Ls~N~Ls~~~p 250 (1142)
+.+++|+.|+|++|.|+. +|..+ .++++|+.|+|++|+|++..+
T Consensus 271 ~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 271 LENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp CSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred ccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 449999999999999996 89888 568999999999999998875
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.84 E-value=5.5e-22 Score=229.11 Aligned_cols=246 Identities=13% Similarity=0.119 Sum_probs=192.1
Q ss_pred cCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCc----ccccCCCCCC-CccEEEeecCCCCcc-CccccCC-----c
Q 001142 23 PSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLI----ESYGNRGGDN-SVEGLYLYKNVLNLI-PKSVGRY-----E 91 (1142)
Q Consensus 23 ~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p----~~~~~l~~L~-~L~~L~Ls~N~Lt~i-P~~l~~L-----~ 91 (1142)
.+..|++++..+..+...++|++|||++|+|++..+ +.+..+ + +|++|+|++|.|+.. +..|..+ +
T Consensus 4 ~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~---~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~ 80 (362)
T 3goz_A 4 KLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANT---PASVTSLNLSGNSLGFKNSDELVQILAAIPA 80 (362)
T ss_dssp ECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTC---CTTCCEEECCSSCGGGSCHHHHHHHHHTSCT
T ss_pred ccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhC---CCceeEEECcCCCCCHHHHHHHHHHHhccCC
Confidence 466788888777777777789999999999998877 555444 7 899999999999966 5556664 8
Q ss_pred CCcEEEccCCCCCcCc-hh----hcCC-CCCCEEEccCCCCCCCcc-c----ccC-CCCCCEEECCCCCCCCCc-ccchh
Q 001142 92 KLRNLKFFGNEINLFP-SE----VGNL-LGLECLQIKISSPGVNGF-A----LNK-LKGLKELELSKVPPRPSV-LTLLS 158 (1142)
Q Consensus 92 ~L~~L~Ls~N~L~~lP-~~----l~~L-~~L~~L~Ls~N~l~~~~~-~----~~~-L~~L~~L~Ls~n~~n~~~-~~lp~ 158 (1142)
+|++|+|++|.|+..+ .. +..+ ++|+.|+|++|.++..+. . +.. .++|++|+|++|.+.... ..++.
T Consensus 81 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~ 160 (362)
T 3goz_A 81 NVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQ 160 (362)
T ss_dssp TCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHH
T ss_pred CccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHH
Confidence 9999999999998554 33 4455 899999999999776653 2 334 369999999997654322 24556
Q ss_pred hhcCCC-CCcEEEccCCCCCccCc-----ccCCC-CCCCEEEccCCCCCc-----cchhhcCC-CCCCEEEccCCCCCcc
Q 001142 159 EIAGLK-CLTKLSVCHFSIRYLPP-----EIGCL-SNLEQLDLSFNKMKY-----LPTEICYL-KALISLKVANNKLVEL 225 (1142)
Q Consensus 159 ~l~~L~-~L~~L~Ls~N~L~~IP~-----~l~~L-~~L~~L~Ls~N~L~~-----lP~~l~~L-~~L~~L~Ls~N~Ls~I 225 (1142)
.+..++ +|+.|+|++|+|+..+. .+..+ ++|+.|+|++|.|+. ++..+..+ ++|+.|+|++|.|+.+
T Consensus 161 ~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~ 240 (362)
T 3goz_A 161 ILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGP 240 (362)
T ss_dssp HHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCC
T ss_pred HHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcH
Confidence 666776 99999999999985543 34455 599999999999986 77777774 5999999999999865
Q ss_pred C-----ccccCCCCCCEEeCcCCcCCCCCcc-------cccCCCCCCEEEccCCCCCC
Q 001142 226 P-----SGLYLLQRLENLDLSNNRLTSLGSL-------DLCLMHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 226 P-----~~l~~L~~L~~L~Ls~N~Ls~~~p~-------~l~~L~~L~~L~Ls~N~L~~ 271 (1142)
+ ..+..+++|+.|+|++|.++++.+. .+..+++|+.|||++|++..
T Consensus 241 ~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~ 298 (362)
T 3goz_A 241 SLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHP 298 (362)
T ss_dssp CHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCG
T ss_pred HHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCC
Confidence 4 3346689999999999997776654 56788899999999999876
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.83 E-value=2.6e-20 Score=214.14 Aligned_cols=234 Identities=16% Similarity=0.118 Sum_probs=160.8
Q ss_pred cccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCC-ccCc-cccCCcCCcE-EE
Q 001142 21 KLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLN-LIPK-SVGRYEKLRN-LK 97 (1142)
Q Consensus 21 ~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt-~iP~-~l~~L~~L~~-L~ 97 (1142)
.+....++|+.++... .+++++|+|++|+|+.+.+..|+. +++|++|+|++|.+. .+|. .|.++++|.. +.
T Consensus 13 ~v~C~~~~Lt~iP~~l---~~~l~~L~Ls~N~i~~i~~~~f~~---l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~ 86 (350)
T 4ay9_X 13 VFLCQESKVTEIPSDL---PRNAIELRFVLTKLRVIQKGAFSG---FGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 86 (350)
T ss_dssp EEEEESTTCCSCCTTC---CTTCSEEEEESCCCSEECTTSSTT---CTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEE
T ss_pred EEEecCCCCCccCcCc---CCCCCEEEccCCcCCCcCHHHHcC---CCCCCEEECcCCCCCCccChhHhhcchhhhhhhc
Confidence 3555667777776433 246788888888887766655543 478888888888764 4654 5677776654 66
Q ss_pred ccCCCCCcCc-hhhcCCCCCCEEEccCCCCCCCcc-cccCCCCCCEEECCCCCCCCCcccch-hhhcCCC-CCcEEEccC
Q 001142 98 FFGNEINLFP-SEVGNLLGLECLQIKISSPGVNGF-ALNKLKGLKELELSKVPPRPSVLTLL-SEIAGLK-CLTKLSVCH 173 (1142)
Q Consensus 98 Ls~N~L~~lP-~~l~~L~~L~~L~Ls~N~l~~~~~-~~~~L~~L~~L~Ls~n~~n~~~~~lp-~~l~~L~-~L~~L~Ls~ 173 (1142)
+++|+|+.+| ..|.++++|++|++++|.+..++. .+....++..|++.++ +....+| ..|..+. .|+.|+|++
T Consensus 87 ~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~---~~i~~l~~~~f~~~~~~l~~L~L~~ 163 (350)
T 4ay9_X 87 EKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDN---INIHTIERNSFVGLSFESVILWLNK 163 (350)
T ss_dssp EEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESC---TTCCEECTTSSTTSBSSCEEEECCS
T ss_pred ccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccc---cccccccccchhhcchhhhhhcccc
Confidence 6678888774 446778888888888887665553 4555666777777652 2233333 3445543 577888888
Q ss_pred CCCCccCcccCCCCCCCEEEccC-CCCCccch-hhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeCcC-CcCCCCCc
Q 001142 174 FSIRYLPPEIGCLSNLEQLDLSF-NKMKYLPT-EICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSN-NRLTSLGS 250 (1142)
Q Consensus 174 N~L~~IP~~l~~L~~L~~L~Ls~-N~L~~lP~-~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls~-N~Ls~~~p 250 (1142)
|+|+.||..+....+|+.|+|++ |.++.||. .|..+++|+.|+|++|+|+.||... +.+|+.|.+.+ +.++.+|
T Consensus 164 N~i~~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~--~~~L~~L~~l~~~~l~~lP- 240 (350)
T 4ay9_X 164 NGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYG--LENLKKLRARSTYNLKKLP- 240 (350)
T ss_dssp SCCCEECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSS--CTTCCEEECTTCTTCCCCC-
T ss_pred ccccCCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhh--hccchHhhhccCCCcCcCC-
Confidence 88888888777777888888874 77888875 4678888888888888888888643 45566666444 4555555
Q ss_pred ccccCCCCCCEEEccCC
Q 001142 251 LDLCLMHNLQNLNLQYN 267 (1142)
Q Consensus 251 ~~l~~L~~L~~L~Ls~N 267 (1142)
.+..+++|+.++++++
T Consensus 241 -~l~~l~~L~~l~l~~~ 256 (350)
T 4ay9_X 241 -TLEKLVALMEASLTYP 256 (350)
T ss_dssp -CTTTCCSCCEEECSCH
T ss_pred -CchhCcChhhCcCCCC
Confidence 3778888888888754
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.83 E-value=7.7e-20 Score=200.13 Aligned_cols=175 Identities=22% Similarity=0.275 Sum_probs=137.4
Q ss_pred CCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCcCCcEEEccCCCCCcCch-hhcCCCCCCEE
Q 001142 42 DDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLRNLKFFGNEINLFPS-EVGNLLGLECL 119 (1142)
Q Consensus 42 ~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~-~l~~L~~L~~L~Ls~N~L~~lP~-~l~~L~~L~~L 119 (1142)
+.+++|+++|+++.+++. +. ++|+.|+|++|.|+.++. .|.++++|++|+|++|.|+.++. .|.++++|+.|
T Consensus 15 ~~~~l~~~~~~l~~~p~~-~~-----~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 88 (251)
T 3m19_A 15 GKKEVDCQGKSLDSVPSG-IP-----ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTL 88 (251)
T ss_dssp GGTEEECTTCCCSSCCSC-CC-----TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred CCeEEecCCCCccccCCC-CC-----CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEE
Confidence 467889999988865543 21 578899999999987754 68888999999999999987654 47778888888
Q ss_pred EccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCcc-cCCCCCCCEEEccCCC
Q 001142 120 QIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPE-IGCLSNLEQLDLSFNK 198 (1142)
Q Consensus 120 ~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~-l~~L~~L~~L~Ls~N~ 198 (1142)
+|++|.+..++ +..|..+++|+.|+|++|+|+.+|.. |..+++|+.|+|++|+
T Consensus 89 ~L~~n~l~~~~--------------------------~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 142 (251)
T 3m19_A 89 GLANNQLASLP--------------------------LGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQ 142 (251)
T ss_dssp ECTTSCCCCCC--------------------------TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred ECCCCcccccC--------------------------hhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCc
Confidence 88877655433 22455677788888888888877664 5788889999999999
Q ss_pred CCccch-hhcCCCCCCEEEccCCCCCccCc-cccCCCCCCEEeCcCCcCCCC
Q 001142 199 MKYLPT-EICYLKALISLKVANNKLVELPS-GLYLLQRLENLDLSNNRLTSL 248 (1142)
Q Consensus 199 L~~lP~-~l~~L~~L~~L~Ls~N~Ls~IP~-~l~~L~~L~~L~Ls~N~Ls~~ 248 (1142)
|+.+|. .|..+++|+.|+|++|+|+.+|. .+..+++|+.|+|++|.+++.
T Consensus 143 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 143 LQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 988865 68888899999999999987765 567788999999999998876
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.83 E-value=1.3e-21 Score=222.37 Aligned_cols=241 Identities=18% Similarity=0.176 Sum_probs=168.4
Q ss_pred CcccccCCCCCCcccCCCCCCCC--CCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCc--cCccccCCcCC
Q 001142 18 IKEKLPSEANKINNEKNGSVNDD--DDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNL--IPKSVGRYEKL 93 (1142)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l--~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~--iP~~l~~L~~L 93 (1142)
....+++..|++. +..+..+ ++++.|+|++|.+++.++.. ..+++|++|+|++|.++. +|..+..+++|
T Consensus 48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~~----~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L 120 (336)
T 2ast_B 48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEH----FSPFRVQHMDLSNSVIEVSTLHGILSQCSKL 120 (336)
T ss_dssp TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCSC----CCCBCCCEEECTTCEECHHHHHHHHTTBCCC
T ss_pred hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchhh----ccCCCCCEEEccCCCcCHHHHHHHHhhCCCC
Confidence 4667777777665 3445555 78888888888888776652 245788888888888773 67777888888
Q ss_pred cEEEccCCCCC-cCchhhcCCCCCCEEEccCC-CCCC--CcccccCCCCCCEEECCCC-CCCCCcccchhhhcCCC-CCc
Q 001142 94 RNLKFFGNEIN-LFPSEVGNLLGLECLQIKIS-SPGV--NGFALNKLKGLKELELSKV-PPRPSVLTLLSEIAGLK-CLT 167 (1142)
Q Consensus 94 ~~L~Ls~N~L~-~lP~~l~~L~~L~~L~Ls~N-~l~~--~~~~~~~L~~L~~L~Ls~n-~~n~~~~~lp~~l~~L~-~L~ 167 (1142)
++|+|++|.++ .+|..++++++|+.|+|++| .++. ++..+..+++|++|++++| .+.. ..++..+..++ +|+
T Consensus 121 ~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~--~~~~~~~~~l~~~L~ 198 (336)
T 2ast_B 121 QNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTE--KHVQVAVAHVSETIT 198 (336)
T ss_dssp SEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCH--HHHHHHHHHSCTTCC
T ss_pred CEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcCh--HHHHHHHHhcccCCC
Confidence 88888888887 56777888888888888887 4553 4555777888888888875 3321 12455667777 888
Q ss_pred EEEccCCC--CC--ccCcccCCCCCCCEEEccCCC-CC-ccchhhcCCCCCCEEEccCCC-CC-ccCccccCCCCCCEEe
Q 001142 168 KLSVCHFS--IR--YLPPEIGCLSNLEQLDLSFNK-MK-YLPTEICYLKALISLKVANNK-LV-ELPSGLYLLQRLENLD 239 (1142)
Q Consensus 168 ~L~Ls~N~--L~--~IP~~l~~L~~L~~L~Ls~N~-L~-~lP~~l~~L~~L~~L~Ls~N~-Ls-~IP~~l~~L~~L~~L~ 239 (1142)
.|++++|. ++ .+|..+..+++|+.|+|++|. ++ ..+..+..+++|+.|+|++|. ++ .....+.++++|+.|+
T Consensus 199 ~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~ 278 (336)
T 2ast_B 199 QLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQ 278 (336)
T ss_dssp EEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEE
T ss_pred EEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEe
Confidence 88888883 43 466666778888888888888 55 556777788888888888884 32 1112466788888888
Q ss_pred CcCCcCCCCCcccccCCC-CCCEEEccCCCCCC
Q 001142 240 LSNNRLTSLGSLDLCLMH-NLQNLNLQYNKLLS 271 (1142)
Q Consensus 240 Ls~N~Ls~~~p~~l~~L~-~L~~L~Ls~N~L~~ 271 (1142)
|++| ++ ...+..+. .|..|++++|++++
T Consensus 279 l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~~ 307 (336)
T 2ast_B 279 VFGI-VP---DGTLQLLKEALPHLQINCSHFTT 307 (336)
T ss_dssp CTTS-SC---TTCHHHHHHHSTTSEESCCCSCC
T ss_pred ccCc-cC---HHHHHHHHhhCcceEEecccCcc
Confidence 8887 33 22333332 36666678888877
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.83 E-value=2.4e-22 Score=238.20 Aligned_cols=252 Identities=17% Similarity=0.095 Sum_probs=149.7
Q ss_pred CCcccccCCCCCCcccCCCC-CCCCC----CCCEEEccCCCCCC----CCcccccCCCCCCCccEEEeecCCCCcc-Ccc
Q 001142 17 PIKEKLPSEANKINNEKNGS-VNDDD----DDSVIDVSGKTVDF----PLIESYGNRGGDNSVEGLYLYKNVLNLI-PKS 86 (1142)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~~~-f~~l~----~L~~LdLs~N~L~~----~~p~~~~~l~~L~~L~~L~Ls~N~Lt~i-P~~ 86 (1142)
+.++.|.+..|+|+...... +..++ +|++|+|++|+|+. .++..+. .+++|++|+|++|.++.. +..
T Consensus 56 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~---~~~~L~~L~Ls~n~i~~~~~~~ 132 (461)
T 1z7x_W 56 PALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLR---TLPTLQELHLSDNLLGDAGLQL 132 (461)
T ss_dssp TTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTT---SCTTCCEEECCSSBCHHHHHHH
T ss_pred CCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHHHc---cCCceeEEECCCCcCchHHHHH
Confidence 46777777777776643322 22333 57778888777763 3344443 347777777777777632 222
Q ss_pred c-----cCCcCCcEEEccCCCCCc-----CchhhcCCCCCCEEEccCCCCCCCcc-ccc-----CCCCCCEEECCCCCCC
Q 001142 87 V-----GRYEKLRNLKFFGNEINL-----FPSEVGNLLGLECLQIKISSPGVNGF-ALN-----KLKGLKELELSKVPPR 150 (1142)
Q Consensus 87 l-----~~L~~L~~L~Ls~N~L~~-----lP~~l~~L~~L~~L~Ls~N~l~~~~~-~~~-----~L~~L~~L~Ls~n~~n 150 (1142)
+ ..+++|++|+|++|.|+. ++..+..+++|+.|+|++|.++..+. .+. .+++|++|++++|.+.
T Consensus 133 l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~ 212 (461)
T 1z7x_W 133 LCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVT 212 (461)
T ss_dssp HHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCB
T ss_pred HHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCc
Confidence 2 224567777777777763 35556667777777777776543221 111 2557777777775443
Q ss_pred CCc-ccchhhhcCCCCCcEEEccCCCCCcc------CcccCCCCCCCEEEccCCCCCc-----cchhhcCCCCCCEEEcc
Q 001142 151 PSV-LTLLSEIAGLKCLTKLSVCHFSIRYL------PPEIGCLSNLEQLDLSFNKMKY-----LPTEICYLKALISLKVA 218 (1142)
Q Consensus 151 ~~~-~~lp~~l~~L~~L~~L~Ls~N~L~~I------P~~l~~L~~L~~L~Ls~N~L~~-----lP~~l~~L~~L~~L~Ls 218 (1142)
... ..++..+..+++|+.|++++|.++.. +..+..+++|+.|+|++|+|+. +|..+..+++|+.|+|+
T Consensus 213 ~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls 292 (461)
T 1z7x_W 213 SDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLA 292 (461)
T ss_dssp TTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECT
T ss_pred HHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECC
Confidence 221 12455566677777777777776632 1222356677777777777764 56666667777777777
Q ss_pred CCCCCc-----cCccccC-CCCCCEEeCcCCcCCCC----CcccccCCCCCCEEEccCCCCCC
Q 001142 219 NNKLVE-----LPSGLYL-LQRLENLDLSNNRLTSL----GSLDLCLMHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 219 ~N~Ls~-----IP~~l~~-L~~L~~L~Ls~N~Ls~~----~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1142)
+|.++. +...+.. .++|+.|+|++|.+++. .+..+..+++|+.|+|++|+++.
T Consensus 293 ~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~ 355 (461)
T 1z7x_W 293 GNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLED 355 (461)
T ss_dssp TCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHH
T ss_pred CCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCcccc
Confidence 777652 2222221 24666777777766654 23345556666666766666654
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.82 E-value=1.6e-20 Score=210.80 Aligned_cols=169 Identities=21% Similarity=0.241 Sum_probs=74.0
Q ss_pred CCccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCC
Q 001142 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKV 147 (1142)
Q Consensus 68 ~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n 147 (1142)
++|+.|++++|.++.+|. +..+++|++|+|++|+|+.++. +.++++|+.|+|++|.+..++. +..+++|++|++++|
T Consensus 46 ~~L~~L~l~~~~i~~~~~-~~~l~~L~~L~L~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~L~~n 122 (291)
T 1h6t_A 46 NSIDQIIANNSDIKSVQG-IQYLPNVTKLFLNGNKLTDIKP-LANLKNLGWLFLDENKVKDLSS-LKDLKKLKSLSLEHN 122 (291)
T ss_dssp HTCCEEECTTSCCCCCTT-GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCGGG-GTTCTTCCEEECTTS
T ss_pred CcccEEEccCCCcccChh-HhcCCCCCEEEccCCccCCCcc-cccCCCCCEEECCCCcCCCChh-hccCCCCCEEECCCC
Confidence 444444444444444432 4444444444444444444443 4444444444444444333221 222333333333332
Q ss_pred CCCCCcccchhhhcCCCCCcEEEccCCCCCccCcccCCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCc
Q 001142 148 PPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPS 227 (1142)
Q Consensus 148 ~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~IP~ 227 (1142)
.+... ..+..+++|+.|++++|+++.+ ..+..+++|+.|+|++|+|+.++. +..+++|+.|+|++|.|+.+|.
T Consensus 123 ~i~~~-----~~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~L~~N~i~~l~~ 195 (291)
T 1h6t_A 123 GISDI-----NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISDLRA 195 (291)
T ss_dssp CCCCC-----GGGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCBCGG
T ss_pred cCCCC-----hhhcCCCCCCEEEccCCcCCcc-hhhccCCCCCEEEccCCccccchh-hcCCCccCEEECCCCcCCCChh
Confidence 22111 1233444444444444444444 334444455555555555544433 4444455555555555544432
Q ss_pred cccCCCCCCEEeCcCCcCCC
Q 001142 228 GLYLLQRLENLDLSNNRLTS 247 (1142)
Q Consensus 228 ~l~~L~~L~~L~Ls~N~Ls~ 247 (1142)
+..+++|+.|+|++|+++.
T Consensus 196 -l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 196 -LAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp -GTTCTTCSEEEEEEEEEEC
T ss_pred -hccCCCCCEEECcCCcccC
Confidence 4444445555555554444
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.82 E-value=1.7e-20 Score=215.80 Aligned_cols=219 Identities=20% Similarity=0.135 Sum_probs=173.2
Q ss_pred CEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCcCCcEEEccCCCCC-cCchh-hcCCCCCCE-E
Q 001142 44 SVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLRNLKFFGNEIN-LFPSE-VGNLLGLEC-L 119 (1142)
Q Consensus 44 ~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~-~l~~L~~L~~L~Ls~N~L~-~lP~~-l~~L~~L~~-L 119 (1142)
+++++++|+|+.++.. + .++|++|+|++|+|+.||. .|.+|++|++|+|++|+|. .+|.. |.++++|.. +
T Consensus 12 ~~v~C~~~~Lt~iP~~-l-----~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l 85 (350)
T 4ay9_X 12 RVFLCQESKVTEIPSD-L-----PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIR 85 (350)
T ss_dssp TEEEEESTTCCSCCTT-C-----CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEE
T ss_pred CEEEecCCCCCccCcC-c-----CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhh
Confidence 6799999999976433 2 1689999999999999986 6899999999999999985 57654 778998876 5
Q ss_pred EccCCCCCCC-cccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccC-CCCCccCc-ccCCCC-CCCEEEcc
Q 001142 120 QIKISSPGVN-GFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCH-FSIRYLPP-EIGCLS-NLEQLDLS 195 (1142)
Q Consensus 120 ~Ls~N~l~~~-~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~-N~L~~IP~-~l~~L~-~L~~L~Ls 195 (1142)
.++.|++..+ +..|..+++|++|++++|.+... .+..+....++..|++.+ |++..+|. .|..+. .|+.|+|+
T Consensus 86 ~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~---~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~ 162 (350)
T 4ay9_X 86 IEKANNLLYINPEAFQNLPNLQYLLISNTGIKHL---PDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLN 162 (350)
T ss_dssp EEEETTCCEECTTSBCCCTTCCEEEEEEECCSSC---CCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECC
T ss_pred cccCCcccccCchhhhhccccccccccccccccC---Cchhhcccchhhhhhhccccccccccccchhhcchhhhhhccc
Confidence 6677887765 56899999999999999665432 233455667788888865 68888876 555554 68999999
Q ss_pred CCCCCccchhhcCCCCCCEEEcc-CCCCCccCcc-ccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccC-CCCCCC
Q 001142 196 FNKMKYLPTEICYLKALISLKVA-NNKLVELPSG-LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQY-NKLLSY 272 (1142)
Q Consensus 196 ~N~L~~lP~~l~~L~~L~~L~Ls-~N~Ls~IP~~-l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~-N~L~~~ 272 (1142)
+|+|+.||..+....+|+.|+|+ +|.++.||.. +..+++|+.|+|++|+|+.+++..|.+ |+.|.+.+ |.+..
T Consensus 163 ~N~i~~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~---L~~L~~l~~~~l~~- 238 (350)
T 4ay9_X 163 KNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLEN---LKKLRARSTYNLKK- 238 (350)
T ss_dssp SSCCCEECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTT---CCEEECTTCTTCCC-
T ss_pred cccccCCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhcc---chHhhhccCCCcCc-
Confidence 99999999888888899999997 5788999875 567999999999999999998866555 45555444 34554
Q ss_pred CCCCc
Q 001142 273 CQVPS 277 (1142)
Q Consensus 273 ~~iP~ 277 (1142)
+|.
T Consensus 239 --lP~ 241 (350)
T 4ay9_X 239 --LPT 241 (350)
T ss_dssp --CCC
T ss_pred --CCC
Confidence 664
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.82 E-value=2.7e-20 Score=215.01 Aligned_cols=180 Identities=23% Similarity=0.218 Sum_probs=134.1
Q ss_pred cEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchh-hc-CCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCC
Q 001142 71 EGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSE-VG-NLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVP 148 (1142)
Q Consensus 71 ~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~-l~-~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~ 148 (1142)
+.+++++|.|+.||..+.. .|+.|+|++|+|+.+|.. +. ++++|+.|+|++|.+..++
T Consensus 21 ~~l~c~~~~l~~iP~~~~~--~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~------------------ 80 (361)
T 2xot_A 21 NILSCSKQQLPNVPQSLPS--YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFIS------------------ 80 (361)
T ss_dssp TEEECCSSCCSSCCSSCCT--TCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEEC------------------
T ss_pred CEEEeCCCCcCccCccCCC--CCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccC------------------
Confidence 4566666666666665543 466666666666655443 33 5555555555555433222
Q ss_pred CCCCcccchhhhcCCCCCcEEEccCCCCCccCc-ccCCCCCCCEEEccCCCCCcc-chhhcCCCCCCEEEccCCCCCccC
Q 001142 149 PRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELP 226 (1142)
Q Consensus 149 ~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~Ls~N~L~~l-P~~l~~L~~L~~L~Ls~N~Ls~IP 226 (1142)
+..|.++++|+.|+|++|+|+.+|. .|..+++|+.|+|++|+|+.+ |..|..+++|+.|+|++|+|+.+|
T Consensus 81 --------~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~ 152 (361)
T 2xot_A 81 --------SEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFP 152 (361)
T ss_dssp --------TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCC
T ss_pred --------hhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeC
Confidence 2345667778888888888887765 578889999999999999976 677888999999999999999998
Q ss_pred ccc----cCCCCCCEEeCcCCcCCCCCcccccCCCC--CCEEEccCCCCCCCCCCCch
Q 001142 227 SGL----YLLQRLENLDLSNNRLTSLGSLDLCLMHN--LQNLNLQYNKLLSYCQVPSW 278 (1142)
Q Consensus 227 ~~l----~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~--L~~L~Ls~N~L~~~~~iP~~ 278 (1142)
..+ ..+++|+.|+|++|+|+++++..|..++. |+.|+|++|+|.|.|++-.+
T Consensus 153 ~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~C~l~~~ 210 (361)
T 2xot_A 153 VELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDCKLYQL 210 (361)
T ss_dssp GGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEECCHHHHHH
T ss_pred HHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccCCcCcHHH
Confidence 776 46899999999999999999888888887 48899999999998876544
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.82 E-value=6.9e-21 Score=219.90 Aligned_cols=224 Identities=17% Similarity=0.134 Sum_probs=178.6
Q ss_pred EEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccC-----ccccCCc-CCcEEEccCCCCCcC-chhhcCC----
Q 001142 45 VIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIP-----KSVGRYE-KLRNLKFFGNEINLF-PSEVGNL---- 113 (1142)
Q Consensus 45 ~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP-----~~l~~L~-~L~~L~Ls~N~L~~l-P~~l~~L---- 113 (1142)
+++|++|++++.+|..+... ++|++|+|++|.|+.++ ..|..++ +|++|+|++|.|+.. +..+..+
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~---~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~ 78 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIP---HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAI 78 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSC---TTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTS
T ss_pred ccccccccchHHHHHHHhCC---CCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhcc
Confidence 57899999999999876544 67999999999999886 5678888 899999999999855 5566664
Q ss_pred -CCCCEEEccCCCCCCCccc-----ccCC-CCCCEEECCCCCCCCCccc-chhhhcCC-CCCcEEEccCCCCC-----cc
Q 001142 114 -LGLECLQIKISSPGVNGFA-----LNKL-KGLKELELSKVPPRPSVLT-LLSEIAGL-KCLTKLSVCHFSIR-----YL 179 (1142)
Q Consensus 114 -~~L~~L~Ls~N~l~~~~~~-----~~~L-~~L~~L~Ls~n~~n~~~~~-lp~~l~~L-~~L~~L~Ls~N~L~-----~I 179 (1142)
++|++|+|++|.++..+.. +..+ ++|++|+|++|.+...... +...+..+ ++|+.|+|++|.|+ .+
T Consensus 79 ~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l 158 (362)
T 3goz_A 79 PANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDEL 158 (362)
T ss_dssp CTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHH
T ss_pred CCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHH
Confidence 9999999999997765532 5555 8999999999765433221 22234453 69999999999998 34
Q ss_pred CcccCCCC-CCCEEEccCCCCCcc-ch----hhcCC-CCCCEEEccCCCCCc-----cCccccC-CCCCCEEeCcCCcCC
Q 001142 180 PPEIGCLS-NLEQLDLSFNKMKYL-PT----EICYL-KALISLKVANNKLVE-----LPSGLYL-LQRLENLDLSNNRLT 246 (1142)
Q Consensus 180 P~~l~~L~-~L~~L~Ls~N~L~~l-P~----~l~~L-~~L~~L~Ls~N~Ls~-----IP~~l~~-L~~L~~L~Ls~N~Ls 246 (1142)
+..+..++ +|++|+|++|+|+.. +. .+..+ ++|+.|+|++|.|+. +|..+.. .++|+.|+|++|.|+
T Consensus 159 ~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~ 238 (362)
T 3goz_A 159 IQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLH 238 (362)
T ss_dssp HHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCC
T ss_pred HHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCC
Confidence 55566665 999999999999855 33 34455 599999999999986 7777776 458999999999999
Q ss_pred CCCcc----cccCCCCCCEEEccCCCCCC
Q 001142 247 SLGSL----DLCLMHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 247 ~~~p~----~l~~L~~L~~L~Ls~N~L~~ 271 (1142)
+..+. .+..+++|+.|+|++|.+..
T Consensus 239 ~~~~~~l~~~~~~l~~L~~L~L~~n~l~~ 267 (362)
T 3goz_A 239 GPSLENLKLLKDSLKHLQTVYLDYDIVKN 267 (362)
T ss_dssp CCCHHHHHHTTTTTTTCSEEEEEHHHHTT
T ss_pred cHHHHHHHHHHhcCCCccEEEeccCCccc
Confidence 88763 35678999999999999654
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.81 E-value=6.8e-22 Score=234.29 Aligned_cols=251 Identities=15% Similarity=0.120 Sum_probs=106.0
Q ss_pred CcccccCCCCCCcccC----CCCCCCCCCCCEEEccCCCCCCCCcccc-cCCCCCC-CccEEEeecCCCC-----ccCcc
Q 001142 18 IKEKLPSEANKINNEK----NGSVNDDDDDSVIDVSGKTVDFPLIESY-GNRGGDN-SVEGLYLYKNVLN-----LIPKS 86 (1142)
Q Consensus 18 ~l~~L~~~~N~i~~l~----~~~f~~l~~L~~LdLs~N~L~~~~p~~~-~~l~~L~-~L~~L~Ls~N~Lt-----~iP~~ 86 (1142)
.++.|.+..|+|+... ...|..+++|++|||++|.|+...+..+ ..+.... +|++|+|++|.|+ .+|..
T Consensus 29 ~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~ 108 (461)
T 1z7x_W 29 QCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSST 108 (461)
T ss_dssp TCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred CccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHH
Confidence 3444444444444321 1233444455555555555443222211 1121000 3555555555554 23444
Q ss_pred ccCCcCCcEEEccCCCCCcC-chhh-----cCCCCCCEEEccCCCCCCC-----cccccCCCCCCEEECCCCCCCCCccc
Q 001142 87 VGRYEKLRNLKFFGNEINLF-PSEV-----GNLLGLECLQIKISSPGVN-----GFALNKLKGLKELELSKVPPRPSVLT 155 (1142)
Q Consensus 87 l~~L~~L~~L~Ls~N~L~~l-P~~l-----~~L~~L~~L~Ls~N~l~~~-----~~~~~~L~~L~~L~Ls~n~~n~~~~~ 155 (1142)
|..+++|++|+|++|.|+.. +..+ ..+++|+.|+|++|.++.. +..+..+++|++|++++|.+. ..
T Consensus 109 l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~---~~ 185 (461)
T 1z7x_W 109 LRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN---EA 185 (461)
T ss_dssp TTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCH---HH
T ss_pred HccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcc---hH
Confidence 44455555555555554311 1111 1133455555555543321 223334455555555543321 11
Q ss_pred chhhhc-----CCCCCcEEEccCCCCCc-----cCcccCCCCCCCEEEccCCCCCcc-----chh-hcCCCCCCEEEccC
Q 001142 156 LLSEIA-----GLKCLTKLSVCHFSIRY-----LPPEIGCLSNLEQLDLSFNKMKYL-----PTE-ICYLKALISLKVAN 219 (1142)
Q Consensus 156 lp~~l~-----~L~~L~~L~Ls~N~L~~-----IP~~l~~L~~L~~L~Ls~N~L~~l-----P~~-l~~L~~L~~L~Ls~ 219 (1142)
.+..+. .+++|+.|++++|.++. +|..+..+++|+.|+|++|.|+.. ... +..+++|+.|+|++
T Consensus 186 ~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~ 265 (461)
T 1z7x_W 186 GVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWE 265 (461)
T ss_dssp HHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTT
T ss_pred HHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcC
Confidence 111111 23345555555555543 344444455555555555555421 111 12345555555555
Q ss_pred CCCCc-----cCccccCCCCCCEEeCcCCcCCCCCcccccC-----CCCCCEEEccCCCCCC
Q 001142 220 NKLVE-----LPSGLYLLQRLENLDLSNNRLTSLGSLDLCL-----MHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 220 N~Ls~-----IP~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~-----L~~L~~L~Ls~N~L~~ 271 (1142)
|.|+. +|..+..+++|+.|+|++|.|+...+..+.. .++|+.|+|++|.+++
T Consensus 266 n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~ 327 (461)
T 1z7x_W 266 CGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTA 327 (461)
T ss_dssp SCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBG
T ss_pred CCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCch
Confidence 55553 4444444555555555555554333222221 1355555555555543
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.81 E-value=1e-19 Score=204.06 Aligned_cols=191 Identities=24% Similarity=0.226 Sum_probs=168.2
Q ss_pred CCccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCC
Q 001142 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKV 147 (1142)
Q Consensus 68 ~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n 147 (1142)
..+..+.+..+.++.+. .+..+++|+.|++++|.|+.+|. +..+++|+.|+|++|.+..++. +..+++|++|++++|
T Consensus 24 ~~~~~~~l~~~~~~~~~-~~~~l~~L~~L~l~~~~i~~~~~-~~~l~~L~~L~L~~n~l~~~~~-l~~l~~L~~L~l~~n 100 (291)
T 1h6t_A 24 AETIKDNLKKKSVTDAV-TQNELNSIDQIIANNSDIKSVQG-IQYLPNVTKLFLNGNKLTDIKP-LANLKNLGWLFLDEN 100 (291)
T ss_dssp HHHHHHHTTCSCTTSEE-CHHHHHTCCEEECTTSCCCCCTT-GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSS
T ss_pred HHHHHHHhcCCCccccc-chhhcCcccEEEccCCCcccChh-HhcCCCCCEEEccCCccCCCcc-cccCCCCCEEECCCC
Confidence 34555667777777652 34678899999999999999964 8899999999999999888877 999999999999997
Q ss_pred CCCCCcccchhhhcCCCCCcEEEccCCCCCccCcccCCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCc
Q 001142 148 PPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPS 227 (1142)
Q Consensus 148 ~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~IP~ 227 (1142)
.+.. +| .+..+++|+.|+|++|+|+.+ +.+..+++|+.|+|++|+|+.+ ..+..+++|+.|+|++|+|+.++.
T Consensus 101 ~l~~----~~-~l~~l~~L~~L~L~~n~i~~~-~~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~N~l~~~~~ 173 (291)
T 1h6t_A 101 KVKD----LS-SLKDLKKLKSLSLEHNGISDI-NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP 173 (291)
T ss_dssp CCCC----GG-GGTTCTTCCEEECTTSCCCCC-GGGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG
T ss_pred cCCC----Ch-hhccCCCCCEEECCCCcCCCC-hhhcCCCCCCEEEccCCcCCcc-hhhccCCCCCEEEccCCccccchh
Confidence 7644 33 489999999999999999988 4688999999999999999988 679999999999999999998876
Q ss_pred cccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccCCCCCC
Q 001142 228 GLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 228 ~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1142)
+..+++|+.|+|++|+|++++ .+..+++|+.|+|++|+++.
T Consensus 174 -l~~l~~L~~L~L~~N~i~~l~--~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 174 -LAGLTKLQNLYLSKNHISDLR--ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp -GTTCTTCCEEECCSSCCCBCG--GGTTCTTCSEEEEEEEEEEC
T ss_pred -hcCCCccCEEECCCCcCCCCh--hhccCCCCCEEECcCCcccC
Confidence 899999999999999999974 48999999999999999986
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.80 E-value=9.3e-20 Score=224.58 Aligned_cols=172 Identities=20% Similarity=0.231 Sum_probs=95.6
Q ss_pred CCccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCC
Q 001142 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKV 147 (1142)
Q Consensus 68 ~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n 147 (1142)
++|+.|+|++|.|+.+| .|..|++|+.|+|++|.|+.+|. +.+|++|+.|+|++|.+..++ .+..+++|+.|+|++|
T Consensus 43 ~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~l~~l~-~l~~l~~L~~L~Ls~N 119 (605)
T 1m9s_A 43 NSIDQIIANNSDIKSVQ-GIQYLPNVTKLFLNGNKLTDIKP-LTNLKNLGWLFLDENKIKDLS-SLKDLKKLKSLSLEHN 119 (605)
T ss_dssp TTCCCCBCTTCCCCCCT-TGGGCTTCCEEECTTSCCCCCGG-GGGCTTCCEEECCSSCCCCCT-TSTTCTTCCEEECTTS
T ss_pred CCCCEEECcCCCCCCCh-HHccCCCCCEEEeeCCCCCCChh-hccCCCCCEEECcCCCCCCCh-hhccCCCCCEEEecCC
Confidence 45555555555555554 35555555555555555555544 555555555555555544333 3444444444444443
Q ss_pred CCCCCcccchhhhcCCCCCcEEEccCCCCCccCcccCCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCc
Q 001142 148 PPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPS 227 (1142)
Q Consensus 148 ~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~IP~ 227 (1142)
.+... ..+..|++|+.|+|++|.|+.+ ..+..|++|+.|+|++|+|+.++. +..+++|+.|+|++|+|+.+|
T Consensus 120 ~l~~l-----~~l~~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~i~~l~- 191 (605)
T 1m9s_A 120 GISDI-----NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISDLR- 191 (605)
T ss_dssp CCCCC-----GGGGGCTTCSEEECCSSCCCCC-GGGGSCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCBCG-
T ss_pred CCCCC-----ccccCCCccCEEECCCCccCCc-hhhcccCCCCEEECcCCcCCCchh-hccCCCCCEEECcCCCCCCCh-
Confidence 33221 2345566666666666666655 445666666666666666665544 666666666666666666654
Q ss_pred cccCCCCCCEEeCcCCcCCCCCc
Q 001142 228 GLYLLQRLENLDLSNNRLTSLGS 250 (1142)
Q Consensus 228 ~l~~L~~L~~L~Ls~N~Ls~~~p 250 (1142)
.+..|++|+.|+|++|+|++.+.
T Consensus 192 ~l~~l~~L~~L~L~~N~l~~~p~ 214 (605)
T 1m9s_A 192 ALAGLKNLDVLELFSQECLNKPI 214 (605)
T ss_dssp GGTTCTTCSEEECCSEEEECCCC
T ss_pred HHccCCCCCEEEccCCcCcCCcc
Confidence 45666666666666666665543
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.79 E-value=3.3e-19 Score=191.77 Aligned_cols=123 Identities=19% Similarity=0.217 Sum_probs=104.1
Q ss_pred hcCCCCCcEEEccCCCCCccCc-ccCCCCCCCEEEccCCCCCccc-hhhcCCCCCCEEEccCCCCCcc-CccccCCCCCC
Q 001142 160 IAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFNKMKYLP-TEICYLKALISLKVANNKLVEL-PSGLYLLQRLE 236 (1142)
Q Consensus 160 l~~L~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~Ls~N~L~~lP-~~l~~L~~L~~L~Ls~N~Ls~I-P~~l~~L~~L~ 236 (1142)
|..+++|+.|+|++|+|+.+|. .|..+++|++|+|++|+|+.+| ..|..+++|+.|+|++|+|+.+ |..+..+++|+
T Consensus 53 ~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 132 (220)
T 2v70_A 53 FKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVR 132 (220)
T ss_dssp GGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCS
T ss_pred hccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCC
Confidence 4456667777777788876655 6888899999999999999775 4588899999999999999976 67788899999
Q ss_pred EEeCcCCcCCCCCcccccCCCCCCEEEccCCCCCCCCCCCchhhcc
Q 001142 237 NLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCN 282 (1142)
Q Consensus 237 ~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~ 282 (1142)
.|+|++|+|++++|..|..+++|+.|+|++|+|.|.|++.....|.
T Consensus 133 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~l~~~~ 178 (220)
T 2v70_A 133 LLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCYLAWLGEWL 178 (220)
T ss_dssp EEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGGGHHHHHHH
T ss_pred EEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCchHHHHHHH
Confidence 9999999999999999999999999999999999988765544443
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.79 E-value=2.8e-20 Score=211.29 Aligned_cols=231 Identities=16% Similarity=0.123 Sum_probs=188.8
Q ss_pred CCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCC-CcccccCCCCCCCccEEEeecCCCC-ccCccccCCcCCc
Q 001142 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFP-LIESYGNRGGDNSVEGLYLYKNVLN-LIPKSVGRYEKLR 94 (1142)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~-~p~~~~~l~~L~~L~~L~Ls~N~Lt-~iP~~l~~L~~L~ 94 (1142)
+.+..+.+..|.|....+. +..+++|++|+|++|.+++. ++..+..+ ++|++|+|++|.++ .+|..|..+++|+
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~---~~L~~L~L~~~~l~~~~~~~l~~~~~L~ 145 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQC---SKLQNLSLEGLRLSDPIVNTLAKNSNLV 145 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTB---CCCSEEECTTCBCCHHHHHHHTTCTTCS
T ss_pred ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhC---CCCCEEeCcCcccCHHHHHHHhcCCCCC
Confidence 4688899999999998766 55799999999999999875 66666544 99999999999998 5688899999999
Q ss_pred EEEccCC-CCC--cCchhhcCCCCCCEEEccCC-CCCC--CcccccCCC-CCCEEECCCCCCCCCcccchhhhcCCCCCc
Q 001142 95 NLKFFGN-EIN--LFPSEVGNLLGLECLQIKIS-SPGV--NGFALNKLK-GLKELELSKVPPRPSVLTLLSEIAGLKCLT 167 (1142)
Q Consensus 95 ~L~Ls~N-~L~--~lP~~l~~L~~L~~L~Ls~N-~l~~--~~~~~~~L~-~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~ 167 (1142)
+|+|++| .++ .+|..+.++++|+.|+|++| .++. ++..+..++ +|++|++++|.+.-....+|..+.++++|+
T Consensus 146 ~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~ 225 (336)
T 2ast_B 146 RLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLV 225 (336)
T ss_dssp EEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCS
T ss_pred EEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCC
Confidence 9999999 788 47888999999999999999 7764 456788899 999999999632112256677888999999
Q ss_pred EEEccCCC-CC-ccCcccCCCCCCCEEEccCCC-CC-ccchhhcCCCCCCEEEccCCCCCccCc-cccCC-CCCCEEeCc
Q 001142 168 KLSVCHFS-IR-YLPPEIGCLSNLEQLDLSFNK-MK-YLPTEICYLKALISLKVANNKLVELPS-GLYLL-QRLENLDLS 241 (1142)
Q Consensus 168 ~L~Ls~N~-L~-~IP~~l~~L~~L~~L~Ls~N~-L~-~lP~~l~~L~~L~~L~Ls~N~Ls~IP~-~l~~L-~~L~~L~Ls 241 (1142)
.|++++|. ++ ..+..+..+++|+.|+|++|. +. .....+..+++|+.|+|++| + |. .+..+ .+|..|+++
T Consensus 226 ~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i---~~~~~~~l~~~l~~L~l~ 301 (336)
T 2ast_B 226 HLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-V---PDGTLQLLKEALPHLQIN 301 (336)
T ss_dssp EEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-S---CTTCHHHHHHHSTTSEES
T ss_pred EEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-c---CHHHHHHHHhhCcceEEe
Confidence 99999999 66 667788999999999999996 33 11236888999999999999 4 33 22233 236677799
Q ss_pred CCcCCCCCcccccC
Q 001142 242 NNRLTSLGSLDLCL 255 (1142)
Q Consensus 242 ~N~Ls~~~p~~l~~ 255 (1142)
+|+|++..|..+++
T Consensus 302 ~n~l~~~~~~~~~~ 315 (336)
T 2ast_B 302 CSHFTTIARPTIGN 315 (336)
T ss_dssp CCCSCCTTCSSCSS
T ss_pred cccCccccCCcccc
Confidence 99999999977654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=9.9e-20 Score=203.64 Aligned_cols=151 Identities=17% Similarity=0.174 Sum_probs=112.2
Q ss_pred cceeeeecccCceEEEEEEE-CCccEEEEEEecccCCCCh----HH------HHHhHHhHHHHHHHHhhCCCCCccceee
Q 001142 809 LSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSA----DE------IRNFEYSCLGEVRMLGALRHSCIVEMYG 877 (1142)
Q Consensus 809 y~l~~~LG~GsfG~Vy~a~~-~~~~vAvKi~~l~~~~~~~----~~------~~~~~~~~~~Ei~iL~~L~HpNIVkl~g 877 (1142)
|.+.+.||+|+||.||+|.+ .+..+|+|+.+........ .. .......+.+|+.++++++ | +++++
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~ 168 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPK 168 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCC
T ss_pred EEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCe
Confidence 57789999999999999998 4678899986533211100 00 0011234589999999999 4 66666
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 001142 878 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 957 (1142)
Q Consensus 878 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp 957 (1142)
++.. + ..++||||++|++|.+ +. . .....++.||+.||.|||++||+||||||
T Consensus 169 ~~~~-~--------------~~~lvmE~~~g~~L~~-l~---------~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp 221 (282)
T 1zar_A 169 VYAW-E--------------GNAVLMELIDAKELYR-VR---------V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQ 221 (282)
T ss_dssp EEEE-E--------------TTEEEEECCCCEEGGG-CC---------C--SCHHHHHHHHHHHHHHHHHTTEECSCCST
T ss_pred EEec-c--------------ceEEEEEecCCCcHHH-cc---------h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCH
Confidence 5543 2 2299999999999987 31 1 23457999999999999999999999999
Q ss_pred CCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhcc
Q 001142 958 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1020 (1142)
Q Consensus 958 ~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~ 1020 (1142)
+|||++ + +.+||+|||+|+. +..|+|||++..
T Consensus 222 ~NILl~-~-------~~vkl~DFG~a~~-----------------------~~~~~a~e~l~r 253 (282)
T 1zar_A 222 YNVLVS-E-------EGIWIIDFPQSVE-----------------------VGEEGWREILER 253 (282)
T ss_dssp TSEEEE-T-------TEEEECCCTTCEE-----------------------TTSTTHHHHHHH
T ss_pred HHEEEE-C-------CcEEEEECCCCeE-----------------------CCCCCHHHHHHH
Confidence 999999 6 7899999999852 344789999764
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.78 E-value=3.7e-19 Score=219.27 Aligned_cols=189 Identities=20% Similarity=0.172 Sum_probs=163.0
Q ss_pred ccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEEccCC
Q 001142 22 LPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGN 101 (1142)
Q Consensus 22 L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N 101 (1142)
+.+..+.+..+. .+..+++|+.|+|++|.|+... .+ ..|++|+.|+|++|.|+.+|+ |..|++|+.|+|++|
T Consensus 26 l~l~~~~i~~~~--~~~~L~~L~~L~l~~n~i~~l~--~l---~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N 97 (605)
T 1m9s_A 26 DNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQ--GI---QYLPNVTKLFLNGNKLTDIKP-LTNLKNLGWLFLDEN 97 (605)
T ss_dssp HHTTCSCTTSEE--CHHHHTTCCCCBCTTCCCCCCT--TG---GGCTTCCEEECTTSCCCCCGG-GGGCTTCCEEECCSS
T ss_pred HhccCCCccccc--chhcCCCCCEEECcCCCCCCCh--HH---ccCCCCCEEEeeCCCCCCChh-hccCCCCCEEECcCC
Confidence 344455555543 4678899999999999998753 24 455999999999999999977 899999999999999
Q ss_pred CCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCc
Q 001142 102 EINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP 181 (1142)
Q Consensus 102 ~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~ 181 (1142)
.|+.+| .+.+|++|+.|+|++|.+..++ .+..|++|+.|+|++|.+... ..+..|++|+.|+|++|.|+.+++
T Consensus 98 ~l~~l~-~l~~l~~L~~L~Ls~N~l~~l~-~l~~l~~L~~L~Ls~N~l~~l-----~~l~~l~~L~~L~Ls~N~l~~~~~ 170 (605)
T 1m9s_A 98 KIKDLS-SLKDLKKLKSLSLEHNGISDIN-GLVHLPQLESLYLGNNKITDI-----TVLSRLTKLDTLSLEDNQISDIVP 170 (605)
T ss_dssp CCCCCT-TSTTCTTCCEEECTTSCCCCCG-GGGGCTTCSEEECCSSCCCCC-----GGGGSCTTCSEEECCSSCCCCCGG
T ss_pred CCCCCh-hhccCCCCCEEEecCCCCCCCc-cccCCCccCEEECCCCccCCc-----hhhcccCCCCEEECcCCcCCCchh
Confidence 999887 6899999999999999988764 588999999999999877554 468899999999999999998866
Q ss_pred ccCCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCc
Q 001142 182 EIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPS 227 (1142)
Q Consensus 182 ~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~IP~ 227 (1142)
+..+++|+.|+|++|+|+.+| .+..|++|+.|+|++|.|+..|.
T Consensus 171 -l~~l~~L~~L~Ls~N~i~~l~-~l~~l~~L~~L~L~~N~l~~~p~ 214 (605)
T 1m9s_A 171 -LAGLTKLQNLYLSKNHISDLR-ALAGLKNLDVLELFSQECLNKPI 214 (605)
T ss_dssp -GTTCTTCCEEECCSSCCCBCG-GGTTCTTCSEEECCSEEEECCCC
T ss_pred -hccCCCCCEEECcCCCCCCCh-HHccCCCCCEEEccCCcCcCCcc
Confidence 899999999999999999985 68999999999999999987664
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.78 E-value=8.7e-19 Score=188.49 Aligned_cols=123 Identities=24% Similarity=0.282 Sum_probs=102.8
Q ss_pred hhcCCCCCcEEEccCCCCCcc-CcccCCCCCCCEEEccCCCCCccchh-hcCCCCCCEEEccCCCCCcc-CccccCCCCC
Q 001142 159 EIAGLKCLTKLSVCHFSIRYL-PPEIGCLSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKLVEL-PSGLYLLQRL 235 (1142)
Q Consensus 159 ~l~~L~~L~~L~Ls~N~L~~I-P~~l~~L~~L~~L~Ls~N~L~~lP~~-l~~L~~L~~L~Ls~N~Ls~I-P~~l~~L~~L 235 (1142)
.|..+++|+.|+|++|+|+.+ |..|..+++|++|+|++|+|+.+|.. |..+++|+.|+|++|+|+.+ |..+..+++|
T Consensus 51 ~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 130 (220)
T 2v9t_B 51 AFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNL 130 (220)
T ss_dssp SSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred HhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCC
Confidence 345566677777777777765 66788888899999999999988765 57789999999999999876 5677889999
Q ss_pred CEEeCcCCcCCCCCcccccCCCCCCEEEccCCCCCCCCCCCchhhc
Q 001142 236 ENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICC 281 (1142)
Q Consensus 236 ~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~ 281 (1142)
+.|+|++|+|+++++..|..+++|+.|+|++|+|.|.|++.+...|
T Consensus 131 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~l~~l~~~ 176 (220)
T 2v9t_B 131 NLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCHLKWLADY 176 (220)
T ss_dssp CEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGGGHHHHHH
T ss_pred CEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCccHHHHHH
Confidence 9999999999999998899999999999999999999887655544
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.78 E-value=2e-18 Score=186.66 Aligned_cols=116 Identities=29% Similarity=0.342 Sum_probs=97.3
Q ss_pred hhcCCCCCcEEEccCCCCCccCc-ccCCCCCCCEEEccCCCCCccchh-hcCCCCCCEEEccCCCCCccCccccCCCCCC
Q 001142 159 EIAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKLVELPSGLYLLQRLE 236 (1142)
Q Consensus 159 ~l~~L~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~Ls~N~L~~lP~~-l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~ 236 (1142)
.|.++++|+.|+|++|+|+.+|. .|..+++|++|+|++|+|+.+|.. |..+++|+.|+|++|+|+.||..+..+++|+
T Consensus 59 ~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~ 138 (229)
T 3e6j_A 59 VFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLT 138 (229)
T ss_dssp TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCSCCTTGGGCTTCS
T ss_pred HhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCcccccCcccccCCCCC
Confidence 44556667777777777777765 457888889999999988887654 6788999999999999999998898899999
Q ss_pred EEeCcCCcCCCCCcccccCCCCCCEEEccCCCCCCCCC
Q 001142 237 NLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQ 274 (1142)
Q Consensus 237 ~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~~~~ 274 (1142)
.|+|++|+|+++++..|..+++|+.|+|++|+|.|.|+
T Consensus 139 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 139 HLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred EEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 99999999999988888999999999999999998664
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=1.5e-21 Score=238.92 Aligned_cols=195 Identities=23% Similarity=0.218 Sum_probs=148.9
Q ss_pred CCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEEccCCC-------------CC-cCchhhcCCCCCCEEE-
Q 001142 56 PLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNE-------------IN-LFPSEVGNLLGLECLQ- 120 (1142)
Q Consensus 56 ~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~-------------L~-~lP~~l~~L~~L~~L~- 120 (1142)
....++.++..+++|+.|+|++|.|+.||.+|++|++|+.|++++|. +. .+|..+++|++|+.|+
T Consensus 337 ~~~~~~~d~~~~~~L~~L~Ls~n~L~~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~ 416 (567)
T 1dce_A 337 RPECWCRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDP 416 (567)
T ss_dssp CSEEEEECCSTTTTSSSCCCCHHHHHHHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCG
T ss_pred CchhhhcccccCccceeccCChhhHHhhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcc
Confidence 33445544556688888999999888888888888889999887764 22 3455556666666665
Q ss_pred ccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCcccCCCCCCCEEEccCCCCC
Q 001142 121 IKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMK 200 (1142)
Q Consensus 121 Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~ 200 (1142)
++.|. +.+|..+.+++| .+..+|. ..|+.|+|++|.|+.+|. |+.+++|+.|+|++|+|+
T Consensus 417 l~~n~----------~~~L~~l~l~~n----~i~~l~~-----~~L~~L~Ls~n~l~~lp~-~~~l~~L~~L~Ls~N~l~ 476 (567)
T 1dce_A 417 MRAAY----------LDDLRSKFLLEN----SVLKMEY-----ADVRVLHLAHKDLTVLCH-LEQLLLVTHLDLSHNRLR 476 (567)
T ss_dssp GGHHH----------HHHHHHHHHHHH----HHHHHHH-----TTCSEEECTTSCCSSCCC-GGGGTTCCEEECCSSCCC
T ss_pred hhhcc----------cchhhhhhhhcc----cccccCc-----cCceEEEecCCCCCCCcC-ccccccCcEeecCccccc
Confidence 44332 122333333331 1222222 248889999999999987 889999999999999999
Q ss_pred ccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeCcCCcCCCCC-cccccCCCCCCEEEccCCCCCC
Q 001142 201 YLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLG-SLDLCLMHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 201 ~lP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls~N~Ls~~~-p~~l~~L~~L~~L~Ls~N~L~~ 271 (1142)
.||..|+.+++|+.|+|++|+|+.|| .++.|++|+.|+|++|+|++++ |..|..|++|+.|+|++|+|++
T Consensus 477 ~lp~~~~~l~~L~~L~Ls~N~l~~lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~ 547 (567)
T 1dce_A 477 ALPPALAALRCLEVLQASDNALENVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 547 (567)
T ss_dssp CCCGGGGGCTTCCEEECCSSCCCCCG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred ccchhhhcCCCCCEEECCCCCCCCCc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCC
Confidence 99999999999999999999999988 8889999999999999999987 7789999999999999999987
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.77 E-value=8.3e-19 Score=193.91 Aligned_cols=168 Identities=22% Similarity=0.191 Sum_probs=115.1
Q ss_pred CCccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCC
Q 001142 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKV 147 (1142)
Q Consensus 68 ~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n 147 (1142)
.+++.|+|++|.++.++ .+..+++|++|+|++|.|+.+| .+..+++|+.|+|++|.+..++.
T Consensus 19 ~~l~~l~l~~~~i~~~~-~~~~l~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~L~~N~i~~~~~---------------- 80 (263)
T 1xeu_A 19 ANAVKQNLGKQSVTDLV-SQKELSGVQNFNGDNSNIQSLA-GMQFFTNLKELHLSHNQISDLSP---------------- 80 (263)
T ss_dssp HHHHHHHHTCSCTTSEE-CHHHHTTCSEEECTTSCCCCCT-TGGGCTTCCEEECCSSCCCCCGG----------------
T ss_pred HHHHHHHhcCCCccccc-chhhcCcCcEEECcCCCcccch-HHhhCCCCCEEECCCCccCCChh----------------
Confidence 45666677777777665 4666677777777777777666 56666666666666665444332
Q ss_pred CCCCCcccchhhhcCCCCCcEEEccCCCCCccCcccCCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCc
Q 001142 148 PPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPS 227 (1142)
Q Consensus 148 ~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~IP~ 227 (1142)
+..+++|+.|+|++|+|+.+|.... ++|+.|+|++|+|+.+| .+..+++|+.|+|++|+|+.+|
T Consensus 81 ------------l~~l~~L~~L~L~~N~l~~l~~~~~--~~L~~L~L~~N~l~~~~-~l~~l~~L~~L~Ls~N~i~~~~- 144 (263)
T 1xeu_A 81 ------------LKDLTKLEELSVNRNRLKNLNGIPS--ACLSRLFLDNNELRDTD-SLIHLKNLEILSIRNNKLKSIV- 144 (263)
T ss_dssp ------------GTTCSSCCEEECCSSCCSCCTTCCC--SSCCEEECCSSCCSBSG-GGTTCTTCCEEECTTSCCCBCG-
T ss_pred ------------hccCCCCCEEECCCCccCCcCcccc--CcccEEEccCCccCCCh-hhcCcccccEEECCCCcCCCCh-
Confidence 5556666677777777776655323 67777777777777765 4777777777777777777775
Q ss_pred cccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccCCCCCC
Q 001142 228 GLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 228 ~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1142)
.+..+++|+.|+|++|+|++. ..+..+++|+.|+|++|++++
T Consensus 145 ~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~ 186 (263)
T 1xeu_A 145 MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVN 186 (263)
T ss_dssp GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEEC
T ss_pred HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccC
Confidence 566777777777777777776 357777777777777777766
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.77 E-value=2.4e-18 Score=182.53 Aligned_cols=102 Identities=26% Similarity=0.352 Sum_probs=45.6
Q ss_pred CCCCcEEEccCCCCCccCcc-cCCCCCCCEEEccCCCCCccchh-hcCCCCCCEEEccCCCCCccCcc-ccCCCCCCEEe
Q 001142 163 LKCLTKLSVCHFSIRYLPPE-IGCLSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKLVELPSG-LYLLQRLENLD 239 (1142)
Q Consensus 163 L~~L~~L~Ls~N~L~~IP~~-l~~L~~L~~L~Ls~N~L~~lP~~-l~~L~~L~~L~Ls~N~Ls~IP~~-l~~L~~L~~L~ 239 (1142)
+++|++|+|++|+|+.+|.. |..+++|++|+|++|+|+.+|.. +..+++|+.|+|++|+|+.+|.. +..+++|+.|+
T Consensus 75 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 154 (208)
T 2o6s_A 75 LTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIW 154 (208)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEE
T ss_pred CCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEE
Confidence 33444444444444443332 34444444444444444444322 34444455555555554444333 33344555555
Q ss_pred CcCCcCCCCCcccccCCCCCCEEEccCCCCCC
Q 001142 240 LSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 240 Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1142)
|++|.+.+ .+++|++|+++.|.+++
T Consensus 155 l~~N~~~~-------~~~~l~~L~~~~n~~~g 179 (208)
T 2o6s_A 155 LHDNPWDC-------TCPGIRYLSEWINKHSG 179 (208)
T ss_dssp CCSCCBCC-------CTTTTHHHHHHHHHCTT
T ss_pred ecCCCeec-------CCCCHHHHHHHHHhCCc
Confidence 55554332 22344455555555544
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.77 E-value=4.2e-19 Score=196.33 Aligned_cols=173 Identities=18% Similarity=0.221 Sum_probs=134.9
Q ss_pred CCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCE
Q 001142 39 DDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLEC 118 (1142)
Q Consensus 39 ~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~ 118 (1142)
++.++..|+|+.|.++... .+.. +++|+.|+|++|.|+.+| .+..+++|++|+|++|+|+.+|. +.++++|+.
T Consensus 17 ~l~~l~~l~l~~~~i~~~~--~~~~---l~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~L~~N~i~~~~~-l~~l~~L~~ 89 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDLV--SQKE---LSGVQNFNGDNSNIQSLA-GMQFFTNLKELHLSHNQISDLSP-LKDLTKLEE 89 (263)
T ss_dssp HHHHHHHHHHTCSCTTSEE--CHHH---HTTCSEEECTTSCCCCCT-TGGGCTTCCEEECCSSCCCCCGG-GTTCSSCCE
T ss_pred HHHHHHHHHhcCCCccccc--chhh---cCcCcEEECcCCCcccch-HHhhCCCCCEEECCCCccCCChh-hccCCCCCE
Confidence 4566788899999998755 3444 489999999999999998 78999999999999999999988 999999999
Q ss_pred EEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCcccCCCCCCCEEEccCCC
Q 001142 119 LQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNK 198 (1142)
Q Consensus 119 L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~ 198 (1142)
|+|++|.+..++... . ++|+.|+|++|+|+.+| .+..+++|+.|+|++|+
T Consensus 90 L~L~~N~l~~l~~~~----------------------------~-~~L~~L~L~~N~l~~~~-~l~~l~~L~~L~Ls~N~ 139 (263)
T 1xeu_A 90 LSVNRNRLKNLNGIP----------------------------S-ACLSRLFLDNNELRDTD-SLIHLKNLEILSIRNNK 139 (263)
T ss_dssp EECCSSCCSCCTTCC----------------------------C-SSCCEEECCSSCCSBSG-GGTTCTTCCEEECTTSC
T ss_pred EECCCCccCCcCccc----------------------------c-CcccEEEccCCccCCCh-hhcCcccccEEECCCCc
Confidence 999999866554211 1 45667777777777664 46777777777777777
Q ss_pred CCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeCcCCcCCCCCc
Q 001142 199 MKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGS 250 (1142)
Q Consensus 199 L~~lP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls~N~Ls~~~p 250 (1142)
|+.+| .+..+++|+.|+|++|+|+.+ ..+..+++|+.|+|++|.+++.+.
T Consensus 140 i~~~~-~l~~l~~L~~L~L~~N~i~~~-~~l~~l~~L~~L~l~~N~~~~~~~ 189 (263)
T 1xeu_A 140 LKSIV-MLGFLSKLEVLDLHGNEITNT-GGLTRLKKVNWIDLTGQKCVNEPV 189 (263)
T ss_dssp CCBCG-GGGGCTTCCEEECTTSCCCBC-TTSTTCCCCCEEEEEEEEEECCCE
T ss_pred CCCCh-HHccCCCCCEEECCCCcCcch-HHhccCCCCCEEeCCCCcccCCcc
Confidence 77775 577777777777777777766 566777777777777777776644
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.75 E-value=5.9e-18 Score=179.54 Aligned_cols=177 Identities=17% Similarity=0.158 Sum_probs=113.6
Q ss_pred CEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCcCCcEEEccCCCCCcCchh-hcCCCCCCEEEc
Q 001142 44 SVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLRNLKFFGNEINLFPSE-VGNLLGLECLQI 121 (1142)
Q Consensus 44 ~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~-~l~~L~~L~~L~Ls~N~L~~lP~~-l~~L~~L~~L~L 121 (1142)
+.++++++.++..+... .++|++|+|++|.|+.+|. .|..+++|++|+|++|+|+.+|.. |.++++|++|+|
T Consensus 10 ~~v~c~~~~l~~~p~~~------~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 83 (208)
T 2o6s_A 10 TTVECYSQGRTSVPTGI------PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNL 83 (208)
T ss_dssp TEEECCSSCCSSCCSCC------CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CEEEecCCCccCCCCCC------CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEEC
Confidence 35566666655443221 1456666666666665544 345566666666666666655443 345555555555
Q ss_pred cCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCcc-cCCCCCCCEEEccCCCCC
Q 001142 122 KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPE-IGCLSNLEQLDLSFNKMK 200 (1142)
Q Consensus 122 s~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~-l~~L~~L~~L~Ls~N~L~ 200 (1142)
++|.+..++ +..|..+++|+.|+|++|+|+.+|.. |..+++|+.|+|++|+|+
T Consensus 84 s~n~l~~~~--------------------------~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 137 (208)
T 2o6s_A 84 STNQLQSLP--------------------------NGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLK 137 (208)
T ss_dssp CSSCCCCCC--------------------------TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred CCCcCCccC--------------------------HhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccc
Confidence 555433222 22356677777777888887776654 577888888888888888
Q ss_pred ccchh-hcCCCCCCEEEccCCCCCccCccccCCCCCCEEeCcCCcCCCCCcccccCCCC
Q 001142 201 YLPTE-ICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHN 258 (1142)
Q Consensus 201 ~lP~~-l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~ 258 (1142)
.+|.. +..+++|+.|+|++|.+. ..+++|+.|+++.|+++|.+|.+++.++.
T Consensus 138 ~~~~~~~~~l~~L~~L~l~~N~~~------~~~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 138 SVPDGVFDRLTSLQYIWLHDNPWD------CTCPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp CCCTTTTTTCTTCCEEECCSCCBC------CCTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred eeCHHHhccCCCccEEEecCCCee------cCCCCHHHHHHHHHhCCceeeccCccccC
Confidence 77654 677888888888888665 23457888888888888888877776654
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.74 E-value=2e-17 Score=178.90 Aligned_cols=153 Identities=22% Similarity=0.247 Sum_probs=112.9
Q ss_pred ccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcC-chhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCC
Q 001142 70 VEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLF-PSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVP 148 (1142)
Q Consensus 70 L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~l-P~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~ 148 (1142)
.+.+++++|.++.||..+. ++|++|+|++|+|+.+ |..|.++++|+.|+|++|.++.++
T Consensus 21 ~~~v~c~~~~l~~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~------------------ 80 (229)
T 3e6j_A 21 GTTVDCRSKRHASVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALP------------------ 80 (229)
T ss_dssp TTEEECTTSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC------------------
T ss_pred CCEeEccCCCcCccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcC------------------
Confidence 4566677777777766554 4677777777777655 444666666666666666543332
Q ss_pred CCCCcccchhhhcCCCCCcEEEccCCCCCccCcc-cCCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCc
Q 001142 149 PRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPE-IGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPS 227 (1142)
Q Consensus 149 ~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~-l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~IP~ 227 (1142)
+..|..+++|+.|+|++|+|+.+|.. |..+++|+.|+|++|+|+.||..+..+++|+.|+|++|+|+.+|.
T Consensus 81 --------~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~~ 152 (229)
T 3e6j_A 81 --------VGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQNQLKSIPH 152 (229)
T ss_dssp --------TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCSCCTTGGGCTTCSEEECCSSCCCCCCT
T ss_pred --------hhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCcccccCcccccCCCCCEEECCCCcCCccCH
Confidence 12345677788888888888877664 578889999999999999999888889999999999999998875
Q ss_pred -cccCCCCCCEEeCcCCcCCCCCc
Q 001142 228 -GLYLLQRLENLDLSNNRLTSLGS 250 (1142)
Q Consensus 228 -~l~~L~~L~~L~Ls~N~Ls~~~p 250 (1142)
.+..+++|+.|+|++|.+++..+
T Consensus 153 ~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 153 GAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp TTTTTCTTCCEEECTTSCBCTTBG
T ss_pred HHHhCCCCCCEEEeeCCCccCCcc
Confidence 46678999999999999887654
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.74 E-value=5.2e-19 Score=222.64 Aligned_cols=178 Identities=16% Similarity=0.051 Sum_probs=77.2
Q ss_pred CCCCEEEccCCCCCCCCcccccCCCCCC--CccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCE
Q 001142 41 DDDSVIDVSGKTVDFPLIESYGNRGGDN--SVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLEC 118 (1142)
Q Consensus 41 ~~L~~LdLs~N~L~~~~p~~~~~l~~L~--~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~ 118 (1142)
+.++.|+|++|.+.......+..+ .|. +|..++++.|.+...|..|..+++|+.|+|++|.|..||..++++++|++
T Consensus 173 ~~~~~l~L~~n~~~~~~~~~l~~l-~Ls~~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~~l~~~~~~l~~L~~ 251 (727)
T 4b8c_D 173 PLTPKIELFANGKDEANQALLQHK-KLSQYSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIFNISANIFKYDFLTR 251 (727)
T ss_dssp --------------------------------------------------CCCCCCEEECTTSCCSCCCGGGGGCCSCSC
T ss_pred CccceEEeeCCCCCcchhhHhhcC-ccCcccccCccccccceecChhhhccCCCCcEEECCCCCCCCCChhhcCCCCCCE
Confidence 457778888887776432221111 111 12333444455554456677777777788887777777777777777777
Q ss_pred EEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCcccCCCCCCCEEEccCCC
Q 001142 119 LQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNK 198 (1142)
Q Consensus 119 L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~ 198 (1142)
|+|++|.+..+|..+..|++|++|+|++|.+. .+|..|++|++|+.|+|++|.|+.||..|+.|++|+.|+|++|.
T Consensus 252 L~Ls~N~l~~lp~~~~~l~~L~~L~Ls~N~l~----~lp~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~L~~N~ 327 (727)
T 4b8c_D 252 LYLNGNSLTELPAEIKNLSNLRVLDLSHNRLT----SLPAELGSCFQLKYFYFFDNMVTTLPWEFGNLCNLQFLGVEGNP 327 (727)
T ss_dssp CBCTTSCCSCCCGGGGGGTTCCEEECTTSCCS----SCCSSGGGGTTCSEEECCSSCCCCCCSSTTSCTTCCCEECTTSC
T ss_pred EEeeCCcCcccChhhhCCCCCCEEeCcCCcCC----ccChhhcCCCCCCEEECCCCCCCccChhhhcCCCccEEeCCCCc
Confidence 77777766666655555555555555554332 34555555555555555555555555555555555555555555
Q ss_pred CC-ccchhhcCCC-CCCEEEccCCCCC
Q 001142 199 MK-YLPTEICYLK-ALISLKVANNKLV 223 (1142)
Q Consensus 199 L~-~lP~~l~~L~-~L~~L~Ls~N~Ls 223 (1142)
|+ .+|..+..+. .+..|+|++|.++
T Consensus 328 l~~~~p~~~~~~~~~~~~l~l~~N~l~ 354 (727)
T 4b8c_D 328 LEKQFLKILTEKSVTGLIFYLRDNRPE 354 (727)
T ss_dssp CCSHHHHHHHHHHHHHHHHHHHHCCCC
T ss_pred cCCCChHHHhhcchhhhHHhhccCccc
Confidence 55 3344443321 1123455555554
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=9.6e-18 Score=176.75 Aligned_cols=152 Identities=16% Similarity=0.207 Sum_probs=102.7
Q ss_pred cCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCc
Q 001142 88 GRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLT 167 (1142)
Q Consensus 88 ~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~ 167 (1142)
..+++|+.|+|++|.|+.+| .+..+++|+.|++++|.+... ..+..+++|+
T Consensus 41 ~~l~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~l~~n~~~~~----------------------------~~l~~l~~L~ 91 (197)
T 4ezg_A 41 AQMNSLTYITLANINVTDLT-GIEYAHNIKDLTINNIHATNY----------------------------NPISGLSNLE 91 (197)
T ss_dssp HHHHTCCEEEEESSCCSCCT-TGGGCTTCSEEEEESCCCSCC----------------------------GGGTTCTTCC
T ss_pred hhcCCccEEeccCCCccChH-HHhcCCCCCEEEccCCCCCcc----------------------------hhhhcCCCCC
Confidence 44555666666666666555 455555555555555432211 2355566777
Q ss_pred EEEccCCCCCc-cCcccCCCCCCCEEEccCCCCC-ccchhhcCCCCCCEEEccCCC-CCccCccccCCCCCCEEeCcCCc
Q 001142 168 KLSVCHFSIRY-LPPEIGCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNK-LVELPSGLYLLQRLENLDLSNNR 244 (1142)
Q Consensus 168 ~L~Ls~N~L~~-IP~~l~~L~~L~~L~Ls~N~L~-~lP~~l~~L~~L~~L~Ls~N~-Ls~IP~~l~~L~~L~~L~Ls~N~ 244 (1142)
.|++++|.++. .|..++.+++|++|+|++|+|+ ..|..+..+++|+.|+|++|. ++.+| .+..+++|+.|+|++|+
T Consensus 92 ~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~ 170 (197)
T 4ezg_A 92 RLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDG 170 (197)
T ss_dssp EEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBC
T ss_pred EEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCC
Confidence 77777777773 5667777888888888888887 456777788888888888887 77776 57778888888888888
Q ss_pred CCCCCcccccCCCCCCEEEccCCCCCC
Q 001142 245 LTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 245 Ls~~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1142)
|++++ .+..+++|+.|++++|++..
T Consensus 171 i~~~~--~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 171 VHDYR--GIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp CCCCT--TGGGCSSCCEEEECBC----
T ss_pred CcChH--HhccCCCCCEEEeeCcccCC
Confidence 88765 57778888888888887653
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=5.6e-20 Score=225.06 Aligned_cols=203 Identities=18% Similarity=0.180 Sum_probs=159.0
Q ss_pred CCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCC-------------CC-ccCccccCCcCCcEEE-ccCC
Q 001142 37 VNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNV-------------LN-LIPKSVGRYEKLRNLK-FFGN 101 (1142)
Q Consensus 37 f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~-------------Lt-~iP~~l~~L~~L~~L~-Ls~N 101 (1142)
+..+++|+.|+|++|+|+ .+|+.++.+ ++|+.|++++|. +. .+|..++.|++|+.|+ ++.|
T Consensus 345 ~~~~~~L~~L~Ls~n~L~-~Lp~~i~~l---~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n 420 (567)
T 1dce_A 345 SATDEQLFRCELSVEKST-VLQSELESC---KELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAA 420 (567)
T ss_dssp CSTTTTSSSCCCCHHHHH-HHHHHHHHH---HHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHH
T ss_pred cccCccceeccCChhhHH-hhHHHHHHH---HHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhc
Confidence 367899999999999997 567777666 899999997774 33 5577889999999999 7877
Q ss_pred CCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCc
Q 001142 102 EINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP 181 (1142)
Q Consensus 102 ~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~ 181 (1142)
.+..++. +.++.|.+..++. ..|+.|+|++|.+.. +|. |+.|++|+.|+|++|.|+.||.
T Consensus 421 ~~~~L~~----------l~l~~n~i~~l~~-----~~L~~L~Ls~n~l~~----lp~-~~~l~~L~~L~Ls~N~l~~lp~ 480 (567)
T 1dce_A 421 YLDDLRS----------KFLLENSVLKMEY-----ADVRVLHLAHKDLTV----LCH-LEQLLLVTHLDLSHNRLRALPP 480 (567)
T ss_dssp HHHHHHH----------HHHHHHHHHHHHH-----TTCSEEECTTSCCSS----CCC-GGGGTTCCEEECCSSCCCCCCG
T ss_pred ccchhhh----------hhhhcccccccCc-----cCceEEEecCCCCCC----CcC-ccccccCcEeecCcccccccch
Confidence 6654443 2233333222221 136677777754432 454 7888899999999999999999
Q ss_pred ccCCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCcc--CccccCCCCCCEEeCcCCcCCCCCccc---ccCC
Q 001142 182 EIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVEL--PSGLYLLQRLENLDLSNNRLTSLGSLD---LCLM 256 (1142)
Q Consensus 182 ~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~I--P~~l~~L~~L~~L~Ls~N~Ls~~~p~~---l~~L 256 (1142)
.|+.+++|+.|+|++|+|+.|| .|+.+++|+.|+|++|+|+.+ |..++.|++|+.|+|++|+|++.+|.. +..+
T Consensus 481 ~~~~l~~L~~L~Ls~N~l~~lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~l 559 (567)
T 1dce_A 481 ALAALRCLEVLQASDNALENVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 559 (567)
T ss_dssp GGGGCTTCCEEECCSSCCCCCG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHC
T ss_pred hhhcCCCCCEEECCCCCCCCCc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHC
Confidence 9999999999999999999998 899999999999999999977 889999999999999999999987732 3348
Q ss_pred CCCCEEEc
Q 001142 257 HNLQNLNL 264 (1142)
Q Consensus 257 ~~L~~L~L 264 (1142)
++|+.|++
T Consensus 560 p~L~~L~l 567 (567)
T 1dce_A 560 PSVSSILT 567 (567)
T ss_dssp TTCSEEEC
T ss_pred cccCccCC
Confidence 89998875
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.5e-17 Score=192.02 Aligned_cols=173 Identities=23% Similarity=0.232 Sum_probs=121.0
Q ss_pred CCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCcc-cc-CCcCCcEEEccCCCCCcCch-hhcCCCCCCEE
Q 001142 43 DSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKS-VG-RYEKLRNLKFFGNEINLFPS-EVGNLLGLECL 119 (1142)
Q Consensus 43 L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~-l~-~L~~L~~L~Ls~N~L~~lP~-~l~~L~~L~~L 119 (1142)
-+++++++|+|+.++.. +. ..|+.|+|++|+|+.+|.. |. ++++|++|+|++|+|+.+|. .|.++++|+.|
T Consensus 20 ~~~l~c~~~~l~~iP~~-~~-----~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L 93 (361)
T 2xot_A 20 SNILSCSKQQLPNVPQS-LP-----SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYL 93 (361)
T ss_dssp TTEEECCSSCCSSCCSS-CC-----TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred CCEEEeCCCCcCccCcc-CC-----CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEE
Confidence 35899999999875433 22 4688999999999988654 55 88999999999999998764 58888888888
Q ss_pred EccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCcc-CcccCCCCCCCEEEccCCC
Q 001142 120 QIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYL-PPEIGCLSNLEQLDLSFNK 198 (1142)
Q Consensus 120 ~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~I-P~~l~~L~~L~~L~Ls~N~ 198 (1142)
+|++|.+..++. ..|.++++|+.|+|++|+|+.+ |..|..+++|+.|+|++|+
T Consensus 94 ~Ls~N~l~~~~~--------------------------~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~ 147 (361)
T 2xot_A 94 DLSSNHLHTLDE--------------------------FLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQ 147 (361)
T ss_dssp ECCSSCCCEECT--------------------------TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred ECCCCcCCcCCH--------------------------HHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCc
Confidence 888877554332 2345566666666666666655 4466677777777777777
Q ss_pred CCccchhh----cCCCCCCEEEccCCCCCccCc-cccCCCC--CCEEeCcCCcCCC
Q 001142 199 MKYLPTEI----CYLKALISLKVANNKLVELPS-GLYLLQR--LENLDLSNNRLTS 247 (1142)
Q Consensus 199 L~~lP~~l----~~L~~L~~L~Ls~N~Ls~IP~-~l~~L~~--L~~L~Ls~N~Ls~ 247 (1142)
|+.+|..+ ..+++|+.|+|++|+|+.+|. .+..++. |+.|+|++|.+..
T Consensus 148 l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C 203 (361)
T 2xot_A 148 ISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLEC 203 (361)
T ss_dssp CCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred CCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccC
Confidence 77776554 456777777777777776663 3444555 3667777777653
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.72 E-value=3.7e-17 Score=175.74 Aligned_cols=149 Identities=21% Similarity=0.259 Sum_probs=93.9
Q ss_pred cEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCch-hhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCC
Q 001142 71 EGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPS-EVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPP 149 (1142)
Q Consensus 71 ~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~-~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~ 149 (1142)
+.+++++|.|+.||..+. ++|+.|+|++|+|+.+|. .|.++++|+.|+|++|.+..
T Consensus 14 ~~v~c~~~~l~~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~--------------------- 70 (220)
T 2v9t_B 14 NIVDCRGKGLTEIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE--------------------- 70 (220)
T ss_dssp TEEECTTSCCSSCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCE---------------------
T ss_pred CEEEcCCCCcCcCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCC---------------------
Confidence 345555555555555443 355566666666655543 34444555555444443221
Q ss_pred CCCcccchhhhcCCCCCcEEEccCCCCCccCcc-cCCCCCCCEEEccCCCCCcc-chhhcCCCCCCEEEccCCCCCccCc
Q 001142 150 RPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPE-IGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPS 227 (1142)
Q Consensus 150 n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~-l~~L~~L~~L~Ls~N~L~~l-P~~l~~L~~L~~L~Ls~N~Ls~IP~ 227 (1142)
..|..|.++++|+.|+|++|+|+.+|.. |..+++|+.|+|++|+|+.+ |..|..+++|+.|+|++|+|+.+|.
T Consensus 71 -----~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 145 (220)
T 2v9t_B 71 -----LAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAK 145 (220)
T ss_dssp -----ECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred -----cCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECH
Confidence 1234556666677777777777777664 46777777888888877766 4667777788888888888876654
Q ss_pred -cccCCCCCCEEeCcCCcCCC
Q 001142 228 -GLYLLQRLENLDLSNNRLTS 247 (1142)
Q Consensus 228 -~l~~L~~L~~L~Ls~N~Ls~ 247 (1142)
.+..+++|+.|+|++|.+..
T Consensus 146 ~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 146 GTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp TTTTTCTTCCEEECCSSCEEC
T ss_pred HHHhCCCCCCEEEeCCCCcCC
Confidence 36667788888888887764
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.72 E-value=2.5e-17 Score=173.53 Aligned_cols=150 Identities=19% Similarity=0.252 Sum_probs=97.5
Q ss_pred CCccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCC
Q 001142 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKV 147 (1142)
Q Consensus 68 ~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n 147 (1142)
++|+.|+|++|.|+.+| .+..+++|++|+|++|.++.++ .+.++++|++|+|++|.+..
T Consensus 44 ~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~l~~n~~~~~~-~l~~l~~L~~L~l~~n~l~~------------------- 102 (197)
T 4ezg_A 44 NSLTYITLANINVTDLT-GIEYAHNIKDLTINNIHATNYN-PISGLSNLERLRIMGKDVTS------------------- 102 (197)
T ss_dssp HTCCEEEEESSCCSCCT-TGGGCTTCSEEEEESCCCSCCG-GGTTCTTCCEEEEECTTCBG-------------------
T ss_pred CCccEEeccCCCccChH-HHhcCCCCCEEEccCCCCCcch-hhhcCCCCCEEEeECCccCc-------------------
Confidence 67777777777777777 5777777888888877776554 56677777777776665432
Q ss_pred CCCCCcccchhhhcCCCCCcEEEccCCCCCc-cCcccCCCCCCCEEEccCCC-CCccchhhcCCCCCCEEEccCCCCCcc
Q 001142 148 PPRPSVLTLLSEIAGLKCLTKLSVCHFSIRY-LPPEIGCLSNLEQLDLSFNK-MKYLPTEICYLKALISLKVANNKLVEL 225 (1142)
Q Consensus 148 ~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~-IP~~l~~L~~L~~L~Ls~N~-L~~lP~~l~~L~~L~~L~Ls~N~Ls~I 225 (1142)
..|..+..+++|+.|++++|+++. .|..++.+++|++|+|++|+ ++.+| .+..+++|+.|+|++|+++.+
T Consensus 103 -------~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~~ 174 (197)
T 4ezg_A 103 -------DKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDY 174 (197)
T ss_dssp -------GGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCCC
T ss_pred -------ccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCCcCh
Confidence 122334455566666666666663 45556666677777777776 66665 566677777777777777766
Q ss_pred CccccCCCCCCEEeCcCCcCCC
Q 001142 226 PSGLYLLQRLENLDLSNNRLTS 247 (1142)
Q Consensus 226 P~~l~~L~~L~~L~Ls~N~Ls~ 247 (1142)
| .+..+++|+.|+|++|+|.+
T Consensus 175 ~-~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 175 R-GIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp T-TGGGCSSCCEEEECBC----
T ss_pred H-HhccCCCCCEEEeeCcccCC
Confidence 5 56667777777777776653
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=7e-17 Score=173.58 Aligned_cols=150 Identities=16% Similarity=0.194 Sum_probs=83.0
Q ss_pred EEEeecCCCCccCccccCCcCCcEEEccCCCCCcCch--hhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCC
Q 001142 72 GLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPS--EVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPP 149 (1142)
Q Consensus 72 ~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~--~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~ 149 (1142)
.|++++|.|+.||..+.. .+++|+|++|+|+.++. .|.++++|+.|+|++|.+..++
T Consensus 15 ~l~~s~n~l~~iP~~~~~--~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~------------------- 73 (220)
T 2v70_A 15 TVDCSNQKLNKIPEHIPQ--YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIE------------------- 73 (220)
T ss_dssp EEECCSSCCSSCCSCCCT--TCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEEC-------------------
T ss_pred EeEeCCCCcccCccCCCC--CCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEEC-------------------
Confidence 455555555555544432 34555555555554421 2455555555555555433222
Q ss_pred CCCcccchhhhcCCCCCcEEEccCCCCCccCc-ccCCCCCCCEEEccCCCCCcc-chhhcCCCCCCEEEccCCCCCcc-C
Q 001142 150 RPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVEL-P 226 (1142)
Q Consensus 150 n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~Ls~N~L~~l-P~~l~~L~~L~~L~Ls~N~Ls~I-P 226 (1142)
+..|.++++|+.|+|++|+|+.+|. .|..+++|++|+|++|+|+.+ |..|..+++|+.|+|++|+|+.+ |
T Consensus 74 -------~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 146 (220)
T 2v70_A 74 -------EGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAP 146 (220)
T ss_dssp -------TTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCT
T ss_pred -------HHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECH
Confidence 1133445555555555666655544 355666666666666666655 45566666666666666666655 5
Q ss_pred ccccCCCCCCEEeCcCCcCCCCC
Q 001142 227 SGLYLLQRLENLDLSNNRLTSLG 249 (1142)
Q Consensus 227 ~~l~~L~~L~~L~Ls~N~Ls~~~ 249 (1142)
..+..+++|+.|+|++|.+++..
T Consensus 147 ~~~~~l~~L~~L~L~~N~l~c~c 169 (220)
T 2v70_A 147 GAFDTLHSLSTLNLLANPFNCNC 169 (220)
T ss_dssp TTTTTCTTCCEEECCSCCEECSG
T ss_pred HHhcCCCCCCEEEecCcCCcCCC
Confidence 55666666666666666666543
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=2.4e-17 Score=181.73 Aligned_cols=142 Identities=15% Similarity=0.123 Sum_probs=103.4
Q ss_pred cceeeeecccCceEEEEEEE--CCcc--EEEEEEecccCCCChH----------------HHHHhHHhHHHHHHHHhhCC
Q 001142 809 LSSCDEAGKSVSSSLFRCKF--GSAD--AAAKVRTLKVCGSSAD----------------EIRNFEYSCLGEVRMLGALR 868 (1142)
Q Consensus 809 y~l~~~LG~GsfG~Vy~a~~--~~~~--vAvKi~~l~~~~~~~~----------------~~~~~~~~~~~Ei~iL~~L~ 868 (1142)
|++.+.||+|+||.||+|.+ .+.. +|+|+.+......... ........+.+|+.++.++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 67899999999999999998 7778 9999865432111100 00111234589999999998
Q ss_pred CCCc--cceeeeEecCCCCCCCCCCCccccceEEEEEeccCC-C----CHHHHHHHHhccCCCCCCHHHHHHHHHHHHHH
Q 001142 869 HSCI--VEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKG-G----SVKNYIEKLSETGEKHVSVKLALFIAQDVAAA 941 (1142)
Q Consensus 869 HpNI--Vkl~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~g-g----SL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~g 941 (1142)
|+++ ..++++ . ..+|||||+.+ | +|.++... .++..+..++.||+.|
T Consensus 129 ~~~i~~p~~~~~--~----------------~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~ 182 (258)
T 1zth_A 129 EAGVSVPQPYTY--M----------------KNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVEN 182 (258)
T ss_dssp HTTCCCCCEEEE--E----------------TTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHH
T ss_pred hCCCCCCeEEEc--C----------------CCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHH
Confidence 8764 333332 1 12899999942 3 67665422 2345678899999999
Q ss_pred HHHHH-hCCccccCCCCCCeeeccccccCCCCCeEEEeecCCccc
Q 001142 942 LVELH-SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 985 (1142)
Q Consensus 942 L~yLH-s~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~ 985 (1142)
|.||| +.||+||||||+|||++. .++|+|||+|..
T Consensus 183 l~~lH~~~givHrDlkp~NILl~~---------~~~liDFG~a~~ 218 (258)
T 1zth_A 183 VKRLYQEAELVHADLSEYNIMYID---------KVYFIDMGQAVT 218 (258)
T ss_dssp HHHHHHTSCEECSSCSTTSEEESS---------SEEECCCTTCEE
T ss_pred HHHHHHHCCEEeCCCCHHHEEEcC---------cEEEEECccccc
Confidence 99999 999999999999999974 499999999964
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.70 E-value=3.4e-18 Score=215.25 Aligned_cols=179 Identities=20% Similarity=0.066 Sum_probs=77.4
Q ss_pred CCccEEEeecCCCCccCccccCCcC-----CcEEEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEE
Q 001142 68 NSVEGLYLYKNVLNLIPKSVGRYEK-----LRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKEL 142 (1142)
Q Consensus 68 ~~L~~L~Ls~N~Lt~iP~~l~~L~~-----L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L 142 (1142)
+.++.|.|.+|.+..+|..+..... +..++++.|.+...|..+..+++|+.|+|++|.+..++..+..+++|++|
T Consensus 173 ~~~~~l~L~~n~~~~~~~~~l~~l~Ls~~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~~l~~~~~~l~~L~~L 252 (727)
T 4b8c_D 173 PLTPKIELFANGKDEANQALLQHKKLSQYSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIFNISANIFKYDFLTRL 252 (727)
T ss_dssp -------------------------------------------------CCCCCCEEECTTSCCSCCCGGGGGCCSCSCC
T ss_pred CccceEEeeCCCCCcchhhHhhcCccCcccccCccccccceecChhhhccCCCCcEEECCCCCCCCCChhhcCCCCCCEE
Confidence 4578899988988887665433222 22333444444444555666667777777666666665555566666666
Q ss_pred ECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCcccCCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCC
Q 001142 143 ELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKL 222 (1142)
Q Consensus 143 ~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~L 222 (1142)
+|++|.+. .+|..|.+|++|+.|+|++|.|+.||..|+.|++|++|+|++|.|+.||..|+.|++|+.|+|++|.|
T Consensus 253 ~Ls~N~l~----~lp~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~L~~N~l 328 (727)
T 4b8c_D 253 YLNGNSLT----ELPAEIKNLSNLRVLDLSHNRLTSLPAELGSCFQLKYFYFFDNMVTTLPWEFGNLCNLQFLGVEGNPL 328 (727)
T ss_dssp BCTTSCCS----CCCGGGGGGTTCCEEECTTSCCSSCCSSGGGGTTCSEEECCSSCCCCCCSSTTSCTTCCCEECTTSCC
T ss_pred EeeCCcCc----ccChhhhCCCCCCEEeCcCCcCCccChhhcCCCCCCEEECCCCCCCccChhhhcCCCccEEeCCCCcc
Confidence 66654332 44555555666666666666666566666666666666666666666665566666666666666666
Q ss_pred C-ccCccccCCCC-CCEEeCcCCcCCCCCc
Q 001142 223 V-ELPSGLYLLQR-LENLDLSNNRLTSLGS 250 (1142)
Q Consensus 223 s-~IP~~l~~L~~-L~~L~Ls~N~Ls~~~p 250 (1142)
+ .+|..+..+.. +..|+|++|.+++.+|
T Consensus 329 ~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p 358 (727)
T 4b8c_D 329 EKQFLKILTEKSVTGLIFYLRDNRPEIPLP 358 (727)
T ss_dssp CSHHHHHHHHHHHHHHHHHHHHCCCCCCCC
T ss_pred CCCChHHHhhcchhhhHHhhccCcccCcCc
Confidence 5 33444433211 1235566666665555
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.64 E-value=4.9e-17 Score=198.80 Aligned_cols=253 Identities=16% Similarity=-0.006 Sum_probs=125.6
Q ss_pred CCcccccCCCCCCcccCC----CCCCCCCCCCEEEccCCCCCCCC-----------------------cccccCCCCCCC
Q 001142 17 PIKEKLPSEANKINNEKN----GSVNDDDDDSVIDVSGKTVDFPL-----------------------IESYGNRGGDNS 69 (1142)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~----~~f~~l~~L~~LdLs~N~L~~~~-----------------------p~~~~~l~~L~~ 69 (1142)
+.++.|.+..|.++.+.. ..+.++++|++|+|++|.+++.. +..+..+..+++
T Consensus 192 ~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~ 271 (592)
T 3ogk_B 192 TSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRK 271 (592)
T ss_dssp CCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGGGHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTT
T ss_pred CCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHHHHHHHhhhhHHHhhcccccccccchHHHHHHhhcccc
Confidence 467777777777764432 23446677777777777654411 122233444456
Q ss_pred ccEEEeecCCCCccCccccCCcCCcEEEccCCCCC--cCchhhcCCCCCCEEEccCCC-CCCCcccccCCCCCCEEECCC
Q 001142 70 VEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEIN--LFPSEVGNLLGLECLQIKISS-PGVNGFALNKLKGLKELELSK 146 (1142)
Q Consensus 70 L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~--~lP~~l~~L~~L~~L~Ls~N~-l~~~~~~~~~L~~L~~L~Ls~ 146 (1142)
|+.|+++++....+|..+..+++|++|+|++|.++ .++..+.++++|+.|+|+++. ...++..+..+++|++|++++
T Consensus 272 L~~L~l~~~~~~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~ 351 (592)
T 3ogk_B 272 LCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIER 351 (592)
T ss_dssp CCEEEETTCCTTTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEEC
T ss_pred ccccCccccchhHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeec
Confidence 66666666555566777777778888888888775 233335667777777776221 111222334566667776662
Q ss_pred --------CCCCCCccc-chhhhcCCCCCcEEEccCCCCC-ccCcccCC-CCCCCEEEcc----CCCCCccc------hh
Q 001142 147 --------VPPRPSVLT-LLSEIAGLKCLTKLSVCHFSIR-YLPPEIGC-LSNLEQLDLS----FNKMKYLP------TE 205 (1142)
Q Consensus 147 --------n~~n~~~~~-lp~~l~~L~~L~~L~Ls~N~L~-~IP~~l~~-L~~L~~L~Ls----~N~L~~lP------~~ 205 (1142)
+..+..... ++..+..+++|+.|+++.|.++ ..+..++. +++|+.|+|+ .|+++..| ..
T Consensus 352 g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~ 431 (592)
T 3ogk_B 352 GADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSL 431 (592)
T ss_dssp CCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHH
T ss_pred CccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHH
Confidence 000111111 1222234555566666555555 22233332 5555555553 44555322 22
Q ss_pred hcCCCCCCEEEccCC--CCC-ccCccccC-CCCCCEEeCcCCcCCCC-CcccccCCCCCCEEEccCCCC
Q 001142 206 ICYLKALISLKVANN--KLV-ELPSGLYL-LQRLENLDLSNNRLTSL-GSLDLCLMHNLQNLNLQYNKL 269 (1142)
Q Consensus 206 l~~L~~L~~L~Ls~N--~Ls-~IP~~l~~-L~~L~~L~Ls~N~Ls~~-~p~~l~~L~~L~~L~Ls~N~L 269 (1142)
+..+++|+.|+|+++ .++ ..+..++. +++|+.|+|++|++++. .+..+..+++|+.|+|++|++
T Consensus 432 ~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l 500 (592)
T 3ogk_B 432 LIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCF 500 (592)
T ss_dssp HHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCC
T ss_pred HHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCC
Confidence 334455555555422 233 22222222 44455555555554431 122234444555555555544
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.64 E-value=4.3e-16 Score=163.78 Aligned_cols=136 Identities=18% Similarity=0.275 Sum_probs=113.5
Q ss_pred CEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCcc--cCCCCCCCEEEccCCCCCcc-chhhcCCCCCCEEE
Q 001142 140 KELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPE--IGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLK 216 (1142)
Q Consensus 140 ~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~--l~~L~~L~~L~Ls~N~L~~l-P~~l~~L~~L~~L~ 216 (1142)
+.|++++|.+ ..+|..+. .+|+.|+|++|+|+.+|.. |..+++|++|+|++|+|+.+ |..|..+++|+.|+
T Consensus 11 ~~l~~s~~~l----~~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 84 (192)
T 1w8a_A 11 TTVDCTGRGL----KEIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQ 84 (192)
T ss_dssp TEEECTTSCC----SSCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred CEEEcCCCCc----CcCccCCC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEE
Confidence 4556665433 33444443 2789999999999988763 89999999999999999977 78899999999999
Q ss_pred ccCCCCCccCc-cccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccCCCCCCCCCCCchhhc
Q 001142 217 VANNKLVELPS-GLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICC 281 (1142)
Q Consensus 217 Ls~N~Ls~IP~-~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~ 281 (1142)
|++|+|+.+|. .+..+++|+.|+|++|+|++++|..|..+++|+.|+|++|+|+|.|++.....|
T Consensus 85 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~ 150 (192)
T 1w8a_A 85 LGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEW 150 (192)
T ss_dssp CCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHH
T ss_pred CCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHH
Confidence 99999997755 477899999999999999999999999999999999999999998876544443
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=7.3e-16 Score=162.39 Aligned_cols=139 Identities=20% Similarity=0.240 Sum_probs=116.7
Q ss_pred CEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCcccCCCCCCCEEEccCCCCCccc-hhhcCCCCCCEEEcc
Q 001142 140 KELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLP-TEICYLKALISLKVA 218 (1142)
Q Consensus 140 ~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~lP-~~l~~L~~L~~L~Ls 218 (1142)
+.+++++|.+. .+|..+. ++|+.|+|++|+|+.+|..|..+++|+.|+|++|+|+.++ ..|..+++|+.|+|+
T Consensus 13 ~~l~~~~~~l~----~ip~~~~--~~l~~L~L~~n~i~~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls 86 (193)
T 2wfh_A 13 TVVRCSNKGLK----VLPKGIP--RDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILS 86 (193)
T ss_dssp TEEECTTSCCS----SCCSCCC--TTCCEEECCSSCCCSCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CEEEcCCCCCC----cCCCCCC--CCCCEEECCCCcCchhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECC
Confidence 34555553332 3343332 4789999999999999999999999999999999999885 579999999999999
Q ss_pred CCCCCccCc-cccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccCCCCCCCCCCCchhhccCC
Q 001142 219 NNKLVELPS-GLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLE 284 (1142)
Q Consensus 219 ~N~Ls~IP~-~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~ 284 (1142)
+|+|+.+|. .+..+++|+.|+|++|+|+++++..|..+++|+.|+|++|+|.|.|.+.+...|...
T Consensus 87 ~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~l~~l~~~~~~ 153 (193)
T 2wfh_A 87 YNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCNMQWLSDWVKS 153 (193)
T ss_dssp SSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGGGHHHHHHHHH
T ss_pred CCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCcCHHHHHHHHh
Confidence 999998865 678899999999999999999998899999999999999999999987665555443
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.63 E-value=8.3e-16 Score=174.96 Aligned_cols=222 Identities=12% Similarity=0.104 Sum_probs=131.1
Q ss_pred CCCCCEEEccCCCCC--CCCcccc---------------cCCCC--------CCCccEEEeecCCCCccCc-cccCCcCC
Q 001142 40 DDDDSVIDVSGKTVD--FPLIESY---------------GNRGG--------DNSVEGLYLYKNVLNLIPK-SVGRYEKL 93 (1142)
Q Consensus 40 l~~L~~LdLs~N~L~--~~~p~~~---------------~~l~~--------L~~L~~L~Ls~N~Lt~iP~-~l~~L~~L 93 (1142)
+++|++|||++|+|+ ......+ ..|.+ +++|+.|+|.+ .++.|++ +|.++++|
T Consensus 48 l~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L 126 (329)
T 3sb4_A 48 FPSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNL 126 (329)
T ss_dssp CTTCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTC
T ss_pred hccCeEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCccc
Confidence 788999999999988 1111101 11223 45666666665 4666643 45566666
Q ss_pred cEEEccCCCCCcCchh-hcCCCCCCEEEccCCC-----CCCCcccccCCCCCC-EEECCCCCC-----------------
Q 001142 94 RNLKFFGNEINLFPSE-VGNLLGLECLQIKISS-----PGVNGFALNKLKGLK-ELELSKVPP----------------- 149 (1142)
Q Consensus 94 ~~L~Ls~N~L~~lP~~-l~~L~~L~~L~Ls~N~-----l~~~~~~~~~L~~L~-~L~Ls~n~~----------------- 149 (1142)
+.|+|++|.++.|+.. |.++.+|..|.+..+. .......|..+.+|+ .+.+.....
T Consensus 127 ~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~ 206 (329)
T 3sb4_A 127 KICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQPRDINF 206 (329)
T ss_dssp CEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCCGGGCSE
T ss_pred ceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCCcHHHHHhhcccCccccce
Confidence 6666666666555433 4444444444443311 111222333334443 222221000
Q ss_pred ----CCCcccchhhh-cCCCCCcEEEccCCCCCccCc-ccCCCCCCCEEEccCCCCCccc-hhhcCCCCCC-EEEccCCC
Q 001142 150 ----RPSVLTLLSEI-AGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFNKMKYLP-TEICYLKALI-SLKVANNK 221 (1142)
Q Consensus 150 ----n~~~~~lp~~l-~~L~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~Ls~N~L~~lP-~~l~~L~~L~-~L~Ls~N~ 221 (1142)
..........+ ..+++|+.|+|++|+++.||. .|.++++|+.|+|.+| ++.|+ .+|.++.+|+ .|+|.+ .
T Consensus 207 l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~ 284 (329)
T 3sb4_A 207 LTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-S 284 (329)
T ss_dssp EEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-T
T ss_pred EEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-c
Confidence 00000000011 126778888888888888876 5778888888888887 77775 5577788888 888877 7
Q ss_pred CCccC-ccccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEc
Q 001142 222 LVELP-SGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNL 264 (1142)
Q Consensus 222 Ls~IP-~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~L 264 (1142)
++.|+ ..|.+|++|+.|+|++|+++.+.+..|.++++|+.|+.
T Consensus 285 l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 285 VTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp CCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred ceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 77775 45556888888888888888888888888888887764
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.60 E-value=2.2e-15 Score=154.19 Aligned_cols=134 Identities=20% Similarity=0.128 Sum_probs=77.0
Q ss_pred CCccEEEeecCCCC--ccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECC
Q 001142 68 NSVEGLYLYKNVLN--LIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELS 145 (1142)
Q Consensus 68 ~~L~~L~Ls~N~Lt--~iP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls 145 (1142)
++|+.|+|++|.|+ .+|..+..+++|++|+|++|.|+.+ ..+..+++|++|+|++|.+..
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~----------------- 85 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFG----------------- 85 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCS-----------------
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCch-----------------
Confidence 45666666666666 6666666666666666666666655 445555555555554444222
Q ss_pred CCCCCCCcccchhhhcCCCCCcEEEccCCCCCccC--cccCCCCCCCEEEccCCCCCccch----hhcCCCCCCEEEccC
Q 001142 146 KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLP--PEIGCLSNLEQLDLSFNKMKYLPT----EICYLKALISLKVAN 219 (1142)
Q Consensus 146 ~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP--~~l~~L~~L~~L~Ls~N~L~~lP~----~l~~L~~L~~L~Ls~ 219 (1142)
.+|..+..+++|+.|+|++|.|+.+| ..+..+++|+.|+|++|.|+.+|. .+..+++|+.|++++
T Consensus 86 ---------~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~ 156 (168)
T 2ell_A 86 ---------GLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYD 156 (168)
T ss_dssp ---------CCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEE
T ss_pred ---------HHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCC
Confidence 12333444555666666666666554 455566666666666666665554 455566666666666
Q ss_pred CCCCccCcc
Q 001142 220 NKLVELPSG 228 (1142)
Q Consensus 220 N~Ls~IP~~ 228 (1142)
|.+..+|.+
T Consensus 157 n~~~~~~~~ 165 (168)
T 2ell_A 157 REDQEAPDS 165 (168)
T ss_dssp TTSCBCCSS
T ss_pred CChhhcccc
Confidence 666655543
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.60 E-value=2.1e-15 Score=154.36 Aligned_cols=132 Identities=24% Similarity=0.230 Sum_probs=106.4
Q ss_pred CCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCcccCCCCCCCEEEccCCCCCc-cchhhcCCCCCCEE
Q 001142 137 KGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKY-LPTEICYLKALISL 215 (1142)
Q Consensus 137 ~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~-lP~~l~~L~~L~~L 215 (1142)
++|+.|++++|.+.. +.+|..+..+++|+.|+|++|.|+.+ ..+..+++|++|+|++|+|+. +|..+..+++|+.|
T Consensus 24 ~~L~~L~l~~n~l~~--~~i~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 24 AAVRELVLDNCKSND--GKIEGLTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TSCSEEECCSCBCBT--TBCSSCCGGGGGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred ccCCEEECCCCCCCh--hhHHHHHHhCCCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 455666666533210 24555667778888888888888877 778888999999999999986 77777779999999
Q ss_pred EccCCCCCccC--ccccCCCCCCEEeCcCCcCCCCCc---ccccCCCCCCEEEccCCCCCC
Q 001142 216 KVANNKLVELP--SGLYLLQRLENLDLSNNRLTSLGS---LDLCLMHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 216 ~Ls~N~Ls~IP--~~l~~L~~L~~L~Ls~N~Ls~~~p---~~l~~L~~L~~L~Ls~N~L~~ 271 (1142)
+|++|.|+.+| ..+..+++|+.|+|++|.|++.++ ..+..+++|+.|++++|.+..
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~ 161 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQE 161 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCB
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhh
Confidence 99999998876 678889999999999999998877 578889999999999998876
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.58 E-value=1.6e-16 Score=194.10 Aligned_cols=246 Identities=16% Similarity=0.034 Sum_probs=152.3
Q ss_pred CcccccCCCCC-CcccCC-CCCCCCCCCCEEEccCCCCCCCC----cccccCCCCCCCccEEEeecCCCCc-----cCcc
Q 001142 18 IKEKLPSEANK-INNEKN-GSVNDDDDDSVIDVSGKTVDFPL----IESYGNRGGDNSVEGLYLYKNVLNL-----IPKS 86 (1142)
Q Consensus 18 ~l~~L~~~~N~-i~~l~~-~~f~~l~~L~~LdLs~N~L~~~~----p~~~~~l~~L~~L~~L~Ls~N~Lt~-----iP~~ 86 (1142)
.++.|.+..+. ++.... ..+.++++|++|+|++|.+++.. +..+. ++++|+.|+|++|.++. ++..
T Consensus 139 ~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~---~~~~L~~L~L~~n~~~~~~~~~l~~~ 215 (592)
T 3ogk_B 139 DLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQ---HNTSLEVLNFYMTEFAKISPKDLETI 215 (592)
T ss_dssp GCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHH---HCCCCCEEECTTCCCSSCCHHHHHHH
T ss_pred cCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHh---cCCCccEEEeeccCCCccCHHHHHHH
Confidence 37777776655 211111 11236788888888888876653 22333 34788888888888863 3444
Q ss_pred ccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEccCCCC----CCCcccccCCCCCCEEECCCCCCCCCcccchhhhcC
Q 001142 87 VGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSP----GVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAG 162 (1142)
Q Consensus 87 l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~l----~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~ 162 (1142)
+.++++|+.|+|++|.+..+|..+.++++|+.|+++.... ......+..+++|+.|+++++ ....+|..+..
T Consensus 216 ~~~~~~L~~L~L~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~----~~~~l~~~~~~ 291 (592)
T 3ogk_B 216 ARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYM----GPNEMPILFPF 291 (592)
T ss_dssp HHHCTTCCEEECSSCBGGGGHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTC----CTTTGGGGGGG
T ss_pred HhhCCCCcEEeccCccHHHHHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCcccc----chhHHHHHHhh
Confidence 5677888888888888888887788888888888864331 122234566677777777663 23345555666
Q ss_pred CCCCcEEEccCCCCCc--cCcccCCCCCCCEEEccCCCCC--ccchhhcCCCCCCEEEcc-----------CCCCC--cc
Q 001142 163 LKCLTKLSVCHFSIRY--LPPEIGCLSNLEQLDLSFNKMK--YLPTEICYLKALISLKVA-----------NNKLV--EL 225 (1142)
Q Consensus 163 L~~L~~L~Ls~N~L~~--IP~~l~~L~~L~~L~Ls~N~L~--~lP~~l~~L~~L~~L~Ls-----------~N~Ls--~I 225 (1142)
+++|+.|+|++|.++. ++..+..+++|+.|+|+ |.+. .++..+..+++|+.|+|+ .|.++ .+
T Consensus 292 ~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~ 370 (592)
T 3ogk_B 292 AAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGL 370 (592)
T ss_dssp GGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHH
T ss_pred cCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHH
Confidence 7777777777777652 22334667777777777 4444 334444556677777777 35555 23
Q ss_pred CccccCCCCCCEEeCcCCcCCCCCcccccC-CCCCCEEEcc----CCCCCC
Q 001142 226 PSGLYLLQRLENLDLSNNRLTSLGSLDLCL-MHNLQNLNLQ----YNKLLS 271 (1142)
Q Consensus 226 P~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~-L~~L~~L~Ls----~N~L~~ 271 (1142)
+.-...+++|+.|+|+.|++++..+..+.. +++|+.|+|+ .|.+++
T Consensus 371 ~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~ 421 (592)
T 3ogk_B 371 IALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITD 421 (592)
T ss_dssp HHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSS
T ss_pred HHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccC
Confidence 333334667777777777776655555544 6677777775 455554
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.57 E-value=4.8e-14 Score=165.40 Aligned_cols=229 Identities=10% Similarity=0.097 Sum_probs=187.7
Q ss_pred CCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccC-ccccCCcCCcEEEccCCCCCc
Q 001142 27 NKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIP-KSVGRYEKLRNLKFFGNEINL 105 (1142)
Q Consensus 27 N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP-~~l~~L~~L~~L~Ls~N~L~~ 105 (1142)
|+++.|...+|.+. +|+.++|..| ++.+....|.+ .+|+.|.|.+ .++.|+ ..|.++.+|+.|+|++|+++.
T Consensus 122 ~~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~----~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~ 194 (401)
T 4fdw_A 122 NSVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFN----STVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITK 194 (401)
T ss_dssp TTCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTT----CCCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSE
T ss_pred CccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCC----CCceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceE
Confidence 57899999999985 7999999877 77766666654 3699999986 689996 479999999999999999999
Q ss_pred CchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCc-ccC
Q 001142 106 FPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP-EIG 184 (1142)
Q Consensus 106 lP~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~-~l~ 184 (1142)
||...+..++|+.+.|..|-..+-..+|..+.+|+.|++..+ ....-..+|.+ .+|+.+.| .|.++.|+. .|.
T Consensus 195 I~~~aF~~~~L~~l~lp~~l~~I~~~aF~~~~~L~~l~l~~~----l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~ 268 (401)
T 4fdw_A 195 LPASTFVYAGIEEVLLPVTLKEIGSQAFLKTSQLKTIEIPEN----VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFY 268 (401)
T ss_dssp ECTTTTTTCCCSEEECCTTCCEECTTTTTTCTTCCCEECCTT----CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTT
T ss_pred echhhEeecccCEEEeCCchheehhhHhhCCCCCCEEecCCC----ccCcccccccc-CCccEEEe-CCCccEEChhHhh
Confidence 988866689999999985533344468999999999999862 22222345666 78999999 566888855 789
Q ss_pred CCCCCCEEEccCCCCC-----ccc-hhhcCCCCCCEEEccCCCCCccCcc-ccCCCCCCEEeCcCCcCCCCCcccccCCC
Q 001142 185 CLSNLEQLDLSFNKMK-----YLP-TEICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSNNRLTSLGSLDLCLMH 257 (1142)
Q Consensus 185 ~L~~L~~L~Ls~N~L~-----~lP-~~l~~L~~L~~L~Ls~N~Ls~IP~~-l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~ 257 (1142)
++++|+.|+|.+|.+. .|+ ..|.++++|+.|.|. |.++.|+.. |.+|++|+.|+|.+| ++.+.+..|.++
T Consensus 269 ~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~- 345 (401)
T 4fdw_A 269 YCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT- 345 (401)
T ss_dssp TCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-
T ss_pred CCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-
Confidence 9999999999998876 564 678889999999999 569988654 556899999999655 888888899999
Q ss_pred CCCEEEccCCCCCC
Q 001142 258 NLQNLNLQYNKLLS 271 (1142)
Q Consensus 258 ~L~~L~Ls~N~L~~ 271 (1142)
+|+.|++++|.+..
T Consensus 346 ~L~~l~l~~n~~~~ 359 (401)
T 4fdw_A 346 GIKEVKVEGTTPPQ 359 (401)
T ss_dssp CCCEEEECCSSCCB
T ss_pred CCCEEEEcCCCCcc
Confidence 99999999998765
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.56 E-value=1.9e-14 Score=151.51 Aligned_cols=53 Identities=21% Similarity=0.346 Sum_probs=27.7
Q ss_pred cEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEccCCC
Q 001142 71 EGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISS 125 (1142)
Q Consensus 71 ~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~ 125 (1142)
+.+++++|.|++||..+. ++|++|+|++|+|+.+|..|.++++|+.|+|++|.
T Consensus 13 ~~l~~~~~~l~~ip~~~~--~~l~~L~L~~n~i~~ip~~~~~l~~L~~L~Ls~N~ 65 (193)
T 2wfh_A 13 TVVRCSNKGLKVLPKGIP--RDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNR 65 (193)
T ss_dssp TEEECTTSCCSSCCSCCC--TTCCEEECCSSCCCSCCGGGGGCTTCCEEECCSSC
T ss_pred CEEEcCCCCCCcCCCCCC--CCCCEEECCCCcCchhHHHhhcccCCCEEECCCCc
Confidence 355555555555555443 25556666666655555545444444444444443
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.56 E-value=4.6e-15 Score=171.87 Aligned_cols=150 Identities=18% Similarity=0.148 Sum_probs=100.1
Q ss_pred cceeeeecccCceEEEEEEE-CCccEEEEEEecccCCCCh--------------HHHHHhHHhHHHHHHHHhhCCCCCcc
Q 001142 809 LSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSA--------------DEIRNFEYSCLGEVRMLGALRHSCIV 873 (1142)
Q Consensus 809 y~l~~~LG~GsfG~Vy~a~~-~~~~vAvKi~~l~~~~~~~--------------~~~~~~~~~~~~Ei~iL~~L~HpNIV 873 (1142)
|++.+.||+|++|.||+|.. .+..+|+|+.+........ ...........+|...|.++.+..+.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 79999999999999999987 5778999997643222110 00111112234566666666544432
Q ss_pred ceeeeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 001142 874 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 953 (1142)
Q Consensus 874 kl~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHr 953 (1142)
-..-+... ..+|||||++|++|..+. .......++.||+.+|.|||++|||||
T Consensus 177 vp~p~~~~----------------~~~LVME~i~G~~L~~l~-----------~~~~~~~l~~qll~~l~~lH~~gIVHr 229 (397)
T 4gyi_A 177 VPEPIAQS----------------RHTIVMSLVDALPMRQVS-----------SVPDPASLYADLIALILRLAKHGLIHG 229 (397)
T ss_dssp CCCEEEEE----------------TTEEEEECCSCEEGGGCC-----------CCSCHHHHHHHHHHHHHHHHHTTEECS
T ss_pred CCeeeecc----------------CceEEEEecCCccHhhhc-----------ccHHHHHHHHHHHHHHHHHHHCCCcCC
Confidence 11111111 127999999988875432 112345788999999999999999999
Q ss_pred CCCCCCeeeccccccCCCC---CeEEEeecCCccc
Q 001142 954 DIKSENILIDLERKKADGK---PVVKLCDFDRAVP 985 (1142)
Q Consensus 954 DLKp~NILld~~~~~~~~~---~~vKL~DFGlA~~ 985 (1142)
||||.|||++.++...... ..+.|+||+-+..
T Consensus 230 DLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 230 DFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence 9999999998874211111 1489999998864
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.55 E-value=6.1e-15 Score=147.76 Aligned_cols=127 Identities=25% Similarity=0.249 Sum_probs=99.4
Q ss_pred CCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCcccCCCCCCCEEEccCCCCCc-cchhhcCCCCCCEE
Q 001142 137 KGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKY-LPTEICYLKALISL 215 (1142)
Q Consensus 137 ~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~-lP~~l~~L~~L~~L 215 (1142)
++|+.|++++|.+.. +.+|..+..+++|+.|++++|.|+.+ ..++.+++|++|+|++|+|+. +|..+..+++|+.|
T Consensus 17 ~~l~~L~l~~n~l~~--~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 17 SDVKELVLDNSRSNE--GKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGCSEEECTTCBCBT--TBCCSCCTTCTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred ccCeEEEccCCcCCh--hHHHHHHhhcCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 456666666643210 35566667788888888888888877 667888888899999888886 77777778889999
Q ss_pred EccCCCCCccC--ccccCCCCCCEEeCcCCcCCCCCc---ccccCCCCCCEEEccC
Q 001142 216 KVANNKLVELP--SGLYLLQRLENLDLSNNRLTSLGS---LDLCLMHNLQNLNLQY 266 (1142)
Q Consensus 216 ~Ls~N~Ls~IP--~~l~~L~~L~~L~Ls~N~Ls~~~p---~~l~~L~~L~~L~Ls~ 266 (1142)
+|++|+|+.+| ..+..+++|+.|+|++|.|++.++ ..+..+++|+.|++++
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 99999888764 778888889999999998888877 5688888888888864
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.55 E-value=6.4e-15 Score=154.75 Aligned_cols=125 Identities=22% Similarity=0.227 Sum_probs=61.2
Q ss_pred cEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchh--hcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCC
Q 001142 71 EGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSE--VGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVP 148 (1142)
Q Consensus 71 ~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~--l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~ 148 (1142)
+.|++++|.|++||..+.. +|++|+|++|+|+.+|.. |.++++|+.|+|++|.+..+
T Consensus 11 ~~l~~s~~~l~~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~------------------- 69 (192)
T 1w8a_A 11 TTVDCTGRGLKEIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGI------------------- 69 (192)
T ss_dssp TEEECTTSCCSSCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCB-------------------
T ss_pred CEEEcCCCCcCcCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCc-------------------
Confidence 5666666666666665543 666666666666655442 44444444444443332211
Q ss_pred CCCCcccchhhhcCCCCCcEEEccCCCCCccCc-ccCCCCCCCEEEccCCCCCcc-chhhcCCCCCCEEEccCCCCC
Q 001142 149 PRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLV 223 (1142)
Q Consensus 149 ~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~Ls~N~L~~l-P~~l~~L~~L~~L~Ls~N~Ls 223 (1142)
.|..|.++++|+.|+|++|+|+.+|. .|..+++|++|+|++|+|+.+ |..|..+++|+.|+|++|.++
T Consensus 70 -------~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 139 (192)
T 1w8a_A 70 -------EPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139 (192)
T ss_dssp -------CTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred -------CHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCcc
Confidence 12334444444444444444443332 244444555555555555432 344444444444444444444
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.54 E-value=1.2e-13 Score=162.15 Aligned_cols=239 Identities=8% Similarity=0.066 Sum_probs=194.1
Q ss_pred CcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEE
Q 001142 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLK 97 (1142)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~ 97 (1142)
.+..+.+..| |+.|...+|.+. +|+.|+|.. .++.+.+..| .++.+|+.|+|++|.++.||.......+|+.|.
T Consensus 136 ~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF---~~c~~L~~l~l~~n~l~~I~~~aF~~~~L~~l~ 209 (401)
T 4fdw_A 136 QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIF---YYCYNLKKADLSKTKITKLPASTFVYAGIEEVL 209 (401)
T ss_dssp CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTT---TTCTTCCEEECTTSCCSEECTTTTTTCCCSEEE
T ss_pred CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHh---hCcccCCeeecCCCcceEechhhEeecccCEEE
Confidence 4777777654 999999999995 799999996 7776666655 455999999999999999987654578999999
Q ss_pred ccCCCCCcCchh-hcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCC
Q 001142 98 FFGNEINLFPSE-VGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSI 176 (1142)
Q Consensus 98 Ls~N~L~~lP~~-l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L 176 (1142)
|.+ .++.|+.. |.++++|+.|+|..|-..+-..+|.. .+|+.+.+.+ +....-...|.++++|+.|.+.+|.+
T Consensus 210 lp~-~l~~I~~~aF~~~~~L~~l~l~~~l~~I~~~aF~~-~~L~~i~lp~----~i~~I~~~aF~~c~~L~~l~l~~~~~ 283 (401)
T 4fdw_A 210 LPV-TLKEIGSQAFLKTSQLKTIEIPENVSTIGQEAFRE-SGITTVKLPN----GVTNIASRAFYYCPELAEVTTYGSTF 283 (401)
T ss_dssp CCT-TCCEECTTTTTTCTTCCCEECCTTCCEECTTTTTT-CCCSEEEEET----TCCEECTTTTTTCTTCCEEEEESSCC
T ss_pred eCC-chheehhhHhhCCCCCCEEecCCCccCcccccccc-CCccEEEeCC----CccEEChhHhhCCCCCCEEEeCCccc
Confidence 984 48888655 78899999999987643334456777 8999999954 33333356789999999999999887
Q ss_pred C-----ccCc-ccCCCCCCCEEEccCCCCCccc-hhhcCCCCCCEEEccCCCCCccCc-cccCCCCCCEEeCcCCcCCCC
Q 001142 177 R-----YLPP-EIGCLSNLEQLDLSFNKMKYLP-TEICYLKALISLKVANNKLVELPS-GLYLLQRLENLDLSNNRLTSL 248 (1142)
Q Consensus 177 ~-----~IP~-~l~~L~~L~~L~Ls~N~L~~lP-~~l~~L~~L~~L~Ls~N~Ls~IP~-~l~~L~~L~~L~Ls~N~Ls~~ 248 (1142)
. .|+. .|.++++|+.|.|. |.++.|+ ..|.++++|+.|.|..| ++.|+. .|.++ +|+.|+|++|.+..+
T Consensus 284 ~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l 360 (401)
T 4fdw_A 284 NDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQV 360 (401)
T ss_dssp CCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBC
T ss_pred cCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCccc
Confidence 6 5654 78999999999999 5699886 67888999999999655 888864 55668 999999999999999
Q ss_pred CcccccCCC-CCCEEEccCCCCCC
Q 001142 249 GSLDLCLMH-NLQNLNLQYNKLLS 271 (1142)
Q Consensus 249 ~p~~l~~L~-~L~~L~Ls~N~L~~ 271 (1142)
.+..|..++ .+..|++..|.+..
T Consensus 361 ~~~~F~~~~~~l~~l~vp~~~~~~ 384 (401)
T 4fdw_A 361 FEKVWYGFPDDITVIRVPAESVEK 384 (401)
T ss_dssp CCSSCCCSCTTCCEEEECGGGHHH
T ss_pred ccccccCCCCCccEEEeCHHHHHH
Confidence 988898885 78899998876543
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.52 E-value=7e-14 Score=144.31 Aligned_cols=110 Identities=30% Similarity=0.378 Sum_probs=98.5
Q ss_pred CCCcEEEccCCCCCccCc-ccCCCCCCCEEEccCCCCCccchh-hcCCCCCCEEEccCCCCCccCcc-ccCCCCCCEEeC
Q 001142 164 KCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKLVELPSG-LYLLQRLENLDL 240 (1142)
Q Consensus 164 ~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~Ls~N~L~~lP~~-l~~L~~L~~L~Ls~N~Ls~IP~~-l~~L~~L~~L~L 240 (1142)
++|+.|++++|+++.+|. .|..+++|++|+|++|+|+.+|.. +..+++|+.|+|++|+|+.+|.. +..+++|+.|+|
T Consensus 28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l 107 (177)
T 2o6r_A 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELAL 107 (177)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEEC
Confidence 578999999999998876 468999999999999999988754 68899999999999999988765 577999999999
Q ss_pred cCCcCCCCCcccccCCCCCCEEEccCCCCCCCC
Q 001142 241 SNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYC 273 (1142)
Q Consensus 241 s~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~~~ 273 (1142)
++|+|+++++..+..+++|+.|+|++|+|.+.|
T Consensus 108 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 140 (177)
T 2o6r_A 108 DTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 140 (177)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred cCCcceEeCHHHhcCCcccCEEEecCCCeeccC
Confidence 999999999877899999999999999999854
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.51 E-value=1.6e-14 Score=149.17 Aligned_cols=103 Identities=25% Similarity=0.260 Sum_probs=43.1
Q ss_pred CcEEEccCCCCCccCcccCCCCCCCEEEccCCCCCccchhh-cCCCCCCEEEccCCCCCccCc--cccCCCCCCEEeCcC
Q 001142 166 LTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPS--GLYLLQRLENLDLSN 242 (1142)
Q Consensus 166 L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~lP~~l-~~L~~L~~L~Ls~N~Ls~IP~--~l~~L~~L~~L~Ls~ 242 (1142)
|+.|+|++|.|+.+ ..+..+++|++|+|++|+|+.+|..+ ..+++|+.|+|++|+|+.+|. .+..+++|+.|+|++
T Consensus 44 L~~L~Ls~N~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~l~~ 122 (176)
T 1a9n_A 44 FDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILR 122 (176)
T ss_dssp CSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCS
T ss_pred CCEEECCCCCCCcc-cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCCcchhhHhhhcCCCCCEEEecC
Confidence 33333333333333 23334444444444444444443222 344444444444444444443 344444444444444
Q ss_pred CcCCCCCcc---cccCCCCCCEEEccCCCC
Q 001142 243 NRLTSLGSL---DLCLMHNLQNLNLQYNKL 269 (1142)
Q Consensus 243 N~Ls~~~p~---~l~~L~~L~~L~Ls~N~L 269 (1142)
|.++..++. .+..+++|+.||+++|.+
T Consensus 123 N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~ 152 (176)
T 1a9n_A 123 NPVTNKKHYRLYVIYKVPQVRVLDFQKVKL 152 (176)
T ss_dssp SGGGGSTTHHHHHHHHCTTCSEETTEECCH
T ss_pred CCCCCcHhHHHHHHHHCCccceeCCCcCCH
Confidence 444433321 244444444444444443
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.51 E-value=2.5e-14 Score=147.73 Aligned_cols=134 Identities=19% Similarity=0.175 Sum_probs=114.1
Q ss_pred hhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCccc-CCCC
Q 001142 109 EVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEI-GCLS 187 (1142)
Q Consensus 109 ~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l-~~L~ 187 (1142)
.+.++.+|+.|+|++|.+..++......++|++|++++|.+... ..|..+++|+.|+|++|.|+.+|..+ ..++
T Consensus 14 ~~~~~~~L~~L~l~~n~l~~i~~~~~~~~~L~~L~Ls~N~l~~~-----~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 88 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKL-----DGFPLLRRLKTLLVNNNRICRIGEGLDQALP 88 (176)
T ss_dssp EEECTTSCEEEECTTSCCCSCCCGGGGTTCCSEEECCSSCCCEE-----CCCCCCSSCCEEECCSSCCCEECSCHHHHCT
T ss_pred hcCCcCCceEEEeeCCCCchhHHhhhcCCCCCEEECCCCCCCcc-----cccccCCCCCEEECCCCcccccCcchhhcCC
Confidence 46778899999999999887765444444999999999766532 57888999999999999999888765 8899
Q ss_pred CCCEEEccCCCCCccch--hhcCCCCCCEEEccCCCCCccCcc----ccCCCCCCEEeCcCCcCCC
Q 001142 188 NLEQLDLSFNKMKYLPT--EICYLKALISLKVANNKLVELPSG----LYLLQRLENLDLSNNRLTS 247 (1142)
Q Consensus 188 ~L~~L~Ls~N~L~~lP~--~l~~L~~L~~L~Ls~N~Ls~IP~~----l~~L~~L~~L~Ls~N~Ls~ 247 (1142)
+|++|+|++|+|+.+|. .+..+++|+.|+|++|.++.+|.. +..+++|+.||++.|.+..
T Consensus 89 ~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~~~ 154 (176)
T 1a9n_A 89 DLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKLKE 154 (176)
T ss_dssp TCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred CCCEEECCCCcCCcchhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence 99999999999999987 888999999999999999999885 7889999999999998764
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.50 E-value=1.6e-15 Score=185.22 Aligned_cols=154 Identities=15% Similarity=0.042 Sum_probs=70.2
Q ss_pred CCCCCCEEEccCCCCCCCc--ccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEcc---------CCCCCcc-
Q 001142 112 NLLGLECLQIKISSPGVNG--FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVC---------HFSIRYL- 179 (1142)
Q Consensus 112 ~L~~L~~L~Ls~N~l~~~~--~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls---------~N~L~~I- 179 (1142)
.+++|+.|+|++|.++... ..+..+++|+.|++++| + ....++.....+++|+.|++. .|.++..
T Consensus 287 ~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~--~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~ 363 (594)
T 2p1m_B 287 VCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-I--EDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQG 363 (594)
T ss_dssp HHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-G--HHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHH
T ss_pred hhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-c--CHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHH
Confidence 4577777777777643211 22446677777777653 1 011122222235566666552 2333310
Q ss_pred Cccc-CCCCCCCEEEccCCCCC-ccchhhc-CCCCCCEEEcc--C----CCCCccCc------cccCCCCCCEEeCcCCc
Q 001142 180 PPEI-GCLSNLEQLDLSFNKMK-YLPTEIC-YLKALISLKVA--N----NKLVELPS------GLYLLQRLENLDLSNNR 244 (1142)
Q Consensus 180 P~~l-~~L~~L~~L~Ls~N~L~-~lP~~l~-~L~~L~~L~Ls--~----N~Ls~IP~------~l~~L~~L~~L~Ls~N~ 244 (1142)
...+ ..+++|+.|+++.|+++ ..+..+. .+++|+.|+|+ + |.++..|. -+..+++|+.|+|++ .
T Consensus 364 l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~ 442 (594)
T 2p1m_B 364 LVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-L 442 (594)
T ss_dssp HHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-S
T ss_pred HHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-c
Confidence 1111 23455555555555555 2223332 35555555555 3 34443221 123344555555544 3
Q ss_pred CCCCCcccccC-CCCCCEEEccCCCC
Q 001142 245 LTSLGSLDLCL-MHNLQNLNLQYNKL 269 (1142)
Q Consensus 245 Ls~~~p~~l~~-L~~L~~L~Ls~N~L 269 (1142)
++......+.. +++|+.|+|++|.+
T Consensus 443 l~~~~~~~l~~~~~~L~~L~L~~~~i 468 (594)
T 2p1m_B 443 LTDKVFEYIGTYAKKMEMLSVAFAGD 468 (594)
T ss_dssp CCHHHHHHHHHHCTTCCEEEEESCCS
T ss_pred ccHHHHHHHHHhchhccEeeccCCCC
Confidence 43333323332 44555555555544
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.50 E-value=6.6e-14 Score=144.30 Aligned_cols=107 Identities=27% Similarity=0.323 Sum_probs=98.5
Q ss_pred CcEEEccCCCCCccCcccCCCCCCCEEEccCCCCCcc-chhhcCCCCCCEEEccCCCCCccCccc-cCCCCCCEEeCcCC
Q 001142 166 LTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSGL-YLLQRLENLDLSNN 243 (1142)
Q Consensus 166 L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~l-P~~l~~L~~L~~L~Ls~N~Ls~IP~~l-~~L~~L~~L~Ls~N 243 (1142)
.+.|++++|.|+.||..+. ++|++|+|++|+|+.+ |..|..+++|+.|+|++|+|+.+|... ..+++|+.|+|++|
T Consensus 11 ~~~l~~s~n~l~~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 11 GTTVDCSGKSLASVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TTEEECTTSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CCEEEeCCCCcCccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 5689999999999998764 8999999999999988 677999999999999999999998765 68999999999999
Q ss_pred cCCCCCcccccCCCCCCEEEccCCCCCCCCC
Q 001142 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQ 274 (1142)
Q Consensus 244 ~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~~~~ 274 (1142)
+|+++++..|..+++|+.|+|++|+|+|.|+
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 9999999889999999999999999999764
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.50 E-value=1.5e-13 Score=141.86 Aligned_cols=91 Identities=31% Similarity=0.362 Sum_probs=65.2
Q ss_pred hcCCCCCcEEEccCCCCCccCcc-cCCCCCCCEEEccCCCCCccch-hhcCCCCCCEEEccCCCCCccCccc-cCCCCCC
Q 001142 160 IAGLKCLTKLSVCHFSIRYLPPE-IGCLSNLEQLDLSFNKMKYLPT-EICYLKALISLKVANNKLVELPSGL-YLLQRLE 236 (1142)
Q Consensus 160 l~~L~~L~~L~Ls~N~L~~IP~~-l~~L~~L~~L~Ls~N~L~~lP~-~l~~L~~L~~L~Ls~N~Ls~IP~~l-~~L~~L~ 236 (1142)
|..+++|+.|+|++|+|+.+|.. |..+++|++|+|++|+|+.+|. .+..+++|+.|+|++|+|+.+|..+ ..+++|+
T Consensus 48 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 127 (177)
T 2o6r_A 48 FDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQ 127 (177)
T ss_dssp TTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCC
T ss_pred hcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccC
Confidence 34455666666666766666553 5677778888888888877654 3567788888888888888777654 5578888
Q ss_pred EEeCcCCcCCCCCc
Q 001142 237 NLDLSNNRLTSLGS 250 (1142)
Q Consensus 237 ~L~Ls~N~Ls~~~p 250 (1142)
.|+|++|.+++..|
T Consensus 128 ~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 128 KIWLHTNPWDCSCP 141 (177)
T ss_dssp EEECCSSCBCCCHH
T ss_pred EEEecCCCeeccCc
Confidence 88888888887655
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.49 E-value=4.5e-14 Score=141.41 Aligned_cols=80 Identities=31% Similarity=0.271 Sum_probs=39.7
Q ss_pred CCCCCcEEEccCCCCCc-cCcccCCCCCCCEEEccCCCCCccc--hhhcCCCCCCEEEccCCCCCccCc----cccCCCC
Q 001142 162 GLKCLTKLSVCHFSIRY-LPPEIGCLSNLEQLDLSFNKMKYLP--TEICYLKALISLKVANNKLVELPS----GLYLLQR 234 (1142)
Q Consensus 162 ~L~~L~~L~Ls~N~L~~-IP~~l~~L~~L~~L~Ls~N~L~~lP--~~l~~L~~L~~L~Ls~N~Ls~IP~----~l~~L~~ 234 (1142)
.+++|+.|++++|.++. +|..+..+++|++|+|++|+|+.+| ..+..+++|+.|+|++|.++.+|. .+..+++
T Consensus 62 ~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~ 141 (149)
T 2je0_A 62 KLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQ 141 (149)
T ss_dssp CCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTT
T ss_pred cCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCC
Confidence 33444444444444443 3444444555555555555555433 445555555555555555554443 3444555
Q ss_pred CCEEeCc
Q 001142 235 LENLDLS 241 (1142)
Q Consensus 235 L~~L~Ls 241 (1142)
|+.|+++
T Consensus 142 L~~L~l~ 148 (149)
T 2je0_A 142 LTYLDGY 148 (149)
T ss_dssp CCEETTB
T ss_pred cccccCC
Confidence 5555554
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.48 E-value=1.2e-13 Score=143.13 Aligned_cols=107 Identities=26% Similarity=0.346 Sum_probs=98.2
Q ss_pred CcEEEccCCCCCccCcccCCCCCCCEEEccCCCCCcc-chhhcCCCCCCEEEccCCCCCccCccc-cCCCCCCEEeCcCC
Q 001142 166 LTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSGL-YLLQRLENLDLSNN 243 (1142)
Q Consensus 166 L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~l-P~~l~~L~~L~~L~Ls~N~Ls~IP~~l-~~L~~L~~L~Ls~N 243 (1142)
-+.+++++|+|+.||..+. ++|+.|+|++|+|+.+ |..|..+++|+.|+|++|+|+.||..+ ..+++|+.|+|++|
T Consensus 14 ~~~l~~~~n~l~~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 14 QTLVNCQNIRLASVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SSEEECCSSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CcEEEeCCCCCCccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 3689999999999999775 8999999999999987 678999999999999999999998775 67999999999999
Q ss_pred cCCCCCcccccCCCCCCEEEccCCCCCCCCC
Q 001142 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQ 274 (1142)
Q Consensus 244 ~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~~~~ 274 (1142)
+|+++++..|..+++|+.|+|++|+|.+.|.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence 9999999789999999999999999999653
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.47 E-value=9.4e-16 Score=187.31 Aligned_cols=132 Identities=14% Similarity=0.093 Sum_probs=92.1
Q ss_pred CCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecC-CCCc--cCccccCCcCCcEEEccCCCCCc-----Cchh
Q 001142 38 NDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKN-VLNL--IPKSVGRYEKLRNLKFFGNEINL-----FPSE 109 (1142)
Q Consensus 38 ~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N-~Lt~--iP~~l~~L~~L~~L~Ls~N~L~~-----lP~~ 109 (1142)
..+++|++|+|++|.+++..+..+. ..+++|++|+|++| .++. ++..+.++++|++|+|++|.++. ++.-
T Consensus 102 ~~~~~L~~L~L~~~~~~~~~~~~l~--~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~ 179 (594)
T 2p1m_B 102 SSYTWLEEIRLKRMVVTDDCLELIA--KSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHF 179 (594)
T ss_dssp HHCTTCCEEEEESCBCCHHHHHHHH--HHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGS
T ss_pred HhCCCCCeEEeeCcEEcHHHHHHHH--HhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHH
Confidence 4678999999999988876665553 12489999999988 6664 55556688899999999998763 2222
Q ss_pred hcCCCCCCEEEccCCCCCCCcc----cccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCC
Q 001142 110 VGNLLGLECLQIKISSPGVNGF----ALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHF 174 (1142)
Q Consensus 110 l~~L~~L~~L~Ls~N~l~~~~~----~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N 174 (1142)
...+++|+.|+|++|....... .+..+++|++|++++| .....+|..+..+++|+.|+++.+
T Consensus 180 ~~~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~---~~~~~l~~~~~~~~~L~~L~l~~~ 245 (594)
T 2p1m_B 180 PDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRA---VPLEKLATLLQRAPQLEELGTGGY 245 (594)
T ss_dssp CTTCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTT---SCHHHHHHHHHHCTTCSEEECSBC
T ss_pred hhcCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCC---CcHHHHHHHHhcCCcceEcccccc
Confidence 3367799999998886212122 2345689999999885 233346666777777777775444
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.47 E-value=2.1e-16 Score=166.54 Aligned_cols=110 Identities=26% Similarity=0.263 Sum_probs=79.4
Q ss_pred hhcCCCCCcEEEccCCCCCccCcccCCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCc--cccCCCCCC
Q 001142 159 EIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPS--GLYLLQRLE 236 (1142)
Q Consensus 159 ~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~IP~--~l~~L~~L~ 236 (1142)
.+..+++|+.|++++|.|+.+|..+..+++|++|+|++|+|+.+| .+..+++|+.|+|++|+|+.+|. .+..+++|+
T Consensus 65 ~~~~l~~L~~L~l~~n~l~~l~~~~~~~~~L~~L~L~~N~l~~l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~ 143 (198)
T 1ds9_A 65 SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIASLS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLE 143 (198)
T ss_dssp CHHHHTTCCEEEEEEEEECSCSSHHHHHHHCSEEEEEEEECCCHH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCS
T ss_pred ccccCCCCCEEECCCCCcccccchhhcCCcCCEEECcCCcCCcCC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCC
Confidence 445556666777777777777766666677788888888777776 57777778888888888876654 677778888
Q ss_pred EEeCcCCcCCCCCccc----------ccCCCCCCEEEccCCCCCC
Q 001142 237 NLDLSNNRLTSLGSLD----------LCLMHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 237 ~L~Ls~N~Ls~~~p~~----------l~~L~~L~~L~Ls~N~L~~ 271 (1142)
.|+|++|.+++.+|.. +..+++|+.|| +|+++.
T Consensus 144 ~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~~ 186 (198)
T 1ds9_A 144 DLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVDV 186 (198)
T ss_dssp EEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGTT
T ss_pred EEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccCH
Confidence 8888888887766532 67788888776 666654
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.45 E-value=2.9e-16 Score=165.49 Aligned_cols=43 Identities=12% Similarity=0.199 Sum_probs=21.7
Q ss_pred ccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEccCCC
Q 001142 82 LIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISS 125 (1142)
Q Consensus 82 ~iP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~ 125 (1142)
.+|..|..+++|++|+|++|.|+.+| .+.++++|+.|+|++|.
T Consensus 39 ~l~~~~~~l~~L~~L~ls~n~l~~l~-~~~~l~~L~~L~l~~n~ 81 (198)
T 1ds9_A 39 KMDATLSTLKACKHLALSTNNIEKIS-SLSGMENLRILSLGRNL 81 (198)
T ss_dssp CCHHHHHHTTTCSEEECSEEEESCCC-CHHHHTTCCEEEEEEEE
T ss_pred hhhHHHhcCCCCCEEECCCCCCcccc-ccccCCCCCEEECCCCC
Confidence 33344555555555555555555554 44555555555555444
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.43 E-value=1.8e-13 Score=155.74 Aligned_cols=216 Identities=12% Similarity=0.003 Sum_probs=160.2
Q ss_pred CCCcccccCCCCCCc--------------------ccCCCCCCC--------CCCCCEEEccCCCCCCCCcccccCCCCC
Q 001142 16 GPIKEKLPSEANKIN--------------------NEKNGSVND--------DDDDSVIDVSGKTVDFPLIESYGNRGGD 67 (1142)
Q Consensus 16 ~~~l~~L~~~~N~i~--------------------~l~~~~f~~--------l~~L~~LdLs~N~L~~~~p~~~~~l~~L 67 (1142)
.+.++.|++..|+|. .|+..+|.+ +++|+.|+|.+ +++.+.+..|. ++
T Consensus 48 l~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~---~~ 123 (329)
T 3sb4_A 48 FPSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFK---GC 123 (329)
T ss_dssp CTTCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTT---TC
T ss_pred hccCeEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccCCCcEEECCc-cccchhHHHhh---cC
Confidence 346778888888887 677889999 99999999999 88877766664 55
Q ss_pred CCccEEEeecCCCCccCc-cccCCcCCcEEEccCCC----CCcCc-hhhcCCCCCC------------------------
Q 001142 68 NSVEGLYLYKNVLNLIPK-SVGRYEKLRNLKFFGNE----INLFP-SEVGNLLGLE------------------------ 117 (1142)
Q Consensus 68 ~~L~~L~Ls~N~Lt~iP~-~l~~L~~L~~L~Ls~N~----L~~lP-~~l~~L~~L~------------------------ 117 (1142)
++|+.|+|++|.++.|++ .|.++.+|..|.+..+. +..+. ..|.++.+|+
T Consensus 124 ~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~ 203 (329)
T 3sb4_A 124 DNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQPRD 203 (329)
T ss_dssp TTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCCGGG
T ss_pred cccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCCcHHHHHhhcccCccc
Confidence 999999999999999965 68887778777776632 22222 2244444554
Q ss_pred --EEEccCCCCCCCcc-cccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCc-ccCCCCCCC-EE
Q 001142 118 --CLQIKISSPGVNGF-ALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLE-QL 192 (1142)
Q Consensus 118 --~L~Ls~N~l~~~~~-~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~-~l~~L~~L~-~L 192 (1142)
.+.+.++-...... ....+++|+.|+|++|.+ ...-...|.+|.+|+.|+|.+| ++.|+. .|.++++|+ .|
T Consensus 204 ~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i---~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l 279 (329)
T 3sb4_A 204 INFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNA---TTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTL 279 (329)
T ss_dssp CSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCC---CEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEE
T ss_pred cceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCc---ceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEE
Confidence 33332221000000 112378999999998543 2223346899999999999998 888876 789999999 99
Q ss_pred EccCCCCCccc-hhhcCCCCCCEEEccCCCCCccCc-cccCCCCCCEEeC
Q 001142 193 DLSFNKMKYLP-TEICYLKALISLKVANNKLVELPS-GLYLLQRLENLDL 240 (1142)
Q Consensus 193 ~Ls~N~L~~lP-~~l~~L~~L~~L~Ls~N~Ls~IP~-~l~~L~~L~~L~L 240 (1142)
+|.+ +++.|+ .+|.++++|+.|+|++|.++.|+. .|.++++|+.|+.
T Consensus 280 ~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 280 ELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp EECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred EEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 9998 899885 789999999999999999999976 5667999999874
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.37 E-value=9.8e-13 Score=150.26 Aligned_cols=113 Identities=23% Similarity=0.216 Sum_probs=100.2
Q ss_pred EEEccCC-CCCccCcccCCCCCCCEEEccC-CCCCccc-hhhcCCCCCCEEEccCCCCCccC-ccccCCCCCCEEeCcCC
Q 001142 168 KLSVCHF-SIRYLPPEIGCLSNLEQLDLSF-NKMKYLP-TEICYLKALISLKVANNKLVELP-SGLYLLQRLENLDLSNN 243 (1142)
Q Consensus 168 ~L~Ls~N-~L~~IP~~l~~L~~L~~L~Ls~-N~L~~lP-~~l~~L~~L~~L~Ls~N~Ls~IP-~~l~~L~~L~~L~Ls~N 243 (1142)
.++++++ +|+.||. |..+++|+.|+|++ |+|+.+| ..|+.|++|+.|+|++|+|+.+| ..|.+|++|+.|+|++|
T Consensus 12 ~v~~~~~n~l~~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 90 (347)
T 2ifg_A 12 GLRCTRDGALDSLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (347)
T ss_dssp CEECCSSCCCTTTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred EEEcCCCCCCCccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence 5788888 9999999 99999999999996 9999886 67999999999999999999775 46788999999999999
Q ss_pred cCCCCCcccccCCCCCCEEEccCCCCCCCCCCCchhhcc
Q 001142 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCN 282 (1142)
Q Consensus 244 ~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~ 282 (1142)
+|+++++..|..++ |+.|+|++|+|.|.|++.....|.
T Consensus 91 ~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~ 128 (347)
T 2ifg_A 91 ALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWE 128 (347)
T ss_dssp CCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHH
T ss_pred ccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHH
Confidence 99999997777776 999999999999988876555443
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.31 E-value=6.6e-12 Score=129.91 Aligned_cols=64 Identities=28% Similarity=0.283 Sum_probs=30.9
Q ss_pred CCCCcEEEccCCCCCccCcc-cCCCCCCCEEEccCCCCCccchh-hcCCCCCCEEEccCCCCCccC
Q 001142 163 LKCLTKLSVCHFSIRYLPPE-IGCLSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKLVELP 226 (1142)
Q Consensus 163 L~~L~~L~Ls~N~L~~IP~~-l~~L~~L~~L~Ls~N~L~~lP~~-l~~L~~L~~L~Ls~N~Ls~IP 226 (1142)
+++|+.|+|++|+|+.+|.. |..+++|++|+|++|+|+.+|.. |..+++|+.|+|++|.+...|
T Consensus 56 l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~ 121 (174)
T 2r9u_A 56 LVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNNPWDCEC 121 (174)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCBCTTB
T ss_pred CcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEeCCCCccccc
Confidence 33344444444444444432 34455555555555555554433 445555555555555555443
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.29 E-value=1.3e-11 Score=126.96 Aligned_cols=61 Identities=31% Similarity=0.393 Sum_probs=28.4
Q ss_pred CCCCcEEEccCCCCCccCcc-cCCCCCCCEEEccCCCCCccch-hhcCCCCCCEEEccCCCCC
Q 001142 163 LKCLTKLSVCHFSIRYLPPE-IGCLSNLEQLDLSFNKMKYLPT-EICYLKALISLKVANNKLV 223 (1142)
Q Consensus 163 L~~L~~L~Ls~N~L~~IP~~-l~~L~~L~~L~Ls~N~L~~lP~-~l~~L~~L~~L~Ls~N~Ls 223 (1142)
+++|+.|+|++|+|+.+|.. |..+++|++|+|++|+|+.+|. .|..+++|+.|+|++|.++
T Consensus 53 l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 115 (170)
T 3g39_A 53 LTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNNPWD 115 (170)
T ss_dssp CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred cccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence 33344444444444444332 3444555555555555554433 2444555555555555554
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.18 E-value=1.4e-12 Score=151.41 Aligned_cols=164 Identities=20% Similarity=0.170 Sum_probs=88.2
Q ss_pred CCcEEEccCCCCCcC-----chhhc-CCCCCCEEEccCCCCCCCc--ccccCCCCCCEEECCCCCCCCCccc-chhhh-c
Q 001142 92 KLRNLKFFGNEINLF-----PSEVG-NLLGLECLQIKISSPGVNG--FALNKLKGLKELELSKVPPRPSVLT-LLSEI-A 161 (1142)
Q Consensus 92 ~L~~L~Ls~N~L~~l-----P~~l~-~L~~L~~L~Ls~N~l~~~~--~~~~~L~~L~~L~Ls~n~~n~~~~~-lp~~l-~ 161 (1142)
.|+.|+|++|.|+.. ...+. +.++|+.|+|++|.++..+ .....+.+|+.|+|++|.+...... +...+ .
T Consensus 73 ~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~ 152 (372)
T 3un9_A 73 SLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLH 152 (372)
T ss_dssp TCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHS
T ss_pred hCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHh
Confidence 455666666665522 11122 1245555555555543221 1122334555555555433221111 11122 2
Q ss_pred CCCCCcEEEccCCCCCc-----cCcccCCCCCCCEEEccCCCCCc-----cchhhcCCCCCCEEEccCCCCCc-----cC
Q 001142 162 GLKCLTKLSVCHFSIRY-----LPPEIGCLSNLEQLDLSFNKMKY-----LPTEICYLKALISLKVANNKLVE-----LP 226 (1142)
Q Consensus 162 ~L~~L~~L~Ls~N~L~~-----IP~~l~~L~~L~~L~Ls~N~L~~-----lP~~l~~L~~L~~L~Ls~N~Ls~-----IP 226 (1142)
..++|+.|+|++|.|+. ++..+..+++|++|+|++|.|+. |+..+...++|+.|+|++|.|+. ++
T Consensus 153 ~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~ 232 (372)
T 3un9_A 153 DQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALA 232 (372)
T ss_dssp TTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHH
T ss_pred cCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHH
Confidence 35667777777777753 34445566777777777777762 34556666777777777777762 34
Q ss_pred ccccCCCCCCEEeCcCCcCCCCCcccccC
Q 001142 227 SGLYLLQRLENLDLSNNRLTSLGSLDLCL 255 (1142)
Q Consensus 227 ~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~ 255 (1142)
..+...++|+.|+|++|.|+......+..
T Consensus 233 ~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~ 261 (372)
T 3un9_A 233 RAAREHPSLELLHLYFNELSSEGRQVLRD 261 (372)
T ss_dssp HHHHHCSSCCEEECTTSSCCHHHHHHHHH
T ss_pred HHHHhCCCCCEEeccCCCCCHHHHHHHHH
Confidence 44555667777777777777554444433
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.17 E-value=3.7e-12 Score=147.83 Aligned_cols=133 Identities=20% Similarity=0.265 Sum_probs=83.3
Q ss_pred CCcEEEccCCCCCc--CchhhcCCCCCCEEEccCCCCCCCcc-c----c-cCCCCCCEEECCCCCCCCC-cccchhhhcC
Q 001142 92 KLRNLKFFGNEINL--FPSEVGNLLGLECLQIKISSPGVNGF-A----L-NKLKGLKELELSKVPPRPS-VLTLLSEIAG 162 (1142)
Q Consensus 92 ~L~~L~Ls~N~L~~--lP~~l~~L~~L~~L~Ls~N~l~~~~~-~----~-~~L~~L~~L~Ls~n~~n~~-~~~lp~~l~~ 162 (1142)
+|++|+|++|.|+. +..-...+++|+.|+|++|.++..+. . + ...++|++|+|++|.+... ...++..+..
T Consensus 102 ~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~ 181 (372)
T 3un9_A 102 ALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAG 181 (372)
T ss_dssp CEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHT
T ss_pred CceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhc
Confidence 45555555555441 11111123344555555554433221 1 1 2345666666666543221 1234556677
Q ss_pred CCCCcEEEccCCCCCc-----cCcccCCCCCCCEEEccCCCCCc-----cchhhcCCCCCCEEEccCCCCCc
Q 001142 163 LKCLTKLSVCHFSIRY-----LPPEIGCLSNLEQLDLSFNKMKY-----LPTEICYLKALISLKVANNKLVE 224 (1142)
Q Consensus 163 L~~L~~L~Ls~N~L~~-----IP~~l~~L~~L~~L~Ls~N~L~~-----lP~~l~~L~~L~~L~Ls~N~Ls~ 224 (1142)
+++|+.|+|++|.|+. ++..+...++|+.|+|++|.|+. ++..+...++|+.|+|++|.|+.
T Consensus 182 ~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~ 253 (372)
T 3un9_A 182 NTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSS 253 (372)
T ss_dssp CSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCH
T ss_pred CCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCH
Confidence 8889999999999873 35567778899999999999983 45667778999999999999983
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.06 E-value=3.1e-10 Score=129.47 Aligned_cols=98 Identities=9% Similarity=0.119 Sum_probs=44.8
Q ss_pred cCCCC-CCcccCCCCCCCCCCCCEEEccC-CCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCcCCcEEEcc
Q 001142 23 PSEAN-KINNEKNGSVNDDDDDSVIDVSG-KTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLRNLKFF 99 (1142)
Q Consensus 23 ~~~~N-~i~~l~~~~f~~l~~L~~LdLs~-N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~-~l~~L~~L~~L~Ls 99 (1142)
....+ +|+.++. |..+.+|++|+|++ |+|+++++..|+.+ ++|+.|+|++|+|+.+|+ .|.+|++|++|+|+
T Consensus 14 ~~~~~n~l~~ip~--l~~~~~L~~L~l~~~n~l~~~~~~~~~~l---~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 14 RCTRDGALDSLHH--LPGAENLTELYIENQQHLQHLELRDLRGL---GELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp ECCSSCCCTTTTT--SCSCSCCSEEECCSCSSCCEECGGGSCSC---CCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred EcCCCCCCCccCC--CCCCCCeeEEEccCCCCCCCcChhHhccc---cCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 33333 4554443 44555555555553 55554444433322 455555555555554432 34455555555555
Q ss_pred CCCCCcCchhhcCCCCCCEEEccCCC
Q 001142 100 GNEINLFPSEVGNLLGLECLQIKISS 125 (1142)
Q Consensus 100 ~N~L~~lP~~l~~L~~L~~L~Ls~N~ 125 (1142)
+|+|+.+|..+.....|+.|+|.+|.
T Consensus 89 ~N~l~~~~~~~~~~~~L~~l~l~~N~ 114 (347)
T 2ifg_A 89 FNALESLSWKTVQGLSLQELVLSGNP 114 (347)
T ss_dssp SSCCSCCCSTTTCSCCCCEEECCSSC
T ss_pred CCccceeCHHHcccCCceEEEeeCCC
Confidence 55555444433222224444444443
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.03 E-value=4.9e-10 Score=122.53 Aligned_cols=140 Identities=14% Similarity=0.108 Sum_probs=106.3
Q ss_pred CCCcceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEecCCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKW 884 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~g~~~~~~~ 884 (1142)
+..|++...++.|+.+.||++...+..+++|+....... .... +.+|+++++.+. |..+.++++++...+
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~----~~~~----~~~E~~~l~~l~~~~~vP~v~~~~~~~~- 83 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKG----TTYD----VEREKDMMLWLEGKLPVPKVLHFERHDG- 83 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTT----STTC----HHHHHHHHHHHTTTSCCCCEEEEEEETT-
T ss_pred hccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCC----CHHH----HHHHHHHHHHHhcCCCCCeEEEEEecCC-
Confidence 456889999999999999999887788899986432111 1112 378999999885 777889998877543
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-----------------
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS----------------- 947 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs----------------- 947 (1142)
..|+||||++|.+|.+.+. +......++.+++.+|..||+
T Consensus 84 -------------~~~lv~e~i~G~~l~~~~~----------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~ 140 (263)
T 3tm0_A 84 -------------WSNLLMSEADGVLCSEEYE----------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLA 140 (263)
T ss_dssp -------------EEEEEEECCSSEEHHHHCC----------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHH
T ss_pred -------------ceEEEEEecCCeehhhccC----------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHH
Confidence 3499999999999876521 112234778899999999998
Q ss_pred ------------------------------------------CCccccCCCCCCeeeccccccCCCCCeEEEeecCCcc
Q 001142 948 ------------------------------------------KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 984 (1142)
Q Consensus 948 ------------------------------------------~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~ 984 (1142)
.+++|+|++|.|||++.+ ..+.|+||+.+.
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~-------~~~~lIDwe~a~ 212 (263)
T 3tm0_A 141 ELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG-------KVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETT-------EEEEECCCTTCE
T ss_pred HHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECC-------cEEEEEEchhcc
Confidence 458999999999999754 456799999773
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.95 E-value=2.1e-08 Score=116.70 Aligned_cols=246 Identities=8% Similarity=0.100 Sum_probs=150.0
Q ss_pred CCCCCCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCC---CCCCCcccccCCCCCCCccEEEeecCCCCccCc-ccc
Q 001142 13 SPEGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKT---VDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVG 88 (1142)
Q Consensus 13 ~~~~~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~---L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~-~l~ 88 (1142)
.+....|+.+.+- +.++.|...+|.++.+|+.+.++.|. ++.+-...| .++.+|+.+.+.++ ++.|+. .|.
T Consensus 60 ~~~~~~L~sI~iP-~svt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF---~~c~~L~~i~~~~~-~~~I~~~aF~ 134 (394)
T 4gt6_A 60 CNYKYVLTSVQIP-DTVTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAF---MFCSELTDIPILDS-VTEIDSEAFH 134 (394)
T ss_dssp TTCCSCCCEEEEC-TTCCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTT---TTCTTCCBCGGGTT-CSEECTTTTT
T ss_pred cCCCCcCEEEEEC-CCeeEEhHHHhhCCccCceEeecCCCCCeeeEechhhc---hhcccceeeccCCc-cceehhhhhh
Confidence 3333346665554 35888989999999999999998774 443333334 33456666666544 566643 456
Q ss_pred CCcCCcEEEccCCCCCcCch-hhcCCCCCCEEEccCC----------------------CCCCCcccccCCCCCCEEECC
Q 001142 89 RYEKLRNLKFFGNEINLFPS-EVGNLLGLECLQIKIS----------------------SPGVNGFALNKLKGLKELELS 145 (1142)
Q Consensus 89 ~L~~L~~L~Ls~N~L~~lP~-~l~~L~~L~~L~Ls~N----------------------~l~~~~~~~~~L~~L~~L~Ls 145 (1142)
.+.+|+.+.|.. .++.|+. .|.++.+|+.+.+..+ ....-...|..+.+|......
T Consensus 135 ~c~~L~~i~lp~-~~~~I~~~~F~~c~~L~~i~~~~~~~~I~~~aF~~~~l~~i~ip~~~~~i~~~af~~c~~l~~~~~~ 213 (394)
T 4gt6_A 135 HCEELDTVTIPE-GVTSVADGMFSYCYSLHTVTLPDSVTAIEERAFTGTALTQIHIPAKVTRIGTNAFSECFALSTITSD 213 (394)
T ss_dssp TCTTCCEEECCT-TCCEECTTTTTTCTTCCEEECCTTCCEECTTTTTTCCCSEEEECTTCCEECTTTTTTCTTCCEEEEC
T ss_pred hhcccccccccc-eeeeecccceecccccccccccceeeEeccccccccceeEEEECCcccccccchhhhccccceeccc
Confidence 666666666643 2333332 2444555555555433 222222233444444433322
Q ss_pred CCCCC-------------------------CCcccch--------hhhcCCCCCcEEEccCCCCCccC-cccCCCCCCCE
Q 001142 146 KVPPR-------------------------PSVLTLL--------SEIAGLKCLTKLSVCHFSIRYLP-PEIGCLSNLEQ 191 (1142)
Q Consensus 146 ~n~~n-------------------------~~~~~lp--------~~l~~L~~L~~L~Ls~N~L~~IP-~~l~~L~~L~~ 191 (1142)
.+... ...-.+| .+|.++..|+.+.+..+-. .|. ..|.++++|+.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~v~~i~~~aF~~c~~L~~i~lp~~~~-~I~~~aF~~c~~L~~ 292 (394)
T 4gt6_A 214 SESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIPNGVARIETHAFDSCAYLASVKMPDSVV-SIGTGAFMNCPALQD 292 (394)
T ss_dssp CSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECCTTEEEECTTTTTTCSSCCEEECCTTCC-EECTTTTTTCTTCCE
T ss_pred ccccccccceeecccccccccccccccccccceEEcCCcceEcccceeeecccccEEecccccc-eecCccccccccccc
Confidence 21100 0001122 3466777788887765543 343 36678888888
Q ss_pred EEccCCCCCccc-hhhcCCCCCCEEEccCCCCCccCc-cccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccCCC
Q 001142 192 LDLSFNKMKYLP-TEICYLKALISLKVANNKLVELPS-GLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNK 268 (1142)
Q Consensus 192 L~Ls~N~L~~lP-~~l~~L~~L~~L~Ls~N~Ls~IP~-~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~ 268 (1142)
+.+. +.++.|+ ..|.++.+|+.+.|..| ++.|.. .|.+|.+|+.+.|..+ ++.+....|.++.+|+.+++.+|.
T Consensus 293 i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~ 368 (394)
T 4gt6_A 293 IEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSR 368 (394)
T ss_dssp EECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCH
T ss_pred ccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCce
Confidence 8885 5677776 45777888999998754 777754 4556888999988654 788888888899999999988874
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=98.91 E-value=1e-08 Score=119.36 Aligned_cols=188 Identities=15% Similarity=0.149 Sum_probs=107.9
Q ss_pred CCccEEEeecCCCCccCc-cccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCC
Q 001142 68 NSVEGLYLYKNVLNLIPK-SVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSK 146 (1142)
Q Consensus 68 ~~L~~L~Ls~N~Lt~iP~-~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~ 146 (1142)
.+|+.+.|..| ++.|+. .|.++..|+.+.+.++.. .+.......++|+.+.+..+....-...|..+..|+.+.+..
T Consensus 185 ~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~-~i~~~~~~~~~l~~i~ip~~~~~i~~~~f~~~~~l~~~~~~~ 262 (394)
T 4fs7_A 185 GKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLY-YLGDFALSKTGVKNIIIPDSFTELGKSVFYGCTDLESISIQN 262 (394)
T ss_dssp TTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCC-EECTTTTTTCCCCEEEECTTCCEECSSTTTTCSSCCEEEECC
T ss_pred CCceEEEcCCC-ceEeCchhhccccccceeecCCCce-EeehhhcccCCCceEEECCCceecccccccccccceeEEcCC
Confidence 44444444433 444432 344444444444433221 222223333445555443332222223455555666665554
Q ss_pred CCCCCCcccchhhhcCCCCCcEEEccCCCCCccCc-ccCCCCCCCEEEccCCCCCccc-hhhcCCCCCCEEEccCCCCCc
Q 001142 147 VPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFNKMKYLP-TEICYLKALISLKVANNKLVE 224 (1142)
Q Consensus 147 n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~Ls~N~L~~lP-~~l~~L~~L~~L~Ls~N~Ls~ 224 (1142)
+ ........|..+..|+.+.+..+. +|. .|..+.+|+.+.+..| ++.|+ .+|.++.+|+.++|.++ ++.
T Consensus 263 ~----~~~i~~~~F~~~~~l~~~~~~~~~---i~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~ 333 (394)
T 4fs7_A 263 N----KLRIGGSLFYNCSGLKKVIYGSVI---VPEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEE 333 (394)
T ss_dssp T----TCEECSCTTTTCTTCCEEEECSSE---ECTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCE
T ss_pred C----cceeeccccccccccceeccCcee---eccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccE
Confidence 2 122223345566666666655443 333 4667788888888654 77774 56777888888888644 777
Q ss_pred cCc-cccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccCC
Q 001142 225 LPS-GLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYN 267 (1142)
Q Consensus 225 IP~-~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N 267 (1142)
|+. .|.++++|+.++|..| ++.+....|.++.+|+.++|..|
T Consensus 334 I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 334 IGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp ECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred EhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence 754 4556888888888777 78787778888888888888654
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=98.82 E-value=3.7e-08 Score=114.67 Aligned_cols=232 Identities=13% Similarity=0.110 Sum_probs=123.9
Q ss_pred CCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCcCCcEEEccCCC----
Q 001142 28 KINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLRNLKFFGNE---- 102 (1142)
Q Consensus 28 ~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~-~l~~L~~L~~L~Ls~N~---- 102 (1142)
+++.|...+|.++.+|+.++|.. .++.+...+| .++++|+.++|.+| ++.|+. .|.++.+|+.+.+..+-
T Consensus 58 ~VtsIg~~AF~~c~~L~~i~lp~-~i~~I~~~aF---~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~l~~i~ 132 (394)
T 4fs7_A 58 DVVSIGYAAFQGCRKVTEIKIPS-TVREIGEFAF---ENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLMLKSIG 132 (394)
T ss_dssp EEEEECTTTTTTCTTEEEEECCT-TCCEECTTTT---TTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTTCCEEC
T ss_pred eEeEhHHHHhhCCCCceEEEeCC-CccCcchhHh---hCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCceeeec
Confidence 45666666677766777776653 3554444333 33366666666544 555643 45555555555543321
Q ss_pred -----------------CCcCc-hhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCC
Q 001142 103 -----------------INLFP-SEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLK 164 (1142)
Q Consensus 103 -----------------L~~lP-~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~ 164 (1142)
+..+. ..|.++++|+.+.+..+........|..+.+|+.+.+..+ ....-...|.++.
T Consensus 133 ~~aF~~~~~~~~~~~~~~~~i~~~aF~~c~~L~~i~l~~~~~~I~~~~F~~c~~L~~i~l~~~----~~~I~~~~F~~~~ 208 (394)
T 4fs7_A 133 VEAFKGCDFKEITIPEGVTVIGDEAFATCESLEYVSLPDSMETLHNGLFSGCGKLKSIKLPRN----LKIIRDYCFAECI 208 (394)
T ss_dssp TTTTTTCCCSEEECCTTCCEECTTTTTTCTTCCEEECCTTCCEECTTTTTTCTTCCBCCCCTT----CCEECTTTTTTCT
T ss_pred ceeeecccccccccCccccccchhhhcccCCCcEEecCCccceeccccccCCCCceEEEcCCC----ceEeCchhhcccc
Confidence 11111 2355666777777765543333455666666666666442 1111112233333
Q ss_pred CCcEEEccCC---------------------CCCccCc-ccCCCCCCCEEEccCCCCC--------------------cc
Q 001142 165 CLTKLSVCHF---------------------SIRYLPP-EIGCLSNLEQLDLSFNKMK--------------------YL 202 (1142)
Q Consensus 165 ~L~~L~Ls~N---------------------~L~~IP~-~l~~L~~L~~L~Ls~N~L~--------------------~l 202 (1142)
.|+.+.+..+ .++.|.. .+..+.+|+.+.+..|... .+
T Consensus 209 ~L~~i~~~~~~~~i~~~~~~~~~l~~i~ip~~~~~i~~~~f~~~~~l~~~~~~~~~~~i~~~~F~~~~~l~~~~~~~~~i 288 (394)
T 4fs7_A 209 LLENMEFPNSLYYLGDFALSKTGVKNIIIPDSFTELGKSVFYGCTDLESISIQNNKLRIGGSLFYNCSGLKKVIYGSVIV 288 (394)
T ss_dssp TCCBCCCCTTCCEECTTTTTTCCCCEEEECTTCCEECSSTTTTCSSCCEEEECCTTCEECSCTTTTCTTCCEEEECSSEE
T ss_pred ccceeecCCCceEeehhhcccCCCceEEECCCceecccccccccccceeEEcCCCcceeeccccccccccceeccCceee
Confidence 3333322211 1122222 3445556666666554322 12
Q ss_pred c-hhhcCCCCCCEEEccCCCCCccCcc-ccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccCCCCCC
Q 001142 203 P-TEICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 203 P-~~l~~L~~L~~L~Ls~N~Ls~IP~~-l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1142)
| ..+..+.+|+.+.+.+| ++.|+.. +.++.+|+.++|.++ ++.+....|.++.+|+.++|..| ++.
T Consensus 289 ~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~ 356 (394)
T 4fs7_A 289 PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRK 356 (394)
T ss_dssp CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCE
T ss_pred ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccE
Confidence 2 23556677777777654 6667543 445788888888644 77777777888888888877665 443
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.82 E-value=1.9e-09 Score=124.63 Aligned_cols=82 Identities=13% Similarity=0.175 Sum_probs=49.1
Q ss_pred CCCCCCEEEccCCCCC-ccchhhc---CCCCCCEEEccCCCCCc-----cCccccCCCCCCEEeCcCCcCCCCCcccccC
Q 001142 185 CLSNLEQLDLSFNKMK-YLPTEIC---YLKALISLKVANNKLVE-----LPSGLYLLQRLENLDLSNNRLTSLGSLDLCL 255 (1142)
Q Consensus 185 ~L~~L~~L~Ls~N~L~-~lP~~l~---~L~~L~~L~Ls~N~Ls~-----IP~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~ 255 (1142)
.+++|+.|+|++|.+. ..+..+. .+++|+.|+|+.|.|+. |+..+.++++|+.|+|++|.|+...-..+..
T Consensus 250 ~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~ 329 (362)
T 2ra8_A 250 RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQK 329 (362)
T ss_dssp TCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHH
T ss_pred CCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHH
Confidence 4677777777777776 2333332 46677777777777762 4444455677777777777766432222332
Q ss_pred -CCCCCEEEccCCC
Q 001142 256 -MHNLQNLNLQYNK 268 (1142)
Q Consensus 256 -L~~L~~L~Ls~N~ 268 (1142)
+ ...+++++|+
T Consensus 330 al--g~~~~~~~~~ 341 (362)
T 2ra8_A 330 SL--PMKIDVSDSQ 341 (362)
T ss_dssp HC--CSEEECCSBC
T ss_pred Hc--CCEEEecCCc
Confidence 2 3456666665
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.80 E-value=1.1e-07 Score=109.61 Aligned_cols=238 Identities=13% Similarity=0.066 Sum_probs=134.3
Q ss_pred cccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEEc
Q 001142 19 KEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKF 98 (1142)
Q Consensus 19 l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~L 98 (1142)
++++.+. ..|+.|...+|.++.+|+.++|..+ ++.+-...|.+. +|+.+.+..| ++.|+.......+|+.+.|
T Consensus 48 i~~v~ip-~~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c----~l~~i~~~~~-l~~I~~~aF~~~~L~~i~l 120 (379)
T 4h09_A 48 ISEVRVN-SGITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT----KLQSYTGMER-VKKFGDYVFQGTDLDDFEF 120 (379)
T ss_dssp CSEEEEC-TTEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC----CCCEEEECTT-CCEECTTTTTTCCCSEEEC
T ss_pred CEEEEeC-CCccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC----CCceEECCce-eeEeccceeccCCcccccC
Confidence 4444443 4588899999999999999999754 766655555433 6888888765 8888764333458999998
Q ss_pred cCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCC----------------------------
Q 001142 99 FGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPR---------------------------- 150 (1142)
Q Consensus 99 s~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n---------------------------- 150 (1142)
.++ ++.+....+.-.+|+.+.+..+-.......|..+.+|+.+.+..+...
T Consensus 121 p~~-~~~i~~~~F~~~~l~~~~~~~~v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (379)
T 4h09_A 121 PGA-TTEIGNYIFYNSSVKRIVIPKSVTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTEF 199 (379)
T ss_dssp CTT-CCEECTTTTTTCCCCEEEECTTCCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSEE
T ss_pred CCc-cccccccccccceeeeeeccceeeccccchhcccccccccccccccceeecccceecccccceecccccccccccc
Confidence 754 444444433333555555543332222334555555555444332110
Q ss_pred ----CCcccchhhhcCCCCCcEEEccCCCCCccCc-ccCCCCCCCEEEccCCCCCccc-hhhcCCCCCCEEEccCCCCCc
Q 001142 151 ----PSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFNKMKYLP-TEICYLKALISLKVANNKLVE 224 (1142)
Q Consensus 151 ----~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~Ls~N~L~~lP-~~l~~L~~L~~L~Ls~N~Ls~ 224 (1142)
.........+..+..|+.+.+..+ +..++. .+..+.+|+.+.+..+ ++.|. ..+.++.+|+.+.+.. .++.
T Consensus 200 ~~~~~~~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~-~i~~ 276 (379)
T 4h09_A 200 TIPSTVKTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYA-KVKT 276 (379)
T ss_dssp ECCTTCCEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECC-CCSE
T ss_pred ccccceeEEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhccccccc-ccee
Confidence 000011122334455555555433 333332 4456666666666554 55553 3455566666666643 3555
Q ss_pred cCcc-ccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccCC
Q 001142 225 LPSG-LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYN 267 (1142)
Q Consensus 225 IP~~-l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N 267 (1142)
|+.. +.++++|+.+.|.+|.++.+....|.++.+|+.+.|..|
T Consensus 277 i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~ 320 (379)
T 4h09_A 277 VPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA 320 (379)
T ss_dssp ECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT
T ss_pred ccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc
Confidence 5443 334666666666666666666666666666666666543
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.76 E-value=1.9e-07 Score=108.54 Aligned_cols=235 Identities=11% Similarity=0.130 Sum_probs=155.0
Q ss_pred CCcccCCCCCCCCC-CCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCC---CCccCc-cccCCcCCcEEEccCCC
Q 001142 28 KINNEKNGSVNDDD-DDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNV---LNLIPK-SVGRYEKLRNLKFFGNE 102 (1142)
Q Consensus 28 ~i~~l~~~~f~~l~-~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~---Lt~iP~-~l~~L~~L~~L~Ls~N~ 102 (1142)
.++.|...+|.+++ .|+.+.|-.+ ++.+-..+| .++++|+.+.+..|. ++.|+. +|..+.+|+.+.+.++
T Consensus 50 ~Vt~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF---~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~- 124 (394)
T 4gt6_A 50 PVSKIGDRVFCNYKYVLTSVQIPDT-VTEIGSNAF---YNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS- 124 (394)
T ss_dssp EEEEECTTTTTTCCSCCCEEEECTT-CCEECTTTT---TTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-
T ss_pred eeeEcCHhhccCCCCcCEEEEECCC-eeEEhHHHh---hCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-
Confidence 47889999999985 6999999764 766666555 455999999998874 778865 6888999999888754
Q ss_pred CCcCchh-hcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCC---------CCC-cccch--------hhhcCC
Q 001142 103 INLFPSE-VGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPP---------RPS-VLTLL--------SEIAGL 163 (1142)
Q Consensus 103 L~~lP~~-l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~---------n~~-~~~lp--------~~l~~L 163 (1142)
++.|+.. |.++.+|+.+.+..+........|..+.+|+.+.+..+-. +.+ .-.+| ..|.++
T Consensus 125 ~~~I~~~aF~~c~~L~~i~lp~~~~~I~~~~F~~c~~L~~i~~~~~~~~I~~~aF~~~~l~~i~ip~~~~~i~~~af~~c 204 (394)
T 4gt6_A 125 VTEIDSEAFHHCEELDTVTIPEGVTSVADGMFSYCYSLHTVTLPDSVTAIEERAFTGTALTQIHIPAKVTRIGTNAFSEC 204 (394)
T ss_dssp CSEECTTTTTTCTTCCEEECCTTCCEECTTTTTTCTTCCEEECCTTCCEECTTTTTTCCCSEEEECTTCCEECTTTTTTC
T ss_pred cceehhhhhhhhcccccccccceeeeecccceecccccccccccceeeEeccccccccceeEEEECCcccccccchhhhc
Confidence 7777654 7889999999997665444556788888898888865210 000 00011 223344
Q ss_pred CCCcEEEccCCCCC-----------------------------ccCc--------ccCCCCCCCEEEccCCCCCcc-chh
Q 001142 164 KCLTKLSVCHFSIR-----------------------------YLPP--------EIGCLSNLEQLDLSFNKMKYL-PTE 205 (1142)
Q Consensus 164 ~~L~~L~Ls~N~L~-----------------------------~IP~--------~l~~L~~L~~L~Ls~N~L~~l-P~~ 205 (1142)
..|.......+... .+|. .|..+.+|+.+.+.++. ..| ...
T Consensus 205 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~v~~i~~~aF~~c~~L~~i~lp~~~-~~I~~~a 283 (394)
T 4gt6_A 205 FALSTITSDSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIPNGVARIETHAFDSCAYLASVKMPDSV-VSIGTGA 283 (394)
T ss_dssp TTCCEEEECCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECCTTEEEECTTTTTTCSSCCEEECCTTC-CEECTTT
T ss_pred cccceecccccccccccceeecccccccccccccccccccceEEcCCcceEcccceeeecccccEEeccccc-ceecCcc
Confidence 44444332221111 1222 34556667777775443 334 345
Q ss_pred hcCCCCCCEEEccCCCCCccCcccc-CCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccCCCCCC
Q 001142 206 ICYLKALISLKVANNKLVELPSGLY-LLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 206 l~~L~~L~~L~Ls~N~Ls~IP~~l~-~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1142)
|.++.+|+.+.+. +.++.|+...+ ++.+|+.++|..| ++.+....|.++.+|+.+.|..| ++.
T Consensus 284 F~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~ 347 (394)
T 4gt6_A 284 FMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTK 347 (394)
T ss_dssp TTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCB
T ss_pred cccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCE
Confidence 6677778888775 56777765444 4788888888754 77777777888888888888544 443
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.74 E-value=8.6e-09 Score=111.58 Aligned_cols=134 Identities=14% Similarity=0.114 Sum_probs=91.3
Q ss_pred CCCcceeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCC--ccceeeeEecC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSC--IVEMYGHKISS 882 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~-~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpN--IVkl~g~~~~~ 882 (1142)
+..|.+....+.|..+.||++... +..+++|+..-. .... +.+|+.+++.+.+.+ +.+++++....
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~-------~~~~----~~~E~~~l~~l~~~~~~vP~~~~~~~~~ 87 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG-------ALNE----LQDEAARLSWLATTGVPCAAVLDVVTEA 87 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC-------TTSC----HHHHHHHHHHHHTTTCCBCCEEEEEECS
T ss_pred cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc-------cchh----hhHHHHHHHHHHhCCCCCCeEEEeccCC
Confidence 445666555556777999999764 456888885321 1122 268999998885434 55688876643
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH------------- 949 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~g------------- 949 (1142)
+ ..++||||++|.+|. .. ..+ ...++.+++..|..||+..
T Consensus 88 ~--------------~~~~v~e~i~G~~l~--~~--------~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~ 140 (264)
T 1nd4_A 88 G--------------RDWLLLGEVPGQDLL--SS--------HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHR 140 (264)
T ss_dssp S--------------CEEEEEECCSSEETT--TS--------CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHH
T ss_pred C--------------CCEEEEEecCCcccC--cC--------cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHH
Confidence 3 249999999988873 11 011 1245666777777777543
Q ss_pred ---------------------------------------------ccccCCCCCCeeeccccccCCCCCeEEEeecCCcc
Q 001142 950 ---------------------------------------------IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 984 (1142)
Q Consensus 950 ---------------------------------------------IvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~ 984 (1142)
++|+|++|.|||++.+ ..+.|+|||.+.
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~-------~~~~liD~~~a~ 213 (264)
T 1nd4_A 141 IERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENG-------RFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETT-------EEEEECCCTTCE
T ss_pred HHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECC-------cEEEEEcchhcc
Confidence 9999999999999764 456799999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.73 E-value=1.4e-08 Score=116.44 Aligned_cols=148 Identities=15% Similarity=0.176 Sum_probs=103.8
Q ss_pred ceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC--CCCccceeeeEecCCCCCC
Q 001142 810 SSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR--HSCIVEMYGHKISSKWLPS 887 (1142)
Q Consensus 810 ~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~--HpNIVkl~g~~~~~~~~~~ 887 (1142)
...+.|+.|.++.||++...+..+++|+..... ......... +.+|+.+++.+. +..+.++++++.+....
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~-~~~~~~~~~----~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~-- 113 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPK-SKLLPSAHA----IEREYRVMDALAGTDVPVAKMYALCEDESVI-- 113 (359)
T ss_dssp CEEEECCC-CCSCEEEEECSSCEEEEECCCC-----------C----HHHHHHHHHHHTTSSSCCCCEEEEECCTTTT--
T ss_pred ceEEEcCCcccceEEEEEECCceEEEEeCCCCC-CCCCCcHHH----HHHHHHHHHHhhcCCCCCCcEEEECCCCCcc--
Confidence 346789999999999999877777777532001 000111222 378999999986 55678888887654211
Q ss_pred CCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh--------------------
Q 001142 888 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-------------------- 947 (1142)
Q Consensus 888 ~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs-------------------- 947 (1142)
...++||||++|..+.+.. ...++......++.+++..|..||+
T Consensus 114 ---------g~~~~vme~v~G~~l~~~~-------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~ 177 (359)
T 3dxp_A 114 ---------GRAFYIMEFVSGRVLWDQS-------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQR 177 (359)
T ss_dssp ---------SSCEEEEECCCCBCCCCTT-------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHH
T ss_pred ---------CCeEEEEEecCCeecCCCc-------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHH
Confidence 1348999999987764311 1246788888999999999999997
Q ss_pred --------------------------------------CCccccCCCCCCeeeccccccCCCCCeEEEeecCCccc
Q 001142 948 --------------------------------------KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 985 (1142)
Q Consensus 948 --------------------------------------~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~ 985 (1142)
.+++|||+++.|||++.+.. ..+.|+||+.+..
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~-----~v~~viDwe~a~~ 248 (359)
T 3dxp_A 178 QIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEP-----RVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSS-----CEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCC-----cEEEEECcccccc
Confidence 36999999999999986521 3468999999864
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.64 E-value=1.9e-08 Score=116.25 Aligned_cols=81 Identities=21% Similarity=0.231 Sum_probs=58.4
Q ss_pred CCCCCcEEEccCCCCCc-cCccc---CCCCCCCEEEccCCCCCc-----cchhhcCCCCCCEEEccCCCCC-ccCccccC
Q 001142 162 GLKCLTKLSVCHFSIRY-LPPEI---GCLSNLEQLDLSFNKMKY-----LPTEICYLKALISLKVANNKLV-ELPSGLYL 231 (1142)
Q Consensus 162 ~L~~L~~L~Ls~N~L~~-IP~~l---~~L~~L~~L~Ls~N~L~~-----lP~~l~~L~~L~~L~Ls~N~Ls-~IP~~l~~ 231 (1142)
.+++|+.|+|.+|.++. .+..+ ..+++|+.|+|+.|.|+. |+..+..+++|+.|+|++|.|+ ..-..+..
T Consensus 250 ~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~ 329 (362)
T 2ra8_A 250 RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQK 329 (362)
T ss_dssp TCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHH
T ss_pred CCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHH
Confidence 46788999998888862 22222 357889999999999984 4555667889999999999987 22222332
Q ss_pred -CCCCCEEeCcCCc
Q 001142 232 -LQRLENLDLSNNR 244 (1142)
Q Consensus 232 -L~~L~~L~Ls~N~ 244 (1142)
+ ...++++.|+
T Consensus 330 al--g~~~~~~~~~ 341 (362)
T 2ra8_A 330 SL--PMKIDVSDSQ 341 (362)
T ss_dssp HC--CSEEECCSBC
T ss_pred Hc--CCEEEecCCc
Confidence 2 4668999887
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.61 E-value=6.3e-08 Score=108.54 Aligned_cols=197 Identities=19% Similarity=0.219 Sum_probs=117.6
Q ss_pred eeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCC--ccceeeeEecCCCCCCCC
Q 001142 813 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSC--IVEMYGHKISSKWLPSAD 889 (1142)
Q Consensus 813 ~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpN--IVkl~g~~~~~~~~~~~~ 889 (1142)
+.++.|.+..||++. ..+++|+.. ....... +.+|+++++.+. +.. +.+++........
T Consensus 26 ~~~~~G~~n~v~~v~---~~~vlR~~~------~~~~~~~----~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~----- 87 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN---RDFIFKFPK------HSRGSTN----LFNEVNILKRIHNKLPLPIPEVVFTGMPSET----- 87 (304)
T ss_dssp CEEEECSSEEEEEST---TSEEEEEES------SHHHHHH----HHHHHHHHHHHTTSSSSCCCCEEEECCCCSS-----
T ss_pred EecCCCCcceEEEEC---CEEEEEecC------CcchHHH----HHHHHHHHHHHHhcCCCCCCceEeecCCCCC-----
Confidence 458999999999864 567787642 1122233 378999998874 433 3344443322111
Q ss_pred CCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh----------------------
Q 001142 890 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS---------------------- 947 (1142)
Q Consensus 890 ~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs---------------------- 947 (1142)
....|+|||+++|.+|...... .++..+...++.|++..|..||+
T Consensus 88 ------~~~~~~vm~~i~G~~l~~~~~~-------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~ 154 (304)
T 3sg8_A 88 ------YQMSFAGFTKIKGVPLTPLLLN-------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDN 154 (304)
T ss_dssp ------CSCSCEEEECCCCEECCHHHHH-------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHH
T ss_pred ------CCcceEEEcccCCeECCccccc-------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHH
Confidence 1233899999999887654332 36777888888888888888885
Q ss_pred ------------------------------------CCccccCCCCCCeeeccccccCCCCCeEEEeecCCccccccccc
Q 001142 948 ------------------------------------KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLH 991 (1142)
Q Consensus 948 ------------------------------------~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~ 991 (1142)
..++|+|++|.||+++.+. ...+.|+||+.+..-.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~-----~~~~~~iD~~~~~~~~~~~D 229 (304)
T 3sg8_A 155 KKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEK-----NTICGIIDFGDAAISDPDND 229 (304)
T ss_dssp HHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTT-----TEEEEECCCTTCEEECTTHH
T ss_pred HHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCC-----CCEEEEEeCCCCccCChHHH
Confidence 1479999999999998731 15688999999864322110
Q ss_pred ccccccCCC-CCCC---CccCCCcccc-hhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 001142 992 TCCIAHRGI-PAPD---VCVGTPRWMA-PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM 1051 (1142)
Q Consensus 992 ~~~~~~~~~-~~~~---~~~GT~~Y~A-PE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~Pf~ 1051 (1142)
......... .... .......+.. |+.... .....+.|+++.++|.+.+|..+|.
T Consensus 230 l~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r------~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 230 FISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEK------YRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHH------HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHH------HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 000000000 0000 0000000111 222211 1133689999999999999987763
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.40 E-value=6.8e-06 Score=94.63 Aligned_cols=241 Identities=11% Similarity=0.089 Sum_probs=158.1
Q ss_pred cCCCCCCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCc
Q 001142 12 KSPEGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYE 91 (1142)
Q Consensus 12 ~~~~~~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~ 91 (1142)
+..+. +|+.+.+. ++++.|...+|.++ +|+.+.+..+ ++.+....|.. .+|+.+.|..+ ++.+......-.
T Consensus 65 F~~C~-~L~~I~lp-~~v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~----~~L~~i~lp~~-~~~i~~~~F~~~ 135 (379)
T 4h09_A 65 FNSCY-NMTKVTVA-STVTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG----TDLDDFEFPGA-TTEIGNYIFYNS 135 (379)
T ss_dssp TTTCT-TCCEEEEC-TTCCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT----CCCSEEECCTT-CCEECTTTTTTC
T ss_pred hhCCC-CCCEEEeC-CcceEechhhhcCC-CCceEECCce-eeEeccceecc----CCcccccCCCc-cccccccccccc
Confidence 34444 67777664 45888888899887 6777777644 44443333432 36778877655 555543222222
Q ss_pred CCcEEEccCCCCCcCc-hhhcCCCCCCEEE------------------------------------ccCCCCCCCccccc
Q 001142 92 KLRNLKFFGNEINLFP-SEVGNLLGLECLQ------------------------------------IKISSPGVNGFALN 134 (1142)
Q Consensus 92 ~L~~L~Ls~N~L~~lP-~~l~~L~~L~~L~------------------------------------Ls~N~l~~~~~~~~ 134 (1142)
+|+.+.+..+ ++.+. ..+.+..+|+.+. +..+........+.
T Consensus 136 ~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~f~ 214 (379)
T 4h09_A 136 SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTEFTIPSTVKTVTAYGFS 214 (379)
T ss_dssp CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSEEECCTTCCEECTTTTT
T ss_pred eeeeeeccce-eeccccchhcccccccccccccccceeecccceecccccceeccccccccccccccccceeEEeecccc
Confidence 4444444322 33332 2233344444433 32222222234566
Q ss_pred CCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCc-ccCCCCCCCEEEccCCCCCccc-hhhcCCCCC
Q 001142 135 KLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFNKMKYLP-TEICYLKAL 212 (1142)
Q Consensus 135 ~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~Ls~N~L~~lP-~~l~~L~~L 212 (1142)
...+|+.+.+.. +....-...|.++..|+.+.+..+ ++.|.. .|.++.+|+.+.+.. .+..++ ..|.++.+|
T Consensus 215 ~~~~l~~i~~~~----~~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~-~i~~i~~~aF~~c~~L 288 (379)
T 4h09_A 215 YGKNLKKITITS----GVTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYA-KVKTVPYLLCSGCSNL 288 (379)
T ss_dssp TCSSCSEEECCT----TCCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECC-CCSEECTTTTTTCTTC
T ss_pred cccccceeeecc----ceeEEccccccCCccceEEEcCCC-ccEeCccccceeehhccccccc-cceecccccccccccc
Confidence 677888888765 233333456788899999999776 677755 678899999999965 477776 467889999
Q ss_pred CEEEccCCCCCccCcc-ccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccCCCCC
Q 001142 213 ISLKVANNKLVELPSG-LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLL 270 (1142)
Q Consensus 213 ~~L~Ls~N~Ls~IP~~-l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~ 270 (1142)
+.+.|.+|.++.|+.. +.++.+|+.+.|..| ++.+...+|.++.+|+.+.|..| ++
T Consensus 289 ~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~ 345 (379)
T 4h09_A 289 TKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-IT 345 (379)
T ss_dssp CEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CC
T ss_pred ccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cC
Confidence 9999999999999654 556999999999765 88888888999999999988655 44
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.36 E-value=1.1e-07 Score=99.03 Aligned_cols=115 Identities=14% Similarity=0.069 Sum_probs=82.8
Q ss_pred chhhhcCCCCCcEEEccCC-CCCc-----cCcccCCCCCCCEEEccCCCCC-----ccchhhcCCCCCCEEEccCCCCCc
Q 001142 156 LLSEIAGLKCLTKLSVCHF-SIRY-----LPPEIGCLSNLEQLDLSFNKMK-----YLPTEICYLKALISLKVANNKLVE 224 (1142)
Q Consensus 156 lp~~l~~L~~L~~L~Ls~N-~L~~-----IP~~l~~L~~L~~L~Ls~N~L~-----~lP~~l~~L~~L~~L~Ls~N~Ls~ 224 (1142)
+...+...+.|+.|+|++| .|+. +...+...++|++|+|++|+|. .|...+...++|+.|+|++|.|+.
T Consensus 28 l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~ 107 (185)
T 1io0_A 28 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG 107 (185)
T ss_dssp HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred HHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCH
Confidence 3445566778888888888 7762 3445566778888888888887 245556667788888888888872
Q ss_pred -----cCccccCCCCCCEEeC--cCCcCCCCCc----ccccCCCCCCEEEccCCCCC
Q 001142 225 -----LPSGLYLLQRLENLDL--SNNRLTSLGS----LDLCLMHNLQNLNLQYNKLL 270 (1142)
Q Consensus 225 -----IP~~l~~L~~L~~L~L--s~N~Ls~~~p----~~l~~L~~L~~L~Ls~N~L~ 270 (1142)
|...+...++|+.|+| ++|.|+.... ..+...++|+.|+|++|.+.
T Consensus 108 ~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 108 SGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 5666777778888888 7788875432 23445578888888888764
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.35 E-value=6.8e-08 Score=106.67 Aligned_cols=94 Identities=21% Similarity=0.182 Sum_probs=55.2
Q ss_pred EEccCCCCCccCccc----CCCCCCCEEEccCCCCCcc---chhhcCCCCCCEEEccCCCCCccCccccCCC--CCCEEe
Q 001142 169 LSVCHFSIRYLPPEI----GCLSNLEQLDLSFNKMKYL---PTEICYLKALISLKVANNKLVELPSGLYLLQ--RLENLD 239 (1142)
Q Consensus 169 L~Ls~N~L~~IP~~l----~~L~~L~~L~Ls~N~L~~l---P~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~--~L~~L~ 239 (1142)
++++.|....++..+ .++++|+.|+|++|+|+.| |..+..+++|+.|+|++|+|+.+ ..+..+. +|+.|+
T Consensus 148 l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~-~~l~~l~~l~L~~L~ 226 (267)
T 3rw6_A 148 IDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE-RELDKIKGLKLEELW 226 (267)
T ss_dssp CCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG-GGGGGGTTSCCSEEE
T ss_pred ccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc-hhhhhcccCCcceEE
Confidence 455556544333321 3566777777777777644 34556677777777777777655 2233333 677777
Q ss_pred CcCCcCCCCCc-------ccccCCCCCCEEE
Q 001142 240 LSNNRLTSLGS-------LDLCLMHNLQNLN 263 (1142)
Q Consensus 240 Ls~N~Ls~~~p-------~~l~~L~~L~~L~ 263 (1142)
|++|.|++..| ..+..+++|+.||
T Consensus 227 L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 227 LDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp CTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred ccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 77777765443 1255666676665
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.22 E-value=5e-07 Score=94.08 Aligned_cols=90 Identities=14% Similarity=0.109 Sum_probs=61.6
Q ss_pred hhhhcCCCCCcEEEccCCCCCc-----cCcccCCCCCCCEEEccCCCCCc-----cchhhcCCCCCCEEEc--cCCCCCc
Q 001142 157 LSEIAGLKCLTKLSVCHFSIRY-----LPPEIGCLSNLEQLDLSFNKMKY-----LPTEICYLKALISLKV--ANNKLVE 224 (1142)
Q Consensus 157 p~~l~~L~~L~~L~Ls~N~L~~-----IP~~l~~L~~L~~L~Ls~N~L~~-----lP~~l~~L~~L~~L~L--s~N~Ls~ 224 (1142)
...+...++|+.|+|++|.|+. +...+...++|++|+|++|.|+. |...+...++|+.|+| ++|.|+.
T Consensus 58 ~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~ 137 (185)
T 1io0_A 58 AEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGN 137 (185)
T ss_dssp HHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCH
T ss_pred HHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCH
Confidence 3445566677777777777762 33444555678888888888872 4566777777888888 7788862
Q ss_pred -----cCccccCCCCCCEEeCcCCcCC
Q 001142 225 -----LPSGLYLLQRLENLDLSNNRLT 246 (1142)
Q Consensus 225 -----IP~~l~~L~~L~~L~Ls~N~Ls 246 (1142)
|...+...++|+.|+|++|.+.
T Consensus 138 ~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 138 NVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 4455555677888888888764
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.20 E-value=2.3e-07 Score=102.39 Aligned_cols=78 Identities=24% Similarity=0.212 Sum_probs=62.7
Q ss_pred cCCCCCcEEEccCCCCCccC---cccCCCCCCCEEEccCCCCCccchhhcCCC--CCCEEEccCCCCC-ccCc-------
Q 001142 161 AGLKCLTKLSVCHFSIRYLP---PEIGCLSNLEQLDLSFNKMKYLPTEICYLK--ALISLKVANNKLV-ELPS------- 227 (1142)
Q Consensus 161 ~~L~~L~~L~Ls~N~L~~IP---~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~--~L~~L~Ls~N~Ls-~IP~------- 227 (1142)
.++++|+.|+|++|+|+.++ ..+..+++|+.|+|++|+|+.+ ..+..+. +|+.|+|++|.|. .+|.
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~-~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~ 245 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE-RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISA 245 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG-GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc-hhhhhcccCCcceEEccCCcCccccCcchhHHHH
Confidence 56889999999999998654 5567899999999999999977 3344444 8999999999997 5663
Q ss_pred cccCCCCCCEEe
Q 001142 228 GLYLLQRLENLD 239 (1142)
Q Consensus 228 ~l~~L~~L~~L~ 239 (1142)
.+..+++|+.||
T Consensus 246 il~~~P~L~~LD 257 (267)
T 3rw6_A 246 IRERFPKLLRLD 257 (267)
T ss_dssp HHHHCTTCCEES
T ss_pred HHHHCcccCeEC
Confidence 256689999885
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=98.02 E-value=5.1e-06 Score=81.69 Aligned_cols=72 Identities=19% Similarity=0.166 Sum_probs=61.6
Q ss_pred CEEEccCCCCC--ccCccccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccCCCCCCCCCCCchhhccCCCC
Q 001142 213 ISLKVANNKLV--ELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGN 286 (1142)
Q Consensus 213 ~~L~Ls~N~Ls--~IP~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~~n 286 (1142)
..++.+++.|+ .||..+. .+|+.|+|++|+|+.+++..|..+++|+.|+|++|+|.|.|.+-.+..|.....
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC~l~~l~~wl~~~~ 84 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCRLVPLRAWLAGRP 84 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSGGGHHHHHHHHTSS
T ss_pred CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccCccHHHHHHHHhCc
Confidence 47888899988 8887655 469999999999999999999999999999999999999999877666665443
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.98 E-value=4.1e-05 Score=85.91 Aligned_cols=138 Identities=16% Similarity=0.149 Sum_probs=87.1
Q ss_pred eeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCC---CccceeeeEecCCCCCCC
Q 001142 812 CDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS---CIVEMYGHKISSKWLPSA 888 (1142)
Q Consensus 812 ~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp---NIVkl~g~~~~~~~~~~~ 888 (1142)
.+.++.|....||+. +..+++|+.. ....... +.+|+++|+.+.+. .+.+++.+.....
T Consensus 24 v~~l~~G~~n~v~~v---g~~~VlR~~~------~~~~~~~----~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~----- 85 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---NGDWVFRFPK------SQQGADE----LNKEIQLLPLLVGCVKVNIPQYVYIGKRSD----- 85 (306)
T ss_dssp EEEEEECSSEEEEEE---TTTEEEEEES------SHHHHHH----HHHHHHHHHHHTTTCSSBCCCEEEEEECTT-----
T ss_pred eeecCCCcceeEEEE---CCEEEEEecC------CchHHHH----HHHHHHHHHHHHhcCCCCCCCeEeecccCC-----
Confidence 456789999999988 5778888732 1222233 37999999999642 2456666554211
Q ss_pred CCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh---------------------
Q 001142 889 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS--------------------- 947 (1142)
Q Consensus 889 ~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs--------------------- 947 (1142)
...++||||++|.+|....-. .++......++.+++..|..||+
T Consensus 86 --------g~~~~v~e~i~G~~l~~~~~~-------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~ 150 (306)
T 3tdw_A 86 --------GNPFVGYRKVQGQILGEDGMA-------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKIL 150 (306)
T ss_dssp --------SCEEEEEECCCSEECHHHHHT-------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHH
T ss_pred --------CceEEEEeccCCeECchhhhh-------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHH
Confidence 124899999998877653211 13444444444444444444443
Q ss_pred ---------------------------------------CCccccCCCCCCeeeccccccCCCCCeEEEeecCCccc
Q 001142 948 ---------------------------------------KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 985 (1142)
Q Consensus 948 ---------------------------------------~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~ 985 (1142)
..++|+|++|.|||++.+. .....+.|+||+.+..
T Consensus 151 ~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~---~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 151 LLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNS---RQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTC---SSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCC---CCCceEEEEehhhcCC
Confidence 1469999999999998620 0013458999998854
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.92 E-value=6.9e-05 Score=81.73 Aligned_cols=131 Identities=15% Similarity=0.136 Sum_probs=86.5
Q ss_pred eeecccCce-EEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEecCCCCCCC
Q 001142 813 DEAGKSVSS-SLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWLPSA 888 (1142)
Q Consensus 813 ~~LG~GsfG-~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~g~~~~~~~~~~~ 888 (1142)
+.+..|.+| .||+.... +..+.+|+... .....+ .+|..+|+.+. +--+.++++++.+.+
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-------~~~~~~----~~E~~~l~~l~~~vPVP~v~~~~~~~~----- 93 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKG-------SVANDV----TDEMVRLNWLTAFMPLPTIKHFIRTPD----- 93 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEET-------HHHHHH----HHHHHHHHHHTTTSCCCCEEEEEEETT-----
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCC-------CCHhHH----HHHHHHHHHhccCCCcCeEEEEEEECC-----
Confidence 345556665 68987653 45678887531 122233 68999998885 444677888776543
Q ss_pred CCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------
Q 001142 889 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-------------------- 948 (1142)
Q Consensus 889 ~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~-------------------- 948 (1142)
..++|||+++|.++.+..... ......++.+++..|..||..
T Consensus 94 ---------~~~lvme~l~G~~~~~~~~~~---------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~ 155 (272)
T 4gkh_A 94 ---------DAWLLTTAIPGKTAFQVLEEY---------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQS 155 (272)
T ss_dssp ---------EEEEEEECCCSEEHHHHHHHC---------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHH
T ss_pred ---------eEEEEEEeeCCccccccccCC---------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHH
Confidence 349999999988887765431 112234455555555555531
Q ss_pred --------------------------------------CccccCCCCCCeeeccccccCCCCCeEEEeecCCcc
Q 001142 949 --------------------------------------HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 984 (1142)
Q Consensus 949 --------------------------------------gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~ 984 (1142)
.++|+|+.+.|||++.+ ..+-|+||+.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~-------~~~~viDwe~a~ 222 (272)
T 4gkh_A 156 RMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEG-------KLIGCIDVGRVG 222 (272)
T ss_dssp HHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETT-------EEEEECCCTTCE
T ss_pred HHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECC-------eEEEEEECcccc
Confidence 27899999999999865 456799999874
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00016 Score=82.30 Aligned_cols=86 Identities=10% Similarity=-0.011 Sum_probs=51.6
Q ss_pred ceeeee-cccCceEEEEEEEC--------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-C--CCccceee
Q 001142 810 SSCDEA-GKSVSSSLFRCKFG--------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-H--SCIVEMYG 877 (1142)
Q Consensus 810 ~l~~~L-G~GsfG~Vy~a~~~--------~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-H--pNIVkl~g 877 (1142)
...+.| +.|....+|+.... +..+.+|+........ ...... +.+|+.+++.+. + -.+.++++
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~-~~~~~~----~~~E~~~l~~L~~~~~vpvP~v~~ 97 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVP-VFPTYR----LDHQFEVIRLVGELTDVPVPRVRW 97 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCC-SSSCCC----HHHHHHHHHHHHHHCCSCCCCEEE
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccc-cCchhH----HHHHHHHHHHHhhcCCCCCCcEEE
Confidence 345778 89999999998764 5566777632111000 000112 267888888884 3 35677777
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeccCCCCH
Q 001142 878 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSV 911 (1142)
Q Consensus 878 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL 911 (1142)
+..+.... ...++||||++|..+
T Consensus 98 ~~~~~~~~-----------g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 98 IETTGDVL-----------GTPFFLMDYVEGVVP 120 (357)
T ss_dssp EECSSTTT-----------SSCEEEEECCCCBCC
T ss_pred EccCCCcc-----------CCceEEEEecCCCCh
Confidence 76543211 123899999997654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.35 E-value=0.0019 Score=72.31 Aligned_cols=30 Identities=20% Similarity=0.339 Sum_probs=26.2
Q ss_pred CCccccCCCCCCeeeccccccCCCCCeEEEeecCCcc
Q 001142 948 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 984 (1142)
Q Consensus 948 ~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~ 984 (1142)
.+++|+|+++.|||++.+ +.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~-------~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGEN-------EQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGG-------GCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCC-------CcEEEEehhhcc
Confidence 579999999999999765 579999999874
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.16 E-value=0.00076 Score=78.12 Aligned_cols=82 Identities=12% Similarity=0.005 Sum_probs=45.4
Q ss_pred eeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-C-CC-ccceeeeEecCCCC
Q 001142 811 SCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-H-SC-IVEMYGHKISSKWL 885 (1142)
Q Consensus 811 l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-H-pN-IVkl~g~~~~~~~~ 885 (1142)
..+.||.|.++.||+++. .+..+++|...-...... ........++..|.++++.+. + |. +.+++.+. ...
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~-~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~- 109 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVG-ESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEM- 109 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC--------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTT-
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccC-CCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCc-
Confidence 457899999999999964 456788886431110000 000001112357888888774 2 33 34555432 111
Q ss_pred CCCCCCCccccceEEEEEeccCCC
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGG 909 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~gg 909 (1142)
.++||||+++.
T Consensus 110 -------------~~lvmE~l~g~ 120 (397)
T 2olc_A 110 -------------AVTVMEDLSHL 120 (397)
T ss_dssp -------------TEEEECCCTTS
T ss_pred -------------cEEEEEeCCCc
Confidence 28999999863
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0017 Score=63.57 Aligned_cols=55 Identities=18% Similarity=0.234 Sum_probs=28.9
Q ss_pred EEEccCCCCC-CCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCcCCcEEEccCCCCC
Q 001142 45 VIDVSGKTVD-FPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLRNLKFFGNEIN 104 (1142)
Q Consensus 45 ~LdLs~N~L~-~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~-~l~~L~~L~~L~Ls~N~L~ 104 (1142)
++|.++++|+ ..+|..+. .+|+.|+|++|+|+.||. .|..+++|++|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp-----~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP-----VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC-----TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC-----cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 5666666665 12222111 345666666666666644 3455556666666666553
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0015 Score=68.57 Aligned_cols=109 Identities=15% Similarity=0.124 Sum_probs=74.5
Q ss_pred hcCCCCCcEEEccCC-CCCc-----cCcccCCCCCCCEEEccCCCCC-----ccchhhcCCCCCCEEEccCCCCC-----
Q 001142 160 IAGLKCLTKLSVCHF-SIRY-----LPPEIGCLSNLEQLDLSFNKMK-----YLPTEICYLKALISLKVANNKLV----- 223 (1142)
Q Consensus 160 l~~L~~L~~L~Ls~N-~L~~-----IP~~l~~L~~L~~L~Ls~N~L~-----~lP~~l~~L~~L~~L~Ls~N~Ls----- 223 (1142)
+.+-+.|+.|+|++| +|.. |-..+..-+.|+.|+|++|+|. .|-..+..-+.|+.|+|++|.|+
T Consensus 37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ 116 (197)
T 1pgv_A 37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA 116 (197)
T ss_dssp HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred HhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHH
Confidence 345567888888875 7652 3344555577899999999987 34455666678999999999987
Q ss_pred ccCccccCCCCCCEEeCcCCcC---CCC----CcccccCCCCCCEEEccCCC
Q 001142 224 ELPSGLYLLQRLENLDLSNNRL---TSL----GSLDLCLMHNLQNLNLQYNK 268 (1142)
Q Consensus 224 ~IP~~l~~L~~L~~L~Ls~N~L---s~~----~p~~l~~L~~L~~L~Ls~N~ 268 (1142)
.|-..+..-+.|+.|+|++|.. ... +...+..-+.|..|+|+.|.
T Consensus 117 ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~ 168 (197)
T 1pgv_A 117 RLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 168 (197)
T ss_dssp HHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCC
Confidence 3445566566799999987643 321 12234455788888887664
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.65 E-value=0.0071 Score=67.16 Aligned_cols=71 Identities=13% Similarity=0.117 Sum_probs=42.2
Q ss_pred eeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEecCCCCCCCCC
Q 001142 812 CDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWLPSADG 890 (1142)
Q Consensus 812 ~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~g~~~~~~~~~~~~~ 890 (1142)
.+.|+.|....+|++ ..+.+|+..... ....+. .+|+.+++.+. +.-..+++++..+.
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~-----~~~~~r----~~E~~~l~~l~~~g~~P~~~~~~~~~-------- 81 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGT-----EEYINR----ANEAVAAREAAKAGVSPEVLHVDPAT-------- 81 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC---------CCCH----HHHHHHHHHHHHTTSSCCEEEECTTT--------
T ss_pred eeEcCCcccccccee----eeEEEECCCCCc-----cceeCH----HHHHHHHHHHHHcCCCCceEEEECCC--------
Confidence 688999999999998 667888754211 111111 36777777664 22224555443211
Q ss_pred CCccccceEEEEEecc-CCCCH
Q 001142 891 NPEHHLLQSAIFMEYV-KGGSV 911 (1142)
Q Consensus 891 ~~~~~~~~~~LVmEy~-~ggSL 911 (1142)
-++||||+ +|.+|
T Consensus 82 --------~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 82 --------GVMVTRYIAGAQTM 95 (301)
T ss_dssp --------CCEEEECCTTCEEC
T ss_pred --------CEEEEeecCCCccC
Confidence 17899999 65433
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.65 E-value=0.0062 Score=71.17 Aligned_cols=32 Identities=9% Similarity=0.351 Sum_probs=27.2
Q ss_pred HhCCccccCCCCCCeeeccccccCCCCCeEEEeecCCccc
Q 001142 946 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 985 (1142)
Q Consensus 946 Hs~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~ 985 (1142)
+...++|||++|.|||++.+ . +.++||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~-------~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQD-------S-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSS-------C-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCC-------C-CEEEeCccccc
Confidence 35689999999999999865 3 99999998864
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.50 E-value=0.0016 Score=68.28 Aligned_cols=86 Identities=13% Similarity=0.083 Sum_probs=39.0
Q ss_pred CCCCCCCCEEEccCC-CCCCCCcc-cccCCCCCCCccEEEeecCCCCc-----cCccccCCcCCcEEEccCCCCC-----
Q 001142 37 VNDDDDDSVIDVSGK-TVDFPLIE-SYGNRGGDNSVEGLYLYKNVLNL-----IPKSVGRYEKLRNLKFFGNEIN----- 104 (1142)
Q Consensus 37 f~~l~~L~~LdLs~N-~L~~~~p~-~~~~l~~L~~L~~L~Ls~N~Lt~-----iP~~l~~L~~L~~L~Ls~N~L~----- 104 (1142)
+.+.+.|+.|+|++| +|...-.. ....+..-+.|+.|+|++|.|+. |-..+..-+.|+.|+|++|.|+
T Consensus 37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ 116 (197)
T 1pgv_A 37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA 116 (197)
T ss_dssp HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred HhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHH
Confidence 344556666666664 55321000 01112223456666666666651 2223333345666666666654
Q ss_pred cCchhhcCCCCCCEEEcc
Q 001142 105 LFPSEVGNLLGLECLQIK 122 (1142)
Q Consensus 105 ~lP~~l~~L~~L~~L~Ls 122 (1142)
.|-..+..-+.|+.|+|+
T Consensus 117 ala~aL~~N~tL~~L~L~ 134 (197)
T 1pgv_A 117 RLLRSTLVTQSIVEFKAD 134 (197)
T ss_dssp HHHHHTTTTCCCSEEECC
T ss_pred HHHHHHhhCCceeEEECC
Confidence 122333333445555554
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=96.37 E-value=0.0014 Score=67.68 Aligned_cols=80 Identities=14% Similarity=0.178 Sum_probs=33.9
Q ss_pred CCCEEEccCCCCCcc-chhhcCCCCCCEEEccCCC-CCc-cCccccCC----CCCCEEeCcCC-cCCCCCcccccCCCCC
Q 001142 188 NLEQLDLSFNKMKYL-PTEICYLKALISLKVANNK-LVE-LPSGLYLL----QRLENLDLSNN-RLTSLGSLDLCLMHNL 259 (1142)
Q Consensus 188 ~L~~L~Ls~N~L~~l-P~~l~~L~~L~~L~Ls~N~-Ls~-IP~~l~~L----~~L~~L~Ls~N-~Ls~~~p~~l~~L~~L 259 (1142)
+|+.|||+++.|+.. -..+..+++|+.|+|+++. |+. -=..+..+ ++|+.|+|+++ +||...-..+..+++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 345555555544421 1233445555555555542 431 00122222 23555555554 2443222234445555
Q ss_pred CEEEccCC
Q 001142 260 QNLNLQYN 267 (1142)
Q Consensus 260 ~~L~Ls~N 267 (1142)
+.|+|++.
T Consensus 142 ~~L~L~~c 149 (176)
T 3e4g_A 142 KYLFLSDL 149 (176)
T ss_dssp CEEEEESC
T ss_pred CEEECCCC
Confidence 55555544
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.11 E-value=0.045 Score=61.51 Aligned_cols=76 Identities=12% Similarity=0.040 Sum_probs=55.3
Q ss_pred eeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC---CCCccceeeeEecCCCCCC
Q 001142 811 SCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR---HSCIVEMYGHKISSKWLPS 887 (1142)
Q Consensus 811 l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~---HpNIVkl~g~~~~~~~~~~ 887 (1142)
-.+.|+.|.+..+|+....+..+.+|+.... .... +..|++.|+.|. ...+.+++++....+
T Consensus 40 ~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~-------~~~~----~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g---- 104 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDEVQTVFVKINERS-------YRSM----FRAEADQLALLAKTNSINVPLVYGIGNSQG---- 104 (312)
T ss_dssp EEEEECCSSSSEEEEEESSSCEEEEEEEEGG-------GHHH----HHHHHHHHHHHHHTTSSBCCCEEEEEECSS----
T ss_pred eeEEeCCccceeeeEEEECCCeEEEEeCCcc-------cHHH----HHHHHHHHHHHHhhCCCCcceEEEEeecCC----
Confidence 4577899999999999887778888875421 1222 368888888874 356788888765432
Q ss_pred CCCCCccccceEEEEEeccCCCCH
Q 001142 888 ADGNPEHHLLQSAIFMEYVKGGSV 911 (1142)
Q Consensus 888 ~~~~~~~~~~~~~LVmEy~~ggSL 911 (1142)
..++||||++|..+
T Consensus 105 ----------~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 105 ----------HSFLLLEALNKSKN 118 (312)
T ss_dssp ----------EEEEEEECCCCCCC
T ss_pred ----------ceEEEEEeccCCCC
Confidence 34999999998753
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.98 E-value=0.019 Score=63.96 Aligned_cols=150 Identities=15% Similarity=0.131 Sum_probs=76.8
Q ss_pred ceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-C-CCccceeeeEecCCCCCC
Q 001142 810 SSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-H-SCIVEMYGHKISSKWLPS 887 (1142)
Q Consensus 810 ~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-H-pNIVkl~g~~~~~~~~~~ 887 (1142)
.-.+.|+.|....+|++...+..+.+|+..-. .....+ ..|+.++..+. + -.+.+++... +...+
T Consensus 25 ~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~------~~~~~l----~~e~~~l~~L~~~g~~vP~~~~~~-~g~~~-- 91 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHTTKDPLILTLYEKR------VEKNDL----PFFLGLMQHLAAKGLSCPLPLPRK-DGELL-- 91 (322)
T ss_dssp EEEEEECC---EEEEEEEESSCCEEEEEECC---------CCHH----HHHHHHHHHHHHTTCCCCCBCCBT-TCCSC--
T ss_pred eEeeccCCCcccceEEEEeCCccEEEEEeCCC------CCHHHH----HHHHHHHHHHHHCCCCCCcccCCC-CCCEE--
Confidence 44577888999999999887667888875421 011122 45777776664 2 1133333211 00000
Q ss_pred CCCCCccccceEEEEEeccCCCCHH-----------HH---HHHHhcc-CCC---CCC---HHHHHH------------H
Q 001142 888 ADGNPEHHLLQSAIFMEYVKGGSVK-----------NY---IEKLSET-GEK---HVS---VKLALF------------I 934 (1142)
Q Consensus 888 ~~~~~~~~~~~~~LVmEy~~ggSL~-----------~~---l~~~~~~-~~~---~ls---~~~i~~------------I 934 (1142)
.......++||+|++|..+. .. ++..... ... ... |..... +
T Consensus 92 -----~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l 166 (322)
T 2ppq_A 92 -----GELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGL 166 (322)
T ss_dssp -----EEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTH
T ss_pred -----EEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhh
Confidence 00012358999999975421 11 1211000 000 011 111000 0
Q ss_pred HHHHHHHHHHHHh-------CCccccCCCCCCeeeccccccCCCCCeEEEeecCCcc
Q 001142 935 AQDVAAALVELHS-------KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 984 (1142)
Q Consensus 935 a~qIa~gL~yLHs-------~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~ 984 (1142)
...+...+++++. .+++|+|+.+.|||++.+ ..+.|+||+.+.
T Consensus 167 ~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~-------~~~~lIDf~~a~ 216 (322)
T 2ppq_A 167 REEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGD-------ELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETT-------EEEEECCCTTCE
T ss_pred HHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCC-------ceEEEecchhcc
Confidence 1123445556653 379999999999999865 445799999874
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=95.79 E-value=0.026 Score=63.33 Aligned_cols=35 Identities=34% Similarity=0.468 Sum_probs=26.7
Q ss_pred CCccccCCCCCCeeeccccccCCCCCeEEEeecCCccc
Q 001142 948 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 985 (1142)
Q Consensus 948 ~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~ 985 (1142)
..++|||+.+.|||++.+. .+...+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~---~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPER---EGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTS---CGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCc---CCCCCeEEEeCCCcCc
Confidence 4799999999999997631 0014689999998864
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=95.66 E-value=0.0059 Score=62.91 Aligned_cols=82 Identities=13% Similarity=0.179 Sum_probs=55.6
Q ss_pred CCCcEEEccCCCCCcc-CcccCCCCCCCEEEccCCC-CCc-cchhhcCC----CCCCEEEccCC-CCC--ccCccccCCC
Q 001142 164 KCLTKLSVCHFSIRYL-PPEIGCLSNLEQLDLSFNK-MKY-LPTEICYL----KALISLKVANN-KLV--ELPSGLYLLQ 233 (1142)
Q Consensus 164 ~~L~~L~Ls~N~L~~I-P~~l~~L~~L~~L~Ls~N~-L~~-lP~~l~~L----~~L~~L~Ls~N-~Ls--~IP~~l~~L~ 233 (1142)
-.|+.|+++++.|+.. -..+..+++|+.|+|+++. |+. --..+..+ ++|+.|+|+++ +|+ .+ ..+..++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl-~~L~~~~ 139 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGI-IALHHFR 139 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHH-HHGGGCT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHH-HHHhcCC
Confidence 3577888888877621 1345778888888888874 662 12445543 36888888887 477 34 3566788
Q ss_pred CCCEEeCcCCc-CC
Q 001142 234 RLENLDLSNNR-LT 246 (1142)
Q Consensus 234 ~L~~L~Ls~N~-Ls 246 (1142)
+|+.|+|+++. ++
T Consensus 140 ~L~~L~L~~c~~It 153 (176)
T 3e4g_A 140 NLKYLFLSDLPGVK 153 (176)
T ss_dssp TCCEEEEESCTTCC
T ss_pred CCCEEECCCCCCCC
Confidence 88888888874 44
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.47 E-value=0.068 Score=63.30 Aligned_cols=72 Identities=18% Similarity=0.126 Sum_probs=45.1
Q ss_pred eeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCc-cceeeeEecCCCCCC
Q 001142 811 SCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCI-VEMYGHKISSKWLPS 887 (1142)
Q Consensus 811 l~~~LG~GsfG~Vy~a~~~~--~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNI-Vkl~g~~~~~~~~~~ 887 (1142)
-.+.|+.|-...+|++...+ ..+.+|+..-. . .. .-+. .+|..++..|...++ .++++.+. +
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~-~-~~---~idR----~~E~~vl~~L~~~gl~P~ll~~~~--~---- 176 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPK-T-DE---IINR----EREKKISCILYNKNIAKKIYVFFT--N---- 176 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC--C-CS---CSCH----HHHHHHHHHHTTSSSBCCEEEEET--T----
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCC-h-hh---hcCH----HHHHHHHHHHHhcCCCCCEEEEeC--C----
Confidence 35678899999999999876 67788875211 1 00 0001 478888888864344 56666652 1
Q ss_pred CCCCCccccceEEEEEeccCCC
Q 001142 888 ADGNPEHHLLQSAIFMEYVKGG 909 (1142)
Q Consensus 888 ~~~~~~~~~~~~~LVmEy~~gg 909 (1142)
.+||||++|.
T Consensus 177 ------------G~v~e~I~G~ 186 (458)
T 2qg7_A 177 ------------GRIEEFMDGY 186 (458)
T ss_dssp ------------EEEEECCCSE
T ss_pred ------------eEEEEeeCCc
Confidence 4699999864
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.24 E-value=0.018 Score=65.85 Aligned_cols=29 Identities=24% Similarity=0.398 Sum_probs=24.3
Q ss_pred CccccCCCCCCeeeccccccCCCCCeEEEeecCCccc
Q 001142 949 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 985 (1142)
Q Consensus 949 gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~ 985 (1142)
+++|+|+.+.|||++.+ .+.|+||..+..
T Consensus 213 ~l~HgDl~~~Nil~~~~--------~~~lID~e~a~~ 241 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNK--------CLRLIDFEYSGF 241 (369)
T ss_dssp EEECSCCCGGGEEECC---------CEEECCCTTCEE
T ss_pred EEEeCCCCcccEEecCC--------cEEEEEecCCCC
Confidence 69999999999999753 489999998853
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=94.98 E-value=0.17 Score=55.59 Aligned_cols=75 Identities=19% Similarity=0.111 Sum_probs=48.8
Q ss_pred ceeeeecccCceEEEEEEE-CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-C--CCccceeeeEecCCCC
Q 001142 810 SSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-H--SCIVEMYGHKISSKWL 885 (1142)
Q Consensus 810 ~l~~~LG~GsfG~Vy~a~~-~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-H--pNIVkl~g~~~~~~~~ 885 (1142)
.-.+.+|.|..+.||+.+. +++.+.+|+..-... ..... +..|++.|+.|. . --+.+++++..
T Consensus 18 ~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~----~~~~~----~~~Ea~~L~~L~~~~~vpvP~v~~~~~----- 84 (288)
T 3f7w_A 18 AAVAERGHSHRWHLYRVELADGTPLFVKALPDDAP----ALDGL----FRAEALGLDWLGRSFGSPVPQVAGWDD----- 84 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCC----CCTTH----HHHHHHHHHHHTCSTTCCSCCEEEEET-----
T ss_pred EEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCc----chhhH----HHHHHHHHHHHHhhCCCCcceEEeccC-----
Confidence 5568899999999999997 466788886432211 11112 367988888874 2 23455555421
Q ss_pred CCCCCCCccccceEEEEEeccCCCC
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGS 910 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggS 910 (1142)
.++||||++++.
T Consensus 85 -------------~~lv~e~l~~~~ 96 (288)
T 3f7w_A 85 -------------RTLAMEWVDERP 96 (288)
T ss_dssp -------------TEEEEECCCCCC
T ss_pred -------------ceEEEEeecccC
Confidence 189999998763
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=94.62 E-value=0.039 Score=63.70 Aligned_cols=143 Identities=18% Similarity=0.230 Sum_probs=77.5
Q ss_pred eeecccCceEEEEEEEC---------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEecC
Q 001142 813 DEAGKSVSSSLFRCKFG---------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISS 882 (1142)
Q Consensus 813 ~~LG~GsfG~Vy~a~~~---------~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~g~~~~~ 882 (1142)
+.|..|-...+|++... +..+.+++. .. .......+ .+|.++++.+. +.-..++++++.+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~-g~----~~~~~~~~----~rE~~vl~~L~~~gv~P~ll~~~~~- 125 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLY-GA----ILQGVDSL----VLESVMFAILAERSLGPQLYGVFPE- 125 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEEC-C-------CCHHHH----HHHHHHHHHHHHTTSSCCEEEEETT-
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEEC-CC----ccchHHHH----HHHHHHHHHHHhcCCCCeEEEEcCC-
Confidence 56777888889998874 245666653 11 11112222 57888888874 3334566665431
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHH--------------HHHHHHhccC---CCCC--CHHHHHHHHHHHHH---
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVK--------------NYIEKLSETG---EKHV--SVKLALFIAQDVAA--- 940 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~--------------~~l~~~~~~~---~~~l--s~~~i~~Ia~qIa~--- 940 (1142)
.+||||++|.+|. ..+.+..... .... -+.++.++..++..
T Consensus 126 -----------------g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~ 188 (379)
T 3feg_A 126 -----------------GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPP 188 (379)
T ss_dssp -----------------EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCC
T ss_pred -----------------ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccC
Confidence 4899999875331 2222221111 1112 24556666554422
Q ss_pred ----------------HHHHHH----h----CCccccCCCCCCeeeccccccCCCCCeEEEeecCCccc
Q 001142 941 ----------------ALVELH----S----KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 985 (1142)
Q Consensus 941 ----------------gL~yLH----s----~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~ 985 (1142)
.+..|. . ..++|+|+.+.|||++.+. ...+.+.++||..|..
T Consensus 189 ~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~---~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 189 TGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEP---ENADSLMLVDFEYSSY 254 (379)
T ss_dssp CSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC------CCEEECCCTTCEE
T ss_pred cccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCC---CccCcEEEEecccCCc
Confidence 233333 2 2599999999999997641 0114689999998853
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=94.19 E-value=0.31 Score=51.75 Aligned_cols=99 Identities=15% Similarity=0.104 Sum_probs=60.3
Q ss_pred CCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeeeccccccCCCCCeEEEeecCCccccc
Q 001142 909 GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR 987 (1142)
Q Consensus 909 gSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs-~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~ 987 (1142)
-||.+.++.+ +.++++++++.++.|.+.+|.-+-. +.-..+=+-|..|++..+ |.|-+.+ +.+.
T Consensus 33 vSL~eIL~~~----~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~d-------G~V~f~~-~~s~--- 97 (229)
T 2yle_A 33 LSLEEILRLY----NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRD-------GAVTLAP-AADD--- 97 (229)
T ss_dssp EEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETT-------SCEEECC-C------
T ss_pred ccHHHHHHHc----CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecC-------Cceeccc-cccc---
Confidence 3899999863 4679999999999999999877621 111122233567777666 5555442 1110
Q ss_pred ccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001142 988 SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1046 (1142)
Q Consensus 988 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG 1046 (1142)
.....+.|||... ...+.+.=|||+|++||.-+--
T Consensus 98 -------------------~~~~~~~~pe~~~-----~~~te~~~IysLG~tLY~ALDy 132 (229)
T 2yle_A 98 -------------------AGEPPPVAGKLGY-----SQCMETEVIESLGIIIYKALDY 132 (229)
T ss_dssp ----------------------------CCSS-----SSSCHHHHHHHHHHHHHHHHTT
T ss_pred -------------------ccccCCCChhhcc-----ccchHHHHHHHHHHHHHHHhhc
Confidence 0122366787653 2446888999999999988753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=93.96 E-value=0.25 Score=57.89 Aligned_cols=71 Identities=15% Similarity=0.220 Sum_probs=45.4
Q ss_pred eeeeecccCceEEEEEEEC---------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEe
Q 001142 811 SCDEAGKSVSSSLFRCKFG---------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKI 880 (1142)
Q Consensus 811 l~~~LG~GsfG~Vy~a~~~---------~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~g~~~ 880 (1142)
-.+.|+.|....||++... +..+.+|+.... .. ...+ .+|+.+++.+. +.-..++++.+.
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~----~~--~~~l----i~E~~~l~~L~~~g~~P~l~~~~~ 146 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ET--ESHL----VAESVIFTLLSERHLGPKLYGIFS 146 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CC--HHHH----HHHHHHHHHHHHTTSSSCEEEEET
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC----Cc--HHHH----HHHHHHHHHHHhCCCCCcEEEEeC
Confidence 3467888999999999874 356777775211 11 0222 46888888875 333356666542
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCC
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGG 909 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gg 909 (1142)
+ ++||||++|.
T Consensus 147 --~----------------g~v~e~l~G~ 157 (429)
T 1nw1_A 147 --G----------------GRLEEYIPSR 157 (429)
T ss_dssp --T----------------EEEECCCCEE
T ss_pred --C----------------CEEEEEeCCc
Confidence 1 5899999863
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=93.17 E-value=0.26 Score=54.73 Aligned_cols=29 Identities=28% Similarity=0.287 Sum_probs=24.2
Q ss_pred CCccccCCCCCCeeeccccccCCCCCeEEEeecCCccc
Q 001142 948 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 985 (1142)
Q Consensus 948 ~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~ 985 (1142)
..++|+|+++.|||++ + .+.|+||+.+..
T Consensus 195 ~~l~HgD~~~~Nil~~-~--------~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D--------GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGGGEEES-S--------SEEECCCTTCCE
T ss_pred eeeeeCCCCcccEeEc-C--------CCEEEECCCCCc
Confidence 4689999999999997 2 388999998753
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=92.74 E-value=0.37 Score=54.43 Aligned_cols=31 Identities=26% Similarity=0.454 Sum_probs=26.6
Q ss_pred CCccccCCCCCCeeeccccccCCCCCeEEEeecCCccc
Q 001142 948 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 985 (1142)
Q Consensus 948 ~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~ 985 (1142)
..++|+|+.+.||+++.+ +.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~-------~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNE-------ESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGG-------GCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCC-------CeEEEEECCCCee
Confidence 369999999999999865 5689999998764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=92.70 E-value=0.48 Score=55.45 Aligned_cols=73 Identities=8% Similarity=0.086 Sum_probs=45.2
Q ss_pred eeeeecccCceEEEEEEEC---------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEe
Q 001142 811 SCDEAGKSVSSSLFRCKFG---------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKI 880 (1142)
Q Consensus 811 l~~~LG~GsfG~Vy~a~~~---------~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~g~~~ 880 (1142)
-.+.|..|-...+|++... +..+.+++..-. ....-+. .+|..+++.+. +.-..++++.+.
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~-----t~~~idR----~~E~~~l~~L~~~gi~P~l~~~~~ 144 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKH-----VGKFYDS----KVELDVFRYLSNINIAPNIIADFP 144 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCC-----C-CCCCH----HHHHHHHHHHHHTTSSCCEEEEET
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCC-----cchhcCH----HHHHHHHHHHHhcCCCCCEEEEcC
Confidence 4566778999999999876 466777764211 1111111 47888888774 333455665331
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCC
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGS 910 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggS 910 (1142)
+ ++||||++|..
T Consensus 145 --~----------------~~I~efI~G~~ 156 (424)
T 3mes_A 145 --E----------------GRIEEFIDGEP 156 (424)
T ss_dssp --T----------------EEEEECCCSEE
T ss_pred --C----------------CEEEEEeCCcc
Confidence 1 78999999754
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=83.06 E-value=2.1 Score=49.29 Aligned_cols=36 Identities=28% Similarity=0.329 Sum_probs=26.3
Q ss_pred CccccCCCCCCeeeccccccCCCCCeEEEeecCCccc
Q 001142 949 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 985 (1142)
Q Consensus 949 gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~ 985 (1142)
.++|+|+.+.|||+..+.. ......+.++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~-~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRE-NSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGG-GCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcc-cCcCCeEEEechHhccC
Confidence 3689999999999954311 11226799999999864
|
| >3isr_A Transglutaminase-like enzymes, putative cysteine; protease, hutchinsoni MCSG, structural genomics; 1.90A {Cytophaga hutchinsonii} | Back alignment and structure |
|---|
Probab=80.29 E-value=0.58 Score=51.92 Aligned_cols=46 Identities=30% Similarity=0.504 Sum_probs=39.2
Q ss_pred ccchhhhHHHHHHHhhhccCCCCccccccccccc----CCCccceeEEeeCCch
Q 001142 705 QFGVCRHRAVLLKYLCDRVEPPVPCELVRGYLDF----QPHAWNTILVKKGDSW 754 (1142)
Q Consensus 705 ~~g~~~hr~~l~k~~~d~~~~~~~~~~~~g~~~~----~~~~~~~~~~~~~~~~ 754 (1142)
..|+|++-|.||-.||-.++ ||+|.|.||... ..|||..+-+. +.|
T Consensus 177 ~~G~C~d~A~l~val~Ra~G--IPAR~VsGy~~~~~~~~~HAW~Evyl~--ggW 226 (293)
T 3isr_A 177 RAGVCRDFAHLGIALCRALS--IPARYFTGYAFKLNPPDFHACFEAYIG--GNW 226 (293)
T ss_dssp CEECHHHHHHHHHHHHHHTT--CCEEEEEEEETTCSSCCEEEEEEEEET--TEE
T ss_pred CcEehHHHHHHHHHHHHHCC--CCEEEEEEECCCCCCCCeEEEEEEEEC--CcE
Confidence 47999999999999999999 999999999863 46999876654 356
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1142 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-42 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-38 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-36 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-36 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-36 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-36 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-36 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-36 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-36 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-35 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-34 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-34 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-34 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-34 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-33 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-33 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-33 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-33 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-32 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-32 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-32 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-32 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-32 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-32 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-32 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-31 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 9e-31 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-30 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-30 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-30 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-30 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-30 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-30 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-29 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-29 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-29 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-29 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-29 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-28 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-28 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-28 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-28 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-28 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-27 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-27 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-27 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-26 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-26 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-25 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-25 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-25 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-25 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-25 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-24 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-24 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-24 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-23 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-23 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-22 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-21 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-21 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-17 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-11 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-10 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-11 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-10 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-10 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-07 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-07 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-05 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-10 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 9e-08 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 8e-06 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-05 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-05 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.003 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-05 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 0.004 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.003 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.001 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 3e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.001 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.001 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.001 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 9e-42
Identities = 65/315 (20%), Positives = 123/315 (39%), Gaps = 64/315 (20%)
Query: 816 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 875
G ++++ K+ D A K+ L V + +++ F EV +L RH I+
Sbjct: 17 GSGSFGTVYKGKWHG-DVAVKM--LNVTAPTPQQLQAF----KNEVGVLRKTRHVNILLF 69
Query: 876 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 935
G+ + + I ++ +G S+ +++ + E + + IA
Sbjct: 70 MGYSTAPQLA---------------IVTQWCEGSSLYHHLHII----ETKFEMIKLIDIA 110
Query: 936 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 995
+ A + LH+K I+HRD+KS NI + VK+ DF A + +
Sbjct: 111 RQTAQGMDYLHAKSIIHRDLKSNNIFL-------HEDLTVKIGDFGLATVKSRWSGSHQF 163
Query: 996 AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSE 1055
G+ WMAPEV+R M N Y + D++++G +L EL+T Q+PY ++
Sbjct: 164 EQ--------LSGSILWMAPEVIR-MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 214
Query: 1056 LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 1115
+ + +G+ D + +C + + + C ++
Sbjct: 215 RDQIIFM-VGRGYLSPDLSKVRSNCPKA---------------------MKRLMAECLKK 252
Query: 1116 NPTERPTAGDLYEMF 1130
ERP +
Sbjct: 253 KRDERPLFPQILASI 267
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 5e-38
Identities = 69/314 (21%), Positives = 118/314 (37%), Gaps = 67/314 (21%)
Query: 816 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 875
G +++ + A + + S +E+ ++ + E+ +L + H IV++
Sbjct: 21 GDGAFGKVYKAQNKETSVLAAAKVIDT--KSEEELEDY----MVEIDILASCDHPNIVKL 74
Query: 876 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 935
L I +E+ GG+V + +L E+ ++ +
Sbjct: 75 LDAFYYENNL--------------WILIEFCAGGAVDAVMLEL----ERPLTESQIQVVC 116
Query: 936 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 995
+ AL LH I+HRD+K+ NIL DG +KL DF +
Sbjct: 117 KQTLDALNYLHDNKIIHRDLKAGNILFT-----LDG--DIKLADFGVS----------AK 159
Query: 996 AHRGIPAPDVCVGTPRWMAPEVLRA-MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLS 1054
R I D +GTP WMAPEV+ K Y + D+WS G L+E+ ++ P+ L+
Sbjct: 160 NTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN 219
Query: 1055 ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 1114
+ + I + P L +P S D ++C E
Sbjct: 220 PMRVLLKIAKSEPPTL----------------------AQPS---RWSSNFKDFLKKCLE 254
Query: 1115 ENPTERPTAGDLYE 1128
+N R T L +
Sbjct: 255 KNVDARWTTSQLLQ 268
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 1e-36
Identities = 74/318 (23%), Positives = 115/318 (36%), Gaps = 70/318 (22%)
Query: 816 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 875
G + + S + L + E + + EV +L L+H IV
Sbjct: 13 GTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQML----VSEVNLLRELKHPNIVRY 68
Query: 876 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 935
Y I L I MEY +GG + + I K ++ +++ + L +
Sbjct: 69 YDRIIDRT---------NTTLY---IVMEYCEGGDLASVITKGTKER-QYLDEEFVLRVM 115
Query: 936 QDVAAALVELHSKH-----IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFL 990
+ AL E H + ++HRD+K N+ +D GK VKL DF A
Sbjct: 116 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLD-------GKQNVKLGDFGLA------- 161
Query: 991 HTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1050
I + VGTP +M+PE + M Y + DIWS GCLL EL L P+
Sbjct: 162 ---RILNHDTSFAKAFVGTPYYMSPEQMNRMS----YNEKSDIWSLGCLLYELCALMPPF 214
Query: 1051 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 1110
S+ E+ I+ GK R+ + L ++
Sbjct: 215 TAFSQKELAGKIREGKFRRIPYRY--------------------SDE-------LNEIIT 247
Query: 1111 RCTEENPTERPTAGDLYE 1128
R RP+ ++ E
Sbjct: 248 RMLNLKDYHRPSVEEILE 265
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 1e-36
Identities = 67/317 (21%), Positives = 115/317 (36%), Gaps = 73/317 (23%)
Query: 816 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 875
G+ ++++ L+ + E + F E ML L+H IV
Sbjct: 18 GRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRF----KEEAEMLKGLQHPNIVRF 73
Query: 876 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 935
Y W + G L+ E + G++K Y+++ K + +K+
Sbjct: 74 YDS-----WESTVKGKKCIVLV-----TELMTSGTLKTYLKR-----FKVMKIKVLRSWC 118
Query: 936 QDVAAALVELHSKH--IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR-SFLHT 992
+ + L LH++ I+HRD+K +NI I VK+ D A R SF
Sbjct: 119 RQILKGLQFLHTRTPPIIHRDLKCDNIFIT------GPTGSVKIGDLGLATLKRASFAKA 172
Query: 993 CCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1052
GTP +MAPE+ Y VD++++G +LE+ T + PY
Sbjct: 173 VI-------------GTPEFMAPEMYE-----EKYDESVDVYAFGMCMLEMATSEYPYSE 214
Query: 1053 LSEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRR 1111
+I+ + G +P D++ PE + ++
Sbjct: 215 CQNAAQIYRRVTSGVKPASFDKVAI------------------PEVK--------EIIEG 248
Query: 1112 CTEENPTERPTAGDLYE 1128
C +N ER + DL
Sbjct: 249 CIRQNKDERYSIKDLLN 265
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 1e-36
Identities = 52/294 (17%), Positives = 99/294 (33%), Gaps = 70/294 (23%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
V+ LK + L E ++ L + IV M G + W+
Sbjct: 39 VKILKNEANDPALKDEL----LAEANVMQQLDNPYIVRMIGICEAESWM----------- 83
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
+ ME + G + Y+++ +HV K + + V+ + L + +HRD+
Sbjct: 84 ----LVMEMAELGPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLA 134
Query: 957 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1016
+ N+L+ + K+ DF + LR+ + +W APE
Sbjct: 135 ARNVLL-------VTQHYAKISDFGLSKALRADENYYKAQTH-------GKWPVKWYAPE 180
Query: 1017 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELE 1075
+ + + D+WS+G L+ E + Q PY G+ E+ +++ G+R
Sbjct: 181 CINYYK----FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC- 235
Query: 1076 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1129
P + D+ C + RP +
Sbjct: 236 -------------------PRE-------MYDLMNLCWTYDVENRPGFAAVELR 263
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 2e-36
Identities = 68/311 (21%), Positives = 115/311 (36%), Gaps = 66/311 (21%)
Query: 833 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 892
A K+ L++ + ++I E+++L IV YG S +
Sbjct: 34 MARKLIHLEIKPAIRNQIIR-------ELQVLHECNSPYIVGFYGAFYSDGEI------- 79
Query: 893 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IM 951
+I ME++ GGS+ ++K + ++ ++ V L L KH IM
Sbjct: 80 -------SICMEHMDGGSLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLREKHKIM 127
Query: 952 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR 1011
HRD+K NIL++ + +KLCDF + L + VGT
Sbjct: 128 HRDVKPSNILVN-------SRGEIKLCDFGVSGQLIDSMAN------------SFVGTRS 168
Query: 1012 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI--------- 1062
+M+PE L+ H Y ++ DIWS G L+E+ + P E+ +
Sbjct: 169 YMSPERLQGTH----YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 224
Query: 1063 ------QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF-LVDVFRRCTEE 1115
+ RP + +++ E+ P+ S D +C +
Sbjct: 225 ETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK 284
Query: 1116 NPTERPTAGDL 1126
NP ER L
Sbjct: 285 NPAERADLKQL 295
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 3e-36
Identities = 59/272 (21%), Positives = 98/272 (36%), Gaps = 68/272 (25%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
E ++ LRHS +V++ G + K L I EY+ GS+ +Y+
Sbjct: 50 EASVMTQLRHSNLVQLLGVIVEEK----------GGLY---IVTEYMAKGSLVDYLRS-- 94
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
G + L + DV A+ L + +HRD+ + N+L+ D V K+ D
Sbjct: 95 -RGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS-----EDN--VAKVSD 146
Query: 980 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039
F S T +W APE LR + + D+WS+G L
Sbjct: 147 FGLTKEASSTQDTGK-------------LPVKWTAPEALREKK----FSTKSDVWSFGIL 189
Query: 1040 LLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 1098
L E+ + +VPY + ++ ++ G + D P A
Sbjct: 190 LWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC--------------------PPA- 228
Query: 1099 LETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130
+ +V + C + RP+ L E
Sbjct: 229 ------VYEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 135 bits (341), Expect = 7e-36
Identities = 60/299 (20%), Positives = 109/299 (36%), Gaps = 64/299 (21%)
Query: 833 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWLPSADGN 891
A + SA+E++ + L EV +L + H I+++ ++ +
Sbjct: 32 AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFF------ 85
Query: 892 PEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIM 951
+ + +K G + +Y+ + + +S K I + + + LH +I+
Sbjct: 86 --------FLVFDLMKKGELFDYLTE-----KVTLSEKETRKIMRALLEVICALHKLNIV 132
Query: 952 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR 1011
HRD+K ENIL+ D +KL DF + L GTP
Sbjct: 133 HRDLKPENILL-------DDDMNIKLTDFGFSCQLDPGEKL-----------REVCGTPS 174
Query: 1012 WMAPEVLRAMHKPNL--YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPR 1069
++APE++ N YG EVD+WS G ++ LL P+ ++ + +I G
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 234
Query: 1070 LTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1128
+ E + + D+ R P +R TA +
Sbjct: 235 GSPEWDDYSDT------------------------VKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 7e-36
Identities = 64/298 (21%), Positives = 107/298 (35%), Gaps = 71/298 (23%)
Query: 840 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 899
LKV + E E+ EV + LRH I+ +YG+ + +
Sbjct: 36 LKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY------------- 82
Query: 900 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959
+ +EY G+V ++K + ++A AL HSK ++HRDIK EN
Sbjct: 83 -LILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPEN 136
Query: 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1019
+L+ +K+ DF +V S T GT ++ PE++
Sbjct: 137 LLL-------GSAGELKIADFGWSVHAPSSRRTT------------LCGTLDYLPPEMIE 177
Query: 1020 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGS 1079
+ +VD+WS G L E L + P+ + E + I D +
Sbjct: 178 GRM----HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-EFTFPDFV----- 227
Query: 1080 CHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM-FVARTSS 1136
E D+ R + NP++RP ++ E ++ SS
Sbjct: 228 ---------------TEG-------ARDLISRLLKHNPSQRPMLREVLEHPWITANSS 263
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 133 bits (337), Expect = 5e-35
Identities = 66/289 (22%), Positives = 100/289 (34%), Gaps = 67/289 (23%)
Query: 840 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 899
+K S + + EVR L LRH ++ G + EH
Sbjct: 45 IKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----------EHTAW-- 91
Query: 900 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959
+ MEY G + +K + + L LHS +++HRD+K+ N
Sbjct: 92 -LVMEYCLGSASDLLEVH-----KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGN 145
Query: 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1019
IL+ +VKL DF A PA GTP WMAPEV+
Sbjct: 146 ILL-------SEPGLVKLGDF-------------GSASIMAPANSFV-GTPYWMAPEVIL 184
Query: 1020 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGS 1079
AM + Y +VD+WS G +EL + P ++ + I + P L
Sbjct: 185 AMDE-GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSG------ 237
Query: 1080 CHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1128
E + C ++ P +RPT+ L +
Sbjct: 238 -------------HWSEY-------FRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 2e-34
Identities = 63/295 (21%), Positives = 110/295 (37%), Gaps = 69/295 (23%)
Query: 834 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 893
A K+ +K + I+ E+ + L H +V+ YGH+
Sbjct: 34 AVKIVDMKRAVDCPENIKK-------EICINKMLNHENVVKFYGHRREGNIQ-------- 78
Query: 894 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 953
+F+EY GG + + IE + + A + A +V LH I HR
Sbjct: 79 ------YLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR 127
Query: 954 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 1013
DIK EN+L+ D + +K+ DF L T + + GT ++
Sbjct: 128 DIKPENLLL-------DERDNLKISDFG--------LATVFRYNNRERLLNKMCGTLPYV 172
Query: 1014 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDE 1073
APE+L+ + + VD+WS G +L +L ++P+ S+ K+ L
Sbjct: 173 APELLK---RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL--- 226
Query: 1074 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1128
P +++ S + + + ENP+ R T D+ +
Sbjct: 227 --------------------NPWKKID--SAPLALLHKILVENPSARITIPDIKK 259
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 133 bits (336), Expect = 2e-34
Identities = 48/270 (17%), Positives = 83/270 (30%), Gaps = 64/270 (23%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
E++ + LRH +V ++ + + E++ GG + +
Sbjct: 73 EIQTMSVLRHPTLVNLHDAFEDDNEM--------------VMIYEFMSGGELFEKVAD-- 116
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
+S A+ + V L +H + +H D+K ENI+ +KL D
Sbjct: 117 --EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFT-----TKRSNELKLID 169
Query: 980 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039
F L GT + APEV G D+WS G L
Sbjct: 170 FGLTAHLDPKQSVKV-----------TTGTAEFAAPEVAEGKP----VGYYTDMWSVGVL 214
Query: 1040 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 1099
LL+ P+ G ++ E ++ + ++
Sbjct: 215 SYILLSGLSPFGGENDDETLRNVKSCD-------------------------WNMDDSAF 249
Query: 1100 ETLSF-LVDVFRRCTEENPTERPTAGDLYE 1128
+S D R+ +P R T E
Sbjct: 250 SGISEDGKDFIRKLLLADPNTRMTIHQALE 279
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (329), Expect = 4e-34
Identities = 66/268 (24%), Positives = 102/268 (38%), Gaps = 68/268 (25%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
E+ ++ ++ IV + L + MEY+ GGS+ + + +
Sbjct: 67 EILVMRENKNPNIVNYLDSYLVGDEL--------------WVVMEYLAGGSLTDVVTE-- 110
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
+ + ++ AL LHS ++HRDIKS+NIL+ DG VKL D
Sbjct: 111 ----TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG-----MDGS--VKLTD 159
Query: 980 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039
F + VGTP WMAPEV+ YG +VDIWS G +
Sbjct: 160 FGFCAQITPEQSKR----------STMVGTPYWMAPEVVTRKA----YGPKVDIWSLGIM 205
Query: 1040 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 1099
+E++ + PY+ + L LI P L +
Sbjct: 206 AIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-------------------------- 239
Query: 1100 ETLS-FLVDVFRRCTEENPTERPTAGDL 1126
E LS D RC + + +R +A +L
Sbjct: 240 EKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 5e-34
Identities = 49/287 (17%), Positives = 91/287 (31%), Gaps = 69/287 (24%)
Query: 844 GSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM 903
G+ + + E +++ L + IV + G + + + M
Sbjct: 47 GTEKADTEEM----MREAQIMHQLDNPYIVRLIGVCQAEALM---------------LVM 87
Query: 904 EYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963
E GG + ++ + + V + V+ + L K+ +HRD+ + N+L+
Sbjct: 88 EMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL- 142
Query: 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 1023
+ K+ DF + L + G +W APE +
Sbjct: 143 ------VNRHYAKISDFGLSKALGADDSYYTARSAG-------KWPLKWYAPECINFRK- 188
Query: 1024 PNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE 1082
+ D+WSYG + E L+ Q PY + E+ I+ GKR E
Sbjct: 189 ---FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC-------- 237
Query: 1083 HEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1129
P L + C +RP + +
Sbjct: 238 ------------PPE-------LYALMSDCWIYKWEDRPDFLTVEQR 265
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 131 bits (330), Expect = 1e-33
Identities = 51/284 (17%), Positives = 96/284 (33%), Gaps = 65/284 (22%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
E+ ++ L H ++ ++ + + +E++ GG + + I
Sbjct: 76 EISIMNQLHHPKLINLHDAFEDKYEM--------------VLILEFLSGGELFDRIAA-- 119
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
+ +S + + L +H I+H DIK ENI+ + VK+ D
Sbjct: 120 --EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCE-----TKKASSVKIID 172
Query: 980 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039
F A L T + APE++ G D+W+ G L
Sbjct: 173 FGLATKLNPDEIVKV-----------TTATAEFAAPEIVDREP----VGFYTDMWAIGVL 217
Query: 1040 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 1099
LL+ P+ G +LE ++ +E E
Sbjct: 218 GYVLLSGLSPFAGEDDLETLQNVKRCD-------------------------WEFDEDAF 252
Query: 1100 ETLSF-LVDVFRRCTEENPTERPTAGDLYEM-FVARTSSSISSR 1141
++S D + ++ P +R T D E ++ S+++SR
Sbjct: 253 SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSR 296
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 129 bits (325), Expect = 2e-33
Identities = 55/315 (17%), Positives = 119/315 (37%), Gaps = 69/315 (21%)
Query: 829 GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 888
G + ++TLK G + + R+F L E ++G H ++ + G S +
Sbjct: 51 GKREIFVAIKTLKS-GYTEKQRRDF----LSEASIMGQFDHPNVIHLEGVVTKSTPV--- 102
Query: 889 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK 948
I E+++ GS+ +++ + + +V + + + +AA + L
Sbjct: 103 -----------MIITEFMENGSLDSFLRQ----NDGQFTVIQLVGMLRGIAAGMKYLADM 147
Query: 949 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG 1008
+ +HRD+ + NIL++ ++ V K+ DF + L
Sbjct: 148 NYVHRDLAARNILVN-----SNL--VCKVSDFGLSRFLEDDTSDPTYTSAL-----GGKI 195
Query: 1009 TPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR 1067
RW APE ++ + D+WSYG ++ E+++ + PY ++ ++ + I+ R
Sbjct: 196 PIRWTAPEAIQYRK----FTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR 251
Query: 1068 PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY 1127
++ S L + C +++ RP G +
Sbjct: 252 L---------------------------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284
Query: 1128 EMF--VARTSSSISS 1140
+ R +S+ +
Sbjct: 285 NTLDKMIRNPNSLKA 299
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 2e-33
Identities = 60/295 (20%), Positives = 110/295 (37%), Gaps = 73/295 (24%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
V++LK S D E ++ L+H +V +Y
Sbjct: 42 VKSLKQGSMSPDAFLA-------EANLMKQLQHQRLVRLYAVVTQEPIY----------- 83
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
I EY++ GS+ ++++ +++ L +A +A + + ++ +HRD++
Sbjct: 84 ----IITEYMENGSLVDFLKT---PSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLR 136
Query: 957 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1016
+ NIL+ K+ DF A I A + +W APE
Sbjct: 137 AANILV-------SDTLSCKIADFGLA---------RLIEDNEYTAREGAKFPIKWTAPE 180
Query: 1017 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELE 1075
+ + ++ D+WS+G LL E++T ++PY G++ E+ ++ G R D
Sbjct: 181 AINYGT----FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC- 235
Query: 1076 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130
PE L + R C +E P +RPT L +
Sbjct: 236 -------------------PEE-------LYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 6e-33
Identities = 62/294 (21%), Positives = 106/294 (36%), Gaps = 73/294 (24%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
++ +K S DE E +++ L H +V++YG + +
Sbjct: 33 IKMIKEGSMSEDEFIE-------EAKVMMNLSHEKLVQLYGVCTKQRPIF---------- 75
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
I EY+ G + NY+ + + L + +DV A+ L SK +HRD+
Sbjct: 76 ----IITEYMANGCLLNYLRE----MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLA 127
Query: 957 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1016
+ N L+ + + VVK+ DF + + +T + RW PE
Sbjct: 128 ARNCLV-------NDQGVVKVSDFGLSRYVLDDEYTSSVG---------SKFPVRWSPPE 171
Query: 1017 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELE 1075
VL + + DIW++G L+ E+ +L ++PY + E + I G R
Sbjct: 172 VLMYSK----FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL------- 220
Query: 1076 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1129
+P E + + C E ERPT L
Sbjct: 221 -----------------YRPHLASEK---VYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 2e-32
Identities = 58/295 (19%), Positives = 98/295 (33%), Gaps = 37/295 (12%)
Query: 840 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 899
+K+ S + E E+ LRH I+ AD Q
Sbjct: 31 VKIFSSREERSWFRE----AEIYQTVMLRHENILGFIA----------ADNKDNGTWTQL 76
Query: 900 AIFMEYVKGGSVKNYIEK--LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 957
+ +Y + GS+ +Y+ + ++ G +++ A +A + I HRD+KS
Sbjct: 77 WLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKS 136
Query: 958 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 1017
+NIL+ + D AV S T IA VGT R+MAPEV
Sbjct: 137 KNILV-------KKNGTCCIADLGLAVRHDSATDTIDIAPNHR------VGTKRYMAPEV 183
Query: 1018 LR--AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELE 1075
L K DI++ G + E+ + ++ + P + + +
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243
Query: 1076 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130
+ E L + + R C N R TA + +
Sbjct: 244 VVCEQKLRP------NIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 2e-32
Identities = 58/286 (20%), Positives = 97/286 (33%), Gaps = 39/286 (13%)
Query: 844 GSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM 903
G ++ + L E+++L L H I+ + + ++
Sbjct: 34 GHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI--------------SLVF 79
Query: 904 EYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963
++++ + H L LH I+HRD+K N+L+D
Sbjct: 80 DFMETDLEVIIKDNSLVLTPSH-----IKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD 134
Query: 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 1023
V+KL DF A S V T + APE+L
Sbjct: 135 -------ENGVLKLADFGLAKSFGSPNRAYTH----------QVVTRWYRAPELLFGARM 177
Query: 1024 PNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEH 1083
YG+ VD+W+ GC+L ELL G S+L+ I ++ + S ++
Sbjct: 178 ---YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234
Query: 1084 EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1129
+S G L+D+ + NP R TA +M
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 4e-32
Identities = 63/292 (21%), Positives = 109/292 (37%), Gaps = 70/292 (23%)
Query: 840 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 899
+K F L E +++ LRH +V++Y
Sbjct: 46 IKTLKPGTMSPEAF----LQEAQVMKKLRHEKLVQLYAVVSEEPIY-------------- 87
Query: 900 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959
I EY+ GS+ ++++ K++ + + +A +A+ + + + +HRD+++ N
Sbjct: 88 -IVTEYMSKGSLLDFLKG---ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAAN 143
Query: 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1019
IL+ V K+ DF A + +T A +W APE
Sbjct: 144 ILV-------GENLVCKVADFGLARLIEDNEYT---------ARQGAKFPIKWTAPEAAL 187
Query: 1020 AMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALG 1078
+ ++ D+WS+G LL EL T +VPY G+ E+ D ++ G R E
Sbjct: 188 YGR----FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC---- 239
Query: 1079 SCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130
PE+ L D+ +C + P ERPT L
Sbjct: 240 ----------------PES-------LHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 7e-32
Identities = 52/316 (16%), Positives = 105/316 (33%), Gaps = 74/316 (23%)
Query: 816 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 875
G + + + D A ++T++ S ++ E ++ L H +V++
Sbjct: 14 GSGQFGLVHLGYWLNKDKVA-IKTIREGAMSEEDFIE-------EAEVMMKLSHPKLVQL 65
Query: 876 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 935
YG + + + E+++ G + +Y+ + + L +
Sbjct: 66 YGVCLEQAPI--------------CLVFEFMEHGCLSDYLRT----QRGLFAAETLLGMC 107
Query: 936 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 995
DV + L ++HRD+ + N L+ V+K+ DF + +T
Sbjct: 108 LDVCEGMAYLEEACVIHRDLAARNCLVG-------ENQVIKVSDFGMTRFVLDDQYTSST 160
Query: 996 AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLS 1054
+W +PEV Y + D+WS+G L+ E+ + ++PY S
Sbjct: 161 G---------TKFPVKWASPEVFSFSR----YSSKSDVWSFGVLMWEVFSEGKIPYENRS 207
Query: 1055 ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 1114
E+ + I G R + + + C +
Sbjct: 208 NSEVVEDISTGFRLYKPRLAS---------------------------THVYQIMNHCWK 240
Query: 1115 ENPTERPTAGDLYEMF 1130
E P +RP L
Sbjct: 241 ERPEDRPAFSRLLRQL 256
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 7e-32
Identities = 56/316 (17%), Positives = 99/316 (31%), Gaps = 64/316 (20%)
Query: 816 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 875
G + R ++ + +K + EV + +L H ++ +
Sbjct: 17 GDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRL 76
Query: 876 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 935
YG ++ + E GS+ + + K + H + A
Sbjct: 77 YGVVLTPPMK---------------MVTELAPLGSLLDRLRK----HQGHFLLGTLSRYA 117
Query: 936 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 995
VA + L SK +HRD+ + N+L+ +VK+ DF L +
Sbjct: 118 VQVAEGMGYLESKRFIHRDLAARNLLLATRD-------LVKIGDFGLMRALPQNDDHYVM 170
Query: 996 AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLS 1054
W APE L+ + D W +G L E+ T Q P++GL+
Sbjct: 171 QEH-------RKVPFAWCAPESLKTRT----FSHASDTWMFGVTLWEMFTYGQEPWIGLN 219
Query: 1055 ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 1114
+I I +PE + + +V +C
Sbjct: 220 GSQILHKIDKEGER-----------------------LPRPEDCPQD---IYNVMVQCWA 253
Query: 1115 ENPTERPTAGDLYEMF 1130
P +RPT L +
Sbjct: 254 HKPEDRPTFVALRDFL 269
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 124 bits (312), Expect = 7e-32
Identities = 58/306 (18%), Positives = 106/306 (34%), Gaps = 84/306 (27%)
Query: 845 SSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFME 904
+SAD +F E ++ + IV++ G K + + E
Sbjct: 55 ASADMQADF----QREAALMAEFDNPNIVKLLGVCAVGKPM--------------CLLFE 96
Query: 905 YVKGGSVKNYIEKL-------------------SETGEKHVSVKLALFIAQDVAAALVEL 945
Y+ G + ++ + S G +S L IA+ VAA + L
Sbjct: 97 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL 156
Query: 946 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV 1005
+ +HRD+ + N L+ VVK+ DF + + S + +
Sbjct: 157 SERKFVHRDLATRNCLV-------GENMVVKIADFGLSRNIYSADYYKADGN-------- 201
Query: 1006 CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQM 1064
RWM PE + Y E D+W+YG +L E+ + + PY G++ E+ ++
Sbjct: 202 DAIPIRWMPPESIFYNR----YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRD 257
Query: 1065 GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124
G + P L ++ R C + P +RP+
Sbjct: 258 GNILACPENC--------------------PLE-------LYNLMRLCWSKLPADRPSFC 290
Query: 1125 DLYEMF 1130
++ +
Sbjct: 291 SIHRIL 296
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 124 bits (311), Expect = 8e-32
Identities = 59/292 (20%), Positives = 120/292 (41%), Gaps = 69/292 (23%)
Query: 840 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 899
+K E+ F L E ++ ++H +V++ G
Sbjct: 47 VKTLKEDTMEVEEF----LKEAAVMKEIKHPNLVQLLGVCTREPPF-------------- 88
Query: 900 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959
I E++ G++ +Y L E + VS + L++A +++A+ L K+ +HRD+ + N
Sbjct: 89 YIITEFMTYGNLLDY---LRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARN 145
Query: 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1019
L+ + +VK+ DF + + +T +W APE L
Sbjct: 146 CLVG-----ENH--LVKVADFGLSRLMTGDTYTAHAG---------AKFPIKWTAPESLA 189
Query: 1020 AMHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKRPRLTDELEALG 1078
+ ++ D+W++G LL E+ T + PY G+ ++++L++ R
Sbjct: 190 YNK----FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---------- 235
Query: 1079 SCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130
E+PE E + ++ R C + NP++RP+ ++++ F
Sbjct: 236 --------------ERPEGCPEK---VYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 1e-31
Identities = 52/287 (18%), Positives = 95/287 (33%), Gaps = 66/287 (22%)
Query: 840 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 899
+K+ N E ++ L H V++Y + L
Sbjct: 38 IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL-------------- 83
Query: 900 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959
+ Y K G + YI K F ++ +AL LH K I+HRD+K EN
Sbjct: 84 YFGLSYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 138
Query: 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1019
IL+ + +++ DF A + VGT ++++PE+L
Sbjct: 139 ILL-------NEDMHIQITDFGTA--------KVLSPESKQARANSFVGTAQYVSPELLT 183
Query: 1020 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGS 1079
D+W+ GC++ +L+ P+ +E I I + ++
Sbjct: 184 EKS----ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFF---- 234
Query: 1080 CHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1126
P+A D+ + + T+R ++
Sbjct: 235 ---------------PKA--------RDLVEKLLVLDATKRLGCEEM 258
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 9e-31
Identities = 48/270 (17%), Positives = 96/270 (35%), Gaps = 36/270 (13%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
E+++L RH I+ + + P ++ + ++ G + ++
Sbjct: 56 EIKILLRFRHENIIGINDIIRA----------PTIEQMKDVYLVTHLMGADLYKLLKT-- 103
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
+H+S + + L +HS +++HRD+K N+L+ + +K+CD
Sbjct: 104 ----QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL-------NTTCDLKICD 152
Query: 980 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039
F A V T + APE++ Y +DIWS GC+
Sbjct: 153 FGLARVADPDHDHTGFLTE-------YVATRWYRAPEIMLNSKG---YTKSIDIWSVGCI 202
Query: 1040 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 1099
L E+L+ + + G L+ + I ++L + + S K
Sbjct: 203 LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNR 262
Query: 1100 ETLSF---LVDVFRRCTEENPTERPTAGDL 1126
+ +D+ + NP +R
Sbjct: 263 LFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 1e-30
Identities = 56/314 (17%), Positives = 106/314 (33%), Gaps = 71/314 (22%)
Query: 816 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 875
G+ + RC S+ + +KV G+ ++ E+ +L RH I+ +
Sbjct: 14 GRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKK-------EISILNIARHRNILHL 66
Query: 876 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 935
+ S + L + E++ G + I ++ + +
Sbjct: 67 HESFESMEEL--------------VMIFEFISGLDIFERINT----SAFELNEREIVSYV 108
Query: 936 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 995
V AL LHS +I H DI+ ENI+ +K+ +F +A L+ +
Sbjct: 109 HQVCEALQFLHSHNIGHFDIRPENIIYQ-----TRRSSTIKIIEFGQARQLKPGDNF--- 160
Query: 996 AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSE 1055
+ P + APEV + D+WS G L+ LL+ P++ +
Sbjct: 161 --------RLLFTAPEYYAPEVHQHDV----VSTATDMWSLGTLVYVLLSGINPFLAETN 208
Query: 1056 LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF-LVDVFRRCTE 1114
+I + I + + E + +S +D R
Sbjct: 209 QQIIENIMNAE-------------------------YTFDEEAFKEISIEAMDFVDRLLV 243
Query: 1115 ENPTERPTAGDLYE 1128
+ R TA + +
Sbjct: 244 KERKSRMTASEALQ 257
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 2e-30
Identities = 59/265 (22%), Positives = 94/265 (35%), Gaps = 54/265 (20%)
Query: 863 MLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG 922
A + IV + + LL I ME + GG + + I+ G
Sbjct: 58 HWRASQCPHIVRIVDVYENL-------YAGRKCLL---IVMECLDGGELFSRIQD---RG 104
Query: 923 EKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDR 982
++ + + A I + + A+ LHS +I HRD+K EN+L ++KL DF
Sbjct: 105 DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYT----SKRPNAILKLTDFGF 160
Query: 983 AVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042
A S + TP ++APEVL Y D+WS G ++
Sbjct: 161 AKETTSHNSLTTPCY-----------TPYYVAPEVLGPEK----YDKSCDMWSLGVIMYI 205
Query: 1043 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETL 1102
LL P+ L I ++ R +E P E +
Sbjct: 206 LLCGYPPFYSNHGLAISPGMKTRIRM---------------------GQYEFPNPEWSEV 244
Query: 1103 SF-LVDVFRRCTEENPTERPTAGDL 1126
S + + R + PT+R T +
Sbjct: 245 SEEVKMLIRNLLKTEPTQRMTITEF 269
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 2e-30
Identities = 56/299 (18%), Positives = 102/299 (34%), Gaps = 72/299 (24%)
Query: 833 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 892
A ++T K C +S F L E + H IV++ G I+ +
Sbjct: 36 LAVAIKTCKNC-TSDSVREKF----LQEALTMRQFDHPHIVKLIGV-ITENPVW------ 83
Query: 893 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 952
I ME G ++++++ + + + + A ++ AL L SK +H
Sbjct: 84 --------IIMELCTLGELRSFLQV----RKYSLDLASLILYAYQLSTALAYLESKRFVH 131
Query: 953 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 1012
RDI + N+L+ VKL DF + + + +W
Sbjct: 132 RDIAARNVLVS-------SNDCVKLGDFGLSRYMEDSTYYKA---------SKGKLPIKW 175
Query: 1013 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLT 1071
MAPE + + D+W +G + E+L P+ G+ ++ I+ G+R +
Sbjct: 176 MAPESINFRR----FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP 231
Query: 1072 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130
P L + +C +P+ RP +L
Sbjct: 232 PNC--------------------PPT-------LYSLMTKCWAYDPSRRPRFTELKAQL 263
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 120 bits (301), Expect = 3e-30
Identities = 58/280 (20%), Positives = 96/280 (34%), Gaps = 64/280 (22%)
Query: 848 DEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVK 907
+ E S E+ +L ++H IV + S L + M+ V
Sbjct: 45 KALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHL--------------YLIMQLVS 90
Query: 908 GGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 967
GG + + I + + + + A + V A+ LH I+HRD+K EN+L
Sbjct: 91 GGELFDRIVE-----KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSL-- 143
Query: 968 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 1027
D + + DF + G C GTP ++APEVL Y
Sbjct: 144 --DEDSKIMISDF----------GLSKMEDPGSVLSTAC-GTPGYVAPEVLAQKP----Y 186
Query: 1028 GLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ 1087
VD WS G + LL P+ ++ ++ + I +
Sbjct: 187 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAE--------------------- 225
Query: 1088 SGSGFEKPEAELETLSF-LVDVFRRCTEENPTERPTAGDL 1126
+E + +S D R E++P +R T
Sbjct: 226 ----YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 3e-30
Identities = 71/348 (20%), Positives = 124/348 (35%), Gaps = 88/348 (25%)
Query: 803 PGSFPSLSSCD-----EAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEY 855
P +P L D G+ + + + A ++ +K +S D+ R+F
Sbjct: 1 PTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDF-- 57
Query: 856 SCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY 914
GE+ +L L H I+ + G +L + +EY G++ ++
Sbjct: 58 --AGELEVLCKLGHHPNIINLLGACEHRGYL--------------YLAIEYAPHGNLLDF 101
Query: 915 IEK-----------LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963
+ K ++ + +S + L A DVA + L K +HRD+ + NIL+
Sbjct: 102 LRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 161
Query: 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 1023
V K+ DF + ++ RWMA E L
Sbjct: 162 -------ENYVAKIADFGLSRGQEVYVKKTM-----------GRLPVRWMAIESLNYSV- 202
Query: 1024 PNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE 1082
Y D+WSYG LL E+++L PY G++ E+++ + G R +
Sbjct: 203 ---YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCD------- 252
Query: 1083 HEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130
+ D+ R+C E P ERP+ +
Sbjct: 253 --------------------DEVYDLMRQCWREKPYERPSFAQILVSL 280
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 6e-30
Identities = 51/286 (17%), Positives = 101/286 (35%), Gaps = 31/286 (10%)
Query: 845 SSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFME 904
+E F + L E+++L L+H +V + + + + + +
Sbjct: 44 LMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIY------LVFD 97
Query: 905 YVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964
+ + L ++ + Q + L +H I+HRD+K+ N+LI
Sbjct: 98 FCEHDLAGLLSNVL-----VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT- 151
Query: 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 1024
DG V+KL DF A ++ + V T + PE+L
Sbjct: 152 ----RDG--VLKLADFGLARAFSLAKNSQPNRYTNR------VVTLWYRPPELLLGERD- 198
Query: 1025 NLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHE 1084
YG +D+W GC++ E+ T G +E LI + + + +E
Sbjct: 199 --YGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYE 256
Query: 1085 VAQSGSGFEKPEAELETLSFL----VDVFRRCTEENPTERPTAGDL 1126
+ G ++ + +D+ + +P +R + D
Sbjct: 257 KLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 117 bits (294), Expect = 1e-29
Identities = 65/294 (22%), Positives = 104/294 (35%), Gaps = 60/294 (20%)
Query: 840 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 899
+KV + +F E + AL H IV +Y +
Sbjct: 37 VKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA----------ETPAGPLP 86
Query: 900 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959
I MEYV G ++++ + E ++ K A+ + D AL H I+HRD+K N
Sbjct: 87 YIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPAN 141
Query: 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1019
I+I VK+ DF A + ++ +GT ++++PE R
Sbjct: 142 IMIS-------ATNAVKVMDFGIARAIADSGNSVTQTAA-------VIGTAQYLSPEQAR 187
Query: 1020 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGS 1079
D++S GC+L E+LT + P+ G S + +
Sbjct: 188 GDS----VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP---------- 233
Query: 1080 CHEHEVAQSGSGFEKPEAELETLS-FLVDVFRRCTEENPTERP-TAGDLYEMFV 1131
P A E LS L V + +NP R TA ++ V
Sbjct: 234 ---------------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 2e-29
Identities = 66/292 (22%), Positives = 105/292 (35%), Gaps = 76/292 (26%)
Query: 860 EVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE-- 916
E+ M+ + +H I+ + G L + +EY G+++ Y++
Sbjct: 68 EMEMMKMIGKHKNIINLLGACTQDGPL--------------YVIVEYASKGNLREYLQAR 113
Query: 917 ---------KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 967
S E+ +S K + A VA + L SK +HRD+ + N+L+
Sbjct: 114 RPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---- 169
Query: 968 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 1027
V+K+ DF A + + + +WMAPE L Y
Sbjct: 170 ---EDNVMKIADFGLARDIHHIDYYKKTTN--------GRLPVKWMAPEALFDRI----Y 214
Query: 1028 GLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVA 1086
+ D+WS+G LL E+ TL PY G+ E+ L++ G R
Sbjct: 215 THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNC------------ 262
Query: 1087 QSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF---VARTS 1135
L + R C P++RPT L E VA TS
Sbjct: 263 --------TNE-------LYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 299
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 3e-29
Identities = 54/295 (18%), Positives = 103/295 (34%), Gaps = 69/295 (23%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
++TLK + + LGE ++G H I+ + G K +
Sbjct: 41 IKTLKAGYTEKQRVD-----FLGEAGIMGQFSHHNIIRLEGVISKYKPMM---------- 85
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 956
I EY++ G++ ++ + + SV + + + +AA + L + + +HRD+
Sbjct: 86 ----IITEYMENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLA 137
Query: 957 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1016
+ NIL+ + V K+ DF + L G RW APE
Sbjct: 138 ARNILV-------NSNLVCKVSDFGLSRVLEDDPEATYTTSGG-------KIPIRWTAPE 183
Query: 1017 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM-GLSELEIHDLIQMGKRPRLTDELE 1075
+ + D+WS+G ++ E++T LS E+ I G R
Sbjct: 184 AISYRKFTS----ASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR-------- 231
Query: 1076 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130
++ S + + +C ++ RP D+ +
Sbjct: 232 -------------------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 3e-29
Identities = 61/298 (20%), Positives = 105/298 (35%), Gaps = 66/298 (22%)
Query: 845 SSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFME 904
+ E+ F L E ++ H ++ + G + E L + +
Sbjct: 67 TDIGEVSQF----LTEGIIMKDFSHPNVLSLLGICL----------RSEGSPL---VVLP 109
Query: 905 YVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964
Y+K G ++N+I + +VK + VA + L SK +HRD+ + N ++
Sbjct: 110 YMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML-- 163
Query: 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 1024
D K VK+ DF A + G +WMA E L+
Sbjct: 164 -----DEKFTVKVADFGLARDMYDKEFDSVHNKTG------AKLPVKWMALESLQTQK-- 210
Query: 1025 NLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEH 1083
+ + D+WS+G LL EL+T PY ++ +I + G+R +
Sbjct: 211 --FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC--------- 259
Query: 1084 EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSSISSR 1141
P+ L +V +C RP+ +L A S+ I
Sbjct: 260 -----------PDP-------LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 299
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 115 bits (289), Expect = 9e-29
Identities = 40/271 (14%), Positives = 86/271 (31%), Gaps = 49/271 (18%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
E ++ ++ + + ++++ + ME + +
Sbjct: 52 ESKIYKMMQGGVGIPTIRWCGA---------EGDYNV----MVMELLGPSLEDLFNFC-- 96
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
+ S+K L +A + + + +HSK+ +HRD+K +N L+ L +V + D
Sbjct: 97 ---SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLG----KKGNLVYIID 149
Query: 980 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039
F A R I + GT R+ + + D+ S G +
Sbjct: 150 FGLAKKYRDARTHQHIPY---RENKNLTGTARYASINTHLGIE----QSRRDDLESLGYV 202
Query: 1040 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 1099
L+ +P+ GL + +++ +E L + E
Sbjct: 203 LMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSE--------------- 247
Query: 1100 ETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130
C ++P L ++F
Sbjct: 248 -----FATYLNFCRSLRFDDKPDYSYLRQLF 273
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 1e-28
Identities = 56/296 (18%), Positives = 108/296 (36%), Gaps = 65/296 (21%)
Query: 834 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 893
AAK +K + + EV +L ++H ++ ++ + +
Sbjct: 39 AAKF--IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV-------- 88
Query: 894 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 953
+ +E V GG + +++ + ++ ++ + A + + + LHS I H
Sbjct: 89 ------ILILELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLHSLQIAHF 137
Query: 954 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 1013
D+K ENI++ + KP +K+ DF A + GTP ++
Sbjct: 138 DLKPENIMLL---DRNVPKPRIKIIDFGLAHKIDFGNEFKN-----------IFGTPEFV 183
Query: 1014 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDE 1073
APE++ GLE D+WS G + LL+ P++G ++ E +
Sbjct: 184 APEIVNYEP----LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN------- 232
Query: 1074 LEALGSCHEHEVAQSGSGFEKPEAELETLS-FLVDVFRRCTEENPTERPTAGDLYE 1128
+E + S D RR ++P +R T D +
Sbjct: 233 ------------------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 3e-28
Identities = 47/288 (16%), Positives = 98/288 (34%), Gaps = 70/288 (24%)
Query: 844 GSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM 903
+S + L E ++ ++ + + + G ++S +
Sbjct: 49 ATSPKANKEI----LDEAYVMASVDNPHVCRLLGICLTSTVQ---------------LIT 89
Query: 904 EYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963
+ + G + +Y+ + + ++ + L +A + L + ++HRD+ + N+L+
Sbjct: 90 QLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK 145
Query: 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 1023
VK+ DF A L + + +WMA E +
Sbjct: 146 -------TPQHVKITDFGLAKLLGAEEKEYHA--------EGGKVPIKWMALESILHRI- 189
Query: 1024 PNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE 1082
Y + D+WSYG + EL+T PY G+ EI +++ G+R
Sbjct: 190 ---YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-------------- 232
Query: 1083 HEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130
+P + + +C + RP +L F
Sbjct: 233 ----------PQPPICTIDV---YMIMVKCWMIDADSRPKFRELIIEF 267
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 4e-28
Identities = 61/291 (20%), Positives = 98/291 (33%), Gaps = 81/291 (27%)
Query: 860 EVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK- 917
E++M+ L H IV + G S + + EY G + NY+
Sbjct: 90 ELKMMTQLGSHENIVNLLGACTLSGPI--------------YLIFEYCCYGDLLNYLRSK 135
Query: 918 -----------------LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960
E ++ + L A VA + L K +HRD+ + N+
Sbjct: 136 REKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV 195
Query: 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1020
L+ VVK+CDF A + S + + +WMAPE L
Sbjct: 196 LV-------THGKVVKICDFGLARDIMSDSNYVVRGN--------ARLPVKWMAPESLFE 240
Query: 1021 MHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELE-IHDLIQMGKRPRLTDELEALG 1078
Y ++ D+WSYG LL E+ +L PY G+ + LIQ G +
Sbjct: 241 GI----YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYA---- 292
Query: 1079 SCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1129
E + + + C + +RP+ +L
Sbjct: 293 ----------------TEE-------IYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 4e-28
Identities = 61/264 (23%), Positives = 92/264 (34%), Gaps = 68/264 (25%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
+ + A H + M+ + + L MEY+ GG + +I+
Sbjct: 53 KRVLSLAWEHPFLTHMFCTFQTKENL--------------FFVMEYLNGGDLMYHIQS-- 96
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
+ A F A ++ L LHSK I++RD+K +NIL+D +K+ D
Sbjct: 97 ---CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD-------KDGHIKIAD 146
Query: 980 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039
F GTP ++APE+L Y VD WS+G L
Sbjct: 147 FGMCKENMLGDAKTN----------TFCGTPDYIAPEILLGQK----YNHSVDWWSFGVL 192
Query: 1040 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 1099
L E+L Q P+ G E E+ I+M P LE EA
Sbjct: 193 LYEMLIGQSPFHGQDEEELFHSIRMD-NPFYPRWLE-------------------KEA-- 230
Query: 1100 ETLSFLVDVFRRCTEENPTERPTA 1123
D+ + P +R
Sbjct: 231 ------KDLLVKLFVREPEKRLGV 248
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 6e-28
Identities = 53/268 (19%), Positives = 96/268 (35%), Gaps = 38/268 (14%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
+R L H +V ++ S+ + + E+V L
Sbjct: 60 VLRHLETFEHPNVVRLFDVCTVSR---------TDRETKLTLVFEHVDQD----LTTYLD 106
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
+ E V + + + L LHS ++HRD+K +NIL+ + G+ +
Sbjct: 107 KVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT-----SSGQIKLADFG 161
Query: 980 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039
R + L + T + APEVL Y VD+WS GC+
Sbjct: 162 LARIYSFQMALTSVV-------------VTLWYRAPEVLLQSS----YATPVDLWSVGCI 204
Query: 1040 LLELLTLQVPYMGLSELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 1098
E+ + + G S+++ I + P D + + ++S EK +
Sbjct: 205 FAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTD 264
Query: 1099 LETLSFLVDVFRRCTEENPTERPTAGDL 1126
++ L D+ +C NP +R +A
Sbjct: 265 IDEL--GKDLLLKCLTFNPAKRISAYSA 290
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 112 bits (280), Expect = 1e-27
Identities = 38/230 (16%), Positives = 72/230 (31%), Gaps = 33/230 (14%)
Query: 901 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960
+ + + G S+++ ++ + SVK A+ + A + +H K +++RDIK +N
Sbjct: 77 VLVIDLLGPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNF 132
Query: 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1020
LI K + + DF R + I + GT R+M+
Sbjct: 133 LIGRPNSKNANM--IYVVDFGMVKFYRDPVTKQHIPY---REKKNLSGTARYMSINT--- 184
Query: 1021 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC 1080
H D+ + G + + L +P+ GL + + + L L +
Sbjct: 185 -HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAG 243
Query: 1081 HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130
E P L +F
Sbjct: 244 FPEE--------------------FYKYMHYARNLAFDATPDYDYLQGLF 273
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 1e-27
Identities = 53/300 (17%), Positives = 103/300 (34%), Gaps = 71/300 (23%)
Query: 837 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 896
++T+ S + I L E ++ +V + G +
Sbjct: 55 IKTVNEAASMRERIE-----FLNEASVMKEFNCHHVVRLLGVVSQGQPTL---------- 99
Query: 897 LQSAIFMEYVKGGSVKNYIEKLSETGEKHV-----SVKLALFIAQDVAAALVELHSKHIM 951
+ ME + G +K+Y+ L + S+ + +A ++A + L++ +
Sbjct: 100 ----VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFV 155
Query: 952 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR 1011
HRD+ + N ++ VK+ DF + + R
Sbjct: 156 HRDLAARNCMVA-------EDFTVKIGDFG--------MTRDIYETDYYRKGGKGLLPVR 200
Query: 1012 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRL 1070
WM+PE L+ ++ D+WS+G +L E+ TL + PY GLS ++ + G
Sbjct: 201 WMSPESLK----DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK 256
Query: 1071 TDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130
D + L ++ R C + NP RP+ ++
Sbjct: 257 PDNCPDM---------------------------LFELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 109 bits (274), Expect = 6e-27
Identities = 52/277 (18%), Positives = 101/277 (36%), Gaps = 40/277 (14%)
Query: 851 RNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGS 910
+ + E+ +L L+HS IV++Y + K L + E++
Sbjct: 41 EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLV--------------LVFEHLDQDL 86
Query: 911 VKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 970
K E + A + + H + ++HRD+K +N+LI+
Sbjct: 87 KKLLDVC-----EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN------- 134
Query: 971 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLE 1030
+ +K+ DF A + + T + AP+VL K Y
Sbjct: 135 REGELKIADFGLARAFGIPVRKYT----------HEIVTLWYRAPDVLMGSKK---YSTT 181
Query: 1031 VDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS 1090
+DIWS GC+ E++ + G+SE + I + + +++ +
Sbjct: 182 IDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY 241
Query: 1091 GFEKPEAELETLS-FLVDVFRRCTEENPTERPTAGDL 1126
E+ L+ L +D+ + + +P +R TA
Sbjct: 242 EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 3e-26
Identities = 60/268 (22%), Positives = 97/268 (36%), Gaps = 31/268 (11%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
E++++ L H IV + + S + E +L + ++YV +
Sbjct: 63 ELQIMRKLDHCNIVRLRYF-----FYSSGEKKDEVYL---NLVLDYVPETVYRVARHYSR 114
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
++ + V + +L +HS I HRDIK +N+L+D V+KLCD
Sbjct: 115 A--KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD------PDTAVLKLCD 166
Query: 980 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039
F A L RG P + A Y +D+WS GC+
Sbjct: 167 FGSAKQLV----------RGEPNVSYICSRYYRAPELIFGATD----YTSSIDVWSAGCV 212
Query: 1040 LLELLTLQVPYMGLSELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 1098
L ELL Q + G S ++ I ++ P E + E + Q +
Sbjct: 213 LAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFR 272
Query: 1099 LETLSFLVDVFRRCTEENPTERPTAGDL 1126
T + + R E PT R T +
Sbjct: 273 PRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (269), Expect = 4e-26
Identities = 57/287 (19%), Positives = 102/287 (35%), Gaps = 76/287 (26%)
Query: 860 EVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK- 917
E+++L L H IV + G + EY G + N++ +
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACTIGGPT--------------LVITEYCCYGDLLNFLRRK 121
Query: 918 ------------LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965
+ E E + ++ L + VA + L SK+ +HRD+ + NIL+
Sbjct: 122 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT-- 179
Query: 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 1025
+ K+CDF A +++ + + +WMAPE +
Sbjct: 180 -----HGRITKICDFGLARDIKNDSNYVVKGN--------ARLPVKWMAPESIFNCV--- 223
Query: 1026 LYGLEVDIWSYGCLLLELLTLQVPYMGLSELE--IHDLIQMGKRPRLTDELEALGSCHEH 1083
Y E D+WSYG L EL +L ++ + +I+ G R
Sbjct: 224 -YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRM--------------- 267
Query: 1084 EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1130
PE + D+ + C + +P +RPT + ++
Sbjct: 268 ---------LSPEHAPAEM---YDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 106 bits (266), Expect = 1e-25
Identities = 59/241 (24%), Positives = 101/241 (41%), Gaps = 46/241 (19%)
Query: 840 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 899
+KV E ML + H I+ M+G ++ +
Sbjct: 34 MKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI-------------- 79
Query: 900 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959
+ M+Y++GG + + + K A F A +V AL LHSK I++RD+K EN
Sbjct: 80 FMIMDYIEGGELFSLLRKSQRFPNPV-----AKFYAAEVCLALEYLHSKDIIYRDLKPEN 134
Query: 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1019
IL+D +G +K+ DF A + +T C GTP ++APEV+
Sbjct: 135 ILLD-----KNGH--IKITDFGFAKYVPDVTYTLC-------------GTPDYIAPEVVS 174
Query: 1020 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKR---PRLTDELEA 1076
Y +D WS+G L+ E+L P+ + ++ ++ I + P ++++
Sbjct: 175 TKP----YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKD 230
Query: 1077 L 1077
L
Sbjct: 231 L 231
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 2e-25
Identities = 51/279 (18%), Positives = 99/279 (35%), Gaps = 39/279 (13%)
Query: 849 EIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKG 908
E + + E+ +L L H IV++ + L + E++
Sbjct: 40 ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY--------------LVFEFLH- 84
Query: 909 GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 968
++ + + + + + L + L HS ++HRD+K +N+LI
Sbjct: 85 ---QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI------ 135
Query: 969 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 1028
+ + +KL DF A + T V T + APE+L Y
Sbjct: 136 -NTEGAIKLADFGLARAFGVPVRTYT----------HEVVTLWYRAPEILLGCKY---YS 181
Query: 1029 LEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS 1088
VDIWS GC+ E++T + + G SE++ I + S +++ +
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 1089 GSGFEKPEAELETLS-FLVDVFRRCTEENPTERPTAGDL 1126
+ + L + + +P +R +A
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 5e-25
Identities = 50/270 (18%), Positives = 97/270 (35%), Gaps = 41/270 (15%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
E+R+L +RH ++ + + M ++ G + ++
Sbjct: 67 ELRLLKHMRHENVIGLLDVFT--------PDETLDDFTDFYLVMPFM-GTDLGKLMKH-- 115
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
+ + F+ + L +H+ I+HRD+K N+ + + +K+ D
Sbjct: 116 ----EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV-------NEDCELKILD 164
Query: 980 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039
F A S + T + APEV+ + Y VDIWS GC+
Sbjct: 165 FGLARQADSEMTGYV-------------VTRWYRAPEVILNWMR---YTQTVDIWSVGCI 208
Query: 1040 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE- 1098
+ E++T + + G L+ I + ++ L S + EK +
Sbjct: 209 MAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFAS 268
Query: 1099 -LETLS-FLVDVFRRCTEENPTERPTAGDL 1126
L S V++ + + +R TAG+
Sbjct: 269 ILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 105 bits (264), Expect = 6e-25
Identities = 46/265 (17%), Positives = 86/265 (32%), Gaps = 66/265 (24%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
+ ++ IV M + L + ++ + GG + ++ +
Sbjct: 57 MLSLVSTGDCPFIVCMSYAFHTPDKL--------------SFILDLMNGGDLHYHLSQHG 102
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
E F A ++ L +H++ +++RD+K NIL+ D V++ D
Sbjct: 103 VFSEAD-----MRFYAAEIILGLEHMHNRFVVYRDLKPANILL-------DEHGHVRISD 150
Query: 980 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039
A + GT +MAPEVL+ Y D +S GC+
Sbjct: 151 LGLACDFSKKKPHASV------------GTHGYMAPEVLQKGVA---YDSSADWFSLGCM 195
Query: 1040 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 1099
L +LL P+ + H++ +M + E+ S S PE
Sbjct: 196 LFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-------------ELPDSFS----PELR- 237
Query: 1100 ETLSFLVDVFRRCTEENPTERPTAG 1124
+ + + R
Sbjct: 238 -------SLLEGLLQRDVNRRLGCL 255
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 7e-25
Identities = 59/285 (20%), Positives = 104/285 (36%), Gaps = 68/285 (23%)
Query: 840 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 899
+K+ ++ + E R+L RH + + + L
Sbjct: 35 MKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC------------- 81
Query: 900 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959
MEY GG + ++ + E+ + + A F ++ +AL LHS+ +++RDIK EN
Sbjct: 82 -FVMEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLEN 135
Query: 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1019
+++ D +K+ DF S T GTP ++APEVL
Sbjct: 136 LML-------DKDGHIKITDFGLCKEGISDGATMKT----------FCGTPEYLAPEVLE 178
Query: 1020 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGS 1079
YG VD W G ++ E++ ++P+ + +LI M + R L
Sbjct: 179 DND----YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFPRTLS---- 229
Query: 1080 CHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124
PEA + +++P +R G
Sbjct: 230 ---------------PEA--------KSLLAGLLKKDPKQRLGGG 251
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 1e-24
Identities = 52/272 (19%), Positives = 94/272 (34%), Gaps = 77/272 (28%)
Query: 860 EVRMLGALR--HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGS-VKNYIE 916
EV +L + S ++ + + +E + + ++I
Sbjct: 57 EVVLLKKVSSGFSGVIRLLDWFERPDSF--------------VLILERPEPVQDLFDFIT 102
Query: 917 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 976
+ + +LA V A+ H+ ++HRDIK ENILIDL R + +K
Sbjct: 103 E-----RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE------LK 151
Query: 977 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1036
L DF L+ ++T GT + PE +R +G +WS
Sbjct: 152 LIDFGSGALLKDTVYTD------------FDGTRVYSPPEWIRYHRY---HGRSAAVWSL 196
Query: 1037 GCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE 1096
G LL +++ +P+ E+ + R R++ E +
Sbjct: 197 GILLYDMVCGDIPFEHDEEIIRGQVFF---RQRVSSECQ--------------------- 232
Query: 1097 AELETLSFLVDVFRRCTEENPTERPTAGDLYE 1128
+ R C P++RPT ++
Sbjct: 233 ----------HLIRWCLALRPSDRPTFEEIQN 254
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 2e-24
Identities = 50/270 (18%), Positives = 97/270 (35%), Gaps = 41/270 (15%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
E+R+L ++H ++ + ++ L + ++ G + N ++
Sbjct: 67 ELRLLKHMKHENVIGLLDVFTPARSL---------EEFNDVYLVTHLMGADLNNIVKC-- 115
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
+ ++ F+ + L +HS I+HRD+K N+ ++ +K+ D
Sbjct: 116 ----QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-------EDCELKILD 164
Query: 980 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039
F A + T + APE++ Y VDIWS GC+
Sbjct: 165 FGLARHTDDEMTGYVA-------------TRWYRAPEIMLNWMH---YNQTVDIWSVGCI 208
Query: 1040 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 1099
+ ELLT + + G ++ LI + L+ + S QS + K
Sbjct: 209 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFAN 268
Query: 1100 ETLSF---LVDVFRRCTEENPTERPTAGDL 1126
+ VD+ + + +R TA
Sbjct: 269 VFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 3e-24
Identities = 50/313 (15%), Positives = 108/313 (34%), Gaps = 45/313 (14%)
Query: 816 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 875
G+ ++F+ K ++ +++ + L E+ +L L+H IV +
Sbjct: 11 GEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA----LREICLLKELKHKNIVRL 66
Query: 876 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 935
+ S K L + E+ ++K ++ + ++
Sbjct: 67 HDVLHSDKKLT--------------LVFEFCD-----QDLKKYFDSCNGDLDPEIVKSFL 107
Query: 936 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 995
+ L HS++++HRD+K +N+LI + +KL +F
Sbjct: 108 FQLLKGLGFCHSRNVLHRDLKPQNLLI-------NRNGELKLANFG----------LARA 150
Query: 996 AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP-YMGLS 1054
+ V T + P+VL Y +D+WS GC+ EL P + G
Sbjct: 151 FGIPVRCYSAEVVTLWYRPPDVLFGAKL---YSTSIDMWSAGCIFAELANAGRPLFPGND 207
Query: 1055 ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF-LVDVFRRCT 1113
+ I ++ ++ +++ + L+ D+ +
Sbjct: 208 VDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLL 267
Query: 1114 EENPTERPTAGDL 1126
+ NP +R +A +
Sbjct: 268 KCNPVQRISAEEA 280
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 101 bits (251), Expect = 1e-23
Identities = 51/278 (18%), Positives = 94/278 (33%), Gaps = 51/278 (18%)
Query: 860 EVRMLGALR-HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKL 918
E+++L LR I+ + +P A+ E+V K + L
Sbjct: 79 EIKILENLRGGPNIITLADIVK----------DPVSRTP--ALVFEHVNNTDFKQLYQTL 126
Query: 919 SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 978
++ F ++ AL HS IMHRD+K N++ID E +K ++L
Sbjct: 127 TD--------YDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK------LRLI 172
Query: 979 DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1038
D+ A V + + PE+ + +Y +D+WS GC
Sbjct: 173 DWGLAEFYHPGQEYNV-----------RVASRYFKGPEL---LVDYQMYDYSLDMWSLGC 218
Query: 1039 LLLELLTLQVPYM-GLSELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE 1096
+L ++ + P+ G + I ++ L D ++ + +
Sbjct: 219 MLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKR 278
Query: 1097 AELETLSF--------LVDVFRRCTEENPTERPTAGDL 1126
E S +D + + R TA +
Sbjct: 279 WERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.8 bits (245), Expect = 7e-23
Identities = 58/292 (19%), Positives = 97/292 (33%), Gaps = 66/292 (22%)
Query: 834 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS-CIVEMYGHKISSKWLPSADGNP 892
A KV A + E ++L +R S +V ++ + L
Sbjct: 56 AMKVLKKATIVQKAKTTEHT----RTERQVLEHIRQSPFLVTLHYAFQTETKLH------ 105
Query: 893 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 952
+ ++Y+ GG + ++ + E V + + ++ AL LH I++
Sbjct: 106 --------LILDYINGGELFTHLSQRERFTEHEVQIYVG-----EIVLALEHLHKLGIIY 152
Query: 953 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 1012
RDIK ENIL+D V L DF + + G +
Sbjct: 153 RDIKLENILLD-------SNGHVVLTDFGLSKEFVADETERAYDFCGTI---------EY 196
Query: 1013 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTD 1072
MAP+++R + VD WS G L+ ELLT P+ E I
Sbjct: 197 MAPDIVRGGDSG--HDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK---- 250
Query: 1073 ELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124
+P E + D+ +R ++P +R G
Sbjct: 251 --------------------SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCG 282
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.6 bits (242), Expect = 1e-22
Identities = 61/283 (21%), Positives = 103/283 (36%), Gaps = 71/283 (25%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK-- 917
E+++L + H V L A P L+ + +E+ K G++ Y+
Sbjct: 66 ELKILIHIGHHLNV---------VNLLGACTKPGGPLM---VIVEFCKFGNLSTYLRSKR 113
Query: 918 ---------LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 968
+ + ++++ + + VA + L S+ +HRD+ + NIL+
Sbjct: 114 NEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS----- 168
Query: 969 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 1028
K VVK+CDF A + +WMAPE + Y
Sbjct: 169 --EKNVVKICDFGLARDIYKDPDYVRKGD--------ARLPLKWMAPETIFDRV----YT 214
Query: 1029 LEVDIWSYGCLLLELLTLQV-PYMGLSELE-IHDLIQMGKRPRLTDELEALGSCHEHEVA 1086
++ D+WS+G LL E+ +L PY G+ E ++ G R R D
Sbjct: 215 IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTT----------- 263
Query: 1087 QSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1129
PE + C P++RPT +L E
Sbjct: 264 --------PE--------MYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.8 bits (237), Expect = 1e-21
Identities = 47/281 (16%), Positives = 92/281 (32%), Gaps = 52/281 (18%)
Query: 860 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 919
E+ ++ + H I+ + K L + ME + + +L
Sbjct: 66 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQ--------DVYLVMELMDANLCQVIQMELD 117
Query: 920 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 979
+ ++ + + LHS I+HRD+K NI++ +K+ D
Sbjct: 118 H--------ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV-------KSDCTLKILD 162
Query: 980 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039
F A + V T + APEV+ M Y VDIWS GC+
Sbjct: 163 FGLARTAGTSFMMTPY-----------VVTRYYRAPEVILGMG----YKENVDIWSVGCI 207
Query: 1040 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 1099
+ E++ ++ + G ++ + + + ++ L + V +L
Sbjct: 208 MGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 267
Query: 1100 ETLSF--------------LVDVFRRCTEENPTERPTAGDL 1126
S D+ + +P +R + D
Sbjct: 268 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 94.1 bits (233), Expect = 4e-21
Identities = 47/229 (20%), Positives = 81/229 (35%), Gaps = 43/229 (18%)
Query: 840 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 899
+K+ L E R+L A+ +V++ + L + S
Sbjct: 71 MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS 130
Query: 900 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959
+ S A F A + LHS +++RD+K EN
Sbjct: 131 HLRRI-------------------GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1019
+LI D + +++ DF A ++ T C GTP +APE++
Sbjct: 172 LLI-------DQQGYIQVTDFGFAKRVKGRTWTLC-------------GTPEALAPEIIL 211
Query: 1020 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRP 1068
+ Y VD W+ G L+ E+ P+ ++I++ I GK
Sbjct: 212 SKG----YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 82.0 bits (201), Expect = 4e-17
Identities = 48/290 (16%), Positives = 96/290 (33%), Gaps = 46/290 (15%)
Query: 860 EVRMLGALRHSCIVEMY--GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 917
E+++L + + + G K L +H + + + V +N +
Sbjct: 59 EIKLLQRVNDADNTKEDSMGANHILKLLDH-----FNHKGPNGVHVVMVFEVLGENLLAL 113
Query: 918 LSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSENILIDLERKKADGKPVVK 976
+ + + + + I++ + L +H + I+H DIK EN+L+++ + +K
Sbjct: 114 IKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV-DSPENLIQIK 172
Query: 977 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1036
+ D A T + +PEVL +G DIWS
Sbjct: 173 IADLGNACWYDEHYTNSI-------------QTREYRSPEVLLGAP----WGCGADIWST 215
Query: 1037 GCLLLELLTLQVPYMG-------------------LSELEIHDLIQMGKRPRLTDELEAL 1077
CL+ EL+T + L EL + L + L
Sbjct: 216 ACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLL 275
Query: 1078 GSCHEHEVAQSGSGFEKPEAELETLSF-LVDVFRRCTEENPTERPTAGDL 1126
+ + + + + + + D + +P +R AG L
Sbjct: 276 RNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 72.7 bits (177), Expect = 6e-14
Identities = 47/197 (23%), Positives = 78/197 (39%), Gaps = 17/197 (8%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPS--EVGNLLGLECLQIKISSPGVNG 130
L N ++ I +G L L GN++ + + NL L+ +IS+
Sbjct: 202 LIATNNQISDIT-PLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLA--- 257
Query: 131 FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLE 190
L+ L L EL+L ++ +S +AGL + + I L NL
Sbjct: 258 -PLSGLTKLTELKLGANQ-----ISNISPLAGLTA-LTNLELNENQLEDISPISNLKNLT 310
Query: 191 QLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGS 250
L L FN + + + L L L ANNK+ ++ S L L + L +N+++ L
Sbjct: 311 YLTLYFNNISDIS-PVSSLTKLQRLFFANNKVSDVSS-LANLTNINWLSAGHNQISDL-- 366
Query: 251 LDLCLMHNLQNLNLQYN 267
L + + L L
Sbjct: 367 TPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 64.3 bits (155), Expect = 3e-11
Identities = 37/176 (21%), Positives = 73/176 (41%), Gaps = 16/176 (9%)
Query: 96 LKFFGNEINLFPSEVG--NLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSV 153
L N+I+ NL L ++ G L L L +L+L+ +
Sbjct: 202 LIATNNQISDITPLGILTNLDELSLNGNQLKDIG----TLASLTNLTDLDLAN-----NQ 252
Query: 154 LTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALI 213
++ L+ ++GL LT+L + I + P G + + I LK L
Sbjct: 253 ISNLAPLSGLTKLTELKLGANQISNISPLAGLTAL--TNLELNENQLEDISPISNLKNLT 310
Query: 214 SLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L + N + ++ + L +L+ L +NN+++ + SL + N+ L+ +N++
Sbjct: 311 YLTLYFNNISDISP-VSSLTKLQRLFFANNKVSDVSSL--ANLTNINWLSAGHNQI 363
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 53.1 bits (126), Expect = 1e-07
Identities = 28/163 (17%), Positives = 60/163 (36%), Gaps = 10/163 (6%)
Query: 58 IESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLE 117
++ G ++ L L N ++ + + KL LK N+I+ G L
Sbjct: 231 LKDIGTLASLTNLTDLDLANNQISNLA-PLSGLTKLTELKLGANQISNISPLAG--LTAL 287
Query: 118 CLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIR 177
+ + ++ LK L L L + ++ +S ++ L L +L + +
Sbjct: 288 TNLELNENQLEDISPISNLKNLTYLTLYF-----NNISDISPVSSLTKLQRLFFANNKVS 342
Query: 178 YLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANN 220
+ L+N+ L N++ L + L + L + +
Sbjct: 343 D-VSSLANLTNINWLSAGHNQISDLT-PLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 41.5 bits (96), Expect = 4e-04
Identities = 25/112 (22%), Positives = 49/112 (43%), Gaps = 4/112 (3%)
Query: 172 CHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYL 231
+ + L+NLE L + N++ + + L L L + N+L ++ + L
Sbjct: 182 ISSNKVSDISVLAKLTNLESLIATNNQISDIT-PLGILTNLDELSLNGNQLKDIGT-LAS 239
Query: 232 LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNL 283
L L +LDL+NN++++L L + L L L N++ + +
Sbjct: 240 LTNLTDLDLANNQISNLAPL--SGLTKLTELKLGANQISNISPLAGLTALTN 289
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 41.5 bits (96), Expect = 4e-04
Identities = 15/98 (15%), Positives = 38/98 (38%), Gaps = 4/98 (4%)
Query: 186 LSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRL 245
L+ + L + ++ L + +L+ + + G+ L L ++ SNN+L
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQ-TDLDQVTTLQADRLGIKSI-DGVEYLNNLTQINFSNNQL 78
Query: 246 TSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNL 283
T + L + L ++ + N++ + +
Sbjct: 79 TDI--TPLKNLTKLVDILMNNNQIADITPLANLTNLTG 114
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 65.6 bits (158), Expect = 1e-11
Identities = 22/93 (23%), Positives = 40/93 (43%), Gaps = 10/93 (10%)
Query: 172 CHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYL 231
+ S + +LE+L++S NK+ LP L+ L + N L E+P L
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKLIELPALPPRLE---RLIASFNHLAEVPE---L 322
Query: 232 LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNL 264
Q L+ L + N L + ++++L +
Sbjct: 323 PQNLKQLHVEYNPLREFPD----IPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 61.0 bits (146), Expect = 3e-10
Identities = 26/74 (35%), Positives = 38/74 (51%), Gaps = 7/74 (9%)
Query: 206 ICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQ 265
+L L V+NNKL+ELP+ L RLE L S N L + L NL+ L+++
Sbjct: 280 CDLPPSLEELNVSNNKLIELPA---LPPRLERLIASFNHLAEVPEL----PQNLKQLHVE 332
Query: 266 YNKLLSYCQVPSWI 279
YN L + +P +
Sbjct: 333 YNPLREFPDIPESV 346
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.4 bits (121), Expect = 3e-07
Identities = 25/100 (25%), Positives = 43/100 (43%), Gaps = 12/100 (12%)
Query: 187 SNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLT 246
N EQ +++ ++++ C + L++ N L LP L LE+L S N LT
Sbjct: 20 GNGEQREMAVSRLR-----DCLDRQAHELELNNLGLSSLPE---LPPHLESLVASCNSLT 71
Query: 247 SLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGN 286
L L +L++L + N L + +P + N
Sbjct: 72 ELPE----LPQSLKSLLVDNNNLKALSDLPPLLEYLGVSN 107
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.8 bits (117), Expect = 1e-06
Identities = 26/99 (26%), Positives = 39/99 (39%), Gaps = 7/99 (7%)
Query: 185 CL-SNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNN 243
CL +L+L+ + LP +L+ SL + N L ELP L Q L++L + NN
Sbjct: 35 CLDRQAHELELNNLGLSSLPELPPHLE---SLVASCNSLTELPE---LPQSLKSLLVDNN 88
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCN 282
L +L L L + + N I
Sbjct: 89 NLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDV 127
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 43.3 bits (100), Expect = 1e-04
Identities = 28/117 (23%), Positives = 43/117 (36%), Gaps = 6/117 (5%)
Query: 166 LTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVEL 225
+L + + + LP +LE L S N + LP LK SL V NN L L
Sbjct: 40 AHELELNNLGLSSLPELPP---HLESLVASCNSLTELPELPQSLK---SLLVDNNNLKAL 93
Query: 226 PSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCN 282
LL+ L + +L L + + ++ N +L+ L N
Sbjct: 94 SDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNN 150
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 60.1 bits (145), Expect = 2e-11
Identities = 32/112 (28%), Positives = 50/112 (44%), Gaps = 3/112 (2%)
Query: 154 LTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALI 213
LT+L + L +T L + H +R LPP + L LE L S N ++ + + L L
Sbjct: 10 LTVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD-GVANLPRLQ 68
Query: 214 SLKVANNKLVELP--SGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLN 263
L + NN+L + L RL L+L N L + L L +++
Sbjct: 69 ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVS 120
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 58.2 bits (140), Expect = 1e-10
Identities = 31/105 (29%), Positives = 47/105 (44%), Gaps = 2/105 (1%)
Query: 180 PPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLD 239
+ L + LDLS N+++ LP + L+ L L+ ++N L + L RL+ L
Sbjct: 13 LCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVAN-LPRLQELL 71
Query: 240 LSNNRLTSLGSLD-LCLMHNLQNLNLQYNKLLSYCQVPSWICCNL 283
L NNRL ++ L L LNLQ N L + + L
Sbjct: 72 LCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 61.6 bits (148), Expect = 1e-10
Identities = 48/238 (20%), Positives = 86/238 (36%), Gaps = 37/238 (15%)
Query: 76 YKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLG-LECLQIKISSPGVNGFALN 134
+ + P + KL L N++ P ++ L L + +I+ + F
Sbjct: 64 NNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGL 123
Query: 135 KLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDL 194
+ EL P S G+K L+ + + +I +P G +L +L L
Sbjct: 124 NQMIVVEL---GTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQ--GLPPSLTELHL 178
Query: 195 SFNKMK-YLPTEICYLKALISLK------------------------VANNKLVELPSGL 229
NK+ + L L L + NNKLV++P GL
Sbjct: 179 DGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGL 238
Query: 230 YLLQRLENLDLSNNRLTSLGSLDLCLMH------NLQNLNLQYNKLLSYCQVPSWICC 281
+ ++ + L NN ++++GS D C + ++L N + + PS C
Sbjct: 239 ADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC 296
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 52.7 bits (125), Expect = 1e-07
Identities = 45/210 (21%), Positives = 81/210 (38%), Gaps = 16/210 (7%)
Query: 80 LNLIPKSVGRYEKLRNLKFFGNEI-NLFPSEVGNLLGLECLQIKISS-PGVNGFALNKLK 137
L +PK + L N+I + + NL L L + + ++ A L
Sbjct: 22 LEKVPKDLPPD--TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLV 79
Query: 138 GLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSF 196
L+ L LSK + L L E +L V I + + L+ + ++L
Sbjct: 80 KLERLYLSK-----NQLKELPEKMPKTL-QELRVHENEITKVRKSVFNGLNQMIVVELGT 133
Query: 197 NKMKYL---PTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDL 253
N +K +K L +++A+ + +P GL L L L N++T + + L
Sbjct: 134 NPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGL--PPSLTELHLDGNKITKVDAASL 191
Query: 254 CLMHNLQNLNLQYNKLLSYCQVPSWICCNL 283
++NL L L +N + + +L
Sbjct: 192 KGLNNLAKLGLSFNSISAVDNGSLANTPHL 221
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 51.6 bits (122), Expect = 2e-07
Identities = 28/148 (18%), Positives = 51/148 (34%), Gaps = 11/148 (7%)
Query: 166 LTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLV 223
L + + I + + L NL L L NK+ + P L L L ++ N+L
Sbjct: 33 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92
Query: 224 ELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWI---- 279
ELP + + L+ L + N +T + ++ + + L N L S
Sbjct: 93 ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMK 150
Query: 280 ---CCNLEGNGKDSSNDDFISSSAEMDV 304
+ + S E+ +
Sbjct: 151 KLSYIRIADTNITTIPQGLPPSLTELHL 178
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 45.8 bits (107), Expect = 2e-05
Identities = 22/101 (21%), Positives = 41/101 (40%), Gaps = 3/101 (2%)
Query: 184 GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSN 242
C +L + S ++ +P ++ L + NNK+ E+ G L+ L L L N
Sbjct: 7 RCQCHLRVVQCSDLGLEKVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILIN 64
Query: 243 NRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNL 283
N+++ + + L+ L L N+L + L
Sbjct: 65 NKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQEL 105
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 58.3 bits (140), Expect = 4e-10
Identities = 27/197 (13%), Positives = 59/197 (29%), Gaps = 65/197 (32%)
Query: 851 RNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGS 910
S E R L L+ + ++Y + +A+ ME +
Sbjct: 55 VLAIRSARNEFRALQKLQGLAVPKVYAWE------------------GNAVLMELIDAKE 96
Query: 911 VKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 970
+ + + + + + + + + I+H D+ N+L+
Sbjct: 97 LYRVRVENPDE------------VLDMILEEVAKFYHRGIVHGDLSQYNVLVS------- 137
Query: 971 GKPVVKLCDFDRAVPL-----RSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 1025
+ + + DF ++V + R L DV ++ +
Sbjct: 138 -EEGIWIIDFPQSVEVGEEGWREIL-----------ERDVRN---------IITYFSRT- 175
Query: 1026 LYGLEVDIWSYGCLLLE 1042
Y E DI S +L+
Sbjct: 176 -YRTEKDINSAIDRILQ 191
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.3 bits (136), Expect = 7e-09
Identities = 15/102 (14%), Positives = 38/102 (37%), Gaps = 7/102 (6%)
Query: 188 NLEQLDLSFNKM--KYLPTEICYLKALISLKVANNKL-----VELPSGLYLLQRLENLDL 240
+++ LD+ ++ + L+ +++ + L ++ S L + L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 241 SNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCN 282
+N L +G + + +Q L + C +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVL 104
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (97), Expect = 3e-04
Identities = 20/90 (22%), Positives = 27/90 (30%), Gaps = 23/90 (25%)
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNR 244
S L L L+ + ++ L + L L LDLSNN
Sbjct: 367 PGSVLRVLWLADCDVS------------------DSSCSSLAATLLANHSLRELDLSNNC 408
Query: 245 LTSLGSLDLC--LMHN---LQNLNLQYNKL 269
L G L L + L+ L L
Sbjct: 409 LGDAGILQLVESVRQPGCLLEQLVLYDIYW 438
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.6 bits (120), Expect = 9e-08
Identities = 28/128 (21%), Positives = 48/128 (37%), Gaps = 10/128 (7%)
Query: 166 LTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVEL 225
L +L + L + + Q L ++ P ++ + L ++ L
Sbjct: 1 LNELK--PEQVEQLKLIMSKRYDGSQQALDLKGLRSDP-DLVAQNIDVVLNRRSSMAATL 57
Query: 226 PSGLYLLQRLENLDLSNNRLTSLGSLDLCL--MHNLQNLNLQYNKL-----LSYCQVPSW 278
+ L +L+LSNNRL L + + NL+ LNL N+L L +
Sbjct: 58 RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKL 117
Query: 279 ICCNLEGN 286
L+GN
Sbjct: 118 EELWLDGN 125
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.2 bits (106), Expect = 8e-06
Identities = 24/95 (25%), Positives = 40/95 (42%), Gaps = 3/95 (3%)
Query: 180 PPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLV---ELPSGLYLLQRLE 236
P++ + L+ + L + L+SL ++NN+L ++ S + L+
Sbjct: 35 DPDLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLK 94
Query: 237 NLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
L+LS N L S LD L+ L L N L
Sbjct: 95 ILNLSGNELKSERELDKIKGLKLEELWLDGNSLSD 129
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 45.5 bits (106), Expect = 2e-05
Identities = 16/60 (26%), Positives = 24/60 (40%), Gaps = 3/60 (5%)
Query: 219 NNKLVELPSGLYLLQRLENLDLSNNRLTSLGSL-DLCLMHNLQNLNLQYNKLLSYCQVPS 277
N LP GL L+ L +L++S N L G + + NK L +P+
Sbjct: 254 NRIYGTLPQGLTQLKFLHSLNVSFNNLC--GEIPQGGNLQRFDVSAYANNKCLCGSPLPA 311
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 44.4 bits (103), Expect = 5e-05
Identities = 25/84 (29%), Positives = 36/84 (42%), Gaps = 1/84 (1%)
Query: 172 CHFSIRYLPPEIGCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLVELPSGLY 230
S+ + ++G NL LDL N++ LP + LK L SL V+ N L
Sbjct: 229 AKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG 288
Query: 231 LLQRLENLDLSNNRLTSLGSLDLC 254
LQR + +NN+ L C
Sbjct: 289 NLQRFDVSAYANNKCLCGSPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 42.0 bits (97), Expect = 3e-04
Identities = 14/58 (24%), Positives = 20/58 (34%), Gaps = 1/58 (1%)
Query: 165 CLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKL 222
L LP + L L L++SFN + + L+ ANNK
Sbjct: 247 NGLDLRNNRIYGT-LPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKC 303
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.1 bits (105), Expect = 2e-05
Identities = 16/70 (22%), Positives = 24/70 (34%), Gaps = 2/70 (2%)
Query: 205 EICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNL 264
E+ + + + + L LP L + L LS N L + L L LNL
Sbjct: 5 EVSKVASHLEVNCDKRNLTALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 265 QYNKLLSYCQ 274
+L
Sbjct: 63 DRAELTKLQV 72
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.5 bits (88), Expect = 0.003
Identities = 12/58 (20%), Positives = 21/58 (36%)
Query: 180 PPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLEN 237
+ L NL+ L L N + +P L + N + LY + L++
Sbjct: 165 AGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCEILYFRRWLQD 222
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.8 bits (104), Expect = 3e-05
Identities = 46/236 (19%), Positives = 82/236 (34%), Gaps = 7/236 (2%)
Query: 68 NSVEGLYLYKNVL-NLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSP 126
+ + ++L+ N + ++ S L L N + + L L +
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 127 GVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCL 186
+ GL L + GL L L + +++ LP +
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151
Query: 187 S-NLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKLVEL-PSGLYLLQRLENLDLSNN 243
NL L L N++ +P L +L L + N++ + P L RL L L N
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSS 299
L++L + L + LQ L L N + C+ + L+ S+ + S
Sbjct: 212 NLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKF--RGSSSEVPCSL 264
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.9 bits (86), Expect = 0.004
Identities = 14/76 (18%), Positives = 25/76 (32%), Gaps = 2/76 (2%)
Query: 207 CYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQY 266
CY + ++ L +P G+ + + L NR++ + + NL L L
Sbjct: 8 CYNEPKVTTSCPQQGLQAVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHS 65
Query: 267 NKLLSYCQVPSWICCN 282
N L
Sbjct: 66 NVLARIDAAAFTGLAL 81
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 43.3 bits (100), Expect = 1e-04
Identities = 11/100 (11%), Positives = 32/100 (32%), Gaps = 5/100 (5%)
Query: 188 NLEQLDLSFNKMKYLPTEICYLKALISLKVANNKL-----VELPSGLYLLQRLENLDLSN 242
+L+ ++ K + + ++ + ++ N + L + + LE + S+
Sbjct: 9 SLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68
Query: 243 NRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCN 282
+ + L L+ KL + +
Sbjct: 69 IFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPT 108
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.7 bits (88), Expect = 0.003
Identities = 9/78 (11%), Positives = 21/78 (26%), Gaps = 4/78 (5%)
Query: 210 KALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLM----HNLQNLNLQ 265
K+L + + + L ++ + LS N + + + L +L+
Sbjct: 8 KSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 266 YNKLLSYCQVPSWICCNL 283
L
Sbjct: 68 DIFTGRVKDEIPEALRLL 85
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.0 bits (97), Expect = 2e-04
Identities = 19/94 (20%), Positives = 39/94 (41%), Gaps = 1/94 (1%)
Query: 192 LDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSL 251
LDL+ + T + +I+ + + + + + + R++++DLSN+ +
Sbjct: 5 LDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLH 64
Query: 252 D-LCLMHNLQNLNLQYNKLLSYCQVPSWICCNLE 284
L LQNL+L+ +L NL
Sbjct: 65 GILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLV 98
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.7 bits (91), Expect = 0.001
Identities = 24/140 (17%), Positives = 41/140 (29%), Gaps = 25/140 (17%)
Query: 142 LELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKY 201
L+L+ P V L + + + E ++ +DLS +
Sbjct: 5 LDLTGKNLHPDVTGRLLS----QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNS---- 56
Query: 202 LPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQN 261
++ L L +L+NL L RL+ L NL
Sbjct: 57 -----------------VIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVR 99
Query: 262 LNLQYNKLLSYCQVPSWICC 281
LNL S + + +
Sbjct: 100 LNLSGCSGFSEFALQTLLSS 119
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (93), Expect = 3e-04
Identities = 22/102 (21%), Positives = 43/102 (42%), Gaps = 1/102 (0%)
Query: 181 PEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDL 240
+ +LDL K+ + L ++ ++N++ +L G LL+RL+ L +
Sbjct: 12 AQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLD-GFPLLRRLKTLLV 70
Query: 241 SNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCN 282
+NNR+ +G + +L L L N L+ +
Sbjct: 71 NNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLK 112
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (88), Expect = 0.001
Identities = 23/134 (17%), Positives = 46/134 (34%), Gaps = 1/134 (0%)
Query: 151 PSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLK 210
++ ++ +L + + I + L + +D S N+++ L +
Sbjct: 5 AELIEQAAQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLDGFPLLRR 64
Query: 211 ALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLC-LMHNLQNLNLQYNKL 269
L N L L L L+NN L LG LD + +L L + N +
Sbjct: 65 LKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPV 124
Query: 270 LSYCQVPSWICCNL 283
+ ++ +
Sbjct: 125 TNKKHYRLYVIYKV 138
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 0.001
Identities = 10/75 (13%), Positives = 26/75 (34%), Gaps = 3/75 (4%)
Query: 209 LKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNK 268
I + + + + L ++ + +N+ + S+ + + N+ L L NK
Sbjct: 23 FAETIKDNLKKKSVTDAVT-QNELNSIDQIIANNSDIKSVQGIQY--LPNVTKLFLNGNK 79
Query: 269 LLSYCQVPSWICCNL 283
L + +
Sbjct: 80 LTDIKPLANLKNLGW 94
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 0.001
Identities = 16/59 (27%), Positives = 28/59 (47%), Gaps = 3/59 (5%)
Query: 206 ICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNL 264
+ L L +LK +NK+ ++ L L L + L NN+++ + L NL + L
Sbjct: 169 LANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQISDVSPLANT--SNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 0.001
Identities = 10/75 (13%), Positives = 26/75 (34%), Gaps = 3/75 (4%)
Query: 209 LKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNK 268
L I + + + + + L + L +T++ + +NL L L+ N+
Sbjct: 18 LANAIKIAAGKSNVTDTVT-QADLDGITTLSAFGTGVTTIEGVQYL--NNLIGLELKDNQ 74
Query: 269 LLSYCQVPSWICCNL 283
+ + +
Sbjct: 75 ITDLAPLKNLTKITE 89
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.9 bits (91), Expect = 0.001
Identities = 14/65 (21%), Positives = 28/65 (43%), Gaps = 4/65 (6%)
Query: 165 CLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKV-ANNKL 222
+ ++ LP ++ S LD+S ++ LP+ L+ L L+ + L
Sbjct: 178 LDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYG--LENLKKLRARSTYNL 235
Query: 223 VELPS 227
+LP+
Sbjct: 236 KKLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.1 bits (89), Expect = 0.002
Identities = 11/39 (28%), Positives = 16/39 (41%)
Query: 232 LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLL 270
LD+S R+ SL S L + L+ + K L
Sbjct: 200 ASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKKL 238
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.7 bits (88), Expect = 0.002
Identities = 10/64 (15%), Positives = 23/64 (35%), Gaps = 2/64 (3%)
Query: 219 NNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSW 278
+K+ E+PS L + L +L + +L+ + + N +L + +
Sbjct: 17 ESKVTEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVF 74
Query: 279 ICCN 282
Sbjct: 75 SNLP 78
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.3 bits (90), Expect = 0.001
Identities = 10/74 (13%), Positives = 25/74 (33%), Gaps = 3/74 (4%)
Query: 209 LKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNK 268
L + + + + S L ++ L + S+ ++ +NL +N N+
Sbjct: 17 LAEKMKTVLGKTNVTDTVS-QTDLDQVTTLQADRLGIKSIDGVEYL--NNLTQINFSNNQ 73
Query: 269 LLSYCQVPSWICCN 282
L + +
Sbjct: 74 LTDITPLKNLTKLV 87
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1142 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.94 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.93 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.92 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.9 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.9 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.89 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.88 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.88 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.84 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.83 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.8 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.8 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.78 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.77 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.76 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.76 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.73 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.71 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.66 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.62 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.57 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.5 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.48 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.47 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.42 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.41 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.38 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.38 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.36 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.35 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.34 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.28 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.16 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.16 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.39 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.12 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.82 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.5 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.26 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.84 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.68 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 96.52 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.35 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.68 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 94.24 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 93.71 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=438.04 Aligned_cols=257 Identities=24% Similarity=0.290 Sum_probs=215.1
Q ss_pred CCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 882 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~ 882 (1142)
++++|++.+.||+|+||+||+|++. +..+|+|+..... .........+.+|+.++++++|||||++++++.++
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 78 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-----LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA 78 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHH-----ccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC
Confidence 5788999999999999999999984 5678888754221 11122334458999999999999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
+ ..|+|||||++|+|.+++.. ...+++..+..|+.||+.||+|||++||+||||||+|||+
T Consensus 79 ~--------------~~~ivmEy~~~g~L~~~l~~-----~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill 139 (263)
T d2j4za1 79 T--------------RVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL 139 (263)
T ss_dssp S--------------EEEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred C--------------EEEEEEeecCCCcHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeecccccee
Confidence 5 34999999999999999976 2469999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
+.+ +.+||+|||+|+...... .....||+.|||||++.+ ..|+.++|||||||++||
T Consensus 140 ~~~-------~~~kl~DFG~a~~~~~~~------------~~~~~Gt~~Y~APE~~~~----~~~~~~~DiwSlGvilye 196 (263)
T d2j4za1 140 GSA-------GELKIADFGWSVHAPSSR------------RTTLCGTLDYLPPEMIEG----RMHDEKVDLWSLGVLCYE 196 (263)
T ss_dssp CTT-------SCEEECCCCSCSCCCCCC------------CEETTEEGGGCCHHHHTT----CCCCTTHHHHHHHHHHHH
T ss_pred cCC-------CCEeecccceeeecCCCc------------ccccCCCCcccCHHHHcC----CCCCchhhhhhHhHHHHH
Confidence 887 789999999997544321 123469999999999986 568999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1043 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1043 LLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
|++|+.||.+.+..+....+...... ++ ...++++.+|+.+||+.||++|||
T Consensus 197 ll~G~~Pf~~~~~~~~~~~i~~~~~~-~p---------------------------~~~s~~~~~li~~~L~~dp~~R~t 248 (263)
T d2j4za1 197 FLVGKPPFEANTYQETYKRISRVEFT-FP---------------------------DFVTEGARDLISRLLKHNPSQRPM 248 (263)
T ss_dssp HHHSSCTTCCSSHHHHHHHHHTTCCC-CC---------------------------TTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred HhcCCCCCCCCCHHHHHHHHHcCCCC-CC---------------------------ccCCHHHHHHHHHHccCCHhHCcC
Confidence 99999999988888877776554321 11 134567999999999999999999
Q ss_pred HHHHHHHHHhhcCC
Q 001142 1123 AGDLYEMFVARTSS 1136 (1142)
Q Consensus 1123 a~EVL~~L~~~~ss 1136 (1142)
++|+++|+|+...+
T Consensus 249 ~~eil~hp~~~~~s 262 (263)
T d2j4za1 249 LREVLEHPWITANS 262 (263)
T ss_dssp HHHHHTCHHHHHHC
T ss_pred HHHHHcCcCcCCcC
Confidence 99999999998654
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=437.16 Aligned_cols=259 Identities=25% Similarity=0.437 Sum_probs=213.9
Q ss_pred CCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
.+|++.++||+|+||+||+|++ .+..||+|+...... ...+. +.+|+.++++++|||||++++++.+.+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~----~~~E~~il~~l~HpnIv~~~~~~~~~~- 90 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----PKKEL----IINEILVMRENKNPNIVNYLDSYLVGD- 90 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC----SCHHH----HHHHHHHHHHCCCTTBCCEEEEEEETT-
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC----hHHHH----HHHHHHHHHhCCCCCEeeEeEEEEECC-
Confidence 3699999999999999999997 477899998654422 11223 379999999999999999999998765
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
+.|+|||||+||+|.+++.+ ..+++.+++.|+.||+.||+|||++||+||||||+|||++.
T Consensus 91 -------------~~~ivmEy~~gg~L~~~~~~------~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~ 151 (293)
T d1yhwa1 91 -------------ELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM 151 (293)
T ss_dssp -------------EEEEEEECCTTCBHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT
T ss_pred -------------EEEEEEEecCCCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECC
Confidence 34999999999999998865 36999999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||+|||+|+.+..... ......||+.|+|||++.+ ..|+.++|||||||++|+|+
T Consensus 152 ~-------~~vkl~DFG~a~~~~~~~~----------~~~~~~gt~~Y~aPE~~~~----~~~~~~~DiwSlGvilyeml 210 (293)
T d1yhwa1 152 D-------GSVKLTDFGFCAQITPEQS----------KRSTMVGTPYWMAPEVVTR----KAYGPKVDIWSLGIMAIEMI 210 (293)
T ss_dssp T-------CCEEECCCTTCEECCSTTC----------CBCCCCSCGGGCCHHHHSS----SCBCTHHHHHHHHHHHHHHH
T ss_pred C-------CcEeeccchhheeeccccc----------cccccccCCCccChhhhcC----CCCCchhceehHhHHHHHHh
Confidence 7 7899999999986543211 1224579999999999976 56899999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~ 1124 (1142)
+|+.||.+.+..+....+.....+.+.. ....++.+.+||.+||+.||.+|||++
T Consensus 211 tG~~Pf~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~s~~~~~li~~~L~~dP~~R~s~~ 265 (293)
T d1yhwa1 211 EGEPPYLNENPLRALYLIATNGTPELQN-------------------------PEKLSAIFRDFLNRCLDMDVEKRGSAK 265 (293)
T ss_dssp HSSCTTTTSCHHHHHHHHHHHCSCCCSS-------------------------GGGSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCCCC-------------------------cccCCHHHHHHHHHHccCChhHCcCHH
Confidence 9999999877776665554333222211 114567799999999999999999999
Q ss_pred HHHHHHHhhcCCCCC
Q 001142 1125 DLYEMFVARTSSSIS 1139 (1142)
Q Consensus 1125 EVL~~L~~~~ss~~s 1139 (1142)
|+++|+|++...+.+
T Consensus 266 eil~Hp~~~~~~~~~ 280 (293)
T d1yhwa1 266 ELLQHQFLKIAKPLS 280 (293)
T ss_dssp HHTTCGGGGGCCCGG
T ss_pred HHhcCHhhCCCCCCC
Confidence 999999998765544
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=431.84 Aligned_cols=260 Identities=27% Similarity=0.370 Sum_probs=205.3
Q ss_pred CCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
.++|++.+.||+|+||+||+|++. +..||+|+.... .......+.+ .+|++++++++|||||++++++.+..
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~----~~E~~il~~l~HpnIv~~~~~~~~~~ 76 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYG--SMTEAEKQML----VSEVNLLRELKHPNIVRYYDRIIDRT 76 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCT--TSCHHHHHHH----HHHHHHTTSCCCTTBCCEEEEEEC--
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChh--hCCHHHHHHH----HHHHHHHHHCCCCCEeeEEEEEEeCC
Confidence 367999999999999999999984 567888875432 3334444444 89999999999999999999987532
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccCCCCC
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-----IMHRDIKSE 958 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~g-----IvHrDLKp~ 958 (1142)
. ..+|+|||||++|+|.+++.+.... ...+++..++.|+.||+.||+|||++| |+||||||+
T Consensus 77 ~------------~~~~ivmEy~~~g~L~~~i~~~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~ 143 (269)
T d2java1 77 N------------TTLYIVMEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPA 143 (269)
T ss_dssp --------------CEEEEEECCTTEEHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGG
T ss_pred C------------CEEEEEEecCCCCcHHHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchh
Confidence 1 1459999999999999999764433 357999999999999999999999876 999999999
Q ss_pred CeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001142 959 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1038 (1142)
Q Consensus 959 NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGv 1038 (1142)
|||++.+ +.+||+|||+|+.+..... ......||+.|||||++.+ ..|+.++|||||||
T Consensus 144 NIll~~~-------~~vkl~DFG~a~~~~~~~~----------~~~~~~gt~~Y~APE~l~~----~~~~~~~DIwSlGv 202 (269)
T d2java1 144 NVFLDGK-------QNVKLGDFGLARILNHDTS----------FAKAFVGTPYYMSPEQMNR----MSYNEKSDIWSLGC 202 (269)
T ss_dssp GEEECTT-------SCEEECCHHHHHHC---------------------CCCSCCCHHHHTT----CCCCHHHHHHHHHH
T ss_pred hcCcCCC-------CcEEEeeccceeecccCCC----------ccccCCCCcccCCHHHHcC----CCCChHHHHHhhCH
Confidence 9999887 7899999999987543211 1224579999999999975 57899999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001142 1039 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1118 (1142)
Q Consensus 1039 iL~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~ 1118 (1142)
++|||+||+.||.+.+..++...+..+..+.++. ..++++.+|+.+||+.||.
T Consensus 203 ilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~---------------------------~~s~~l~~li~~~L~~dp~ 255 (269)
T d2java1 203 LLYELCALMPPFTAFSQKELAGKIREGKFRRIPY---------------------------RYSDELNEIITRMLNLKDY 255 (269)
T ss_dssp HHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCT---------------------------TSCHHHHHHHHHHTCSSGG
T ss_pred HHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------ccCHHHHHHHHHHcCCChh
Confidence 9999999999999988888888877665443321 4456799999999999999
Q ss_pred CCCCHHHHHHHHHh
Q 001142 1119 ERPTAGDLYEMFVA 1132 (1142)
Q Consensus 1119 ~RPSa~EVL~~L~~ 1132 (1142)
+|||++|+++|+|.
T Consensus 256 ~Rps~~ell~hp~i 269 (269)
T d2java1 256 HRPSVEEILENPLI 269 (269)
T ss_dssp GSCCHHHHHTSTTC
T ss_pred HCcCHHHHHhCCcC
Confidence 99999999999984
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=432.97 Aligned_cols=261 Identities=24% Similarity=0.279 Sum_probs=205.6
Q ss_pred CCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
+++|++.++||+|+||+||+|++. +..+|+|+...+.. ....+. +.+|+.+|++++|||||++++++.+++
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~---~~~~~~----~~~Ei~~l~~l~HpnIv~~~~~~~~~~ 76 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPEN----IKKEICINKMLNHENVVKFYGHRREGN 76 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------C----HHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc---chHHHH----HHHHHHHHHhCCCCCEeeEeeeeccCc
Confidence 568999999999999999999984 66789998654321 112223 479999999999999999999998765
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
..|+|||||++|+|.++++. ...+++..++.|+.||+.||+|||++||+||||||+|||++
T Consensus 77 --------------~~~ivmEy~~gg~L~~~l~~-----~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~ 137 (271)
T d1nvra_ 77 --------------IQYLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD 137 (271)
T ss_dssp --------------EEEEEEECCTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred --------------eeEEEEeccCCCcHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEEC
Confidence 34999999999999998854 35799999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.+||+|||+|+........ ......+||+.|||||++.+ ...++.++|||||||++|||
T Consensus 138 ~~-------~~~KL~DFG~a~~~~~~~~~--------~~~~~~~GT~~Y~APE~~~~---~~~~~~~~DiwSlGvilyem 199 (271)
T d1nvra_ 138 ER-------DNLKISDFGLATVFRYNNRE--------RLLNKMCGTLPYVAPELLKR---REFHAEPVDVWSCGIVLTAM 199 (271)
T ss_dssp TT-------CCEEECCCTTCEECEETTEE--------CCBCCCCSCGGGSCTHHHHC---SSBCHHHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEccchhheeeccCCcc--------ccccceeeCcCccCHhHhcC---CCCCCCceeeeHhHHHHHHH
Confidence 87 78999999999876432211 11224579999999999876 22356889999999999999
Q ss_pred HhCCCCCCCCCHHH-HHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1044 LTLQVPYMGLSELE-IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~e-l~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
++|+.||....... ....+........ .....++++.+|+.+||+.||++|||
T Consensus 200 l~G~~pf~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~s~~~~~li~~~L~~dP~~R~t 253 (271)
T d1nvra_ 200 LAGELPWDQPSDSCQEYSDWKEKKTYLN--------------------------PWKKIDSAPLALLHKILVENPSARIT 253 (271)
T ss_dssp HHSSCSCSSSSTTSHHHHHHHTTCTTST--------------------------TGGGSCHHHHHHHHHHSCSSTTTSCC
T ss_pred HhCCCCCCCCChHHHHHHHHhcCCCCCC--------------------------ccccCCHHHHHHHHHHcCCChhHCcC
Confidence 99999997654322 2222222111100 01145667899999999999999999
Q ss_pred HHHHHHHHHhhcCC
Q 001142 1123 AGDLYEMFVARTSS 1136 (1142)
Q Consensus 1123 a~EVL~~L~~~~ss 1136 (1142)
++|+++|+|++..-
T Consensus 254 ~~eil~hpwf~~~l 267 (271)
T d1nvra_ 254 IPDIKKDRWYNKPL 267 (271)
T ss_dssp HHHHTTCTTTTCCC
T ss_pred HHHHhcCHhhCcCC
Confidence 99999999998654
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-48 Score=431.81 Aligned_cols=261 Identities=28% Similarity=0.430 Sum_probs=214.4
Q ss_pred CcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
.|++.+.||+|+||+||+|++. +..+|+|+.... .....+.+ .+|+++|++++|||||++++++.+++
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~----~~~~~~~~----~~E~~il~~l~HpnIv~l~~~~~~~~-- 82 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK----SEEELEDY----MVEIDILASCDHPNIVKLLDAFYYEN-- 82 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----SSGGGGGT----HHHHHHHHHCCCTTBCCEEEEEEETT--
T ss_pred CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC----CHHHHHHH----HHHHHHHHhCCCCCCCeEEEEEeeCC--
Confidence 5899999999999999999984 567788875432 22333444 79999999999999999999998765
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
..++|||||++|+|.+++.+. ...+++..+..|+.||+.||.|||++||+||||||+|||++.+
T Consensus 83 ------------~~~lvmEy~~~g~L~~~~~~~----~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~ 146 (288)
T d2jfla1 83 ------------NLWILIEFCAGGAVDAVMLEL----ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLD 146 (288)
T ss_dssp ------------EEEEEEECCTTEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT
T ss_pred ------------eEEEEEecCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCC
Confidence 349999999999999998752 3469999999999999999999999999999999999999987
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhcccc-CCCCCCchhhHHHHHHHHHHHH
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+.+||+|||+|+........ .....||+.|+|||++.... ....|+.++|||||||++|||+
T Consensus 147 -------~~~Kl~DFG~a~~~~~~~~~----------~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyeml 209 (288)
T d2jfla1 147 -------GDIKLADFGVSAKNTRTIQR----------RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 209 (288)
T ss_dssp -------SCEEECCCTTCEECHHHHHH----------HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHH
T ss_pred -------CCEEEEechhhhccCCCccc----------ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHh
Confidence 78999999999765432111 12346999999999986432 2356899999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~ 1124 (1142)
+|+.||.+.+..+....+..+..+.+.. ....++++.+||.+||+.||.+|||++
T Consensus 210 tg~~Pf~~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~s~~~~~li~~~L~~dp~~R~t~~ 264 (288)
T d2jfla1 210 EIEPPHHELNPMRVLLKIAKSEPPTLAQ-------------------------PSRWSSNFKDFLKKCLEKNVDARWTTS 264 (288)
T ss_dssp HSSCTTTTSCGGGHHHHHHHSCCCCCSS-------------------------GGGSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCCCc-------------------------cccCCHHHHHHHHHHccCChhHCcCHH
Confidence 9999999888777777776655433221 014567799999999999999999999
Q ss_pred HHHHHHHhhcCC
Q 001142 1125 DLYEMFVARTSS 1136 (1142)
Q Consensus 1125 EVL~~L~~~~ss 1136 (1142)
|+++|+|+....
T Consensus 265 ell~hp~~~~~~ 276 (288)
T d2jfla1 265 QLLQHPFVTVDS 276 (288)
T ss_dssp HHTTSGGGCCCC
T ss_pred HHhcCcccCCCC
Confidence 999999997543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=422.74 Aligned_cols=255 Identities=24% Similarity=0.351 Sum_probs=202.4
Q ss_pred cceeeeecccCceEEEEEEECCc--cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCC
Q 001142 809 LSSCDEAGKSVSSSLFRCKFGSA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 886 (1142)
Q Consensus 809 y~l~~~LG~GsfG~Vy~a~~~~~--~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~ 886 (1142)
|++.++||+|+||+||+|++..+ .||+|+.. .........+.+ .+|+++|++++|||||++++++.+...
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~--~~~~~~~~~~~~----~~E~~il~~l~HpnIv~~~~~~~~~~~-- 82 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQ--DRKLTKSERQRF----KEEAEMLKGLQHPNIVRFYDSWESTVK-- 82 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEE--GGGSCHHHHHHH----HHHHHHHTTCCCTTBCCEEEEEEEESS--
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEc--hhhCCHHHHHHH----HHHHHHHHhCCCCCeeeEEEEEeeccc--
Confidence 47888999999999999998644 56666543 323333444444 899999999999999999999875321
Q ss_pred CCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCeeecc
Q 001142 887 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENILIDL 964 (1142)
Q Consensus 887 ~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~g--IvHrDLKp~NILld~ 964 (1142)
.....|+||||+++|+|.+++.+ ...+++..++.|+.||+.||+|||+++ |+||||||+|||++.
T Consensus 83 --------~~~~~~ivmE~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~ 149 (270)
T d1t4ha_ 83 --------GKKCIVLVTELMTSGTLKTYLKR-----FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG 149 (270)
T ss_dssp --------SCEEEEEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS
T ss_pred --------cCCEEEEEEeCCCCCcHHHHHhc-----cccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeC
Confidence 12356999999999999999976 246899999999999999999999998 999999999999964
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+. +.+||+|||+|+...... .....||+.|||||++.+ .|+.++|||||||++|||+
T Consensus 150 ~~------~~~Kl~DFGla~~~~~~~------------~~~~~GT~~Y~aPE~~~~-----~~~~~~DIwSlGvilyel~ 206 (270)
T d1t4ha_ 150 PT------GSVKIGDLGLATLKRASF------------AKAVIGTPEFMAPEMYEE-----KYDESVDVYAFGMCMLEMA 206 (270)
T ss_dssp TT------SCEEECCTTGGGGCCTTS------------BEESCSSCCCCCGGGGGT-----CCCTHHHHHHHHHHHHHHH
T ss_pred CC------CCEEEeecCcceeccCCc------------cCCcccCccccCHHHhCC-----CCCCcCchhhHHHHHHHHH
Confidence 31 689999999997533211 124579999999999864 5899999999999999999
Q ss_pred hCCCCCCCCC-HHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1045 TLQVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1045 tG~~Pf~~~~-~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
+|+.||.+.. ..++...+..+..+... ....++++.+||.+||+.||++|||+
T Consensus 207 ~g~~Pf~~~~~~~~~~~~i~~~~~~~~~--------------------------~~~~~~~~~~li~~~l~~dp~~R~s~ 260 (270)
T d1t4ha_ 207 TSEYPYSECQNAAQIYRRVTSGVKPASF--------------------------DKVAIPEVKEIIEGCIRQNKDERYSI 260 (270)
T ss_dssp HSSCTTTTCSSHHHHHHHHTTTCCCGGG--------------------------GGCCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred HCCCCCCCcccHHHHHHHHHcCCCCccc--------------------------CccCCHHHHHHHHHHccCCHhHCcCH
Confidence 9999997644 44455555544332111 11345679999999999999999999
Q ss_pred HHHHHHHHhh
Q 001142 1124 GDLYEMFVAR 1133 (1142)
Q Consensus 1124 ~EVL~~L~~~ 1133 (1142)
+|+++|+|++
T Consensus 261 ~ell~Hp~fk 270 (270)
T d1t4ha_ 261 KDLLNHAFFQ 270 (270)
T ss_dssp HHHHTSGGGC
T ss_pred HHHhCCcccC
Confidence 9999999985
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-47 Score=421.85 Aligned_cols=264 Identities=24% Similarity=0.377 Sum_probs=205.9
Q ss_pred CCCcceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
.++|++.++||+|+||+||+|++++ .||||+.+.. .......+.| .+|+.+|++++|||||++++++.+.
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~--~~~~~~~~~~----~~E~~~l~~l~HpnIv~~~~~~~~~--- 76 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVT--APTPQQLQAF----KNEVGVLRKTRHVNILLFMGYSTAP--- 76 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCS--SCCTTHHHHH----HHHHHHHTTCCCTTBCCEEEEECSS---
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcc--cCCHHHHHHH----HHHHHHHHhCCCCCEeeeeEEEecc---
Confidence 4679999999999999999999865 5888885433 3333444555 8999999999999999999987532
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
..++||||+++|+|.+++.. ....+++..+..|+.||+.||+|||++|||||||||+|||++.+
T Consensus 77 ------------~~~lv~Ey~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~ 140 (276)
T d1uwha_ 77 ------------QLAIVTQWCEGSSLYHHLHI----IETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHED 140 (276)
T ss_dssp ------------SCEEEEECCCEEEHHHHHHT----SCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT
T ss_pred ------------EEEEEEecCCCCCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCC
Confidence 23899999999999999975 23469999999999999999999999999999999999999887
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+.+||+|||+|+........ .......||+.|||||++.+.. ...|+.++|||||||++|||+|
T Consensus 141 -------~~~Kl~DFGla~~~~~~~~~--------~~~~~~~gt~~y~APE~l~~~~-~~~~~~~sDiwS~Gv~l~el~t 204 (276)
T d1uwha_ 141 -------LTVKIGDFGLATVKSRWSGS--------HQFEQLSGSILWMAPEVIRMQD-KNPYSFQSDVYAFGIVLYELMT 204 (276)
T ss_dssp -------SSEEECCCCCSCC--------------------CCCCGGGCCHHHHTTCS-SCCCCHHHHHHHHHHHHHHHHH
T ss_pred -------CCEEEccccceeeccccCCc--------ccccccccCcccCCHHHHhccc-CCCCCchhhhhhhHHHHHHHHH
Confidence 78999999999765432211 1123456999999999987522 2468999999999999999999
Q ss_pred CCCCCCCCCHHH-HHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001142 1046 LQVPYMGLSELE-IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124 (1142)
Q Consensus 1046 G~~Pf~~~~~~e-l~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~ 1124 (1142)
|+.||.+.+... +...+..+..++.... ....+++.+.+|+.+||+.||++||||+
T Consensus 205 g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~-----------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~ 261 (276)
T d1uwha_ 205 GQLPYSNINNRDQIIFMVGRGYLSPDLSK-----------------------VRSNCPKAMKRLMAECLKKKRDERPLFP 261 (276)
T ss_dssp SSCTTTTCCCHHHHHHHHHHTSCCCCGGG-----------------------SCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCCCCCChHHHHHHHHhcCCCCCcchh-----------------------ccccchHHHHHHHHHHcCCCHhHCcCHH
Confidence 999998765544 4444444433221110 0114567899999999999999999999
Q ss_pred HHHHHHHhhc
Q 001142 1125 DLYEMFVART 1134 (1142)
Q Consensus 1125 EVL~~L~~~~ 1134 (1142)
||+++++...
T Consensus 262 ~il~~Le~l~ 271 (276)
T d1uwha_ 262 QILASIELLA 271 (276)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999998754
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9e-47 Score=425.83 Aligned_cols=257 Identities=26% Similarity=0.398 Sum_probs=210.8
Q ss_pred CcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCCh-HHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSA-DEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~-~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
.|++.+.||+|+||+||+|++. +..||||+.... .... ...+. +.+|+.+|++++|||||++++++.+++
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~--~~~~~~~~~~----~~~Ei~il~~l~HpnIv~~~~~~~~~~- 88 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYS--GKQSNEKWQD----IIKEVRFLQKLRHPNTIQYRGCYLREH- 88 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECC--SSCHHHHHHH----HHHHHHHHTTCCCTTBCCEEEEEEETT-
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchh--hccCHHHHHH----HHHHHHHHHHCCCCCEeeEEEEEEECC-
Confidence 3899999999999999999984 566888875432 2222 22233 489999999999999999999998765
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
+.|+|||||++|+|..++.. ...+++..+..|+.||+.||.|||++||+||||||+|||++.
T Consensus 89 -------------~~~iv~E~~~~g~l~~~~~~-----~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~ 150 (309)
T d1u5ra_ 89 -------------TAWLVMEYCLGSASDLLEVH-----KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSE 150 (309)
T ss_dssp -------------EEEEEEECCSEEHHHHHHHH-----TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET
T ss_pred -------------EEEEEEEecCCCchHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECC
Confidence 35999999999998777654 357999999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||+|||+|...... ....||+.|||||++.+.. ...|+.++|||||||++|||+
T Consensus 151 ~-------~~~Kl~DFG~a~~~~~~--------------~~~~GT~~Y~APE~~~~~~-~~~y~~~~DiwSlGvilyel~ 208 (309)
T d1u5ra_ 151 P-------GLVKLGDFGSASIMAPA--------------NSFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIELA 208 (309)
T ss_dssp T-------TEEEECCCTTCBSSSSB--------------CCCCSCGGGCCHHHHTTTT-SCCBCTHHHHHHHHHHHHHHH
T ss_pred C-------CCEEEeecccccccCCC--------------CccccCccccCHHHHhccC-CCCcCchhhhhhHHHHHHHHH
Confidence 7 88999999999754321 1346999999999986522 246889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~ 1124 (1142)
+|..||.+....+....+.....+.... ...++.+.+||.+||+.||.+|||++
T Consensus 209 ~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--------------------------~~~s~~~~~li~~~L~~dP~~Rpt~~ 262 (309)
T d1u5ra_ 209 ERKPPLFNMNAMSALYHIAQNESPALQS--------------------------GHWSEYFRNFVDSCLQKIPQDRPTSE 262 (309)
T ss_dssp HSSCTTTTSCHHHHHHHHHHSCCCCCSC--------------------------TTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HCCCCCCCCCHHHHHHHHHhCCCCCCCC--------------------------CCCCHHHHHHHHHHCcCChhHCcCHH
Confidence 9999999888777776665554433221 14456799999999999999999999
Q ss_pred HHHHHHHhhcCCC
Q 001142 1125 DLYEMFVARTSSS 1137 (1142)
Q Consensus 1125 EVL~~L~~~~ss~ 1137 (1142)
|+++|+|+....+
T Consensus 263 ell~Hp~~~~~~~ 275 (309)
T d1u5ra_ 263 VLLKHRFVLRERP 275 (309)
T ss_dssp HHTTCHHHHSCCC
T ss_pred HHHhCHHhcCCCC
Confidence 9999999986543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-47 Score=423.91 Aligned_cols=259 Identities=21% Similarity=0.262 Sum_probs=209.3
Q ss_pred CCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
.++|++.+.||+|+||+||+|++. +..||+|+...... ..+.....+.+|++++++++|||||++++++.+++
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-----~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 81 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI-----IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE 81 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSS
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHc-----cCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECC
Confidence 357999999999999999999984 66789998643211 11111234589999999999999999999998765
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
..|+||||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 82 --------------~~~ivmEy~~gg~L~~~~~~-----~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~ 142 (288)
T d1uu3a_ 82 --------------KLYFGLSYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN 142 (288)
T ss_dssp --------------EEEEEECCCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred --------------EEEEEEEccCCCCHHHhhhc-----cCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccC
Confidence 34999999999999999876 24699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.+||+|||+|+.+...... ......+||+.|+|||++.+ ..|+.++|||||||++|||
T Consensus 143 ~~-------~~vkl~DFG~a~~~~~~~~~--------~~~~~~~GT~~Y~APE~~~~----~~~~~~~DiwSlGvilyel 203 (288)
T d1uu3a_ 143 ED-------MHIQITDFGTAKVLSPESKQ--------ARANSFVGTAQYVSPELLTE----KSACKSSDLWALGCIIYQL 203 (288)
T ss_dssp TT-------SCEEECCCTTCEECC------------------CCCCGGGCCHHHHHT----CCCCHHHHHHHHHHHHHHH
T ss_pred CC-------ceEEecccccceecccCCcc--------cccccccCCccccCceeecc----CCCCcccceehhhHHHHHH
Confidence 87 78999999999865432211 11224579999999999986 5789999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
++|+.||.+.+..++...+..+... ++ ...++.+.+||.+||+.||.+|||+
T Consensus 204 l~g~~Pf~~~~~~~~~~~i~~~~~~-~p---------------------------~~~s~~~~~li~~~L~~dP~~R~t~ 255 (288)
T d1uu3a_ 204 VAGLPPFRAGNEYLIFQKIIKLEYD-FP---------------------------EKFFPKARDLVEKLLVLDATKRLGC 255 (288)
T ss_dssp HHSSCSSCCSSHHHHHHHHHTTCCC-CC---------------------------TTCCHHHHHHHHTTSCSSGGGSTTS
T ss_pred hhCCCCCCCcCHHHHHHHHHcCCCC-CC---------------------------ccCCHHHHHHHHHHccCCHhHCcCH
Confidence 9999999988888877777654321 11 0345679999999999999999999
Q ss_pred HH------HHHHHHhhcC
Q 001142 1124 GD------LYEMFVARTS 1135 (1142)
Q Consensus 1124 ~E------VL~~L~~~~s 1135 (1142)
+| +++|+|++.-
T Consensus 256 ~e~~~~~~i~~Hpff~~i 273 (288)
T d1uu3a_ 256 EEMEGYGPLKAHPFFESV 273 (288)
T ss_dssp GGGTCHHHHHTSGGGTTC
T ss_pred HHHcCCHHHHcCCccCCC
Confidence 88 5677777653
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.3e-46 Score=431.66 Aligned_cols=260 Identities=22% Similarity=0.262 Sum_probs=214.0
Q ss_pred CCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
+++|++.++||+|+||+||+|++. +..||+|+.... .....+. +.+|+.+|++++|||||++++++.+.+
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~----~~~~~~~----~~~E~~il~~l~HpnIv~~~~~~~~~~ 96 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKET----VRKEIQTMSVLRHPTLVNLHDAFEDDN 96 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC----SHHHHHH----HHHHHHHHHHTCCTTBCCEEEEEEETT
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc----chhhHHH----HHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 568999999999999999999984 667888875322 2233333 489999999999999999999998765
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
+.|+|||||+||+|.+++.. ....+++..+..|+.||+.||+|||++|||||||||+|||++
T Consensus 97 --------------~~~ivmE~~~gg~L~~~l~~----~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~ 158 (350)
T d1koaa2 97 --------------EMVMIYEFMSGGELFEKVAD----EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFT 158 (350)
T ss_dssp --------------EEEEEECCCCSCBHHHHHTC----TTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES
T ss_pred --------------EEEEEEEcCCCCCHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeec
Confidence 45999999999999999853 234699999999999999999999999999999999999996
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+.. +.+||+|||+|+.+..... .....||+.|||||++.+ ..|+.++|||||||++|+|
T Consensus 159 ~~~~-----~~vkL~DFG~a~~~~~~~~-----------~~~~~gT~~Y~aPEv~~~----~~~~~~~DiwSlGvilyel 218 (350)
T d1koaa2 159 TKRS-----NELKLIDFGLTAHLDPKQS-----------VKVTTGTAEFAAPEVAEG----KPVGYYTDMWSVGVLSYIL 218 (350)
T ss_dssp STTS-----CCEEECCCTTCEECCTTSC-----------EEEECSCTTTCCHHHHHT----CCBCHHHHHHHHHHHHHHH
T ss_pred cCCC-----CeEEEeecchheecccccc-----------cceecCcccccCHHHHcC----CCCChhHhhhhhhHHHHHH
Confidence 5421 6899999999986543221 124579999999999986 5688999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
++|+.||.+.+..+....+.......... .....++.+.+||.+||+.||++|||+
T Consensus 219 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~s~~~~~li~~~L~~dP~~R~t~ 274 (350)
T d1koaa2 219 LSGLSPFGGENDDETLRNVKSCDWNMDDS------------------------AFSGISEDGKDFIRKLLLADPNTRMTI 274 (350)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHTCCCSCCG------------------------GGGGCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCCcc------------------------cccCCCHHHHHHHHHHccCChhHCcCH
Confidence 99999999888888887776544321111 011456779999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 001142 1124 GDLYEMFVARTS 1135 (1142)
Q Consensus 1124 ~EVL~~L~~~~s 1135 (1142)
+|+++|+|+...
T Consensus 275 ~eil~hp~~~~~ 286 (350)
T d1koaa2 275 HQALEHPWLTPG 286 (350)
T ss_dssp HHHHHSTTTSCT
T ss_pred HHHhcCcccCCC
Confidence 999999999754
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=421.80 Aligned_cols=266 Identities=22% Similarity=0.282 Sum_probs=214.8
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
+.|++.+.||+|+||+||+|++. +..+|+|+........... ......+.+|+.+|++++|||||++++++.+.+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~- 86 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRR--GVSREDIEREVSILKEIQHPNVITLHEVYENKT- 86 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSS--SBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhh--hHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-
Confidence 35999999999999999999984 6788999865433221111 111223489999999999999999999998765
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
+.|||||||++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 87 -------------~~~iv~E~~~gg~L~~~i~~-----~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~ 148 (293)
T d1jksa_ 87 -------------DVILILELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 148 (293)
T ss_dssp -------------EEEEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESC
T ss_pred -------------EEEEEEEcCCCccccchhcc-----ccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEec
Confidence 45999999999999999976 246999999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
++ .....+||+|||+|........ .....||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 149 ~~---~~~~~vkl~DfG~a~~~~~~~~-----------~~~~~~t~~y~APE~~~~----~~~~~~~DiwSlGvilyell 210 (293)
T d1jksa_ 149 RN---VPKPRIKIIDFGLAHKIDFGNE-----------FKNIFGTPEFVAPEIVNY----EPLGLEADMWSIGVITYILL 210 (293)
T ss_dssp SS---SSSCCEEECCCTTCEECTTSCB-----------CSCCCCCGGGCCHHHHTT----CCBCTHHHHHHHHHHHHHHH
T ss_pred CC---CcccceEecchhhhhhcCCCcc-----------ccccCCCCcccCHHHHcC----CCCCCcccchhhhHHHHHHH
Confidence 62 1124699999999976543221 124468999999999976 56899999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~ 1124 (1142)
+|+.||.+.+..+....+..+........ ....++.+.+||.+||+.||.+|||++
T Consensus 211 ~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~------------------------~~~~s~~~~~li~~~L~~dP~~R~s~~ 266 (293)
T d1jksa_ 211 SGASPFLGDTKQETLANVSAVNYEFEDEY------------------------FSNTSALAKDFIRRLLVKDPKKRMTIQ 266 (293)
T ss_dssp HSSCSSCCSSHHHHHHHHHTTCCCCCHHH------------------------HTTSCHHHHHHHHTTSCSSGGGSCCHH
T ss_pred cCCCCCCCCCHHHHHHHHHhcCCCCCchh------------------------cCCCCHHHHHHHHHHccCChhHCcCHH
Confidence 99999999888888777766543221111 114567799999999999999999999
Q ss_pred HHHHHHHhhcC
Q 001142 1125 DLYEMFVARTS 1135 (1142)
Q Consensus 1125 EVL~~L~~~~s 1135 (1142)
|+++|+|++..
T Consensus 267 eil~hp~~~~~ 277 (293)
T d1jksa_ 267 DSLQHPWIKPK 277 (293)
T ss_dssp HHHHSTTTCC-
T ss_pred HHhcCcccCCC
Confidence 99999999853
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.9e-46 Score=421.28 Aligned_cols=264 Identities=20% Similarity=0.337 Sum_probs=202.9
Q ss_pred CCCcceeeeecccCceEEEEEEECC---ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFGS---ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 882 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~~---~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~ 882 (1142)
..+|++.++||+|+||+||+|++.. ..++|+++.+... ......++| .+|+.+|++++|||||+++|++.+.
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~----~~E~~~l~~l~HpnIv~l~g~~~~~ 99 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDF----LSEASIMGQFDHPNVIHLEGVVTKS 99 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHHH----HHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc-cCHHHHHHH----HHHHHHHHhCCCCCCccEEEEEeeC
Confidence 4678999999999999999999842 3345555555432 233334445 8999999999999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
+.+ ++|||||++|+|.+++.. ....+++.++..|+.||+.||+|||++||+||||||+|||+
T Consensus 100 ~~~--------------~iv~Ey~~~g~L~~~~~~----~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl 161 (299)
T d1jpaa_ 100 TPV--------------MIITEFMENGSLDSFLRQ----NDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV 161 (299)
T ss_dssp SSC--------------EEEEECCTTEEHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred CEE--------------EEEEEecCCCcceeeecc----ccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEE
Confidence 544 999999999999998864 23469999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
+.+ +++||+|||+|+.+........ ........||+.|||||++.+ ..|+.++|||||||++||
T Consensus 162 ~~~-------~~~Kl~DFGla~~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~----~~~~~~sDvwS~Gvvl~e 225 (299)
T d1jpaa_ 162 NSN-------LVCKVSDFGLSRFLEDDTSDPT-----YTSALGGKIPIRWTAPEAIQY----RKFTSASDVWSYGIVMWE 225 (299)
T ss_dssp CTT-------CCEEECCC----------------------------CGGGSCHHHHHS----CCCCHHHHHHHHHHHHHH
T ss_pred CCC-------CcEEECCcccceEccCCCCcce-----eeecccccCCccccCHHHHhc----CCCCcccccccchHHHHH
Confidence 987 8899999999986544221110 011122358999999999876 578999999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1043 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1043 LLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
|+| |+.||.+....++...+..+..+..+. .+++.+.+|+.+||+.||++||
T Consensus 226 l~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~cl~~~P~~RP 278 (299)
T d1jpaa_ 226 VMSYGERPYWDMTNQDVINAIEQDYRLPPPM---------------------------DCPSALHQLMLDCWQKDRNHRP 278 (299)
T ss_dssp HHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSTTTSC
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------cchHHHHHHHHHHcCCCHhHCc
Confidence 998 899999888888888776655433221 4566799999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001142 1122 TAGDLYEMFVARTS 1135 (1142)
Q Consensus 1122 Sa~EVL~~L~~~~s 1135 (1142)
||.||+++|.....
T Consensus 279 s~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 279 KFGQIVNTLDKMIR 292 (299)
T ss_dssp CHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHhc
Confidence 99999999865433
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-46 Score=424.55 Aligned_cols=261 Identities=22% Similarity=0.216 Sum_probs=200.4
Q ss_pred CcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
.|++.+.||+|+||+||+|++. +..||+|+...+.. . ...+ .+.+|+.+|++++|||||++++++.+++
T Consensus 10 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~-~~~~----~~~~Ei~il~~l~HpnIv~l~~~~~~~~-- 80 (307)
T d1a06a_ 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--E-GKEG----SMENEIAVLHKIKHPNIVALDDIYESGG-- 80 (307)
T ss_dssp TEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------------CHHHHHHHTCCCTTBCCEEEEEECSS--
T ss_pred ceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHh--h-hHHH----HHHHHHHHHHhCCCCCCCcEEEEEEECC--
Confidence 4999999999999999999984 66788888643321 1 1112 3478999999999999999999998765
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
..|+|||||+||+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+...
T Consensus 81 ------------~~~lvmE~~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~ 143 (307)
T d1a06a_ 81 ------------HLYLIMQLVSGGELFDRIVE-----KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSL 143 (307)
T ss_dssp ------------EEEEEECCCCSCBHHHHHHT-----CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSS
T ss_pred ------------EEEEEEeccCCCcHHHhhhc-----ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeeccc
Confidence 35999999999999999975 3579999999999999999999999999999999999999642
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
. ..+.+||+|||+|+...... .....+||+.|||||++.+ ..|+.++|||||||++|||++
T Consensus 144 ~----~~~~vkl~DFG~a~~~~~~~-----------~~~~~~GT~~y~APE~~~~----~~~~~~~DiwSlGvilyell~ 204 (307)
T d1a06a_ 144 D----EDSKIMISDFGLSKMEDPGS-----------VLSTACGTPGYVAPEVLAQ----KPYSKAVDCWSIGVIAYILLC 204 (307)
T ss_dssp S----TTCCEEECCC-----------------------------CTTSCHHHHTT----CCCCTHHHHHHHHHHHHHHHH
T ss_pred C----CCceEEEeccceeEEccCCC-----------eeeeeeeCccccCcHHHcC----CCCCcHHHhhhhhHHHHHHHh
Confidence 1 12789999999997644321 1124569999999999976 578999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001142 1046 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1125 (1142)
Q Consensus 1046 G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~E 1125 (1142)
|+.||.+....+....+..+....... .....++.+.+|+.+||+.||++|||++|
T Consensus 205 g~~Pf~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e 260 (307)
T d1a06a_ 205 GYPPFYDENDAKLFEQILKAEYEFDSP------------------------YWDDISDSAKDFIRHLMEKDPEKRFTCEQ 260 (307)
T ss_dssp SSCSCCCSSHHHHHHHHHTTCCCCCTT------------------------TTTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCCCCCCCHHHHHHHHhccCCCCCCc------------------------cccCCCHHHHHHHHHHccCCHhHCcCHHH
Confidence 999999888888777776554321110 00145677999999999999999999999
Q ss_pred HHHHHHhhcCCC
Q 001142 1126 LYEMFVARTSSS 1137 (1142)
Q Consensus 1126 VL~~L~~~~ss~ 1137 (1142)
+++|+|++....
T Consensus 261 il~hp~~~~~~~ 272 (307)
T d1a06a_ 261 ALQHPWIAGDTA 272 (307)
T ss_dssp HHHSTTTTSSCC
T ss_pred HhcCHhhCCCCc
Confidence 999999986543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-47 Score=428.28 Aligned_cols=280 Identities=24% Similarity=0.319 Sum_probs=203.3
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
++|++.++||+|+||+||+|++. +..||+|+.+.+. . ..... ++.+|+.+|++++|||||++++++.+.+
T Consensus 6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~-~~~~~----~~~~Ei~il~~l~HpnIv~l~~~~~~~~- 77 (322)
T d1s9ja_ 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--K-PAIRN----QIIRELQVLHECNSPYIVGFYGAFYSDG- 77 (322)
T ss_dssp GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--C-TTHHH----HHHHHGGGGGGCCCTTBCCEEEEEECSS-
T ss_pred cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--C-HHHHH----HHHHHHHHHHhCCCCCCCcEEEEEEECC-
Confidence 57999999999999999999984 5678888765332 1 22223 3479999999999999999999998765
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeeec
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILID 963 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs-~gIvHrDLKp~NILld 963 (1142)
+.|+||||++||+|.+++.+ ...+++..++.++.||+.||.|||+ +||+||||||+|||++
T Consensus 78 -------------~~~iVmEy~~gg~L~~~l~~-----~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~ 139 (322)
T d1s9ja_ 78 -------------EISICMEHMDGGSLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN 139 (322)
T ss_dssp -------------EEEEEEECCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEEC
T ss_pred -------------EEEEEEEcCCCCcHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeEC
Confidence 45999999999999999976 2469999999999999999999997 5999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.+||+|||+|+...... ....+||+.|+|||++.+ ..|+.++||||+||++|||
T Consensus 140 ~~-------~~vkl~DFGla~~~~~~~------------~~~~~GT~~Y~APEvl~~----~~y~~~~DiWSlGvil~el 196 (322)
T d1s9ja_ 140 SR-------GEIKLCDFGVSGQLIDSM------------ANSFVGTRSYMSPERLQG----THYSVQSDIWSMGLSLVEM 196 (322)
T ss_dssp TT-------CCEEECCCCCCHHHHHHT------------C---CCSSCCCCHHHHHC----SCCCTTHHHHHHHHHHHHH
T ss_pred CC-------CCEEEeeCCCccccCCCc------------cccccCCccccCchHHcC----CCCCcHHHHHHHHHHHHHH
Confidence 87 789999999998654321 124579999999999986 6799999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHH---HhCCCCCchhHHhhhcccccccccccC-------------CCCCCchhhhhhHHHHHH
Q 001142 1044 LTLQVPYMGLSELEIHDLI---QMGKRPRLTDELEALGSCHEHEVAQSG-------------SGFEKPEAELETLSFLVD 1107 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I---~~~~~p~l~~~l~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~L~d 1107 (1142)
++|+.||.+.+..+..... ..+.....+.................. ............+.++.+
T Consensus 197 l~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 276 (322)
T d1s9ja_ 197 AVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQD 276 (322)
T ss_dssp HHSSCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHH
T ss_pred HHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHH
Confidence 9999999865433221110 111100000000000000000000000 000000011134678999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001142 1108 VFRRCTEENPTERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1108 LI~~CL~~DP~~RPSa~EVL~~L~~~~s 1135 (1142)
|+.+||+.||.+||||+|+++|+|++..
T Consensus 277 li~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 277 FVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 9999999999999999999999999854
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-46 Score=411.79 Aligned_cols=255 Identities=21% Similarity=0.358 Sum_probs=201.2
Q ss_pred CCCcceeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~-~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
..+|++.+.||+|+||+||+|++. +..||||+. +..... .++| .+|++++++++|||||+++|++.+.+.
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i--~~~~~~---~~~~----~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI--REGAMS---EEDF----IEEAEVMMKLSHPKLVQLYGVCLEQAP 74 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEEC--CSSSSC---HHHH----HHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEE--CCCcCc---HHHH----HHHHHHHHhcCCCCcccccceeccCCc
Confidence 457999999999999999999985 556888874 332222 2344 799999999999999999999987654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
. ++||||+++|+|.+++.. ....+++..+..|+.||+.||+|||+++|+||||||+|||++.
T Consensus 75 ~--------------~lv~E~~~~g~L~~~l~~----~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~ 136 (263)
T d1sm2a_ 75 I--------------CLVFEFMEHGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE 136 (263)
T ss_dssp C--------------EEEEECCTTCBHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECG
T ss_pred e--------------EEEEEecCCCcHHHHhhc----cccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecC
Confidence 4 999999999999999865 2356899999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||+|||+++........ ......||+.|+|||++.+ ..|+.++|||||||++|||+
T Consensus 137 ~-------~~~Kl~DFGla~~~~~~~~~---------~~~~~~gt~~y~aPE~l~~----~~~~~k~DVwS~Gvil~el~ 196 (263)
T d1sm2a_ 137 N-------QVIKVSDFGMTRFVLDDQYT---------SSTGTKFPVKWASPEVFSF----SRYSSKSDVWSFGVLMWEVF 196 (263)
T ss_dssp G-------GCEEECSCC---------------------------CTTSCCHHHHTT----CCCCHHHHHHHHHHHHHHHH
T ss_pred C-------CCeEecccchheeccCCCce---------eecceecCcccCChHHhcC----CCCCchhhhcchHHHHHHHH
Confidence 8 78999999999765432211 1123468999999999976 57899999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1045 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1045 t-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
| |.+||...+..++...+..+..+..+. ..++.+.+|+.+||+.||++||||
T Consensus 197 t~~~~~~~~~~~~~~~~~i~~~~~~~~p~---------------------------~~~~~l~~li~~cl~~~p~~Rps~ 249 (263)
T d1sm2a_ 197 SEGKIPYENRSNSEVVEDISTGFRLYKPR---------------------------LASTHVYQIMNHCWKERPEDRPAF 249 (263)
T ss_dssp TTSCCTTCSCCHHHHHHHHHHTCCCCCCT---------------------------TSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HCCCCCCCCCCHHHHHHHHHhcCCCCCcc---------------------------ccCHHHHHHHHHHccCCHhHCcCH
Confidence 9 577777777777777776665443221 345679999999999999999999
Q ss_pred HHHHHHHHhhc
Q 001142 1124 GDLYEMFVART 1134 (1142)
Q Consensus 1124 ~EVL~~L~~~~ 1134 (1142)
+||+++|....
T Consensus 250 ~~il~~L~~i~ 260 (263)
T d1sm2a_ 250 SRLLRQLAEIA 260 (263)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99999987654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.7e-46 Score=421.28 Aligned_cols=254 Identities=24% Similarity=0.325 Sum_probs=213.2
Q ss_pred CCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 882 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~ 882 (1142)
++++|++.+.||+|+||+||+|++. +..||+|+...... ........+.+|+.++++++|||||++++++.+.
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-----~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 76 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV-----VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA 76 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHc-----cCHHHHHHHHHHHHHHHhccCcChhheeeeEeeC
Confidence 5788999999999999999999984 67889998643211 1111123458999999999999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
+ +.|+||||++||+|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 77 ~--------------~~~ivmE~~~gg~l~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl 137 (316)
T d1fota_ 77 Q--------------QIFMIMDYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL 137 (316)
T ss_dssp S--------------EEEEEECCCCSCBHHHHHHH-----TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE
T ss_pred C--------------eeeeEeeecCCccccccccc-----cccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeE
Confidence 5 45999999999999999876 3568999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
+.+ +.+||+|||+|+..... .....||+.|||||++.+ ..|+.++|||||||++||
T Consensus 138 ~~~-------g~vkL~DFG~a~~~~~~-------------~~~~~Gt~~Y~APE~l~~----~~y~~~~DiwSlGvilye 193 (316)
T d1fota_ 138 DKN-------GHIKITDFGFAKYVPDV-------------TYTLCGTPDYIAPEVVST----KPYNKSIDWWSFGILIYE 193 (316)
T ss_dssp CTT-------SCEEECCCSSCEECSSC-------------BCCCCSCTTTCCHHHHTT----CCBCTTHHHHHHHHHHHH
T ss_pred cCC-------CCEEEecCccceEeccc-------------cccccCcccccCHHHHcC----CCCCchhhccccchhHHH
Confidence 887 78999999999765432 123579999999999976 568999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-
Q 001142 1043 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP- 1121 (1142)
Q Consensus 1043 LLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP- 1121 (1142)
|++|+.||.+.+..+....+..+.... + ...++++.+++.+||+.||.+||
T Consensus 194 mltG~~Pf~~~~~~~~~~~i~~~~~~~-p---------------------------~~~s~~~~~li~~~L~~dp~~R~~ 245 (316)
T d1fota_ 194 MLAGYTPFYDSNTMKTYEKILNAELRF-P---------------------------PFFNEDVKDLLSRLITRDLSQRLG 245 (316)
T ss_dssp HHHSSCTTCCSSHHHHHHHHHHCCCCC-C---------------------------TTSCHHHHHHHHHHTCSCTTTCTT
T ss_pred HHhCCCCCCCcCHHHHHHHHHcCCCCC-C---------------------------CCCCHHHHHHHHHHhhhCHHhccc
Confidence 999999999988888887776554211 1 03456799999999999999996
Q ss_pred ----CHHHHHHHHHhhc
Q 001142 1122 ----TAGDLYEMFVART 1134 (1142)
Q Consensus 1122 ----Sa~EVL~~L~~~~ 1134 (1142)
|++++++|+|++.
T Consensus 246 ~~r~t~~~il~Hp~f~~ 262 (316)
T d1fota_ 246 NLQNGTEDVKNHPWFKE 262 (316)
T ss_dssp SSTTTTHHHHTSGGGSS
T ss_pred cchhhHHHHHcCccccc
Confidence 9999999999975
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6.9e-46 Score=412.23 Aligned_cols=268 Identities=25% Similarity=0.366 Sum_probs=220.4
Q ss_pred CCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCC-ChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEec
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGS-SADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKIS 881 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~-~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~g~~~~ 881 (1142)
.++|++.+.||+|+||+||+|++ .+..+|+|+........ .....+....++.+|+.++++++ |||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 46899999999999999999998 56788899865443322 23344555567789999999997 9999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 001142 882 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 961 (1142)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NIL 961 (1142)
++. .||||||+++|+|.++++. ...+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 82 ~~~--------------~~ivmE~~~~g~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nil 142 (277)
T d1phka_ 82 NTF--------------FFLVFDLMKKGELFDYLTE-----KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENIL 142 (277)
T ss_dssp SSE--------------EEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred Ccc--------------eEEEEEcCCCchHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEE
Confidence 653 4999999999999999976 246999999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhcccc--CCCCCCchhhHHHHHHH
Q 001142 962 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH--KPNLYGLEVDIWSYGCL 1039 (1142)
Q Consensus 962 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~--~~~~~s~ksDVwSLGvi 1039 (1142)
++.+ +.+||+|||+++.+.... ......||+.|+|||++.+.. ....++.++||||+||+
T Consensus 143 l~~~-------~~~kl~DFG~a~~~~~~~-----------~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvi 204 (277)
T d1phka_ 143 LDDD-------MNIKLTDFGFSCQLDPGE-----------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI 204 (277)
T ss_dssp ECTT-------CCEEECCCTTCEECCTTC-----------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHH
T ss_pred EcCC-------CCeEEccchheeEccCCC-----------ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchh
Confidence 9887 789999999998654321 112356999999999987532 23457899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001142 1040 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1119 (1142)
Q Consensus 1040 L~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~ 1119 (1142)
+|||++|+.||.+.+..+....+..+....... .....++++++|+.+||+.||.+
T Consensus 205 lyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~s~~~~~li~~~L~~~p~~ 260 (277)
T d1phka_ 205 MYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP------------------------EWDDYSDTVKDLVSRFLVVQPQK 260 (277)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT------------------------TGGGSCHHHHHHHHHHCCSSGGG
T ss_pred hhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCc------------------------ccccCCHHHHHHHHHHccCChhH
Confidence 999999999999988877777776554321110 01156678999999999999999
Q ss_pred CCCHHHHHHHHHhhc
Q 001142 1120 RPTAGDLYEMFVART 1134 (1142)
Q Consensus 1120 RPSa~EVL~~L~~~~ 1134 (1142)
|||++||++|+|++.
T Consensus 261 R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 261 RYTAEEALAHPFFQQ 275 (277)
T ss_dssp SCCHHHHTTSGGGCT
T ss_pred CcCHHHHHcCHHHHH
Confidence 999999999999974
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-46 Score=423.74 Aligned_cols=258 Identities=22% Similarity=0.307 Sum_probs=214.8
Q ss_pred CCCCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001142 804 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 881 (1142)
Q Consensus 804 ~~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~ 881 (1142)
.++++|++.+.||+|+||.||+|++ .+..+|+|+...... ..+....++.+|+.+|++++|||||++++++.+
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~-----~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 76 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI-----IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT 76 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhc-----cCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc
Confidence 3578899999999999999999997 467888888643211 111122344799999999999999999999997
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 001142 882 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 961 (1142)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NIL 961 (1142)
.+. .|+||||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 77 ~~~--------------~~iv~ey~~gg~L~~~~~~-----~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIL 137 (337)
T d1o6la_ 77 HDR--------------LCFVMEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM 137 (337)
T ss_dssp SSE--------------EEEEEECCTTCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE
T ss_pred ccc--------------cccceeccCCCchhhhhhc-----ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeE
Confidence 664 4999999999999999986 346899999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001142 962 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1041 (1142)
Q Consensus 962 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ 1041 (1142)
++.+ +.+||+|||+|+....... .....+||+.|+|||++.+ ..|+.++||||+||++|
T Consensus 138 l~~~-------g~vkl~DFG~a~~~~~~~~----------~~~~~~GT~~Y~aPE~~~~----~~y~~~~DiwSlGvily 196 (337)
T d1o6la_ 138 LDKD-------GHIKITDFGLCKEGISDGA----------TMKTFCGTPEYLAPEVLED----NDYGRAVDWWGLGVVMY 196 (337)
T ss_dssp ECTT-------SCEEECCCTTCBCSCCTTC----------CBCCCEECGGGCCGGGGSS----SCBCTTHHHHHHHHHHH
T ss_pred ecCC-------CCEEEeecccccccccCCc----------ccccceeCHHHhhhhhccC----CCCChhhcccchhhHHH
Confidence 9987 8899999999976433211 1224579999999999986 57899999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1042 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1042 ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
||++|++||.+.+..++...+..+... ++. ..++++.+||.+||+.||.+||
T Consensus 197 eml~G~~pf~~~~~~~~~~~i~~~~~~-~p~---------------------------~~s~~~~dli~~~L~~dP~~R~ 248 (337)
T d1o6la_ 197 EMMCGRLPFYNQDHERLFELILMEEIR-FPR---------------------------TLSPEAKSLLAGLLKKDPKQRL 248 (337)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHCCCC-CCT---------------------------TSCHHHHHHHHHHTCSSTTTST
T ss_pred HHHHCCCCCCCcCHHHHHHHHhcCCCC-CCc---------------------------cCCHHHHHHHHhhccCCchhhc
Confidence 999999999998888887777654421 111 4456789999999999999999
Q ss_pred C-----HHHHHHHHHhhc
Q 001142 1122 T-----AGDLYEMFVART 1134 (1142)
Q Consensus 1122 S-----a~EVL~~L~~~~ 1134 (1142)
+ ++|+++|+|++.
T Consensus 249 ~~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 249 GGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp TCSTTTHHHHHTSGGGTT
T ss_pred ccccccHHHHHcCccccc
Confidence 4 999999999864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.7e-46 Score=428.10 Aligned_cols=260 Identities=20% Similarity=0.276 Sum_probs=213.5
Q ss_pred CCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
++.|++.++||+|+||+||+|++ .+..||+|+.... .....+. +.+|+.+|++++|||||++++++.+++
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~----~~~Ei~il~~l~HpnIv~~~~~~~~~~ 99 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKYT----VKNEISIMNQLHHPKLINLHDAFEDKY 99 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SHHHHHH----HHHHHHHHTTCCSTTBCCEEEEEECSS
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc----chhHHHH----HHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 45699999999999999999998 4677888875432 2222333 479999999999999999999998765
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
+.|||||||+||+|.+++.. ...++++.+++.|+.||+.||+|||++||+||||||+|||++
T Consensus 100 --------------~~~ivmE~~~gg~L~~~~~~----~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~ 161 (352)
T d1koba_ 100 --------------EMVLILEFLSGGELFDRIAA----EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCE 161 (352)
T ss_dssp --------------EEEEEEECCCCCBHHHHTTC----TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES
T ss_pred --------------EEEEEEEcCCCChHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccccccccccc
Confidence 34999999999999887653 234699999999999999999999999999999999999997
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.... +.+||+|||+|+.+.... ......||+.|+|||++.+ ..|+.++|||||||++|+|
T Consensus 162 ~~~~-----~~vkL~DFGla~~~~~~~-----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlGvilyel 221 (352)
T d1koba_ 162 TKKA-----SSVKIIDFGLATKLNPDE-----------IVKVTTATAEFAAPEIVDR----EPVGFYTDMWAIGVLGYVL 221 (352)
T ss_dssp STTC-----CCEEECCCTTCEECCTTS-----------CEEEECSSGGGCCHHHHTT----CCBCHHHHHHHHHHHHHHH
T ss_pred ccCC-----CeEEEeecccceecCCCC-----------ceeeccCcccccCHHHHcC----CCCCCccchHHHHHHHHHH
Confidence 4321 789999999998764322 1124568999999999976 5789999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
++|+.||.+.+..+....+..+........ ....++++.+||.+||+.||.+|||+
T Consensus 222 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~------------------------~~~~s~~~~~li~~~L~~dp~~R~s~ 277 (352)
T d1koba_ 222 LSGLSPFAGEDDLETLQNVKRCDWEFDEDA------------------------FSSVSPEAKDFIKNLLQKEPRKRLTV 277 (352)
T ss_dssp HHSCCSSCCSSHHHHHHHHHHCCCCCCSST------------------------TTTSCHHHHHHHHTTSCSSGGGSCCH
T ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCCccc------------------------ccCCCHHHHHHHHHHccCChhHCcCH
Confidence 999999999888888777766543211100 01456779999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 001142 1124 GDLYEMFVARTS 1135 (1142)
Q Consensus 1124 ~EVL~~L~~~~s 1135 (1142)
.|+++|+|++..
T Consensus 278 ~eil~Hp~~~~~ 289 (352)
T d1koba_ 278 HDALEHPWLKGD 289 (352)
T ss_dssp HHHHTSTTTSSC
T ss_pred HHHhcCHhhCCC
Confidence 999999999754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-46 Score=418.75 Aligned_cols=284 Identities=22% Similarity=0.226 Sum_probs=205.4
Q ss_pred eeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCC
Q 001142 811 SCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 888 (1142)
Q Consensus 811 l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~~ 888 (1142)
..++||+|+||+||+|++ .++.||+|+....... ...+.+..++.+|+.++++++|||||++++++.+++.+
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~--- 75 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRS---EAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI--- 75 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC---------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC---
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhh---hhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCce---
Confidence 568999999999999997 4667888875433221 11122334458999999999999999999999876644
Q ss_pred CCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecccccc
Q 001142 889 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 968 (1142)
Q Consensus 889 ~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~ 968 (1142)
|+||||++++++..+.. ....+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 76 -----------~ivmE~~~~~~~~~~~~-----~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~--- 136 (299)
T d1ua2a_ 76 -----------SLVFDFMETDLEVIIKD-----NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN--- 136 (299)
T ss_dssp -----------EEEEECCSEEHHHHHTT-----CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---
T ss_pred -----------eehhhhhcchHHhhhhh-----cccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCC---
Confidence 99999999776665543 24578999999999999999999999999999999999999987
Q ss_pred CCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCC
Q 001142 969 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV 1048 (1142)
Q Consensus 969 ~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG~~ 1048 (1142)
+.+||+|||+|+....... .....+||+.|+|||++.. ...|+.++|||||||++|||++|++
T Consensus 137 ----~~~KL~DFG~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwSlGvil~el~~g~~ 199 (299)
T d1ua2a_ 137 ----GVLKLADFGLAKSFGSPNR----------AYTHQVVTRWYRAPELLFG---ARMYGVGVDMWAVGCILAELLLRVP 199 (299)
T ss_dssp ----CCEEECCCGGGSTTTSCCC----------CCCCSCCCCTTCCHHHHTT---CSCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred ----CccccccCccccccCCCcc----------cccceecChhhccHHHHcc---CCCCChhhhhhhcchHHHHHHhCcC
Confidence 7899999999976543211 1224579999999999875 2468999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001142 1049 PYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1128 (1142)
Q Consensus 1049 Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~ 1128 (1142)
||.+.+..+....+...........+...........................++++.+|+.+||+.||++||||+|+++
T Consensus 200 pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 200 FLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp SSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 99988887776666432111111111000000000000000000001111245678999999999999999999999999
Q ss_pred HHHhhcCC
Q 001142 1129 MFVARTSS 1136 (1142)
Q Consensus 1129 ~L~~~~ss 1136 (1142)
|+|++...
T Consensus 280 Hp~f~~~p 287 (299)
T d1ua2a_ 280 MKYFSNRP 287 (299)
T ss_dssp SGGGTSSS
T ss_pred CHhhCCCC
Confidence 99998653
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=417.98 Aligned_cols=259 Identities=21% Similarity=0.277 Sum_probs=213.7
Q ss_pred CCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
+++|++.+.||+|+||+||+|.+. +..+|+|+...+ . ..... +.+|+++|++++|||||++++++.+++
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~----~-~~~~~----~~~Ei~il~~l~HpnIv~~~~~~~~~~ 74 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----G-TDQVL----VKKEISILNIARHRNILHLHESFESME 74 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----T-HHHHH----HHHHHHHHHHSCCTTBCCEEEEEEETT
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC----c-ccHHH----HHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 578999999999999999999984 667888876432 1 22222 479999999999999999999998765
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
+.|+|||||+||+|.+++.. ....+++.++..|+.||+.||+|||++||+||||||+|||++
T Consensus 75 --------------~~~lvmE~~~gg~L~~~i~~----~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~ 136 (321)
T d1tkia_ 75 --------------ELVMIFEFISGLDIFERINT----SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQ 136 (321)
T ss_dssp --------------EEEEEECCCCCCBHHHHHTS----SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES
T ss_pred --------------EEEEEEecCCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeec
Confidence 35999999999999999864 234699999999999999999999999999999999999997
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+.. ..+||+|||+++....... .....||+.|+|||.+.+ ..|+.++|||||||++|+|
T Consensus 137 ~~~~-----~~ikl~DFG~~~~~~~~~~-----------~~~~~~t~~y~ape~~~~----~~~~~~~DiWSlGvily~l 196 (321)
T d1tkia_ 137 TRRS-----STIKIIEFGQARQLKPGDN-----------FRLLFTAPEYYAPEVHQH----DVVSTATDMWSLGTLVYVL 196 (321)
T ss_dssp SSSC-----CCEEECCCTTCEECCTTCE-----------EEEEESCGGGSCHHHHTT----CEECHHHHHHHHHHHHHHH
T ss_pred CCCc-----eEEEEcccchhhccccCCc-----------ccccccccccccchhccC----CCCCchhhcccHHHHHHHH
Confidence 6522 6899999999976543221 123468999999999876 5688999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
++|+.||.+.+..++...+..+........+ ...++++.+||.+||+.||.+|||+
T Consensus 197 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~------------------------~~~s~~~~~li~~~L~~dp~~R~s~ 252 (321)
T d1tkia_ 197 LSGINPFLAETNQQIIENIMNAEYTFDEEAF------------------------KEISIEAMDFVDRLLVKERKSRMTA 252 (321)
T ss_dssp HHSSCTTCCSSHHHHHHHHHHTCCCCCHHHH------------------------TTSCHHHHHHHHTTSCSSGGGSCCH
T ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCChhhc------------------------cCCCHHHHHHHHHHccCChhHCcCH
Confidence 9999999998888888887665433221111 1456679999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 001142 1124 GDLYEMFVARTS 1135 (1142)
Q Consensus 1124 ~EVL~~L~~~~s 1135 (1142)
+|+++|+|++..
T Consensus 253 ~eil~hp~~~~~ 264 (321)
T d1tkia_ 253 SEALQHPWLKQK 264 (321)
T ss_dssp HHHHHSHHHHSC
T ss_pred HHHhcCHhhccC
Confidence 999999999754
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-45 Score=407.56 Aligned_cols=249 Identities=21% Similarity=0.338 Sum_probs=199.5
Q ss_pred eeecccCceEEEEEEEC----CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCC
Q 001142 813 DEAGKSVSSSLFRCKFG----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 888 (1142)
Q Consensus 813 ~~LG~GsfG~Vy~a~~~----~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~~~ 888 (1142)
++||+|+||+||+|.+. +..||||+.+.. .......+. +.+|+.+|++++|||||+++|++..+.
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~----~~~E~~il~~l~HpnIv~~~g~~~~~~----- 81 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE--ANDPALKDE----LLAEANVMQQLDNPYIVRMIGICEAES----- 81 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHH----HHHHHHHHHTCCCTTBCCEEEEEESSS-----
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChh--hCCHHHHHH----HHHHHHHHHhCCCCCCceEEEEeccCC-----
Confidence 47999999999999873 245778875322 222222333 489999999999999999999986432
Q ss_pred CCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecccccc
Q 001142 889 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 968 (1142)
Q Consensus 889 ~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~~~ 968 (1142)
.+|||||+++|+|.++++. ...+++..+..|+.||+.||+|||+++|+||||||+|||++.+
T Consensus 82 ----------~~lvmE~~~~g~L~~~l~~-----~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~--- 143 (277)
T d1xbba_ 82 ----------WMLVMEMAELGPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ--- 143 (277)
T ss_dssp ----------EEEEEECCTTEEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET---
T ss_pred ----------EEEEEEcCCCCcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhccccc---
Confidence 3899999999999999976 3569999999999999999999999999999999999999987
Q ss_pred CCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-CC
Q 001142 969 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQ 1047 (1142)
Q Consensus 969 ~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt-G~ 1047 (1142)
+.+||+|||+|+.+........ ......||+.|||||++.+ ..++.++|||||||++|||+| |+
T Consensus 144 ----~~~kl~DFGla~~~~~~~~~~~-------~~~~~~gt~~y~APE~l~~----~~~~~~sDiwS~Gv~l~ellt~g~ 208 (277)
T d1xbba_ 144 ----HYAKISDFGLSKALRADENYYK-------AQTHGKWPVKWYAPECINY----YKFSSKSDVWSFGVLMWEAFSYGQ 208 (277)
T ss_dssp ----TEEEECCCTTCEECCTTCSEEE-------C----CCCGGGCCHHHHHH----CEEEHHHHHHHHHHHHHHHHTTTC
T ss_pred ----Ccccccchhhhhhccccccccc-------cccccCCCceecCchhhcC----CCCCchhhhccchhhhhHHhhCCC
Confidence 8899999999986543221110 1223468999999999976 568899999999999999998 89
Q ss_pred CCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHH
Q 001142 1048 VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY 1127 (1142)
Q Consensus 1048 ~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL 1127 (1142)
.||.+.+..++...+..+.++..+. .+++++.+|+.+||+.||++|||+++|+
T Consensus 209 ~Pf~~~~~~~~~~~i~~~~~~~~p~---------------------------~~~~~~~~li~~cl~~dp~~RPs~~~i~ 261 (277)
T d1xbba_ 209 KPYRGMKGSEVTAMLEKGERMGCPA---------------------------GCPREMYDLMNLCWTYDVENRPGFAAVE 261 (277)
T ss_dssp CSSTTCCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCc---------------------------ccCHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 9999988888888887766544331 4556799999999999999999999995
Q ss_pred ---HHHHh
Q 001142 1128 ---EMFVA 1132 (1142)
Q Consensus 1128 ---~~L~~ 1132 (1142)
+++|+
T Consensus 262 ~~L~~~~~ 269 (277)
T d1xbba_ 262 LRLRNYYY 269 (277)
T ss_dssp HHHHHHHH
T ss_pred HHhhCHHh
Confidence 45554
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-45 Score=403.34 Aligned_cols=252 Identities=25% Similarity=0.351 Sum_probs=210.4
Q ss_pred CCCcceeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~-~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
.++|++.++||+|+||+||+|++. +..||||+.+.. ... .++| .+|+.++++++|||||+++|++.+++.
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~--~~~---~~~~----~~Ev~~~~~l~HpnIv~~~g~~~~~~~ 73 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG--SMS---EDEF----IEEAKVMMNLSHEKLVQLYGVCTKQRP 73 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS--SSC---HHHH----HHHHHHHHTCCCTTBCCEEEEECCSSS
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC--cCC---HHHH----HHHHHHHHhcCCCceeeEEEEEeeCCc
Confidence 468899999999999999999995 457888875432 222 2344 799999999999999999999986553
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
.++||||+++|+|..++.. ....+++..+.+|+.||++||+|||++||+||||||+|||++.
T Consensus 74 --------------~~iv~Ey~~~g~l~~~~~~----~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~ 135 (258)
T d1k2pa_ 74 --------------IFIITEYMANGCLLNYLRE----MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVND 135 (258)
T ss_dssp --------------EEEEEECCTTEEHHHHHHS----GGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECT
T ss_pred --------------eEEEEEccCCCcHHHhhhc----cccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcC
Confidence 4999999999999999764 2346899999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 136 ~-------~~~kl~DfG~a~~~~~~~~~---------~~~~~~~t~~y~aPE~~~~----~~~~~ksDiwS~G~~l~el~ 195 (258)
T d1k2pa_ 136 Q-------GVVKVSDFGLSRYVLDDEYT---------SSVGSKFPVRWSPPEVLMY----SKFSSKSDIWAFGVLMWEIY 195 (258)
T ss_dssp T-------CCEEECCCSSCCBCSSSSCC---------CCCCSCCCGGGCCHHHHHH----CCCCHHHHHHHHHHHHHHHH
T ss_pred C-------CcEEECcchhheeccCCCce---------eecccCCCCCcCCcHHhcC----CCCCcceeecccchhhHhHH
Confidence 7 78999999999765432211 1223568999999999986 56899999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1045 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1045 t-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
| |+.||.+.+..++...+..+.++..+. ..++.+.+|+.+||+.||++|||+
T Consensus 196 t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~---------------------------~~~~~l~~li~~cl~~dP~~RPt~ 248 (258)
T d1k2pa_ 196 SLGKMPYERFTNSETAEHIAQGLRLYRPH---------------------------LASEKVYTIMYSCWHEKADERPTF 248 (258)
T ss_dssp TTSCCTTTTSCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHTTCSSGGGSCCH
T ss_pred hcCCCCCCCCCHHHHHHHHHhCCCCCCcc---------------------------cccHHHHHHHHHHccCCHhHCcCH
Confidence 8 899999988888888887665443321 345679999999999999999999
Q ss_pred HHHHHHHH
Q 001142 1124 GDLYEMFV 1131 (1142)
Q Consensus 1124 ~EVL~~L~ 1131 (1142)
+||++||.
T Consensus 249 ~eil~~L~ 256 (258)
T d1k2pa_ 249 KILLSNIL 256 (258)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHhh
Confidence 99999984
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.4e-45 Score=409.97 Aligned_cols=255 Identities=23% Similarity=0.407 Sum_probs=206.5
Q ss_pred CCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
.++|++.++||+|+||+||+|++. +..||||+. +.... ..++| .+|+++|++++|||||++++++.+.+
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i--~~~~~---~~~~~----~~E~~il~~l~HpnIv~~~~~~~~~~ 86 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTM---EVEEF----LKEAAVMKEIKHPNLVQLLGVCTREP 86 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEEC--CTTCS---CHHHH----HHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEE--CCccc---hHHHH----HHHHHHHHhCCCCCEecCCccEeeCC
Confidence 457999999999999999999985 556777763 33221 22344 79999999999999999999998765
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
.+ ++||||+++|+|.+++.. .....+++..+..|+.||+.||+|||++||+||||||+|||++
T Consensus 87 ~~--------------~iv~E~~~~g~l~~~l~~---~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~ 149 (287)
T d1opja_ 87 PF--------------YIITEFMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG 149 (287)
T ss_dssp SC--------------EEEEECCTTCBHHHHHHH---SCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred ee--------------EEEeecccCcchHHHhhh---ccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEEC
Confidence 44 999999999999999976 3345799999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.+||+|||+|+........ ......||+.|+|||++.+ ..|+.++|||||||++|||
T Consensus 150 ~~-------~~~Kl~DFG~a~~~~~~~~~---------~~~~~~g~~~y~aPE~~~~----~~~~~k~DiwS~Gv~l~el 209 (287)
T d1opja_ 150 EN-------HLVKVADFGLSRLMTGDTYT---------AHAGAKFPIKWTAPESLAY----NKFSIKSDVWAFGVLLWEI 209 (287)
T ss_dssp GG-------GCEEECCCCCTTTCCSSSSE---------EETTEEECGGGCCHHHHHH----CCCSHHHHHHHHHHHHHHH
T ss_pred CC-------CcEEEccccceeecCCCCce---------eeccccccccccChHHHcC----CCCCchhhhhhHHHHHHHH
Confidence 87 78999999999865432211 1123458899999999886 5789999999999999999
Q ss_pred HhCCCC-CCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1044 LTLQVP-YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1044 LtG~~P-f~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
++|..| |.+.+..++.+.+..+..+..+. ..++.+.+|+.+||+.||++|||
T Consensus 210 l~~~~p~~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~cl~~dP~~Rps 262 (287)
T d1opja_ 210 ATYGMSPYPGIDLSQVYELLEKDYRMERPE---------------------------GCPEKVYELMRACWQWNPSDRPS 262 (287)
T ss_dssp HTTSCCSSTTCCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HhCCCCCCCcchHHHHHHHHhcCCCCCCCc---------------------------cchHHHHHHHHHHcCCCHhHCcC
Confidence 996555 55566666666666554433221 45567999999999999999999
Q ss_pred HHHHHHHHHhh
Q 001142 1123 AGDLYEMFVAR 1133 (1142)
Q Consensus 1123 a~EVL~~L~~~ 1133 (1142)
++||++.+...
T Consensus 263 ~~ei~~~L~~~ 273 (287)
T d1opja_ 263 FAEIHQAFETM 273 (287)
T ss_dssp HHHHHHHHHHT
T ss_pred HHHHHHHHHHH
Confidence 99999877543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-45 Score=407.95 Aligned_cols=256 Identities=22% Similarity=0.307 Sum_probs=206.5
Q ss_pred CCcceeee-ecccCceEEEEEEEC----CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001142 807 PSLSSCDE-AGKSVSSSLFRCKFG----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 881 (1142)
Q Consensus 807 ~~y~l~~~-LG~GsfG~Vy~a~~~----~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~ 881 (1142)
++|.+.+. ||+|+||+||+|.+. +..||||+. +.. ......+.| .+|+++|++++|||||+++|++.+
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l--~~~-~~~~~~~~~----~~E~~il~~l~HpnIv~l~g~~~~ 80 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQG-TEKADTEEM----MREAQIMHQLDNPYIVRLIGVCQA 80 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEE--CSS-CCHHHHHHH----HHHHHHHHHCCCTTBCCEEEEEES
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEE--Chh-cCHHHHHHH----HHHHHHHHhCCCCCEeeEeeeecc
Confidence 35778784 999999999999873 234677764 322 233344444 899999999999999999999864
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 001142 882 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 961 (1142)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NIL 961 (1142)
+ ..|+||||+++|+|.+++.. ....+++..+..|+.||+.||+|||++||+||||||+|||
T Consensus 81 ~---------------~~~lvmE~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nil 141 (285)
T d1u59a_ 81 E---------------ALMLVMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVL 141 (285)
T ss_dssp S---------------SEEEEEECCTTEEHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred C---------------eEEEEEEeCCCCcHHHHhhc----cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhhee
Confidence 3 24899999999999998754 2356999999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001142 962 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1041 (1142)
Q Consensus 962 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ 1041 (1142)
++.+ +.+||+|||+|+.+....... .......||+.|+|||++.+ ..++.++|||||||++|
T Consensus 142 l~~~-------~~~Kl~DFGla~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~----~~~~~ksDVwS~Gv~l~ 203 (285)
T d1u59a_ 142 LVNR-------HYAKISDFGLSKALGADDSYY-------TARSAGKWPLKWYAPECINF----RKFSSRSDVWSYGVTMW 203 (285)
T ss_dssp EEET-------TEEEECCCTTCEECTTCSCEE-------CCCCSSCCCGGGCCHHHHHH----CEECHHHHHHHHHHHHH
T ss_pred eccC-------Cceeeccchhhhccccccccc-------ccccccccCccccChHHHhC----CCCCccchhhcchHHHH
Confidence 9987 889999999998765432111 11224468999999999976 56899999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1042 ELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1042 ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
||+| |+.||.+.+..++...+..+.++..+. .+++++.+|+.+||+.||++|
T Consensus 204 E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~---------------------------~~~~~l~~li~~cl~~~p~~R 256 (285)
T d1u59a_ 204 EALSYGQKPYKKMKGPEVMAFIEQGKRMECPP---------------------------ECPPELYALMSDCWIYKWEDR 256 (285)
T ss_dssp HHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHTTCSSGGGS
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------cCCHHHHHHHHHHcCCCHhHC
Confidence 9998 899999888888888887766554332 455679999999999999999
Q ss_pred CCHHHHHH---HHHhh
Q 001142 1121 PTAGDLYE---MFVAR 1133 (1142)
Q Consensus 1121 PSa~EVL~---~L~~~ 1133 (1142)
|||.+|++ ++|+.
T Consensus 257 Ps~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 257 PDFLTVEQRMRACYYS 272 (285)
T ss_dssp CCHHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHHHH
Confidence 99999955 45554
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.3e-45 Score=419.90 Aligned_cols=256 Identities=23% Similarity=0.281 Sum_probs=213.5
Q ss_pred CCCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001142 804 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 881 (1142)
Q Consensus 804 ~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~ 881 (1142)
..+++|++.+.||+|+||+||+|++. +..+|+|+...... ........+.+|+.+|++++|||||++++++.+
T Consensus 38 ~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~-----~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 112 (350)
T d1rdqe_ 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-----VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD 112 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHc-----cCHHHHHHHHHHHHHHHHcCCCcEeeccccccc
Confidence 34678999999999999999999984 67889998542211 111112344799999999999999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 001142 882 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 961 (1142)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NIL 961 (1142)
.. ..++||||+.+|+|..++.. ...+++..++.|+.||+.||.|||++|||||||||+|||
T Consensus 113 ~~--------------~~~~v~e~~~~g~l~~~l~~-----~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NIL 173 (350)
T d1rdqe_ 113 NS--------------NLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173 (350)
T ss_dssp SS--------------EEEEEEECCTTCBHHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred cc--------------ccccccccccccchhhhHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcc
Confidence 55 34999999999999999976 246999999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001142 962 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1041 (1142)
Q Consensus 962 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ 1041 (1142)
++.+ +.+||+|||+|+..... .....||+.|||||++.+ ..|+.++|||||||++|
T Consensus 174 l~~~-------g~ikL~DFG~a~~~~~~-------------~~~~~Gt~~Y~APE~~~~----~~~~~~~DiwSlGvily 229 (350)
T d1rdqe_ 174 IDQQ-------GYIQVTDFGFAKRVKGR-------------TWTLCGTPEALAPEIILS----KGYNKAVDWWALGVLIY 229 (350)
T ss_dssp ECTT-------SCEEECCCTTCEECSSC-------------BCCCEECGGGCCHHHHTT----CCBCTHHHHHHHHHHHH
T ss_pred cCCC-------CCEEeeeceeeeecccc-------------cccccCccccCCHHHHcC----CCCCccccccchhHHHH
Confidence 9887 78999999999865431 123569999999999986 56889999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC-
Q 001142 1042 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER- 1120 (1142)
Q Consensus 1042 ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~R- 1120 (1142)
||+||+.||.+.+...+...+..+..... ...++++.+||.+||+.||.+|
T Consensus 230 emltG~~Pf~~~~~~~~~~~i~~~~~~~p----------------------------~~~s~~~~~li~~~L~~dP~kR~ 281 (350)
T d1rdqe_ 230 EMAAGYPPFFADQPIQIYEKIVSGKVRFP----------------------------SHFSSDLKDLLRNLLQVDLTKRF 281 (350)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHCCCCCC----------------------------TTCCHHHHHHHHHHSCSCTTTCT
T ss_pred HHHhCCCCCCCcCHHHHHHHHhcCCCCCC----------------------------ccCCHHHHHHHHHHhhhCHHhcc
Confidence 99999999999888887777765542211 1445679999999999999999
Q ss_pred ----CCHHHHHHHHHhhcC
Q 001142 1121 ----PTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1121 ----PSa~EVL~~L~~~~s 1135 (1142)
||++|+++|+|++..
T Consensus 282 ~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 282 GNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp TSSTTTTHHHHTSGGGTTC
T ss_pred ccccccHHHHHcCccccCC
Confidence 499999999999753
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=406.77 Aligned_cols=251 Identities=24% Similarity=0.414 Sum_probs=203.2
Q ss_pred CCCcceeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~-~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
.++|++.++||+|+||+||+|++. +..||||+.. ..... .+.| .+|+.++++++|||||+++|++.++.
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~--~~~~~---~~~~----~~E~~~l~~l~HpnIv~~~g~~~~~~- 81 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK--QGSMS---PDAF----LAEANLMKQLQHQRLVRLYAVVTQEP- 81 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEEC--TTSSC---HHHH----HHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEc--cCcCC---HHHH----HHHHHHHHhCCCCCEeEEEeeeccCC-
Confidence 467999999999999999999995 4678888753 22211 2334 79999999999999999999875422
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
.++||||+++|+|.+++.... ...+++..+..|+.||+.||.|||+++|+||||||+|||++.
T Consensus 82 --------------~~iv~Ey~~~g~L~~~~~~~~---~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~ 144 (272)
T d1qpca_ 82 --------------IYIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSD 144 (272)
T ss_dssp --------------CEEEEECCTTCBHHHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred --------------eEEEEEeCCCCcHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeec
Confidence 389999999999999875421 235899999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||+|||+|+........ ......||+.|+|||++.. ..++.++|||||||++|||+
T Consensus 145 ~-------~~~Kl~DFGla~~~~~~~~~---------~~~~~~gt~~y~APE~~~~----~~~~~~sDvwS~Gvvl~ell 204 (272)
T d1qpca_ 145 T-------LSCKIADFGLARLIEDNEYT---------AREGAKFPIKWTAPEAINY----GTFTIKSDVWSFGILLTEIV 204 (272)
T ss_dssp T-------SCEEECCCTTCEECSSSCEE---------CCTTCCCCTTTSCHHHHHH----CEECHHHHHHHHHHHHHHHH
T ss_pred c-------cceeeccccceEEccCCccc---------cccccCCcccccChHHHhC----CCCCchhhhhhhHHHHHHHH
Confidence 7 88999999999876432211 1223468999999999976 56889999999999999999
Q ss_pred hC-CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1045 TL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1045 tG-~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
|| .+||......++...+..+..+..+. ..++.+.+|+.+||+.||++||||
T Consensus 205 t~~~~~~~~~~~~~~~~~i~~~~~~~~p~---------------------------~~~~~l~~li~~cl~~~P~~Rpt~ 257 (272)
T d1qpca_ 205 THGRIPYPGMTNPEVIQNLERGYRMVRPD---------------------------NCPEELYQLMRLCWKERPEDRPTF 257 (272)
T ss_dssp TTTCCSSTTCCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred hCCCCCCCCCCHHHHHHHHHhcCCCCCcc---------------------------cChHHHHHHHHHHcCCCHhHCcCH
Confidence 95 55666667777777776655443321 445679999999999999999999
Q ss_pred HHHHHHH
Q 001142 1124 GDLYEMF 1130 (1142)
Q Consensus 1124 ~EVL~~L 1130 (1142)
+||++.|
T Consensus 258 ~ei~~~L 264 (272)
T d1qpca_ 258 DYLRSVL 264 (272)
T ss_dssp HHHHHHH
T ss_pred HHHHHHh
Confidence 9999854
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.2e-45 Score=423.63 Aligned_cols=263 Identities=20% Similarity=0.257 Sum_probs=204.2
Q ss_pred CCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 882 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~ 882 (1142)
++++|++.++||+|+||.||+|++. +..||+|+...... ..........+...|+.+++.++|||||++++++.+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~--~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~ 79 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI--KMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 79 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHc--chhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC
Confidence 5789999999999999999999984 67788888542211 0111111111113457778888999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
+ ..|+||||++||+|.+++.. ...+++..++.|+.||+.||.|||++|||||||||+|||+
T Consensus 80 ~--------------~~~ivmE~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl 140 (364)
T d1omwa3 80 D--------------KLSFILDLMNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL 140 (364)
T ss_dssp S--------------EEEEEECCCCSCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred C--------------EEEEEEEecCCCcHHHHHHh-----cccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEE
Confidence 5 34999999999999999976 2468999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
+.+ +.+||+|||+|+.+... ......||+.|+|||++.. +..|+.++|||||||++||
T Consensus 141 ~~~-------g~iKl~DFGla~~~~~~------------~~~~~~GT~~y~APE~~~~---~~~~~~~~DiwSlGvilye 198 (364)
T d1omwa3 141 DEH-------GHVRISDLGLACDFSKK------------KPHASVGTHGYMAPEVLQK---GVAYDSSADWFSLGCMLFK 198 (364)
T ss_dssp CSS-------SCEEECCCTTCEECSSS------------CCCSCCSCGGGCCHHHHST---TCCCCTHHHHHHHHHHHHH
T ss_pred cCC-------CcEEEeeeceeeecCCC------------cccccccccccchhHHhhc---CCCCCcccchhHHHHHHHH
Confidence 887 78999999999765432 1224569999999999864 2468999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1043 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1043 LLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
|+||+.||.+....+.............. .....++.+.+||.+||+.||.+|||
T Consensus 199 mltG~~Pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~s~~~~~li~~~L~~dP~~R~t 253 (364)
T d1omwa3 199 LLRGHSPFRQHKTKDKHEIDRMTLTMAVE-------------------------LPDSFSPELRSLLEGLLQRDVNRRLG 253 (364)
T ss_dssp HHHSSCSSCSSCSSCHHHHHHHSSSCCCC-------------------------CCSSSCHHHHHHHHHHTCSSTTTSTT
T ss_pred HHhCCCCCCCCCHHHHHHHHHhcccCCCC-------------------------CCCCCCHHHHHHHHHHcccCHHHhCC
Confidence 99999999865433322222211111000 00145667999999999999999999
Q ss_pred -----HHHHHHHHHhhcC
Q 001142 1123 -----AGDLYEMFVARTS 1135 (1142)
Q Consensus 1123 -----a~EVL~~L~~~~s 1135 (1142)
|+|+++|+|++.-
T Consensus 254 ~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 254 CLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp TSSSTHHHHHTSGGGTTC
T ss_pred CcccCHHHHHcCccccCC
Confidence 8999999999753
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=402.26 Aligned_cols=258 Identities=22% Similarity=0.352 Sum_probs=199.9
Q ss_pred CCCcceeeeecccCceEEEEEEECCc------cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeE
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFGSA------DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 879 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~~~------~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~ 879 (1142)
...|++.++||+|+||+||+|.+... .||||+.. .. .......+| .+|+.++++++|||||+++|++
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~--~~-~~~~~~~~~----~~E~~il~~l~H~nIv~~~g~~ 78 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK--AG-YTEKQRVDF----LGEAGIMGQFSHHNIIRLEGVI 78 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEEC--TT-CCHHHHHHH----HHHHHHHHTCCCTTBCCEEEEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEEC--cc-cChHHHHHH----HHHHHHHHhcCCCCEeeeeEEE
Confidence 35689999999999999999987432 46666643 22 223333344 8999999999999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 001142 880 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959 (1142)
Q Consensus 880 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~N 959 (1142)
.+... .++||||+.++++.+++.. ....+++..+..|+.||+.||+|||+++|+||||||+|
T Consensus 79 ~~~~~--------------~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~N 140 (283)
T d1mqba_ 79 SKYKP--------------MMIITEYMENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARN 140 (283)
T ss_dssp CSSSS--------------EEEEEECCTTEEHHHHHHH----TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred ecCCc--------------eEEEEEecccCcchhhhhc----ccccccHHHHHHHHHHHHHhhhhccccccccCccccce
Confidence 86553 4999999999999998875 23569999999999999999999999999999999999
Q ss_pred eeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001142 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039 (1142)
Q Consensus 960 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGvi 1039 (1142)
||++.+ +.+||+|||+|+.+....... .......||+.|+|||++.+ ..++.++|||||||+
T Consensus 141 ILl~~~-------~~~Kl~DFGla~~~~~~~~~~-------~~~~~~~gt~~Y~APE~l~~----~~~~~~sDI~S~Gvi 202 (283)
T d1mqba_ 141 ILVNSN-------LVCKVSDFGLSRVLEDDPEAT-------YTTSGGKIPIRWTAPEAISY----RKFTSASDVWSFGIV 202 (283)
T ss_dssp EEECTT-------CCEEECCCCC------------------------CCCGGGSCHHHHHS----CCCCHHHHHHHHHHH
T ss_pred EEECCC-------CeEEEcccchhhcccCCCccc-------eEeccCCCCccccCHHHHcc----CCCCCcccccccHHH
Confidence 999987 889999999998654322110 11223458999999999876 578999999999999
Q ss_pred HHHHHhC-CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001142 1040 LLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1118 (1142)
Q Consensus 1040 L~ELLtG-~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~ 1118 (1142)
+|||+++ .+|+.+.+..++...+..+.++..+. ..++.+.+|+.+||+.||+
T Consensus 203 l~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~cl~~~p~ 255 (283)
T d1mqba_ 203 MWEVMTYGERPYWELSNHEVMKAINDGFRLPTPM---------------------------DCPSAIYQLMMQCWQQERA 255 (283)
T ss_dssp HHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT---------------------------TCBHHHHHHHHHHTCSSTT
T ss_pred HHHHHhCCCCccccCCHHHHHHHHhccCCCCCch---------------------------hhHHHHHHHHHHHCcCCHh
Confidence 9999995 55566666777777776665443321 4456799999999999999
Q ss_pred CCCCHHHHHHHHHhh
Q 001142 1119 ERPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1119 ~RPSa~EVL~~L~~~ 1133 (1142)
+||||.||++.+...
T Consensus 256 ~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 256 RRPKFADIVSILDKL 270 (283)
T ss_dssp TSCCHHHHHHHHHHH
T ss_pred HCcCHHHHHHHHHHH
Confidence 999999999988654
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=400.88 Aligned_cols=256 Identities=21% Similarity=0.344 Sum_probs=200.2
Q ss_pred CCcceeeeecccCceEEEEEEEC---CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG---SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~---~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
++|++.+.||+|+||.||+|++. +..++||++.++... .....+.+ .+|+.++++++|||||++++++.+ +
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~~----~~E~~~l~~l~HpnIv~l~~~~~~-~ 80 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKF----LQEALTMRQFDHPHIVKLIGVITE-N 80 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHH----HHHHHHHHTCCCTTBCCEEEEECS-S
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-CHHHHHHH----HHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 57999999999999999999984 334666666554322 23333344 899999999999999999999853 2
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
. .++||||+++|+|.+++.. ....+++..++.++.||+.||.|||+++|+||||||+||+++
T Consensus 81 ~--------------~~iv~E~~~~g~l~~~~~~----~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~ 142 (273)
T d1mp8a_ 81 P--------------VWIIMELCTLGELRSFLQV----RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS 142 (273)
T ss_dssp S--------------CEEEEECCTTEEHHHHHHH----TTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred e--------------EEEEEEeccCCcHHhhhhc----cCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeec
Confidence 2 3999999999999998765 235689999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.+||+|||+|+........ ......||+.|+|||++.+ ..|+.++|||||||++|||
T Consensus 143 ~~-------~~~Kl~DfG~a~~~~~~~~~---------~~~~~~gt~~y~apE~l~~----~~~~~~~DiwSlGvil~e~ 202 (273)
T d1mp8a_ 143 SN-------DCVKLGDFGLSRYMEDSTYY---------KASKGKLPIKWMAPESINF----RRFTSASDVWMFGVCMWEI 202 (273)
T ss_dssp ET-------TEEEECC----------------------------CCGGGCCHHHHHH----CCCSHHHHHHHHHHHHHHH
T ss_pred CC-------CcEEEccchhheeccCCcce---------eccceecCcccchhhHhcc----CCCCCccccccchHHHHHH
Confidence 87 78999999999765432111 1223468999999999986 5789999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1044 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1044 Lt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
++ |.+||.+.+..++...+..+..+..+. .+++.+.+||.+||+.||++|||
T Consensus 203 lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~~~~li~~cl~~dp~~Rps 255 (273)
T d1mp8a_ 203 LMHGVKPFQGVKNNDVIGRIENGERLPMPP---------------------------NCPPTLYSLMTKCWAYDPSRRPR 255 (273)
T ss_dssp HTTSCCTTTTCCGGGHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HhcCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHcCCCHhHCcC
Confidence 98 899999888888888777665543321 45667999999999999999999
Q ss_pred HHHHHHHHHhh
Q 001142 1123 AGDLYEMFVAR 1133 (1142)
Q Consensus 1123 a~EVL~~L~~~ 1133 (1142)
+.||++++...
T Consensus 256 ~~ei~~~L~~i 266 (273)
T d1mp8a_ 256 FTELKAQLSTI 266 (273)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99999998653
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-45 Score=414.58 Aligned_cols=256 Identities=26% Similarity=0.334 Sum_probs=209.2
Q ss_pred CCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHh-hCCCCCccceeeeEecC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLG-ALRHSCIVEMYGHKISS 882 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~-~L~HpNIVkl~g~~~~~ 882 (1142)
+++|++.+.||+|+||+||+|++ .+..||+|+...... ..++....+.+|+.++. .++|||||++++++.+.
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~-----~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~ 75 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV-----LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK 75 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhc-----cChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC
Confidence 47899999999999999999998 467788887643211 01111122356777665 68999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
+. .|+||||+++|+|.++++. ...+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 76 ~~--------------~yivmEy~~~g~L~~~i~~-----~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~ 136 (320)
T d1xjda_ 76 EN--------------LFFVMEYLNGGDLMYHIQS-----CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL 136 (320)
T ss_dssp SE--------------EEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE
T ss_pred Cc--------------eeEEEeecCCCcHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceee
Confidence 53 4999999999999999986 2468999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
+.+ +.+||+|||+|+....... ......||+.|+|||++.+ ..|+.++|||||||++||
T Consensus 137 ~~~-------~~~kl~DFG~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlGvilye 195 (320)
T d1xjda_ 137 DKD-------GHIKIADFGMCKENMLGDA----------KTNTFCGTPDYIAPEILLG----QKYNHSVDWWSFGVLLYE 195 (320)
T ss_dssp CTT-------SCEEECCCTTCBCCCCTTC----------CBCCCCSCGGGCCHHHHTT----CCBCTHHHHHHHHHHHHH
T ss_pred cCC-------Cceeccccchhhhcccccc----------cccccCCCCCcCCHHHHcC----CCCCchhhhhhhhHHHHH
Confidence 987 7899999999976443211 1224569999999999986 578999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1043 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1043 LLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
|++|+.||.+.+..++...+..+.. ..+. ..++.+.+||.+||+.||++|||
T Consensus 196 mltG~~PF~~~~~~~~~~~i~~~~~-~~p~---------------------------~~s~~~~dli~~~L~~dP~~R~s 247 (320)
T d1xjda_ 196 MLIGQSPFHGQDEEELFHSIRMDNP-FYPR---------------------------WLEKEAKDLLVKLFVREPEKRLG 247 (320)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHCCC-CCCT---------------------------TSCHHHHHHHHHHSCSSGGGSBT
T ss_pred HHhCCCCCCCCCHHHHHHHHHcCCC-CCCc---------------------------cCCHHHHHHHHHhcccCCCCCcC
Confidence 9999999999888888877765432 1111 34567999999999999999999
Q ss_pred HH-HHHHHHHhhc
Q 001142 1123 AG-DLYEMFVART 1134 (1142)
Q Consensus 1123 a~-EVL~~L~~~~ 1134 (1142)
+. |+++|+|++.
T Consensus 248 ~~~~l~~hpff~~ 260 (320)
T d1xjda_ 248 VRGDIRQHPLFRE 260 (320)
T ss_dssp TBSCGGGSGGGTT
T ss_pred HHHHHHhCchhcc
Confidence 95 8999999864
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-45 Score=413.76 Aligned_cols=260 Identities=25% Similarity=0.345 Sum_probs=200.9
Q ss_pred CCCcceeeeecccCceEEEEEEECCc-------cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceee
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFGSA-------DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYG 877 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~~~-------~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g 877 (1142)
.++|++.++||+|+||+||+|++.+. .||+|+. ..... ..... .+.+|+.++.++ +|||||++++
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~--~~~~~-~~~~~----~~~~E~~~l~~l~~HpnIv~l~~ 108 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML--KEKAD-SSERE----ALMSELKMMTQLGSHENIVNLLG 108 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEE--CC-------CH----HHHHHHHHHHHHCCCTTBCCEEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEe--ccccC-HHHHH----HHHHHHHHHHHhcCCCcEeEEEE
Confidence 35799999999999999999997321 3555553 22111 12222 347999999998 8999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc------------------cCCCCCCHHHHHHHHHHHH
Q 001142 878 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE------------------TGEKHVSVKLALFIAQDVA 939 (1142)
Q Consensus 878 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~------------------~~~~~ls~~~i~~Ia~qIa 939 (1142)
++.+.+.+ ++|||||++|+|.++++.... .....+++..++.|+.||+
T Consensus 109 ~~~~~~~~--------------~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~ 174 (325)
T d1rjba_ 109 ACTLSGPI--------------YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVA 174 (325)
T ss_dssp EECSSSSC--------------EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHH
T ss_pred EEeeCCeE--------------EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHH
Confidence 99876644 999999999999999975221 0123589999999999999
Q ss_pred HHHHHHHhCCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhc
Q 001142 940 AALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1019 (1142)
Q Consensus 940 ~gL~yLHs~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~ 1019 (1142)
.||+|||+++||||||||+|||++.+ +.+||+|||+|+......... ......||+.|||||++.
T Consensus 175 ~gl~yLH~~~IiHRDlKp~Nill~~~-------~~~Kl~DFGla~~~~~~~~~~--------~~~~~~gt~~y~aPE~l~ 239 (325)
T d1rjba_ 175 KGMEFLEFKSCVHRDLAARNVLVTHG-------KVVKICDFGLARDIMSDSNYV--------VRGNARLPVKWMAPESLF 239 (325)
T ss_dssp HHHHHHHHTTEEETTCSGGGEEEETT-------TEEEECCCGGGSCGGGCTTSE--------EETTEEECGGGCCHHHHH
T ss_pred HHHHHHHhCCeeeccCchhccccccC-------CeEEEeeccccccccCCCcee--------eeccccCCCccCChHHHc
Confidence 99999999999999999999999987 899999999997654322110 112346899999999988
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH-HHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchh
Q 001142 1020 AMHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEI-HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 1097 (1142)
Q Consensus 1020 ~~~~~~~~s~ksDVwSLGviL~ELLt-G~~Pf~~~~~~el-~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~ 1097 (1142)
+ ..|+.++|||||||++|||+| |+.||.+.+..+. ...+..+.++..+
T Consensus 240 ~----~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p-------------------------- 289 (325)
T d1rjba_ 240 E----GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQP-------------------------- 289 (325)
T ss_dssp H----CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCC--------------------------
T ss_pred C----CCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCC--------------------------
Confidence 6 578999999999999999998 8999987655443 3444444333221
Q ss_pred hhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 001142 1098 ELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVA 1132 (1142)
Q Consensus 1098 ~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~ 1132 (1142)
...++.+.+||.+||+.||++|||++||++||-.
T Consensus 290 -~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 290 -FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp -TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 1456679999999999999999999999999853
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-44 Score=400.23 Aligned_cols=284 Identities=19% Similarity=0.263 Sum_probs=208.2
Q ss_pred CCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
+++|++.++||+|+||+||+|++. ++.||+|+..... .... ...++.+|+++|++++|||||++++++.+.+
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~----~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~ 74 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ETEG----VPSTAIREISLLKELNHPNIVKLLDVIHTEN 74 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhh--cChH----HHHHHHHHHHHHHhCCCCcEEEecccccccc
Confidence 468999999999999999999984 6778999865332 1111 2233489999999999999999999998765
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
+.|+||||+. +++.+++.. .....+++..+..++.||+.||+|||++|||||||||+|||++
T Consensus 75 --------------~~~iv~e~~~-~~~~~~~~~---~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~ 136 (298)
T d1gz8a_ 75 --------------KLYLVFEFLH-QDLKKFMDA---SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN 136 (298)
T ss_dssp --------------EEEEEEECCS-EEHHHHHHH---TTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred --------------ceeEEEeecC-Cchhhhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeec
Confidence 4599999997 555555543 2345699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.+||+|||.|+....... ......||+.|+|||++.. ...++.++|||||||++|+|
T Consensus 137 ~~-------~~~kl~DFG~a~~~~~~~~----------~~~~~~gt~~y~apE~~~~---~~~~~~~~DiwSlGvily~m 196 (298)
T d1gz8a_ 137 TE-------GAIKLADFGLARAFGVPVR----------TYTHEVVTLWYRAPEILLG---CKYYSTAVDIWSLGCIFAEM 196 (298)
T ss_dssp TT-------SCEEECSTTHHHHHCCCSB----------CTTCCBCCCTTCCHHHHTT---CSSCCTHHHHHHHHHHHHHH
T ss_pred cc-------CcceeccCCcceeccCCcc----------cceeecccceeeehhhhcc---ccCCCccccccccchhhhHH
Confidence 87 7899999999976543221 1234579999999999875 24568999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHh--CCCCCchhHHhhhccccccc-ccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1044 LTLQVPYMGLSELEIHDLIQM--GKRPRLTDELEALGSCHEHE-VAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~--~~~p~l~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
++|+.||.+.+..+....+.. +....... .......... .................++.+.+|+.+||+.||.+|
T Consensus 197 ~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R 274 (298)
T d1gz8a_ 197 VTRRALFPGDSEIDQLFRIFRTLGTPDEVVW--PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKR 274 (298)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS--TTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTS
T ss_pred hhCCCCCCCCCHHHHHHHHHHhcCCCchhhc--cccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHC
Confidence 999999998877665554422 22111111 0000000000 000000000011112456789999999999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 001142 1121 PTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1121 PSa~EVL~~L~~~~s 1135 (1142)
||++|+++|+|++.-
T Consensus 275 ~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 275 ISAKAALAHPFFQDV 289 (298)
T ss_dssp CCHHHHHTSGGGTTC
T ss_pred cCHHHHhCCHhhccC
Confidence 999999999999754
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=398.09 Aligned_cols=252 Identities=24% Similarity=0.379 Sum_probs=204.3
Q ss_pred CCCCcceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
+.++|++.++||+|+||.||+|++.++.||||+.+ .. ...+.+ .+|++++++++|||||+++|++.+...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~--~~----~~~~~~----~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK--ND----ATAQAF----LAEASVMTQLRHSNLVQLLGVIVEEKG 74 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECC--CC----C--HHH----HHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred CHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEEC--cH----HHHHHH----HHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence 45679999999999999999999999999998743 21 122344 799999999999999999999864321
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
..++||||+++|+|.+++.... ...+++..++.|+.||+.||.|||+++|+||||||+|||++.
T Consensus 75 -------------~~~lv~ey~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~ 138 (262)
T d1byga_ 75 -------------GLYIVTEYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSE 138 (262)
T ss_dssp -------------CCEEEECCCTTEEHHHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT
T ss_pred -------------cEEEEEeccCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecC
Confidence 2399999999999999997532 235899999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 139 ~-------~~~kl~dfg~s~~~~~~-------------~~~~~~~~~y~aPE~l~~----~~~t~~sDIwSfG~il~el~ 194 (262)
T d1byga_ 139 D-------NVAKVSDFGLTKEASST-------------QDTGKLPVKWTAPEALRE----KKFSTKSDVWSFGILLWEIY 194 (262)
T ss_dssp T-------SCEEECCCCC-------------------------CCTTTSCHHHHHH----CCCCHHHHHHHHHHHHHHHH
T ss_pred C-------CCEeecccccceecCCC-------------CccccccccCCChHHHhC----CCCChHHHHHhHHHHHHHHH
Confidence 7 88999999999754331 123357899999999976 57899999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1045 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1045 t-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
| |++||...+..++...+..+..+..+. ..++.+.+|+.+||+.||.+||||
T Consensus 195 t~~~~p~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~~~~li~~cl~~dP~~Rps~ 247 (262)
T d1byga_ 195 SFGRVPYPRIPLKDVVPRVEKGYKMDAPD---------------------------GCPPAVYEVMKNCWHLDAAMRPSF 247 (262)
T ss_dssp TTSCCSCTTSCGGGHHHHHTTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HCCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------cCCHHHHHHHHHHcccCHhHCcCH
Confidence 8 799998887777888877665554332 345679999999999999999999
Q ss_pred HHHHHHHHhh
Q 001142 1124 GDLYEMFVAR 1133 (1142)
Q Consensus 1124 ~EVL~~L~~~ 1133 (1142)
.+++++|...
T Consensus 248 ~~l~~~L~~i 257 (262)
T d1byga_ 248 LQLREQLEHI 257 (262)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999998654
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=9.2e-44 Score=394.54 Aligned_cols=265 Identities=24% Similarity=0.279 Sum_probs=202.4
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
++|++.+.||+|+||+||+|++. ++.||+|+...... ......+ ++.+|+.++++++|||||++++++...+.
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~----~~~~E~~~l~~~~hpniv~~~~~~~~~~~ 81 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLA-RDPSFYL----RFRREAQNAAALNHPAIVAVYDTGEAETP 81 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTT-TCHHHHH----HHHHHHHHHHTCCCTTBCCEEEEEEEECS
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhc-cCHHHHH----HHHHHHHHHHhcCCCCCCcccceeeeccC
Confidence 45999999999999999999974 77788888543221 1222223 34899999999999999999999886442
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
. ....|+||||++|++|.+++.. ...+++.+++.|+.||+.||+|||++||+||||||+|||++.
T Consensus 82 ~----------~~~~~lvmE~~~g~~L~~~~~~-----~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~ 146 (277)
T d1o6ya_ 82 A----------GPLPYIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 146 (277)
T ss_dssp S----------SEEEEEEEECCCEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET
T ss_pred C----------CceEEEEEECCCCCEehhhhcc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCc
Confidence 1 2346999999999999999876 246999999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.++++|||.+......... ........||+.|+|||++.+ ..|+.++|||||||++|||+
T Consensus 147 ~-------~~~~l~d~~~~~~~~~~~~~-------~~~~~~~~Gt~~Y~aPE~~~~----~~~~~~~DiwSlGvilyell 208 (277)
T d1o6ya_ 147 T-------NAVKVMDFGIARAIADSGNS-------VTQTAAVIGTAQYLSPEQARG----DSVDARSDVYSLGCVLYEVL 208 (277)
T ss_dssp T-------SCEEECCCTTCEECC-----------------------TTCCHHHHTT----CCCCHHHHHHHHHHHHHHHH
T ss_pred c-------ccceeehhhhhhhhcccccc-------ccccccccCcccccCHHHHcC----CCCCcceecccchHHHHHHH
Confidence 7 78999999998754332211 112234579999999999876 57899999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-CH
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-TA 1123 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP-Sa 1123 (1142)
||++||.+.+..+....+.......... .....++.+.++|.+||+.||.+|| |+
T Consensus 209 tG~~Pf~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~s~~l~~li~~~L~~dp~~R~~sa 264 (277)
T d1o6ya_ 209 TGEPPFTGDSPVSVAYQHVREDPIPPSA------------------------RHEGLSADLDAVVLKALAKNPENRYQTA 264 (277)
T ss_dssp HSSCSCCCSSHHHHHHHHHHCCCCCGGG------------------------TSSSCCHHHHHHHHHHTCSSGGGSCSSH
T ss_pred hCCCCCCCcCHHHHHHHHHhcCCCCCch------------------------hccCCCHHHHHHHHHHccCCHhHCHhHH
Confidence 9999999888777665554433221110 0014567899999999999999999 78
Q ss_pred HHHHHHHHhh
Q 001142 1124 GDLYEMFVAR 1133 (1142)
Q Consensus 1124 ~EVL~~L~~~ 1133 (1142)
+++++.+...
T Consensus 265 ~~l~~~l~r~ 274 (277)
T d1o6ya_ 265 AEMRADLVRV 274 (277)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 8887766543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-44 Score=403.05 Aligned_cols=255 Identities=19% Similarity=0.323 Sum_probs=203.7
Q ss_pred CCcceeeeecccCceEEEEEEECC--c----cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFGS--A----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 880 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~~--~----~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~ 880 (1142)
.+|++.++||+|+||+||+|.+.. . .||+|.. +.. ......++ +.+|+.++++++|||||+++|++.
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~--~~~-~~~~~~~~----~~~E~~~l~~l~HpnIv~l~g~~~ 81 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REA-TSPKANKE----ILDEAYVMASVDNPHVCRLLGICL 81 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEE--CC-----CTHHH----HHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEe--ccc-cCHHHHHH----HHHHHHHHHhCCCCCEeeEEEEEe
Confidence 579999999999999999999843 2 3555543 221 11122333 489999999999999999999997
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NI 960 (1142)
+.. .+++|||+.+++|.+++.. ....+++..++.|+.||+.||+|||++||+||||||+||
T Consensus 82 ~~~---------------~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NI 142 (317)
T d1xkka_ 82 TST---------------VQLITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNV 142 (317)
T ss_dssp SSS---------------EEEEEECCTTCBHHHHHHH----TSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred cCC---------------eeEEEEeccCCcccccccc----cccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcc
Confidence 543 3789999999999998875 245799999999999999999999999999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
|++.+ +.+||+|||+|+........ .......||+.|+|||++.+ ..|+.++|||||||++
T Consensus 143 ll~~~-------~~~kl~DFGla~~~~~~~~~--------~~~~~~~gt~~y~APE~l~~----~~~~~~sDvwS~Gvil 203 (317)
T d1xkka_ 143 LVKTP-------QHVKITDFGLAKLLGAEEKE--------YHAEGGKVPIKWMALESILH----RIYTHQSDVWSYGVTV 203 (317)
T ss_dssp EEEET-------TEEEECCCSHHHHTTTTCC----------------CCTTTSCHHHHHH----CCCCHHHHHHHHHHHH
T ss_pred eeCCC-------CCeEeeccccceeccccccc--------ccccccccCccccChHHHhc----CCCChhhhhhhHHHHH
Confidence 99987 88999999999865432211 11123458999999999986 5789999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001142 1041 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1119 (1142)
Q Consensus 1041 ~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~ 1119 (1142)
|||+| |.+||.+.+..++...+..+.++..+. .+++.+.+|+.+||+.||.+
T Consensus 204 ~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~---------------------------~~~~~~~~li~~cl~~dP~~ 256 (317)
T d1xkka_ 204 WELMTFGSKPYDGIPASEISSILEKGERLPQPP---------------------------ICTIDVYMIMVKCWMIDADS 256 (317)
T ss_dssp HHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCT---------------------------TBCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------ccCHHHHHHHHHhCCCChhh
Confidence 99998 899999887777777777665543321 45567999999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 001142 1120 RPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1120 RPSa~EVL~~L~~~ 1133 (1142)
|||+.||+++++..
T Consensus 257 RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 257 RPKFRELIIEFSKM 270 (317)
T ss_dssp SCCHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHH
Confidence 99999999998754
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-44 Score=403.06 Aligned_cols=264 Identities=25% Similarity=0.423 Sum_probs=211.1
Q ss_pred CCCCCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeee
Q 001142 802 DPGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGH 878 (1142)
Q Consensus 802 ~~~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~ 878 (1142)
+..++++|++.++||+|+||+||+|++. +..++||+++++.... ....+.+ .+|+++|.++ +|||||+++++
T Consensus 5 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~----~~E~~~l~~l~~HpnIv~~~~~ 79 (309)
T d1fvra_ 5 PVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDF----AGELEVLCKLGHHPNIINLLGA 79 (309)
T ss_dssp SBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHH----HHHHHHHTTCCCCTTBCCEEEE
T ss_pred CccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccC-hHHHHHH----HHHHHHHHhccCCCCEeeEEEE
Confidence 4567889999999999999999999984 4455666665543222 2233344 8999999999 69999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHh-----------ccCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 001142 879 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS-----------ETGEKHVSVKLALFIAQDVAAALVELHS 947 (1142)
Q Consensus 879 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~-----------~~~~~~ls~~~i~~Ia~qIa~gL~yLHs 947 (1142)
+.+.+ ..++||||+++|+|.++++... ......+++..+..++.||+.||.|||+
T Consensus 80 ~~~~~--------------~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~ 145 (309)
T d1fvra_ 80 CEHRG--------------YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ 145 (309)
T ss_dssp EEETT--------------EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH
T ss_pred EecCC--------------eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc
Confidence 98765 3499999999999999997421 1223579999999999999999999999
Q ss_pred CCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCC
Q 001142 948 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 1027 (1142)
Q Consensus 948 ~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~ 1027 (1142)
++|+||||||+|||++.+ +.+||+|||+|+....... .....||..|+|||.+.+ ..|
T Consensus 146 ~~iiHrDlkp~NIL~~~~-------~~~kl~DfG~a~~~~~~~~-----------~~~~~gt~~y~aPE~l~~----~~~ 203 (309)
T d1fvra_ 146 KQFIHRDLAARNILVGEN-------YVAKIADFGLSRGQEVYVK-----------KTMGRLPVRWMAIESLNY----SVY 203 (309)
T ss_dssp TTEECSCCSGGGEEECGG-------GCEEECCTTCEESSCEECC-----------C----CCTTTCCHHHHHH----CEE
T ss_pred CCccccccccceEEEcCC-------CceEEcccccccccccccc-----------ccceecCCcccchHHhcc----CCC
Confidence 999999999999999988 7899999999975433211 123468999999999976 578
Q ss_pred CchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHH
Q 001142 1028 GLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLV 1106 (1142)
Q Consensus 1028 s~ksDVwSLGviL~ELLtG-~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~ 1106 (1142)
+.++|||||||++|||++| .+||.+.+..++...+..+.++..+. ..++.+.
T Consensus 204 ~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~~~ 256 (309)
T d1fvra_ 204 TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL---------------------------NCDDEVY 256 (309)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCCCCT---------------------------TBCHHHH
T ss_pred CccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCc---------------------------cCCHHHH
Confidence 9999999999999999996 46788888888887776655443321 4556799
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001142 1107 DVFRRCTEENPTERPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1107 dLI~~CL~~DP~~RPSa~EVL~~L~~~ 1133 (1142)
+||.+||+.||++||||.||+++|...
T Consensus 257 ~li~~cl~~dP~~RPs~~eil~~L~~i 283 (309)
T d1fvra_ 257 DLMRQCWREKPYERPSFAQILVSLNRM 283 (309)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 999999999999999999999987654
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.3e-44 Score=399.60 Aligned_cols=284 Identities=19% Similarity=0.209 Sum_probs=207.6
Q ss_pred CCCcceeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~-~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
+++|++.++||+|+||+||+|++. +..||+|+...... ... ...++.+|+.+|++++|||||++++++..++.
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~--~~~----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 74 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE--DEG----IPSTTIREISILKELKHSNIVKLYDVIHTKKR 74 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG--GGC----CCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred CCCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhc--ChH----HHHHHHHHHHHHHhCCCCcEEeeeeecccCCc
Confidence 468999999999999999999984 57789998654321 111 12334799999999999999999999987664
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
.+++|||+.++.+..+.+. ...+++..+..|+.||+.||+|||++|||||||||+|||++.
T Consensus 75 --------------~~i~~e~~~~~~~~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~ 135 (286)
T d1ob3a_ 75 --------------LVLVFEHLDQDLKKLLDVC-----EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINR 135 (286)
T ss_dssp --------------EEEEEECCSEEHHHHHHTS-----TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred --------------eeEEEEeehhhhHHHHHhh-----cCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcC
Confidence 4999999986665555432 357999999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+||+|||.|........ ......|++.|+|||.+.+ ...++.++|||||||++|||+
T Consensus 136 ~-------~~~kl~DfG~a~~~~~~~~----------~~~~~~~~~~y~~pE~~~~---~~~~~~~~DiwslGv~l~el~ 195 (286)
T d1ob3a_ 136 E-------GELKIADFGLARAFGIPVR----------KYTHEIVTLWYRAPDVLMG---SKKYSTTIDIWSVGCIFAEMV 195 (286)
T ss_dssp T-------SCEEECCTTHHHHHCC-------------------CCCTTCCHHHHTT---CCSCCTHHHHHHHHHHHHHHH
T ss_pred C-------CCEEecccccceecccCcc----------ccceecccchhhhHHHHhC---CCCCCcceeehhcCcHHHHHH
Confidence 7 7899999999976543221 1123468999999999875 246789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccccc-ccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE-HEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
+|+.||.+.+..+....+...........+........ ...................++.+.+|+.+||+.||++|||+
T Consensus 196 ~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~ 275 (286)
T d1ob3a_ 196 NGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA 275 (286)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred HCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCH
Confidence 99999998877766555432111111111110000000 00000001111111122456789999999999999999999
Q ss_pred HHHHHHHHhhc
Q 001142 1124 GDLYEMFVART 1134 (1142)
Q Consensus 1124 ~EVL~~L~~~~ 1134 (1142)
+|+++|+|++.
T Consensus 276 ~ell~Hp~f~~ 286 (286)
T d1ob3a_ 276 KQALEHAYFKE 286 (286)
T ss_dssp HHHHTSGGGGC
T ss_pred HHHhcCcccCc
Confidence 99999999973
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-43 Score=398.33 Aligned_cols=261 Identities=24% Similarity=0.391 Sum_probs=210.5
Q ss_pred CCCcceeeeecccCceEEEEEEECC-------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeee
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 878 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~~-------~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~ 878 (1142)
-++|++.+.||+|+||+||+|++.+ ..||||+.. .. ......++| .+|++++++++||||++++++
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~--~~-~~~~~~~~~----~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK--EE-ASADMQADF----QREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECC--TT-CCHHHHHHH----HHHHHHHHTCCCTTBCCEEEE
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEC--hh-cChHHHHHH----HHHHHHHHhcCCCCcccceee
Confidence 4579999999999999999999743 467887643 21 223333344 899999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc-------------------cCCCCCCHHHHHHHHHHHH
Q 001142 879 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-------------------TGEKHVSVKLALFIAQDVA 939 (1142)
Q Consensus 879 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~-------------------~~~~~ls~~~i~~Ia~qIa 939 (1142)
+.+.... ++||||+++|+|.++++.... .....+++..++.|+.||+
T Consensus 85 ~~~~~~~--------------~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~ 150 (301)
T d1lufa_ 85 CAVGKPM--------------CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVA 150 (301)
T ss_dssp ECSSSSC--------------EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHH
T ss_pred eccCCce--------------EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHH
Confidence 9876544 999999999999999975211 1123589999999999999
Q ss_pred HHHHHHHhCCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhc
Q 001142 940 AALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1019 (1142)
Q Consensus 940 ~gL~yLHs~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~ 1019 (1142)
.||+|||+++||||||||+|||++.+ +.+||+|||+|+........ .......||+.|+|||.+.
T Consensus 151 ~gl~ylH~~~ivHrDlKp~NILld~~-------~~~Kl~DFGls~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~ 215 (301)
T d1lufa_ 151 AGMAYLSERKFVHRDLATRNCLVGEN-------MVVKIADFGLSRNIYSADYY--------KADGNDAIPIRWMPPESIF 215 (301)
T ss_dssp HHHHHHHHTTCCCSCCSGGGEEECGG-------GCEEECCCSCHHHHTGGGCB--------C----CCBCGGGCCHHHHH
T ss_pred HHhhhcccCCeEeeEEcccceEECCC-------CcEEEccchhheeccCCccc--------cccCCCCcCcCcCCHHHHc
Confidence 99999999999999999999999987 78999999999765432211 1122456899999999998
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhh
Q 001142 1020 AMHKPNLYGLEVDIWSYGCLLLELLTLQ-VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 1098 (1142)
Q Consensus 1020 ~~~~~~~~s~ksDVwSLGviL~ELLtG~-~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1142)
+ ..|+.++|||||||++|||++|. +||.+.+..++...+..+..+..+.
T Consensus 216 ~----~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~~~~p~-------------------------- 265 (301)
T d1lufa_ 216 Y----NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPE-------------------------- 265 (301)
T ss_dssp H----CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCT--------------------------
T ss_pred c----CCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCc--------------------------
Confidence 6 67899999999999999999985 6898888888888887766544321
Q ss_pred hhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001142 1099 LETLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1099 ~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~ 1133 (1142)
.+++++.+|+.+||+.||++||||.||++.|...
T Consensus 266 -~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 266 -NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp -TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred -cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 4456799999999999999999999999988754
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-44 Score=399.58 Aligned_cols=288 Identities=20% Similarity=0.187 Sum_probs=207.7
Q ss_pred CCCcceeeeecccCceEEEEEEEC---CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC---CCCCccceeeeE
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG---SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL---RHSCIVEMYGHK 879 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~---~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L---~HpNIVkl~g~~ 879 (1142)
-++|++.++||+|+||+||+|++. +..||+|+.+...... .....+ .+|+.+++.+ +|||||++++++
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~--~~~~~~----~~E~~~l~~l~~~~HpnIv~~~~~~ 79 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--GMPLST----IREVAVLRHLETFEHPNVVRLFDVC 79 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT--SCBCTH----HHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc--hHHHHH----HHHHHHHHHHhhcCCCCcceeeeee
Confidence 357999999999999999999983 4458899865443221 111122 5677776665 799999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 001142 880 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959 (1142)
Q Consensus 880 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~N 959 (1142)
...... ...+.+++|||++++++..... .....+++..++.++.||+.||+|||++||+||||||+|
T Consensus 80 ~~~~~~---------~~~~~~~~~e~~~~~~~~~~~~----~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~N 146 (305)
T d1blxa_ 80 TVSRTD---------RETKLTLVFEHVDQDLTTYLDK----VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQN 146 (305)
T ss_dssp EEEECS---------SEEEEEEEEECCSCBHHHHHHH----SCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred cccccc---------cCceEEEEEEeccCCchhhhhh----ccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccE
Confidence 753211 2346799999998766544332 234568999999999999999999999999999999999
Q ss_pred eeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001142 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039 (1142)
Q Consensus 960 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGvi 1039 (1142)
||++.+ +.+||+|||+++....... .....||+.|+|||++.+ ..|+.++||||+||+
T Consensus 147 ILi~~~-------~~~kl~dfg~~~~~~~~~~-----------~~~~~gT~~Y~APE~~~~----~~y~~~~DiwSlG~i 204 (305)
T d1blxa_ 147 ILVTSS-------GQIKLADFGLARIYSFQMA-----------LTSVVVTLWYRAPEVLLQ----SSYATPVDLWSVGCI 204 (305)
T ss_dssp EEECTT-------CCEEECSCCSCCCCCGGGG-----------GCCCCCCCTTCCHHHHTT----CCCCTHHHHHHHHHH
T ss_pred EEEcCC-------CCeeecchhhhhhhccccc-----------CCCcccChhhcCcchhcC----CCCChhehhhchHHH
Confidence 999887 7899999999875433221 124579999999999976 678999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001142 1040 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1119 (1142)
Q Consensus 1040 L~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~ 1119 (1142)
+|||++|+.||.+.+..+....+...........+......... .................++.+.+||.+||+.||++
T Consensus 205 l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~ 283 (305)
T d1blxa_ 205 FAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQ-AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAK 283 (305)
T ss_dssp HHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGG-GSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTT
T ss_pred HHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhh-hhccccccchhhccccCCHHHHHHHHHHCcCChhH
Confidence 99999999999988877766665332111111111100000000 00000111111112245678999999999999999
Q ss_pred CCCHHHHHHHHHhhcC
Q 001142 1120 RPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1120 RPSa~EVL~~L~~~~s 1135 (1142)
||||+|+++|+|++.-
T Consensus 284 R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 284 RISAYSALSHPYFQDL 299 (305)
T ss_dssp SCCHHHHHTSGGGTTC
T ss_pred CcCHHHHhcChhhcCc
Confidence 9999999999999753
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-44 Score=396.70 Aligned_cols=253 Identities=26% Similarity=0.383 Sum_probs=199.4
Q ss_pred CCCCcceeeeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~~~-~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
+.++|++.+.||+|+||.||+|++.+ ..||||+. +..... .+.| .+|+.++++++|||||+++|++.++.
T Consensus 15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l--~~~~~~---~~~~----~~E~~~l~~l~h~nIv~~~g~~~~~~ 85 (285)
T d1fmka3 15 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMS---PEAF----LQEAQVMKKLRHEKLVQLYAVVSEEP 85 (285)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEC--CTTSSC---HHHH----HHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEE--CcccCC---HHHH----HHHHHHHHhcccCCEeEEEEEEecCC
Confidence 45789999999999999999999854 46778774 332222 2334 79999999999999999999985432
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
.++||||+++|+|..++.... ...+++.+++.|+.||+.||+|||++||+||||||+||||+
T Consensus 86 ---------------~~lv~Ey~~~g~l~~~~~~~~---~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~ 147 (285)
T d1fmka3 86 ---------------IYIVTEYMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG 147 (285)
T ss_dssp ---------------CEEEECCCTTCBHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred ---------------eEEEEEecCCCchhhhhhhcc---cccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEEC
Confidence 389999999999999886521 23599999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +++||+|||+|+........ ......||+.|+|||++.. ..++.++|||||||++|||
T Consensus 148 ~~-------~~~kl~DfGla~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~----~~~~~ksDI~S~Giil~el 207 (285)
T d1fmka3 148 EN-------LVCKVADFGLARLIEDNEYT---------ARQGAKFPIKWTAPEAALY----GRFTIKSDVWSFGILLTEL 207 (285)
T ss_dssp GG-------GCEEECCCCTTC-----------------------CCGGGSCHHHHHH----CCCCHHHHHHHHHHHHHHH
T ss_pred CC-------CcEEEcccchhhhccCCCce---------eeccccccccccChHHHhC----CCCCcHHhhhcchHHHHHH
Confidence 87 78999999999765432111 1223468999999999986 5789999999999999999
Q ss_pred HhC-CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001142 1044 LTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1122 (1142)
Q Consensus 1044 LtG-~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPS 1122 (1142)
++| .+|+.+....++...+..+..+..+. .+++.+.+|+.+||+.||++|||
T Consensus 208 ~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~cl~~dP~~Rps 260 (285)
T d1fmka3 208 TTKGRVPYPGMVNREVLDQVERGYRMPCPP---------------------------ECPESLHDLMCQCWRKEPEERPT 260 (285)
T ss_dssp HTTTCCSSTTCCHHHHHHHHHTTCCCCCCT---------------------------TSCHHHHHHHHHHTCSSGGGSCC
T ss_pred HhCCCCCCCCCCHHHHHHHHHhcCCCCCCc---------------------------ccCHHHHHHHHHHcccCHhHCcC
Confidence 995 55556666777777776655433221 45567999999999999999999
Q ss_pred HHHHHHHHH
Q 001142 1123 AGDLYEMFV 1131 (1142)
Q Consensus 1123 a~EVL~~L~ 1131 (1142)
+++|++.+.
T Consensus 261 ~~~i~~~L~ 269 (285)
T d1fmka3 261 FEYLQAFLE 269 (285)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHh
Confidence 999998553
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-44 Score=410.03 Aligned_cols=266 Identities=23% Similarity=0.267 Sum_probs=202.2
Q ss_pred CCCcceee-eecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEec
Q 001142 806 FPSLSSCD-EAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 881 (1142)
Q Consensus 806 ~~~y~l~~-~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g~~~~ 881 (1142)
+++|++.+ .||+|+||+||+|++ .+..||+|+.. .. .. +.+|+.++.++ +|||||+++++|.+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~--~~-------~~----~~~E~~~~~~~~~hpnIv~l~~~~~~ 76 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--DC-------PK----ARREVELHWRASQCPHIVRIVDVYEN 76 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEE--CS-------HH----HHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEEC--Cc-------HH----HHHHHHHHHHhcCCCCCCeEEEEEee
Confidence 56898875 699999999999998 46678888753 11 12 26899987655 79999999999875
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 001142 882 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 961 (1142)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NIL 961 (1142)
... ...++|+|||||+||+|.+++.+ .+...+++.+++.|+.||+.||+|||++||+||||||+|||
T Consensus 77 ~~~----------~~~~~~ivmEy~~gg~L~~~i~~---~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIl 143 (335)
T d2ozaa1 77 LYA----------GRKCLLIVMECLDGGELFSRIQD---RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 143 (335)
T ss_dssp EET----------TEEEEEEEEECCCSEEHHHHHHS---CSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred ccc----------CCCEEEEEEECCCCCcHHHHHHh---cCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccc
Confidence 211 12356999999999999999975 33457999999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001142 962 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1041 (1142)
Q Consensus 962 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ 1041 (1142)
++... ..+.+||+|||+|+...... ......||+.|||||++.+ ..|+.++|||||||++|
T Consensus 144 l~~~~----~~~~~Kl~DFG~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~~----~~y~~~~DiwSlGvily 204 (335)
T d2ozaa1 144 YTSKR----PNAILKLTDFGFAKETTSHN-----------SLTTPCYTPYYVAPEVLGP----EKYDKSCDMWSLGVIMY 204 (335)
T ss_dssp ESCSS----TTCCEEECCCTTCEECCCCC-----------CCCCCSCCCSSCCCCCCCG----GGGSHHHHHHHHHHHHH
T ss_pred ccccc----ccccccccccceeeeccCCC-----------ccccccCCcccCCcHHHcC----CCCCHHHHHHhhchhHH
Confidence 98642 23689999999997654321 1224569999999999876 56899999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhCC-CCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1042 ELLTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1042 ELLtG~~Pf~~~~~~el~~~I~~~~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
+|+||+.||.+.+.......+.... .... .+..+ .....++++.+||.+||+.||++|
T Consensus 205 ~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~--------------------~~~~~-~~~~~s~~~~~li~~~L~~dP~~R 263 (335)
T d2ozaa1 205 ILLCGYPPFYSNHGLAISPGMKTRIRMGQY--------------------EFPNP-EWSEVSEEVKMLIRNLLKTEPTQR 263 (335)
T ss_dssp HHTTSSCSCEETTCC--------CCCSCSS--------------------SCCTT-HHHHSCHHHHHHHHHHSCSSTTTS
T ss_pred HHhhCCCCCCCCCHHHHHHHHHHHHhcCCC--------------------CCCCc-ccccCCHHHHHHHHHHccCChhHC
Confidence 9999999997654433332221110 0000 00011 112567789999999999999999
Q ss_pred CCHHHHHHHHHhhcCCC
Q 001142 1121 PTAGDLYEMFVARTSSS 1137 (1142)
Q Consensus 1121 PSa~EVL~~L~~~~ss~ 1137 (1142)
||+.|+++|+|+.....
T Consensus 264 ~s~~eil~hp~~~~~~~ 280 (335)
T d2ozaa1 264 MTITEFMNHPWIMQSTK 280 (335)
T ss_dssp CCHHHHHHSHHHHTTTS
T ss_pred cCHHHHHcCHHhhCCCC
Confidence 99999999999976543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-44 Score=397.45 Aligned_cols=250 Identities=22% Similarity=0.241 Sum_probs=197.9
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCCh--HHHHHhHHhHHHHHHHHhhCC--CCCccceeeeEe
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSA--DEIRNFEYSCLGEVRMLGALR--HSCIVEMYGHKI 880 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~--~~~~~~~~~~~~Ei~iL~~L~--HpNIVkl~g~~~ 880 (1142)
.+|++.++||+|+||+||+|++. +..||+|+.......... .....+ .+|+.++++++ |||||++++++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~----~~E~~il~~l~~~h~nIv~~~~~~~ 79 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV----PMEVVLLKKVSSGFSGVIRLLDWFE 79 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEE----EHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHH----HHHHHHHHHhccCCCCccEEEEEEe
Confidence 36999999999999999999984 677889886543322111 111223 68999999986 999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCC-CCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKG-GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~g-gSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~N 959 (1142)
+.+ ..++||||+.+ +++.+++.. ...+++..++.++.||+.||+|||++||+||||||+|
T Consensus 80 ~~~--------------~~~lv~e~~~~~~~l~~~~~~-----~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~N 140 (273)
T d1xwsa_ 80 RPD--------------SFVLILERPEPVQDLFDFITE-----RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDEN 140 (273)
T ss_dssp CSS--------------EEEEEEECCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred eCC--------------eEEEEEEeccCcchHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccc
Confidence 765 34999999976 588888875 2469999999999999999999999999999999999
Q ss_pred eeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001142 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039 (1142)
Q Consensus 960 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGvi 1039 (1142)
||++.+. +.+||+|||+|+...... .....||+.|+|||++.+ ...++.++|||||||+
T Consensus 141 Ill~~~~------~~vkl~DFG~a~~~~~~~------------~~~~~GT~~y~aPE~~~~---~~~~~~~~DiwSlGvi 199 (273)
T d1xwsa_ 141 ILIDLNR------GELKLIDFGSGALLKDTV------------YTDFDGTRVYSPPEWIRY---HRYHGRSAAVWSLGIL 199 (273)
T ss_dssp EEEETTT------TEEEECCCTTCEECCSSC------------BCCCCSCGGGSCHHHHHH---SCBCHHHHHHHHHHHH
T ss_pred eEEecCC------CeEEECccccceeccccc------------ccccccCCCcCCHHHHcC---CCCCCcccccccceee
Confidence 9998542 689999999997543311 124569999999999876 2345688999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001142 1040 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1119 (1142)
Q Consensus 1040 L~ELLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~ 1119 (1142)
+|||++|+.||.+. . .+..+... ++ ...++++.+||.+||+.||++
T Consensus 200 lyell~g~~Pf~~~--~----~i~~~~~~-~~---------------------------~~~s~~~~~li~~~L~~dp~~ 245 (273)
T d1xwsa_ 200 LYDMVCGDIPFEHD--E----EIIRGQVF-FR---------------------------QRVSSECQHLIRWCLALRPSD 245 (273)
T ss_dssp HHHHHHSSCSCCSH--H----HHHHCCCC-CS---------------------------SCCCHHHHHHHHHHTCSSGGG
T ss_pred ehhHhhCCCCCCCc--h----HHhhcccC-CC---------------------------CCCCHHHHHHHHHHccCCHhH
Confidence 99999999999752 1 12222110 00 134567999999999999999
Q ss_pred CCCHHHHHHHHHhhc
Q 001142 1120 RPTAGDLYEMFVART 1134 (1142)
Q Consensus 1120 RPSa~EVL~~L~~~~ 1134 (1142)
|||++|+++|+|++.
T Consensus 246 R~s~~eil~hp~~~~ 260 (273)
T d1xwsa_ 246 RPTFEEIQNHPWMQD 260 (273)
T ss_dssp SCCHHHHHTSGGGSS
T ss_pred CcCHHHHhcCHhhCC
Confidence 999999999999975
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-43 Score=391.24 Aligned_cols=258 Identities=23% Similarity=0.326 Sum_probs=197.4
Q ss_pred CCCcceeeeecccCceEEEEEEEC---Cc--cEEEEEEecccCCC-ChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeE
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFG---SA--DAAAKVRTLKVCGS-SADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 879 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~---~~--~vAvKi~~l~~~~~-~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~ 879 (1142)
..+|++.+.||+|+||.||+|++. +. .||+|+ ++.... .....++ +.+|+.+|++++|||||+++|++
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~--l~~~~~~~~~~~~~----~~~Ei~~l~~l~H~nIv~~~g~~ 80 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKC--LKPDVLSQPEAMDD----FIREVNAMHSLDHRNLIRLYGVV 80 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC----------CHHHHH----HHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEE--EChhhcCCHHHHHH----HHHHHHHHHhCCCCCEEEEEEEE
Confidence 467999999999999999999873 23 355554 433221 1122333 48999999999999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 001142 880 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 959 (1142)
Q Consensus 880 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~N 959 (1142)
.+. . .++||||+++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|
T Consensus 81 ~~~-~--------------~~lv~e~~~~~~l~~~~~~~----~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~N 141 (273)
T d1u46a_ 81 LTP-P--------------MKMVTELAPLGSLLDRLRKH----QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARN 141 (273)
T ss_dssp CSS-S--------------CEEEEECCTTCBHHHHHHHH----GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred eec-c--------------hheeeeeecCcchhhhhhcc----cCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHH
Confidence 653 2 28999999999999988752 2469999999999999999999999999999999999
Q ss_pred eeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001142 960 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1039 (1142)
Q Consensus 960 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGvi 1039 (1142)
||++.+ +.+||+|||+++......... .......||..|+|||++.+ ..++.++|||||||+
T Consensus 142 Ill~~~-------~~vkl~DfGl~~~~~~~~~~~-------~~~~~~~~~~~~~aPE~~~~----~~~~~~~Di~S~Gvi 203 (273)
T d1u46a_ 142 LLLATR-------DLVKIGDFGLMRALPQNDDHY-------VMQEHRKVPFAWCAPESLKT----RTFSHASDTWMFGVT 203 (273)
T ss_dssp EEEEET-------TEEEECCCTTCEECCC-CCEE-------EC-----CCGGGCCHHHHHH----CEEEHHHHHHHHHHH
T ss_pred hccccc-------cceeeccchhhhhcccCCCcc-------eecCccccCcccCCHHHHhC----CCCCcchhhhhhHHH
Confidence 999987 789999999998764432211 12234468889999999986 568899999999999
Q ss_pred HHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001142 1040 LLELLT-LQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1117 (1142)
Q Consensus 1040 L~ELLt-G~~Pf~~~~~~el~~~I~~~~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP 1117 (1142)
+|||+| |+.||.+.+..+....+.... .+..+ ...++.+.+|+.+||+.||
T Consensus 204 l~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~~l~~li~~cl~~dp 256 (273)
T d1u46a_ 204 LWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP---------------------------EDCPQDIYNVMVQCWAHKP 256 (273)
T ss_dssp HHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCC---------------------------TTCCHHHHHHHHHHTCSSG
T ss_pred HHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCc---------------------------ccccHHHHHHHHHHcCCCh
Confidence 999998 899999988888877764432 22211 1455679999999999999
Q ss_pred CCCCCHHHHHHHHHhh
Q 001142 1118 TERPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1118 ~~RPSa~EVL~~L~~~ 1133 (1142)
++||||.||++.|...
T Consensus 257 ~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 257 EDRPTFVALRDFLLEA 272 (273)
T ss_dssp GGSCCHHHHHHHHHHH
T ss_pred hHCcCHHHHHHHHHhc
Confidence 9999999999877643
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-43 Score=391.86 Aligned_cols=262 Identities=24% Similarity=0.380 Sum_probs=196.3
Q ss_pred CCCcceeeeecccCceEEEEEEECC-------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceee
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYG 877 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~~-------~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~g 877 (1142)
.++|++.++||+|+||.||+|++.+ +.||||+. +.. ......+.+ .+|+.++.++ +|+|||.+++
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l--~~~-~~~~~~~~~----~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEG-ATHSEHRAL----MSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-------CHHHHHHH----HHHHHHHHHHCCCTTBCCEEE
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEE--ccc-cCcHHHHHH----HHHHHHHHhhcCCCeEEEeee
Confidence 3579999999999999999999732 35777763 321 122333333 6788888777 6999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc-----------CCCCCCHHHHHHHHHHHHHHHHHHH
Q 001142 878 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAALVELH 946 (1142)
Q Consensus 878 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~-----------~~~~ls~~~i~~Ia~qIa~gL~yLH 946 (1142)
++...+. ..++|||||++|+|.++++..... ....+++..+..|+.||+.||+|||
T Consensus 85 ~~~~~~~-------------~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH 151 (299)
T d1ywna1 85 ACTKPGG-------------PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA 151 (299)
T ss_dssp EECSTTS-------------CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH
T ss_pred eeccCCC-------------eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH
Confidence 8765331 349999999999999999763221 1235899999999999999999999
Q ss_pred hCCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCC
Q 001142 947 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 1026 (1142)
Q Consensus 947 s~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 1026 (1142)
++|||||||||+|||++.+ +++||+|||+|+........ .......||+.|+|||++.+ ..
T Consensus 152 ~~~ivHrDlKp~NILl~~~-------~~~Kl~DFGla~~~~~~~~~--------~~~~~~~gt~~y~APE~l~~----~~ 212 (299)
T d1ywna1 152 SRKCIHRDLAARNILLSEK-------NVVKICDFGLARDIYKDPDY--------VRKGDARLPLKWMAPETIFD----RV 212 (299)
T ss_dssp HTTCCCSCCCGGGEEECGG-------GCEEECC------CCSCTTS--------CCTTSCCCGGGGCCHHHHHH----CC
T ss_pred hCCCcCCcCCccceeECCC-------CcEEEccCcchhhccccccc--------cccCceeeCccccchhHhhc----CC
Confidence 9999999999999999987 78999999999765432211 12234579999999999986 57
Q ss_pred CCchhhHHHHHHHHHHHHhC-CCCCCCCCHH-HHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHH
Q 001142 1027 YGLEVDIWSYGCLLLELLTL-QVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF 1104 (1142)
Q Consensus 1027 ~s~ksDVwSLGviL~ELLtG-~~Pf~~~~~~-el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1104 (1142)
++.++|||||||++|||+|| .+||.+.... .+...+..+..+..+. ..++.
T Consensus 213 ~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~ 265 (299)
T d1ywna1 213 YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD---------------------------YTTPE 265 (299)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCT---------------------------TCCHH
T ss_pred CCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCc---------------------------cCCHH
Confidence 89999999999999999986 5678765433 3445555555443321 34567
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001142 1105 LVDVFRRCTEENPTERPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1105 L~dLI~~CL~~DP~~RPSa~EVL~~L~~~ 1133 (1142)
+.+++.+||+.||++||||+||++||...
T Consensus 266 l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 266 MYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 99999999999999999999999998754
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=396.99 Aligned_cols=284 Identities=19% Similarity=0.228 Sum_probs=205.5
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
++|++.++||+|+||+||+|.+. +..||+|+.. .........+. +.+|+.+|++++|||||++++++...+.
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~--~~~~~~~~~~~----~~~Ei~il~~l~hpniv~l~~~~~~~~~ 91 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY--RPFQSELFAKR----AYRELRLLKHMRHENVIGLLDVFTPDET 91 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECS--STTSSHHHHHH----HHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEc--hhhcChHHHHH----HHHHHHHHHhcCCCCeeEEEEEeccCcc
Confidence 47999999999999999999984 6778888743 32233333333 4899999999999999999999987553
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
. ....+.|+||||+ +.+|..+++. ..+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 92 ~--------~~~~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~ 156 (346)
T d1cm8a_ 92 L--------DDFTDFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNE 156 (346)
T ss_dssp T--------TTCCCCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT
T ss_pred c--------cccceEEEEEecc-cccHHHHHHh------ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccc
Confidence 2 1234569999999 5788888765 46999999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+|++|||.|+..... .....||+.|+|||++.+ ...++.++||||+||++|+|+
T Consensus 157 ~-------~~~kl~Dfg~a~~~~~~-------------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwSlGvil~ell 213 (346)
T d1cm8a_ 157 D-------CELKILDFGLARQADSE-------------MTGYVVTRWYRAPEVILN---WMRYTQTVDIWSVGCIMAEMI 213 (346)
T ss_dssp T-------CCEEECCCTTCEECCSS-------------CCSSCSCGGGCCTHHHHT---TTCCCTTHHHHHHHHHHHHHH
T ss_pred c-------cccccccccceeccCCc-------------cccccccccccCHHHHcC---CCCCCccchhhcchHHHHHHH
Confidence 7 78999999999765431 124569999999999875 245789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccC---CCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG---SGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
+|++||.+.+..+....+........................... ............++.+.+||.+||+.||.+||
T Consensus 214 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ 293 (346)
T d1cm8a_ 214 TGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 293 (346)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSC
T ss_pred HCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCc
Confidence 999999987776655544332221111111110000000000000 00001111124567789999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 001142 1122 TAGDLYEMFVART 1134 (1142)
Q Consensus 1122 Sa~EVL~~L~~~~ 1134 (1142)
||.|+++|+|++.
T Consensus 294 ta~eiL~Hp~f~~ 306 (346)
T d1cm8a_ 294 TAGEALAHPYFES 306 (346)
T ss_dssp CHHHHHHSGGGTT
T ss_pred CHHHHhcChhhCc
Confidence 9999999999975
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-42 Score=397.52 Aligned_cols=285 Identities=22% Similarity=0.218 Sum_probs=205.8
Q ss_pred CcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
+|+..++||+|+||+||+|++. +..||+|+...+.. .. .+|+++|++++|||||++++++......
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--------~~----~~Ei~il~~l~h~niv~~~~~~~~~~~~ 88 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--------FK----NRELQIMRKLDHCNIVRLRYFFYSSGEK 88 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS--------SC----CHHHHHHHHCCCTTBCCEEEEEEEC--C
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch--------HH----HHHHHHHHhcCCCCCCcEEEEEEecCcc
Confidence 5899999999999999999984 66788887543211 11 4799999999999999999998754311
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
....+.+|||||++++ +...+.... .....+++..++.|+.||+.||+|||++||+||||||+|||++.+
T Consensus 89 --------~~~~~~~lv~Ey~~~~-~~~~l~~~~-~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~ 158 (350)
T d1q5ka_ 89 --------KDEVYLNLVLDYVPET-VYRVARHYS-RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPD 158 (350)
T ss_dssp --------CSCCEEEEEEECCSEE-HHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTT
T ss_pred --------CCceEEEEEEeccCCc-cHHHHHhhh-hccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecC
Confidence 1234679999999854 444443322 234579999999999999999999999999999999999999876
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+ ..+||+|||+++...... ......||+.|+|||.+.+ ...|+.++||||+||++|||++
T Consensus 159 ~------~~~kl~DFG~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~~---~~~~~~~~DIwSlG~il~el~~ 218 (350)
T d1q5ka_ 159 T------AVLKLCDFGSAKQLVRGE-----------PNVSYICSRYYRAPELIFG---ATDYTSSIDVWSAGCVLAELLL 218 (350)
T ss_dssp T------CCEEECCCTTCEECCTTS-----------CCCSCCSCTTSCCHHHHTT---CSSCCTHHHHHHHHHHHHHHHH
T ss_pred C------CceeEecccchhhccCCc-----------ccccccccccccChHHhhc---ccCCCcceeecccceEEEehhh
Confidence 2 479999999997654321 1224569999999999875 2468999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccc-ccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001142 1046 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC-HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1124 (1142)
Q Consensus 1046 G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~ 1124 (1142)
|+.||...+..+....+...........+...... .....................++++.+|+.+||+.||++||||.
T Consensus 219 g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~ 298 (350)
T d1q5ka_ 219 GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 298 (350)
T ss_dssp TSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHH
Confidence 99999988777766555332211212222111100 00000000000000001124567899999999999999999999
Q ss_pred HHHHHHHhhc
Q 001142 1125 DLYEMFVART 1134 (1142)
Q Consensus 1125 EVL~~L~~~~ 1134 (1142)
|+++|+|++.
T Consensus 299 e~L~Hp~f~~ 308 (350)
T d1q5ka_ 299 EACAHSFFDE 308 (350)
T ss_dssp HHHTSGGGGG
T ss_pred HHhcCHhhcc
Confidence 9999999974
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=389.95 Aligned_cols=261 Identities=25% Similarity=0.395 Sum_probs=205.8
Q ss_pred CCCcceeeeecccCceEEEEEEECC---------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccce
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKFGS---------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 875 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~~~---------~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl 875 (1142)
.++|++.++||+|+||.||+|++.+ ..||||+ ++.. .......++ .+|+..+.++ +|||||++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~--~~~~-~~~~~~~~~----~~e~~~l~~~~~HpnIv~~ 84 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM--LKSD-ATEKDLSDL----ISEMEMMKMIGKHKNIINL 84 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEEC--CCTT-CCHHHHHHH----HHHHHHHHHHCCCTTBCCE
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEE--ECcc-cChHHHHHH----HHHHHHHHHhcCCCeEEec
Confidence 4689999999999999999998632 2466665 3322 223333444 7899999888 79999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc-----------cCCCCCCHHHHHHHHHHHHHHHHH
Q 001142 876 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAALVE 944 (1142)
Q Consensus 876 ~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~-----------~~~~~ls~~~i~~Ia~qIa~gL~y 944 (1142)
++++.+++.. ++||||+++|+|.+++..... .....+++..++.++.||+.||+|
T Consensus 85 ~~~~~~~~~~--------------~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~y 150 (299)
T d1fgka_ 85 LGACTQDGPL--------------YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 150 (299)
T ss_dssp EEEECSSSSC--------------EEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHH
T ss_pred ccccccCCeE--------------EEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHH
Confidence 9999876544 999999999999999975321 113468999999999999999999
Q ss_pred HHhCCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCC
Q 001142 945 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 1024 (1142)
Q Consensus 945 LHs~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~ 1024 (1142)
||+++||||||||+|||++.+ +.+||+|||+++........ .......||+.|+|||.+.+
T Consensus 151 lH~~~ivHrDiKp~NiLl~~~-------~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~l~~---- 211 (299)
T d1fgka_ 151 LASKKCIHRDLAARNVLVTED-------NVMKIADFGLARDIHHIDYY--------KKTTNGRLPVKWMAPEALFD---- 211 (299)
T ss_dssp HHHTTCCCSCCSGGGEEECTT-------CCEEECSTTCCCCGGGCCTT--------CCCTTSCCGGGGSCHHHHHH----
T ss_pred hhhCCEEeeeecccceeecCC-------CCeEeccchhhccccccccc--------cccccCCCChhhhhhhHhcC----
Confidence 999999999999999999987 78999999999866442211 11234568999999999976
Q ss_pred CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHH
Q 001142 1025 NLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLS 1103 (1142)
Q Consensus 1025 ~~~s~ksDVwSLGviL~ELLt-G~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1103 (1142)
..|+.++|||||||++|||++ |.+||.+.+..++...+..+..+..+. ..++
T Consensus 212 ~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~p~---------------------------~~~~ 264 (299)
T d1fgka_ 212 RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPS---------------------------NCTN 264 (299)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCS---------------------------SCCH
T ss_pred CCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------cchH
Confidence 679999999999999999998 799999888888877777665544331 3456
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001142 1104 FLVDVFRRCTEENPTERPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1104 ~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~ 1133 (1142)
.+.+||.+||+.||.+||||.||++.|...
T Consensus 265 ~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 265 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 799999999999999999999999998765
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=392.81 Aligned_cols=298 Identities=17% Similarity=0.200 Sum_probs=206.8
Q ss_pred CCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 882 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~ 882 (1142)
++++|++.++||+|+||+||+|++. ++.||||+...+.. ... ...++.+|+.+|++++||||+++++.+...
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~----~~~~~~~E~~il~~l~h~nii~~~~~~~~~ 81 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE--KEG----FPITALREIKILQLLKHENVVNLIEICRTK 81 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C--TTS----SCHHHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred ccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chH----HHHHHHHHHHHHHHhcCCCccceEeeeecc
Confidence 3688999999999999999999984 67789987544322 111 222347999999999999999999998764
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 001142 883 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 962 (1142)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILl 962 (1142)
... ......+.++||||+.++.+..... ....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 82 ~~~------~~~~~~~~~iv~e~~~~~~~~~~~~-----~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl 150 (318)
T d3blha1 82 ASP------YNRCKGSIYLVFDFCEHDLAGLLSN-----VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI 150 (318)
T ss_dssp ---------------CEEEEEECCCEEHHHHHTC-----TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred ccc------ccccCceEEEEEeccCCCccchhhh-----cccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheee
Confidence 321 1112235799999998665543332 24578999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001142 963 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1042 (1142)
Q Consensus 963 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~E 1042 (1142)
+.+ +.+||+|||+++......... ........||+.|+|||++.+ ...|+.++|||||||++||
T Consensus 151 ~~~-------~~~kl~dfg~~~~~~~~~~~~------~~~~~~~~gT~~Y~aPE~~~~---~~~~~~k~DiwSlGvil~e 214 (318)
T d3blha1 151 TRD-------GVLKLADFGLARAFSLAKNSQ------PNRYTNRVVTLWYRPPELLLG---ERDYGPPIDLWGAGCIMAE 214 (318)
T ss_dssp CTT-------SCEEECCCTTCEECCC-----------CCCCCSCCSCGGGCCHHHHTT---CSSCCTHHHHHHHHHHHHH
T ss_pred cCC-------CcEEeeecceeeecccccccc------cccccceecCHHHhhHHHHcC---CCCCCcHHHcccCCceeee
Confidence 987 789999999997654322111 112234579999999999876 2468899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCch----hhhhhHHHHHHHHHHhcccCCC
Q 001142 1043 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE----AELETLSFLVDVFRRCTEENPT 1118 (1142)
Q Consensus 1043 LLtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~L~dLI~~CL~~DP~ 1118 (1142)
|++|+.||.+.+..+....+.................................. .....++.+.+||.+||++||+
T Consensus 215 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~ 294 (318)
T d3blha1 215 MWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPA 294 (318)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTT
T ss_pred HhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChh
Confidence 999999999877766655553321111111111100000000000000000100 0113356788999999999999
Q ss_pred CCCCHHHHHHHHHhhcC
Q 001142 1119 ERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1119 ~RPSa~EVL~~L~~~~s 1135 (1142)
+||||+|+++|+||+..
T Consensus 295 ~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 295 QRIDSDDALNHDFFWSD 311 (318)
T ss_dssp TSCCHHHHHHSGGGSSS
T ss_pred HCcCHHHHHcChhhccC
Confidence 99999999999999854
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-42 Score=385.99 Aligned_cols=264 Identities=22% Similarity=0.349 Sum_probs=213.2
Q ss_pred CCCCcceeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceee
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 877 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~~-------~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g 877 (1142)
+.++|++.++||+|+||+||+|.+. +..||||+. +.. ........| .+|+.++++++|||||++++
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~--~~~-~~~~~~~~~----~~E~~il~~l~h~nIv~~~~ 90 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--NEA-ASMRERIEF----LNEASVMKEFNCHHVVRLLG 90 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEEC--CTT-SCHHHHHHH----HHHHHHGGGCCCTTBCCEEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEE--Ccc-cChHHHHHH----HHHHHHHHHcCCCCEeeeee
Confidence 3578999999999999999999874 346777764 322 223333334 89999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc-----cCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 001142 878 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----TGEKHVSVKLALFIAQDVAAALVELHSKHIMH 952 (1142)
Q Consensus 878 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~-----~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvH 952 (1142)
++...... ++||||+++|+|.+++..... .....+++..+..|+.|++.||.|||+++|+|
T Consensus 91 ~~~~~~~~--------------~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivH 156 (308)
T d1p4oa_ 91 VVSQGQPT--------------LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVH 156 (308)
T ss_dssp EECSSSSC--------------EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred EEecCCce--------------eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeee
Confidence 99765543 999999999999999875321 12235789999999999999999999999999
Q ss_pred cCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhh
Q 001142 953 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 1032 (1142)
Q Consensus 953 rDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksD 1032 (1142)
|||||+|||++.+ +++||+|||+|+......... ......||+.|+|||.+.+ ..++.++|
T Consensus 157 rDlk~~NiLld~~-------~~~Kl~DFGla~~~~~~~~~~--------~~~~~~~t~~y~aPe~l~~----~~~~~~~D 217 (308)
T d1p4oa_ 157 RDLAARNCMVAED-------FTVKIGDFGMTRDIYETDYYR--------KGGKGLLPVRWMSPESLKD----GVFTTYSD 217 (308)
T ss_dssp SCCSGGGEEECTT-------CCEEECCTTCCCGGGGGGCEE--------GGGSSEECGGGCCHHHHHH----CCCCHHHH
T ss_pred ceEcCCceeecCC-------ceEEEeecccceeccCCccee--------eccceecccccCCHHHHcc----CCCCcccc
Confidence 9999999999987 889999999998665432211 1123358999999999986 57889999
Q ss_pred HHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHH
Q 001142 1033 IWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRR 1111 (1142)
Q Consensus 1033 VwSLGviL~ELLtG-~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~ 1111 (1142)
||||||++|||+|| ..||.+.+..+....+..+..+..+. .+++.+.+++.+
T Consensus 218 v~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~~p~---------------------------~~~~~l~~li~~ 270 (308)
T d1p4oa_ 218 VWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD---------------------------NCPDMLFELMRM 270 (308)
T ss_dssp HHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHH
T ss_pred cccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCCCcc---------------------------cchHHHHHHHHH
Confidence 99999999999998 58898888888888776665543321 445679999999
Q ss_pred hcccCCCCCCCHHHHHHHHHhhcC
Q 001142 1112 CTEENPTERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1112 CL~~DP~~RPSa~EVL~~L~~~~s 1135 (1142)
||+.||.+|||+.+|+++|.....
T Consensus 271 cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 271 CWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HcCCChhHCcCHHHHHHHHHHhcC
Confidence 999999999999999998876533
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-42 Score=385.57 Aligned_cols=261 Identities=22% Similarity=0.347 Sum_probs=200.4
Q ss_pred ceeeeecccCceEEEEEEECC---ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCC
Q 001142 810 SSCDEAGKSVSSSLFRCKFGS---ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 886 (1142)
Q Consensus 810 ~l~~~LG~GsfG~Vy~a~~~~---~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~ 886 (1142)
.+.++||+|+||+||+|++.. +.++|++|.++.. ......++| .+|+++|++++|||||+++|++.+.+
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~----~~E~~~l~~l~HpnIv~~~g~~~~~~--- 101 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQF----LTEGIIMKDFSHPNVLSLLGICLRSE--- 101 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHH----HHHHHHHHTCCCTTBCCCCEEEEETT---
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHH----HHHHHHHHhCCCCCEeEEeEEEEecC---
Confidence 446899999999999999832 3344444445432 234444455 89999999999999999999986532
Q ss_pred CCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecccc
Q 001142 887 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 966 (1142)
Q Consensus 887 ~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~~ 966 (1142)
...++|||||++|+|.+++.. ....+++..+..++.|++.||.|||+.+|+||||||+|||++.+
T Consensus 102 ----------~~~~lv~E~~~~g~l~~~~~~----~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~- 166 (311)
T d1r0pa_ 102 ----------GSPLVVLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK- 166 (311)
T ss_dssp ----------TEEEEEEECCTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-
T ss_pred ----------CceEEEEEEeecCchhhhhcc----ccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCC-
Confidence 145999999999999999874 23467889999999999999999999999999999999999887
Q ss_pred ccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001142 967 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1046 (1142)
Q Consensus 967 ~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLtG 1046 (1142)
+.+||+|||+++......... ........||+.|+|||.+.. ..++.++||||||+++|||+||
T Consensus 167 ------~~~kL~DFG~~~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~----~~~~~ksDI~SfGivl~El~t~ 230 (311)
T d1r0pa_ 167 ------FTVKVADFGLARDMYDKEFDS------VHNKTGAKLPVKWMALESLQT----QKFTTKSDVWSFGVLLWELMTR 230 (311)
T ss_dssp ------CCEEECSSGGGCCTTTTTCCC------TTCTTCSSCCGGGSCHHHHHH----CCCCHHHHHHHHHHHHHHHHTT
T ss_pred ------CCEEEecccchhhcccccccc------ceecccccccccccChHHHhc----CCCCChhHhhhhHHHHHHHHHC
Confidence 789999999998764432111 111223468999999999876 5789999999999999999997
Q ss_pred CCCCCC-CCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001142 1047 QVPYMG-LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1125 (1142)
Q Consensus 1047 ~~Pf~~-~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~E 1125 (1142)
..||.. .+..++...+..+.++..+. .+++.+.+|+.+||+.||++|||+.|
T Consensus 231 ~~p~~~~~~~~~~~~~i~~g~~~~~p~---------------------------~~~~~l~~li~~cl~~dP~~RPs~~e 283 (311)
T d1r0pa_ 231 GAPPYPDVNTFDITVYLLQGRRLLQPE---------------------------YCPDPLYEVMLKCWHPKAEMRPSFSE 283 (311)
T ss_dssp SCCSCC------CHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCcc---------------------------cCcHHHHHHHHHHcCCCHhHCcCHHH
Confidence 777754 33334455555555433221 34567999999999999999999999
Q ss_pred HHHHHHhhcCC
Q 001142 1126 LYEMFVARTSS 1136 (1142)
Q Consensus 1126 VL~~L~~~~ss 1136 (1142)
|+++|....++
T Consensus 284 i~~~L~~i~~~ 294 (311)
T d1r0pa_ 284 LVSRISAIFST 294 (311)
T ss_dssp HHHHHHHHHHT
T ss_pred HHHHHHHHHHh
Confidence 99998776544
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-42 Score=380.24 Aligned_cols=284 Identities=19% Similarity=0.221 Sum_probs=209.3
Q ss_pred CCCcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001142 806 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 883 (1142)
Q Consensus 806 ~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~ 883 (1142)
+++|++.++||+|+||+||+|++ .+..||||+.+... ........ +.+|+.++++++|||||++++++.+..
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~----~~~E~~il~~l~h~niv~~~~~~~~~~ 74 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD--DDEGVPSS----ALREICLLKELKHKNIVRLHDVLHSDK 74 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC--SSTTHHHH----HHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh--CChHHHHH----HHHHHHHHHhcCcCCEEeecccccccc
Confidence 36899999999999999999998 45678888865443 22222333 479999999999999999999998765
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
+.++||||+.+++|..+++. ...+++..++.++.|++.||+|||++||+||||||+|||++
T Consensus 75 --------------~~~iv~~~~~~~~l~~~~~~-----~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~ 135 (292)
T d1unla_ 75 --------------KLTLVFEFCDQDLKKYFDSC-----NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN 135 (292)
T ss_dssp --------------EEEEEEECCSEEHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred --------------ceeEEeeecccccccccccc-----ccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccc
Confidence 34999999998888877754 35789999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
.+ +.+||+|||.|+....... ......+++.|+|||++.. ...++.++|||||||++|||
T Consensus 136 ~~-------~~~kl~DFG~a~~~~~~~~----------~~~~~~~~~~~~~pe~~~~---~~~~~~~~DiwSlG~il~el 195 (292)
T d1unla_ 136 RN-------GELKLANFGLARAFGIPVR----------CYSAEVVTLWYRPPDVLFG---AKLYSTSIDMWSAGCIFAEL 195 (292)
T ss_dssp TT-------CCEEECCCTTCEECCSCCS----------CCCSCCSCGGGCCHHHHTT---CSCCCTHHHHHHHHHHHHHH
T ss_pred cC-------CceeeeecchhhcccCCCc----------cceeeccccchhhhhHhcc---CCCCCchhhccccchHHHHH
Confidence 77 7899999999976543221 1223457889999999876 23578999999999999999
Q ss_pred HhCCCCCC-CCCHHHHHHHHHhCCCCCchhHHhhhcccccc-cccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1044 LTLQVPYM-GLSELEIHDLIQMGKRPRLTDELEALGSCHEH-EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1044 LtG~~Pf~-~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
++|+.||. +.+..+....+.....+.....+......... ..................++.+.+|+.+||+.||.+||
T Consensus 196 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ 275 (292)
T d1unla_ 196 ANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI 275 (292)
T ss_dssp TTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSC
T ss_pred hhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCc
Confidence 99998864 44555555554322211111111110000000 00000001111112225567899999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 001142 1122 TAGDLYEMFVART 1134 (1142)
Q Consensus 1122 Sa~EVL~~L~~~~ 1134 (1142)
||+|+++|+|++.
T Consensus 276 sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 276 SAEEALQHPYFSD 288 (292)
T ss_dssp CHHHHTTSGGGSS
T ss_pred CHHHHhcChhhcC
Confidence 9999999999974
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-42 Score=384.78 Aligned_cols=267 Identities=25% Similarity=0.279 Sum_probs=197.8
Q ss_pred CCcceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 886 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~~ 886 (1142)
.+|.+.++||+|+||.||+|++++..||||++..+ ..+.+ ..+.|+..+.+++|||||++++++.+.+.
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~-------~~~~~--~~e~ei~~~~~~~HpnIv~~~~~~~~~~~-- 71 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR-------EERSW--FREAEIYQTVMLRHENILGFIAADNKDNG-- 71 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGG-------GHHHH--HHHHHHHTSTTCCCTTBCCEEEEEEEECS--
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECcc-------chhHH--HHHHHHHHHhhCCCCcCcceEEEEEeCCC--
Confidence 36889999999999999999999999999986422 11122 11345556667899999999999986432
Q ss_pred CCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh--------CCccccCCCCC
Q 001142 887 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS--------KHIMHRDIKSE 958 (1142)
Q Consensus 887 ~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs--------~gIvHrDLKp~ 958 (1142)
...+.++||||+++|+|.+++++ ..+++..+..++.|++.||+|||+ +||+||||||+
T Consensus 72 --------~~~~~~lv~Ey~~~g~L~~~l~~------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~ 137 (303)
T d1vjya_ 72 --------TWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSK 137 (303)
T ss_dssp --------SSEEEEEEEECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGG
T ss_pred --------cceEEEEEEecccCCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCcc
Confidence 23367999999999999999986 358999999999999999999996 59999999999
Q ss_pred CeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccC--CCCCCchhhHHHH
Q 001142 959 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK--PNLYGLEVDIWSY 1036 (1142)
Q Consensus 959 NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~--~~~~s~ksDVwSL 1036 (1142)
||||+.+ +.+||+|||+++......... ........||+.|+|||++.+... ...++.++|||||
T Consensus 138 NILl~~~-------~~~Kl~DFGl~~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~ 204 (303)
T d1vjya_ 138 NILVKKN-------GTCCIADLGLAVRHDSATDTI------DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM 204 (303)
T ss_dssp GEEECTT-------SCEEECCCTTCEEEETTTTEE------CC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHH
T ss_pred ceEEcCC-------CCeEEEecCccccccCCCcce------eccccceecccCcCChhhccccccccCCCcCcchhhhhh
Confidence 9999887 899999999998765433221 112234579999999999875321 1135789999999
Q ss_pred HHHHHHHHhCCCCCCCCC---------------HHHHHHHHHh-CCCCCchhHHhhhcccccccccccCCCCCCchhhhh
Q 001142 1037 GCLLLELLTLQVPYMGLS---------------ELEIHDLIQM-GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELE 1100 (1142)
Q Consensus 1037 GviL~ELLtG~~Pf~~~~---------------~~el~~~I~~-~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 1100 (1142)
||++|||+||..||.... .......+.. ..+|.++.. .....
T Consensus 205 Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~----------------------~~~~~ 262 (303)
T d1vjya_ 205 GLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNR----------------------WQSCE 262 (303)
T ss_dssp HHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGG----------------------GGGCH
T ss_pred HHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcc----------------------cCChH
Confidence 999999999988774311 1111111111 111211111 11124
Q ss_pred hHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001142 1101 TLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 1133 (1142)
Q Consensus 1101 ~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~ 1133 (1142)
....+.+|+.+||+.||++|||+.||+++|...
T Consensus 263 ~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 263 ALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp HHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 566799999999999999999999999988654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-42 Score=387.06 Aligned_cols=263 Identities=24% Similarity=0.373 Sum_probs=206.5
Q ss_pred CCCCcceeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCcccee
Q 001142 805 SFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMY 876 (1142)
Q Consensus 805 ~~~~y~l~~~LG~GsfG~Vy~a~~~-------~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~ 876 (1142)
+.++|++.++||+|+||.||+|++. +..||||+.. ... .......+ .+|+.+++++ +|||||+++
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~--~~~-~~~~~~~~----~~E~~~~~~l~~HpnIv~~~ 93 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK--PSA-HLTEREAL----MSELKVLSYLGNHMNIVNLL 93 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEEC--TTC-CHHHHHHH----HHHHHHHHHHCCCTTBCCEE
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEEC--ccc-CHHHHHHH----HHHHHHHHhccCCCCEEEEE
Confidence 3468999999999999999999873 2357777643 222 23333344 7999999999 699999999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc-------------cCCCCCCHHHHHHHHHHHHHHHH
Q 001142 877 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-------------TGEKHVSVKLALFIAQDVAAALV 943 (1142)
Q Consensus 877 g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~-------------~~~~~ls~~~i~~Ia~qIa~gL~ 943 (1142)
+++.+.+.. ++|||||++|+|.++++.... .....+++..+..|+.||+.||+
T Consensus 94 g~~~~~~~~--------------~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ 159 (311)
T d1t46a_ 94 GACTIGGPT--------------LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA 159 (311)
T ss_dssp EEECSSSSC--------------EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHH
T ss_pred EEEeeCCEE--------------EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHH
Confidence 999876544 999999999999999976321 12336899999999999999999
Q ss_pred HHHhCCccccCCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccC
Q 001142 944 ELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 1023 (1142)
Q Consensus 944 yLHs~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~ 1023 (1142)
|||+++||||||||+|||++.+ +.+|++|||.++......... ......||+.|+|||++.+
T Consensus 160 ~LH~~~ivHrDLKp~NIl~~~~-------~~~ki~DfG~~~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~--- 221 (311)
T d1t46a_ 160 FLASKNCIHRDLAARNILLTHG-------RITKICDFGLARDIKNDSNYV--------VKGNARLPVKWMAPESIFN--- 221 (311)
T ss_dssp HHHHTTCCCSCCSGGGEEEETT-------TEEEECCCGGGSCTTSCTTSE--------ECSSSEECGGGCCHHHHHH---
T ss_pred HHHhCCeeeccccccccccccc-------CcccccccchheeccCCCcce--------EeeecccChHHcCHHHhcC---
Confidence 9999999999999999999887 889999999998654422111 1234578999999999986
Q ss_pred CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH-HHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhh
Q 001142 1024 PNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEI-HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELET 1101 (1142)
Q Consensus 1024 ~~~~s~ksDVwSLGviL~ELLt-G~~Pf~~~~~~el-~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1101 (1142)
..++.++|||||||++|||+| |.+||.+.+..+. ...+..+.++..+. ..
T Consensus 222 -~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~ 273 (311)
T d1t46a_ 222 -CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPE---------------------------HA 273 (311)
T ss_dssp -CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCT---------------------------TS
T ss_pred -CCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcc---------------------------cc
Confidence 578999999999999999999 6666766555443 34445544433221 34
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001142 1102 LSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1134 (1142)
Q Consensus 1102 ~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~~ 1134 (1142)
++.+.+||.+||+.||.+||||+||++.|..+.
T Consensus 274 ~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 274 PAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 567999999999999999999999999987653
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-41 Score=386.85 Aligned_cols=287 Identities=18% Similarity=0.221 Sum_probs=203.7
Q ss_pred CcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001142 808 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~~ 885 (1142)
+|++.++||+|+||+||+|++. ++.||||+.. ... .....+. +.+|+.+|++++|||||++++++......
T Consensus 9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~--~~~-~~~~~~~----~~~Ei~il~~l~hp~iv~~~~~~~~~~~~ 81 (345)
T d1pmea_ 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS--PFE-HQTYCQR----TLREIKILLRFRHENIIGINDIIRAPTIE 81 (345)
T ss_dssp TEEEEEECC---CCCEEEEEETTTCSEEEEEEEC--CTT-CHHHHHH----HHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEe--hhc-ChHHHHH----HHHHHHHHHHcCCCCCCcEEEEEeecccc
Confidence 5999999999999999999984 6778888753 211 2233333 47999999999999999999998765422
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccc
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 965 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~~ 965 (1142)
.... +++|+|+.+|+|.+++.. ..+++..++.++.||+.||+|||++|||||||||+|||++.+
T Consensus 82 ---------~~~~-~~l~~~~~~g~L~~~l~~------~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~ 145 (345)
T d1pmea_ 82 ---------QMKD-VYLVTHLMGADLYKLLKT------QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT 145 (345)
T ss_dssp ---------TCCC-EEEEEECCCEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT
T ss_pred ---------ccce-EEEEEeecCCchhhhhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCC
Confidence 1112 444556668999999975 369999999999999999999999999999999999999887
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001142 966 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1045 (1142)
Q Consensus 966 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELLt 1045 (1142)
+.+||+|||+|+......... ......+||+.|+|||++.. ...++.++||||+||++|+|++
T Consensus 146 -------~~~kl~DfG~a~~~~~~~~~~-------~~~~~~~gt~~y~aPE~l~~---~~~~~~~~DiwSlG~il~eml~ 208 (345)
T d1pmea_ 146 -------CDLKICDFGLARVADPDHDHT-------GFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLS 208 (345)
T ss_dssp -------CCEEECCCTTCEECCGGGCBC-------CTTCCCCSCGGGCCGGGTTT---BCSCSTHHHHHHHHHHHHHHHH
T ss_pred -------CCEEEcccCceeeccCCCccc-------eeeccccccceechHHHhhc---CCCCCchhhhhccCceehHHhh
Confidence 789999999997654432111 11234579999999999865 2467899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHh-CCCCCchhHHhhhccccccc-ccccCC--CCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1046 LQVPYMGLSELEIHDLIQM-GKRPRLTDELEALGSCHEHE-VAQSGS--GFEKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1046 G~~Pf~~~~~~el~~~I~~-~~~p~l~~~l~~~~~~~~~~-~~~~~~--~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
|+.||.+.+..+....... ...+... ............ ...... ...........++.+.+|+.+||+.||.+||
T Consensus 209 g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 287 (345)
T d1pmea_ 209 NRPIFPGKHYLDQLNHILGILGSPSQE-DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI 287 (345)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCSCCHH-HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSC
T ss_pred CCCCCCCCCHHHHHHHHhhhccCCChh-hhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCc
Confidence 9999988776655444322 1222111 110000000000 000000 0000111124456799999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001142 1122 TAGDLYEMFVARTS 1135 (1142)
Q Consensus 1122 Sa~EVL~~L~~~~s 1135 (1142)
||+|+++|+|++..
T Consensus 288 ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 288 EVEQALAHPYLEQY 301 (345)
T ss_dssp CHHHHHTSGGGTTT
T ss_pred CHHHHhcCHhhccC
Confidence 99999999998743
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.9e-41 Score=383.03 Aligned_cols=282 Identities=19% Similarity=0.214 Sum_probs=202.8
Q ss_pred CCCCCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEe
Q 001142 804 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKI 880 (1142)
Q Consensus 804 ~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~g~~~ 880 (1142)
...++|++.++||+|+||+||+|++. +..||+|+.+ .. ..+. +.+|+.+|++++ ||||+++++++.
T Consensus 32 ~~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~--~~-----~~~~----~~~Ei~il~~l~~hpnIv~~~~~~~ 100 (328)
T d3bqca1 32 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK--PV-----KKKK----IKREIKILENLRGGPNIITLADIVK 100 (328)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC--SS-----CHHH----HHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred CCCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEC--HH-----HHHH----HHHHHHHHHhccCCCCCcEEEEEEE
Confidence 34568999999999999999999984 6778888753 21 1223 378999999995 999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001142 881 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 960 (1142)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NI 960 (1142)
.... .+.++||||+++++|..+. ..+++..++.++.||+.||+|||++||+||||||+||
T Consensus 101 ~~~~------------~~~~~v~e~~~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NI 160 (328)
T d3bqca1 101 DPVS------------RTPALVFEHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNV 160 (328)
T ss_dssp CTTT------------CSEEEEEECCCSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred ecCC------------CceeEEEeecCCCcHHHHh--------cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccce
Confidence 5321 2469999999999986653 3589999999999999999999999999999999999
Q ss_pred eeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001142 961 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1040 (1142)
Q Consensus 961 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL 1040 (1142)
|++.++ ..+||+|||+|+...... ......||+.|+|||.+.+ ...++.++||||+||++
T Consensus 161 Li~~~~------~~vkl~DFG~a~~~~~~~-----------~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~~l 220 (328)
T d3bqca1 161 MIDHEH------RKLRLIDWGLAEFYHPGQ-----------EYNVRVASRYFKGPELLVD---YQMYDYSLDMWSLGCML 220 (328)
T ss_dssp EEETTT------TEEEECCGGGCEECCTTC-----------CCCSCCSCGGGCCHHHHTT---CCCCCTHHHHHHHHHHH
T ss_pred EEcCCC------CeeeecccccceeccCCC-----------cccccccCccccCcccccC---CCCCCcccchhhhhhhh
Confidence 998652 579999999997654321 1234568999999999876 24578999999999999
Q ss_pred HHHHhCCCCCCCCCH-HHHHHHHHhCCCCCchhHH-hhhccccccccccc--------CCCCCCchhhhhhHHHHHHHHH
Q 001142 1041 LELLTLQVPYMGLSE-LEIHDLIQMGKRPRLTDEL-EALGSCHEHEVAQS--------GSGFEKPEAELETLSFLVDVFR 1110 (1142)
Q Consensus 1041 ~ELLtG~~Pf~~~~~-~el~~~I~~~~~p~l~~~l-~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~L~dLI~ 1110 (1142)
|+|++|+.||..... .+....+............ .............. .............++++.+||.
T Consensus 221 ~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~ 300 (328)
T d3bqca1 221 ASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLD 300 (328)
T ss_dssp HHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHH
T ss_pred HHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHH
Confidence 999999999975432 2222222111000000000 00000000000000 0000011112245678999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHhhcCC
Q 001142 1111 RCTEENPTERPTAGDLYEMFVARTSS 1136 (1142)
Q Consensus 1111 ~CL~~DP~~RPSa~EVL~~L~~~~ss 1136 (1142)
+||+.||.+||||+|+++|+||+...
T Consensus 301 ~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 301 KLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp HHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred HHccCChhHCcCHHHHhcCcccCCCC
Confidence 99999999999999999999998643
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-41 Score=386.43 Aligned_cols=283 Identities=17% Similarity=0.222 Sum_probs=202.3
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
.+|++.++||+|+||+||+|++. +..||||+...+ ......... +.+|+.++++++|||||++++++...+.
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~--~~~~~~~~~----~~~Ei~il~~l~hpnIv~~~~~f~~~~~ 90 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP--FQNQTHAKR----AYRELVLMKCVNHKNIISLLNVFTPQKT 90 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEEST--TSSHHHHHH----HHHHHHHHHHCCCTTBCCCSEEECSCCS
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChh--hcCHHHHHH----HHHHHHHHHhcCCCCeeEEEEEEecccc
Confidence 67999999999999999999984 778888886433 223333333 4899999999999999999999976542
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
. ....+.|+||||+.+ ++.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 91 ~--------~~~~~~~iv~Ey~~~-~l~~~~~-------~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~ 154 (355)
T d2b1pa1 91 L--------EEFQDVYLVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 154 (355)
T ss_dssp T--------TTCCEEEEEEECCSE-EHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred c--------ccCceeEEEEeccch-HHHHhhh-------cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccccc
Confidence 2 234578999999975 5554442 35899999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+|++|||.++...... ......||+.|+|||++.+ ..++.++||||+||++++|+
T Consensus 155 ~-------~~~kl~df~~~~~~~~~~-----------~~~~~~~t~~y~aPE~l~~----~~~~~~~DiwSlG~~l~ell 212 (355)
T d2b1pa1 155 D-------CTLKILDFGLARTAGTSF-----------MMTPYVVTRYYRAPEVILG----MGYKENVDIWSVGCIMGEMV 212 (355)
T ss_dssp T-------CCEEECCCCC--------------------------CCTTCCHHHHTT----CCCCTTHHHHHHHHHHHHHH
T ss_pred c-------cceeeechhhhhcccccc-----------ccccccccccccChhhhcC----CCCCCCcccccccchHHHHh
Confidence 7 789999999987544321 1224468999999999976 57889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccc---------------cccccCCCCCCchhhhhhHHHHHHHH
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEH---------------EVAQSGSGFEKPEAELETLSFLVDVF 1109 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~L~dLI 1109 (1142)
+|+.||.+.+.......+........+..+......... ........ .........++.+.+||
T Consensus 213 ~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~dll 291 (355)
T d2b1pa1 213 RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFP-ADSEHNKLKASQARDLL 291 (355)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSC-CSSHHHHHHHHHHHHHH
T ss_pred hCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCcccccccccccccccccc-ccccccccCCHHHHHHH
Confidence 999999988776665555332222222211111000000 00000000 01112235678899999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHhhc
Q 001142 1110 RRCTEENPTERPTAGDLYEMFVART 1134 (1142)
Q Consensus 1110 ~~CL~~DP~~RPSa~EVL~~L~~~~ 1134 (1142)
.+||+.||++||||+||++|+|++.
T Consensus 292 ~~mL~~dP~~R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 292 SKMLVIDPAKRISVDDALQHPYINV 316 (355)
T ss_dssp HHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred HHHCcCChhHCcCHHHHhcCcccCC
Confidence 9999999999999999999999975
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-42 Score=389.74 Aligned_cols=263 Identities=22% Similarity=0.267 Sum_probs=204.3
Q ss_pred CCCCCcceeeeecccCceEEEEEEE-----CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCC-CCccceee
Q 001142 804 GSFPSLSSCDEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH-SCIVEMYG 877 (1142)
Q Consensus 804 ~~~~~y~l~~~LG~GsfG~Vy~a~~-----~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H-pNIVkl~g 877 (1142)
..+++|++.++||+|+||+||+|+. .++.||+|+++...........+.+ .+|++++++++| |||+++++
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~----~~E~~il~~l~h~pnIv~~~~ 96 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHT----RTERQVLEHIRQSPFLVTLHY 96 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGC----CCHHHHHHHHHTCTTBCCEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHH----HHHHHHHHhccCCCeEEEeee
Confidence 4578899999999999999999986 3567999986433211111122233 689999999965 89999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 001142 878 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 957 (1142)
Q Consensus 878 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp 957 (1142)
++.+.. ..++||||+.+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||
T Consensus 97 ~~~~~~--------------~~~~v~e~~~~~~L~~~i~~~-----~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp 157 (322)
T d1vzoa_ 97 AFQTET--------------KLHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKL 157 (322)
T ss_dssp EEEETT--------------EEEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred eeccCC--------------ceeeeeecccccHHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCc
Confidence 998765 349999999999999999862 4578899999999999999999999999999999
Q ss_pred CCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHH
Q 001142 958 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1037 (1142)
Q Consensus 958 ~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLG 1037 (1142)
+|||++.+ +.+||+|||+|+.+...... ......|++.|+|||.+.+. ...++.++||||||
T Consensus 158 ~Nill~~~-------~~vkL~DFG~a~~~~~~~~~---------~~~~~~g~~~~~~pe~~~~~--~~~~~~ksDIWSlG 219 (322)
T d1vzoa_ 158 ENILLDSN-------GHVVLTDFGLSKEFVADETE---------RAYDFCGTIEYMAPDIVRGG--DSGHDKAVDWWSLG 219 (322)
T ss_dssp GGEEECTT-------SCEEESCSSEEEECCGGGGG---------GGCGGGSCCTTCCHHHHTTC--C---CTHHHHHHHH
T ss_pred cceeecCC-------CCEEEeeccchhhhcccccc---------cccccccccccchhHHhhcC--CcCCCchhhhHHHH
Confidence 99999987 78999999999765432211 11245699999999998752 23578899999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHh---CCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcc
Q 001142 1038 CLLLELLTLQVPYMGLSELEIHDLIQM---GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 1114 (1142)
Q Consensus 1038 viL~ELLtG~~Pf~~~~~~el~~~I~~---~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~ 1114 (1142)
|+||+|++|+.||.+....+....+.. ...+..+ ...++.+.+|+.+||+
T Consensus 220 ~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~---------------------------~~~s~~~~~li~~~l~ 272 (322)
T d1vzoa_ 220 VLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP---------------------------QEMSALAKDLIQRLLM 272 (322)
T ss_dssp HHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC---------------------------TTSCHHHHHHHHHHTC
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCc---------------------------ccCCHHHHHHHHHHcc
Confidence 999999999999977543332222211 1111110 1456779999999999
Q ss_pred cCCCCCC-----CHHHHHHHHHhhc
Q 001142 1115 ENPTERP-----TAGDLYEMFVART 1134 (1142)
Q Consensus 1115 ~DP~~RP-----Sa~EVL~~L~~~~ 1134 (1142)
+||++|| |++|+++|+|++.
T Consensus 273 ~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 273 KDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp SSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred cCHHHcCCCCcccHHHHHcCHhhcC
Confidence 9999999 5899999999975
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-41 Score=385.78 Aligned_cols=285 Identities=19% Similarity=0.232 Sum_probs=206.5
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 884 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~~~~~~ 884 (1142)
++|++.++||+|+||+||+|++. +..||+|+. +.........+.+ .+|+.+|++++|||||++++++.....
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i--~~~~~~~~~~~~~----~~Ei~il~~l~h~~iv~~~~~~~~~~~ 91 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRT----YRELRLLKHMKHENVIGLLDVFTPARS 91 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEEC--SCTTSSHHHHHHH----HHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEE--CchhcChHHHHHH----HHHHHHHHhcCCCCeeeEEEEEeeccc
Confidence 57999999999999999999984 667888874 3333333333344 799999999999999999999875432
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 001142 885 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 964 (1142)
Q Consensus 885 ~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld~ 964 (1142)
. .....++||+|+.+|+|.++++. ..+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 92 ~---------~~~~~~~i~~~~~gg~L~~~~~~------~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~ 156 (348)
T d2gfsa1 92 L---------EEFNDVYLVTHLMGADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 156 (348)
T ss_dssp T---------TTCCCCEEEEECCSEEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT
T ss_pred c---------ccCceEEEEEeecCCchhhhccc------ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccc
Confidence 2 01122566777789999999853 46999999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001142 965 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1044 (1142)
Q Consensus 965 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~ELL 1044 (1142)
+ +.+|++|||.+....... ....||+.|+|||++.+ ...++.++|||||||++|+|+
T Consensus 157 ~-------~~~kl~dfg~a~~~~~~~-------------~~~~g~~~y~apE~~~~---~~~~~~~~DiwSlGv~l~~ll 213 (348)
T d2gfsa1 157 D-------CELKILDFGLARHTDDEM-------------TGYVATRWYRAPEIMLN---WMHYNQTVDIWSVGCIMAELL 213 (348)
T ss_dssp T-------CCEEECCC----CCTGGG-------------SSSCHHHHTSCHHHHTT---CSCCCTTHHHHHHHHHHHHHH
T ss_pred c-------ccccccccchhcccCccc-------------ccccccccccCchhhcC---CccCCcccchhhhhHHHHHHH
Confidence 7 789999999996543321 23468999999999775 245689999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCC---CCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001142 1045 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF---EKPEAELETLSFLVDVFRRCTEENPTERP 1121 (1142)
Q Consensus 1045 tG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~L~dLI~~CL~~DP~~RP 1121 (1142)
+|+.||.+.+.......+.............................. .........++.+++||.+||+.||.+||
T Consensus 214 ~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ 293 (348)
T d2gfsa1 214 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 293 (348)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSC
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCc
Confidence 999999988877766666333222211111100000000000000000 00111124567899999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001142 1122 TAGDLYEMFVARTS 1135 (1142)
Q Consensus 1122 Sa~EVL~~L~~~~s 1135 (1142)
||+|+++|+|++.-
T Consensus 294 ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 294 TAAQALAHAYFAQY 307 (348)
T ss_dssp CHHHHHTSGGGTTT
T ss_pred CHHHHhcCHhhCCC
Confidence 99999999999853
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-39 Score=364.03 Aligned_cols=268 Identities=16% Similarity=0.170 Sum_probs=192.6
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeE-ecCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK-ISSK 883 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g~~-~~~~ 883 (1142)
++|++.++||+|+||+||+|++. +..||||+...+.. .+++ .+|+++++.++|+|+|..+..+ .+.+
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------~~~~----~~E~~i~~~l~~~~~i~~~~~~~~~~~ 76 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HPQL----HIESKIYKMMQGGVGIPTIRWCGAEGD 76 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT------SCCH----HHHHHHHHHSTTSTTCCCEEEEEEETT
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc------CHHH----HHHHHHHHHccCCCcccEEEEEEecCC
Confidence 36999999999999999999984 67899998654321 1123 6899999999877766555444 4333
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
..++||||+. ++|...+.. ....+++..+..++.|++.||+|||++||+||||||+|||++
T Consensus 77 --------------~~~ivme~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~ 137 (299)
T d1ckia_ 77 --------------YNVMVMELLG-PSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMG 137 (299)
T ss_dssp --------------EEEEEEECCC-CBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred --------------EEEEEEEEcC-Cchhhhhhh----ccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhcccc
Confidence 3589999994 778777654 235799999999999999999999999999999999999986
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
..+ ....+||+|||+|+.+........ ..........||+.|||||++.+ ..++.++|||||||++|||
T Consensus 138 ~~~----~~~~vkl~DFG~a~~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~~l~el 206 (299)
T d1ckia_ 138 LGK----KGNLVYIIDFGLAKKYRDARTHQH---IPYRENKNLTGTARYASINTHLG----IEQSRRDDLESLGYVLMYF 206 (299)
T ss_dssp CGG----GTTCEEECCCSSCEECBCTTTCCB---CCCCBCCSCCCCSSSCCHHHHTT----BCCCHHHHHHHHHHHHHHH
T ss_pred ccC----CCceeeeeccCcceeccccccccc---eeccccCCcCCCccccCHHHHhC----CCCCChhhEEecCHHHHHH
Confidence 432 126799999999987654322111 11122345679999999999886 5689999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001142 1044 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1123 (1142)
Q Consensus 1044 LtG~~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa 1123 (1142)
++|+.||...........+...... .... ..+.....+++++.+++..||+.||++||++
T Consensus 207 ~tg~~P~~~~~~~~~~~~~~~~~~~----~~~~----------------~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~ 266 (299)
T d1ckia_ 207 NLGSLPWQGLKAATKRQKYERISEK----KMST----------------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDY 266 (299)
T ss_dssp HHSSCTTCCCC-------HHHHHHH----HHHS----------------CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCH
T ss_pred HhCCCcccccchHHHHHHHHHhhcc----cCCC----------------ChhHhccCCCHHHHHHHHHHccCChhHCcCH
Confidence 9999999875544332222110000 0000 0000111456789999999999999999999
Q ss_pred HHH---HHHHHhhc
Q 001142 1124 GDL---YEMFVART 1134 (1142)
Q Consensus 1124 ~EV---L~~L~~~~ 1134 (1142)
+++ +++++.+.
T Consensus 267 ~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 267 SYLRQLFRNLFHRQ 280 (299)
T ss_dssp HHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHc
Confidence 865 56666543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.6e-38 Score=352.38 Aligned_cols=264 Identities=17% Similarity=0.183 Sum_probs=197.9
Q ss_pred CCcceeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEecCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSK 883 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~g~~~~~~ 883 (1142)
.+|++.++||+|+||+||+|++. ++.+|+|+..... . ...+ .+|+++++.+. |+|++.+++++.+..
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~----~~~~----~~e~~~~~~l~~~~~i~~~~~~~~~~~ 74 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--D----APQL----RDEYRTYKLLAGCTGIPNVYYFGQEGL 74 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--T----SCCH----HHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--C----cHHH----HHHHHHHHHhcCCCCCCEEEEEeecCC
Confidence 46999999999999999999984 6778888754321 1 1122 67899999996 599999999987654
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 001142 884 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 963 (1142)
Q Consensus 884 ~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp~NILld 963 (1142)
+.++||||+ +++|.++++. ....+++..+..++.|++.||+|||++||+||||||+|||++
T Consensus 75 --------------~~~~vme~~-~~~l~~~~~~----~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~ 135 (293)
T d1csna_ 75 --------------HNVLVIDLL-GPSLEDLLDL----CGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIG 135 (293)
T ss_dssp --------------EEEEEEECC-CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC
T ss_pred --------------ccEEEEEec-CCCHHHHHHh----hccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeec
Confidence 349999999 6999999875 234699999999999999999999999999999999999997
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001142 964 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1043 (1142)
Q Consensus 964 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVwSLGviL~EL 1043 (1142)
... ....+.+||+|||+|+.......... ..........||+.|||||++.+ ..++.++|||||||++|||
T Consensus 136 ~~~--~~~~~~vkl~DFG~a~~~~~~~~~~~---~~~~~~~~~~GT~~y~aPE~~~~----~~~~~~~DiwSlG~~l~el 206 (293)
T d1csna_ 136 RPN--SKNANMIYVVDFGMVKFYRDPVTKQH---IPYREKKNLSGTARYMSINTHLG----REQSRRDDLEALGHVFMYF 206 (293)
T ss_dssp CSS--STTTTCEEECCCTTCEESBCTTTCCB---CCCCCCCCCCSCTTTCCHHHHTT----CCCCHHHHHHHHHHHHHHH
T ss_pred Ccc--cccCCceEEcccceeEEcccCccccc---eeecccCceEEchhhcCHHHhcC----CCCChHHHHHHhhHHHHHH
Confidence 531 12236799999999987654322111 11123345679999999999986 5789999999999999999
Q ss_pred HhCCCCCCCCC---HHHHHHHHHhCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001142 1044 LTLQVPYMGLS---ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1120 (1142)
Q Consensus 1044 LtG~~Pf~~~~---~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~CL~~DP~~R 1120 (1142)
++|+.||.+.. ..+....+........... .....++++.+++..|+..+|++|
T Consensus 207 ltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~-----------------------l~~~~p~~l~~ii~~~~~~~~~~r 263 (293)
T d1csna_ 207 LRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE-----------------------LCAGFPEEFYKYMHYARNLAFDAT 263 (293)
T ss_dssp HHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH-----------------------HTTTSCHHHHHHHHHHHHCCTTCC
T ss_pred HhCCCcCCCccchhHHHHHHHHHhccCCCChHH-----------------------hcCCCCHHHHHHHHHHhcCCcccC
Confidence 99999997543 2223333321110000000 001456679999999999999999
Q ss_pred CCHHHHHHHHH
Q 001142 1121 PTAGDLYEMFV 1131 (1142)
Q Consensus 1121 PSa~EVL~~L~ 1131 (1142)
|+++.+.+.+.
T Consensus 264 P~y~~l~~~l~ 274 (293)
T d1csna_ 264 PDYDYLQGLFS 274 (293)
T ss_dssp CCHHHHHHHHH
T ss_pred cCHHHHHHHHH
Confidence 99887766443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.2e-35 Score=340.21 Aligned_cols=284 Identities=19% Similarity=0.242 Sum_probs=190.0
Q ss_pred CcceeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-----------CCCccc
Q 001142 808 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-----------HSCIVE 874 (1142)
Q Consensus 808 ~y~l~~~LG~GsfG~Vy~a~~--~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-----------HpNIVk 874 (1142)
+|++.++||+|+||+||+|++ .+..||||+.+.+ ....+. +.+|+.+++.++ |+|||+
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-----~~~~~~----~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~ 84 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-----KVYTEA----AEDEIKLLQRVNDADNTKEDSMGANHILK 84 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHH----HHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-----ccchHH----HHHHHHHHHHhcchhhhhhhhcCcCceEE
Confidence 599999999999999999998 4677888886422 122222 367888887775 578999
Q ss_pred eeeeEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccc
Q 001142 875 MYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHR 953 (1142)
Q Consensus 875 l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs-~gIvHr 953 (1142)
+++++..... ...+++|+++..+........ ......+++..++.++.||+.||+|||+ +||+||
T Consensus 85 ~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHr 150 (362)
T d1q8ya_ 85 LLDHFNHKGP------------NGVHVVMVFEVLGENLLALIK--KYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHT 150 (362)
T ss_dssp CCEEEEEEET------------TEEEEEEEECCCCEEHHHHHH--HTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECS
T ss_pred EEEEeeeccc------------cceeeeeeecccccccccccc--cccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccc
Confidence 9998875332 133566666554433332222 1334578999999999999999999998 899999
Q ss_pred CCCCCCeeeccccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhH
Q 001142 954 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 1033 (1142)
Q Consensus 954 DLKp~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDV 1033 (1142)
||||+|||++.++. ......++++|||.+...... .....||+.|+|||++.+ ..|+.++||
T Consensus 151 DlKp~NIll~~~~~-~~~~~~~kl~dfg~s~~~~~~-------------~~~~~gt~~y~aPE~~~~----~~~~~~~Di 212 (362)
T d1q8ya_ 151 DIKPENVLMEIVDS-PENLIQIKIADLGNACWYDEH-------------YTNSIQTREYRSPEVLLG----APWGCGADI 212 (362)
T ss_dssp CCSGGGEEEEEEET-TTTEEEEEECCCTTCEETTBC-------------CCSCCSCGGGCCHHHHHT----CCCCTHHHH
T ss_pred cCChhHeeeeccCc-ccccceeeEeecccccccccc-------------cccccccccccChhhccc----cCCCccccc
Confidence 99999999986631 111135999999998754321 124569999999999886 568899999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCHH------H-HHHHH-HhCCCCCchhHHhhhccc-----ccccccccCCCCC-------
Q 001142 1034 WSYGCLLLELLTLQVPYMGLSEL------E-IHDLI-QMGKRPRLTDELEALGSC-----HEHEVAQSGSGFE------- 1093 (1142)
Q Consensus 1034 wSLGviL~ELLtG~~Pf~~~~~~------e-l~~~I-~~~~~p~l~~~l~~~~~~-----~~~~~~~~~~~~~------- 1093 (1142)
||+||++++|++|+.||...... + ....+ ..+..+. ........ .............
T Consensus 213 wSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (362)
T d1q8ya_ 213 WSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPS---YLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDV 289 (362)
T ss_dssp HHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCH---HHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHH
T ss_pred cchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCH---HHhhcccccccccccchhhhccccccCCchhhh
Confidence 99999999999999999753221 1 11111 1121111 11000000 0000000000000
Q ss_pred ---CchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001142 1094 ---KPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1135 (1142)
Q Consensus 1094 ---~~~~~~~~~~~L~dLI~~CL~~DP~~RPSa~EVL~~L~~~~s 1135 (1142)
........++.+.+|+.+||+.||.+||||+|+|+|+|++..
T Consensus 290 ~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 290 LTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 334 (362)
T ss_dssp HHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred cccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCC
Confidence 000112567889999999999999999999999999999844
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.94 E-value=3.1e-27 Score=264.47 Aligned_cols=228 Identities=21% Similarity=0.250 Sum_probs=166.4
Q ss_pred CCCEEEccCCCCCCC--CcccccCCCCCCCccEEEeec-CCCC-ccCccccCCcCCcEEEccCCCCCcC-chhhcCCCCC
Q 001142 42 DDSVIDVSGKTVDFP--LIESYGNRGGDNSVEGLYLYK-NVLN-LIPKSVGRYEKLRNLKFFGNEINLF-PSEVGNLLGL 116 (1142)
Q Consensus 42 ~L~~LdLs~N~L~~~--~p~~~~~l~~L~~L~~L~Ls~-N~Lt-~iP~~l~~L~~L~~L~Ls~N~L~~l-P~~l~~L~~L 116 (1142)
.++.|||++|++++. +|..++.+ ++|++|+|++ |.++ .||.+|++|++|++|+|++|+|..+ |..+.++.+|
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L---~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L 127 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANL---PYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTL 127 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGC---TTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTC
T ss_pred EEEEEECCCCCCCCCCCCChHHhcC---ccccccccccccccccccccccccccccchhhhccccccccccccccchhhh
Confidence 577788888888773 55655544 7888888875 6676 7788888888888888888888744 4557778888
Q ss_pred CEEEccCCC-CCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCC-cEEEccCCCCC-ccCcccCCCCCCCEEE
Q 001142 117 ECLQIKISS-PGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCL-TKLSVCHFSIR-YLPPEIGCLSNLEQLD 193 (1142)
Q Consensus 117 ~~L~Ls~N~-l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L-~~L~Ls~N~L~-~IP~~l~~L~~L~~L~ 193 (1142)
+.++++.|. ...+|..+..++.|+.+++++| ...+.+|..+..+..+ +.+++++|+++ ..|..+..+.. ..++
T Consensus 128 ~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n---~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~-~~l~ 203 (313)
T d1ogqa_ 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGN---RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNL-AFVD 203 (313)
T ss_dssp CEEECCSSEEESCCCGGGGGCTTCCEEECCSS---CCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCC-SEEE
T ss_pred cccccccccccccCchhhccCcccceeecccc---cccccccccccccccccccccccccccccccccccccccc-cccc
Confidence 888888777 5556777788888888888773 4455677777777665 67788888877 34556665543 3677
Q ss_pred ccCCCCC-ccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccCCCCCCC
Q 001142 194 LSFNKMK-YLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSY 272 (1142)
Q Consensus 194 Ls~N~L~-~lP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~~ 272 (1142)
+++|.+. .+|..++.+++|+.|++++|.++..|+.++.+++|+.|+|++|+|+|.+|..|++|++|+.|+|++|+|++
T Consensus 204 l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g- 282 (313)
T d1ogqa_ 204 LSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG- 282 (313)
T ss_dssp CCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEE-
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccc-
Confidence 7777776 66777777778888888888777555567777788888888888887777778888888888888888876
Q ss_pred CCCCch
Q 001142 273 CQVPSW 278 (1142)
Q Consensus 273 ~~iP~~ 278 (1142)
.||..
T Consensus 283 -~iP~~ 287 (313)
T d1ogqa_ 283 -EIPQG 287 (313)
T ss_dssp -ECCCS
T ss_pred -cCCCc
Confidence 56654
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.93 E-value=6.6e-26 Score=253.51 Aligned_cols=250 Identities=16% Similarity=0.180 Sum_probs=218.8
Q ss_pred cccccCCCCCCccc--CCCCCCCCCCCCEEEccC-CCCCCCCcccccCCCCCCCccEEEeecCCCCcc-CccccCCcCCc
Q 001142 19 KEKLPSEANKINNE--KNGSVNDDDDDSVIDVSG-KTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLI-PKSVGRYEKLR 94 (1142)
Q Consensus 19 l~~L~~~~N~i~~l--~~~~f~~l~~L~~LdLs~-N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~i-P~~l~~L~~L~ 94 (1142)
+..|++..|++++. -+..+.++++|++|||++ |+++|.+|..++.+ ++|++|+|++|+|+.+ |..+..+.+|+
T Consensus 52 v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L---~~L~~L~Ls~N~l~~~~~~~~~~~~~L~ 128 (313)
T d1ogqa_ 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKL---TQLHYLYITHTNVSGAIPDFLSQIKTLV 128 (313)
T ss_dssp EEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGC---TTCSEEEEEEECCEEECCGGGGGCTTCC
T ss_pred EEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccc---cccchhhhccccccccccccccchhhhc
Confidence 56788999999875 357899999999999997 89999999888766 9999999999999976 55688999999
Q ss_pred EEEccCCCCC-cCchhhcCCCCCCEEEccCCCCC-CCcccccCCCCC-CEEECCCCCCCCCcccchhhhcCCCCCcEEEc
Q 001142 95 NLKFFGNEIN-LFPSEVGNLLGLECLQIKISSPG-VNGFALNKLKGL-KELELSKVPPRPSVLTLLSEIAGLKCLTKLSV 171 (1142)
Q Consensus 95 ~L~Ls~N~L~-~lP~~l~~L~~L~~L~Ls~N~l~-~~~~~~~~L~~L-~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~L 171 (1142)
+|++++|.+. .+|..+.++++|+.+++++|.+. .+|..+..+..| +.+++++| .+.+..|..+..+..+ .+++
T Consensus 129 ~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n---~l~~~~~~~~~~l~~~-~l~l 204 (313)
T d1ogqa_ 129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN---RLTGKIPPTFANLNLA-FVDL 204 (313)
T ss_dssp EEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSS---EEEEECCGGGGGCCCS-EEEC
T ss_pred ccccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccc---cccccccccccccccc-cccc
Confidence 9999999987 78999999999999999999955 678888888876 88999884 5566677788877655 7999
Q ss_pred cCCCCC-ccCcccCCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCC-ccCccccCCCCCCEEeCcCCcCCCCC
Q 001142 172 CHFSIR-YLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRLENLDLSNNRLTSLG 249 (1142)
Q Consensus 172 s~N~L~-~IP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls-~IP~~l~~L~~L~~L~Ls~N~Ls~~~ 249 (1142)
++|.+. .+|..+..+++|+.|++++|.++..|..++.+++|+.|+|++|+|+ .||.++++|++|+.|+|++|+|+|.+
T Consensus 205 ~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~i 284 (313)
T d1ogqa_ 205 SRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI 284 (313)
T ss_dssp CSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEEC
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccC
Confidence 999887 6678889999999999999999976778999999999999999999 89999999999999999999999988
Q ss_pred cccccCCCCCCEEEccCCCCCCCCCCC
Q 001142 250 SLDLCLMHNLQNLNLQYNKLLSYCQVP 276 (1142)
Q Consensus 250 p~~l~~L~~L~~L~Ls~N~L~~~~~iP 276 (1142)
| .+++|++|+.+++++|++.|..++|
T Consensus 285 P-~~~~L~~L~~l~l~~N~~l~g~plp 310 (313)
T d1ogqa_ 285 P-QGGNLQRFDVSAYANNKCLCGSPLP 310 (313)
T ss_dssp C-CSTTGGGSCGGGTCSSSEEESTTSS
T ss_pred C-CcccCCCCCHHHhCCCccccCCCCC
Confidence 8 6789999999999999854433455
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.92 E-value=2.7e-24 Score=239.27 Aligned_cols=246 Identities=22% Similarity=0.283 Sum_probs=208.4
Q ss_pred CCCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcE
Q 001142 16 GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRN 95 (1142)
Q Consensus 16 ~~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~ 95 (1142)
++.++.|.+..|+|+.+++.+|.++++|++|++++|.++...|..|.. +++|++|+|++|+|+.+|..+. ..|..
T Consensus 30 ~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~---l~~L~~L~l~~n~l~~l~~~~~--~~l~~ 104 (305)
T d1xkua_ 30 PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAP---LVKLERLYLSKNQLKELPEKMP--KTLQE 104 (305)
T ss_dssp CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTT---CTTCCEEECCSSCCSBCCSSCC--TTCCE
T ss_pred CCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhC---CCccCEecccCCccCcCccchh--hhhhh
Confidence 357999999999999999999999999999999999999888876654 4999999999999999987654 47899
Q ss_pred EEccCCCCCcCchh-hcCCCCCCEEEccCCCCCCC---cccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEc
Q 001142 96 LKFFGNEINLFPSE-VGNLLGLECLQIKISSPGVN---GFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSV 171 (1142)
Q Consensus 96 L~Ls~N~L~~lP~~-l~~L~~L~~L~Ls~N~l~~~---~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~L 171 (1142)
|++++|.+..++.. +.....+..+++..|..... +..+..+++|+.|++++|.+. .+|..+ +++|+.|++
T Consensus 105 L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~----~l~~~~--~~~L~~L~l 178 (305)
T d1xkua_ 105 LRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT----TIPQGL--PPSLTELHL 178 (305)
T ss_dssp EECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC----SCCSSC--CTTCSEEEC
T ss_pred hhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc----ccCccc--CCccCEEEC
Confidence 99999999988665 56678888999888874433 346888999999999986654 334332 578999999
Q ss_pred cCCCCC-ccCcccCCCCCCCEEEccCCCCCcc-chhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeCcCCcCCCCC
Q 001142 172 CHFSIR-YLPPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLG 249 (1142)
Q Consensus 172 s~N~L~-~IP~~l~~L~~L~~L~Ls~N~L~~l-P~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls~N~Ls~~~ 249 (1142)
++|.++ ..|..|..++.++.|++++|.|+.+ |..+..+++|++|+|++|+|+.||.++.++++|+.|+|++|+|+.+.
T Consensus 179 ~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~lp~~l~~l~~L~~L~Ls~N~i~~i~ 258 (305)
T d1xkua_ 179 DGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIG 258 (305)
T ss_dssp TTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEECCSSCCCCCC
T ss_pred CCCcCCCCChhHhhccccccccccccccccccccccccccccceeeecccccccccccccccccCCCEEECCCCccCccC
Confidence 999988 4466889999999999999999977 56788899999999999999999999999999999999999999887
Q ss_pred cccc------cCCCCCCEEEccCCCCCCC
Q 001142 250 SLDL------CLMHNLQNLNLQYNKLLSY 272 (1142)
Q Consensus 250 p~~l------~~L~~L~~L~Ls~N~L~~~ 272 (1142)
...| ..+.+|+.|+|++|+|+.+
T Consensus 259 ~~~f~~~~~~~~~~~L~~L~L~~N~~~~~ 287 (305)
T d1xkua_ 259 SNDFCPPGYNTKKASYSGVSLFSNPVQYW 287 (305)
T ss_dssp TTSSSCSSCCTTSCCCSEEECCSSSSCGG
T ss_pred hhhccCcchhcccCCCCEEECCCCcCccC
Confidence 6554 3567899999999999764
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=3e-23 Score=226.99 Aligned_cols=209 Identities=24% Similarity=0.238 Sum_probs=150.2
Q ss_pred CCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCcCCcEEEccCCCCCcCchhhcCCCCC
Q 001142 38 NDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLRNLKFFGNEINLFPSEVGNLLGL 116 (1142)
Q Consensus 38 ~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~-~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L 116 (1142)
.+..++..+|+++++|+.+ |+.+. ++|++|+|++|.|+.+|. .|.++++|++|+|++|+|+.+|. ++.+++|
T Consensus 7 ~~~~~~~~v~C~~~~L~~i-P~~lp-----~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~~-~~~l~~L 79 (266)
T d1p9ag_ 7 SKVASHLEVNCDKRNLTAL-PPDLP-----KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV-DGTLPVL 79 (266)
T ss_dssp ECSTTCCEEECTTSCCSSC-CSCCC-----TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC-CSCCTTC
T ss_pred cccCCCeEEEccCCCCCee-CcCcC-----cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccccc-ccccccc
Confidence 3445556667777777754 32221 456777777777776653 46667777777777777776653 3456666
Q ss_pred CEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCc-ccCCCCCCCEEEcc
Q 001142 117 ECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLS 195 (1142)
Q Consensus 117 ~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~Ls 195 (1142)
+.|+|++|++... +..+.++++|+.|++++|.+..++. .+..+.+|+.|+++
T Consensus 80 ~~L~Ls~N~l~~~---------------------------~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~ 132 (266)
T d1p9ag_ 80 GTLDLSHNQLQSL---------------------------PLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLK 132 (266)
T ss_dssp CEEECCSSCCSSC---------------------------CCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECT
T ss_pred ccccccccccccc---------------------------ccccccccccccccccccccceeecccccccccccccccc
Confidence 6666665554433 3345566777788888888776654 55788889999999
Q ss_pred CCCCCccch-hhcCCCCCCEEEccCCCCCccCcc-ccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccCCCCCCCC
Q 001142 196 FNKMKYLPT-EICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYC 273 (1142)
Q Consensus 196 ~N~L~~lP~-~l~~L~~L~~L~Ls~N~Ls~IP~~-l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~~~ 273 (1142)
+|.|+.+|. .+..+++|+.|++++|+|+.+|.. +..+++|+.|+|++|+|+.+++ .+..+++|+.|+|++|+|.|.|
T Consensus 133 ~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~lp~-~~~~~~~L~~L~L~~Np~~CdC 211 (266)
T d1p9ag_ 133 GNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPK-GFFGSHLLPFAFLHGNPWLCNC 211 (266)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCT-TTTTTCCCSEEECCSCCBCCSG
T ss_pred ccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCcccCh-hHCCCCCCCEEEecCCCCCCCc
Confidence 999998864 456688999999999999977654 6679999999999999996655 6778999999999999999998
Q ss_pred CCCchhhc
Q 001142 274 QVPSWICC 281 (1142)
Q Consensus 274 ~iP~~~~~ 281 (1142)
.+-+...|
T Consensus 212 ~~~~l~~w 219 (266)
T d1p9ag_ 212 EILYFRRW 219 (266)
T ss_dssp GGHHHHHH
T ss_pred chHHHHHH
Confidence 86543333
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.90 E-value=1.3e-22 Score=225.54 Aligned_cols=240 Identities=19% Similarity=0.231 Sum_probs=205.0
Q ss_pred ccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCcc-CccccCCcCCcEEEc
Q 001142 20 EKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLI-PKSVGRYEKLRNLKF 98 (1142)
Q Consensus 20 ~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~i-P~~l~~L~~L~~L~L 98 (1142)
..++-..++|+.++..-+ +++++|||++|+|+.+.+.+|..+ ++|++|++++|.++.+ |..|.++++|++|+|
T Consensus 13 ~~~~C~~~~L~~lP~~l~---~~l~~L~Ls~N~i~~l~~~~f~~l---~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l 86 (305)
T d1xkua_ 13 RVVQCSDLGLEKVPKDLP---PDTALLDLQNNKITEIKDGDFKNL---KNLHTLILINNKISKISPGAFAPLVKLERLYL 86 (305)
T ss_dssp TEEECTTSCCCSCCCSCC---TTCCEEECCSSCCCCBCTTTTTTC---TTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred CEEEecCCCCCccCCCCC---CCCCEEECcCCcCCCcChhHhhcc---ccccccccccccccccchhhhhCCCccCEecc
Confidence 446667778998876432 579999999999998887766555 9999999999999988 567999999999999
Q ss_pred cCCCCCcCchhhcCCCCCCEEEccCCCCCCCc-ccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCC
Q 001142 99 FGNEINLFPSEVGNLLGLECLQIKISSPGVNG-FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIR 177 (1142)
Q Consensus 99 s~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~-~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~ 177 (1142)
++|+|+.+|..+. ..|..|++..|.+..++ ..+.....+..++...|.. ......+..+..+++|+.+++++|.++
T Consensus 87 ~~n~l~~l~~~~~--~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~-~~~~~~~~~~~~l~~L~~l~l~~n~l~ 163 (305)
T d1xkua_ 87 SKNQLKELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPL-KSSGIENGAFQGMKKLSYIRIADTNIT 163 (305)
T ss_dssp CSSCCSBCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCC-CGGGBCTTGGGGCTTCCEEECCSSCCC
T ss_pred cCCccCcCccchh--hhhhhhhccccchhhhhhhhhhccccccccccccccc-cccCCCccccccccccCccccccCCcc
Confidence 9999999997653 68999999999977655 4577788889999888654 344445667888999999999999999
Q ss_pred ccCcccCCCCCCCEEEccCCCCC-ccchhhcCCCCCCEEEccCCCCCcc-CccccCCCCCCEEeCcCCcCCCCCcccccC
Q 001142 178 YLPPEIGCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLVEL-PSGLYLLQRLENLDLSNNRLTSLGSLDLCL 255 (1142)
Q Consensus 178 ~IP~~l~~L~~L~~L~Ls~N~L~-~lP~~l~~L~~L~~L~Ls~N~Ls~I-P~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~ 255 (1142)
.+|..+ +++|+.|+|++|.++ ..|..+..++.++.|++++|.|+.+ |..+.++++|+.|+|++|+|+.+++ .|..
T Consensus 164 ~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~lp~-~l~~ 240 (305)
T d1xkua_ 164 TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPG-GLAD 240 (305)
T ss_dssp SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCT-TTTT
T ss_pred ccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccccccc-cccc
Confidence 998764 689999999999999 5578899999999999999999977 5667789999999999999998854 8999
Q ss_pred CCCCCEEEccCCCCCC
Q 001142 256 MHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 256 L~~L~~L~Ls~N~L~~ 271 (1142)
+++|+.|+|++|+|+.
T Consensus 241 l~~L~~L~Ls~N~i~~ 256 (305)
T d1xkua_ 241 HKYIQVVYLHNNNISA 256 (305)
T ss_dssp CSSCCEEECCSSCCCC
T ss_pred ccCCCEEECCCCccCc
Confidence 9999999999999987
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=3.8e-23 Score=227.96 Aligned_cols=225 Identities=21% Similarity=0.225 Sum_probs=184.3
Q ss_pred CEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCcCCcEEEccCCCCCcCchh-hcCCCCCCEEEc
Q 001142 44 SVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLRNLKFFGNEINLFPSE-VGNLLGLECLQI 121 (1142)
Q Consensus 44 ~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~-~l~~L~~L~~L~Ls~N~L~~lP~~-l~~L~~L~~L~L 121 (1142)
..+++++++++.++ ..+. +++++|+|++|+|++||. .|.++++|++|++++|+|+.++.. +.+++.+..+..
T Consensus 14 ~~v~c~~~~L~~iP-~~ip-----~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~ 87 (284)
T d1ozna_ 14 VTTSCPQQGLQAVP-VGIP-----AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDL 87 (284)
T ss_dssp CEEECCSSCCSSCC-TTCC-----TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred eEEEcCCCCCCccC-CCCC-----CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccc
Confidence 45678888887553 3221 567888898888888875 588888889999988888866544 566788888876
Q ss_pred c-CCCCCCC-cccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCc-ccCCCCCCCEEEccCCC
Q 001142 122 K-ISSPGVN-GFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFNK 198 (1142)
Q Consensus 122 s-~N~l~~~-~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~Ls~N~ 198 (1142)
. .|.+..+ +..|..+++|++|++++|.+. ...+..+..+.+|+.+++++|+|+.+|. .|..+++|+.|+|++|+
T Consensus 88 ~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~---~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~ 164 (284)
T d1ozna_ 88 SDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ---ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNR 164 (284)
T ss_dssp CSCTTCCCCCTTTTTTCTTCCEEECTTSCCC---CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred ccccccccccchhhcccccCCEEecCCcccc---cccccccchhcccchhhhccccccccChhHhccccchhhcccccCc
Confidence 5 3445544 567888889999999885543 2234467778899999999999998865 67889999999999999
Q ss_pred CCccc-hhhcCCCCCCEEEccCCCCCcc-CccccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccCCCCCCCCCCC
Q 001142 199 MKYLP-TEICYLKALISLKVANNKLVEL-PSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVP 276 (1142)
Q Consensus 199 L~~lP-~~l~~L~~L~~L~Ls~N~Ls~I-P~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP 276 (1142)
|+.+| ..|.++++|+.|+|++|+++.+ |..+..+++|+.|++++|+++++++..|..+++|+.|+|++|+|.|.|++-
T Consensus 165 l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~ 244 (284)
T d1ozna_ 165 ISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR 244 (284)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH
T ss_pred ccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccch
Confidence 99885 6788899999999999999966 788889999999999999999999999999999999999999999988754
Q ss_pred c
Q 001142 277 S 277 (1142)
Q Consensus 277 ~ 277 (1142)
.
T Consensus 245 ~ 245 (284)
T d1ozna_ 245 P 245 (284)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=8.2e-23 Score=223.51 Aligned_cols=196 Identities=19% Similarity=0.215 Sum_probs=161.3
Q ss_pred CcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEE
Q 001142 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLK 97 (1142)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~ 97 (1142)
.+.++....++|+.++..-. ++|++|||++|+|+++.+..|.. +++|++|+|++|+|+.+|. ++.+++|++|+
T Consensus 11 ~~~~v~C~~~~L~~iP~~lp---~~l~~L~Ls~N~i~~l~~~~f~~---l~~L~~L~L~~N~l~~l~~-~~~l~~L~~L~ 83 (266)
T d1p9ag_ 11 SHLEVNCDKRNLTALPPDLP---KDTTILHLSENLLYTFSLATLMP---YTRLTQLNLDRAELTKLQV-DGTLPVLGTLD 83 (266)
T ss_dssp TCCEEECTTSCCSSCCSCCC---TTCCEEECTTSCCSEEEGGGGTT---CTTCCEEECTTSCCCEEEC-CSCCTTCCEEE
T ss_pred CCeEEEccCCCCCeeCcCcC---cCCCEEECcCCcCCCcCHHHhhc---ccccccccccccccccccc-ccccccccccc
Confidence 34557888899999865432 57999999999999887776754 5999999999999999974 57899999999
Q ss_pred ccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCC
Q 001142 98 FFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIR 177 (1142)
Q Consensus 98 Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~ 177 (1142)
|++|+|+.+|..+.++++|+.|++++|.+..++ +..+..+.+|+.|++++|.++
T Consensus 84 Ls~N~l~~~~~~~~~l~~L~~L~l~~~~~~~~~--------------------------~~~~~~l~~l~~L~l~~n~l~ 137 (266)
T d1p9ag_ 84 LSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLP--------------------------LGALRGLGELQELYLKGNELK 137 (266)
T ss_dssp CCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCC--------------------------SSTTTTCTTCCEEECTTSCCC
T ss_pred cccccccccccccccccccccccccccccceee--------------------------ccccccccccccccccccccc
Confidence 999999999999999999999999888754433 123455677788888888888
Q ss_pred ccCcc-cCCCCCCCEEEccCCCCCccc-hhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeCcCCcCC
Q 001142 178 YLPPE-IGCLSNLEQLDLSFNKMKYLP-TEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLT 246 (1142)
Q Consensus 178 ~IP~~-l~~L~~L~~L~Ls~N~L~~lP-~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls~N~Ls 246 (1142)
.+|.. +..+++|+.|++++|+|+.+| ..|..+++|+.|+|++|+|+.||.+++.+++|+.|+|++|.+.
T Consensus 138 ~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 138 TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp CCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBC
T ss_pred eeccccccccccchhcccccccccccCccccccccccceeecccCCCcccChhHCCCCCCCEEEecCCCCC
Confidence 77664 467888999999999998775 4577888999999999999999988888889999999999775
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.88 E-value=5.5e-22 Score=225.63 Aligned_cols=173 Identities=24% Similarity=0.347 Sum_probs=142.1
Q ss_pred ccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCC
Q 001142 87 VGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCL 166 (1142)
Q Consensus 87 l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L 166 (1142)
+..++++..|++++|.++.+++ +...++|+.|++++|.+..++ .+..+++|+.|++++|.+... + .+..+++|
T Consensus 193 ~~~l~~~~~l~l~~n~i~~~~~-~~~~~~L~~L~l~~n~l~~~~-~l~~l~~L~~L~l~~n~l~~~----~-~~~~~~~L 265 (384)
T d2omza2 193 LAKLTNLESLIATNNQISDITP-LGILTNLDELSLNGNQLKDIG-TLASLTNLTDLDLANNQISNL----A-PLSGLTKL 265 (384)
T ss_dssp GGGCTTCSEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCCG-GGGGCTTCSEEECCSSCCCCC----G-GGTTCTTC
T ss_pred cccccccceeeccCCccCCCCc-ccccCCCCEEECCCCCCCCcc-hhhcccccchhccccCccCCC----C-cccccccC
Confidence 3445678888999999998765 567889999999999987765 578899999999999766433 2 37788999
Q ss_pred cEEEccCCCCCccCcccCCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeCcCCcCC
Q 001142 167 TKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLT 246 (1142)
Q Consensus 167 ~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls~N~Ls 246 (1142)
+.|++++|.++.+++ +..++.++.++++.|.++.++ .+..+++|+.|+|++|+|+.++. +..+++|+.|+|++|+|+
T Consensus 266 ~~L~l~~~~l~~~~~-~~~~~~l~~l~~~~n~l~~~~-~~~~~~~l~~L~ls~n~l~~l~~-l~~l~~L~~L~L~~n~l~ 342 (384)
T d2omza2 266 TELKLGANQISNISP-LAGLTALTNLELNENQLEDIS-PISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFANNKVS 342 (384)
T ss_dssp SEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCSCCG-GGGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEECCSSCCC
T ss_pred CEeeccCcccCCCCc-ccccccccccccccccccccc-ccchhcccCeEECCCCCCCCCcc-cccCCCCCEEECCCCCCC
Confidence 999999999988764 677888899999999888765 47778889999999999988763 778888999999999988
Q ss_pred CCCcccccCCCCCCEEEccCCCCCC
Q 001142 247 SLGSLDLCLMHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 247 ~~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1142)
+++ .|.++++|+.|+|++|++++
T Consensus 343 ~l~--~l~~l~~L~~L~l~~N~l~~ 365 (384)
T d2omza2 343 DVS--SLANLTNINWLSAGHNQISD 365 (384)
T ss_dssp CCG--GGGGCTTCCEEECCSSCCCB
T ss_pred CCh--hHcCCCCCCEEECCCCcCCC
Confidence 754 58888999999999998887
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.88 E-value=1.2e-21 Score=222.71 Aligned_cols=235 Identities=22% Similarity=0.264 Sum_probs=199.5
Q ss_pred CcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEE
Q 001142 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLK 97 (1142)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~ 97 (1142)
.+..|.+..+.|+.+. .+..+++|++|||++|+|++..+ ++++++|++|+|++|.|+.+++ +..+++|+.|+
T Consensus 45 ~l~~L~l~~~~I~~l~--gl~~L~nL~~L~Ls~N~l~~l~~-----l~~L~~L~~L~L~~n~i~~i~~-l~~l~~L~~L~ 116 (384)
T d2omza2 45 QVTTLQADRLGIKSID--GVEYLNNLTQINFSNNQLTDITP-----LKNLTKLVDILMNNNQIADITP-LANLTNLTGLT 116 (384)
T ss_dssp TCCEEECCSSCCCCCT--TGGGCTTCCEEECCSSCCCCCGG-----GTTCTTCCEEECCSSCCCCCGG-GTTCTTCCEEE
T ss_pred CCCEEECCCCCCCCcc--ccccCCCCCEEeCcCCcCCCCcc-----ccCCcccccccccccccccccc-ccccccccccc
Confidence 5788999999999874 57789999999999999998653 4566999999999999998864 88999999999
Q ss_pred ccCCCCCcCc----------------------------------------------------------------hhhcCC
Q 001142 98 FFGNEINLFP----------------------------------------------------------------SEVGNL 113 (1142)
Q Consensus 98 Ls~N~L~~lP----------------------------------------------------------------~~l~~L 113 (1142)
+++|.++.++ ..+..+
T Consensus 117 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 196 (384)
T d2omza2 117 LFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKL 196 (384)
T ss_dssp CCSSCCCCCGGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGC
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccccccccccccc
Confidence 9998876321 234556
Q ss_pred CCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCcccCCCCCCCEEE
Q 001142 114 LGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLD 193 (1142)
Q Consensus 114 ~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~ 193 (1142)
++++.|++++|.+..++. +..+++|+.|++++|.+... +.+..+++|+.|++++|.++.++. ++.+++|+.|+
T Consensus 197 ~~~~~l~l~~n~i~~~~~-~~~~~~L~~L~l~~n~l~~~-----~~l~~l~~L~~L~l~~n~l~~~~~-~~~~~~L~~L~ 269 (384)
T d2omza2 197 TNLESLIATNNQISDITP-LGILTNLDELSLNGNQLKDI-----GTLASLTNLTDLDLANNQISNLAP-LSGLTKLTELK 269 (384)
T ss_dssp TTCSEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCC-----GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCSEEE
T ss_pred cccceeeccCCccCCCCc-ccccCCCCEEECCCCCCCCc-----chhhcccccchhccccCccCCCCc-ccccccCCEee
Confidence 788899999988776553 56788999999999765432 357889999999999999998865 78899999999
Q ss_pred ccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccCCCCCC
Q 001142 194 LSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 194 Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1142)
+++|+++.++. +..++.++.++++.|.++.++ .+..+++|+.|+|++|+|+++++ +..+++|+.|+|++|+|+.
T Consensus 270 l~~~~l~~~~~-~~~~~~l~~l~~~~n~l~~~~-~~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~l~~ 343 (384)
T d2omza2 270 LGANQISNISP-LAGLTALTNLELNENQLEDIS-PISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD 343 (384)
T ss_dssp CCSSCCCCCGG-GTTCTTCSEEECCSSCCSCCG-GGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCC
T ss_pred ccCcccCCCCc-ccccccccccccccccccccc-ccchhcccCeEECCCCCCCCCcc--cccCCCCCEEECCCCCCCC
Confidence 99999998864 778999999999999999875 47788999999999999999864 8899999999999999987
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.84 E-value=3.4e-21 Score=212.22 Aligned_cols=247 Identities=20% Similarity=0.187 Sum_probs=187.7
Q ss_pred ccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCcCCcEEEcc-
Q 001142 22 LPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLRNLKFF- 99 (1142)
Q Consensus 22 L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~-~l~~L~~L~~L~Ls- 99 (1142)
+.....+++.++..-. +++++|||++|+|+++.+..|..+ ++|++|++++|.|+.++. .+..+..+..|+..
T Consensus 16 v~c~~~~L~~iP~~ip---~~~~~L~Ls~N~i~~i~~~~f~~l---~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~ 89 (284)
T d1ozna_ 16 TSCPQQGLQAVPVGIP---AASQRIFLHGNRISHVPAASFRAC---RNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89 (284)
T ss_dssp EECCSSCCSSCCTTCC---TTCSEEECTTSCCCEECTTTTTTC---TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred EEcCCCCCCccCCCCC---CCCCEEECcCCcCCCCCHHHhhcc---cccccccccccccccccccccccccccccccccc
Confidence 4455566777754322 467899999999988777666544 889999999999998854 46777888888764
Q ss_pred CCCCCcC-chhhcCCCCCCEEEccCCCCCCC-cccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCC
Q 001142 100 GNEINLF-PSEVGNLLGLECLQIKISSPGVN-GFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIR 177 (1142)
Q Consensus 100 ~N~L~~l-P~~l~~L~~L~~L~Ls~N~l~~~-~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~ 177 (1142)
.|.++.+ |..|.++++|++|++++|.+..+ +..+..+.+|+.+++++|.+.. ..+..|..+++|+.|++++|+|+
T Consensus 90 ~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~---i~~~~f~~~~~L~~L~l~~N~l~ 166 (284)
T d1ozna_ 90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA---LPDDTFRDLGNLTHLFLHGNRIS 166 (284)
T ss_dssp CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCC---CCTTTTTTCTTCCEEECCSSCCC
T ss_pred ccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccc---cChhHhccccchhhcccccCccc
Confidence 6667777 55588899999999999886554 4567788899999999865532 23456788899999999999999
Q ss_pred ccCc-ccCCCCCCCEEEccCCCCCcc-chhhcCCCCCCEEEccCCCCCccC-ccccCCCCCCEEeCcCCcCCCCCccccc
Q 001142 178 YLPP-EIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELP-SGLYLLQRLENLDLSNNRLTSLGSLDLC 254 (1142)
Q Consensus 178 ~IP~-~l~~L~~L~~L~Ls~N~L~~l-P~~l~~L~~L~~L~Ls~N~Ls~IP-~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~ 254 (1142)
.+|. .|.++++|+.|+|++|+++.+ |..|..+++|+.|++++|+++.+| ..+..+++|+.|+|++|.+...-+. ..
T Consensus 167 ~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~-~~ 245 (284)
T d1ozna_ 167 SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RP 245 (284)
T ss_dssp EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG-HH
T ss_pred ccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccc-hH
Confidence 8754 678899999999999999966 788999999999999999999775 5677899999999999998865331 11
Q ss_pred CCCCCCEEEccCCCCCCCCCCCchhh
Q 001142 255 LMHNLQNLNLQYNKLLSYCQVPSWIC 280 (1142)
Q Consensus 255 ~L~~L~~L~Ls~N~L~~~~~iP~~~~ 280 (1142)
-+..++.+....+.+.| ..|..+.
T Consensus 246 l~~~l~~~~~~~~~~~C--~~p~~l~ 269 (284)
T d1ozna_ 246 LWAWLQKFRGSSSEVPC--SLPQRLA 269 (284)
T ss_dssp HHHHHHHCCSEECCCBE--EESGGGT
T ss_pred HHHHHHhCcCCCCceEe--CCchHHc
Confidence 11234555666677766 5666554
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.83 E-value=3.2e-21 Score=200.39 Aligned_cols=140 Identities=18% Similarity=0.215 Sum_probs=105.5
Q ss_pred cceeeeecccCceEEEEEEE-CCccEEEEEEecccCCCC----------hHHHHHhHHhHHHHHHHHhhCCCCCccceee
Q 001142 809 LSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSS----------ADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 877 (1142)
Q Consensus 809 y~l~~~LG~GsfG~Vy~a~~-~~~~vAvKi~~l~~~~~~----------~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~g 877 (1142)
+.+.++||+|+||+||+|++ ++..||+|+.+....... ..........+.+|+..+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 46899999999999999986 678899998653221100 0011112234467899999999999998876
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 001142 878 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 957 (1142)
Q Consensus 878 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~ggSL~~~l~~~~~~~~~~ls~~~i~~Ia~qIa~gL~yLHs~gIvHrDLKp 957 (1142)
+.. .++||||+++..+. .++...+..++.|++.+|.|||++||+||||||
T Consensus 82 ~~~------------------~~lvme~~~~~~~~------------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP 131 (191)
T d1zara2 82 WEG------------------NAVLMELIDAKELY------------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQ 131 (191)
T ss_dssp EET------------------TEEEEECCCCEEGG------------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCST
T ss_pred ecC------------------CEEEEEeecccccc------------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCCh
Confidence 532 18999999865432 244556678999999999999999999999999
Q ss_pred CCeeeccccccCCCCCeEEEeecCCcccc
Q 001142 958 ENILIDLERKKADGKPVVKLCDFDRAVPL 986 (1142)
Q Consensus 958 ~NILld~~~~~~~~~~~vKL~DFGlA~~l 986 (1142)
+|||++++ .++|+|||.|+..
T Consensus 132 ~NILv~~~--------~~~liDFG~a~~~ 152 (191)
T d1zara2 132 YNVLVSEE--------GIWIIDFPQSVEV 152 (191)
T ss_dssp TSEEEETT--------EEEECCCTTCEET
T ss_pred hheeeeCC--------CEEEEECCCcccC
Confidence 99999864 5899999998654
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.80 E-value=2.1e-19 Score=191.15 Aligned_cols=191 Identities=22% Similarity=0.287 Sum_probs=116.8
Q ss_pred CCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCC
Q 001142 36 SVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLG 115 (1142)
Q Consensus 36 ~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~ 115 (1142)
.+.++.+|+.|+|++|+|+.. + .+ ..+++|++|+|++|.|+.+++ +..+++|++|++++|.++.++ .+.++++
T Consensus 36 ~~~~l~~L~~L~l~~~~i~~l-~-~l---~~l~~L~~L~ls~n~i~~~~~-l~~l~~l~~l~~~~n~~~~i~-~l~~l~~ 108 (227)
T d1h6ua2 36 TQADLDGITTLSAFGTGVTTI-E-GV---QYLNNLIGLELKDNQITDLAP-LKNLTKITELELSGNPLKNVS-AIAGLQS 108 (227)
T ss_dssp CHHHHHTCCEEECTTSCCCCC-T-TG---GGCTTCCEEECCSSCCCCCGG-GTTCCSCCEEECCSCCCSCCG-GGTTCTT
T ss_pred CHHHcCCcCEEECCCCCCCcc-h-hH---hcCCCCcEeecCCceeecccc-ccccccccccccccccccccc-ccccccc
Confidence 334455555555555555432 1 12 233555555555555555432 455555555555555555443 2444455
Q ss_pred CCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCcccCCCCCCCEEEcc
Q 001142 116 LECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLS 195 (1142)
Q Consensus 116 L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls 195 (1142)
|+.|+++.+. .... ..+...+.+..+.++.+.+...+ .+..+++|+.|+++
T Consensus 109 L~~l~l~~~~-----------------------~~~~-----~~~~~~~~~~~l~~~~~~~~~~~-~~~~~~~L~~L~l~ 159 (227)
T d1h6ua2 109 IKTLDLTSTQ-----------------------ITDV-----TPLAGLSNLQVLYLDLNQITNIS-PLAGLTNLQYLSIG 159 (227)
T ss_dssp CCEEECTTSC-----------------------CCCC-----GGGTTCTTCCEEECCSSCCCCCG-GGGGCTTCCEEECC
T ss_pred cccccccccc-----------------------cccc-----chhccccchhhhhchhhhhchhh-hhcccccccccccc
Confidence 5554444433 2211 12445566777777777766442 35667778888888
Q ss_pred CCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccC
Q 001142 196 FNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQY 266 (1142)
Q Consensus 196 ~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~ 266 (1142)
+|.++.++. +.++++|+.|+|++|+|+.+|. +.++++|+.|+|++|+|++++| +.++++|+.|+|++
T Consensus 160 ~n~~~~~~~-l~~l~~L~~L~Ls~n~l~~l~~-l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 160 NAQVSDLTP-LANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226 (227)
T ss_dssp SSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEE
T ss_pred ccccccchh-hcccccceecccCCCccCCChh-hcCCCCCCEEECcCCcCCCCcc--cccCCCCCEEEeeC
Confidence 888776543 7778888888888888887764 7778888888888888887764 77888888888763
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.80 E-value=3.4e-18 Score=190.94 Aligned_cols=238 Identities=24% Similarity=0.217 Sum_probs=163.2
Q ss_pred CcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEE
Q 001142 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLK 97 (1142)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~ 97 (1142)
.+..|++..|.|+.++. ..++|++|+|++|+|+. +|+.+ .+|+.|++++|.++.|+.. . +.|++|+
T Consensus 39 ~l~~LdLs~~~L~~lp~----~~~~L~~L~Ls~N~l~~-lp~~~------~~L~~L~l~~n~l~~l~~l-p--~~L~~L~ 104 (353)
T d1jl5a_ 39 QAHELELNNLGLSSLPE----LPPHLESLVASCNSLTE-LPELP------QSLKSLLVDNNNLKALSDL-P--PLLEYLG 104 (353)
T ss_dssp TCSEEECTTSCCSCCCS----CCTTCSEEECCSSCCSS-CCCCC------TTCCEEECCSSCCSCCCSC-C--TTCCEEE
T ss_pred CCCEEEeCCCCCCCCCC----CCCCCCEEECCCCCCcc-cccch------hhhhhhhhhhcccchhhhh-c--ccccccc
Confidence 46789999999998863 35789999999999985 45433 5789999999999988742 1 3699999
Q ss_pred ccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcc-------------------cccCCCCCCEEECCCCCCCCCcc----
Q 001142 98 FFGNEINLFPSEVGNLLGLECLQIKISSPGVNGF-------------------ALNKLKGLKELELSKVPPRPSVL---- 154 (1142)
Q Consensus 98 Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~~-------------------~~~~L~~L~~L~Ls~n~~n~~~~---- 154 (1142)
|++|.|+.+|. ++++++|+.|++++|.+...+. .+..++.++.|++.+|.......
T Consensus 105 L~~n~l~~lp~-~~~l~~L~~L~l~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~ 183 (353)
T d1jl5a_ 105 VSNNQLEKLPE-LQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLS 183 (353)
T ss_dssp CCSSCCSSCCC-CTTCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCCCCTT
T ss_pred ccccccccccc-hhhhccceeeccccccccccccccccccchhhccccccccccccccccceeccccccccccccccccc
Confidence 99999999985 6789999999998887554432 23445667777777655322110
Q ss_pred -----------cchhhhcCCCCCcEEEccCCCCCccCcccCC-----------------CCCCCEEEccCCCCCcc---c
Q 001142 155 -----------TLLSEIAGLKCLTKLSVCHFSIRYLPPEIGC-----------------LSNLEQLDLSFNKMKYL---P 203 (1142)
Q Consensus 155 -----------~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~-----------------L~~L~~L~Ls~N~L~~l---P 203 (1142)
.....+..++.|+.+++++|....+|..... ..++..+++..|.+..+ |
T Consensus 184 ~~~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~l~ 263 (353)
T d1jl5a_ 184 LESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELP 263 (353)
T ss_dssp CCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCSCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSEESCCC
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 1112345677888888888887766543211 12233334333333211 1
Q ss_pred hh--------------hcCCCCCCEEEccCCCCCccCccccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccCCCC
Q 001142 204 TE--------------ICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269 (1142)
Q Consensus 204 ~~--------------l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L 269 (1142)
.. ...+++|++|+|++|+|+.||.. +++|+.|+|++|+|+.++. .+++|+.|+|++|+|
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~---~~~L~~L~L~~N~L~~l~~----~~~~L~~L~L~~N~L 336 (353)
T d1jl5a_ 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIELPAL---PPRLERLIASFNHLAEVPE----LPQNLKQLHVEYNPL 336 (353)
T ss_dssp TTCCEEECCSSCCSEECCCCTTCCEEECCSSCCSCCCCC---CTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCC
T ss_pred chhcccccccCccccccccCCCCCEEECCCCccCccccc---cCCCCEEECCCCcCCcccc----ccCCCCEEECcCCcC
Confidence 11 11246789999999999888864 4678888999999887653 356788899999998
Q ss_pred CCCCCCCc
Q 001142 270 LSYCQVPS 277 (1142)
Q Consensus 270 ~~~~~iP~ 277 (1142)
+.+..+|.
T Consensus 337 ~~lp~~~~ 344 (353)
T d1jl5a_ 337 REFPDIPE 344 (353)
T ss_dssp SSCCCCCT
T ss_pred CCCCcccc
Confidence 87544443
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.78 E-value=4.1e-19 Score=188.96 Aligned_cols=185 Identities=18% Similarity=0.227 Sum_probs=141.8
Q ss_pred CcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEE
Q 001142 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLK 97 (1142)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~ 97 (1142)
.++.|.+..|+|+.+. .+..+++|++|+|++|+|++..| + .++++|++|++++|.++.++ .+..+++|+.|+
T Consensus 42 ~L~~L~l~~~~i~~l~--~l~~l~~L~~L~ls~n~i~~~~~--l---~~l~~l~~l~~~~n~~~~i~-~l~~l~~L~~l~ 113 (227)
T d1h6ua2 42 GITTLSAFGTGVTTIE--GVQYLNNLIGLELKDNQITDLAP--L---KNLTKITELELSGNPLKNVS-AIAGLQSIKTLD 113 (227)
T ss_dssp TCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCGG--G---TTCCSCCEEECCSCCCSCCG-GGTTCTTCCEEE
T ss_pred CcCEEECCCCCCCcch--hHhcCCCCcEeecCCceeecccc--c---cccccccccccccccccccc-cccccccccccc
Confidence 5788899999999884 58999999999999999998654 3 45599999999999999986 588999999999
Q ss_pred ccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCC
Q 001142 98 FFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIR 177 (1142)
Q Consensus 98 Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~ 177 (1142)
+++|.+..++. +...+.+..+.++.+.+.... .+.++++|+.|++++|.++
T Consensus 114 l~~~~~~~~~~-~~~~~~~~~l~~~~~~~~~~~----------------------------~~~~~~~L~~L~l~~n~~~ 164 (227)
T d1h6ua2 114 LTSTQITDVTP-LAGLSNLQVLYLDLNQITNIS----------------------------PLAGLTNLQYLSIGNAQVS 164 (227)
T ss_dssp CTTSCCCCCGG-GTTCTTCCEEECCSSCCCCCG----------------------------GGGGCTTCCEEECCSSCCC
T ss_pred cccccccccch-hccccchhhhhchhhhhchhh----------------------------hhccccccccccccccccc
Confidence 99999886653 556677777777655533221 2344566677777777766
Q ss_pred ccCcccCCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeCcC
Q 001142 178 YLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSN 242 (1142)
Q Consensus 178 ~IP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls~ 242 (1142)
.++. ++.+++|+.|+|++|+|+.+|. +..+++|++|+|++|+|+.||+ +.++++|+.|+|++
T Consensus 165 ~~~~-l~~l~~L~~L~Ls~n~l~~l~~-l~~l~~L~~L~Ls~N~lt~i~~-l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 165 DLTP-LANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQISDVSP-LANTSNLFIVTLTN 226 (227)
T ss_dssp CCGG-GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECTTSCCCBCGG-GTTCTTCCEEEEEE
T ss_pred cchh-hcccccceecccCCCccCCChh-hcCCCCCCEEECcCCcCCCCcc-cccCCCCCEEEeeC
Confidence 5433 6777778888888888777754 7777888888888888887763 77778888887763
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.77 E-value=1.3e-18 Score=183.44 Aligned_cols=163 Identities=25% Similarity=0.310 Sum_probs=84.1
Q ss_pred CCccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCC
Q 001142 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKV 147 (1142)
Q Consensus 68 ~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n 147 (1142)
.+|++|++++|.++.++. +..+++|++|+|++|+|+.++. ++++++|+.|++++|++..++
T Consensus 46 ~~L~~L~l~~~~i~~l~~-l~~l~~L~~L~L~~n~i~~l~~-~~~l~~L~~L~l~~n~i~~l~----------------- 106 (210)
T d1h6ta2 46 NSIDQIIANNSDIKSVQG-IQYLPNVTKLFLNGNKLTDIKP-LANLKNLGWLFLDENKVKDLS----------------- 106 (210)
T ss_dssp HTCCEEECTTSCCCCCTT-GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCGG-----------------
T ss_pred cCccEEECcCCCCCCchh-HhhCCCCCEEeCCCccccCccc-cccCccccccccccccccccc-----------------
Confidence 455666666666665542 5556666666666666665542 455555555555555543332
Q ss_pred CCCCCcccchhhhcCCCCCcEEEccCCCCCccCcccCCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCc
Q 001142 148 PPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPS 227 (1142)
Q Consensus 148 ~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~IP~ 227 (1142)
.+.++++|+.|++++|.+..++ .+..+++|+.+++++|.++.++ .+..+++|+.|++++|+++.+++
T Consensus 107 -----------~l~~l~~L~~L~l~~~~~~~~~-~l~~l~~l~~l~~~~n~l~~~~-~~~~l~~L~~l~l~~n~l~~i~~ 173 (210)
T d1h6ta2 107 -----------SLKDLKKLKSLSLEHNGISDIN-GLVHLPQLESLYLGNNKITDIT-VLSRLTKLDTLSLEDNQISDIVP 173 (210)
T ss_dssp -----------GGTTCTTCCEEECTTSCCCCCG-GGGGCTTCCEEECCSSCCCCCG-GGGGCTTCSEEECCSSCCCCCGG
T ss_pred -----------cccccccccccccccccccccc-cccccccccccccccccccccc-ccccccccccccccccccccccc
Confidence 2333444444444444444332 2444455555555555554432 24445555555555555555442
Q ss_pred cccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEcc
Q 001142 228 GLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQ 265 (1142)
Q Consensus 228 ~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls 265 (1142)
+.++++|+.|+|++|+|+.++ .|..+++|+.|+|+
T Consensus 174 -l~~l~~L~~L~Ls~N~i~~l~--~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 174 -LAGLTKLQNLYLSKNHISDLR--ALAGLKNLDVLELF 208 (210)
T ss_dssp -GTTCTTCCEEECCSSCCCBCG--GGTTCTTCSEEEEE
T ss_pred -ccCCCCCCEEECCCCCCCCCh--hhcCCCCCCEEEcc
Confidence 455555555555555555432 35555555555554
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=1.4e-18 Score=185.82 Aligned_cols=216 Identities=20% Similarity=0.124 Sum_probs=158.9
Q ss_pred CCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCcCCcEEEccCCCCCc-Cch-hhcCCCCCCEE
Q 001142 43 DSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLRNLKFFGNEINL-FPS-EVGNLLGLECL 119 (1142)
Q Consensus 43 L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~-~l~~L~~L~~L~Ls~N~L~~-lP~-~l~~L~~L~~L 119 (1142)
.+++++++++|+.+++..+ +++++|+|++|.|+.||. .|.++++|++|+|++|.+.. +|. .|.++++++.|
T Consensus 10 ~~~i~c~~~~l~~iP~~l~------~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l 83 (242)
T d1xwdc1 10 NRVFLCQESKVTEIPSDLP------RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEI 83 (242)
T ss_dssp SSEEEEESCSCSSCCSCSC------SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEE
T ss_pred CCEEEEeCCCCCCcCCCCC------CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccc
Confidence 3578888888875443322 467888888888888875 57788888888888888764 443 46778888888
Q ss_pred EccC-CCCC-CCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCc-ccCCCC-CCCEEEcc
Q 001142 120 QIKI-SSPG-VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP-EIGCLS-NLEQLDLS 195 (1142)
Q Consensus 120 ~Ls~-N~l~-~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~-~l~~L~-~L~~L~Ls 195 (1142)
.+.. |.+. ..+..|..+++|+.|++.+|.+.... ....+..+..|..+...++.+..++. .+..++ .++.|+++
T Consensus 84 ~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~--~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~ 161 (242)
T d1xwdc1 84 RIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLP--DVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLN 161 (242)
T ss_dssp EEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCC--CCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECC
T ss_pred cccccccccccccccccccccccccccchhhhcccc--cccccccccccccccccccccccccccccccccccceeeecc
Confidence 7754 4443 34456788888888888886553221 12234556677777788888887754 555554 78899999
Q ss_pred CCCCCccchhhcCCCCCCEE-EccCCCCCccCcc-ccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccC
Q 001142 196 FNKMKYLPTEICYLKALISL-KVANNKLVELPSG-LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQY 266 (1142)
Q Consensus 196 ~N~L~~lP~~l~~L~~L~~L-~Ls~N~Ls~IP~~-l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~ 266 (1142)
+|+|+.++..+....++..+ ++++|+|+.||.. +.++++|+.|+|++|+|+.+++..|.++++|+.|++.+
T Consensus 162 ~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~ 234 (242)
T d1xwdc1 162 KNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN 234 (242)
T ss_dssp SSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred cccccccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCC
Confidence 99999998777777776655 5788899999876 56699999999999999999887788888888777654
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.76 E-value=3.5e-18 Score=178.39 Aligned_cols=178 Identities=23% Similarity=0.286 Sum_probs=95.1
Q ss_pred EEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEccCC
Q 001142 45 VIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKIS 124 (1142)
Q Consensus 45 ~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N 124 (1142)
.++++.+.+++.++. .. +.+|+.|++++|.|+.++ .+..+++|++|+|++|+|+.+++ +.++++|+.|+++.|
T Consensus 22 ~~~l~~~~~~~~~~~--~~---l~~l~~L~l~~~~i~~l~-~l~~l~nL~~L~Ls~N~l~~~~~-l~~l~~L~~L~l~~n 94 (199)
T d2omxa2 22 KTVLGKTNVTDTVSQ--TD---LDQVTTLQADRLGIKSID-GVEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNN 94 (199)
T ss_dssp HHHTTCSSTTSEECH--HH---HTTCCEEECTTSCCCCCT-TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSS
T ss_pred HHHhCCCCCCCccCH--HH---hcCCCEEECCCCCCCCcc-ccccCCCcCcCccccccccCccc-ccCCccccccccccc
Confidence 344555555554332 12 256666666666666663 35666666677777666666654 666666666666655
Q ss_pred CCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCcccCCCCCCCEEEccCCCCCccch
Q 001142 125 SPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPT 204 (1142)
Q Consensus 125 ~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~lP~ 204 (1142)
.+..++ .+.+++.|+.|++++|.+..++ .+..+++|+.|++++|++..+|
T Consensus 95 ~~~~~~----------------------------~l~~l~~L~~L~l~~~~~~~~~-~~~~l~~L~~L~l~~n~l~~~~- 144 (199)
T d2omxa2 95 QIADIT----------------------------PLANLTNLTGLTLFNNQITDID-PLKNLTNLNRLELSSNTISDIS- 144 (199)
T ss_dssp CCCCCG----------------------------GGTTCTTCSEEECCSSCCCCCG-GGTTCTTCSEEECCSSCCCCCG-
T ss_pred cccccc----------------------------cccccccccccccccccccccc-ccchhhhhHHhhhhhhhhcccc-
Confidence 543333 1333444444444444444332 2444555555555555555443
Q ss_pred hhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEE
Q 001142 205 EICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNL 262 (1142)
Q Consensus 205 ~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L 262 (1142)
.+..+++|+.|++++|+++.++ .+.++++|+.|+|++|+|+.++ .+..+++|+.|
T Consensus 145 ~l~~~~~L~~L~l~~n~l~~l~-~l~~l~~L~~L~ls~N~i~~i~--~l~~L~~L~~L 199 (199)
T d2omxa2 145 ALSGLTSLQQLNFSSNQVTDLK-PLANLTTLERLDISSNKVSDIS--VLAKLTNLESL 199 (199)
T ss_dssp GGTTCTTCSEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCCCG--GGGGCTTCSEE
T ss_pred cccccccccccccccccccCCc-cccCCCCCCEEECCCCCCCCCc--cccCCCCCCcC
Confidence 3445555555555555555554 2555555555555555555542 24555555543
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=1.6e-17 Score=174.89 Aligned_cols=178 Identities=19% Similarity=0.181 Sum_probs=124.5
Q ss_pred CCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEEccCCCC
Q 001142 24 SEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEI 103 (1142)
Q Consensus 24 ~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L 103 (1142)
+..+.++.... ...+.+|+.|++++|+++.... + ..+++|++|+|++|.|+.++. +..+++|++|+|++|+|
T Consensus 31 l~~~~~~~~~~--~~~L~~L~~L~l~~~~i~~l~~--l---~~l~~L~~L~L~~n~i~~l~~-~~~l~~L~~L~l~~n~i 102 (210)
T d1h6ta2 31 LKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--I---QYLPNVTKLFLNGNKLTDIKP-LANLKNLGWLFLDENKV 102 (210)
T ss_dssp TTCSCTTSEEC--HHHHHTCCEEECTTSCCCCCTT--G---GGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCC
T ss_pred hCcCccCCccC--HHHhcCccEEECcCCCCCCchh--H---hhCCCCCEEeCCCccccCccc-cccCccccccccccccc
Confidence 44455544322 2356789999999999987542 3 445999999999999999874 78899999999999999
Q ss_pred CcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCccc
Q 001142 104 NLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEI 183 (1142)
Q Consensus 104 ~~lP~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l 183 (1142)
+.+| .+.++++|+.|++++|....++ .+.+++.|+.++++.|.++.++ .+
T Consensus 103 ~~l~-~l~~l~~L~~L~l~~~~~~~~~----------------------------~l~~l~~l~~l~~~~n~l~~~~-~~ 152 (210)
T d1h6ta2 103 KDLS-SLKDLKKLKSLSLEHNGISDIN----------------------------GLVHLPQLESLYLGNNKITDIT-VL 152 (210)
T ss_dssp CCGG-GGTTCTTCCEEECTTSCCCCCG----------------------------GGGGCTTCCEEECCSSCCCCCG-GG
T ss_pred cccc-cccccccccccccccccccccc----------------------------cccccccccccccccccccccc-cc
Confidence 9998 5888999999999887754332 2344455555666666555432 34
Q ss_pred CCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeCc
Q 001142 184 GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLS 241 (1142)
Q Consensus 184 ~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls 241 (1142)
..+++|+.|++++|+++.++. +.++++|+.|+|++|+|+.|| .+..|++|+.|+|+
T Consensus 153 ~~l~~L~~l~l~~n~l~~i~~-l~~l~~L~~L~Ls~N~i~~l~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 153 SRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISDLR-ALAGLKNLDVLELF 208 (210)
T ss_dssp GGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCBCG-GGTTCTTCSEEEEE
T ss_pred ccccccccccccccccccccc-ccCCCCCCEEECCCCCCCCCh-hhcCCCCCCEEEcc
Confidence 556666666666666666543 566666666666666666665 46666666666665
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.73 E-value=2.4e-16 Score=175.68 Aligned_cols=233 Identities=23% Similarity=0.204 Sum_probs=163.5
Q ss_pred CCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEE
Q 001142 41 DDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQ 120 (1142)
Q Consensus 41 ~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~ 120 (1142)
.++++|||++|+|+. +|+.+ ++|++|+|++|+|++||..+ .+|+.|++++|+++.|+.- .+.|++|+
T Consensus 38 ~~l~~LdLs~~~L~~-lp~~~------~~L~~L~Ls~N~l~~lp~~~---~~L~~L~l~~n~l~~l~~l---p~~L~~L~ 104 (353)
T d1jl5a_ 38 RQAHELELNNLGLSS-LPELP------PHLESLVASCNSLTELPELP---QSLKSLLVDNNNLKALSDL---PPLLEYLG 104 (353)
T ss_dssp HTCSEEECTTSCCSC-CCSCC------TTCSEEECCSSCCSSCCCCC---TTCCEEECCSSCCSCCCSC---CTTCCEEE
T ss_pred cCCCEEEeCCCCCCC-CCCCC------CCCCEEECCCCCCcccccch---hhhhhhhhhhcccchhhhh---cccccccc
Confidence 368999999999986 45432 68999999999999999764 4789999999999988742 24699999
Q ss_pred ccCCCCCCCcccccCCCCCCEEECCCCCCCCCccc---------------chhhhcCCCCCcEEEccCCCCCccCc----
Q 001142 121 IKISSPGVNGFALNKLKGLKELELSKVPPRPSVLT---------------LLSEIAGLKCLTKLSVCHFSIRYLPP---- 181 (1142)
Q Consensus 121 Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~---------------lp~~l~~L~~L~~L~Ls~N~L~~IP~---- 181 (1142)
+++|.+..+|. +..+++|+.|+++++.+...... .+..+..++.++.|.+.+|.+..++.
T Consensus 105 L~~n~l~~lp~-~~~l~~L~~L~l~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~ 183 (353)
T d1jl5a_ 105 VSNNQLEKLPE-LQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLS 183 (353)
T ss_dssp CCSSCCSSCCC-CTTCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCCCCTT
T ss_pred ccccccccccc-hhhhccceeeccccccccccccccccccchhhccccccccccccccccceeccccccccccccccccc
Confidence 99999988885 67899999999998765432211 12335667788888888887654331
Q ss_pred ---------------ccCCCCCCCEEEccCCCCCccchhhcC-----------------CCCCCEEEccCCCCCcc---C
Q 001142 182 ---------------EIGCLSNLEQLDLSFNKMKYLPTEICY-----------------LKALISLKVANNKLVEL---P 226 (1142)
Q Consensus 182 ---------------~l~~L~~L~~L~Ls~N~L~~lP~~l~~-----------------L~~L~~L~Ls~N~Ls~I---P 226 (1142)
.+..++.|+.|++++|.+..+|..... ...+..+++..|.+..+ |
T Consensus 184 ~~~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~l~ 263 (353)
T d1jl5a_ 184 LESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELP 263 (353)
T ss_dssp CCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCSCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSEESCCC
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 245577889999999888766543221 12344444444443322 1
Q ss_pred cc--------------ccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccCCCCCCCCCCCchhh-ccCCCCCCCCC
Q 001142 227 SG--------------LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC-CNLEGNGKDSS 291 (1142)
Q Consensus 227 ~~--------------l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~-~~l~~n~l~~~ 291 (1142)
.. ...+++|++|+|++|+|+.++. .+++|+.|+|++|+|+.+.++|..+. +.++.|.+...
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~lp~----~~~~L~~L~L~~N~L~~l~~~~~~L~~L~L~~N~L~~l 339 (353)
T d1jl5a_ 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIELPA----LPPRLERLIASFNHLAEVPELPQNLKQLHVEYNPLREF 339 (353)
T ss_dssp TTCCEEECCSSCCSEECCCCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSSC
T ss_pred chhcccccccCccccccccCCCCCEEECCCCccCcccc----ccCCCCEEECCCCcCCccccccCCCCEEECcCCcCCCC
Confidence 11 1124689999999999997654 36789999999999987544443222 55555555443
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=3e-17 Score=171.14 Aligned_cols=128 Identities=23% Similarity=0.358 Sum_probs=106.1
Q ss_pred cCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCcccCCCCCCCEEEccCCCCCccchhhcCCCCCC
Q 001142 134 NKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALI 213 (1142)
Q Consensus 134 ~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~ 213 (1142)
..+++|++|++++|.+.. ++ .+.++++|+.|++++|.+..+|. +..+++|+.|++++|.+..++ .+..+++|+
T Consensus 59 ~~l~nL~~L~Ls~N~l~~----~~-~l~~l~~L~~L~l~~n~~~~~~~-l~~l~~L~~L~l~~~~~~~~~-~~~~l~~L~ 131 (199)
T d2omxa2 59 EYLNNLTQINFSNNQLTD----IT-PLKNLTKLVDILMNNNQIADITP-LANLTNLTGLTLFNNQITDID-PLKNLTNLN 131 (199)
T ss_dssp GGCTTCCEEECCSSCCCC----CG-GGTTCTTCCEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCCCCG-GGTTCTTCS
T ss_pred ccCCCcCcCccccccccC----cc-cccCCcccccccccccccccccc-ccccccccccccccccccccc-ccchhhhhH
Confidence 344455555555543322 22 26788899999999999998864 889999999999999998774 478899999
Q ss_pred EEEccCCCCCccCccccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccCCCCCC
Q 001142 214 SLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 214 ~L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1142)
.|++++|++..+| .+..+++|+.|++++|+++++++ +.++++|+.|+|++|+++.
T Consensus 132 ~L~l~~n~l~~~~-~l~~~~~L~~L~l~~n~l~~l~~--l~~l~~L~~L~ls~N~i~~ 186 (199)
T d2omxa2 132 RLELSSNTISDIS-ALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKVSD 186 (199)
T ss_dssp EEECCSSCCCCCG-GGTTCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred Hhhhhhhhhcccc-cccccccccccccccccccCCcc--ccCCCCCCEEECCCCCCCC
Confidence 9999999999886 58889999999999999999764 8999999999999999987
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.71 E-value=5.2e-17 Score=173.45 Aligned_cols=201 Identities=16% Similarity=0.168 Sum_probs=167.3
Q ss_pred cEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchh-hcCCCCCCEEEccCCCCCC-C-cccccCCCCCCEEECCCC
Q 001142 71 EGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSE-VGNLLGLECLQIKISSPGV-N-GFALNKLKGLKELELSKV 147 (1142)
Q Consensus 71 ~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~-l~~L~~L~~L~Ls~N~l~~-~-~~~~~~L~~L~~L~Ls~n 147 (1142)
+.++.+++.|+++|..+. +++++|+|++|+|+.+|.. |.++++|++|+|++|.+.. + +..|..++++++|.+..+
T Consensus 11 ~~i~c~~~~l~~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~ 88 (242)
T d1xwdc1 11 RVFLCQESKVTEIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88 (242)
T ss_dssp SEEEEESCSCSSCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECC
T ss_pred CEEEEeCCCCCCcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccc
Confidence 689999999999998775 4899999999999999875 7899999999999998543 3 457899999999988752
Q ss_pred CCCCCcccchhhhcCCCCCcEEEccCCCCCccCc--ccCCCCCCCEEEccCCCCCccc-hhhcCCC-CCCEEEccCCCCC
Q 001142 148 PPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP--EIGCLSNLEQLDLSFNKMKYLP-TEICYLK-ALISLKVANNKLV 223 (1142)
Q Consensus 148 ~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~--~l~~L~~L~~L~Ls~N~L~~lP-~~l~~L~-~L~~L~Ls~N~Ls 223 (1142)
++.....+..|.++++|+.|++++|.+..+|. .+..+..|..+..+++.+..++ ..+..++ .++.|++++|+|+
T Consensus 89 --n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~ 166 (242)
T d1xwdc1 89 --NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 166 (242)
T ss_dssp --TTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred --ccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccc
Confidence 24555556778999999999999999987654 3456677777888889999885 4555554 7999999999999
Q ss_pred ccCccccCCCCCCEE-eCcCCcCCCCCcccccCCCCCCEEEccCCCCCCCCCCCch
Q 001142 224 ELPSGLYLLQRLENL-DLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSW 278 (1142)
Q Consensus 224 ~IP~~l~~L~~L~~L-~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~ 278 (1142)
.|+..+++..++..+ ++++|+|+.+++..|.++++|+.|+|++|+|+. +|.+
T Consensus 167 ~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~---l~~~ 219 (242)
T d1xwdc1 167 EIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHS---LPSY 219 (242)
T ss_dssp EECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCC---CCSS
T ss_pred ccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCc---cCHH
Confidence 999888887776655 678899999988889999999999999999986 6644
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.66 E-value=5.9e-17 Score=167.96 Aligned_cols=171 Identities=17% Similarity=0.117 Sum_probs=118.6
Q ss_pred ccEEEeecCCCCccCccccCCcCCcEEEccCCCCCc-Cc-hhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCC
Q 001142 70 VEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINL-FP-SEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKV 147 (1142)
Q Consensus 70 L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~-lP-~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n 147 (1142)
.+.++.++|+|++||..+. +++++|+|++|+|+. ++ ..|.++++|+.|+|++|.+..+
T Consensus 10 ~~~v~Cs~~~L~~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~------------------ 69 (192)
T d1w8aa_ 10 GTTVDCTGRGLKEIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGI------------------ 69 (192)
T ss_dssp TTEEECTTSCCSSCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCB------------------
T ss_pred CCEEEEeCCCcCccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccc------------------
Confidence 4577888888888887664 477888888888863 43 3355666666666666553332
Q ss_pred CCCCCcccchhhhcCCCCCcEEEccCCCCCccCc-ccCCCCCCCEEEccCCCCCccc-hhhcCCCCCCEEEccCCCCCcc
Q 001142 148 PPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFNKMKYLP-TEICYLKALISLKVANNKLVEL 225 (1142)
Q Consensus 148 ~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~Ls~N~L~~lP-~~l~~L~~L~~L~Ls~N~Ls~I 225 (1142)
.+..|..+++|+.|+|++|+|+.||+ .|.++++|++|+|++|+|+.|| ..|..+++|++|+|++|.+...
T Consensus 70 --------~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~ 141 (192)
T d1w8aa_ 70 --------EPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp --------CTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred --------cccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccc
Confidence 23456677778888888888887755 5778888888888888888875 4577788888888888888744
Q ss_pred CccccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccCCCCCC
Q 001142 226 PSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 226 P~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1142)
+....-...|+.+.+..|.++...|. .+..++.++|+.|.|.|
T Consensus 142 ~~~~~~~~~l~~~~l~~~~~~c~~p~---~l~~~~l~~L~~n~l~C 184 (192)
T d1w8aa_ 142 CHLAWFAEWLRKKSLNGGAARCGAPS---KVRDVQIKDLPHSEFKC 184 (192)
T ss_dssp GGGHHHHHHHHHHCCSGGGCBBCSST---TTTTSBGGGSCTTTCCC
T ss_pred cchHHHhhhhhhhcccCCCeEeCCCh---hhcCCEeeecCHhhCcC
Confidence 32211123356667777877765553 34566777888888877
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.62 E-value=2.7e-16 Score=162.91 Aligned_cols=174 Identities=17% Similarity=0.166 Sum_probs=132.5
Q ss_pred CCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCc-cC-ccccCCcCCcEEEccCCCCCcCc-hhhcCCCCCCE
Q 001142 42 DDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNL-IP-KSVGRYEKLRNLKFFGNEINLFP-SEVGNLLGLEC 118 (1142)
Q Consensus 42 ~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~-iP-~~l~~L~~L~~L~Ls~N~L~~lP-~~l~~L~~L~~ 118 (1142)
..+++|+++|+|+.+++..+ +++++|+|++|.|+. ++ ..|.++++|+.|+|++|+|..++ ..+..+++|+.
T Consensus 9 ~~~~v~Cs~~~L~~iP~~lp------~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~ 82 (192)
T d1w8aa_ 9 EGTTVDCTGRGLKEIPRDIP------LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQE 82 (192)
T ss_dssp ETTEEECTTSCCSSCCSCCC------TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCE
T ss_pred cCCEEEEeCCCcCccCCCCC------CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccce
Confidence 35689999999997654322 589999999999985 54 46889999999999999999765 55777888998
Q ss_pred EEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCc-ccCCCCCCCEEEccCC
Q 001142 119 LQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFN 197 (1142)
Q Consensus 119 L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~Ls~N 197 (1142)
|+|++|++..++ |..|.++++|+.|+|++|+|+.||+ .|..+++|++|+|++|
T Consensus 83 L~Ls~N~l~~l~--------------------------~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N 136 (192)
T d1w8aa_ 83 LQLGENKIKEIS--------------------------NKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136 (192)
T ss_dssp EECCSCCCCEEC--------------------------SSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTC
T ss_pred eeeccccccccC--------------------------HHHHhCCCcccccccCCccccccCHHHhcCCccccccccccc
Confidence 888888755443 3356778888899999999998865 5788999999999999
Q ss_pred CCCccchhhcCCCCCCEEEccCCCCC-ccCccccCCCCCCEEeCcCCcCCCCCc
Q 001142 198 KMKYLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRLENLDLSNNRLTSLGS 250 (1142)
Q Consensus 198 ~L~~lP~~l~~L~~L~~L~Ls~N~Ls-~IP~~l~~L~~L~~L~Ls~N~Ls~~~p 250 (1142)
.+...+....-...|+.+.+..|.++ ..|.. +..++.++|+.|.|+-..+
T Consensus 137 ~~~~~~~~~~~~~~l~~~~l~~~~~~c~~p~~---l~~~~l~~L~~n~l~C~~~ 187 (192)
T d1w8aa_ 137 PFNCNCHLAWFAEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEFKCSSE 187 (192)
T ss_dssp CBCCSGGGHHHHHHHHHHCCSGGGCBBCSSTT---TTTSBGGGSCTTTCCCCCC
T ss_pred ccccccchHHHhhhhhhhcccCCCeEeCCChh---hcCCEeeecCHhhCcCCCC
Confidence 98844322211234566677788887 66754 4567778999999876544
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.57 E-value=4.8e-15 Score=142.93 Aligned_cols=110 Identities=31% Similarity=0.362 Sum_probs=94.7
Q ss_pred cEEEccCCCCCccCcccCCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeCcCCcCC
Q 001142 167 TKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLT 246 (1142)
Q Consensus 167 ~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~L~Ls~N~Ls 246 (1142)
++|+|++|+|+.+|. +..+++|++|+|++|+|+.+|..++.+++|+.|+|++|+|+.+| .+..+++|+.|++++|+|+
T Consensus 1 R~L~Ls~n~l~~l~~-l~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~~l~-~~~~l~~L~~L~l~~N~i~ 78 (124)
T d1dcea3 1 RVLHLAHKDLTVLCH-LEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD-GVANLPRLQELLLCNNRLQ 78 (124)
T ss_dssp SEEECTTSCCSSCCC-GGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCCCG-GGTTCSSCCEEECCSSCCC
T ss_pred CEEEcCCCCCCCCcc-cccCCCCCEEECCCCccCcchhhhhhhhcccccccccccccccC-ccccccccCeEECCCCccC
Confidence 478999999998864 78899999999999999999988999999999999999999887 4888999999999999999
Q ss_pred CCCc-ccccCCCCCCEEEccCCCCCCCCCCCch
Q 001142 247 SLGS-LDLCLMHNLQNLNLQYNKLLSYCQVPSW 278 (1142)
Q Consensus 247 ~~~p-~~l~~L~~L~~L~Ls~N~L~~~~~iP~~ 278 (1142)
.++. ..+..+++|+.|++++|+++....++..
T Consensus 79 ~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~ 111 (124)
T d1dcea3 79 QSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQER 111 (124)
T ss_dssp SSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTH
T ss_pred CCCCchhhcCCCCCCEEECCCCcCCcCccHHHH
Confidence 8764 4688899999999999999875444433
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.50 E-value=9.1e-15 Score=147.55 Aligned_cols=125 Identities=19% Similarity=0.187 Sum_probs=62.7
Q ss_pred ccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCC
Q 001142 87 VGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCL 166 (1142)
Q Consensus 87 l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~~L~~L 166 (1142)
+.++.+|++|+|++|+|+.||..+..+++|+.|+|++|.+..++ .|..+++|
T Consensus 14 ~~n~~~lr~L~L~~n~I~~i~~~~~~l~~L~~L~Ls~N~i~~l~----------------------------~~~~l~~L 65 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLD----------------------------GFPLLRRL 65 (162)
T ss_dssp EECTTSCEEEECTTSCCCSCCCGGGGTTCCSEEECCSSCCCEEC----------------------------CCCCCSSC
T ss_pred ccCcCcCcEEECCCCCCCccCccccccccCCEEECCCCCCCccC----------------------------CcccCcch
Confidence 33445566666666666655543344444444444444322211 12334455
Q ss_pred cEEEccCCCCCccCccc-CCCCCCCEEEccCCCCCccch--hhcCCCCCCEEEccCCCCCccCc----cccCCCCCCEEe
Q 001142 167 TKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPT--EICYLKALISLKVANNKLVELPS----GLYLLQRLENLD 239 (1142)
Q Consensus 167 ~~L~Ls~N~L~~IP~~l-~~L~~L~~L~Ls~N~L~~lP~--~l~~L~~L~~L~Ls~N~Ls~IP~----~l~~L~~L~~L~ 239 (1142)
+.|++++|+|+.+|..+ ..+++|+.|+|++|+|+.++. .+..+++|+.|+|++|.++.+|. .+..+++|+.||
T Consensus 66 ~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 66 KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp CEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred hhhhcccccccCCCccccccccccccceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 55555555555554432 345555555555555555542 44555555555555555555442 234455555544
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.48 E-value=5.2e-14 Score=135.55 Aligned_cols=99 Identities=20% Similarity=0.128 Sum_probs=70.7
Q ss_pred CEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEccC
Q 001142 44 SVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKI 123 (1142)
Q Consensus 44 ~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~ 123 (1142)
++|||++|+|+.. +. + +++++|++|+|++|.|+.+|+.|+.+++|++|+|++|+|+.+|. +.++++|+.|++++
T Consensus 1 R~L~Ls~n~l~~l-~~-l---~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~~l~~-~~~l~~L~~L~l~~ 74 (124)
T d1dcea3 1 RVLHLAHKDLTVL-CH-L---EQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG-VANLPRLQELLLCN 74 (124)
T ss_dssp SEEECTTSCCSSC-CC-G---GGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCCCGG-GTTCSSCCEEECCS
T ss_pred CEEEcCCCCCCCC-cc-c---ccCCCCCEEECCCCccCcchhhhhhhhcccccccccccccccCc-cccccccCeEECCC
Confidence 5788888888754 22 3 34488888888888888888888888888888888888888864 77888888888888
Q ss_pred CCCCCCcc--cccCCCCCCEEECCCCC
Q 001142 124 SSPGVNGF--ALNKLKGLKELELSKVP 148 (1142)
Q Consensus 124 N~l~~~~~--~~~~L~~L~~L~Ls~n~ 148 (1142)
|.+..++. .+..+++|+.|++++|+
T Consensus 75 N~i~~~~~~~~l~~~~~L~~L~l~~N~ 101 (124)
T d1dcea3 75 NRLQQSAAIQPLVSCPRLVLLNLQGNS 101 (124)
T ss_dssp SCCCSSSTTGGGGGCTTCCEEECTTSG
T ss_pred CccCCCCCchhhcCCCCCCEEECCCCc
Confidence 87665542 34444444444444433
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.47 E-value=8.1e-15 Score=164.89 Aligned_cols=236 Identities=17% Similarity=0.134 Sum_probs=173.5
Q ss_pred CCCCCCCCCEEEccCCCCCCCCccccc-CCCCCCCccEEEeecCCCCcc----C-------ccccCCcCCcEEEccCCCC
Q 001142 36 SVNDDDDDSVIDVSGKTVDFPLIESYG-NRGGDNSVEGLYLYKNVLNLI----P-------KSVGRYEKLRNLKFFGNEI 103 (1142)
Q Consensus 36 ~f~~l~~L~~LdLs~N~L~~~~p~~~~-~l~~L~~L~~L~Ls~N~Lt~i----P-------~~l~~L~~L~~L~Ls~N~L 103 (1142)
.+.....|+.|+|++|.|+..-...++ .+...++|+.|+|+++.+..+ | ..+..+++|+.|+|++|.|
T Consensus 26 ~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i 105 (344)
T d2ca6a1 26 VLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAF 105 (344)
T ss_dssp HHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCC
T ss_pred HHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccccccc
Confidence 355578999999999988654333332 345668999999998866533 2 2345678899999999998
Q ss_pred Cc-----CchhhcCCCCCCEEEccCCCCCCCcc--------------cccCCCCCCEEECCCCCCCCCc-ccchhhhcCC
Q 001142 104 NL-----FPSEVGNLLGLECLQIKISSPGVNGF--------------ALNKLKGLKELELSKVPPRPSV-LTLLSEIAGL 163 (1142)
Q Consensus 104 ~~-----lP~~l~~L~~L~~L~Ls~N~l~~~~~--------------~~~~L~~L~~L~Ls~n~~n~~~-~~lp~~l~~L 163 (1142)
+. +...+...++|+.|++++|.++.... .......|+.|.+++|.+.... ..+...+...
T Consensus 106 ~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~ 185 (344)
T d2ca6a1 106 GPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSH 185 (344)
T ss_dssp CTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHC
T ss_pred ccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhh
Confidence 73 45556678999999999987543211 1235678999999997664332 2344556778
Q ss_pred CCCcEEEccCCCCCc------cCcccCCCCCCCEEEccCCCCC-----ccchhhcCCCCCCEEEccCCCCCc-----cCc
Q 001142 164 KCLTKLSVCHFSIRY------LPPEIGCLSNLEQLDLSFNKMK-----YLPTEICYLKALISLKVANNKLVE-----LPS 227 (1142)
Q Consensus 164 ~~L~~L~Ls~N~L~~------IP~~l~~L~~L~~L~Ls~N~L~-----~lP~~l~~L~~L~~L~Ls~N~Ls~-----IP~ 227 (1142)
+.|+.|+|++|+|+. +...+..+++|+.|+|++|.|+ .+...+..+++|++|+|++|.|+. |-.
T Consensus 186 ~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~ 265 (344)
T d2ca6a1 186 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVD 265 (344)
T ss_dssp TTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHH
T ss_pred hhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHH
Confidence 899999999999873 2345677899999999999987 255677889999999999999983 223
Q ss_pred cccC--CCCCCEEeCcCCcCCCCC----cccc-cCCCCCCEEEccCCCCCC
Q 001142 228 GLYL--LQRLENLDLSNNRLTSLG----SLDL-CLMHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 228 ~l~~--L~~L~~L~Ls~N~Ls~~~----p~~l-~~L~~L~~L~Ls~N~L~~ 271 (1142)
.+.. ...|+.|+|++|+|+... ...+ .++++|+.|+|++|++..
T Consensus 266 ~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 266 AFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp HHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred HhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 3333 357999999999987532 1123 257899999999999976
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.42 E-value=1.2e-13 Score=139.31 Aligned_cols=111 Identities=25% Similarity=0.317 Sum_probs=71.7
Q ss_pred hcCCCCCcEEEccCCCCCccCcccCCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCcccc-CCCCCCEE
Q 001142 160 IAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLY-LLQRLENL 238 (1142)
Q Consensus 160 l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~-~L~~L~~L 238 (1142)
+.++..|+.|+|++|+|+.||..+..+++|+.|+|++|+|+.++ .|..+++|+.|+|++|+|+.+|+.+. .+++|+.|
T Consensus 14 ~~n~~~lr~L~L~~n~I~~i~~~~~~l~~L~~L~Ls~N~i~~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L 92 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL 92 (162)
T ss_dssp EECTTSCEEEECTTSCCCSCCCGGGGTTCCSEEECCSSCCCEEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred ccCcCcCcEEECCCCCCCccCccccccccCCEEECCCCCCCccC-CcccCcchhhhhcccccccCCCccccccccccccc
Confidence 34555666677777777766655556666777777777776663 36666677777777777776665543 46667777
Q ss_pred eCcCCcCCCCCc-ccccCCCCCCEEEccCCCCCC
Q 001142 239 DLSNNRLTSLGS-LDLCLMHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 239 ~Ls~N~Ls~~~p-~~l~~L~~L~~L~Ls~N~L~~ 271 (1142)
+|++|+|+.+.. ..+..+++|+.|++++|+++.
T Consensus 93 ~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~ 126 (162)
T d1a9na_ 93 ILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN 126 (162)
T ss_dssp ECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGG
T ss_pred eeccccccccccccccccccccchhhcCCCcccc
Confidence 777777665543 345666677777777776654
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.41 E-value=3.6e-13 Score=134.75 Aligned_cols=120 Identities=21% Similarity=0.151 Sum_probs=103.6
Q ss_pred CCCCCcEEEccCCCCCccCcccCCCCCCCEEEccCC-CCCccc-hhhcCCCCCCEEEccCCCCCccC-ccccCCCCCCEE
Q 001142 162 GLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFN-KMKYLP-TEICYLKALISLKVANNKLVELP-SGLYLLQRLENL 238 (1142)
Q Consensus 162 ~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N-~L~~lP-~~l~~L~~L~~L~Ls~N~Ls~IP-~~l~~L~~L~~L 238 (1142)
.+.....++.+++.+..+|..+..+++|+.|+|++| .|+.|+ ..|.++++|+.|+|++|+|+.|+ ..|..+++|+.|
T Consensus 6 ~c~~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L 85 (156)
T d2ifga3 6 CPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRL 85 (156)
T ss_dssp CCSSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEE
T ss_pred CcCCCCeEEecCCCCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccce
Confidence 344566789999999999999999999999999876 599996 56899999999999999999995 557789999999
Q ss_pred eCcCCcCCCCCcccccCCCCCCEEEccCCCCCCCCCCCchhhcc
Q 001142 239 DLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCN 282 (1142)
Q Consensus 239 ~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~ 282 (1142)
+|++|+|+.+++..|..+ +|+.|+|++|+|.|.|.+.+...|.
T Consensus 86 ~Ls~N~l~~l~~~~~~~~-~l~~L~L~~Np~~C~C~~~~l~~~~ 128 (156)
T d2ifga3 86 NLSFNALESLSWKTVQGL-SLQELVLSGNPLHCSCALRWLQRWE 128 (156)
T ss_dssp ECCSSCCSCCCSTTTCSC-CCCEEECCSSCCCCCGGGHHHHHHH
T ss_pred eccCCCCcccChhhhccc-cccccccCCCcccCCchHHHHHHHH
Confidence 999999999998777655 7999999999999999876655554
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.38 E-value=1.7e-14 Score=165.81 Aligned_cols=85 Identities=26% Similarity=0.239 Sum_probs=50.7
Q ss_pred CCCCEEEccCCCCCcc-----chhhcCCCCCCEEEccCCCCC-----ccCccccC-CCCCCEEeCcCCcCCCC----Ccc
Q 001142 187 SNLEQLDLSFNKMKYL-----PTEICYLKALISLKVANNKLV-----ELPSGLYL-LQRLENLDLSNNRLTSL----GSL 251 (1142)
Q Consensus 187 ~~L~~L~Ls~N~L~~l-----P~~l~~L~~L~~L~Ls~N~Ls-----~IP~~l~~-L~~L~~L~Ls~N~Ls~~----~p~ 251 (1142)
..|+.+++++|.++.. ...+...++|++|+|++|+|+ .++..+.. .+.|+.|+|++|.|+.. +..
T Consensus 312 ~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~ 391 (460)
T d1z7xw1 312 CQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAA 391 (460)
T ss_dssp CCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHH
T ss_pred cccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHH
Confidence 4566666666666522 223344556777777777775 24444442 45677777777777642 222
Q ss_pred cccCCCCCCEEEccCCCCCC
Q 001142 252 DLCLMHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 252 ~l~~L~~L~~L~Ls~N~L~~ 271 (1142)
.+..+++|+.|+|++|+++.
T Consensus 392 ~l~~~~~L~~L~Ls~N~i~~ 411 (460)
T d1z7xw1 392 TLLANHSLRELDLSNNCLGD 411 (460)
T ss_dssp HHHHCCCCCEEECCSSSCCH
T ss_pred HHhcCCCCCEEECCCCcCCH
Confidence 34456777777777777653
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.38 E-value=1.2e-13 Score=151.51 Aligned_cols=177 Identities=17% Similarity=0.151 Sum_probs=85.9
Q ss_pred CCcCCcEEEccCCCCC--cCchhhcCCCCCCEEEccCCCCCC-CcccccCCCCCCEEECCCCCCCCCcc-cchhhhcCCC
Q 001142 89 RYEKLRNLKFFGNEIN--LFPSEVGNLLGLECLQIKISSPGV-NGFALNKLKGLKELELSKVPPRPSVL-TLLSEIAGLK 164 (1142)
Q Consensus 89 ~L~~L~~L~Ls~N~L~--~lP~~l~~L~~L~~L~Ls~N~l~~-~~~~~~~L~~L~~L~Ls~n~~n~~~~-~lp~~l~~L~ 164 (1142)
...+|++|||+++.++ .++.-+.++++|++|+|+++.+.. ....+..+++|++|+++++.. ... .+..-+.+++
T Consensus 44 ~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~--itd~~l~~l~~~~~ 121 (284)
T d2astb2 44 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSG--FSEFALQTLLSSCS 121 (284)
T ss_dssp CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBS--CCHHHHHHHHHHCT
T ss_pred cCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCcccccccc--ccccccchhhHHHH
Confidence 3345555555555554 233334455555555555554321 123344555555555555211 110 1111123455
Q ss_pred CCcEEEccCC-CCC--ccCcccC-CCCCCCEEEccCC--CCC--ccchhhcCCCCCCEEEccCC-CCC-ccCccccCCCC
Q 001142 165 CLTKLSVCHF-SIR--YLPPEIG-CLSNLEQLDLSFN--KMK--YLPTEICYLKALISLKVANN-KLV-ELPSGLYLLQR 234 (1142)
Q Consensus 165 ~L~~L~Ls~N-~L~--~IP~~l~-~L~~L~~L~Ls~N--~L~--~lP~~l~~L~~L~~L~Ls~N-~Ls-~IP~~l~~L~~ 234 (1142)
+|+.|+++++ .++ .++..+. ..++|+.|+|++. .++ .+..-+.++++|+.|+|++| .++ ..+..+.++++
T Consensus 122 ~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~ 201 (284)
T d2astb2 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNY 201 (284)
T ss_dssp TCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTT
T ss_pred hccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCc
Confidence 6666666653 333 1222222 2345666666543 333 23333345566666666654 344 34455556666
Q ss_pred CCEEeCcC-CcCCCCCcccccCCCCCCEEEccCC
Q 001142 235 LENLDLSN-NRLTSLGSLDLCLMHNLQNLNLQYN 267 (1142)
Q Consensus 235 L~~L~Ls~-N~Ls~~~p~~l~~L~~L~~L~Ls~N 267 (1142)
|+.|+|++ +.++......++++++|+.|+++++
T Consensus 202 L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 202 LQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp CCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred CCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 66666666 3455444445556666666666654
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.36 E-value=5.4e-15 Score=154.14 Aligned_cols=81 Identities=31% Similarity=0.308 Sum_probs=33.4
Q ss_pred CCcEEEccCCCCCccCcccCCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccC--ccccCCCCCCEEeCcC
Q 001142 165 CLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELP--SGLYLLQRLENLDLSN 242 (1142)
Q Consensus 165 ~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~IP--~~l~~L~~L~~L~Ls~ 242 (1142)
+|+.|+|++|.|+.+|..+..+++|++|+|++|+|+.++ .+..+++|+.|+|++|+|+.++ ..+..+++|+.|+|++
T Consensus 71 ~L~~L~Ls~N~i~~i~~~~~~~~~L~~L~l~~N~i~~l~-~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~ 149 (198)
T d1m9la_ 71 NLRILSLGRNLIKKIENLDAVADTLEELWISYNQIASLS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAG 149 (198)
T ss_dssp TCCEEECCEEEECSCSSHHHHHHHCCEEECSEEECCCHH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECS
T ss_pred cccChhhcccccccccccccccccccccccccccccccc-cccccccccccccccchhccccccccccCCCccceeecCC
Confidence 333333333433333332222333444444444444432 2334444444444444444333 2334444444444444
Q ss_pred CcCC
Q 001142 243 NRLT 246 (1142)
Q Consensus 243 N~Ls 246 (1142)
|.++
T Consensus 150 N~l~ 153 (198)
T d1m9la_ 150 NPLY 153 (198)
T ss_dssp SHHH
T ss_pred Cccc
Confidence 4443
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.35 E-value=2.7e-13 Score=152.23 Aligned_cols=233 Identities=15% Similarity=0.117 Sum_probs=172.2
Q ss_pred CCcccccCCCCCCcccC----CCCCCCCCCCCEEEccCCCCCCCC---cc----cccCCCCCCCccEEEeecCCCCc---
Q 001142 17 PIKEKLPSEANKINNEK----NGSVNDDDDDSVIDVSGKTVDFPL---IE----SYGNRGGDNSVEGLYLYKNVLNL--- 82 (1142)
Q Consensus 17 ~~l~~L~~~~N~i~~l~----~~~f~~l~~L~~LdLs~N~L~~~~---p~----~~~~l~~L~~L~~L~Ls~N~Lt~--- 82 (1142)
..++.|.+..|+|.... ...+...++|+.|+|+++.+.... +. .+..+..+++|+.|+|++|.++.
T Consensus 31 ~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~ 110 (344)
T d2ca6a1 31 DSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQ 110 (344)
T ss_dssp SCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTH
T ss_pred CCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccccccccc
Confidence 36788999999885533 235778899999999998765432 11 12233456899999999999984
Q ss_pred --cCccccCCcCCcEEEccCCCCCc-----Cch---------hhcCCCCCCEEEccCCCCCCCc-----ccccCCCCCCE
Q 001142 83 --IPKSVGRYEKLRNLKFFGNEINL-----FPS---------EVGNLLGLECLQIKISSPGVNG-----FALNKLKGLKE 141 (1142)
Q Consensus 83 --iP~~l~~L~~L~~L~Ls~N~L~~-----lP~---------~l~~L~~L~~L~Ls~N~l~~~~-----~~~~~L~~L~~ 141 (1142)
+...+...++|+.|+|++|.|+. +.. .....+.|+.|.+++|.++... ..+...+.|+.
T Consensus 111 ~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~ 190 (344)
T d2ca6a1 111 EPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHT 190 (344)
T ss_dssp HHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCE
T ss_pred cchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhcc
Confidence 34456677899999999999852 111 1245778999999999866433 24567889999
Q ss_pred EECCCCCCCCC--cccchhhhcCCCCCcEEEccCCCCCc-----cCcccCCCCCCCEEEccCCCCCc-----cchhhcC-
Q 001142 142 LELSKVPPRPS--VLTLLSEIAGLKCLTKLSVCHFSIRY-----LPPEIGCLSNLEQLDLSFNKMKY-----LPTEICY- 208 (1142)
Q Consensus 142 L~Ls~n~~n~~--~~~lp~~l~~L~~L~~L~Ls~N~L~~-----IP~~l~~L~~L~~L~Ls~N~L~~-----lP~~l~~- 208 (1142)
|+|++|.+... ...+...+..+++|+.|+|++|.|+. +...+..+++|++|+|++|.|+. +-..+..
T Consensus 191 L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~ 270 (344)
T d2ca6a1 191 VKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKL 270 (344)
T ss_dssp EECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTC
T ss_pred cccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhc
Confidence 99999776432 11234457788999999999999863 44567788999999999999983 2234443
Q ss_pred -CCCCCEEEccCCCCC-----ccCcccc-CCCCCCEEeCcCCcCCCCC
Q 001142 209 -LKALISLKVANNKLV-----ELPSGLY-LLQRLENLDLSNNRLTSLG 249 (1142)
Q Consensus 209 -L~~L~~L~Ls~N~Ls-----~IP~~l~-~L~~L~~L~Ls~N~Ls~~~ 249 (1142)
.+.|+.|+|++|+|+ .+...+. ++++|+.|+|++|+|....
T Consensus 271 ~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~~~ 318 (344)
T d2ca6a1 271 ENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 318 (344)
T ss_dssp SSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred cCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCCcc
Confidence 367999999999997 2455554 5789999999999997643
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.34 E-value=6.1e-13 Score=145.92 Aligned_cols=221 Identities=19% Similarity=0.163 Sum_probs=147.9
Q ss_pred CCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCc--cCccccCCcCCcEEEccCCCCC-cCchhhcCCCCCCEE
Q 001142 43 DSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNL--IPKSVGRYEKLRNLKFFGNEIN-LFPSEVGNLLGLECL 119 (1142)
Q Consensus 43 L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~--iP~~l~~L~~L~~L~Ls~N~L~-~lP~~l~~L~~L~~L 119 (1142)
+..+.++...+...+...+ ...+|++|+|+++.++. ++..+.++++|++|+|+++.++ ..+..++++++|+.|
T Consensus 25 ~~~lrl~~~~~~~~~~~~~----~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L 100 (284)
T d2astb2 25 VIAFRCPRSFMDQPLAEHF----SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRL 100 (284)
T ss_dssp CSEEECTTCEECSCCCSCC----CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEE
T ss_pred ceEeeccccccccchhhhc----cCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCc
Confidence 4556666655554333222 33578999998887763 4555778889999999998887 566778888899999
Q ss_pred EccCCC-CCCCc--ccccCCCCCCEEECCCCCCCCCcccchhhhc-CCCCCcEEEccCC--CCC--ccCcccCCCCCCCE
Q 001142 120 QIKISS-PGVNG--FALNKLKGLKELELSKVPPRPSVLTLLSEIA-GLKCLTKLSVCHF--SIR--YLPPEIGCLSNLEQ 191 (1142)
Q Consensus 120 ~Ls~N~-l~~~~--~~~~~L~~L~~L~Ls~n~~n~~~~~lp~~l~-~L~~L~~L~Ls~N--~L~--~IP~~l~~L~~L~~ 191 (1142)
+|+++. ++..+ .....+++|++|+++++..-. ...+...+. ..++|+.|+++++ .++ .+..-+..+++|+.
T Consensus 101 ~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~-~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~ 179 (284)
T d2astb2 101 NLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFT-EKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVH 179 (284)
T ss_dssp ECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCC-HHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSE
T ss_pred cccccccccccccchhhHHHHhccccccccccccc-cccchhhhcccccccchhhhcccccccccccccccccccccccc
Confidence 998753 54322 234578899999998742111 112222333 3468999999864 344 24333467889999
Q ss_pred EEccCC-CCC-ccchhhcCCCCCCEEEccC-CCCC-ccCccccCCCCCCEEeCcCCcCCCCCcccccCCCCCCEEEccCC
Q 001142 192 LDLSFN-KMK-YLPTEICYLKALISLKVAN-NKLV-ELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYN 267 (1142)
Q Consensus 192 L~Ls~N-~L~-~lP~~l~~L~~L~~L~Ls~-N~Ls-~IP~~l~~L~~L~~L~Ls~N~Ls~~~p~~l~~L~~L~~L~Ls~N 267 (1142)
|+|++| .++ ..+..+..+++|++|+|++ +.++ .....++++++|+.|+++++--.+..+.....+++| .+..+
T Consensus 180 L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~~~d~~l~~l~~~lp~L---~i~~~ 256 (284)
T d2astb2 180 LDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHL---QINCS 256 (284)
T ss_dssp EECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTSSCTTCHHHHHHHSTTS---EESCC
T ss_pred cccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCCCCHHHHHHHHHhCccc---cccCc
Confidence 999986 477 5667888899999999999 4677 445678889999999998872222222122345555 45667
Q ss_pred CCCC
Q 001142 268 KLLS 271 (1142)
Q Consensus 268 ~L~~ 271 (1142)
+++.
T Consensus 257 ~ls~ 260 (284)
T d2astb2 257 HFTT 260 (284)
T ss_dssp CSCC
T ss_pred cCCC
Confidence 7765
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.28 E-value=2.9e-14 Score=148.49 Aligned_cols=125 Identities=20% Similarity=0.147 Sum_probs=69.1
Q ss_pred ccEEEeecC--CCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCC
Q 001142 70 VEGLYLYKN--VLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKV 147 (1142)
Q Consensus 70 L~~L~Ls~N--~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~n 147 (1142)
++.+++..+ .++.+|..|..|++|++|+|++|+|+.++ .|.++++|+.|+|++|.+..++..+.
T Consensus 25 ~~~~~l~~~~~~i~~l~~sl~~L~~L~~L~Ls~n~I~~i~-~l~~l~~L~~L~Ls~N~i~~i~~~~~------------- 90 (198)
T d1m9la_ 25 AEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKIS-SLSGMENLRILSLGRNLIKKIENLDA------------- 90 (198)
T ss_dssp CSCEECCBCCTTCCCCHHHHHHTTTCCEEECSEEEESCCC-CHHHHTTCCEEECCEEEECSCSSHHH-------------
T ss_pred cceeeeecccCchhhhhhHHhcccccceeECcccCCCCcc-cccCCccccChhhccccccccccccc-------------
Confidence 344444443 34455556666666666666666666664 35566666666666655443332221
Q ss_pred CCCCCcccchhhhcCCCCCcEEEccCCCCCccCcccCCCCCCCEEEccCCCCCccc--hhhcCCCCCCEEEccCCCCC
Q 001142 148 PPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLP--TEICYLKALISLKVANNKLV 223 (1142)
Q Consensus 148 ~~n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~lP--~~l~~L~~L~~L~Ls~N~Ls 223 (1142)
.+++|+.|++++|+|+.++ .+..+++|+.|+|++|+|+.++ ..+..+++|+.|+|++|.+.
T Consensus 91 --------------~~~~L~~L~l~~N~i~~l~-~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 91 --------------VADTLEELWISYNQIASLS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp --------------HHHHCCEEECSEEECCCHH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred --------------ccccccccccccccccccc-cccccccccccccccchhccccccccccCCCccceeecCCCccc
Confidence 1234555555555555543 2455556666666666666554 34556666666666666655
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.16 E-value=3.6e-11 Score=119.95 Aligned_cols=60 Identities=25% Similarity=0.355 Sum_probs=24.4
Q ss_pred CCCCcEEEccCCCCCccC-cccCCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCC
Q 001142 163 LKCLTKLSVCHFSIRYLP-PEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKL 222 (1142)
Q Consensus 163 L~~L~~L~Ls~N~L~~IP-~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~L 222 (1142)
+++|+.|+|++|+|+.|+ ..|..+++|++|+|++|+|+++|..+....+|+.|+|++|.+
T Consensus 55 l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~~~l~~L~L~~Np~ 115 (156)
T d2ifga3 55 LGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPL 115 (156)
T ss_dssp CCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCCCCEEECCSSCC
T ss_pred ccccCcceeeccccCCcccccccccccccceeccCCCCcccChhhhccccccccccCCCcc
Confidence 333444444444444332 233444444444444444444443333223344444444444
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.16 E-value=3.2e-12 Score=146.48 Aligned_cols=110 Identities=12% Similarity=0.067 Sum_probs=81.9
Q ss_pred CcccccCCCCCCcccCC-CCCCCCCCCCEEEccCCCCCCCCcccc-cCCCCCCCccEEEeecCCCCc-----cCccccC-
Q 001142 18 IKEKLPSEANKINNEKN-GSVNDDDDDSVIDVSGKTVDFPLIESY-GNRGGDNSVEGLYLYKNVLNL-----IPKSVGR- 89 (1142)
Q Consensus 18 ~l~~L~~~~N~i~~l~~-~~f~~l~~L~~LdLs~N~L~~~~p~~~-~~l~~L~~L~~L~Ls~N~Lt~-----iP~~l~~- 89 (1142)
++++|++..|+|+.... ..+..++++++|+|++|+|+..-...+ ..+..+++|++|+|++|.|+. +...+..
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 57889999999988653 346778999999999999874221111 112345899999999999973 2333332
Q ss_pred CcCCcEEEccCCCCCc-----CchhhcCCCCCCEEEccCCCCC
Q 001142 90 YEKLRNLKFFGNEINL-----FPSEVGNLLGLECLQIKISSPG 127 (1142)
Q Consensus 90 L~~L~~L~Ls~N~L~~-----lP~~l~~L~~L~~L~Ls~N~l~ 127 (1142)
..+|++|+|++|+|+. ++..+..+++|++|+|++|.++
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccch
Confidence 3479999999999973 4667888999999999988754
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.39 E-value=3.4e-09 Score=105.86 Aligned_cols=80 Identities=23% Similarity=0.133 Sum_probs=39.5
Q ss_pred CCCCCCCEEEccCCCCCcc---chhhcCCCCCCEEEccCCCCCccCc-cccCCCCCCEEeCcCCcCCCCCcc-------c
Q 001142 184 GCLSNLEQLDLSFNKMKYL---PTEICYLKALISLKVANNKLVELPS-GLYLLQRLENLDLSNNRLTSLGSL-------D 252 (1142)
Q Consensus 184 ~~L~~L~~L~Ls~N~L~~l---P~~l~~L~~L~~L~Ls~N~Ls~IP~-~l~~L~~L~~L~Ls~N~Ls~~~p~-------~ 252 (1142)
..+++|++|+|++|+|+.+ +..+..+++|+.|+|++|.|+.+++ ......+|+.|+|++|.++..... .
T Consensus 62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i 141 (162)
T d1koha1 62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAI 141 (162)
T ss_dssp HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHH
T ss_pred HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHH
Confidence 3445555555555555533 2334445555555555555555543 112223455556666655544331 1
Q ss_pred ccCCCCCCEEE
Q 001142 253 LCLMHNLQNLN 263 (1142)
Q Consensus 253 l~~L~~L~~L~ 263 (1142)
+..+|+|+.||
T Consensus 142 ~~~~P~L~~LD 152 (162)
T d1koha1 142 RERFPKLLRLD 152 (162)
T ss_dssp HTTSTTCCEET
T ss_pred HHHCCCCCEEC
Confidence 34456666554
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.12 E-value=6.4e-08 Score=96.38 Aligned_cols=103 Identities=25% Similarity=0.168 Sum_probs=77.9
Q ss_pred CcEEEccCCCCCccCcccCCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccC---ccccCCCCCCEEeCcC
Q 001142 166 LTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELP---SGLYLLQRLENLDLSN 242 (1142)
Q Consensus 166 L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~Ls~IP---~~l~~L~~L~~L~Ls~ 242 (1142)
.+.|+++++.. . ..+..+..+..|++.+|.+..++..+..+++|+.|+|++|+|+.++ ..+..+++|+.|+|++
T Consensus 24 ~~~Ldls~l~~--~-~~l~~~~~~~~l~~~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~ 100 (162)
T d1koha1 24 QQALDLKGLRS--D-PDLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSG 100 (162)
T ss_dssp SCCBCCCCCSS--C-TTTTTTTCCCCTTSHHHHHHHHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTT
T ss_pred hCeeecccCCC--C-chhhhccchhhcchhhhHhhhhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCccccccccc
Confidence 44566665542 2 2344455566666666655566666677999999999999999764 4456799999999999
Q ss_pred CcCCCCCcccccCCCCCCEEEccCCCCCC
Q 001142 243 NRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1142)
Q Consensus 243 N~Ls~~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1142)
|+|+.+.+..+.....|+.|+|++|+++.
T Consensus 101 N~i~~l~~l~~l~~~~L~~L~L~~Npl~~ 129 (162)
T d1koha1 101 NELKSERELDKIKGLKLEELWLDGNSLSD 129 (162)
T ss_dssp SCCCCGGGHHHHTTCCCSSCCCTTSTTSS
T ss_pred CccccchhhhhhhccccceeecCCCCcCc
Confidence 99999887666666789999999999986
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.82 E-value=3.1e-05 Score=81.49 Aligned_cols=85 Identities=9% Similarity=0.053 Sum_probs=55.4
Q ss_pred CCcceeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEecCCCC
Q 001142 807 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWL 885 (1142)
Q Consensus 807 ~~y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~g~~~~~~~~ 885 (1142)
+.|+..+..+.++.+.||+....+..+.+|+..-..... .. .+.+|..++..+. +--+.+++++...++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~----~~----~~~~E~~~l~~l~~~vpvP~vl~~~~~~~-- 83 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT----TY----DVEREKDMMLWLEGKLPVPKVLHFERHDG-- 83 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTS----TT----CHHHHHHHHHHHTTTSCCCCEEEEEEETT--
T ss_pred hceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccc----hh----hHHHHHHHHHHHhccCCCCcEEEEEecCC--
Confidence 456777776666667899998777778888753221111 11 1257888887774 444567777665443
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHH
Q 001142 886 PSADGNPEHHLLQSAIFMEYVKGGSVKN 913 (1142)
Q Consensus 886 ~~~~~~~~~~~~~~~LVmEy~~ggSL~~ 913 (1142)
..++||++++|.++.+
T Consensus 84 ------------~~~lv~~~l~G~~~~~ 99 (263)
T d1j7la_ 84 ------------WSNLLMSEADGVLCSE 99 (263)
T ss_dssp ------------EEEEEEECCSSEEHHH
T ss_pred ------------ceEEEEEecccccccc
Confidence 3489999999877644
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.50 E-value=3.6e-05 Score=76.26 Aligned_cols=106 Identities=17% Similarity=0.184 Sum_probs=64.0
Q ss_pred CCCCCcEEEccCC-CCCc-----cCcccCCCCCCCEEEccCCCCC-----ccchhhcCCCCCCEEEccCCCCCc-----c
Q 001142 162 GLKCLTKLSVCHF-SIRY-----LPPEIGCLSNLEQLDLSFNKMK-----YLPTEICYLKALISLKVANNKLVE-----L 225 (1142)
Q Consensus 162 ~L~~L~~L~Ls~N-~L~~-----IP~~l~~L~~L~~L~Ls~N~L~-----~lP~~l~~L~~L~~L~Ls~N~Ls~-----I 225 (1142)
+.+.|+.|+|+++ .++. +-..+...++|+.|+|++|.|. .+-..+...+.|+.|+|++|.|+. |
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l 92 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 92 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence 3456666676653 3441 1223455566777777777776 223445556777778887777762 2
Q ss_pred CccccCCCCCCEEeCcCCcCCCCC-------cccccCCCCCCEEEccCC
Q 001142 226 PSGLYLLQRLENLDLSNNRLTSLG-------SLDLCLMHNLQNLNLQYN 267 (1142)
Q Consensus 226 P~~l~~L~~L~~L~Ls~N~Ls~~~-------p~~l~~L~~L~~L~Ls~N 267 (1142)
-..+...++|+.|+|++|.+..+. ...+..-++|+.|+++.+
T Consensus 93 ~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~ 141 (167)
T d1pgva_ 93 LRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFA 141 (167)
T ss_dssp HHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCC
T ss_pred HHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCC
Confidence 344555667888888877766542 222334567777877665
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.26 E-value=0.0001 Score=72.87 Aligned_cols=65 Identities=14% Similarity=0.136 Sum_probs=28.7
Q ss_pred CCCCCEEEccCC-CCCCC-CcccccCCCCCCCccEEEeecCCCCc-----cCccccCCcCCcEEEccCCCCC
Q 001142 40 DDDDSVIDVSGK-TVDFP-LIESYGNRGGDNSVEGLYLYKNVLNL-----IPKSVGRYEKLRNLKFFGNEIN 104 (1142)
Q Consensus 40 l~~L~~LdLs~N-~L~~~-~p~~~~~l~~L~~L~~L~Ls~N~Lt~-----iP~~l~~L~~L~~L~Ls~N~L~ 104 (1142)
.++|+.|+|+++ .++.. ....+..+...+.|+.|+|++|.|+. +...+...+.|+.|+|++|.|+
T Consensus 14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~ 85 (167)
T d1pgva_ 14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 85 (167)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcc
Confidence 455666666543 34321 11112223333455555555555541 1122333445555555555554
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.84 E-value=0.00021 Score=70.12 Aligned_cols=109 Identities=14% Similarity=0.098 Sum_probs=63.5
Q ss_pred cCCCCCcEEEccC-CCCCc-----cCcccCCCCCCCEEEccCCCCC-----ccchhhcCCCCCCEEEccCCCCC-----c
Q 001142 161 AGLKCLTKLSVCH-FSIRY-----LPPEIGCLSNLEQLDLSFNKMK-----YLPTEICYLKALISLKVANNKLV-----E 224 (1142)
Q Consensus 161 ~~L~~L~~L~Ls~-N~L~~-----IP~~l~~L~~L~~L~Ls~N~L~-----~lP~~l~~L~~L~~L~Ls~N~Ls-----~ 224 (1142)
.+.+.|+.|+|++ +.++. +-..+...++|+.|+|++|.|+ .|-..+...+.|+.|++++|.++ .
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHH
Confidence 4556677777765 34541 2223455667777777777776 12334555677777777777775 2
Q ss_pred cCccccCCCCCCEEeC--cCCcCCCC----CcccccCCCCCCEEEccCCCC
Q 001142 225 LPSGLYLLQRLENLDL--SNNRLTSL----GSLDLCLMHNLQNLNLQYNKL 269 (1142)
Q Consensus 225 IP~~l~~L~~L~~L~L--s~N~Ls~~----~p~~l~~L~~L~~L~Ls~N~L 269 (1142)
|-..+...++|+.++| ++|.+... +...+...++|+.|+++.|..
T Consensus 94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 3355556667776444 45556431 122344667777777766643
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.68 E-value=0.0011 Score=74.38 Aligned_cols=29 Identities=21% Similarity=0.287 Sum_probs=25.0
Q ss_pred CccccCCCCCCeeeccccccCCCCCeEEEeecCCccc
Q 001142 949 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 985 (1142)
Q Consensus 949 gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~~ 985 (1142)
.++|||+.|.|||++.+ .++|+||..|..
T Consensus 224 ~LiHGDl~~gNIlv~~~--------~~~vID~E~a~~ 252 (392)
T d2pula1 224 TLIHGDLHTGSIFASEH--------ETKVIDPEFAFY 252 (392)
T ss_dssp EEECSCCCGGGEEECSS--------CEEECCCTTCEE
T ss_pred ceeccCCcCCceeEcCC--------ceEEechhhccc
Confidence 59999999999999864 489999998853
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=96.52 E-value=0.0025 Score=65.93 Aligned_cols=74 Identities=12% Similarity=0.088 Sum_probs=44.6
Q ss_pred eeecccCc-eEEEEEEECCc-cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC--CCCccceeeeEecCCCCCCC
Q 001142 813 DEAGKSVS-SSLFRCKFGSA-DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR--HSCIVEMYGHKISSKWLPSA 888 (1142)
Q Consensus 813 ~~LG~Gsf-G~Vy~a~~~~~-~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~--HpNIVkl~g~~~~~~~~~~~ 888 (1142)
+.+..|.. +.||+....+. .+.+|+.... . ...+ ..|+..++.+. .-.+.+++++..+.+
T Consensus 16 ~~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~----~---~~~l----~~E~~~l~~L~~~gvpvP~v~~~~~~~~----- 79 (255)
T d1nd4a_ 16 AQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG----A---LNEL----QDEAARLSWLATTGVPCAAVLDVVTEAG----- 79 (255)
T ss_dssp EECSCTTSSCEEEEEECTTSCCEEEEEECSC----T---TSCH----HHHHHHHHHHHTTTCCBCCEEEEEECSS-----
T ss_pred EEcCCcccCCeEEEEEeCCCCEEEEEeCCcc----C---HhHH----HHHHHHHHHHHhcCCCCCceeeeccccc-----
Confidence 34555654 67999987544 4666764321 1 1122 56777777663 333567777765443
Q ss_pred CCCCccccceEEEEEeccCCCCH
Q 001142 889 DGNPEHHLLQSAIFMEYVKGGSV 911 (1142)
Q Consensus 889 ~~~~~~~~~~~~LVmEy~~ggSL 911 (1142)
..++||+|++|.++
T Consensus 80 ---------~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 80 ---------RDWLLLGEVPGQDL 93 (255)
T ss_dssp ---------CEEEEEECCSSEET
T ss_pred ---------ceEEEEEeeecccc
Confidence 24899999987543
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.35 E-value=0.00064 Score=66.55 Aligned_cols=88 Identities=16% Similarity=0.137 Sum_probs=54.0
Q ss_pred hhhcCCCCCcEEEccCCCCCc-----cCcccCCCCCCCEEEccCCCCC-----ccchhhcCCCCCCEEEc--cCCCCC--
Q 001142 158 SEIAGLKCLTKLSVCHFSIRY-----LPPEIGCLSNLEQLDLSFNKMK-----YLPTEICYLKALISLKV--ANNKLV-- 223 (1142)
Q Consensus 158 ~~l~~L~~L~~L~Ls~N~L~~-----IP~~l~~L~~L~~L~Ls~N~L~-----~lP~~l~~L~~L~~L~L--s~N~Ls-- 223 (1142)
..+...++|+.|+|++|.++. |-..+...++|+.|++++|.++ .+-..+...++|+.++| ++|.+.
T Consensus 40 ~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~ 119 (166)
T d1io0a_ 40 EALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNN 119 (166)
T ss_dssp HHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHH
T ss_pred HHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHH
Confidence 344566677777777777652 2223445567777777777775 23355666677776544 456665
Q ss_pred ---ccCccccCCCCCCEEeCcCCcC
Q 001142 224 ---ELPSGLYLLQRLENLDLSNNRL 245 (1142)
Q Consensus 224 ---~IP~~l~~L~~L~~L~Ls~N~L 245 (1142)
.|-..+...++|+.|+|+.|..
T Consensus 120 ~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 120 VEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 2445555677778887776643
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.68 E-value=0.037 Score=58.95 Aligned_cols=36 Identities=17% Similarity=0.054 Sum_probs=25.3
Q ss_pred CCCCCcceeeeecccCceEEEEEEECCccEEEEEEe
Q 001142 804 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRT 839 (1142)
Q Consensus 804 ~~~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAvKi~~ 839 (1142)
+.+....-.+.|..|.--+.|+.+..+..+.+|++.
T Consensus 15 Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~ 50 (316)
T d2ppqa1 15 YDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYE 50 (316)
T ss_dssp BCCCCEEEEEEECC---EEEEEEEESSCCEEEEEEC
T ss_pred CCCCCceEeecCCCCcccCeEEEEECCCcEEEEEcC
Confidence 344555666778889889999999888889999864
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=94.24 E-value=0.037 Score=61.27 Aligned_cols=70 Identities=17% Similarity=0.270 Sum_probs=45.0
Q ss_pred eeeecccCceEEEEEEECC---------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEec
Q 001142 812 CDEAGKSVSSSLFRCKFGS---------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKIS 881 (1142)
Q Consensus 812 ~~~LG~GsfG~Vy~a~~~~---------~~vAvKi~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~g~~~~ 881 (1142)
.+.|+.|-.-.+|++.... ..+.+++.- . ... .. +. .+|..+++.+. +.-..++++++.+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~--~~~--~i-dr----~~E~~i~~~ls~~gl~Pkll~~~~~ 116 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N--PET--ES-HL----VAESVIFTLLSERHLGPKLYGIFSG 116 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S--CCC--HH-HH----HHHHHHHHHHHHTTSSSCEEEEETT
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C--cch--hh-HH----HHHHHHHHHHHhCCCCCeEEEEcCC
Confidence 4678889999999998642 234455532 1 111 11 11 47888888885 5444577777642
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCC
Q 001142 882 SKWLPSADGNPEHHLLQSAIFMEYVKGG 909 (1142)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~LVmEy~~gg 909 (1142)
++||||++|.
T Consensus 117 ------------------g~I~efi~g~ 126 (395)
T d1nw1a_ 117 ------------------GRLEEYIPSR 126 (395)
T ss_dssp ------------------EEEECCCCEE
T ss_pred ------------------ceEEEEeccc
Confidence 7899999864
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=93.71 E-value=0.06 Score=57.84 Aligned_cols=28 Identities=29% Similarity=0.258 Sum_probs=23.1
Q ss_pred CCccccCCCCCCeeeccccccCCCCCeEEEeecCCcc
Q 001142 948 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 984 (1142)
Q Consensus 948 ~gIvHrDLKp~NILld~~~~~~~~~~~vKL~DFGlA~ 984 (1142)
.++||+|+.+.|||++.+ ..++||+-+.
T Consensus 192 ~~liHgDlh~~NvL~~~~---------~~~IDFdd~~ 219 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG---------PMFVDLDDAR 219 (325)
T ss_dssp CEECCSSCSGGGEEESSS---------EEECCCTTCC
T ss_pred ceeecCCCCcccEEEeCC---------ceEEechhcc
Confidence 369999999999999743 4579999875
|